FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Kanno, AI
   Leite, LCD
   Pereira, LR
   de Jesus, MJR
   Andreata-Santos, R
   Alves, RPD
   Durigon, EL
   Ferreira, LCD
   Goncalves, VM
AF Kanno, Alex Issamu
   de Cerqueira Leite, Luciana Cezar
   Pereira, Lennon Ramos
   Rodrigues de Jesus, Monica Josiane
   Andreata-Santos, Robert
   dos Santos Alves, Rubens Prince
   Durigon, Edison Luiz
   de Souza Ferreira, Luis Carlos
   Goncalves, Viviane Maimoni
TI Optimization and scale-up production of Zika virus Delta NS1 in
   Escherichia coli: application of Response Surface Methodology
SO AMB EXPRESS
LA English
DT Article
DE Zika NS1; Serological diagnosis; E; coli; Heterologous protein
   production; Soluble expression; Response Surface Methodology
ID RECOMBINANT PROTEIN EXPRESSION; HUMAN GROWTH-HORMONE;
   STREPTOCOCCUS-PNEUMONIAE; CROSS-REACTIVITY; DENGUE; PURIFICATION;
   OVEREXPRESSION; SPECIFICITY; PRECURSORS; INFECTION
AB Diagnosing Zika virus (ZIKV) infections has been challenging due to the cross-reactivity of induced antibodies with other flavivirus. The concomitant occurrence of ZIKV and Dengue virus (DENV) in endemic regions requires diagnostic tools with the ability to distinguish these two viral infections. Recent studies demonstrated that immunoassays using the C-terminal fragment of ZIKV NS1 antigen (Delta NS1) can be used to discriminate ZIKV from DENV infections. In order to be used in serological tests, the expression/solubility of Delta NS1 and growth of recombinant E. coli strain were optimized by Response Surface Methodology. Temperature, time and IPTG concentration were evaluated. According to the model, the best condition determined in small scale cultures was 21 degrees C for 20 h with 0.7 mM of IPTG, which predicted 7.5 g/L of biomass and 962 mg/L of Delta NS1. These conditions were validated and used in a 6-L batch in the bioreactor, which produced 6.4 g/L of biomass and 500 mg/L of Delta NS1 in 12 h of induction. The serological ELISA test performed with purified Delta NS1 showed low cross-reactivity with antibodies from DENV-infected human subjects. Denaturation of Delta NS1 decreased the detection of anti-ZIKV antibodies, thus indicating the contribution of conformational epitopes and confirming the importance of properly folded Delta NS1 for the specificity of the serological analyses. Obtaining high yields of soluble Delta NS1 supports the viability of an effective serologic diagnostic test capable of differentiating ZIKV from other flavivirus infections.
C1 [Kanno, Alex Issamu; de Cerqueira Leite, Luciana Cezar; Goncalves, Viviane Maimoni] Inst Butantan, Lab Desenvolvimento Vacinas, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
   [Pereira, Lennon Ramos; Rodrigues de Jesus, Monica Josiane; Andreata-Santos, Robert; dos Santos Alves, Rubens Prince; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Lab Desenvolvimento Vacinas, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
   [Durigon, Edison Luiz] Univ Sao Paulo, Lab Virol, Inst Ciencias Biomed, Sao Paulo, SP, Brazil.
RP Goncalves, VM (corresponding author), Inst Butantan, Lab Desenvolvimento Vacinas, Ave Vital Brasil 1500, BR-05503900 Sao Paulo, SP, Brazil.
EM viviane.goncalves@butantan.gov.br
RI Goncalves, Viviane/B-9674-2012
OI Goncalves, Viviane/0000-0002-0980-8116
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/23124-4,
   2016/20045-7, 2014/17595-0]; Fundacao Butantan
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP) under Project 2012/23124-4, 2016/20045-7,
   2014/17595-0 and Fundacao Butantan.
CR Abergel Chantal, 2003, Journal of Structural and Functional Genomics, V4, P141, DOI 10.1023/A:1026177202925
   Amorim JH, 2010, J VIROL METHODS, V167, P186, DOI 10.1016/j.jviromet.2010.04.003
   Bae S, 2005, BIOTECHNOL BIOENG, V90, P20, DOI 10.1002/bit.20325
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Baneyx F, 1999, CURR OPIN BIOTECH, V10, P411, DOI 10.1016/S0958-1669(99)00003-8
   Baneyx F, 2004, NAT BIOTECHNOL, V22, P1399, DOI 10.1038/nbt1029
   Berrow NS, 2006, ACTA CRYSTALLOGR D, V62, P1218, DOI 10.1107/S0907444906031337
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Chua A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005269
   Chura-Chambi RM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211162
   Alves RPD, 2016, CLIN VACCINE IMMUNOL, V23, P460, DOI 10.1128/CVI.00081-16
   Einsfeldt K, 2011, VACCINE, V29, P7136, DOI 10.1016/j.vaccine.2011.05.073
   Emamipour N, 2019, APPL MICROBIOL BIOT, V103, P3393, DOI 10.1007/s00253-019-09719-w
   Estofolete CF, 2016, J CLIN VIROL, V81, P25, DOI 10.1016/j.jcv.2016.05.012
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266
   Fischer C, 2018, EMERG INFECT DIS, V24, P888, DOI 10.3201/eid2405.171747
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Ghaderi H, 2018, MOL BIOL REP, V45, P1197, DOI 10.1007/s11033-018-4272-y
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202
   Heyland J, 2011, J BIOTECHNOL, V155, P178, DOI 10.1016/j.jbiotec.2011.06.016
   JENSEN EB, 1990, BIOTECHNOL BIOENG, V36, P1, DOI 10.1002/bit.260360102
   Jia B, 2016, OPEN BIOL, V6, DOI 10.1098/rsob.160196
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kikuti M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1015-6
   Kram KE, 2015, APPL ENVIRON MICROB, V81, P4442, DOI 10.1128/AEM.00722-15
   Larentis AL, 2011, PROTEIN EXPRES PURIF, V78, P38, DOI 10.1016/j.pep.2011.02.013
   Losen M, 2004, BIOTECHNOL PROGR, V20, P1062, DOI 10.1021/bp034282t
   Maharjan S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096259
   Marini G, 2014, BMC BIOTECHNOL, V14, DOI 10.1186/1472-6750-14-1
   Marthos BV, 2015, APPL MICROBIOL BIOT, V99, P10447, DOI 10.1007/s00253-015-6928-z
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Montgomery DC, 2008, DESIGN ANAL EXPT
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Osadska M, 2014, APPL MICROBIOL BIOT, V98, P9259, DOI 10.1007/s00253-014-5840-2
   Papaneophytou C, 2016, PROTEIN EXPRES PURIF, V120, P126, DOI 10.1016/j.pep.2015.12.014
   Papaneophytou CP, 2014, PROTEIN EXPRES PURIF, V94, P22, DOI 10.1016/j.pep.2013.10.016
   Papaneophytou CP, 2013, PROTEIN EXPRES PURIF, V90, P9, DOI 10.1016/j.pep.2013.04.005
   Papaneophytou CP, 2012, PROTEIN EXPRES PURIF, V86, P35, DOI 10.1016/j.pep.2012.09.002
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Restaino OF, 2013, APPL MICROBIOL BIOT, V97, P3893, DOI 10.1007/s00253-012-4682-z
   da Silva CMR, 2018, BMC BIOTECHNOL, V18, DOI 10.1186/s12896-018-0486-2
   Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172
   SCHEIN CH, 1988, BIO-TECHNOL, V6, P291, DOI 10.1038/nbt0388-291
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Swalley SE, 2006, ANAL BIOCHEM, V351, P122, DOI 10.1016/j.ab.2005.11.046
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   TUNAC JB, 1989, J FERMENT BIOENG, V68, P157, DOI 10.1016/0922-338X(89)90068-8
   Uhoraningoga Albert, 2018, Bioengineering-Basel, V5, P89, DOI 10.3390/bioengineering5040089
   Vallejo LF, 2004, MICROB CELL FACT, V3, DOI 10.1186/1475-2859-3-11
   Vincentelli R, 2011, METHODS, V55, P65, DOI 10.1016/j.ymeth.2011.08.010
   Wood WN, 2017, J MICROBIOL METH, V133, P46, DOI 10.1016/j.mimet.2016.12.016
   World Health Organization, 2016, ZIK SIT REP
   Xie L, 2003, APPL MICROBIOL BIOT, V63, P267, DOI 10.1007/s00253-003-1388-2
   Yang Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022981
   Zamani M, 2015, MOL BIOTECHNOL, V57, P241, DOI 10.1007/s12033-014-9818-1
   Zheng HC, 2019, APPL MICROBIOL BIOT, V103, P1441, DOI 10.1007/s00253-018-9509-0
NR 62
TC 1
Z9 1
U1 160
U2 160
PU SPRINGEROPEN
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND
SN 2191-0855
J9 AMB EXPRESS
JI AMB Express
PD DEC
PY 2020
VL 10
IS 1
AR 1
DI 10.1186/s13568-019-0926-y
PG 13
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA JZ2WE
UT WOS:000504963600001
PM 31893321
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, MBS
   Valentim, IB
   Rocha, TS
   Santos, JC
   Pires, KSN
   Tanabe, ELL
   Borbely, KSC
   Borbely, AU
   Goulart, MOF
AF Oliveira, Monika B. S.
   Valentim, Iara B.
   Rocha, Tauane S.
   Santos, Jaqueline C.
   Pires, Keyla S. N.
   Tanabe, Eloiza L. L.
   Borbely, Karen S. C.
   Borbely, Alexandre U.
   Goulart, Marilia O. F.
TI Schinus terebenthifolius Raddi extracts: From sunscreen activity toward
   protection of the placenta to Zika virus infection, new uses for a
   well-known medicinal plant
SO INDUSTRIAL CROPS AND PRODUCTS
LA English
DT Article
DE Schinus terebinthifolius Raddi; Photoprotection; Sunscreen formulation;
   Zika virus; Placenta protection; Antiviral activity
ID P-COUMARIC ACID; TEREBINTHIFOLIUS RADDI; IN-VITRO; PHOTOPROTECTIVE
   ACTIVITY; INHIBITS ZIKA; GALLIC ACID; KAPPA-B; ANTIOXIDANT; FRUITS; PEEL
AB Schinus terebinthifolius Raddi is a well-known medicinal plant native of South America. This species has demonstrated important biological activities such as antihypertensive and vasodilator, antimicrobial, anti-inflammatory and antioxidant. However, no studies have been, so far, reported with the fruits of S. terebinthifolius as a protector of the placenta against Zika virus infection and as sunscreen agents. The present study aimed to investigate new uses for the ethanolic fruit extracts of S. terebinthifolius, from fruits'peel (STPE) and from the whole fruits (STWFE). Zika virus (ZIKV) has been linked to several fetal malformations, such as microcephaly and other central nervous system abnormalities. Thus, the potential of these natural extracts against ZIKV infection was evaluated, using an in vitro method. The photoprotective potential, determined by spectrometry, along with phenolic content, antioxidant capacity, and chemical composition of both extracts were also evaluated. The chemical composition of the extracts was evaluated by HPLC-UV / vis. The cytotoxicity of peel and whole fruit extracts in vero E6 cell lines, in placental cell lines and placental explant cultures were evaluated by the MTT assay. The infectivity of placental cells and explants was evaluated by qRT-PCR and the effects of extracts on ZIKV infection were investigated using HTR-8/SVneo cells, pre-treated with 100 mu g mL(-1) of STWFE for 1 h, and infected with MR766 (AD) or PE243 (EH) ZIKV strains. STFE and STWFE were well-tolerated by both placental-derived trophoblast cell line HTR-8/SVneo as well as by term placental chorionic villi explants, which indicate absence of cytotoxicity in all analysed concentrations. Two strains of ZIKV were tested to access if pretreatment of trophoblast cells with the STWFE would protect them against infection. Flow cytometry analysis revealed that STWFE extract greatly reduced ZIKV infection. The extracts were also photoprotective with SPF values equivalent to the standard, benzophenone-3. The formulations prepared in different concentrations of the extracts (5-10 %) had shown maximum SPF values of 32.21. STWFE represents a potential natural mixture to be used in pregnancy in order to restrain placental infection by ZIKV and might potentially protect fetus against ZIKV-related malformations. The extracts exhibited photoprotective activity and some of the phenolic compounds, mainly resveratrol, catechin and epicatechin, are active ingredients in all assayed activities. The development of biotechnological/medical products, giving extra value to products from family farming, is expected, with strong prospects for success.
C1 [Oliveira, Monika B. S.; Rocha, Tauane S.; Goulart, Marilia O. F.] Univ Fed Alagoas UFAL, Inst Quim & Biotecnol, Campus AC Simoes,Av Lourival Melo Mota S-N, BR-57072970 Maceio, Alagoas, Brazil.
   [Valentim, Iara B.] Inst Fed Educ Ciencia & Tecnol Alagoas IFAL, Rua Mizael Domingues 75, BR-57020600 Maceio, Alagoas, Brazil.
   [Santos, Jaqueline C.; Pires, Keyla S. N.; Tanabe, Eloiza L. L.; Borbely, Karen S. C.; Borbely, Alexandre U.] Univ Fed Alagoas UFAL, Inst Ciencias Biol & Saude, Lab Biol Celular, Av Lourival Melo Mota S-N, BR-57072970 Maceio, Alagoas, Brazil.
   [Borbely, Karen S. C.] Univ Fed Alagoas UFAL, Fac Nutr, Av Lourival Melo Mota S-N, BR-57072970 Maceio, Alagoas, Brazil.
RP Goulart, MOF (corresponding author), Univ Fed Alagoas UFAL, Inst Quim & Biotecnol, Campus AC Simoes,Av Lourival Melo Mota S-N, BR-57072970 Maceio, Alagoas, Brazil.; Borbely, AU (corresponding author), Univ Fed Alagoas UFAL, Inst Ciencias Biol & Saude, Lab Biol Celular, Av Lourival Melo Mota S-N, BR-57072970 Maceio, Alagoas, Brazil.
EM alexandre.borbely@icbs.ufal.br; mofg@qui.ufal.br
RI Goulart, Marilia/A-1199-2013; Borbely, Alexandre Urban/Q-2884-2019
OI Goulart, Marilia/0000-0001-9860-3667; Borbely, Alexandre
   Urban/0000-0001-6737-0901
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); CAPES/RENORBIO/PROAP; CAPES/PROCADCAPES; INCT-Bioanalysis;
   FAPEAL (PPSUS/Decit/MS/CNPq/SESAU-AL/FAPEAL) [06/2016:60030 000819/2016]
FX The authors gratefully acknowledge the financial support of the
   Brazilian research funding agencies CNPq, CAPES/RENORBIO/PROAP,
   CAPES/PROCAD, INCT-Bioanalysis and FAPEAL
   (PPSUS/Decit/MS/CNPq/SESAU-AL/FAPEAL n.06/2016:60030 000819/2016). The
   authors wish to thank Aldy dos Santos and Juliane Pereira Silva Barreto
   for technical assistance, and Dr Jose Roberto Fonseca for providing the
   Schinus terebinthifolius Raddi samples. We thank Dr. Alessandra Borges
   for the donation of Vero E3 cells and C6/36 cells, and Dr. Enio Bassi
   and the IMMUNOREG group for the help with viral growing and titration.
   We are also thankful to Farmanguinhos for providing chloroquine
   diphosphate.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Adibi JJ, 2016, CELL HOST MICROBE, V20, P9, DOI 10.1016/j.chom.2016.06.013
   Afaq F, 2011, ARCH BIOCHEM BIOPHYS, V508, P144, DOI 10.1016/j.abb.2010.12.007
   Afonso S, 2014, J PHOTOCH PHOTOBIO B, V140, P36, DOI 10.1016/j.jphotobiol.2014.07.004
   Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014
   Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Alencar -Filho J.M.T., 2016, J MED PLANTS RES, V10, P848, DOI [10.5897/JMPR2016.6273., DOI 10.5897/JMPR2016.6273, 10.5897/JMPR2016.6273]
   Ali SI, 2014, INT J PHARM CLIN RES, V6, P348
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004682
   Anvisa, 2011, FORM FIT FARM BRAS
   Arruda C, 2020, REV BRAS FARMACOGN, V30, P169, DOI 10.1007/s43450-020-00043-3
   Arumugasaamy N, 2018, ANN BIOMED ENG, V46, P1963, DOI 10.1007/s10439-018-2090-y
   Badhani B, 2015, RSC ADV, V5, P27540, DOI 10.1039/c5ra01911g
   Bae J., 2020, BIOMED DERM, DOI [10.1186/s41702-020-0057-8., DOI 10.1186/S41702-020-0057-8]
   Batista MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010049
   Omena CMB, 2012, FOOD RES INT, V49, P334, DOI 10.1016/j.foodres.2012.07.010
   Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292
   Bernardes NR, 2014, REV BRAS FARMACOGN, V24, P644, DOI 10.1016/j.bjp.2014.10.012
   Boo YC, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080275
   Brazilian Ministry of Health, 2017, REL NAC MED ESS RENA, P0
   Bulla MK, 2015, PHOTOCHEM PHOTOBIOL, V91, P558, DOI 10.1111/php.12419
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cavalher-Machado SC, 2008, INT IMMUNOPHARMACOL, V8, P1552, DOI 10.1016/j.intimp.2008.06.012
   Chaouat G, 2015, J REPROD IMMUNOL, V108, P56, DOI 10.1016/j.jri.2014.10.004
   Cicco N, 2009, MICROCHEM J, V91, P107, DOI 10.1016/j.microc.2008.08.011
   Cosarca S., 2019, Acta Biologica Marisiensis, V2, P21, DOI 10.2478/abmj-2019-0003
   Costa COD, 2015, PHARMACOGN MAG, V11, P607, DOI 10.4103/0973-1296.160459
   da Rocha PD, 2018, APPL BIOCHEM BIOTECH, V184, P869, DOI 10.1007/s12010-017-2589-y
   da Silva MM, 2017, REV BRAS FARMACOGN, V27, P445, DOI 10.1016/j.bjp.2016.12.007
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Dal Pra V, 2017, ULTRASON SONOCHEM, V36, P362, DOI 10.1016/j.ultsonch.2016.12.021
   Gomes RBD, 2020, IND CROP PROD, V143, DOI 10.1016/j.indcrop.2019.05.079
   De Clercq E, 2002, NAT REV DRUG DISCOV, V1, P13, DOI 10.1038/nrd703
   Torres KAD, 2016, REV BRAS GINECOL OBS, V38, P593, DOI 10.1055/s-0036-1597694
   de Oliveira AC, 2009, FOOD CHEM, V115, P469, DOI 10.1016/j.foodchem.2008.12.045
   Degaspari CH, 2004, VIS ACAD, V05, P83
   Degaspari CH, 2005, CIENC AGROTEC, V29, P617, DOI 10.1590/S1413-70542005000300016
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Dias TDMF, 2018, REV VIRTUAL QUIM, V10, P86, DOI 10.21577/1984-6835.20180009
   DiCiaula MC, 2014, QUIM NOVA, V37, P158, DOI 10.1590/S0100-40422014000100026
   Dwibedi Vagish, 2020, Proceedings of the Indian National Science Academy Part B Biological Sciences, V90, P207, DOI 10.1007/s40011-019-01098-6
   Dzialo M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020160
   Faith SA, 2006, ANTIVIR RES, V72, P242, DOI 10.1016/j.antiviral.2006.06.011
   Ferreira PG, 2018, ARCH VIROL, V163, P1567, DOI 10.1007/s00705-018-3774-1
   Feuereisen MM, 2017, J AGR FOOD CHEM, V65, P5330, DOI 10.1021/acs.jafc.7b00480
   Feuereisen MM, 2014, J AGR FOOD CHEM, V62, P6219, DOI 10.1021/jf500977d
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Geeta W.S.W., 2019, PHARM SCI RES, V6, P111, DOI [10.7454/prs.v6i2.4510., DOI 10.7454/PRS.V6I2.4510]
   Gloria LD, 2017, MOLECULES, V22, DOI 10.3390/molecules22101792
   Gregoris E, 2011, INT J PHARMACEUT, V405, P97, DOI 10.1016/j.ijpharm.2010.11.052
   Haddad JG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102382
   Ibrahim G.M., 2018, RES J APPL BIOTECH, V4, P87, DOI [10.21608/rjab.2018.57527., DOI 10.21608/RJAB.2018.57527]
   Ilakkiya Ezhil, 2017, Journal of Advanced Pharmacy Education and Research, V7, P22
   Jassim SAA, 2003, J APPL MICROBIOL, V95, P412, DOI 10.1046/j.1365-2672.2003.02026.x
   Kahkeshani N, 2019, IRAN J BASIC MED SCI, V22, P225, DOI 10.22038/ijbms.2019.32806.7897
   Kao JC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006715
   Rodriguez AK, 2019, EXCLI J, V18, P988, DOI 10.17179/excli2019-1825
   Kaur CD, 2011, INT J PHARMACOL, V7, P400, DOI 10.3923/ijp.2011.400.404
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee JH, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060157
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li YF, 2006, FOOD CHEM, V96, P254, DOI 10.1016/j.foodchem.2005.02.033
   Lin SC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2253-8
   Luo HL, 2018, ANTIVIR RES, V151, P55, DOI 10.1016/j.antiviral.2018.01.003
   Macedo S. K. S., 2015, Journal of Medicinal Plants Research, V9, P207
   Mansur J. S., 1986, ANAIS BRASILEIROS DE, V61, P121
   Miller RK, 2005, PLACENTA, V26, P439, DOI 10.1016/j.placenta.2004.10.002
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mohd A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50674-3
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Musarra-Pizzo M, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102355
   Nunes AR, 2018, J PHOTOCH PHOTOBIO B, V189, P119, DOI 10.1016/j.jphotobiol.2018.10.013
   Oliveira RL, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9824698
   Ozcelik B, 2011, PHARM BIOL, V49, P396, DOI 10.3109/13880209.2010.519390
   Pagani A. A. C., 2014, INT J ENG INNOVATIVE, V4, P37
   Pei KH, 2016, J SCI FOOD AGR, V96, P2952, DOI 10.1002/jsfa.7578
   Polonini HC, 2013, BIOORGAN MED CHEM, V21, P964, DOI 10.1016/j.bmc.2012.11.052
   Prakash M, 2019, J FUNCT FOODS, V52, P14, DOI 10.1016/j.jff.2018.10.021
   Prasanth B., 2020, WORLD J CURR MED PHA, V2, P14, DOI [10.37022/WJCMPR.2020.02019., DOI 10.37022/WJCMPR.2020.02019]
   Ribeiro C., 2006, COSMETOLOGIA APLICAD
   Rodriguez-Morales AJ, 2018, TRAVEL MED INFECT DI, V25, P20, DOI 10.1016/j.tmaid.2018.06.006
   Sabitha R, 2019, ASIAN PAC J TROP BIO, V9, P188, DOI 10.4103/2221-1691.258998
   Saewan N., 2013, Journal of Applied Pharmaceutical Science, V3, P129
   Sanchez-Moreno C, 1999, FOOD RES INT, V32, P407, DOI 10.1016/S0963-9969(99)00097-6
   Santana JS, 2012, PHARM BIOL, V50, P1248, DOI 10.3109/13880209.2012.666880
   SAYRE RM, 1979, PHOTOCHEM PHOTOBIOL, V29, P559, DOI 10.1111/j.1751-1097.1979.tb07090.x
   Scalia S, 2010, PHOTOCHEM PHOTOBIOL, V86, P273, DOI 10.1111/j.1751-1097.2009.00655.x
   Shaito A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062084
   Shen YB, 2019, BIOMED PHARMACOTHER, V111, P579, DOI 10.1016/j.biopha.2018.12.074
   Shiryaev SA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15467-6
   Silva BG, 2017, J FOOD QUALITY, DOI 10.1155/2017/3152797
   Silva RV, 2016, IND CROP PROD, V83, P509, DOI 10.1016/j.indcrop.2015.12.077
   Song JM, 2018, CLIN EXP VACCINE RES, V7, P37, DOI 10.7774/cevr.2018.7.1.37
   Stevanato R, 2014, REGUL TOXICOL PHARM, V69, P71, DOI 10.1016/j.yrtph.2014.02.014
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tlili N, 2018, IND CROP PROD, V122, P559, DOI 10.1016/j.indcrop.2018.05.080
   Uddin SJ, 2020, FOOD REV INT, DOI 10.1080/87559129.2020.1734609
   Varela-Rodriguez Luis, 2020, BMC Complement Med Ther, V20, P110, DOI 10.1186/s12906-020-02900-z
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Widowati Wahyu, 2016, Journal of Natural Remedies, V16, P88, DOI 10.18311/jnr/2016/7220
   You HL, 2018, J CHIN MED ASSOC, V81, P458, DOI 10.1016/j.jcma.2017.11.007
   Zhou F, 2018, BIOCHEM BIOPH RES CO, V499, P662, DOI 10.1016/j.bbrc.2018.03.207
NR 104
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0926-6690
EI 1872-633X
J9 IND CROP PROD
JI Ind. Crop. Prod.
PD SEP 15
PY 2020
VL 152
AR 112503
DI 10.1016/j.indcrop.2020.112503
PG 13
WC Agricultural Engineering; Agronomy
SC Agriculture
GA LV0EV
UT WOS:000538118500019
PM 32346222
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Aghriche, A
   Yafia, R
   Alaoui, MAA
   Tridane, A
AF Aghriche, Ahmed
   Yafia, Radouane
   Alaoui, M. A. Aziz
   Tridane, Abdessamad
TI OSCILLATIONS INDUCED BY QUIESCENT ADULT FEMALE IN A MODEL OF WILD AEDES
   AEGYPTI MOSQUITOES
SO DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS-SERIES S
LA English
DT Article; Proceedings Paper
CT Workshop on Delay Differential Equations - Theory, Applications and New
   Trends (DDEs-TANTs)
CY OCT 03-04, 2018
CL United Arab Emirates Univ, Al Ain, U ARAB EMIRATES
HO United Arab Emirates Univ
DE Ae. aegypti; DDE; stability; Hopf bifurcation; direction of bifurcation
ID BIFURCATION-ANALYSIS; POPULATION-DYNAMICS; DENGUE; STABILITY; FEVER;
   DELAY
AB Aedes aegypti (Ae. aegypti: mosquito) is a known vector of several viruses including yellow fever, dengue, chikungunya and zika. In the current paper, we present a delayed mathematical model describing the dynamics of Ae. aegypti. Our model is governed by a system of three delay differential equations modeling the interactions between three compartments of the Ae. aegypti life cycle (females, eggs and pupae). By using time delay as a parameter of bifurcation, we prove stability/switch stability of the possible equilibrium points and the existence of bifurcating branch of small amplitude periodic solutions when time delay crosses some critical value. We establish an algorithm determining the direction of bifurcation and stability of bifurcating periodic solutions. In the end, some numerical simulations are carried out to support theoretical results..
C1 [Aghriche, Ahmed] Ibn Zohr Univ, CST Campus Univ Ait Melloul, Agadir, Morocco.
   [Yafia, Radouane] Ibn Tofail Univ, Lab Anal Geometry & Applicat LAGA, Dept Math, Fac Sci, Campus Univ,BP 133, Kenitra, Morocco.
   [Alaoui, M. A. Aziz] Normandie Univ, Caen, France.
   [Alaoui, M. A. Aziz] LMAH, ULH, F-76600 Le Havre, France.
   [Alaoui, M. A. Aziz] ISCN, FR CNRS 3335, 25 Rue Ph Lebon, F-76600 Le Havre, France.
   [Tridane, Abdessamad] United Arab Emirates Univ Al Ain, Dept Math Sci, Abu Dhabi, U Arab Emirates.
RP Yafia, R (corresponding author), Ibn Tofail Univ, Lab Anal Geometry & Applicat LAGA, Dept Math, Fac Sci, Campus Univ,BP 133, Kenitra, Morocco.
EM aghriche87@gmail.com; yafia1@yahoo.fr; aziz.alaoui@univ-lehavre.fr;
   a-tridane@uaeu.ac.ae
CR Diniz DFA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2235-0
   Barrera R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001378
   Bellman R., 1963, DIFFERENTIAL DIFFERE
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boese FG, 1998, J MATH ANAL APPL, V228, P293, DOI 10.1006/jmaa.1998.6109
   Cai LM, 2018, MATH BIOSCI ENG, V15, P1181, DOI 10.3934/mbe.2018054
   Chadee DD, 2000, J VECTOR ECOL, V25, P158
   Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0
   Cooke K.L., 1986, FUNKC EKVACIOJ-SER I, V29, P77
   Cushing J. M., 1977, LECT NOTES BIOMATHEM, V20
   Danks H. V., 1987, BIOL SURVEY CANADA M
   Dieudonne J., 1960, PURE APPL MATH, V10
   DYE C, 1984, J ANIM ECOL, V53, P247, DOI 10.2307/4355
   Gopalsamy K., 1992, MATH ITS APPL, V74
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gyekye YN, 2015, APPL COMPUT MATH, V4, P363, DOI DOI 10.11648/J.ACM.20150405.15
   Hassard B., 1981, LONDON MATH SOC LECT, V41
   Huraux T., MODELISATION IMPACT
   Kuang Y., 1993, MATH SCI ENG, V191
   Li RY, 2019, P NATL ACAD SCI USA, V116, P3624, DOI 10.1073/pnas.1806094116
   MacDonald N., 1978, LECT NOTES BIOMATHEM, V27
   Marsden J. E., 1976, APPL MATH SCI, V19
   Martins R., 2000, OECOLOGIA BRAS, V8, P149
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oliva LO, 2018, INSECTS, V9, DOI 10.3390/insects9030111
   Ruan SG, 2003, DYNAM CONT DIS SER A, V10, P863
   RUEDA LM, 1990, J MED ENTOMOL, V27, P892, DOI 10.1093/jmedent/27.5.892
   Saulo A. C. T., 2017, APPL MATH SCI, V11, P1123
   Song YL, 2006, NONLINEAR ANAL-REAL, V7, P265, DOI 10.1016/j.nonrwa.2005.03.002
   Vacus G., 2012, THESIS
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Walsh RK, 2013, AM J TROP MED HYG, V89, P68, DOI 10.4269/ajtmh.12-0378
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Zhou XB, 2009, CHAOS SOLITON FRACT, V40, P1493, DOI 10.1016/j.chaos.2007.09.034
NR 36
TC 0
Z9 0
U1 0
U2 0
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1937-1632
EI 1937-1179
J9 DISCRETE CONT DYN-S
JI Discret. Contin. Dyn. Syst.-Ser. S
PD SEP
PY 2020
VL 13
IS 9
SI SI
BP 2443
EP 2463
DI 10.3934/dcdss.2020194
PG 21
WC Mathematics, Applied
SC Mathematics
GA MA3KH
UT WOS:000541815700007
OA Other Gold
DA 2020-07-08
ER

PT J
AU Jaeger, AS
   Weiler, AM
   Moriarty, RV
   Rybarczyk, S
   O'Connor, SL
   O'Connor, DH
   Seelig, DM
   Fritsch, MK
   Friedrich, TC
   Aliota, MT
AF Jaeger, Anna S.
   Weiler, Andrea M.
   Moriarty, Ryan, V
   Rybarczyk, Sierra
   O'Connor, Shelby L.
   O'Connor, David H.
   Seelig, Davis M.
   Fritsch, Michael K.
   Friedrich, Thomas C.
   Aliota, Matthew T.
TI Spondweni virus causes fetal harm in Ifnar1(-/-) mice and is transmitted
   by Aedes aegypti mosquitoes
SO VIROLOGY
LA English
DT Article
DE Arbovirus; Flavivirus; Spondweni virus; Zika virus; Aedes aegypti;
   Vector competence; Congenital zika syndrome
ID ARTHROPOD-BORNE VIRUSES; ZIKA VIRUS; INDIGENOUS RESIDENTS; SOUTH-AFRICA;
   ANTIBODIES; DENGUE; INFECTION; TRANSMISSION; ARBOVIRUSES; ISOLATIONS
AB Spondweni virus (SPONV) is the most closely related known flavivirus to Zika virus (ZIKV). Its pathogenic potential and vector specificity have not been well defined. SPONV has been found predominantly in Africa, but was recently detected in a pool of Culex quinquefasciatus mosquitoes in Haiti. Here we show that SPONV can cause significant fetal harm, including demise, comparable to ZIKV, in a mouse model of vertical transmission. Following maternal inoculation, we detected infectious SPONV in placentas and fetuses, along with significant fetal and placental histopathology, together suggesting vertical transmission. To test vector competence, we exposed Aedes aegypti and Culex quinquefasciatus mosquitoes to SPONV-infected bloodmeals. Aedes aegypti could efficiently transmit SPONV, whereas Culex quinquefasciatus could not. Our results suggest that SPONV has the same features that made ZIKV a public health risk.
C1 [Jaeger, Anna S.; Aliota, Matthew T.] Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA.
   [Weiler, Andrea M.; Moriarty, Ryan, V; Rybarczyk, Sierra; O'Connor, Shelby L.; O'Connor, David H.; Friedrich, Thomas C.] Univ Wisconsin Madison, Wisconsin Natl Primate Res Ctr, Madison, WI USA.
   [O'Connor, Shelby L.; O'Connor, David H.; Fritsch, Michael K.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI USA.
   [Seelig, Davis M.] Univ Minnesota, Dept Vet Clin Sci, Minneapolis, MN USA.
   [Friedrich, Thomas C.] Univ Wisconsin Madison, Dept Pathobiol Sci, Madison, WI USA.
RP Aliota, MT (corresponding author), Univ Minnesota, Dept Vet & Biomed Sci, Minneapolis, MN 55455 USA.
EM mtaliota@umn.edu
OI RYBARCZYK, SIERRA/0000-0003-3564-9750
FU DHHS/PHS/NIH [R21AI131454, R01AI132563]
FX The authors acknowledge the University of Minnesota, Twin Cities BSL3
   Program for facilities and Neal Heuss for support. We thank Natalie
   Benett for her contribution in mosquito maintenance, and the University
   of Minnesota, Twin Cities Comparative Pathology Shared Resource for
   preparation of histological sections. Funding for this project came from
   DHHS/PHS/NIH R21AI131454 and R01AI132563 to M.T.A. The publication's
   contents are solely the responsibility of the authors and do not
   necessarily represent the official views of the NCRR or NIH.
CR Aliota M.T., 2016, TROP DIS, V10
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   ANDERSEN A A, 1970, Infection and Immunity, V2, P320
   ARDOIN P, 1976, TROP GEOGR MED, V28, P309
   BOORMAN JPT, 1968, T ROY SOC TROP MED H, V62, P269, DOI 10.1016/0035-9203(68)90168-5
   BROTTES H, 1966, B WORLD HEALTH ORGAN, V35, P811
   Carrington LB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00290
   Casazza RL, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3446
   CHRISTENSEN BM, 1984, T AM MICROSC SOC, V103, P423, DOI 10.2307/3226478
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Dzul-Manzanilla F, 2016, T ROY SOC TROP MED H, V110, P141, DOI 10.1093/trstmh/trv106
   Flores LE, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-38
   Goodin Michael M, 2016, Annu Rev Virol, V3, pvi, DOI 10.1146/annurev-vi-3-100316-100011
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Hassan AO, 2019, CELL REP, V28, P2634, DOI 10.1016/j.celrep.2019.08.005
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Jagger BW, 2019, J INFECT DIS, V220, P1577, DOI 10.1093/infdis/jiz338
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P563, DOI 10.1016/0035-9203(65)90159-8
   KOKERNOT RH, 1965, T ROY SOC TROP MED H, V59, P553, DOI 10.1016/0035-9203(65)90158-6
   Lambrechts L, 2011, TRENDS PARASITOL, V27, P111, DOI 10.1016/j.pt.2010.12.001
   Lauck M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-107
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mcdonald E.M., 2017, TROP DIS, V11
   McINTOSH B. M., 1961, S AFRICAN MED JOUR, V35, P647
   MCINTOSH BM, 1972, J MED ENTOMOL, V9, P155
   MCLENNAN H, 1976, CAN J PHYSIOL PHARM, V54, P70, DOI 10.1139/y76-011
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   MILLER BR, 1987, T ROY SOC TROP MED H, V81, P1011, DOI 10.1016/0035-9203(87)90381-6
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Ramesh Anita, 2019, Wellcome Open Res, V4, P93, DOI 10.12688/wellcomeopenres.15295.1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407
   Salazar V, 2019, CELL REP, V26, P1585, DOI 10.1016/j.celrep.2019.01.052
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Theiler M., 1973, ARTHROPOD BORNE VIRU, P174
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   WOLFE MS, 1982, LANCET, V2, P1306
   WORTH CB, 1961, AM J TROP MED HYG, V10, P583, DOI 10.4269/ajtmh.1961.10.583
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
NR 62
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD AUG
PY 2020
VL 547
BP 35
EP 46
DI 10.1016/j.virol.2020.05.005
PG 12
WC Virology
SC Virology
GA MA2WK
UT WOS:000541778600006
PM 32560903
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Potter, JA
   Tong, M
   Aldo, P
   Kwon, JY
   Pitruzzello, M
   Mor, G
   Abrahams, VM
AF Potter, Julie A.
   Tong, Mancy
   Aldo, Paulomi
   Kwon, Ja Young
   Pitruzzello, Mary
   Mor, Gil
   Abrahams, Vikki M.
TI Viral infection dampens human fetal membrane type I interferon responses
   triggered by bacterial LPS
SO JOURNAL OF REPRODUCTIVE IMMUNOLOGY
LA English
DT Article
DE Bacteria; Fetal membrane; Innate immune; Interferon; Pregnancy; Virus
ID INTRAUTERINE INFECTION; ANTIVIRAL RESPONSES; PRETERM LABOR; ZIKA VIRUS;
   INFLAMMATION; RECOGNITION; RNA; LIPOPOLYSACCHARIDE; ACTIVATION;
   SENSITIZES
AB The maternal-fetal interface possesses innate immune strategies to protect against infections. We previously reported that prior viral infection of human fetal membranes (FMs) in vitro and mouse FMs in vivo sensitized the tissue to low dose bacterial LPS leading to augmented inflammation. The objective of this study was to examine FM production of type I interferons (IFNs) and IFN-stimulated genes (ISGs) in the context of this polymicrobial model. Human FM explants and pregnant C57BL/6 mice were treated with or without low dose LPS following exposure to media or the gamma-herpes virus, MHV-68. FM RNA was analyzed by qRT-PCR for type I IFNs, ISGs, upstream signaling, and MHV-68 open reading frames (ORFs). Pre-exposure to MHV-68 followed by LPS treatment inhibited the ability of LPS to induce human FM type I IFNs (IFNA, IFNB); ISGs (OAS, MxA, APOBEC3G) and upstream signaling mediators (RIG-I, TBK-1). Signaling mediators IRF-3 and IRF-7 were also reduced. In mouse FMs, pre-exposure to MHV-68 followed by LPS treatment reduced the ability of LPS to upregulate Ifna, Ifnb, Mxa, Irf7, and also reduced Irf3. MHV-68 infection of FMs induced ORF45 which targets IRF7, and this was further augmented in response to a combination of MHV-68 and LPS. Together, these findings indicate that a viral infection blunts FM type I IFN production and signaling in response to LPS leading to a suppressed ISG response. Our studies suggest that a viral infection inhibits this protective FM response by negatively regulating IRF-7 through ORF45, leaving the maternal-fetal interface vulnerable to further viral attack.
C1 [Potter, Julie A.; Tong, Mancy; Aldo, Paulomi; Kwon, Ja Young; Pitruzzello, Mary; Mor, Gil; Abrahams, Vikki M.] Yale Univ, Sch Med, Dept Obstet Gynecol & Reprod Sci, 333 Cedar St, New Haven, CT 06510 USA.
   [Kwon, Ja Young] Yonsei Univ, Coll Med, Dept Obstet & Gynecol, Seoul, South Korea.
   [Mor, Gil] Wayne State Univ, CS Mott Ctr Human Growth & Dev, Detroit, MI USA.
RP Abrahams, VM (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, 310 Cedar St,LSOG 305C, New Haven, CT 06510 USA.
EM vikki.abrahams@yale.edu
OI Kwon, Ja-Young/0000-0003-3009-6325
FU NIAID, NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI121183]
FX This study was supported by grant R01AI121183 (VMA) from the NIAID, NIH.
CR Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599
   Abrahams VM, 2013, AM J REPROD IMMUNOL, V69, P33, DOI 10.1111/aji.12016
   Abrahams VM, 2011, J REPROD IMMUNOL, V88, P112, DOI 10.1016/j.jri.2010.12.003
   Bakaysa SL, 2014, MOL HUM REPROD, V20, P701, DOI 10.1093/molehr/gau028
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288
   Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Christensen MH, 2017, CELL MOL IMMUNOL, V14, P4, DOI 10.1038/cmi.2016.06
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cross SN, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.12861
   Cross SN, 2017, J IMMUNOL, V199, P2885, DOI 10.4049/jimmunol.1700870
   Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616
   DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001
   Elovitz MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09285-9
   Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Goncalves LF, 2002, MENT RETARD DEV D R, V8, P3, DOI 10.1002/mrdd.10008
   Hoang M, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115428
   Ilievski V, 2010, BIOL REPROD, V83, P767, DOI 10.1095/biolreprod.110.085464
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Kang HR, 2014, J VIROL, V88, P6832, DOI 10.1128/JVI.03460-13
   Lappas M, 2014, AM J REPROD IMMUNOL, V71, P189, DOI 10.1111/aji.12174
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368
   Lee AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02061
   Liu Q., 2019, VIRUSES, V11
   O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079
   Paludan SR, 2011, NAT REV IMMUNOL, V11, P143, DOI 10.1038/nri2937
   Paradowska E, 1997, PLACENTA, V18, P441, DOI 10.1016/S0143-4004(97)80045-8
   Potter JA, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124032
   Racicot K, 2017, J CLIN INVEST, V127, P1591, DOI 10.1172/JCI87490
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Richards KH, 2011, MICROBES INFECT, V13, P291, DOI 10.1016/j.micinf.2010.12.007
   Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773
   Tabata T, 2016, AM J PATHOL, V186, P2970, DOI 10.1016/j.ajpath.2016.07.016
   Tong M, 2019, J IMMUNOL, V203, P500, DOI 10.4049/jimmunol.1900262
   Uchide N, 2002, BIOL PHARM BULL, V25, P239, DOI 10.1248/bpb.25.239
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Wood BM, 2013, VIROLOGY, V443, P123, DOI 10.1016/j.virol.2013.04.036
   Yoneda N, 2016, AM J REPROD IMMUNOL, V75, P112, DOI 10.1111/aji.12456
NR 42
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0165-0378
EI 1872-7603
J9 J REPROD IMMUNOL
JI J. Reprod. Immunol.
PD AUG
PY 2020
VL 140
AR UNSP 103126
DI 10.1016/j.jri.2020.103126
PG 6
WC Immunology; Reproductive Biology
SC Immunology; Reproductive Biology
GA LZ2RW
UT WOS:000541076700002
PM 32289593
DA 2020-07-08
ER

PT J
AU Ong, NH
   Chua, CL
   Liew, JWK
   Sulaiman, WYW
   Chan, YF
   Sam, IC
   Vythilingam, I
AF Ong, Nyee Huey
   Chua, Chong Long
   Liew, Jonathan Wee Kent
   Sulaiman, Wan Yusoff Wan
   Chan, Yoke Fun
   Sam, I-Ching
   Vythilingam, Indra
TI Vector competence of Malaysian Aedes aegypti to Zika virus and impact of
   sequential arbovirus infections
SO ACTA TROPICA
LA English
DT Article
DE Aedes aegypti; Zika virus; Dengue serotype 2 virus; Sequential
   infection; Malaysia
ID DENGUE VIRUS; MOSQUITOS; TRANSMISSION; OUTBREAK; FEVER; HOST
AB Zika virus (ZIKV) is a mosquito-borne flavivirus with global impact since 2015. Although ZIKV was first isolated from Aedes aegypti in Malaysia in 1965, not much is known about the competency of Malaysian Ae. aegypti to ZIKV. To date only 9 cases of ZIKV have been reported in Malaysia despite the abundance of mosquito vectors. This study aimed to determine the susceptibility of Ae. aegypti to ZIKV, and the impact of sequential infections in Ae. aegypti mosquitoes with DENV serotype 2 (DENV-2) followed by ZIKV. Field-caught urban Ae. aegypti were orally challenged with a Martinique strain of ZIKV, and midgut, head/thorax and saliva were collected at 3, 7 and 14 days post-infection (dpi). At 14 dpi, ZIKV-exposed mosquitoes had infection and dissemination rates of 59% (n=10/17) and 90% (n=9/10), respectively. Average titres of 3.9 and 4.4 log pfu infectious ZIKV were recovered in midgut and head/thorax, respectively. In sequential infection, prior exposure of Ae. aegypti to DENV did not affect the subsequent ZIKV infection in head/thorax albeit with a low sample size. In conclusion, Malaysian urban Ae. aegypti is susceptible to the contemporary Asian lineage of ZIKV. The established and continuous DENV circulation in Ae. aegypti did not suppress ZIKV emergence in Malaysia. Other factors contributing to low level of ZIKV circulation in Malaysia remain to be explored.
C1 [Ong, Nyee Huey; Liew, Jonathan Wee Kent; Sulaiman, Wan Yusoff Wan; Vythilingam, Indra] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.
   [Chua, Chong Long; Chan, Yoke Fun; Sam, I-Ching] Univ Malaya, Fac Med, Dept Med Microbiol, Kuala Lumpur 50603, Malaysia.
RP Vythilingam, I (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur 50603, Malaysia.
EM indrav@um.edu.my
FU Ministry of Higher Education, MalaysiaMinistry of Education, Malaysia
   [FRGS FP016-2017A];  [GPF012C-2018]
FX This study was supported by a grant from the Ministry of Higher
   Education, Malaysia (FRGS FP016-2017A) and Faculty research grant
   (GPF012C-2018).
CR Abrao EP, 2016, VECTOR-BORNE ZOONOT, V16, P124, DOI 10.1089/vbz.2015.1804
   Appassakij H, 2013, TRANSFUSION, V53, P2567, DOI 10.1111/j.1537-2995.2012.03960.x
   Armstrong PM, 2020, NAT MICROBIOL, V5, P239, DOI 10.1038/s41564-019-0619-y
   AZAR SR, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11090867
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Cui YJ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111056
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dony J.J.F., 2018, PLOS CURRENTS OUTBRE, DOI [10.1371/currents.outbreaks, DOI 10.1371/CURRENTS.OUTBREAKS]
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Folimonova SY, 2012, J VIROL, V86, P5554, DOI 10.1128/JVI.00310-12
   Gloria-Soria Andrea, 2019, PLoS Negl Trop Dis, V13, pe0007930, DOI 10.1371/journal.pntd.0007930
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hunter FF, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01248
   Joanne S, 2017, TROP MED INT HEALTH, V22, P1154, DOI 10.1111/tmi.12918
   Kantor AM, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100571
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lambrechts L, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000646
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Long KC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007116
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mazeaud C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00595
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Platt KB, 1997, AM J TROP MED HYG, V57, P119, DOI 10.4269/ajtmh.1997.57.119
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Romo H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0180-4
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Sam IC, 2019, T ROY SOC TROP MED H, V113, P678, DOI 10.1093/trstmh/trz056
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Woon YL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3786-9
   Yong Y. K., 2007, SMJ Singapore Medical Journal, V48, P662
NR 47
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD AUG
PY 2020
VL 208
AR UNSP 105472
DI 10.1016/j.actatropica.2020.105472
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LY8XY
UT WOS:000540814000008
PM 32389451
DA 2020-07-08
ER

PT J
AU Ou, TP
   Yun, C
   Auerswald, H
   In, S
   Leang, R
   Huy, R
   Choeung, R
   Dussart, P
   Duong, V
AF Ou, Tey Putita
   Yun, Chanvannak
   Auerswald, Heidi
   In, Saraden
   Leang, Rithea
   Huy, Rekol
   Choeung, Rithy
   Dussart, Philippe
   Duong, Veasna
TI Improved detection of dengue and Zika viruses using multiplex RT-qPCR
   assays
SO JOURNAL OF VIROLOGICAL METHODS
LA English
DT Article
DE dengue virus; Zika virus; one-step duplex real-time RT-qPCR; fourplex
   real-time RT-qPCR; diagnosis; arbovirus
ID REVERSE TRANSCRIPTION-PCR; MOLECULAR-DETECTION; CHIKUNGUNYA; RNA;
   QUANTITATION; INFECTION; SPECIMENS; CAMBODIA; URINE
AB Dengue virus (DENV) and Zika virus (ZIKV) are important viral pathogens, known to cause human infections with similar symptoms, are transmitted by common vectors and co-circulate in intertropical regions. Moreover, dengue fever results from infection with one of four different serotypes of dengue virus. Considering the recent ZIKV emergence, multiplex and up-to-date assays are more preferable for detection of both viruses in a single reaction. This study aimed to develop: (i) an one-step duplex real-time reverse transcription polymerase chain reaction (RT-qPCR) assay to efficiently and simultaneously detect and quantify DENV and ZIKV; (ii) a fourplex RT-qPCR to differentiate and quantify the four DENV serotypes. The detection limit of the duplex assay was 0.028 and 0.065 FFU (focus forming unit)/ml for DENV and ZIKV respectively. The lower limit of analytical sensitivity of fourplex assay was 0.01 FFU/ml for DENV-1 and 0.1 FFU/ml for DENV-2,-3 and -4. The assessment of specificity indicated both assays were highly specific to targeted viruses with negative results for other Flaviviridae such as Japanese encephalitis, West Nile, Yellow fever or Hepatitis C viruses. The newly developed RT-qPCRs were shown to be more sensitive than a previously described assay in detecting DENV in clinical samples and are suitable for the routine diagnosis.
C1 [Ou, Tey Putita; Yun, Chanvannak; Auerswald, Heidi; In, Saraden; Choeung, Rithy; Dussart, Philippe; Duong, Veasna] Inst Pasteur Cambodge, Inst Pasteur Int Network, Virol Unit, Phnom Penh, Cambodia.
   [Leang, Rithea; Huy, Rekol] Natl Ctr Parasitol Entomol & Malaria Control, Phnom Penh, Cambodia.
RP Duong, V (corresponding author), Inst Pasteur Cambodge, 5 Monivong Blvd,POB 983, Phnom Penh 120210, Cambodia.
EM oteyputita@pasteur-kh.org; ychanvannak@pasteur-kh.org;
   hauerswald@pasteur-kh.org; insaraden@pasteur-kh.org;
   rithealeang@gmail.com; kolhuy@gmail.com; rithychoeung88@yahoo.com;
   pdussart@pasteur-kh.org; dveasna@pasteur-kh.org
RI Dussart, Philippe/P-4152-2014
OI Dussart, Philippe/0000-0002-1931-3037
FU Institut Pasteur du Cambodge; Calmette and Yersin Programme of the
   Institut Pasteur Department of International Affairs
FX The authors thank Dr Robert Tesh from the World Reference Center for
   Emerging Viruses and Arboviruses at the University of Texas Medical
   Branch (Galveston, TX, USA) who kindly provided ZIKV strain FSS13025; Dr
   Myrielle Dupont-Rouzeyrol from URE Dengue et Arboviroses, Institut
   Pasteur de Nouvelle-Caledonie who kindly provided ZIKV strain
   NC-2014-5132 and CHIKV Caribbean strain LN898093; Dr Mawlouth Diallo
   from Unite Entomologie Medicale and Dr Oumar Faye, Unite Arbovirus et
   fievres hemorragiques virales, Institut Pasteur de Dakar who kindly
   provided ZIKV strain HD78788; EVAg (European Virus Archive geos global:
   https://www.europeanvirus-archive.com/evag-portal) who kingly provided
   ZIKV strain MRS_OPY_Martinigue_PaRi_2015; Institut Pasteur Dakar and
   Institut Pasteur Laos who kindly provided West Nile virus (WNV) strain
   B956 (Uganda 1937, AY532665) and strain EG101 (Egypt 1951, AF260968) The
   authors gratefully acknowledge Dr Tineke Cantaert for her editorial
   comments and suggestions. This work was funded by Institut Pasteur du
   Cambodge. The postdoctoral fellowship of Heidi Auerswald is supported by
   the Calmette and Yersin Programme of the Institut Pasteur Department of
   International Affairs.
CR Andries AC, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004100
   Andries AC, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001993
   Anez G, 2017, TRANSFUSION, V57, P1977, DOI 10.1111/trf.14130
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Auerswald H, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3357-3
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Chan K, 2016, SCI REP-UK, V6, DOI 10.1038/srep38223
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Duong V, 2012, EMERG INFECT DIS, V18, P2066, DOI 10.3201/eid1812.120471
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Espinoza JC, 2002, J VIROL METHODS, V105, P81, DOI 10.1016/S0166-0934(02)00083-6
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Huy R, 2010, B WORLD HEALTH ORGAN, V88, P650, DOI 10.2471/BLT.09.073908
   Kalendar R, 2017, GENOMICS, V109, P312, DOI 10.1016/j.ygeno.2017.05.005
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Kweka E., 2018, ECOLOGY AEDES MOSQUI, DOI [10.5772/intechopen.81439, DOI 10.5772/INTECHOPEN.81439]
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P1576, DOI 10.1128/JCM.02153-16
   Lai YL, 2007, J CLIN MICROBIOL, V45, P935, DOI 10.1128/JCM.01258-06
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee H, 2019, ANN LAB MED, V39, P566, DOI 10.3343/alm.2019.39.6.566
   Liu SQ, 2018, J MED VIROL, V90, P389, DOI 10.1002/jmv.24970
   Messina JP, 2014, TRENDS MICROBIOL, V22, P138, DOI 10.1016/j.tim.2013.12.011
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Niedrig M, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3611-x
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Reynes JM, 2003, J CLIN MICROBIOL, V41, P3864, DOI 10.1128/JCM.41.8.3864-3867.2003
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Rossini G, 2017, J INFECTION, V75, P242, DOI 10.1016/j.jinf.2017.05.021
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Saxena P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-20
   Stothard P, 2000, BIOTECHNIQUES, V28, P1102, DOI 10.2144/00286ir01
   Vandenbussche F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164463
   Villordo SM, 2009, VIRUS RES, V139, P230, DOI 10.1016/j.virusres.2008.07.016
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P3418, DOI 10.1128/JCM.01359-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   WHO, 2017, ZIK SIT REP
   Wu SJ, 2008, AM J TROP MED HYG, V79, P505, DOI 10.4269/ajtmh.2008.79.505
NR 49
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-0934
EI 1879-0984
J9 J VIROL METHODS
JI J. Virol. Methods
PD AUG
PY 2020
VL 282
AR 113862
DI 10.1016/j.jviromet.2020.113862
PG 8
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Virology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Virology
GA LY9GJ
UT WOS:000540835900003
PM 32417207
DA 2020-07-08
ER

PT J
AU Li, Y
   Pan, MZ
   Tao, GW
   Ma, Z
   Wu, HF
   Li, Q
AF Li, Yang
   Pan, Ming-Zhi
   Tao, Guo-Wei
   Ma, Zhe
   Wu, Hai-Fang
   Li, Qi
TI Effect of head circumference in combination with facial profile line on
   ultrasonic diagnosis of microcephaly
SO JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE
LA English
DT Article
DE Facial profile line; head circumference; microcephaly; ROC curve;
   ultrasonic diagnosis
ID INTERIM GUIDANCE; ZIKA; INFECTION
AB Objective: Recently, microcephaly has usually been misdiagnosed only by ultrasound via measurement of head circumference (HC). Therefore, the aim of this study is to find another diagnostic index to supplement the original diagnostic method of microcephaly, to improve the detection rate of fetal microcephaly and to reduce the misdiagnosis rate. Methods: We retrospectively analyzed 123 pregnant women from February 2012 to January 2017 with fetal HC less than two standard deviations (SD). The facial profile line (FPL) was determined by ultrasonography. The first method (M1) was only used HC to determine whether the fetus was microcephaly, the second one (M2) was to combine HC and FPL for the diagnosis of microcephaly. Results were classified into five orderly categories by experienced sonographers. ROC curve was drawn to evaluate the diagnostic effect. Results: Among the pregnant women, 14 cases of fetal head circumference were less than 3SD, 109 were -2SD < HC <= -3SD. A total of 12 cases were confirmed of microcephaly by magnetic resonance imaging (MRI) or postnatal, 10 cases of HC were less than 3SD, 2 were -2SD < HC <= -3SD. The area under the ROC curve for M1 and M2 were 0.751 and 0.983 respectively. Conclusion: The HC in combination with FPL can be used to evaluate the fetal HC and forehead development quickly, and to improve the sensitivity and specificity of diagnosing fetal microcephaly.
C1 [Li, Yang; Pan, Ming-Zhi] Shandong Prov Family Planning Inst Sci & Technol, Key Lab Improving Birth Outcome Tech, Maternal & Child Hlth Care Shandong Prov, Key Lab Birth Regulat & Control Technol Natl Hlth, Jinan, Peoples R China.
   [Tao, Guo-Wei; Ma, Zhe; Wu, Hai-Fang; Li, Qi] Shandong Univ, Qilu Hosp, Jinan, Peoples R China.
RP Tao, GW (corresponding author), Shandong Univ, Qilu Hosp, Jinan, Peoples R China.
EM taoguowei2006@163.com
CR Imaizumi Yoko, 1994, Congenital Anomalies, V34, P131, DOI 10.1111/j.1741-4520.1994.tb00796.x
   Jong-Pleij EAP, 2012, PRENAT DIAGN, V32, P797
   Leibovitz Z, 2016, ULTRASOUND OBST GYN, V47, P586, DOI 10.1002/uog.15801
   Lewis DW, 2002, NEUROLOGY, V59, P490, DOI 10.1212/WNL.59.4.490
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   Orioli IM, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5018
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Sadeghi Z, 2016, J MAZANDARAN U MED S, V25, P345
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
NR 14
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-7058
EI 1476-4954
J9 J MATERN-FETAL NEO M
JI J. Matern.-Fetal Neonatal Med.
PD JUL 17
PY 2020
VL 33
IS 14
BP 2372
EP 2376
DI 10.1080/14767058.2018.1551349
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LS9TL
UT WOS:000536721200008
PM 30608016
DA 2020-07-08
ER

PT J
AU Rejali, NA
   Zuiter, AM
   Quackenbush, JF
   Wittwer, CT
AF Rejali, Nick A.
   Zuiter, Aisha M.
   Quackenbush, John F.
   Wittwer, Carl T.
TI Reverse transcriptase kinetics for one-step RT-PCR
SO ANALYTICAL BIOCHEMISTRY
LA English
DT Article
DE Reverse transcriptase assay; One-step RT-PCR; cDNA predictions; Extreme
   RT-PCR; Transient-state kinetics; Steady-state kinetics
ID MURINE LEUKEMIA-VIRUS; STRAND DISPLACEMENT SYNTHESIS; DNA
   POLYMERIZATION; STEADY-STATE; EXTREME PCR; BINDING; MECHANISM; FIDELITY;
   TIME; AMPLIFICATION
AB Understanding reverse transcriptase (RT) activity is critical for designing fast one-step RT-PCRs. We report a stopped-flow assay that monitors SYBR Green I fluorescence to investigate RT activity in PCR conditions. We studied the influence of PCR conditions on RT activity and assessed the accuracy of cDNA synthesis predictions for one-step RT-PCR.
   Nucleotide incorporation increased from 26 to 89 s(-1) between 1.5 and 6 mM MgCl2 but was largely unaffected by changes in KCl. Conversely, increasing KCl from 15 to 75 mM increased apparent rate constants for RT-oligonucleotide binding (0.010-0.026 nm(-1) s(-1)) and unbinding (0.2-1.5 s(-1)). All rate constants increased between 22 and 42 degrees C.
   When evaluated by PCR quantification cycle, cDNA predictions differed from experiments using RNase H + RT (average 1.7 cycles) and RNase H- (average 4.5 cycles). Decreasing H+ RT concentrations 10 to 10(4)-fold from manufacturer recommendations improved cDNA predictions (average 0.8 cycles) and increased RT-PCR assay efficiency.
   RT activity assays and models can be used to aid assay design and improve the speed of RT-PCRs. RT type and concentration must be selected to promote rapid cDNA synthesis but minimize nonspecific amplification. We demonstrate 2-min one-step RT-PCR of a Zika virus target using reduced RT concentrations and extreme PCR.
C1 [Rejali, Nick A.; Zuiter, Aisha M.; Quackenbush, John F.; Wittwer, Carl T.] Univ Utah, Hlth Sci Ctr, Dept Pathol, Salt Lake City, UT 84132 USA.
RP Wittwer, CT (corresponding author), Univ Utah, Med Sch, Dept Pathol, Room 266,383 Colorow Dr, Salt Lake City, UT 84108 USA.
EM carl.wittwer@path.utah.edu
FU BioFire Diagnostics
FX This research was supported by a grant from BioFire Diagnostics.
CR ALTHAUS IW, 1993, BIOCHEMISTRY-US, V32, P6548, DOI 10.1021/bi00077a008
   Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049
   BEARD WA, 1993, BIOCHEMISTRY-US, V32, P9745, DOI 10.1021/bi00088a029
   Buckle M, 1996, P NATL ACAD SCI USA, V93, P889, DOI 10.1073/pnas.93.2.889
   Cavaluzzi MJ, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh015
   Farrar JS, 2015, CLIN CHEM, V61, P145, DOI 10.1373/clinchem.2014.228304
   Gerard GF, 2002, NUCLEIC ACIDS RES, V30, P3118, DOI 10.1093/nar/gkf417
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Gorshkova II, 2001, ANAL BIOCHEM, V291, P198, DOI 10.1006/abio.2001.5053
   GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155
   Heller RC, 2019, NUCLEIC ACIDS RES, V47, P3619, DOI 10.1093/nar/gkz104
   HSIEH JC, 1993, J BIOL CHEM, V268, P24607
   HUBER HE, 1989, J BIOL CHEM, V264, P4669
   Islam SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061340
   Johnson KA, 2009, ANAL BIOCHEM, V387, P30, DOI 10.1016/j.ab.2008.12.025
   Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024
   Jovin T M, 1977, Mol Biol Biochem Biophys, V24, P245
   Kaboev OK, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e94
   KATI WM, 1992, J BIOL CHEM, V267, P25988
   Kelleher CD, 1998, J BIOL CHEM, V273, P9976, DOI 10.1074/jbc.273.16.9976
   Koukhareva I, 2009, ANAL CHEM, V81, P4955, DOI 10.1021/ac8026977
   KRUHOFFER M, 1993, NUCLEIC ACIDS RES, V21, P3943, DOI 10.1093/nar/21.17.3943
   Kumar VS, 2015, CLIN CHEM, V61, P674, DOI 10.1373/clinchem.2014.236950
   Lanchy JM, 1996, EMBO J, V15, P7178, DOI 10.1002/j.1460-2075.1996.tb01109.x
   Marko RA, 2013, J PHYS CHEM B, V117, P4560, DOI 10.1021/jp308674g
   Millington Adam L, 2019, Biomol Detect Quantif, V17, P100081, DOI 10.1016/j.bdq.2019.100081
   Mizuguchi H, 1999, J BIOCHEM-TOKYO, V126, P762, DOI 10.1093/oxfordjournals.jbchem.a022514
   Montgomery JL, 2014, CLIN CHEM, V60, P334, DOI 10.1373/clinchem.2013.212829
   Montgomery JL, 2013, ANAL BIOCHEM, V441, P133, DOI 10.1016/j.ab.2013.07.008
   Nolte F.S., 2016, MOL MICROBIOL DIAGNO, P3, DOI [10.1128/9781555819071., DOI 10.1128/9781555819071]
   Paliksa S, 2018, PROTEIN ENG DES SEL, V31, P79, DOI 10.1093/protein/gzy003
   PATEL PH, 1995, BIOCHEMISTRY-US, V34, P5351, DOI 10.1021/bi00016a006
   PETERS T, 1985, ADV PROTEIN CHEM, V37, P161, DOI 10.1016/S0065-3233(08)60065-0
   Quackenbush JF, 2014, METHODS MOL BIOL, V1102, P641, DOI 10.1007/978-1-62703-727-3_34
   REARDON JE, 1992, BIOCHEMISTRY-US, V31, P4473, DOI 10.1021/bi00133a013
   Rejali NA, 2018, CLIN CHEM, V64, P801, DOI 10.1373/clinchem.2017.282285
   Rothwell PJ, 2003, P NATL ACAD SCI USA, V100, P1655, DOI 10.1073/pnas.0434003100
   SELLNER LN, 1992, NUCLEIC ACIDS RES, V20, P1487, DOI 10.1093/nar/20.7.1487
   SELWYN MJ, 1965, BIOCHIM BIOPHYS ACTA, V105, P193, DOI 10.1016/S0926-6593(65)80190-4
   Shi QL, 2002, BIOCHEMISTRY-US, V41, P14831, DOI 10.1021/bi0258389
   Skasko M, 2005, J BIOL CHEM, V280, P12190, DOI 10.1074/jbc.M412859200
   Suslov O, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni176
   Wang Xiaofang, 2014, Environ Health Toxicol, V29, pe2014007, DOI 10.5620/eht.2014.29.e2014007
   WITTWER CT, 1991, BIOTECHNIQUES, V10, P76
   Wohrl BM, 1999, J MOL BIOL, V292, P333, DOI 10.1006/jmbi.1999.3057
   WONG I, 1991, BIOCHEMISTRY-US, V30, P526, DOI 10.1021/bi00216a030
   Wu L, 2005, ACTA BIOCH BIOPH SIN, V37, P634, DOI 10.1111/j.1745-7270.2005.00088.x
   Wulf MG, 2019, J BIOL CHEM, V294, P18220, DOI 10.1074/jbc.RA119.010676
   Yasukawa K, 2010, J BIOTECHNOL, V150, P299, DOI 10.1016/j.jbiotec.2010.09.961
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 50
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0003-2697
EI 1096-0309
J9 ANAL BIOCHEM
JI Anal. Biochem.
PD JUL 15
PY 2020
VL 601
AR UNSP 113768
DI 10.1016/j.ab.2020.113768
PG 10
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA LX9YS
UT WOS:000540182300006
PM 32416095
DA 2020-07-08
ER

PT J
AU de Souza, GAP
   Salvador, EA
   de Oliveira, FR
   Malaquias, LCC
   Abrahao, JS
   Coelho, LFL
AF Pires de Souza, Gabriel Augusto
   Salvador, Ezequiel Aparecido
   de Oliveira, Fernanda Roza
   Cotta Malaquias, Luiz Cosme
   Abrahao, Jonatas Santos
   Leomil Coelho, Luiz Felipe
TI An in silico integrative protocol for identifying key genes and pathways
   useful to understand emerging virus disease pathogenesis
SO VIRUS RESEARCH
LA English
DT Article
DE Integrative bioinformatics; Emerging virus disease; Pathogenesis
ID ZIKA-VIRUS
AB The pathogenesis of an emerging virus disease is a difficult task due to lack of scientific data about the emerging virus during outbreak threats. Several biological aspects should be studied faster, such as virus replication and dissemination, immune responses to this emerging virus on susceptible host and specially the virus pathogenesis. Integrative in silico transcriptome analysis is a promising approach for understanding biological events in complex diseases. In this study, we propose an in silico protocol for identifying key genes and pathways useful to understand emerging virus disease pathogenesis. To validate our protocol, the emerging arbovirus Zika virus (ZIKV) was chosen as a target micro-organism. First, an integrative transcriptome data from neural cells infected with ZIKV was used to identify shared differentially expressed genes (DEGs). The DEGs were used to identify the potential candidate genes and pathways in ZIKV pathogenesis through gene enrichment analysis and protein-protein interaction network construction. Thirty DEGs (24 upregulated and 6 downregulated) were identified in all ZIKV-infected cells, primarily associated with endoplasmic reticulum stress and DNA replication pathways. Some of these genes and pathways had biological functions linked to neurogenesis and/or apoptosis, confirming the potential of this protocol to find key genes and pathways involved on disease pathogenesis. Moreover, the proposed in silico protocol performed anintegrated analysis that is able to predict and identify putative biomarkers from different transcriptome data. These biomarkers could be useful to understand virus disease pathogenesis and also help the identification of candidate antiviral drugs.
C1 [Pires de Souza, Gabriel Augusto; Salvador, Ezequiel Aparecido; de Oliveira, Fernanda Roza; Cotta Malaquias, Luiz Cosme; Leomil Coelho, Luiz Felipe] Univ Fed Alfenas, Inst Ciencias Biomed, Dept Microbiol & Imunol, Lab Vacinas, Alfenas, MG, Brazil.
   [Pires de Souza, Gabriel Augusto; Abrahao, Jonatas Santos] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Microbiol, Lab Virus, Belo Horizonte, MG, Brazil.
RP Coelho, LFL (corresponding author), Univ Fed Alfenas, Inst Ciencias Biomed, Lab Vacinas, Rua Gabriel Monteiro,700 Ctr, BR-37130000 Alfenas, MG, Brazil.
EM luiz.coelho@unifal-mg.edu.br
OI Salvador, Ezequiel/0000-0002-1403-8953; Coelho, Luiz
   Felipe/0000-0003-4289-384X
FU Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)Minas
   Gerais State Research Foundation (FAPEMIG) [APQ-01165-16, PPM-00399-18];
   FAPEMIGMinas Gerais State Research Foundation (FAPEMIG); Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq -
   PIBIC)National Council for Scientific and Technological Development
   (CNPq); CNPqNational Council for Scientific and Technological
   Development (CNPq); Coordenacao deAperfeicoamento de Pessoal de Nivel
   Superior, Brasil (CAPES)CAPES [001]
FX This work was supported in part by the Fundacao de Amparo a Pesquisa do
   Estado de Minas Gerais (FAPEMIG) (grants APQ-01165-16 and PPM-00399-18).
   G.A.P.S. and E.A.S. received fellowships from FAPEMIG. F.R.O. received
   fellowships from Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq - PIBIC). L.F.L.C. and J.S.A. received PQ fellowship
   from CNPq. This study was financed in part by the Coordenacao
   deAperfeicoamento de Pessoal de Nivel Superior, Brasil (CAPES). Finance
   Code 001.
CR Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379
   Afrough B, 2019, CLIN EXP IMMUNOL, V196, P157, DOI 10.1111/cei.13295
   Amrit F.R.G., 2017, JOVE-J VIS EXP, V122, P1, DOI [10.3791/55473, DOI 10.3791/55473.]
   Bastian M., 2009, GEPHI OPEN SOURCE SO
   BATTARRA R, 2016, NATURE, P1, DOI DOI 10.1038/NATURE18952
   Beltran PMJ, 2017, MOL SYST BIOL, V13, DOI 10.15252/msb.20167062
   Berkhout B, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00031
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cinegaglia NC, 2016, ONCOTARGET, V7, P28920, DOI 10.18632/oncotarget.8713
   Dang JW, 2019, CELL REP, V27, P3618, DOI 10.1016/j.celrep.2019.05.059
   Ellwanger JH, 2016, BRAZ J INFECT DIS, V20, P403, DOI 10.1016/j.bjid.2016.02.003
   Hammack C, 2019, J VIROL, V93, DOI 10.1128/JVI.00638-19
   Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036
   Hoshida Y, 2009, CANCER RES, V69, P7385, DOI 10.1158/0008-5472.CAN-09-1089
   Jin C, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00250
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Tellechea AL, 2018, BIRTH DEFECTS RES, V110, P1016, DOI 10.1002/bdr2.1347
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liao QB, 2017, J TRANSL MED, V15, DOI 10.1186/s12967-017-1130-y
   Linda Hans, 2011, Front Neurol, V2, P30, DOI 10.3389/fneur.2011.00030
   Mahar M, 2018, NAT REV NEUROSCI, V19, P323, DOI 10.1038/s41583-018-0001-8
   Moni MA, 2017, J INFECT DIS, V216, P703, DOI 10.1093/infdis/jix327
   Moslehi R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02407
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Olival KJ, 2017, NATURE, V546, P646, DOI 10.1038/nature22975
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Russso B.R., 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI [10.1016/j.bbrc.2017.01.074., DOI 10.1016/J.BBRC.2017.01.074]
   Shi Y., 2017, TRENDS BIOCHEM SCI, P1, DOI [10.1016/j.tibs.2017.02.009.xx., DOI 10.1016/J.TIBS.2017.02.009.XX.]
   Singh P.K., 2018, SCI REP, V8, P1, DOI [10.1038/s41598-018-29329-2., DOI 10.1038/S41598-018-29329-2.]
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   TAN L, 2018, J AM CERAM SOC, P1
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Varis A, 2006, CHROMOSOMA, V115, P288, DOI 10.1007/s00412-005-0046-0
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zhang FR, 2016, NUCLEIC ACIDS RES, V44, P8610, DOI [10.1093/nar/gkw765, 10]
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 43
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JUL 15
PY 2020
VL 284
AR 197986
DI 10.1016/j.virusres.2020.197986
PG 9
WC Virology
SC Virology
GA LQ6SF
UT WOS:000535130400006
PM 32339536
DA 2020-07-08
ER

PT J
AU Jones, AS
   Cohen, D
   Alberdi, F
   Sanabria, A
   Clausell, N
   Roca, M
   Fionah, AK
   Kumar, N
   Solo-Gabriele, HM
   Zahran, EM
AF Jones, Athena S.
   Cohen, David
   Alberdi, Francisco
   Sanabria, Amanda
   Clausell, Nakiya
   Roca, Matthew
   Fionah, Abelline K.
   Kumar, Naresh
   Solo-Gabriele, Helena M.
   Zahran, Elsayed M.
TI Persistence of aerially applied mosquito-pesticide, Naled, in fresh and
   marine waters
SO SCIENCE OF THE TOTAL ENVIRONMENT
LA English
DT Article
DE Naled; Dichlorvos; Aerial spray; Water; Zika
ID HEALTH RISK-ASSESSMENT; DEGRADATION; DICHLORVOS; TOXICITY;
   DEHALOGENATION
AB Naled, an organophosphate pesticide, received considerable attention during 2016 as it was applied aerially to control the first mosquito-borne Zika virus outbreak in the continental United States. Stakeholders living in affected areas raised concerns about its environmental impacts. One factor influencing environmental impacts is the persistence of the chemical applied. The objective of this study was to evaluate the persistence of naled and its degradation bi-product, dichlorvos - in natural waters. Initial naled concentrations were measured at ground level after full-scale aerial spray activities. Laboratory experiments were designed to evaluate factors (fresh versus marine water chemistry, temperature, and sunlight) that may promote the degradation of naled and dichlorvos in the environment. Results show that natural fresh and marine water chemistry promoted naled degradation as experiments with de-ionized water resulted in half-lives greater than 6 days. The half-life in natural waters without light ranged from 5 to 20 h with lower half lives at higher temperatures. Under light exposure, degradation was accelerated and yielded more dichlorvos. Detectable levels (0.05 mu M for naled and 0.10 mu M for dichlorvos) were measured in water samples collected from the field during aerial spray events. Results can be used in risk assessments that consider both naled and dichlorvos to better understand ecological impacts and to develop improved public health recommendations. (C) 2020 Elsevier B.V. All rights reserved.
C1 [Jones, Athena S.; Cohen, David; Alberdi, Francisco; Sanabria, Amanda; Clausell, Nakiya; Roca, Matthew; Solo-Gabriele, Helena M.] Univ Miami, Dept Civil Architectural & Environm Engn, Coral Gables, FL 33124 USA.
   [Kumar, Naresh] Univ Miami, Dept Publ Hlth Sci, Coral Gables, FL 33124 USA.
   [Fionah, Abelline K.; Zahran, Elsayed M.] Ball State Univ, Dept Chem, Muncie, IN 47306 USA.
RP Solo-Gabriele, HM (corresponding author), 1251 Mem Dr,McArthur Engn Bldg,POB 248294, Coral Gables, FL 33124 USA.
EM hmsolo@miami.edu
OI Solo-Gabriele, Helena/0000-0003-3390-3823; Kumar,
   Naresh/0000-0001-6200-9172
FU NSFNational Science Foundation (NSF) [CBET-1709939]; Ball State
   University
FX This study was funded by NSF CBET-1709939. We thank AMVAC for the
   provision of the naled standard and the Miami-Dade, Collier, and Broward
   County mosquito control districts for sharing information about their
   local spray activities. We are also appreciative of MiamiDade County
   Department of Health for guidance on public outreach. EMZ acknowledges
   support from Ball State University.
CR Agency for Toxic Substances and Disease Registry (ATSDR), 1997, TOX PROF DICHL
   AMVAC Chemical Corporation, 2015, SAFETY DATA SHEET
   [Anonymous], 2016, DAILY NEWS
   Davis RS, 2007, INTEGR ENVIRON ASSES, V3, P373, DOI 10.1002/ieam.5630030308
   Dukes J, 2004, J AM MOSQUITO CONTR, V20, P36
   Dulin F, 2012, ECOTOX ENVIRON SAFE, V79, P13, DOI 10.1016/j.ecoenv.2012.01.007
   Fontaine B, 2013, J GEOCHEM EXPLOR, V129, P28, DOI 10.1016/j.gexplo.2012.11.003
   Gan Q, 2006, ENVIRON SCI TECHNOL, V40, P778, DOI 10.1021/es051482n
   Gan Q, 2006, ENVIRON SCI TECHNOL, V40, P5717, DOI 10.1021/es060485c
   GORE R C, 1971, Journal of the Association of Official Analytical Chemists, V54, P1040
   Hall GL, 1997, J AGR FOOD CHEM, V45, P145, DOI 10.1021/jf9601224
   Hengel M, 2014, ENVIRON MONIT ASSESS, V186, P1343, DOI 10.1007/s10661-013-3395-9
   Herald Miami, 2016, TEMPERS FLARE PUBLIC
   Hertz-Picciotto I, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002671
   Hoang TC, 2011, ENVIRON TOXICOL CHEM, V30, P997, DOI 10.1002/etc.462
   Howard P.H., 1991, HDB ENV FATE EXPOSUR
   Johnson W.W., 1980, RESOURCE PUBLICATION, V137
   LATIF S, 1984, J CHROMATOGR, V287, P77, DOI 10.1016/S0021-9673(01)87675-5
   Mills PK, 2003, J OCCUP ENVIRON MED, V45, P249, DOI 10.1097/01.jom.0000058339.05741.0c
   National Pesticide Information Center (NPIC), 1996, EXT EXT TOX NETW PES
   Ollerton J, 2011, OIKOS, V120, P321, DOI 10.1111/j.1600-0706.2010.18644.x
   Park JW, 2000, ARCH ENVIRON CON TOX, V38, P405, DOI 10.1007/s002449910054
   Peterson RKD, 2006, ENVIRON HEALTH PERSP, V114, P366, DOI 10.1289/ehp.8667
   Pierce RH, 2005, REV BIOL TROP, V53, P117
   Rinkevich FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139841
   Sadowsky D, 2014, ENVIRON SCI TECHNOL, V48, P10904, DOI 10.1021/es5028822
   Schleier JJ, 2008, HUM ECOL RISK ASSESS, V14, P392, DOI 10.1080/10807030801934812
   Schleier JJ, 2010, ECOTOXICOLOGY, V19, P1140, DOI 10.1007/s10646-010-0497-9
   Schleier JJ, 2010, ARCH ENVIRON CON TOX, V58, P105, DOI 10.1007/s00244-009-9353-4
   Schleier JJ, 2009, STOCH ENV RES RISK A, V23, P555, DOI 10.1007/s00477-008-0227-5
   Silver MK, 2017, ENVIRON INT, V106, P248, DOI 10.1016/j.envint.2017.05.015
   Skoog D.A., 1992, ANAL CHEM INTRO, P50
   Tietze NS, 1996, J AM MOSQUITO CONTR, V12, P251
   U.S. Department of Agriculture (USDA), 2018, DRAFT HUM HLTH EC RI
   U.S. Environmental Protection Agency, 2020, NAL
   U.S. Environmental Protection Agency, 2016, NAL MOSQ CONTR
   U.S. Environmental Protection Agency (U.S. EPA), 1995, DICHL DDVP DEL CERT, P19580
   Zhong H, 2003, ARCH ENVIRON CON TOX, V45, P216, DOI 10.1007/s00244-002-0185-8
NR 38
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0048-9697
EI 1879-1026
J9 SCI TOTAL ENVIRON
JI Sci. Total Environ.
PD JUL 10
PY 2020
VL 725
AR 138391
DI 10.1016/j.scitotenv.2020.138391
PG 9
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA LU0CG
UT WOS:000537430800020
PM 32302840
DA 2020-07-08
ER

PT J
AU Majee, P
   Shankar, U
   Pasadi, S
   Muniyappa, K
   Nayak, D
   Kumar, A
AF Majee, Prativa
   Shankar, Uma
   Pasadi, Sanjeev
   Muniyappa, K.
   Nayak, Debasis
   Kumar, Amit
TI Genome-wide analysis reveals a regulatory role for G-quadruplexes during
   Adenovirus multiplication
SO VIRUS RESEARCH
LA English
DT Article
DE Human Adenovirus; Adenovirus-based vectors; G-quadruplex; Braco-19;
   Virus multiplication
ID LONG TERMINAL REPEAT; MILITARY RECRUITS; DNA; OUTBREAK; MOTIFS; RNA;
   EPIDEMIOLOGY; RADIODURANS; PREDICTION; BINDING
AB The G-quadruplex (GQ) motifs have recently been gaining prominence because of their role as gene cis-regulatory elements in a variety of organisms and as potential druggable targets for anti-cancer therapy and ageing. Several studies have demonstrated the existence of GQs in the genomes of emerging and re-emerging human pathogens, such as hepatitis virus, herpesviruses, Ebola virus, Zika virus and Nipah virus. Human Adenovirus (HAdV) exhibits a large number of clinical manifestations especially infecting the children and the immunocompromised patients. Moreover, the HAdV-based vectors have been widely used to deliver foreign DNAs to cells in gene therapy. However, the DNA secondary structural elements in AdV-based vectors could significantly determine the gene delivery efficacy of the vectors. In this study, using a combination of whole genome sequence analysis, biochemical, biophysical and interaction assays, we revealed fifteen putative GQs that are conserved across the different species of HAdV. We further showed that the GQs are embedded in the sequences of essential viral genes, namely E1B, E2B, and L3 genes (among others), which are involved in the early and late stages of the viral life cycle. Notably, Braco-19 (a well-known GQ binding ligand) interacted specifically with the HAdV GQs and increased their stability and further blocked the HAdV multiplication in human cells. Taken together, our data strongly supported the existence of G-quadruplex structures in the HAdV genome that affect the virus multiplication and posit that such structures may influence the efficacy of the genedelivery vectors or even the HAdV virus life-cycle.
C1 [Majee, Prativa; Shankar, Uma; Nayak, Debasis; Kumar, Amit] Indian Inst Technol Indore, Discipline Biosci & Biomed Engn, Indore 453552, Madhya Pradesh, India.
   [Pasadi, Sanjeev; Muniyappa, K.] Indian Inst Sci, Dept Biochem, Bangalore 560012, Karnataka, India.
RP Kumar, A (corresponding author), Indian Inst Technol Indore, Discipline Biosci & Biomed Engn, Indore 453552, Madhya Pradesh, India.
EM amitk@iiti.ac.in
FU SERB, DST, New Delhi, India [EMR/2016/003897]; MHRD, New Delhi; J.C.
   Bose National Fellowship from the Government of India, New Delhi; CSIR
   Bhatnagar Fellowship from the Government of India, New Delhi
FX The authors are grateful to SIC Facility at IIT Indore for access to NMR
   and CD instruments. A.K. is thankful to SERB, DST, New Delhi, India for
   the EMR grant (EMR/2016/003897). P.M. and U.S. are thankful to MHRD, New
   Delhi for their individual fellowships. K.M. is the recipient of J.C.
   Bose National Fellowship, CSIR Bhatnagar Fellowship from the Government
   of India, New Delhi.
CR Adrian M, 2012, METHODS, V57, P11, DOI 10.1016/j.ymeth.2012.05.003
   Artusi S, 2015, ANTIVIR RES, V118, P123, DOI 10.1016/j.antiviral.2015.03.016
   Beaume N, 2013, NUCLEIC ACIDS RES, V41, P76, DOI 10.1093/nar/gks1071
   Bhattacharyya D, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00038
   Bidzinska J, 2013, MOLECULES, V18, P12368, DOI 10.3390/molecules181012368
   Biswas B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3282-1
   Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295
   Cheng J, 2016, AM J TRANSL RES, V8, P2331
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   De Nicola B, 2016, NUCLEIC ACIDS RES, V44, P6442, DOI 10.1093/nar/gkw432
   Del Villar-Guerra Rafael, 2017, Curr Protoc Nucleic Acid Chem, V68, DOI 10.1002/cpnc.23
   Fay MM, 2017, J MOL BIOL, V429, P2127, DOI 10.1016/j.jmb.2017.05.017
   Fleming AM, 2016, ACS INFECT DIS, V2, P674, DOI 10.1021/acsinfecdis.6b00109
   Frasson I, 2019, MOLECULES, V24, DOI 10.3390/molecules24132375
   Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   Hershman SG, 2008, NUCLEIC ACIDS RES, V36, P144, DOI 10.1093/nar/gkm986
   Jeon K, 2007, EUR J CLIN MICROBIOL, V26, P481, DOI 10.1007/s10096-007-0312-6
   Kaplan OI, 2016, NUCLEIC ACIDS RES, V44, P9083, DOI 10.1093/nar/gkw769
   Khanal S, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010030
   Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253
   Kong JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32222-7
   Kota S, 2015, APPL MICROBIOL BIOT, V99, P9761, DOI 10.1007/s00253-015-6808-6
   Luo J, 2007, NAT PROTOC, V2, P1236, DOI 10.1038/nprot.2007.135
   Lynch JP, 2016, SEMIN RESP CRIT CARE, V37, P586, DOI 10.1055/s-0036-1584923
   Majee Prativa, 2020, Sci Rep, V10, P1477, DOI 10.1038/s41598-020-58406-8
   Mishra SK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38400-x
   Mishra SK, 2016, SCI REP-UK, V6, DOI 10.1038/srep38144
   Perrone R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05867-z
   Perrone R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02291-1
   Perrone R, 2015, J MED CHEM, V58, P9639, DOI 10.1021/acs.jmedchem.5b01283
   Perrone R, 2014, J ANTIMICROB CHEMOTH, V69, P3248, DOI 10.1093/jac/dku280
   Perrone R, 2013, J MED CHEM, V56, P6521, DOI 10.1021/jm400914r
   Radin JM, 2014, CLIN INFECT DIS, V59, P962, DOI 10.1093/cid/ciu507
   Rawal P, 2006, GENOME RES, V16, P644, DOI 10.1101/gr.4508806
   Ruggiero E, 2019, ACS INFECT DIS, V5, P1150, DOI 10.1021/acsinfecdis.9b00011
   Ruggiero E, 2018, NUCLEIC ACIDS RES, V46, P3270, DOI 10.1093/nar/gky187
   Sun D, 2010, METHODS MOL BIOL, V608, P65, DOI 10.1007/978-1-59745-363-9_5
   Tawani A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03906-3
   Tawani A, 2016, SCI REP-UK, V6, DOI 10.1038/srep39239
   Tawani A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17574
   Tluckova K, 2013, BIOCHEMISTRY-US, V52, P7207, DOI 10.1021/bi400897g
   Voter AF, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00607-19
   Walls T, 2003, LANCET INFECT DIS, V3, P79, DOI 10.1016/S1473-3099(03)00515-2
   Wang SR, 2016, CELL CHEM BIOL, V23, P1113, DOI 10.1016/j.chembiol.2016.07.019
   Wang SR, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501535
   Waye MMY, 2010, PHARMACEUTICALS-BASE, V3, P3343, DOI 10.3390/ph3103343
   Wold WSM, 2013, CURR GENE THER, V13, P421
   Yildiz U, 2020, MOL BIOL REP, V47, P1563, DOI 10.1007/s11033-019-05239-y
   Yu PB, 2013, MICROBIOL IMMUNOL, V57, P553, DOI 10.1111/1348-0421.12074
   Yusof MA, 2012, EMERG INFECT DIS, V18, P852, DOI 10.3201/eid1805.110865
   Zahin M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195625
NR 52
TC 0
Z9 0
U1 12
U2 12
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD JUL 2
PY 2020
VL 283
AR 197960
DI 10.1016/j.virusres.2020.197960
PG 11
WC Virology
SC Virology
GA LK7YP
UT WOS:000531077800010
PM 32289341
DA 2020-07-08
ER

PT J
AU Kanodia, P
   Prasanth, KR
   Roa-Linares, VC
   Bradrick, SS
   Garcia-Blanco, MA
   Miller, WA
AF Kanodia, Pulkit
   Prasanth, K. Reddisiva
   Roa-Linares, Vicky C.
   Bradrick, Shelton S.
   Garcia-Blanco, Mariano A.
   Miller, W. Allen
TI A rapid and simple quantitative method for specific detection of smaller
   coterminal RNA by PCR (DeSCo-PCR): application to the detection of viral
   subgenomic RNAs
SO RNA
LA English
DT Article
DE truncated RNA; flavivirus; Tombusviridae; Zika virus; long noncoding RNA
ID LOCKED NUCLEIC-ACIDS; FLAVIVIRUS RNA; ZIKA VIRUS; GENE-EXPRESSION;
   TRANSCRIPTION; INTERFERENCE; REPLICATION; TRANSLATION; PSEUDOKNOT
AB RNAs that are 5'-truncated versions of a longer RNA but share the same 3' terminus can be generated by alternative promoters in transcription of cellular mRNAs or by replicating RNA viruses. These truncated RNAs cannot be distinguished from the longer RNA by a simple two-primer RT-PCR because primers that anneal to the cDNA from the smaller RNA also anneal to-and amplify-the longer RNA-derived cDNA. Thus, laborious methods, such as northern blot hybridization, are used to distinguish shorter from longer RNAs. For rapid, low-cost, and specific detection of these truncated RNAs, we report detection of smaller coterminal RNA by PCR (DeSCo-PCR). DeSCo-PCR uses a nonextendable blocking primer (BP), which outcompetes a forward primer (FP) for annealing to longer RNA-derived cDNA, while FP outcompetes BP for annealing to shorter RNA-derived cDNA. In the presence of BP, FP, and the reverse primer, only cDNA from the shorter RNA is amplified in a single-tube reaction containing both RNAs. Many positive strand RNA viruses generate 5'-truncated forms of the genomic RNA (gRNA) called subgenomic RNAs (sgRNA), which play key roles in viral gene expression and pathogenicity. We demonstrate that DeSCo-PCR is easily optimized to selectively detect relative quantities of sgRNAs of red clover necrotic mosaic virus from plants and Zika virus from human cells, each infected with viral strains that generate different amounts of sgRNA. This technique should be readily adaptable to other sgRNA-producing viruses, and for quantitative detection of any truncated or alternatively spliced RNA.
C1 [Kanodia, Pulkit; Miller, W. Allen] Iowa State Univ, Interdept Genet & Genom, Ames, IA 50011 USA.
   [Kanodia, Pulkit; Miller, W. Allen] Iowa State Univ, Plant Pathol & Microbiol Dept, Ames, IA 50011 USA.
   [Prasanth, K. Reddisiva; Roa-Linares, Vicky C.; Bradrick, Shelton S.; Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Roa-Linares, Vicky C.] Univ Antioquia, Inst Med Res, Mol & Translat Med Grp, Fac Med, Medellin 050010, Colombia.
   [Garcia-Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore 169857, Singapore.
   [Garcia-Blanco, Mariano A.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Bradrick, Shelton S.] MRIGlobal, Kansas City, MO 64110 USA.
RP Miller, WA (corresponding author), Iowa State Univ, Interdept Genet & Genom, Ames, IA 50011 USA.; Miller, WA (corresponding author), Iowa State Univ, Plant Pathol & Microbiol Dept, Ames, IA 50011 USA.
EM wamiller@iastate.edu
RI ; kanodia, pulkit/H-7150-2016
OI Garcia-Blanco, Mariano/0000-0001-8538-1997; kanodia,
   pulkit/0000-0001-7904-5129; Roa Linares, Vicky/0000-0001-9253-615X;
   Bradrick, Shelton/0000-0003-1566-9797
FU Iowa State University Plant Sciences Institute Faculty Scholar award;
   National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01 GM067104];
   University of Texas Medical Branch; University of Texas STARs Award;
   Comite para el Desarrollo de la Investigacion of University of Antioquia
   [2014-1041]
FX We thank Dr. Tim L. Sit and Dr. S.A. Lommel for providing us with RCNMV
   clones, Dr. Surapathrudu Kanakala for his support, critique, and advice
   on developing the method, and Dr. Steve Whitham for advising on the
   manuscript. This work was supported by Iowa State University Plant
   Sciences Institute Faculty Scholar award (W.A.M.); National Institute of
   General Medical Sciences (grant number R01 GM067104) (W.A.M.); start-up
   funds from the University of Texas Medical Branch and a University of
   Texas STARs Award (M.A.G.B.); and financial support from Comite para el
   Desarrollo de la Investigacion of University of Antioquia/Grant
   2014-1041 (V.C.R.L.).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Amiss T, 2005, MOL DIAGNOSTICS CLIN, P31
   Ballantyne KN, 2008, GENOMICS, V91, P301, DOI 10.1016/j.ygeno.2007.10.016
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Bidet K, 2014, BIOCHEM J, V462, P215, DOI 10.1042/BJ20140456
   Contigiani MS, 2017, ARTHROPOD BORNE DIS, P115
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Ferraris P, 2019, MICROBES INFECT, V21, P353, DOI 10.1016/j.micinf.2019.04.005
   Finol E, 2019, ISCIENCE, V16, P94, DOI 10.1016/j.isci.2019.05.019
   Flobinus A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030137
   Flobinus A, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100272
   Galipon J, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020068
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   GOULD AR, 1981, VIROLOGY, V108, P499, DOI 10.1016/0042-6822(81)90457-8
   HIRUKI C, 1987, ADV VIRUS RES, V33, P257, DOI 10.1016/S0065-3527(08)60320-6
   Iwakawa HO, 2008, J VIROL, V82, P10162, DOI 10.1128/JVI.01027-08
   Kandoi G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50119-x
   Kandoi G, 2017, IEEE INT C BIOINFORM, P2163, DOI 10.1109/BIBM.2017.8217993
   KESSLER C, 1990, BIOL CHEM H-S, V371, P917, DOI 10.1515/bchm3.1990.371.2.917
   Koev G, 2000, J VIROL, V74, P5988, DOI 10.1128/JVI.74.13.5988-5996.2000
   Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5
   Lee JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051101
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Miller WA, 2016, MOL PLANT MICROBE IN, V29, P156, DOI 10.1094/MPMI-10-15-0226-FI
   Miller WA, 2015, VIRUS RES, V206, P37, DOI 10.1016/j.virusres.2015.03.009
   Miller WA, 2000, VIROLOGY, V273, P1, DOI 10.1006/viro.2000.0421
   MONROE SS, 1993, J VIROL, V67, P3611, DOI 10.1128/JVI.67.6.3611-3614.1993
   Moon SL, 2015, VIROLOGY, V485, P322, DOI 10.1016/j.virol.2015.08.009
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Peltier C, 2012, J GEN VIROL, V93, P1093, DOI 10.1099/vir.0.039685-0
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Qin ZY, 2018, NUCLEIC ACIDS RES, V46, DOI 10.1093/nar/gky053
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112
   Royall E, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8040104
   SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463
   Scheets K, 2000, VIROLOGY, V267, P90, DOI 10.1006/viro.1999.0107
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shen RZ, 2006, J VIROL, V80, P10045, DOI 10.1128/JVI.00991-06
   Shen RZ, 2004, VIROLOGY, V327, P196, DOI 10.1016/j.virol.2004.06.025
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sit TL, 1998, SCIENCE, V281, P829, DOI 10.1126/science.281.5378.829
   Soto-Acosta R, 2018, ELIFE, V7, DOI 10.7554/eLife.39023
   Steckelberg AL, 2018, P NATL ACAD SCI USA, V115, P6404, DOI 10.1073/pnas.1802429115
   STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994
   Sztuba-Solinska J, 2011, VIROLOGY, V412, P245, DOI 10.1016/j.virol.2011.02.007
   Veedu RN, 2008, J AM CHEM SOC, V130, P8124, DOI 10.1021/ja801389n
   Wang X, 2016, MOL SYST BIOL, V12, DOI 10.15252/msb.20166941
   XIONG ZG, 1991, VIROLOGY, V182, P388, DOI 10.1016/0042-6822(91)90687-7
   Xu TZ, 2019, VIRUS RES, V259, P97, DOI 10.1016/j.virusres.2018.10.013
NR 55
TC 0
Z9 0
U1 1
U2 1
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD JUL
PY 2020
VL 26
IS 7
BP 888
EP 901
DI 10.1261/rna.074963.120
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA MA4PP
UT WOS:000541897400011
PM 32238481
OA Bronze
DA 2020-07-08
ER

PT J
AU Nadim, SS
   Ghosh, I
   Martcheva, M
   Chattopadhyay, J
AF Nadim, Sk Shahid
   Ghosh, Indrajit
   Martcheva, Maia
   Chattopadhyay, Joydev
TI Impact of venereal transmission on the dynamics of vertically
   transmitted viral diseases among mosquitoes
SO MATHEMATICAL BIOSCIENCES
LA English
DT Article
DE Mosquito-borne diseases; Venereal transmission; Mathematical model;
   Basic reproduction number; Stability analysis; Numerical simulation
ID WEST-NILE-VIRUS; AEDES-AEGYPTI DIPTERA; DENGUE VIRUSES; WOLBACHIA
   INFECTION; CHIKUNGUNYA VIRUS; CULEX
AB Despite centuries of enormous control efforts, mosquito-borne diseases continue to show upward trend of morbidity. According to WHO reports, malaria caused 438000 deaths in the year 2015 and dengue cases have been increased 30-fold over the last five decades. To control these diseases, it is necessary to understand the transmission dynamics of them among mosquitoes. There are some vertically transmitted mosquito-borne diseases which can also be spread among mosquitoes through sexual contact (e.g., dengue, zika, chikungunya). Recent experimental observations indicate that for virus persistence in mosquito population, the role of venereal transmission cannot be ignored. It is therefore important to investigate which transmission route is more responsible for the persistence of the virus when there is no host. To this aim, we propose and analyze a novel compartmental model considering mosquito population only. To the best of authors knowledge, this is the first attempt to take into account both vertical and sexual transmission of the virus in a mathematical model. Expression representing the basic reproduction number is derived using Jacobian approach. Local stability conditions for disease-free equilibrium and complete infection equilibrium are obtained. Global sensitivity analysis of the system is performed with respect to an epidemiologically important response. While investigating the impact of sexual transmission in presence of vertical transmission, we observed that sexual transmission route has the potential to drive the equilibrium from disease free to endemic states. Further numerical experiments reveal that the virus will have higher half life in fertilized infected female mosquitoes for vertical transmission only than for venereal transmission alone. Furthermore, when both transmission pathways are active, a variety of parameters indicate threshold like behavior of the infection.
C1 [Nadim, Sk Shahid; Ghosh, Indrajit; Chattopadhyay, Joydev] Indian Stat Inst, Agr & Ecol Res Unit, Kolkata 700108, W Bengal, India.
   [Martcheva, Maia] Univ Florida, Dept Math, Gainesville, FL 32611 USA.
RP Ghosh, I (corresponding author), Indian Stat Inst, Agr & Ecol Res Unit, Kolkata 700108, W Bengal, India.
EM indra7math@gmail.com
FU CSIR, Government of India, New DelhiCouncil of Scientific & Industrial
   Research (CSIR) - India; Indian Statistical Institute, Kolkata
FX The authors are grateful to the anonymous referees for their careful
   reading, valuable comments and helpful suggestions, which have helped
   them to improve the standard of this work. Sk Shahid Nadim receives
   fellowship from CSIR, Government of India, New Delhi. Research of
   Indrajit Ghosh is financially supported in part by the Indian
   Statistical Institute, Kolkata during his visiting scientist position at
   this institute.
CR Abdelrazec A, 2016, MATH BIOSCI, V271, P136, DOI 10.1016/j.mbs.2015.11.004
   Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   BAQAR S, 1993, AM J TROP MED HYG, V48, P757, DOI 10.4269/ajtmh.1993.48.757
   Charron MVP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074213
   Chotiwan N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006853
   Christophers S., 1960, AEDES AEGYPTI L YELL
   Clements Alan Neville, 1992, BIOL MOSQUITOES DEV, V1, P509
   de Pinho Suani Tavares Rubim, 2010, PHIL T R SOC A, V368, P5679
   Dohm DJ, 2002, J MED ENTOMOL, V39, P640, DOI 10.1603/0022-2585-39.4.640
   Esteva L, 2000, MATH BIOSCI, V167, P51, DOI 10.1016/S0025-5564(00)00024-9
   Farnesi LC, 2009, MEM I OSWALDO CRUZ, V104, P124, DOI 10.1590/S0074-02762009000100020
   Fontenille D, 1997, T ROY SOC TROP MED H, V91, P533, DOI 10.1016/S0035-9203(97)90013-4
   Foster WA, 2019, MEDICAL AND VETERINARY ENTOMOLOGY, 3RD EDITION, P261, DOI 10.1016/B978-0-12-814043-7.00015-7
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   JOUSSET FX, 1981, ANN INST PASTEUR VIR, V132, P357, DOI 10.1016/S0769-2617(81)80006-8
   Kamgang JC, 2008, MATH BIOSCI, V213, P1, DOI 10.1016/j.mbs.2008.02.005
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Li YZ, 2017, NONLINEAR ANAL-REAL, V37, P412, DOI 10.1016/j.nonrwa.2017.03.003
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Miller BR, 2000, AM J TROP MED HYG, V62, P240, DOI 10.4269/ajtmh.2000.62.240
   Murillo D., 2014, BIOL LETT, V1, P249, DOI DOI 10.1080/23737867.2014.11414484
   Chavez JP, 2017, MATH BIOSCI, V289, P29, DOI 10.1016/j.mbs.2017.04.005
   Paul E.M., 1975, ANN NY ACAD SCI, V266, P173
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Qu ZL, 2018, SIAM J APPL MATH, V78, P826, DOI 10.1137/17M1130800
   Ren XX, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000135
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   ROSEN L, 1987, CR ACAD SCI III-VIE, V304, P347
   ROSEN L, 1978, SCIENCE, V199, P909, DOI 10.1126/science.203035
   ROSEN L, 1987, AM J TROP MED HYG, V37, P398
   Siler Joseph Franklin, 1926, PHILIPP J SCI, V29
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Sun W, 2018, J MATH ANAL APPL, V468, P998, DOI 10.1016/j.jmaa.2018.08.033
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tun-Lin W, 2000, MED VET ENTOMOL, V14, P31, DOI 10.1046/j.1365-2915.2000.00207.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yang X, 1996, COMPUT MATH APPL, V32, P109, DOI 10.1016/0898-1221(96)00129-0
NR 44
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0025-5564
EI 1879-3134
J9 MATH BIOSCI
JI Math. Biosci.
PD JUL
PY 2020
VL 325
AR 108366
DI 10.1016/j.mbs.2020.108366
PG 10
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA LZ5KX
UT WOS:000541263900005
PM 32387647
DA 2020-07-08
ER

PT J
AU Molas, RB
   Ribeiro, MR
   dos Santos, MJCR
   Borbely, AU
   Oliani, DV
   Oliani, AH
   Nadkarni, S
   Nogueira, ML
   Moreli, JB
   Oliani, SM
AF Molas, Rafaela Batista
   Ribeiro, Milene Rocha
   Ramalho dos Santos, Maria Juliana C.
   Borbely, Alexandre Urban
   Oliani, Denise Vaz
   Oliani, Antonio Helio
   Nadkarni, Suchita
   Nogueira, Mauricio Lacerda
   Moreli, Jusciele Brogin
   Oliani, Sonia Maria
TI The involvement of annexin A1 in human placental response to maternal
   Zika virus infection
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Human placenta; Syncytiotrophoblast; Inflammation; Leukocytes; Annexin
   A1
ID TO-CHILD TRANSMISSION; HYPERGLYCEMIA; INFLAMMATION; NEUTROPHILS;
   RECEPTOR; HIV
AB The association of Zika virus infection (ZIKV) with congenital malformation and neurological sequelae brought a significant global concern. Recent studies have shown that maternal viral infection leads to inflammation in the placental tissue. In this context, the antiinflammatory protein annexin 1 (ANXA1) has a major determination of the resolution of inflammation and it has been positively associated with antiparasitic activity in infected placental explants. Although these effects have been explored to some degree, ANXA1 expression and potential properties have not yet been fully elucidated in placentas infected with ZIKV. This study was conducted to evaluate the histopathology, inflammatory process and elucidate if ANXA1 were differently expressed in placentas of ZIKV-infected mothers. Three classification groups were used in this study: Neg/Neg (mother and placenta negative for the virus), Pos/Neg (infected mother, but no virus detected in placenta) and Pos/Pos (mother and placenta infected with ZIKV). ANXA1 was expressed in syncytiotrophoblast cells of all studied groups, and its expression was decreased in Pos/Neg group, which displayed also an increase of the inflammatory response, as evinced from the recruitment of inflammatory cells, increased levels of placenta cytokines, and evidence of impaired tissue repair. The presence of ZIKV in placentas of Pos/Pos group shows structural alterations, including detachment and disorganization of the trophoblastic epithelium. In summary, our results suggest that maternal infection with ZIKV, even without direct tissue infection, leads to a placental inflammatory response probably related to the modulation of ANXA1. After placental infection, structural changes - including inflammatory cells influx - are observed leading to placental dysfunction and reduced fetal weight. Our study sheds additional light on the outcomes of ZIKV infection in trophoblast and reveals a potential involvement of ANXA1 in the placental biology.
C1 [Molas, Rafaela Batista; Ribeiro, Milene Rocha; Oliani, Sonia Maria] Sao Paulo State Univ, Sch Biosci Humanities & Exact Sci, Dept Biol, UNESP, Rus Cristovao Colombo 2265, BR-15054 Sao Jose Do Rio Preto, SP, Brazil.
   [Ramalho dos Santos, Maria Juliana C.; Borbely, Alexandre Urban] Univ Fed Alagoas, Inst Hlth & Biol Sci, Cell Biol Lab, Maceio, Alagoas, Brazil.
   [Oliani, Denise Vaz; Oliani, Antonio Helio] Sao Jose Do Rio Preto Sch Med FAMERP, Dept Gynecol & Obstet, Sao Jose Do Rio Preto, SP, Brazil.
   [Nadkarni, Suchita] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, London, England.
   [Nogueira, Mauricio Lacerda] Sao Jose Do Rio Preto Sch Med FAMERP, Dept Dermatol Infect & Parasit Dis, Sao Jose Do Rio Preto, SP, Brazil.
   [Moreli, Jusciele Brogin] Faceres Sch Med, Sao Jose Do Rio Preto, SP, Brazil.
   [Moreli, Jusciele Brogin; Oliani, Sonia Maria] Fed Univ Sao Paulo UNIFESP, Postgrad Struct & Funct Biol, Sao Paulo, SP, Brazil.
RP Oliani, SM (corresponding author), Sao Paulo State Univ, Sch Biosci Humanities & Exact Sci, Dept Biol, UNESP, Rus Cristovao Colombo 2265, BR-15054 Sao Jose Do Rio Preto, SP, Brazil.
EM sonia.oliani@unesp.br
RI Oliani, Sonia Maria/E-3476-2012
OI Oliani, Sonia Maria/0000-0003-0918-2130; Urban Borbely,
   Alexandre/0000-0001-6737-0901
FU Fundacao de Amparo a Pesquisa do Estado de Sao PauloFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2017/09136-3, 2018/07895-7,
   2016/02012-4]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico -CNPqNational Council for Scientific and Technological
   Development (CNPq) [308144/2014-7]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (grant numbers 2017/09136-3 and 2018/07895-7 to R.B.M and
   2016/02012-4to S.M.O) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico -CNPq (Grant number 308144/2014-7 to S.M.O.).
CR Aldo P, 2016, AM J REPROD IMMUNOL, V76, P348, DOI 10.1111/aji.12578
   Aliyu IA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040335
   Arora S, 2016, CELL DEATH DIFFER, V23, P1243, DOI 10.1038/cdd.2016.19
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brogin Moreli Jusciele, 2012, ISRN Obstet Gynecol, V2012, P230742, DOI 10.5402/2012/230742
   Calderon IMP, 2007, DIABETES RES CLIN PR, V78, P65, DOI 10.1016/j.diabres.2007.01.023
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Correa-Silva S, 2018, CYTOKINE, V111, P41, DOI 10.1016/j.cyto.2018.07.020
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Damazo AS, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-59
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Cardoso MFD, 2018, MICROB PATHOGENESIS, V123, P153, DOI 10.1016/j.micpath.2018.07.005
   FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x
   Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342
   Gobbetti T, 2016, BIOL CHEM, V397, P981, DOI 10.1515/hsz-2016-0200
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hu YW, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0308-9
   Kennedy JR, 2020, MED HYPOTHESES, V135, DOI 10.1016/j.mehy.2019.109462
   Lacerda JZ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01015
   Lieberman RW, 2011, EMERG INFECT DIS, V17, P107, DOI 10.3201/eid1701.091895
   Liotta G, 2015, INT J ENV RES PUB HE, V12, P13224, DOI 10.3390/ijerph121013224
   Nadkarni S, 2016, P NATL ACAD SCI USA, V113, pE8415, DOI 10.1073/pnas.1611944114
   NUNES D, 2019, METAL OXIDES, P1
   Opasawatchai A, 2019, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.03007
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   Rahman F, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051400
   Schloer S, 2019, FASEB J, V33, P12188, DOI 10.1096/fj.201901265R
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Stevens J, 2014, J INFECTION, V69, pS56, DOI 10.1016/j.jinf.2014.07.018
   Stuqui B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130803
   Sun M, 1996, PLACENTA, V17, P181, DOI 10.1016/S0143-4004(96)80012-9
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xu X, 2018, BONE RES, V6, DOI 10.1038/s41413-017-0005-4
   Zukor K, 2018, J NEUROVIROL, V24, P273, DOI 10.1007/s13365-017-0595-z
NR 36
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2020
VL 179
AR UNSP 104809
DI 10.1016/j.antiviral.2020.104809
PG 8
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA LY2IV
UT WOS:000540344700006
PM 32360947
DA 2020-07-08
ER

PT J
AU Qi, Y
   Han, L
   Qi, YF
   Jin, X
   Zhang, B
   Niu, JQ
   Zhong, J
   Xu, YF
AF Qi, Yue
   Han, Lin
   Qi, Yanfei
   Jin, Xia
   Zhang, Bo
   Niu, Junqi
   Zhong, Jin
   Xu, Yongfen
TI Anti-flavivirus activity of polyoxometalate
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Anti-Viral; DENV; JEV; ZIKV; Polyoxometalate; Virucidal
ID JAPANESE ENCEPHALITIS-VIRUS; REPLICON CELL-LINE; INFECTION; INHIBITORS;
   ASSAY
AB Viruses in the Flaviviridae family such as Zika virus (ZIKV), dengue virus (DENV), and Japanese encephalitis virus (JEV) are major public health concerns. The development of antiviral agents against these viruses is urgently needed. We have previously discovered that the Keggin structured polyoxometalate POM-12 has potent inhibitory activity against hepatitis C virus, another member of the Flaviviridae family. In this study, we tested its antiviral activity of DENV, JEV and ZIKV, and found that POM-12 dramatically inhibited their infection with IC50value of 1.16 mu M, 1.9 mu M and 0.64 mu M, respectively. Mechanistic studies indicated that POM-12 directly disrupted the integrity of these virions. Moreover, POM-12 also targeted the post-entry steps of viral replication of JEV, but having no similar activities on ZIKV and DENV. The differential actions of POM-12 on these viruses suggest that surface topology and charge of virion may have influence on its drug effect, and thus POM-12 may be modified to more efficiently inhibit these and other similar viruses.
C1 [Qi, Yue; Qi, Yanfei; Niu, Junqi] Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130021, Jilin, Peoples R China.
   [Han, Lin; Jin, Xia; Zhong, Jin; Xu, Yongfen] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Viral Hepatitis, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Qi, Yanfei] Jilin Univ, Sch Publ Hlth, Changchun 130021, Jilin, Peoples R China.
   [Han, Lin; Zhong, Jin] Shanghai Tech Univ, Shanghai 201210, Peoples R China.
   [Zhang, Bo] Chinese Acad Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Jin, Xia] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.
RP Qi, Y (corresponding author), Jilin Univ, Hosp 1, Dept Hepatol, Changchun 130021, Jilin, Peoples R China.; Xu, YF (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Viral Hepatitis, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
EM qq9377@sina.com; xuyf@ips.ac.cn
FU Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [81600468]; National Science and Technology Major Projects for
   "Major New Drugs Innovation and Development" [2018ZX09711003-001-004];
   Shanghai Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [19ZR1462800]; European Union Horizon 2020 Research
   and Innovation Program [734548]; MOST Key International Cooperation
   Program of China [2016YFE0133500]; Chinese Academy of SciencesChinese
   Academy of Sciences [15321KYSB20160001]; Institute Pasteur of Shanghai,
   Chinese Academy of Sciences, Shanghai, China
FX This work was supported by grants from the Natural Science Foundation of
   China(81600468) to Y.Q., National Science and Technology Major Projects
   for "Major New Drugs Innovation and Development"
   (2018ZX09711003-001-004) to Y.X., the Shanghai Natural Science
   Foundation of China (19ZR1462800) to Y.X., and the European Union
   Horizon 2020 Research and Innovation Program under ZIKAlliance Grant
   Agreement 734548 and MOST Key International Cooperation Program of China
   2016YFE0133500 to J.Z., the external cooperation
   program(15321KYSB20160001) of Chinese Academy of Sciences to J.Z.. We
   thank Shuzhu Lin and Jinze Li in BSL-2 laboratory, Institute Pasteur of
   Shanghai, Chinese Academy of Sciences, Shanghai, China for supporting.
   The authors declare no competing financial interests.
CR BARTHOLOMEUSZ A, 1994, ANTIVIR RES, V24, P341, DOI 10.1016/0166-3542(94)90080-9
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Cao RY, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx009
   Dan K, 2002, PHARMACOL RES, V46, P357, DOI 10.1016/S1043661802001706
   Francese R, 2019, ANTIVIR RES, V163, P29, DOI 10.1016/j.antiviral.2019.01.005
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hosseini SM, 2012, INT J MOL CELL MED, V1, P21
   Judd DA, 2001, J AM CHEM SOC, V123, P886, DOI 10.1021/ja001809e
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuadkitkan A, 2020, J INFECT PUBLIC HEAL, V13, P11, DOI 10.1016/j.jiph.2019.09.012
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Qi Y, 2013, ANTIVIR RES, V100, P392, DOI 10.1016/j.antiviral.2013.08.025
   Qiu XD, 2018, NAT MICROBIOL, V3, P287, DOI 10.1038/s41564-017-0099-x
   Schoeberl C, 1998, INT J ONCOL, V12, P153
   Shigeta S, 2003, ANTIVIR RES, V58, P265, DOI 10.1016/S0166-3542(03)00009-3
   Shigeta S, 2006, BIOMED PHARMACOTHER, V60, P211, DOI 10.1016/j.biopha.2006.03.009
   Wang J, 2014, ACS APPL MATER INTER, V6, P9785, DOI 10.1021/am502193f
   Wang X., 2018, VIRUSES, V10
   Witvrouw M, 2000, J MED CHEM, V43, P778, DOI 10.1021/jm980263s
   Yang J., 2020, ACS INFECT DIS
   Zandi K., 2019, ANTIMICROB AGENTS CH, V63
   Zhang QY, 2017, ARCH VIROL, V162, P3417, DOI 10.1007/s00705-017-3508-9
   Zhang WH, 2020, SCI BULL, V65, P402, DOI 10.1016/j.scib.2019.11.006
   Zhao Y, 2018, PROCEEDINGS OF 2018 TENTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P1, DOI 10.1109/ICACI.2018.8377543
NR 27
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2020
VL 179
AR UNSP 104813
DI 10.1016/j.antiviral.2020.104813
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA LY2IV
UT WOS:000540344700010
PM 32376449
DA 2020-07-08
ER

PT J
AU Wang, XG
   Zheng, BH
   Ashraf, U
   Zhang, H
   Cao, C
   Li, Q
   Chen, Z
   Imran, M
   Chen, HC
   Cao, SB
   Ye, J
AF Wang, Xugang
   Zheng, Bohan
   Ashraf, Usama
   Zhang, Hao
   Cao, Chen
   Li, Qi
   Chen, Zheng
   Imran, Muhammad
   Chen, Huanchun
   Cao, Shengbo
   Ye, Jing
TI Artemisinin inhibits the replication of flaviviruses by promoting the
   type I interferon production
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Artemisinin; Flavivirus; Antiviral; Therapy; Type I interferon
ID WEST NILE; EVASION; MECHANISMS; IMMUNITY; DENGUE
AB Flaviviruses are considered to be major emerging human pathogens globally. Currently available anti-flavivirus approaches are ineffective, thus there is a desperate need for broad-spectrum drugs that can be active against existing and emerging flaviviruses. Artemisinin has been found to cause an antiviral effect against several viruses; however, its antiviral effect against flaviviruses remains unexplored. Here the antiviral activity of artemisinin against flaviviruses such as JEV, DENY, and ZIKV was evaluated by measuring the hallmark features of virus replication both in vitro and in vivo. Mechanistically, the artemisinin-induced antiviral effect was associated with enhanced host type I interferon response. The blocking of interferon signaling inhibited the artemisinin-induced interferon-stimulated genes expression and rescued the artemisinin-suppressed virus replication. This study demonstrated for the first time the antiviral activity of artemisinin against flaviviruses with a novel antiviral mechanism. The therapeutic application of artemisinin may constitute a broad-spectrum approach to cure infections caused by flaviviruses.
C1 [Wang, Xugang; Zheng, Bohan; Ashraf, Usama; Zhang, Hao; Cao, Chen; Li, Qi; Chen, Zheng; Imran, Muhammad; Chen, Huanchun; Cao, Shengbo; Ye, Jing] Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
   [Wang, Xugang; Zheng, Bohan; Ashraf, Usama; Zhang, Hao; Cao, Chen; Li, Qi; Chen, Zheng; Imran, Muhammad; Chen, Huanchun; Cao, Shengbo; Ye, Jing] Huazhong Agr Univ, Coll Vet Med, Lab Anim Virol, Wuhan 430070, Hubei, Peoples R China.
   [Wang, Xugang; Zheng, Bohan; Zhang, Hao; Cao, Chen; Li, Qi; Chen, Zheng; Imran, Muhammad; Chen, Huanchun; Cao, Shengbo; Ye, Jing] Huazhong Agr Univ, Cooperat Innovat Ctr Sustainable Pig Prod, Wuhan 430070, Hubei, Peoples R China.
RP Ye, J (corresponding author), Huazhong Agr Univ, State Key Lab Agr Microbiol, Wuhan 430070, Hubei, Peoples R China.
EM yej@mail.hzau.edu.cn
OI Ashraf, Usama/0000-0001-8686-9054
FU National Key Research and Development Program of China [2016YFD0500407];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31825025, 31972721]; Fundamental Research Funds for
   the Central UniversitiesFundamental Research Funds for the Central
   Universities [2662018QD025]; Natural Science Foundation of Hubei
   ProvinceNatural Science Foundation of Hubei Province [2019CFA010]
FX This work was supported by National Key Research and Development Program
   of China (2016YFD0500407); National Natural Science Foundation of China
   (31825025 and 31972721); Fundamental Research Funds for the Central
   Universities (2662018QD025); and Natural Science Foundation of Hubei
   Province (2019CFA010).
CR Amorim JFS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54474-7
   Ashraf U, 2016, J VIROL, V90, P4780, DOI 10.1128/JVI.02586-15
   Blitvich BJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060154
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Calderon-Pelaez MA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01435
   Capasso A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007622
   Chen Z, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1280-8
   Chen Z, 2012, HYBRIDOMA, V31, P137, DOI 10.1089/hyb.2011.0107
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Denny JE, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48454-0
   Diamond MS, 2003, IMMUNOL CELL BIOL, V81, P196, DOI 10.1046/j.1440-1711.2003.01157.x
   Efferth T, 2008, CLIN INFECT DIS, V47, P804, DOI 10.1086/591195
   Efferth T, 2018, BIOTECHNOL ADV, V36, P1730, DOI 10.1016/j.biotechadv.2018.01.001
   Flobinus A, 2014, J ANTIMICROB CHEMOTH, V69, P34, DOI 10.1093/jac/dkt346
   Garcia-Diaz A, 2019, CELL REP, V29, P3766, DOI 10.1016/j.celrep.2019.11.113
   Goodwin CM, 2019, J VIROL, V93, DOI 10.1128/JVI.01052-19
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Huang SM, 2019, J COLLOID INTERF SCI, V542, P198, DOI 10.1016/j.jcis.2019.02.010
   Idowu AO, 2018, INT J MED SCI, V15, P1449, DOI 10.7150/ijms.27350
   Imran M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111011
   Jefferies CA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00325
   Liu XH, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109070
   Long HB, 2016, AM J EMERG MED, V34, P772, DOI 10.1016/j.ajem.2015.12.075
   Lu BW, 2019, NEURAL REGEN RES, V14, P1494, DOI 10.4103/1673-5374.255960
   Maximova OA, 2018, ANNU REV VIROL, V5, P255, DOI 10.1146/annurev-virology-092917-043439
   Mustafa YM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00525
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   O'Flaherty K, 2019, J INFECT DIS, V220, P1178, DOI 10.1093/infdis/jiz247
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Ramanan P, 2011, VIRUSES-BASEL, V3, P1634, DOI 10.3390/v3091634
   Sharma BN, 2014, ANTIMICROB AGENTS CH, V58, P6724, DOI 10.1128/AAC.03714-14
   Sips GJ, 2012, REV MED VIROL, V22, P69, DOI 10.1002/rmv.712
   Szelag M, 2016, ONCOTARGET, V7, P48788, DOI 10.18632/oncotarget.9195
   Tsuchiya N, 2019, CELL REP, V29, P162, DOI 10.1016/j.celrep.2019.08.086
   Wei FH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008062
   Wohlfarth C, 2009, ACTA PHARMACOL SIN, V30, P25, DOI 10.1038/aps.2008.5
   Wong YK, 2017, MED RES REV, V37, P1492, DOI 10.1002/med.21446
   Wu YW, 2016, CELL MOL IMMUNOL, V13, P379, DOI 10.1038/cmi.2015.13
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zhang H, 2015, J PROTEOME RES, V14, P5157, DOI 10.1021/acs.jproteome.5b00424
   Zheng BH, 2019, VET MICROBIOL, V238, DOI 10.1016/j.vetmic.2019.108430
NR 42
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD JUL
PY 2020
VL 179
AR UNSP 104810
DI 10.1016/j.antiviral.2020.104810
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA LY2IV
UT WOS:000540344700007
PM 32360948
DA 2020-07-08
ER

PT J
AU Tepper, NK
   Zapata, LB
   Hurst, S
   Curtis, KM
   Lathrop, E
   Romero, L
   Acosta-Perez, E
   Mendoza, Z
   Whiteman, MK
AF Tepper, Naomi K.
   Zapata, Lauren B.
   Hurst, Stacey
   Curtis, Kathryn M.
   Lathrop, Eva
   Romero, Lisa
   Acosta-Perez, Edna
   Mendoza, Zipatly
   Whiteman, Maura K.
TI Physician and clinic staff attitudes and practices during implementation
   of the Zika Contraception Access Network
SO CONTRACEPTION
LA English
DT Article
DE Contraception; Survey; Zika; Family planning
ID PUERTO-RICO; VIRUS-INFECTION; PREGNANCY; OUTCOMES; DISEASE
AB Objective: The Zika Contraception Access Network (Z-CAN) provided women in Puerto Rico access to contraceptive counseling and the full range of reversible contraceptive methods, on the same day and at no cost, during the Zika virus outbreak. Because trained physicians and clinic staff were crucial to the program, we aimed to assess the implementation of and satisfaction with Z-CAN from their perspectives.
   Study design: Physicians and clinic staff in the Z-CAN program participated in an online survey on program implementation (e.g., on-site and same-day contraceptive provision), program satisfaction, and knowledge consistent with program training (e.g., contraceptive initiation and safety, client-centered contraceptive counseling, intrauterine device [IUD] and implant insertion and removal).
   Results: Survey respondents included 63 physicians and 53 clinic staff members. A high proportion of physicians (>93%) reported providing IUDs, implants, pills, rings, condoms, and injections and most were very often or always able to provide same-day access to most methods. Over 90% of physicians were satisfied with the Z-CAN program, training, and ongoing support. Staff satisfaction with these program elements was similar but slightly lower. Knowledge about exams and tests needed for initiation and safety of methods varied but was generally consistent with guidelines on which physicians received training. Most physicians (>90%) reported confidence in skills on which they received training as part of the program.
   Conclusions: From the perspectives of participating physicians and clinic staff, the program was generally implemented as intended and providers were largely satisfied with program strategies including training and on-going support. Published by Elsevier Inc.
C1 [Tepper, Naomi K.; Zapata, Lauren B.; Hurst, Stacey; Curtis, Kathryn M.; Romero, Lisa; Whiteman, Maura K.] Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
   [Lathrop, Eva] Emory Univ, Dept Gynecol & Obstet, Atlanta, GA 30322 USA.
   [Acosta-Perez, Edna] Univ Puerto Rico, San Juan, PR 00936 USA.
   [Acosta-Perez, Edna] Univ Carlos Albizu, Third Mission Inst, San Juan, PR USA.
   [Mendoza, Zipatly] Ctr Dis Control & Prevent, Natl Fdn, Atlanta, GA USA.
RP Tepper, NK (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30333 USA.
EM ntepper@cdc.gov
FU Department of Health and Human Services, Centers for Disease Control and
   PreventionUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA
FX This evaluation project was funded by the Department of Health and Human
   Services, Centers for Disease Control and Prevention.
CR Bergin A, 2012, CONTRACEPTION, V86, P694, DOI 10.1016/j.contraception.2012.05.011
   Biggs MA, 2015, CONTRACEPTION, V91, P167, DOI 10.1016/j.contraception.2014.10.009
   Curtis KM, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6504a1
   Finer LB, 2016, NEW ENGL J MED, V374, P843, DOI 10.1056/NEJMsa1506575
   Flodgren G, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010669.pub2
   Gavin L, 2014, MMWR RECOMM REP, V63, P1
   Henry J, 2016, DISTRIBUTION NONELDE
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Peipert JF, 2012, OBSTET GYNECOL, V120, P1291, DOI [10.1097/AOG.0b013e318273eb56, http://10.1097/AOG.0b013e318273eb56]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ricketts S, 2014, PERSPECT SEX REPRO H, V46, P125, DOI 10.1363/46e1714
   Romero L, 2018, AM J PUBLIC HEALTH, V108, pS227, DOI 10.2105/AJPH.2018.304558
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD JUL
PY 2020
VL 102
IS 1
BP 34
EP 38
DI 10.1016/j.contraception.2020.04.002
PG 5
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LU2XL
UT WOS:000537624400007
PM 32298716
DA 2020-07-08
ER

PT J
AU Chen, HN
   Lao, ZZ
   Xu, JT
   Li, ZX
   Long, HS
   Li, DT
   Lin, LP
   Liu, XH
   Yu, LW
   Liu, WY
   Li, G
   Wu, JG
AF Chen, Huini
   Lao, Zizhao
   Xu, Jiangtao
   Li, Zhaoxin
   Long, Haishan
   Li, Detang
   Lin, Luping
   Liu, Xiaohong
   Yu, Liangwen
   Liu, Weiyong
   Li, Geng
   Wu, Jianguo
TI Antiviral activity of lycorine against Zika virus in vivo and in vitro
SO VIROLOGY
LA English
DT Article
DE ZIKV; Lycorine; Alkaloid; Antiviral; AG6 mice; RdRp inhibitor
ID FDA-APPROVED DRUG; INFECTION; IDENTIFICATION; AMARYLLIDACEAE;
   SOFOSBUVIR; RIBAVIRIN; EFFICACY; BIOLOGY
AB The emergence and re-emergence of Zika virus (ZIKV), is a cause for international concern. These highly pathogenic arboviruses represent a serious health burden in tropical and subtropical areas worldwide. Despite these burdens, antiviral therapies do not exist, and inhibitors of ZIKV are therefore urgently needed. To elucidate the anti-ZIKV effect of lycorine, we used reverse transcription-quantitative real-time PCR (qRT-PCR), immunofluorescence, (westernwestern) blot, and plaque forming assay to analyse viral RNA (vRNA), viral protein, progeny virus counts, and validated inhibitors in vitro using a variety of cell lines. Additionally, we found that lycorine acts post-infection according to time-of-addition assay, and inhibits RdRp activity. Lycorine protected AG6 mice against ZIKV-induced lethally by decreasing the viral load in the blood. Due to its potency and ability to target ZIKV infection in vivo and in vitro, lycorine might offer promising therapeutic possibilities for combatting ZIKV infections in the future.
C1 [Chen, Huini; Li, Geng; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangdong Key Lab Virol, Guangzhou 510632, Peoples R China.
   [Lao, Zizhao] Guangzhou Univ Chinese Med, Math Engn Acad Chinese Med, Guangzhou 510006, Peoples R China.
   [Xu, Jiangtao; Li, Zhaoxin; Long, Haishan; Li, Geng] Guangzhou Univ Chinese Med, Lab Anim Ctr, Guangzhou 510006, Peoples R China.
   [Li, Detang] Guangzhou Univ Chinese Med, Dept Pharm, Affiliated Hosp 1, Guangzhou 510405, Peoples R China.
   [Lin, Luping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou 510060, Peoples R China.
   [Liu, Xiaohong] Guangzhou Univ Chinese Med, Affiliated Hosp 1, Guangzhou 510000, Peoples R China.
   [Yu, Liangwen] Guangzhou Univ Chinese Med, Guangzhou 510006, Peoples R China.
   [Liu, Weiyong] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China.
RP Wu, JG (corresponding author), Jinan Univ, Inst Med Microbiol, Guangdong Key Lab Virol, Guangzhou 510632, Peoples R China.; Yu, LW (corresponding author), Guangzhou Univ Chinese Med, Guangzhou 510006, Peoples R China.; Liu, WY (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Lab Med, Wuhan, Peoples R China.; Li, G (corresponding author), Jinan Univ, Guangzhou Univ Chinese Med, Lab Anim Ctr, Inst Med Microbiol,Guangdong Key Lab Virol, Guangzhou 510006, Peoples R China.
EM fisherman@gzucm.edu.cn; wyliu@hust.edu.cn; lg@gzucm.edu.cn;
   wu9988@vip.sina.com
FU Natural Science Foundation of Guangdong ProvinceNational Natural Science
   Foundation of Guangdong Province [2017A030313626]; Excellent Young
   Scholars Project of the First Affiliated Hospital of Guangzhou
   University of Chinese Medicine [2019QN22, 2017ZWB10]; Science &
   Technology Planning Project of Guangzhou [201804010029]; National Nature
   Science Foundation of ChinaNational Natural Science Foundation of China
   [81973549, 81803813, 81730061, 81471942]; State Key Laboratory of
   Natural Medicines [SKLNMKF201906]; Science & Technology Planning Project
   of Guangdong Province Office of Education [2018KCXTD007, 2014GKXM032];
   Program of Guangdong Natural Science Foundation of China
   [S201230006598]; Key Research Projects of GZUCM First-class Universities
   and Top Disciplines [A1-AFD018191A17]; GZUCM First-class Universities
   and Top Disciplines Scientific Research Team Projects [2019KYTD102];
   Guangdong Province "Pearl River Talent Plan" Innovation and
   Entrepreneurship Team Project [2017ZT07Y580]
FX This work was generously supported by the Natural Science Foundation of
   Guangdong Province (2017A030313626), Excellent Young Scholars Project of
   the First Affiliated Hospital of Guangzhou University of Chinese
   Medicine (2019QN22 and 2017ZWB10), Science & Technology Planning Project
   of Guangzhou (201804010029), National Nature Science Foundation of China
   (81973549,81803813, 81730061, and 81471942), The Open Project of State
   Key Laboratory of Natural Medicines (SKLNMKF201906), Science &
   Technology Planning Project of Guangdong Province Office of Education
   (2014GKXM032), Program of Guangdong Natural Science Foundation of China
   (S201230006598), Science & Technology Planning Project of Guangdong
   Province Office of Education (2018KCXTD007), Key Research Projects of
   GZUCM First-class Universities and Top Disciplines (A1-AFD018191A17),
   GZUCM First-class Universities and Top Disciplines Scientific Research
   Team Projects (2019KYTD102), and Guangdong Province "Pearl River Talent
   Plan" Innovation and Entrepreneurship Team Project (2017ZT07Y580).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Bausch DG, 2010, CLIN INFECT DIS, V51, P1435, DOI 10.1086/657315
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Cedron JC, 2010, BIOORGAN MED CHEM, V18, P4694, DOI 10.1016/j.bmc.2010.05.023
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen DZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14972
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Citoglu GS, 2012, FITOTERAPIA, V83, P81, DOI 10.1016/j.fitote.2011.09.008
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   GABRIELSEN B, 1992, J NAT PROD, V55, P1569, DOI 10.1021/np50089a003
   Guo Y, 2016, ANTIMICROB AGENTS CH, V60, P913, DOI 10.1128/AAC.02274-15
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He J, 2013, INFLUENZA OTHER RESP, V7, P922, DOI 10.1111/irv.12035
   Hwang YC, 2008, ANTIVIR RES, V77, P232, DOI 10.1016/j.antiviral.2007.12.009
   Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kornienko A, 2008, CHEM REV, V108, P1982, DOI 10.1021/cr078198u
   Kretzing S, 2011, TOXICON, V57, P117, DOI 10.1016/j.toxicon.2010.10.012
   Lamoral-Theys D, 2010, MINI-REV MED CHEM, V10, P41, DOI 10.2174/138955710791112604
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Li CF, 2017, EBIOMEDICINE, V24, P189, DOI 10.1016/j.ebiom.2017.09.034
   Li SY, 2005, ANTIVIR RES, V67, P18, DOI 10.1016/j.antiviral.2005.02.007
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Lin Y, 2019, INT J ANTIMICROB AG, V54, P502, DOI 10.1016/j.ijantimicag.2019.07.010
   Liu JN, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-483
   Loe MWC, 2019, ANTIVIR RES, V172, DOI 10.1016/j.antiviral.2019.104637
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606
   Park JG, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00718
   Perez-Cabezas V, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz035
   RENARDNOZAKI J, 1989, RES VIROLOGY, V140, P115, DOI 10.1016/S0923-2516(89)80089-5
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Routhu NK, 2018, MOL PHARMACEUT, V15, P4284, DOI 10.1021/acs.molpharmaceut.8b00068
   Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059
   Taguwa S, 2019, CELL REP, V26, P906, DOI 10.1016/j.celrep.2018.12.095
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Tham HW, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01040
   Toriizuka Y, 2008, BIOORGAN MED CHEM, V16, P10182, DOI 10.1016/j.bmc.2008.10.061
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
NR 43
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD JUL
PY 2020
VL 546
BP 88
EP 97
DI 10.1016/j.virol.2020.04.009
PG 10
WC Virology
SC Virology
GA LS2IQ
UT WOS:000536213500009
PM 32452420
OA Green Published
DA 2020-07-08
ER

PT J
AU Luhken, R
   Heitmann, A
   Jansen, S
   Schmidt-Chanasit, J
   Borstler, J
   Werner, D
   Kampen, H
   Kuhn, C
   Pluskota, B
   Ferstl, I
   Jost, A
   Becker, N
   Tannich, E
AF Luehken, Renke
   Heitmann, Anna
   Jansen, Stephanie
   Schmidt-Chanasit, Jonas
   Boerstler, Jessica
   Werner, Doreen
   Kampen, Helge
   Kuhn, Carola
   Pluskota, Bjoern
   Ferstl, Ina
   Joest, Artur
   Becker, Norbert
   Tannich, Egbert
TI Microsatellite typing of Aedes albopictus (Diptera: Culicidae)
   populations from Germany suggests regular introductions
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Aedes albopictus; Asian tiger mosquito; Microsatellites; Introduction;
   Genetic structure
ID ASIAN TIGER MOSQUITO; INVASIVE MOSQUITOS; CHIKUNGUNYA VIRUS; SKUSE
   DIPTERA; AEGYPTI; SEPTEMBER; INFERENCE; OUTBREAK; PATTERNS; CLUSTERS
AB The global spread of the Asian tiger mosquito Aedes albopictus is of concern, as this mosquito species constitutes an important vector of a number of emerging pathogens including dengue virus, chikungunya virus and Zika virus. Since its first appearance in Albania (1979) and Italy (1990), the species has been reported from more than twenty-five European countries. However, the dispersion process in Europe is largely unknown, as information on population genetic structure is lacking, which is relevant to understand the observed spread. In order to determine whether the ten Ae. albopictus populations detected in Germany until 2017 originate from a single introduction event or from independent importations, genetic analyses with a set of sixteen microsatellite markers were performed. The samples included specimens from three locations with potentially overwintering populations, collected in three consecutive years. The results indicate a heterogeneous population structure consisting of two clusters with significant substructuring, suggesting regular, independent introductions instead of a continuous spread across Germany originating from one or few sites. Moreover, the analyses provide further evidence for Ae. albopictus overwintering in Germany as samples from identical locations collected in three consecutive years had a relatively high genetic similarity. However, the population structure is probably influenced by local mosquito control activities. The results presented provide further evidence for regular introductions of Ae. albopictus specimens into Germany, probably leading to local establishment north of the Alps. This highlights the need for constant surveillance and control of Ae. albopictus not only in southern, but also in Central Europe.
C1 [Luehken, Renke; Heitmann, Anna; Jansen, Stephanie; Schmidt-Chanasit, Jonas; Boerstler, Jessica; Tannich, Egbert] Bernhard Nocht Inst Trop Med, Hamburg, Germany.
   [Luehken, Renke; Schmidt-Chanasit, Jonas] Univ Hamburg, Fac Math Informat & Nat Sci, Hamburg, Germany.
   [Werner, Doreen] Leibniz Ctr Agr Landscape Res, Muencheberg, Germany.
   [Kampen, Helge] Friedrich Loeffler Inst, Fed Res Inst Anim Hlth, Greifswald, Insel Rims, Germany.
   [Kuhn, Carola] German Environm Agcy UBA, Berlin, Germany.
   [Pluskota, Bjoern; Ferstl, Ina; Joest, Artur; Becker, Norbert] Inst Dipterol, Speyer, Germany.
   [Becker, Norbert] Heidelberg Univ, Heidelberg, Germany.
   [Tannich, Egbert] German Ctr Infect Res DZIF, Partner Site Hamburg Luebeck Borstel Riems, Hamburg, Germany.
RP Luhken, R (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.
EM renkeluhken@gmail.com; heitmann@bnitm.de; jansen@bnitm.de;
   jonassi@gmx.de; jessica_boerstler@hotmail.de; doreen.werner@zalf.de;
   helge.kampen@fli.de; carola.kuhn@uba.de; bjoern.pluskota@kabs-gfs.de;
   Inschen-F@web.de; artur.joest@kabs-gfs.de; NorbertFBecker@web.de;
   tannich@bnitm.de
FU German Federal Ministry for the Environment, Nature Conservation,
   Building and Nuclear Safety (BMUB) through the Federal Environment
   Agency (UBA) [FKZ3714484080]; German Federal Ministry of Food and
   Agriculture (BMEL) through the Federal Office for Agriculture and Food
   (BLE) [2819104315, 2819104115, 2819104615]
FX We thank Birgit Muntau, Michelle Helms and David Hofmann for excellent
   technical assistance and Hanna Jost for logistic support. This work was
   financially supported by the German Federal Ministry for the
   Environment, Nature Conservation, Building and Nuclear Safety (BMUB)
   through the Federal Environment Agency (UBA), grant number
   FKZ3714484080, and the German Federal Ministry of Food and Agriculture
   (BMEL) through the Federal Office for Agriculture and Food (BLE), grant
   numbers 2819104315, 2819104115 and 2819104615.
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Battaglia V, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00208
   Becker N, 2017, PARASITOL RES, V116, P847, DOI 10.1007/s00436-016-5356-z
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1
   Becker N, 2008, PARASITOL RES, V103, pS19, DOI 10.1007/s00436-008-1210-2
   Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Core Team R., 2015, R LANG ENV STAT COMP
   Core Team R, 2019, R LANG ENV STAT COMP
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864
   European Centre for Disease Prevention and Control (ECDC), 2019, ZIK VIR DIS VAR DEP
   European Centre for Disease Prevention and Control (ECDC), 2017, AED ALB CURR KNOWN D
   European Centre for Disease Prevention and Control (ECDC), 2017, CLUST AUT CHIK CAS F
   Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x
   Falush D, 2003, GENETICS, V164, P1567
   Faraji A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003037
   Flacio E, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0793-6
   Francis RM, 2017, MOL ECOL RESOUR, V17, P27, DOI 10.1111/1755-0998.12509
   Gasperi G, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001836
   GIRON S, 2015, LANCET, V13, P217
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Heitmann A., 2017, EUROSURVEILLANCE, V22, DOI [10.2807/1560-7917.ES.2017.22.2.30437, DOI 10.2807/1560-7917.ES.2017.22.2.30437.PII=30437]
   Heitmann A, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.29.1800033
   Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x
   Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233
   Jombart T., 2015, TUTORIAL DISCRIMINAN
   Jombart T, 2011, BIOINFORMATICS, V27, P3070, DOI 10.1093/bioinformatics/btr521
   Jombart T, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-94
   Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kampen H, 2013, PARASITOL RES, V112, P905, DOI 10.1007/s00436-012-3128-y
   Kamvar ZN, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00208
   Kamvar ZN, 2014, PEERJ, V2, DOI 10.7717/peerj.281
   Kaspar F., 2017, KLIMAWANDEL DEUTSCHL, P17, DOI [10.1007/978-3-662-50397-3_3, DOI 10.1007/978-3-662-50397-3_3]
   Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177
   Kuhlisch C, 2018, ACTA TROP, V188, P78, DOI 10.1016/j.actatropica.2018.08.019
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lowe S., 2000, IUCN SSC INVASIVE SP, DOI [10.2807/ese.15.39. 19676-en, DOI 10.2807/ESE.15.39.19676-EN]
   Manni M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005332
   Manni M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0794-5
   Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661
   Maynard AJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005546
   Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Minard G, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00970
   Mousson L, 2005, GENET RES, V86, P1, DOI 10.1017/S0016672305007627
   Ngoagouni C, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2101-0
   Paradis E, 2010, BIOINFORMATICS, V26, P419, DOI 10.1093/bioinformatics/btp696
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pichler V, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007554
   Pluskota B., 2011, THESIS
   Pluskota B, 2016, PARASITOL RES, V115, P3245, DOI 10.1007/s00436-016-5078-2
   Pluskota Bjorn, 2008, European Mosquito Bulletin, V26, P1
   Pritchard J.K., 2010, DOCUMENTATION STRUCT, P2010
   Pritchard JK, 2000, GENETICS, V155, P945
   Putman AI, 2014, ECOL EVOL, V4, P4399, DOI 10.1002/ece3.1305
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Schaffner F, 2013, CLIN MICROBIOL INFEC, V19, P685, DOI 10.1111/1469-0691.12189
   Schmidt-Chanasit J., 2010, EURO SURVEILL, V15, DOI 10.2807/ese.15.40.19677-en
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   Severini F, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006435
   Sherpa S, 2019, MOL ECOL, V28, P2360, DOI 10.1111/mec.15071
   Studio Team R., 2015, RSTUDIO INT DEV R
   Succo T, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.21.30240
   Suter TT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004315
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Venturi G, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.8.30148
   Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002
   Walther D, 2017, ACTA TROP, V166, P186, DOI 10.1016/j.actatropica.2016.11.024
   Werner D, 2012, EUROSURVEILLANCE, V17, P14
   Zhong DB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068586
   Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093
NR 79
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2020
VL 81
AR 104237
DI 10.1016/j.meegid.2020.104237
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA LN1FH
UT WOS:000532689800006
PM 32045712
DA 2020-07-08
ER

PT J
AU Artika, IM
   Wiyatno, A
   Ma'roef, CN
AF Artika, I. Made
   Wiyatno, Ageng
   Ma'roef, Chairin Nisa
TI Pathogenic viruses: Molecular detection and characterization
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Review
DE Pathogenic viruses; Virus detection; Polymerase chain reaction; DNA
   sequencing; Unidirectional workflow
ID ACUTE RESPIRATORY SYNDROME; AVIAN INFLUENZA-VIRUS; REAL-TIME PCR;
   NESTED-RT-PCR; EBOLA-VIRUS; ZIKA VIRUS; LABORATORY DIAGNOSIS; SYNDROME
   CORONAVIRUS; RAPID DETECTION; INFECTION
AB Pathogenic viruses are viruses that can infect and replicate within human cells and cause diseases. The continuous emergence and re-emergence of pathogenic viruses has become a major threat to public health. Whenever pathogenic viruses emerge, their rapid detection is critical to enable implementation of specific control measures and the limitation of virus spread. Further molecular characterization to better understand these viruses is required for the development of diagnostic tests and countermeasures. Advances in molecular biology techniques have revolutionized the procedures for detection and characterization of pathogenic viruses. The development of PCR-based techniques together with DNA sequencing technology, have provided highly sensitive and specific methods to determine virus circulation. Pathogenic viruses potentially having global catastrophic consequences may emerge in regions where capacity for their detection and characterization is limited. Development of a local capacity to rapidly identify new viruses is therefore critical. This article reviews the molecular biology of pathogenic viruses and the basic principles of molecular techniques commonly used for their detection and characterization. The principles of good laboratory practices for handling pathogenic viruses are also discussed. This review aims at providing researchers and laboratory personnel with an overview of the molecular biology of pathogenic viruses and the principles of molecular techniques and good laboratory practices commonly implemented for their detection and characterization.
C1 [Artika, I. Made] Eijkman Inst Mol Biol, Biosafety Level 3 Unit, Jalan Diponegoro 69, Jakarta 10430, Indonesia.
   [Artika, I. Made] Bogor Agr Univ, Fac Math & Nat Sci, Dept Biochem, Darmaga Campus, Bogor 16680, Indonesia.
   [Wiyatno, Ageng; Ma'roef, Chairin Nisa] Eijkman Inst Mol Biol, Emerging Virus Res Unit, Jalan Diponegoro 69, Jakarta 10430, Indonesia.
RP Artika, IM (corresponding author), Eijkman Inst Mol Biol, Biosafety Level 3 Unit, Jalan Diponegoro 69, Jakarta 10430, Indonesia.; Artika, IM (corresponding author), Bogor Agr Univ, Fac Math & Nat Sci, Dept Biochem, Darmaga Campus, Bogor 16680, Indonesia.
EM imart@eijkman.go.id
OI Artika, I/0000-0003-4293-3389
CR Abrahao JS, 2010, J MED VIROL, V82, P692, DOI 10.1002/jmv.21617
   Adisasmito W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-571
   Agustiningsih A., 2018, PLOS ONEPLOS ONE, V13, P1, DOI DOI 10.1371/JOURNAL.PONE.0201427.
   Agustiningsih Agustiningsih, 2016, BMC Res Notes, V9, P423, DOI 10.1186/s13104-016-2235-8
   Aitichou M, 2005, J VIROL METHODS, V124, P21, DOI 10.1016/j.jviromet.2004.10.004
   ALLARD A, 1990, J CLIN MICROBIOL, V28, P2659, DOI 10.1128/JCM.28.12.2659-2667.1990
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Artika I.M., 2018, AM J BIOCH BIOTECHNO, V14, P108, DOI DOI 10.3844/AJBBSP.2018.108.116.
   Artika IM, 2017, ASIAN PAC J TROP BIO, V7, P483, DOI 10.1016/j.apjtb.2017.01.020
   Artika IM, 2013, AM J BIOCH BIOTECHNO, V9, P423
   Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209
   Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   Bloom DE, 2017, P NATL ACAD SCI USA, V114, P4055, DOI 10.1073/pnas.1701410114
   Broadhurst MJ, 2016, CLIN MICROBIOL REV, V29, P773, DOI 10.1128/CMR.00003-16
   BROWN TA, 2002, GENOMES
   Calisher CH, 2006, CLIN MICROBIOL REV, V19, P531, DOI 10.1128/CMR.00017-06
   Causey D, 2008, J INFECT DIS, V197, pS29, DOI 10.1086/524991
   CDC, 2019, LAB SAF WORK ZIK VIR
   Chan KH, 2004, EMERG INFECT DIS, V10, P294, DOI 10.3201/eid1002.030610
   Chan PKS, 2004, EMERG INFECT DIS, V10, P825, DOI 10.3201/eid1005.030682
   Cherpillod P, 2016, J CLIN VIROL, V77, P9, DOI 10.1016/j.jcv.2016.01.017
   Chertow DS, 2018, SCIENCE, V360, P381, DOI 10.1126/science.aat4982
   Chiu C., 2016, MOL MICROBIOLOGY DIA, DOI [10.1128/9781555819071.ch6, DOI 10.1128/9781555819071.CH6]
   Chosewood C.L., 2009, BIOSAFETY MICROBIOLO
   Chow Ken Yan Ching, 2003, Genomics Proteomics & Bioinformatics, V1, P247
   Chua KB, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.34
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cotten M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093269
   De Diego ML, 2014, VIRUS RES, V194, P124, DOI 10.1016/j.virusres.2014.07.024
   de Jong W, 2018, CRIT REV MICROBIOL, V44, P487, DOI [10.1080/1040841X.2018.1438986, 10.1080/1040841x.2018.1438986]
   Dhenni R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006198
   Djikeng A, 2009, FUTURE VIROL, V4, P47, DOI 10.2217/17460794.4.1.47
   Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354
   Falasca L, 2015, CELL DEATH DIFFER, V22, P1250, DOI 10.1038/cdd.2015.67
   Fooks AR, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000530
   Fowler VL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109322
   Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11
   Gao XY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002459
   Garcia-Sastre A, 2013, CURR OPIN VIROL, V3, P210, DOI 10.1016/j.coviro.2013.02.001
   Garibyan L, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2013.1
   Gijavanekar C, 2011, FEBS J, V278, P1676, DOI 10.1111/j.1742-4658.2011.08091.x
   Gregory CJ, 2017, J INFECT DIS, V216, pS875, DOI 10.1093/infdis/jix396
   Grubaugh ND, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002349
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Haagmans BL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000557
   Hartoyo E, 2017, INT J INFECT DIS, V54, P1, DOI 10.1016/j.ijid.2016.10.029
   Hayman DTS, 2016, ANNU REV VIROL, V3, P77, DOI 10.1146/annurev-virology-110615-042203
   Hoenen T, 2006, TRENDS MOL MED, V12, P206, DOI 10.1016/j.molmed.2006.03.006
   Hofmann J, 2018, EMERG INFECT DIS, V24, P1099, DOI 10.3201/eid2406.172044
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Ie SI, 2015, AM J TROP MED HYG, V93, P1349, DOI 10.4269/ajtmh.15-0331
   Jensen MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011024
   JOHNSON FB, 1990, CLIN MICROBIOL REV, V3, P120, DOI 10.1128/CMR.3.2.120-131.1990
   Joob B, 2015, ANN TROP MED PUBLIC, V8, DOI 10.4103/1755-6783.162395
   Karo-karo D, 2019, EMERG INFECT DIS, V25, P465, DOI 10.3201/eid2503.180167
   Killian Mary Lea, 2008, V436, P7, DOI 10.1007/978-1-59745-279-3_2
   Kohl C, 2015, EMERG INFECT DIS, V21, P48, DOI 10.3201/eid2101.140766
   Korteweg C, 2008, AM J PATHOL, V172, P1155, DOI 10.2353/ajpath.2008.070791
   Kosasih H, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002483
   Kulski JK, 2016, NEXT GENERATION SEQU
   Lam WY, 2007, J CLIN MICROBIOL, V45, P3631, DOI 10.1128/JCM.00280-07
   Lambert AJ, 2003, J CLIN MICROBIOL, V41, P379, DOI 10.1128/JCM.41.1.379-385.2003
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   Leal ED, 2000, MEM I OSWALDO CRUZ, V95, P193
   Lee K., 2020, METHODS
   Li LM, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0541-9
   Li S., 2017, PLOS ONEPLOS ONE, V12, DOI DOI 10.1371/JOURNAL.PONE.0169256.
   LODISH H, 2000, MOL CELL BIOL
   Looi Lai-Meng, 2007, Malays J Pathol, V29, P63
   Lopez-Jimena B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006448
   Lu XY, 2014, J CLIN MICROBIOL, V52, P67, DOI 10.1128/JCM.02533-13
   Luis AD, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2753
   Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292
   Mackenzie JS, 2013, CURR OPIN VIROL, V3, P170, DOI 10.1016/j.coviro.2013.02.002
   Mahony JB, 2005, J MOL DIAGN, V7, P551, DOI 10.1016/S1525-1578(10)60587-9
   MARSTON DA, 2013, BMC GENOMICS, V14, DOI DOI 10.1094/PHYTO-02-18-0067-R?URL_VER=Z39.88-2003&RFR_ID=
   Massart S, 2019, PHYTOPATHOLOGY, V109, P488, DOI 10.1094/PHYTO-02-18-0067-R
   McBride R, 2012, VIRUSES-BASEL, V4, P2902, DOI 10.3390/v4112902
   McGinnis J, 2016, J CLIN VIROL, V79, P44, DOI 10.1016/j.jcv.2016.03.005
   Michel F., 2018, INT J ENV RES PUB HE, V15, P2
   Moise L., 2016, IQT Q, V7, P20
   Morens DM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003467
   Myint KSA, 2014, AM J TROP MED HYG, V90, P260, DOI 10.4269/ajtmh.13-0445
   Nagata N, 2010, VET PATHOL, V47, P881, DOI 10.1177/0300985810378760
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Ng EKO, 2005, EMERG INFECT DIS, V11, P1303, DOI 10.3201/eid1108.041317
   Nii-Trebi NI, 2017, BIOMED RES INT, V2017, P1, DOI 10.1155/2017/5245021
   Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63
   Obenrader S., 2003, SANGER METHOD
   Ogden N H, 2017, Can Commun Dis Rep, V43, P206, DOI 10.14745/ccdr.v43i10a03
   Parida MM, 2008, J BIOSCIENCES, V33, P617, DOI 10.1007/s12038-008-0079-7
   Parrish CR, 2008, MICROBIOL MOL BIOL R, V72, P457, DOI 10.1128/MMBR.00004-08
   Parrish CR, 2015, J VIROL, V89, P2990, DOI 10.1128/JVI.03146-14
   Pekosz Andrew, 2008, Md Med, V9, P13
   Perkasa A, 2016, EMERG INFECT DIS, V22, P924, DOI 10.3201/eid2205.151915
   Plowright RK, 2017, NAT REV MICROBIOL, V15, P502, DOI 10.1038/nrmicro.2017.45
   Powers AM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005421
   Public Health England, 2013, UK STAND MICR INV GO, V4, P44
   Putkuri N, 2009, J MED VIROL, V81, P146, DOI 10.1002/jmv.21385
   Reed Kurt D, 2003, Clin Med Res, V1, P5
   Riaz MN, 2016, J PATHOG, V2016, DOI 10.1155/2016/3219793
   Riswari SF, 2016, J CLIN VIROL, V74, P61, DOI 10.1016/j.jcv.2015.11.017
   Rivera A, 2016, J LEUKOCYTE BIOL, V100, P889, DOI 10.1189/jlb.4RI0316-099RR
   Ro YT, 2017, MICROBIOL IMMUNOL, V61, P130, DOI 10.1111/1348-0421.12475
   Rosenberg R, 2013, P NATL ACAD SCI USA, V110, P13961, DOI 10.1073/pnas.1307243110
   Ruckert C, 2018, TRENDS PARASITOL, V34, P310, DOI 10.1016/j.pt.2017.12.004
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Sanchez-Seco MP, 2001, J VIROL METHODS, V95, P153, DOI 10.1016/S0166-0934(01)00306-8
   Sasmono RT, 2015, INFECT GENET EVOL, V32, P165, DOI 10.1016/j.meegid.2015.03.006
   Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002
   Saylan Y., 2019, BIOSENSORS, V9, P1
   Scaramozzino N, 2007, CLIN CHEM, V53, P606, DOI 10.1373/clinchem.2006.068635
   Scheuch D.E., 2018, VIRUSES, V10, P1
   Schneeberger PHH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178195
   Schneeberger PHH, 2016, INFECT GENET EVOL, V40, P389, DOI 10.1016/j.meegid.2015.08.044
   Seib KL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000612
   Shimada T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184699
   Singh J., 2014, INT J ADV RES BIOL S, V1, P65
   Souf S., 2016, BIOSCIENCE HORIZONS, V9, P1
   Susilawathi NM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-81
   Tong S, 2008, J CLIN MICROBIOL, V46, P2652, DOI 10.1128/JCM.00192-08
   van Doorn H Rogier, 2014, Medicine (Abingdon), V42, P60
   Vanchiere JA, 2005, J INFECT DIS, V192, P658, DOI 10.1086/432076
   VanDevanter DR, 1996, J CLIN MICROBIOL, V34, P1666, DOI 10.1128/JCM.34.7.1666-1671.1996
   Viana R.V., 2011, WIDE SPECTRA QUALITY, P30
   Vibin J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26851-1
   Vieira C.J.D.S., 2019, INFECT GENET EVOL, V75, P1
   Vina-Rodriguez V., 2016, BIOMED RES INT, P1
   Wacharapluesadee S, 2007, J VIROL METHODS, V141, P97, DOI 10.1016/j.jviromet.2006.11.023
   Wacker Michael J, 2005, J Biomol Tech, V16, P266
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang B, 2005, J CLIN MICROBIOL, V43, P2339, DOI 10.1128/JCM.43.5.2339-2344.2005
   Wang F., 2016, BIOMED RES INT, P1
   Wang LF, 2014, REV SCI TECH OIE, V33, P569, DOI 10.20506/rst.33.2.2311
   Watanabe S, 2010, EMERG INFECT DIS, V16, P1217, DOI 10.3201/eid1608.100208
   Wertheim HFL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000231
   WHO, 2020, CUM NUMB CONF HUM CA
   Wiyatno Ageng, 2018, JMM Case Rep, V5, pe005139, DOI 10.1099/jmmcr.0.005139
   Wiyatno A, 2016, J INFECT DEV COUNTR, V10, P880, DOI 10.3855/jidc.7573
   Wolking D., 2013, GUIDE IMPLEMENTING C
   Wong YP, 2018, J APPL MICROBIOL, V124, P626, DOI 10.1111/jam.13647
   World Health Organization, 2016, LAB TEST ZIK VIR INF
   World Health Organization, 2018, EB VIR DIS
   World Health Organization (WHO), 2008, GUID EST VIR LAB DEV
   World Health Organization (WHO), 2011, WHO INF MOL DIAGN IN
   World Health Organization (WHO), 2014, LAB DIAGN EB VIR DIS, P1
   World Health Organization (WHO), 2006, COLL PRES SHIPP SPEC
   World Health Organization (WHO), 2005, WHO LAB BIOS GUID HA
   World Health Organization (WHO), 2009, GOOD CLIN LAB PAR GC
   Ye JX, 2007, AM J PATHOL, V170, P538, DOI 10.2353/ajpath.2007.060469
   Yogesh AS, 2011, BIOMED RES-INDIA, V22, P81
   Yudhaputri FA, 2017, VIROLOGY, V510, P248, DOI 10.1016/j.virol.2017.07.026
   Zhai JH, 2007, J CLIN MICROBIOL, V45, P224, DOI 10.1128/JCM.01893-06
NR 153
TC 0
Z9 0
U1 32
U2 32
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUL
PY 2020
VL 81
AR 104215
DI 10.1016/j.meegid.2020.104215
PG 14
WC Infectious Diseases
SC Infectious Diseases
GA LL4NS
UT WOS:000531533700003
PM 32006706
OA Green Published
DA 2020-07-08
ER

PT J
AU Bouyer, J
   Culbert, NJ
   Dicko, AH
   Pacheco, MG
   Virginio, J
   Pedrosa, MC
   Garziera, L
   Pinto, ATM
   Klaptocz, A
   Germann, J
   Wallner, T
   Salvador-Herranz, G
   Herrero, RA
   Yamada, H
   Balestrino, F
   Vreysen, MJB
AF Bouyer, J.
   Culbert, N. J.
   Dicko, A. H.
   Pacheco, M. Gomez
   Virginio, J.
   Pedrosa, M. C.
   Garziera, L.
   Pinto, A. T. Macedo
   Klaptocz, A.
   Germann, J.
   Wallner, T.
   Salvador-Herranz, G.
   Herrero, R. Argiles
   Yamada, H.
   Balestrino, F.
   Vreysen, M. J. B.
TI Field performance of sterile male mosquitoes released from an uncrewed
   aerial vehicle
SO SCIENCE ROBOTICS
LA English
DT Article
ID DIPTERA-CULICIDAE; GENE DRIVE; ERADICATION; MODELS
AB Genetic control methods of mosquito vectors of malaria, dengue, yellow fever, and Zika are becoming increasingly popular due to the limitations of other techniques such as the use of insecticides. The sterile insect technique is an effective genetic control method to manage insect populations. However, it is crucial to release sterile mosquitoes by air to ensure homogeneous coverage, especially in large areas. Here, we report a fully automated adult mosquito release system operated from an uncrewed aerial vehicle or drone. Our system, developed and tested in Brazil, enabled a homogeneous dispersal of sterile male Aedes aegypti while maintaining their quality, leading to a homogeneous sterile-to-wild male ratio due to their aggregation in the same sites. Our results indicate that the released sterile males were able to compete with the wild males in mating with the wild females; thus, the sterile males were able to induce sterility in the native female population. The use of drones to implement the sterile insect technique will lead to improvements in areal coverage and savings in operational costs due to the requirement of fewer release sites and field staff.
C1 [Bouyer, J.] Univ Montpellier, INRA, CIRAD, Unite Mixte Rech ASTRE, Montpellier, France.
   [Bouyer, J.; Culbert, N. J.; Wallner, T.; Herrero, R. Argiles; Yamada, H.; Balestrino, F.; Vreysen, M. J. B.] Joint FAO IAEA Programme Nucl Tech Food & Agr, Insect Pest Control Lab, A-1400 Vienna, Austria.
   [Culbert, N. J.] Univ Liverpool, Inst Integrat Biol, Liverpool, Merseyside, England.
   [Culbert, N. J.] Univ Liverpool, Ctr Genom Res, Liverpool, Merseyside, England.
   [Dicko, A. H.; Klaptocz, A.; Germann, J.; Wallner, T.; Salvador-Herranz, G.] WeRobotics, Rue Italie 11, CH-1204 Geneva, Switzerland.
   [Dicko, A. H.] Stat Dev STATS4D, Sacre Coeur 3,1 Bis,PO 11000, Dakar, Senegal.
   [Pacheco, M. Gomez; Virginio, J.; Pedrosa, M. C.; Garziera, L.; Pinto, A. T. Macedo] Biofabr Moscamed Brasil, Av C1,992 Quadra 13,Lote 15, Dist Ind Sao Francisco, BA, Brazil.
   [Salvador-Herranz, G.] Univ Politecn Valencia, Inst Invest & Innovac Bioingn I3B, Camino Vera S-N, Valencia 46022, Spain.
   [Balestrino, F.] Ctr Agr Ambiente Giorgio Nicoli Srl CAA, Via St Agata 835, I-40014 Crevalcore, BO, Italy.
RP Bouyer, J (corresponding author), Univ Montpellier, INRA, CIRAD, Unite Mixte Rech ASTRE, Montpellier, France.
EM j.bouyer@iaea.org
FU USAID through the project "Combatting Zika and future threats, a grand
   challenge for development"; Joint Food and Agriculture Organization of
   the United Nations/IAEA Division of Nuclear Techniques in Food and
   Agriculture; European Research Council under the European Union's
   Horizon 2020 research and innovation program [682387-REVOLINC]
FX This project received funding from the USAID through the project
   "Combatting Zika and future threats, a grand challenge for development,"
   the Joint Food and Agriculture Organization of the United Nations/IAEA
   Division of Nuclear Techniques in Food and Agriculture, and the European
   Research Council under the European Union's Horizon 2020 research and
   innovation program (grant agreement no. 682387-REVOLINC). This article
   reflects only the authors' views, and the agency is not responsible for
   any use that may be made of the information it contains.
CR Adelman ZN, 2016, TRENDS PARASITOL, V32, P219, DOI 10.1016/j.pt.2015.12.003
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Bassene MD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006172
   Bellini R, 2013, J MED ENTOMOL, V50, P94, DOI 10.1603/ME11058
   Bloem S., 2007, P591, DOI 10.1007/978-1-4020-6059-5_55
   Bouyer J., 2017, Patent No. [WO2017190991A1, 2017190991]
   Bouyer J, 2020, TRENDS PARASITOL, V36, P325, DOI 10.1016/j.pt.2020.01.004
   Bouyer J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11616-9
   Burnham K. P., 2002, MODEL SELECTION MULT
   Callaway E, 2016, NATURE, V539, P17, DOI 10.1038/nature.2016.20878
   Culbert NJ, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04066-6
   Culbert NJ, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-3125-z
   Culbert NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34469-6
   Damiens D, 2012, J MED ENTOMOL, V49, P1001, DOI 10.1603/ME11289
   Damiens D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163788
   Dicko AH, 2014, P NATL ACAD SCI USA, V111, P10149, DOI 10.1073/pnas.1407773111
   EFRON B, 1979, ANN STAT, V7, P1, DOI 10.1214/aos/1176344552
   Enkerlin W., 2007, GUIDANCE PACKING SHI
   Enkerlin W, 2015, FLA ENTOMOL, V98, P665, DOI 10.1653/024.098.0242
   FAY R. W., 1959, MOSQUITO NEWS, V19, P144
   Feldmann U, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P701, DOI 10.1007/1-4020-4051-2_27
   FOCKS DA, 1980, J MED ENTOMOL, V17, P567, DOI 10.1093/jmedent/17.6.567
   FRIED M, 1971, J ECON ENTOMOL, V64, P869, DOI 10.1093/jee/64.4.869
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Hall AB, 2015, SCIENCE, V348, P1268, DOI 10.1126/science.aaa2850
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Harris AF, 2011, NAT BIOTECHNOL, V29, P1034, DOI 10.1038/nbt.2019
   HURVICH CM, 1995, BIOMETRICS, V51, P1077, DOI 10.2307/2533006
   Krzywinska E, 2016, SCIENCE, V353, P67, DOI 10.1126/science.aaf5605
   Maiga H., 2017, GUIDELINES ROUTINE C
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   Mubarqui RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103077
   Pagabeleguem S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0869-3
   Parker A, 2007, FLA ENTOMOL, V90, P88, DOI 10.1653/0015-4040(2007)90[88:SITAMF]2.0.CO;2
   Pennisi E., 2016, SCIENCE
   Segoli M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003294
   Servick K., 2016, WILL IT WORK SCI
   Tan LT, 2013, J APPL ENTOMOL, V137, P126, DOI 10.1111/j.1439-0418.2011.01649.x
   Tween G., 2007, P229, DOI 10.1007/978-1-4020-6059-5_21
   Vreysen MJB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000907
   Vreysen MJB, 2000, J ECON ENTOMOL, V93, P123, DOI 10.1603/0022-0493-93.1.123
   WHO IAEA, 2020, GUID FRAM TEST STER
   WHO UNICEF, 2017, GLOB VECT CONTR RESP
   Whyard S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0716-6
   Wyss JH, 2000, ANN NY ACAD SCI, V916, P186, DOI 10.1111/j.1749-6632.2000.tb05289.x
   Yahouedo GA, 2014, ACTA TROP, V132, pS96, DOI 10.1016/j.actatropica.2013.11.014
   Yamada H, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3698-y
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
NR 49
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2470-9476
J9 SCI ROBOT
JI Sci. Robot.
PD JUN 17
PY 2020
VL 5
IS 43
AR eaba6251
DI 10.1126/scirobotics.aba6251
PG 10
WC Robotics
SC Robotics
GA LY8UZ
UT WOS:000540805800003
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Wang, R
   Zhen, ZD
   Turtle, L
   Hou, BH
   Li, YQ
   Wu, N
   Gao, N
   Fan, DY
   Chen, H
   An, J
AF Wang, Ran
   Zhen, Zida
   Turtle, Lance
   Hou, Baohua
   Li, Yueqi
   Wu, Na
   Gao, Na
   Fan, Dongying
   Chen, Hui
   An, Jing
TI T cell immunity rather than antibody mediates cross-protection against
   Zika virus infection conferred by a live attenuated Japanese
   encephalitis SA14-14-2 vaccine
SO APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
LA English
DT Article; Early Access
DE Japanese encephalitis virus; T cell; SA14-14-2 vaccine; Zika virus;
   Cross-protection; Cross-reactivity
ID DENGUE VIRUS; REACTIVITY; RESPONSES
AB Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are closely related to mosquito-borne flaviviruses. Japanese encephalitis (JE) vaccine SA14-14-2 has been in the Chinese national Expanded Program on Immunization since 2007. The recent recognition of severe disease syndromes associated with ZIKV, and the identification of ZIKV from mosquitoes in China, prompts an urgent need to investigate the potential interaction between the two. In this study, we showed that SA14-14-2 is protective against ZIKV infection in mice. JE vaccine SA14-14-2 triggered both Th1 and Th2 cross-reactive immune responses to ZIKV; however, it was cellular immunity that predominantly mediated cross-protection against ZIKV infection. Passive transfer of immune sera did not result in significant cross-protection but did mediate antibody-dependent enhancement in vitro, though this did not have an adverse impact on survival. This study suggests that the SA14-14-2 vaccine can protect against ZIKV through a cross-reactive T cell response. This is vital information in terms of ZIKV prevention or precaution in those ZIKV-affected regions where JEV circulates or SA14-14-2 is in widespread use, and opens a promising avenue to develop a novel bivalent vaccine against both ZIKV and JEV.
C1 [Wang, Ran] Capital Med Univ, Beijing Key Lab Pediat Resp Infect Dis,Natl Ctr C, Key Lab Major Dis Children,Beijing Pediat Res Ins, Minist Educ,Lab Infect & Virol,Beijing Childrens, 2019RU016, Beijing 100045, Peoples R China.
   [Wang, Ran; Zhen, Zida; Hou, Baohua; Li, Yueqi; Gao, Na; Fan, Dongying; Chen, Hui; An, Jing] Capital Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100069, Peoples R China.
   [Turtle, Lance] Univ Liverpool, Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool L69 7BE, Merseyside, England.
   [Turtle, Lance] Liverpool Univ Hosp Fdn Trust, Trop & Infect Dis Unit, Liverpool Hlth Partners, Liverpool L7 8XP, Merseyside, England.
   [Wu, Na] Capital Med Univ, Lab Anim Ctr, Beijing 100069, Peoples R China.
   [An, Jing] Beijing Inst Brain Disorders, Ctr Epilepsy, Beijing 100069, Peoples R China.
RP Chen, H (corresponding author), Capital Med Univ, Sch Basic Med Sci, Dept Microbiol & Parasitol, Beijing 100069, Peoples R China.
EM chenhuicxh@ccmu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81772172, 81671971]; Cultivation Fund Project of
   the National Natural Science Foundation in Beijing Children's Hospital,
   Capital Medical University [GPQN201909]; Wellcome TrustWellcome Trust
   [205228/Z/16/Z]; EU Horizon 2020 ZikaPLAN (Preparedness Latin America
   Network) consortium [734584]
FX This study was supported by the National Natural Science Foundation of
   China (grant numbers 81772172 to Hui Chen and 81671971 to Jing An), and
   the Cultivation Fund Project of the National Natural Science Foundation
   in Beijing Children's Hospital, Capital Medical University (grant number
   GPQN201909 to Ran Wang), which funded the experimental work. Lance
   Turtle is supported by the Wellcome Trust (grant number 205228/Z/16/Z)
   and EU Horizon 2020 ZikaPLAN (Preparedness Latin America Network)
   consortium (grant number 734584).
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Breitbach ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007766
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Franco LD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02260
   Fu SH, 2017, SCI CHINA LIFE SCI, V60, P1364, DOI 10.1007/s11427-017-9196-8
   Gao N, 2019, APPL MICROBIOL BIOT, V103, P4977, DOI 10.1007/s00253-019-09798-9
   Gaunt MW, 2020, ANTIVIR RES, V174, DOI 10.1016/j.antiviral.2019.104676
   GERMANN T, 1995, EUR J IMMUNOL, V25, P823, DOI 10.1002/eji.1830250329
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grazel R, 2018, ADV NEONAT CARE, V18, P350, DOI 10.1097/ANC.0000000000000557
   GROSSMAN RA, 1974, AM J EPIDEMIOL, V100, P69, DOI 10.1093/oxfordjournals.aje.a112010
   Guarner J, 2019, SEMIN DIAGN PATHOL, V36, P170, DOI 10.1053/j.semdp.2019.04.009
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Lecouturier V, 2019, VACCINE, V37, P2679, DOI 10.1016/j.vaccine.2019.04.013
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Mendez N, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0233-5
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Rivino L, 2017, IMMUNOLOGY, V150, P146, DOI 10.1111/imm.12681
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Sanchez-Trincado JL, 2017, J IMMUNOL RES, DOI 10.1155/2017/2680160
   Shan C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13589-1
   Slon-Campos JL, 2019, NAT IMMUNOL, V20, P1291, DOI 10.1038/s41590-019-0477-z
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Strauss JH, 2001, CELL, V105, P5, DOI 10.1016/S0092-8674(01)00291-4
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Wang R, 2020, ZOOL RES, V41, P90, DOI 10.24272/j.issn.2095-8137.2020.016
   Wang R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01113
   Wang R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00147
   Wang R, 2019, VIROL SIN, V34, P243, DOI 10.1007/s12250-019-00099-z
   Wang R, 2018, VACCINE, V36, P3522, DOI 10.1016/j.vaccine.2018.04.051
   Wang XX, 2017, NAT COMMUN, V8, DOI [10.1038/s41467-017-00024-6, 10.1038/s41467-017-01822-8]
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Xiao PP, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00359
   Zhou J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax7142
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 44
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0175-7598
EI 1432-0614
J9 APPL MICROBIOL BIOT
JI Appl. Microbiol. Biotechnol.
DI 10.1007/s00253-020-10710-z
EA JUN 2020
PG 11
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA LZ0RK
UT WOS:000540938700002
PM 32556415
OA Other Gold
DA 2020-07-08
ER

PT J
AU Moreira-Soto, A
   Sampaio, GD
   Pedroso, C
   Postigo-Hidalgo, I
   Berneck, BS
   Ulbert, S
   Brites, C
   Netto, EM
   Drexler, JF
AF Moreira-Soto, Andres
   de Souza Sampaio, Gilmara
   Pedroso, Celia
   Postigo-Hidalgo, Ignacio
   Berneck, Beatrice Sarah
   Ulbert, Sebastian
   Brites, Carlos
   Netto, Eduardo Martins
   Drexler, Jan Felix
TI Rapid decline of Zika virus NS1 antigen-specific antibody responses,
   northeastern Brazil
SO VIRUS GENES
LA English
DT Article; Early Access
DE Zika virus; Flavivirus; Serology; Antigens
ID OUTBREAK
AB Zika virus (ZIKV) is a positive-stranded RNA virus within theFlaviviridaefamily. After decades of circulation in Asia, ZIKV was introduced to Brazil in 2014-2015, associated with a rise in congenital malformations. Unlike the genetically related dengue virus (DENV), ZIKV constitutes only one serotype. Although assumed that ZIKV infection may engender lifelong immunity, the long-term kinetics of ZIKV antibody responses are unclear. We assessed long-term kinetics of ZIKV NS1-IgG response in 144 individuals from 3 different subpopulations: HIV patients, tuberculosis patients and healthy individuals first tested in 2016 and retested 1.5-2 years after the 2015-2016 ZIKV epidemic in Salvador de Bahia, Brazil, using a widely distributed NS1-based commercial ELISA. The seropositivity in 2016 reached 59.0% (85/144, 95% confidence interval (CI) 50.7-66.7%), and decreased to 38.6% (56/144, CI 31.3-47.0%) 1.5-2 years later. In addition, the median ZIKV NS1-ELISA reactivity for individuals that remained positive in both timepoints significantly decreased from a ratio of 4.4 (95% CI 3.8-5.0) to 1.6 (95% CI 1.6-1.9) over the 2-year interval (Z: - 6.1;p < 0.001) irrespective of the subpopulation analyzed. Initial 2016 DENV antibody response was non-significant between groups, suggesting comparable DENV background. The high 20.6% seroreversion suggest that widely used serologic tests may fail to account a considerable proportion of past ZIKV infections in flavivirus endemic countries. In addition, ZIKV immunity might be shorter-lived than previously thought, which may contribute to local ZIKV resurgence once individual immune responses wane sufficiently to reduce community protective immunity in addition to birth and migration.
C1 [Moreira-Soto, Andres; Postigo-Hidalgo, Ignacio; Drexler, Jan Felix] Humboldt Univ, Charite Univ Med Berlin, Berlin, Germany.
   [Moreira-Soto, Andres; Postigo-Hidalgo, Ignacio; Drexler, Jan Felix] Berlin Inst Hlth, Inst Virol, Berlin, Germany.
   [de Souza Sampaio, Gilmara; Pedroso, Celia; Brites, Carlos; Netto, Eduardo Martins] Univ Fed Bahia, Salvador, BA, Brazil.
   [Berneck, Beatrice Sarah; Ulbert, Sebastian] Fraunhofer Inst Cell Therapy & Immunol, Dept Immunol, Leipzig, Germany.
   [Netto, Eduardo Martins] Fundacao Jose Silveira, Salvador, BA, Brazil.
   [Drexler, Jan Felix] German Ctr Infect Res DZIF, Braunschweig, Germany.
   [Drexler, Jan Felix] Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.
   [Drexler, Jan Felix] Campus Charite Mitte, Helmut Ruska Haus, Inst Virol, Charitepl 1, D-10098 Berlin, Germany.
RP Drexler, JF (corresponding author), Humboldt Univ, Charite Univ Med Berlin, Berlin, Germany.; Drexler, JF (corresponding author), Berlin Inst Hlth, Inst Virol, Berlin, Germany.; Drexler, JF (corresponding author), German Ctr Infect Res DZIF, Braunschweig, Germany.; Drexler, JF (corresponding author), Sechenov Univ, Martsinovsky Inst Med Parasitol Trop & Vector Bor, Moscow, Russia.; Drexler, JF (corresponding author), Campus Charite Mitte, Helmut Ruska Haus, Inst Virol, Charitepl 1, D-10098 Berlin, Germany.
EM felix.drexler@charite.de
OI Drexler, Jan Felix/0000-0002-3509-0232
FU European UnionEuropean Union (EU) [734548, 721367]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation program through the ZIKAlliance project (Grant No.
   734548) and the Innovative Training Networks HONOURs project (Grant No.
   721367) to Jan Felix Drexler.
CR Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bozza FA, 2019, EMERG INFECT DIS, V25, P311, DOI 10.3201/eid2502.180166
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cleton NB, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003580
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Fischer C, 2019, LANCET INFECT DIS, V19, P240, DOI 10.1016/S1473-3099(19)30049-0
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Goo L, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006178
   Henderson AD, 2020, ELIFE, V9, DOI 10.7554/eLife.48460
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lustig Y, 2018, J CLIN VIROL, V99-100, P31, DOI 10.1016/j.jcv.2017.12.007
   Marques ETA, 2019, MBIO, V10, DOI 10.1128/mBio.01849-19
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Oliveira RAS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190098
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
DI 10.1007/s11262-020-01772-2
EA JUN 2020
PG 6
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA LY3ID
UT WOS:000540418500001
PM 32542479
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhang, RR
   Ye, Q
   Li, XF
   Deng, YQ
   Xu, YP
   Huang, XY
   Xia, Q
   Qin, CF
AF Zhang, Rong-Rong
   Ye, Qing
   Li, Xiao-Feng
   Deng, Yong-Qiang
   Xu, Yan-Peng
   Huang, Xing-Yao
   Xia, Qing
   Qin, Cheng-Feng
TI Construction and characterization of UAA-controlled recombinant Zika
   virus by genetic code expansion
SO SCIENCE CHINA-LIFE SCIENCES
LA English
DT Letter; Early Access
ID LIVE; GENERATION
C1 [Zhang, Rong-Rong; Qin, Cheng-Feng] Anhui Med Univ, Grad Sch, Hefei 230032, Peoples R China.
   [Zhang, Rong-Rong; Ye, Qing; Li, Xiao-Feng; Deng, Yong-Qiang; Xu, Yan-Peng; Huang, Xing-Yao; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Xia, Qing] Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
RP Qin, CF (corresponding author), Anhui Med Univ, Grad Sch, Hefei 230032, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Xia, Q (corresponding author), Peking Univ, Sch Pharmaceut Sci, Dept Biol Chem, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
EM xqing@bjmu.edu.cn; chengfeng_qin@126.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81701996]; National Key Research and Development
   Project of China [2018YFA0900801]
FX We thank Dr. Pei-Yong Shi for providing the infectious clone of ZIKV
   FSS13025. This work was supported by the National Natural Science
   Foundation of China (81701996) and the National Key Research and
   Development Project of China (2018YFA0900801).
CR Lin SX, 2013, ANGEW CHEM INT EDIT, V52, P13970, DOI 10.1002/anie.201305787
   Si LL, 2016, SCIENCE, V354, P1170, DOI 10.1126/science.aah5869
   Wang L, 2001, SCIENCE, V292, P498, DOI 10.1126/science.1060077
   Wang NX, 2014, ANGEW CHEM INT EDIT, V53, P4867, DOI 10.1002/anie.201402092
   Zhang CL, 2016, BIOMATERIALS, V80, P134, DOI 10.1016/j.biomaterials.2015.11.066
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SCIENCE PRESS
PI BEIJING
PA 16 DONGHUANGCHENGGEN NORTH ST, BEIJING 100717, PEOPLES R CHINA
SN 1674-7305
EI 1869-1889
J9 SCI CHINA LIFE SCI
JI Sci. China-Life Sci.
DI 10.1007/s11427-020-1737-3
EA JUN 2020
PG 3
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA LY2YE
UT WOS:000540392600001
PM 32542514
DA 2020-07-08
ER

PT J
AU Aguiar, RS
   Pohl, F
   Morais, GL
   Nogueira, FCS
   de Carvalho, JB
   Guida, L
   Arge, LWP
   Melo, A
   Moreira, MEL
   Cunha, DP
   Gomes, L
   Portari, EA
   Velasquez, E
   Melani, RD
   Pezzuto, P
   de Castro, FL
   Geddes, VEV
   Gerber, AL
   Azevedo, GS
   Schamber-Reis, BL
   Goncalves, AL
   Junqueira-de-Azevedo, I
   Nishiyama, MY
   Ho, P
   Schanoski, A
   Schuch, V
   Tanuri, A
   Chimelli, L
   Vasconcelos, ZFM
   Domont, GB
   Vasconcelos, ATR
   Nakaya, HI
AF Aguiar, Renato S.
   Pohl, Fabio
   Morais, Guilherme L.
   Nogueira, Fabio C. S.
   de Carvalho, Joseane B.
   Guida, Leticia
   Arge, Luis W. P.
   Melo, Adriana
   Moreira, Maria E. L.
   Cunha, Daniela P.
   Gomes, Leonardo
   Portari, Elyzabeth A.
   Velasquez, Erika
   Melani, Rafael D.
   Pezzuto, Paula
   de Castro, Fernanda L.
   Geddes, Victor E. V.
   Gerber, Alexandra L.
   Azevedo, Girlene S.
   Schamber-Reis, Bruno L.
   Goncalves, Alessandro L.
   Junqueira-de-Azevedo, Inacio
   Nishiyama Jr, Milton Y.
   Ho, Paulo
   Schanoski, Alessandra
   Schuch, Viviane
   Tanuri, Amilcar
   Chimelli, Leila
   Vasconcelos, Zilton F. M.
   Domont, Gilberto B.
   Vasconcelos, Ana T. R.
   Nakaya, Helder, I
TI Molecular alterations in the extracellular matrix in the brains of
   newborns with congenital Zika syndrome
SO SCIENCE SIGNALING
LA English
DT Article
ID VIRUS-INFECTION; RNA-SEQ; COLLAGEN; MUTATIONS; DATABASE; VISUALIZATION;
   POLYMORPHISM; DISRUPTION; PROTEINS; REGIONS
AB Zika virus (ZIKV) infection during pregnancy can cause a set of severe abnormalities in the fetus known as congenital Zika syndrome (CZS). Experiments with animal models and in vitro systems have substantially contributed to our understanding of the pathophysiology of ZIKV infection. Here, to investigate the molecular basis of CZS in humans, we used a systems biology approach to integrate transcriptomic, proteomic, and genomic data from the postmortem brains of neonates with CZS. We observed that collagens were greatly reduced in expression in CZS brains at both the RNA and protein levels and that neonates with CZS had several single-nucleotide polymorphisms in collagen-encoding genes that are associated with osteogenesis imperfecta and arthrogryposis. These findings were validated by immunohistochemistry and comparative analysis of collagen abundance in ZIKV-infected and uninfected samples. In addition, we showed a ZIKV-dependent increase in the expression of cell adhesion factors that are essential for neurite outgrowth and axon guidance, findings that are consistent with the neuronal migration defects observed in CZS. Together, these findings provide insights into the underlying molecular alterations in the ZIKV-infected brain and reveal host genes associated with CZS susceptibility.
C1 [Aguiar, Renato S.; Pezzuto, Paula; de Castro, Fernanda L.; Geddes, Victor E. V.; Goncalves, Alessandro L.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, Brazil.
   [Aguiar, Renato S.] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Biol Geral, Belo Horizonte, MG, Brazil.
   [Pohl, Fabio; Schuch, Viviane; Nakaya, Helder, I] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Morais, Guilherme L.; de Carvalho, Joseane B.; Arge, Luis W. P.; Gerber, Alexandra L.; Vasconcelos, Ana T. R.] LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.
   [Nogueira, Fabio C. S.; Velasquez, Erika; Melani, Rafael D.; Domont, Gilberto B.] Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.
   [Nogueira, Fabio C. S.] Univ Fed Rio de Janeiro, Inst Chem, LADETEC, Lab Prote, Rio De Janeiro, Brazil.
   [Guida, Leticia; Moreira, Maria E. L.; Cunha, Daniela P.; Gomes, Leonardo; Portari, Elyzabeth A.; Vasconcelos, Zilton F. M.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Melo, Adriana; Azevedo, Girlene S.] Inst Pesquisa Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Schamber-Reis, Bruno L.] Ctr Univ UniFacisa, Nucleo Genet Med, Fac Ciencias Med Campina Grande, Campina Grande, Paraiba, Brazil.
   [Junqueira-de-Azevedo, Inacio; Nishiyama Jr, Milton Y.] Butantan Inst, Special Lab Appl Toxinol, Sao Paulo, Brazil.
   [Ho, Paulo; Schanoski, Alessandra] Butantan Inst, Bacteriol Lab, Sao Paulo, Brazil.
   [Chimelli, Leila] Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.
   [Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
RP Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Vasconcelos, ATR (corresponding author), LNCC MCTI, Natl Lab Sci Computat, Petropolis, RJ, Brazil.; Domont, GB (corresponding author), Univ Fed Rio de Janeiro, Inst Chem, Dept Biochem, Prote Unit, Rio De Janeiro, Brazil.; Vasconcelos, ZFM (corresponding author), Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.; Chimelli, L (corresponding author), Inst Estadual Cerebro, Lab Neuropatol, Rio De Janeiro, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
EM chimelli@hucff.ufrj.br; zilton.vasconcelos@iff.fiocruz.br;
   gilbertodomont@gmail.com; atrv@lncc.br; hnakaya@usp.br
RI ; Aguiar, Renato/G-3542-2015; Nishiyama Junior, Milton/H-4002-2013;
   Nogueira, Fabio/G-9580-2011
OI Pohl, Fabio/0000-0003-1695-4936; Aguiar, Renato/0000-0001-5180-3717;
   Guida, Leticia/0000-0003-3543-1532; /0000-0002-2034-0294; Nishiyama
   Junior, Milton/0000-0002-2410-0562; Nogueira, Fabio/0000-0001-5507-7142
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440900/2016-6, 313662/2017-7, 440613/2016-7, 303170/2017-4]; CAPESCAPES
   [88881.130757/2016-01, 001, 88887.130697]; FINEPCiencia Tecnologia e
   Inovacao (FINEP) [01.16.0078.00]; Sao Paulo Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/50137-3, 2012/19278-6, 2018/14933-2, 2018/21934-5, 2013/08216-2];
   FAPERJCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/202.650/2018, 26/202.903/20]
FX This research was supported by CNPq (grant no. 440900/2016-6), CAPES
   (grant no. 88881.130757/2016-01), and FINEP (grant no. 01.16.0078.00).
   H.I.N. is supported by CNPq (313662/2017-7) and the Sao Paulo Research
   Foundation (FAPESP; grants 2017/50137-3, 2012/19278-6, 2018/14933-2,
   2018/21934-5, and 2013/08216-2). F.L.d.C., V.E.V.G., J.B.C., and
   L.W.P.A. are funded by CAPES (grant 001). G.B.D. has financial support
   from grants 88887.130697 (CAPES) and 440613/2016-7 (CNPq). F.C.S.N. is
   supported by FAPERJ (E-26/202.650/2018). A.T.R.V. is supported by CNPq
   (303170/2017-4) and FAPERJ (26/202.903/20).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Andersen LL, 2015, J EXP MED, V212, P1371, DOI 10.1084/jem.20142274
   Baeten KM, 2011, DEV NEUROBIOL, V71, P1018, DOI 10.1002/dneu.20954
   Bateman JF, 2009, NAT REV GENET, V10, P173, DOI 10.1038/nrg2520
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Buxbaum JD, 2008, MOL PSYCHIATR, V13, P162, DOI 10.1038/sj.mp.4001991
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen Y, 2017, INT J CLIN EXP MED, V10, P14904
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695
   Cingolani Pablo, 2012, Frontiers in Genetics, V3, P35, DOI 10.3389/fgene.2012.00035
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Deckx S, 2016, FASEB J, V30, P2651, DOI 10.1096/fj.201500096R
   DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806
   Dittrich R, 2007, NEUROLOGY, V68, P2120, DOI 10.1212/01.wnl.0000264892.92538.a9
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faqeih E, 2009, AM J MED GENET A, V149A, P461, DOI 10.1002/ajmg.a.32653
   Fernandez-Calle R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0823-8
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Garcez PP, 2017, SCI REP-UK, V7, DOI 10.1038/srep40780
   Gorshkov V, 2015, ANAL CHEM, V87, P6319, DOI 10.1021/acs.analchem.5b01166
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HIPC-CHI Signatures Project Team; HIPC-I Consortium, 2017, SCI IMMUNOL, V2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kuboyama K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048797
   Kuo DS, 2012, HUM MOL GENET, V21, pR97, DOI 10.1093/hmg/dds346
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larroche J.-C., 1977, DEV PATHOLOGY NEONAT, Vxviii
   Lex A, 2014, IEEE T VIS COMPUT GR, V20, P1983, DOI 10.1109/TVCG.2014.2346248
   Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630
   Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932
   Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mala JGS, 2010, LIFE SCI, V87, P579, DOI 10.1016/j.lfs.2010.09.024
   Mammoto T, 2013, AM J PATHOL, V183, P1293, DOI 10.1016/j.ajpath.2013.06.026
   Maness PF, 2007, NAT NEUROSCI, V10, P263, DOI 10.1038/nn0207-263b
   Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429
   McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nadarajah B, 2003, CEREB CORTEX, V13, P607, DOI 10.1093/cercor/13.6.607
   Nakaya HI, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0146
   Naslavsky MS, 2017, HUM MUTAT, V38, P751, DOI 10.1002/humu.23220
   Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407
   Ogus AC, 2004, EUR RESPIR J, V23, P219, DOI 10.1183/09031936.03.00061703
   Pariser H, 2005, BIOCHEM BIOPH RES CO, V332, P664, DOI 10.1016/j.bbrc.2005.05.007
   Plotkin Horacio, 2004, BMC Pediatr, V4, P16, DOI 10.1186/1471-2431-4-16
   Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Robinson KA, 2017, MATRIX BIOL, V64, P81, DOI 10.1016/j.matbio.2017.08.004
   Sakurai T, 1997, J CELL BIOL, V136, P907, DOI 10.1083/jcb.136.4.907
   Schiela B, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02177
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Schroder NWJ, 2005, J IMMUNOL, V175, P2534, DOI 10.4049/jimmunol.175.4.2534
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308
   Shin J, 2015, CELL STEM CELL, V17, P360, DOI 10.1016/j.stem.2015.07.013
   Siqueira WL, 2016, BRAZ ORAL RES, V30, DOI 10.1590/1807-3107BOR-2016.vol30.0046
   Van der Auwera Geraldine A, 2013, Curr Protoc Bioinformatics, V43, DOI [10.1002/0471250953.bi1201s43, 10.1002/0471250953.bi1110s43]
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teichmann SA, 2000, J MOL BIOL, V296, P1367, DOI 10.1006/jmbi.1999.3497
   Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]
   Useche YM, 2019, J INFECT PUBLIC HEAL, V12, P43, DOI 10.1016/j.jiph.2018.08.009
   van der Velde KJ, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-016-1141-7
   Varghese F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096801
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Weng YC, 2012, ANN NEUROL, V71, P470, DOI 10.1002/ana.22682
   Wojtas AM, 2017, P NATL ACAD SCI USA, V114, pE6962, DOI 10.1073/pnas.1701137114
   Xia JG, 2014, NUCLEIC ACIDS RES, V42, pW167, DOI 10.1093/nar/gku443
   Zhu Zhe, 2017, J Exp Med, V214, P3145, DOI 10.1084/jem.2017109309122017c
   Zou YQ, 2014, HUM MOL GENET, V23, P2339, DOI 10.1093/hmg/ddt627
NR 86
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JUN 9
PY 2020
VL 13
IS 635
AR eaay6736
DI 10.1126/scisignal.aay6736
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LY4UD
UT WOS:000540523900001
PM 32518143
DA 2020-07-08
ER

PT J
AU Eckhardt, CM
   Cummings, MJ
   Rajagopalan, KN
   Borden, S
   Bitan, ZC
   Wolf, A
   Kantor, A
   Briese, T
   Meyer, BJ
   Jacobson, SD
   Scotto, D
   Mishra, N
   Philip, NM
   Stotler, BA
   Schwartz, J
   Shaz, B
   Spitalnik, SL
   Eisenberg, A
   Hod, EA
   Justman, J
   Cheung, K
   Lipkin, WI
   O'Donnell, MR
AF Eckhardt, Christina M.
   Cummings, Matthew J.
   Rajagopalan, Kartik N.
   Borden, Sarah
   Bitan, Zachary C.
   Wolf, Allison
   Kantor, Alex
   Briese, Thomas
   Meyer, Benjamin J.
   Jacobson, Samuel D.
   Scotto, Dawn
   Mishra, Nischay
   Philip, Neena M.
   Stotler, Brie A.
   Schwartz, Joseph
   Shaz, Beth
   Spitalnik, Steven L.
   Eisenberg, Andrew
   Hod, Eldad A.
   Justman, Jessica
   Cheung, Ken
   Lipkin, W. Ian
   O'Donnell, Max R.
TI Evaluating the efficacy and safety of human anti-SARS-CoV-2 convalescent
   plasma in severely ill adults with COVID-19: A structured summary of a
   study protocol for a randomized controlled trial
SO TRIALS
LA English
DT Letter
DE COVID-19; SARS-CoV-2; Respiratory Failure; Randomized controlled trial;
   Protocol; Convalescent Plasma; Anti-SARS-CoV-2 plasma
AB ObjectivesThe aim of this study is to evaluate the efficacy and safety of human anti-SARS-CoV-2 convalescent plasma in hospitalized adults with severe SARS-CoV-2 infection.Trial DesignThis is a prospective, single-center, phase 2, randomized, controlled trial that is blinded to participants and clinical outcome assessor.ParticipantsEligible participants include adults (>= 18 years) with evidence of SARS-CoV-2 infection by PCR test of nasopharyngeal or oropharyngeal swab within 14 days of randomization, evidence of infiltrates on chest radiography, peripheral capillary oxygen saturation (SpO2) <= 94% on room air, and/or need for supplemental oxygen, non-invasive mechanical ventilation, or invasive mechanical ventilation, who are willing and able to provide written informed consent prior to performing study procedures or who have a legally authorized representative available to do so. Exclusion criteria include participation in another clinical trial of anti-viral agent(s)* for coronavirus disease-2019 (COVID-19), receipt of any anti-viral agent(s)* with possible activity against SARS-CoV-2 <24 hours prior to plasma infusion, mechanical ventilation (including extracorporeal membrane oxygenation [ECMO]) for >= 5 days, severe multi-organ failure, history of allergic reactions to transfused blood products per NHSN/CDC criteria, known IgA deficiency, and pregnancy. Included participants will be hospitalized at the time of randomization and plasma infusion.*Use of remdesivir as treatment for COVID-19 is permitted.The study will be undertaken at Columbia University Irving Medical Center in New York, USA.Intervention and comparatorThe investigational treatment is anti-SARS-CoV-2 human convalescent plasma. To procure the investigational treatment, volunteers who recovered from COVID-19 will undergo testing to confirm the presence of anti-SARS-CoV-2 antibody to the spike trimer at a 1:400 dilution. Donors will also be screened for transfusion-transmitted infections (e.g. HIV, HBV, HCV, WNV, HTLV-I/II, T. cruzi, ZIKV). If donors have experienced COVID-19 symptoms within 28 days, they will be screened with a nasopharyngeal swab to confirm they are SARS-CoV-2 PCR-negative. Plasma will be collected using standard apheresis technology by the New York Blood Center. Study participants will be randomized in a 2:1 ratio to receive one unit (200 - 250 mL) of anti-SARS-CoV-2 plasma versus one unit (200 - 250 mL) of the earliest available control plasma. The control plasma cannot be tested for presence of anti-SARS-CoV-2 antibody prior to the transfusion, but will be tested for anti- SARS-CoV-2 antibody after the transfusion to allow for a retrospective per-protocol analysis.Main outcomesThe primary endpoint is time to clinical improvement. This is defined as time from randomization to either discharge from the hospital or improvement by one point on the following seven-point ordinal scale, whichever occurs first.1. Not hospitalized with resumption of normal activities2. Not hospitalized, but unable to resume normal activities3. Hospitalized, not requiring supplemental oxygen4. Hospitalized, requiring supplemental oxygen5. Hospitalized, requiring high-flow oxygen therapy or non-invasive mechanical ventilation6. Hospitalized, requiring ECMO, invasive mechanical ventilation, or both7. DeathThis scale, designed to assess clinical status over time, was based on that recommended by the World Health Organization for use in determining efficacy end-points in clinical trials in hospitalized patients with COVID-19.
   A recent clinical trial evaluating the efficacy and safety of lopinavir- ritonavir for patients hospitalized with severe COVID-19 used a similar ordinal scale, as have recent clinical trials of novel therapeutics for severe influenza, including a post-hoc analysis of a trial evaluating immune plasma.The primary safety endpoints are cumulative incidence of grade 3 and 4 adverse events and cumulative incidence of serious adverse events during the study period.RandomizationStudy participants will be randomized in a 2:1 ratio to receive anti-SARS-CoV-2 plasma versus control plasma using a web-based randomization platform. Treatment assignments will be generated using randomly permuted blocks of different sizes to minimize imbalance while also minimizing predictability.Blinding (masking)The study participants and the clinicians who will evaluate post-treatment outcomes will be blinded to group assignment. The blood bank and the clinical research team will not be blinded to group assignment.Numbers to be randomized (sample size)We plan to enroll 129 participants, with 86 in the anti-SARS-CoV-2 arm, and 43 in the control arm. Among the participants, we expect 70% or n = 72 will achieve clinical improvement. This will yield an 80% power for a one-sided Wald test at 0.15 level of significance under the proportional hazards model with a hazard ratio of 1.5.Trial StatusProtocol AAAS9924, Version 17APR2020, 4/17/2020Start of recruitment: April 20, 2020Recruitment is ongoing.Trial registrationClinicalTrials.gov: NCT04359810Date of trial registration: April 24, 2020Retrospectively registeredFull protocolThe full protocol is attached as an additional file, accessible from the Trials website (Additional file 1). In the interest of expediting dissemination of this material, the familiar formatting has been eliminated; this Letter serves as a summary of the key elements of the full protocol.
C1 [Eckhardt, Christina M.; Cummings, Matthew J.; Rajagopalan, Kartik N.; Borden, Sarah; Bitan, Zachary C.; Wolf, Allison; Kantor, Alex; Briese, Thomas; Meyer, Benjamin J.; Jacobson, Samuel D.; Scotto, Dawn; Mishra, Nischay; Philip, Neena M.; Stotler, Brie A.; Schwartz, Joseph; Shaz, Beth; Spitalnik, Steven L.; Eisenberg, Andrew; Hod, Eldad A.; Justman, Jessica; Cheung, Ken; Lipkin, W. Ian; O'Donnell, Max R.] Columbia Univ, Med Ctr, New York, NY 10027 USA.
RP Eckhardt, CM (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.
EM cme2113@cumc.columbia.edu
OI Eckhardt, Christina/0000-0002-3249-926X
FU Amazon
FX This trial is funded by an unrestricted gift from Amazon. The funder
   played no role in the design of the study, the collection, analysis, and
   interpretation of data, or in writing the manuscript.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD JUN 8
PY 2020
VL 21
IS 1
AR 499
DI 10.1186/s13063-020-04422-y
PG 3
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA LZ3AA
UT WOS:000541098100008
PM 32513308
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU dos Santos, CR
   Rodovalho, CD
   Jablonka, W
   Martins, AJ
   Lima, JBP
   Dias, LD
   Neto, MACD
   Atella, GC
AF dos Santos, Carlucio Rocha
   de Melo Rodovalho, Cynara
   Jablonka, Willy
   Martins, Ademir Jesus
   Lima, Jose Bento Pereira
   dos Santos Dias, Luciana
   da Silva Neto, Mario Alberto Cardoso
   Atella, Georgia Correa
TI Insecticide resistance, fitness and susceptibility to Zika infection of
   an interbred Aedes aegypti population from Rio de Janeiro, Brazil
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Mosquito; Insecticide resistance; Fitness
ID LUTZOMYIA-LONGIPALPIS; METABOLIC RESISTANCE; STEGOMYIA-AEGYPTI;
   LIFE-SPAN; DIPTERA; CULICIDAE; MECHANISMS; PERMETHRIN; FIELD;
   IDENTIFICATION
AB Background Aedes aegypti is a vector of high relevance, since it transmits several arboviruses, including dengue, chikungunya and Zika. Studies on vector biology are usually conducted with laboratory strains presenting a divergent genetic composition from field populations. This may impair vector control policies that were based on laboratory observations employing only long maintained laboratory strains. In the present study we characterized a laboratory strain interbreed with Ae. aegypti collected from five different localities in Rio de Janeiro (Aedes Rio), for insecticide resistance (IR), IR mechanisms, fitness and Zika virus infection. Methods We compared the recently established Aedes Rio with the laboratory reference strain Rockefeller. Insecticide resistance (deltamethrin, malathion and temephos), activity of metabolic resistance enzymes and kdr mutation frequency were determined. Some life table parameters (longevity, blood-feeding, number and egg viability) and Zika virus susceptibility was also determined. Results Aedes Rio showed resistance to deltamethrin (resistance ratio, RR50 = 32.6) and temephos (RR50 = 7.0) and elevated activity of glutathione S-transferase (GST) and esterases (alpha-EST and pNPA-EST), but not acetylcholinesterase (AChE). In total, 92.1% of males genotyped for kdr presented a "resistant" genotype. Weekly blood-fed females from both strains, presented reduced mortality compared to sucrose-fed mosquitoes; however, Aedes Rio blood-fed females did not live as long (mean lifespan: Rockefeller = 70 +/- 3.07; Aedes Rio = 53.5 +/- 2.16 days). There were no differences between strains in relation to blood-feeding and number of eggs, but Aedes Rio eggs presented reduced viability (mean hatch: Rockefeller = 77.79 +/- 1.4%; Aedes Rio = 58.57 +/- 1.77%). Zika virus infection (plaque-forming unit, PFU) was similar in both strains (mean PFU +/- SE: Aedes Rio: 4.53 x 10(4) +/- 1.14 x 10(4) PFU; Rockefeller: 2.02 x 10(4) +/- 0.71 x 10(4) PFU). Conclusion Selected conditions in the field, such as IR mechanisms, may result in pleiotropic effects that interfere in general physiology of the insect. Therefore, it is important to well characterize field populations to be tested in parallel with laboratory reference strains. This practice would improve the significance of laboratory tests for vector control methods.
C1 [dos Santos, Carlucio Rocha; Jablonka, Willy; da Silva Neto, Mario Alberto Cardoso] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Sinalizacao Celular, Programa Biol Mol & Biotecnol, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Carlucio Rocha; de Melo Rodovalho, Cynara; Martins, Ademir Jesus; Lima, Jose Bento Pereira; dos Santos Dias, Luciana] Fiocruz MS, Inst Oswaldo Cruz, Lab Fisiol & Controle Artropodes Vetores, Rio De Janeiro, RJ, Brazil.
   [dos Santos, Carlucio Rocha; de Melo Rodovalho, Cynara; Martins, Ademir Jesus; Lima, Jose Bento Pereira; dos Santos Dias, Luciana] Inst Biol Exercito, Lab Entomol, Rio De Janeiro, RJ, Brazil.
   [Atella, Georgia Correa] Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Bioquim Lipidios & Lipoprot, Programa Biol Mol & Biotecnol, Rio De Janeiro, RJ, Brazil.
RP dos Santos, CR (corresponding author), Univ Fed Rio de Janeiro, Inst Bioquim Med Leopoldo de Meis, Lab Sinalizacao Celular, Programa Biol Mol & Biotecnol, Rio De Janeiro, RJ, Brazil.
EM carluciorsantos@gmail.com
FU FAPERJ-ZIKA [210.896/2014]; NIH UORUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (Capes)CAPES; FAPERJ-Zika
FX This study was funded by FAPERJ-ZIKA (210.896/2014) and partially
   supported by a post-doctoral scholarship from NIH UOR, FAPERJ-Zika and
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (Capes) to
   CRS.
CR ABEDI Z. H., 1961, MOSQUITO NEWS, V21, P1
   Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Ahmed SB, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-126
   [Anonymous], 2016, MON MAN INS RES AED
   [Anonymous], 1981, INSTR DET SUSC RES M
   Diniz DFA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1276-5
   Belinato TA, 2016, INSECTICIDES RESISTANCE, P243, DOI 10.5772/61826
   Belinato TA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130719
   Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013
   Bellinato DF, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8603263
   Benedict MQ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S4
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   BRIEGEL H, 1973, GERONTOLOGY, V19, P240, DOI 10.1159/000211976
   BRISCOE DA, 1992, CONSERV BIOL, V6, P416, DOI 10.1046/j.1523-1739.1992.06030416.x
   Brito LP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2410819
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chediak M, 2016, MEM I OSWALDO CRUZ, V111, P311, DOI 10.1590/0074-02760150409
   Cheng YL, 2016, SCI REP-UK, V6, DOI 10.1038/srep32000
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Corbel V, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3591-8
   Cornet S, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-315
   da-Cunha MP, 2005, MEM I OSWALDO CRUZ, V100, P441, DOI 10.1590/S0074-02762005000400017
   Dalla Bona AC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1634-y
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Donnelly MJ, 2016, TRENDS PARASITOL, V32, P197, DOI 10.1016/j.pt.2015.12.001
   Faucon F, 2015, GENOME RES, V25, P1347, DOI 10.1101/gr.189225.115
   Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Gary RE, 2001, J MED ENTOMOL, V38, P22, DOI 10.1603/0022-2585-38.1.22
   Gloria-Soria A, 2019, PLOS NEGLECT TROP D, V12, pe0007930
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Hardstone MC, 2010, J MED ENTOMOL, V47, P188, DOI 10.1603/ME09131
   Hemingway J, 2004, INSECT BIOCHEM MOLEC, V34, P653, DOI 10.1016/j.ibmb.2004.03.018
   Howell PI, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S2-S8
   Huho BJ, 2007, J EXP BIOL, V210, P2939, DOI 10.1242/jeb.005033
   Jaramillo N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096379
   Joy TK, 2010, EXP GERONTOL, V45, P685, DOI 10.1016/j.exger.2010.04.009
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kristensen TN, 2005, ANIM SCI, V80, P121, DOI 10.1079/ASC41960121
   Laurenti MD, 2009, SCAND J IMMUNOL, V70, P389, DOI 10.1111/j.1365-3083.2009.02310.x
   Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Lozano-Fuentes S, 2019, J MED ENTOMOL, V56, P233, DOI 10.1093/jme/tjy114
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   Macoris MLG, 1995, REV PATOL TROP, V24, P31
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x
   Martins AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031889
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Martins AJ, 2001, INSECTICIDES BASIC O, P17
   Martins J, 2007, INSECT MOL BIOL, V16, P777, DOI 10.1111/j.1365-2583.2007.00771.x
   Mebrahtu YB, 1997, AM J TROP MED HYG, V56, P456, DOI 10.4269/ajtmh.1997.56.456
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Mukhopadhyay J, 1997, AM J TROP MED HYG, V57, P216, DOI 10.4269/ajtmh.1997.57.216
   MUNSTERMANN LE, 1994, ANN ENTOMOL SOC AM, V87, P157, DOI 10.1093/aesa/87.2.157
   Norris DE, 2001, J MED ENTOMOL, V38, P336, DOI 10.1603/0022-2585-38.2.336
   Nunes RD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005034
   Ohm JR, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1392-x
   Oliver SV, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-390
   Pakpour N, 2013, MICROBES INFECT, V15, P243, DOI 10.1016/j.micinf.2013.01.003
   Platt N, 2015, HEREDITY, V115, P243, DOI 10.1038/hdy.2015.33
   Poupardin R, 2010, INSECT MOL BIOL, V19, P185, DOI 10.1111/j.1365-2583.2009.00967.x
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117
   Reddy BPN, 2012, BIOINFORMATION, V8, P430, DOI 10.6026/97320630008430
   Reisen WK, 2004, ECOLOGICAL ASPECTS A, P25
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Roberts MW, 2010, J NANOTECHNOL, V2010, DOI 10.1155/2010/868492
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2014, INSECT MOL BIOL, V23, P199, DOI 10.1111/imb.12073
   Serrato IM, 2017, MED VET ENTOMOL, V31, P312, DOI 10.1111/mve.12237
   Shorrocks B, 1978, GENESIS DIVERSITY
   Strode C, 2008, INSECT BIOCHEM MOLEC, V38, P113, DOI 10.1016/j.ibmb.2007.09.007
   Styer LM, 2007, AM J TROP MED HYG, V76, P111, DOI 10.4269/ajtmh.2007.76.111
   Styer LM, 2007, VECTOR-BORNE ZOONOT, V7, P86, DOI 10.1089/vbz.2007.0216
   Taracena ML, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006498
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Valle D, 2006, QUANTIFICATION METOD
   Vezilier J, 2012, P ROY SOC B-BIOL SCI, V279, P4033, DOI 10.1098/rspb.2012.1394
   Viana-Medeiros PF, 2017, MED VET ENTOMOL, V31, P340, DOI 10.1111/mve.12241
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 91
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD JUN 8
PY 2020
VL 13
IS 1
AR 293
DI 10.1186/s13071-020-04166-3
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LY9FV
UT WOS:000540834500004
PM 32513248
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liu, D
   Li, Y
   Guo, XC
   Ji, W
   Lin, WH
AF Liu, Dong
   Li, Yong
   Guo, Xingchen
   Ji, Wei
   Lin, Wenhan
TI Chartarlactams Q-T, Dimeric Phenylspirodrimanes with Antibacterial and
   Antiviral Activities
SO CHEMISTRY & BIODIVERSITY
LA English
DT Article; Early Access
DE Stachybotrys chartarum; chartarlactams Q-T; structure elucidation;
   antivirus activity; antibacterial activity
ID FUNGUS STACHYBOTRYS-CHARTARUM; A-C; MEROTERPENOIDS; STACHYFLIN
AB Four new phenylspirodrimane-type dimers, namely chartarlactams Q-T, along with stachyin B were isolated from the fermentation broth of a sponge-derived fungus Stachybotrys chartarum WGC-25 C-6. Chartarlactams Q-T were structurally featured by the dimerization of two units of phenylspirodrimane linked by a C-N bond. Their structures were determined on the basis of extensive spectroscopic analysis, while quantum ECD calculation and modified Mosher's method were used for the assignment of absolute configurations. Chartarlactams Q-S and stachyin B showed moderate inhibition against bacterial pathogen Staphylococcus aureus with MIC values ranging from 4 mu g/mL to 16 mu g/mL, and chartarlactam T exhibited significant inhibition toward ZIKV virus.
C1 [Liu, Dong; Li, Yong; Guo, Xingchen; Lin, Wenhan] Peking Univ, Inst Ocean Res, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
   [Ji, Wei] Peking Univ, Basic Med Sch, Beijing 100191, Peoples R China.
RP Lin, WH (corresponding author), Peking Univ, Inst Ocean Res, State Key Lab Nat & Biomimet Drugs, Beijing 100191, Peoples R China.
EM whlin@bjmu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81991525, 21861142006, 81872793, 81630089]; MOST
   [2018ZX09711001-001-008]; COMRA [DY135-B-05]
FX This work was financially supported by the National Natural Science
   Foundation of China (81991525, 21861142006, 81872793, 81630089), COMRA
   (DY135-B-05) and MOST (2018ZX09711001-001-008).
CR Ding ZG, 2018, NAT PROD RES, V32, P2370, DOI 10.1080/14786419.2017.1413565
   Ding ZG, 2018, FITOTERAPIA, V125, P94, DOI 10.1016/j.fitote.2017.12.022
   Feng JM, 2019, FITOTERAPIA, V136, DOI 10.1016/j.fitote.2019.04.013
   Javed F, 2018, J BASIC MICROB, V58, P3, DOI 10.1002/jobm.201700398
   KANETO R, 1994, J ANTIBIOT, V47, P727, DOI 10.7164/antibiotics.47.727
   Latypov SK, 1996, J ORG CHEM, V61, P8569, DOI 10.1021/jo960719i
   Li C, 2016, CHEMBIOCHEM, V17, P904, DOI 10.1002/cbic.201600087
   Li Y, 2014, TETRAHEDRON, V70, P7010, DOI 10.1016/j.tet.2014.07.047
   Li Y, 2014, J NAT PROD, V77, P138, DOI 10.1021/np400824u
   Liu D, 2017, TETRAHEDRON LETT, V58, P1826, DOI 10.1016/j.tetlet.2017.03.079
   Liu JM, 2020, ORG CHEM FRONT, V7, P531, DOI 10.1039/c9qo01284b
   Ma XH, 2013, J NAT PROD, V76, P2298, DOI 10.1021/np400683h
   Matsumoto N, 2014, J BIOL CHEM, V289, P35826, DOI 10.1074/jbc.M114.588087
   Minagawa K, 2002, J ANTIBIOT, V55, P155, DOI 10.7164/antibiotics.55.155
   Stephens PJ, 2010, CHIRALITY, V22, P229, DOI 10.1002/chir.20733
   Wu B, 2014, MAR DRUGS, V12, P1924, DOI 10.3390/md12041924
   Yoshimoto J, 2000, J PHARM PHARMACOL, V52, P1247, DOI 10.1211/0022357001777225
   Zhang H, 2019, RSC ADV, V9, P3520, DOI 10.1039/c8ra10195g
   Zhang M, 2019, CHINESE CHEM LETT, V30, P435, DOI 10.1016/j.cclet.2018.04.031
   Zhang PP, 2017, RSC ADV, V7, P49910, DOI 10.1039/c7ra09859f
   Zhao JL, 2018, BIOORG MED CHEM LETT, V28, P355, DOI 10.1016/j.bmcl.2017.12.039
NR 21
TC 0
Z9 0
U1 4
U2 4
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1612-1872
EI 1612-1880
J9 CHEM BIODIVERS
JI Chem. Biodivers.
DI 10.1002/cbdv.202000170
EA JUN 2020
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LW1OD
UT WOS:000538913900001
PM 32289204
DA 2020-07-08
ER

PT J
AU Michiels, E
   Roose, K
   Gallardo, R
   Khodaparast, L
   Khodaparast, L
   van der Kant, R
   Siemons, M
   Houben, B
   Ramakers, M
   Wilkinson, H
   Guerreiro, P
   Louros, N
   Kaptein, SJF
   Ibanez, LI
   Smet, A
   Baatsen, P
   Liu, S
   Vorberg, I
   Bormans, G
   Neyts, J
   Saelens, X
   Rousseau, F
   Schymkowitz, J
AF Michiels, Emiel
   Roose, Kenny
   Gallardo, Rodrigo
   Khodaparast, Ladan
   Khodaparast, Laleh
   van der Kant, Rob
   Siemons, Maxime
   Houben, Bert
   Ramakers, Meine
   Wilkinson, Hannah
   Guerreiro, Patricia
   Louros, Nikolaos
   Kaptein, Suzanne J. F.
   Ibanez, Lorena Itati
   Smet, Anouk
   Baatsen, Pieter
   Liu, Shu
   Vorberg, Ina
   Bormans, Guy
   Neyts, Johan
   Saelens, Xavier
   Rousseau, Frederic
   Schymkowitz, Joost
TI Reverse engineering synthetic antiviral amyloids
SO NATURE COMMUNICATIONS
LA English
DT Article
ID CELL-CULTURE; PROTEIN; AGGREGATION; SPECIFICITY; BRAIN
AB Human amyloids have been shown to interact with viruses and interfere with viral replication. Based on this observation, we employed a synthetic biology approach in which we engineered virus-specific amyloids against influenza A and Zika proteins. Each amyloid shares a homologous aggregation-prone fragment with a specific viral target protein. For influenza we demonstrate that a designer amyloid against PB2 accumulates in influenza A-infected tissue in vivo. Moreover, this amyloid acts specifically against influenza A and its common PB2 polymorphisms, but not influenza B, which lacks the homologous fragment. Our model amyloid demonstrates that the sequence specificity of amyloid interactions has the capacity to tune amyloid-virus interactions while allowing for the flexibility to maintain activity on evolutionary diverging variants. Some human amyloid proteins have been shown to interact with viral proteins, suggesting that they may have potential as therapeutic agents. Here the authors design synthetic amyloids specific for influenza A and Zika virus proteins, respectively, and show that they can inhibit viral replication.
C1 [Michiels, Emiel; Gallardo, Rodrigo; Khodaparast, Ladan; Khodaparast, Laleh; van der Kant, Rob; Siemons, Maxime; Houben, Bert; Ramakers, Meine; Wilkinson, Hannah; Guerreiro, Patricia; Louros, Nikolaos; Baatsen, Pieter; Rousseau, Frederic; Schymkowitz, Joost] VIB Ctr Brain & Dis Res, Leuven, Belgium.
   [Michiels, Emiel; Gallardo, Rodrigo; Khodaparast, Ladan; Khodaparast, Laleh; van der Kant, Rob; Siemons, Maxime; Houben, Bert; Ramakers, Meine; Wilkinson, Hannah; Guerreiro, Patricia; Louros, Nikolaos; Rousseau, Frederic; Schymkowitz, Joost] Katholieke Univ Leuven, Switch Lab, Dept Cellular & Mol Med, Leuven, Belgium.
   [Roose, Kenny; Ibanez, Lorena Itati; Smet, Anouk; Saelens, Xavier] VIB Ctr Med Biotechnol, Ghent, Belgium.
   [Roose, Kenny; Ibanez, Lorena Itati; Smet, Anouk; Saelens, Xavier] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.
   [Siemons, Maxime; Bormans, Guy] Katholieke Univ Leuven, Lab Radiopharm, Dept Pharmaceut & Pharmacol Sci, Leuven, Belgium.
   [Kaptein, Suzanne J. F.; Neyts, Johan] Katholieke Univ Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst Med Res, Lab Virol & Chemotherapy, Leuven, Belgium.
   [Baatsen, Pieter] Katholieke Univ Leuven, VIB Bio Imaging Core, Electron Microscopy Platform, Leuven, Belgium.
   [Liu, Shu; Vorberg, Ina] German Ctr Neurodegenerat Dis DZNE eV, Bonn, Germany.
   [Vorberg, Ina] Rheinische Friedrich Wilhelms Univ Bonn, Bonn, Germany.
RP Rousseau, F; Schymkowitz, J (corresponding author), VIB Ctr Brain & Dis Res, Leuven, Belgium.; Rousseau, F; Schymkowitz, J (corresponding author), Katholieke Univ Leuven, Switch Lab, Dept Cellular & Mol Med, Leuven, Belgium.
EM frederic.rousseau@kuleuven.vib.be; joost.schymkowitz@kuleuven.vib.be
RI ; NEYTS, Johan/U-8267-2017
OI Louros, Nikolaos/0000-0002-4030-1022; Khodaparast,
   Laleh/0000-0002-5865-7748; Khodaparast, ladan/0000-0001-6373-8019; van
   der Kant, Rob/0000-0003-3639-9749; Michiels, Emiel/0000-0001-6065-5576;
   Siemons, Maxime/0000-0001-7736-1582; NEYTS, Johan/0000-0002-0033-7514
FU Funds for Scientific Research Flanders (FWO)FWO; European Research
   Council under the European Union's Horizon 2020 Framework Programme ERC
   Grant [647458]; Flanders institute for biotechnology (VIB); University
   of Leuven ("Industrieel Onderzoeksfonds"); Flanders Agency for
   innovation by Science and Technology (IWT, SBO grant)Institute for the
   Promotion of Innovation by Science and Technology in Flanders (IWT)
   [60839]; FWO projectFWO [AKUL/15/34]; Federal Office for Scientific
   Affairs of Belgium (Belspo), IUAP [P7/16]; IWT, SBOInstitute for the
   Promotion of Innovation by Science and Technology in Flanders (IWT)
   [60839]; Hercules Foundation (FWO) [ZW13-02]; Rega Foundation, KU Leuven
   [ZW13-02]
FX E.M. was supported by a PhD Fellowship from the Funds for Scientific
   Research Flanders (FWO). The Switch Laboratory was supported by grants
   from the European Research Council under the European Union's Horizon
   2020 Framework Programme ERC Grant agreement 647458 (MANGO) to J.S., the
   Flanders institute for biotechnology (VIB), the University of Leuven
   ("Industrieel Onderzoeksfonds"), the Funds for Scientific Research
   Flanders (FWO), the Flanders Agency for innovation by Science and
   Technology (IWT, SBO grant 60839), the FWO project AKUL/15/34 (Hercules
   Grant), and the Federal Office for Scientific Affairs of Belgium
   (Belspo), IUAP, grant number P7/16. The Saelens Lab was supported by
   IWT, SBO grant 60839. Super resolution fluorescence and electron
   microscopy were performed at the Light Microscopy and Imaging Network
   (Limone) and the Electron Microscopy platform of VIB-KU Leuven,
   respectively. We would like to thank Mathias De Decker for taking the
   confocal microscopy images and Caroline Collard for co-performing the
   Zika screen. Part of this research work was performed using the
   "Caps-It" research infrastructure (project ZW13-02) that was financially
   supported by the Hercules Foundation (FWO) and Rega Foundation, KU
   Leuven.
CR Alberti S, 2009, CELL, V137, P146, DOI 10.1016/j.cell.2009.02.044
   Betti C, 2016, PLANT PHYSIOL, V171, P773, DOI 10.1104/pp.16.00335
   Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004
   Bourgade K, 2016, J ALZHEIMERS DIS, V50, P1227, DOI 10.3233/JAD-150652
   Broersen K, 2011, PROTEIN ENG DES SEL, V24, P743, DOI 10.1093/protein/gzr020
   Chockalingam AK, 2016, DIS MARKERS, DOI 10.1155/2016/9296457
   Couceiro JR, 2015, J BIOL CHEM, V290, P242, DOI 10.1074/jbc.M114.586636
   Cribbs DH, 2000, BIOCHEMISTRY-US, V39, P5988, DOI 10.1021/bi000029f
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030
   Ezzat K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10192-2
   Fehlinger A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07260-2
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006
   Gallardo R, 2016, SCIENCE, V354, DOI 10.1126/science.aah4949
   Giasson BI, 2001, J BIOL CHEM, V276, P2380, DOI 10.1074/jbc.M008919200
   Itzhaki RF, 1997, LANCET, V349, P241, DOI 10.1016/S0140-6736(96)10149-5
   Kao RY, 2010, NAT BIOTECHNOL, V28, P600, DOI 10.1038/nbt.1638
   Kayed R, 2009, J BIOL CHEM, V284, P4230, DOI 10.1074/jbc.M808591200
   Khodaparast L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03131-0
   Krebs MRH, 2004, PROTEIN SCI, V13, P1933, DOI 10.1110/ps.04707004
   Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104
   Matrosovich M, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-63
   O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200
   Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/BSE0560207, 10.1042/bse0560207]
   Rousseau F, 2006, J MOL BIOL, V355, P1037, DOI 10.1016/j.jmb.2005.11.035
   Shivu B, 2013, BIOCHEMISTRY-US, V52, P5176, DOI 10.1021/bi400625v
   Vogler TO, 2018, NATURE, V117, P209
   Wolf H, 2015, J VIROL, V89, P9853, DOI 10.1128/JVI.01276-15
   Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195
   Yuan SF, 2016, J ANTIMICROB CHEMOTH, V71, P2489, DOI 10.1093/jac/dkw194
   Zhu M, 2004, J BIOL CHEM, V279, P24452, DOI 10.1074/jbc.M400004200
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 33
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD JUN 5
PY 2020
VL 11
IS 1
DI 10.1038/s41467-020-16721-8
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY4TU
UT WOS:000540523000002
PM 32504029
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Prow, NA
   Liu, L
   McCarthy, MK
   Walters, K
   Kalkeri, R
   Geiger, J
   Koide, F
   Cooper, TH
   Eldi, P
   Nakayama, E
   Diener, KR
   Howley, PM
   Hayball, JD
   Morrison, TE
   Suhrbier, A
AF Prow, Natalie A.
   Liu, Liang
   McCarthy, Mary K.
   Walters, Kevin
   Kalkeri, Raj
   Geiger, Jillian
   Koide, Fusataka
   Cooper, Tamara H.
   Eldi, Preethi
   Nakayama, Eri
   Diener, Kerrilyn R.
   Howley, Paul M.
   Hayball, John D.
   Morrison, Thomas E.
   Suhrbier, Andreas
TI The vaccinia virus based Sementis Copenhagen Vector vaccine against Zika
   and chikungunya is immunogenic in non-human primates
SO NPJ VACCINES
LA English
DT Article
ID NEUTRALIZING MONOCLONAL-ANTIBODIES; DEPENDENT ENHANCEMENT; PARTICLE
   VACCINE; RESPONSES; DISEASE; INFECTION; EFFICACY; EPITOPE; CELL;
   PROTECTS
AB The Sementis Copenhagen Vector (SCV) is a new vaccinia virus-derived, multiplication-defective, vaccine technology assessed herein in non-human primates. Indian rhesus macaques (Macaca mulatta) were vaccinated with a multi-pathogen recombinant SCV vaccine encoding the structural polyproteins of both Zika virus (ZIKV) and chikungunya virus (CHIKV). After one vaccination, neutralising antibody responses to ZIKV and four strains of CHIKV, representative of distinct viral genotypes, were generated. A second vaccination resulted in significant boosting of neutralising antibody responses to ZIKV and CHIKV. Following challenge with ZIKV, SCV-ZIKA/CHIK-vaccinated animals showed significant reductions in viremias compared with animals that had received a control SCV vaccine. Two SCV vaccinations also generated neutralising and IgG ELISA antibody responses to vaccinia virus. These results demonstrate effective induction of immunity in non-human primates by a recombinant SCV vaccine and illustrates the utility of SCV as a multi-disease vaccine platform capable of delivering multiple large immunogens.
C1 [Prow, Natalie A.; Nakayama, Eri; Suhrbier, Andreas] QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld 4029, Australia.
   [Prow, Natalie A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld 4029, Australia.
   [Prow, Natalie A.; Suhrbier, Andreas] Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
   [Prow, Natalie A.; Liu, Liang; Cooper, Tamara H.; Eldi, Preethi; Diener, Kerrilyn R.; Hayball, John D.] Univ South Australia, Sch Pharm & Med Sci, UniSA Canc Res Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
   [McCarthy, Mary K.; Morrison, Thomas E.] Univ Colorado, Dept Immunol & Microbiol, Sch Med, Aurora, CO 80045 USA.
   [Walters, Kevin; Kalkeri, Raj; Geiger, Jillian; Koide, Fusataka] Southern Res Inst, Dept Infect Dis Res, Frederick, MD 21701 USA.
   [Nakayama, Eri] Natl Inst Infect Dis, Dept Virol 1, Tokyo 1628640, Japan.
   [Diener, Kerrilyn R.] Univ Adelaide, Robinson Res Inst, Adelaide, SA 5005, Australia.
   [Diener, Kerrilyn R.] Univ Adelaide, Adelaide Med Sch, Adelaide, SA 5005, Australia.
   [Howley, Paul M.] Sementis Ltd, Berwick, Vic 3806, Australia.
RP Suhrbier, A (corresponding author), QIMR Berghofer Med Res Inst, Inflammat Biol, Brisbane, Qld 4029, Australia.; Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, Brisbane, Qld 4029, Australia.; Suhrbier, A (corresponding author), Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.; Hayball, JD (corresponding author), Univ South Australia, Sch Pharm & Med Sci, UniSA Canc Res Inst, Expt Therapeut Lab, Adelaide, SA 5000, Australia.
EM john.hayball@unisa.edu.au; Andreas.Suhrbier@qimrberghofer.edu.au
OI Nakayama, Eri/0000-0002-0826-3513
FU Federal funds from the National Institute of Allergy and Infectious
   Diseases (NIAID), National Institutes of Health (NIH), Department of
   Health and Human Services (USA) [HHSN272201000022I]; Southern Research
   [14889.06.02]; Public Health Service grants from the NIAID, NIH [R01
   AI108725, F32 AI122463]; Advance Queensland Research Fellowship from the
   Queensland Government, Australia - Sementis; National Health and Medical
   Research Council of AustraliaNational Health and Medical Research
   Council of Australia; Daiichi Sankyo Foundation of Life Science;
   Sementis Ltd via Australian Department of Industry, Enterprise Connect
   Researchers in Business Fellowships; Sementis Ltd via Science Industry
   Endowment Fund, STEM+Business Fellowship; Sementis Ltd via Australian
   Research CouncilAustralian Research Council [LP160100633]
FX The NHP work was supported by Federal funds from the National Institute
   of Allergy and Infectious Diseases (NIAID), National Institutes of
   Health (NIH), Department of Health and Human Services (USA), under
   Contract number HHSN272201000022I, preclinical services programme (Task
   Order; Zika virus vaccine evaluation in NHPs) and Southern Research
   Study number 14889.06.02. This NHP study thus represents an independent
   third-party assessment of the SCV technology. We thank Drs Thames
   Pickett and Sara Woodson (NIAID, NIH) for their support, oversight and
   dedicated service to this project. The CHIKV serology was supported by
   Public Health Service grants R01 AI108725 (to T.E.M.) and F32 AI122463
   (to M.K.M.) from the NIAID, NIH. N.A.P. was supported by an Advance
   Queensland Research Fellowship from the Queensland Government,
   Australia, which was co-funded by Sementis. A.S. holds a Principal
   Research Fellowship from the National Health and Medical Research
   Council of Australia. E.N. was supported in part by the Daiichi Sankyo
   Foundation of Life Science. SCV vaccine development work was supported
   in part by Sementis Ltd via (i) Australian Department of Industry,
   Enterprise Connect Researchers in Business Fellowships for L.L. and
   T.H.C., (ii) a Science Industry Endowment Fund, STEM+Business Fellowship
   for T.H.C and L.L. and (iii) an Australian Research Council Linkage
   grant LP160100633 awarded to J.D.H. and P.M.H. We also thank Dr V.
   Lutzky (QIMRB) for excellent proof reading and Professor R Drillien
   (University of Strasbourg) and Dr M. Saijo (NIID, Japan) for helpful
   suggestions and discussions.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Bekker LG, 2018, LANCET HIV, V5, pE366, DOI 10.1016/S2352-3018(18)30071-7
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Broeckel R, 2015, PATHOGENS, V4, P662, DOI 10.3390/pathogens4030662
   Callendret B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192312
   Cardoso CW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005334
   Chattopadhyay A, 2018, VACCINE, V36, P3894, DOI 10.1016/j.vaccine.2018.05.095
   Chea LS, 2017, EXPERT REV VACCINES, V16, P973, DOI 10.1080/14760584.2017.1371594
   Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059
   Chua CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004960
   Chung KY, 2015, VACCINE, V33, P3953, DOI 10.1016/j.vaccine.2015.06.047
   DeFilippis Victor R, 2019, Curr Top Microbiol Immunol, DOI 10.1007/82_2019_175
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Eldi P, 2017, MOL THER, V25, P2332, DOI 10.1016/j.ymthe.2017.06.017
   Elong Ngono A, 2019, PLOS PATHOG, V15
   Eto A, 2019, VACCINE, V37, P6588, DOI 10.1016/j.vaccine.2019.09.006
   Gatti-Mays ME, 2019, CLIN CANCER RES, V25, P4933, DOI 10.1158/1078-0432.CCR-19-0183
   Goertz GP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005654
   Goh LYH, 2013, CLIN IMMUNOL, V149, P487, DOI 10.1016/j.clim.2013.10.004
   Goo L, 2016, J INFECT DIS, V214, P1487, DOI 10.1093/infdis/jiw431
   Grant GB, 2019, MMWR-MORBID MORTAL W, V68, P855, DOI 10.15585/mmwr.mm6839a5
   Gray ES, 2011, J VIROL, V85, P4828, DOI 10.1128/JVI.00198-11
   Greenberg RN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142802
   Hassert M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01678
   Hawman DW, 2016, CELL REP, V16, P1326, DOI 10.1016/j.celrep.2016.06.076
   Imvanex-European Medicines Agency, ANN 1 SUMM PROD CHAR
   Jin J, 2015, CELL REP, V13, P2553, DOI 10.1016/j.celrep.2015.11.043
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Khurana S, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0076-2
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Langsjoen RM, 2018, MBIO, V9, DOI 10.1128/mBio.02449-17
   Lauer KB, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00298-16
   Lee AW, 2017, EXPERT REV VACCINES, V16, P85, DOI 10.1080/14760584.2017.1268920
   Leon A, 2016, VACCINE, V34, P5878, DOI 10.1016/j.vaccine.2016.10.043
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Lopez-Camacho C, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040216
   Maslow Joel N, 2019, Trop Med Infect Dis, V4, DOI 10.3390/tropicalmed4030104
   Meng XZ, 2018, VIROLOGY, V518, P284, DOI 10.1016/j.virol.2018.03.005
   Moss B, 2011, IMMUNOL REV, V239, P8, DOI 10.1111/j.1600-065X.2010.00975.x
   Nagata LP, 2018, BIOTECHNOL GENET ENG, V34, P107, DOI 10.1080/02648725.2018.1471643
   Newcomer BW, 2015, THERIOGENOLOGY, V83, P360, DOI 10.1016/j.theriogenology.2014.09.028
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Pantaleo G, 2019, LANCET HIV, V6, pE737, DOI 10.1016/S2352-3018(19)30262-0
   Pittman PR, 2019, NEW ENGL J MED, V381, P1897, DOI 10.1056/NEJMoa1817307
   Prow NA, 2018, EXPERT REV VACCINES, V17, P925, DOI 10.1080/14760584.2018.1522255
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Selvarajah S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002423
   Sharma V, 2020, CAN J MICROBIOL, V66, P87, DOI 10.1139/cjm-2019-0331
   Slon-Campos JL, 2019, NAT IMMUNOL, V20, P1291, DOI 10.1038/s41590-019-0477-z
   Souza TML, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39406-9
   Suhrbier A, 2003, TRENDS IMMUNOL, V24, P165, DOI 10.1016/S1471-4906(03)00065-6
   Suhrbier A, 2019, NAT REV RHEUMATOL, V15, P597, DOI 10.1038/s41584-019-0276-9
   Sun SY, 2013, ELIFE, V2, DOI 10.7554/eLife.00435
   Volz A, 2017, ADV VIRUS RES, V97, P187, DOI 10.1016/bs.aivir.2016.07.001
   White SK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196857
   Wressnigg N, 2015, CLIN VACCINE IMMUNOL, V22, P267, DOI 10.1128/CVI.00546-14
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 60
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD JUN 2
PY 2020
VL 5
IS 1
AR 44
DI 10.1038/s41541-020-0191-8
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LU9LV
UT WOS:000538069000001
PM 32550013
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pacheco, O
   Newton, SM
   Daza, M
   Cates, JE
   Reales, JAM
   Burkel, VK
   Mercado, M
   Godfred-Cato, S
   Gonzalez, M
   Anderson, KN
   Woodworth, KR
   Valencia, D
   Tong, V
   Gilboa, SM
   Osorio, MB
   Rodriguez, DYS
   Prieto-Alvarado, FE
   Moore, CA
   Honein, MA
   Martinez, MLO
AF Pacheco, Oscar
   Newton, Suzanne M.
   Daza, Marcela
   Cates, Jordan E.
   Madero Reales, Javier Alberto
   Burkel, Veronica K.
   Mercado, Marcela
   Godfred-Cato, Shana
   Gonzalez, Maritza
   Anderson, Kayla N.
   Woodworth, Kate R.
   Valencia, Diana
   Tong, Van T.
   Gilboa, Suzanne M.
   Osorio, May Bibiana
   Sanchez Rodriguez, Dora Yurany
   Edwin Prieto-Alvarado, Franklyn
   Moore, Cynthia A.
   Honein, Margaret A.
   Martinez, Martha L. Ospina
TI Neurodevelopmental findings in children 20-30 months of age with
   postnatal Zika infection at 1-12 months of age, Colombia,
   September-November 2017
SO PAEDIATRIC AND PERINATAL EPIDEMIOLOGY
LA English
DT Article; Early Access
DE child development; eye; hearing; neurologic examination; Zika virus
ID VIRUS; BIRTH
AB Background Zika virus (ZIKV) infection during pregnancy can cause infant brain and eye abnormalities and has been associated with adverse neurodevelopmental outcomes in exposed infants. Evidence is limited on ZIKV's effects on children infected postnatally within the first year of life.
   Objective To determine whether any adverse neurodevelopmental outcomes occurred in early childhood for children infected postnatally with ZIKV during infancy, given the neurotoxicity of ZIKV infection and the rapid brain development that occurs in infancy and early childhood.
   Methods The Colombia Instituto Nacional de Salud (INS) conducted health and developmental screenings between September and November 2017 to evaluate 60 children at ages 20-30 months who had laboratory-confirmed symptomatic postnatal ZIKV infection at ages 1-12 months. We examined the frequency of adverse neurologic, hearing, eye, and developmental outcomes as well as the relationship between age at Zika symptom onset and developmental outcomes.
   Results Nine of the 60 (15.0%) children had adverse outcomes on the neurologic, hearing, or eye examination. Six of the 47 (12.8%) children without these adverse findings, and who received a valid developmental screening, had an alert score in the hearing-language domain which signals the need for additional developmental evaluation.
   Conclusion Neurologic, hearing, eye, and developmental findings suggest reassuring results. Since the full spectrum of neurodevelopmental outcomes in children postnatally infected with ZIKV remains unknown, routine paediatric care is advised to monitor the development of these children to ensure early identification of any adverse neurodevelopmental outcomes.
C1 [Pacheco, Oscar; Mercado, Marcela; Gonzalez, Maritza; Osorio, May Bibiana; Edwin Prieto-Alvarado, Franklyn; Martinez, Martha L. Ospina] Inst Nacl Salud, Bogota, Colombia.
   [Newton, Suzanne M.; Cates, Jordan E.; Burkel, Veronica K.; Godfred-Cato, Shana; Anderson, Kayla N.; Woodworth, Kate R.; Valencia, Diana; Tong, Van T.; Gilboa, Suzanne M.; Moore, Cynthia A.; Honein, Margaret A.] CDC, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Newton, Suzanne M.] Eagle Global Sci, Atlanta, GA USA.
   [Daza, Marcela] Vysnova Partners Inc, Atlanta, GA USA.
   [Madero Reales, Javier Alberto; Sanchez Rodriguez, Dora Yurany] Inst Nacl Salud, Field Epidemiol Training Program, Bogota, Colombia.
   [Burkel, Veronica K.] Eagle Med Serv LLC, Atlanta, GA USA.
RP Newton, SM (corresponding author), CDC, Div Birth Defects & Infant Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM snewton@cdc.gov
OI Pacheco Garcia, Oscar Eduardo/0000-0001-5939-6407
FU US Centers for Disease Control and Prevention (CDC)United States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA; Office of Infectious Disease, Bureau for Global
   Health, US Agency for International Development (USAID)United States
   Agency for International Development (USAID); CDCUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA;  [NU2GGH001732]
FX This publication was made possible through support provided by the US
   Centers for Disease Control and Prevention (CDC) and the Office of
   Infectious Disease, Bureau for Global Health, US Agency for
   International Development (USAID), under the terms of an Interagency
   Agreement with CDC. Support for national surveillance efforts was
   supported through a cooperative agreement to Vysnova Partners, Inc
   (NU2GGH001732). The opinions expressed herein are those of the authors
   and do not necessarily represent the official position of the funding
   agencies.
CR Asturias EJ, 2018, JAMA PEDIATR, V172, P624, DOI 10.1001/jamapediatrics.2018.0921
   Centers for Disease Control and Prevention, PREV MOSQ BIT 2019
   Centers for Disease Control and Prevention, ZIK INF CHILDR 2018
   Colombia Ministerio de Salud Publica, 1993, DIS NORM ESC ABR DES
   de Onis M, 2015, WORLD REV NUTR DIET, V113, P278, DOI 10.1159/000360352
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Knickmeyer RC, 2008, J NEUROSCI, V28, P12176, DOI 10.1523/JNEUROSCI.3479-08.2008
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mekki M, 2019, DEV MED CHILD NEUROL, V61, P1139, DOI 10.1111/dmcn.14166
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Rasmussen SA, 2018, BIRTH DEFECTS RES, V110, P722
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Science M, 2014, J PEDIATR-US, V165, P779, DOI 10.1016/j.jpeds.2014.06.014
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
NR 15
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-5022
EI 1365-3016
J9 PAEDIATR PERINAT EP
JI Paediatr. Perinat. Epidemiol.
DI 10.1111/ppe.12690
EA JUN 2020
PG 6
WC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
SC Public, Environmental & Occupational Health; Obstetrics & Gynecology;
   Pediatrics
GA LT4KD
UT WOS:000537040100001
PM 32488915
DA 2020-07-08
ER

PT J
AU Faye, O
   Monteiro, MD
   Vrancken, B
   Prot, M
   Lequime, S
   Diarra, M
   Ndiaye, O
   Valdez, T
   Tavarez, S
   Ramos, J
   Leal, SD
   Pires, C
   Moreira, A
   Tavares, MF
   Fernandes, L
   Barreto, JN
   Teixeira, MD
   Mendonca, MLD
   Gomes, CCDL
   Castellon, MS
   Ma, L
   Lemoine, F
   Gambaro-Roglia, F
   Delaune, D
   Fall, G
   Fall, IS
   Diop, M
   Sakuntabhai, A
   Loucoubar, C
   Lemey, P
   Holmes, EC
   Faye, O
   Sall, AA
   Simon-Loriere, E
AF Faye, Oumar
   Monteiro, Maria de Lourdes
   Vrancken, Bram
   Prot, Matthieu
   Lequime, Sebastian
   Diarra, Maryam
   Ndiaye, Oumar
   Valdez, Tomas
   Tavarez, Sandra
   Ramos, Jessica
   Leal, Silvania da Veiga
   Pires, Cecilio
   Moreira, Antonio
   Tavares, Maria Filomena
   Fernandes, Linete
   Barreto, Jorge Noel
   Teixeira, Maria do Ceu
   Mendonca, Maria Luz de Lima
   Gomes, Carolina Cardoso da Silva Leite
   Castellon, Mariano Salazar
   Ma, Laurence
   Lemoine, Frederic
   Gambaro-Roglia, Fabiana
   Delaune, Deborah
   Fall, Gamou
   Fall, Ibrahima Soce
   Diop, Mamadou
   Sakuntabhai, Anavaj
   Loucoubar, Cheikh
   Lemey, Philippe
   Holmes, Edward C.
   Faye, Ousmane
   Sall, Amadou Alpha
   Simon-Loriere, Etienne
TI Genomic Epidemiology of 2015-2016 Zika Virus Outbreak in Cape Verde
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB During 2015-2016, Cape Verde, an island nation off the coast of West Africa, experienced a Zika virus (ZIKV) outbreak involving 7,580 suspected Zika cases and 18 microcephaly cases. Analysis of the complete genomes of 3 ZIKV isolates from the outbreak indicated the strain was of the Asian (not African) lineage. The Cape Verde ZIKV sequences formed a distinct monophylogenetic group and possessed 1-2 (T659A, I756V) unique amino acid changes in the envelope protein. Phylogeographic and serologic evidence support earlier introduction of this lineage into Cape Verde, possibly from northeast Brazil, between June 2014 and August 2015, suggesting cryptic circulation of the virus before the initial wave of cases were detected in October 2015. These findings underscore the utility of genomic-scale epidemiology for outbreak investigations.
C1 [Faye, Oumar; Diarra, Maryam; Ndiaye, Oumar; Fall, Gamou; Diop, Mamadou; Loucoubar, Cheikh; Faye, Ousmane; Sall, Amadou Alpha] Inst Pasteur, Dakar, Senegal.
   [Monteiro, Maria de Lourdes; Valdez, Tomas; Tavarez, Sandra; Ramos, Jessica; Leal, Silvania da Veiga; Pires, Cecilio; Moreira, Antonio; Tavares, Maria Filomena; Fernandes, Linete; Barreto, Jorge Noel; Teixeira, Maria do Ceu; Mendonca, Maria Luz de Lima] Minist Saude, Praia, Cape Verde.
   [Vrancken, Bram; Lequime, Sebastian; Lemey, Philippe] Katholieke Univ Leuven, Leuven, Belgium.
   [Prot, Matthieu; Ma, Laurence; Gambaro-Roglia, Fabiana; Delaune, Deborah; Simon-Loriere, Etienne] Inst Pasteur, 28 Rue Docteur Roux, F-75724 Paris 15, France.
   [Gomes, Carolina Cardoso da Silva Leite; Castellon, Mariano Salazar; Fall, Ibrahima Soce] WHO, Praia, Cape Verde.
   [Lemoine, Frederic] CNRS, USR 3756, Paris, France.
   [Gambaro-Roglia, Fabiana] Univ Paris, Sorbonne Paris Cite, Paris, France.
   [Delaune, Deborah] Univ Paris Sud Paris Saclay, Orsay, France.
   [Delaune, Deborah] Inst Rech Biomed Armees, Bretigny Sur Orge, France.
   [Sakuntabhai, Anavaj] CNRS, UMR 2000, Paris, France.
   [Holmes, Edward C.] Univ Sydney, Sydney, NSW, Australia.
RP Simon-Loriere, E (corresponding author), Inst Pasteur, 28 Rue Docteur Roux, F-75724 Paris 15, France.
EM etienne.simon-loriere@pasteur.fr
RI Vrancken, Bram/D-9538-2018; Lequime, Sebastian/E-9380-2011
OI Vrancken, Bram/0000-0001-6547-5283; Lequime,
   Sebastian/0000-0002-3140-0651
FU Institut Pasteur de Dakar; European Research Council under the European
   Union's Horizon 2020 Research and Innovation ProgrammeEuropean Research
   Council (ERC) [725422-ReservoirDOCS]; Wellcome TrustWellcome Trust
   [206298/Z/17/Z]; Fonds Wetenschappelijk Onderzoek (Belgium); INCEPTION
   program (Investissements d'Avenir grant)French National Research Agency
   (ANR) [ANR46-CONY-0005]; Institut Pasteur; Australian Research Council
   Australian Laureate FellowshipAustralian Research Council [FL170100022]
FX This work was supported by Institut Pasteur de Dakar. P.L. received
   funding by the European Research Council under the European Union's
   Horizon 2020 Research and Innovation Programme (grant agreement no.
   725422-ReservoirDOCS) and by the Wellcome Trust through project
   206298/Z/17/Z S.L. and B.V. are supported by the Fonds Wetenschappelijk
   Onderzoek (Belgium). E.S.-E. received funding from the INCEPTION program
   (Investissements d'Avenir grant ANR46-CONY-0005) and Institut Pasteur.
   F.G.-R. is part of the Pasteur-Paris University International doctoral
   program, BioSPC doctoral school. E.C.H. is funded by an Australian
   Research Council Australian Laureate Fellowship (FL170100022).
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lourenco J, 2018, PLOS CURR, V10, P10
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Pan American Health Organization; World Health Organization, 2018, ZIK CAS CONG SYNDR A
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Servico de Vigilancia Integrada e Resposta a Epidemias Ministerio da Saude e da Seguranca Social, 2016, B INF SEM INF VIR ZI
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   SOW A, 2016, MALAR J, V15
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
NR 26
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2020
VL 26
IS 6
BP 1084
EP 1090
DI 10.3201/eid2606.190928
PG 7
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LZ9BL
UT WOS:000541513900004
PM 32441631
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mizumoto, K
   Chowell, G
AF Mizumoto, Kenji
   Chowell, Gerardo
TI Temporary Fertility Decline after Large Rubella Outbreak, Japan
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ADVANCED MATERNAL AGE; BIRTH-RATE; ZIKA; EPIDEMIC; REDUCTION; RISK
AB Japan experienced 2 large rubella epidemics in 2004 and 2012-2014. Because of suboptimal immunization levels, the country has been experiencing a third major outbreak during 2018-2020. We conducted time series analyses to evaluate the effect of the 2012-2014 nationwide rubella epidemic on prefecture-level natality in Japan. We identified a statistically significant decline in fertility rates associated with rubella epidemic activity and increased Google searches for the term "rubella." We noted that the timing of fertility declines in 2014 occurred 9-13 months after peak rubella incidence months in 2013 in 4 prefectures with the highest rubella incidence. Public health interventions should focus on enhancing vaccination campaigns against rubella, not only to protect pregnant women from infection but also to mitigate declines in population size and birth rates.
C1 [Mizumoto, Kenji] Kyoto Univ, Kyoto, Japan.
   [Mizumoto, Kenji] Hokkaido Univ, Sapporo, Hokkaido, Japan.
   [Mizumoto, Kenji; Chowell, Gerardo] Georgia State Univ, Atlanta, GA 30303 USA.
   [Chowell, Gerardo] NIH, Fogarty Int Ctr, Bldg 10, Bethesda, MD 20892 USA.
RP Mizumoto, K (corresponding author), Kyoto Univ, Grad Sch Adv Integrated Studies Human Survivabil, Sakyo Ku, Yoshida Nakaadachi Cho, Kyoto 6068306, Japan.
EM mizumoto.kenji.5a@kyoto-u.ac.jp
FU Japan Society for the Promotion of Science KAKENHIMinistry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for
   the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [15K20936]; Program for Advancing Strategic International Networks to
   Accelerate the Circulation of Talented Researchers [G2801]; Leading
   Initiative for Excellent Young Researchers from the Ministry of
   Education, Culture, Sport, Science & Technology of Japan; National
   Science FoundationNational Science Foundation (NSF) [1414374]; National
   Science Foundation, National Institutes of HealthNational Science
   Foundation (NSF)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [1414374]; National
   Science Foundation, US Department of Agriculture Ecology and Evolution
   of Infectious Diseases program [1414374]; UK Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BB/M008894/1]
FX KM. received support from the Japan Society for the Promotion of Science
   KAKENHI (grant no. 15K20936), from the Program for Advancing Strategic
   International Networks to Accelerate the Circulation of Talented
   Researchers (grant no. G2801), and from the Leading Initiative for
   Excellent Young Researchers from the Ministry of Education, Culture,
   Sport, Science & Technology of Japan. G.C. received support from the
   National Science Foundation (grant no. 1414374) as part of the joint
   National Science Foundation, National Institutes of Health, and US
   Department of Agriculture Ecology and Evolution of Infectious Diseases
   program and a grant from the UK Biotechnology and Biological Sciences
   Research Council (no. BB/M008894/1).
CR Brockwell PJ, 2002, INTRO TIME SERIES FO
   Bureau of the Census, 1923, BIRTH STAT REG AR US
   Carolan M, 2011, MIDWIFERY, V27, P793, DOI 10.1016/j.midw.2010.07.006
   Cazelles B, 2008, OECOLOGIA, V156, P287, DOI 10.1007/s00442-008-0993-2
   Chandra S, 2018, AM J EPIDEMIOL, V187, P2585, DOI 10.1093/aje/kwy153
   Chandra S, 2015, BIODEMOGR SOC BIOL, V61, P266, DOI 10.1080/19485565.2015.1062718
   Dahal S, 2018, AM J EPIDEMIOL, V187, P2577, DOI 10.1093/aje/kwy146
   Diaz-Quijano FA, 2018, AM J PUBLIC HEALTH, V108, P514, DOI [10.2105/AJPH.2017.304260, 10.2105/ajph.2017.304260]
   Diaz-Quijano FA, 2017, ANN EPIDEMIOL, V27, P616, DOI 10.1016/j.annepidem.2017.08.009
   Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1
   Gianfredi V, 2018, PUBLIC HEALTH, V165, P9, DOI 10.1016/j.puhe.2018.09.001
   Heffner LJ, 2004, NEW ENGL J MED, V351, P1927, DOI 10.1056/NEJMp048087
   Hsieh TT, 2010, EUR J OBSTET GYN R B, V148, P21, DOI 10.1016/j.ejogrb.2009.08.022
   Infectious Disease Surveillance Center National Institute of Infectious Diseases Japan, INF DIS WEEKL REP
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kato T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172544
   Kendall M, 1983, ADV THEORY STAT, V3, DOI 10.1093/aje/kwyl46
   Kinoshita R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009928
   Metcalf CJE, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0901
   Minakami H, 2014, J INFECTION, V68, P99, DOI 10.1016/j.jinf.2013.09.002
   National Institute of Infectious Diseases, 2013, INFECT AGENTS SURVEI, V34, P90
   National Institute of Infectious Diseases, 2013, RISK ASS RUB OUTBR C
   Nishiura H, 2016, EPIDEMICS-NETH, V15, P66, DOI 10.1016/j.epidem.2016.03.001
   Nishiura H, 2015, INT J INFECT DIS, V38, P16, DOI 10.1016/j.ijid.2015.07.006
   Saito MM, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15040572
   Schmidt L, 2012, HUM REPROD UPDATE, V18, P29, DOI 10.1093/humupd/dmr040
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sugishita Y, 2015, JPN J INFECT DIS, V68, P159, DOI 10.7883/yoken.JJID.2014.195
   Suzuki K, 2016, J EPIDEMIOL, V26, P76, DOI 10.2188/jea.JE20150055
   Tanaka-Taya K, 2013, MMWR-MORBID MORTAL W, V62, P457
   Tucker JD, 2014, LANCET, V383, P1460, DOI 10.1016/S0140-6736(14)60712-1
   World Health Organization South-East Asia, TOT FERT RAT HLTH SI
NR 32
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD JUN
PY 2020
VL 26
IS 6
BP 1122
EP 1129
DI 10.3201/eid2606.181718
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LZ9BL
UT WOS:000541513900008
PM 32441617
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Andreata-Santos, R
   Pereira, SS
   Pereira, LR
   Felix, AC
   Romano, CM
   Ferreira, LCD
AF Andreata-Santos, Robert
   Pereira, Samuel Santos
   Pereira, Lennon Ramos
   Felix, Alvina Clara
   Romano, Camila Malta
   de Souza Ferreira, Luis Carlos
TI Specificity of NS1-based immunochromatographic tests for dengue virus
   with regard to the Zika virus protein
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Immunochromatographic tests; NS1 protein; Dengue; Zika; Cross-reactivity
ID CROSS-REACTIVITY; INFECTION; ANTIGEN; NS1; DIAGNOSIS
AB Objectives: This study was performed to determine whether Dengue virus (DENV) immunochromatographic tests can detect and differentiate nonstructural protein 1 (NS1) from each of the four DENV serotypes and do not cross-react with the Zika virus (ZIKV) NS1 protein.
   Methods: We compared the specificity of six NS1-based DENV immunochromatographic tests (point of care) in the detection of NS1 proteins from each of the four DENV serotypes and ZIKV. The tests were performed with NS1 proteins produced in mammalian cells. Cross-reactivity was confirmed with a purified recombinant ZIKV NS1 protein and DENV+ or ZIKV(+) human serum samples.
   Results: Cross-reaction was observed in 2 out of the 6 evaluated tests using cell culture supernatants containing NS1 protein of each tested virus. Cross-reactivity with ZIKV was confirmed with purified recombinant ZIKV NS1 produced in Escherichia coli. Further analyses with serum samples collected from DENV+ or ZIKV(+) patients confirmed the cross-reactivity with ZIKV protein in 2 tests.
   Conclusions: The detection of the NS1 protein is the basis for several commercially available serological DENV diagnostic tests. The present results emphasize the relevance of testing specificity of presently available NS1-based DENV serological tests and the need of adjustments of tests that cross-react with the ZIKV protein. Our results are particularly relevant for regions where both viruses are endemically found, as in the case of Brazil. (c) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Andreata-Santos, Robert; Pereira, Samuel Santos; Pereira, Lennon Ramos; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, Sao Paulo, Brazil.
   [Felix, Alvina Clara; Romano, Camila Malta] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Fac Med, Hosp Clin HCFMUSP LIM52, Sao Paulo, Brazil.
RP Ferreira, LCD (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, Sao Paulo, Brazil.
EM lcsf@usp.br
OI Andreata-Santos, Robert/0000-0002-4506-3756
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/20045-7,
   2016/23560-0]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq)National Council for Scientific and Technological
   Development (CNPq) [440409/16-0, 88881.130787/2016-01,
   88887.137920/2017-00]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (CAPES)CAPES [8888130782/2016-00]
FX This work was supported by Fundacao de Amparo a Pesquisa do Estado de
   Sao Paulo (FAPESP), grant numbers 2016/20045-7 and (R. A.S.)
   2016/23560-0; by the Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (CNPq), grant numbers 440409/16-0 and (R.A.S.)
   88881.130787/2016-01 (88887.137920/2017-00); and by Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), grant number
   (S.S.P.) 8888130782/2016-00.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Cuzzubbo AJ, 2001, CLIN DIAGN LAB IMMUN, V8, P1150, DOI 10.1128/CDLI.8.6.1150-1155.2001
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Gyurech D, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14296
   Kanno AI, 2020, AMB EXPRESS, V10, DOI 10.1186/s13568-019-0926-y
   Lee H, 2019, ANN LAB MED, V39, P566, DOI 10.3343/alm.2019.39.6.566
   Matheus S, 2016, EMERG INFECT DIS, V22, P1691, DOI 10.3201/eid2209.160725
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Oliveira DBL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110615
   World Health Organization, DENG SEV DENG
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zaidi MB, 2020, ACTA TROP, V201, DOI 10.1016/j.actatropica.2019.105201
NR 15
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2020
VL 95
BP 276
EP 278
DI 10.1016/j.ijid.2020.04.012
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA LY7VW
UT WOS:000540737100047
PM 32289563
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Bharucha, T
   Shearer, FM
   Vongsouvath, M
   Mayxay, M
   de Lamballerie, X
   Newton, PN
   Zitzmann, N
   Gould, E
   Dubot-Peres, A
AF Bharucha, Tehmina
   Shearer, Freya M.
   Vongsouvath, Manivanh
   Mayxay, Mayfong
   de lamballerie, Xavier
   Newton, Paul N.
   Zitzmann, Nicole
   Gould, Ernest
   Dubot-Peres, Audrey
TI A need to raise the bar - A systematic review of temporal trends in
   diagnostics for Japanese encephalitis virus infection, and perspectives
   for future research
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Flaviviruses; Neurological infection; Diagnostics
ID SINGLE-RADIAL-HEMOLYSIS; LINKED-IMMUNOSORBENT-ASSAY; WEST NILE VIRUS;
   ZIKA VIRUS; IMMUNOGLOBULIN-M; CEREBROSPINAL-FLUID;
   DIFFERENTIAL-DIAGNOSIS; CLINICAL PRESENTATIONS; CAPTURE IMMUNOASSAY;
   UTTAR-PRADESH
AB Objective: Japanese encephalitis virus infection (JE) remains a leading cause of neurological disease in Asia, mainly involving individuals living in remote areas with limited access to treatment centers and diagnostic facilities. Laboratory confirmation is fundamental for the justification and implementation of vaccination programs. We reviewed the literature on historical developments and current diagnostic capability worldwide, to identify knowledge gaps and instill urgency to address them.
   Methods: Searches were performed in Web of Science and PubMed using the term 'Japanese encephalitis' up to 13th October 2019. Studies reporting laboratory-confirmed symptomatic JE cases in humans were included, and data on details of diagnostic tests were extracted. A JE case was classified according to confirmatory levels (Fischer et al., 2008; Campbell et al., 2011; Pearce et al., 2018; Heffelfinger et al., 2017), where level 1 represented the highest level of confidence.
   Findings: 20,212 published JE cases were identified from 205 studies. 15,167 (75%) of these positive cases were confirmed with the lowest-confidence diagnostic tests (level 3 or 4, or level 4). Only 109 (53%) of the studies reported contemporaneous testing for dengue-specific antibodies.
   Conclusion: A fundamental pre-requisite for the control of JEV is lacking - that of a simple and specific diagnostic procedure that can be adapted for point-of-care tests and readily used throughout JE-endemic regions of the world. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Bharucha, Tehmina; Zitzmann, Nicole] Univ Oxford, Dept Biochem, Oxford, England.
   [Bharucha, Tehmina; Vongsouvath, Manivanh; Mayxay, Mayfong; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit, Viangchan, Laos.
   [Shearer, Freya M.] Univ Melbourne, Modelling & Simulat Unit, Ctr Epidemiol & Biostat, Melbourne Sch Populat & Global Hlth, Melbourne, Vic, Australia.
   [Mayxay, Mayfong] Univ Hlth Sci, Inst Res & Educ Dev, Viangchan, Laos.
   [Newton, Paul N.; Dubot-Peres, Audrey] Univ Oxford, Nuffield Dept Med, Ctr Trop Med & Global Hlth, Oxford, England.
   [de lamballerie, Xavier; Gould, Ernest; Dubot-Peres, Audrey] UVE Aix Marseille Univ, IHU Mediterranee Infect, Unite Virus Emergents, IRD 190,Inserm 1207, Marseille, France.
RP Bharucha, T (corresponding author), Inst Glycobiol, Dept Biochem, 2nd Floor,South Parks Rd, Oxford OX1 3RQ, England.
EM t.bharucha@doctors.org.uk
FU University of Oxford; Medical Research CouncilMedical Research Council
   UK (MRC) [MR/N013468/1]; Oxford Glycobiology endowment; Institute of
   Research for Development (IRD), Aix-Marseille University; Wellcome Trust
   of Great BritainWellcome Trust
FX The authors acknowledge Joshua Longbottom and Kirsten Duda for helping
   to assemble the study reference library. The work was supported by the
   University of Oxford and the Medical Research Council [grant number
   MR/N013468/1]. It was also supported by the Oxford Glycobiology
   endowment, the Institute of Research for Development (IRD),
   Aix-Marseille University, the Wellcome Trust of Great Britain that
   supports the work of LOMWRU.
CR Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Amaro F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020179
   Anga G, 2010, ANN TROP PAEDIATR, V30, P109, DOI 10.1179/146532810X12703902243818
   Anukumar B, 2014, J CLIN VIROL, V61, P152, DOI 10.1016/j.jcv.2014.06.003
   Ariffin EY, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18041173
   Bai YL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33223-2
   Balmaseda A, 2003, CLIN DIAGN LAB IMMUN, V10, P317, DOI 10.1128/CDLI.10.2.317-322.2003
   Balmaseda A, 2008, J CLIN VIROL, V43, P287, DOI 10.1016/j.jcv.2008.07.016
   BARZAGA N G, 1989, Southeast Asian Journal of Tropical Medicine and Public Health, V20, P587
   BENENSON MW, 1975, AM J TROP MED HYG, V24, P974, DOI 10.4269/ajtmh.1975.24.974
   Bharucha T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26333-4
   Bharucha T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194412
   Borah J, 2011, J CLIN VIROL, V52, P45, DOI 10.1016/j.jcv.2011.06.001
   Borthakur AK, 2013, J GLOB INFECT DIS, V5, P76, DOI 10.4103/0974-777X.112294
   Brown JR, 2018, J INFECTION, V76, P225, DOI 10.1016/j.jinf.2017.12.014
   BUESCHER EL, 1959, J IMMUNOL, V83, P582
   BURKE DS, 1987, J MED VIROL, V23, P165, DOI 10.1002/jmv.1890230209
   BURKE DS, 1982, J CLIN MICROBIOL, V16, P1034, DOI 10.1128/JCM.16.6.1034-1042.1982
   Calvert AE, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00234-18, 10.1128/jcm.00234-18]
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Cao L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004686
   CARDOSA M J, 1991, Southeast Asian Journal of Tropical Medicine and Public Health, V22, P341
   Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9
   Casals J, 1941, J EXP MED, V74, P409, DOI 10.1084/jem.74.5.409
   Casals J, 1941, SCIENCE, V94, P330, DOI 10.1126/science.94.2440.330
   Castro T., 2018, J ORAL MICROBIOL, V10, P1
   Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P123
   Chan K, 2018, ANAL BIOCHEM, V545, P4, DOI 10.1016/j.ab.2018.01.008
   CHAN YC, 1985, B WORLD HEALTH ORGAN, V63, P1043
   Chen L., 2011, Morbidity and Mortality Weekly Report, V60, P276
   CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561
   Colonetti T, 2018, AN ACAD BRAS CIENC, V90, P3147, DOI 10.1590/0001-3765201820170989
   Cutfield NJ, 2005, INTERN MED J, V35, P497, DOI 10.1111/j.1445-5994.2005.00852.x
   Desai A, 1997, EPIDEMIOL INFECT, V118, P165, DOI 10.1017/S0950268896007327
   Ding D, 2007, AM J TROP MED HYG, V77, P528
   Kim DTH, 2018, THERANOSTICS, V8, P3629, DOI 10.7150/thno.25955
   Dodd RY, 2015, TRANSFUS MED REV, V29, P153, DOI 10.1016/j.tmrv.2015.03.001
   Dubot-Peres A, 2015, LANCET INFECT DIS, V15, P1376, DOI 10.1016/S1473-3099(15)00405-3
   DUCA M, 1979, B WORLD HEALTH ORGAN, V57, P937
   EDELMAN R, 1973, AM J EPIDEMIOL, V98, P29, DOI 10.1093/oxfordjournals.aje.a121529
   Feng Y, 2013, EMERG INFECT DIS, V19, P672, DOI 10.3201/eid1904.120137
   Ferguson M, 2008, BIOLOGICALS, V36, P111, DOI 10.1016/j.biologicals.2007.07.002
   Fischer Marc, 2008, V8, P93
   Francis TJ, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806
   Frietze KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171511
   Gajanana A., 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P673
   Ganguli A, 2017, BIOMED MICRODEVICES, V19, DOI 10.1007/s10544-017-0209-9
   Gao XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003015
   GEORGE S, 1986, INDIAN J MED RES, V84, P565
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Granerod J, 2010, EPIDEMIOL INFECT, V138, P783, DOI 10.1017/S0950268810000725
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   GUNAKASEM P, 1981, Southeast Asian Journal of Tropical Medicine and Public Health, V12, P333
   Guo XG, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0591-6
   Hayashi M, 1933, PSYCHIAT CLIN NEUROS, V1, P419
   Heffelfinger JD, 2017, MMWR-MORBID MORTAL W, V66, P579, DOI 10.15585/mmwr.mm6622a3
   Hennessy S, 1996, LANCET, V347, P1583, DOI 10.1016/S0140-6736(96)91075-2
   Hills S, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-214
   Hills SL, 2014, J TRAVEL MED, V21, P310, DOI 10.1111/jtm.12127
   HOKE CH, 1988, NEW ENGL J MED, V319, P608, DOI 10.1056/NEJM198809083191004
   Hossain MJ, 2010, AM J TROP MED HYG, V82, P344, DOI 10.4269/ajtmh.2010.09-0125
   Huang C., 2017, TECHNOL ANAL STRATEG, V8, P1
   Impoinvil DE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002334
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   John CC, 2015, NATURE, V527, pS178, DOI 10.1038/nature16033
   Johnson BW, 2016, AM J TROP MED HYG, V94, P820, DOI 10.4269/ajtmh.15-0631
   JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510
   Kelly C, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-145
   Kim JG, 2018, TALANTA, V190, P391, DOI 10.1016/j.talanta.2018.08.019
   Kumar JS, 2018, INDIAN J MED RES, V147, P293, DOI 10.4103/0971-5916.234607
   Kumar JS, 2011, J MED VIROL, V83, P1063, DOI 10.1002/jmv.22097
   KUMAR R, 1990, ARCH DIS CHILD, V65, P1227, DOI 10.1136/adc.65.11.1227
   KUMAR R, 1994, NEUROEPIDEMIOLOGY, V13, P97, DOI 10.1159/000110365
   KUROKOCHI Y, 1950, Jpn Med J (Natl Inst Health Jpn), V3, P237
   Kurosaki Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13836-9
   Kuttner AG, 1936, J CLIN INVEST, V15, P525, DOI 10.1172/JCI100805
   Kyaw AK, 2019, AM J TROP MED HYG, V100, P643, DOI 10.4269/ajtmh.18-0530
   Lamb LE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22102-5
   Langevin S, 2012, J TRAVEL MED, V19, P127, DOI 10.1111/j.1708-8305.2011.00582.x
   Lebani K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180669
   Lee DW, 2012, INT J INFECT DIS, V16, pE448, DOI 10.1016/j.ijid.2012.02.006
   LEE GCY, 1965, J INFECT DIS, V115, P321, DOI 10.1093/infdis/115.4.321
   Lehtinen VA, 2008, J CLIN VIROL, V43, P93, DOI 10.1016/j.jcv.2008.05.001
   Li JW, 2016, BIOMED ENVIRON SCI, V29, P902, DOI 10.3967/bes2016.121
   Li YZ, 2012, J VIROL METHODS, V179, P8, DOI 10.1016/j.jviromet.2011.06.008
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Lopez-Jimena B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006381
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   MATHUR A, 1982, INDIAN J MED RES, V75, P161
   MATHUR A, 1990, INDIAN J MED RES-A, V91, P1
   Mauk Michael G, 2017, Clin Lab Int, V41, P25
   de Vasconcelos ZFM, 2018, CHILD NERV SYST, V34, P79, DOI 10.1007/s00381-017-3641-5
   Mikanatha NM, 2013, INFECTIOUS DISEASE SURVEILLANCE, 2ND EDITION, P1, DOI 10.1002/9781118543504
   MIYAKE MASASHL, 1964, BULL WORLD HLTH ORGAN, V30, P153
   Muniaraj M, 2019, HUM VACC IMMUNOTHER, V15, P834, DOI 10.1080/21645515.2018.1564435
   Murhekar M, 2017, INDIAN J MED RES, V145, P63, DOI 10.4103/ijmr.IJMR_712_16
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Nastiti CMRR, 2017, PHARMACEUTICS, V9, DOI 10.3390/pharmaceutics9040037
   Mai NTH, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx046
   OKUNO T, 1975, JPN J MED SCI BIOL, V28, P235, DOI 10.7883/yoken1952.28.235
   Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022
   Ompusunggu S, 2008, AM J TROP MED HYG, V79, P963, DOI 10.4269/ajtmh.2008.79.963
   Onyango CO, 2017, J CLIN MICROBIOL, V55, P2035, DOI [10.1128/JCM.02469-16, 10.1128/jcm.02469-16]
   Ozawa S, 2017, B WORLD HEALTH ORGAN, V95, P629, DOI 10.2471/BLT.16.178475
   Pearce JC, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay009
   PEIRIS JSM, 1992, T ROY SOC TROP MED H, V86, P307, DOI 10.1016/0035-9203(92)90325-7
   Piyasena TBH, 2017, VECTOR-BORNE ZOONOT, V17, P825, DOI 10.1089/vbz.2017.2172
   Prasad S R, 1993, Indian Pediatr, V30, P905
   Preziuso S, 2018, ZOONOSES PUBLIC HLTH, V65, P798, DOI 10.1111/zph.12501
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   RAVI V, 1989, J VIROL METHODS, V23, P291, DOI 10.1016/0166-0934(89)90161-4
   Ravi V, 2009, AM J TROP MED HYG, V81, P1144, DOI 10.4269/ajtmh.2009.09-0144
   Rayamajhi A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122608
   Robinson JS, 2010, AM J TROP MED HYG, V83, P1146, DOI 10.4269/ajtmh.2010.10-0212
   Rockstroh A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.87
   Ronnberg B, 2017, MED MICROBIOL IMMUN, V206, P383, DOI 10.1007/s00430-017-0517-y
   Rose NR, 1992, MANUAL CLIN LAB IMMU
   Saa P, 2018, NEW ENGL J MED, V378, P1778, DOI 10.1056/NEJMoa1714977
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   SABIN AB, 1947, AM J HYG, V46, P356, DOI 10.1093/oxfordjournals.aje.a119174
   SABIN AB, 1947, P SOC EXP BIOL MED, V65, P183, DOI 10.3181/00379727-65-15903
   SABIN AB, 1947, JAMA-J AM MED ASSOC, V133, P281, DOI 10.1001/jama.1947.02880050001001
   Saito M, 2015, SCI WORLD J, V2015
   Saito Mika, 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P277
   Sengvilaipaseuth O, 2017, T ROY SOC TROP MED H, V111, P373, DOI 10.1093/trstmh/trx067
   SEVER JL, 1962, J IMMUNOL, V88, P320
   Shen WF, 2017, J MICROBIOL IMMUNOL, V50, P167, DOI 10.1016/j.jmii.2015.05.008
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014
   Solomon T, 2008, B WORLD HEALTH ORGAN, V86, P178, DOI 10.2471/BLT.07.043307
   Song JZ, 2018, ANAL CHEM, V90, P4823, DOI 10.1021/acs.analchem.8b00283
   Sunwoo JS, 2016, EMERG INFECT DIS, V22, P1841, DOI 10.3201/eid2210.160288
   Tan KK, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3065-1
   Tandale BV, 2018, J INFECT PUBLIC HEAL, V11, P713, DOI 10.1016/j.jiph.2018.04.011
   Team RDC, 2010, R LANG ENV STAT COMP
   THISYAKORN U, 1985, Southeast Asian Journal of Tropical Medicine and Public Health, V16, P93
   Tiroumourougane SV, 2003, J TROP PEDIATRICS, V49, P153, DOI 10.1093/tropej/49.3.153
   Touch S, 2009, TROP MED INT HEALTH, V14, P1365, DOI 10.1111/j.1365-3156.2009.02380.x
   Tsai WY, 2018, EMERG INFECT DIS, V24, P1355, DOI 10.3201/eid2407.171170
   Upreti SR, 2017, PLOS NEGLECT TROP D, V11, DOI [10.1371/journal.pntd.0005866, 10.1371/journal.pntd.000586]
   VAUGHN DW, 1992, EPIDEMIOL REV, V14, P197, DOI 10.1093/oxfordjournals.epirev.a036087
   Wand NIV, 2018, J GEN VIROL, V99, P1012, DOI 10.1099/jgv.0.001083
   Warnecke JM, 2019, J VIROL METHODS, V267, P8, DOI 10.1016/j.jviromet.2019.02.005
   Wasik D, 2017, BIOSENS BIOELECTRON, V91, P811, DOI 10.1016/j.bios.2017.01.017
   WHOROft Western, 2014, 4 HANDS TRAIN WORKSH
   Wilson ML, 2018, LANCET, V391, P1927, DOI [10.1016/S0140-6736(18)30458-6, 10.1016/S0140-6736]
   WITTESJO B, 1995, LANCET, V345, P856, DOI 10.1016/S0140-6736(95)92990-8
   World Health Organization G, 2018, SURV STAND VACC PREV
   World Health Organization G, 2019, OFF COUNTR REP COV E
   World Health Organization G, 2019, IMM VACC BIOL DAT ST
   World Health Organization G, 2007, MAN LAB DIAGN JAP EN
   World Health Organization G, 2017, JRF SUPPL QUEST SURV
   World Health Organization G, 2017, IMM VACC BIOL DAT ST
   Yang Y, 2016, INT J INFECT DIS, V45, P135, DOI 10.1016/j.ijid.2016.03.004
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
   Yaren O, 2018, JOVE-J VIS EXP, DOI 10.3791/57051
   Yu WZ, 2018, VACCINE, V36, P8131, DOI 10.1016/j.vaccine.2018.10.005
   Zang FH, 2019, ADV MATER, V31, DOI 10.1002/adma.201902331
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhang YH, RAPID METHOD DETECTI, P24
   Zhao JT, 2019, VIRUS GENES, V55, P43, DOI 10.1007/s11262-018-1612-x
   Zhu TC, 2018, ANAL BIOCHEM, V556, P112, DOI 10.1016/j.ab.2018.06.030
   Zuo R, 2019, FRONT COMPUT NEUROSC, V13, DOI 10.3389/fncom.2019.00006
NR 165
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD JUN
PY 2020
VL 95
BP 444
EP 456
DI 10.1016/j.ijid.2020.03.039
PG 13
WC Infectious Diseases
SC Infectious Diseases
GA LY7VW
UT WOS:000540737100081
PM 32205287
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vongsouvath, M
   Bharucha, T
   Seephonelee, M
   de Lamballerie, X
   Newton, PN
   Dubot-Peres, A
AF Vongsouvath, Manivanh
   Bharucha, Tehmina
   Seephonelee, Malee
   de Lamballerie, Xavier
   Newton, Paul N.
   Dubot-Peres, Audrey
TI Harnessing Dengue Rapid Diagnostic Tests for the Combined Surveillance
   of Dengue, Zika, and Chikungunya Viruses in Laos
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
AB Recent expansions of vector-borne diseases highlight the need for improved surveillance, especially in resource-poor settings. Dengue virus (DENV), chikungunya virus (CHIKV), and Zika virus (ZIKV) share the same vectors as well as similar clinical presentations, suggesting that combined surveillance would be useful. We hypothesized that blood spotted on dengue rapid diagnostic tests (RDTs) could be harnessed for sample collection in remote areas for subsequent detection of DENV, CHIKV, and ZIKV by reverse transcription real-time polymerase chain reaction (RT-qPCR). CHIKV and ZIKV dilutions were spotted on dengue RDTs (SD BIOLINE Dengue DUO, Standard Diagnostics, Gyeonggi-do, Republic of Korea), dried, and extracted. As reference, aliquots of each viral dilution were directly extracted. Using specific RT-qPCR tests, both viruses were successfully detected from RDT extracts. However, the limit of detection was slightly lower in comparison to direct extracts, two logfold for CHIKV and one logfold for ZIKV. For analysis of temperature stability, DENV dilutions were spotted on RDTs and stored for up to 2 months at -80 degrees C, 4 degrees C, or 35 degrees C before testing. Storage of RDTs for 2 months at 35 degrees C did not compromise detection of RNA by RT-qPCR; only minimal degradation was observed. This proof-of-principle study demonstrates the potential of using dengue RDTs for DENV/CHIKV/ZIKV combined surveillance in areas without access to laboratory facilities. Further investigations are needed for evaluation of tri-viral surveillance under field conditions using patient samples. Large-scale implementation of surveillance for these viruses is of crucial public health importance for the early detection of epidemics. This method also has important implications for improving understanding of the molecular epidemiology of the three viruses.
C1 [Vongsouvath, Manivanh; Bharucha, Tehmina; Seephonelee, Malee; Newton, Paul N.; Dubot-Peres, Audrey] Mahosot Hosp, Lao Oxford Mahosot Hosp Wellcome Trust Res Unit L, Microbiol Lab, Viangchan, Laos.
   [Bharucha, Tehmina] Univ Oxford, Inst Glycobiol, Dept Biochem, Oxford, England.
   [de Lamballerie, Xavier; Dubot-Peres, Audrey] Aix Marseille Univ, IRD 190, Inserm 1207, IHU Mediterranee Infect,Unite Virus Emergents UVE, Marseille, France.
   [Newton, Paul N.; Dubot-Peres, Audrey] Univ Oxford, Churchill Hosp, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
RP Dubot-Peres, A (corresponding author), IHU Mediterranee Infect, UVE, 19-21 Bd Jean Moulin, F-13005 Marseille, France.
EM manivanh@tropmedres.ac; tehminabharucha@googlemail.com;
   malee@tropmedres.ac; xavier.de-lamballerie@univ-amu.fr;
   paul@tropmedres.ac; audrey@tropmedres.ac
FU Wellcome Trust of Great BritainWellcome Trust; Institute of Research for
   Development (IRD), Aix-Marseille University; European UnionEuropean
   Union (EU) [653316]
FX This work was supported by the Wellcome Trust of Great Britain, the
   Institute of Research for Development (IRD), Aix-Marseille University,
   and by the European Union's Horizon 2020 research and innovation
   programme EVAg under grant agreement number 653316.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Choi JR, 2017, CRIT REV BIOTECHNOL, V37, P100, DOI 10.3109/07388551.2016.1139541
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   Pastorino B, 2005, J VIROL METHODS, V124, P65, DOI 10.1016/j.jviromet.2004.11.002
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Peeling RW, 2017, COMPUT STRUCT BIOTEC, V15, P271, DOI 10.1016/j.csbj.2017.02.003
   Peeling RW, 2014, EXPERT REV MOL DIAGN, V14, P525, DOI 10.1586/14737159.2014.915748
   Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y
   Phommasone K, 2015, AM J TROP MED HYG, V93, P33, DOI 10.4269/ajtmh.15-0142
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Vongsouvath M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004704
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wikan N, 2017, ASIAN PAC J TROP MED, V10, P1, DOI 10.1016/j.apjtm.2016.11.013
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 20
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD JUN
PY 2020
VL 102
IS 6
BP 1244
EP 1248
DI 10.4269/ajtmh.19-0881
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LV9SO
UT WOS:000538787600030
PM 32157991
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Caragata, EP
   Otero, LM
   Carlson, JS
   Dizaji, NB
   Dimopoulos, G
AF Caragata, Eric P.
   Otero, Luisa M.
   Carlson, Jenny S.
   Dizaji, Nahid Borhani
   Dimopoulos, George
TI A Nonlive Preparation of Chromobacterium sp. Panama (Csp_P) Is a Highly
   Effective Larval Mosquito Biopesticide
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
DE mosquito control; insecticide; biopesticide; Chromobacterium Csp_P;
   Aedes aegypti; Anopheles gambiae; Culex quinquefasciatus; semi-field
   trial
ID INSECTICIDE RESISTANCE; SP NOV.; SPHAERICUS; BACTERIUM; DENGUE
AB Given the continued high prevalence of mosquito-transmitted diseases, there is a clear need to develop novel disease and vector control strategies. Biopesticides of microbial origin represent a promising source of new approaches to target disease-transmitting mosquito populations. Here, we describe the development and characterization of a novel mosquito biopesticide, derived from an air-dried, nonlive preparation of the bacterium Chromobacterium sp. Panama (family: Neisseriaceae). This preparation rapidly and effectively kills the larvae of prominent mosquito vectors, including the dengue and Zika vector Aedes aegypti and the human malaria vector Anopheles gambiae. During semi-field trials in Puerto Rico, we observed high efficacy of the biopesticide against field-derived A. aegypti populations, and against A. aegypti and Culex species larvae in natural breeding water, indicating the suitability of the biopesticide for use under more natural conditions. In addition to high efficacy, the nonlive Csp_P biopesticide has a low effective dose, a long shelf life, and high heat stability and can be incorporated into attractive larval baits, all of which are desirable characteristics for a biopesticide.
   IMPORTANCE We have developed a novel preparation to kill mosquitoes from an abundant soil bacterium, Chromobacterium sp. Panama. This preparation is an air-dried powder containing no live bacteria, and it can be incorporated into an attractive bait and fed directly to mosquito larvae. We demonstrate that the preparation has broad spectrum activity against the larval form of the mosquitoes responsible for the transmission of malaria and the dengue, chikungunya, yellow fever, West Nile, and Zika viruses, as well as mosquito larvae that are already resistant to commonly used mosquitocidal chemicals. Our preparation possesses many favorable traits: it kills at a low dosage, and it does not lose activity when exposed to high temperatures, all of which suggest that this preparation could eventually become an effective new tool for controlling mosquitoes and the diseases they spread.
C1 [Caragata, Eric P.; Otero, Luisa M.; Carlson, Jenny S.; Dizaji, Nahid Borhani; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
EM gdimopo1@jhu.edu
CR Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P293, DOI 10.2987/13-6345R.1
   Beier JC, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-31
   Beier JC, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-S1-S4
   Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackburn MB, 2019, INT J SYST EVOL MICR, V69, P2681, DOI 10.1099/ijsem.0.003508
   Blackburn MB, 2017, INT J SYST EVOL MICR, V67, P3417, DOI 10.1099/ijsem.0.002127
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Chandler D, 2011, PHILOS T R SOC B, V366, P1987, DOI 10.1098/rstb.2010.0390
   Conrad MD, 2019, LANCET INFECT DIS, V19, pE338, DOI 10.1016/S1473-3099(19)30261-0
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   EPA, 2002, 8306317 EPA OPPTS
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Lima-Bittencourt CI, 2011, LETT APPL MICROBIOL, V52, P642, DOI 10.1111/j.1472-765X.2011.03052.x
   Lima-Bittencourt CI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-58
   Macoris MD, 2003, MEM I OSWALDO CRUZ, V98, P703, DOI 10.1590/S0074-02762003000500020
   MILLER JE, 1991, MED VET ENTOMOL, V5, P465, DOI 10.1111/j.1365-2915.1991.tb00575.x
   Muller GC, 2010, MED VET ENTOMOL, V24, P346, DOI 10.1111/j.1365-2915.2010.00876.x
   Nishiura JT, 2003, J MED ENTOMOL, V40, P498, DOI 10.1603/0022-2585-40.4.498
   Poole-Smith BK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003462
   Protopopoff N, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-149
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Ranson H, 2016, TRENDS PARASITOL, V32, P187, DOI 10.1016/j.pt.2015.11.010
   Ray HA, 2014, FLA ENTOMOL, V97, P972, DOI 10.1653/024.097.0355
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Santini AC, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027955
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Saraiva RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24296-0
   Scholte EJ, 2005, SCIENCE, V308, P1641, DOI 10.1126/science.1108639
   Shapiro-Ilan DI, 2017, ENVIRON ENTOMOL, V46, P1299, DOI 10.1093/ee/nvx144
   Short SM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26680-2
   Short SM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2822-8
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soby SD, 2013, INT J SYST EVOL MICR, V63, P1840, DOI 10.1099/ijs.0.045161-0
   Stewart ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084168
   Vontas J, 2012, PESTIC BIOCHEM PHYS, V104, P126, DOI 10.1016/j.pestbp.2012.05.008
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   World Health Organization, 2018, WORLD MALARIA REPORT
   World Health Organization, 2019, MAL FACT SHEET
   World Health Organization, 2019, YELL FEV FACT SHEET
   World Health Organization, 2019, DENG SEV DENG FACT S
   World Health Organization, 2018, ZIK VIR FACT SHEET
   World Health Organization, 2011, GLOB INS US VECT BOR
   World Health Organization, 2017, CHIK FACT SHEET
NR 48
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
EI 1098-5336
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD JUN
PY 2020
VL 86
IS 11
AR e00240-20
DI 10.1128/AEM.00240-20
PG 15
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA LW3CI
UT WOS:000539019800001
PM 32220845
DA 2020-07-08
ER

PT J
AU Qi, JM
   Yin, Y
   Yu, WL
   Shen, LJ
   Xu, JJ
   Hu, T
AF Qi, Jinming
   Yin, Ying
   Yu, Weili
   Shen, Lijuan
   Xu, Junjie
   Hu, Tao
TI Conjugation of beta-Glucan with the Hydrazone and Disulfide Linkers
   Markedly Improves the Immunogenicity of Zika Virus E Protein
SO MOLECULAR PHARMACEUTICS
LA English
DT Article
DE Zika virus; beta-glucan; E protein; adjuvant; hydrazine; disulfide
ID DRUG-DELIVERY; ADJUVANT; VACCINE; PH; PRODRUG; ANTIGEN
AB The diseases caused by Zika virus (ZIKV) have received widespread concerns. As a key viral element of ZIKV, E protein was an ideal antigen for vaccine development. However, the poor immunogenicity of E protein necessitated the formulation with adjuvants. Formulation of E protein by conjugation with beta-glucan was a strategy to improve the immunogenicity of E protein, where beta-glucan was a polysaccharide adjuvant that could activate macrophages and trigger intracellular processes. However, the antigenic epitopes of E protein and the immunomodulatory sites of beta-glucan were shielded in the conjugate. Moreover, the conjugate might elicit the undesired immune response to beta-glucan. Thus, the acidic-labile hydrazone and the thiol-sensitive disulfide bonds were used as the linkers between E protein and beta-glucan. Hydrazone hydrolysis and disulfide reduction could sufficiently detach the two components in the immune cells to overcome the two disadvantages. As compared with the conjugate without the two linkers, the conjugate with the two linkers (E-PS-4) elicited high E protein-specific IgG titers and low beta-glucan-specific IgG titers. E-PS-4 elicited high levels of IFN-gamma, TNF-alpha, IL-2, and IL-10. Moreover, E-PS-4 greatly facilitated the activation of dendritic cells without significant toxicity to the organs. A pharmacokinetic study revealed that the serum duration of E-PS-4 was longer than that of E protein. Accordingly, conjugation of E protein with beta-glucan by the hydrazone and disulfide linkers could promote a potent cellular and humoral immune response to E protein. Thus, our study could facilitate the development of an effective vaccine against ZIKV.
C1 [Yin, Ying; Xu, Junjie] Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 100071, Peoples R China.
   [Qi, Jinming; Yu, Weili; Shen, Lijuan; Hu, Tao] Chinese Acad Sci, State Key Lab Biochem Engn, Inst Proc Engn, Beijing 100190, Peoples R China.
RP Xu, JJ (corresponding author), Beijing Inst Biotechnol, Lab Vaccine & Antibody Engn, Beijing 100071, Peoples R China.; Hu, T (corresponding author), Chinese Acad Sci, State Key Lab Biochem Engn, Inst Proc Engn, Beijing 100190, Peoples R China.
EM xujunjie@sina.com; thu@home.ipe.ac.cn
FU National Key Research and Development Project of China [2018YFA0900804];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31970875, 81703445, 81700181]
FX This study was financially supported by National Key Research and
   Development Project of China (2018YFA0900804) and National Natural
   Science Foundation of China (31970875, 81703445, and 81700181).
CR Agger EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003116
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bautista LE, 2019, J NEUROL SCI, V403, P99, DOI 10.1016/j.jns.2019.06.019
   Berner VK, 2008, APPL MICROBIOL BIOT, V80, P1053, DOI 10.1007/s00253-008-1618-8
   Brito LA, 2014, J CONTROL RELEASE, V190, P563, DOI 10.1016/j.jconrel.2014.06.027
   Britto C, 2018, EXPERT OPIN BIOL TH, V18, P1171, DOI 10.1080/14712598.2018.1526277
   Callis PR, 2014, J MOL STRUCT, V1077, P22, DOI 10.1016/j.molstruc.2014.04.051
   Capasso A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007622
   Chaung HC, 2009, VET IMMUNOL IMMUNOP, V131, P147, DOI 10.1016/j.vetimm.2009.04.004
   Chen LH, 2019, CURR OPIN INFECT DIS, V32, P381, DOI 10.1097/QCO.0000000000000575
   Cheng R, 2011, J CONTROL RELEASE, V152, P2, DOI 10.1016/j.jconrel.2011.01.030
   Choi H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007042
   Cleary JA, 1999, IMMUNOL CELL BIOL, V77, P395, DOI 10.1046/j.1440-1711.1999.00848.x
   Cunningham AL, 2016, VACCINE, V34, P6655, DOI 10.1016/j.vaccine.2016.10.016
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876
   Duan X, 2018, J MATER CHEM B, V6, P39, DOI 10.1039/c7tb02817b
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Hasan S, 2019, J INT SOC PREV COMMU, V9, P316, DOI 10.4103/jispcd.JISPCD_433_18
   Huang P, 2019, THERANOSTICS, V9, P5755, DOI 10.7150/thno.36163
   Huang QR, 2016, BIOCONJUGATE CHEM, V27, P1165, DOI 10.1021/acs.bioconjchem.6b00116
   Khaiboullina SF, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01465
   Lee J, 2018, ACTA BIOMATER, V80, P31, DOI 10.1016/j.actbio.2018.08.033
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nithiyanantham SF, 2019, CAN J PUBLIC HEALTH, V110, P638, DOI 10.17269/s41997-019-00215-2
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Prompers JJ, 1999, FEBS LETT, V456, P409, DOI 10.1016/S0014-5793(99)00990-4
   Qadir A, 2018, EUR J MED CHEM, V156, P444, DOI 10.1016/j.ejmech.2018.07.014
   Qiao WL, 2015, VACCINE, V33, P2066, DOI 10.1016/j.vaccine.2015.02.045
   Skeiky YAW, 2004, J IMMUNOL, V172, P7618, DOI 10.4049/jimmunol.172.12.7618
   Slutter B, 2010, J CONTROL RELEASE, V143, P207, DOI 10.1016/j.jconrel.2010.01.007
   Sonawane SJ, 2017, EUR J PHARM SCI, V99, P45, DOI 10.1016/j.ejps.2016.12.011
   van Dissel JT, 2011, VACCINE, V29, P2100, DOI 10.1016/j.vaccine.2010.12.135
   Vetvicka V, 2011, WORLD J CLIN ONCOL, V2, P115, DOI 10.5306/wjco.v2.i2.115
   Xie JJ, 2018, INT J NANOMED, V13, P1381, DOI 10.2147/IJN.S152312
   Xu ZG, 2017, COLLOID SURFACE B, V150, P50, DOI 10.1016/j.colsurfb.2016.11.021
   Yu WL, 2016, MOL PHARMACEUT, V13, P3626, DOI 10.1021/acs.molpharmaceut.6b00138
   Zhang Y, 2010, COMPUT METH PROG BIO, V99, P306, DOI 10.1016/j.cmpb.2010.01.007
NR 39
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD JUN 1
PY 2020
VL 17
IS 6
BP 1933
EP 1944
DI 10.1021/acs.molpharmaceut.0c00010
PG 12
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA LV3KC
UT WOS:000538337600014
PM 32347735
DA 2020-07-08
ER

PT J
AU Castro-de-Araujo, LFS
   Machado, DB
AF Silva Castro-de-Araujo, Luis Fernando
   Machado, Daiane Borges
TI Impact of COVID-19 on mental health in a Low and Middle-Income Country
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE COVID-19; Mental health; Brazil; Dementias; Bipolar disorder
ID ANXIETY
AB Mental disorders (MD) are commonly comorbid with cardiovascular, metabolic, and some infectious diseases. Since the current SARS-CoV-2 epidemic is affecting the most multimorbid individuals, we might expect that the epidemic will be particularly problematic for people with MD. Understanding the burden of an outbreak on mental health is fundamental to effective action towards containing the spread of the disease, as psychopathology might reduce endurance during the lockdown. This can potentially reduce adhesion to ongoing treatment resulting in avoidable recurrence of a disorder. Additionally, there is the stress caused by the eminent risk of infection or economic uncertainty, especially in low-middle income settings. This is an overview on the expected influence of the COVID-19 on mental health from a research group that has not long ago been involved in the Zika epidemic. It aims to discuss the effects of the pandemic on a Low and Middle-Income country (LMIC), Brazil.
C1 [Silva Castro-de-Araujo, Luis Fernando; Machado, Daiane Borges] Ctr Data & Knowledge Integrat Hlth CIDACS, Rede CoVida Ciencia Informacao & Solidariedade, R Mundo 121 Parque Tecnol Edf Tecnoctr 315, BR-41745715 Salvador, BA, Brazil.
RP Castro-de-Araujo, LFS (corresponding author), Ctr Data & Knowledge Integrat Hlth CIDACS, Rede CoVida Ciencia Informacao & Solidariedade, R Mundo 121 Parque Tecnol Edf Tecnoctr 315, BR-41745715 Salvador, BA, Brazil.
EM ldearaujo@unimelb.edu.au
OI B Machado, Daiane/0000-0003-2959-4650; Araujo, Luis
   Fernando/0000-0002-0952-5052
FU Wellcome TrustWellcome Trust
FX The Wellcome Trust funds both authors with a research associate
   scholarship at CIDAS/Fiocruz.
CR Asmundson GJG, 2010, CURR PSYCHIAT REP, V12, P306, DOI 10.1007/s11920-010-0123-9
   Bao YP, 2020, LANCET, V395, pE37, DOI 10.1016/S0140-6736(20)30309-3
   Blakey SM, 2017, J CLIN PSYCHOL MED S, V24, P270, DOI 10.1007/s10880-017-9514-y
   Gofton TE, 2011, CAN J NEUROL SCI, V38, P673, DOI 10.1017/S0317167100012269
   Huremovic D., 2019, PSYCHIAT PANDEMICS M
   Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639
NR 6
TC 0
Z9 0
U1 0
U2 0
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD JUN
PY 2020
VL 25
SU 1
BP 2457
EP 2460
DI 10.1590/1413-81232020256.1.10932020
PG 4
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LX1WX
UT WOS:000539630300007
PM 32520289
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ahmad, MN
   Dasgupta, A
   Chopra, S
AF Ahmad, M. Naiyaz
   Dasgupta, A.
   Chopra, S.
TI Remdesivir RNA-dependent RNA polymerase inhibitor Treatment of Ebola
   virus infection Treatment of SARS-CoV-2 infection (COVID-19)
SO DRUGS OF THE FUTURE
LA English
DT Article
DE Remdesivir; GS-5734; RNA-dependent RNA polymerase; Ebola; SARS-CoV-2;
   COVID-19
ID GS-5734
AB Remdesivir (GS-5734) is a promising broad-spectrum experimental antiviral drug developed by Gilead Sciences. It is a nucleo-side analogue prodrug that undergoes rapid conversion into nucleoside triphosphate (NTP) by intracellular metabolic processes. These NTPs inhibit viral polymerase by acting as an alternate substrate. Initially, remdesivir was developed to treat Ebola virus disease as it exerts antiviral activity by inhibiting RNA-dependent RNA polymerase. As RNA-dependent RNA polymerase is a common enzyme found in all viruses belonging to the realm Riboviria, remdesivir has the potential to be used as a broad-spectrum antiviral against a wide range of viruses, which has been reflected in several in vitro and in vivo studies in which it has efficiently prevented the replication of viruses belonging to diverse families such as Ebola virus, coronavirus, Zika virus and Nipah virus. After qualifying preclinical efficacy and safety criteria, remdesivir is currently in randomized clinical trials in patients of Ebola virus and the recently emerged SARS-CoV-2.
   [GRAPHICS]
C1 [Ahmad, M. Naiyaz; Dasgupta, A.; Chopra, S.] CSIR Cent Drug Res Inst, Div Microbiol, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
   [Ahmad, M. Naiyaz] Acad Sci & Innovat Res AcSIR, Ghaziabad, India.
RP Chopra, S (corresponding author), CSIR Cent Drug Res Inst, Div Microbiol, Sect 10,Sitapur Rd, Lucknow 226031, Uttar Pradesh, India.
EM skchopra007@gmail.com
CR Agostini ML, 2018, MBIO, V9, DOI 10.1128/mBio.00221-18
   [Anonymous], GLOB HLTH OBS
   [Anonymous], 2019, EB WHO R D BLUEPR AD
   [Anonymous], SOL CLIN TRIAL COVID
   [Anonymous], 2020, GIL SCI STAT REQ RES
   [Anonymous], 2015, REMD ORPH DRUG DES
   Beigel J.H., 2020, N ENGL J MED
   Bloom D. E., 2018, Finance & Development, V55, P46
   Brown AJ, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104541
   Chun B.K., Patent No. [US 2018311263, 2018311263]
   Chun B.K., Patent No. [WO 2016069826, 2016069826]
   Committee for Orphan Medicinal Products (COMP), 2016, COMM ORPH MED PROD C
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Development of remdesivir, DEV REMD
   European Medicines Agency, 2020, SUMM COMP US REMD GI
   Grein J, 2020, N ENGL J MED
   Lo MK, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau9242
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Mackman R.L., Patent No. [WO 2012012776, 2012012776]
   Madelain V, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06215-z
   McMullan LK, 2019, LANCET INFECT DIS, V19, P1023, DOI 10.1016/S1473-3099(19)30291-9
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   OConnor S.J., Patent No. [WO 2007056170, 2007056170]
   Sheahan Timothy P, 2020, Nat Commun, V11, P222, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594
   Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326
   Walker PJ, 2019, ARCH VIROL, V164, P2417, DOI 10.1007/s00705-019-04306-w
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2020, LANCET, V395, P1569, DOI 10.1016/S0140-6736(20)31022-9
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
NR 31
TC 0
Z9 0
U1 0
U2 0
PU PROUS SCIENCE, SAU-THOMSON REUTERS
PI BARCELONA
PA 398 PROVENCA, 08025 BARCELONA, SPAIN
SN 0377-8282
EI 2013-0368
J9 DRUG FUTURE
JI Drug Future
PD JUN
PY 2020
VL 45
IS 6
BP 369
EP 382
DI 10.1358/dof.2020.45.6.3146067
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA LV7KK
UT WOS:000538615500001
DA 2020-07-08
ER

PT J
AU Koike, H
   Fukami, Y
   Nishi, R
   Kawagashira, Y
   Iijima, M
   Katsuno, M
   Sobue, G
AF Koike, Haruki
   Fukami, Yuki
   Nishi, Ryoji
   Kawagashira, Yuichi
   Iijima, Masahiro
   Katsuno, Masahisa
   Sobue, Gen
TI Ultrastructural mechanisms of macrophage-induced demyelination in
   Guillain-Barre syndrome
SO JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
LA English
DT Article
ID EXPERIMENTAL ALLERGIC NEURITIS; IDIOPATHIC POLYNEURITIS; NORTHERN CHINA;
   AXONAL FORM; ZIKA VIRUS; FEATURES; POLYNEUROPATHY; PATHOGENESIS;
   ANTIBODIES; NEUROPATHY
AB Objective To describe the pathological features of Guillain-Barre syndrome focusing on macrophage-associated myelin lesions.
   Methods Longitudinal sections of sural nerve biopsy specimens from 11 patients with acute inflammatory demyelinating polyneuropathy (AIDP) exhibiting macrophage-associated demyelinating lesions were examined using electron microscopy. A total of 1205 nodes of Ranvier were examined to determine the relationship of the macrophage-associated demyelinating lesions with the nodal regions. Additionally, immunohistochemical and immunofluorescent studies were performed to elucidate the sites of complement deposition.
   Results Overall, 252 macrophage-associated myelin lesions were identified in longitudinal sections. Of these, 40 lesions exhibited complete demyelination with no association with the lamellar structures of myelin. In 183 lesions, macrophage cytoplasm was located at internodes without association with the nodes of Ranvier or paranodes. In particular, these internodal lesions were more frequent in one patient (152 lesions). In the remaining 29 lesions, the involvement of nodal regions was obvious. Lesions involving nodal regions were more frequently observed than those involving internodes in four patients. Invasion of the macrophage cytoplasmic processes into the space between the paranodal myelin terminal loops and the axolemma from the nodes of Ranvier was observed in three of these patients. Immunostaining suggested complement deposition corresponding to putative initial macrophage-associated demyelinating lesions.
   Conclusions The initial macrophage-associated demyelinating lesions appeared to be located at internodes and at nodal regions. The sites at which the macrophages initiated phagocytosis of myelin might be associated with the location of complement deposition in certain patients with AIDP.
C1 [Koike, Haruki; Fukami, Yuki; Nishi, Ryoji; Kawagashira, Yuichi; Iijima, Masahiro; Katsuno, Masahisa; Sobue, Gen] Nagoya Univ, Grad Sch Med, Dept Neurol, Nagoya, Aichi 4668550, Japan.
   [Sobue, Gen] Nagoya Univ, Res Div Dementia & Neurodegenerat Dis, Grad Sch Med, Nagoya, Aichi, Japan.
RP Koike, H (corresponding author), Nagoya Univ, Neurol, Grad Sch Med, Nagoya, Aichi 4668550, Japan.
EM koike-haruki@med.nagoya-u.ac.jp
FU Ministry of Health, Labor and Welfare (Research on rare and intractable
   diseases) [H29-022]; Ministry of Education, Culture, Sports, Science and
   Technology of JapanMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT) [17K09777]
FX This work was supported by grants from the Ministry of Health, Labor and
   Welfare (Research on rare and intractable diseases, H29-022) and the
   Ministry of Education, Culture, Sports, Science and Technology
   (17K09777) of Japan.
CR ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707
   ASBURY AK, 1969, MEDICINE, V48, P173, DOI 10.1097/00005792-196905000-00001
   Berciano J, 1997, MUSCLE NERVE, V20, P846
   BERCIANO J, 1993, MUSCLE NERVE, V16, P744, DOI 10.1002/mus.880160709
   Berciano J, 2017, J NEUROL, V264, P221, DOI 10.1007/s00415-016-8204-2
   BROSTOFF SW, 1977, NATURE, V268, P752, DOI 10.1038/268752a0
   Delmont E, 2017, BRAIN, V140, P1851, DOI 10.1093/brain/awx124
   Devaux JJ, 2012, J PERIPHER NERV SYST, V17, P62, DOI 10.1111/j.1529-8027.2012.00372.x
   Dyck PJ, 2005, PERIPHERAL NEUROPATH, P733
   FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115
   Gabriel CM, 1998, BRAIN, V121, P1895, DOI 10.1093/brain/121.10.1895
   Giannini C, 1996, MICROSC RES TECHNIQ, V34, P436, DOI 10.1002/(SICI)1097-0029(19960801)34:5<436::AID-JEMT3>3.0.CO;2-K
   Gordon PH, 2001, ARCH NEUROL-CHICAGO, V58, P913, DOI 10.1001/archneur.58.6.913
   GRIFFIN JW, 1995, BRAIN, V118, P577, DOI 10.1093/brain/118.3.577
   HaferMacko C, 1996, ANN NEUROL, V40, P635, DOI 10.1002/ana.410400414
   HaferMacko CE, 1996, ANN NEUROL, V39, P627, DOI 10.1002/ana.410390512
   Hashimoto R, 2015, J NEUROPATH EXP NEUR, V74, P1127, DOI [10.1093/jnen/74.12.1127, 10.1097/NEN.0000000000000257]
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   ILYAS AA, 1992, J NEUROL SCI, V107, P111, DOI 10.1016/0022-510X(92)90217-9
   Koike H, 2018, NEUROLOGY, V91, P1051, DOI 10.1212/WNL.0000000000006625
   Koike H, 2017, J NEUROL NEUROSUR PS, V88, P465, DOI 10.1136/jnnp-2016-314895
   KUSUNOKI S, 1995, MUSCLE NERVE, V18, P409, DOI 10.1002/mus.880180407
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Kuwahara M, 2011, J NEUROIMMUNOL, V239, P87, DOI 10.1016/j.jneuroim.2011.08.016
   LAMPERT PW, 1969, LAB INVEST, V20, P127
   Lucchese G, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12608
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Makowska A, 2008, J NEUROL NEUROSUR PS, V79, P664, DOI 10.1136/jnnp.2007.123943
   MILNER P, 1987, J NEUROL SCI, V79, P275, DOI 10.1016/0022-510X(87)90235-8
   Misawa S, 2018, LANCET NEUROL, V17, P519, DOI 10.1016/S1474-4422(18)30114-5
   Mori K, 2002, NEUROLOGY, V58, P979, DOI 10.1212/WNL.58.6.979
   PRINEAS JW, 1972, LAB INVEST, V26, P133
   Sawai S, 2014, NEUROLOGY, V83, P113, DOI 10.1212/WNL.0000000000000566
   SCHRODER JM, 1970, ACTA NEUROPATHOL, V14, P261, DOI 10.1007/BF00685783
   Sobue G, 1997, NEUROLOGY, V48, P1694, DOI 10.1212/WNL.48.6.1694
   Tomita M, 2013, BRAIN, V136, P2563, DOI 10.1093/brain/awt193
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Vallat JM, 2018, BRAIN, V141, DOI 10.1093/brain/awy134
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
NR 40
TC 1
Z9 1
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0022-3050
EI 1468-330X
J9 J NEUROL NEUROSUR PS
JI J. Neurol. Neurosurg. Psychiatry
PD JUN
PY 2020
VL 91
IS 6
BP 650
EP 659
DI 10.1136/jnnp-2019-322479
PG 10
WC Clinical Neurology; Psychiatry; Surgery
SC Neurosciences & Neurology; Psychiatry; Surgery
GA LW3RG
UT WOS:000539061900014
PM 32245766
DA 2020-07-08
ER

PT J
AU Gallo, LG
   Martinez-Cajas, J
   Peixoto, HM
   Pereira, ACED
   Carter, JE
   McKeown, S
   Schaub, B
   Ventura, CV
   de Franca, GVA
   Pomar, L
   Ventura, LO
   Nerurkar, VR
   de Araujo, WN
   Velez, MP
AF Gallo, Luciana Guerra
   Martinez-Cajas, Jorge
   Peixoto, Henry Maia
   Pereira, Ana Carolina Esteves da Silva
   Carter, Jillian E.
   McKeown, Sandra
   Schaub, Bruno
   Ventura, Camila V.
   de Franca, Giovanny Vinicius Araujo
   Pomar, Leo
   Ventura, Liana O.
   Nerurkar, Vivek R.
   de Araujo, Wildo Navegantes
   Velez, Maria P.
TI Another piece of the Zika puzzle: assessing the associated factors to
   microcephaly in a systematic review and meta-analysis
SO BMC PUBLIC HEALTH
LA English
DT Review
DE Zika virus; Microcephaly; Pregnancy; Congenital disease; Risk factors;
   Systematic review; Congenital Zika syndrome
ID VIRUS-INFECTION; SOCIAL DETERMINANTS; OUTCOMES; PREGNANCY; HEALTH
AB Background Although it is known that Zika virus (ZIKV) infection during pregnancy may lead to microcephaly in the fetus, the prognostic factors associated with this tragic disorder remain unclear. We conducted a systematic review and meta-analysis to assess the prognostic factors associated with the incidence of microcephaly in congenital ZIKV infection. Methods We conducted a comprehensive search in Ovid MEDLINE, Ovid MEDLINE (R) Epub ahead of print, Embase, Embase Classic, Web of Science, CINAHL, Cochrane CENTRAL, LILACS, and various thesis databases to identify human studies reporting microcephaly associated with congenital ZIKV infection. We requested primary data from the authors of the included studies to calculate summary estimates and conduct the meta-analysis of the most prevalent factors. Results We screened 4106 titles and abstracts, and identified 12 studies for inclusion in the systematic review. The assessment of ZIKV infection and the definition of microcephaly varied among studies. A total of 6154 newborns/fetuses were enrolled; of those, 1120 (18.20%) had a diagnostic of ZIKV infection, of which 509 (45.45%) were diagnosed with microcephaly. Nine studies addressed the link between congenital ZIKV infection and neurological findings in newborns/fetuses. Half of the studies provided primary data. Three out of 11 factors of interest seem to be prognostic factors of microcephaly: infant's sex - males compared to females: Relative Risk (RR) 1.30, 95% Confidence Interval (95% CI) 1.14 to 1.49; the stage of pregnancy when infection occurred - infection in the first trimester of pregnancy compared to infection at other stages of pregnancy: RR 1.41, 95% CI 1.09 to 1.82; and asymptomatic infection compared to symptomatic infection during pregnancy: RR 0.68; 95% CI 0.60 to 0.77. Conclusion Our findings support the female-biased resistance hypothesis and reinforce the risk associated with the stage of pregnancy when ZIKV infection occurs. Continued surveillance of ZIKV infection during pregnancy is needed to identify additional factors that could contribute to developing microcephaly in affected fetuses. Protocol registration This systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO), registration no. .
C1 [Gallo, Luciana Guerra; Peixoto, Henry Maia; de Araujo, Wildo Navegantes] Univ Brasilia, Postgrad Program Trop Med, Brasilia, DF, Brazil.
   [Gallo, Luciana Guerra; Carter, Jillian E.; Velez, Maria P.] Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada.
   [Gallo, Luciana Guerra; Carter, Jillian E.; Velez, Maria P.] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.
   [Martinez-Cajas, Jorge] Queens Univ, Dept Med, Kingston, ON, Canada.
   [Pereira, Ana Carolina Esteves da Silva] Fundacao Oswaldo Cruz, Program Evidence Policies & Hlth Technol, Brasilia, DF, Brazil.
   [McKeown, Sandra] Queens Univ, Bracken Hlth Sci Lib, Kingston, ON, Canada.
   [Schaub, Bruno] Univ Hosp Martinique, Ctr Pluridisciplinaire Diagnost Prenatal Martiniq, Maison Femme Mere & Enfant, Fort De France, Martinique, France.
   [Ventura, Camila V.] Altino Ventura Fdn, Dept Sci Invest, Recife, PE, Brazil.
   [de Franca, Giovanny Vinicius Araujo] Brazilian Minist Hlth, Brasilia, DF, Brazil.
   [Pomar, Leo] Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, Lausanne, Switzerland.
   [Pomar, Leo] Ctr Hosp Ouest Guyanais Franck Joly, Dept Obstet & Gynaecol, St Laurent Du Maroni, French Guiana.
   [Ventura, Liana O.] Altino Ventura Fdn, Dept Pediat Ophthalmol & Strabismus, Recife, PE, Brazil.
   [Nerurkar, Vivek R.] Univ Hawaii Manoa, John A Burns Sch Med, Dept Trop Med Med Microbiol & Pharmacol, Honolulu, HI 96822 USA.
RP Velez, MP (corresponding author), Queens Univ, Dept Obstet & Gynecol, Kingston, ON, Canada.; Velez, MP (corresponding author), Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada.
EM maria.velez@queensu.ca
OI Maia Peixoto, Henry/0000-0001-5982-8855
FU CAPES Foundation, Brazilian Ministry of Education (CAPES/PDSE/Grant),
   BrazilCAPES [88881.133664/2016-01]
FX LGG received sponsorship from CAPES Foundation, Brazilian Ministry of
   Education (CAPES/PDSE/Grant no. 88881.133664/2016-01), Brazil. The
   funding source played no role in this study.
CR Al-Qaraghouli M, 2017, FRONT PEDIATR, V5, DOI 10.3389/fped.2017.00144
   Alvarado MG, 2017, ARCH PATHOL LAB MED, V141, P26, DOI 10.5858/arpa.2016-0382-RA
   Amjad S, 2019, PAEDIATR PERINAT EP, V33, P88, DOI 10.1111/ppe.12529
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Baldotto SB, 2015, TOXOPLASMOSE COM REP, V9, P34
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bernin H, 2014, J INFECT DIS, V209, pS107, DOI 10.1093/infdis/jit610
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brazil, 2018, B EP, V49, P8
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Cauchemez S, 2016, LANCET, V71, P512
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Pone MVD, 2018, CHILD NERV SYST, V34, P63, DOI 10.1007/s00381-017-3635-3
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P139, DOI 10.1016/S1473-3099(18)30001-X
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Frank C, 2016, EMBO MOL MED, V8, P305, DOI 10.15252/emmm.201506058
   Gallo LG, 2018, RISK FACTORS MICROCE
   Guerra-Silveira F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062390
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hawaii, 2011, HAW BIRTH DEF SURV R
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Johansson MA, 2016, NEW ENGL J MED, V375
   Kanmaz AG, 2019, J GYNECOL OBSTET HUM
   Kimberlin D, 2004, CLIN MICROBIOL REV
   Kleber de O, 2016, LANCET, V390, P1051
   Kleber de O, 2016, LANCET, V390, P861
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Kumar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005262
   Matos SBde, 2011, REV SAUDE COM, V7, P55
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Mitsuka-Bregano R, 2010, TOXOPLASMOSE ADQUIRI
   Modesti PA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147601
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Mondal D, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0220-4
   O'Malley PA, 2016, CLIN NURSE SPEC, V30, P194, DOI 10.1097/NUR.0000000000000218
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Patrick M, 2014, MED MICROBIOLOGY, V7
   Pawluk MS, 2014, ARCH ARGENT PEDIATR, V112, P215, DOI [10.1590/S0325-00752014000300004, 10.5546/aap.2014.215, 10.5546/aap.2014.eng.215]
   Penas J, 2003, PEDIAT INTEGR
   Peters R, 2019, CLIN MICROBIOL INFEC, V25, P142, DOI 10.1016/j.cmi.2018.12.002
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Puthussery S, 2016, BEST PRACT RES CL OB, V32, P39, DOI 10.1016/j.bpobgyn.2015.09.003
   Rasmussen SA, 2017, BIRTH DEFECTS RES, V109, P363, DOI 10.1002/bdr2.1006
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawal Gautam, 2016, J Family Med Prim Care, V5, P523, DOI 10.4103/2249-4863.197256
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Tosun G, 2020, J MATERN-FETAL NEO M, V33, P217, DOI 10.1080/14767058.2018.1488163
   Vargas A, 2016, EPIDEMIOL SERV SAUDE, V25, P691, DOI 10.5123/S1679-49742016000400003
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Verburg PE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158807
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Wells G, 2000, NEWCASTLE OTTAWA SCA
   WHO, 2016, 16 WHO
   WHO, 2016, ZIK CAUS STAT
   Williamson J, 2018, SYNTHESE, P1, DOI DOI 10.1007/S11229-018-1866-9
   Wiwanitkit V, 2017, J CRANIOFAC SURG, V28, P299, DOI 10.1097/SCS.0000000000003276
   World Health Organization, 2016, 1 M INT HLTH REG 200
   Yamada H, 2018, J INFECT CHEMOTHER, V24, P702, DOI 10.1016/j.jiac.2018.04.010
   Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48
NR 72
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD JUN 1
PY 2020
VL 20
IS 1
AR 827
DI 10.1186/s12889-020-08946-5
PG 15
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LU9HV
UT WOS:000538058600006
PM 32487247
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mercado, M
   Ailes, EC
   Daza, M
   Tong, VT
   Osorio, J
   Valencia, D
   Rico, A
   Galang, RR
   Gonzalez, M
   Ricaldi, JN
   Anderson, KN
   Kama, N
   Thomas, JD
   Villanueva, J
   Burke, VK
   Meaney-Delman, D
   Gilboa, SM
   Honein, MA
   Jamieson, DJ
   Ospina, ML
AF Mercado, Marcela
   Ailes, Elizabeth C.
   Daza, Marcela
   Tong, Van T.
   Osorio, Johana
   Valencia, Diana
   Rico, Angelica
   Galang, Romeo R.
   Gonzalez, Maritza
   Ricaldi, Jessica N.
   Anderson, Kayla N.
   Kama, Nazia
   Thomas, Jennifer D.
   Villanueva, Julie
   Burke, Veronica K.
   Meaney-Delman, Dana
   Gilboa, Suzanne M.
   Honein, Margaret A.
   Jamieson, Denise J.
   Ospina, Martha L.
TI Zika virus detection in amniotic fluid and Zika-associated birth defects
SO AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
LA English
DT Article
DE amniotic fluid; birth defect; microcephaly; PCR; pregnancy; Zika virus;
   ZIKV disease
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; INFECTION; FETUSES; MANAGEMENT;
   PREGNANCY; DIAGNOSIS; INFANTS; WOMEN
AB BACKGROUND: Zika virus infection during pregnancy can cause serious birth defects, which include brain and eye abnormalities. The clinical importance of detection of Zika virus RNA in amniotic fluid is unknown.
   OBJECTIVE: The purpose of this study was to describe patterns of Zika virus RNA testing of amniotic fluid relative to other clinical specimens and to examine the association between Zika virus detection in amniotic fluid and Zika-associated birth defects. Our null hypothesis was that Zika virus detection in amniotic fluid was not associated with Zika-associated birth defects.
   STUDY DESIGN: We conducted a retrospective cohort analysis of women with amniotic fluid specimens submitted to Colombia's National Institute of Health as part of national Zika virus surveillance from January 2016 to January 2017. Specimens (maternal serum, amniotic fluid, cord blood, umbilical cord tissue, and placental tissue) were tested for the presence of Zika virus RNA with the use of a singleplex or multiplex realtime reverse transcriptase-polymerase chain reaction assay. Birth defect information was abstracted from maternal prenatal and infant birth records and reviewed by expert clinicians. Chi-square and Fisher's exact tests were used to compare the frequency of Zika-associated birth defects (defined as brain abnormalities [with or without microcephaly, but excluding neural tube defects and their associated findings] or eye abnormalities) by frequency of detection of Zika virus RNA in amniotic fluid.
   RESULTS: Our analysis included 128 women with amniotic fluid specimens. Seventy-five women (58%) had prenatally collected amniotic fluid; 42 women (33%) had amniotic fluid collected at delivery, and 11 women (9%) had missing collection dates. Ninety-one women had both amniotic fluid and other clinical specimens submitted for testing, which allowed for comparison across specimen types. Of those 91 women, 68 had evidence of Zika virus infection based on detection of Zika virus RNA in >= 1 specimen. Testing of amniotic fluid that was collected prenatally or at delivery identified 39 of these Zika virus infections (57%; 15 [22%] infections were identified only in amniotic fluid), and 29 infections (43%) were identified in other specimen types and not amniotic fluid. Among women who were included in the analysis, 89 had pregnancy outcome information available, which allowed for the assessment of the presence of Zika-associated birth defects. Zika-associated birth defects were significantly (P<.05) more common among pregnancies with Zika virus RNA detected in amniotic fluid specimens collected prenatally (19/32 specimens; 59%) than for those with no laboratory evidence of Zika virus infection in any specimen (6/23 specimens; 26%), but the proportion was similar in pregnancies with only Zika virus RNA detected in specimens other than amniotic fluid (10/23 specimens; 43%). Although Zikaassociated birth defects were more common among women with any Zika virus RNA detected in amniotic fluid specimens (ie, collected prenatally or at delivery; 21/43 specimens; 49%) than those with no laboratory evidence of Zika virus infection (6/23 specimens; 26%), this comparison did not reach statistical significance (P=.07).
   CONCLUSION: Testing of amniotic fluid provided additional evidence for maternal diagnosis of Zika virus infection. Zika-associated birth defects were more common among women with Zika virus RNA that was detected in prenatal amniotic fluid specimens than women with no laboratory evidence of Zika virus infection, but similar to women with Zika virus RNA detected in other, nonamniotic fluid specimen types.
C1 [Mercado, Marcela; Rico, Angelica; Gonzalez, Maritza; Ospina, Martha L.] Inst Nacl Salud, Bogota, Colombia.
   [Ailes, Elizabeth C.; Tong, Van T.; Valencia, Diana; Galang, Romeo R.; Anderson, Kayla N.; Burke, Veronica K.; Meaney-Delman, Dana; Gilboa, Suzanne M.; Honein, Margaret A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Ricaldi, Jessica N.] Ctr Dis Control & Prevent, Lab Leadership Serv, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA.
   [Anderson, Kayla N.] Ctr Dis Control & Prevent, Epidem Intelligence Serv, Atlanta, GA USA.
   [Kama, Nazia; Thomas, Jennifer D.; Villanueva, Julie] Ctr Dis Control & Prevent, Div Preparedness & Emerging Infect, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA USA.
   [Daza, Marcela; Osorio, Johana] Vysnova Partners, Res Div, Bethesda, MD USA.
   [Burke, Veronica K.] Eagle Med Serv LLC, Atlanta, GA USA.
   [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Gynecol & Obstet, Atlanta, GA USA.
RP Ailes, EC (corresponding author), Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
EM eailes@cdc.gov
OI Daza, Marcela/0000-0003-4592-2685
FU Office of Infectious Disease, Bureau for Global Health, US Agency for
   International Development (USAID)United States Agency for International
   Development (USAID); CDCUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA;  [NU2GGH001732]
FX Supported by the Office of Infectious Disease, Bureau for Global Health,
   US Agency for International Development (USAID), under the terms of an
   Interagency Agreement with CDC and funding by CDC; support for national
   surveillance efforts was supported through cooperative agreement to
   Vysnova Partners, Inc (NU2GGH001732).
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752
   Besnard M, 2014, EURO SURVEILL, V19
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2017, TRIOPL REAL TIM RT P
   Centers for Disease Control and Prevention, 2016, GUID US LAB TEST ZIK
   Centers for Disease Control and Prevention, GUID US LAB TEST ZIK
   Carvalho FHC, 2016, PRENATAL DIAG, V36, P882, DOI 10.1002/pd.4882
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto Nacional de Salud, NEW GUID STRENGTH LA
   Instituto Nacional de Salud, PUBL HLTH SURV PROT
   Instituto Nacional de Salud, PUBL HLTH SURV PROT
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Cuevas EL, 2016, MMWR-MORBID MORTAL W, V65, P1409, DOI 10.15585/mmwr.mm6549e1
   Lozier MJ, 2018, CLIN INFECT DIS, V67, P624, DOI 10.1093/cid/ciy209
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Olson SM, 2019, BIRTH DEFECTS RES, V111, P938, DOI 10.1002/bdr2.1546
   Pan American Health Organization, 2017, COL ZIK EP REP, V2018
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pereira JP, 2019, CLIN INFECT DIS, V69, P713, DOI 10.1093/cid/ciz013
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3
   Reagan-Steiner S, 2017, MMWR-MORBID MORTAL W, V66, P636, DOI 10.15585/mmwr.mm6624a3
   Revello MG, 2004, J CLIN VIROL, V29, P71, DOI 10.1016/j.jcv.2003.09.012
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rodo C, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.02.008
   Rodo C, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.022
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Schaub B, 2017, LANCET CHILD ADOLESC, V1, P45, DOI 10.1016/S2352-4642(17)30001-9
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
NR 42
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0002-9378
EI 1097-6868
J9 AM J OBSTET GYNECOL
JI Am. J. Obstet. Gynecol.
PD JUN
PY 2020
VL 222
IS 6
DI 10.1016/j.ajog.2020.01.009
PG 13
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LT8LD
UT WOS:000537318500021
PM 31954155
DA 2020-07-08
ER

PT J
AU Pearson, MA
   Blore, K
   Efstathion, C
   Aryaprema, VS
   Muller, GC
   Xue, RD
   Qualls, WA
AF Pearson, Mandi A.
   Blore, Kai
   Efstathion, Caroline
   Aryaprema, Vindhya S.
   Muller, Gunter C.
   Xue, Rui-De
   Qualls, Whitney A.
TI Evaluation of boric acid as toxic sugar bait against resistant Aedes
   aegypti mosquitoes
SO JOURNAL OF VECTOR ECOLOGY
LA English
DT Article
DE Toxic sugar bait; Aedes aegypti; insecticide resistance; sugar-feeding;
   integrated vector management
ID NONTARGET ORGANISMS; DIPTERA-CULICIDAE; ZIKA VIRUS; ALBOPICTUS; ATSB;
   OUTBREAK; FLORIDA; IMPACT
AB Current methods of broad area application of contact insecticides used in mosquito control are becoming less effective, primarily due to resistance within mosquito populations. New methods that can deliver ingestible insecticides are being investigated as a means to mitigate resistance. This study evaluated insecticide delivery through toxic sugar baits (TSB) and resulting mortality of susceptible and resistant strains of Aedes aegypti. Two Ae. aegypti strains were evaluated using a 1% boric acid TSB: the susceptible Orlando 1952 (ORL) strain and the resistant Puerto Rican (PR) strain. The TSB resulted in high mortality for both ORL and PR strain of Ae. aegypti. Average mortality of female mosquitoes given TSB was 90.8% for PR and 99.3% for ORL. Our study suggests that targeting resistant mosquitoes with ingestible insecticides through TSBs could be a viable alternative to current mosquito control strategies and should be considered when developing an integrated vector management program.
C1 [Pearson, Mandi A.; Blore, Kai; Efstathion, Caroline; Aryaprema, Vindhya S.; Xue, Rui-De; Qualls, Whitney A.] Anastasia Mosquito Control Dist, 120 EOC Dr, St Augustine, FL USA.
   [Muller, Gunter C.] Univ Sci Tech & Technol Bamako, Fac Med Pharm & Odontostomatol, Malaria Res & Training Ctr, BP 1805, Bamako, Mali.
RP Qualls, WA (corresponding author), Anastasia Mosquito Control Dist, 120 EOC Dr, St Augustine, FL USA.
EM quallsamcd@bellsouth.net
FU Center for Disease Control and Prevention Southeastern Regional Center
   of Excellence in Vector Borne Disease: The Gateway Program (CDC grant)
   [1U01CK00510-01]
FX We acknowledge the Center for Disease Control and Prevention
   Southeastern Regional Center of Excellence in Vector Borne Disease: The
   Gateway Program for providing funding in part to complete this study
   (CDC grant 1U01CK00510-01). The CDC had no role in the design of the
   study, the collection, analysis, and interpretation of data, or in
   writing the manuscript. We thank Lea Bangonan for providing assistance
   to complete this project. This is a research report only and specific
   mention of any commercial products does not imply endorsement by the
   Anastasia Mosquito Control District.
CR Barbosa DS, 2019, TROP BIOMED, V36, P578
   Cornel Anthony J, 2016, F1000Res, V5, P194, DOI 10.12688/f1000research.8107.2
   Estep AS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006544
   Estep AS, 2017, J MED ENTOMOL, V54, P1643, DOI 10.1093/jme/tjx143
   Fiorenzano JM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040398
   Furnival-Adams JEC, 2020, MALARIA J, V19, DOI 10.1186/s12936-019-3095-1
   Gu Z.Y., 2019, ACTA TROP, DOI [10.1016/j.actatropica.2019.105256, DOI 10.1016/J.ACTATR0PICA.2019.105256]
   Hossain TT, 2014, FLA ENTOMOL, V97, P1865, DOI 10.1653/024.097.0469
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Naranjo DP, 2013, PARASITOL RES, V112, P1583, DOI 10.1007/s00436-013-3312-8
   Qualls WA, 2014, ACTA TROP, V131, P104, DOI 10.1016/j.actatropica.2013.12.004
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Revay EE, 2014, PARASITOL RES, V113, P73, DOI 10.1007/s00436-013-3628-4
   Scott-Fiorenzano JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1937-z
   Stewart ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084168
   Xue RD, 2008, J AM MOSQUITO CONTR, V24, P415, DOI 10.2987/5683.1
   Xue RD, 2006, J AM MOSQUITO CONTR, V22, P497, DOI 10.2987/8756-971X(2006)22[497:AOBABT]2.0.CO;2
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
NR 18
TC 0
Z9 0
U1 1
U2 1
PU SOC VECTOR ECOLOGY
PI CORONA
PA 1966 COMPTON AVE, CORONA, CA 92881 USA
SN 1081-1710
EI 1948-7134
J9 J VECTOR ECOL
JI J. Vector Ecol.
PD JUN
PY 2020
VL 45
IS 1
BP 100
EP 103
DI 10.1111/jvec.12377
PG 4
WC Entomology
SC Entomology
GA LU1YI
UT WOS:000537557000011
PM 32492274
OA Bronze
DA 2020-07-08
ER

PT J
AU Merriam, AA
   Nhan-Chang, CL
   Huerta-Bogdan, BI
   Wapner, R
   Gyamfi-Bannerman, C
AF Merriam, Audrey A.
   Nhan-Chang, Chia-Ling
   Huerta-Bogdan, B. Isabel
   Wapner, Ronald
   Gyamfi-Bannerman, Cynthia
TI A Single-Center Experience with a Pregnant Immigrant Population and Zika
   Virus Serologic Screening in New York City
SO AMERICAN JOURNAL OF PERINATOLOGY
LA English
DT Article
DE Zika virus; immigrant population; ultrasound; perinatal; infection;
   screening
ID UNITED-STATES; INFECTION; HEAD; FETUSES; INFANTS; WEIGHT; BIRTH; WOMEN
AB Objective Our institution is in an area of New York City with a large population of immigrants from Zika virus endemic areas. With the recent Zika virus outbreak, we sought to examine our center's experience with screening for Zika virus and outcomes among patients who tested positive for the disease during pregnancy.
   Study Design We performed a chart review of all pregnant patients who tested positive (positive serum or urine polymerase chain reaction [PCR]) or presumed positive (immunoglobulin M [IgM] enzyme-linked immunosorbent assay [ELISA] positive or IgM ELISA equivocal with positive plaque reduction neutralization test) for Zika virus. All tests were performed by the Department of Health (DOH) and followed Centers for Disease Control and Prevention guidelines in effect at the time of specimen collection. Testing of cord blood, placenta, and/or neonatal blood were/was performed by the DOH for New York County. Prenatal ultrasounds for fetal head size and surveillance for calcifications were performed by maternal-fetal medicine specialists. Infant head ultrasound results were included when available.
   Results Between March 2016 and April 2017, 70 pregnant patients were positive or presumed positive for Zika infection during pregnancy. Of those, 16 women had positive urine or serum PCR and the remaining 54 were presumed positive. Among positive cases, five women tested positive via urine PCR only, nine women tested positive via serum PCR only, and two women had both positive urine and serum PCR. Fifteen of 67 infants (22%) born during the study period were born to mothers with positive urine or serum PCR testing. Sixty-five newborns were clinically normal with normal head measurements. Of the intracranial ultrasound performed, one infant had a grade 1 intraventricular hemorrhage, four had incidental choroid plexus cysts, and one had severe ventriculomegaly that was also noted antenatally. There were 2 positive and 15 equivocal infant serum IgM samples and 1 positive placental PCR from these pregnancies. There were four pregnancy terminations and two cases with fetal anomalies in this population that were split evenly between patients who tested positive and those who tested presumed positive for Zika virus during pregnancy.
   Conclusion We found no differences in pregnancy or neonatal outcomes between women who tested positive and presumed positive for Zika virus during pregnancy. Testing of infants and placenta tissue after delivery was largely inconclusive. Improvement in testing for Zika virus infection is needed to determine which pregnancies are at risk for congenital anomalies. Further research is still needed to determine which children are at risk for poor neurodevelopmental outcomes related to Zika virus and how to best coordinate care among the immigrant population during a new disease epidemic.
C1 [Merriam, Audrey A.; Nhan-Chang, Chia-Ling; Huerta-Bogdan, B. Isabel; Wapner, Ronald; Gyamfi-Bannerman, Cynthia] Columbia Univ, Coll Phys & Surg, Dept Obstet & Gynecol, New York, NY USA.
RP Merriam, AA (corresponding author), Yale Univ, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Fetal Med, Sch Med, POB 208062, New Haven, CT 06520 USA.
EM audrey.merriam@yale.edu
CR Alexander GR, 1996, OBSTET GYNECOL, V87, P163, DOI 10.1016/0029-7844(95)00386-X
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Barbier A, 2013, PEDIATRICS, V131, pE1158, DOI 10.1542/peds.2011-3846
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   HADLOCK FP, 1985, AM J OBSTET GYNECOL, V151, P333, DOI 10.1016/0002-9378(85)90298-4
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Parra-Saavedra M, 2017, OBSTET GYNECOL, V130, P207, DOI 10.1097/AOG.0000000000002105
   Rao R, 2017, OBSTET GYNECOL, V129, P1098, DOI 10.1097/AOG.0000000000002049
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sanz Cortes M, 2018, AM J OBSTET GYNECOL, V218, p440e1
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
NR 19
TC 0
Z9 0
U1 1
U2 1
PU THIEME MEDICAL PUBL INC
PI NEW YORK
PA 333 SEVENTH AVE, NEW YORK, NY 10001 USA
SN 0735-1631
EI 1098-8785
J9 AM J PERINAT
JI Am. J. Perinatol.
PD JUN
PY 2020
VL 37
IS 7
BP 731
EP 737
DI 10.1055/s-0039-1688819
PG 7
WC Obstetrics & Gynecology; Pediatrics
SC Obstetrics & Gynecology; Pediatrics
GA LS9DS
UT WOS:000536679800010
PM 31146294
DA 2020-07-08
ER

PT J
AU Sobhani, NC
   Avvad-Portari, E
   Nascimento, ACM
   Machado, HN
   Lobato, DSS
   Pereira, JP
   Esquivel, MS
   Vasconcelos, ZC
   Zin, AA
   Tsui, I
   Adachi, K
   Brickley, EB
   Fisher, SJ
   Nielsen-Saines, K
   Brasil, P
   Moreira, ME
   Gaw, SL
AF Sobhani, Nasim C.
   Avvad-Portari, Elyzabeth
   Nascimento, Aline C. M.
   Machado, Heloisa N.
   Lobato, Daniel S. S.
   Pereira, Jose Paulo
   Esquivel, Mikaela S.
   Vasconcelos, Zilton C.
   Zin, Andrea A.
   Tsui, Irena
   Adachi, Kristina
   Brickley, Elizabeth B.
   Fisher, Susan J.
   Nielsen-Saines, Karin
   Brasil, Patricia
   Moreira, Maria E.
   Gaw, Stephanie L.
TI Discordant Zika Virus Findings in Twin Pregnancies Complicated by
   Antenatal Zika Virus Exposure: A Prospective Cohort
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE congenital Zika syndrome; perinatal infection; TORCH infection; twin;
   vertical transmission
ID PLACENTAL PATHOLOGY; INFECTION; CELLS; INFANTS
AB Background. There are limited data on the natural history of antenatal Zika virus (ZIKV) exposure in twin pregnancies, especially regarding intertwin concordance of prenatal, placental, and infant outcomes.
   Methods. This prospective cohort study included twin pregnancies referred to a single institution from September 2015 to June 2016 with maternal ZIKV. Polymerase chain reaction (PCR) testing of maternal, placental, and neonatal samples was performed. Prenatal ultrasounds were completed for each twin, and histomorphologic analysis was performed for each placenta. Abnormal neonatal outcome was defined as abnormal exam and/or abnormal imaging. Two- to three-year follow-up of infants included physical exams, neuroimaging, and Bayley-III developmental assessment.
   Results. Among 244 pregnancies, 4 twin gestations without coinfection were identified. Zika virus infection occurred at 16-33 weeks gestation. Zika virus PCR testing revealed discordance between dichorionic twins, between placentas in a dichorionic pair, between portions of a monochorionic placenta, and between a neonate and its associated placenta. Of the 8 infants, 3 (38%) had an abnormal neonatal outcome. Of 6 infants with long-term follow-up, 3 (50%) have demonstrated ZIKV-related abnormalities.
   Conclusions. Neonatal PCR testing, placental findings, and infant outcomes can be discordant between co-twins with antenatal ZIKV exposure. These findings demonstrate that each twin should be evaluated independently for vertical transmission.
C1 [Sobhani, Nasim C.; Esquivel, Mikaela S.; Fisher, Susan J.; Gaw, Stephanie L.] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, Div Maternal Fetal Med, San Francisco, CA USA.
   [Avvad-Portari, Elyzabeth; Nascimento, Aline C. M.; Machado, Heloisa N.; Lobato, Daniel S. S.; Pereira, Jose Paulo; Vasconcelos, Zilton C.; Zin, Andrea A.; Brasil, Patricia; Moreira, Maria E.] Fiocruz MS, Fernandes Figueira Inst, Rio De Janeiro, Brazil.
   [Tsui, Irena] Univ Calif Los Angeles, Jules Stein Eye Inst, Retina Div, Los Angeles, CA 90024 USA.
   [Adachi, Kristina; Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Div Pediat Infect Dis, Los Angeles, CA 90024 USA.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London, England.
RP Gaw, SL (corresponding author), Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, 513 Parnassus Ave,Box 0556 16HSE, San Francisco, CA 94143 USA.
EM stephanie.gaw@ucsf.edu
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [K08AI141728]; Foundation for the Society of
   MaternalFetal Medicine Queenan Fellowship for Global Health; National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID) [R21AI28697,
   R21AI129534]; National Eye Institute (NEI)United States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Eye Institute (NEI) [R21EY028318]; Brazilian Ministry of
   Health; Wellcome TrustWellcome Trust [205377/Z/16/Z]; UK's Department
   for International Development [205377/Z/16/Z]; European UnionEuropean
   Union (EU) [734584]; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ); Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ
FX This work was funded by the following: National Institute of Allergy and
   Infectious Diseases (NIAID) (K08AI141728) and the Foundation for the
   Society of Maternal Fetal Medicine Queenan Fellowship for Global Health
   (to S. L. G.); generous support from Marc and Lynne Benioff (to S. J.
   F.); National Institute of Allergy and Infectious Diseases (R21AI28697
   and R21AI129534) and National Eye Institute (NEI) (R21EY028318) (to K.
   N.-S.); the Brazilian Ministry of Health (to P. B. and M. E. M.);
   Wellcome Trust and the UK's Department for International Development
   (205377/Z/16/Z; to M. E. M. and E. B.); the European Union's Horizon
   2020 Research and Innovation Programme under ZikaPLAN grant agreement
   number 734584 and FAPERJ (to M. E. M.); and the Program for Research
   Incentives (PIP)/Fernandes Figueira Institute/FIOCRUZ (EAP).
CR AHLFORS K, 1988, EARLY HUM DEV, V18, P125, DOI 10.1016/0378-3782(88)90049-7
   Ballot DE, 2017, INT SCH RES NOTICES, V2017, DOI DOI 10.1155/2017/1631760
   BAYLEY N, 1965, CHILD DEV, V36, P379, DOI 10.2307/1126464
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03497-1
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Dickinson JE, 2006, TWIN RES HUM GENET, V9, P456, DOI 10.1375/183242706777591353
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Harteman JC, 2013, J PEDIATR-US, V163, P968, DOI 10.1016/j.jpeds.2013.06.010
   Higgins M, 2011, PEDIATR DEVEL PATHOL, V14, P273, DOI 10.2350/10-07-0872-OA.1
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Kim JS, 2008, HISTOPATHOLOGY, V52, P457, DOI 10.1111/j.1365-2559.2008.02964.x
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Pereira L, 2017, PLACENTA, V59, pS8, DOI 10.1016/j.placenta.2017.04.020
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Redline RW, 2015, AM J OBSTET GYNECOL, V213, pS21, DOI 10.1016/j.ajog.2015.05.056
   Reyes L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02628
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Satosar A, 2004, HUM PATHOL, V35, P536, DOI 10.1016/j.humpath.2004.01.015
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tabata T, 2015, J VIROL, V89, P5134, DOI 10.1128/JVI.03674-14
   Thapa R, 2009, INDIAN J PEDIATR, V76, P1069, DOI 10.1007/s12098-009-0208-9
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 27
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD JUN 1
PY 2020
VL 221
IS 11
BP 1838
EP 1845
DI 10.1093/infdis/jiz629
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LU0MN
UT WOS:000537458000014
PM 31773163
DA 2020-07-08
ER

PT J
AU Sandler, ZJ
   Firpo, MR
   Omoba, OS
   Vu, MN
   Menachery, VD
   Mounce, BC
AF Sandler, Zachary J.
   Firpo, Mason R.
   Omoba, Oreoluwa S.
   Vu, Michelle N.
   Menachery, Vineet D.
   Mounce, Bryan C.
TI Novel Ionophores Active against La Crosse Virus Identified through Rapid
   Antiviral Screening
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE bunyaviruses; La Crosse virus; antivirals; ionophores
ID VALLEY FEVER VIRUS; AEDES-ALBOPICTUS; REPLICATION; INHIBITORS;
   INFECTION; VALINOMYCIN; CHIKUNGUNYA; TRISERIATUS; DEPENDENCE; MEMBRANE
AB Bunyaviruses are significant human pathogens, causing diseases ranging from hemorrhagic fevers to encephalitis. Among these viruses, La Crosse virus (LACV), a member of the California serogroup, circulates in the eastern and midwestern United States. While LACV infection is often asymptomatic, dozens of cases of encephalitis are reported yearly. Unfortunately, no antivirals have been approved to treat LACV infection. Here, we developed a method to rapidly test potential antivirals against LACV infection. From this screen, we identified several potential antiviral molecules, including known antivirals. Additionally, we identified many novel antivirals that exhibited antiviral activity without affecting cellular viability. Valinomycin, a potassium ionophore, was among our top targets. We found that valinomycin exhibited potent anti-LACV activity in multiple cell types in a dose-dependent manner. Valinomycin did not affect particle stability or infectivity, suggesting that it may preclude virus replication by altering cellular potassium ions, a known determinant of LACV entry. We extended these results to other ionophores and found that the antiviral activity of valinomycin extended to other viral families, including bunyaviruses (Rift Valley fever virus, Keystone virus), enteroviruses (coxsackievirus, rhinovirus), flavirivuses (Zika virus), and coronaviruses (human coronavirus 229E [HCoV-229E] and Middle East respiratory syndrome CoV [MERS-CoV]). In all viral infections, we observed significant reductions in virus titer in valinomycin-treated cells. In sum, we demonstrate the importance of potassium ions to virus infection, suggesting a potential therapeutic target to disrupt virus replication.
C1 [Sandler, Zachary J.; Firpo, Mason R.; Omoba, Oreoluwa S.; Mounce, Bryan C.] Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.
   [Sandler, Zachary J.; Omoba, Oreoluwa S.; Mounce, Bryan C.] Loyola Univ Chicago, Stritch Sch Med, Infect Dis & Immunol Res Inst, Maywood, IL 60153 USA.
   [Vu, Michelle N.; Menachery, Vineet D.] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA.
   [Menachery, Vineet D.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Mounce, BC (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA.; Mounce, BC (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Infect Dis & Immunol Res Inst, Maywood, IL 60153 USA.
EM bmounce@luc.edu
OI Menachery, Vineet/0000-0001-8803-7606
FU National Institute of Allergy and Infectious Diseases (NIAID) of the
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [U19AI100625]; STARs award by University of
   Texas System; Graduate School of Biomedical Sciences at UTMB
FX This research was supported by a grant from the National Institute of
   Allergy and Infectious Diseases (NIAID) of the NIH (U19AI100625 to
   V.D.M.). The research was also supported by a STARs award provided by
   the University of Texas System to V.D.M. and trainee funding provided by
   the Graduate School of Biomedical Sciences at UTMB.
CR Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   BEDOWS E, 1982, J NAT PROD, V45, P725, DOI 10.1021/np50024a015
   Berka U, 2009, J VIROL, V83, P3778, DOI 10.1128/JVI.01739-08
   Bermejo M, 2016, BIOCHEM PHARMACOL, V106, P30, DOI 10.1016/j.bcp.2016.02.002
   Bewick S, 2016, EMERG INFECT DIS, V22, P1921, DOI 10.3201/eid2211.160308
   BIZIAGOS E, 1987, J MED VIROL, V22, P57, DOI 10.1002/jmv.1890220108
   CAPLEN H, 1985, J GEN VIROL, V66, P2271, DOI 10.1099/0022-1317-66-10-2271
   CDC, 2019, CROSS ENC EP GEOGR D
   Charlton FW, 2019, J BIOL CHEM, V294, P7335, DOI 10.1074/jbc.RA119.007618
   Curren EJ, 2018, MMWR-MORBID MORTAL W, V67, P1137, DOI 10.15585/mmwr.mm6741a1
   de Wispelaere M, 2013, J VIROL, V87, P7367, DOI 10.1128/JVI.00632-13
   Deng L, 2007, J VIROL, V81, P13392, DOI 10.1128/JVI.00770-07
   do Carmo Lagrota M H, 1986, Rev Latinoam Microbiol, V28, P221
   Dong SZ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007681
   Evans AB, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090794
   Faburay B, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030029
   FESEN MR, 1993, P NATL ACAD SCI USA, V90, P2399, DOI 10.1073/pnas.90.6.2399
   FRUGULHETTI ICPP, 1989, J GEN VIROL, V70, P3493, DOI 10.1099/0022-1317-70-12-3493
   Furuta A, 2015, INT J MOL SCI, V16, P18439, DOI 10.3390/ijms160818439
   Garcia-Serradilla M, 2019, VIRUS RES, V264, P22, DOI 10.1016/j.virusres.2019.02.011
   HAFURI Y, 1988, J ANTIBIOT, V41, P1471, DOI 10.7164/antibiotics.41.1471
   Hammond TG, 1998, J MEMBRANE BIOL, V162, P157, DOI 10.1007/s002329900353
   Hover S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006845
   Huang Q, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1639-8
   Ikegami T, 2006, J VIROL, V80, P2933, DOI 10.1128/JVI.80.6.2933-2940.2006
   Ikegami T, 2017, EXPERT REV VACCINES, V16, P601, DOI 10.1080/14760584.2017.1321482
   Irurzun A, 2001, BIOCHEMISTRY-US, V40, P3589, DOI 10.1021/bi002069p
   Jackson BT, 2012, J MED ENTOMOL, V49, P1424, DOI 10.1603/ME12023
   Johnson BA, 2019, J VIROL, V93, DOI 10.1128/JVI.01282-19
   Jung E, 2018, BIOORG MED CHEM LETT, V28, P2533, DOI 10.1016/j.bmcl.2018.05.046
   Lang YK, 2019, VET MICROBIOL, V230, P110, DOI 10.1016/j.vetmic.2019.01.027
   Lou ZY, 2014, TRENDS PHARMACOL SCI, V35, P86, DOI 10.1016/j.tips.2013.11.006
   LUKACS GL, 1992, J BIOL CHEM, V267, P14568
   Matter AM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007194
   Mercorelli B, 2018, TRENDS MICROBIOL, V26, P865, DOI 10.1016/j.tim.2018.04.004
   Micewicz ED, 2018, BIOORG MED CHEM LETT, V28, P452, DOI 10.1016/j.bmcl.2017.12.019
   Min BS, 2002, ARCH PHARM RES, V25, P441, DOI 10.1007/BF02976598
   MOSE JR, 1980, ARZNEIMITTELFORSCH, V30-2, P1571
   Norris MJ, 2018, AM J RESP CELL MOL, V59, P733, DOI 10.1165/rcmb.2017-0345OC
   Park SW, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-171
   Promsong A, 2018, ORAL DIS, V24, P249, DOI 10.1111/odi.12835
   Punch EK, 2018, J BIOL CHEM, V293, P9937, DOI 10.1074/jbc.RA118.002494
   Sacau EP, 2003, BIOORGAN MED CHEM, V11, P483, DOI 10.1016/S0968-0896(02)00542-4
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Shin MS, 2005, ANTIVIR RES, V67, P163, DOI 10.1016/j.antiviral.2005.06.005
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Westby KM, 2015, J AM MOSQUITO CONTR, V31, P233, DOI 10.2987/moco-31-03-233-241.1
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu CY, 2004, P NATL ACAD SCI USA, V101, P10012, DOI 10.1073/pnas.0403596101
NR 49
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUN
PY 2020
VL 64
IS 6
AR e00086-20
DI 10.1128/AAC.00086-20
PG 12
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA LR8KV
UT WOS:000535946300004
PM 32284379
DA 2020-07-08
ER

PT J
AU Basch, CH
   Fera, J
   Garcia, P
AF Basch, Corey H.
   Fera, Joseph
   Garcia, Philip
TI Information regarding Zika virus on the Internet: A cross-sectional
   study of readability
SO AMERICAN JOURNAL OF INFECTION CONTROL
LA English
DT Article
DE On-line material; Infectious disease; Health literacy; Reading level
AB The purpose of this study was to determine the readability of 100 articles posted on the Internet related to the Zika virus. An on-line readability calculator was used to generate scores on each website from 5 readability tests. Most of the material analyzed was written at a level beyond grade 10. The data in this study make a compelling case that websites containing information on the Zika virus are being written at levels beyond what is recommended. It would behoove those who create health information to consider ways to adapt their materials in a way that is consistent with recommended readability levels. (C) 2019 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved.
C1 [Basch, Corey H.; Garcia, Philip] William Paterson Univ, Dept Publ Hlth, Univ Hall 366, Wayne, NJ 07470 USA.
   [Fera, Joseph] CUNY, Dept Math, Lehman Coll, Bronx, NY USA.
RP Basch, CH (corresponding author), William Paterson Univ, Dept Publ Hlth, Univ Hall 366, Wayne, NJ 07470 USA.
EM baschc@wpunj.edu
CR Basch CH, 2019, AM J INFECT CONTROL, V47, P1298, DOI 10.1016/j.ajic.2019.04.178
   Centers for Disease Control and Prevention, 2019, ZIKA US
   Fox S, 2019, NATL SURVEY PEW RES
   McKenzie J.F., 2016, PLANNING IMPLEMENTIN
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Wood MJ, 2018, CYBERPSYCH BEH SOC N, V21, P485, DOI 10.1089/cyber.2017.0669
NR 6
TC 0
Z9 0
U1 1
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0196-6553
EI 1527-3296
J9 AM J INFECT CONTROL
JI Am. J. Infect. Control
PD JUN
PY 2020
VL 48
IS 6
BP 714
EP 715
DI 10.1016/j.ajic.2019.11.014
PG 2
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA LR7GQ
UT WOS:000535862500023
PM 31862166
DA 2020-07-08
ER

PT J
AU Carbaugh, DL
   Lazear, HM
AF Carbaugh, Derek L.
   Lazear, Helen M.
TI Flavivirus Envelope Protein Glycosylation: Impacts on Viral Infection
   and Pathogenesis
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE DC-SIGN; DC-SIGNR; flavivirus; West Nile virus; Zika virus; dengue
   virus; glycosylation
ID TICK-BORNE ENCEPHALITIS; WEST-NILE-VIRUS; HUMAN DENDRITIC CELLS; MURRAY
   VALLEY ENCEPHALITIS; N-LINKED GLYCOSYLATION; WATER-SOLUBLE ANALOG;
   DENGUE VIRUS; ZIKA VIRUS; DC-SIGN; IN-VITRO
AB Flaviviruses encode one, two, or no N-linked glycosylation sites on their envelope proteins. Glycosylation can impact virus interactions with cell surface attachment factors and also may impact virion stability and virus replication. Envelope protein glycosylation has been identified as a virulence determinant for multiple flaviviruses, but the mechanisms by which glycosylation mediates pathogenesis remain unclear. In this Gem, we summarize current knowledge on flavivirus envelope protein glycosylation and its impact on viral infection and pathogenesis.
C1 [Carbaugh, Derek L.; Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
RP Lazear, HM (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.
EM helen.lazear@med.unc.edu
OI Carbaugh, Derek/0000-0002-5721-7097; Lazear, Helen/0000-0002-8649-4579
FU  [R21AI129431];  [R01AI139512];  [T32AI007419]
FX This work was supported by grants R21AI129431 and R01AI139512 to H.M.L.
   D.L.C. was supported by grant T32AI007419.
CR Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001
   Alen MMF, 2012, ANTIVIR RES, V96, P280, DOI 10.1016/j.antiviral.2012.10.007
   Alsaleh K, 2016, VIROLOGY, V492, P53, DOI 10.1016/j.virol.2016.02.009
   An YM, 2019, J VIROL, V93, DOI 10.1128/JVI.01693-18
   Angenvoort J, 2013, VET MICROBIOL, V167, P168, DOI 10.1016/j.vetmic.2013.08.013
   Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   Banet-Noach C, 2003, AVIAN PATHOL, V32, P489, DOI 10.1080/0307945031000154080
   Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005
   Benzarti E, 2019, J GEN VIROL, V100, P119, DOI 10.1099/jgv.0.001203
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Brockmann SO, 2018, EUROSURVEILLANCE, V23, P8, DOI 10.2807/1560-7917.ES.2018.23.15.17-00336
   Broom AK, 2003, AM J TROP MED HYG, V69, P277, DOI 10.4269/ajtmh.2003.69.277
   Bryant JE, 2007, VIROLOGY, V366, P415, DOI 10.1016/j.virol.2007.05.007
   BUTTERS TD, 1981, BIOCHIM BIOPHYS ACTA, V640, P672, DOI 10.1016/0005-2736(81)90097-3
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Chambers TJ, 1999, J VIROL, V73, P3095, DOI 10.1128/JVI.73.4.3095-3101.1999
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen WT, 2017, J VIROL METHODS, V249, P10, DOI 10.1016/j.jviromet.2017.08.002
   Davis CW, 2006, J BIOL CHEM, V281, P37183, DOI 10.1074/jbc.M605429200
   Davis CW, 2006, J VIROL, V80, P1290, DOI 10.1128/JVI.80.3.1290-1301.2006
   de la Fuente J, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00114
   Dinglasan RR, 2005, INFECT IMMUN, V73, P7797, DOI 10.1128/IAI.73.12.7797-7807.2005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Garmendia AE, 2001, MICROBES INFECT, V3, P223, DOI 10.1016/S1286-4579(01)01374-0
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Goto A, 2005, VACCINE, V23, P3043, DOI 10.1016/j.vaccine.2004.11.068
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Hacker K, 2009, J GEN VIROL, V90, P2097, DOI 10.1099/vir.0.012120-0
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hadfield J, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008042
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   HSIEH P, 1984, J BIOL CHEM, V259, P2375
   HSIEH P, 1983, J BIOL CHEM, V258, P2548
   Hudopisk N, 2013, EMERG INFECT DIS, V19, P806, DOI 10.3201/eid1905.121442
   JOHNSON AJ, 1994, VIROLOGY, V203, P241, DOI 10.1006/viro.1994.1481
   Jolly CL, 2013, ADV EXP MED BIOL, V790, P1, DOI 10.1007/978-1-4614-7651-1_1
   Khoo US, 2008, J MOL MED, V86, P861, DOI 10.1007/s00109-008-0350-2
   Kilpatrick AM, 2019, J MED ENTOMOL, V56, P1491, DOI 10.1093/jme/tjz149
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Ladner JT, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00377-16
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Li XS, 2015, J CLIN MICROBIOL, V53, P2734, DOI 10.1128/JCM.00770-15
   Liang JJ, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00239
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Llorente F, 2015, VET RES, V46, DOI 10.1186/s13567-015-0233-9
   LOBIGS M, 1988, VIROLOGY, V165, P245, DOI 10.1016/0042-6822(88)90678-2
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Maharaj PD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007473
   MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989
   Martina BEE, 2008, VIRUS RES, V135, P64, DOI 10.1016/j.virusres.2008.02.008
   May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Mossenta M, 2017, BIOCHEM BIOPH RES CO, V492, P579, DOI 10.1016/j.bbrc.2017.01.022
   Moudy RM, 2009, VIROLOGY, V387, P222, DOI 10.1016/j.virol.2009.01.038
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   Pletnev AG, 2000, VIROLOGY, V274, P26, DOI 10.1006/viro.2000.0426
   PLETNEV AG, 1993, J VIROL, V67, P4956, DOI 10.1128/JVI.67.8.4956-4963.1993
   Pletnev AG, 2002, P NATL ACAD SCI USA, V99, P3036, DOI 10.1073/pnas.022652799
   Pokidysheva E, 2006, CELL, V124, P485, DOI 10.1016/j.cell.2005.11.042
   POST PR, 1992, VIROLOGY, V188, P160, DOI 10.1016/0042-6822(92)90745-B
   Prow NA, 2011, J GEN VIROL, V92, P2286, DOI 10.1099/vir.0.034793-0
   Rendic D, 2008, CROAT CHEM ACTA, V81, P7
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   RUSH JS, 1995, J CELL BIOL, V130, P529, DOI 10.1083/jcb.130.3.529
   Rush JS, 1998, GLYCOBIOLOGY, V8, P1195, DOI 10.1093/glycob/8.12.1195
   Shi XZ, 2007, CURR DRUG TARGETS, V8, P1116, DOI 10.2174/138945007782151360
   Shirato K, 2004, J GEN VIROL, V85, P3637, DOI 10.1099/vir.0.80247-0
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Wang P, 2016, VIROLOGY, V488, P108, DOI 10.1016/j.virol.2015.11.006
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   WINKLER G, 1987, VIROLOGY, V159, P237, DOI 10.1016/0042-6822(87)90460-0
   Yan DW, 2018, J VIROL, V92, DOI [10.1128/jvi.00427-18, 10.1128/JVI.00427-18]
   Yap SSL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01415
   Yoshii K, 2013, J GEN VIROL, V94, P2249, DOI 10.1099/vir.0.055269-0
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
NR 87
TC 0
Z9 0
U1 4
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2020
VL 94
IS 11
AR e00104-20
DI 10.1128/JVI.00104-20
PG 10
WC Virology
SC Virology
GA LP8YJ
UT WOS:000534602800007
PM 32161171
OA Bronze
DA 2020-07-08
ER

PT J
AU Gurung, S
   Nadeau, H
   Maxted, M
   Peregrine, J
   Reuter, D
   Norris, A
   Edwards, R
   Hyatt, K
   Singleton, K
   Papin, JF
   Myers, DA
AF Gurung, Sunam
   Nadeau, Hugh
   Maxted, Marta
   Peregrine, Jamie
   Reuter, Darlene
   Norris, Abby
   Edwards, Rodney
   Hyatt, Kimberly
   Singleton, Krista
   Papin, James F.
   Myers, Dean A.
TI Maternal Zika Virus (ZIKV) Infection following Vaginal Inoculation with
   ZIKV-Infected Semen in Timed-Pregnant Olive Baboons
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika; baboon; fetus; flavivirus; placenta; pregnancy; primate; sexual
   transmission; vertical transfer; virus
ID VECTOR-BORNE TRANSMISSION; MALE SEXUAL TRANSMISSION; STATES
AB Zika virus (ZIKV) infection is now firmly linked to congenital Zika syndrome (CZS), including fetal microcephaly. While Aedes species of mosquito are the primary vector for ZIKV, sexual transmission of ZIKV is a significant route of infection. ZIKV has been documented in human, mouse, and nonhuman primate (NHP) semen. It is critical to establish NHP models of the vertical transfer of ZIKV that recapitulate human pathogenesis. We hypothesized that vaginal deposition of ZIKV-infected baboon semen would lead to maternal infection and vertical transfer in the olive baboon (Papio anubis). Epidemiological studies suggest an increased rate of CZS in the Americas compared to the original link to CZS in French Polynesia; therefore, we also compared the French Polynesian (FP) ZIKV isolate to the Puerto Rican (PR) isolate. Timed-pregnant baboons (n = 6) were inoculated via vaginal deposition of baboon semen containing 10(6) focus-forming units (FFU) of ZIKV (n = 3 for FP isolate H/PF/2013; n = 3 for PR isolate PRVABC59) at midgestation (86 to 95 days of gestation [dG]; term, 183 dG) on day 0 (all dams) and then at 7-day intervals through 3 weeks. Maternal blood, saliva, and cervicovaginal wash (CVW) samples were obtained. Animals were euthanized at 28 days (n = 5) or 39 days (n = 1) after the initial inoculation, and maternal/fetal tissues were collected. Viremia was achieved in 3/3 FP ZIKV-infected dams and 2/3 PR ZIKV-infected dams. ZIKV RNA was detected in CVW samples of 5/6 dams. ZIKV RNA was detected in lymph nodes but not the ovaries, uterus, cervix, or vagina in FP isolate-infected dams. ZIKV RNA was detected in lymph nodes (3/3), uterus (2/3), and vagina (2/3) in PR isolate-infected dams. Placenta, amniotic fluid, and fetal tissues were ZIKV RNA negative in the FP isolate-infected dams, whereas 2/3 PR isolate-infected dam placentas were ZIKV RNA positive. We conclude that ZIKV-infected semen is a means of ZIKV transmission during pregnancy in primates. The PR isolate appeared more capable of widespread dissemination to tissues, including reproductive tissues and placenta, than the FP isolate.
   IMPORTANCE Zika virus remains a worldwide health threat, with outbreaks still occurring in the Americas. While mosquitos are the primary vector for the spread of the virus, sexual transmission of Zika virus is also a significant means of infection, especially in terms of passage from an infected to an uninfected partner. While sexual transmission has been documented in humans, and male-to-female transmission has been reported in mice, ours is the first study in nonhuman primates to demonstrate infection via vaginal deposition of Zika virus-infected semen. The latter is important since a recent publication indicated that human semen inhibited, in a laboratory setting, Zika virus infection of reproductive tissues. We also found that compared to the French Polynesian isolate, the Puerto Rican Zika virus isolate led to greater spread throughout the body, particularly in reproductive tissues. The American isolates of Zika virus appear to have acquired mutations that increase their efficacy.
C1 [Gurung, Sunam; Nadeau, Hugh; Maxted, Marta; Peregrine, Jamie; Edwards, Rodney; Hyatt, Kimberly; Singleton, Krista; Myers, Dean A.] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA.
   [Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Oklahoma City, OK USA.
   [Reuter, Darlene; Norris, Abby; Papin, James F.] Univ Oklahoma, Hlth Sci Ctr, Div Comparat Med, Oklahoma City, OK USA.
RP Myers, DA (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Oklahoma City, OK 73190 USA.
EM dean-myers@ouhsc.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HD096240-01A1, NS103772-01]
FX This work was funded by NIH grants HD096240-01A1 and NS103772-01.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Allard A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006633
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Coelho AVC, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081714
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Clancy CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33528-2
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Desclaux A, 2018, NEW ENGL J MED, V378, P1458, DOI 10.1056/NEJMc1710453
   Dudley DM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02222-8
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Eppes C, 2017, AM J OBSTET GYNECOL, V216, P209, DOI 10.1016/j.ajog.2017.01.020
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Maness NJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49209-7
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Myers DA, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.105049
   National Institutes of Health, 2002, PUBL HLTH SERV POL H
   Nazmi A, 2014, VIRUS RES, V185, P32, DOI 10.1016/j.virusres.2014.03.013
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Nold C, 2020, AM J REPROD IMMUNOL, V83, DOI 10.1111/aji.13192
   Oliveira DBL, 2016, NEW ENGL J MED, V375, P1202, DOI 10.1056/NEJMc1607583
   Peregrine J, 2020, J VIROL, V94, DOI 10.1128/JVI.01434-19
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yellon SM, 2017, BIOL REPROD, V96, P13, DOI 10.1095/biolreprod.116.142844
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 55
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2020
VL 94
IS 11
AR e00058-20
DI 10.1128/JVI.00058-20
PG 16
WC Virology
SC Virology
GA LP8YJ
UT WOS:000534602800005
PM 32188737
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Mahar, JE
   Shi, M
   Hall, RN
   Strive, T
   Holmes, EC
AF Mahar, Jackie E.
   Shi, Mang
   Hall, Robyn N.
   Strive, Tanja
   Holmes, Edward C.
TI Comparative Analysis of RNA Virome Composition in Rabbits and Associated
   Ectoparasites
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE virus; ectoparasites; transmission; calicivirus; meta-transcriptomics;
   evolution
ID HEMORRHAGIC-DISEASE VIRUS; MECHANICAL TRANSMISSION;
   ORYCTOLAGUS-CUNICULUS; METAGENOMIC ANALYSIS; WILD RABBITS;
   IDENTIFICATION; ALIGNMENT; PICOBIRNAVIRUSES; GASTROENTERITIS;
   PICORNAVIRUS
AB Ectoparasites play an important role in virus transmission among vertebrates. Little, however, is known about the nature of those viruses that pass between invertebrates and vertebrates. In Australia, flies and fleas support the mechanical transmission of two viral biological controls against wild rabbits-rabbit hemorrhagic disease virus (RHDV) and myxoma virus. We compared virome compositions in rabbits and these ectoparasites, sequencing total RNA from multiple tissues and gut contents of wild rabbits, fleas collected from these rabbits, and flies trapped sympatrically. Meta-transcriptomic analyses identified 50 novel viruses from multiple RNA virus families. Rabbits and their ectoparasites were characterized by markedly different viromes, with virus abundance greatest in flies. Although viral contigs from six virus families/groups were found in both rabbits and ectoparasites, they clustered in distinct host-dependent lineages. A novel calicivirus and a picornavirus detected in rabbit cecal content were vertebrate specific; the newly detected calicivirus was distinct from known rabbit caliciviruses, while the picornavirus clustered with sapeloviruses. Several picobirnaviruses were also identified that fell in diverse phylogenetic positions, compatible with the idea that they are associated with bacteria. Further comparative analysis revealed that the remaining viruses found in rabbits, and all those from ectoparasites, were likely associated with invertebrates, plants, and coinfecting endosymbionts. While no full genomes of vertebrate-associated viruses were detected in ectoparasites, small numbers of reads from rabbit astrovirus, RHDV, and other lagoviruses were present in flies. This supports a role for flies in the mechanical transmission of RHDV, while their involvement in astrovirus transmission merits additional exploration.
   IMPORTANCE Ectoparasites play an important role in the transmission of many vertebrate-infecting viruses, including Zika and dengue viruses. Although it is becoming increasingly clear that invertebrate species harbor substantial virus diversity, it is unclear how many of the viruses carried by invertebrates have the potential to infect vertebrate species. We used the European rabbit (Oryctolagus cuniculus) as a model species to compare virome compositions in a vertebrate host and known associated ectoparasite mechanical vectors, in this case, fleas and blowflies. In particular, we aimed to infer the extent of viral transfer between these distinct types of host. Our analysis revealed that despite extensive viral diversity in both rabbits and associated ectoparasites, and the close interaction of these vertebrate and invertebrate species, biological viral transmission from ectoparasites to vertebrate species is rare. We did, however, find evidence to support the idea of a role of blowflies in transmitting viruses without active replication in the insect.
C1 [Mahar, Jackie E.; Shi, Mang; Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Mahar, Jackie E.; Shi, Mang; Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
   [Mahar, Jackie E.; Hall, Robyn N.; Strive, Tanja] Commonwealth Sci & Ind Res Org Black Mt, Hlth & Biosecur, Canberra, ACT, Australia.
   [Hall, Robyn N.; Strive, Tanja] Univ Canberra, Ctr Invas Species Solut, Bruce, ACT, Australia.
RP Holmes, EC (corresponding author), Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.; Holmes, EC (corresponding author), Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
EM edward.holmes@sydney.edu.au
RI Hall, Robyn/E-3121-2017
OI Hall, Robyn/0000-0002-5836-2990; Shi, Mang/0000-0002-6154-4437; Holmes,
   Edward/0000-0001-9596-3552
FU ARC Australian Laureate FellowshipAustralian Research Council
   [FL170100022]
FX E.C.H. is supported by an ARC Australian Laureate Fellowship
   (FL170100022).
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Asgari S, 1998, VIRUS RES, V54, P123, DOI 10.1016/S0168-1702(98)00017-3
   Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348
   Capucci L, 1996, J VIROL, V70, P8614, DOI 10.1128/JVI.70.12.8614-8623.1996
   Chihota CM, 2001, EPIDEMIOL INFECT, V126, P317, DOI 10.1017/S0950268801005179
   Cooke BD, 2002, WILDLIFE RES, V29, P689, DOI 10.1071/WR02010
   Cummings MJ, 2019, CLIN INFECT DIS, V68, P1118, DOI 10.1093/cid/ciy656
   DOLIN R, 1978, J AM VET MED ASSOC, V173, P615
   Eden JS, 2013, J VIROL, V87, P6270, DOI 10.1128/JVI.03464-12
   FEINSTONE SM, 1973, SCIENCE, V182, P1026, DOI 10.1126/science.182.4116.1026
   FENNER F, 1952, AUST J EXP BIOL MED, V30, P139, DOI 10.1038/icb.1952.13
   FORSYTHE SJ, 1985, J APPL BACTERIOL, V58, P363, DOI 10.1111/j.1365-2672.1985.tb01475.x
   Gall A, 2007, VET MICROBIOL, V120, P17, DOI 10.1016/j.vetmic.2006.10.006
   Ganesh Balasubramanian, 2014, VirusDisease, V25, P223, DOI 10.1007/s13337-014-0207-y
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guan TP, 2018, VIROLOGY, V521, P77, DOI 10.1016/j.virol.2018.05.027
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Hall RN, 2018, TRANSBOUND EMERG DIS, V65, pe444, DOI 10.1111/tbed.12779
   Hall RN, 2019, TRANSBOUND EMERG DIS, V66, P2025, DOI 10.1111/tbed.13250
   Hall RN, 2015, EMERG INFECT DIS, V21, P2276, DOI 10.3201/eid2112.151210
   Harvey E, 2019, VIROLOGY, V535, P189, DOI 10.1016/j.virol.2019.07.010
   Harvey E, 2019, J VIROL, V93, DOI 10.1128/JVI.01358-18
   HOPLA CE, 1994, REV SCI TECH OIE, V13, P985, DOI 10.20506/rst.13.4.815
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Knox MA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120685
   Krishnamurthy SR, 2018, VIROLOGY, V516, P108, DOI 10.1016/j.virol.2018.01.006
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   L'Homme Y, 2009, VIRUS GENES, V39, P66, DOI 10.1007/s11262-009-0360-3
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lau SKP, 2012, J VIROL, V86, P395, DOI 10.1128/JVI.06253-11
   Lau SKP, 2011, J VIROL, V85, P8819, DOI 10.1128/JVI.02364-10
   Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692
   Li C, 2015, ELIFE, V4, DOI 10.7554/eLife.06587
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   LUDERT JE, 1995, RES VET SCI, V59, P222, DOI 10.1016/0034-5288(95)90006-3
   Luo XL, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0020-6
   Mahar JE, 2018, J VIROL, V92, DOI 10.1128/JVI.01374-17
   Mahar JE, 2018, EMERG INFECT DIS, V24, P22, DOI 10.3201/eid2401.170412
   Martella V, 2011, EMERG INFECT DIS, V17, P2287, DOI 10.3201/eid1712.110967
   McColl KA, 2002, EPIDEMIOL INFECT, V129, P655, DOI 10.1017/S0950268802007756
   Merchant JC, 2003, EPIDEMIOL INFECT, V130, P135, DOI 10.1017/S0950268802007847
   Neimanis A, 2018, VET RES, V49, DOI 10.1186/s13567-018-0540-z
   NORRIS KR, 1965, ANNU REV ENTOMOL, V10, P47, DOI 10.1146/annurev.en.10.010165.000403
   Ohlinger V F, 1991, Rev Sci Tech, V10, P311
   OHLINGER VF, 1990, J VIROL, V64, P3331, DOI 10.1128/JVI.64.7.3331-3336.1990
   Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219
   Rodhain F, 2015, REV SCI TECH OIE, V34, P83
   Rosenberg R, 2011, EMERG INFECT DIS, V17, P769, DOI 10.3201/eid1705.110310
   Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7
   Shi M, 2018, VIRUS RES, V243, P83, DOI 10.1016/j.virusres.2017.10.016
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Smits SL, 2012, EMERG INFECT DIS, V18, P1539, DOI 10.3201/eid1809.120507
   Smits SL, 2011, EMERG INFECT DIS, V17, P2328, DOI 10.3201/eid1712.110934
   SOBEY WR, 1971, J HYG-CAMB, V69, P331, DOI 10.1017/S0022172400021574
   Strive T, 2009, VIROLOGY, V384, P97, DOI 10.1016/j.virol.2008.11.004
   THORNHILL TS, 1975, J INFECT DIS, V132, P28, DOI 10.1093/infdis/132.1.28
   Tseng CH, 2007, VIRUS RES, V129, P104, DOI 10.1016/j.virusres.2007.06.023
   Urayama SI, 2016, MICROBES ENVIRON, V31, P33, DOI 10.1264/jsme2.ME15171
   Velasco-Galilea M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02144
   Wells AI, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11050460
   Woo PCY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01886
   Woo PCY, 2014, VIROLOGY, V471, P117, DOI 10.1016/j.virol.2014.09.020
   WOO PCY, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/v11060574
   Zell R, 2018, ARCH VIROL, V163, P299, DOI 10.1007/s00705-017-3614-8
   Zhang WB, 2017, J ACUPUNCT MERIDIAN, V10, P5, DOI 10.1016/j.jams.2016.12.004
NR 72
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD JUN
PY 2020
VL 94
IS 11
AR e02119-19
DI 10.1128/JVI.02119-19
PG 21
WC Virology
SC Virology
GA LP8YJ
UT WOS:000534602800025
PM 32188733
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Fini, MB
AF Fini, Maryam Baghizadeh
TI What dentists need to know about COVID-19
SO ORAL ONCOLOGY
LA English
DT Review
DE COVID-19; Epidemiology; Dentistry; Infection control
ID CONVALESCENT PLASMA; ZIKA VIRUS; CORONAVIRUS; SARS; THERAPY
AB This article aims at collecting all information needed for dentists regarding the COVID-19 pandemic throughout the world by reviewing articles published by now. In late 2019, a pneumonia outbreak of uncertain etiology happened in Wuhan, China. There were many reports related to a live-animal and seafood market, supporting that the pathogens were transferred from animals to humans, rapidly evolving into transmission from human to human. The pathogen was classified as 2019 Novel Corona Virus (2019-nCoV), and the disease was named COrona VIrus Disease 2019 (COVID-19). Given that COVID-19 has lately been detected in infected patients' saliva, the COVID-19 outbreak is an alert that all dental and other health professionals must be vigilant in defending against the infectious disease spread, and it may enable to assess whether non-invasive saliva diagnostic for COVID-19. There has so far been no evidence from randomized controlled trials to prescribe any particular anti-nCoV treatment or vaccine, and COVID-19 management has been widely supportive. Since the ACE-2 was expressing on oral cavity mucosa, there is a potentially huge COVID-19 infectious vulnerability risk for oral cavity and brought up a proof for the future prevention procedure in dental practice and daily life. As a result, the whole dental teams should be vigilant and keep patients and themselves in a safe environment by following the guideline in this study.
C1 [Fini, Maryam Baghizadeh] Univ Tehran Med Sci, Sch Dent, Tehran, Iran.
   [Fini, Maryam Baghizadeh] Oklahoma State Univ, Hlth Promot, Stillwater, OK USA.
RP Fini, MB (corresponding author), 1208 N Knoblock, Stillwater, OK USA.
EM m.baghizadeh92@gmail.com
CR Ather A, 2020, J ENDODONT, V46, P584, DOI 10.1016/j.joen.2020.03.008
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Belser JA, 2013, MICROBIOL MOL BIOL R, V77, P144, DOI 10.1128/MMBR.00058-12
   Chen J, 2020, PROC ASME INT TECH C
   Chen L, 2020, LANCET INFECT DIS, V20, P398, DOI 10.1016/S1473-3099(20)30141-9
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1039, DOI 10.1001/jama.2020.1490
   Fan Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030210
   Fehr AR, CORONAVIRUSES 2015, P1
   Garraud O, 2016, TRANSFUS CLIN BIOL, V23, P39, DOI 10.1016/j.tracli.2015.12.003
   Gautret Philippe, 2020, Int J Antimicrob Agents, P105949, DOI 10.1016/j.ijantimicag.2020.105949
   Ge ZY, 2020, J ZHEJIANG UNIV-SC B, P1
   Gorbalenya AE, 2006, VIRUS RES, V117, P17, DOI 10.1016/j.virusres.2006.01.017
   Guan WJ, MEDRXIV
   Guo H, 2020, J DENT SCI
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Li H, 2020, UPDATED APPROACHES S
   Li RWK, 2004, BRIT DENT J, V197, P130, DOI 10.1038/sj.bdj.4811522
   Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x
   Lu CW, 2020, LANCET, V395, pE39, DOI 10.1016/S0140-6736(20)30313-5
   Marano G, 2016, BLOOD TRANSFUS-ITALY, V14, P152, DOI 10.2450/2015.0131-15
   Marui VC, 2019, J AM DENT ASSOC, V150, P1015, DOI 10.1016/j.adaj.2019.06.024
   Meng L, 2020, J DENT RES, V99, P481, DOI 10.1177/0022034520914246
   Ng MY, 2020, RADIOL CARDIOTHORAC, V2, DOI [10.1148/ryct.2020200034, DOI 10.1148/RYCT.2020200034]
   Peng X, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0075-9
   Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147
   Rothe C, 2020, N ENGL J MED
   Sabino-Silva R., 2020, CLIN ORAL INVEST, V24, P1
   Segal A, 2008, EUR J DENT EDUC, V12, P22, DOI 10.1111/j.1600-0579.2007.00477.x
   To K.K., 2020, CLIN INFECT DIS
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   Wang J, HIGH TEMPERATURE HIG
   WAX RS, 2020, CAN J ANAESTH, P1, DOI DOI 10.1007/S12630-020-01591-X.
   Weiss SR, 2011, ADV VIRUS RES, V81, P85, DOI 10.1016/B978-0-12-385885-6.00009-2
   World Health Organization, 2020, 46 WHO
   Wu F, 2020, NEW CORONAVIRUS ASSO
   Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus
   Xu H, 2020, INT J ORAL SCI, V12, DOI 10.1038/s41368-020-0074-x
   Xu Z, 2020, LANCET RESP MED, P17
   Yin YD, 2018, RESPIROLOGY, V23, P130, DOI 10.1111/resp.13196
   Zhou PYX, 2020, BIORXIV
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 42
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1368-8375
EI 1879-0593
J9 ORAL ONCOL
JI Oral Oncol.
PD JUN
PY 2020
VL 105
AR UNSP 104741
DI 10.1016/j.oraloncology.2020.104741
PG 5
WC Oncology; Dentistry, Oral Surgery & Medicine
SC Oncology; Dentistry, Oral Surgery & Medicine
GA LO3ZC
UT WOS:000533567700024
PM 32380453
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ellington, SR
   Rodriguez, RS
   Goldberg, H
   Bertolli, J
   Simeone, RM
   Mercado, AS
   Pazol, K
   Jamieson, DJ
   Honein, MA
   Swartzendruber, A
   Miles, T
   Cordero, JF
   Shapiro-Mendoza, CK
AF Ellington, Sascha R.
   Rodriguez, Ruby Serrano
   Goldberg, Howard
   Bertolli, Jeanne
   Simeone, Regina M.
   Mercado, Amilcar Soto
   Pazol, Karen
   Jamieson, Denise J.
   Honein, Margaret A.
   Swartzendruber, Andrea
   Miles, Toni
   Cordero, Jose F.
   Shapiro-Mendoza, Carrie K.
TI Assessment of contraceptive use in Puerto Rico during the 2016 Zika
   virus outbreak
SO CONTRACEPTION
LA English
DT Article
DE Contraceptive prevalence; Reproductive health survey; Public health
   emergencies; Zika virus; Puerto Rico; Population data
ID UNITED-STATES; ACCESS
AB Objectives: The objectives of this analysis were to 1) estimate prevalence of contraceptive use among women at risk for unintended pregnancy and 2) identify correlates of contraceptive use among women with ongoing or potential need for contraceptive services in Puerto Rico during the 2016 Zika virus (ZIKV) outbreak.
   Study design: We conducted a cell-phone survey July-November, 2016. Women aged 18-49 years living in Puerto Rico were eligible. We completed 3059 interviews; the overall response rate was 69.2%. After weighting, the data provide population-based estimates. For this analysis, we included women at risk for unintended pregnancy, and assessed ongoing or potential need for contraceptive services in this group, excluding women using permanent contraceptive methods.
   Results: Most women reported using contraception (82.8%), and use increased with age. Female sterilization and male condoms were most frequently reported (40.8% and 17.1%, respectively). Among women with ongoing or potential need for contraceptive services, 24.7% talked to a healthcare provider about ZIKV, and 31.2% reported a change in childbearing intentions due to ZIKV. Most women were at least a little worried about getting infected with ZIKV (74.3%) or having a baby with a birth defect (80.9%). Being very worried about getting infected with ZIKV and already having Zika were significantly associated with use of any contraception (adjusted prevalence ratio: 1.19, 95% CI: 1.03-1.38 and 1.32, 95% CI: 1.01-1.72, respectively).
   Conclusions: These findings underscore the need for regular contraceptive prevalence studies to inform programs about contraceptive needs, especially during public health emergencies.Published by Elsevier Inc.
C1 [Ellington, Sascha R.; Goldberg, Howard; Shapiro-Mendoza, Carrie K.] Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30333 USA.
   [Ellington, Sascha R.; Swartzendruber, Andrea; Miles, Toni; Cordero, Jose F.] Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
   [Rodriguez, Ruby Serrano; Mercado, Amilcar Soto] Puerto Rico Dept Hlth, San Juan, PR USA.
   [Bertolli, Jeanne] Ctr Dis Control & Prevent, Div Human Dev & Disabil, Atlanta, GA USA.
   [Simeone, Regina M.; Pazol, Karen; Honein, Margaret A.] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
   [Jamieson, Denise J.] Emory Univ, Sch Med, Dept Obstet & Gynecol, Atlanta, GA USA.
RP Ellington, SR (corresponding author), Ctr Dis Control & Prevent, Div Reprod Hlth, Atlanta, GA 30333 USA.; Ellington, SR (corresponding author), Univ Georgia, Coll Publ Hlth, Dept Epidemiol & Biostat, Athens, GA 30602 USA.
EM sellington@cdc.gov
OI Miles, Toni/0000-0003-0823-2319
CR [Anonymous], 2016, WEIGHT BRFSS DAT
   Bensyl Diana M., 2005, Morbidity and Mortality Weekly Report, V54, P1
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Centers for Disease Control and Prevention, 2010, DIST PUBL HLTH RES P
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P451, DOI 10.15585/mmwr.mm6517e2
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Estado Libre Asociado De Puerto Rico Departamento de Salud, 2016, INF SEM ENF ARB
   Guttmacher Institute, 2017, AB LAT AM CAR
   Hatcher R. A., 2018, CONTRACEPTIVE TECHNO
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Kavanaugh ML, 2018, CONTRACEPTION, V97, P14, DOI 10.1016/j.contraception.2017.10.003
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Tepper NK, 2016, MMWR-MORBID MORTAL W, V65, P311, DOI 10.15585/mmwr.mm6512e1
   Thomas DL, 2016, MMWR-MORBID MORTAL W, V65, P154, DOI 10.15585/mmwr.mm6506e2
   U.S. Census Buerau American Fact Finder, ANN EST RES POP 2015
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
NR 23
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0010-7824
EI 1879-0518
J9 CONTRACEPTION
JI Contraception
PD JUN
PY 2020
VL 101
IS 6
BP 405
EP 411
DI 10.1016/j.contraception.2020.03.001
PG 7
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA LO3JJ
UT WOS:000533524600008
PM 32194040
OA Bronze
DA 2020-07-08
ER

PT J
AU Zhang, YN
   Wang, SB
   Song, SS
   Hu, PY
   Zhou, YC
   Mou, YP
   Mou, XZ
AF Zhang, You-Ni
   Wang, Shi-Bing
   Song, Shu-Shu
   Hu, Pei-Yang
   Zhou, Yu-Cheng
   Mou, Yi-Ping
   Mou, Xiao-Zhou
TI Recent advances in targeting cancer stem cells using oncolytic viruses
SO BIOTECHNOLOGY LETTERS
LA English
DT Review
DE Antitumor immunity; Cancer; Cancer stem cells; Oncolytic virus;
   Virotherapy
ID VACCINIA VIRUS; ZIKA VIRUS; IN-VITRO; IMMUNOVIROTHERAPY; ADENOVIRUSES;
   COMBINATION; AUTOPHAGY; BLOCKADE; RECEPTOR; THERAPY
AB Oncolytic virotherapy is a promising antitumor strategy which utilizes the lytic nature of viral replication to kill cancer cells. Oncolytic viruses (OVs) can induce cancer cell death and trigger immune responses to metastatic cancer in vivo. Reverse genetic systems have aided the insertion of anticancer genes into various OVs to augment their oncolytic capacity. Furthermore, OVs target and destroy the population of tumor-initiating cancer stem cells. These cancer stem cells are associated with metastasis and development of resistance to conventional anticancer approaches. Targeting cancer stem cells is essential since killing only differentiated tumor cells may lead to enrichment of cancer stem cells and thus indicate a poor prognosis. In this review, we summarize the oncolytic activity of various classes of OVs towards different types of cancer stem cells and also discuss the synergistic activity achieved by the combination of OVs with traditional therapies on chemo- and radiotherapy-resistant cancer stem cells.
C1 [Zhang, You-Ni] Tiantai Peoples Hosp Zhejiang Prov, Clin Lab, Tiantai Branch, Zhejiang Peoples Hosp, Taizhou 317200, Peoples R China.
   [Zhang, You-Ni; Song, Shu-Shu; Zhou, Yu-Cheng; Mou, Yi-Ping] Zhejiang Prov Peoples Hosp, Key Lab Gastroenterol Zhejiang Prov, Hangzhou Med Coll, Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Peoples R China.
   [Zhang, You-Ni; Wang, Shi-Bing; Song, Shu-Shu; Mou, Xiao-Zhou] Zhejiang Prov Peoples Hosp, Clin Res Inst, Peoples Hosp, Hangzhou Med Coll, 158 Shangtang Rd, Hangzhou 310014, Peoples R China.
   [Hu, Pei-Yang] Tiantai Peoples Hosp Zhejiang Prov, Dept Traumatol, Tiantai Branch, Zhejiang Peoples Hosp, Taizhou 317200, Peoples R China.
   [Zhou, Yu-Cheng; Mou, Yi-Ping] Zhejiang Prov Peoples Hosp, Gastroenterol & Pancreat Surg Dept, Peoples Hosp, Hangzhou Med Coll, Hangzhou 310014, Peoples R China.
RP Zhou, YC; Mou, YP (corresponding author), Zhejiang Prov Peoples Hosp, Key Lab Gastroenterol Zhejiang Prov, Hangzhou Med Coll, Peoples Hosp, 158 Shangtang Rd, Hangzhou 310014, Peoples R China.; Mou, XZ (corresponding author), Zhejiang Prov Peoples Hosp, Clin Res Inst, Peoples Hosp, Hangzhou Med Coll, 158 Shangtang Rd, Hangzhou 310014, Peoples R China.
EM zhouyucheng@hmc.edu.cn; yipingmou@126.com; mouxz@zju.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81672430, 81602706]; Zhejiang Provincial Medical
   and Healthy Science and Technology Projects [2019KY248]
CR Blagosklonny MV, 2006, LEUKEMIA, V20, P385, DOI 10.1038/sj.leu.2404075
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126
   Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733
   Ebben JD, 2010, EXPERT OPIN THER TAR, V14, P621, DOI 10.1517/14712598.2010.485186
   Esaki S, 2017, INT J CANCER, V141, P2348, DOI 10.1002/ijc.30929
   Fu LQ, 2019, VIRUS RES, V270, DOI 10.1016/j.virusres.2019.197675
   Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762
   Hanauer JRH, 2016, Mol Ther-Oncolytics, V3, DOI 10.1038/mto.2016.3
   Hiraga T, 2011, ONCOL REP, V25, P289, DOI 10.3892/or_00001073
   Iannolo G, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1499-z
   Jahan N, 2017, INT J CANCER, V141, P1671, DOI 10.1002/ijc.30811
   Jiang B, 2017, BIOMED PHARMACOTHER, V95, P1201, DOI 10.1016/j.biopha.2017.09.030
   Jiang K, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4522-3
   Josupeit R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050138
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kazimirsky G, 2016, STEM CELL RES THER, V7, DOI 10.1186/s13287-016-0414-0
   Kleinlutzum D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00127
   Klonisch T, 2008, TRENDS MOL MED, V14, P450, DOI 10.1016/j.molmed.2008.08.003
   Lal S, 2018, NEURO-ONCOLOGY, V20, P1606, DOI 10.1093/neuonc/noy089
   Li S, 2016, APPL MICROBIOL BIOT, V100, P8325, DOI 10.1007/s00253-016-7806-z
   Lv SQ, 2017, J CANCER, V8, P199, DOI 10.7150/jca.16406
   Ning JF, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw229
   Ottolino-Perry K, 2010, MOL THER, V18, P251, DOI 10.1038/mt.2009.283
   Palomeras S, 2018, MOLECULES, V23, DOI 10.3390/molecules23092193
   Park JS, 2017, J MICROBIOL, V55, P75, DOI 10.1007/s12275-017-6542-0
   Passaro C, 2019, CLIN CANCER RES, V25, P290, DOI 10.1158/1078-0432.CCR-18-2311
   Perez MC, 2018, ANN SURG ONCOL, V25, P3960, DOI 10.1245/s10434-018-6803-0
   Peters C, 2018, J VIROL, V92, DOI 10.1128/JVI.00246-18
   Raghunath S, 2017, J BIOTECHNOL, V260, P91, DOI 10.1016/j.jbiotec.2017.09.015
   Rajaraman S, 2019, MOL THER-ONCOLYTICS, V12, P147, DOI 10.1016/j.omto.2018.12.010
   Saha D, 2018, IMMUNOTHERAPY-UK, V10, P779, DOI 10.2217/imt-2018-0009
   Saha D, 2018, CLIN CANCER RES, V24, P3409, DOI 10.1158/1078-0432.CCR-17-1717
   Saha D, 2017, CANCER CELL, V32, P253, DOI 10.1016/j.ccell.2017.07.006
   Samudio I, 2016, BLOOD, V127, P2575, DOI 10.1182/blood-2015-04-639088
   Sato-Dahlman M, 2017, ONCOTARGET, V8, P76044, DOI 10.18632/oncotarget.18340
   Shao XY, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00436
   Terai K, 2018, STEM CELLS, V36, P1154, DOI 10.1002/stem.2835
   Tong Yin, 2014, Stem Cell Investig, V1, P20, DOI 10.3978/j.issn.2306-9759.2014.11.01
   Wang JH, 2013, ONCOL REP, V30, P833, DOI 10.3892/or.2013.2511
   Warner SG, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.13
   Xu B, 2019, NAT BIOTECHNOL, V37, P45, DOI 10.1038/nbt.4302
   Yang H, 2016, GENE THER, V23, P450, DOI 10.1038/gt.2016.15
   Ye T, 2018, AM J CANCER RES, V8, P1514
   Ying C, 2018, ACTA PHARMACOL SIN, V39, P405, DOI 10.1038/aps.2017.91
   Yoo SY, 2017, ONCOTARGET, V8, P71489, DOI 10.18632/oncotarget.17288
   Yoo SY, 2016, ONCOTARGET, V7, P16479, DOI 10.18632/oncotarget.7660
   Yu ZR, 2012, INT J BIOCHEM CELL B, V44, P2144, DOI 10.1016/j.biocel.2012.08.022
   Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095
   Zendedel E, 2019, J CELL PHYSIOL, V234, P14906, DOI 10.1002/jcp.28320
   Zhand S, 2019, J CANCER RES THER, V15, P61, DOI 10.4103/jcrt.JCRT_13_17
   Zhang J, 2017, BIOCHEM BIOPH RES CO, V491, P469, DOI 10.1016/j.bbrc.2017.07.041
   Zhang XM, 2016, ONCOTARGET, V7, P29346, DOI 10.18632/oncotarget.8830
   Zhao X, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184816
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 55
TC 0
Z9 0
U1 18
U2 18
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0141-5492
EI 1573-6776
J9 BIOTECHNOL LETT
JI Biotechnol. Lett.
PD JUN
PY 2020
VL 42
IS 6
BP 865
EP 874
DI 10.1007/s10529-020-02857-6
PG 10
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA LK9KY
UT WOS:000531178900001
PM 32166558
DA 2020-07-08
ER

PT J
AU Paiva, MHS
   Guedes, DRD
   Krokovsky, L
   Machado, LC
   Rezende, TMT
   Sobral, MCD
   Ayres, CFJ
   Wallau, GL
AF Santos Paiva, Marcelo Henrique
   Duarte Guedes, Duschinka Ribeiro
   Krokovsky, Larissa
   Machado, Lais Ceschini
   Teodoro Rezende, Tatiana Maria
   de Morais Sobral, Mariana Carolina
   Junqueira Ayres, Constancia Flavia
   Wallau, Gabriel Luz
TI Sequencing of ZIKV genomes directly from Ae. aegypti and Cx.
   quinquefasciatus mosquitoes collected during the 2015-16 epidemics in
   Recife
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE ZIKV; Arboviruses; Surveillance; Aedes aegypti; Culex quinquefasciatus
ID AEDES-AEGYPTI; VIRUS OUTBREAK; CULEX-QUINQUEFASCIATUS; VERTICAL
   TRANSMISSION; SINGLE MUTATION; PCR METHOD; BRAZIL; PERFORMANCE;
   ALIGNMENT; VIEWER
AB Zika virus (ZIKV) is a negative sense RNA virus from the Flaviviridae family, which was relatively unknown until the first human epidemic in Micronesia, in 2007. Since then, it spread to French Polynesia and the Americas. Recife, the capital of Pernambuco state and epicenter of the Zika epidemic in Brazil, experienced a large number of microcephaly cases and other congenital abnormalities associated to the ZIKV infection from, 2015 to 16. Evidences suggest that both Aedes aegypti and Culex quinquefasciatus mosquitoes from Recife are capable of replicating and transmitting the virus. Here, we conducted high throughput sequencing of ZIKV genomes directly from Ae. aegypti and Cx. quinquefasciatus mosquitoes collected during the ZIKV epidemics in Recife, in order to investigate the variability and evolution of the virus. We obtained 11 draft ZIKV genomes derived from 5 pools from each Ae. aegypti and Cx. quinquefasciatus species. Genome coverage breadth ranged from 16 to 100% and average depth from 45 to 46,584 x . Two of these genomes were obtained from pools of Cx. quinquefasciatus females with no sign of blood in the abdomen. Amino acid substitutions found here were not species-specific. In addition, molecular clock dating estimated that ZIKV draft genomes obtained here were co-circulating in other regions of the country during the epidemics. Overall results highlight that viral mutations and even minor variants can be detected in genomes directly sequenced from mosquito samples and insights about natural viral genomic variability and viral evolution can be useful when designing tools for mosquito control programs.
C1 [Santos Paiva, Marcelo Henrique] Univ Fed Pernambuco, Caruaru, Brazil.
   [Santos Paiva, Marcelo Henrique; Duarte Guedes, Duschinka Ribeiro; Krokovsky, Larissa; Machado, Lais Ceschini; Teodoro Rezende, Tatiana Maria; de Morais Sobral, Mariana Carolina; Junqueira Ayres, Constancia Flavia; Wallau, Gabriel Luz] Fundacao Oswaldo Cruz, Entomol Dept, Aggeu Magalhaes Inst, Av Prof Moraes Rego S-N,Cidade Univ, BR-50740465 Recife, PE, Brazil.
RP Wallau, GL (corresponding author), Fundacao Oswaldo Cruz, Entomol Dept, Aggeu Magalhaes Inst, Av Prof Moraes Rego S-N,Cidade Univ, BR-50740465 Recife, PE, Brazil.
EM gabriel.wallau@cpqam.fiocruz.br
RI Ayres, Constancia/AAQ-3448-2020; Wallau, Gabriel/B-5911-2008
OI Wallau, Gabriel/0000-0002-1419-5713
FU Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   [APQ-0078-2.02/16, APQ-0085-2.13/16, APQ-1608-2.13/15]; Brazilian
   National Council for Research and Development (CNPq)National Council for
   Scientific and Technological Development (CNPq) [441100/2016-3];
   Programme for Technological Development in Tools for Health
FX We are thankful to all the researchers that have made ZIKV genome
   sequences available and to Illumina for providing early access to the
   ZIKV probe kit enrichment and sequencing. This work was funded by
   Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco
   (APQ-0078-2.02/16, APQ-0085-2.13/16 and APQ-1608-2.13/15) and the
   Brazilian National Council for Research and Development (CNPq; grant
   441100/2016-3). We are also thankful to the Programme for Technological
   Development in Tools for Health (PDTIS-FIOCRUZ) for assistance with
   sequencing.
CR Albuquerque M, 2018, CAD SAUDE PUBLICA, V34
   Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453
   Azar SR, 2019, EMERG MICROBES INFEC, V8, P242, DOI 10.1080/22221751.2018.1561157
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bonica MB, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007433
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos TD, 2018, INT J GENOMICS, DOI 10.1155/2018/6941735
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Ciota AT, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-71
   Cleaveland S, 2007, CURR TOP MICROBIOL, V315, P85
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Elizondo-Quiroga D, 2018, SCI REP-UK, V8, DOI [10.1038/s41598-018-25807-9, 10.1038/s41598-017-18682-3]
   ESPIN N.I.n.-C.m.E.d.S.P.d.I.N., 2015, PROCEDIMENTOS PRELIM
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Giovanetti M, 2016, INFECT GENET EVOL, V41, P142, DOI 10.1016/j.meegid.2016.03.030
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Holmes E. C, 2009, EVOLUTION EMERGENCE
   Ayres CFJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3461-4
   Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Larsson A, 2014, BIOINFORMATICS, V30, P3276, DOI 10.1093/bioinformatics/btu531
   Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Pereira-Silva JW, 2018, MEM I OSWALDO CRUZ, V113, P56, DOI 10.1590/0074-02760170329
   Phumee A., 2019, PATHOGENS, V8
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Ramirez AL, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2901-x
   Regis L, 2000, T ROY SOC TROP MED H, V94, P488, DOI 10.1016/S0035-9203(00)90061-0
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Barbosa RMR, 2011, MEM I OSWALDO CRUZ, V106, P451, DOI 10.1590/S0074-02762011000400011
   Paiva MHS, 2017, GENET MOL BIOL, V40, P597, DOI [10.1590/1678-4685-GMB-2016-0312, 10.1590/1678-4685-gmb-2016-0312]
   Shrivastava S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34147-7
   Smartt CT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00768
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zimler RA, 2019, J MED ENTOMOL, V56, P341, DOI 10.1093/jme/tjy231
NR 64
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUN
PY 2020
VL 80
AR 104180
DI 10.1016/j.meegid.2020.104180
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA LD0XO
UT WOS:000525757000012
PM 31918041
DA 2020-07-08
ER

PT J
AU Shahid, F
   Ashfaq, UA
   Javaid, A
   Khalid, H
AF Shahid, Farah
   Ashfaq, Usman Ali
   Javaid, Anam
   Khalid, Hina
TI Immunoinformatics guided rational design of a next generation multi
   epitope based peptide (MEBP) vaccine by exploring Zika virus proteome
SO INFECTION GENETICS AND EVOLUTION
LA English
DT Article
DE Multi-epitope vaccine; Immuno-informatics; Adjuvant; Molecular docking
ID PREDICTION; ANTIGEN; IMMUNOGENICITY; TRANSMISSION; OUTBREAK; TARGET;
   WEB; INFECTIONS; CHALLENGE; STRATEGY
AB Zika virus (ZIKV) is an RNA virus that has spread through mosquito sting. Currently, no vaccine and antiviral medication available so far against ZIKV. Therefore, it has fostered a study to design MEBP vaccine enabling effective prevention against the ZIKV infection. In this study combination of immuno-informatics and molecular docking approach was used to constitute a MEBP vaccine. The ZIKV proteome was used for prediction of B-cell, T-cell (HTL & CTL) and IFN-gamma epitopes. After prediction, highly antigenic and overlapping epitopes have been shortlisted which includes 14 CTL and 11 HTL epitopes that have been linked to the final peptide through AAY and GPGPG linkers respectively. An adjuvant at the N-end of the vaccine was added to improve the immunogenicity of the vaccine through the EAAAK linker. The final construct constitutes 435 amino acids after the addition of linkers and adjuvant. The existence of B-cell and IFN-gamma epitopes affirms the humoral and cell-mediated immune responses acquired by the construct. Allergenicity, antigenicity and different physiochemical attributes of the vaccine were evaluated to assure its safety and immunogenicity profile. In fact, the construct was antigenic and non-allergenic. Docking was performed among vaccine and TLR-3 to evaluate the binding affinity and the molecular interaction. Finally, the construct was subjected to In silico cloning to confers the authenticity of its expression efficiency. However, the proposed construct need to be validate experimentally to ensure its safety and immunogenic profile.
C1 [Shahid, Farah; Ashfaq, Usman Ali; Javaid, Anam; Khalid, Hina] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan.
RP Ashfaq, UA (corresponding author), Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan.
EM ashfaqua@gcuf.edu.pk
OI shahid, Farah/0000-0001-6534-868X
CR Ahmad B, 2019, MICROB PATHOGENESIS, V132, P243, DOI 10.1016/j.micpath.2019.05.010
   Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Arai R, 2001, PROTEIN ENG, V14, P529, DOI 10.1093/protein/14.8.529
   Ashfaq UA, 2016, VIRAL IMMUNOL, V29, P436, DOI 10.1089/vim.2016.0033
   Barrett ADT, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.23
   Benson DA, 2008, NUCLEIC ACIDS RES, V36, pD25, DOI 10.1093/nar/gkm929
   Bergmann CC, 1996, J IMMUNOL, V157, P3242
   BJELLQVIST B, 1993, ELECTROPHORESIS, V14, P1023, DOI 10.1002/elps.11501401163
   Brennick CA, 2017, IMMUNOTHERAPY-UK, V9, P361, DOI 10.2217/imt-2016-0146
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Bui HH, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-361
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chauhan V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39299-8
   Davies MN, 2007, DRUG DISCOV TODAY, V12, P389, DOI 10.1016/j.drudis.2007.03.010
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   De Gregorio E, 2012, MICROB BIOTECHNOL, V5, P149, DOI 10.1111/j.1751-7915.2011.00276.x
   Deleage G, 2017, BIOINFORMATICS, V33, P3991, DOI 10.1093/bioinformatics/btx521
   Dhanda SK, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-30
   Dimitrov I, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S6-S4
   Doytchinova IA, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-4
   Dubey KK, 2018, BRIEF FUNCT GENOMICS, V17, P295, DOI 10.1093/bfgp/ely020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gillespie GMA, 2000, J VIROL, V74, P8140, DOI 10.1128/JVI.74.17.8140-8150.2000
   Grote A, 2005, NUCLEIC ACIDS RES, V33, pW526, DOI 10.1093/nar/gki376
   He R, 2018, CELL MOL IMMUNOL, V15, P815, DOI 10.1038/cmi.2017.3
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Homan J., 2016, BIORXIV, DOI [10.1101/044834, DOI 10.1101/044834]
   Ikram A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34254-5
   Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889
   Jouannic JM, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00625-5
   Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053
   Khan A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196484
   Khatoon N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08842-w
   Larsen MV, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-424
   신웅희, 2014, Biodesign, V2, P1
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Livingston B, 2002, J IMMUNOL, V168, P5499, DOI 10.4049/jimmunol.168.11.5499
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Lu CY, 2017, BRIT J HAEMATOL, V178, P413, DOI 10.1111/bjh.14686
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Mallet H. P., 2016, Bulletin Epidemiologique Hebdomadaire, P367
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Mohan T, 2014, IMMUNOL RES, V58, P139, DOI 10.1007/s12026-013-8428-5
   Mohan T, 2013, VACCINE, V31, P1707, DOI 10.1016/j.vaccine.2013.01.041
   Monath TP, 2003, J INFECT DIS, V188, P1213, DOI 10.1086/378356
   MOORE DL, 1975, ANN TROP MED PARASIT, V69, P49, DOI 10.1080/00034983.1975.11686983
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nezafat N, 2016, COMPUT BIOL CHEM, V62, P82, DOI 10.1016/j.compbiolchem.2016.04.006
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ojha R, 2019, ACS OMEGA, V4, P13069, DOI 10.1021/acsomega.9b00944
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pandey RK, 2018, J CELL BIOCHEM, V119, P7631, DOI 10.1002/jcb.27110
   Pandey RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19456-1
   Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P791, DOI 10.1080/07391102.2016.1161560
   Patronov A, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120139
   Peng J, 2011, PROTEINS, V79, P161, DOI 10.1002/prot.23175
   Perera R, 2008, ANTIVIR RES, V80, P11, DOI 10.1016/j.antiviral.2008.05.004
   Perrie Y, 2008, INT J PHARMACEUT, V364, P272, DOI 10.1016/j.ijpharm.2008.04.036
   Prevention E.C. f.D. Control, 2014, RAP RISK ASS ZIK VIR
   Putnak R, 1996, J INFECT DIS, V174, P1176, DOI 10.1093/infdis/174.6.1176
   Saha S, 2006, PROTEINS, V65, P40, DOI 10.1002/prot.21078
   Shrinet J., 2016, MMWR-MORBID MORTAL W, V22
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Stasyk T, 2016, J CELL BIOCHEM, V117, P836, DOI 10.1002/jcb.25418
   ul Qamar MT, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1672-7
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Walker J. M., 2005, PROTEOMICS PROTOCOLS
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290
   Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407
   Yang XD, 2009, REV MED VIROL, V19, P77, DOI 10.1002/rmv.602
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang LF, 2018, CELL MOL IMMUNOL, V15, P182, DOI 10.1038/cmi.2017.92
NR 86
TC 1
Z9 1
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-1348
EI 1567-7257
J9 INFECT GENET EVOL
JI Infect. Genet. Evol.
PD JUN
PY 2020
VL 80
AR 104199
DI 10.1016/j.meegid.2020.104199
PG 18
WC Infectious Diseases
SC Infectious Diseases
GA LD0XO
UT WOS:000525757000029
PM 31962160
DA 2020-07-08
ER

PT J
AU Vianna, RAD
   Rua, EC
   Fernandes, AR
   dos Santos, TCS
   Dalcastel, LAB
   dos Santos, MLB
   de Paula, PD
   de Carvalho, FR
   de Faria, ADP
   Almeida, PL
   Sales, LD
   Riley, LW
   de Oliveira, SA
   Cardoso, CAA
AF de Oliveira Vianna, Renata Artimos
   Rua, Erica Conti
   Fernandes, Alexandre Ribeiro
   Sarmet dos Santos, Teresa Cristina
   Bataglin Dalcastel, Luis Antonio
   Bernardes dos Santos, Maria Luiza
   de Paula, Patricia da Silva
   de Carvalho, Fabiana Rabe
   Pache de Faria, Armanda de Oliveira
   Almeida, Paulo Leandro
   Sales, Lais de Freitas
   Riley, Lee Woodland
   de Oliveira, Solange Artimos
   Araujo Cardoso, Claudete Aparecida
TI Experience in diagnosing congenital Zika syndrome in Brazilian children
   born to asymptomatic mothers
SO ACTA TROPICA
LA English
DT Article
DE Congenital Zika syndrome; Zika virus; Microcephaly at birth; Post-natal
   microcephaly; RT-PCR
AB Introduction: Typical symptoms of primary Zika virus infection are not specific and share similarities with other arbovirus infections such as dengue fever and chikungunya. As acute infection can be asymptomatic in up to 73% of cases, infants with microcephaly represent a diagnostic challenge for pediatricians. We describe the frequency of congenital Zika syndrome (CZS) in Brazilian children born to asymptomatic pregnant mothers and its differential diagnosis.
   Methods: This longitudinal, observational study was conducted on children with suspected CZS whose mothers did not report rash during pregnancy, referred to the reference hospital in a metropolitan area of Rio de Janeiro, Brazil. The diagnosis of suspected CZS was based on Brazilian Ministry of Health protocol.
   Results: Forty-three (17%) of 246 referred children were born to mothers without rash history during pregnancy. Thirteen (30%) of 43 children met the Brazilian Ministry of Health criteria for CZS, all with microcephaly (two post-natal). The other children included 11 cases with post-natal microcephaly due to hypoxic-ischemic encephalopathy (6), non-progressive encephalopathy of unknown etiology (2), microcephaly under investigation (2) and congenital toxoplasmosis (1); 17 children were misdiagnosed with microcephaly and progressed with normal head circumference during the follow-up period; one child was included because of epidemiological link and one was loss to follow-up. All children who underwent laboratory investigation for ZIKV infection during neonatal period had negative RT-qPCR tests.
   Conclusion: We emphasize the increasing importance of CZS in differential diagnosis of microcephaly at birth or post-natal period. Detailed clinical investigation assisted by neuroimaging tests may clarify the diagnosis of CZS when laboratory tests are not available during the acute phase of the disease.
C1 [de Oliveira Vianna, Renata Artimos; Rua, Erica Conti; Fernandes, Alexandre Ribeiro; Sarmet dos Santos, Teresa Cristina; Bataglin Dalcastel, Luis Antonio; Bernardes dos Santos, Maria Luiza; de Paula, Patricia da Silva; de Carvalho, Fabiana Rabe; Pache de Faria, Armanda de Oliveira; Almeida, Paulo Leandro; Sales, Lais de Freitas; de Oliveira, Solange Artimos; Araujo Cardoso, Claudete Aparecida] Univ Fed Fluminense, Niteroi, RJ, Brazil.
   [Riley, Lee Woodland] Univ Calif Berkeley, Berkeley, CA 94720 USA.
RP Cardoso, CAA (corresponding author), Univ Fed Fluminense, Fac Med, Rua Marques de Parana 303, Niteroi, RJ, Brazil.
EM claudetecardoso@id.uff.br
OI Fernandes, Alexandre/0000-0001-6253-265X
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES
   [001]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX This work was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (CAPES) -Finance Code 001 and Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Aragao V.F.A., 2016, BMJ-BRIT MED J, V353, pi1901
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Carvalho FR, 2019, ACTA TROP, V192, P49, DOI 10.1016/j.actatropica.2019.01.020
   Cordeiro M.T., 2016, LANCET, P30254
   Cortes MS, 2018, AM J OBSTET GYNECOL, V218, DOI 10.1016/j.ajog.2018.01.012
   Franca T.L.B., 2018, INT J ENV RES PUBLIC, V15
   Frankenburg W.K., 1992, DENVER 2 TRINING MAN
   Lima GP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3908-4
   Mehrjardi Mohammad Zare, 2017, VirusDisease, V28, P247, DOI 10.1007/s13337-017-0399-z
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Nogueira M.L., 2017, CLINMICROBIOLINFECT
   Pawley DC, 2019, ACS OMEGA, V4, P6808, DOI 10.1021/acsomega.9b00374
   Siedner M.J., 2018, LANCET PUBLIC HEALTH, V3, pe109
   Snyder RE, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005287
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   Van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1
   van der Linden V, 2017, ARQ NEURO-PSIQUIAT, V75, P381, DOI [10.1590/0004-282x20170066, 10.1590/0004-282X20170066]
   Vianna R.A.O., 2019, J TROP PEDIATRICS, DOI [10.1093/tropej/fmz019, DOI 10.1093/TROPEJ/FMZ019.APR]
   Villar J, 2013, BJOG-INT J OBSTET GY, V120, P9, DOI 10.1111/1471-0528.12047
   WHO multicentre growth reference study group, 2006, ACTA PAEDIATR, V450, pS86
   World Health Organization, 2006, ACTA PAEDIATR, V450, pS76
NR 27
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2020
VL 206
AR UNSP 105438
DI 10.1016/j.actatropica.2020.105438
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LF7CR
UT WOS:000527575700009
PM 32165128
DA 2020-07-08
ER

PT J
AU Hendy, A
   Hernandez-Acosta, E
   Chaves, BA
   Fe, NF
   Valerio, D
   Mendonca, C
   de Lacerda, MVG
   Buenemann, M
   Vasilakis, N
   Hanley, KA
AF Hendy, Adam
   Hernandez-Acosta, Eduardo
   Chaves, Barbara Aparecida
   Fe, Nelson Ferreira
   Valerio, Danielle
   Mendonca, Claudia
   Guimaraes de Lacerda, Marcus Vinicius
   Buenemann, Michaela
   Vasilakis, Nikos
   Hanley, Kathryn A.
TI Into the woods: Changes in mosquito community composition and presence
   of key vectors at increasing distances from the urban edge in urban
   forest parks in Manaus, Brazil
SO ACTA TROPICA
LA English
DT Article
DE Mosquito; Arbovirus; Zika virus; Spillback; Forest edge; NDVI
ID AEDES-ALBOPICTUS DIPTERA; TAMARIN SAGUINUS-BICOLOR; SYLVATIC
   YELLOW-FEVER; ZIKA VIRUS HISTORY; SAO-PAULO; SPATIAL-DISTRIBUTION;
   MUNICIPAL PARKS; AEGYPTI; STATE; AREA
AB Mosquito-borne Zika virus (ZIKV) was recently introduced into the Americas and now has the potential to spill back into a sylvatic cycle in the region, likely involving non-human primates and Aedes, Haemagogus, and Sabethes species mosquitoes. We investigated potential routes of mosquito-borne virus exchange between urban and sylvatic transmission cycles by characterizing mosquito communities in three urban forest parks that receive heavy traffic from both humans and monkeys in Manaus, Brazil.
   Parks were stratified by both distance from the urban-forest edge (0, 50, 100, and 500 m) and relative Normalized Difference Vegetation Index (NDVI) (low, medium, or high), and mosquitoes were sampled at randomly selected sites within each stratum using BG-Sentinel traps. Additionally, temperature, relative humidity, and other environmental data were collected at each site.
   A total of 1,172 mosquitoes were collected from 184 sites sampled in 2018, of which 98 sites were resampled in 2019. Using park as the unit of replication (i.e. 3 replicates per sampling stratum), a two-way ANOVA showed no effect of distance or NDVI on the mean number of identified species (P > 0.05 for both comparisons) or on species diversity as measured by the Shannon-Wiener diversity index (P > 0.10 for both comparisons). However, the Morisita overlap index revealed that mosquito communities changed substantially with increasing distance from edge, with communities at 0 m and 500 m being quite distinct. Aedes albopictus and Ae. aegypti penetrated at least 100 m into the forest, while forest specialists including Haemagogus janthinomys, Sabethes glaucodaemon, and Sa. tridentatus were detected in low numbers within 100 m from the forest edge. Trichoprosopon digitatum and Psorophora amazonica were among the most abundant species collected, and both showed distributions extending from the forest edge to its interior.
   Our results show overlapping distributions of urban and forest mosquitoes at park edges, which highlights the risk of arbovirus exchange via multiple bridge vectors in Brazilian urban forest parks. These parks may also provide refugia for both Ae. albopictus and Ae. aegypti from mosquito control programs.
C1 [Hendy, Adam; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Hendy, Adam; Vasilakis, Nikos] Univ Texas Med Branch, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.
   [Hernandez-Acosta, Eduardo; Hanley, Kathryn A.] New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
   [Chaves, Barbara Aparecida; Fe, Nelson Ferreira; Valerio, Danielle; Mendonca, Claudia; Guimaraes de Lacerda, Marcus Vinicius] Fundacao Med Trop Doutor Heitor Vieria Dourado, BR-69040 Manaus, Amazonas, Brazil.
   [Buenemann, Michaela] New Mexico State Univ, Dept Geog, Las Cruces, NM 88003 USA.
RP Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Dept Pathol, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Vasilakis, N (corresponding author), Univ Texas Med Branch, Ctr Trop Dis, Ctr Biodef & Emerging Infect Dis, Inst Human Infect & Immun, Galveston, TX 77555 USA.; Hanley, KA (corresponding author), New Mexico State Univ, Dept Biol, Las Cruces, NM 88003 USA.
EM nivasila@utmb.edu; khanley@nmsu.edu
FU International Collaborations in Infectious Disease Research (ICIDR) -
   National Institutes of Health [U01 AI115577]; Consejo Nacional de
   Ciencia y Tecnologia fellowship - government of Mexico [709139]
FX This research was funded by an International Collaborations in
   Infectious Disease Research (ICIDR) grant, U01 AI115577, awarded to NV
   by the National Institutes of Health, and a Consejo Nacional de Ciencia
   y Tecnologia fellowship awarded to EHA by the government of Mexico,
   709139.
CR Agencia Nacional de Aguas, 2019, HIDROWEB SIST INF HI
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P688, DOI 10.4269/ajtmh.1957.6.688
   ARNELL J H, 1973, Contributions of the American Entomological Institute, V10, P1
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barrera R, 2011, AM J TROP MED HYG, V85, P1087, DOI 10.4269/ajtmh.2011.11-0381
   BATES M, 1946, AM J TROP MED, V26, P585, DOI 10.4269/ajtmh.1946.s1-26.585
   Berlin O.G.W., 1980, CONTRIB AM ENTOMOL I, V17
   Berry N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50918-2
   Birungi J, 2002, ANN ENTOMOL SOC AM, V95, P125, DOI 10.1603/0013-8746(2002)095[0125:GSOAAD]2.0.CO;2
   Braks MAH, 2003, J MED ENTOMOL, V40, P785, DOI 10.1603/0022-2585-40.6.785
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Buja K., 2016, SAMPLING DESIGN TOOL
   Callender DM, 2019, GLOB PUBLIC HEALTH, V14, P445, DOI 10.1080/17441692.2018.1512144
   CAUSEY OR, 1961, AM J TROP MED HYG, V10, P227, DOI 10.4269/ajtmh.1961.10.227
   Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DERODANICHE E, 1957, AM J TROP MED HYG, V6, P232, DOI 10.4269/ajtmh.1957.6.232
   Despommier D, 2006, ECOHEALTH, V3, P281, DOI 10.1007/s10393-006-0063-3
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diuk-Wasser MA, 2006, VECTOR-BORNE ZOONOT, V6, P283, DOI 10.1089/vbz.2006.6.283
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   DOWNS WG, 1955, AM J TROP MED HYG, V4, P837, DOI 10.4269/ajtmh.1955.4.837
   Ewers RM, 2007, ECOLOGY, V88, P96, DOI 10.1890/0012-9658(2007)88[96:SIBEAA]2.0.CO;2
   Farias IP, 2015, J HERED, V106, P512, DOI 10.1093/jhered/esv048
   Faust CL, 2018, ECOL LETT, V21, P471, DOI 10.1111/ele.12904
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Fernandes RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56669-4
   Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002
   Ferreira-de-Lima VH, 2020, ACTA TROP, V205, DOI 10.1016/j.actatropica.2020.105386
   Forattini O.P., 1996, CULICIDOLOGIA MEDICA, P549
   GALINDO P, 1959, AM J TROP MED HYG, V8, P557, DOI 10.4269/ajtmh.1959.8.557
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Mourao MPG, 2015, REV SOC BRAS MED TRO, V48, P20, DOI 10.1590/0037-8682-0133-2013
   Saraiva MDG, 2013, REV SOC BRAS MED TRO, V46, P223, DOI 10.1590/0037-8682-1573-2013
   Gordo M, 2013, DEV PRIMATOL-PROG PR, P357, DOI 10.1007/978-1-4614-8839-2_23
   Guimaraes J.H., 1997, SYSTEMATIC DATABASE, P286
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Hanley KA, 2013, INFECT GENET EVOL, V19, P292, DOI 10.1016/j.meegid.2013.03.008
   Heinisch MRS, 2019, ACTA TROP, V189, P104, DOI 10.1016/j.actatropica.2018.09.011
   Honorio NA, 2018, BIOL INVASIONS, V20, P653, DOI 10.1007/s10530-017-1565-3
   Honorio NA, 2009, CAD SAUDE PUBLICA, V25, P1203, DOI 10.1590/S0102-311X2009000600003
   INMET, 2019, BANC DAD MET ENS PES
   Instituto Brasileiro de Geografia e Estatistica, 2017, MANAUS
   Juliano SA, 2004, OECOLOGIA, V139, P583, DOI 10.1007/s00442-004-1532-4
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   Khaklang S, 2014, J VECTOR ECOL, V39, P448, DOI 10.1111/jvec.12122
   Lane J, 1953, NEOTROPICAL CULICIDA, V2, P1112
   Lane J., 1953, NEOTROPICAL CULICIDA, V1, P1112
   Laurance WF, 2004, PHILOS T R SOC B, V359, P345, DOI 10.1098/rstb.2003.1430
   Leite TF, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00145
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   LOPES OD, 1981, AM J EPIDEMIOL, V113, P122
   Lounibos LP, 2018, BIOL INVASIONS, V20, P1913, DOI 10.1007/s10530-018-1674-7
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   Lourenco-de-Oliveira R, 1994, PRINCIPAIS MOSQUITOS, P228, DOI DOI 10.7476/9788575412909
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Malcolm JR, 1998, CLIMATIC CHANGE, V39, P487, DOI 10.1023/A:1005376603186
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Medeiros-Sousa AR, 2015, ACTA TROP, V150, P200, DOI 10.1016/j.actatropica.2015.08.002
   Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1
   Mendenhall IH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005667
   Ministerio da Saude, 2014, B EPIDEMIOL, V45
   Ministerio da Saude, 2019, B EPIDEMIOL, V50
   Ministerio da Saude, 2017, B EPIDEMIOL, V48
   Miot EF, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007783
   Mordecai EA, 2019, ECOL LETT, V22, P1690, DOI 10.1111/ele.13335
   Mucci LF, 2016, J AM MOSQUITO CONTR, V32, P329, DOI 10.2987/16-6587.1
   OKSANEN J, 2007, COMMUNITY ECOLOGY PA, V10, P631
   Pan American Health Organization, 2017, ZIK EP REP BRAZ
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   REINERT J. F., 2009, EUROPEAN MOSQUITO B, V27, P68
   Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Richman R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2832-6
   Rodaniche E.d, 1961, AM J TROP MED HYG, V10, P393, DOI 10.4269/ajtmh.1961.10.393.
   Rodriguez E., 2005, ASSESSMENT SRTM TOPO
   Roiz D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128112
   Sallam MF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101230
   Sallum MAM, 1996, J AM MOSQUITO CONTR, V12, P517
   SAS Institute Inc, 2018, JMP VERS 14
   Seferovic M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25205-1
   Shubeita FD, 2012, BRAZ SYM COMPUT SYST, P225, DOI 10.1109/SBESC.2012.53
   Sileshi G, 2006, B ENTOMOL RES, V96, P479, DOI 10.1079/BER2006449
   Steiger DBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1675-2
   Steiger DM, 2012, J VECTOR ECOL, V37, P69, DOI 10.1111/j.1948-7134.2012.00201.x
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   USGS, 2000, SHUTTL RAD TOP MISS
   Valencia J.D., 1973, CONTRIB AM ENTOMOL I, V9
   Vanchiere JA, 2018, AM J TROP MED HYG, V98, P173, DOI 10.4269/ajtmh.17-0322
   Vasconcelos PFC, 1997, AM J TROP MED HYG, V57, P132, DOI 10.4269/ajtmh.1997.57.132
   Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602
   WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121
   Walter Reed Biosystematics Unit, 2019, WRBU NEW MOSQS CLASS
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wood CL, 2014, ECOLOGY, V95, P817, DOI 10.1890/13-1041.1
NR 98
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD JUN
PY 2020
VL 206
AR UNSP 105441
DI 10.1016/j.actatropica.2020.105441
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LF7CR
UT WOS:000527575700011
PM 32173316
OA Other Gold
DA 2020-07-08
ER

PT J
AU Lucia, A
   Toloza, AC
   Fanucce, M
   Fernandez-Pena, L
   Ortega, F
   Rubio, RG
   Coviella, C
   Guzman, E
AF Lucia, Alejandro
   Toloza, Ariel Ceferino
   Fanucce, Micaela
   Fernandez-Pena, Laura
   Ortega, Francisco
   Rubio, Ramon G.
   Coviella, Carlos
   Guzman, Eduardo
TI Nanoemulsions based on thymol-eugenol mixtures: characterization,
   stability and larvicidal activity against Aedes aegypti
SO BULLETIN OF INSECTOLOGY
LA English
DT Article
DE yellow fever mosquito; essential oils; nanoemulsions; larvicidal
   activity; botanical products; thymol; eugenol
ID PLANT ESSENTIAL OILS; ISRAELENSIS BTI; ZIKA VIRUS; NANOPARTICLES;
   PERMETHRIN; EUCALYPTUS; EMERGENCE; MOSQUITOS; TOXICITY; VECTORS
AB Dengue, Zika, chikungunya and yellow fever are the most important vector-borne diseases worldwide transmitted to humans by Aedes aegypti (L.) (Diptera Culicidae). Thus, the control of this vector is of vital importance in order to avoid epidemics in tropical and neo-tropical areas. To find new and effective larvicidal formulations for control programs against mosquito populations, aqueous dispersions containing thymol and eugenol were characterized and tested against Ae. aegypti larvae. The dispersion and stabilization of thymol and eugenol in water was possible using a triblock copolymer with two lateral blocks of poly(ethylene oxide) and a central block of poly(propylene oxide), the so-called poloxamer 407, which allows obtaining oil in water (o/w) emulsion. Dynamic Light Scattering (DLS) points out that emulsions containing eugenol were in most cases monodisperse with an average apparent hydrodynamic diameter of the droplets in the 20-25 nm without destabilization after 28 months from their preparation, which plays a key role for the potential application of the studied formulations. On the other side, those emulsions containing only thymol as oil phase had higher polydispersity, suggesting a central role of eugenol in the dispersion of thymol in water. Furthermore, the combined effect of thymol and eugenol against Ae. aegypti larvae was evaluated. The nanoemulsion containing thymol as main component of the oil phase (100%) showed the lowest LC50 and the introduction of eugenol to the nanoemulsions facilitated the dispersion and stability of thymol in water, even though reducing the effectiveness of the emulsions. The findings on the larvicidal effects of the combined application of the monoterpenes tested could be considered a promising contribution to the development of botanical-derived larvicidal formulations against mosquitos.
C1 [Lucia, Alejandro; Coviella, Carlos] CONICET UNLu, Inst Ecol & Desarrollo Sustentable INEDES, Ruta 5 & Ave Constituc, RA-6700 Buenos Aires, DF, Argentina.
   [Lucia, Alejandro] UNLP, Fac Ciencias Agr & Forestales, Ctr Invest Sanidad Vegetal CISaV, La Plata, Argentina.
   [Toloza, Ariel Ceferino] Consejo Nacl Invest Cient & Tecn, Ctr Invest Plagas & Insecticidas, UNIDEF, San Juan Bautista La Salle 4397,B1603ALO, Buenos Aires, DF, Argentina.
   [Fanucce, Micaela] Adm Nacl Boratorios & Inst Salud ANLIS, Ctr Nacl Diagnost & Invest Endemoepidem CeNDIE, Buenos Aires, DF, Argentina.
   [Fernandez-Pena, Laura; Ortega, Francisco; Rubio, Ramon G.; Guzman, Eduardo] Univ Complutense Madrid, Fac Ciencias Quim, Dept Quim Fis, Ciudad Univ S-N, E-28040 Madrid, Spain.
   [Ortega, Francisco; Rubio, Ramon G.; Guzman, Eduardo] Univ Complutense Madrid, Inst Pluridisciplinar, Madrid, Spain.
   [Coviella, Carlos] Univ Nacl Lujan, Dept Ciencias Basicas, Lujan, Buenos Aires, Argentina.
RP Lucia, A (corresponding author), CONICET UNLu, Inst Ecol & Desarrollo Sustentable INEDES, Ruta 5 & Ave Constituc, RA-6700 Buenos Aires, DF, Argentina.; Lucia, A (corresponding author), UNLP, Fac Ciencias Agr & Forestales, Ctr Invest Sanidad Vegetal CISaV, La Plata, Argentina.
EM luciaalejandro@yahoo.com.ar
RI Guzman, Eduardo/D-9201-2011
OI Guzman, Eduardo/0000-0002-4682-2734
FU Programa Estatal de Investigacion, desarrollo e innovacion orientada a
   los retos de la sociedad [CTQ2016-78895-R]; Agencia Nacional de
   Promocion Cientifica y Tecnica (ANPCyT)ANPCyT [PICT 2016-1111]
FX Alejandro Lucia is especially grateful to the Research Institute of
   Theoretical and Applied Physical Chemistry for the use of their services
   (Dynamic Light Scattering (DLS) experiments) (INIFTA/UNLP-CONICET), La
   Plata, Argentina. We also are grateful to C.A.I. de Espectroscopia y
   Correlacion of the Universidad Complutense de Madrid, for the use of
   their facilities. Francisco Ortega, Ramon G. Rubio and Eduardo Guzman
   carried out this research with the financial support of Programa Estatal
   de Investigacion, desarrollo e innovacion orientada a los retos de la
   sociedad with the Project title "Propiedades de nuevos sistemas
   nanoestructurados de importancia tecnologica" (CTQ2016-78895-R), and
   Alejandro Lucia and Ariel Toloza were funded by Agencia Nacional de
   Promocion Cientifica y Tecnica (ANPCyT) under grant PICT 2016-1111
   entitled "Nuevas formulaciones biocompatibles de origen botanico para el
   control de piojos de la cabeza resistentes a permetrina: un enfoque
   integral".
CR Albo GN, 2003, APIDOLOGIE, V34, P417, DOI 10.1051/apido:2003040
   Andrade-Ochoa S, 2018, INSECTS, V9, DOI 10.3390/insects9010025
   Baskar K, 2018, PHYSIOL MOL PLANT P, V101, P197, DOI 10.1016/j.pmpp.2017.03.002
   BATRAKOVA E. V., 2006, NANOPARTICULATES DRU, P5
   Batrakova EV, 2008, J CONTROL RELEASE, V130, P98, DOI 10.1016/j.jconrel.2008.04.013
   Benelli G, 2016, ASIAN PAC J TROP BIO, V6, P353, DOI 10.1016/j.apjtb.2015.10.015
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   BERNE B. J., 2013, DYNAMIC LIGHT SCATTE
   Boyce R, 2013, TROP MED INT HEALTH, V18, P564, DOI 10.1111/tmi.12087
   Campolo O, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13413-0
   CARVALHO L. A. D. F., 2000, ENTOMOL VECTORES, V7, P191
   Chen CD, 2009, TROP BIOMED, V26, P360
   Enan E, 2001, COMP BIOCHEM PHYS C, V130, P325, DOI 10.1016/S1532-0456(01)00255-1
   Entwistle J, 2014, URBAN INSECT PESTS: SUSTAINABLE MANAGEMENT STRATEGIES, P23, DOI 10.1079/9781780642758.0023
   Faraone N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127774
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Gashout HA, 2009, J APICULT RES, V48, P263, DOI 10.3896/IBRA.1.48.4.06
   Girisgin AO, 2014, ISR J VET MED, V69, P192
   Godoi IP, 2017, J COMP EFFECT RES, V6, P165, DOI 10.2217/cer-2016-0045
   Govindarajan M, 2016, ENVIRON SCI POLLUT R, V23, P23228, DOI 10.1007/s11356-016-7568-2
   Gross AD, 2017, MED VET ENTOMOL, V31, P55, DOI 10.1111/mve.12197
   GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55
   Imdorf A, 1999, APIDOLOGIE, V30, P209, DOI 10.1051/apido:19990210
   Isman M., 1999, Pesticide Outlook, V10, P68
   Isman MB, 2008, PEST MANAG SCI, V64, P8, DOI 10.1002/ps.1470
   Isman MB, 2014, TRENDS PLANT SCI, V19, P140, DOI 10.1016/j.tplants.2013.11.005
   Khadka P, 2014, ASIAN J PHARM SCI, V9, P304, DOI 10.1016/j.ajps.2014.05.005
   Kim S, 2010, TARGETED DELIVERY OF SMALL AND MACROMOLECULAR DRUGS, P513, DOI 10.1201/9781420087734-c19
   Lau KW, 2015, J MED ENTOMOL, V52, P199, DOI 10.1093/jme/tju019
   Lucia A, 2008, ENTOMOL EXP APPL, V129, P107, DOI 10.1111/j.1570-7458.2008.00757.x
   Lucia A, 2007, J AM MOSQUITO CONTR, V23, P299, DOI 10.2987/8756-971X(2007)23[299:LEOEGE]2.0.CO;2
   Lucia A, 2017, PEERJ, V5, DOI 10.7717/peerj.3171
   Maggi MD, 2010, J ESSENT OIL RES, V22, P119, DOI 10.1080/10412905.2010.9700278
   Masetti A, 2016, B INSECTOL, V69, P307
   Masuh H., 2008, Dengue Bulletin, V32, P44
   Moretti M. D., 2002, AAPS PHARMSCITECH, V3, P64, DOI DOI 10.1208/PT030213
   Mossa A. T. H., 2016, Journal of Environmental Science and Technology, V9, P354
   MOTOYMA N., 2004, APISNIELLIFERA, V23, P371
   Norris EJ, 2015, J MED ENTOMOL, V52, P993, DOI 10.1093/jme/tjv090
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Pavoni L, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9091285
   Picollo MI, 2008, FITOTERAPIA, V79, P271, DOI 10.1016/j.fitote.2008.01.005
   Qualls WA, 2014, ACTA TROP, V131, P104, DOI 10.1016/j.actatropica.2013.12.004
   RAGAEI M, 2014, INT J SCI ENV TECHNO, V3, P528
   Regnault-Roger C, 2012, ANNU REV ENTOMOL, V57, P405, DOI 10.1146/annurev-ento-120710-100554
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   SAMAR S. I., 2019, HORTICULTURAL CROPS
   Savjani Ketan, 2012, ISRN PHARM
   Tisserand R, 1995, ESSENTIAL OILS SAFET
   Tong F, 2013, J MED ENTOMOL, V50, P826, DOI 10.1603/ME13002
   WADLEY F. M., 1967, EXPT STAT ENTOMOLOGY
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WILLIAMS AC, 1991, PHARM RES-DORDR, V8, P17, DOI 10.1023/A:1015813803205
NR 54
TC 1
Z9 1
U1 1
U2 1
PU ALMA MATER STUDIORUM, UNIV BOLOGNA
PI BOLOGNA
PA DEPT AGROENVIRONMENTAL SCIENCES & TECHNOLOGY, VIALE G FANIN, 42,
   BOLOGNA, 40127, ITALY
SN 1721-8861
J9 B INSECTOL
JI Bull. Insectology
PD JUN
PY 2020
VL 73
IS 1
BP 153
EP 160
PG 8
WC Entomology
SC Entomology
GA LD1YT
UT WOS:000525828400018
DA 2020-07-08
ER

PT J
AU Huang, MG
   Tang, MX
   Yu, JS
   Zheng, B
AF Huang, Mugen
   Tang, Moxun
   Yu, Jianshe
   Zheng, Bo
TI A STAGE STRUCTURED MODEL OF DELAY DIFFERENTIAL EQUATIONS FOR AEDES
   MOSQUITO POPULATION SUPPRESSION
SO DISCRETE AND CONTINUOUS DYNAMICAL SYSTEMS
LA English
DT Article
DE Dengue fever; Wolbachia; cytoplasmic incompatibility; population
   suppression strategy; delay differential equation
ID WOLBACHIA INFECTION DYNAMICS; ALBOPICTUS; DENGUE; ESTABLISHMENT;
   COMPETITION; ABUNDANCE; INVASION; SPREAD
AB Tremendous efforts have been devoted to the development and analysis of mathematical models to assess the efficacy of the endosymbiotic bacterium Wolbachia in the control of infectious diseases such as dengue and Zika, and their transmission vector Aedes mosquitoes. However, the larval stage has not been included in most models, which causes an inconvenience in testing directly the density restriction on population growth. In this work, we introduce a system of delay differential equations, including both the adult and larval stages of wild mosquitoes, interfered by Wolbachia infected males that can cause complete female sterility. We clarify its global dynamics rather completely by using delicate analyses, including a construction of Liapunovtype functions, and determine the threshold level Ro of infected male releasing. The wild population is suppressed completely if the releasing level exceeds R-0 uniformly. The dynamical complexity revealed by our analysis, such as bistability and semi-stability, is further exhibited through numerical examples. Our model generates a temporal profile that captures several critical features of Aedes albopictus population in Guangzhou from 2011 to 2016. Our estimate for optimal mosquito control suggests that the most cost-efficient releasing should be started no less than 7 weeks before the peak dengue season.
C1 [Huang, Mugen] Guangdong Univ Finance & Econ, Sch Stat & Math, Guangzhou 510320, Peoples R China.
   [Tang, Moxun] Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
   [Yu, Jianshe; Zheng, Bo] Guangzhou Univ, Ctr Appl Math, Guangzhou 510006, Peoples R China.
   [Yu, Jianshe; Zheng, Bo] Guangzhou Univ, Coll Math & Informat Sci, Guangzhou 510006, Peoples R China.
RP Tang, MX (corresponding author), Michigan State Univ, Dept Math, E Lansing, MI 48824 USA.
EM mghuang@gduf.edu.cn; tang@math.msu.edu; jsyu@gzhu.edu.cn;
   zhengbo611@outlook.com
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11471085, 11631005]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2017A030310597]; Guangdong University of Finance & Economics
   Big Data and Educational Statistics Application Lab [2017WSYS001]
FX This work was supported by National Natural Science Foundation of China
   (11471085, 11631005), Natural Science Foundation of Guangdong Province
   (2017A030310597), and Guangdong University of Finance & Economics Big
   Data and Educational Statistics Application Lab. (2017WSYS001).
CR Agnew P, 2002, ECOL ENTOMOL, V27, P396, DOI 10.1046/j.1365-2311.2002.00430.x
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cailly P, 2012, ECOL MODEL, V227, P7, DOI 10.1016/j.ecolmodel.2011.10.027
   Cheng Q, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004417
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1018, DOI 10.1093/jmedent/30.6.1018
   FREEDMAN HI, 1980, MONOGRAPHS TXB PURE, V57
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hu LC, 2019, J DIFFER EQUATIONS, V266, P4377, DOI 10.1016/j.jde.2018.09.035
   Hu LC, 2019, J THEOR BIOL, V462, P247, DOI 10.1016/j.jtbi.2018.11.009
   Hu LC, 2015, THEOR POPUL BIOL, V106, P32, DOI 10.1016/j.tpb.2015.09.003
   Huang MG, 2019, J APPL ANAL COMPUT, V9, P211, DOI 10.11948/2019.211
   Huang MG, 2018, J THEOR BIOL, V440, P1, DOI 10.1016/j.jtbi.2017.12.012
   Huang MG, 2016, SCI CHINA MATH, V59, P1249, DOI 10.1007/s11425-016-5149-y
   Huang MG, 2015, SCI CHINA MATH, V58, P77, DOI 10.1007/s11425-014-4934-8
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Lana RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190673
   Li Y. J., 2014, PLOS NEGLECT TROP D, V8
   Lin HL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004919
   Liu Fusheng, 1992, Acta Scientiarum Naturalium Universitatis Sunyatseni, V31, P84
   Liu Fusheng, 1990, Acta Scientiarum Naturalium Universitatis Sunyatseni, V29, P118
   LIU ZW, 1985, ACTA ENTOMOL SINICA, V28, P274
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Smith H, 2011, TEXTS APPL MATH, V57, P1, DOI 10.1007/978-1-4419-7646-8
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Walsh RK, 2011, J VECTOR ECOL, V36, P300, DOI 10.1111/j.1948-7134.2011.00170.x
   Walsh RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035959
   Waltz E, 2016, NATURE, V533, P450, DOI 10.1038/533450a
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yu JS, 2019, J DIFFER EQU APPL, V25, P1549, DOI 10.1080/10236198.2019.1669578
   Yu JS, 2018, SIAM J APPL MATH, V78, P3168, DOI 10.1137/18M1204917
   Zheng B, 2019, J THEOR BIOL, V472, P95, DOI 10.1016/j.jtbi.2019.04.010
   Zheng B, 2018, ECOL MODEL, V387, P38, DOI 10.1016/j.ecolmodel.2018.09.004
   Zheng B, 2018, MATH BIOSCI ENG, V15, P523, DOI 10.3934/mbe.2018024
   Zheng B, 2018, J MATH BIOL, V76, P235, DOI 10.1007/s00285-017-1142-5
   Zheng B, 2014, SIAM J APPL MATH, V74, P743, DOI 10.1137/13093354X
   Zhong Z, 1988, ZHONGSHAN YI KE DA X, V9, P35
   ZHONG Z-L, 1990, Acta Entomologica Sinica, V33, P64
NR 40
TC 1
Z9 1
U1 6
U2 6
PU AMER INST MATHEMATICAL SCIENCES-AIMS
PI SPRINGFIELD
PA PO BOX 2604, SPRINGFIELD, MO 65801-2604 USA
SN 1078-0947
EI 1553-5231
J9 DISCRETE CONT DYN-A
JI Discret. Contin. Dyn. Syst.
PD JUN
PY 2020
VL 40
IS 6
SI SI
BP 3467
EP 3484
DI 10.3934/dcds.2020042
PG 18
WC Mathematics, Applied; Mathematics
SC Mathematics
GA KU2LO
UT WOS:000519540200022
OA Other Gold
DA 2020-07-08
ER

PT J
AU Cunha, MS
   Luchs, A
   dos Santos, FCP
   Caleiro, GS
   Nogueira, ML
   Maiorka, PC
AF Cunha, Mariana Sequetin
   Luchs, Adriana
   Pereira dos Santos, Fabiana Cristina
   Caleiro, Giovana Santos
   Nogueira, Mauricio Lacerda
   Maiorka, Paulo Cesar
TI Applying a pan-flavivirus RT-qPCR assay in Brazilian public health
   surveillance
SO ARCHIVES OF VIROLOGY
LA English
DT Article; Early Access
ID INSECT-SPECIFIC FLAVIVIRUSES; ZIKA VIRUS; IDENTIFICATION; ARBOVIRUS;
   MOSQUITOS; POLYMERASE; STATE; GENUS; RNA
AB The aim of this study was to improve flavivirus field monitoring in Brazil using a reliable probe-based RT-qPCR assay. Standard flavivirus strains were employed to evaluate the performance of the assay, and its applicability was evaluated using 235 stored pools of Culicidae samples collected between 1993 and 1997 and in 2016. Flavivirus species were identified by sequencing. Sixteen (6.8%) samples tested positive: Ilheus virus, Iguape virus, and Saint Louis encephalitis virus were identified in historical specimens from 1993-1994, while insect-specific flaviviruses were detected in the samples from 2016. This approach was demonstrated to be accurate for flavivirus detection and characterization, and it can be successfully applied for vector surveillance and for monitoring and discovery of insect specific flaviviruses.
C1 [Cunha, Mariana Sequetin; Caleiro, Giovana Santos] Adolfo Lutz Inst, Virol Ctr, Vector Borne Dis Lab, Sao Paulo, Brazil.
   [Luchs, Adriana] Adolfo Lutz Inst, Virol Ctr, Enter Dis Lab, Sao Paulo, Brazil.
   [Pereira dos Santos, Fabiana Cristina] Adolfo Lutz Inst, Virol Ctr, Resp Dis Lab, Sao Paulo, Brazil.
   [Caleiro, Giovana Santos] Univ Sao Paulo, Sao Paulo Inst Trop Med, Virol Lab, Sao Paulo, Brazil.
   [Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto FAMERP, Sao Paulo, SP, Brazil.
   [Maiorka, Paulo Cesar] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, Sao Paulo, Brazil.
RP Cunha, MS (corresponding author), Adolfo Lutz Inst, Virol Ctr, Vector Borne Dis Lab, Sao Paulo, Brazil.
EM masequetin@yahoo.com.br
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2012/23645-4, 2013/21719-3]
FX This work was also supported by FAPESP #2012/23645-4 (Dr. Paulo Cesar
   Mayorca) and FAPESP #2013/21719-3 (Dr. Mauricio Lacerda Nogueira).
CR Batista WC, 2011, REV SOC BRAS MED TRO, V44, P528, DOI 10.1590/S0037-86822011000400028
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biacchesi S, 2005, J VIROL METHODS, V128, P192, DOI 10.1016/j.jviromet.2005.05.005
   Bocato-Chamelet Esther Luiza, 2001, Revista do Instituto Adolfo Lutz, V60, P65
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Bronzoni RVD, 2005, J CLIN MICROBIOL, V43, P696, DOI 10.1128/JCM.43.2.696-702.2005
   Carrera JP, 2015, AM J TROP MED HYG, V93, P1014, DOI 10.4269/ajtmh.15-0117
   Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101
   COIMBRA TLM, 1993, INTERVIROLOGY, V36, P144, DOI 10.1159/000150333
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Vieira CJDP, 2019, T ROY SOC TROP MED H, V113, P424, DOI 10.1093/trstmh/trz031
   Domingo C, 2012, J CLIN MICROBIOL, V50, P4054, DOI 10.1128/JCM.01799-12
   Dyer J, 2007, J VIROL METHODS, V145, P9, DOI 10.1016/j.jviromet.2007.05.001
   Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   GOMES G, 1959, P SOC EXP BIOL MED, V101, P275, DOI 10.3181/00379727-101-24909
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gravina HD, 2019, VIROLOGY, V527, P98, DOI 10.1016/j.virol.2018.11.008
   GUBLER DJ, 1984, AM J TROP MED HYG, V33, P158, DOI 10.4269/ajtmh.1984.33.158
   Guiana F, 2019, EPIDEMIOLOGICAL UPDA, P6
   Guzman H, 2018, AM J TROP MED HYG, V98, P410, DOI 10.4269/ajtmh.17-0350
   Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2
   Hoshino K, 2012, J MED ENTOMOL, V49, P175, DOI 10.1603/ME11123
   Junglen S, 2009, J VIROL, V83, P4462, DOI 10.1128/JVI.00014-09
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Moureau G, 2007, VECTOR-BORNE ZOONOT, V7, P467, DOI 10.1089/vbz.2007.0206
   Moureau G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117849
   Nassar ES, 1997, INTERVIROLOGY, V40, P247, DOI 10.1159/000150554
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   Pauvolid-Correa A, 2015, ARCH VIROL, V160, P21, DOI 10.1007/s00705-014-2219-8
   Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318
   Pereira LE, 2001, REV SAUDE PUBL, V35, P119, DOI 10.1590/S0034-89102001000200003
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Rocco Iray M., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P281, DOI 10.1590/S0036-46652005000500008
   Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93
   Romeiro MF, 2016, REV SOC BRAS MED TRO, V49, P279, DOI 10.1590/0037-8682-0444-2015
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   TANAKA M, 1993, J VIROL METHODS, V41, P311, DOI 10.1016/0166-0934(93)90020-R
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
NR 45
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
DI 10.1007/s00705-020-04680-w
EA MAY 2020
PG 6
WC Virology
SC Virology
GA LS5VD
UT WOS:000536450600003
PM 32474687
DA 2020-07-08
ER

PT J
AU Jitsatja, A
   Ramphan, S
   Promma, P
   Kuadkitkan, A
   Wikan, N
   Uiprasertkul, M
   Phatihattakorn, C
   Smith, DR
AF Jitsatja, Anusara
   Ramphan, Suwipa
   Promma, Ploenphit
   Kuadkitkan, Atichat
   Wikan, Nitwara
   Uiprasertkul, Mongkol
   Phatihattakorn, Chayawat
   Smith, Duncan R.
TI Comparative analysis of a Thai congenital-Zika-syndrome-associated virus
   with a Thai Zika-fever-associated virus
SO ARCHIVES OF VIROLOGY
LA English
DT Article; Early Access
ID INFECTION; MUTATION
AB In this study, we compared the characteristics of two strains of Zika virus (ZIKV) isolated in Thailand, one isolated from a febrile patient and one isolated from tissues of a fetus medically terminated due to congenital Zika syndrome (CZS). Replication profiles showed that the isolate from the fetal tissues replicated significantly more slowly than the fever-associated isolate in human lung A549 cells during the first 24 hours postinfection but showed a similar growth profile over longer-term infection. A much smaller difference was observed in Aedes albopictus C6/36 cells. In a quasispecies analysis, a high proportion (approximately 20%) of nonfunctional genomes was identified, caused by an adenine insertion in the prM gene. This insertion was found to be present in two Thai fever strains and as such may represent a common feature of Thai endemic ZIKV. Comparison between viral RNA copy number and viral titer showed that the isolate from fetal tissues was produced more efficiently than the fever-associated isolate. Together, these results suggest that different ZIKV isolates differ in their replication capacity, and this might contribute to the fetotropic potential of a particular strain.
C1 [Jitsatja, Anusara; Ramphan, Suwipa; Promma, Ploenphit; Kuadkitkan, Atichat; Wikan, Nitwara; Smith, Duncan R.] Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
   [Uiprasertkul, Mongkol] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Pathol, Bangkok, Thailand.
   [Phatihattakorn, Chayawat] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Obstet & Gynaecol, Bangkok, Thailand.
RP Smith, DR (corresponding author), Mahidol Univ, Inst Mol Biosci, Salaya, Nakhon Pathom, Thailand.
EM duncan_r_smith@hotmail.com
RI Smith, Duncan R./C-6891-2011
OI Smith, Duncan R./0000-0002-6592-9852
FU Thailand Research FundThailand Research Fund (TRF) [IRN5802PHDW03,
   IRN58W0002, BRG6080006]; National Science and Technology Development
   Agency [P-16-50685]; Health Systems Research Institute [HSRI 60-064];
   Mahidol University
FX This research was funded by the Thailand Research Fund (grant numbers
   BRG6080006 and IRN58W0002), the National Science and Technology
   Development Agency (grant number P-16-50685), the Health Systems
   Research Institute (grant no. HSRI 60-064) and Mahidol University. SR is
   supported by a scholarship from the Thailand Research Fund
   (IRN5802PHDW03 under IRN58W0002). The funders had no role in the design
   of the study, in the collection, analysis, or interpretation of data, in
   the writing of the manuscript, or in the decision to publish the
   results.
CR Abramoff MD, 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   BASSAM BJ, 1991, ANAL BIOCHEM, V196, P80, DOI 10.1016/0003-2697(91)90120-I
   Borresen AL, 2002, CURR PROTOC HUM GENE
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Oliveira WK, 2016, MMWR-MORBID MORTAL W, V65
   Domingo E, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008271
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   Heang V, 2012, EMERG INFECT DIS, V18, P349, DOI 10.3201/eid1802.111224
   Hung SL, 1999, VIROLOGY, V257, P156, DOI 10.1006/viro.1999.9633
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kuadkitkan A, 2020, J INFECT PUBLIC HEAL, V13, P11, DOI 10.1016/j.jiph.2019.09.012
   Lan PT, 2017, PLOS CURR
   Li BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203331
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nitatpattana N, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00121-18, 10.1128/genomea.00121-18]
   Potapov V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169774
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10
   Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   van Boheemen S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02652-w
   Venkataraman S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020076
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wongsurawat T, 2018, MICROBIOL RESOUR ANN, V7, DOI [10.1128/MRA.01020-18, 10.1128/mra.01020-18]
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zybert IA, 2008, J GEN VIROL, V89, P3047, DOI 10.1099/vir.0.2008/002535-0
NR 41
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
DI 10.1007/s00705-020-04667-7
EA MAY 2020
PG 11
WC Virology
SC Virology
GA LS5VD
UT WOS:000536450600001
PM 32474686
DA 2020-07-08
ER

PT J
AU Rodriguez, S
   Sanz, AM
   Llano, G
   Navarro, A
   Parra-Lara, LG
   Krystosik, AR
   Rosso, F
AF Rodriguez, Sarita
   Maria Sanz, Ana
   Llano, Gonzalo
   Navarro, Andres
   Gabriel Parra-Lara, Luis
   Krystosik, Amy R.
   Rosso, Fernando
TI Acceptability and usability of a mobile application for management and
   surveillance of vector-borne diseases in Colombia: An implementation
   study
SO PLOS ONE
LA English
DT Article
ID DENGUE; CHIKUNGUNYA; COINFECTION; ILLNESS; ZIKA
AB Background
   Vector-borne diseases are a public health problem in Colombia, where dengue virus infection is hyperendemic. The introduction of other arboviruses, such as chikungunya and Zika in the last three years, has aggravated the situation. Mobile health (mHealth) offers new strategies for strengthening health care and surveillance systems promoting the collection, delivery, and access of health information to professionals, researchers, and patients. Assessing mobile application performance has been a challenge in low- and middle-income countries due to the difficulty of implementing these technologies in different clinical settings. In this study, we evaluate the usability and acceptability of a mobile application, FeverDX, as a support tool in the management of patients with febrile syndrome and suspected arboviruses infection by general practitioners from Colombia.
   Methods
   A pilot implementation study was conducted to evaluate the usability and acceptability of FeverDX using the modified version of the Mobile Application Rating Scale (uMARS). The evaluation form included 25 questions regarding quantity and quality of information, engagement, functionality, aesthetics, impact, and acceptability by healthcare workers. Each item uses a 5-point scale (1-Inadequate, 2-Poor, 3-Acceptable, 4-Good, 5-Excellent). A global score was obtained for the evaluation form test by determining the median scores of each subsection. A descriptive statistical analysis of the data obtained was performed.
   Results
   Between December 2016 and January 2017, a total of 20 general practitioners from the Emergency room and hospitalization areas evaluated FeverDX. Less than half (9/20) of the evaluators had a comprehensive knowledge of the Colombian Ministry of Health's guidelines for the diagnosis and management of arboviruses, and evaluators partially (4/9) or completely (5/9) agreed that the content of the application follows the management guidelines. On uMARS scale, FeverDX excelled regarding impact (median 5; IQR = 5-5), functionality (median 5; IQR = 4.8-5), and information and scientific basis (median 4; IQR = 4-4). FeverDX scored well regarding user feedback (median 4; IQR = 4-4.5), design and aesthetics (median 4; IQR = 4-4.3), and subjective assessment of quality (median 4.5; IQR = 4.3-4.8).
   Conclusions
   FeverDX, a mobile application, is a novel mHealth strategy to strengthen care processes and facilitate the detection and reporting of notifiable surveillance diseases. It could improve adherence to clinical practice guidelines for the management and prevention of prevalent diseases as arboviruses in healthcare settings.
   Although this pilot study used a small sample size, FeverDx performed adequately in a simulated emergency consultation. Further implementation studies are needed to increase the reliability of mHealth technologies in different scenarios.
C1 [Rodriguez, Sarita; Maria Sanz, Ana; Gabriel Parra-Lara, Luis; Rosso, Fernando] Fdn Valle Lili, CIC, Cali, Colombia.
   [Llano, Gonzalo; Navarro, Andres] Univ Icesi, Grp Invest I2T, Cali, Colombia.
   [Gabriel Parra-Lara, Luis; Rosso, Fernando] Univ Icesi, Fac Ciencias Salud, Cali, Colombia.
   [Krystosik, Amy R.] Stanford Univ, Dept Pediat, Sch Med, Div Infect Dis, Stanford, CA 94305 USA.
   [Rosso, Fernando] Fdn Valle Lili, Dept Internal Med, Infect Dis Serv, Cali, Colombia.
RP Rodriguez, S (corresponding author), Fdn Valle Lili, CIC, Cali, Colombia.
EM sarita.rodriguez@fvl.org.co
OI LLano Ramirez, Gonzalo/0000-0001-7231-9510; Parra Lara, Luis
   Gabriel/0000-0002-4877-1117
FU Fundacion Valle del Lili; Universidad Icesi
FX This study was funded by Fundacion Valle del Lili and Universidad Icesi.
   The funders don't play role in the study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Agarwal S, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1174
   Agarwal S, 2015, TROP MED INT HEALTH, V20, P1003, DOI 10.1111/tmi.12525
   Alvis-Guzman N, 2017, REV MVZ CORDOBA, V22, P5994, DOI 10.21897/rmvz.1069
   Austad B, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0490-3
   Bhagat K, 2001, East Afr Med J, V78, P30
   Boyce SP, 2019, J GLOB HEALTH, V9, DOI 10.7189/jogh.09.010811
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Early J, 2019, HEALTH PROMOT PRACT, V20, P805, DOI 10.1177/1524839919855391
   Fougerouse P-A, 2018, AMIA ANN S P AMIA S, V2017, P715
   Furuya-Kanamori L, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1417-2
   Garcia Perez C, 2013, REV ARCH MED CAMAG, V17, P784
   Gasca Mantilla Maira Cecilia, 2014, Tecnura, V18, P20
   Grau I, 2016, Semergen, V42, P575, DOI 10.1016/j.semerg.2015.12.001
   Grundy QH, 2016, AM J PREV MED, V51, P1051, DOI 10.1016/j.amepre.2016.07.009
   Hamrioui S, 2018, INT J CLIN MED INFOR, V1, P13
   Haque F, 2017, PLOS NEGLECT TROP D, V11, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005290
   Instituto Nacional de Salud (INS), 2016, PROT VIG SAL PUBL LE
   Jahns R-G, 2013, MOBILE HLTH MARKET R, P116
   Jairo Barrera Valencia John, 2018, ANALISIS SALUD MOVIL
   Madan A, 2012, INT J ENG SCI TECHNO, V4, P590
   Marcondes CB, 2017, J MED ENTOMOL, V54, P509, DOI 10.1093/jme/tjw209
   Mattar S, 2017, J INFECT PUBLIC HEAL, V10, P507, DOI 10.1016/j.jiph.2016.09.014
   Ministerio de Salud y Proteccion Social, 2010, GUIA AT CLIN INT PAC
   Ministerio de Salud y Proteccion Social, 2013, LIN MAN CLIN PAC VIR
   Ministerio de Salud y Proteccion Social, 2016, LIN AT CLIN INT PAC
   Ministerio de Tecnologias de la Informacion y las Comunicaciones, POL TRAT PROT DAT PE
   Mohanty B, 2019, GLOB BIOSECURITY, V1, P37, DOI [10.31646/gbio.39, DOI 10.31646/GBIO.39]
   Parreira R, 2014, EUROSURVEILLANCE, V19, P7
   Proctor E, 2011, ADM POLICY MENT HLTH, V38, P65, DOI 10.1007/s10488-010-0319-7
   Rojas Palacios JH., 2016, B EPIDEMIOLOGICO, V10
   Sim I, 2019, NEW ENGL J MED, V381, P956, DOI 10.1056/NEJMra1806949
   Stoyanov SR, 2016, JMIR MHEALTH UHEALTH, V4, P589, DOI 10.2196/mhealth.5849
   Stoyanov SR, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.3422
   World Health Organization, 2005, 58 AS MUND SAL, P128
   World Health Organization, 2011, MHEALTH NEW HORIZONS, V3, P66, DOI [10.4258/hir.2012.18.3.231, DOI 10.4258/HIR.2012.18.3.231]
   World Health Organization, 2019, DENG SEV DENG
   World Medical Association, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI DOI 10.1001/JAMA.2013.281053
NR 37
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2020
VL 15
IS 5
AR e0233269
DI 10.1371/journal.pone.0233269
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LU1WS
UT WOS:000537552800053
PM 32469894
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ward, MJ
   Carter, BH
   Walsh, CES
   Yukich, JO
   Wesson, DM
   Christofferson, RC
AF Ward, Matthew J.
   Carter, Brendan H.
   Walsh, Christine E. S.
   Yukich, Joshua O.
   Wesson, Dawn M.
   Christofferson, Rebecca C.
TI Short Report: Asymptomatic Zika virus infections with low viral loads
   not likely to establish transmission in New Orleans Aedes populations
SO PLOS ONE
LA English
DT Article
ID VECTOR COMPETENCE; MOSQUITOS; CHIKUNGUNYA; WOLBACHIA; DENGUE; OUTBREAK;
   VIREMIA
AB Aedes aegypti and Aedes albopictus are both vectors of Zika virus and both are endemic to the New Orleans Metropolitan area. Fortunately, to date there has been no known autochthonous transmission of Zika virus in New Orleans. No studies of the vector competence of local populations of Ae. aegypti and Ae. albopictus for Zika virus transmission have been conducted. To determine if New Orleans Ae. aegypti and Ae. albopictus mosquitoes are competent for Zika virus, mosquitoes were reared to generation F3 from eggs collected in New Orleans during the 2018 mosquito season. Adults were fed an infectious blood meal and kept for 15 days in an environmental chamber. Transmission assays were conducted at 4, 10, and 15 days post exposure and RT-PCR was run on bodies and saliva to detect the presence of Zika virus RNA. We observed remarkably low susceptibility of both Ae. aegypti and Ae. albopictus from New Orleans to a Zika strain from Panama after oral challenge. These results suggest a limited risk of Zika virus transmission should it be introduced to the New Orleans area, and may partially explain why no transmission was detected in Louisiana during the 2016 epidemic in the Americas, despite multiple known travel associated introductions to New Orleans. Despite these results these mosquito populations are known to be competent vectors for some other mosquito-borne viruses and control measures should not be relaxed.
C1 [Ward, Matthew J.; Carter, Brendan H.; Yukich, Joshua O.; Wesson, Dawn M.] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA.
   [Ward, Matthew J.] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA.
   [Walsh, Christine E. S.; Christofferson, Rebecca C.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.
   [Yukich, Joshua O.] Tulane Univ, Sch Publ Hlth & Trop Med, Ctr Appl Malaria Res & Evaluat, New Orleans, LA USA.
   [Christofferson, Rebecca C.] Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.
RP Christofferson, RC (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Baton Rouge, LA 70803 USA.; Christofferson, RC (corresponding author), Louisiana State Univ, Ctr Computat & Technol, Baton Rouge, LA 70803 USA.
EM rcarri1@lsu.edu
OI Ward, Matthew/0000-0001-8373-8438
FU Louisiana Mosquito Control Association Operational Research Fund Grant;
   National Institutes of Health/National Institute of General Medical
   SciencesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM122077]
FX This study was supported by a Louisiana Mosquito Control Association
   Operational Research Fund Grant -DMW-(http://www.lmca.us/) and the
   National Institutes of Health/National Institute of General Medical
   Sciences R01GM122077 - RCC-(https://www.nigms.nih.gov/).The funders had
   no role in study design, data collection and analysis, decision to
   publish, or preparation of the manuscript.
CR Allaire J XY, 2019, IANNONE R RMARKDOWN
   [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   [Anonymous], 2016, EPIDEMIOLOGY ID
   [Anonymous], 2016, TEXAS ANNOUNCES LOCA
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   BLACK WC, 1988, HEREDITY, V60, P173, DOI 10.1038/hdy.1988.29
   BOORMAN J, 1987, MED VET ENTOMOL, V1, P211, DOI 10.1111/j.1365-2915.1987.tb00346.x
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016298
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   FOCKS DA, 1981, AM J TROP MED HYG, V30, P1329, DOI 10.4269/ajtmh.1981.30.1329
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gonzalez MA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3359-1
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hugo LE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007281
   Kilpatrick AM, 2010, AM J TROP MED HYG, V83, P607, DOI 10.4269/ajtmh.2010.10-0005
   King JG, 2011, J BIOL CHEM, V286, P40824, DOI 10.1074/jbc.M111.280552
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   LMCA, 2007, MOSQ CONTR TRAIN MAN
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087
   McKenzie BA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216794
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Team R.C., 2018, R LANG ENV STAT COMP
   Tesla B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006733
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Thongsripong P, 2017, INVESTIGATION AEDES
   Tramonte AR, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214306
   UC Davis CfV-bDR, 2006, PROCEDURES PROCESSIN
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weeks DE, 2012, POWERPKG POWER ANAL
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wickham H, 2018, SCALES SCALE FUNCTIO
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Xie Y, 2019, KNITR GEN PURPOSE PA
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388
NR 44
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 29
PY 2020
VL 15
IS 5
AR e0233309
DI 10.1371/journal.pone.0233309
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LU1WS
UT WOS:000537552800061
PM 32469909
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lwin, MO
   Lu, JH
   Sheldenkar, A
   Cayabyab, YM
   Yee, AZH
   Smith, HE
AF Lwin, May Oo
   Lu, Jiahui
   Sheldenkar, Anita
   Cayabyab, Ysa Marie
   Yee, Andrew Zi Han
   Smith, Helen Elizabeth
TI Temporal and textual analysis of social media on collective discourses
   during the Zika virus pandemic
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika; Social media; Facebook; Twitter; Public health; Health
   communication
ID FACEBOOK; TWITTER; CRISIS; RISK
AB BackgroundWhile existing studies have investigated the role of social media on health-related communication, little is known about the potential differences between different users groups on different social media platforms in responses to a health event. This study sets out to explore the online discourse of governmental authorities and the public in Singapore during the recent Zika pandemic in 2016.MethodsSocial media data were extracted from Facebook and Twitter using retroactive keyword sourcing of the word "Zika" to search for posts and a location filter of "Singapore". Government posts, public posts, and replies to these original posts were included in the temporal and textual analysis.ResultsOverall, Facebook contained more government and individual content whereas Twitter had more content from news media accounts. Though the relative volume of Zika content from different data sources paralleled the peaks and troughs of Zika activities across time, discourses from different data sources differed in their temporal patterns, such that the public discourse died down faster than the government discourse after the outbreak was declared. In addition, the content of discourses differed among data sources. While government discourse included factual information of the disease, public discourse contained more elements of care such as worry about the risks to pregnant women, and elements of community such as well-wishes to each other.ConclusionsOur study demonstrates the temporal and content differences between user groups and social media platforms in social media conversations during the Zika pandemic. It suggests that future research should examine the collective discourse of a health event by investigating social media discourses within varied sources rather than focusing on a singular social media platform and by one particular type of users.
C1 [Lwin, May Oo; Sheldenkar, Anita; Cayabyab, Ysa Marie] Nanyang Technol Univ, Wee Kim Wee Sch Commun & Informat, 31 Nanyang Link, Singapore 637718, Singapore.
   [Lu, Jiahui] Tianjin Univ, Sch New Media & Commun, Tianjin 300072, Peoples R China.
   [Yee, Andrew Zi Han] Singapore Univ Technol & Design, Human Arts & Social Sci, 8 Sompah Rd, Singapore 487372, Singapore.
   [Smith, Helen Elizabeth] Nanyang Technol Univ, Lee Kong Chian Sch Med, 59 Nanyang Dr, Singapore 636921, Singapore.
RP Lu, JH (corresponding author), Tianjin Univ, Sch New Media & Commun, Tianjin 300072, Peoples R China.
EM jhlu@ntu.edu.sg
OI Lu, Jiahui/0000-0003-2984-7435
FU Singapore Ministry of Health's National Medical Research CouncilNational
   Medical Research Council, Singapore [NMRC/ZRRF/0004/2016]
FX This research is supported by the Singapore Ministry of Health's
   National Medical Research Council under its NMRC/ZRRF/0004/2016. The
   funders played no role in the design of the study and collection,
   analysis, and interpretation of data and in writing the manuscript.
CR Adebayo G, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000296
   Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   [Anonymous], 2013, R LANG ENV STAT COMP
   [Anonymous], 2016, WEEKLY INFECT DIS B
   Chapman B, 2014, PERSPECT PUBLIC HEAL, V134, P225, DOI 10.1177/1757913914538015
   Chia L., 2016, CHANNEL NEWS ASIA
   Csardi G., 2014, INT J COMPLEX SYST, DOI [10.3724/SP.J.1087.2009.02191., DOI 10.3724/SP.J.1087.2009.02191]
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Feinerer I, 2008, J STAT SOFTW, V25, P1
   Fellows I, 2014, WORDCLOUD WORD CLOUD, DOI [10.1097/QAD.0b013e32834c4adbcom/inward/record.url?eid=2-s2.0-8487840092&partnerID=tZOtx3y1, 10.3945/ajcn.112.053728]
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Kaplan AM, 2010, BUS HORIZONS, V53, P59, DOI 10.1016/j.bushor.2009.09.003
   Kenneth Benoit DM, 2017, STOPWORDS MULTILINGU
   Kwak H., 2010, WWW, P591, DOI DOI 10.1145/1772690.1772751
   Lwin MO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091974
   Moorhead SA, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.1933
   Neiger BL, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2775
   Nuti SV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109583
   Osborne M, 2014, ICWSM 2014
   Radzikowski Jacek, 2016, JMIR Public Health Surveill, V2, pe1, DOI 10.2196/publichealth.5059
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Rutsaert P, 2013, TRENDS FOOD SCI TECH, V30, P84, DOI 10.1016/j.tifs.2012.10.006
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Thackeray R, 2008, HEALTH PROMOT PRACT, V9, P338, DOI 10.1177/1524839908325335
   Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015
   Vijaykumar S, 2017, J AM MED INFORM ASSN, V24, P1155, DOI 10.1093/jamia/ocx028
   WHO, 2016, STRAITSTIMES SINGAPO
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Wijffels J, 2018, UDPIPE TOKENIZATION
   Winer RS, 2009, J INTERACT MARK, V23, P108, DOI 10.1016/j.intmar.2009.02.004
NR 32
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 29
PY 2020
VL 20
IS 1
DI 10.1186/s12889-020-08923-y
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LU8CY
UT WOS:000537977800002
PM 32471495
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Luo , D
   Miao , YJ
   Ke, XL
   Tan, ZY
   Hu, C
   Li, PH
   Wang, T
   Zhang, Y
   Sun, JH
   Liu, Y
   Wang, HZ
   Zheng, ZH
AF Luo, Dan
   Miao, Yuanjiu
   Ke, Xianliang
   Tan, Zhongyuan
   Hu, Chun
   Li, Penghui
   Wang, Ting
   Zhang, Yuan
   Sun, Jianhong
   Liu, Yan
   Wang, Hanzhong
   Zheng, Zhenhua
TI Baculovirus Surface Display of Zika Virus Envelope Protein Protects
   against Virus Challenge in Mouse Model
SO VIROLOGICA SINICA
LA English
DT Article; Early Access
DE Zika virus (ZIKV); Envelope protein; Baculovirus; Immunogenicity;
   Neutralizing antibody; Viral challenge
ID IMMUNITY; INSECT; TRANSMISSION; ANTIBODIES; VECTORS; MICE
AB Zika virus (ZIKV) is emerging as a significant pathogen worldwide and may cause severe neurological disorders such as fetal microcephaly and Guillain-Barre syndrome. No drug or listed vaccines are currently available for preventing ZIKV infection. As a major target of neutralizing, ZIKV envelop (E) protein usually used for vaccine development. Nevertheless, the immunogenicity of ZIKV envelop (E) protein expressed by baculovirus display system has never been assessed. In this study, we reported a new strategy for surface display of ZIKV E protein by a recombinant baculovirus vector derived from Autographa californica multiple nuclear polyhedrosis virus (AcMNPV) and assessed its immunogenicity in mice. We produced recombinant fusion ZIKV E protein linked with signal peptide (SP) and transmembrane domain (TM) of AcMNPV GP64. The results showed that the recombinant protein was easy to produce by baculovirus display system. BALB/c mice immunized with this recombinant E protein developed ZIKV specific serum antibodies. The anti-E protein sera from the mice were able to effectively neutralize ZIKV in vitro. More importantly, AG6 (IFN-alpha/beta and IFN-gamma receptor deficient) mice immunized with recombinant E protein were protected against lethal ZIKV challenge. Together, these findings demonstrated that the recombinant E protein displayed by baculovirus can be conveniently prepared and displayed good immunogenicity in immunized mice. It is a promising practical approach for prompting the development of vaccine and related immunology research.
C1 [Luo, Dan; Miao, Yuanjiu; Ke, Xianliang; Tan, Zhongyuan; Li, Penghui; Wang, Ting; Zhang, Yuan; Sun, Jianhong; Liu, Yan; Wang, Hanzhong; Zheng, Zhenhua] Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
   [Hu, Chun] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Comp Ctr, Wuhan 430030, Peoples R China.
   [Wang, Ting] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan 430071, Peoples R China.
RP Zheng, ZH (corresponding author), Chinese Acad Sci, Ctr Emerging Infect Dis, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan 430071, Peoples R China.
EM zhengzh@wh.iov.cn
FU National Key R&D Program of China [2016YFD0500406]; National Natural
   Science Foundation of China (NSFC)National Natural Science Foundation of
   China [81672036]; Youth Innovation Promotion Association of CAS
   [2016302]
FX This study was supported by grants from the National Key R&D Program of
   China (2016YFD0500406), the National Natural Science Foundation of China
   (NSFC) (no. 81672036), and the Youth Innovation Promotion Association of
   CAS (2016302). We are grateful for Dr. Qibin Leng from the Institute
   Pasteur of Shanghai, Chinese Academy of Sciences, for providing AG6
   mice. We also thank Xuefang An from Animal Resource Center of the Wuhan
   Institute of Virology, Chinese Academy of Sciences, for support in
   animal experiments. We would like to thank Pei Zhang and Du An-na from
   The Core Facility and Technical Support, Wuhan Institute of Virology,
   for their help with producing TEM micrographs.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Bai BK, 2008, MOL IMMUNOL, V45, P868, DOI 10.1016/j.molimm.2007.08.010
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baxter R, 2011, VACCINE, V29, P2272, DOI 10.1016/j.vaccine.2011.01.039
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   da Silva S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050255
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dai SY, 2018, VIROL SIN, V33, P213, DOI 10.1007/s12250-018-0030-5
   Davila-Castrodad NM, 2018, P R HEALTH SCI J, V37, pS81
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Ghaffar KA, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040077
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gupta K, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030198
   Kaname Y, 2010, J VIROL, V84, P3210, DOI 10.1128/JVI.02519-09
   Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lecouturier V, 2019, VACCINE, V37, P2679, DOI 10.1016/j.vaccine.2019.04.013
   Li PH, 2018, J VIROL, V92, DOI [10.1128/JVI.00701-18, 10.1128/jvi.00701-18]
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Lindley KM, 2000, J IMMUNOL METHODS, V234, P123, DOI 10.1016/S0022-1759(99)00133-7
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martinez-Sobrido L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030258
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ono C, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090510
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Peng RC, 2017, P NATL ACAD SCI USA, V114, pE8905, DOI 10.1073/pnas.1706125114
   Premanand B, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060298
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Saiz JC, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10090453
   Saxena M, 2013, MICROBIOL-SGM, V159, P1, DOI 10.1099/mic.0.049601-0
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Wang BY, 2015, MBIO, V6, DOI 10.1128/mBio.00237-15
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017
   Xu XG, 2011, VACCINE, V29, P636, DOI 10.1016/j.vaccine.2010.11.045
   Yamaji H, 2014, APPL MICROBIOL BIOT, V98, P1963, DOI 10.1007/s00253-013-5474-9
   Yang CP, 2019, VIROL SIN, V34, P168, DOI 10.1007/s12250-019-00093-5
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zheng H, 2018, MOL GENET GENOMICS, V293, P1265, DOI 10.1007/s00438-018-1459-9
NR 55
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1674-0769
EI 1995-820X
J9 VIROL SIN
JI Virol. Sin.
DI 10.1007/s12250-020-00238-x
EA MAY 2020
PG 14
WC Virology
SC Virology
GA LS3XZ
UT WOS:000536322000001
PM 32472451
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Lu, J
   du Plessis, L
   Liu, Z
   Hill, V
   Kang, M
   Lin, HF
   Sun, JF
   Francois, S
   Kraemer, MUG
   Faria, NR
   McCrone, JT
   Peng, JJ
   Xiong, QL
   Yuan, RY
   Zeng, LL
   Zhou, PP
   Liang, CM
   Yi, LN
   Liu, J
   Xiao, JP
   Hu, JX
   Liu, T
   Ma, WJ
   Li, W
   Su, J
   Zheng, HY
   Peng, B
   Fang, SS
   Su, WZ
   Li, KB
   Sun, RL
   Bai, R
   Tang, X
   Liang, MF
   Quick, J
   Song, T
   Rambaut, A
   Loman, N
   Raghwani, J
   Pybus, OG
   Ke, CW
AF Lu, Jing
   du Plessis, Louis
   Liu, Zhe
   Hill, Verity
   Kang, Min
   Lin, Huifang
   Sun, Jiufeng
   Francois, Sarah
   Kraemer, Moritz U. G.
   Faria, Nuno R.
   McCrone, John T.
   Peng, Jinju
   Xiong, Qianling
   Yuan, Runyu
   Zeng, Lilian
   Zhou, Pingping
   Liang, Chumin
   Yi, Lina
   Liu, Jun
   Xiao, Jianpeng
   Hu, Jianxiong
   Liu, Tao
   Ma, Wenjun
   Li, Wei
   Su, Juan
   Zheng, Huanying
   Peng, Bo
   Fang, Shisong
   Su, Wenzhe
   Li, Kuibiao
   Sun, Ruilin
   Bai, Ru
   Tang, Xi
   Liang, Minfeng
   Quick, Josh
   Song, Tie
   Rambaut, Andrew
   Loman, Nick
   Raghwani, Jayna
   Pybus, Oliver G.
   Ke, Changwen
TI Genomic Epidemiology of SARS-CoV-2 in Guangdong Province, China
SO CELL
LA English
DT Article
ID READ ALIGNMENT; PERFORMANCE; VIRUS; ZIKA
AB Coronavirus disease 2019 (COVID-19) is caused by SARS-CoV-2 infection and was first reported in central China in December 2019. Extensive molecular surveillance in Guangdong, China's most populous province, during early 2020 resulted in 1,388 reported RNA-positive cases from 1.6 million tests. In order to understand the molecular epidemiology and genetic diversity of SARS-CoV-2 in China, we generated 53 genomes from infected individuals in Guangdong using a combination of metagenomic sequencing and tiling amplicon approaches. Combined epidemiological and phylogenetic analyses indicate multiple independent introductions to Guangdong, although phylogenetic clustering is uncertain because of low virus genetic variation early in the pandemic. Our results illustrate how the timing, size, and duration of putative local transmission chains were constrained by national travel restrictions and by the province's large-scale intensive surveillance and intervention measures. Despite these successes, COVID-19 surveillance in Guangdong is still required, because the number of cases imported from other countries has increased.
C1 [Lu, Jing; Liu, Zhe; Lin, Huifang; Sun, Jiufeng; Peng, Jinju; Xiong, Qianling; Yuan, Runyu; Zeng, Lilian; Zhou, Pingping; Liang, Chumin; Yi, Lina; Xiao, Jianpeng; Hu, Jianxiong; Liu, Tao; Ma, Wenjun] Guangdong Prov Inst Publ Hlth, Guangzhou 511430, Peoples R China.
   [Lu, Jing; Liu, Zhe; Kang, Min; Lin, Huifang; Sun, Jiufeng; Peng, Jinju; Xiong, Qianling; Yuan, Runyu; Zeng, Lilian; Zhou, Pingping; Liang, Chumin; Yi, Lina; Liu, Jun; Xiao, Jianpeng; Liu, Tao; Ma, Wenjun; Li, Wei; Su, Juan; Zheng, Huanying; Song, Tie; Ke, Changwen] Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China.
   [du Plessis, Louis; Francois, Sarah; Kraemer, Moritz U. G.; Faria, Nuno R.; Raghwani, Jayna; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
   [Hill, Verity; McCrone, John T.; Rambaut, Andrew] Univ Edinburgh, Inst Evolutionary Biol, Edinburgh EH8 9YL, Midlothian, Scotland.
   [Peng, Bo; Fang, Shisong] Shenzhen Ctr Dis Control & Prevent, Shenzhen 518055, Peoples R China.
   [Su, Wenzhe; Li, Kuibiao] Guangzhou Ctr Dis Control & Prevent, Guangzhou 510440, Peoples R China.
   [Sun, Ruilin; Bai, Ru] Guangdong Prov Second Peoples Hosp, Guangzhou 510320, Peoples R China.
   [Tang, Xi; Liang, Minfeng] Foshan First Peoples Hosp, Foshan 528000, Peoples R China.
   [Quick, Josh; Loman, Nick] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England.
RP Ke, CW (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangzhou 511430, Peoples R China.; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3SZ, England.
EM oliver.pybus@zoo.ox.ac.uk; kecw1965@aliyun.com
OI Francois, Sarah/0000-0002-1138-8800
FU Guangdong Provincial Novel Coronavirus Scientific and Technological
   Project [2020111107001]; Science and Technology Planning Project of
   Guangdong [2018B020207006]; Key Research and Development Program of
   Guangdong Province [2019B111103001]; Oxford Martin School; Biotechnology
   and Biological Sciences Research Council (BBSRC)Biotechnology and
   Biological Sciences Research Council (BBSRC) [BB/M010996/1]; Wellcome
   TrustWellcome Trust; Royal Society Sir Henry Dale Fellowship
   [204311/Z/16/Z]; Medical Research CouncilMedical Research Council UK
   (MRC); FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [MR/S0195/1]; UK Research and Innovation Future Leaders
   Fellowship; European Research CouncilEuropean Research Council (ERC)
   [725422-ReservoirDOCS]; Wellcome Trust ARTIC network [206298/Z/17/Z]
FX LWe gratefully acknowledge the efforts of local CDCs, hospitals, and the
   thirdparty detection institutions in epidemiological investigations,
   sample collection, and detection. We would like to thank all the authors
   who have kindly deposited and shared genome data on GISAID. A table with
   genome sequence acknowledgments can be found in Table S1.4. This work
   was supported by grants from Guangdong Provincial Novel Coronavirus
   Scientific and Technological Project (2020111107001), Science and
   Technology Planning Project of Guangdong (2018B020207006), and the Key
   Research and Development Program of Guangdong Province (2019B111103001).
   O.G.P., M.U.G.K., and L.d.P. were supported by the Oxford Martin School.
   V.H. is supported by the Biotechnology and Biological Sciences Research
   Council (BBSRC) (BB/M010996/1). N.R.F. acknowledges funding from a
   Wellcome Trust and Royal Society Sir Henry Dale Fellowship
   (204311/Z/16/Z) and from a Medical Research Council and FAPESP award
   (MR/S0195/1). J.Q. is funded by a UK Research and Innovation Future
   Leaders Fellowship. A.R. is supported by the European Research Council
   (725422-ReservoirDOCS). This work was supported by the Wellcome Trust
   ARTIC network (Collaborators Award206298/Z/17/Z).
CR Ayres DL, 2012, SYST BIOL, V61, P170, DOI 10.1093/sysbio/syr100
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Flightradar24, 2020, AIR TRAFF CHIN BUS A
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Itokawa K., 2020, BIORXIV, DOI [10.1101/2020.03.10.985150, DOI 10.1101/2020.03.10.985150]
   Kang M., 2020, EVIDENCE CHARACTERIS, DOI [10.1101/2020.02.03.20019141, DOI 10.1101/2020.02.03.20019141]
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2020, SCIENCE, V368, P493, DOI 10.1126/science.abb4218
   Ladner JT, 2019, NAT MED, V25, P206, DOI 10.1038/s41591-019-0345-2
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Leung Kathy, 2020, Lancet, V395, P1382, DOI 10.1016/S0140-6736(20)30746-7
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Liu Y, 2020, LANCET INFECT DIS, V20, P656, DOI 10.1016/S1473-3099(20)30232-2
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Quick J., 2020, ARTIC NCOV2019 PRIME
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A., 2020, PHYLODYNAMIC ANAL 17
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rannala B, 1996, J MOL EVOL, V43, P304, DOI 10.1007/BF02338839
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105
   WHO, 2020, COR DIS COVID 2019 S
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 31
TC 3
Z9 3
U1 3
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 28
PY 2020
VL 181
IS 5
BP 997
EP +
DI 10.1016/j.cell.2020.04.023
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA LT9QF
UT WOS:000537399500008
PM 32359424
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Diaz-Arias, LA
   Pardo, CA
   Probasco, JC
AF Diaz-Arias, Luisa A.
   Pardo, Carlos A.
   Probasco, John C.
TI Infectious Encephalitis in the Neurocritical Care Unit
SO CURRENT TREATMENT OPTIONS IN NEUROLOGY
LA English
DT Review
DE Encephalitis; Infectious; Neurocritical care; Intensive care; HSV
   encephalitis; TB encephalitis
ID CENTRAL-NERVOUS-SYSTEM; RECONSTITUTION INFLAMMATORY SYNDROME; ST-LOUIS
   ENCEPHALITIS; ZIKA VIRUS MENINGOENCEPHALITIS; HERPES-SIMPLEX
   ENCEPHALITIS; TICK-BORNE ENCEPHALITIS; LA-CROSSE ENCEPHALITIS;
   FREE-LIVING AMEBAS; IMMUNE RECONSTITUTION; TUBERCULOUS MENINGITIS
AB Purpose of review Infectious encephalitis is a rapidly progressive encephalopathy caused by a variety of pathogens, most commonly viruses. It is associated with significant mortality and morbidity, often requiring evaluation and treatment in the intensive care unit. This review article discusses the diagnosis of the infectious etiologies, the assessment for differential diagnoses, and the initiation of therapies, and most importantly, it entails the rapid and efficient management of the associated complications. Recent findings Novel emerging technologies (e.g., metagenomic next-generation sequencing) have the potential to assist in the diagnosis, etiology identification, and treatment of encephalitis. Interventions such as ketogenic diet therapies have been promising in their potential to treat patients with refractory status epilepticus in the setting of infectious encephalitides. Early recognition of encephalitis and appropriate treatment of the primary infection and its complications are essential to increase survival and reduce sequelae. Intensivists are crucial given the high mortality rate of infectious encephalitis in the ICU setting, and their role may significantly impact patients' outcomes.
C1 [Diaz-Arias, Luisa A.; Pardo, Carlos A.; Probasco, John C.] Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St,Meyer 6-113, Baltimore, MD 21287 USA.
RP Probasco, JC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Neurol, 600 N Wolfe St,Meyer 6-113, Baltimore, MD 21287 USA.
EM jprobas1@jhmi.edu
CR Abdelmalik PA, 2015, CASE REP NEUROL MED, DOI 10.1155/2015/673724
   Akkoc G, 2016, CASE REP INFECT DIS, DOI 10.1155/2016/7549252
   Al-Zubeidi D, 2014, PEDIATR NEUROL, V51, P448, DOI 10.1016/j.pediatrneurol.2014.04.006
   Alsolami A, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx145
   Ambrosioni J, 2017, J NEUROVIROL, V23, P679, DOI 10.1007/s13365-017-0548-6
   Anticona EMF, 2012, CASE REP INFECT DIS, DOI 10.1155/2012/839458
   ARMSTRONG RW, 1993, CLIN INFECT DIS, V16, P689, DOI 10.1093/clind/16.5.689
   Bahr NC, 2018, LANCET INFECT DIS, V18, P68, DOI [10.1016/s1473-3099(17)30474-7, 10.1016/S1473-3099(17)30474-7]
   Beardsley J, 2016, NEW ENGL J MED, V374, P542, DOI 10.1056/NEJMoa1509024
   Beckham J David, 2015, Continuum (Minneap Minn), V21, P1599, DOI 10.1212/CON.0000000000000240
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biebl A, 2009, NAT CLIN PRACT NEURO, V5, P171, DOI 10.1038/ncpneuro1043
   Billioux BJ, 2016, NEUROTHERAPEUTICS, V13, P461, DOI 10.1007/s13311-016-0457-z
   Biofire, FILM ARR MEN ME PAN
   Birge J, 2012, EMERG INFECT DIS, V18, P1669, DOI 10.3201/eid1810.120621
   Bloch KC, 2015, EMERG INFECT DIS, V21, P1562, DOI 10.3201/eid2109.150295
   Bonthius DJ, 2012, SEMIN PEDIATR NEUROL, V19, P89, DOI 10.1016/j.spen.2012.02.002
   Boucher A, 2017, MED MALADIES INFECT, V47, P221, DOI 10.1016/j.medmal.2017.02.003
   Bradshaw MJ, 2016, NEUROTHERAPEUTICS, V13, P493, DOI 10.1007/s13311-016-0433-7
   Britton PN, 2015, INTERN MED J, V45, P563, DOI 10.1111/imj.12749
   Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0
   Brown JR, 2018, J INFECTION, V76, P225, DOI 10.1016/j.jinf.2017.12.014
   BURNS J, 1986, J CLIN PATHOL, V39, P1066, DOI 10.1136/jcp.39.10.1066
   Byrd Brian D, 2016, N C Med J, V77, P330, DOI 10.18043/ncm.77.5.330
   Canadian Task Force on the Periodic Health Examination, 1979, CAN MED ASSOC J, V121, P1193
   Cardenas G, 2010, NEUROSURGERY, V67, P1081, DOI 10.1227/NEU.0b013e3181eda396
   Carpio A, 2002, LANCET INFECT DIS, V2, P751, DOI 10.1016/S1473-3099(02)00454-1
   Castellazzi ML, 2018, ITAL J PEDIATR, V44, DOI 10.1186/s13052-018-0595-5
   Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1171
   Cerna F, 1999, AM J NEURORADIOL, V20, P1281
   Cervenka MC, 2017, NEUROLOGY, V88, P938, DOI [10.1212/WNL.0000000000003690, 10.1212/wnl.0000000000003690]
   Chaudhuri A, 2002, POSTGRAD MED J, V78, P575, DOI 10.1136/pmj.78.924.575
   Chiu CY, 2017, EMERG INFECT DIS, V23, P1694, DOI 10.3201/eid2310.161986
   Chow FC, 2011, SEMIN NEUROL, V31, P286, DOI 10.1055/s-0031-1287658
   Coiffard B, 2014, CLIN NUCL MED, V39, pE389, DOI 10.1097/RLU.0000000000000276
   DarrasJoly C, 1996, CLIN INFECT DIS, V23, P369, DOI 10.1093/clinids/23.2.369
   Davis LE, 2008, NEUROL CLIN, V26, P727, DOI 10.1016/j.ncl.2008.03.012
   De Broucker T, 2012, CLIN MICROBIOL INFEC, V18, P808, DOI 10.1111/j.1469-0691.2011.03705.x
   de Seze J, 2007, ARCH NEUROL-CHICAGO, V64, P1426, DOI 10.1001/archneur.64.10.1426
   DeBiasi RL, 2006, NAT CLIN PRACT NEURO, V2, P264, DOI 10.1038/ncpneuro0176
   DEMEY HE, 1988, ARCH INTERN MED, V148, P1459, DOI 10.1001/archinte.148.6.1459
   Denkinger CM, 2014, EUR RESPIR J, V44, P435, DOI 10.1183/09031936.00007814
   Desai Soaham Dilip, 2016, Indian J Sex Transm Dis AIDS, V37, P185
   Di Giovanni S, 2000, NEUROLOGY, V55, P854, DOI 10.1212/WNL.55.6.854
   DINA TS, 1991, RADIOLOGY, V179, P823, DOI 10.1148/radiology.179.3.2027999
   Dorsett M, 2016, EMERG MED CLIN N AM, V34, P917, DOI 10.1016/j.emc.2016.06.013
   DOUGLASS JA, 1992, AM REV RESPIR DIS, V146, P517, DOI 10.1164/ajrccm/146.2.517
   Dubey D, 2018, ANN NEUROL, V83, P166, DOI 10.1002/ana.25131
   Eleftheriou A, 2019, J STROKE CEREBROVASC, V28, pE119, DOI 10.1016/j.jstrokecerebrovasdis.2019.05.028
   Erdem H, 2014, CLIN MICROBIOL INFEC, V20, pO600, DOI 10.1111/1469-0691.12478
   Fan Eddy, 2004, Can Respir J, V11, P354
   FERRANTE A, 1991, PARASITE IMMUNOL, V13, P31, DOI 10.1111/j.1365-3024.1991.tb00261.x
   Finocchio T, 2019, J INTENSIVE CARE MED, V34, P897, DOI 10.1177/0885066618803871
   Fitch MT, 2008, NAT CLIN PRACT NEURO, V4, P97, DOI 10.1038/ncpneuro0713
   Fogang Y, 2017, NEUROPHYSIOL CLIN, V47, P5, DOI 10.1016/j.neucli.2016.09.001
   Fox A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071671
   Fulton BD, 2020, PLOS ONE, V15, pe0226895
   Garg RK, 2011, J NEUROL, V258, P3, DOI 10.1007/s00415-010-5744-8
   Gavin PJ, 2005, CLIN MICROBIOL REV, V18, P703, DOI 10.1128/CMR.18.4.703-718.2005
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gewurz Benjamin E, 2008, Curr Infect Dis Rep, V10, P292, DOI 10.1007/s11908-008-0048-1
   Gika AD, 2010, DEV MED CHILD NEUROL, V52, P99, DOI 10.1111/j.1469-8749.2009.03405.x
   Gilden D, 2004, HERPES, V11, P89
   Gonzalez-Gil J, 2000, J FORENSIC SCI, V45, P204
   Grace E, 2015, ANTIMICROB AGENTS CH, V59, P6677, DOI 10.1128/AAC.01293-15
   Grahn A, 2015, J INFECTION, V71, P281, DOI 10.1016/j.jinf.2015.06.004
   Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X
   Grant PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011416
   Graybill JR, 2000, CLIN INFECT DIS, V30, P47, DOI 10.1086/313603
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0235-2
   Hagiya H, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-225
   Halperin JJ, 2017, HAND CLINIC, V140, P337, DOI 10.1016/B978-0-444-63600-3.00018-0
   Hariri OR, 2015, J NEUROL SURG REP, V76, P167, DOI 10.1055/s-0035-1554932
   Hayton Emma, 2012, Pract Neurol, V12, P234, DOI 10.1136/practneurol-2012-000234
   Heppner PA, 2008, J CLIN NEUROSCI, V15, P1157, DOI 10.1016/j.jocn.2007.07.001
   Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166
   Hermance ME, 2017, VECTOR-BORNE ZOONOT, V17, P453, DOI 10.1089/vbz.2017.2110
   Hills SL, 2010, AM J TROP MED HYG, V82, P930, DOI 10.4269/ajtmh.2010.09-0676
   Hirsch HH, 2004, CLIN INFECT DIS, V38, P1159, DOI 10.1086/383034
   Hirsch J F, 1986, J Neurosurg Sci, V30, P29
   Honnorat E, 2013, MED MALADIES INFECT, V43, P230, DOI 10.1016/j.medmal.2013.05.003
   Honnorat J, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-22
   Horger M, 2012, AM J ROENTGENOL, V199, P420, DOI 10.2214/AJR.11.7911
   Hu ZL, 2018, ANN CLIN MICROB ANTI, V17, DOI 10.1186/s12941-018-0298-1
   Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302
   Jackson AC, 2011, ADV VIRUS RES, V79, P365, DOI 10.1016/B978-0-12-387040-7.00017-2
   Jacobs M, 2016, LANCET, V388, P498, DOI 10.1016/S0140-6736(16)30386-5
   Jain S, 2014, PATHOG GLOB HEALTH, V108, P216, DOI 10.1179/2047773214Y.0000000145
   Jang S, 2012, NEURORADIOLOGY, V54, P239, DOI 10.1007/s00234-011-0921-8
   Jaquet P, 2019, INTENS CARE MED, V45, P1103, DOI 10.1007/s00134-019-05684-0
   Jassi P, 2016, ANN INDIAN ACAD NEUR, V19, P125, DOI 10.4103/0972-2327.167712
   Jayaraman K, 2018, J NEUROSCI RURAL PRA, V9, P556, DOI 10.4103/jnrp.jnrp_120_18
   Jha S K, 2003, Med J Armed Forces India, V59, P326, DOI 10.1016/S0377-1237(03)80147-8
   Johnson TP, 2019, ANN NEUROL, V86, P695, DOI 10.1002/ana.25588
   Jones J L, 1999, MMWR CDC Surveill Summ, V48, P1
   Jones JL, 2012, CLIN INFECT DIS, V54, pE58, DOI 10.1093/cid/cir990
   Josephson SA, 2014, HARRISONS PRINCIPLES
   Jubelt B, 2009, ATLAS CLIN NEUROLOGY, P441
   Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013
   Kalita J, 2007, EUR J NEUROL, V14, P33, DOI 10.1111/j.1468-1331.2006.01534.x
   Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013
   Koeltz A, 2018, EMERG INFECT DIS, V24, P794, DOI 10.3201/eid2404.161536
   Kramer AH, 2013, CRIT CARE CLIN, V29, P621, DOI 10.1016/j.ccc.2013.03.011
   Kuivanen S, 2018, EMERG INFECT DIS, V24, P946, DOI 10.3201/eid2405.171986
   Kusulja M, 2018, INT J INFECT DIS, V73, P49, DOI 10.1016/j.ijid.2018.05.016
   Lacomis D, 1996, ANN NEUROL, V40, P645, DOI 10.1002/ana.410400415
   Lammering JC, 2013, AM J ROENTGENOL, V200, P1334, DOI 10.2214/AJR.12.9264
   Lan SY, 2016, PEDIATR NEONATOL, V57, P402, DOI 10.1016/j.pedneo.2015.11.002
   Latronico N, 2005, CURR OPIN CRIT CARE, V11, P126, DOI 10.1097/01.ccx.0000155357.24360.89
   Le Monnier A, 2011, J CLIN MICROBIOL, V49, P3917, DOI 10.1128/JCM.01072-11
   Leber AL, 2016, J CLIN MICROBIOL, V54, P2251, DOI 10.1128/JCM.00730-16
   Lee BY, 2004, CLIN NUCL MED, V29, P620, DOI 10.1097/00003072-200410000-00004
   Lee Kyung Yeon, 2016, Korean J Pediatr, V59, P395
   Lee SH, 2019, J MICROBIOL IMMUNOL, V52, P760, DOI 10.1016/j.jmii.2019.04.005
   LEVY RM, 1986, AM J ROENTGENOL, V147, P977, DOI 10.2214/ajr.147.5.977
   Li GH, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00449
   LOCKHART B P, 1991, Antiviral Chemistry and Chemotherapy, V2, P9
   Long LL, 2016, SCI REP-UK, V6, DOI 10.1038/srep23444
   LUFT BJ, 1992, CLIN INFECT DIS, V15, P211, DOI 10.1093/clinids/15.2.211
   Mahadevan A, 2016, NEUROTHERAPEUTICS, V13, P477, DOI 10.1007/s13311-016-0452-4
   Malhotra A, 2017, CLINICS PRACT, V7, P121, DOI 10.4081/cp.2017.1002
   Manabe YC, 2007, JAIDS-J ACQ IMM DEF, V46, P456, DOI 10.1097/QAI.0b013e3181594c8c
   Manesh A, 2018, AM J TROP MED HYG, V98, P207, DOI 10.4269/ajtmh.17-0153
   Mansbridge CT, 2018, IDCases, V11, P22, DOI 10.1016/j.idcr.2017.12.002
   McJunkin JE, 2001, NEW ENGL J MED, V344, P801, DOI 10.1056/NEJM200103153441103
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Metcalf T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198695
   Miller S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01739-19
   Mozaffar T, 2007, MUSCLE NERVE, V35, P55, DOI 10.1002/mus.20647
   Mpaka M, 2008, HEART LUNG, V37, P61, DOI 10.1016/j.hrtlng.2007.02.009
   Muller M, 2010, LANCET INFECT DIS, V10, P251, DOI 10.1016/S1473-3099(10)70026-8
   Munoz LS, 2018, SEMIN NEUROL, V38, P163, DOI 10.1055/s-0038-1647247
   Murdoch DA, 2008, AIDS, V22, P601, DOI 10.1097/QAD.0b013e3282f4a607
   Murray R, 2001, EUR J CLIN MICROBIOL, V20, P199, DOI 10.1007/PL00011252
   Newcomb G, 2019, AM J RESP CRIT CARE, V199
   Taravilla CN, 2019, EMERG INFECT DIS, V25, P25, DOI 10.3201/eid2501.181089
   Ouezada JAO, 2017, J NEUROL SCI, V381, P1007, DOI 10.1016/j.jns.2017.08.2841
   Pahud BA, 2011, J INFECT DIS, V203, P316, DOI 10.1093/infdis/jiq066
   Pastula DM, 2016, J NEUROVIROL, V22, P257, DOI 10.1007/s13365-016-0428-5
   Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536
   Patterson TF, 2016, CLIN INFECT DIS, V63, pE1, DOI 10.1093/cid/ciw326
   Pepper DJ, 2009, CLIN INFECT DIS, V48, pE96, DOI 10.1086/598988
   Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895
   Piantadosi A, 2016, CLIN INFECT DIS, V62, P707, DOI 10.1093/cid/civ1005
   Poltronieri P, 2015, CURR GENOMICS, V16, P327, DOI 10.2174/1389202916666150707160613
   POSCHER ME, 1994, AIDS, V8, P1115, DOI 10.1097/00002030-199408000-00012
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Prasad K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002244.pub4
   Probasco JC, 2017, NEUROL-NEUROIMMUNOL, V4, DOI 10.1212/NXI.0000000000000352
   Prosch S, 1998, J CLIN MICROBIOL, V36, P3636
   Pruss H, 2017, CURR OPIN NEUROL, V30, P327, DOI 10.1097/WCO.0000000000000445
   Rajma J, 2017, INDIAN PEDIATR, V54, P689, DOI 10.1007/s13312-017-1136-9
   Ramirez-Avila L, 2009, CLIN INFECT DIS, V48, P322, DOI 10.1086/595852
   Ratnam I, 2006, CLIN INFECT DIS, V42, P418, DOI 10.1086/499356
   Rhein J, 2016, DIAGN MICR INFEC DIS, V84, P268, DOI 10.1016/j.diagmicrobio.2015.11.017
   Righi E, 2017, J NEUROVIROL, V23, P908, DOI 10.1007/s13365-017-0566-4
   Rodrigo-Armenteros P, 2019, CLIN NEUROL NEUROSUR, V185, DOI 10.1016/j.clineuro.2019.105492
   Rossetti AO, 2011, LANCET NEUROL, V10, P922, DOI 10.1016/S1474-4422(11)70187-9
   Ryu W-S, 2017, MOL VIROLOGY HUMAN P, P83
   Salama S, 2019, MULT SCLER J, V25, P1427, DOI 10.1177/1352458519837705
   Sawlani V, 2009, J NEUROL SCI, V287, P221, DOI 10.1016/j.jns.2009.07.010
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Sellner J, 2012, J NEUROL, V259, P2019, DOI 10.1007/s00415-012-6494-6
   Senocak EU, 2010, DIAGN INTERV RADIOL, V16, P3, DOI 10.4261/1305-3825.DIR.2673-09.1
   Shahani L, 2014, BMJ CASE REP, V2014
   Shelburne SA, 2006, J ANTIMICROB CHEMOTH, V57, P167, DOI 10.1093/jac/dki444
   Solomon T, 2012, J INFECTION, V64, P347, DOI 10.1016/j.jinf.2011.11.014
   Soni Brijesh K, 2017, Indian J Radiol Imaging, V27, P125, DOI 10.4103/ijri.IJRI_322_16
   Sonneville R, 2011, J INFECTION, V62, P301, DOI 10.1016/j.jinf.2011.02.003
   Srikanta D, 2014, YEAST, V31, P47, DOI 10.1002/yea.2997
   Stahl JP, 2019, EXTRAPULMONARY TUBER, P121
   Suman V, 2016, J CLIN DIAGN RES, V10, pOD18, DOI 10.7860/JCDR/2016/16917.7274
   Sunwoo JS, 2017, AM J TROP MED HYG, V97, P369, DOI 10.4269/ajtmh.17-0054
   Taccone FS, 2015, CRIT CARE, V19, DOI 10.1186/s13054-014-0722-7
   Tanveer F, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.13013
   Teleron ALA, 2016, AM J MED, V129, P881, DOI 10.1016/j.amjmed.2016.03.021
   Thakur KT, 2014, NEUROLOGY, V82, P665, DOI 10.1212/WNL.0000000000000151
   Troncoso Alcides, 2002, J Int Assoc Physicians AIDS Care (Chic), V1, P131, DOI 10.1177/154510970200100404
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   TYLER KL, 2004, HERPES J IHMF, V11, P57
   Van Den Tooren HK, 2019, BMJ CASE REP, V12
   Venkat H, 2017, TRANSFUSION, V57, P2987, DOI 10.1111/trf.14314
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Venkatesan A, 2018, NEUROL CLIN, V36, P705, DOI 10.1016/j.ncl.2018.07.001
   Viola L, 1998, PEDIATR EMERG CARE, V14, P212, DOI 10.1097/00006565-199806000-00011
   Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x
   Vora NM, 2014, NEUROLOGY, V82, P443, DOI 10.1212/WNL.0000000000000086
   Wagner I, 2011, MINERVA ANESTESIOL, V77, P371
   Walker MD, 2005, SEMIN NEUROL, V25, P262, DOI 10.1055/s-2005-917663
   Wasay M, 2000, ARCH NEUROL-CHICAGO, V57, P114, DOI 10.1001/archneur.57.1.114
   Wendel KA, 2003, CLIN INFECT DIS, V37, P1107, DOI 10.1086/378300
   Wheat J, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010245
   Wilson MR, 2019, NEW ENGL J MED, V380, P2327, DOI 10.1056/NEJMoa1803396
   Wilson MR, 2014, NEW ENGL J MED, V370, P2408, DOI 10.1056/NEJMoa1401268
   WOLINSKY JS, 1977, LAB INVEST, V37, P229
   Wong KK, 2008, CLIN NUCL MED, V33, P443, DOI 10.1097/RLU.0b013e318170d4e0
   Woo AR, 2017, KOREAN J RADIOL, V18, P378, DOI 10.3348/kjr.2017.18.2.378
   Yu YA, 2019, CLIN PEDIATR, V58, P245, DOI 10.1177/0009922818806842
   Zarlasht F, 2017, INT J GEN MED, V10, P371, DOI 10.2147/IJGM.S143335
NR 199
TC 0
Z9 0
U1 0
U2 0
PU CURRENT MEDICINE GROUP
PI PHILADELPHIA
PA 400 MARKET STREET, STE 700, PHILADELPHIA, PA 19106 USA
SN 1092-8480
EI 1534-3138
J9 CURR TREAT OPTION NE
JI Curr. Treat. Options Neurol.
PD MAY 28
PY 2020
VL 22
IS 6
AR 18
DI 10.1007/s11940-020-00623-7
PG 28
WC Clinical Neurology
SC Neurosciences & Neurology
GA LS0JX
UT WOS:000536081500001
OA Bronze
DA 2020-07-08
ER

PT J
AU Su, XJ
   Wang, Q
   Wen, YM
   Jiang, SB
   Lu, L
AF Su, Xiaojie
   Wang, Qian
   Wen, Yumei
   Jiang, Shibo
   Lu, Lu
TI Protein- and Peptide-Based Virus Inactivators: Inactivating Viruses
   Before Their Entry Into Cells
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE enveloped virus; envelope proteins; inactivation; virus inactivator;
   emerging viruses
ID HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT SOLUBLE CD4; HIV-1 FUSION
   INHIBITOR; AIDS-RELATED-COMPLEX; INFLUENZA-A VIRUS; SINGLE HUMAN CD4;
   DENGUE-VIRUS; ENVELOPE PROTEIN; RECEPTOR-BINDING; GENE-THERAPY
AB Infectious diseases caused by human immunodeficiency virus (HIV) and other highly pathogenic enveloped viruses, have threatened the global public health. Most antiviral drugs act as passive defenders to inhibit viral replication inside the cell, while a few of them function as gate keepers to combat viruses outside the cell, including fusion inhibitors, e.g., enfuvirtide, and receptor antagonists, e.g., maraviroc, as well as virus inactivators (including attachment inhibitors). Different from fusion inhibitors and receptor antagonists that must act in the presence of target cells, virus inactivators can actively inactivate cell-free virions in the blood, through interaction with one or more sites in the envelope glycoproteins (Envs) on virions. Notably, a number of protein- and peptide-based virus inactivators (PPVIs) under development are expected to have a better utilization rate than the current antiviral drugs and be safer for in vivo human application than the chemical-based virus inactivators. Here we have highlighted recent progress in developing PPVIs against several important enveloped viruses, including HIV, influenza virus, Zika virus (ZIKV), dengue virus (DENV), and herpes simplex virus (HSV), and the potential use of PPVIs for urgent treatment of infection by newly emerging or re-emerging viruses.
C1 [Su, Xiaojie; Wang, Qian; Wen, Yumei; Jiang, Shibo; Lu, Lu] Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.
   [Jiang, Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
RP Jiang, SB; Lu, L (corresponding author), Fudan Univ, Sch Basic Med Sci, Key Lab Med Mol Virol MOE NHC CAMS, Shanghai, Peoples R China.; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA.
EM shibojiang@fudan.edu.cn; lul@fudan.edu.cn
FU National Mega-Projects of China for Major Infectious Diseases
   [2018ZX10301403]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81661128041, 81672019, 81822045,
   81630090, 81701998]
FX This study was supported by grants from the National Mega-Projects of
   China for Major Infectious Diseases (2018ZX10301403 to LL) and the
   National Natural Science Foundation of China (81661128041, 81672019, and
   81822045 to LL, 81630090 to SJ, and 81701998 to QW).
CR Akkarawongsa R, 2009, ANTIMICROB AGENTS CH, V53, P987, DOI 10.1128/AAC.00793-08
   Alhoot MA, 2013, INT J MED SCI, V10, P719, DOI 10.7150/ijms.5037
   ALLAWAY GP, 1995, AIDS RES HUM RETROV, V11, P533, DOI 10.1089/aid.1995.11.533
   Aneja R, 2015, J MED CHEM, V58, P3843, DOI 10.1021/acs.jmedchem.5b00073
   Arii J, 2018, ADV EXP MED BIOL, V1045, P3, DOI 10.1007/978-981-10-7230-7_1
   Arii J, 2015, J VIROL, V89, P1879, DOI 10.1128/JVI.03079-14
   Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420
   Arvin A, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P1, DOI 10.2277/ 0521827140
   Atanasiu D, 2007, P NATL ACAD SCI USA, V104, P18718, DOI 10.1073/pnas.0707452104
   Atanasiu D, 2016, J VIROL, V90, P10535, DOI 10.1128/JVI.01501-16
   Atanasiu D, 2010, J VIROL, V84, P12292, DOI 10.1128/JVI.01700-10
   Atanasiu D, 2010, J VIROL, V84, P3825, DOI 10.1128/JVI.02687-09
   Azab W, 2017, ADV ANAT EMBRYOL CEL, V223, P1, DOI 10.1007/978-3-319-53168-7_1
   Baseler L, 2017, ANNU REV PATHOL-MECH, V12, P387, DOI 10.1146/annurev-pathol-052016-100506
   Bastian AR, 2011, CHEMMEDCHEM, V6, P1335, DOI 10.1002/cmdc.201100177
   Bastian AR, 2015, J BIOL CHEM, V290, P529, DOI 10.1074/jbc.M114.608315
   Bastian AR, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-153
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biorn AC, 2004, BIOCHEMISTRY-US, V43, P1928, DOI 10.1021/bi035088i
   Bohm SW, 2016, J VIROL, V90, P421, DOI 10.1128/JVI.01985-15
   Bosch BJ, 2010, J VIROL, V84, P10366, DOI 10.1128/JVI.01035-10
   Bright RA, 2006, JAMA-J AM MED ASSOC, V295, P891, DOI 10.1001/jama.295.8.joc60020
   BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0
   Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891
   Cairns TM, 2019, J VIROL, V93, DOI 10.1128/JVI.00289-19
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Carfi A, 2001, MOL CELL, V8, P169, DOI 10.1016/S1097-2765(01)00298-2
   Cetina-Corona A, 2016, INTERVIROLOGY, V59, P235, DOI 10.1159/000464134
   Chaiken I, 2015, FUTURE MED CHEM, V7, P2305, DOI 10.4155/fmc.15.152
   Chan DC, 1998, CELL, V93, P681, DOI 10.1016/S0092-8674(00)81430-0
   Chaudhuri S, 2018, ANTIVIR RES, V155, P76, DOI 10.1016/j.antiviral.2018.05.005
   Chen WZ, 2008, P NATL ACAD SCI USA, V105, P17121, DOI 10.1073/pnas.0805297105
   Chen WZ, 2014, J VIROL, V88, P1125, DOI 10.1128/JVI.02566-13
   Chen WZ, 2011, J VIROL, V85, P9395, DOI 10.1128/JVI.05119-11
   Cheshenko N, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006766
   Cheshenko N, 2013, FASEB J, V27, P2584, DOI 10.1096/fj.12-220285
   Chew MF, 2017, INT J MED SCI, V14, P1342, DOI 10.7150/ijms.21875
   Chowdary TK, 2010, NAT STRUCT MOL BIOL, V17, P882, DOI 10.1038/nsmb.1837
   Cocchi F, 2004, P NATL ACAD SCI USA, V101, P7445, DOI 10.1073/pnas.0401883101
   Connolly SA, 2011, NAT REV MICROBIOL, V9, P369, DOI 10.1038/nrmicro2548
   Costin JM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000721
   Cui LY, 2017, EBIOMEDICINE, V20, P193, DOI 10.1016/j.ebiom.2017.04.029
   Culshaw Abigail, 2018, F1000Res, V7, P203, DOI 10.12688/f1000research.12271.1
   D'Souza MP, 2000, JAMA-J AM MED ASSOC, V284, P215, DOI 10.1001/jama.284.2.215
   DAAR ES, 1990, P NATL ACAD SCI USA, V87, P6574, DOI 10.1073/pnas.87.17.6574
   Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4
   Day PM, 2014, CURR OPIN VIROL, V4, P24, DOI 10.1016/j.coviro.2013.11.002
   De Groot AS, 2008, BLOOD, V112, P3303, DOI 10.1182/blood-2008-02-138073
   de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512
   Deeks SG, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.35
   DEEN KC, 1988, NATURE, V331, P82, DOI 10.1038/331082a0
   Di Giovine P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002277
   Dou D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01581
   Dwyer JJ, 2007, P NATL ACAD SCI USA, V104, P12772, DOI 10.1073/pnas.0701478104
   Egerer L, 2011, MOL THER, V19, P1236, DOI 10.1038/mt.2011.30
   Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800
   Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414
   Ekiert DC, 2009, SCIENCE, V324, P246, DOI 10.1126/science.1171491
   ENGLUND JA, 1990, ANN INTERN MED, V112, P416, DOI 10.7326/0003-4819-76-3-112-6-416
   Falkenhagen A, 2014, GENE THER, V21, P175, DOI 10.1038/gt.2013.70
   Falkenhagen A, 2017, MOL THER-NUCL ACIDS, V9, P132, DOI 10.1016/j.omtn.2017.08.017
   Fatkenheuer G, 2005, NAT MED, V11, P1170, DOI 10.1038/nm1319
   Ferrer M, 1999, J VIROL, V73, P5795, DOI 10.1128/JVI.73.7.5795-5802.1999
   Fleishman SJ, 2011, SCIENCE, V332, P816, DOI 10.1126/science.1202617
   Galdiero S, 2013, J PEPT SCI, V19, P148, DOI 10.1002/psc.2489
   Gallagher JR, 2013, J VIROL, V87, P12656, DOI 10.1128/JVI.01727-13
   Gamblin SJ, 2010, J BIOL CHEM, V285, P28403, DOI 10.1074/jbc.R110.129809
   Ganz T, 2003, INTEGR COMP BIOL, V43, P300, DOI 10.1093/icb/43.2.300
   Gauduin MC, 1998, J VIROL, V72, P3475, DOI 10.1128/JVI.72.4.3475-3478.1998
   GOMPELS U, 1986, VIROLOGY, V153, P230, DOI 10.1016/0042-6822(86)90026-7
   Haase AT, 2005, NAT REV IMMUNOL, V5, P783, DOI 10.1038/nri1706
   Haim H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000360
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Han YS, 2018, EXPERT OPIN INV DRUG, V27, P951, DOI 10.1080/13543784.2018.1548609
   Harrison SC, 2008, NAT STRUCT MOL BIOL, V15, P690, DOI 10.1038/nsmb.1456
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548
   Holthausen DJ, 2017, IMMUNITY, V46, P587, DOI 10.1016/j.immuni.2017.03.018
   Houser K, 2015, CELL HOST MICROBE, V17, P295, DOI 10.1016/j.chom.2015.02.012
   Hrobowski YM, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-49
   Huerta V, 2008, VIRUS RES, V137, P225, DOI 10.1016/j.virusres.2008.07.022
   Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004
   Jacobson JM, 2004, ANTIMICROB AGENTS CH, V48, P423, DOI 10.1128/AAC.48.2.423-429.2004
   Jacobson JM, 2000, J INFECT DIS, V182, P326, DOI 10.1086/315698
   JIANG SB, 1993, NATURE, V365, P113, DOI 10.1038/365113a0
   JIANG SB, 1993, BIOCHEM BIOPH RES CO, V195, P533, DOI 10.1006/bbrc.1993.2078
   KAHN JO, 1990, ANN INTERN MED, V112, P254, DOI 10.7326/0003-4819-112-4-
   Klein DE, 2013, J VIROL, V87, P2287, DOI 10.1128/JVI.02957-12
   Krummenacher C, 2005, EMBO J, V24, P4144, DOI 10.1038/sj.emboj.7600875
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar CS, 2018, TRENDS MICROBIOL, V26, P525, DOI 10.1016/j.tim.2017.09.010
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lalezari JP, 2003, NEW ENGL J MED, V348, P2175, DOI 10.1056/NEJMoa035026
   Lee CC, 2013, ACTA CRYSTALLOGR D, V69, P1935, DOI 10.1107/S0907444913016776
   Li H, 2007, BIOORGAN MED CHEM, V15, P4220, DOI 10.1016/j.bmc.2007.03.064
   Li HG, 2004, BIOCONJUGATE CHEM, V15, P783, DOI 10.1021/bc049960r
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liu J, 2008, NATURE, V455, P109, DOI 10.1038/nature07159
   Lok SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050995
   Lu L, 2016, CURR TOP MED CHEM, V16, P1074, DOI 10.2174/1568026615666150901114527
   Lu L, 2012, RETROVIROLOGY, V9, DOI 10.1186/1742-4690-9-104
   Matsubara T, 2016, BIOORGAN MED CHEM, V24, P1106, DOI 10.1016/j.bmc.2016.01.039
   Matsubara T, 2010, J MED CHEM, V53, P4441, DOI 10.1021/jm1002183
   Mazumder R, 2007, VIRUS GENES, V35, P175, DOI 10.1007/s11262-007-0103-2
   Melikyan GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-111
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Moir S, 2011, ANNU REV PATHOL-MECH, V6, P223, DOI 10.1146/annurev-pathol-011110-130254
   Moise L, 2016, EXPERT REV VACCINES, V15, P607, DOI 10.1586/14760584.2016.1123098
   Mubarak A, 2019, J IMMUNOL RES, DOI 10.1155/2019/6491738
   Ng Kimberly E, 2019, P T, V44, P9
   Nicola AV, 2016, TRAFFIC, V17, P965, DOI 10.1111/tra.12408
   Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004
   ORLOFF SL, 1993, J VIROL, V67, P1461, DOI 10.1128/JVI.67.3.1461-1471.1993
   Palese P., 2007, FIELDS VIROLOGY, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019
   Pan CG, 2009, J VIROL, V83, P7862, DOI 10.1128/JVI.00168-09
   Panya A, 2015, CHEM BIOL DRUG DES, V86, P1093, DOI 10.1111/cbdd.12576
   Panya A, 2014, CHEM BIOL DRUG DES, V84, P148, DOI 10.1111/cbdd.12309
   Parajuli B, 2018, BIOCHEM J, V475, P931, DOI 10.1042/BCJ20170662
   Parajuli B, 2016, BIOCHEMISTRY-US, V55, P6100, DOI 10.1021/acs.biochem.6b00570
   Pellett P. E., 2013, FIELDS VIROLOGY, P1802
   Perez EE, 2005, CLIN IMMUNOL, V115, P26, DOI 10.1016/j.clim.2005.02.019
   Phillips DM, 2000, CONTRACEPTION, V62, P149, DOI 10.1016/S0010-7824(00)00156-6
   POLSKY B, 1988, LANCET, V1, P1456
   Priyadarzini TRK, 2012, J BIOL CHEM, V287, P34547, DOI 10.1074/jbc.M112.357061
   Qi QQ, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.46
   Roizman B, 2013, FIELDS VIROLOGY, V2, P1823
   Sanders RW, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-99
   Sato Masatoki, 2020, J Infect Dis, V222, P121, DOI 10.1093/infdis/jiaa061
   Satoh T, 2008, CELL, V132, P935, DOI 10.1016/j.cell.2008.01.043
   Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   SCHOOLEY RT, 1990, ANN INTERN MED, V112, P247, DOI 10.7326/0003-4819-112-4-247
   Seo MD, 2012, MOLECULES, V17, P12276, DOI 10.3390/molecules171012276
   Sharma D, 2005, BIOCHEMISTRY-US, V44, P16192, DOI 10.1021/bi051120s
   Skehel JJ, 2000, ANNU REV BIOCHEM, V69, P531, DOI 10.1146/annurev.biochem.69.1.531
   STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6
   Su S, 2017, AIDS, V31, P885, DOI [10.1097/QAD.0000000000001415, 10.1097/qad.0000000000001415]
   Suenaga T, 2010, P NATL ACAD SCI USA, V107, P866, DOI 10.1073/pnas.0913351107
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   Sullivan N, 1998, J VIROL, V72, P6332, DOI 10.1128/JVI.72.8.6332-6338.1998
   Sun XJ, 2013, ADV EXP MED BIOL, V790, P72, DOI 10.1007/978-1-4614-7651-1_4
   Takashita E, 2019, EUROSURVEILLANCE, V24, P9, DOI 10.2807/1560-7917.ES.2019.24.12.1900170
   Tian YS, 2018, CHEM PHARM BULL, V66, P191, DOI 10.1248/cpb.c17-00794
   TRAUNECKER A, 1988, NATURE, V331, P84, DOI 10.1038/331084a0
   TRKOLA A, 1995, J VIROL, V69, P6609, DOI 10.1128/JVI.69.11.6609-6617.1995
   Vigant F, 2015, NAT REV MICROBIOL, V13, P426, DOI 10.1038/nrmicro3475
   Vita C, 1999, P NATL ACAD SCI USA, V96, P13091, DOI 10.1073/pnas.96.23.13091
   Wang XH, 2017, FRONT MED-PRC, V11, P449, DOI 10.1007/s11684-017-0589-5
   Warfield KL, 2016, ANTIVIR RES, V129, P93, DOI 10.1016/j.antiviral.2016.03.001
   Weber CA, 2009, ADV DRUG DELIVER REV, V61, P965, DOI 10.1016/j.addr.2009.07.001
   Weed DJ, 2017, ADV ANAT EMBRYOL CEL, V223, P29, DOI 10.1007/978-3-319-53168-7_2
   Weissenhorn W, 2007, FEBS LETT, V581, P2150, DOI 10.1016/j.febslet.2007.01.093
   Whittle JRR, 2011, P NATL ACAD SCI USA, V108, P14216, DOI 10.1073/pnas.1111497108
   WILD CT, 1994, P NATL ACAD SCI USA, V91, P9770, DOI 10.1073/pnas.91.21.9770
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu W, 2014, JAIDS-J ACQ IMM DEF, V67, P1, DOI 10.1097/QAI.0000000000000265
   Yamada S, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02031
   Yang J, 2013, VIRUSES-BASEL, V5, P352, DOI 10.3390/v5010352
   Yu YF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15672
   Zaman R, 2019, J CONTROL RELEASE, V301, P176, DOI 10.1016/j.jconrel.2019.02.016
   Zeev-Ben-Mordehai T, 2016, P NATL ACAD SCI USA, V113, P4176, DOI 10.1073/pnas.1523234113
   Zeng LY, 2017, EXPERT OPIN INV DRUG, V26, P63, DOI 10.1080/13543784.2017.1269170
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
NR 163
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAY 25
PY 2020
VL 11
AR 1063
DI 10.3389/fmicb.2020.01063
PG 19
WC Microbiology
SC Microbiology
GA LY5IW
UT WOS:000540563800001
PM 32523582
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Anders, KL
   Indriani, C
   Ahmad, RA
   Tantowijoyo, W
   Arguni, E
   Andari, B
   Jewell, NP
   Dufault, SM
   Ryan, PA
   Tanamas, SK
   Rances, E
   O'Neill, SL
   Simmons, CP
   Utarini, A
AF Anders, Katherine L.
   Indriani, Citra
   Ahmad, Riris Andono
   Tantowijoyo, Warsito
   Arguni, Eggi
   Andari, Bekti
   Jewell, Nicholas P.
   Dufault, Suzanne M.
   Ryan, Peter A.
   Tanamas, Stephanie K.
   Rances, Edwige
   O'Neill, Scott L.
   Simmons, Cameron P.
   Utarini, Adi
TI Update to the AWED (Applying Wolbachia to Eliminate Dengue) trial study
   protocol: a cluster randomised controlled trial in Yogyakarta, Indonesia
SO TRIALS
LA English
DT Letter
DE Wolbachia; Dengue; Chikungunya; Zika; Vector-borne disease; Cluster
   randomised trial; Test-negative design; Indonesia
AB BackgroundThe AWED (Applying Wolbachia to Eliminate Dengue) trial is a parallel, two-arm, non-blinded cluster randomised controlled trial that is under way in Yogyakarta, Indonesia, with the aim of measuring the efficacy of Wolbachia-infected Aedes aegypti deployments in reducing dengue incidence in an endemic setting. Enrolment began in January 2018 and is ongoing. The original study protocol was published in April 2018. Here, we describe amendments that have been made to the study protocol since commencement of the trial.MethodsThe key protocol amendments are (1) a revised study duration with planned end of participant enrolment in August 2020, (2) the addition of new secondary objectives (i) to estimate serotype-specific efficacy of the Wolbachia intervention and (ii) to compare Ae. aegypti abundance in intervention versus untreated clusters, (3) an additional exposure classification for the per-protocol analysis where the Wolbachia exposure index is calculated using only the cluster-level Wolbachia prevalence in the participant's cluster of residence, (4) power re-estimation using a multinomial sampling method that better accounts for randomness in sampling, and (5) the addition of two trial stopping rules to address the potential for persistently low rates of virologically confirmed dengue case enrolment and Wolbachia contamination into untreated clusters. Additional minor changes to the protocol are also described.DiscussionThe findings from this study will provide the first experimental evidence for the efficacy of Wolbachia in reducing dengue incidence. Enrolment in the trial will conclude this year (2020) and results will be reported shortly thereafter.
C1 [Anders, Katherine L.; Ryan, Peter A.; Tanamas, Stephanie K.; Rances, Edwige; O'Neill, Scott L.; Simmons, Cameron P.] Monash Univ, Inst Vector Borne Dis, 12 Innovat Walk, Melbourne, Vic 3800, Australia.
   [Indriani, Citra; Ahmad, Riris Andono] Univ Gadjah Mada, Dept Biostat Epidemiol & Populat Hlth, Jl Medika, Yogyakarta 55281, Indonesia.
   [Indriani, Citra; Ahmad, Riris Andono; Arguni, Eggi; Andari, Bekti; Utarini, Adi] Univ Gadjah Mada, Ctr Trop Med, Fac Med, Jl Medika, Yogyakarta 55281, Indonesia.
   [Tantowijoyo, Warsito] Univ Gadjah Mada, World Mosquito Program, Ctr Trop Med, Fac Med, Jl Medika, Yogyakarta 55281, Indonesia.
   [Arguni, Eggi] Univ Gadjah Mada, Dept Pediat, Jl Medika, Yogyakarta 55281, Indonesia.
   [Jewell, Nicholas P.] London Sch Hyg & Trop Med, Ctr Stat Methodol, Keppel St, London WC1E 7HT, England.
   [Dufault, Suzanne M.] Univ Calif Berkeley, Sch Publ Hlth, 2121 Berkeley Way, Berkeley, CA 94720 USA.
   [Utarini, Adi] Univ Gadjah Mada, Dept Hlth Policy & Management, Jl Medika, Yogyakarta 55281, Indonesia.
RP Anders, KL (corresponding author), Monash Univ, Inst Vector Borne Dis, 12 Innovat Walk, Melbourne, Vic 3800, Australia.
EM katie.anders@worldmosquito.org
FU Yayasan Tahija (the Tahija Foundation), Indonesia
FX This study is funded by Yayasan Tahija (the Tahija Foundation),
   Indonesia. The funders have not had a role in the design of the study
   and will not be involved in the collection, analysis or interpretation
   of the data.
CR Anders KL, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2670-z
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
NR 2
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1745-6215
J9 TRIALS
JI Trials
PD MAY 25
PY 2020
VL 21
IS 1
AR 429
DI 10.1186/s13063-020-04367-2
PG 5
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA LU4EI
UT WOS:000537709900007
PM 32450914
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arenas, M
AF Arenas, Miguel
TI Protein Evolution in the Flaviviruses
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Letter; Early Access
DE Protein evolution; Virus evolution; Flavivirus; Molecular adaptation;
   Substitution process; Antiviral therapy
ID MODELS; CONSERVATION; DYNAMICS; DISORDER
AB Proteins are commonly used as molecular targets against pathogens such as viruses and bacteria. However, pathogens can evolve rapidly permitting their populations to increase in protein diversity over time and thus escape to the activity of a molecular therapy. Subsequently, in order to design more durable and robust therapies as well as to understand viral evolution in a host and subsequent transmission, it is central to understand the evolution of pathogen proteins. This understanding can enable the detection of protein regions that can be potential targets for therapies and predict the emergence of molecular resistance against therapies. In this direction, two articles published recently in the Journal of Molecular Evolution investigated the evolution of proteomes of diverse flaviviruses, including Zika virus, Dengue virus and West Nile virus. Here I discuss the importance of considering the evolution of viral proteins, with the use of as realistic as possible models and methods that mimic protein evolution, to improve the design of antiviral therapies.
C1 [Arenas, Miguel] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain.
   [Arenas, Miguel] Univ Vigo, Biomed Res Ctr CINBIO, Vigo 36310, Spain.
   [Arenas, Miguel] Galicia Hlth Res Inst IIS Galicia, Vigo 36310, Spain.
RP Arenas, M (corresponding author), Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain.; Arenas, M (corresponding author), Univ Vigo, Biomed Res Ctr CINBIO, Vigo 36310, Spain.; Arenas, M (corresponding author), Galicia Hlth Res Inst IIS Galicia, Vigo 36310, Spain.
EM marenas@uvigo.es
RI Arenas, Miguel/C-4831-2009
OI Arenas, Miguel/0000-0002-0516-2717
FU Spanish Ministry of Economy and Competitivity [RYC-2015-18241]; Xunta de
   GaliciaXunta de Galicia [ED431F 2018/08]
FX I thank the Grants "RYC-2015-18241" (MA) from the Spanish Ministry of
   Economy and Competitivity and "ED431F 2018/08" (MA) from the Xunta de
   Galicia that support my research.
CR Abadi S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08822-w
   Abascal F, 2007, MOL BIOL EVOL, V24, P1
   Arbiza L, 2011, GENOME BIOL EVOL, V3, P896, DOI 10.1093/gbe/evr080
   Arenas M, 2020, METHODS ECOL EVOL, V11, P248, DOI 10.1111/2041-210X.13341
   Arenas M, 2018, INFECT GENET EVOL, V63, P295, DOI 10.1016/j.meegid.2017.09.029
   Arenas M, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00319
   Arenas M, 2010, CURR HIV RES, V8, P613, DOI 10.2174/157016210794088263
   Bastolla U, 2019, METHODS MOL BIOL, V1851, P215, DOI 10.1007/978-1-4939-8736-8_11
   Bordner AJ, 2014, MOL BIOL EVOL, V31, P736, DOI 10.1093/molbev/mst240
   Chong B, 2018, ACS OMEGA, V3, P15643, DOI 10.1021/acsomega.8b02092
   Cuong CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-99
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Del Amparo R, 2020, BIOINFORMATICS, V36, P430, DOI 10.1093/bioinformatics/btz558
   Echave J, 2017, ANNU REV BIOPHYS, V46, P85, DOI 10.1146/annurev-biophys-070816-033819
   Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18
   Gerth M, 2019, NEGLECTING MODEL SEL, DOI [10.1101/849018v1.abstract, DOI 10.1101/849018V1.ABSTRACT]
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jimenez-Santos MJ, 2018, PEERJ, V6, DOI 10.7717/peerj.5549
   Kaehler BD, 2017, GENOME BIOL EVOL, V9, P134, DOI 10.1093/gbe/evw308
   Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29
   Lemey P, 2006, AIDS REV, V8, P125
   Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520
   Liberles DA, 2013, GENOME BIOL EVOL, V5, P2008, DOI 10.1093/gbe/evt151
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503
   Nunez-Castilla J, 2020, J MOL EVOL, V88, P399, DOI 10.1007/s00239-020-09941-5
   Ortiz JF, 2013, GENOME BIOL EVOL, V5, P504, DOI 10.1093/gbe/evt026
   Ribeiro AJM, 2020, J BIOL CHEM, V295, P314, DOI 10.1074/jbc.REV119.006289
   Spielman SJ, 2018, MOL BIOL EVOL, V35, P2307, DOI 10.1093/molbev/msy127
   Le TK, 2020, J MOL EVOL, V88, P445, DOI 10.1007/s00239-020-09943-3
   Voskarides K, 2020, J MOL EVOL, V88, P421, DOI 10.1007/s00239-020-09947-z
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Wilke CO, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002572
   Woodford N, 2007, CLIN MICROBIOL INFEC, V13, P5, DOI 10.1111/j.1469-0691.2006.01492.x
   Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145
NR 37
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0022-2844
EI 1432-1432
J9 J MOL EVOL
JI J. Mol. Evol.
DI 10.1007/s00239-020-09953-1
EA MAY 2020
PG 4
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA LR0KZ
UT WOS:000535387000001
PM 32451560
DA 2020-07-08
ER

PT J
AU Diouf, B
   Gaye, A
   Diagne, CT
   Diallo, M
   Diallo, D
AF Diouf, Babacar
   Gaye, Alioune
   Diagne, Cheikh Tidiane
   Diallo, Mawlouth
   Diallo, Diawo
TI Zika virus in southeastern Senegal: survival of the vectors and the
   virus during the dry season
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Aedes; Eggs; Vertical transmission; Local maintenance;
   Southeastern Senegal
ID AEDES-AEGYPTI DIPTERA; VERTICAL TRANSMISSION; EGGS; ALBOPICTUS;
   CULICIDAE; TEMPERATURE; DESICCATION; INFECTIONS; PREVALENCE
AB BackgroundZika virus (ZIKV, genus Flavivirus, family Flaviviridae) is transmitted mainly by Aedes mosquitoes. This virus has become an emerging concern of global public health with recent epidemics associated to neurological complications in the pacific and America. ZIKV is the most frequently amplified arbovirus in southeastern Senegal. However, this virus and its adult vectors are undetectable during the dry season. The aim of this study was to investigate how ZIKV and its vectors are maintained locally during the dry season.MethodsSoil, sand, and detritus contained in 1339 potential breeding sites (tree holes, rock holes, fruit husks, discarded containers, used tires) were collected in forest, savannah, barren and village land covers and flooded for eggs hatching. The emerging larvae were reared to adult, identified, and blood fed for F1 production. The F0 and F1 adults were identified and tested for ZIKV by Reverse Transcriptase-Real time Polymerase Chain Reaction.ResultsA total of 1016 specimens, including 13 Aedes species, emerged in samples collected in the land covers and breeding sites investigated. Ae. aegypti was the dominant species representing 56.6% of this fauna with a high plasticity. Ae. furcifer and Ae. luteocephalus were found in forest tree holes, Ae. taylori in forest and village tree holes, Ae. vittatus in rock holes. ZIKV was detected from 4 out of the 82 mosquito pools tested. Positive pools included Ae. bromeliae (2 pools), Ae. unilineatus (1 pool), and Ae. vittatus (1 pool), indicating that the virus is maintained in these Aedes eggs during the dry season.ConclusionOur investigation identified breeding sites types and land cover classes where several ZIKV vectors are maintained, and their maintenance rates during the dry season in southeastern Senegal. The maintenance of the virus in these vectors in nature could explain its early amplification at the start of the rainy season in this area.
C1 [Diouf, Babacar; Gaye, Alioune; Diagne, Cheikh Tidiane; Diallo, Mawlouth; Diallo, Diawo] Inst Pasteur, Pole Zool Med, 36 Ave Pasteur,BP 220, Dakar, Senegal.
RP Diouf, B; Diallo, D (corresponding author), Inst Pasteur, Pole Zool Med, 36 Ave Pasteur,BP 220, Dakar, Senegal.
EM Babacar.DIOUF2@pasteur.sn; Diawo.DIALLO@pasteur.sn
OI DIALLO, Diawo/0000-0002-7478-5248
CR Adam F, 2005, VIRUS AFRIQUE BASE D
   Adebote David A., 2008, Journal of Vector Borne Diseases, V45, P21
   [Anonymous], AG NAT STAT DEM
   Baud D, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12614
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   BRES P., 1963, BULL SOC PATHOL EXOTIQUE, V56, P384
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Capasso A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007622
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   CORDELLIER R, 1974, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V12, P57
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P149
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-286
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Edwards F.W., 1941, MOSQUITOES ETHIOPIAN
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Ferrara L, 1984, CAH ORSTOM EMP, V22, P179
   Gerberg EJ, 1994, BULLETIN, V5
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   HAMMON WM, 1958, AM J TROP MED HYG, V7, P323, DOI 10.4269/ajtmh.1958.7.323
   HUANG YM, 1986, J MED ENTOMOL, V23, P196, DOI 10.1093/jmedent/23.2.196
   Juliano SA, 2002, OECOLOGIA, V130, P458, DOI 10.1007/s004420100811
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Safadi MAP, 2017, PEDIATR INFECT DIS J, V36, P333, DOI 10.1097/INF.0000000000001449
   Costa EAPD, 2010, REV BRAS ENTOMOL, V54, P488, DOI 10.1590/S0085-56262010000300021
   R Core Team, 2016, R LANG ENV STAT COMP
   RENAUDET J, 1978, B SOC PATHOL EXOT, V71, P131
   Richman R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2832-6
   Roberts D, 2004, J ARID ENVIRON, V57, P203, DOI 10.1016/S0140-1963(03)00108-3
   Roth A, 2014, EUROSURVEILLANCE, V19, P1560
   Service MW, 1965, J APPL ECOL, V2, P1, DOI DOI 10.2307/2401689
   Simard F, 2005, J MED ENTOMOL, V42, P726, DOI 10.1603/0022-2585(2005)042[0726:GDABSP]2.0.CO;2
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   SOTA T, 1992, ENTOMOL EXP APPL, V63, P155, DOI 10.1007/BF00343575
   Tewari SC, 2004, TROP MED INT HEALTH, V9, P499, DOI 10.1111/j.1365-3156.2004.01103.x
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Zahouli JBZ, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1778-9
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 48
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 24
PY 2020
VL 20
IS 1
DI 10.1186/s12879-020-05093-5
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA LU4FM
UT WOS:000537712900010
PM 32448116
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Santos-Pinto, CD
   Soares-Marangoni, DD
   Ferrari, FP
   Ajalla, MEA
   Venancio, FA
   da Rosa, TS
   de Oliveira, EF
AF Santos-Pinto, Claudia Du Bocage
   Soares-Marangoni, Daniele De Almeida
   Ferrari, Fernando Pierette
   Araujo Ajalla, Maria Elizabeth
   Venancio, Fabio Antonio
   da Rosa, Thais Silveira
   de Oliveira, Everton Falcao
TI Health demands and care of children with congenital Zika syndrome and
   their mothers in a Brazilian state
SO BMC PUBLIC HEALTH
LA English
DT Article
DE Zika virus infection; Congenital Zika syndrome; Disabilities; Health
   systems
ID CEREBRAL-PALSY; VIRUS-INFECTION; INTERVENTIONS; OUTBREAK; INFANTS
AB Background A Zika virus (ZIKV) infection outbreak occurred in Brazil in 2015, accompanied by a marked increase in the number of newborns presenting with microcephaly and other neurological disorders. This characteristic set of birth defects was later termed congenital Zika syndrome (CZS). The therapeutic itinerary of mothers and children infected by ZIKV can be determined by several factors, including the relationship established with existing healthcare services. Here, we aimed to describe and analyze the extent to which children with CZS, born from 2015 to 2018 in the state of Mato Grosso do Sul, Brazil, and their mothers were treated according to the guidelines established by the Brazilian Ministry of Health. Methods This was a descriptive cross-sectional study that considered all children (and respective mothers) with confirmed or suspected CZS born in Mato Grosso do Sul. Children and their mothers were identified based on all suspected or confirmed cases of congenital anomalies in Mato Grosso do Sul that were reported to the Registry of Public Health Events. We analyzed data on the epidemiological profile of mother-child pairs and the care received by them. Data were summarized using statistical descriptive analysis. Results We showed that most mothers were white women (57%) with low income. Among pregnant women, 73% had a diagnosis of fever caused by ZIKV infection at a primary health care institution (PHCI), but only 36% received the necessary information regarding the risk of CZS. Over a third (36%) of the mothers did not receive guidance about childcare follow-up and 73% did not receive guidance regarding the availability of social support after childbirth. Gaps in medical care were observed mainly in pregnant women treated at a PHCI. Specialized assistance for children was adequate in most cases. Psychosocial support was not made available to women throughout their therapeutic itineraries. Conclusions Here, we identified gaps in the care of families and children with disabilities, which can have an important impact on their quality of life. Beyond protocols, practical interventions must cover all the needs that arise throughout the therapeutic itineraries not only of children but also of pregnant women and mothers.
C1 [Santos-Pinto, Claudia Du Bocage; Soares-Marangoni, Daniele De Almeida; Ferrari, Fernando Pierette; Araujo Ajalla, Maria Elizabeth; de Oliveira, Everton Falcao] Univ Fed Mato Grosso do Sul, Inst Integrad Saude, Campo Grande, MS, Brazil.
   [Venancio, Fabio Antonio; de Oliveira, Everton Falcao] Univ Fed Mato Grosso do Sul, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil.
   [da Rosa, Thais Silveira] Univ Fed Mato Grosso do Sul, Programa Residencia Multiprofiss Reabilitacao Fis, Campo Grande, MS, Brazil.
RP de Oliveira, EF (corresponding author), Univ Fed Mato Grosso do Sul, Inst Integrad Saude, Campo Grande, MS, Brazil.; de Oliveira, EF (corresponding author), Univ Fed Mato Grosso do Sul, Programa Posgrad Doencas Infecciosas & Parasitari, Campo Grande, MS, Brazil.
EM efalcao.oliveira@gmail.com
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Brasil
   (CAPES) [001]; Universidade Federal de Mato Grosso do Sul (UFMS)
FX This study was financed in part by the Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior, Brasil (CAPES) (https://www.capes.gov.br/)
   Financial Code 001, and by Universidade Federal de Mato Grosso do Sul
   (UFMS) (https://www.ufms.br/).
CR Albuquerque MSV, 2019, HEALTH POLICY PLANN, V34, P499, DOI 10.1093/heapol/czz059
   [Anonymous], 2016, DIR EST PREC CRIANC
   [Anonymous], 2017, VIR ZIK NO BRAS RESP
   [Anonymous], 2016, PROT AT SAUD RESP OC
   [Anonymous], 2015, PROT VIG RESP OC MIC
   [Anonymous], 2018, SINT IND SOC AN COND
   [Anonymous], 2016, CDC CONCL ZIK CAUS M
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Brasil. Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49, P53
   Brasil. Ministerio da Saude, 2017, OR INT VIG AT SAUD A
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz SG, 2017, REPROD HEALTH MATTER, V25, P21, DOI 10.1080/09688080.2017.1397442
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hadders-Algra M, 2017, DEV MED CHILD NEUROL, V59, P246, DOI 10.1111/dmcn.13331
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Herskind A, 2015, DEV MED CHILD NEUROL, V57, P29, DOI 10.1111/dmcn.12531
   Kolb B, 2017, DEV MED CHILD NEUROL, V59, P1218, DOI 10.1111/dmcn.13546
   Lesser J, 2016, ESTUD AV-SAO PAULO, V30, P167, DOI DOI 10.1590/S0103-40142016.30880012
   McIntyre S, 2011, DEV DISABIL RES REV, V17, P114, DOI 10.1002/ddrr.1106
   Morano JP, 2017, INT J INFECT DIS, V65, P142, DOI 10.1016/j.ijid.2017.10.006
   Morgan C, 2016, DEV MED CHILD NEUROL, V58, P900, DOI 10.1111/dmcn.13105
   Morgan C, 2013, PEDIATRICS, V132, pE735, DOI 10.1542/peds.2012-3985
   Novak I, 2013, DEV MED CHILD NEUROL, V55, P885, DOI 10.1111/dmcn.12246
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Freitas PDS, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.24
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Venancio FA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224842
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization, 2016, PSYCH SUPP PREGN WOM
NR 33
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2458
J9 BMC PUBLIC HEALTH
JI BMC Public Health
PD MAY 24
PY 2020
VL 20
IS 1
AR 762
DI 10.1186/s12889-020-08880-6
PG 10
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LT7AF
UT WOS:000537218700013
PM 32448272
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Acharya, A
   Kevadiya, BD
   Gendelman, HE
   Byrareddy, SN
AF Acharya, Arpan
   Kevadiya, Bhavesh D.
   Gendelman, Howard E.
   Byrareddy, Siddappa N.
TI SARS-CoV-2 Infection Leads to Neurological Dysfunction
SO JOURNAL OF NEUROIMMUNE PHARMACOLOGY
LA English
DT Article
DE COVID-19; SARS-CoV-2; CNS; Neurologic manifestations; Animal models;
   Guillain-Barre syndrome; Therapeutics
ID CORONAVIRUS SPIKE PROTEIN; CENTRAL-NERVOUS-SYSTEM; ZIKA; IDENTIFICATION;
   REPLICATION; PNEUMONIA; OUTBREAK; ABSENCE
AB A number of neurological disease complications have been seen following infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). While most person with COVID-19 respiratory disease demonstrate headache, nausea and vomiting, up to 40% present also experience dizziness, confusion, cerebrovascular disease, muscle pain, ataxia and seizures. Loss of taste and smell, defects in visual acuity and pain occur in parallel. Such central nervous system (CNS) signs and symptoms linked to laboratory-confirmed SARS-CoV-2 infection is often life threatening. Health care providers currently evaluating patients with neurologic symptoms need consider COVID-19 in any differential diagnosis. These considerations will facilitate prompt testing, isolation and prevention of viral transmission speeding best clinical outcomes.
C1 [Acharya, Arpan; Kevadiya, Bhavesh D.; Gendelman, Howard E.; Byrareddy, Siddappa N.] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
   [Kevadiya, Bhavesh D.] Stanford Univ, Dept Radiol, Intervent Regenerat Med & Imaging Lab, Palo Alto, CA 94304 USA.
RP Gendelman, HE; Byrareddy, SN (corresponding author), Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE 68198 USA.
EM hegendel@unmc.edu; sid.byrareddy@unmc.edu
FU Frances E. Lageschulte and Evelyn B. Weese New Frontiers in Medical
   Research Fund [R21MH113455]; Frances and Louie Blumkin Foundation;
   Harriet Singer Research Foundation [P30MH062261, 1R01AI145542-01A1, P01
   DA028555, R01 NS36126, P01 NS31492, 2R01 NS034239, P01 MH64570, P01
   NS43985, R01 AG043540, 1 R56 AI138613-01A1]
FX We thank Michellie Thurman and Robin Taylor for editorial help. The work
   contained in this study is dedicated to the life and legacy of Ms.
   Harriet Singer whose philanthropy and dogged spirit enabled this and
   countless works possible for studies of human brain disease. This work
   was supported, in part, by R21MH113455, Frances E. Lageschulte and
   Evelyn B. Weese New Frontiers in Medical Research Fund to SNB and the
   Carol Swarts, M.D. Emerging Neuroscience Research Laboratory, the
   Margaret R. Larson Professorship, and the Frances and Louie Blumkin and
   Harriet Singer Research Foundations. P30MH062261 to HEG and SNB and
   1R01AI145542-01A1, P01 DA028555, R01 NS36126, P01 NS31492, 2R01
   NS034239, P01 MH64570, P01 NS43985, R01 AG043540, and 1 R56
   AI138613-01A1 to HEG.
CR ABRAHAM S, 1990, VIROLOGY, V176, P296, DOI 10.1016/0042-6822(90)90257-R
   Andersen KG, 2020, NAT MED, DOI 10.1038/s41591-020-0820-9
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Arbour N, 2000, J VIROL, V74, P8913, DOI 10.1128/JVI.74.19.8913-8921.2000
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Asadi-Pooya AA, 2020, J NEUROL SCI, V413, DOI 10.1016/j.jns.2020.116832
   Bagdonaite I, 2018, GLYCOBIOLOGY, V28, P443, DOI 10.1093/glycob/cwy021
   Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Beniac DR, 2006, NAT STRUCT MOL BIOL, V13, P751, DOI 10.1038/nsmb1123
   Bergmann CC, 2006, NAT REV MICROBIOL, V4, P121, DOI 10.1038/nrmicro1343
   Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1
   Chen L, 2020, N ENGL J MED, DOI 10.1056/NEJMc2009226
   Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Collins AR, 2002, CLIN DIAGN LAB IMMUN, V9, P1392, DOI 10.1128/CDLI.9.6.1392-1395.2002
   Colson PW, 2020, AIDS BEHAV, DOI 10.1007/s10461-020-02901-6
   Cardona GC, 2020, J NEUROL SCI, V412, DOI 10.1016/j.jns.2020.116824
   DELMAS B, 1990, J VIROL, V64, P5367, DOI 10.1128/JVI.64.11.5367-5375.1990
   Desforges M, 2019, VIRUSES, V12, P14
   Desforges M, 2007, VIRUS RES, V130, P228, DOI 10.1016/j.virusres.2007.06.016
   Desforges M, 2014, VIRUS RES, V194, P145, DOI 10.1016/j.virusres.2014.09.011
   Desforges M, 2014, ADV EXP MED BIOL, V807, P75, DOI 10.1007/978-81-322-1777-0_6
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Dube M, 2018, J VIROL, V92, DOI 10.1128/JVI.00404-18
   Duong LS, 2020, BRAIN BEHAV IMMUN, V87, P33, DOI 10.1016/j.bbi.2020.04.024
   Eliezer M, 2020, HEAD NECK SURG, DOI [10.1001/jamaoto.2020.0832, DOI 10.1001/JAMA0T0.2020.0832]
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Foley JE, 2003, J FELINE MED SURG, V5, P313, DOI 10.1016/S1098-612X(03)00048-2
   Fu LW, 2020, J INFECTION, V80, P656, DOI 10.1016/j.jinf.2020.03.041
   GREIG AS, 1962, CAN J COMP MED VET S, V26, P49
   Gu J, 2005, J EXP MED, V202, P415, DOI 10.1084/jem.20050828
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Jin Huijuan, 2020, Stroke Vasc Neurol, V5, P146, DOI 10.1136/svn-2020-000382
   Khosravani Rajendram Notario L, 2020, PROTECTED CODE STROK, DOI [10.1161/STROKEAHA.120.029838., DOI 10.1161/STR0KEAHA.120.029838, 10.1161/STROKEAHA.120.029838]
   Kim JE, 2017, J CLIN NEUROL, V13, P227, DOI 10.3988/jcn.2017.13.3.227
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Leonhard SE, 2019, NAT REV NEUROL, V15, P671, DOI 10.1038/s41582-019-0250-9
   Li K, 2016, J INFECT DIS, V213, P712, DOI 10.1093/infdis/jiv499
   Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728
   Li YY, 2016, INTERVIROLOGY, V59, P163, DOI 10.1159/000453066
   Luk HKH, 2019, INFECT GENET EVOL, V71, P21, DOI 10.1016/j.meegid.2019.03.001
   LUYTJES W, 1987, VIROLOGY, V161, P479, DOI 10.1016/0042-6822(87)90142-5
   Major CG, 2018, P R HEALTH SCI J, V37, pS85
   Mao Ling, 2020, JAMA Neurol, DOI 10.1001/jamaneurol.2020.1127
   McCray PB, 2007, J VIROL, V81, P813, DOI 10.1128/JVI.02012-06
   McGavern DB, 2011, NAT REV IMMUNOL, V11, P318, DOI 10.1038/nri2971
   Netland J, 2008, J VIROL, V82, P7264, DOI 10.1128/JVI.00737-08
   Nicholls JM, 2006, PLOS MED, V3, P222, DOI 10.1371/journal.pmed.0030027
   Pan Lei, 2020, Am J Gastroenterol, V115, P766, DOI 10.14309/ajg.0000000000000620
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433
   SALMI A, 1982, NEUROLOGY, V32, P292, DOI 10.1212/WNL.32.3.292
   STEWART JN, 1992, VIROLOGY, V191, P502, DOI 10.1016/0042-6822(92)90220-J
   Stripp TK, 2020, UGESKRIFT LAEGER, V182
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Wu GF, 2000, J VIROL, V74, P7683, DOI 10.1128/JVI.74.16.7683-7686.2000
   Xydakis MS, 2020, LANCET INFECT DIS
   Zhao Hua, 2020, Lancet Neurol, V19, P383, DOI 10.1016/S1474-4422(20)30109-5
   Zhao L, 2012, CELL HOST MICROBE, V11, P607, DOI 10.1016/j.chom.2012.04.011
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 60
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1557-1890
EI 1557-1904
J9 J NEUROIMMUNE PHARM
JI J. Neuroimmune Pharm.
PD JUN
PY 2020
VL 15
IS 2
BP 167
EP 173
DI 10.1007/s11481-020-09924-9
EA MAY 2020
PG 7
WC Neurosciences; Pharmacology & Pharmacy
SC Neurosciences & Neurology; Pharmacology & Pharmacy
GA LU1DJ
UT WOS:000534986800001
PM 32447746
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Valente, PK
   Morin, C
   Roy, M
   Mercier, A
   Atlani-Duault, L
AF Valente, Pablo K.
   Morin, Celine
   Roy, Melissa
   Mercier, Arnaud
   Atlani-Duault, Laetitia
TI Sexual transmission of Zika virus on Twitter: A depoliticised epidemic
SO GLOBAL PUBLIC HEALTH
LA English
DT Article; Early Access
DE Zika virus; social media; health communication; communications media;
   reproductive health
ID EBOLA; SENSATIONALISM; COVERAGE; CRISIS; BRAZIL; MEDIA; NEWS
AB During global health crises, different narratives regarding infectious disease epidemics circulate in traditional media (e.g. news agencies, television channels) and social media. Our study investigated the narratives related to sexual transmission of Zika virus that circulated on Twitter during a public health emergency and analyzed the relationship between information on Twitter and on traditional media. We examined 10,748 tweets posted during the peaks of Twitter activity between January and March 2016. Posts in English, Spanish, French, and Portuguese and websites linked to tweets were manually reviewed and analyzed thematically. During the study period, there were three peaks of Twitter activity related to the sexual transmission of Zika. Most tweets in the first peak (n = 412) had humorous/sarcastic content (55%). Most tweets in the second and third peaks (n = 5,154 and n = 5,182, respectively) disseminated information (>93%). Across languages, textual and visual content on the websites were predominantly placed online by traditional media and highlighted epidemiological narratives published by public health agencies, with little or no mention of the concerns or experiences of individuals most affected by Zika. Prioritising epidemiological/clinical aspects of epidemics may have a depoliticising effect and contribute to overlooking socio-economic determinants of the Zika epidemic and issues related to reproductive justice.
C1 [Valente, Pablo K.] Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, 121 South Main St,3rd Floor, Providence, RI 02912 USA.
   [Valente, Pablo K.] Columbia Univ, Mailman Sch Publ Hlth, Dept Sociomed Sci, New York, NY USA.
   [Morin, Celine] Univ Paris Ouest, HAR, Informat & Commun, Paris, France.
   [Roy, Melissa] Univ Ottawa, Sch Social Work, Ottawa, ON, Canada.
   [Mercier, Arnaud] Univ Paris 2, Inst Francais Presse, Informat & Commun, Assas CARISM, Paris, France.
   [Atlani-Duault, Laetitia] Paris V Univ, INSERM, CEPED, Social Anthropol,IRD, Paris, France.
   [Atlani-Duault, Laetitia] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA.
RP Valente, PK (corresponding author), Brown Univ, Sch Publ Hlth, Dept Behav & Social Sci, 121 South Main St,3rd Floor, Providence, RI 02912 USA.
EM pablo_valente@brown.edu
OI Valente, Pablo/0000-0002-2058-3472
FU Institut National de la Sante et de la Recherche Medicale
   (INSERM)/REACting, France
FX This work was supported by the Institut National de la Sante et de la
   Recherche Medicale (INSERM)/REACting, France (PI: Prof. Laetitia
   Atlani-Duault). The institution was not involved in the preparation,
   review, or approval of this manuscript.
CR Althaus CL, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002157
   [Anonymous], 2016, GUARDIAN
   Atlani-Duault L, 2015, CULT MED PSYCHIAT, V39, P43, DOI 10.1007/s11013-014-9410-y
   Bausch DG, 2015, J INFECT DIS, V212, pS79, DOI 10.1093/infdis/jiv359
   Bode L, 2018, HEALTH COMMUN, V33, P1131, DOI 10.1080/10410236.2017.1331312
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Bruns A, 2012, JOURNALISM STUD, V13, P801, DOI 10.1080/1461670X.2012.664428
   Campbell JL, 2013, SOCIOL METHOD RES, V42, P294, DOI 10.1177/0049124113500475
   Centers for Disease Control and Prevention, 2019, ZIK VIR SEX TRANSM P
   Centers for Disease Control and Prevention, 2019, STAT MAPS
   Chandler C, 2015, LANCET, V385, P1275, DOI 10.1016/S0140-6736(14)62382-5
   CNN Espanol, 2016, AUT REP 1 CAS AUT ZI
   Dagnaud M., 2013, GENERATION JEUNES RE
   Davis M, 2018, GLOB PUBLIC HEALTH, V13, P1158, DOI 10.1080/17441692.2017.1336248
   DELLER R., 2011, PARTICIPATIONS JOURN, V8, P216
   Diderichsen F, 2019, GLOB PUBLIC HEALTH, V14, P675, DOI 10.1080/17441692.2018.1532528
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2017, DISASTER MED PUBLIC, V11, P656, DOI 10.1017/dmp.2017.23
   Gabarron E, 2014, J MED INTERNET RES, V16, P152, DOI 10.2196/jmir.3259
   Gilbert C., 2011, PRESSES SCI PO TRIBU, V3, P55, DOI 10.3917/seve.032.0055
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Graham M, 2014, PROF GEOGR, V66, P568, DOI 10.1080/00330124.2014.907699
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills S. L., 2016, MORBIDITY MORTALITY
   Ihekweazu C, 2017, HEALTH COMMUN, V32, P741, DOI 10.1080/10410236.2016.1172287
   Kilgo DK, 2019, HEALTH COMMUN, V34, P811, DOI 10.1080/10410236.2018.1437524
   Leach M, 2010, GLOBAL ENVIRON CHANG, V20, P369, DOI 10.1016/j.gloenvcha.2009.11.008
   Malta M, 2018, GLOB PUBLIC HEALTH, V13, P1577, DOI 10.1080/17441692.2018.1429006
   Marmot M, 2017, LANCET, V389, P497, DOI 10.1016/S0140-6736(17)30207-6
   Miller Michele, 2017, JMIR Public Health Surveill, V3, pe38, DOI 10.2196/publichealth.7157
   Moreau N, 2020, INT REV SOCIOL SPORT, DOI 10.1177/1012690219899610
   Morin C, 2019, SOCIETIES, V9, DOI 10.3390/soc9010012
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Novaes HMD, 2000, SOC SCI MED, V50, P41, DOI 10.1016/S0277-9536(99)00255-5
   Odlum M, 2015, AM J INFECT CONTROL, V43, P563, DOI 10.1016/j.ajic.2015.02.023
   Pew Research Center, 2019, SOC MED FACT SHEET
   Ribeiro B, 2018, SOC SCI MED, V200, P137, DOI 10.1016/j.socscimed.2018.01.023
   Roberts H, 2017, J HEALTH COMMUN, V22, P51, DOI 10.1080/10810730.2016.1209598
   Roy M, 2020, CULT MED PSYCHIAT, V44, P56, DOI 10.1007/s11013-019-09635-8
   Schulz A., 2013, 7 INT AAAI C WEBL SO
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Semiocast, 2020, PUBL
   Septfons A, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.32.30315
   Shepard B, 2000, Health Hum Rights, V4, P110, DOI 10.2307/4065198
   Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512
   Sorensen K, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-80
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Valente PK, 2017, AM J PUBLIC HEALTH, V107, P1376, DOI 10.2105/AJPH.2017.303924
   Vignoud L, 2018, IEEE CPMT SYMP JAP, P11, DOI 10.1109/ICSJ.2018.8602522
   Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015
   Wald P, 2008, CONTAGIOUS CULTURES
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   World Health Organization, 2016, SIT REP ZIK VIR MICR
NR 54
TC 0
Z9 0
U1 0
U2 0
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1744-1692
EI 1744-1706
J9 GLOB PUBLIC HEALTH
JI Glob. Public Health
DI 10.1080/17441692.2020.1768275
EA MAY 2020
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LU7OA
UT WOS:000537939000001
PM 32436470
DA 2020-07-08
ER

PT J
AU Roy, U
AF Roy, Urmi
TI Structural and molecular analyses of functional epitopes and escape
   mutants in Japanese encephalitis virus envelope protein domain III
SO IMMUNOLOGIC RESEARCH
LA English
DT Article
DE Envelope protein; Escape mutation; Japanese encephalitis virus;
   Simulation; Structural immunology
ID NEUTRALIZING-ANTIBODY; CRYSTAL-STRUCTURE; GLYCOPROTEIN; DYNAMICS;
   TRANSFERRIN; RECEPTOR; STRAIN
AB The Japanese encephalitis virus (JEV) is one of the vector borne causes of encephalitis found in southeastern Asia. This positive single-stranded RNA virus is a member of the Flaviviridae family, which notably includes dengue, tick-borne, West Nile, Zika as well as yellow fever, and transmits to humans by infected mosquitos. The main site of interactions for antibodies against this virus is the envelope protein domain III (ED3). The present report investigates the time-dependent structural and conformational changes of JEV ED3 functional epitopes and escape mutants by computer simulations. The results indicate the presence of significant structural differences between the functional epitopes and the escape mutants. Mutation-induced structural/conformational instabilities of this type can decrease the antibody neutralization activity. Among the different escape mutants studied here, Ser40Lys/Asp41Arg appear to be most unstable, while Ser40Glu/Asp41Leu exhibit the lowest structural variations. The highest level of escape mutation observed in Ser40Lys is linked to the relatively higher values of root mean square deviation/fluctuation found in the molecular dynamics simulation of this protein. Secondary-structure deviations and depletion of H bonding are other contributing factors to the protein's increased instability. Overall, the proteins with residue 41 mutations are found to be structurally more ordered than those with residue 40 mutations. The detailed time-based structural assessment of the mutant epitopes described here may contribute to the development of novel vaccines and antiviral drugs necessary to defend against future outbreaks of JEV escape mutants.
C1 [Roy, Urmi] Clarkson Univ, Dept Chem & Biomol Sci, 8 Clarkson Ave, Potsdam, NY 13699 USA.
RP Roy, U (corresponding author), Clarkson Univ, Dept Chem & Biomol Sci, 8 Clarkson Ave, Potsdam, NY 13699 USA.
EM urmi@clarkson.edu
OI Roy, Urmi/0000-0003-0928-0574
CR [Anonymous], 98 WHO
   [Anonymous], 2015, DISCOVERY STUDIO MOD
   Bazzone LE, 2019, MBIO, V10, DOI 10.1128/mBio.02734-18
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Borrego F, 2002, MOL IMMUNOL, V38, P637, DOI 10.1016/S0161-5890(01)00107-9
   Cai Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9277
   Chiou SS, 2012, J GEN VIROL, V93, P1185, DOI 10.1099/vir.0.040238-0
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dilioglou S, 2001, EXP MOL PATHOL, V71, P73, DOI 10.1006/exmp.2001.2356
   Dube S, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-120
   Dubey KD, 2011, BBA-PROTEINS PROTEOM, V1814, P1796, DOI 10.1016/j.bbapap.2011.09.012
   Durrant JD, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-71
   Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311
   Ghosh D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000437
   Greenspan NS, 1999, NAT BIOTECHNOL, V17, P936, DOI 10.1038/13590
   HASEGAWA H, 1992, VIROLOGY, V191, P158, DOI 10.1016/0042-6822(92)90177-Q
   Hiramatsu K, 1996, VIROLOGY, V224, P437, DOI 10.1006/viro.1996.0550
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Ieong P, 2015, BIOPHYS J, V108, P2704, DOI 10.1016/j.bpj.2015.04.025
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kaya T, 2009, BIOORG CHEM, V37, P57, DOI 10.1016/j.bioorg.2009.01.001
   Kolaskar AS, 1999, VIROLOGY, V261, P31, DOI 10.1006/viro.1999.9859
   Korber B, 2006, PLOS COMPUT BIOL, V2, P484, DOI 10.1371/journal.pcbi.0020071
   LI Y, 1993, MOL PHARMACOL, V44, P742
   Ligoudistianou C, 2005, BIOCHEM J, V387, P165, DOI 10.1042/BJ20041196
   Lin CW, 2003, J VIROL, V77, P2600, DOI 10.1128/JVI.77.4.2600-2606.2003
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   Luck LA, 1997, MAGN RESON CHEM, V35, P477, DOI 10.1002/(SICI)1097-458X(199707)35:7<477::AID-OMR119>3.3.CO;2-H
   Mason AB, 2009, J MOL RECOGNIT, V22, P521, DOI 10.1002/jmr.979
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Ndifon W, 2009, P NATL ACAD SCI USA, V106, P8701, DOI 10.1073/pnas.0903427106
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Loyola PKR, 2013, IMMUNOL RES, V56, P44, DOI 10.1007/s12026-013-8385-z
   Roy U, 2007, BIOCHEM MOL BIOL EDU, V35, P238, DOI 10.1002/bmb.65
   Roy U, 2019, PROTEIN J, V38, P525, DOI 10.1007/s10930-019-09833-8
   Roy U, 2019, MOL INFORM, V38, DOI 10.1002/minf.201800011
   Roy U, 2017, BIOTECHNOL APPL BIOC, V64, P454, DOI 10.1002/bab.1523
   Roy U, 2016, BIOCHEM MOL BIOL EDU, V44, P246, DOI 10.1002/bmb.20937
   Roy U, 2016, PROTEIN J, V35, P51, DOI 10.1007/s10930-015-9646-6
   SEIF SA, 1995, VACCINE, V13, P1515, DOI 10.1016/0264-410X(95)00097-K
   Sheinerman FB, 1997, PROTEINS, V29, P193, DOI 10.1002/(SICI)1097-0134(199710)29:2<193::AID-PROT7>3.0.CO;2-E
   Shen MY, 2013, MOL BIOSYST, V9, P361, DOI 10.1039/c2mb25408e
   Soares ROS, 2013, BBA-PROTEINS PROTEOM, V1834, P221, DOI 10.1016/j.bbapap.2012.09.007
   Sun H, 2008, BIOCHEM BIOPH RES CO, V377, P962, DOI 10.1016/j.bbrc.2008.10.096
   Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200
   Wise MC, 2020, J CLIN INVEST, V130, P827, DOI 10.1172/JCI132779
   Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200
   Wu SC, 2001, VIRUS RES, V76, P59, DOI 10.1016/S0168-1702(01)00246-5
   Wu SC, 1997, VIRUS RES, V51, P173, DOI 10.1016/S0168-1702(97)00098-1
   Zaslavsky E, 2012, IMMUNOL RES, V54, P160, DOI 10.1007/s12026-012-8322-6
NR 53
TC 0
Z9 0
U1 2
U2 2
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA
SN 0257-277X
EI 1559-0755
J9 IMMUNOL RES
JI Immunol. Res.
PD APR
PY 2020
VL 68
IS 2
BP 81
EP 89
DI 10.1007/s12026-020-09130-y
EA MAY 2020
PG 9
WC Immunology
SC Immunology
GA LY8HK
UT WOS:000534875700001
PM 32445181
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Raper, J
   Kovacs-Balint, Z
   Mavigner, M
   Gumber, S
   Burke, MW
   Habib, J
   Mattingly, C
   Fair, D
   Earl, E
   Feczko, E
   Styner, M
   Jean, SM
   Cohen, JK
   Suthar, MS
   Sanchez, MM
   Alvarado, MC
   Chahroudi, A
AF Raper, Jessica
   Kovacs-Balint, Zsofia
   Mavigner, Maud
   Gumber, Sanjeev
   Burke, Mark W.
   Habib, Jakob
   Mattingly, Cameron
   Fair, Damien
   Earl, Eric
   Feczko, Eric
   Styner, Martin
   Jean, Sherrie M.
   Cohen, Joyce K.
   Suthar, Mehul S.
   Sanchez, Mar M.
   Alvarado, Maria C.
   Chahroudi, Ann
TI Long-term alterations in brain and behavior after postnatal Zika virus
   infection in infant macaques
SO NATURE COMMUNICATIONS
LA English
DT Article
ID SOCIAL-BEHAVIOR; RHESUS MACAQUES; CHILDREN; AMYGDALA; DISEASE; MEMORY;
   MATURATION; OUTBREAK; CORTISOL; MONKEYS
AB Zika virus (ZIKV) infection has a profound impact on the fetal nervous system. The postnatal period is also a time of rapid brain growth, and it is important to understand the potential neurobehavioral consequences of ZIKV infection during infancy. Here we show that postnatal ZIKV infection in a rhesus macaque model resulted in long-term behavioral, motor, and cognitive changes, including increased emotional reactivity, decreased social contact, loss of balance, and deficits in visual recognition memory at one year of age. Structural and functional MRI showed that ZIKV-infected infant rhesus macaques had persistent enlargement of lateral ventricles, smaller volumes and altered functional connectivity between brain areas important for socioemotional behavior, cognitive, and motor function (e.g. amygdala, hippocampus, cerebellum). Neuropathological changes corresponded with neuroimaging results and were consistent with the behavioral and memory deficits. Overall, this study demonstrates that postnatal ZIKV infection in this model may have long-lasting neurodevelopmental consequences. The consequences of postnatal Zika infection are not fully understood. Here, the authors show that postnatal Zika infection in infant rhesus macaques alters neurodevelopment resulting in social, cognitive and motor impairments, as well as structural and functional changes in the brain.
C1 [Raper, Jessica; Kovacs-Balint, Zsofia; Gumber, Sanjeev; Jean, Sherrie M.; Cohen, Joyce K.; Suthar, Mehul S.; Sanchez, Mar M.; Alvarado, Maria C.; Chahroudi, Ann] Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.
   [Raper, Jessica; Mavigner, Maud; Habib, Jakob; Mattingly, Cameron; Chahroudi, Ann] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.
   [Mavigner, Maud; Suthar, Mehul S.; Chahroudi, Ann] Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Atlanta, GA 30322 USA.
   [Mavigner, Maud; Suthar, Mehul S.; Chahroudi, Ann] Emory Univ, Atlanta, GA 30322 USA.
   [Burke, Mark W.] Howard Univ, Dept Physiol & Biophys, Washington, DC USA.
   [Fair, Damien; Earl, Eric; Feczko, Eric] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
   [Styner, Martin] Univ N Carolina, Dept Psychiat, Chapel Hill, NC 27515 USA.
   [Cohen, Joyce K.; Sanchez, Mar M.] Emory Univ, Psychiat & Behav Sci, Sch Med, Atlanta, GA USA.
   [Suthar, Mehul S.] Emory Vaccine Ctr, Atlanta, GA 30329 USA.
RP Chahroudi, A (corresponding author), Emory Univ, Yerkes Natl Primate Res Ctr, Atlanta, GA 30322 USA.; Chahroudi, A (corresponding author), Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA.; Chahroudi, A (corresponding author), Childrens Healthcare Atlanta, Ctr Childhood Infect & Vaccines, Atlanta, GA 30322 USA.; Chahroudi, A (corresponding author), Emory Univ, Atlanta, GA 30322 USA.
EM achahro@emory.edu
OI Raper, Jessica/0000-0002-0964-9944; Fair, Damien/0000-0001-8602-393X
FU Pilot Grant Program of the Yerkes National Primate Research Center -
   National Institutes of Health's Office of the Director, Office of
   Research Infrastructures Programs [P51 OD011132]; Center for Childhood
   Infections and Vaccines of Emory University; Children's Healthcare of
   Atlanta
FX The authors would like to thank Stephanie Ehnert and the YNPRC Division
   of Research Resources for expert assistance with animal procedures and
   Shanice Wilson, B.S. for her assistance with social behavior
   assessments. Funding for this study was provided by the Pilot Grant
   Program of the Yerkes National Primate Research Center, which is
   supported by the National Institutes of Health's Office of the Director,
   Office of Research Infrastructures Programs, P51 OD011132, and the
   Center for Childhood Infections and Vaccines of Emory University and
   Children's Healthcare of Atlanta (to A.C.).
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alvarado MC, 2000, LEARN MEMORY, V7, P244, DOI 10.1101/lm.35100
   Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Asturias EJ, 2018, JAMA PEDIATR, V172, P624, DOI 10.1001/jamapediatrics.2018.0921
   Bauman MD, 2004, J COGNITIVE NEUROSCI, V16, P1388, DOI 10.1162/0898929042304741
   Bauman MD, 2014, BIOL PSYCHIAT, V75, P332, DOI 10.1016/j.biopsych.2013.06.025
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Besnard M, 2017, EMERG INFECT DIS, V23, P1421, DOI 10.3201/eid2308.170198
   Bick J, 2015, JAMA PEDIATR, V169, P211, DOI 10.1001/jamapediatrics.2014.3212
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   Blue SN, 2013, J INT NEUROPSYCH SOC, V19, P1053, DOI 10.1017/S1355617713000799
   BOOTHE RG, 1985, ANNU REV NEUROSCI, V8, P495, DOI 10.1146/annurev.ne.08.030185.002431
   Bourne JA, 2010, J ANAT, V217, P449, DOI 10.1111/j.1469-7580.2010.01275.x
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carryl H, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7040040
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Chen Q, 2014, INT J EPIDEMIOL, V43, P83, DOI 10.1093/ije/dyt152
   CHURCHLAND PS, 1988, SCIENCE, V242, P741, DOI 10.1126/science.3055294
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Fair DA, 2007, P NATL ACAD SCI USA, V104, P13507, DOI 10.1073/pnas.0705843104
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Goodroe SC, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00250
   Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hinde K, 2015, BEHAV ECOL, V26, P269, DOI 10.1093/beheco/aru186
   HINDE RA, 1967, ANIM BEHAV, V15, P169, DOI 10.1016/S0003-3472(67)80029-0
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Howell BR, 2013, BIOL MOOD ANXIETY DI, V3, DOI 10.1186/2045-5380-3-21
   Hutchison RM, 2013, HUM BRAIN MAPP, V34, P2154, DOI 10.1002/hbm.22058
   Jankiewicz M, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00088
   King DR, 2018, BEHAV BRAIN RES, V354, P1, DOI 10.1016/j.bbr.2017.07.031
   Kong LH, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0776
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   Malkova L, 2010, BEHAV NEUROSCI, V124, P742, DOI 10.1037/a0021622
   Markov NT, 2014, CEREB CORTEX, V24, P17, DOI 10.1093/cercor/bhs270
   Mavigner M, 2018, J VIROL, V92, DOI 10.1128/JVI.00562-18
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   McLaren DG, 2010, METHODS, V50, P157, DOI 10.1016/j.ymeth.2009.10.003
   Miranda-Dominguez O, 2014, J NEUROSCI, V34, P5552, DOI 10.1523/JNEUROSCI.4229-13.2014
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mulkey SB, 2019, JAMA PEDIATR, V173, P52, DOI 10.1001/jamapediatrics.2018.4138
   National Institute of Health, 2017, STUD EX EFF ZIK INF
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Payne C, 2010, HIPPOCAMPUS, V20, P922, DOI 10.1002/hipo.20688
   Petrides M, 2005, PHILOS T ROY SOC B, V360, P781, DOI 10.1098/rstb.2005.1631
   Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048
   RAKIC P, 1986, SCIENCE, V232, P232, DOI 10.1126/science.3952506
   Raper J, 2017, PSYCHONEUROENDOCRINO, V76, P57, DOI 10.1016/j.psyneuen.2016.11.018
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Saleem K. S., 2012, COMBINED MRI HISTOLO
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schumann CM, 2019, J COMP NEUROL, V527, P3034, DOI 10.1002/cne.24728
   Shi YD, 2017, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00617
   SMITHBURN KC, 1952, J IMMUNOL, V69, P223
   Snyder-Keller A, 2019, J NEUROSCI, V39, P5393, DOI 10.1523/JNEUROSCI.2666-18.2019
   Styner M, 2007, PROC SPIE, V6512, DOI 10.1117/12.710027
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tolosa N, 2017, PAEDIATR PERINAT EP, V31, P537, DOI 10.1111/ppe.12391
   Uban KA, 2015, AIDS, V29, P1035, DOI 10.1097/QAD.0000000000000648
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang JH, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00007
   WEINBREN M. P., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P263, DOI 10.1016/0035-9203(58)90085-3
   Wellman LL, 2016, J NEUROSCI, V36, P8746, DOI 10.1523/JNEUROSCI.0333-16.2016
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   World Health Organization, 2019, ZIK VIR
   Zeamer A, 2010, J NEUROSCI, V30, P9157, DOI 10.1523/JNEUROSCI.0022-10.2010
NR 82
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 21
PY 2020
VL 11
IS 1
AR 2534
DI 10.1038/s41467-020-16320-7
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LT4UE
UT WOS:000537066900006
PM 32439858
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Williamson, DA
   Chen, MY
AF Williamson, Deborah A.
   Chen, Marcus Y.
TI Emerging and Reemerging Sexually Transmitted Infections
SO NEW ENGLAND JOURNAL OF MEDICINE
LA English
DT Review
ID UNITED-STATES; NEISSERIA-MENINGITIDIS; MYCOPLASMA-GENITALIUM;
   MENINGOCOCCAL DISEASE; LYMPHOGRANULOMA-VENEREUM; RESISTANT SHIGELLOSIS;
   ZIKA VIRUS; MEN; SEX; TRANSMISSION
AB Sexually transmitted infections are increasing in frequency, and resistant strains are complicating treatment. Genomic technologies, education, and cooperation between government and nongovernmental organizations with community involvement may foster improved control.
C1 [Williamson, Deborah A.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3100, Australia.
   [Williamson, Deborah A.] Royal Melbourne Hosp, Dept Microbiol, Melbourne, Vic, Australia.
   [Chen, Marcus Y.] Monash Univ, Alfred Hlth, Melbourne Sexual Hlth Ctr, Melbourne, Vic, Australia.
   [Chen, Marcus Y.] Monash Univ, Cent Clin Sch, Melbourne, Vic, Australia.
RP Williamson, DA (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, 792 Elizabeth St, Melbourne, Vic 3100, Australia.
EM deborah.williamson@unimelb.edu.au
CR [Anonymous], 2017, J ENDOCRINOL METAB D, V22, pS1
   [Anonymous], 2017, OUTBREAKS EU EEA MOS
   [Anonymous], 2018, REP GLOB SEX TRANSM
   [Anonymous], 2020, EB VIR DIS FACT SHEE
   [Anonymous], 2019, WHO GUID PREV SEX TR
   Aragon TJ, 2007, CLIN INFECT DIS, V44, P327, DOI 10.1086/510593
   Baker KS, 2015, LANCET INFECT DIS, V15, P913, DOI 10.1016/S1473-3099(15)00002-X
   Bazan JA, 2017, CLIN INFECT DIS, V65, P92, DOI 10.1093/cid/cix215
   Beale MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11216-7
   Beymer MR, 2014, SEX TRANSM INFECT, V90, P567, DOI 10.1136/sextrans-2013-051494
   Bibbins-Domingo K, 2016, JAMA-J AM MED ASSOC, V315, P2321, DOI 10.1001/jama.2016.5824
   Bissessor M, 2013, SEX TRANSM DIS, V40, P768, DOI 10.1097/OLQ.0000000000000022
   Bowen A, 2016, EMERG INFECT DIS, V22, P1613, DOI 10.3201/eid2209.160624
   Bozio CH, 2018, MMWR-MORBID MORTAL W, V67, P1060, DOI 10.15585/mmwr.mm6738a4
   Brennan J, 2019, MMWR-MORBID MORTAL W, V68, P328, DOI 10.15585/mmwr.mm6814a3
   Centers for Disease Control and Prevention, 2018, SEX TRANSM DIS SURV
   Centers for Disease Control and Prevention (CDC), 2019, ANT RES THREATS US 2
   Chen GJ, 2017, J INFECT DIS, V215, P1339, DOI 10.1093/infdis/jix123
   Chen MY, 2019, LANCET INFECT DIS, V19, P833, DOI 10.1016/S1473-3099(19)30116-1
   Chen WC, 2019, EUROSURVEILLANCE, V24, P38, DOI 10.2807/1560-7917.ES.2019.24.14.1800133
   Chiou CS, 2016, CLIN MICROBIOL INFEC, V22, DOI 10.1016/j.cmi.2015.12.021
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Vries HJC, 2019, J EUR ACAD DERMATOL, V33, P1821, DOI 10.1111/jdv.15729
   de Vries HJC, 2019, CURR OPIN INFECT DIS, V32, P43, DOI [10.1097/QCO.0000000000000519, 10.1097/qco.0000000000000519]
   Dionne-Odom J, 2018, CLIN INFECT DIS, V66, P796, DOI 10.1093/cid/cix853
   Durukan D, 2019, CLIN INFECT DIS
   European Centre for Disease Prevention and Control, 2018, ANN EP REP 2016
   Eyre DW, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.10.1900147
   Folaranmi TA, 2017, CLIN INFECT DIS, V65, P756, DOI 10.1093/cid/cix438
   Foster MA, 2019, MMWR-MORBID MORTAL W, V68, P413, DOI 10.15585/mmwr.mm6818a2
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gaudreau C, 2015, CLIN INFECT DIS, V61, P1549, DOI 10.1093/cid/civ570
   Gaydos CA, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.01125-19
   Gilbart VL, 2015, SEX TRANSM INFECT, V91, P598, DOI 10.1136/sextrans-2015-052014
   Golden M, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00572-19, 10.1128/jcm.00572-19]
   Golden MR, 2017, J INFECT DIS, V216, pS420, DOI 10.1093/infdis/jix200
   Handsfield HH, 2018, SEX TRANSM DIS, V45, P409, DOI 10.1097/OLQ.0000000000000853
   Hughes G, 2013, SEX TRANSM INFECT, V89, P542, DOI 10.1136/sextrans-2013-051051
   Hung CC, 2012, LANCET INFECT DIS, V12, P729, DOI 10.1016/S1473-3099(12)70147-0
   Ingle DJ, 2019, CLIN INFECT DIS, V69, P1535, DOI 10.1093/cid/ciz005
   JANDA WM, 1980, JAMA-J AM MED ASSOC, V244, P2060, DOI 10.1001/jama.244.18.2060
   Jennison AV, 2019, EUROSURVEILLANCE, V24, P15, DOI 10.2807/1560-7917.ES.2019.24.8.1900118
   Jensen JS, 2016, J EUR ACAD DERMATOL, V30, P1650, DOI 10.1111/jdv.13849
   Kamiya H, 2015, MMWR-MORBID MORTAL W, V64, P1256, DOI 10.15585/mmwr.mm6444a6
   Koch J, 2016, EUROSURVEILLANCE, V21, P12, DOI 10.2807/1560-7917.ES.2016.21.5.30122
   Leeyaphan C, 2016, EMERG INFECT DIS, V22, P1778, DOI 10.3201/eid2210.160986
   Ma KC, 2017, J CLIN MICROBIOL, V55, P3374, DOI 10.1128/JCM.01018-17
   MacNeil JR, 2016, MMWR-MORBID MORTAL W, V65, P1189, DOI 10.15585/mmwr.mm6543a3
   Mate SE, 2015, NEW ENGL J MED, V373, P2448, DOI 10.1056/NEJMoa1509773
   Miglietta A, 2018, EUROSURVEILLANCE, V23
   Mohan K, 2018, SEX TRANSM INFECT, V94, P67, DOI 10.1136/sextrans-2016-052962
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray GL, 2017, EMERG INFECT DIS, V23, P809, DOI 10.3201/eid2305.161745
   Murray K, 2017, EMERG INFECT DIS, V23, P332, DOI 10.3201/eid2302.161203
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nanduri S, 2016, MMWR-MORBID MORTAL W, V65, P939, DOI 10.15585/mmwr.mm6535e1
   Ndumbi P, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.33.1700641
   Newman KL, 2019, CLIN INFECT DIS
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Retchless AC, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4560-x
   Rivas V, 2018, EUROSURVEILLANCE, V23, P9, DOI DOI 10.2807/1560-7917
   Ruscher C, 2019, EUROSURVEILLANCE, V24, P32, DOI 10.2807/1560-7917.ES.2019.24.21.1800460
   Shea S, 2017, J CLIN MICROBIOL, V55, P10, DOI [10.1128/JCM.01624-16, 10.1128/jcm.01624-16]
   Simms I, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.43.20946
   Simons R, 2018, SEX TRANSM DIS, V45, P406, DOI 10.1097/OLQ.0000000000000772
   Sissoko D, 2017, LANCET GLOB HEALTH, V5, pE80, DOI 10.1016/S2214-109X(16)30243-1
   Soni S, 2019, INT J STD AIDS, V30, P938, DOI 10.1177/0956462419825948
   Spaargaren J, 2005, EMERG INFECT DIS, V11, P1787, DOI 10.3201/eid1111.050821
   Stafford IA, 2019, JAMA
   Tao YS, 2020, CLIN INFECT DIS, V70, P136, DOI 10.1093/cid/ciz331
   Taylor SN, 2018, NEW ENGL J MED, V379, P1835, DOI 10.1056/NEJMoa1706988
   Taylor SN, 2018, CLIN INFECT DIS, V67, P504, DOI 10.1093/cid/ciy145
   Taylor-Robinson D, 2011, CLIN MICROBIOL REV, V24, P498, DOI 10.1128/CMR.00006-11
   Toh E, 2017, EMERG INFECT DIS, V23, P336, DOI 10.3201/eid2302.161434
   Towns JM, 2016, SEX TRANSM INFECT, V92, P110, DOI 10.1136/sextrans-2015-052219
   TULLY JG, 1981, LANCET, V1, P1288
   Werner RN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208107
   Williamson D, 2019, NEW ENGL J MED, V381, P2477, DOI 10.1056/NEJMc1910648
   Wu HH, 2019, SEX TRANSM INFECT, V95, P67, DOI 10.1136/sextrans-2017-053410
   Yang CJ, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2015.04.018
NR 81
TC 0
Z9 0
U1 0
U2 0
PU MASSACHUSETTS MEDICAL SOC
PI WALTHAM
PA WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA
SN 0028-4793
EI 1533-4406
J9 NEW ENGL J MED
JI N. Engl. J. Med.
PD MAY 21
PY 2020
VL 382
IS 21
BP 2023
EP 2032
DI 10.1056/NEJMra1907194
PG 10
WC Medicine, General & Internal
SC General & Internal Medicine
GA LT1TD
UT WOS:000536856000017
PM 32433838
DA 2020-07-08
ER

PT J
AU Martin, E
   Tang, W
   Briggs, C
   Hopson, H
   Juarez, JG
   Garcia-Luna, S
   de Valdez, MW
   Badillo-Vargas, IE
   Borucki, MK
   Frank, M
   Hamer, GL
AF Martin, Estelle
   Tang, Wendy
   Briggs, Cierra
   Hopson, Helena
   Juarez, Jose Guillermo
   Garcia-Luna, Selene
   de Valdez, Megan Wise
   Badillo-Vargas, Ismael E.
   Borucki, Monica K.
   Frank, Matthias
   Hamer, Gabriel L.
TI Cell fusing agent virus (Flavivirus) infection in Aedes aegypti in
   Texas: seasonality, comparison by trap type, and individual viral loads
SO ARCHIVES OF VIROLOGY
LA English
DT Article; Early Access
ID WEST-NILE-VIRUS; INSECT-SPECIFIC FLAVIVIRUS; DENGUE HEMORRHAGIC-FEVER;
   CULEX FLAVIVIRUS; MEXICO BORDER; SOUTH TEXAS; MOSQUITO; TRANSMISSION;
   DIPTERA; SURVEILLANCE
AB South Texas has experienced local transmission of Zika virus and of other mosquito-borne viruses such as chikungunya virus and dengue virus in the last decades. Using a mosquito surveillance program in the Lower Rio Grande Valley (LRGV) and San Antonio, TX, from 2016 to 2018, we detected the presence of an insect-specific virus, cell fusing agent virus (CFAV), in the Aedes aegypti mosquito population. We tested 6,326 females and 1,249 males from the LRGV and 659 females from San Antonio for CFAV by RT-PCR using specific primers. Infection rates varied from 0 to 261 per 1,000 mosquitoes in the LRGV and 115 to 208 per 1,000 in San Antonio depending on the month of collection. Infection rates per 1,000 individuals appeared higher in females collected from BG Sentinel 2 traps compared to Autocidal Gravid Ovitraps, but the ratio of the percentage of infected pools did not differ by trap type. The natural viral load in individual males ranged from 1.25 x 10(2) to 5.50 x 10(6) RNA copies and in unfed females from 5.42 x 10(3) to 8.70 x 10(6) RNA copies. Gravid females were found to harbor fewer viral particles than males and unfed females.
C1 [Martin, Estelle; Tang, Wendy; Briggs, Cierra; Hopson, Helena; Juarez, Jose Guillermo; Garcia-Luna, Selene; Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Martin, Estelle] Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.
   [de Valdez, Megan Wise] Texas A&M Univ San Antonio, Dept Sci & Math, San Antonio, TX USA.
   [Badillo-Vargas, Ismael E.] Texas A&M AgriLife Res, Dept Entomol, Weslaco, TX USA.
   [Borucki, Monica K.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA.
RP Martin, E; Hamer, GL (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.; Martin, E (corresponding author), Univ Florida, Dept Entomol & Nematol, Gainesville, FL 32611 USA.
EM estellemartin@ufl.edu; ghamer@tamu.edu
OI Garcia-Luna, Selene M./0000-0001-8420-5078; Juarez Valdez,
   Jose/0000-0002-0583-478X
FU Texas A&M AgriLife Research Insect Vectored Diseases Seed Grant;
   Lawrence Livermore National LaboratoryUnited States Department of Energy
   (DOE); U.S. Department of Energy by LLNL [DE-AC52-07NA27344]
FX We are grateful to the residents of the Lower Rio Grande Valley and San
   Antonio, TX, who granted us permission to trap mosquitoes on their
   property. We also thank our field team of staff and students for the
   work in the LRGV and San Antonio: Ester Carbajal, Edwin Valdez, Courtney
   Avila, Joel Obregon, Oluwaseun Aloba, Michelle Ximenez, Estefany
   Villalobos, Janelle Garcia, Nacera Benslamine, Humberto Garcia,
   Alejandra Moya, Keren Hernandez, and Krista Lazo. We also thank the
   Texas Veterinary Medical Diagnostic Laboratory for the use of their
   equipment. This work was funded by Texas A&M AgriLife Research Insect
   Vectored Diseases Seed Grant and Lawrence Livermore National Laboratory
   and was performed, in part, under the auspices of the U.S. Department of
   Energy by LLNL under Contract DE-AC52-07NA27344.
CR Contreras-Gutierrez MA, 2017, AM J TROP MED HYG, V97, P299, DOI 10.4269/ajtmh.16-0987
   [Anonymous], 2016, DSHS ANN 1 TEX ACQ C
   Baidaliuk A, 2019, J VIROL, V93, DOI 10.1128/JVI.00705-19
   Barrera R, 2014, AM J TROP MED HYG, V91, P1269, DOI 10.4269/ajtmh.14-0426
   Barrera R, 2014, J MED ENTOMOL, V51, P145, DOI 10.1603/ME13096
   Biggerstaff B. J., 2009, POOLEDINFRATE VERSIO
   Blitvich BJ, 2009, J MED ENTOMOL, V46, P934, DOI 10.1603/033.046.0428
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474
   Brunkard JM, 2007, EMERG INFECT DIS, V13, P1477, DOI 10.3201/eid1310.061586
   Clark GG, 2008, AM J TROP MED HYG, V78, P361, DOI 10.4269/ajtmh.2008.78.361
   Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0
   Crockett RK, 2012, J MED ENTOMOL, V49, P165, DOI 10.1603/ME11080
   Espinoza-Gomez F, 2011, ARCH VIROL, V156, P1263, DOI 10.1007/s00705-011-0967-2
   Fernandes LN, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120666
   Ginsberg HS, 2010, J VECTOR ECOL, V35, P35, DOI 10.1111/j.1948-7134.2010.00025.x
   Goenaga S, 2015, VIRUSES-BASEL, V7, P5801, DOI 10.3390/v7112911
   Haddow AD, 2013, VIROLOGY, V440, P134, DOI 10.1016/j.virol.2012.12.008
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025
   Iwashita H, 2018, TROP MED HEALTH, V46, DOI 10.1186/s41182-018-0095-8
   Kenney JL, 2014, J GEN VIROL, V95, P2796, DOI 10.1099/vir.0.068031-0
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kihara Y, 2007, J VIROL METHODS, V146, P372, DOI 10.1016/j.jviromet.2007.07.008
   Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lukacik G, 2006, J AM MOSQUITO CONTR, V22, P264, DOI 10.2987/8756-971X(2006)22[264:WNVSIM]2.0.CO;2
   Lutomiah JJL, 2007, J INSECT SCI, V7
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mackay AJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-225
   Martin E, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01202-19
   Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006
   Moore C.G., 1993, GUIDELINES ARBOVIRUS
   Nasci RS, 1996, J AM MOSQUITO CONTR, V12, P167
   Noriega FG, 1996, INSECT MOL BIOL, V5, P25, DOI 10.1111/j.1365-2583.1996.tb00037.x
   Oliveira J, 2011, SMALL, V7, P3, DOI 10.1002/smll.201002161
   Perkins TA, 2013, PLOS COMPUT BIOL, V12
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Roiz D, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-223
   Roundy CM, 2017, ADV VIRUS RES, V98, P119, DOI 10.1016/bs.aivir.2016.10.001
   Saiyasombat R, 2011, J MED ENTOMOL, V48, P1031, DOI 10.1603/ME11043
   Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8
   STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0
   Tabachnick WJ, 2016, CURR OPIN VIROL, V21, P124, DOI 10.1016/j.coviro.2016.09.008
   Valderrama A, 2017, BIOCHEM BIOPH RES CO, V492, P541, DOI 10.1016/j.bbrc.2017.05.050
   Williams GM, 2007, J VECTOR ECOL, V32, P285, DOI 10.3376/1081-1710(2007)32[285:COLTGT]2.0.CO;2
   Yamanaka A, 2013, INFECT GENET EVOL, V19, P188, DOI 10.1016/j.meegid.2013.07.012
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2
NR 52
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER WIEN
PI WIEN
PA SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA
SN 0304-8608
EI 1432-8798
J9 ARCH VIROL
JI Arch. Virol.
DI 10.1007/s00705-020-04652-0
EA MAY 2020
PG 8
WC Virology
SC Virology
GA LQ0SQ
UT WOS:000534723200001
PM 32440701
OA Other Gold
DA 2020-07-08
ER

PT J
AU Caldas, LA
   Azevedo, RC
   da Silva, JL
   de Souza, W
AF Caldas, Lucio Ayres
   Azevedo, Renata Campos
   da Silva, Jerson Lima
   de Souza, Wanderley
TI Microscopy analysis of Zika virus morphogenesis in mammalian cells
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ULTRASTRUCTURAL CHARACTERIZATION; 3-DIMENSIONAL ARCHITECTURE;
   REPLICATION; INFECTION; TRANSMISSION; PARTICLES; RNA
AB Zika virus (ZIKV) is an arbovirus that recently emerged in the Americas as an important pathogen mainly because of its expanded pathogenesis, and elevated tropism for neuronal cells, transposition across the placental barrier, and replication in reproductive tract cells. Thus, transmission modes are eventually independent of an invertebrate vector, which is an atypical behavior for the flavivirus genus and indicates the need to study the replication of this virus in different cell types. Although ZIKV became a target for public health programs, the interaction of this flavivirus with the infected cell is still poorly understood. Herein, we analyzed the main stages of virus morphogenesis in mammalian cells, from establishment of the viroplasm-like zone to viral release from infected cells, using super-resolution fluorescence microscopy and electron microscopy. In addition, we compared this with other host cell types and other members of the Flaviviridae family that present a similar dynamic.
C1 [Caldas, Lucio Ayres; de Souza, Wanderley] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, Predio CCS, Av Carlos Chagas Filho 373,Bloco C,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Caldas, Lucio Ayres; de Souza, Wanderley] Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Ctr Ciencias Saude CCS, Ave Carlos Chagas Filho 373,Bloco M,Unidade 3, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [Azevedo, Renata Campos] Univ Fed Rio de Janeiro, Inst Microbiol Prof Paulo de Goes, Lab Interacao Virus Celula, Predio CCS, Av Carlos Chagas Filho 373,Bloco 1, BR-21941902 Rio De Janeiro, RJ, Brazil.
   [da Silva, Jerson Lima] Univ Fed Rio de Janeiro, Lab Termodinam Prot & Estruturas Virais Gregorio, Inst Bioquim Med Leopoldo de Meis, Predio CCS, Av Carlos Chagas Filho 373,Bloco E,Sala 10, BR-21941902 Rio De Janeiro, RJ, Brazil.
RP Caldas, LA (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Ultraestrutura Celular Hertha Meyer, Predio CCS, Av Carlos Chagas Filho 373,Bloco C,Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.; Caldas, LA (corresponding author), Inst Nacl Ciencia & Tecnol Biol Estrutural & Bioi, Ctr Ciencias Saude CCS, Ave Carlos Chagas Filho 373,Bloco M,Unidade 3, BR-21941902 Rio De Janeiro, RJ, Brazil.
EM lucio@biof.ufrj.br
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior
   (CAPES)CAPES; Financiadora de Estudos e Projetos (FINEP)Ciencia
   Tecnologia e Inovacao (FINEP)
FX DWe thank Davis Fernandes Ferreira for generously providing the virus
   and some of the reagents that were used to detect ZIKV in fluorescence
   microscopy. This work was supported by grants from Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Financiadora de
   Estudos e Projetos (FINEP) - to the authors.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Aktepe TE, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12884
   Arakawa M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092336
   Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Barreto-Vieira DF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184397
   Barreto-Vieira DF, 2016, MEM I OSWALDO CRUZ, V111, P532, DOI 10.1590/0074-02760160104
   Bartenschlager R, 2008, FUTURE MICROBIOL, V3, P155, DOI 10.2217/17460913.3.2.155
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brinton M. A, 1986, TOGAVIRIDAE FLAVIVIR, P327
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Caldas LA, 2018, BRAZ J MICROBIOL, V49, P785, DOI 10.1016/j.bjm.2017.12.010
   Cardinali G, 1998, J VIROL, V72, P9738, DOI 10.1128/JVI.72.12.9738-9746.1998
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chatel-Chaix L, 2016, CELL HOST MICROBE, V20, P342, DOI 10.1016/j.chom.2016.07.008
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ertel KJ, 2017, ELIFE, V6, DOI 10.7554/eLife.25940
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Forterre P, 2016, CURR OPIN MICROBIOL, V31, P44, DOI 10.1016/j.mib.2016.02.001
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Holcman D, 2018, NAT CELL BIOL, V20, P1118, DOI 10.1038/s41556-018-0192-2
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285
   Klinger MHF, 2001, ARCH VIROL, V146, P2291, DOI 10.1007/s007050170003
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Netherton CL, 2011, CURR OPIN VIROL, V1, P381, DOI 10.1016/j.coviro.2011.09.008
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Paredes-Santos TC, 2012, J STRUCT BIOL, V177, P420, DOI 10.1016/j.jsb.2011.11.028
   Raghunayakula S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144508
   Rossignol ED, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12740
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Schultz MJ, 2018, VIROLOGY, V518, P406, DOI 10.1016/j.virol.2018.03.022
   Short JR, 2016, J VIROL, V90, P3676, DOI 10.1128/JVI.03080-15
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 48
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 20
PY 2020
VL 10
IS 1
DI 10.1038/s41598-020-65409-y
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY3XY
UT WOS:000540463800009
PM 32433502
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hayd, RLN
   Carrara, L
   Lima, JD
   de Almeida, NCV
   Lima, JBP
   Martins, A
AF Nogueira Hayd, Ramao Luciano
   Carrara, Luana
   Lima, Joel de Melo
   Vargas de Almeida, Nathalia Coelho
   Pereira Lima, Jose Bento
   Martins, Ademir
TI Evaluation of resistance to pyrethroid and organophosphate adulticides
   and kdr genotyping in Aedes aegypti populations from Roraima, the
   northernmost Brazilian State
SO PARASITES & VECTORS
LA English
DT Article
DE Vector control; Insecticide resistance monitoring; Rorainopolis;
   Pacaraima; Bonfim; Boa Vista; Deltamethrin; Malathion
ID TEMEPHOS
AB BackgroundRoraima, the northernmost State in Brazil, borders Venezuela and Guyana. Although mostly covered by the tropical forests, the urban centers of this state are highly infested with Ae. aegypti and are endemic for dengue, Zika and chikungunya. We accessed the insecticide resistance status of Ae. aegypti populations from the capital Boa Vista, two cities on international borders (Pacaraima and Bonfim) and Rorainopolis bordering Amazonas State, in order to evaluate the chemical control efficacy in these localities.MethodsTests with World Health Organization (WHO)-like tubes impregnated with the pyrethroid deltamethrin (0.05% and 0.12%) and the organophosphate malathion (0.7%) were conducted with Ae. aegypti from Boa Vista, Pacaraima, Bonfim and Rorainopolis, collected in 2016 and 2018. Genotyping of kdr mutations, related to resistance to pyrethroids, was performed for the SNP variations at sites 1016 and 1534 of the voltage gated sodium channel gene (Na-V) with a TaqMan qPCR approach.ResultsAedes albopictus was absent in our collections, and therefore only Ae. aegypti was tested. All Ae. aegypti populations were susceptible to 0.7% malathion in 2016; however, mortality dropped to under 90% in Bonfim and Pacaraima populations in 2018. All populations were resistant to 0.05% deltamethrin in both years. The time that 50% of females suffered knockdown (KdT(50)) under exposure to 0.05% deltamethrin was 3.3-5.9-fold longer in mosquitoes from the natural populations compared to the susceptible Rockefeller strain. Only the Pacaraima population (2018) remained resistant to 0.12% deltamethrin. Kdr genotyping revealed the absence of the wild-type NaVS haplotype (1016Val+1534Phe) in the populations from Roraima, indicating that all tested insects had a genetic background for pyrethroid resistance. The double kdr Na(V)R2 haplotype (1016Ile+15434Cys) was present in higher frequencies in all populations except for Rorainopolis, where this haplotype seems to have arrived recently.ConclusionsThese results are important for the knowledge about insecticide resistance status of Ae. aegypti populations from Roraima and will help improve vector control strategies that may be applied to diverse localities under similar geographical and urban conditions.
C1 [Nogueira Hayd, Ramao Luciano] Univ Fed Roraima, Lab Parasitol & Monitoramento Artropodes Vetores, Boa Vista, RR, Brazil.
   [Carrara, Luana; Pereira Lima, Jose Bento; Martins, Ademir] Inst Oswaldo Cruz, FIOCRUZ, Lab Fisiol & Controle Artropodes Vetores, Av Brasil 4365, Rio De Janeiro, RJ, Brazil.
   [Lima, Joel de Melo] Secretaria Estado Saude Roraima, Nucleo Febre Amarela & Dengue, Coordenadoria Geral Vigilancia Saude, Boa Vista, RR, Brazil.
   [Vargas de Almeida, Nathalia Coelho] Secretaria Estado Saude Roraima, Nucleo Estadual Entomol, Coordenadoria Geral Vigilancia Saude, Boa Vista, RR, Brazil.
   [Martins, Ademir] Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, INCT EM, Rio De Janeiro, RJ, Brazil.
RP Martins, A (corresponding author), Inst Oswaldo Cruz, FIOCRUZ, Lab Fisiol & Controle Artropodes Vetores, Av Brasil 4365, Rio De Janeiro, RJ, Brazil.; Martins, A (corresponding author), Univ Fed Rio de Janeiro, Inst Nacl Ciencia & Tecnol Entomol Mol, INCT EM, Rio De Janeiro, RJ, Brazil.
EM ademirjr@iocfiocruz.br
OI Martins, Ademir/0000-0001-5739-1215
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [UO1 AI115595];
   Instituto Nacional de Ciencia e Tecnologia em Entomologia Molecular
   (INCT-EM) [465678/2014-9]; Fundacao de Amparo a Pesquisa do Estado do
   Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/202.795/2019]
FX Funding for the study was obtained from the National Institutes of
   Health (NIH, Grant No. UO1 AI115595), Instituto Nacional de Ciencia e
   Tecnologia em Entomologia Molecular (INCT-EM, Grant No. 465678/2014-9),
   and Fundacao de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ,
   Grant No. E-26/202.795/2019).
CR Abad-Franch F, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003702
   Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   Belinato TA, 2012, MEM I OSWALDO CRUZ, V107, P916, DOI 10.1590/S0074-02762012000700013
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P295
   Brito LP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2410819
   de Souza RP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001439
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Evans BR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49660-6
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Kotsakiozi P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005653
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Lima JBP, 2003, AM J TROP MED HYG, V68, P329, DOI 10.4269/ajtmh.2003.68.329
   Maciel-de-Freitas R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092424
   Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390
   Martins Ademir Jesus, 2013, Evolution Medicine and Public Health, P148, DOI 10.1093/emph/eot012
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   ONEILL SL, 2019, GATES OPEN RES, V2, P36, DOI DOI 10.12688/GATESOPENRES.12844.3
   PEIRIS HTR, 1990, B ENTOMOL RES, V80, P49, DOI 10.1017/S0007485300045910
   Raymond M., 1985, Cahiers O.R.S.T.O.M., Serie Entomologie Medicale et Parasitologie, V23, P117
   Valle Denise, 2019, Mem. Inst. Oswaldo Cruz, V114, pe180544, DOI 10.1590/0074-02760180544
   Medeiros PFV, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006734
   WHO, 2016, MON MAN INS RES AED
NR 25
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 20
PY 2020
VL 13
IS 1
DI 10.1186/s13071-020-04127-w
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LT4YH
UT WOS:000537077800002
PM 32434575
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Venturini, FP
   de Souza, LM
   Garbuio, M
   Inada, NM
   de Souza, JP
   Kurachi, C
   de Oliveira, KT
   Bagnato, VS
AF Venturini, Francine Perri
   de Souza, Larissa Marila
   Garbuio, Matheus
   Inada, Natalia Mayumi
   de Souza, Jaqueline Perola
   Kurachi, Cristina
   de Oliveira, Kleber Thiago
   Bagnato, Vanderlei Salvador
TI Environmental safety and mode of action of a novel curcumin-based
   photolarvicide
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article; Early Access
DE Aedes aegypti; Danio rerio; Daphnia magna; Photolarvicidal; Curcuma
   longa; Vector control; Ecotoxicity; Mode of action
ID AEDES-AEGYPTI DIPTERA; CULEX-PIPIENS DIPTERA; LARVICIDAL ACTIVITY;
   OXIDATIVE STRESS; ESSENTIAL OILS; DAPHNIA-MAGNA; MOSQUITO LARVAE;
   AQUATIC ORGANISMS; PLANT-EXTRACTS; ACUTE TOXICITY
AB Aedes aegypti is the vector of important diseases like dengue, zika, chikungunya, and yellow fever. Vector control is pivotal in combating the spread of these mosquito-borne illnesses. Photoactivable larvicide curcumin obtained from Curcuma longa Linnaeus has shown high potential for Ae. aegypti larvae control. However, the toxicity of this photosensitizer (PS) might jeopardize non-target aquatic organisms. The aim of this study was to evaluate the toxicity of this PS to Daphnia magna and Danio rerio, besides assessing its mode of action through larvae biochemical and histological studies. Three PS formulations were tested: PS in ethanol+DMSO, PS in sucrose, and PS in D-mannitol. The LC50 of PS in ethanol+DMSO to D. rerio was 5.9 mg L-1, while in D. magna the solvents were extremely toxic, and LC50 was not estimated. The PS formulations in sugars were not toxic to neither of the organisms. Reactive oxygen species (ROS) were generated in D. magna exposed to 50 mg L-1 of PS in D-mannitol, and D. rerio did not elicit this kind of response. D. magna feeding rates were not affected by the PS in D-mannitol. Concerning Ae. aegypti larvae, there were changes in reduced glutathione and protein levels, while catalase activity remained stable after exposure to PS in D-mannitol and sunlight. Histological changes were observed in larvae exposed to PS in sucrose and D-mannitol, most of them irreversible and deleterious. Our results show the feasibility of this photolarvicide use in Ae. aegypti larvae control and its safety to non-target organisms. These data are crucial to this original vector control approach implementation in public health policies.
C1 [Venturini, Francine Perri; de Souza, Jaqueline Perola] Univ Sao Paulo, Nanomed & Nanotoxicol Grp, Sao Carlos Inst Phys, BR-13560970 Sao Carlos, SP, Brazil.
   [Venturini, Francine Perri; de Souza, Larissa Marila; Garbuio, Matheus; Inada, Natalia Mayumi; Kurachi, Cristina; Bagnato, Vanderlei Salvador] Univ Sao Paulo, Sao Carlos Inst Phys, Opt Grp, BR-13560970 Sao Carlos, SP, Brazil.
   [de Souza, Larissa Marila; Garbuio, Matheus] Univ Fed Sao Carlos, PPG Biotec, BR-13565905 Sao Carlos, SP, Brazil.
   [de Oliveira, Kleber Thiago] Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil.
RP Venturini, FP (corresponding author), Univ Sao Paulo, Nanomed & Nanotoxicol Grp, Sao Carlos Inst Phys, BR-13560970 Sao Carlos, SP, Brazil.; Venturini, FP (corresponding author), Univ Sao Paulo, Sao Carlos Inst Phys, Opt Grp, BR-13560970 Sao Carlos, SP, Brazil.
EM francineventurini@gmail.com
OI de Souza, Larissa Marila/0000-0001-7884-2011
FU Coordination for the Improvement of Higher Education Personnel; National
   Council for Scientific and Technological Development/Ministry of Science
   and Technology and Department of Science and Technology [44058520163,
   1538187]; Sao Paulo Research Foundation-FAPESPFundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07276-1, 2018/00106-7];
   National Science and Technology Institutes (INCT)-Basic Optics and
   Applied to Life Sciences [465360/2014-9]
FX This research was funded by Coordination for the Improvement of Higher
   Education Personnel, National Council for Scientific and Technological
   Development/Ministry of Science and Technology and Department of Science
   and Technology (Grant No. 44058520163; 1538187), Sao Paulo Research
   Foundation-FAPESP (Grant No. 2013/07276-1, Optics and Photonics Research
   CenterCePOF, 2018/00106-7), and National Science and Technology
   Institutes (INCT)-Basic Optics and Applied to Life Sciences (Grant No.
   465360/2014-9).
CR Abe FR, 2019, WATER AIR SOIL POLL, V230, DOI 10.1007/s11270-019-4128-7
   Abe FR, 2014, J TOXICOL ENV HEAL A, V77, P37, DOI 10.1080/15287394.2014.865581
   Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003
   Akinyemi AJ, 2018, METAB BRAIN DIS, V33, P369, DOI 10.1007/s11011-017-0100-7
   Al-Mekhlafi FA, 2018, SAUDI J BIOL SCI, V25, P52, DOI 10.1016/j.sjbs.2017.02.010
   Ali A, 2015, J MED ENTOMOL, V52, P979, DOI 10.1093/jme/tjv072
   ALLEN Y, 1995, ENVIRON TOXICOL CHEM, V14, P1625, DOI 10.1002/etc.5620140923
   [Anonymous], 2004, GUID TEST CHEM DAPHN
   [Anonymous], 1992, GUID TEST CHEM FISH
   Antwi FB, 2015, ENVIRON TOXICOL PHAR, V40, P915, DOI 10.1016/j.etap.2015.09.023
   Arruda Walquíria, 2003, Rev. Soc. Bras. Med. Trop., V36, P17, DOI 10.1590/S0037-86822003000100004
   Bae E, 2016, ECOTOX ENVIRON SAFE, V132, P366, DOI 10.1016/j.ecoenv.2016.06.034
   Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013
   Barbazuk WB, 2000, GENOME RES, V10, P1351, DOI 10.1101/gr.144700
   BEERS RF, 1952, J BIOL CHEM, V195, P133
   Benelli G, 2019, IND CROP PROD, V137, P356, DOI 10.1016/j.indcrop.2019.05.037
   Beutler E, 1984, RED CELL METABOLISM, P187
   de Castro DSB, 2016, EXP PARASITOL, V171, P84, DOI 10.1016/j.exppara.2016.10.008
   Carmona-Vargas CC, 2017, REACT CHEM ENG, V2, P366, DOI 10.1039/c6re00207b
   Cheng D, 2019, MOL PHARMACEUT, V16, P1881, DOI 10.1021/acs.molpharmaceut.8b01246
   Conti B, 2014, PARASITOL RES, V113, P251, DOI 10.1007/s00436-013-3651-5
   Couling DJ, 2006, GREEN CHEM, V8, P82, DOI [10.1039/b511333d, 10.1039/B511333D]
   DADD RH, 1982, ANN ENTOMOL SOC AM, V75, P605, DOI 10.1093/aesa/75.6.605
   David JP, 2000, J INVERTEBR PATHOL, V75, P9, DOI 10.1006/jipa.1999.4886
   Di Giulio Richard T., 2008, P273, DOI 10.1201/9780203647295.ch6
   Dondji B, 2005, J MED ENTOMOL, V42, P652, DOI 10.1603/0022-2585(2005)042[0652:AOLAFA]2.0.CO;2
   Duguma D, 2017, J VECTOR ECOL, V42, P51, DOI 10.1111/jvec.12239
   Ernst W, 2001, MAR POLLUT BULL, V42, P433, DOI 10.1016/S0025-326X(00)00177-6
   Fabris C, 2012, PHOTOCH PHOTOBIO SCI, V11, P294, DOI 10.1039/c1pp05154g
   Ferreira Barreto Cleyde, 2006, Revista de Patologia Tropical, V35, P37
   Fujiwara GM, 2017, ECOTOX ENVIRON SAFE, V139, P238, DOI 10.1016/j.ecoenv.2017.01.046
   Fulcher A, 2014, J MED ENTOMOL, V51, P896, DOI 10.1603/ME13243
   Geis SW, 2000, ENVIRON TOXICOL CHEM, V19, P36, DOI 10.1002/etc.5620190105
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V133, P395, DOI 10.1016/j.ecoenv.2016.07.035
   Haap T, 2008, CHEMOSPHERE, V73, P353, DOI 10.1016/j.chemosphere.2008.05.062
   Hasnain SE, 1999, J BIOSCIENCE, V24, P13, DOI 10.1007/BF02941101
   Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin
   Inoue Luis Antônio Kioshi Aoki, 2003, Cienc. Rural, V33, P943, DOI 10.1590/S0103-84782003000500023
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Kelly SA, 1998, ENVIRON HEALTH PERSP, V106, P375, DOI 10.2307/3434064
   Koskella J, 2002, CAN J MICROBIOL, V48, P262, DOI [10.1139/w02-005, 10.1139/W02-005]
   Kosower NS, 1976, GLUTATHIONE METABOLI, P159
   Kruger NJ., 1994, METHOD MOL BIOL, V32, P15
   Lammer E, 2009, COMP BIOCHEM PHYS C, V149, P196, DOI 10.1016/j.cbpc.2008.11.006
   Le Goff G, 2006, INSECT BIOCHEM MOLEC, V36, P674, DOI 10.1016/j.ibmb.2006.05.009
   LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012
   Lekamge S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214398
   Lima AR, 2018, INSECTS, V9, DOI 10.3390/insects9030109
   Lushchak VI, 2014, CHEM-BIOL INTERACT, V224, P164, DOI 10.1016/j.cbi.2014.10.016
   Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006
   Magro M, 2019, J PHOTOCH PHOTOBIO B, V194, P21, DOI 10.1016/j.jphotobiol.2019.03.004
   Maharajan K, 2018, AQUAT TOXICOL, V196, P132, DOI 10.1016/j.aquatox.2018.01.010
   Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007
   Michaelakis A, 2009, PARASITOL RES, V105, P769, DOI 10.1007/s00436-009-1452-7
   Morrison AC, 2008, PLOS MED, V5, P362, DOI 10.1371/journal.pmed.0050068
   MUKHERJEE SN, 1993, EXPERIENTIA, V49, P557, DOI 10.1007/BF01955163
   ODAJIMA T, 1972, BIOCHIM BIOPHYS ACTA, V284, P355, DOI 10.1016/0005-2744(72)90130-1
   Paiva MHS, 2016, GENOMICS, V107, P40, DOI 10.1016/j.ygeno.2015.11.004
   Parthiban E, 2020, ECOTOX ENVIRON SAFE, V189, DOI 10.1016/j.ecoenv.2019.110050
   Pavela R, 2019, ACTA TROP, V193, P236, DOI 10.1016/j.actatropica.2019.01.019
   Pavela R, 2017, J PEST SCI, V90, P683, DOI [10.1007/s10340-016-0828-6, 10.1007/s10340-016-0763-6]
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pavela R, 2014, PLANT PROTECT SCI, V50, P36, DOI 10.17221/48/2013-PPS
   Pereira JL, 2009, ECOTOXICOLOGY, V18, P455, DOI 10.1007/s10646-009-0300-y
   PFLEEGER T, 1991, AM SOC TEST MATER, V1115, P355, DOI 10.1520/STP19530S
   Pisa LW, 2015, ENVIRON SCI POLLUT R, V22, P68, DOI 10.1007/s11356-014-3471-x
   Procopio TF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126612
   Promsiri Suwannee, 2006, Insect Science, V13, P179, DOI 10.1111/j.1744-7917.2006.00080.x
   Rey D, 1999, J CHEM ECOL, V25, P537, DOI 10.1023/A:1020953804114
   Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005
   ROSSI R, 1995, BBA-GEN SUBJECTS, V1243, P230, DOI 10.1016/0304-4165(94)00133-I
   Ruiz LM, 2004, MEM I OSWALDO CRUZ, V99, P73, DOI 10.1590/S0074-02762004000100013
   Sagnou M, 2012, ACTA TROP, V123, P190, DOI 10.1016/j.actatropica.2012.05.006
   Shaalan EAS, 2005, ENVIRON INT, V31, P1149, DOI 10.1016/j.envint.2005.03.003
   Shanmugam MK, 2019, TRANSL EPIGENET SER, V8, P107, DOI 10.1016/B978-0-12-812494-9.00005-6
   Shiao SH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217355
   Singh NS, 2018, MODERN AGE ENV PROBL, P49, DOI [DOI 10.1007/978-3-319-64501-8_3, 10.1007/978-3-319-64501-8_3]
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Souza LM, 2019, J ASIA-PAC ENTOMOL, V22, P151
   Sukari MA, 2010, ASIAN J CHEM, V22, P7915
   Sulukan E, 2017, CHEMOSPHERE, V180, P77, DOI 10.1016/j.chemosphere.2017.04.018
   TAKAHASHI IT, 1987, B ENVIRON CONTAM TOX, V39, P229, DOI 10.1007/BF01689411
   Truong L, 2016, ENVIRON POLLUT, V218, P1089, DOI 10.1016/j.envpol.2016.08.061
   Tyagi P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121313
   Urban DJ, 1986, HAZARD EVALUATION DI
   Santos VSV, 2017, J TOXICOL ENV HEAL A, V80, P155, DOI 10.1080/15287394.2016.1266721
   Vivekanandhan Perumal, 2019, Nat Prod Res, P1, DOI 10.1080/14786419.2018.1547290
   Zhang L, 2003, ECOTOX ENVIRON SAFE, V55, P330, DOI 10.1016/S0147-6513(02)00081-7
   Zucker E, 1985, USITC PUBL
NR 89
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
DI 10.1007/s11356-020-09210-4
EA MAY 2020
PG 14
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA LP7SE
UT WOS:000534517400001
PM 32430723
DA 2020-07-08
ER

PT J
AU Cirne-Santos, CC
   Barros, CD
   de Oliveira, MC
   Rabelo, VWH
   Azevedo, RC
   Teixeira, VL
   Ferreira, DF
   Paixao, ICND
AF Cirne-Santos, Claudio Cesar
   Barros, Caroline de Souza
   de Oliveira, Mariana Cavalcante
   Rabelo, Vitor Won-Held
   Azevedo, Renata Campos
   Teixeira, Valeria Laneuville
   Ferreira, Davis Fernandes
   Nunes de Palmer Paixao, Izabel Christina
TI In vitro Studies on The Inhibition of Replication of Zika and
   Chikungunya Viruses by Dolastane Isolated from Seaweed Canistrocarpus
   cervicornis
SO SCIENTIFIC REPORTS
LA English
DT Article
ID ANTIVIRAL ACTIVITY; BROWN ALGA; TRANSMISSION; DITERPENES; PROFILE;
   DRUGS; EGCG
AB The lack of vaccines and antiviral treatment, along with the increasing number of cases of Zika virus (ZIKV) and Chikungunya virus (CHIKV) infections, emphasize the need for searching for new therapeutic strategies. In this context, the marine brown seaweed Canistrocarpus cervicornis has been proved to hold great antiviral potential. Hence, the aim of this work was to evaluate the anti-ZIKV and anti-CHIKV activity of a marine dolastane isolated from brown seaweed C. cervicornis and its crude extract. Vero cells were used in antiviral assays, submitted to ZIKV and CHIKV, and treated with different concentrations of C. cervicornis extract or dolastane. The crude extract of C. cervicornis showed inhibitory activities for both ZIKV and CHIKV, with EC50 values of 3.3 mu g/mL and 3.1 mu g/mL, respectively. However, the isolated dolastane showed a more significant and promising inhibitory effect (EC50=0.95 mu M for ZIKV and 1.3 mu M for CHIKV) when compared to both the crude extract and ribavirin, which was used as control. Also, the dolastane showed a very potent virucidal activity against CHIKV and was able to inhibit around 90% of the virus infectivity at 10 mu M. For the ZIKV, the effects were somewhat lower, although interesting, at approximately 64% in this same concentration. Further, we observed that both the extract and the dolastane were able to inhibit the replication of ZIKV and CHIKV at different times of addition post-infection, remaining efficient even if added after 8hours post-infection, but declining soon after. A synergistic effect using sub-doses of the extract and isolates was associated with ribavirin, inhibiting above 80% replication even at the lowest concentrations. Therefore, this work has unveiled the anti-ZIKV and CHIKV potential of C. cervicornis crude extract and an isolated dolastane, which, in turn, can be used as a preventive or therapeutic strategy in the future.
C1 [Cirne-Santos, Claudio Cesar; Barros, Caroline de Souza; de Oliveira, Mariana Cavalcante; Rabelo, Vitor Won-Held; Nunes de Palmer Paixao, Izabel Christina] Univ Fed Fluminense, Dept Biol Celular & Mol, Programa Posgrad Ciencias & Biotecnol, Inst Biol,Lab Virol Mol & Biotecnol Marinha, Niteroi, RJ, Brazil.
   [Barros, Caroline de Souza; Teixeira, Valeria Laneuville] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Lab Prod Nat Algas Marinhas ALGAMAR, Niteroi, RJ, Brazil.
   [Azevedo, Renata Campos; Ferreira, Davis Fernandes] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, Rio De Janeiro, Brazil.
   [Teixeira, Valeria Laneuville] Univ Fed Estado Rio De Janeiro, Inst Biociencias, Programa Posgrad Biodiversidade Neotrop, Lab Biol & Taxon Algas LABIOTAL, Rio De Janeiro, RJ, Brazil.
RP Cirne-Santos, CC; Paixao, ICND (corresponding author), Univ Fed Fluminense, Dept Biol Celular & Mol, Programa Posgrad Ciencias & Biotecnol, Inst Biol,Lab Virol Mol & Biotecnol Marinha, Niteroi, RJ, Brazil.
EM claudiocirne@gmail.com; izabeluff@gmail.com
OI Teixeira, Valeria Laneuville/0000-0003-4962-6912
FU CNPq (Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico)National Council for Scientific and Technological
   Development (CNPq) [443930/2014-7, 304070/2014-9]; FAPERJ (Fundacao de
   Amparo a Pesquisa do Estado do Rio de Janeiro)Carlos Chagas Filho
   Foundation for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/201.442/2014]; CAPES (Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior)CAPES; FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ) [E-26/201.344/2016];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]
FX The authors are grateful to CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico) for financial support and for Productivity
   Fellowships to ICNPP and VLT (443930/2014-7 and 304070/2014-9). ICNPP
   and VLT (E-26/201.442/2014) also thank the FAPERJ (Fundacao de Amparo a
   Pesquisa do Estado do Rio de Janeiro) for the Cientista do Nosso Estado
   Fellowship. CCCS thanks to CAPES (Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior) for the Postdoc fellowship and CSB thanks
   FAPERJ for the Postdoc fellowship (E-26/201.344/2016). The postgraduate
   program in sciences and biotechnology of UFF (PPBI-UFF). This study was
   financed in part by the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES) - Finance Code 001.
CR Abdelnabi R, 2016, METHODS MOL BIOL, V1426, P243, DOI 10.1007/978-1-4939-3618-2_22
   Arora N, 2016, FUTURE VIROL, V11, P395, DOI 10.2217/fvl-2016-0048
   Atta-ur-Rahman F., 2016, STUDIES NATURAL PROD
   Barrios C, 2016, J AM SOC NEPHROL, V27, P933, DOI 10.1681/ASN.2015010109
   Barros CD, 2017, J APPL PHYCOL, V29, P769, DOI 10.1007/s10811-016-0865-9
   Barros CD, 2016, J APPL PHYCOL, V28, P2523, DOI 10.1007/s10811-015-0776-1
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Buckheit RW, 2010, ANTIVIR RES, V85, P142, DOI 10.1016/j.antiviral.2009.10.013
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Cavalcanti LPD, 2017, MEM I OSWALDO CRUZ, V112, P583, DOI 10.1590/0074-02760160537
   de Oliveira A, 2015, ANTIVIR RES, V118, P56, DOI 10.1016/j.antiviral.2015.03.009
   Di Veroli GY, 2016, BIOINFORMATICS, V32, P2866, DOI 10.1093/bioinformatics/btw230
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gulland A, 2016, ZIKA VIRUS IS GLOBAL
   Levi J, 2017, ISBT SCI SERIES, V12, P233, DOI [10.1111/voxs.12334, DOI 10.1111/VOXS.12334]
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Masmejan S., 2018, EXPERT REV ANTIINFEC
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Newman DJ, 2016, J NAT PROD, V79, P629, DOI 10.1021/acs.jnatprod.5b01055
   Nothias-Scaglia LF, 2015, J NAT PROD, V78, P1277, DOI 10.1021/acs.jnatprod.5b00073
   Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14
   Pemovska T, 2018, CURR OPIN PHARMACOL, V42, P102, DOI 10.1016/j.coph.2018.07.008
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rebensburg S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20394
   Siddharta A, 2017, J INFECT DIS, V215, P902, DOI 10.1093/infdis/jix046
   Snyder B, 2018, J MED VIROL, V90, P8, DOI 10.1002/jmv.24932
   TEIXEIRA VL, 1986, J NAT PROD, V49, P570, DOI 10.1021/np50046a002
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Vallim MA, 2010, J MED PLANTS RES, V4, P2379
   Vasilakis N, 2016, AM J TROP MED HYG, V95, P488, DOI [10.4269/ajtmh.16-0281, DOI 10.4269/AJTMH.16-0281]
   Weaver SC, 2004, NAT REV MICROBIOL, V2, P789, DOI 10.1038/nrmicro1006
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 38
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2045-2322
J9 SCI REP-UK
JI Sci Rep
PD MAY 19
PY 2020
VL 10
IS 1
DI 10.1038/s41598-020-65357-7
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LY5KL
UT WOS:000540568100056
PM 32427940
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kumar, D
   Sharma, N
   Aarthy, M
   Singh, SK
   Giri, R
AF Kumar, Deepak
   Sharma, Nitin
   Aarthy, Murali
   Singh, Sanjeev Kumar
   Giri, Rajanish
TI Mechanistic Insights into Zika Virus NS3 Helicase Inhibition by
   Epigallocatechin-3-Gallate
SO ACS OMEGA
LA English
DT Article
ID INTRINSICALLY DISORDERED PROTEINS; GREEN TEA CATECHIN; ATP HYDROLYSIS;
   KIX DOMAIN; C-MYB; BINDING; GALLATE; RECOGNITION; DYNAMICS
AB Since 2007, repeated outbreaks of Zika virus (ZIKV) have affected millions of people worldwide and created a global health concern with major complications like microcephaly and Guillain Barre's syndrome. To date, there is not a single Zika-specific licensed drug present in the market. However, in recent months, several antiviral molecules have been screened against ZIKV. Among those, (-)-epigallocatechin-3-gallate (EGCG), a green tea polyphenol, has shown great virucidal potential against flaviviruses including ZIKV. The mechanistic understanding of EGCG-targeting viral proteins is not yet entirely deciphered except that little is known about its interaction with viral envelope protein and viral protease. We designed our current study to find inhibitory actions of EGCG against ZIKV NS3 helicase. NS3 helicase performs a significant role in viral replication by unwinding RNA after hydrolyzing NTP. We employed molecular docking and simulation approach and found significant interactions at the ATPase site and also at the RNA binding site. Further, the enzymatic assay has shown significant inhibition of NTPase activity with an IC50 value of 295.7 nM and Ki of 0.387 +/- 0.034/AM. Our study suggests the possibility that EGCG could be considered as a prime backbone molecule for further broadspectrum inhibitor development against ZIKV and other flaviviruses.
C1 [Kumar, Deepak; Sharma, Nitin; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175005, Himachal Prades, India.
   [Giri, Rajanish] Indian Inst Technol Mandi, BioX Ctr, Mandi 175005, Himachal Prades, India.
   [Aarthy, Murali; Singh, Sanjeev Kumar] Alagappa Univ, Comp Aided Drug Design & Mol Modeling Lab, Dept Bioinformat, Karaikkudi 630003, Tamil Nadu, India.
RP Giri, R (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175005, Himachal Prades, India.; Giri, R (corresponding author), Indian Inst Technol Mandi, BioX Ctr, Mandi 175005, Himachal Prades, India.
EM rajanishgiri@iitmandi.ac.in
RI Giri, Rajanish/Q-6530-2018
OI Giri, Rajanish/0000-0002-2046-836X; Kumar Singh,
   Sanjeev/0000-0003-4153-6437; Sharma, Nitin/0000-0002-8176-7056
FU DBT grant, India [BT/11/IYBA/2018/06]; MHRD-SPARC grant
   [SPARC/2018-2019/P37/SL]; ICMR fellowship, India; MHRD fellowship
FX R.G. acknowledges DBT grant, India (BT/11/IYBA/2018/06), for partially
   supporting this work. D.K. is grateful for ICMR fellowship, India. R.G.
   also acknowledges the MHRD-SPARC grant (SPARC/2018-2019/P37/SL). N.S. is
   thankful for MHRD fellowship.
CR Briguglio I, 2011, INT J MED CHEM, DOI 10.1155/2011/213135
   Calland N, 2012, HEPATOLOGY, V55, P720, DOI 10.1002/hep.24803
   Campen A, 2008, PROTEIN PEPTIDE LETT, V15, P956, DOI 10.2174/092986608785849164
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cheng FX, 2016, TRENDS MOL MED, V22, P919, DOI 10.1016/j.molmed.2016.09.006
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   GELADOPOULOS TP, 1991, ANAL BIOCHEM, V192, P112, DOI 10.1016/0003-2697(91)90194-X
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Giri R, 2013, P NATL ACAD SCI USA, V110, P14942, DOI 10.1073/pnas.1307337110
   Gradisar H, 2007, J MED CHEM, V50, P264, DOI 10.1021/jm060817o
   Gunasekaran D, 2017, J BIOMOL STRUCT DYN, V35, P1654, DOI 10.1080/07391102.2016.1190791
   Gupta S, 2017, INT J BIOL MACROMOL, V94, P621, DOI 10.1016/j.ijbiomac.2016.10.008
   Ismail NA, 2017, INTERDISCIP SCI, V9, P499, DOI 10.1007/s12539-016-0157-8
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   KODAMA T, 1986, J BIOCHEM-TOKYO, V99, P1465, DOI 10.1093/oxfordjournals.jbchem.a135616
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   Kumar D, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1650830
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Martinez JP, 2015, NAT PROD REP, V32, P29, DOI 10.1039/c4np00085d
   Mayank, 2020, NEW J CHEM, V44, P1872, DOI 10.1039/c9nj05225a
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nance CL, 2009, J ALLERGY CLIN IMMUN, V123, P459, DOI 10.1016/j.jaci.2008.12.024
   Panwar U, 2018, J BIOMOL STRUCT DYN, V36, P3199, DOI 10.1080/07391102.2017.1384400
   Ramharack P, 2017, RSC ADV, V7, P22133, DOI 10.1039/c7ra01376k
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Shen B, 2015, CELL, V163, P1297, DOI 10.1016/j.cell.2015.11.031
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Sirin S, 2014, PROTEINS, V82, P3397, DOI 10.1002/prot.24694
   Song JM, 2005, ANTIVIR RES, V68, P66, DOI 10.1016/j.antiviral.2005.06.010
   Suryanarayanan V, 2015, J RECEPT SIG TRANSD, V35, P370, DOI 10.3109/10799893.2014.956756
   Tetro JA, 2016, MICROBES INFECT, V18, P167, DOI 10.1016/j.micinf.2015.12.010
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Tokuriki N, 2009, TRENDS BIOCHEM SCI, V34, P53, DOI 10.1016/j.tibs.2008.10.009
   Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994
   Toto A, 2014, PROTEIN SCI, V23, P962, DOI 10.1002/pro.2480
   Uversky V. N., 2013, INTRINSICALLY DISORD, V1
   Wang JH, 2011, INT J MOL SCI, V12, P3205, DOI 10.3390/ijms12053205
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Xu J, 2017, MOLECULES, V22, DOI 10.3390/molecules22081337
   Xue B, 2014, CHEM REV, V114, P6880, DOI 10.1021/cr4005692
   Yang XY, 2018, FASEB J, V32, P5250, DOI 10.1096/fj.201701140R
NR 50
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2470-1343
J9 ACS OMEGA
JI ACS Omega
PD MAY 19
PY 2020
VL 5
IS 19
BP 11217
EP 11226
DI 10.1021/acsomega.0c01353
PG 10
WC Chemistry, Multidisciplinary
SC Chemistry
GA LT5XY
UT WOS:000537145000066
PM 32455246
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guzman-Teran, C
   Calderon-Rangel, A
   Rodriguez-Morales, A
   Mattar, S
AF Guzman-Teran, Camilo
   Calderon-Rangel, Alfonso
   Rodriguez-Morales, Alfonso
   Mattar, Salim
TI Venezuelan equine encephalitis virus: the problem is not over for
   tropical America
SO ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS
LA English
DT Review
DE Arbovirus; Equine; Chiroptera; Alphavirus; Zoonoses; Americas
ID ENCEPHALOMYELITIS; ALPHAVIRUSES; GUATEMALA; INFECTION; EPIDEMIC;
   COLOMBIA; COMPLEX; STRAIN; PIXUNA; PANAMA
AB The equine encephalitis viruses, Venezuelan (VEEV), East (EEEV) and West (WEEV), belong to the genus alphavirus, family Togaviridae and still represent a threat for human and animal public health in the Americas. In both, these infections are characterized by high viremia, rash, fever, encephalitis and death. VEEV encephalitis is similar, clinically, to other arboviral diseases, such as dengue, Zika or chikungunya. Most of the alphaviruses are transmitted between vertebrates and mosquitoes. They are able to replicate in a wide number of hosts, including mammals, birds, reptiles, amphibian and arthropods. The VEEV has enzootic and epizootic transmission cycles. At the enzootic one, enzootic strains (subtype I, serotypes D-F and serotypes II-VI) are continuously circulating between mosquitoes and wild rodents in tropical forests and mangroves of the Americas. The main reseroivrs are wild rodent species of the subfamily Sigmodontinae. However, bats can be also accidental reservoirs of VEEV. In this article, we reviewed the main features, epidemiology, clinical aspects and the current perspectives of the VEEV.
C1 [Guzman-Teran, Camilo] Univ Cordoba, Inst Invest Biol Trop IIBT, Fac Ciencias Salud, Programa Regencia Farm, Cordoba, Colombia.
   [Calderon-Rangel, Alfonso; Mattar, Salim] Univ Cordoba, Inst Invest Biol Trop IIBT, Fac Med Vet & Zootecnia, Cordoba, Colombia.
   [Rodriguez-Morales, Alfonso] Univ Tecnol Pereira, Publ Hlth & Infect Res Grp, Fac Hlth Sci, Pereira, Risaralda, Colombia.
   [Rodriguez-Morales, Alfonso] Fdn Univ Autonoma Amer, Fac Med, Grp Invest Biomed, Pereira, Risaralda, Colombia.
RP Mattar, S (corresponding author), Univ Cordoba, Inst Invest Biol Trop IIBT, Fac Med Vet & Zootecnia, Cordoba, Colombia.
EM mattarsalim@hotmail.com
FU Universidad de Cordoba
FX Universidad de Cordoba.
CR Aguilar PV, 2011, FUTURE VIROL, V6, P721, DOI 10.2217/FVL.11.50
   Aguilar PV, 2004, EMERG INFECT DIS, V10, P880, DOI 10.3201/eid1005.030634
   Artsob H., 1979, Arctic and tropical arboviruses., P39
   Pisano MB, 2010, VECTOR-BORNE ZOONOT, V10, P199, DOI 10.1089/vbz.2008.0156
   Cameron G. D. W., 1942, CANADIAN PUBL HEALTH JOUR, V33, P383
   Carrera JP, 2018, AM J TROP MED HYG, V98, P1798, DOI 10.4269/ajtmh.17-0679
   CDC, 1964, W EQ ENC VIR NEUR DI
   Deardorff ER, 2010, AM J TROP MED HYG, V82, P1047, DOI 10.4269/ajtmh.2010.09-0556
   Delfraro A, 2011, EMERG INFECT DIS, V17, P952, DOI 10.3201/eid1705.101068
   Forrester NL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005693
   Go YY, 2014, CLIN EXP VACCINE RES, V3, P58, DOI 10.7774/cevr.2014.3.1.58
   Gonzalez-Salazar D, 2003, EMERG INFECT DIS, V9, P161
   GROOT H, 1959, AM J TROP MED HYG, V8, P175, DOI 10.4269/ajtmh.1959.8.175
   Groot H, 1972, PAN AM HLTH ORG SCI, V243, P7
   Groot H, 1972, PAHO243 SCI PUB, P7
   Guerbois M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002197
   Gupta P, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2355-3
   HAHN CS, 1988, P NATL ACAD SCI USA, V85, P5997, DOI 10.1073/pnas.85.16.5997
   HINMAN AR, 1971, AM J EPIDEMIOL, V93, P130, DOI 10.1093/oxfordjournals.aje.a121233
   Gil PI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05983-w
   Johnson K M, 1974, Adv Vet Sci Comp Med, V18, P79
   Juarez D, 2018, EMERG INFECT DIS, V24, P1578, DOI 10.3201/eid2408.171274
   KINNEY RM, 1992, J GEN VIROL, V73, P3301, DOI 10.1099/0022-1317-73-12-3301
   Kontaris I, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00035
   Kubes V, 1939, SCIENCE, V90, P20, DOI 10.1126/science.90.2323.20
   Kumar Balvinder, 2018, Open Virol J, V12, P80, DOI 10.2174/1874357901812010080
   LONDON WT, 1977, TERATOLOGY, V16, P285, DOI 10.1002/tera.1420160307
   Lord R D, 1974, Bull Pan Am Health Organ, V8, P100
   Mattar S, 2018, REV MVZ CORDOBA, V23, P6937, DOI 10.21897/rmvz.1480
   Medina G, 2015, AM J TROP MED HYG, V93, P7, DOI 10.4269/ajtmh.14-0543
   Mesa FA, 2005, ENCEPHALITIS EQUINAS, P74
   MONATH TP, 1980, AM J TROP MED HYG, V29, P969, DOI 10.4269/ajtmh.1980.29.969
   Morilla-Gonzales A, 1976, VET SCI SPANISH VERS, P163
   Neira MV, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00184
   Oberste MS, 1998, AM J TROP MED HYG, V58, P41, DOI 10.4269/ajtmh.1998.58.41
   Paessler S, 2009, VACCINE, V27, pD80, DOI 10.1016/j.vaccine.2009.07.095
   Poddar S, 2016, J VIROL, V90, P8780, DOI 10.1128/JVI.00655-16
   Quiroz E, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000472
   Reisen WK, 1988, ARBOVIRUSES EPIDEMIO, P89
   Reta-Pettersson G, 1970, INT ROUND TABLE VEE, P1
   Reta-Pettersson G, 1970, PROBLEM VENEZUELAN E, V6, P1
   Rivas F, 1997, J INFECT DIS, V175, P828, DOI 10.1086/513978
   Ronca SE, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00959
   SANMARTINBARBERI C, 1954, AM J TROP MED HYG, V3, P283, DOI 10.4269/ajtmh.1954.3.283
   Silva MLCR, 2017, TRANSBOUND EMERG DIS, V64, P990, DOI 10.1111/tbed.12441
   SOTOMAYOR CG, 1946, J AM VET MED ASSOC, V109, P478
   Sotomayor-Bonilla J, 2017, J WILDLIFE DIS, V53, P657, DOI 10.7589/2016-11-249
   Suarez Agudelo angela Natalia, THESIS
   SUDIA WD, 1971, AM J EPIDEMIOL, V93, P137, DOI 10.1093/oxfordjournals.aje.a121234
   Thompson NN, 2015, ZOONOSES PUBLIC HLTH, V62, P53, DOI 10.1111/zph.12118
   Vittor AY, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004554
   Zacks MA, 2010, VET MICROBIOL, V140, P281, DOI 10.1016/j.vetmic.2009.08.023
   Zarate M, 1978, VET SCI SPANISH VERS, P157
NR 53
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1476-0711
J9 ANN CLIN MICROB ANTI
JI Ann. Clin. Microbiol. Antimicrob.
PD MAY 19
PY 2020
VL 19
IS 1
AR 19
DI 10.1186/s12941-020-00360-4
PG 8
WC Microbiology
SC Microbiology
GA LS7PX
UT WOS:000536574400001
PM 32429942
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Raamkumar, AS
   Tan, SG
   Wee, HL
AF Raamkumar, Aravind Sesagiri
   Tan, Soon Guan
   Wee, Hwee Lin
TI Measuring the Outreach Efforts of Public Health Authorities and the
   Public Response on Facebook During the COVID-19 Pandemic in Early 2020:
   Cross-Country Comparison
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; sentiment analysis; emotion analysis; public health
   authorities; infectious disease; outbreak; public engagement; social
   media; public health; virus
ID RISK COMMUNICATION; LESSONS; DISEASE; ZIKA
AB Background: The coronavirus disease (COVID-19) pandemic presents one of the most challenging global crises at the dawn of a new decade. Public health authorities (PHAs) are increasingly adopting the use of social media such as Facebook to rapidly communicate and disseminate pandemic response measures to the public. Understanding of communication strategies across different PHAs and examining the public response on the social media landscapes can help improve practices for disseminating information to the public.
   Objective: This study aims to examine COVID-19-related outreach efforts of PHAs in Singapore, the United States, and England, and the corresponding public response to these outreach efforts on Facebook.
   Methods: Posts and comments from the Facebook pages of the Ministry of Health (MOH) in Singapore, the Centers for Disease Control and Prevention (CDC) in the United States, and Public Health England (PHE) in England were extracted from January 1, 2019, to March 18, 2020. Posts published before January 1, 2020, were categorized as pre-COVID-19, while the remaining posts were categorized as peri-COVID-19 posts. COVID-19-related posts were identified and classified into themes. Metrics used for measuring outreach and engagement were frequency, mean posts per day (PPD), mean reactions per post, mean shares per post, and mean comments per post. Responses to the COVID-19 posts were measured using frequency, mean sentiment polarity, positive to negative sentiments ratio (PNSR), and positive to negative emotions ratio (PNER). Toxicity in comments were identified and analyzed using frequency, mean likes per toxic comment, and mean replies per toxic comment. Trend analysis was performed to examine how the metrics varied with key events such as when COVID-19 was declared a pandemic.
   Results: The MOH published more COVID-19 posts (n=271; mean PPD 5.0) compared to the CDC (n=94; mean PPD 2.2) and PHE (n=45; mean PPD 1.4). The mean number of comments per COVID-19 post was highest for the CDC (mean CPP 255.3) compared to the MOH (mean CPP 15.6) and PHE (mean CPP 12.5). Six major themes were identified, with posts about prevention and safety measures and situation updates being prevalent across the three PHAs. The themes of the MOH's posts were diverse, while the CDC and PHE posts focused on a few themes. Overall, response sentiments for the MOH posts (PNSR 0.94) were more favorable compared to response sentiments for the CDC (PNSR 0.57) and PHE (PNSR 0.55) posts. Toxic comments were rare (0.01%) across all PHAs.
   Conclusions: PHAs' extent of Facebook use for outreach purposes during the COVID-19 pandemic varied among the three PHAs, highlighting the strategies and approaches that other PHAs can potentially adopt. Our study showed that social media analysis was capable of providing insights about the communication strategies of PHAs during disease outbreaks.
C1 [Raamkumar, Aravind Sesagiri; Tan, Soon Guan; Wee, Hwee Lin] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, MD1 10-01,12 Sci Dr 2, Singapore 117549, Singapore.
   [Wee, Hwee Lin] Natl Univ Singapore, Dept Pharm, Singapore, Singapore.
RP Wee, HL (corresponding author), Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, MD1 10-01,12 Sci Dr 2, Singapore 117549, Singapore.
EM ephwhl@nus.edu.sg
RI ; Wee, Hwee Lin/D-4126-2012; Sesagiri Raamkumar, Aravind/G-9502-2017
OI Tan, Soon Guan/0000-0003-2287-166X; Wee, Hwee Lin/0000-0002-7150-1801;
   Sesagiri Raamkumar, Aravind/0000-0001-7200-7787
FU National University Health System Strategic Funds titled "Phen-Gen
   Research Repository and Pre-Emptive Pharmacogenomics"; Centre for Health
   Services and Policy Research, a center under the National University
   Health Systems Pte Ltd; Saw Swee Hock School of Public Health, National
   University of SingaporeNational University of Singapore
FX We would like to thank Miss Yu-Ting, CHEN (research assistant) for
   providing administrative support to submitting this manuscript. ASR was
   hired under a grant from the National University Health System Strategic
   Funds titled "Phen-Gen Research Repository and Pre-Emptive
   Pharmacogenomics." During COVID-19, safe distancing measures prevented
   him from accessing data stored in a dedicated workstation without
   internet access. He was thus reassigned to this study. The grantor had
   no role in the design and conduct of the study; collection, management,
   analysis, and interpretation of the data; preparation, review, or
   approval of the manuscript; or the decision to submit the manuscript for
   publication. This work was also supported by the Centre for Health
   Services and Policy Research, a center under the National University
   Health Systems Pte Ltd and Saw Swee Hock School of Public Health,
   National University of Singapore. We would like to thank the Perspective
   API team of Google for generously extending the usage quota of their API
   service, which we used to measure the toxicity of Facebook comments for
   our research study.
CR Abdullah Z, 2020, SINGAPORE CONFIRMS 1
   Al Jazeera Uras U., 2020, CORONAVIRUS COMPARIN
   Al-Hajjar D, 2015, 2015 IEEE JORDAN CONFERENCE ON APPLIED ELECTRICAL ENGINEERING AND COMPUTING TECHNOLOGIES (AEECT)
   [Anonymous], 2020, STRAITS TIMES
   [Anonymous], 2020, WASHINGTON POST
   Barron L, 2020, TIME
   Biesecker M., 2020, GLOBAL NEWS     0405
   Cheng J, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P1217, DOI 10.1145/2998181.2998213
   Costello A., 2020, GUARDIAN
   Daniulaityte R, 2017, J STUD ALCOHOL DRUGS, V78, P910
   de Araujo DHM, 2019, SOCIAL NETWORKS APPL, P679, DOI [10.1007/978-3-319-96089-0_74, DOI 10.1007/978-3-319-96089-0_74]
   Erlingsson C, 2017, AFR J EMERG MED, V7, P93, DOI 10.1016/j.afjem.2017.08.001
   Evers C, 2013, APPETITE, V68, P1, DOI 10.1016/j.appet.2013.04.007
   Felbo Bjarke, 2017, P 2017 C EMP METH NA, P1615, DOI DOI 10.18653/V1/D17-1169
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Hoffman SJ, 2018, AM J PUBLIC HEALTH, V108, P329, DOI [10.2105/ajph.2017.304245, 10.2105/AJPH.2017.304245]
   Holmes BJ, 2008, HEALTH RISK SOC, V10, P349, DOI 10.1080/13698570802166431
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hutto C, 2014, AAI PUBLICATIONS
   Junger J, 2019, FACEPAGER
   Lee VJ, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa039
   Lwin MO, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091974
   Mamidi R, 2019, JMIR PUBLIC HLTH SUR, V5, P78, DOI 10.2196/11036
   Ministry of Health, 2020, PREC MEAS RESP SEV P
   Ministry of Health, 2020, RISK ASS RAIS DOR OR
   Moss P, 2020, LANCET, V395, pE46, DOI 10.1016/S0140-6736(20)30463-3
   Plutchik R., 2014, APPROACHES EMOTION
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Strekalova YA, 2017, HEALTH EDUC BEHAV, V44, P332, DOI 10.1177/1090198116660310
   Teo J., 2020, STRAITS TIMES
   Vaughan E, 2009, AM J PUBLIC HEALTH, V99, pS324, DOI 10.2105/AJPH.2009.162537
   Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P549, DOI 10.1016/j.ajic.2017.10.015
   Vijaykumar S, 2017, J AM MED INFORM ASSN, V24, P1155, DOI 10.1093/jamia/ocx028
   Vijaykumar S, 2015, J HOMEL SECUR EMERG, V12, P653, DOI 10.1515/jhsem-2014-0072
   Wong John E L, 2020, JAMA, DOI 10.1001/jama.2020.2467
   World Health Organization, 2020, WHO DIR GEN OP REM M
   World Health Organization, 2018, COMM RISK PUBL HLTH
   Worldometers, 2020, COUNTR COVID 19 HAS
NR 38
TC 0
Z9 0
U1 10
U2 10
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAY 19
PY 2020
VL 22
IS 5
AR e19334
DI 10.2196/19334
PG 12
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA LO7EN
UT WOS:000533791100001
PM 32401219
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Girard, M
   Nelson, CB
   Picot, V
   Gubler, DJ
AF Girard, Marc
   Nelson, Christopher B.
   Picot, Valentina
   Gubler, Duane J.
TI Arboviruses: A global public health threat
SO VACCINE
LA English
DT Article
DE Zika virus; Yellow fever virus; Dengue virus; Chikungunya virus; West
   Nile virus; Aedes mosquitoes; Flaviviruses; Arboviruses
ID DENGUE; WOLBACHIA; VIRUS
AB A conference on "ARBOVIRUSES, A GLOBAL PUBLIC HEALTH THREAT" was organized on June 20-22, 2018 at the Merieux Foundation Conference Center in Veyrier du Lac, France, to review and raise awareness to the global public health threat of epidemic arboviruses, and to advance the discussion on the control and prevention of arboviral diseases. The presentations by scientists and public health officials from Asia, the Americas, Europe and Africa strengthened the notion that arboviral diseases of both humans and domestic animals are progressively becoming dominant public health problems in the world. The repeated occurrence of recent deadly epidemics strongly reinforces the call for action against these viral diseases, and the need for developing effective vaccines, drugs, vector control tools and strong prevention programs.
C1 [Girard, Marc] Acad Natl Med, 16 Rue Bonaparte, Paris 75006, France.
   [Nelson, Christopher B.] SanofiPasteur, Lyon, France.
   [Picot, Valentina] Fondat Merieux, 17 Rue Bourgelat, Lyon 69002, France.
   [Gubler, Duane J.] Duke NUS Med Sch, Singapore, Singapore.
   [Nelson, Christopher B.] Sanofipasteur, 1541 Ave Marcel Merieux, Marcy Letoile 69280, France.
RP Girard, M (corresponding author), Acad Natl Med, 16 Rue Bonaparte, Paris 75006, France.
EM marc.girard36@wanadoo.fr; christopher.nelson@sanofi.com;
   valentina.picot@fondation-merieux.org; duane.gubler@duke-nus.edu.sg
CR Anders KL, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2670-z
   [Anonymous], 2017, B WORLD HEALTH ORGAN, V95, P639
   [Anonymous], 2019, YELL FEV EP UPD
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869
   Brent SE, 2018, B WORLD HEALTH ORGAN, V96, P343, DOI 10.2471/BLT.17.205658
   Casey RM, 2019, NEW ENGL J MED, V381, P444, DOI 10.1056/NEJMoa1710430
   Dorigatti I, 2018, TRENDS PARASITOL, V34, P102, DOI 10.1016/j.pt.2017.11.002
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Gessner BD, 2017, VACCINE, V35, P6255, DOI 10.1016/j.vaccine.2017.09.048
   Gubler D.J., 2008, VECTOR BORNE DIS UND
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead Scott B., 1992, World Health Statistics Quarterly, V45, P292
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lambrechts L, 2015, LANCET INFECT DIS, V15, P862, DOI 10.1016/S1473-3099(15)00091-2
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Saadatian-Elahi M, 2016, VACCINE, V34, P1139, DOI 10.1016/j.vaccine.2016.01.021
   Samuel M, 2017, PLOS NEGLTROP DIS, V11, DOI [10.1371/journal.pntd.0005837e0005837, DOI 10.1371/JOURNAL.PNTD.0005837E0005837]
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   WHO, 2012, WHO REPORT
   WHO Immunization, 2018, VACC POS PAP
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax008
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 33
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAY 19
PY 2020
VL 38
IS 24
BP 3989
EP 3994
DI 10.1016/j.vaccine.2020.04.011
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LJ2US
UT WOS:000530025400002
PM 32336601
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Stracker, TH
   Morrison, CG
   Gergely, F
AF Stracker, Travis H.
   Morrison, Ciaran G.
   Gergely, Fanni
TI Molecular causes of primary microcephaly and related diseases: a report
   from the UNIA Workshop
SO CHROMOSOMA
LA English
DT Review
DE Microcephaly; Neurodevelopment; Cell fate; Growth defects; DNA damage
   response; Centrosomes; Cilia; Mitosis; Differentiation; Stem cells
ID CELL-CYCLE EXIT; CENTROSOME LOSS; PROTEIN; MUTATIONS; COMPLEX; GEMC1;
   DIFFERENTIATION; NEUROGENESIS; PROGENITORS; MINIBRAIN
AB The International University of Andalucia (UNIA) Current Trends in Biomedicine Workshop on Molecular Causes of Primary Microcephaly and Related Diseases took place in Baeza, Spain, November 18-20, 2019. This meeting brought together scientists from Europe, the USA and China to discuss recent advances in our molecular and genetic understanding of a group of rare neurodevelopmental diseases characterised by primary microcephaly, a condition in which head circumference is smaller than normal at birth. Microcephaly can be caused by inherited mutations that affect key cellular processes, or environmental exposure to radiation or other toxins. It can also result from viral infection, as exemplified by the recent Zika virus outbreak in South America. Here we summarise a number of the scientific advances presented and topics discussed at the meeting.
C1 [Stracker, Travis H.] Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.
   [Stracker, Travis H.] Barcelona Inst Sci & Technol, Barcelona 08028, Spain.
   [Morrison, Ciaran G.] Natl Univ Ireland Galway, Ctr Chromosome Biol, Sch Nat Sci, Biosci Bldg, Galway H91 TK33, Ireland.
   [Gergely, Fanni] Univ Cambridge, Canc Res UK Cambridge Inst, Li Ka Shing Ctr, Robinson Way, Cambridge CB2 0RE, England.
RP Stracker, TH (corresponding author), Inst Res Biomed IRB Barcelona, Barcelona 08028, Spain.; Stracker, TH (corresponding author), Barcelona Inst Sci & Technol, Barcelona 08028, Spain.
EM travis.stracker@irbbarcelona.org; ciaran.morrison@nuigalway.ie;
   Fanni.Gergely@cruk.cam.ac.uk
RI Morrison, Ciaran/B-6568-2008; Stracker, Travis/I-2815-2015
OI Morrison, Ciaran/0000-0003-2401-7029; Stracker,
   Travis/0000-0002-8650-2081
FU Spanish Ministry of Science, Innovation and Universities
   [PGC2018-095616-B-I00/GINDATA]; Spanish Ministry of Science, Innovation
   and Universities (FEDER); Centres of Excellence Severo Ochoa award;
   CERCA Programme
FX T.H.S. was funded by the Spanish Ministry of Science, Innovation and
   Universities (PGC2018-095616-B-I00/GINDATA and FEDER), the Centres of
   Excellence Severo Ochoa award and the CERCA Programme.
CR Arbi M, 2016, EMBO REP, V17, P400, DOI 10.15252/embr.201540882
   Arroyo M, 2019, FASEB J, V33, P8363, DOI 10.1096/fj.201802009RR
   Avela K, 2000, NAT GENET, V25, P298, DOI 10.1038/77053
   Balestrini A, 2010, NAT CELL BIOL, V12, P484, DOI 10.1038/ncb2050
   Bazzi H, 2014, P NATL ACAD SCI USA, V111, pE1491, DOI 10.1073/pnas.1400568111
   Benito-Kwiecinski Silvia, 2019, Cold Spring Harb Perspect Biol, DOI 10.1101/cshperspect.a035709
   Cologne A, 2019, RNA, V25, P1130, DOI 10.1261/rna.071423.119
   Fong CS, 2016, ELIFE, V5, DOI [10.7554/eLife.16270, 10.7554/eLite.16270]
   Gottardo M, 2015, CURR BIOL, V25, P2319, DOI 10.1016/j.cub.2015.07.038
   Hammerle B, 2011, DEVELOPMENT, V138, P2543, DOI 10.1242/dev.066167
   Heyn P, 2019, NAT GENET, V51, P96, DOI 10.1038/s41588-018-0274-x
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831
   Johnson MB, 2018, NATURE, V556, P370, DOI 10.1038/s41586-018-0035-0
   Kottemann MC, 2018, MOL CELL, V69, P24, DOI 10.1016/j.molcel.2017.11.035
   Lalioti ME, 2019, GLIA, V67, P2360, DOI 10.1002/glia.23690
   Lambrus BG, 2017, TRENDS CELL BIOL, V27, P314, DOI 10.1016/j.tcb.2017.01.004
   Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee SB, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat4985
   Lelieveld SH, 2016, NAT NEUROSCI, V19, P1194, DOI 10.1038/nn.4352
   Letard P, 2018, HUM MUTAT, V39, P319, DOI 10.1002/humu.23381
   Liu XQ, 2017, EMBO J, V36, P3666, DOI 10.15252/embj.201694443
   Lu H, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.172643
   Ma LN, 2014, GENE DEV, V28, P1461, DOI 10.1101/gad.243832.114
   Mao HQ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006282
   Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676
   Martin CA, 2016, GENE DEV, V30, P2158, DOI 10.1101/gad.286351.116
   McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022
   McMahon JJ, 2016, INT J DEV NEUROSCI, V55, P117, DOI 10.1016/j.ijdevneu.2016.03.006
   Meitinger F, 2016, J CELL BIOL, V214, P155, DOI 10.1083/jcb.201604081
   Merico D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9718
   Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001
   Nigg EA, 2018, NAT REV MOL CELL BIO, V19, P297, DOI 10.1038/nrm.2017.127
   Ogungbenro YA, 2018, J CELL BIOL, V217, P1205, DOI 10.1083/jcb.201706095
   Ortiz-Alvarez G, 2019, NEURON, V102, P159, DOI 10.1016/j.neuron.2019.01.051
   Pefani DE, 2011, J BIOL CHEM, V286, P23234, DOI 10.1074/jbc.M110.207688
   Pilaz LJ, 2016, NEURON, V89, P83, DOI 10.1016/j.neuron.2015.12.007
   Putoux A, 2016, CLIN GENET, V90, P550, DOI 10.1111/cge.12781
   Raschle M, 2015, SCIENCE, V348, DOI 10.1126/science.1253671
   Reijnders MRF, 2018, AM J HUM GENET, V102, P1195, DOI 10.1016/j.ajhg.2018.04.014
   Rice G, 2007, AM J HUM GENET, V81, P713, DOI 10.1086/521373
   Segura-Bayona S, 2019, TOUSLED KINASE ACTIV, DOI [10.1101/621409, DOI 10.1101/621409]
   Segura-Bayona S, 2019, CELL MOL LIFE SCI, V76, P3827, DOI 10.1007/s00018-019-03208-z
   Shaikh MN, 2018, J NEUROGENET, V32, P37, DOI 10.1080/01677063.2018.1438427
   Shaikh MN, 2016, DEVELOPMENT, V143, P3195, DOI 10.1242/dev.134338
   Shao W, 2020, NATURE, DOI 10.1038/s41586-020-2139-6
   Sheehan CJ, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.182295
   Sir JH, 2011, NAT GENET, V43, P1147, DOI 10.1038/ng.971
   Soppa U, 2014, CELL CYCLE, V13, P2084, DOI 10.4161/cc.29104
   Tatton-Brown Katrina, 2018, Wellcome Open Res, V3, P46, DOI 10.12688/wellcomeopenres.14430.1
   Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917
   Taylor AMR, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0113-0
   TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4
   Terre B, 2016, EMBO J, V35, P942, DOI 10.15252/embj.201592821
   Topf A, 2020, EUR J HUM GENET, V28, P383, DOI 10.1038/s41431-019-0519-x
   Vargas-Hurtado D, 2019, CURR BIOL, V29, P2993, DOI 10.1016/j.cub.2019.07.061
   Verreet T, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1243527
   Yang TT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04469-1
   Zhou F, 2015, CURR BIOL, V25, P3267, DOI 10.1016/j.cub.2015.10.062
NR 60
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0009-5915
EI 1432-0886
J9 CHROMOSOMA
JI Chromosoma
PD JUN
PY 2020
VL 129
IS 2
BP 115
EP 120
DI 10.1007/s00412-020-00737-6
EA MAY 2020
PG 6
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA LS4BE
UT WOS:000533798900001
PM 32424716
DA 2020-07-08
ER

PT J
AU Huang, CM
   Xu, XJ
   Cai, YY
   Ge, QM
   Zeng, GW
   Li, XP
   Zhang, WD
   Ji, C
   Yang, L
AF Huang, Chunmei
   Xu, Xinjie
   Cai, Yuyang
   Ge, Qinmin
   Zeng, Guangwang
   Li, Xiaopan
   Zhang, Weide
   Ji, Chen
   Yang, Ling
TI Mining the Characteristics of COVID-19 Patients in China: Analysis of
   Social Media Posts
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE SARS-CoV-2; COVID-19; coronavirus disease; social media; Sina Weibo;
   help
ID ZIKA VIRUS; EBOLA; INFECTION
AB Background: In December 2019, pneumonia cases of unknown origin were reported in Wuhan City, Hubei Province, China. Identified as the coronavirus disease (COVID-19), the number of cases grew rapidly by human-to-human transmission in Wuhan. Social media, especially Sina Weibo (a major Chinese microblogging social media site), has become an important platform for the public to obtain information and seek help.
   Objective: This study aims to analyze the characteristics of suspected or laboratory-confirmed COVID-19 patients who asked for help on Sina Weibo.
   Methods: We conducted data mining on Sina Weibo and extracted the data of 485 patients who presented with clinical symptoms and imaging descriptions of suspected or laboratory-confirmed cases of COVID-19. In total, 9878 posts seeking help on Sina Weibo from February 3 to 20, 2020 were analyzed. We used a descriptive research methodology to describe the distribution and other epidemiological characteristics of patients with suspected or laboratory-confirmed SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infection. The distance between patients' home and the nearest designated hospital was calculated using the geographic information system ArcGIS.
   Results: All patients included in this study who sought help on Sina Weibo lived in Wuhan, with a median age of 63.0 years (IQR 55.0-71.0). Fever (408/485, 84.12%) was the most common symptom. Ground-glass opacity (237/314, 75.48%) was the most common pattern on chest computed tomography; 39.67% (167/421) of families had suspected and/or laboratory-confirmed family members; 36.58% (154/421) of families had 1 or 2 suspected and/or laboratory-confirmed members; and 70.52% (232/329) of patients needed to rely on their relatives for help. The median time from illness onset to real-time reverse transcription-polymerase chain reaction (RT-PCR) testing was 8 days (IQR 5.0-10.0), and the median time from illness onset to online help was 10 days (IQR 6.0-12.0). Of 481 patients, 32.22% (n=155) lived more than 3 kilometers away from the nearest designated hospital.
   Conclusions: Our findings show that patients seeking help on Sina Weibo lived in Wuhan and most were elderly. Most patients had fever symptoms, and ground-glass opacities were noted in chest computed tomography. The onset of the disease was characterized by family clustering and most families lived far from the designated hospital. Therefore, we recommend the following: (1) the most stringent centralized medical observation measures should be taken to avoid transmission in family clusters; and (2) social media can help these patients get early attention during Wuhan's lockdown. These findings can help the government and the health department identify high-risk patients and accelerate emergency responses following public demands for help.
C1 [Huang, Chunmei; Zeng, Guangwang; Yang, Ling] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Geriatr, 1665 Kongjiang Rd, Shanghai, Peoples R China.
   [Xu, Xinjie; Ge, Qinmin] Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Emergency, Shanghai, Peoples R China.
   [Cai, Yuyang] Shanghai Jiao Tong Univ, Sch Med, Sch Publ Hlth, Shanghai, Peoples R China.
   [Zeng, Guangwang] Hlth Ctr Nansheng Town, Wuzhishan, Peoples R China.
   [Li, Xiaopan] Ctr Dis Control & Prevent, Shanghai, Peoples R China.
   [Li, Xiaopan] Fudan Univ, Pudong Inst Prevent Med, Shanghai, Peoples R China.
   [Zhang, Weide] Fudan Univ, Zhongshan Hosp, Big Data & Artificial Intelligence Ctr, Shanghai, Peoples R China.
   [Ji, Chen] Warwick Med Sch, Warwick Clin Trials Unit, Coventry, W Midlands, England.
RP Yang, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Xinhua Hosp, Dept Geriatr, 1665 Kongjiang Rd, Shanghai, Peoples R China.
EM yangling01@xinhuamed.com.cn
OI Ji, Chen/0000-0003-4919-3299; Huang, Chunmei/0000-0002-9925-8073
FU Zhejiang University Special Scientific Research Fund for COVID-19
   prevention and control [2020XGZX065]; National Natural Science
   Foundation of ChinaNational Natural Science Foundation of China
   [71432006]; National Social Science Fund of China [17BSH056]; Shanghai
   Jiao Tong University think tank research project [ZKYJ-20200114];
   Shanghai Jiaotong University special scientific research fund for
   "Technology Promotion Project" in 2019 [ZT201903]; Shanghai science and
   Technology Fund [18441905200]
FX This study was supported by the Zhejiang University Special Scientific
   Research Fund for COVID-19 prevention and control (2020XGZX065); the
   National Natural Science Foundation of China (71432006); the National
   Social Science Fund of China (grant number 17BSH056); and the Shanghai
   Jiao Tong University think tank research project (ZKYJ-20200114). The
   funders had no role in the study design, data collection, data analysis
   and interpretation, writing of the report, or the decision to submit the
   paper for publication. The Authors were also supported by the Shanghai
   Jiaotong University special scientific research fund for "Technology
   Promotion Project" in 2019 (ZT201903) and the Shanghai science and
   Technology Fund (18441905200).
CR Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chen Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46898-y
   Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003
   Feng SH, 2018, DISASTER MED PUBLIC, V12, P26, DOI 10.1017/dmp.2017.29
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2016, AM J INFECT CONTROL, V44, P1660, DOI 10.1016/j.ajic.2016.05.011
   Fung ICH, 2016, PUBLIC HEALTH REP, V131, P461, DOI 10.1177/003335491613100312
   Fung ICH, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-31
   Gu H, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2911
   Guan Q, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P629, DOI 10.3760/cma.j.cn112338-20200223-00152
   Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032
   Gui Xinning, 2017, AMIA Annu Symp Proc, V2017, P820
   Guo P, 2019, SCI TOTAL ENVIRON, V647, P752, DOI 10.1016/j.scitotenv.2018.08.044
   Househ M, 2016, HEALTH INFORM J, V22, P470, DOI 10.1177/1460458214568037
   Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang R, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30147-X
   Jakovljevic Miro, 2020, Psychiatr Danub, V32, P6, DOI 10.24869/psyd.2020.6
   Ji YP, 2020, LANCET GLOB HEALTH, V8, pE480, DOI 10.1016/S2214-109X(20)30068-1
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Liu K, 2020, CHINESE MED J-PEKING, V133, P1025, DOI 10.1097/CM9.0000000000000744
   Liu YS, 2020, CLIN CHEM LAB MED, V58, P1077, DOI 10.1515/cclm-2020-0332
   Phan LT, 2020, NEW ENGL J MED, V382, P872, DOI 10.1056/NEJMc2001272
   Qiu Y Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P494, DOI 10.3760/cma.j.cn112338-20200221-00147
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Seltzer EK, 2015, PUBLIC HEALTH, V129, P1273, DOI 10.1016/j.puhe.2015.07.025
   Tian SJ, 2020, J INFECTION, V80, P401, DOI 10.1016/j.jinf.2020.02.018
   Wang Z, 2018, TELEMED E-HEALTH, V24, P702, DOI 10.1089/tmj.2017.0189
   Wong R, 2018, DISASTER MED PUBLIC, V12, P287, DOI 10.1017/dmp.2017.69
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Xie TS, 2014, INT J INFECT DIS, V22, P1, DOI 10.1016/j.ijid.2013.11.013
   Xu X, 2020, FIGSHARE
   Yang H Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P623, DOI 10.3760/cma.j.cn112338-20200223-00153
   Yu M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16162813
   Zhao YX, 2020, J MED INTERNET RES, V22, DOI 10.2196/18825
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
NR 37
TC 2
Z9 2
U1 17
U2 17
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAY 17
PY 2020
VL 22
IS 5
AR e19087
DI 10.2196/19087
PG 11
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA LO2SS
UT WOS:000533480900001
PM 32401210
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, XM
   Hua, S
   Gao, C
   Blackmer, JE
   Ouyang, ZY
   Ard, K
   Ciaranello, A
   Yawetz, S
   Sax, PE
   Rosenberg, ES
   Lichterfeld, M
   Yu, XG
AF Sun, Xiaoming
   Hua, Stephane
   Gao, Ce
   Blackmer, Jane E.
   Ouyang, Zhengyu
   Ard, Kevin
   Ciaranello, Andrea
   Yawetz, Sigal
   Sax, Paul E.
   Rosenberg, Eric S.
   Lichterfeld, Mathias
   Yu, Xu G.
TI Immune-profiling of ZIKV-infected patients identifies a distinct
   function of plasmacytoid dendritic cells for immune cross-regulation
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VIRUS-INFECTION; I INTERFERON; DNA VACCINE; ANTIBODIES; INNATE;
   IMMUNOGENICITY; REPLICATION; PHASE-1; BIOLOGY; PROTEIN
AB Zika virus (ZIKV) is a mosquito-borne pathogen with increasing public health significance. To characterize immune responses to ZIKV, here we examine transcriptional signatures of CD4 T, CD8 T, B, and NK cells, monocytes, myeloid dendritic cells (mDCs), and plasmacytoid dendritic cells (pDCs) from three individuals with ZIKV infection. While gene expression patterns from most cell subsets display signs of impaired antiviral immune activity, pDCs from infected host have distinct transcriptional response associated with activation of innate immune recognition and type I interferon signaling pathways, but downregulation of key host factors known to support ZIKV replication steps; meanwhile, pDCs exhibit a unique expression pattern of gene modules that are correlated with alternative cell populations, suggesting collaborative interactions between pDCs and other immune cells, particularly B cells. Together, these results point towards a discrete but integrative function of pDCs in the human immune responses to ZIKV infection. Zika virus (ZIKV) poses a significant public health threat, but the immune landscape changes following ZIKV infection is still unclear. Here, the authors show, using flow cytometry and transcriptomic data, that ZIKV induces a multitude of immune responses, with plasmacytoid dendritic cells poised centrally to interact with other immune cell types.
C1 [Sun, Xiaoming; Hua, Stephane; Gao, Ce; Blackmer, Jane E.; Ouyang, Zhengyu; Lichterfeld, Mathias; Yu, Xu G.] Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA.
   [Ard, Kevin; Ciaranello, Andrea; Rosenberg, Eric S.] Massachusetts Gen Hosp, Infect Dis Div, Boston, MA 02114 USA.
   [Yawetz, Sigal; Sax, Paul E.; Lichterfeld, Mathias; Yu, Xu G.] Brigham & Womens Hosp, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA.
RP Yu, XG (corresponding author), Massachusetts Gen Hosp, Ragon Inst MGH MIT & Harvard, Boston, MA 02114 USA.; Yu, XG (corresponding author), Brigham & Womens Hosp, Infect Dis Div, 75 Francis St, Boston, MA 02115 USA.
EM xyu@mgh.harvard.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI078799, AI089339, HL121890,
   AI098484, HL126554, AI116228, AI087452]; Sundry fund from the Ragon
   Institute of MGH, MIT, and Harvard
FX X.G.Y. is supported by NIH (grants AI078799, AI089339, HL121890,
   AI098484, HL126554, AI116228, and AI087452) and by a Sundry fund from
   the Ragon Institute of MGH, MIT, and Harvard.
CR Aagaard KM, 2017, SCI REP-UK, V7, DOI 10.1038/srep41389
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Assil S, 2019, CELL HOST MICROBE, V25, P730, DOI 10.1016/j.chom.2019.03.005
   Barzon L, 2018, CLIN INFECT DIS, V66, P1173, DOI 10.1093/cid/cix967
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brooks JT, 2016, MMWR-MORBID MORTAL W, V65, P745, DOI 10.15585/mmwr.mm6529e2
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Deal EM, 2013, J CLIN INVEST, V123, P2464, DOI 10.1172/JCI60945
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Duan XQ, 2019, FUTURE VIROL, V14, P9, DOI 10.2217/fvl-2018-0115
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Magoro T, 2019, J BIOL CHEM, V294, P14591, DOI 10.1074/jbc.RA119.007555
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rusinova I, 2013, NUCLEIC ACIDS RES, V41, pD1040, DOI 10.1093/nar/gks1215
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Sinigaglia L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29235-7
   Smith N, 2016, SCI REP-UK, V6, DOI 10.1038/srep29891
   Stelzer Gil, 2016, Curr Protoc Bioinformatics, V54, DOI 10.1002/cpbi.5
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Swiecki M, 2015, NAT REV IMMUNOL, V15, P471, DOI 10.1038/nri3865
   Szabo A, 2013, AM J CLIN EXP IMMUNO, V2, P195
   Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Trombetta J.J., 2014, CURR PROTOC MOL BIOL, DOI [DOI 10.1002/0471142727.MB0422S107, 10.1002/0471142727.mb0422s107]
   Webster B, 2016, J VIROL, V90, P10050, DOI 10.1128/JVI.01692-16
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Wilson JAC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006155
   Xia JG, 2015, NAT PROTOC, V10, P823, DOI 10.1038/nprot.2015.052
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhu X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.146
NR 69
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 15
PY 2020
VL 11
IS 1
AR 2421
DI 10.1038/s41467-020-16217-5
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LS7OG
UT WOS:000536569900019
PM 32415086
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pan, CY
   Liu, WL
   Su, MP
   Chang, TP
   Ho, HP
   Shu, PY
   Huang, JJ
   Lin, LJ
   Chen, CH
AF Pan, Chao-Ying
   Liu, Wei-Liang
   Su, Matthew-P
   Chang, Te-Pin
   Ho, Hui-Pin
   Shu, Pei-Yun
   Huang, Joh-Jong
   Lin, Li-Jen
   Chen, Chun-Hong
TI Epidemiological analysis of the Kaohsiung city strategy for dengue fever
   quarantine and epidemic prevention
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Dengue virus; Imported dengue cases; Concealment; Indigenous dengue
   fever; Airport fever screening; Noncontact infrared thermometers
ID DISEASES; TAIWAN; ARBOVIRUSES; CHIKUNGUNYA; ZIKA
AB Background Dengue is endemic in over 100 countries and is an important public health problem worldwide. Dengue fever is not endemic in Taiwan; the importation of dengue viruses from neighboring countries via close commercial links and air travel is considered to be the cause of local outbreaks. Therefore, efforts toward disease control have focused on preventing the importation of dengue into Taiwan. In this study, we investigated the relationships between the numbers of imported and indigenous dengue cases to test the validity of this strategy. Methods Data on cases of dengue fever that occurred between 2013 and 2018 were obtained from the surveillance systems of the Taiwan Center for Disease Control and Kaohsiung City Health Department. Standard epidemiological data, including the monthly numbers of indigenous and imported cases of dengue, were calculated. Potential associations between the numbers of indigenous and imported cases were investigated using correlation analyses. Results We identified a possible relationship between the period of disease concealment and the number of imported dengue cases, which resulted in epidemics of indigenous dengue fever within local communities. Further analysis of confirmed cases during previous epidemics in Kaohsiung City found that the risk of indigenous dengue fever may be related to the likelihood that patients with imported dengue fever will stay within local communities. Conclusion Given the correlations found between imported and indigenous cases of dengue fever, as well as the relationship between the disease concealment period and the risk of indigenous dengue fever, prevention of disease importation and efficient identification of dengue cases within high-risk communities remain the major priorities for disease control.
C1 [Pan, Chao-Ying; Ho, Hui-Pin; Lin, Li-Jen] Kaohsiung City Govt, Dept Hlth, Kaohsiung, Taiwan.
   [Liu, Wei-Liang; Chang, Te-Pin; Chen, Chun-Hong] Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Zhunan, Taiwan.
   [Su, Matthew-P] Nagoya Univ, Dept Biol Sci, Nagoya, Aichi 4648602, Japan.
   [Shu, Pei-Yun] Minist Hlth & Welf, Ctr Dis Control, Ctr Diagnost & Vaccine Dev, Taipei, Taiwan.
   [Huang, Joh-Jong] Tainan City Govt, Bur Social Affairs, Tainan, Taiwan.
   [Chen, Chun-Hong] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
RP Lin, LJ (corresponding author), Kaohsiung City Govt, Dept Hlth, Kaohsiung, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Mosquito Borne Dis Control Res Ctr, Zhunan, Taiwan.; Chen, CH (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
EM eight@kcg.gov.tw; chunhong@gmail.com
OI Su, Matthew/0000-0002-6186-211X; CHEN, CHUN-HONG/0000-0002-3028-5508
FU National Health Research Institutes, TaiwanNational Health Research
   Institutes - Taiwan [07A1-MRAP06-035, 08A1-MRAP04-035]; 
   [07A1-MRPP09-035];  [08A1-MRGP12-035]
FX CHC, WLL, MPS and TPC were funded by grant 07A1-MRPP09-035 and
   08A1-MRGP12-035. CYP, HPH, PYS, JJH and LJL were funded by grant
   07A1-MRAP06-035 and 08A1-MRAP04-035 (National Health Research
   Institutes, Taiwan). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Benitez MA, 2009, LANCET, V373, P1070, DOI 10.1016/S0140-6736(09)60634-6
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Chang CJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190637
   Chang K, 2017, AM J TROP MED HYG, V97, P361, DOI 10.4269/ajtmh.16-1018
   Chang LH, 2007, J MED ENTOMOL, V44, P205, DOI 10.1603/0022-2585(2007)44[205:DSOAAA]2.0.CO;2
   Chen KT, 2005, INT J INFECT DIS, V9, P77, DOI 10.1016/j.ijid.2004.04.015
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Huang JH, 2007, AM J TROP MED HYG, V77, P903, DOI 10.4269/ajtmh.2007.77.903
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuan MM, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-182
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Massad E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22590-5
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Oidtman RJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09035-x
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Perng GC, 2019, EMERG INFECT DIS, V25, P814, DOI 10.3201/eid2504.181449
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Shu PY, 2005, EMERG INFECT DIS, V11, P460, DOI 10.3201/eid1103.040420
   Tsai JJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006879
   Wang L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02344-z
   Wang SF, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.124
   Weeratunga P, 2017, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD012759, DOI 10.1002/14651858.CD012759]
   Yang CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006773
NR 28
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 15
PY 2020
VL 20
IS 1
AR 347
DI 10.1186/s12879-020-4942-y
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA LS0JM
UT WOS:000536080400001
PM 32414340
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Darcy, AW
   Kanda, S
   Dalipanda, T
   Joshua, C
   Shimono, T
   Lamaningao, P
   Mishima, N
   Nishiyama, T
AF Darcy, Andrew Waleluma
   Kanda, Seiji
   Dalipanda, Tenneth
   Joshua, Cynthia
   Shimono, Takaki
   Lamaningao, Pheophet
   Mishima, Nobuyuki
   Nishiyama, Toshimasa
TI Multiple arboviral infections during a DENV-2 outbreak in Solomon
   Islands
SO TROPICAL MEDICINE AND HEALTH
LA English
DT Article
DE Dengue fever; Arbovirus; Seroprevalence; Molecular; Immunity
ID DENGUE; SEROPREVALENCE; FEVER
AB Background Solomon Islands, a country made up of tropical islands, has suffered cyclic dengue fever (DF) outbreaks in the past three decades. An outbreak of dengue-like illness (DLI) that occurred in April 2016 prompted this study, which aimed to determine the population's immunity status and identify the arboviruses circulating in the country. Methods A household survey, involving 188 participants in two urban areas (Honiara and Gizo), and a parallel hospital-based clinical survey were conducted in April 2016. The latter was repeated in December after a surge in DLI cases. Arbovirus IgG ELISA were performed on the household blood samples to determine the prevalence of arboviruses in the community, while qPCR testing of the clinical samples was used to identify the circulating arboviruses. Dengue virus (DENV)-positive samples were further characterized by amplifying and sequencing the envelope gene. Results The overall prevalence rates of DENV, Zika virus, and chikungunya virus were 83.4%, 7.6%, and 0.9%, respectively. The qPCR positivity rates of the clinical samples collected in April 2016 were as follows: DENV 39.6%, Zika virus 16.7%, and chikungunya virus 6.3%, which increased to 74%, 48%, and 20% respectively in December 2016. The displacement of the circulating serotype-3, genotype-1, with DENV serotype 2, genotype cosmopolitan was responsible for the outbreak in 2016. Conclusions A DENV outbreak in Solomon Islands was caused by the introduction of a single serotype. The high prevalence of DENV provided transient cross-protection, which prevented the introduction of a new serotype from the hyperendemic region for at least 3 years. The severe outcomes seen in the recent outbreak probably resulted from changes in the causative viruses and the effects of population immunity and changes in the outbreak pattern. Solomon Islands needs to step up surveillance to include molecular tools, increase regional communication, and perform timely interventions.
C1 [Darcy, Andrew Waleluma; Kanda, Seiji; Shimono, Takaki; Lamaningao, Pheophet; Mishima, Nobuyuki; Nishiyama, Toshimasa] Kansai Med Univ, Dept Hyg & Publ Hlth, Hirakata, Osaka, Japan.
   [Dalipanda, Tenneth; Joshua, Cynthia] Minist Hlth & Med Serv, Honiara, Solomon Islands.
RP Kanda, S (corresponding author), Kansai Med Univ, Dept Hyg & Publ Hlth, Hirakata, Osaka, Japan.
EM kandas@hirakata.kmu.ac.jp
OI Kanda, Seiji/0000-0002-1797-3509
FU grant D2 from the Kansai Medical University
FX This research was partially funded by grant D2 from the Kansai Medical
   University. The funders had no role in the study design, data collection
   or analysis, the decision to publish, or the preparation of the
   manuscript.
CR Adams B, 2006, P NATL ACAD SCI USA, V103, P14234, DOI 10.1073/pnas.0602768103
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Aubry M, 2018, EMERG INFECT DIS, V24, P558, DOI 10.3201/eid2403.171149
   Cao-Lormeau VM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029555
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Craig AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198487
   Darcy ACH, 2001, P N G MED J
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duncombe J, 2013, EMERG INFECT DIS, V19, P324, DOI 10.3201/eid1902.120464
   Dupont-Rouzeyrol M, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-61
   Flipse J, 2013, TRAFFIC, V14, P25, DOI 10.1111/tra.12012
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 1999, DHF EPIDEMICS CUBA 1
   Holmes EC, 2009, J CLIN INVEST, V119, P2488, DOI 10.1172/JCI38050
   Kosasih H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080891
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Leparc-Goffart I, 2009, J CLIN VIROL, V45, P61, DOI 10.1016/j.jcv.2009.02.010
   Liu LT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202304
   Moore PR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.103
   Nogareda F, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/WPSAR.2013.4.2.013, 10.5365/wpsar.2013.4.2.013]
   Phommanivong Viengvaly, 2016, Trop Med Health, V44, P24, DOI 10.1186/s41182-016-0020-y
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Pyke AT, 2016, PLOS CURR, V7, P8
   Ramirez AH, 2009, DIAGN MICR INFEC DIS, V65, P247, DOI 10.1016/j.diagmicrobio.2009.07.022
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Rico-Hesse R, 2010, CURR TOP MICROBIOL, V338, P45, DOI 10.1007/978-3-642-02215-9_4
   Roth A, 2014, EMERG INFECT DIS, V20
   Senn N, 2011, AM J TROP MED HYG, V85, P132, DOI 10.4269/ajtmh.2011.10-0482
   Steel A, 2010, VIROLOGY, V405, P505, DOI 10.1016/j.virol.2010.05.033
   Tam CC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002259
   Tewari K, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.021
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Tom H, 2005, BIOEDIT VERSION 7 05
   Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560
   Waman VP, 2016, PEERJ, V4, DOI 10.7717/peerj.2326
   Wei HY, 2016, AM J TROP MED HYG, V95, P322, DOI 10.4269/ajtmh.15-0905
   Whitaker HJ, 2004, STAT MED, V23, P2429, DOI 10.1002/sim.1819
NR 41
TC 1
Z9 1
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1348-8945
EI 1349-4147
J9 TROP MED HEALTH
JI Trop. Med. Health
PD MAY 15
PY 2020
VL 48
IS 1
AR 33
DI 10.1186/s41182-020-00217-8
PG 11
WC Tropical Medicine
SC Tropical Medicine
GA LS0FX
UT WOS:000536071100001
PM 32435149
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guo, YM
   Li, TT
AF Guo, Youming
   Li, Tingting
TI Optimal control and stability analysis of an online game addiction model
   with two stages
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article
DE forward and backward sweep method; game addiction model; Lyapunov
   function; optimal control; two stages
ID COST-EFFECTIVENESS ANALYSIS; ZIKA VIRUS
AB In this paper, we establish a mathematical model of online game addiction with two stages to research the dynamic properties of it. The existence of all equilibria is obtained, and the basic reproduction number is calculated by the method of next-generation matrix. The global asymptotic stability of disease-free equilibrium (DFE) is proved by comparison principle, and the global asymptotic stability of endemic equilibrium (EE) is proved by constructing an appropriate Lyapunov function. Then we use the Pontryagin's maximum principle to find the optimal solution of the model, so that the number of infected people can be minimized. In numerical simulation, firstly, we validate the global stability of DFE and EE. Secondly, we consider three kind of control measures (treatment, isolation, and education) and divide them into four cases. The models with control and without control are solved numerically by using forward and backward sweep Runge-Kutta method. In order to achieve the best control effect, we suggest that three kind of measures should be used simultaneously according to the optimal control strategy.
C1 [Guo, Youming; Li, Tingting] Guilin Univ Technol, Coll Sci, Guilin 541004, Guangxi, Peoples R China.
RP Li, TT (corresponding author), Guilin Univ Technol, Coll Sci, Guilin 541004, Guangxi, Peoples R China.
EM wsltt0621@163.com
FU Basic Competence Promotion Project for Young and Middle-aged Teachers in
   Guangxi, China [2018KY0262, 2019KY0269]
FX Basic Competence Promotion Project for Young and Middle-aged Teachers in
   Guangxi, China, Grant/Award Number: 2018KY0262 and 2019KY0269
CR Agusto FB, 2018, MATH BIOSCI, V305, P102, DOI 10.1016/j.mbs.2018.09.007
   [Anonymous], 2018, WORLD HLTH STAT
   [Anonymous], 2019, STAT CLASSIFICATION
   Bonyah E, 2019, OPTIM CONTR APPL MET, V40, P394, DOI 10.1002/oca.2483
   Bonyah E, 2019, MATH BIOSCI, V309, P1, DOI 10.1016/j.mbs.2018.12.015
   Bonyah E, 2018, CHAOS SOLITON FRACT, V117, P150, DOI 10.1016/j.chaos.2018.10.025
   Fleming W. H., 1975, DETERMINISTIC STOCHA
   Hattaf K, 2012, ISRN BIOMATHEMATICS, V2012
   Huo HF, 2016, APPL MATH MODEL, V40, P9474, DOI 10.1016/j.apm.2016.06.029
   JIANG X, 2016, MATH PRACTICE THEORY, V46, P277
   Khan MA, 2019, NONLINEAR ANAL-REAL, V50, P144, DOI 10.1016/j.nonrwa.2019.04.006
   LaSalle j. P., 1976, REGIONAL C SERIES AP
   Li TT, 2019, FILOMAT, V33, P5691, DOI 10.2298/FIL1917691L
   Lukes DL, 1982, DIFFERENTIAL EQUATIO
   Mathews CL, 2019, AM J DRUG ALCOHOL AB, V45, P67, DOI 10.1080/00952990.2018.1472269
   McAsey M, 2012, COMPUT OPTIM APPL, V53, P207, DOI 10.1007/s10589-011-9454-7
   Momoh AA, 2018, OPER RES HEALTH CARE, V18, P99, DOI 10.1016/j.orhc.2017.08.004
   Mulone G, 2012, INT J BIOMATH, V5, DOI 10.1142/S1793524511001453
   Sana M, 2015, SCI INT LABORE, V27, P839
   Sharomi O, 2008, APPL MATH COMPUT, V195, P475, DOI 10.1016/j.amc.2007.05.012
   Tang CSK, 2017, ASIA-PAC J PUBLIC HE, V29, P673, DOI 10.1177/1010539517739558
   Ullah S, 2019, OPTIM CONTR APPL MET, V40, P529, DOI 10.1002/oca.2493
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Viriyapong R, 2018, MATH METHOD APPL SCI, V1, P1
   Wang X, 2019, APPL MATH COMPUT, V359, P165, DOI 10.1016/j.amc.2019.04.026
   ZHAO Q, 2017, J BEIJING U CIVIL EN, V8, DOI DOI 10.1186/S13287-017-0473-X
   Zhou WK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213898
NR 27
TC 0
Z9 0
U1 3
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
PD MAY 15
PY 2020
VL 43
IS 7
BP 4391
EP 4408
DI 10.1002/mma.6200
PG 18
WC Mathematics, Applied
SC Mathematics
GA LQ8JL
UT WOS:000535244500036
DA 2020-07-08
ER

PT J
AU Gonzalez, PV
   Harburguer, L
AF Gonzalez, Paula V.
   Harburguer, Laura
TI Lufenuron can be transferred by gravid Aedes aegypti females to breeding
   sites and can affect their fertility, fecundity and blood intake
   capacity
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Lufenuron; Auto-disemination; Fertility; Fecundity
ID INSECT GROWTH-REGULATORS; CHITIN SYNTHESIS INHIBITOR; EFFICACY; DIPTERA;
   PYRIPROXYFEN; MOSQUITOS; REPRODUCTION; RESISTANCE; CULICIDAE; TEMEPHOS
AB Background Aedes aegypti (L.) is the main vector of dengue, yellow fever, Zika and chikungunya viruses. A new method for controlling this mosquito has been developed based on the possibility that wild adult mosquitoes exposed to artificial resting sites contaminated with a larvicide, can disseminate it to larval breeding sites, is named "auto-dissemination". The present study was undertaken to evaluate if a chitin synthesis inhibitor like lufenuron can be disseminated to larval breeding sites and prevent adult emergence and also if forced contact of Ae. aegypti females with treated surfaces can affect its fertility, fecundity, and blood intake capacity. Methods Larval susceptibility to lufenuron was measured through EI50 and EI90. On the other hand, gravid females were exposed by tarsal contact to lufenuron-treated papers, we used the WHO susceptibility test kit tube to line the papers, and 1, 3 or 5 females for the transference. We also evaluated if the exposure of female mosquitoes to lufenuron-treated papers (0.4 and 1 mg a.i./cm(2)) has an effect on their fertility, fecundity or in the ability to feed on blood. In each assay 12-15 female mosquitoes were exposed to lufenuron for 1 h, 24 h before blood meal (BBM) or 24 h after a blood meal (ABM). Results Lufenuron proved to be very active against Ae. aegypti larvae with an EI50 of 0.164 ppb and EI90 of 0.81 ppb. We also found that lufenuron can be transferred by females from treated surfaces to clean containers causing the inhibition of emergence of the larvae (between 30 and 50%). This effect was dependent on the concentration applied on the paper and the number of females added to each cage. Conclusions This study introduces an innovation by first exploring the possibility that an insect growth regulator (IGR) belonging to the group of benzoylphenyl ureas, such as lufenuron, can be transferred by gravid females to breeding sites and that at the same time can have an effect on fertility, fecundity and blood intake capacity of adult mosquitoes.
C1 [Gonzalez, Paula V.; Harburguer, Laura] Ctr Invest Plagas & Insecticidas CIPEI UNIDEF CIT, JB de La Salle 4397, RA-1603 Buenos Aires, DF, Argentina.
RP Harburguer, L (corresponding author), Ctr Invest Plagas & Insecticidas CIPEI UNIDEF CIT, JB de La Salle 4397, RA-1603 Buenos Aires, DF, Argentina.
EM lharburguer@citedef.gob.ar
FU Bunge y Born Foundation; Agencia Nacional de Promocion Cientifica y
   Tecnologica (Argentina)ANPCyT [PICT 1729-2015]
FX This investigation received support from the Bunge y Born Foundation and
   the Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)
   through PICT 1729-2015.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Aiku A O, 2006, West Afr J Med, V25, P22
   Ali A, 1999, J AM MOSQUITO CONTR, V15, P43
   Araujo AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-297
   Belinato TA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-83
   Belinato TA, 2009, MEM I OSWALDO CRUZ, V104, P43, DOI 10.1590/S0074-02762009000100007
   Bisset J, 2005, PROTOCOLO DETERMINAR
   Braga IA, 2004, MEM I OSWALDO CRUZ, V99, P199, DOI 10.1590/S0074-02762004000200015
   Caputo B, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001793
   Cetin H, 2006, J AM MOSQUITO CONTR, V22, P343, DOI 10.2987/8756-971X(2006)22[343:EODACS]2.0.CO;2
   Chandel K, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005235
   Chism BD, 2003, MED VET ENTOMOL, V17, P211, DOI 10.1046/j.1365-2915.2003.00433.x
   COHEN E, 1987, ANNU REV ENTOMOL, V32, P71, DOI 10.1146/annurev.en.32.010187.000443
   Dean SR, 1998, J MED ENTOMOL, V35, P720, DOI 10.1093/jmedent/35.5.720
   Devine GJ, 2009, P NATL ACAD SCI USA, V106, P11530, DOI 10.1073/pnas.0901369106
   FOURNET F, 1993, J AM MOSQUITO CONTR, V9, P426
   Gaugler R, 2012, MED VET ENTOMOL, V26, P37, DOI 10.1111/j.1365-2915.2011.00970.x
   GILLETT JD, 1977, PROC R SOC SER B-BIO, V196, P223, DOI 10.1098/rspb.1977.0038
   GRAF JF, 1993, PARASITOL TODAY, V9, P471, DOI 10.1016/0169-4758(93)90106-P
   Harburguer L, 2014, J MED ENTOMOL, V51, P436, DOI 10.1603/ME13137
   Harburguer L, 2012, PEST MANAG SCI, V68, P137, DOI 10.1002/ps.2237
   Harris C, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-144
   ITOH T, 1994, J AM MOSQUITO CONTR, V10, P344
   IWANAGA K, 1988, APPL ENTOMOL ZOOL, V23, P186, DOI 10.1303/aez.23.186
   Jirakanjanakit N, 2007, ENVIRON ENTOMOL, V36, P506, DOI 10.1603/0046-225X(2007)36[506:TOTRIA]2.0.CO;2
   KELADA NL, 1981, J AGR SCI, V96, P611, DOI 10.1017/S0021859600034596
   LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99
   Martins AJ, 2008, PEST MANAG SCI, V64, P676, DOI 10.1002/ps.1547
   Mbare O, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-280
   MIURA T, 1976, J ECON ENTOMOL, V69, P655, DOI 10.1093/jee/69.5.655
   MIYAMOTO J, 1993, ACS SYM SER, V524, P144
   MULLA MS, 1986, J AM MOSQUITO CONTR, V2, P314
   MULLA MS, 1995, J AM MOSQUITO CONTR, V11, P269
   Muthukrishnan S, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P193, DOI 10.1016/B978-0-12-384747-8.10007-8
   NEWTON EAC, 1992, AM J TROP MED HYG, V47, P709, DOI 10.4269/ajtmh.1992.47.709
   Novartis, 1998, MATCH REL LEP CONTR
   Ohashi K, 2012, J MED ENTOMOL, V49, P1052, DOI 10.1603/ME12006
   Ohba S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067045
   PERICH MJ, 1990, J AM MOSQUITO CONTR, V6, P1
   Perich MJ, 2000, J MED ENTOMOL, V37, P541, DOI 10.1603/0022-2585-37.4.541
   Pilger D., 2010, TROPIKA, V1, P1
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Salokhe SG, 2010, CURR SCI INDIA, V99, P1256
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P608, DOI 10.2987/5738.1
   Sihuincha M, 2005, J MED ENTOMOL, V42, P620, DOI 10.1603/0022-2585(2005)042[0620:PUOPFC]2.0.CO;2
   Suman D. S., 2010, Journal of Entomology, V7, P33, DOI 10.3923/je.2010.33.43
   Tunaz Hasan, 2004, Turkish Journal of Agriculture and Forestry, V28, P377
   Vasuki V., 1999, Southeast Asian Journal of Tropical Medicine and Public Health, V30, P200
   VASUKI V, 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P121
   VASUKI V, 1992, MEM I OSWALDO CRUZ, V87, P275, DOI 10.1590/S0074-02761992000200016
   Yap HH, 1997, J AM MOSQUITO CONTR, V13, P384
NR 52
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 15
PY 2020
VL 13
IS 1
AR 257
DI 10.1186/s13071-020-04130-1
PG 8
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LS0HH
UT WOS:000536074700001
PM 32414396
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cannalire, R
   Chan, KWK
   Burali, MS
   Gwee, CP
   Wang, S
   Astolfi, A
   Massari, S
   Sabatini, S
   Tabarrini, O
   Mastrangelo, E
   Barreca, ML
   Cecchetti, V
   Vasudevan, SG
   Manfroni, G
AF Cannalire, Rolando
   Chan, Kitti Wing Ki
   Burali, Maria Sole
   Gwee, Chin Piaw
   Wang, Sai
   Astolfi, Andrea
   Massari, Serena
   Sabatini, Stefano
   Tabarrini, Oriana
   Mastrangelo, Eloise
   Barreca, Maria Letizia
   Cecchetti, Violetta
   Vasudevan, Subhash G.
   Manfroni, Giuseppe
TI Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering
   Multiple Functions of NS5 Polymerase
SO ACS MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Antivirals; Dengue inhibitors; Zika inhibitors; NS5 RdRp inhibitors;
   protein-protein interaction inhibitors
ID PROTEIN; RNA; REPLICATION
AB Treatment of dengue virus (DENY) and other flavivirus infections is an unmet medical need. The highly conserved flaviviral NS5 RNA-dependent RNA polymerase (RdRp) is an attractive antiviral target that interacts with NS3 and viral RNA within the replication complex assembly. Biochemical and cell-based evidence indicate that targeting cavity B may lead to dual RdRp and NS5-NS3 interaction inhibitors. By ligand-based design around 1H-pyrido[2,1-b][1,3]benzothiazol-1-one (PBTZ) 1, we identified new potent and selective DENY inhibitors that exert dual inhibition of NS5 RdRp and NS3-NS5 interaction, likely through binding cavity B. Resistance studies with compound 4 generated sequence variants in the 3'-untranslated region of RNA while further biochemical experiments demonstrated its ability to block also RNA-NS5 interaction, required for correct RNA synthesis in cells. These findings shed light on the potential mechanism of action for this class of compounds, underlying how PBTZs are very promising lead candidates for further evaluation.
C1 [Cannalire, Rolando; Burali, Maria Sole; Astolfi, Andrea; Massari, Serena; Sabatini, Stefano; Tabarrini, Oriana; Barreca, Maria Letizia; Cecchetti, Violetta; Manfroni, Giuseppe] Univ Perugia, Dipartimento Sci Farmaceut, I-06123 Perugia, Italy.
   [Chan, Kitti Wing Ki; Gwee, Chin Piaw; Wang, Sai; Vasudevan, Subhash G.] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.
   [Vasudevan, Subhash G.] Griffith Univ, Inst Glyc, Brisbane, Qld 4022, Australia.
   [Vasudevan, Subhash G.] Natl Univ Singapore, Dept Microbiol & Immunol, Singapore 117545, Singapore.
   [Mastrangelo, Eloise] Univ Milan, Dipartimento Biosci, I-120133 Milan, Italy.
   [Mastrangelo, Eloise] CNR, CNR IBF, I-120133 Milan, Italy.
RP Manfroni, G (corresponding author), Univ Perugia, Dipartimento Sci Farmaceut, I-06123 Perugia, Italy.; Vasudevan, SG (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, Singapore 169857, Singapore.; Vasudevan, SG (corresponding author), Griffith Univ, Inst Glyc, Brisbane, Qld 4022, Australia.; Vasudevan, SG (corresponding author), Natl Univ Singapore, Dept Microbiol & Immunol, Singapore 117545, Singapore.
EM giuseppe.manfroni@unipg.it; subhash.vasudevan@duke-nus.edu.sg
FU SILVER project of the European Commission within the seventh Framework
   Program Cooperation Project [2606444]; Scientific Independence of young
   Researchers (SIR) project from Italian Ministry of Education, University
   and Research [RBSI14C78S]; National Medical Research CouncilMedical
   Research Council UK (MRC) [NMRC/CBRG/0103/2016]; National Research
   Foundation [NRF2016NRF-CRP001-063]; Ministry of HealthMinistry of Health
   - Turkey [MOH-OFIRG18may-0006/2019]
FX This work has been realized in part thanks to (a) SILVER project of the
   European Commission within the seventh Framework Program Cooperation
   Project; grant agreement number: 2606444; (b) Scientific Independence of
   young Researchers (SIR) project from Italian Ministry of Education,
   University and Research; grant number: RBSI14C78S to G.M. and E.M.; and
   (c) National Medical Research Council grant NMRC/CBRG/0103/2016,
   National Research Foundation grant NRF2016NRF-CRP001-063 and a Ministry
   of Health grant (MOH-OFIRG18may-0006/2019) to S.G.V.
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BioSolveIT GmbH, SEESAR VERS 5 5
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Cannalire R, 2019, ANTIVIR RES, V167, P6, DOI 10.1016/j.antiviral.2019.03.004
   Duan YP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100929
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Kong GH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005139
   Lescar J, 2018, ADV EXP MED BIOL, V1062, P115, DOI 10.1007/978-981-10-8727-1_9
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Manfroni G, 2012, BIOORGAN MED CHEM, V20, P866, DOI 10.1016/j.bmc.2011.11.061
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Ng WC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060137
   StarDrop, ADMEQSAR MOD
   Surfhvv P., 2018, WHO, V29, P389
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Voter AF, 2018, ADV PROTEIN CHEM STR, V111, P197, DOI 10.1016/bs.apcsb.2017.07.005
   Wang S, 2020, ACS INFECT DIS, V6, P436, DOI 10.1021/acsinfecdis.9b00384
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, pE31, DOI 10.1016/S1473-3099(18)30494-8
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organization, 10 THREATS GLOB HLTH
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 25
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-5875
J9 ACS MED CHEM LETT
JI ACS Med. Chem. Lett.
PD MAY 14
PY 2020
VL 11
IS 5
BP 773
EP 782
DI 10.1021/acsmedchemlett.9b00619
PG 10
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA LQ8XJ
UT WOS:000535281200026
PM 32435384
DA 2020-07-08
ER

PT J
AU Walker, CL
   Ehinger, N
   Mason, B
   Oler, E
   Little, MTE
   Ohuma, EO
   Papageorghiou, AT
   Nayeri, U
   Curry, C
   Waldorf, KMA
AF Walker, Christie L.
   Ehinger, Noah
   Mason, Brittney
   Oler, Elizabeth
   Little, Marie-Terese E.
   Ohuma, Eric O.
   Papageorghiou, Aris T.
   Nayeri, Unzila
   Curry, Christine
   Waldorf, Kristina M. Adams
TI Ultrasound prediction of Zika virus-associated congenital injury using
   the profile of fetal growth
SO PLOS ONE
LA English
DT Article
ID INFECTION; INFANTS; OUTCOMES; PREGNANCY; BIRTH; WOMEN; BORN
AB Zika virus (ZIKV) is a mosquito-transmitted flavivirus, recently linked to microcephaly and central nervous system anomalies following infection in pregnancy. Striking findings of disproportionate growth with a smaller than expected head relative to body length have been observed more commonly among fetuses with exposure to ZIKV in utero compared to pregnancies without ZIKV infection regardless of other signs of congenital infection including microcephaly. This study's objective was to determine the diagnostic accuracy of femursparing profile of intrauterine growth restriction for the identification of ZIKV-associated congenital injuries on postnatal testing. A retrospective cohort study of pregnant women with possible or confirmed ZIKV infection between January 1, 2016 and December 31, 2017 were included. Subjects were excluded if no prenatal ultrasound was available. A femursparing profile of growth restriction determined using INTERGROWTH-21st sonographic standard for head circumference to femur length (HC: FL). Congenital injuries were determined postnatally by imaging, comprehensive eye exam and standard newborn hearing screen. A total of 111 pregnant women diagnosed with ZIKV infection underwent fetal ultrasound and 95 neonates had complete postnatal evaluation. Prenatal microcephaly was detected in 5% of fetuses (6/111). Postnatal testing detected ZIKV-associated congenital injuries in 25% of neonates (24/95). A HC: FL Z-score <=-1.3 had a 52% specificity (95% CI 41-63%), 82% negative predictive value (NPV, 95% CI 73-88%) for the detection of ZIKV-associated congenital injuries in the neonatal period. A more stringent threshold with a Z-score <=-2 was associated with a 90% specificity (95% CI 81-95%), 81% NPV (95% CI 77-85%). Excluding cases of fetal microcephaly, HC: FL (Z-score <=-2) demonstrated a similar specificity (89%, 95% CI 81-95%) with superior NPV (87%, 95% CI 84-90%). The sono-graphic recognition of a normally proportioned fetus may be useful prenatally to exclude a wider spectrum of ZIKV-associated congenital injuries detected postnatally.
C1 [Walker, Christie L.; Oler, Elizabeth] Univ Washington, Dept Obstet & Gynecol, Div Maternal Fetal Med, Seattle, WA 98195 USA.
   [Ehinger, Noah; Mason, Brittney; Curry, Christine] Univ Miami Hlth Syst, Dept Obstet & Gynecol, Miami, FL USA.
   [Little, Marie-Terese E.] 4th Dimens Biomed Res Commun, Victoria, BC, Canada.
   [Ohuma, Eric O.] Univ Oxford, Ctr Trop Med & Global Hlth, Nuffield Dept Med, Oxford, England.
   [Ohuma, Eric O.] Univ Oxford, Ctr Stat Med, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford, England.
   [Papageorghiou, Aris T.] Univ Oxford, Green Templeton Coll, Nuffield Dept Obstet & Gynaecol, Oxford, England.
   [Papageorghiou, Aris T.] Univ Oxford, Green Templeton Coll, Oxford Maternal & Perinatal Hlth Inst, Oxford, England.
   [Nayeri, Unzila] Univ Miami Hlth Syst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Miami, FL USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.
   [Waldorf, Kristina M. Adams] Gothenburg Univ, Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.
RP Curry, C (corresponding author), Univ Miami Hlth Syst, Dept Obstet & Gynecol, Miami, FL USA.; Nayeri, U (corresponding author), Univ Miami Hlth Syst, Dept Obstet & Gynecol, Div Maternal Fetal Med, Miami, FL USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.; Waldorf, KMA (corresponding author), Gothenburg Univ, Univ Gothenburg, Sahlgrenska Acad, Gothenburg, Sweden.
EM unzilanayeri@gmail.com; clcurry@gmail.com; adamsk@uw.edu
RI Adams Waldorf, Kristina/F-2608-2013
OI Adams Waldorf, Kristina/0000-0002-6939-7224
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD); National
   Institute of Allergy and Infectious DiseasesUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID); National
   Center for Research Resources of the National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Center for Research Resources (NCRR)
   [AI143265, AI144938]
FX This work was supported by the Eunice Kennedy Shriver National Institute
   of Child Health and Human Development, the National Institute of Allergy
   and Infectious Diseases and the National Center for Research Resources
   of the National Institutes of Health [grant numbers AI143265 (K.A. W)
   and AI144938 (K.A.W.). The content is solely the responsibility of the
   authors and does not necessarily represent the official views of the
   National Institutes of Health or other funders. The funders had no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Adams Waldorf KM, 2018, TRENDS MICROBIOL
   Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   [Anonymous], 2017, INTERGROWTH 21 APPL
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cauchemez S, 2016, LANCET
   Centers for Disease Control and Prevention, 2017, GUID LAB TEST ZIK VI
   Chibueze EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01991-y
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   HADLOCK FP, 1991, RADIOLOGY, V181, P129, DOI 10.1148/radiology.181.1.1887021
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Louis GMB, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.08.032
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Mulkey SB, 2018, JAMA PEDIAT
   Papageorghiou AT, 2014, LANCET, V384, P869, DOI 10.1016/S0140-6736(14)61490-2
   Pereira JP, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.6529
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Sanz Cortes M, 2018, AM J OBSTET GYNECOLO
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979
   Soc Maternal-Fetal Med SMFM Public, 2016, AM J OBSTET GYNECOL, V214, pB2, DOI 10.1016/j.ajog.2016.02.043
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   2002, INT J GYNECOL OBSTET, V76, P95
NR 33
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAY 13
PY 2020
VL 15
IS 5
AR e0233023
DI 10.1371/journal.pone.0233023
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LU0VG
UT WOS:000537481000048
PM 32401826
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jorge, MR
   Crispim, BD
   Merey, FM
   Barufatti, A
   Cabrini, I
   Dantas, FGD
   de Oliveira, KMP
   Kummrow, F
   Beatriz, A
   Santos, T
   Dias, C
   Ventura, J
   Nogueira, CR
   Gomes, RD
   de Arruda, EJ
AF Jorge, Marcia Ramos
   Crispim, Bruno do Amaral
   Merey, Felipe Mendes
   Barufatti, Alexeia
   Cabrini, Isaias
   da Silva Dantas, Fabiana Gomes
   Pires de Oliveira, Kelly Mari
   Kummrow, Fabio
   Beatriz, Adilson
   Santos, Tiago
   Dias, Catarina
   Ventura, Joao
   Nogueira, Claudio Rodrigo
   Gomes, Roberto da Silva
   de Arruda, Eduardo Jose
TI Sulphonates' mixtures and emulsions obtained from technical cashew nut
   shell liquid and cardanol for control of Aedes aegypti (Diptera:
   Culicidae)
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article; Early Access
DE Vector control; Larvicidal activity; Industrial by-products; Surfactant;
   Sustainability; Green chemistry
ID ANACARDIUM-OCCIDENTALE; LARVICIDAL ACTIVITY; MOSQUITO; DENGUE; CNSL;
   SURFACTANT; CHALLENGES; CHEMISTRY; TOXICITY; POLYMERS
AB Aedes aegypti is the main mosquito vector of dengue, zika, chikungunya, and yellow fever diseases. The low effectiveness of vector control options is mainly related to the increased insect's resistance and to the toxicity of products used for non-target organisms. The development of new environmentally friendly and safer products is imperative. Technical cashew nut shell liquid (tCNSL), mostly composed by cardanol (C), is an abundant by-product of the cashew (Anacardium occidentale L.) production chain, available at low cost, and with proven larvicidal activity. However, chemical modifications in both tCNSL and cardanol were required to increase their water solubilities. Our objectives were to synthesise and characterise sustainable, low-cost and easy-to-use multiple function products based on tCNSL, cardanol, and the sulphonates obtained from both; and to evaluate all these products efficacy as surfactants, larvicidal, and antimicrobial agents. None of the sulphonates presented antimicrobial and larvicidal activities. tCNSL and cardanol were successfully emulsified with sodium technical cashew nut shell liquid sulphonate (NatCNSLS, complex mixture of surfactants). The emulsions obtained presented larvicidal activity due to the presence of tCNSL and cardanol in their composition. Our results showed that the tCNSL+NatCNSLS mixture emulsion was an effective larvicide and surfactant multiple function product, with high availability and easy-to-use, which can facilitate its large-scale use in different environments.
C1 [Jorge, Marcia Ramos; Crispim, Bruno do Amaral; Merey, Felipe Mendes; Barufatti, Alexeia; Cabrini, Isaias; da Silva Dantas, Fabiana Gomes; Pires de Oliveira, Kelly Mari; Nogueira, Claudio Rodrigo; de Arruda, Eduardo Jose] Fundacao Univ Fed Grande Dourados, Rodovia Dourados Itahum,Km 12 Unidade 2,Cidade, Dourados 79804970, MS, Brazil.
   [Kummrow, Fabio] Univ Fed Sao Paulo, Inst Ciencias Ambientais Quim & Farmaceut, Campus Diadema,Rua Sao Nicolau,210 Ctr, Diadema 09913030, SP, Brazil.
   [Beatriz, Adilson] Univ Fed Mato Grosso do Sul, Inst Quim, Ave Senador Filinto Muller,1555 Cidade Univ, Campo Grande 79074460, MS, Brazil.
   [Santos, Tiago] Univ Porto, Inst Nacl Engn Biomed, Inst Invest & Inovacao Saude, Rua Alfredo Allen 208, Porto 4200135, Portugal.
   [Dias, Catarina; Ventura, Joao] Univ Porto, Inst Fis Mat Avancados Nanotecnol & Foton, Rua Campo Alegre 687, Porto 4169007, Portugal.
   [Gomes, Roberto da Silva] North Dakota State Univ, Sch Pharm, 1401 Albrecht Blvd, Fargo, ND 58102 USA.
   [de Arruda, Eduardo Jose] Fundacao Univ Fed Grande Dourados, Fac Ciencias Exatas & Tecnol, Rodovia Dourados Itahum,Km 12 Unidade 2 Caixa, Dourados 79804970, MS, Brazil.
RP de Arruda, EJ (corresponding author), Fundacao Univ Fed Grande Dourados, Rodovia Dourados Itahum,Km 12 Unidade 2,Cidade, Dourados 79804970, MS, Brazil.; de Arruda, EJ (corresponding author), Fundacao Univ Fed Grande Dourados, Fac Ciencias Exatas & Tecnol, Rodovia Dourados Itahum,Km 12 Unidade 2 Caixa, Dourados 79804970, MS, Brazil.
EM ejarruda@gmail.com
RI Barufatti, Alexeia/AAQ-9563-2020
OI Barufatti, Alexeia/0000-0001-8789-2117
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq); Fundacao de Apoio ao Desenvolvimento do Ensino, Ciencia e
   Tecnologia do Estado do Mato Grosso do Sul (FUNDECT)Fundect; Coordenacao
   de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)CAPES; Fundacao
   para a Ciencia e TecnologiaPortuguese Foundation for Science and
   Technology [SFRH/BD/101661/2014]; FCTPortuguese Foundation for Science
   and Technology [SFRH/BD/101661/2014];  [PTDC/EMD-EMD/31540/2017]; 
   [POCI-01-0145-FEDER-031540]
FX The authors would like to thank Universidade Federal da Grande Dourados
   (UFGD, Brazil), Universidade Federal de Mato Grosso do Sul (UFMS,
   Brazil), Universidade Estadual de Campinas (UNICAMP, Brazil),
   Universidade Federal do Amazonas (UFAM, Brazil), Instituto de Fisica de
   Materiais Avancados, Nanotecnologia e Fotonica, Universidade do Porto
   (IFIMUP, Portugal), Instituto de Investigacao e Inovacao em
   Saude/Instituto Nacional de Engenharia Biomedica (i3S/INEB) da
   Universidade do Porto (Portugal) for logistical support, and Conselho
   Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao de
   Apoio ao Desenvolvimento do Ensino, Ciencia e Tecnologia do Estado do
   Mato Grosso do Sul (FUNDECT), Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior (CAPES) and Fundacao para a Ciencia e Tecnologia
   [SFRH/BD/101661/2014] for financial support. This work was also
   partially supported by PTDC/EMD-EMD/31540/2017
   (POCI-01-0145-FEDER-031540). C Dias is thankful to FCT for grant
   SFRH/BD/101661/2014.
CR [Anonymous], 2016, CHROMATOGRAPHY
   [Anonymous], 2015, M07A10 CLIN LAB STAN
   Baer C, 2010, J CHEM EDUC, V87, P724, DOI 10.1021/ed100284z
   Balachandran VS, 2013, CHEM SOC REV, V42, P427, DOI 10.1039/c2cs35344j
   Beatriz A, 2016, BR Pat, Patent No. [102014030002-3 A2, 102014030002]
   Ben-Othman S, 2020, MOLECULES, V25, DOI 10.3390/molecules25030510
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Bueno SM, 2010, QUIM NOVA, V33, P1572, DOI 10.1590/S0100-40422010000700026
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Chen J, 2015, RSC ADV, V5, P56171, DOI 10.1039/c5ra07096a
   CLSI Methods for Determining Bactericidal Activity of Antimicrobial Agents, 1999, M26A CLIN LAB STAND
   Oliveira MSC, 2011, ACTA TROP, V117, P165, DOI 10.1016/j.actatropica.2010.08.003
   Daltin D., 2011, TENSOATIVOS QUIMICA
   David MR, 2016, MEM I OSWALDO CRUZ, V111, P577, DOI 10.1590/0074-02760160238
   de Arruda EJ, 2011, BRAZ ARCH BIOL TECHN, V54, P503, DOI 10.1590/S1516-89132011000300010
   De Matteis V, 2018, ADV EXP MED BIOL, V1048, P1, DOI 10.1007/978-3-319-72041-8_1
   dos Santos ML, 1999, J BRAZIL CHEM SOC, V10, P13, DOI 10.1590/S0103-50531999000100003
   Bardach AE, 2019, TROP MED INT HEALTH, V24, P530, DOI 10.1111/tmi.13217
   de Carvalho GHF, 2019, ENVIRON SCI POLLUT R, V26, P5514, DOI 10.1007/s11356-018-3905-y
   Ferreira SG, 2015, J COLLOID INTERF SCI, V456, P190, DOI 10.1016/j.jcis.2015.06.012
   Finney DJ, 2009, PROBIT ANAL STAT TRE
   Fontana A, 2015, ORG BIOMOL CHEM, V13, P9214, DOI 10.1039/c5ob01059d
   Marcelino PRF, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187125
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Gaumet M, 2008, EUR J PHARM BIOPHARM, V69, P1, DOI 10.1016/j.ejpb.2007.08.001
   Guissoni A.C.P., 2013, Rev. bras. plantas med., V15, P363, DOI 10.1590/S1516-05722013000300008
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Kala S, 2019, S AFR J BOT, V127, P293, DOI 10.1016/j.sajb.2019.10.006
   Kale S. N., 2016, SYSTEMATIC REV PHARM, V8, P39, DOI DOI 10.5530/SRP.2017.1.8
   Kanehashi S, 2015, J APPL POLYM SCI, V132, DOI 10.1002/app.42725
   Komalamisra Narumon, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P1412
   KUBO I, 1993, J AGR FOOD CHEM, V41, P1016, DOI 10.1021/jf00030a036
   Kumar G, 2016, J VECTOR DIS, V53, P144
   Kumar PP, 2002, J AGR FOOD CHEM, V50, P4705, DOI 10.1021/jf020224w
   Lenardao EJ, 2003, QUIM NOVA, V26, P123, DOI 10.1590/S0100-40422003000100020
   Lima C. A. de A., 2000, Ciencia e Tecnologia de Alimentos, V20, P358, DOI 10.1590/S0101-20612000000300013
   Lomonaco D, 2009, GREEN CHEM, V11, P31, DOI 10.1039/b811504d
   Lopez O, 2005, GREEN CHEM, V7, P431, DOI 10.1039/b500733j
   Lubi MC, 2000, DES MONOMERS POLYM, V3, P123, DOI 10.1163/156855500300142834
   Marsalek R, 2009, ENERG SOURCE PART A, V31, P66, DOI 10.1080/15567030701468142
   Mazzetto SE, 2009, QUIM NOVA, V32, P732, DOI 10.1590/S0100-40422009000300017
   Mgaya J, 2019, GREEN CHEM, V21, P1186, DOI 10.1039/c8gc02972e
   Mora-Huertas CE, 2010, INT J PHARMACEUT, V385, P113, DOI 10.1016/j.ijpharm.2009.10.018
   Morais SM, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10010031
   Mukhopadhyay AK, 2010, J VECTOR DIS, V47, P257
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Njuku FW, 2014, CHEM MATER, V6, P50
   Paiva DR, 2017, AN ACAD BRAS CIENC, V89, P373, DOI 10.1590/0001-3765201720160615
   Panghal M, 2011, ANN CLIN MICROB ANTI, V10, DOI 10.1186/1476-0711-10-21
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Peungjitton P, 2009, J SURFACTANTS DETERG, V12, P85, DOI 10.1007/s11743-008-1082-6
   Phulkerd P, 2014, FUEL PROCESS TECHNOL, V119, P256, DOI 10.1016/j.fuproc.2013.11.013
   R Core Team, 2019, R LANG ENV STAT COMP
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rodrigues FHA, 2011, POLIMEROS, V21, P156, DOI 10.1590/S0104-14282011005000028
   Scorzza C, 2010, J SURFACTANTS DETERG, V13, P27, DOI 10.1007/s11743-009-1143-5
   Sharma S, 2010, INT J APPL CHEM, V6, P279
   Shi W., 2014, OPEN J APPL SCI, V4, P360, DOI DOI 10.4236/OJAPPS.2014.46033
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Swamy parasa Lakshmana, 2011, INT J PHARM PHARM SC, V3, P436
   Takaishi K, 2004, BIOSCI BIOTECH BIOCH, V68, P2398, DOI 10.1271/bbb.68.2398
   Thirukumaran P, 2016, POLYM COMPOSITE, V37, P1821, DOI 10.1002/pc.23356
   Vani JM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193509
   Voirin C, 2014, POLYM CHEM-UK, V5, P3142, DOI 10.1039/c3py01194a
   Wang JQ, 2015, ACS NANO, V9, P7195, DOI 10.1021/acsnano.5b02017
   Wang J, 2011, ADV MATER RES-SWITZ, V183-185, P1534, DOI 10.4028/www.scientific.net/AMR.183-185.1534
   WHO-World Health Organization, 1992, VECT RES PEST 15 REP
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wu P, 2019, CELL HOST MICROBE, V25, P101, DOI 10.1016/j.chom.2018.11.004
NR 74
TC 0
Z9 0
U1 4
U2 4
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
DI 10.1007/s11356-020-08998-5
EA MAY 2020
PG 15
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA LN0NV
UT WOS:000532643300001
PM 32405938
DA 2020-07-08
ER

PT J
AU Khalil, A
   Sotiriadis, A
   Chaoui, R
   Costa, FD
   D'Antonio, F
   Heath, PT
   Jones, C
   Malinger, G
   Odibo, A
   Prefumo, F
   Salomon, LJ
   Wood, S
   Ville, Y
AF Khalil, A.
   Sotiriadis, A.
   Chaoui, R.
   Costa, F. da Silva
   D'Antonio, F.
   Heath, P. T.
   Jones, C.
   Malinger, G.
   Odibo, A.
   Prefumo, F.
   Salomon, L. J.
   Wood, S.
   Ville, Y.
CA Clinical Stand Comm
TI ISUOG Practice Guidelines: role of ultrasound in congenital infection
SO ULTRASOUND IN OBSTETRICS & GYNECOLOGY
LA English
DT Article; Early Access
ID PARVOVIRUS B19 INFECTION; POLYMERASE-CHAIN-REACTION; ZIKA
   VIRUS-INFECTION; PRIMARY CYTOMEGALOVIRUS-INFECTION; PEAK SYSTOLIC
   VELOCITY; PRIMARY TOXOPLASMA INFECTION; TIME PCR QUANTIFICATION;
   PRENATAL-DIAGNOSIS; AMNIOTIC-FLUID; DOPPLER ULTRASONOGRAPHY
C1 [Khalil, A.] Univ London, St Georges Univ Hosp NHS Fdn Trust, Fetal Med Unit, London, England.
   [Khalil, A.] St Georges Univ London, Mol & Clin Sci Res Inst, Vasc Biol Res Ctr, London, England.
   [Sotiriadis, A.] Aristotle Univ Thessaloniki, Fac Med, Dept Obstet & Gynecol 2, Thessaloniki, Greece.
   [Chaoui, R.] Ctr Prenatal Diag & Human Genet, Berlin, Germany.
   [Costa, F. da Silva] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Gynecol & Obstet, Ribeirao Preto, SP, Brazil.
   [Costa, F. da Silva] Monash Univ, Dept Obstet & Gynaecol, Melbourne, Vic, Australia.
   [D'Antonio, F.] UiT Arctic Univ Norway, Fac Hlth Sci, Dept Clin Med, Womens Hlth & Perinatol Res Grp, Tromso, Norway.
   [D'Antonio, F.] Univ Hosp Northern Norway, Dept Obstet & Gynecol, Tromso, Norway.
   [Heath, P. T.] St Georges Univ London, Paediat Infect Dis Res Grp, London, England.
   [Heath, P. T.] St Georges Univ London, Vaccine Inst, London, England.
   [Heath, P. T.] St Georges Univ Hosp NHS Trust, London, England.
   [Jones, C.] Univ Southampton, Fac Med, Southampton, Hants, England.
   [Jones, C.] Univ Southampton, Inst Life Sci, Southampton, Hants, England.
   [Jones, C.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.
   [Malinger, G.] Tel Aviv Univ, Lis Matern Hosp, Tel Aviv Sourasky Med Ctr, Sackler Sch Med,Ultrasound Unit, Tel Aviv, Israel.
   [Odibo, A.] Univ S Florida, Dept Obstet & Gynecol, Morsani Coll Med, Tampa, FL 33620 USA.
   [Prefumo, F.] Univ Brescia, Dept Clin & Expt Sci, Div Obstet & Gynecol, Brescia, Italy.
   [Salomon, L. J.; Ville, Y.] Paris Descartes Univ, Hop Necker Enfants Malad, AP HP, Dept Obstet & Fetal Med, Paris, France.
   [Wood, S.] CMV Act, London, England.
RP Khalil, A (corresponding author), Univ London, St Georges Univ Hosp NHS Fdn Trust, Fetal Med Unit, London, England.; Khalil, A (corresponding author), St Georges Univ London, Mol & Clin Sci Res Inst, Vasc Biol Res Ctr, London, England.
CR Adler S, 2010, INFECT DIS FETUS NEW, P845
   American College of Obstetricians and Gynecologists, 2015, Obstet Gynecol, V125, P1510, DOI 10.1097/01.AOG.0000466430.19823.53
   Arav-Boger R, 2015, INFECT DIS CLIN N AM, V29, P401, DOI 10.1016/j.idc.2015.05.009
   Bale JF, 2000, J INFECT DIS, V182, P933, DOI 10.1086/315770
   BALFOUR HH, 1992, J PEDIATR-US, V120, P627, DOI 10.1016/S0022-3476(05)82495-3
   Bascietto F, 2018, ULTRASOUND OBST GYN, V52, P569, DOI 10.1002/uog.19092
   Benoist G, 2009, FETAL MED BASIC SCI
   Benoist G, 2013, FETAL DIAGN THER, V33, P203, DOI 10.1159/000342752
   Bizjak G, 2009, ULTRASOUND OBST GYN, V34, P234, DOI 10.1002/uog.6454
   Bodeus M, 1999, OBSTET GYNECOL, V93, P658, DOI 10.1016/S0029-7844(98)00538-9
   Boppana SB, 1997, PEDIATRICS, V99, P409, DOI 10.1542/peds.99.3.409
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   Bottiger B, 1997, CLIN DIAGN VIROL, V8, P105, DOI 10.1016/S0928-0197(97)00018-4
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Bredl S, 2011, J CLIN VIROL, V51, P115, DOI 10.1016/j.jcv.2011.03.012
   Brennand JE, 2000, HOSP MED, V61, P93, DOI 10.12968/hosp.2000.61.2.1288
   BROWN KE, 1995, BLOOD REV, V9, P176, DOI 10.1016/0268-960X(95)90023-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cannie MM, 2016, EUR RADIOL, V26, P3760, DOI 10.1007/s00330-015-4187-0
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, TOX
   Centers for Disease Control and Prevention, ZIK TRAV INF
   Chauvet A, 2011, FETAL DIAGN THER, V30, P41, DOI 10.1159/000323821
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   COHEN B, 1995, BMJ-BRIT MED J, V311, P1549, DOI 10.1136/bmj.311.7019.1549
   Cosmi E, 2002, AM J OBSTET GYNECOL, V187, P1290, DOI 10.1067/mob.2002.128024
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DAFFOS F, 1988, NEW ENGL J MED, V318, P271, DOI 10.1056/NEJM198802043180502
   Daiminger A, 2005, BJOG-INT J OBSTET GY, V112, P166, DOI 10.1111/j.1471-0528.2004.00328.x
   De Carolis S, 2018, LUPUS, V27, P841, DOI 10.1177/0961203317741564
   de Haan TR, 2008, BJOG-INT J OBSTET GY, V115, P76, DOI 10.1111/j.1471-0528.2007.01555.x
   de Jong EP, 2011, PRENATAL DIAG, V31, P419, DOI 10.1002/pd.2714
   de Laval F, 2016, LANCET, V388, P868, DOI 10.1016/S0140-6736(16)31429-5
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   De Vries LS, 2004, NEUROPEDIATRICS, V35, P113, DOI 10.1055/s-2004-815833
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Delle Chiaie L, 2001, ULTRASOUND OBST GYN, V18, P232, DOI 10.1046/j.0960-7692.2001.00540.x
   DESMONTS G, 1984, ANN PEDIATR-PARIS, V31, P805
   DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003
   Desveaux C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005395
   Dhombres F, 2017, FETAL DIAGN THER, V41, P8, DOI 10.1159/000445113
   Dieck D, 1999, PRENATAL DIAG, V19, P1119, DOI 10.1002/(SICI)1097-0223(199912)19:12<1119::AID-PD716>3.0.CO;2-X
   Dijkmans AC, 2012, CURR OPIN OBSTET GYN, V24, P95, DOI 10.1097/GCO.0b013e3283505a9d
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   DUNKLE LM, 1991, NEW ENGL J MED, V325, P1539, DOI 10.1056/NEJM199111283252203
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   Elmore SA, 2010, TRENDS PARASITOL, V26, P190, DOI 10.1016/j.pt.2010.01.009
   Enders G, 2001, PRENATAL DIAG, V21, P362, DOI 10.1002/pd.59
   ENDERS G, 1989, INFECTION, V17, P218, DOI 10.1007/BF01639523
   ENDERS G, 1994, LANCET, V343, P1548, DOI 10.1016/S0140-6736(94)92943-2
   ENDERS G, 1988, LANCET, V1, P1445
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Enders M, 2017, PRENATAL DIAG, V37, P389, DOI 10.1002/pd.5025
   Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940
   Fabbri E, 2011, BJOG-INT J OBSTET GY, V118, P448, DOI 10.1111/j.1471-0528.2010.02822.x
   FAIRLEY CK, 1995, LANCET, V346, P1335, DOI 10.1016/S0140-6736(95)92346-2
   Farkas N, 2011, PRENATAL DIAG, V31, P360, DOI 10.1002/pd.2694
   Faure-Bardon V, 2019, CLIN INFECT DIS, V69, P1526, DOI 10.1093/cid/ciy1128
   Foulon W, 1999, AM J OBSTET GYNECOL, V181, P843, DOI 10.1016/S0002-9378(99)70311-X
   FOWLER KB, 1993, J INFECT DIS, V168, P552, DOI 10.1093/infdis/168.3.552
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Garcia Aparecida Gomes Pinto, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P145, DOI 10.1590/S0036-46651998000300003
   Ghi T, 2016, ULTRASOUND OBST GYN, V48, P26, DOI [10.1002/uog.15969, 10.1002/uog.15945]
   Gindes L, 2008, BJOG-INT J OBSTET GY, V115, P830, DOI 10.1111/j.1471-0528.2007.01651.x
   Goegebuer T, 2009, J CLIN MICROBIOL, V47, P660, DOI 10.1128/JCM.01576-08
   Gouarin S, 2002, J CLIN MICROBIOL, V40, P1767, DOI 10.1128/JCM.40.5.1767-1772.2002
   GrangeotKeros L, 1997, J INFECT DIS, V175, P944, DOI 10.1086/513996
   Grant GB, 2017, MMWR-MORBID MORTAL W, V66, P1256, DOI 10.15585/mmwr.mm6645a4
   GRATACOS E, 1995, J INFECT DIS, V171, P1360, DOI 10.1093/infdis/171.5.1360
   GRILLNER L, 1983, SCAND J INFECT DIS, V15, P321, DOI 10.3109/inf.1983.15.issue-4.01
   Guerra B, 2007, AM J OBSTET GYNECOL, V196, P221, DOI 10.1016/j.ajog.2006.08.039
   Guerra B, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.052
   Hadar E, 2010, PRENATAL DIAG, V30, P1213, DOI 10.1002/pd.2654
   HALL CB, 1993, PEDIATRICS, V91, P674
   Halsby K, 2014, EPIDEMIOL INFECT, V142, P1653, DOI 10.1017/S095026881300246X
   Hanif F, 2007, AM J PERINAT, V24, P501, DOI 10.1055/s-2007-986683
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   HEDMAN K, 1989, J INFECT DIS, V159, P736, DOI 10.1093/infdis/159.4.736
   Hofmeyr GJ, 1996, PRENATAL DIAG, V16, P1148, DOI 10.1002/(SICI)1097-0223(199612)16:12<1148::AID-PD7>3.0.CO;2-J
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Isaac BM, 2017, CLIN VACCINE IMMUNOL, V24, DOI [10.1128/CVI.00102-17, 10.1128/cvi.00102-17]
   Jacquemard F, 2007, BJOG-INT J OBSTET GY, V114, P1113, DOI 10.1111/j.1471-0528.2007.01308.x
   Jordan JA, 1999, PLACENTA, V20, P103, DOI 10.1053/plac.1998.0353
   JOYNSON DHM, 1992, SCAND J INFECT DIS, P65
   Kagan KO, 2019, ULTRASOUND OBST GYN, V53, P383, DOI 10.1002/uog.19164
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kesson AM, 1996, J PAEDIATR CHILD H, V32, P211, DOI 10.1111/j.1440-1754.1996.tb01556.x
   KHALIL A, 2018, BJOG, V125, pE1, DOI [10.1111/1471-0528.14836, DOI 10.1111/1471-0528.1483629139205]
   Khorrami SMS, 2015, J MED VIROL, V87, P1846, DOI 10.1002/jmv.24250
   Kimberlin DW, 2007, SEMIN PERINATOL, V31, P19, DOI 10.1053/j.semperi.2007.01.003
   Korndewal MJ, 2017, DEV MED CHILD NEUROL, V59, P1261, DOI 10.1111/dmcn.13556
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   KURTZ AB, 1980, J CLIN ULTRASOUND, V8, P11, DOI 10.1002/jcu.1870080104
   La Torre R, 2006, CLIN INFECT DIS, V43, P994, DOI 10.1086/507634
   Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P175, DOI 10.1111/j.1471-0528.2010.02749.x
   Lanari M, 2006, PEDIATRICS, V117, pE76, DOI 10.1542/peds.2005-0629
   Landry ML, 2017, ARCH PATHOL LAB MED, V141, P60, DOI 10.5858/arpa.2016-0406-SA
   LAPPALAINEN M, 1995, PEDIATR INFECT DIS J, V14, P354, DOI 10.1097/00006454-199505000-00004
   LAPPALAINEN M, 1993, J INFECT DIS, V167, P691, DOI 10.1093/infdis/167.3.691
   Lazzarotto T, 2011, CLIN MICROBIOL INFEC, V17, P1285, DOI 10.1111/j.1469-0691.2011.03564.x
   LECURU F, 1994, EUR J OBSTET GYN R B, V56, P67, DOI 10.1016/0028-2243(94)90156-2
   Lefevre-Pettazzoni M, 2007, CLIN VACCINE IMMUNOL, V14, P239, DOI 10.1128/CVI.00311-06
   Leruez-Ville M, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.03.052
   Levy R, 1997, Obstet Gynecol Surv, V52, P254, DOI 10.1097/00006254-199704000-00023
   Liesenfeld O, 1997, J CLIN MICROBIOL, V35, P174, DOI 10.1128/JCM.35.1.174-178.1997
   Liesnard C, 2000, OBSTET GYNECOL, V95, P881, DOI 10.1016/S0029-7844(99)00657-2
   Lipitz S, 2013, ULTRASOUND OBST GYN, V41, P508, DOI 10.1002/uog.12377
   Lipitz S, 2010, ULTRASOUND OBST GYN, V36, P709, DOI 10.1002/uog.7657
   Mace G, 2014, PRENATAL DIAG, V34, P1023, DOI 10.1002/pd.4413
   Maldonado YA, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-3860
   Malinger G, 2011, PRENATAL DIAG, V31, P881, DOI 10.1002/pd.2795
   Malinger G, 2003, AM J NEURORADIOL, V24, P28
   Malinger G, 2011, FETAL DIAGN THER, V29, P117, DOI 10.1159/000321346
   Mandelbrot L, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.05.031
   Mari G, 2005, J ULTRAS MED, V24, P425, DOI 10.7863/jum.2005.24.4.425
   Mari G, 2000, NEW ENGL J MED, V342, P9, DOI 10.1056/NEJM200001063420102
   Markenson GR, 1998, SEMIN PERINATOL, V22, P309, DOI 10.1016/S0146-0005(98)80019-0
   Martinez-Portilla R J, 2019, Ultrasound Obstet Gynecol, V54, P722, DOI 10.1002/uog.20273
   Mattson SN, 2003, PEDIATR INFECT DIS J, V22, P819, DOI 10.1097/01.inf.0000086402.18710.54
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meroni V, 2009, CLIN VACCINE IMMUNOL, V16, P1517, DOI 10.1128/CVI.00253-09
   METZMAN R, 1989, J PEDIATR GASTR NUTR, V9, P112
   Meyberg-Solomayer GC, 2006, FETAL DIAGN THER, V21, P296, DOI 10.1159/000091360
   MILLER E, 1989, LANCET, V2, P371
   MILLER E, 1982, LANCET, V2, P781
   Montoya JG, 2002, J INFECT DIS, V185, pS73, DOI 10.1086/338827
   Montoya JG, 2008, CLIN INFECT DIS, V47, P554, DOI 10.1086/590149
   Morgan-Capner P, 2002, Commun Dis Public Health, V5, P59
   Morgan-Capner P, 1991, CDR (Lond Engl Rev), V1, pR57
   Mossong J, 2008, EPIDEMIOL INFECT, V136, P1059, DOI 10.1017/S0950268807009661
   Mouly F, 1997, AM J OBSTET GYNECOL, V177, P894, DOI 10.1016/S0002-9378(97)70291-6
   Nagel HTC, 2007, OBSTET GYNECOL, V109, P42, DOI 10.1097/01.AOG.0000249611.67873.94
   National Institute for Health Care Excellence, 2008, ANT CAR UNC PREGN CL
   Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337
   Nigro G, 2002, PRENATAL DIAG, V22, P558, DOI 10.1002/pd.366
   Odibo AO, 1998, J ULTRAS MED, V17, P547
   Oepkes D, 2006, NEW ENGL J MED, V355, P156, DOI 10.1056/NEJMoa052855
   Papageorghiou AT, 2016, ULTRASOUND OBST GYN, V47, P530, DOI 10.1002/uog.15896
   Paquet C, 2018, J OBSTET GYNAECOL CA, V40, pE687, DOI 10.1016/j.jogc.2018.05.036
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pasternak B, 2010, JAMA-J AM MED ASSOC, V304, P859, DOI 10.1001/jama.2010.1206
   PASTUSZAK AL, 1994, NEW ENGL J MED, V330, P901, DOI 10.1056/NEJM199403313301305
   Pelloux H, 1998, DIAGN MICR INFEC DIS, V32, P69, DOI 10.1016/S0732-8893(98)00077-7
   Petersen E, 2005, J CLIN MICROBIOL, V43, P1570, DOI 10.1128/JCM.43.4.1570-1574.2005
   Petersson K, 2004, J PERINAT MED, V32, P516, DOI 10.1515/JPM.2004.128
   Picone O, 2004, PRENATAL DIAG, V24, P1001, DOI 10.1002/pd.942
   Picone O, 2013, PRENATAL DIAG, V33, P751, DOI 10.1002/pd.4118
   Picone O, 2007, J INFECT DIS, V196, P1719, DOI 10.1086/522340
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   PORTER HJ, 1988, LANCET, V1, P535
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   PRETORIUS DH, 1992, J ULTRAS MED, V11, P459
   Public Health Englan, 2019, ZIK VIR CONG INF GUI
   Public Health England, GUID INV DIAGN MAN V
   Public Health England, 2016, ZIK VIR CONG INF INT
   Puccetti C, 2012, PRENATAL DIAG, V32, P897, DOI 10.1002/pd.3930
   RCOG RCM PHE HPS, 2019, ZIK VIR INF PREGN IN
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   Revello MG, 2006, J INFECT DIS, V193, P783, DOI 10.1086/500509
   Revello MG, 1999, J CLIN VIROL, V14, P57, DOI 10.1016/S1386-6532(99)00016-5
   Revello MG, 2002, CLIN MICROBIOL REV, V15, P680, DOI 10.1128/CMR.15.4.680-715.2002
   Rivera LB, 2002, PEDIATRICS, V110, P762, DOI 10.1542/peds.110.4.762
   Robert-Gangneux F, 2012, CLIN MICROBIOL REV, V25, P264, DOI 10.1128/CMR.05013-11
   Rodis JE, 1998, AM J OBSTET GYNECOL, V179, P985, DOI 10.1016/S0002-9378(98)70203-0
   Romand S, 2004, AM J OBSTET GYNECOL, V190, P797, DOI 10.1016/j.ajog.2003.09.039
   Romand S, 2001, OBSTET GYNECOL, V97, P296, DOI 10.1016/S0029-7844(00)01118-2
   Sabella C, 1999, AM FAM PHYSICIAN, V60, P1455
   Sagel U, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-348
   SAINTMARTIN J, 1990, J PEDIATR-US, V116, P1007, DOI 10.1016/S0022-3476(05)80677-8
   Sauerbrei A, 2000, J Perinatol, V20, P548, DOI 10.1038/sj.jp.7200457
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Simms RA, 2009, FETAL DIAGN THER, V25, P373, DOI 10.1159/000236149
   Skariah S, 2010, PARASITOL RES, V107, P253, DOI 10.1007/s00436-010-1899-6
   Skjoldebrand-Sparre L, 1999, AM J OBSTET GYNECOL, V180, P1595, DOI 10.1016/S0002-9378(99)70059-1
   STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904
   STRAYPEDERSEN B, 1993, BAILLIERE CLIN OB GY, V7, P107, DOI 10.1016/S0950-3552(05)80149-X
   Tang JW, 2003, PRENATAL DIAG, V23, P509, DOI 10.1002/pd.631
   Thiebaut R, 2007, LANCET, V369, P115
   Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018
   UK Standards for Microbiology Investigations, INV TOX INF PREGN
   US National Library of Medicine, RAND TRIAL PREV CONG
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Vauloup-Fellous C, 2007, CLIN VACCINE IMMUNOL, V14, P644, DOI 10.1128/CVI.00032-07
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   von Kaisenberg CS, 2001, FETAL DIAGN THER, V16, P427, DOI 10.1159/000053953
   Vyse AJ, 2007, EPIDEMIOL INFECT, V135, P1354, DOI 10.1017/S0950268807007856
   Walker SP, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-96
   WALLACE MR, 1992, ANN INTERN MED, V117, P358, DOI 10.7326/0003-4819-117-5-358
   Wallon M, 2014, PEDIATRICS, V133, pE601, DOI 10.1542/peds.2013-2153
   Wallon M, 2010, OBSTET GYNECOL, V115, P727, DOI 10.1097/AOG.0b013e3181d57b09
   WHO, 2016, WHO VECT CONTR OP FR
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   WILSON CB, 1980, PEDIATRICS, V66, P767
   YOTO Y, 1994, LANCET, V344, P624, DOI 10.1016/S0140-6736(94)92014-1
   YOUNG N, 1988, SEMIN HEMATOL, V25, P159
NR 202
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0960-7692
EI 1469-0705
J9 ULTRASOUND OBST GYN
JI Ultrasound Obstet. Gynecol.
DI 10.1002/uog.21991
EA MAY 2020
PG 24
WC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
SC Acoustics; Obstetrics & Gynecology; Radiology, Nuclear Medicine &
   Medical Imaging
GA LL8WG
UT WOS:000531834100001
PM 32400006
OA Bronze
DA 2020-07-08
ER

PT J
AU Sanchez, CHM
   Bennett, JB
   Wu, SL
   Rasic, G
   Akbari, OS
   Marshall, JM
AF Sanchez, Hector M. C.
   Bennett, Jared B.
   Wu, Sean L.
   Rasic, Gordana
   Akbari, Omar S.
   Marshall, John M.
TI Modeling confinement and reversibility of threshold-dependent gene drive
   systems in spatially-explicit Aedes aegypti populations
SO BMC BIOLOGY
LA English
DT Article
DE Chromosomal translocations; Underdominance; Metapopulation; Population
   dynamics; Population replacement; Biosafety; Field trials
ID WOLBACHIA; DENGUE; TRANSLOCATIONS; DYNAMICS; UNDERDOMINANCE;
   TEMPERATURE; EFFICIENT; DIPTERA; SPREAD; WILD
AB BackgroundThe discovery of CRISPR-based gene editing and its application to homing-based gene drive systems has been greeted with excitement, for its potential to control mosquito-borne diseases on a wide scale, and concern, for the invasiveness and potential irreversibility of a release. Gene drive systems that display threshold-dependent behavior could potentially be used during the trial phase of this technology, or when localized control is otherwise desired, as simple models predict them to spread into partially isolated populations in a confineable manner, and to be reversible through releases of wild-type organisms. Here, we model hypothetical releases of two recently engineered threshold-dependent gene drive systems-reciprocal chromosomal translocations and a form of toxin-antidote-based underdominance known as UDMEL-to explore their ability to be confined and remediated.ResultsWe simulate releases of Aedes aegypti, the mosquito vector of dengue, Zika, and other arboviruses, in Yorkeys Knob, a suburb of Cairns, Australia, where previous biological control interventions have been undertaken on this species. We monitor spread to the neighboring suburb of Trinity Park to assess confinement. Results suggest that translocations could be introduced on a suburban scale, and remediated through releases of non-disease-transmitting male mosquitoes with release sizes on the scale of what has been previously implemented. UDMEL requires fewer releases to introduce, but more releases to remediate, including of females capable of disease transmission. Both systems are expected to be confineable to the release site; however, spillover of translocations into neighboring populations is less likely.ConclusionsOur analysis supports the use of translocations as a threshold-dependent drive system capable of spreading disease-refractory genes into Ae. aegypti populations in a confineable and reversible manner. It also highlights increased release requirements when incorporating life history and population structure into models. As the technology nears implementation, further ecological work will be essential to enhance model predictions in preparation for field trials.
C1 [Sanchez, Hector M. C.; Wu, Sean L.; Marshall, John M.] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.
   [Bennett, Jared B.] Univ Calif Berkeley, Biophys Grad Grp, Berkeley, CA 94720 USA.
   [Rasic, Gordana] QIMR Berghofer Med Res Inst, Mosquito Control Lab, Brisbane, Qld, Australia.
   [Akbari, Omar S.] Univ Calif San Diego, Div Biol Sci, Cell & Dev Biol Sect, San Diego, CA 92093 USA.
   [Marshall, John M.] Innovat Genom Inst, Berkeley, CA 94720 USA.
RP Marshall, JM (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.; Marshall, JM (corresponding author), Innovat Genom Inst, Berkeley, CA 94720 USA.
EM john.marshall@berkeley.edu
FU DARPA Safe Genes Program [HR001117-2-0047]; Innovative Genomics
   Institute
FX This work was supported by a DARPA Safe Genes Program Grant
   (HR001117-2-0047), awarded to OSA and JMM, and funds from the Innovative
   Genomics Institute, awarded to JMM.
CR Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932
   Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059
   Alphey L, 2002, INSECT BIOCHEM MOLEC, V32, P1243, DOI 10.1016/S0965-1748(02)00087-5
   Altrock PM, 2010, J THEOR BIOL, V267, P62, DOI 10.1016/j.jtbi.2010.08.004
   Buchman AB, 2018, ACS SYNTH BIOL, V7, P1359, DOI 10.1021/acssynbio.7b00451
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Champer J, 2019, POPULATION DYNAMICS, DOI [10.1101/449355, DOI 10.1101/449355]
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   CURTIS CF, 1971, GENETICS, V69, P97
   CURTIS CF, 1968, NATURE, V218, P368, DOI 10.1038/218368a0
   Davis S, 2001, J THEOR BIOL, V212, P83, DOI 10.1006/jtbi.2001.2357
   Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108
   Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096
   Edgington MP, 2019, J THEOR BIOL, V479, P14, DOI 10.1016/j.jtbi.2019.06.024
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   FAY RICHARD W., 1964, MOSQUITO NEWS, V24, P300
   FOCKS DA, 1993, J MED ENTOMOL, V30, P1003, DOI 10.1093/jmedent/30.6.1003
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   Gould F, 2008, P ROY SOC B-BIOL SCI, V275, P2823, DOI 10.1098/rspb.2008.0846
   Guerra CA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-276
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   Hancock PA, 2019, J APPL ECOL, V56, P1674, DOI 10.1111/1365-2664.13423
   Hancock PA, 2016, J APPL ECOL, V53, P785, DOI 10.1111/1365-2664.12620
   Hancock PA, 2012, J R SOC INTERFACE, V9, P3045, DOI 10.1098/rsif.2012.0253
   Hancock PA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-98
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Horsfall WR, 1955, MOSQUITOES THEIR BIO
   Huang YX, 2011, EVOL APPL, V4, P415, DOI 10.1111/j.1752-4571.2010.00153.x
   Kandul NP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07964-7
   Khamis D, 2018, J THEOR BIOL, V456, P1, DOI 10.1016/j.jtbi.2018.07.024
   Koenraadt CJM, 2008, AM J TROP MED HYG, V79, P230, DOI 10.4269/ajtmh.2008.79.230
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   Leftwich PT, 2018, BIOCHEM SOC T, V46, P1203, DOI 10.1042/BST20180076
   Marshall JM, 2018, ACS CHEM BIOL, V13, P424, DOI 10.1021/acschembio.7b00923
   Marshall JM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02744-7
   Marshall JM, 2012, J THEOR BIOL, V294, P153, DOI 10.1016/j.jtbi.2011.10.032
   Marshall JM, 2009, J THEOR BIOL, V258, P250, DOI 10.1016/j.jtbi.2009.01.031
   Maselko M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01007-3
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Noble C, 2019, P NATL ACAD SCI USA, V116, P8275, DOI 10.1073/pnas.1716358116
   Noble C, 2018, ELIFE, V7, DOI 10.7554/eLife.33423
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Ritchie SA, 2013, J MED ENTOMOL, V50, P624, DOI 10.1603/ME12201
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Ross PA, 2014, AM J TROP MED HYG, V91, P198, DOI 10.4269/ajtmh.13-0576
   Sanchez CHM, 2020, METHODS ECOL EVOL, V11, P229, DOI 10.1111/2041-210X.13318
   Schmidt TL, 2018, HEREDITY, V120, P386, DOI 10.1038/s41437-017-0039-9
   Schmidt TL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2001894
   Serebrovsky A.S., 1940, ZOOL ZH, V19, P618
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wright S, 1941, AM NAT, V75, P513, DOI 10.1086/280996
NR 56
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD MAY 12
PY 2020
VL 18
IS 1
AR 50
DI 10.1186/s12915-020-0759-9
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA LR7PK
UT WOS:000535887600001
PM 32398005
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marteleto, LJ
   Guedes, G
   Coutinho, RZ
   Weitzman, A
AF Marteleto, Leticia J.
   Guedes, Gilvan
   Coutinho, Raquel Z.
   Weitzman, Abigail
TI Live Births and Fertility Amid the Zika Epidemic in Brazil
SO DEMOGRAPHY
LA English
DT Article; Early Access
DE Fertility; Birth rates; Brazil; Latin America; Zika
ID HOUSEHOLD SURVEY; INFECTION; ABORTION; VIRUS; TRANSMISSION; UNCERTAINTY;
   POPULATION; BEHAVIORS; PREGNANCY; EDUCATION
AB In late 2015, the Brazilian Ministry of Health and the Pan American Health Organization classified the increase in congenital malformations associated with the Zika virus (ZIKV) as a public health emergency. The risk of ZIKV-related congenital syndrome poses a threat to reproductive outcomes that could result in declining numbers of live births and potentially fertility. Using monthly microdata on live births from the Brazilian Information System on Live Births (SINASC), this study examines live births and fertility trends amid the ZIKV epidemic in Brazil. Findings suggest a decline in live births that is stratified across educational and geographic lines, beginning approximately nine months after the link between ZIKV and microcephaly was publicly announced. Although declines in total fertility rates were small, fertility trends estimated by age and maternal education suggest important differences in how Zika might have impacted Brazil's fertility structure. Further findings confirm the significant declines in live births in mid-2016 even when characteristics of the municipality are controlled for; these results highlight important nuances in the timing and magnitude of the decline. Combined, our findings illustrate the value of understanding how the risk of a health threat directed at fetuses has led to declines in live births and fertility.
C1 [Marteleto, Leticia J.; Weitzman, Abigail] Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA.
   [Marteleto, Leticia J.; Weitzman, Abigail] Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA.
   [Guedes, Gilvan; Coutinho, Raquel Z.] Univ Fed Minas Gerais, Demog Dept, Belo Horizonte, MG, Brazil.
   [Guedes, Gilvan; Coutinho, Raquel Z.] Univ Fed Minas Gerais, Ctr Dev & Reg Planning Cedeplar, Belo Horizonte, MG, Brazil.
RP Marteleto, LJ (corresponding author), Univ Texas Austin, Populat Res Ctr, Austin, TX 78712 USA.; Marteleto, LJ (corresponding author), Univ Texas Austin, Dept Sociol, Austin, TX 78712 USA.
EM marteleto@prc.utexas.edu
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [R01HD091257,
   P2CHD042849]; Brazilian Technological and Scientific Development Council
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [431872/2016-3, 314392/2018-1, CSA-APQ-01553-16]; Minas Gerais
   Research Foundation (FAPEMIG)Minas Gerais State Research Foundation
   (FAPEMIG) [431872/2016-3, 314392/2018-1, CSA-APQ-01553-16]; Universidade
   Federal de Minas Gerais
FX This research was funded by grant R01HD091257, Reproductive Responses to
   the Zika Virus Epidemic in Brazil, awarded to PI L. J. Marteleto by the
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development. This research was also supported by grant P2CHD042849,
   Population Research Center, awarded to the PRC at The University of
   Texas at Austin by the Eunice Kennedy Shriver National Institute of
   Child Health and Human Development and Grants 431872/2016-3,
   314392/2018-1, and CSA-APQ-01553-16 awarded to Gilvan Guedes by the
   Brazilian Technological and Scientific Development Council (CNPq) and by
   the Minas Gerais Research Foundation (FAPEMIG). The content is solely
   the responsibility of the authors and does not necessarily represent the
   official views of the NIH or the CNPq. Raquel Z. Coutinho gratefully
   acknowledges support from the Universidade Federal de Minas Gerais
   (Edital 11/2017 - ADRC - Programa Institucional de Auxilio a Pesquisa de
   Docentes Recem-Contratados ou Recem-Doutorados da UFMG). The authors
   thank Julia Almeida Calazans, John Casterline, Suzana Cavenaghi, Diane
   Coffey, Samantha Haussmann, Ana Maria Hermeto C. De Oliveira, Kristine
   Hopkins, Bernardo Lanza, Vanessa di Lego, Sandra Valongueiro, Joe
   Potter, Laura Wong, the anonymous reviewers, and Editors for their
   helpful comments at different stages of this research. We also thank
   Marcia Castro for discussions on the ZIKV epidemic early on in this
   research. We also thank the participants of the PRC (UTexas), CCPR
   (UCLA), and CPC (UNC) brown bags for their helpful suggestions.
CR Agadjanian V, 2002, DEMOGRAPHY, V39, P215, DOI 10.2307/3088336
   Aiken ARA, 2016, NEW ENGL J MED, V375, P396, DOI 10.1056/NEJMc1605389
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Amaral E., 2016, 2798918 SSRN
   [Anonymous], 2015, SATURDAY BRAZILIAN H
   [Anonymous], 2019, PORT SAUD SIST INF N
   [Anonymous], 2015, MINISTRY HLTH CONFIR, pG1
   BALDWIN J, 2001, REV INTERAMERICANA P, V35, P9
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Behrman JA, 2016, STUD FAMILY PLANN, V47, P3, DOI 10.1111/j.1728-4465.2016.00045.x
   BONGAARTS J, 1978, POPUL DEV REV, V4, P105, DOI 10.2307/1972149
   Brasil, 2019, B EP NUM ESP
   Brasil, 2015, B EPIDEMIOLOGICO, V46
   Brasil, 2016, B EPIDEMIOLOGICO, V47
   Brasil, 2017, B EPIDEMIOLOGICO, V48
   Brasil, 2015, MIN SAUD CONF REL EN
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camarano A. A. O., 2014, NOVO REGIME DEMOGRAF
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Cavenaghi S., 2014, COMPORTAMIENTO REPRO, P220
   Cavenaghi S., 2009, ANN M POP ASS AM DET
   Cedeplar, 2014, PROJ POP SEX GRUP ET
   Coutinho R. Z, 2016, THESIS
   Cummings DR, 2014, AM J HUM BIOL, V26, P424, DOI 10.1002/ajhb.22534
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diniz D, 2017, CIENC SAUDE COLETIVA, V22, P653, DOI 10.1590/1413-81232017222.23812016
   Diniz D, 2010, CIENC SAUDE COLETIVA, V15, P959, DOI 10.1590/S1413-81232010000700002
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Dip A, 2013, CADA 2 DIAS BRASILEI
   Farias MR, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006176, 10.1590/s1518-8787.2016050006176]
   Ferreira Francisco H. G., 2003, Rev. Bras. Econ., V57, P59, DOI 10.1590/S0034-71402003000100003
   Finlay J. E, 2009, 4883 WORLD BANK
   Guedes GR, 2018, CAD SAUDE PUBLICA, V34, DOI [10.1590/0102-311X00003217, 10.1590/0102-311x00003217]
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   IBGE, 2013, PROJ POP BRAS SEX ID
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2019, PESQ NAC AM DOM CONT
   Instituto Brasileiro de Geografia e Estatistica (IBGE), 2012, CENS DEM 2010 NUPC F
   Itaborai N. R, 2015, DESIGUALDADES CLASE, V42, P61
   Johnson-Hanks J, 2004, EUR J POPUL, V20, P351, DOI 10.1007/s10680-004-4095-5
   Johnson-Hanks J., 2006, UNCERTAIN HONOR MODE
   Joventino ES, 2013, PUBLIC HEALTH NURS, V30, P150, DOI 10.1111/j.1525-1446.2012.01042.x
   Lam D, 1999, J HUM RESOUR, V34, P160, DOI 10.2307/146306
   Le HH, 2014, IN J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   Lima EEC, 2018, POPUL DEV REV, V44, P723, DOI 10.1111/padr.12157
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Marteleto LJ, 2013, DEMOGR RES, V28, P793, DOI 10.4054/DemRes.2013.28.28
   Marteleto LJ, 2012, DEMOGRAPHY, V49, P1453, DOI 10.1007/s13524-012-0118-8
   Martine G, 1996, POPUL DEV REV, V22, P47, DOI 10.2307/2137686
   Martins-MeloI FR, 2014, REV SAUDE PUBL, V48, P508, DOI 10.1590/S0034-8910.2014048004878
   McNeil Jr D.G, 2015, NY TIMES
   Menezes G, 2009, CAD SAUDE PUBLICA, V25, pS193, DOI 10.1590/S0102-311X2009001400002
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Ministerio da Saude, 2017, SAUD BRAS 2015 2016
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   de Andrade LOM, 2015, LANCET, V385, P1343, DOI 10.1016/S0140-6736(14)61494-X
   Moreira M, 2013, 29 C AS LAT SOC SANT
   Nascimento Ellany Gurgel Cosme do, 2017, Rev. salud pública, V19, P39, DOI 10.15446/rsap.v19n1.44544
   Nobles J, 2015, DEMOGRAPHY, V52, P15, DOI 10.1007/s13524-014-0362-1
   Oria MOB, 2009, PUBLIC HEALTH NURS, V26, P574, DOI 10.1111/j.1525-1446.2009.00817.x
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL ZIK VIR INF
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2016, WHO ANN PUBL HLTH EM
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, EP AL INCR MICR NE B
   Pan American Health Organization (PAHO)/World Health Organization (WHO), 2015, CONF CIRC VIR ZIK BR
   Potter JE, 2010, POPUL DEV REV, V36, P283, DOI 10.1111/j.1728-4457.2010.00330.x
   Preston SH, 2001, DEMOGRAPHY MEASURING
   Pulerwitz J, 2008, MEN MASC, V10, P322, DOI 10.1177/1097184X06298778
   Rabe-Hesketh S., 2012, MULTILEVEL LONGITUDI
   Rangel M. A., DEMOGRAPHY
   Rios-Neto ELG, 2018, POPUL DEV REV, V44, P489, DOI 10.1111/padr.12165
   Rodriguez J., 2017, INT POP C CAP TOWN S
   Schuck-Paim Cynthia, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.7038a6813f734c1db547240c2a0ba291
   Silva KC, 2009, MEM I OSWALDO CRUZ, V104, P885, DOI 10.1590/S0074-02762009000600011
   Sims A, 2015, INDEPENDENT
   Singh S, 1991, INT FAM PLAN PERSPEC, V17, P8
   Siqueira JB, 2004, AM J TROP MED HYG, V71, P646, DOI 10.4269/ajtmh.2004.71.646
   Sobotka T, 2011, POPUL DEV REV, V37, P267, DOI 10.1111/j.1728-4457.2011.00411.x
   Szwarcwald CL, 2014, POPUL HEALTH METR, V12, DOI 10.1186/1478-7954-12-16
   Szwarcwald CL, 2005, AIDS, V19, pS51, DOI 10.1097/01.aids.0000191491.66736.16
   Trinitapoli J, 2011, AM SOCIOL REV, V76, P935, DOI 10.1177/0003122411427672
   Borges ALV, 2016, REV SAUDE PUBL, V50, DOI 10.1590/S01518-8787.2016050006686
   Vrachnis N, 2014, LANCET, V383, P692, DOI 10.1016/S0140-6736(14)60252-X
   World Bank, 2018, DAT BRAZ
   World Health Organization, 2019, ZIK EP UPD
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 86
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0070-3370
EI 1533-7790
J9 DEMOGRAPHY
JI Demography
DI 10.1007/s13524-020-00871-x
EA MAY 2020
PG 30
WC Demography
SC Demography
GA LM2PQ
UT WOS:000532094600001
PM 32399856
DA 2020-07-08
ER

PT J
AU Ottaviani, D
   Boso, F
   Tranquillini, E
   Gapeni, I
   Pedrotti, G
   Cozzio, S
   Guarrera, GM
   Giometto, B
AF Ottaviani, Donatella
   Boso, Federica
   Tranquillini, Enzo
   Gapeni, Ilaria
   Pedrotti, Giovanni
   Cozzio, Susanna
   Guarrera, Giovanni M.
   Giometto, Bruno
TI Early Guillain-Barre syndrome in coronavirus disease 2019 (COVID-19): a
   case report from an Italian COVID-hospital
SO NEUROLOGICAL SCIENCES
LA English
DT Article
DE Coronavirus disease 2019 (COVID-19); SARS-CoV-2 neurological
   complications; Guillain-Barre syndrome; Para-infectious Guillain-Barre
   syndrome
ID ZIKA VIRUS-INFECTION
AB Guillain-Barre syndrome (GBS) is an acute polyradiculoneuropathy associated with dysimmune processes, often related to a previous infectious exposure. During Italian severe acute respiratory syndrome coronavirus-2 outbreak, a woman presented with a rapidly progressive flaccid paralysis with unilateral facial neuropathy after a few days of mild respiratory symptoms. Coronavirus was detected by nasopharyngeal swab, but there was no evidence of its presence in her cerebrospinal fluid, which confirmed the typical albumin-cytological dissociation of GBS, along with consistent neurophysiological data. Despite immunoglobulin infusions and intensive supportive care, her clinical picture worsened simultaneously both from the respiratory and neurological point of view, as if reflecting different aspects of the same systemic inflammatory response. Similar early complications have already been observed in patients with para-infectious GBS related to Zika virus, but pathological mechanisms have yet to be established.
C1 [Ottaviani, Donatella; Boso, Federica; Tranquillini, Enzo; Gapeni, Ilaria; Giometto, Bruno] Azienda Prov & Serv Sanitari APSS Trento, Rovereto Hosp, Neurol Unit, Trento, Italy.
   [Boso, Federica] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy.
   [Pedrotti, Giovanni] Azienda Prov & Serv Sanitari APSS Trento, Rovereto Hosp, Intens Care Unit, Trento, Italy.
   [Cozzio, Susanna] Azienda Prov & Serv Sanitari APSS Trento, Rovereto Hosp, Internal Med Unit, Trento, Italy.
   [Guarrera, Giovanni M.] Azienda Prov & Serv Sanitari APSS Trento, Hlth Trust, Trento, Italy.
RP Giometto, B (corresponding author), Azienda Prov & Serv Sanitari APSS Trento, Rovereto Hosp, Neurol Unit, Trento, Italy.
EM bruno.giometto@apss.tn.it
CR Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Desforges M, 2014, ADV EXPT MED BIOL, V807
   Kim JE, 2017, J CLIN NEUROL, V13, P227, DOI 10.3988/jcn.2017.13.3.227
   Munoz LS, 2017, J INFECT DIS, V216, pS897, DOI 10.1093/infdis/jix511
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Shang P, 2020, J NEUROL, DOI 10.1007/s00415-020-09742-2
   Sharma K, 2019, SAGE OPEN MED CASE R, V7, DOI 10.1177/2050313X19838750
   Toscano G., 2020, N ENGL J MED
   Tsai LK, 2004, ARCH NEUROL-CHICAGO, V61, P1669, DOI 10.1001/archneur.61.11.1669
   Turgay C, 2015, J PEDIATR NEUROSCI, V10, P280, DOI 10.4103/1817-1745.165716
   Uncini A, 2017, J NEUROL NEUROSUR PS, V88, P266, DOI 10.1136/jnnp-2016-314310
   Zhao Hua, 2020, Lancet Neurol, V19, P383, DOI 10.1016/S1474-4422(20)30109-5
NR 12
TC 4
Z9 4
U1 0
U2 0
PU SPRINGER-VERLAG ITALIA SRL
PI MILAN
PA VIA DECEMBRIO, 28, MILAN, 20137, ITALY
SN 1590-1874
EI 1590-3478
J9 NEUROL SCI
JI Neurol. Sci.
PD JUN
PY 2020
VL 41
IS 6
BP 1351
EP 1354
DI 10.1007/s10072-020-04449-8
EA MAY 2020
PG 4
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LV4CR
UT WOS:000532387800004
PM 32399950
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Mundis, SJ
   Estep, AS
   Waits, CM
   Ryan, SJ
AF Mundis, Stephanie J.
   Estep, Alden S.
   Waits, Christy M.
   Ryan, Sadie J.
TI Spatial variation in the frequency of knockdown resistance genotypes in
   Florida Aedes aegypti populations
SO PARASITES & VECTORS
LA English
DT Article
DE Insecticide resistance; Aedes aegypti; Spatial scan statistic; Beta
   regression; Knockdown resistance
ID INSECTICIDE RESISTANCE; MOSQUITO-CONTROL; VECTORS; IMPACT
AB Background The development of insecticide resistance in disease-vectoring mosquito species can lead to vector control failure and disease resurgence. However, insecticide applications remain an essential public health intervention. In Florida, insecticide resistance in Aedes aegypti, an anthropophilic mosquito species capable of transmitting dengue, chikungunya, and Zika virus, is a major concern. Understanding the location, scale, and driving factors of insecticide resistance can enhance the ability of vector control organizations to target populations effectively. Methods We used previously collected data on frequencies of mutations that confer resistance to commonly used pyrethroid insecticides in Ae. aegypti specimens from 62 sites distributed across 18 counties in Florida. To determine the scale of clustering for the most resistant variant, we used a Ripley's K function. We also used a spatial scanning statistic technique to identify locations of clusters where higher than expected frequencies of susceptible or resistant mosquitoes occurred. We then tested for associations between landscape, demographic, and insecticide-use factors using a beta regression modelling approach and evaluated the effect of spatial lag and spatial error terms on overall explanatory power of these models. Results The scale at which maximum clustering of the most resistant variant occurs is approximately 20 kilometers. We identified statistically significant clusters of genotypes associated with resistance in several coastal cities, although some of these clusters were near significant clusters of susceptible mosquitoes, indicating selection pressures vary at the local scale. Vegetation density, distance from roads, and pyrethroid-use by vector control districts were consistently significant predictors of knockdown resistance genotype frequency in the top-performing beta regression models, although pyrethroid use surprisingly had a negatively associated with resistance. The incorporation of spatial lags resulted in improvements to the fit and explanatory power of the models, indicating an underlying diffusion process likely explains some of the spatial patterns observed. Conclusions The genetic mutations that confer resistance to pyrethroids in Ae. aegypti mosquitoes in Florida exhibit spatial autocorrelation and patterns that can be partially explained by landscape and insecticide-use factors. Further work at local scales should be able to identify the mechanisms by which these variables influence selection for alleles associated with resistance.
C1 [Mundis, Stephanie J.; Ryan, Sadie J.] Univ Florida, Quantitat Dis Ecol & Conservat QDEC Lab, Dept Geog, Gainesville, FL 32607 USA.
   [Mundis, Stephanie J.; Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32608 USA.
   [Estep, Alden S.; Waits, Christy M.] Navy Entomol Ctr Excellence, R&D Dept, Gainesville, FL 32608 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
RP Mundis, SJ; Ryan, SJ (corresponding author), Univ Florida, Quantitat Dis Ecol & Conservat QDEC Lab, Dept Geog, Gainesville, FL 32607 USA.
EM s.mundis@ufl.edu; sjryan@ufl.edu
OI Ryan, Sadie/0000-0002-4308-6321
FU University of Florida Graduate School Preeminence Award; CDC grant
   [1U01CK000510-01]; Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA
FX Funding for the original data collection is described in Estep et al.
   2018. SJM was supported by a University of Florida Graduate School
   Preeminence Award during completion of this work. SJR was funded by CDC
   grant 1U01CK000510-01: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program. This publication was
   supported by the Cooperative Agreement Number above from the Centers for
   Disease Control and Prevention. Its contents are solely the
   responsibility of the authors and do not necessarily represent the
   official views of the Centers for Disease Control and Prevention.
   Funding bodies had no role in the design, analysis and interpretation of
   the study, or writing of the paper.
CR Barton K, 2013, PACKAGE MUMIN MODEL
   Bivand R, 2015, PACKAGE SPDEP R PACK
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Brogdon W, 2010, CDC TECH REP, V1, P1
   Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644
   Chanda E, 2016, EMERG INFECT DIS, V22, P773, DOI 10.3201/eid2205.150984
   Christiansen LE, 2006, J AGR BIOL ENVIR ST, V11, P411, DOI 10.1198/108571106X154858
   Cohen JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-122
   Connelly CR, 2009, FLORIDA MOSQUITO CON
   Darmofal D., 2015, SPATIAL ANAL SOCIAL
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617
   Didan K., 2015, MOD13Q1 MODIS TERRA, DOI [10.5067/MODIS/MOD13Q1.006, DOI 10.5067/MODIS/MOD13Q1.006]
   Dixon PM, 2002, ENCY ENV
   Estep AS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006544
   Ferrari SLP, 2004, J APPL STAT, V31, P799, DOI 10.1080/0266476042000214501
   FRANK JH, 1985, ENTOMOL EXP APPL, V37, P169, DOI 10.1111/j.1570-7458.1985.tb03469.x
   Gray L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30968-8
   Grossman MK, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-018-3275-9
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Insecticide Resistance Action Committee, 2011, PREV MAN INS RES VEC
   Jung I, 2010, STAT MED, V29, P1910, DOI 10.1002/sim.3951
   Karunaratne SHPP, 2013, PESTIC BIOCHEM PHYS, V107, P98, DOI 10.1016/j.pestbp.2013.05.011
   KIM JO, 1981, SOCIOL METHOD RES, V10, P187, DOI 10.1177/004912418101000203
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995
   Liu HQ, 2004, J MED ENTOMOL, V41, P408, DOI 10.1603/0022-2585-41.3.408
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Naimi B, 2015, PACKAGE USDM UNCERTA
   Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Richards SL, 2017, J AM MOSQUITO CONTR, V33, P331, DOI 10.2987/17-6669.1
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007448
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Shin D, 2016, J VECTOR ECOL, V41, P63, DOI 10.1111/jvec.12195
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Stoops CA, 2019, ENVIRON HEALTH INSIG, V13, DOI 10.1177/1178630219859004
   Tabachnick WJ, 2016, INSECTS, V7, DOI 10.3390/insects7040050
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   U.S. Census Bureau, 2016, AM COMM SURV 5 YEAR
   United States Census Bureau, 2010, TIGER LIN SHAP
   United States Department of Agriculture [USDA], 2016, NAT AGR STAT SERV CR
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Vezzani D, 2009, MED VET ENTOMOL, V23, P78, DOI 10.1111/j.1365-2915.2008.00783.x
   WHO, 2012, GLOB PLAN INS RES MA
   Yadouleton A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0638-3
   Yang LM, 2018, ISPRS J PHOTOGRAMM, V146, P108, DOI 10.1016/j.isprsjprs.2018.09.006
   Zeileis A., 2016, PACKAGE BETAREG R PA
   Zimmerman D, 1999, MATH GEOL, V31, P375, DOI 10.1023/A:1007586507433
NR 52
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAY 11
PY 2020
VL 13
IS 1
AR 241
DI 10.1186/s13071-020-04112-3
PG 12
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LP5DR
UT WOS:000534338400002
PM 32393364
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nguyen, CT
   Moi, ML
   Le, TQM
   Nguyen, TTT
   Vu, TBH
   Nguyen, HT
   Pham, TTH
   Le, THT
   Nguyen, LMH
   Ly, MHP
   Ng, CFS
   Takemura, T
   Morita, K
   Hasebe, F
AF Co Thach Nguyen
   Meng Ling Moi
   Thi Quynh Mai Le
   Thi Thu Thuy Nguyen
   Thi Bich Hau Vu
   Hai Tuan Nguyen
   Thi Thu Hang Pham
   Thi Hien Thu Le
   Le Manh Hung Nguyen
   Minh Huong Phu Ly
   Ng, Chris Fook Sheng
   Takemura, Taichiro
   Morita, Kouichi
   Hasebe, Futoshi
TI Prevalence of Zika virus neutralizing antibodies in healthy adults in
   Vietnam during and after the Zika virus epidemic season: a longitudinal
   population-based survey
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Zika virus infection; Seroprevalence; Seroepidemiologic
   studies; Neutralizing antibodies; Vietnam
ID TRANSMISSION; INFECTION; OUTBREAK
AB Background Between 2016 and 2019, 265 cases of Zika virus (ZIKV) infection were reported in Vietnam, predominantly in southern Vietnam. In 2016, a case of ZIKV-associated microcephaly was confirmed in the Central Highlands, and several members of the infant's family were confirmed to be infected with ZIKV. The study aims to determine the level of immunity to ZIKV in the general population of the ZIKV epidemic region. Methods A total of 879 serum samples were collected from 801 participants between January 2017 and July 2018, during and after the ZIKV epidemic in Vietnam. The samples were tested for anti-ZIKV immunoglobulin M (IgM) and immunoglobulin G (IgG), and anti-dengue virus (DENV) IgG antibodies using enzyme-linked immunosorbent assays (ELISA). Plaque-reduction neutralization test (PRNT) for ZIKV was performed on all samples, and for DENV on the samples that ZIKV neutralizing antibody positive. Results A total of 83 (10.3%) participants had anti-ZIKV IgM. Of the 83, 6 were confirmed to be ZIKV antibodies positive using PRNT and anti-ZIKV IgG ELISA. Of the 718 participants who were anti-ZIKV IgM negative, a further 3 cases were confirmed as positive for antibodies against ZIKV. Of the 9 participants with ZIKV infection, 5 lived in the same village as the infant with ZIKV-associated microcephaly and the other 4 lived in 2 neighboring communes. Repeat samples were collected from the 83 ZIKV IgM positive participants 1.5 years after the first collection. No new cases of ZIKV infection were detected. In addition, 2 of 3 participants with anti-ZIKV NS1 IgG demonstrated a 4- to 8-fold increase in ZIKV neutralizing antibody titer. Conclusions ZIKV was present in the area around Krong Buk, with the rate of ZIKV-specific antibodies was 1.1% in the community since at least 2016. While the low levels of circulation together with low seroprevalence suggests a limited outbreak in the region, the results also reflect on low levels of protective immunity to Zika within the population. These results provide a better understanding of the current ZIKV epidemic status in the region and demonstrate a need for implementation of more effective ZIKV infection control measures.
C1 [Co Thach Nguyen; Meng Ling Moi; Minh Huong Phu Ly; Morita, Kouichi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan.
   [Co Thach Nguyen; Meng Ling Moi; Minh Huong Phu Ly; Morita, Kouichi; Hasebe, Futoshi] Nagasaki Univ, Inst Trop Med, Dept Virol, Sakamoto 1-12-4, Nagasaki 8528523, Japan.
   [Co Thach Nguyen; Meng Ling Moi; Morita, Kouichi] Nagasaki Univ, Program Nurturing Global Leaders Trop & Emerging, Nagasaki, Japan.
   [Thi Quynh Mai Le; Thi Thu Thuy Nguyen; Thi Bich Hau Vu; Hai Tuan Nguyen; Thi Thu Hang Pham; Thi Hien Thu Le] Natl Inst Hyg & Epidemiol, Hanoi, Vietnam.
   [Le Manh Hung Nguyen] Tay Nguyen Inst Hyg & Epidemiol, Tay Nguyen, Dak Lak, Vietnam.
   [Ng, Chris Fook Sheng] Nagasaki Univ, Sch Trop Med & Global Hlth, Nagasaki, Japan.
   [Takemura, Taichiro; Hasebe, Futoshi] Nagasaki Univ, Ctr Infect Dis Res Asia & Africa, Inst Trop Med, Vietnam Res Stn, Nagasaki, Japan.
RP Moi, ML (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan.; Moi, ML (corresponding author), Nagasaki Univ, Inst Trop Med, Dept Virol, Sakamoto 1-12-4, Nagasaki 8528523, Japan.; Moi, ML (corresponding author), Nagasaki Univ, Program Nurturing Global Leaders Trop & Emerging, Nagasaki, Japan.
EM sherry@nagasaki.u.ac.jp
FU Japan Agency for Medical Research and Development (AMED)Japan Agency for
   Medical Research and Development (AMED) [JP19fm0108001, JP20wm0125006];
   AMED Research on Emerging and Re-emerging Infectious Diseases
   [19fk0108109h0001, 20fk0108109h0001, 20fk0108123h1101]; Nagasaki
   University; Japanese government (Monbukagakusho) ScholarshipMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)
FX This research was supported by Japan Agency for Medical Research and
   Development (AMED) under Grant Number JP19fm0108001(Japan Initiative for
   Global Research Network on Infectious Diseases (J-GRID), AMED
   JP20wm0125006; and AMED Research on Emerging and Re-emerging Infectious
   Diseases (19fk0108109h0001, 20fk0108109h0001, 20fk0108123h1101) and
   Nagasaki University. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript. CTN was a recipient of the Japanese government
   (Monbukagakusho) Scholarship.
CR Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Bui TC, 2018, INT J GYNECOL OBSTET, V141, P390, DOI 10.1002/ijgo.12456
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duong V, 2017, EMERG INFECT DIS, V23, P296, DOI 10.3201/eid2302.161432
   Focus Diagnostics, DENG VIR IGM CAP DXE
   Hashimoto T, 2017, EMERG INFECT DIS, V23, P1222, DOI 10.3201/eid2307.170519
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Kandel N, 2016, B WORLD HEALTH ORGAN, V94, P705, DOI 10.2471/BLT.16.171504
   Katanami Y, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax031
   Kuno G, 1998, PHYLOGENY GENUS FLAV
   Kutsuna S, 2017, CLIN EXP NEUROIMMUNO, V8, P192, DOI [10.1111/cen3.12408, DOI 10.1111/CEN3.12408]
   Lan PT, 2017, PLOS CURR, V9, DOI [10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa, DOI 10.1371/CURRENTS.0UTBREAKS.1C8F631E0EF8CD7777D639EBA48647FA]
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Quyen NTH, 2017, AM J TROP MED HYG, V97, P146, DOI 10.4269/ajtmh.16-0979
   OLIVEIRA RA, 2019, MEM I O CRUZ, V114, P1
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pham HV, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-172
   Pourhoseingholi Mohamad Amin, 2013, Gastroenterol Hepatol Bed Bench, V6, P14
   R&D Systems, HUM ANT VIR IGG ELIS
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Thai KTD, 2005, TROP MED INT HEALTH, V10, P379, DOI 10.1111/j.1365-3156.2005.01388.x
   Hung TM, 2018, TRENDS PARASITOL, V34, P904, DOI 10.1016/j.pt.2018.07.007
   Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708
   Van Le T, 2017, VIETNAM REV BIOL TRO, V65, P819
   Van Tuan L, 2017, AM J EPIDEMIOL INFEC, V5, P8
   WHO, 2016, LAB TEST ZIK VIR INF, V1, DOI [10.1038/sj.mp.4001048, DOI 10.1038/SJ.MP.4001048]
   Wijesooriya SL, 2020, LANCET INFECT DIS, V20, P168, DOI 10.1016/S1473-3099(19)30677-2
   Wiwanitkit V, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016026
   Woon YL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3786-9
   World Health Organization, 2019, ZIK EP UPD
   Zamani M, 2017, IRAN J PUBLIC HEALTH, V46, P1305
NR 43
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD MAY 11
PY 2020
VL 20
IS 1
AR 332
DI 10.1186/s12879-020-05042-2
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA LP5BK
UT WOS:000534332200002
PM 32393198
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simoni, A
   Hammond, AM
   Beaghton, AK
   Galizi, R
   Taxiarchi, C
   Kyrou, K
   Meacci, D
   Gribble, M
   Morselli, G
   Burt, A
   Nolan, T
   Crisanti, A
AF Simoni, Alekos
   Hammond, Andrew M.
   Beaghton, Andrea K.
   Galizi, Roberto
   Taxiarchi, Chrysanthi
   Kyrou, Kyros
   Meacci, Dario
   Gribble, Matthew
   Morselli, Giulia
   Burt, Austin
   Nolan, Tony
   Crisanti, Andrea
TI A male-biased sex-distorter gene drive for the human malaria vector
   Anopheles gambiae
SO NATURE BIOTECHNOLOGY
LA English
DT Article; Early Access
ID POPULATION-GENETICS; MEIOTIC DRIVE; MOSQUITO; REQUIREMENTS; SYSTEMS;
   RATIO
AB A sex-distorter gene drive causes population collapse in the malaria mosquito.
   Only female insects transmit diseases such as malaria, dengue and Zika; therefore, control methods that bias the sex ratio of insect offspring have long been sought. Genetic elements such as sex-chromosome drives can distort sex ratios to produce unisex populations that eventually collapse, but the underlying molecular mechanisms are unknown. We report a male-biased sex-distorter gene drive (SDGD) in the human malaria vector Anopheles gambiae. We induced super-Mendelian inheritance of the X-chromosome-shredding I-PpoI nuclease by coupling this to a CRISPR-based gene drive inserted into a conserved sequence of the doublesex (dsx) gene. In modeling of invasion dynamics, SDGD was predicted to have a quicker impact on female mosquito populations than previously developed gene drives targeting female fertility. The SDGD at the dsx locus led to a male-only population from a 2.5% starting allelic frequency in 10-14 generations, with population collapse and no selection for resistance. Our results support the use of SDGD for malaria vector control.
C1 [Simoni, Alekos; Hammond, Andrew M.; Beaghton, Andrea K.; Galizi, Roberto; Taxiarchi, Chrysanthi; Kyrou, Kyros; Meacci, Dario; Gribble, Matthew; Morselli, Giulia; Nolan, Tony; Crisanti, Andrea] Imperial Coll London, Dept Life Sci, London, England.
   [Simoni, Alekos] Polo Innovaz Genom Genet & Biol, Terni, Italy.
   [Hammond, Andrew M.] Johns Hopkins Univ, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD USA.
   [Galizi, Roberto] Keele Univ, Ctr Appl Entomol & Parasitol, Sch Life Sci, Keele, Staffs, England.
   [Burt, Austin] Imperial Coll London, Dept Life Sci, Silwood Pk, Ascot, Berks, England.
   [Nolan, Tony] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England.
   [Crisanti, Andrea] Univ Padua, Dept Mol Med, Padua, Italy.
RP Crisanti, A (corresponding author), Imperial Coll London, Dept Life Sci, London, England.; Crisanti, A (corresponding author), Univ Padua, Dept Mol Med, Padua, Italy.
EM acrs@imperial.ac.uk
OI Simoni, Alekos/0000-0001-8629-721X; Galizi, Roberto/0000-0003-3134-7480;
   Crisanti, Andrea/0000-0002-2406-4426; Burt, Austin/0000-0001-5146-9640
FU Bill & Melinda Gates FoundationGates Foundation; European
   CommissionEuropean Commission Joint Research Centre [731060 - Infravec2]
FX This work was supported by grants from the Bill & Melinda Gates
   Foundation and additionally by grants from the European Commission
   (731060 - Infravec2) to A.C.
CR Akbari OS, 2015, SCIENCE, V349, P927, DOI 10.1126/science.aac7932
   [Anonymous], 2016, GEN DRIV HOR ADV SCI
   Beaghton A, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1932-7
   Beaghton A, 2017, GENETICS, V205, P1587, DOI 10.1534/genetics.116.197632
   Beaghton AK, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.1586
   Burt A., 2009, GENES CONFLICT BIOL
   Deredec A, 2008, GENETICS, V179, P2013, DOI 10.1534/genetics.108.089037
   Deredec A, 2011, P NATL ACAD SCI USA, V108, pE874, DOI 10.1073/pnas.1110717108
   Fuchs Silke, 2013, Methods Mol Biol, V923, P601
   Galizi R, 2016, SCI REP-UK, V6, DOI 10.1038/srep31139
   Galizi R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4977
   Gantz VM, 2015, P NATL ACAD SCI USA, V112, pE6736, DOI 10.1073/pnas.1521077112
   HAMILTON WD, 1967, SCIENCE, V156, P477, DOI 10.1126/science.156.3774.477
   Hammond A. M, 2018, IMPROVED CRISPR BASE, DOI [10.1101/360339, DOI 10.1101/360339]
   Hammond A, 2016, NAT BIOTECHNOL, V34, P78, DOI 10.1038/nbt.3439
   HASTINGS IM, 1994, PHILOS T R SOC B, V344, P313, DOI 10.1098/rstb.1994.0069
   Helleu Q, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017616
   HICKEY WA, 1966, GENETICS, V53, P1177
   James S, 2018, AM J TROP MED HYG, V98, P1, DOI 10.4269/ajtmh.18-0083
   Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356
   Kyrou K, 2018, NAT BIOTECHNOL, V36, P1062, DOI 10.1038/nbt.4245
   LYTTLE TW, 1977, GENETICS, V86, P413
   Mollahosseini A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-122
   North AR, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0645-5
   Pinzone CA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1397
   Price TAR, 2008, SCIENCE, V322, P1241, DOI 10.1126/science.1163766
   Reese M. G., 1996, P PAC S BIOC 96, P737
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Scott TW, 2005, ILAR J, V46, P53, DOI 10.1093/ilar.46.1.53
   Scudellari M, 2019, NATURE, V571, P160, DOI 10.1038/d41586-019-02087-5
   Sinkins SP, 2006, NAT REV GENET, V7, P427, DOI 10.1038/nrg1870
   SWEENY TL, 1978, GENETICS, V88, P427
   Taxiarchi C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51181-1
   Taylor JE, 2002, GENETICS, V160, P1721
   Turner JMA, 2007, DEVELOPMENT, V134, P1823, DOI 10.1242/dev.000018
   Volohonsky G, 2015, G3-GENES GENOM GENET, V5, P1151, DOI 10.1534/g3.115.016808
   Windbichler N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000291
   Wolfram Research Inc, 2019, MATHEMATICA
NR 38
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1087-0156
EI 1546-1696
J9 NAT BIOTECHNOL
JI Nat. Biotechnol.
DI 10.1038/s41587-020-0508-1
EA MAY 2020
PG 12
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA LL8AK
UT WOS:000531777100001
PM 32393821
OA Green Accepted, Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Panchaud, A
   Favre, G
   Pomar, L
   Vouga, M
   Aebi-Popp, K
   Baud, D
AF Panchaud, Alice
   Favre, Guillaume
   Pomar, Leo
   Vouga, Manon
   Aebi-Popp, Karoline
   Baud, David
TI An international registry for emergent pathogens and pregnancy
SO LANCET
LA English
DT Letter
ID ZIKA VIRUS
C1 [Panchaud, Alice] Lausanne Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Inst Pharmaceut Sci Western Switzerland, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Lausanne, Lausanne, Switzerland.
   [Panchaud, Alice] Univ Geneva, Geneva, Switzerland.
   [Panchaud, Alice] Lausanne Univ Hosp, Serv Pharm Serv, Lausanne, Switzerland.
   [Favre, Guillaume; Pomar, Leo; Vouga, Manon; Baud, David] Lausanne Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
   [Aebi-Popp, Karoline] Univ Hosp Bern, Dept Infect Dis, Bern, Switzerland.
   [Aebi-Popp, Karoline] Univ Bern, Bern, Switzerland.
RP Baud, D (corresponding author), Lausanne Univ Hosp, Dept Femme Mere Enfant, Maternofetal & Obstet Res Unit, CH-1011 Lausanne, Switzerland.
EM david.baud@chuv.ch
RI Gil Guevara, Enrique/N-1336-2016
OI Gil Guevara, Enrique/0000-0001-6515-2599; Feki, Anis/0000-0002-9817-9445
CR Chen HJ, 2020, LANCET, V395, P809, DOI 10.1016/S0140-6736(20)30360-3
   Favre G, 2020, LANCET, V395, pE40, DOI 10.1016/S0140-6736(20)30311-1
   Li Y, 2020, EMERG INFECT DIS, V26, P1335, DOI 10.3201/eid2606.200287
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Panchaud A, 2016, LANCET INFECT DIS, V16, P995, DOI 10.1016/S1473-3099(16)30255-9
   Schwartz DA, 2020, ARCH PATHOL LAB MED, DOI [10.5858., 2020 Mar 18]
   Vouga M, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz077
   Wellcome Trust, 2020, SHAR RES DAT FIND RE
   Zhang Jian-ping, 2003, Zhonghua Fu Chan Ke Za Zhi, V38, P516
   Zhu HP, 2020, TRANSL PEDIATR, V9, P51, DOI 10.21037/tp.2020.02.06
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0140-6736
EI 1474-547X
J9 LANCET
JI Lancet
PD MAY 9
PY 2020
VL 395
IS 10235
BP 1483
EP 1484
DI 10.1016/S0140-6736(20)30981-8
PG 2
WC Medicine, General & Internal
SC General & Internal Medicine
GA LO3QU
UT WOS:000533544900020
PM 32353329
OA Green Published, Bronze, Green Accepted
DA 2020-07-08
ER

PT J
AU Gabriel, E
   Ramani, A
   Altinisik, N
   Gopalakrishnan, J
AF Gabriel, Elke
   Ramani, Anand
   Altinisik, Nazlican
   Gopalakrishnan, Jay
TI Human Brain Organoids to Decode Mechanisms of Microcephaly
SO FRONTIERS IN CELLULAR NEUROSCIENCE
LA English
DT Review
DE centrosomes; primary cilia; neural progenitor cells (NPCs); induced
   pluripotent stem cells (iPSCs); human brain organoids; microcephaly;
   neurodevelopmental disorders; neurogenesis
ID PLURIPOTENT STEM-CELLS; CORTICAL DEVELOPMENT; ZIKA VIRUS; NEURAL
   PROGENITORS; PERICENTRIOLAR MATERIAL; PRIMORDIAL DWARFISM; CEREBRAL
   ORGANOIDS; MAJOR DETERMINANT; IN-VITRO; MUTATIONS
AB Brain organoids are stem cell-based self-assembling 3D structures that recapitulate early events of human brain development. Recent improvements with patient-specific 3D brain organoids have begun to elucidate unprecedented details of the defective mechanisms that cause neurodevelopmental disorders of congenital and acquired microcephaly. In particular, brain organoids derived from primary microcephaly patients have uncovered mechanisms that deregulate neural stem cell proliferation, maintenance, and differentiation. Not only did brain organoids reveal unknown aspects of neurogenesis but also have illuminated surprising roles of cellular structures of centrosomes and primary cilia in regulating neurogenesis during brain development. Here, we discuss how brain organoids have started contributing to decoding the complexities of microcephaly, which are unlikely to be identified in the existing non-human models. Finally, we discuss the yet unresolved questions and challenges that can be addressed with the use of brain organoids as in vitro models of neurodevelopmental disorders.
C1 [Gabriel, Elke; Ramani, Anand; Altinisik, Nazlican; Gopalakrishnan, Jay] Heinrich Heine Univ, Univ Klinikum Dusseldorf, Lab Centrosome & Cytoskeleton Biol, Dusseldorf, Germany.
RP Gopalakrishnan, J (corresponding author), Heinrich Heine Univ, Univ Klinikum Dusseldorf, Lab Centrosome & Cytoskeleton Biol, Dusseldorf, Germany.
EM jay.gopalakrishnan@hhu.de
FU Fritz-Thyssen Foundation
FX This work was supported by a grant from the Fritz-Thyssen Foundation to
   JG. Authors' apology for not being able to cite several relevant works
   of literature due to a space constraint in this manuscript.
CR Al-Dosari MS, 2010, J MED GENET, V47, P411, DOI 10.1136/jmg.2009.076646
   Alcantara D, 2014, AM J MED GENET C, V166, P124, DOI 10.1002/ajmg.c.31397
   Aldape K, 2019, NAT REV CLIN ONCOL, V16, P509, DOI 10.1038/s41571-019-0177-5
   Ali F, 2008, MOL BIOL EVOL, V25, P2247, DOI 10.1093/molbev/msn184
   Alkuraya FS, 2011, AM J HUM GENET, V88, P536, DOI 10.1016/j.ajhg.2011.04.003
   Amartely H, 2014, CHEM COMMUN, V50, P5245, DOI 10.1039/c3cc45096a
   Anttinen A, 2008, BRAIN, V131, P1979, DOI 10.1093/brain/awn126
   Avidor-Reiss T, 2013, CURR OPIN CELL BIOL, V25, P72, DOI 10.1016/j.ceb.2012.10.016
   Babrowski T, 2013, SURGERY, V153, P36, DOI 10.1016/j.surg.2012.06.022
   Baffet AD, 2016, METHOD CELL BIOL, V131, P349, DOI 10.1016/bs.mcb.2015.06.013
   Barnes DE, 1998, CURR BIOL, V8, P1395, DOI 10.1016/S0960-9822(98)00021-9
   Barrera JA, 2010, DEV CELL, V18, P913, DOI 10.1016/j.devcel.2010.05.017
   Basel-Vanagaite L, 2010, PEDIATR NEUROL, V43, P7, DOI 10.1016/j.pediatrneurol.2010.02.015
   Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025
   Bendriem RM, 2019, ELIFE, V8, DOI 10.7554/eLife.49376
   Benmerah Alexandre, 2015, Cilia, V4, P5, DOI 10.1186/s13630-015-0014-0
   Bhaduri A, 2020, NATURE, V578, P142, DOI 10.1038/s41586-020-1962-0
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Borrell V, 2014, CURR OPIN NEUROBIOL, V27, P39, DOI 10.1016/j.conb.2014.02.007
   Buchman JJ, 2010, NEURON, V66, P386, DOI 10.1016/j.neuron.2010.03.036
   Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen HY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00305-0
   Chu G, 1996, TRENDS GENET, V12, P187, DOI 10.1016/0168-9525(96)10021-4
   Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dauber A, 2012, J CLIN ENDOCR METAB, V97, pE2140, DOI 10.1210/jc.2012-2150
   Deans B, 2000, EMBO J, V19, P6675, DOI 10.1093/emboj/19.24.6675
   El Ghouzzi V, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1159-8
   Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055
   Faghri S, 2008, J MED GENET, V45, P609, DOI 10.1136/jmg.2008.058743
   Farooq M, 2016, J HUM GENET, V61, P271, DOI 10.1038/jhg.2015.138
   Florio M, 2017, CURR OPIN NEUROBIOL, V42, P33, DOI 10.1016/j.conb.2016.11.004
   Florio M, 2014, DEVELOPMENT, V141, P2182, DOI 10.1242/dev.090571
   Fu JY, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120104
   Fujimori A, 2014, BRAIN DEV-JPN, V36, P661, DOI 10.1016/j.braindev.2013.10.006
   Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005
   Gabriel E, 2016, EMBO J, V35, P803, DOI 10.15252/embj.201593679
   Gao YJ, 1998, CELL, V95, P891, DOI 10.1016/S0092-8674(00)81714-6
   Geschwind DH, 2013, NEURON, V80, P633, DOI 10.1016/j.neuron.2013.10.045
   Giandomenico SL, 2017, CURR OPIN CELL BIOL, V44, P36, DOI 10.1016/j.ceb.2017.01.001
   Gopalakrishnan J, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201900011
   Gopalakrishnan J, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1367
   Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80
   Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003
   Henry MP, 2019, FRONT GENET, V9, DOI 10.3389/fgene.2018.00623
   Hill RS, 2005, NATURE, V437, P64, DOI 10.1038/nature04103
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005
   Insolera R, 2014, NAT NEUROSCI, V17, P1528, DOI 10.1038/nn.3831
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Jayaraman D, 2018, ANNU REV GENOM HUM G, V19, P177, DOI 10.1146/annurev-genom-083117-021441
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kalay E, 2011, NAT GENET, V43, P23, DOI 10.1038/ng.725
   Khan MA, 2014, HUM MOL GENET, V23, P5940, DOI 10.1093/hmg/ddu318
   Kim S, 2011, NAT CELL BIOL, V13, P351, DOI 10.1038/ncb2183
   Lancaster MA, 2014, SCIENCE, V345, DOI 10.1126/science.1247125
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lawo S, 2012, NAT CELL BIOL, V14, P1148, DOI 10.1038/ncb2591
   Li HD, 2016, AM J HUM GENET, V99, P501, DOI 10.1016/j.ajhg.2016.07.004
   Li R, 2017, PROTEIN CELL, V8, P823, DOI 10.1007/s13238-017-0479-2
   Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102
   Lin YC, 2013, EMBO J, V32, P1141, DOI 10.1038/emboj.2013.56
   Lizarraga SB, 2010, DEVELOPMENT, V137, P1907, DOI 10.1242/dev.040410
   Maldonado M, 2016, STEM CELL RES, V17, P222, DOI 10.1016/j.scr.2016.07.009
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109
   Marjanovic M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8676
   McIntyre RE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003022
   Minh Nguyen Tuyet Le, 2019, Bioengineering-Basel, V6, DOI 10.3390/bioengineering6020048
   Miyoshi K, 2009, FASEB J, V23, P3289, DOI 10.1096/fj.08-124420
   Moawia A, 2017, ANN NEUROL, V82, P562, DOI 10.1002/ana.25044
   Molnar Z, 2012, PROG BRAIN RES, V195, P45, DOI 10.1016/B978-0-444-53860-4.00003-9
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   NORTHCUTT RG, 1995, TRENDS NEUROSCI, V18, P373
   O'Driscoll M, 2003, NAT GENET, V33, P497, DOI 10.1038/ng1129
   Orii KE, 2006, P NATL ACAD SCI USA, V103, P10017, DOI 10.1073/pnas.0602436103
   Ostergaard P, 2012, AM J HUM GENET, V90, P356, DOI 10.1016/j.ajhg.2011.12.018
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Passemard S, 2011, J CLIN INVEST, V121, P3072, DOI 10.1172/JCI43824
   Pirozzi F, 2018, DIALOGUES CLIN NEURO, V20, P267, DOI 10.31887/DCNS.2018.20.4/gmirzaa
   Poirier K, 2013, NAT GENET, V45, P639, DOI 10.1038/ng.2613
   Pulvers JN, 2010, P NATL ACAD SCI USA, V107, P16595, DOI 10.1073/pnas.1010494107
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P
   Ramani A, 2018, CELL REP, V25, P3618, DOI 10.1016/j.celrep.2018.11.102
   Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174
   Reardon PK, 2018, SCIENCE, V360, P1222, DOI 10.1126/science.aar2578
   RILLING JK, 2014, SCI ENG ETHICS, V18, P46, DOI DOI 10.1016/J.TICS.2013.09.013
   Romaniello R, 2012, DEV MED CHILD NEUROL, V54, P765, DOI 10.1111/j.1469-8749.2012.04316.x
   Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002
   Setia H, 2019, SEMIN CELL DEV BIOL, V95, P93, DOI 10.1016/j.semcdb.2019.03.002
   Shaheen R, 2016, HUM GENET, V135, P1191, DOI 10.1007/s00439-016-1722-2
   Shamseldin H, 2015, AM J HUM GENET, V97, P862, DOI 10.1016/j.ajhg.2015.10.012
   Shohayeb B, 2020, HUM MOL GENET, V29, P248, DOI 10.1093/hmg/ddz281
   Su J, 2019, CELL REP, V28, P1400, DOI 10.1016/j.celrep.2019.07.011
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Varon R, 1998, CELL, V93, P467, DOI 10.1016/S0092-8674(00)81174-5
   Vemuri MC, 2001, CELL DEATH DIFFER, V8, P245, DOI 10.1038/sj.cdd.4400806
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435
   Wei HM, 2020, AM J MED GENET A, V182, P576, DOI 10.1002/ajmg.a.61444
   Wolf B, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.160231
   Yoshihara M, 2017, STEM CELL REV REP, V13, P7, DOI 10.1007/s12015-016-9680-6
   Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714
   Zhang W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10497-2
   Zheng XD, 2014, P NATL ACAD SCI USA, V111, pE354, DOI 10.1073/pnas.1317535111
   ZHENG YX, 1995, NATURE, V378, P578, DOI 10.1038/378578a0
   Zhou ZW, 2013, DNA REPAIR, V12, P645, DOI 10.1016/j.dnarep.2013.04.017
NR 114
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1662-5102
J9 FRONT CELL NEUROSCI
JI Front. Cell. Neurosci.
PD MAY 8
PY 2020
VL 14
AR 115
DI 10.3389/fncel.2020.00115
PG 13
WC Neurosciences
SC Neurosciences & Neurology
GA LT0PH
UT WOS:000536778400001
PM 32457578
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Acosta, PL
   Byrne, AB
   Hijano, DR
   Talarico, LB
AF Acosta, Patricio L.
   Byrne, Alana B.
   Hijano, Diego R.
   Talarico, Laura B.
TI Human Type I Interferon Antiviral Effects in Respiratory and Reemerging
   Viral Infections
SO JOURNAL OF IMMUNOLOGY RESEARCH
LA English
DT Review
ID WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS-VIRUS; INFLUENZA-A VIRUS;
   PAPAIN-LIKE PROTEASE; SINGLE-STRANDED RNA; INDUCIBLE GENE-I;
   PLASMACYTOID DENDRITIC CELLS; DENGUE HEMORRHAGIC-FEVER; TOLL-LIKE
   RECEPTORS; ZIKA VIRUS
AB Type I interferons (IFN-I) are a group of related proteins that help regulate the activity of the immune system and play a key role in host defense against viral infections. Upon infection, the IFN-I are rapidly secreted and induce a wide range of effects that not only act upon innate immune cells but also modulate the adaptive immune system. While IFN-I and many IFN stimulated genes are well-known for their protective antiviral role, recent studies have associated them with potential pathogenic functions. In this review, we summarize the current knowledge regarding the complex effects of human IFN-I responses in respiratory as well as reemerging flavivirus infections of public health significance and the molecular mechanisms by which viral proteins antagonize the establishment of an antiviral host defense. Antiviral effects and immune modulation of IFN-stimulated genes is discussed in resisting and controlling pathogens. Understanding the mechanisms of these processes will be crucial in determining how viral replication can be effectively controlled and in developing safe and effective vaccines and novel therapeutic strategies.
C1 [Acosta, Patricio L.; Byrne, Alana B.; Talarico, Laura B.] Hosp Ninos Dr Ricardo Gutierrez, Dept Med, Unidad Infectol, Lab Invest Infectol & Biol Mol, RA-1425 Buenos Aires, DF, Argentina.
   [Acosta, Patricio L.; Byrne, Alana B.; Talarico, Laura B.] Consejo Nacl Invest Cient & Tecn CONICET, RA-1425 Buenos Aires, DF, Argentina.
   [Hijano, Diego R.] St Jude Childrens Res Hosp, Dept Infect Dis, 332 N Lauderdale St, Memphis, TN 38105 USA.
RP Talarico, LB (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Dept Med, Unidad Infectol, Lab Invest Infectol & Biol Mol, RA-1425 Buenos Aires, DF, Argentina.; Talarico, LB (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, RA-1425 Buenos Aires, DF, Argentina.
EM patricioacosta@conicet.gov.ar; alanabyrne@conicet.gov.ar;
   diego.hijano@stjude.org; ltalarico@conicet.gov.ar
RI Hijano, Diego/N-2665-2018
OI Hijano, Diego/0000-0002-2903-666X
FU Agencia Nacional de Promocion Cientifica y Tecnologica (Grant PICT 2015)
   [0076]; CONICETConsejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET)
FX The authors apologize to colleagues whose work could not be cited due to
   space constraints. This work was supported by Agencia Nacional de
   Promocion Cientifica y Tecnologica (Grant PICT 2015 No 0076) and
   CONICET. PLA and LBT are career researchers from CONICET and ABB is a
   fellow from the same institution.
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Andrejeva J, 2004, P NATL ACAD SCI USA, V101, P17264, DOI 10.1073/pnas.0407639101
   Andrejeva J, 2002, J VIROL, V76, P2159, DOI 10.1128/JVI.76.5.2159-2167.2002
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Ashour J, 2010, CELL HOST MICROBE, V8, P410, DOI 10.1016/j.chom.2010.10.007
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Assil S, 2019, CELL HOST MICROBE, V25, P730, DOI 10.1016/j.chom.2019.03.005
   Bao XY, 2008, J VIROL, V82, P8224, DOI 10.1128/JVI.02584-07
   Barral PM, 2009, VIROLOGY, V391, P171, DOI 10.1016/j.virol.2009.06.045
   Bartlett NW, 2012, EMBO MOL MED, V4, P1244, DOI 10.1002/emmm.201201650
   Becker TM, 2013, ANN ALLERG ASTHMA IM, V111, P397, DOI 10.1016/j.anai.2013.07.029
   Becquart P, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-356
   Belgnaoui SM, 2011, CURR OPIN IMMUNOL, V23, P564, DOI 10.1016/j.coi.2011.08.001
   Bergmann M, 2000, J VIROL, V74, P6203, DOI 10.1128/JVI.74.13.6203-6206.2000
   Bermejo-Martin JF, 2007, EUR CYTOKINE NETW, V18, P162
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bin Seo Y, 2014, INFECT CHEMOTHER, V46, P67, DOI 10.3947/ic.2014.46.2.67
   Blasius AL, 2010, IMMUNITY, V32, P305, DOI 10.1016/j.immuni.2010.03.012
   Bloom JD, 2010, SCIENCE, V328, P1272, DOI 10.1126/science.1187816
   BOCCI V, 1984, CANC DRUG DEL, V1, P337, DOI 10.1089/cdd.1984.1.337
   Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10
   Boonyaratanakornkit JB, 2009, J VIROL, V83, P1892, DOI 10.1128/JVI.01373-08
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   BRINKMANN V, 1993, J EXP MED, V178, P1655, DOI 10.1084/jem.178.5.1655
   Brooks TJG, 1999, ANTIVIR RES, V41, P57, DOI 10.1016/S0166-3542(98)00063-1
   Caballero MT, 2015, J CLIN INVEST, V125, P571, DOI 10.1172/JCI75183
   Cakebread JA, 2011, J ALLERGY CLIN IMMUN, V127, P1148, DOI 10.1016/j.jaci.2011.01.023
   Cameron MJ, 2007, J VIROL, V81, P8692, DOI 10.1128/JVI.00527-07
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Canaday DH, 2010, J CLIN IMMUNOL, V30, P373, DOI 10.1007/s10875-010-9374-9
   Caraceni A, 1998, CANCER, V83, P482, DOI 10.1002/(SICI)1097-0142(19980801)83:3<482::AID-CNCR17>3.0.CO;2-S
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Centers for Disease Control and Prevention, W NIL VIR STAT MAPS
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chan-Tack KM, 2005, SCAND J INFECT DIS, V37, P944, DOI 10.1080/00365540500262690
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chen JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16459
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chen RF, 2007, T ROY SOC TROP MED H, V101, P1106, DOI 10.1016/j.trstmh.2007.06.019
   Chen Y, 2020, J MED VIROL, V92, P418, DOI 10.1002/jmv.25681
   Chen Y, 2016, VIROLOGY, V499, P361, DOI 10.1016/j.virol.2016.09.026
   Childs K, 2007, VIROLOGY, V359, P190, DOI 10.1016/j.virol.2006.09.023
   Childs KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064202
   Crosse KM, 2018, J INNATE IMMUN, V10, P85, DOI 10.1159/000484258
   Cumberworth SL, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12737
   Curtsinger JM, 2005, J IMMUNOL, V174, P4465, DOI 10.4049/jimmunol.174.8.4465
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dai JF, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-468
   Davidson S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4864
   Hernandez SID, 2014, J CLIN VIROL, V60, P196, DOI 10.1016/j.jcv.2014.04.002
   Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200
   Dhiman G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46389-0
   Di Trolio R, 2015, CYTOKINE GROWTH F R, V26, P203, DOI 10.1016/j.cytogfr.2014.11.008
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000
   Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114
   Dinwiddie DL, 2008, AM J RESP CELL MOL, V38, P661, DOI 10.1165/rcmb.2007-0285OC
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Oliveira RAD, 2016, MEM I OSWALDO CRUZ, V111, P378, DOI 10.1590/0074-02760150453
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Drahos J, 2009, J VIROL, V83, P11581, DOI 10.1128/JVI.01490-09
   Dubois J, 1999, J PEDIATR-US, V135, P782, DOI 10.1016/S0022-3476(99)70104-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin RK, 2013, IMMUNOL REV, V255, P25, DOI 10.1111/imr.12101
   Dyer O, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6983
   Edwards MR, 2013, MUCOSAL IMMUNOL, V6, P797, DOI 10.1038/mi.2012.118
   Ehrhardt C, 2009, CELL MICROBIOL, V11, P863, DOI 10.1111/j.1462-5822.2009.01309.x
   Elliott J, 2007, J VIROL, V81, P3428, DOI 10.1128/JVI.02303-06
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Espert L, 2003, J BIOL CHEM, V278, P16151, DOI 10.1074/jbc.M209628200
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Everitt AR, 2012, NATURE, V484, P519, DOI 10.1038/nature10921
   Falsey AR, 2005, NEW ENGL J MED, V352, P1749, DOI 10.1056/NEJMoa043951
   FARR BM, 1984, ANTIMICROB AGENTS CH, V26, P31, DOI 10.1128/AAC.26.1.31
   Fendrick A Mark, 2003, Am J Ther, V10, P193, DOI 10.1097/00045391-200305000-00006
   Feuillet F, 2012, J CLIN VIROL, V53, P97, DOI 10.1016/j.jcv.2011.10.002
   Fitzgerald-Bocarsly P, 2007, BIOCHIMIE, V89, P843, DOI 10.1016/j.biochi.2007.04.018
   Forbes RL, 2012, J INFECT DIS, V206, P646, DOI 10.1093/infdis/jis377
   Frieman M, 2009, J VIROL, V83, P6689, DOI 10.1128/JVI.02220-08
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gandini M, 2011, MEM I OSWALDO CRUZ, V106, P594, DOI 10.1590/S0074-02762011000500012
   Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gaunt ER, 2011, J CLIN VIROL, V52, P215, DOI 10.1016/j.jcv.2011.07.017
   Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488
   Gern JE, 2010, J VIROL, V84, P7418, DOI 10.1128/JVI.02290-09
   Gogas H, 2004, ANTICANCER RES, V24, P1947
   Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Goutagny N, 2010, J IMMUNOL, V184, P1168, DOI 10.4049/jimmunol.0902750
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gray TJ, 2014, INT J GEN MED, V7, P193, DOI 10.2147/IJGM.S59902
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0
   Hale BG, 2010, J VIROL, V84, P6909, DOI 10.1128/JVI.00081-10
   Hall CB, 2009, NEW ENGL J MED, V360, P588, DOI 10.1056/NEJMoa0804877
   HALL CB, 1978, J PEDIATR-US, V93, P28, DOI 10.1016/S0022-3476(78)80594-0
   Haller O, 2011, J INTERF CYTOK RES, V31, P79, DOI 10.1089/jir.2010.0076
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hancock WT, 2014, EMERG INFECT DIS, V20, P1960, DOI [10.3201/eid2011.141253, 10.3201/eid2011.141380]
   HARINASUTA C, 1984, Southeast Asian Journal of Tropical Medicine and Public Health, V15, P564
   Hartmann CA, 2017, AM J TRANSPLANT, V17, P2200, DOI 10.1111/ajt.14336
   Hastings AK, 2015, J VIROL, V89, P4405, DOI 10.1128/JVI.03275-14
   HAYDEN FG, 1986, NEW ENGL J MED, V314, P71, DOI 10.1056/NEJM198601093140202
   HAYDEN FG, 1983, J INFECT DIS, V148, P543, DOI 10.1093/infdis/148.3.543
   Hayes EB, 2006, ANNU REV MED, V57, P181, DOI 10.1146/annurev.med.57.121304.131418
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019
   Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178
   Hernandez N, 2019, J EXP MED, V216, P2057, DOI 10.1084/jem.20182295
   Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201
   Hewson CA, 2005, J VIROL, V79, P12273, DOI 10.1128/JVI.79.19.12273-12279.2005
   Hishiki T, 2014, BIOCHEM BIOPH RES CO, V448, P95, DOI 10.1016/j.bbrc.2014.04.081
   Hogner K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003188
   Hoffman KW, 2016, J INFECT DIS, V214, P634, DOI 10.1093/infdis/jiw179
   Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009
   Hu YW, 2019, CELL BIOSCI, V9, DOI 10.1186/s13578-019-0308-9
   Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258
   Hwang J, 2015, J KOREAN MED SCI, V30, P343, DOI 10.3346/jkms.2015.30.3.343
   Ioannidis I, 2012, J VIROL, V86, P5422, DOI 10.1128/JVI.06757-11
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049
   ISAACS A, 1987, J INTERFERON RES, V7, P429, DOI 10.1089/jir.1987.7.429
   Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   Iwasaki A, 2004, NAT IMMUNOL, V5, P987, DOI 10.1038/ni1112
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Jewell NA, 2007, J VIROL, V81, P9790, DOI 10.1128/JVI.00530-07
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Jin H, 2000, VIROLOGY, V273, P210, DOI 10.1006/viro.2000.0393
   Kahn JS, 2006, CLIN MICROBIOL REV, V19, P546, DOI 10.1128/CMR.00014-06
   Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945
   Kamaladasa A, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104554
   Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734
   Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091
   Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006
   Kennedy JL, 2014, AM J RESP CRIT CARE, V189, P532, DOI 10.1164/rccm.201310-1767OC
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Kim ES, 2016, J KOREAN MED SCI, V31, P1717, DOI 10.3346/jkms.2016.31.11.1717
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Klein MI, 2008, PEDIATRICS, V121, pE1510, DOI 10.1542/peds.2007-1757
   Knipe D.M., 2013, FIELDS VIROLOGY
   Koerner I, 2007, J VIROL, V81, P2025, DOI 10.1128/JVI.01718-06
   KOMADA H, 1989, VIROLOGY, V171, P28, DOI 10.1016/0042-6822(89)90507-2
   Krug RM, 2015, CURR OPIN VIROL, V12, P1, DOI 10.1016/j.coviro.2015.01.007
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   KURANE I, 1993, AM J TROP MED HYG, V48, P222, DOI 10.4269/ajtmh.1993.48.222
   KURANE I, 1988, J GEN VIROL, V69, P445, DOI 10.1099/0022-1317-69-2-445
   Lai JH, 2018, EMBO REP, V19, DOI 10.15252/embr.201846182
   Laurent-Rolle M, 2019, DNA CELL BIOL, V38, P1414, DOI 10.1089/dna.2019.5115
   Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0
   Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368
   Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001
   Lewis M, 2007, PHARMACOTHERAPY, V27, P455, DOI 10.1592/phco.27.3.455
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liao AP, 2010, CLIN IMMUNOL, V136, P130, DOI 10.1016/j.clim.2010.02.014
   Liao S, 2008, J GEN VIROL, V89, P1978, DOI 10.1099/vir.0.2008/000778-0
   Libraty DH, 2002, J INFECT DIS, V185, P1213, DOI 10.1086/340365
   Lin RJ, 2006, J VIROL, V80, P5908, DOI 10.1128/JVI.02714-05
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Lin RJ, 2004, J VIROL, V78, P9285, DOI 10.1128/JVI.78.17.9285-9294.2004
   Ling Z, 2009, J VIROL, V83, P3734, DOI 10.1128/JVI.02434-08
   Liu BM, 2016, J VIROL, V90, P4369, DOI 10.1128/JVI.03172-15
   Liu BM, 2014, J VIROL, V88, P13821, DOI 10.1128/JVI.02505-14
   Lo MS, 2005, J VIROL, V79, P9315, DOI 10.1128/JVI.79.14.9315-9319.2005
   Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   LUBY JP, 1975, J INFECT DIS, V132, P361, DOI 10.1093/infdis/132.4.361
   Lund JM, 2004, P NATL ACAD SCI USA, V101, P5598, DOI 10.1073/pnas.0400937101
   Luthra P, 2011, P NATL ACAD SCI USA, V108, P2118, DOI 10.1073/pnas.1012409108
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665
   Malmo J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155484
   Malur AG, 2004, VIRUS RES, V99, P199, DOI 10.1016/j.virusres.2003.11.009
   Manocha GD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-24
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Marques RE, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0837-2
   Marr N, 2014, J IMMUNOL, V192, P948, DOI 10.4049/jimmunol.1302007
   Marrack P, 1999, J EXP MED, V189, P521, DOI 10.1084/jem.189.3.521
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez J, 2008, J IMMUNOL, V180, P1592, DOI 10.4049/jimmunol.180.3.1592
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Mazzon M, 2009, J INFECT DIS, V200, P1261, DOI 10.1086/605847
   MCINTOSH K, 1978, J PEDIATR-US, V93, P33, DOI 10.1016/S0022-3476(78)80595-2
   McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787
   Melendi GA, 2010, ACTA PAEDIATR, V99, P1517, DOI 10.1111/j.1651-2227.2010.01862.x
   Menachery VD, 2014, MBIO, V5, DOI 10.1128/mBio.01174-14
   Mielech AM, 2014, VIROLOGY, V450, P64, DOI 10.1016/j.virol.2013.11.040
   Minami T, 2013, J GASTROENTEROL, V48, P254, DOI 10.1007/s00535-012-0631-y
   Miorin L, 2019, J VIROL, V93, DOI 10.1128/JVI.00151-19
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   MONTO AS, 1989, ANTIMICROB AGENTS CH, V33, P387, DOI 10.1128/AAC.33.3.387
   Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Moynagh Paul N, 2005, J Cell Sci, V118, P4589, DOI 10.1242/jcs.02579
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   MURPHY DG, 1991, VIROLOGY, V181, P760, DOI 10.1016/0042-6822(91)90913-V
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nogales A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120708
   Omrani AS, 2014, LANCET INFECT DIS, V14, P1090, DOI 10.1016/S1473-3099(14)70920-X
   Orozco S, 2012, J GEN VIROL, V93, P2152, DOI 10.1099/vir.0.045088-0
   Oshansky CM, 2014, AM J RESP CRIT CARE, V189, P449, DOI 10.1164/rccm.201309-1616OC
   Pagani I, 2017, SCI REP-UK, V7, DOI 10.1038/srep44286
   Pagni S, 2012, IMMUNOL RES, V54, P152, DOI 10.1007/s12026-012-8334-2
   Torres REP, 2016, J MED VIROL, V88, P395, DOI 10.1002/jmv.24343
   Perdomo-Celis F, 2017, VIROLOGY, V507, P11, DOI 10.1016/j.virol.2017.04.004
   Pestka S, 2004, IMMUNOL REV, V202, P8, DOI 10.1111/j.0105-2896.2004.00204.x
   Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998
   Pierson C. P., 2013, FIELDS VIROLOGY, P747
   Pindel A, 2011, J INTERF CYTOK RES, V31, P59, DOI 10.1089/jir.2010.0099
   PORTNOY J, 1988, ANTIMICROB AGENTS CH, V32, P589, DOI 10.1128/AAC.32.4.589
   Price GE, 2000, J VIROL, V74, P3996, DOI 10.1128/JVI.74.9.3996-4003.2000
   Qu HR, 2016, VIRUS GENES, V52, P759, DOI 10.1007/s11262-016-1366-2
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rahal JJ, 2004, J INFECT DIS, V190, P1084, DOI 10.1086/423325
   Ramaswamy M, 2006, VIROLOGY, V344, P328, DOI 10.1016/j.virol.2005.09.009
   Ramaswamy M, 2004, AM J RESP CELL MOL, V30, P893, DOI 10.1165/rcmb.2003-0410OC
   Rawle DJ, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0279-3
   Reisen William K, 2003, Adv Virus Res, V61, P139, DOI 10.1016/S0065-3527(03)61004-3
   Ren JP, 2012, J VIROL, V86, P13049, DOI 10.1128/JVI.01248-12
   Ren JP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024496
   Ren JP, 2011, J GEN VIROL, V92, P2153, DOI 10.1099/vir.0.032987-0
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012
   ROBERTS NJ, 1992, MICROB PATHOGENESIS, V12, P409, DOI 10.1016/0882-4010(92)90003-7
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P4845, DOI 10.1128/JVI.02514-09
   Sabbah A, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-200
   Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782
   Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Santos CNO, 2019, J INFECT DIS, V220, P1797, DOI 10.1093/infdis/jiz392
   Savale L, 2014, EUR RESPIR J, V44, P1627, DOI 10.1183/09031936.00057914
   Schaap-Nutt A, 2012, VIROLOGY, V433, P320, DOI 10.1016/j.virol.2012.08.027
   Schaap-Nutt A, 2010, VIROLOGY, V397, P285, DOI 10.1016/j.virol.2009.11.018
   Scheuplein VA, 2015, J VIROL, V89, P3859, DOI 10.1128/JVI.03607-14
   Schierhorn KL, 2017, J VIROL, V91, DOI 10.1128/JVI.00198-17
   Schmidinger Manuela, 2013, EJC Suppl, V11, P172, DOI 10.1016/j.ejcsup.2013.07.016
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862
   Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Schomacker H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028382
   Setoh YX, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110326
   Shafagati Nazly, 2018, F1000Res, V7, P135, DOI 10.12688/f1000research.12625.1
   Shi CS, 2014, J IMMUNOL, V193, P3080, DOI 10.4049/jimmunol.1303196
   Siegal FP, 1999, SCIENCE, V284, P1835, DOI 10.1126/science.284.5421.1835
   Silverman RH, 2007, J VIROL, V81, P12720, DOI 10.1128/JVI.01471-07
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh PK, 2019, OCUL SURF, V17, P551, DOI 10.1016/j.jtos.2019.03.006
   Singla M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004497
   Sinigaglia L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29235-7
   Siu KL, 2009, J BIOL CHEM, V284, P16202, DOI 10.1074/jbc.M109.008227
   Slater L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001178
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2
   Soto JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02466
   Stabell AC, 2018, ELIFE, V7, DOI [10.7554/eLife.31919, 10.7554/elife.31919]
   Subramanian G, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006877
   SUNG RYT, 1993, ARCH DIS CHILD, V69, P440, DOI 10.1136/adc.69.4.440
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Sykes A, 2012, J ALLERGY CLIN IMMUN, V129, P1506, DOI 10.1016/j.jaci.2012.03.044
   Szretter KJ, 2009, J VIROL, V83, P5825, DOI 10.1128/JVI.02144-08
   Tailor P, 2006, CELL RES, V16, P134, DOI 10.1038/sj.cr.7310018
   Takamatsu Y, 2015, J GEN VIROL, V96, P2194, DOI 10.1099/vir.0.000168
   Talarico LB, 2017, J CLIN VIROL, V97, P10, DOI 10.1016/j.jcv.2017.10.010
   Tang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012644
   Taniguchi T, 2002, CURR OPIN IMMUNOL, V14, P111, DOI 10.1016/S0952-7915(01)00305-3
   te Velthuis AJW, 2016, NAT REV MICROBIOL, V14, P479, DOI 10.1038/nrmicro.2016.87
   Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843
   Thwaites RS, 2018, AM J RESP CRIT CARE, V198, P1074, DOI 10.1164/rccm.201712-2567OC
   Tobler LH, 2008, J INFECT DIS, V198, P979, DOI 10.1086/591466
   Tregoning JS, 2010, CLIN MICROBIOL REV, V23, P74, DOI 10.1128/CMR.00032-09
   Triantafilou K, 2011, VIRULENCE, V2, P22, DOI 10.4161/viru.2.1.13807
   Tricarico PM, 2017, BIOCHEM BIOPH RES CO, V492, P597, DOI 10.1016/j.bbrc.2017.01.158
   Unni SK, 2011, MICROBES INFECT, V13, P312, DOI 10.1016/j.micinf.2011.01.002
   Lopez JFV, 2019, J INTERF CYTOK RES, V39, P507, DOI 10.1089/jir.2019.0058
   Valdez F, 2019, J VIROL, V93, DOI 10.1128/JVI.00104-19
   Van Cleve W, 2006, VIROLOGY, V352, P61, DOI 10.1016/j.virol.2006.04.011
   van den Hoogen BG, 2001, NAT MED, V7, P719, DOI 10.1038/89098
   van der Hoek L, 2007, ANTIVIR THER, V12, P651
   Vilcek J, 2006, IMMUNITY, V25, P343, DOI 10.1016/j.immuni.2006.08.008
   Wang KZ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007287
   Wang LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03912-5
   Wang Q, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002070
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Wang WS, 2017, TRENDS MICROBIOL, V25, P574, DOI 10.1016/j.tim.2017.01.001
   Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009
   Watkinson RE, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005253
   Weinberg GA, 2009, J PEDIATR-US, V154, P694, DOI 10.1016/j.jpeds.2008.11.034
   Westfechtel L, 2018, SEX TRANSM INFECT, V94, P21, DOI 10.1136/sextrans-2017-053150
   Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xi Y, 2015, CLIN TRANSL IMMUNOL, V4, DOI 10.1038/cti.2015.27
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229
   Yang DR, 2015, WORLD J GASTROENTERO, V21, P3786, DOI 10.3748/wjg.v21.i13.3786
   Ye J, 2017, J VIROL, V91, DOI [10.1128/jvi.00039-17, 10.1128/JVI.00039-17]
   Yeo KT, 2018, CLIN INFECT DIS, V67, P1603, DOI 10.1093/cid/ciy311
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yu SP, 2019, VIROLOGY, V527, P107, DOI 10.1016/j.virol.2018.10.015
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang HL, 2017, J VIROL, V91, DOI [10.1128/jvi.02396-16, 10.1128/JVI.02396-16]
   Zhang WD, 2005, NAT MED, V11, P56, DOI 10.1038/nm1174
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
   Zhu YP, 2008, RNA BIOL, V5, P65, DOI 10.4161/rna.5.2.6044
   Zimmerman MG, 2019, J VIROL, V93, DOI 10.1128/JVI.00664-19
   Zou CL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007202
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 325
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-8861
EI 2314-7156
J9 J IMMUNOL RES
JI J Immunol. Res.
PD MAY 8
PY 2020
VL 2020
AR 1372494
DI 10.1155/2020/1372494
PG 27
WC Immunology
SC Immunology
GA LS1IK
UT WOS:000536145200001
PM 32455136
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, SX
   Zhao, H
   Yang, HW
   Hou, WH
   Cruz-Corme, R
   Cao, RY
   Chen, C
   Wang, W
   Xu, LF
   Jun, Z
   Zhong, W
   Xia, NS
   Tang, QY
   Cheng, T
AF Li, Shuxuan
   Zhao, Huan
   Yang, Hongwei
   Hou, Wangheng
   Cruz-Corme, Ruth
   Cao, Ruiyuan
   Chen, Chunye
   Wang, Wei
   Xu, Longfa
   Jun, Zhang
   Zhong, Wu
   Xia, Ningshao
   Tang, Qiyi
   Cheng, Tong
TI Rapid Neutralization Testing System for Zika Virus Based on an
   Enzyme-Linked Immunospot Assay
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; ELISPOT; neutralization test; neutralizing antibody
ID ANTIBODIES; GAMMA
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has been associated with neuropathology in fetuses and adults, imposing a serious health concern. Therefore, the development of a vaccine is a global health priority. Notably, neutralization tests have a significant value for vaccine development and virus diagnosis. The cytopathic effect (CPE)-based neutralization test (Nt-CPE) is a common neutralization method for ZIKV. However, this method has some drawbacks, such as being time-consuming and labor-intensive and having low-throughput, which precludes its application in the detection of large numbers of specimens. To improve this problem, we developed a neutralization test based on an enzyme-linked immunospot assay (Nt-ELISPOT) for ZIKV and performed the assay in a 96-well format. A monoclonal antibody (b), 11C11, with high affinity and reactivity to ZIKV was used to detect ZIKV-infected cells. To optimize this method, the infectious dose of ZIKV was set at a multiplicity of infection (MOI) of 0.0625, and a detection experiment was performed after incubating for 24 h. As a result, under these conditions, the Nt-ELISPOT had good consistency with the traditional Nt-CPE to measure neutralizing titers of sera and neutralizing antibodies. Additionally, three neutralizing antibodies against ZIKV were screened by this method. Overall, we successfully developed an efficient neutralization test for ZIKV that is high-throughput and rapid. This Nt-ELISPOT can potentially be applied to detecting neutralizing titers of large numbers of specimens in vaccine evaluation and neutralizing antibody screening for ZIKV.
C1 [Li, Shuxuan; Zhao, Huan; Yang, Hongwei; Hou, Wangheng; Chen, Chunye; Wang, Wei; Xu, Longfa; Jun, Zhang; Xia, Ningshao; Cheng, Tong] Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost,Sch Pub, Xiamen 361102, Fujian, Peoples R China.
   [Cruz-Corme, Ruth; Tang, Qiyi] Howard Univ, Dept Microbiol, Coll Med, 520 W St NW, Washington, DC 20059 USA.
   [Cao, Ruiyuan; Zhong, Wu] Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Emergency Drug, Beijing 100850, Peoples R China.
RP Cheng, T (corresponding author), Xiamen Univ, Sch Life Sci, Natl Inst Diagnost & Vaccine Dev Infect Dis, State Key Lab Mol Vaccinol & Mol Diagnost,Sch Pub, Xiamen 361102, Fujian, Peoples R China.; Tang, QY (corresponding author), Howard Univ, Dept Microbiol, Coll Med, 520 W St NW, Washington, DC 20059 USA.
EM qiyi.tang@howard.edu; tcheng@xmu.edu.cn
OI Xia, Ningshao/0000-0003-0179-5266
FU National Science and Technology Major Projects for Major New Drugs
   Innovation and Development [2018ZX09711003-005-003]; National Science
   and Technology Major Project of Infectious Diseases [2017ZX10304402];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81871648, 81701999, 31670933, XMULAC20160049]
FX This work was supported by a grant from the National Science and
   Technology Major Projects for Major New Drugs Innovation and Development
   (No. 2018ZX09711003-005-003), the National Science and Technology Major
   Project of Infectious Diseases (No. 2017ZX10304402), and the National
   Natural Science Foundation of China (Nos. 81871648, 81701999, and
   31670933). The sponsors had no role in the study design, data collection
   and analysis, decision to publish, or preparation of the manuscript. All
   of the animal experiments in this study were approved by the
   Institutional Animal Care and Use Committee at Xiamen University and
   conducted in accordance with animal ethics guidelines and approved
   protocols. The Animal Ethics Committee approval No. was XMULAC20160049.
CR Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cagno V, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.04.016
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   CZERKINSKY CC, 1983, J IMMUNOL METHODS, V65, P109, DOI 10.1016/0022-1759(83)90308-3
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Harlow Ed, 1999
   Hou WH, 2015, J VIROL METHODS, V215, P56, DOI 10.1016/j.jviromet.2015.02.010
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Langerak T, 2019, J INFECT DIS, V220, P28, DOI 10.1093/infdis/jiz063
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   Li TD, 2014, J VIROL METHODS, V209, P7, DOI 10.1016/j.jviromet.2014.08.012
   Li XQ, 2013, APPL MICROBIOL BIOT, V97, P6503, DOI 10.1007/s00253-013-5021-8
   Liu DX, 2019, APPL MICROBIOL BIOT, V103, P1931, DOI 10.1007/s00253-018-09598-7
   Liu LD, 2012, CLIN VACCINE IMMUNOL, V19, P73, DOI 10.1128/CVI.05388-11
   Luo Y, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0508-4
   Mao QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079599
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   NAKANE PK, 1974, J HISTOCHEM CYTOCHEM, V22, P1084, DOI 10.1177/22.12.1084
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Rodrigo WWSI, 2009, AM J TROP MED HYG, V80, P61
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   TAGUCHI T, 1990, J IMMUNOL METHODS, V128, P65, DOI 10.1016/0022-1759(90)90464-7
   Yang LS, 2014, CLIN VACCINE IMMUNOL, V21, P312, DOI 10.1128/CVI.00359-13
   Zambrano LI, 2019, INT J INFECT DIS, V84, P136, DOI 10.1016/j.ijid.2019.05.008
NR 42
TC 0
Z9 0
U1 3
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAY 8
PY 2020
VL 6
IS 5
BP 811
EP 819
DI 10.1021/acsinfecdis.9b00333
PG 9
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA LQ7JV
UT WOS:000535176700006
PM 31840495
DA 2020-07-08
ER

PT J
AU Yang, JJ
   Xu, YF
   Yan, YZ
   Li, W
   Zhao, L
   Dai, QS
   Li, YX
   Li, S
   Zhong, J
   Cao, RY
   Zhong, W
AF Yang, Jingjing
   Xu, Yongfen
   Yan, Yunzheng
   Li, Wei
   Zhao, Lei
   Dai, Qingsong
   Li, Yuexiang
   Li, Song
   Zhong, Jin
   Cao, Ruiyuan
   Zhong, Wu
TI Small Molecule Inhibitor of ATPase Activity of HSP70 as a Broad-Spectrum
   Inhibitor against Flavivirus Infections
SO ACS INFECTIOUS DISEASES
LA English
DT Article
DE flavivirus; antiviral; Apoptozole; Zika virus; innate immunity
ID C VIRUS-INFECTION; SHOCK-PROTEIN 72; JAPANESE ENCEPHALITIS; ZIKA VIRUS;
   IMMUNE-RESPONSE; REPLICATION; HSC70; CHAPERONE; REVEALS; TARGET
AB Flaviviruses including Zika virus, Dengue virus, Japanese Encephalitis virus, and Yellow Fever virus cause heavy burdens to public health around the world. No specific antiviral drug is available in the clinic against these flavivirus infections. Heat-shock protein 70 (HSP70) has recently been proven to be a promising antiviral target against Zika virus and Dengue virus. Here, we report that Apoptozole, a small molecule inhibitor of ATPase activity of HSP70, has broad-spectrum anti-flavivirus potential. The mode of action analysis revealed that Apoptozole acted at the post-entry step. Transcriptome analysis revealed that genes related to cholesterol metabolism, fatty acid synthesis, and innate immunity were differentially expressed after treatment with Apoptozole. In vivo data suggested Apoptozole exerted protection effects against Zika virus (ZIKV) infection in a mouse model by enhancing the innate immune response, which suggested a novel anti-ZIKV mechanism of HSP70 inhibitors.
C1 [Xu, Yongfen; Zhong, Jin] Chinese Acad Sci, Inst Pasteur Shanghai, Unit Viral Hepatitis, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Yang, Jingjing; Yan, Yunzheng; Li, Wei; Zhao, Lei; Dai, Qingsong; Li, Yuexiang; Li, Song; Cao, Ruiyuan; Zhong, Wu] Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Emergency Drug, Beijing 100850, Peoples R China.
RP Zhong, J (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, Unit Viral Hepatitis, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.; Cao, RY; Zhong, W (corresponding author), Beijing Inst Pharmacol & Toxicol, Natl Engn Res Ctr Emergency Drug, Beijing 100850, Peoples R China.
EM jzhong@ips.ac.cn; zhongwu@bmi.ac.cn
FU National Natural Science Foundation of China (NSFC)National Natural
   Science Foundation of China [81773631]; National Science and Technology
   Major Projects [2018ZX09711003]; Major New Drugs Innovation and
   Development [2018ZX09711003]; External Cooperation Program of the
   Chinese Academy of SciencesChinese Academy of Sciences
   [153211KYSB20160001]; European Union 2020 Research and Innovation
   Program under ZIKAlliance Grant Agreement [734548]; MOST Key
   International Cooperation Program of China [2016YFE0133500]
FX This work was supported by research grants from the National Natural
   Science Foundation of China (NSFC, 81773631, to R.C.); the National
   Science and Technology Major Projects and "Major New Drugs Innovation
   and Development" (2018ZX09711003, to W. Z.); the External Cooperation
   Program (153211KYSB20160001) of the Chinese Academy of Sciences (to
   J.Z.); the European Union Horizon 2020 Research and Innovation Program
   under ZIKAlliance Grant Agreement 734548 and MOST Key International
   Cooperation Program of China 2016YFE0133500 (to J.Z.).
CR Assimon VA, 2013, CURR PHARM DESIGN, V19, P404
   Baek KH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17642
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bocking T, 2011, NAT STRUCT MOL BIOL, V18, P295, DOI 10.1038/nsmb.1985
   Bozzacco L, 2016, J VIROL, V90, P3212, DOI 10.1128/JVI.03077-15
   Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233
   Carroll SS, 2003, J BIOL CHEM, V278, P11979, DOI 10.1074/jbc.M210914200
   Chen YJ, 2010, J BIOL CHEM, V285, P28183, DOI 10.1074/jbc.M110.118323
   Chuang CK, 2015, J GEN VIROL, V96, P793, DOI 10.1099/jgv.0.000015
   Dansako H, 2018, FEBS OPEN BIO, V8, P361, DOI 10.1002/2211-5463.12373
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong Q, 2018, ANTIVIR RES, V150, P39, DOI 10.1016/j.antiviral.2017.11.020
   Osuna-Ramos JF, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00388
   Gullberg RC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007261
   Gurbuxani S, 2001, ONCOGENE, V20, P7478, DOI 10.1038/sj.onc.1204948
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hishiki T, 2019, ANTIVIR RES, V165, P42, DOI 10.1016/j.antiviral.2019.03.002
   Howe MK, 2016, ANTIVIR RES, V130, P81, DOI 10.1016/j.antiviral.2016.03.017
   Khademi F, 2018, J CELL PHYSIOL, V233, P2920, DOI 10.1002/jcp.26040
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Lim YS, 2012, J VIRAL HEPATITIS, V19, P353, DOI 10.1111/j.1365-2893.2011.01556.x
   Liu WJ, 2018, ONCOTARGETS THER, V11, P6605, DOI 10.2147/OTT.S155930
   Liu ZL, 2009, MOL ENDOCRINOL, V23, P649, DOI 10.1210/me.2008-0412
   Massa C, 2005, CANCER RES, V65, P7942, DOI 10.1158/0008-5472.CAN-05-0377
   Nain M, 2017, J VIROL, V91, DOI [10.1128/JVI.02274-16, 10.1128/jvi.02274-16]
   Nazerai L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00593
   Paciullo F, 2017, J CELL PHYSIOL, V232, P2330, DOI 10.1002/jcp.25767
   Pujhari S, 2019, EMERG MICROBES INFEC, V8, P8, DOI 10.1080/22221751.2018.1557988
   Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6
   Read SA, 2014, J GEN VIROL, V95, P1900, DOI 10.1099/vir.0.065300-0
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Rothwell C, 2009, VIROLOGY, V389, P8, DOI 10.1016/j.virol.2009.03.025
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Shelby T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07620-y
   Shi YZ, 2006, SHOCK, V26, P277, DOI 10.1097/01.shk.0000223134.17877.ad
   Taguwa S, 2019, CELL REP, V26, P906, DOI 10.1016/j.celrep.2018.12.095
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Tan ELC, 2004, EMERG INFECT DIS, V10, P581, DOI 10.3201/eid1004.030458
   Tang WC, 2014, J VIROL, V88, P6793, DOI 10.1128/JVI.00045-14
   Tongluan N, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0685-9
   [王强 Wang Qiang], 2016, [科学通报, Chinese Science Bulletin], V61, P2463
   Xin YZ, 2019, BIOSCI BIOTECH BIOCH, V83, P641, DOI 10.1080/09168451.2018.1559719
   Ye J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075188
   York AG, 2015, CELL, V163, P1716, DOI 10.1016/j.cell.2015.11.045
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Zarate S, 2003, J VIROL, V77, P7254, DOI 10.1128/JVI.77.13.7254-7260.2003
   Zhang MY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42160-7
NR 49
TC 0
Z9 0
U1 2
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAY 8
PY 2020
VL 6
IS 5
BP 832
EP 843
DI 10.1021/acsinfecdis.9b00376
PG 12
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA LQ7JV
UT WOS:000535176700008
PM 31967789
DA 2020-07-08
ER

PT J
AU Xu, JM
   Shi, PY
   Li, HM
   Zhou, J
AF Xu, Jimin
   Shi, Pei-Yong
   Li, Hongmin
   Zhou, Jia
TI Broad Spectrum Antiviral Agent Niclosamide and Its Therapeutic Potential
SO ACS INFECTIOUS DISEASES
LA English
DT Review
DE niclosamide; broad antiviral agents; coronavirus; SARS-CoV; MERS-CoV;
   SARS-CoV-2 (COVID-19); flavivirus; Zika virus; Ebola virus; human
   adenovirus
ID CORONAVIRUS MAIN PROTEINASE; EPSTEIN-BARR-VIRUS; ZIKA VIRUS;
   NITAZOXANIDE; IDENTIFICATION; REPLICATION; INHIBITION; DISCOVERY;
   DERIVATIVES; RESISTANCE
AB The recent outbreak of coronavirus disease 2019 (COVID-19) highlights an urgent need for therapeutics. Through a series of drug repurposing screening campaigns, niclosamide, an FDA-approved anthelminthic drug, was found to be effective against various viral infections with nanomolar to micromolar potency such as SARS-CoV, MERS-CoV, ZIKV, HCV, and human adenovirus, indicating its potential as an antiviral agent. In this brief review, we summarize the broad antiviral activity of niclosamide and highlight its potential clinical use in the treatment of COVID-19.
C1 [Xu, Jimin; Zhou, Jia] Univ Texas Med Branch, Chem Biol Program, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.
   [Shi, Pei-Yong; Zhou, Jia] Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Li, Hongmin] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12208 USA.
RP Zhou, J (corresponding author), Univ Texas Med Branch, Chem Biol Program, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Zhou, J (corresponding author), Univ Texas Med Branch, Sealy Ctr Struct Biol & Mol Biophys, Galveston, TX 77555 USA.
EM jizhou@utmb.edu
OI Zhou, Jia/0000-0002-2811-1090; Li, Hongmin/0000-0002-8684-5308
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R01 AI131669, R21 AI134568]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA; John D. Stobo, the M. D. Distinguished
   Chair Endowment Fund; John Sealy Memorial Endowment Fund at UTMB;
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI142759, AI127744, AI136126]; Kleberg
   Foundation; John S. Dunn Foundation; Amon G. Carter Foundation; Gilson
   Longenbaugh Foundation; Summerfield Robert Foundation
FX This work was supported by grants R01 AI131669 and R21 AI134568 from the
   National Institute of Allergy and Infectious Diseases (NIAID), the
   National Institutes of Health, John D. Stobo, the M. D. Distinguished
   Chair Endowment Fund, and the John Sealy Memorial Endowment Fund at
   UTMB. P.-Y.S. was supported by NIH grants AI142759, AI127744, and
   AI136126, and awards from the Kleberg Foundation, John S. Dunn
   Foundation, Amon G. Carter Foundation, Gilson Longenbaugh Foundation,
   and Summerfield Robert Foundation. We thank Ms. Xiuna Yang in Prof. Zihe
   Rao's laboratory for her courtesy in sharing the PDB file of SARS-CoV-2
   (2019-nCoV) 3CL protease (PDB ID: 6LU7).
CR Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658
   ANDREWS P, 1982, PHARMACOL THERAPEUT, V19, P245, DOI 10.1016/0163-7258(82)90064-X
   Ashburn T. T., 2004, NAT REV DRUG
   Barbosa EJ, 2019, EUR J PHARM BIOPHARM, V141, P58, DOI 10.1016/j.ejpb.2019.05.004
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1991, J VIROL, V65, P6042, DOI 10.1128/JVI.65.11.6042-6050.1991
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   Chang YW, 2006, J FOOD DRUG ANAL, V14, P329
   Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082
   Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001
   Chou KC, 2003, BIOCHEM BIOPH RES CO, V308, P148, DOI 10.1016/S0006-291X(03)01342-1
   Cohen J., CAN ANTIHIV COMBINAT
   Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001
   Costabile G, 2015, MOL PHARMACEUT, V12, P2604, DOI 10.1021/acs.molpharmaceut.5b00098
   de Caryalho LPS, 2011, ACS MED CHEM LETT, V2, P849, DOI 10.1021/ml200157f
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Fan XZ, 2019, TUBERCULOSIS, V116, pS28, DOI 10.1016/j.tube.2019.04.008
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1
   Gassen NC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13659-4
   GU J, 2020, J MED CHEM, V196, DOI DOI 10.1021/ACS.JMED-CHEM.9B01950
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Huang L, 2017, ANTIVIR RES, V138, P68, DOI 10.1016/j.antiviral.2016.12.002
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Jacobs SE, 2013, CLIN MICROBIOL REV, V26, P135, DOI 10.1128/CMR.00077-12
   JONES WE, 1979, AM J TROP MED HYG, V28, P300, DOI 10.4269/ajtmh.1979.28.300
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Korba BE, 2008, ANTIMICROB AGENTS CH, V52, P4069, DOI 10.1128/AAC.00078-08
   Kutok JL, 2006, ANNU REV PATHOL-MECH, V1, P375, DOI 10.1146/annurev.pathol.1.110304.100209
   Li GD, 2020, NAT REV DRUG DISCOV, V19, P149, DOI 10.1038/d41573-020-00016-0
   Li YH, 2014, CANCER LETT, V349, P8, DOI 10.1016/j.canlet.2014.04.003
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lin CK, 2016, ONCOTARGET, V7, P8993, DOI 10.18632/oncotarget.7113
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Marrugal-Lorenzo JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37290-3
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mook RA, 2015, BIOORGAN MED CHEM, V23, P5829, DOI 10.1016/j.bmc.2015.07.001
   Osada T, 2011, CANCER RES, V71, P4172, DOI 10.1158/0008-5472.CAN-10-3978
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Satoh K, 2016, CLIN CANCER RES, V22, P3458, DOI 10.1158/1078-0432.CCR-15-2256
   Shie JJ, 2005, J MED CHEM, V48, P4469, DOI 10.1021/jm050184y
   Stachulski AV, 2011, J MED CHEM, V54, P8670, DOI 10.1021/jm201264t
   Sun Z., 1999, Tubercle and Lung Disease, V79, P319, DOI 10.1054/tuld.1999.0212
   Tao HL, 2014, NAT MED, V20, P1263, DOI 10.1038/nm.3699
   Uyeki TM, 2020, NEW ENGL J MED, V382
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   WEINBACH EC, 1969, NATURE, V221, P1016, DOI 10.1038/2211016a0
   Wen CC, 2007, J MED CHEM, V50, P4087, DOI 10.1021/jm070295s
   World Health Organization, 2020, E RESP SYNDR COR MER
   World Health Organization Model List of Essential Medicines, 2019, WHO MOD LIST ESS MED
   World Health Organization(WHO), 2003, SUMM PROB SARS CAS O
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Xu JM, 2019, BIOORG MED CHEM LETT, V29, P1399, DOI 10.1016/j.bmcl.2019.03.032
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100
   Yon C, 2011, ANTIVIR RES, V91, P233, DOI 10.1016/j.antiviral.2011.05.017
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zumla A, 2016, NAT REV DRUG DISCOV, V15, P327, DOI 10.1038/nrd.2015.37
NR 64
TC 11
Z9 11
U1 11
U2 11
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 2373-8227
J9 ACS INFECT DIS
JI ACS Infect. Dis.
PD MAY 8
PY 2020
VL 6
IS 5
BP 909
EP 915
DI 10.1021/acsinfecdis.0c00052
PG 7
WC Chemistry, Medicinal; Infectious Diseases
SC Pharmacology & Pharmacy; Infectious Diseases
GA LQ7JV
UT WOS:000535176700016
PM 32125140
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Kumar, D
   Kumar, P
   Singh, H
   Agrawal, V
AF Kumar, Dinesh
   Kumar, Pawan
   Singh, Himmat
   Agrawal, Veena
TI Biocontrol of mosquito vectors through herbal-derived silver
   nanoparticles: prospects and challenges
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Review; Early Access
DE Silver nanoparticles; Insecticides; Plant extract; Vector-borne
   diseases; Scanning electron microscope; Transmission electron microscopy
ID ANOPHELES-STEPHENSI LISTON; CULEX-QUINQUEFASCIATUS DIPTERA; ZIKA VIRUS
   VECTOR; AEDES-AEGYPTI L.; MEDIATED GREEN SYNTHESIS; COPEPOD
   MEGACYCLOPS-FORMOSANUS; BANCROFTIAN FILARIASIS VECTOR; RAPID BIOLOGICAL
   SYNTHESIS; MEDICINAL-PLANT EXTRACTS; AQUEOUS LEAF EXTRACT
AB Mosquitoes spread several life-threatening diseases such as malaria, filaria, dengue, Japanese encephalitis, West Nile fever, chikungunya, and yellow fever and are associated with millions of deaths every year across the world. However, insecticides of synthetic origin are conventionally used for controlling various vector-borne diseases but they have various associated drawbacks like impact on non-targeted species, negative effects on the environment, and development of resistance in vector species by alteration of the target site. Plant extracts, phytochemicals, and their nanoformulations can serve as ovipositional attractants, insect growth regulators, larvicides, and repellents with least effects on the environment. Such plant-derived products exhibit broad-spectrum resistance against various mosquito species and are relatively cheaper, environmentally safer, biodegradable, easily accessible, and are non-toxic to non-targeted organisms. Therefore, in this review article, the current knowledge of phytochemical sources exhibiting larvicidal activity and their variations in response to solvents used for their extraction is underlined. Also, different methods such as physical, chemical, and biological for silver nanoparticle (AgNPs) synthesis, their mechanism of synthesis using plant extract, their potent larvicidal activity, and the possible mechanism by which these particles kill mosquito larvae are discussed. In addition, constraints related to commercialization of nanoherbal products at government and academic or research level and barriers from laboratory experiments to field trial have also been discussed. This comprehensive information can be gainfully employed for the development of herbal larvicidal formulations and nanopesticides against insecticide-resistant vector species in the near future.
C1 [Kumar, Dinesh; Kumar, Pawan; Singh, Himmat] Natl Inst Malaria Res, Delhi 110077, India.
   [Kumar, Dinesh; Agrawal, Veena] Univ Delhi, Med Plant Biotechnol Lab, Dept Bot, Delhi 110007, India.
RP Agrawal, V (corresponding author), Univ Delhi, Med Plant Biotechnol Lab, Dept Bot, Delhi 110007, India.
EM drveena_du@yahoo.co.in
FU Science and Engineering Research Board, Government of India
   [EMR/2016/001673]; University of Delhi, India; ICMR-NIMR; ICMR, New
   DelhiIndian Council of Medical Research (ICMR)
FX The authors are grateful to the Science and Engineering Research Board,
   Government of India for providing Major Research Project
   (EMR/2016/001673) to Veena Agrawal and the University of Delhi, India
   for their support in searching literature and preparation of the review
   article. Dinesh kumar is indebted to the Director of ICMR-NIMR and ICMR,
   New Delhi for the ICMR-PostDoctoral Research Fellowship.
CR Aarthi C, 2017, ENVIRON SCI POLLUT R, P1
   Adamo SA, 2017, DEV COMP IMMUNOL, V66, P24, DOI 10.1016/j.dci.2016.06.005
   Ahamed M, 2011, PHYSICA E, V43, P1266, DOI 10.1016/j.physe.2011.02.014
   Ahluwalia V, 2018, MICROB PATHOGENESIS, V114, P402, DOI 10.1016/j.micpath.2017.11.052
   Ahmed S, 2016, J ADV RES, V7, P17, DOI 10.1016/j.jare.2015.02.007
   Aina DA, 2019, KARBALA INT J MOD SC, V5, P2, DOI [10.33640/2405-609X.1018, DOI 10.33640/2405-609X.1018]
   Al-Mekhlafi FA, 2018, SAUDI J BIOL SCI, V25, P52, DOI 10.1016/j.sjbs.2017.02.010
   Al-Naami MTAA, 2017, INT J SCI NAT, V8, P303
   Al-Quraishy S, 2012, PARASITOL RES, V110, P335, DOI 10.1007/s00436-011-2495-0
   Alharbi NS, 2018, J TRACE ELEM MED BIO, V50, P146, DOI 10.1016/j.jtemb.2018.06.016
   Ali SI, 2018, S AFR J BOT, V114, P117, DOI 10.1016/j.sajb.2017.10.018
   Ali SI, 2019, NAT PROD RES, V33, P1463, DOI 10.1080/14786419.2017.1416374
   AlQahtani FS, 2017, J ASIA-PAC ENTOMOL, V20, P157, DOI 10.1016/j.aspen.2016.12.004
   Alsammarraie FK, 2018, COLLOID SURFACE B, V171, P398, DOI 10.1016/j.colsurfb.2018.07.059
   Amutha V, 2019, J CLUST SCI, V30, P797, DOI 10.1007/s10876-019-01542-7
   Anandan M, 2019, PROCESS BIOCHEM, V80, P80, DOI 10.1016/j.procbio.2019.02.014
   Anees AM, 2008, PARASITOL RES, V103, P1451, DOI 10.1007/s00436-008-0991-7
   ANNIE SW, 2015, INT J MOSQ RES A, V2, P43
   Ansari M. A., 2005, Journal of Vector Borne Diseases, V42, P95
   Arjunan NK, 2012, VECTOR-BORNE ZOONOT, V12, P262, DOI 10.1089/vbz.2011.0661
   Armstrong N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053186
   Arya G, 2018, ARTIF CELL NANOMED B, V46, P985, DOI 10.1080/21691401.2017.1354302
   Asogwa EU, 2010, J MED PLANTS RES, V4, P1
   Avalos A, 2015, FOOD CHEM TOXICOL, V85, P114, DOI 10.1016/j.fct.2015.06.024
   Azarudeen RMST, 2017, J ASIA-PAC ENTOMOL, V20, P359, DOI 10.1016/j.aspen.2017.02.007
   Aziz A, 2020, SCI TOTAL ENVIRON, V700, DOI 10.1016/j.scitotenv.2019.134443
   Bagavan A, 2008, PARASITOL RES, V103, P223, DOI 10.1007/s00436-008-0962-z
   Banala RR, 2015, SAUDI J BIOL SCI, V22, P637, DOI 10.1016/j.sjbs.2015.01.007
   Bankar A, 2010, COLLOID SURFACE A, V368, P58, DOI 10.1016/j.colsurfa.2010.07.024
   Bansal SK, 2011, J ENVIRON BIOL, V32, P71
   Banumathi B, 2017, J CLUST SCI, V28, P2857, DOI 10.1007/s10876-017-1263-4
   Barik M, 2019, NAT PROD RES, V33, P1682, DOI 10.1080/14786419.2018.1428585
   Barnawi A. A. B. M., 2019, International Journal of Mosquito Research, V6, P55
   Bavani Govindarajulu, 2015, International Journal of Current Microbiology and Applied Sciences, V4, P132
   Beg M, 2017, J MOL RECOGNIT, V30, DOI 10.1002/jmr.2565
   Behravan M, 2019, INT J BIOL MACROMOL, V124, P148, DOI 10.1016/j.ijbiomac.2018.11.101
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P1
   Benelli G, 2018, ACTA TROP, V178, P73, DOI 10.1016/j.actatropica.2017.10.021
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10228, DOI 10.1007/s11356-017-8482-y
   Benelli G, 2017, TICKS TICK-BORNE DIS, V8, P821, DOI 10.1016/j.ttbdis.2017.08.004
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhagat M, 2019, J INORG ORGANOMET P, V29, P1039, DOI 10.1007/s10904-018-0994-5
   Bockarie MJ, 1999, ANN TROP MED PARASIT, V93, P213, DOI 10.1080/00034989958465
   Borah R, 2010, AFR J BIOTECHNOL, V9, P2527
   Borase H. P., 2014, Journal of Entomological and Acarological Research, V46, P59, DOI 10.4081/jear.2014.1920
   Borase PH, 2013, J NANOMEDINE BIOTHER, V3, P111
   Brogdon WG, 1997, J AM MOSQUITO CONTR, V13, P233
   Buteler M, 2015, INT J PEST MANAGE, V61, P80, DOI 10.1080/09670874.2014.1001008
   Callaway E, 2015, NATURE, V526, P174, DOI 10.1038/nature.2015.18507
   Campbell FL, 1933, J ECON ENTOMOL, V26, P500, DOI 10.1093/jee/26.2.500
   Chandran SP, 2006, BIOTECHNOL PROGR, V22, P577, DOI 10.1021/bp0501423
   Chandrasekaran T, 2019, REV SOC BRAS MED TRO, V52, DOI 10.1590/0037-8682-0459-2018
   Chandrashekhar D.P., 2011, PARASITOL RES, V108, P1253
   Chansang U, 2005, J VECTOR ECOL, V30, P195
   Chung IM, 2016, NANOSCALE RES LETT, V11, DOI 10.1186/s11671-016-1257-4
   Chung SK, 2013, J FOOD SCI, V78, pE709, DOI 10.1111/1750-3841.12111
   Chung SW, 2005, SMALL, V1, P64, DOI 10.1002/smll.200400005
   Couzin-Frankel J, 2010, SCIENCE, V328, P1088, DOI 10.1126/science.328.5982.1088
   Covell G, 1943, HLTH B, P11
   Voris DGD, 2018, ENVIRON SCI POLLUT R, V25, P22541, DOI 10.1007/s11356-018-2362-y
   Daffalla HM, 2018, J ADV RES PHARM SCI, V2, P7
   Rivera-Rangel RD, 2018, COLLOID SURFACE A, V536, P60, DOI 10.1016/j.colsurfa.2017.07.051
   Das N. G., 2007, Journal of Vector Borne Diseases, V44, P145
   Das R. K, 2017, NANOTECHNOL ENV ENG, V2, P18, DOI [DOI 10.1007/S41204-017-0029-4, 10.1007/s41204-017-0029-4]
   Deepak P, 2017, ARTIF CELL NANOMED B, V45, P990, DOI 10.1080/21691401.2016.1198365
   Dehghanizade S, 2018, ARTIF CELL NANOMED B, V46, P160, DOI 10.1080/21691401.2017.1304402
   Devanesan S, 2017, J CLUST SCI, V28, P595, DOI 10.1007/s10876-016-1134-4
   Dhand V, 2016, MAT SCI ENG C-MATER, V58, P36, DOI 10.1016/j.msec.2015.08.018
   Dhara Shukla, 2018, International Journal of Mosquito Research, V5, P19
   Dharmagadda VSS, 2005, BIORESOURCE TECHNOL, V96, P1235, DOI 10.1016/j.biortech.2004.10.020
   Dhuper S., 2012, NANO TRENDS J NANOTE, V13, P16, DOI DOI 10.5829/ID0SI.AEJSR.2013.8.4.1121
   Duan HH, 2015, CHEM SOC REV, V44, P5778, DOI 10.1039/c4cs00363b
   Dubey M, 2009, DIG J NANOMATER BIOS, V4, P537
   Dudhane AA, 2019, INT J NANOSCI NANOTE, V15, P75
   Edwards Falicia L, 2005, Int J Environ Res Public Health, V2, P430, DOI 10.3390/ijerph2005030007
   El-Akhal F, 2016, INT J PHARM PHARM SC, V8, P372
   Elango G, 2009, PARASITOL RES, V104, P1381, DOI 10.1007/s00436-009-1339-7
   Elavazhagan T, 2011, INT J NANOMED, V6, P1265, DOI 10.2147/IJN.S18347
   Elemike EE, 2017, MAT SCI ENG C-MATER, V75, P980, DOI 10.1016/j.msec.2017.02.161
   Elumalai D., 2016, ENG AGR ENV FOOD EAE, V9, P1, DOI [DOI 10.1016/j.eaef.2015.08.002, DOI 10.1016/J.EAEF.2015.08.002]
   Elumalai Devan, 2017, Parasite Epidemiol Control, V2, P15, DOI 10.1016/j.parepi.2017.09.001
   Erick ON, 2017, FRONT NANOSCI NANOTE, V3, P1
   Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3
   Ferreira MC, 2017, MOLECULES, V22, DOI 10.3390/molecules22010175
   Firdhouse M.J., 2012, ASIAN J PHARM CLIN R, V6, P92
   Foldbjerg R, 2015, TOXICOL RES-UK, V4, P563, DOI 10.1039/c4tx00110a
   Fouad H, 2018, ARTIF CELL NANOMED B, V46, P558, DOI 10.1080/21691401.2017.1329739
   Francis S, 2018, ARTIF CELL NANOMED B, V46, P795, DOI 10.1080/21691401.2017.1345921
   Francis S, 2017, ENVIRON SCI POLLUT R, V24, P17347, DOI 10.1007/s11356-017-9329-2
   Francois G, 1996, J ETHNOPHARMACOL, V54, P125, DOI 10.1016/S0378-8741(96)01459-6
   Fruijtier-Polloth C, 2012, TOXICOLOGY, V294, P61, DOI 10.1016/j.tox.2012.02.001
   Ga'al H, 2018, ARTIF CELL NANOMED B, V46, P1171, DOI 10.1080/21691401.2017.1365723
   Geethalakshmi R., 2010, INT J ENG SCI TECHNO, V2, P970, DOI DOI 10.1007/S00253-012-3969-4
   Ghosh A, 2012, INDIAN J MED RES, V135, P581
   Ghosh S., 2016, IOSR J AGR VET SCI, V9, P36
   Ghosh S, 2015, EXP APPL ACAROL, V66, P159, DOI 10.1007/s10493-015-9890-7
   Ghramh HA, 2018, J ASIA-PAC ENTOMOL, V21, P205, DOI 10.1016/j.aspen.2017.12.001
   Gnanadesigan M, 2011, ASIAN PAC J TROP MED, V4, P799, DOI 10.1016/S1995-7645(11)60197-1
   Gogoi S. J., 2013, Advances in Applied Science Research, V4, P274
   GONDWAL M, 2013, INT J PHARM BIOL SCI, V4, P635
   Goodarzi S, 2019, ENVIRON SCI POLLUT R, V26, P7711, DOI 10.1007/s11356-019-04149-7
   Gopinath V, 2012, COLLOID SURFACE B, V96, P69, DOI 10.1016/j.colsurfb.2012.03.023
   Govindarajan M, 2011, PARASITOL RES, V109, P353, DOI 10.1007/s00436-011-2263-1
   Govindarajan M, 2009, EUR REV MED PHARMACO, V13, P99
   Govindarajan M, 2017, ARTIF CELL NANOMED B, V45, P1317, DOI 10.1080/21691401.2016.1228664
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, ECOTOX ENVIRON SAFE, V129, P85, DOI 10.1016/j.ecoenv.2016.03.007
   Govindaraju K., 2010, J BIOPESTICIDES, V1, P394
   Granados-Echegoyen CA, 2019, J MED ENTOMOL, V56, P261, DOI 10.1093/jme/tjy159
   Gretscher RR, 2016, SCI REP-UK, V6, DOI 10.1038/srep24082
   Grzywacz D, 2014, FOOD SECUR, V6, P71, DOI 10.1007/s12571-013-0313-5
   Gunasekaran K, 2009, INDIAN J MED RES, V130, P138
   Gunasekaran K, 2009, J ENVIRON BIOL, V29, P941
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hamelian M, 2018, APPL ORGANOMET CHEM, V32, DOI 10.1002/aoc.4458
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hossain E, 2011, ASIAN PAC J TROP MED, V4, P436, DOI 10.1016/S1995-7645(11)60121-1
   Huang H., 2019, P ICLR, DOI DOI 10.20944/PREPRINTS201907.0140.V1
   Iravani S, 2019, NANOTECH LIFE SCI, P13, DOI 10.1007/978-3-030-16439-3_2
   Iravani S, 2011, GREEN CHEM, V13, P2638, DOI 10.1039/c1gc15386b
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Islam J, 2017, ACTA TROP, V167, P216, DOI 10.1016/j.actatropica.2016.12.031
   Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146
   Isman MB, 2015, PEST MANAG SCI, V71, P1587, DOI 10.1002/ps.4088
   Jain D, 2009, DIG J NANOMATER BIOS, V4, P557
   Jang YS, 2005, J AM MOSQUITO CONTR, V21, P400, DOI 10.2987/8756-971X(2006)21[400:MLAOAC]2.0.CO;2
   Jayaseelan C, 2011, PARASITOL RES, V109, P185, DOI 10.1007/s00436-010-2242-y
   Jeyasankar A., 2018, J INFECT DIS MED MIC, V2, P11
   Jiang S, 2015, ACS BIOMATER SCI ENG, V1, P1077, DOI 10.1021/acsbiomaterials.5b00163
   Jinu U, 2018, PHYSIOL MOL PLANT P, V101, P163, DOI 10.1016/j.pmpp.2017.05.003
   Jiraungkoorskul W, 2019, ENVIRON SCI POLLUT R, V26, P14712, DOI 10.1007/s11356-018-2429-9
   Jokanovic M, 2009, CURR MED CHEM, V16, P2177, DOI 10.2174/092986709788612729
   Kalaiselvi D, 2019, CROP PROT, V117, P108, DOI 10.1016/j.cropro.2018.11.020
   Kalaivani K, 2012, PARASITOL RES, V110, P1261, DOI 10.1007/s00436-011-2623-x
   Kalimuthu K., 2013, Journal of Entomological and Acarological Research, V45, P57, DOI 10.4081/jear.2013.e11
   Kalimuthu K, 2017, PROCESS SAF ENVIRON, V109, P82, DOI 10.1016/j.psep.2017.03.027
   Kalimuthu K, 2017, HYDROBIOLOGIA, V785, P359, DOI 10.1007/s10750-016-2943-z
   Kamalakannan S, 2011, J ASIA-PAC ENTOMOL, V14, P41, DOI 10.1016/j.aspen.2010.11.011
   Kamaraj C, 2011, INDIAN J MED RES, V134, P101
   Kannathasan K, 2007, PARASITOL RES, V101, P1721, DOI 10.1007/s00436-007-0714-5
   Karmegam N, 1997, BIORESOURCE TECHNOL, V59, P137, DOI 10.1016/S0960-8524(96)00157-5
   Kathiravan V, 2014, SPECTROCHIM ACTA A, V130, P116, DOI 10.1016/j.saa.2014.03.107
   Kaviya S, 2011, SPECTROCHIM ACTA A, V79, P594, DOI 10.1016/j.saa.2011.03.040
   Keiser J, 2005, ACTA TROP, V95, P40, DOI 10.1016/j.actatropica.2005.04.012
   Kesharwani JG, 2009, J BIONANOSCIENCE, V3, P39, DOI DOI 10.1166/jbns.2009.1008
   Khader SZA, 2018, EGYPTIAN J BASIC APP, V5, P54, DOI [10.1016/j.ejbas.2018.01.002, DOI 10.1016/J.EJBAS.2018.01.002]
   Kiran SR, 2006, BIORESOURCE TECHNOL, V97, P2481, DOI 10.1016/j.biortech.2005.10.003
   Korbekandi H, 2009, CRIT REV BIOTECHNOL, V29, P279, DOI 10.3109/07388550903062462
   Kovendan K, 2012, PARASITOL RES, V110, P669, DOI 10.1007/s00436-011-2540-z
   Kovendan K, 2012, PARASITOL RES, V110, P571, DOI 10.1007/s00436-011-2525-y
   Krishnaraj C, 2010, COLLOID SURFACE B, V76, P50, DOI 10.1016/j.colsurfb.2009.10.008
   Kumar B, 2017, SAUDI J BIOL SCI, V24, P45, DOI 10.1016/j.sjbs.2015.09.006
   Kumar DA, 2014, SPECTROCHIM ACTA A, V127, P168, DOI 10.1016/j.saa.2014.02.058
   Kumar D, 2018, PROCESS SAF ENVIRON, V116, P137, DOI 10.1016/j.psep.2018.02.001
   Kumar D, 2018, PARASITOL RES, V117, P377, DOI 10.1007/s00436-017-5711-8
   Kumar PPNV, 2014, IND CROP PROD, V52, P562, DOI 10.1016/j.indcrop.2013.10.050
   Kumar PP, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/ab3ce9
   Kumar PM, 2016, PARASITOL RES, V115, P751, DOI 10.1007/s00436-015-4799-y
   KUMAR S, 2013, INT J PHARM BIOL SCI, V4, P378
   Kumar S, 2012, PARASITOL RES, V111, P173, DOI 10.1007/s00436-011-2814-5
   Kumar Sarita, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P85, DOI 10.1016/S2221-1691(11)60001-4
   Kumar VA, 2017, J PHOTOCH PHOTOBIO B, V171, P1, DOI 10.1016/j.jphotobiol.2017.04.022
   Kumarasamyraja D, 2013, INT J PHARM BIOL SCI, V4, P469
   Kuppusamy P, 2016, SAUDI PHARM J, V24, P473, DOI 10.1016/j.jsps.2014.11.013
   Lakshmanan G., 2018, Karbala International Journal of Modern Science, V4, P61, DOI 10.1016/j.kijoms.2017.10.007
   Lallawmawma H, 2015, ENVIRON SCI POLLUT R, V22, P17753, DOI 10.1007/s11356-015-5001-x
   Lateef A, 2016, J NANOSTRUCTURE CHEM, V6, P159, DOI 10.1007/s40097-016-0191-4
   Logeswari P, 2013, SCI IRAN, V20, P1049, DOI 10.1016/j.scient.2013.05.016
   Logeswari P, 2015, J SAUDI CHEM SOC, V19, P311, DOI 10.1016/j.jscs.2012.04.007
   Lopez-Miranda JL, 2016, MATER LETT, V176, P285, DOI 10.1016/j.matlet.2016.04.126
   Ma WR, 2015, INT J BIOL SCI, V11, P860, DOI 10.7150/ijbs.12059
   Mahendran G., 2016, Food Science and Human Wellness, V5, P207, DOI 10.1016/j.fshw.2016.10.001
   Mahyoub JA, 2017, J CLUST SCI, V28, P565, DOI 10.1007/s10876-016-1127-3
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Malathi S, 2019, J ENVIRON BIOL, V40, P626, DOI 10.22438/jeb/40/4/MRN-934
   Mandal S, 2010, ASIAN PAC J TROP MED, V3, P605, DOI 10.1016/S1995-7645(10)60147-2
   Manjari MS, 2014, PARASITOL RES, V113, P2475, DOI 10.1007/s00436-014-3896-7
   Manosalva N, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2664-3
   Mao BH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20728-z
   Mariselvam R, 2014, SPECTROCHIM ACTA A, V129, P537, DOI 10.1016/j.saa.2014.03.066
   Marwa Thamer N, 2017, INT J SCI NAT, V8, P303
   Mathew N, 2009, PARASITOL RES, V104, P1017, DOI 10.1007/s00436-008-1284-x
   Mathivanan D, 2018, PHYSIOL MOL PLANT P, V101, P187, DOI 10.1016/j.pmpp.2017.03.008
   Mehmood A, 2017, ARAB J CHEM, V10, pS3048, DOI 10.1016/j.arabjc.2013.11.046
   Meng X, 2017, BIOL TRACE ELEM RES, V180, P327, DOI 10.1007/s12011-017-1001-7
   MIRANDA JLL, 2017, MEX J MAT SCI ENG, V4, P15
   Mohan DR, 2007, AFR J BIOTECHNOL, V6, P631
   Mohan L, 2005, J ENVIRON BIOL, V26, P399
   Mohankumar TK, 2017, ASIA PAC J, V2320, P5504
   Moise IK, 2018, LOCAL GLOBAL IMPACT
   Mommaerts V, 2012, NANOTOXICOLOGY, V6, P554, DOI 10.3109/17435390.2011.590905
   Mondal S, 2011, COLLOID SURFACE B, V82, P497, DOI 10.1016/j.colsurfb.2010.10.007
   Morejon B, 2018, J NANOTECHNOL, V2018, DOI 10.1155/2018/6917938
   MubarakAli D, 2011, COLLOID SURFACE B, V85, P360, DOI 10.1016/j.colsurfb.2011.03.009
   Mulla MS, 1999, J AM MOSQUITO CONTR, V15, P133
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Murugan K, 2017, PARASITOL RES, V116, P495, DOI 10.1007/s00436-016-5310-0
   Muthukumaran U, 2015, PARASITOL RES, V114, P1817, DOI 10.1007/s00436-015-4368-4
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Muthuraman MS, 2019, MICROB PATHOGENESIS, V126, P1, DOI 10.1016/j.micpath.2018.10.024
   Nabikhan A, 2010, COLLOID SURFACE B, V79, P488, DOI 10.1016/j.colsurfb.2010.05.018
   Nakkala JR, 2014, EUR J MED CHEM, V85, P784, DOI 10.1016/j.ejmech.2014.08.024
   Nalini M., 2017, EGYPTIAN J BASIC APP, V4, P212, DOI DOI 10.1016/j.ejbas.2017.04.005
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Narayanan KB, 2014, EUR J PLANT PATHOL, V140, P185, DOI 10.1007/s10658-014-0399-4
   Nasar S, 2019, J ELECTRON MATER, V48, P3562, DOI 10.1007/s11664-019-07109-6
   Natesan Geetha, 2014, Australian Journal of Basic and Applied Sciences, V8, P324
   Nathan SS, 2007, BIORESOURCE TECHNOL, V98, P1856, DOI 10.1016/j.biortech.2006.07.044
   Nayak D, 2016, MAT SCI ENG C-MATER, V58, P44, DOI 10.1016/j.msec.2015.08.022
   Okumu FO, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-63
   Olikiabo JI, 2018, J MED PLANTS RES, V8, P3
   Pandey V, 2007, PARASITOL RES, V102, P171, DOI 10.1007/s00436-007-0763-9
   Pandey V, 2011, PARASITOL RES, V108, P297, DOI 10.1007/s00436-010-2056-y
   Parthiban Ezhumalai, 2019, Biotechnol Rep (Amst), V21, pe00297, DOI 10.1016/j.btre.2018.e00297
   Patel MK, 2018, INT J CUR RES REV, V10, P16, DOI [10.31782/IJCRR.2018.10144, DOI 10.31782/IJCRR.2018.10144]
   Patil CD, 2012, PARASITOL RES, V111, P555, DOI 10.1007/s00436-012-2867-0
   Patil CD, 2012, PARASITOL RES, V110, P1815, DOI 10.1007/s00436-011-2704-x
   Patil CD, 2011, PARASITOL RES, V108, P1253, DOI 10.1007/s00436-010-2174-6
   Pavela R, 2019, ACTA TROP, V193, P236, DOI 10.1016/j.actatropica.2019.01.019
   Pavela R, 2017, IND CROP PROD, V97, P338, DOI 10.1016/j.indcrop.2016.12.046
   Pavela R, 2016, TRENDS PLANT SCI, V21, P1000, DOI 10.1016/j.tplants.2016.10.005
   Pavela R, 2016, PLANT PROTECT SCI, V52, P54, DOI 10.17221/62/2015-PPS
   Pavela R, 2014, J ASIA-PAC ENTOMOL, V17, P287, DOI 10.1016/j.aspen.2014.02.001
   Pineda-Cortel MRB, 2019, PHARM BIOL, V57, P120, DOI 10.1080/13880209.2018.1561727
   Pirtarighat S, 2019, J NANOSTRUCTURE CHEM, V9, P1, DOI 10.1007/s40097-018-0291-4
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Poopathi S, 2015, ENVIRON SCI POLLUT R, V22, P2956, DOI 10.1007/s11356-014-3560-x
   Posgai R, 2011, CHEMOSPHERE, V85, P34, DOI 10.1016/j.chemosphere.2011.06.040
   Prabakar K, 2004, BIORESOURCE TECHNOL, V95, P113, DOI 10.1016/j.biortech.2003.05.001
   Prasad KM, 2017, J VECTOR DIS, V54, P226, DOI 10.4103/0972-9062.217613
   Prasad T. N. V. K. V., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P439, DOI 10.1016/S2221-1691(11)60096-8
   Pratheeba T, 2019, BIOCATAL AGRIC BIOTE, V19, DOI 10.1016/j.bcab.2019.101137
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Rafique M, 2019, MAT SCI ENG C-MATER, V99, P1313, DOI 10.1016/j.msec.2019.02.059
   Raghavendra K, 2009, INDIAN J MED RES, V130, P74
   Rahuman A. Abdul, 2000, Fitoterapia, V71, P553, DOI 10.1016/S0367-326X(00)00164-7
   Raj A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178051
   Rajakumar G, 2011, ACTA TROP, V118, P196, DOI 10.1016/j.actatropica.2011.03.003
   Rajesh A, 2017, INT J MOSQ RES B, V4, P142
   Rajkumar R, 2018, J CLUST SCI, V29, P1243, DOI 10.1007/s10876-018-1443-x
   Rajkumar S., 2005, African Journal of Biomedical Research, V8, P31
   Rautela Akhil, 2019, J ANAL SCI TECHNOL, V10
   Raveen R, 2017, INT J MOSQ RES A, V4, P17
   Ravichandran V, 2016, MATER LETT, V180, P264, DOI 10.1016/j.matlet.2016.05.172
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   RAWLINS SC, 1995, J AM MOSQUITO CONTR, V11, P59
   Roark R. C., 1947, ECON BOT, V1, P437, DOI 10.1007/BF02858908
   Rodrigues AM, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030112
   Rolim WR, 2019, APPL SURF SCI, V463, P66, DOI 10.1016/j.apsusc.2018.08.203
   Roni M, 2013, PARASITOL RES, V112, P981, DOI 10.1007/s00436-012-3220-3
   Roopan SM, 2013, IND CROP PROD, V43, P631, DOI 10.1016/j.indcrop.2012.08.013
   Rout A., 2013, INT J PHARM BIOL SCI, V4, P661
   Rupiasih NN, 2013, J PHYS CONF SER, V423, DOI 10.1088/1742-6596/423/1/012032
   Sadeghi B, 2015, SPECTROCHIM ACTA A, V134, P326, DOI 10.1016/j.saa.2014.05.078
   Sadeghi B, 2015, SPECTROCHIM ACTA A, V134, P310, DOI 10.1016/j.saa.2014.06.046
   Saini H, 2019, J CLUST SCI, P1
   Sakthivadivel M, 2016, VECTOR BIOL J, V10, P19
   Sakulku U, 2009, INT J PHARMACEUT, V372, P105, DOI 10.1016/j.ijpharm.2008.12.029
   SALAM HA, 2012, INT RES J BIOL SCI, V1, P85
   Santhosh SB, 2015, J PHOTOCH PHOTOBIO B, V153, P184, DOI 10.1016/j.jphotobiol.2015.09.018
   Santhoshkumar T, 2011, PARASITOL RES, V108, P693, DOI 10.1007/s00436-010-2115-4
   Sap-lam N, 2010, Journal of Applied Sciences, V10, P3132
   Saratale RG, 2018, ENVIRON SCI POLLUT R, V25, P10392, DOI 10.1007/s11356-017-9581-5
   Sareen Sarah J, 2012, RES J RECENT SCI, V1, P52
   Sarsar V., 2017, J MICROBIOL BIOTECHN, V3, P27
   SCHMUTTERER H, 1988, J INSECT PHYSIOL, V34, P713, DOI 10.1016/0022-1910(88)90082-0
   Schmutterer H, 1990, ANNU REV ENTOMOL, V15, P197
   Senthilkumar A, 2013, PARASITOL RES, V112, P1337, DOI 10.1007/s00436-012-3188-z
   Shah M., 2016, INT J RES MED SCI, V4, P3427
   Shahi M, 2010, J VECTOR DIS, V47, P185
   Shahzad Kiran, 2019, Drug Chem Toxicol, P1, DOI 10.1080/01480545.2018.1525393
   Shaik MR, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10040913
   Shankar SS, 2004, J COLLOID INTERF SCI, V275, P496, DOI 10.1016/j.jcis.2004.03.003
   Sharma G, 2014, PARASITOL RES, V113, P197, DOI 10.1007/s00436-013-3644-4
   Sharma P, 2006, BIORESOURCE TECHNOL, V97, P1599, DOI 10.1016/j.biortech.2005.07.024
   Sharma V, 2019, APPL MICROBIOL BIOT, V103, P881, DOI 10.1007/s00253-018-9488-1
   Sharma VK, 2009, ADV COLLOID INTERFAC, V145, P83, DOI 10.1016/j.cis.2008.09.002
   Shivakumar MS, 2013, ASIAN J PHARM CLIN R, V6, P77
   Sillo Albert J, 2019, J Exp Pharmacol, V11, P23, DOI 10.2147/JEP.S187837
   Singh A, 2010, DIG J NANOMATER BIOS, V5, P483
   Singh R. K., 2006, Journal of Vector Borne Diseases, V43, P88
   SINGH RK, 2014, J ENTOMOL ZOOL STU B, V2, P83
   Singh S. P., 2008, Journal of Communicable Diseases, V40, P255
   Sogan N, 2018, J VECTOR DIS, V55, P282, DOI 10.4103/0972-9062.256563
   Sola P, 2014, FOOD SECUR, V6, P369, DOI 10.1007/s12571-014-0343-7
   Song JY, 2009, BIOPROC BIOSYST ENG, V32, P79, DOI 10.1007/s00449-008-0224-6
   Srinivasan S, 2015, ASIAN J PHARM CLIN R, V8, P316
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Subashini K., 2016, INT J ZOOL STUD, V1, P7
   Subramaniam J, 2012, SAUDI J BIOL SCI, V19, P503, DOI 10.1016/j.sjbs.2012.07.003
   Suganya A, 2013, PARASITOL RES, V112, P1385, DOI 10.1007/s00436-012-3269-z
   Suganya G, 2014, PARASITOL RES, V113, P875, DOI 10.1007/s00436-013-3718-3
   SUKUMAR K, 1991, J AM MOSQUITO CONTR, V7, P210
   Sultana N, 2018, ENVIRON CHEM LETT, V16, P1017, DOI 10.1007/s10311-018-0712-0
   Sundaravadivelan C, 2013, PARASITOL RES, V112, P303, DOI [10.1007/s00436-012-3138-9, 10.100]
   SUNITA D, 2014, INT J PHARM BIOL SCI, V5, P457
   Sutthanont N, 2019, INSECTS, V10, DOI 10.3390/insects10010027
   Tesfazghi K, 2016, HEALTH POLICY PLANN, V31, P91, DOI 10.1093/heapol/czv055
   Thakkar KN, 2010, NANOMED-NANOTECHNOL, V6, P257, DOI 10.1016/j.nano.2009.07.002
   Thatoi P, 2016, J PHOTOCH PHOTOBIO B, V163, P311, DOI 10.1016/j.jphotobiol.2016.07.029
   Thomas B, 2019, J NANOSCI NANOTECHNO, V19, P2640, DOI 10.1166/jnn.2019.16025
   Thomas TG, 2004, JPN J INFECT DIS, V57, P176
   THOMBRE R, 2014, INT J PHARM BIOL SCI, V5, P114
   Tiwary Mohini, 2007, Journal of Vector Borne Diseases, V44, P198
   Tu YY, 2011, NAT MED, V17, P1217, DOI 10.1038/nm.2471
   Ulug B, 2015, SPECTROCHIM ACTA A, V135, P153, DOI 10.1016/j.saa.2014.06.142
   Vahitha R, 2002, BIORESOURCE TECHNOL, V82, P203, DOI 10.1016/S0960-8524(01)00175-4
   Vanaja M, 2013, J NANOSTRUCTURE CHEM, V3, DOI 10.1186/2193-8865-3-17
   Vatandoost H, 2004, East Mediterr Health J, V10, P573
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Veerakumar K, 2013, PARASITOL RES, V112, P4073, DOI 10.1007/s00436-013-3598-6
   Veerasamy R, 2011, J SAUDI CHEM SOC, V15, P113, DOI 10.1016/j.jscs.2010.06.004
   Veisi H, 2018, J CLEAN PROD, V170, P1536, DOI 10.1016/j.jclepro.2017.09.265
   Velayutham K, 2013, ASIAN PAC J TROP MED, V6, P95, DOI 10.1016/S1995-7645(13)60002-4
   Velu K, 2015, ENVIRON SCI POLLUT R, V22, P17769, DOI 10.1007/s11356-015-4919-3
   Veni Thangapandi, 2017, J Parasit Dis, V41, P693, DOI 10.1007/s12639-016-0869-z
   Veni T, 2016, INT J PURE APPL ZOOL, V4, P149
   Vetrivel C, 2019, NANOSCI NANOTECH LET, V11, P11, DOI 10.1166/nnl.2019.2845
   Vijayaraghavan K, 2012, COLLOID SURFACE B, V94, P114, DOI 10.1016/j.colsurfb.2012.01.026
   Villaverde JJ, 2014, PEST MANAG SCI, V70, P2, DOI 10.1002/ps.3663
   Warikoo Radhika, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P152, DOI 10.1016/S2221-1691(11)60211-6
   WHO (World Health Organization), 2017, WORLD MALARIA REPORT
   Xia H, 2018, VIROL SIN, V33, P5, DOI 10.1007/s12250-018-0002-9
   Yadav R, 2019, MAT SCI ENG C-MATER, V104, DOI 10.1016/j.msec.2019.109984
   Yamaguchi K, 2012, INSECT BIOCHEM MOLEC, V42, P183, DOI 10.1016/j.ibmb.2011.11.009
   Zargar M, 2011, MOLECULES, V16, P6667, DOI 10.3390/molecules16086667
   Zhang XF, 2016, INT J MOL SCI, V17, DOI [10.3390/ijms17091534, 10.3390/ijms17020153]
NR 332
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
DI 10.1007/s11356-020-08444-6
EA MAY 2020
PG 38
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA LK8WF
UT WOS:000531139200005
PM 32385820
DA 2020-07-08
ER

PT J
AU Esan, V
   Mahboob, S
   Al-Ghanim, KA
   Elanchezhiyan, C
   Al-Misned, F
   Ahmed, Z
   Govindarajan, M
AF Esan, Venkattan
   Mahboob, Shahid
   Al-Ghanim, Khalid A.
   Elanchezhiyan, Chakkaravarthy
   Al-Misned, Fahad
   Ahmed, Zubair
   Govindarajan, Marimuthu
TI Novel Biogenic Synthesis of Silver Nanoparticles Using Alstonia venenata
   Leaf Extract: An Enhanced Mosquito Larvicidal Agent with Negligible
   Impact on Important Eco-biological Fish and Insects
SO JOURNAL OF CLUSTER SCIENCE
LA English
DT Article; Early Access
DE Green-synthesis; Nanotechnology; XRD; TEM; AFM; Zika virus; Biological
   control
ID ANOPHELES-STEPHENSI LISTON; FRIENDLY GREEN SYNTHESIS;
   CULEX-QUINQUEFASCIATUS; AEDES-AEGYPTI; ANTIMICROBIAL ACTIVITY;
   VETERINARY IMPORTANCE; VECTOR CONTROL; ESSENTIAL OIL; CONTROL TOOL;
   BIOSYNTHESIS
AB Bio-fabrication of metal nanocrystals can be achieved using eco-friendly and cost-effective routes with plants as reducing and capping mediators. A rapid and simple method for producing silver nanoparticles (AgNPs) using the plant Alstonia venenata (R. Br.) (Family: Apocynaceae) was investigated. The mosquito larvicidal potential and the effect of the A. venenata aqueous leaf extract and AgNPs on non-target fish and insects were evaluated. The AgNPs were studied using UV-Vis spectroscopy, FTIR spectroscopy, SEM, TEM, AFM, and XRD analysis. The larvicidal effectiveness on early third instar larvae was higher for the AgNPs than the plant extract; this was observed by testing on Anopheles stephensi (LC50 = 12.28 mu g/mL), Aedes aegypti (LC50 = 13.49 mu g/mL), and Culex quinquefasciatus (LC50 = 14.50 mu g/mL). Furthermore, the plant extract and AgNPs were found to be safe for the environment-friendly Gambusia affinis fish, and Anisops bouvieri and Diplonychus indicus aquatic insects. This study confirmed that A. venenata is a potential bio-resource for the fabrication of nanocrystals as an effective mosquito control tool with negligible harmful on aquatic fish and insects in the environment.
C1 [Esan, Venkattan; Elanchezhiyan, Chakkaravarthy; Govindarajan, Marimuthu] Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.
   [Mahboob, Shahid; Al-Ghanim, Khalid A.; Al-Misned, Fahad; Ahmed, Zubair] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia.
   [Govindarajan, Marimuthu] Govt Coll Women Autonomous, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
RP Govindarajan, M (corresponding author), Annamalai Univ, Dept Zool, Unit Vector Control Phytochem & Nanotechnol, Annamalainagar 608002, Tamil Nadu, India.; Mahboob, S (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia.; Govindarajan, M (corresponding author), Govt Coll Women Autonomous, Dept Zool, Kumbakonam 612001, Tamil Nadu, India.
EM mushahid@ksu.edu.sa; drgovind1979@gmail.com
RI Mahboob, Shahid/P-1131-2014
OI Mahboob, Shahid/0000-0003-4969-5387; Govindarajan,
   Marimuthu/0000-0002-4662-8931
FU Deanship of Scientific at King Saud UniversityDeanship of Scientific
   Research at King Saud University [RG-1435-012]
FX The authors (SM, KAH, FAM and ZA) would like to their sincere
   appreciation to the Deanship of Scientific at King Saud University for
   its funding of this research through the Research Group Project No.
   RG-1435-012.
CR Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Ahmad A, 2003, COLLOID SURFACE B, V28, P313, DOI 10.1016/S0927-7765(02)00174-1
   Ahmad T, 2013, COLLOID SURFACE B, V107, P227, DOI 10.1016/j.colsurfb.2013.02.004
   Alfuraydi AA, 2019, J PHOTOCH PHOTOBIO B, V192, P83, DOI 10.1016/j.jphotobiol.2019.01.011
   AlSalhi MS, 2016, INT J NANOMED, V11, P4439, DOI 10.2147/IJN.S113193
   Ankanna S, 2010, DIG J NANOMATER BIOS, V5, P369
   Aziz A, 2018, J PHOTOCH PHOTOBIO B, V180, P225, DOI 10.1016/j.jphotobiol.2018.02.012
   Basu B.D., 1975, INDIAN MED PLANTS, VII
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10228, DOI 10.1007/s11356-017-8482-y
   Benelli G, 2017, J CLUST SCI, V28, P287, DOI 10.1007/s10876-016-1088-6
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES MG, V8, P155, DOI 10.1007/978-3-319-25292-6_8
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   DEO P G, 1988, International Pest Control, V30, P118
   Devanesan S, 2018, NANOSCALE RES LETT, V13, DOI 10.1186/s11671-018-2731-y
   Devanesan S, 2017, J CLUST SCI, V28, P595, DOI 10.1007/s10876-016-1134-4
   Dubey M, 2009, DIG J NANOMATER BIOS, V4, P537
   Finney D.T., 1971, PROBIT ANAL
   Fouad H, 2018, ARTIF CELL NANOMED B, V46, P558, DOI 10.1080/21691401.2017.1329739
   Fouad H, 2017, ARTIF CELL NANOMED B, V45, P1369, DOI 10.1080/21691401.2016.1241793
   Ga'al H, 2018, ARTIF CELL NANOMED B, V46, P1171, DOI 10.1080/21691401.2017.1365723
   Ga'al H, 2018, PESTIC BIOCHEM PHYS, V144, P49, DOI 10.1016/j.pestbp.2017.11.004
   Golwala DK, 2009, INT J PHARM SCI DRUG, V1, P119
   Govindarajan M, 2005, Trop Biomed, V22, P1
   Govindarajan M, 2017, J CLUST SCI, V28, P15, DOI 10.1007/s10876-016-1035-6
   Govindarajan M, 2016, RES VET SCI, V107, P95, DOI 10.1016/j.rvsc.2016.05.017
   Govindarajan M, 2016, RSC ADV, V6, P59021, DOI 10.1039/c6ra10228j
   Govindarajan M, 2016, J CLUST SCI, V27, P745, DOI 10.1007/s10876-016-0977-z
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P51, DOI 10.1016/j.aspen.2015.11.009
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2016, EXP PARASITOL, V161, P40, DOI 10.1016/j.exppara.2015.12.011
   Govindarajan M, 2013, PARASITOL RES, V112, P3713, DOI 10.1007/s00436-013-3557-2
   Govindarajan M, 2012, PARASITOL RES, V110, P1607, DOI 10.1007/s00436-011-2669-9
   Govindarajan M, 2011, ASIAN PAC J TROP MED, V4, P176, DOI 10.1016/S1995-7645(11)60064-3
   Govindarajan M, 2011, PARASITOL RES, V109, P93, DOI 10.1007/s00436-010-2224-0
   Haldar KM, 2013, PARASITOL RES, V112, P1451, DOI 10.1007/s00436-013-3288-4
   Hanan SA, 2018, RES J BIOTECHNOL, V13, P65
   Hotez PJ, 2004, CLIN INFECT DIS, V38, P871, DOI 10.1086/382077
   Lee SE, 2001, AGR CHEM BIOTECHNOL, V44, P105
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Mandal SC, 2003, PHYTOTHER RES, V17, P817, DOI 10.1002/ptr.1095
   Mathivanan T, 2010, J VECTOR DIS, V47, P178
   Mehlhorn H, 2012, PARASITOL RES, V110, P259, DOI 10.1007/s00436-011-2480-7
   Murugan K, 2015, RES VET SCI, V102, P127, DOI 10.1016/j.rvsc.2015.08.001
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   Patil S., 2014, AM J ETHNOMED, V1, P174
   Priyadarshini KA, 2012, PARASITOL RES, V111, P997, DOI 10.1007/s00436-012-2924-8
   Rawani A, 2013, ACTA TROP, V128, P613, DOI 10.1016/j.actatropica.2013.09.007
   Sarwar M, 2009, PAK J BOT, V41, P3047
   Sathyavathi R, 2010, ADV SCI LETT, V3, P138, DOI 10.1166/asl.2010.1099
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Sivagnaname N, 2004, MEM I OSWALDO CRUZ, V99, P115, DOI 10.1590/S0074-02762004000100021
   Srinivasan R., 2015, J BIOL ACTIVE PROD N, V4, P391
   Subarani S, 2013, PARASITOL RES, V112, P487, DOI 10.1007/s00436-012-3158-5
   Suresh U, 2015, PARASITOL RES, V114, P1551, DOI 10.1007/s00436-015-4339-9
   Thomas SK, 2015, INT J PHARM SCI RES, V6, P1741, DOI 10.13040/IJPSR.0975-8232.6(4).1741-45
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Vivek R, 2012, PROCESS BIOCHEM, V47, P2405, DOI 10.1016/j.procbio.2012.09.025
   *WHO, 2005, WHOCDSWHOPESGCDPP200
NR 60
TC 0
Z9 0
U1 6
U2 6
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 1040-7278
EI 1572-8862
J9 J CLUST SCI
JI J. Clust. Sci.
DI 10.1007/s10876-020-01808-5
EA MAY 2020
PG 9
WC Chemistry, Inorganic & Nuclear
SC Chemistry
GA LK8VE
UT WOS:000531136500001
DA 2020-07-08
ER

PT J
AU Thawani, A
   Sammudin, NH
   Reygaerts, HS
   Wozniak, AN
   Munnamalai, V
   Kuhn, RJ
   Fekete, DM
AF Thawani, Ankita
   Sammudin, Nabilah H.
   Reygaerts, Hannah S.
   Wozniak, Alexis N.
   Munnamalai, Vidhya
   Kuhn, Richard J.
   Fekete, Donna M.
TI Zika virus can directly infect and damage the auditory and vestibular
   components of the embryonic chicken inner ear
SO DEVELOPMENTAL DYNAMICS
LA English
DT Article; Early Access
DE cell death; cochlea; inner ear development; otocyst; semicircular
   canals; Zika infection
ID NEURAL CREST CELLS; EXPRESSION; MELANOCYTES; ORGANOIDS; INFANTS
AB Background Sensorineural hearing loss is an understudied consequence of congenital Zika syndrome, and balance disorders are essentially unreported to date. Also lacking is information about the susceptibility and the pathogenesis of the developing inner ear following Zika virus (ZIKV) exposure. To address this, ZIKV was delivered directly into the otic cup/otocyst of chicken embryos and infection of inner ear tissues was evaluated using immunohistochemistry.
   Results After injections on embryonic days 2 to 5, ZIKV infection was observed in 90% of the samples harvested 2 to 8 days later; however, the degree of infection was highly variable across individuals. ZIKV was detected in all regions of the inner ear, associated ganglia, and in the surrounding periotic mesenchyme. Detection of virus peaked earlier in the ganglion and vestibular compartments, and later in the cochlea. ZIKV infection increased cell death robustly in the auditory ganglion, and modestly in the auditory sensory organ. Macrophage accumulation was found to overlap with dense viral infection in some tissues. Additionally, dysmorphogenesis of the semicircular canals and ganglion was observed for a subset of injection conditions.
   Conclusions This article presents evidence of direct ZIKV infection of developing inner ear epithelium and shows previously unknown inner ear dysmorphogenesis phenotypes.
C1 [Thawani, Ankita; Sammudin, Nabilah H.; Reygaerts, Hannah S.; Wozniak, Alexis N.; Kuhn, Richard J.; Fekete, Donna M.] Purdue Univ, Dept Biol Sci, W Lafayette, IN 47907 USA.
   [Thawani, Ankita; Sammudin, Nabilah H.; Fekete, Donna M.] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.
   [Thawani, Ankita; Kuhn, Richard J.; Fekete, Donna M.] Purdue Univ, Purdue Inst Inflammat Immunol & Infect Dis, W Lafayette, IN 47907 USA.
   [Fekete, Donna M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA.
   [Munnamalai, Vidhya] Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.
RP Fekete, DM (corresponding author), 915 W State St,LILY 2-122, W Lafayette, IN USA.
EM dfekete@purdue.edu
RI Fekete, Donna M./B-9170-2009; Munnamalai, Vidhya/B-7811-2016
OI Fekete, Donna M./0000-0003-0662-0246; Munnamalai,
   Vidhya/0000-0002-4985-8265
FU National Institute on Deafness and Other Communication DisordersUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute on Deafness & Other
   Communication Disorders (NIDCD) [R21DC016732]
FX National Institute on Deafness and Other Communication Disorders,
   Grant/Award Number: R21DC016732
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Bissonnette JP, 1996, J COMP NEUROL, V368, P620, DOI 10.1002/(SICI)1096-9861(19960513)368:4<620::AID-CNE12>3.0.CO;2-L
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   DAMICOMARTEL A, 1983, AM J ANAT, V166, P445, DOI 10.1002/aja.1001660406
   de Carvalho Leal M, 2016, BRAZ J OTORHINOLAR, V30, P30127
   Barbosa MHD, 2019, BRAZ J OTORHINOLAR, V85, P642, DOI 10.1016/j.bjorl.2019.05.002
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Fekete DM, 1997, DEVELOPMENT, V124, P2451
   Ficenec SC, 2019, AM J TROP MED HYG, V101, P484, DOI 10.4269/ajtmh.18-0934
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garcia-Morales C, 2014, DEV COMP IMMUNOL, V42, P278, DOI 10.1016/j.dci.2013.09.011
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Julander JG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27611-x
   KATAYAMA A, 1989, J COMP NEUROL, V281, P129, DOI 10.1002/cne.902810110
   Kiernan AE, 2006, BRAIN RES, V1091, P270, DOI 10.1016/j.brainres.2006.02.037
   KNOWLTON VY, 1967, J MORPHOL, V121, P179, DOI 10.1002/jmor.1051210302
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Li HW, 2004, J COMP NEUROL, V477, P1, DOI 10.1002/cne.20190
   Liang JK, 2010, DEV BIOL, V337, P324, DOI 10.1016/j.ydbio.2009.11.001
   Lim R, 2016, HEARING RES, V338, P9, DOI 10.1016/j.heares.2016.02.004
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mittal R, 2018, JAMA OTOLARYNGOL, V144, P3, DOI 10.1001/jamaoto.2017.1798
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Neves J, 2007, J COMP NEUROL, V503, P487, DOI 10.1002/cne.21299
   Nishitani AM, 2017, DEVELOPMENT, V144, P3349, DOI 10.1242/dev.144519
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Sanchez-Calderon H, 2005, GENE EXPR PATTERNS, V5, P763, DOI 10.1016/j.modgep.2005.04.007
   STEEL KP, 1989, DEVELOPMENT, V107, P453
   Stone JS, 2007, INT J DEV BIOL, V51, P633, DOI 10.1387/ijdb.072408js
   Stone JS, 2003, J COMP NEUROL, V460, P487, DOI 10.1002/cne.10662
   Tachibana M, 1999, PIGM CELL RES, V12, P344, DOI 10.1111/j.1600-0749.1999.tb00518.x
   Thawani A, 2018, CELL REP, V23, P692, DOI 10.1016/j.celrep.2018.03.080
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   Wu DK, 1996, J NEUROSCI, V16, P6454
   Wu DK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008409
NR 45
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1058-8388
EI 1097-0177
J9 DEV DYNAM
JI Dev. Dyn.
DI 10.1002/dvdy.176
EA MAY 2020
PG 17
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA LK5QQ
UT WOS:000530921300001
PM 32384225
DA 2020-07-08
ER

PT J
AU Hue, BTB
   Nguyen, PH
   De, TQ
   Hieu, MV
   Jo, E
   Tuan, NV
   Thoa, TT
   Anh, L
   Son, NH
   Thanh, DLD
   Dupont-Rouzeyrol, M
   Grailhe, R
   Windisch, MP
AF Hue, Bui Thi Buu
   Nguyen, Phuong Hong
   De, Tran Quang
   Van Hieu, Mai
   Jo, Eunji
   Van Tuan, Nguyen
   Thoa, Than Thi
   Anh, Le Duc
   Son, Nguyen Hoang
   Duc Thanh, Danh La
   Dupont-Rouzeyrol, Myrielle
   Grailhe, Regis
   Windisch, Marc P.
TI Benzimidazole Derivatives as Novel Zika Virus Inhibitors
SO CHEMMEDCHEM
LA English
DT Article; Early Access
DE Antivirals; benzimidazoles; o-phenylenediamine; phenotypic screening;
   sodium metabisulfite; Zika virus
ID CATALYZED SYNTHESIS; SIRTUIN INHIBITORS; IN-VITRO; ELECTROLUMINESCENCE;
   TRANSMISSION; ENTRY
AB We have synthesized 50 benzimidazole (BMZ) derivatives with 1,2-phenylenediamines and aromatic aldehydes under mild oxidation conditions by using inexpensive, nontoxic inorganic salt sodium metabisulfite in a one-pot condensation reaction and screened their ability to interfere with Zika virus (ZIKV) infection utilizing a cell-based phenotypic assay. Seven BMZs inhibited an African ZIKV strain with a selectivity index (SI=CC50/EC50) of 9-37. Structure-activity relationship analysis demonstrated that substitution at the C-2, N-1, and C-5 positions of the BMZ ring were important for anti-ZIKV activity. The hybrid structure of BMZ and naphthalene rings was a structural feature responsible for the high anti-ZIKV activity. Importantly, BMZs inhibited ZIKV in human neural stem cells, a physiologically relevant system considering the severe congenital anomalies, like microcephaly, caused by ZIKV infection. Compound 39 displayed the highest antiviral efficacy against the African ZIKV strain in Huh-7 (SI>37) and neural stem cells (SI=12). Compound 35 possessed the highest activity in Vero cells (SI=115). Together, our data indicate that BMZs derivatives have to be considered for the development of ZIKV therapeutic interventions.
C1 [Hue, Bui Thi Buu; De, Tran Quang; Van Hieu, Mai; Van Tuan, Nguyen; Anh, Le Duc; Son, Nguyen Hoang; Duc Thanh, Danh La] Can Tho Univ, Coll Nat Sci, Dept Chem, Campus 2,3-2 St, Can Tho City, Vietnam.
   [Nguyen, Phuong Hong; Jo, Eunji; Thoa, Than Thi; Windisch, Marc P.] Inst Pasteur Korea, Appl Mol Virol Lab, Discovery Biol Div, Seongnam 13488, South Korea.
   [Nguyen, Phuong Hong; Windisch, Marc P.] Univ Sci & Technol, Div Biomed Sci & Technol, Daejeon 34141, South Korea.
   [Dupont-Rouzeyrol, Myrielle] Inst Pasteur Nouvelle Caledonie, URE Dengue & Arboviruses, Noumea 98800, New Caledonia.
   [Grailhe, Regis] Inst Pasteur Korea, Technol Dev Platform, Seongnam 13488, South Korea.
RP Hue, BTB (corresponding author), Can Tho Univ, Coll Nat Sci, Dept Chem, Campus 2,3-2 St, Can Tho City, Vietnam.; Windisch, MP (corresponding author), Inst Pasteur Korea, Appl Mol Virol Lab, Discovery Biol Div, Seongnam 13488, South Korea.; Windisch, MP (corresponding author), Univ Sci & Technol, Div Biomed Sci & Technol, Daejeon 34141, South Korea.
EM btbhue@ctu.edu.vn; marc.windisch@ip-korea.org
OI Mai, Hieu V./0000-0002-5077-2899
FU Vietnam National Foundation for Science and Technology Development
   (NAFOSTED)National Foundation for Science & Technology Development
   (NAFOSTED) [104.01-2018.51]; National Research Foundation of Korea (NRF)
   - Korean government (MSIT) [NRF-2017M3A9G6068246]
FX This research was funded by the Vietnam National Foundation for Science
   and Technology Development (NAFOSTED) (104.01-2018.51) and a National
   Research Foundation of Korea (NRF) grant funded by the Korean government
   (MSIT, NRF-2017M3A9G6068246).
CR Ahn SY, 2015, SYNTHETIC MET, V199, P8, DOI 10.1016/j.synthmet.2014.11.005
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Hue BTB, 2019, HETEROCYCLES, V98, P650, DOI 10.3987/COM-19-14071
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Chandrika NT, 2016, BIOORGAN MED CHEM, V24, P3680, DOI 10.1016/j.bmc.2016.06.010
   Delang L, 2012, ANTIVIR RES, V93, P30, DOI 10.1016/j.antiviral.2011.10.012
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   Ding K, 2014, BIOORG MED CHEM LETT, V24, P3113, DOI 10.1016/j.bmcl.2014.05.009
   El Diwani HI, 2014, CHEM PHARM BULL, V62, P856, DOI 10.1248/cpb.c13-01009
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Gillard JR, 2012, ORG SYNTH, V89, P131, DOI 10.15227/orgsyn.089.0131
   Bui HTB, 2016, TETRAHEDRON LETT, V57, P887, DOI 10.1016/j.tetlet.2016.01.042
   IEMURA R, 1986, J MED CHEM, V29, P1178, DOI 10.1021/jm00157a010
   Karthik D, 2016, DYES PIGMENTS, V133, P132, DOI 10.1016/j.dyepig.2016.05.046
   Ko C, 2015, ANTIVIR THER, V20, P835, DOI 10.3851/IMP2965
   Kommi DN, 2013, GREEN CHEM, V15, P798, DOI 10.1039/c3gc37004f
   Lee M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44676
   Lee M, 2016, ANTIVIR RES, V132, P287, DOI 10.1016/j.antiviral.2016.07.002
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Mader M, 2008, BIOORG MED CHEM LETT, V18, P179, DOI 10.1016/j.bmcl.2007.10.106
   Onyshchenko MI, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/634914
   osterlund P., 2019, SCI REP, V9, P1
   Rao A, 2002, FARMACO, V57, P819, DOI 10.1016/S0014-827X(02)01300-9
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Raut R, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0248-x
   Roy P, 2013, TETRAHEDRON LETT, V54, P5243, DOI 10.1016/j.tetlet.2013.07.083
   Sadig JER, 2012, J ORG CHEM, V77, P9473, DOI 10.1021/jo301805d
   Shao Q, 2017, DEVELOPMENT, V144, P4114, DOI 10.1242/dev.156752
   Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321
   Siddiqui H, 2016, BIOORGAN MED CHEM, V24, P3387, DOI 10.1016/j.bmc.2016.05.018
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tonelli M, 2008, CHEM BIODIVERS, V5, P2386, DOI 10.1002/cbdv.200890203
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Xie CX, 2017, ORG BIOMOL CHEM, V15, P5811, DOI 10.1039/c7ob00945c
   Yoon YK, 2015, EUR J MED CHEM, V93, P614, DOI 10.1016/j.ejmech.2013.06.025
   Yoon YK, 2014, TETRAHEDRON LETT, V55, P4697, DOI 10.1016/j.tetlet.2014.07.008
   Yoon YK, 2014, EUR J MED CHEM, V83, P448, DOI 10.1016/j.ejmech.2014.06.060
   Yoon YK, 2013, BIOORG CHEM, V49, P33, DOI 10.1016/j.bioorg.2013.06.008
   Yoon YK, 2014, BIOORGAN MED CHEM, V22, P703, DOI 10.1016/j.bmc.2013.12.029
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 42
TC 0
Z9 0
U1 2
U2 2
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1860-7179
EI 1860-7187
J9 CHEMMEDCHEM
JI ChemMedChem
DI 10.1002/cmdc.202000124
EA MAY 2020
PG 12
WC Chemistry, Medicinal; Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA LK2JJ
UT WOS:000530685200001
PM 32281263
DA 2020-07-08
ER

PT J
AU Kaid, C
   Madi, RAD
   Astray, R
   Goulart, E
   Caires, LC
   Mitsugi, TG
   Moreno, ACR
   Castro-Amarante, MF
   Pereira, LR
   Porchia, BFMM
   de Andrade, TO
   Landini, V
   Sanches, DS
   Pires, CG
   Tanioka, RKO
   Pereira, MCL
   Barbosa, IN
   Massoco, CO
   Ferreira, LCD
   Okamoto, OK
   Zatz, M
AF Kaid, Carolini
   dos Santos Madi, Raquel Azevedo
   Astray, Renato
   Goulart, Ernesto
   Caires-Junior, Luiz Carlos
   Mitsugi, Thiago Giove
   Ramos Moreno, Ana Carolina
   Castro-Amarante, Maria Fernanda
   Pereira, Lennon Ramos
   Milazzotto Maldonado Porchia, Bruna Felicio
   de Andrade, Thais Oliveira
   Landini, Vivian
   Sanches, Daniel Soares
   Pires, Carolina Goncalves
   Oliveira Tanioka, Rubens Koji
   Pereira, Marcia C. L.
   Barbosa, Igor Neves
   Massoco, Cristina O.
   de Souza Ferreira, Luis Carlos
   Okamoto, Oswaldo Keith
   Zatz, Mayana
TI Safety, Tumor Reduction, and Clinical Impact of Zika Virus Injection in
   Dogs with Advanced-Stage Brain Tumors
SO MOLECULAR THERAPY
LA English
DT Article
ID ONCOLYTIC VIROTHERAPY; IMMUNE; CANINE; NEUROONCOLOGY; CELLS
AB Malignant brain tumors are among the most aggressive cancers with poor prognosis and no effective treatment. Recently, we reported the oncolytic potential of Zika virus infecting and destroying the human central nervous system (CNS) tumors in vitro and in immunodeficient mice model. However, translating this approach to humans requires pre-clinical trials in another immunocompetent animal model. Here, we analyzed the safety of Brazilian Zika virus (ZIKV(BR)) intrathecal injections in three dogs bearing spontaneous CNS tumors aiming an anti-tumoral therapy. We further assessed some aspects of the innate immune and inflammatory response that triggers the anti-tumoral response observed during the ZIKV(BR) administration in vivo and in vitro. For the first time, we showed that there were no negative clinical side effects following ZIKV(BR) CNS injections in dogs, confirming the safety of the procedure. Furthermore, the intrathecal ZIKV(BR) injections reduced tumor size in immunocompetent dogs bearing spontaneous intracranial tumors, improved their neurological clinical symptoms significantly, and extended their survival by inducing the destruction specifically of tumor cells, sparing normal neurons, and activating an immune response. These results open new perspectives for upcoming virotherapy using ZIKV to destroy and induce an anti-tumoral immune response in CNS tumors for which there are currently no effective treatments.
C1 [Kaid, Carolini; Goulart, Ernesto; Caires-Junior, Luiz Carlos; Mitsugi, Thiago Giove; de Andrade, Thais Oliveira; Landini, Vivian; Pereira, Marcia C. L.; Barbosa, Igor Neves; Okamoto, Oswaldo Keith; Zatz, Mayana] Univ Sao Paulo, Human Genome & Stem Cell Res Ctr HUG CEL, Inst Biosci, Cidade Univ, BR-05508009 Sao Paulo, Brazil.
   [dos Santos Madi, Raquel Azevedo; Oliveira Tanioka, Rubens Koji] Hosp Vet Granja Viana, BR-06345410 Granja Viana, Brazil.
   [Astray, Renato] Butantan Inst, BR-05503900 Sao Paulo, Brazil.
   [Ramos Moreno, Ana Carolina; Castro-Amarante, Maria Fernanda; Pereira, Lennon Ramos; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Vaccine Dev Lab, BR-05508900 Sao Paulo, Brazil.
   [Milazzotto Maldonado Porchia, Bruna Felicio] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Lab Tumor Immunol, BR-05508900 Sao Paulo, Brazil.
   [Sanches, Daniel Soares; Pires, Carolina Goncalves] Vet Pathol Anat Ctr, BR-05376070 Sao Paulo, Brazil.
   [Massoco, Cristina O.] Univ Sao Paulo, Sch Vet Med & Anim Sci, Dept Pathol, BR-05508270 Sao Paulo, Brazil.
   [Okamoto, Oswaldo Keith] Hosp Israelita Albert Einstein, Hemotherapy & Cellular Therapy Dept, BR-05652900 Sao Paulo, Brazil.
RP Zatz, M (corresponding author), Univ Sao Paulo, Human Genome & Stem Cell Res Ctr HUG CEL, Inst Biosci, Cidade Univ, BR-05508009 Sao Paulo, Brazil.
EM mayazatz@usp.br
RI Kaid, Carolini/AAQ-9294-2020; massoco, cristina/N-2634-2015
OI Kaid, Carolini/0000-0002-1852-6997; massoco,
   cristina/0000-0001-8030-0609
FU FAPESP-CEPIDFundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2013/08028-1]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior - Brasil (CAPES)CAPES [001]; CNPq, BrazilNational Council
   for Scientific and Technological Development (CNPq) [309206/2011-1,
   444722/2014-9]; INCT-CETGEN, Brazil [573633/2008-8]; FINEP-CTC, Brazil
   [0108057900]
FX We are extremely grateful to the dogs' owners, in particular Gladys
   Aparecida Bernadino dos Santos and her daughter Carolina, and for the
   generous contribution of Rosalia Raia, Carol Sandler, Adriana Cesar
   Carvalho, Elizabete Piedade, Ester Hadassa Sandler, Irene Faiguenboim,
   Mariana Fischer, Paulo Sousa, Sergio Cipullo, and Simone Schapira
   Wajman. We also thanks Felipe Chica Lopes, the owner of the Hospital
   Veterinario Granja Viana (Sao Paulo, Brazil), where the dogs were
   maintained and treated. This study was financed in part by the
   FAPESP-CEPID (2013/08028-1); Coordenacao de Aperfeicoamento de Pessoal
   de Nivel Superior - Brasil (CAPES) - Finance Code 001; CNPq, Brazil
   (309206/2011-1; 444722/2014-9); INCT-CETGEN, Brazil (573633/2008-8); and
   FINEP-CTC, Brazil (0108057900). C.K. is a fellow of FAPESP, Sao Paulo,
   Brazil (2018/16213-7).
CR Bentley RT, 2017, NEURO-ONCOLOGY, V19, P312, DOI 10.1093/neuonc/now109
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Candolfi M, 2007, J NEURO-ONCOL, V85, P133, DOI 10.1007/s11060-007-9400-9
   Chiocca EA, 2014, CANCER IMMUNOL RES, V2, P295, DOI 10.1158/2326-6066.CIR-14-0015
   Chon HJ, 2019, CLIN CANCER RES, V25, P1612, DOI 10.1158/1078-0432.CCR-18-1932
   Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felsburg PJ, 2002, HUM EXP TOXICOL, V21, P487, DOI 10.1191/0960327102ht286oa
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   Foreman PM, 2017, NEUROTHERAPEUTICS, V14, P333, DOI 10.1007/s13311-017-0516-0
   Galan A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190474
   Gardeck AM, 2017, EXPERT OPIN BIOL TH, V17, P457, DOI 10.1080/14712598.2017.1296132
   Gomes JP, 2018, DNA CELL BIOL, V37, P798, DOI 10.1089/dna.2018.4158
   HEIDNER GL, 1991, J VET INTERN MED, V5, P219, DOI 10.1111/j.1939-1676.1991.tb00952.x
   Hodi FS, 2016, J CLIN ONCOL, V34, P1510, DOI 10.1200/JCO.2015.64.0391
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kim K, 2018, CAN VET J, V59, P93
   Kimmelman J, 2007, CANCER RES, V67, P4541, DOI 10.1158/0008-5472.CAN-06-3792
   Kishimoto TE, 2018, VET PATHOL, V55, P634, DOI 10.1177/0300985818777794
   Koehler JW, 2018, J NEUROPATH EXP NEUR, V77, P2018, DOI 10.1093/jnen/nly085
   MacNeill AL, 2015, ONCOLYTIC VIROTHER, V4, P95, DOI 10.2147/OV.S66358
   Moirano SJ, 2018, VET COMP ONCOL, V16, P459, DOI 10.1111/vco.12401
   Momozawa Y., 2019, TRANSL REGUL SCI, V1, P31
   Motta L, 2012, VET J, V192, P153, DOI 10.1016/j.tvjl.2011.10.008
   Okada Hideho, 2015, Lancet Oncol, V16, pe534, DOI 10.1016/S1470-2045(15)00088-1
   Okada SS, 2016, CELL IMMUNOL, V300, P18, DOI 10.1016/j.cellimm.2015.11.003
   Oliveira DBL, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110615
   Ranjan S, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4131-1
   Ruble GR, 2006, J AM ASSOC LAB ANIM, V45, P25
   Schiffman JD, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0231
   Song RB, 2013, J VET INTERN MED, V27, P1143, DOI 10.1111/jvim.12136
   Stoica G, 2009, VET PATHOL, V46, P391, DOI 10.1354/vp.08-VP-0218-S-FL
   Stucklin ASG, 2018, CURR OPIN PEDIATR, V30, P3, DOI 10.1097/MOP.0000000000000562
   Thongyuan S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180013
   Vakilian A, 2017, NEUROCHEM INT, V103, P1, DOI 10.1016/j.neuint.2016.12.013
   Zhang YS, 2018, BIOMED PHARMACOTHER, V104, P566, DOI 10.1016/j.biopha.2018.05.079
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008
NR 39
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1525-0016
EI 1525-0024
J9 MOL THER
JI Mol. Ther.
PD MAY 6
PY 2020
VL 28
IS 5
BP 1276
EP 1286
DI 10.1016/j.ymthe.2020.03.004
PG 11
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine,
   Research & Experimental
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Research &
   Experimental Medicine
GA LK7ZW
UT WOS:000531081100006
PM 32220305
OA Other Gold
DA 2020-07-08
ER

PT J
AU Throckmorton, L
   Hancher, J
AF Throckmorton, Laura
   Hancher, Jonathan
TI Management of Travel-Related Infectious Diseases in the Emergency
   Department
SO CURRENT EMERGENCY AND HOSPITAL MEDICINE REPORTS
LA English
DT Article
DE International infectious diseases; Traveler's diarrhea; Febrile
   traveler; Emergency department; Malaria; Global Health
ID UNITED-STATES; TYPHOID-FEVER; LEPTOSPIROSIS; DIARRHEA; MALARIA;
   RECOMMENDATIONS; SURVEILLANCE; MORTALITY; ETIOLOGY; VIRUS
AB Purpose of Review Emergency physicians generally have limited exposure to internationally acquired illnesses. However, travelers can present quite ill, and delays in recognition and treatment can lead to increased morbidity and mortality. This paper aims to summarize typical presentations of common international diseases and provide the emergency physician with a practical approach based on current guidelines. Recent Findings In the treatment of traveler's diarrhea, azithromycin has become the treatment of choice due to the growing antibiotic resistance. Intravenous artesunate was approved in 2019 under investigational new drug protocol for the treatment of severe malaria, and artemisinin-based combination therapies (ACTs) have become the first-line treatment for most cases of uncomplicated malaria. Since the 2015 outbreak, Zika has become a concern to many travelers, but the current treatment is supportive. Clinicians should be aware of a few noteworthy updates in the treatment of internationally acquired illnesses, but more importantly, they must recognize warning signs of severe illness and treat promptly. Future research on workup and disposition could help emergency physicians identify which patients need admission in well-appearing febrile travelers.
C1 [Throckmorton, Laura] Univ Hosp Cleveland, Ctr Emergency Med, Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.
   [Hancher, Jonathan] Univ N Carolina, Univ North Carolina Hosp, Dept Emergency Med, Phys Off Bldg,170 Manning Dr,CB 7594, Chapel Hill, NC 27599 USA.
RP Throckmorton, L (corresponding author), Univ Hosp Cleveland, Ctr Emergency Med, Med Ctr, 11100 Euclid Ave, Cleveland, OH 44106 USA.
EM LThrock22@gmail.com; jonathanhancher@gmail.com
CR Abgueguen P, 2008, J INFECTION, V57, P171, DOI 10.1016/j.jinf.2008.06.010
   Akselrod H, 2018, AM J TROP MED HYG, V99, P1511, DOI 10.4269/ajtmh.18-0608
   Alian S, 2014, IRAN RED CRESCENT ME, V16, DOI 10.5812/ircmj.16030
   Anonymous, 2006, Morbidity and Mortality Weekly Report, V55, P1
   Ballard SB, 2018, MMWR-MORBID MORTAL W, V67, P424, DOI 10.15585/mmwr.mm6714a4
   Breman JG, 2019, UPTODATE
   Centers for Disease Control and Prevention, 2016, EM PREP RESP REC MAN
   Centers for Disease Control and Prevention, 2019, LEPT HEALTHC WORK
   Centers for Disease Control and Prevention, 2019, DENG HEALTHC PROV
   Centers for Disease Control and Prevention, CHIK INF HEALTHC PRO
   Centers for Disease Control and Prevention, 2019, CDC MAL DIAGN TREATM
   Centers for Disease Control and Prevention, 2015, NAT TYPH PAR FEV SUR
   Chatham-Stephens K, 2019, MMWR-MORBID MORTAL W, V68, P11, DOI [10.15585/mmwr.mm6801a3, 10.1128/mBio.02112-18]
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Chisti MJ, 2009, SE ASIAN J TROP MED, V40, P1065
   Colucci B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30998-2
   Daily J, 2019, UPTODATE
   Day N, 2019, UPTODATE
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flamand C, 2016, EURO SURVEILL, V22
   Greenwood Z, 2008, J TRAVEL MED, V15, P221, DOI 10.1111/j.1708-8305.2008.00203.x
   GUPTA SP, 1985, J TROP MED HYG, V88, P377
   Hill DR, 2010, CURR OPIN INFECT DIS, V23, P481, DOI 10.1097/QCO.0b013e32833dfca5
   HOFFMAN SL, 1984, NEW ENGL J MED, V310, P82, DOI 10.1056/NEJM198401123100203
   Jackson BR, 2015, UPDATED RECOMMENDATI
   JOHNSON WD, 1975, JAMA-J AM MED ASSOC, V233, P981, DOI 10.1001/jama.233.9.981
   Khuu D, 2017, AM J TROP MED HYG, V97, P213, DOI 10.4269/ajtmh.17-0101
   LaBeaud AD., 2020, UPTODATE
   LaRocque R, 2020, UPTODATE
   Mace KE, 2019, MMWR SURVEILL SUMM, V68, P1, DOI 10.15585/mmwr.ss6805a1
   Mendoza MT, 2013, SE ASIAN J TROP MED, V44, P1021
   Miner JJ, 2019, CHIKUNGUNYA FEVER TR
   Miner JJ, 2015, ARTHRITIS RHEUMATOL, V67, P1214, DOI 10.1002/art.39027
   Neil KP, 2012, CLIN INFECT DIS, V54, P1091, DOI 10.1093/cid/cis025
   Pappachan MJ, 2004, NATL MED J INDIA, V17, P240
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Puca E, 2016, TRAVEL MED INFECT DI, V14, P143, DOI 10.1016/j.tmaid.2015.11.011
   Rodrigo C, 2014, T ROY SOC TROP MED H, V108, P743, DOI 10.1093/trstmh/tru148
   Ryan ET, 2018, EPIDEMIOLOGY MICROBI
   Ryan ET, 2019, UPTODATE
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X
   Shah N, 2009, AM J TROP MED HYG, V80, P609, DOI 10.4269/ajtmh.2009.80.609
   Steffen R, 1999, JAMA-J AM MED ASSOC, V281, P811, DOI 10.1001/jama.281.9.811
   Stoney RJ, 2017, AM J TROP MED HYG, V96, P1388, DOI 10.4269/ajtmh.16-0447
   Tan KR, 2019, CDC YELLOW BOOK 2020
   Thomas SJ, 2019, UPTODATE
   U.S. Food and Drug Administration, 2019, CURR RES DRUG SHORT
   Visser BJ, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-463
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   WHO, 2015, GUID TREATM MAL
   Wilson M, 2020, CHIKUNGUNYA FEVER EP
   World Health Organization, 2016, CONS CAUS LINK ZIK N
   World Health Organization, 2019, DENG SEV DENG
   World Health Organization-WHO, 2003, HUM LEPT GUID DIAGN
NR 55
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2167-4884
J9 CURR EMERG HOSP ME R
JI Curr. Emerg. Hosp. Med. Rep.
PD JUN
PY 2020
VL 8
IS 2
BP 50
EP 59
DI 10.1007/s40138-020-00213-6
EA MAY 2020
PG 10
WC Emergency Medicine
SC Emergency Medicine
GA LL8GL
UT WOS:000530763200001
PM 32377443
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Carlson, CJ
   Chipperfield, JD
   Benito, BM
   Telford, RJ
   O'Hara, RB
AF Carlson, Colin J.
   Chipperfield, Joseph D.
   Benito, Blas M.
   Telford, Richard J.
   O'Hara, Robert B.
TI Species distribution models are inappropriate for COVID-19
SO NATURE ECOLOGY & EVOLUTION
LA English
DT Article
ID ZIKA VIRUS
AB Species distribution models are a powerful tool for ecological inference, but not every use is biologically justified. Applying these tools to the COVID-19 pandemic is unlikely to yield new insights, and could mislead policymakers at a critical moment.
C1 [Carlson, Colin J.] Georgetown Univ, Med Ctr, Ctr Global Hlth Sci & Secur, Washington, DC 20007 USA.
   [Chipperfield, Joseph D.] Norwegian Inst Nat Res, Bergen, Norway.
   [Benito, Blas M.] Univ Alicante, Dept Ecol, Alicante, Spain.
   [Benito, Blas M.] Univ Alicante, Multidisciplinary Inst Environm Studies Ramon Mar, Alicante, Spain.
   [Telford, Richard J.] Univ Bergen, Dept Biol Sci, Bergen, Norway.
   [Telford, Richard J.] Bjerknes Ctr Climate Res, Bergen, Norway.
   [O'Hara, Robert B.] Norwegian Univ Sci & Technol, Dept Math Sci, Trondheim, Norway.
   [O'Hara, Robert B.] Norwegian Univ Sci & Technol, Ctr Biodivers Dynam, Trondheim, Norway.
RP Carlson, CJ (corresponding author), Georgetown Univ, Med Ctr, Ctr Global Hlth Sci & Secur, Washington, DC 20007 USA.
EM colin.carlson@georgetown.edu
RI Telford, Richard/C-1668-2008; Benito, Blas M./D-4681-2014
OI Telford, Richard/0000-0001-9826-3076; Benito, Blas
   M./0000-0001-5105-7232
CR Allen T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00923-8
   Andersen KG, 2020, NAT MED, DOI 10.1038/s41591-020-0820-9
   [Anonymous], 2020, RAP EXP CONS SARS CO, DOI [10.17226/25771, DOI 10.17226/25771]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Burke M, 2015, ECON J, V125, P1157, DOI 10.1111/ecoj.12149
   Carlson CJ, 2019, NAT MICROBIOL, V4, P1337, DOI 10.1038/s41564-019-0435-4
   Carlson CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22989-0
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Dougherty ER, 2018, ECOL LETT, V21, P588, DOI 10.1111/ele.12917
   Fourcade Y, 2018, GLOBAL ECOL BIOGEOGR, V27, P245, DOI 10.1111/geb.12684
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gog JR, 2020, NAT REV PHYS, V2, P274, DOI 10.1038/s42254-020-0175-7
   Hay SI, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0250
   Johnson EE, 2019, TRENDS ECOL EVOL, V34, P655, DOI 10.1016/j.tree.2019.03.004
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Kraemer MUG, 2016, TRENDS PARASITOL, V32, P19, DOI 10.1016/j.pt.2015.09.006
   Lowen AC, 2014, J VIROL, V88, P7692, DOI 10.1128/JVI.03544-13
   Marr LC, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0298
   Maudlin I, 2009, PHILOS T R SOC B, V364, P2777, DOI 10.1098/rstb.2009.0067
   Meltzer Martin I, 2014, MMWR Suppl, V63, P1
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Park JE, 2020, INFLUENZA OTHER RESP, V14, P11, DOI 10.1111/irv.12682
   Qian H, 2020, PREPRINT, DOI [10.1101/2020.04.04.20053058, DOI 10.1101/2020.04.04.20053058]
   Reeves Tarian, 2015, BMC Res Notes, V8, P801, DOI 10.1186/s13104-015-1789-1
   Rodgers SE, 2007, J MED ENTOMOL, V44, P372, DOI 10.1603/0022-2585(2007)44[372:DOETSA]2.0.CO;2
   Samy AM, 2016, MEM I OSWALDO CRUZ, V111, P559, DOI 10.1590/0074-02760160149
   Shapiro LLM, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003489
   Smith KF, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0950
   van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI 10.1056/NEJMc2004973
   Zhu GP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093390
NR 30
TC 0
Z9 0
U1 4
U2 4
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2397-334X
J9 NAT ECOL EVOL
JI Nat. Ecol. Evol.
PD JUN
PY 2020
VL 4
IS 6
BP 770
EP 771
DI 10.1038/s41559-020-1212-8
EA MAY 2020
PG 2
WC Ecology; Evolutionary Biology
SC Environmental Sciences & Ecology; Evolutionary Biology
GA LY0IT
UT WOS:000530808100001
PM 32377007
OA Bronze
DA 2020-07-08
ER

PT J
AU Chen, ML
   Du, YZ
   Nomura, Y
   Zhorov, BS
   Dong, K
AF Chen, Mengli
   Du, Yuzhe
   Nomura, Yoshiko
   Zhorov, Boris S.
   Dong, Ke
TI Chronology of sodium channel mutations associated with pyrethroid
   resistance in Aedes aegypti
SO ARCHIVES OF INSECT BIOCHEMISTRY AND PHYSIOLOGY
LA English
DT Review
DE Aedes aegypti; knockdown resistance; pyrethroid resistance; pyrethroids;
   sodium channels
ID COMMON BED BUG; KNOCKDOWN RESISTANCE; INSECTICIDE RESISTANCE;
   DIPTERA-CULICIDAE; KDR MUTATIONS; FIELD POPULATIONS; POINT MUTATIONS;
   1ST REPORT; NATURAL-POPULATIONS; CROSS-RESISTANCE
AB Aedes aegypti is the primary mosquito vector of dengue, yellow fever, Zika and chikungunya. Current strategies to control Ae. aegypti rely heavily on insecticide interventions. Pyrethroids are a major class of insecticides used for mosquito control because of their fast acting, highly insecticidal activities and low mammalian toxicity. However, Ae. aegypti populations around the world have begun to develop resistance to pyrethroids. So far, more than a dozen mutations in the sodium channel gene have been reported to be associated with pyrethroid resistance in Ae. aegypti. Co-occurrence of resistance-associated mutations is common in pyrethroid-resistant Ae. aegypti populations. As global use of pyrethroids in mosquito control continues, new pyrethroid-resistant mutations keep emerging. In this microreview, we compile pyrethroid resistance-associated mutations in Ae. aegypti in a chronological order, as they were reported, and summarize findings from functional evaluation of these mutations in an in vitro sodium channel expression system. We hope that the information will be useful for tracing possible evolution of pyrethroid resistance in this important human disease vector, in addition to the development of methods for global monitoring and management of pyrethroid resistance in Ae. aegypti.
C1 [Chen, Mengli] China Jiliang Univ, Coll Life Sci, Zhejiang Prov Key Lab Biometrol & Inspect & Quara, Hangzhou, Peoples R China.
   [Du, Yuzhe] USDA ARS, Biol Control Pest Res Unit, Stoneville, MS 38776 USA.
   [Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA.
   [Nomura, Yoshiko; Dong, Ke] Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA.
   [Zhorov, Boris S.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.
   [Zhorov, Boris S.] Russian Acad Sci, Sechenov Inst Evolutionary Physiol & Biochem, St Petersburg, Russia.
RP Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Genet Program, E Lansing, MI 48824 USA.; Dong, K (corresponding author), Michigan State Univ, Dept Entomol, Neurosci Program, E Lansing, MI 48824 USA.
EM dongk@msu.edu
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31801758]; National Institutes of HealthUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [GM 57440, GM115475]
FX National Natural Science Foundation of China, Grant/Award Number:
   31801758; National Institutes of Health, Grant/Award Numbers: GM 57440,
   GM115475
CR Aguirre-Obando OA, 2015, ZOOLOGIA-CURITIBA, V32, P14, DOI 10.1590/S1984-46702015000100003
   Aguirre-Obando OA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2089-5
   Aguirre-Obando OA, 2016, REV BRAS ENTOMOL, V60, P94, DOI 10.1016/j.rbe.2015.11.009
   Al Nazawi AM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2096-6
   Alvarez LC, 2015, PEST MANAG SCI, V71, P863, DOI 10.1002/ps.3846
   Amelia-Yap ZH, 2019, J MED ENTOMOL, V56, P953, DOI 10.1093/jme/tjz035
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Aponte A, 2019, ACTA TROP, V191, P146, DOI 10.1016/j.actatropica.2018.12.021
   Badolo A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007439
   Biduda S, 2019, AM J TROP MED HYG, V101, P973, DOI 10.4269/ajtmh.19-0289
   Bingham G, 2011, TROP MED INT HEALTH, V16, P492, DOI 10.1111/j.1365-3156.2010.02717.x
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   Bona ACD, 2016, PARASITE VECTOR, V9, P1
   Brengues C, 2003, MED VET ENTOMOL, V17, P87, DOI 10.1046/j.1365-2915.2003.00412.x
   Brito LP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2410819
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   Chen ML, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007432
   Chung HH, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007291
   Atencia MC, 2016, BIOMEDICA, V36, P432, DOI 10.7705/biomedica.v36i3.2834
   Collet M L, 2016, Genet Mol Res, V15, DOI 10.4238/gmr15048940
   Cornel Anthony J, 2016, F1000Res, V5, P194, DOI 10.12688/f1000research.8107.2
   Dafalla O, 2019, E MEDITERR HEALTH J, V25, P905, DOI 10.26719/emhj.19.081
   Dang K, 2015, PEST MANAG SCI, V71, P914, DOI 10.1002/ps.3861
   de Araujo AP, 2019, J INSECT SCI, V19, DOI 10.1093/jisesa/iez054
   Deming R, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1346-3
   Dolabella SS, 2016, J MED ENTOMOL, V53, P967, DOI 10.1093/jme/tjw053
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Dusfour I, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004226
   Fan YJ, 2020, PEST MANAG SCI, V76, P2251, DOI 10.1002/ps.5763
   Fernando SD, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3113-0
   Field LM, 2017, EUR BIOPHYS J BIOPHY, V46, P675, DOI 10.1007/s00249-016-1195-1
   Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673
   Gao JP, 2018, INFECT DIS POVERTY, V7, DOI 10.1186/s40249-018-0471-y
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Garcia-Rejon Julian E., 2018, International Journal of Mosquito Research, V5, P112
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Granada Y, 2018, INSECTS, V9, DOI 10.3390/insects9010023
   Grossman MK, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-018-3275-9
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hamid PH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/1735358
   Hamid PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189680
   Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hu ZN, 2011, INSECT BIOCHEM MOLEC, V41, P9, DOI 10.1016/j.ibmb.2010.09.005
   Ishak IH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0797-2
   Islami S., 2018, ROLE VOLTAGE GATED S, DOI [10.20944/preprints201803.0070.v1, DOI 10.20944/PREPRINTS201803.0070.V1]
   Kandel Y, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212693
   Kasai S, 2019, EUROSURVEILLANCE, V24, P48, DOI 10.2807/1560-7917.ES.2019.24.5.1700847
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kasai S, 2011, JPN J INFECT DIS, V64, P217
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kawada H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003032
   Kawada H, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000527
   Kushwah R. B., 2019, NEW KNOCKDOWN RESIST
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Leong CS, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3472-1
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   Li Y., 2018, INT J ORG INNOV, V11, P1, DOI DOI 10.1186/S13068-018-1048-5
   Liebman KA, 2019, J MED ENTOMOL, V56, P1353, DOI 10.1093/jme/tjz076
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lopez-Monroy B, 2018, PEST MANAG SCI, V74, P2176, DOI 10.1002/ps.4916
   Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390
   Maestre-Serrano R, 2019, PEST MANAG SCI, V75, P1681, DOI 10.1002/ps.5287
   Marcombe Sebastien, 2019, PLoS Negl Trop Dis, V13, pe0007852, DOI 10.1371/journal.pntd.0007852
   Marcombe S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101992
   Marcombe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030989
   Martins Ademir Jesus, 2013, Evolution Medicine and Public Health, P148, DOI 10.1093/emph/eot012
   Martins AJ, 2009, TROP MED INT HEALTH, V14, P1351, DOI 10.1111/j.1365-3156.2009.02378.x
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Mulyaningsih B, 2018, INDONES BIOMED J, V10, P250, DOI 10.18585/inabj.v10i3.425
   Murcia O, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3309-y
   Muthusamy R, 2015, ACTA TROP, V148, P137, DOI 10.1016/j.actatropica.2015.04.026
   NARAHASHI T, 1988, INT CONGR SER, V832, P269
   Lien NTK, 2018, J VECTOR ECOL, V43, P184, DOI 10.1111/jvec.12298
   Pang SC, 2015, TROP BIOMED, V32, P140
   Pichler V, 2019, PEST MANAG SCI, V75, P2642, DOI 10.1002/ps.5369
   Pinto J, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3739-6
   Plernsub S, 2016, ACTA TROP, V162, P125, DOI 10.1016/j.actatropica.2016.06.019
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Ponce-Garcia G, 2016, J MED ENTOMOL, V53, P1410, DOI 10.1093/jme/tjw115
   Prapanthadara L., 2002, Dengue Bulletin, V26, P185
   Rajatileka S, 2008, ACTA TROP, V108, P54, DOI 10.1016/j.actatropica.2008.08.004
   Rasli R, 2018, INSECTS, V9, DOI 10.3390/insects9020043
   Rath A, 2018, PEST MANAG SCI, V74, P1431, DOI 10.1002/ps.4827
   Rinkevich FD, 2013, PESTIC BIOCHEM PHYS, V106, P93, DOI 10.1016/j.pestbp.2013.02.007
   Ryan S. J., 2018, PHENOTYPIC GENOTYPIC
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0
   Saha P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215541
   Saingamsook J, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2416-x
   Sayono S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150577
   Schmidt TL, 2019, EVOL APPL, V12, P1136, DOI 10.1111/eva.12787
   Seixas G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005799
   Siller Q, 2011, J AM MOSQUITO CONTR, V27, P357, DOI 10.2987/11-6149.1
   Silva JJ, 2020, INSECT MOL BIOL, V29, P9, DOI 10.1111/imb.12605
   Silver KS, 2014, ADV INSECT PHYSIOL, V46, P389, DOI 10.1016/B978-0-12-417010-0.00005-7
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Soderlund D.M., 2005, P1
   Soderlund DM, 1990, PESTICIDE RESISTANCE, P58
   Sombie A, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-018-0134-5
   Son-un P, 2018, J MED ENTOMOL, V55, P975, DOI 10.1093/jme/tjy037
   Srisawat R, 2012, SE ASIAN J TROP MED, V43, P1380
   Srisawat R, 2010, APPL ENTOMOL ZOOL, V45, P275, DOI 10.1303/aez.2010.275
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Villanueva-Segura K., 2019, MULTIPLEX PCR SIMULT
   Villanueva-Segura OK, 2020, J MED ENTOMOL, V57, P218, DOI 10.1093/jme/tjz148
   Wuliandari JR, 2015, INSECTS, V6, P658, DOI 10.3390/insects6030658
   Xu JB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004696
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
   Yanola J, 2010, PESTIC BIOCHEM PHYS, V96, P127, DOI 10.1016/j.pestbp.2009.10.005
   Yoon KS, 2008, J MED ENTOMOL, V45, P1092, DOI 10.1603/0022-2585(2008)45[1092:BAMAOD]2.0.CO;2
   Zardkoohi A., 2019, J MED ENTOMOL, P1
   Zhou XJ, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3423-x
NR 118
TC 0
Z9 0
U1 4
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0739-4462
EI 1520-6327
J9 ARCH INSECT BIOCHEM
JI Arch. Insect Biochem. Physiol.
PD JUN
PY 2020
VL 104
IS 2
SI SI
AR e21686
DI 10.1002/arch.21686
EA MAY 2020
PG 16
WC Biochemistry & Molecular Biology; Entomology; Physiology
SC Biochemistry & Molecular Biology; Entomology; Physiology
GA LP3PV
UT WOS:000530600600001
PM 32378259
DA 2020-07-08
ER

PT J
AU Blum, L
   Geisslinger, G
   Parnham, MJ
   Grunweller, A
   Schiffmann, S
AF Blum, Leonard
   Geisslinger, Gerd
   Parnham, Michael J.
   Gruenweller, Arnold
   Schiffmann, Susanne
TI Natural antiviral compound silvestrol modulates human monocyte-derived
   macrophages and dendritic cells
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE antiviral; cytokines; eIF4A; energy metabolism; immune modulation; RNA
   viruses; rocaglate
ID INHIBITOR SILVESTROL; PIM KINASES; IN-VITRO; TRANSLATION;
   DIFFERENTIATION; ERYTHROMYCIN; ACTIVATION; REQUIRES; INNATE; IL-6
AB Outbreaks of infections with viruses like Sars-CoV-2, Ebola virus and Zika virus lead to major global health and economic problems because of limited treatment options. Therefore, new antiviral drug candidates are urgently needed. The promising new antiviral drug candidate silvestrol effectively inhibited replication of Corona-, Ebola-, Zika-, Picorna-, Hepatis E and Chikungunya viruses. Besides a direct impact on pathogens, modulation of the host immune system provides an additional facet to antiviral drug development because suitable immune modulation can boost innate defence mechanisms against the pathogens. In the present study, silvestrol down-regulated several pro- and anti-inflammatory cytokines (IL-6, IL-8, IL-10, CCL2, CCL18) and increased TNF-alpha during differentiation and activation of M1-macrophages, suggesting that the effects of silvestrol might cancel each other out. However, silvestrol amplified the anti-inflammatory potential of M2-macrophages by increasing expression of anti-inflammatory surface markers CD206, TREM2 and reducing release of pro-inflammatory IL-8 and CCL2. The differentiation of dendritic cells in the presence of silvestrol is characterized by down-regulation of several surface markers and cytokines indicating that differentiation is impaired by silvestrol. In conclusion, silvestrol influences the inflammatory status of immune cells depending on the cell type and activation status.
C1 [Blum, Leonard; Geisslinger, Gerd] Goethe Univ Hosp Frankfurt, Inst Clin Pharmacol, Pharmazentrum Frankfurt ZAFES, Frankfurt, Germany.
   [Geisslinger, Gerd; Parnham, Michael J.; Schiffmann, Susanne] Fraunhofer Inst Mol Biol & Appl Ecol IME, Branch Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.
   [Gruenweller, Arnold] Philipps Univ Marburg, Inst Pharmaceut Chem, Marburg, Germany.
RP Schiffmann, S (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Branch Translat Med & Pharmacol TMP, Theodor Stern Kai 7, D-60596 Frankfurt, Germany.
EM susanne.schiffmann@ime.fraunhofer.de
OI Schiffmann, Susanne/0000-0001-5035-2504
FU LOEWE TMP; LOEWE TBG; LOEWE DRUID
FX LOEWE TBG; LOEWE DRUID; LOEWE TMP
CR Atri C, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061801
   Azad AK, 2014, J CYTOL MOL BIOL, V1, DOI DOI 10.13188/2325-4653.1000003
   Beharry Z, 2011, P NATL ACAD SCI USA, V108, P528, DOI 10.1073/pnas.1013214108
   Biedenkopf N, 2017, ANTIVIR RES, V137, P76, DOI 10.1016/j.antiviral.2016.11.011
   Blum L, 2018, FIGHTING ANTIMICROBI
   Bordeleau ME, 2008, J CLIN INVEST, V118, P2651, DOI 10.1172/JCI34753
   Cerezo M, 2018, NAT MED, V24, P1877, DOI 10.1038/s41591-018-0217-1
   Chen WL, 2016, BMC CANCER, V16, DOI 10.1186/s12885-015-1988-0
   Chenivesse C, 2018, CYTOKINE, V109, P52, DOI 10.1016/j.cyto.2018.01.023
   Chomarat P, 2000, NAT IMMUNOL, V1, P510, DOI 10.1038/82763
   Collin M, 2013, IMMUNOLOGY, V140, P22, DOI 10.1111/imm.12117
   Corinti S, 2001, J IMMUNOL, V166, P4312, DOI 10.4049/jimmunol.166.7.4312
   Diskin C, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00270
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Fabriek BO, 2009, BLOOD, V113, P887, DOI 10.1182/blood-2008-07-167064
   Gazi U, 2009, IMMUNOBIOLOGY, V214, P554, DOI 10.1016/j.imbio.2008.11.004
   Gerold Gisa, 2013, Curr Hepat Rep, V12, P200, DOI 10.1007/s11901-013-0187-1
   Glitscher M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060301
   Henss L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110592
   Hillmer EJ, 2016, CYTOKINE GROWTH F R, V31, P1, DOI 10.1016/j.cytogfr.2016.05.001
   Huang Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep39566
   Jackson SH, 2004, J IMMUNOL, V172, P2307, DOI 10.4049/jimmunol.172.4.2307
   Kawasaki S, 1998, ANTIMICROB AGENTS CH, V42, P1499, DOI 10.1128/AAC.42.6.1499
   KHAIR OA, 1995, EUR RESPIR J, V8, P1451
   Kim S, 2007, ANTICANCER RES, V27, P2175
   Kogure T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076136
   Kok SH, 2009, ARTHRITIS RHEUM-US, V60, P1451, DOI 10.1002/art.24452
   Liang S, 2008, P NATL ACAD SCI USA, V105, P8357, DOI 10.1073/pnas.0803341105
   Lucas DM, 2009, BLOOD, V113, P4656, DOI 10.1182/blood-2008-09-175430
   Mason CP, 2015, MOLECULES, V20, P2229, DOI 10.3390/molecules20022229
   McCormick SM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00549
   Meixlsperger S, 2013, BLOOD, V121, P5034, DOI 10.1182/blood-2012-12-473413
   Muller C, 2018, ANTIVIR RES, V150, P123, DOI 10.1016/j.antiviral.2017.12.010
   Muller KH, 2012, TRENDS PHARMACOL SCI, V33, P89, DOI 10.1016/j.tips.2011.10.004
   Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603
   ODA H, 1994, CHEST, V106, P1116, DOI 10.1378/chest.106.4.1116
   Patton JT, 2015, ONCOTARGET, V6, P2693, DOI 10.18632/oncotarget.2098
   Regis G, 2008, SEMIN CELL DEV BIOL, V19, P351, DOI 10.1016/j.semcdb.2008.06.004
   Sadlish H, 2013, ACS CHEM BIOL, V8, P1519, DOI 10.1021/cb400158t
   Savill John, 2000, Kidney and Blood Pressure Research, V23, P173
   Schatz JH, 2011, J EXP MED, V208, P1799, DOI 10.1084/jem.20110846
   Shaimerdenova M, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-017-0128-7
   Shiratori H, 2018, EUR J PHARMACOL, V833, P328, DOI 10.1016/j.ejphar.2018.06.017
   Solari R, 2015, EUR J PHARMACOL, V763, P169, DOI 10.1016/j.ejphar.2015.05.018
   Song JH, 2015, ONCOGENE, V34, P3728, DOI 10.1038/onc.2014.306
   Sun Jian, 2015, Biochem Biophys Rep, V4, P397, DOI 10.1016/j.bbrep.2015.11.003
   van der Voort R, 2005, J LEUKOCYTE BIOL, V77, P739, DOI 10.1189/jlb.0804435
   Vrancic M, 2012, BRIT J PHARMACOL, V165, P1348, DOI 10.1111/j.1476-5381.2011.01576.x
   WHO Ebola Response Team, 2015, NEW ENGL J MED, V372, P584, DOI 10.1056/NEJMc1414992
   Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485
   Yu CI, 2014, J IMMUNOL, V193, P4335, DOI 10.4049/jimmunol.1401159
NR 51
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JUN
PY 2020
VL 24
IS 12
BP 6988
EP 6999
DI 10.1111/jcmm.15360
EA MAY 2020
PG 12
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA LY6PW
UT WOS:000530485900001
PM 32374474
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wheeler, A
   Toth, D
   Ridenour, T
   Nobrega, LL
   Firmino, RB
   da Silva, CM
   Carvalho, P
   Marques, D
   Okoniewski, K
   Ventura, LO
   Bailey, DB
   Ventura, CV
AF Wheeler, Anne
   Toth, Danielle
   Ridenour, Ty
   Nobrega, Lucelia Lima
   Firmino, Raine Borba
   da Silva, Claudia Marques
   Carvalho, Pollyanna
   Marques, Douglas
   Okoniewski, Katherine
   Ventura, Liana O.
   Bailey, Donald B., Jr.
   Ventura, Camila V.
TI Developmental Outcomes Among Young Children With Congenital Zika
   Syndrome in Brazil
SO JAMA NETWORK OPEN
LA English
DT Article
ID VIRUS-INFECTION; INFANTS; HEALTH; BORN
AB Importance Although birth defects in children with congenital Zika syndrome (CZS) are expected to result in significant intellectual disabilities, the extent of delay and profiles of development have yet to be fully described. Objectives To describe the neurodevelopmental profiles of children with CZS and to test whether prenatal and postpartum characteristics were associated with the severity of developmental delays. Design, Setting, and Participants This is a case series of the trajectories of developmental, behavioral, and medical needs of 121 young children with CZS who were assessed at a specialized rehabilitation center in Recife, Brazil, beginning in January 2018 as part of 5-year longitudinal study. Children were included if they had serologic confirmation of Zika virus and met clinical criteria accompanied by parental report of suspected exposure to Zika virus during pregnancy. Exposures Prenatal Zika virus exposure. Main Outcomes and Measures The Brazilian version of the Bayley Scales of Infant and Toddler Development, Third Edition, was administered by trained assessors as part of an initial comprehensive assessment battery. Caregiver interviews and medical record reviews were conducted to gather basic demographic information and medical comorbidities. Linear regression was used to identify potential factors for development. Results The sample included 121 young children (mean [SD] age, 31.2 [1.9] months; 61 [50.4%] girls). At age approximately 2.5 years, nearly all children in this sample demonstrated profound developmental delays across all domains of functioning, with a mean (SD) developmental age equivalent to approximately 2 to 4 months (eg, cognitive domain, 2.24 [3.09] months; fine motor subscale, 2.15 [2.93] months; expressive language subscale, 2.30 [2.52] months). A relative strength was found in receptive language, with scores on this scale significantly higher than most other domains (eg, cognition: t = 3.73; P < .001; fine motor: t = 6.99; P < .001). Head circumference at birth was the single strongest factor associated with outcomes across all developmental domains (eg, cognitive: beta = 1.41; SE, 0.67; P = .04; fine motor: beta = 1.36; SE, 0.49; P = .007). Conclusions and Relevance The findings of this study provide important information regarding the severity of disability that these children and their families will experience. The findings also establish an initial point from which to monitor developmental trajectories, medical comorbidities (eg, seizures), effectiveness of interventions, and cumulative consequences on families.
   This case series describes the neurodevelopmental profiles of children with CZS and tests whether prenatal and postpartum characteristics were associated with the severity of developmental delays.
   Question What are the observed neurodevelopmental sequelae among young children with congenital Zika syndrome (CZS) identified during the Zika virus outbreak in Brazil from 2015 to 2016? Findings In this case series of 121 young children, nearly all children with CZS demonstrated profound developmental delays at age 2 to 3 years across all domains of functioning, with a relative strength in receptive communication. Severity of microcephaly at birth was the only significant factor associated with the severity of delays. Meaning In this study, most children diagnosed with CZS had profound developmental delays; however, there was variability within their developmental profile, providing direction for intervention.
C1 [Wheeler, Anne; Toth, Danielle; Ridenour, Ty; Okoniewski, Katherine; Bailey, Donald B., Jr.] Res Triangle Inst Int, Ctr Newborn Screening Eth & Disabil Studies, Res Triangle Pk, NC 27709 USA.
   [Nobrega, Lucelia Lima; Firmino, Raine Borba; da Silva, Claudia Marques; Carvalho, Pollyanna; Marques, Douglas; Ventura, Liana O.; Ventura, Camila V.] Altino Ventura Fdn, Rehabil Ctr Menina Olhos, Recife, PE, Brazil.
RP Wheeler, A (corresponding author), Res Triangle Inst Int, 3040 Cornwallis Rd, Res Triangle Pk, NC 27709 USA.
EM acwheeler@rti.org
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   DevelopmentUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National
   Institute of Child Health & Human Development (NICHD) [1R01HD093572-0]
FX Funding for the study was provided by grant 1R01HD093572-0 from the
   Eunice Kennedy Shriver National Institute of Child Health and Human
   Development.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Bayley N, 1969, MANUAL BAYLEY SCALES
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005
   Chard M, 2014, J APPL RES INTELLECT, V27, P481, DOI 10.1111/jar.12079
   de Fatima Viana Vasco Aragao Maria, 2019, Top Magn Reson Imaging, V28, P1, DOI 10.1097/RMR.0000000000000193
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Fleming-Dutra KE, 2016, MMWR-MORBID MORTAL W, V65, P182, DOI 10.15585/mmwr.mm6507e1
   Franca TLB, 2018, INT J ENV RES PUB HE, V15, pE1990
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2430-4
   MacDonald PDM, 2018, PEDIATRICS, V141, pS137, DOI 10.1542/peds.2017-2038B
   Madaschi Vanessa, 2016, Paidéia (Ribeirão Preto), V26, P189, DOI 10.1590/1982-43272664201606
   Melo A, 2020, DEV MED CHILD NEUROL, V62, P221, DOI 10.1111/dmcn.14227
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Sansone SM, 2014, J NEURODEV DISORD, V6, DOI 10.1186/1866-1955-6-16
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Secretaria de Vigilancia em Saude Ministerio da Saude, MON CAS ARB URB TRAN
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Tonnsen BL, 2018, J NEURODEV DISORD, V10, DOI 10.1186/s11689-018-9224-2
   van der Linden V, 2019, JAMA NEUROL, V76, P203, DOI 10.1001/jamaneurol.2018.3553
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Wolford RW, 2019, ZIKA VIRUS
   World Health Organization, 2016, SCREEN ASS MAN NEON
   World Health Organization, 2017, SIT REP ZIK VIR MICR
   World Health Organization, 2019, ZIK EP UPD JUL 2019
NR 33
TC 0
Z9 0
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2574-3805
J9 JAMA NETW OPEN
JI JAMA Netw. Open
PD MAY 5
PY 2020
VL 3
IS 5
DI 10.1001/jamanetworkopen.2020.4096
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA LP0SQ
UT WOS:000534032300004
PM 32369180
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Slonchak, A
   Hugo, LE
   Freney, ME
   Hall-Mendelin, S
   Amarilla, AA
   Torres, FJ
   Setoh, YX
   Peng, NYG
   Sng, JDJ
   Hall, RA
   van den Hurk, AF
   Devine, GJ
   Khromykh, AA
AF Slonchak, Andrii
   Hugo, Leon E.
   Freney, Morgan E.
   Hall-Mendelin, Sonja
   Amarilla, Alberto A.
   Torres, Francisco J.
   Setoh, Yin Xiang
   Peng, Nias Y. G.
   Sng, Julian D. J.
   Hall, Roy A.
   van den Hurk, Andrew F.
   Devine, Gregor J.
   Khromykh, Alexander A.
TI Zika virus noncoding RNA suppresses apoptosis and is required for virus
   transmission by mosquitoes
SO NATURE COMMUNICATIONS
LA English
DT Article
ID WEST-NILE-VIRUS; MITOCHONDRIAL RESPIRATORY-CHAIN; FLAVIVIRUS RNA;
   INFECTION; PSEUDOKNOT; AUTOPHAGY; VECTOR
AB Flaviviruses, including Zika virus (ZIKV), utilise host mRNA degradation machinery to produce subgenomic flaviviral RNA (sfRNA). In mammalian hosts, this noncoding RNA facilitates replication and pathogenesis of flaviviruses by inhibiting IFN-signalling, whereas the function of sfRNA in mosquitoes remains largely elusive. Herein, we conduct a series of in vitro and in vivo experiments to define the role of ZIKV sfRNA in infected Aedes aegypti employing viruses deficient in production of sfRNA. We show that sfRNA-deficient viruses have reduced ability to disseminate and reach saliva, thus implicating the role for sfRNA in productive infection and transmission. We also demonstrate that production of sfRNA alters the expression of mosquito genes related to cell death pathways, and prevents apoptosis in mosquito tissues. Inhibition of apoptosis restored replication and transmission of sfRNA-deficient mutants. Hence, we propose anti-apoptotic activity of sfRNA as the mechanism defining its role in ZIKV transmission. The function on subgenomic flaviviral RNA (sfRNA) in the mosquito vector is not well understood. Here, Slonchak et al. show that sfRNA affects virus-induced apoptosis and dissemination of ZIKV in Aedes aegypti mosquitoes, suggesting a role of sfRNA in Zika virus replication and transmission.
C1 [Slonchak, Andrii; Freney, Morgan E.; Amarilla, Alberto A.; Torres, Francisco J.; Setoh, Yin Xiang; Peng, Nias Y. G.; Sng, Julian D. J.; Hall, Roy A.; Khromykh, Alexander A.] Univ Queensland, Brisbane, Qld 4072, Australia.
   [Hugo, Leon E.; Devine, Gregor J.] QIMR Berghofer Med Res Inst, Brisbane, Qld 4006, Australia.
   [Hall-Mendelin, Sonja; van den Hurk, Andrew F.] Queensland Govt, Forens & Sci Serv, Dept Hlth, Publ Hlth Virol, Brisbane, Qld 4108, Australia.
RP Khromykh, AA (corresponding author), Univ Queensland, Brisbane, Qld 4072, Australia.
EM a.khromykh@uq.edu.au
RI Hugo, Leon/O-3013-2018; Slonchak, Andrii/Y-4162-2019
OI Hugo, Leon/0000-0002-6767-9850; Slonchak, Andrii/0000-0003-3258-0508;
   Torres Tobar, Francisco Javier/0000-0003-1961-9754
FU NHMRCNational Health and Medical Research Council of Australia
   [APP1127916]; Australian Infectious Diseases Research Centre's seed
   grant
FX We acknowledge the excellent histology support of Clay Winterford (QIMR
   Berghofer) and thank Prof Scott Ritchie (JCU Cairns) for providing Ae.
   aegypti eggs from Innisfail, Australia. Work was funded by NHMRC grant
   APP1127916 to A.A.K. and Australian Infectious Diseases Research
   Centre's seed grant to R.H. and G.D. A.A.K. is the Senior Research
   Fellow with the NHMRC (APP1059794).
CR Acharya B, 2019, AM J TROP MED HYG, V100, P783, DOI 10.4269/ajtmh.18-0761
   Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Bartholomay LC, 2018, ANNU REV ENTOMOL, V63, P145, DOI 10.1146/annurev-ento-010715-023530
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Clarke BD, 2015, VIRUS RES, V206, P53, DOI 10.1016/j.virusres.2015.01.026
   Edmonds J, 2013, J VIROL, V87, P2367, DOI 10.1128/JVI.03162-12
   Eng MW, 2016, INSECT BIOCHEM MOLEC, V76, P70, DOI 10.1016/j.ibmb.2016.07.004
   Etebari K, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00456-17
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Girard YA, 2007, AM J TROP MED HYG, V76, P118, DOI 10.4269/ajtmh.2007.76.118
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Goertz GP, 2019, P NATL ACAD SCI USA, V116, P19136, DOI 10.1073/pnas.1905617116
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Hall-Mendelin S, 2018, VECTOR-BORNE ZOONOT, V18, P317, DOI 10.1089/vbz.2017.2232
   Hugo LE, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1838-1
   KUNO G, 1983, IN VITRO CELL DEV B, V19, P707
   Kwong JQ, 2007, J CELL BIOL, V179, P1163, DOI 10.1083/jcb.200704059
   Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167
   Liu QZ, 2011, APOPTOSIS, V16, P105, DOI 10.1007/s10495-010-0558-9
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   MacFadden A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02604-y
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Moon SL, 2012, RNA, V18, P2029, DOI 10.1261/rna.034330.112
   Motulsky HJ, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-123
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   O'Neill K, 2015, P NATL ACAD SCI USA, V112, pE1152, DOI 10.1073/pnas.1424469112
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Piyasena TBH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03120-1
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Schnettler E, 2014, NUCLEIC ACIDS RES, V42, P9436, DOI 10.1093/nar/gku657
   Schnettler E, 2012, J VIROL, V86, P13486, DOI 10.1128/JVI.01104-12
   Setoh YX, 2019, NAT MICROBIOL, V4, P876, DOI 10.1038/s41564-019-0399-4
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Slonchak A, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5835-6
   Slonchak A, 2018, ANTIVIR RES, V159, P13, DOI 10.1016/j.antiviral.2018.09.006
   Slonchak A, 2016, J VIROL, V90, P2388, DOI 10.1128/JVI.02608-15
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   Tyler AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29334-5
   Vaidyanathan R, 2006, APOPTOSIS, V11, P1643, DOI 10.1007/s10495-006-8783-y
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   WOLVETANG EJ, 1994, FEBS LETT, V339, P40, DOI 10.1016/0014-5793(94)80380-3
NR 48
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 5
PY 2020
VL 11
IS 1
AR 2205
DI 10.1038/s41467-020-16086-y
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LM6LU
UT WOS:000532362000004
PM 32371874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Esswein, SR
   Gristick, HB
   Jurado, A
   Peace, A
   Keeffe, JR
   Lee, YE
   Voll, AV
   Saeed, M
   Nussenzweig, MC
   Rice, CM
   Robbiani, DF
   MacDonald, MR
   Bjorkman, PJ
AF Esswein, Shannon R.
   Gristick, Harry B.
   Jurado, Andrea
   Peace, Avery
   Keeffe, Jennifer R.
   Lee, Yu E.
   Voll, Alisa V.
   Saeed, Mohsan
   Nussenzweig, Michel C.
   Rice, Charles M.
   Robbiani, Davide F.
   MacDonald, Margaret R.
   Bjorkman, Pamela J.
TI Structural basis for Zika envelope domain III recognition by a germline
   version of a recurrent neutralizing antibody
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Zika; germline antibody; flavivirus; affinity maturation;
   antibody-dependent enhancement
ID DENGUE-VIRUS; DEPENDENT ENHANCEMENT; MONOCLONAL-ANTIBODIES;
   CROSS-REACTIVITY; INFECTION; TRANSMISSION; PATHOGENESIS; EVOLUTION;
   IDENTIFICATION; RESPONSES
AB Recent epidemics demonstrate the global threat of Zika virus (ZIKV), a flavivirus transmitted by mosquitoes. Although infection is usually asymptomatic or mild, newborns of infected mothers can display severe symptoms, including neurodevelopmental abnormalities and microcephaly. Given the large-scale spread, symptom severity, and lack of treatment or prophylaxis, a safe and effective ZIKV vaccine is urgently needed. However, vaccine design is complicated by concern that elicited antibodies (Abs) may cross-react with other flaviviruses that share a similar envelope protein, such as dengue virus, West Nile virus, and yellow fever virus. This cross-reactivity may worsen symptoms of a subsequent infection through Ab-dependent enhancement. To better understand the neutralizing Ab response and risk of Ab-dependent enhancement, further information on germline Ab binding to ZIKV and the maturation process that gives rise to potently neutralizing Abs is needed. Here we use binding and structural studies to compare mature and inferred-germline Ab binding to envelope protein domain III of ZIKV and other flaviviruses. We show that affinity maturation of the light-chain variable domain is important for strong binding of the recurrent VH3-23/VK1-5 neutralizing Abs to ZIKV envelope protein domain III, and identify interacting residues that contribute to weak, cross-reactive binding to West Nile virus. These findings provide insight into the affinity maturation process and potential cross-reactivity of VH3-23/VK1-5 neutralizing Abs, informing precautions for protein-based vaccines designed to elicit germline versions of neutralizing Abs.
C1 [Esswein, Shannon R.; Gristick, Harry B.; Keeffe, Jennifer R.; Lee, Yu E.; Voll, Alisa V.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Jurado, Andrea; Peace, Avery; Saeed, Mohsan; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Nussenzweig, Michel C.; Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
   [Saeed, Mohsan] Boston Univ, Dept Biochem, Sch Med, Boston, MA 02118 USA.
   [Saeed, Mohsan] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02118 USA.
RP Bjorkman, PJ (corresponding author), CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
EM bjorkman@caltech.edu
OI Esswein, Shannon/0000-0002-5142-0190; Robbiani, Davide
   F./0000-0001-7379-3484; Jurado, Andrea/0000-0002-4023-8000
FU Gordon and Betty Moore FoundationGordon and Betty Moore Foundation;
   Beckman Institute; Sanofi-Aventis Bioengineering Research Program; US
   Department of EnergyUnited States Department of Energy (DOE); NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P01AI138938, 5-T32-GM007616-40]; NIH National
   Research Service Award FellowshipUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [F30AI147579];
   NIH National Institute of General Medical Sciences Training Grant
   through the University of California, Los Angeles-California Institute
   of Technology Medical Scientist Training Program [T32-GM008042]; Beckman
   Institute at the California Institute of Technology
FX We thank Dr. Jost Vielmetter at the Caltech Protein Expression Center
   funded by the Beckman Institute at the California Institute of
   Technology for protein expression and surface plasmon resonance
   instrument usage; Dr. Jens Kaiser at the California Institute of
   Technology Molecular Observatory for assistance with X-ray data
   collection; Dr. Anthony West for discussions regarding germline gene
   assignments; Alex Cohen for suggestions on EDIII production; Dr.
   Christopher Barnes for coordinating Advanced Photon Source (APS)
   beamline collection and beamline scientists at Stanford Synchrotron
   Radiation Lightsource and APS GM/CA 23-ID-D; and Dr. Ted Pierson for
   providing pDENV1/WP/CprME and pDENV2/16681/CprME plasmids. The
   California Institute of Technology Molecular Observatory is supported by
   the Gordon and Betty Moore Foundation, the Beckman Institute, and the
   Sanofi-Aventis Bioengineering Research Program. Operations at Stanford
   Synchrotron Radiation Lightsource are supported by the US Department of
   Energy and NIH. Operations at APS are supported by US Department of
   Energy. This work was supported by NIH Grant P01AI138938 (to D.F.R.,
   C.M.R., M.C.N., P.J.B.); NIH Training Grant 5-T32-GM007616-40 (to
   S.R.E.); NIH National Research Service Award Fellowship F30AI147579 (to
   S.R.E.); and NIH National Institute of General Medical Sciences Training
   Grant T32-GM008042 (to S.R.E.) through the University of California, Los
   Angeles-California Institute of Technology Medical Scientist Training
   Program.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   [Anonymous], 2015, PYMOL MOL GRAPH SYST
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barzon L., 2016, EUROSURVEILLANCE, V21, P2016, DOI DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chang HH, 2017, B WORLD HEALTH ORGAN, V95, P517, DOI 10.2471/BLT.16.182105
   Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   FOOTE J, 1994, P NATL ACAD SCI USA, V91, P10370, DOI 10.1073/pnas.91.22.10370
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao F, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02424
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Klein F, 2014, J EXP MED, V211, P2361, DOI 10.1084/jem.20141050
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McGee CE, 2010, VECTOR-BORNE ZOONOT, V10, P267, DOI 10.1089/vbz.2009.0067
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   MORENS DM, 1994, CLIN INFECT DIS, V19, P500, DOI 10.1093/clinids/19.3.500
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nelson CA, 2014, METHODS MOL BIOL, V1140, P145, DOI 10.1007/978-1-4939-0354-2_11
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Robbiani DF, 2019, J EXP MED, V216, P2302, DOI 10.1084/jem.20191061
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scharf L, 2016, ELIFE, V5, DOI 10.7554/eLife.13783
   Scharf L, 2013, P NATL ACAD SCI USA, V110, P6049, DOI 10.1073/pnas.1303682110
   Simonich CA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09481-7
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Suy A, 2016, NEW ENGL J MED, V375, P2611, DOI 10.1056/NEJMc1607580
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Thorpe IF, 2007, P NATL ACAD SCI USA, V104, P8821, DOI 10.1073/pnas.0610064104
   Van Rompay K. K. A., 2020, BIORXIV
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Wahala WMPB, 2009, VIROLOGY, V392, P103, DOI 10.1016/j.virol.2009.06.037
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang L, 2019, CELL REP, V26, P3360, DOI 10.1016/j.celrep.2019.02.062
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wedemayer GJ, 1997, SCIENCE, V276, P1665, DOI 10.1126/science.276.5319.1665
   West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yu L, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.93042
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao HY, 2020, J EXP MED, V217, DOI 10.1084/jem.20191792
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 79
TC 0
Z9 0
U1 4
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAY 5
PY 2020
VL 117
IS 18
BP 9865
EP 9875
DI 10.1073/pnas.1919269117
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LK7UR
UT WOS:000531067600038
PM 32321830
OA Green Accepted
DA 2020-07-08
ER

PT J
AU Soliman, M
   Lyubchich, V
   Gel, YR
AF Soliman, Marwah
   Lyubchich, Vyacheslav
   Gel, Yulia R.
TI Ensemble forecasting of the Zika space-time spread with topological data
   analysis
SO ENVIRONMETRICS
LA English
DT Article; Early Access
DE Bayesian model averaging; epidemics; machine learning; neural network;
   Zika virus
ID VIRUS; MODEL; TRANSMISSION; OUTBREAK
AB As per the records of the World Health Organization, the first formally reported incidence of Zika virus occurred in Brazil in May 2015. The disease then rapidly spread to other countries in Americas and East Asia, affecting more than 1,000,000 people. Zika virus is primarily transmitted through bites of infected mosquitoes of the species Aedes (Aedes aegypti and Aedes albopictus). The abundance of mosquitoes and, as a result, the prevalence of Zika virus infections are common in areas which have high precipitation, high temperature, and high population density. Nonlinear spatio-temporal dependency of such data and lack of historical public health records make prediction of the virus spread particularly challenging. In this article, we enhance Zika forecasting by introducing the concepts of topological data analysis and, specifically, persistent homology of atmospheric variables, into the virus spread modeling. The topological summaries allow for capturing higher order dependencies among atmospheric variables that otherwise might be unassessable via conventional spatio-temporal modeling approaches based on geographical proximity assessed via Euclidean distance. We introduce a new concept of cumulative Betti numbers and then integrate the cumulative Betti numbers as topological descriptors into three predictive machine learning models: random forest, generalized boosted regression, and deep neural network. Furthermore, to better quantify for various sources of uncertainties, we combine the resulting individual model forecasts into an ensemble of the Zika spread predictions using Bayesian model averaging. The proposed methodology is illustrated in application to forecasting of the Zika space-time spread in Brazil in the year 2018.
C1 [Soliman, Marwah; Gel, Yulia R.] Univ Texas Dallas, Dept Math Sci, 800 West Campbell Rd, Richardson, TX 75080 USA.
   [Lyubchich, Vyacheslav] Univ Maryland, Chesapeake Biol Lab, Ctr Environm Sci, Solomons, MD 20688 USA.
RP Gel, YR (corresponding author), Univ Texas Dallas, Dept Math Sci, 800 West Campbell Rd, Richardson, TX 75080 USA.
EM ygl@utdallas.edu
FU NSF DMSNational Science Foundation (NSF) [1925346]
FX NSF DMS, Grant/Award Number: 1925346
CR Bluman AG, 2009, ELEMENTARY STAT STEP
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Breiman L, 1997, 486 U CAL STAT DEP
   Breiman L, 2018, PACKAGE RANDOMFOREST, V4, P6
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   CDC, 2018, CTR DIS CONTR PREV Z
   Chazal F., 2017, ARXIV171004019
   Costa JP, 2014, P EUR C COMPL SCI
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Diggle P, 2005, ENVIRONMETRICS, V16, P423, DOI 10.1002/env.712
   Fasy BT, 2018, TDA STAT TOOLS TOPOL
   Ferraris P, 2019, MICROBES INFECT, V21, P353, DOI 10.1016/j.micinf.2019.04.005
   Fragoso TM, 2018, INT STAT REV, V86, P1, DOI 10.1111/insr.12243
   Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451
   Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2
   Gidea M, 2018, PHYSICA A, V491, P820, DOI 10.1016/j.physa.2017.09.028
   Goeijenbier M, 2016, NETH J MED, V74, P104
   Greenwell Brandon, 2019, GBM GEN BOOSTED REGR
   HAGAN MT, 1994, IEEE T NEURAL NETWOR, V5, P989, DOI 10.1109/72.329697
   Hastie T., 2009, ELEMENTS STAT LEARNI
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   Hoeting JA, 1999, STAT SCI, V14, P382, DOI 10.1214/ss/1009212519
   ISLAMBEKOV U, 2019, ENVIRONMETRICS 1219, V31, DOI DOI 10.1002/ENV.2612
   Islambekov U, 2019, ENVIRONMETRICS, V30, DOI 10.1002/env.2539
   Jang MJ, 2007, ENVIRONMETRICS, V18, P809, DOI 10.1002/env.877
   Kim J, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-2894-2
   LeDell E., 2019, H2O R INTERFACE H2O
   Li B., 2020, SUSTAINABLE RESILIEN, P1, DOI [10.1080/23789689.2019.1708182, DOI 10.1080/23789689.2019.1708182]
   Lo D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192120
   Loh JM, 2011, ENVIRONMETRICS, V22, P179, DOI 10.1002/env.1042
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   Manore C, 2016, SIAM NEWS
   McDermott PL, 2019, ENVIRONMETRICS, V30, DOI 10.1002/env.2553
   McGough S. F., 2017, PLOS NEGLECT TROP D, V11, P1
   Munoz AG, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01291
   Nobre AA, 2005, ENVIRONMETRICS, V16, P291, DOI 10.1002/env.704
   Peck R., 2015, INTRO STAT DATA ANAL
   Raftery AE, 2005, MON WEATHER REV, V133, P1155, DOI 10.1175/MWR2906.1
   Ragas J, 2018, HIST CIENC SAUDE-MAN, V25, P1185, DOI [10.1590/S0104-59702018000500016, 10.1590/s0104-59702018000500016]
   Rees EE, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2867-8
   Ridgeway G., 2019, UPDATE, V1, P2019
   RIEDMILLER M, 1993, 1993 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS, VOLS 1-3, P586, DOI 10.1109/ICNN.1993.298623
   Saggar M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03664-4
   Self SCW, 2018, ENVIRONMETRICS, V29, DOI 10.1002/env.2538
   Seo J, 2018, INT CONF COMPUT NETW, P238, DOI 10.1109/ICCNC.2018.8390279
   Soliman M, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.05.004
   Starnes D. S., 2010, PRACTICE STAT
   Suparit P, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0083-z
   Teng Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165085
   Tjaden NB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002207
   Torabi M, 2013, ENVIRONMETRICS, V24, P180, DOI 10.1002/env.2199
   Ugarte MD, 2009, ENVIRONMETRICS, V20, P647, DOI 10.1002/env.969
   WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510
   Zhang JR, 2007, APPL MATH COMPUT, V185, P1026, DOI 10.1016/j.amc.2006.07.025
   Zomorodian A, 2005, DISCRETE COMPUT GEOM, V33, P249, DOI 10.1007/s00454-004-1146-y
NR 58
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1180-4009
EI 1099-095X
J9 ENVIRONMETRICS
JI Environmetrics
DI 10.1002/env.2629
EA MAY 2020
PG 13
WC Environmental Sciences; Mathematics, Interdisciplinary Applications;
   Statistics & Probability
SC Environmental Sciences & Ecology; Mathematics
GA LJ3RU
UT WOS:000530086100001
DA 2020-07-08
ER

PT J
AU Ahmad, N
   Badshah, SL
   Junaid, M
   Rehman, AU
   Muhammad, A
   Khan, K
AF Ahmad, Nasir
   Badshah, Syed Lal
   Junaid, Muhammad
   Ur Rehman, Ashfaq
   Muhammad, Akhtar
   Khan, Khalid
TI Structural insights into the Zika virus NS1 protein inhibition using a
   computational approach
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Zika virus; non-structural protein 1; molecular dynamics simulation;
   molecular docking; Gibbs free energy
ID ANTIVIRAL ACTIVITY; FLAVONOIDS; SIMULATION; INFECTION; DOCKING; SURFACE;
   MODEL
AB Zika virus is part of the flaviviruses that spread through the Aedes mosquito species and causes neurological infectious diseases. The non-structural protein 1 (NS1) is an essential enzyme that is involved in the replication of Zika virus. In this study, the newly isolated flavonoid analogs were docked against the NS1 protein. Most of the compounds showed strong interactions with favorable binding energies in the active site of NS1. One of the suitable docked ligand-protein complexes was simulated along with the apo form of the enzyme for 100 ns. The simulation results validated the docking data. The molecular dynamics simulation analysis comprising of root mean square deviation and fluctuation, the radius of gyration, hydrogen bonding, potential energy, principle component analysis, and MM/PBSA revealed about the stability of the apo and complex systems. These flavonoids analogs can inhibit the hexamerization of the NS1 which is necessary for the Zika virus replication. Communicated by Ramaswamy H. Sarma
C1 [Ahmad, Nasir; Badshah, Syed Lal; Muhammad, Akhtar; Khan, Khalid] Islamia Coll Univ, Dept Chem, Peshawar 25120, Pakistan.
   [Junaid, Muhammad; Ur Rehman, Ashfaq] Shanghai Jiao Tong Univ, State Key Lab Microbial Metab, Dept Bioinformat & Biostat, Natl Expt Teaching Ctr Life Sci & Biotechnol,Coll, Shanghai, Peoples R China.
RP Badshah, SL; Khan, K (corresponding author), Islamia Coll Univ, Dept Chem, Peshawar 25120, Pakistan.
EM shahbiochemist@gmail.com; drkhalidchem@yahoo.com
CR Ahmad N, 2020, J MOL STRUCT, V1203, DOI 10.1016/j.molstruc.2019.127428
   Ahmad N, 2017, J MOL GRAPH MODEL, V72, P266, DOI 10.1016/j.jmgm.2016.12.010
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Badshah S. L., 2018, CURR TOP ZIKA, DOI [10.5772/intechopen.72507, DOI 10.5772/INTECHOPEN.72507]
   Badshah SL, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa044
   Badshah SL, 2019, BMC CHEM, V13, DOI 10.1186/s13065-019-0582-y
   Badshah SL, 2016, OPEN CHEM, V14, P188, DOI 10.1515/chem-2016-0021
   Badshah SL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010007
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Certara, 2012, SYBYL X SUIT VERS 2
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   DeLano W. L., 2014, PYMOL MOL GRAPH SYST
   Dussart P, 2006, CLIN VACCINE IMMUNOL, V13, P1185, DOI 10.1128/CVI.00229-06
   Edeling MA, 2014, P NATL ACAD SCI USA, V111, P4285, DOI 10.1073/pnas.1322036111
   Gonzalez-Freire M, 2015, J GERONTOL A-BIOL, V70, P1334, DOI 10.1093/gerona/glv070
   Grienke U, 2016, SCI REP-UK, V6, DOI 10.1038/srep27156
   Havsteen BH, 2002, PHARMACOL THERAPEUT, V96, P67, DOI 10.1016/S0163-7258(02)00298-X
   Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Khan H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1051925
   Khan K, 2019, NAT PROD COMMUN, V14, DOI 10.1177/1934578X19848157
   King AMQ, 2012, 9 INT COMM TAX VIR
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Kwon HJ, 2010, BIOORGAN MED CHEM, V18, P7668, DOI 10.1016/j.bmc.2010.07.073
   Labute P, 2008, J COMPUT CHEM, V29, P1693, DOI 10.1002/jcc.20933
   Lani R, 2016, ANTIVIR RES, V133, P50, DOI 10.1016/j.antiviral.2016.07.009
   Li BQ, 2000, BIOCHEM BIOPH RES CO, V276, P534, DOI 10.1006/bbrc.2000.3485
   Lulu SS, 2016, NAT PROD RES, V30, P464, DOI 10.1080/14786419.2015.1020490
   Lyu SY, 2005, ARCH PHARM RES, V28, P1293, DOI 10.1007/BF02978215
   Martinez AM, 2001, IEEE T PATTERN ANAL, V23, P228, DOI 10.1109/34.908974
   Matias AA, 2010, INT J FOOD SCI NUTR, V61, P357, DOI 10.3109/09637480903430990
   Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h
   Muhammad A, 2019, ACS OMEGA, V4, P14188, DOI 10.1021/acsomega.9b01041
   Muhammad A, 2015, IND CROP PROD, V78, P66, DOI 10.1016/j.indcrop.2015.10.011
   Muhammad A, 2012, ARCH PHARM RES, V35, P431, DOI 10.1007/s12272-012-0305-6
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Ruhle V., 2007, BERENDSEN NOSE HOOVE
   Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Su XW, 2013, FOOD ENVIRON VIROL, V5, P97, DOI 10.1007/s12560-013-9106-4
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Ul Qamar MT, 2014, BIOINFORMATION, V10, P460, DOI 10.6026/97320630010460
   Van P., 2009, J STAT MECH THEORY E, V2009, pP0254
   Wang CH, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00087
   Zandi K, 2011, J MED PLANTS RES, V5, P5534
   Zhang T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030259
NR 49
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1759453
EA MAY 2020
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LM7BA
UT WOS:000532402500001
PM 32321364
DA 2020-07-08
ER

PT J
AU Zhao, YX
   Cheng, SX
   Yu, XY
   Xu, HL
AF Zhao, Yuxin
   Cheng, Sixiang
   Yu, Xiaoyan
   Xu, Huilan
TI Chinese Public's Attention to the COVID-19 Epidemic on Social Media:
   Observational Descriptive Study
SO JOURNAL OF MEDICAL INTERNET RESEARCH
LA English
DT Article
DE COVID-19; Sina Microblog; public attention; social media; China; public
   health emergency; infodemic
ID CYBER-USER AWARENESS; INFLUENZA-A H7N9; ZIKA VIRUS; EBOLA; TWITTER;
   DISEASE
AB Background: Since the coronavirus disease (COVID-19) epidemic in China in December 2019, information and discussions about COVID-19 have spread rapidly on the internet and have quickly become the focus of worldwide attention, especially on social media.
   Objective: This study aims to investigate and analyze the public's attention to events related to COVID-19 in China at the beginning of the COVID-19 epidemic (December 31, 2019, to February 20, 2020) through the Sina Microblog hot search list.
   Methods: We collected topics related to the COVID-19 epidemic on the Sina Microblog hot search list from December 31, 2019, to February 20, 2020, and described the trend of public attention on COVID-19 epidemic-related topics. ROST Content Mining System version 6.0 was used to analyze the collected text for word segmentation, word frequency, and sentiment analysis. We further described the hot topic keywords and sentiment trends of public attention. We used VOSviewer to implement a visual cluster analysis of hot keywords and build a social network of public opinion content.
   Results: The study has four main findings. First, we analyzed the changing trend of the public's attention to the COVID-19 epidemic, which can be divided into three stages. Second, the hot topic keywords of public attention at each stage were slightly different. Third, the emotional tendency of the public toward the COVID-19 epidemic-related hot topics changed from negative to neutral, with negative emotions weakening and positive emotions increasing as a whole. Fourth, we divided the COVID-19 topics with the most public concern into five categories: the situation of the new cases of COVID-19 and its impact, frontline reporting of the epidemic and the measures of prevention and control, expert interpretation and discussion on the source of infection, medical services on the frontline of the epidemic, and focus on the worldwide epidemic and the search for suspected cases.
   Conclusions: Our study found that social media (eg, Sina Microblog) can be used to measure public attention toward public health emergencies. During the epidemic of the novel coronavirus, a large amount of information about the COVID-19 epidemic was disseminated on Sina Microblog and received widespread public attention. We have learned about the hotspots of public concern regarding the COVID-19 epidemic. These findings can help the government and health departments better communicate with the public on health and translate public health needs into practice to create targeted measures to prevent and control the spread of COVID-19.
C1 [Zhao, Yuxin; Cheng, Sixiang; Yu, Xiaoyan; Xu, Huilan] Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha 410078, Peoples R China.
RP Xu, HL (corresponding author), Cent South Univ, Xiangya Sch Publ Hlth, Dept Social Med & Hlth Management, Changsha 410078, Peoples R China.
EM xhl_csu@163.com
CR Anh-Tien T, 2020, RAPID IDENTIFICATION, pe, DOI [10.26434/chemrxiv.11860077, DOI 10.26434/CHEMRXIV.11860077]
   Chen JL, 2020, MICROBES INFECT, V22, P69, DOI 10.1016/j.micinf.2020.01.004
   Chen Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46898-y
   Chen Y, 2019, CHINESE J STRUC CHEM, V38, P76, DOI 10.14102/j.cnki.0254-5861.2011-2051
   El-Tholoth M, 2020, SINGLE 2 STAGE CLOSE, DOI [10.26434/chemrxiv.11860137, DOI 10.26434/CHEMRXIV.11860137]
   Fang Q., 2014, COURSE ED RES, P234, DOI [10.1093/oxfordhb/9780199811755.013.008, DOI 10.1093/OXFORDHB/9780199811755.013.008]
   Fang YC, 2020, RADIOLOGY, V295, P208, DOI [10.1148/2020200280, 10.1148/radiol.2020200280]
   Feng SH, 2018, DISASTER MED PUBLIC, V12, P26, DOI 10.1017/dmp.2017.29
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Fung ICH, 2016, AM J INFECT CONTROL, V44, P1660, DOI 10.1016/j.ajic.2016.05.011
   Fung ICH, 2016, PUBLIC HEALTH REP, V131, P461, DOI 10.1177/003335491613100312
   Fung ICH, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-31
   Gu H, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2911
   Gui Xinning, 2017, AMIA Annu Symp Proc, V2017, P820
   Househ M, 2016, HEALTH INFORM J, V22, P470, DOI 10.1177/1460458214568037
   Hu GY, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071273
   Lam TTY, 2020, IDENTIFICATION 2019, DOI [10.1101/2020.02.13.945485, DOI 10.1101/2020.02.13.945485]
   Lazard AJ, 2017, TOB CONTROL, V26, pe112, DOI 10.1136/tobaccocontrol-2016-053295
   Li Q, 2020, SIMPLE LAB PARAMETER, pe, DOI [10.1101/2020.02.13.20022830, DOI 10.1101/2020.02.13.20022830]
   Liang WH, 2020, LANCET ONCOL, V21, P335, DOI 10.1016/S1470-2045(20)30096-6
   Lipsitch M, 2020, NEW ENGL J MED, V382, P1194, DOI 10.1056/NEJMp2002125
   Liu BY, 2015, INT J INFECT DIS, V40, P34, DOI 10.1016/j.ijid.2015.09.017
   Liu CY, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02280-y
   Liu P, 2020, ARE PANGOLINS INTERM, DOI [10.1101/2020.02.18.954628, DOI 10.1101/2020.02.18.954628]
   Massey PM, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.6670
   Micholas S, 2020, REPURPOSING THERAPEU, pe, DOI [10.26434/chemrxiv.11871402.v3, DOI 10.26434/CHEMRXIV.11871402.V3]
   Mizumoto K., 2020, EARLY EPIDEMIOLOGICA, DOI [10.1101/2020.02.12.20022434, DOI 10.1101/2020.02.12.20022434]
   Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370
   Pan XF, 2020, LANCET INFECT DIS, V20, P410, DOI 10.1016/S1473-3099(20)30114-6
   Rimanshee A, 2020, POTENTIAL INHIBITORS, pe, DOI [10.26434/chemrxiv.11860011, DOI 10.26434/CHEMRXIV.11860011]
   Seltzer EK, 2017, PUBLIC HEALTH, V150, P170, DOI 10.1016/j.puhe.2017.07.015
   Seltzer EK, 2015, PUBLIC HEALTH, V129, P1273, DOI 10.1016/j.puhe.2015.07.025
   Silverstein WK, 2020, LANCET, V395, P734, DOI 10.1016/S0140-6736(20)30370-6
   Sina microblog data center, 2018, 2018 SIN MICR US DEV
   Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002
   Sun KY, 2020, LANCET DIGIT HEALTH, V2, pE201, DOI 10.1016/S2589-7500(20)30026-1
   To Kelvin Kai-Wang, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa149
   [王心瑶 Wang Xinyao], 2018, [中国预防医学杂志, China Preventive Medicine], V19, P401
   Wong M. C., 2020, EVIDENCE RECOMBINATI, DOI [10.1101/2020.02.07.939207, DOI 10.1101/2020.02.07.939207]
   Wong R, 2018, DISASTER MED PUBLIC, V12, P287, DOI 10.1017/dmp.2017.69
   World Health Organization, 2020, NOV CONR 2019 NCOV S
   World Health Organization (WHO), COR DIS COVID 19 TEC
   Wuhan Municipal Health Committee, REP WUH MUN HLTH COM
   Xiao K., 2020, ISOLATION CHARACTERI, DOI [10.1101/2020.02.17.951335, DOI 10.1101/2020.02.17.951335]
   Xie TS, 2014, INT J INFECT DIS, V22, P1, DOI 10.1016/j.ijid.2013.11.013
   Xu B, 2020, LANCET INFECT DIS, V20, P534, DOI 10.1016/S1473-3099(20)30119-5
   Xu XW, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m606
   Yang Y, 2020, EVALUATING ACCURACY, DOI [DOI 10.1101/2020.02.11.20021493, 10.1101/2020.02.11.20021493]
   Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X
NR 49
TC 4
Z9 4
U1 33
U2 33
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 1438-8871
J9 J MED INTERNET RES
JI J. Med. Internet Res.
PD MAY 4
PY 2020
VL 22
IS 5
AR e18825
DI 10.2196/18825
PG 13
WC Health Care Sciences & Services; Medical Informatics
SC Health Care Sciences & Services; Medical Informatics
GA LJ2TC
UT WOS:000530021200001
PM 32314976
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pierson, TC
   Diamond, MS
AF Pierson, Theodore C.
   Diamond, Michael S.
TI The continued threat of emerging flaviviruses
SO NATURE MICROBIOLOGY
LA English
DT Review; Early Access
ID WEST-NILE-VIRUS; ANTIBODY-DEPENDENT ENHANCEMENT; JAPANESE
   ENCEPHALITIS-VIRUS; CD8(+) T-CELL; YELLOW-FEVER VIRUS; TETRAVALENT
   DENGUE VACCINE; ORIGINAL ANTIGENIC SIN; ZIKA-VIRUS; BROAD-SPECTRUM;
   DISEASE SEVERITY
AB Flaviviruses are vector-borne RNA viruses that can emerge unexpectedly in human populations and cause a spectrum of potentially severe diseases including hepatitis, vascular shock syndrome, encephalitis, acute flaccid paralysis, congenital abnormalities and fetal death. This epidemiological pattern has occurred numerous times during the last 70 years, including epidemics of dengue virus and West Nile virus, and the most recent explosive epidemic of Zika virus in the Americas. Flaviviruses are now globally distributed and infect up to 400 million people annually. Of significant concern, outbreaks of other less well-characterized flaviviruses have been reported in humans and animals in different regions of the world. The potential for these viruses to sustain epidemic transmission among humans is poorly understood. In this Review, we discuss the basic biology of flaviviruses, their infectious cycles, the diseases they cause and underlying host immune responses to infection. We describe flaviviruses that represent an established ongoing threat to global health and those that have recently emerged in new populations to cause significant disease. We also provide examples of lesser-known flaviviruses that circulate in restricted areas of the world but have the potential to emerge more broadly in human populations. Finally, we discuss how an understanding of the epidemiology, biology, structure and immunity of flaviviruses can inform the rapid development of countermeasures to treat or prevent human infections as they emerge.
   Flaviviruses, a group of vector-borne RNA viruses that includes dengue virus, West Nile virus, Zika virus and several lesser-known species, often emerge in human populations and cause epidemics. Here, Pierson and Diamond review the basic biology of these viruses, their life cycles, the diseases they cause and available therapeutic options. They also discuss the global distribution of flaviviruses, with a focus on lesser-known species that have the potential to emerge more broadly in human populations.
C1 [Pierson, Theodore C.] NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Med, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Pathol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Immunol, St Louis, MO 63110 USA.
RP Pierson, TC (corresponding author), NIAID, Lab Viral Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Med, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Mol Microbiol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Pathol, St Louis, MO 63110 USA.; Diamond, MS (corresponding author), Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, Dept Immunol, St Louis, MO 63110 USA.
EM piersontc@mail.nih.gov; diamond@wusm.wustl.edu
FU intramural program of the National Institute of Allergy and Infectious
   DiseasesUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID); National Institutes of Health (NIH)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [R01 AI073755, R01 AI127828, R01 HD091218]
FX This work is dedicated to the memory of Dr Michael Rossmann (1930-2019),
   who pioneered our structural understanding of flaviviruses and their
   interactions with the host. This work was supported by the intramural
   program of the National Institute of Allergy and Infectious Diseases and
   the National Institutes of Health (NIH; grant nos. R01 AI073755, R01
   AI127828 and R01 HD091218 to M.S.D). We thank Ethan Tyler (NIH Office of
   the Director) for preparation of the figures. We also thank N. Vasilakis
   and S. Weaver for their editorial comments.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abelz A., 2007, Morbidity and Mortality Weekly Report, V56, P785
   Aberle JH, 2018, J CLIN VIROL, V108, P126, DOI 10.1016/j.jcv.2018.09.020
   Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aktepe TE, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12884
   Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Aliota MT, 2014, VECTOR-BORNE ZOONOT, V14, P245, DOI 10.1089/vbz.2013.1475
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Anders KL, 2018, TRIALS, V19, DOI 10.1186/s13063-018-2670-z
   Anez G, 2012, AM J TROP MED HYG, V87, P548, DOI 10.4269/ajtmh.2012.12-0091
   [Anonymous], 2015, WKLY EPIDEMIOL REC, V90, P421
   [Anonymous], 2019, W NIL VIR STAT MAPS
   Appaiahgari MB, 2010, EXPERT REV VACCINES, V9, P1371, DOI [10.1586/erv.10.139, 10.1586/ERV.10.139]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrett ADT, 2007, ANNU REV ENTOMOL, V52, P209, DOI 10.1146/annurev.ento.52.110405.091454
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beaumier CM, 2009, VIRAL IMMUNOL, V22, P215, DOI 10.1089/vim.2008.0089
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869
   Bournazos S, 2015, J EXP MED, V212, P1361, DOI 10.1084/jem.20151267
   Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097
   Breitbach ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007766
   Brien JD, 2007, EUR J IMMUNOL, V37, P1855, DOI 10.1002/eji.200737196
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Burger-Calderon R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006518
   BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cadar D, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.4.30452
   Cain MD, 2019, NEURON, V103, P771, DOI 10.1016/j.neuron.2019.07.015
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Casey RM, 2019, NEW ENGL J MED, V381, P444, DOI 10.1056/NEJMoa1710430
   Chao LH, 2018, ELIFE, V7, DOI 10.7554/eLife.36461
   Chao LH, 2014, ELIFE, V3, DOI 10.7554/eLife.04389
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen YL, 2015, ANTIVIR RES, V122, P12, DOI 10.1016/j.antiviral.2015.07.010
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Connor Bradley, 2017, Trop Dis Travel Med Vaccines, V3, P14, DOI 10.1186/s40794-017-0057-x
   Corver J, 2000, VIROLOGY, V269, P37, DOI 10.1006/viro.1999.0172
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Vieira CJDP, 2019, T ROY SOC TROP MED H, V113, P424, DOI 10.1093/trstmh/trz031
   de Rezende IM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006538
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Diamond MS, 2013, NAT REV IMMUNOL, V13, P46, DOI 10.1038/nri3344
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   DRAPER C C, 1965, West Afr Med J, V14, P16
   Duehr J, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00011-18, 10.1128/mspheredirect.00011-18]
   Dupuis AP, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-185
   Ebel GD, 2001, J GEN VIROL, V82, P1657, DOI 10.1099/0022-1317-82-7-1657
   Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006
   Elshuber S, 2003, J GEN VIROL, V84, P183, DOI 10.1099/vir.0.18723-0
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Erdelyi K, 2007, VECTOR-BORNE ZOONOT, V7, P181, DOI 10.1089/vbz.2006.0586
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Fernandez E, 2018, MBIO, V9, DOI [10.1128/mBio.00008-18, 10.1128/mbio.00008-18]
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fischer Marc, 2010, Morbidity and Mortality Weekly Report, V59, P1
   Franz AWE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002833
   Gaibani P, 2017, MICROBES INFECT, V19, P382, DOI 10.1016/j.micinf.2017.05.003
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   GOLLINS SW, 1986, J GEN VIROL, V67, P157, DOI 10.1099/0022-1317-67-1-157
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Graham RR, 1999, AM J TROP MED HYG, V61, P412, DOI 10.4269/ajtmh.1999.61.412
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Gubler Duane J, 2006, Novartis Found Symp, V277, P3, DOI 10.1002/0470058005.ch2
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hackett BA, 2015, P NATL ACAD SCI USA, V112, P7797, DOI 10.1073/pnas.1424098112
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Haddow AD, 2016, B WORLD HEALTH ORGAN, V94, P711, DOI 10.2471/BLT.16.181503
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hadler JL, 2015, EMERG INFECT DIS, V21, P1159, DOI 10.3201/eid2107.140858
   Halai UA, 2017, CLIN INFECT DIS, V65, P877, DOI 10.1093/cid/cix472
   Halstead S. B., 2008, VACCINES, P311
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2017, VACCINE, V35, P6355, DOI 10.1016/j.vaccine.2017.09.089
   Halstead SB, 2017, EMERG INFECT DIS, V23, P569, DOI 10.3201/eid2304.161879
   Halstead SB, 2011, EXPERT REV VACCINES, V10, P355, DOI [10.1586/erv.11.7, 10.1586/ERV.11.7]
   Hamer DH, 2018, MMWR-MORBID MORTAL W, V67, P340, DOI 10.15585/mmwr.mm6711e1
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006284
   Hammond SN, 2005, AM J TROP MED HYG, V73, P1063
   Hanna JN, 1999, MED J AUSTRALIA, V170, P533, DOI 10.5694/j.1326-5377.1999.tb127878.x
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Hermance ME, 2017, VECTOR-BORNE ZOONOT, V17, P453, DOI 10.1089/vbz.2017.2110
   Higgs S, 2005, P NATL ACAD SCI USA, V102, P8871, DOI 10.1073/pnas.0503835102
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Huang CYH, 2003, J VIROL, V77, P11436, DOI 10.1128/JVI.77.21.11436-11447.2003
   Huang CYH, 2000, J VIROL, V74, P3020, DOI 10.1128/JVI.74.7.3020-3028.2000
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Huang YJS, 2015, VECTOR-BORNE ZOONOT, V15, P709, DOI 10.1089/vbz.2015.1821
   Hubalek Z, 1999, EMERG INFECT DIS, V5, P643, DOI 10.3201/eid0505.990505
   Ingelbeen B, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007029
   Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317
   Iwamoto M, 2003, NEW ENGL J MED, V348, P2196, DOI 10.1056/NEJMoa022987
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Jeffries CL, 2014, J GEN VIROL, V95, P1005, DOI 10.1099/vir.0.062356-0
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Johansson MA, 2014, T ROY SOC TROP MED H, V108, P482, DOI 10.1093/trstmh/tru092
   Jordan TX, 2016, CURR OPIN VIROL, V19, P7, DOI 10.1016/j.coviro.2016.05.007
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kalayanarooj Siripen, 2003, J Med Assoc Thai, V86 Suppl 3, pS673
   Kasabi GS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002025
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kemenesi G, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00106-17
   Kim H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116547
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Knox KK, 2017, VECTOR-BORNE ZOONOT, V17, P463, DOI 10.1089/vbz.2016.2082
   KOKERNOT R. H., 1957, S AFRICAN JOUR MED SCI, V22, P103
   Kose N, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw6647
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Krow-Lucal ER, 2018, VECTOR-BORNE ZOONOT, V18, P286, DOI 10.1089/vbz.2017.2239
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar P, 2004, J INFECT DIS, V189, P880, DOI 10.1086/381768
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Li M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200478
   Li MH, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001231
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lim JK, 2008, J INFECT DIS, V197, P262, DOI 10.1086/524691
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindsey NP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01115-17
   Ling Y, 2016, EMERG INFECT DIS, V22, P1317, DOI 10.3201/eid2207.160469
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   Lorenz IC, 2002, J VIROL, V76, P5480, DOI 10.1128/JVI.76.11.5480-5491.2002
   Lucas TM, 2016, J VIROL, V90, P2600, DOI 10.1128/JVI.02463-15
   Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006
   Majerova T, 2019, BIOCHIMIE, V166, P132, DOI 10.1016/j.biochi.2019.05.004
   Mansfield KL, 2017, VET MICROBIOL, V201, P85, DOI 10.1016/j.vetmic.2017.01.014
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Maringer K, 2014, CYTOKINE GROWTH F R, V25, P669, DOI 10.1016/j.cytogfr.2014.08.004
   Mathew A, 2008, IMMUNOL REV, V225, P300, DOI 10.1111/j.1600-065X.2008.00678.x
   Maximova OA, 2018, ANNU REV VIROL, V5, P255, DOI 10.1146/annurev-virology-092917-043439
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   McLean RG, 2002, CURR TOP MICROBIOL, V267, P271
   Medeiros DBA, 2007, J GEN VIROL, V88, P2237, DOI 10.1099/vir.0.82883-0
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2015, NAT MED, V21, P1464, DOI 10.1038/nm.3974
   Miorin L, 2017, BIOCHEM BIOPH RES CO, V492, P587, DOI 10.1016/j.bbrc.2017.05.146
   MITCHELL CJ, 1981, AM J TROP MED HYG, V30, P465, DOI 10.4269/ajtmh.1981.30.465
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mohammed MAF, 2011, INFECT GENET EVOL, V11, P855, DOI 10.1016/j.meegid.2011.01.020
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   MONATH TP, 1978, AM J TROP MED HYG, V27, P1251, DOI 10.4269/ajtmh.1978.27.1251
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Montgomery RR, 2015, EXPERT REV ANTI-INFE, V13, P317, DOI 10.1586/14787210.2015.1007043
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0
   Mukhopadhyay S, 2003, SCIENCE, V302, P248, DOI 10.1126/science.1089316
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Murray K, 2006, EPIDEMIOL INFECT, V134, P1325, DOI 10.1017/S0950268806006339
   Murthy HMK, 2009, J BIOL CHEM, V284, P34468, DOI 10.1074/jbc.A005573200
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Navarro-Sanchez E, 2003, EMBO REP, V4, P723, DOI 10.1038/sj.embor.embor866
   Netland J, 2013, VIRUSES-BASEL, V5, P2573, DOI 10.3390/v5102573
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nhan NT, 2001, CLIN INFECT DIS, V32, P204, DOI 10.1086/318479
   Nitsche C, 2018, ADV EXP MED BIOL, V1062, P175, DOI 10.1007/978-981-10-8727-1_13
   Niyomrattanakit P, 2010, J VIROL, V84, P5678, DOI 10.1128/JVI.02451-09
   Ooi MH, 2008, CLIN INFECT DIS, V47, P458, DOI 10.1086/590008
   Palma-Ocampo HK, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0383-4
   Pandit PS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07896-2
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pauvolid-Correa A, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002706
   Pauvolid-Correa A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002318
   Pauvolid-Correa A, 2011, MEM I OSWALDO CRUZ, V106, P467, DOI 10.1590/S0074-02762011000400014
   Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Phipps P, 2018, VET REC, V183, DOI 10.1136/vr.k3497
   Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Poh MK, 2009, ANTIVIR RES, V84, P260, DOI 10.1016/j.antiviral.2009.09.011
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Puerta-Guardo H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005738
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rendi-Wagner P, 2008, EXPERT REV VACCINES, V7, P589, DOI 10.1586/14760584.7.5.589
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Reyes-Sandoval A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01651
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Ruzek D, 2009, VIROLOGY, V384, P1, DOI 10.1016/j.virol.2008.11.023
   Sakuntabhai A, 2005, NAT GENET, V37, P507, DOI 10.1038/ng1550
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schmidt AG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002627
   Schmidt AG, 2010, J VIROL, V84, P12549, DOI 10.1128/JVI.01440-10
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756
   Schoggins John W, 2018, F1000Res, V7, P309, DOI 10.12688/f1000research.12450.1
   Schoggins JW, 2014, CURR OPIN VIROL, V6, P40, DOI 10.1016/j.coviro.2014.03.006
   Shaw WR, 2019, NAT MICROBIOL, V4, P20, DOI 10.1038/s41564-018-0214-7
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shrestha B, 2006, J VIROL, V80, P119, DOI 10.1128/JVI.80.1.119-129.2006
   Shrestha B, 2007, J VIROL, V81, P11749, DOI 10.1128/JVI.01136-07
   Simmons CP, 2007, J INFECT DIS, V196, P416, DOI 10.1086/519170
   Simon-Loriere E, 2017, NEW ENGL J MED, V376, P1483, DOI 10.1056/NEJMc1701600
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith JL, 2018, ANTIVIR RES, V155, P12, DOI 10.1016/j.antiviral.2018.04.019
   Smithburn K. C., 1940, AM J TROP MED HYG, V20, P471, DOI DOI 10.4269/AJTMH.1940.S1-20.471
   Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Straatmann A, 1997, Rev Soc Bras Med Trop, V30, P511, DOI 10.1590/S0037-86821997000600012
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Tabachnick WJ, 2016, ANNU REV VIROL, V3, P125, DOI 10.1146/annurev-virology-110615-035630
   Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840
   Thackray LB, 2018, CELL REP, V22, P3440, DOI 10.1016/j.celrep.2018.03.001
   Therkelsen MD, 2018, P NATL ACAD SCI USA, V115, P11608, DOI 10.1073/pnas.1809304115
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2
   Tuboi SH, 2007, T ROY SOC TROP MED H, V101, P169, DOI 10.1016/j.trstmh.2006.04.001
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   VanBlargan LA, 2018, CELL REP, V25, P3382, DOI 10.1016/j.celrep.2018.11.082
   Venter M, 2018, CURR OPIN VIROL, V28, P74, DOI 10.1016/j.coviro.2017.11.004
   Veo C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090814
   VIEIRA WT, 1983, HISTOPATHOLOGY, V7, P195, DOI 10.1111/j.1365-2559.1983.tb02235.x
   Vogt MR, 2011, J VIROL, V85, P11567, DOI 10.1128/JVI.05859-11
   Wang SB, 2020, CELL REP, V30, P969, DOI 10.1016/j.celrep.2019.11.020
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weissenbock H, 2002, EMERG INFECT DIS, V8, P652, DOI 10.3201/eid0807.020094
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Weyer J, 2013, VECTOR-BORNE ZOONOT, V13, P330, DOI 10.1089/vbz.2012.1181
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Wu JH, 2005, J VIROL, V79, P10268, DOI 10.1128/JVI.79.16.10268-10277.2005
   Wuertz KM, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007899
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yi ZG, 2012, J VIROL, V86, P11815, DOI 10.1128/JVI.01022-12
   Young PR, 2018, ADV EXP MED BIOL, V1062, P1, DOI 10.1007/978-981-10-8727-1_1
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang W, 2017, J GEN VIROL, V98, P2413, DOI 10.1099/jgv.0.000908
   Zhu Z, 2020, CELL STEM CELL, V26, P187, DOI 10.1016/j.stem.2019.11.016
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 291
TC 0
Z9 0
U1 6
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2058-5276
J9 NAT MICROBIOL
JI NAT. MICROBIOL
DI 10.1038/s41564-020-0714-0
EA MAY 2020
PG 17
WC Microbiology
SC Microbiology
GA LJ5GU
UT WOS:000530194600001
PM 32367055
OA Bronze
DA 2020-07-08
ER

PT J
AU Cho, JH
   Bassit, LC
   Amblard, F
   Schinazi, RF
AF Cho, Jong Hyun
   Bassit, Leda C.
   Amblard, Franck
   Schinazi, Raymond F.
TI Synthesis of 7-trifluoromethyl-7-deazapurine ribonucleoside analogs and
   their monophosphate prodrugs
SO NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
LA English
DT Article
DE 7-trifluoromethyl-7-deazapurine ribonucleoside; protides;
   Silyl-Hilbert-Johnson; RNA viruses
ID BETA-L-RIBONUCLEOSIDES; ANTIVIRAL ACTIVITY; PRACTICAL SYNTHESIS;
   EFFICIENT SYNTHESIS; NUCLEOSIDE; INHIBITORS; TRIFLUOROMETHYLATION; RNA;
   GLYCOSYLATION; PERFLUOROALKYLATION
AB Novel 7-trifluoromethyl-7-deazapurine ribonucleoside analogs (13a-c) and their Protides (15a-c) were successfully synthesized from ribolactol or 1-alpha-bromo-ribose derivatives using Silyl-Hilbert-Johnson or nucleobase-anion substitution reactions followed by key aromatic trifluoromethyl substitution. Newly prepared compounds were evaluated against a panel of RNA viruses, including HCV, Ebola or Zika viruses.
C1 [Cho, Jong Hyun] Dong A Univ, Dept Med Biotechnol, Busan, South Korea.
   [Bassit, Leda C.; Amblard, Franck; Schinazi, Raymond F.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.
RP Schinazi, RF (corresponding author), Emory Univ, Dept Pediat, Atlanta, GA 30322 USA.
EM rschina@emory.edu
CR Alonso C, 2015, CHEM REV, V115, P1847, DOI 10.1021/cr500368h
   ANZAI K, 1957, J ANTIBIOT, V10, P201
   Arumugham B, 2006, BIOORG MED CHEM LETT, V16, P285, DOI 10.1016/j.bmcl.2005.10.007
   Bio MM, 2004, J ORG CHEM, V69, P6257, DOI 10.1021/jo0491096
   Bourderioux A, 2011, J MED CHEM, V54, P5498, DOI 10.1021/jm2005173
   Bradner J. F., 2016, [No title captured], Patent No. [US 20160060269, 20160060269]
   Charpentier J, 2015, CHEM REV, V115, P650, DOI 10.1021/cr500223h
   Congiatu C, 2006, J MED CHEM, V49, P452, DOI 10.1021/jm0509896
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   Di Francesco ME, 2012, BIOORGAN MED CHEM, V20, P4801, DOI 10.1016/j.bmc.2012.05.067
   Eldrup AB, 2004, J MED CHEM, V47, P5284, DOI 10.1021/jm040068f
   Eldrup AB, 2004, J MED CHEM, V47, P2283, DOI 10.1021/jm030424e
   Fennewald JC, 2014, GREEN CHEM, V16, P1097, DOI 10.1039/c3gc42119h
   Fisher P. V., 2003, PCT Int. Appl., Patent No. [WO 2003000842, 2003000842]
   GERSTER JF, 1969, J HETEROCYCLIC CHEM, V6, P207, DOI 10.1002/jhet.5570060211
   HarryOkuru RE, 1997, J ORG CHEM, V62, P1754, DOI 10.1021/jo961893+
   Hocek M, 1999, COLLECT CZECH CHEM C, V64, P229, DOI 10.1135/cccc19990229
   Hu WD, 2010, BIOORG MED CHEM LETT, V20, P7297, DOI 10.1016/j.bmcl.2010.10.076
   Ji YN, 2011, P NATL ACAD SCI USA, V108, P14411, DOI 10.1073/pnas.1109059108
   Jordheim LP, 2013, NAT REV DRUG DISCOV, V12, P447, DOI 10.1038/nrd4010
   KASAI H, 1975, BIOCHEMISTRY-US, V14, P4198, DOI 10.1021/bi00690a008
   KOBAYASHI Y, 1980, J CHEM SOC PERK T 1, P2755, DOI 10.1039/p19800002755
   Liu X, 2015, CHEM REV, V115, P683, DOI 10.1021/cr400473a
   Ma JA, 2004, CHEM REV, V104, P6119, DOI 10.1021/cr030143e
   McCarty RM, 2012, BIOORG CHEM, V43, P15, DOI 10.1016/j.bioorg.2012.01.001
   McGuigan C, 2005, BIOORGAN MED CHEM, V13, P3219, DOI 10.1016/j.bmc.2005.02.041
   Naus P, 2014, J MED CHEM, V57, P1097, DOI 10.1021/jm4018948
   Naus P, 2012, BIOORGAN MED CHEM, V20, P5202, DOI 10.1016/j.bmc.2012.07.003
   Naus P, 2010, J MED CHEM, V53, P460, DOI 10.1021/jm901428k
   NIEDBALLA U, 1976, J ORG CHEM, V41, P2084, DOI 10.1021/jo00874a002
   NISHIMURA H, 1956, J ANTIBIOT, V9, P60
   Peng X, 2007, NUCLEOS NUCLEOT NUCL, V26, P603, DOI 10.1080/15257770701490332
   Pradere U, 2014, CHEM REV, V114, P9154, DOI 10.1021/cr5002035
   Prasad ASB, 1997, TETRAHEDRON, V53, P7237
   PUDLO JS, 1990, J MED CHEM, V33, P1984, DOI 10.1021/jm00169a028
   Qing FL, 1997, J CHEM SOC PERK T 1, P3053, DOI 10.1039/a702607b
   Ramzaeva N, 1999, HELV CHIM ACTA, V82, P12, DOI 10.1002/(SICI)1522-2675(19990113)82:1<12::AID-HLCA12>3.0.CO;2-L
   Rao K. V., 1963, ANTIMICROB AGENTS CH, P77
   RAO KV, 1968, J MED CHEM, V11, P939, DOI 10.1021/jm00311a005
   Schiltz G. E., 2014, [No title captured], Patent No. [WO 2014145576, 2014145576]
   SCHINAZI RF, 1990, ANTIMICROB AGENTS CH, V34, P1061, DOI 10.1128/AAC.34.6.1061
   Seela F, 2006, J ORG CHEM, V71, P81, DOI 10.1021/jo0516640
   SEELA F, 1988, J CHEM SOC PERK T 1, P697, DOI 10.1039/p19880000697
   Seela F, 2007, TETRAHEDRON, V63, P9850, DOI 10.1016/j.tet.2007.06.107
   Shi JX, 2011, BIOORG MED CHEM LETT, V21, P7094, DOI 10.1016/j.bmcl.2011.09.089
   Song Y, 2011, SYNTHESIS-STUTTGART, P1442, DOI 10.1055/s-0030-1259975
   Stuyver LJ, 2003, ANTIMICROB AGENTS CH, V47, P244, DOI 10.1128/AAC.47.1.244-254.2003
   Stuyver LJ, 2002, ANTIMICROB AGENTS CH, V46, P3854, DOI 10.1128/AAC.46.12.3854-3860.2002
   Suhadolnik R. J, 1970, PYRROLOPYRIMIDINE NU, P298
   Sznaidman ML, 2004, NUCLEOS NUCLEOT NUCL, V23, P1875, DOI 10.1081/NCN-200040643
   Tang XQ, 1999, J ORG CHEM, V64, P747, DOI 10.1021/jo981329u
   TANN CH, 1985, J ORG CHEM, V50, P3644, DOI 10.1021/jo00219a048
   Tomashenko OA, 2011, CHEM REV, V111, P4475, DOI 10.1021/cr1004293
   Uebelhoer LS, 2014, ANTIVIR RES, V106, P86, DOI 10.1016/j.antiviral.2014.03.018
   Ugarkar BG, 2003, J MED CHEM, V46, P4750, DOI 10.1021/jm030230z
   Veliz EA, 2001, ORG LETT, V3, P2969, DOI 10.1021/ol016295i
   VORBRUGGEN H, 1981, CHEM BER-RECL, V114, P1234, DOI 10.1002/cber.19811140404
   Vorbruggen H., 2000, ORG REACTIONS, V55, P1
   Vorbruggen H., 2001, HDB NUCLEOSIDE SYNTH
   Wang XJ, 2004, NUCLEOS NUCLEOT NUCL, V23, P161, DOI 10.1081/NCN-120027825
   Yin Z, 2009, P NATL ACAD SCI USA, V106, P20435, DOI 10.1073/pnas.0907010106
   Zhou LH, 2016, ACS MED CHEM LETT, V7, P17, DOI 10.1021/acsmedchemlett.5b00402
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 64
TC 0
Z9 0
U1 1
U2 3
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1525-7770
EI 1532-2335
J9 NUCLEOS NUCLEOT NUCL
JI Nucleosides Nucleotides Nucleic Acids
PD MAY 3
PY 2020
VL 39
IS 5
BP 671
EP 687
DI 10.1080/15257770.2019.1674333
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LT4BG
UT WOS:000537016700002
PM 31588837
DA 2020-07-08
ER

PT J
AU Olson, MK
   Vos, SC
   Sutton, J
AF Olson, Michele K.
   Vos, Sarah C.
   Sutton, Jeannette
TI Threat and Efficacy in Television News: Reporting on an Emerging
   Infectious Disease
SO WESTERN JOURNAL OF COMMUNICATION
LA English
DT Article; Early Access
DE Efficacy; Emerging Infectious Disease; Media Coverage; Risk
   Communication
ID PROTECTION-MOTIVATION; RISK COMMUNICATION; HEALTH-RISKS; FEAR APPEALS;
   CRISIS; COVERAGE; INFORMATION; ATTENTION; BEHAVIOR; PRINT
AB During an emerging infectious disease outbreak, television news becomes an important channel for communicating threat and efficacy information. In this study, we conduct a content analysis to assess the degree to which television news contained threat and efficacy information during the 2016 Zika virus outbreak. The results show significantly more threat information than efficacy information in broadcast news reports. Individual efficacy and collective efficacy information were communicated at approximately the same rate. These findings indicate a continued need for public health communicators to emphasize collective and individual efficacy information when communicating with the media.
C1 [Olson, Michele K.; Sutton, Jeannette] Univ Kentucky, Dept Commun, Lexington, KY 40506 USA.
   [Vos, Sarah C.] Univ Kentucky, Coll Publ Hlth, Dept Hlth Management & Policy, Lexington, KY 40506 USA.
RP Sutton, J (corresponding author), Univ Kentucky, Dept Commun, Lexington, KY 40506 USA.
EM jeannette.sutton@uky.edu
FU National Science FoundationNational Science Foundation (NSF)
   [CMMI-1536347]
FX This research was supported by grant funding from the National Science
   Foundation, CMMI-1536347 (PI Sutton).
CR Abramson D., 2016, 1 NYU COLL GLOB PUBL
   [Anonymous], 2016, REUTERS
   [Anonymous], 2006, CRISIS EMERGENCY RIS
   [Anonymous], 2017, NETWORK NEWS FACT SH
   Bandura A, 2000, CURR DIR PSYCHOL SCI, V9, P75, DOI 10.1111/1467-8721.00064
   Bandura A, 2004, HEALTH EDUC BEHAV, V31, P143, DOI 10.1177/1090198104263660
   Bandura A., 1986, SOCIAL FDN THOUGHT A
   Bandura A., 1997, SELF EFFICACY EXERCI
   Bol GF, 2016, EMBO REP, V17, P1, DOI 10.15252/embr.201541678
   Bomlitz LJ, 2008, J PUBLIC HEALTH-UK, V30, P202, DOI 10.1093/pubmed/fdn009
   BULMER MG, 1979, PRINCIPLES STAT
   Centers for Disease Control and Prevention, 2017, OV ZIK VIR
   Centers for Disease Control and Prevention, 2017, 2016 CAS COUNTS US
   Covello V., 2001, SOLUTIONS ENV PERIL, P164
   Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802
   Dudo AD, 2007, SCI COMMUN, V28, P429, DOI 10.1177/1075547007302211
   Dutta-Bergman M. J., 2003, SOCIAL MARKETING Q, V9, P17
   Dutta-Bergman MJ, 2005, HEALTH COMMUN, V18, P103, DOI 10.1207/s15327027hc1802_1
   Evensen DT, 2012, SCI COMMUN, V34, P392, DOI 10.1177/1075547011421020
   Freimuth V, 2000, EMERG INFECT DIS, V6, P337, DOI 10.3201/eid0604.000403
   Frisby BN, 2014, HEALTH COMMUN, V29, P347, DOI 10.1080/10410236.2012.755604
   Goddard R. D., 2004, ED RES, V33, P3, DOI DOI 10.3102/0013189X033003003
   Goodall C, 2012, J HEALTH COMMUN, V17, P338, DOI 10.1080/10810730.2011.626499
   Griffin DW, 2011, PSYCHOL SCI, V22, P572, DOI 10.1177/0956797611405678
   Gursky Elin, 2003, Biosecur Bioterror, V1, P97, DOI 10.1089/153871303766275763
   Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664
   Hermida A, 2012, JOURNALISM STUD, V13, P815, DOI 10.1080/1461670X.2012.664430
   Holmes BJ, 2009, J RISK RES, V12, P793, DOI 10.1080/13669870802648486
   Howell D.C., 2007, STAT METHODS PSYCHOL
   Ihekweazu C, 2017, HEALTH COMMUN, V32, P741, DOI 10.1080/10410236.2016.1172287
   Kasperson RE, 1996, ANN AM ACAD POLIT SS, V545, P95, DOI 10.1177/0002716296545001010
   Long M., 1995, PUBLIC UNDERST SCI, V4, P119
   Luber G., 2014, CLIMATE CHANGE IMPAC, P220, DOI DOI 10.7930/J0PN93H5
   Mitchell A., 2016, MODERN NEWS CONSUMER
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Neuwirth K, 2000, RISK ANAL, V20, P721, DOI 10.1111/0272-4332.205065
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   Reynolds B, 2005, J HEALTH COMMUN, V10, P43, DOI 10.1080/10810730590904571
   Riffe D., 1998, ANAL MEDIA MESSAGES
   RIPPETOE PA, 1987, J PERS SOC PSYCHOL, V52, P596, DOI 10.1037/0022-3514.52.3.596
   Roberto A. J., 2009, HDB RISK CRISIS COMM, P287
   Roche JP, 2003, SCI COMMUN, V24, P353, DOI 10.1177/1075547002250300
   Savoia E, 2013, BIOSECUR BIOTERROR, V11, P170, DOI 10.1089/bsp.2013.0038
   Seeger MW, 2006, J APPL COMMUN RES, V34, P232, DOI 10.1080/00909880600769944
   Slater MD, 2007, COMMUN RES, V34, P355, DOI 10.1177/0093650207302783
   Slater Michael D, 2015, Commun Yearb, V39, P3
   Slater MD, 2009, J HEALTH COMMUN, V14, P262, DOI 10.1080/10810730902805838
   Slater MD, 2009, J COMMUN, V59, P117, DOI 10.1111/j.1460-2466.2008.01407.x
   Smith RA, 2007, HEALTH COMMUN, V21, P55, DOI 10.1080/10410230701283389
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Tabachnick B.G., 2007, USING MULTIVARIATE S
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   Tuggle CA, 2001, J BROADCAST ELECTRON, V45, P335, DOI 10.1207/s15506878jobem4502_9
   Turner MM, 2013, RISK MANAG-UK, V15, P79, DOI 10.1057/rm.2012.13
   Ulmer R. R., 2007, EFFECTIVE CRISIS COM
   Valenti J, 1995, PUBLIC UNDERST SCI, V4, P177, DOI DOI 10.1088/0963-6625/4/2/005
   Veil SR, 2010, COMMUN STUD, V61, P412, DOI 10.1080/10510974.2010.491336
   Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506
   Witte K, 1996, J Health Commun, V1, P317, DOI 10.1080/108107396127988
   WITTE K, 1992, COMMUN MONOGR, V59, P329, DOI 10.1080/03637759209376276
   WITTE K, 1994, COMMUN MONOGR, V61, P113, DOI 10.1080/03637759409376328
   World Health Organization, 2018, MICR FACT SHEET
   Zhang Ll, 2015, ATL J COMMUN, V23, P67, DOI 10.1080/15456870.2015.1013101
NR 63
TC 0
Z9 0
U1 4
U2 4
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1057-0314
EI 1745-1027
J9 WESTERN J COMM
JI West. J. Commun.
DI 10.1080/10570314.2020.1755721
EA MAY 2020
PG 18
WC Communication
SC Communication
GA LO0YV
UT WOS:000533356400001
DA 2020-07-08
ER

PT J
AU Kalimuthu, K
   Tseng, LC
   Murugan, K
   Panneerselvam, C
   Aziz, AT
   Benelli, G
   Hwang, JS
AF Kalimuthu, Kandasamy
   Tseng, Li-Chun
   Murugan, Kadarkarai
   Panneerselvam, Chellasamy
   Aziz, Al Thabiani
   Benelli, Giovanni
   Hwang, Jiang-Shiou
TI Ultrasonic Technology Applied against Mosquito Larvae
SO APPLIED SCIENCES-BASEL
LA English
DT Article
DE mosquito control; ultrasound; electromagnetic control; biological
   control; Aedes aegypti; Megacyclops formosanus; biosafety
ID VETERINARY IMPORTANCE; DENGUE; CELLS; ZIKA; CHIKUNGUNYA; CHALLENGES;
   APOPTOSIS; DISEASES; VECTORS; IMPACT
AB The effective management of mosquito vectors is a timely challenge for medical and veterinary entomology. In this study, we evaluated the acoustic Larvasonic device to control young instars of the mosquito Aedes aegypti in diverse freshwater environments. Under laboratory conditions, we investigated the effect of exposure time and distance from the transducer on the mortality of larvae and pupae of Ae. aegypti. Furthermore, we evaluated the effectiveness of the ultrasound window of the electromagnetic spectrum under different field conditions. Results showed that first and second instar larvae were more sensitive to the frequency range of 18-30 kHz of the Larvasonic device. Ultrasonic waves applied for 180 s at a frequency from 18 to 30 kHz caused 100% larval mortality at a distance of 60 cm from the transducer. No mortality was observed in the non-target copepod Megacyclops formosanus. The exposure to the soundwaves produced by the acoustic larvicidal device over different distances effectively damaged Ae. aegypti through destruction of the larval dorsal tracheal trunk, thorax and abdomen. Overall, results indicated that the Larvasonic device tested can provide an alternative tool to reduce young instar populations of Ae. aegypti, without any effects on non-target aquatic invertebrates like copepods. It turned out to be a useful device for mosquito biocontrol. This technology has a relevant potential to fight the spread of mosquito-borne diseases.
C1 [Kalimuthu, Kandasamy; Tseng, Li-Chun; Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.
   [Murugan, Kadarkarai] Bharathiar Univ, Sch Life Sci, Div Entomol, Dept Zool, Coimbatore 641046, Tamil Nadu, India.
   [Panneerselvam, Chellasamy; Aziz, Al Thabiani] Univ Tabuk, Dept Biol, Fac Sci, Tabuk 71491, Saudi Arabia.
   [Benelli, Giovanni] Univ Pisa, Dept Agr Food & Environm, Via Borghetto 80, I-56124 Pisa, Italy.
   [Hwang, Jiang-Shiou] Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan.
RP Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Inst Marine Biol, Keelung 20224, Taiwan.; Hwang, JS (corresponding author), Natl Taiwan Ocean Univ, Ctr Excellence Oceans, Keelung 20224, Taiwan.
EM biokalimuthu@gmail.com; lichun@mail.bestredeye.org; kmvvkg@gmail.com;
   cpselva@ymail.com; aalthbyani@ut.edu.sa; giovanni.benelli@unipi.it;
   jshwang@mail.ntou.edu.tw
OI Hwang, Jiang-Shiou/0000-0003-4881-1163
FU Ministry of Science and Technology (MOST) of TaiwanMinistry of Science
   and Technology, Taiwan [MOST 104-2611-M-019-004, MOST
   105-2621-M-019-001, MOST 105-2918-I-019-001, MOST 106-2621-M-019-001,
   MOST 107-2621-M-019-001, MOST 108-2621-M-019-003, MOST
   104-2811-M-019-005, MOST 105-2811-M-019-008, MOST 107-2811-M-019-004,
   MOST 108-2811-M-019-504]
FX The authors are grateful for financial support from the Ministry of
   Science and Technology (MOST) of Taiwan through grant no. MOST
   104-2611-M-019-004, MOST 105-2621-M-019-001, MOST 105-2918-I-019-001,
   MOST 106-2621-M-019-001, MOST 107-2621-M-019-001 and MOST
   108-2621-M-019-003 to J.-S. Hwang, as well as the grant no. MOST
   104-2811-M-019-005, MOST 105-2811-M-019-008, MOST 107-2811-M-019-004 and
   MOST 108-2811-M-019-504 to L.-C. Tseng. The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ashush H, 2000, CANCER RES, V60, P1014
   Awasthi AK, 2015, HYDROBIOLOGIA, V749, P113, DOI 10.1007/s10750-014-2154-4
   Awasthi AK, 2012, ZOOL STUD, V51, P927
   Awasthi AK, 2012, ZOOL STUD, V51, P1225
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosworth BG, 2001, J ANIM SCI, V79, P1483
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Britch SC, 2016, J AM MOSQUITO CONTR, V32, P341, DOI 10.2987/16-6606.1
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cisneros F, 1996, J ANIM SCI, V74, P2566
   Colucci L.A., 2010, AWPD, V7, P1
   Dhanker R, 2013, HYDROBIOLOGIA, V716, P147, DOI 10.1007/s10750-013-1559-9
   Donskoy D.M., 1995, 5 INT ZEBR MUSS OTH, P103
   Emenheiser JC, 2010, J ANIM SCI, V88, P2932, DOI 10.2527/jas.2009-2661
   Farhat A., 2009, Research Journal of Agriculture and Biological Sciences, V5, P731
   Fernandes JN, 2018, TRENDS PARASITOL, V34, P359, DOI 10.1016/j.pt.2018.01.005
   FOSTER WA, 1985, J AM MOSQUITO CONTR, V1, P199
   Fredregill CL, 2015, J AM MOSQUITO CONTR, V31, P366, DOI 10.2987/8756-971X-31.4.366
   FRINGS H, 1948, Pest Control, V16, P9
   Gomez Olmedilla D., 2012, THESIS
   Hawkes FM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17632-3
   Jameson E, 2016, WESTERN HIST QUART, V47, P1, DOI 10.1093/whq/whv041
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kleczek K, 2009, ARCH TIERZUCHT, V52, P538
   Lagneaux L, 2002, EXP HEMATOL, V30, P1293, DOI 10.1016/S0301-472X(02)00920-7
   LaLiberte Gina, 2014, Wisconsin Department of Natural Resources Research Report, V195, P1
   Lambert B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22712-z
   Lee SJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23980-5
   Ma BZ, 2005, COLLOID SURFACE B, V41, P197, DOI 10.1016/j.colsurfb.2004.12.010
   Madge BA, 2002, WATER ENVIRON RES, V74, P159, DOI 10.2175/106143002X139875
   Mankin R. W., 2012, CAB Reviews, V7, P1, DOI 10.1079/PAVSNNR20127001
   Mason TJ, 2000, ULTRASON SONOCHEM, V7, P145, DOI 10.1016/S1350-4177(99)00041-3
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Mehier-Humbert S, 2005, ADV DRUG DELIVER REV, V57, P733, DOI 10.1016/j.addr.2004.12.007
   MILLER DL, 1983, ENVIRON EXP BOT, V23, P1, DOI 10.1016/0098-8472(83)90017-5
   Mohankumar D., 2010, ULTRASOUND INSECTS
   Morlein D, 2005, MEAT SCI, V69, P187, DOI 10.1016/j.meatsci.2004.06.011
   Murugan K, 2016, PARASITOL RES, V115, P651, DOI 10.1007/s00436-015-4783-6
   Naqqash MN, 2016, PARASITOL RES, V115, P1363, DOI 10.1007/s00436-015-4898-9
   Nyberg Herbert J, 2020, Sci Rep, V10, P2378, DOI 10.1038/s41598-020-59321-8
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   QURAISHI MS, 1963, J ECON ENTOMOL, V56, P668, DOI 10.1093/jee/56.5.668
   Rajasekhar P, 2012, WATER RES, V46, P1473, DOI 10.1016/j.watres.2011.11.017
   Schwab SR, 2018, EPIDEMICS-NETH, V23, P55, DOI 10.1016/j.epidem.2017.12.004
   Stelzleni AM, 2002, J ANIM SCI, V80, P3150
   Sueur J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021089
   Suresh U, 2018, PHYSIOL MOL PLANT P, V101, P225, DOI 10.1016/j.pmpp.2017.01.002
   Tang JW, 2004, COLLOID SURFACE B, V36, P115, DOI 10.1016/j.col.surfb.2004.06.003
   Tian ZM, 2005, ULTRASOUND MED BIOL, V31, P121, DOI 10.1016/j.ultrasmedbio.2004.09.008
   Uteshev VK, 2006, BIOFIZIKA+, V51, P539
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Zar J. H., 1999, BIOSTATISTICAL ANAL
   Zhang GM, 2006, ULTRASON SONOCHEM, V13, P501, DOI 10.1016/j.ultsonch.2005.11.001
NR 58
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-3417
J9 APPL SCI-BASEL
JI Appl. Sci.-Basel
PD MAY
PY 2020
VL 10
IS 10
DI 10.3390/app10103546
PG 15
WC Chemistry, Multidisciplinary; Engineering, Multidisciplinary; Materials
   Science, Multidisciplinary; Physics, Applied
SC Chemistry; Engineering; Materials Science; Physics
GA LZ7ZE
UT WOS:000541440000207
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Ekins, S
   Mottin, M
   Ramos, PRPS
   Sousa, BKP
   Neves, B
   Foil, DH
   Zorn, KM
   Braga, RC
   Coffee, M
   Southan, C
   Puhl, AC
   Andrade, CH
AF Ekins, Sean
   Mottin, Melina
   Ramos, Paulo R. P. S.
   Sousa, Bruna K. P.
   Junior Neves, Bruno
   Foil, Daniel H.
   Zorn, Kimberley M.
   Braga, Rodolpho C.
   Coffee, Megan
   Southan, Christopher
   Puhl, Ana C.
   Andrade, Carolina Horta
TI Deja vu: Stimulating open drug discovery for SARS-CoV-2
SO DRUG DISCOVERY TODAY
LA English
DT Review
ID RESPIRATORY SYNDROME CORONAVIRUS; ACCURATE DOCKING; BINDING; GLIDE;
   MODEL; SPIKE; INHIBITORS; PROTEASE; DOMAIN
AB In the past decade we have seen two major Ebola virus outbreaks in Africa, the Zika virus in Brazil and the Americas and the current pandemic of coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). There is a strong sense of deja vu because there are still no effective treatments. In the COVID-19 pandemic, despite being a new virus, there are already drugs suggested as active in in vitro assays that are being repurposed in clinical trials. Promising SARS-CoV-2 viral targets and computational approaches are described and discussed. Here, we propose, based on open antiviral drug discovery approaches for previous outbreaks, that there could still be gaps in our approach to drug discovery.
C1 [Ekins, Sean; Foil, Daniel H.; Zorn, Kimberley M.; Puhl, Ana C.] Collaborat Pharmaceut, 840 Main Campus Dr,Lab 3510, Raleigh, NC 27606 USA.
   [Mottin, Melina; Ramos, Paulo R. P. S.; Sousa, Bruna K. P.; Junior Neves, Bruno; Andrade, Carolina Horta] Univ Fed Goias, Fac Farm, LabMol Lab Mol Modeling & Drug Design, BR-74605170 Goiania, Go, Brazil.
   [Braga, Rodolpho C.] InsilicAll, BR-04363090 Sao Paulo, SP, Brazil.
   [Coffee, Megan] NYU, Dept Med, Div Infect Dis & Immunol, New York, NY 10003 USA.
   [Coffee, Megan] Columbia Univ, Mailman Sch Publ Hlth, Dept Populat & Family Hlth, New York, NY 10027 USA.
   [Southan, Christopher] TW2Informatics Ltd, S-42166 Gothenburg, Sweden.
   [Andrade, Carolina Horta] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, BR-13083864 Campinas, SP, Brazil.
RP Ekins, S (corresponding author), Collaborat Pharmaceut, 840 Main Campus Dr,Lab 3510, Raleigh, NC 27606 USA.
EM sean@collaborationspharma.com
RI Braga, Rodolpho/A-9655-2011
OI Braga, Rodolpho/0000-0003-3814-3464; Foil, Daniel/0000-0003-0512-8997
FU NIH from NCATS [R21TR001718]; NIH from NIGMS [R44GM122196-02A1];
   Brazilian funding agency CNPqNational Council for Scientific and
   Technological Development (CNPq); Brazilian funding agency FAPEG;
   Brazilian funding agency CAPESCAPES [001]; Brazilian CNPq/FAPEG
   [300508/2017-4]; L'Oreal-UNESCOABC Para Mulheres na Ciencia;
   L'Oreal-UNESCO International Rising Talents
FX We kindly acknowledge NIH funding: R21TR001718 from NCATS and
   R44GM122196-02A1 from NIGMS (PI-Sean Ekins). We also acknowledge
   Brazilian funding agencies, CNPq, FAPEG and CAPES (Finance Code 001) for
   the financial support and fellowships. M. M. and C.H.A. thank the
   support of the Brazilian CNPq/FAPEG (grant 300508/2017-4). C.H.A. also
   thanks the 'L'Oreal-UNESCOABC Para Mulheres na Ciencia' and
   'L'Oreal-UNESCO International Rising Talents' for the awards and
   fellowships received, which partially funded this work. C.H.A. is CNPq
   research fellow. We kindly acknowledge the support and encouragement of
   the IBM World Community Grid team, and the community of volunteers who
   donate their dormant computer power for our docking calculations. S.E.
   kindly thanks Biovia for providing Discovery Studio and the many
   collaborators on our Ebola and Zika projects. S.E. acknowledges Dr Alex
   Clark (Molecular Materials Informatics) for assistance with Assay
   Central<SUP>TM</SUP>.
CR Anantpadma M, 2019, ACS OMEGA, V4, P2353, DOI 10.1021/acsomega.8b02948
   Andrade CH, 2019, CURR MED CHEM, V26, P4355, DOI 10.2174/0929867325666180309114824
   Bajema KL, 2020, MMWR-MORBID MORTAL W, V69, P166, DOI 10.15585/mmwr.mm6906e1
   Barratt JLN, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007609
   Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340
   Chong CR, 2007, NATURE, V448, P645, DOI 10.1038/448645a
   Chou CY, 2004, BIOCHEMISTRY-US, V43, P14958, DOI 10.1021/bi0490237
   Coleman CM, 2016, J VIROL, V90, P8924, DOI 10.1128/JVI.01429-16
   de Wilde AH, 2014, ANTIMICROB AGENTS CH, V58, P4875, DOI 10.1128/AAC.03011-14
   de Wit E, 2020, P NATL ACAD SCI USA, V117, P6771, DOI 10.1073/pnas.1922083117
   Dyall J, 2017, DRUGS, V77, P1935, DOI [10.1007/s40265-017-0830-1, DOI 10.1007/S40265-017-0830-1]
   Dyall J, 2014, ANTIMICROB AGENTS CH, V58, P4885, DOI 10.1128/AAC.03036-14
   Ekins S, 2015, F1000RES, V48, P4
   Ekins S, 2019, NAT MATER, V18, P435, DOI 10.1038/s41563-019-0338-z
   Ekins S, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01711-17
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P275
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Ekins Sean, 2015, F1000Res, V4, P1091, DOI 10.12688/f1000research.7217.1
   Ekins Sean, 2015, F1000Res, V4, P58, DOI 10.12688/f1000research.6181.1
   Ekins Sean, 2014, F1000Res, V3, P277, DOI 10.12688/f1000research.5741.2
   Ekins S, 2011, DRUG DISCOV TODAY, V16, P298, DOI 10.1016/j.drudis.2011.02.016
   FDA, 2019, CASE MED RES, DOI DOI 10.31525/CMR-24AB0C1
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Furuyama W, 2019, ANNU REV VIROL, V6, P435, DOI 10.1146/annurev-virology-092818-015708
   Gignoux E, 2016, NEW ENGL J MED, V374, P23, DOI 10.1056/NEJMoa1504605
   Gorbalenya A.E., 2020, SEVERE ACUTE RESP SY, DOI [DOI 10.1101/2020.02.07.937862, 10.1101/2020.02.07.937862]
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200
   Jesus J.G., 2020, 1 REPORT COVID 19 S
   Kankanamalage ACG, 2018, EUR J MED CHEM, V150, P334, DOI 10.1016/j.ejmech.2018.03.004
   Lane TR, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01142-19
   Li CC, 2019, DRUG DISCOV TODAY, V24, P726, DOI 10.1016/j.drudis.2019.01.018
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li H, 2020, Zhonghua Jie He He Hu Xi Za Zhi, V43, pE002, DOI 10.3760/cma.j.issn.1001-0939.2020.0002
   Lim J, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e79
   Litterman Nadia, 2015, F1000Res, V4, P38, DOI 10.12688/f1000research.6120.1
   Liu J, 2020, J MED VIROL, V92, P491, DOI 10.1002/jmv.25709
   Liu X., 2020, CRYSTAL STRUCTURE CO
   Lu HZ, 2020, BIOSCI TRENDS, V14, P69, DOI 10.5582/bst.2020.01020
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Momattin H, 2019, TRAVEL MED INFECT DI, V30, P9, DOI 10.1016/j.tmaid.2019.06.012
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nishiura H, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020488
   Pan YY, 2020, EUR RADIOL, V30, P3306, DOI 10.1007/s00330-020-06731-x
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   Russo DP, 2018, MOL PHARMACEUT, V15, P4361, DOI 10.1021/acs.molpharmaceut.8b00546
   Schrodinger, 2015, PYMOL MOL GRAPH SYST
   Shi JH, 2004, J BIOL CHEM, V279, P24765, DOI 10.1074/jbc.M311744200
   Silva S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54169-z
   Sisk JM, 2015, ACS INFECT DIS, V1, P401, DOI 10.1021/acsinfecdis.5b00089
   Smith N, 2020, AM J PUBLIC HEALTH, V110, P648, DOI 10.2105/AJPH.2020.305618
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Stoermer M., 2020, HOMOLOGY MODELS WUHA
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Xu XT, 2020, SCI CHINA LIFE SCI, V63, P457, DOI 10.1007/s11427-020-1637-5
   Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07
   Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100
   Yuan S, 2015, MBIO, V6, DOI 10.1128/mBio.01120-15
   Zhang C., 2020, STRUCTURE MODELS ALL
   Zhang H., 2020, DEEP LEARNING BASED, DOI DOI 10.20944/PREPRINTS202002.0061.V1
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhang LL, 2020, SCIENCE, V368, P409, DOI 10.1126/science.abb3405
   Zhu Y., 2020, CRYSTAL STRUCTURE HR
   Ziebuhr J, 2003, J VIROL, V77, P1415, DOI 10.1128/JVI.77.2.1415-1426.2003
   Zorn KM, 2019, MOL PHARMACEUT, V16, P1620, DOI 10.1021/acs.molpharmaceut.8b01297
NR 73
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1359-6446
EI 1878-5832
J9 DRUG DISCOV TODAY
JI Drug Discov. Today
PD MAY
PY 2020
VL 25
IS 5
BP 928
EP 941
DI 10.1016/j.drudis.2020.03.019
PG 14
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA MA2LV
UT WOS:000541749200014
PM 32320852
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Mancini, MV
   Damiani, C
   Short, SM
   Cappelli, A
   Ulissi, U
   Capone, A
   Serrao, A
   Rossi, P
   Amici, A
   Kalogris, C
   Dimopoulos, G
   Ricci, I
   Favia, G
AF Mancini, Maria Vittoria
   Damiani, Claudia
   Short, Sarah M.
   Cappelli, Alessia
   Ulissi, Ulisse
   Capone, Aida
   Serrao, Aurelio
   Rossi, Paolo
   Amici, Augusto
   Kalogris, Cristina
   Dimopoulos, George
   Ricci, Irene
   Favia, Guido
TI Inhibition of Asaia in Adult Mosquitoes Causes Male-Specific Mortality
   and Diverse Transcriptome Changes
SO PATHOGENS
LA English
DT Article
DE Asaia; Anopheles; symbiont
ID PURINE BIOSYNTHESIS; ANOPHELES; PLASMODIUM; BACTERIA; PROTEINS
AB Mosquitoes can transmit many infectious diseases, such as malaria, dengue, Zika, yellow fever, and lymphatic filariasis. Current mosquito control strategies are failing to reduce the severity of outbreaks that still cause high human morbidity and mortality worldwide. Great expectations have been placed on genetic control methods. Among other methods, genetic modification of the bacteria colonizing different mosquito species and expressing anti-pathogen molecules may represent an innovative tool to combat mosquito-borne diseases. Nevertheless, this emerging approach, known as paratransgenesis, requires a detailed understanding of the mosquito microbiota and an accurate characterization of selected bacteria candidates. The acetic acid bacteria Asaia is a promising candidate for paratransgenic approaches. We have previously reported that Asaia symbionts play a beneficial role in the normal development of Anopheles mosquito larvae, but no study has yet investigated the role(s) of Asaia in adult mosquito biology. Here we report evidence on how treatment with a highly specific anti-Asaia monoclonal antibody impacts the survival and physiology of adult Anopheles stephensi mosquitoes. Our findings offer useful insight on the role of Asaia in several physiological systems of adult mosquitoes, where the influence differs between males and females.
C1 [Mancini, Maria Vittoria; Damiani, Claudia; Cappelli, Alessia; Ulissi, Ulisse; Capone, Aida; Serrao, Aurelio; Rossi, Paolo; Amici, Augusto; Kalogris, Cristina; Ricci, Irene; Favia, Guido] Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy.
   [Mancini, Maria Vittoria] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
   [Damiani, Claudia; Cappelli, Alessia; Serrao, Aurelio; Rossi, Paolo; Ricci, Irene; Favia, Guido] Ctr Interuniv Ric Malaria, Italian Malaria Network, Milan, Italy.
   [Short, Sarah M.] Ohio State Univ, Dept Entomol, 1735 Neil Ave, Columbus, OH 43210 USA.
   [Short, Sarah M.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
RP Favia, G (corresponding author), Univ Camerino, Sch Biosci & Vet Med, I-62032 Camerino, Italy.; Favia, G (corresponding author), Ctr Interuniv Ric Malaria, Italian Malaria Network, Milan, Italy.
EM MariaVittoria.Mancini@glasgow.ac.uk; claudia.damiani@unicam.it;
   short343@osu.edu; alessia.cappelli@unicam.it; ulisse.ulissi@unicam.it;
   aida.capone@unicam.it; aurelio.serrao@unicam.it; paolo.rossi@unicam.it;
   augusto.amici@unicam.it; cristina.kalogris@unicam.it; gdimopo1@jhu.edu;
   irene.ricci@unicam.it; guido.favia@unicam.it
FU Italian Ministry for Education and Research (MIUR)Ministry of Education,
   Universities and Research (MIUR) [PRIN 2012-2012T85B3R, PRIN
   2015-JXC3JF]; University of Camerino [FAR2015]; Ruth L. Kirschstein
   National Research Service AwardUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
   [F32AI112208-01A1]; Bloomberg Philanthropies
FX This work was supported by the Italian Ministry for Education and
   Research (MIUR), awards numbers PRIN 2012-2012T85B3R and PRIN
   2015-JXC3JF, both to G.F., and by the University of Camerino, award
   number FAR2015 to G.F., by the Bloomberg Philanthropies, and S.M.S. was
   supported by a Ruth L. Kirschstein National Research Service Award
   F32AI112208-01A1.
CR Bongio NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143541
   Cappelli A, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00836
   Cheng JZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-337
   Chouaia B, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S2
   Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831
   Danielli A, 2003, J BIOL CHEM, V278, P4184, DOI 10.1074/jbc.M208187200
   Djadid ND, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028484
   Forthal D.N., 2015, ANTIB INFECT DIS, P23, DOI [10.1128/9781555817411.ch2, DOI 10.1128/9781555817411.CH2]
   Gendrin M, 2017, J INNATE IMMUN, V9, P333, DOI 10.1159/000452797
   Gonella E, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00795
   Kanost MR, 2015, CURR OPIN INSECT SCI, V11, P47, DOI 10.1016/j.cois.2015.09.003
   KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868
   Kim JK, 2014, APPL ENVIRON MICROB, V80, P4374, DOI 10.1128/AEM.00739-14
   Kim JK, 2014, ISME J, V8, P552, DOI 10.1038/ismej.2013.168
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3
   Mitraka E, 2013, PATHOG GLOB HEALTH, V107, P305, DOI 10.1179/2047773213Y.0000000106
   Norris EJ, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020124
   Pike A, 2014, INSECT BIOCHEM MOLEC, V52, P82, DOI 10.1016/j.ibmb.2014.06.005
   Pondeville E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079861
   Povelones M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003623
   Ramsey JS, 2010, INSECT MOL BIOL, V19, P241, DOI 10.1111/j.1365-2583.2009.00945.x
   Ricci I, 2012, PATHOG GLOB HEALTH, V106, P380, DOI 10.1179/2047773212Y.0000000051
   Ricci I, 2012, CURR OPIN MICROBIOL, V15, P278, DOI 10.1016/j.mib.2012.03.004
   Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008
   Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Short SM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005677
   Sierralta J, 2004, BRAIN RES REV, V47, P105, DOI 10.1016/j.brainresrev.2004.06.002
   Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5
   Vogel H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15186
   Yassine H, 2014, J INNATE IMMUN, V6, P806, DOI 10.1159/000363296
NR 32
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAY
PY 2020
VL 9
IS 5
AR 380
DI 10.3390/pathogens9050380
PG 10
WC Microbiology
SC Microbiology
GA LZ8AP
UT WOS:000541443700063
PM 32429180
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Manuel, M
   Misse, D
   Pompon, J
AF Manuel, Menchie
   Misse, Dorothee
   Pompon, Julien
TI Highly Efficient Vertical Transmission for Zika Virus in Aedes aegypti
   after Long Extrinsic Incubation Time
SO PATHOGENS
LA English
DT Article
DE Zika virus; Aedes aegypti; vertical transmission
ID TRANS-OVARIAL TRANSMISSION; YELLOW-FEVER VIRUS; DENGUE VIRUSES;
   DIPTERA-CULICIDAE; MOSQUITOS; GENERATIONS; ALBOPICTUS; INFECTION
AB While the Zika virus (ZIKV) 2014-2017 pandemic has subsided, there remains active transmission. Apart from horizontal transmission to humans, the main vector Aedes aegypti can transmit the virus vertically from mother to offspring. Large variation in vertical transmission (VT) efficiency between studies indicates the influence of parameters, which remain to be characterized. To determine the roles of extrinsic incubation time and gonotrophic cycle, we deployed an experimental design that quantifies ZIKV in individual progeny and larvae. We observed an early infection of ovaries that exponentially progressed. We quantified VT rate, filial infection rate, and viral load per infected larvae at 10 days post oral infection (d.p.i.) on the second gonotrophic cycle and at 17 d.p.i. on the second and third gonotrophic cycle. As compared to previous reports that studied pooled samples, we detected a relatively high VT efficiency from 1.79% at 10 d.p.i. and second gonotrophic cycle to 66% at 17 d.p.i. and second gonotrophic cycle. At 17 d.p.i., viral load largely varied and averaged around 800 genomic RNA (gRNA) copies. Longer incubation time and fewer gonotrophic cycles promoted VT. These results shed light on the mechanism of VT, how environmental conditions favor VT, and whether VT can maintain ZIKV circulation.
C1 [Manuel, Menchie; Pompon, Julien] Duke NUS Med Sch, Dept Emerging Infect Dis, Singapore 169857, Singapore.
   [Misse, Dorothee; Pompon, Julien] Univ Montpellier, CNRS, MIVEGEC, IRD, F-34394 Montpellier, France.
RP Pompon, J (corresponding author), Duke NUS Med Sch, Dept Emerging Infect Dis, Singapore 169857, Singapore.; Pompon, J (corresponding author), Univ Montpellier, CNRS, MIVEGEC, IRD, F-34394 Montpellier, France.
EM menchie.manuel@duke-nus.edu.sg; dorothee.misse@ird.fr;
   Julien.pompon@ird.fr
RI ; Misse, Dorothee/A-7590-2012
OI Pompon, Julien/0000-0003-1110-9039; Misse, Dorothee/0000-0002-6485-3841
FU National Medical Research Council of SingaporeNational Medical Research
   Council, Singapore [NMRC/ZRRF/0007/2017]; Ministry of Education,
   SingaporeMinistry of Education, Singapore [MOE2015-T3-1-003]; Agency for
   Science, Technology, and Research (A*Star), SingaporeAgency for Science
   Technology & Research (ASTAR); Ministry of Health, SingaporeMinistry of
   Health-Singapore
FX This research was funded by the National Medical Research Council of
   Singapore (NMRC/ZRRF/0007/2017) and the Ministry of Education, Singapore
   (MOE2015-T3-1-003). Support was also received through a Zika response
   allocation from the Duke-NUS Signature Research Program funded by the
   Agency for Science, Technology, and Research (A*Star), Singapore, and
   the Ministry of Health, Singapore.
CR Adams B, 2010, EPIDEMICS-NETH, V2, P1, DOI 10.1016/j.epidem.2010.01.001
   Anderson JF, 2008, J MED ENTOMOL, V45, P445, DOI 10.1603/0022-2585(2008)45[445:EIPFHA]2.0.CO;2
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   BEATY BJ, 1980, AM J TROP MED HYG, V29, P125, DOI 10.4269/ajtmh.1980.29.125
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chadee DD, 2012, PATHOG GLOB HEALTH, V106, P413, DOI 10.1179/2047773212Y.0000000036
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   Clements A.N., 1992, BIOL MOSQUITOES DEV
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Day JF, 2016, INSECTS, V7, DOI 10.3390/insects7040065
   Diallo M, 2000, AM J TROP MED HYG, V62, P151, DOI 10.4269/ajtmh.2000.62.151
   European Center for Disease Prevention and Control, 2019, ZIK VIR TRANSM WORLD
   Felix GE, 2018, J AM MOSQUITO CONTR, V34, P233, DOI 10.2987/18-6741.1
   FREIER JE, 1988, AM J TROP MED HYG, V39, P218, DOI 10.4269/ajtmh.1988.39.218
   Grunnill M, 2016, J MED ENTOMOL, V53, P1, DOI 10.1093/jme/tjv168
   Gutierrez-Bugallo G, 2019, NAT ECOL EVOL, V3, P561, DOI 10.1038/s41559-019-0836-z
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Hernandez-Triana LM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3467-y
   Higgs S., 2004, BIOL DIS VECTORS
   Joshi V, 2002, AM J TROP MED HYG, V67, P158, DOI 10.4269/ajtmh.2002.67.158
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lequime S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005548
   Lequime S, 2014, INFECT GENET EVOL, V28, P681, DOI 10.1016/j.meegid.2014.07.025
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Maia LMS, 2019, MED VET ENTOMOL, V33, P437, DOI 10.1111/mve.12369
   Maniero VC, 2019, BRAZ J MED BIOL RES, V52, DOI [10.1590/1414-431X20198339, 10.1590/1414-431x20198339]
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Phumee A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41727-8
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   Rohani A., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P813
   ROSEN L, 1983, AM J TROP MED HYG, V32, P1108, DOI 10.4269/ajtmh.1983.32.1108
   ROSEN L, 1988, AM J TROP MED HYG, V39, P123, DOI 10.4269/ajtmh.1988.39.123
   Salazar MI, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-9
   Sanchez-Vargas Irma, 2018, PLoS Negl Trop Dis, V12, pe0006754, DOI 10.1371/journal.pntd.0006754
   SHROYER DA, 1990, J AM MOSQUITO CONTR, V6, P312
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   Tesh R.B., 1984, CURRENT TOPICS VECTO
   Turell M.J., 1988, ARBOVIRUSES EPIDEMIO
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wong J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001015
   Zimler RA, 2019, J MED ENTOMOL, V56, P341, DOI 10.1093/jme/tjy231
NR 42
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAY
PY 2020
VL 9
IS 5
AR 366
DI 10.3390/pathogens9050366
PG 12
WC Microbiology
SC Microbiology
GA LZ8AP
UT WOS:000541443700049
PM 32403319
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Soriano-Arandes, A
   Frick, MA
   Lopez-Hortelano, MG
   Sulleiro, E
   Rodo, C
   Sanchez-Seco, MP
   Cabrera-Lafuente, M
   Suy, A
   De la Calle, M
   Santos, M
   Antolin, E
   Vinuela, MD
   Espiau, M
   Salazar, A
   Guarch-Ibanez, B
   Vazquez, A
   Navarro-Moron, J
   Ramos-Amador, JT
   Martin-Nalda, A
   Duenas, E
   Blazquez-Gamero, D
   Reques-Cosme, R
   Olabarrieta, I
   Prieto, L
   De Ory, F
   Thorne, C
   Byrne, T
   Ades, AE
   Ruiz-Burga, E
   Giaquinto, C
   Mellado-Pena, MJ
   Garcia-Alix, A
   Carreras, E
   Soler-Palacin, P
AF Soriano-Arandes, Antoni
   Antoinette Frick, Marie
   Garcia Lopez-Hortelano, Milagros
   Sulleiro, Elena
   Rodo, Carlota
   Paz Sanchez-Seco, Maria
   Cabrera-Lafuente, Marta
   Suy, Anna
   De la Calle, Maria
   Santos, Mar
   Antolin, Eugenia
   del Carmen Vinuela, Maria
   Espiau, Maria
   Salazar, Ainara
   Guarch-Ibanez, Borja
   Vazquez, Ana
   Navarro-Moron, Juan
   Ramos-Amador, Jose-Tomas
   Martin-Nalda, Andrea
   Duenas, Eva
   Blazquez-Gamero, Daniel
   Reques-Cosme, Resurreccion
   Olabarrieta, Iciar
   Prieto, Luis
   De Ory, Fernando
   Thorne, Claire
   Byrne, Thomas
   Ades, Anthony E.
   Ruiz-Burga, Elisa
   Giaquinto, Carlo
   Jose Mellado-Pena, Maria
   Garcia-Alix, Alfredo
   Carreras, Elena
   Soler-Palacin, Pere
TI Clinical Outcomes of a Zika Virus Mother-Child Pair Cohort in Spain
SO PATHOGENS
LA English
DT Article
DE zika virus; microcephaly; congenital infection; adverse outcome;
   arboviruses
ID INFECTION; INFANTS
AB Background: Zika virus (ZIKV) infection has been associated with congenital microcephaly and other neurodevelopmental abnormalities. There is little published research on the effect of maternal ZIKV infection in a non-endemic European region. We aimed to describe the outcomes of pregnant travelers diagnosed as ZIKV-infected in Spain, and their exposed children. Methods: This prospective observational cohort study of nine referral hospitals enrolled pregnant women (PW) who travelled to endemic areas during their pregnancy or the two previous months, or those whose sexual partners visited endemic areas in the previous 6 months. Infants of ZIKV-infected mothers were followed for about two years. Results: ZIKV infection was diagnosed in 163 PW; 112 (70%) were asymptomatic and 24 (14.7%) were confirmed cases. Among 143 infants, 14 (9.8%) had adverse outcomes during follow-up; three had a congenital Zika syndrome (CZS), and 11 other potential Zika-related outcomes. The overall incidence of CZS was 2.1% (95%CI: 0.4-6.0%), but among infants born to ZIKV-confirmed mothers, this increased to 15.8% (95%CI: 3.4-39.6%). Conclusions: A nearly 10% overall risk of neurologic and hearing adverse outcomes was found in ZIKV-exposed children born to a ZIKV-infected traveler PW. Longer-term follow-up of these children is needed to assess whether there are any later-onset manifestations.
C1 [Soriano-Arandes, Antoni; Antoinette Frick, Marie; Espiau, Maria; Salazar, Ainara; Martin-Nalda, Andrea; Soler-Palacin, Pere] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Res Inst, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona 08035, Spain.
   [Garcia Lopez-Hortelano, Milagros; Jose Mellado-Pena, Maria] Hosp Univ La Paz, Dept Paediat, Madrid 28046, Spain.
   [Sulleiro, Elena] Hosp Univ Vall dHebron, Dept Microbiol, Barcelona 08035, Spain.
   [Rodo, Carlota; Suy, Anna; Carreras, Elena] Hosp Univ Vall dHebron, Dept Obstet, Unit Fetal Med, Barcelona 08035, Spain.
   [Paz Sanchez-Seco, Maria; Vazquez, Ana; De Ory, Fernando] Inst Salud Carlos III, Madrid 28029, Spain.
   [Cabrera-Lafuente, Marta] Hosp Univ La Paz, Dept Neonatol, Madrid 28046, Spain.
   [De la Calle, Maria; Antolin, Eugenia] Hosp Univ La Paz, Dept Obstet, Madrid 28046, Spain.
   [Santos, Mar; Duenas, Eva] Hosp Gen Univ Gregorio Maranon, Dept Paediat, Madrid 28009, Spain.
   [del Carmen Vinuela, Maria] Hosp Gen Univ Gregorio Maranon, Dept Obstet, Madrid 28009, Spain.
   [Guarch-Ibanez, Borja] Hosp Univ Josep Trueta, Dept Paediat, Girona 17007, Spain.
   [Navarro-Moron, Juan] Hosp Costa del Sol, Marbella 29603, Spain.
   [Ramos-Amador, Jose-Tomas] Hosp Univ Clin San Carlos, Dept Paediat, Madrid 28040, Spain.
   [Blazquez-Gamero, Daniel; Prieto, Luis] Hosp Univ 12 Octubre, Pediat Infect Dis Unit, Madrid, Spain.
   [Blazquez-Gamero, Daniel; Prieto, Luis] Univ Complutense, Imas12, Inst Invest Hosp 12 Octubre, Babol Sar 28041, Iran.
   [Reques-Cosme, Resurreccion] Hosp El Escorial, Madrid 28200, Spain.
   [Olabarrieta, Iciar] Hosp Severo Ochoa, Madrid 28911, Spain.
   [Thorne, Claire; Byrne, Thomas; Ruiz-Burga, Elisa] Univ Coll London Great Ormond St Inst Child Hlth, GOSH NIHR BRC, London WC1N 1EH, England.
   [Ades, Anthony E.] Univ Bristol, Bristol BS9 1AF, Avon, England.
   [Giaquinto, Carlo] Univ Padua, Dept Woman & Child Hlth, Div Pediat Infect Dis, I-35122 Padua, Italy.
   [Garcia-Alix, Alfredo] Fundacio NeNe, Madrid 28010, Spain.
RP Soriano-Arandes, A (corresponding author), Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Vall dHebron Res Inst, Paediat Infect Dis & Immunodeficiencies Unit, Barcelona 08035, Spain.
EM tsorianoarandes@gmail.com; mafrick@vhebron.net;
   mghortelano@salud.madrid.org; esulleir@vhebron.net; crodo@vhebron.net;
   paz.sanchez@isciii.es; mcabreral@salud.madrid.org; asuy@vhebron.net;
   mcallefm@gmail.com; marimarsantos5@gmail.com; eantolin@salud.madrid.org;
   mcvinuela73@hotmail.com; mespiau@vhebron.net; salazarainara2@gmail.com;
   borjaguarch@hotmail.com; a.vazquez@isciii.es; jnavarromoron@gmail.com;
   josetomas.ramos@salud.madrid.org; andmartin@vhebron.net;
   evadue9@gmail.com; danielblazquez@hotmail.com; resureques@hotmail.com;
   iciar.olabarrieta@gmail.com; luismanuel.prieto@salud.madrid.org;
   fory@isciii.es; claire.thorne@ucl.ac.uk; t.byrne@ucl.ac.uk;
   t.ades@bristol.ac.uk; e.burga@ucl.ac.uk; carlo.giaquinto@unipd.it;
   mariajose.mellado@salud.madrid.org; alfredoalix@gmail.com;
   ecarrera@vhebron.net; psoler@vhebron.net
RI ; Vazquez, Ana/H-4911-2013
OI Suy Franch, Anna/0000-0003-2987-6105; Garcia-Alix,
   Alfredo/0000-0002-7972-8453; De Ory, Fernando/0000-0002-6981-1261;
   Vazquez, Ana/0000-0002-9872-3316; Soriano Arandes,
   Antoni/0000-0001-9613-7228; Ruiz-Burga, Elisa/0000-0002-0529-0372
FU European Union's Horizon 2020 research and innovation programme [734857]
FX This work was supported by the European Union's Horizon 2020 research
   and innovation programme under grant agreement No 734857 (ZIKAction).
CR Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   [Anonymous], 2017, PROC MAN INF VIR ZIK
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Bermejo E, 2008, B ECEMC REV DISMORFO, V7, P58
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/AOG.0000000000002737, 10.1097/aog.0000000000002737]
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Escobar-Ipuz FA, 2019, INT J PEDIATR OTORHI, V127, DOI 10.1016/j.ijporl.2019.109647
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Marco J., 2003, LIBRO BLANCO HIPOACU
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Rodo C, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.02.008
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Werner H, 2017, J OBSTET GYNAECOL CA, V39, P1150, DOI 10.1016/j.jogc.2017.05.013
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
NR 26
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAY
PY 2020
VL 9
IS 5
AR 352
DI 10.3390/pathogens9050352
PG 14
WC Microbiology
SC Microbiology
GA LZ8AP
UT WOS:000541443700035
PM 32392815
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yen, PS
   Failloux, AB
AF Yen, Pei-Shi
   Failloux, Anna-Bella
TI A Review: Wolbachia-Based Population Replacement for Mosquito Control
   Shares Common Points with Genetically Modified Control Approaches
SO PATHOGENS
LA English
DT Review
DE mosquito control; replacement strategy; Wolbachia; environmental
   factors; arbovirus; viral adaptation
ID ANTIBODY-DEPENDENT ENHANCEMENT; AEDES-AEGYPTI; DENGUE VIRUS;
   YELLOW-FEVER; CHIKUNGUNYA VIRUS; BACTERIOPHAGE-WO; ZIKA VIRUS; ARBOVIRUS
   INFECTION; VECTOR COMPETENCE; USUTU VIRUS
AB The growing expansion of mosquito vectors has made mosquito-borne arboviral diseases a global threat to public health, and the lack of licensed vaccines and treatments highlight the urgent need for efficient mosquito vector control. Compared to genetically modified control strategies, the intracellular bacterium Wolbachia, endowing a pathogen-blocking phenotype, is considered an environmentally friendly strategy to replace the target population for controlling arboviral diseases. However, the incomplete knowledge regarding the pathogen-blocking mechanism weakens the reliability of a Wolbachia-based population replacement strategy. Wolbachia infections are also vulnerable to environmental factors, temperature, and host diet, affecting their densities in mosquitoes and thus the virus-blocking phenotype. Here, we review the properties of the Wolbachia strategy as an approach to control mosquito populations in comparison with genetically modified control methods. Both strategies tend to limit arbovirus infections but increase the risk of selecting arbovirus escape mutants, rendering these strategies less reliable.
C1 [Yen, Pei-Shi; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, F-75724 Paris, France.
RP Yen, PS; Failloux, AB (corresponding author), Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, F-75724 Paris, France.
EM pei-shi.yen@pasteur.fr; anna-bella.failloux@pasteur.fr
OI FAILLOUX, Anna-Bella/0000-0001-6890-0820; Yen,
   Pei-Shi/0000-0002-2113-7394
FU French Government's Investissement d'Avenir program, Laboratoire
   d'Excellence "Integrative Biology of Emerging Infectious Diseases,
   IBEID"French National Research Agency (ANR) [n_ANR-10-LABX-62-IBEID];
   National Health Research InstitutesNational Health Research Institutes,
   Japan [NHRI-PP-108-0324-01-17-07]
FX This study was funded by the French Government's Investissement d'Avenir
   program, Laboratoire d'Excellence "Integrative Biology of Emerging
   Infectious Diseases, IBEID" (grant n_ANR-10-LABX-62-IBEID) (A.-B.F.) and
   the National Health Research Institutes (NHRI-PP-108-0324-01-17-07)
   (P.-S.Y.).
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Ahmad NA, 2017, AM J TROP MED HYG, V96, P148, DOI 10.4269/ajtmh.16-0516
   ANDERSON CR, 1957, AM J TROP MED HYG, V6, P1012, DOI 10.4269/ajtmh.1957.6.1012
   Angelini R., 2007, EUROSURVEILLANCE, V12, DOI [DOI 10.2807/ESW.12.36.03260-EN, 10.2807/esw.12.36.03260-en]
   Ashraf U, 2015, VIRUSES-BASEL, V7, P219, DOI 10.3390/v7010219
   Balaji S, 2019, FEMS MICROBIOL LETT, V366, DOI 10.1093/femsle/fnz055
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Bennett KL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48414-8
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blair CD, 2011, FUTURE MICROBIOL, V6, P265, DOI [10.2217/FMB.11.11, 10.2217/fmb.11.11]
   Bonneau M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007364
   Bordenstein SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029106
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Buchman A, 2020, PLOS PATHOG, V16, DOI [10.1371/journal.ppat.1008103, 10.1371/journal.ppat.1008103.r001, 10.1371/journal.ppat.1008103.r002, 10.1371/journal.ppat.1008103.r003, 10.1371/journal.ppat.1008103.r004]
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Carballar-Lejarazu R, 2017, PATHOG GLOB HEALTH, V111, P424, DOI 10.1080/20477724.2018.1427192
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carter JR, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-111
   Carvajal TM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3629-y
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chauvatcharin N, 2006, MOL ECOL, V15, P2451, DOI 10.1111/j.1365-294X.2006.02947.x
   Cirimotich CM, 2011, CELL HOST MICROBE, V10, P307, DOI 10.1016/j.chom.2011.09.006
   Coffey LL, 2013, FUTURE MICROBIOL, V8, P155, DOI [10.2217/FMB.12.139, 10.2217/fmb.12.139]
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Crain PR, 2013, J MED ENTOMOL, V50, P1152, DOI 10.1603/ME12263
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dohm DJ, 2002, J MED ENTOMOL, V39, P221, DOI 10.1603/0022-2585-39.1.221
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Engel D, 2016, MBIO, V7, DOI 10.1128/mBio.01938-15
   Fang J, 2010, NATURE, V466, P432, DOI 10.1038/466432a
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Flasche Stefan, 2019, Wellcome Open Res, V4, P165, DOI 10.12688/wellcomeopenres.15507.1
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Foo Isabelle Jia-Hui, 2019, Trop Med Infect Dis, V4, DOI 10.3390/tropicalmed4010013
   Franz AWE, 2006, P NATL ACAD SCI USA, V103, P4198, DOI 10.1073/pnas.0600479103
   Gavotte L, 2004, INSECT MOL BIOL, V13, P147, DOI 10.1111/j.0962-1075.2004.00471.x
   Gavotte L, 2007, MOL BIOL EVOL, V24, P427, DOI 10.1093/molbev/msl171
   Geoghegan V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00610-8
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hegde S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02160
   Hertig M, 1924, J MED RES, V44, P329
   Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Koh C, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez012
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kulkarni A, 2019, ECOL EVOL, V9, P6148, DOI 10.1002/ece3.5198
   Lambrechts L, 2019, CELL HOST MICROBE, V26, P309, DOI 10.1016/j.chom.2019.08.005
   Landmann F, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.BAI-0018-2019
   Silva JBL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181678
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.2117
   Martinez J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005021
   Masui S, 2000, J MOL EVOL, V51, P491, DOI 10.1007/s002390010112
   Mathur G, 2010, INSECT MOL BIOL, V19, P753, DOI 10.1111/j.1365-2583.2010.01032.x
   Mayoral JG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096107
   Minard G, 2013, FEMS MICROBIOL ECOL, V83, P63, DOI 10.1111/j.1574-6941.2012.01455.x
   Mishra P, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8060163
   Moghadas SM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05013-9
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mourya DT, 2004, AM J TROP MED HYG, V70, P346, DOI 10.4269/ajtmh.2004.70.346
   Mousson L, 2010, MOL ECOL, V19, P1953, DOI 10.1111/j.1365-294X.2010.04606.x
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Nikolay B, 2011, VECTOR-BORNE ZOONOT, V11, P1417, DOI 10.1089/vbz.2011.0631
   Okorie PN, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-154
   Silva NIO, 2020, VIROL J, V17, DOI 10.1186/s12985-019-1277-7
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Ostera GR, 2011, JAMA-J AM MED ASSOC, V305, P930, DOI 10.1001/jama.2011.246
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Pan XL, 2012, P NATL ACAD SCI USA, V109, pE23, DOI 10.1073/pnas.1116932108
   Patterson EI, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey001
   Pietri JE, 2016, MICROBIOLOGYOPEN, V5, P923, DOI 10.1002/mbo3.390
   Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Ramyasoma HPBKD, 2020, RNA BIOL, DOI 10.1080/15476286.2020.1735210
   Ross PA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007357
   Schlagenhauf P, 2017, INT J INFECT DIS, V60, P91, DOI 10.1016/j.ijid.2017.06.003
   Serbus LR, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004777
   Shearer FM, 2018, LANCET GLOB HEALTH, V6, pE270, DOI 10.1016/S2214-109X(18)30024-X
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Slonchak A, 2014, J VIROL, V88, P8457, DOI 10.1128/JVI.00317-14
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   St John AL, 2019, NAT REV IMMUNOL, V19, P218, DOI 10.1038/s41577-019-0123-x
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Teo C., 2017, TROP BIOMED, V34, P14
   Teramoto T, 2019, J VIROL, V93, DOI 10.1128/JVI.00581-19
   Thongsripong P, 2018, ECOL EVOL, V8, P1352, DOI 10.1002/ece3.3676
   Tsai CH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2493-x
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   WHO Expert Committee on Biological Standardization, 1995, WHO EXP COMM BIOL ST, V858, P1
   Wilder-Smith A, 2019, LANCET, V394, P2151, DOI 10.1016/S0140-6736(19)32525-5
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, P241, DOI 10.1016/S1473-3099(19)30050-7
   Ye YH, 2016, AM J TROP MED HYG, V94, P812, DOI 10.4269/ajtmh.15-0801
   Yen PS, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-017-0011-5
   Zhang GM, 2013, P NATL ACAD SCI USA, V110, P10276, DOI 10.1073/pnas.1303603110
   Zouache K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006388
NR 116
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAY
PY 2020
VL 9
IS 5
AR 404
DI 10.3390/pathogens9050404
PG 14
WC Microbiology
SC Microbiology
GA LZ8AP
UT WOS:000541443700087
PM 32456036
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mendoza-Almanza, G
   Esparza-Ibarra, EL
   Ayala-Lujan, JL
   Mercado-Reyes, M
   Godina-Gonzalez, S
   Hernandez-Barrales, M
   Olmos-Soto, J
AF Mendoza-Almanza, Gretel
   Esparza-Ibarra, Edgar L.
   Ayala-Lujan, Jorge L.
   Mercado-Reyes, Marisa
   Godina-Gonzalez, Susana
   Hernandez-Barrales, Marisa
   Olmos-Soto, Jorge
TI The Cytocidal Spectrum ofBacillus thuringiensisToxins: From Insects to
   Human Cancer Cells
SO TOXINS
LA English
DT Review
DE Bacillus thuringiensis; Cry; Cyt; parasporins; S-layer proteins; Vip;
   Sip; membrane receptors; insecticidal activity; anticancer activity
ID VEGETATIVE INSECTICIDAL PROTEIN; SELECTIVE CYTOTOXIC-ACTIVITY; SEXTA
   BT-R-1 RECEPTOR; PORE-FORMING TOXIN; MODIFIED BT TOXINS;
   BACILLUS-THURINGIENSIS; MANDUCA-SEXTA; CRYSTAL PROTEIN; DELTA-ENDOTOXIN;
   DOMAIN-II
AB Bacillus thuringiensis(Bt) is a ubiquitous bacterium in soils, insect cadavers, phylloplane, water, and stored grain, that produces several proteins, each one toxic to different biological targets such as insects, nematodes, mites, protozoa, and mammalian cells. Most Bt toxins identify their particular target through the recognition of specific cell membrane receptors. Cry proteins are the best-known toxins from Bt and a great amount of research has been published. Cry are cytotoxic to insect larvae that affect important crops recognizing specific cell membrane receptors such as cadherin, aminopeptidase-N, and alkaline phosphatase. Furthermore, some Cry toxins such as Cry4A, Cry4B, and Cry11A act synergistically with Cyt toxins against dipteran larvae vectors of human disease. Research developed with Cry proteins revealed that these toxins also could kill human cancer cells through the interaction with specific receptors. Parasporins are a small group of patented toxins that may or may not have insecticidal activity. These proteins could kill a wide variety of mammalian cancer cells by recognizing specific membrane receptors, just like Cry toxins do. Surface layer proteins (SLP), unlike the other proteins produced by Bt, are also produced by most bacteria and archaebacteria. It was recently demonstrated that SLP produced by Bt could interact with membrane receptors of insect and human cancer cells to kill them. Cyt toxins have a structure that is mostly unrelated to Cry toxins; thereby, other mechanisms of action have been reported to them. These toxins affect mainly mosquitoes that are vectors of human diseases likeAnopheles spp(malaria),Aedes spp(dengue, zika, and chikungunya), andCulex spp(Nile fever and Rift Valley fever), respectively. In addition to the Cry, Cyt, and parasporins toxins produced during spore formation as inclusion bodies, Bt strains also produce Vip (Vegetative insecticidal toxins) and Sip (Secreted insecticidal proteins) toxins with insecticidal activity during their vegetative growth phase.
C1 [Mendoza-Almanza, Gretel] Autonomous Univ Zacatecas, Natl Council Sci & Technol, Zacatecas 98000, Zacatecas, Mexico.
   [Esparza-Ibarra, Edgar L.; Mercado-Reyes, Marisa] Autonomous Univ Zacatecas, Acad Unit Biol Sci, Zacatecas 98068, Zacatecas, Mexico.
   [Ayala-Lujan, Jorge L.; Godina-Gonzalez, Susana; Hernandez-Barrales, Marisa] Autonomous Univ Zacatecas, Acad Unit Chem Sci, Zacatecas 98160, Zacatecas, Mexico.
   [Olmos-Soto, Jorge] Ctr Sci Res & Higher Educ Ensenada, Dept Marine Biotechnol, Ensenada 22860, Baja California, Mexico.
RP Olmos-Soto, J (corresponding author), Ctr Sci Res & Higher Educ Ensenada, Dept Marine Biotechnol, Ensenada 22860, Baja California, Mexico.
EM grmendoza@conacyt.mx; lesparza@uaz.edu.mx; jayala69@uaz.edu.mx;
   marisamercado@uaz.edu.mx; sgodina@uaz.edu.mx; marisahb@uaz.edu.mx;
   jolmos@cicese.mx
OI Mendoza, Gretel/0000-0002-0426-7410
CR Abdelkefi-Mesrati L, 2011, J INVERTEBR PATHOL, V107, P198, DOI 10.1016/j.jip.2011.05.014
   Abe Y, 2017, J INVERTEBR PATHOL, V142, P71, DOI 10.1016/j.jip.2016.11.008
   Aboul-Soud MAM, 2019, MOLECULES, V24, DOI 10.3390/molecules24030506
   Adang MJ, 2014, ADV INSECT PHYSIOL, V47, P39, DOI 10.1016/B978-0-12-800197-4.00002-6
   Akiba T, 2004, ACTA CRYSTALLOGR D, V60, P2355, DOI 10.1107/S0907444904026307
   Akiba T, 2017, J INVERTEBR PATHOL, V142, P44, DOI 10.1016/j.jip.2016.10.005
   Akiba T, 2009, J MOL BIOL, V386, P121, DOI 10.1016/j.jmb.2008.12.002
   Amano H, 2005, BIOSCI BIOTECH BIOCH, V69, P2063, DOI 10.1271/bbb.69.2063
   Arenas I, 2010, J BIOL CHEM, V285, P12497, DOI 10.1074/jbc.M109.085266
   Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004
   Becker N., 2000, ENTOMOPATHOGENIC BAC, P383, DOI 10.1007/978-94-017-1429-7_21
   Bel Y, 2017, TOXINS, V9, DOI 10.3390/toxins9040131
   Berry C, 2002, APPL ENVIRON MICROB, V68, P5082, DOI 10.1128/AEM.68.10.5082-5095.2002
   Bi Y, 2015, APPL MICROBIOL BIOT, V99, P753, DOI 10.1007/s00253-014-5966-2
   Brasseur K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135106
   Bravo A, 2004, BBA-BIOMEMBRANES, V1667, P38, DOI 10.1016/j.bbamem.2004.08.013
   Bravo A., 2005, COMPREHENSIVE MOL IN, P175, DOI 10.1016/B0-44-451924-6/00081-8
   Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022
   Bravo A, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P858, DOI 10.1016/B978-0-12-800188-2.00030-6
   BULLA LA, 1981, J BIOL CHEM, V256, P3000
   Butko P, 1996, BIOCHEMISTRY-US, V35, P11355, DOI 10.1021/bi960970s
   Butko P, 2003, APPL ENVIRON MICROB, V69, P2415, DOI 10.1128/AEM.69.5.2415-2422.2003
   Castella C, 2019, BIOL OPEN, V8, DOI 10.1242/bio.037085
   Chakroun M, 2016, MICROBIOL MOL BIOL R, V80, P329, DOI 10.1128/MMBR.00060-15
   Chen M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002284
   Chougule NP, 2013, P NATL ACAD SCI USA, V110, P8465, DOI 10.1073/pnas.1222144110
   Christou P, 2006, TRENDS PLANT SCI, V11, P302, DOI 10.1016/j.tplants.2006.04.001
   Chubicka T, 2018, J BIOSCIENCES, V43, P407, DOI 10.1007/s12038-018-9759-0
   Crickmore N., BACILLUS THURINGIENS
   Dal Peraro M, 2016, NAT REV MICROBIOL, V14, P77, DOI 10.1038/nrmicro.2015.3
   Melo ALD, 2016, CRIT REV BIOTECHNOL, V36, P317, DOI 10.3109/07388551.2014.960793
   de Maagd RA, 2003, ANNU REV GENET, V37, P409, DOI 10.1146/annurev.genet.37.110801.143042
   de Maagd RA, 2001, TRENDS GENET, V17, P193, DOI 10.1016/S0168-9525(01)02237-5
   Donovan WP, 2006, APPL MICROBIOL BIOT, V72, P713, DOI 10.1007/s00253-006-0332-7
   Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1
   DuMont AL, 2014, TRENDS MICROBIOL, V22, P21, DOI 10.1016/j.tim.2013.10.004
   Ekino K, 2014, TOXINS, V6, P1882, DOI 10.3390/toxins6061882
   FISCHHOFF DA, 1987, BIO-TECHNOL, V5, P807, DOI 10.1038/nbt0887-807
   Gomez I, 2003, BIOCHEMISTRY-US, V42, P10482, DOI 10.1021/bi034440p
   Gomez I, 2001, J BIOL CHEM, V276, P28906, DOI 10.1074/jbc.M103007200
   Gomez I, 2002, J BIOL CHEM, V277, P30137, DOI 10.1074/jbc.M203121200
   Gomez I, 2002, FEBS LETT, V513, P242, DOI 10.1016/S0014-5793(02)02321-9
   Gonzalez E, 2011, CURR MICROBIOL, V62, P1643, DOI 10.1007/s00284-011-9905-5
   Gouaux E, 1997, CURR OPIN STRUC BIOL, V7, P566, DOI 10.1016/S0959-440X(97)80123-6
   GROCHULSKI P, 1995, J MOL BIOL, V254, P447, DOI 10.1006/jmbi.1995.0630
   Guo G, 2008, FEMS MICROBIOL LETT, V282, P1, DOI 10.1111/j.1574-6968.2008.01087.x
   Hayakawa T, 2007, CURR MICROBIOL, V55, P278, DOI 10.1007/s00284-006-0351-8
   Hazes B, 1996, PROTEIN SCI, V5, P1490, DOI 10.1002/pro.5560050805
   Heckel DG, 2012, PESTIC BIOCHEM PHYS, V104, P103, DOI 10.1016/j.pestbp.2012.05.007
   HOFTE H, 1989, MICROBIOL REV, V53, P242
   Hotze EM, 2013, INFECT IMMUN, V81, P216, DOI 10.1128/IAI.00927-12
   Hunt S, 2010, ADV EXP MED BIOL, V677, P116
   Iacovache I, 2015, COMPREHENSIVE SOURCEBOOK OF BACTERIAL PROTEIN TOXINS, 4TH EDITION, P773, DOI 10.1016/B978-0-12-800188-2.00026-4
   Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013
   Inouye K, 2008, FOOD SCI BIOTECHNOL, V17, P219
   Ito A, 2004, J BIOL CHEM, V279, P21282, DOI 10.1074/jbc.M401881200
   Jucovic M, 2008, PROTEIN ENG DES SEL, V21, P631, DOI 10.1093/protein/gzn038
   Jung YC, 2007, J APPL MICROBIOL, V103, P65, DOI 10.1111/j.1365-2672.2006.03260.x
   Katayama H, 2005, J BIOCHEM, V137, P17, DOI 10.1093/jb/mvi003
   Katayama H., 2011, U.S. Patent, Patent No. 20110038880
   Kim HS, 2000, J APPL MICROBIOL, V89, P16, DOI 10.1046/j.1365-2672.2000.01087.x
   Kitada S, 2006, J BIOL CHEM, V281, P26350, DOI 10.1074/jbc.M602589200
   Kitada S, 2009, TOXICOLOGY, V264, P80, DOI 10.1016/j.tox.2009.07.016
   KNOWLES BH, 1993, BIOESSAYS, V15, P469, DOI 10.1002/bies.950150706
   Koch MS, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00283
   Kotze AC, 2005, INT J PARASITOL, V35, P1013, DOI 10.1016/j.ijpara.2005.03.010
   Krishnan V, 2017, BIOCHEM J, V474, P1591, DOI 10.1042/BCJ20170122
   Kristan KC, 2009, TOXICON, V54, P1125, DOI 10.1016/j.toxicon.2009.02.026
   Kuadkitkan A, 2012, CURR MICROBIOL, V65, P446, DOI 10.1007/s00284-012-0178-4
   Kuroda S, 2013, CURR MICROBIOL, V66, P475, DOI 10.1007/s00284-013-0301-1
   Kwa MSG, 1998, J INVERTEBR PATHOL, V71, P121, DOI 10.1006/jipa.1997.4723
   LAKEY JH, 1994, TOXICOLOGY, V87, P85, DOI 10.1016/0300-483X(94)90156-2
   Lee DW, 2000, BIOCHEM BIOPH RES CO, V272, P218, DOI 10.1006/bbrc.2000.2765
   Lee DW, 2001, BBA-PROTEIN STRUCT M, V1547, P57, DOI 10.1016/S0167-4838(01)00169-8
   Lee MK, 2000, MOL MICROBIOL, V38, P289, DOI 10.1046/j.1365-2958.2000.02109.x
   Lenina NK, 2014, 3 BIOTECH, V4, P545, DOI 10.1007/s13205-013-0190-9
   Lesieur C, 1997, MOL MEMBR BIOL, V14, P45, DOI 10.3109/09687689709068435
   Leuber M, 2006, BIOCHEMISTRY-US, V45, P283, DOI 10.1021/bi051351z
   Li J, 1996, J MOL BIOL, V257, P129, DOI 10.1006/jmbi.1996.0152
   Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257
   LIN JY, 1973, NATURE, V246, P524, DOI 10.1038/246524a0
   Lin SC, 2004, J MOL BIOL, V343, P477, DOI 10.1016/j.jmb.2004.08.045
   Liu Li, 2018, J Proteomics Bioinform, V11, P201, DOI 10.4172/0974-276X.1000487
   Manasherob R, 2006, MICROBIOL-SGM, V152, P2651, DOI 10.1099/mic.0.28981-0
   Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003
   Mendoza G, 2012, INT MICROBIOL, V15, P210, DOI 10.2436/20.1501.01.174
   Mendoza-Almanza G, 2019, CURR PHARM BIOTECHNO, V20, P1018, DOI 10.2174/1389201020666190802114739
   Mizuki E, 1999, J APPL MICROBIOL, V86, P477, DOI 10.1046/j.1365-2672.1999.00692.x
   Mizuki E, 2000, CLIN DIAGN LAB IMMUN, V7, P625, DOI 10.1128/CDLI.7.4.625-634.2000
   Moazamian E, 2018, CURR MICROBIOL, V75, P1090, DOI 10.1007/s00284-018-1479-z
   Moniatte M, 1996, FEBS LETT, V384, P269, DOI 10.1016/0014-5793(96)00328-6
   Nadarajah V. D., 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P235
   Nagamatsu Y, 2010, BIOSCI BIOTECH BIOCH, V74, P494, DOI 10.1271/bbb.90615
   Namba A, 2003, BBA-GEN SUBJECTS, V1622, P29, DOI 10.1016/S0304-4165(03)00102-8
   Ocelotl J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02545-y
   OHBA M, 1986, J INVERTEBR PATHOL, V47, P12, DOI 10.1016/0022-2011(86)90158-8
   Ohba M, 2009, ANTICANCER RES, V29, P427
   Okumura S, 2006, PROTEIN EXPRES PURIF, V47, P144, DOI 10.1016/j.pep.2005.10.011
   Okumura S, 2005, J AGR FOOD CHEM, V53, P6313, DOI 10.1021/jf0506129
   Okumura S, 2004, LETT APPL MICROBIOL, V39, P89, DOI 10.1111/j.1472-765X.2004.01544.x
   Okumura S., 2010, PARASPORIN NOMENCLAT
   Okumura S, 2013, BIOTECHNOL LETT, V35, P1889, DOI 10.1007/s10529-013-1275-6
   Okumura S, 2011, BBA-BIOMEMBRANES, V1808, P1476, DOI 10.1016/j.bbamem.2010.11.003
   Okumura S, 2008, BIOTECHNOL ANN REV, V14, P225, DOI 10.1016/S1387-2656(08)00009-4
   Pacheco S, 2009, J BIOL CHEM, V284, P32750, DOI 10.1074/jbc.M109.024968
   Palma L, 2014, TOXINS, V6, P3296, DOI 10.3390/toxins6123296
   Pardo-Lopez L, 2006, BIOCHEMISTRY-US, V45, P10329, DOI 10.1021/bi060297z
   Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x
   Parker MW, 2005, PROG BIOPHYS MOL BIO, V88, P91, DOI 10.1016/j.pbiomolbio.2004.01.009
   Pena G, 2006, APPL ENVIRON MICROB, V72, P353, DOI 10.1128/AEM.72.1.353-360.2006
   Perez C, 2005, P NATL ACAD SCI USA, V102, P18303, DOI 10.1073/pnas.0505494102
   Pigott CR, 2007, MICROBIOL MOL BIOL R, V71, P255, DOI 10.1128/MMBR.00034-06
   Porta H, 2011, INSECT BIOCHEM MOLEC, V41, P513, DOI 10.1016/j.ibmb.2011.04.013
   Rajamohan F, 1996, J BIOL CHEM, V271, P25220, DOI 10.1074/jbc.271.41.25220
   Rodriguez-Almazan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005545
   Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547
   Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180
   Rubio VP, 2017, J MICROBIOL BIOTECHN, V27, P36, DOI 10.4014/jmb.1607.07020
   Sahin B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206813
   Saitoh H, 2006, BIOSCI BIOTECH BIOCH, V70, P2935, DOI 10.1271/bbb.60352
   Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000
   Sattar S, 2011, J MICROBIOL BIOTECHN, V21, P937, DOI 10.4014/jmb.1105.05030
   Schnepf E, 1998, MICROBIOL MOL BIOL R, V62, P775, DOI 10.1128/MMBR.62.3.775-806.1998
   SCHNEPF HE, 1981, P NATL ACAD SCI-BIOL, V78, P2893, DOI 10.1073/pnas.78.5.2893
   Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f
   Shi Y, 2004, J APPL MICROBIOL, V97, P757, DOI 10.1111/j.1365-2672.2004.02365.x
   SLEYTR UB, 1993, MOL MICROBIOL, V10, P911, DOI 10.1111/j.1365-2958.1993.tb00962.x
   Sleytr UB, 2014, FEMS MICROBIOL REV, V38, P823, DOI 10.1111/1574-6976.12063
   Soberon M, 2007, SCIENCE, V318, P1640, DOI 10.1126/science.1146453
   Soberon M, 2013, PEPTIDES, V41, P87, DOI 10.1016/j.peptides.2012.05.023
   Tabashnik BE, 2017, NAT BIOTECHNOL, V35, P926, DOI 10.1038/nbt.3974
   Tabashnik BE, 2011, NAT BIOTECHNOL, V29, P1128, DOI 10.1038/nbt.1988
   Thomas DJI, 2000, APPL ENVIRON MICROB, V66, P118, DOI 10.1128/AEM.66.1.118-124.2000
   THOMAS WE, 1983, J CELL SCI, V60, P181
   Torres-Quintero MC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22740-9
   Uemori A, 2008, ANTICANCER RES, V28, P91
   VAECK M, 1987, NATURE, V328, P33, DOI 10.1038/328033a0
   van Frankenhuyzen K, 2009, J INVERTEBR PATHOL, V101, P1, DOI 10.1016/j.jip.2009.02.009
   Warren G.W., 1997, ADV INSECT CONTROL R, P109, DOI [DOI 10.1201/9780203211731.CH7, 10.4324/9780203211731_chapter_7]
   WICKHAM TJ, 1992, BIOTECHNOL PROGR, V8, P391, DOI 10.1021/bp00017a003
   Wirth MC, 2001, APPL ENVIRON MICROB, V67, P3280, DOI 10.1128/AEM.67.7.3280-3284.2001
   Xu CC, 2014, TOXINS, V6, P2732, DOI 10.3390/toxins6092732
   Yamagiwa M., 2002, MEM FAC ENG OKAYAMA, V36, P61
   Yamashita S, 2000, CAN J MICROBIOL, V46, P913, DOI 10.1139/cjm-46-10-913
   Yamashita S, 2005, J BIOCHEM, V138, P663, DOI 10.1093/jb/mvi177
   Yasutake K, 2008, Z NATURFORSCH C, V63, P139
   Yasutake K, 2006, CAN J MICROBIOL, V52, P365, DOI 10.1139/W05-134
   Zhang BH, 2006, BIOSCI BIOTECH BIOCH, V70, P2199, DOI 10.1271/bbb.60140
   Zhang Q, 2017, INSECT SCI, V24, P714, DOI 10.1111/1744-7917.12401
   Zhang XB, 2006, P NATL ACAD SCI USA, V103, P9897, DOI 10.1073/pnas.0604017103
   Zhong CH, 2000, J INVERTEBR PATHOL, V76, P131, DOI 10.1006/jipa.2000.4962
   Zhu Lihong, 2008, Weishengwu Xuebao, V48, P690
   Zhuang MB, 2002, J BIOL CHEM, V277, P13863, DOI 10.1074/jbc.M110057200
NR 153
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6651
J9 TOXINS
JI Toxins
PD MAY
PY 2020
VL 12
IS 5
AR 301
DI 10.3390/toxins12050301
PG 22
WC Food Science & Technology; Toxicology
SC Food Science & Technology; Toxicology
GA MA3EA
UT WOS:000541799400009
PM 32384723
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Musso, D
   Despres, P
AF Musso, Didier
   Despres, Philippe
TI Serological Diagnosis of Flavivirus-Associated Human Infections
SO DIAGNOSTICS
LA English
DT Review
DE antigenic cross-reactivity; arbovirus; diagnosis; Flavivirus;
   immunoassay; infection; serology
ID WEST-NILE-VIRUS; QUALITY-CONTROL ASSESSMENT; ROSS RIVER VIRUS; ZIKA
   VIRUS; DENGUE VIRUS; CROSS-REACTIVITY; FRENCH-POLYNESIA; PROLONGED
   DETECTION; YELLOW-FEVER; BLOOD
AB Arthropod-borne viruses (arboviruses) belonging to the Flavivirus genus of the Flaviviridae family, are a major public health threat in tropical and subtropical regions, and have recently become a medical concern in temperate zones. Most flaviviruses are classified as zoonotic viruses. Human flavivirus infections can be asymptomatic, responsible for unspecific symptoms in the first few days following infection, or responsible for severe complications potentially resulting in death. During the first days following symptom onset, laboratory diagnosis of acute human flavivirus infection is mainly based on molecular detection of the viral genome by RT-PCR methods, followed by the capture of specific antibodies using serological tests after the first week of infection. The detection of antibodies that have virus neutralizing activity can be used to confirm flavivirus infection. However, human flavivirus infections induce the production of cross-reactive antibodies, often making serology inconclusive. Indeed, serological diagnosis of flavivirus infection can be hampered by a patient's history of flavivirus exposure, particularly in regions where multiple antigenically related flaviviruses co-circulate. We focus our mini review on conventional immunoassays that allow the diagnosis of major flavivirus-associated human infections in basic, routine and high-profile central health centers; and the interpretation of diagnostic serology tests for patients living within different epidemiological situations.
C1 [Musso, Didier] Aix Marseille Univ, IHU Mediterranee Infect, VITROME, IRD,AP HM,SSA, F-13005 Marseille, France.
   [Musso, Didier] Lab Eurofins Labazur Guyane, 35 Rue Lieutenant Brasse, Cayenne 97300, French Guiana.
   [Despres, Philippe] Univ La Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, CNRS,UMR 9192,INSERM,U1187,IRD,UMR 249, F-97491 St Clothilde, La Reunion, France.
RP Musso, D (corresponding author), Aix Marseille Univ, IHU Mediterranee Infect, VITROME, IRD,AP HM,SSA, F-13005 Marseille, France.; Musso, D (corresponding author), Lab Eurofins Labazur Guyane, 35 Rue Lieutenant Brasse, Cayenne 97300, French Guiana.
EM dmusso12345@gmail.com; philippe.despres@univ-reunion.fr
FU POE FEDER 2014-20 of the Conseil Regional de La Reunion (ZIKAlert
   program) [SYNERGIE RE00001902]
FX This work was supported by the POE FEDER 2014-20 of the Conseil Regional
   de La Reunion (ZIKAlert program, Nffi SYNERGIE RE00001902).
CR Allwinn R, 2002, MED MICROBIOL IMMUN, V190, P199, DOI 10.1007/s00430-001-0107-9
   ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552
   ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102
   Aubry M, 2017, EMERG INFECT DIS, V23, P1751, DOI 10.3201/eid2310.170583
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Barzon L, 2013, J INFECT DIS, V208, P1086, DOI 10.1093/infdis/jit290
   Basile AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075670
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Buonora SN, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1368-7
   Busch MP, 2005, NEW ENGL J MED, V353, P460, DOI 10.1056/NEJMoa044029
   Calisher CH, 2003, ADV VIRUS RES, V59, P1, DOI 10.1016/S0065-3527(03)59001-7
   Campos RD, 2016, J CLIN VIROL, V77, P69, DOI 10.1016/j.jcv.2016.02.009
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Center for disease control and prevention, UPD GUID US LAB TEST
   Change for Centers for Disease Control and Prevention, 2009, BIOSAFETY MICROBIOLO
   Charrel RN, 2016, TRAVEL MED INFECT DI, V14, P11, DOI 10.1016/j.tmaid.2016.01.006
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Domingo C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0877-0
   European Centre for Disease Prevention and Control (ECDC), 2018, LOC TRANSM DENG FEV
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Frumence E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030066
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Giron S, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.45.1900655
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Gubler DJ, 1998, EMERG INFECT DIS, V4, P442, DOI 10.3201/eid0403.980326
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Gubler DJ, 2014, DENGUE AND DENGUE HEMORRHAGIC FEVER, 2ND EDITION, P1, DOI 10.1079/9781845939649.0001
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Hassing RJ, 2010, EUROSURVEILLANCE, V15, P22
   Henss L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010082
   Houghton-Triviño Natalia, 2008, Rev. salud pública, V10, P299
   Johnson BW, 2016, AM J TROP MED HYG, V94, P820, DOI 10.4269/ajtmh.15-0631
   Khawar W, 2017, CUREUS, V9, DOI 10.7759/cureus.1099
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lanteri MC, 2014, TRANSFUSION, V54, P3232, DOI 10.1111/trf.12764
   Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041
   Levi JE, 2016, J INFECT DIS, V213, P689, DOI 10.1093/infdis/jiv322
   Lim JK, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2789-8
   Lin R, 2017, J VIROL METHODS, V247, P15, DOI 10.1016/j.jviromet.2017.04.012
   Lukman N, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/5253842
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   Mead PS, 2018, NEW ENGL J MED, V378, P1377, DOI [10.1056/NEJMoa1711038, 10.1056/nejmoa1711038]
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Musso D, 2018, LANCET INFECT DIS, V18, pE355, DOI [10.1016/s1473-3099(18)30269-x, 10.1016/S1473-3099(18)30269-X]
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nash D, 2001, NEW ENGL J MED, V344, P1807, DOI 10.1056/NEJM200106143442401
   Niedrig M, 2008, CLIN VACCINE IMMUNOL, V15, P177, DOI 10.1128/CVI.00078-07
   Niedrig M, 2007, J CLIN VIROL, V38, P260, DOI 10.1016/j.jcv.2006.12.013
   Pang JX, 2017, J CLIN MICROBIOL, V55, P3339, DOI 10.1128/JCM.00707-17
   Papa A, 2011, J MED VIROL, V83, P1861, DOI 10.1002/jmv.22180
   PAVRI KM, 1969, B WORLD HEALTH ORGAN, V40, P984
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Rathore APS, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00334
   Reusken C, 2019, J CLIN VIROL, V120, P78, DOI 10.1016/j.jcv.2019.09.009
   Rodriguez-Morales AJ, 2016, TRAVEL MED INFECT DI, V14, P177, DOI 10.1016/j.tmaid.2016.05.004
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Sambri V, 2013, VIRUSES-BASEL, V5, P2329, DOI 10.3390/v5102329
   Sanchini A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002184
   Souza NCSE, 2019, INT J INFECT DIS, V81, P4, DOI 10.1016/j.ijid.2019.01.023
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Taylor CT, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050253
   The Academy of Medical Sciences, 2016, IMPR DEV DEPL RAP DI
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Trevethan R, 2020, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00408
   Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7
   Tyson J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007649
   Cao-Lormeau VM, 2016, EMERG INFECT DIS, V22, P913, DOI 10.3201/eid2205.150547
   Venkateswaran K.N., 2018, J IMMUNOL, V200, P25
   Venkateswaran N., 2017, J IMMUNOL, V198, P81
   Ward MJ, 2018, AM J TROP MED HYG, V99, P780, DOI 10.4269/ajtmh.18-0237
   Welch RJ, 2014, J VIROL METHODS, V195, P247, DOI 10.1016/j.jviromet.2013.10.019
   WHITE LA, 1987, J CLIN MICROBIOL, V25, P1221, DOI 10.1128/JCM.25.7.1221-1224.1987
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yan G, 2020, LANCET INFECT DIS, V20, P536, DOI 10.1016/S1473-3099(20)30158-4
NR 90
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2075-4418
J9 DIAGNOSTICS
JI Diagnostics
PD MAY
PY 2020
VL 10
IS 5
AR 302
DI 10.3390/diagnostics10050302
PG 13
WC Medicine, General & Internal
SC General & Internal Medicine
GA LZ1XJ
UT WOS:000541022500015
PM 32423058
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Desjardins, MR
   Casas, I
   Victoria, AM
   Carbonell, D
   Davalos, DM
   Delmelle, EM
AF Desjardins, M. R.
   Casas, I
   Victoria, A. M.
   Carbonell, D.
   Davalos, D. M.
   Delmelle, E. M.
TI Knowledge, attitudes, and practices regarding dengue, chikungunya, and
   Zika in Cali, Colombia
SO HEALTH & PLACE
LA English
DT Article
DE Vector-borne disease; Community surveys; Dengue; Chikungunya; Zika
ID AEDES-AEGYPTI DIPTERA; BORNE DISEASES; FEVER; EPIDEMIOLOGY; PROXIMITY;
   CULICIDAE; BURDEN
AB Dengue fever (DENF), chikungunya (CHIK), and Zika are responsible for the majority of the burden caused by vector-borne diseases (VBDs); which are produced by viruses primarily transmitted by the Aedes mosquito. Aedes have become prolific in urban areas due to a combination of climate change, rapid urbanization, increased human mobility, and globalization, causing the three VBDs to emerge in novel regions. Community knowledge can provide detailed insights about the spatial heterogeneity of disease risk and rates within a particular region, improving public health interventions. Knowledge, Attitude, and Practice (KAP) surveys are used to shed light on at-risk communities' understanding of the vector, the pathogen, prevention and treatment strategies. Little is known how KAP varies among diseases, and among neighborhoods within a city. Understanding KAP variation among co-circulating VBDs at a fine-level, especially differences between endemic and emerging diseases, can improve targeted interventions, education programs, and health policy. We administered KAP surveys to 327 individuals in healthcare centers and selected neighborhoods in Cali, Colombia in June 2019. We utilized generalized linear models (GLMs) to identify significant predictors of KAP. Our findings suggest that knowledge is related to community characteristics (e.g. strata), while attitudes and practices are more related to individual-level factors. Access to healthcare also forms significant predictor of residents participating in preventative practices. The results can be leveraged to inform public health officials and communities to motivate at-risk neighborhoods to take an active role in vector surveillance and control, while improving educational and surveillance resources in Cali, Colombia.
C1 [Desjardins, M. R.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.
   [Desjardins, M. R.] Johns Hopkins Bloomberg Sch Publ Hlth, Spatial Sci Publ Hlth Ctr, Baltimore, MD 21205 USA.
   [Casas, I] Louisiana Tech Univ, Dept Social Sci, Ruston, LA 71272 USA.
   [Victoria, A. M.; Davalos, D. M.] Univ Icesi, Dept Publ Hlth & Community Med, Cali, Colombia.
   [Carbonell, D.] Univ Libre Secc Cali, Dept Hlth Sci, Cali, Colombia.
   [Delmelle, E. M.] Univ North Carolina Charlotte, Dept Geog & Earth Sci, Charlotte, NC 28223 USA.
   [Delmelle, E. M.] Univ North Carolina Charlotte, Ctr Appl Geog Informat Sci, Charlotte, NC 28223 USA.
RP Desjardins, MR (corresponding author), 627 N Washington St,Floor 2, Baltimore, MD 21205 USA.
EM mdesjar3@jhmi.edu
FU American Association of Geographers (AAG); UNC-Charlotte Graduate School
   Summer Fellowship
FX This research was supported by a 2019 American Association of
   Geographers (AAG) Dissertation Research Grant; and a 2019 UNC-Charlotte
   Graduate School Summer Fellowship.
CR Alobuia WM, 2015, ANN GLOB HEALTH, V81, P654, DOI 10.1016/j.aogh.2015.08.013
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Calle-Giraldo JP, 2019, PEDIATR INFECT DIS J, V38, P735, DOI [10.1097/INF.0000000000002307, 10.1097/inf.0000000000002307]
   Calvet GA, 2016, CURR OPIN INFECT DIS, V29, P459, DOI 10.1097/QCO.0000000000000301
   Casas I, 2017, J TRANSP HEALTH, V4, P18, DOI 10.1016/j.jth.2016.08.001
   Castañeda-Porras Oneida, 2017, Revista médica Risaralda, V23, P14
   Castrillon JC, 2015, REV CHIL INFECTOL, V32, P142, DOI 10.4067/S0716-10182015000300002
   Castro M., 2008, REV CUBANA MED TROP, V60
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Corrin T, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0061-x
   Delmelle E, 2016, ACTA TROP, V164, P169, DOI 10.1016/j.actatropica.2016.08.028
   Delmelle E, 2014, INT J GEOGR INF SCI, V28, P1107, DOI 10.1080/13658816.2013.871285
   Desjardins MR, 2018, ACTA TROP, V185, P77, DOI 10.1016/j.actatropica.2018.04.023
   Diaz-Quijano FA, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5055-z
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Eastin MD, 2014, AM J TROP MED HYG, V91, P598, DOI 10.4269/ajtmh.13-0303
   Flamand C, 2017, AM J TROP MED HYG, V97, P344, DOI 10.4269/ajtmh.16-1028
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006167
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Giustini D., 2018, ONLINE J PUBL HLTH I, V10
   GUBLER DJ, 1994, AM J TROP MED HYG, V50, P50, DOI 10.4269/ajtmh.1994.50.50
   Guilland A., 2016, ZIKA VIRUS IS GLOBAL, pi657
   Hagenlocher M, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-36
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Healy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108504
   Heintze C, 2007, T ROY SOC TROP MED H, V101, P317, DOI 10.1016/j.trstmh.2006.08.007
   Hernández-Escolar Jacqueline, 2014, Rev. salud pública, V16, P281, DOI 10.15446/rsap.v16n2.43464
   Hoarau J.J., 2010, J IMMUNOL
   Hohl A, 2016, SPAT SPATIO-TEMPORAL, V19, P10, DOI 10.1016/j.sste.2016.05.002
   INS, 2017, PROT VIG SAL PUBL EN
   INS, 2019, B EP SEM BES CHIK
   INS, 2014, INF QUINC EP NAC IQE
   Krystosik AR, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15102144
   Krystosik AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181208
   Kuri-Morales PA, 2017, J MED ENTOMOL, V54, P1305, DOI 10.1093/jme/tjx076
   Launiala A., 2009, ANTHR MATTERS, V11, P1
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Potter A, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00032
   Raina Sunil, 2013, N Am J Med Sci, V5, P249, DOI 10.4103/1947-2714.109226
   Higuera-Mendieta DR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005016
   Rudisill C, 2012, SOC SCI MED, V75, P1362, DOI 10.1016/j.socscimed.2012.06.005
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Sarmiento D, 2019, BIOMEDICA, V39
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Simon Fabrice, 2011, Curr Infect Dis Rep, V13, P218, DOI 10.1007/s11908-011-0180-1
   Sissoko D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000389
   Toan NT, 2015, TROP MED INT HEALTH, V20, P840, DOI 10.1111/tmi.12498
   Udayanga L, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2995-y
   Valle delCauca S.D.d.S., 2019, AUTORIDADES SALUD ES
   Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1
   Whiteman A, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6172-4
   Wong LP, 2017, J COMMUN HEALTH, V42, P854, DOI 10.1007/s10900-017-0326-7
   Wong LP, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13121210
NR 55
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1353-8292
EI 1873-2054
J9 HEALTH PLACE
JI Health Place
PD MAY
PY 2020
VL 63
AR 102339
DI 10.1016/j.healthplace.2020.102339
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LZ3YO
UT WOS:000541164200012
PM 32543427
DA 2020-07-08
ER

PT J
AU Iwamura, T
   Guzman-Holst, A
   Murray, KA
AF Iwamura, Takuya
   Guzman-Holst, Adriana
   Murray, Kris A.
TI Accelerating invasion potential of disease vector Aedes aegypti under
   climate change
SO NATURE COMMUNICATIONS
LA English
DT Article
ID VIRUS MOSQUITO VECTOR; DIPTERA-CULICIDAE; ALBOPICTUS DIPTERA;
   DENGUE-FEVER; TEMPERATURE-FLUCTUATIONS; POPULATION-DYNAMICS;
   DISTRIBUTION MODELS; STEGOMYIA AEGYPTI; COLD-HARDINESS; WORLD MAP
AB Vector-borne diseases remain a major contributor to the global burden of disease, while climate change is expected to exacerbate their risk. Characterising vector development rate and its spatio-temporal variation under climate change is central to assessing the changing basis of human disease risk. We develop a mechanistic phenology model and apply it to Aedes aegypti, an invasive mosquito vector for arboviruses (e.g. dengue, zika and yellow fever). The model predicts the number of life-cycle completions (LCC) for a given location per unit time based on empirically derived biophysical responses to environmental conditions. Results suggest that the world became 1.5% more suitable per decade for the development of Ae. aegypti during 1950-2000, while this trend is predicted to accelerate to 3.2-4.4% per decade by 2050. Invasion fronts in North America and China are projected to accelerate from 2 to 6km/yr by 2050. An increase in peak LCC combined with extended periods suitable for mosquito development is simulated to accelerate the vector's global invasion potential.
C1 [Iwamura, Takuya] Tel Aviv Univ, Sch Zool, Dept Life Sci, Tel Aviv, Israel.
   [Guzman-Holst, Adriana] Imperial Coll London, Sch Publ Hlth, London, England.
   [Murray, Kris A.] Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Global Infect Dis Anal, London, England.
   [Murray, Kris A.] Imperial Coll London, Grantham Inst Climate Change & Environm, London, England.
   [Murray, Kris A.] Gambia London Sch Hyg & Trop Med, MRC Unit, Atlantic Blvd,POB 273, Banjul, Gambia.
RP Iwamura, T (corresponding author), Tel Aviv Univ, Sch Zool, Dept Life Sci, Tel Aviv, Israel.; Murray, KA (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Infect Dis Epidemiol, MRC Ctr Global Infect Dis Anal, London, England.; Murray, KA (corresponding author), Imperial Coll London, Grantham Inst Climate Change & Environm, London, England.; Murray, KA (corresponding author), Gambia London Sch Hyg & Trop Med, MRC Unit, Atlantic Blvd,POB 273, Banjul, Gambia.
EM takuya@tauex.tau.ac.il; kris.murray@imperial.ac.uk
RI Iwamura, Takuya/D-1125-2018
OI Iwamura, Takuya/0000-0002-3740-7758; Murray, Kris/0000-0002-8382-0674
FU Tel Aviv University; Imperial College London
FX T.I. received the start-up fund from Tel Aviv University for this study.
   A.G.-H. received scholarship from Imperial College London.
CR Angilletta MJ, 2006, J THERM BIOL, V31, P541, DOI 10.1016/j.jtherbio.2006.06.002
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Braks MAH, 2004, ANN ENTOMOL SOC AM, V97, P130, DOI 10.1603/0013-8746(2004)097[0130:ICBTIS]2.0.CO;2
   Broennimann O, 2012, GLOBAL ECOL BIOGEOGR, V21, P481, DOI 10.1111/j.1466-8238.2011.00698.x
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campbell-Lendrum D, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0552
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824
   Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190
   Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242
   Cayton HL, 2015, ECOLOGY, V96, P1473, DOI 10.1890/15-0131.1
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   ECDPC, 2019, INV MOSQ SPP CURR KN
   Eisen L, 2014, J MED ENTOMOL, V51, P496, DOI 10.1603/ME13214
   Elith J, 2017, INVASIVE SPECIES: RISK ASSESSMENT AND MANAGEMENT, P93
   Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159
   Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   Eritja R, 2005, ISSUES BIOINVASION S, DOI [10.1007/1-4020-3870-4_8, DOI 10.1007/1-4020-3870-4_8]
   Gritti ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068823
   Gu WD, 2006, J VECTOR ECOL, V31, P107, DOI 10.3376/1081-1710(2006)31[107:SEODDO]2.0.CO;2
   Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9
   Hahn MB, 2017, J MED ENTOMOL, V54, P1420, DOI 10.1093/jme/tjx088
   Hales S, 2002, LANCET, V360, P830, DOI 10.1016/S0140-6736(02)09964-6
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006284
   HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P35
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hirzel AH, 2008, J APPL ECOL, V45, P1372, DOI 10.1111/j.1365-2664.2008.01524.x
   HOLSTEIN M, 1967, B WORLD HEALTH ORGAN, V36, P541
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   Jarvis Claire H., 2001, Diversity and Distributions, V7, P223, DOI 10.1046/j.1366-9516.2001.00113.x
   Jonsson AM, 2013, GLOBAL CHANGE BIOL, V19, P1043, DOI 10.1111/gcb.12119
   Kilpatrick AM, 2012, LANCET, V380, P1946, DOI 10.1016/S0140-6736(12)61151-9
   Kotsakiozi P, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2933-2
   Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lega J, 2017, J MED ENTOMOL, V54, P1375, DOI 10.1093/jme/tjx077
   Liu-Helmersson J, 2019, ENVIRON RES, V172, P693, DOI 10.1016/j.envres.2019.02.026
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Louis C, 2012, EMERG INFECT DIS, V18, P78, DOI 10.3201/eid1801.110191
   Lozano-Fuentes S, 2012, AM J TROP MED HYG, V87, P902, DOI 10.4269/ajtmh.2012.12-0244
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Mogi M, 2011, J MED ENTOMOL, V48, P212, DOI 10.1603/ME10196
   Monaghan A. J, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76, DOI 10.1371/CURRENTS.0UTBREA]
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Moreno-Madrinan MJ, 2014, ISPRS INT J GEO-INF, V3, P732, DOI 10.3390/ijgi3020732
   Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1
   Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Murray KA, 2018, ECOGRAPHY, V41, P1411, DOI 10.1111/ecog.03625
   Ogden NH, 2017, FEMS MICROBIOL LETT, V364, DOI 10.1093/femsle/fnx186
   Otero M, 2006, B MATH BIOL, V68, P1945, DOI 10.1007/s11538-006-9067-y
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Penteriani V, 2005, P ROY SOC B-BIOL SCI, V272, P1265, DOI 10.1098/rspb.2005.3075
   Peterson AT, 2007, ECOGRAPHY, V30, P550, DOI 10.1111/j.2007.0906-7590.05102.x
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554
   Reiter P, 2010, EUROSURVEILLANCE, DOI [10.2807/ese.15.10.19509-en, DOI 10.2807/ESE.15.10.19509-EN]
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Simoy MI, 2015, ECOL MODEL, V314, P100, DOI 10.1016/j.ecolmodel.2015.07.007
   Smith KR, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, P709
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   STEDINGER JR, 1985, BIOMETRICS, V41, P691, DOI 10.2307/2531289
   SUTHERST RW, 1985, AGR ECOSYST ENVIRON, V13, P281, DOI 10.1016/0167-8809(85)90016-7
   Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Thrasher Bridget, 2013, Eos, Transactions American Geophysical Union, V94, P321
   Thrasher B, 2012, HYDROL EARTH SYST SC, V16, P3309, DOI 10.5194/hess-16-3309-2012
   Tjaden NB, 2018, TRENDS PARASITOL, V34, P227, DOI 10.1016/j.pt.2017.11.006
   Trewin BJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005848
   VanDerWal J, 2009, AM NAT, V174, P282, DOI 10.1086/600087
   Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100
   Warszawski L, 2014, P NATL ACAD SCI USA, V111, P3228, DOI 10.1073/pnas.1312330110
   Wearing HJ, 2016, PARASITOLOGY, V143, P860, DOI 10.1017/S0031182016000421
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Webber BL, 2011, DIVERS DISTRIB, V17, P978, DOI 10.1111/j.1472-4642.2011.00811.x
   WELCH SM, 1978, ENVIRON ENTOMOL, V7, P482, DOI 10.1093/ee/7.4.487
   Zhu GH, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4015-2
NR 85
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 2041-1723
J9 NAT COMMUN
JI Nat. Commun.
PD MAY 1
PY 2020
VL 11
IS 1
AR 2130
DI 10.1038/s41467-020-16010-4
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LL2ZQ
UT WOS:000531425700011
PM 32358588
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lim, KY
   Tham, HW
AF Lim, Kah Yee
   Tham, Hong-Wai
TI Knowledge, Awareness, and Perception of Community Pharmacists to Zika
   Virus Infection in Klang Valley, Malaysia
SO HEALTH SERVICES INSIGHTS
LA English
DT Article
DE Zika virus; knowledge; awareness; perception; community pharmacists;
   Klang Valley; survey
ID STUDENTS
AB Background:
   Zika fever is a mosquito-borne disease with global health concern. It has been underreported or misdiagnosed due to its unspecific clinical manifestations, including mild-influenza like and subclinical symptoms. However, its associated serious complications which include fetal microcephaly and Guillain-Barre syndrome remained a challenge to the public health sectors. This research aimed to evaluate the knowledge, awareness, and perception toward Zika virus infection among community pharmacists in the Klang Valley of Malaysia and to determine the association between the knowledge of Zika virus infectious disease and years of community practice experience among community pharmacists in this region.
   Methods:
   This survey research was conducted from August to December 2018 through a pre-tested, self-administration, and cross-sectional random convenient sampling at various districts in the Klang Valley. A total of 275 registered community pharmacists were involved in this study by completing a pilot-tested questionnaire. Descriptive analysis, Mann-Whitney U test, and Kruskal-Wallis H test were used to analyze the data.
   Results:
   The knowledge toward Zika virus infection of respondents was classified into "poor" (5.1%), "basic" (70.9%), and "broad" (24.0%). Most of the participants (n = 195, 70.9%) presented with basic knowledge toward Zika virus infection. A total of 268 (97.5%) participants presented with high awareness toward Zika virus infection. The mean score of respondents' knowledge and awareness was 15.88 +/- 3.61 (maximum score = 28) and 13.96 +/- 1.60 (maximum score = 16), respectively. There was a statistically significant difference between the years of practice of community pharmacists and the level of knowledge toward Zika virus infection.
   Conclusions:
   In conclusion, our respondents demonstrated a basic level of knowledge and high awareness toward Zika virus infection. Also, we highlighted some possible pitfalls in the knowledge of Zika virus infection, including the virus transmission, symptoms, diagnosis, treatment, prevention, and complications of the disease.
C1 [Lim, Kah Yee; Tham, Hong-Wai] SEGi Univ, Fac Pharm, Biopharmaceut Res Unit, Jalan Teknol, Petaling Jaya 47810, Selangor, Malaysia.
RP Tham, HW (corresponding author), SEGi Univ, Fac Pharm, Biopharmaceut Res Unit, Jalan Teknol, Petaling Jaya 47810, Selangor, Malaysia.
EM thamhongwai@outlook.my
FU SEGi University Research Grant, Faculty of Pharmacy, and Research &
   Innovation Management Centre (RIMC)
FX The author(s) disclosed receipt of the following financial support for
   the research, authorship, and/or publication of this article: Research
   and publication were supported by SEGi University Research Grant,
   Faculty of Pharmacy, and Research & Innovation Management Centre (RIMC).
CR Arief M, 2017, JPPCM, V3, P81, DOI DOI 10.5530/jppcm.2017.2.20
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bautista LE, 2019, J NEUROL SCI, V403, P99, DOI 10.1016/j.jns.2019.06.019
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Car LT, 2016, BMC FAM PRACT, V17, DOI 10.1186/s12875-016-0552-6
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Christine E, 2017, AWARENESS BELIEFS AC
   Bedoya-Arias JE, 2015, J INFECT DEV COUNTR, V9, P330, DOI 10.3855/jidc.6445
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Ibrahim NK, 2018, J INFECT PUBLIC HEAL, V11, P18, DOI 10.1016/j.jiph.2017.02.015
   Katler Q, 2017, INFECT DIS OBSTET GY, V2017
   Korzeniewski K, 2016, INT MARIT HEALTH, V67, P31, DOI 10.5603/IMH.2016.0007
   Malaysia Pharmaceutical Society, AN REP DISTR POIS LI
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i720
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nguyen NM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004667
   Oster A M, 2016, MMWR-MORBID MORTAL W, V65, P1, DOI DOI 10.15585/MMWR.MM6505ELER
   Rabbani SA, 2018, J ADV PHARM TECHNOL, V9, P20, DOI 10.4103/japtr.JAPTR_239_17
   Rajiah K, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030087
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Sanchez-Montalva A, 2019, NEW ENGL J MED, V380, P198, DOI 10.1056/NEJMc1814416
   Shi YC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21894-w
   T Ismail Tengku Nur Saffawati, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3030077
   Woon YL, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3786-9
   Yadav S, 2016, J TRANSL INTERN MED, V4, P42, DOI 10.1515/jtim-2016-0009
NR 30
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1178-6329
J9 HEALTH SERV INSIGHTS
JI HEALTH SERV. INSIGHTS
PD MAY
PY 2020
VL 13
AR UNSP 1178632920921425
DI 10.1177/1178632920921425
PG 11
WC Health Care Sciences & Services
SC Health Care Sciences & Services
GA LW0ZQ
UT WOS:000538876200001
PM 32528223
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Haddad, JG
   Grauzdyte, D
   Koishi, AC
   Viranaicken, W
   Venskutonis, PR
   dos Santos, CND
   Despres, P
   Diotel, N
   El Kalamouni, C
AF Haddad, Juliano G.
   Grauzdyte, Dovile
   Koishi, Andrea Cristine
   Viranaicken, Wildriss
   Venskutonis, Petras Rimantas
   Duarte dos Santos, Claudia Nunes
   Despres, Philippe
   Diotel, Nicolas
   El Kalamouni, Chaker
TI The Geraniin-Rich Extract from Reunion Island Endemic Medicinal Plant
   Phyllanthus phillyreifolius Inhibits Zika and Dengue Virus Infection at
   Non-Toxic Effect Doses in Zebrafish
SO MOLECULES
LA English
DT Article
DE zika virus; dengue virus; medicinal plants; antiviral activity;
   geraniin; Phyllanthus phillyreifolius; zebrafish
ID IN-VITRO; CELLS; PHYTOCHEMISTRY; PHARMACOLOGY; EPIDEMIC; ENTRY
AB The mosquito-borne viruses dengue (DENV) and Zika (ZIKV) viruses are two medically important pathogens in tropical and subtropical regions of the world. There is an urgent need of therapeutics against DENV and ZIKV, and medicinal plants are considered as a promising source of antiviral bioactive metabolites. In the present study, we evaluated the ability of Phyllanthus phillyreifolius, an endemic medicinal plant from Reunion Island, to prevent DENV and ZIKV infection in human cells. At non-cytotoxic concentration in vitro, incubation of infected A549 cells with a P. phillyreifolius extract or its major active phytochemical geraniin resulted in a dramatic reduction of virus progeny production for ZIKV as well as four serotypes of DENV. Virological assays showed that P. phillyreifolius extract-mediated virus inhibition relates to a blockade in internalization of virus particles into the host cell. Infectivity studies on ZIKV showed that both P. phillyreifolius and geraniin cause a loss of infectivity of the viral particles. Using a zebrafish model, we demonstrated that administration of P. phillyreifolius and geraniin has no effect on zebrafish locomotor activity while no morbidity nor mortality was observed up to 5 days post-inoculation. Thus, P. phillyreifolius could act as an important source of plant metabolite geraniin which is a promising antiviral compound in the fight against DENV and ZIKV.
C1 [Haddad, Juliano G.; Viranaicken, Wildriss; Despres, Philippe; El Kalamouni, Chaker] Univ Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, INSERM,U1187,CNRS,UMR 9192,IRD,UMR 249, F-94791 St Clotilde, France.
   [Grauzdyte, Dovile; Venskutonis, Petras Rimantas] Kaunas Univ Technol, Dept Food Sci & Technol, Radvilenu Pl 19, LT-50254 Kaunas, Lithuania.
   [Koishi, Andrea Cristine; Duarte dos Santos, Claudia Nunes] Inst Carlos Chagas, Lab Virol Mol, FIOCRUZ, ICC,PR, BR-81350010 Curitiba, Parana, Brazil.
   [Diotel, Nicolas] Univ La Reunion, Diabete Atherothrombose Therapies Reunion Ocean I, INSERM, UMR 1188, F-97490 St Denis De La Reunion, France.
RP El Kalamouni, C (corresponding author), Univ Reunion, Unite Mixte Proc Infect Milieu Insulaire Trop, Plateforme Technol CYROI, INSERM,U1187,CNRS,UMR 9192,IRD,UMR 249, F-94791 St Clotilde, France.
EM juliano.haddad@univ-reunion.fr; dovile.grauzdyte@ktu.lt;
   ackoishi@gmail.com; wildriss.viranaicken@univ-reunion.fr;
   rimas.venskutonis@ktu.lt; clsantos@fiocruz.br;
   philippe.despres@univ-reunion.fr; nicolas.diotel@univ-reunion.fr;
   chaker.el-kalamouni@univ-reunion.fr
FU POE FEDER 2014-20 of the Conseil Regional de La Reunion (ZIKAlert
   program) [SYNERGIE: RE00001902]; FEDEREuropean Union (EU) [RE0022527];
   Research Federation BioST, Universite de La Reunion; CAPES-COFECUBCAPES
   [Me889/17]; ZIKAlert program
FX This research was funded by POE FEDER 2014-20 of the Conseil Regional de
   La Reunion (ZIKAlert program, Nffi SYNERGIE: RE00001902), FEDER
   RE0022527 (ZEBRATOX), Research Federation BioST, Universite de La
   Reunion and CAPES-COFECUB Me889/17 ZIKANET project. J.G.H. received
   funding from the ZIKAlert program.
CR Ahmad SAA, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0895-1
   Balasubramanian A, 2019, ANTIVIR RES, V162, P71, DOI 10.1016/j.antiviral.2018.12.002
   Besnard M, 2016, EUROSURVEILLANCE, V21, P22, DOI 10.2807/1560-7917.ES.2016.21.13.30181
   Borchering RK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13628-x
   Bos S, 2018, PATHOG GLOB HEALTH, V112, P294, DOI 10.1080/20477724.2018.1514136
   Byler KG, 2016, J MOL GRAPH MODEL, V69, P78, DOI 10.1016/j.jmgm.2016.08.011
   Calvet GA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2965-4
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.67
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Choi JG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48430-8
   Clain E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081860
   Clain E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29183-2
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Frabasile S, 2017, SCI REP-UK, V7, DOI 10.1038/srep41864
   Frumence E, 2016, VIROLOGY, V493, P217, DOI 10.1016/j.virol.2016.03.006
   Gadea G, 2016, VIROLOGY, V497, P157, DOI 10.1016/j.virol.2016.07.015
   Gaudry A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19041093
   Grauzdyte D, 2020, NAT PROD RES, V34, P706, DOI 10.1080/14786419.2018.1493586
   Grauzdyte D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207672
   Gu C, 2019, FITOTERAPIA, V137, DOI 10.1016/j.fitote.2019.04.006
   Haddad JG, 2019, MOLECULES, V24, DOI 10.3390/molecules24193447
   Haddad JG, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20102382
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hill AJ, 2005, TOXICOL SCI, V86, P6, DOI 10.1093/toxsci/kfi110
   Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111
   Jung J, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0792-3
   Kaur N, 2017, PHYTOTHER RES, V31, P980, DOI 10.1002/ptr.5825
   Lee NYS, 2016, J PHARM PHARMACOL, V68, P953, DOI 10.1111/jphp.12565
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Mahomoodally MF, 2019, FOOD RES INT, V115, P425, DOI 10.1016/j.foodres.2018.10.075
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nisar MF, 2018, MOLECULES, V23, DOI 10.3390/molecules23102567
   Pan SY, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/627375
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pascalis H, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01455
   Patel JR, 2011, J ETHNOPHARMACOL, V138, P286, DOI 10.1016/j.jep.2011.09.040
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Powers CN, 2016, COMB CHEM HIGH T SCR, V19, P516, DOI 10.2174/1386207319666160506123715
   Romero JAF, 2003, PHYTOTHER RES, V17, P980, DOI 10.1002/ptr.1300
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Tan WC, 2013, INT J MED SCI, V10, P1817, DOI 10.7150/ijms.6902
   Tang TL, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040523
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Williams CH, 2011, INT J MOL SCI, V12, P2262, DOI 10.3390/ijms12042262
   Yang CM, 2007, J ETHNOPHARMACOL, V110, P555, DOI 10.1016/j.jep.2006.09.039
   Yang YJ, 2012, BIOORG MED CHEM LETT, V22, P2209, DOI 10.1016/j.bmcl.2012.01.102
   Yeh CM, 2019, ENVIRON TOXICOL, V34, P1085, DOI 10.1002/tox.22809
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zhou YM, 2019, ENVIRON TOXICOL PHAR, V69, P80, DOI 10.1016/j.etap.2019.04.003
NR 58
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD MAY
PY 2020
VL 25
IS 10
DI 10.3390/molecules25102316
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LW6ZT
UT WOS:000539293400049
PM 32429073
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kim, J
   Alejandro, B
   Hetman, M
   Hattab, EM
   Joiner, J
   Schroten, H
   Ishikawa, H
   Chung, DH
AF Kim, Jihye
   Alejandro, Brian
   Hetman, Michal
   Hattab, Eyas M.
   Joiner, Joshua
   Schroten, Horst
   Ishikawa, Hiroshi
   Chung, Dong-Hoon
TI Zika virus infects pericytes in the choroid plexus and enters the
   central nervous system through the blood-cerebrospinal fluid barrier
SO PLOS PATHOGENS
LA English
DT Article
ID EPITHELIAL-CELLS; MOUSE MODEL; AXL; ANTIBODIES; RHESUS; ENTRY
AB Author summary
   Zika virus invades the human brains and causes Zika-associated neurological complications; however, the mechanism(s) by which Zika virus accesses the central nerves system remain unclear. Understanding of the cellular and molecular mechanisms will shed light on development of novel therapeutic and prophylactic targets for Zika virus and other neurotropic viruses. Here we use in vivo and in vitro models to understand how Zika virus enters the brain. In mouse models, we found that Zika virus infects pericytes in the choroid plexus at very early stages of infection and neutralization of Zika virus in the cerebrospinal fluid significantly attenuates the brain infection. Further we show evidence that Zika virus can cross the epithelial cell layers in the choroid plexus from the blood side. Our research highlights that ZIKV invades the host brain by exploiting the blood-CSF barrier rather than the blood-brain barrier.
   Zika virus (ZIKV) can infect and cause microcephaly and Zika-associated neurological complications in the developing fetal and adult brains. In terms of pathogenesis, a critical question is how ZIKV overcomes the barriers separating the brain from the circulation and gains access to the central nervous system (CNS). Despite the importance of ZIKV pathogenesis, the route ZIKV utilizes to cross CNS barriers remains unclear. Here we show that in mouse models, ZIKV-infected cells initially appeared in the periventricular regions of the brain, including the choroid plexus and the meninges, prior to infection of the cortex. The appearance of ZIKV in cerebrospinal fluid (CSF) preceded infection of the brain parenchyma. Further the brain infection was significantly attenuated by neutralization of the virus in the CSF, indicating that ZIKV in the CSF at the early stage of infection might be responsible for establishing a lethal infection of the brain. We show that cells infected by ZIKV in the choroid plexus were pericytes. Using in vitro systems, we highlight the possibility that ZIKV crosses the blood-CSF barrier by disrupting the choroid plexus epithelial layer. Taken together, our results suggest that ZIKV might exploit the blood-CSF barrier rather than the blood-brain barrier to invade the CNS.
C1 [Kim, Jihye; Alejandro, Brian; Chung, Dong-Hoon] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.
   [Hetman, Michal] Univ Louisville, Sch Med, Dept Neurol Surg, Louisville, KY 40292 USA.
   [Hattab, Eyas M.] Univ Louisville, Dept Pathol & Lab Med, Louisville, KY 40292 USA.
   [Joiner, Joshua] Ctr Coll Danville, Danville, KY USA.
   [Schroten, Horst] Heidelberg Univ, Med Fac Mannheim, Dept Pediat Pediat Infect Dis, Mannheim, Germany.
   [Ishikawa, Hiroshi] Univ Tsukuba, Fac Med, Dept Neurosurg, Lab Clin Regenerat Med, Tsukuba, Ibaraki, Japan.
   [Chung, Dong-Hoon] Univ Louisville, Sch Med, Ctr Predict Med, Louisville, KY 40292 USA.
RP Chung, DH (corresponding author), Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA.; Chung, DH (corresponding author), Univ Louisville, Sch Med, Ctr Predict Med, Louisville, KY 40292 USA.
EM dhchun01@louisville.edu
RI ; Hattab, Eyas/E-9342-2016
OI Alejandro, Brian/0000-0001-9711-8950; Hattab, Eyas/0000-0002-3660-6261
FU Collaborative Matching Grant Program from School of Medicine, University
   of Louisville
FX D.C and M.H were supported by the Collaborative Matching Grant Program
   from School of Medicine, University of Louisville. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   [Anonymous], 2016, ISRAEL NUMISMATIC J, V19, P120
   [Anonymous], 2014, J CLIN DIAGN RES, V8
   Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522
   BEARER EL, 1985, J CELL BIOL, V100, P418, DOI 10.1083/jcb.100.2.418
   Benarroch EE, 2016, NEUROLOGY, V86, P286, DOI 10.1212/WNL.0000000000002298
   Bergman I, 1998, J PHARMACOL EXP THER, V284, P111
   Boroujerdi A, 2014, METHODS MOL BIOL, V1135, P383, DOI 10.1007/978-1-4939-0320-7_31
   Bowyer JF, 2012, JOVE-J VIS EXP, DOI 10.3791/4285
   Cain MD, 2017, J NEUROIMMUNOL, V308, P118, DOI 10.1016/j.jneuroim.2017.04.008
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang CY, 2017, BRAIN BEHAV IMMUN, V66, P230, DOI 10.1016/j.bbi.2017.07.003
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Cheng JP, 2018, ACTA NEUROPATHOL, V136, P507, DOI 10.1007/s00401-018-1893-0
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Dinner S, 2016, JOVE-J VIS EXP, DOI 10.3791/54061
   Dore-Duffy P, 2008, CURR PHARM DESIGN, V14, P1581, DOI 10.2174/138161208784705469
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duan LH, 2018, NEURON, V100, P183, DOI 10.1016/j.neuron.2018.08.030
   da Silva IRF, 2017, JAMA NEUROL, V74, P1190, DOI 10.1001/jamaneurol.2017.1703
   Gaceb A, 2018, ADV EXP MED BIOL, V1109, P139, DOI 10.1007/978-3-030-02601-1_11
   Goritz C, 2011, SCIENCE, V333, P238, DOI 10.1126/science.1203165
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grapp M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3123
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hartmann DA, 2015, MICROCIRCULATION, V22, P168, DOI 10.1111/micc.12176
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Ishiwata Isamu, 2005, Hum Cell, V18, P67
   Janssen SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083345
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johnson DM, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8010114
   Johnson MB, 2015, NAT NEUROSCI, V18, P637, DOI 10.1038/nn.3980
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kowapradit J, 2010, AAPS PHARMSCITECH, V11, P497, DOI 10.1208/s12249-010-9399-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazarevic I, 2016, FLUIDS BARRIERS CNS, V13, DOI 10.1186/s12987-016-0027-0
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liddelow SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106592
   Lim NKH, 2018, JOVE-J VIS EXP, DOI 10.3791/56774
   Manangeeswaran M, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0096-z
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Montagne A, 2018, NAT MED, V24, P326, DOI 10.1038/nm.4482
   Nigri F, 2016, SURG NEUROL INT S31, V7, pS785
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Hara BA, 2018, J VIROL, V92, DOI 10.1128/JVI.00105-18
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Praetorius J, 2017, AM J PHYSIOL-CELL PH, V312, pC673, DOI 10.1152/ajpcell.00041.2017
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sarin H, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-14
   Saunders NR, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00404
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Strange DP, 2019, MBIO, V10, DOI 10.1128/mBio.01372-19
   Sweeney MD, 2016, NAT NEUROSCI, V19, P771, DOI 10.1038/nn.4288
   The Lancet Haematology, 2018, LANCET HAEMATOL, V5, pe127
   Uriarte M, 2019, MOL NEUROBIOL, V56, P4120, DOI 10.1007/s12035-018-1362-8
   Wang F, 2012, J MOL DIAGN, V14, P22, DOI 10.1016/j.jmoldx.2011.08.002
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wolburg H, 2010, ACTA NEUROPATHOL, V119, P75, DOI 10.1007/s00401-009-0627-8
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   ZHENG W, 1991, FASEB J, V5, P2188
NR 75
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2020
VL 16
IS 5
AR e1008204
DI 10.1371/journal.ppat.1008204
PG 27
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA LU9GE
UT WOS:000538054300053
PM 32357162
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Simanjuntak, Y
   Ko, HY
   Lee, YL
   Yu, GY
   Lin, YL
AF Simanjuntak, Yogy
   Ko, Hui-Ying
   Lee, Yi-Ling
   Yu, Guann-Yi
   Lin, Yi-Ling
TI Preventive effects of folic acid on Zika virus-associated poor pregnancy
   outcomes in immunocompromised mice
SO PLOS PATHOGENS
LA English
DT Article
ID SPONTANEOUS-ABORTION; IN-VIVO; INFECTION; PLACENTA; BARRIER;
   SUPPLEMENTATION; JUNCTIONS; ALPHA; CELLS; WOMEN
AB Author summary
   Zika virus (ZIKV) infection in pregnant women may cause a broad spectrum of abnormal pregnancy outcomes. Folic acid (FA) is an essential water-soluble vitamin B required for placental and fetal development to avoid placental abruption, neural tube defects, intrauterine growth restriction, and pregnancy loss. However, the beneficial role of FA in improving clinical presentations with in utero transmission of ZIKV is unknown. We observe that FA treatment increases the level of maternal serum FA and improves feto-placental outcomes in two mouse models of in utero transmission of ZIKV. FA blocks ZIKV transmission in a cell culture model of blood-placental barrier by inhibiting viral replication in endothelial cells. This study may serve as a scientific reference for public health practitioners to evaluate the FA status of pregnant women with ZIKV-infection and the correlation with their pregnancy outcomes.
   Zika virus (ZIKV) infection may lead to congenital microcephaly and pregnancy loss in pregnant women. In the context of pregnancy, folic acid (FA) supplementation may reduce the risk of abnormal pregnancy outcomes. Intriguingly, FA may have a beneficial effect on the adverse pregnancy outcomes associated with ZIKV infection. Here, we show that FA inhibits ZIKV replication in human umbilical vein endothelial cells (HUVECs) and a cell culture model of blood-placental barrier (BPB). The inhibitory effect of FA against ZIKV infection is associated with FR alpha-AMPK signaling. Furthermore, treatment with FA reduces pathological features in the placenta, number of fetal resorptions, and stillbirths in two mouse models of in utero ZIKV transmission. Mice with FA treatment showed lower viral burden and better prognostic profiles in the placenta including reduced inflammatory response, and enhanced integrity of BPB. Overall, our findings suggest the preventive role of FA supplementation in ZIKV-associated abnormal pregnancy and warrant nutritional surveillance to evaluate maternal FA status in areas with active ZIKV transmission.
C1 [Simanjuntak, Yogy; Ko, Hui-Ying; Lee, Yi-Ling; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Ko, Hui-Ying] Natl Chung Hsing Univ, Grad Inst Microbiol & Publ Hlth, Coll Vet Med, Taichung, Taiwan.
   [Yu, Guann-Yi] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Zhunan, Taiwan.
RP Simanjuntak, Y; Lin, YL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
EM yogy@ibms.sinica.edu.tw; yll@ibms.sinica.edu.tw
RI ; Lin, Yi-Ling/N-7128-2018
OI Lee, Yi-Ling/0000-0002-0220-1119; Yu, Guann-Yi/0000-0002-0580-8282;
   Simanjuntak, Yogy/0000-0002-8983-0451; Lin, Yi-Ling/0000-0002-1838-6410
FU Academia SinicaAcademia Sinica - Taiwan [AS-Summit-109,
   109-2101-01-19-20]; Ministry of Science and Technology, TaiwanMinistry
   of Science and Technology, Taiwan [MOST 108-3114-Y-001-002, MOST
   108-2321-B-001-011, MOST 108-2320-B-001-030-MY3]
FX This work was supported by Academia Sinica (AS-Summit-109,
   109-2101-01-19-20 to YLLIN) and the Ministry of Science and Technology,
   Taiwan (MOST 108-3114-Y-001-002, MOST 108-2321-B-001-011, MOST
   108-2320-B-001-030-MY3 to YLLIN).The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation to the manuscript.
CR Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19
   Agrawal T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069465
   [Anonymous], 2017, EUR GERIATR MED, V8, pS98
   [Anonymous], 2015, AM J PHYSIOL-HEART C, V309, pH532
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bailey L. B., 2012, Present knowledge in nutrition, P321
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baschat AA, 2004, BJOG-INT J OBSTET GY, V111, P1031, DOI 10.1111/j.1471-0528.2004.00273.x
   Bibbins-Domingo K, 2017, JAMA-J AM MED ASSOC, V317, P183, DOI 10.1001/jama.2016.19438
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Charan J, 2013, J PHARMACOL PHARMACO, V4, P303, DOI 10.4103/0976-500X.119726
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen LK, 1996, VIROLOGY, V223, P79, DOI 10.1006/viro.1996.0457
   Cotechini T, 2015, PLACENTA, V36, P960, DOI 10.1016/j.placenta.2015.05.016
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Forster MD, 2007, CYTOM PART A, V71A, P945, DOI 10.1002/cyto.a.20456
   Gaskins AJ, 2014, OBSTET GYNECOL, V124, P23, DOI 10.1097/AOG.0000000000000343
   Gelber SE, 2015, J IMMUNOL, V195, P1129, DOI 10.4049/jimmunol.1402220
   Gonce A, 2018, EMERG INFECT DIS, V24, P933, DOI 10.3201/eid2405.171479
   Greijer AE, 2004, J CLIN PATHOL, V57, P1009, DOI 10.1136/jcp.2003.015032
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Holven KB, 2002, ARTERIOSCL THROM VAS, V22, P699, DOI 10.1161/01.ATV.0000013288.35930.90
   Huang XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151553
   Hunt Michelle A, 2010, J Biomol Tech, V21, P66
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Kaiser WJ, 2004, J IMMUNOL, V172, P1699, DOI 10.4049/jimmunol.172.3.1699
   Kelemen LE, 2006, INT J CANCER, V119, P243, DOI 10.1002/ijc.21712
   Kumagai A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103076
   Kumar A, 2019, J IMMUNOL, V202, P12719
   Leach L, 2002, J ANAT, V200, P599, DOI 10.1046/j.1469-7580.2002.00062.x
   Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998
   Linhares AO, 2017, CIENC SAUDE COLETIVA, V22, P535, DOI 10.1590/1413-81232017222.06302016
   McDonald SD, 2002, AM J OBSTET GYNECOL, V187, P620, DOI 10.1067/mob.2002.125239
   Miller B, 2010, CONTEMP SECUR POL, V31, P134, DOI 10.1080/13523261003640967
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Niu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067203
   Parks WH, 2010, NEW YORK U J INT LAW, V42, P769
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861
   Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Sarno M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004517
   Selhub J, 2016, BIOCHIMIE, V126, P71, DOI 10.1016/j.biochi.2016.04.010
   Shahraki Azar Danesh, 2016, Adv Biomed Res, V5, P192, DOI 10.4103/2277-9175.190944
   Silva JF, 2016, CELL ADHES MIGR, V10, P88, DOI 10.1080/19336918.2015.1120397
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Stanhewicz AE, 2017, NUTR REV, V75, P61, DOI 10.1093/nutrit/nuw053
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Thaker SK, 2019, CELL METAB, V29, P1206, DOI 10.1016/j.cmet.2019.01.024
   Tossetta G, 2014, PLACENTA, V35, P509, DOI 10.1016/j.placenta.2014.03.016
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wald NJ, 2001, LANCET, V358, P2069, DOI 10.1016/S0140-6736(01)07104-5
   Wen SW, 2008, CAN MED ASSOC J, V179, P1263, DOI 10.1503/cmaj.080859
   Westin SN, 2012, CLIN GYNECOLOGIC ONC, P539
   Williams PJ, 2011, BIOL REPROD, V84, P1148, DOI 10.1095/biolreprod.110.088351
   Wu YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11568-4
NR 58
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2020
VL 16
IS 5
AR e1008521
DI 10.1371/journal.ppat.1008521
PG 23
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA LU9GE
UT WOS:000538054300057
PM 32392268
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tan, TY
   Fibriansah, G
   Lok, SM
AF Tan, Ter Yong
   Fibriansah, Guntur
   Lok, Shee-Mei
TI Capsid protein is central to the birth of flavivirus particles
SO PLOS PATHOGENS
LA English
DT Article
ID DENGUE VIRUS; ZIKA VIRUS; IN-VITRO; IMMATURE; ORGANIZATION; MATURATION;
   INSIGHT; REGION; PH
C1 [Tan, Ter Yong; Fibriansah, Guntur; Lok, Shee-Mei] Duke Natl Univ Singapore, Programme Emerging Infect Dis, Sch Med, Singapore, Singapore.
   [Tan, Ter Yong; Fibriansah, Guntur; Lok, Shee-Mei] Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore, Singapore.
RP Lok, SM (corresponding author), Duke Natl Univ Singapore, Programme Emerging Infect Dis, Sch Med, Singapore, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Dept Biol Sci, Ctr BioImaging Sci, Singapore, Singapore.
EM sheemei.lok@duke-nus.edu.sg
OI Lok, Shee-Mei/0000-0003-4631-8041; Tan, Ter Yong/0000-0002-6540-7026
FU Singapore Ministry of Education Tier 3 grantMinistry of Education,
   Singapore [MOE2012-T3-1-008]; National Research Foundation
   Investigatorship award [NRF-NRFI2016-01]; National Research Foundation
   competitive Research Project [NRF2016NRF-CRP001-063,
   NRF2017NRF-CRP001-027]; DukeNUS Signature Research Programme - Ministry
   of Health, SingaporeMinistry of Health-SingaporeNational University of
   Singapore
FX The work in this publication was supported by Singapore Ministry of
   Education Tier 3 grant (MOE2012-T3-1-008), National Research Foundation
   Investigatorship award (NRF-NRFI2016-01), and National Research
   Foundation competitive Research Project grants (NRF2016NRF-CRP001-063
   and NRF2017NRF-CRP001-027) awarded to S-ML, and the DukeNUS Signature
   Research Programme funded by the Ministry of Health, Singapore. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR AMBERG SM, 1994, J VIROL, V68, P3794, DOI 10.1128/JVI.68.6.3794-3802.1994
   Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   de Haan CAM, 2005, ADV VIRUS RES, V64, P165, DOI 10.1016/S0065-3527(05)64006-7
   Dokland T, 2004, STRUCTURE, V12, P1157, DOI 10.1016/j.str.2004.04.024
   Ferlenghi I, 2001, MOL CELL, V7, P593, DOI 10.1016/S1097-2765(01)00206-4
   Garoff H, 2004, VIRUS RES, V106, P103, DOI 10.1016/j.virusres.2004.08.008
   Klumpp K, 2018, GASTROENTEROLOGY, V154, P652, DOI 10.1053/j.gastro.2017.10.017
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kostyuchenko VA, 2013, J VIROL, V87, P7700, DOI 10.1128/JVI.00197-13
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Martinez MG, 2014, J VIROL, V88, P6922, DOI 10.1128/JVI.00592-14
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Neuman BW, 2006, J VIROL, V80, P7918, DOI 10.1128/JVI.00645-06
   Paroutis P, 2004, PHYSIOLOGY, V19, P207, DOI 10.1152/physiol.00005.2004
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Selzer L, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a021394
   Shang ZF, 2018, J MOL BIOL, V430, P948, DOI 10.1016/j.jmb.2018.02.006
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tan Ter Yong, 2020, Nat Commun, V11, P895, DOI 10.1038/s41467-020-14647-9
   Tellinghuisen TL, 2001, J VIROL, V75, P2810, DOI 10.1128/JVI.75.6.2810-2817.2001
   Thenin-Houssier S, 2016, CURR HIV RES, V14, P270, DOI 10.2174/1570162X14999160224103555
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
NR 28
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2020
VL 16
IS 5
AR e1008542
DI 10.1371/journal.ppat.1008542
PG 8
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA LU9GE
UT WOS:000538054300017
PM 32463839
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, JQ
   Ye, HQ
   Zhang, QY
   Lu, GL
   Zhang, B
   Gong, P
AF Wu, Jiqin
   Ye, Han-Qing
   Zhang, Qiu-Yan
   Lu, Guoliang
   Zhang, Bo
   Gong, Peng
TI A conformation-based intra-molecular initiation factor identified in the
   flavivirus RNA-dependent RNA polymerase
SO PLOS PATHOGENS
LA English
DT Article
ID DENGUE-VIRUS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ZIKA-VIRUS; NS5;
   PROTEIN; METHYLTRANSFERASE; TRANSCRIPTION; ELONGATION; DOMAIN
AB The flaviviruses pose serious threats to human health. Being a natural fusion of a methyltransferase (MTase) and an RNA-dependent RNA polymerase (RdRP), NS5 is the most conserved flavivirus protein and an important antiviral target. Previously reported NS5 structures represented by those from the Japanese encephalitis virus (JEV) and Dengue virus serotype 3 (DENV3) exhibit two apparently different global conformations, defining two sets of intra-molecular MTase-RdRP interactions. However, whether these NS5 conformations are conserved in flaviviruses and their specific functions remain elusive. Here we report two forms of DENV serotype 2 (DENV2) NS5 crystal structures representing two conformational states with defined analogies to the JEV-mode and DENV3-mode conformations, respectively, demonstrating the conservation of both conformation modes and providing clues for how different conformational states may be interconnected. Data from in vitro polymerase assays further demonstrate that perturbing the JEV-mode but not the DENV3-mode intra-molecular interactions inhibits catalysis only at initiation, while the cell-based virological analysis suggests that both modes of interactions are important for virus proliferation. Our work highlights the role of MTase as a unique intra-molecular initiation factor specifically only through the JEV-mode conformation, providing an example of conformation-based crosstalk between naturally fused protein functional modules.
   Author summary
   The function of a protein is often dictated by a single defined fold, which in turn is determined by its amino acid sequences. However, multiple global conformations can be utilized by a protein to fulfill distinct functions under different circumstances. The flavivirus NS5 protein, a natural fusion of an N-terminal methyltransferase (MTase) and a C-terminal RNA-dependent RNA polymerase (RdRP), may be such an example. Previously reported NS5 crystal structures exhibit two apparently different global conformations. In this work, we demonstrate that both conformations are conserved in the flaviviruses and important for virus proliferation, but only one of them is clearly relevant to RdRP catalysis, in particular at the early stages of the RNA synthesis.
C1 [Wu, Jiqin; Ye, Han-Qing; Zhang, Qiu-Yan; Lu, Guoliang; Zhang, Bo; Gong, Peng] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.
   [Wu, Jiqin; Zhang, Qiu-Yan; Lu, Guoliang] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Wu, Jiqin] Chinese Acad Sci, Wuhan Inst Phys & Math, Wuhan, Hubei, Peoples R China.
   [Gong, Peng] Nankai Univ, Drug Discovery Ctr Infect Dis, Tianjin, Peoples R China.
RP Gong, P (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Hubei, Peoples R China.; Gong, P (corresponding author), Nankai Univ, Drug Discovery Ctr Infect Dis, Tianjin, Peoples R China.
EM gongpeng@wh.iov.cn
OI Ye, Han-Qing/0000-0001-7770-4071; Zhang, Bo/0000-0002-8895-3679; Zhang,
   Qiuyan/0000-0003-2223-6869; ?, ?/0000-0002-8264-7523
FU National Key Research and Development Program of China [2018YFA0507200,
   2016YFC1200400]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [31670154, 31370198]
FX This work was supported by the National Key Research and Development
   Program of China (www.most.gov.cn, 2018YFA0507200 to PG, and
   2016YFC1200400 to HQY), the National Natural Science Foundation of China
   (www.nsfc.gov.cn, 31670154 to PG and 31370198 to PG).The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   [Anonymous], 2014, J CLIN DIAGN RES, V8
   Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200
   Bruenn JA, 2003, NUCLEIC ACIDS RES, V31, P1821, DOI 10.1093/nar/gkg277
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254
   Bukrejewska M, 2017, ACTA CRYSTALLOGR D, V73, P767, DOI 10.1107/S2059798317010737
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Dubankova A, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104536
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   El Sahili A, 2020, J VIROL, V94, DOI 10.1128/JVI.01294-19
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Ferrero DS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007656
   Geiss BJ, 2009, J MOL BIOL, V385, P1643, DOI 10.1016/j.jmb.2008.11.058
   Gerlach P, 2015, CELL, V161, P1267, DOI 10.1016/j.cell.2015.05.006
   Gorbalenya AE, 2002, J MOL BIOL, V324, P47, DOI 10.1016/S0022-2836(02)01033-1
   Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7
   Hobdey SE, 2010, J VIROL, V84, P8072, DOI 10.1128/JVI.02147-09
   Hodel AE, 1996, CELL, V85, P247, DOI 10.1016/S0092-8674(00)81101-0
   HONDA A, 1986, J BIOL CHEM, V261, P5987
   Jia HX, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01945
   Jin ZN, 2012, J BIOL CHEM, V287, P10674, DOI 10.1074/jbc.M111.325530
   Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li XD, 2014, J GEN VIROL, V95, P806, DOI 10.1099/vir.0.061838-0
   Liang B, 2015, CELL, V162, P314, DOI 10.1016/j.cell.2015.06.018
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Liu WC, 2018, NUCLEIC ACIDS RES, V46, P10840, DOI 10.1093/nar/gky848
   Lu GL, 2016, ONCOTARGET, V7, P35498, DOI 10.18632/oncotarget.9565
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   Ma YH, 2017, VIRUS RES, V232, P34, DOI [10.1016/j.virusres.2017.01.021, 10.1016/j.virusres.2017.01.020]
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Manimekalai MSS, 2016, ACTA CRYSTALLOGR D, V72, P795, DOI 10.1107/S2059798316006665
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Otwinowski Z, 1997, PROCESSING XRAY DIFF
   Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008
   Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X
   Potisopon S, 2014, NUCLEIC ACIDS RES, V42, P11642, DOI 10.1093/nar/gku666
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Saberi A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007314
   SAMUELS M, 1984, J BIOL CHEM, V259, P2517
   Saw WG, 2015, ACTA CRYSTALLOGR D, V71, P2309, DOI 10.1107/S1399004715017721
   Shu B, 2017, RNA BIOL, V14, P1314, DOI 10.1080/15476286.2017.1300221
   Shu B, 2016, P NATL ACAD SCI USA, V113, pE4005, DOI 10.1073/pnas.1602591113
   Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129
   Theis Karsten, 2013, Virologica Sinica, V28, P337, DOI 10.1007/s12250-013-3397-3
   Theobald DL, 2006, BIOINFORMATICS, V22, P2171, DOI 10.1093/bioinformatics/btl332
   Thompson AA, 2004, EMBO J, V23, P3462, DOI 10.1038/sj.emboj.7600357
   Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Wang BX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14763
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Wu JQ, 2015, J VIROL, V89, P249, DOI 10.1128/JVI.02085-14
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yin YW, 2002, SCIENCE, V298, P1387, DOI 10.1126/science.1077464
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao YQ, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004682
   Zheng ZF, 2018, J IMMUNOL, V201, P53, DOI 10.4049/jimmunol.1701507
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 62
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAY
PY 2020
VL 16
IS 5
AR e1008484
DI 10.1371/journal.ppat.1008484; 10.1371/journal.ppat.1008484.r001;
   10.1371/journal.ppat.1008484.r002; 10.1371/journal.ppat.1008484.r003;
   10.1371/journal.ppat.1008484.r004
PG 25
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA LU9GE
UT WOS:000538054300051
PM 32357182
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Niemeyer, B
   Hollanda, R
   Muniz, B
   Marchiori, E
AF Niemeyer, Bruno
   Hollanda, Rafael
   Muniz, Bernardo
   Marchiori, Edson
TI What We Can Find Beyond the Classic Neuroimaging Findings of Congenital
   Zika Virus Syndrome?
SO EUROPEAN NEUROLOGY
LA English
DT Review
DE Congenital infection; Congenital Zika syndrome; Magnetic resonance
   imaging; Neuroinfectiology; Neuroimaging; Zika virus
ID TERATOGEN UPDATE; INFECTION; SPECTRUM
AB Background: In 1947, Zika virus (ZIKV) was first discovered in Monkeys, in Zika Forest, in Uganda, Africa. Five years later, (1952) the first human Zika infection was detected in Nigeria, Africa. After this date, only sporadic cases happened, until the first 3 epidemics occurred, all outside Africa. The first epidemic was in Yap Island in 2007, the second in French Polynesia in 2013, and the third in 2015 in the northeast of Brazil, and then the spread to the Americas in 2015 and 2016. However, it was only after the epidemic in the northeast of Brazil, in the first half of 2015, that many babies were born with microcephaly in the second semester of that same year and in 2016. Until now, every year, some babies are still born with congenital ZIKV syndrome (CZVS). Summary: The objective of this article is to describe infrequent and rarely discussed imaging (computed tomography and magnetic resonance imaging) findings of CZVS, in addition to those classically described such as a simplified gyral pattern, ventriculomegaly, corpus callosum dysgenesis, craniofacial disproportion, and redundant scalp, thus suggesting an increase in the spectrum of neurological findings related to the syndrome.
C1 [Niemeyer, Bruno] Hosp Casa Portugal, Inst Estadual Cerebro Paulo Niemeyer, Rio De Janeiro, Brazil.
   [Niemeyer, Bruno] Hosp Casa Portugal, 3D Diagnost Imagem, Rua Bispo 72, BR-20261064 Rio De Janeiro, RJ, Brazil.
   [Hollanda, Rafael; Muniz, Bernardo] Hosp Casa Portugal, 3D Diagnost Imagem, Dept Radiol, Rio De Janeiro, Brazil.
   [Marchiori, Edson] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil.
RP Niemeyer, B (corresponding author), Hosp Casa Portugal, 3D Diagnost Imagem, Rua Bispo 72, BR-20261064 Rio De Janeiro, RJ, Brazil.
EM bruno.niemeyer@hotmail.com
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1045, DOI 10.3174/ajnr.A5125
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Blazquez AB, WORLD J VIROL
   Ribeiro BND, 2018, J NEURORADIOLOGY, V45, P152, DOI 10.1016/j.neurad.2017.11.007
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, EUR J MED GENET, V60, P55, DOI 10.1016/j.ejmg.2016.10.004
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Hajra A, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12607
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   LAMMER EJ, 1987, TERATOLOGY, V35, P465, DOI 10.1002/tera.1420350319
   Lowe R, INT J ENV RES PUBLIC
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, N ENGL J MED
   Moniz N, 2018, PR INT CONF DATA SC, P150, DOI 10.1109/DSAA.2018.00025
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Niemeyer B, 2017, EUR NEUROL, V77, P45, DOI 10.1159/000453396
   Peixoto Filho Aníbal Araujo Alves, 2018, Radiol Bras, V51, P119, DOI 10.1590/0100-3984.2016.0135
   Petribu NC, BMJ
   Pinheiro TJ, 2016, ARQ NEURO-PSIQUIAT, V74, P937, DOI [10.1590/0004-282x20160138, 10.1590/0004-282X20160138]
   Rezende AC, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5177-3
   Ribeiro Bruno Niemeyer de Freitas, 2018, Radiol Bras, V51, pVII, DOI 10.1590/0100-3984.2018.51.2e2
   Ribeiro Bruno Niemeyer de Freitas, 2017, Radiol Bras, V50, P314, DOI 10.1590/0100-3984.2017.0098
   SHEPARD TH, 1994, TERATOLOGY, V50, P97, DOI 10.1002/tera.1420500202
   Ticconi C, 2016, PATHOG GLOB HEALTH, V110, P262, DOI 10.1080/20477724.2016.1234804
   van der Linden V, 2019, JAMA NEUROL, V76, P203, DOI 10.1001/jamaneurol.2018.3553
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wang JN, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13101031
   Webster WS, 1998, TERATOLOGY, V58, P13
   Werner H, 2016, PRENATAL DIAG, V36, P785, DOI 10.1002/pd.4860
   Yadav S, 2016, J CLIN DIAGN RES, V10, pDM1, DOI 10.7860/JCDR/2016/19170.8133
   Younger DS, 2016, NEUROL CLIN, V34, P1049, DOI 10.1016/j.ncl.2016.06.008
   Zare Mehrjardi M, JPN J RADIOL
NR 39
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-3022
EI 1421-9913
J9 EUR NEUROL
JI Eur. Neurol.
PD MAY
PY 2020
VL 83
IS 1
BP 17
EP 24
DI 10.1159/000505834
PG 8
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA LU6TN
UT WOS:000537885700002
PM 31968331
OA Bronze
DA 2020-07-08
ER

PT J
AU Ventura, LO
   Travassos, S
   Ventura, MC
   Marinho, P
   Lawrence, L
   Wilson, ME
   Carreiro, N
   Xavier, V
   Gois, AL
   Ventura, CV
AF Ventura, Liana O.
   Travassos, Simone
   Ventura Filho, Marcelo C.
   Marinho, Polyana
   Lawrence, Linda
   Wilson, M. Edward
   Carreiro, NoeIle
   Xavier, Valeska
   Gois, Adriana L.
   Ventura, Camila V.
TI Congenital Zika Syndrome: Surgical and Visual Outcomes After Surgery for
   Infantile Strabismus
SO JOURNAL OF PEDIATRIC OPHTHALMOLOGY & STRABISMUS
LA English
DT Article
ID OCULAR ALIGNMENT; CHILDREN; IMPAIRMENT; ACUITY; RECESSION; ADULTS;
   FIELDS
AB Purpose: To evaluate the surgical and functional outcomes in children with congenital Zika syndrome who underwent strabismus surgery.
   Methods: This prospective case series included children with congenital Zika syndrome who presented with horizontal infantile strabismus and underwent strabismus surgery. Ocular motility and visual fields were assessed preoperatively and postoperatively. Visual fields were considered normal if they exceeded 70 degrees in the temporal meridian. Postoperatively, parents and caregivers answered a questionnaire that assessed their child's behavioral improvements. A final ocular alignment within +/- 10 prism diopters (PD) and expansion of the visual fields were considered satisfactory motor surgical results at 6 months postoperatively.
   Results: Five children (3 girls [60%]) with congenital Zika syndrome (age: 36.4 +/- 0.9 months) were included in this study. All children (100%) presented with moderate to severe visual impairment and 4 (80%) presented with funduscopic abnormalities. Preoperatively, 4 children (80%) had infantile esotropia (mean preoperative angle of deviation: 41.3 +/- 6.3 PD) and 1 (20%) had infantile exotropia measuring 65 PD. The postoperative outcomes demonstrated ocular alignment in 4 children (80%) at the 6-month follow-up visit. Expansion of the temporal visual field was observed in 7 eyes (70%) of 4 children (80%). Four caregivers (80%) reported behavioral improvement in daily activities, and all caregivers (100%) reported improved peripheral target detection and socialization skills.
   Conclusions: Strabismus surgery can be an effective procedure for treating horizontal strabismus in children with congenital Zika syndrome because it can improve ocular alignment, expand the visual field, and improve the child's social, functional, and behavioral skills.
C1 [Ventura, Liana O.; Travassos, Simone; Ventura Filho, Marcelo C.; Marinho, Polyana; Carreiro, NoeIle; Xavier, Valeska; Gois, Adriana L.; Ventura, Camila V.] Altino Ventura Fdn, Dept Ophthalmol, Recife, PE, Brazil.
   [Ventura, Liana O.; Travassos, Simone; Marinho, Polyana; Carreiro, NoeIle; Gois, Adriana L.; Ventura, Camila V.] HOPE Eye Hosp, Dept Ophthalmol, Recife, PE, Brazil.
   [Lawrence, Linda] Private Ophthalmol Practice, Salina, KS USA.
   [Wilson, M. Edward] Med Univ South Carolina, Storm Eye Inst, Charleston, SC 29425 USA.
RP Ventura, CV (corresponding author), Altino Ventura Fdn, Rua Soledade,170 Boa Vista, BR-50070040 Recife, PE, Brazil.
EM camilaventuramd@gmail.com
FU Department of Research of the Altino Ventura Foundation
FX The authors thank the Department of Research of the Altino Ventura
   Foundation for their efforts with the preparation of this manuscript and
   the children and their families for participation in this study.
CR Binder NR, 2016, J AAPOS, V20, P121, DOI 10.1016/j.jaapos.2015.12.010
   Can CU, 2012, INT J OPHTHALMOL-CHI, V5, P113, DOI 10.3980/j.issn.2222-3959.2012.01.23
   Colenbrander A., 2003, VISUAL IMPAIRMENT RE, V5, P115, DOI DOI 10.1080/1388235039048919
   Ghasia F, 2009, BRIT J OPHTHALMOL, V93, P1068, DOI 10.1136/bjo.2008.156372
   Ghasia F, 2011, INVEST OPHTH VIS SCI, V52, P7664, DOI 10.1167/iovs.10-6906
   Good WV, 2007, J AAPOS, V11, P424, DOI 10.1016/j.jaapos.2007.08.002
   Habot-Wilner Z, 2006, J AAPOS, V10, P150, DOI 10.1016/j.jaapos.2005.11.013
   Habot-Wilner Z, 2012, J AAPOS, V16, P32, DOI 10.1016/j.jaapos.2011.10.013
   Han SY, 2015, BRIT J OPHTHALMOL, V99, P757, DOI 10.1136/bjophthalmol-2014-305758
   HILES D A, 1974, American Orthoptic Journal, V24, P63
   Jackson Jorie, 2006, Am Orthopt J, V56, P86, DOI 10.3368/aoj.56.1.86
   Jacobson L, 2002, Strabismus, V10, P179
   KUSHNER BJ, 1994, ARCH OPHTHALMOL-CHIC, V112, P639, DOI 10.1001/archopht.1994.01090170083027
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Myers VS, 1999, ARCH OPHTHALMOL-CHIC, V117, P94
   Philip SS, 2014, CLIN EXP OPTOM, V97, P196, DOI 10.1111/cxo.12155
   PICKERING JD, 1995, J PEDIATR OPHTHALMOL, V32, P225, DOI 10.3928/0191-3913-19950701-05
   QUINN GE, 1991, J PEDIATR OPHTHALMOL, V28, P314
   Richa S, 2010, CNS DRUGS, V24, P501, DOI 10.2165/11533180-000000000-00000
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779
   Ventura LO, 2018, J AAPOS, V22, P218, DOI 10.1016/j.jaapos.2018.01.009
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Yahalom C, 2010, J AAPOS, V14, P117, DOI 10.1016/j.jaapos.2010.01.009
NR 25
TC 0
Z9 0
U1 0
U2 0
PU SLACK INC
PI THOROFARE
PA 6900 GROVE RD, THOROFARE, NJ 08086 USA
SN 0191-3913
EI 1938-2405
J9 J PEDIAT OPHTH STRAB
JI J. Pediatr. Ophthalmol. Strabismus.
PD MAY-JUN
PY 2020
VL 57
IS 3
BP 169
EP +
DI 10.3928/01913913-20200331-01
PG 8
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA LT2FC
UT WOS:000536887200007
PM 32453850
DA 2020-07-08
ER

PT J
AU Halabi, J
   Jagger, BW
   Salazar, V
   Winkler, ES
   White, JP
   Humphrey, PA
   Hirsch, AJ
   Streblow, DN
   Diamond, MS
   Moley, K
AF Halabi, Jacques
   Jagger, Brett W.
   Salazar, Vanessa
   Winkler, Emma S.
   White, James P.
   Humphrey, Peter A.
   Hirsch, Alec J.
   Streblow, Daniel N.
   Diamond, Michael S.
   Moley, Kelle
TI Zika Virus Causes Acute and Chronic Prostatitis in Mice and Macaques
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE animal models; inflammation; prostatitis; Zika virus
ID SEXUAL TRANSMISSION; MOUSE MODEL; INFECTION; INFLAMMATION;
   DIFFERENTIATION; PATHOLOGY; ANATOMY
AB Background. Sexual transmission and persistence of Zika virus (ZIKV) in the male reproductive tract has raised concerned for potential damaging effects on function. Animal studies have demonstrated that ZIKV virus can infect and damage the testis and epididymis, and these results has been correlated to lower sperm counts in ZIKV-infected humans. The prostate plays a vital role in the male reproductive tract, with acute and chronic prostatitis linked to male infertility.
   Methods. In this study, we evaluated the effects of ZIKV virus on the prostate in mice and nonhuman primates.
   Results. In mice, ZIKV infected the prostate and triggered inflammation that persisted even after virus clearance. Evidence of chronic prostatitis associated with ZIKV infection remained for several months. Similar histological findings were observed in the prostate of ZIKV-infected rhesus macaques.
   Conclusions. These studies establish that ZIKV replicates in the prostate and can cause acute and chronic inflammatory and proliferative changes in mouse and nonhuman primate models.
C1 [Halabi, Jacques; Moley, Kelle] Washington Univ, Sch Med, Dept Obstet & Gynecol, St Louis, MO 63110 USA.
   [Jagger, Brett W.] Western Michigan Univ, Dept Med, Homer Stryker MD Sch Med, Kalamazoo, MI 49008 USA.
   [Salazar, Vanessa; Winkler, Emma S.; White, James P.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA.
   [Humphrey, Peter A.] Yale Sch Med, Dept Pathol, New Haven, CT USA.
   [Hirsch, Alec J.; Streblow, Daniel N.] Oregon Hlth & Sci Univ, Vaccine & Gene Therapy Inst, Beaverton, OR USA.
   [Hirsch, Alec J.; Streblow, Daniel N.] Oregon Natl Primate Res Ctr, Div Pathobiol & Immunol, Beaverton, OR USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA.
   [Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.
RP Diamond, MS (corresponding author), Washington Univ, Sch Med, St Louis, MO 63110 USA.
EM diamond@wusm.wustl.edu
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 AI073755,
   R01 AI127828, R01 HD091218, R01 HD083895, R21 HD091032,
   5T32AI007172-39]; Oregon National Primate Research Center [P51 OD011092
   NIH]
FX This work was funded by grants from the National Institutes of Health
   (NIH) (R01 AI073755, R01 AI127828, and R01 HD091218 [to M. S. D.]; R01
   HD083895 [to K. M.]; and R21 HD091032 [to D. N. S.]); 5T32AI007172-39
   [to B.W.J.] and the Oregon National Primate Research Center (P51
   OD011092 NIH Core grant).
CR Arsuaga M, 2016, LANCET INFECT DIS, V16, P1107, DOI 10.1016/S1473-3099(16)30320-6
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Boehm BJ, 2012, PROSTATE, V72, P307, DOI 10.1002/pros.21433
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Clancy CS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44582-9
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   De Marzo AM, 1999, AM J PATHOL, V155, P1985, DOI 10.1016/S0002-9440(10)65517-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Froeschl G, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2123-9
   Fujimoto N, 2006, J ENDOCRINOL, V190, P793, DOI 10.1677/joe.1.06733
   Gandaglia G, 2017, CURR OPIN UROL, V27, P99, DOI 10.1097/MOU.0000000000000369
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Krieger JN, 2003, INFECT DIS CLIN N AM, V17, P395, DOI 10.1016/S0891-5520(03)00003-5
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kurscheidt FA, 2019, NAT REV UROL, V16, P211, DOI 10.1038/s41585-019-0149-7
   Kwon OJ, 2014, P NATL ACAD SCI USA, V111, pE592, DOI 10.1073/pnas.1318157111
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LEWIS RW, 1981, PROSTATE, V2, P51, DOI 10.1002/pros.2990020106
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   MCNEAL JE, 1968, AM J CLIN PATHOL, V49, P347
   Mubiru JN, 2008, PROSTATE, V68, P1546, DOI 10.1002/pros.20814
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   Oliveira DSM, 2016, BOSNIAN J BASIC MED, V16, P8, DOI 10.17305/bjbms.2016.917
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06
   Spencer JL, 2018, J INFECT DIS, V217, P538, DOI 10.1093/infdis/jix436
   Tsetsarkin KA, 2016, MBIO, V7, DOI 10.1128/mBio.01114-16
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Wang YZ, 2001, DIFFERENTIATION, V68, P270, DOI 10.1046/j.1432-0436.2001.680414.x
   Wilson AH, 2014, JAMA-J AM MED ASSOC, V312, P562, DOI 10.1001/jama.2013.279650
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 44
TC 2
Z9 2
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAY 1
PY 2020
VL 221
IS 9
BP 1506
EP 1517
DI 10.1093/infdis/jiz533
PG 12
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LS6SN
UT WOS:000536512000016
PM 31616920
DA 2020-07-08
ER

PT J
AU Squires, RC
   Oxen, CJ
   Cognat, S
   Konings, F
AF Squires, Raynal C.
   Oxen, Christopher J.
   Cognat, Sebastien
   Konings, Frank
TI Performance of Eastern Mediterranean Region laboratories in the World
   Health Organization external quality assessment programme for arbovirus
   diagnostics
SO EASTERN MEDITERRANEAN HEALTH JOURNAL
LA English
DT Article
DE arbovirus; diagnostics; quality; laboratory; assessment
AB Background: Arboviruses such as dengue virus, yellow fever virus, Zika virus and chikungunya virus are major threats to human health globally, including countries in the Eastern Mediterranean Region (EMR).
   Aims: This study aimed to assess laboratory proficiency in EMR countries for detection of dengue virus, yellow fever virus, Zika virus and chikungunya virus.
   Methods: A global external quality assessment programme for arbovirus diagnostics was developed and run in 2016 and 2018. National-level public health laboratories were instructed to apply the polymerase chain reaction detection method on specimen panels containing dengue virus, yellow fever virus, Zika virus and chikungunya virus.
   Results: Over both rounds of the programme, 100% of participating EMR laboratories correctly detected yellow fever virus and chikungunya virus, >= 84.6% detected dengue fever virus and >= 76.9% detected Zika virus.
   Conclusion: While participating EMR countries demonstrated good proficiency in detecting arboviruses, only half of them were enrolled in the global external quality assessment programme, providing an incomplete picture of regional capacity. Effort should be put into increasing participation in subsequent rounds.
C1 [Squires, Raynal C.; Konings, Frank] WHO, Reg Off Eastern Mediterranean, Cairo, Egypt.
   [Oxen, Christopher J.; Cognat, Sebastien] WHO, Lyon, France.
RP Squires, RC (corresponding author), WHO, Reg Off Eastern Mediterranean, Cairo, Egypt.
EM squiresr@who.int
CR Abdad MY, 2017, WEST PAC SURVEILL RE, V8, DOI 10.5365/wpsar.2017.8.3.001
   [Anonymous], 2017, EP PAND PRON DIS NEW
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Humphrey JM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005707
   Humphrey JM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005194
   World Health Organization, 2013, WEEKL EP MON, V6, P50
   World Health Organization, 2019, WEEKL EP MON, V12, P3
NR 7
TC 0
Z9 0
U1 0
U2 0
PU WHO EASTERN MEDITERRANEAN REGIONAL OFFICE
PI NASR CITY, CAIRO
PA P. O. BOX 7608, NASR CITY, CAIRO, EGYPT
SN 1020-3397
EI 1687-1634
J9 E MEDITERR HEALTH J
JI East Mediterr. Health J.
PD MAY
PY 2020
VL 26
IS 5
BP 616
EP 619
DI 10.26719/emhj.20.015
PG 4
WC Health Care Sciences & Services; Health Policy & Services; Public,
   Environmental & Occupational Health
SC Health Care Sciences & Services; Public, Environmental & Occupational
   Health
GA LR9DM
UT WOS:000535995800020
PM 32538457
OA Bronze
DA 2020-07-08
ER

PT J
AU Einspieler, C
   Marschik, PB
AF Einspieler, Christa
   Marschik, Peter B.
TI The developmental spectrum of prenatal Zika virus exposure
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Editorial Material
C1 [Einspieler, Christa; Marschik, Peter B.] Med Univ Graz, Div Phoniatr, Interdisciplinary Dev Neurosci, Graz, Austria.
   [Marschik, Peter B.] Univ Med Ctr Gottingen, Child & Adolescent Psychiat & Psychotherapy, Gottingen, Germany.
   [Marschik, Peter B.] Leibniz ScienceCampus Primate Cognit, Gottingen, Germany.
   [Marschik, Peter B.] Karolinska Inst Stockholm, Dept Womens & Childrens Hlth, Ctr Neurodev Disorders, Stockholm, Sweden.
RP Einspieler, C (corresponding author), Med Univ Graz, Div Phoniatr, Interdisciplinary Dev Neurosci, Graz, Austria.
EM christa.einspieler@medunigraz.at
CR Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   de Carvalho AL, 2020, J CHILD NEUROL, V35, P202, DOI 10.1177/0883073819885724
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Faical AV, 2019, BMJ PAEDIAT OPEN, V5
   Pereira HVFS, 2020, LANCET CHILD ADOLESC, V4, P378, DOI 10.1016/S2352-4642(20)30041-9
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerzson LR, 2020, J CHILD NEUROL, V35, P278, DOI 10.1177/0883073819892128
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Prechtl HFR, 1997, LANCET, V349, P1361, DOI 10.1016/S0140-6736(96)10182-3
   Prins JR, 2018, J REPROD IMMUNOL, V126, P18, DOI 10.1016/j.jri.2018.01.004
NR 10
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD MAY
PY 2020
VL 4
IS 5
BP 345
EP 346
DI 10.1016/S2352-4642(20)30071-7
PG 2
WC Pediatrics
SC Pediatrics
GA LS9XC
UT WOS:000536730700005
PM 32199079
DA 2020-07-08
ER

PT J
AU Pereira, HVFS
   dos Santos, SP
   Amancio, APRL
   de Oliveira-Szejnfeld, PS
   Flor, EO
   Tavares, JD
   Ferreira, RVB
   Tovar-Moll, F
   de Amorim, MMR
   Melo, A
AF Fernandes Souza Pereira, Heloisa Viscaino
   dos Santos, Stella Pinto
   Rodrigues Lazzari Amancio, Ana Paula
   de Oliveira-Szejnfeld, Patricia Soares
   Flor, Edneusa Oliveira
   Tavares, Jousilene de Sales
   Brandao Ferreira, Rayssa Vieira
   Tovar-Moll, Fernanda
   Ramos de Amorim, Melania Maria
   Melo, Adriana
TI Neurological outcomes of congenital Zika syndrome in toddlers and
   preschoolers: a case series
SO LANCET CHILD & ADOLESCENT HEALTH
LA English
DT Article
ID CLASSIFICATION-SYSTEM; CEREBRAL-PALSY; VIRUS; CHILDREN; INFANTS;
   RELIABILITY; SPECTRUM; EPILEPSY; CLASSIFY; ABILITY
AB Background Congenital Zika syndrome causes a spectrum of neurological symptoms with varying effects on function that require different therapeutic strategies. To date, this spectrum of effects and its clinical implications have not been completely described. We describe the neurological examination findings in toddlers and preschoolers, including predominant symptom complexes and comorbidities.
   Methods This study is a case-series neurological evaluation of 75 children with congenital Zika syndrome in Campina Grande, Brazil. The study is part of a cohort of children with congenital Zika syndrome that started in 2015 and is still ongoing. Children with Zika virus infection detected during pregnancy (mothers exhibited rash and were followed and diagnosed by fetal ultrasound abnormalities or RT-PCR) or through microcephaly screening after birth, using Intergrowth 21 guidelines, were selected by laboratory and radiological criteria. Children were examined during a 10-day period in September, 2018, and underwent neurological interview, examination, and assessment of functional outcomes and comorbidities. Children were divided in groups of predominant corticospinal or neuromuscular clinical signs and the associations between these groups and clinical comorbidities were assessed.
   Findings All of the children recruited to the study from Nov 29, 2015 to Nov 30, 2017 had imaging correlates of congenital Zika syndrome. Children were assigned to groups depending on the signs exhibited, either corticospinal or neuromuscular, with or without dyskinetic signs. 75 children completed the evaluation, 38 (51%) girls and 37 (49%) boys. Median age was 33 months (range 26-40 months; IQR 29-34). Microcephaly was present at birth in 56 (75%) children, and 19 (25%) children were born with normal head circumference, 15 of whom later developed microcephaly. Neurological examination grouped four children as having isolated dyskinetic signs, 48 children were assigned to the corticospinal group and 23 into the neuromuscular group. Dyskinetic findings were present in 30 (40%) children, either alone (four [5%]) or combined with corticospinal (19 [40%] of 48) or neuromuscular (seven [30%] of 23) findings. Comorbidities were highly prevalent, and the neuromuscular group had worse functional outcomes, evaluated by gross motor function (p=0.026), manual abilities (p=0.0013), and communication function (p<0.0005) classification scales, than the corticospinal group, whereas pneumonia (p<0.0005) and urinary tract infections (p<0.0005) were more frequent in the corticospinal group. Cortical hyperexcitability was supported by several clinical correlates, such as early onset epilepsy, persistence of primitive reflexes, and dystonia.
   Interpretation We describe distinct neurological profiles in the congenital Zika syndrome spectrum, with functional outcomes tending to correlate with these groups. The clinical division of children based on the disease signs proposed here is supported by the literature on central and peripheral nervous system pathology in congenital Zika syndrome. The high prevalence of dyskinetic symptoms merits special attention. Copyright (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Fernandes Souza Pereira, Heloisa Viscaino; dos Santos, Stella Pinto; Flor, Edneusa Oliveira] Univ Estado Rio De Janeiro, Pediat Neurol Clin, Dept Pediat, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio Janeiro, Inst Biomed Sci, Rio De Janeiro, Brazil.
   [Tovar-Moll, Fernanda] Fed Univ Rio Janeiro, Natl Ctr Struct Biol & Bioimaging, Rio De Janeiro, Brazil.
   [Fernandes Souza Pereira, Heloisa Viscaino; de Oliveira-Szejnfeld, Patricia Soares; Tovar-Moll, Fernanda] DOr Inst Res & Educ, Rio De Janeiro, Brazil.
   [Rodrigues Lazzari Amancio, Ana Paula] Adao Pereira Nunes State Hosp, Rio De Janeiro, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Sao Paulo, Dept Diagnost Imaging, Sao Paulo, Brazil.
   [de Oliveira-Szejnfeld, Patricia Soares] Univ Fed Sao Paulo, Fdn Inst Educ & Res Diagnost Imaging, Sao Paulo, Brazil.
   [Tavares, Jousilene de Sales; Brandao Ferreira, Rayssa Vieira; Ramos de Amorim, Melania Maria; Melo, Adriana] Res Inst Prof Amorim Neto, Campina Grande, Paraiba, Brazil.
   [Ramos de Amorim, Melania Maria; Melo, Adriana] Univ Fed Campina Grande, Campina Grande, Paraiba, Brazil.
RP Pereira, HVFS (corresponding author), Univ Estado Rio De Janeiro, Pediat Neurol Clin, Dept Pediat, Rio De Janeiro, Brazil.
EM heloisa.pereira@hupe.uerj.br
RI Amorim, Melania/C-5807-2013
OI Amorim, Melania/0000-0003-1047-2514
FU Brazilian National Council for Scientific and Technological
   DevelopmentNational Council for Scientific and Technological Development
   (CNPq); Coordination for the Improvement of Higher Education Personnel
FX Brazilian National Council for Scientific and Technological Development
   and by the Coordination for the Improvement of Higher Education
   Personnel.
CR Abramov DM, 2018, NEUROLOGY, V90, pE606, DOI 10.1212/WNL.0000000000004974
   Barbeito-Andres J, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006592
   Campbell SK, 2005, TEST INFANT MOTOR PE
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Einspieler C., 2008, PRECHTLS METHOD QUAL
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Eliasson AC, 2006, DEV MED CHILD NEUROL, V48, P549, DOI 10.1017/S0012162206001162
   Hadders-Algra M, 2018, DEV MED CHILD NEUROL, V60, P39, DOI 10.1111/dmcn.13540
   Hallett M, 2001, EPILEPSY MOVEMENT DI, P111
   Hidecker MJC, 2011, DEV MED CHILD NEUROL, V53, P704, DOI 10.1111/j.1469-8749.2011.03996.x
   Himmelmann K, 2007, DEV MED CHILD NEUROL, V49, P246, DOI 10.1111/j.1469-8749.2007.00246.x
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   PediTools, CDC GROWTH CALC 2 20
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Pinato L, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy009
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sellers D, 2014, DEV MED CHILD NEUROL, V56, P245, DOI 10.1111/dmcn.12352
   Swaiman KF, 2018, SWAIMANS PEDIAT NEUR, P7
   The International Fetal and Newborn Growth Consortium for the 21st Century, INTERGROWTH 21
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   van der Linden V, 2017, ZIKA IN FOCUS
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
NR 30
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 2352-4642
J9 LANCET CHILD ADOLESC
JI Lancet Child. Adolesc. Health
PD MAY
PY 2020
VL 4
IS 5
BP 378
EP 387
DI 10.1016/S2352-4642(20)30041-9
PG 10
WC Pediatrics
SC Pediatrics
GA LS9XC
UT WOS:000536730700016
PM 32199080
DA 2020-07-08
ER

PT J
AU Khubchandani, J
   Jordan, TR
   Yang, YT
AF Khubchandani, Jagdish
   Jordan, Timothy R.
   Yang, Y. Tony
TI Ebola, Zika, Corona ...What Is Next for Our World?
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Editorial Material
DE coronavirus; pandemics; global health; COVID-19; public health; poverty;
   population; pollution; globalization
ID SECURITY
AB In the past century, there have been several pandemics. Within the context of global health, these pandemics have often been viewed from the lens of determinants such as population, poverty, and pollution. With an ever-changing world and the COVID-19 pandemic, the current global determinants of public health need to be expanded. In this editorial, we explore and redefine the major determinants of global public health to prevent future pandemics. Policymakers and global leaders should keep at heart the determinants suggested hereby in any planning, implementation, and evaluation of efforts to improve global public health and prevent pandemics.
C1 [Khubchandani, Jagdish] Ball State Univ, Coll Hlth, Muncie, IN 47306 USA.
   [Jordan, Timothy R.] Univ Toledo, Coll Hlth & Human Serv, Toledo, OH 43606 USA.
   [Yang, Y. Tony] George Washington Univ, Ctr Hlth Policy & Media Engagement, Washington, DC 20006 USA.
RP Khubchandani, J (corresponding author), Ball State Univ, Coll Hlth, Muncie, IN 47306 USA.
EM jkhubchandan@bsu.edu; timothy.jordan2@utoledo.edu; ytyang@email.gwu.edu
FU Ball State University
FX Jagdish Khubchandani is the recipient of 2020 Cohen Peace Fellowship
   from Ball State University.
CR Abela GJ, 2016, P NATL ACAD SCI USA, V113, P14294, DOI 10.1073/pnas.1611386113
   Barua S., 2020, UNDERSTANDING CORONA
   Elbe S, 2018, PANDEMICS PILLS POLI
   Fouilleux E, 2017, J EUR PUBLIC POLICY, V24, P1658, DOI 10.1080/13501763.2017.1334084
   Garfin DR, 2020, HEALTH PSYCHOL, V39, P355, DOI 10.1037/hea0000875
   Heymann DL, 2015, LANCET, V385, P1884, DOI 10.1016/S0140-6736(15)60858-3
   Holmberg M, 2018, GLOB PUBLIC HEALTH, V13, P99, DOI 10.1080/17441692.2016.1149202
   Kahn Jeffrey S, 2005, Pediatr Infect Dis J, V24, pS223, DOI 10.1097/01.inf.0000188166.17324.60
   Khubchandani J, 2012, HEALTH PROMOT PRACT, V13, P293, DOI 10.1177/1524839912439063
   Landrigan PJ, 2018, LANCET, V391, P462, DOI 10.1016/S0140-6736(17)32345-0
   Madhav N, 2017, DIS CONTROL PRIORITI
   McMichael AJ, 2013, NEW ENGL J MED, V368, P1335, DOI 10.1056/NEJMra1109341
   Merchant RM, 2020, JAMA-J AM MED ASSOC, V323, P2011, DOI 10.1001/jama.2020.4469
   Merson M.H., 2018, GLOBAL HLTH DIS PROG
   Moon S, 2015, LANCET, V386, P2204, DOI 10.1016/S0140-6736(15)00946-0
   National Academy of Medicine, 2016, NEGL DIM GLOB SEC FR
   Osterholm MT, 2005, NEW ENGL J MED, V352, P1839, DOI 10.1056/NEJMp058068
   Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097
   Pincock S, 2012, LANCET, V380, P882, DOI 10.1016/S0140-6736(12)61495-0
   Rust G, 2009, AM J PUBLIC HEALTH, V99, pS316, DOI 10.2105/AJPH.2009.161125
   Sharma A, 2016, INT J RHEUM DIS, V19, P300, DOI 10.1111/1756-185X.12336
   Ubokudom SE, 2010, WORLD MED HEALTH POL, V2, P331, DOI 10.2202/1948-4682.1010
   United Nations, SUST DEV GOALS
   Waage J, 2015, LANCET GLOB HEALTH, V3, pE251, DOI 10.1016/S2214-109X(15)70112-9
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weyer J, 2015, CURR INFECT DIS REP, V17, DOI 10.1007/s11908-015-0480-y
   WINKELSTEIN W, 1992, AM J PUBLIC HEALTH, V82, P931, DOI 10.2105/AJPH.82.7.931
   Xie Bo, 2020, J Assoc Inf Sci Technol, DOI 10.1002/asi.24357
   Xu Z., 2020, PRIMARY CARE PRACTIT, DOI [10.1101/2020.02.11.20022095, DOI 10.1101/2020.02.11.20022095]
   Ye ZW, 2020, INT J BIOL SCI, V16, P1686, DOI 10.7150/ijbs.45472
NR 30
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD MAY
PY 2020
VL 17
IS 9
AR 3171
DI 10.3390/ijerph17093171
PG 7
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA LR5OY
UT WOS:000535745400195
PM 32370141
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, XX
   Cai, YL
   Wang, K
   Fu, SM
   Wang, WM
AF Li, Xinxin
   Cai, Yongli
   Wang, Kai
   Fu, Shengmao
   Wang, Weiming
TI Non-constant positive steady states of a host-parasite model with
   frequency- and density-dependent transmissions
SO JOURNAL OF THE FRANKLIN INSTITUTE-ENGINEERING AND APPLIED MATHEMATICS
LA English
DT Article
ID EPIDEMIC MODEL; ASYMPTOTIC PROFILES; COMPLEX DYNAMICS; ZIKA VIRUS;
   DIFFUSION; DISEASE; STABILITY; HETEROGENEITY; PATTERN
AB The present work is concerned with some fundamental analytic properties of a host-parasite model with frequency- and density-dependent transmissions under homogeneous Neumann boundary condition. The global existence and the boundedness of solution are investigated. The stability of the constant positive steady state is discussed, and the Turing instability is determined. Furthermore, the framework of the occurrence of the Turing pattern of the model is established: when the diffusion coefficients of the susceptible and infected hosts are large enough, there is nonexistence of non-constant positive steady states, which impies that the diffusion is helpful for creating non-constant positive steady states to the model; when the diffusion coefficient of the infected hosts is properly chosen and other parameters are fixed, the model exhibits non-constant positive steady-states, and the stationary Turing pattern can arise as a result of diffusion. Via numerical simulations, the evolutionary processes of the pattern formation of the uninfected/infected hosts with local diffusion are presented, which shows that the model dynamics exhibits a diffusion-controlled formation growth of spots, stripes and holes pattern replication. In the viewpoint of epidemiology, the parameters must be adjusted in the specific feasible range to control the disease. (C) 2020 The Franklin Institute. Published by Elsevier Ltd. All rights reserved.
C1 [Li, Xinxin; Cai, Yongli; Wang, Weiming] Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
   [Li, Xinxin; Fu, Shengmao] Northwest Normal Univ, Sch Math & Stat, Lanzhou 730070, Peoples R China.
   [Wang, Kai] Xinjiang Med Univ, Dept Med Engn & Technol, Urumqi 830011, Peoples R China.
RP Wang, WM (corresponding author), Huaiyin Normal Univ, Sch Math Sci, Huaian 223300, Peoples R China.
EM caiyongli@hytc.edu.cn; wangkaimath@sina.com; fusm@nwnu.edu.cn;
   wangwm_math@hytc.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [11761063, 11661051]; Huaian Key Laboratory for
   Infectious Diseases Control and Prevention [HAP201704]
FX The authors would like to thank the anonymous referees for very helpful
   suggestions and comments which led to improvement of our original
   manuscript. Y. Cai and W. Wang were supported by the National Natural
   Science Foundation of China (Grant numbers 61672013, 11601179 and
   61772017), and the Huaian Key Laboratory for Infectious Diseases Control
   and Prevention (HAP201704). K. Wang was supported by the National
   Natural Science Foundation of China (Grant number 11961071). S. Fu was
   supported by the National Natural Science Foundation of China (Grant
   number 11761063 and 11661051).
CR Allen LJS, 2007, SIAM J APPL MATH, V67, P1283, DOI 10.1137/060672522
   Allen LJS, 2008, DISCRETE CONT DYN-A, V21, P1
   Berezovsky F, 2005, MATH BIOSCI ENG, V2, P133
   Brauer F., 2012, MATH MODELS POPULATI, V40
   Cai YL, 2019, APPL MATH LETT, V92, P190, DOI 10.1016/j.aml.2019.01.015
   Cai YL, 2019, NONLINEAR ANAL-REAL, V46, P178, DOI 10.1016/j.nonrwa.2018.09.006
   Cai YL, 2019, PHYSICA A, V514, P729, DOI 10.1016/j.physa.2018.09.100
   Cai YL, 2018, APPL MATH COMPUT, V329, P210, DOI 10.1016/j.amc.2018.02.009
   Cai YL, 2018, NONLINEAR ANAL-REAL, V40, P444, DOI 10.1016/j.nonrwa.2017.10.001
   Cai YL, 2016, NONLINEAR ANAL-REAL, V30, P99, DOI 10.1016/j.nonrwa.2015.12.002
   Capasso V., 2012, MATH STRUCTURES EPID
   Caraco T, 1998, J THEOR BIOL, V192, P351, DOI 10.1006/jtbi.1998.0663
   Carrero G., 2003, CANADIAN APPL MATH Q, V11, P1
   Castillo-Chavez C, 2001, MATH BIOSCI, V173, P35, DOI 10.1016/S0025-5564(01)00065-7
   COMINS HN, 1992, J ANIM ECOL, V61, P735, DOI 10.2307/5627
   Du ZJ, 2016, J MATH BIOL, V72, P1429, DOI 10.1007/s00285-015-0914-z
   Hattaf K., 2014, ELECTRON J QUAL THEO, V3, P1
   Hattaf K, 2013, COMPUT MATH APPL, V66, P1488, DOI 10.1016/j.camwa.2013.08.023
   Henry D., 1981, GEOMETRIC THEORY SEM
   Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907
   HOLT RD, 1993, J ANIM ECOL, V62, P89, DOI 10.2307/5485
   Kang Y, 2014, MATH BIOSCI ENG, V11, P877, DOI 10.3934/mbw.4.11.877
   Korobeinikov A, 2005, MATH MED BIOL, V22, P113, DOI 10.1093/imammb/dqi001
   Lou Y, 1999, J DIFFER EQUATIONS, V154, P157, DOI 10.1006/jdeq.1998.3559
   Lou Y, 1996, J DIFFER EQUATIONS, V131, P79, DOI 10.1006/jdeq.1996.0157
   Ma JL, 2006, MATH BIOSCI ENG, V3, P161
   Maron JL, 1997, SCIENCE, V278, P1619, DOI 10.1126/science.278.5343.1619
   Neuhauser C., 2001, NOT AM MATH SOC, V48, P1304
   Pang PYH, 2004, J DIFFER EQUATIONS, V200, P245, DOI 10.1016/j.jde.2004.01.004
   Ruan S, 2007, BIOL MED PHYS BIOMED, P97
   Ryder JJ, 2005, P NATL ACAD SCI USA, V102, P15140, DOI 10.1073/pnas.0505139102
   Ryder JJ, 2007, OIKOS, V116, P2017, DOI 10.1111/j.2007.0030-1299.15863.x
   Shan CH, 2014, J DIFFER EQUATIONS, V257, P1662, DOI 10.1016/j.jde.2014.05.030
   Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598
   Wang WM, 2018, J FRANKLIN I, V355, P7226, DOI 10.1016/j.jfranklin.2018.07.014
   Wang WM, 2018, PHYSICA A, V509, P921, DOI 10.1016/j.physa.2018.06.099
   Wang WD, 2012, SIAM J APPL DYN SYST, V11, P1652, DOI 10.1137/120872942
   Webberley KM, 2006, J ANIM ECOL, V75, P33, DOI 10.1111/j.1365-2656.2005.01020.x
   Yang JY, 2019, J FRANKLIN I, V356, P8438, DOI 10.1016/j.jfranklin.2019.08.016
   Yang JY, 2019, NONLINEAR ANAL-REAL, V50, P192, DOI 10.1016/j.nonrwa.2019.04.013
NR 40
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0016-0032
EI 1879-2693
J9 J FRANKLIN I
JI J. Frankl. Inst.-Eng. Appl. Math.
PD MAY
PY 2020
VL 357
IS 7
BP 4392
EP 4413
DI 10.1016/j.jfranklin.2020.02.058
PG 22
WC Automation & Control Systems; Engineering, Multidisciplinary;
   Engineering, Electrical & Electronic; Mathematics, Interdisciplinary
   Applications
SC Automation & Control Systems; Engineering; Mathematics
GA LR7VB
UT WOS:000535903500026
DA 2020-07-08
ER

PT J
AU Wong, HH
   Sanyal, S
AF Wong, Ho Him
   Sanyal, Sumana
TI Omic approaches to decipher the molecular mechanisms of fibrosis, and
   design new anti -fibrotic strategies
SO SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
LA English
DT Review
DE Autophagy; Positive stranded RNA virus; Viral subversion strategies
ID HEPATITIS-C VIRUS; DENGUE VIRUS; ZIKA VIRUS; ENDOPLASMIC-RETICULUM;
   ULTRASTRUCTURAL CHARACTERIZATION; CORONAVIRUS REPLICATION; SELECTIVE
   AUTOPHAGY; VIRAL REPLICATION; DISEASE VIRUS; CELL-DEATH
AB Autophagy is an evolutionarily conserved process central to host metabolism. Among its major functions are conservation of energy during starvation, recycling organelles, and turnover of long-lived proteins. Besides, autophagy plays a critical role in removing intracellular pathogens and very likely represents a primordial intrinsic cellular defence mechanism. More recent findings indicate that it has not only retained its ability to degrade intracellular pathogens, but also functions to augment and fine tune antiviral immune responses. Interestingly, viruses have also co-evolved strategies to manipulate this pathway and use it to their advantage. Particularly intriguing is infection-dependent activation of autophagy with positive stranded (+)RNA virus infections, which benefit from the pathway without succumbing to lysosomal degradation. In this review we summarise recent data on viral manipulation of autophagy, with a particular emphasis on +RNA viruses and highlight key unanswered questions in the field that we believe merit further attention.
C1 [Wong, Ho Him; Sanyal, Sumana] Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China.
   [Sanyal, Sumana] Univ Hong Kong, Sch Biomed Sci, LKS Fac Med, Hong Kong, Peoples R China.
RP Sanyal, S (corresponding author), Univ Hong Kong, Sch Publ Hlth, HKU Pasteur Res Pole, Hong Kong, Peoples R China.
EM sanyal@hku.hk
FU Health and Medical Research Funds [16150592, 17161202, 17161032];
   Research Grants Council-General research funds [17112617]; Croucher
   Foundation
FX This work was supported by Health and Medical Research Funds (16150592
   and 17161202 and 17161032), and partially by Research Grants
   Council-General research funds (17112617). SS is supported by the
   Croucher Foundation.
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Aleyas AG, 2010, J IMMUNOL, V185, P1429, DOI 10.4049/jimmunol.0902536
   Alirezaei M, 2015, AUTOPHAGY, V11, P1389, DOI 10.1080/15548627.2015.1063769
   Angelini MM, 2013, MBIO, V4, DOI 10.1128/mBio.00524-13
   Ao D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125828
   Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Chase AJ, 2011, J INFECT DIS, V203, P1763, DOI 10.1093/infdis/jir197
   Chen XJ, 2014, PROTEIN CELL, V5, P912, DOI 10.1007/s13238-014-0104-6
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6
   Corona AK, 2018, CELL REP, V22, P3304, DOI 10.1016/j.celrep.2018.03.003
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cottam EM, 2014, AUTOPHAGY, V10, P1426, DOI 10.4161/auto.29309
   Cottam EM, 2011, AUTOPHAGY, V7, P1335, DOI 10.4161/auto.7.11.16642
   Crawford SE, 2012, P NATL ACAD SCI USA, V109, pE3405, DOI 10.1073/pnas.1216539109
   DALES S, 1965, VIROLOGY, V26, P379, DOI 10.1016/0042-6822(65)90001-2
   Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4
   Doring T, 2018, J VIROL, V92, DOI 10.1128/JVI.01513-17
   Dreux M, 2009, P NATL ACAD SCI USA, V106, P14046, DOI 10.1073/pnas.0907344106
   Fahmy AM, 2017, SCI REP-UK, V7, DOI 10.1038/srep40351
   Ferraris P, 2010, J GEN VIROL, V91, P2230, DOI 10.1099/vir.0.022186-0
   Filipe A, 2015, TRENDS MOL MED, V21, P34, DOI 10.1016/j.molmed.2014.11.003
   Gerstenmaier L, 2015, P NATL ACAD SCI USA, V112, pE687, DOI 10.1073/pnas.1423318112
   Goldsmith CS, 2004, EMERG INFECT DIS, V10, P320, DOI 10.3201/eid1002.030913
   Gosert R, 2002, J VIROL, V76, P3697, DOI 10.1128/JVI.76.8.3697-3708.2002
   Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9
   Hansen MD, 2017, P NATL ACAD SCI USA, V114, pE3462, DOI 10.1073/pnas.1616683114
   Heaton NS, 2011, VIRUSES-BASEL, V3, P1332, DOI 10.3390/v3081332
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Hou L, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-156
   Huang SC, 2009, J MED VIROL, V81, P1241, DOI 10.1002/jmv.21502
   Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156
   Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474
   Kemball CC, 2010, J VIROL, V84, P12110, DOI 10.1128/JVI.01417-10
   Khakpoor A, 2009, J GEN VIROL, V90, P1093, DOI 10.1099/vir.0.007914-0
   Kim N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10631
   Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003285
   Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451
   Klein KA, 2011, J VIROL, V85, P9651, DOI 10.1128/JVI.00316-11
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738
   Kyei GB, 2009, J CELL BIOL, V186, P255, DOI 10.1083/jcb.200903070
   Lee YR, 2008, VIROLOGY, V374, P240, DOI 10.1016/j.virol.2008.02.016
   Lee YR, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0080-4
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390
   Levine B, 2008, AUTOPHAGY, V4, P600, DOI 10.4161/auto.6260
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liang XH, 1998, J VIROL, V72, P8586, DOI 10.1128/JVI.72.11.8586-8596.1998
   Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Lundin A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004166
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Mijaljica D, 2006, TRAFFIC, V7, P1590, DOI 10.1111/j.1600-0854.2006.00495.x
   Miller S, 2008, NAT REV MICROBIOL, V6, P363, DOI 10.1038/nrmicro1890
   Mohamud Y, 2019, CELL DEATH DIFFER, V26, P1062, DOI 10.1038/s41418-018-0185-5
   Mohamud Y, 2018, CELL REP, V22, P3292, DOI 10.1016/j.celrep.2018.02.090
   O'Donnell V, 2011, VIROLOGY, V410, P142, DOI 10.1016/j.virol.2010.10.042
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Orvedahl A, 2007, CELL HOST MICROBE, V1, P23, DOI 10.1016/j.chom.2006.12.001
   Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546
   Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007
   Palmer DR, 2005, J VIROL, V79, P2432, DOI 10.1128/JVI.79.4.2432-2439.2005
   Panyasrivanit M, 2009, J GEN VIROL, V90, P448, DOI 10.1099/vir.0.005355-0
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul David, 2013, World J Virol, V2, P32, DOI 10.5501/wjv.v2.i2.32
   Pombo JP, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01276
   Ponpuak M, 2015, CURR OPIN CELL BIOL, V35, P106, DOI 10.1016/j.ceb.2015.04.016
   Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200
   Reggiori F, 2010, CELL HOST MICROBE, V7, P500, DOI 10.1016/j.chom.2010.05.013
   Richards AL, 2014, MBIO, V5, DOI 10.1128/mBio.00833-13
   Richards AL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003046
   Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Sharma M, 2014, AUTOPHAGY, V10, P1637, DOI 10.4161/auto.29455
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Shi JY, 2013, AUTOPHAGY, V9, P1591, DOI 10.4161/auto.26059
   Shibutani ST, 2014, CELL RES, V24, P58, DOI 10.1038/cr.2013.159
   Shrivastava S, 2012, J VIROL, V86, P8705, DOI 10.1128/JVI.00616-12
   Shrivastava S, 2011, HEPATOLOGY, V53, P406, DOI 10.1002/hep.24073
   Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976
   Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464
   SMITH JD, 1978, J VIROL, V26, P102, DOI 10.1128/JVI.26.1.102-109.1978
   Snijder EJ, 2001, J GEN VIROL, V82, P985, DOI 10.1099/0022-1317-82-5-985
   Staring J, 2017, NATURE, V541, P412, DOI 10.1038/nature21032
   Su WC, 2011, J VIROL, V85, P10561, DOI 10.1128/JVI.00173-11
   Suhy DA, 2000, J VIROL, V74, P8953, DOI 10.1128/JVI.74.19.8953-8965.2000
   Sumpter R, 2016, CELL, V165, P867, DOI 10.1016/j.cell.2016.04.006
   Sun P, 2018, AUTOPHAGY, V14, P336, DOI 10.1080/15548627.2017.1405187
   Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13
   Tanida I, 2009, AUTOPHAGY, V5, P937, DOI 10.4161/auto.5.7.9243
   Taylor MP, 2007, J VIROL, V81, P12543, DOI 10.1128/JVI.00755-07
   Wang J, 2013, J BIOL CHEM, V288, P27287, DOI 10.1074/jbc.M113.498899
   Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08
   Wu H, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050131
   Wu YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep32243
   Yoon SY, 2008, J VIROL, V82, P11976, DOI 10.1128/JVI.01028-08
   Yoon SY, 2009, AUTOPHAGY, V5, P388, DOI 10.4161/auto.5.3.7723
   Zhang JS, 2018, CELL HOST MICROBE, V23, P819, DOI 10.1016/j.chom.2018.05.005
   Zhang JS, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02286
   Zhang YN, 2011, AUTOPHAGY, V7, P613, DOI 10.4161/auto.7.6.15267
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zhao ZJ, 2007, AUTOPHAGY, V3, P581, DOI 10.4161/auto.4782
NR 110
TC 0
Z9 0
U1 3
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1084-9521
EI 1096-3634
J9 SEMIN CELL DEV BIOL
JI Semin. Cell Dev. Biol.
PD MAY
PY 2020
VL 101
BP 3
EP 11
DI 10.1016/j.semcdb.2019.12.009
PG 9
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA LP3NR
UT WOS:000534226200002
PM 31883993
DA 2020-07-08
ER

PT J
AU Stone, EF
   Shaz, BH
AF Stone, Elizabeth F.
   Shaz, Beth H.
TI Zika virus and its implications on cord blood banking and
   transplantation
SO TRANSFUSION
LA English
DT Review
AB KEY IDEAS
   Umbilical cord blood is an important cellular therapy product used for hematopoietic stem cell transplantation, but the US Food and Drug Administration guidance regarding donor screening to reduce the risk of Zika transmission has decreased the number of licensed, eligible cord blood units available for transplantation.
   There is a crucial need for updated travel risk assessment for Zika virus transmission, validated screening tests for Zika virus in umbilical cord blood, and further research on Zika virus transmissibility due to umbilical cord blood products to ensure that umbilical cord blood and related tissues are safe and available for transplantation.
C1 [Stone, Elizabeth F.; Shaz, Beth H.] New York Blood Ctr, 310 E 67 St, New York, NY 10028 USA.
RP Shaz, BH (corresponding author), New York Blood Ctr, 310 E 67 St, New York, NY 10028 USA.
EM bshaz@nybc.org
CR Adams Z, 2018, BIOL BLOOD MARROW TR, V24, P861, DOI 10.1016/j.bbmt.2017.11.032
   [Anonymous], 2018, DON SCREEN REC RED R
   Benjamin I, 2017, FERTIL STERIL, V107, P1319, DOI 10.1016/j.fertnstert.2017.02.112
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Centers for Disease Control and Prevention, ZIK VIR
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Mayani H, 2019, BONE MARROW TRANSPL, V55, P48
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744
   Scaradavou A, 2019, STEM CELL TRANSL MED, V8
NR 13
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAY
PY 2020
VL 60
IS 5
BP 889
EP 891
DI 10.1111/trf.15771
PG 3
WC Hematology
SC Hematology
GA LO8PU
UT WOS:000533888700004
PM 32208533
DA 2020-07-08
ER

PT J
AU Holm, A
AF Holm, Anja
TI New paths for sustainable solutions to tackle global and emerging
   infectious threats
SO BIOLOGICALS
LA English
DT Article
AB With the dramatic background of a newly emerged virus (SARS-CoV-2) spreading around the world, Coronavirus and other infectious health threats for the human and animal populations were illustrated and debated in excellent presentations at the IABS meeting 26-28 of February 2020. Historical evidence of pandemics and lessons learned from recent epidemics or epizootics caused by many pathogens (e.g., Ebola, Zika, and African Swine Fever viruses) illustrated the overarching need for close international cooperation. New and old technologies in vaccine development and their use were presented, resulting in a call for greater interaction between the human and the veterinary fields in order to leverage the expertise and knowledge in both human and animal medicine. The One Health concept was also emphasized for eliminating the 59,000 fatal human rabies cases annually attributed to unvaccinated dogs. For preventable, infectious diseases commonly spreading in the poorer regions of the world, a new regulatory approach and governance structure was called for to give access to affordable vaccines. Vaccines were touted as one of the most successful health invention ever introduced; on a similar level to health improvements due to clean water.
C1 [Holm, Anja] Cent VetPharma Consultancy Aps, Hauchsvej 7, DK-4180 Soroe, Denmark.
RP Holm, A (corresponding author), Cent VetPharma Consultancy Aps, Hauchsvej 7, DK-4180 Soroe, Denmark.
EM anjaholm@centralvetpharma.com
CR Amirthaligam, 2014, EFFECTIVENESS MATERN, DOI [10.1016/S0140-6736(14)60686-3, DOI 10.1016/S0140-6736(14)60686-3]
   [Anonymous], 2016, DEATHS CAUS AG SEX C
   Barnighausen, 2014, PNEUMOCOCCAL DIS CAN, DOI [10.1073/pnas.1400475111, DOI 10.1073/PNAS.1400475111]
   Cicchetti, 2018, VACCINATION INFLUENZ
   Dabbagh, 2018, WEEKLY EPIDEMIOL REC, V93, P649
   Ethgen, 2018, VACCINATION BUDGET E, DOI [10.1080/21645515.2018.1504528, DOI 10.1080/21645515.2018.1504528]
   Geall, 2012, NONVIRAL DELIVERY SE, DOI [10.1073/pnas.1209367109, DOI 10.1073/PNAS.1209367109]
   Kieny MP, 2016, LANCET, V387, P1509, DOI 10.1016/S0140-6736(16)00686-3
   Sevilla, 2019, ADULT PD VACCINATION, DOI [10.1016/j.jeoa.2019.100203, DOI 10.1016/J.JEOA.2019.100203]
   Verguet, 2013, ROTAVIRUS VACCINATIO, DOI [10.1016/j.vaccine.2013.07.014., DOI 10.1016/J.VACCINE.2013.07.014]
   WHO UNICEF World Bank, 2009, STATE WORLD VACCINES
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 1045-1056
EI 1095-8320
J9 BIOLOGICALS
JI Biologicals
PD MAY
PY 2020
VL 65
BP 42
EP 45
DI 10.1016/j.biologicals.2020.04.003
PG 4
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Pharmacology & Pharmacy
GA LP3YW
UT WOS:000534255800007
PM 32327306
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zuniga, J
   Choreno-Parra, JA
   Jimenez-Alvarez, L
   Cruz-Lagunas, A
   Marquez-Garcia, JE
   Ramirez-Martinez, G
   Goodina, A
   Hernandez-Montiel, E
   Fernandez-Lopez, LA
   Cabrera-Cornejo, MF
   Cabello, C
   Castillejos, M
   Hernandez, A
   Regino-Zamarripa, NE
   Mendoza-Milla, C
   Vivanco-Cid, H
   Escobar-Gutierrez, A
   Fonseca-Coronado, S
   Belaunzaran-Zamudio, PF
   Perez-Patrigeon, S
   Guerrero, L
   Regalado, J
   Najera-Cancino, G
   Caballero-Sosa, S
   Rincon-Leon, H
   Smolskis, M
   Mateja, A
   Hunsberger, S
   Beigel, JH
   Ruiz-Palacios, G
AF Zuniga, Joaquin
   Alberto Choreno-Parra, Jose
   Jimenez-Alvarez, Luis
   Cruz-Lagunas, Alfredo
   Eduardo Marquez-Garcia, Jose
   Ramirez-Martinez, Gustavo
   Goodina, Aminadab
   Hernandez-Montiel, Erika
   Alejandro Fernandez-Lopez, Luis
   Fernanda Cabrera-Cornejo, Maria
   Cabello, Carlos
   Castillejos, Manuel
   Hernandez, Andres
   Regino-Zamarripa, Nora E.
   Mendoza-Milla, Criselda
   Vivanco-Cid, Hector
   Escobar-Gutierrez, Alejandro
   Fonseca-Coronado, Salvador
   Belaunzaran-Zamudio, Pablo F.
   Perez-Patrigeon, Santiago
   Guerrero, Lourdes
   Regalado, Justino
   Najera-Cancino, Gabriel
   Caballero-Sosa, Sandra
   Rincon-Leon, Hector
   Smolskis, Mary
   Mateja, Allyson
   Hunsberger, Sally
   Beigel, John H.
   Ruiz-Palacios, Guillermo
CA Emerging Infect Dis
TI A unique immune signature of serum cytokine and chemokine dynamics in
   patients with Zika virus infection from a tropical region in Southern
   Mexico
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika virus; Cytokines; Chemokines; Inflammatory profile; Acute
   infection; Clinical symptoms
ID ASSOCIATION; EPIDEMIC; OUTBREAK; CXCR3
AB Objectives: To describe the kinetics of circulating cytokines and chemokines in humans with ZIKAV infection.
   Methods: Serum levels of different immune mediators in patients with ZIKAV infection were measured at distinct stages of the disease, as well as in culture supernatants from human monocytes infected with a clinical ZIKAV isolate. We also looked for clinical features associated with specific immune signatures among symptomatic patients.
   Results: We evaluated 23 ZIKAV-infected patients. Their mean age was 32 +/- 8.3 years and 65% were female. ZIKAV patients showed elevated IL-9, IL-17A, and CXCL10 levels at acute stages of the disease. At day 28, levels of CCL4 and CCL5 were increased, whereas IL-1RA, CXCL8 and CCL2 were decreased. At baseline, IL-7 was increased among patients with headache, whereas CCL2, and CCL3 were decreased in patients with bleeding and rash, respectively. Our clinical ZIKAV isolate induced a broad immune response in monocytes that did not resemble the signature observed in ZIKAV patients.
   Conclusions: We showed a unique immune signature in our cohort of ZIKAV-infected patients. Our study may provide valuable evidence helpful to identify immune correlates of protection against ZIKAV. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Zuniga, Joaquin; Alberto Choreno-Parra, Jose; Jimenez-Alvarez, Luis; Cruz-Lagunas, Alfredo; Eduardo Marquez-Garcia, Jose; Ramirez-Martinez, Gustavo; Goodina, Aminadab; Hernandez-Montiel, Erika; Alejandro Fernandez-Lopez, Luis; Fernanda Cabrera-Cornejo, Maria; Cabello, Carlos; Castillejos, Manuel; Hernandez, Andres; Regino-Zamarripa, Nora E.; Mendoza-Milla, Criselda; Regalado, Justino] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Immunobiol & Genet, Tlalpan 4502, Mexico City 14080, DF, Mexico.
   [Zuniga, Joaquin; Goodina, Aminadab; Hernandez-Montiel, Erika; Fernanda Cabrera-Cornejo, Maria; Regino-Zamarripa, Nora E.; Mendoza-Milla, Criselda] Escuela Med & Ciencias Salud, Tecnol Monterrey, Mexico City, DF, Mexico.
   [Alberto Choreno-Parra, Jose] Inst Politecn Nacl, Escuela Nacl Ciencias Biol, Mexico City, DF, Mexico.
   [Vivanco-Cid, Hector] Univ Veracruzana, Inst Invest Med Biol, Xalapa, Veracruz, Mexico.
   [Escobar-Gutierrez, Alejandro] Inst Diagnost & Referencia Epidemiol, Dept Immunol Invest, Mexico City, DF, Mexico.
   [Fonseca-Coronado, Salvador] Univ Nacl Autonoma Mexico, FES Iztacala, Mexico City, DF, Mexico.
   [Belaunzaran-Zamudio, Pablo F.; Perez-Patrigeon, Santiago; Guerrero, Lourdes; Ruiz-Palacios, Guillermo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Infectol, Mexico City, DF, Mexico.
   [Najera-Cancino, Gabriel] Hosp Reg Alta Especialidad Ciudad Salud, Tapachula, Chiapas, Mexico.
   [Caballero-Sosa, Sandra] Inst Seguridad & Serv Sociales Trabajadores Estad, Tapachula, Chiapas, Mexico.
   [Rincon-Leon, Hector] Inst Mexicano Seguro Social, Tapachula, Chiapas, Mexico.
   [Belaunzaran-Zamudio, Pablo F.; Smolskis, Mary; Beigel, John H.] NIAID, NIH, 9000 Rockville Pike, Rockville, MD 20892 USA.
   [Hunsberger, Sally] NIAID, BRB, Rockville, MD USA.
   [Mateja, Allyson] Leidos Biomed Res, Frederick, MD USA.
RP Zuniga, J (corresponding author), Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Lab Immunobiol & Genet, Tlalpan 4502, Mexico City 14080, DF, Mexico.
EM joazu@yahoo.com
OI Rincon Leon, Hector Armando/0000-0003-0715-200X; Belaunzaran,
   Pablo/0000-0003-4775-4734
FU Research Funds of the National Institute of Respiratory Diseases in
   Mexico; National Council of Science and Technology of Mexico
   (CONACYT)Consejo Nacional de Ciencia y Tecnologia (CONACyT) [CVU
   737347]; Mexico Emerging Infectious Diseases Clinical Research
   Network(La Red); Mexican Government [71260, 127088]; US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA; National Cancer
   Institute, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [HHSN261200800001E]
FX This work was supported by the Research Funds of the National Institute
   of Respiratory Diseases in Mexico. JCP was supported by the National
   Council of Science and Technology of Mexico (CONACYT,CVU 737347) to
   achieve his Ph.D. degree.; The Zik01 study was funded through the Mexico
   Emerging Infectious Diseases Clinical Research Network(La Red). La Red
   is collaboration between the Mexico Ministry of Health and the U.S.
   National Institute of Allergy and Infectious Diseases. The Mexican
   Government funded the Zik01 study in part by CONACYT (Fondo Sectorial
   SSA/IMSS/ISSSTE, Projects No. 71260 and No. 127088). The US National
   Institutes of Health funded the study with federal funds from the
   National Cancer Institute, NIH, under Contract No. HHSN261200800001E.
   The content of this publication does not necessarily reflect the views
   or policies of the Department of Health and Human Services, nor does
   mention of trade names, commercial products, or organizations imply
   endorsement by the U.S. Government.
CR Aickin M, 1996, AM J PUBLIC HEALTH, V86, P726, DOI 10.2105/AJPH.86.5.726
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen WQ, 2015, J VIROL, V89, P581, DOI 10.1128/JVI.02034-14
   Colavita F, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/2450540
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   DIAZQUINONEZ JA, 2016, GENOME ANNOUNC, V4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enriquez-de-Salamanca A, 2008, CYTOKINE, V44, P160, DOI 10.1016/j.cyto.2008.07.007
   Fernandez TD, 2009, CURR OPIN INFECT DIS, V22, P272, DOI 10.1097/QCO.0b013e3283298e62
   Gaffen SL, 2008, CYTOKINE, V43, P402, DOI 10.1016/j.cyto.2008.07.017
   Galliez RM, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw203
   Geevarghese B, 2014, HUM VACC IMMUNOTHER, V10, P1047, DOI 10.4161/hv.27908
   Gouel-Cheron A, 2019, ANTIVIR RES, V172, DOI 10.1016/j.antiviral.2019.104638
   Groom JR, 2011, IMMUNOL CELL BIOL, V89, P207, DOI 10.1038/icb.2010.158
   Hsieh MF, 2006, J IMMUNOL, V177, P1855, DOI 10.4049/jimmunol.177.3.1855
   Ip PP, 2010, J IMMUNOL, V184, P5705, DOI 10.4049/jimmunol.0903484
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kelvin AA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001279
   KHAIBOULLINA S, 2017, BLOOD, V130
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lohachanakul J, 2015, J MED VIROL, V87, P733, DOI 10.1002/jmv.24081
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   PAHO/WHO, 2016, ZIK RES CAS DEF
   Rayichandran S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09914-3
   SCHALL TJ, 1990, NATURE, V347, P669, DOI 10.1038/347669a0
   Tappe D, 2016, MED MICROBIOL IMMUN, V205, P269, DOI 10.1007/s00430-015-0445-7
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   WHO, 2016, INT GUID
   WHO, 2016, LEISHMANIASIS, P1
   World Health Organization, 2017, WORLD MALARIA REPORT, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Zuniga, 2013, EXP MOL PATHOL, V94, DOI [10.1016/j.yexmp.2013.03.007, DOI 10.1016/J.YEXMP.2013.03.007]
   Zuniga J, 2013, EXP MOL PATHOL, V94, P486, DOI [10.1016/j.yexmp.2013.03.007, DOI 10.1016/J.YEXMP.2013.03.007]
NR 33
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAY
PY 2020
VL 94
BP 4
EP 11
DI 10.1016/j.ijid.2020.02.014
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA LO5BT
UT WOS:000533643700002
PM 32081772
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Morrison, RE
   Cunha, A
AF Morrison, Rebecca E.
   Cunha, Americo
TI Embedded model discrepancy: A case study of Zika modeling
SO CHAOS
LA English
DT Article
ID VIRUS; TRANSMISSION; CALIBRATION; WOMEN
AB Mathematical models of epidemiological systems enable investigation of and predictions about potential disease outbreaks. However, commonly used models are often highly simplified representations of incredibly complex systems. Because of these simplifications, the model output, of, say, new cases of a disease over time or when an epidemic will occur, may be inconsistent with the available data. In this case, we must improve the model, especially if we plan to make decisions based on it that could affect human health and safety, but direct improvements are often beyond our reach. In this work, we explore this problem through a case study of the Zika outbreak in Brazil in 2016. We propose an embedded discrepancy operator-a modification to the model equations that requires modest information about the system and is calibrated by all relevant data. We show that the new enriched model demonstrates greatly increased consistency with real data. Moreover, the method is general enough to easily apply to many other mathematical models in epidemiology.
C1 [Morrison, Rebecca E.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.
   [Cunha, Americo] Rio de Janeiro State Univ UERJ, Dept Appl Math, BR-20550 Rio De Janeiro, Brazil.
RP Morrison, RE (corresponding author), Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA.
EM rebeccam@colorado.edu; americo@ime.uerj.br
RI ; Cunha Jr, Americo/D-5261-2009
OI Morrison, Rebecca/0000-0002-5180-7088; Cunha Jr,
   Americo/0000-0002-8342-0363
FU Brazilian agency Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior-Brasil (CAPES) [001]; Carlos Chagas Filho Research Foundation
   of Rio de Janeiro State (FAPERJ)Carlos Chagas Filho Foundation for
   Research Support of the State of Rio de Janeiro (FAPERJ) [210.021/2018,
   211.037/2019]
FX The authors acknowledge Professor Davi Antonio dos Santos (ITA Brazil)
   for very helpful discussions, especially regarding the linear feedback
   aspect of this work. The second author acknowledges the financial
   support given by the Brazilian agencies Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior-Brasil (CAPES)-Finance Code 001 and the
   Carlos Chagas Filho Research Foundation of Rio de Janeiro State (FAPERJ)
   under Grant Nos. 210.021/2018 and 211.037/2019.
CR Bastos MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205001
   Carrie M., 2016, MATH MODELS FIGHTING
   Chang LL, 2020, CHAOS, V30, DOI 10.1063/1.5135069
   Childs ML, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0335
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Coleman TF, 1996, SIAM J OPTIMIZ, V6, P418, DOI 10.1137/0806023
   Conn AR, 2000, MOS-SIAM SER OPTIMIZ
   Dantas E, 2018, APPL MATH COMPUT, V338, P249, DOI 10.1016/j.amc.2018.06.024
   Forgoston E, 2009, CHAOS, V19, DOI 10.1063/1.3247350
   Frauenthal J. C., 2012, MATH MODELING EPIDEM
   Ghanbari B, 2019, CHAOS, V29, DOI 10.1063/1.5117285
   Givon D, 2004, NONLINEARITY, V17, pR55, DOI 10.1088/0951-7715/17/6/R01
   Gong YW, 2018, CHAOS, V28, DOI 10.1063/1.5021167
   Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0
   Hernandez-Bermejo B., 2019, ARXIV190913837
   Howson C., 2006, SCI REASONING BAYESI
   Jaynes E. T., 2003, PROBABILITY THEORY L
   Kennedy MC, 2001, J ROY STAT SOC B, V63, P425, DOI 10.1111/1467-9868.00294
   Martin MR, 2015, STUD PERFORM EARLY, P61
   Morrison R. E., REBECCAEM ZIKA INITI, DOI [10.5281/ZENODO.3666845, DOI 10.5281/ZENODO.3666845]
   Morrison R. E., 2019, ARXIV191008191
   Morrison R. E., 2019, ARXIV190913837
   Morrison RE, 2018, SIAM-ASA J UNCERTAIN, V6, P457, DOI 10.1137/16M1106419
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Nelson K. E., 2014, INFECT DIS EPIDEMIOL
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Pfeiffer D., 2008, SPATIAL ANAL EPIDEMI, V142
   Prudencio EE, 2012, LECT NOTES COMPUT SC, V7155, P398, DOI 10.1007/978-3-642-29737-3_44
   Secretaria de Vigilancia em Saude, 2017, B EP MON CAS DENG FE, V48
   Silva DH, 2018, CHAOS, V28, DOI 10.1063/1.5050807
   Sun MF, 2017, CHAOS, V27, DOI 10.1063/1.4984217
NR 31
TC 0
Z9 0
U1 0
U2 0
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 1054-1500
EI 1089-7682
J9 CHAOS
JI Chaos
PD MAY
PY 2020
VL 30
IS 5
DI 10.1063/5.0005204
PG 9
WC Mathematics, Applied; Physics, Mathematical
SC Mathematics; Physics
GA LM5GL
UT WOS:000532276400003
PM 32491876
OA Other Gold
DA 2020-07-08
ER

PT J
AU Cunha, LS
   Medeiros, WR
   Lima, FAV
   Pereira, SA
AF Cunha, Lizailma Silva
   Medeiros, Wilton Rodrigues
   Vieira Lima Junior, Francisco Assis
   Pereira, Silvana Alves
TI Relationship between social inequality indicators and the spatial
   distribution of Zika Virus cases
SO CIENCIA & SAUDE COLETIVA
LA English
DT Article
DE Zika virus; Violence; Health indicators; Microcephaly; Epidemiology
ID MORTALITY
AB The aim of this article was to analyze the possible relationship between social inequality indicators and the spatial distribution of ZIKV cases in a state in Northeastern Brazil in 2015-16. This is an ecological study with the data of notified ZIKV cases and the sociodemographic indicators of Rio Grande do Norte state (RN), based on information from the State Public Health Department (SESAP-RN) and DATASUS. The data were analyzed in Terraview version 4.2.2, Geoda version 1.12 and IBM SPSS Statistics 21. Both the average incidence rate (AIR) of ZIKV cases in 2015-16 (Moran = 0.139; p= 0.03) and the AIR of violence (Moran= 0.295; p= 0.02), average household income (Moran= 0.344; p=0.01) and unemployment rate (Moran= 0.231; p=0.01) exhibited a geographic spatial distribution pattern. In multiple linear regression analysis, the variables AIR of violence and average household income explained 55% of the variation in the AIR of ZIKV in 2015-16 (adjusted R2 = 0.55). Municipalities with more notifications of violence and higher average income, such as the state capital, reported a higher number of ZIKV cases, possibly due to better organization, greater awareness of socioenvironmental problems and easier access to health services.
C1 [Cunha, Lizailma Silva; Pereira, Silvana Alves] Univ Fed Rio Grande do Norte UFRN, Programa Posgrad Saude Colet, R Teodorico Bezerra S-N,Campus Santa Cruz, BR-59200000 Santa Cruz, RN, Brazil.
   [Medeiros, Wilton Rodrigues] UFRN, Hosp Univ Ana Bezerra, Santa Cruz, RN, Brazil.
   [Vieira Lima Junior, Francisco Assis] Ctr Univ Rio Grande do Norte, Natal, RN, Brazil.
RP Cunha, LS (corresponding author), Univ Fed Rio Grande do Norte UFRN, Programa Posgrad Saude Colet, R Teodorico Bezerra S-N,Campus Santa Cruz, BR-59200000 Santa Cruz, RN, Brazil.
EM apsilvana@gmail.com
RI ; Alves Pereira, Silvana/I-5635-2017
OI Silva Cunha, Lizailma/0000-0003-4816-3493; Alves Pereira,
   Silvana/0000-0002-6226-2837; Rodrigues Medeiros,
   Wilton/0000-0002-9096-8108; LIMA JUNIOR, FRANCISCO ASSIS
   VIEIRA/0000-0001-8877-5406
CR Abreu T. T., 2016, Revista de Ciencias Medicas e Biologicas, V15, P426, DOI 10.9771/cmbio.v15i3.18347
   ALMEIDA C. A. P., 2018, HYGEIA UBERLANDIA, V14, P56
   Almeida LS, 2019, CIEN SAUDE COLET
   Assis VC, 2014, REV APS, V17, P429
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barreto ML, 2017, CIENC SAUDE COLETIVA, V22, P2097, DOI 10.1590/1413-81232017227.02742017
   Brasil. Ministerio da Saude (MS), 2018, B EPIDEMIOLOGICO, V49, P1
   Brasil. Ministerio da Saude (MS). Secretaria de Vig- ilancia em Saude, 2019, GUIA VIG SAUD
   Buss Paulo Marchiori, 2007, Physis, V17, P77, DOI 10.1590/S0103-73312007000100006
   Butler D, 2016, NATURE, V535, P475, DOI 10.1038/nature.2016.20309
   Camara G, 2004, ANALISE ESPACIAL DAD
   Cardia N, 2002, CIENCIA CULTURA TEMA, V54, P25
   Dahlberg Linda L., 2006, Ciênc. saúde coletiva, V11, P1163
   Fernandes LA, 2018, BRAZ J HLTH REV, V1, P314
   Ferri CP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-209
   Fontoura Fabíola Chaves, 2014, Texto contexto - enferm., V23, P907, DOI 10.1590/0104-07072014002320013
   Freitas RMS, 2018, MEDINDO SANEAMENTO P
   Garcia LP, 2018, TEXTO DISCUSSAO
   Gottschalg MFS, 2012, SEGREGACAO SOCIOESPA
   Governo do Estado do Rio Grande do Norte. Sec- retaria de Estado da Saude Publica (SESAP), 2015, SESAP MON CAS ZIK VI
   IBGE, 2010, CENS POP 2010
   Instituto de Pesquisa Economica Aplicada (IPEA), 2018, ATLAS DA VIOLENCIA
   Ishitani LH, 2006, REV SAUDE PUBL, V40, P684, DOI 10.1590/S0034-89102006000500019
   Koizumi M, 2007, REV SAUDE, V1, P37
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   LOPES N, 2014, REV PAN-AMAZ SAUDE, V5, P55, DOI DOI 10.5123/S2176-62232014000300007
   Macedo AC, 2001, REV SAUDE PUBL, V35, P515, DOI 10.1590/S0034-89102001000600004
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Menezes SA, 2016, REV EXPRESSAO CATOLI, V1, P25
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, B EPIDEMIOL, V48, P1, DOI DOI 10.5588/IJTLD.11.0170
   Moraes CH, 2017, DISERTACIONES ANUARI, V10, P16
   Morais IRD, 2018, HYGIEA, V14, P17
   Nunes João, 2016, Lua Nova, V0, P21, DOI 10.1590/0102-6445021-046/98
   Resende João Paulo de, 2011, Estud. Econ., V41, P173, DOI 10.1590/S0101-41612011000100007
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Sant'anna Cynthia Fontella, 2010, Rev. Gaúcha Enferm., V31, P92, DOI 10.1590/S1983-14472010000100013
   Travassos Claudia, 2006, Ciênc. saúde coletiva, V11, P975, DOI 10.1590/S1413-81232006000400019
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 0
Z9 0
U1 1
U2 1
PU ABRASCO-ASSOC BRASILEIRA POS-GRADUACAO & SAUDE COLETIVA
PI RIO DE JANEIRO
PA AVENIDA BRASIL, 4036, SALA 700 MANGUINHOS-1, RIO DE JANEIRO, 21040-36,
   BRAZIL
SN 1413-8123
EI 1678-4561
J9 CIENC SAUDE COLETIVA
JI Cienc. Saude Coletiva
PD MAY
PY 2020
VL 25
IS 5
BP 1839
EP 1849
DI 10.1590/1413-81232020255.34642019
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LM6VW
UT WOS:000532389000024
PM 32402031
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Dhavan, PP
   Jadhav, BL
AF Dhavan, Pratik P.
   Jadhav, Bhaskar L.
TI Eco-friendly approach to control dengue vector Aedes aegypti larvae with
   their enzyme modulation by Lumnitzera racemosa fabricated zinc oxide
   nanorods
SO SN APPLIED SCIENCES
LA English
DT Article
DE Aedes aegypti; Green synthesis; Lumnitzera racemosa; ZnO nanorods;
   Mosquito-larvicidal
ID GLUTATHIONE S-TRANSFERASES; ZNO NANOPARTICLES; ANTIBACTERIAL ACTIVITY;
   MOSQUITO VECTORS; AG NANOPARTICLES; GREEN SYNTHESIS; SEED EXTRACT;
   TOXICITY; MALARIA; ACETYLCHOLINESTERASE
AB Aedes aegypti mosquito species is a primary vector for dengue, chikungunya and Zika infections, and vector control is the only key approach for reducing their transmission. The present study emphasizes on environmental friendly approach for the fabrication of zinc oxide nanorods (ZnO NRs) using aqueous extract of Lumnitzera racemosa flower buds (LB) as a reducing and stabilizing agent. ZnO NRs were examined by UV-Vis spectroscopy with characteristic absorbance band at 373.82 nm and bandgap of 3.25 eV. FT-IR analysis revealed the functional groups associated with ZnO NRs. The crystallinity of LB-ZnO NRs was further investigated using X-ray diffraction. The Zeta potential displayed a surface charge of -23.5 mV on NRs. Energy dispersive spectra analysis and SEM analysis confirmed the formation of ZnO NRs whilst TEM highlighted the average length and diameter in the range of 250-300 nm and 45-50 nm respectively. LB-ZnO NRs were found to be efficacious against Ae. aegypti 4th instar larvae with LC50 of 24.74 mu g/ml. Decreased acetylcholinesterase (60.6%) and glutathione S-transferase (24.4%) activities were also evaluated in Ae. aegypti larvae which were exposed to synthesized LB-ZnO NRs with no genetic aberrations. All these outcomes propose the potential employment of LB-ZnO NRs in mosquito control, as well as an effective alternative to insecticide resistance.
   [GRAPHICS]
   .
C1 [Dhavan, Pratik P.; Jadhav, Bhaskar L.] Univ Mumbai, Dept Life Sci, Vidyanagari Campus, Mumbai 400098, Maharashtra, India.
RP Dhavan, PP (corresponding author), Univ Mumbai, Dept Life Sci, Vidyanagari Campus, Mumbai 400098, Maharashtra, India.
EM pratik.dhavan11@gmail.com; drbljadhav@gmail.com
OI Dhavan, Pratik/0000-0002-8387-6053
CR Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Al RN, 2016, J NAT SCI RES, V6, P2224
   Ali M. Syed, 2012, Asian Pacific Journal of Tropical Disease, V2, P401, DOI 10.1016/S2222-1808(12)60087-5
   Anjaneyulu M, 2003, PROG NEURO-PSYCHOPH, V27, P1001, DOI 10.1016/S0278-5846(03)00160-X
   Applerot G, 2009, ADV FUNCT MATER, V19, P842, DOI 10.1002/adfm.200801081
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Awwad A. M., 2012, NANOSCI NANOTECHNOL, V2, P164, DOI [10.5923/j.nn.20120206.03, DOI 10.5923/J.NN.20120206.03]
   Azizullah A, 2014, PARASITOL RES, V113, P4321, DOI 10.1007/s00436-014-4175-3
   Bala N, 2015, RSC ADV, V5, P4993, DOI 10.1039/c4ra12784f
   Banumathi B, 2017, PARASITOL RES, V116, P1637, DOI 10.1007/s00436-017-5438-6
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Chennimalai M, 2019, MAT SCI ENG C-MATER, V103, DOI 10.1016/j.msec.2019.109844
   Coelho JS, 2009, CHEMOSPHERE, V77, P934, DOI 10.1016/j.chemosphere.2009.08.022
   D'Souza L, 2010, INDIAN J MAR SCI, V39, P294
   Davis K, 2019, RSC ADV, V9, P14638, DOI 10.1039/c9ra02091h
   de Castro BM, 2009, MOL CELL BIOL, V29, P5238, DOI 10.1128/MCB.00245-09
   DELACERDA LD, 1986, BIOTROPICA, V18, P350, DOI 10.2307/2388579
   Dobrucka R, 2016, SAUDI J BIOL SCI, V23, P517, DOI 10.1016/j.sjbs.2015.05.016
   Elango G, 2016, J PHOTOCH PHOTOBIO B, V162, P162, DOI 10.1016/j.jphotobiol.2016.06.045
   ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9
   Fillinger U, 2011, MAL J, V10, P1
   Finlayson C, 2015, ACTA TROP, V152, P245, DOI 10.1016/j.actatropica.2015.09.026
   Fortunato EMC, 2005, ADV MATER, V17, P590, DOI 10.1002/adma.200400368
   Fouad H, 2018, ARTIF CELL NANOMED B, V46, P558, DOI 10.1080/21691401.2017.1329739
   Fournier D, 2005, CHEM-BIOL INTERACT, V157, P257, DOI 10.1016/j.cbi.2005.10.040
   Giordano G, 2007, TOXICOL APPL PHARM, V219, P181, DOI 10.1016/j.taap.2006.09.016
   GLASEL JA, 1995, BIOTECHNIQUES, V18, P62
   Gupta Shivani, 2012, Annals of Biological Research, V3, P1553
   Gupta V. K., 2015, ENZYME RES, V2015, P1, DOI [10.1155/2015/370705, DOI 10.1155/2015/370705]
   HABIG WH, 1974, J BIOL CHEM, V249, P7130
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Ikezawa H., 1981, METHODS ENZYMOLOGY C, V71, P731, DOI DOI 10.1016/0076-6879(81)71086-3
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Jisha S, 2018, INDIAN J SCI RES, V20, P68
   Kavithaa K., 2016, INT J MOD SCI, V2, P46, DOI [10.1016/j.kijoms.2016.01.002, DOI 10.1016/j.kijoms.2016.01.002, DOI 10.1016/J.KIJOMS.2016.01.002]
   Kim IH, 2003, TETRAHEDRON, V59, P9985, DOI 10.1016/j.tet.2003.10.048
   Kim SJ, 2009, APPL SURF SCI, V255, P5363, DOI 10.1016/j.apsusc.2008.10.028
   Kirthi AV, 2011, PARASITOL RES, V109, P461, DOI 10.1007/s00436-011-2277-8
   Koodalingam A, 2011, ACTA TROP, V118, P27, DOI 10.1016/j.actatropica.2011.01.003
   Kumar S, 2010, PARASITOL RES, V107, P901, DOI 10.1007/s00436-010-1948-1
   Lardeux F, 2002, ANN TROP MED PARASIT, V96, pS105, DOI 10.1179/000349802125002455
   LIN TC, 1993, J NAT PROD, V56, P629, DOI 10.1021/np50094a030
   Loan TT, 2009, J PHYS D APPL PHYS, V42, DOI 10.1088/0022-3727/42/6/065412
   Lu FC, 2002, LUS BASIC TOXICOLOGY, P386
   Mahamuni Pranjali P, 2019, Biochem Biophys Rep, V17, P71, DOI 10.1016/j.bbrep.2018.11.007
   Malaikozhundan B, 2017, MICROB PATHOGENESIS, V104, P268, DOI 10.1016/j.micpath.2017.01.029
   Melo-Santos MAV, 2010, ACTA TROP, V113, P180, DOI 10.1016/j.actatropica.2009.10.015
   Murugan K, 2011, HYDROBIOLOGIA, V666, P331, DOI 10.1007/s10750-011-0629-0
   Murugan K, 2017, HYDROBIOLOGIA, V797, P335, DOI 10.1007/s10750-017-3196-1
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Napoleao TH, 2012, PARASITOL RES, V110, P609, DOI 10.1007/s00436-011-2529-7
   Narendhran S, 2016, B MATER SCI, V39, P1, DOI 10.1007/s12034-015-1136-0
   Nie L, 2006, SMALL, V2, P621, DOI 10.1002/smll.200500193
   PARKES TL, 1993, GENOME, V36, P1007, DOI 10.1139/g93-134
   Rajasekharreddy P, 2014, MAT SCI ENG C-MATER, V39, P203, DOI 10.1016/j.msec.2014.03.003
   Rajesh R, 2009, CURR NANOSCI, V5, P117
   Ramesh AV, 2017, INT J ENG APPL SCI T, V2, P2143
   Ravikumar Sundaram, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P348, DOI 10.1016/S2221-1691(11)60078-6
   Saeb ATM, 2014, SCI WORLD J, DOI 10.1155/2014/704708
   Senthilkumar N, 2017, NEW J CHEM, V41, P10347, DOI 10.1039/c7nj02664a
   Shankar SS, 2003, BIOTECHNOL PROGR, V19, P1627, DOI 10.1021/bp034070w
   Sharma D, 2010, THIN SOLID FILMS, V519, P1224, DOI 10.1016/j.tsf.2010.08.073
   Sirelkhatim A, 2015, NANO-MICRO LETT, V7, P219, DOI 10.1007/s40820-015-0040-x
   Solairaj D, 2017, J POLYM ENVIRON, V25, P435, DOI 10.1007/s10924-016-0822-3
   Suganthy N, 2009, J ENZYM INHIB MED CH, V24, P702, DOI 10.1080/14756360802334719
   Vanathi P, 2014, MATER LETT, V134, P13, DOI 10.1016/j.matlet.2014.07.029
   Vanhaelen N, 2001, PESTIC BIOCHEM PHYS, V71, P170, DOI 10.1006/pest.2001.2573
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Vontas JG, 2001, BIOCHEM J, V357, P65, DOI 10.1042/0264-6021:3570065
   Vontas JG, 2000, PESTIC BIOCHEM PHYS, V68, P184, DOI 10.1006/pest.2000.2512
   Vorbrodt A, 1959, POSTEP HIG MED DOSW, V13, P200
   Wang ZY, 2010, CHEMOSPHERE, V79, P86, DOI 10.1016/j.chemosphere.2009.12.051
   Wang ZY, 2009, CHEMOSPHERE, V77, P67, DOI 10.1016/j.chemosphere.2009.05.015
   World Health Organization, 2012, HDB INT VECT MAN
   Xiong G, 2006, PHYS STATUS SOLIDI C, V3, P3577, DOI 10.1002/pssc.200672164
   Xiong HM, 2013, ADV MATER, V25, P5329, DOI 10.1002/adma.201301732
   Yoon SH, 2006, ISAF IEEE, P322
   Yuvakkumar R, 2015, SPECTROCHIM ACTA A, V137, P250, DOI 10.1016/j.saa.2014.08.022
   Zaim M, 2005, WHOPES
   Zak AK, 2013, ADV POWDER TECHNOL, V24, P618, DOI 10.1016/j.apt.2012.11.008
   Zak AK, 2011, CERAM INT, V37, P393, DOI 10.1016/j.ceramint.2010.08.017
   Zhang GL, 2013, RSC ADV, V3, P1878, DOI 10.1039/c2ra22442a
   Zheng JW, 2011, METHODS MOL BIOL, V697, P93, DOI 10.1007/978-1-60327-198-1_9
NR 87
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2523-3963
EI 2523-3971
J9 SN APPL SCI
JI SN Appl. Sci.
PD MAY
PY 2020
VL 2
IS 5
AR 843
DI 10.1007/s42452-020-2636-0
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LN3IA
UT WOS:000532834300060
OA Bronze
DA 2020-07-08
ER

PT J
AU Harville, EW
   Buekens, PM
   Cafferata, ML
   Gilboa, S
   Tomasso, G
   Tong, V
AF Harville, Emily W.
   Buekens, Pierre M.
   Luisa Cafferata, Maria
   Gilboa, Suzanne
   Tomasso, Giselle
   Tong, Van
TI Measurement error, microcephaly prevalence and implications for Zika: an
   analysis of Uruguay perinatal data
SO ARCHIVES OF DISEASE IN CHILDHOOD
LA English
DT Article
ID GESTATIONAL-AGE; VIRUS-INFECTION; INTERGROWTH-21ST; STANDARDS;
   DIAGNOSIS; INFANTS; BRAZIL
AB Background and objective The Zika virus outbreak has drawn attention to microcephaly, whose definition is based on head circumference measuring below a percentile or number of SDs below the mean. The objective of this analysis was to assess how differences in measurement precision might affect prevalence and trends of microcephaly.
   Methods Data from all births in Uruguay during 2010-2015 were obtained from the Perinatal Information System. The prevalence of births with microcephaly was calculated based on head circumference measurement at birth applying the INTERGROWTH-21st standards for sex and gestational age, and compared by method of ascertaining gestational age.
   Results Rounding and digit preference was observed: 74% of head circumference measurements were reported as a whole centimetre value. The prevalence of births varied substantially by the criterion used to define microcephaly (<3 SD, <2 SD, <3rd percentile for gestational age) and could be halved or doubled based on adding or subtracting a half-centimetre from all reported head circumference measurements. If 4 days were added to gestational age calculations, rather than using completed gestational weeks (without days) for gestational age reporting, the prevalence was 1.7-2 times higher.
   Discussion Rounding in measurement of head circumference and reporting preferences of gestational age may have contributed to a lower prevalence of microcephaly than expected in this population. Differences in head circumference measurement protocols and gestational age dating have the potential to affect the prevalence of babies reported with microcephaly, and this limitation should be acknowledged when interpreting head circumference data collected for surveillance.
C1 [Harville, Emily W.; Buekens, Pierre M.] Tulane Univ, Tulane Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70118 USA.
   [Luisa Cafferata, Maria] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina.
   [Gilboa, Suzanne; Tong, Van] Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA.
   [Tomasso, Giselle] Clin & Epidemiol Res Unit, Montevideo, Uruguay.
RP Harville, EW (corresponding author), Tulane Univ, New Orleans, LA 70112 USA.
EM eharvill@tulane.edu
OI Harville, Emily/0000-0003-0319-0922
FU Vysnova Partners [SC-2017-3034-TU]
FX This study was funded by Vysnova Partners (SC-2017-3034-TU).
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Bamberg C, 2017, J PERINAT MED, V45, P305, DOI 10.1515/jpm-2016-0005
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Candelo E, 2018, BIOMEDICA, V38, P127, DOI 10.7705/biomedica.v38i0.4413
   CAPURRO H, 1978, J PEDIATR-US, V93, P120, DOI 10.1016/S0022-3476(78)80621-0
   Centers for Disease Control and Prevention, 2016, MEAS HEAD CIRC
   Centers for Disease Control and Prevention, 2016, MEAS INF HEAD CIRC I
   de Magalhaes-Barbosa MC, 2017, TRAVEL MED INFECT DI, V16, P52, DOI 10.1016/j.tmaid.2017.03.009
   DeSilva M, 2017, VACCINE, V35, P6472, DOI 10.1016/j.vaccine.2017.01.044
   dos Santos CND, 2016, TRENDS PARASITOL, V32, P508, DOI 10.1016/j.pt.2016.03.008
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Grantz KL, 2018, AM J OBSTET GYNECOL, V218, pS641, DOI 10.1016/j.ajog.2017.11.593
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kalmin MM, 2019, PAEDIATR PERINAT EP, V33, P286, DOI 10.1111/ppe.12561
   Latin American Center of Perinatology Women and Reproductive Health, SIST INF PER
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morris JK, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4721
   ORIOLI IM, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J5018
   Pan American Health Organization, 2017, REG ZIK EP UPD AM AU
   Quinto L, 2017, J TROP PEDIATRICS, V63, P495, DOI 10.1093/tropej/fmx015
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rick AM, 2017, GLOB HEALTH-SCI PRAC, V5, P686, DOI 10.9745/GHSP-D-17-00116
   Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601
   Silva AA, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2017-0589
   Souza S W, 1976, Arch Dis Child, V51, P624
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
NR 29
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0003-9888
EI 1468-2044
J9 ARCH DIS CHILD
JI Arch. Dis. Child.
PD MAY
PY 2020
VL 105
IS 5
BP 428
EP 432
DI 10.1136/archdischild-2019-317678
PG 5
WC Pediatrics
SC Pediatrics
GA LL2HP
UT WOS:000531376700004
PM 31836636
OA Bronze
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   DeBiasi, RL
AF Mulkey, Sarah B.
   DeBiasi, Roberta L.
TI Do Not Judge a Book by Its Cover: Critical Need for Longitudinal
   Neurodevelopmental Assessment of In Utero Zika-Exposed Children
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Editorial Material
C1 [Mulkey, Sarah B.; DeBiasi, Roberta L.] Childrens Natl Hosp, Washington, DC USA.
   [Mulkey, Sarah B.; DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.] George Washington Univ, Sch Med & Hlth Sci, Dept Neurol, Washington, DC 20052 USA.
   [Mulkey, Sarah B.; DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Trop Med & Infect Dis, Washington, DC 20052 USA.
RP Mulkey, SB (corresponding author), Childrens Natl Hosp, Fetal Med Inst, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
FU Thrasher Research Fund
FX S. B. M. and R. L. D. receive support for their Zika studies from the
   Thrasher Research Fund.
CR Bertolli J, 2020, AM J TROP MED HYG, V102, P955, DOI 10.4269/ajtmh.19-0961
   Connery AK, 2019, AM J TROP MED HYG, V100, P438, DOI 10.4269/ajtmh.18-0713
   Hillman B, 2019, BIRTH DEFECTS RES, V111, P360, DOI 10.1002/bdr2.1486
   Mavigner M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao6975
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Pecanha PM, 2020, PLOS ONE, V15
   Santana CM, 2015, GLOB PEDIAT HLTH, V2
   Wilder-Smith Annelies, 2019, BMJ Open, V9, pe026092, DOI 10.1136/bmjopen-2018-026092
NR 9
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2020
VL 102
IS 5
BP 913
EP 914
DI 10.4269/ajtmh.20-0197
PG 2
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8CB
UT WOS:000531086800001
PM 32274991
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Bertolli, J
   Attell, JE
   Rose, C
   Moore, CA
   Melo, F
   Staples, JE
   Kotzky, K
   Krishna, N
   Satterfield-Nash, A
   Pereira, IO
   Pessoa, A
   Smith, DC
   Santelli, ACFES
   Boyle, CA
   Peacock, G
AF Bertolli, Jeanne
   Attell, Jacob Elijah
   Rose, Charles
   Moore, Cynthia A.
   Melo, Flavio
   Staples, Jennifer Erin
   Kotzky, Kim
   Krishna, Nevin
   Satterfield-Nash, Ashley
   Pereira, Isabela Ornelas
   Pessoa, Andre
   Smith, Donna Camille
   Santelli, Ana Carolina Faria e Silva
   Boyle, Coleen A.
   Peacock, Georgina
TI Functional Outcomes among a Cohort of Children in Northeastern Brazil
   Meeting Criteria for Follow-Up of Congenital Zika Virus Infection
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID INFANTS; QUESTIONNAIRE; OUTBREAK; BORN
AB Following the large outbreak of Zika virus in the Western Hemisphere, many infants have been born with congenital Zika virus infection. It is important to describe the functional outcomes seen with congenital infections to allow for their recognition and appropriate interventions. We evaluated 120 children conceived during the 2015-2016 Zika virus outbreak in Paraiba, Brazil, who were approximately 24 months old, to assess functional outcomes. All children met either anthropometric criteria or laboratory criteria suggestive of possible congenital Zika virus infection. We collected results of previous medical evaluations, interviewed parents, and performed physical examinations and functional assessments, for example, the Hammersmith Infant Neurological Examination (HINE). We compared patterns of neurologic outcomes and developmental delay at age 24 months by whether children met anthropometric or laboratory criteria, or both. Among children meeting both criteria, 60% (26/43) were multiply affected (had severe motor impairment, severe developmental delay, and suboptimal HINE scores), compared with 5% (3/57) meeting only laboratory criteria and none (0/20) meeting only anthropometric criteria. Of the remaining 91 children, 49% (45) had developmental delay, with more severe delay seen in children meeting both criteria. Although children meeting physical and laboratory criteria for potential congenital Zika virus infection were more severely affected, we did identify several children with notable adverse neurologic outcomes and developmental delay with no physical findings but potential laboratory evidence of Zika virus infection. Given this, all children who were potentially exposed in utero to Zika virus should be monitored in early childhood for deficits to allow for early intervention.
C1 [Bertolli, Jeanne; Peacock, Georgina] Ctr Dis Control & Prevent CDC, Div Human Dev & Disabil, 1600 Clifton Rd,Mailstop E88, Atlanta, GA 30329 USA.
   [Attell, Jacob Elijah] Eagle Global Sci, San Antonio, TX USA.
   [Rose, Charles; Moore, Cynthia A.; Boyle, Coleen A.] CDC, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.
   [Melo, Flavio] Hosp Reg Guarabira Governo Estado Paraiba, Joao Pessoa, Paraiba, Brazil.
   [Staples, Jennifer Erin] CDC, Div Vector Borne Dis, Ft Collins, CO USA.
   [Kotzky, Kim; Satterfield-Nash, Ashley] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA.
   [Krishna, Nevin] CDC, Off Publ Hlth Preparedness & Response, Atlanta, GA 30333 USA.
   [Pereira, Isabela Ornelas] Minist Hlth Brazil, Transmissible Dis Dept DEVIT, Brasilia, DF, Brazil.
   [Pessoa, Andre] Hosp Infantil Albert Sabin, Fortaleza, Ceara, Brazil.
   [Smith, Donna Camille] CDC, Div Congenital & Dev Disorders, Atlanta, GA 30333 USA.
   [Santelli, Ana Carolina Faria e Silva] CDC, Div Global HIV & TB, Ctr Global Hlth, Atlanta, GA 30333 USA.
RP Bertolli, J (corresponding author), Ctr Dis Control & Prevent CDC, Div Human Dev & Disabil, 1600 Clifton Rd,Mailstop E88, Atlanta, GA 30329 USA.
EM jub7@cdc.gov
FU Office of Infectious Diseases, Bureau of Global Health, U.S. Agency for
   International Development (USAID)United States Agency for International
   Development (USAID); Centers for Disease Control and Prevention
   (CDC)United States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [NU2G GH001152]
FX This research was made possible through support provided by the Office
   of Infectious Diseases, Bureau of Global Health, U.S. Agency for
   International Development (USAID), under the terms of an Interagency
   Agreement with the Centers for Disease Control and Prevention (CDC) and
   Cooperative Agreement number NU2G GH001152. While they contributed to
   this project, two of the authors were supported by appointments to the
   Research Participation Program administered by the Oak Ridge Institute
   for Science and Education through an interagency agreement between the
   U.S. Department of Energy and CDC.
CR Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito C, 2015, ACTA MEDICA PORT, V28, P679
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Douglass LM, 2016, PEDIATR NEUROL, V54, P64, DOI 10.1016/j.pediatrneurol.2015.09.016
   Durkin M, 2002, MENT RETARD DEV D R, V8, P206, DOI 10.1002/mrdd.10039
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Filgueiras A, 2013, EARLY HUM DEV, V89, P561, DOI 10.1016/j.earlhumdev.2013.02.005
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gottlieb CA, 2009, LANCET, V374, P1831, DOI 10.1016/S0140-6736(09)61871-7
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   International Fetal and Newborn Growth Consortium for the 21st Century, 2017, STAND NEWB REF VER P
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Maitre NL, 2016, PEDIATR NEUROL, V65, P31, DOI 10.1016/j.pediatrneurol.2016.09.010
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Pan American Health Organization, 2016, TIM EM ZIK VIR AM
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Simeonson RJ, 1992, PRIMARY PEDIAT CARE, P867
   Squires J, 2009, ASQ 3 USERS GUIDE, P157
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Valdes V, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.14061
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   World Health Organization, 2017, CHILD GROWTH STAND H
NR 36
TC 1
Z9 1
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2020
VL 102
IS 5
BP 955
EP 963
DI 10.4269/ajtmh.19-0961
PG 9
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8CB
UT WOS:000531086800014
PM 32228785
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Ali, R
   Azmi, RA
   Ahmad, NW
   Hadi, AA
   Muhamed, KA
   Rasli, R
   Ling, CY
   Chua, HA
   Wan, KL
   Lee, HL
AF Ali, Roziah
   Azmi, Ruziyatul Aznieda
   Ahmad, Nazni Wasi
   Hadi, Azahari Abd
   Muhamed, Khairul Asuad
   Rasli, Rosilawati
   Ling, Cheong Yoon
   Chua, Henry Anak
   Wan, Kiew Lian
   Lee, Han Lim
TI Entomological Surveillance Associated with Human Zika Cases in Miri
   Sarawak, Malaysia
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID AEDES-AEGYPTI; VERTICAL TRANSMISSION; VIRUS; ALBOPICTUS; MOSQUITOS;
   VECTOR
AB Two confirmed human cases of Zika virus (ZIKV) were reported in the district of Miri, Sarawak, in 2016. Following that, a mosquito-based ZIKV surveillance study was conducted within 200-m radius from the case houses. Mosquito surveillance was conducted using five different methods, that is, biogents sentinel mosquito (BG) sentinel trap, modified sticky ovitrap, resting catch, larval surveillance, and conventional ovitrap. A total of 527 and 390 mosquito samples were obtained from the case houses in two localities, namely, Kampung Lopeng and Taman Shang Ri La, Miri, Sarawak, respectively. All mosquitoes collected were identified, which consisted of 11 species. Aedes albopictus, both the adult and larval stages, was the dominant species. Resting catch method obtained the highest number of adult mosquitoes (67%), whereas ovitrap showed the highest catch for larval mosquitoes (84%). Zika virus was detected in both adults and larvae of Ae. albopictus together with adults of Culex gelidus, and Culex quinquefasciatus using the real-time reverse transcriptase polymerase chain reaction (PCR) technique. It was noteworthy that Ae. albopictus positive with ZIKV were caught and obtained from four types of collection method. By contrast, Cx. gelidus and Culex quinquefasciatus adults collected from sticky ovitraps were also found positive with ZIKV. This study reveals vital information regarding the potential vectors of ZIKV and the possibility of transovarian transmission of the virus in Malaysia. These findings will be essentials for vector control program managers to devise preparedness and contingency plans of prevention and control of the arboviral disease.
C1 [Ali, Roziah; Azmi, Ruziyatul Aznieda; Ahmad, Nazni Wasi; Hadi, Azahari Abd; Muhamed, Khairul Asuad; Rasli, Rosilawati; Ling, Cheong Yoon; Lee, Han Lim] WHO Collaborating Ctr Vectors, Inst Med Res, Med Entomol Unit, Jalan Pahang, Kuala Lumpur 50588, Malaysia.
   [Ali, Roziah; Wan, Kiew Lian] Univ Kebangsaan Malaysia, Sch Biosci & Biotechnol, Fac Sci & Technol, Bangi, Selangor, Malaysia.
   [Chua, Henry Anak] Miri Dist Hlth Off, Jalan Temenggong Oyong Lawai Jau, Miri, Malaysia.
RP Ali, R (corresponding author), WHO Collaborating Ctr Vectors, Inst Med Res, Med Entomol Unit, Jalan Pahang, Kuala Lumpur 50588, Malaysia.
EM roziah@imr.gov.my
FU Ministry of Health Malaysia [NMRR-16-706-30254]
FX This work was supported by the Ministry of Health Malaysia Research
   Grant (NMRR-16-706-30254).
CR Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Chang KS, 2018, AM J TROP MED HYG, V98, P166, DOI 10.4269/ajtmh.17-0587
   Ciota AT, 2017, EMERG INFECT DIS, V23, P880, DOI 10.3201/eid2305.162041
   Dick GWA, 1952, T R SOC TROP MED HYG, V46, P5
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0004993
   Gaspe MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006804
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Huang YJS, 2016, VECTOR-BORNE ZOONOT, V16, P673, DOI 10.1089/vbz.2016.2058
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lau KW, 2017, TROP BIOMED, V34, P795
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Li MZI, 2012, PLOS NEGLECT TROP D, V6, P8
   Li MZI, 2012, PLOS NEGLECT TROP D, V6, P8
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mombo IM, 2014, PLOS NEGLECT TROP D, V8, P1
   Phumee A, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010030
   Prada P, 2016, REUTERS
   Rozilawati H, 2015, TROP BIOMED, V32, P49
   Rudnick A, 1986, IMR B, V23
   Tappe D, 2014, J NEUROL NEUROSUR PS, V17, P183
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   VDC Shields, 2017, BIOL CONTROL PEST VE
   Wan-Norafikah O, 2017, ADV SCI LETT, V23, P1480, DOI 10.1166/asl.2017.8397
NR 25
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2020
VL 102
IS 5
BP 964
EP 970
DI 10.4269/ajtmh.19-0339
PG 7
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8CB
UT WOS:000531086800015
PM 32228777
DA 2020-07-08
ER

PT J
AU Leontsini, E
   Maloney, S
   Ramirez, M
   Mazariegos, LM
   Chavez, EJ
   Kumar, D
   Parikh, P
   Hunter, GC
AF Leontsini, Elli
   Maloney, Sean
   Ramirez, Margarita
   Mazariegos, Luisa Maria
   Chavez, Elisa Juarez
   Kumar, Diana
   Parikh, Priya
   Hunter, Gabrielle C.
TI Community Perspectives on Zika Virus Disease Prevention in Guatemala: A
   Qualitative Study
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID AEDES-AEGYPTI; HEALTH; PERCEPTIONS; WASHBASINS; OUTBREAK; RISK
AB Zika virus, which is transmitted by Aedes aegypti mosquitoes and through sexual transmission, disproportionally affects the human fetus. Guatemala experienced a surge of Zika cases beginning in 2016. We conducted a qualitative study of community perceptions of the seriousness of Zika, as well as the effectiveness, feasibility, and collective efficacy of Zika prevention actions. Free listing elicited the preventive actions salient for 68 participants comprising pregnant women, men with a pregnant partner, and women likely to become pregnant; 12 focus group discussions in a highland and a lowland town explored other concepts through rank orderings of prevention practices depicted on cards. Participants' initial concern about Zika, based on recent experience with chikungunya and high media coverage, diminished because of its mild symptoms and reduced media coverage. Participants identified more than 32 salient preventive actions, many of which are considered effective by programs. Participants ranked water storage container cleaning and regular unspecified cleaning of the house and its surroundings as highly effective, feasible, and of high collective efficacy; however, the actions lacked the specificity needed to effectively destroy mosquito eggs. Community-level removal of tires and discarded containers had lower collective efficacy than household-level implementation because of the municipal and community cooperation needed. Condom use, although salient for Zika prevention, was hindered by gender roles. The findings indicate space for increasing self-efficacy for condom use among fathers-to-be, abandoning nonspecific terms such as "cleaning" and "standing water," increasing people's skills in using bleach as an ovicide, and promoting antenatal care and family planning counseling.
C1 [Leontsini, Elli] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.
   [Maloney, Sean; Chavez, Elisa Juarez; Kumar, Diana; Parikh, Priya; Hunter, Gabrielle C.] Johns Hopkins Ctr Commun Programs, Baltimore, MD USA.
RP Leontsini, E (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Social & Behav Intervent Program, 615 N Wolfe St, Baltimore, MD 21205 USA.
EM eleontsi@jhu.edu
FU American people through the U.S. Agency for International Development
   (USAID) under the the Health Communication Capacity Collaborative (HC3)
   and Breakthrough ACTION Cooperative AgreementsUnited States Agency for
   International Development (USAID) [AID-OAA-A-12-00058,
   AID-OAA-A-17-00017]
FX The study was made possible by the support of the American people
   through the U.S. Agency for International Development (USAID) under the
   the Health Communication Capacity Collaborative (HC3) and Breakthrough
   ACTION Cooperative Agreements, #AID-OAA-A-12-00058 and
   #AID-OAA-A-17-00017, respectively. Breakthrough ACTION and HC3 are based
   in the Johns Hopkins Center for Communication Programs (CCP).
CR Bandura A, 2000, CURR DIR PSYCHOL SCI, V9, P75, DOI 10.1111/1467-8721.00064
   Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Breakthrough Action, 2018, ZIK PREV BEH MATR
   Carter MW, 2002, CULT HEALTH SEX, V4, P259, DOI 10.1080/13691050110112784
   Cho HY, 2005, HEALTH PROMOT PRACT, V6, P482, DOI 10.1177/1524839904263912
   CIALDINI RB, 1990, J PERS SOC PSYCHOL, V58, P1015, DOI 10.1037/0022-3514.58.6.1015
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Fernandez EA, 1998, ACTA TROP, V70, P171, DOI 10.1016/S0001-706X(98)00033-3
   Foley I, 2018, INT J INFECT DIS, V73, P223, DOI 10.1016/j.ijid.2018.04.3920
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Guerra-Reyes L, 2018, REV PANAM SALUD PUBL, V42, DOI [10.26633/RPSP.2018.43, 10.26633/rpsp.2018.43]
   Kim CR, 2018, LANCET GLOB HEALTH, V6, pE24, DOI 10.1016/S2214-109X(17)30419-9
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Leontsini E., 2004, Dengue Bulletin, V28, P22
   Malterud K, 2016, QUAL HEALTH RES, V26, P1753, DOI 10.1177/1049732315617444
   MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401
   McNaughton Darlene, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3020067
   Merritt AP, 2016, STRATEGIC COMMUNICAT
   Miranda E, 2019, PREHOSP DISASTER MED, V34, pS36
   Moise IK, 2018, EMERG INFECT DIS, V24, P1379, DOI 10.3201/eid2407.171650
   Nelson EJ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3952-0
   Nichter M., 2008, GLOBAL HLTH WHY CULT
   Pan American Health Organization/World Health Organization, 2017, ZIK SUSP CONF CAS RE
   Pan American Health Organization/World Health Organization, 2017, ZIK EP REP GUAT
   PONS JA, 2002, CIENC SOC, V27, P73
   Posada M, 2017, EMERGING EPIDEMICS R
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Reyes-Medina YN, 2018, P R HEALTH SCI J, V37, pS57
   Sherman C, 1998, AM J TROP MED HYG, V58, P257, DOI 10.4269/ajtmh.1998.58.257
   Smith J. Jerome, 1993, CULTURAL ANTHR METHO, V5, P1, DOI DOI 10.1177/1525822X9300500301
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Weldon Caroline T, 2018, PLoS Negl Trop Dis, V12, pe0006708, DOI 10.1371/journal.pntd.0006708
   Weller SC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198606
   Winch P, 2008, DENGUE, P407
   World Health Organization, 2016, 5 M EM COMM INT HLTH
NR 38
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2020
VL 102
IS 5
BP 971
EP 981
DI 10.4269/ajtmh.19-0578
PG 11
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8CB
UT WOS:000531086800016
PM 32100677
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU de Vasconcelos, RAL
   Ximenes, RAA
   Calado, AA
   Martelli, CMT
   Goncalves, AV
   Brickley, EB
   de Araujo, TVB
   Rocha, MAW
   Miranda, DD
AF de Vasconcelos, Romulo A. L.
   Ximenes, Ricardo A. A.
   Calado, Adriano A.
   Martelli, Celina M. T.
   Goncalves, Andreia V.
   Brickley, Elizabeth B.
   de Araujo, Thalia V. B.
   Wanderley Rocha, Maria Angela
   Miranda-Filho, Democrito de B.
TI Cryptorchidism in Children with Zika-Related Microcephaly
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID BRAZIL
AB The genitourinary tract was recently identified as a potential site of complications related to the congenital Zika syndrome (CZS). We provide the first report of a series of cryptorchidism cases in 3-year-old children with Zika-related microcephaly who underwent consultations between October 2018 and April 2019 as part of the follow-up of the children cohort of the Microcephaly Epidemic Research Group, Pernambuco, Brazil. Of the 22 males examined, eight (36.4%) presented with cryptorchidism. Among 14 undescended testis cases, 11 (78.6%) could be palpated in the inguinal region. Seven of the eight children had severe microcephaly. Conventional risk factors for cryptorchidism were relatively infrequent in these children. We hypothesize that cryptorchidism is an additional manifestation of CZS present in children with severe microcephaly. As in our cases, for most of the children, the testes were located in the inguinal region, and the possible mechanisms for cryptorchidism were gubernaculum disturbance or cremasteric abnormality.
C1 [de Vasconcelos, Romulo A. L.; Ximenes, Ricardo A. A.; Calado, Adriano A.; Goncalves, Andreia V.; Wanderley Rocha, Maria Angela; Miranda-Filho, Democrito de B.] Univ Pernambuco, Rua Arnobio Marques 310 Santo Amaro, BR-50100130 Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.; Goncalves, Andreia V.; de Araujo, Thalia V. B.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [Martelli, Celina M. T.] Fiocruz MS, Inst Pesquisa Aggeu Magalhaes, Recife, PE, Brazil.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, London, England.
RP de Vasconcelos, RAL (corresponding author), Univ Pernambuco, Rua Arnobio Marques 310 Santo Amaro, BR-50100130 Recife, PE, Brazil.
EM romulo.alv@hotmail.com
FU European Union's Horizon 2020 Research and Innovation programme
   [734584]; Wellcome TrustWellcome Trust [MC_PC_15088]; UK Department for
   International Development [201870/Z/16/Z, 205377/Z/16/Z]; Wellcome
   Trust-Research Enrichment in Epidemic Situations [107779/Z/15/Z, ER1505,
   ER1601]; Medical Research Council on behalf of the Newton Fund; Fundacao
   de Amparo a Ciencia e Tecnologiade PE-FACEPE [APQ-0192-4.01/17];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil
   (CAPES)CAPES [001]; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq) [309722/2017-9, 306708/2014-0]; Secretariade Vigilanciaem
   Saude/Ministerio da Saude de Brasil Resposta a Emergencia em Saude
   Publica Zikavirus e Microcefalia [837058/2016]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior; Departamento de Ciencia e Tecnologia
   [440839/2016-5]
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation programme (https://ec.europa.eu/programmes/horizon2020/)
   under ZikaPLANgrant agreement (No. 734584
   toRAAXhttps://zikaplan.tghn.org/); Wellcome Trust and the UK Department
   for International Development (201870/Z/16/Z to DBMF and 205377/Z/16/Z
   to RAAX; https://wellcome.ac.uk/); Wellcome Trust-Research Enrichment in
   Epidemic Situations (107779/Z/15/Z; with ER1505 and ER1601 to RAAX);
   Medical Research Council on behalf of the Newton Fund and Wellcome Trust
   (MC_PC_15088; https://mrc.ukri.org/); Fundacao de Amparo a Ciencia e
   Tecnologiade PE-FACEPE (APQ-0192-4.01/17 to Programa de Pos-graduacao em
   Ciencias da Saude-UPE; http://www.facepe.br/); Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) -Finance
   Code 001; Scholarship: Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico (309722/2017-9 to RAAX, 306708/2014-0 to CMTM;
   http://www.cnpq.br/), Secretariade Vigilanciaem Saude/Ministerio da
   Saude de Brasil Resposta a Emergencia em Saude Publica Zikavirus e
   Microcefalia (837058/2016 to RAAX); Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior (http://www.capes.gov.br/); Departamento de Ciencia e
   Tecnologia (http://rebrats.saude.gov.br/noticias/59DECIT) for Prevencao
   e Combate ao virus Zika I (440839/2016-5 to RAAX).
CR Abaci A, 2013, J CLIN RES PEDIATR E, V5, P65, DOI 10.4274/Jcrpe.883
   Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Barthold J, 2018, FRONT ENDOCRINOL, V9, P1
   Monteiro LMC, 2019, J PEDIATR UROL, V15, DOI 10.1016/j.jpurol.2019.04.018
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   Damgaard IN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003051
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gurney JK, 2017, NAT REV UROL, V14, P534, DOI 10.1038/nrurol.2017.90
   Haid B, 2019, J PEDIAT UROL, V15
   Kalfa N, 2019, CLIN GENET, V95, P122, DOI 10.1111/cge.13432
   Lucey D, 2017, JAMA-J AM MED ASSOC, V317, P1368, DOI 10.1001/jama.2017.1553
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Radmayr C, 2018, EAU GUIDELINES PAEDI
NR 13
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2020
VL 102
IS 5
BP 982
EP 984
DI 10.4269/ajtmh.19-0753
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8CB
UT WOS:000531086800017
PM 32157994
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Eskildsen, GA
   Kramer, LD
   Zink, SD
   Dupuis, AP
   Wong, SJ
   Furuya, A
   Loaiza, JR
AF Eskildsen, Gilberto A.
   Kramer, Laura D.
   Zink, Steven D.
   Dupuis, Alan P., II
   Wong, Susan J.
   Furuya, Andrea
   Loaiza, Jose R.
TI Integrated Arbovirus Surveillance Improves the Detection Onset of Zika
   Virus in Panama
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID CHIKUNGUNYA VIRUS; DENGUE; INFECTION
AB We tested 700 serum samples collected throughout Panama from 2015 to 2016 for detecting antibodies and RNA of arboviruses. In convalescent specimens, microsphere immunoassay detected an antibody prevalence of 59.3% for dengue virus (DENV) and 30.3% for Zika virus (ZIKV), which included samples that were collected before the Panamanian surveillance system reported the first case of Zika in the country. For acute sera, the most common arbovirus was DENV with 18 positive samples (6%), followed by four (1.3%) of ZIKV and one (0.6%) of chikungunya virus (CHIKV). Our results indicate a change in the chronology of when ZIKV was first detected in Panama and stress the importance of integrating various approaches to enable improved surveillance of both endemic and emerging arboviruses.
C1 [Eskildsen, Gilberto A.; Loaiza, Jose R.] Inst Invest Cient & Serv Alta Tecnol, Panama City, Panama.
   [Eskildsen, Gilberto A.] Acharya Nagarjuna Univ, Dept Biotechnol, Guntur, Andhra Pradesh, India.
   [Kramer, Laura D.; Zink, Steven D.; Dupuis, Alan P., II; Wong, Susan J.; Furuya, Andrea] Wadsworth Ctr, New York State Dept Hlth, Albany, NY USA.
   [Loaiza, Jose R.] Smithsonian Trop Res Inst, Balboa Ancon, Panama.
   [Loaiza, Jose R.] Univ Panama, Programa Ctr Amer Maestria Entomol, Panama City, Panama.
RP Loaiza, JR (corresponding author), INDICASAT AIP, 208 City Knowledge, Panama City 084301103, Panama.
EM jloaiza@indicasat.org.pa
FU National Secretariat for Science, Technology and Innovation of Panama
   [SENACYT-IDDS15-047, SENACYT-APY-GC-2014-024]; National Investigation
   System of SENACYT (SNI) [05-2016, 157-2017]
FX This work was supported by the National Secretariat for Science,
   Technology and Innovation of Panama grant (SENACYT-IDDS15-047) to J. R.
   L. and the travel fellowship grant (SENACYT-APY-GC-2014-024) to G. A. E.
   Research by J. R. L. is also supported by the National Investigation
   System of SENACYT (SNI, 05-2016 and 157-2017).
CR Arauz D, 2016, EMERG INFECT DIS, V22, P1515, DOI 10.3201/eid2208.160292
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Diaz Y, 2015, AM J TROP MED HYG, V92, P482, DOI 10.4269/ajtmh.14-0404
   Furuya AKM, 2019, CLIN SCI, V133, P859, DOI 10.1042/CS20180874
   Giry C, 2017, BMC MICROBIOL, V17, P84
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Matheus S, 2005, J CLIN MICROBIOL, V43, P2793, DOI 10.1128/JCM.43.6.2793-2797.2005
   MINSA, 2019, EP B SEM
   Naze F, 2009, J VIROL METHODS, V162, P1, DOI 10.1016/j.jviromet.2009.03.006
   Pabbaraju K, 2016, J CLIN VIROL, V83, P66, DOI 10.1016/j.jcv.2016.09.001
   Pachar MR, 2018, AM J TROP MED HYG, V99, P1318, DOI 10.4269/ajtmh.18-0261
   Quiroz E, 1997, Rev Cubana Med Trop, V49, P86
   Saeed MF, 2000, J GEN VIROL, V81, P743, DOI 10.1099/0022-1317-81-3-743
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Young NA, 1968, AM J TROP MED HYG, V17, P432
NR 16
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAY
PY 2020
VL 102
IS 5
BP 985
EP 987
DI 10.4269/ajtmh.19-0316
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8CB
UT WOS:000531086800018
PM 32228787
DA 2020-07-08
ER

PT J
AU Tambo, E
   El-Dessouky, AG
   Khater, EIM
   Xianonng, Z
AF Tambo, Ernest
   El-Dessouky, Ashraf G.
   Khater, Emad I. M.
   Xianonng, Zhou
TI Enhanced surveillance and response approaches for pilgrims and local
   Saudi populations against emerging Nipah, Zika and Ebola viral diseases
   outbreaks threats
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Review
DE Emerging; Nipah; Ebola and Zika virus; Outbreaks; Surveillance; Hajj;
   Saudi Arabia
ID VIRUS-INFECTION; HAJJ; TRANSMISSION; BATS
AB Increasing emergence and spread of Nipah, ZIKV and Ebola case and potential outbreaks threats have been reported in several regions around the globe. Yet, emerging Nipah, Ebola and Zika viral diseases outbreaks have been indirectly linked to substantially globalization of trade and travel, climate change and intense urbanization impact, healthcare and socioeconomic inequities as well in affected community settings. Although no case has been documented in Saudi Arabia, there is a great risk of sudden emergence of any of these viruses and others via introducing among pilgrims coming from endemic regions during ritual ceremonies of mass gatherings. Consequently, promoting and investing on new and sensitive proven effective and innovative surveillance and monitoring approaches, including enhanced risk communication, improved integrated vectors surveillance in addition to improved sustainable highly pathogens surveillance control programs to human motility and environmental sanitation strategies all represent 'One Health' approach implementation strategic core. Initiation, development and implementation leaded by Saudi government and international stakeholders' of new partnership, coordinated response leadership and resource mobilization for multidisciplinary and intersectorial advocacy on emerging viral disease outbreaks, accompanied with R&D roadmap and taskforce is crucial. More efforts in epidemiological and laboratory early screening and surveillance of highly pathogenic germs/microbes, and confirmation of asymptomatic and syndromic cases amongst suspected Hajj and Umrah pilgrims, local vulnerable populations and expatriate workers is vital in generating reliable data and data sharing platform for timely risk communication and tourist information update, appropriate immunization campaigns or safe and efficacious care delivery implementation. Moreover, increase Hajj/Umrah mass gathering emergency outbreak preparedness, pilgrims health education and engagement outreach, pre-, during and post programs coverage and effectiveness is needed through One Health approach integration in attaining pilgrims and local population health safety and security, in advancing Saudi sustainable health development goals. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Tambo, Ernest] Africa Dis Intelligence & Surveillance & Response, Yaounde, Cameroon.
   [Tambo, Ernest] Univ Witwatersrand, Sch Publ Hlth, Johannesburg, South Africa.
   [El-Dessouky, Ashraf G.] Jeddah Governate, Publ Hlth Pests Lab, Microbiol Unit, Jeddah, Saudi Arabia.
   [El-Dessouky, Ashraf G.] Ain Shams Univ, Fac Med, Med Genet Ctr, Biochem Genet Unit, Cairo, Egypt.
   [Khater, Emad I. M.] Ain Shams Univ, Fac Sci, Dept Entomol, Cairo, Egypt.
   [Xianonng, Zhou] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Sanghai 200025, Peoples R China.
RP Tambo, E (corresponding author), Africa Dis Intelligence & Surveillance & Response, Yaounde, Cameroon.
EM tambo0711@gmail.com
CR Ahmad MD, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0161-6
   Ahmed Q, 2016, FRONT MED-PRC, V10, P527, DOI 10.1007/s11684-016-0487-2
   Ahmed QA, 2016, TRAVEL MED INFECT DI, V14, P429, DOI 10.1016/j.tmaid.2016.09.007
   Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Almutairi KM, 2016, J INFECT DEV COUNTR, V10, P829, DOI 10.3855/jidc.6941
   Alva-Urcia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187897
   Ang BSP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01875-17
   Aziz H, 2017, J MED VIROL, V89, P943, DOI 10.1002/jmv.24731
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2016, EURO SURVEILL
   Carroll D, 2018, B WORLD HEALTH ORGAN, V96, P292, DOI 10.2471/BLT.17.205005
   de Aragao MFV, 2016, BMJ
   de Wit E, 2015, J PATHOL, V235, P196, DOI 10.1002/path.4444
   Enchery F, 2017, INT REV IMMUNOL, V36, P108, DOI 10.1080/08830185.2016.1255883
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Getz WM, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/736507
   Glynn RW, 2016, GLOBALIZATION HEALTH, V12, DOI 10.1186/s12992-016-0173-9
   Gurley ES, 2017, EMERG INFECT DIS, V23, P1446, DOI 10.3201/eid2309.161922
   Kucharski AJ, 2016, EMERG INFECT DIS, V22, P105, DOI 10.3201/eid2201.151410
   Lo Presti A, 2016, J MED VIROL, V88, P380, DOI 10.1002/jmv.24345
   Marsh GA, 2012, CURR OPIN VIROL, V2, P242, DOI 10.1016/j.coviro.2012.03.006
   Memish ZA, 2014, TRAVEL MED INFECT DI, V12, P415, DOI 10.1016/j.tmaid.2014.09.003
   Oduyebo T, 2017, UPDATE INTERIM GUIDA
   Platt DJ, 2017, CURR OPIN VIROL, V27, P1, DOI 10.1016/j.coviro.2017.09.005
   Prescott J, 2015, VACCINE, V33, P2823, DOI 10.1016/j.vaccine.2015.03.089
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Sazzad HMS, 2013, EMERG INFECT DIS, V19, P210, DOI 10.3201/eid1902.120971
   Shrivastava SR, 2015, J RES MED SCI, V20, P107
   Tambo E, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0278-2
   Tambo E, 2016, J INFECT PUBLIC HEAL, V9, P240, DOI 10.1016/j.jiph.2016.02.005
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-41
   Tambo E, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-29
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Weilg Claudia, 2018, BMC Res Notes, V11, P311, DOI 10.1186/s13104-018-3400-z
   WHO, NIPAH R D ROAD MAP
   World Health Organization (WHO), 2017, EB VIR DIS DEM REP C
   World Health Organization (WHO), 2018, NEW EB OUTBR DECL DE
NR 37
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY
PY 2020
VL 13
IS 5
BP 674
EP 678
DI 10.1016/j.jiph.2020.01.313
PG 5
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA LK5GQ
UT WOS:000530894700026
PM 32265162
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Marinho, RDS
   Duro, RLS
   Santos, GL
   Hunter, J
   Teles, MDR
   Brustulin, R
   Milagres, FAD
   Sabino, EC
   Diaz, RS
   Komninakis, SV
AF Marinho, Robson dos Santos S.
   Sanz Duro, Rodrigo L.
   Santos, Giulia L.
   Hunter, James
   Rodrigues Teles, Maria da Aparecida
   Brustulin, Rafael
   de Padua Milagres, Flavio A.
   Sabino, Ester C.
   Diaz, Ricardo S.
   Komninakis, Shirley, V
TI Detection of coinfection with Chikungunya virus and Dengue virus
   serotype 2 in serum samples of patients in State of Tocantins, Brazil
SO JOURNAL OF INFECTION AND PUBLIC HEALTH
LA English
DT Article
DE Arbovirus; RT-qPCR; Coinfection; Chikungunya; Dengue
ID OUTBREAKS; FEATURES; FEVER
AB Background: The co-circulation of Chikungunya (CHIKV), Dengue (DENV) and Zika (ZIKV) viruses increased the risk of outbreaks and coinfections among them. Here, we report cases of coinfection in clinical samples from state of Tocantins, Brazil.
   Methods: In 2017, the Central Public Health Laboratory (LACEN) received samples of patients who consulted health units with symptoms compatible with arboviral infections. A total of 102 samples were sent to the Retrovirology Laboratory at the Federal University of Sao Paulo, where they were tested by RT-qPCR to confirm DENV, ZIKV and CHIKV infections and to detect coinfected patients.
   Results: We identified with CHIKV monoinfection (52), DENV serotypes 1 (28) and serotypes 2 (22). We did not detect ZIKV. Five patients were characterized with coinfection involving CHIKV and DENV serotype 2.
   Conclusions: The presence of co-circulating arboviruses increases the chance of coinfection and demonstrates the importance of differential diagnosis and vector control. (C) 2020 Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
C1 [Marinho, Robson dos Santos S.; Sanz Duro, Rodrigo L.; Santos, Giulia L.; Hunter, James; Diaz, Ricardo S.; Komninakis, Shirley, V] Univ Fed Sao Paulo, Lab Retrovirol, Sao Paulo 04023062, Brazil.
   [Komninakis, Shirley, V] Fac Med ABC, Santo Andre 09060870, SP, Brazil.
   [de Padua Milagres, Flavio A.; Sabino, Ester C.] Univ Sao Paulo, Fac Med, LIM 46, Sao Paulo 01246903, Brazil.
   [Brustulin, Rafael; de Padua Milagres, Flavio A.] Secretaria Saude Tocantins, Tocantins 77453000, Brazil.
   [Brustulin, Rafael; de Padua Milagres, Flavio A.] Univ Fed Tocantins, Inst Ciencias Biol, Tocantins 77001090, Brazil.
   [Rodrigues Teles, Maria da Aparecida; Brustulin, Rafael; de Padua Milagres, Flavio A.] Lab Cent Saude Publ Tocantins LACEN, Tocantins 77016330, Brazil.
   [Sabino, Ester C.] Univ Sao Paulo, Inst Med Trop, Sao Paulo 05403000, Brazil.
RP Komninakis, SV (corresponding author), Univ Fed Sao Paulo, Lab Retrovirol, Sao Paulo 04023062, Brazil.
EM skomninakis@yahoo.com.br
RI Hunter, James/J-6106-2016
OI Hunter, James/0000-0001-9524-0629; Dos Santos Souza Marinho,
   Robson/0000-0001-5272-9651
FU National Council for Scientific and Technological Development
   [CNPQ]National Council for Scientific and Technological Development
   (CNPq) [167330/2018-7]; Foundation for Research Support of the State of
   Sao Paulo [FAPESP]Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP) [2015/19343-0]
FX National Council for Scientific and Technological Development [CNPQ]
   [scholarship no 167330/2018-7] and the Foundation for Research Support
   of the State of Sao Paulo [FAPESP] [grant no 2015/19343-0].
CR Alm E, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1226-z
   Bagno FF, 2019, J CLIN VIROL, V113, P27, DOI 10.1016/j.jcv.2019.02.006
   Bhooshan S, 2015, INT J HEALTHCARE BIO, V03, P117
   Farias LABG, 2019, ARQ BRAS CARDIOL, V113, P783, DOI 10.5935/abc.20190187
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Centers for Disease Control and Prevention (CDC), 2019, DIAGN TEST
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Augusto LGD, 2016, LANCET, V387, P1052, DOI 10.1016/S0140-6736(16)00626-7
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Edwards T, 2016, EMERG INFECT DIS, V22, P2003, DOI 10.3201/eid2211.161017
   Kularatne SAM, 2009, POSTGRAD MED J, V85, P342, DOI 10.1136/pgmj.2007.066746
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leroy EM, 2009, EMERG INFECT DIS, V15, P591, DOI 10.3201/eid1504.080664
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Machado LC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007332
   Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638
   Mercado M, 2016, EUROSURVEILLANCE, V21, P33, DOI 10.2807/1560-7917.ES.2016.21.22.30244
   Mercado-Reyes M, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/s095026881800359x, 10.1017/S095026881800359X]
   Milagres F, 2018, INT J INFECT DIS, V73, P106, DOI 10.1016/j.ijid.2018.04.3661
   Mukherjee S, 2017, EUR J CLIN MICROBIOL, V36, P2273, DOI 10.1007/s10096-017-3061-1
   Osanai CH, 1984, REV INST MED TROP SP, V25, P53
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Rico-Mendoza A, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.49
   Secretary of Health of the Tocantins, EP B DENG CHIK ZIK C
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   Singh J, 2018, TZU CHI MED J, V30, P158, DOI 10.4103/tcmj.tcmj_138_17
   Taraphdar D, 2012, AM J TROP MED HYG, V86, P720, DOI 10.4269/ajtmh.2012.11-0704
   World Health Organization (WHO), 2019, INF ARB THER AM
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 30
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1876-0341
EI 1876-035X
J9 J INFECT PUBLIC HEAL
JI J. Infect. Public Health
PD MAY
PY 2020
VL 13
IS 5
BP 724
EP 729
DI 10.1016/j.jiph.2020.02.034
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA LK5GQ
UT WOS:000530894700008
PM 32224108
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Grifoni, A
   Voic, H
   Dhanda, SK
   Kidd, CK
   Brien, JD
   Buus, S
   Stryhn, A
   Durbin, AP
   Whitehead, S
   Diehl, SA
   De Silva, AD
   Balmaseda, A
   Harris, E
   Weiskopf, D
   Sette, A
AF Grifoni, Alba
   Voic, Hannah
   Dhanda, Sandeep Kumar
   Kidd, Conner K.
   Brien, James D.
   Buus, Soren
   Stryhn, Anette
   Durbin, Anna P.
   Whitehead, Stephen
   Diehl, Sean A.
   De Silva, Aruna D.
   Balmaseda, Angel
   Harris, Eva
   Weiskopf, Daniela
   Sette, Alessandro
TI T Cell Responses Induced by Attenuated Flavivirus Vaccination Are
   Specific and Show Limited Cross-Reactivity with Other Flavivirus Species
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE DENV; T cells; YFV; flaviviruses; vaccines
ID TETRAVALENT DENGUE VACCINE; ORIGINAL ANTIGENIC SIN; PROTECTIVE ROLE;
   VIRUS SEROTYPES; ALLELES
AB Members of the flavivirus genus share a high level of sequence similarity and often circulate in the same geographical regions. However, whether T cells induced by one viral species cross-react with other related flaviviruses has not been globally addressed. In this study, we tested pools of epitopes derived from dengue (DENV), Zika (ZIKV), Japanese encephalitis (JEV), West Nile (WNV), and yellow fever (YFV) viruses by intracellular cytokine staining (ICS) using peripheral blood mononuclear cells (PBMCs) of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccine. CD8 T cell responses recognized epitopes from multiple flaviviruses; however, the magnitude of cross-reactive responses was consistently severalfold lower than those to the autologous epitope pools and was associated with lower expression of activation markers such as CD40L, CD69, and CD137. Next, we characterized the antigen sensitivity of short-term T cell lines (TCL) representing 29 different individual epitope/donor combinations. TCL derived from DENV monovalent vaccinees induced CD8 and CD4 T cells that cross-reacted within the DENV serocomplex but were consistently associated with >100-fold-lower antigen sensitivity for most other flaviviruses, with no cross-recognition of YFV-derived peptides. CD8 and CD4 TCL from YF17D vaccinees were associated with very limited cross-reactivity with any other flaviviruses and in five out of eight cases >1,000-fold-lower antigen sensitivity. Overall, our data suggest limited cross-reactivity for both CD4 and CD8 T cell responses between flaviviruses and have implications for understanding immunity elicited by natural infection and strategies to develop live attenuated vaccines against flaviviral species.
   IMPORTANCE The envelope (E) protein is the dominant target of neutralizing antibodies for dengue virus (DENV) and yellow fever virus (YFV). Accordingly, several DENV vaccine constructs use the E protein in a live attenuated vaccine format, utilizing a backbone derived from a heterologous flavivirus (such as YF) as a delivery vector. This backbone comprises the nonstructural (NS) and capsid (C) antigens, which are dominant targets of T cell responses. Here, we demonstrate that cross-reactivity at the level of T cell responses among different flaviviruses is very limited, despite high levels of sequence homology. Thus, the use of heterologous flavivirus species as a live attenuated vaccine vector is not likely to generate optimal T cell responses and might thus impair vaccine performance.
C1 [Grifoni, Alba; Voic, Hannah; Dhanda, Sandeep Kumar; Kidd, Conner K.; De Silva, Aruna D.; Weiskopf, Daniela; Sette, Alessandro] La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.
   [Brien, James D.] St Louis Univ, St Louis, MO 63103 USA.
   [Buus, Soren; Stryhn, Anette] Univ Copenhagen, Fac Hlth Sci, Lab Expt Immunol, Copenhagen, Denmark.
   [Durbin, Anna P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Baltimore, MD USA.
   [Whitehead, Stephen] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Diehl, Sean A.] Univ Vermont, Sch Med, Burlington, VT 05405 USA.
   [De Silva, Aruna D.] Gen Sir John Kotelawala Def Univ, Dept Paraclin Sci, Ratmalana, Sri Lanka.
   [Balmaseda, Angel] Minist Hlth, Natl Virol Lab, Natl Ctr Diag & Reference, Managua, Nicaragua.
   [Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Sette, Alessandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Sette, A (corresponding author), La Jolla Inst Immunol, Div Vaccine Discovery, La Jolla, CA 92037 USA.; Sette, A (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
EM alex@lji.org
RI Dhanda, Sandeep/J-8471-2016
OI Dhanda, Sandeep/0000-0003-1381-7434
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HHSN272200900042C,
   HHSN27220140045C, 75N9301900065, P01AI106695]; Intramural Research
   Program of the NIH, NIAIDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [HHSN272200900010C]; 
   [HHSN272200900045C]
FX This work was supported by National Institutes of Health contracts
   HHSN272200900042C and HHSN27220140045C to A. Sette, 75N9301900065 to A.
   Sette and D. Weiskopf, and P01AI106695 to E. Harris. Additional support
   was provided by contract HHSN272200900045C to E. Harris. The TV003/005
   clinical trials were funded by contract HHSN272200900010C of the
   Intramural Research Program of the NIH, NIAID.
CR Angelo MA, 2017, J VIROL, V91, DOI 10.1128/JVI.02147-16
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Pro SC, 2015, J IMMUNOL RES, DOI 10.1155/2015/763461
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Dhanda SK, 2018, IMMUNOLOGY, V155, P331, DOI 10.1111/imm.12984
   Dhanda SK, 2019, NUCLEIC ACIDS RES, V47, pW502, DOI 10.1093/nar/gkz452
   Dhanda SK, 2018, BIOINFORMATICS, V34, P3931, DOI 10.1093/bioinformatics/bty463
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   EVAVOLD BD, 1991, SCIENCE, V252, P1308, DOI 10.1126/science.1833816
   Grifoni A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01568
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   GUBLER DJ, 2019, BMJ-BRIT MED J, V367, DOI DOI 10.1136/BMJ.L5710.
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guy B, 2010, HUM VACCINES, V6, P696, DOI 10.4161/hv.6.9.12739
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hassert M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01045
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Henry C, 2018, TRENDS IMMUNOL, V39, P70, DOI 10.1016/j.it.2017.08.003
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2017, VACCINE, V35, P4659, DOI 10.1016/j.vaccine.2017.07.045
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   Li GY, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6040073
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Mongkolsapaya J, 2006, J IMMUNOL, V176, P3821, DOI 10.4049/jimmunol.176.6.3821
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Nivarthi UK, 2017, J VIROL, V91, DOI 10.1128/JVI.02041-16
   Osorio JE, 2016, EXPERT REV VACCINES, V15, P497, DOI 10.1586/14760584.2016.1128328
   Paul Sinu, 2016, Curr Protoc Immunol, V114, DOI 10.1002/cpim.12
   Paul S, 2013, J IMMUNOL, V191, P5831, DOI 10.4049/jimmunol.1302101
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   SETTE A, 1986, J IMMUNOL METHODS, V86, P265, DOI 10.1016/0022-1759(86)90463-1
   SloanLancaster J, 1996, ANNU REV IMMUNOL, V14, P1, DOI 10.1146/annurev.immunol.14.1.1
   Swanstrom JA, 2019, J INFECT DIS, V220, P219, DOI 10.1093/infdis/jiz109
   Thomas SJ, 2019, HUM VACC IMMUNOTHER, V15, P2295, DOI 10.1080/21645515.2019.1658503
   Tian Y, 2019, J CLIN INVEST, V129, P1727, DOI 10.1172/JCI123726
   Tian Y, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00531
   VanBlargan LA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003761
   Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006
   Waickman AT, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01778
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00093
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
NR 61
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2020
VL 94
IS 10
AR e00089-20
DI 10.1128/JVI.00089-20
PG 19
WC Virology
SC Virology
GA LK7GB
UT WOS:000531029500005
PM 32132233
DA 2020-07-08
ER

PT J
AU Yan, G
   Lee, CK
   Lam, LTM
   Yan, B
   Chua, YX
   Lim, AYN
   Phang, KF
   Sen Kew, G
   Teng, H
   Ngai, CH
   Lin, L
   Foo, RM
   Pada, S
   Ng, LC
   Tambyah, PA
AF Yan, Gabriel
   Lee, Chun Kiat
   Lam, Lawrence T. M.
   Yan, Benedict
   Chua, Ying Xian
   Lim, Anita Y. N.
   Phang, Kee Fong
   Sen Kew, Guan
   Teng, Hazel
   Ngai, Chin Hong
   Lin, Li
   Foo, Rui Min
   Pada, Surinder
   Ng, Lee Ching
   Tambyah, Paul Anantharajah
TI Covert COVID-19 and false-positive dengue serology in Singapore
SO LANCET INFECTIOUS DISEASES
LA English
DT Letter
ID VIRUSES; ZIKA; CHIKUNGUNYA
C1 [Yan, Gabriel; Lim, Anita Y. N.; Phang, Kee Fong; Sen Kew, Guan; Teng, Hazel; Ngai, Chin Hong; Tambyah, Paul Anantharajah] Natl Univ Hlth Syst, Dept Med, Singapore 119228, Singapore.
   [Lee, Chun Kiat; Yan, Benedict] Natl Univ Hlth Syst, Dept Lab Med, Univ Med Cluster, Singapore, Singapore.
   [Lam, Lawrence T. M.; Chua, Ying Xian] Natl Univ Hlth Syst, Natl Univ Polyclin, Pioneer Polyclin, Singapore, Singapore.
   [Lin, Li; Foo, Rui Min; Pada, Surinder] Ng Teng Fong Gen Hosp, Dept Med, Singapore, Singapore.
   [Ng, Lee Ching] Natl Environm Agcy, Environm Hlth Inst, Singapore, Singapore.
RP Yan, G (corresponding author), Natl Univ Hlth Syst, Dept Med, Singapore 119228, Singapore.
EM gabriel_zherong_yan@nuhs.edu.sg
OI Yan, Gabriel/0000-0003-3513-428X
CR Chen NS, 2020, LANCET, V395, P507, DOI 10.1016/S0140-6736(20)30211-7
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   Lim CK, 2009, AM J TROP MED HYG, V81, P865, DOI 10.4269/ajtmh.2009.09-0009
   Lura T, 2019, J VECTOR ECOL, V44, P205, DOI 10.1111/jvec.12347
   Yan G, 2018, EMERG INFECT DIS, V24, P1565, DOI 10.3201/eid2408.171883
NR 6
TC 8
Z9 8
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAY
PY 2020
VL 20
IS 5
BP 536
EP 536
DI 10.1016/S1473-3099(20)30158-4
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA LK2PI
UT WOS:000530702900030
PM 32145189
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Malla, A
   Shanmugaraj, B
   Ramalingam, S
AF Malla, Ashwini
   Shanmugaraj, Balamurugan
   Ramalingam, Sathishkumar
TI Emerging mosquito-borne arboviral infection Zika-An epidemiological
   review
SO ASIAN PACIFIC JOURNAL OF TROPICAL BIOMEDICINE
LA English
DT Review
ID ENCEPHALITIS-VIRUS; TRANSMISSION; DENGUE; GLYCOPROTEIN; CHIKUNGUNYA;
   PROTECTION; BIOLOGY; CELLS; DRUG
AB The unprecedented resurgence and geographical expansion of arboviral infections such as dengue, Chikungunya, yellow fever, and Zika have a significant impact on human health and pose a serious threat to public health globally in recent years. Zika virus is a Flavivirus and is transmitted to humans through an infected mosquito bite. The Zika virus has been identified in many countries in Africa, Asia, and Pacific islands and sporadic human cases have been reported since 1947. The non-specific clinical symptoms of Zika fever are often misdiagnosed with other arboviral infections, especially dengue and chikungunya. Till now, there is no vaccine or specific antiviral treatment for Zika infection. The recent emergence of Zika is alarming and highlights the need for arboviral research to develop an effective treatment. Here in this review, we discussed the epidemiology of Zika, which has re-emerged in the recent decade and caused international concern.
C1 [Malla, Ashwini; Shanmugaraj, Balamurugan; Ramalingam, Sathishkumar] Bharathiar Univ, Dept Biotechnol, Plant Genet Engn Lab, Coimbatore, Tamil Nadu, India.
RP Ramalingam, S (corresponding author), Bharathiar Univ, Dept Biotechnol, Plant Genet Engn Lab, Coimbatore, Tamil Nadu, India.
EM rsathish@buc.edu.in
OI , Sathishkumar/0000-0002-3145-7324
FU Department of Biotechnology, Bharathiar University, Coimbatore, Tamil
   Nadu, India through DST-FIST; Department of Biotechnology, Bharathiar
   University, Coimbatore, Tamil Nadu, India through UGC-SAP; Department of
   Biotechnology, Bharathiar University, Coimbatore, Tamil Nadu, India
   through UGC-UKIERI
FX The authors are very thankful to The Department of Biotechnology,
   Bharathiar University, Coimbatore, Tamil Nadu, India for supporting this
   research through DST-FIST, UGC-SAP and UGC-UKIERI.
CR Agumadu VC, 2018, CUREUS, V10, DOI 10.7759/cureus.3025
   Alam A, 2017, BIOMED PHARMACOTHER, V91, P1152, DOI 10.1016/j.biopha.2017.05.045
   Ansar V, 2015, PRIMARY CARE, V42, P189, DOI 10.1016/j.pop.2015.01.001
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benjamin RJ, 2017, BLOOD, V129, P144, DOI 10.1182/blood-2016-12-751925
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913
   Calvez E, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004374
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1989, VIROLOGY, V169, P100, DOI 10.1016/0042-6822(89)90045-7
   Chambers TJ, 1990, ANNU REV MICROBIOL, V44, P5
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Costello A, 2016, B WORLD HEALTH ORGAN, V94, P406, DOI 10.2471/BLT.16.176990
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Diamond MS, 2003, VIRAL IMMUNOL, V16, P259, DOI 10.1089/088282403322396082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Freire C. C. d, 2015, BIORXIV, DOI [10.1101/032839, DOI 10.1101/032839]
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Javed F, 2018, J BASIC MICROB, V58, P3, DOI 10.1002/jobm.201700398
   Johansson MA, 2016, NEW ENGL J MED, V375
   Khaiboullina SF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16072-3
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kutsuna S, 2014, EURO SURVEILL
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   LOURENCO M, 2018, PLOS CURR, V10, DOI DOI 10.1371/19433B1E4D007451C691F138E1E67E8C
   Lu GF, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01967-16, 10.1128/aac.01967-16]
   Ma LX, 2004, P NATL ACAD SCI USA, V101, P3414, DOI 10.1073/pnas.0305892101
   Mackenzie JM, 1998, VIROLOGY, V245, P203, DOI 10.1006/viro.1998.9156
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Maurer-Stroh S, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.38.30347
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mourya DT, 2016, INDIAN J MED RES, V143, P553, DOI 10.4103/0971-5916.187103
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Murugan SB, 2016, ASIAN PAC J TROP MED, V9, P910, DOI 10.1016/j.apjtm.2016.07.020
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Nelwan EJ, 2014, ACTA MED INDONES, V46, P339
   Noorbakhsh F, 2019, IRAN J PUBLIC HEALTH, V48, P20
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Reznik SE, 2017, INT J INFECT DIS, V55, P29, DOI 10.1016/j.ijid.2016.12.011
   Roby JA, 2015, J GEN VIROL, V96, P1551, DOI 10.1099/vir.0.000097
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Shanmugaraj B, 2019, ASIAN PAC J TROP BIO, V9, P135, DOI 10.4103/2221-1691.256726
   Shanmugaraj BM, 2017, VECTOR BORNE DIS TRE
   Sharma R, 2019, INDIAN J MED SPEC, V10, P184, DOI 10.4103/INJMS.INJMS_65_19
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Simmons CP, 2012, NEW ENGL J MED, V366, P1423, DOI 10.1056/NEJMra1110265
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Dinh TC, 2019, EUR J CLIN MICROBIOL, V38, P1585, DOI 10.1007/s10096-019-03563-6
   Vazquez-Calvo A, 2012, VIRUS RES, V167, P125, DOI 10.1016/j.virusres.2012.05.024
   Vorou R, 2016, EUROSURVEILLANCE, V21, P27, DOI 10.2807/1560-7917.ES.2016.21.10.30161
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wolfe ND, 2001, AM J TROP MED HYG, V64, P310, DOI 10.4269/ajtmh.2001.64.310
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization, COUNTR TERR CURR PRE
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 85
TC 1
Z9 1
U1 0
U2 0
PU WOLTERS KLUWER MEDKNOW PUBLICATIONS
PI MUMBAI
PA WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2
   VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA
SN 2221-1691
EI 2588-9222
J9 ASIAN PAC J TROP BIO
JI Asian Pac. Trop. Biomed.
PD MAY
PY 2020
VL 10
IS 5
BP 193
EP 200
DI 10.4103/2221-1691.281139
PG 8
WC Tropical Medicine
SC Tropical Medicine
GA LJ6OJ
UT WOS:000530282000001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Cerrizuela, S
   Vega-Lopez, GA
   Aybar, MJ
AF Cerrizuela, Santiago
   Vega-Lopez, Guillermo A.
   Aybar, Manuel J.
TI The role of teratogens in neural crest development
SO BIRTH DEFECTS RESEARCH
LA English
DT Review
DE applied developmental biology; blood placental barrier; congenital
   malformations; environmental developmental biology; FASD; fetal
   development; fetotoxic; infectious agents; neural crest;
   neurocristopathy; teratogens; virus
ID RENIN-ANGIOTENSIN-SYSTEM; ZIKA VIRUS-INFECTION; ARYL-HYDROCARBON
   RECEPTOR; CONGENITAL HEART-DEFECTS; NICOTINIC ACETYLCHOLINE-RECEPTORS;
   ATTENUATES BEHAVIORAL ALTERATIONS; AGRICULTURAL PESTICIDE EXPOSURES;
   SEROTONIN REUPTAKE INHIBITORS; NEONATAL ALCOHOL EXPOSURE; LOW-DOSE
   METHOTREXATE
AB The neural crest (NC), discovered by Wilhelm His 150 years ago, gives rise to a multipotent migratory embryonic cell population that generates a remarkably diverse and important array of cell types during the development of the vertebrate embryo. These cells originate in the neural plate border (NPB), which is the ectoderm between the neural plate and the epidermis. They give rise to the neurons and glia of the peripheral nervous system, melanocytes, chondrocytes, smooth muscle cells, odontoblasts and neuroendocrine cells, among others. Neurocristopathies are a class of congenital diseases resulting from the abnormal induction, specification, migration, differentiation or death of NC cells (NCCs) during embryonic development and have an important medical and societal impact. In general, congenital defects affect an appreciable percentage of newborns worldwide. Some of these defects are caused by teratogens, which are agents that negatively impact the formation of tissues and organs during development. In this review, we will discuss the teratogens linked to the development of many birth defects, with a strong focus on those that specifically affect the development of the NC, thereby producing neurocristopathies. Although increasing attention is being paid to the effect of teratogens on embryonic development in general, there is a strong need to critically evaluate the specific role of these agents in NC development. Therefore, increased understanding of the role of these factors in NC development will contribute to the planning of strategies aimed at the prevention and treatment of human neurocristopathies, whose etiology was previously not considered.
C1 [Cerrizuela, Santiago; Vega-Lopez, Guillermo A.; Aybar, Manuel J.] UNT, CONICET, Inst Super Invest Biol INSIBIO, Area Biol Expt, San Miguel De Tucuman, Argentina.
   [Cerrizuela, Santiago; Vega-Lopez, Guillermo A.; Aybar, Manuel J.] Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Biol Dr Francisco D Barbieri, Chacabuco 461,T4000ILI, San Miguel De Tucuman, Argentina.
   [Cerrizuela, Santiago] German Canc Res Ctr, Div Mol Neurobiol, Heidelberg, Germany.
RP Aybar, MJ (corresponding author), Univ Nacl Tucuman, Fac Bioquim Quim & Farm, Inst Biol Dr Francisco D Barbieri, Chacabuco 461,T4000ILI, San Miguel De Tucuman, Argentina.
EM mjaybar@fbqf.unt.edu.ar
RI Aybar, Manuel/Y-5632-2018; Vega Lopez, Guillermo/M-3403-2014
OI Aybar, Manuel/0000-0002-7187-6435; Cerrizuela,
   Santiago/0000-0002-6734-0398; Vega Lopez, Guillermo/0000-0002-2426-2844
FU ANPCyT-FoncytANPCyTFONCyT
FX We are grateful to our colleagues for their helpful discussions. This
   publication was supported by grants from ANPCyT-Foncyt (to MJA
   PICT2013-1686, PICT2015-1207 and PICT2018-1370; to GAVL, PICT2016-0835),
   and by grants from CIUNT (to MJA, PIUNT 26/D506; PIUNT 26/D605). We
   specially thank Ms. Virginia Mendez for her proofreading.
CR Abdel-Rahman AA, 2002, ARCH TOXICOL, V76, P452, DOI 10.1007/s00204-002-0366-2
   Abou-Donia MB, 2008, J TOXICOL ENV HEAL A, V71, P119, DOI 10.1080/15287390701613140
   Abraham S, 2015, THER CLIN RISK MANAG, V11, P939, DOI 10.2147/TCRM.S82561
   Achterberg EJM, 2014, PSYCHOPHARMACOLOGY, V231, P1503, DOI 10.1007/s00213-013-3272-9
   Adam MP, 2003, AM J MED GENET A, V123A, P72, DOI 10.1002/ajmg.a.20503
   Adams J, 2003, BIRTH DEFECTS RES A, V67, P895, DOI 10.1002/bdra.10140
   Adams J, 2010, BIRTH DEFECTS RES A, V88, P895, DOI 10.1002/bdra.20721
   Jimenez NA, 2018, DEV BIOL, V444, pS193, DOI 10.1016/j.ydbio.2018.08.001
   Alizadeh A, 2008, PIGM CELL MELANOMA R, V21, P63, DOI 10.1111/j.1755-148X.2007.00425.x
   Alwan S., 2007, OBSTET GYNECOLOGICAL, V62, P702, DOI 10.1097/01.ogx.0000286792.22798.b7
   Amiel J, 2008, J MED GENET, V45, P1, DOI 10.1136/jmg.2007.053959
   Anderson RB, 2006, CELL TISSUE RES, V323, P11, DOI 10.1007/s00441-005-0047-6
   Aoyama N, 2002, ANAT RECORD, V267, P213, DOI 10.1002/ar.10101
   Aramaki M, 2005, AM J MED GENET A, V139A, P156, DOI 10.1002/ajmg.a.30917
   Arima Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2258
   Aris A, 2011, REPROD TOXICOL, V31, P528, DOI 10.1016/j.reprotox.2011.02.004
   Atreya CD, 2004, BIRTH DEFECTS RES A, V70, P431, DOI 10.1002/bdra.20045
   Aujla PK, 2011, DEV BIOL, V353, P61, DOI 10.1016/j.ydbio.2011.02.018
   Aven L, 2013, ORGANOGENESIS, V9, P194, DOI 10.4161/org.24842
   Avery John, 2016, Methods Mol Biol, V1341, P197, DOI 10.1007/7651_2015_234
   Baker CVH, 1997, DEVELOPMENT, V124, P3077
   Balakrishnan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153256
   Barlas N, 2002, HUM EXP TOXICOL, V21, P217, DOI 10.1191/0960327102ht187oa
   Barman SA, 2005, LUNG, V183, P425, DOI 10.1007/s00408-005-2554-3
   BARR M, 1983, J PEDIATR-US, V102, P565, DOI 10.1016/S0022-3476(83)80185-1
   BARR M, 1991, TERATOLOGY, V44, P485, DOI 10.1002/tera.1420440503
   Barraud P, 2010, P NATL ACAD SCI USA, V107, P21040, DOI 10.1073/pnas.1012248107
   Barriga EH, 2015, DEVELOPMENT, V142, P1555, DOI 10.1242/dev.121590
   Bateman BT, 2017, OBSTET GYNECOL, V129, P174, DOI 10.1097/AOG.0000000000001775
   Bayless NL, 2016, CELL HOST MICROBE, V20, P423, DOI 10.1016/j.chom.2016.09.006
   Beedie SL, 2016, ONCOTARGET, V7, P33237, DOI 10.18632/oncotarget.8909
   Benzick AE, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.1.e4
   Berard A, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.034
   Berres ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169351
   Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642
   Bisseling TM, 2004, PLACENTA, V25, P588, DOI 10.1016/j.placenta.2003.11.010
   Blair A., 2015, PESTICIDES HUMAN HLT
   Bloom S. L., 2014, WILLIAMS OBSTET
   Blower PR, 2003, SUPPORT CARE CANCER, V11, P93, DOI 10.1007/s00520-002-0410-z
   Bohnsack BL, 2013, DEV BIOL, V373, P300, DOI 10.1016/j.ydbio.2012.11.005
   Bohnsack BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022991
   Bokor Gyula, 2014, J Pharm Pract, V27, P582, DOI 10.1177/0897190014525754
   Bold J, 2018, ANAT SCI INT, V93, P35, DOI 10.1007/s12565-016-0363-9
   BOLOGNESE RJ, 1973, AM J OBSTET GYNECOL, V117, P939, DOI 10.1016/0002-9378(73)90065-3
   Bolognesi C, 2009, J TOXICOL ENV HEAL A, V72, P986, DOI 10.1080/15287390902929741
   Bonano M, 2008, DEV BIOL, V323, P114, DOI 10.1016/j.ydbio.2008.08.007
   Bonfanti P, 2018, AQUAT TOXICOL, V195, P103, DOI 10.1016/j.aquatox.2017.12.007
   Bonthius DJ, 2003, DEV BRAIN RES, V140, P15, DOI 10.1016/S0165-3806(02)00549-7
   Botting J, 2002, DRUG NEWS PERSPECT, V15, P604, DOI 10.1358/dnp.2002.15.9.840066
   Botto LD, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.10.880
   Breckling B., 2014, P 3 GMLS C 2012 BREM, DOI [10.3726/978-3-653-03248-2, DOI 10.3726/978-3-653-03248-2]
   Brent Robert L., 2001, Congenital Anomalies, V41, P3, DOI 10.1111/j.1741-4520.2001.tb00869.x
   Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC
   Briggs G, 2011, DRUGS PREGNANCY LACT
   Britsch S, 2007, ADV ANAT EMBRYOL CEL, V190, P1
   Britsch S, 1998, GENE DEV, V12, P1825, DOI 10.1101/gad.12.12.1825
   Bronchain OJ, 2017, MOL CELL ENDOCRINOL, V439, P233, DOI 10.1016/j.mce.2016.09.007
   Budai P, 2012, Commun Agric Appl Biol Sci, V77, P449
   BURCHFIELD DJ, 1991, JAMA-J AM MED ASSOC, V265, P1968, DOI 10.1001/jama.265.15.1968
   Burke RD, 2017, J NEUROCHEM, V142, P162, DOI 10.1111/jnc.14077
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carmichael SL, 2014, ENVIRON RES, V135, P133, DOI 10.1016/j.envres.2014.08.030
   Cavanaugh AM, 2015, DEV BIOL, V404, P103, DOI 10.1016/j.ydbio.2015.06.002
   CETIN I, 1990, AM J OBSTET GYNECOL, V162, P253, DOI 10.1016/0002-9378(90)90860-A
   Chan BWH, 2002, DIABETES, V51, P2811, DOI 10.2337/diabetes.51.9.2811
   Channick RN, 2001, LANCET, V358, P1119, DOI 10.1016/S0140-6736(01)06250-X
   Chen J, 2008, BIRTH DEFECTS RES A, V82, P508, DOI 10.1002/bdra.20448
   Chen SY, 2005, DEV NEUROSCI-BASEL, V27, P13, DOI 10.1159/000084528
   Chen SY, 2004, FASEB J, V18, P1234, DOI 10.1096/fj.03-0850fje
   Choi DS, 1997, DEVELOPMENT, V124, P1745
   Cimino AM, 2017, ENVIRON HEALTH PERSP, V125, P155, DOI 10.1289/EHP515
   Clementi M, 1999, AM J MED GENET, V83, P43
   Clouthier DE, 1998, DEVELOPMENT, V125, P813
   COCHARD P, 1983, DEV BIOL, V98, P221, DOI 10.1016/0012-1606(83)90351-2
   Cohen-Kerem R, 2003, NEUROTOXICOL TERATOL, V25, P1, DOI 10.1016/S0892-0362(02)00324-0
   Colugnati FAB, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-71
   Cooper J. M., 2018, SEM PER CONG SYPH
   Cooper WO, 2018, JAMA PSYCHIAT, V75, P127, DOI 10.1001/jamapsychiatry.2017.3882
   Costa GD, 2016, REPROD BIOMED ONLINE, V32, P170, DOI 10.1016/j.rbmo.2015.11.016
   Coste C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177962
   Council N. R, 2000, SCI FRONT DEV TOX RI
   Crofton KM, 2011, ALTEX-ALTERN ANIM EX, V28, P9
   Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3
   Culjat M, 2016, CLIN INFECT DIS, V63, P805, DOI 10.1093/cid/ciw324
   CUMMINGS AM, 1992, FUND APPL TOXICOL, V18, P288, DOI 10.1016/0272-0590(92)90057-O
   Czarnobaj J, 2014, ARCH ORAL BIOL, V59, P500, DOI 10.1016/j.archoralbio.2014.02.005
   DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082
   Davis SW, 2016, BMC DEV BIOL, V16, DOI 10.1186/s12861-016-0118-9
   de Araujo JSA, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3153-3
   de Jong E, 2011, TOXICOL APPL PHARM, V253, P103, DOI 10.1016/j.taap.2011.03.014
   de la Cuadra-Blanco C, 2003, J ANAT, V203, P531, DOI 10.1046/j.1469-7580.2003.00233.x
   de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Melo ASD, 2017, JAMA NEUROL, V74, P610, DOI 10.1001/jamaneurol.2017.0051
   de Raaf MA, 2015, REPROD TOXICOL, V56, P45, DOI 10.1016/j.reprotox.2015.06.048
   Decimo I, 2012, AM J STEM CELLS, V1, P92
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deo M, 2013, J INVEST DERMATOL, V133, P49, DOI 10.1038/jid.2012.240
   DESESSO JM, 1977, TERATOLOGY, V15, P199, DOI 10.1002/tera.1420150211
   Dhaun N, 2009, HYPERTENSION, V54, pE19, DOI 10.1161/HYPERTENSIONAHA.109.138263
   Di Renzo F, 2007, BIRTH DEFECTS RES B, V80, P2, DOI 10.1002/bdrb.20097
   Diav-Citrin O, 2008, BRIT J CLIN PHARMACO, V66, P695, DOI 10.1111/j.1365-2125.2008.03261.x
   Ding HL, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00281
   Dolle P, 2010, DEV DYNAM, V239, P3260, DOI 10.1002/dvdy.22479
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duncan S, 2007, CURR OPIN NEUROL, V20, P175, DOI 10.1097/WCO.0b013e32805866fb
   Ebert AD, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3000
   Edwards MJ, 1997, INT J DEV BIOL, V41, P345
   Ekfeldt A, 2008, ACTA ODONTOL SCAND, V66, P300, DOI 10.1080/00016350802307638
   Ema M, 2010, REPROD TOXICOL, V29, P49, DOI 10.1016/j.reprotox.2009.09.003
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Espinosa-Medina I, 2014, SCIENCE, V345, P87, DOI 10.1126/science.1253286
   Esser C, 2013, SEMIN IMMUNOPATHOL, V35, P677, DOI 10.1007/s00281-013-0394-4
   Etchevers HC, 2001, DEVELOPMENT, V128, P1059
   Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405
   Fainsod A, 2018, BIOCHEM CELL BIOL, V96, P77, DOI 10.1139/bcb-2017-0219
   Farag A, 2011, BIRTH DEFECTS RES B, V92, P122, DOI 10.1002/bdrb.20290
   FELDKAMP M, 1993, TERATOLOGY, V47, P533, DOI 10.1002/tera.1420470605
   Felix LM, 2014, NEUROTOXICOL TERATOL, V41, P27, DOI 10.1016/j.ntt.2013.11.005
   Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181
   Ferre FC, 2014, STEM CELLS DEV, V23, P2895, DOI 10.1089/scd.2013.0547
   Fetter E, 2015, REPROD TOXICOL, V57, P10, DOI 10.1016/j.reprotox.2015.04.012
   Figueiredo M, 2016, DEV BIOL, V418, P268, DOI 10.1016/j.ydbio.2016.08.012
   Fijak M, 2006, IMMUNOL REV, V213, P66, DOI 10.1111/j.1600-065X.2006.00438.x
   Fiori E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183430
   FIUMARA NJ, 1970, ARCH DERMATOL, V102, P78, DOI 10.1001/archderm.102.1.78
   Fleck D, 2012, CURR ALZHEIMER RES, V9, P178, DOI 10.2174/156720512799361637
   FLEET WF, 1974, JAMA-J AM MED ASSOC, V227, P621, DOI 10.1001/jama.227.6.621
   Flentke GR, 2019, BIRTH DEFECTS RES, V111, P686, DOI 10.1002/bdr2.1508
   Flentke GR, 2018, BIOCHEM CELL BIOL, V96, P98, DOI 10.1139/bcb-2017-0205
   Flentke GR, 2011, BIRTH DEFECTS RES A, V91, P591, DOI 10.1002/bdra.20833
   Fogo A, 1996, AM J PATHOL, V149, P1797
   Fonseca BF, 2017, BMC DEV BIOL, V17, DOI 10.1186/s12861-017-0155-z
   FONTAINE J, 1979, GEN COMP ENDOCR, V37, P81, DOI 10.1016/0016-6480(79)90049-2
   Food and Drug Administration HHS, 2014, Fed Regist, V79, P72063
   Foster K, 2008, J IMMUNOL, V180, P3183, DOI 10.4049/jimmunol.180.5.3183
   Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3
   Freem LJ, 2010, J ANAT, V217, P651, DOI 10.1111/j.1469-7580.2010.01295.x
   FROESCHER W, 1984, EPILEPSIA, V25, P244, DOI 10.1111/j.1528-1157.1984.tb04183.x
   Fuller LC, 2002, REPROD TOXICOL, V16, P825, DOI 10.1016/S0890-6238(02)00059-X
   Furlan A, 2018, DEV BIOL, V444, pS25, DOI 10.1016/j.ydbio.2018.02.008
   Furlan A, 2017, SCIENCE, V357, P46, DOI 10.1126/science.aal3753
   Furu K, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1798
   Gao LR, 2016, J AGR FOOD CHEM, V64, P9078, DOI 10.1021/acs.jafc.6b03381
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Garg A., 2017, ACTA OPHTHALMOL, V95, pn/a, DOI [10.1111/j.1755-3768.2017.01163, DOI 10.1111/J.1755-3768.2017.01163]
   Garic A, 2011, J NEUROCHEM, V118, P646, DOI 10.1111/j.1471-4159.2011.07273.x
   Garratt AN, 2000, J CELL BIOL, V148, P1035, DOI 10.1083/jcb.148.5.1035
   Giavini E, 2012, REPROD TOXICOL, V34, P180, DOI 10.1016/j.reprotox.2012.05.003
   Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99
   Gofflot F, 1996, DEV BRAIN RES, V93, P62, DOI 10.1016/0165-3806(96)00031-4
   Gonseth S, 2015, EPIGENETICS-US, V10, P1166, DOI 10.1080/15592294.2015.1117889
   Gordon CT, 2015, AM J HUM GENET, V96, P519, DOI 10.1016/j.ajhg.2015.01.015
   GREENBERG F, 1987, AM J MED GENET, V28, P931, DOI 10.1002/ajmg.1320280419
   Greene RM, 2019, BIRTH DEFECTS RES, V111, P1294, DOI 10.1002/bdr2.1571
   Grigoriadis S, 2013, J CLIN PSYCHIAT, V74, pE293, DOI 10.4088/JCP.12r07966
   Groppelli S, 2005, AQUAT TOXICOL, V73, P370, DOI 10.1016/j.aquatox.2005.04.004
   Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027
   Guron G, 2000, J HYPERTENS, V18, P123, DOI 10.1097/00004872-200018020-00001
   Hall BK, 1999, NEURAL CREST DEV EVO
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hansson SR, 1999, NEUROSCIENCE, V89, P243, DOI 10.1016/S0306-4522(98)00281-4
   Hasan W, 2013, ORGANOGENESIS, V9, P176, DOI 10.4161/org.24892
   HASSLER JA, 1986, J CRAN GENET DEV BIO, P129
   HEATON MB, 1993, BRAIN RES, V620, P78, DOI 10.1016/0006-8993(93)90273-P
   Heaton MB, 2000, J NEUROBIOL, V45, P95, DOI 10.1002/1097-4695(20001105)45:2<95::AID-NEU4>3.0.CO;2-Y
   HENDERSON GI, 1995, J LAB CLIN MED, V126, P184
   Hendrick V, 2003, AM J PSYCHIAT, V160, P993, DOI 10.1176/appi.ajp.160.5.993
   Herfarth HH, 2012, DIGEST DIS, V30, P112, DOI 10.1159/000342735
   Hobbs CA, 2005, AM J CLIN NUTR, V81, P147
   Hood R. D., 2016, DEV REPROD TOXICOLOG, P12
   Hori J, 2003, STEM CELLS, V21, P405, DOI 10.1634/stemcells.21-4-405
   Horvat S, 2011, DRUG METAB REV, V43, P69, DOI 10.3109/03602532.2010.540580
   HOWARD MJ, 1995, DEV BIOL, V170, P479, DOI 10.1006/dbio.1995.1231
   Hu YF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-151
   Huang JLY, 2015, CANCER RES, V75, P3384, DOI 10.1158/0008-5472.CAN-14-3229
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Hutchins EJ, 2018, DEV BIOL, V444, pS98, DOI 10.1016/j.ydbio.2018.07.004
   Hutson MR, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aal4055
   Hyoun SC, 2012, BIRTH DEFECTS RES A, V94, P187, DOI 10.1002/bdra.23003
   Ichi S, 2010, J BIOL CHEM, V285, P36922, DOI 10.1074/jbc.M110.126714
   IDANPAAN.J, 1972, AM J OBSTET GYNECOL, V112, P387
   Ioannou S, 2016, AM J PHYS ANTHROPOL, V159, P617, DOI 10.1002/ajpa.22924
   Ionescu DF, 2015, BIPOLAR DISORD, V17, P438, DOI 10.1111/bdi.12277
   Isern J, 2014, ELIFE, V3, DOI 10.7554/eLife.03696
   Issa S, 2017, HUM MUTAT, V38, P581, DOI 10.1002/humu.23206
   Item CB, 2017, CLIN BIOCHEM, V50, P159, DOI 10.1016/j.clinbiochem.2016.10.001
   Itinteang T, 2015, ANN PLAS SURG, V74, P383, DOI 10.1097/SAP.0000000000000426
   Itinteang T, 2014, FRONT SURG, V1, DOI 10.3389/fsurg.2014.00038
   Itinteang T, 2011, PLAST RECONSTR SURG, V128, P499, DOI 10.1097/PRS.0b013e31821b63a0
   Ivy DD, 2000, AM J PHYSIOL-LUNG C, V279, pL758
   Ivy DD, 1997, J CLIN INVEST, V99, P1179, DOI 10.1172/JCI119274
   Jacobs H, 2011, ENVIRON HEALTH PERSP, V119, P1590, DOI 10.1289/ehp.1003075
   Jacobson SW, 2018, ALCOHOL CLIN EXP RES, V42, P1327, DOI 10.1111/acer.13769
   Jacobson SM, 2010, AQUAT TOXICOL, V100, P101, DOI 10.1016/j.aquatox.2010.07.015
   Jahani SAG, 2016, J CHILD ORTHOP, V10, P691, DOI 10.1007/s11832-016-0797-6
   Janebodin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027526
   Jaskoll T, 2002, CELLS TISSUES ORGANS, V170, P83, DOI 10.1159/000046183
   Jaskoll T, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-33
   Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487
   Ji R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115140
   Jia SH, 2016, DEV BIOL, V420, P110, DOI 10.1016/j.ydbio.2016.10.001
   Jimenez L, 2016, DIS MODEL MECH, V9, P389, DOI 10.1242/dmm.021790
   Jin EJ, 1999, BBA-MOL CELL RES, V1449, P93, DOI 10.1016/S0167-4889(98)00176-1
   Johnsson E, 1997, LANCET, V350, P1520, DOI 10.1016/S0140-6736(05)63942-6
   Junker R, 2001, CARDIOVASC RES, V51, P251, DOI 10.1016/S0008-6363(01)00286-3
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Jux B, 2011, J INVEST DERMATOL, V131, P203, DOI 10.1038/jid.2010.269
   Kalcheim C, 2018, GENESIS, V56, DOI 10.1002/dvg.23090
   Kalkan T, 2009, MOL BIOL CELL, V20, P3436, DOI 10.1091/mbc.E08-03-0325
   Kaminen-Ahola N, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000811
   Kanagawa Y, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-47
   Kasiotis K. M., 2015, Hellenic Plant Protection Journal, V8, P33
   Kastriti ME, 2017, CURR OPIN NEUROBIOL, V47, P196, DOI 10.1016/j.conb.2017.11.004
   Kawakami M, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-68
   Kawasaki-Nishihara A, 2011, DEV DYNAM, V240, P1454, DOI 10.1002/dvdy.22649
   Keating E, 2009, REPROD TOXICOL, V28, P511, DOI 10.1016/j.reprotox.2009.07.001
   Keil AP, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-3
   Kempf H, 1998, DEVELOPMENT, V125, P4931
   Kennedy AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185729
   Keyte A, 2012, DIFFERENTIATION, V84, DOI 10.1016/j.diff.2012.04.005
   Keyte AL, 2014, BIRTH DEFECTS RES C, V102, P309, DOI 10.1002/bdrc.21076
   Kholdani CA, 2014, VASC HEALTH RISK MAN, V10, P665, DOI 10.2147/VHRM.S33904
   Kidd GJ, 2013, HAND CLINIC, V115, P55, DOI 10.1016/B978-0-444-52902-2.00005-9
   Kimura-Kuroda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032432
   Kirby M. L., 2018, NEUROENDOCRINE IMMUN, P1
   KIRBY ML, 1990, J INHERIT METAB DIS, V13, P634, DOI 10.1007/BF01799518
   KIRBY ML, 1987, PEDIATR RES, V21, P219, DOI 10.1203/00006450-198703000-00001
   KIRBY ML, 1990, CIRCULATION, V82, P332, DOI 10.1161/01.CIR.82.2.332
   KIRBY ML, 1983, SCIENCE, V220, P1059, DOI 10.1126/science.6844926
   Kirby T, 2015, LANCET PSYCHIAT, V2, P783, DOI 10.1016/S2215-0366(15)00392-2
   Kirschbrown WP, 2019, CANCER CHEMOTH PHARM, V84, P539, DOI 10.1007/s00280-019-03871-w
   Klinck R, 2011, GENE EXPR PATTERNS, V11, P415, DOI 10.1016/j.gep.2011.06.004
   Kloas W, 2002, INT REV CYTOL, V216, P1
   Kostis WJ, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0859-x
   Koturbash I, 2011, TOXICOL SCI, V122, P448, DOI 10.1093/toxsci/kfr133
   Krausova T, 2007, J THERM BIOL, V32, P193, DOI 10.1016/j.jtherbio.2006.12.003
   Kubalak SW, 2002, DEVELOPMENT, V129, P733
   Kulin NA, 1998, JAMA-J AM MED ASSOC, V279, P609, DOI 10.1001/jama.279.8.609
   Kumar SD, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-34
   Kuo BR, 2011, DEV DYNAM, V240, P2084, DOI 10.1002/dvdy.22715
   KURIHARA Y, 1995, J CLIN INVEST, V96, P293, DOI 10.1172/JCI118033
   Kurokawa YK, 2018, TOXICOL LETT, V285, P74, DOI 10.1016/j.toxlet.2018.01.001
   Lajiness JD, 2014, P NATL ACAD SCI USA, V111, pE1374, DOI 10.1073/pnas.1319208111
   Lajmanovich RC, 2003, B ENVIRON CONTAM TOX, V70, P612, DOI 10.1007/s00128-003-0029-x
   Lake JI, 2013, J CLIN INVEST, V123, P4875, DOI 10.1172/JCI69781
   Lake JI, 2013, AM J PHYSIOL-GASTR L, V305, pG1, DOI 10.1152/ajpgi.00452.2012
   LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401
   Lange S, 2017, JAMA PEDIATR, V171, P948, DOI 10.1001/jamapediatrics.2017.1919
   Lanzieri TM, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2610
   Lanzieri TM, 2014, INT J INFECT DIS, V22, P44, DOI 10.1016/j.ijid.2013.12.010
   Larribere L, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00111
   LAUDER JM, 1993, TRENDS NEUROSCI, V16, P233, DOI 10.1016/0166-2236(93)90162-F
   Lauder JM, 2000, INT J DEV NEUROSCI, V18, P653, DOI 10.1016/S0736-5748(00)00032-0
   Le Douarin NM, 2007, BRAIN RES REV, V55, P237, DOI 10.1016/j.brainresrev.2007.06.023
   LEDOUARI.NM, 1973, J EMBRYOL EXP MORPH, V30, P31
   Lee ER, 2007, STEM CELLS, V25, P2191, DOI 10.1634/stemcells.2007-0203
   Lee VM, 2003, DEV BIOL, V263, P176, DOI 10.1016/j.ydbio.2003.07.004
   Leger S, 2012, EUR J HUM GENET, V20, P584, DOI 10.1038/ejhg.2011.234
   LENZ W, 1988, TERATOLOGY, V38, P203, DOI 10.1002/tera.1420380303
   Lenz W, 1985, Prog Clin Biol Res, V163C, P77
   Levy M, 2005, PEDIATR RES, V57, P248, DOI 10.1203/01.PDR.0000148280.86670.7B
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Li JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027198
   Li P, 2011, J NEUROSCI RES, V89, P1295, DOI 10.1002/jnr.22644
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lie RT, 2008, EPIDEMIOLOGY, V19, P606, DOI 10.1097/EDE.0b013e3181690731
   Lin AE, 2011, AM J MED GENET A, V155A, P748, DOI 10.1002/ajmg.a.33934
   Lin S, 2018, ENVIRON INT, V118, P211, DOI 10.1016/j.envint.2018.04.043
   Liu JA, 2016, DEV BIOL, V419, P199, DOI 10.1016/j.ydbio.2016.09.006
   Liu M, 2016, TOXICOL SCI, V153, P137, DOI 10.1093/toxsci/kfw111
   Liu YW, 2002, DIFFERENTIATION, V70, P36, DOI 10.1046/j.1432-0436.2002.700104.x
   LONGO LD, 1980, AM J OBSTET GYNECOL, V137, P162, DOI 10.1016/0002-9378(80)90770-X
   Lopez-Olivo MA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000957.pub2
   Loscalzo J, 1996, J CLIN INVEST, V98, P5, DOI 10.1172/JCI118776
   Louik C., 2008, OBSTET ANESTHESIA DI, V28, P24, DOI [10.1097/01.aoa.0000308307.15941.b1, DOI 10.1097/01.AOA.0000308307.15941.B1]
   Luecke S, 2010, PIGM CELL MELANOMA R, V23, P828, DOI 10.1111/j.1755-148X.2010.00762.x
   Soto-Hernandez JL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00435
   MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738
   Maeda K, 2016, DEV BIOL, V409, P72, DOI 10.1016/j.ydbio.2015.10.026
   Maguire LH, 2015, DEV DYNAM, V244, P311, DOI 10.1002/dvdy.24226
   Mai CT, 2015, BIRTH DEFECTS RES A, V103, P972, DOI 10.1002/bdra.23461
   Maier SE, 2001, ALCOHOL RES HEALTH, V25, P168
   Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069
   Makori N, 1998, J MED PRIMATOL, V27, P210, DOI 10.1111/j.1600-0684.1998.tb00073.x
   MARCHANT B, 1978, PHARMACOL THER PT B, V3, P305, DOI 10.1016/S0306-039X(78)80001-4
   Marino MD, 2004, INT J DEV NEUROSCI, V22, P363, DOI 10.1016/j.ijdevneu.2004.04.005
   Mario JT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142172
   Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299
   Marshall H, 1996, FASEB J, V10, P969
   Martik ML, 2017, TRENDS GENET, V33, P715, DOI 10.1016/j.tig.2017.07.015
   MARTIN P, 1989, International Journal of Developmental Biology, V33, P379
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinez-Frias ML, 1998, AM J MED GENET, V78, P140, DOI 10.1002/(SICI)1096-8628(19980630)78:2<140::AID-AJMG8>3.0.CO;2-S
   May PA, 2013, DRUG ALCOHOL DEPEN, V133, P502, DOI 10.1016/j.drugalcdep.2013.07.013
   Mayanil CS, 2011, VITAM HORM, V87, P143, DOI 10.1016/B978-0-12-386015-6.00028-7
   Mayor R, 2001, CELL TISSUE RES, V305, P203, DOI 10.1007/s004410100369
   MCCREDIE J, 1976, J NEUROL SCI, V28, P373, DOI 10.1016/0022-510X(76)90031-9
   McCredie J, 2009, J MED IMAG RADIAT ON, V53, P433, DOI 10.1111/j.1754-9485.2009.02101.x
   McKay JA, 2016, P NUTR SOC, V75, P90, DOI 10.1017/S0029665115004280
   Meador K, 2008, EPILEPSY RES, V81, P1, DOI 10.1016/j.eplepsyres.2008.04.022
   Medina MT, 2017, J NEUROL SCI, V383, P214, DOI 10.1016/j.jns.2017.10.046
   Melnik BC, 2018, EXP DERMATOL, V27, P91, DOI 10.1111/exd.13420
   Melnik BC, 2017, ACTA DERM-VENEREOL, V97, P173, DOI 10.2340/00015555-2535
   Melo FR, 2017, CELL MOL NEUROBIOL, V37, P371, DOI 10.1007/s10571-016-0383-y
   Meltzer HY, 2003, PROG NEURO-PSYCHOPH, V27, P1159, DOI 10.1016/j.pnpbp.2003.09.010
   Mendez-Maldonado K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124025
   Menegola E, 2000, IN VITRO CELL DEV-AN, V36, P88, DOI 10.1290/1071-2690(2000)036<0088:IVTPOT>2.0.CO;2
   Menegola E, 2005, BIRTH DEFECTS RES B, V74, P392, DOI 10.1002/bdrb.20053
   Menegola E, 2003, BIRTH DEFECTS RES A, V67, P116, DOI 10.1002/bdra.10022
   Menegola E, 2005, BIRTH DEFECTS RES B, V74, P185, DOI 10.1002/bdrb.20035
   Menegola E, 2005, TOXICOL IN VITRO, V19, P737, DOI 10.1016/j.tiv.2005.04.005
   Menegola E, 2013, ARCH TOXICOL, V87, P1989, DOI 10.1007/s00204-013-1048-y
   Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108
   MEYER D, 1995, NATURE, V378, P386, DOI 10.1038/378386a0
   Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025
   Michelis JP, 2016, PARKINSONISM RELAT D, V31, P153, DOI 10.1016/j.parkreldis.2016.07.020
   Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166
   Miller CT, 2000, DEVELOPMENT, V127, P3815
   Miller M T, 1991, J Pediatr Ophthalmol Strabismus, V28, P47
   Miller MT, 2011, CURR OPIN OPHTHALMOL, V22, P356, DOI 10.1097/ICU.0b013e3283499f24
   Mishina Y, 2014, EXP CELL RES, V325, P138, DOI 10.1016/j.yexcr.2014.01.019
   Mjaatvedt CH, 2005, ANAT REC PART A, V285A, P748, DOI 10.1002/ar.a.20210
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MOISEIWITSCH JRD, 1995, P NATL ACAD SCI USA, V92, P7182, DOI 10.1073/pnas.92.16.7182
   Mol F, 2008, HUM REPROD UPDATE, V14, P309, DOI 10.1093/humupd/dmn012
   Mondal Dipankar, 2017, Int J Appl Basic Med Res, V7, P264, DOI 10.4103/ijabmr.IJABMR_469_16
   Monsoro-Burq AH, 2005, DEV CELL, V8, P167, DOI 10.1016/j.devcel.2004.12.017
   Moody SA, 2015, CURR TOP DEV BIOL, V111, P301, DOI 10.1016/bs.ctdb.2014.11.009
   MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675
   Morgan SC, 2008, BIRTH DEFECTS RES A, V82, P453, DOI 10.1002/bdra.20457
   Mort RL, 2015, DEVELOPMENT, V142, P620, DOI 10.1242/dev.106567
   Mose T, 2008, J TOXICOL ENV HEAL A, V71, P984, DOI 10.1080/01932690801934513
   Muller-Schulte E, 2018, ARCH DIS CHILD-FETAL, V103, pF467, DOI 10.1136/archdischild-2017-313615
   Muktyaz Hussein, 2014, Scholars Journal of Applied Medical Sciences, V2, P67
   Mulder GB, 2000, TERATOLOGY, V62, P214, DOI 10.1002/1096-9926(200010)62:4<214::AID-TERA7>3.0.CO;2-N
   Musk GC, 2012, LAB ANIM-UK, V46, P46, DOI 10.1258/la.2011.010179
   Musselman DL, 2001, NEW ENGL J MED, V344, P961, DOI 10.1056/NEJM200103293441303
   Myers JP, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0117-0
   Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005
   Nagy N., 2017, SEM CELL DEV BIOL
   Narboux-Neme N, 2008, NEUROPHARMACOLOGY, V55, P994, DOI 10.1016/j.neuropharm.2008.08.020
   Nascimento OJM, 2017, NEUROLOGY, V88, P2330, DOI 10.1212/WNL.0000000000004026
   NAU H, 1984, J PEDIATR-US, V104, P627, DOI 10.1016/S0022-3476(84)80567-3
   Nau H, 2001, J AM ACAD DERMATOL, V45, pS183, DOI 10.1067/mjd.2001.113720
   Navarro-Guerrero E, 2016, STEM CELLS, V34, P1637, DOI 10.1002/stem.2331
   Nazir Muhammad Ashraf, 2017, Int J Health Sci (Qassim), V11, P72
   Nebigil CG, 2001, CIRCULATION, V103, P2973, DOI 10.1161/01.CIR.103.24.2973
   Negro A, 2004, RECENT PROG HORM RES, V59, P1, DOI 10.1210/rp.59.1.1
   Neidhart W, 1996, CHIMIA, V50, P519
   Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859
   Newbern JM, 2015, CURR TOP DEV BIOL, V111, P201, DOI 10.1016/bs.ctdb.2014.11.007
   Newport DJ, 2007, AM J PSYCHIAT, V164, P1214, DOI 10.1176/appi.ajp.2007.06111886
   Newport DJ, 2005, AM J PSYCHIAT, V162, P2162, DOI 10.1176/appi.ajp.162.11.2162
   Nie XG, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007491
   Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340
   Niibe K, 2017, JPN DENT SCI REV, V53, P25, DOI 10.1016/j.jdsr.2016.09.001
   NISHIJIMA M, 1972, Acta Obstetrica et Gynaecologica Japonica (English Edition), V19, P80
   Norman MA, 1996, CANCER EPIDEM BIOMAR, V5, P127
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nyffeler J, 2017, ALTEX-ALTERN ANIM EX, V34, P75, DOI 10.14573/altex.1605031
   Ohazama A, 2004, CURR OPIN GENET DEV, V14, P513, DOI 10.1016/j.gde.2004.07.008
   Okamura Y, 2008, DEVELOPMENT, V135, P3555, DOI 10.1242/dev.022319
   Oster ME, 2010, BIRTH DEFECTS RES A, V88, P1, DOI 10.1002/bdra.20621
   Oyedele OO, 2013, ALCOHOL, V47, P417, DOI 10.1016/j.alcohol.2013.04.001
   Paganelli A, 2010, CHEM RES TOXICOL, V23, P1586, DOI 10.1021/tx1001749
   Pallocca G, 2016, ARCH TOXICOL, V90, P159, DOI 10.1007/s00204-015-1658-7
   Pandey SP, 2015, CHEMOSPHERE, V122, P227, DOI 10.1016/j.chemosphere.2014.11.061
   Papis E, 2007, GENE EXPR PATTERNS, V7, P137, DOI 10.1016/j.modgep.2006.06.003
   Park B.-Y., 2010, C SER DEV BIOL
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Parry G. J., 2007, GUILLAIN BARRE SYNDR
   Parvez S, 2018, ENVIRON HEALTH-GLOB, V17, DOI 10.1186/s12940-018-0367-0
   Patorno E, 2017, NEW ENGL J MED, V376, P2245, DOI 10.1056/NEJMoa1612222
   Patthey C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001625
   Patthey C, 2009, DEVELOPMENT, V136, P73, DOI 10.1242/dev.025890
   Payvandi F, 2004, CELL IMMUNOL, V230, P81, DOI 10.1016/j.cellimm.2004.09.003
   Pedersen LH, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3569
   Peraudeau E, 2018, J CONTROL RELEASE, V269, P36, DOI 10.1016/j.jconrel.2017.11.011
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Petrelli B, 2019, GENESIS, V57, DOI 10.1002/dvg.23278
   Phillips GDL, 2017, BREAST CANCER RES TR, V164, P581, DOI 10.1007/s10549-017-4279-4
   Piersma Aldert H, 2017, Reprod Toxicol, V72, P53, DOI 10.1016/j.reprotox.2017.05.014
   Piggott KD, 2011, PEDIATR CARDIOL, V32, P518, DOI 10.1007/s00246-011-9913-z
   Pijacka W, 2012, ENDOCR CONNECT, V1, P22, DOI 10.1530/EC-12-0013
   Piontkivska H, 2019, BIOESSAYS, V41, DOI 10.1002/bies.201800239
   Pla P, 2003, INT J DEV BIOL, V47, P315
   Pla P, 2018, DEV BIOL, V444, pS36, DOI 10.1016/j.ydbio.2018.05.018
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Plouhinec JL, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2004045
   Poggi SH, 2011, FERTIL STERIL, V96, P669, DOI 10.1016/j.fertnstert.2011.06.014
   POLAK JM, 1974, HISTOCHEMISTRY, V40, P209, DOI 10.1007/BF00501955
   POMERANZ HD, 1991, DEVELOPMENT, V111, P647
   Popova S, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7213-3
   Popova S, 2017, LANCET GLOB HEALTH, V5, pE290, DOI 10.1016/S2214-109X(17)30021-9
   PRICE LH, 1994, NEW ENGL J MED, V331, P591
   PRYDE PG, 1993, J AM SOC NEPHROL, V3, P1575
   Purves D., 2017, NEUROSCIENCES
   Rahi M, 2007, J PSYCHOPHARMACOL, V21, P751, DOI 10.1177/0269881106074065
   Rajagopalan PTR, 2002, P NATL ACAD SCI USA, V99, P13481, DOI 10.1073/pnas.172501499
   Rampono J, 2009, PHARMACOPSYCHIATRY, V42, P95, DOI 10.1055/s-0028-1103296
   Rauh VA, 2006, PEDIATRICS, V118, pE1845, DOI 10.1542/peds.2006-0338
   Rauh VA, 2012, P NATL ACAD SCI USA, V109, P7871, DOI 10.1073/pnas.1203396109
   Reardon S, 2015, NATURE, V517, P130, DOI 10.1038/517130a
   Reinert RB, 2014, DEVELOPMENT, V141, P1480, DOI 10.1242/dev.098657
   Reisenberger K, 1996, AM J OBSTET GYNECOL, V174, P1450, DOI 10.1016/S0002-9378(96)70587-2
   Rengasamy P., 2015, DEV REPROD TOXICOLOG, P17
   Resendiz M, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00285
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Riethmacher D, 1997, NATURE, V389, P725, DOI 10.1038/39593
   Rogers CD, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.322
   Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8
   Rosario FJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03888-2
   Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724
   Rothstein M, 2018, DEV BIOL, V444, pS170, DOI 10.1016/j.ydbio.2018.07.026
   Roullet FI, 2013, NEUROTOXICOL TERATOL, V36, P47, DOI 10.1016/j.ntt.2013.01.004
   Roux M, 2017, MECH DEVELOP, V143, P1, DOI 10.1016/j.mod.2016.11.006
   Roux S, 1999, J MOL MED-JMM, V77, P364, DOI 10.1007/s001090050363
   Rovasio RA, 2002, ALCOHOL CLIN EXP RES, V26, P1286, DOI 10.1097/01.ALC>0000026102.7386.65
   Rubin LJ, 2002, NEW ENGL J MED, V346, P896, DOI 10.1056/NEJMoa012212
   Sabrautzki S, 2016, MAMM GENOME, V27, P587, DOI 10.1007/s00335-016-9664-5
   Sahakyan V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21103-8
   Sanbe A, 2009, N-S ARCH PHARMACOL, V380, P569, DOI 10.1007/s00210-009-0455-3
   Sari Y, 2003, INT J DEV NEUROSCI, V21, P417, DOI 10.1016/j.ijdevneu.2003.10.002
   Sato T, 2005, DEVELOPMENT, V132, P2355, DOI 10.1242/dev.01823
   Savastano CP, 2014, GENET MOL BIOL, V37, P250, DOI 10.1590/S1415-47572014000200011
   Scheil V, 2009, ARCH ENVIRON CON TOX, V56, P238, DOI 10.1007/s00244-008-9192-8
   Schenker S, 1995, P SOC EXP BIOL MED, V210, P213
   SCHLEUNING M, 1987, NEW ENGL J MED, V317, P1666
   Schlosser G, 2015, CURR TOP DEV BIOL, V111, P235, DOI 10.1016/bs.ctdb.2014.11.008
   Schmidt JV, 1996, P NATL ACAD SCI USA, V93, P6731, DOI 10.1073/pnas.93.13.6731
   Schmidt S, 2016, CHEMOSPHERE, V152, P503, DOI 10.1016/j.chemosphere.2016.03.006
   Schoen C, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00165
   Schotte A, 1996, PSYCHOPHARMACOLOGY, V124, P57, DOI 10.1007/BF02245606
   SCHOU M, 1975, AM J OBSTET GYNECOL, V122, P541, DOI 10.1016/S0002-9378(16)33564-5
   Schutz S, 1996, AM J PATHOL, V149, P2067
   SCOTT AK, 1994, CLIN PHARMACOKINET, V27, P337, DOI 10.2165/00003088-199427050-00002
   SCOTT WJ, 1977, TERATOLOGY, V16, P333, DOI 10.1002/tera.1420160313
   Seagraves NJ, 2012, MOL GENET METAB, V107, P650, DOI 10.1016/j.ymgme.2012.08.001
   Semmler A, 2017, SEIZURE-EUR J EPILEP, V46, P7, DOI 10.1016/j.seizure.2017.01.003
   Shan TF, 2015, CELL BIOL INT, V39, P35, DOI 10.1002/cbin.10340
   Sheets LP, 2010, HAYES' HANDBOOK OF PESTICIDE TOXICOLOGY, VOLS 1 AND 2, 3RD EDITION, P2055, DOI 10.1016/B978-0-12-374367-1.00095-1
   Sherrard RM, 2003, ECOTOX ENVIRON SAFE, V56, P327, DOI 10.1016/S0147-6513(02)00073-8
   Shi Y, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00009
   Shiau CE, 2008, NAT NEUROSCI, V11, P269, DOI 10.1038/nn2051
   Shimada K, 2012, ACTA HISTOCHEM CYTOC, V45, P65, DOI 10.1267/ahc.11052
   Shookhoff JM, 2010, GENESIS, V48, P282, DOI 10.1002/dvg.20623
   SHUEY DL, 1993, ANAT EMBRYOL, V187, P75
   SHUEY DL, 1992, TERATOLOGY, V46, P367, DOI 10.1002/tera.1420460407
   Sieber-Blum M, 2000, MOL CELL BIOCHEM, V212, P61, DOI 10.1023/A:1007100803568
   Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129
   Silveira AB, 2015, ONCOTARGET, V6, P13105, DOI 10.18632/oncotarget.3524
   Simkin JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064077
   Sitarek K, 2001, TERATOGEN CARCIN MUT, V21, P335, DOI 10.1002/tcm.1021.abs
   Sjogreen L, 2012, J LARYNGOL OTOL, V126, P902, DOI 10.1017/S0022215112001429
   SMITH MSR, 1992, NEUROPATH APPL NEURO, V18, P71, DOI 10.1111/j.1365-2990.1992.tb00765.x
   Solanky N, 2010, PLACENTA, V31, P134, DOI 10.1016/j.placenta.2009.11.017
   Soleimani E, 2016, FOOD CHEM TOXICOL, V96, P263, DOI 10.1016/j.fct.2016.07.009
   Sommer L, 2011, PIGM CELL MELANOMA R, V24, P411, DOI 10.1111/j.1755-148X.2011.00834.x
   Songur SH, 2005, CELL BIOCHEM FUNCT, V23, P457, DOI 10.1002/cbf.1181
   Sorensen D, 2017, REPROD TOXICOL, V70, P126, DOI 10.1016/j.reprotox.2017.01.010
   Souders CL, 2019, NEUROTOXICOL TERATOL, V74, DOI 10.1016/j.ntt.2019.106809
   Sourander A, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3144
   Sowa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084206
   Spence S, 1999, REPROD TOXICOL, V13, P15, DOI 10.1016/S0890-6238(98)00064-1
   Spencer F, 1996, J APPL TOXICOL, V16, P211
   Srinivasan A, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00039
   Staal YCM, 2018, ARCH TOXICOL, V92, P3549, DOI 10.1007/s00204-018-2320-y
   STAHL A, 1968, INT DENT J, V18, P631
   Stefanovic S, 2017, MECH DEVELOP, V143, P9, DOI 10.1016/j.mod.2016.12.002
   Steventon B, 2014, DEV BIOL, V389, P28, DOI 10.1016/j.ydbio.2014.01.021
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Sullivan KE, 2019, IMMUNOL REV, V287, P186, DOI 10.1111/imr.12701
   Suzuki N, 1996, DIABETOLOGIA, V39, P401, DOI 10.1007/s001250050459
   Taira K., 2014, JPN J CLIN ECOL, V23, P14
   Taiti C, 2017, WOOD SCI TECHNOL, V51, P273, DOI 10.1007/s00226-016-0866-5
   Takaki F, 2015, CELL TISSUE RES, V359, P441, DOI 10.1007/s00441-014-2051-1
   TAMIR H, 1992, SYNAPSE, V12, P155, DOI 10.1002/syn.890120209
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Theunissen PT, 2012, TOXICOL SCI, V125, P430, DOI 10.1093/toxsci/kfr293
   Thiersch J. B., 1952, PROBLEMS BIRTH DEFEC, P195
   Thill M, 2019, BREAST CARE, V14, P17, DOI 10.1159/000496503
   Thomas JD, 2004, NEUROTOXICOL TERATOL, V26, P35, DOI 10.1016/j.ntt.2003.10.002
   Thomas JD, 2001, ALCOHOL CLIN EXP RES, V25, P764, DOI 10.1111/j.1530-0277.2001.tb02277.x
   Thomas JD, 2000, NEUROTOXICOL TERATOL, V22, P703, DOI 10.1016/S0892-0362(00)00097-0
   Thomas JD, 2007, BEHAV NEUROSCI, V121, P120, DOI 10.1037/0735-7044.121.1.120
   Thomas JD, 2009, NEUROTOXICOL TERATOL, V31, P303, DOI 10.1016/j.ntt.2009.07.002
   Tiboni GM, 2005, PEDIATR RES, V58, P94, DOI 10.1203/01.PDR.0000166754.24957.73
   Tolosa EJ, 2016, EUR J CELL BIOL, V95, P136, DOI 10.1016/j.ejcb.2016.02.003
   Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134
   Tomizawa M, 2005, ANNU REV PHARMACOL, V45, P247, DOI 10.1146/annurev.pharmtox.45.120403.095930
   Treinen KA, 1999, TERATOLOGY, V59, P51, DOI 10.1002/(SICI)1096-9926(199901)59:1<51::AID-TERA10>3.0.CO;2-I
   Tribulo C, 2003, DEVELOPMENT, V130, P6441, DOI 10.1242/dev.00878
   Trokovic N, 2005, INT J DEV BIOL, V49, P797, DOI 10.1387/ijdb.051976nt
   TUNNICLIFF G, 1991, PHARMACOL TOXICOL, V69, P149, DOI 10.1111/j.1600-0773.1991.tb01289.x
   De Wals P, 1991, Paediatr Perinat Epidemiol, V5, P445
   Tussellino M, 2016, ENVIRON MOL MUTAGEN, V57, P630, DOI 10.1002/em.22057
   Tzimas G, 1996, TERATOLOGY, V54, P255, DOI 10.1002/(SICI)1096-9926(199611)54:5<255::AID-TERA6>3.3.CO;2-M
   Ueharu H, 2017, J ANAT, V230, P373, DOI 10.1111/joa.12572
   Uggini GK, 2012, ENVIRON TOXICOL, V27, P166, DOI 10.1002/tox.20627
   Unsicker K, 2005, NEUROCHEM RES, V30, P921, DOI 10.1007/s11064-005-6966-5
   UPFOLD JB, 1991, MED HYPOTHESES, V35, P244, DOI 10.1016/0306-9877(91)90240-Y
   Urtatiz O, 2018, PIGM CELL MELANOMA R, V31, P541, DOI 10.1111/pcmr.12680
   Van Calsteren K, 2010, INT J GYNECOL CANCER, V20, P1456, DOI 10.1111/IGC.0b013e3181fb18c8
   van Gelder MMHJ, 2010, HUM REPROD UPDATE, V16, P378, DOI 10.1093/humupd/dmp052
   Vasti C, 2014, WORLD J CARDIOL, V6, P653, DOI 10.4330/wjc.v6.i7.653
   Vega-Lopez GA, 2018, DEV BIOL, V444, pS110, DOI 10.1016/j.ydbio.2018.05.013
   Vega-Lopez GA, 2017, INT J DEV BIOL, V61, P5, DOI 10.1387/ijdb.160408gv
   Vega-Lopez GA, 2015, DEV DYNAM, V244, P988, DOI 10.1002/dvdy.24295
   Vichier-Guerre C, 2017, TOXICOL LETT, V281, P20, DOI 10.1016/j.toxlet.2017.08.012
   Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407
   Wada H, 2006, DEV DYNAM, V235, P1522, DOI 10.1002/dvdy.20730
   Waddington RJ, 2009, CELLS TISSUES ORGANS, V189, P268, DOI 10.1159/000151447
   WAHL CM, 1994, DEV DYNAM, V201, P191, DOI 10.1002/aja.1002010209
   Wahl SE, 2015, DEV BIOL, V405, P108, DOI 10.1016/j.ydbio.2015.07.001
   Waller DK, 2018, BIRTH DEFECTS RES, V110, P342, DOI 10.1002/bdr2.1147
   Wang CJ, 2016, J AGR FOOD CHEM, V64, P4705, DOI 10.1021/acs.jafc.6b01478
   Wang LL, 2009, HUM REPROD, V24, P562, DOI 10.1093/humrep/den439
   Wang R, 2002, J PEDIATR-US, V141, P611, DOI 10.1067/mpd.2002.128891
   Wang XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep18321
   Wang XW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121869
   Ward NJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4436-0
   Wei D, 2014, DIABETES, V63, P3512, DOI 10.2337/db14-0231
   Wei KL, 2016, TOXICOL APPL PHARM, V306, P86, DOI 10.1016/j.taap.2016.06.004
   Wells Peter G, 2005, Toxicol Appl Pharmacol, V207, P354, DOI 10.1016/j.taap.2005.01.061
   Wemakor A, 2015, EUR J EPIDEMIOL, V30, P1187, DOI 10.1007/s10654-015-0065-y
   Wenstrom KD, 2001, AM J OBSTET GYNECOL, V184, P806, DOI 10.1067/mob.2001.113845
   White MG, 2007, PROG BRAIN RES, V162, P347, DOI 10.1016/S0079-6123(06)62017-7
   Wicher V, 2001, CLIN INFECT DIS, V33, P354, DOI 10.1086/321904
   Wieser CB, 2017, DEV BIOL, V429, P356, DOI 10.1016/j.ydbio.2017.04.011
   Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100
   Wilkemeyer MF, 2002, J PHARMACOL EXP THER, V303, P110, DOI 10.1124/jpet.102.036277
   Wilkie AL, 2002, DEVELOPMENT, V129, P3349
   Williams AL, 2019, GENESIS, V57, DOI 10.1002/dvg.23308
   Williams AL, 2015, BIRTH DEFECTS RES C, V105, P87, DOI 10.1002/bdrc.21095
   Wilson J. G., 1973, ENV BIRTH DEFECTS
   Wobus AM, 2011, ARCH TOXICOL, V85, P79, DOI 10.1007/s00204-010-0641-6
   Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062
   Woodhoo A, 2004, MOL CELL NEUROSCI, V25, P30, DOI 10.1016/j.mcn.2003.09.006
   Wright JK, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0661-1
   Wu J, 2009, ACTA PHARMACOL SIN, V30, P653, DOI 10.1038/aps.2009.89
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YQ, 2018, ECOTOX ENVIRON SAFE, V158, P293, DOI 10.1016/j.ecoenv.2018.04.048
   Wurst KE, 2010, BIRTH DEFECTS RES A, V88, P159, DOI 10.1002/bdra.20627
   Xie Q, 2017, NUCLEIC ACIDS RES, V45, P2472, DOI 10.1093/nar/gkw1208
   Yamazaki H, 2005, INT IMMUNOL, V17, P549, DOI 10.1093/intimm/dxh237
   Yanagisawa H, 1998, DEVELOPMENT, V125, P825
   Yang QH, 2000, CANCER EPIDEM BIOMAR, V9, P967
   Yang W, 2014, AM J EPIDEMIOL, V179, P740, DOI 10.1093/aje/kwt324
   Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703
   YAVARONE MS, 1993, TERATOLOGY, V47, P573, DOI 10.1002/tera.1420470609
   YAVARONE MS, 1993, PLACENTA, V14, P149, DOI 10.1016/S0143-4004(05)80257-7
   Yelin R, 2005, DEV BIOL, V279, P193, DOI 10.1016/j.ydbio.2004.12.014
   Yoon CS, 2003, ENVIRON TOXICOL, V18, P327, DOI 10.1002/tox.10133
   Yu JK, 2003, PEDIATR SURG INT, V19, P355, DOI 10.1007/s00383-003-1010-9
   Yuan FQ, 2018, EXP NEUROL, V300, P60, DOI 10.1016/j.expneurol.2017.10.020
   Zalc A, 2015, DEV CELL, V33, P56, DOI 10.1016/j.devcel.2015.02.006
   Zarella CS, 2016, J CRANIOFAC SURG, V27, P450, DOI 10.1097/SCS.0000000000002423
   Zebral YD, 2017, CHEMOSPHERE, V185, P860, DOI 10.1016/j.chemosphere.2017.07.069
   Zehir A, 2010, DEV BIOL, V340, P459, DOI 10.1016/j.ydbio.2010.01.039
   Zhang JA, 1996, NATURE, V381, P238, DOI 10.1038/381238a0
   Zhang P, 2017, TOXICOL LETT, V281, P53, DOI 10.1016/j.toxlet.2017.09.010
   Zhao YG, 1999, P NATL ACAD SCI USA, V96, P15002, DOI 10.1073/pnas.96.26.15002
   Zhou JH, 2015, REPROD TOXICOL, V51, P64, DOI 10.1016/j.reprotox.2014.12.008
   Zhou Ru, 2010, F1000 Biol Rep, V2, DOI 10.3410/B2-3
   Zhu Q, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201700067
   Zhu XQ, 2016, STEM CELL REP, V6, P228, DOI 10.1016/j.stemcr.2015.10.007
   Ziermann JM, 2018, GENESIS, V56, DOI 10.1002/dvg.23097
   Zimmer B, 2012, ENVIRON HEALTH PERSP, V120, P1116, DOI 10.1289/ehp.1104489
   Ziskin MC, 2011, INT J HYPERTHER, V27, P374, DOI 10.3109/02656736.2011.553769
NR 575
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2472-1727
J9 BIRTH DEFECTS RES
JI Birth Defects Res.
PD MAY
PY 2020
VL 112
IS 8
BP 584
EP 632
DI 10.1002/bdr2.1644
PG 49
WC Developmental Biology; Toxicology
SC Developmental Biology; Toxicology
GA LI6FR
UT WOS:000529579800002
PM 31926062
DA 2020-07-08
ER

PT J
AU McAllister, JC
   Porcelli, M
   Medina, JM
   Delorey, MJ
   Connelly, CR
   Godsey, MS
   Panella, NA
   Dzuris, N
   Boegler, KA
   Kenney, JL
   Kothera, L
   Vizcaino, L
   Lenhart, AE
   Mutebi, JP
   Vasquez, C
AF McAllister, Janet C.
   Porcelli, Mario
   Medina, Johana M.
   Delorey, Mark J.
   Connelly, C. Roxanne
   Godsey, Marvin S.
   Panella, Nicholas A.
   Dzuris, Nicole
   Boegler, Karen A.
   Kenney, Joan L.
   Kothera, Linda
   Vizcaino, Lucrecia
   Lenhart, Audrey E.
   Mutebi, John-Paul
   Vasquez, Chalmers
TI Mosquito Control Activities during Local Transmission of Zika Virus,
   Miami-Dade County, Florida, USA, 2016
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
AB In 2016, four clusters of local mosquitoborne Zika virus transmission were identified in Miami-Dade County, Florida, USA, generating "red zones" (areas into which pregnant women were advised against traveling). The Miami-Dade County Mosquito Control Division initiated intensive control activities, including property inspections, community education, and handheld sprayer applications of larvicides and adulticides. For the first time, the Mosquito Control Division used a combination of areawide ultralow-volume adulticide and low-volume larvicide spraying to effectively control Aedes aegypti mosquitoes, the primary Zika virus vector within the county. The number of mosquitoes rapidly decreased, and Zika virus transmission was interrupted within the red zones immediately after the combination of adulticide and larvicide spraying.
C1 [McAllister, Janet C.; Delorey, Mark J.; Connelly, C. Roxanne; Godsey, Marvin S.; Panella, Nicholas A.; Boegler, Karen A.; Kenney, Joan L.; Kothera, Linda; Mutebi, John-Paul] Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
   [Porcelli, Mario; Medina, Johana M.; Vasquez, Chalmers] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
   [Connelly, C. Roxanne] Florida Med Entomol Lab, Vero Beach, FL USA.
   [Dzuris, Nicole; Vizcaino, Lucrecia; Lenhart, Audrey E.] Ctr Dis Control & Prevent, Atlanta, GA USA.
   [McAllister, Janet C.] CDC, Arboviral Dis Branch, Div Vector Borne Dis, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA.
RP McAllister, JC (corresponding author), Ctr Dis Control & Prevent, 3150 Rampart Rd, Ft Collins, CO 80521 USA.
EM jvm6@cdc.gov
FU Florida Department of Health and Florida Department of Agriculture and
   Consumer Services
FX We recognize all the employees from the cities of Miami and Miami Beach
   and Miami-Dade County, Florida. Many individuals from Miami-Dade County
   departments played a role in containing the outbreak: Lilian Rivera,
   Reynald Jean, and staff of the Department of Health; Samir Elmir and
   staff of the Department of Health's Environmental Health and Engineering
   Division; and Alina Hudak, Paul Mauriello, Aimee Cabrera, Lee Casey, and
   staff of the Department of Solid Waste Management. We extend special
   thanks to the leaders of Miami Beach, the city of Miami, and Miami-Dade
   County, whose leadership and cooperation were crucial in successfully
   stopping the spread of Zika virus. Alden Estep graciously supplied the
   Ae. aegypti-susceptible strain. Finally, we thank the Florida Department
   of Health and Florida Department of Agriculture and Consumer Services
   for their support of the vector control activities.
CR ANDIS MD, 1987, J AM MOSQUITO CONTR, V3, P125
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Brogdon WG, 1998, J AM MOSQUITO CONTR, V14, P159
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carney RM, 2008, EMERG INFECT DIS, V14, P747, DOI 10.3201/eid1405.071347
   Fillinger U, 2009, B WORLD HEALTH ORGAN, V87, P655, DOI 10.2471/BLT.08.055632
   Killick R, 2012, J AM STAT ASSOC, V107, P1590, DOI 10.1080/01621459.2012.737745
   Kuehnert MJ, 2016, MMWR-MORBID MORTAL W, V65, P627, DOI 10.15585/mmwr.mm6524e2
   Lam PHY, 2010, SE ASIAN J TROP MED, V41, P1071
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 13
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2020
VL 26
IS 5
BP 872
EP 880
DI 10.3201/eid2605.191606
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LI2II
UT WOS:000529306800006
PM 32310079
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diarra, I
   Nurtop, E
   Sangare, AK
   Sagara, I
   Pastorino, B
   Sacko, S
   Zeguime, A
   Coulibaly, D
   Fofana, B
   Gallian, P
   Priet, S
   Drexler, JF
   Failloux, AB
   Dabo, A
   Thera, MA
   Djimde, A
   Kouriba, B
   Cauchemez, S
   de Lamballerie, X
   Hoze, N
   Doumbo, OK
AF Diarra, Issa
   Nurtop, Elif
   Sangare, Abdoul Karim
   Sagara, Issaka
   Pastorino, Boris
   Sacko, Souleymane
   Zeguime, Amatigue
   Coulibaly, Drissa
   Fofana, Bakary
   Gallian, Pierre
   Priet, Stephane
   Drexler, Jan Felix
   Failloux, Anna-Bella
   Dabo, Abdoulaye
   Thera, Mahamadou Ali
   Djimde, Abdoulaye
   Kouriba, Bourema
   Cauchemez, Simon
   de Lamballerie, Xavier
   Hoze, Nathanael
   Doumbo, Ogobara K.
TI Zika Virus Circulation in Mali
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID BLOOD-DONORS; PREVALENCE; SEROPREVALENCE; TRANSMISSION; ARBOVIRUS;
   OUTBREAK; ANGOLA; IGG
AB The circulation of Zika virus (ZIKV) in Mali has not been clearly characterized. Therefore, we conducted a serologic survey of 793 asymptomatic volunteers >15 years of age (2016), and 637 blood donors (2013) to assess the seroprevalence of ZIKV infection in 2 ecoclimatic regions of Mali, tropical savannah and warm semiarid region, using ELISA and seroneutralization assays. The overall seroprevalence was approximate to 12% and increased with age, with no statistical difference between male and female participants. In the warm semiarid study sites we detected immunological markers of an outbreak that occurred in the late 1990s in 18% (95% CI 13%-23%) of participants. In tropical savannah sites, we estimated a low rate of endemic transmission, with 2.5% (95% CI 2.0%-3.1%) of population infected by ZIKV annually. These data demonstrate the circulation of ZIKV in Mali and provide evidence of a previously unidentified outbreak that occurred in the late 1990s.
C1 [Diarra, Issa; Nurtop, Elif; Pastorino, Boris; Gallian, Pierre; Priet, Stephane; de Lamballerie, Xavier] Aix Marseille Univ, UVE, IRD 190, INSERM 1207,IHU Mediterranee Infect, Marseille, France.
   [Diarra, Issa; Sangare, Abdoul Karim; Sagara, Issaka; Zeguime, Amatigue; Coulibaly, Drissa; Fofana, Bakary; Dabo, Abdoulaye; Thera, Mahamadou Ali; Djimde, Abdoulaye; Kouriba, Bourema; Doumbo, Ogobara K.] Univ Sci Tech & Technol Bamako, Malaria Res & Training Ctr, Bamako, Mali.
   [Sangare, Abdoul Karim; Kouriba, Bourema] Ctr Infectiol Charles Merieux, Bamako, Mali.
   [Sacko, Souleymane] Minist Sante & Affaires Sociales Mali, Bamako, Mali.
   [Gallian, Pierre] Etab Francais Sang Prov Alpes Cote dAzur & Corse, Lab Virol, Marseille, France.
   [Drexler, Jan Felix] German Ctr Infect Res, Bonn, Germany.
   [Drexler, Jan Felix] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Failloux, Anna-Bella; Cauchemez, Simon; Hoze, Nathanael] Inst Pasteur, Paris, France.
   [Cauchemez, Simon; Hoze, Nathanael] CNRS, Paris, France.
RP de Lamballerie, X (corresponding author), Aix Marseille Univ, Unite Virus Emergents, IRD 190, Inserm 1207,EFS,IRBA,Fac Med Marseille, 27 Bd Jean Moulin, F-13005 Marseille 05, France.
EM xavier.de-lamballerie@univ-amu.fr
OI pastorino, boris/0000-0001-5233-5193
FU AXA Research Fund; Investissement d'Avenir programFrench National
   Research Agency (ANR); Laboratoire d'Excellence Integrative Biology of
   Emerging Infectious Diseases program [ANR-10-LABX-62-IBEID]; Models of
   Infectious Disease Agent Study of the National Institute of General
   Medical Sciences; INCEPTION project [PIA/ANR-16-CONV-0005]; Minister of
   Health and Hygiene of Mali from the Mali World Health Organization Local
   Office [2016/668116-0]; European UnionEuropean Union (EU) [734548];
   European Virus Archive EVAg; European Union-Horizon 2020 programme
   [653316]
FX N.H. and S.C. acknowledge financial support from the AXA Research Fund,
   the Investissement d'Avenir program, the Laboratoire d'Excellence
   Integrative Biology of Emerging Infectious Diseases program (grant
   ANR-10-LABX-62-IBEID) and the Models of Infectious Disease Agent Study
   of the National Institute of General Medical Sciences, the INCEPTION
   project (PIA/ANR-16-CONV-0005).; This work was supported by the Minister
   of Health and Hygiene of Mali through the subvention no. 2016/668116-0
   from the Mali World Health Organization Local Office, the European
   Union's Horizon 2020 Research and Innovation Programme under ZIKAlliance
   Grant Agreement no. 734548 and the European Virus Archive EVAg; European
   Union-Horizon 2020 programme under grant agreement no. 653316.
CR de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Boeuf P, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0660-0
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   BRES P, 1970, B WORLD HEALTH ORGAN, V43, P223
   Cauchemez S, 2019, TRENDS PARASITOL, V35, P369, DOI 10.1016/j.pt.2019.01.009
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FILIPE AR, 1975, AM J TROP MED HYG, V24, P516, DOI 10.4269/ajtmh.1975.24.516
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Henderson AD, 2020, ELIFE, V9, DOI 10.7554/eLife.48460
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hery L, 2019, EMERG MICROBES INFEC, V8, P699, DOI 10.1080/22221751.2019.1615849
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Kouriba B, 2017, TRANSFUS CLIN BIOL, V24, P62, DOI 10.1016/j.tracli.2017.03.002
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Mathe P, 2018, J CLIN VIROL, V105, P35, DOI 10.1016/j.jcv.2018.05.011
   Meda N, 2016, ZIKA VIRUS EPIDEMIC
   Munoz LS, 2016, SEMIN REPROD MED, V34, P273, DOI 10.1055/s-0036-1592066
   Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Spiegelhalter DJ, 2002, J ROY STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353
   Stan Development Team, 2016, RSTAN R INT STAN
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Willcox AC, 2018, AM J TROP MED HYG, V99, P756, DOI 10.4269/ajtmh.18-0156
NR 33
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2020
VL 26
IS 5
BP 945
EP 952
DI 10.3201/eid2605.191383
PG 8
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LI2II
UT WOS:000529306800014
PM 32310065
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Williams, L
   D'Angelo, DV
   Bauman, B
   Dieke, AC
   Ellington, SR
   Shapiro-Mendoza, CK
   Cox, S
   Hastings, P
   Shulman, H
   Harrison, L
   Kapaya, M
   Barfield, WD
   Warner, L
AF Williams, Letitia
   D'Angelo, Denise, V
   Bauman, Brenda
   Dieke, Ada C.
   Ellington, Sascha R.
   Shapiro-Mendoza, Carrie K.
   Cox, Shanna
   Hastings, Philip
   Shulman, Holly
   Harrison, Leslie
   Kapaya, Martha
   Barfield, Wanda D.
   Warner, Lee
CA PRAMS Zika State Working Grp
TI Women's Awareness and Healthcare Provider Discussions about Zika Virus
   during Pregnancy, United States, 2016-2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID INTERIM GUIDELINES; PREVENTION; OUTBREAK
AB We surveyed women with a recent live birth who resided in 16 US states and 1 city during the 2016 Zika outbreak. We found high awareness about the risk of Zika virus infection during pregnancy and about advisories to avoid travel to affected areas but moderate levels of discussions with healthcare providers.
C1 [Williams, Letitia] Ctr Dis Control & Prevent, Womens Hlth & Fertil Branch, Div Reprod Hlth, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA 30341 USA.
   [D'Angelo, Denise, V; Bauman, Brenda; Dieke, Ada C.; Ellington, Sascha R.; Shapiro-Mendoza, Carrie K.; Cox, Shanna; Hastings, Philip; Shulman, Holly; Harrison, Leslie; Kapaya, Martha; Barfield, Wanda D.; Warner, Lee] Ctr Dis Control & Prevent, 4770 Buford Hwy NE,Mailstop F-74, Atlanta, GA 30341 USA.
RP Williams, L (corresponding author), Ctr Dis Control & Prevent, 4770 Buford Hwy NE,Mailstop F-74, Atlanta, GA 30341 USA.
EM LMWilliams@cdc.gov
CR Berenson AB, 2017, AM J TROP MED HYG, V97, P155, DOI 10.4269/ajtmh.17-0062
   Centers for Disease Control and Prevention, CDC ISS INT TRAV GUI
   Centers for Disease Control and Prevention, PRAMS ZIK SUPPL 2016
   Guo Fangjian, 2017, Prev Med Rep, V7, P26, DOI 10.1016/j.pmedr.2017.05.003
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shulman HB, 2018, AM J PUBLIC HEALTH, V108, P1305, DOI 10.2105/AJPH.2018.304563
NR 10
TC 0
Z9 0
U1 1
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2020
VL 26
IS 5
BP 998
EP 1001
DI 10.3201/eid2605.190727
PG 4
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LI2II
UT WOS:000529306800022
PM 32310074
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sell, TK
   Watson, C
   Meyer, D
   Snyder, MR
   Ravi, SJ
   McGinty, EE
   Pechta, LE
   Rose, DA
   Podgornik, MN
   Lubell, KM
AF Sell, Tara Kirk
   Watson, Crystal
   Meyer, Diane
   Snyder, Michael R.
   Ravi, Sanjana J.
   McGinty, Emma E.
   Pechta, Laura E.
   Rose, Dale A.
   Podgornik, Michelle N.
   Lubell, Keri M.
TI Zika Inquiries Made to the CDC-INFO System, December 2015-September 2017
SO EMERGING INFECTIOUS DISEASES
LA English
DT Letter
AB We examined Zika-related inquiries to CDC-INFO, the national contact center for the Centers for Disease Control and Prevention, to identify potential communication gaps. The most frequently asked questions related to travel or geographic location of Zika (42% of all inquiries), information about laboratory testing (13%), or acquiring a Zika test (11%).
C1 [Sell, Tara Kirk] Johns Hopkins Bloomberg Sch Publ Hlth, Johns Hopkins Ctr Hlth Secur, Baltimore, MD USA.
   [Sell, Tara Kirk] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA.
   [Watson, Crystal; Meyer, Diane; Snyder, Michael R.; Ravi, Sanjana J.; McGinty, Emma E.] Johns Hopkins Bloomberg Sch Publ Hlth, 621 East Pratt St,Ste 210, Baltimore, MD 21202 USA.
   [Pechta, Laura E.; Rose, Dale A.; Podgornik, Michelle N.; Lubell, Keri M.] Ctr Dis Control & Prevent, Atlanta, GA USA.
RP Sell, TK (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, 621 East Pratt St,Ste 210, Baltimore, MD 21202 USA.
EM tksell@jhu.edu
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [200-2016-92378]
FX This research was supported by CDC contract #200-2016-92378
CR Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Slaughter L, 2005, J BIOMED INFORM, V38, P298, DOI 10.1016/j.jbi.2004.12.006
   US Centers for Disease Control and Prevention, 2016 CAS COUNTS US
   US Centers for Disease Control and Prevention, 2017 CAS COUNTS US
NR 4
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD MAY
PY 2020
VL 26
IS 5
BP 1022
EP 1024
DI 10.3201/eid2605.181694
PG 3
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LI2II
UT WOS:000529306800028
PM 32310059
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Guo, XX
   Li, CX
   Deng, YQ
   Jiang, YT
   Sun, AJ
   Liu, QM
   Dong, YD
   Xing, D
   Cao, WC
   Qin, CF
   Zhao, TY
AF Guo, Xiaoxia
   Li, Chunxiao
   Deng, Yongqiang
   Jiang, Yuting
   Sun, Aijuan
   Liu, Qinmei
   Dong, Yande
   Xing, Dan
   Cao, Wuchun
   Qin, Chengfeng
   Zhao, Tongyan
TI Vector Competence and Vertical Transmission of Zika Virus in Aedes
   albopictus (Diptera: Culicidae)
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE ZIKV; vector competence; Aedes albopictus; vertical transmission
ID GENOMIC CHARACTERIZATION; GEOGRAPHIC STRAINS; AEGYPTI MOSQUITOS;
   YELLOW-FEVER; SUSCEPTIBILITY; INFECTION
AB Zika virus (ZIKV) is an emerging mosquito-borne pathogen belonging to the genus Flavivirus of the family Flaviviridae. Aedes albopictus is widely distributed in China. However, little is known about the vector competence of Ae. albopictus in China. The present study presents the oral susceptibility and vector competence of Ae. albopictus Guangzhou strain to ZIKV. Additionally, vertical transmission of ZIKV is described. The results demonstrated the susceptibility of local Ae. albopictus mosquitoes to ZIKV with an extrinsic incubation period of 6 days. Disseminated infection was observed in Ae. albopictus starting on day 2 postinfection (PI). Starting on day 6 PI, the saliva of Ae. albopictus exhibited ZIKV infection, and the transmission rate was 36.4%. Vertical transmission was observed during the first gonotrophic cycle. The minimum infection rate was observed in third-to-fourth instar larvae.
C1 [Guo, Xiaoxia; Li, Chunxiao; Jiang, Yuting; Sun, Aijuan; Liu, Qinmei; Dong, Yande; Xing, Dan; Zhao, Tongyan] Inst Microbiol & Epidemiol, Dept Vector Biol & Control, Beijing Key Lab Vector Borne & Nat Focus Infect D, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Deng, Yongqiang; Qin, Chengfeng] Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Cao, Wuchun] Inst Microbiol & Epidemiol, Dept Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
RP Qin, CF (corresponding author), Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.; Zhao, TY (corresponding author), Inst Microbiol & Epidemiol, Dept Vector Biol & Control, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
EM chengfeng_qin@126.com; tongyanzhao@126.com
FU Infective Diseases Prevention and Cure Project of China [2017ZX
   1000303404]; National Key Technology Support ProgramNational Key
   Technology R&D Program [2014BAI13B01]; Zika Prevention and Control
   Project of China
FX This work was funded by grants from the Infective Diseases Prevention
   and Cure Project of China (no. 2017ZX 1000303404), the National Key
   Technology Support Program (no. 2014BAI13B01), and the Zika Prevention
   and Control Project of China.
CR Akoua-Koffi C, 2001, B SOC PATHOL EXOT, V94, P227
   Anderson JF, 2012, AM J TROP MED HYG, V86, P134, DOI 10.4269/ajtmh.2012.11-0473
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   BOORMAN J. P. T., 1956, TRANS ROY SOC TROP MED AND HYG, V50, P238, DOI 10.1016/0035-9203(56)90029-3
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   CORNET M, 1979, Cahiers O.R.S.T.O.M. (Office de la Recherche Scientifique et Technique Outre-Mer) Serie Entomologie Medicale et Parasitologie, V17, P47
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Diallo D, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001649
   Diallo M, 2003, EMERG INFECT DIS, V9, P362, DOI 10.3201/eid0903.020219
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kramer LD, 2003, ADV VIRUS RES, V60, P187, DOI 10.1016/S0065-3527(03)60006-0
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lambrechts L, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-160
   Lu BL, 1990, VECTOR DENGUE FEVER
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mavale M, 2010, AM J TROP MED HYG, V83, P1242, DOI 10.4269/ajtmh.2010.09-0577
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
NR 33
TC 0
Z9 0
U1 5
U2 5
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD MAY 1
PY 2020
VL 20
IS 5
BP 374
EP 379
DI 10.1089/vbz.2019.2492
PG 6
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA LI7SP
UT WOS:000529681000007
PM 31934825
DA 2020-07-08
ER

PT J
AU Evans, AS
   Lenneman, NJ
   Coyne, CB
AF Evans, Azia S.
   Lenneman, Nicholas J.
   Coyne, Carolyn B.
TI BPIFB3 Regulates Endoplasmic Reticulum Morphology To Facilitate
   Flavivirus Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE BPIFB3; autophagy; flavivirus; reticulophagy; viral membrane
   manipulation; viral replication
ID DENGUE VIRUS; VIRAL REPLICATION; AUTOPHAGY; INFECTION; PROTEINS;
   PATHWAY; DEGRADATION; INHIBITION; TURNOVER; CELLS
AB Flaviviruses, including dengue virus (DENV) and Zika virus (ZIKV), rely heavily on the availability of endoplasmic reticulum (ER) membranes throughout their life cycle, and degradation of ER membranes restricts flavivirus replication. Accordingly, DENV and ZIKV restrict ER turnover by protease-mediated cleavage of reticulophagy regulator 1 (RETREG1), also known as FAM134B, an autophagy receptor responsible for targeted ER sheet degradation. Given that the induction of autophagy may play an important role in flavivirus replication, the antiviral role of RETREG1 suggests that specialized autophagic pathways may have differential effects on the flavivirus life cycle. We previously identified BPI fold-containing family B member 3 (BPIFB3) as a regulator of autophagy that negatively controls enterovirus replication. Here, we show that in contrast to enteroviruses, BPIFB3 functions as a positive regulator of DENV and ZIKV infection and that its RNA interference-mediated silencing inhibits the formation of viral replication organelles. Mechanistically, we show that depletion of BPIFB3 enhances RETREG1-dependent reticulophagy, leading to enhanced ER turnover and the suppression of viral replication. Consistent with this, the antiviral effects of BPIFB3 depletion can be reversed by RETREG1 silencing, suggesting a specific role for BPIFB3 in regulating ER turnover. These studies define BPIFB3 as a required host factor for both DENV and ZIKV replication and further contribute to our understanding of the requirements for autophagy during flavivirus infection.
   IMPORTANCE Flaviviruses and other arthropod-transmitted viruses represent a wide-spread global health problem, with limited treatment options currently available. Thus, a better understanding of the cellular requirements for their infection is needed. Both DENV and ZIKV rely on expansion of the endoplasmic reticulum (ER) and the induction of autophagy to establish productive infections. However, little is known regarding the interplay between the requirements for autophagy initiation during infection and the mechanisms used by these viruses to avoid clearance through the autophagic pathway. Our study highlights the importance of the host factor BPIFB3 in regulating flavivirus replication and further confirms that the RETREG1-dependent reticulophagy pathway is antiviral to both DENV and ZIKV.
C1 [Evans, Azia S.; Lenneman, Nicholas J.; Coyne, Carolyn B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.
   [Evans, Azia S.; Lenneman, Nicholas J.; Coyne, Carolyn B.] UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.
   [Coyne, Carolyn B.] UPMC, Childrens Hosp Pittsburgh, Richard K Mellon Inst Pediat Res, Pittsburgh, PA 15224 USA.
RP Coyne, CB (corresponding author), Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA.; Coyne, CB (corresponding author), UPMC, Childrens Hosp Pittsburgh, Ctr Microbial Pathogenesis, Pittsburgh, PA 15224 USA.; Coyne, CB (corresponding author), UPMC, Childrens Hosp Pittsburgh, Richard K Mellon Inst Pediat Res, Pittsburgh, PA 15224 USA.
EM coynec2@pitt.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01-AI081759, T32-AI049820]; Burroughs
   Wellcome Investigators in the Pathogenesis of Infectious Disease
   AwardBurroughs Wellcome Fund; Children's Hospital of Pittsburgh of the
   UPMC Health System
FX This project was supported by NIH R01-AI081759 (C.B.C.), NIH
   T32-AI049820 (A.S.E.), a Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease Award (C.B.C), and the Children's
   Hospital of Pittsburgh of the UPMC Health System (C.B.C.).
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bento CF, 2016, ANNU REV BIOCHEM, V85, P685, DOI 10.1146/annurev-biochem-060815-014556
   Bingle CD, 2004, PROTEIN SCI, V13, P422, DOI 10.1110/ps.03332704
   Bingle CD, 2002, HUM MOL GENET, V11, P937, DOI 10.1093/hmg/11.8.937
   Bingle CD, 2011, BIOCHEM SOC T, V39, P977, DOI 10.1042/BST0390977
   Bramley JC, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00206-17
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035
   Datan E, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.409
   Delorme-Axford E, 2014, MBIO, V5, DOI 10.1128/mBio.02147-14
   Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110
   Dykstra KM, 2010, MOL BIOL CELL, V21, P1556, DOI 10.1091/mbc.E09-12-1002
   Fang YT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110655
   Fumagalli F, 2016, NAT CELL BIOL, V18, P1173, DOI 10.1038/ncb3423
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555
   Harris KG, 2015, CELL HOST MICROBE, V18, P221, DOI 10.1016/j.chom.2015.07.007
   Heaton NS, 2010, P NATL ACAD SCI USA, V107, P17345, DOI 10.1073/pnas.1010811107
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kemball CC, 2010, J VIROL, V84, P12110, DOI 10.1128/JVI.01417-10
   Khaminets A, 2015, NATURE, V522, P354, DOI 10.1038/nature14498
   Kirkegaard K, 2009, CURR TOP MICROBIOL, V335, P323, DOI 10.1007/978-3-642-00302-8_16
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Morosky S, 2016, J VIROL, V90, P5098, DOI 10.1128/JVI.00170-16
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Pena J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038202
   Schuck S, 2014, J CELL SCI, V127, P4078, DOI 10.1242/jcs.154716
   Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406
   Stolz A, 2019, FEBS J, V286, P4642, DOI 10.1111/febs.15031
   Wang S, 2016, ELIFE, V5, DOI 10.7554/eLife.14211
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wong J, 2008, J VIROL, V82, P9143, DOI 10.1128/JVI.00641-08
   Wu H, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050131
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
NR 47
TC 1
Z9 1
U1 4
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2020
VL 94
IS 9
AR e00029-20
DI 10.1128/JVI.00029-20
PG 13
WC Virology
SC Virology
GA LF4BF
UT WOS:000527363300014
PM 32102874
DA 2020-07-08
ER

PT J
AU Martinez, LE
   Garcia, G
   Contreras, D
   Gong, DY
   Sun, R
   Arumugaswami, V
AF Martinez, Laura E.
   Garcia, Gustavo, Jr.
   Contreras, Deisy
   Gong, Danyang
   Sun, Ren
   Arumugaswami, Vaithilingaraja
TI Zika Virus Mucosal Infection Provides Protective Immunity
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Zika virus; immunization; rectal infection
ID MALE SEXUAL TRANSMISSION; RECTAL IMMUNIZATION; UNITED-STATES; SEMEN;
   GLYCOSYLATION; RESPONSES; INFANTS; BRAZIL; MODEL; MICE
AB Zika virus (ZIKV) is a major human pathogen. ZIKV can replicate in female and male reproductive organs, thus facilitating the human-human transmission cycle. Viral shedding in the semen can increase the risk of ZIKV transmission through sexual mode. Therefore, the vaginal and anorectal mucosa are relevant sites for ZIKV infection. However, the pathobiology of ZIKV transmission through the rectal route is not well understood. Here, we utilize a mouse model system to investigate the immunopathological consequences following ZIKV infection of the rectal mucosa compared to a subcutaneous route of infection. We show that ZIKV-rectal inoculation results in viremia with subclinical infection. ZIKV infects the mucosal epithelium and submucosal dendritic cells, inducing immune and inflammatory cell infiltration. Rectal transmission of ZIKV resulted in the generation of serum-neutralizing antibody responses. Mass cytometry analyses of splenocytes showed a significantly reduced level of inflammatory monocyte and neutrophil cellular responses in the rectal route group. Furthermore, immunological priming through the rectal mucosa with an attenuated ZIKV strain resulted in significant protection from lethal subcutaneous ZIKV challenge, further eliciting robust memory CD4-positive (CD4(+)) and CD8(+) T-cell and ZIKV-specific serum-neutralizing antibody responses. Thus, our study provides deeper immunopathobiological insights on rectal transmission and highlights a rational strategy for mucosal immunization. This model system recapitulates clinical aspects of human ZIKV disease outcome, where most infections are well controlled and result in subclinical and asymptomatic outcomes.
   IMPORTANCE Zika virus is a clinically significant human pathogen that is primarily transmitted and spread by Aedes species mosquitoes but is also sexually transmissible. The recent pandemic in the Americas led to an unprecedented increase of newborn babies with developmental brain and eye abnormalities. To date, there is no licensed vaccine or therapeutic intervention available for the fight against ZIKV. Understanding the sexual transmission of ZIKV through vaginal and rectal routes is necessary to restrict virus transmission and spread. This study examines the early immunological and pathological consequences of rectal and subcutaneous routes of ZIKV infection using a mouse model. We characterized the primary target cells of ZIKV infection and the subsequent mucosal immune responses to infection, and we demonstrate the protective effect of mucosal rectal immunization using an attenuated ZIKV strain. This mucosal vaccination approach can be further developed to prevent future ZIKV outbreaks.
C1 [Martinez, Laura E.; Garcia, Gustavo, Jr.; Gong, Danyang; Sun, Ren; Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Contreras, Deisy; Arumugaswami, Vaithilingaraja] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.
   [Sun, Ren] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.
RP Arumugaswami, V (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Arumugaswami, V (corresponding author), Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.; Arumugaswami, V (corresponding author), Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA.
EM VArumugaswami@mednet.ucla.edu
OI Garcia Jr, Gustavo/0000-0002-1649-9251
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [P30 CA016042, 5P30
   AI028697]; JCCC; David Geffen School of Medicine at UCLA; UCLA
   Chancellor's Office; UCLA AIDS Institute; California Institute for
   Regenerative Medicine (CIRM) Quest-Discovery Stage Research Projects
   Grant [DISC2-10188]; UCLA Interdisciplinary Postdoctoral Training Grant
   (T32) in Virology and Gene Therapy [5T32AI060567-14]; Cedars-Sinai
   Medical Center's Institutional Research Award; UCLA Vice Chancellor's
   Office of Research
FX Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer
   Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility,
   which are supported by the National Institutes of Health awards P30
   CA016042 and 5P30 AI028697, and by the JCCC, the UCLA AIDS Institute,
   the David Geffen School of Medicine at UCLA, the UCLA Chancellor's
   Office, and the UCLA Vice Chancellor's Office of Research. T his
   research was funded by Cedars-Sinai Medical Center's Institutional
   Research Award to V.A., the California Institute for Regenerative
   Medicine (CIRM) Quest-Discovery Stage Research Projects Grant
   (DISC2-10188) to V.A. at UCLA, and the UCLA Interdisciplinary
   Postdoctoral Training Grant (T32) in Virology and Gene Therapy to L.E.M.
   (5T32AI060567-14).
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Botto-Menezes CHA, 2019, EMERG INFECT DIS, V25, P951, DOI 10.3201/eid2505.180904
   Atkinson B, 2017, EMERG INFECT DIS, V23, P611, DOI 10.3201/eid2304.161692
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Chiang N, 2017, J IMMUNOL, V198, P842, DOI 10.4049/jimmunol.1601650
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Davidson A, 2016, MMWR-MORBID MORTAL W, V65, P716, DOI 10.15585/mmwr.mm6528e2
   Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3
   Duggal NK, 2017, CELL REP, V18, P1751, DOI 10.1016/j.celrep.2017.01.056
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Garcia G, 2020, AM J PATHOL, V190, P844, DOI 10.1016/j.ajpath.2019.12.005
   Gaskell KM, 2017, EMERG INFECT DIS, V23, P137, DOI 10.3201/eid2301.161300
   Gong DY, 2018, ISCIENCE, V1, P97, DOI 10.1016/j.isci.2018.02.005
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Haddow AD, 2017, EMERG INFECT DIS, V23, P1274, DOI 10.3201/eid2308.170036
   Harrower J, 2016, EMERG INFECT DIS, V22, P1855, DOI 10.3201/eid2210.160951
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Khan S, 2016, J EXP MED, V213, P2913, DOI 10.1084/jem.20161289
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li CH, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0211-1
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   McDonald EM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005990
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mitchell LA, 2003, VACCINE, V21, P1527, DOI 10.1016/S0264-410X(02)00699-0
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   O'Connor MA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05826-w
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Parez N, 2006, J VIROL, V80, P1752, DOI 10.1128/JVI.80.4.1752-1761.2006
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Thaker SK, 2019, CELL METAB, V29, P1206, DOI 10.1016/j.cmet.2019.01.024
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
NR 48
TC 0
Z9 0
U1 4
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAY
PY 2020
VL 94
IS 9
AR e00067-20
DI 10.1128/JVI.00067-20
PG 18
WC Virology
SC Virology
GA LF4BF
UT WOS:000527363300023
PM 32051274
DA 2020-07-08
ER

PT J
AU Yang, SNY
   Atkinson, SC
   Wang, CX
   Lee, A
   Bogoyevitch, MA
   Borg, NA
   Jans, DA
AF Yang, Sundy N. Y.
   Atkinson, Sarah C.
   Wang, Chunxiao
   Lee, Alexander
   Bogoyevitch, Marie A.
   Borg, Natalie A.
   Jans, David A.
TI The broad spectrum antiviral ivermectin targets the host nuclear
   transport importin alpha/beta 1 heterodimer
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Flavivirus; Nuclear transport inhibitors; Importins; Viral infection;
   West nile virus; Dengue virus; Zika virus
ID NONSTRUCTURAL PROTEIN 5; LOCALIZATION SEQUENCE; STRUCTURAL BASIS; CAPSID
   PROTEIN; GLOBAL BURDEN; INHIBITOR; IDENTIFICATION; PHARMACOKINETICS;
   REPLICATION; TRAFFICKING
AB Infection by RNA viruses such as human immunodeficiency virus (HIV)-1, influenza, and dengue virus (DENV) represent a major burden for human health worldwide. Although RNA viruses replicate in the infected host cell cytoplasm, the nucleus is central to key stages of the infectious cycle of HIV-1 and influenza, and an important target of DENV nonstructural protein 5 (NS5) in limiting the host antiviral response. We previously identified the small molecule ivermectin as an inhibitor of HIV-1 integrase nuclear entry, subsequently showing ivermectin could inhibit DENV NS5 nuclear import, as well as limit infection by viruses such as HIV-1 and DENV. We show here that ivermectin's broad spectrum antiviral activity relates to its ability to target the host importin (IMP)alpha/beta 1 nuclear transport proteins responsible for nuclear entry of cargoes such as integrase and NS5. We establish for the first time that ivermectin can dissociate the preformed IMP alpha/beta 1 heterodimer, as well as prevent its formation, through binding to the IMP alpha armadillo (ARM) repeat domain to impact IMP alpha thermal stability and ahelicity. We show that ivermectin inhibits NS5-IMP alpha interaction in a cell context using quantitative bimolecular fluorescence complementation. Finally, we show for the first time that ivermectin can limit infection by the DENV-related West Nile virus at low (mu M) concentrations. Since it is FDA approved for parasitic indications, ivermectin merits closer consideration as a broad spectrum antiviral of interest.
C1 [Yang, Sundy N. Y.; Wang, Chunxiao; Lee, Alexander; Jans, David A.] Monash Univ, Monash Biomed Discovery Inst, Nucl Signalling Lab, Clayton, Vic 3800, Australia.
   [Yang, Sundy N. Y.; Atkinson, Sarah C.; Wang, Chunxiao; Lee, Alexander; Borg, Natalie A.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.
   [Atkinson, Sarah C.; Borg, Natalie A.] Monash Univ, Monash Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic 3800, Australia.
   [Bogoyevitch, Marie A.] Univ Melbourne, Dept Biochem & Mol Biol, Melbourne, Vic, Australia.
   [Atkinson, Sarah C.; Borg, Natalie A.] RMIT Univ, Sch Hlth & Biomed Sci, Chron Infect & Inflammatory Dis Res, Immun & Immune Evas Lab, Bundoora, Vic 3083, Australia.
RP Jans, DA (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Nucl Signalling Lab, Clayton, Vic 3800, Australia.; Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.
EM David.Jans@monash.edu
FU National Health and Medical Research Council AustraliaNational Health
   and Medical Research Council of Australia [APP1002486/APP1103050,
   APP1043511, APP1117470, APP1072267]; Australian Research
   CouncilAustralian Research Council [110100223]
FX The authors acknowledge the financial support of the National Health and
   Medical Research Council Australia (Senior Principal Research Fellowship
   APP1002486/APP1103050; Project grant APP1043511; Development grant
   APP1117470; Early Career Fellowship APP1072267) and Australian Research
   Council (Future Fellowship #110100223). The Monash Micro Imaging
   Facility (Clayton) is also acknowledged.
CR Alvarez-Garcia D, 2014, J MED CHEM, V57, P8530, DOI 10.1021/jm5010418
   Atkinson SC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18742-8
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Caly L, 2012, ANTIVIR RES, V95, P202, DOI 10.1016/j.antiviral.2012.06.008
   Canga AG, 2008, AAPS J, V10, P42, DOI 10.1208/s12248-007-9000-9
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Giovannoni F, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00284
   Gotz V., 2016, SCI REP, V6, DOI [10.1038/srep25428, DOI 10.1038/SREP25428.]
   Gras S, 2012, J IMMUNOL, V188, P311, DOI 10.4049/jimmunol.1102686
   Guzzo CA, 2002, J CLIN PHARMACOL, V42, P1122, DOI 10.1177/009127002401382731
   Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3
   Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191
   Jans DA, 2019, CURR OPIN CELL BIOL, V58, P50, DOI 10.1016/j.ceb.2019.01.001
   Jans DA, 2018, ADV EXP MED BIOL, V1062, P199, DOI 10.1007/978-981-10-8727-1_15
   Ji W, 2020, VIROLOGY, V541, P124, DOI 10.1016/j.virol.2019.10.010
   Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842
   Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625
   Kodama Y, 2010, BIOTECHNIQUES, V49, P793, DOI 10.2144/000113519
   Kosyna FK, 2015, BIOL CHEM, V396, P1357, DOI 10.1515/hsz-2015-0171
   LAUE TM, 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1
   Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031
   Lopez-Denman AJ, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12848
   Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Munoz J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006020
   MUNOZ V, 1995, PROTEIN SCI, V4, P1577, DOI 10.1002/pro.5560040816
   Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9
   Ng IHW, 2019, ACS INFECT DIS, V5, P932, DOI 10.1021/acsinfecdis.8b00373
   Ortblad KF, 2013, AIDS, V27, P2003, DOI 10.1097/QAD.0b013e328362ba67
   PATEL LR, 1994, P NATL ACAD SCI USA, V91, P7360, DOI 10.1073/pnas.91.15.7360
   Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x
   Rawlinson SM, 2009, J BIOL CHEM, V284, P15589, DOI 10.1074/jbc.M808271200
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Shechter S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17672-9
   Shyu YJ, 2006, BIOTECHNIQUES, V40, P61, DOI 10.2144/000112036
   Tan MJA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121519
   Tay MYF, 2013, ANTIVIR RES, V99, P301, DOI 10.1016/j.antiviral.2013.06.002
   Thomas DR, 2018, ANTIVIR RES, V151, P8, DOI 10.1016/j.antiviral.2018.01.007
   van der Watt PJ, 2016, MOL CANCER THER, V15, P560, DOI 10.1158/1535-7163.MCT-15-0052
   VIHINEN M, 1987, PROTEIN ENG, V1, P477, DOI 10.1093/protein/1.6.477
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wagstaff KM, 2011, J BIOMOL SCREEN, V16, P192, DOI 10.1177/1087057110390360
   Wang CX, 2017, BIOCHEM BIOPH RES CO, V493, P1555, DOI 10.1016/j.bbrc.2017.10.016
   Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191
   Xu TL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006934
   Yang SNY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030281
   Zachariae U, 2008, STRUCTURE, V16, P906, DOI 10.1016/j.str.2008.03.007
NR 52
TC 6
Z9 6
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAY
PY 2020
VL 177
AR 104760
DI 10.1016/j.antiviral.2020.104760
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA LE0KB
UT WOS:000526412700009
PM 32135219
DA 2020-07-08
ER

PT J
AU Pereira, AA
   Pereira, RHM
   da Silva, NCS
   Malta, LGF
   Serravite, AM
   de Almeida, CGC
   Fujiwara, RT
   Bartholomeu, DC
   Giunchetti, RC
   Pessoa, GCD
   Koerich, LB
   Pereira, MH
   Araujo, RN
   Gontijo, ND
   Sant'Anna, MRV
AF Pereira-Filho, Adalberto Alves
   Mateus Pereira, Rafael Henrique
   Sales da Silva, Naylene Carvalho
   Ferreira Malta, Luccas Gabriel
   Serravite, Artur Metzker
   Carvalho de Almeida, Caio Gabriel
   Fujiwara, Ricardo Toshio
   Bartholomeu, Daniella Castanheira
   Giunchetti, Rodolfo Cordeiro
   D'Avila Pessoa, Grasielle Caldas
   Koerich, Leonardo Barbosa
   Pereira, Marcos Horacio
   Araujo, Ricardo Nascimento
   Gontijo, Nelder de Figueiredo
   Viana Sant'Anna, Mauricio Roberto
TI The gut anti-complement activity of Aedes aegypti: Investigating new
   ways to control the major human arboviruses vector in the Americas
SO INSECT BIOCHEMISTRY AND MOLECULAR BIOLOGY
LA English
DT Article
DE Aedes aegypti; Human complement; Gut; Classical pathway; Factor H; C4
   cleavage
ID FACTOR-H-BINDING; ARTHROPOD SALIVA; PROTEIN; SYSTEM; INHIBITION;
   EXPRESSION; MOSQUITO; TICK
AB Aedes aegypti is the main urban vector of dengue virus, chikungunya virus and Zika virus due to its great dispersal capacity and virus susceptibility. A. aegypti feed on plant-derived sugars but females need a blood meal for egg maturation. Haematophagous arthropods need to overcome host haemostasis and local immune reactions in order to take a blood meal. In this context, molecules present in the saliva and/or intestinal contents of these arthropods must contain inhibitors of the complement system (CS). CS salivary and/or intestinal inhibitors are crucial to protect gut cells of haematophagous arthropods against complement attack. The present work aimed to investigate the anti-complement activity of A. aegypti intestinal contents on the alternative, classical and lectin pathways of the human complement system. Here we show that A. aegypti gut contents inhibited the human classical and the lectin pathways but not the alternative pathway. The A. aegypti gut content has a serine protease able to specifically cleave and inactivate human C4, which is a novel mechanism for human complement inactivation in haematophagous arthropods. The gut of female A. aegypti was capable of capturing human serum factor H (a negative complement modulator), unlike males. C3 molecules in recently blood-fed female A. aegypti remain in their original state, being inactivated to iC3b soon after a blood feed. A transmission-blocking vaccine using these complement inhibitory proteins as antigens has the potential to interfere with the insect's survival, reproductive fitness and block their infection by the arboviruses they transmit to humans.
C1 [Pereira-Filho, Adalberto Alves; Mateus Pereira, Rafael Henrique; Sales da Silva, Naylene Carvalho; Ferreira Malta, Luccas Gabriel; Serravite, Artur Metzker; Carvalho de Almeida, Caio Gabriel; D'Avila Pessoa, Grasielle Caldas; Koerich, Leonardo Barbosa; Pereira, Marcos Horacio; Araujo, Ricardo Nascimento; Gontijo, Nelder de Figueiredo; Viana Sant'Anna, Mauricio Roberto] Fed Univ Minas Gerais UFMG, Biol Sci Inst, Dept Parasitol, Physiol Haematophagous Insects Lab, Belo Horizonte, MG, Brazil.
   [Fujiwara, Ricardo Toshio; Bartholomeu, Daniella Castanheira] Fed Univ Minas Gerais UFMG, Biol Sci Inst, Dept Parasitol, Lab Immunol & Genom Parasites, Belo Horizonte, MG, Brazil.
   [Giunchetti, Rodolfo Cordeiro] Fed Univ Minas Gerais UFMG, Biol Sci Inst, Morphol Dept, Lab Cell Cell Interact, Belo Horizonte, MG, Brazil.
   [Sales da Silva, Naylene Carvalho] Univ Fed Maranhao, Dept Patol, Sao Luis, Maranhao, Brazil.
RP Sant'Anna, MRV (corresponding author), Fed Univ Minas Gerais UFMG, Biol Sci Inst, Dept Parasitol, Physiol Haematophagous Insects Lab, Belo Horizonte, MG, Brazil.
EM mrvsantanna@gmail.com
RI Fujiwara, Ricardo/J-7579-2012
OI Fujiwara, Ricardo/0000-0002-4713-575X; Henrique Mateus Pereira,
   Rafael/0000-0002-3668-2889; Metzker Serravite, Artur/0000-0001-9556-8042
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [440724/2016-3, 426392/2018-3, 306560/2016-0]; CAPES, INCT-Molecular
   Entomology and Pro-Reitoria de Pesquisa, Universidade Federal de Minas
   Gerais [88887.130709/2016-00]
FX The authors would like to thank Cesar Nonato de Oliveira for technical
   assistance. This work is funded by the CNPq grant #426392/2018-3
   (Universal), CNPq grant #440724/2016-3 and CAPES grant
   #88887.130709/2016-00 (Prevencao e Combate ao virus Zika),
   INCT-Molecular Entomology and Pro-Reitoria de Pesquisa, Universidade
   Federal de Minas Gerais. MRVS is funded by a CNPq Grant #306560/2016-0.
CR Andrade BB, 2005, AN ACAD BRAS CIENC, V77, P665, DOI 10.1590/S0001-37652005000400008
   Barrington R, 2001, IMMUNOL REV, V180, P5, DOI 10.1034/j.1600-065X.2001.1800101.x
   Barros VC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006047
   Brackney DE, 2010, J INSECT PHYSIOL, V56, P736, DOI 10.1016/j.jinsphys.2010.01.003
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Carvalho FD, 2017, NEOTROP ENTOMOL, V46, P243, DOI 10.1007/s13744-017-0520-4
   Cavalcante RR, 2003, PARASITOLOGY, V127, P87, DOI 10.1017/S0031182003003329
   Colomb MG, 1996, RES IMMUNOL, V147, P75, DOI 10.1016/0923-2494(96)87177-X
   Couvreur B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001400
   Daix V, 2007, INSECT MOL BIOL, V16, P155, DOI 10.1111/j.1365-2583.2006.00710.x
   Dempsey P.W., 1985, SCIENCE, V675, P150
   Dieterich R, 2010, INFECT IMMUN, V78, P4467, DOI 10.1128/IAI.00138-10
   Ferreira VP, 2016, SCI REP-UK, V6, DOI 10.1038/srep19300
   Franco PF, 2016, EXP PARASITOL, V164, P91, DOI 10.1016/j.exppara.2016.03.002
   Gillespie RD, 2000, PARASITE IMMUNOL, V22, P319, DOI 10.1046/j.1365-3024.2000.00309.x
   Gillet L, 2009, VET RES, V40, DOI 10.1051/vetres/2009034
   Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009
   Hacl A, 2017, J FORENSIC RADIOL IM, V11, P1, DOI 10.1016/j.jofri.2017.08.004
   Khattab A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003513
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Magalhaes T, 2008, ARCH INSECT BIOCHEM, V68, P134, DOI 10.1002/arch.20238
   Malito E, 2013, P NATL ACAD SCI USA, V110, P3304, DOI 10.1073/pnas.1222845110
   Margos G, 2001, INFECT IMMUN, V69, P5064, DOI 10.1128/IAI.69.8.5064-5071.2001
   MARINOTTI O, 1990, J INSECT PHYSIOL, V36, P545, DOI 10.1016/0022-1910(90)90021-7
   Mendes-Sousa AF, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01065
   Mendes-Sousa AF, 2018, INSECT BIOCHEM MOLEC, V92, P12, DOI 10.1016/j.ibmb.2017.11.004
   Mika A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040489
   Miller DP, 2011, ACTA CRYSTALLOGR F, V67, P678, DOI 10.1107/S1744309111011298
   Nikbakhtzadeh MR, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00004
   Oktarianti R, 2015, J INFECT PUBLIC HEAL, V8, P575, DOI 10.1016/j.jiph.2015.04.022
   Ooi CP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003448
   Rashid A., 2019, J MED ENTOMOL, V56, P1
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812
   RIBEIRO JMC, 1995, INFECT AGENT DIS, V4, P143
   Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923
   Sanchez-Corral P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01607
   Silva NCS, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1726-8
   Simon N, 2018, VACCINE, V36, P1545, DOI 10.1016/j.vaccine.2018.01.080
   Titus R.G., 2006, PARASITE IMMUNOL, DOI [10.1111/j.1365-3024.2006, DOI 10.1111/J.1365-3024.2006]
   Tyson K, 2007, INSECT MOL BIOL, V16, P469, DOI 10.1111/j.1365-2583.2007.00742.x
   Valenzuela JG, 2000, J BIOL CHEM, V275, P18717, DOI 10.1074/jbc.M001486200
   Villiers MB, 1999, IMMUNOPHARMACOLOGY, V42, P151, DOI 10.1016/S0162-3109(99)00017-X
   Wikel SK, 2001, VET PARASITOL, V101, P275, DOI 10.1016/S0304-4017(01)00556-8
NR 44
TC 0
Z9 0
U1 2
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0965-1748
EI 1879-0240
J9 INSECT BIOCHEM MOLEC
JI Insect Biochem. Mol. Biol.
PD MAY
PY 2020
VL 120
AR 103338
DI 10.1016/j.ibmb.2020.103338
PG 12
WC Biochemistry & Molecular Biology; Entomology
SC Biochemistry & Molecular Biology; Entomology
GA LD1XV
UT WOS:000525825800008
PM 32126277
DA 2020-07-08
ER

PT J
AU Lorenz, C
   Chiaravalloti-Neto, F
   Lage, MD
   Quintanilha, JA
   Parra, MC
   Dibo, MR
   Favaro, EA
   Guirado, MM
   Nogueira, ML
AF Lorenz, Camila
   Chiaravalloti-Neto, Francisco
   Lage, Mariana de Oliveira
   Quintanilha, Jose Alberto
   Parra, Maisa Carla
   Dibo, Margareth Regina
   Favaro, Eliane Aparecida
   Guirado, Marluci Monteiro
   Nogueira, Mauricio Lacerda
TI Remote sensing for risk mapping of Aedes aegypti infestations: Is this a
   practical task?
SO ACTA TROPICA
LA English
DT Article
DE Mosquito control; Bayesian approach; Landscape; Geostatistical analysis
ID MARK-RELEASE-RECAPTURE; DENGUE VECTOR; DIPTERA-CULICIDAE; LARVAL
   HABITATS; PUERTO-RICO; ALBOPICTUS; DISPERSAL; SURVEILLANCE; OVIPOSITION;
   CITY
AB Mosquito-borne diseases affect millions of individuals worldwide; the area of endemic transmission has been increasing due to several factors linked to globalization, urban sprawl, and climate change. The Aedes aegypti mosquito plays a central role in the dissemination of dengue, Zika, chikungunya, and urban yellow fever. Current preventive measures include mosquito control programs; however, identifying high-risk areas for mosquito infestation over a large geographic region based only on field surveys is labor-intensive and time-consuming. Thus, the objective of this study was to assess the potential of remote satellite images (WorldView) for determining land features associated with Ae. aegypti adult infestations in Sao Jose do Rio Preto/SP, Brazil. We used data from 60 adult mosquito traps distributed along four summers; the remote sensing images were classified by land cover types using a supervised classification method. We modeled the number of Ae. aegypti using a Poisson probability distribution with a geostatistical approach. The models were constructed in a Bayesian context using the Integrated nested Laplace Approximations and Stochastic Partial Differential Equation method. We showed that an infestation of Ae. aegypti adult mosquitoes was positively associated with the presence of asbestos roofing and roof slabs. This may be related to several other factors, such as socioeconomic or environmental factors. The usage of asbestos roofing may be more prevalent in socioeconomically poor areas, while roof slabs may retain rainwater and contribute to the generation of temporary mosquito breeding sites. Although preliminary, our results demonstrate the utility of satellite remote sensing in identifying landscape differences in urban environments using a geostatistical approach, and indicated directions for future research. Further analyses including other variables, such as land surface temperature, may reveal more complex relationships between urban mosquito micro-habitats and land cover features.
C1 [Lorenz, Camila; Chiaravalloti-Neto, Francisco] Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Av Dr Arnaldo 715, Sao Paulo, SP, Brazil.
   [Lage, Mariana de Oliveira; Quintanilha, Jose Alberto] Univ Sao Paulo, IEE, Div Cient Gestao Ciencia & Tecnol Ambiental, Sao Paulo, SP, Brazil.
   [Parra, Maisa Carla; Favaro, Eliane Aparecida; Nogueira, Mauricio Lacerda] Fac Med Sao Jose do Rio Preto, Lab Pesquisa Virol, Sao Jose Do Rio Preto, SP, Brazil.
   [Dibo, Margareth Regina] Superintendencia Controle Endemias Estado Sao Paul, Lab Entomol, Sao Paulo, SP, Brazil.
   [Guirado, Marluci Monteiro] Superintendencia Controle Endemias, Lab Vetores, Sao Jose Do Rio Preto, SP, Brazil.
RP Lorenz, C (corresponding author), Univ Sao Paulo, Fac Saude Publ, Dept Epidemiol, Av Dr Arnaldo 715, Sao Paulo, SP, Brazil.
EM camilalorenz@usp.br
RI Lorenz, Camila/C-3635-2019; Nogueira, Mauricio/B-7599-2012;
   Chiaravalloti-Neto, Francisco/F-8006-2012
OI Lorenz, Camila/0000-0003-2121-9063; Quintanilha,
   Jose/0000-0003-3261-7825; Nogueira, Mauricio/0000-0003-1102-2419;
   Chiaravalloti-Neto, Francisco/0000-0003-2686-8740
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2017/10297-1, 2013/21719-3]; CAPESCAPES
   [001]
FX Sao Paulo Research Foundation (FAPESP) grants 2017/10297-1 (C.L.) and
   2013/21719-3 (M.L.N. and F.C.N.). MLN and FCN are CNPq Research Fellow.
   This work was supported by CAPES (Grant #001).
CR Abe M, 2005, TROP MED INT HEALTH, V10, P597, DOI 10.1111/j.1365-3156.2005.01428.x
   Araujo RV, 2015, BRAZ J INFECT DIS, V19, P146, DOI 10.1016/j.bjid.2014.10.004
   Azevedo T.S., 2018, GEOSPAT HLTH, V13
   Barrera R, 2006, J MED ENTOMOL, V43, P484, DOI 10.1603/0022-2585(2006)43[484:EFIAAD]2.0.CO;2
   Bergquist NR, 2001, ACTA TROP, V79, P13, DOI 10.1016/S0001-706X(01)00099-7
   BERMAN DM, 1986, INT J HEALTH SERV, V16, P253, DOI 10.2190/3TGT-UTUF-HNWR-GCPK
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Lazcano JAB, 2006, REV PANAM SALUD PUBL, V19, P379, DOI 10.1590/S1020-49892006000600003
   Blangiardo M, 2015, SPATIAL AND SPATIO-TEMPORAL BAYESIAN MODELS WITH R-INLA, P1, DOI 10.1002/9781118950203
   CALDERONARGUEDA.O, 2004, REV BIOMED, V15, P73
   Cator LJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-84
   Chadee DD, 2004, B ENTOMOL RES, V94, P201, DOI 10.1079/BER2004297
   CHAN YC, 1971, B WORLD HEALTH ORGAN, V44, P651
   Chiaravalloti Neto Francisco, 1997, Revista da Sociedade Brasileira de Medicina Tropical, V30, P279, DOI 10.1590/S0037-86821997000400002
   Chiaravalloti-Neto F, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4074-4
   CONGALTON RG, 1991, REMOTE SENS ENVIRON, V37, P35, DOI 10.1016/0034-4257(91)90048-B
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   Correia Virginia Ragoni de Moraes, 2004, Cad. Saúde Pública, V20, P891, DOI 10.1590/S0102-311X2004000400003
   Costa F, 2017, TRENDS PARASITOL, V33, P660, DOI 10.1016/j.pt.2017.05.010
   Teixeira TRD, 2011, CAD SAUDE PUBLICA, V27, P591, DOI 10.1590/S0102-311X2011000300019
   De La Rocque S, 2004, COMP IMMUNOL MICROB, V27, P331, DOI 10.1016/j.cimid.2004.03.003
   Edman JD, 1998, J MED ENTOMOL, V35, P578, DOI 10.1093/jmedent/35.4.578
   Ferreira AC, 2007, REV SAUDE PUBL, V41, P915, DOI 10.1590/S0034-89102007000600005
   Focks DA, 1997, AM J TROP MED HYG, V56, P159, DOI 10.4269/ajtmh.1997.56.159
   Foody GM, 2002, REMOTE SENS ENVIRON, V80, P185, DOI 10.1016/S0034-4257(01)00295-4
   Forattini O.P., 2002, CULICIDOLOGIA MED ID, V2
   Fuller DO, 2010, INT J REMOTE SENS, V31, P3, DOI 10.1080/01431160902865756
   Getis A, 2003, AM J TROP MED HYG, V69, P494, DOI 10.4269/ajtmh.2003.69.494
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005
   Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012
   LaDeau SL, 2013, INT J ENV RES PUB HE, V10, P1505, DOI 10.3390/ijerph10041505
   Leisnham PT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091655
   Little E, 2017, J MED ENTOMOL, V54, P1183, DOI 10.1093/jme/tjx103
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   MCDONALD PT, 1977, J MED ENTOMOL, V14, P49, DOI 10.1093/jmedent/14.1.49
   Misslin R, 2016, ANN NY ACAD SCI, V1382, P56, DOI 10.1111/nyas.13084
   Moloney JM, 1998, AM J TROP MED HYG, V59, P261, DOI 10.4269/ajtmh.1998.59.261
   MONSERUD RA, 1992, ECOL MODEL, V62, P275, DOI 10.1016/0304-3800(92)90003-W
   Morrison AC, 2004, J MED ENTOMOL, V41, P1123, DOI 10.1603/0022-2585-41.6.1123
   Morrison AC, 1998, AM J TROP MED HYG, V58, P287, DOI 10.4269/ajtmh.1998.58.287
   Muir LE, 1998, AM J TROP MED HYG, V58, P277, DOI 10.4269/ajtmh.1998.58.277
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Mushinzimana E, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-13
   OLIVEIRA RM, 2001, CAD SAUDE PUBLICA S, V17, pS77
   Paupy C, 2010, VECTOR-BORNE ZOONOT, V10, P259, DOI 10.1089/vbz.2009.0005
   Parra MCP, 2018, ACTA TROP, V182, P43, DOI 10.1016/j.actatropica.2018.02.018
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 2007, VECTOR-BORNE ZOONOT, V7, P261, DOI 10.1089/vbz.2006.0630
   RIBEIRO PJ, 2001, R NEWS, V1, P15, DOI DOI 10.1159/000323281
   Roberts DR, 1996, AM J TROP MED HYG, V54, P304, DOI 10.4269/ajtmh.1996.54.304
   Rue H, 2009, J R STAT SOC B, V71, P319, DOI 10.1111/j.1467-9868.2008.00700.x
   Scandar SAS, 2010, B EPIDEMIOL PAUL, V7, P4
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   Service M. W., 1992, Southeast Asian Journal of Tropical Medicine and Public Health, V23, P681
   Souza-Santos R, 2000, Cad Saude Publica, V16, P31, DOI 10.1590/S0102-311X2000000100004
   TINKER MILTON E., 1964, MOSQUITO NEWS, V24, P426
   Troyo A., 2007, THESIS
   TunLin W, 1995, AM J TROP MED HYG, V53, P591, DOI 10.4269/ajtmh.1995.53.591
   Vezzani D, 2004, MEM I OSWALDO CRUZ, V99, P351, DOI 10.1590/S0074-02762004000400002
   WELCH JB, 1989, J AM MOSQUITO CONTR, V5, P147
   WHO, 2016, GLOB VECT CONTR RESP
NR 64
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD MAY
PY 2020
VL 205
AR UNSP 105398
DI 10.1016/j.actatropica.2020.105398
PG 7
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LD1OM
UT WOS:000525801200036
PM 32068030
DA 2020-07-08
ER

PT J
AU Bi, KM
   Chen, YY
   Wu, CH
   Ben-Arieh, D
AF Bi, Kaiming
   Chen, Yuyang
   Wu, Chih-Hang (john)
   Ben-Arieh, David
TI A memetic algorithm for solving optimal control problems of Zika virus
   epidemic with equilibriums and backward bifurcation analysis
SO COMMUNICATIONS IN NONLINEAR SCIENCE AND NUMERICAL SIMULATION
LA English
DT Article
DE Zika virus; Memetic algorithm; Optimal control; Bifurcation analysis;
   Equilibrium
ID SEXUAL TRANSMISSION; OUTBREAK; DYNAMICS; MAXIMUM; DENGUE; MODEL
AB The large-scale outbreak of Zika virus in 2015-2016 attracted global attention. As of January 2018, 137,515 cases of Zika virus were confirmed in the United States and Brazil, and 223,477 cases were confirmed in the world by PAHO and WHO. This paper utilizes an existed mathematics model in the Zika virus, then analyzes the stability and bifurcation by changing the closed population system to an open system. Moreover, this paper establishes an optimal control problem associated with the open population system based on several popular disease intervention strategies frequently used by public health agencies to mitigate the Zika epidemics. Comparisons of traditional Pontryagin's maximum principle and a new memetic algorithm are conducted for different intervention strategies. Also, our computational results suggest that continuous optimal control strategies may not be practical in real-world applications. Instead, the memetic algorithm-based discrete is relatively easy to be implemented. Published by Elsevier B.V.
C1 [Bi, Kaiming; Chen, Yuyang; Wu, Chih-Hang (john); Ben-Arieh, David] Kansas State Univ, Dept Ind & Mfg Syst Engn, Manhattan, KS 66506 USA.
RP Wu, CH (corresponding author), Kansas State Univ, Dept Ind & Mfg Syst Engn, Manhattan, KS 66506 USA.
EM chw@ksu.edu
RI Wu, Chih-Hang/C-2518-2015
OI Wu, Chih-Hang/0000-0001-9929-4421
CR Abbink P, 2016, SCIENCE
   Agusto FB, 2017, ECOL COMPLEX, V29, P61, DOI 10.1016/j.ecocom.2016.12.007
   ANDERSON R M, 1991
   Andraud M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049085
   Bearcroft W, 1956, T R SOC TROP MED HYG, V50
   Bi K., 2018, COMPUT IND ENG
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Chen YY, 2019, COMPUT IND ENG, V137, DOI 10.1016/j.cie.2019.106010
   Chen YY, 2017, CHAOS SOLITON FRACT, V104, P531, DOI 10.1016/j.chaos.2017.09.001
   Chikaki E, 2009, J INFECT DEV COUNTR, V3, P711, DOI 10.3855/jidc.616
   Cruz IL, 2002, EFFICIENT EVOLUTIONA
   Medeiros LCD, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000942
   Ding C, 2016, CONTR C CCCC 2016 35
   Diseases N.I.o.A.a.I, 2017, PHASE 2 ZIKA VACCINE
   Dong X, 2016, NATURE, V538, P257, DOI 10.1038/nature19793
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Garba SM, 2008, MATH BIOSCI, V215, P11, DOI 10.1016/j.mbs.2008.05.002
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Isea R., 2016, ARXIV160608233
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kim N, 2011, IEEE T CONTR SYST T, V19, P1279, DOI 10.1109/TCST.2010.2061232
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Lima EP, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-5
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Martinuzzi S, 2007, LANDSCAPE URBAN PLAN, V79, P288, DOI 10.1016/j.landurbplan.2006.02.014
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Medford A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212345
   Mladenovic N, 1997, COMPUT OPER RES, V24, P1097, DOI 10.1016/S0305-0548(97)00031-2
   Moscato P, 1989, CALTECH CONCURRENT C, V826, P1989
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Muthumani K, 2016, NPJ VACCINES, V1, DOI 10.1038/npjvaccines.2016.21
   PAHO P.A.H.O, 2018, PAHO ZIK CUM CAS
   Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11
   Pontryagin L.S., 1987, MATH THEORY OPTIMAL
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Saerens B, 2010, LECT NOTES CONTR INF, V402, P119
   Shah NH, 2017, APPL MATH, V8, P500
   STREKALOVSKY AS, 1995, J GLOBAL OPTIM, V7, P75, DOI 10.1007/BF01100206
   Tchuenche JM, 2011, ACTA BIOTHEOR, V59, P1, DOI 10.1007/s10441-010-9095-8
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Zhao S, 2016, J MATH BIOL, V73, P1525, DOI 10.1007/s00285-016-0999-z
NR 50
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1007-5704
EI 1878-7274
J9 COMMUN NONLINEAR SCI
JI Commun. Nonlinear Sci. Numer. Simul.
PD MAY
PY 2020
VL 84
AR 105176
DI 10.1016/j.cnsns.2020.105176
PG 16
WC Mathematics, Applied; Mathematics, Interdisciplinary Applications;
   Mechanics; Physics, Fluids & Plasmas; Physics, Mathematical
SC Mathematics; Mechanics; Physics
GA KZ9DD
UT WOS:000523556300004
DA 2020-07-08
ER

PT J
AU Yin, Z
   Ramshani, Z
   Waggoner, JJ
   Pinsky, BA
   Senapati, S
   Chang, HC
AF Yin, Ze
   Ramshani, Zeinab
   Waggoner, Jesse J.
   Pinsky, Benjamin A.
   Senapati, Satyajyoti
   Chang, Hsueh-Chia
TI A non-optical multiplexed PCR diagnostic platform for serotype-specific
   detection of dengue virus
SO SENSORS AND ACTUATORS B-CHEMICAL
LA English
DT Article
DE Dengue virus; Electrokinetic; On-chip PCR; Ion selective membrane;
   Multiplexing
ID FIELD-EFFECT TRANSISTOR; DNA; PERSPECTIVES; CHIKUNGUNYA; EXTRACTION;
   ASSAYS; CUBA; ZIKA
AB Viable point-of-care multi-target diagnostics requires single-sample multiplexed detection in a single PCR reactor with non-optical instruments. We report an integrated multiplexed PCR chip platform with a novel ion-selective membrane sensor array that eliminates the key selectivity and sensitivity issues for multiplexed PCR, such as primer dimerization and nonspecific amplification (mis-priming). The depletion action of the ion-selective membrane renders the sensor insensitive to pH and ionic strength variation or non-specific binding, which plague the current electrochemical sensor arrays. We validate the platform with robust, sensitive and selective detection of each of the four dengue virus (DENV) serotypes, even in the presence of misprimed non-target products, with plasma samples spiked with heterogeneous RNA populations that include all the serotypes. The assay time is similar to 90 min with a detection sensitivity of DENV RNA template down to 100 copies per mL. By replacing the optical sensing technology of RT-PCR with the membrane sensor, the platform is scalable and can allow simultaneous screening for multiple viral infections in a single sample within a single PCR reactor chip for point-of-care applications.
C1 [Yin, Ze; Ramshani, Zeinab; Senapati, Satyajyoti; Chang, Hsueh-Chia] Univ Notre Dame, Dept Chem & Biomol Engn, Notre Dame, IN 46556 USA.
   [Waggoner, Jesse J.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Stanford, CA 94305 USA.
RP Senapati, S; Chang, HC (corresponding author), 218 Stinson Remick Hall, Notre Dame, IN 46556 USA.
EM ssenapat@nd.edu; hchang@nd.edu
RI Yin, Ze/W-5285-2019
OI Yin, Ze/0000-0001-9666-7317; Pinsky, Benjamin/0000-0001-8751-4810
FU Far Eastern Group
FX The authors would like to thank the The Far Eastern Group for financial
   support. The authors would also like to thank Dr. Muktha S. Natrajan,
   Emory University for providing the Zika virus strain.
CR [Anonymous], 2014, RECOMMENDED DYE COMB
   Back Anne Tuiskunen, 2013, Infect Ecol Epidemiol, V3, DOI 10.3402/iee.v3i0.19839
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Chang HC, 2012, ANNU REV FLUID MECH, V44, P401, DOI 10.1146/annurev-fluid-120710-101046
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Deng JJ, 2013, SENSORS-BASEL, V13, P7774, DOI 10.3390/s130607774
   Duarte-Guevara C, 2014, ANAL CHEM, V86, P8359, DOI 10.1021/ac501912x
   Gan WP, 2017, ANAL CHEM, V89, P3568, DOI 10.1021/acs.analchem.6b04882
   Gupta E, 2014, INFECT DRUG RESIST, V7, P337, DOI 10.2147/IDR.S55376
   Guzman MG, 2012, INT J INFECT DIS, V16, pE198, DOI 10.1016/j.ijid.2011.09.026
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Guzman MG, 2000, AM J EPIDEMIOL, V152, P793, DOI 10.1093/aje/152.9.793
   Heera K.C., 2016, BIRAT J HLTH SCI, V1, P38, DOI [10.3126/bjhs.v1i1.17095., DOI 10.3126/BJHS.V1I1.17095]
   Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024
   Jangam SR, 2009, J CLIN MICROBIOL, V47, P2363, DOI 10.1128/JCM.r00092-09
   Joob Beuy, 2016, Med J Armed Forces India, V72, P194, DOI 10.1016/j.mjafi.2015.11.015
   Kao Chuan-Liang, 2005, Journal of Microbiology Immunology and Infection, V38, P5
   Kerman K, 2004, MEAS SCI TECHNOL, V15, pR1, DOI 10.1088/0957-0233/15/2/R01
   Lee CS, 2009, SENSORS-BASEL, V9, P7111, DOI 10.3390/s90907111
   Levi JE, 2015, TRANSFUSION, V55, P961, DOI 10.1111/trf.12944
   Loureiro Fernanda C. C. L., 2017, Sensing and Bio-Sensing Research, V13, P96, DOI 10.1016/j.sbsr.2016.10.002
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mustafa M S, 2015, Med J Armed Forces India, V71, P67, DOI 10.1016/j.mjafi.2014.09.011
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Ramshani Z, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0435-1
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Senapati S, 2014, BIOSENS BIOELECTRON, V60, P92, DOI 10.1016/j.bios.2014.04.008
   Shamala Devi Sekaran, 2015, INT MED J MALAYSIA, V14
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Slouka Z, 2014, ANNU REV ANAL CHEM, V7, P317, DOI 10.1146/annurev-anchem-071213-020155
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Stern E, 2007, NANO LETT, V7, P3405, DOI 10.1021/nl071792z
   Suni II, 2008, TRAC-TREND ANAL CHEM, V27, P604, DOI 10.1016/j.trac.2008.03.012
   Takei F, 2018, CHEMISTRYSELECT, V3, P973, DOI 10.1002/slct.201702542
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wang WK, 2003, VIROLOGY, V305, P330, DOI 10.1006/viro.2002.1704
   World Health Organization, 2012, GLOB STRAT DENG PREV, P43
   Yap G, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001046
   Zhang YX, 2006, ANAL BIOCHEM, V356, P161, DOI 10.1016/j.ab.2006.06.036
NR 40
TC 1
Z9 1
U1 17
U2 17
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
EI 0925-4005
J9 SENSOR ACTUAT B-CHEM
JI Sens. Actuator B-Chem.
PD MAY 1
PY 2020
VL 310
AR 127854
DI 10.1016/j.snb.2020.127854
PG 10
WC Chemistry, Analytical; Electrochemistry; Instruments & Instrumentation
SC Chemistry; Electrochemistry; Instruments & Instrumentation
GA KT9BA
UT WOS:000519306300005
DA 2020-07-08
ER

PT J
AU Knot, IE
   Zouganelis, GD
   Weedall, GD
   Wich, SA
   Rae, R
AF Knot, Ineke E.
   Zouganelis, George D.
   Weedall, Gareth D.
   Wich, Serge A.
   Rae, Robbie
TI DNA Barcoding of Nematodes Using the MinION
SO FRONTIERS IN ECOLOGY AND EVOLUTION
LA English
DT Article
DE MinION; DNA barcoding; biomonitoring; 18S (SSU) rRNA gene; Anisakis
   simplex; Panagrellus redivivus; Turbatrix aceti; Caenorhabditis elegans
ID MULTIPLE SEQUENCE ALIGNMENT; TRICHODORIDAE THORNE; IDENTIFICATION;
   GENOME; VIRUS; ZIKA
AB Many nematode species are parasitic and threaten the health of plants and animals, including humans, on a global scale. Advances in DNA sequencing techniques have allowed for the rapid and accurate identification of many organisms including nematodes. However, the steps taken from sample collection in the field to molecular analysis and identification can take many days and depend on access to both immovable equipment and a specialized laboratory. Here, we present a protocol to genetically identify nematodes using 18S SSU rRNA sequencing using the MinION, a portable third generation sequencer, and proof that it is possible to perform all the molecular preparations on a fully portable molecular biology lab - the Bentolab. We show that both parasitic and free-living nematode species (Anisakis simplex, Panagrellus redivivus, Turbatrix aceti, and Caenorhabditis elegans) can be identified with a 96-100% accuracy compared to Sanger sequencing, requiring only 10-15 min of sequencing. This protocol is an essential first step toward genetically identifying nematodes in the field from complex natural environments (such as feces, soil, or marine sediments). This increased accessibility could in turn improve global information of nematode presence and distribution, aiding near-real-time global biomonitoring.
C1 [Knot, Ineke E.; Wich, Serge A.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.
   [Zouganelis, George D.; Weedall, Gareth D.; Wich, Serge A.; Rae, Robbie] Liverpool John Moores Univ, Sch Biol & Environm Sci, Liverpool, Merseyside, England.
RP Knot, IE (corresponding author), Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands.
EM ineke@inekeknot.nl
FU University of Amsterdam
FX This work was financially supported by the WorldWildlife FundNetherlands
   and the University of Amsterdam.
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anderson R. C., 2000, THEIR DEV TRANSMISSI
   Benitez-Paez A, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0111-z
   Bhadury P, 2006, MAR ECOL PROG SER, V320, P1, DOI 10.3354/meps320001
   Bhadury P, 2006, AQUAT MICROB ECOL, V44, P97, DOI 10.3354/ame044097
   Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160
   BRENNER S, 1974, GENETICS, V77, P71
   Bruggemann J, 2012, J WORLD AQUACULT SOC, V43, P739, DOI 10.1111/j.1749-7345.2012.00608.x
   Chai JY, 2005, INT J PARASITOL, V35, P1233, DOI 10.1016/j.ijpara.2005.07.013
   Deamer D, 2016, NAT BIOTECHNOL, V34, P518, DOI 10.1038/nbt.3423
   Decraemer W, 1998, FUND APPL NEMATOL, V21, P37
   Eccles D, 2018, BMC BIOL, V16, DOI 10.1186/s12915-017-0473-4
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Edwards A., 2016, BIORXIV, P1, DOI [10.1101/073965, DOI 10.1101/073965]
   Eisenstein M, 2019, NAT METHODS, V16, P683, DOI 10.1038/s41592-019-0507-7
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fauver JR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55908-y
   Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x
   Floyd RM, 2005, MOL ECOL NOTES, V5, P611, DOI 10.1111/j.1471-8286.2005.01009.x
   Goodwin S, 2016, NAT REV GENET, V17, P333, DOI 10.1038/nrg.2016.49
   Goordial J, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02594
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Heeger F, 2018, MOL ECOL RESOUR, V18, P1500, DOI 10.1111/1755-0998.12937
   Hope WD, 2009, J NEMATOL, V41, P64
   Hunt VL, 2016, NAT GENET, V48, P299, DOI 10.1038/ng.3495
   JAIN M, 2016, GENOME BIOL, V17, P1, DOI DOI 10.1186/s13059-016-1103-0l
   Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009
   Karanastasi E, 2001, NEMATOLOGY, V3, P525, DOI 10.1163/156854101753389130
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Kircher M, 2010, BIOESSAYS, V32, P524, DOI 10.1002/bies.200900181
   Krehenwinkel H, 2019, GENES-BASEL, V10, DOI 10.3390/genes10110858
   Krehenwinkel H, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz006
   Kumar Sujai, 2012, Worm, V1, P42, DOI 10.4161/worm.19046
   Lambshead P. J. D., 2004, NEMATOLOGY ADV PERSP, P1
   Lawton JH, 1998, NATURE, V391, P72, DOI 10.1038/34166
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Maestri S, 2019, GENES-BASEL, V10, DOI 10.3390/genes10060468
   McIntyre ABR, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.35
   Menegon M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184741
   Nature Biotechnology, 2016, BENTO LAB, DOI [10.1038/nbt0516-455, DOI 10.1038/NBT0516-455]
   Oberacker P, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000107
   Pafco B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24126-3
   Parker J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08461-5
   Piper AM, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz092
   Plesivkova D, 2019, WIRES FORENSIC SCI, V1, pe1323, DOI [10.1002/wfs2.1323, DOI 10.1002/WFS2.1323]
   Pomerantz A, 2018, GIGASCIENCE, V7, DOI 10.1093/gigascience/giy033
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Quick J, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0677-2
   REISS U, 1975, J BIOL CHEM, V250, P826
   Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584
   Schmidt K, 2017, J ANTIMICROB CHEMOTH, V72, P104, DOI 10.1093/jac/dkw397
   Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156
   Seesao Y, 2017, J MICROBIOL METH, V138, P37, DOI 10.1016/j.mimet.2016.05.030
   Shokralla S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09687
   Srinivasan J, 2013, GENETICS, V193, P1279, DOI 10.1534/genetics.112.148809
   Srivathsan A, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0706-9
   Tyson JR, 2018, GENOME RES, V28, P266, DOI 10.1101/gr.221184.117
   van Dijk EL, 2014, TRENDS GENET, V30, P418, DOI 10.1016/j.tig.2014.07.001
NR 61
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-701X
J9 FRONT ECOL EVOL
JI Front. Ecol. Evol.
PD APR 30
PY 2020
VL 8
AR 100
DI 10.3389/fevo.2020.00100
PG 11
WC Ecology
SC Environmental Sciences & Ecology
GA LR3HG
UT WOS:000535583900001
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Nobrega, PR
   Morais, NMD
   Braga-Neto, P
   Barros, LSD
   Honorio, FPP
   Dellavance, A
   Hoftberger, R
   Dutra, LA
AF Nobrega, Paulo Ribeiro
   Morais, Norma Martins de Menezes
   Braga-Neto, Pedro
   Barros, Liziana Sofia da Silva
   Honorio, Fernanda Paiva Pereira
   Dellavance, Alessandra
   Hoftberger, Romana
   Dutra, Livia Almeida
TI NMDAR Encephalitis Associated With Acute Chikungunya Virus Infection: A
   New Trigger?
SO FRONTIERS IN PEDIATRICS
LA English
DT Article
DE autoimmune; encephalitis; anti-NMDAR; Chikungunya; Arboviral diseases
ID RECEPTOR ENCEPHALITIS; AUTOIMMUNE ENCEPHALITIS
AB Background: Anti-NMDAR encephalitis is the most frequent cause of autoimmune encephalitis. Chikungunya (CHIK) is an arbovirus responsible for outbreaks of fever, cutaneous rash and arthritis in underdeveloped countries, and a trigger for autoimmunity.
   Case Presentation: We report a five-year-old male patient with fever, myalgia, headache and conjunctivitis for 5 days. After 1 week he developed tonic-clonic seizures and evolved with dystonia and oromandibular dyskinesia followed by onset of focal motor seizures, decreased level of consciousness, dysautonomia and central apnea. Brain MRI was normal, CSF analysis revealed 15 cells, protein 16.6 mg/dL and glucose 68 mg/dL. Anti-NMDAR antibodies were detected in serum and CSF after 3 weeks of symptom onset. CHIK serology was positive for both IgM and IgG, suggesting a recent infection. Dengue and Zika serologies were negative. CSF PCR for herpes viruses and arboviruses (CHIK, Dengue and Zika) were negative.
   Conclusion: We report the occurrence of anti-NMDAR encephalitis after acute CHIK infection. The biphasic course, positivity for both CHIK IgM and IgG and negative CHIK CSF PCR results, as well as a dramatic response to immunotherapy suggest an immune-mediated pathogenesis. Because of the global epidemic of CHIK infection and unknown mechanisms involving CHIK and autoimmunity, patients with acute CHIK infections and neurological manifestations should be considered for antineuronal antibody testing.
C1 [Nobrega, Paulo Ribeiro; Braga-Neto, Pedro] Univ Fed Ceara, Div Neurol, Dept Clin Med, Fortaleza, Ceara, Brazil.
   [Morais, Norma Martins de Menezes] Unichristus Med Sch, Dept Pediat, Fortaleza, Ceara, Brazil.
   [Morais, Norma Martins de Menezes; Barros, Liziana Sofia da Silva; Honorio, Fernanda Paiva Pereira] Univ Estadual Ceara, Hosp Univ Walter Cantidio, Pediat Serv, Fortaleza, Ceara, Brazil.
   [Braga-Neto, Pedro] Univ Estadual Ceara, Ctr Hlth Sci, Fortaleza, Ceara, Brazil.
   [Dellavance, Alessandra] Lab Fleury, Sao Paulo, Brazil.
   [Hoftberger, Romana] Med Univ Vienna, Inst Neurol, Vienna, Austria.
   [Dutra, Livia Almeida] Fac Israelita Ciencias Saude Albert Einstein, Sao Paulo, Brazil.
RP Braga-Neto, P (corresponding author), Univ Fed Ceara, Div Neurol, Dept Clin Med, Fortaleza, Ceara, Brazil.; Braga-Neto, P (corresponding author), Univ Estadual Ceara, Ctr Hlth Sci, Fortaleza, Ceara, Brazil.
EM pbraganeto@ufc.br
FU Laboratorio Fleury, Sao Paulo, Brazil
FX LD received a grant from Laboratorio Fleury, Sao Paulo, Brazil,
   (Brazilian Autoimmune Encephalitis Network).
CR Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Cerny T, 2017, NEUROCRIT CARE, V27, P447, DOI 10.1007/s12028-017-0413-8
   Chang AY, 2018, ARTHRITIS RHEUMATOL, V70, P585, DOI 10.1002/art.40383
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   Danieli D, 2017, EUR J NEUROL, V24, pE46, DOI 10.1111/ene.13332
   Das T, 2015, J GEN VIROL, V96, P294, DOI 10.1099/vir.0.071175-0
   Dutra LA, 2018, ARQ NEURO-PSIQUIAT, V76, P41, DOI [10.1590/0004-282x20170176, 10.1590/0004-282X20170176]
   Gasque P, 2016, J INFECT DIS, V214, pS446, DOI 10.1093/infdis/jiw362
   Amaral JK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030289
   Leypoldt F, 2013, NEUROLOGY, V81, P1637, DOI 10.1212/WNL.0b013e3182a9f531
   Nobrega PR, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00472
   Puccioni-Sohler M, 2018, EMERG INFECT DIS, V24, P939, DOI 10.3201/eid2405.171763
   Scott SSD, 2017, J NEUROVIROL, V23, P625, DOI 10.1007/s13365-017-0535-y
   Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1
   Zuliani L, 2019, NEUROL SCI, V40, P2017, DOI 10.1007/s10072-019-03930-3
NR 15
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-2360
J9 FRONT PEDIATR
JI Front. Pediatr.
PD APR 30
PY 2020
VL 8
AR 176
DI 10.3389/fped.2020.00176
PG 4
WC Pediatrics
SC Pediatrics
GA LS0UH
UT WOS:000536108500001
PM 32426307
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Le, TK
   Vinh, L
AF Thu Kim Le
   Le Sy Vinh
TI FLAVI: An Amino Acid Substitution Model for Flaviviruses
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Article
DE Evolution; Flaviviruses; Dengue virus; West nile virus; Zika virus;
   Amino acid substitution model
ID MAXIMUM-LIKELIHOOD-ESTIMATION; PROTEIN EVOLUTION; DNA-SEQUENCES;
   MATRICES; TREE; CONFIDENCE
AB Amino acid substitution models represent substitution rates among amino acids during the evolution. The models play an important role in analyzing protein sequences, especially inferring phylogenies. The rapid evolution of flaviviruses is expanding the threat in public health. A number of models have been estimated for some viruses, however, they are unable to properly represent amino acid substitution patterns of flaviviruses. In this study, we collected protein sequences from the flavivirus genus to specifically estimate an amino acid substitution model, called FLAVI, for flaviviruses. Experiments showed that the collected dataset was sufficient to estimate a stable model. More importantly, the FLAVI model was remarkably better than other existing models in analyzing flavivirus protein sequences. We recommend researchers to use the FLAVI model when studying protein sequences of flaviviruses or closely related viruses.
C1 [Thu Kim Le; Le Sy Vinh] Vietnam Natl Univ Hanoi, Univ Engn & Technol, 144 Xuan Thuy, Hanoi 10000, Vietnam.
   [Thu Kim Le] Hanoi Univ Sci & Technol, 1 Dai Co Viet, Hanoi 10000, Vietnam.
RP Vinh, L (corresponding author), Vietnam Natl Univ Hanoi, Univ Engn & Technol, 144 Xuan Thuy, Hanoi 10000, Vietnam.
EM vinhls@vnu.edu.vn
FU Vietnam National Foundation for Science and Technology Development
   (NAFOSTED)National Foundation for Science & Technology Development
   (NAFOSTED) [102.01.2019.06]
FX This research is funded by Vietnam National Foundation for Science and
   Technology Development (NAFOSTED) under Grant number 102.01.2019.06.
CR AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Dang CC, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-341
   Dang CC, 2011, BIOINFORMATICS, V27, P2758, DOI 10.1093/bioinformatics/btr435
   Cuong CD, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-99
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281
   Dimmic MW, 2002, J MOL EVOL, V55, P65, DOI 10.1007/s00239-001-2304-y
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/NMETH.4285, 10.1038/nmeth.4285]
   Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300
   Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067
   Le SQ, 2012, MOL BIOL EVOL, V29, P2921, DOI 10.1093/molbev/mss112
   Minh BQ, 2020, QMAKER ESTIMAT UNPUB
   Nickle DC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000503
   Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698
   ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2
   Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246
   Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913
   Thorne JL, 2000, CURR OPIN GENET DEV, V10, P602, DOI 10.1016/S0959-437X(00)00142-8
   Le VS, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-0987-y
   Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851
   YANG ZH, 1993, MOL BIOL EVOL, V10, P1396
NR 26
TC 1
Z9 1
U1 1
U2 1
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0022-2844
EI 1432-1432
J9 J MOL EVOL
JI J. Mol. Evol.
PD JUL
PY 2020
VL 88
IS 5
BP 445
EP 452
DI 10.1007/s00239-020-09943-3
EA APR 2020
PG 8
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA LS4OW
UT WOS:000529714600001
PM 32356020
DA 2020-07-08
ER

PT J
AU Kim, YC
   Dema, B
   Reyes-Sandoval, A
AF Kim, Young Chan
   Dema, Barbara
   Reyes-Sandoval, Arturo
TI COVID-19 vaccines: breaking record times to first-in-human trials
SO NPJ VACCINES
LA English
DT Article
ID ZIKA VIRUS; CORONAVIRUS; PNEUMONIA; OUTBREAK; ISLAND; FEVER
AB The twenty-first century has come with a new era in vaccinology, in which recombinant genetic technology has contributed to setting an unprecedented fast pace in vaccine development, clearly demonstrated during the recent COVID-19 pandemic.
C1 [Kim, Young Chan; Dema, Barbara; Reyes-Sandoval, Arturo] Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England.
RP Reyes-Sandoval, A (corresponding author), Univ Oxford, Jenner Inst, Nuffield Dept Med, Oxford, England.
EM arturo.reyes@ndm.ox.ac.uk
OI Kim, Young Chan/0000-0003-2847-9407
FU Department of Health and Social Care using UK Aid [16/107/05]
FX This research is funded by the Department of Health and Social Care
   using UK Aid funding and is managed by the NIHR, project 16/107/05. The
   views expressed in this publication are those of the author(s) and not
   necessarily those of the Department of Health and Social Care.
CR Agnandji ST, 2016, NEW ENGL J MED, V374, P1647, DOI 10.1056/NEJMoa1502924
   [Anonymous], 2020, WHO COVID 19 DASHBOA
   Ashburn PM, 2004, J INFECT DIS, V189, P1747
   Bhurani V, 2018, INT REV IMMUNOL, V37, P249, DOI 10.1080/08830185.2018.1471479
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FDA News, 2020, FDA NEWS
   FRAME JD, 1970, AM J TROP MED HYG, V19, P670, DOI 10.4269/ajtmh.1970.19.670
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   HARRISON VR, 1971, J IMMUNOL, V107, P643
   PATTYN S, 1977, LANCET, V1, P573
   Regules JA, 2017, NEW ENGL J MED, V376, P330, DOI 10.1056/NEJMoa1414216
   Rosling L, 2003, BRIT MED J, V326, P416, DOI 10.1136/bmj.326.7386.416
   ROSS R. W., 1956, JOUR HYG, V54, P177
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sergon K, 2008, AM J TROP MED HYG, V78, P333, DOI 10.4269/ajtmh.2008.78.333
   Simpson D I, 1967, East Afr Med J, V44, P86
   Vitelli A, 2017, EXPERT REV VACCINES, V16, P1241, DOI 10.1080/14760584.2017.1394842
   Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9
   Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 25
TC 0
Z9 0
U1 3
U2 3
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD APR 30
PY 2020
VL 5
IS 1
AR 34
DI 10.1038/s41541-020-0188-3
PG 3
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LI7XH
UT WOS:000529693200001
PM 32377399
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Boopathi, S
   Poma, AB
   Kolandaivel, P
AF Boopathi, Subramanian
   Poma, Adolfo B.
   Kolandaivel, Ponmalai
TI Novel 2019 coronavirus structure, mechanism of action, antiviral drug
   promises and rule out against its treatment
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Coronavirus; computational simulation; coronavirus Spike; ACE2 receptor;
   antiviral drugs; COVID-19
ID MAIN PROTEASE; ION CHANNELS; SARS; SPIKE; INHIBITORS; CHLOROQUINE;
   BINDING; DESIGN
AB In the past two decades, the world has faced several infectious disease outbreaks. Ebola, Influenza A (H1N1), SARS, MERS, and Zika virus have had a massive global impact in terms of economic disruption, the strain on local and global public health. Most recently, the global outbreak of novel coronavirus 2019 (SARS-CoV-2) that causes COVID-19 is a newly discovered virus from the coronavirus family in Wuhan city, China, known to be a great threat to the public health systems. As of 15 April 2020, The Johns Hopkins University estimated that the COVID-19 affected more than two million people, resulting in a death toll above 130,000 around the world. Infected people in Europe and America correspond about 40% and 30% of the total reported cases respectively. At this moment only few Asian countries have controlled the disease, but a second wave of new infections is expected. Predicting inhibitor and target to the COVID-19 is an urgent need to protect human from the disease. Therefore, a protocol to identify anti-COVID-19 candidate based on computer-aided drug design is urgently needed. Thousands of compounds including approved drugs and drugs in the clinical trial are available in the literature. In practice, experimental techniques can measure the time and space average properties but they cannot be captured the structural variation of the COVID-19 during the interaction of inhibitor. Computer simulation is particularly suitable to complement experiments to elucidate conformational changes at the molecular level which are related to inhibition process of the COVID-19. Therefore, computational simulation is essential tool to elucidate the phenomenon. The structure-based virtual screening computational approach will be used to filter the best drugs from the literature, the investigate the structural variation of COVID-19 with the interaction of the best inhibitor is a fundamental step to design new drugs and vaccines which can combat the coronavirus. This mini-review will address novel coronavirus structure, mechanism of action, and trial test of antiviral drugs in the lab and patients with COVID-19.
C1 [Boopathi, Subramanian] Univ Talca, Ctr Bioinformat & Simulac Mol CBSM, 1 Poniente 1141, Talca 3460000, Chile.
   [Poma, Adolfo B.] Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Pawinskiego 5B, PL-02106 Warsaw, Poland.
   [Kolandaivel, Ponmalai] Periyar Univ, Salem, Tamil Nadu, India.
RP Boopathi, S (corresponding author), Univ Talca, Ctr Bioinformat & Simulac Mol CBSM, 1 Poniente 1141, Talca 3460000, Chile.; Poma, AB (corresponding author), Polish Acad Sci, Inst Fundamental Technol Res, Dept Biosyst & Soft Matter, Pawinskiego 5B, PL-02106 Warsaw, Poland.; Kolandaivel, P (corresponding author), Periyar Univ, Salem, Tamil Nadu, India.
EM boopathialzheimer@outlook.com; apoma@ippt.pan.pl; ponkvel@hotmail.com
RI Poma, Adolfo/AAA-5145-2020; Boopathi, Subramanian/AAP-7497-2020
OI Poma, Adolfo/0000-0002-8875-3220; Boopathi,
   Subramanian/0000-0002-9249-1112
FU National Science Centre, Poland [2017/26/D/NZ1/00466]
FX This work was supported by the National Science Centre, Poland, under
   Grant number 2017/26/D/NZ1/00466.
CR Amanat F, 2020, IMMUNITY, V52, P583, DOI 10.1016/j.immuni.2020.03.007
   Anand K, 2003, SCIENCE, V300, P1763, DOI 10.1126/science.1085658
   [Anonymous], 2020, COR COVID 19 GLOB CA
   [Anonymous], 2020, COVID 19 FEATURED CO
   Bacharier LB, 2015, JAMA-J AM MED ASSOC, V314, P2034, DOI 10.1001/jama.2015.13896
   Baden L. R., 2020, NEW ENGLAND J MED, DOI 10.1056/NEJMe2005477
   Bosseboeuf E., 2018, J ANTIVIR ANTIRETROV, V10, P6, DOI [10.4172/1948-5964.1000173, DOI 10.4172/1948-5964.1000173]
   Bostrom J, 2018, NAT REV DRUG DISCOV, V17, P709, DOI 10.1038/nrd.2018.116
   Caly L, 2020, ANTIVIR RES, V178, DOI 10.1016/j.antiviral.2020.104787
   Cao B, 2020, NEW ENGL J MED, V382, P1787, DOI 10.1056/NEJMoa2001282
   Centers for Desease Control and Prevention, 2005, CTR DIS CONTR PREV F
   Chu CM, 2004, THORAX, V59, P252, DOI 10.1136/thorax.2003.012658
   Colson P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105932
   Gao JJ, 2020, BIOSCI TRENDS, V14, P72, DOI 10.5582/bst.2020.01047
   Gautret P., 2020, INT J ANTIMICROB AG, DOI DOI 10.1016/J.IJANTIMICAG.2020.105949
   Graham RL, 2013, NAT REV MICROBIOL, V11, P836, DOI 10.1038/nrmicro3143
   Gupta M. K., 2020, J BIOMOLECULAR STRUC, DOI 10.1080/07391102.2020.1751300
   Hasan A, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1754293
   Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6
   Jin Z.-M., 2020, BIORXIV
   Khan RJ, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1753577
   Kirchdoerfer RN, 2016, NATURE, V531, P118, DOI 10.1038/nature17200
   Koenig KL, 2015, WEST J EMERG MED, V16, P619, DOI 10.5811/westjem.2015.7.27915
   Kupferschmidt K, 2020, SCIENCE, V367, P1412, DOI 10.1126/science.367.6485.1412
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Lissenberg A, 2005, J VIROL, V79, P15054, DOI 10.1128/JVI.79.24.15054-15063.2005
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Mulangu S, 2019, NEW ENGL J MED, V381, P2293, DOI 10.1056/NEJMoa1910993
   Muralidharan N, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1752802
   Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077
   Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511
   Pillaiyar T, 2016, J MED CHEM, V59, P6595, DOI 10.1021/acs.jmedchem.5b01461
   Ren ZL, 2013, PROTEIN CELL, V4, P248, DOI 10.1007/s13238-013-2841-3
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Sarma P., 2020, J BIOMOLECULAR STRUC, DOI 10.1080/07391102.2020.1753580
   Savarino A, 2006, LANCET INFECT DIS, V6, P67, DOI 10.1016/S1473-3099(06)70361-9
   Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102
   Song HC, 2004, J VIROL, V78, P10328, DOI 10.1128/JVI.78.19.10328-10335.2004
   Tian Xiaolong, 2020, Emerg Microbes Infect, V9, P382, DOI 10.1080/22221751.2020.1729069
   Torres J, 2007, PROTEIN SCI, V16, P2065, DOI 10.1110/ps.062730007
   van Hemert MJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000054
   Verdia-Baguena C, 2012, VIROLOGY, V432, P485, DOI 10.1016/j.virol.2012.07.005
   Vincent MJ, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-69
   Walls AC, 2020, CELL, V181, P281, DOI 10.1016/j.cell.2020.02.058
   Wang FH, 2017, J MED CHEM, V60, P3212, DOI 10.1021/acs.jmedchem.7b00103
   Wang ML, 2020, CELL RES, V30, P269, DOI 10.1038/s41422-020-0282-0
   Wang Q, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-99
   Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033
   Wilson L, 2006, VIROLOGY, V353, P294, DOI 10.1016/j.virol.2006.05.028
   World Health Organization, 2019, MIDDL E RESP SYNDR C
   World Health Organization, DIR GEN REM MED BRIE
   Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]
   Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3
   Xue XY, 2008, J VIROL, V82, P2515, DOI 10.1128/JVI.02114-07
   Yan YW, 2013, CELL RES, V23, P300, DOI 10.1038/cr.2012.165
   Yang HT, 2005, PLOS BIOL, V3, P1742, DOI 10.1371/journal.pbio.0030324
   Yang HT, 2003, P NATL ACAD SCI USA, V100, P13190, DOI 10.1073/pnas.1835675100
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhao Q, 2008, J VIROL, V82, P8647, DOI 10.1128/JVI.00298-08
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 66
TC 16
Z9 16
U1 23
U2 23
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1758788
EA APR 2020
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LM3LR
UT WOS:000532152900001
PM 32306836
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Billington, J
   Deschamps, I
   Erck, SC
   Gerberding, JL
   Hanon, E
   Ivol, S
   Shiver, JW
   Spencer, JA
   Van Hoof, J
AF Billington, John
   Deschamps, Isabelle
   Erck, Stanley C.
   Gerberding, Julie L.
   Hanon, Emmanuel
   Ivol, Sabrina
   Shiver, John W.
   Spencer, Julia A.
   Van Hoof, Johan
TI Developing Vaccines for SARS-CoV-2 and Future Epidemics and Pandemics:
   Applying Lessons from Past Outbreaks
SO HEALTH SECURITY
LA English
DT Editorial Material
DE Epidemic management; response; Infectious diseases; Vaccine development;
   SARS-CoV-2; COVID-19
ID TECHNOLOGIES; TRIAL
AB The COVID-19 pandemic is a stark reminder of the heavy toll that emerging infectious diseases (EIDs) with epidemic and pandemic potential can inflict. Vaccine development, scale-up, and commercialization is a long, expensive, and risky enterprise that requires substantial upfront planning and offers no guarantee of success. EIDs are a particularly challenging target for global health preparedness, including for vaccine development. Insufficient attention has been given to challenges, lessons learned, and potential solutions to support and sustain vaccine industry engagement in vaccine development for EIDs. Drawing from lessons from the most recent Ebola epidemic in the Democratic Republic of the Congo, as well as the 2009 H1N1 influenza, 2014-2016 Ebola, and 2015-16 Zika outbreaks preceding it, we offer our perspective on challenges facing EID vaccine development and recommend additional solutions to prioritize in the near term. The 6 recommendations focus on reducing vaccine development timelines and increasing business certainty to reduce risks for companies. The global health security community has an opportunity to build on the current momentum to design a sustainable model for EID vaccines.
C1 [Billington, John] GSK Vaccines, Sci Policy, Wavre, Belgium.
   [Hanon, Emmanuel] GSK Vaccines, R&D, Wavre, Belgium.
   [Deschamps, Isabelle] Sanofi Pasteur, Global Vaccine Publ Affairs, Lyon, France.
   [Shiver, John W.] Sanofi Pasteur, R&D, Lyon, France.
   [Erck, Stanley C.] Novavax, Gaithersburg, MD USA.
   [Gerberding, Julie L.] Merck & Co Inc, Strateg Commun Global Publ Policy & Populat Hlth, Kenilworth, NJ USA.
   [Spencer, Julia A.] Merck & Co Inc, Global Publ Policy, Kenilworth, NJ USA.
   [Ivol, Sabrina] Janssen Vaccines & Prevent BV, Janssen Pharmaceut R&D, Policy, Leiden, Netherlands.
   [Van Hoof, Johan] Janssen Vaccines & Prevent BV, Janssen Pharmaceut R&D, Leiden, Netherlands.
RP Billington, J (corresponding author), GSK Vaccines, Sci Policy, Wavre, Belgium.
EM john.k.billington@gsk.com
CR Adalja AA, 2019, VACCINE PLATFORMS ST
   Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P453
   [Anonymous], 2018, AH1N1 PDM09 CA UNPUB
   [Anonymous], 2018, ZIKA CASE STUD UNPUB
   [Anonymous], 2019, COMMUNICATION   1011
   [Anonymous], 2018, EBOLA CASE STU UNPUB
   Bloom DE, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00549
   Branswell H., 2018, STAT
   Centers for Disease Control and Prevention, 2019, 2014 2016 EB OUTBR W
   Centers for Disease Control and Prevention, 2012, 1 GLOB EST 2009 H1N1
   CEPI, PRIOR DIS
   CEPI, RESP COVID 19
   Conerly B., 2020, FORBES
   Cueni TB, 2020, STAT
   Gates B, 2018, NEW ENGL J MED, V378, P2057, DOI 10.1056/NEJMp1806283
   Gavi the Vaccine Alliance, 2020, GAV BOARD CALLS BOLD
   Gouglas D, 2018, LANCET GLOB HEALTH, V6, pE1386, DOI 10.1016/S2214-109X(18)30346-2
   Graham BS, 2018, JAMA-J AM MED ASSOC, V319, P1431, DOI 10.1001/jama.2018.0345
   Gupta SB, 2018, EXPERT REV VACCINES, V17, P913, DOI 10.1080/14760584.2018.1527692
   Henao-Restrepo AM, 2017, LANCET, V389, P505, DOI 10.1016/S0140-6736(16)32621-6
   Hirschler B, 2010, REUTERS
   Hodgson J., 2020, NAT BIOTECHNOL
   Huber C, 2018, J INFECT DIS, V218, pS698, DOI 10.1093/infdis/jiy213
   Hume HKC, 2017, VACCINE, V35, P4480, DOI 10.1016/j.vaccine.2017.02.069
   Innovative Medicines Initiative, 2020, EB EB OTH FIL HAEM F
   Innovative Medicines Initiative, 2017, EBODAC CONS ORG S CO
   International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), 2019, COMPL JOURN VACC STE
   Johns Hopkins Center for Health Security, EV 201
   Kennedy SB, 2016, CLIN TRIALS, V13, P49, DOI 10.1177/1740774515621037
   Kieny MP, 2016, EXPERT REV VACCINES, V15, P1075, DOI 10.1080/14760584.2016.1188695
   Lipsitch M, 2017, SCIENCE, V357, P153, DOI 10.1126/science.aam8334
   Maslow Joel N, 2019, Trop Med Infect Dis, V4, DOI 10.3390/tropicalmed4030104
   Nathan C, 2015, NAT REV MICROBIOL, V13, P651, DOI 10.1038/nrmicro3523
   National Institute of Allergy and Infectious Diseases, NIAID EM INF DIS PAT
   Pan American Health Organization ; World Health Organization, 2016, ZIK EP UPD
   Plotkin S, 2017, VACCINE, V35, P4064, DOI 10.1016/j.vaccine.2017.06.003
   Pronker ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057755
   The Centers for Disease Control and Prevention, 2014 EB OUTBR W AFR
   World Health Organization, 2020, INT RAND TRIAL CAND
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   World Health Organization, RES DEV BLUEPR ACT P
NR 41
TC 0
Z9 0
U1 6
U2 6
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 2326-5094
EI 2326-5108
J9 HEALTH SECUR
JI Health Secur.
PD JUN 1
PY 2020
VL 18
IS 3
BP 241
EP 249
DI 10.1089/hs.2020.0043
EA APR 2020
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LZ4WT
UT WOS:000529994400001
PM 32348165
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Amaral, MP
   Apostolico, JD
   Tomita, N
   Coirada, FC
   Lunardelli, VAS
   Fernandes, ER
   Souza, HFS
   Astray, RM
   Boscardin, SB
   Rosa, DS
AF Amaral, Marcelo Pires
   Apostolico, Juliana de Souza
   Tomita, Nadia
   Coirada, Fernanda Caroline
   Santos Lunardelli, Victoria Alves
   Fernandes, Edgar Ruz
   Santos Souza, Higo Fernando
   Astray, Renato Mancini
   Boscardin, Silvia Beatriz
   Rosa, Daniela Santoro
TI Homologous prime-boost with Zika virus envelope protein and poly (I:C)
   induces robust specific humoral and cellular immune responses
SO VACCINE
LA English
DT Article
DE Subunit vaccine; DNA vaccine; Prime-boost; Adjuvant; Envelope; Zika
   virus
ID DNA VACCINE; INFECTION; ANTIBODIES; CELLS
AB The recent outbreaks of Zika virus (ZIKV) infection and the potential association with Guillain-Barre syndrome in adults and with congenital abnormalities have highlighted the urgency for an effective vaccine. The ZIKV Envelope glycoprotein (E-ZIKV) is the most abundant protein on the virus surface, and has been evaluated together with the pre-membrane protein (prM) of the viral coat as a vaccine candidate in clinical trials. In this study, we performed a head-to-head comparison of the immune response induced by different E-ZIKV-based vaccine candidates in mice. We compared different platforms (DNA, recombinant protein), adjuvants (poly (I:C), CpG ODN 1826) and immunization strategies (homologous, heterologous).
   The hierarchy of adjuvant potency showed that poly (I:C) was a superior adjuvant than CpG ODN. While poly (I:C) assisted immunization reached a plateau in antibody titers after two doses, the CpG ODN group required an extra immunization dose. Besides, the administration of poly (I:C) induced higher E-ZIKV-specific cellular immune responses than CpG ODN. We also show that immunization with homologous prime-boost EZIKV protein + poly (I:C) regimen induced a more robust humoral response than homologous DNA (pVAX-E-ZIKV) or heterologous regimens (DNA/protein or protein/DNA). A detailed analysis of cellular immune responses revealed that homologous (E-ZIKV + poly (I:C)) and heterologous (pVAX-E-ZIKV/E-ZIKV + poly (I:C)) prime-boost regimens induced the highest magnitude of IFN-gamma secreting cells and cytokine-producing CD4(+) T cells.
   Overall, our data demonstrate that homologous E-ZIKV + poly (I:C) prime-boost immunization is sufficient to induce more robust specific-E-ZIKV humoral and cellular immune responses than the other strategies that contemplate homologous DNA (pVAX-E-ZIKV) or heterologous (pVAX-E-ZIKV/E-ZIKV + poly (I:C), and vice-versa) immunizations. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Amaral, Marcelo Pires; Apostolico, Juliana de Souza; Tomita, Nadia; Coirada, Fernanda Caroline; Santos Lunardelli, Victoria Alves; Fernandes, Edgar Ruz; Rosa, Daniela Santoro] Fed Univ Sao Paulo UNIFESP EPM, Dept Microbiol Immunol & Parasitol, Sao Paulo, Brazil.
   [Apostolico, Juliana de Souza; Santos Lunardelli, Victoria Alves; Boscardin, Silvia Beatriz; Rosa, Daniela Santoro] INCT, Inst Invest Immunol 3, Sao Paulo, Brazil.
   [Santos Souza, Higo Fernando; Boscardin, Silvia Beatriz] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, Brazil.
   [Astray, Renato Mancini] Butantan Inst, Viral Immunol Lab, Sao Paulo, Brazil.
RP Rosa, DS (corresponding author), Rua Botucatu,862-4 Andar, BR-04023062 Sao Paulo, SP, Brazil.
EM dsantororosa@gmail.com
RI Apostolico, Juliana/W-8804-2018; Lunardelli, Victoria/AAB-5424-2020;
   Amaral, Marcelo Pires/AAB-5077-2020; Fernandes, Edgar Ruz/T-6160-2019;
   rosa, daniela/D-2190-2012; Boscardin, Silvia Beatriz/C-3397-2012
OI Apostolico, Juliana/0000-0002-3507-3117; Amaral, Marcelo
   Pires/0000-0002-5335-6196; rosa, daniela/0000-0003-4536-891X; Fernandes,
   Edgar Ruz/0000-0001-5981-5149; Boscardin, Silvia
   Beatriz/0000-0002-7845-7110
FU Sao Paulo Research Foundation [FAPESP]Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2017/17471-7]; Brazilian National Research
   Council (CNPq)/Institute for Investigation in Immunology [CNPq]
   [465434/2014-2]; Coordenacao de Aperfeicoamento de Pessoal de Nivel
   Superior [CAPES]CAPES [001]; CNPq/FAPESPNational Council for Scientific
   and Technological Development (CNPq)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP); CAPESCAPES
FX This research was supported by Sao Paulo Research Foundation [FAPESP,
   grant number 2017/17471-7], the Brazilian National Research Council
   (CNPq)/Institute for Investigation in Immunology [CNPq, grant number
   465434/2014-2] and the Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior [CAPES, Finance Code 001]. JSA, VASL, FCC, ERF, NT, SBB
   and DSR received fellowships from CNPq/FAPESP. MPA and HFSS received
   fellowships from CAPES.
CR Abbink P, 2016, SCIENCE
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Akondy RS, 2009, J IMMUNOL, V183, P7919, DOI 10.4049/jimmunol.0803903
   Ammi R, 2015, PHARMACOL THERAPEUT, V146, P120, DOI 10.1016/j.pharmthera.2014.09.010
   Apostolico JD, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00101
   Apostolico JD, 2016, J IMMUNOL RES, DOI 10.1155/2016/1459394
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Britto C, 2018, EXPERT OPIN BIOL TH, V18, P1171, DOI 10.1080/14712598.2018.1526277
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chang GJJ, 2003, VIROLOGY, V306, P170, DOI 10.1016/S0042-6822(02)00028-4
   Collins MH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124588
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Han JF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10595-5
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Hemmi H, 2003, J IMMUNOL, V170, P3059, DOI 10.4049/jimmunol.170.6.3059
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432
   Kwissa M, 2012, BLOOD, V119, P2044, DOI 10.1182/blood-2011-10-388579
   Larocca RA, 2016, NATURE
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Martins KA, 2015, EXPERT REV VACCINES, V14, P447, DOI 10.1586/14760584.2015.966085
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Report S, 2017, ZIK VIR MICR GUILL B
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roos AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007226
   Rosa DS, 2015, J VACC VACC, V6
   Sant AJ, 2012, J EXP MED, V209, P1391, DOI 10.1084/jem.20121517
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shirota H, 2017, IMMUNOPOTENTIATORS IN MODERN VACCINES, 2ND EDITION, P163, DOI 10.1016/B978-0-12-804019-5.00009-8
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Tebas P, 2017, N ENGL J MED
   Touret F, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0161-7
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 61
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 29
PY 2020
VL 38
IS 20
BP 3653
EP 3664
DI 10.1016/j.vaccine.2020.03.037
PG 12
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LC4TO
UT WOS:000525318200004
PM 32247567
DA 2020-07-08
ER

PT J
AU Huang, YY
   Wang, YJ
   Meng, SH
   Chen, ZH
   Kong, HF
   Pan, T
   Lu, G
   Li, XF
AF Huang, Yuyi
   Wang, Yujie
   Meng, Shuhui
   Chen, Zhuohang
   Kong, Haifan
   Pan, Ting
   Lu, Gen
   Li, Xuefeng
TI Autophagy Contributes to Host Immunity and Protection against Zika Virus
   Infection via Type I IFN Signaling
SO MEDIATORS OF INFLAMMATION
LA English
DT Article
ID DENGUE VIRUS; 3-DIMENSIONAL ARCHITECTURE; REPLICATION SITES; INHIBITION;
   INDUCTION; PROVIDES; CELLS
AB Recent studies have indicated that the Zika virus (ZIKV) has a significant impact on the fetal brain, and autophagy is contributing to host immune response and defense against virus infection. Here, we demonstrate that ZIKV infection triggered increased LC3 punctuation in mouse monocyte-macrophage cell line (RAW264.7), mouse microglial cell line (BV2), and hindbrain tissues, proving the occurrence of autophagy both in vitro and in vivo. Interestingly, manual intervention of autophagy, like deficiency inhibited by 3-MA, can reduce viral clearance in RAW264.7 cells upon ZIKV infection. Besides, specific siRNA strategy confirmed that autophagy can be activated through Atg7-Atg5 and type I IFN signaling pathway upon ZIKV infection, while knocking down of Atg7 and Atg5 effectively decreased the ZIKV clearance in phagocytes. Furthermore, we analyzed that type I IFN signaling could contribute to autophagic clearance of invaded ZIKV in phagocytes. Taken together, our findings demonstrate that ZIKV-induced autophagy is favorable to activate host immunity, particularly through type I IFN signaling, which participates in host protection and defense against ZIKV infection.
C1 [Huang, Yuyi; Wang, Yujie; Meng, Shuhui; Li, Xuefeng] Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Guangzhou 511436, Peoples R China.
   [Huang, Yuyi; Wang, Yujie; Meng, Shuhui; Li, Xuefeng] Guangzhou Med Univ, Affiliated Hosp 2, State Key Lab Resp Dis, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 511436, Peoples R China.
   [Huang, Yuyi; Wang, Yujie; Meng, Shuhui; Li, Xuefeng] Guangzhou Med Univ, Sino French Hoffmann Inst, Sch Basic Med Sci, Guangzhou 511436, Peoples R China.
   [Chen, Zhuohang] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Shenzhen 510006, Peoples R China.
   [Kong, Haifan] Guangzhou Med Univ, Nan Shan Sch, Guangzhou 511436, Peoples R China.
   [Pan, Ting] Sun Yat Sen Univ, Sch Med, Guangzhou 510080, Peoples R China.
   [Lu, Gen] Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou 510120, Peoples R China.
   [Li, Xuefeng] Shenzhen Univ, Affiliated Hosp 3, Shenzhen Luohu Peoples Hosp, Shenzhen 518001, Peoples R China.
   [Li, Xuefeng] Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth,Key Lab Regenerat Bi, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Peoples R China.
RP Li, XF (corresponding author), Guangzhou Med Univ, Qingyuan Peoples Hosp, Affiliated Hosp 6, Guangzhou 511436, Peoples R China.; Li, XF (corresponding author), Guangzhou Med Univ, Affiliated Hosp 2, State Key Lab Resp Dis, Guangdong Prov Key Lab Allergy & Clin Immunol, Guangzhou 511436, Peoples R China.; Li, XF (corresponding author), Guangzhou Med Univ, Sino French Hoffmann Inst, Sch Basic Med Sci, Guangzhou 511436, Peoples R China.; Lu, G (corresponding author), Guangzhou Med Univ, Guangzhou Women & Childrens Med Ctr, Guangzhou 510120, Peoples R China.; Li, XF (corresponding author), Shenzhen Univ, Affiliated Hosp 3, Shenzhen Luohu Peoples Hosp, Shenzhen 518001, Peoples R China.; Li, XF (corresponding author), Chinese Acad Sci, South China Inst Stem Cell Biol & Regenerat Med, Guangzhou Inst Biomed & Hlth,Key Lab Regenerat Bi, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou 510530, Peoples R China.
EM lugen@gzhmu.edu.cn; xuefengli@gzhmu.edu.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81972204, 81702327]; Natural Science Foundation of
   Guangdong ProvinceNational Natural Science Foundation of Guangdong
   Province [2019A1515011097]; Science and Technology Planning Project of
   Guangzhou [201904010089]; State Key Laboratory of Respiratory Disease,
   Guangzhou Medical University [SKLRD-Z-202002]; Innovation Program of
   Shenzhen [JCYJ20180508165208399]; China Postdoctoral Science
   FoundationChina Postdoctoral Science Foundation [2018M640834,
   2019T120756]; 111 Project from the Ministry of Education of
   ChinaMinistry of Education, China - 111 Project [D18010]
FX This work was supported by the National Natural Science Foundation of
   China (81972204, 81702327), Natural Science Foundation of Guangdong
   Province (2019A1515011097), Science and Technology Planning Project of
   Guangzhou (201904010089), grant from the State Key Laboratory of
   Respiratory Disease, Guangzhou Medical University (SKLRD-Z-202002),
   Innovation Program of Shenzhen (JCYJ20180508165208399), China
   Postdoctoral Science Foundation (2018M640834, 2019T120756), and the 111
   Project from the Ministry of Education of China (D18010).
CR Balasubramanian A, 2017, ANTIVIR RES, V137, P141, DOI 10.1016/j.antiviral.2016.11.015
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chan CH, 2014, CELL BIOSCI, V4, DOI 10.1186/2045-3701-4-59
   Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Evans AS, 2020, J VIROL, V94, DOI 10.1128/JVI.00029-20
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gratton R, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051048
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   He S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005743
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Jin L, 2018, NAT IMMUNOL, V19, P342, DOI 10.1038/s41590-018-0063-9
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kodati S, 2017, LANCET, V389, P125, DOI 10.1016/S0140-6736(16)32518-1
   Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782
   Li XF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005363
   Li XF, 2015, J IMMUNOL, V194, P1112, DOI 10.4049/jimmunol.1401958
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liang QM, 2015, J VIROL, V89, P5308, DOI 10.1128/JVI.00102-15
   Liang QM, 2013, J VIROL, V87, P12499, DOI 10.1128/JVI.01898-13
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Metz P, 2015, J VIROL, V89, P8026, DOI 10.1128/JVI.00787-15
   Miorin L, 2013, J VIROL, V87, P6469, DOI 10.1128/JVI.03456-12
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moretti J, 2017, CELL, V171, P809, DOI 10.1016/j.cell.2017.09.034
   Muenz C, 2009, ANNU REV IMMUNOL, V27, P423, DOI 10.1146/annurev.immunol.021908.132537
   Pan T, 2018, J VIROL, V92, DOI [10.1128/JVI.01018-18, 10.1128/jvi.01018-18]
   Peng HP, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050259
   Roze B, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.16.30205
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128
   SHARP TM, 2016, CLIN INFECT DIS, pIW476
   Shoji-Kawata S, 2009, BBA-MOL CELL RES, V1793, P1478, DOI 10.1016/j.bbamcr.2009.02.008
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Sun P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14115-z
   Taguwa S, 2019, CELL REP, V26, P906, DOI 10.1016/j.celrep.2018.12.095
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Williams LR, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00170
   Yang XC, 2018, BIOCHEM BIOPH RES CO, V498, P207, DOI 10.1016/j.bbrc.2018.02.211
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 54
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 0962-9351
EI 1466-1861
J9 MEDIAT INFLAMM
JI Mediat. Inflamm.
PD APR 28
PY 2020
VL 2020
AR 9527147
DI 10.1155/2020/9527147
PG 15
WC Cell Biology; Immunology
SC Cell Biology; Immunology
GA LN9ZG
UT WOS:000533288500003
PM 32410874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Michlmayr, D
   Kim, EY
   Rahman, AH
   Raghunathan, R
   Kim-Schulze, S
   Che, Y
   Kalayci, S
   Gumus, ZH
   Kuan, G
   Balmaseda, A
   Kasarskis, A
   Wolinsky, SM
   Suarez-Farinas, M
   Harris, E
AF Michlmayr, Daniela
   Kim, Eun-Young
   Rahman, Adeeb H.
   Raghunathan, Rohit
   Kim-Schulze, Seunghee
   Che, Yan
   Kalayci, Selim
   Gumus, Zeynep H.
   Kuan, Guillermina
   Balmaseda, Angel
   Kasarskis, Andrew
   Wolinsky, Steven M.
   Suarez-Farinas, Mayte
   Harris, Eva
TI Comprehensive Immunoprofiling of Pediatric Zika Reveals Key Role for
   Monocytes in the Acute Phase and No Effect of Prior Dengue Virus
   Infection
SO CELL REPORTS
LA English
DT Article
ID WEST NILE VIRUS; DENDRITIC CELLS; DATA INTEGRATION; BLOOD MONOCYTES;
   EXPRESSION; ANTIBODIES; CHIKUNGUNYA; MODELS; TARGET; GENES
AB Zika virus (ZIKV) is an emerging, mosquito-borne flavivirus responsible for recent epidemics across the Americas, and it is closely related to dengue virus (DENV). Here, we study samples from 46 DENV-naive and 43 DENV-immune patients with RT-PCR-confirmed ZIKV infection at early-acute, late-acute, and convalescent time points from our pediatric cohort study in Nicaragua. We analyze the samples via RNA sequencing (RNA-seq), CyTOF, and multiplex cytokine/chemokine Luminex to generate a comprehensive, innate immune profile during ZIKV infection. Immunophenotyping and analysis of cytokines/chemokines reveal that CD14(+) monocytes play a key role during ZIKV infection. Further, we identify CD169 (Siglec-1) on CD14(+) monocytes as a potential biomarker of acute ZIKV infection. Strikingly distinct transcriptomic and immunophenotypic signatures are observed at all three time points. Interestingly, pre-existing dengue immunity has minimal impact on the innate immune response to Zika. Finally, this comprehensive immune profiling and network analysis of ZIKV infection in children serves as a valuable resource.
C1 [Michlmayr, Daniela; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Rahman, Adeeb H.; Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Human Immune Monitoring Ctr, New York, NY 10029 USA.
   [Raghunathan, Rohit; Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Populat Hlth Sci & Policy, New York, NY 10029 USA.
   [Kim, Eun-Young; Che, Yan; Wolinsky, Steven M.] Northwestern Univ, Div Infect Dis, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Dept Oncol Sci, Tisch Canc Inst, New York, NY 10029 USA.
   [Kim-Schulze, Seunghee] Icahn Sch Med Mt Sinai, Immunol Inst, New York, NY 10029 USA.
   [Rahman, Adeeb H.; Kalayci, Selim; Gumus, Zeynep H.; Kasarskis, Andrew; Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.
   [Kalayci, Selim; Gumus, Zeynep H.; Kasarskis, Andrew] Icahn Sch Med Mt Sinai, Icahn Inst Data Sci & Genom Technol, New York, NY 10029 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
   [Kuan, Guillermina; Balmaseda, Angel] Sustainable Sci Inst, Managua, Nicaragua.
   [Balmaseda, Angel] Minist Hlth, Lab Nacl Virol, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
RP Harris, E (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
FU National Institute of Allergy and Infectious Diseases (NIAID) of the
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [U19AI118610,
   P01AI106695]
FX This work was supported by grants U19AI118610 (E.H.) and P01AI106695
   (E.H.) from the National Institute of Allergy and Infectious Diseases
   (NIAID) of the National Institutes of Health (NIH). We thank Michael
   Stewart for help with RNA isolation and sequencing and Theodore Pak and
   Li Wang for their constructive comments on the manuscript and data
   analysis. We also thank study personnel at the Centro de Salud So '
   crates Flores Vivas, the National Virology Laboratory of the Nicaraguan
   Ministry of Health, and the Sustainable Sciences Institute in Managua,
   Nicaragua. Finally, we are grateful to the study participants and their
   families.
CR Andrade P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08845-3
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Ashour J, 2009, J VIROL, V83, P5408, DOI 10.1128/JVI.02188-08
   Balmaseda A, 2006, TROP MED INT HEALTH, V11, P935, DOI 10.1111/j.1365-3156.2006.01641.x
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2015, J IMMUNOL, V195, P4306, DOI 10.4049/jimmunol.1500352
   Bastian Mathieu, 2009, P 3 INT ICWSM C
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Burger-Calderon R, 2020, LANCET INFECT DIS, V20, P371, DOI 10.1016/S1473-3099(19)30547-X
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682
   Centers for Disease Control and Prevention, 2017, TRIOPL REAL TIM RT P
   Chaudhary V, 2017, J VIROL, V91, DOI 10.1128/JVI.00163-17
   Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   de-Oliveira-Pinto LM, 2012, MEM I OSWALDO CRUZ, V107, P48, DOI 10.1590/S0074-02762012000100007
   Fabregat A, 2016, NUCLEIC ACIDS RES, V44, pD481, DOI 10.1093/nar/gkv1351
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gorman MJ, 2016, J VIROL, V90, P8212, DOI 10.1128/JVI.00581-16
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grifoni A., 2017, J VIROL, V91, P601
   Hsu YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079518
   Hu Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1026
   Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]
   Kim WK, 2015, AIDS RES HUM RETROV, V31, P696, DOI [10.1089/aid.2015.0003, 10.1089/AID.2015.0003]
   King CA, 2002, J VIROL, V76, P8408, DOI 10.1128/JVI.76.16.8408-8419.2002
   Kutmon M, 2016, NUCLEIC ACIDS RES, V44, pD488, DOI 10.1093/nar/gkv1024
   Langfelder P, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-54
   Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559
   Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057
   Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29
   Leeman JR, 2008, GENE, V423, P97, DOI 10.1016/j.gene.2008.07.015
   Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Lim JK, 2011, J IMMUNOL, V186, P471, DOI 10.4049/jimmunol.1003003
   Lim JK, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000321
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Lum FM, 2018, J INFECT DIS, V218, P814, DOI 10.1093/infdis/jiy225
   Lum FM, 2018, MSPHERE, V3, DOI [10.1128/mSphereDirect.00120-18, 10.1128/mspheredirect.00120-18]
   Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285
   MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210
   Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778
   Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118
   Michlmayr D., 2014, INT J INTERFERON CYT, V6, P1, DOI [DOI 10.2147/IJICMR.S35953, 10.2147/IJICMR.S35953]
   Michlmayr D, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20177862
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Naveca FG, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170542
   Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122
   Popper SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001966
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675
   Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Suprun M, 2019, BIOINFORMATICS, V35, P1605, DOI 10.1093/bioinformatics/bty853
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   van Dinther D, 2018, CELL REP, V22, P1484, DOI 10.1016/j.celrep.2018.01.021
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Yi L., 2017, PLOS ONE, V12
   Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128
   Zhang J, 2016, IMMUNOLOGY, V148, P363, DOI 10.1111/imm.12615
   Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558
   Zompi S, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001568
NR 75
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 28
PY 2020
VL 31
IS 4
AR UNSP 107569
DI 10.1016/j.celrep.2020.107569
PG 24
WC Cell Biology
SC Cell Biology
GA LH8YE
UT WOS:000529070000006
PM 32348760
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Wen, JS
   Wang, YT
   Valentine, KM
   Alves, RPD
   Xu, ZG
   Regla-Nava, JA
   Ngono, AE
   Young, MP
   Ferreira, LCS
   Shresta, S
AF Wen, Jinsheng
   Wang, Ying-Ting
   Valentine, Kristen M.
   dos Santos Alves, Rubens Prince
   Xu, Zhigang
   Regla-Nava, Jose Angel
   Ngono, Annie Elong
   Young, Matthew P.
   Ferreira, Luis C. S.
   Shresta, Sujan
TI CD4(+) T Cells Cross-Reactive with Dengue and Zika Viruses Protect
   against Zika Virus Infection
SO CELL REPORTS
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; RESPONSES; DISEASE; INSIGHTS; VACCINE
AB The underlying mechanisms by which prior immunity to dengue virus (DENV) affords cross-protection against the related flavivirus Zika virus (ZIKV) are poorly understood. Here, we examine the ability of DENV/ZIKVcross-reactive CD4(+) T cells to protect against versus exacerbate ZIKV infection by using a histocompatibility leukocyte antigen (HLA)-DRB1*0101 transgenic, interferon a/b receptor-deficient mouse model that supports robust DENV and ZIKV replication. By mapping the HLA-DRB1*0101-restricted T cell response, we identify DENV/ZIKV-cross-reactive CD4(+) T cell epitopes that stimulate interferon gamma (IFNg) and/or tumor necrosis factor (TNF) production. Vaccination of naive HLA-DRB1*0101 transgenic mice with these peptides induces a CD4(+) T cell response sufficient to reduce tissue viral burden following ZIKV infection. Notably, this protective response requires IFNg and/or TNF secretion but not anti-ZIKV immunoglobulin G (IgG) production. Thus, DENV/ZIKV-cross-reactive CD4(+) T cells producing canonical Th1 cytokines can suppress ZIKV replication in an antibody-independent manner. These results may have important implications for increasing the efficacy and safety of DENV/ZIKV vaccines and for developing pan-flavivirus vaccines.
C1 [Wen, Jinsheng; Wang, Ying-Ting; Valentine, Kristen M.; dos Santos Alves, Rubens Prince; Xu, Zhigang; Regla-Nava, Jose Angel; Ngono, Annie Elong; Young, Matthew P.; Shresta, Sujan] La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [Wen, Jinsheng] Ningbo Univ, Immunol Innovat Team, Sch Med, Ningbo 315211, Zhejiang, Peoples R China.
   [dos Santos Alves, Rubens Prince; Ferreira, Luis C. S.] Univ Sao Paulo, Inst Biomed Sci, Vaccine Dev Lab, BR-14040901 Sao Paulo, Brazil.
RP Wen, JS; Shresta, S (corresponding author), La Jolla Inst Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.; Wen, JS (corresponding author), Ningbo Univ, Immunol Innovat Team, Sch Med, Ningbo 315211, Zhejiang, Peoples R China.
EM wenjinsheng@nbu.edu.cn; sujan@lji.org
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [AI116813, AI140063,
   NS106387]; National Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [31870159]; Zhejiang Provincial Natural
   Science FoundationNatural Science Foundation of Zhejiang Province
   [LY17C010004]
FX This work was supported by the grants from the National Institutes of
   Health (AI116813, AI140063, and NS106387 to S.S.), the National Natural
   Science Foundation of China (31870159 to J.W.), and the Zhejiang
   Provincial Natural Science Foundation (LY17C010004 to J.W.).
CR Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Carlin AF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007053
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   CHAUDHURI AA, 2016, PLOS CURR, V8, DOI DOI 10.7759/CUREUS.484
   Choumet V, 2015, REV SCI TECH OIE, V34, P473
   de Alwis R, 2016, J VIROL, V90, P4771, DOI 10.1128/JVI.02892-15
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   DiPiazza A, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00548-16
   Earl PL, 2004, NATURE, V428, P182, DOI 10.1038/nature02331
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liang HB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11754-0
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Marsh S.G.E., 1999, THE HLA FACTSBOOK
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Ngono AE, 2016, EBIOMEDICINE, V13, P284, DOI 10.1016/j.ebiom.2016.10.006
   Panagioti E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00276
   Paquin-Proulx Dominic, 2017, Pathog Immun, V2, P274, DOI 10.20411/pai.v2i2.188
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Robbiani DF, 2019, J EXP MED, V216, P2302, DOI 10.1084/jem.20191061
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Salek-Ardakani S, 2011, J CLIN INVEST, V121, P296, DOI 10.1172/JCI42056
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang WW, 2015, CURR OPIN VIROL, V13, P61, DOI 10.1016/j.coviro.2015.04.007
   Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Weiskopf D, 2011, J IMMUNOL, V187, P4268, DOI 10.4049/jimmunol.1101970
   Wen JS, 2019, CURR OPIN IMMUNOL, V59, P1, DOI 10.1016/j.coi.2019.02.001
   Wen JS, 2017, J INTERF CYTOK RES, V37, P475, DOI 10.1089/jir.2017.0106
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Zellweger RM, 2015, J VIROL, V89, P6494, DOI 10.1128/JVI.00036-15
NR 62
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 28
PY 2020
VL 31
IS 4
AR UNSP 107566
DI 10.1016/j.celrep.2020.107566
PG 17
WC Cell Biology
SC Cell Biology
GA LH8YE
UT WOS:000529070000004
PM 32348763
OA DOAJ Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Zhang, SJ
   Loy, T
   Ng, TS
   Lim, XN
   Chew, SYV
   Tan, T
   Xu, MH
   Kostyuchenko, VA
   Tukijan, F
   Shi, J
   Fink, K
   Lok, SM
AF Zhang, Shuijun
   Loy, Thomas
   Ng, Thiam-Seng
   Lim, Xin-Ni
   Chew, Shyn-Yun Valerie
   Tan, Ter Yong
   Xu, Meihui
   Kostyuchenko, Victor A.
   Tukijan, Farhana
   Shi, Jian
   Fink, Katja
   Lok, Shee-Mei
TI A Human Antibody Neutralizes Different Flaviviruses by Using Different
   Mechanisms
SO CELL REPORTS
LA English
DT Article
ID DENGUE VIRUS; CRYO-EM; POTENT; SYSTEM
AB Human antibody SIgN-3C neutralizes dengue virus (DENV) and Zika virus (ZIKV) differently. DENV:SIgN-3C Fab and ZIKV:SIgN-3C Fab cryoelectron microscopy (cryo-EM) complex structures show Fabs crosslink E protein dimers at extracellular pH 8.0 condition and also when further incubated at acidic endosomal conditions (pH 8.0-6.5). We observe Fab binding to DENV (pH 8.0-5.0) prevents virus fusion, and the number of bound Fabs increase (from120 to 180). For ZIKV, although there are already 180 copies of Fab at pH 8.0, virus structural changes at pH 5.0 are not inhibited. The immunoglobulin G (IgG):DENV structure at pH 8.0 shows both Fab arms bind to epitopes around the 2-fold vertex. On ZIKV, an additional Fab around the 5-fold vertex at pH 8.0 suggests one IgG arm would engage with an epitope, although the other may bind to other viruses, causing aggregation. For DENV2 at pH 5.0, a similar scenario would occur, suggesting DENV2:IgG complex would aggregate in the endosome. Hence, a single antibody employs different neutralization mechanisms against different flaviviruses.
C1 [Zhang, Shuijun; Ng, Thiam-Seng; Lim, Xin-Ni; Chew, Shyn-Yun Valerie; Tan, Ter Yong; Kostyuchenko, Victor A.; Lok, Shee-Mei] Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore 169857, Singapore.
   [Zhang, Shuijun; Ng, Thiam-Seng; Lim, Xin-Ni; Chew, Shyn-Yun Valerie; Tan, Ter Yong; Kostyuchenko, Victor A.; Shi, Jian; Lok, Shee-Mei] Natl Univ Singapore, Ctr Biolmaging Sci, Singapore 117557, Singapore.
   [Loy, Thomas; Xu, Meihui; Tukijan, Farhana; Fink, Katja] Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138632, Singapore.
   [Loy, Thomas; Fink, Katja] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Shi, Jian] Natl Univ Singapore, Dept Biol Sci, CryoEM Unit, Singapore 117557, Singapore.
RP Lok, SM (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore 169857, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Ctr Biolmaging Sci, Singapore 117557, Singapore.; Fink, K (corresponding author), Agcy Sci Technol & Res, Singapore Immunol Network, Singapore 138632, Singapore.; Fink, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
EM kfink@vir.bio; sheemei.lok@duke-nus.edu.sg
FU Singapore National Research Foundation InvestigatorshipSingapore
   National Research Foundation [NRF-NRFI2015-16]; Singapore National
   Research Foundation Competitive Research ProgramSingapore National
   Research Foundation [NRF2016NRF-CRP001-063]; A*GA under the SIgN-NTU-NUS
   program
FX We thank the European Virus Archive for consenting to the use of the
   ZIKV H/PF/2013 strain, M.S. Diamond for sending the ZIKV, E.E. Ooi for
   providing DENV2 PVP94/07, and J. Wang and J.S.G. Ooi for help with the
   fusion assay. The work is supported by Singapore National Research
   Foundation Investigatorship (NRF-NRFI2015-16) and Singapore National
   Research Foundation Competitive Research Program grants
   (NRF2016NRF-CRP001-063). T.L. received a PhD fellowship from A*GA under
   the SIgN-NTU-NUS program.
CR Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P531, DOI 10.1107/S2059798318006551
   Ayala-Nunez NV, 2011, METHODS, V55, P137, DOI 10.1016/j.ymeth.2011.07.009
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Carragher B, 2000, J STRUCT BIOL, V132, P33, DOI 10.1006/jsbi.2000.4314
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Ilca SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9843
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lok SM, 2016, TRENDS MICROBIOL, V24, P284, DOI 10.1016/j.tim.2015.12.004
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rodenhuis-Zybert IA, 2011, TRENDS MICROBIOL, V19, P248, DOI 10.1016/j.tim.2011.02.002
   Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008
   Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Xu MH, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-016-0003-3
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193
   Zust R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003521
NR 37
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD APR 28
PY 2020
VL 31
IS 4
AR UNSP 107584
DI 10.1016/j.celrep.2020.107584
PG 19
WC Cell Biology
SC Cell Biology
GA LH8YE
UT WOS:000529070000002
PM 32348755
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU El-Sayed, A
   Kamel, M
AF El-Sayed, Amr
   Kamel, Mohamed
TI Climatic changes and their role in emergence and re-emergence of
   diseases
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Review
DE Climate; Climate change; Global warming; Disease; Vector; Mosquitoes;
   Tick; Sandflies; West Nile; Lyme; Malaria; Zika; Ticks; Tick-borne
   diseases; Emerging and resurging pathogens; Zoonoses; Vector ecology
ID TICK-BORNE ENCEPHALITIS; WEST NILE VIRUS; INFECTIOUS-DISEASES;
   COXIELLA-BURNETII; PHYLOGENETIC ANALYSIS; CERCARIAL DERMATITIS;
   NAEGLERIA-FOWLERI; UNITED-STATES; VECTOR; MALARIA
AB Global warming and the associated climate changes are predictable. They are enhanced by burning of fossil fuels and the emission of huge amounts of CO2 gas which resulted in greenhouse effect. It is expected that the average global temperature will increase with 2-5 degrees C in the next decades. As a result, the earth will exhibit marked climatic changes characterized by extremer weather events in the coming decades, such as the increase in temperature, rainfall, summertime, droughts, more frequent and stronger tornadoes and hurricanes. Epidemiological disease cycle includes host, pathogen and in certain cases intermediate host/vector. A complex mixture of various environmental conditions (e.g. temperature and humidity) determines the suitable habitat/ecological niche for every vector host. The availability of suitable vectors is a precondition for the emergence of vector-borne pathogens. Climate changes and global warming will have catastrophic effects on human, animal and environmental ecosystems. Pathogens, especially neglected tropical disease agents, are expected to emerge and re-emerge in several countries including Europe and North America. The lives of millions of people especially in developing countries will be at risk in direct and indirect ways. In the present review, the role of climate changes in the spread of infectious agents and their vectors is discussed. Examples of the major emerging viral, bacterial and parasitic diseases are also summarized.
C1 [El-Sayed, Amr; Kamel, Mohamed] Cairo Univ, Dept Med & Infect Dis, Fac Vet Med, Giza, Egypt.
RP Kamel, M (corresponding author), Cairo Univ, Dept Med & Infect Dis, Fac Vet Med, Giza, Egypt.
EM m_salah@staff.cu.edu.eg
RI Kamel, Mohamed S/Q-4191-2016
OI Kamel, Mohamed S/0000-0001-5540-0114
CR Adams DA, 2015, SUMMARY NOTIFIABLE I
   Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401
   Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802
   Andersson Y, 2006, EURO SURVEILL, V11
   Andreassen A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-177
   [Anonymous], 2013, LYMPH FIL EP RISK FA
   Antonenko YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061902
   Aransay AM, 2004, PARASITOL RES, V94, P416, DOI 10.1007/s00436-004-1231-4
   Ariza L, 2013, EUR J CLIN MICROBIOL, V32, P373, DOI 10.1007/s10096-012-1752-1
   Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328
   BA Allsopp, 2015, HEARTWATER EHRLICHIA
   Babaie Javad, 2018, Journal of Parasitic Diseases, V42, P331, DOI 10.1007/s12639-018-1017-8
   Baker-Austin C, 2013, NAT CLIM CHANGE, V3, P73, DOI [10.1038/nclimate1628, 10.1038/NCLIMATE1628]
   Ballart C, 2012, ACTA TROP, V122, P155, DOI 10.1016/j.actatropica.2011.11.011
   Baylis M, 2017, ENVIRON HEALTH-GLOB, V16, P45, DOI 10.1186/s12940-017-0326-1
   Beesley NJ, 2018, TRANSBOUND EMERG DIS, V65, P199, DOI 10.1111/tbed.12682
   Ben Ari T, 2008, BIOL LETTERS, V4, P737, DOI 10.1098/rsbl.2008.0363
   Bern C, 2007, JAMA-J AM MED ASSOC, V298, P2171, DOI 10.1001/jama.298.18.2171
   Berthova L, 2016, EXP APPL ACAROL, V68, P299, DOI 10.1007/s10493-015-9975-3
   Beugnet F, 2013, COMP IMMUNOL MICROB, V36, P559, DOI 10.1016/j.cimid.2013.07.003
   Biagini P, 2012, VARIOLA VIRUS 300 YE
   Bidle KD, 2007, P NATL ACAD SCI USA, V104, P13455, DOI 10.1073/pnas.0702196104
   Biswas G, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0146
   Boecken G, 2011, J DTSCH DERMATOL GES, V9, P1, DOI 10.1111/j.1610-0379.2011.07820.x
   Boissier J, 2015, LANCET INFECT DIS, V15, P757, DOI 10.1016/S1473-3099(15)00084-5
   Bouchard C, 2019, RELEVE MALADIES TRAN, V45, P89, DOI [10.14745/ccdr.v45i04a02f, DOI 10.14745/CCDR.V45I04A02F]
   Brown WC, 2016, ANNU REV ANIM BIOSCI, V4, P177, DOI 10.1146/annurev-animal-022513-114206
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Cann KF, 2013, EPIDEMIOL INFECT, V141, P671, DOI 10.1017/S0950268812001653
   Cassell JA, 2018, LANCET INFECT DIS, V18, P894, DOI 10.1016/S1473-3099(18)30347-5
   CDC, 2017, CTR DIS CONTR PREV B
   CDC, 2017, EP RISK FACT
   Chandler DJ, 2019, DERMATOLOGY, V235, P79, DOI 10.1159/000495290
   Chenier S, 2010, CAN VET J, V51, P1011
   Cull B, 2018, TICKS TICK-BORNE DIS, V9, P605, DOI 10.1016/j.ttbdis.2018.01.011
   Daniel M, 2003, EUR J CLIN MICROBIOL, V22, P327, DOI 10.1007/s10096-003-0918-2
   Danis K, 2011, EUROSURVEILLANCE, V16, P2
   Dantas-Torres F, 2015, INT J PARASITOL-PAR, V4, P452, DOI 10.1016/j.ijppaw.2015.07.001
   deGentile L, 1996, B WORLD HEALTH ORGAN, V74, P159
   Dekoninck W, 2011, J MED ENTOMOL, V48, P924, DOI 10.1603/ME10235
   Dereure J, 2009, VECTOR-BORNE ZOONOT, V9, P687, DOI 10.1089/vbz.2008.0126
   Dhar-Chowdhury P, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005475
   Dhimal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129869
   Dhimal M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003545
   Dikid T, 2013, INDIAN J MED RES, V138, P18
   Dujardin JC, 2008, EMERG INFECT DIS, V14, P1013, DOI 10.3201/eid1407.071589
   ECDC, 2013, PHLEB SANDFL DISTR M
   Eisen RJ, 2018, TRENDS PARASITOL, V34, P295, DOI 10.1016/j.pt.2017.12.006
   El Sayed A, 2008, TROP ANIM HEALTH PRO, V40, P469, DOI 10.1007/s11250-007-9122-1
   El-Sayed A, 2018, INT J VET SCI MED, V6, P8, DOI 10.1016/j.ijvsm.2018.05.001
   El-Sayed A, 2018, INT J VET SCI MED, V6, pS31, DOI 10.1016/j.ijvsm.2018.01.008
   Epizooties OId, 2014, TERR AN HLTH COD
   Fatmi SS, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00342
   Fischer D, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-51
   Foldvari G, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1599-x
   Frank C, 2006, EURO SURVEILL, V11
   Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030
   Gaibani P, 2017, MICROBES INFECT, V19, P382, DOI 10.1016/j.micinf.2017.05.003
   Galvez R, 2011, VECTOR-BORNE ZOONOT, V11, P799, DOI 10.1089/vbz.2010.0109
   Garcia-Solache MA, 2010, MBIO, V1, DOI 10.1128/mBio.00061-10
   Gassner F, 2007, EMERGING PESTS VECTO, V207
   Geisler WM, 2012, INFECT CAUSED CHLAMY, P335
   Ghazali DA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15071379
   Gilbert L, 2016, EXP APPL ACAROL, V68, P363, DOI 10.1007/s10493-015-9952-x
   Gilbert L, 2010, OECOLOGIA, V162, P217, DOI 10.1007/s00442-009-1430-x
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Greenblatt CL, 1999, MICROBIAL ECOL, V38, P58, DOI 10.1007/s002489900153
   Greer A, 2008, CAN MED ASSOC J, V178, P715, DOI 10.1503/cmaj.081325
   Gunda R, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-2036-0
   Haines A, 2004, JAMA-J AM MED ASSOC, V291, P99, DOI 10.1001/jama.291.1.99
   Hakalahti T, 2006, J HELMINTHOL, V80, P93, DOI 10.1079/JOH2006351
   Hampson K, 2015, PLOS NEGLECTED TROPI, V9
   Handmer J, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P231
   Hansen A, 2015, INT J INFECT DIS, V33, P212, DOI 10.1016/j.ijid.2015.02.010
   Hargrove JW, 2005, TRYPANOSOMIASES, P113
   Hartemink N, 2016, EXP APPL ACAROL, V68, P269, DOI 10.1007/s10493-015-0003-4
   Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505
   Hayes ML, 2001, HYDROBIOLOGIA, V460, P213, DOI 10.1023/A:1013121503937
   Hofhuis A, 2015, TICKS TICK-BORNE DIS, V6, P69, DOI 10.1016/j.ttbdis.2014.09.006
   Holbrook MR, 2012, ANTIVIR RES, V96, P353, DOI 10.1016/j.antiviral.2012.10.005
   HUIZINGA HW, 1990, APPL ENVIRON MICROB, V56, P2200, DOI 10.1128/AEM.56.7.2200-2205.1990
   IPC C, 2001, CLIMATE CHANGE 2001
   IPPC, 2017, 3 ASS REP
   Ivanescu L, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8560519
   Jado I, 2007, EMERG INFECT DIS, V13, P1405, DOI 10.3201/eid1309.060186
   Jaenson TGT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-184
   Jimenez-Clavero Miguel A., 2012, Frontiers in Genetics, V3, P105, DOI 10.3389/fgene.2012.00105
   Jore S, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-84
   Katayama T, 2007, APPL ENVIRON MICROB, V73, P2360, DOI 10.1128/AEM.01715-06
   Kawahara M, 2004, INT J SYST EVOL MICR, V54, P1837, DOI 10.1099/ijs.0.63260-0
   Kazimirova M, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00339
   Kernif T., 2016, MICROBIOLOGY SPECTRU, V10, P295, DOI [10.1128/563665, DOI 10.1128/9781555819453.ch16]
   Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082
   Koehler LM, 2019, COMP IMMUNOL MICROB, V64, P67, DOI 10.1016/j.cimid.2019.02.004
   Kolarova L, 2007, FOLIA PARASIT, V54, P81, DOI 10.14411/fp.2007.010
   Kruger A, 2001, TROP MED INT HEALTH, V6, P983, DOI 10.1046/j.1365-3156.2001.00816.x
   Kuhn KG, 2003, P NATL ACAD SCI USA, V100, P9997, DOI 10.1073/pnas.1233687100
   Kulkarni MA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.33
   Larsen A, 2004, ACTA PARASITOL, V49
   Leistner Rasmus, 2017, J Infect Prev, V18, P189, DOI 10.1177/1757177417690920
   Lindgren E, 2001, LANCET, V358, P16, DOI 10.1016/S0140-6736(00)05250-8
   Lindgren E, 2000, ENVIRON HEALTH PERSP, V108, P119, DOI 10.2307/3454509
   Lu PY, 2016, EXP APPL ACAROL, V68, P113, DOI 10.1007/s10493-015-9987-z
   Ludwig A, 2019, Can Commun Dis Rep, V45, P91, DOI 10.14745/ccdr.v45i04a03
   Lukan M, 2010, EMERG INFECT DIS, V16, P524, DOI 10.3201/eid1603.081364
   Mackey TK, 2014, CLIN MICROBIOL REV, V27, P949, DOI 10.1128/CMR.00045-14
   Majoros G, 2008, EMERG INFECT DIS, V14, P1812, DOI 10.3201/eid1411.080479
   Mannelli A, 2012, FEMS MICROBIOL REV, V36, P837, DOI 10.1111/j.1574-6976.2011.00312.x
   Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0
   Marcogliese DJ, 2008, REV SCI TECH OIE, V27, P467, DOI 10.20506/rst.27.2.1820
   Mas-Coma S, 2008, REV SCI TECH OIE, V27, P443, DOI 10.20506/rst.27.2.1822
   McCarthy J. J., 2001, CLIMATE CHANGE 2001
   McMullan LK, 2012, NEW ENGL J MED, V367, P834, DOI 10.1056/NEJMoa1203378
   Medialdea-Carrera R, 2018, EUROSURVEILLANCE, V23
   Medone P, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0560
   Merhej V, 2014, INFECT GENET EVOL, V25, P122, DOI 10.1016/j.meegid.2014.03.014
   Micallef MJ, 2016, GEOGRAPHICA, V5, P7
   Milazzo A, 2017, FOODBORNE PATHOG DIS, V14, P125, DOI 10.1089/fpd.2016.2201
   Min Ji-guang, 1996, Southeast Asian Journal of Tropical Medicine and Public Health, V27, P810
   Mitra Amal K, 2017, Trop Med Infect Dis, V2, DOI 10.3390/tropicalmed2030036
   Molyneux E, 2009, T ROY SOC TROP MED H, V103, P11, DOI 10.1016/j.trstmh.2008.07.002
   Monge-Maillo B, 2012, MEDITERR J HEMATOL I, V4, DOI 10.4084/MJHID.2012.014
   Moore S, 2012, J R SOC INTERFACE, V9, P817, DOI 10.1098/rsif.2011.0654
   Mor S, 2018, CLIMATIC INFLUENCE A
   Morgan JAT, 2001, PARASITOLOGY, V123, pS211
   Nakazawa Y, 2007, VECTOR-BORNE ZOONOT, V7, P529, DOI 10.1089/vbz.2007.0125
   Nava A, 2017, ILAR J, V58, P393, DOI 10.1093/ilar/ilx034
   Neghina R, 2011, VECTOR-BORNE ZOONOT, V11, P1285, DOI 10.1089/vbz.2010.0275
   Ng V, 2019, Can Commun Dis Rep, V45, P98, DOI 10.14745/ccdr.v45i04a04
   Nicolescu G, 2016, INT J INFECT DIS, V45, P187, DOI 10.1016/j.ijid.2016.02.436
   Ogden N H, 2019, Can Commun Dis Rep, V45, P76, DOI 10.14745/ccdr.v45i04a01
   Ogden NH, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0532-4
   Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015
   Pacheco RC, 2013, EMERG INFECT DIS, V19, P344, DOI 10.3201/eid1902.120362
   Paddock CD, 2003, CLIN MICROBIOL REV, V16, P37, DOI 10.1128/CMR.16.1.37-64.2003
   Paddock CD, 2015, J MED ENTOMOL, V52, P230, DOI 10.1093/jme/tju022
   Papa A, 2015, J CLIN VIROL, V64, P137, DOI 10.1016/j.jcv.2014.08.029
   Park MS, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15112482
   Parola P, 2005, CLIN MICROBIOL REV, V18, P719, DOI 10.1128/CMR.18.4.719-756.2005
   Parola P, 2001, CLIN MICROBIOL INFEC, V7, P80, DOI 10.1046/j.1469-0691.2001.00200.x
   Parola P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000338
   Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766
   Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561
   Pijnacker R, 2016, EUROSURVEILLANCE, V21, P23, DOI 10.2807/1560-7917.ES.2016.21.17.30211
   PLOS Medicine Editors, 2007, PLOS MED, V3, pe380, DOI DOI 10.1371/journal.ppat.0030201
   Pointier JP, 2005, J HELMINTHOL, V79, P249, DOI 10.1079/JOH2005292
   Porretta D, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-271
   Portier Christopher J., 2017, HUMAN HLTH PERSPECTI
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Prudhomme J, 2019, EMERG MICROBES INFEC, V8, P962, DOI 10.1080/22221751.2019.1634489
   Purse BV, 2005, NAT REV MICROBIOL, V3, P171, DOI 10.1038/nrmicro1090
   Ramos JM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004321
   Randolph SE, 2004, INT J MED MICROBIOL, V293, P5, DOI 10.1016/S1433-1128(04)80004-4
   Ready PD, 2010, EUROSURVEILLANCE, V15, P29
   Redshaw CH, 2013, J TOXICOL ENV HEAL B, V16, P285, DOI 10.1080/10937404.2013.802265
   Renn O, 2011, AMBIO, V40, P231, DOI 10.1007/s13280-010-0134-0
   Report W, 2015, YELLOW FEVER
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x
   Rizzoli A, 2011, EUROSURVEILLANCE, V16, P2
   Rose JB, 2001, ENVIRON HEALTH PERSP, V109, P211, DOI 10.2307/3435011
   Sallares R., 2002, MALARIA ROME HIST MA
   Sanyaolu A., 2016, SM J PUBLIC HLTH EPI, V2, P1028
   Schets F, 2006, EUROSURVEILLANCE, V11, P3077, DOI DOI 10.2807/ESW.11.45.03077-EN
   Schmidt JP, 2017, EMERG INFECT DIS, V23, P415, DOI 10.3201/eid2303.160101
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   Semenza JC, 2012, CRIT REV ENV SCI TEC, V42, P857, DOI 10.1080/10643389.2010.534706
   Shikanai-Yasuda MA, 2012, CLIN INFECT DIS, V54, P845, DOI 10.1093/cid/cir956
   Smith KR, 2017, HUMAN HLTH IMPACTS A
   Solomon S, 2007, IPCC 4 ASSESSMENT RE
   Sonenshine DE, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15030478
   Sousa CA, 2012, EUROSURVEILLANCE, V17, P15
   Ssempiira Julius, 2018, Parasite Epidemiol Control, V3, pe00070, DOI 10.1016/j.parepi.2018.e00070
   Stuen S, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00031
   SYKORA JL, 1983, APPL ENVIRON MICROB, V45, P974, DOI 10.1128/AEM.45.3.974-979.1983
   Talapko J, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7060179
   Teklehaimanot HD, 2004, EMERG INFECT DIS, V10, P1220, DOI 10.3201/eid1007.030722
   Thomas RJ, 2009, EXPERT REV ANTI-INFE, V7, P709, DOI 10.1586/ERI.09.44
   Thompson AA, 2012, INT J ENV RES PUB HE, V9, P831, DOI 10.3390/ijerph9030831
   Tokarevich NK, 2011, GLOBAL HEALTH ACTION, V4, DOI 10.3402/gha.v4i0.8448
   Tokarz R, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00614-17, 10.1128/msphere.00614-17]
   Tokarz R, 2014, J VIROL, V88, P11480, DOI 10.1128/JVI.01858-14
   Tong C, 2019, EUROSURVEILLANCE, V24
   Touchon M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000344
   Vannier E, 2020, BABESIOSIS HUNTERS T, P799
   Vannier E, 2012, NEW ENGL J MED, V366, P2397, DOI 10.1056/NEJMra1202018
   Vazquez A, 2011, EUROSURVEILLANCE, V16, P22
   Walsh AS, 2008, ENVIRON ECOL STAT, V15, P279, DOI 10.1007/s10651-007-0056-6
   WHO, 2017, WHO REP 2017 GLOB EN
   *WHO, 2005, US CLIM PRED INF DIS
   WHO, 2018, COP24 SPEC REP HLTH
   Wikel Stephen K, 2018, Vet Sci, V5, DOI 10.3390/vetsci5020060
   Ziegler U, 2019, ANTIVIR RES, V162, P39, DOI 10.1016/j.antiviral.2018.12.005
NR 194
TC 1
Z9 1
U1 6
U2 6
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD JUN
PY 2020
VL 27
IS 18
SI SI
BP 22336
EP 22352
DI 10.1007/s11356-020-08896-w
EA APR 2020
PG 17
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA LY0XL
UT WOS:000529493300023
PM 32347486
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Diosa-Toro, M
   Prasanth, KR
   Bradrick, SS
   Blanco, MAG
AF Diosa-Toro, Mayra
   Prasanth, K. Reddisiva
   Bradrick, Shelton S.
   Garcia Blanco, Mariano A.
TI Role of RNA-binding proteins during the late stages of Flavivirus
   replication cycle
SO VIROLOGY JOURNAL
LA English
DT Review
DE RNA-binding proteins; Flavivirus infection; Viral assembly; RNA export;
   Exosomes
ID HEPATITIS-C-VIRUS; WEST-NILE-VIRUS; YELLOW-FEVER VIRUS; NUCLEOLAR
   HELICASE DDX56; BORNE ENCEPHALITIS-VIRUS; STRESS GRANULE FORMATION;
   DENGUE VIRUS; JAPANESE ENCEPHALITIS; NONSTRUCTURAL PROTEINS; CAPSID
   PROTEIN
AB The genus Flavivirus encompasses several worldwide-distributed arthropod-borne viruses including, dengue virus, Japanese encephalitis virus, West Nile virus, yellow fever virus, Zika virus, and tick-borne encephalitis virus. Infection with these viruses manifest with symptoms ranging from febrile illness to life- threatening hypotensive shock and encephalitis. Therefore, flaviviruses pose a great risk to public health. Currently, preventive measures are falling short to control epidemics and there are no antivirals against any Flavivirus. Flaviviruses carry a single stranded positive-sense RNA genome that plays multiple roles in infected cells: it is translated into viral proteins, used as template for genome replication, it is the precursor of the subgenomic flaviviral RNA and it is assembled into new virions. Furthermore, viral RNA genomes are also packaged into extracellular vesicles, e.g. exosomes, which represent an alternate mode of virus dissemination. Because RNA molecules are at the center of Flavivirus replication cycle, viral and host RNA-binding proteins (RBPs) are critical determinants of infection. Numerous studies have revealed the function of RBPs during Flavivirus infection, particularly at the level of RNA translation and replication. These proteins, however, are also critical participants at the late stages of the replication cycle. Here we revise the function of host RBPs and the viral proteins capsid, NS2A and NS3, during the packaging of viral RNA and the assembly of new virus particles. Furthermore, we go through the evidence pointing towards the importance of host RBPs in mediating cellular RNA export with the idea that the biogenesis of exosomes harboring Flavivirus RNA would follow an analogous pathway.
C1 [Diosa-Toro, Mayra; Garcia Blanco, Mariano A.] Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.
   [Prasanth, K. Reddisiva; Bradrick, Shelton S.; Garcia Blanco, Mariano A.] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Bradrick, Shelton S.] MRIGlobal, Global Hlth Surveillance & Diagnost Grp, Kansas City, MO USA.
   [Bradrick, Shelton S.; Garcia Blanco, Mariano A.] Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
RP Diosa-Toro, M; Blanco, MAG (corresponding author), Duke NUS Med Sch, Programme Emerging Infect Dis, Singapore, Singapore.; Blanco, MAG (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.; Blanco, MAG (corresponding author), Univ Texas Med Branch, Inst Human Infect & Immun, Galveston, TX 77555 USA.
EM mayra.diosa@duke-nus.edu.sg; maragarc@utmb.edu
FU Dutch Research Council (NWO)Netherlands Organization for Scientific
   Research (NWO); Duke-NUS Medical School Signature Research Programme -
   Agency for Science, Technology and Research (A*STAR), Singapore;
   Ministry of Health, SingaporeMinistry of Health-Singapore; University of
   Texas Medical Branch
FX MDT is recipient of a Rubicon Fellowship from the Dutch Research Council
   (NWO). The group in Singapore acknowledges funding from the Duke-NUS
   Medical School Signature Research Programme funded by the Agency for
   Science, Technology and Research (A*STAR), Singapore, and the Ministry
   of Health, Singapore (MAGB). The group in Galveston acknowledges funding
   from the University of Texas Medical Branch (MAGB).
CR Abernathy E, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2006926
   Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   Ahmad M, 2016, NUCLEIC ACIDS RES, V44, P6335, DOI 10.1093/nar/gkw508
   Albornoz A, 2014, J VIROL, V88, P6611, DOI 10.1128/JVI.03736-13
   Altan-Bonnet N, 2019, VIRUS RES, V265, P143, DOI 10.1016/j.virusres.2019.03.023
   Altan-Bonnet N, 2016, CURR OPIN MICROBIOL, V32, P77, DOI 10.1016/j.mib.2016.05.004
   Amberg SM, 1999, J VIROL, V73, P8083, DOI 10.1128/JVI.73.10.8083-8094.1999
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Balinsky CA, 2013, J VIROL, V87, P13094, DOI 10.1128/JVI.00704-13
   Barrett ADT, 2009, CURR OPIN IMMUNOL, V21, P308, DOI 10.1016/j.coi.2009.05.018
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Basu A, 2008, FEMS IMMUNOL MED MIC, V53, P287, DOI 10.1111/j.1574-695X.2008.00420.x
   Batagov AO, 2013, BIOL DIRECT, V8, DOI 10.1186/1745-6150-8-12
   Bellingham SA, 2012, NUCLEIC ACIDS RES, V40, P10937, DOI 10.1093/nar/gks832
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bidet K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004242
   Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869
   Blazquez AB, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00797
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bredenbeek PJ, 2003, J GEN VIROL, V84, P1261, DOI 10.1099/vir.0.18860-0
   BRINTON MA, 1986, VIROLOGY, V153, P113, DOI 10.1016/0042-6822(86)90012-7
   Bukong TN, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004424
   Byk LA, 2016, ANNU REV VIROL, P1
   Byk LA, 2016, MBIO, V7, DOI 10.1128/mBio.00804-16
   Campos RK, 2017, CURR TOP MICROBIOL I, V419
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   CARRASCO L, 1995, ADV VIRUS RES, V45, P61, DOI 10.1016/S0065-3527(08)60058-5
   Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang CJ, 2001, DNA CELL BIOL, V20, P569, DOI 10.1089/104454901317094981
   Chang KS, 2007, J VIROL, V81, P13783, DOI 10.1128/JVI.01091-07
   Chang YS, 1999, J VIROL, V73, P6257, DOI 10.1128/JVI.73.8.6257-6264.1999
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   Chen YH, 2015, CELL, V160, P619, DOI 10.1016/j.cell.2015.01.032
   Chu JJH, 2004, J VIROL, V78, P10543, DOI 10.1128/JVI.78.19.10543-10555.2004
   Counotte Michel Jacques, 2018, F1000Res, V7, P196, DOI 10.12688/f1000research.13704.1
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Diaz O, 2006, J GEN VIROL, V87, P2983, DOI 10.1099/vir.0.82033-0
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003
   Filomatori CV, 2006, GENE DEV, V20, P2238, DOI 10.1101/gad.1444206
   Finlay C, 1937, Yale J Biol Med, V9, P589
   Frankel EB, 2018, SEMIN CELL DEV BIOL, V74, P4, DOI 10.1016/j.semcdb.2017.08.020
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Garcia-Blanco MA, 2016, ANTIVIR RES, V134, P244, DOI 10.1016/j.antiviral.2016.09.010
   Gebhard LG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036244
   Gebhard LG, 2011, VIRUSES-BASEL, V3, P1739, DOI 10.3390/v3091739
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gould SJ, 2003, P NATL ACAD SCI USA, V100, P10592, DOI 10.1073/pnas.1831413100
   HAHN CS, 1987, J MOL BIOL, V198, P33, DOI 10.1016/0022-2836(87)90455-4
   HALSTEAD SB, 1977, NATURE, V265, P739, DOI 10.1038/265739a0
   Halstead SB, 2016, J INFECT DIS, V214, P1793, DOI 10.1093/infdis/jiw340
   Halstead SB, 2010, CLIN INFECT DIS, V50, P1155, DOI 10.1086/651271
   Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Hsu AYH, 2015, SCI REP, V11, P5
   Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838
   Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329
   Kalamvoki M, 2014, P NATL ACAD SCI USA, V111, pE4991, DOI 10.1073/pnas.1419338111
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7
   Khatua AK, 2009, J VIROL, V83, P512, DOI 10.1128/JVI.01658-08
   Khromykh AA, 2001, J VIROL, V75, P4633, DOI 10.1128/JVI.75.10.4633-4640.2001
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Kim KM, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1413
   Kouwaki T, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030666
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kummerer BM, 2002, J VIROL, V76, P4773, DOI 10.1128/JVI.76.10.4773-4784.2002
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Leidal AM, 2020, NAT CELL BIOL, DOI 10.1038/s41556-019-0450-y
   Leung JY, 2008, J VIROL, V82, P4731, DOI 10.1128/JVI.00002-08
   Li Kuohan, 2014, Virologica Sinica, V29, P74, DOI 10.1007/s12250-014-3438-6
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Li MH, 2019, NAT MICROBIOL, V4, P985, DOI 10.1038/s41564-019-0375-z
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   LOBIGS M, 1993, P NATL ACAD SCI USA, V90, P6218, DOI 10.1073/pnas.90.13.6218
   Longatti A, 2015, J VIROL, V89, P2956, DOI 10.1128/JVI.02721-14
   MacFadden A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02604-y
   Mackenzie J, 2005, TRAFFIC, V6, P967, DOI 10.1111/j.1600-0854.2005.00339.x
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Reyes-Ruiz JM, 2019, VIRUS RES, V266, P1, DOI 10.1016/j.virusres.2019.03.015
   Martinez FJ, 2016, NEURON, V92, P780, DOI 10.1016/j.neuron.2016.09.050
   Martins SD, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01792
   Mateo R, 2013, J VIROL, V87, P1312, DOI 10.1128/JVI.02177-12
   Mazeaud C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00595
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Okamoto T, 2006, EMBO J, V25, P5015, DOI 10.1038/sj.emboj.7601367
   Paranjape SM, 2007, J BIOL CHEM, V282, P30497, DOI 10.1074/jbc.M705755200
   Patkar CG, 2008, J VIROL, V82, P3342, DOI 10.1128/JVI.02447-07
   Patton JG, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27494
   Phillips SL, 2016, MBIO, V7, DOI 10.1128/mBio.01865-15
   Pijlman GP, 2006, J VIROL, V80, P11255, DOI 10.1128/JVI.01559-06
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Pong WL, 2011, FEBS LETT, V585, P2575, DOI 10.1016/j.febslet.2011.06.038
   PREUGSCHAT F, 1990, J VIROL, V64, P4364, DOI 10.1128/JVI.64.9.4364-4374.1990
   Quaresma AJC, 2009, EXP CELL RES, V315, P968, DOI 10.1016/j.yexcr.2009.01.012
   Ramakrishnaiah V, 2013, P NATL ACAD SCI USA, V110, P13109, DOI 10.1073/pnas.1221899110
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   Reed W, 1901, J AMER MED ASSOC, V36, P431
   Reed W, 2008, JAMA CLASS, V36, P1
   Reid CR, 2017, VIROLOGY, V500, P169, DOI 10.1016/j.virol.2016.10.025
   Reid DW, 2018, J VIROL, V92, DOI 10.1128/JVI.01766-17
   Ressel S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1535
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Russell PK, 1980, TOGAVIRUSES, P503, DOI 10.1016/b978-0-12-625380-1.50023-0.
   Saadatpour L, 2016, CANCER GENE THER, V23, P415, DOI 10.1038/cgt.2016.48
   Samsa MM, 2012, J VIROL, V86, P1046, DOI 10.1128/JVI.05431-11
   Santangelo L, 2016, CELL REP, V17, P799, DOI 10.1016/j.celrep.2016.09.031
   Schmidt O, 2012, CURR BIOL, V22, pR116, DOI 10.1016/j.cub.2012.01.028
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109
   Shrivastava G, 2017, VIRULENCE, V8, P1450, DOI 10.1080/21505594.2017.1356540
   Shurtleff MJ, 2017, P NATL ACAD SCI USA, V114, pE8987, DOI 10.1073/pnas.1712108114
   Shurtleff MJ, 2016, ELIFE, V5, DOI 10.7554/eLife.19276
   Slonchak A, 2018, ANTIVIR RES, V159, P13, DOI 10.1016/j.antiviral.2018.09.006
   SMITH TJ, 1970, J VIROL, V5, P524, DOI 10.1128/JVI.5.4.524-532.1970
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Statello L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195969
   Stockley PG, 2013, J BIOL PHYS, V39, P277, DOI 10.1007/s10867-013-9313-0
   Swarbrick CMD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1127
   Tabata K, 2016, CELL REP, V16, P2339, DOI 10.1016/j.celrep.2016.07.068
   Thepparit C, 2019, VIRUS RES, V261, P65, DOI 10.1016/j.virusres.2018.12.015
   Tsuda Y, 2006, MICROBIOL IMMUNOL, V50, P225, DOI 10.1111/j.1348-0421.2006.tb03789.x
   Urcuqui-Inchima S, 2010, ADV VIRUS RES, V77, P1, DOI [10.1016/B978-0-12-385034-8.00001-6, 10.1016/S0065-3527(10)77001-9]
   Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596
   van der Schaar HM, 2007, J VIROL, V81, P12019, DOI 10.1128/JVI.00300-07
   Villarroya-Beltri C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3980
   Villas-Boas CSA, 2009, BRAZ J MED BIOL RES, V42, P1020, DOI 10.1590/S0100-879X2009001100004
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Vora A, 2018, P NATL ACAD SCI USA, V115, pE6604, DOI 10.1073/pnas.1720125115
   Vossmann S, 2015, J VIROL, V89, P4951, DOI 10.1128/JVI.03351-14
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   WENGLER G, 1989, J VIROL, V63, P2521, DOI 10.1128/JVI.63.6.2521-2526.1989
   Xie XP, 2019, CELL HOST MICROBE, V26, P606, DOI 10.1016/j.chom.2019.09.015
   Xie XP, 2015, J VIROL, V89, P1298, DOI 10.1128/JVI.02882-14
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Xu ZK, 2012, VIROLOGY, V433, P226, DOI 10.1016/j.virol.2012.08.011
   Xu ZK, 2011, J VIROL, V85, P5571, DOI 10.1128/JVI.01933-10
   Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011
   Yao ZY, 2018, J ZHEJIANG UNIV-SC B, V19, P183, DOI 10.1631/jzus.B1600490
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131
   Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001
   Zhang Q, 2013, J HAZARD MATER, V262, P1147, DOI 10.1016/j.jhazmat.2013.02.017
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XW, 2019, MBIO, V10, DOI 10.1128/mBio.02375-19
   Zhang Y, 2007, J STRUCT BIOL, V157, P356, DOI 10.1016/j.jsb.2006.09.002
   Zhou WS, 2019, EMERG MICROBES INFEC, V8, P307, DOI 10.1080/22221751.2019.1578188
   Zhou WS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006764
   Zirwes RF, 2000, MOL BIOL CELL, V11, P1153, DOI 10.1091/mbc.11.4.1153
NR 162
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD APR 25
PY 2020
VL 17
IS 1
AR 60
DI 10.1186/s12985-020-01329-7
PG 14
WC Virology
SC Virology
GA LJ2IK
UT WOS:000529993400001
PM 32334603
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lanteri, MC
   Santa-Maria, F
   Laughhunn, A
   Girard, YA
   Picard-Maureau, M
   Payrat, JM
   Irsch, J
   Stassinopoulos, A
   Bringmann, P
AF Lanteri, Marion C.
   Santa-Maria, Felicia
   Laughhunn, Andrew
   Girard, Yvette A.
   Picard-Maureau, Marcus
   Payrat, Jean-Marc
   Irsch, Johannes
   Stassinopoulos, Adonis
   Bringmann, Peter
TI Inactivation of a broad spectrum of viruses and parasites by
   photochemical treatment of plasma and platelets using amotosalen and
   ultraviolet A light
SO TRANSFUSION
LA English
DT Review
ID ROSS RIVER VIRUS; INTERCEPT BLOOD SYSTEM; PATHOGEN INACTIVATION;
   CHIKUNGUNYA VIRUS; ZIKA VIRUS; THERAPEUTIC-EFFICACY; WINDOW PHASE;
   MAYARO-VIRUS; HEPATITIS-E; SAO-PAULO
AB BACKGROUND The INTERCEPT Blood System pathogen reduction technology (PRT), which uses amotosalen and ultraviolet A light treatment (amotosalen/UV-PRT), inactivates pathogens in plasma and platelet components (PCs). This review summarizes data describing the inactivation efficacy of amotosalen/UVA-PRT for a broad spectrum of viruses and parasites.
   METHODS Twenty-five enveloped viruses, six nonenveloped viruses (NEVs), and four parasites species were evaluated for sensitivity to amotosalen/UVA-PRT. Pathogens were spiked into plasma and PC at high titers. Samples were collected before and after PRT and assessed for infectivity with cell cultures or animal models. Log reduction factors (LRFs) were defined as the difference in infectious titers before and after amotosalen/UV-PRT.
   RESULTS LRFs of >= 4.0 log were reported for 19 pathogens in plasma (range, >= 4.0 to >= 7.6), 28 pathogens in PC in platelet additive solution (PC-PAS; >= 4.1->= 7.8), and 14 pathogens in PC in 100% plasma (PC-100%; (>= 4.3->8.4). Twenty-five enveloped viruses and two NEVs were sensitive to amotosalen/UV-PRT; LRF ranged from >2.9 to >= 7.6 in plasma, 2.4 or greater to greater than 6.9 in PC-PAS and >3.5 to >6.5 in PC-100%. Infectious titers for four parasites were reduced by >4.0 log in all PC and plasma (>= 4.9 to >8.4).
   CONCLUSION Amotosalen/UVA-PRT demonstrated effective infectious titer reduction for a broad spectrum of viruses and parasites. This confirms the capacity of this system to reduce the risk of viral and parasitic transfusion-transmitted infections by plasma and PCs in various geographies.
C1 [Lanteri, Marion C.; Stassinopoulos, Adonis] Cerus Corp, Dept Sci Affairs, Concord, CA USA.
   [Santa-Maria, Felicia; Laughhunn, Andrew; Girard, Yvette A.; Bringmann, Peter] Cerus Corp, Dept Microbiol, Concord, CA USA.
   [Picard-Maureau, Marcus; Payrat, Jean-Marc; Irsch, Johannes] Cerus Europe BV, Dept Sci Affairs, Amersfoort, Netherlands.
RP Lanteri, MC (corresponding author), Cerus Corp, 1220 Concord Ave, Concord, CA 94520 USA.
EM mlanteri@cerus.com
CR Allen ES, 2019, TRANSFUSION, V59, P3120, DOI 10.1111/trf.15480
   Aly M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183850
   Angheben A, 2015, BLOOD TRANSFUS-ITALY, V13, P540, DOI 10.2450/2015.0040-15
   [Anonymous], 2018, INTERCEPTR BLOOD SYS
   Arslan O, 2013, VOX SANG, V105, P155
   Aubry M, 2017, EMERG INFECT DIS, V23, P1751, DOI 10.3201/eid2310.170583
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Bahar B, 2020, BRIT J HAEMATOL, V188, P465, DOI 10.1111/bjh.16187
   Benjamin RJ, 2017, TRANSFUSION, V57, P2946, DOI 10.1111/trf.14284
   Bloch EM, 2014, VOX SANG, V107, P333, DOI 10.1111/vox.12182
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Bruneel F, 2004, INTENS CARE MED, V30, P1851, DOI 10.1007/s00134-004-2366-6
   Busch MP, 2019, BLOOD, V133, P1854, DOI 10.1182/blood-2018-11-833996
   Butler EK, 2018, TRANSFUSION, V58, P854, DOI 10.1111/trf.14497
   Candotti D, 2020, TRANSFUSION, V60, P106, DOI 10.1111/trf.15593
   Candotti D, 2019, GUT, V68, P313, DOI 10.1136/gutjnl-2018-316490
   Castro G, 2018, TRANSFUSION, V58, P1506, DOI 10.1111/trf.14589
   Cazenave JP, 2010, TRANSFUSION, V50, P1210, DOI 10.1111/j.1537-2995.2009.02579.x
   Chang L, 2020, TRANSFUS MED REV, V34, P75, DOI 10.1016/j.tmrv.2020.02.003
   Ciaravino V, 2009, TRANSFUSION, V49, P985, DOI 10.1111/j.1537-2995.2008.02076.x
   Cinqualbre J, 2015, TRANSFUSION, V55, P1710, DOI 10.1111/trf.13100
   Corash L, 2011, TRANSFUSION, V51, P1355, DOI 10.1111/j.1537-2995.2011.03061.x
   Custer B, 2019, TRANSFUSION, V59, p9A
   Custer B, 2018, TRANSFUSION, V58, P1307, DOI 10.1111/trf.14598
   Czerwinski M, 2017, TRANSFUSION, V57, P1998, DOI 10.1111/trf.14163
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   Dalton HR, 2016, TRANSFUS APHER SCI, V55, P271, DOI 10.1016/j.transci.2016.10.016
   Davison KL, 2019, VOX SANG, V114, P666, DOI 10.1111/vox.12826
   de Vos AS, 2017, TRANSFUSION, V57, P258, DOI 10.1111/trf.13978
   Dodd R, 2009, FUTURE MICROBIOL, V4, P807, DOI 10.2217/FMB.09.63
   Dodd R, 2009, BIOLOGICALS, V37, P62, DOI 10.1016/j.biologicals.2009.01.006
   Dodd RY, 2019, TRANSFUSION, V59, P1162, DOI 10.1111/trf.15223
   Dodd RY, 2019, TRANSFUSION, V59, P9, DOI 10.1111/trf.15081
   Domanovic D, 2017, EUROSURVEILLANCE, V22, P6, DOI 10.2807/1560-7917.ES.2017.22.16.30514
   Domanovic D, 2019, BLOOD TRANSFUS-ITALY, V17, P433, DOI 10.2450/2019.0288-19
   Dupuis K, 2014, VOX SANG, V107, P126
   DUPUIS K, 2012, TRANSFUSION S3, V52, pA22
   Eastman RT, 2005, TRANSFUSION, V45, P1459, DOI 10.1111/j.1537-2995.2005.00552.x
   El Ekiaby M, 2010, BIOLOGICALS, V38, P59, DOI 10.1016/j.biologicals.2009.10.015
   Faddy HM, 2018, TRANSFUSION, V58, P485, DOI 10.1111/trf.14472
   Food and Drug Administration, 2014, GUID IND REC DON QUE
   Girard YA, 2020, TRANSFUSION, V60, P622, DOI 10.1111/trf.15673
   Goncalez T, 2010, TRANSFUSION, V50, P1806, DOI 10.1111/j.1537-2995.2010.02650.x
   Goncalez TT, 2008, AIDS BEHAV, V12, pS39, DOI 10.1007/s10461-008-9391-3
   Goodrich RP, 2010, TRANSFUSION, V50, P1827, DOI 10.1111/j.1537-2995.2010.02635.x
   Gosbell IB, 2019, VOX SANG, V114, P628, DOI 10.1111/vox.12790
   Grass JA, 1998, BLOOD, V91, P2180, DOI 10.1182/blood.V91.6.2180.2180_2180_2188
   Grellier P, 2008, TRANSFUSION, V48, P1676, DOI 10.1111/j.1537-2995.2007.01762.x
   Groves JA, 2017, TRANSFUSION, V57, P850, DOI 10.1111/trf.14018
   Hashem AM, 2019, TRANSFUSION MED, DOI 10.1111/tme.12638
   Hayes C, 2019, TRANSFUSION, DOI 10.1111/trf.15568
   Hindawi SI, 2018, TRANSFUSION, V58, P52, DOI 10.1111/trf.14422
   Hui DS, 2020, INT J INFECT DIS, V91, P264, DOI 10.1016/j.ijid.2020.01.009
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Jauvin V, 2005, TRANSFUSION, V45, P1151, DOI 10.1111/j.1537-2995.2005.04400.x
   Jordan CT, 2004, TRANSFUSION, V44, P1159, DOI 10.1111/j.1537-2995.2004.03351.x
   Klasse PJ, 2015, PROG MOL BIOL TRANSL, V129, P285, DOI 10.1016/bs.pmbts.2014.10.012
   Kleinman S, 2018, TRANSFUSION, V58, P2545, DOI 10.1111/trf.14930
   Kleinman SH, 2009, TRANSFUSION, V49, P2454, DOI 10.1111/j.1537-2995.2009.02322.x
   Knutson F, 2015, VOX SANG, V109, P343, DOI 10.1111/vox.12287
   Kwon SY, 2014, VOX SANG, V107, P254, DOI 10.1111/vox.12158
   Lanteri MC, 2016, TRANSFUSION, V56, P1907, DOI 10.1111/trf.13677
   Lau C, 2017, INT J INFECT DIS, V57, P73, DOI 10.1016/j.ijid.2017.01.041
   LAUGHHUNN A, 2017, TRANSFUSION S3, V57, pA19
   Leiby DA, 2008, TRANSFUSION, V48, P2222, DOI 10.1111/j.1537-2995.2008.01825.x
   Leiby DA, 2019, VOX SANG, V114, P17, DOI 10.1111/vox.12727
   Levin AE, 2016, CURR OPIN HEMATOL, V23, P573, DOI 10.1097/MOH.0000000000000287
   Lin LL, 2005, TRANSFUSION, V45, P580, DOI 10.1111/j.0041-1132.2005.04316.x
   Ling AE, 2000, JAMA-J AM MED ASSOC, V284, P210, DOI 10.1001/jama.284.2.210
   Lozano M, 2011, BRIT J HAEMATOL, V153, P393, DOI 10.1111/j.1365-2141.2011.08635.x
   Maria FS, 2017, TRANSFUSION, V57, p47A
   Marks PW, 2016, J INFECT DIS, V213, P1676, DOI 10.1093/infdis/jiw089
   Mavian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07152-5
   McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443
   McCullough J, 2019, TRANSFUSION, V59, P1132, DOI 10.1111/trf.15103
   Muller-Steinhardt M, 2017, TRANSFUS MED HEMOTH, V44, P217, DOI 10.1159/000479192
   Murphy WG, 2002, PATHOPHYSIOL HAEMO T, V32, P1, DOI 10.1159/000057291
   Musso D, 2014, TRANSFUSION, V54, P2924, DOI 10.1111/trf.12713
   Nahler G, 2009, DICT PHARM MED
   Osselaer JC, 2008, TRANSFUSION, V48, P1061, DOI 10.1111/j.1537-2995.2008.01643.x
   Osselaer JC, 2009, TRANSFUSION, V49, P1412, DOI 10.1111/j.1537-2995.2009.02151.x
   Perkins HA, 2010, TRANSFUSION, V50, P2080, DOI 10.1111/j.1537-2995.2010.02851.x
   Petersen LR, 2019, AM J TROP MED HYG, V100, P242, DOI 10.4269/ajtmh.18-0841
   Petersen LR, 2010, TRANSFUS MED REV, V24, P15, DOI 10.1016/j.tmrv.2009.09.002
   Petrik J, 2016, VOX SANG, V110, P93, DOI 10.1111/vox.12285
   Pierelli L, 2018, TRANSFUSION, V58, P3027, DOI 10.1111/trf.14892
   Pinna D, 2005, TRANSFUSION MED, V15, P269, DOI 10.1111/j.0958-7578.2005.00588.x
   Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Roback JD, 2006, TRANSFUS MED REV, V20, P45, DOI 10.1016/j.tmrv.2005.08.004
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Rutter S, 2019, TRANSFUSION, V59, P1628, DOI 10.1111/trf.15241
   Saa P, 2019, TRANSFUSION, V59, P3164, DOI 10.1111/trf.15484
   SABLE CA, 1994, CLIN INFECT DIS, V18, P273, DOI 10.1093/clinids/18.3.273
   Santa Maria F, 2017, TRANSFUSION, V57, P2016, DOI 10.1111/trf.14161
   Sauvage C, 2020, TRANSFUSION, V60, P73, DOI 10.1111/trf.15623
   Sawyer L, 2008, TRANSFUSION, V48, p88A
   Sawyer L, 2007, TRANSFUSION, V47, P1062, DOI 10.1111/j.1537-2995.2007.01237.x
   Schlenke P, 2011, ANN HEMATOL, V90, P1457, DOI 10.1007/s00277-011-1222-3
   Schulz WL, 2019, J PEDIATR-US, V209, P220, DOI 10.1016/j.jpeds.2019.01.046
   Seed CR, 2017, VOX SANG, V112, P473, DOI 10.1111/vox.12516
   Sim J, 2019, TRANSFUSION, V59, P1953, DOI 10.1111/trf.15269
   Singh Y, 2006, TRANSFUSION, V46, P1168, DOI 10.1111/j.1537-2995.2006.00867.x
   Slot E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176414
   Snyder EL, 2015, NEW ENGL J MED, V372, P1882, DOI 10.1056/NEJMp1500154
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Sykes W, 2019, J INFECT DIS, V220, P643, DOI 10.1093/infdis/jiz145
   Tilak Rina, 2016, Med J Armed Forces India, V72, P157, DOI 10.1016/j.mjafi.2016.02.017
   Tsetsarkin KA, 2013, AM J TROP MED HYG, V88, P1163, DOI 10.4269/ajtmh.12-0603
   US Department of Health and Human Services, 2016, FEBR REC DON SCREEN
   US Department of Health and Human Services, 2019, FDA2014D1814 US DEP
   US Department of Health and Human Services, 2019, REC RED RISK TRANSF
   Vahidnia F, 2016, TRANSFUSION, V56, P2013, DOI 10.1111/trf.13678
   Van Voorhis WC, 2003, ANTIMICROB AGENTS CH, V47, P475, DOI 10.1128/AAC.47.2.475-479.2003
   Vermeulen M, 2019, TRANSFUSION, V59, P267, DOI 10.1111/trf.14959
   Vermeulen M, 2013, TRANSFUSION, V53, P2384, DOI 10.1111/trf.12117
   Ward SJ, 2018, TRANSFUSION, V58, P1916, DOI 10.1111/trf.14912
   Ware AD, 2018, VOX SANG, V113, P3, DOI 10.1111/vox.12620
   Weimer A, 2019, TRANSFUSION, V59, P412, DOI 10.1111/trf.14949
   Weiner E, 2016, TRANSFUSION, V56, p201A
   Wendel S, 2007, ISBT SCI SER, V2, P19, DOI 10.1111/j.1751-2824.2007.00098.x
   Wentz AE, 2019, PUBLIC HEALTH REP, V134, P36, DOI 10.1177/0033354918815182
   Weusten J, 2011, TRANSFUSION, V51, P203, DOI 10.1111/j.1537-2995.2010.02804.x
   Willemse SB, 2017, BONE MARROW TRANSPL, V52, P622, DOI 10.1038/bmt.2016.327
   Willyard C, 2017, NATURE, V549, pS19, DOI 10.1038/549S19a
   World Health Organization, 2016, ANG GRAPPL WORST YEL
   World Health Organization WHO, 2018, YELL FEV BRAZ DIS OU
   World Health Organization WHO, 2004, WHO EXP COMM BIOL ST
   Wu YY, 2010, TRANSFUSION, V50, P776, DOI 10.1111/j.1537-2995.2009.02486.x
NR 131
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD JUN
PY 2020
VL 60
IS 6
BP 1319
EP 1331
DI 10.1111/trf.15807
EA APR 2020
PG 13
WC Hematology
SC Hematology
GA LY1ZB
UT WOS:000528187200001
PM 32333396
OA Other Gold
DA 2020-07-08
ER

PT J
AU Dayan, GH
   Langevin, E
   Gilbert, PB
   Wu, YK
   Moodie, Z
   Forrat, R
   Price, B
   Frago, C
   Bouckenooghe, A
   Cortes, M
   Noriega, F
   DiazGranados, CA
AF Dayan, Gustavo H.
   Langevin, Edith
   Gilbert, Peter B.
   Wu, Yukun
   Moodie, Zoe
   Forrat, Remi
   Price, Brenda
   Frago, Carina
   Bouckenooghe, Alain
   Cortes, Margarita
   Noriega, Fernando
   DiazGranados, Carlos A.
TI Assessment of the long-term efficacy of a dengue vaccine against
   symptomatic, virologically-confirmed dengue disease by baseline dengue
   serostatus
SO VACCINE
LA English
DT Article; Proceedings Paper
CT Annual Conference on Vaccinology Research
CY APR 03-05, 2019
CL Baltimore, MD
DE CYD-TDV; Vaccine efficacy; Serostatus; Asia-Pacific; Latin America
ID ZIKA VIRUS; COHORT
AB CYD-TDV is a live, attenuated, tetravalent dengue vaccine licensed in 21 countries. We undertook a posthoc analysis of the long-term efficacy of CYD-TDV during the surveillance expansion phase (SEP) of two Phase III studies (CYD14 in the Asia-Pacific region; CYD15 in Latin America). The SEP included approximately Year 5 and the entire Year 6 of follow-up after the first study injection. Vaccine efficacy against symptomatic virologically-confirmed dengue (VCD) was assessed by participant age (any age, >= 9, <9, 2-5, and 6-8 years at the time of the first injection) and baseline dengue serostatus using a casecohort framework. Baseline dengue serostatus was estimated by several methods including logistic regression-based multiple imputation (MI) to predict PRNT50 with key predictor being Month 13 (M13) anti-non-structural protein (NS1) titers; superlearner-based imputation by targeted minimum loss based estimation (TMLE); and M13 anti-NS1 titer threshold 9 EU/mL (NS1 M13). There were 436 symptomatic VCD cases (CYD14: n = 360; CYD15: n = 76) during the SEP. Vaccine efficacy in seropositive participants aged >= 9 years was assessed by MI (47.9% [95% CI 19.4; 66.3]), TMLE (53.0% [95% CI 23; 71]), and NS1 M13 (52.4% [95% CI 30.8; 67.3]). Vaccine efficacy estimates were lower in seropositive individuals aged <9 years compared with individuals >= 9 years. Among seropositive individuals aged 2-5 and 6-8 years, vaccine efficacy across the different approaches for assessing serostatus ranged from between -25.7 to 36.9% and 44.4 to 64.7% during the SEP, respectively. In the pooled CYD14/15 data of seronegatives, vaccine efficacy was null to modest. In conclusion, CYD-TDV was shown to maintain efficacy against symptomatic VCD in seropositive participants aged >= 9 years up to six years after the first dose. Persistence of efficacy was also observed in seropositive participants aged 6-8 years. (C) 2020 Sanofi Pasteur. Published by Elsevier Ltd.
C1 [Dayan, Gustavo H.; Wu, Yukun; Noriega, Fernando] Sanofi Pasteur, Discovery Dr, Swiftwater, PA 18370 USA.
   [Langevin, Edith; Forrat, Remi; DiazGranados, Carlos A.] Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.
   [Gilbert, Peter B.; Moodie, Zoe; Price, Brenda] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, 1124 Columbia St, Seattle, WA 98104 USA.
   [Frago, Carina; Bouckenooghe, Alain] Sanofi Pasteur, 38 Beach Rd 18-11,South Beach Tower, Singapore 189767, Singapore.
   [Cortes, Margarita] Sanofi Pasteur, Bogota, Colombia.
RP Dayan, GH (corresponding author), Sanofi Pasteur, Discovery Dr, Swiftwater, PA 18370 USA.
EM Gustavo.Dayan@sanofi.com; Edith.Langevin@sanofi.com;
   pgilbert@fredhutch.org; Yukun.Wu@sanofi.com; zoe@fredhutch.org;
   Remi.Forrat@sanofi.com; blp7@uw.edu; Carina.Frago@sanofi.com;
   Margarita.Cortes@sanofi.com; Carlos.DiazGranados@sanofi.com
FU Sanofi Pasteur
FX This work was supported by Sanofi Pasteur.
CR Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476
   Barba-Spaeth G, 2016, NATURE, V539, DOI 10.1038/nature19780
   BARLOW WE, 1994, BIOMETRICS, V50, P1064, DOI 10.2307/2533444
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Nascimento EJM, 2018, J VIROL METHODS, V257, P48, DOI 10.1016/j.jviromet.2018.03.007
   PRENTICE RL, 1986, BIOMETRIKA, V73, P1
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Simon AK, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.3085
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Trung DT, 2010, CURR TOP MICROBIOL, V338, P57, DOI 10.1007/978-3-642-02215-9_5
   Vannice KS, 2018, VACCINE, V36, P3411, DOI 10.1016/j.vaccine.2018.02.062
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   WHO, 2007, GUID PLAQ RED NEUTR
   Wills BA, 2004, J INFECT DIS, V190, P810, DOI 10.1086/422754
   World Health Organization, 2008, GUID CLIN EV DENG VA
NR 21
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 23
PY 2020
VL 38
IS 19
BP 3531
EP 3536
DI 10.1016/j.vaccine.2020.03.029
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LC4TN
UT WOS:000525318100005
PM 32204943
OA Other Gold
DA 2020-07-08
ER

PT J
AU Campos, GS
   Carvalho, RH
   Bandeira, AC
   Reboredo-Oliveira, L
   Costa, RD
   Figueiredo, CA
   Sardi, SI
AF Campos, Gubio Soares
   Carvalho, Rejane Hughes
   Bandeira, Antonio Carlos
   Reboredo-Oliveira, Luciana
   Costa, Ryan dos Santos
   Figueiredo, Camila Alexandrina
   Sardi, Silvia Ines
TI New Challenge for Zika Virus Infection: Human Reservoirs?
SO VIRAL IMMUNOLOGY
LA English
DT Article; Early Access
DE Zika virus; persistence; viremia; immune complacency
ID PERSISTENCE
AB Zika virus (ZIKV) is considered to cause an acute self-limited infection in adults, and microcephaly in fetus. Presence of the virus for long periods has been detected in body fluids; however, persistent viremia in serum for more than 1 year has not yet been reported. We have investigated persistence of ZIKV in serum samples of 77 subjects who were infected by the virus between 18 months and 3 years before the start of this study. The subjects included children with microcephaly and their parents. Serum samples were subjected to routine RT-qPCR assay for ZIKV, Chikungunya virus, and Dengue virus. From the 77 subjects, five showed positive for the presence of ZIKV particles by RT-qPCR, including four members of the same family. Viral isolation in Vero cells and C6/36 cells confirmed the result and showed the viral particles were active. We have detected viremia in healthy carriers up to 3 years after symptom onset. Humans acting as potential viral reservoirs have major implication for the current understanding of ZIKV infection.
C1 [Campos, Gubio Soares; Carvalho, Rejane Hughes; Sardi, Silvia Ines] Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Av Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Hosp Inst Couto Maia, Salvador, BA, Brazil.
   [Bandeira, Antonio Carlos] Hosp Alianca, Salvador, BA, Brazil.
   [Reboredo-Oliveira, Luciana; Costa, Ryan dos Santos; Figueiredo, Camila Alexandrina] Univ Fed Bahia, Hlth Sci Inst, Salvador, BA, Brazil.
RP Carvalho, RH (corresponding author), Univ Fed Bahia, Hlth Sci Inst, Virol Lab, Av Reitor Miguel Calmon S-N, BR-40110100 Salvador, BA, Brazil.
EM hughescv@gmail.com
FU  [88887-116628/2016];  [FINEP-FNDCT 011/2016-ZIKA]
FX This research was funded by the Zika Fast TrackCAPES project no.
   88887-116628/2016 and FINEP-FNDCT 011/2016-ZIKA.
CR Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Brett DLB, 2013, FIELDS VIROLOGY, VI, P735
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Duarte G, 2017, REV BRAS GINECOL OBS, V39, P235, DOI 10.1055/s-0037-1603450
   Garcia MN, 2015, MICROBES INFECT, V17, P163, DOI 10.1016/j.micinf.2014.12.003
   Hansen TR, 2010, AM J REPROD IMMUNOL, V64, P295, DOI 10.1111/j.1600-0897.2010.00904.x
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Kerr JR, 2005, J VET MED B, V52, P335, DOI 10.1111/j.1439-0450.2005.00859.x
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Moorman JP, 2001, ARCH IMMUNOL THER EX, V49, P189
   Murray KO, 2013, AM J TROP MED HYG, V89, P996, DOI 10.4269/ajtmh.13-0232
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pomar L, 2019, PRENATAL DIAG, V39, P420, DOI 10.1002/pd.5446
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Sanchez-Montalva A, 2018, TROP MED INT HEALTH, V23, P92, DOI 10.1111/tmi.13019
   SHARMA S, 1991, CLIN EXP IMMUNOL, V85, P85, DOI 10.1111/j.1365-2249.1991.tb05687.x
   Tsuboi T, 2011, RES VET SCI, V90, P174, DOI 10.1016/j.rvsc.2010.04.024
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
NR 22
TC 0
Z9 0
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 0882-8245
EI 1557-8976
J9 VIRAL IMMUNOL
JI Viral Immunol.
DI 10.1089/vim.2019.0187
EA APR 2020
PG 4
WC Immunology; Virology
SC Immunology; Virology
GA LG0MN
UT WOS:000527805900001
PM 32311307
DA 2020-07-08
ER

PT J
AU Cappelletti, M
   Presicce, P
   Kallapur, SG
AF Cappelletti, Monica
   Presicce, Pietro
   Kallapur, Suhas G.
TI Immunobiology of Acute Chorioamnionitis
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE inflammation; infection; immune cells; animal model; fetal membrane
ID REGULATORY T-CELLS; PRETERM PREMATURE RUPTURE; NATURAL-KILLER-CELLS;
   INVARIANT NKT CELLS; TOLL-LIKE RECEPTORS; SYSTEMIC INFLAMMATORY
   RESPONSES; HUMAN CHORIONIC-GONADOTROPIN; ENDOTHELIAL GROWTH-FACTOR;
   MATERNAL-FETAL INTERFACE; BLOOD DENDRITIC CELLS
AB Acute chorioamnionitis is characterized by neutrophilic infiltration and inflammation at the maternal fetal interface. It is a relatively common complication of pregnancy and can have devastating consequences including preterm labor, maternal infections, fetal infection/inflammation, fetal lung, brain, and gastrointestinal tract injury. In this review, we will discuss current understanding of the pathogenesis, immunobiology, and mechanisms of this condition. Most commonly, acute chorioamnionitis is a result of ascending infection with relatively low-virulence organisms such as the Ureaplasma species. Furthermore, recent vaginal microbiome studies suggest that there is a link between vaginal dysbiosis, vaginal inflammation, and ascending infection. Although less common, microorganisms invading the maternal-fetal interface via hematogenous route (e.g., Zika virus, Cytomegalovirus, and Listeria) can cause placental villitis and severe fetal inflammation and injury. We will provide an overview of the knowledge gleaned from different animal models of acute chorioamnionitis and the role of different immune cells in different maternal-fetal compartments. Lastly, we will discuss how infectious agents can break the maternal tolerance of fetal allograft during pregnancy and highlight the novel future therapeutic approaches.
C1 [Kallapur, Suhas G.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Los Angeles, CA 90095 USA.
   Univ Calif Los Angeles, David Geffen Sch Med, Div Dev Biol, Los Angeles, CA 90095 USA.
RP Kallapur, SG (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Los Angeles, CA 90095 USA.
EM skallapur@mednet.ucla.edu
FU  [R21HD90856];  [R01HD98389]
FX This study was supported by R21HD90856 (SK) and R01HD98389 (SK).
CR Abrahams VM, 2005, J IMMUNOL, V175, P8096, DOI 10.4049/jimmunol.175.12.8096
   Adams KM, 2007, PLACENTA, V28, P477, DOI 10.1016/j.placenta.2006.08.004
   Agrawal V, 2016, J LEUKOCYTE BIOL, V100, P261, DOI 10.1189/jlb.3HI0515-200RR
   Agrawal V, 2012, SEMIN FETAL NEONAT M, V17, P12, DOI 10.1016/j.siny.2011.09.001
   Akgul Y, 2014, J CLIN INVEST, V124, P5481, DOI 10.1172/JCI78765
   Alfei A, 2014, ARCH GYNECOL OBSTET, V290, P211, DOI 10.1007/s00404-014-3222-8
   Amsalem H, 2014, J IMMUNOL, V193, P3070, DOI 10.4049/jimmunol.1303117
   Anders AP, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12623
   [Anonymous], 2017, OBSTET GYNECOL, V130, pe95, DOI [DOI 10.1097/AOG.0000000000002236, 10.1097/AOG.0000000000002236]
   Arenas-Hernandez M, 2019, GENES IMMUN, V20, P56, DOI 10.1038/s41435-017-0010-z
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Ashkar AA, 2000, J EXP MED, V192, P259, DOI 10.1084/jem.192.2.259
   Bachy V, 2008, J REPROD IMMUNOL, V78, P11, DOI 10.1016/j.jri.2007.09.004
   Bae GE, 2017, J PERINAT MED, V45, P483, DOI 10.1515/jpm-2015-0353
   Balkundi DR, 2003, BIOL REPROD, V69, P718, DOI 10.1095/biolreprod.102.013102
   Bao SH, 2011, EUR J OBSTET GYN R B, V155, P94, DOI 10.1016/j.ejogrb.2010.11.007
   Bartmann C, 2014, AM J REPROD IMMUNOL, V71, P109, DOI 10.1111/aji.12185
   Beloosesky R, 2006, AM J OBSTET GYNECOL, V195, P1053, DOI 10.1016/j.ajog.2006.06.081
   Berberich I, 2017, CELL DEATH DIFFER, V24, P572, DOI 10.1038/cdd.2017.25
   Bernardini G, 2008, BLOOD, V111, P3626, DOI 10.1182/blood-2007-08-106203
   Blois SM, 2011, J REPROD IMMUNOL, V88, P86, DOI 10.1016/j.jri.2010.11.002
   Boldenow E, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah4576
   Bove H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11654-3
   Boyman O, 2012, CELL MOL LIFE SCI, V69, P1597, DOI 10.1007/s00018-012-0968-7
   Boyson JE, 2002, P NATL ACAD SCI USA, V99, P13741, DOI 10.1073/pnas.162491699
   Brennan PJ, 2013, NAT REV IMMUNOL, V13, P101, DOI 10.1038/nri3369
   Brown MB, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00606
   Brown RG, 2018, BMC MED, V16, DOI 10.1186/s12916-017-0999-x
   Bugl S, 2013, BLOOD, V121, P723, DOI 10.1182/blood-2012-05-429589
   Bukowski R, 2017, PEERJ, V5, DOI 10.7717/peerj.3685
   Busse M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45860-2
   Callahan BJ, 2017, P NATL ACAD SCI USA, V114, P9966, DOI 10.1073/pnas.1705899114
   Calo G, 2017, HUM REPROD, V32, P55, DOI 10.1093/humrep/dew292
   Cappelletti M, 2013, PLACENTA, V34, P35, DOI 10.1016/j.placenta.2012.10.016
   Cappelletti M, 2018, J LEUKOCYTE BIOL, V103, P535, DOI 10.1002/JLB.3MA0717-274RR
   Cappelletti M, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91288
   Cappelletti M, 2016, J LEUKOCYTE BIOL, V99, P67, DOI 10.1189/jlb.3MR0615-272RR
   Cardenas I, 2011, AM J REPROD IMMUNOL, V65, P110, DOI 10.1111/j.1600-0897.2010.00908.x
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Caro MR, 2009, VET MICROBIOL, V135, P103, DOI 10.1016/j.vetmic.2008.09.029
   Carter AM, 2016, PLACENTA, V48, pS21, DOI 10.1016/j.placenta.2015.10.012
   Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582
   Chang EY, 2011, J MATERN-FETAL NEO M, V24, P732, DOI 10.3109/14767058.2010.528089
   Chang Z, 2014, ARTHRITIS RHEUMATOL, V66, P3227, DOI 10.1002/art.38811
   Chattopadhyay A, 2010, INFECT IMMUN, V78, P2292, DOI 10.1128/IAI.01186-09
   Chaturvedi V, 2015, J CLIN INVEST, V125, P1713, DOI 10.1172/JCI78578
   Chen GY, 2010, NAT REV IMMUNOL, V10, P826, DOI 10.1038/nri2873
   Chin PY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36112
   Co EC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.099465
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032
   Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb
   Croxatto D, 2016, MUCOSAL IMMUNOL, V9, P1372, DOI 10.1038/mi.2016.10
   Croxatto D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089006
   Dada T, 2014, BRAIN BEHAV IMMUN, V38, P142, DOI 10.1016/j.bbi.2014.01.014
   Dasari S, 2007, J PROTEOME RES, V6, P1258, DOI 10.1021/pr0605419
   De Silva D, 2010, BRIT J PHARMACOL, V160, P1808, DOI 10.1111/j.1476-5381.2010.00839.x
   Della Bella S, 2011, CLIN EXP IMMUNOL, V164, P180, DOI 10.1111/j.1365-2249.2011.04330.x
   Deshmukh H, 2019, ANNU REV PATHOL-MECH, V14, P185, DOI 10.1146/annurev-pathmechdis-012418-012743
   DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112
   DiGiulio DB, 2012, SEMIN FETAL NEONAT M, V17, P2, DOI 10.1016/j.siny.2011.10.001
   DiGiulio DB, 2010, AM J REPROD IMMUNOL, V64, P38, DOI 10.1111/j.1600-0897.2010.00830.x
   Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800
   Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435
   Dorrington MG, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00705
   Doster RS, 2018, MBIO, V9, DOI 10.1128/mBio.02084-18
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dulay AT, 2015, CYTOKINE, V76, P236, DOI 10.1016/j.cyto.2015.04.014
   Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566
   Eidem HR, 2015, BMC MED GENOMICS, V8, DOI 10.1186/s12920-015-0099-8
   Elovitz MA, 2004, TRENDS ENDOCRIN MET, V15, P479, DOI 10.1016/j.tem.2004.10.009
   Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003
   Familari M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218799
   Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494
   Fatemi SH, 2012, NEUROPHARMACOLOGY, V62, P1290, DOI 10.1016/j.neuropharm.2011.01.011
   Fest S, 2007, AM J REPROD IMMUNOL, V57, P55, DOI 10.1111/j.1600-0897.2006.00446.x
   Fettke F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00495
   Fettweis JM, 2019, NAT MED, V25, P1012, DOI 10.1038/s41591-019-0450-2
   Filipovic I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06918-3
   Filipovich Y, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.025
   Filipovich Y, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.038
   Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605
   Gargett CE, 2001, HUM REPROD, V16, P1065, DOI 10.1093/humrep/16.6.1065
   Gelber SE, 2015, J IMMUNOL, V195, P1129, DOI 10.4049/jimmunol.1402220
   GELLIN BG, 1991, AM J EPIDEMIOL, V133, P392, DOI 10.1093/oxfordjournals.aje.a115893
   Gillaux C, 2011, J IMMUNOL, V187, P2766, DOI 10.4049/jimmunol.1100217
   Girard S, 2010, J IMMUNOL, V184, P3997, DOI 10.4049/jimmunol.0903349
   Gisslen T, 2014, INNATE IMMUN-LONDON, V20, P214, DOI 10.1177/1753425913488430
   Gleditsch DD, 2014, PEDIATR RES, V76, P33, DOI 10.1038/pr.2014.57
   Goepfert AR, 2001, AM J OBSTET GYNECOL, V184, P483, DOI 10.1067/mob.2001.109653
   Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4
   Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002
   Gomez-Lopez N, 2019, J PERINAT MED, V47, P822, DOI 10.1515/jpm-2019-0262
   Gomez-Lopez N, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13184
   Gomez-Lopez N, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.09.013
   Gomez-Lopez N, 2018, J MATERN-FETAL NEO M, V31, P439, DOI 10.1080/14767058.2017.1287894
   Gomez-Lopez N, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12617
   Gomez-Lopez N, 2016, AM J REPROD IMMUNOL, V76, P386, DOI 10.1111/aji.12562
   Gomez-Lopez N, 2014, CELL MOL IMMUNOL, V11, P571, DOI 10.1038/cmi.2014.46
   Gomez-Lopez N, 2013, REPROD SCI, V20, P276, DOI 10.1177/1933719112452473
   Gomez-Lopez N, 2013, AM J REPROD IMMUNOL, V69, P212, DOI 10.1111/aji.12074
   Gravett MG, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.03.064
   Grigsby PL, 2010, REPROD SCI, V17, P85, DOI 10.1177/1933719109348025
   Guleria I, 2000, NAT MED, V6, P589
   Gupta AK, 2005, HUM IMMUNOL, V66, P1146, DOI 10.1016/j.humimm.2005.11.003
   Guzeloglu-Kayisli O, 2015, J PATHOL, V237, P423, DOI 10.1002/path.4589
   Hafez S, 2017, PROG MOL BIOL TRANSL, V145, P1, DOI 10.1016/bs.pmbts.2016.12.001
   Han YPW, 2004, INFECT IMMUN, V72, P2272, DOI 10.1128/IAI.72.4.2272-2279.2004
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Hartert TV, 2003, AM J OBSTET GYNECOL, V189, P1705, DOI 10.1016/S0002-9378(03)00857-3
   Heitmann RJ, 2017, REPROD SCI, V24, P1014, DOI 10.1177/1933719116675054
   Higgins RD, 2016, OBSTET GYNECOL, V127, P426, DOI 10.1097/AOG.0000000000001246
   Hillier SL, 1995, NEW ENGL J MED, V333, P1737, DOI 10.1056/NEJM199512283332604
   Hirsch E, 2006, AM J OBSTET GYNECOL, V194, P1334, DOI 10.1016/j.ajog.2005.11.004
   Honig A, 2004, J REPROD IMMUNOL, V61, P79, DOI 10.1016/j.jri.2003.11.002
   Houser BL, 2011, J IMMUNOL, V186, P2633, DOI 10.4049/jimmunol.1003153
   Huang BH, 2017, NAT MED, V23, P128, DOI 10.1038/nm.4244
   Huynh M, 2006, PAEDIATR PERINAT EP, V20, P454, DOI 10.1111/j.1365-3016.2006.00759.x
   Iams JD, 2008, LANCET, V371, P164, DOI 10.1016/S0140-6736(08)60108-7
   Ireland DJ, 2015, MOL HUM REPROD, V21, P479, DOI 10.1093/molehr/gav005
   Ireland DJ, 2017, INNATE IMMUN-LONDON, V23, P20, DOI 10.1177/1753425916672313
   Ito K, 2000, P NATL ACAD SCI USA, V97, P740, DOI 10.1073/pnas.97.2.740
   Jackel D, 2013, CLIN INFECT DIS, V56, P555, DOI 10.1093/cid/cis936
   Jaiswal MK, 2013, J IMMUNOL, V191, P5702, DOI 10.4049/jimmunol.1301604
   Jamieson DJ, 2012, AM J OBSTET GYNECOL, V207, pS17, DOI 10.1016/j.ajog.2012.06.070
   Jasic M, 2019, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2019.1638906
   Jiang XX, 2018, CELL MOL IMMUNOL, V15, P1027, DOI 10.1038/s41423-018-0008-0
   Kahn DA, 2010, P NATL ACAD SCI USA, V107, P9299, DOI 10.1073/pnas.1003909107
   Kalkunte S, 2008, AM J REPROD IMMUNOL, V59, P425, DOI 10.1111/j.1600-0897.2008.00595.x
   Kallapur SG, 2004, AM J PHYSIOL-LUNG C, V287, pL1178, DOI 10.1152/ajplung.00049.2004
   Kallapur SG, 2007, J IMMUNOL, V179, P8491, DOI 10.4049/jimmunol.179.12.8491
   Kallapur SG, 2014, SEMIN REPROD MED, V32, P56, DOI 10.1055/s-0033-1361823
   Kallapur SG, 2011, AM J PHYSIOL-LUNG C, V301, pL285, DOI 10.1152/ajplung.00446.2010
   Kallapur SG, 2011, J IMMUNOL, V187, P2688, DOI 10.4049/jimmunol.1100779
   Kallapur SG, 2009, AM J RESP CRIT CARE, V179, P955, DOI 10.1164/rccm.200811-1728OC
   KAPLAN BS, 1994, PEDIATR NEPHROL, V8, P700, DOI 10.1007/BF00869093
   Keelan JA, 2018, J REPROD IMMUNOL, V125, P89, DOI 10.1016/j.jri.2017.12.004
   Keelan JA, 2009, J IMMUNOL, V183, P5270, DOI 10.4049/jimmunol.0802660
   Kenyon S, 2008, LANCET, V372, P1319, DOI 10.1016/S0140-6736(08)61203-9
   Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040
   Kim MJ, 2009, LAB INVEST, V89, P924, DOI 10.1038/labinvest.2009.49
   Kim MJ, 2009, J IMMUNOL, V182, P3919, DOI 10.4049/jimmunol.0803834
   Koga K, 2010, AM J REPROD IMMUNOL, V63, P587, DOI 10.1111/j.1600-0897.2010.00848.x
   Koga K, 2009, AM J REPROD IMMUNOL, V61, P196, DOI 10.1111/j.1600-0897.2008.00682.x
   Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305
   Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566
   Kumar D, 2018, PLACENTA, V68, P9, DOI 10.1016/j.placenta.2018.06.305
   Kuypers E, 2013, REPROD SCI, V20, P946, DOI 10.1177/1933719112472742
   Kwon JY, 2014, AM J REPROD IMMUNOL, V71, P387, DOI 10.1111/aji.12243
   Lahra MM, 2009, PEDIATRICS, V123, P1314, DOI 10.1542/peds.2008-0656
   Lannon SMR, 2014, REPROD SCI, V21, P1215, DOI 10.1177/1933719114534535
   Lappas M, 2003, J CLIN ENDOCR METAB, V88, P1723, DOI 10.1210/jc.2002-021677
   Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250
   Lei J, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.122678
   Leitner K, 2014, AM J REPROD IMMUNOL, V71, P418, DOI 10.1111/aji.12216
   Leng Y, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13102
   Li CL, 2009, P NATL ACAD SCI USA, V106, P5767, DOI 10.1073/pnas.0901173106
   Li LP, 2012, J IMMUNOL, V188, P4681, DOI 10.4049/jimmunol.1102628
   Li LP, 2015, MOL HUM REPROD, V21, P369, DOI 10.1093/molehr/gav001
   Li LP, 2010, MOL HUM REPROD, V16, P267, DOI 10.1093/molehr/gap106
   Liang SC, 2003, EUR J IMMUNOL, V33, P2706, DOI 10.1002/eji.200324228
   Lockwood CJ, 2010, AM J PATHOL, V177, P1755, DOI 10.2353/ajpath.2010.090781
   Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0
   Maki Yohei, 2017, Infect Dis Obstet Gynecol, V2017, P9060138, DOI 10.1155/2017/9060138
   Malassine A, 2003, HUM REPROD UPDATE, V9, P531, DOI 10.1093/humupd/dmg043
   Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024
   Marchant EA, 2015, PEDIATR RES, V78, P492, DOI 10.1038/pr.2015.132
   Martinez-Varea A, 2017, J PERINAT MED, V45, P523, DOI 10.1515/jpm-2016-0225
   McNamara M F, 1997, Infect Dis Obstet Gynecol, V5, P273, DOI 10.1002/(SICI)1098-0997(1997)5:4<273::AID-IDOG3>3.0.CO;2-Y
   Mellor AL, 2001, NAT IMMUNOL, V2, P64, DOI 10.1038/83183
   Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015
   Menon R, 2019, PLACENTA, V79, P40, DOI 10.1016/j.placenta.2018.11.003
   Mitchell CM, 2019, MOL HUM REPROD, V25, P228, DOI 10.1093/molehr/gaz007
   Moffett A, 2014, J CLIN INVEST, V124, P1872, DOI 10.1172/JCI68107
   Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886
   Mor G, 2005, CRIT REV IMMUNOL, V25, P375, DOI 10.1615/CritRevImmunol.v25.i5.30
   Moss TJM, 2003, AM J OBSTET GYNECOL, V189, P1771, DOI 10.1016/S0002-9378(03)00810-X
   Mueller MD, 2000, FERTIL STERIL, V74, P107, DOI 10.1016/S0015-0282(00)00555-0
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Nadeau-Vallee M, 2017, J IMMUNOL, V198, P2047, DOI 10.4049/jimmunol.1601600
   Nadeau-Vallee M, 2016, REPRODUCTION, V152, pR277, DOI 10.1530/REP-16-0453
   Nadeau-Vallee M, 2015, J IMMUNOL, V195, P3402, DOI 10.4049/jimmunol.1500758
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Negishi Y, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12658
   Newnham JP, 2009, OBSTET GYNECOL, V114, P1239, DOI 10.1097/AOG.0b013e3181c15b40
   NEWTON ER, 1988, OBSTET GYNECOL, V71, P198
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nikiforou M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29806
   Oh KJ, 2011, PLACENTA, V32, P732, DOI 10.1016/j.placenta.2011.07.080
   Omer SB, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000441
   Paintlia MK, 2008, PEDIATR RES, V64, P334, DOI 10.1203/PDR.0b013e318181e07c
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Petty HR, 2006, J IMMUNOL, V176, P3205, DOI 10.4049/jimmunol.176.5.3205
   Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682
   POLLARD JW, 1991, DEV BIOL, V148, P273, DOI 10.1016/0012-1606(91)90336-2
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Presicce P, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98306
   Presicce P, 2015, BIOL REPROD, V92, DOI 10.1095/biolreprod.114.124420
   Pudney J, 2016, PLACENTA, V46, P1, DOI 10.1016/j.placenta.2016.07.005
   Racicot K, 2017, J IMMUNOL, V198, P3029, DOI 10.4049/jimmunol.1601824
   Racicot K, 2016, AM J REPROD IMMUNOL, V75, P451, DOI 10.1111/aji.12501
   Racicot K, 2013, J IMMUNOL, V191, P934, DOI 10.4049/jimmunol.1300661
   Rajagopalan S, 2014, CELL MOL IMMUNOL, V11, P460, DOI 10.1038/cmi.2014.53
   Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x
   Randis TM, 2014, J INFECT DIS, V210, P265, DOI 10.1093/infdis/jiu067
   Redline RW, 2012, SEMIN FETAL NEONAT M, V17, P20, DOI 10.1016/j.siny.2011.08.003
   Redline RW, 2003, PEDIATR DEVEL PATHOL, V6, P435, DOI 10.1007/s10024-003-7070-y
   REGAN JA, 1991, OBSTET GYNECOL, V77, P604
   Regan JK, 2016, REPROD SCI, V23, P69, DOI 10.1177/1933719115594014
   Renaud SJ, 2011, J IMMUNOL, V186, P1799, DOI 10.4049/jimmunol.1002679
   Reyes L, 2017, RESULTS PROBL CELL D, V62, P45, DOI 10.1007/978-3-319-54090-0_3
   Rinaldi SF, 2015, MOL HUM REPROD, V21, P309, DOI 10.1093/molehr/gav002
   Rinaldi SF, 2015, AM J PATHOL, V185, P1201, DOI 10.1016/j.ajpath.2015.01.009
   Rinaldi SF, 2014, J IMMUNOL, V192, P2315, DOI 10.4049/jimmunol.1302891
   Ristich V, 2005, EUR J IMMUNOL, V35, P1133, DOI 10.1002/eji.200425741
   Rito DC, 2017, PEDIATR RES, V81, P639, DOI 10.1038/pr.2016.254
   Robertson SA, 2010, ENDOCRINOLOGY, V151, P3996, DOI 10.1210/en.2010-0063
   Rogers LM, 2018, AM J REPROD IMMUNOL, V80, DOI 10.1111/aji.13032
   Rolle L, 2013, AM J REPROD IMMUNOL, V70, P448, DOI 10.1111/aji.12157
   Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x
   ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O
   ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P969, DOI 10.1016/0002-9378(91)90450-6
   ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x
   Romero R, 2008, AM J OBSTET GYNECOL, V198, P1, DOI 10.1016/j.ajog.2007.11.031
   Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296
   Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-4
   Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460
   Roth I, 1996, J EXP MED, V184, P539, DOI 10.1084/jem.184.2.539
   Rowe JH, 2011, CELL HOST MICROBE, V10, P54, DOI 10.1016/j.chom.2011.06.005
   Rueda CM, 2016, J IMMUNOL, V196, P3706, DOI 10.4049/jimmunol.1502613
   Rueda CM, 2015, HUM IMMUNOL, V76, P65, DOI 10.1016/j.humimm.2014.10.016
   Sadowsky DR, 2000, AM J OBSTET GYNECOL, V183, P173, DOI 10.1067/mob.2000.105968
   Sadowsky DW, 2006, AM J OBSTET GYNECOL, V195, P1578, DOI 10.1016/j.ajog.2006.06.072
   SALAFIA CM, 1989, OBSTET GYNECOL, V73, P383
   Sampson JE, 1997, AM J OBSTET GYNECOL, V176, P77, DOI 10.1016/S0002-9378(97)80015-4
   Samstein RM, 2012, CELL, V150, P29, DOI 10.1016/j.cell.2012.05.031
   Sasaki Y, 2004, MOL HUM REPROD, V10, P347, DOI 10.1093/molehr/gah044
   Schanzer DL, 2007, J OBSTET GYNAECOL CA, V29, P622, DOI 10.1016/S1701-2163(16)32559-2
   Schumacher A, 2013, J IMMUNOL, V190, P2650, DOI 10.4049/jimmunol.1202698
   Schumacher A, 2009, J IMMUNOL, V182, P5488, DOI 10.4049/jimmunol.0803177
   Senthamaraikannan P, 2016, J INFECT DIS, V214, P1597, DOI 10.1093/infdis/jiw408
   Seyyed Elahe Zarean, 2013, Med Arch, V67, P124, DOI 10.5455/medarh.2013.67.124-125
   Shah NM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01138
   Shahin AY, 2009, INT J GYNECOL OBSTET, V104, P44, DOI 10.1016/j.ijgo.2008.08.026
   Sharma L, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00117
   Shima T, 2015, J REPROD IMMUNOL, V108, P72, DOI 10.1016/j.jri.2015.02.005
   Shynlova O, 2013, J CELL MOL MED, V17, P311, DOI 10.1111/jcmm.12012
   Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887
   Singh AM, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0297-y
   Somerset DA, 2004, IMMUNOLOGY, V112, P38, DOI 10.1111/j.1365-2567.2004.01869.x
   SPERLING RS, 1988, J INFECT DIS, V157, P113, DOI 10.1093/infdis/157.1.113
   St Louis D, 2016, J IMMUNOL, V196, P1044, DOI 10.4049/jimmunol.1501962
   STALLMACH T, 1995, LAB INVEST, V73, P384
   Steel JH, 2005, PLACENTA, V26, P672, DOI 10.1016/j.placenta.2004.10.003
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959
   Straszewski-Chavez SL, 2005, ENDOCR REV, V26, P877, DOI 10.1210/er.2005-0003
   Subramaniam Akila, 2012, Infect Dis Obstet Gynecol, V2012, P157159, DOI 10.1155/2012/157159
   Sweeney EL, 2017, CLIN MICROBIOL REV, V30, P349, DOI 10.1128/CMR.00091-16
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Takashima A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109009
   Tecchio C, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00508
   Tilburgs T, 2006, PLACENTA, V27, pS47, DOI 10.1016/j.placenta.2005.11.008
   Tilburgs T, 2015, P NATL ACAD SCI USA, V112, P7219, DOI 10.1073/pnas.1507977112
   Tilburgs T, 2010, J IMMUNOL, V185, P4470, DOI 10.4049/jimmunol.0903597
   Trowsdale J, 2006, NAT IMMUNOL, V7, P241, DOI 10.1038/ni1317
   Tsuda H, 2001, AM J REPROD IMMUNOL, V45, P295, DOI 10.1111/j.8755-8920.2001.450505.x
   Ueda Y, 2003, HUM IMMUNOL, V64, P1144, DOI 10.1016/j.humimm.2003.08.342
   Vacca P, 2010, P NATL ACAD SCI USA, V107, P11918, DOI 10.1073/pnas.1001749107
   van Boeckel SR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43766-7
   van den Broek NR, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000191
   van Nieuwenhoven ALV, 2003, HUM REPROD UPDATE, V9, P347, DOI 10.1093/humupd/dmg026
   Vanderhoeven JP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003920
   Vinketova K, 2016, J PREGNANCY, V2016, DOI 10.1155/2016/8689436
   Volchek M, 2010, HUM REPROD, V25, P2455, DOI 10.1093/humrep/deq224
   von Chamier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044047
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Waldorf KMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028972
   Wang F, 2017, CELL BIOL INT, V41, P155, DOI 10.1002/cbin.10710
   Wang S, 2002, CELL IMMUNOL, V215, P98, DOI 10.1016/S0008-8749(02)00009-6
   Wang SC, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.112
   Wiley CA, 2012, INFLUENZA OTHER RESP, V6, pe1, DOI 10.1111/j.1750-2659.2011.00310.x
   Winger EE, 2008, AM J REPROD IMMUNOL, V60, P8, DOI 10.1111/j.1600-0897.2008.00585.x
   Witko-Sarsat V, 2011, TRENDS IMMUNOL, V32, P117, DOI 10.1016/j.it.2011.01.001
   Wolfs TGA, 2013, MUCOSAL IMMUNOL, V6, P547, DOI 10.1038/mi.2012.97
   Wolfs TGAM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018355
   Xu Y, 2018, AM J REPROD IMMUNOL, V79, DOI 10.1111/aji.12820
   Xu Y, 2012, AM J REPROD IMMUNOL, V67, P184, DOI 10.1111/j.1600-0897.2011.01088.x
   Yao YL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00792
   Yougbare I, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00269-1
   Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367
   Zhang JH, 2019, EBIOMEDICINE, V39, P531, DOI 10.1016/j.ebiom.2018.12.015
   Zhang YH, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00120
NR 293
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 16
PY 2020
VL 11
AR 649
DI 10.3389/fimmu.2020.00649
PG 21
WC Immunology
SC Immunology
GA LJ9RD
UT WOS:000530496900001
PM 32373122
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cavalcante, ACP
   de Olinda, RA
   Gomes, A
   Traxler, J
   Smith, M
   Santos, S
AF Cavalcante, Ana Carolina Policarpo
   de Olinda, Ricardo Alves
   Gomes, Alexandrino
   Traxler, John
   Smith, Matt
   Santos, Silvana
TI Spatial modelling of the infestation indices of Aedes aegypti: an
   innovative strategy for vector control actions in developing countries
SO PARASITES & VECTORS
LA English
DT Article
DE Arbovirus infections; Aedes; Spatial analysis
ID ZIKA VIRUS
AB Background Larval indices such as the house index (HI), Breteau index (BI) and container index (CI) are widely used to interpret arbovirus vector density in surveillance programmes. However, the use of such data as an alarm signal is rarely considered consciously when planning programmes. The present study aims to investigate the spatial distribution pattern of the infestation of Aedes aegypti, considering the data available in the Ae. aegypti Infestation Index Rapid Survey (LIRAa) for the city of Campina Grande, Paraiba State in Brazil. Methods The global and local Moran's indices were used in spatial analysis to measure the effects of spatial dependencies between neighbourhoods, using secondary data related to HI and BI gathered from surveillance service. Results Our analysis shows that there is a predominance of high rates of mosquito infestation, placing Campina Grande at a near-constant risk of arbovirus outbreaks and epidemics. A highly significant Moran's index value (P < 0.001) was observed, indicating a positive spatial dependency between the neighbourhoods in Campina Grande. Using the Moran mapping and LISA mapping, the autocorrelation patterns of Ae. aegypti infestation rates among neighbourhoods have revealed hotpots that should be considered a priority to preventive actions of the entomological surveillance services. Predominance of high infestation rates and clearer relationships of these between neighbourhoods were observed between the months of May and July, the period with the highest rainfall in the city. Conclusions This analysis is an innovative strategy capable of providing detailed information on infestation locations to the relevant public health authorities, which will enable a more efficient allocation of resources, particularly for arbovirus prevention.
C1 [Cavalcante, Ana Carolina Policarpo; de Olinda, Ricardo Alves; Gomes, Alexandrino; Santos, Silvana] Univ Estadual Paraiba, Publ Hlth Program, BR-58429500 Campina Grande, Paraiba, Brazil.
   [Traxler, John; Smith, Matt] Univ Wolverhampton, Inst Educ, Walsall Campus,Gorway Rd, Walsall WS1 3BD, W Midlands, England.
RP Santos, S (corresponding author), Univ Estadual Paraiba, Publ Hlth Program, BR-58429500 Campina Grande, Paraiba, Brazil.
EM silvanasantosuepb@gmail.com
OI Santos, Silvana/0000-0002-5252-0206
FU Fundacao de Apoio a Pesquisa do Estado da Paraiba (FAPESQ/Edital Zika
   Virus); British CouncilThe British Council in India [274560199]
FX The present study was funded by Fundacao de Apoio a Pesquisa do Estado
   da Paraiba (FAPESQ/Edital Zika Virus) and British Council 274560199. The
   role of the funding body: the design of the study; collection, analysis,
   and interpretation of data; and in writing the manuscript.
CR Agha SB, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2598-2
   Agha SB, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005858
   Albuquerque M, 2018, CAD SAUDE PUBLICA, V34
   Alves MCGP, 2001, REV SAUDE PUBL, V35, P467, DOI 10.1590/S0034-89102001000500010
   Barbosa GL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002873
   Borges ED, 2019, J ASSIST REPROD GEN, V36, P1339, DOI 10.1007/s10815-019-01493-y
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brazil M da S, 2013, LEVANTAMENTO RAPIDO
   Carvalho S, 2017, REV SAUDE PUBL, V51, DOI [10.11606/S1518-8787.2017051006239, 10.11606/s1518-8787.2017051006239]
   Zanotto PMD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01964
   de Oliveira FLB, 2015, REV ELETRONICA GESTA, V7, P260, DOI [10.18673/gs.v7i1.22079, DOI 10.18673/GS.V7I1.22079]
   de Souza WV, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5039-z
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferede G, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018015
   Ferreira AC, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000414, 10.11606/s1518-8787.2018052000414]
   Thi KLP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2422-z
   Lana RM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190673
   Lutomiah J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004981
   Marinho RA, 2016, J VECTOR ECOL, V41, P1, DOI 10.1111/jvec.12187
   Pilger D, 2011, TROP MED INT HEALTH, V16, P1143, DOI 10.1111/j.1365-3156.2011.02818.x
   Possas C, 2017, ZIKA PUZZLE BRAZIL P
   R Development Core Team, 2019, R LANG ENV STAT COMP
   Ribeiro AG, THESIS, DOI [10.11606/t.6.2018.tde-14062018-123942, DOI 10.11606/T.6.2018.TDE-14062018-123942]
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Rivas AV, 2018, REV SOC BRAS MED TRO, V51, P71, DOI 10.1590/0037-8682-0228-2017
   Lopes TRR, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860043, 10.1590/s1678-9946201860043]
   Sarfraz MS, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-853
   Tsai PJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2606-6
   Tuson M, 2019, INT J HEALTH GEOGR, V18, DOI 10.1186/s12942-019-0170-3
   Udayanga L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2961-y
   Villabona-Arenas CJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002620
NR 31
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 16
PY 2020
VL 13
IS 1
AR 197
DI 10.1186/s13071-020-04070-w
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LH6RK
UT WOS:000528912000001
PM 32299496
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Diamos, AG
   Pardhe, MD
   Sun, HY
   Hunter, JGL
   Mor, T
   Meador, L
   Kilbourne, J
   Chen, Q
   Mason, HS
AF Diamos, Andrew G.
   Pardhe, Mary D.
   Sun, Haiyan
   Hunter, Joseph G. L.
   Mor, Tsafrir
   Meador, Lydia
   Kilbourne, Jacquelyn
   Chen, Qiang
   Mason, Hugh S.
TI Codelivery of improved immune complex and virus-like particle vaccines
   containing Zika virus envelope domain III synergistically enhances
   immunogenicity
SO VACCINE
LA English
DT Article
DE Zika virus; Envelope protein; Recombinant immune complex; Virus-like
   particle; Plant-made vaccine
ID ANTIBODY-DEPENDENT ENHANCEMENT; ANTIGEN; INFECTION; IMMUNIZATION;
   VACCINATION; RESPONSES; PLANTS
AB Zika virus (ZIKV) reemergence poses a significant health threat especially due to its risks to fetal development, necessitating safe and effective vaccines that can protect pregnant women. Zika envelope domain III (ZE3) has been identified as a safe and effective vaccine candidate, however it is poorly immunogenic. We previously showed that plant-made recombinant immune complex (RIC) vaccines are a robust platform to improve the immunogenicity of weak antigens. In this study, we altered the antigen fusion site on the RIC platform to accommodate N-terminal fusion to the IgG heavy chain (N-RIC), and thus a wider range of antigens, with a resulting 40% improvement in RIC expression over the normal C-terminal fusion (C-RIC). Both types of RICs containing ZE3 were efficiently assembled in plants and purified to >95% homogeneity with a simple one-step purification. Both ZE3 RICs strongly bound complement receptor C1q and elicited strong ZE3-specific antibody titers that correlated with ZIKV neutralization. When either N-RIC or C-RIC was codelivered with plant-produced hepatitis B core (HBc) virus-like particles (VLP) displaying ZE3, the combination elicited 5-fold greater antibody titers (>1,000,000) and more strongly neutralized ZIKV than either RICs or VLPs alone, after only two doses without adjuvant. These findings demonstrate that antigens that require a free N-terminus for optimal antigen display can now be used with the RIC system, and that plant-made RICs and VLPs are highly effective vaccines targeting ZE3. Thus, the RIC platform can be more generally applied to a wider variety of antigens. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Mason, Hugh S.] Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85287 USA.
   Arizona State Univ, Tempe, AZ 85287 USA.
RP Mason, HS (corresponding author), Arizona State Univ, Ctr Immunotherapy Vaccines & Virotherapy, Biodesign Inst, Tempe, AZ 85287 USA.
EM hugh.mason@asu.edu
OI chen, qiang/0000-0003-1498-7013; Mason, Hugh/0000-0002-0192-6716
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R33AI101329]
FX This work was supported in part by a grant from National Institute of
   Allergy and Infectious Diseases (NIAID) #R33AI101329 to QC.
CR Alam A, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00102
   Barzon L, 2017, EXPERT OPIN BIOL TH, V17, P1185, DOI 10.1080/14712598.2017.1346081
   Belmusto-Worn VE, 2005, RANDOMIZED DOUBLE BL
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Brinkmann U, 2017, MABS-AUSTIN, V9, P182, DOI 10.1080/19420862.2016.1268307
   Castilho A, 2012, BIOTECHNOL J, V7, DOI 10.1002/biot.201200032
   Chargelegue D, 2005, INFECT IMMUN, V73, P5915, DOI 10.1128/IAI.73.9.5915-5922.2005
   Chen Qiang, 2016, F1000Res, V5, DOI 10.12688/f1000research.8010.1
   Chen Q, 2013, HUM VACC IMMUNOTHER, V9, P26, DOI 10.4161/hv.22218
   Chun J, 2019, J MICROBIOL BIOTECHN, V29, P813, DOI 10.4014/jmb.1903.03043
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Diamos AG, 2019, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01974
   Diamos AG, 2019, VACCINE, V37, P137, DOI 10.1016/j.vaccine.2018.11.021
   Diamos AG, 2018, PROTEIN EXPRES PURIF, V151, P86, DOI 10.1016/j.pep.2018.06.011
   Diamos AG, 2018, PLANT BIOTECHNOL J, V16, P1971, DOI 10.1111/pbi.12931
   Diamos AG, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00200
   Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Fletcher EAK, 2018, J IMMUNOL, V201, P87, DOI 10.4049/jimmunol.1700911
   Freivalds J, 2011, PROTEIN EXPRES PURIF, V75, P218, DOI 10.1016/j.pep.2010.09.010
   Haiyan Zhao A, 2016, CELL, V166, DOI [10.1016/j.cell.2016.07.020, DOI 10.1016/J.CELL.2016.07.020.]
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Hioe CE, 2009, VACCINE, V28, P352, DOI 10.1016/j.vaccine.2009.10.040
   Ho NI, 2017, J IMMUNOL, V198, P4235, DOI 10.4049/jimmunol.1602169
   Huang Z, 2004, PLANT BIOTECHNOL J, V2, P241, DOI 10.1111/j.1467-7652.2004.00068.x
   Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200
   Kallolimath Somanath, 2014, Human Antibodies, V23, P45, DOI 10.3233/HAB-150283
   Kim MY, 2015, VACCINE, V33, P1830, DOI 10.1016/j.vaccine.2015.02.036
   Manolova V, 2008, EUR J IMMUNOL, V38, P1404, DOI 10.1002/eji.200737984
   Marusic C, 2018, BIOTECHNOL BIOENG, V115, P565, DOI 10.1002/bit.26503
   Mason HS, 2016, HUM VACC IMMUNOTHER, V12, P988, DOI 10.1080/21645515.2015.1116655
   Mastrangeli R, 2019, GLYCOBIOLOGY, V29, P199, DOI 10.1093/glycob/cwy092
   McCluskie MJ, 1998, VIRAL IMMUNOL, V11, P245, DOI 10.1089/vim.1998.11.245
   MORRISON SL, 1966, J IMMUNOL, V96, P901
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Peyret H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120751
   Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x
   Rabaan AA, 2017, J INFECT PUBLIC HEAL, V10, P141, DOI 10.1016/j.jiph.2016.05.007
   Santi L, 2008, VACCINE, V26, P1846, DOI 10.1016/j.vaccine.2008.01.053
   Schmidt JA, 2019, NAT PLANTS, V5, P715, DOI 10.1038/s41477-019-0467-z
   Simon D, 2018, VIRUSES, V10, DOI [10.3390/v10120698, DOI 10.3390/V10120698.]
   Simon D, 2017, BIOCHEM BIOPH RES CO, V492, P572, DOI 10.1016/j.bbrc.2017.06.088
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Tuse D, 2014, BIOMED RES INT, DOI 10.1155/2014/256135
   Wang G, 2016, MOL CELL, V63, P135, DOI 10.1016/j.molcel.2016.05.016
   Wang XY, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-018-0095-z
   Wen YM, 2016, EMBO MOL MED, V8, P1120, DOI 10.15252/emmm.201606593
   Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zeitlin L, 2011, P NATL ACAD SCI USA, V108, P20690, DOI 10.1073/pnas.1108360108
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
NR 55
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD APR 16
PY 2020
VL 38
IS 18
BP 3455
EP 3463
DI 10.1016/j.vaccine.2020.02.089
PG 9
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LC4TM
UT WOS:000525318000007
PM 32173095
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Tang, BA
   Xiao, YN
   Sander, B
   Kulkarni, MA
   Wu, JH
AF Tang, Biao
   Xiao, Yanni
   Sander, Beate
   Kulkarni, Manisha A.
   Wu, Jianhong
CA RADAM LAC Res Team
TI Modelling the impact of antibody-dependent enhancement on disease
   severity of Zika virus and dengue virus sequential and co-infection
SO ROYAL SOCIETY OPEN SCIENCE
LA English
DT Article
DE DENV; ZIKV; mathematical model; antibody-dependent enhancement; viral
   dynamics; parameter estimation
ID DYNAMICS; PATHOGENESIS; INFECTION; EPIDEMIC
AB Human infections with viruses of the genus Flavivirus, including dengue virus (DENV) and Zika virus (ZIKV), are of increasing global importance. Owing to antibody-dependent enhancement (ADE), secondary infection with one Flavivirus following primary infection with another Flavivirus can result in a significantly larger peak viral load with a much higher risk of severe disease. Although several mathematical models have been developed to quantify the virus dynamics in the primary and secondary infections of DENV, little progress has been made regarding secondary infection of DENV after a primary infection of ZIKV, or DENV-ZIKV co-infection. Here, we address this critical gap by developing compartmental models of virus dynamics. We first fitted the models to published data on dengue viral loads of the primary and secondary infections with the observation that the primary infection reaches its peak much more gradually than the secondary infection. We then quantitatively show that ADE is the key factor determining a sharp increase/decrease of viral load near the peak time in the secondary infection. In comparison, our simulations of DENV and ZIKV co-infection (simultaneous rather than sequential) show that ADE has very limited influence on the peak DENV viral load. This indicates pre-existing immunity to ZIKV is the determinant of a high level of ADE effect. Our numerical simulations show that (i) in the absence of ADE effect, a subsequent co-infection is beneficial to the second virus; and (ii) if ADE is feasible, then a subsequent co-infection can induce greater damage to the host with a higher peak viral load and a much earlier peak time for the second virus, and for the second peak for the first virus.
C1 [Tang, Biao; Wu, Jianhong] York Univ, LIAM, Toronto, ON, Canada.
   [Tang, Biao; Sander, Beate] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada.
   [Tang, Biao; Sander, Beate] Toronto Hlth Econ & Technol Assessment, Toronto, ON, Canada.
   [Xiao, Yanni] Xi An Jiao Tong Univ, Sch Math & Stat, Xian 710049, Peoples R China.
   [Kulkarni, Manisha A.] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.
RP Wu, JH (corresponding author), York Univ, LIAM, Toronto, ON, Canada.
EM wujh@yorku.ca
FU Canadian Institutes for Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); International Development Research Centre
   (IDRC)'s CIHR-IDRC Canada-Latin America; Caribbean Zika Virus Research
   Program
FX This research is part of an international project entitled `Research on
   Arbovirus Dynamics and Mitigation-Latin America and Canada' (RADAM-LAC),
   with field study sites in Colombia, Ecuador and Argentina. The RADAM-LAC
   Research Team consists of Beate Sander, Camila Gonzalez, Manisha
   Kulkarni, Marcos Miretti, Mauricio Espinel, Jianhong Wu and Varsovia
   Cevallos. This study was funded by a grant from the Canadian Institutes
   for Health Research (CIHR) and International Development Research Centre
   (IDRC)'s CIHR-IDRC Canada-Latin America and Caribbean Zika Virus
   Research Program to the RADAM-LAC Research Team.
CR Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Ben-Shachar R, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2014.0886
   Best K, 2018, IMMUNOL REV, V285, P81, DOI 10.1111/imr.12687
   Best K, 2017, P NATL ACAD SCI USA, V114, P8847, DOI 10.1073/pnas.1704011114
   Billings L, 2007, J THEOR BIOL, V246, P18, DOI 10.1016/j.jtbi.2006.12.023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Gomez MC, 2019, MATH MED BIOL, V36, P411, DOI 10.1093/imammb/dqy016
   Clapham HE, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004951
   Clapham HE, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0094
   Cummings DAT, 2005, P NATL ACAD SCI USA, V102, P15259, DOI 10.1073/pnas.0507320102
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Ferguson N, 1999, P NATL ACAD SCI USA, V96, P790, DOI 10.1073/pnas.96.2.790
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Gujarati TP, 2014, J MATH BIOL, V69, P1773, DOI 10.1007/s00285-013-0749-4
   Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   HAMMON WM, 1960, SCIENCE, V131, P1102, DOI 10.1126/science.131.3407.1102
   Handel A, 2010, J R SOC INTERFACE, V7, P35, DOI 10.1098/rsif.2009.0067
   Hu K, 2013, J THEOR BIOL, V319, P62, DOI 10.1016/j.jtbi.2012.11.021
   Khandia R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00597
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Massad E, 2014, LANCET INFECT DIS, V14, P552, DOI 10.1016/S1473-3099(14)70807-2
   Maucourant C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020131
   MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522
   Montoya M, 2018, J INFECT DIS, V218, P536, DOI 10.1093/infdis/jiy164
   Nikin-Beers R, 2015, MATH BIOSCI, V263, P83, DOI 10.1016/j.mbs.2015.02.004
   Pessoa R, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003201
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Tang B, 2019, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.6q573n5vj, DOI 10.5061/DRYAD.6Q573N5VJ]
   Tang B, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0085-x
   Tang B, 2016, SCI REP-UK, V6, DOI 10.1038/srep35623
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
NR 41
TC 0
Z9 0
U1 1
U2 1
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2054-5703
J9 ROY SOC OPEN SCI
JI R. Soc. Open Sci.
PD APR 15
PY 2020
VL 7
IS 4
AR 191749
DI 10.1098/rsos.191749
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LG0AZ
UT WOS:000527775000004
PM 32431874
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Martins, IC
   Santos, NC
AF Martins, Ivo C.
   Santos, Nuno C.
TI Intrinsically disordered protein domains in flavivirus infection
SO ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
LA English
DT Review
DE Intrinsically disordered protein (IDP); Intrinsically disordered protein
   regions (IDPRs); Dengue virus (DENV); Zika virus (ZIKV); Flavivirus
ID DENGUE VIRUS NS4A; WEST NILE VIRUS; ZIKA VIRUS; NS2B-NS3 PROTEASE;
   AMYLOID FIBRILS; SECONDARY STRUCTURE; STRUCTURAL BIOLOGY; PREDICTION;
   BINDING; MECHANISM
AB Intrinsically disordered protein regions are at the core of biological processes and involved in key protein-ligand interactions. The Flavivirus proteins, of viruses of great biomedical importance such as Zika and dengue viruses, exemplify this. Several proteins of these viruses have disordered regions that are of the utmost importance for biological activity. Disordered proteins can adopt several conformations, each able to interact with and/or bind to different ligands. In fact, such interactions can help stabilize a particular fold. Moreover, by being promiscuous in the number of target molecules they can bind to, these protein regions increase the number of functions that their small proteome (10 proteins) can achieve. A folding energy waterfall better describes the protein folding landscape of these proteins. A disordered protein can be thought as rolling down the folding energy cascade, in order "to fall, fold and function". This is the case of many viral protein regions, as seen in the flaviviruses proteome. Given their small size, flaviviruses are a good model system for understanding the role of intrinsically disordered protein regions in viral function. Finally, studying these viruses disordered protein regions will certainly contribute to the development of therapeutic approaches against such promising (yet challenging) targets.
C1 [Martins, Ivo C.; Santos, Nuno C.] Univ Lisbon, Fac Med, Inst Med Mol, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
RP Martins, IC; Santos, NC (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Av Prof Egas Moniz, P-1649028 Lisbon, Portugal.
EM ivomartins@fm.ul.pt; nsantos@fm.ul.pt
RI Santos, Nuno/N-7248-2013; Martins, Ivo/G-2534-2013
OI Santos, Nuno/0000-0002-0580-0475; Martins, Ivo/0000-0002-9284-8599
FU Fundacao para a Ciencia e a Tecnologia -Ministerio da Ciencia,
   Tecnologia e Ensino Superior (FCT-MCTES, Portugal)Portuguese Foundation
   for Science and Technology; Fundacao Calouste Gulbenkian (Portugal);
   FCT-MCTES Program "Investigador FCT" [IF/00772/2013]; FCT-MCTES Program
   "Concurso de Estimulo ao Emprego Cientifico" [CEECIND/01670/2017];
   FCT-MCTES through "Fundos do Orcamento de Estado" [UID/BIM/50005/2019]
FX This work was supported by Fundacao para a Ciencia e a Tecnologia
   -Ministerio da Ciencia, Tecnologia e Ensino Superior (FCT-MCTES,
   Portugal) and by Fundacao Calouste Gulbenkian (Portugal). I.C.M. also
   acknowledges FCT-MCTES Programs "Investigador FCT" (IF/00772/2013) and
   "Concurso de Estimulo ao Emprego Cientifico" (CEECIND/01670/2017). This
   work was also supported by UID/BIM/50005/2019, project funded by
   FCT-MCTES through "Fundos do Orcamento de Estado". The authors declare
   that there are no conflicts of interest.
CR Aguilera-Pesantes D, 2017, BIOCHEM BIOPH RES CO, V492, P659, DOI 10.1016/j.bbrc.2017.02.035
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   ANFINSEN CB, 1961, P NATL ACAD SCI USA, V47, P1309, DOI 10.1073/pnas.47.9.1309
   ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223
   Anglero-Rodriguez YI, 2014, CLIN VACCINE IMMUNOL, V21, P29, DOI 10.1128/CVI.00500-13
   Blanco LP, 2012, TRENDS MICROBIOL, V20, P66, DOI 10.1016/j.tim.2011.11.005
   Boon P.L.S., 2019, GENOME WIDE ASS FLAV, DOI [10.1101/606905., DOI 10.1101/606905]
   Boon PLS, 2018, ACS CHEM BIOL, V13, P1621, DOI 10.1021/acschembio.8b00231
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   CAI YY, 2015, NUCLEIC ACIDS RES, P1774, DOI DOI 10.1093/NAR/GKV342
   Camilloni C, 2016, SCI REP-UK, V6, DOI 10.1038/srep28285
   Carvalho FA, 2013, ARCH BIOCHEM BIOPHYS, V531, P116, DOI 10.1016/j.abb.2012.11.007
   Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chen XY, 2015, BIOCHEM BIOPH RES CO, V461, P148, DOI 10.1016/j.bbrc.2015.04.004
   Cherny I, 2008, ANGEW CHEM INT EDIT, V47, P4062, DOI 10.1002/anie.200703133
   Cruzeiro L, 2018, SPRINGER COMPLEX, P3, DOI 10.1007/978-3-319-72218-4_1
   DELEAGE G, 1987, PROTEIN ENG, V1, P289, DOI 10.1093/protein/1.4.289
   Du X, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020144
   Dunker A K, 2000, Genome Inform Ser Workshop Genome Inform, V11, P161
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Ekins Sean, 2016, F1000Res, V5, P275
   Faustino AE, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163870
   Faustino AF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37599-z
   Faustino AF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10592
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Faustino AF, 2014, NANOMED-NANOTECHNOL, V10, P247, DOI 10.1016/j.nano.2013.06.004
   Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012
   Ferreon ACM, 2011, BBA-PROTEINS PROTEOM, V1814, P1021, DOI 10.1016/j.bbapap.2011.01.011
   Forli S, 2016, NAT PROTOC, V11, P905, DOI 10.1038/nprot.2016.051
   Garces AP, 2013, BIOCHEMISTRY-US, V52, P6856, DOI 10.1021/bi400782w
   Gazit E, 2016, J INHERIT METAB DIS, V39, P483, DOI 10.1007/s10545-016-9946-9
   Gazit E, 2007, PRION, V1, P32, DOI 10.4161/pri.1.1.4095
   Gianni S, 2012, BIOCHEM BIOPH RES CO, V428, P205, DOI 10.1016/j.bbrc.2012.09.112
   Gilead S, 2005, SUPRAMOL CHEM, V17, P87, DOI 10.1080/10610270412331328943
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Goh GKM, 2016, MOL BIOSYST, V12, P1881, DOI 10.1039/c6mb00228e
   Goh GKM, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-126
   Goh GKM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S4
   Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371
   GORDON J, 2016, ANAL ULTRACENTRIFUGA, P329
   Gruba N, 2016, FEBS LETT, V590, P3459, DOI 10.1002/1873-3468.12443
   Hammer ND, 2008, J ALZHEIMERS DIS, V13, P407
   Harrison RS, 2007, REV PHYSIOL BIOCH P, V159, P1, DOI 10.1007/112_2007_0701
   Hauser CAE, 2014, CHEM SOC REV, V43, P5326, DOI 10.1039/c4cs00082j
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Hebrard E, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-23
   Huang SY, 2010, INT J MOL SCI, V11, P3016, DOI 10.3390/ijms11083016
   Hwang H, 2017, P NATL ACAD SCI USA, V114, P13685, DOI 10.1073/pnas.1705381114
   Iconomidou VA, 2008, CURR PROTEIN PEPT SC, V9, P291, DOI 10.2174/138920308784534041
   Ivanyi-Nagy R, 2010, PROTEIN PEPTIDE LETT, V17, P1019, DOI 10.2174/092986610791498911
   Jackson MP, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7040071
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar D, 2017, CANCER INFORM, V16, DOI 10.1177/1176935117699408
   Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211
   Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Leon-Juarez M, 2016, VIROL J, V13, DOI 10.1186/s12985-015-0456-4
   Levinthal C., 1969, MOSSBAUER SPECTROSCO, P22
   Li G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020157
   Li L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43125-6
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Li Y, 2018, BBA-BIOMEMBRANES, V1860, P442, DOI 10.1016/j.bbamem.2017.10.016
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lin HH, 2018, BIOTECHNOL ADV, V36, P47, DOI 10.1016/j.biotechadv.2017.09.004
   Lin KH, 2017, J VIROL, V91, DOI 10.1128/JVI.00045-17
   Lin MH, 2014, J BIOMOL STRUCT DYN, V32, P1552, DOI 10.1080/07391102.2013.826599
   Ma JF, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00459
   Martin-Acebes MA, 2016, PROG LIPID RES, V64, P123, DOI 10.1016/j.plipres.2016.09.005
   Martins AS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00008
   Martins AS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01951
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Martins IC, 2008, EMBO J, V27, P224, DOI 10.1038/sj.emboj.7601953
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Meng FC, 2017, CELL MOL LIFE SCI, V74, P3069, DOI 10.1007/s00018-017-2555-4
   Meng Fanchi, 2017, Curr Protoc Protein Sci, V88, DOI 10.1002/cpps.28
   Meng FC, 2015, FEBS J, V282, P3368, DOI 10.1111/febs.13349
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mukherjee S, 2011, J VIROL, V85, P12067, DOI 10.1128/JVI.05559-11
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Na JH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020381
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Nelson D. L., 2000, PRINCIPLES BIOCH
   Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060
   Neurath H, 1944, CHEM REV, V34, P157, DOI 10.1021/cr60108a003
   Ng EY, 2019, PROTEIN EXPRES PURIF, V154, P1, DOI 10.1016/j.pep.2018.09.013
   Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947
   Phong WY, 2011, BIOSCIENCE REP, V31, P399, DOI 10.1042/BSR20100142
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pimenta J, 2013, PEPTIDES, V49, P32, DOI 10.1016/j.peptides.2013.08.013
   Pimenta J, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-25
   Ragoza M, 2017, J CHEM INF MODEL, V57, P942, DOI 10.1021/acs.jcim.6b00740
   Reches M, 2006, CURR NANOSCI, V2, P105, DOI 10.2174/157341306776875802
   Redwan EM, 2019, CELL MOL LIFE SCI, V76, P577, DOI 10.1007/s00018-018-2968-8
   Rodenhuis-Zybert IA, 2011, J VIROL, V85, P11800, DOI 10.1128/JVI.05237-11
   Rothan HA, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-314
   Sadava David, 2010, LIFE SCI BIOL
   Schad E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r120
   Schymkowitz JWH, 2005, P NATL ACAD SCI USA, V102, P10147, DOI 10.1073/pnas.0501980102
   Senthilvel P, 2013, BIOINFORMATION, V9, P889, DOI 10.6026/97320630009889
   Setoh YX, 2012, J GEN VIROL, V93, P1965, DOI 10.1099/vir.0.044453-0
   Shafee N, 2003, J GEN VIROL, V84, P2191, DOI 10.1099/vir.0.19022-0
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893
   Sironi M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004978
   Skrabanek L, 2008, MOL BIOTECHNOL, V38, P1, DOI 10.1007/s12033-007-0069-2
   Tadeo X, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000257
   Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004
   Toto A, 2016, SCI REP-UK, V6, DOI 10.1038/srep21994
   Uversky VN, 2019, PROG MOL BIOL TRANSL, V166, P1, DOI 10.1016/bs.pmbts.2019.05.003
   Uversky VN, 2019, FRONT PHYS-LAUSANNE, V7, DOI 10.3389/fphy.2019.00010
   Uversky VN, 2014, CHEM REV, V114, P6557, DOI 10.1021/cr500288y
   van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m
   Vicente Miranda H, 2017, BRAIN, V140, P1399, DOI 10.1093/brain/awx056
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wei G, 2017, CHEM SOC REV, V46, P4661, DOI 10.1039/c6cs00542j
   Wolk B, 2000, J VIROL, V74, P2293, DOI 10.1128/JVI.74.5.2293-2304.2000
   Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920
   Yang JY, 2013, NUCLEIC ACIDS RES, V41, pD1096, DOI 10.1093/nar/gks966
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhang Y, 2003, EMBO J, V22, P2604, DOI 10.1093/emboj/cdg270
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
NR 131
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0003-9861
EI 1096-0384
J9 ARCH BIOCHEM BIOPHYS
JI Arch. Biochem. Biophys.
PD APR 15
PY 2020
VL 683
AR UNSP 108298
DI 10.1016/j.abb.2020.108298
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LC6NL
UT WOS:000525450400005
PM 32045581
DA 2020-07-08
ER

PT J
AU Dolai, S
   Tabib-Azar, M
AF Dolai, Subhashish
   Tabib-Azar, Massood
TI 433 MHz Lithium Niobate Microbalance Aptamer-Coated Whole Zika Virus
   Sensor With 370 Hz/ng Sensitivity
SO IEEE SENSORS JOURNAL
LA English
DT Article
DE 433 MHz Lithium Niobate crystal microbalance; whole virus sensor; Zika;
   aptamer
ID QUARTZ-CRYSTAL; DEVICES; PCR
AB Three different microbalances were coated with aptamers with thiol termination designed to attach to the capsid proteins of the whole Zika virus. The first microbalance was a 5 MHz commercial AT-cut (QSense) quartz microbalance that showed 1 Hz/ng sensitivity with minimum detectable signal (MDS) of 1 ng. The second sensor was a 10 MHz AT-cut quartz sensor that was extracted from a communication filter. It had 10 Hz/ng sensitivity and MDS of 0.1 ng. The third sensor was a 433 MHz Lithium Niobate (LiNbO3) sensor that was also extracted from a communication filter. It had 370 Hz/ng sensitivity and 2.7 pg MDS. These studies verify binding of the aptamers to the sensor surface and the Zika virus. They also clearly show the advantage of using the LiNbO3 high frequency microbalance.
C1 [Dolai, Subhashish; Tabib-Azar, Massood] Univ Utah, Elec & Comp Engn Dept, Salt Lake City, UT 84112 USA.
RP Tabib-Azar, M (corresponding author), Univ Utah, Elec & Comp Engn Dept, Salt Lake City, UT 84112 USA.
EM subhashish.dolai@utah.edu; azar.m@utah.edu
OI Tabib-Azar, Massood/0000-0001-9475-0782; Dolai,
   Subhashish/0000-0002-3435-0020
FU National Science Foundation (NSF) EAGER through Dr. Leon
   EsterowitzNational Science Foundation (NSF) [1931100]
FX This work was supported by the National Science Foundation (NSF) EAGER
   through Dr. Leon Esterowitz under Grant 1931100.
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Base Pair Biotechnologies, BAS PAIR BIOT APT DI
   Bizet K, 1999, ANALUSIS, V27, P609, DOI 10.1051/analusis:1999270609
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Charrel RN, 2016, B WORLD HEALTH ORGAN, V94, P574, DOI 10.2471/BLT.16.171207
   Dickert FL, 1998, SENSOR ACTUAT B-CHEM, V46, P120, DOI 10.1016/S0925-4005(98)00097-5
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Haug CJ, 2016, NEW ENGL J MED, V374, P1801, DOI 10.1056/NEJMp1603734
   Ilic B, 2004, APPL PHYS LETT, V85, P2604, DOI 10.1063/1.1794378
   Jenik M, 2009, ANAL CHEM, V81, P5320, DOI 10.1021/ac8019569
   JENISON RD, 1994, SCIENCE, V263, P1425, DOI 10.1126/science.7510417
   Kim KS, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/23/235501
   Klungthong C, 2007, J CLIN MICROBIOL, V45, P2480, DOI 10.1128/JCM.00305-07
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000
   Maehashi K, 2007, ANAL CHEM, V79, P782, DOI 10.1021/ac060830g
   MARTIN SJ, 1994, ANAL CHEM, V66, P2201, DOI 10.1021/ac00086a003
   Matko V, 2006, SENSORS-BASEL, V6, P746, DOI 10.3390/s6070746
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Negri P, 2012, ANAL CHEM, V84, P5501, DOI 10.1021/ac202427e
   Ohno Y, 2010, J AM CHEM SOC, V132, P18012, DOI 10.1021/ja108127r
   Prospec Protein Specialists, ZIK ENV REC ANT ZIK
   Ruslinda AR, 2013, BIOSENS BIOELECTRON, V40, P277, DOI 10.1016/j.bios.2012.07.048
   Ruslinda AR, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3643067
   SAUERBREY G, 1959, Z PHYS, V155, P206, DOI 10.1007/BF01337937
   Shin J, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021002
   So HM, 2008, SMALL, V4, P197, DOI 10.1002/smll.200700664
NR 29
TC 0
Z9 0
U1 4
U2 4
PU IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC
PI PISCATAWAY
PA 445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA
SN 1530-437X
EI 1558-1748
J9 IEEE SENS J
JI IEEE Sens. J.
PD APR 15
PY 2020
VL 20
IS 8
BP 4269
EP 4274
DI 10.1109/JSEN.2019.2961611
PG 6
WC Engineering, Electrical & Electronic; Instruments & Instrumentation;
   Physics, Applied
SC Engineering; Instruments & Instrumentation; Physics
GA KX9PE
UT WOS:000522206500034
OA Bronze
DA 2020-07-08
ER

PT J
AU Park, T
   Kang, MG
   Baek, SH
   Lee, CH
   Park, D
AF Park, Tamina
   Kang, Myung-gyun
   Baek, Seung-hwa
   Lee, Chang Hoon
   Park, Daeui
TI Zika virus infection differentially affects genome-wide transcription in
   neuronal cells and myeloid dendritic cells
SO PLOS ONE
LA English
DT Article
ID PROTEIN
AB Zika virus (ZIKV) is an emerging mosquito-borne flavivirus that has attracted global attention and international awareness. ZIKV infection exhibits mild symptoms including fever and pains; however, ZIKV has recently been shown to be related to increased birth defects, including microcephaly, in infants. In addition, ZIKV is related to the onset of neurological disorders, such as a type of paralysis similar to Guillain-Barre syndrome. However, the mechanisms through which ZIKV affect neuronal cells and myeloid dendritic cells and how ZIKV avoids host immunity are unclear. Accordingly, in this study, we analyzed RNA sequencing data from ZIKV-infected neuronal cells and myeloid dendritic cells by comparative network analyses using protein-protein interaction information. Comparative network analysis revealed major genes showing differential changes in the peripheral neurons, neural crest cells, and myeloid dendritic cells after ZIKV infection. The genes were related to DNA repair systems and prolactin signaling as well as the interferon signaling, neuroinflammation, and cell cycle pathways. These pathways were interconnected by the interaction of proteins in the pathway and significantly regulated by ZIKV infection in neuronal cells and myeloid dendritic cells. Our analysis showed that neuronal cell damage occurred through up-regulation of neuroinflammation and down-regulation of the DNA repair system, but not in myeloid dendritic cells. Interestingly, immune escape by ZIKV infection could be caused by downregulation of prolactin signaling including IRS2, PIK3C3, JAK3, STAT3, and IRF1 as well as mitochondria dysfunction and oxidative phosphorylation in myeloid dendritic cells. These findings provide insight into the mechanisms of ZIKV infection in the host and the association of ZIKV with neurological and immunological symptoms, which may facilitate the development of therapeutic agents and vaccines.
C1 [Park, Tamina; Kang, Myung-gyun; Baek, Seung-hwa; Park, Daeui] Korea Inst Toxicol, Dept Predict Toxicol, Daejeon, South Korea.
   [Park, Tamina; Park, Daeui] Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon, South Korea.
   [Baek, Seung-hwa; Park, Daeui] Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea.
   [Lee, Chang Hoon] Korea Res Inst Chem Technol, Ctr Informat Based Drug Res, Bio & Drug Discovery Div, Daejeon, South Korea.
RP Park, D (corresponding author), Korea Inst Toxicol, Dept Predict Toxicol, Daejeon, South Korea.; Park, D (corresponding author), Univ Sci & Technol, Dept Human & Environm Toxicol, Daejeon, South Korea.; Park, D (corresponding author), Korea Res Inst Chem Technol, Ctr Convergent Res Emerging Virus Infect, Daejeon, South Korea.; Lee, CH (corresponding author), Korea Res Inst Chem Technol, Ctr Informat Based Drug Res, Bio & Drug Discovery Div, Daejeon, South Korea.
EM lee2014@krict.re.kr; daeui.park@kitox.re.kr
OI Park, Daeui/0000-0002-9452-5849
FU National Research Council of Science & Technology grant by the Korea
   government [CRC-16-01-KRICT]
FX This work was supported by National Research Council of Science &
   Technology grant by the Korea government (CRC-16-01-KRICT) to DP.
CR Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chougnet CA, 2015, J IMMUNOL, V195, P2624, DOI 10.4049/jimmunol.1501006
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Daz L, 2013, PROLACTIN IMMUNE SYS, DOI [10.5772/53538, DOI 10.5772/53538]
   Breda CND, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101255
   Devhare P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.517
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Enninga EAL, 2014, MAYO CLIN PROC, V89, P520, DOI 10.1016/j.mayocp.2014.01.006
   Hammack C, 2019, J VIROL, V93, DOI 10.1128/JVI.00638-19
   Hirayama D, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010092
   Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Magalhaes T, 2018, VIRUS RES, V254, P1, DOI 10.1016/j.virusres.2017.07.011
   Mahony R, 2017, CELL MOL LIFE SCI, V74, P1755, DOI 10.1007/s00018-016-2435-3
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Paploski IAD, 2016, EMERG INFECT DIS, V22, P1438, DOI 10.3201/eid2208.160496
   Patil MJ, 2014, CHANNELS, V8, DOI 10.4161/chan.28946
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   Radhakrishnan A, 2012, J CELL COMMUN SIGNAL, V6, P169, DOI 10.1007/s12079-012-0168-0
   Riquelme SA, 2015, EUR J IMMUNOL, V45, P3269, DOI 10.1002/eji.201545671
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Sager G, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100559
   Salvador JM, 2013, ADV EXP MED BIOL, V793, P1, DOI 10.1007/978-1-4614-8289-5_1
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang Zichen, 2016, F1000Res, V5, P1574, DOI 10.12688/f1000research.9110.1
   Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059
NR 38
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 14
PY 2020
VL 15
IS 4
AR e0231049
DI 10.1371/journal.pone.0231049
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LR9DZ
UT WOS:000535997100012
PM 32287277
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chen, MY
   Chai, KM
   Chiang, CY
   Wu, CC
   Yu, GY
   Liu, SJ
   Chen, HW
AF Chen, Mei-Yu
   Chai, Kit Man
   Chiang, Chen-Yi
   Wu, Chiao-Chieh
   Yu, Guann-Yi
   Liu, Shih-Jen
   Chen, Hsin-Wei
TI Recombinant lipidated Zika virus envelope protein domain III elicits
   durable neutralizing antibody responses against Zika virus in mice
SO JOURNAL OF BIOMEDICAL SCIENCE
LA English
DT Article
DE Envelope protein domain III; Neutralizing antibody; Recombinant
   lipoprotein; Vaccine; Zika virus
ID DENGUE-VIRUS; IMMUNE-RESPONSES; LIPOPROTEIN; BINDING
AB Background The emergence of Zika virus (ZV) in tropical and subtropical areas of the world has created an urgent need for vaccines against ZV. However, approved vaccines that prevent ZV infection are not available. To develop an effective vaccine against ZV infection, a lipidated form of ZV envelope protein domain III that possesses an intrinsic adjuvant property was rationally designed. Our goal was to examine the immunogenicity of recombinant lipidated ZV envelope protein domain III (rLZE3) and evaluate its potential as a vaccine candidate against ZV. Methods Recombinant ZV envelope protein domain III (rZE3) and rLZE3 were prepared with an Escherichia coli-based system. Dendritic cell surface marker expression and cytokine production upon stimulation were analyzed to evaluate the function of rLZE3. Neutralizing antibody capacities were evaluated using focus reduction neutralization tests after immunization. To investigate the protective immunity in immunized mice, serum samples collected from immunized mice were adoptively transferred into AG129 mice, and then viremia levels and survival times were examined after ZV challenge. Results rLZE3 alone but not rZE3 alone efficiently activated dendritic cells in vitro and was taken up by dendritic cells in vivo. Immunization of C57BL/6 mice with rLZE3 alone (without exogenous adjuvant) could induce ZV-specific neutralizing antibody responses. Furthermore, serum samples obtained from rLZE3-immunized mice provided protection as indicated by a reduction in viremia levels and prolongation of survival times after ZV challenge. Conclusion These results indicate that rLZE3 is an excellent vaccine candidate and has great potential that should be evaluated in further preclinical studies.
C1 [Chen, Mei-Yu; Chai, Kit Man; Chiang, Chen-Yi; Wu, Chiao-Chieh; Yu, Guann-Yi; Liu, Shih-Jen; Chen, Hsin-Wei] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.
   [Liu, Shih-Jen; Chen, Hsin-Wei] China Med Univ, Grad Inst Biomed Sci, Taichung, Taiwan.
   [Liu, Shih-Jen; Chen, Hsin-Wei] Kaohsiung Med Univ, Grad Inst Med, Coll Med, Kaohsiung, Taiwan.
RP Liu, SJ; Chen, HW (corresponding author), Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan.
EM levent@nhri.org.tw; chenhw@nhri.org.tw
OI Chen, Hsin-Wei/0000-0002-3207-2397
FU Ministry of Science and Technology, TaiwanMinistry of Science and
   Technology, Taiwan [MOST 106-2321-B-400-009, MOST 107-2321-B-400-006,
   MOST 108-2321-B-400-012]; National Health Research Institutes,
   TaiwanNational Health Research Institutes - Taiwan [MR-108-GP-08]
FX This work was supported by grants from the Ministry of Science and
   Technology, Taiwan (MOST 106-2321-B-400-009, MOST 107-2321-B-400-006,
   and MOST 108-2321-B-400-012) and National Health Research Institutes,
   Taiwan (MR-108-GP-08).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Cabral-Miranda G, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030072
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen HW, 2013, ARCH VIROL, V158, P1523, DOI 10.1007/s00705-013-1639-1
   Chen HW, 2009, VACCINE, V27, P1400, DOI 10.1016/j.vaccine.2008.12.043
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Chiang CY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00822
   Chiang CY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30648
   Chiang CY, 2016, VACCINE, V34, P1054, DOI 10.1016/j.vaccine.2016.01.009
   Chiang CY, 2014, VACCINE, V32, P1346, DOI 10.1016/j.vaccine.2014.01.041
   Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432
   Chiang CY, 2013, MICROBES INFECT, V15, P719, DOI 10.1016/j.micinf.2013.06.002
   Chiang CY, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001645
   Chiang CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023319
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fajardo A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2015.01667
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Hung JJ, 2004, J VIROL, V78, P378, DOI 10.1128/JVI.78.1.378-388.2004
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Leng CH, 2009, MICROBES INFECT, V11, P288, DOI 10.1016/j.micinf.2008.12.004
   Pierson TC, 2016, CELL, V167, P625, DOI 10.1016/j.cell.2016.09.020
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shimizu T, 2008, INFECT IMMUN, V76, P3672, DOI 10.1128/IAI.00257-08
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tai WB, 2019, J VIROL, V93, DOI 10.1128/JVI.02187-18
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tawaratsumida K, 2009, J BIOL CHEM, V284, P9147, DOI 10.1074/jbc.M900429200
   Thakran S, 2008, J BIOL CHEM, V283, P3751, DOI 10.1074/jbc.M706854200
   VanBlargan LA, 2016, MICROBIOL MOL BIOL R, V80, DOI 10.1128/MMBR.00024-15
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhang W, 2019, ANTIVIR RES, V170, DOI 10.1016/j.antiviral.2019.104578
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 41
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1021-7770
EI 1423-0127
J9 J BIOMED SCI
JI J. Biomed. Sci.
PD APR 14
PY 2020
VL 27
IS 1
AR 51
DI 10.1186/s12929-020-00646-x
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA LH3GD
UT WOS:000528674500001
PM 32290844
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Angueyra, C
   Abou Hatab, H
   Pathak, A
AF Angueyra, Chantal
   Abou Hatab, Hani
   Pathak, Anil
TI Congenital Cytomegalovirus and Zika Infections
SO INDIAN JOURNAL OF PEDIATRICS
LA English
DT Review; Early Access
DE Congenital infections; Congenital cytomegalovirus; Congenital CMV;
   Congenital Zika; Microcephaly; Sensorineural hearing loss; Developmental
   delay; Zika virus exposure; Zika virus screening; CMV screening;
   Breastfeeding mothers with CMV; Breastfeeding mothers with Zika virus;
   Diagnosis of congenital Zika; Diagnosis of congenital CMV; CMV
   transmission; Zika virus transmission
ID SENSORINEURAL HEARING-LOSS; TO-CHILD TRANSMISSION; VIRUS-INFECTION;
   BREAST-MILK; MOTHER; EPIDEMIOLOGY; PREVENTION; INFANT; BIRTH
AB Congenital infections affecting newborn infants can have potentially devastating clinical outcomes. They are usually caused by viruses that infect mothers during pregnancy and are transmitted to the fetus or newborn during the prenatal, perinatal or postnatal periods. Congenital cytomegalovirus (cCMV) is the most common congenital infection affecting up to 2.5% of all live births. Even though most infected infants are asymptomatic at birth, cCMV is an important cause of neurodevelopmental impairment and represents the main cause of non-hereditary sensorineural hearing loss. Also, congenital Zika infection has emerged in recent years as a cause of microcephaly and neurodevelopmental delays. Currently, universal screening is not recommended for either infection in pregnant women or newborn infants. Therefore, screening for both conditions is based on multiple factors such as maternal immune status, exposure, and clinical manifestations of the infant. Use of antiviral medications on symptomatic cCMV has shown improvement in outcomes, in contrast with congenital Zika for which there are no therapeutic options available. Even though both viruses can be present in breast milk, there are no recommendations against breastfeeding in full-term infants. Close follow-up for affected infants is necessary to monitor for developmental delays and sensory impairments to implement interventional therapies at the earliest time possible.
C1 [Angueyra, Chantal] Columbia Univ, Dept Pediat, Div Neonatal Perinatal Med, Med Ctr, New York, NY 10027 USA.
   [Abou Hatab, Hani] Cleveland Clin, Emergency Serv Inst, Cleveland, OH 44106 USA.
   [Pathak, Anil] Harlem Hosp Med Ctr, Dept Pediat, Div Neonatol, New York, NY USA.
RP Angueyra, C (corresponding author), Columbia Univ, Dept Pediat, Div Neonatal Perinatal Med, Med Ctr, New York, NY 10027 USA.
EM chantal.angueyra@gmail.com
CR [Anonymous], 2019, WHO GUID PREV SEX TR
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Boppana SB, 2010, JAMA-J AM MED ASSOC, V303, P1375, DOI 10.1001/jama.2010.423
   Centers for Disease Control and Prevention, 2017, UPD INT GUID DIAGN E
   Centers for Disease Control and Prevention, 2017, EST INC PER ZIK VIR
   Centers for Disease Control and Prevention, 2018, UPD INT GUID PREC CO
   Centers for Disease Control and Prevention, 2019, EXPOS TEST RISKS
   Centers for Disease Control and Prevention, 2017, UPD INT GUID HLTH CA
   Centers for Disease Control and Prevention, 2019, CONG ZIK SYNDR BIRTH
   Centers for Disease Control and Prevention, 2018, ZIK INF CHILDR
   Centers for Disease Control and Prevention, 2016, LIT REV ZIK VIR
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Faure-Bardon V, 2019, CLIN INFECT DIS, V69, P1526, DOI 10.1093/cid/ciy1128
   Foulon I, 2008, J PEDIATR-US, V153, P84, DOI 10.1016/j.jpeds.2007.12.049
   Fowler KB, 2017, PEDIATRICS, V139, DOI 10.1542/peds.2016-2128
   Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016
   Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hamprecht K, 2001, LANCET, V357, P513, DOI 10.1016/S0140-6736(00)04043-5
   Josephson CD, 2014, JAMA PEDIATR, V168, P1054, DOI 10.1001/jamapediatrics.2014.1360
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2015, NEW ENGL J MED, V372, P933, DOI 10.1056/NEJMoa1404599
   Kimberlin DW, 2003, J PEDIATR-US, V143, P16, DOI 10.1016/S0022-3476(03)00192-6
   Kurath S, 2010, CLIN MICROBIOL INFEC, V16, P1172, DOI 10.1111/j.1469-0691.2010.03140.x
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Maschmann J, 2019, ARCH DIS CHILD-FETAL, V104, pF604, DOI 10.1136/archdischild-2018-316117
   Meier J, 2005, J CLIN MICROBIOL, V43, P1318, DOI 10.1128/JCM.43.3.1318-1324.2005
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Nogueira ML, 2017, AM J TRANSPLANT, V17, DOI 10.1111/ajt.14047
   Palma S, 2019, ACTA OTORHINOLARYNGO, V39, P40, DOI 10.14639/0392-100X-2020
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pass RF, 2009, OBSTET GYNECOL SURV, V64, P502, DOI [10.1097/01.ogx.0000356753.12837.a8, DOI 10.1097/01.OGX.0000356753.12837.A8]
   Pass RF, 2014, J PEDIATR INFECT DIS, V3, pS2, DOI 10.1093/jpids/piu069
   Rawlinson WD, 2017, LANCET INFECT DIS, V17, pE177, DOI 10.1016/S1473-3099(17)30143-3
   Riga M, 2018, INT J PEDIATR OTORHI, V115, P156, DOI 10.1016/j.ijporl.2018.10.005
   Rosenthal LS, 2009, PEDIATR INFECT DIS J, V28, P515, DOI 10.1097/INF.0b013e318198c724
   Wikan N, 2017, LANCET INFECT DIS, V17, P15, DOI 10.1016/S1473-3099(16)30525-4
NR 45
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER INDIA
PI NEW DELHI
PA 7TH FLOOR, VIJAYA BUILDING, 17, BARAKHAMBA ROAD, NEW DELHI, 110 001,
   INDIA
SN 0019-5456
EI 0973-7693
J9 INDIAN J PEDIATR
JI Indian J. Pediatr.
DI 10.1007/s12098-020-03260-9
EA APR 2020
PG 6
WC Pediatrics
SC Pediatrics
GA LC6ZX
UT WOS:000525483200001
PM 32281058
DA 2020-07-08
ER

PT J
AU Chan, KK
   Auguste, AJ
   Brewster, CC
   Paulson, SL
AF Chan, Kevin K.
   Auguste, Albert J.
   Brewster, Carlyle C.
   Paulson, Sally L.
TI Vector competence of Virginia mosquitoes for Zika and Cache Valley
   viruses
SO PARASITES & VECTORS
LA English
DT Article
DE Zika virus; Cache Valley virus; Vector competence; Aedes japonicus;
   Aedes albopictus; Aedes triseriatus; Aedes aegypti; Culex pipiens; Culex
   restuans; Infection barriers
ID AEDES-ALBOPICTUS DIPTERA; BUNYAMWERA SEROGROUP VIRUSES; LOUIS
   ENCEPHALITIS-VIRUS; J. JAPONICUS DIPTERA; LA-CROSSE VIRUS; BUNYAVIRIDAE
   ORTHOBUNYAVIRUS; EXPERIMENTAL TRANSMISSION; BIOLOGICAL TRANSMISSION;
   GEOGRAPHIC STRAINS; AEGYPTI MOSQUITOS
AB Background: Vector-borne diseases are a major public health concern and cause significant morbidity and mortality. Zika virus (ZIKV) is the etiologic agent of a massive outbreak in the Americas that originated in Brazil in 2015 and shows a strong association with congenital ZIKV syndrome in newborns. Cache Valley virus (CVV) is a bunyavirus that causes mild to severe illness in humans and ruminants. In this study, we investigated the vector competence of Virginia mosquitoes for ZIKV and CVV to explore their abilities to contribute to potential outbreaks.
   Methods: To determine vector competence, mosquitoes were fed a blood meal comprised of defibrinated sheep blood and virus. The presence of midgut or salivary gland barriers to ZIKV infection were determined by intrathoracic inoculation vs oral infection. After 14-days post-exposure, individual mosquitoes were separated into bodies, legs and wings, and saliva expectorant. Virus presence was detected by plaque assay to determine midgut infection, dissemination, and transmission rates.
   Results: Transmission rates for Ae. albopictus orally infected (24%) and intrathoracically inoculated (63%) with ZIKV was similar to Ae. aegypti (48% and 71%, respectively). Transmission rates of ZIKV in Ae. japonicus were low, and showed evidence of a midgut infection barrier demonstrated by low midgut infection and dissemination rates from oral infection (3%), but increased transmission rates after intrathoracic inoculation (19%). Aedes triseriatus was unable to transmit ZIKV following oral infection or intrathoracic inoculation. CVV transmission was dose-dependent where mosquitoes fed high titer (ht) virus blood meals developed higher rates of midgut infection, dissemination, and transmission compared to low titer (lt) virus blood meals. CVV was detected in the saliva of Ae. albopictus (ht: 68%, lt: 24%), Ae. triseriatus (ht: 52%, lt: 7%), Ae. japonicus (ht: 22%, lt: 0%) and Ae. aegypti (ht: 10%; lt: 7%). Culex pipiens and Cx. restuans were not competent for ZIKV or CVV.
   Conclusions: This laboratory transmission study provided further understanding of potential ZIKV and CVV transmission cycles with Aedes mosquitoes from Virginia. The ability for these mosquitoes to transmit ZIKV and CVV make them a public health concern and suggest targeted control programs by mosquito and vector abatement districts.
C1 [Chan, Kevin K.; Auguste, Albert J.; Paulson, Sally L.] Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.
   [Brewster, Carlyle C.] Clemson Univ, Plant & Environm Sci Dept, Clemson, SC USA.
RP Paulson, SL (corresponding author), Virginia Tech, Dept Entomol, Blacksburg, VA 24061 USA.
EM spaulson@vt.edu
FU Graduate Research Development Programme at Virginia Tech
FX This study was supported by a grant from Graduate Research Development
   Programme at Virginia Tech.
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Aliota MT, 2017, ANTIVIR RES, V144, P223, DOI 10.1016/j.antiviral.2017.06.001
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Amraoui F, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.35.30333
   Andreadis TG, 2014, VECTOR-BORNE ZOONOT, V14, P763, DOI 10.1089/vbz.2014.1669
   Armistead JS, 2012, J MED ENTOMOL, V49, P1318, DOI 10.1603/ME11261
   Armstrong PM, 2015, AM J TROP MED HYG, V93, P11, DOI 10.4269/ajtmh.15-0132
   Armstrong PM, 2013, J MED ENTOMOL, V50, P1310, DOI 10.1603/ME13099
   Ayers VB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3103-2
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Barker CM, 2003, J MED ENTOMOL, V40, P403, DOI 10.1603/0022-2585-40.4.403
   Bennett KE, 2002, AM J TROP MED HYG, V67, P85, DOI 10.4269/ajtmh.2002.67.85
   Blackmore CGM, 1998, J MED ENTOMOL, V35, P660, DOI 10.1093/jmedent/35.5.660
   BURKOT TR, 1982, AM J TROP MED HYG, V31, P376, DOI 10.4269/ajtmh.1982.31.376
   CALISHER CH, 1986, AM J TROP MED HYG, V35, P429, DOI 10.4269/ajtmh.1986.35.429
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   CAMPBELL GL, 1989, AM J TROP MED HYG, V40, P428, DOI 10.4269/ajtmh.1989.40.428
   Campbell GL, 2006, EMERG INFECT DIS, V12, P854, DOI 10.3201/eid1205.051625
   CDC, 2019, ZIK CAS US
   Centers for Disease Control and Prevention (CDC), 2017, WORLD MAP AR RISK ZI
   CHAMBERLAIN RW, 1959, AM J HYG, V70, P221, DOI 10.1093/oxfordjournals.aje.a120072
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cunze S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1853-2
   Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111
   Dibernardo A, 2017, J AM MOSQUITO CONTR, V33, P276, DOI 10.2987/17-6664.1
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423
   EDWARDS JF, 1989, VET PATHOL, V26, P33, DOI 10.1177/030098588902600106
   Erickson SM, 2006, J MED ENTOMOL, V43, P966, DOI 10.1603/0022-2585(2006)43[966:TPOATD]2.0.CO;2
   European Centre for Disease Prevention and Control (ECDC), 2014, AED TRIS FACTSH EXP
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Goddard LB, 2002, EMERG INFECT DIS, V8, P1385, DOI 10.3201/eid0812.020536
   GUBLER DJ, 1976, AM J TROP MED HYG, V25, P318, DOI 10.4269/ajtmh.1976.25.318
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Jackson BT, 2012, J MED ENTOMOL, V49, P1424, DOI 10.1603/ME12023
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Kaufman MG, 2014, ANNU REV ENTOMOL, V59, P31, DOI 10.1146/annurev-ento-011613-162012
   Khoo CCH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-130
   KRAMER LD, 1981, AM J TROP MED HYG, V30, P190, DOI 10.4269/ajtmh.1981.30.190
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kuno G, 2005, CLIN MICROBIOL REV, V18, P608, DOI 10.1128/CMR.18.4.608-637.2005
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Liu ZZ, 2017, EMERG INFECT DIS, V23, P1085, DOI 10.3201/eid2307.161528
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McKenzie BA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216794
   MILLER BR, 1989, T ROY SOC TROP MED H, V83, P252, DOI 10.1016/0035-9203(89)90667-6
   Mitchell CJ, 1998, J MED ENTOMOL, V35, P573, DOI 10.1093/jmedent/35.4.573
   MITCHELL CJ, 1991, J AM MOSQUITO CONTR, V7, P446
   Molaei G, 2009, J AM MOSQUITO CONTR, V25, P210, DOI 10.2987/09-0012.1
   Muturi EJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005377
   NEITZEL DF, 1991, J WILDLIFE DIS, V27, P230, DOI 10.7589/0090-3558-27.2.230
   Ngo KA, 2006, J MED ENTOMOL, V43, P1004, DOI 10.1603/0022-2585(2006)43[1004:IOBSVB]2.0.CO;2
   PAULSON SL, 1989, MED VET ENTOMOL, V3, P113, DOI 10.1111/j.1365-2915.1989.tb00485.x
   Richards SL, 2006, J MED ENTOMOL, V43, P543, DOI 10.1603/0022-2585(2006)43[543:HPOAAD]2.0.CO;2
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   ROSEN L, 1974, AM J TROP MED HYG, V23, P1153, DOI 10.4269/ajtmh.1974.23.1153
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sanchez-Trinidad A, 2014, J VECTOR ECOL, V39, P134, DOI 10.1111/j.1948-7134.2014.12079.x
   Sardelis MR, 2003, J AM MOSQUITO CONTR, V19, P159
   Sardelis MR, 2002, J MED ENTOMOL, V39, P635, DOI 10.1603/0022-2585-39.4.635
   Sardelis MR, 2002, J MED ENTOMOL, V39, P480, DOI 10.1603/0022-2585-39.3.480
   Sardelis MR, 2001, J AM MOSQUITO CONTR, V17, P137
   Sardelis MR, 2001, EMERG INFECT DIS, V7, P1018, DOI 10.3201/eid0706.010617
   Shan GG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188709
   TESH RB, 1976, AM J TROP MED HYG, V25, P326, DOI 10.4269/ajtmh.1976.25.326
   Texas Health and Human Services, 2016, TEX ANN LOC ZIK VIR
   Turell MJ, 2000, AM J TROP MED HYG, V62, P413, DOI 10.4269/ajtmh.2000.62.413
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1219, DOI 10.1001/jamaophthalmol.2016.3623
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Yang F, 2018, EMERG INFECT DIS, V24, P553, DOI 10.3201/eid2403.161275
   YUILL TM, 1970, AM J TROP MED HYG, V19, P513, DOI 10.4269/ajtmh.1970.19.513
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 80
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 10
PY 2020
VL 13
IS 1
AR 188
DI 10.1186/s13071-020-04042-0
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LC8ZY
UT WOS:000525622800001
PM 32276649
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schrauf, S
   Tschismarov, R
   Tauber, E
   Ramsauer, K
AF Schrauf, Sabrina
   Tschismarov, Roland
   Tauber, Erich
   Ramsauer, Katrin
TI Current Efforts in the Development of Vaccines for the Prevention of
   Zika and Chikungunya Virus Infections
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE Zika virus; Chikungunya virus; vaccine development; arbovirus; emerging
   diseases
ID GUILLAIN-BARRE-SYNDROME; NONHUMAN PRIMATE MODELS; MESSENGER-RNA
   VACCINES; DNA VACCINE; PROTECTIVE IMMUNITY; SINGLE MUTATION;
   DOUBLE-BLIND; ACUTE-PHASE; IN-VITRO; T-CELLS
AB Arboviruses represent major challenges to public health, particularly in tropical, and subtropical regions, and a substantial risk to other parts of the world as respective vectors extend their habitats. In recent years, two viruses transmitted by Aedes mosquitoes, Chikungunya and Zika virus, have gathered increased interest. After decades of regionally constrained outbreaks, both viruses have recently caused explosive outbreaks on an unprecedented scale, causing immense suffering and massive economic burdens in affected regions. Chikungunya virus causes an acute febrile illness that often transitions into a chronic manifestation characterized by debilitating arthralgia and/or arthritis in a substantial subset of infected individuals. Zika infection frequently presents as a mild influenza-like illness, often subclinical, but can cause severe complications such as congenital malformations in pregnancy and neurological disorders, including Guillain-Barre syndrome. With no specific treatments or vaccines available, vector control remains the most effective measure to manage spread of these diseases. Given that both viruses cause antibody responses that confer long-term, possibly lifelong protection and that such responses are cross-protective against the various circulating genetic lineages, the development of Zika and Chikungunya vaccines represents a promising route for disease control. In this review we provide a brief overview on Zika and Chikungunya viruses, the etiology and epidemiology of the illnesses they cause and the host immune response against them, before summarizing past and current efforts to develop vaccines to alleviate the burden caused by these emerging diseases. The development of the urgently needed vaccines is hampered by several factors including the unpredictable epidemiology, feasibility of rapid clinical trial implementation during outbreaks and regulatory pathways. We will give an overview of the current developments.
C1 [Schrauf, Sabrina; Tschismarov, Roland; Tauber, Erich; Ramsauer, Katrin] Themis BioSci GmbH, Vienna, Austria.
RP Ramsauer, K (corresponding author), Themis BioSci GmbH, Vienna, Austria.
EM katrin.ramsauer@themisbio.com
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akahata W, 2010, NAT MED, V16, P334, DOI 10.1038/nm.2105
   de Brito CAA, 2017, MEM I OSWALDO CRUZ, V112, P650, DOI 10.1590/0074-02760170124
   Aubry M, 2015, INT J INFECT DIS, V41, P11, DOI 10.1016/j.ijid.2015.10.005
   Auerswald H, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0010-0
   Baldwin WR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34735-7
   Bao HH, 2013, VIRAL IMMUNOL, V26, P75, DOI 10.1089/vim.2012.0061
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Basu R, 2020, VACCINE, V38, P2542, DOI 10.1016/j.vaccine.2020.01.091
   Basu R, 2018, VACCINE, V36, P1256, DOI 10.1016/j.vaccine.2018.01.056
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Betancourt D, 2017, J IMMUNOL, V198, P3023, DOI 10.4049/jimmunol.1602180
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Borgherini G, 2007, CLIN INFECT DIS, V44, P1401, DOI 10.1086/517537
   Bouquillard E, 2018, JOINT BONE SPINE, V85, P207, DOI 10.1016/j.jbspin.2017.01.014
   Brady OJ, 2019, LANCET, V394, P1991, DOI 10.1016/S0140-6736(19)32790-4
   Brandler S, 2013, VACCINE, V31, P3718, DOI 10.1016/j.vaccine.2013.05.086
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Broeckel R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005637
   Broeckel R, 2015, PATHOGENS, V4, P662, DOI 10.3390/pathogens4030662
   Broeckel RM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02563
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos RK, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040231
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chang LJ, 2014, LANCET, V384, P2046, DOI 10.1016/S0140-6736(14)61185-5
   Chattopadhyay A, 2013, J VIROL, V87, P395, DOI 10.1128/JVI.01860-12
   Chu HY, 2013, VACCINE, V31, P3353, DOI 10.1016/j.vaccine.2013.05.059
   Chua CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004960
   Couderc T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040029
   Couderc T, 2015, ANTIVIR RES, V121, P120, DOI 10.1016/j.antiviral.2015.07.002
   Couderc T, 2009, J INFECT DIS, V200, P516, DOI 10.1086/600381
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Creange A, 2016, REV NEUROL-FRANCE, V172, P770, DOI 10.1016/j.neurol.2016.10.011
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Davis BS, 2001, J VIROL, V75, P4040, DOI 10.1128/JVI.75.9.4040-4047.2001
   Dempsey A, 2015, VIROLOGY, V479, P146, DOI 10.1016/j.virol.2015.03.013
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis-Maguiraga L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001446
   ECDC, 2017, AUT TRANSM CHIK VIR
   Edelman R, 2000, AM J TROP MED HYG, V62, P681, DOI 10.4269/ajtmh.2000.62.681
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Erasmus JH, 2017, NAT MED, V23, P192, DOI 10.1038/nm.4253
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   Galatas B, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004281
   Garcia-Arriaza J, 2014, J VIROL, V88, P3527, DOI 10.1128/JVI.03418-13
   Gardner J, 2010, J VIROL, V84, P8021, DOI 10.1128/JVI.02603-09
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Giron S, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.45.1900655
   Goo L, 2016, J INFECT DIS, V214, P1487, DOI 10.1093/infdis/jiw431
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Gorchakov R, 2012, J VIROL, V86, P6084, DOI 10.1128/JVI.06449-11
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Gouglas D, 2019, EPIDEMIOL REV, V41, P28, DOI 10.1093/epirev/mxz012
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Guo Q, 2018, J INFECT DIS, V218, P365, DOI 10.1093/infdis/jiy187
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   Haist KC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006748
   Hallengard D, 2014, J VIROL, V88, P13333, DOI 10.1128/JVI.01926-14
   Hallengard D, 2014, J VIROL, V88, P2858, DOI 10.1128/JVI.03453-13
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Harris E., 2006, NOVART FDN SYMP, V40, P251
   HARRISON VR, 1971, J IMMUNOL, V107, P643
   HARRISON VR, 1967, AM J TROP MED HYG, V16, P786, DOI 10.4269/ajtmh.1967.16.786
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Hoke CH, 2012, VACCINE, V30, P6713, DOI 10.1016/j.vaccine.2012.08.025
   Holzmann H, 1996, J MED VIROL, V48, P102, DOI 10.1002/(SICI)1096-9071(199601)48:1&lt;102::AID-JMV16&gt;3.0.CO;2-I
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jagger BW, 2019, J INFECT DIS, V220, P1577, DOI 10.1093/infdis/jiz338
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Josseran L, 2006, EMERG INFECT DIS, V12, P1994
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kam YW, 2012, J VIROL, V86, P13005, DOI 10.1128/JVI.01780-12
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kell AM, 2015, VIROLOGY, V479, P110, DOI 10.1016/j.virol.2015.02.017
   Khan M, 2012, VIRUS RES, V167, P236, DOI 10.1016/j.virusres.2012.05.004
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Kreil TR, 1997, CLIN EXP IMMUNOL, V110, P358, DOI 10.1046/j.1365-2249.1997.4311446.x
   Kumar M, 2012, VACCINE, V30, P6142, DOI 10.1016/j.vaccine.2012.07.072
   Labadie K, 2010, J CLIN INVEST, V120, P894, DOI 10.1172/JCI40104
   Laiton-Donato K, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.01719-18
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Langsjoen RM, 2018, MBIO, V9, DOI 10.1128/mBio.02449-17
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lecouturier V, 2019, VACCINE, V37, P2679, DOI 10.1016/j.vaccine.2019.04.013
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   LEVITT NH, 1986, VACCINE, V4, P157, DOI 10.1016/0264-410X(86)90003-4
   Neto ASL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007575
   Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Long Kristin M, 2015, Curr Trop Med Rep, V2, P13
   Lopez-Camacho C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040322
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Lum FM, 2015, ANTIVIR RES, V120, P165, DOI 10.1016/j.antiviral.2015.06.009
   Mallilankaraman K, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000928
   Marimoutou C, 2012, MEDICINE, V91, P212, DOI 10.1097/MD.0b013e318260b604
   Marshall V, 2011, PEDIATRICS, V127, pS23, DOI 10.1542/peds.2010-1722E
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Metz SW, 2013, VACCINE, V31, P6092, DOI 10.1016/j.vaccine.2013.09.045
   Metz SW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002124
   Metz SW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-353
   Milligan GN, 2019, VACCINE, V37, P7427, DOI 10.1016/j.vaccine.2018.10.033
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Nurnberger C, 2019, J VIROL, V93, DOI 10.1128/JVI.01485-18
   Osuna CE, 2017, J INFECT DIS, V216, pS928, DOI 10.1093/infdis/jix540
   Pal P, 2014, J VIROL, V88, P8213, DOI 10.1128/JVI.01032-14
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Partidos CD, 2012, VACCINE, V30, P4638, DOI 10.1016/j.vaccine.2012.04.099
   Petersen L, 2016, CHIKUNGUNYA EPIDEMIO, DOI [10.12688/f1000research.7171.1, DOI 10.12688/F1000RESEARCH.7171.1]
   Petitdemange C, 2015, J ALLERGY CLIN IMMUN, V135, P846, DOI 10.1016/j.jaci.2015.01.039
   Phuklia W, 2013, VIRUS RES, V177, P179, DOI 10.1016/j.virusres.2013.08.011
   Pierro A., 2015, New Microbes and New Infections, V7, P23, DOI 10.1016/j.nmni.2015.04.002
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Plante K, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002142
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prow NA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03662-6
   Quicke KM, 2013, VIRUSES-BASEL, V5, P2643, DOI 10.3390/v5112643
   Ramsauer K, 2015, LANCET INFECT DIS, V15, P519, DOI 10.1016/S1473-3099(15)70043-5
   Rappuoli R, 2018, CURR OPIN IMMUNOL, V53, P111, DOI 10.1016/j.coi.2018.04.019
   Reisinger EC, 2018, LANCET, V392, P2718, DOI 10.1016/S0140-6736(18)32488-7
   Rey FA, 2017, CURR OPIN VIROL, V24, P132, DOI 10.1016/j.coviro.2017.06.009
   Rezza G, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006919
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Roques P, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.83527
   Rossi SL, 2019, J INFECT DIS, V220, P735, DOI 10.1093/infdis/jiz202
   Roy CJ, 2014, J INFECT DIS, V209, P1891, DOI 10.1093/infdis/jiu014
   Rudd PA, 2012, J VIROL, V86, P9888, DOI 10.1128/JVI.00956-12
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Saraswat S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004782
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Schilte C, 2012, J IMMUNOL, V188, P2967, DOI 10.4049/jimmunol.1103185
   Schilte C, 2010, J EXP MED, V207, P429, DOI 10.1084/jem.20090851
   Semenza JC, 2018, FEMS MICROBIOL LETT, V365, DOI 10.1093/femsle/fnx244
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Silva LA, 2017, J CLIN INVEST, V127, P737, DOI 10.1172/JCI84417
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smalley C, 2016, VACCINE, V34, P2976, DOI 10.1016/j.vaccine.2016.03.076
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Suhrbier A, 2019, NAT REV RHEUMATOL, V15, P597, DOI 10.1038/s41584-019-0276-9
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Teo TH, 2013, J IMMUNOL, V190, P259, DOI 10.4049/jimmunol.1202177
   Tiwari M, 2009, VACCINE, V27, P2513, DOI 10.1016/j.vaccine.2009.02.062
   Tretyakova I, 2014, J INFECT DIS, V209, P1882, DOI 10.1093/infdis/jiu114
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   van den Doel P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003101
   van Duijl-Richter MKS, 2015, VIRUSES-BASEL, V7, P3647, DOI 10.3390/v7072792
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Volk SM, 2010, J VIROL, V84, P6497, DOI 10.1128/JVI.01603-09
   Voss JE, 2010, NATURE, V468, P709, DOI 10.1038/nature09555
   Wahid B, 2017, INT J INFECT DIS, V58, P69, DOI 10.1016/j.ijid.2017.03.006
   Wang D, 2011, VACCINE, V29, P2803, DOI 10.1016/j.vaccine.2011.01.108
   Wang E, 2008, VACCINE, V26, P5030, DOI 10.1016/j.vaccine.2008.07.054
   Wang EY, 2011, J VIROL, V85, P9249, DOI 10.1128/JVI.00844-11
   Wauquier N, 2011, J INFECT DIS, V204, P115, DOI 10.1093/infdis/jiq006
   Weaver SC, 2015, NEW ENGL J MED, V373, P94, DOI 10.1056/NEJMc1505501
   Weger-Lucarelli J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002970
   WHO, 2015, WEEKLY EPIDEMIOLOGIC, V90, P617
   WHO, 2018, WHO CONS CHIK VACC E
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xie XP, 2017, MBIO, V8, DOI [10.1128/mBio.02134-16, 10.1128/mbio.02134-16]
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Yang SX, 2017, VACCINE, V35, P4851, DOI 10.1016/j.vaccine.2017.07.065
   Yoon IK, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003764
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang R, 2018, NATURE, V557, P570, DOI 10.1038/s41586-018-0121-3
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 207
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD APR 9
PY 2020
VL 11
AR 592
DI 10.3389/fimmu.2020.00592
PG 20
WC Immunology
SC Immunology
GA LJ1HV
UT WOS:000529924300001
PM 32373111
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pach, S
   Sarter, TM
   Yousef, R
   Schaller, D
   Bergemann, S
   Arkona, C
   Rademann, J
   Nitsche, C
   Wolber, G
AF Pach, Szymon
   Sarter, Tim M.
   Yousef, Rafe
   Schaller, David
   Bergemann, Silke
   Arkona, Christoph
   Rademann, Joerg
   Nitsche, Christoph
   Wolber, Gerhard
TI Catching a Moving Target: Comparative Modeling of Flaviviral NS2B-NS3
   Reveals Small Molecule Zika Protease Inhibitors
SO ACS MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Flavivirus; protease; inhibitors; PyRod; 3D pharmacophores; Dynophores
ID VIRUS NS3 PROTEASE; SERINE-PROTEASE; IN-VITRO; DENGUE; IDENTIFICATION;
   VACCINE; MUTAGENESIS; DISCOVERY; PROGRESS; LIGANDS
AB The pivotal role of viral proteases in virus replication has already been successfully exploited in several antiviral drug design campaigns. However, no efficient antivirals are currently available against flaviviral infections. In this study, we present lead-like small molecule inhibitors of the Zika Virus (ZIKV) NS2B-NS3 protease. Since only few nonpeptide competitive ligands are known, we take advantage of the high structural similarity with the West Nile Virus (WNV) NS2B-NS3 protease. A comparative modeling approach involving our in-house software PyRod was employed to systematically analyze the binding sites and develop molecular dynamics-based 3D pharmacophores for virtual screening. The identified compounds were biochemically characterized revealing low micromolar affinity for both ZIKV and WNV proteases. Their lead-like properties together with rationalized binding modes represent valuable starting points for future lead optimization. Since the NS2B-NS3 protease is highly conserved among flaviviruses, these compounds may also drive the development of pan-flaviviral antiviral drugs.
C1 [Pach, Szymon; Yousef, Rafe; Schaller, David; Bergemann, Silke; Arkona, Christoph; Rademann, Joerg; Wolber, Gerhard] Free Univ Berlin, Pharmaceut & Med Chem, Inst Pharm, D-14195 Berlin, Germany.
   [Sarter, Tim M.; Nitsche, Christoph] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
RP Wolber, G (corresponding author), Free Univ Berlin, Pharmaceut & Med Chem, Inst Pharm, D-14195 Berlin, Germany.
EM gerhard.wolber@fu-berlin.de
RI ; Wolber, Gerhard/C-7133-2008
OI Schaller, David/0000-0002-1881-4518; Wolber, Gerhard/0000-0002-5344-0048
FU Australian Research CouncilAustralian Research Council [DE190100015]
FX We acknowledge MS Pharma, Biosupramol (Freie Universitat Berlin) for
   providing us the analytical devices and Lukas Harps and Jan Joseph
   (Pharmaceutical and Medicinal Chemistry, Institute of Pharmacy, Freie
   Universitat Berlin) for the purity control of tested compounds. C.N.
   thanks the Australian Research Council for a Discovery Early Career
   Research Award (DE190100015).
CR Asselah T, 2016, LIVER INT, V36, P47, DOI 10.1111/liv.13027
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   BAZAN JF, 1989, VIROLOGY, V171, P637, DOI 10.1016/0042-6822(89)90639-9
   BERGER A, 1970, PHILOS T R SOC B, V257, P249, DOI 10.1098/rstb.1970.0024
   Bock A., 2016, J BIOL CHEM, V291, P16375
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Chappell KJ, 2005, J BIOL CHEM, V280, P2896, DOI 10.1074/jbc.M409931200
   Chesnut M, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00223
   Collins MH, 2017, CLIN THER, V39, P1519, DOI 10.1016/j.clinthera.2017.07.001
   Cregar-Hernandez Lynne, 2011, Antiviral Chemistry & Chemotherapy, V21, P209, DOI 10.3851/IMP1767
   Ekonomiuk D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000356
   Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   FALGOUT B, 1991, J VIROL, V65, P2467, DOI 10.1128/JVI.65.5.2467-2475.1991
   Ganesh VK, 2005, BIOORGAN MED CHEM, V13, P257, DOI 10.1016/j.bmc.2004.09.036
   Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697
   Guy B, 2011, VACCINE, V29, P7229, DOI 10.1016/j.vaccine.2011.06.094
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Lim HA, 2013, EUR J MED CHEM, V62, P199, DOI 10.1016/j.ejmech.2012.12.043
   Millies B, 2019, J MED CHEM, V62, P11359, DOI 10.1021/acs.jmedchem.9b01697
   Mortier J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13366-4
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Rassias G, 2019, EUR J MED CHEM, V180, P536, DOI 10.1016/j.ejmech.2019.07.007
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Schaller D, 2019, J CHEM INF MODEL, V59, P2818, DOI 10.1021/acs.jcim.9b00281
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Srivastava AK, 2001, VACCINE, V19, P4557, DOI 10.1016/S0264-410X(01)00208-0
   Theiler M, 1937, J EXP MED, V65, P787, DOI 10.1084/jem.65.6.787
   Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e
   Wolber G, 2006, J COMPUT AID MOL DES, V20, P773, DOI 10.1007/s10822-006-9078-7
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zent O, 2003, VACCINE, V21, P3584, DOI 10.1016/S0264-410X(03)00421-3
NR 48
TC 0
Z9 0
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1948-5875
J9 ACS MED CHEM LETT
JI ACS Med. Chem. Lett.
PD APR 9
PY 2020
VL 11
IS 4
BP 514
EP 520
DI 10.1021/acsmedchemlett.9b00629
PG 7
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA LE0GI
UT WOS:000526402700018
PM 32292558
DA 2020-07-08
ER

PT J
AU Bhushan, G
   Lim, L
   Bird, I
   Chothe, SK
   Nissly, RH
   Kuchipudi, SV
AF Bhushan, Gitanjali
   Lim, Levina
   Bird, Ian
   Chothe, Shubhada K.
   Nissly, Ruth H.
   Kuchipudi, Suresh V.
TI Iminosugars With Endoplasmic Reticulum alpha-Glucosidase Inhibitor
   Activity Inhibit ZIKV Replication and Reverse Cytopathogenicity in vitro
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; antiviral; iminosugar; ER-AGI; castanospermine; celgosivir;
   DNJ
ID DENGUE VIRUS-INFECTION; CELGOSIVIR; BRAIN; PROTEIN; CELLS;
   CASTANOSPERMINE; GLYCOSYLATION; ANTIVIRALS; EFFICACY
AB Zika virus (ZIKV), a vector-borne virus of the family Flaviviridae, continues to spread and remains a significant global public health threat. Currently, there are no approved vaccines or antivirals against ZIKV. We investigated the anti-ZIKV ability of three iminosugars with endoplasmic reticulum alpha-glucosidase inhibitor (ER-AGI) activity, namely deoxynojirimycin (DNJ), castanospermine, and celgosivir. None of the three iminosugars showed any significant cytotoxicity in Vero or human microglia CHME3 cells when applied for 72 h at concentrations up to 100 mu M. Iminosugar treatment of Vero or CHME3 cells prior to ZIKV infection resulted in significant inhibition of ZIKV replication over 48 h. Reduction in ZIKV replication in iminosugar-treated cells was not associated with any significant change in the expression levels of key antiviral genes. Following infection with three different strains of ZIKV, iminosugar-treated Vero or CHME3 cells showed no cell death, whereas vehicle-treated control cells exhibited 50-60% cell death at 72 h post-infection (hpi). While there was no significant difference in apoptosis between iminosugar-treated and control cells, iminosugar-treated cells exhibited a substantial reduction of necrosis at 72 hpi following ZIKV infection. In summary, iminosugars with ER-AGI activity inhibit ZIKV replication and significantly reduce necrosis without altering the antiviral gene expression and apoptosis of infected human cells. The results of this study strongly suggest that iminosugars are promising anti-ZIKV antiviral agents and such warrant further in vivo studies.
C1 [Bhushan, Gitanjali; Lim, Levina; Bird, Ian; Chothe, Shubhada K.; Nissly, Ruth H.; Kuchipudi, Suresh V.] Penn State Univ, Dept Vet & Biomed Sci, Penn State Anim Diagnost Lab, University Pk, PA 16802 USA.
RP Kuchipudi, SV (corresponding author), Penn State Univ, Dept Vet & Biomed Sci, Penn State Anim Diagnost Lab, University Pk, PA 16802 USA.
EM skuchipudi@psu.edu
FU Penn State University Department of Veterinary and Biomedical Sciences
FX This work was supported by funding from the Penn State University
   Department of Veterinary and Biomedical Sciences to SK.
CR Alonzi DS, 2017, BIOCHEM SOC T, V45, P571, DOI 10.1042/BST20160182
   Anfasa F, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00292-17, 10.1128/msphere.00292-17]
   [Anonymous], 2016, ZIK VIR MICR GUILL B
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Chang JH, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.77
   Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023
   Costa VV, 2017, MBIO, V8, DOI [10.1128/mBio.00350-17, 10.1128/mbio.00350-17]
   DATEMA R, 1987, PHARMACOL THERAPEUT, V33, P221, DOI 10.1016/0163-7258(87)90066-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Durantel D, 2009, CURR OPIN INVEST DR, V10, P860
   FISCHL MA, 1994, J ACQ IMMUN DEF SYND, V7, P139
   Fletcher III T., 2000, PROMEGA NOTES, V75, P13
   Goebel S, 2016, J VIROL METHODS, V238, P13, DOI 10.1016/j.jviromet.2016.09.015
   Gu Baohua, 2007, Antiviral Chemistry & Chemotherapy, V18, P49
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Jaeger AS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007343
   Kim MJ, 2008, J VIROL, V82, P1474, DOI 10.1128/JVI.01650-07
   Kim SY, 2017, PHARMACEUTICALS-BASE, V10, DOI 10.3390/ph10020044
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Livingstone M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133482
   Ma JL, 2018, ANTIVIR RES, V150, P112, DOI 10.1016/j.antiviral.2017.12.008
   Majumder Maimuna S, 2018, F1000Res, V7, P159, DOI 10.12688/f1000research.13858.1
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Megiorni F, 2005, NEUROSCI LETT, V381, P169, DOI 10.1016/j.neulet.2005.02.027
   Mehta A, 1998, FEBS LETT, V430, P17, DOI 10.1016/S0014-5793(98)00525-0
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muramatsu D, 2014, SCI REP-UK, V4, DOI 10.1038/srep04777
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nasirudeen AMA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000926
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Olmo IG, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01016
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989
   Perry ST, 2013, ANTIVIR RES, V98, P35, DOI 10.1016/j.antiviral.2013.01.004
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Qu XW, 2011, ANTIMICROB AGENTS CH, V55, P1036, DOI 10.1128/AAC.01319-10
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Reemst K, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3339/fnhum.2016.00566
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Russo FB, 2017, BIOCHEM BIOPH RES CO, V492, P603, DOI 10.1016/j.bbrc.2017.01.074
   Sadat MA, 2014, NEW ENGL J MED, V370, P1615, DOI 10.1056/NEJMoa1302846
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   SCHLESINGER S, 1985, VIRUS RES, V2, P139, DOI 10.1016/0168-1702(85)90244-8
   Seng LG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109023
   Sheridan MA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200086
   Simsek Ender, 2006, Antiviral Chemistry & Chemotherapy, V17, P259
   Smith JA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00222
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Steinke JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115271
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Swartwout BK, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040049
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   TAYLOR DL, 1988, ANTIVIR RES, V10, P11, DOI 10.1016/0166-3542(88)90011-3
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Whitby Kevin, 2004, Antiviral Chemistry & Chemotherapy, V15, P141
   Wu SF, 2002, J VIROL, V76, P3596, DOI 10.1128/JVI.76.8.3596-3604.2002
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398
NR 74
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 7
PY 2020
VL 11
AR 531
DI 10.3389/fmicb.2020.00531
PG 15
WC Microbiology
SC Microbiology
GA LI5MT
UT WOS:000529530600001
PM 32373079
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ye, FQ
   Han, YF
   Zhu, JJ
   Li, P
   Zhang, Q
   Lin, YF
   Wang, TW
   Lv, H
   Wang, CJ
   Wang, CH
   Zhang, JH
AF Ye, Fuqiang
   Han, Yifang
   Zhu, Juanjuan
   Li, Peng
   Zhang, Qi
   Lin, Yanfeng
   Wang, Taiwu
   Lv, Heng
   Wang, Changjun
   Wang, Chunhui
   Zhang, Jinhai
TI First Identification of Human Adenovirus Subtype 21a in China With
   MinION and Illumina Sequencers
SO FRONTIERS IN GENETICS
LA English
DT Article
DE human adenovirus subtype 21a; adenovirus infection; pathogen detection;
   MinION sequencing; Illumina sequencing
ID INFECTIONS; OUTBREAK; VIRUS; ZIKA
AB Human adenoviruses (HAdVs) have been demonstrated to cause a diversity of diseases among children and adults. The circulation of human adenovirus type 21 (HAdV21) has been mainly documented within closed environments in several countries. Nonetheless, respiratory infections or outbreaks due to HAdV21 have never been reported in China. MinION and Illumina platforms were employed to identify the potential pathogen from a throat swab. Discrepancies between MinION and Illumina sequencing were validated and corrected via polymerase chain reaction (PCR). Genomic characterization and recombinant event detection were then performed. Among the 35,466 high-quality MinION reads, a total of 5,999 reads (16.91%) could be aligned to HAdV21 reference genomes (genome sizes approximate to 35.3 kb), among which 20 had a length of >30 kb. A genome sequence assembled from MinION reads was further classified as HAdV subtype 21a. Random downsampling revealed as few as 500 nanopore reads could cover >= 96.49% of current genome. Illumina sequencing displayed good consistency (pairwise nucleotide identity = 99.91%) with MinION sequencing but with 31 discrepancies that were further validated and confirmed by PCR coupled with Sanger sequencing. Restriction enzymes such as BamHI and KpnI were able to distinguish the present genome from HAdV21 prototype and HAdV21b. Phylogenetic analysis employing whole-genome sequences placed our genome with members only from subtype 21a. Common features among HAdV21a strains were identified, including polymorphisms discovered in penton and 100 kDa hexon assembly-associated proteins and a recombinant event in the E4 gene. Using MinION and Illumina sequencers, we identified the first HAdV21a strain from China, which could provide key genomic data for disease control and epidemiological investigations.
C1 [Ye, Fuqiang; Han, Yifang; Zhang, Qi; Wang, Taiwu; Lv, Heng; Wang, Chunhui; Zhang, Jinhai] Eastern Theater Command, Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Nanjing, Peoples R China.
   [Zhu, Juanjuan] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Peoples R China.
   [Li, Peng; Lin, Yanfeng; Wang, Changjun] Peoples Liberat Army, Ctr Dis Control & Prevent, Ctr Infect Dis Control, Beijing, Peoples R China.
RP Wang, CH; Zhang, JH (corresponding author), Eastern Theater Command, Ctr Dis Control & Prevent, Dept Dis Control & Prevent, Nanjing, Peoples R China.
EM tommi414@139.com; ahoi@163.com
FU Major National Science and Technology Projects [2017ZX10303401,
   2018ZX10713003, AWS16J020]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [31701158, 81602325]
FX This work was supported by Major National Science and Technology
   Projects (Grant Nos. 2017ZX10303401, 2018ZX10713003, and AWS16J020) and
   the National Natural Science Foundation of China (Grant Nos. 31701158
   and 81602325). The funders had no role in study design, data collection
   and interpretation, or the decision to submit the work for publication.
CR Ameur A, 2019, TRENDS BIOTECHNOL, V37, P72, DOI 10.1016/j.tibtech.2018.07.013
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Barnadas C, 2018, J CLIN VIROL, V104, P16, DOI 10.1016/j.jcv.2018.04.012
   Barrero PR, 2012, J CLIN VIROL, V53, P145, DOI 10.1016/j.jcv.2011.11.001
   Bautista-Gogel J, 2020, J INFECT DIS, V221, P697, DOI 10.1093/infdis/jiz060
   Castro-Wallace SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18364-0
   De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149
   Edwards A., 2016, BIORXIV, P1, DOI [10.1101/073965, DOI 10.1101/073965]
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188
   Greig DR, 2019, GIGASCIENCE, V8, DOI 10.1093/gigascience/giz104
   Hage E, 2014, J INFECTION, V69, P490, DOI 10.1016/j.jinf.2014.06.015
   Imai K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02748
   Ison MG, 2006, CLIN INFECT DIS, V43, P331, DOI 10.1086/505498
   Johnson Sarah S, 2017, J Biomol Tech, V28, P2, DOI 10.7171/jbt.17-2801-009
   Kafetzopoulou LE, 2019, SCIENCE, V363, P74, DOI 10.1126/science.aau9343
   Kajon AE, 2015, J INFECT DIS, V212, P871, DOI 10.1093/infdis/jiv141
   Kajon AE, 2010, J CLIN MICROBIOL, V48, P1438, DOI 10.1128/JCM.01928-09
   Kandel R, 2010, INFECT CONT HOSP EP, V31, P755, DOI 10.1086/653612
   Kim D, 2016, GENOME RES, V26, P1721, DOI 10.1101/gr.210641.116
   Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116
   Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096
   Lee J, 2010, J CLIN VIROL, V49, P115, DOI 10.1016/j.jcv.2010.07.007
   Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589
   Lewis PF, 2009, J INFECT DIS, V199, P1427, DOI 10.1086/598521
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2011, BIOINFORMATICS, V27, P2987, DOI 10.1093/bioinformatics/btr509
   Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109
   Li XY, 2014, INT J INFECT DIS, V28, P117, DOI 10.1016/j.ijid.2014.06.019
   Lin SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060843
   Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13
   Liu Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10168-2
   Loman NJ, 2015, NAT METHODS, V12, P733, DOI [10.1038/nmeth.3444, 10.1038/NMETH.3444]
   McIntyre ABR, 2016, NPJ MICROGRAVITY, V2, DOI 10.1038/npjmgrav.2016.35
   Pfortmueller CA, 2019, J CRIT CARE, V51, P99, DOI 10.1016/j.jcrc.2019.02.019
   Phillippy AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r55
   Philo SE, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy188
   Prusinkiewicz MA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020141
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Radke JR, 2018, CURR OPIN INFECT DIS, V31, P251, DOI [10.1097/qco.0000000000000451, 10.1097/QCO.0000000000000451]
   ROWE WP, 1953, P SOC EXP BIOL MED, V84, P570, DOI 10.3181/00379727-84-20714
   Sammons JS, 2019, OPHTHALMOLOGY, V126, P137, DOI 10.1016/j.ophtha.2018.07.008
   Scott MK, 2016, EMERG INFECT DIS, V22, P1044, DOI 10.3201/eid2206.151898
   Sharpe RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152404
   Simpson JT, 2017, NAT METHODS, V14, P407, DOI 10.1038/nmeth.4184
   van Dijk EL, 2018, TRENDS GENET, V34, P666, DOI 10.1016/j.tig.2018.05.008
   Wang J, 2017, BIOMED ENVIRON SCI, V30, P718, DOI 10.3967/bes2017.097
   Weitzman MD, 2005, FRONT BIOSCI-LANDMRK, V10, P1106, DOI 10.2741/1604
   Xiao CL, 2018, MOL CELL, V71, P306, DOI 10.1016/j.molcel.2018.06.015
   Xiao CL, 2017, NAT METHODS, V14, P1072, DOI [10.1038/NMETH.4432, 10.1038/nmeth.4432]
   Xu YF, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02225
   Yao LH, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1185-x
   Zhang J, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020129
NR 55
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 1664-8021
J9 FRONT GENET
JI Front. Genet.
PD APR 7
PY 2020
VL 11
AR 285
DI 10.3389/fgene.2020.00285
PG 11
WC Genetics & Heredity
SC Genetics & Heredity
GA LH8JP
UT WOS:000529029300001
PM 32318094
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sung, KJ
   Al Maalouf, YJ
   Johns, QR
   Miller, EA
   Sikes, HD
AF Sung, Ki-Joo
   Al Maalouf, Yara Jabbour
   Johns, Quinlan R.
   Miller, Eric A.
   Sikes, Hadley D.
TI Functional comparison of paper-based immunoassays based on antibodies
   and engineered binding proteins
SO ANALYST
LA English
DT Article
ID ZIKA-VIRUS; ASSAY; DIAGNOSTICS; ANTIGEN; NS1; SERA
AB Binding protein scaffolds, such as rcSso7d, have been investigated for use in diagnostic tests; however, the functional performance of rcSso7d has not yet been studied in comparison to antibodies. Here, we assessed the analyte-binding capabilities of rcSso7d and antibodies on cellulose with samples in buffer and 100% human serum.
C1 [Sung, Ki-Joo; Al Maalouf, Yara Jabbour; Johns, Quinlan R.; Miller, Eric A.; Sikes, Hadley D.] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Sikes, Hadley D.] Singapore MIT Alliance Res & Technol Ctr SMART, 1 CREATE Way, Singapore 138602, Singapore.
RP Sikes, HD (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.; Sikes, HD (corresponding author), Singapore MIT Alliance Res & Technol Ctr SMART, 1 CREATE Way, Singapore 138602, Singapore.
EM sikes@mit.edu
OI /0000-0002-7096-138X
FU NSF GRFPNational Science Foundation (NSF)NSF - Office of the Director
   (OD) [1122374]; Singapore-MIT Alliance for Research and Technology (AMR
   IRG)Singapore-MIT Alliance for Research and Technology Centre; MIT
   Deshpande Center for Technological Innovation; MIT Tata Center for
   Technology and Design; MIT's UROP Program
FX KS acknowledges NSF GRFP (1122374). This work was supported by the
   Singapore-MIT Alliance for Research and Technology (AMR IRG), MIT
   Deshpande Center for Technological Innovation, and MIT Tata Center for
   Technology and Design. YJAM and QRJ acknowledge support from MIT's UROP
   Program. HDS acknowledges the Esther and Harold E. Edgerton chair at
   MIT. Authors thank Emma Yee for valuable discussions.
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Badu-Tawiah AK, 2015, LAB CHIP, V15, P655, DOI 10.1039/c4lc01239a
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Banta S, 2013, ANNU REV BIOMED ENG, V15, P93, DOI 10.1146/annurev-bioeng-071812-152412
   Bedin F., 2017, J MED VIROL, V9999, P1
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   Camacho SA, 2018, ACS SENSORS, V3, P587, DOI 10.1021/acssensors.7b00639
   Gera N, 2011, J MOL BIOL, V409, P601, DOI 10.1016/j.jmb.2011.04.020
   Gupta S, 2019, TUBERCULOSIS, V118, DOI 10.1016/j.tube.2019.07.003
   Hesketh EL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43945-6
   Iijima M, 2017, BIOSENS BIOELECTRON, V89, P810, DOI 10.1016/j.bios.2016.10.009
   Kim S, 2019, ACS APPL MATER INTER, V11, P28469, DOI 10.1021/acsami.9b08125
   Lee KH, 2017, ANAL CHEM, V89, P12743, DOI 10.1021/acs.analchem.7b02862
   Li T, 2018, ANAL CHIM ACTA, V1029, P65, DOI 10.1016/j.aca.2018.04.061
   Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841
   Miller EA, 2016, MOL SYST DES ENG, V1, P377, DOI [10.1039/c6me00032k, 10.1039/C6ME00032K]
   Miller EA, 2020, ACS COMB SCI, V22, P49, DOI 10.1021/acscombsci.9b00176
   Miller EA, 2018, ANAL CHEM, V90, P9472, DOI 10.1021/acs.analchem.8b02113
   Miller EA, 2018, BIOSENS BIOELECTRON, V102, P456, DOI 10.1016/j.bios.2017.11.050
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pawley DC, 2019, ACS OMEGA, V4, P6808, DOI 10.1021/acsomega.9b00374
   RICHMAN DD, 1982, J IMMUNOL, V128, P2300
   Rong Z, 2019, ANAL CHIM ACTA, V1055, P140, DOI 10.1016/j.aca.2018.12.043
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Shpigel E, 2000, BIOTECHNOL APPL BIOC, V31, P197, DOI 10.1042/BA20000002
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Straw S., 2013, J BIOMED SCI ENG, V6, P32
   Sung KJ, 2018, MOL SYST DES ENG, V3, P877, DOI 10.1039/c8me00049b
   Thaler M, 2019, ANAL BIOANAL CHEM, V411, P7623, DOI 10.1007/s00216-019-01974-0
   Torres JEP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26732-7
   Traxlmayr MW, 2016, J BIOL CHEM, V291, P22496, DOI 10.1074/jbc.M116.741314
   Tsarfati-BarAd I, 2019, SENSOR ACTUAT B-CHEM, V284, P289, DOI 10.1016/j.snb.2018.12.153
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Wu YF, 2019, J AM CHEM SOC, V141, P1162, DOI 10.1021/jacs.8b09397
   Xu L, 2019, MOLECULES, V24, DOI 10.3390/molecules24101890
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
   Zhang L, 2018, SUSTAIN, V10, P1
   Zhao N, 2017, ANAL BIOCHEM, V521, P59, DOI 10.1016/j.ab.2016.12.021
   Zhao N, 2016, FEBS J, V283, P1351, DOI 10.1111/febs.13674
   Zhu M, 2014, J TRANSL MED, V12, DOI 10.1186/s12967-014-0352-5
NR 42
TC 0
Z9 0
U1 3
U2 3
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0003-2654
EI 1364-5528
J9 ANALYST
JI Analyst
PD APR 7
PY 2020
VL 145
IS 7
BP 2515
EP 2519
DI 10.1039/d0an00299b
PG 5
WC Chemistry, Analytical
SC Chemistry
GA LE6HW
UT WOS:000526825700006
PM 32163071
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kramer, IM
   Kress, A
   Klingelhofer, D
   Scherer, C
   Phuyal, P
   Kuch, U
   Ahrens, B
   Groneberg, DA
   Dhimal, M
   Muller, R
AF Kramer, Isabelle M.
   Kress, Aljoscha
   Klingelhoefer, Doris
   Scherer, Christian
   Phuyal, Parbati
   Kuch, Ulrich
   Ahrens, Bodo
   Groneberg, David A.
   Dhimal, Meghnath
   Mueller, Ruth
TI Does winter cold really limit the dengue vector Aedes aegypti in Europe?
SO PARASITES & VECTORS
LA English
DT Article
DE Cold hardiness; Distribution limits; Cold tolerance; Overwintering;
   Phenotypic plasticity; Sub-zero exposure; Winter survival
ID ALBOPICTUS DIPTERA; CULICIDAE EGGS; HARDINESS; SURVIVAL; TIGER;
   SURVIVORSHIP; TEMPERATURE; ACCLIMATION; CLIMATE
AB BackgroundAedes aegypti is a potential vector for several arboviruses including dengue and Zika viruses. The species seems to be restricted to subtropical/tropical habitats and has difficulties in establishing permanent populations in southern Europe, probably due to constraints during the winter season. The aim of this study was to systematically analyze the cold tolerance (CT) of Ae. aegypti in its most cold-resistant life stage, the eggs.MethodsThe CT of Ae. aegypti eggs was compared with that of Ae. albopictus which is well established in large parts of Europe. By systematically studying the literature (meta-analysis), we recognized that CT has been rarely tested in Ae. aegypti eggs, but eggs can survive at zero and sub-zero temperatures for certain exposure periods. To overcome potential bias from experimental differences between studies, we then conducted species comparisons using a harmonized high-resolution CT measuring method. From subtropical populations of the same origin, the survival (hatching in %) and emergence of adults of both species were measured after zero and sub-zero temperature exposures for up to 9 days (3 degrees C, 0 degrees C and -2 degrees C: <= 9 days; -6 degrees C: <= 2 days).ResultsOur data show that Ae. aegypti eggs can survive low and sub-zero temperatures for a short time period similar to or even better than those of Ae. albopictus. Moreover, after short sub-zero exposures of eggs of both species, individuals still developed into viable adults (Ae. aegypti: 3 adults emerged after 6 days at -2 degrees C, Ae. albopictus: 1 adult emerged after 1 day at -6 degrees C).ConclusionsThus, both the literature and the present experimental data indicate that a cold winter may not be the preventing factor for the re-establishment of the dengue vector Ae. aegypti in southern Europe.
C1 [Kramer, Isabelle M.; Kress, Aljoscha; Klingelhoefer, Doris; Scherer, Christian; Phuyal, Parbati; Kuch, Ulrich; Groneberg, David A.; Mueller, Ruth] Goethe Univ, Inst Occupat Social & Environm Med, Frankfurt, Germany.
   [Ahrens, Bodo] Goethe Univ, Inst Atmospher & Environm Sci, Frankfurt, Germany.
   [Dhimal, Meghnath] Nepal Hlth Res Council, Kathmandu, Nepal.
   [Mueller, Ruth] Inst Trop Med, Unit Entomol, Antwerp, Belgium.
RP Kramer, IM (corresponding author), Goethe Univ, Inst Occupat Social & Environm Med, Frankfurt, Germany.
EM kramer@med.uni-frankfurt.de
OI Dhimal, Meghnath/0000-0001-7176-7821
FU Federal Ministry of Education and Research of Germany (BMBF) under the
   project AECO as part of the National Research Network on Zoonotic
   Infectious Diseases of GermanyFederal Ministry of Education & Research
   (BMBF) [01Kl1717]
FX The work was funded by the Federal Ministry of Education and Research of
   Germany (BMBF) under the project AECO (Number 01Kl1717) as part of the
   National Research Network on Zoonotic Infectious Diseases of Germany.
CR Almeida APG, 2007, EUROSURVEILLANCE, V12, P6
   BACOT A. W., 1916, Yellow Fever Commission, V3, P1
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   BOND HA, 1970, MOSQ NEWS, V30, P394
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Christophers R, 1960, AEDES AEGYPTI L YELL
   Craig GBJ, 1991, ASIAN TIGER MOSQUITO
   Davis NC, 1932, AM J HYG, V16, P177, DOI 10.1093/oxfordjournals.aje.a117854
   European Centre for Disease Preventation and Control (ECDC), FACTSH AED ALB
   European Centre for Disease Prevention and Control (ECDC), 2019, AED ALB
   Fischer S, 2019, J INSECT PHYSIOL, V117, DOI 10.1016/j.jinsphys.2019.05.005
   Hanson S. M., 1991, THESIS
   HANSON SM, 1995, J MED ENTOMOL, V32, P599, DOI 10.1093/jmedent/32.5.599
   HANSON SM, 1993, J AM MOSQUITO CONTR, V9, P78
   HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P354
   HANSON SM, 1995, J AM MOSQUITO CONTR, V11, P35
   HANSON SM, 1994, J MED ENTOMOL, V31, P192, DOI 10.1093/jmedent/31.2.192
   HATCHETT SP, 1946, PUBLIC HEALTH REP, V61, P1234, DOI 10.2307/4585803
   HAWLEY W A, 1988, Journal of the American Mosquito Control Association, V4, P2
   HAWLEY WA, 1989, J MED ENTOMOL, V26, P122, DOI 10.1093/jmedent/26.2.122
   HAWLEY WA, 1987, SCIENCE, V236, P1114, DOI 10.1126/science.3576225
   Hoffmann AA, 2018, J ECON ENTOMOL, V111, P501, DOI 10.1093/jee/toy024
   Jiang YX, 2018, J AM MOSQUITO CONTR, V34, P255, DOI 10.2987/18-6775.1
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kress A, 2017, J INSECT PHYSIOL, V99, P113, DOI 10.1016/j.jinsphys.2017.04.003
   Kress A, 2014, J PEST SCI, V87, P739, DOI 10.1007/s10340-014-0620-4
   Medley KA, 2019, J APPL ECOL, V56, P2518, DOI 10.1111/1365-2664.13480
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Mogi M, 2011, J MED ENTOMOL, V48, P212, DOI 10.1603/ME10196
   MORI A, 1981, Tropical Medicine, V23, P79
   Muller R, 2013, J MED ENTOMOL, V50, P668, DOI 10.1603/ME12094
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Reed W, 1911, YELLOW FEVER COMPILA
   Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2
   Ross PA, 2019, EVOL APPL, V12, P572, DOI 10.1111/eva.12740
   Rozeboom LE, 1938, P OKLA ACAD SCI, P81
   RStudio Team, 2015, RSTUDIO INT DEV R
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Tadano T., 1990, Tropical Biomedicine, V7, P119
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Tippelt L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219553
   Toma L, 2011, MONOGRAFIA, P23
   Tubiello FN, 2000, EUR J AGRON, V13, P179, DOI 10.1016/S1161-0301(00)00073-3
   Yunicheva Yu. V., 2008, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P40
   Zhang MC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007139
NR 47
TC 0
Z9 0
U1 3
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD APR 7
PY 2020
VL 13
IS 1
DI 10.1186/s13071-020-04054-w
PG 13
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LE2MI
UT WOS:000526556800003
PM 32264941
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Nunez-Castilla, J
   Rahaman, J
   Ahrens, JB
   Balbin, CA
   Siltberg-Liberles, J
AF Nunez-Castilla, Janelle
   Rahaman, Jordon
   Ahrens, Joseph B.
   Balbin, Christian A.
   Siltberg-Liberles, Jessica
TI Exploring Evolutionary Constraints in the Proteomes of Zika, Dengue, and
   Other Flaviviruses to Find Fitness-Critical Sites
SO JOURNAL OF MOLECULAR EVOLUTION
LA English
DT Article
DE Zika virus; Dengue virus; West Nile virus; Structural disorder; Vector
   specificity; Evolutionary rates
ID CULEX-QUINQUEFASCIATUS MOSQUITOS; ANTIBODY-DEPENDENT ENHANCEMENT;
   PROTEIN-STRUCTURE; STRUCTURAL BASIS; INTRINSIC DISORDER;
   CROSS-REACTIVITY; RNA REPLICATION; CORE PROTEINS; VIRUS; PREDICTION
AB Dengue virus (DENV) challenges vaccine design due to antibody-dependent enhancement (ADE) and evidence suggests that Zika virus (ZIKV) experiences ADE with DENV and West Nile virus (WNV) antibodies. Thus, multiple flaviviruses must be considered when developing novel therapies against ZIKV. We analyzed 42 flavivirus polyproteins in their evolutionary context to identify motifs conserved in sequence with low real-time and evolutionary conformational flexibility, thought to be fitness-critical sites. We also analyzed evolutionary rate-shifts between clades for insight on vector specificity. For mosquito-borne flaviviruses, two conserved motifs were identified within the RNA-dependent RNA polymerase (RdRP), critical for flavivirus genome replication. Clade-specific motifs were identified for the ZIKV+DENV and WNV clades, many of which were also in RdRP. Six sites in motifs for WNV experienced significant evolutionary rate-shifts, suggesting their importance for functional divergence. Overall, some of these motifs are prime candidates as broadly neutralizing antiviral drug targets across different mosquito-borne flaviviruses.
C1 [Nunez-Castilla, Janelle; Rahaman, Jordon; Ahrens, Joseph B.; Balbin, Christian A.; Siltberg-Liberles, Jessica] Florida Int Univ, Biomol Sci Inst, Dept Biol Sci, 11200 SW 8th St, Miami, FL 33199 USA.
   [Ahrens, Joseph B.] Univ Colorado Denver, Dept Biochem & Mol Genet, Computat Biosci Program, Aurora, CO USA.
RP Siltberg-Liberles, J (corresponding author), Florida Int Univ, Biomol Sci Inst, Dept Biol Sci, 11200 SW 8th St, Miami, FL 33199 USA.
EM jliberle@fiu.edu
CR Ahrens JB, 2018, GENES-BASEL, V9, DOI 10.3390/genes9110553
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Batool M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112783
   Bhatia HK, 2014, J PHARMACOL PHARMACO, V5, P278, DOI 10.4103/0976-500X.142464
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Bussetta C, 2012, BIOCHEMISTRY-US, V51, P5921, DOI 10.1021/bi300406n
   CAO X, 2016, NUCLEIC ACIDS RES, DOI DOI 10.1093/nar/gkw941
   CDC, 2018, WORLD MAP AR RISK ZI
   Cheng Y, 2006, TRENDS BIOTECHNOL, V24, P435, DOI 10.1016/j.tibtech.2006.07.005
   Chong B, 2018, ACS OMEGA, V3, P15643, DOI 10.1021/acsomega.8b02092
   Clark MJ, 2016, CELL CHEM BIOL, V23, P443, DOI 10.1016/j.chembiol.2016.03.010
   de Lamballerie X, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-33
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dodson BL, 2018, PEERJ, V6, DOI 10.7717/peerj.4324
   Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541
   Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071
   Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferreira AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09797-8
   Fuxreiter M, 2007, BIOINFORMATICS, V23, P950, DOI 10.1093/bioinformatics/btm035
   Gaucher EA, 2001, P NATL ACAD SCI USA, V98, P548, DOI 10.1073/pnas.98.2.548
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Goh GKM, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110710
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gu X, 1999, MOL BIOL EVOL, V16, P1664, DOI 10.1093/oxfordjournals.molbev.a026080
   Gu X, 2002, BIOINFORMATICS, V18, P500, DOI 10.1093/bioinformatics/18.3.500
   Gu X, 2013, MOL BIOL EVOL, V30, P1713, DOI 10.1093/molbev/mst069
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guo XX, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.102
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Hodge K, 2016, J BIOL CHEM, V291, P17437, DOI 10.1074/jbc.M116.724013
   Hsieh SC, 2014, J BIOL CHEM, V289, P33149, DOI 10.1074/jbc.M114.610428
   Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Ivanyi-Nagy R, 2008, NUCLEIC ACIDS RES, V36, P712, DOI 10.1093/nar/gkm1051
   Ivanyi-Nagy R, 2010, PROTEIN PEPTIDE LETT, V17, P1019, DOI 10.2174/092986610791498911
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kaufusi PH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084040
   Klema VJ, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005451
   Kuhn RJ, 2015, VIROLOGY, V479, P508, DOI 10.1016/j.virol.2015.03.025
   Kuno G, 2007, J MED ENTOMOL, V44, P93, DOI 10.1603/0022-2585(2007)44[93:HRSOFC]2.0.CO;2
   Le Breton M, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-234
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Li XD, 2016, J VIROL, V90, P5735, DOI 10.1128/JVI.00340-16
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Makhluf H, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6010007
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   McGuffin LJ, 2000, BIOINFORMATICS, V16, P404, DOI 10.1093/bioinformatics/16.4.404
   Meng FC, 2015, FEBS J, V282, P3368, DOI 10.1111/febs.13349
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Orengo CA, 1996, METHOD ENZYMOL, V266, P617
   Ortiz JF, 2013, GENOME BIOL EVOL, V5, P504, DOI 10.1093/gbe/evt026
   Penn O, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000214
   Potisopon S, 2014, FUTURE VIROL, V9, P53, DOI 10.2217/fvl.13.121
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Punta M, 2012, NUCLEIC ACIDS RES, V40, pD290, DOI 10.1093/nar/gkr1065
   Pupko T, 2002, BIOINFORMATICS, V18, P1116, DOI 10.1093/bioinformatics/18.8.1116
   Rahaman J, 2016, GENOME BIOL EVOL, V8, P3471, DOI 10.1093/gbe/evw246
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Ruvinsky AM, 2012, J BIOINF COMPUT BIOL, V10, DOI 10.1142/S0219720012410028
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019
   Schrodinger L, 2014, MESQUITE MODULAR SYS, V1, P2
   Shiryaev SA, 2009, J GEN VIROL, V90, P2081, DOI 10.1099/vir.0.012864-0
   Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75
   Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2011, AMINO ACIDS, V41, P1159, DOI 10.1007/s00726-009-0370-4
   Suzek BE, 2015, BIOINFORMATICS, V31, P926, DOI 10.1093/bioinformatics/btu739
   TAYLOR WR, 1989, J MOL BIOL, V208, P1, DOI 10.1016/0022-2836(89)90084-3
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   Vazquez-Calvo A, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.68
   Vertrees J, 2019, FINDSURFACERESIDUES
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Ward JJ, 2004, BIOINFORMATICS, V20, P2138, DOI 10.1093/bioinformatics/bth195
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Yon C, 2005, J BIOL CHEM, V280, P27412, DOI 10.1074/jbc.M501393200
   Zhang CS, 2011, BIOCHEM SOC T, V39, P1382, DOI 10.1042/BST0391382
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhang Y, 2007, STRUCTURE, V15, P1141, DOI 10.1016/j.str.2007.07.012
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 103
TC 1
Z9 1
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0022-2844
EI 1432-1432
J9 J MOL EVOL
JI J. Mol. Evol.
PD MAY
PY 2020
VL 88
IS 4
BP 399
EP 414
DI 10.1007/s00239-020-09941-5
EA APR 2020
PG 16
WC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
SC Biochemistry & Molecular Biology; Evolutionary Biology; Genetics &
   Heredity
GA LD9ZT
UT WOS:000524410600001
PM 32266427
DA 2020-07-08
ER

PT J
AU Van Rompay, KKA
   Coffey, LL
   Kapoor, T
   Gazumyan, A
   Keesler, RI
   Jurado, A
   Peace, A
   Agudelo, M
   Watanabe, J
   Usachenko, J
   Singapuri, A
   Immareddy, R
   Ardeshir, A
   Stuart, JB
   Bournazos, S
   Ravetch, JV
   Balderes, PJ
   Lorenz, IC
   Esswein, SR
   Keeffe, JR
   Bjorkman, PJ
   Wang, Q
   Rice, CM
   MacDonald, MR
   Nussenzweig, MC
   Robbiani, DF
AF Van Rompay, Koen K. A.
   Coffey, Lark L.
   Kapoor, Tania
   Gazumyan, Anna
   Keesler, Rebekah I.
   Jurado, Andrea
   Peace, Avery
   Agudelo, Marianna
   Watanabe, Jennifer
   Usachenko, Jodie
   Singapuri, Anil
   Immareddy, Ramya
   Ardeshir, Amir
   Stuart, Jackson B.
   Bournazos, Stylianos
   Ravetch, Jeffrey V.
   Balderes, Paul J.
   Lorenz, Ivo C.
   Esswein, Shannon R.
   Keeffe, Jennifer R.
   Bjorkman, Pamela J.
   Wang, Qiao
   Rice, Charles M.
   MacDonald, Margaret R.
   Nussenzweig, Michel C.
   Robbiani, Davide F.
TI A combination of two human monoclonal antibodies limits fetal damage by
   Zika virus in macaques
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Fc domain modifications; Zika virus; macaque pregnancy model;
   antibody-dependent enhancement; congenital Zika syndrome
ID DEPENDENT ENHANCEMENT; DENGUE DISEASE; DNA VACCINE; INFECTION;
   NEUTRALIZATION; PROTECTION
AB Human infection by Zika virus (ZIKV) during pregnancy can lead to vertical transmission and fetal aberrations, including microcephaly. Prophylactic administration of antibodies can diminish or prevent ZIKV infection in animal models, but whether passive immunization can protect nonhuman primates and their fetuses during pregnancy has not been determined. Z004 and Z021 are neutralizing monoclonal antibodies to domain III of the envelope (EDIII) of ZIKV. Together the two antibodies protect nonpregnant macaques against infection even after Fc modifications to prevent antibody-dependent enhancement (ADE) in vitro and extend their half-lives. Here we report on prophylactic coadministration of the Fc-modified antibodies to pregnant rhesus macaques challenged three times with ZIKV during first and second trimester. The two antibodies did not entirely eliminate maternal viremia but limited vertical transmission, protecting the fetus from neurologic damage. Thus, maternal passive immunization with two antibodies to EDIII can shield primate fetuses from the harmful effects of ZIKV.
C1 [Van Rompay, Koen K. A.; Keesler, Rebekah I.; Watanabe, Jennifer; Usachenko, Jodie; Singapuri, Anil; Immareddy, Ramya; Ardeshir, Amir] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.
   [Van Rompay, Koen K. A.; Coffey, Lark L.; Stuart, Jackson B.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Kapoor, Tania; Gazumyan, Anna; Agudelo, Marianna; Wang, Qiao; Nussenzweig, Michel C.; Robbiani, Davide F.] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Jurado, Andrea; Peace, Avery; Rice, Charles M.; MacDonald, Margaret R.] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.
   [Bournazos, Stylianos; Ravetch, Jeffrey V.] Rockefeller Univ, Lab Mol Genet & Immunol, New York, NY 10065 USA.
   [Balderes, Paul J.; Lorenz, Ivo C.] Triinst Therapeut Discovery Inst, New York, NY 10065 USA.
   [Esswein, Shannon R.; Keeffe, Jennifer R.; Bjorkman, Pamela J.] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Wang, Qiao] Fudan Univ, Chinese Acad Med Sci, Key Lab Med Mol Virol,Shanghai Med Coll, Natl Hlth Commiss,Sch Basic Med Sci,Minist Educ, Shanghai 200032, Peoples R China.
   [Nussenzweig, Michel C.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
RP Van Rompay, KKA (corresponding author), Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA.; Van Rompay, KKA (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.; Nussenzweig, MC; Robbiani, DF (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.; Nussenzweig, MC (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
EM kkvanrompay@ucdavis.edu; nussen@rockefeller.edu;
   drobbiani@rockefeller.edu
RI ; ARDESHIR, AMIR/Q-1258-2017
OI Kapoor, Tania/0000-0002-0396-4476; ARDESHIR, AMIR/0000-0002-4330-4659;
   Robbiani, Davide F./0000-0001-7379-3484; Jurado,
   Andrea/0000-0002-4023-8000; Van Rompay, Koen/0000-0002-7375-1337
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [U19AI111825, P01AI138938, UL1TR001866,
   R01AI037526, UM1AI100663]; Lyda Hill Philanthropies; Rockefeller
   University Development Office; Office of Research Infrastructure
   Programs/OD [P51OD011107]; Pathology, Microbiology, and Immunology
   Department [R21AI129479-S]; Robertson Therapeutic Development Fund;
   Studienstiftung des Deutschen Volkes; NIH National Research Service
   Award FellowshipUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [F30AI147579]; NIH
   National Institute of General Medical Sciences Training grant through
   the University of California, Los Angeles-Caltech Medical Scientist
   Training Program [T32-GM008042]; CCHI pilot project [R01AI124690,
   U19AI057229]
FX We thank Kai-Hui Yao and Daniel Yost at Rockefeller University, as well
   as A. Gibbons, M. Allen, V. Bakula, M. Christensen, I. Cazares, W. von
   Morgenland, the veterinary staff, pathology staff, and the staffs of
   Colony Management and Research Services and the Clinical Laboratory at
   the California National Primate Center for expert assistance. We also
   thank Mohsan Saeed (Boston University) for construction of plasmid
   pZIKV/HPF/CprM*PRVABC59E. This work was supported by awards from NIH,
   U19AI111825, P01AI138938, and UL1TR001866 (to D.F.R.), R01AI037526,
   UM1AI100663, U19AI111825, P01AI138938, and UL1TR001866 (to M.C.N.);
   funding from Lyda Hill Philanthropies (to M.C.N.); grants R01AI124690
   and U19AI057229 (CCHI pilot project); The Rockefeller University
   Development Office, and anonymous donors (to C.M.R. and M.R.M.); the
   Office of Research Infrastructure Programs/OD (grant P51OD011107);
   start-up funds from the Pathology, Microbiology, and Immunology
   Department (to L.L.C.); and grant R21AI129479-S (to K.K.A.V.R.). Support
   was also provided by the Robertson Therapeutic Development Fund (to
   D.F.R. and M.C.N.) and a scholarship from the Studienstiftung des
   Deutschen Volkes (to T.K.). S.R.E. is supported by NIH National Research
   Service Award Fellowship F30AI147579 and NIH National Institute of
   General Medical Sciences Training grant T32-GM008042 through the
   University of California, Los Angeles-Caltech Medical Scientist Training
   Program. M.C.N. is a Howard Hughes Medical Institute Investigator.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Azevedo RSS, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120496
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Carvalho Marilia Sa, 2020, Sci Rep, V10, P1752, DOI 10.1038/s41598-020-58407-7
   Coffey LL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04777-6
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Forootan Amin, 2017, Biomol Detect Quantif, V12, P1, DOI 10.1016/j.bdq.2017.04.001
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Gautam R, 2018, NAT MED, V24, P610, DOI 10.1038/s41591-018-0001-2
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Horton HM, 2008, CANCER RES, V68, P8049, DOI 10.1158/0008-5472.CAN-08-2268
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Keeffe JR, 2018, CELL REP, V25, P1385, DOI 10.1016/j.celrep.2018.10.031
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Mouquet H, 2012, P NATL ACAD SCI USA, V109, pE3268, DOI 10.1073/pnas.1217207109
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Pierson TC, 2006, VIROLOGY, V346, P53, DOI 10.1016/j.virol.2005.10.030
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Robbiani DF, 2019, J EXP MED, V216, P2302, DOI 10.1084/jem.20191061
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Salje H, 2018, NATURE, V557, P719, DOI 10.1038/s41586-018-0157-4
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shallie PD, 2019, INT J DEV NEUROSCI, V73, P41, DOI 10.1016/j.ijdevneu.2019.01.003
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stouffer RL, 2017, ILAR J, V58, P281, DOI 10.1093/ilar/ilx027
   Van Rompay KKA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aay2736
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weitzenfeld P, 2019, J CLIN INVEST, V129, P3952, DOI 10.1172/JCI128437
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Zalevsky J, 2010, NAT BIOTECHNOL, V28, P157, DOI 10.1038/nbt.1601
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 54
TC 0
Z9 0
U1 3
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 7
PY 2020
VL 117
IS 14
BP 7981
EP 7989
DI 10.1073/pnas.2000414117
PG 9
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LB2ST
UT WOS:000524486300060
PM 32209664
OA Green Published, Green Accepted, Other Gold
DA 2020-07-08
ER

PT J
AU Suarez, GP
   Udiani, O
   Allan, BF
   Price, C
   Ryan, SJ
   Lofgren, E
   Coman, A
   Stone, CM
   Gallos, LK
   Fefferman, NH
AF Suarez, Gonzalo P.
   Udiani, Oyita
   Allan, Brian F.
   Price, Candice
   Ryan, Sadie J.
   Lofgren, Eric
   Coman, Alin
   Stone, Chris M.
   Gallos, Lazaros K.
   Fefferman, Nina H.
TI A generic arboviral model framework for exploring trade-offs between
   vector control and environmental concerns
SO JOURNAL OF THEORETICAL BIOLOGY
LA English
DT Article
DE Mosquito-borne; Epidemiology; Environmental protection; Mathematical
   model; Risk perception
ID HEALTH; VACCINATION; MOVEMENTS; IMPACT; RISK
AB Effective public health measures must balance potentially conflicting demands from populations they serve. In the case of infectious disease risks from mosquito-borne infections, such as Zika virus, public concern about the pathogen may be counterbalanced by public concern about environmental contamination from chemical agents used for vector control. Here we introduce a generic framework for modeling how the spread of an infectious pathogen might lead to varying public perceptions, and therefore tolerance, of both disease risk and pesticide use. We consider how these dynamics might impact the spread of a vector-borne disease. We tailor and parameterize our model for direct application to Zika virus as spread by Aedes aegypti mosquitoes, though the framework itself has broad applicability to any arboviral infection. We demonstrate how public risk perception of both disease and pesticides may drastically impact the spread of a mosquito-borne disease in a susceptible population. We conclude that models hoping to inform public health decision making about how best to mitigate arboviral disease risks should explicitly consider the potential public demand for, or rejection of, chemical control of mosquito populations. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Suarez, Gonzalo P.; Udiani, Oyita; Fefferman, Nina H.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.
   [Udiani, Oyita; Fefferman, Nina H.] Univ Tennessee, Natl Inst Math & Biol Synth NIMBioS, Knoxville, TN 37996 USA.
   [Allan, Brian F.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA.
   [Price, Candice] Univ San Diego, Dept Math, San Diego, CA 92110 USA.
   [Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Ryan, Sadie J.] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa.
   [Lofgren, Eric] Washington State Univ, Dept Math & Stat, Pullman, WA 99164 USA.
   [Lofgren, Eric] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA.
   [Coman, Alin] Princeton Univ, Dept Psychol, Princeton, NJ 08544 USA.
   [Stone, Chris M.] Univ Illinois, Illinois Nat Hist Survey, Champaign, IL 61820 USA.
   [Gallos, Lazaros K.] Rutgers State Univ, Ctr Discrete Math & Theoret Comp Sci DIMACS, Piscataway, NJ 08854 USA.
   [Fefferman, Nina H.] Univ Tennessee, Dept Math, Knoxville, TN 37996 USA.
RP Suarez, GP (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.
EM gsuarez1@utk.edu
OI Suarez, Gonzalo/0000-0001-9717-6851
FU National Socio-Environmental Synthesis Center (SESYNC)National Science
   Foundation (NSF)NSF - Directorate for Biological Sciences (BIO);
   National Science FoundationNational Science Foundation (NSF)
   [DBI-1639145, DEB -1640951]
FX This work was supported by the National Socio-Environmental Synthesis
   Center (SESYNC) under funding received from the National Science
   Foundation DBI-1639145, and also by DEB -1640951.
CR Baicus A., 2012, WORLD J VIROL, V1, P08, DOI [10.5501/wjv.v1i4.108., DOI 10.5501/WJV.V1I4.108]
   Bartlett LJ, 2018, J APICULT RES, V57, P709, DOI 10.1080/00218839.2018.1494914
   Bauch CT, 2004, P NATL ACAD SCI USA, V101, P13391, DOI 10.1073/pnas.0403823101
   Blume S, 2006, SOC SCI MED, V62, P628, DOI 10.1016/j.socscimed.2005.06.020
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Bouwman H, 2011, ENVIRON HEALTH PERSP, V119, P744, DOI 10.1289/ehp.1002127
   Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Dube E, 2015, EXPERT REV VACCINES, V14, P99, DOI 10.1586/14760584.2015.964212
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Fourrier J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132985
   Gamble JC, 2010, NEW ZEAL J CROP HORT, V38, P57, DOI 10.1080/01140671003767842
   Gangarosa EJ, 1998, LANCET, V351, P356, DOI 10.1016/S0140-6736(97)04334-1
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   MACDONALD G, 1950, Trop Dis Bull, V47, P907
   Macdonald G., 1950, Tropical Diseases Bulletin, V47, P915
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   Morriss Andrew P., 2002, FORDHAM ENVTL LJ, V14, P1
   Ratnapradipa D, 2015, J ENVIRON HEALTH, V77, P22
   REITER P, 1995, AM J TROP MED HYG, V52, P177, DOI 10.4269/ajtmh.1995.52.177
   Roberts DR, 1997, EMERG INFECT DIS, V3, P295, DOI 10.3201/eid0303.970305
   Ross R, 1911, NATURE, V87, P466, DOI 10.1038/087466a0
   Ross R, 1911, PREVENTION MALARIA, P651
   Shampine LF, 1997, SIAM J SCI COMPUT, V18, P1, DOI 10.1137/S1064827594276424
   Sharma A, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006977
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Stone CM, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0336
   Townson H, 2005, B WORLD HEALTH ORGAN, V83, P942
   van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785
NR 31
TC 0
Z9 0
U1 4
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-5193
EI 1095-8541
J9 J THEOR BIOL
JI J. Theor. Biol.
PD APR 7
PY 2020
VL 490
AR 110161
DI 10.1016/j.jtbi.2020.110161
PG 9
WC Biology; Mathematical & Computational Biology
SC Life Sciences & Biomedicine - Other Topics; Mathematical & Computational
   Biology
GA KR1DQ
UT WOS:000517359900005
PM 31953137
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Carvajal, A
   Vasquez, C
   Petrie, WD
   Beier, JC
AF Wilke, Andre B. B.
   Carvajal, Augusto
   Vasquez, Chalmers
   Petrie, William D.
   Beier, John C.
TI Urban farms in Miami-Dade county, Florida have favorable environments
   for vector mosquitoes
SO PLOS ONE
LA English
DT Article
ID AUTOCHTHONOUS DENGUE-FEVER; ZIKA VIRUS; TERRITORIES; DIVERSITY
AB The creation of urban farms in complex urban built environments may create suitable local conditions for vector mosquitoes. Urban farms have been implicated in the proliferation of mosquitoes in Africa, but there is a dearth in the knowledge of their role in the proliferation of mosquitoes elsewhere. In this study, we surveyed two urban farms in Miami-Dade County, Florida. Our results show that urban farms provide favorable conditions for populations of vector mosquito species by providing a wide range of essential resources such as larval habitats, suitable outdoor resting sites, sugar-feeding centers, and available hosts for blood-feeding. A total of 2,185 specimens comprising 12 species of mosquitoes were collected over 7 weeks. The results varied greatly according to the urban farm. At the Wynwood urban farm, 1,016 specimens were collected but were distributed only between 3 species; while the total number of specimens collected at the Golden Glades urban farm was 1,168 specimens comprising 12 species. The presence of vector mosquitoes in urban farms may represent a new challenge for the development of effective strategies to control populations of vector mosquito species in urban areas.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Carvajal, Augusto; Vasquez, Chalmers; Petrie, William D.] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU Miami-Dade County; CDCUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [1U01CK000510-03]
FX This research was supported by the Miami-Dade County and the CDC
   (https://www.cdc.gov/) grant 1U01CK000510-03: Southeastern Regional
   Center of Excellence in Vector-Borne Diseases: The Gateway Program. CDC
   had no role in the design of the study and collection, analysis, and
   interpretation of data and in writing the manuscript.
CR Adrain JM, 2000, PALEOBIOLOGY, V26, P625, DOI 10.1666/0094-8373(2000)026<0625:STADAT>2.0.CO;2
   AFRANE YA, 2012, PARASITE VECTOR, V5, DOI DOI 10.1186/1756-3305-5-1
   Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Wilke ABB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185150
   Buzas MA, 1998, J FORAMIN RES, V28, P233
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Colwell R. K., 2009, PRINCETON GUIDE ECOL, P257, DOI DOI 10.1111/J.1442-9993.2012.02436.X
   COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091
   Darsie Jr RF, 2000, KEYS ADULT FEMALES 4, V1
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Florida Department of Health, 2019, MOSQ BORN ILLN ADV
   Franklinos LHV, 2019, LANCET INFECT DIS, V19, pE302, DOI 10.1016/S1473-3099(19)30161-6
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Knop E, 2016, GLOBAL CHANGE BIOL, V22, P228, DOI 10.1111/gcb.13091
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Matthys B, 2006, AM J TROP MED HYG, V75, P1223, DOI 10.4269/ajtmh.2006.75.1223
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   Medeiros-Sousa AR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18208-x
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Multini LC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220773
   PAHO/WHO, 2015, ZIK CAS CONG SYNDR A
   Palmer L, 2018, NAT SUSTAIN, V1, P5, DOI 10.1038/s41893-017-0014-8
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   United States Census Bureau, 2016, INCOME POVERTY US
   United States Department of Agriculture (USDA), URB AGR
   Wilke Andre B B, 2020, PLoS Negl Trop Dis, V14, pe0007864, DOI 10.1371/journal.pntd.0007864
   Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51787-5
   Wilke ABB, 2019, CURR OPIN INSECT SCI, V35, P1, DOI 10.1016/j.cois.2019.06.002
   Wilke ABB, 2019, TRENDS PARASITOL, V35, P607, DOI 10.1016/j.pt.2019.05.009
   Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45337-2
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217177
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688
   Wilke ABB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209625
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
NR 45
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 6
PY 2020
VL 15
IS 4
AR e0230825
DI 10.1371/journal.pone.0230825
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LR8OD
UT WOS:000535955000021
PM 32251419
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gross, R
   Bauer, R
   Kruger, F
   Rucker-Braun, E
   Olari, LR
   Standker, L
   Preising, N
   Rodriguez, AA
   Conzelmann, C
   Gerbl, F
   Sauter, D
   Kirchhoff, F
   Hagemann, B
   Gacanin, J
   Weil, T
   Ruiz-Blanco, YB
   Sanchez-Garcia, E
   Forssmann, WG
   Mankertz, A
   Santibanez, S
   Stenger, S
   Walther, P
   Wiese, S
   Spellerberg, B
   Munch, J
AF Gross, Ruediger
   Bauer, Richard
   Krueger, Franziska
   Ruecker-Braun, Elke
   Olari, Lia-Raluca
   Staendker, Ludger
   Preising, Nico
   Rodriguez, Armando A.
   Conzelmann, Carina
   Gerbl, Fabian
   Sauter, Daniel
   Kirchhoff, Frank
   Hagemann, Benjamin
   Gacanin, Jasmina
   Weil, Tanja
   Ruiz-Blanco, Yasser B.
   Sanchez-Garcia, Elsa
   Forssmann, Wolf-Georg
   Mankertz, Annette
   Santibanez, Sabine
   Stenger, Steffen
   Walther, Paul
   Wiese, Sebastian
   Spellerberg, Barbara
   Muench, Jan
TI A Placenta Derived C-Terminal Fragment of beta-Hemoglobin With Combined
   Antibacterial and Antiviral Activity
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE placenta; AMP; hemoglobin fragment; proteolytic generation; antiviral
ID HERPES-SIMPLEX-VIRUS; LINKED-IMMUNOSORBENT-ASSAY; CATHEPSIN-D;
   ANTIMICROBIAL ACTIVITY; EPITHELIAL-CELLS; GENITAL HERPES; HUMAN PEPTIDE;
   INFECTION; TYPE-1; DISCOVERY
AB The placenta acts as physical and immunological barrier against the transmission of viruses and bacteria from mother to fetus. However, the specific mechanisms by which the placenta protects the developing fetus from viral and bacterial pathogens are poorly understood. To identify placental peptides and small proteins protecting from viral and bacterial infections, we generated a peptide library from 10 kg placenta by chromatographic means. Screening the resulting 250 fractions against Herpes-Simplex-Virus 2 (HSV-2), which is rarely transmitted through the placenta, in a cell-based system identified two adjacent fractions with significant antiviral activity. Further rounds of chromatographic purification and anti-HSV-2 testing allowed to purify the bioactive peptide. Mass spectrometry revealed the presence of a 36-mer derived from the C-terminal region of the hemoglobin beta subunit. The purified and corresponding chemically synthesized peptide, termed HBB(112-147), inhibited HSV-2 infection in a dose-dependent manner, with a mean IC50 in the median mu g/ml range. Full-length hemoglobin tetramer had no antiviral activity. HBB(112-147) did not impair infectivity by direct targeting of the virions but prevented HSV-2 infection at the cell entry level. The peptide was inactive against Human Immunodeficiency Virus Type 1, Rubella and Zika virus infection, suggesting a specific anti-HSV-2 mechanism. Notably, HBB(112-147) has previously been identified as broad-spectrum antibacterial agent. It is abundant in placenta, reaching concentrations between 280 and 740 mu g/ml, that are well sufficient to inhibit HSV-2 and prototype Gram-positive and -negative bacteria. We here additionally show, that HBB(112-147) also acts potently against Pseudomonas aeruginosa strains (including a multi-drug resistant strain) in a dose dependent manner, while full-length hemoglobin is inactive. Interestingly, the antibacterial activity of HBB(112-147) was increased under acidic conditions, a hallmark of infection and inflammatory conditions. Indeed, we found that HBB(112-147) is released from the hemoglobin precursor by Cathepsin D and Napsin A, acidic proteases highly expressed in placental and other tissues. We propose that upon viral or bacterial infection, the abundant hemoglobin precursor is proteolytically processed to release HBB(112-147), a broadly active antimicrobial innate immune defense peptide.
C1 [Gross, Ruediger; Krueger, Franziska; Olari, Lia-Raluca; Conzelmann, Carina; Sauter, Daniel; Kirchhoff, Frank; Muench, Jan] Ulm Univ, Inst Mol Virol, Med Ctr, Ulm, Germany.
   [Bauer, Richard; Gerbl, Fabian; Hagemann, Benjamin; Stenger, Steffen; Spellerberg, Barbara] Ulm Univ, Inst Med Microbiol & Hyg, Med Ctr, Ulm, Germany.
   [Ruecker-Braun, Elke] Univ Hosp Dresden, Dept Med 1, Dresden, Germany.
   [Staendker, Ludger; Preising, Nico; Rodriguez, Armando A.; Muench, Jan] Ulm Univ, Core Facil Funct Peptid, Med Ctr, Ulm, Germany.
   [Rodriguez, Armando A.; Wiese, Sebastian] Ulm Univ, Core Unit Mass Spectrometry & Proteom, Ulm, Germany.
   [Gacanin, Jasmina; Weil, Tanja] Max Planck Inst Polymer Res, Mainz, Germany.
   [Gacanin, Jasmina; Weil, Tanja] Univ Ulm, Inst Inorgan Chem 1, Ulm, Germany.
   [Ruiz-Blanco, Yasser B.; Sanchez-Garcia, Elsa] Univ Duisburg Essen, Fac Biol, Computat Biochem, Essen, Germany.
   [Forssmann, Wolf-Georg] Pharis Biotec GmbH, Hannover, Germany.
   [Mankertz, Annette; Santibanez, Sabine] WHO, Measles Rubella European RRL & NRC Measles, Robert Koch Inst, Berlin, Germany.
   [Walther, Paul] Ulm Univ, Cent Facil Electron Microscopy, Ulm, Germany.
RP Munch, J (corresponding author), Ulm Univ, Inst Mol Virol, Med Ctr, Ulm, Germany.; Spellerberg, B (corresponding author), Ulm Univ, Inst Med Microbiol & Hyg, Med Ctr, Ulm, Germany.; Munch, J (corresponding author), Ulm Univ, Core Facil Funct Peptid, Med Ctr, Ulm, Germany.
EM barbara.spellerberg@uniklinik-ulm.de; jan.muench@uni-ulm.de
FU German Research Foundation (DFG)German Research Foundation (DFG)
   [CRC1279]; Deutsche Forschungsgemeinschaft (DFG, German Research
   Foundation) under Germany's Excellence StrategyGerman Research
   Foundation (DFG) [EXC 2033, 390677874]; DFGGerman Research Foundation
   (DFG) [SPP 1923]
FX LS, SW, FKi, ES-G, SSt, JM, and BS thank the German Research Foundation
   (DFG) for funding within the CRC1279. ES-G was also funded by the
   Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under
   Germany's Excellence Strategy -EXC 2033 -Projektnummer 390677874
   (Gefordert durch die Deutsche Forschungsgemeinschaft (DFG) im Rahmen der
   Exzellenzstrategie des Bundes und der Lander -EXC 2033 Projektnummer
   390677874). FKi and DS were supported by the DFG priority program SPP
   1923 "Innate Sensing and Restriction of Retroviruses".
CR Abrahams VM, 2004, J IMMUNOL, V173, P4286, DOI 10.4049/jimmunol.173.7.4286
   Arnold F, 2012, J VIROL, V86, P1244, DOI 10.1128/JVI.06121-11
   Avgil M, 2006, REPROD TOXICOL, V21, P436, DOI 10.1016/j.reprotox.2004.11.014
   BARRETT AJ, 1970, BIOCHEM J, V117, P601, DOI 10.1042/bj1170601
   Benes P, 2008, CRIT REV ONCOL HEMAT, V68, P12, DOI 10.1016/j.critrevonc.2008.02.008
   BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5
   Berger JR, 2008, ARCH NEUROL-CHICAGO, V65, P596, DOI 10.1001/archneur.65.5.596
   Bosso M, 2018, BIOORGAN MED CHEM, V26, P2719, DOI 10.1016/j.bmc.2017.10.038
   Brown ZA, 2005, OBSTET GYNECOL, V106, P845, DOI 10.1097/01.AOG.0000180779.35572.3a
   Brown ZA, 2003, JAMA-J AM MED ASSOC, V289, P203, DOI 10.1001/jama.289.2.203
   Chouard T, 2011, NATURE, V471, P151, DOI 10.1038/471151a
   Detheux M, 2000, J EXP MED, V192, P1501, DOI 10.1084/jem.192.10.1501
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   DIMENT S, 1989, J BIOL CHEM, V264, P13403
   Dolan A, 1998, J VIROL, V72, P2010, DOI 10.1128/JVI.72.3.2010-2021.1998
   Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030
   Dyer AP, 1997, J VIROL, V71, P191, DOI 10.1128/JVI.71.1.191-198.1997
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Easterhoff D, 2013, ANTIMICROB AGENTS CH, V57, P2443, DOI 10.1128/AAC.02464-12
   Erra Diaz F., 2018, MEDIAT INFLAMM, V2018
   Finger-Jardim F, 2014, J MED VIROL, V86, P519, DOI 10.1002/jmv.23817
   Finsterbusch T, 2009, J GEN VIROL, V90, P2739, DOI 10.1099/vir.0.013524-0
   Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134
   Forssmann WG, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001697
   Hagemann JB, 2018, J ANTIMICROB CHEMOTH, V73, P1812, DOI 10.1093/jac/dky105
   Herold BC, 1996, J VIROL, V70, P3461, DOI 10.1128/JVI.70.6.3461-3469.1996
   Hertz CJ, 2003, J IMMUNOL, V171, P6820, DOI 10.4049/jimmunol.171.12.6820
   Huang YX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081708
   HUTTON RD, 1973, P SOC EXP BIOL MED, V142, P27, DOI 10.3181/00379727-142-36950
   International Commission on Microbiological Specifications for Foods, 2002, 2002 MICR FOODS, V7, DOI DOI 10.1093/pch/7.1.19
   John H, 2005, ANAL BIOCHEM, V341, P173, DOI 10.1016/j.ab.2005.03.025
   Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020
   Khatami MH, 2014, BBA-BIOMEMBRANES, V1838, P2778, DOI 10.1016/j.bbamem.2014.07.013
   Kimberlin DW, 2007, SEMIN PERINATOL, V31, P19, DOI 10.1053/j.semperi.2007.01.003
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   Krause A, 2000, FEBS LETT, V480, P147, DOI 10.1016/S0014-5793(00)01920-7
   Krause A, 2003, PROTEIN SCI, V12, P143, DOI 10.1110/ps.0213603
   Kruger F, 2019, ADV SCI, V6, DOI 10.1002/advs.201802095
   LANGELAND N, 1988, J GEN VIROL, V69, P1137, DOI 10.1099/0022-1317-69-6-1137
   LANGELAND N, 1987, J VIROL, V61, P3388, DOI 10.1128/JVI.61.11.3388-3393.1987
   Liepke C, 2003, J CHROMATOGR B, V791, P345, DOI 10.1016/S1570-0232(03)00245-9
   Liepke C, 2001, J CHROMATOGR B, V752, P369, DOI 10.1016/S0378-4347(00)00516-8
   Lkhider M, 2004, J CELL SCI, V117, P5155, DOI 10.1242/jcs.01396
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Mahnert N, 2007, AM J OBSTET GYNECOL, V196, DOI 10.1016/j.ajog.2006.10.911
   Malhotra S, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00138-18
   Malik E, 2016, PHARMACEUTICALS, V9, DOI 10.3390/ph9040067
   Malkin Jean-Elie, 2004, Herpes, V11 Suppl 1, p2A
   Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911
   Mohr KB, 2015, ANAL BIOCHEM, V476, P29, DOI 10.1016/j.ab.2015.01.023
   Mor G, 2015, AM J OBSTET GYNECOL, V213, pS131, DOI 10.1016/j.ajog.2015.06.039
   Muller JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04442-y
   Munch J, 2007, CELL, V131, P1059, DOI 10.1016/j.cell.2007.10.014
   Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042
   Munch J, 2014, NAT REV MICROBIOL, V12, P715, DOI 10.1038/nrmicro3312
   Munch J, 2002, ANTIMICROB AGENTS CH, V46, P982, DOI 10.1128/AAC.46.4.982-990.2002
   Papagianni M, 2003, BIOTECHNOL ADV, V21, P465, DOI 10.1016/S0734-9750(03)00077-6
   Papkalla A, 2002, J VIROL, V76, P8455, DOI 10.1128/JVI.76.16.8455-8459.2002
   Pendleton JN, 2013, EXPERT REV ANTI-INFE, V11, P297, DOI [10.1586/eri.13.12, 10.1586/ERI.13.12]
   Piret J, 2011, ANTIMICROB AGENTS CH, V55, P459, DOI 10.1128/AAC.00615-10
   PROFFITT MR, 1995, CLIN DIAGN VIROL, V4, P175, DOI 10.1016/0928-0197(95)00011-V
   Pulido D, 2012, J INNATE IMMUN, V4, P327, DOI 10.1159/000336713
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Roberts S, 2009, CURR OPIN OBSTET GYN, V21, P124, DOI 10.1097/GCO.0b013e3283294840
   Rocker A, 2018, CHEM COMMUN, V54, P7557, DOI 10.1039/c8cc01491d
   Schandock F, 2017, ADV HEALTHC MATER, V6, DOI 10.1002/adhm.201700748
   Scoular A, 2002, SEX TRANSM INFECT, V78, P160, DOI 10.1136/sti.78.3.160
   SHIEH MT, 1992, J CELL BIOL, V116, P1273, DOI 10.1083/jcb.116.5.1273
   Sitaram N, 2002, CURR PHARM DESIGN, V8, P727, DOI 10.2174/1381612023395358
   Smith JS, 2002, J INFECT DIS, V186, pS3, DOI 10.1086/343739
   Standker L, 2010, ANAL BIOCHEM, V401, P53, DOI 10.1016/j.ab.2010.02.019
   Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858
   Trybala E, 2000, J VIROL, V74, P9106, DOI 10.1128/JVI.74.19.9106-9114.2000
   Weiss H., 2004, HERPES S, V11, P24
   Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zhang J, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010587
   Zirafi O, 2015, CELL REP, V11, P737, DOI 10.1016/j.celrep.2015.03.061
NR 78
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD APR 6
PY 2020
VL 11
AR 508
DI 10.3389/fmicb.2020.00508
PG 17
WC Microbiology
SC Microbiology
GA LH8QM
UT WOS:000529047300001
PM 32328038
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sorgi, S
   Bonezi, V
   Dominguez, MR
   Gimenez, AM
   Dobrescu, I
   Boscardin, S
   Nakaya, HI
   Bargieri, DY
   Soares, IS
   Silveira, ELV
AF Sorgi, Sara
   Bonezi, Vivian
   Dominguez, Mariana R.
   Gimenez, Alba Marina
   Dobrescu, Irina
   Boscardin, Silvia
   Nakaya, Helder I.
   Bargieri, Daniel Y.
   Soares, Irene S.
   Silveira, Eduardo L. V.
TI Sao Paulo School of Advanced Sciences on Vaccines: an overview
SO JOURNAL OF VENOMOUS ANIMALS AND TOXINS INCLUDING TROPICAL DISEASES
LA English
DT Review
DE Vaccine history; WHO priorities and challenges; Immune responses;
   Antigen search; Delivery systems and strategies
ID T-CELL RESPONSES; DENDRITIC CELLS; ZIKA VIRUS; SCHISTOSOMA-MANSONI;
   TRYPANOSOMA-CRUZI; PROTECTIVE IMMUNITY; BINDING-PROTEIN; WHOLE-GENOME;
   SEROGROUP-B; IN-VITRO
AB Two years ago, we held an exciting event entitled the Sao Paulo School of Advanced Sciences on Vaccines (SPSASV). Sixty-eight Ph.D. students, postdoctoral fellows and independent researchers from 37 different countries met at the Mendes Plaza Hotel located in the city of Santos, SP - Brazil to discuss the challenges and the new frontiers of vaccinology. The SPSASV provided a critical and comprehensive view of vaccine research from basics to the current state-of-the-art techniques performed worldwide. For 10 days, we discussed all the aspects of vaccine development in 36 lectures, 53 oral presentations and 2 poster sessions. At the end of the course, participants were further encouraged to present a model of a grant proposal related to vaccine development against individual pathogens. Among the targeted pathogens were viruses (Chikungunya, HIV, RSV, and Influenza), bacteria (Mycobacterium tuberculosis and Streptococcus pyogenes), parasites (Plasmodium falciparum or Plasmodium vivax), and the worm Strongyloides stercoralis. This report highlights some of the knowledge shared at the SPSASV.
C1 [Sorgi, Sara; Bonezi, Vivian; Dominguez, Mariana R.; Gimenez, Alba Marina; Nakaya, Helder I.; Soares, Irene S.; Silveira, Eduardo L. V.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.
   [Sorgi, Sara] Univ Siena, Dipartimento Biotecnol Med, Siena, Italy.
   [Dobrescu, Irina; Boscardin, Silvia; Bargieri, Daniel Y.] Univ Sao Paulo, Inst Biomed Sci, Dept Parasitol, Sao Paulo, SP, Brazil.
RP Silveira, ELV (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, SP, Brazil.
EM eduardosilveira@usp.br
RI Gimenez, Alba Marina/I-3456-2018; Dominguez, Mariana R/E-8407-2017;
   Soares, Irene Silva/C-5974-2012; Silveira, Eduardo L V/E-5733-2014
OI Gimenez, Alba Marina/0000-0001-8251-1346; Soares, Irene
   Silva/0000-0002-3336-6856; Silveira, Eduardo L V/0000-0001-8333-2884;
   Dominguez, Mariana/0000-0002-3517-3599
FU FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/17349-7]; Brazilian Society of Immunology; National Institute of
   Science and Technology for Vaccines
FX The financial support of the event Sao Paulo School of Advanced Sciences
   on Vaccines was provided mostly by FAPESP (grant number 2017/17349-7) as
   well as the Brazilian Society of Immunology, and the National Institute
   of Science and Technology for Vaccines. The School of Pharmaceutical
   Sciences (USP), Pro-reitoria de Pesquisa (USP), Biomedical Sciences
   Institute (USP), BD Biosciences, Eppendorf and Synapse also contributed
   to this event.
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ackerman ME, 2018, NAT MED, V24, P1590, DOI 10.1038/s41591-018-0161-0
   Aguiar JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136109
   Allen CDC, 2007, IMMUNITY, V27, P190, DOI 10.1016/j.immuni.2007.07.009
   Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114
   Bear JW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31272-1
   Boscardin SB, 2006, J EXP MED, V203, P599, DOI 10.1084/jem.20051639
   Butkeviciute E, 2018, FUTURE MICROBIOL, V13, P1193, DOI 10.2217/fmb-2018-0026
   Buzzo CL, 2010, J BIOL CHEM, V285, P32087, DOI 10.1074/jbc.M110.124297
   Byberg S, 2017, VACCINE, V35, P33, DOI 10.1016/j.vaccine.2016.11.049
   Calvert AE, 2016, ANTIVIR RES, V131, P92, DOI 10.1016/j.antiviral.2016.04.013
   Campi-Azevedo AC, 2019, EMERG INFECT DIS, V25, P1511, DOI 10.3201/eid2508.181432
   Campos MA, 2004, J IMMUNOL, V172, P1711, DOI 10.4049/jimmunol.172.3.1711
   de Paiva RMC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005296
   Carvalho BO, 2010, J INFECT DIS, V202, P638, DOI 10.1086/654815
   Christopher M. E., 2011, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, V10, P327
   Clemente T, 2013, METHODS, V61, P105, DOI 10.1016/j.ymeth.2013.02.007
   Clemente T, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.506
   Coventry BJ, 2002, BRIT J CANCER, V86, P546, DOI 10.1038/sj.bjc.6600132
   Cox Manon M J, 2015, Ther Adv Vaccines, V3, P97, DOI 10.1177/2051013615595595
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030
   Dall'Oglio Marcos, 2003, Int. braz j urol., V29, P517, DOI 10.1590/S1677-55382003000600006
   Dalod M, 2002, J EXP MED, V195, P517, DOI 10.1084/jem.20011672
   Damasceno L, 2017, PROTEIN EXPRES PURIF, V134, P72, DOI 10.1016/j.pep.2017.04.002
   de Alencar BCG, 2009, INFECT IMMUN, V77, P4383, DOI 10.1128/IAI.01459-08
   Denapoli PMA, 2017, FRONT PARASITOL, P531
   Dillon PM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0295-5
   Dominguez MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022011
   Duarte-Neto AN, 2019, HISTOPATHOLOGY, V75, P638, DOI 10.1111/his.13904
   Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652
   Eickhoff CS, 2019, VACCINE, V37, P5364, DOI 10.1016/j.vaccine.2019.07.034
   Exner M, 2017, GMS HYG INFECT CONTR, V12, DOI 10.3205/dgkh000290
   Farrington CP, 2009, TROP MED INT HEALTH, V14, P977, DOI 10.1111/j.1365-3156.2009.02302.x
   Farrington CP, 2014, BMJ-BRIT MED J, V311, P484
   Favorov M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032567
   Fernandes AP, 2008, VACCINE, V26, P5888, DOI 10.1016/j.vaccine.2008.05.095
   Fonseca SG, 2006, AIDS, V20, P2263, DOI 10.1097/01.aids.0000253353.48331.5f
   France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482
   Freyne B, 2015, T ROY SOC TROP MED H, V109, P52, DOI 10.1093/trstmh/tru197
   Freyne B, 2014, ARCH DIS CHILD, V99, P182, DOI 10.1136/archdischild-2013-305655
   Gimenez AM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01275
   Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853
   Halle S, 2017, TRENDS IMMUNOL, V38, P432, DOI 10.1016/j.it.2017.04.002
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Holscher C, 1998, INFECT IMMUN, V66, P1208
   Huang CJ, 2011, APPL MICROBIOL BIOT, V90, P235, DOI 10.1007/s00253-011-3118-5
   INABA K, 1994, J EXP MED, V180, P1849, DOI 10.1084/jem.180.5.1849
   Inaba K, 2000, J EXP MED, V191, P927, DOI 10.1084/jem.191.6.927
   INABA K, 1990, J EXP MED, V172, P631, DOI 10.1084/jem.172.2.631
   Janeway CA, 2001, MICROBES INFECT, V3, P1167, DOI 10.1016/S1286-4579(01)01477-0
   Junqueira C, 2018, NAT MED, V24, P1330, DOI 10.1038/s41591-018-0117-4
   Kagina BMN, 2010, AM J RESP CRIT CARE, V182, P1073, DOI 10.1164/rccm.201003-0334OC
   Kallas EG, 2019, LANCET INFECT DIS, V19, P750, DOI 10.1016/S1473-3099(19)30125-2
   Kanoi BN, 2017, VACCINE, V35, P873, DOI 10.1016/j.vaccine.2017.01.001
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Lage SL, 2013, P NATL ACAD SCI USA, V110, pE3321, DOI 10.1073/pnas.1305316110
   Lanzavecchia A, 2001, CELL, V106, P263, DOI 10.1016/S0092-8674(01)00455-X
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li Y, 2011, J GENE MED, V13, P60, DOI 10.1002/jgm.1536
   Liu SD, 2009, J IMMUNOL, V182, P5283, DOI 10.4049/jimmunol.0803811
   Lopes SCP, 2014, J INFECT DIS, V209, P1403, DOI 10.1093/infdis/jiu018
   Lopez-Camacho C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04859-5
   Luiz WB, 2015, INFECT IMMUN, V83, P4555, DOI 10.1128/IAI.00858-15
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Magnani DM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005655
   Martins KAO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089735
   Mascarenhas DPA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006502
   Matarrese P, 2005, J BIOL CHEM, V280, P6969, DOI 10.1074/jbc.M409752200
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melief CJM, 2015, J CLIN INVEST, V125, P3401, DOI 10.1172/JCI80009
   Meyer-Hermann M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02020
   Morita M, 2017, SCI REP-UK, V7, DOI 10.1038/srep46086
   Moriyama M, 2017, VACCINE, V35, P6620, DOI 10.1016/j.vaccine.2017.10.038
   Nagato T, 2014, CLIN CANCER RES, V20, P1223, DOI 10.1158/1078-0432.CCR-13-2781
   Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b
   Nankabirwa V, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1497-8
   Ntege EH, 2016, VACCINE, V34, P5612, DOI 10.1016/j.vaccine.2016.09.028
   Nussenzweig MC, 2012, P NATL ACAD SCI US
   Oliveira AC, 2017, ELIFE, V6, DOI [10.7554/eLife.30883, 10.7554/elife.30883]
   Oliveira AC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000870
   Owczarek B, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4216060
   Pinho MP, 2016, CYTOTHERAPY, V18, P570, DOI 10.1016/j.jcyt.2016.01.005
   Pizza M, 2000, SCIENCE, V287, P1816, DOI 10.1126/science.287.5459.1816
   Pollard AJ, 2017, ARCH DIS CHILD, V102, P1077, DOI 10.1136/archdischild-2015-310282
   Polonio CM, 2017, J VENOM ANIM TOXINS, V23, DOI 10.1186/s40409-017-0131-x
   Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006
   Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688
   Rappuoli R, 2016, J EXP MED, V213, P469, DOI 10.1084/jem.20151960
   Regina-Silva S, 2016, VACCINE, V34, P2233, DOI 10.1016/j.vaccine.2016.03.019
   Reyes-Sandoval A, 2010, INFECT IMMUN, V78, P145, DOI 10.1128/IAI.00740-09
   Ritz N, 2012, AM J RESP CRIT CARE, V185, P213, DOI 10.1164/rccm.201104-0714OC
   ROSA DS, 2011, J VACCINES VACCIN, V6, DOI DOI 10.1371/JOURNAL.PONE.0016921
   Roth A, 2005, INT J EPIDEMIOL, V34, P540, DOI 10.1093/ije/dyh392
   Russo PST, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2053-1
   Santos PM, 2018, J IMMUNOL, V200, P443, DOI 10.4049/jimmunol.1701024
   Serruto D, 2012, VACCINE, V30, pB87, DOI 10.1016/j.vaccine.2012.01.033
   Shao BZ, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00320
   Silveira TN, 2010, INFECT IMMUN, V78, P1403, DOI 10.1128/IAI.00905-09
   SMITHERS SR, 1989, PARASITE IMMUNOL, V11, P301, DOI 10.1111/j.1365-3024.1989.tb00669.x
   STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142
   Steinman RM, 2003, ANN NY ACAD SCI, V987, P15, DOI 10.1111/j.1749-6632.2003.tb06029.x
   Tagliabue A, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01068
   Tendler M, 1996, P NATL ACAD SCI USA, V93, P269, DOI 10.1073/pnas.93.1.269
   Thomas R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00947
   Trumpfheller C, 2006, J EXP MED, V203, P607, DOI 10.1084/jem.20052005
   Tsuboi T, 2008, INFECT IMMUN, V76, P1702, DOI 10.1128/IAI.01539-07
   Uthayakumar D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02869
   Vasconcelos JR, 2014, HUM GENE THER, V25, P350, DOI 10.1089/hum.2013.218
   Vasconcelos JR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002699
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032
   Walsh G, 2014, NAT BIOTECHNOL, V32, P992, DOI 10.1038/nbt.3040
   Wang YM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00374
   World Health Organization, 2019, WORLD MAL REP 2018
   World Health Organization, DIS SPEC AR WORK
   World Health Organization, GLOB VACC ACT PLAN
   Yau HL, 2017, BIORXIV
   Zufferey C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077334
NR 120
TC 0
Z9 0
U1 0
U2 0
PU CEVAP-SAO PAULO STATE UNIV-UNESP
PI BOTUCATU
PA CENTER STUDY VENOMS & VENOMOUS, SUA JOSE BARROS, BOTUCATU, SP 18610-307,
   BRAZIL
EI 1678-9199
J9 J VENOM ANIM TOXINS
JI J. Venom. Anim. Toxins Trop. Dis.
PD APR 6
PY 2020
VL 26
AR E20190061
DI 10.1590/1678-9199-JVATITD-2019-0061
PG 14
WC Toxicology; Tropical Medicine; Zoology
SC Toxicology; Tropical Medicine; Zoology
GA LC5DA
UT WOS:000525344000001
PM 32362926
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Choudhry, FR
   Munawar, K
   Kassab, YW
   Bakrin, FS
   Al-Worafi, YM
   Khan, TM
AF Choudhry, Fahad Riaz
   Munawar, Khadeeja
   Kassab, Yaman W.
   Bakrin, Faizah Safina
   Al-Worafi, Yaser Mohammed
   Khan, Tahir Mehmood
TI Public Perception About the Zika Virus in Working Professionals: A
   Qualitative Inquiry
SO INTERNATIONAL QUARTERLY OF COMMUNITY HEALTH EDUCATION
LA English
DT Article; Early Access
DE Zika virus; Zika infection; inductive analysis; public perception
ID BELIEFS; CARE; HIV; WORKERS; MEN
AB Aims
   The Global Outbreak Alert and Response Network recently warned that the Zika virus-containing mosquitoes are being found in Pakistan and the health sector is on high alert. It is thus significant to understand public beliefs and perceptions of the Zika virus and vaccination in the current scenario of Pakistan.
   Methods
   Twenty semistructured qualitative interviews were conducted and analyzed through an inductive approach to analysis.
   Results
   The findings were presented in three main categories which were coded: Reality vs. Conspiracy, Vaccination Concerns, and Public Worries. The majority believed that the Zika virus is a real problem and that authorities might be trying to hide the Zika cases in Pakistan. Moreover, they believed that health organizations are being incompetent by failing to take timely remedial measures to manage the Zika. However, 20% have an opposing view and believed that the Zika virus is a conspiracy against Pakistan from the West.
   Conclusion
   Overall, most participants were concerned about the lack of treatment and preventive methods and emphasized the need to create awareness among the public. It is observed that the participants' perceptions ranged from perceiving the Zika virus as real to as a conspiracy.
C1 [Choudhry, Fahad Riaz] Int Islamic Univ Malaysia, Kulliyyah Islamic Revealed Knowledge & Human Sci, Dept Psychol, Gombak, Selangor, Malaysia.
   [Munawar, Khadeeja] Monash Univ, Jeffrey Cheah Sch Med & Hlth Sci, Dept Psychol, Subang Jaya, Malaysia.
   [Munawar, Khadeeja] Univ Wah, Dept Psychol, Wah Cantonment, Punjab, Pakistan.
   [Kassab, Yaman W.] Cyberjaya Univ, Coll Med Sci, Dept Hosp & Clin Pharm, Cyberjaya, Malaysia.
   [Bakrin, Faizah Safina] KPJ Healthcare Univ Coll, Sch Pharm, Nilai, Negeri Sembilan, Malaysia.
   [Al-Worafi, Yaser Mohammed] Univ Sci & Technol Fujairah, Coll Pharm, Clin Pharm Dept, Fujairah, U Arab Emirates.
   [Al-Worafi, Yaser Mohammed] Univ Sci & Technol, Coll Pharm, Sanaa, Yemen.
   [Khan, Tahir Mehmood] Univ Vet & Anim Sci, Inst Pharmaceut Sci, Lahore, Pakistan.
   [Khan, Tahir Mehmood] Monash Univ Malaysia, Sch Pharm, Sunway City, Selangor, Malaysia.
RP Munawar, K (corresponding author), Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Dept Psychol, Jalan Lagoon Selatan, Bandar Sunway 47500, Selangor Darul, Malaysia.
EM khadeeja.munawar@monash.edu
OI Munawar, Khadeeja/0000-0002-8058-9331
CR Al-Busaidi Zakiya Q, 2008, Sultan Qaboos Univ Med J, V8, P11
   Ali M, 2019, LANCET, V394, P915, DOI 10.1016/S0140-6736(19)32101-4
   BARTNOF HS, 1988, DEATH STUD, V12, P547, DOI 10.1080/07481188808252269
   Bogart LM, 2010, JAIDS-J ACQ IMM DEF, V53, P648, DOI 10.1097/QAI.0b013e3181c57dbc
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Butt AM, 2016, LANCET GLOB HEALTH, V4, pE913, DOI 10.1016/S2214-109X(16)30246-7
   Choudhry FR, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00187
   Choudhry FR, 2017, INT J QUAL STUD HEAL, V12, DOI 10.1080/17482631.2016.1267344
   Choudhry FR, 2013, INT J QUAL STUD HEAL, V8, DOI 10.3402/qhw.v8i0.22469
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duc JLW, 2014, VIRAL INFECT HUMANS
   Eichie FE, 2011, INT J HLTH RES, V4, P57
   Evans AS., 1976, VIRAL INFECT HUMANS
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   FISHER JD, 1992, PSYCHOL BULL, V111, P455, DOI 10.1037/0033-2909.111.3.455
   Frith H., 2004, PSYCHOL MEN MASCULIN, V5, P40, DOI DOI 10.1037/1524-9220.5.1.40
   Gao JL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-100
   Gonzalez JS, 2007, ANN BEHAV MED, V34, P46, DOI 10.1007/BF02879920
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   HARRIS T, 1996, AFR AM REV, V30, P117, DOI 10.2307/3042099
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Kalichman SC, 2007, J BEHAV MED, V30, P497, DOI 10.1007/s10865-007-9123-6
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Lathlean J., 2010, RES PROCESS NURSING
   MAJ M, 1991, ACTA PSYCHIAT SCAND, V83, P161, DOI 10.1111/j.1600-0447.1991.tb05517.x
   Mestrovic T, 2017, NEWS MED
   Mostashari F, 1998, J ACQ IMMUN DEF SYND, V18, P341, DOI 10.1097/00042560-199808010-00005
   Munawar K, 2017, MENT HEALTH REV J, V22, P300, DOI 10.1108/MHRJ-02-2017-0012
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   ODONNELL L, 1987, J APPL SOC PSYCHOL, V17, P269, DOI 10.1111/j.1559-1816.1987.tb00314.x
   Olajide AS, 2010, INT J BIOMED ADV RES, V1, P117
   Patton MQ, 1990, QUALITATIVE EVALUATI, P532
   Pope C, 2002, QUAL SAF HEALTH CARE, V11, P148, DOI 10.1136/qhc.11.2.148
   Rosengren K.E., 1981, ADV CONTENT ANAL, P9
   Somra G., 2015, CNN
   Spencer L, 2003, QUALITATIVE RES PRAC, P199
   Twagirumukiza M, 2009, AM J TROP MED HYG, V81, P776, DOI 10.4269/ajtmh.2009.09-0109
   Weber R., 1990, BASIC CONTENT ANAL
   WHO, 2016, HIST ZIK VIR
   Yusuf M, 2016, J PAK MED ASSOC, V66, P789
NR 41
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0272-684X
EI 1541-3519
J9 INT Q COMMUNITY HEAL
JI Int. Q. Community Health Educ.
AR 0272684X20916621
DI 10.1177/0272684X20916621
EA APR 2020
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KZ8ZR
UT WOS:000523546600001
PM 32249680
DA 2020-07-08
ER

PT J
AU Collins, MH
   Zepeda, O
   Blette, B
   Jadi, R
   Morales, M
   Perez, R
   Liou, GJA
   Montoya-Cruz, M
   Harris, E
   Becker-Dreps, S
   de Silva, AM
   Stringer, J
   Bucardo, F
   Stringer, E
AF Collins, Matthew H.
   Zepeda, Omar
   Blette, Bryan
   Jadi, Ramesh
   Morales, Marlen
   Perez, Rigoberto
   Liou, Guei-Jiun Alice
   Montoya-Cruz, Magelda
   Harris, Eva
   Becker-Dreps, Sylvia
   de Silva, Aravinda M.
   Stringer, Jeffrey
   Bucardo, Filemon
   Stringer, Elizabeth
TI Serologic surveillance of maternal Zika infection in a prospective
   cohort in Leon, Nicaragua during the peak of the Zika epidemic
SO PLOS ONE
LA English
DT Article
ID VIRUS; BRAZIL; ANTIBODIES
AB Background
   Zika virus caused thousands of congenital anomalies during a recent epidemic. Because Zika emerged in areas endemic for dengue and these related flaviviruses elicit cross-reactive antibodies, it is challenging to serologically monitor pregnant women for Zika infection.
   Methods
   A prospective cohort of 253 pregnant women was established in Leon, Nicaragua. Women were followed during prenatal care through delivery. Serologic specimens were obtained at each visit, and birth outcome was recorded. Established flavivirus serologic methods were adapted to determine Zika seroprevalence, and a stepwise testing algorithm estimated timing of Zika infection in relation to pregnancy.
   Results
   Zika seroprevalence was approximately 59% among women tested. Neutralization testing was highly concordant with Zika NS1 BOB results. Per study algorithm, 21% (40/187) of women were classified as experiencing Incident ZIKV infection during pregnancy. Importantly, the Incident ZIKV group included mostly women pregnant during the 2016 Zika epidemic peak and the only 3 subjects in the cohort with RT-PCR-confirmed infections. Approximately 17% of births had complications; 1.5% (3/194) manifesting clinical criteria of congenital Zika syndrome, one was RT-PCR-confirmed as a case of congenital Zika syndrome. Adverse birth outcome did not correlate with timing of Zika infection.
   Conclusions
   By leveraging prenatal care systems, we developed a simple algorithm for identifying women who were likely infected by Zika during pregnancy.
C1 [Collins, Matthew H.] Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Zepeda, Omar; Morales, Marlen; Bucardo, Filemon] Natl Autonomous Univ Nicaragua, Fac Med Sci, Dept Microbiol, Leon UNAN Leon, Managua, Nicaragua.
   [Blette, Bryan] Univ N Carolina, Dept Biostat, Gillings Sch Global Publ Hlth, Chapel Hill, NC 27515 USA.
   [Jadi, Ramesh; Liou, Guei-Jiun Alice; de Silva, Aravinda M.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27515 USA.
   [Perez, Rigoberto] Natl Autonomous Univ Nicaragua, Fac Med Sci, Dept Obstet & Gynecol, Leon UNAN Leon, Managua, Nicaragua.
   [Montoya-Cruz, Magelda; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Becker-Dreps, Sylvia] Univ N Carolina, Dept Family Med & Epidemiol, Sch Med, Chapel Hill, NC 27515 USA.
   [Stringer, Jeffrey] Univ N Carolina, Dept Obstet & Gynecol, Div Global Womens Hlth, Sch Med, Chapel Hill, NC 27515 USA.
   [Stringer, Elizabeth] Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC 27515 USA.
RP Collins, MH (corresponding author), Emory Univ, Sch Med, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.; Stringer, E (corresponding author), Univ N Carolina, Dept Obstet & Gynecol, Sch Med, Chapel Hill, NC 27515 USA.
EM matthew.collins@emory.edu; elizabeth_stringer@med.unc.edu
OI Liou, Guei-Jiun/0000-0003-4451-9077; Blette, Bryan/0000-0002-3121-7718
FU Understanding Maternal Fetal Transmission of Zika virus [ECBR_003
   6/2016-6/2017]; UNC; Structure based design of recombinant Zika virus
   antigens for serodiagnosis NIH/NIAID [R21 AI134073]; CDC Diagnosis of
   recent and remote Zika infections [00HVCLJB-2017-04191]; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [P01 AI106695, 1K22AI137306-01]; NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [5R21AI129532-02]; Thrasher Research Fund
FX This work was supported by the following funding sources: 1.
   Understanding Maternal Fetal Transmission of Zika virus ECBR_003
   6/2016-6/2017 UNC Pilot to PI E. Stringer for startup supplies and
   recruitment of pregnancy cohort in Nicaragua 2. F Bucardo received a
   Fogarty fellowship from UNC that supported some of his effort on this
   work 3. Structure based design of recombinant Zika virus antigens for
   serodiagnosis R21 AI134073 (MPI: de Silva) NIH/NIAID 4.
   00HVCLJB-2017-04191 (PI: de Silva) CDC Diagnosis of recent and remote
   Zika infections supported assay development and serologic testing of
   cohort specimens at UNC 5. NIH P01 AI106695 (EH); funders played no role
   in the writing of the manuscript or the decision to submit it for
   publication. 6. S. Becker-Dreps was supported by NIAID 5R21AI129532-02.
   7. MHC is supported by NIH 1K22AI137306-01 and Thrasher Research Fund.
CR [Anonymous], 2017, PROLONGED IGM ANTIBO, V402
   [Anonymous], 2018, ZIKA MAC ELISA USE E
   Balmaseda A, 2017, P NATL ACAD SCI USA
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Baronti C, 2014, GENOME ANNOUNC, V2
   Bogoch II, 2016, LANCET INFECT DIS, P57
   Brasil P, 2016, N ENGL J MED
   Centers for Disease Control and Prevention (CDC), 2018, CONG ZIK SYNDR OTH B
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Coyne CB, 2016, NAT REV MICROBIOL
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Halai U-A, 2017, CLIN INFECT DIS
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hay JA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006991
   Koishi AC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006342
   Lopez-Perez M, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1125-9
   Lozier MJ, 2018, DURATION DETECTION A
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Montoya M, 2018, J INFECT DIS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   PERKINS TA, 2017, BMJ GLOB HEALTH, V2, DOI DOI 10.1038/NMICROBIOL.2017.51
   Premkumar L, 2017, J CLIN MICROBIOL
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Reller ME, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005026
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Sesay SSS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183330
   Simister NE, 2003, VACCINE, V21, P3365, DOI 10.1016/S0264-410X(03)00334-7
   Speer SD, 2016, SCIENCE, V353, P750, DOI 10.1126/science.aah6187
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
NR 39
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 3
PY 2020
VL 15
IS 4
AR e0230692
DI 10.1371/journal.pone.0230692
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LR8MC
UT WOS:000535949600012
PM 32243482
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Moradi, SV
   Gagoski, D
   Mureev, S
   Walden, P
   Mcmahon, KA
   Parton, RG
   Johnston, WA
   Alexandrov, K
AF Moradi, Shayli Varasteh
   Gagoski, Dejan
   Mureev, Sergey
   Walden, Patricia
   Mcmahon, Kerrie-Ann
   Parton, Robert G.
   Johnston, Wayne A.
   Alexandrov, Kirill
TI Mapping Interactions among Cell-Free Expressed Zika Virus Proteins
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Leishmania tarentolae in vitro translation system; Zika virus;
   protein-protein interactions; AlphaLISA technology
ID STRUCTURAL BIOLOGY; NS2B-NS3 PROTEASE; DENGUE; NS4B; NS3; ALPHASCREEN;
   COMPLEX
AB The rapid spread of arthropod-borne Zika virus poses a serious public health threat that calls for effective ways of controlling and treating viral infection. This in turn necessitates better understanding of the mechanisms of virus assembly and its interaction with the host cells. In order to facilitate such efforts, we developed a new multihost expression vector pmCellFree that allows rapid and multiplexed production of ZIKV proteins in any in vitro translation system as well as in mammalian cells. Using a combination of in vitro expression in Leishmania cell-free system and AlphaLISA interaction assay, pairwise protein interactions of all ZIKV proteins were systematically tested. We identified thirty-three intraviral binary protein interactions, of which 13 interactions are novel. These findings were further validated by expressing selected protein pairs in mammalian HEK293T cell line and assessing their interactions in the cellular lysate. The results of these interaction assays were identical to those obtained with in vitro expressed proteins. The observed novel protein-protein interactions were further validated using a pulldown assay. The unrevealed novel protein interactions may point to the previously unappreciated complexity of the ZIKV assembly process and may play an important role in the infection process. These interactions may represent new targets for antiviral drug development.
C1 [Moradi, Shayli Varasteh; Mureev, Sergey; Walden, Patricia; Johnston, Wayne A.; Alexandrov, Kirill] Queensland Univ Technol, Ctr Trop Crops & Biocommod, CSIRO QUT Synthet Biol Alliance, Brisbane, Qld 4001, Australia.
   [Gagoski, Dejan] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.
   [Mcmahon, Kerrie-Ann; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia.
   [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia.
RP Alexandrov, K (corresponding author), Queensland Univ Technol, Ctr Trop Crops & Biocommod, CSIRO QUT Synthet Biol Alliance, Brisbane, Qld 4001, Australia.
EM kirill.alexandrov@qut.edu.au
RI Gagoski, Dejan/C-9681-2017; mureev, sergey/K-3521-2014
OI Gagoski, Dejan/0000-0001-6194-8514; mureev, sergey/0000-0001-9999-3150
FU Australian Research CouncilAustralian Research Council [DP160100973,
   DP150100936]; ITTC grant [IC160100027]; NHMRCNational Health and Medical
   Research Council of Australia [APP1113262, APP1037320, APP1058565,
   APP569542]; ARC (Centre of Excellence in Convergent Bio-Nano Science and
   Technology)Australian Research Council; ARCAustralian Research Council
   [DP 150100505]
FX This work was supported in part by the Australian Research Council
   Discovery Projects DP160100973 and DP150100936 as well as ITTC grant
   IC160100027 and NHMRC grant APP1113262 to K.A. R.G.P. was supported by
   grants and a fellowship from the NHMRC (grant numbers APP1037320,
   APP1058565 and APP569542) and by the ARC (Centre of Excellence in
   Convergent Bio-Nano Science and Technology and DP 150100505). Authors
   are grateful to Paul Young and Alexander Khromykh for stimulating
   discussions at early stages of the project.
CR Ariotti N, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005473
   Beaudet L., 2008, NAT METHODS, V5, pan8, DOI DOI 10.1038/NMETH.F.230
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Eaton JRO, 2018, J BIOL CHEM, V293, P6134, DOI 10.1074/jbc.RA117.000487
   Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002
   Gagoski D, 2016, BIOTECHNOL BIOENG, V113, P292, DOI 10.1002/bit.25814
   Gagoski D, 2015, J BIOTECHNOL, V195, P1, DOI 10.1016/j.jbiotec.2014.12.006
   Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Johnston WA, 2014, METHODS MOL BIOL, V1118, P1, DOI 10.1007/978-1-62703-782-2_1
   Kubala MH, 2010, PROTEIN SCI, V19, P2389, DOI 10.1002/pro.519
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee CM, 2015, J VIROL, V89, P6171, DOI 10.1128/JVI.00546-15
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li T, 2018, CELL RES, V28, P497, DOI 10.1038/s41422-018-0007-9
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Matsuoka K, 2010, J PROTEOME RES, V9, P4264, DOI 10.1021/pr9010553
   Meyniel-Schicklin L, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014738
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mureev S, 2009, NAT BIOTECHNOL, V27, P747, DOI 10.1038/nbt.1556
   Osterman A, 2015, SCI REP-UK, V5, DOI 10.1038/srep13872
   PerkinElmer, ANT ALPH PROT
   PerkinElmer, US GUID ALPH ASS PRO
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Shiryaev SA, 2009, J GEN VIROL, V90, P2081, DOI 10.1099/vir.0.012864-0
   Shrivastava G, 2017, VIRULENCE, V8, P1450, DOI 10.1080/21505594.2017.1356540
   Sierecki E, 2014, MOL CELL PROTEOMICS, V13, P2233, DOI 10.1074/mcp.M113.037275
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Skalamera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020057
   Taouji S, 2009, CURR GENOMICS, V10, P93, DOI 10.2174/138920209787847041
   Tay MYF, 2018, ADV EXP MED BIOL, V1062, P147, DOI 10.1007/978-981-10-8727-1_11
   Tay MYF, 2015, J BIOL CHEM, V290, P2379, DOI 10.1074/jbc.M114.607341
   Ullman EF, 1996, CLIN CHEM, V42, P1518
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Weill U, 2019, J MOL BIOL, V431, P636, DOI 10.1016/j.jmb.2018.12.004
   WHO, ZIK VIR REP
   Wu RH, 2017, J VIROL, V91, DOI [10.1128/JVI.01836-16, 10.1128/jvi.01836-16]
   Yasgar A, 2016, METHODS MOL BIOL, V1439, P77, DOI 10.1007/978-1-4939-3673-1_5
   Yu L, 2013, VIROLOGY, V446, P365, DOI 10.1016/j.virol.2013.08.006
   Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou J, 2015, J VIROL, V89, P3471, DOI 10.1128/JVI.03454-14
   Zou J, 2015, J VIROL, V89, P3455, DOI 10.1128/JVI.03453-14
   Zou J, 2014, J VIROL, V88, P3379, DOI 10.1128/JVI.02782-13
NR 52
TC 0
Z9 0
U1 2
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD APR 3
PY 2020
VL 19
IS 4
BP 1522
EP 1532
DI 10.1021/acs.jproteome.9b00771
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA LD9HZ
UT WOS:000526337800016
PM 32081002
DA 2020-07-08
ER

PT J
AU Bharadwaj, S
   Rao, AK
   Dwivedi, VD
   Mishra, SK
   Yadava, U
AF Bharadwaj, Shiv
   Rao, Akhilesh Kumar
   Dwivedi, Vivek Dhar
   Mishra, Sarad Kumar
   Yadava, Umesh
TI Structure-based screening and validation of bioactive compounds as Zika
   virus methyltransferase (MTase) inhibitors through first-principle
   density functional theory, classical molecular simulation and QM/MM
   affinity estimation
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Zika virus; N-terminal methyltransferase; density functional theory;
   classical molecular simulation; binding affinity
ID CRYSTAL-STRUCTURE; DYNAMICS SIMULATIONS; FT-RAMAN; DOCKING; NS5; DENGUE;
   PEPTIDES; PROTEASE; ASSIGNMENTS; DERIVATIVES
AB Recent Zika virus (ZIKV) outbreak and association with human diseases such as neurological disorders have raised global health concerns. However, in the absence of an approved anti-ZIKV drug has generated urgency for the drug development against ZIKV infection. Here, structure-based virtual screening of 8589 bioactive compounds, screened at the substrate-binding site of ZIKV nonstructural 5 (NS5)-based structure N-terminal methyltransferase (MTase) domain followed by ADMET (absorption, distribution, metabolism, excretion and toxicity) profiling concluded the four potential lead inhibitors, i.e. (4-acetylamino-benzenesulfonylamino)-acetic acid (F3342-0450), 3-(5-methylfuran-2-yl)-N-(4-sulfamoylphenyl)propanamide (F1736-0142), 8-(2-hydroxy-ethylamino)-1,3-dimethyl-7-(3-methyl-benzyl)-3,7-dihydro-purine-2,6-dione (F0886-0080) and N-[4-(aminosulfonyl)phenyl]-2,3-dihydro-1,4-benzodioxine-2-carboxamide (F0451-2187). Collectively, extra precision docking and Density Functional Theory(DFT) calculations studies identified the F3342-0450 molecule, having strong interactions on the active site of MTase, further supported by molecular dynamics simulation, binding affinity and hybrid QM/MM calculations, suggest a new drug molecule for the antiviral drug development against ZIKV infection.
C1 [Bharadwaj, Shiv] Sabanci Univ, Nanotechnol Res & Applicat Ctr, Istanbul, Turkey.
   [Rao, Akhilesh Kumar; Yadava, Umesh] Deen Dayal Upadhyay Gorakhpur Univ, Dept Phys, Gorakhpur, Uttar Pradesh, India.
   [Dwivedi, Vivek Dhar] Pathfinder Res & Training Fdn, Ctr Bioinformat Computat & Syst Biol, Greater Noida, India.
   [Mishra, Sarad Kumar] Deen Dayal Upadhyaya Gorakhpur Univ, Dept Biotechnol, Gorakhpur, Uttar Pradesh, India.
RP Yadava, U (corresponding author), Deen Dayal Upadhyay Gorakhpur Univ, Dept Phys, Gorakhpur, Uttar Pradesh, India.; Mishra, SK (corresponding author), Deen Dayal Upadhyaya Gorakhpur Univ, Dept Biotechnol, Gorakhpur, Uttar Pradesh, India.
EM saradmishra5@gmail.com; u_yadava@yahoo.com
RI Dwivedi, Vivek Dhar/AAD-4206-2019
OI Dwivedi, Vivek Dhar/0000-0003-0767-1328; Yadava,
   Umesh/0000-0002-9127-532X
CR Akaberi D, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1704882
   [Anonymous], 2012, PRIME
   [Anonymous], 2012, GLID VERS 5 8
   Bharadwaj S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55723-5
   Bharadwaj S, 2019, J CELL BIOCHEM, V120, P19064, DOI 10.1002/jcb.29229
   Bowers K.J., 2006, P 2006 ACM IEEE C SU, DOI [10.1145/1188455.1188544, DOI 10.1109/SC.2006.54]
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chadha N, 2015, J BIOMOL STRUCT DYN, V33, P573, DOI 10.1080/07391102.2014.897258
   Coleman RG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075992
   Dagan-Wiener A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12359-7
   Daina A, 2017, SCI REP-UK, V7, DOI 10.1038/srep42717
   Decroly E, 2012, NAT REV MICROBIOL, V10, P51, DOI 10.1038/nrmicro2675
   Dong HP, 2010, VIROLOGY, V405, P568, DOI 10.1016/j.virol.2010.06.039
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Dwivedi VD, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2020.1734485
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Eryilmaz S, 2016, J MOL STRUCT, V1108, P209, DOI 10.1016/j.molstruc.2015.11.079
   Ezat AA, 2019, LIFE SCI, V217, P176, DOI 10.1016/j.lfs.2018.12.004
   Ezat AA, 2014, PROTEIN J, V33, P32, DOI 10.1007/s10930-013-9538-6
   Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o
   Fukuda R, 2003, GAUSSIAN 03 REVISION
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Guo ZJ, 2010, CHEM BIOL DRUG DES, V75, P348, DOI 10.1111/j.1747-0285.2010.00951.x
   Harder E, 2016, J CHEM THEORY COMPUT, V12, P281, DOI 10.1021/acs.jctc.5b00864
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Kaushik AC, 2018, ACS OMEGA, V3, P18214, DOI 10.1021/acsomega.8b01941
   Krautler V, 2001, J COMPUT CHEM, V22, P501, DOI 10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V
   Kroemer RT, 2004, J CHEM INF COMP SCI, V44, P871, DOI 10.1021/ci049970m
   Kumar D, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1689851
   Lee KE, 2019, J ENZYM INHIB MED CH, V34, P927, DOI 10.1080/14756366.2019.1596904
   Li SH, 2013, J VIROL, V87, P5812, DOI 10.1128/JVI.02806-12
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Lyne PD, 2006, J MED CHEM, V49, P4805, DOI 10.1021/jm060522a
   Mena-Ulecia K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142774
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   MULLIKEN RS, 1955, J CHEM PHYS, V23, P1833, DOI 10.1063/1.1740588
   Murray CL, 2008, NAT REV MICROBIOL, V6, P699, DOI 10.1038/nrmicro1928
   Murray JS, 2011, WIRES COMPUT MOL SCI, V1, P153, DOI 10.1002/wcms.19
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Onodera K, 2007, J CHEM INF MODEL, V47, P1609, DOI 10.1021/ci7000378
   Patil R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012029
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Prabavathi N, 2013, SPECTROCHIM ACTA A, V114, P101, DOI 10.1016/j.saa.2013.05.013
   Ramharack P, 2018, J BIOMOL STRUCT DYN, V36, P1118, DOI 10.1080/07391102.2017.1313175
   Rizwana BF, 2019, COMPUT BIOL CHEM, V78, P9, DOI 10.1016/j.compbiolchem.2018.11.014
   Rocha JA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198476
   Rodriguez YA, 2016, CHEM BIOL DRUG DES, V88, P498, DOI 10.1111/cbdd.12773
   Rothan HA, 2014, TROP BIOMED, V31, P286
   Saleem HN, 2019, ACS OMEGA, V4, P1525, DOI 10.1021/acsomega.8b02861
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Stephen P, 2016, J AM CHEM SOC, V138, P16212, DOI 10.1021/jacs.6b10399
   Vennila P, 2016, J MOL STRUCT, V1111, P151, DOI 10.1016/j.molstruc.2016.01.068
   Vijayaraj R, 2009, J CHEM THEORY COMPUT, V5, P2744, DOI 10.1021/ct900347f
   VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159
   Wang BX, 2018, CELL MOL LIFE SCI, V75, P1723, DOI 10.1007/s00018-018-2751-x
   Wang HX, 2019, PHYS CHEM CHEM PHYS, V21, P24147, DOI 10.1039/c9cp04353e
   Yadav R, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1709546
   Yadava U, 2019, J MOL LIQ, V280, P135, DOI 10.1016/j.molliq.2019.01.164
   Yadava U, 2017, DNA REPAIR, V60, P9, DOI 10.1016/j.dnarep.2017.10.005
   Yadava U, 2015, J BIOL PHYS, V41, P117, DOI 10.1007/s10867-014-9369-5
   Yadava U, 2012, MED CHEM RES, V21, P2162, DOI 10.1007/s00044-011-9724-z
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   Zhu MQ, 2020, ENVIRON POLLUT, V256, DOI 10.1016/j.envpol.2019.113427
   Zou XW, 2014, ACTA CRYSTALLOGR D, V70, P1549, DOI 10.1107/S1399004714005239
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 68
TC 0
Z9 0
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1747545
EA APR 2020
PG 14
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LE1IA
UT WOS:000526475300001
PM 32216596
DA 2020-07-08
ER

PT J
AU Linde-Arias, AR
   Roura, M
   Siqueira, E
AF Linde-Arias, Ana Rosa
   Roura, Maria
   Siqueira, Eduardo
TI Solidarity, vulnerability and mistrust: how context, information and
   government affect the lives of women in times of Zika
SO BMC INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Women; Social determinants; Information; Public health; Maternal
   and child health
ID SEXUAL TRANSMISSION; VIRUS; HEALTH; HIV; CONTRACEPTION; GUIDELINES;
   EPIDEMICS; ABORTION; ACCESS; DENGUE
AB Background The public health response to Zika outbreak has mostly focused on epidemiological surveillance, vector control, and individual level preventative measures. This qualitative study employs a social-ecological framework to examine how macro (historical, legislative, political, socio-economic factors), meso (sources of information, social support, social mobilization) and micro level factors (individual actions, behavioral changes) interacted to influence the response and behavior of women with respect to Zika in different contexts. Methods A qualitative study was carried out. Women were recruited through the snowball sampling technique from various locations in Brazil, Puerto Rico, and the United States. They were of different nationalities and ethnicities. Data were collected through semi-structured interviews. The data transcripts were analyzed using thematic analysis. Results Women in this study deemed the information provided as insufficient, which led them to actively reach out and access a variety of media sources. Social networks played a vital role in sharing information but also resulted in the spread of hoaxes or rumors. Participants in our research perceived socio-economic inequities but focused on how to remedy their microenvironments. They did not engage in major social activities. Lack of trust in governments placed women in vulnerable situations by preventing them to follow the guidance of health authorities. These impacts were also a result of the response tactics of health and government administrations in their failed attempts to ensure the well-being of their countries' populations. Conclusions Our findings call for public health interventions that go beyond individual level behavioral change campaigns, to more comprehensively address the broader meso and macro level factors that influence women' willingness and possibility to protect themselves.
C1 [Linde-Arias, Ana Rosa; Siqueira, Eduardo] Univ Massachusetts, Mauricio Gaston Inst Latino Community Dev & Publ, Boston, MA 02125 USA.
   [Roura, Maria] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland.
   [Roura, Maria] Univ Limerick, Hlth Res Inst, Limerick, Ireland.
   [Siqueira, Eduardo] Univ Massachusetts, Sch Environm, Boston, MA 02125 USA.
RP Linde-Arias, AR (corresponding author), Univ Massachusetts, Mauricio Gaston Inst Latino Community Dev & Publ, Boston, MA 02125 USA.
EM linde14@yahoo.com
FU Healey research grant from the University of Massachusetts Boston
FX This research was supported by a Healey research grant from the
   University of Massachusetts Boston. The grant funded Dr. ARLA to perform
   data analysis and manuscript writing.
CR [Anonymous], 2010, FREQ ASK QUEST MICR
   [Anonymous], 2017, MAES ANJOS MOSTRA QU
   [Anonymous], 2017, ZIKA VIRUS BRAZIL SU
   Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018
   Barata G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190482
   Bauza V, 1994, MS, V5, P14
   Blanchard K, 2017, LANCET, V389, P1603, DOI 10.1016/S0140-6736(17)31010-3
   Briggs Laura, 1998, DIFFERENCES, V10, P30
   Carabali M, 2018, GLOB HEALTH RES POL, V3, DOI 10.1186/s41256-018-0069-8
   Chan MPS, 2018, SOC SCI MED, V212, P50, DOI 10.1016/j.socscimed.2018.07.007
   Check HE, 2016, NATURE, V531, P9, DOI [10.1038/531009a, DOI 10.1038/531009A]
   Conaway J, 2017, ABORTION RIGHTS STIL
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dahlgren G, 1991, POLICIES STRATEGIES
   Davtyan M, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.26058
   Delamou A, 2014, LANCET, V384, P2105, DOI 10.1016/S0140-6736(14)62364-3
   Diniz D., 2017, ZIKA BRAZILIAN BACKL
   Epstein S., 1996, IMPURE SCI AIDS ACTI
   Fee E, 2005, B HIST MED, V79, P380, DOI 10.1353/bhm.2005.0061
   Frieden TR, 2016, JAMA-J AM MED ASSOC, V316, P1443, DOI 10.1001/jama.2016.11941
   Geffen N, 2017, CURR OPIN HIV AIDS, V12, P398, DOI 10.1097/COH.0000000000000381
   Golden SD, 2012, HEALTH EDUC BEHAV, V39, P364, DOI 10.1177/1090198111418634
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Harman S, 2016, THIRD WORLD Q, V37, P524, DOI 10.1080/01436597.2015.1108827
   Kempner M, 2016, WHY ARE SOME COUNTRI
   Lathrop E, 2018, LANCET PUBLIC HEALTH, V3, pE91, DOI 10.1016/S2468-2667(18)30001-X
   Linde AR, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00178917
   Linde-Arias AR, 2019, J HUM GROWTH DEV, V29, P14, DOI [10.7322/jhgd.150807, DOI 10.7322/JHGD.150807]
   Marks L, 1999, HIST TECHNOL, V15, P263, DOI 10.1080/07341519908581949
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433
   Oster AM, 2016, MMWR-MORBID MORTAL W, V65, P120, DOI 10.15585/mmwr.mm6505e1
   Perez-Guerra CL, 2009, REV PANAM SALUD PUBL, V25, P218, DOI 10.1590/S1020-49892009000300005
   Phuanukoonnon S, 2005, TROP MED INT HEALTH, V10, P755, DOI 10.1111/j.1365-3156.2005.01452.x
   Piltch-Loeb R, 2019, RISK ANAL, V39, P2683, DOI 10.1111/risa.13369
   Poonam D, 2017, ZIKAS NEVER ENDING E
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Puerto Rico Department of Health, 2017, VIR ZIK MAT ED COM
   Mota VMR, 2018, REV BRAS GINECOL OBS, V40, P417, DOI 10.1055/s-0038-1648219
   Rodriguez M, 2020, SEX TRANSM INFECT, V96, P80, DOI 10.1136/sextrans-2019-054093
   Roura M, 2009, SEX TRANSM INFECT, V85, P308, DOI 10.1136/sti.2008.033183
   Saunders TL, 2014, CONTEMP SOCIOL, V43, P385, DOI 10.1177/0094306114531284dd
   Sherley M, 2018, SEX HEALTH, V15, P183, DOI 10.1071/SH17046
   Sousa CA, 2018, REVISTAGAUCHA ENFERM, V39
   Stopa SR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051000074, 10.1590/s1518-8787.2017051000074]
   Tambo E, 2017, PHILOS ETHICS HUM ME, V12, DOI 10.1186/s13010-017-0046-8
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tobar G, 2016, NEWS NATL VICEMINIST
   Tokar A, 2018, AIDS BEHAV, V22, P2435, DOI 10.1007/s10461-018-2043-3
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   Viterna J, 2016, REVISTA CAMBRIDGE, V15, P24
   Vouga M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00383-4
   Walker JL, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010305
   WARREN CW, 1986, DEMOGRAPHY, V23, P351, DOI 10.2307/2061435
   Watts J, 2016, LANCET, V387, P1603, DOI 10.1016/S0140-6736(16)30249-5
   World Health Organization, 2019, ZIK EP UPD
NR 57
TC 0
Z9 0
U1 3
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1471-2334
J9 BMC INFECT DIS
JI BMC Infect. Dis.
PD APR 3
PY 2020
VL 20
IS 1
AR 263
DI 10.1186/s12879-020-04987-8
PG 12
WC Infectious Diseases
SC Infectious Diseases
GA KZ7NO
UT WOS:000523446100003
PM 32245370
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sell, TK
   Ravi, SJ
   Watson, C
   Meyer, D
   Pechta, LE
   Rose, DA
   Lubell, KM
   Podgornik, MN
   Schoch-Spana, M
AF Sell, Tara Kirk
   Ravi, Sanjana J.
   Watson, Crystal
   Meyer, Diane
   Pechta, Laura E.
   Rose, Dale A.
   Lubell, Keri M.
   Podgornik, Michelle N.
   Schoch-Spana, Monica
TI A Public Health Systems View of Risk Communication About Zika
SO PUBLIC HEALTH REPORTS
LA English
DT Article
DE communicable diseases; outbreaks; emerging infectious diseases; public
   health practice; preparedness; health communications
ID LOCAL HEALTH; UNITED-STATES; PREPAREDNESS; COMMUNITY; PROGRAMS; VIRUS
AB Objectives
   The spread of Zika virus throughout Latin America and parts of the United States in 2016 and 2017 presented a challenge to public health communicators. The objective of our study was to describe emergency risk communication practices during the 2016-2017 Zika outbreak to inform future infectious disease communication efforts.
   Methods
   We conducted semi-structured telephone interviews with 13 public health policy makers and practitioners, 10 public information officers, and 5 vector-control officials from May through August 2017.
   Results
   Within the public health macro-environment, extended outbreak timeframe, government trust, US residence status, and economic insecurity set the backdrop for Zika communication efforts. Limited resources, staffing, and partnerships negatively affected public health structural capacity for communication efforts. Public health communicators and practitioners used a range of processes and practices to engage in education and outreach, including fieldwork, community meetings, and contact with health care providers. Overall, public health agencies' primary goals were to prevent Zika infection, reduce transmission, and prevent adverse birth outcomes.
   Conclusions
   Lessons learned from this disease response included understanding the macro-environment, developing partnerships across agencies and the community, and valuing diverse message platforms. These lessons can be used to improve communication approaches for health officials at the local, state, and federal levels during future infectious disease outbreaks.
C1 [Sell, Tara Kirk; Ravi, Sanjana J.; Watson, Crystal; Meyer, Diane; Schoch-Spana, Monica] Johns Hopkins Ctr Hlth Secur, 621 E Pratt St,Ste 210, Baltimore, MD 21230 USA.
   [Sell, Tara Kirk; Ravi, Sanjana J.; Watson, Crystal; Meyer, Diane; Schoch-Spana, Monica] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Environm Hlth & Engn, Baltimore, MD USA.
   [Pechta, Laura E.; Rose, Dale A.; Lubell, Keri M.; Podgornik, Michelle N.] Ctr Dis Control & Prevent, Ctr Preparedness & Response, Atlanta, GA USA.
RP Sell, TK (corresponding author), Johns Hopkins Ctr Hlth Secur, 621 E Pratt St,Ste 210, Baltimore, MD 21230 USA.
EM tksell@jhu.edu
OI Sell, Tara/0000-0002-8342-476X
FU CDCUnited States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [200-2016-92378]
FX The authors declared the following financial support with respect to the
   research, authorship, and/or publication of this article: The research
   was funded under contract #200-2016-92378 with CDC.
CR Association of State and Territorial Health Officials National Association of County and City Health Officials Association of Public Health Laboratories Council of State and Territorial Epidemiologists, 2016, IMP RED PUBL HLTH EM
   Centers for Disease Control and Prevention, 2014, CRIS E RISK COMM CER
   Centers for Disease Control and Prevention, 2018, ZIK VIR 2017 CAS COU
   Glik DC, 2007, ANNU REV PUBL HEALTH, V28, P33, DOI 10.1146/annurev.publhealth.28.021406.144123
   Handler A, 2001, AM J PUBLIC HEALTH, V91, P1235, DOI 10.2105/AJPH.91.8.1235
   Hornik R. C, 2002, PUBLIC HLTH COMMUNIC
   Kroelinger CD, 2017, MMWR-MORBID MORTAL W, V66, P1230, DOI 10.15585/mmwr.mm6644a6
   Lee CT, 2018, J PUBLIC HEALTH MAN, V24, P533, DOI 10.1097/PHH.0000000000000684
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lin L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-484
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Mays GP, 2015, AM J PUBLIC HEALTH, V105, pS280, DOI 10.2105/AJPH.2014.302456
   National Association of County and City Health Officials, 2015, FORC CHANG
   National Association of County and City Health Officials, 2015, CHANG PUBL HLTH LAND
   National Association of County and City Health Officials, 2015, IMP PUBL HLTH EM PRE
   National Association of County and City Health Officials, 2016, 2016 NAT PROF LOC HL
   Piltch-Loeb R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188666
   QSR International Pty Ltd, 2015, NVIVO QUAL DAT AN SO
   Quinn SC, 2008, BIOSECUR BIOTERROR, V6, P321, DOI 10.1089/bsp.2007.0064
   Reschovsky A, 2016, J PUBLIC HEALTH MAN, V22, P120, DOI 10.1097/PHH.0b013e31828ebf8c
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Santibanez S, 2017, PUBLIC HEALTH REP, V132, P436, DOI 10.1177/0033354917710212
   Schoch-Spana M, 2018, PUBLIC HEALTH REP, V133, P366, DOI 10.1177/0033354918773069
   Schoch-Spana M, 2018, J PUBLIC HEALTH MAN, V24, P360, DOI 10.1097/PHH.0000000000000685
   Schoch-Spana M, 2018, J PUBLIC HEALTH MAN, V24, P350, DOI 10.1097/PHH.0000000000000680
   Schoch-Spana M, 2013, BIOSECUR BIOTERROR, V11, P118, DOI 10.1089/bsp.2013.0027
   Schoch-Spana M, 2010, BIOSECUR BIOTERROR, V8, P243, DOI 10.1089/bsp.2010.0021
   Tinker TL, 2010, CRISIS COMMUNICATION
   Watson C, 2017, HEALTH SECUR, V15, P351, DOI 10.1089/hs.2017.0047
   Watson CR, 2017, AM J PUBLIC HEALTH, V107, pS165, DOI [10.2105/ajph.2017.303963, 10.2105/AJPH.2017.303963]
   Willard R, 2012, J PUBLIC HEALTH MAN, V18, P106, DOI 10.1097/PHH.0b013e3182461cf2
   World Health Organization, 2018, COMM RISK PUBL HLTH
   Ye J, 2015, J PUBLIC HEALTH MAN, V21, P126, DOI 10.1097/PHH.0000000000000074
NR 33
TC 1
Z9 1
U1 7
U2 7
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 0033-3549
EI 1468-2877
J9 PUBLIC HEALTH REP
JI Public Health Rep.
PD MAY
PY 2020
VL 135
IS 3
BP 343
EP 353
AR 0033354920912215
DI 10.1177/0033354920912215
EA APR 2020
PG 11
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LN3LT
UT WOS:000523524100001
PM 32243762
OA Bronze
DA 2020-07-08
ER

PT J
AU Chang, CY
   Ting, HC
   Liu, CA
   Su, HL
   Chiou, TW
   Lin, SZ
   Harn, HJ
   Ho, TJ
AF Chang, Chia-Yu
   Ting, Hsiao-Chien
   Liu, Ching-Ann
   Su, Hong-Lin
   Chiou, Tzyy-Wen
   Lin, Shinn-Zong
   Harn, Horng-Jyh
   Ho, Tsung-Jung
TI Review Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative
   Disease Models for Phenotype Recapitulation and Drug Screening
SO MOLECULES
LA English
DT Review
DE iPSC; neurodegenerative diseases; drug screening
ID SPINAL MUSCULAR-ATROPHY; FAMILIAL ALZHEIMERS-DISEASE; DIFFERENTIATION
   IN-VITRO; HUMAN BRAIN-DEVELOPMENT; DIRECTED DIFFERENTIATION; CEREBRAL
   ORGANOIDS; MOTOR-NEURONS; EFFICIENT GENERATION; DOPAMINE NEURONS; HUMAN
   OLIGODENDROCYTES
AB Neurodegenerative diseases represent a significant unmet medical need in our aging society. There are no effective treatments for most of these diseases, and we know comparatively little regarding pathogenic mechanisms. Among the challenges faced by those involved in developing therapeutic drugs for neurodegenerative diseases, the syndromes are often complex, and small animal models do not fully recapitulate the unique features of the human nervous system. Human induced pluripotent stem cells (iPSCs) are a novel technology that ideally would permit us to generate neuronal cells from individual patients, thereby eliminating the problem of species-specificity inherent when using animal models. Specific phenotypes of iPSC-derived cells may permit researchers to identify sub-types and to distinguish among unique clusters and groups. Recently, iPSCs were used for drug screening and testing for neurologic disorders including Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), spinocerebellar atrophy (SCA), and Zika virus infection. However, there remain many challenges still ahead, including how one might effectively recapitulate sporadic disease phenotypes and the selection of ideal phenotypes and for large-scale drug screening. Fortunately, quite a few novel strategies have been developed that might be combined with an iPSC-based model to solve these challenges, including organoid technology, single-cell RNA sequencing, genome editing, and deep learning artificial intelligence. Here, we will review current applications and potential future directions for iPSC-based neurodegenerative disease models for critical drug screening.
C1 [Chang, Chia-Yu; Ting, Hsiao-Chien; Liu, Ching-Ann; Su, Hong-Lin; Chiou, Tzyy-Wen; Lin, Shinn-Zong; Harn, Horng-Jyh] Buddhist Tzu Chi Med Fdn, Bioinnovat Ctr, Hualien 970, Taiwan.
   [Chang, Chia-Yu; Liu, Ching-Ann] Hualien Tzu Chi Hosp, Dept Med Res, Hualien 970, Taiwan.
   [Chang, Chia-Yu; Liu, Ching-Ann] Hualien Tzu Chi Hosp, Neurosci Ctr, Hualien 970, Taiwan.
   [Su, Hong-Lin] Natl Chung Hsing Univ, Dept Life Sci, Taichung 402, Taiwan.
   [Chiou, Tzyy-Wen] Natl Dong Hwa Univ, Dept Life Sci, Hualien 974, Taiwan.
   [Lin, Shinn-Zong] Hualien Tzu Chi Hosp, Dept Neurosurg, Hualien 970, Taiwan.
   [Harn, Horng-Jyh] Hualien Tzu Chi Hosp, Dept Pathol, Hualien 970, Taiwan.
   [Harn, Horng-Jyh] Tzu Chi Univ, Hualien 970, Taiwan.
   [Ho, Tsung-Jung] Hualien Tzu Chi Hosp, Dept Chinese Med, Hualien 970, Taiwan.
   [Ho, Tsung-Jung] Hualien Tzu Chi Hosp, Integrat Ctr Tradit Chinese & Modern Med, Hualien 970, Taiwan.
   [Ho, Tsung-Jung] Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien 970, Taiwan.
RP Harn, HJ (corresponding author), Buddhist Tzu Chi Med Fdn, Bioinnovat Ctr, Hualien 970, Taiwan.; Harn, HJ (corresponding author), Hualien Tzu Chi Hosp, Dept Pathol, Hualien 970, Taiwan.; Harn, HJ (corresponding author), Tzu Chi Univ, Hualien 970, Taiwan.; Ho, TJ (corresponding author), Hualien Tzu Chi Hosp, Dept Chinese Med, Hualien 970, Taiwan.; Ho, TJ (corresponding author), Hualien Tzu Chi Hosp, Integrat Ctr Tradit Chinese & Modern Med, Hualien 970, Taiwan.; Ho, TJ (corresponding author), Tzu Chi Univ, Sch Postbaccalaureate Chinese Med, Hualien 970, Taiwan.
EM scata0726@hotmail.com; sharkzoe@yahoo.com.tw; sagianne@gmail.com;
   suhonglin@gmail.com; twchiou@gms.ndhu.edu.tw; shinnzong@yahoo.com.tw;
   arthewduke@gmail.com; jeron888@gmail.com
FU Bioinnovation Center; Ministry of Science and Technology, TaiwanMinistry
   of Science and Technology, Taiwan [MOST 106-2320-B-303-001-MY3, MOST
   106-2320-B-303-002-MY3, MOST 107-2314-B-303-003-MY3, MOST
   108-2314-B-303-009-]; Buddhist Tzu Chi Medical Foundation; Hualien Tzu
   Chi Hospital, Hualien, Taiwan [TCRD108-64]
FX This work was supported by The Bioinnovation Center and financially
   supported by the Ministry of Science and Technology, Taiwan (MOST
   106-2320-B-303-001-MY3, MOST 106-2320-B-303-002-MY3, MOST
   107-2314-B-303-003-MY3 and MOST 108-2314-B-303-009-), Buddhist Tzu Chi
   Medical Foundation and Hualien Tzu Chi Hospital (TCRD108-64), Hualien,
   Taiwan.
CR Alves CJ, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fncel.2015.00332, 10.3389/fncel.2015.00289]
   An MC, 2012, CELL STEM CELL, V11, P253, DOI 10.1016/j.stem.2012.04.026
   Barber K, 2019, NAT PROTOC, V14, P1261, DOI 10.1038/s41596-019-0141-y
   Beers J, 2012, NAT PROTOC, V7, P2029, DOI 10.1038/nprot.2012.130
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Boldog E, 2018, NAT NEUROSCI, V21, P1185, DOI 10.1038/s41593-018-0205-2
   Borghese L, 2010, STEM CELLS, V28, P955, DOI 10.1002/stem.408
   Brafman D, 2017, DEV NEUROBIOL, V77, P1239, DOI 10.1002/dneu.22517
   Burkhardt MF, 2013, MOL CELL NEUROSCI, V56, P355, DOI 10.1016/j.mcn.2013.07.007
   Cai S, 2017, STEM CELL TRANSL MED, V6, P369, DOI 10.5966/sctm.2015-0424
   Cakir B, 2019, NAT METHODS, V16, P1169, DOI 10.1038/s41592-019-0586-5
   Canals I, 2018, NAT METHODS, V15, P693, DOI 10.1038/s41592-018-0103-2
   Cao B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4951
   Cederquist GY, 2019, NAT BIOTECHNOL, V37, P436, DOI 10.1038/s41587-019-0085-3
   Chambers SM, 2012, NAT BIOTECHNOL, V30, P715, DOI 10.1038/nbt.2249
   Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529
   Chang C.Y, 2018, CELL TRANSPLANT
   Chang CY, 2018, CELL TRANSPLANT, V27, P379, DOI 10.1177/0963689718754560
   Chang CY, 2015, SCI REP-UK, V5, DOI 10.1038/srep08744
   Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/NMETH.1593, 10.1038/nmeth.1593]
   Chen H, 2014, CELL STEM CELL, V14, P796, DOI 10.1016/j.stem.2014.02.004
   Clark AJ, 2017, BRAIN, V140, P898, DOI 10.1093/brain/awx012
   Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985
   Deverman BE, 2009, NEURON, V64, P61, DOI 10.1016/j.neuron.2009.09.002
   Devine MJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1453
   di Domenico A, 2019, STEM CELL REP, V12, P213, DOI 10.1016/j.stemcr.2018.12.011
   Douvaras P, 2014, STEM CELL REP, V3, P250, DOI 10.1016/j.stemcr.2014.06.012
   Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626
   Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677
   Egawa N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004052
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Fattahi F, 2016, NATURE, V531, P105, DOI 10.1038/nature16951
   Ferraiuolo L, 2016, P NATL ACAD SCI USA, V113, pE6496, DOI 10.1073/pnas.1607496113
   Fujimori K, 2018, NAT MED, V24, P1579, DOI 10.1038/s41591-018-0140-5
   Fuller HR, 2016, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00506
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giandomenico SL, 2019, NAT NEUROSCI, V22, P669, DOI 10.1038/s41593-019-0350-2
   Goldman SA, 2015, DEVELOPMENT, V142, P3983, DOI 10.1242/dev.126409
   Gorris R, 2015, GLIA, V63, P2152, DOI 10.1002/glia.22882
   Guo WT, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00911-y
   Haenseler W, 2019, STEM CELLS, V37, P724, DOI 10.1002/stem.2995
   HD iPSC Consortium, 2012, CELL STEM CELL, V11, P264, DOI 10.1016/j.stem.2012.04.027
   Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107
   Hu BY, 2009, DEVELOPMENT, V136, P1443, DOI 10.1242/dev.029447
   Huang X, 2004, DEV BIOL, V275, P1, DOI 10.1016/j.ydbio.2004.07.033
   Ichiyanagi N, 2016, STEM CELL REP, V6, P496, DOI 10.1016/j.stemcr.2016.02.011
   Imamura K, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf3962
   Ingber DE, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.156125
   Ishida Y, 2016, CELL REP, V17, P1482, DOI 10.1016/j.celrep.2016.10.026
   Israel MA, 2012, NATURE, V482, P216, DOI 10.1038/nature10821
   Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008
   Jeon I, 2012, STEM CELLS, V30, P2054, DOI 10.1002/stem.1135
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Kim HS, 2017, STEM CELL REP, V8, P1714, DOI 10.1016/j.stemcr.2017.04.011
   Kim TG, 2014, STEM CELLS, V32, P1789, DOI 10.1002/stem.1704
   Kirkeby A, 2012, CELL REPORTS, V1, P703, DOI 10.1016/j.celrep.2012.04.009
   Kiskinis E, 2014, CELL STEM CELL, V14, P781, DOI 10.1016/j.stem.2014.03.004
   Ko HJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8101751
   Koch P, 2011, NATURE, V480, P543, DOI 10.1038/nature10671
   Kondo T, 2017, CELL REP, V21, P2304, DOI 10.1016/j.celrep.2017.10.109
   Kondo T, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0337-0
   Kondo T, 2013, CELL STEM CELL, V12, P487, DOI 10.1016/j.stem.2013.01.009
   Krencik R, 2011, NAT PROTOC, V6, P1710, DOI 10.1038/nprot.2011.405
   Krencik R, 2011, NAT BIOTECHNOL, V29, P528, DOI 10.1038/nbt.1877
   Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648
   Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Le Dreau G, 2012, DEV NEUROBIOL, V72, P1471, DOI 10.1002/dneu.22015
   Lekven AC, 2003, DEV BIOL, V254, P172, DOI 10.1016/S0012-1606(02)00044-1
   Li L, 2018, CELL STEM CELL, V23, P239, DOI 10.1016/j.stem.2018.07.009
   Li X, 2018, STEM CELL REP, V11, P998, DOI 10.1016/j.stemcr.2018.08.019
   Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620
   Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624
   Lin CY, 2019, ELIFE, V8, DOI 10.7554/eLife.49175
   Lin X, 2017, ONCOTARGET, V8, P42030, DOI 10.18632/oncotarget.14925
   Liu Y, 2013, NAT PROTOC, V8, P1670, DOI 10.1038/nprot.2013.106
   Liu Y, 2013, NAT BIOTECHNOL, V31, P440, DOI 10.1038/nbt.2565
   Lu JF, 2016, NAT BIOTECHNOL, V34, P89, DOI 10.1038/nbt.3435
   Mansour AA, 2018, NAT BIOTECHNOL, V36, P432, DOI 10.1038/nbt.4127
   Maroof AM, 2013, CELL STEM CELL, V12, P559, DOI 10.1016/j.stem.2013.04.008
   Maury Y, 2015, NAT BIOTECHNOL, V33, P89, DOI 10.1038/nbt.3049
   McGivern JV, 2013, GLIA, V61, P1418, DOI 10.1002/glia.22522
   Merkle FT, 2015, DEVELOPMENT, V142, P633, DOI 10.1242/dev.117978
   Mertens J, 2018, ANNU REV GENET, V52, P271, DOI 10.1146/annurev-genet-120417-031534
   Miller JD, 2013, CELL STEM CELL, V13, P691, DOI 10.1016/j.stem.2013.11.006
   Mitne-Neto M, 2011, HUM MOL GENET, V20, P3642, DOI 10.1093/hmg/ddr284
   Monzel AS, 2017, STEM CELL REP, V8, P1144, DOI 10.1016/j.stemcr.2017.03.010
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Muguruma K, 2010, NAT NEUROSCI, V13, P1171, DOI 10.1038/nn.2638
   Muratore CR, 2014, HUM MOL GENET, V23, P3523, DOI 10.1093/hmg/ddu064
   Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594
   Nekrasov ED, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0092-5
   Nicholas CR, 2013, CELL STEM CELL, V12, P573, DOI 10.1016/j.stem.2013.04.005
   Nistor GI, 2005, GLIA, V49, P385, DOI 10.1002/glia.20127
   Okawa T, 2013, CELL TRANSPLANT, V22, P1767, DOI 10.3727/096368912X657710
   Oksanen M, 2017, STEM CELL REP, V9, P1885, DOI 10.1016/j.stemcr.2017.10.016
   Osaki T, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5847
   Ou ZH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6701793
   Patel AP, 2014, SCIENCE, V344, P1396, DOI 10.1126/science.1254257
   Penney J, 2020, MOL PSYCHIATR, V25, P148, DOI 10.1038/s41380-019-0468-3
   Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004
   Pradat PF, 2007, ANN NEUROL, V62, P15, DOI 10.1002/ana.21122
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   Sanchez-Danes A, 2012, EMBO MOL MED, V4, P380, DOI 10.1002/emmm.201200215
   Sanders LH, 2014, NEUROBIOL DIS, V62, P381, DOI 10.1016/j.nbd.2013.10.013
   Serio A, 2013, P NATL ACAD SCI USA, V110, P4697, DOI 10.1073/pnas.1300398110
   Shakhova O, 2008, STEMBOOK
   Shaltouki A, 2013, STEM CELLS, V31, P941, DOI 10.1002/stem.1334
   Shi YC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003771
   Sproul AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084547
   Steinbeck JA, 2016, CELL STEM CELL, V18, P134, DOI 10.1016/j.stem.2015.10.002
   Sunmonu NA, 2011, DEVELOPMENT, V138, P725, DOI 10.1242/dev.055665
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024
   Tao YL, 2016, CELL STEM CELL, V19, P573, DOI 10.1016/j.stem.2016.10.015
   Tchieu J, 2019, NAT BIOTECHNOL, V37, P267, DOI 10.1038/s41587-019-0035-0
   Tchieu J, 2017, CELL STEM CELL, V21, P399, DOI 10.1016/j.stem.2017.08.015
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   Tyzack GE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01283-z
   Ulloa F, 2010, DEV DYNAM, V239, P69, DOI 10.1002/dvdy.22058
   Vatine GD, 2019, CELL STEM CELL, V24, P995, DOI 10.1016/j.stem.2019.05.011
   Wada T, 2012, STEM CELL TRANSL MED, V1, P396, DOI 10.5966/sctm.2011-0061
   Wang S, 2013, CELL STEM CELL, V12, P252, DOI 10.1016/j.stem.2012.12.002
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weick JP, 2013, P NATL ACAD SCI USA, V110, P9962, DOI 10.1073/pnas.1216575110
   Xi JJ, 2012, STEM CELLS, V30, P1655, DOI 10.1002/stem.1152
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Yagi T, 2011, HUM MOL GENET, V20, P4530, DOI 10.1093/hmg/ddr394
   Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365
   Yoshida M, 2015, STEM CELL REP, V4, P561, DOI 10.1016/j.stemcr.2015.02.010
   Zeltner N, 2016, NAT MED, V22, P1421, DOI 10.1038/nm.4220
   Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Ziegler L, 2011, STEM CELL REV REP, V7, P394, DOI 10.1007/s12015-010-9198-2
NR 138
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD APR 2
PY 2020
VL 25
IS 8
AR 2000
DI 10.3390/molecules25082000
PG 21
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LP9DX
UT WOS:000534617300137
PM 32344649
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hengphasatporn, K
   Plaimas, K
   Suratanee, A
   Wongsriphisant, P
   Yang, JM
   Shigeta, Y
   Chavasiri, W
   Boonyasuppayakorn, S
   Rungrotmongkol, T
AF Hengphasatporn, Kowit
   Plaimas, Kitiporn
   Suratanee, Apichat
   Wongsriphisant, Peemapat
   Yang, Jinn-Moon
   Shigeta, Yasuteru
   Chavasiri, Warinthorn
   Boonyasuppayakorn, Siwaporn
   Rungrotmongkol, Thanyada
TI Target Identification Using Homopharma and Network-Based Methods for
   Predicting Compounds Against Dengue Virus-Infected Cells
SO MOLECULES
LA English
DT Article
DE dengue; homopharma; network-based analysis; phenolic lipid; target
   identification; bioinformatic; virus-host interactions
ID GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE GAPDH; ZIKA VIRUS;
   EPIGALLOCATECHIN GALLATE; PROTEIN; ANTIBODY; BINDING; PERSPECTIVE;
   MOLECULES; STRATEGY; BIOLOGY
AB Drug target prediction is an important method for drug discovery and design, can disclose the potential inhibitory effect of active compounds, and is particularly relevant to many diseases that have the potential to kill, such as dengue, but lack any healing agent. An antiviral drug is urgently required for dengue treatment. Some potential antiviral agents are still in the process of drug discovery, but the development of more effective active molecules is in critical demand. Herein, we aimed to provide an efficient technique for target prediction using homopharma and network-based methods, which is reliable and expeditious to hunt for the possible human targets of three phenolic lipids (anarcardic acid, cardol, and cardanol) related to dengue viral (DENV) infection as a case study. Using several databases, the similarity search and network-based analyses were applied on the three phenolic lipids resulting in the identification of seven possible targets as follows. Based on protein annotation, three phenolic lipids may interrupt or disturb the human proteins, namely KAT5, GAPDH, ACTB, and HSP90AA1, whose biological functions have been previously reported to be involved with viruses in the family Flaviviridae. In addition, these phenolic lipids might inhibit the mechanism of the viral proteins: NS3, NS5, and E proteins. The DENV and human proteins obtained from this study could be potential targets for further molecular optimization on compounds with a phenolic lipid core structure in anti-dengue drug discovery. As such, this pipeline could be a valuable tool to identify possible targets of active compounds.
C1 [Hengphasatporn, Kowit; Shigeta, Yasuteru] Univ Tsukuba, Ctr Computat Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.
   [Plaimas, Kitiporn; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Grad Sch, Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.
   [Plaimas, Kitiporn; Wongsriphisant, Peemapat] Chulalongkorn Univ, Dept Math & Comp Sci, Adv Virtual & Intelligent Comp AVIC Ctr, Fac Sci, Bangkok 10330, Thailand.
   [Suratanee, Apichat] King Mongkuts Univ Technol North Bangkok, Fac Sci Appl, Dept Math, Bangkok 10800, Thailand.
   [Yang, Jinn-Moon] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu 300, Taiwan.
   [Yang, Jinn-Moon] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Coll Biol Sci & Technol, Hsinchu 300, Taiwan.
   [Yang, Jinn-Moon] Natl Chiao Tung Univ, Ctr Intelligent Drug Syst & Smart Biodevices, Hsinchu 300, Taiwan.
   [Chavasiri, Warinthorn] Chulalongkorn Univ, Dept Chem, Fac Sci, Bangkok 10330, Thailand.
   [Boonyasuppayakorn, Siwaporn] Chulalongkorn Univ, Dept Microbiol, Appl Med Virol Res Unit, Fac Med, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Fac Sci, Bangkok 10330, Thailand.
RP Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Grad Sch, Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.; Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Fac Sci, Bangkok 10330, Thailand.
EM kowith@ccs.tsukuba.ac.jp; kitiporn.p@chula.ac.th;
   apichat.s@sci.kmutnb.ac.th; Peemapat.W@gmail.com;
   moon@faculty.nctu.edu.tw; shigeta@ccs.tsukuba.ac.jp;
   warinthorn.c@chula.ac.th; siwaporn.b@chula.ac.th; Thanyada.r@chula.ac.th
RI ; Shigeta, Yasuteru/D-4714-2015
OI Plaimas, Kitiporn/0000-0002-0416-8316; Suratanee,
   Apichat/0000-0002-3439-6619; Shigeta, Yasuteru/0000-0002-3219-6007
FU Chulalongkorn UniversityChulalongkorn University [GB-CU-61-15-30-05];
   NCTU Taiwan Elite Internship Program
FX This Research is funded by Chulalongkorn University GB-CU-61-15-30-05.
   Through travel grants for a short research visit, this research was also
   supported by the NCTU Taiwan Elite Internship Program (for K.H.).
CR Anastasiu D. C., 2017, INT J DATA SCI ANAL, V4, P153
   [Anonymous], 2018, LANCET INFECT DIS, V18, P123, DOI [10.1016/S1473-3099(17)30752-1, 10.1016/S1473-3099(18)30023-9]
   Backman TWH, 2011, NUCLEIC ACIDS RES, V39, pW486, DOI 10.1093/nar/gkr320
   Bajusz D, 2015, J CHEMINFORMATICS, V7, DOI 10.1186/s13321-015-0069-3
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Bastian M., 2009, P 3 INT AAAI C WEBL
   Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989
   Bento AP, 2014, NUCLEIC ACIDS RES, V42, pD1083, DOI 10.1093/nar/gkt1031
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Bredel M, 2004, NAT REV GENET, V5, P262, DOI 10.1038/nrg1317
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cabarcas-Montalvo M, 2016, EUR J MED CHEM, V110, P87, DOI 10.1016/j.ejmech.2015.12.030
   Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280
   Cereto-Massague A, 2015, METHODS, V71, P58, DOI 10.1016/j.ymeth.2014.08.005
   Chao LH, 2018, ELIFE, V7, DOI 10.7554/eLife.36461
   Chew MF, 2017, INT J MED SCI, V14, P1342, DOI 10.7150/ijms.21875
   Chiu YY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S8
   Coloma J, 2015, NAT IMMUNOL, V16, P135, DOI 10.1038/ni.3081
   Cregan S, 2016, INT J ONCOL, V48, P1290, DOI 10.3892/ijo.2016.3335
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dey L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005879
   Disease T.V.-B, 2017, DENGUE SITUATION THA
   El Sahili A, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040091
   Feng FL, 2014, INT J CLIN EXP PATHO, V7, P80
   Feng Y, 2017, BIOMED RES INT, V2017, P1
   Fernando S, 2016, MOL BIOTECHNOL, V58, P801, DOI 10.1007/s12033-016-9979-1
   Garcia LL, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0761-1
   Gibbons RV, 2002, BRIT MED J, V324, P1563, DOI 10.1136/bmj.324.7353.1563
   Gilson MK, 2016, NUCLEIC ACIDS RES, V44, pD1045, DOI 10.1093/nar/gkv1072
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead S, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz062
   He W, 2013, INT J CLIN EXP PATHO, V6, P2864
   Hengphasatporn K, 2020, SCI PHARM, V88, DOI 10.3390/scipharm88010002
   Hengphasatporn K, 2019, J MOL LIQ, V274, P140, DOI 10.1016/j.molliq.2018.10.111
   Huang R, 2017, FRONT ENV SCI, V5, P906
   Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x
   Hundt J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117514
   Ismail NA, 2017, INTERDISCIP SCI, V9, P499, DOI 10.1007/s12539-016-0157-8
   Jadav SS, 2015, BIOORG MED CHEM LETT, V25, P1747, DOI 10.1016/j.bmcl.2015.02.059
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Kanyaboon P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35035-w
   Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320
   Keiser MJ, 2007, NAT BIOTECHNOL, V25, P197, DOI 10.1038/nbt1284
   Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506
   Kim S, 2016, EXPERT OPIN DRUG DIS, V11, P843, DOI 10.1080/17460441.2016.1216967
   Kim S, 2016, NUCLEIC ACIDS RES, V44, pD1202, DOI 10.1093/nar/gkv951
   Kolountzakis M.N, 2010, ALGORITHMS MODELS WE
   Kumar Vigneshwari Easwar, 2018, BMC Res Notes, V11, P550, DOI 10.1186/s13104-018-3620-2
   Leelananda SP, 2016, BEILSTEIN J ORG CHEM, V12, P2694, DOI 10.3762/bjoc.12.267
   Li J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48372-1
   Liang L, 2019, J CHEMINFORMATICS, V11, DOI 10.1186/s13321-019-0370-7
   Lim SP, 2019, ANTIVIR RES, V163, P156, DOI 10.1016/j.antiviral.2018.12.016
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lo YC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004153
   Lomenick B, 2009, P NATL ACAD SCI USA, V106, P21984, DOI 10.1073/pnas.0910040106
   Mishra Bibhudutta, 2019, VirusDisease, V30, P477, DOI 10.1007/s13337-019-00561-2
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Normile D, 2014, SCIENCE, V345, P367, DOI 10.1126/science.345.6195.367
   Plaimas K, 2016, IDENTIFYING ANTIMALA
   Plaimas K, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-56
   Raj M, 2017, J GEN VIROL, V98, P977, DOI 10.1099/jgv.0.000754
   Ramsay RR, 2018, CLIN TRANSL MED, V7, DOI 10.1186/s40169-017-0181-2
   Rappaport N, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat018
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rodrigues E, 2019, COLOQUIO-LETRAS, P177
   Rognan D., 2011, DOCKING METHODS VIRT, P153
   Rothman AL, 2003, ADV VIRUS RES, V60, P397, DOI 10.1016/S0065-3527(03)60010-2
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Silva EM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39157-7
   Srisutthisamphan K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22639-5
   Srivarangkul P, 2018, ANTIVIR RES, V151, P27, DOI 10.1016/j.antiviral.2018.01.010
   Talevi A, 2015, FRONT PHARMACOL, V6, P673
   Tambunan USF, 2015, DRUG TARGET INSIGHT, V9, P33, DOI 10.4137/DTI.S31566
   Teerasripreecha D, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-27
   Ul Qamar MT, 2014, BIOINFORMATION, V10, P460, DOI 10.6026/97320630010460
   Wadman M, 2012, NAT BIOTECHNOL, V30, P309, DOI 10.1038/nbt.2176
   Wang YL, 2012, NUCLEIC ACIDS RES, V40, pD400, DOI 10.1093/nar/gkr1132
   Wilder-Smith A, 2019, J TRAVEL MED, V26, P1195
   Wirawan M, 2019, STRUCTURE, V27, P253, DOI 10.1016/j.str.2018.10.009
   Wong KZ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060294
   World Health Organisation, 2002, DENGUE DENGUE HAEMOR
   Yacoub S, 2014, 15 DENGUE MANSONS TR
   Yang SH, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-40
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
   Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000
   Yu Donghyeon, 2013, Genomics & Informatics, V11, P200, DOI 10.5808/GI.2013.11.4.200
   Yu HY, 2007, PLOS COMPUT BIOL, V3, P713, DOI 10.1371/journal.pcbi.0030059
   Zhang CY, 2017, BIOCHEM BIOPH RES CO, V492, P624, DOI 10.1016/j.bbrc.2016.11.098
   Zhang HY, 2005, FEBS LETT, V579, P5260, DOI 10.1016/j.febslet.2005.09.006
   Zhang XW, 2019, MBIO, V10, DOI 10.1128/mBio.02375-19
   Zhang Y, 2019, VIROL SIN, V34, P30, DOI 10.1007/s12250-019-00086-4
NR 95
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD APR 2
PY 2020
VL 25
IS 8
AR 1883
DI 10.3390/molecules25081883
PG 18
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LP9DX
UT WOS:000534617300066
PM 32325755
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Leung, KKY
   Hon, KL
   Yeung, A
   Leung, AKC
   Man, E
AF Leung, Karen K. Y.
   Hon, K. L.
   Yeung, Alice
   Leung, Alexander K. C.
   Man, Elim
TI Congenital infections in Hong Kong: an overview of TORCH
SO HONG KONG MEDICAL JOURNAL
LA English
DT Review
ID HERPES-SIMPLEX-VIRUS; TO-CHILD TRANSMISSION; CYTOMEGALOVIRUS-INFECTION;
   MATERNAL RUBELLA; NEONATAL HERPES; TOXOPLASMOSIS; DIAGNOSIS; SYPHILIS;
   RISK; PREVALENCE
AB Congenital infections refer to a group of perinatal infections that may have similar clinical presentations, including rash and ocular findings. TORCH is the acronym that covers these infections (toxoplasmosis, other [syphilis], rubella, cytomegalovirus, herpes simplex virus). There are, however, other important causes of intrauterine/perinatal infections, including enteroviruses, varicella zoster virus, Zika virus, and parvovirus B19. Intrauterine and perinatal infections are significant causes of fetal and neonatal mortality and important contributors to childhood morbidity. A high index of suspicion for congenital infections and awareness of the prominent features of the most common congenital infections can help to facilitate early diagnosis, tailor appropriate diagnostic evaluation, and if appropriate, initiate early treatments. In the absence of maternal laboratory results diagnostic of intrauterine infections, congenital infections should be suspected in newborns with certain clinical features or combinations of clinical features, including hydrops fetalis, microcephaly, seizures, cataract, hearing loss, congenital heart disease, hepatosplenomegaly, jaundice, or rash. Primary prevention of maternal infections during pregnancy is the cornerstone of prevention of congenital infection. Available resources should focus on the promotion of public health.
C1 [Leung, Karen K. Y.; Hon, K. L.; Man, Elim] Hong Kong Childrens Hosp, Dept Paediat & Adolescent Med, Kowloon Bay, Hong Kong, Peoples R China.
   [Yeung, Alice] Chinese Univ Hong Kong, Fac Med, Shatin, Hong Kong, Peoples R China.
   [Leung, Alexander K. C.] Univ Calgary, Dept Pediat, Calgary, AB, Canada.
   [Leung, Alexander K. C.] Alberta Childrens Prov Gen Hosp, Calgary, AB, Canada.
RP Hon, KL (corresponding author), Hong Kong Childrens Hosp, Dept Paediat & Adolescent Med, Kowloon Bay, Hong Kong, Peoples R China.
EM ehon@hotmail.com
CR Alexander JM, 1999, OBSTET GYNECOL, V93, P5, DOI 10.1016/S0029-7844(98)00338-X
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P301
   BART SW, 1985, REV INFECT DIS, V7, pS95
   Bodeus M, 1999, OBSTET GYNECOL, V93, P658, DOI 10.1016/S0029-7844(98)00538-9
   Boppana SB, 2001, NEW ENGL J MED, V344, P1366, DOI 10.1056/NEJM200105033441804
   Boppana SB, 2013, CLIN INFECT DIS, V57, pS178, DOI 10.1093/cid/cit629
   Brown ZA, 1997, NEW ENGL J MED, V337, P509, DOI 10.1056/NEJM199708213370801
   BRUMBACK RA, 1976, PEDIATRICS, V58, P916
   Cannon MJ, 2009, J CLIN VIROL, V46, pS6, DOI 10.1016/j.jcv.2009.09.002
   Centers for Disease Control and Prevention US Government, 2017, SEX TRANSM DIS SURV
   Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P289
   Centre for Health Protection Department of Health Hong Kong SAR Government, 2019, NUMB NOT INF DIS MON
   Centre for Health Protection Department of Health Hong Kong SAR Government, 2018, SER RAT CYT ANT
   Chik TS, 2019, TOXOPLASMOSIS HIV MA
   Cook AJC, 2000, BRIT MED J, V321, P142, DOI 10.1136/bmj.321.7254.142
   Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633
   Cornu C, 2009, EUROSURVEILLANCE, V14, P21
   Cortina-Borja M, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000351
   Dahle A J, 2000, J Am Acad Audiol, V11, P283
   De Santis Marco, 2012, Infect Dis Obstet Gynecol, V2012, P430585, DOI 10.1155/2012/430585
   Demmler-Harrison GJ, CONGENITAL CYTOMEGAL
   DEVORE NE, 1983, AM J NURS, V83, P1660
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Dontigny L, 2008, J OBSTET GYNAECOL CA, V30, P152, DOI 10.1016/S1701-2163(16)32740-2
   Dunn D, 1999, LANCET, V353, P1829, DOI 10.1016/S0140-6736(98)08220-8
   DUTHIE SJ, 1990, AUST NZ J OBSTET GYN, V30, P29, DOI 10.1111/j.1479-828X.1990.tb03190.x
   FIUMARA N J, 1975, Clinical Obstetrics and Gynecology, V18, P183, DOI 10.1097/00003081-197503000-00016
   Food and Health Bureau Hong Kong SAR Government, 2012, HONG KONG REF FRAM P
   Fuerst HT, 1975, PEDIATRICS, V56, P107
   Garland SM, 2014, BEST PRACT RES CL OB, V28, P1098, DOI 10.1016/j.bpobgyn.2014.07.015
   Gay-Andrieu F, 2003, PRENATAL DIAG, V23, P558, DOI 10.1002/pd.632
   Halonen Sandra K, 2013, Handb Clin Neurol, V114, P125, DOI 10.1016/B978-0-444-53490-3.00008-X
   Herremans T, 2010, EUR J CLIN MICROBIOL, V29, P495, DOI 10.1007/s10096-010-0900-8
   Ho FW, 2017, COMMUN DIS WATCH, V14, P66
   Hon KL, 2012, HONG KONG MED J, V18, P60
   James SH, 2014, J PEDIATR INFECT DIS, V3, pS19, DOI 10.1093/jpids/piu050
   Jenson HB., 1999, SEMIN PEDIAT INFECT, V10, P183
   Jones JL, 2010, ZOONOSES PUBLIC HLTH, V57, P27, DOI 10.1111/j.1863-2378.2009.01277.x
   KANGRO HO, 1994, J MED VIROL, V43, P91, DOI 10.1002/jmv.1890430117
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kimberlin DW, 2007, SEMIN PERINATOL, V31, P19, DOI 10.1053/j.semperi.2007.01.003
   Kimberlin DW, 2018, RED BOOK REPORT COMM, P310
   KO RC, 1980, T ROY SOC TROP MED H, V74, P351, DOI 10.1016/0035-9203(80)90098-X
   Lago EG, 2013, SEX TRANSM DIS, V40, P85, DOI 10.1097/OLQ.0b013e31827bd688
   Lao TT, 2010, VACCINE, V28, P2227, DOI 10.1016/j.vaccine.2009.12.052
   Lazzarotto T, 2011, CLIN MICROBIOL INFEC, V17, P1285, DOI 10.1111/j.1469-0691.2011.03564.x
   Lee NL, 2019, MAJOR OPPORTUNISTIC
   LELAND D, 1983, PEDIATRICS, V72, P41
   Leung A K, 1989, Asia Oceania J Obstet Gynaecol, V15, P77
   Leung AK, 2018, CASE REP PEDIAT, V2018
   Leung AKC, 2003, J NATL MED ASSOC, V95, P213
   Leung AKC, 2019, HONG KONG MED J, V25, P134, DOI 10.12809/hkmj187785
   Leung AKC, 2017, RECENT PATENTS INFLA, V11, P107, DOI 10.2174/1872213X11666171003151717
   Lim W. L., 1994, Journal of the Hong Kong Medical Association, V46, P306
   Mannelli L, 2013, EMERG RADIOL, V20, P337, DOI 10.1007/s10140-013-1112-1
   McAuley JB, 2014, J PEDIAT INF DIS SOC, V3, pS30, DOI 10.1093/jpids/piu077
   MILLER E, 1982, LANCET, V2, P781
   Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X
   NAHMIAS AJ, 1971, PEDIATR RES, V5, P405, DOI 10.1203/00006450-197108000-00144
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Nigro G, 2009, J MATERN-FETAL NEO M, V22, P169, DOI 10.1080/14767050802609767
   Paquet C, 2013, J OBSTET GYNAECOL CA, V35, P78, DOI 10.1016/S1701-2163(15)31053-7
   Pass RF, 2006, J CLIN VIROL, V35, P216, DOI 10.1016/j.jcv.2005.09.015
   Pomares C, 2016, J CLIN MICROBIOL, V54, P2448, DOI 10.1128/JCM.00487-16
   Public Health Agency of Canada. Government of Canada, 2019, SECT 5 10 CAN GUID S
   Reef SE, 2000, CLIN INFECT DIS, V31, P85, DOI 10.1086/313928
   Sagel U, 2013, J BACTERIOL PARASITO, pS5
   Schwartz DA, 2017, ARCH PATHOL LAB MED, V141, P18, DOI [10.5858/arpa.2016-04, 10.5858/arpa.2016-0429-ED]
   Serranti D, 2011, EUR REV MED PHARMACO, V15, P193
   SEVER JL, 1988, PEDIATRICS, V82, P181
   Sheffield JS, 2002, AM J OBSTET GYNECOL, V186, P569, DOI 10.1067/mob.2002.121541
   Special Preventive Programme Centre for Health Protection Department of Health Hong Kong SAR Government, 2017, HONG KONG STD AIDS U, V23
   Stegmann Barbara J, 2002, Curr Womens Health Rep, V2, P253
   Tamma Pranita, 2007, Pediatr Rev, V28, P470, DOI 10.1542/pir.28-12-470
   Torgerson PR, 2013, B WORLD HEALTH ORGAN, V91, P501, DOI 10.2471/BLT.12.111732
   Wang CB, 2011, CLIN INFECT DIS, V52, pE11, DOI 10.1093/cid/ciq085
   Watson J C, 1998, MMWR Recomm Rep, V47, P1
   WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109
   WILSON CB, 1980, PEDIATRICS, V66, P767
   Wilson CB, 2016, REMINGTON KLEINS INF, P513
   Woods Charles R, 2005, Semin Pediatr Infect Dis, V16, P245
   World Health Organization, 2019, GLOB VAL EL MOTH CHI
   World Health Organization, 2017, GLOB EL CONG SYPH RA
   World Health Organization, 2017, MAN LAB DIAGN MEASL
NR 84
TC 0
Z9 0
U1 1
U2 1
PU HONG KONG ACAD MEDICINE PRESS
PI HONG KONG
PA 9/F/, ROOM 901, 99 WONG CHUK HANG RD, ABERDEEN, HONG KONG, 00000,
   PEOPLES R CHINA
SN 1024-2708
J9 HONG KONG MED J
JI Hong Kong Med. J.
PD APR
PY 2020
VL 26
IS 2
BP 127
EP 138
DI 10.12809/hkmj198287
PG 12
WC Medicine, General & Internal
SC General & Internal Medicine
GA MA3OE
UT WOS:000541825900008
PM 32245914
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Chen, XM
   Li, CX
   Lin, WW
   Li, TT
   Li, XJ
   Bai, XF
   Wulin, SZ
   Zhang, QS
   Li, S
   Liu, M
   Liu, JH
   Zhang, Y
AF Chen, Xueming
   Li, Chenxi
   Lin, Weiwei
   Li, Tongtong
   Li, Xiaojun
   Bai, Xiaofei
   Wulin, Shaozhou
   Zhang, Qingshan
   Li, Shuang
   Liu, Ming
   Liu, Jyung-Hurng
   Zhang, Yun
TI A Novel Neutralizing Antibody Targeting a Unique Cross-Reactive Epitope
   on the hi Loop of Domain II of the Envelope Protein Protects Mice
   against Duck Tembusu Virus
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; CRYSTAL-STRUCTURE; ZIKA VIRUS;
   GLYCOPROTEIN; INFECTION; VACCINE; ENHANCEMENT
AB The Flavivirus E protein induces protective immunity, and its Abs cause serious problems for serodiagnosis because of the difficulty in differentiating cross-reactive Abs. Moreover, cross-reactive Abs may increase disease severity after secondary Flavivirus infections via Ab-dependent enhancement. Cross-reactive epitopes are therefore critical for understanding serodiagnosis and improving the general knowledge of Flavivirus infections. A minimal epitope, 227GSSAGTWQN235, was identified by a neutralizing mAb 1G2 against duck Tembusu virus (DTMUV), which recognized only monomer E protein under nonreducing conditions. It was unexpectedly found that mutations in the epitope residues G231 or W233 completely abolished reactivity to 1G2 and sera from mice infected with Japanese encephalitis virus, West Nile virus, and Zika virus. An immunofluorescence assay confirmed that mAb 1G2 could cross-react with the E proteins from Japanese encephalitis virus, West Nile virus, and Zika virus. Protein and virus modeling revealed that the epitope was surface accessible in the mature virus and located in the hi loop of domain IL The neutralization of DTMUV by 1G2 played a clear therapeutic role in mouse models. The passive transfer of 1G2 resulted in 100% survival, reduced weight loss, and the complete clearance of DTMUV from the blood of BALB/c mice. Our findings document, for the first time to our knowledge, that mAb 1G2 targets the cross-reactive epitope on the hi loop of domain II in the E protein and might be of potential therapeutic value in treating DTMUV infection and improve the understanding of the issues related to serodiagnosis.
C1 [Chen, Xueming; Li, Chenxi; Lin, Weiwei; Li, Tongtong; Li, Xiaojun; Bai, Xiaofei; Wulin, Shaozhou; Zhang, Qingshan; Li, Shuang; Liu, Ming; Zhang, Yun] Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150069, Peoples R China.
   [Liu, Jyung-Hurng] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan.
RP Liu, M; Zhang, Y (corresponding author), Chinese Acad Agr Sci, State Key Lab Vet Biotechnol, Harbin Vet Res Inst, Harbin 150069, Peoples R China.; Liu, JH (corresponding author), Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 40227, Taiwan.
EM liuming04@126.com; yunzhang03@yahoo.com; jhliu@nchu.edu.tw
OI Liu, Jyung-Hurng/0000-0002-7173-0372
FU National Key Research and Development Program [2016YFD0500100]; National
   Natural Science Foundation of ChinaNational Natural Science Foundation
   of China [31670153]; Foundation of Science and Technology of Taiwan
   [MOST 106-2313B-005-029]
FX This work was supported by the National Key Research and Development
   Program (2016YFD0500100), the National Natural Science Foundation of
   China (31670153), and the Foundation of Science and Technology of Taiwan
   (Grant MOST 106-2313B-005-029). Y.Z. supervised and provided funding for
   the study.
CR Bai XF, 2015, ARCH VIROL, V160, P757, DOI 10.1007/s00705-014-2312-z
   Bai XF, 2013, VIRUS GENES, V47, P478, DOI 10.1007/s11262-013-0966-3
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Burland T G, 2000, Methods Mol Biol, V132, P71
   Callens N, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005476
   Cavallo L, 2003, NUCLEIC ACIDS RES, V31, P3364, DOI 10.1093/nar/gkg601
   Chen HL, 2005, NUCLEIC ACIDS RES, V33, P3193, DOI 10.1093/nar/gki633
   Costin JM, 2013, J VIROL, V87, P52, DOI 10.1128/JVI.02273-12
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611
   Dall'Acqua W, 1998, BIOCHEMISTRY-US, V37, P7981, DOI 10.1021/bi980148j
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DELANO WL, 2004, PYMOL MOL GRAPHICS S
   Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024
   Hombach J, 2005, VACCINE, V23, P5205, DOI [10.1016/j.vaccine.2005.07.002, 10.1016/j.vaccine.2004.11.040]
   Kanai R, 2006, J VIROL, V80, P11000, DOI 10.1128/JVI.01735-06
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li CX, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8110306
   Li CX, 2016, SCI REP-UK, V6, DOI 10.1038/srep36288
   Li YF, 2012, VIRUS RES, V163, P546, DOI 10.1016/j.virusres.2011.12.006
   Lindenbach B. D, 2007, FIELDS VIROLOGY, P1101, DOI [10.1016/0038-092X(88)90131-4, DOI 10.1016/0038-092X(88)90131-4]
   Liu M, 2012, J CLIN MICROBIOL, V50, P2807, DOI 10.1128/JCM.00655-12
   Liu ZL, 2013, VIRUS RES, V176, P216, DOI 10.1016/j.virusres.2013.06.010
   Luca VC, 2012, J VIROL, V86, P2337, DOI 10.1128/JVI.06072-11
   MASON RA, 1973, APPL MICROBIOL, V25, P539, DOI 10.1128/AEM.25.4.539-544.1973
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Puttikhunt C, 2009, ARCH VIROL, V154, P1211, DOI 10.1007/s00705-009-0426-5
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Shaozhou WL, 2015, VIRUS GENES, V51, P39, DOI 10.1007/s11262-015-1200-2
   Smith SA, 2013, MBIO, V4, DOI 10.1128/mBio.00873-13
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Su JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018106
   Tang Y, 2013, TRANSBOUND EMERG DIS, V60, P193, DOI 10.1111/tbed.12085
   Wang LF, 2004, CURR DRUG TARGETS, V5, P1, DOI 10.2174/1389450043490668
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Yan DW, 2018, J VIROL, V92, DOI [10.1128/jvi.00427-18, 10.1128/JVI.00427-18]
NR 42
TC 0
Z9 0
U1 0
U2 0
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD APR 1
PY 2020
VL 204
IS 7
BP 1836
EP 1848
DI 10.4049/jimmunol.1901352
PG 13
WC Immunology
SC Immunology
GA KX2SF
UT WOS:000521730100013
PM 32132180
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Schleunes, A
AF Schleunes, Amy
TI Zika, Cancer Warrior?
SO SCIENTIST
LA English
DT Editorial Material
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LABX MEDIA GROUP
PI MIDLAND
PA PO BOX 216, 478 BAY ST, MIDLAND, ONTARIO L4R 1K9, CANADA
SN 0890-3670
EI 1547-0806
J9 SCIENTIST
JI Scientist
PD APR
PY 2020
VL 34
IS 4
BP 47
EP 47
PG 1
WC Information Science & Library Science; Multidisciplinary Sciences
SC Information Science & Library Science; Science & Technology - Other
   Topics
GA LD4CZ
UT WOS:000525980000013
DA 2020-07-08
ER

PT J
AU Campos, D
   Navarro, S
   Llamas-Gonzalez, YY
   Sugasti, M
   Gonzalez-Santamaria, J
AF Campos, Dalkiria
   Navarro, Susana
   Yadira Llamas-Gonzalez, Yessica
   Sugasti, Madelaine
   Gonzalez-Santamaria, Jose
TI Broad Antiviral Activity of Ginkgolic Acid against Chikungunya, Mayaro,
   Una, and Zika Viruses
SO VIRUSES-BASEL
LA English
DT Article
DE alphaviruses; chikungunya; Mayaro; Una; flavivirus; zika; ginkgolic
   acid; replication; inhibition
ID PERFORMANCE LIQUID-CHROMATOGRAPHY; ARBOVIRAL DISEASES; PROTEIN; CANCER;
   CELLS; EMERGENCE; VECTOR
AB The alphaviruses Chikungunya (CHIKV), Mayaro (MAYV), Una (UNAV), and the flavivirus Zika (ZIKV) are emerging or re-emerging arboviruses which are responsible for frequent epidemic outbreaks. Despite the large impact of these arboviruses on health systems, there are no approved vaccines or treatments to fight these infections. As a consequence, there is an urgent need to discover new antiviral drugs. Natural products are a rich source of compounds with distinct biological activities, including antiviral properties. Thus, we aimed to explore the potential antiviral activity of Ginkgolic acid against the arboviruses CHIKV, MAYV, UNAV, and ZIKV. Viral progeny production in supernatants from cells treated or not treated with Ginkgolic acid was quantified by plaque-forming assay. Ginkgolic acid's direct virucidal activity against these arboviruses was also determined. Additionally, viral protein expression was assessed using Western blot and immunofluorescence. Our results reveal that Ginkgolic acid promotes a dose-dependent decrease in viral titers in all tested viruses. Moreover, the compound demonstrated strong virucidal activity. Finally, we found that viral protein expression was affected by treatment with this drug. Collectively, these findings suggest that Ginkgolic acid could have broader antiviral activity.
C1 [Campos, Dalkiria; Navarro, Susana; Yadira Llamas-Gonzalez, Yessica; Sugasti, Madelaine; Gonzalez-Santamaria, Jose] Inst Conmemorativo Gorgas Estudios Salud, Grp Biol Celular & Mol Arbovirus, Panama City 081602593, Panama.
   [Yadira Llamas-Gonzalez, Yessica] Univ Republica, Programa Doctorado Ciencias Biol, Montevideo 11200, Uruguay.
RP Gonzalez-Santamaria, J (corresponding author), Inst Conmemorativo Gorgas Estudios Salud, Grp Biol Celular & Mol Arbovirus, Panama City 081602593, Panama.
EM dcampos@gorgas.gob.pa; nsusana09@gmail.com; qfb.y.llamas@gmail.com;
   madelaine313@gmail.com; jgonzalezsantamaria@gorgas.gob.pa
OI Sugasti Salazar, Madelaine Esmeralda/0000-0003-1370-1407; Gonzalez
   Santamaria, Jose/0000-0003-1244-3477; Llamas,
   Yessica/0000-0003-3404-1313
FU Secretaria Nacional de Ciencia, Tecnologia e Innovacion de Panama
   (SENACYT) [FID017-2016]; Ministerio de Economia y Finanzas
   [0090044.060]; Ministerio de Salud (MINSA) [17-137]; Sistema Nacional de
   Investigacion (SNI from SENACYT)
FX This research was funded by grants from Secretaria Nacional de Ciencia,
   Tecnologia e Innovacion de Panama (SENACYT), grant FID017-2016,
   Ministerio de Economia y Finanzas, grant 0090044.060 and Ministerio de
   Salud (MINSA), Project 17-137. J.G.-S was supported by Sistema Nacional
   de Investigacion (SNI from SENACYT).
CR de Brito CAA, 2017, REV SOC BRAS MED TRO, V50, P585, DOI 10.1590/0037-8682-0479-2016
   Berg K, 2015, TOXICOLOGY, V327, P47, DOI 10.1016/j.tox.2014.10.001
   Bertol JW, 2011, ANTIVIR RES, V92, P73, DOI 10.1016/j.antiviral.2011.06.015
   Bonifay T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207406
   Carrera JP, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005338
   CAUSEY OR, 1963, AM J TROP MED HYG, V12, P777, DOI 10.4269/ajtmh.1963.12.777
   Chen SX, 2008, J ETHNOPHARMACOL, V118, P503, DOI 10.1016/j.jep.2008.05.023
   Conway MJ, 2014, ANNU REV VIROL, V1, P71, DOI 10.1146/annurev-virology-031413-085513
   Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008
   Evans MV, 2018, TRENDS PARASITOL, V34, P544, DOI 10.1016/j.pt.2018.02.010
   Fan WC, 2016, VIRUS RES, V220, P112, DOI 10.1016/j.virusres.2016.04.021
   Fukuda I, 2009, CHEM BIOL, V16, P133, DOI 10.1016/j.chembiol.2009.01.009
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Hua ZB, 2017, BMC BIOTECHNOL, V17, DOI 10.1186/s12896-016-0324-3
   Huang YJS, 2019, CURR OPIN VIROL, V34, P104, DOI 10.1016/j.coviro.2019.01.001
   Kauffman EB, 2017, J INFECT DIS, V216, pS976, DOI 10.1093/infdis/jix405
   Lee JS, 2008, PLANTA MED, V74, P532, DOI 10.1055/s-2008-1074497
   Leung JYS, 2011, ADV VIROL, V2011, DOI 10.1155/2011/249640
   Li J, 2018, PHARMAZIE, V73, P408, DOI 10.1681/ph.2018.8397
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lin LT, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-187
   Liu ZH, 2009, TOXICOL LETT, V187, P131, DOI 10.1016/j.toxlet.2009.02.012
   Llamas-Gonzalez YY, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040370
   Lu JM, 2012, MED SCI MONITOR, V18, pBR293
   Ma JG, 2015, ONCOTARGET, V6, P20993, DOI 10.18632/oncotarget.3663
   Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872
   Martins KA, 2019, AM J TROP MED HYG, V100, P1541, DOI 10.4269/ajtmh.18-0756
   Mazeaud C, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00595
   Mounce BC, 2017, ANTIVIR RES, V142, P148, DOI 10.1016/j.antiviral.2017.03.014
   Olivia Lwande Wesula, 2015, Infection Ecology & Epidemiology, V5, P29853, DOI 10.3402/iee.v5.29853
   Powers AM, 2006, AM J TROP MED HYG, V75, P461, DOI 10.4269/ajtmh.2006.75.461
   Qian YY, 2017, CHEM-BIOL INTERACT, V273, P11, DOI 10.1016/j.cbi.2017.05.020
   Qiao LN, 2017, ONCOL LETT, V14, P5831, DOI 10.3892/ol.2017.6967
   Rupp JC, 2015, J GEN VIROL, V96, P2483, DOI 10.1099/jgv.0.000249
   Schwarz S, 2014, PLANTA MED, V80, P177, DOI 10.1055/s-0033-1360277
   Suhrbier A, 2012, NAT REV RHEUMATOL, V8, P420, DOI 10.1038/nrrheum.2012.64
   Ugwu CE, 2019, BIOMED ENVIRON SCI, V32, P300, DOI 10.3967/bes2019.040
   van Beek TA, 2001, J CHROMATOGR A, V930, P109, DOI 10.1016/S0021-9673(01)01194-3
   Vasconcelos PFC, 2016, VECTOR-BORNE ZOONOT, V16, P295, DOI 10.1089/vbz.2016.1952
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Weber C, 2015, ANTIVIR RES, V113, P1, DOI 10.1016/j.antiviral.2014.11.001
   Xia HJ, 2010, J CHROMATOGR B, V878, P2701, DOI 10.1016/j.jchromb.2010.08.009
   Zhou CC, 2010, CHEMOTHERAPY, V56, P393, DOI 10.1159/000317750
NR 44
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2020
VL 12
IS 4
AR 449
DI 10.3390/v12040449
PG 12
WC Virology
SC Virology
GA LX0IV
UT WOS:000539525300091
PM 32326564
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Liao, XZ
   Xie, H
   Li, SL
   Ye, HY
   Li, S
   Ren, K
   Li, YJ
   Xu, M
   Lin, WY
   Duan, XQ
   Yang, CH
   Chen, LM
AF Liao, Xinzhong
   Xie, He
   Li, Shilin
   Ye, Haiyan
   Li, Shuang
   Ren, Kai
   Li, Yujia
   Xu, Min
   Lin, Wenyu
   Duan, Xiaoqiong
   Yang, Chunhui
   Chen, Limin
TI 2 ', 5 '-Oligoadenylate Synthetase 2 (OAS2) Inhibits Zika Virus
   Replication through Activation of Type I IFN Signaling Pathway
SO VIRUSES-BASEL
LA English
DT Article
DE OAS2; ZIKV replication; IFN beta; Jak/STAT signaling pathway
ID INTERFERON-STIMULATED GENES; RIG-I; RNASE L; EXPRESSION; INFECTION;
   TRANSMISSION; SYSTEM
AB Background: 2', 5'-oligoadenylate synthetase 2 (OAS2) has been known as an antiviral interferon-stimulated gene (ISG). However, the role of OAS2 on Zika virus (ZIKV) replication is still unknown. In this study, we sought to explore the effect of OAS2 on ZIKV replication and its underlying mechanism. Methods: We performed RNA-Seq in A549 cells with or without ZIKV infection. OAS2 or RIG-I was overexpressed by plasmid transfection or knocked down by siRNA in A549 cells. Expression levels of mRNA and protein of selected genes were detected by RT-qPCR and Western Blot, respectively. Interferon stimulated response element (ISRE) activity was examined by dual luciferase assay. Results: We found that ZIKV infection induced OAS2 expression through a RIG-I-dependent pathway. OAS2 overexpression inhibited ZIKV replication, while OAS2 knockdown increased ZIKV replication. We observed that OAS2 inhibited ZIKV replication through enhanced IFN beta expression, leading to the activation of the Jak/STAT signaling pathway. Conclusion: ZIKV infection induced OAS2 expression, which in turn exerted its anti-ZIKV activities through the IFN-activated Jak/STAT signaling pathway.
C1 [Liao, Xinzhong; Xie, He; Li, Shilin; Ye, Haiyan; Li, Shuang; Ren, Kai; Li, Yujia; Xu, Min; Duan, Xiaoqiong; Yang, Chunhui; Chen, Limin] Chinese Acad Med Sci, Inst Blood Transfus, Chengdu 100730, Peoples R China.
   [Liao, Xinzhong; Xie, He; Li, Shilin; Ye, Haiyan; Li, Shuang; Ren, Kai; Li, Yujia; Xu, Min; Duan, Xiaoqiong; Yang, Chunhui; Chen, Limin] Peking Union Med Coll, Chengdu 100730, Peoples R China.
   [Lin, Wenyu; Duan, Xiaoqiong] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Liver Ctr & Gastrointestinal Div, Boston, MA 02114 USA.
RP Duan, XQ; Yang, CH; Chen, LM (corresponding author), Chinese Acad Med Sci, Inst Blood Transfus, Chengdu 100730, Peoples R China.; Duan, XQ; Yang, CH; Chen, LM (corresponding author), Peking Union Med Coll, Chengdu 100730, Peoples R China.; Duan, XQ (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Liver Ctr & Gastrointestinal Div, Boston, MA 02114 USA.
EM liaoxzxy@163.com; ixiehe000@163.com; shilin-li@hotmail.com;
   haiyan_ye0720@163.com; lishuang17600@126.com; kairenshanxi@126.com;
   lily83630@163.com; xumin999@foxmail.com; WLIN1@mgh.harvard.edu;
   xiaoqiongduan@yahoo.com; yangchunhui@ibt.pumc.edu.cn;
   limin_chen_99@yahoo.com
FU CAMS Initiative for Innovative Medicine [CAMS-2016-I2M-3-025]; Ministry
   of Science and Technology of ChinaMinistry of Science and Technology,
   China [2018YFE0107500]; Science and Technology Partnership Program,
   Ministry of Science and Technology of China [KY201904011]; Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [NSFC 81871661]; Sichuan Provincial Science and Technology Department
   Funding [2019YJ0281]
FX This work is supported by the CAMS Initiative for Innovative Medicine
   (grant CAMS-2016-I2M-3-025 to L.C.), Ministry of Science and Technology
   of China (2018YFE0107500 to L.C.), Science and Technology Partnership
   Program, Ministry of Science and Technology of China (KY201904011 to
   L.C.), Natural Science Foundation of China (NSFC 81871661 to W.L) and
   Sichuan Provincial Science and Technology Department Funding (2019YJ0281
   to X.D.).
CR Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen YZ, 2017, VIRUS RES, V227, P231, DOI 10.1016/j.virusres.2016.10.013
   de Veer MJ, 2001, J LEUKOCYTE BIOL, V69, P912
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Domingo-Gil E, 2006, APOPTOSIS, V11, P725, DOI 10.1007/s10495-006-5541-0
   Drappier M, 2015, CURR OPIN VIROL, V15, P19, DOI 10.1016/j.coviro.2015.07.002
   Elbahesh H, 2011, VIROLOGY, V409, P262, DOI 10.1016/j.virol.2010.10.016
   Feng X, 2002, J NEUROIMMUNOL, V129, P205, DOI 10.1016/S0165-5728(02)00182-0
   Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   HADDOW AJ, 1964, B WORLD HEALTH ORGAN, V31, P57
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hong XX, 2013, J BIOL CHEM, V288, P16196, DOI 10.1074/jbc.M112.435461
   Kato H, 2017, J INTERF CYTOK RES, V37, P207, DOI 10.1089/jir.2016.0095
   Kim KI, 2006, J CLIN PHARM THER, V31, P441, DOI 10.1111/j.1365-2710.2006.00761.x
   Kristiansen H, 2010, J VIROL, V84, P11898, DOI 10.1128/JVI.01003-10
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kwon YC, 2013, FEBS LETT, V587, P156, DOI 10.1016/j.febslet.2012.11.010
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li YZ, 2016, P NATL ACAD SCI USA, V113, P2241, DOI 10.1073/pnas.1519657113
   Lin RJ, 2009, J IMMUNOL, V183, P8035, DOI 10.4049/jimmunol.0902728
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Mashimo T, 2002, P NATL ACAD SCI USA, V99, P11311, DOI 10.1073/pnas.172195399
   Mihm U, 2009, J HEPATOL, V50, P49, DOI 10.1016/j.jhep.2008.08.024
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shi XZ, 2017, J MED VIROL, V89, P2173, DOI 10.1002/jmv.24867
   Shindo M, 2008, HEPATOL RES, V38, P1213, DOI 10.1111/j.1872-034X.2008.00397.x
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Whelan JN, 2019, J VIROL, V93, DOI 10.1128/JVI.00313-19
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xu L, 2017, HEPATOLOGY, V65, P1823, DOI 10.1002/hep.29105
   Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Zhao MM, 2017, MICROB PATHOGENESIS, V111, P14, DOI 10.1016/j.micpath.2017.08.011
   Zheng S, 2016, J MED VIROL, V88, P760, DOI 10.1002/jmv.24397
NR 47
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2020
VL 12
IS 4
AR 418
DI 10.3390/v12040418
PG 16
WC Virology
SC Virology
GA LX0IV
UT WOS:000539525300060
PM 32276512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Olson, MF
   Ndeffo-Mbah, ML
   Juarez, JG
   Garcia-Luna, S
   Martin, E
   Borucki, MK
   Frank, M
   Estrada-Franco, JG
   Rodriguez-Perez, MA
   Fernandez-Santos, NA
   Molina-Gamboa, GD
   Aguirre, SDC
   Reyes-Berrones, BD
   Cortes-De la Cruz, LJ
   Garcia-Barrientos, A
   Huidobro-Guevara, RE
   Brussolo-Ceballos, RM
   Ramirez, J
   Salazar, A
   Chaves, LF
   Badillo-Vargas, IE
   Hamer, GL
AF Olson, Mark F.
   Ndeffo-Mbah, Martial L.
   Juarez, Jose G.
   Garcia-Luna, Selene
   Martin, Estelle
   Borucki, Monica K.
   Frank, Matthias
   Guillermo Estrada-Franco, Jose
   Rodriguez-Perez, Mario A.
   Fernandez-Santos, Nadia A.
   de Jesus Molina-Gamboa, Gloria
   Carmona Aguirre, Santos Daniel
   de Lourdes Reyes-Berrones, Bernardita
   Javier Cortes-De la Cruz, Luis
   Garcia-Barrientos, Alejandro
   Huidobro-Guevara, Raul E.
   Brussolo-Ceballos, Regina M.
   Ramirez, Josue
   Salazar, Aaron
   Chaves, Luis F.
   Badillo-Vargas, Ismael E.
   Hamer, Gabriel L.
TI High Rate of Non-Human Feeding by Aedes aegypti Reduces Zika Virus
   Transmission in South Texas
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; Aedes aegypti; Culex quinquefasciatus; host selection;
   reproductive number
ID CULEX-PIPIENS MOSQUITOS; DIPTERA-CULICIDAE; BLOOD-MEAL; VERTEBRATE
   HOSTS; DENGUE; IDENTIFICATION; EPIDEMIC; ALBOPICTUS; DISEASE; DNA
AB Mosquito-borne viruses are emerging or re-emerging globally, afflicting millions of people around the world. Aedes aegypti, the yellow fever mosquito, is the principal vector of dengue, Zika, and chikungunya viruses, and has well-established populations across tropical and subtropical urban areas of the Americas, including the southern United States. While intense arboviral epidemics have occurred in Mexico and further south in the Americas, local transmission in the United States has been minimal. Here, we study Ae. aegypti and Culex quinquefasciatus host feeding patterns and vertebrate host communities in residential environments of South Texas to identify host-utilization relative to availability. Only 31% of Ae. aegypti blood meals were derived from humans, while 50% were from dogs and 19% from other wild and domestic animals. In Cx. quinquefasciatus, 67% of blood meals were derived from chicken, 22% came from dogs, 9% from various wild avian species, and 2% from other mammals including one human, one cat, and one pig. We developed a model for the reproductive number, R-0, for Zika virus (ZIKV) in South Texas relative to northern Mexico using human disease data from Tamaulipas, Mexico. We show that ZIKV R-0 in South Texas communities could be greater than one if the risk of human exposure to Ae. aegypti bites in these communities is at least 60% that of Northern Mexico communities. The high utilization of non-human vertebrates and low risk of human exposure in South Texas diminishes the outbreak potential for human-amplified urban arboviruses transmitted by Ae. aegypti.
C1 [Olson, Mark F.; Juarez, Jose G.; Garcia-Luna, Selene; Martin, Estelle; Badillo-Vargas, Ismael E.; Hamer, Gabriel L.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
   [Ndeffo-Mbah, Martial L.] Texas A&M Univ, Coll Vet Med, Vet Integrat Biosci, College Stn, TX 77843 USA.
   [Borucki, Monica K.; Frank, Matthias] Lawrence Livermore Natl Lab, Biosci & Biotechnol Div, Chem Mat & Life Sci Directorate, Livermore, CA 94550 USA.
   [Guillermo Estrada-Franco, Jose; Rodriguez-Perez, Mario A.; Fernandez-Santos, Nadia A.] Inst Politecn Nacl, Ctr Biotecnol Genom, Cd Reynosa 88710, Tamaulipas, Mexico.
   [de Jesus Molina-Gamboa, Gloria; Carmona Aguirre, Santos Daniel; de Lourdes Reyes-Berrones, Bernardita; Javier Cortes-De la Cruz, Luis; Garcia-Barrientos, Alejandro; Huidobro-Guevara, Raul E.; Brussolo-Ceballos, Regina M.] Secretary Hlth State Tamaulipas, Epidemiol Directorate, Cd Victoria 87000, Tamaulipas, Mexico.
   [Ramirez, Josue] City Of Harlingen, Dept Hlth, Harlingen, TX 78550 USA.
   [Salazar, Aaron] Hidalgo Cty Hlth & Human Serv, Edinburg, TX 78539 USA.
   [Chaves, Luis F.] Inst Costarricense Invest & Ensenanza Nutr & Salu, Apartado Postal, Tres Rios 42250, Cartago, Costa Rica.
RP Hamer, GL (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.
EM markus9@tamu.edu; mndeffo@cvm.tamu.edu; jua05396@tamu.edu;
   selene.marysol@gmail.com; estellemartin@ufl.edu; borucki2@llnl.gov;
   frank1@llnl.gov; joseestradaf@hotmail.com; drmarodriguez@hotmail.com;
   nadiafriend@hotmail.com; gloria.molina@tam.gob.mx;
   santos.carmona@tam.gob.mx; lespt@hotmail.com; blanca_luis5@hotmail.com;
   alejandro.garcia@tam.gob.mx; Raul.huidobro@tam.gob.mx;
   rmbrussolo@gmail.com; jramirez@myharlingen.us; aaron.salazar@hchd.org;
   lfchavs@gmail.com; ibadill1@southtexascollege.edu; ghamer@tamu.edu
OI Olson, Mark/0000-0001-5288-1223; Juarez Valdez,
   Jose/0000-0002-0583-478X; Garcia-Luna, Selene M./0000-0001-8420-5078
FU U.S. Department of EnergyUnited States Department of Energy (DOE)
   [DE-AC52-07NA27344]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI128953,
   K01AI128005]; Texas A&M AgriLife Insect Vector Seed Grant;
   CONACyT-MEXBOL [295569]; IPN [SIP 20181120, 20195706]; Centers for
   Disease Control and PreventionUnited States Department of Health & Human
   ServicesCenters for Disease Control & Prevention - USA [U01CK000512,
   200-2017-93141]
FX This work was performed, in part, under the auspices of the U.S.
   Department of Energy by Lawrence Livermore National Laboratory under
   Contract DE-AC52-07NA27344 to G.L.H., M.F., M.K.B. Additional support
   came from NIH R21AI128953 (G.L.H. and I.E.B.-V.), K01AI128005 (G.L.H.),
   Texas A&M AgriLife Insect Vector Seed Grant (G.L.H. and I.E.B.-V.),
   CONACyT-MEXBOL (No. 295569), IPN (SIP 20181120 and 20195706) to
   M.A.R.-P. This publication was supported by Cooperative Agreement Number
   U01CK000512 (G.L.H. and I.E.B.-V.) and contract 200-2017-93141 (G.L.H.
   and I.E.B.-V.), funded by the Centers for Disease Control and
   Prevention. Its contents are solely the responsibility of the authors
   and do not necessarily represent the o fficial views of the Centers for
   Disease Control and Prevention or the Department of Health and Human
   Services.
CR Adanns LE, 2019, AM J TROP MED HYG, V101, P884, DOI 10.4269/ajtmh.19-0309
   Baak-Baak CM, 2018, J VECTOR DIS, V55, P58, DOI 10.4103/0972-9062.234628
   Barrera R, 2012, J MED ENTOMOL, V49, P917, DOI 10.1603/ME12046
   Brady OJ, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002755
   Brown LD, 2001, STAT SCI, V16, P101, DOI 10.1214/ss/1009213286
   Centers for Disease Control and Prevention, 2007, MMWR MORBIDITY MORTA
   Chaves LF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-3
   Chepkorir E, 2018, ACTA TROP, V186, P50, DOI 10.1016/j.actatropica.2018.07.008
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   Davis GE, 1931, AM J HYG, V14, P130, DOI 10.1093/oxfordjournals.aje.a117751
   de Thoisy B, 2009, VECTOR-BORNE ZOONOT, V9, P157, DOI 10.1089/vbz.2007.0280
   Espinal MA, 2019, AM J PUBLIC HEALTH, V109, P387, DOI 10.2105/AJPH.2018.304849
   Fantini B., 1994, Parassitologia (Rome), V36, P83
   Farajollahi A, 2011, INFECT GENET EVOL, V11, P1577, DOI 10.1016/j.meegid.2011.08.013
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Feria-Arroyo T.P., 2020, SUBTROP AGR ENV, V71, P12
   Fitzpatrick DM, 2019, J MED ENTOMOL, V56, P1170, DOI 10.1093/jme/tjz037
   Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294
   Fox M., 2007, MOSQUITO CONTROL TRA, P86
   Fritz ML, 2015, MED VET ENTOMOL, V29, P115, DOI 10.1111/mve.12096
   Garcia-Rejon JE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.3201
   Garrett-Jones C., 1964, Bulletin of the World Health Organization, V30, P241
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Graham CB, 2012, J MED ENTOMOL, V49, P1442, DOI 10.1603/ME12071
   Greenstone MH, 2012, MOL ECOL RESOUR, V12, P464, DOI 10.1111/j.1755-0998.2012.03112.x
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hackett LW, 1931, AM J HYG, V13, P57, DOI 10.1093/oxfordjournals.aje.a117124
   Hahn MB, 2016, J MED ENTOMOL, V53, P1169, DOI 10.1093/jme/tjw072
   Hamer GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023767
   Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268
   Hamer SA, 2015, J MED ENTOMOL, V52, P1043, DOI 10.1093/jme/tjv063
   HEISCH R. B., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P41, DOI 10.1016/0035-9203(59)90082-3
   Hernandez-Triana LM, 2017, ZOOTAXA, V4250, P67, DOI 10.11646/zootaxa.4250.1.5
   HESS AD, 1970, AM J TROP MED HYG, V19, P327, DOI 10.4269/ajtmh.1970.19.327
   Hodo CL, 2019, J VET INTERN MED, V33, P158, DOI 10.1111/jvim.15352
   Huang YJS, 2019, CURR OPIN VIROL, V34, P104, DOI 10.1016/j.coviro.2019.01.001
   Hughes GL, 2014, P NATL ACAD SCI USA, V111, P12498, DOI 10.1073/pnas.1408888111
   Iwashita H, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-52
   Jansen CC, 2009, AM J TROP MED HYG, V81, P849, DOI 10.4269/ajtmh.2009.09-0008
   Janssen N, 2015, TROP MED INT HEALTH, V20, P1488, DOI 10.1111/tmi.12587
   Kent RJ, 2010, J AM MOSQUITO CONTR, V26, P332, DOI 10.2987/09-5953.1
   Komar N, 2018, VECTOR-BORNE ZOONOT, V18, P485, DOI 10.1089/vbz.2018.2285
   Koolhof IS, 2017, EPIDEMIOL INFECT, V145, P656, DOI 10.1017/S0950268816002739
   Kotsakiozi P, 2018, ECOL EVOL, V8, P7835, DOI 10.1002/ece3.4278
   KRISHNAMURTHY B. S., 1965, Bulletin of the Indian Society for Malaria & Other Communicable Diseases, V2, P56
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Ledesma NA, 2019, JAVMA-J AM VET MED A, V254, P93, DOI 10.2460/javma.254.1.93
   LUMSDEN W. H. R., 1955, TANGANYIKA TERRITORY IN 1952 53 II TRANS ROY SOC TROP MED AND HYG, V49, P33, DOI 10.1016/0035-9203(55)90081-X
   MACDONALD WW, 1967, B WORLD HEALTH ORGAN, V36, P597
   Macpherson C, 2016, AM J TROP MED HYG, V95, P890, DOI 10.4269/ajtmh.16-0122
   Mahande A, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-100
   Main BJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006303
   Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   McCall JW, 2008, ADV PARASIT, V66, P193, DOI 10.1016/S0065-308X(08)00204-2
   MCCLELLAND GAH, 1963, ANN TROP MED PARASIT, V57, P214, DOI 10.1080/00034983.1963.11686176
   Medeiros MCI, 2015, PARASITOLOGY, V142, P1612, DOI 10.1017/S0031182015001183
   MOLAEI G, 2007, AM J TROP MED HYG, V77, P73
   Ndeffo-Mbah M.L., 2019, J INF DIS
   Padmanabha H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144451
   Paris V, 2018, INSECTS, V9, DOI 10.3390/insects9040140
   PATERSON H. E., 1964, Medical Proceedings, V10, P188
   Pauvolid-Correa A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11121164
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Ramos MM, 2008, AM J TROP MED HYG, V78, P364
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Russell P.F., 1963, PRACTICAL MALARIOLOG
   Schmidt WP, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001082
   Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89
   SCOTT TW, 1993, J MED ENTOMOL, V30, P922, DOI 10.1093/jmedent/30.5.922
   Secretaria de Salud M, 2019, DIR GEN EP
   SELLA Massimo, 1920, International Journal of Public Health, V1, P316
   Serrao ML, 2001, MEM I OSWALDO CRUZ, V96, P593, DOI 10.1590/S0074-02762001000500001
   Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43
   Sivan A, 2015, PARASITOL RES, V114, P3539, DOI 10.1007/s00436-015-4634-5
   Stenn T, 2019, J MED ENTOMOL, V56, P10, DOI 10.1093/jme/tjy148
   TEESDALE C., 1955, Bulletin of Entomological Research, V46, P711, DOI 10.1017/S0007485300039614
   TEMPELIS CH, 1970, AM J TROP MED HYG, V19, P335, DOI 10.4269/ajtmh.1970.19.335
   Thomas DL, 2016, EMERG INFECT DIS, V22, P1002, DOI 10.3201/eid2206.152000
   Tiawsirisup Sonthaya, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P110
   Walker KR, 2018, J MED ENTOMOL, V55, P955, DOI 10.1093/jme/tjy011
   Wilson J. John, 2015, Academic Journal of Entomology, V8, P80
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 88
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2020
VL 12
IS 4
AR 453
DI 10.3390/v12040453
PG 20
WC Virology
SC Virology
GA LX0IV
UT WOS:000539525300095
PM 32316394
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Parry, R
   Naccache, F
   Ndiaye, E
   Fall, G
   Castelli, I
   Luhken, R
   Medlock, J
   Cull, B
   Hesson, JC
   Montarsi, F
   Failloux, AB
   Kohl, A
   Schnettler, E
   Diallo, M
   Asgari, S
   Dietrich, I
   Becker, SC
AF Parry, Rhys
   Naccache, Fanny
   Ndiaye, El Hadji
   Fall, Gamou
   Castelli, Ilaria
   Luehken, Renke
   Medlock, Jolyon
   Cull, Benjamin
   Hesson, Jenny C.
   Montarsi, Fabrizio
   Failloux, Anna-Bella
   Kohl, Alain
   Schnettler, Esther
   Diallo, Mawlouth
   Asgari, Sassan
   Dietrich, Isabelle
   Becker, Stefanie C.
TI Identification and RNAi Profile of a Novel Iflavirus Infecting
   Senegalese Aedes vexans arabiensis Mosquitoes
SO VIRUSES-BASEL
LA English
DT Article
DE Aedes vexans; iflavirus; RNAi; virus discovery
ID PICORNA-LIKE VIRUS; DIPTERA-CULICIDAE; VECTOR COMPETENCE; SPP.
   MOSQUITOS; SEQUENCE; TRANSMISSION; INSECT; POPULATIONS; ALIGNMENT;
   NIPPONII
AB The inland floodwater mosquito Aedes vexans (Meigen, 1830) is a competent vector of numerous arthropod-borne viruses such as Rift Valley fever virus (Phenuiviridae) and Zika virus (Flaviviridae). Aedes vexans spp. have widespread Afrotropical distribution and are common European cosmopolitan mosquitoes. We examined the virome of Ae. vexans arabiensis samples from Barkedji village, Senegal, with small RNA sequencing, bioinformatic analysis, and RT-PCR screening. We identified a novel 9494 nt iflavirus (Picornaviridae) designated here as Aedes vexans iflavirus (AvIFV). Annotation of the AvIFV genome reveals a 2782 amino acid polyprotein with iflavirus protein domain architecture and typical iflavirus 5' internal ribosomal entry site and 3' poly-A tail. Aedes vexans iflavirus is most closely related to a partial virus sequence from Venturia canescens (a parasitoid wasp) with 56.77% pairwise amino acid identity. Analysis of AvIFV-derived small RNAs suggests that AvIFV is targeted by the exogenous RNA interference pathway but not the PIWI-interacting RNA response, as similar to 60% of AvIFV reads corresponded to 21 nt Dicer-2 virus-derived small RNAs and the 24-29 nt AvIFV read population did not exhibit a "ping-pong" signature. The RT-PCR screens of archival and current (circa 2011-2020) Ae. vexans arabiensis laboratory samples and wild-caught mosquitoes from Barkedji suggest that AvIFV is ubiquitous in these mosquitoes. Further, we screened wild-caught European Ae. vexans samples from Germany, the United Kingdom, Italy, and Sweden, all of which tested negative for AvIFV RNA. This report provides insight into the diversity of commensal Aedes viruses and the host RNAi response towards iflaviruses.
C1 [Parry, Rhys; Asgari, Sassan] Univ Queensland, Sch Biol Sci, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia.
   [Naccache, Fanny; Becker, Stefanie C.] Univ Vet Med Hannover, Inst Parasitol, D-30559 Hannover, Germany.
   [Naccache, Fanny; Becker, Stefanie C.] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, D-30559 Hannover, Germany.
   [Ndiaye, El Hadji; Diallo, Mawlouth] Inst Pasteur Dakar, Pole Zool Med, Dakar Bp 220, Senegal.
   [Fall, Gamou] Inst Pasteur Dakar, Pole Virol, Unite Arbovirus & Virus Fievres Hemorrag, Dakar Bp 220, Senegal.
   [Castelli, Ilaria; Failloux, Anna-Bella] Inst Pasteur, Arboviruses & Insect Vectors, Dept Virol, F-75724 Paris, France.
   [Luehken, Renke; Schnettler, Esther] Univ Hamburg, Fac Math Informat & Nat Sci, D-20148 Hamburg, Germany.
   [Luehken, Renke; Schnettler, Esther] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany.
   [Medlock, Jolyon] Publ Hlth England, Hlth Protect Res Unit Emerging & Zoonot Infect, Salisbury SP4 0JG, Wilts, England.
   [Cull, Benjamin; Hesson, Jenny C.] Publ Hlth England, Med Entomol & Zoonoses Ecol, Emergency Response Dept Sci & Technol, Salisbury SP4 0JG, Wilts, England.
   [Hesson, Jenny C.] Uppsala Univ, Dept Med Biochem & Microbiol, Zoonosis Sci Ctr, S-75237 Uppsala, Sweden.
   [Montarsi, Fabrizio] Ist Zooprofilatt Sperimentale Venezie, Parasitol Lab, I-35020 Padua, Italy.
   [Kohl, Alain] MRC Univ Glasgow Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland.
   [Schnettler, Esther] German Ctr Infect Res, Partner Site Hamburg Lubeck Borstel Riems, D-20359 Hamburg, Germany.
   [Dietrich, Isabelle] Pirbright Inst, Pirbright GU24 0NF, England.
   [Cull, Benjamin] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA.
RP Becker, SC (corresponding author), Univ Vet Med Hannover, Inst Parasitol, D-30559 Hannover, Germany.; Becker, SC (corresponding author), Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses, D-30559 Hannover, Germany.; Dietrich, I (corresponding author), Pirbright Inst, Pirbright GU24 0NF, England.
EM r.parry@uq.edu.au; fanny.naccache@tiho-hannover.de;
   elhadji.ndiaye@pasteur.sn; gamou.fall@pasteur.sn;
   castelli.ilaria84@gmail.com; luehken@bnitm.de;
   jolyon.medlock@phe.gov.uk; ben.cull@phe.gov.uk;
   jenny.hesson@imbim.uu.se; fmontarsi@izsvenezie.it;
   anna-bella.failloux@pasteur.fr; alain.kohl@glasgow.ac.uk;
   schnettler@bnitm.de; mawlouth.diallo@pasteur.sn; s.asgari@uq.edu.au;
   isabelle.dietrich@pirbright.ac.uk; stefanie.becker@tiho-hannover.de
OI Luhken, Renke/0000-0002-1984-839X; Cull, Benjamin/0000-0001-6814-5669;
   Parry, Rhys/0000-0001-9238-1952
FU Australian Research CouncilAustralian Research Council [DP190102048]; UK
   Medical Research CouncilMedical Research Council UK (MRC)
   [MC_UU_12014/8]; University of Queensland scholarship; Biotechnology and
   Biological Sciences Research CouncilBiotechnology and Biological
   Sciences Research Council (BBSRC) [BBS/E/I/00007033, BBS/E/I/00007035];
   Swedish Society for Medical Research
FX Sassan Asgari is supported by the Australian Research Council, grant
   number DP190102048. Alain Kohl is supported by the UK Medical Research
   Council (MC_UU_12014/8). Rhys Parry is supported by a University of
   Queensland scholarship. Isabelle Dietrich is supported by the
   Biotechnology and Biological Sciences Research Council (grant numbers
   BBS/E/I/00007033 and BBS/E/I/00007035). Jenny C. Hesson is supported by
   the Swedish Society for Medical Research.
CR Asgari S, 2018, ADV INSECT PHYSIOL, V55, P19, DOI 10.1016/bs.aiip.2018.07.004
   Baidaliuk A, 2019, J VIROL, V93, DOI 10.1128/JVI.00705-19
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Barnard AC, 2012, GENES-BASEL, V3, P702, DOI 10.3390/genes3040702
   Bockova E, 2013, PARASITOL RES, V112, P3465, DOI 10.1007/s00436-013-3526-9
   Bolling BG, 2012, VIROLOGY, V427, P90, DOI 10.1016/j.virol.2012.02.016
   Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650
   Bronkhorst AW, 2014, CURR OPIN VIROL, V7, P19, DOI 10.1016/j.coviro.2014.03.010
   Carballo A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177301
   Chejanovsky N, 2014, VIROLOGY, V454, P176, DOI 10.1016/j.virol.2014.02.012
   Cholleti H, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0981-z
   Cock PJA, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0080-7
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Dietrich I., 2017, PLOS NEGL TROP DIS, V11
   Dietrich I, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00090-17
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Franzke K, 2018, J GEN VIROL, V99, P1739, DOI 10.1099/jgv.0.001173
   Geng P, 2017, VIROLOGY, V502, P171, DOI 10.1016/j.virol.2016.12.014
   Aguiar ERGR, 2015, NUCLEIC ACIDS RES, V43, P6191, DOI 10.1093/nar/gkv587
   Hall-Mendelin S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1683-2
   Hermanns K, 2020, J GEN VIROL, V101, P96, DOI 10.1099/jgv.0.001344
   Hobson-Peters J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056534
   Hoffmann B, 2006, J VIROL METHODS, V136, P200, DOI 10.1016/j.jviromet.2006.05.020
   Isawa H, 1998, ARCH VIROL, V143, P127, DOI 10.1007/s007050050273
   Jakubowska AK, 2016, PEERJ, V4, DOI 10.7717/peerj.1687
   Jakubowska AK, 2014, J INVERTEBR PATHOL, V121, P56, DOI 10.1016/j.jip.2014.06.009
   Johansen CA, 2005, J AM MOSQUITO CONTR, V21, P222, DOI 10.2987/8756-971X(2005)21[222:FROAAV]2.0.CO;2
   Kent RJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000671
   Kobayashi D, 2017, J GEN VIROL, V98, P2876, DOI 10.1099/jgv.0.000929
   Kolekar P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27436
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006
   Lee JS, 2013, VIROLOGY, V435, P220, DOI 10.1016/j.virol.2012.10.020
   Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158
   Luke GA, 2008, J GEN VIROL, V89, P1036, DOI 10.1099/vir.0.83428-0
   Modlmaier M, 2002, INT J MED MICROBIOL, V291, P164, DOI 10.1016/S1438-4221(02)80031-5
   Morazzani EM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002470
   Mordecai GJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34983
   Ndiaye E, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1383-y
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0
   Parry R, 2019, VIROLOGY, V528, P89, DOI 10.1016/j.virol.2018.12.006
   Parry R, 2018, J VIROL, V92, DOI [10.1128/JVI.00224-18, 10.1128/jvi.00224-18]
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Reineke A, 2005, J INSECT PHYSIOL, V51, P127, DOI 10.1016/j.jinsphys.2004.05.005
   Reinert J.F., 1973, CONTRIBUTIONS MOSQUI
   RODL P, 1979, FOLIA PARASIT, V26, P61
   Ruckert C, 2019, INSECT BIOCHEM MOLEC, V109, P13, DOI 10.1016/j.ibmb.2019.04.008
   Ryabov EV, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004230
   Sabin LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055458
   Sanborn MA, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030222
   Shi M, 2017, J VIROL, V91, DOI 10.1128/JVI.00680-17
   Shi M, 2016, J VIROL, V90, P659, DOI 10.1128/JVI.02036-15
   Staley M, 2010, J AM MOSQUITO CONTR, V26, P214, DOI 10.2987/09-5968.1
   TAKASHIMA I, 1983, ARCH VIROL, V76, P299, DOI 10.1007/BF01311197
   Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164
   Talavera S, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2887-4
   Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004
   Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485
   Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2
   Vaidyanathan R, 1997, J MED ENTOMOL, V34, P346, DOI 10.1093/jmedent/34.3.346
   van Cleef KWR, 2014, NUCLEIC ACIDS RES, V42, P8732, DOI 10.1093/nar/gku528
   van Oers MM, 2010, INSECT VIROLOGY, P231
   Varjak M, 2018, J GEN VIROL, V99, P1551, DOI 10.1099/jgv.0.001157
   Virto C, 2014, J INVERTEBR PATHOL, V122, P22, DOI 10.1016/j.jip.2014.07.007
   Weber F, 2006, J VIROL, V80, P5059, DOI 10.1128/JVI.80.10.5059-5064.2006
   WHITE G B, 1975, Mosquito Systematics, V7, P303
   Ye S, 2012, VIROLOGY, V428, P136, DOI 10.1016/j.virol.2012.04.002
   Zakrzewski M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22945-y
   Zhang GH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02347-2
NR 70
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2020
VL 12
IS 4
AR 440
DI 10.3390/v12040440
PG 15
WC Virology
SC Virology
GA LX0IV
UT WOS:000539525300082
PM 32295109
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU de Abreu, FVS
   Ferreira-De-Brito, A
   Azevedo, AD
   Linhares, JHR
   Santos, VD
   Miranda, EH
   Neves, MSAS
   Yousfi, L
   Ribeiro, IP
   dos Santos, AAC
   dos Santos, E
   dos Santos, TP
   Teixeira, DS
   Gomes, MQ
   Fernandes, CB
   da Silva, AMV
   Lima, MDQ
   Paupy, C
   Romano, APM
   Bom, APDA
   de Oliveira-Pinto, LM
   Moutailler, S
   Motta, MD
   Castro, MG
   Bonaldo, MC
   de Lima, SMB
   Lourenco-de-Oliveira, R
AF Santos de Abreu, Filipe Vieira
   Ferreira-de-Brito, Anielly
   Azevedo, Adriana de Souza
   Rezende Linhares, Jose Henrique
   Santos, Vanessa de Oliveira
   Miranda, Emily Hime
   Alberto Santos Neves, Maycon Sebastiao
   Yousfi, Lena
   Ribeiro, Ieda Pereira
   Cunhad dos Santos, Alexandre Araujo
   dos Santos, Edmilson
   dos Santos, Taissa Pereira
   Teixeira, Danilo Simonini
   Gomes, Marcelo Quintela
   Fernandes, Camilla Bayma
   Vieira da Silva, Andrea Marques
   Queiroz Lima, Monique da Rocha
   Paupy, Christophe
   Martins Romano, Alessandro Pecego
   Dinis Ano Bom, Ana Paula
   de Oliveira-Pinto, Luzia Maria
   Moutailler, Sara
   Motta, Monique de Albuquerque
   Castro, Marcia Goncalves
   Bonaldo, Myrna Cristina
   Barbosa de Lima, Sheila Maria
   Lourenco-de-Oliveira, Ricardo
TI Survey on Non-Human Primates and Mosquitoes Does not Provide Evidences
   of Spillover/Spillback between the Urban and Sylvatic Cycles of Yellow
   Fever and Zika Viruses Following Severe Outbreaks in Southeast Brazil
SO VIRUSES-BASEL
LA English
DT Article
DE arboviruses; Flavivirus; serology; PRNT; high throughput real time PCR
ID ESPIRITO-SANTO; AEDES-AEGYPTI; SAO-PAULO; EMERGENCE; MONKEYS; DENGUE;
   STATE; INFECTION; DIAGNOSIS; EPIDEMIC
AB In the last decade, Flaviviruses such as yellow fever (YFV) and Zika (ZIKV) have expanded their transmission areas. These viruses originated in Africa, where they exhibit both sylvatic and interhuman transmission cycles. In Brazil, the risk of YFV urbanization has grown, with the sylvatic transmission approaching the most densely populated metropolis, while concern about ZIKV spillback to a sylvatic cycle has risen. To investigate these health threats, we carried out extensive collections and arbovirus screening of 144 free-living, non-human primates (NHPs) and 5219 mosquitoes before, during, and after ZIKV and YFV outbreaks (2015-2018) in southeast Brazil. ZIKV infection was not detected in any NHP collected at any time. In contrast, current and previous YFV infections were detected in NHPs sampled between 2017 and 2018, but not before the onset of the YFV outbreak. Mosquito pools screened by high-throughput PCR were positive for YFV when captured in the wild and during the YFV outbreak, but were negative for 94 other arboviruses, including ZIKV, regardless of the time of collection. In conclusion, there was no evidence of YFV transmission in coastal southeast Brazil before the current outbreak, nor the spread or establishment of an independent sylvatic cycle of ZIKV or urban Aedes aegypti transmission of YFV in the region. In view of the region's receptivity and vulnerability to arbovirus transmission, surveillance of NHPs and mosquitoes should be strengthened and continuous.
C1 [Santos de Abreu, Filipe Vieira; Ferreira-de-Brito, Anielly; Alberto Santos Neves, Maycon Sebastiao; Gomes, Marcelo Quintela; Motta, Monique de Albuquerque; Castro, Marcia Goncalves; Lourenco-de-Oliveira, Ricardo] Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, BR-21040900 Rio De Janeiro, Brazil.
   [Santos de Abreu, Filipe Vieira] Inst Fed Norte Minas Gerais, BR-39560000 Salinas, Brazil.
   [Azevedo, Adriana de Souza; Rezende Linhares, Jose Henrique; Santos, Vanessa de Oliveira; Miranda, Emily Hime; Barbosa de Lima, Sheila Maria] Inst Tecnol Imunobiol Biomanguinhos, Lab Tecnol Virol, BR-21040900 Rio De Janeiro, Brazil.
   [Yousfi, Lena; Moutailler, Sara] Univ Paris Est, UMR BIPAR, Hlth Anim Lab, ANSES,INRA,Ecole Natl Vet Alfort, F-94700 Maisons Alfort, France.
   [Ribeiro, Ieda Pereira; Cunhad dos Santos, Alexandre Araujo; Bonaldo, Myrna Cristina] Inst Oswaldo Cruz, Lab Biol Mol Flavivirus, BR-21040900 Rio De Janeiro, Brazil.
   [dos Santos, Edmilson] Secretaria Saude Rio Grande Sul, Div Vigilancia Ambiental Saude, BR-90610000 Porto Alegre, RS, Brazil.
   [dos Santos, Taissa Pereira; Paupy, Christophe] Univ Montpellier, MIVEGEC, CNRS, Inst Rech Dev IRD, F-34394 Montpellier, France.
   [Teixeira, Danilo Simonini] Univ Estadual Santa Cruz, Nucleo Atendimento & Pesquisa Anim Silvestres, BR-45662900 Ilheus, BA, Brazil.
   [Fernandes, Camilla Bayma; Vieira da Silva, Andrea Marques; Dinis Ano Bom, Ana Paula] Inst Tecnol Imunobiol Biomanguinhos, Lab Tecnol Imunol, BR-21040900 Rio De Janeiro, Brazil.
   [Queiroz Lima, Monique da Rocha; de Oliveira-Pinto, Luzia Maria] Inst Oswaldo Cruz, Lab Imunol Viral, BR-21040900 Rio De Janeiro, Brazil.
   [Martins Romano, Alessandro Pecego] Minist Saude, Secretaria Vigilancia Saude, BR-70719040 Brasilia, DF, Brazil.
RP Lourenco-de-Oliveira, R (corresponding author), Inst Oswaldo Cruz, Lab Mosquitos Transmissores Hematozoarios, BR-21040900 Rio De Janeiro, Brazil.
EM filipe.vieira@ifnmg.edu.br; aniellya@gmail.com;
   adriana.soares@bio.fiocruz.br; henrique.rznd@hotmail.com;
   vanessa.oliveira@bio.fiocruz.br; emily@bio.fiocruz.br;
   mayconnev@gmail.com; lenayousfi@hotmail.fr; iedapr@gmail.com;
   xande_acs@hotmail.com; edmilsondvas@gmail.com; tayssadnz@gmail.com;
   simonini.danilo@gmail.com; marcquintela@gmail.com;
   camilla.bayma@bio.fiocruz.br; amarques@bio.fiocruz.br;
   moniquerql@gmail.com; christophe.paupy@ird.fr;
   alessandropecego@gmail.com; adinis@bio.fiocruz.br;
   lmopnogueira@gmail.com; sara.moutailler@anses.fr; moniquemot@gmail.com;
   marciadengue@gmail.com; mbonaldo@ioc.fiocruz.br; smaria@bio.fiocruz.br;
   lourenco@ioc.fiocruz.br
RI Abreu, Filipe/F-6364-2019; Paupy, Christophe/I-4847-2017
OI Abreu, Filipe/0000-0001-9768-4688; Ribeiro, Ieda
   Pereira/0000-0002-0874-6072; Barbosa de Lima, Sheila
   Maria/0000-0001-9234-1678; Bonaldo, Myrna/0000-0001-9899-3386; Pereira
   dos santos, Taissa/0000-0001-6916-0297; MOUTAILLER,
   Sara/0000-0003-3010-6968; Paupy, Christophe/0000-0002-7122-2079;
   Lourenco-de-Oliveira, Ricardo/0000-0003-0423-5694
FU EUROPEAN UNION'S HORIZON 2020 Research and Innovation Programme:
   ZIKAlliance [734548]; CONSELHO NACIONAL DE DESENVOLVIMENTO CIENTIFICO E
   TECNOLOGICONational Council for Scientific and Technological Development
   (CNPq) [309577/2013-6, 312446/2018-7, 309471/2016-8, 426767/2018-7,
   88881.130684/2016-01]; FUNDACAO CARLOS CHAGAS FILHO DE AMPARO A PESQUISA
   DO ESTADO DO RIO DE JANEIRO [E-26/203.064/2016]; INSTITUT PASTEUR [528];
   COORDENACAODE APERFEICOAMENTODE PESSOAL DE NIVEL SUPERIORCAPES [Cofecub
   799-14, Auxpe 1731/2014]; FUNDACAO OSWALDO CRUZ [VPPIS-004-FIO18]
FX This research was funded by EUROPEAN UNION'S HORIZON 2020 Research and
   Innovation Programme: ZIKAlliance 734548; CONSELHO NACIONAL DE
   DESENVOLVIMENTO CIENTIFICO E TECNOLOGICO: 309577/2013-6 and
   312446/2018-7 and 309471/2016-8 and 426767/2018-7 and
   88881.130684/2016-01; FUNDACAO CARLOS CHAGAS FILHO DE AMPARO A PESQUISA
   DO ESTADO DO RIO DE JANEIRO: E-26/203.064/2016; INSTITUT PASTEUR: PTR
   No. 528; COORDENACAODE APERFEICOAMENTODE PESSOAL DE NIVEL SUPERIOR:
   Cofecub 799-14 and Auxpe 1731/2014; FUNDACAO OSWALDO CRUZ:
   VPPIS-004-FIO18.
CR Abreu F.V.S.D., 2019, MEM I O CRUZ, V114
   Abreu F, 2019, AM J PRIMATOL, V81, DOI 10.1002/ajp.22963
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Araujo FAA, 2011, EPIDEMIOL SERV SAUDE, V20, P527, DOI 10.5123/S1679-49742011000400012
   [Anonymous], 2017, BRAZ GUIA VIG EP PRI
   [Anonymous], 2003, WHO GUID PLAQ RED NE
   de Almeida MAB, 2019, J MED PRIMATOL, V48, P211, DOI 10.1111/jmp.12417
   de Almeida MAB, 2012, AM J PRIMATOL, V74, P68, DOI 10.1002/ajp.21010
   Berry N., 2019, SCI REP, V9, P1
   Bicca-marques J.C., 2017, SCI ADV, V1600946, P18
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Brasil P, 2017, LANCET GLOB HEALTH, V5, pE1038, DOI 10.1016/S2214-109X(17)30333-9
   Bryant JE, 2007, PLOS PATHOG, V3, P668, DOI 10.1371/journal.ppat.0030075
   Catenacci LS, 2018, ECOHEALTH, V15, P777, DOI 10.1007/s10393-018-1361-2
   Causey O.R., 1949, AM J TROP MED HYG  S, V1, P555, DOI DOI 10.4269/AJTMH.1949.S1-29.555
   Chiu CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17067-w
   Fernandes NCCD, 2017, EMERG INFECT DIS, V23, P2038, DOI 10.3201/eid2312.170685
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Cunha MS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41950-3
   Cunha MS, 2019, SCI REP, V9, P1, DOI DOI 10.1038/s41598-018-37186-2
   Vasconcelos PFD, 2010, REV SAUDE PUBL, V44, P1144, DOI 10.1590/S0034-89102010005000046
   Davis N C, 1930, J Exp Med, V52, P405
   Davis NC, 1930, AM J HYG, V11, P321
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Avila-Pires Fernando Dias, 2018, Revista de Patologia Tropical, V47, P1, DOI 10.5216/rpt.v47i1.52274
   de Oliveira EF, 2018, TRANSBOUND EMERG DIS, V65, P1094, DOI 10.1111/tbed.12829
   de Souza RP, 2011, REV INST MED TROP SP, V53, P133, DOI 10.1590/S0036-46652011000300004
   Delatorre E, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01079
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Favoretto SR, 2019, ECOHEALTH, V16, P61, DOI 10.1007/s10393-019-01394-7
   Fedigan L.M., 2017, INT ENCY PRIMATOLOGY, P1
   Fernandes RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56669-4
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Franco O., 1969, HIST FEBRE AMARELA B, V1, P210
   Garcia de Oliveira, 2019, B WORLD HEALTH ORGAN, V97, P6
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   HADDOW AJ, 1948, ANN TROP MED PARASIT, V42, P218, DOI 10.1080/00034983.1948.11685365
   Heukelbach J, 2016, J INFECT DEV COUNTR, V10, P116, DOI 10.3855/jidc.8217
   IVERSSON LB, 1984, REV SAUDE PUBL, V18, P323, DOI 10.1590/S0034-89101984000400007
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   Klitting R, 2018, GENES-BASEL, V9, DOI 10.3390/genes9060291
   KUMM HW, 1950, AM J TROP MED, V30, P733
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LAEMMERT HW, 1946, AM J TROP MED, V26, P33
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Miagostovich MP, 1999, J CLIN VIROL, V14, P183, DOI 10.1016/S1386-6532(99)00059-1
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Moreira-Soto A, 2018, MSPHERE, V3, DOI [10.1128/mSphere.00523-17, 10.1128/msphere.00523-17]
   Moreno ES, 2015, MEM I OSWALDO CRUZ, V110, P865, DOI 10.1590/0074-02760150075
   Moussallem TM, 2019, REV PANAM SALUD PUBL, V43, DOI 10.26633/RPSP.2019.29
   Moutailler S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100904
   Pinheiro GG, 2019, INSECTS, V10, DOI 10.3390/insects10050136
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Soper F.L., 1937, REV HIG SAUDE PUBLIC, V10, P104
   Soper FL, 1933, AM J HYG, V18, P555, DOI 10.1093/oxfordjournals.aje.a117967
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Terzian ACB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34423-6
   Travassos-da-Rosa A.P.D.A, 2016, REV PAN AMAZONICA SA, V7, P61, DOI DOI 10.5123/S2176-62232016000500007
   Vanchiere J.A., 2017, J TROP MED HYG, V98, P173
   Weaver SC, 2013, TRENDS MICROBIOL, V21, P360, DOI 10.1016/j.tim.2013.03.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 67
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD APR
PY 2020
VL 12
IS 4
AR 364
DI 10.3390/v12040364
PG 21
WC Virology
SC Virology
GA LX0IV
UT WOS:000539525300006
PM 32224891
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Passos, MJ
   Matta, G
   Lyra, TM
   Moreira, MEL
   Kuper, H
   Penn-Kekana, L
   Mendonca, M
AF Passos, Maria Joana
   Matta, Gustavo
   Lyra, Tereza Maciel
   Lopes Moreira, Maria Elisabeth
   Kuper, Hannah
   Penn-Kekana, Loveday
   Mendonca, Mila
TI The promise and pitfalls of social science research in an emergency:
   lessons from studying the Zika epidemic in Brazil, 2015-2016
SO BMJ GLOBAL HEALTH
LA English
DT Article
ID VIRUS-INFECTION; HUMAN-RIGHTS
AB Social science generates evidence necessary to control epidemics. It can help to craft appropriate public health responses, develop solutions to the epidemic impacts and improve understanding of why the epidemic occurred. Yet, there are practical constraints in undertaking this international research in a way that produces quality, ethical and appropriate data, and that values all voices and experiences, especially those of local researchers and research participants. In this paper, we reflected on the experience of undertaking social science research during the 2015/2016 Zika epidemic in Brazil. This experience was considered from the perspective of this paper's authors: three Brazilian academics, two UK academics and two mothers of children affected by congenital Zika syndrome. This group came together through the conduct of the Social and Economic Impact of Zika study, a mixed-methods social science study. The key findings highlight practical issues in the achievement of three goals: the conduct of high-quality social science in emergencies and efforts towards the decolonisation of global health in terms of levelling the power between Brazilian and UK researchers and optimising the role of patients within research. From our perspective, the information collected through social science was valuable, providing detailed insight into the programmatic needs of mothers and their affected children (eg, economic and social support and mental health services). Social science was considered a low priority within the Zika epidemic despite its potential importance. There were logistical challenges in conducting social science research, foremost of which are the difficulties in developing a trusting and balanced power relationship between the UK and Brazilian researchers in a short time frame. When these issues were overcome, each partner brought unique qualities, making the research stronger. The mothers of affected children expressed dissatisfaction with research, as they were involved in many studies which were not coordinated, and from which they did not see a benefit. In conclusion, the importance of social science in epidemics must continue to be promoted by funders. Funders can also set in place mechanisms to help equalise the power dynamics between foreign and local researchers, researchers and participants, both to promote justice and to create best quality data.
C1 [Passos, Maria Joana; Mendonca, Mila] Abraco Microcefalia, Salvador, BA, Brazil.
   [Matta, Gustavo] Fundacao Oswaldo Cruz, Escola Nacl Saude Publ, Rio De Janeiro, Brazil.
   [Lyra, Tereza Maciel] FIOCRUZ PE, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Lyra, Tereza Maciel] Univ Pernambuco, Fac Med, Recife, PE, Brazil.
   [Lopes Moreira, Maria Elisabeth] Fiocruz MS, Fernando Figueira Maternal & Childrens Inst, Rio De Janeiro, Brazil.
   [Kuper, Hannah] London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.
   [Penn-Kekana, Loveday] London Sch Hyg & Trop Med, Infect Dis Epidemiol, London, England.
RP Kuper, H (corresponding author), London Sch Hyg & Trop Med, Int Ctr Evidence Disabil, London, England.
EM Hannah.Kuper@lshtm.ac.uk
FU Wellcome TrustWellcome Trust [205377/Z/16/Z]; UK's Department for
   International Development [205377/Z/16/Z]; European Union's Horizon 2020
   research and innovation programme under ZikaPLAN grant [734584]
FX The Social and Economic Impact of Zika study was supported by the
   Wellcome Trust & the UK's Department for International Development
   (205377/Z/16/Z to LCR, https://wellcome.ac.uk/); the European Union's
   Horizon 2020 research and innovation programme
   (https://ec.europa.eu/programmes/horizon2020/) under ZikaPLAN grant
   agreement number 734584, https://zikaplan.tghn.org/).
CR Abimbola S, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-002068
   Abimbola S, 2017, LANCET GLOB HEALTH, V5, pE25, DOI 10.1016/S2214-109X(16)30302-3
   Albuquerque MSV, 2019, HEALTH POLICY PLANN, V34, P499, DOI 10.1093/heapol/czz059
   Caleo G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5158-6
   Coltart CEM, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0297
   Cook N, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026514
   Diniz D, 2019, INT J GYNECOL OBSTET, V147, P268, DOI 10.1002/ijgo.12924
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Diniz D, 2017, J FAM PLAN REPROD H, V43, P80, DOI 10.1136/jfprhc-2016-101678
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Duttine Antony, 2019, Wellcome Open Res, V4, P80, DOI 10.12688/wellcomeopenres.15085.1
   Gibb R, 2017, SOCIOL REV, V65, P134, DOI 10.1111/1467-954X.12389
   GloPID-R, 2020, GLOPID R GLOBAL RES
   Goodridge K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183134
   Hacking Ian, 2000, SOCIAL CONSTRUCTION
   HARAWAY D, 1988, FEMINIST STUD, V14, P575, DOI 10.2307/3178066
   Hedt-Gauthier BL, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001853
   Janes CR, 2012, LANCET, V380, P1884, DOI 10.1016/S0140-6736(12)61725-5
   Keikelame MJ, 2019, GLOBAL HEALTH ACTION, V12, DOI 10.1080/16549716.2018.1561175
   Kuper H, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007768
   Kuper Hannah, 2018, Wellcome Open Res, V3, P127, DOI 10.12688/wellcomeopenres.14838.1
   Matta GC, 2019, FRAMING ANIMALS EPID, P211
   Mbaye R, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001855
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Moreira MCN, 2018, CAD SAUDE PUBLICA, V34, DOI 10.1590/0102-311X00075718
   Parker M, 2019, LANCET, V393, P2585, DOI 10.1016/S0140-6736(19)31364-9
   Rasanathan JJK, 2017, AM J PUBLIC HEALTH, V107, P525, DOI 10.2105/AJPH.2017.303658
   Reidpath DD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2019-001719
   Saha S, 2019, C WORD TACKLING ENDU
   Stellmach D, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000534
   UNICEF and IDS, 2020, SOC SCI HUM ACT COMM
   Vargha D., 2016, SOMATSOPHERENET
   Wellcome Trust, 2016, STAT DAT SHAR PUBL H
   WHO, 2019, COMM ENG SOC MOB
   2018, LANCET GLOB HLTH, V6, pE59
NR 35
TC 0
Z9 0
U1 0
U2 0
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 2059-7908
J9 BMJ GLOB HEALTH
JI BMJ Glob. Health
PD APR
PY 2020
VL 5
IS 4
AR e002307
DI 10.1136/bmjgh-2020-002307
PG 9
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LV0PA
UT WOS:000538145000023
PM 32345582
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Quintero, J
   Pulido, NR
   Logan, J
   Ant, T
   Bruce, J
   Carrasquilla, G
AF Quintero, Juliana
   Pulido, Nicolas Ronderos
   Logan, James
   Ant, Thomas
   Bruce, Jane
   Carrasquilla, Gabriel
TI Effectiveness of an intervention for Aedes aegypti control scaled-up
   under an inter-sectoral approach in a Colombian city hyper-endemic for
   dengue virus
SO PLOS ONE
LA English
DT Article
ID WATER CONTAINER COVERS; INSECTICIDE-TREATED CURTAINS; VECTOR CONTROL
   INTERVENTIONS; ECONOMIC BURDEN; LATIN-AMERICA; DISEASE; HEALTH;
   TRANSMISSION; PREVENTION; DYNAMICS
AB Aedes aegypti transmitted arboviral diseases are of significant importance in Colombia, particularly since the 2014/2015 introduction of chikungunya and Zika in the Americas and the increasing spread of dengue. In response, the Colombian government initiated the scaling-up of a community-based intervention under inter and multi-sector partnerships in two out of four sectors in Girardot, one of the most hyper-endemic dengue cities in the country. Using a quasi-experimental research design a scaled-up community-led Aedes control intervention was assessed for its capacity to reduce dengue from January 2010 to August 2017 in Girardot, Colombia. Reported dengue cases, and associated factors were analysed from available data sets from the Colombian disease surveillance systems. We estimated the reduction in dengue cases before and after the intervention using, Propensity Score Matching and an Autoregressive Moving Average model for robustness. In addition, the differences in dengue incidence among scaling-up phases (pre-implementation vs sustainability) and between treatment groups (intervention and control areas) were modelled. Evidence was found in favour of the intervention, although to maximise impact the scaling-up of the intervention should continue until it covers the remaining sectors. It is expected that a greater impact of the intervention can be documented in the next outbreak of dengue in Girardot.
C1 [Quintero, Juliana; Logan, James; Carrasquilla, Gabriel] Fdn Santa Fe Bogota, Eje Salud Poblac, Bogota, Colombia.
   [Quintero, Juliana; Pulido, Nicolas Ronderos] Univ Santo Tomas, Bogota, Colombia.
   [Logan, James; Ant, Thomas; Bruce, Jane] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Dis Control, London, England.
RP Quintero, J (corresponding author), Fdn Santa Fe Bogota, Eje Salud Poblac, Bogota, Colombia.; Quintero, J (corresponding author), Univ Santo Tomas, Bogota, Colombia.
EM juliana.quintero@lshtm.ac.uk
OI Quintero, Juliana/0000-0003-3005-4184
FU Administrative Department of Science, Technology and Innovation of
   Colombia (Colciencias)Departamento Administrativo de Ciencia, Tecnologia
   e Innovacion Colciencias [622172553374]; International Development
   Research Center of Canada (IDRC) Project [107843-001]
FX The study was supported financially by a grant from the following
   institutions: Administrative Department of Science, Technology and
   Innovation of Colombia (Colciencias) Project 622172553374 and by the
   International Development Research Center of Canada (IDRC) Project
   107843-001. The nets employed in this study were donated by the Ministry
   of Health of Colombia. Colciencias URL:
   https://www.colciencias.gov.co/IDRC URL: https://www.idrc.ca/The funders
   had no role in the e study design, data collection and analysis,
   decision to publish, or preparation of the manuscript. JQ and GC
   received boths awards.
CR Alcala L, 2015, BIOMEDICA, V35, P258, DOI [10.7705/biomedica.v35i2.2567, 10.1590/S0120-41572015000200014]
   Alfonso-Sierra E, 2016, PATHOG GLOB HEALTH, V110, P14, DOI 10.1080/20477724.2016.1142057
   Alvarado-Castro V, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4290-z
   Villar LA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003499
   Arunachalam N, 2012, PATHOG GLOB HEALTH, V106, P488, DOI 10.1179/2047773212Y.0000000056
   Arunachalam N, 2010, B WORLD HEALTH ORGAN, V88, P173, DOI 10.2471/BLT.09.067892
   Aunger R, 2016, HEALTH PSYCHOL REV, V10, P425, DOI 10.1080/17437199.2016.1219673
   Ballenger-Browning KK, 2009, TROP MED INT HEALTH, V14, P1542, DOI 10.1111/j.1365-3156.2009.02396.x
   Barker PM, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0374-x
   Bernal R, 2011, GUIA PRACTICA EVALUA, DOI [10.7440/j.ctt1b3t82z, DOI 10.7440/J.CTT1B3T82Z]
   Bouzid M, PUBLIC HLTH INTERVEN
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Buttenheim Alison, 2018, SOCARXIV, P1
   Caliendo M, 2008, J ECON SURV, V22, P31, DOI 10.1111/j.1467-6419.2007.00527.x
   Campbell M, 2000, BRIT MED J, V321, P694, DOI 10.1136/bmj.321.7262.694
   Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426
   Rodriguez RC, 2016, AM J TROP MED HYG, V94, P1065, DOI 10.4269/ajtmh.15-0280
   Coelho GE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004705
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   Eisenstein M, 2016, NATURE, V531, pS61, DOI 10.1038/531S61a
   Enduri MK, 2018, SPAT SPATIO-TEMPORAL, V25, P57, DOI 10.1016/j.sste.2018.03.001
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Fabián, 2015, Physis, V25, P571, DOI 10.1590/S0103-73312015000200013
   Fuentes-Vallejo M, 2015, CAD SAUDE PUBLICA, V31, P517, DOI 10.1590/0102-311X00057214
   Garcia-Betancourt T, 2014, ECOHEALTH, V11, P434, DOI 10.1007/s10393-014-0953-8
   Gomez-Dantes H, 2009, CAD SAUDE PUBLICA, V25, pS19, DOI 10.1590/S0102-311X2009001300003
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Henna Hasson, 2010, IEEE INT C COMM CAP, P1, DOI 10.1186/1748-5908-5-1
   Hernandez-Suarez CM, 2016, GLOBAL HEALTH ACTION, V9, DOI 10.3402/gha.v9.28026
   Horstick O, 2018, LANCET INFECT DIS, V18, pE147, DOI 10.1016/S1473-3099(17)30422-X
   Horstick O, 2010, T ROY SOC TROP MED H, V104, P379, DOI 10.1016/j.trstmh.2009.07.027
   INDIG D, 2017, BMC PUBLIC HEALTH, V18, DOI DOI 10.1186/S12889-017-4524-0
   Instituto Nacional de Salud, 2012, DENG SURV PROT, DOI [10.1111/j.1467-6419.2007.00527.x, DOI 10.1111/J.1467-6419.2007.00527.X]
   Instituto Nacional de Salud, 2015, B EP SEM SEM EP NUM
   Kraemer MUG, 2015, ALBOPICTUS, P1
   Kroeger A, 2006, BMJ-BRIT MED J, V332, P1247, DOI 10.1136/bmj.332.7552.1247
   Liyanage P, 2019, LANCET PLANET HEALTH, V3, pE211, DOI 10.1016/S2542-5196(19)30057-9
   Lotufo PA, 2016, SAO PAULO MED J, V134, P95, DOI 10.1590/1516-3180.2016.13421602
   Maria Turchi Martelli C, 2015, EC IMPACT DENGUE MUL
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Messina JP, 2014, GLOBAL COMPENDIUM HU
   Milat AJ, 2013, HEALTH PROMOT INT, V28, P285, DOI 10.1093/heapro/dar097
   Moore GF, 2017, SSM-POPUL HLTH, V3, P132, DOI 10.1016/j.ssmph.2016.12.005
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Nishikawa AM, 2016, VALUE HEALTH, V19, pA216, DOI 10.1016/j.jval.2016.03.1217
   Ooi EE, 2001, LANCET, V357, P685, DOI 10.1016/S0140-6736(00)04137-4
   Overgaard HJ, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2295-1
   Padilla JC, 2012, DENGUE COLOMBIA EPID
   QGIS Development Team, 2014, QGIS GEOGR INF SYST
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Quintero J, 2009, CAD SAUDE PUBLICA, V25, pS93, DOI 10.1590/S0102-311X2009001300009
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Rojas DP, 2016, EURO SURVEILL, V21
   Salje H, 2017, SCIENCE, V355, P1302, DOI 10.1126/science.aaj9384
   San Martin JL, 2007, REV PANAM SALUD PUBL, V21, P55, DOI 10.1590/S1020-49892007000100011
   Sarti E, 2016, INT J INFECT DIS, V44, P44, DOI 10.1016/j.ijid.2016.01.015
   Schmunis G A, 2000, Cad Saude Publica, V16 Suppl 2, P117, DOI 10.1590/S0102-311X2000000800016
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Smith DL, 2014, T ROY SOC TROP MED H, V108, P185, DOI 10.1093/trstmh/tru026
   Sommerfeld J, 2015, T ROY SOC TROP MED H, V109, P85, DOI 10.1093/trstmh/tru176
   Sommerfeld J, 2012, PATHOG GLOB HEALTH, V106, P428, DOI 10.1179/2047773212Y.0000000055
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Stoddard ST, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000481
   Torres JR, 2007, CAD SAUDE PUBLICA, V23, pS23, DOI 10.1590/S0102-311X2007001300004
   Vanlerberghe V, 2011, TROP MED INT HEALTH, V16, P72
   Vanlerberghe V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000994
   Wilson AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003228
   World Health Organization. WHO, 2018, GLOB VECT CONTR RESP
NR 71
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 1
PY 2020
VL 15
IS 4
AR e0230486
DI 10.1371/journal.pone.0230486
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LR8IA
UT WOS:000535938700020
PM 32236142
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, QX
   Kang, CB
AF Li, Qingxin
   Kang, CongBao
TI Insights into Structures and Dynamics of Flavivirus Proteases from NMR
   Studies
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Review
DE flavivirus; Dengue virus; Zika virus; West Nile virus; protease; NMR;
   protein structure
ID VIRUS NS2B-NS3 PROTEASE; ZIKA VIRUS; CRYSTAL-STRUCTURE; NS3 PROTEASE;
   PSEUDOCONTACT SHIFTS; DENGUE; INHIBITORS; COFACTOR; DISCOVERY; BIOLOGY
AB Nuclear magnetic resonance (NMR) spectroscopy plays important roles in structural biology and drug discovery, as it is a powerful tool to understand protein structures, dynamics, and ligand binding under physiological conditions. The protease of flaviviruses is an attractive target for developing antivirals because it is essential for the maturation of viral proteins. High-resolution structures of the proteases in the absence and presence of ligands/inhibitors were determined using X-ray crystallography, providing structural information for rational drug design. Structural studies suggest that proteases from Dengue virus (DENV), West Nile virus (WNV), and Zika virus (ZIKV) exist in open and closed conformations. Solution NMR studies showed that the closed conformation is predominant in solution and should be utilized in structure-based drug design. Here, we reviewed solution NMR studies of the proteases from these viruses. The accumulated studies demonstrated that NMR spectroscopy provides additional information to understand conformational changes of these proteases in the absence and presence of substrates/inhibitors. In addition, NMR spectroscopy can be used for identifying fragment hits that can be further developed into potent protease inhibitors.
C1 [Li, Qingxin] Guangzhou Sugarcane Ind Res Inst, Guangdong Prov Bioengn Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou 510316, Guangdong, Peoples R China.
   [Kang, CongBao] ASTAR, Expt Drug Dev Ctr EDDC, 10 Biopolis Rd,05-01, Singapore 138670, Singapore.
RP Li, QX (corresponding author), Guangzhou Sugarcane Ind Res Inst, Guangdong Prov Bioengn Inst, Guangdong Key Lab Sugarcane Improvement & Biorefi, Guangzhou 510316, Guangdong, Peoples R China.; Kang, CB (corresponding author), ASTAR, Expt Drug Dev Ctr EDDC, 10 Biopolis Rd,05-01, Singapore 138670, Singapore.
EM qingxin_li@outlook.com; cbkang@eddc.a-star.edu.sg
OI kang, congbao/0000-0002-9886-9374
FU "Hundred-Talent Program", Guangdong Academy of Sciences, China
   [2020GDASYL-20200102010, 2020GDASYL-20200102009]; Singapore Ministry of
   Health's National Medical Research CouncilNational Medical Research
   Council, Singapore [OFIRG17may050, NMRC/OFIRG/0051/2017]
FX This research was supported by funding from the "Hundred-Talent Program"
   (Grant Numbers: 2020GDASYL-20200102010 and 2020GDASYL-20200102009),
   Guangdong Academy of Sciences, China. This research was also supported
   by Singapore Ministry of Health's National Medical Research Council
   under its open fund individual research grant (OFIRG17may050,
   NMRC/OFIRG/0051/2017).
CR Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Batool M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112783
   Becker W, 2018, J BIOMOL NMR, V70, P211, DOI 10.1007/s10858-018-0173-6
   Bi YC, 2013, BIOMOL NMR ASSIGN, V7, P137, DOI 10.1007/s12104-012-9395-9
   Bodenreider C, 2009, ANAL BIOCHEM, V395, P195, DOI 10.1016/j.ab.2009.08.013
   Brecher Matthew, 2013, Virologica Sinica, V28, P326, DOI 10.1007/s12250-013-3390-x
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chappell KJ, 2008, J GEN VIROL, V89, P1010, DOI 10.1099/vir.0.83447-0
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Clum S, 1997, J BIOL CHEM, V272, P30715, DOI 10.1074/jbc.272.49.30715
   de la Cruz L, 2014, FEBS J, V281, P1517, DOI 10.1111/febs.12729
   de la Cruz L, 2011, J AM CHEM SOC, V133, P19205, DOI 10.1021/ja208435s
   Ekonomiuk D, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000356
   Ekonomiuk D, 2009, J MED CHEM, V52, P4860, DOI 10.1021/jm900448m
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109
   Gayen S, 2012, BIOCHEM BIOPH RES CO, V423, P799, DOI 10.1016/j.bbrc.2012.06.043
   Graham B, 2011, BIOCONJUGATE CHEM, V22, P2118, DOI 10.1021/bc200353c
   Gupta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134823
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Huang QW, 2013, PROTEIN EXPRES PURIF, V92, P156, DOI 10.1016/j.pep.2013.09.015
   Huang QW, 2011, PROTEIN EXPRES PURIF, V80, P169, DOI 10.1016/j.pep.2011.08.008
   Kang CB, 2019, CURR MED CHEM, V26, P4964, DOI 10.2174/0929867326666190610160534
   Kang C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010139
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kang CB, 2013, ANTIVIR RES, V97, P137, DOI 10.1016/j.antiviral.2012.11.008
   Kessler D, 2019, P NATL ACAD SCI USA, V116, P15823, DOI 10.1073/pnas.1904529116
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Lee MD, 2015, CHEM SCI, V6, P2614, DOI 10.1039/c4sc03892d
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li Y, 2018, BIOCHEM BIOPH RES CO, V503, P691, DOI 10.1016/j.bbrc.2018.06.062
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Y, 2015, BBA-BIOMEMBRANES, V1848, P2244, DOI 10.1016/j.bbamem.2015.06.010
   Liew LSY, 2016, PROTEIN EXPRES PURIF, V121, P141, DOI 10.1016/j.pep.2016.02.001
   Lim SP, 2019, ANTIVIR RES, V163, P156, DOI 10.1016/j.antiviral.2018.12.016
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977
   Lim SP, 2013, ANTIVIR RES, V100, P500, DOI 10.1016/j.antiviral.2013.09.013
   Lindenbach B.D., 2013, FIELDS VIROLOGY, P712
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Ng EY, 2019, PROTEIN EXPRES PURIF, V154, P1, DOI 10.1016/j.pep.2018.09.013
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2017, CHEM COMMUN, V53, P10894, DOI 10.1039/c7cc06155b
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Norton RS, 2016, MOLECULES, V21, DOI 10.3390/molecules21070860
   Page R, 2005, P NATL ACAD SCI USA, V102, P1901, DOI 10.1073/pnas.0408490102
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Pierson TC, 2013, CURR OPIN VIROL, V3, P3, DOI 10.1016/j.coviro.2012.12.001
   Pilla KB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127053
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Quek JP, 2020, ANTIVIR RES, V175, DOI 10.1016/j.antiviral.2020.104707
   Radichev I, 2008, J GEN VIROL, V89, P636, DOI 10.1099/vir.0.83359-0
   Robin G, 2009, J MOL BIOL, V385, P1568, DOI 10.1016/j.jmb.2008.11.026
   Schmitz C, 2012, J MOL BIOL, V416, P668, DOI 10.1016/j.jmb.2011.12.056
   Schone T, 2017, ANTIVIR RES, V146, P174, DOI 10.1016/j.antiviral.2017.09.008
   Shannon AE, 2016, PROTEIN EXPRES PURIF, V119, P124, DOI 10.1016/j.pep.2015.11.022
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Stamford A, 2013, CURR OPIN CHEM BIOL, V17, P320, DOI 10.1016/j.cbpa.2013.04.016
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Su XC, 2009, FEBS J, V276, P4244, DOI 10.1111/j.1742-4658.2009.07132.x
   Sugiki T, 2018, MOLECULES, V23, DOI 10.3390/molecules23010148
   Takeuchi K, 2019, J MAGN RESON, V306, P195, DOI 10.1016/j.jmr.2019.07.045
   Tian HL, 2016, PROTEIN CELL, V7, P450, DOI 10.1007/s13238-016-0275-4
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhu L, 2015, BIOCHEM BIOPH RES CO, V461, P677, DOI 10.1016/j.bbrc.2015.04.090
NR 86
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD APR
PY 2020
VL 21
IS 7
AR 2527
DI 10.3390/ijms21072527
PG 16
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LR3DN
UT WOS:000535574200269
PM 32260545
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jesus, T
   Wanner, E
   Cardoso, R
AF Jesus, Tales
   Wanner, Elizabeth
   Cardoso, Rodrigo
TI A receding horizon control approach for integrated vector management of
   Aedes aegypti using chemical and biological control: A mono and a
   multiobjective approach
SO MATHEMATICAL METHODS IN THE APPLIED SCIENCES
LA English
DT Article
DE control problems; cost-effectiveness analysis; epidemiology;
   mono-objective and multiobjective optimization; receding horizon control
AB This paper addresses an integrated vector management (IVM) approach for combating Aedes aegypti, the transmission vector of dengue, zika, and chikungunya diseases, some of themost important viral epidemics worldwide. In order to tackle this problem, a receding horizon control (RHC) strategy is adopted, considering a mono-objective and a multiobjective version of the optimal control model of combating the mosquito using chemical and biological control. RHC is essentially a suboptimal scheme of classical optimal control strategies considering discrete-time approximations. The integrated vector control actions used in this work consist in applying insecticides and inserting sterile males produced by irradiation in the population of mosquitoes. The cost function is defined in terms of social and economic costs, in order to quantify the effectiveness of the proposed epidemiological control throughout a time window of 4 months. Numerical simulations show that the obtained results are better than those from the optimal control strategies found in literature. Furthermore, through the application of the multiobjetive approach, varying the scenarios in the mono-objective formulation is no longer necessary and a set of optimal strategies can be obtained at once. Finally, in order to help health authorities in the choice of the best solution of the Pareto-optimal set to be implemented in practice, a cost-effectiveness analysis is performed and a strategy representing the most cost-effective control policy is obtained.
C1 [Jesus, Tales; Wanner, Elizabeth] CEFET MG, Dept Comp, Belo Horizonte, MG, Brazil.
   [Wanner, Elizabeth] Aston Univ, EASS, Birmingham, W Midlands, England.
   [Cardoso, Rodrigo] CEFET MG, Dept Phys & Math, Belo Horizonte, MG, Brazil.
RP Jesus, T (corresponding author), CEFET MG, Dept Comp, Belo Horizonte, MG, Brazil.
EM tales@cefetmg.br
RI ; Wanner, Elizabeth/F-4927-2016
OI Jesus, Tales/0000-0001-9279-1249; Cardoso, Rodrigo/0000-0002-6784-2929;
   Wanner, Elizabeth/0000-0001-6450-3043
FU Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG);
   Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq); Coordenacao
   de Aperfeicoamento de Pessoal de Nivel SuperiorCAPES; Fundacao de Amparo
   a Pesquisa do Estado de Minas GeraisMinas Gerais State Research
   Foundation (FAPEMIG)
FX Centro Federal de Educacao Tecnologica de Minas Gerais (CEFET-MG);
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico;
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao de
   Amparo a Pesquisa do Estado de Minas Gerais
CR Barsante LS, 2011, P 43 BRAZ S OP RES U
   Brown VL, 2011, MATH BIOSCI, V231, P126, DOI 10.1016/j.mbs.2011.02.009
   Cela A, 2013, OPTIMAL DESIGN DISTR
   Clarke J, 2013, B MATH BIOL, V75, P1747, DOI 10.1007/s11538-013-9867-9
   David J, 2011, OPTIM CONTR APPL MET, V32, P681, DOI 10.1002/oca.969
   Deb K., 2001, MULTIOBJECTIVE OPTIM
   Dias WO, 2015, MATH BIOSCI, V269, P37, DOI 10.1016/j.mbs.2015.08.019
   Dias WO, 2013, BIOMAT, P136
   Du Toit NE, 2012, IEEE T ROBOT, V28, P101, DOI 10.1109/TRO.2011.2166435
   Elhia M, 2012, APPL MATH SCI, V6, P4057
   Esteva L, 2006, MAT APL COMPUT, V7, P259
   Fiorentino HO, 2014, MATH BIOSCI, V258, P77, DOI 10.1016/j.mbs.2014.08.013
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Joshi HR, 2002, OPTIM CONTR APPL MET, V23, P199, DOI 10.1002/oca.710
   Keviczky T., 2005, DECENTRALIZED RECEDI
   Kim N, 2012, P I MECH ENG D-J AUT, V226, P1160, DOI 10.1177/0954407012438304
   Kirk D. E., 1998, OPTIMAL CONTROL THEO
   Mohseni F, 2016, IEEE SYST J, V10, P198, DOI 10.1109/JSYST.2014.2325219
   Ohtsuka T, 2004, AUTOMATICA, V40, P563, DOI 10.1016/j.automatica.2003.11.005
   Okosun KO, 2013, BIOSYSTEMS, V111, P83, DOI 10.1016/j.biosystems.2012.09.008
   Peng HJ, 2016, ISA T, V60, P38, DOI 10.1016/j.isatra.2015.10.015
   Peng HJ, 2013, ADV SPACE RES, V51, P2093, DOI 10.1016/j.asr.2013.01.013
   Peng H, 2018, IEEE T AERO ELEC SYS, V54, P144, DOI 10.1109/TAES.2017.2739938
   Rafikov  M., 2015, J APPL MATH, V9, P1, DOI [10.1155/2015/918194, DOI 10.1155/2015/918194]
   Rawlings J., 2009, MODEL PREDICTIVE CON
   Rodrigues HS, 2014, MATH BIOSCI, V247, P1, DOI 10.1016/j.mbs.2013.10.006
   Rodrigues HS, 2010, MATH COMPUT MODEL, V52, P1667, DOI 10.1016/j.mcm.2010.06.034
   Rodrigues HSF, 2012, OPTIMAL CONTROL NUME
   Selley F., 2014, RECEDING HORIZON CON
   Selley F, 2015, SIAM J APPL DYN SYST, V14, P168, DOI 10.1137/130947039
   Sepulveda LS, 2016, MATH METHOD APPL SCI, V39, P5475, DOI 10.1002/mma.3932
   Sharomi O, 2017, ANN OPER RES, V251, P55, DOI 10.1007/s10479-015-1834-4
   SHIM H, 2003, INT J CONTROL AUTOM, V1, P401
   Thome RCA, 2010, MATH BIOSCI, V223, P12, DOI 10.1016/j.mbs.2009.08.009
   Tian BL, 2011, ACTA ASTRONAUT, V68, P1176, DOI 10.1016/j.actaastro.2010.10.010
   World Health Organization, 2016, WAT REL DIS DENG DEN
   World Health Organization, 2014, STAT ART PREV CONTR
   Yusuf T.J., 2012, WORLD J MODEL SIMUL, V8, P194
   Zurakowski R, 2006, J THEOR BIOL, V238, P368, DOI 10.1016/j.jtbi.2005.05.004
NR 39
TC 1
Z9 1
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0170-4214
EI 1099-1476
J9 MATH METHOD APPL SCI
JI Math. Meth. Appl. Sci.
PD APR
PY 2020
VL 43
IS 6
BP 3220
EP 3237
DI 10.1002/mma.6115
PG 18
WC Mathematics, Applied
SC Mathematics
GA LQ8FO
UT WOS:000535233900024
DA 2020-07-08
ER

PT J
AU Kretschmer, M
   Kadlubowska, P
   Hoffmann, D
   Schwalbe, B
   Auerswald, H
   Schreiber, M
AF Kretschmer, Maibritt
   Kadlubowska, Patrycja
   Hoffmann, Daniel
   Schwalbe, Birco
   Auerswald, Heidi
   Schreiber, Michael
TI Zikavirus prME Envelope Pseudotyped Human Immunodeficiency Virus Type-1
   as a Novel Tool for Glioblastoma-Directed Virotherapy
SO CANCERS
LA English
DT Article
DE oncolytic viruses; zika virus; glioma stem cells; HIV-1; pseudotyped
   virus; neurotropism; HIV-1 packaging system; virotherapy
ID RECURRENT MALIGNANT GLIOMAS; ZIKA VIRUS; STEM-CELLS; ONCOLYTIC VIRUS;
   PHASE; TRIAL; EXPRESSION; INJECTION; SAFETY; MUTANT
AB Glioblastoma multiforme is the most lethal type of brain tumor that is not yet curable owing to its frequent resurgence after surgery. Resistance is mainly caused by the presence of a subpopulation of tumor cells, the glioma stem cells (GSCs), which are highly resistant to radiation and chemotherapy. In 2015, Zikavirus (ZIKV)-induced microcephaly emerged in newborns, indicating that ZIKV has a specific neurotropism. Accordingly, an oncolytic tropism for infecting GSCs was demonstrated in a murine tumor model. Like other flaviviruses, ZIKV is enveloped by two proteins, prM and E. The pME expression plasmid along with the HIV-1 vector pNL Luc AM generated prME pseudotyped viral particles. Four different prME envelopes, Z1 to Z4, were cloned, and the corresponding pseudotypes, Z1- to Z4-HIVluc, produced by this two-plasmid system, were tested for entry efficiency using Vero-B4 cells. The most efficient pseudotype, Z1-HIVluc, also infected glioma-derived cell lines U87 and 86HG39. The pseudotype system was then extended by using a three-plasmid system including pME-Z1, the HIV-1 packaging plasmid psPAX2, and the lentiviral vector pLenti-luciferase-P2A-Neo. The corresponding pseudotype, designated Z1-LENTIluc, also infected U87 and 86HG39 cells. Altogether, a pseudotyped virus especially targeting glioma-derived cells might be a promising candidate for a prospective glioblastoma-directed virotherapy.
C1 [Kretschmer, Maibritt; Kadlubowska, Patrycja; Hoffmann, Daniel; Auerswald, Heidi; Schreiber, Michael] Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany.
   [Schwalbe, Birco] Asklepios Kliniken Hamburg GmbH, Asklepios Klin Nord Heidberg, Dept Neurosurg, D-22417 Hamburg, Germany.
   [Auerswald, Heidi] Inst Pasteur Cambodia, Virol Unit, Phnom Penh 12201, Cambodia.
RP Schreiber, M (corresponding author), Bernhard Nocht Inst Trop Med, Dept Virol, D-20359 Hamburg, Germany.
EM Michael.Schreiber@bnitm.de
OI Auerswald, Heidi/0000-0002-4717-7618
FU Werner-Otto-Stiftung, Hamburg, Germany [6/95]
FX This research was funded by the Werner-Otto-Stiftung, Hamburg, Germany,
   grant number 6/95 on May 2019.
CR Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853
   Ao ZJ, 2008, ANTIVIR RES, V79, P12, DOI 10.1016/j.antiviral.2008.02.001
   Asin-Milan O, 2014, J VIROL METHODS, V204, P53, DOI 10.1016/j.jviromet.2014.04.004
   Bello L, 2001, NEUROSURGERY, V49, P380, DOI 10.1097/00006123-200108000-00022
   BILZER T, 1991, VIRCHOWS ARCH A, V418, P281, DOI 10.1007/BF01600156
   Carnell GW, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00161
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chiocca EA, 2004, MOL THER, V10, P958, DOI 10.1016/j.ymthe.2004.07.021
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435
   Dey M, 2011, STEM CELL REV REP, V7, P119, DOI 10.1007/s12015-010-9132-7
   Forsyth P, 2008, MOL THER, V16, P627, DOI 10.1038/sj.mt.6300403
   Freeman AI, 2006, MOL THER, V13, P221, DOI 10.1016/j.ymthe.2005.08.016
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Geletneky K, 2017, MOL THER, V25, P2620, DOI 10.1016/j.ymthe.2017.08.016
   Gil M, 2014, J IMMUNOL, V193, P5327, DOI 10.4049/jimmunol.1400201
   Gil M, 2013, P NATL ACAD SCI USA, V110, pE1291, DOI 10.1073/pnas.1220580110
   Gladson CL, 1996, J NEUROPATH EXP NEUR, V55, P1143, DOI 10.1097/00005072-199611000-00005
   Grehan K, 2015, METHODSX, V2, P379, DOI 10.1016/j.mex.2015.09.003
   Guo DH, 2014, DNA CELL BIOL, V33, P20, DOI 10.1089/dna.2013.2193
   Harrow S, 2004, GENE THER, V11, P1648, DOI 10.1038/sj.gt.3302289
   HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995
   HEINZ FX, 1994, VIROLOGY, V198, P109, DOI 10.1006/viro.1994.1013
   HIGGINS G K, 1951, Bull Hosp Joint Dis, V12, P379
   Hou PP, 2015, SCI REP-UK, V5, DOI 10.1038/srep15577
   Hu HP, 2007, VIROLOGY, V368, P376, DOI 10.1016/j.virol.2007.06.026
   Iannolo G, 2008, CRIT REV ONCOL HEMAT, V66, P42, DOI 10.1016/j.critrevonc.2007.09.004
   Iannolo G, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1499-z
   Kelly E, 2007, MOL THER, V15, P651, DOI 10.1038/sj.mt.6300108
   Kicielinski KP, 2014, MOL THER, V22, P1056, DOI 10.1038/mt.2014.21
   Kobinger GP, 2001, NAT BIOTECHNOL, V19, P225, DOI 10.1038/85664
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lang FF, 2018, J CLIN ONCOL, V36, P1419, DOI 10.1200/JCO.2017.75.8219
   Li CQ, 2019, VET MICROBIOL, V237, DOI 10.1016/j.vetmic.2019.108400
   Li QQ, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1963
   Maniatis T., 1982, MOL CLONING LABORATO, P86
   Markert JM, 2014, MOL THER, V22, P1048, DOI 10.1038/mt.2014.22
   Markert JM, 2009, MOL THER, V17, P199, DOI 10.1038/mt.2008.228
   Markert JM, 2000, GENE THER, V7, P867, DOI 10.1038/sj.gt.3301205
   Matsuda M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34865-y
   Mercier-Delarue S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177882
   Nie YC, 2004, BIOCHEM BIOPH RES CO, V321, P994, DOI 10.1016/j.bbrc.2004.07.060
   Papanastassiou V, 2002, GENE THER, V9, P398, DOI 10.1038/sj.gt.3301664
   Pierson TC, 2005, VIROLOGY, V334, P28, DOI 10.1016/j.virol.2005.01.021
   Pierson TC, 2012, CURR OPIN VIROL, V2, P168, DOI 10.1016/j.coviro.2012.02.011
   PONTEN J, 2009, ACTA PATHOL MIC SC, V74, P465
   Rampling R, 2000, GENE THER, V7, P859, DOI 10.1038/sj.gt.3301184
   Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287
   Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146
   Schambach A, 2016, RECENT RESULTS CANC, V209, P17, DOI 10.1007/978-3-319-42934-2_2
   Schnell O, 2008, BRAIN PATHOL, V18, P378, DOI 10.1111/j.1750-3639.2008.00137.x
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Stepanenko AA, 2018, CANCERS, V10, DOI 10.3390/cancers10120492
   Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7
   Suphatrakul A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194399
   Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400
   Vazquez C, 2020, CELL STEM CELL, V26, P133, DOI 10.1016/j.stem.2020.01.007
   Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886
   Wang SB, 2020, CELL REP, V30, P969, DOI 10.1016/j.celrep.2019.11.020
   Weller M, 2016, ONCOTARGET, V7, P15018, DOI 10.18632/oncotarget.7588
   Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xu YL, 2018, CANCER CELL, V33, P13, DOI 10.1016/j.ccell.2017.12.002
   Zhu GD, 2011, BRAIN RES, V1390, P59, DOI 10.1016/j.brainres.2011.03.050
   Zhu Z, 2020, CELL STEM CELL, V26, P187, DOI 10.1016/j.stem.2019.11.016
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 67
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2072-6694
J9 CANCERS
JI Cancers
PD APR
PY 2020
VL 12
IS 4
AR 1000
DI 10.3390/cancers12041000
PG 18
WC Oncology
SC Oncology
GA LR3IP
UT WOS:000535587400228
PM 32325703
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Almeida, RD
   Braz-de-Melo, HA
   Santos, ID
   Correa, R
   Kobinger, GP
   Magalhaes, KG
AF Almeida, Raquel das Neves
   Braz-de-Melo, Heloisa Antoniella
   Santos, Igor de Oliveira
   Correa, Rafael
   Kobinger, Gary P.
   Magalhaes, Kelly Grace
TI The Cellular Impact of the ZIKA Virus on Male Reproductive Tract
   Immunology and Physiology
SO CELLS
LA English
DT Review
DE Sertoli cells; Leydig cells; ZIKA virus; arboviruses; infertility
ID BLOOD-TESTIS BARRIER; SEXUAL TRANSMISSION; IMMUNE PRIVILEGE; MAST-CELLS;
   GERM-CELLS; CROSS-TALK; INFECTION; SERTOLI; IDENTIFICATION; VACCINE
AB Zika virus (ZIKV) has been reported by several groups as an important virus causing pathological damage in the male reproductive tract. ZIKV can infect and persist in testicular somatic and germ cells, as well as spermatozoa, leading to cell death and testicular atrophy. ZIKV has also been detected in semen samples from ZIKV-infected patients. This has huge implications for human reproduction. Global scientific efforts are being applied to understand the mechanisms related to arboviruses persistency, pathogenesis, and host cellular response to suggest a potential target to develop robust antiviral therapeutics and vaccines. Here, we discuss the cellular modulation of the immunologic and physiologic properties of the male reproductive tract environment caused by arboviruses infection, focusing on ZIKV. We also present an overview of the current vaccine effects and therapeutic targets against ZIKV infection that may impact the testis and male fertility.
C1 [Almeida, Raquel das Neves; Braz-de-Melo, Heloisa Antoniella; Santos, Igor de Oliveira; Correa, Rafael; Magalhaes, Kelly Grace] Univ Brasilia, Dept Cell Biol, Lab Immunol & Inflammat, BR-70910900 Brasilia, DF, Brazil.
   [Kobinger, Gary P.] Univ Laval, Dept Microbiol Infectiol & Immunol, Quebec City, PQ G1V 4G2, Canada.
   [Kobinger, Gary P.] Univ Laval, Ctr Rech Infectiol, CHU Quebec, Quebec City, PQ G1V 4G2, Canada.
RP Magalhaes, KG (corresponding author), Univ Brasilia, Dept Cell Biol, Lab Immunol & Inflammat, BR-70910900 Brasilia, DF, Brazil.
EM raquel.unb.bio@gmail.com; heloisa.antoniella@gmail.com;
   igorosantosbio@gmail.com; rafaelcorrea31@gmail.com;
   Gary.Kobinger@crchudequebec.ulaval.ca; kellymagalhaes@unb.br
RI ; Magalhaes, Kelly Grace/A-6966-2010
OI Correa, Rafael/0000-0003-2989-2383; SANTOS, IGOR/0000-0001-6036-6694;
   Magalhaes, Kelly Grace/0000-0002-7435-5272; Braz de Melo, Heloisa
   Antoniella/0000-0003-3327-4633
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Alves MG, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.23992
   Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1
   Cardona-Ospina JA, 2018, INT J INFECT DIS, V76, P126, DOI 10.1016/j.ijid.2018.08.022
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Ayres CFJ, 2016, LANCET INFECT DIS, V16, P278, DOI 10.1016/S1473-3099(16)00073-6
   Bagasra O, 2017, APPL IMMUNOHISTO M M, V25, P679, DOI 10.1097/PAI.0000000000000580
   Barbosa CM, 2018, EMERG INFECT DIS, V24, P176, DOI 10.3201/eid2401.171310
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bhushan S, 2009, J REPROD IMMUNOL, V83, P164, DOI 10.1016/j.jri.2009.07.007
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carlos A., 2016, IDCASES, V6, P100
   Cassuto NG, 2018, J GYNECOL OBSTET HUM, V47, P211, DOI 10.1016/j.jogoh.2018.02.004
   Center for Disease Control and Prevention CDC, CDC 1 FEM TO MAL SEX
   Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790
   Moizeis RNC, 2018, PATHOG GLOB HEALTH, V112, P182, DOI 10.1080/20477724.2018.1478777
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de La Vega MA, 2019, J INFECT DIS, V219, P365, DOI 10.1093/infdis/jiy336
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong SP, 2018, VIROL SIN, V33, P125, DOI 10.1007/s12250-018-0007-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   European Centre for Disease Prevention and Control, RAP RISK ASS SEX TRA
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Filippini A, 2001, HUM REPROD UPDATE, V7, P444, DOI 10.1093/humupd/7.5.444
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Fujisawa M, 2001, UROL RES, V29, P144, DOI 10.1007/s002400100179
   Garg H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110631
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   Griswold MD, 1998, SEMIN CELL DEV BIOL, V9, P411, DOI 10.1006/scdb.1998.0203
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gurung P., 2019, PHYSL MALE REPROD SY
   Halabi J, 2020, J INFECT DIS, V221, P1506, DOI 10.1093/infdis/jiz533
   Han DS, 2016, ENCYCLOPEDIA OF IMMUNOBIOLOGY, VOL 5: PHYSIOLOGY AND IMMUNE SYSTEM DYSFUNCTION, P46, DOI 10.1016/B978-0-12-374279-7.19009-5
   Hedger MP, 2000, J REPROD IMMUNOL, V48, P69, DOI 10.1016/S0165-0378(00)00071-1
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Huits R, 2017, B WORLD HEALTH ORGAN, V95, P802, DOI [10.2471/BLT.17.181370, 10.2471/blt.17.181370]
   Hussain A, 2018, CUREUS, V10, DOI 10.7759/cureus.3290
   Hussein MR, 2005, FERTIL STERIL, V83, P1447, DOI 10.1016/j.fertnstert.2004.11.062
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Jiang XH, 2014, ASIAN J ANDROL, V16, P572, DOI 10.4103/1008-682X.125401
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jones R.E., 2013, HUMAN REPROD BIOL
   Kaur G, 2017, ENVIRON EPIGENETICS, V3, DOI 10.1093/eep/dvx012
   Kelly DA, 2016, INTEGR COMP BIOL, V56, P630, DOI 10.1093/icb/icw103
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lalle E, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.18.18-00197
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Laureti M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02180
   Li MWM, 2009, CYTOKINE GROWTH F R, V20, P329, DOI 10.1016/j.cytogfr.2009.07.007
   Luca G, 2018, PROTEIN PEPTIDE LETT, V25, P440, DOI 10.2174/0929866525666180412163151
   Mackay IM, 2015, LANCET INFECT DIS, V15, P149, DOI 10.1016/S1473-3099(14)71033-3
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Matheron S, 2016, CLIN INFECT DIS, V63, DOI 10.1093/cid/ciw509
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   MCCARREY JR, 1992, DEV BIOL, V154, P160, DOI 10.1016/0012-1606(92)90056-M
   McDonald EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006691
   Mital P, 2011, BIOL REPROD, V84, P851, DOI 10.1095/biolreprod.110.087452
   Mlera L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010042
   Molton JS, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay023
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Mossadegh-Keller N, 2018, CELL IMMUNOL, V330, P120, DOI 10.1016/j.cellimm.2018.03.009
   Mossadegh-Keller N, 2017, J EXP MED, V214, P2829, DOI 10.1084/jem.20170829
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2017, CLIN MICROBIOL INFEC, V23, DOI 10.1016/j.cmi.2017.07.006
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009
   Nicastri E, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.32.30314
   NISTAL M, 1984, ACTA ANAT, V119, P155
   Souto IO, 2018, ENFERM INFEC MICR CL, V36, P21, DOI 10.1016/j.eimc.2016.10.009
   Patel D.A., 2003, REPROD HLTH EPIDEMIO, P3
   Picut C.A., 2017, IMMUNOPATHOLOGY TOXI
   PUDNEY J, 1991, AM J PATHOL, V139, P149
   RAGHUPATHY R, 1990, CURR OPIN IMMUNOL, V2, P757, DOI 10.1016/0952-7915(90)90046-J
   Ramaswamy S., 2015, SPERMATOGENESIS, V4, DOI DOI 10.1080/21565562.2014.996025
   Rival C, 2006, CELL TISSUE RES, V324, P311, DOI 10.1007/s00441-005-0129-5
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roulet V, 2006, AM J PATHOL, V169, P2094, DOI 10.2353/ajpath.2006.060191
   Roundy CM, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.85
   Saiz JC, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00496
   Salam AP, 2017, EMERG INFECT DIS, V23, P1922, DOI 10.3201/eid2311.171049
   Salas-Huetos A, 2020, ANDROLOGY-US, V8, P7, DOI 10.1111/andr.12714
   Schrade A, 2016, ENDOCRINOLOGY, V157, P2416, DOI 10.1210/en.2015-1927
   Shamim M, 2011, J PAK MED ASSOC, V61, P601
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Si LL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02250
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Smith RD, 2004, HUM PATHOL, V35, P254, DOI 10.1016/j.humpath.2003.09.007
   Sourisseau M, 2007, PLOS PATHOG, V3, P804, DOI 10.1371/journal.ppat.0030089
   Stassen L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040198
   Strange DP, 2019, MBIO, V10, DOI 10.1128/mBio.01372-19
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Syriou V, 2018, EUR CYTOKINE NETW, V29, P73, DOI 10.1684/ecn.2018.0412
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Vouga M, 2016, PRENATAL DIAG, V36, P799, DOI 10.1002/pd.4880
   Wang LF, 2018, EXP THER MED, V15, P300, DOI 10.3892/etm.2017.5386
   Wang M, 2017, J IMMUNOL, V198, P4327, DOI 10.4049/jimmunol.1700162
   Windschuttl S, 2014, ANDROLOGY-US, V2, P615, DOI 10.1111/j.2047-2927.2014.00227.x
   Winnall WR, 2013, J REPROD IMMUNOL, V97, P147, DOI 10.1016/j.jri.2013.01.001
   World Health Organization, SEX TRANSM INF STIS
   World Health Organization (WHO), 2018, GLOB HLTH SECT STRAT
   World Health Organization (WHO), 2016, P EM COMM ZIK VIR OB
   Wu SW, 2020, TRENDS MOL MED, V26, P215, DOI 10.1016/j.molmed.2019.09.006
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao ST, 2014, CELL MOL IMMUNOL, V11, P428, DOI 10.1038/cmi.2014.38
   Zheng BH, 2019, VET MICROBIOL, V238, DOI 10.1016/j.vetmic.2019.108430
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 123
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD APR
PY 2020
VL 9
IS 4
AR 1006
DI 10.3390/cells9041006
PG 17
WC Cell Biology
SC Cell Biology
GA LR2XW
UT WOS:000535559500217
PM 32325652
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rabelo, K
   Goncalves, AJD
   de Souza, LJ
   Sales, AP
   de Lima, SMB
   Trindade, GF
   Ciambarella, BT
   Tasmo, NRA
   Diaz, BL
   de Carvalho, JJ
   Duarte, MPD
   Paes, MV
AF Rabelo, Kissila
   da Silva Goncalves, Antonio Jose
   de Souza, Luiz Jose
   Sales, Anna Paula
   Barbosa de Lima, Sheila Maria
   Trindade, Gisela Freitas
   Ciambarella, Bianca Torres
   Amorim Tasmo, Natalia Recardo
   Diaz, Bruno Lourenco
   de Carvalho, Jorge Jose
   de Oliveira Duarte, Marcia Pereira
   Paes, Marciano Viana
TI Zika Virus Infects Human Placental Mast Cells and the HMC-1 Cell Line,
   and Triggers Degranulation, Cytokine Release and Ultrastructural Changes
SO CELLS
LA English
DT Article
DE flavivirus; immune response; inflammatory mediator
ID BETA-HEXOSAMINIDASE; EXPRESSION; IL-6
AB Zika virus (ZIKV) is an emergent arthropod-borne virus whose outbreak in Brazil has brought major public health problems. Infected individuals have different symptoms, including rash and pruritus, which can be relieved by the administration of antiallergics. In the case of pregnant women, ZIKV can cross the placenta and infect the fetus leading to congenital defects. We have identified that mast cells in the placentae of patients who had Zika during pregnancy can be infected. This led to our investigation on the possible role of mast cells during a ZIKV infection, using the HMC-1 cell line. We analyzed their permissiveness to infection, release of mediators and ultrastructural changes. Flow cytometry detection of ZIKV-NS1 expression 24 h post infection in 45.3% of cells showed that HMC-1 cells are permissive to ZIKV infection. Following infection, beta-hexosaminidase was measured in the supernatant of the cells with a notable release at 30 min. In addition, an increase in TNF-alpha, IL-6, IL-10 and VEGF levels were measured at 6 h and 24 h post infection. Lastly, different intracellular changes were observed in an ultrastructural analysis of infected cells. Our findings suggest that mast cells may represent an important source of mediators that can activate other immune cell types during a ZIKV infection, which has the potential to be a major contributor in the spread of the virus in cases of vertical transmission.
C1 [Rabelo, Kissila; Ciambarella, Bianca Torres; de Carvalho, Jorge Jose] Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, BR-20551030 Rio De Janeiro, Brazil.
   [da Silva Goncalves, Antonio Jose; de Oliveira Duarte, Marcia Pereira; Paes, Marciano Viana] Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040900 Rio De Janeiro, Brazil.
   [de Souza, Luiz Jose; Sales, Anna Paula] Fac Med Campos, BR-28035581 Rio De Janeiro, Brazil.
   [Barbosa de Lima, Sheila Maria; Trindade, Gisela Freitas] Biomanguinhos, Lab Tecnol Virol, BR-21040900 Rio De Janeiro, Brazil.
   [Amorim Tasmo, Natalia Recardo; Diaz, Bruno Lourenco] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Lab Inflamacao, BR-21941170 Rio De Janeiro, Brazil.
RP Rabelo, K (corresponding author), Univ Estado Rio de Janeiro, Lab Ultraestrutura & Biol Tecidual, BR-20551030 Rio De Janeiro, Brazil.; Duarte, MPD; Paes, MV (corresponding author), Inst Oswaldo Cruz, Lab Interdisciplinar Pesquisas Med, BR-21040900 Rio De Janeiro, Brazil.
EM kissilarabelo91@gmail.com; ajsgoncalves@gmail.com;
   luizjosedes@gmail.com; ap.sss@hotmail.com; smaria@bio.fiocruz.br;
   gisela.freitas@bio.fiocruz.br; bia.btc2@gmail.com;
   nataliaamorim1@hotmail.com; bldiaz@biof.ufrj.br; jjcarv@gmail.com;
   marciapo@gmail.com; marciano@ioc.fiocruz.br
OI Trindade, Gisela/0000-0002-1630-4143; Paes,
   Marciano/0000-0002-2266-2801; Rabelo, Kissila/0000-0001-7579-7788
FU CNPqNational Council for Scientific and Technological Development
   (CNPq); FAPERJCarlos Chagas Filho Foundation for Research Support of the
   State of Rio de Janeiro (FAPERJ) [E-26/010.001.498/2016,
   E-26/110.511/2014]
FX This research was funded by CNPq and the FAPERJ, grant number
   (E-26/010.001.498/2016 and E-26/110.511/2014).
CR Abushouk AI, 2016, J CLIN VIROL, V84, P53, DOI 10.1016/j.jcv.2016.09.012
   Arciuch LP, 1999, ACTA BIOCHIM POL, V46, P977, DOI 10.18388/abp.1999_4122
   Babina M, 2016, EXP DERMATOL, V25, P434, DOI 10.1111/exd.12924
   Brown MG, 2006, J LEUKOCYTE BIOL, V80, P1242, DOI 10.1189/jlb.0805441
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chang HW, 2020, ALLERGY, V75, P1371, DOI 10.1111/all.14186
   Cochrane DE, 2011, INFLAMM RES, V60, P1139, DOI 10.1007/s00011-011-0378-6
   Cop N, 2018, CYTOM PART B-CLIN CY, V94, P405, DOI 10.1002/cyto.b.21547
   Derbala Y, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13128
   EADY RAJ, 1979, BRIT J DERMATOL, V100, P623, DOI 10.1111/j.1365-2133.1979.tb08065.x
   Escadafal C, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002730
   Faas MM, 2018, PLACENTA, V69, P125, DOI 10.1016/j.placenta.2018.04.012
   Fish-Low CY, 2019, MALAYS J PATHOL, V41, P41
   Fukuishi N, 2014, J IMMUNOL, V193, P1886, DOI 10.4049/jimmunol.1302520
   Furuta T, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001505
   Gilchrist M, 2008, IMMUNOLOGY, V123, P209, DOI 10.1111/j.1365-2567.2007.02688.x
   Garcell HG, 2020, J INFECT PUBLIC HEAL, V13, P173, DOI 10.1016/j.jiph.2019.07.006
   Gubler D., 2007, FIELDS VIROLOGY
   Haase K, 2019, ADV SCI, V6, DOI 10.1002/advs.201900878
   Hunter CA, 2015, NAT IMMUNOL, V16, P448, DOI 10.1038/ni.3153
   Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169
   Kam YW, 2017, J INFECT DIS, V216, P172, DOI 10.1093/infdis/jix261
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Londono-Renteria B, 2017, DNA CELL BIOL, V36, P423, DOI 10.1089/dna.2017.3765
   Matsuno T, 2018, ALLERGOL INT, V67, pS18, DOI 10.1016/j.alit.2018.05.001
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   McHale C, 2018, BBA-GEN SUBJECTS, V1862, P1069, DOI 10.1016/j.bbagen.2018.01.020
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   NILSSON G, 1994, SCAND J IMMUNOL, V39, P489, DOI 10.1111/j.1365-3083.1994.tb03404.x
   Pagliari C, 2006, MYCOPATHOLOGIA, V162, P331, DOI 10.1007/s11046-006-0069-y
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Polukort SH, 2016, J IMMUNOL, V196, P4865, DOI 10.4049/jimmunol.1600066
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Schemann M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052104
   Sherif NA, 2020, REV MED VIROL, V30, DOI 10.1002/rmv.2084
   Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tadkalkar N, 2019, INDIAN J HEMATOL BLO, V35, P502, DOI 10.1007/s12288-018-1058-2
   Tanaka T, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016295
   Teixeira FME, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00175
   Troupin A, 2016, J IMMUNOL, V197, P4382, DOI 10.4049/jimmunol.1600846
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Woidacki K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00029
   Zulu MZ, 2019, J INNATE IMMUN, V11, P447, DOI 10.1159/000497416
NR 50
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD APR
PY 2020
VL 9
IS 4
AR 975
DI 10.3390/cells9040975
PG 15
WC Cell Biology
SC Cell Biology
GA LR2XW
UT WOS:000535559500186
PM 32316163
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roby, JA
   Esser-Nobis, K
   Dewey-Verstelle, EC
   Fairgrieve, MR
   Schwerk, J
   Lu, AY
   Soveg, FW
   Hemann, EA
   Hatfield, LD
   Keller, BC
   Shapiro, A
   Forero, A
   Stencel-Baerenwald, JE
   Savan, R
   Gale, M
AF Roby, Justin A.
   Esser-Nobis, Katharina
   Dewey-Verstelle, Elyse C.
   Fairgrieve, Marian R.
   Schwerk, Johannes
   Lu, Amy Y.
   Soveg, Frank W.
   Hemann, Emily A.
   Hatfield, Lauren D.
   Keller, Brian C.
   Shapiro, Alexander
   Forero, Adriana
   Stencel-Baerenwald, Jennifer E.
   Savan, Ram
   Gale, Michael, Jr.
TI Flavivirus Nonstructural Protein NS5 Dysregulates HSP90 to Broadly
   Inhibit JAK/STAT Signaling
SO CELLS
LA English
DT Article
DE flavivirus; JAK; STAT; cytokine; West Nile virus; Zika virus; HSP90;
   NS5; virus-host interactions; anti-viral signaling; immune response
ID WEST-NILE-VIRUS; ZIKA VIRUS; ALPHA/BETA-INTERFERON; DENGUE VIRUS;
   REPLICATION; INFECTION; STRAIN; CELLS; HEAT-SHOCK-PROTEIN-70; RESISTANCE
AB Pathogenic flaviviruses antagonize host cell Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling downstream of interferons alpha/beta. Here, we show that flaviviruses inhibit JAK/STAT signaling induced by a wide range of cytokines beyond interferon, including interleukins. This broad inhibition was mapped to viral nonstructural protein 5 (NS5) binding to cellular heat shock protein 90 (HSP90), resulting in reduced Janus kinase-HSP90 interaction and thus destabilization of unchaperoned JAKs (and other kinase clients) of HSP90 during infection by Zika virus, West Nile virus, and Japanese encephalitis virus. Our studies implicate viral dysregulation of HSP90 and the JAK/STAT pathway as a critical determinant of cytokine signaling control during flavivirus infection.
C1 [Roby, Justin A.; Esser-Nobis, Katharina; Dewey-Verstelle, Elyse C.; Fairgrieve, Marian R.; Schwerk, Johannes; Lu, Amy Y.; Soveg, Frank W.; Hemann, Emily A.; Hatfield, Lauren D.; Forero, Adriana; Stencel-Baerenwald, Jennifer E.; Savan, Ram; Gale, Michael, Jr.] Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98109 USA.
   [Lu, Amy Y.; Gale, Michael, Jr.] Univ Washington, Dept Global Hlth & Microbiol, Seattle, WA 98195 USA.
   [Keller, Brian C.] Ohio State Univ, Div Pulm Crit Care & Sleep Med, Coll Med, Columbus, OH 43210 USA.
   [Shapiro, Alexander] Shorewood High Sch, Shoreline, WA 98133 USA.
   [Roby, Justin A.] Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.
RP Roby, JA; Gale, M (corresponding author), Univ Washington, Sch Med, Ctr Innate Immun & Immune Dis, Dept Immunol, Seattle, WA 98109 USA.; Gale, M (corresponding author), Univ Washington, Dept Global Hlth & Microbiol, Seattle, WA 98195 USA.; Roby, JA (corresponding author), Charles Sturt Univ, Sch Biomed Sci, Wagga Wagga, NSW 2678, Australia.
EM jroby@csu.edu.au; ken10@uw.edu; edewey@uw.edu;
   marianfairgrieve@gmail.com; jschwerk@uw.edu; amyyhlu@uw.edu;
   fsoveg@uw.edu; eahemann@uw.edu; ldaarreberg@gmail.com;
   Keller2@osumc.edu; ags245@cornell.edu; forera@uw.edu;
   Jen.Baerenwald@gmail.com; savanram@uw.edu; mgale@uw.edu
OI Roby, Justin/0000-0003-2434-4273; Schwerk, Johannes/0000-0002-5964-7162
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32AI007509,
   AI145296, AI143265, AI104002, AI100625, AI127463]; AHAAmerican Heart
   Association [17POST33660907]; Perkins Coie Award for Discovery
FX This research was funded by National Institutes of Health grants
   T32AI007509, AI145296, AI143265, AI104002, AI100625, AI127463, and AHA
   Award 17POST33660907 (EAH). A Perkins Coie Award for Discovery supported
   J.A.R.
CR Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bauer S, 2007, NAT REV NEUROSCI, V8, P221, DOI 10.1038/nrn2054
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bocchini Claire E, 2014, JAKSTAT, V3, pe970459, DOI 10.4161/21623988.2014.970459
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Chang YS, 2006, J CELL BIOCHEM, V97, P156, DOI 10.1002/jcb.20623
   Daffis S, 2011, J VIROL, V85, P5664, DOI 10.1128/JVI.00232-11
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Evans JD, 2007, J VIROL, V81, P11809, DOI 10.1128/JVI.00791-07
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581
   JEN G, 1980, J VIROL, V35, P150, DOI 10.1128/JVI.35.1.150-156.1980
   Keller BC, 2006, J VIROL, V80, P9424, DOI 10.1128/JVI.00768-06
   Kovanich D, 2019, J PROTEOME RES, V18, P3203, DOI 10.1021/acs.jproteome.9b00318
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Lu CY, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18050954
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Muller DA, 2013, ANTIVIR RES, V98, P192, DOI 10.1016/j.antiviral.2013.03.008
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Paradkar PN, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005143
   Pujhari S, 2019, EMERG MICROBES INFEC, V8, P8, DOI 10.1080/22221751.2018.1557988
   Robert J, 2003, DEV COMP IMMUNOL, V27, P449, DOI 10.1016/S0145-305X(02)00160-X
   Roehrig JT, 2013, VIRUSES-BASEL, V5, P3088, DOI 10.3390/v5123088
   Rothan HA, 2019, ANTIVIR RES, V171, DOI 10.1016/j.antiviral.2019.104590
   Schoof N, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-17
   Schopf FH, 2017, NAT REV MOL CELL BIO, V18, P345, DOI 10.1038/nrm.2017.20
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shang LM, 2006, J BIOL CHEM, V281, P1876, DOI 10.1074/jbc.M509901200
   Shuai K, 2003, NAT REV IMMUNOL, V3, P900, DOI 10.1038/nri1226
   Smith AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016206
   Srisutthisamphan K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22639-5
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Suthar MS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000757
   Taguwa S, 2019, CELL REP, V26, P906, DOI 10.1016/j.celrep.2018.12.095
   Taguwa S, 2015, CELL, V163, P1108, DOI 10.1016/j.cell.2015.10.046
   Waldorf KMA, 2018, NAT MED, V24, P368, DOI 10.1038/nm.4485
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004
NR 50
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD APR
PY 2020
VL 9
IS 4
AR 899
DI 10.3390/cells9040899
PG 20
WC Cell Biology
SC Cell Biology
GA LR2XW
UT WOS:000535559500110
PM 32272626
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Athayde, CC
   Nishijuka, FA
   Queiroz, MCD
   Luna, MM
   Figueiredo, JL
   de Albuquerque, NM
   de Castilho, SCR
   Castro, RRT
AF de Athayde, Carolina Cunto
   Nishijuka, Fabio Akio
   de Campos Queiroz, Marcia Cavalcanti
   Luna, Monica Medeiros
   Figueiredo, Jaime Lobo
   de Albuquerque, Nadia Matias
   Ribeiro de Castilho, Sebastiao Carlos
   Castro, Renata R. T.
TI Acute Decompensated Heart Failure due to Chikungunya Fever
SO ARQUIVOS BRASILEIROS DE CARDIOLOGIA
LA English
DT Article
DE Heart Failure/physiopathology; Treatment Refusai; Pneumococcal Vaccine,
   Arbovirus Infections; Zika Virus Infection; ChiKungunia fever
ID MYOCARDITIS; DISEASE
C1 [de Athayde, Carolina Cunto; Nishijuka, Fabio Akio; de Campos Queiroz, Marcia Cavalcanti; Luna, Monica Medeiros; Figueiredo, Jaime Lobo; de Albuquerque, Nadia Matias; Ribeiro de Castilho, Sebastiao Carlos; Castro, Renata R. T.] Hosp Naval Marcilio Dias, Card Iol, Rua Cesar Zama 185, BR-20725090 Rio De Janeiro, RJ, Brazil.
   [Castro, Renata R. T.] Brigham & Womens Hosp, Med, 75 Francis St, Boston, MA 02115 USA.
RP de Athayde, CC (corresponding author), Hosp Naval Marcilio Dias, Card Iol, Rua Cesar Zama 185, BR-20725090 Rio De Janeiro, RJ, Brazil.
EM carol.athayde@me.com
RI Nishijuka, Fabio Akio/J-2734-2015
OI Nishijuka, Fabio Akio/0000-0002-9926-0368
CR Alvarez Maria Fernanda, 2017, F1000Res, V6, P390, DOI 10.12688/f1000research.11078.1
   Barretto Antonio Carlos Pereira, 2008, Arq. Bras. Cardiol., V91, P335, DOI 10.1590/S0066-782X2008001700009
   Benjamin EJ, 2018, CIRCULATION, V137, pE67, DOI 10.1161/CIR.0000000000000558
   de Albuquerque DC, 2015, ARQ BRAS CARDIOL, V104, P433, DOI 10.5935/abc.20150031
   DONALISIO MR, 2017, REV SAUDE PUBL, V51, P10
   Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Mirabel M, 2007, INT J CARDIOL, V121, pE7, DOI 10.1016/j.ijcard.2007.04.153
   Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7
   OBEYESEKERE I, 1973, AM HEART J, V85, P186, DOI 10.1016/0002-8703(73)90459-6
   Rohde LEP, 2018, ARQ BRAS CARDIOL, V111, P436, DOI 10.5935/abc.20180190
NR 11
TC 0
Z9 0
U1 0
U2 0
PU ARQUIVOS BRASILEIROS CARDIOLOGIA
PI RIO DE JANEIRO
PA AVENIDA MARECHAL CAMARA 160-330 CENTRO, RIO DE JANEIRO, RJ 20 020-907,
   BRAZIL
SN 0066-782X
J9 ARQ BRAS CARDIOL
JI Arq. Bras. Cardiol.
PD APR
PY 2020
VL 114
IS 4
SU 1
BP 19
EP 22
DI 10.36660/abc.20180316
PG 4
WC Cardiac & Cardiovascular Systems
SC Cardiovascular System & Cardiology
GA LP8ZV
UT WOS:000534606600006
PM 32428107
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Volkmar, N
   Christianson, JC
AF Volkmar, Norbert
   Christianson, John C.
TI Squaring the EMC - how promoting membrane protein biogenesis impacts
   cellular functions and organismal homeostasis
SO JOURNAL OF CELL SCIENCE
LA English
DT Review
DE EMC; Membrane protein; Protein quality control; Protein folding
ID ENDOPLASMIC-RETICULUM; TETRATRICOPEPTIDE REPEAT; TRANSMEMBRANE PROTEIN;
   LIPID HOMEOSTASIS; QUALITY-CONTROL; ZIKA VIRUS; IDENTIFICATION; COMPLEX;
   SURFACTANT; MUTATIONS
AB Integral membrane proteins play key functional roles at organelles and the plasma membrane, necessitating their efficient and accurate biogenesis to ensure appropriate targeting and activity. The endoplasmic reticulum membrane protein complex (EMC) has recently emerged as an important eukaryotic complex for biogenesis of integral membrane proteins by promoting insertion and stability of atypical and sub-optimal transmembrane domains (TMDs). Although confirmed as a bona fide complex almost a decade ago, light is just now being shed on themechanism and selectivity underlying the cellular responsibilities of the EMC. In this Review, we revisit the myriad of functions attributed the EMC through the lens of these new mechanistic insights, to address questions of the cellular and organismal roles the EMC has evolved to undertake.
C1 [Volkmar, Norbert] Univ Cambridge, Jeffrey Cheah Biomed Ctr, Dept Med, Cambridge Biomed Campus, Cambridge CB2 0XY, England.
   [Christianson, John C.] Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford Ctr Translat Myeloma Res, Botnar Res Ctr, Oxford OX3 7LD, England.
RP Christianson, JC (corresponding author), Univ Oxford, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford Ctr Translat Myeloma Res, Botnar Res Ctr, Oxford OX3 7LD, England.
EM john.christianson@ndorms.ox.ac.uk
OI Christianson, John/0000-0002-0474-1207; Volkmar,
   Norbert/0000-0003-0766-5606
FU University of Oxford
FX Open access funding provided by University of Oxford. Deposited in PMC
   for immediate release.
CR Abu-Safieh L, 2013, GENOME RES, V23, P236, DOI 10.1101/gr.144105.112
   Anghel SA, 2017, CELL REP, V21, P3708, DOI 10.1016/j.celrep.2017.12.006
   Bagchi P, 2016, ELIFE, V5, DOI 10.7554/eLife.21470
   Ballinger CA, 1999, MOL CELL BIOL, V19, P4535
   Bircham PW, 2011, MOL BIOSYST, V7, P2589, DOI 10.1039/c1mb05175j
   Blatch GL, 1999, BIOESSAYS, V21, P932, DOI 10.1002/(SICI)1521-1878(199911)21:11<932::AID-BIES5>3.0.CO;2-N
   Borowska MT, 2015, STRUCTURE, V23, P1715, DOI 10.1016/j.str.2015.06.025
   Brambillasca S, 2005, EMBO J, V24, P2533, DOI 10.1038/sj.emboj.7600730
   Brockerhoff SE, 1997, J NEUROSCI, V17, P4236
   Chang HCJ, 1997, MOL CELL BIOL, V17, P318, DOI 10.1128/MCB.17.1.318
   Chen R, 2009, J PROTEOME RES, V8, P651, DOI 10.1021/pr8008012
   CHEN W, 1995, P NATL ACAD SCI USA, V92, P6229, DOI 10.1073/pnas.92.14.6229
   Chen ZJ, 2015, CELL REP, V13, P573, DOI 10.1016/j.celrep.2015.09.018
   Chitwood PJ, 2019, TRENDS CELL BIOL, V29, P371, DOI 10.1016/j.tcb.2019.01.007
   Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009
   Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383
   Coelho JPL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08632-0
   Cunha DA, 2008, J CELL SCI, V121, P2308, DOI 10.1242/jcs.026062
   Diamantopoulou A, 2017, P NATL ACAD SCI USA, V114, pE6127, DOI 10.1073/pnas.1615719114
   Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356
   Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200
   Feng B, 2003, NAT CELL BIOL, V5, P781, DOI 10.1038/ncb1035
   Fitzgerald ML, 2007, J LIPID RES, V48, P621, DOI 10.1194/jlr.M600449-JLR200
   Geetha TS, 2018, MOL GENET GENOM MED, V6, P282, DOI 10.1002/mgg3.352
   Goodwin EC, 2011, MBIO, V2, DOI 10.1128/mBio.00101-11
   Goytain A, 2008, AM J PHYSIOL-CELL PH, V294, pC495, DOI 10.1152/ajpcell.00238.2007
   Greenblatt EJ, 2011, NAT STRUCT MOL BIOL, V18, P1147, DOI 10.1038/nsmb.2111
   Guna A, 2018, CURR BIOL, V28, pR498, DOI 10.1016/j.cub.2018.02.004
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012
   Harel T, 2016, AM J HUM GENET, V98, P562, DOI 10.1016/j.ajhg.2016.01.011
   Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053
   Houck SA, 2012, BBA-BIOMEMBRANES, V1818, P1108, DOI 10.1016/j.bbamem.2011.11.007
   Janer A, 2016, EMBO MOL MED, V8, P1019, DOI 10.15252/emmm.201506159
   Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983
   Junes-Gill KS, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-920
   Junes-Gill KS, 2011, J NEURO-ONCOL, V102, P197, DOI 10.1007/s11060-010-0314-6
   Kleopa KA, 2012, BRAIN RES, V1487, P198, DOI 10.1016/j.brainres.2012.03.068
   Kopec KO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077074
   Kramer NJ, 2018, NAT GENET, V50, P603, DOI 10.1038/s41588-018-0070-7
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kudze T, 2018, CELL STRESS CHAPERON, V23, P1101, DOI 10.1007/s12192-018-0908-z
   Lahiri H, 2014, ASIA-PAC J-JPN FOCU, V12
   Lakshminarayan R, 2020, CURR BIOL, V30, P854, DOI 10.1016/j.cub.2019.12.060
   Le Sommer C, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001820
   Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002
   Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033
   Li YJ, 2013, AUTOPHAGY, V9, P150, DOI 10.4161/auto.22742
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404
   Luo WJ, 2002, TRAFFIC, V3, P730, DOI 10.1034/j.1600-0854.2002.31005.x
   Ma D, 2018, NATURE, V562, P286, DOI 10.1038/s41586-018-0568-2
   Ma HM, 2015, CELL REP, V12, P673, DOI 10.1016/j.celrep.2015.06.049
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Markovich S, 2004, ANTIMICROB AGENTS CH, V48, P3871, DOI 10.1128/AAC.48.10.3871-3876.2004
   Marquez J, 2020, J CLIN INVEST, V130, P813, DOI 10.1172/JCI129308
   McClellan AJ, 2007, CELL, V131, P121, DOI 10.1016/j.cell.2007.07.036
   Mehrtash AB, 2019, SEMIN CELL DEV BIOL, V93, P111, DOI 10.1016/j.semcdb.2018.09.013
   Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007
   Ngo AM, 2019, ELIFE, V8, DOI 10.7554/eLife.48469
   Ninagawa S, 2015, J CELL BIOL, V211, P775, DOI 10.1083/jcb.201504109
   Olzmann JA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013185
   Probert F, 2015, J PROTEOME RES, V14, P2036, DOI 10.1021/pr501039k
   Raj S, 2016, ANTIMICROB AGENTS CH, V60, P1438, DOI 10.1128/AAC.02239-15
   Ravindran MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005086
   Reboll MR, 2017, CIRCULATION, V136, P1809, DOI 10.1161/CIRCULATIONAHA.117.029980
   Richard M, 2013, P NATL ACAD SCI USA, V110, pE1055, DOI 10.1073/pnas.1216154110
   Ridley AJ, 2011, CELL, V145, P1012, DOI 10.1016/j.cell.2011.06.010
   Ring G, 2008, FEBS LETT, V582, P2637, DOI 10.1016/j.febslet.2008.06.042
   Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042
   Saeed M, 2011, J BIOL CHEM, V286, P37264, DOI 10.1074/jbc.M111.259085
   Satoh T, 2015, ELIFE, V4, DOI 10.7554/eLife.06306
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2
   Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025
   Shen X, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.408
   Sherwood PW, 1999, P NATL ACAD SCI USA, V96, P7415, DOI 10.1073/pnas.96.13.7415
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Smirle J., 2013, COLD SPRING HARB PER, V5, DOI [10.1101/Science cshperspect.a015073, DOI 10.1101/SCIENCECSHPERSPECT.A015073]
   Smith CL, 2018, NUCLEIC ACIDS RES, V46, pD836, DOI 10.1093/nar/gkx1006
   Spassieva SD, 2009, BIOCHEM J, V424, P273, DOI 10.1042/BJ20090699
   Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036
   Sunde M, 2017, ANNU REV BIOCHEM, V86, P585, DOI 10.1146/annurev-biochem-061516-044847
   Tam AB, 2018, DEV CELL, V46, P327, DOI 10.1016/j.devcel.2018.04.023
   Tang XF, 2017, J CLIN INVEST, V127, P4314, DOI 10.1172/JCI94152
   Taylor MR, 2005, GENETICS, V170, P263, DOI 10.1534/genetics.104.036434
   Tian SH, 2019, CELL REP, V28, P2517, DOI 10.1016/j.celrep.2019.08.006
   Toscano MG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01160
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546
   Volkmar N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.223453
   Volmer R, 2015, CURR OPIN CELL BIOL, V33, P67, DOI 10.1016/j.ceb.2014.12.002
   Walczak CP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004007
   Wanamaker CP, 2007, J BIOL CHEM, V282, P31113, DOI 10.1074/jbc.M705369200
   Wang XK, 2017, BMB REP, V50, P411, DOI 10.5483/BMBRep.2017.50.8.065
   Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.2
   Xiong LY, 2020, CELL DEATH DIFFER, V27, P646, DOI 10.1038/s41418-019-0378-6
   Xu B, 2013, CELL, V152, P262, DOI 10.1016/j.cell.2012.11.052
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zhao RM, 2005, CELL, V120, P715, DOI 10.1016/j.cell.2004.12.024
NR 101
TC 0
Z9 0
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD APR
PY 2020
VL 133
IS 8
AR jcs243519
DI 10.1242/jcs.243519
PG 14
WC Cell Biology
SC Cell Biology
GA LP5WT
UT WOS:000534388600020
PM 32332093
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Fontenille, D
   Powell, JR
AF Fontenille, Didier
   Powell, Jeffrey R.
TI From Anonymous to Public Enemy: How Does a Mosquito Become a Feared
   Arbovirus Vector?
SO PATHOGENS
LA English
DT Article
DE mosquito; culicidae; Aedes aegypti; Aedes albopictus; emergence;
   arbovirus
ID AEDES-ALBOPICTUS DIPTERA; YELLOW-FEVER; AEGYPTI; VIRUS; CULICIDAE;
   GENOMICS; DENGUE
AB The past few decades have seen the emergence of several worldwide arbovirus epidemics (chikungunya, Zika), the expansion or recrudescence of historical arboviruses (dengue, yellow fever), and the modification of the distribution area of major vector mosquitoes such as Aedes aegypti and Ae. albopictus, raising questions about the risk of appearance of new vectors and new epidemics. In this opinion piece, we review the factors that led to the emergence of yellow fever in the Americas, define the conditions for a mosquito to become a vector, analyse the recent example of the new status of Aedes albopictus from neglected mosquito to major vector, and propose some scenarios for the future.
C1 [Fontenille, Didier] Univ Montpellier, Inst Rech Dev IRD, MIVEGEC Unit, CNRS, BP 64501, F-34394 Montpellier, France.
   [Powell, Jeffrey R.] Yale Univ, Dept Ecol & Evolutionary Biol, 21 Sachem St, New Haven, CT 06511 USA.
RP Fontenille, D (corresponding author), Univ Montpellier, Inst Rech Dev IRD, MIVEGEC Unit, CNRS, BP 64501, F-34394 Montpellier, France.
EM didier.fontenille@ird.fr; jeffrey.powell@yale.edu
OI Powell, Jeffrey/0000-0002-7651-5153
FU Institut de Recherche pour le Developpement (IRD)
FX Publication fees were covered by Institut de Recherche pour le
   Developpement (IRD).
CR Abad-Franch F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001846
   Agramonte A., 1908, BOSTON MED SURG J, V158, P927, DOI 10.1056/NEJM190806181582501
   AZAR SR, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11090867
   Brady OJ, 2020, ANNU REV ENTOMOL, V65, P191, DOI 10.1146/annurev-ento-011019-024918
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Brey PT, 2018, NATURE, V554, P31
   Chippaux JP, 2018, J VENOM ANIM TOXINS, V24, DOI 10.1186/s40409-018-0162-y
   Christophers S.R., 1960, ITS LIFE HIST BIONOM
   Cohuet A, 2010, TRENDS PARASITOL, V26, P130, DOI 10.1016/j.pt.2009.12.001
   COMBES C, 2001, PARASITISM ECOLOGY E, P728
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Delatte H, 2008, VECTOR-BORNE ZOONOT, V8, P25, DOI 10.1089/vbz.2007.0649
   Delatte H, 2011, INFECT GENET EVOL, V11, P1769, DOI 10.1016/j.meegid.2011.07.016
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Fernandes RS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56669-4
   Finlay C.J., 1881, REAL AC CIEN MED FSI
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Grmek M., 1983, MALADIES AUBE CIVILI, P527
   Haddow AD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005083
   Hadfield J, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008042
   Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1
   Houe Vincent, 2019, Emerg Microbes Infect, V8, P1265, DOI 10.1080/22221751.2019.1657785
   HUANG Y-M, 1972, Contributions of the American Entomological Institute, V9, P1
   Jacome R, 2019, INT J INFECT DIS, V87, P143, DOI 10.1016/j.ijid.2019.07.033
   Kotsakiozi P, 2017, ECOL EVOL, V7, P10143, DOI 10.1002/ece3.3514
   Lee JM, 2020, ECOHEALTH, V17, P52, DOI 10.1007/s10393-019-01457-9
   Lemos PD, 2017, MITOCHONDRIAL DNA A, V28, P50, DOI 10.3109/19401736.2015.1110793
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Macdonald G, 1957, EPIDEMIOLOGY CONTROL
   McNeill J.R., 2010, ECOLOGY WAR GREATER
   Miot E., 2019, THESIS
   Mogi M, 2017, J MED ENTOMOL, V54, P1615, DOI 10.1093/jme/tjx156
   Figueiredo LTM, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00259
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Murphy FA, 2004, EMERG INFECT DIS, V10, P762
   Nicolle C., 1933, DESTIN MALADIES INFE, P216
   Pandit PS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07896-2
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Pezzi L, 2020, ANTIVIR RES, V174, DOI 10.1016/j.antiviral.2019.104670
   Powell JR, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01266
   Powell JR, 2018, BIOSCIENCE, V68, P854, DOI 10.1093/biosci/biy119
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Reed W., 1900, PHILA MED J, V6, P790
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Schuffenecker I, 2006, PLOS MED, V3, P1058, DOI 10.1371/journal.pmed.0030263
   Smith DR, 2012, INSECT MOL BIOL, V21, P1, DOI 10.1111/j.1365-2583.2011.01098.x
   SOPER FL, 1963, AM J PUBLIC HEALTH N, V53, P7, DOI 10.2105/AJPH.53.1.7
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   TABACHNICK WJ, 1985, AM J TROP MED HYG, V34, P1219, DOI 10.4269/ajtmh.1985.34.1219
   Tangena JAA, 2017, J MED ENTOMOL, V54, P1589, DOI 10.1093/jme/tjx071
   Wasserman S, 2016, INT J INFECT DIS, V48, P98, DOI 10.1016/j.ijid.2016.04.025
   Weaver SC, 2018, ANTIVIR RES, V156, P80, DOI 10.1016/j.antiviral.2018.06.009
   Webb JLA, 2016, LANCET, V388, P556, DOI 10.1016/S0140-6736(16)31225-9
   White SK, 2018, EMERG INFECT DIS, V24, P1765, DOI 10.3201/eid2409.171957
   WHO, 1986, PREV CONTR YELL FEV, P96
   WHO, 2005, INT HLTH REG, P74
NR 58
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD APR
PY 2020
VL 9
IS 4
AR 265
DI 10.3390/pathogens9040265
PG 11
WC Microbiology
SC Microbiology
GA LP1AB
UT WOS:000534051600051
PM 32260491
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wang, WH
   Urbina, AN
   Wu, CC
   Lin, CY
   Thitithanyanont, A
   Assavalapsakul, W
   Lu, PL
   Chen, YH
   Wang, SF
AF Wang, Wen-Hung
   Urbina, Aspiro Nayim
   Wu, Chia-Ching
   Lin, Chih-Yen
   Thitithanyanont, Arunee
   Assavalapsakul, Wanchai
   Lu, Po-Liang
   Chen, Yen-Hsu
   Wang, Sheng-Fan
TI An epidemiological survey of the current status of Zika and the immune
   interaction between dengue and Zika infection in Southern Taiwan
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Zika; Dengue; Importation; Taiwan; Antibody-dependent enhancement;
   Plaque reduction neutralization test
ID PLAQUE-REDUCTION NEUTRALIZATION; ANTIBODY-DEPENDENT ENHANCEMENT;
   TRANSCRIPTASE PCR ASSAYS; IN-VITRO; VIRUS; PATHOGENESIS; OUTBREAK
AB Objectives: This study was performed to examine the current status of Zika and the effects of pre-existing dengue immunity on Zika virus (ZIKV) infection in Southern Taiwan.
   Methods: A phylogenetic tree was used to analyze the phylogeny of detected ZIKVs. Paired sera from dengue patients were collected for the determination of dengue and Zika infection. Plaque reduction neutralization tests (PRNT) and quantitative reverse transcription PCR (qRT-PCR) were used to determine the titers of neutralizing antibodies and viruses, respectively. An antibody-dependent enhancement (ADE) assay was used to evaluate the effect of anti-dengue antibodies on ZIKV infection.
   Results: Epidemiological data indicated the continuous importation of ZIKV infection from neighboring Zika epidemic countries into Taiwan. A total of 78 dengue patients were enrolled and 21 paired serum samples were obtained. PRNT90 results for the 21 samples identified eight cases of primary dengue infection and 13 cases of secondary dengue infection; two samples were positive for ZIKV (MR766). Results from the ADE assay indicated that convalescent sera from primary and secondary dengue infection patients displayed significant ADE of the ZIKV infection when compared to healthy controls (p < 0.05).
   Conclusions: This study suggests that pre-existing dengue immunity facilitates ZIKV infection and that the continuous importation of ZIKV infection may pose a threat to indigenous Zika emergence in Southern Taiwan. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Wang, Wen-Hung; Urbina, Aspiro Nayim; Lin, Chih-Yen; Chen, Yen-Hsu; Wang, Sheng-Fan] Kaohsiung Med Univ, Ctr Trop Med & Infect Dis, Kaohsiung 80708, Taiwan.
   [Wang, Wen-Hung; Lu, Po-Liang; Chen, Yen-Hsu] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung 80708, Taiwan.
   [Urbina, Aspiro Nayim] Kaohsiung Med Univ, Coll Med, Program Trop Med, Kaohsiung 80708, Taiwan.
   [Lin, Chih-Yen; Lu, Po-Liang; Wang, Sheng-Fan] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung 80708, Taiwan.
   [Thitithanyanont, Arunee] Mahidol Univ, Dept Microbiol, Fac Sci, Bangkok 10400, Thailand.
   [Assavalapsakul, Wanchai] Chulalongkorn Univ, Dept Microbiol, Fac Sci, Bangkok 10330, Thailand.
   [Wang, Sheng-Fan] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 80708, Taiwan.
RP Wang, SF (corresponding author), Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung 80708, Taiwan.
EM wasf1234@kmu.edu.tw
OI Lu, Po-Liang/0000-0002-7423-6783; Thitithanyanont,
   Arunee/0000-0002-9756-4763; Wang, Sheng-Fan/0000-0002-4183-3872; Chen,
   Yen-hsu/0000-0002-8667-4844
FU Ministry of Science and Technology, ROC [MOST
   107-2923-B-005-005-MY3,108-2918-I-037-001, 108-2320-B-037-035-MY3,
   108-2320-B-037-037, MOST 107-2923-B-005-005-MY3]
FX This work was supported by grants from the Ministry of Science and
   Technology, ROC (MOST 107-2923-B-005-005-MY3,108-2918-I-037-001,
   108-2320-B-037-035-MY3, 108-2320-B-037-037 and MOST
   107-2923-B-005-005-MY3).
CR Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Bureau TT, 2019, INB VIS TAIW TOUR ST
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chao DY, 2007, J CLIN MICROBIOL, V45, P584, DOI 10.1128/JCM.00842-06
   Chien LJ, 2006, J CLIN MICROBIOL, V44, P1295, DOI 10.1128/JCM.44.4.1295-1304.2006
   Chien YW, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4491-4
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P521, DOI 10.1016/0035-9203(52)90043-6
   Duca LM, 2017, CURR INFECT DIS REP, V19, DOI 10.1007/s11908-017-0557-x
   Duggal NK, 2019, VIROLOGY, V530, P19, DOI 10.1016/j.virol.2019.02.004
   Hermanns K, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0199-6
   Hunger I., 2018, COPING PUBLIC HLTH E
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Maeda A, 2013, VET J, V195, P33, DOI 10.1016/j.tvjl.2012.08.019
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Morrone SR, 2019, CURR OPIN VIROL, V36, P1, DOI 10.1016/j.coviro.2019.02.002
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Oliveira RAS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190098
   Pang XJ, 2017, VIROL SIN, V32, P16, DOI 10.1007/s12250-016-3855-9
   Perng GC, 2019, EMERG INFECT DIS, V25, P814, DOI 10.3201/eid2504.181449
   Pillinger M., 2016, WASHINGTON POST
   Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233
   Reid S, 2018, NEUROL CLIN, V36, P767, DOI 10.1016/j.ncl.2018.06.003
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Sa-Ngasang A, 2006, EPIDEMIOL INFECT, V134, P820, DOI 10.1017/S0950268805005753
   Salgado DM, 2020, INT J INFECT DIS, V90, P104, DOI 10.1016/j.ijid.2019.10.030
   Screaton G, 2015, NAT REV IMMUNOL, V15, P745, DOI 10.1038/nri3916
   Smith DR, 2018, AM J TROP MED HYG, V98, P432, DOI 10.4269/ajtmh.17-0685
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Taiwan CDC, 2019, ZIK VIR INF TAIW
   Wang SF, 2016, AM J TROP MED HYG, V94, P193, DOI 10.4269/ajtmh.15-0422
   Wang SF, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.46
   Wang WH, 2019, INT J INFECT DIS, V88, P88, DOI 10.1016/j.ijid.2019.09.007
   Weger-Lucarelli J, 2017, J VIROL, V91, DOI 10.1128/JVI.01765-16
   WHO, 2009, WHO DENG GUID DIAGN
   Yang CF, 2014, ACTA TROP, V130, P17, DOI 10.1016/j.actatropica.2013.10.013
   Zambrano LI, 2019, INT J INFECT DIS, V84, P136, DOI 10.1016/j.ijid.2019.05.008
   Zhao HY, 2020, J EXP MED, V217, DOI 10.1084/jem.20191792
NR 44
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2020
VL 93
BP 151
EP 159
DI 10.1016/j.ijid.2020.01.031
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA LO5AW
UT WOS:000533641400023
PM 31982624
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Mascitti, H
   Calin, R
   Dinh, A
   Makhloufi, S
   Davido, B
AF Mascitti, Helene
   Calin, Ruxandra
   Dinh, Aurelien
   Makhloufi, Sabrina
   Davido, Benjamin
TI Testicular pain associated with clear fluid meningitis: How many cases
   of Toscana virus are we missing?
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE Toscana virus; Meningitis; Testicular pain
AB Toscana virus (TOSV) is a common cause of meningitis in Mediterranean area. However, rare publications reported extra-meningeal signs. We report the third case of testicular pain associated with TOSV meningitis despite the fact that there is no evidence of semen involvement in other well-known arboviruses, except in Zika virus. (C) 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Mascitti, Helene; Calin, Ruxandra; Dinh, Aurelien; Makhloufi, Sabrina; Davido, Benjamin] Hop Univ Paris Ile De France Ouest, AP HP, Malad Infect, F-92380 Garches, France.
RP Davido, B (corresponding author), Raymond Poincare Teaching Hosp, Infect Dis Dept, F-92380 Garches, France.
EM benjamin.davido@aphp.fr
CR Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Baldelli F, 2004, CLIN INFECT DIS, V38, P515, DOI 10.1086/381201
   BEACOCK CJM, 1991, BRIT J UROL, V67, P328, DOI 10.1111/j.1464-410X.1991.tb15149.x
   Charrel RN, 2005, EMERG INFECT DIS, V11, P1657, DOI 10.3201/eid1111.050869
   Cusi Maria G, 2010, Open Virol J, V4, P22, DOI 10.2174/1874357901004020022
   de Souza AWS, 2013, REV BRAS REUMATOL, V53, P365, DOI 10.1590/S0482-50042013000400009
   Hernandez-Rodriguez J, 2012, MEDICINE, V91, P75, DOI 10.1097/MD.0b013e31824156a7
   Hviid A, 2008, LANCET, V371, P932, DOI 10.1016/S0140-6736(08)60419-5
   Miglis MG, 2010, NEUROCRIT CARE, V12, P83, DOI 10.1007/s12028-009-9278-9
   Sanbonmatsu-Gamez S, 2009, EMERG INFECT DIS, V15, P347, DOI 10.3201/eid1502.081001
   Venturi G, 2016, EUROSURVEILL B EUR S, V21
   Zanelli G, 2013, INFECTION, V41, P735, DOI 10.1007/s15010-012-0368-9
NR 12
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2020
VL 93
BP 198
EP 200
DI 10.1016/j.ijid.2020.02.008
PG 3
WC Infectious Diseases
SC Infectious Diseases
GA LO5AW
UT WOS:000533641400030
PM 32062059
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Andersen, PI
   Ianevski, A
   Lysvand, H
   Vitkauskiene, A
   Oksenych, V
   Bjoras, M
   Telling, K
   Lutsar, I
   Dumpis, U
   Irie, Y
   Tenson, T
   Kantele, A
   Kainov, DE
AF Andersen, Petter I.
   Ianevski, Aleksandr
   Lysvand, Hilde
   Vitkauskiene, Astra
   Oksenych, Valentyn
   Bjoras, Magnar
   Telling, Kaidi
   Lutsar, Irja
   Dumpis, Uga
   Irie, Yasuhiko
   Tenson, Tanel
   Kantele, Anu
   Kainov, Denis E.
TI Discovery and development of safe-in-man broad-spectrum antiviral agents
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Review
DE Virus; Antiviral drug; Drug discovery and development; Broad-spectrum
   antiviral agents; BSAAs
ID ZIKA VIRUS-INFECTION; ANIMAL-MODELS; ROTAVIRUS INFECTION; SYSTEMATIC
   ANALYSIS; GLOBAL BURDEN; 195 COUNTRIES; REPLICATION; INHIBITION;
   DISEASES; DRUGS
AB Viral diseases are one of the leading causes of morbidity and mortality in the world. Virus-specific vaccines and antiviral drugs are the most powerful tools to combat viral diseases. However, broad-spectrum antiviral agents (BSAAs, i.e. compounds targeting viruses belonging to two or more viral families) could provide additional protection of the general population from emerging and re-emerging viral diseases, reinforcing the arsenal of available antiviral options. Here, we review discovery and development of BSAAs and summarize the information on 120 safe-in-man agents in a freely accessible database (https://drugvirus.info/). Future and ongoing pre-clinical and clinical studies will increase the number of BSAAs, expand the spectrum of their indications, and identify drug combinations for treatment of emerging and re-emerging viral infections as well as co-infections. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Andersen, Petter I.; Ianevski, Aleksandr; Lysvand, Hilde; Oksenych, Valentyn; Bjoras, Magnar; Kainov, Denis E.] Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, N-7028 Trondheim, Norway.
   [Vitkauskiene, Astra] Lithuanian Univ Hlth Sci, Dept Lab Med, LT-44307 Kaunas, Lithuania.
   [Telling, Kaidi; Irie, Yasuhiko; Tenson, Tanel; Kainov, Denis E.] Univ Tartu, Inst Technol, EE-50090 Tartu, Estonia.
   [Lutsar, Irja] Univ Tartu, Inst Med Microbiol, EE-50411 Tartu, Estonia.
   [Dumpis, Uga] Latvian Biomed Res & Study Ctr, LV-1067 Riga, Latvia.
   [Kantele, Anu] Helsinki Univ Hosp HUS, Helsinki 00290, Finland.
   [Kantele, Anu] Univ Helsinki, Helsinki 00290, Finland.
   [Kainov, Denis E.] Univ Helsinki, Inst Mol Med Finland, FIMM, Helsinki 00014, Finland.
RP Kainov, DE (corresponding author), Norwegian Univ Sci & Technol NTNU, Dept Clin & Mol Med, N-7028 Trondheim, Norway.
EM denis.kainov@ntnu.no
RI Oksenych, Valentyn/J-6216-2019
OI Oksenych, Valentyn/0000-0002-5088-3791; Ianevski,
   Aleksandr/0000-0002-7780-482X; Dumpis, Uga/0000-0001-6778-9411; Irie,
   Yasuhiko/0000-0002-7162-4772
FU European Regional Development FundEuropean Union (EU); Mobilitas Pluss
   Project [MOBTT39]
FX This study was supported by the European Regional Development Fund, the
   Mobilitas Pluss Project MOBTT39 (to D.K.).
CR Alabaster V, 2002, FALL RISE VIVO PHAR, V23, P13
   Alves MP, 2018, VIRUSES, V10
   Andersen PI, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100964
   Barre-Sinoussi F, 2015, FUTUR SCI OA, V1, DOI [10.4155/fso.15.63, 10.4155/FSO.15.63]
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Bekerman E, 2015, SCIENCE, V348, P282, DOI 10.1126/science.aaa3778
   Boonham N, 2014, VIRUS RES, V186, P20, DOI 10.1016/j.virusres.2013.12.007
   Boonyasuppayakorn S, 2014, ANTIVIR RES, V106, P125, DOI 10.1016/j.antiviral.2014.03.014
   Bosl K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02186
   Bulanova D, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100271
   Cairns DM, 2018, BIOL OPEN, V7, DOI 10.1242/bio.031807
   Carter M, 2015, GUIDE RES TECHNIQUES, P295, DOI DOI 10.1016/B978-0-12-800511-8.00014-9
   Valadao ALC, 2015, MOLECULES, V20, P11474, DOI 10.3390/molecules200611474
   Cheng YS, 2019, CURR OPIN PHARMACOL, V48, P92, DOI 10.1016/j.coph.2019.07.006
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Graaf M, 2007, J VIROL METHODS, V143, P169, DOI 10.1016/j.jviromet.2007.03.005
   Deans RM, 2016, NAT CHEM BIOL, V12, P361, DOI [10.1038/NCHEMBIO.2050, 10.1038/nchembio.2050]
   Debing Y, 2015, CURR OPIN INFECT DIS, V28, P596, DOI 10.1097/QCO.0000000000000212
   DECLERCQ E, 1983, ANTIVIR RES, V3, P17, DOI 10.1016/0166-3542(83)90011-6
   Denisova OV, 2012, J BIOL CHEM, V287, P35324, DOI 10.1074/jbc.M112.392142
   Eurosurveillance Editorial T, 2020, EURO SURVEILL
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Ferreira AC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01389-18
   Fink SL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27224-4
   Fischer C, 2017, EMERG INFECT DIS, V23, P1867, DOI 10.3201/eid2311.171131
   Foucquier J, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.149
   Fu Y, 2016, ANTIVIR RES, V133, P23, DOI 10.1016/j.antiviral.2016.07.008
   Gopinath S, 2018, NAT MICROBIOL, V3, P611, DOI 10.1038/s41564-018-0138-2
   Habjan M, 2008, J GEN VIROL, V89, P2157, DOI 10.1099/vir.0.2008/002097-0
   Haese NN, 2016, J INFECT DIS, V214, pS482, DOI 10.1093/infdis/jiw284
   Howard CR, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.47
   Huang L, 2017, ANTIVIR RES, V138, P68, DOI 10.1016/j.antiviral.2016.12.002
   Hulseberg CE, 2019, J VIROL, V93, DOI [10.1128/JVI.02185-18, 10.1128/jvi.02185-18]
   Ianevski A, 2019, DRUG DISCOV TODAY, V24, P1224, DOI 10.1016/j.drudis.2019.04.006
   Ianevski A, 2018, ANTIVIR RES, V154, P174, DOI 10.1016/j.antiviral.2018.04.016
   Iwasawa C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20040810
   James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]
   Jang Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01441-18
   Jupille HJ, 2011, VIROLOGY, V410, P216, DOI 10.1016/j.virol.2010.11.012
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kao JC, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006715
   Kashiwase H, 1999, CHEMOTHERAPY, V45, P48, DOI 10.1159/000007164
   Kim S, 2019, NUCLEIC ACIDS RES, V47, pD1102, DOI 10.1093/nar/gky1033
   Kittel C, 2004, VIROLOGY, V324, P67, DOI 10.1016/j.virol.2004.03.035
   Koban R, 2018, ANTIVIR RES, V150, P20, DOI 10.1016/j.antiviral.2017.12.005
   Konig A, 2019, J HEPATOL, V71, P289, DOI 10.1016/j.jhep.2019.04.010
   Kuivanen S, 2017, ANTIVIR RES, V139, P117, DOI 10.1016/j.antiviral.2016.12.022
   Kyu HH, 2018, LANCET, V392, P1859, DOI [10.1016/S0140-6736(18)32335-3, 10.1016/s0140-6736(18)32335-3]
   Laamiri N, 2018, VIROLOGY, V515, P29, DOI 10.1016/j.virol.2017.11.021
   LANDRY ML, 1990, CLIN BIOCHEM, V23, P267, DOI 10.1016/0009-9120(90)80053-L
   Lanko K, 2017, ANTIVIR RES, V145, P82, DOI 10.1016/j.antiviral.2017.07.010
   Lee MN, 2014, SCIENCE, V343, P1119, DOI 10.1126/science.1246980
   Lee M, 2017, SCI REP-UK, V7, DOI 10.1038/srep44676
   Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012
   Louz D, 2013, CRIT REV MICROBIOL, V39, P325, DOI 10.3109/1040841X.2012.711740
   MacGibeny MA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007188
   Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159
   Marston HD, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009872
   Mazzon M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020176
   MENEGHINI KA, 1967, VISION RES, V7, P243, DOI 10.1016/0042-6989(67)90088-0
   Montoya MC, 2018, MBIO, V9, DOI 10.1128/mBio.02272-18
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Muller KH, 2014, ANTIMICROB AGENTS CH, V58, P2905, DOI 10.1128/AAC.02284-13
   Mukhopadhyay R, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005717
   Muller KH, 2011, BRIT J PHARMACOL, V164, P344, DOI 10.1111/j.1476-5381.2011.01346.x
   Nishimura Y, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01068
   Oh DY, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00080
   Pan T., J BIOL CHEM, V291
   Parasuraman S, 2011, J PHARMACOL PHARMACO, V2, P74, DOI 10.4103/0976-500X.81895
   Patil SA, 2017, MED CHEM, V13, P787, DOI 10.2174/1573406413666170330094822
   Perez JT, 2013, CURR PROTOC MICROBIO, DOI [DOI 10.1002/9780471729259.MC15G04S29, 10.1002/9780471729259.mc15g04s29]
   Pickett BE, 2012, VIRUSES-BASEL, V4, P3209, DOI 10.3390/v4113209
   Pizzorno A., 2019, DRUG REPURPOSING APP, P10
   Postnikova E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194880
   Puschnik AS, 2017, NAT REV MICROBIOL, V15, P351, DOI 10.1038/nrmicro.2017.29
   Pushpakom S, 2019, NAT REV DRUG DISCOV, V18, P41, DOI 10.1038/nrd.2018.168
   RADA B, 1977, ANN NY ACAD SCI, V284, P410, DOI 10.1111/j.1749-6632.1977.tb21977.x
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rizk ML, 2017, CTS-CLIN TRANSL SCI, V10, P133, DOI 10.1111/cts.12448
   Robinson CL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04444-w
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sarzotti-Kelsoe M, 2014, J IMMUNOL METHODS, V409, P131, DOI 10.1016/j.jim.2013.11.022
   Sashital DG, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0543-4
   Schor S, 2018, ACS INFECT DIS, V4, P88, DOI 10.1021/acsinfecdis.7b00268
   Shanks Niall, 2009, Philos Ethics Humanit Med, V4, P2, DOI 10.1186/1747-5341-4-2
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Shen L, 2019, J VIROL, V93, DOI 10.1128/JVI.00023-19
   SIDWELL RW, 1972, SCIENCE, V177, P705, DOI 10.1126/science.177.4050.705
   Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010
   Smee Donald F, 2013, Methods Mol Biol, V1030, P407, DOI 10.1007/978-1-62703-484-5_31
   Soderholm S, 2016, MOL CELL PROTEOMICS, V15, P3203, DOI 10.1074/mcp.M116.057984
   Stachulski AV, 2011, J MED CHEM, V54, P8670, DOI 10.1021/jm201264t
   Taylor G, 2017, VACCINE, V35, P469, DOI 10.1016/j.vaccine.2016.11.054
   Thangavel RR, 2014, J IMMUNOL METHODS, V410, P60, DOI 10.1016/j.jim.2014.03.023
   U.S. Food and Drug Administration, 2018, DRUG DEV PROC STEP 3
   Umscheid CA, 2011, POSTGRAD MED, V123, P194, DOI 10.3810/pgm.2011.09.2475
   Ursu O, 2019, NUCLEIC ACIDS RES, V47, pD963, DOI 10.1093/nar/gky963
   Utt A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151616
   Wang YM, 2016, ANTIVIR RES, V135, P81, DOI 10.1016/j.antiviral.2016.10.003
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   WHO, 2015, WHO PUBL LIST TOP EM
   Wishart DS, 2018, NUCLEIC ACIDS RES, V46, pD1074, DOI 10.1093/nar/gkx1037
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Xia Y, 2017, J HEPATOL, V66, P494, DOI 10.1016/j.jhep.2016.10.009
   Xing LY, 2016, J VIROL METHODS, V233, P56, DOI 10.1016/j.jviromet.2016.03.008
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu YP, 2019, CELL RES, V29, P265, DOI 10.1038/s41422-019-0152-9
   Yang S, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0034-1
   Yin YB, 2018, ANTIVIR RES, V156, P92, DOI 10.1016/j.antiviral.2018.06.011
   Yin YB, 2016, ANTIVIR RES, V133, P41, DOI 10.1016/j.antiviral.2016.07.017
   Yin YB, 2015, ANTIVIR RES, V123, P120, DOI 10.1016/j.antiviral.2015.09.010
   Young DD, 2010, J AM CHEM SOC, V132, P7976, DOI 10.1021/ja910275u
   Zhang YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2433
   Zheng W, 2018, BRIT J PHARMACOL, V175, P181, DOI 10.1111/bph.13895
   Zhou L, 2018, J CELL MOL MED, V22, P5807, DOI 10.1111/jcmm.13925
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
NR 117
TC 3
Z9 3
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD APR
PY 2020
VL 93
BP 268
EP 276
DI 10.1016/j.ijid.2020.02.018
PG 9
WC Infectious Diseases
SC Infectious Diseases
GA LO5AW
UT WOS:000533641400044
PM 32081774
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Stefanik, M
   Valdes, JJ
   Ezebuo, FC
   Haviernik, J
   Uzochukwu, IC
   Fojtikova, M
   Salat, J
   Eyer, L
   Ruzek, D
AF Stefanik, Michal
   Valdes, James J.
   Ezebuo, Fortunatus C.
   Haviernik, Jan
   Uzochukwu, Ikemefuna C.
   Fojtikova, Martina
   Salat, Jiri
   Eyer, Ludek
   Ruzek, Daniel
TI FDA-Approved Drugs Efavirenz, Tipranavir, and Dasabuvir Inhibit
   Replication of Multiple Flaviviruses in Vero Cells
SO MICROORGANISMS
LA English
DT Article
DE FDA; flavivirus; Zika virus; tick-borne encephalitis virus; West Nile
   virus; antiviral
ID NUCLEOSIDE INHIBITORS; VIRUS; PROTEIN; SCREEN; PELE
AB Vector-borne flaviviruses (VBFs) affect human health worldwide, but no approved drugs are available specifically to treat VBF-associated infections. Here, we performed in silico screening of a library of U.S. Food and Drug Administration-approved antiviral drugs for their interaction with Zika virus proteins. Twelve hit drugs were identified by the docking experiments and tested in cell-based antiviral assay systems. Efavirenz, tipranavir, and dasabuvir at micromolar concentrations were identified to inhibit all VBFs tested; i.e., two representatives of mosquito-borne flaviviruses (Zika and West Nile viruses) and one representative of flaviviruses transmitted by ticks (tick-borne encephalitis virus). The results warrant further research into these drugs, either individually or in combination, as possible pan-flavivirus inhibitors.
C1 [Stefanik, Michal; Valdes, James J.; Haviernik, Jan; Fojtikova, Martina; Salat, Jiri; Eyer, Ludek; Ruzek, Daniel] Vet Res Inst, Dept Virol, Hudcova 70, CZ-62100 Brno, Czech Republic.
   [Stefanik, Michal] Mendel Univ Brno, Dept Chem & Biochem, Zemedelska 1, CZ-61300 Brno, Czech Republic.
   [Valdes, James J.; Eyer, Ludek; Ruzek, Daniel] Czech Acad Sci, Inst Parasitol, Biol Ctr, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
   [Ezebuo, Fortunatus C.; Uzochukwu, Ikemefuna C.] Nnamdi Azikiwe Univ, Fac Pharmaceut Sci, Dept Pharmaceut & Med Chem, PMB 5025, Awka 420281, Nigeria.
   [Haviernik, Jan] Masaryk Univ, Fac Sci, Kamenice 5, CZ-62500 Brno, Czech Republic.
RP Ruzek, D (corresponding author), Vet Res Inst, Dept Virol, Hudcova 70, CZ-62100 Brno, Czech Republic.; Ruzek, D (corresponding author), Czech Acad Sci, Inst Parasitol, Biol Ctr, Branisovska 31, CZ-37005 Ceske Budejovice, Czech Republic.
EM stefanik@vri.cz; valdjj@gmail.com; fortunatus.ezebuo@unn.edu.ng;
   haviernik@vri.cz; ic.uzochukwu@unizik.edu.ng;
   fojtikovamartina@seznam.cz; salat@vri.cz; eyer@vri.cz;
   ruzekd@paru.cas.cz
RI ; Ruzek, Daniel/G-9275-2014
OI Ezebuo, Fortunatus Chidolue/0000-0002-2832-1215; Uzochukwu,
   Ikemefuna/0000-0002-5139-1537; Ruzek, Daniel/0000-0003-4655-2380
FU Ministry of Health of the Czech RepublicMinistry of Health, Czech
   Republic [16-34238A]; Ministry of Education, Youth and Sports of the
   Czech Republic (project "FIT" Pharmacology, Immunotherapy,
   nanoToxicology) [CZ.02.1.01/0.0/0.0/15_003/0000495]
FX The authors acknowledge financial support from the Ministry of Health of
   the Czech Republic (grant No. 16-34238A) and Ministry of Education,
   Youth and Sports of the Czech Republic (project "FIT" Pharmacology,
   Immunotherapy, nanoToxicology; grant No.
   CZ.02.1.01/0.0/0.0/15_003/0000495).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Baier A., 2011, FLAVIVIRUS ENCEPHALI, P89
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Borrelli KW, 2005, J CHEM THEORY COMPUT, V1, P1304, DOI 10.1021/ct0501811
   Cerny J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096070
   DEMADRID AT, 1969, B WORLD HEALTH ORGAN, V40, P113
   Deval J, 2014, CURR OPIN VIROL, V9, P1, DOI 10.1016/j.coviro.2014.08.004
   Duarte H, 2017, J PHARM SCI-US, V106, P3161, DOI 10.1016/j.xphs.2017.06.004
   Eyer L, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.02093-18, 10.1128/AAC.02093-18]
   Eyer L, 2017, J VIROL, V91, DOI 10.1128/JVI.01028-17
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Gentile I, 2014, REV RECENT CLIN TRIA, V9, P115, DOI 10.2174/1574887109666140529222602
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   Irwin JJ, 2012, J CHEM INF MODEL, V52, P1757, DOI 10.1021/ci3001277
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   Julander JG, 2014, ANTIMICROB AGENTS CH, V58, P6607, DOI 10.1128/AAC.03368-14
   Kati W, 2015, ANTIMICROB AGENTS CH, V59, P1510, DOI 10.1128/AAC.04619-14
   Keshavarz F, 2013, PHYS CHEM RES, V1, P111
   King JR, 2017, CLIN PHARMACOKINET, V56, P1115, DOI 10.1007/s40262-017-0519-3
   Lazear HM, 2016, JAMA-J AM MED ASSOC, V315, P1945, DOI 10.1001/jama.2016.2899
   Luna B, 2007, CLIN THER, V29, P2309, DOI 10.1016/j.clinthera.2007.11.007
   Madadkar-Sobhani A, 2013, NUCLEIC ACIDS RES, V41, pW322, DOI 10.1093/nar/gkt454
   Madrid PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060579
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33
   Pascoalino Bruno S, 2016, F1000Res, V5, P2523
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Ren J, 2000, STRUCTURE, V8, P1089, DOI 10.1016/S0969-2126(00)00513-X
   Sanner MF, 1999, J MOL GRAPH MODEL, V17, P57
   Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8
   Schapiro JM, 2010, ANTIVIR THER, V15, P1011, DOI 10.3851/IMP1670
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Trivella JP, 2015, EXPERT OPIN PHARMACO, V16, P617, DOI 10.1517/14656566.2015.1012493
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Wang SB, 2017, J VIROL, V91, DOI [10.1128/jvi.01055-17, 10.1128/JVI.01055-17]
   Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958
   Wong-Sam A, 2018, ACS OMEGA, V3, P12132, DOI 10.1021/acsomega.8b01683
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 43
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-2607
J9 MICROORGANISMS
JI Microorganisms
PD APR
PY 2020
VL 8
IS 4
AR 599
DI 10.3390/microorganisms8040599
PG 17
WC Microbiology
SC Microbiology
GA LO3DX
UT WOS:000533510400128
PM 32326119
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lan, QS
   Xia, S
   Wang, Q
   Xu, W
   Huang, HY
   Jiang, SB
   Lu, L
AF Lan Qiaoshuai
   Xia Shuai
   Wang Qian
   Xu Wei
   Huang Haiyan
   Jiang Shibo
   Lu Lu
TI Development of oncolytic virotherapy: from genetic modification to
   combination therapy
SO FRONTIERS OF MEDICINE
LA English
DT Review
DE immunotherapy; oncolytic virus; genetic modification; immune checkpoint
   blockade; chimeric antigen receptor T cell
ID NEWCASTLE-DISEASE VIRUS; VESICULAR STOMATITIS-VIRUS; IMMUNE CHECKPOINT
   BLOCKADE; UNRESECTABLE STAGE-III; LAHERPAREPVEC T-VEC; VACCINIA VIRUS;
   TALIMOGENE LAHERPAREPVEC; ZIKA VIRUS; PHASE-I; CANCER-IMMUNOTHERAPY
AB Oncolytic virotherapy (OVT) is a novel form of immunotherapy using natural or genetically modified viruses to selectively replicate in and kill malignant cells. Many genetically modified oncolytic viruses (OVs) with enhanced tumor targeting, antitumor efficacy, and safety have been generated, and some of which have been assessed in clinical trials. Combining OVT with other immunotherapies can remarkably enhance the antitumor efficacy. In this work, we review the use of wild-type viruses in OVT and the strategies for OV genetic modification. We also review and discuss the combinations of OVT with other immunotherapies.
C1 [Lan Qiaoshuai; Xia Shuai; Wang Qian; Xu Wei; Jiang Shibo; Lu Lu] Fudan Univ, Key Lab Med Mol Virol MOE NHC CAMS, Sch Basic Med Sci, Shanghai 200032, Peoples R China.
   [Lan Qiaoshuai; Xia Shuai; Wang Qian; Xu Wei; Jiang Shibo; Lu Lu] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.
   [Huang Haiyan] Qingdao Univ, Yantai Yuhuangding Hosp, Yantai 264000, Peoples R China.
   [Jiang Shibo] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
RP Jiang, SB; Lu, L (corresponding author), Fudan Univ, Key Lab Med Mol Virol MOE NHC CAMS, Sch Basic Med Sci, Shanghai 200032, Peoples R China.; Jiang, SB; Lu, L (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 200032, Peoples R China.; Jiang, SB (corresponding author), New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10065 USA.
EM shibojiang@fudan.edu.cn; lul@fudan.edu.cn
OI Lan, Qiaoshuai/0000-0001-5524-3542
CR Abdullahi S, 2018, J VIROL, V92, DOI 10.1128/JVI.01386-18
   Navarro SA, 2016, EXPERT OPIN THER PAT, V26, P1095, DOI 10.1080/13543776.2016.1211640
   Achard C, 2018, EBIOMEDICINE, V31, P17, DOI 10.1016/j.ebiom.2018.04.020
   Aghi M, 2005, ONCOGENE, V24, P7802, DOI 10.1038/sj.onc.1209037
   Ajina A, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0294-6
   Alessandrini F, 2019, ONCOGENE, V38, P4467, DOI 10.1038/s41388-019-0737-2
   Alsaab HO, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00561
   Anderson JK, 2019, EXPERT REV HEMATOL, V12, P551, DOI 10.1080/17474086.2019.1629901
   ANDTBACKA RHI, 2015, J CLIN ONCOL S, V33
   Andtbacka RHI, 2016, HEAD NECK-J SCI SPEC, V38, P1752, DOI 10.1002/hed.24522
   Angelova AL, 2017, VIRUSES, V9, P12
   Angelova AL, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00093
   Annels NE, 2019, CLIN CANC RES
   Annels NE, 2019, CLIN CANCER RES, V25, P5818, DOI 10.1158/1078-0432.CCR-18-4022
   [Anonymous], 2018, Cancer Discov, V8, pOF2, DOI 10.1158/2159-8290.CD-NB2018-090
   Aref S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100294
   Atherton MJ, 2018, VACCINE, V36, P2181, DOI 10.1016/j.vaccine.2018.02.070
   Au GG, 2007, BRIT J HAEMATOL, V137, P133, DOI 10.1111/j.1365-2141.2007.06550.x
   Autio K, 2014, MOL THER-ONCOLYTICS, V1, DOI 10.1038/mto.2014.2
   Badrinath N, 2016, INT J NANOMED, V11, P4835, DOI 10.2147/IJN.S116447
   Bauzon M, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00074
   Bell J, 2014, CELL HOST MICROBE, V15, P260, DOI 10.1016/j.chom.2014.01.002
   Besser MJ, 2013, CLIN CANCER RES, V19, P4792, DOI 10.1158/1078-0432.CCR-13-0380
   Betancourt D, 2015, J VIROL, V89, P11786, DOI 10.1128/JVI.01356-15
   Binz E, 2017, MOL THER-ONCOLYTICS, V6, P10, DOI 10.1016/j.omto.2017.04.001
   Bommareddy PK, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aau0417
   Bommareddy PK, 2018, NAT REV IMMUNOL, V18, P498, DOI 10.1038/s41577-018-0014-6
   Bourgeois-Daigneault MC, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao1641
   Bourgeois-Daigneault MC, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0744-y
   Bourhill T, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080421
   Bradley S, 2014, ONCOLYTIC VIROTHER, V3, P47, DOI 10.2147/OV.S56322
   Breitbach CJ, 2015, CURR OPIN VIROL, V13, P49, DOI 10.1016/j.coviro.2015.03.016
   Breitbach CJ, 2013, CANCER RES, V73, P1265, DOI 10.1158/0008-5472.CAN-12-2687
   Breitbach CJ, 2011, MOL THER, V19, P886, DOI 10.1038/mt.2011.26
   Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930
   Brown MC, 2015, CURR OPIN VIROL, V13, P81, DOI 10.1016/j.coviro.2015.05.007
   Brown MC, 2014, CANCER-AM CANCER SOC, V120, P3277, DOI 10.1002/cncr.28862
   Chalikonda S, 2008, CANCER GENE THER, V15, P115, DOI 10.1038/sj.cgt.7701110
   Chen CY, 2018, ONCOLYTIC VIROTHER, V7, P65, DOI 10.2147/OV.S145532
   Chen CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02503-8
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chen S, 2019, ONCOL REP, V41, P2818, DOI 10.3892/or.2019.7077
   Cherkassky L, 2016, J CLIN INVEST, V126, P3130, DOI 10.1172/JCI83092
   Chesney J, 2018, J CLIN ONCOL, V36, P1658, DOI 10.1200/JCO.2017.73.7379
   Cheung A, 2016, ONCOTARGET, V7, P52553, DOI 10.18632/oncotarget.9651
   Chiocca EA, 2014, CANCER IMMUNOL RES, V2, P295, DOI 10.1158/2326-6066.CIR-14-0015
   Choi AH, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030018
   Cody JJ, 2015, ONCOLYTIC VIROTHER, V4, P63, DOI 10.2147/OV.S63045
   Conry RM, 2018, HUM VACC IMMUNOTHER, V14, P839, DOI 10.1080/21645515.2017.1412896
   Desjardins A, 2018, NEW ENGL J MED, V379, P150, DOI 10.1056/NEJMoa1716435
   Dias JD, 2010, CLIN CANCER RES, V16, P2540, DOI 10.1158/1078-0432.CCR-09-2974
   Dispenzieri A, 2017, LEUKEMIA, V31, P2791, DOI 10.1038/leu.2017.120
   Dmitrieva N, 2011, CLIN CANCER RES, V17, P1362, DOI 10.1158/1078-0432.CCR-10-2213
   Domingo-Musibay E, 2014, CANCER GENE THER, V21, P483, DOI 10.1038/cgt.2014.54
   Dornan MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep26786
   Durham NM, 2017, MOL THER, V25, P1917, DOI 10.1016/j.ymthe.2017.05.006
   Eissa IR, 2018, CANCERS, V10, DOI 10.3390/cancers10100356
   Eissa Ibrahim Ragab, 2017, Front Oncol, V7, P149, DOI 10.3389/fonc.2017.00149
   Erbs P, 2000, CANCER RES, V60, P3813
   Eriksson E, 2017, CLIN CANCER RES, V23, P5846, DOI 10.1158/1078-0432.CCR-17-0285
   Felt SA, 2017, J GEN VIROL, V98, P2895, DOI 10.1099/jgv.0.000980
   Fend L, 2017, CANCER RES, V77, P4146, DOI 10.1158/0008-5472.CAN-16-2165
   Foloppe J, 2019, MOL THER-ONCOLYTICS, V14, P1, DOI 10.1016/j.omto.2019.03.005
   Foreman PM, 2017, NEUROTHERAPEUTICS, V14, P333, DOI 10.1007/s13311-017-0516-0
   Frentzen A, 2009, P NATL ACAD SCI USA, V106, P12915, DOI 10.1073/pnas.0900660106
   Fujiwara T, 2011, EXPERT REV ANTICANC, V11, P525, DOI [10.1586/ERA.10.200, 10.1586/era.10.200]
   Gajewski TF, 2013, CURR OPIN IMMUNOL, V25, P268, DOI 10.1016/j.coi.2013.02.009
   Galanis E, 2012, MOL THER, V20, P1998, DOI 10.1038/mt.2012.146
   Garant KA, 2016, ONCOGENE, V35, P771, DOI 10.1038/onc.2015.136
   Garofalo M, 2018, J CONTROL RELEASE, V283, P223, DOI 10.1016/j.jconrel.2018.05.015
   Geiss C, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100301
   Geletneky K, 2017, MOL THER, V25, P2620, DOI 10.1016/j.ymthe.2017.08.016
   Geletneky K, 2015, CURR OPIN VIROL, V13, P17, DOI 10.1016/j.coviro.2015.03.008
   Gong Jun, 2016, World J Methodol, V6, P25, DOI 10.5662/wjm.v6.i1.25
   Goodwin JM, 2012, CANCER INVEST, V30, P243, DOI 10.3109/07357907.2012.654870
   Grigg C, 2016, SEMIN ONCOL, V43, P638, DOI 10.1053/j.seminoncol.2016.10.005
   Guedan S, 2010, MOL THER, V18, P1275, DOI 10.1038/mt.2010.79
   Haddad D, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00096
   Hajda J, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3604-y
   Hamano S, 2015, CANCER LETT, V356, P846, DOI 10.1016/j.canlet.2014.10.046
   Hamid O, 2017, CANCER IMMUNOL IMMUN, V66, P1249, DOI 10.1007/s00262-017-2025-8
   Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013
   Hardcastle J, 2007, CURR CANCER DRUG TAR, V7, P181, DOI 10.2174/156800907780058880
   Hardcastle J, 2017, NEURO-ONCOLOGY, V19, P493, DOI 10.1093/neuonc/now179
   Heo J, 2013, NAT MED, V19, P329, DOI 10.1038/nm.3089
   Hock K, 2017, SURGERY, V161, P735, DOI 10.1016/j.surg.2016.08.045
   Howells A, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00195
   Hu C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0325-3
   Hu JQ, 2018, ACTA BIOCH BIOPH SIN, V50, P1018, DOI 10.1093/abbs/gmy096
   Huang JH, 2010, MOL THER, V18, P264, DOI 10.1038/mt.2009.205
   Huang P, 2010, CANCER GENE THER, V17, P484, DOI 10.1038/cgt.2010.5
   Huang PY, 2012, MOL THER, V20, P298, DOI 10.1038/mt.2011.245
   Huehls AM, 2015, IMMUNOL CELL BIOL, V93, P290, DOI 10.1038/icb.2014.93
   Hutzen B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-206
   Jackson HJ, 2016, NAT REV CLIN ONCOL, V13, P370, DOI 10.1038/nrclinonc.2016.36
   Jefferson A, 2015, CRIT REV ONCOL HEMAT, V95, P407, DOI 10.1016/j.critrevonc.2015.04.001
   Jhawar SR, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00202
   Jiang K, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4522-3
   Johnson DB, 2015, IMMUNOTHERAPY-UK, V7, P611, DOI [10.2217/IMT.15.35, 10.2217/imt.15.35]
   KALBASI A, 2020, NAT REV IMMUNOL, V20, P25, DOI DOI 10.1038/S41577-019-0218-4
   Kanai R, 2012, J VIROL, V86, P4420, DOI 10.1128/JVI.00017-12
   Kasuya H, 2014, HEPATO-GASTROENTEROL, V61, P599, DOI 10.5754/hge14104
   Kaufman HL, 2015, NAT REV DRUG DISCOV, V14, P642, DOI 10.1038/nrd4663
   Kaufman HL, 2010, FUTURE ONCOL, V6, P941, DOI 10.2217/FON.10.66
   Kelly KR, 2018, LEUKEMIA, V32, P230, DOI 10.1038/leu.2017.272
   Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25
   Kim JH, 2006, JNCI-J NATL CANCER I, V98, P1482, DOI 10.1093/jnci/djj397
   Kirn DH, 2009, NAT REV CANCER, V9, P64, DOI 10.1038/nrc2545
   Kohlhapp FJ, 2015, DRUG TODAY, V51, P549, DOI 10.1358/dot.2015.51.9.2383044
   Kohlhapp FJ, 2016, CLIN CANCER RES, V22, P1048, DOI 10.1158/1078-0432.CCR-15-2667
   Lang FF, 2018, J CLIN ONCOL, V36, P1419, DOI 10.1200/JCO.2017.75.8219
   Lauer UM, 2018, CLIN CANCER RES, V24, P4388, DOI 10.1158/1078-0432.CCR-18-0244
   Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014
   Leber MF, 2011, MOL THER, V19, P1097, DOI 10.1038/mt.2011.55
   Leber MF, 2018, MOL THER-ONCOLYTICS, V9, P30, DOI 10.1016/j.omto.2018.04.002
   Leoni V, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007209
   Letendre P, 2017, FUTURE ONCOL, V13, P625, DOI 10.2217/fon-2016-0385
   Li JM, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-241
   Li J, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0568-6
   Liang JK, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03913-6
   Liang M, 2018, CURR CANCER DRUG TAR, V18, P171, DOI 10.2174/1568009618666171129221503
   Lin WH, 2013, INT J CANCER, V132, P1451, DOI 10.1002/ijc.27770
   Lin Y, 2014, P NATL ACAD SCI USA, V111, pE4504, DOI 10.1073/pnas.1408759111
   Liu L, 2012, INT J MOL MED, V30, P747, DOI 10.3892/ijmm.2012.1077
   Liu ZQ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06954-z
   Liu ZQ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14754
   Long KB, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02740
   Lorence RM, 2007, CURR CANCER DRUG TAR, V7, P157, DOI 10.2174/156800907780058853
   Mahalingam D, 2018, CANCERS, V10, DOI 10.3390/cancers10060160
   Mahalingam D, 2017, CANCER CHEMOTH PHARM, V79, P697, DOI 10.1007/s00280-017-3260-6
   Mahoney KM, 2015, NAT REV DRUG DISCOV, V14, P561, DOI 10.1038/nrd4591
   Maroun J, 2017, FUTURE VIROL, V12, P193, DOI 10.2217/fvl-2016-0129
   Martinez-Velez N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10043-0
   Martinez-Velez N, 2016, CLIN CANCER RES, V22, P2217, DOI 10.1158/1078-0432.CCR-15-1899
   MARTUZA RL, 1991, SCIENCE, V252, P854, DOI 10.1126/science.1851332
   Masoud SJ, 2019, ANN SURG ONCOL, V26, P4633, DOI 10.1245/s10434-019-07691-3
   McCart JA, 2001, CANCER RES, V61, P8751
   McKenzie BA, 2015, NEURO-ONCOLOGY, V17, P1086, DOI 10.1093/neuonc/nou359
   McKie EA, 1996, BRIT J CANCER, V74, P745, DOI 10.1038/bjc.1996.431
   Mell LK, 2017, CLIN CANCER RES, V23, P5696, DOI 10.1158/1078-0432.CCR-16-3232
   Menotti L, 2008, J VIROL, V82, P10153, DOI 10.1128/JVI.01133-08
   Miest TS, 2014, NAT REV MICROBIOL, V12, P23, DOI 10.1038/nrmicro3140
   Mikkilineni L, 2017, BLOOD, V130, P2594, DOI 10.1182/blood-2017-06-793869
   Miller A, 2016, EXPERT OPIN BIOL TH, V16, P15, DOI 10.1517/14712598.2016.1100162
   Moran AE, 2013, CURR OPIN IMMUNOL, V25, P230, DOI 10.1016/j.coi.2013.01.004
   Msaouel P, 2018, CURR CANCER DRUG TAR, V18, P177, DOI 10.2174/1568009617666170222125035
   Nakajima O, 2009, ONCOL REP, V22, P1039, DOI 10.3892/or_00000533
   Nguyen A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00145
   Niemann J, 2017, VIRUS GENES, V53, P700, DOI 10.1007/s11262-017-1488-1
   Nishio N, 2014, CANCER RES, V74, P5195, DOI 10.1158/0008-5472.CAN-14-0697
   Noonan AM, 2016, MOL THER, V24, P1150, DOI 10.1038/mt.2016.66
   Nuesch JPF, 2012, CLIN CANCER RES, V18, P3516, DOI 10.1158/1078-0432.CCR-11-2325
   O'Cathail SM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00153
   Packiam VT, 2018, UROL ONCOL-SEMIN ORI, V36, P440, DOI 10.1016/j.urolonc.2017.07.005
   Pagel JM, 2017, JAMA ONCOL, V3, P1595, DOI 10.1001/jamaoncol.2017.2989
   Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239
   Pascual-Pasto G, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat9321
   Patel DM, 2016, HUM GENE THER CL DEV, V27, P69, DOI 10.1089/humc.2016.031
   Pearl TM, 2019, MOL THER-ONCOLYTICS, V13, P14, DOI 10.1016/j.omto.2019.03.001
   Pease DF, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00179
   Peng KW, 2002, NAT MED, V8, P527, DOI 10.1038/nm0502-527
   Pento JT, 2017, ANTICANCER RES, V37, P5935, DOI 10.21873/anticanres.12040
   Pesonen S, 2012, CANCER RES, V72, P1621, DOI 10.1158/0008-5472.CAN-11-3001
   Pikor LA, 2015, TRENDS CANCER, V1, P266, DOI 10.1016/j.trecan.2015.10.004
   Postow MA, 2018, NEW ENGL J MED, V378, P158, DOI 10.1056/NEJMra1703481
   Puskas J, 2011, IMMUNOLOGY, V133, P206, DOI 10.1111/j.1365-2567.2011.03428.x
   Puzanov I, 2016, J CLIN ONCOL, V34, P2619, DOI 10.1200/JCO.2016.67.1529
   Quetglas JI, 2015, CANCER IMMUNOL RES, V3, P449, DOI 10.1158/2326-6066.CIR-14-0216
   Ramachandran M, 2017, CLIN CANCER RES, V23, P1519, DOI 10.1158/1078-0432.CCR-16-0925
   Ribas A, 2017, CELL, V170, P1109, DOI 10.1016/j.cell.2017.08.027
   Robinson S, 2017, EXPERT OPIN BIOL TH, V17, P353, DOI 10.1080/14712598.2017.1288713
   Rodriguez-Garcia A, 2015, CLIN CANCER RES, V21, P1406, DOI 10.1158/1078-0432.CCR-14-2213
   Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4
   Roth JC, 2014, HUM GENE THER CL DEV, V25, P16, DOI 10.1089/humc.2013.201
   Russell L, 2019, BIODRUGS, V33, P485, DOI 10.1007/s40259-019-00367-0
   Saha D, 2017, CANCER CELL, V32, P253, DOI 10.1016/j.ccell.2017.07.006
   Salter AI, 2015, NAT BIOTECHNOL, V33, P1040, DOI 10.1038/nbt.3370
   Samson A, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aam7577
   Santos JM, 2017, INT J CANCER, V141, P1458, DOI 10.1002/ijc.30839
   Sborov DW, 2014, CLIN CANCER RES, V20, P5946, DOI 10.1158/1078-0432.CCR-14-1404
   Schafer S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-366
   Schepelmann S, 2006, CURR GENE THER, V6, P647, DOI 10.2174/156652306779010679
   Schirrmacher V, 2016, BIOMEDICINES, V4, DOI 10.3390/biomedicines4030016
   Scott EM, 2018, MACROMOL BIOSCI, V18, DOI 10.1002/mabi.201700187
   Serganova I, 2017, MOL THER-ONCOLYTICS, V4, P41, DOI 10.1016/j.omto.2016.11.005
   Shan C, 2018, CELL HOST MICROBE, V24, P12, DOI 10.1016/j.chom.2018.05.021
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shaw AR, 2017, MOL THER, V25, P6
   Shaw AR, 2016, CURR OPIN VIROL, V21, P9, DOI 10.1016/j.coviro.2016.06.009
   Shayestehpour M, 2017, VIRUS RES, V240, P207, DOI 10.1016/j.virusres.2017.08.016
   Shen WW, 2016, BLOOD, V127, P1449, DOI [10.1182/blood-201506-652503, 10.1182/blood-2015-06-652503]
   Shibata T, 2016, GENE THER, V23, P479, DOI 10.1038/gt.2016.17
   Singh P, 2015, FUTURE ONCOL, V11, P2137, DOI 10.2217/fon.15.120
   Siveen KS, 2017, CURR VASC PHARMACOL, V15, P339, DOI 10.2174/1570161115666170105124038
   Smith E, 2011, HUM GENE THER, V22, P1053, DOI 10.1089/hum.2010.227
   Stepanenko AA, 2018, VIRUS RES, V257, P40, DOI 10.1016/j.virusres.2018.08.012
   Stieglmaier J, 2015, EXPERT OPIN BIOL TH, V15, P1093, DOI 10.1517/14712598.2015.1041373
   Stiff A, 2016, MOL CANCER THER, V15, P830, DOI 10.1158/1535-7163.MCT-15-0240-T
   Sun L, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0337-7
   Svane IM, 2014, CANCER IMMUNOL IMMUN, V63, P1081, DOI 10.1007/s00262-014-1580-5
   Syed YY, 2017, DRUGS, V77, P1369, DOI 10.1007/s40265-017-0782-5
   Taipale K, 2015, MOL THER, V23, P964, DOI 10.1038/mt.2015.17
   Taki M, 2005, ONCOGENE, V24, P3130, DOI 10.1038/sj.onc.1208460
   Tan GW, 2015, INT J CANCER, V136, P1718, DOI 10.1002/ijc.29163
   Tanoue K, 2017, CANCER RES, V77, P2040, DOI 10.1158/0008-5472.CAN-16-1577
   Tayeb S, 2015, ONCOLYTIC VIROTHER, V4, P49, DOI 10.2147/OV.S78600
   TOOLAN HW, 1965, P SOC EXP BIOL MED, V119, P711, DOI 10.3181/00379727-119-30278
   Topalian SL, 2015, CANCER CELL, V27, P450, DOI 10.1016/j.ccell.2015.03.001
   Torres-Dominguez LE, 2019, EXPERT OPIN BIOL TH, V19, P561, DOI 10.1080/14712598.2019.1600669
   Tsuji T, 2013, INT J CANCER, V132, P485, DOI 10.1002/ijc.27681
   Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954
   Uchida H, 2013, MOL THER, V21, P561, DOI 10.1038/mt.2012.211
   Viallard C, 2017, ANGIOGENESIS, V20, P409, DOI 10.1007/s10456-017-9562-9
   Vidal L, 2008, CLIN CANCER RES, V14, P7127, DOI 10.1158/1078-0432.CCR-08-0524
   Wang PJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01385-8
   Wang QH, 2017, INT IMMUNOPHARMACOL, V46, P210, DOI 10.1016/j.intimp.2017.03.015
   Watanabe D, 2018, ADV EXP MED BIOL, V1045, P63, DOI 10.1007/978-981-10-7230-7_4
   Watanabe K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99573
   Wei D, 2018, HUM GENE THER, V29, P151, DOI 10.1089/hum.2017.212
   WHEELOCK EF, 1964, NEW ENGL J MED, V271, P645, DOI 10.1056/NEJM196409242711302
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wilkinson MJ, 2016, ONCOTARGET, V7, P81208, DOI 10.18632/oncotarget.12820
   Wing A, 2018, CANCER IMMUNOL RES, V6, P605, DOI 10.1158/2326-6066.CIR-17-0314
   Wu YZ, 2016, J PHARMACOL SCI, V132, P24, DOI 10.1016/j.jphs.2016.03.012
   Xiao X., 2018, NAT COMMUN, V9, P1
   Yang YP, 2015, J CLIN INVEST, V125, P3335, DOI 10.1172/JCI83871
   Yu F, 2014, MOL THER, V22, P102, DOI 10.1038/mt.2013.240
   Yun SI, 2017, J MICROBIOL, V55, P204, DOI 10.1007/s12275-017-7063-6
   Zamarin D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008095
   Zeh HJ, 2015, MOL THER, V23, P202, DOI 10.1038/mt.2014.194
   Zhang HP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7996
   Zhang HP, 2016, HUM GENE THER, V27, P700, DOI 10.1089/hum.2016.038
   Zhang J, 2015, AAPS J, V17, P102, DOI 10.1208/s12248-014-9675-7
   Zhang W, 2015, ONCOTARGET, V6, P20345, DOI 10.18632/oncotarget.3884
   Zhou W, 2017, GENE THER, V24, P199, DOI 10.1038/gt.2017.2
   Zhu W, 2013, CANCER BIOL THER, V14, P1016, DOI 10.4161/cbt.26043
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zolov SN, 2018, CYTOTHERAPY, V20, P1259, DOI 10.1016/j.jcyt.2018.07.005
   ZYGIERT Z, 1971, LANCET, V1, P593
NR 239
TC 0
Z9 0
U1 5
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2095-0217
EI 2095-0225
J9 FRONT MED-PRC
JI Front. Med.
PD APR
PY 2020
VL 14
IS 2
BP 160
EP 184
DI 10.1007/s11684-020-0750-4
PG 25
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA LN1TA
UT WOS:000532726700006
PM 32146606
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Putri, ND
   Dhenni, R
   Handryastuti, S
   Johar, E
   Ma'roef, CN
   Fadhilah, A
   Iskandar, ATP
   Prayitno, A
   Karyanti, MR
   Satari, HI
   Jumiyanti, N
   Aprilia, YY
   Sriyani, IY
   Dewi, YP
   Yudhaputri, FA
   Safari, D
   Hadinegoro, SR
   Rosenberg, R
   Powers, AM
   Myint, KSA
AF Putri, Nina Dwi
   Dhenni, Rama
   Handryastuti, Setyo
   Johar, Edison
   Ma'roef, Chairin Nisa
   Fadhilah, Araniy
   Iskandar, Adhi Teguh Perma
   Prayitno, Ari
   Karyanti, Mulya Rahma
   Satari, Hindra Irawan
   Jumiyanti, Niphidiah
   Aprilia, Yuni Yudha
   Sriyani, Ida Yus
   Dewi, Yora Permata
   Yudhaputri, Frilasita A.
   Safari, Dodi
   Hadinegoro, Sri Rezeki
   Rosenberg, Ronald
   Powers, Ann M.
   Myint, Khin Saw Aye
TI Absence of Evidence of Zika Virus Infection in Cord Blood and Urine from
   Newborns with Congenital Abnormalities, Indonesia
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID ANTIBODIES
AB Zika virus (ZIKV) has recently been confirmed as endemic in Indonesia, but no congenital anomalies (CA) related to ZIKV infection have been reported. We performed molecular and serological testing for ZIKV and other flavi-viruses on cord serum and urine samples collected in October 2016 to April 2017 during a prospective, cross-sectional study of neonates in Jakarta, Indonesia. Of a total of 429 neonates, 53 had CA, including 14 with microcephaly. These 53, and 113 neonate controls without evidence of CA, were tested by ZIKV-specific real-time reverse transcription polymerase chain reaction (RT-PCR), pan-flavivirus RT-PCR, anti-ZIKV and anti-DENV IgM ELISA, and plaque reduction neutralization test. There was no evidence of ZIKV infection among neonates in either the CA or non-CA cohorts, except in three cases with low titers of anti-ZIKV neutralizing antibodies. Further routine evaluation throughout Indonesia of pregnant women and their newborns for exposure to ZIKV should be a high priority for determining risk.
C1 [Putri, Nina Dwi; Handryastuti, Setyo; Iskandar, Adhi Teguh Perma; Prayitno, Ari; Karyanti, Mulya Rahma; Satari, Hindra Irawan; Jumiyanti, Niphidiah; Aprilia, Yuni Yudha; Hadinegoro, Sri Rezeki] Univ Indonesia, Dept Paediat, Dr Cipto Mangunkusumo Natl Cent Hosp, Fac Med, Jakarta, Indonesia.
   [Dhenni, Rama; Johar, Edison; Ma'roef, Chairin Nisa; Fadhilah, Araniy; Sriyani, Ida Yus; Dewi, Yora Permata; Yudhaputri, Frilasita A.; Safari, Dodi; Myint, Khin Saw Aye] Eijkman Inst Mol Biol, Emerging Virus Res Unit, Jakarta, Indonesia.
   [Rosenberg, Ronald; Powers, Ann M.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Myint, KSA (corresponding author), Eijkman Inst Mol Biol, Jl Diponegoro 69, Jakarta 10430, Indonesia.
EM khinsawying@hotmail.com
OI Dhenni, Rama/0000-0001-9782-6666; Johar, Edison/0000-0002-9491-6487;
   Dewi, Yora Permata/0000-0001-5279-8892
FU Ministry of Research, Technology, and Higher Education of the Republic
   of Indonesia; U.S. Centers for Disease Control and PreventionUnited
   States Department of Health & Human ServicesCenters for Disease Control
   & Prevention - USA; Office of Infectious Diseases, Bureau for Global
   Health, U.S. Agency for International DevelopmentUnited States Agency
   for International Development (USAID); CDCUnited States Department of
   Health & Human ServicesCenters for Disease Control & Prevention - USA
FX This work was supported by the Ministry of Research, Technology, and
   Higher Education of the Republic of Indonesia, and the U.S. Centers for
   Disease Control and Prevention. Funding for this work was also provided
   by the Office of Infectious Diseases, Bureau for Global Health, U.S.
   Agency for International Development, under the terms of an Interagency
   Agreement with CDC.
CR Castanha PMS, 2018, PLOS NEGLECT TROP D, V13, P1
   Christianson A, 2006, GLOBAL REPORT BIRTH
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Fenton TR, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-59
   Hunsperger EA, 2009, EMERG INFECT DIS, V15, P436, DOI 10.3201/eid1503.080923
   Jun SR, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1894-3
   Kementerian Kesehatan RI, 2018, KEL BAW
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   Mawuntu AHP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207440
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Moreira-Soto Andres, 2017, J Infect Dis, V216, P1501, DOI 10.1093/infdis/jix539
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   PAHO/WHO, 2018, ZIK CAS CONG SYNDR A
   Putri ND, 2019, INT J INFECT DIS, V86, P31, DOI 10.1016/j.ijid.2019.06.009
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V3099, P1
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   WHO, 2014, HEAD CIRC FOR AG
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   Yudhaputri FA, 2017, VIROLOGY, V510, P248, DOI 10.1016/j.virol.2017.07.026
NR 25
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD APR
PY 2020
VL 102
IS 4
BP 876
EP 879
DI 10.4269/ajtmh.19-0593
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8BM
UT WOS:000531085300031
PM 32043460
DA 2020-07-08
ER

PT J
AU Assis, FL
   Sippert, E
   Rocha, BC
   Volkova, E
   Fares-Gusmao, R
   Ok, S
   Chancey, C
   Rios, M
AF Assis, Felipe Lopes
   Sippert, Emilia
   Rocha, Bruno Coelho
   Volkova, Evgeniya
   Fares-Gusmao, Rafaelle
   Ok, Suzan
   Chancey, Caren
   Rios, Maria
TI Genomic and Phylogenetic Analysis of Zika Virus Isolates from
   Asymptomatic Blood Donors in the United States and Puerto Rico, 2016
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID TRANSMISSION; EVOLUTION; SPREAD
AB Zika virus (ZIKV) caused a public health threat in the United States in 2016, leading to rapid development and implementation of blood screening assays for ZIKV RNA. Several ZIKV sequences from clinical cases have been reported, but none from asymptomatic/pre-symptomatic infections. We isolated and sequenced ZIKV from asymptomatic/presymptomatic blood donor (ABD-ZIKV) samples and compared with reported clinical sequences. Twelve ABD-ZIKV isolates were produced from 67 cultivated samples, and isolates were genetically similar among themselves. Most isolates shared mutations with the clinical isolate PRVABC59 2015, whereas two ABD-ZIKV isolates shared specific mutations with U.S. clinical isolates from 2016. The ABD-ZIKV strains clustered into two distinct subclades: one comprised mostly ABD-ZIKV from Puerto Rico, and another one comprised ABD-ZIKV fronn Florida and QTX-02 isolate (Puerto Rico). In this study, we showed the circulation of two slightly distinct virus strains among Puerto Rico blood donors, one of which was also reported in Florida.
C1 [Assis, Felipe Lopes; Sippert, Emilia; Rocha, Bruno Coelho; Volkova, Evgeniya; Fares-Gusmao, Rafaelle; Ok, Suzan; Chancey, Caren; Rios, Maria] Food & Drug Adm FDA, Div Emerging & Transfus Transmitted Dis DETTD, Off Blood Res & Review OBRR, Ctr Biol Evaluat & Res CBER, 10903 New Hampshire Ave,Bldg 52-72,Rm 5308, Silver Spring, MD 20993 USA.
RP Rios, M (corresponding author), Food & Drug Adm FDA, Div Emerging & Transfus Transmitted Dis DETTD, Off Blood Res & Review OBRR, Ctr Biol Evaluat & Res CBER, 10903 New Hampshire Ave,Bldg 52-72,Rm 5308, Silver Spring, MD 20993 USA.
EM maria.rios@fda.hhs.gov
FU FDA Medical Countermeasures Initiative (MCMi) [OCET 2016-331]; U.S.
   Department of EnergyUnited States Department of Energy (DOE); U.S. Food
   and Drug Administration
FX We are grateful to the test developers and blood banks for providing the
   samples used in this study. This project was funded by the FDA Medical
   Countermeasures Initiative (MCMi), Grant OCET 2016-331, and supported in
   part by an appointment to the ORISE Research Fellowship Program at the
   Center for Biologics Evaluation and Research administered by the Oak
   Ridge Institute for Science and Education through an interagency
   agreement between the U.S. Department of Energy and the U.S. Food and
   Drug Administration.
CR Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CDC, 2019, ZIK CAS US
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Gong Z, 2016, TRENDS MICROBIOL, V24, P521, DOI 10.1016/j.tim.2016.05.002
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Metsky HC, 2017, NATURE, V546, P411, DOI 10.1038/nature22402
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Sall AA, 2010, J VIROL, V84, P765, DOI 10.1128/JVI.01738-09
   Shen S, 2016, VIROL SIN, V31, P118, DOI 10.1007/s12250-016-3774-9
   Sippert E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11111058
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   U.S. Department of Health and Human Services Food and Drug Administration Center for Biologics Evaluation and Research, 2018, REV REC RED RISK ZIK
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD APR
PY 2020
VL 102
IS 4
BP 880
EP 883
DI 10.4269/ajtmh.19-0747
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK8BM
UT WOS:000531085300032
PM 32043455
DA 2020-07-08
ER

PT J
AU Harsh, S
AF Harsh, Sneh
TI First person - Sneh Harsh
SO DISEASE MODELS & MECHANISMS
LA English
DT Editorial Material
AB First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping early-career researchers promote themselves alongside their papers. Sneh Harsh is first author on 'Zika virus non-structural protein NS4A restricts eye growth in Drosophila through regulation of JAK/STAT signaling', published in DMM. Sneh conducted the research described in this article while a postdoctoral researcher in Ioannis Eleftherianos's lab at The George Washington University, Washington, DC, USA. She is now a postdoctoral researcher in the lab of Erika Bach at NYU Langone Health, New York, NY, USA, investigating host pathophysiology upon Zika virus infection using Drosophila developing organs as the model system.
C1 [Harsh, Sneh] NYU Langone Hlth, Alexandria Ctr Life Sci, New York, NY 10016 USA.
RP Harsh, S (corresponding author), NYU Langone Hlth, Alexandria Ctr Life Sci, New York, NY 10016 USA.
EM Sneh.Harsh@nyulangone.org
CR Harsh S, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.040816
NR 1
TC 0
Z9 0
U1 1
U2 1
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD APR
PY 2020
VL 13
IS 4
AR dmm044826
DI 10.1242/dmm.044826
PG 2
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA LN1SL
UT WOS:000532725200011
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Harsh, S
   Fu, YL
   Kenney, E
   Han, Z
   Eleftherianos, I
AF Harsh, Sneh
   Fu, Yulong
   Kenney, Eric
   Han, Zhe
   Eleftherianos, Ioannis
TI Zika virus non-structural protein NS4A restricts eye growth in
   Drosophila through regulation of JAK/STAT signaling
SO DISEASE MODELS & MECHANISMS
LA English
DT Article
DE Drosophila; Eye development; JAK/STAT signaling; Host-pathogen
   interaction; Zika virus
ID GUILLAIN-BARRE-SYNDROME; CELL-CYCLE; TYROSINE PHOSPHORYLATION; ANTIVIRAL
   IMMUNITY; STRUCTURAL BIOLOGY; HUMAN-DISEASE; PATHWAY; NOTCH; EXPRESSION;
   TRANSCRIPTION
AB To gain a comprehensive view of the changes in host gene expression underlying Zika virus (ZIKV) pathogenesis, we performed whole genome RNA sequencing (RNA-seq) of ZIKV-infected Drosophila adult flies. RNA-seq analysis revealed that ZIKV infection alters several and diverse biological processes, including stress, locomotion, lipid metabolism, imaginal disc morphogenesis and regulation of JAK/STAT signaling. To explore the interaction between ZIKV infection and JAK/STAT signaling regulation, we generated genetic constructs overexpressing ZIKV-specific non-structural proteins NS2A, NS2B, NS4A and NS4B. We found that ectopic expression of non-structural proteins in the developing Drosophila eye significantly restricts growth of the larval and adult eye and correlates with considerable repression of the in vivo JAK/STAT reporter. 10XStat92E-GFP. At the cellular level, eye growth defects are associated with reduced rate of proliferation without affecting the overall rate of apoptosis. In addition, ZIKV NS4A genetically interacts with the JAK/STAT signaling components; co-expression of NS4A along with the dominant-negative form of domeless or StatRNAi results in aggravated reduction in eye size, while co-expression of NS4A in HopTuml (also known as hop(Tum)) mutant background partially rescues the hop-induced eye overgrowth phenotype. The function of ZIKV NS4A in regulating growth is maintained in the wing, where ZIKV NS4A overexpression in the pouch domain results in reduced growth linked with diminished expression of Notch targets, Wingless (Wg) and Cut, and the Notch reporter. NRE-GFP. Thus, our study provides evidence that ZIKV infection in Drosophila results in restricted growth of the developing eye and wing, wherein eye phenotype is induced through regulation of JAK/STAT signaling, whereas restricted wing growth is induced through regulation of Notch signaling. The interaction of ZIKV non-structural proteins with the conserved host signaling pathways further advance our understanding of ZIKV-induced pathogenesis.
   This article has an associated First Person interview with the first author of the paper.
C1 [Harsh, Sneh; Kenney, Eric; Eleftherianos, Ioannis] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.
   [Harsh, Sneh] NYU Langone Hlth, Alexandria Ctr Life Sci, New York, NY 10016 USA.
   [Fu, Yulong; Han, Zhe] George Washington Univ, Ctr Genet Med Res, Dept Genom & Precis Med, Childrens Natl Hlth Syst,Sch Med & Hlth Sci, Washington, DC 20010 USA.
RP Eleftherianos, I (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.
EM ioannise@gwu.edu
OI HARSH, SNEH/0000-0002-3224-9586; Han, Zhe/0000-0002-5177-7798;
   Eleftherianos, Ioannis/0000-0002-4822-3110
FU National Institute of Allergy and Infectious DiseasesUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [1R01AI110675-01A1]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases (1R01AI110675-01A1 to I.E.).
CR Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411
   Bach EA, 2003, GENETICS, V165, P1149
   Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003
   Bernards A, 2001, CURR OPIN GENET DEV, V11, P274, DOI 10.1016/S0959-437X(00)00190-8
   Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3
   Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Cifuentes FJ, 1997, P NATL ACAD SCI USA, V94, P11405, DOI 10.1073/pnas.94.21.11405
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dong SZ, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3775-6
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237
   Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646
   Ekas LA, 2006, DEVELOPMENT, V133, P4721, DOI 10.1242/dev.02675
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Flaherty MS, 2009, DEV DYNAM, V238, P2235, DOI 10.1002/dvdy.21989
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freeman M, 1997, DEVELOPMENT, V124, P261
   Furtado JM, 2016, NEW ENGL J MED, V375, P394, DOI 10.1056/NEJMc1603618
   GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251
   Giraldez AJ, 2003, DEVELOPMENT, V130, P6533, DOI 10.1242/dev.00904
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guo JT, 2005, J VIROL, V79, P1343, DOI 10.1128/JVI.79.3.1343-1350.2005
   Harsh S, 2018, J IMMUNOL, V201, P3058, DOI 10.4049/jimmunol.1800597
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   HAWLEY RJ, 1988, GENE DEV, V2, P341, DOI 10.1101/gad.2.3.341
   Holmes AL, 1998, GENETICS, V148, P1189
   Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211
   Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923
   Hughes TT, 2012, VIROLOGY, V423, P1, DOI 10.1016/j.virol.2011.11.016
   Irvine KD, 1997, CURR OPIN CELL BIOL, V9, P867, DOI 10.1016/S0955-0674(97)80090-7
   Jones M, 2005, J VIROL, V79, P5414, DOI 10.1128/JVI.79.9.5414-5420.2005
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Kallio J, 2010, FASEB J, V24, P4467, DOI 10.1096/fj.10-162784
   Kemp C, 2013, J IMMUNOL, V190, P650, DOI 10.4049/jimmunol.1102486
   Kile BT, 2001, CELL MOL LIFE SCI, V58, P1627, DOI 10.1007/PL00000801
   Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Lee SB, 2005, J CELL SCI, V118, P1851, DOI 10.1242/jcs.02312
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Link N, 2019, DEV CELL, V51, P713, DOI 10.1016/j.devcel.2019.10.009
   Liu RJ, 2015, NUCLEIC ACIDS RES, V43, pE97, DOI 10.1093/nar/gkv412
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Mauzy-Melitz D, 2003, DEV BIOL, V255, P193, DOI 10.1016/S0012-1606(02)00084-2
   Mead PS, 2018, CURR OPIN INFECT DIS, V31, P39, DOI 10.1097/QCO.0000000000000414
   Merkling SH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12758
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mukherjee T, 2005, ONCOGENE, V24, P2503, DOI 10.1038/sj.onc.1208487
   Munoz-Jordan JL, 2003, P NATL ACAD SCI USA, V100, P14333, DOI 10.1073/pnas.2335168100
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Neumann CJ, 1996, DEVELOPMENT, V122, P3477
   Neumann CJ, 1998, SCIENCE, V281, P409, DOI 10.1126/science.281.5375.409
   NG M, 1995, DEVELOPMENT, V121, P589
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Op De Beeck A, 1997, Prog Cell Cycle Res, V3, P1
   Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129
   Pandey UB, 2011, PHARMACOL REV, V63, P411, DOI 10.1124/pr.110.003293
   Patro R, 2014, NAT BIOTECHNOL, V32, P462, DOI 10.1038/nbt.2862
   PERRIMON N, 1986, DEV BIOL, V118, P28, DOI 10.1016/0012-1606(86)90070-9
   Poon B, 1998, SCIENCE, V281, P266, DOI 10.1126/science.281.5374.266
   Rawlings JS, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-38
   Recasens-Alvarez C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13815
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Saj A, 2010, DEV CELL, V18, P862, DOI 10.1016/j.devcel.2010.03.013
   SCHINDLER C, 1992, SCIENCE, V257, P809, DOI 10.1126/science.1496401
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Shirasu-Hiza MM, 2007, CELL MICROBIOL, V9, P2775, DOI 10.1111/j.1462-5822.2007.01042.x
   SHUAI K, 1994, CELL, V76, P821, DOI 10.1016/0092-8674(94)90357-3
   SHUAI K, 1992, SCIENCE, V258, P1808, DOI 10.1126/science.1281555
   Silies M, 2007, J NEUROSCI, V27, P13130, DOI 10.1523/JNEUROSCI.3583-07.2007
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Souza-Neto JA, 2009, P NATL ACAD SCI USA, V106, P17841, DOI 10.1073/pnas.0905006106
   Steinberg R, 2008, TRANSGENIC RES, V17, P105, DOI 10.1007/s11248-007-9136-5
   STELLER H, 1987, CELL, V50, P1139, DOI 10.1016/0092-8674(87)90180-2
   Sun JF, 2016, JAMA OPHTHALMOL, V134, P1330, DOI 10.1001/jamaophthalmol.2016.3417
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Thomson TC, 2012, GENESIS, V50, P453, DOI 10.1002/dvg.22004
   Tsai YC, 2004, GENESIS, V39, P141, DOI 10.1002/gene.20035
   VELAZQUEZ L, 1992, CELL, V70, P313, DOI 10.1016/0092-8674(92)90105-L
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang J, 2018, BIOCHEM BIOPH RES CO, V497, P619, DOI 10.1016/j.bbrc.2018.02.118
   Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356
   WATLING D, 1993, NATURE, V366, P166, DOI 10.1038/366166a0
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Wong SLA, 2005, BIOCHEM BIOPH RES CO, V337, P720, DOI 10.1016/j.bbrc.2005.09.098
   Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhao RY, 2011, J NEUROIMMUNE PHARM, V6, P216, DOI 10.1007/s11481-011-9261-z
   Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279
NR 106
TC 1
Z9 1
U1 1
U2 1
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 1754-8403
EI 1754-8411
J9 DIS MODEL MECH
JI Dis. Model. Mech.
PD APR
PY 2020
VL 13
IS 4
AR dmm040816
DI 10.1242/dmm.040816
PG 17
WC Cell Biology; Pathology
SC Cell Biology; Pathology
GA LN1SL
UT WOS:000532725200001
PM 32152180
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cavany, SM
   Espana, G
   Lloyd, AL
   Waller, LA
   Kitron, U
   Astete, H
   Elson, WH
   Vazquez-Prokopec, GM
   Scott, TW
   Morrison, AC
   Reiner, RC
   Perkins, TA
AF Cavany, Sean M.
   Espana, Guido
   Lloyd, Alun L.
   Waller, Lance A.
   Kitron, Uriel
   Astete, Helvio
   Elson, William H.
   Vazquez-Prokopec, Gonzalo M.
   Scott, Thomas W.
   Morrison, Amy C.
   Reiner, Robert C., Jr.
   Perkins, T. Alex
TI Optimizing the deployment of ultra-low volume and indoor residual
   spraying for dengue outbreak response
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID AEDES-AEGYPTI; SENSITIVITY-ANALYSIS; EMERGENCY CONTROL; TRANSMISSION;
   VECTOR; DYNAMICS; EFFICACY; IMPACT; MODEL; TIME
AB Author summary
   Over half of the world's population is at risk of infection by dengue virus (DENV) from Aedes aegypti mosquitoes. While most infected people experience mild or asymptomatic infections, dengue can cause severe symptoms, such as hemorrhage, shock, and death. A vaccine against dengue exists, but it can increase the risk of severe disease in people who have not been previously infected by one of the four DENV serotypes. In many places, therefore, the best currently available way to prevent outbreaks is by controlling the mosquito population. Our study used a simulation model to explore alternative strategies for deploying insecticide in the city of Iquitos in the Peruvian Amazon. Our simulations closely matched empirical patterns from studies of dengue's ecology and epidemiology in Iquitos, such as mosquito population dynamics, human household structure, demography, human and mosquito movement, and virus transmission. Our results indicate that an insecticide that has a long-lasting, residual effect will have the biggest impact on reducing DENV transmission. For non-residual insecticides, we find that it is best to begin spraying close to the start of the dengue transmission season, as mosquito populations can rebound quickly and resume previous levels of transmission.
   Recent years have seen rising incidence of dengue and large outbreaks of Zika and chikungunya, which are all caused by viruses transmitted by Aedes aegypti mosquitoes. In most settings, the primary intervention against Aedes-transmitted viruses is vector control, such as indoor, ultra-low volume (ULV) spraying. Targeted indoor residual spraying (TIRS) has the potential to more effectively impact Aedes-borne diseases, but its implementation requires careful planning and evaluation. The optimal time to deploy these interventions and their relative epidemiological effects are, however, not well understood. We used an agent-based model of dengue virus transmission calibrated to data from Iquitos, Peru to assess the epidemiological effects of these interventions under differing strategies for deploying them. Specifically, we compared strategies where spray application was initiated when incidence rose above a threshold based on incidence in recent years to strategies where spraying occurred at the same time(s) each year. In the absence of spraying, the model predicted 361,000 infections [inter-quartile range (IQR): 347,000-383,000] in the period 2000-2010. The ULV strategy with the fewest median infections was spraying twice yearly, in March and October, which led to a median of 172,000 infections [IQR: 158,000-183,000], a 52% reduction from baseline. Compared to spraying once yearly in September, the best threshold-based strategy utilizing ULV had fewer median infections (254,000 vs. 261,000), but required more spraying (351 vs. 274 days). For TIRS, the best strategy was threshold-based, which led to the fewest infections of all strategies tested (9,900; [IQR: 8,720-11,400], a 94% reduction), and required fewer days spraying than the equivalent ULV strategy (280). Although spraying twice each year is likely to avert the most infections, our results indicate that a threshold-based strategy can become an alternative to better balance the translation of spraying effort into impact, particularly if used with a residual insecticide.
C1 [Cavany, Sean M.; Espana, Guido; Perkins, T. Alex] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.
   [Cavany, Sean M.; Espana, Guido; Perkins, T. Alex] Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
   [Lloyd, Alun L.] North Carolina State Univ, Dept Math, Raleigh, NC USA.
   [Lloyd, Alun L.] North Carolina State Univ, Biomath Grad Program, Raleigh, NC USA.
   [Waller, Lance A.] Emory Univ, Rollins Sch Publ Hlth, Dept Biostat & Bioinformat, Atlanta, GA 30322 USA.
   [Kitron, Uriel; Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.
   [Astete, Helvio] US Naval Med Res Unit Six, Lima, Peru.
   [Elson, William H.; Scott, Thomas W.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.
   [Morrison, Amy C.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Reiner, Robert C., Jr.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.
RP Cavany, SM; Perkins, TA (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.; Cavany, SM; Perkins, TA (corresponding author), Univ Notre Dame, Eck Inst Global Hlth, Notre Dame, IN 46556 USA.
EM scavany@nd.edu; taperkins@nd.edu
OI Cavany, Sean/0000-0002-2559-797X; Waller, Lance/0000-0001-5002-8886;
   Lloyd, Alun/0000-0002-6389-6321; Elson, William/0000-0002-8630-1378;
   Camargo Espana, guido/0000-0002-9915-8056
FU National Institutes of Health, National Institute for Allergy and
   Infectious DiseaseUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [P01AI098670]
FX SMC, GE, GMV-P, ACM, TWS, RCR, and TAP were supported by grant
   P01AI098670 (TWS, PI) from the National Institutes of Health, National
   Institute for Allergy and Infectious Disease
   (https://www.niaid.nih.gov).The funders had no role in the study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   [Anonymous], 2015, NEWMAN NUMISMATIC PO, V18, P4
   Armada Gessa J A, 1986, Bull Pan Am Health Organ, V20, P186
   Barbu C, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000416
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Boubidi SC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1881-y
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2020, ANNU REV ENTOMOL, V65, P191, DOI 10.1146/annurev-ento-011019-024918
   Brady OJ, 2015, EPIDEMICS-NETH, V11, P92, DOI 10.1016/j.epidem.2015.03.002
   Breidenbaugh MS, 2009, J AM MOSQUITO CONTR, V25, P467, DOI 10.2987/08-5892.1
   Castro Mirley, 2007, Rev. salud pública, V9, P106, DOI 10.1590/S0124-00642007000100011
   Campos NBD, 2019, INT J ENVIRON HEAL R, DOI 10.1080/09603123.2019.1656801
   Dunbar MW, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007203
   Ellis AM, 2011, AM J TROP MED HYG, V85, P257, DOI 10.4269/ajtmh.2011.10-0516
   Espana G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210041
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Finger F, 2019, BMC MED, V17, DOI 10.1186/s12916-019-1288-7
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Funk S, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006785
   Gao DZ, 2014, AM J TROP MED HYG, V91, P936, DOI 10.4269/ajtmh.13-0474
   Gastanaduy PA, 2018, AM J EPIDEMIOL, V187, P2002, DOI 10.1093/aje/kwy082
   Getis A, 2010, ADV SPAT SCI, P203, DOI 10.1007/978-3-642-01976-0_15
   Grais RF, 2008, J R SOC INTERFACE, V5, P67, DOI 10.1098/rsif.2007.1038
   Gunning CE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006378
   Herman J., 2017, JOSS, V2, P97, DOI DOI 10.21105/J0SS.00097
   Hladish TJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006570
   Cuong HQ, 2013, EMERG INFECT DIS, V19, P945, DOI 10.3201/eid1906.121323
   Koenraadt CJM, 2007, J MED ENTOMOL, V44, P65, DOI 10.1603/0022-2585(2007)44[65:SATPIT]2.0.CO;2
   Kucharski AJ, 2015, P NATL ACAD SCI USA, V112, P14366, DOI 10.1073/pnas.1508814112
   LaCon G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003038
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Liebman KA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001472
   Magori K, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000508
   Marini G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006831
   Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Nishiura H, 2007, J INFECT DIS, V195, P1007, DOI 10.1086/511825
   Olowokure B, 2007, J EPIDEMIOL COMMUN H, V61, P385, DOI 10.1136/jech.2005.042598
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   PANT CP, 1974, B WORLD HEALTH ORGAN, V51, P409
   Paredes-Esquivel C, 2016, ACTA TROP, V154, P139, DOI 10.1016/j.actatropica.2015.10.020
   Perich MJ, 2003, J AM MOSQUITO CONTR, V19, P58
   Perich MJ, 2001, J AM MOSQUITO CONTR, V17, P221
   Perkins TA, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006710
   Perkins TA, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0642
   Perkins TA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003327
   Peterson AT, 2005, T ROY SOC TROP MED H, V99, P647, DOI 10.1016/j.trstmh.2005.02.004
   Polonsky JA, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0276
   R Core Team, 2018, R LANG ENV STAT COMP
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Reiner RC, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007255
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018
   Schliessman DJ, 1974, REV STATUS YELLOW FE
   Selvaraj P, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3319-y
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Stoddard ST, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003003
   Stoddard ST, 2013, P NATL ACAD SCI USA, V110, P994, DOI 10.1073/pnas.1213349110
   Tao Y, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006161
   Thompson KM, 2016, RISK ANAL, V36, P1404, DOI 10.1111/risa.12440
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Wahid I, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007606
   Worrall E, 2007, TROP MED INT HEALTH, V12, P75, DOI 10.1111/j.1365-3156.2006.01772.x
   Wu JY, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.1018
   Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730
NR 68
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD APR
PY 2020
VL 16
IS 4
AR e1007743
DI 10.1371/journal.pcbi.1007743; 10.1371/journal.pcbi.1007743.r001;
   10.1371/journal.pcbi.1007743.r002; 10.1371/journal.pcbi.1007743.r003;
   10.1371/journal.pcbi.1007743.r004
PG 28
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA LL2EG
UT WOS:000531366700053
PM 32310958
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Flores, HA
   de Bruyne, JT
   O'Donnell, TB
   Nhu, VT
   Giang, NT
   Trang, HTX
   Van, HTT
   Long, VT
   Dui, LT
   Huy, HL
   Le Duyen, HT
   Van Thuy, NT
   Phong, NT
   Chau, NV
   Kien, DTH
   Vi, TT
   Wills, B
   O'Neill, SL
   Simmons, CP
   Carrington, LB
AF Flores, Heather A.
   Taneja de Bruyne, Jyotika
   O'Donnell, Tanya B.
   Tuyet Nhu, Vu
   Thi Giang, Nguyen
   Thi Xuan Trang, Huynh
   Thi Thuy Van, Huynh
   Thi Long, Vo
   Thi Dui, Le
   Le Anh Huy, Huynh
   Thi Le Duyen, Huynh
   Thi Van Thuy, Nguyen
   Thanh Phong, Nguyen
   Van Vinh Chau, Nguyen
   Thi Hue Kien, Duong
   Thuy Vi, Tran
   Wills, Bridget
   O'Neill, Scott L.
   Simmons, Cameron P.
   Carrington, Lauren B.
TI Multiple Wolbachia strains provide comparative levels of protection
   against dengue virus infection in Aedes aegypti
SO PLOS PATHOGENS
LA English
DT Article
ID BLOCKS DENGUE; ESTABLISHMENT; TRANSMISSION; POPULATION
AB The insect bacterium Wolbachia pipientis is being introgressed into Aedes aegypti populations as an intervention against the transmission of medically important arboviruses. Here we compare Ae. aegypti mosquitoes infected with wMelCS or wAlbB to the widely used wMel Wolbachia strain on an Australian nuclear genetic background for their susceptibility to infection by dengue virus (DENV) genotypes spanning all four serotypes. All Wolbachia-infected mosquitoes were more resistant to intrathoracic DENV challenge than their wildtype counterparts. Blocking of DENV replication was greatest by wMelCS. Conversely, wAlbB-infected mosquitoes were more susceptible to whole body infection than wMel and wMelCS. We extended these findings via mosquito oral feeding experiments, using viremic blood from 36 acute, hospitalised dengue cases in Vietnam, additionally including wMel and wildtype mosquitoes on a Vietnamese nuclear genetic background. As above, wAlbB was less effective at blocking DENV replication in the abdomen compared to wMel and wMelCS. The transmission potential of all Wolbachia-infected mosquito lines (measured by the presence/absence of infectious DENV in mosquito saliva) after 14 days, was significantly reduced compared to their wildtype counterparts, and lowest for wMelCS and wAlbB. These data support the use of wAlbB and wMelCS strains for introgression field trials and the biocontrol of DENV transmission. Furthermore, despite observing significant differences in transmission potential between wildtype mosquitoes from Australia and Vietnam, no difference was observed between wMel-infected mosquitoes from each background suggesting that Wolbachia may override any underlying variation in DENV transmission potential.
   Author summary
   Aedes aegypti transmit a number of medically important arboviruses, including dengue, Zika, chikungunya, Mayaro and yellow fever viruses. Over the past 50 years, the burden of Ae. aegypti-transmitted disease has significantly increased-underscoring how current methods of vector control are unable to cope with this problem. Wolbachia-based biocontrol methods show extreme promise in reducing the global burden of vector-borne disease. The wMel strain, widely being used in field trials around the world, substantially reduces the ability of Ae. aegypti mosquitoes to transmit dengue, Zika, and other viruses. Here we describe a comprehensive comparative study of the viral blocking abilities of wMel to wMelCS and wAlbB which have previously been shown to have stronger viral blocking or an expanded utility in extreme environments, respectively. Using two different methods to measure viral replication and transmission potential, we show that both strains provide improved viral protection over wMel in the lab supporting further examination in field trials. We further compare the transmission potential of wMel in two different genetic backgrounds and find that wMel provides equivalent levels of viral blocking despite differences observed in wildtype mosquitoes, suggesting that viral blocking induced by wMel may override any underlying variation for DENV transmission potential.
C1 [Flores, Heather A.; Taneja de Bruyne, Jyotika; O'Donnell, Tanya B.; O'Neill, Scott L.; Simmons, Cameron P.] Monash Univ, Inst Vector Borne Dis, World Mosquito Program, Clayton, Vic, Australia.
   [Tuyet Nhu, Vu; Thi Giang, Nguyen; Thi Xuan Trang, Huynh; Thi Thuy Van, Huynh; Thi Long, Vo; Thi Dui, Le; Le Anh Huy, Huynh; Thi Le Duyen, Huynh; Thi Van Thuy, Nguyen; Thi Hue Kien, Duong; Thuy Vi, Tran; Wills, Bridget; Simmons, Cameron P.; Carrington, Lauren B.] Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam.
   [Thanh Phong, Nguyen; Van Vinh Chau, Nguyen] Hosp Trop Dis, Ho Chi Minh City, Vietnam.
   [Wills, Bridget; Simmons, Cameron P.; Carrington, Lauren B.] Univ Oxford, Nuffield Dept Med, Oxford, England.
RP Flores, HA (corresponding author), Monash Univ, Inst Vector Borne Dis, World Mosquito Program, Clayton, Vic, Australia.; Carrington, LB (corresponding author), Hosp Trop Dis, Oxford Univ Clin Res Unit, Ho Chi Minh City, Vietnam.; Carrington, LB (corresponding author), Univ Oxford, Nuffield Dept Med, Oxford, England.
EM heather.flores@monash.edu; lbcarrington@gmail.com
RI O'Neill, Scott L/B-3568-2009
OI O'Neill, Scott L/0000-0002-4131-3615
FU Wellcome TrustWellcome Trust [102591/Z/13/Z]
FX This work was supported by a Wellcome Trust Award No.102591/Z/13/Z to
   Monash University through its World Mosquito Program. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR [Anonymous], 2013, BMC P S6, V7, pO1
   [Anonymous], 2016, TOP AGRAR, V10, P18
   Ant TH, 2018, PLOS PATHOG, V14, P19, DOI DOI 10.1371/J0URNAL.PPAT.1006815
   Axford JK, 2016, AM J TROP MED HYG, V94, P507, DOI 10.4269/ajtmh.15-0608
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Caragata EP, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003459
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Carrington LB, 2018, P NATL ACAD SCI USA, V115, P361, DOI 10.1073/pnas.1715788115
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Duong V, 2015, P NATL ACAD SCI USA, V112, P14688, DOI 10.1073/pnas.1508114112
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Flores HA, 2018, NAT REV MICROBIOL, V16, P508, DOI 10.1038/s41579-018-0025-0
   Fraser JE, 2017, PLOS PATHOG, V13, P19
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Garcia GD, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007023
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kien DTH, 2011, J VIROL METHODS, V177, P168, DOI 10.1016/j.jviromet.2011.08.002
   McGraw EA, 2013, NAT REV MICROBIOL, V11, P181, DOI 10.1038/nrmicro2968
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Nazni WA, 2019, CURR BIOL, V29, P4241, DOI 10.1016/j.cub.2019.11.007
   NCCN Clinical Practice, 2018, ACUTE MYELOID LEUKEM, VV2, pMS28
   Nguyen NM, 2013, P NATL ACAD SCI USA, V110, P9072, DOI 10.1073/pnas.1303395110
   Pereira TN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25236-8
   Rances E, 2013, J VIROL, V87, P11945, DOI 10.1128/JVI.01522-13
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Ritchie SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068137
   Ross PA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007357
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ryan Peter A, 2019, Gates Open Res, V3, P1547, DOI 10.12688/gatesopenres.13061.2
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Whitehorn J, 2015, J INFECT DIS, V212, P1182, DOI 10.1093/infdis/jiv173
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Yeap HL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-58
NR 37
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2020
VL 16
IS 4
AR e1008433
DI 10.1371/journal.ppat.1008433
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA LL2DU
UT WOS:000531365400043
PM 32282862
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hui, LX
   Nie, YW
   Li, SH
   Guo, MJ
   Yang, W
   Huang, R
   Chen, JS
   Liu, YX
   Lu, XC
   Chen, Z
   Yang, QY
   Wu, Y
AF Hui, Lixia
   Nie, Yiwen
   Li, Shihua
   Guo, Moujian
   Yang, Wei
   Huang, Rui
   Chen, Junsen
   Liu, Yingxia
   Lu, Xuancheng
   Chen, Zhen
   Yang, Qingyu
   Wu, Ying
TI Matrix metalloproteinase 9 facilitates Zika virus invasion of the testis
   by modulating the integrity of the blood-testis barrier
SO PLOS PATHOGENS
LA English
DT Article
ID SEXUAL TRANSMISSION; JUNCTION PROTEINS; MOUSE MODEL; INFECTION; BRAIN;
   METALLOPROTEINASES; TRANSMIGRATION; EXPRESSION; DYNAMICS; MICE
AB Zika virus (ZIKV) is a unique flavivirus with high tropism to the testes. ZIKV can persist in human semen for months and can cause testicular damage in male mice. However, the mechanisms through which ZIKV enters the testes remain unclear. In this study, we revealed that matrix metalloproteinase 9 (MMP9) was upregulated by ZIKV infection in cell culture and in A129 mice. Furthermore, using an in vitro Sertoli cell barrier model and MMP9(-/-) mice, we found that ZIKV infection directly affected the permeability of the blood-testis barrier (BTB), and knockout or inhibition of MMP9 reduced the effects of ZIKV on the Sertoli cell BTB, highlighting its role in ZIKV-induced disruption of the BTB. Interestingly, the protein levels of MMP9 were elevated by ZIKV nonstructural protein 1 (NS1) in primary mouse Sertoli cells (mSCs) and other cell lines. Moreover, the interaction between NS1 and MMP9 induced the K63-linked polyubiquitination of MMP9, which enhanced the stability of MMP9. The upregulated MMP9 level led to the degradation of essential proteins involved in the maintenance of the BTB, such as tight junction proteins (TJPs) and type & x2163; collagens. Collectively, we concluded that ZIKV infection promoted the expression of MMP9 which was further stabilized by NS1 induced K63-linked polyubiquitination to affect the TJPs/ type & x2163; collagen network, thereby disrupting the BTB and facilitating ZIKV entry into the testes.
   Author summary
   Zika virus (ZIKV) is a flavivirus that shows high tropism to the testes and can persist in human semen for a long period. However, the entry mechanism of ZIKV into the testes has remained unclear. Here, we explored the mechanisms underlying matrix metalloproteinase 9 (MMP9)-modulated ZIKV infection in mice. We showed that MMP9 was upregulated by ZIKV infection both in vivo and in vitro. ZIKV infection affected the permeability of the blood-testis barrier (BTB) through MMP9 mediated degradation of TJPs and type & x2163; collagens that are critically involved in the maintenance of the BTB. Additionally, the interaction between MMP9 and ZIKV NS1 induced the K63-linked polyubiquitination of MMP9, which enhanced the stability and function of MMP9.
   Overall, our findings provided important insights into the mechanisms through which MMP9 disrupted the BTB and promoted ZIKV entry into the testes.
C1 [Hui, Lixia; Nie, Yiwen; Guo, Moujian; Yang, Wei; Huang, Rui; Chen, Junsen; Wu, Ying] Wuhan Univ, Sch Basic Med Sci, State Key Lab Virol, Wuhan, Peoples R China.
   [Li, Shihua] Chinese Acad Sci, Inst Microbiol, CAS Key Lab Pathogen Microbiol & Immunol, Beijing, Peoples R China.
   [Liu, Yingxia] Southern Univ Sci & Technol, Shenzhen Key Lab Pathogen & Immun, State Key Discipline Infect Dis, Hosp Affiliated 2,Shenzhen Peoples Hosp 3, Shenzhen, Peoples R China.
   [Lu, Xuancheng] Chinese Ctr Dis Control & Prevent, Lab Anim Ctr, Beijing, Peoples R China.
   [Chen, Zhen] Wuhan Univ, Dept Tissue & Embryol, Sch Basic Med Sci, Wuhan, Peoples R China.
   [Yang, Qingyu] Wuhan Jinyintan Hosp, Ctr Translat Med, Wuhan, Hubei, Peoples R China.
   [Wu, Ying] Hubei Prov Key Lab Allergy & Immunol, Wuhan, Peoples R China.
RP Wu, Y (corresponding author), Wuhan Univ, Sch Basic Med Sci, State Key Lab Virol, Wuhan, Peoples R China.; Wu, Y (corresponding author), Hubei Prov Key Lab Allergy & Immunol, Wuhan, Peoples R China.
EM yingwu@whu.edu.cn
FU National Science and Technology Major Project [2018ZX10733403];
   Fundamental Research Funds for the Central UniversitiesFundamental
   Research Funds for the Central Universities [2042018kf0208]
FX This work was supported by the National Science and Technology Major
   Project (Grant No. 2018ZX10733403) and the Fundamental Research Funds
   for the Central Universities (Grant No. 2042018kf0208), received by WY.
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR [Anonymous], 2018, J CANC RES THER, V14, pS622
   Romero HA, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01617
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Borges ED, 2019, J ASSIST REPROD GEN, V36, P1339, DOI 10.1007/s10815-019-01493-y
   Bowen JR, 2018, VIRUS RES, V254, P21, DOI 10.1016/j.virusres.2017.08.018
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chen JH, 2017, INDIAN J PHYS, V91, P9, DOI 10.1007/s12648-016-0892-z
   Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Dilworth MR, 2013, PLACENTA, V34, pS34, DOI 10.1016/j.placenta.2012.10.011
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5
   Ho YJ, 2019, BIOCH BIOPHYS RES CO
   Hosoya K, 2013, ADV EXP MED BIOL, V763, P85
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   LEPPERT D, 1995, J IMMUNOL, V154, P4379
   Li C, 2016, CELL STEM CELL, V19, P672, DOI 10.1016/j.stem.2016.10.017
   Li LL, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aas9332
   Lydka Marta, 2012, Spermatogenesis, V2, P294
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mok KW, 2013, INT REV CEL MOL BIO, V301, P291, DOI 10.1016/B978-0-12-407704-1.00006-3
   Mok KW, 2014, J CELL SCI, V127, P4870, DOI 10.1242/jcs.152231
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Puerta-Guardo H, 2020, J INFECT DIS, V221, P313, DOI 10.1093/infdis/jiz331
   Qiu LL, 2016, TOXICOLOGY, V373, P1, DOI 10.1016/j.tox.2016.11.003
   Rempe RG, 2016, J CEREBR BLOOD F MET, V36, P1481, DOI 10.1177/0271678X16655551
   Sampaio GD, 2019, EPIDEMIOL SERV SAUDE, V28, DOI 10.5123/S1679-49742019000200022
   Sheng ZY, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00272
   Siemann DN, 2017, J VIROL, V91, DOI 10.1128/JVI.00623-17
   Stanton PG, 2016, SEMIN CELL DEV BIOL, V59, P166, DOI 10.1016/j.semcdb.2016.06.018
   Strange DP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27027-7
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001
   Tsetsarkin KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07782-x
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Verma S, 2009, VIROLOGY, V385, P425, DOI 10.1016/j.virol.2008.11.047
   Wang PH, 2008, J VIROL, V82, P8978, DOI 10.1128/JVI.00314-08
   WELGUS HG, 1990, J CLIN INVEST, V86, P1496, DOI 10.1172/JCI114867
   Wen Q, 2018, BBA-BIOMEMBRANES, V1860, P141, DOI 10.1016/j.bbamem.2017.04.020
   Xin QL, 2017, J VIROL, V91, DOI [10.1128/JVI.00554-17, 10.1128/jvi.00554-17]
   Yeo SJ, 2002, ARCH VIROL, V147, P229, DOI 10.1007/s705-002-8316-1
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Zhang S, 2018, NEUROSCIENCE, V377, P126, DOI 10.1016/j.neuroscience.2018.02.035
NR 51
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD APR
PY 2020
VL 16
IS 4
AR e1008509
DI 10.1371/journal.ppat.1008509
PG 22
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA LL2DU
UT WOS:000531365400022
PM 32302362
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cardenas, AM
   Whitehead, MT
   Bulas, DI
AF Cardenas, Agustin M.
   Whitehead, Matthew T.
   Bulas, Dorothy I.
TI Fetal Neuroimaging Update
SO SEMINARS IN PEDIATRIC NEUROLOGY
LA English
DT Review
ID CENTRAL-NERVOUS-SYSTEM; ZIKA VIRUS-INFECTION; PRENATAL-DIAGNOSIS;
   BRAIN-DEVELOPMENT; IMAGING FINDINGS; CORTICAL DEVELOPMENT; AQUEDUCTAL
   STENOSIS; VENTRICULAR WIDTH; CORPUS-CALLOSUM; MRI
AB Objectives: To review the current imaging techniques available for the evaluation of the fetal brain. Findings: Ultrasound remains the initial screening modality with routine scanning typically performed at 18-20 weeks gestation. When a central nervous system (CNS) abnormality is noted by ultrasound, MRI is increasingly being used to further clarify findings. Fetal MRI has the unique ability to provide high detailed anatomical information of the entire human fetus with high contrast resolution. This technique has grown due to the development of rapid single shot image acquisition sequences, improvement of motion correction strategies and optimizing shimming techniques. Conclusions: The assessment of fetal CNS anomalies continues to improve. Advanced MRI techniques have allowed for further delineation of CNS anomalies and have become a cornerstone in the assessment of fetal brain well-being. Those interpreting fetal studies need to be familiar with the strengths and limitations of each exam and be sensitive to the impact discussing findings can have regarding perinatal care and delivery planning. Collaboration with neurologists, neurosurgeons, geneticists, counselors, and maternal fetal specialists are key in providing the best care to the families we treat.
C1 [Cardenas, Agustin M.; Whitehead, Matthew T.; Bulas, Dorothy I.] Univ Alabama Birmingham, Childrens Alabama, Dept Radiol, Birmingham, AL USA.
   [Bulas, Dorothy I.] George Washington Sch Med, Washington, DC USA.
RP Bulas, DI (corresponding author), Childrens Natl Med Ctr, Dept Radiol, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM dbulas@childrensnational.org
CR ALAGAPPAN R, 1994, RADIOLOGY, V193, P405, DOI 10.1148/radiology.193.2.7972753
   Almog B, 2003, J ULTRAS MED, V22, P39, DOI 10.7863/jum.2003.22.1.39
   American Institute of Ultrasound in Medicine, 2013, J Ultrasound Med, V32, P1083, DOI 10.7863/ultra.32.6.1083
   Andescavage NN, 2017, CEREB CORTEX, V27, P5274, DOI 10.1093/cercor/bhw306
   [Anonymous], 12 1 SUPRATENTORIAL
   Averill LW, 2015, SEMIN ULTRASOUND CT, V36, P476, DOI 10.1053/j.sult.2015.04.001
   Bar-Yosef O, 2017, PRENATAL DIAG, V37, P764, DOI 10.1002/pd.5078
   Barkovich AJ, 2011, PEDIAT NEUROIMAGING, P367
   Barzilay E, 2017, AM J NEURORADIOL, V38, P371, DOI 10.3174/ajnr.A5009
   Benacerraf BR, 2007, J ULTRAS MED, V26, P1513, DOI 10.7863/jum.2007.26.11.1513
   Biran-Gol Y, 2010, ULTRASOUND OBST GYN, V36, P147, DOI 10.1002/uog.7585
   Blondiaux E, 2013, ULTRASOUND OBST GYN, V42, P149, DOI 10.1002/uog.12340
   Bouchet C, 2007, HUM MUTAT, V28, P1020, DOI 10.1002/humu.20561
   CARDOZA JD, 1988, RADIOLOGY, V169, P711, DOI 10.1148/radiology.169.3.3055034
   Carta S, 2018, ULTRASOUND OBST GYN, V52, P165, DOI 10.1002/uog.19038
   Chen C.P., 2007, TAIWANESE J OBSTETRI, V46, P187
   Chitty LS, 2009, PRENATAL DIAG, V29, P301, DOI 10.1002/pd.2242
   Clouchoux C, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.10.002
   Craven I, 2015, CLIN RADIOL, V70, P248, DOI 10.1016/j.crad.2014.11.004
   D'Addario V, 2012, SEMIN FETAL NEONAT M, V17, P310, DOI 10.1016/j.siny.2012.06.007
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   de Souza AS, 2018, CHILD NERV SYST, V34, P85, DOI 10.1007/s00381-017-3637-1
   Delmas HL, 2008, ULTRASOUND OBST GYN, V32, P188, DOI 10.1002/uog.5348
   DEMYER W, 1963, CONFIN NEUROL, V23, P1
   Den Hollander NS, 2000, ULTRASOUND OBST GYN, V15, P282, DOI 10.1046/j.1469-0705.2000.00092.x
   Devisme L, 2012, BRAIN, V135, P469, DOI 10.1093/brain/awr357
   Di Donato N, 2017, AM J MED GENET A, V173, P1473, DOI 10.1002/ajmg.a.38245
   Donkelaar T, 2014, CLIN NEUROEMBRIOLOGY
   Fanou EM, 2013, PEDIATR RADIOL, V43, P1591, DOI 10.1007/s00247-013-2745-7
   FILLY RA, 1991, RADIOLOGY, V181, P1
   Gaglioti P, 2005, ULTRASOUND OBST GYN, V25, P372, DOI 10.1002/uog.1857
   Garcia-Flores J, 2013, J MATERN-FETAL NEO M, V26, P1517, DOI 10.3109/14767058.2013.791275
   Garel C, 2001, AM J NEURORADIOL, V22, P184
   Gat I, 2016, ULTRASCHALL MED, V37, P176, DOI 10.1055/s-0034-1384935
   Ghai S, 2006, RADIOGRAPHICS, V26, P389, DOI 10.1148/rg.262055059
   Glastonbury Christine M, 2002, Australas Radiol, V46, P22
   Glenn OA, 2005, J ULTRAS MED, V24, P791, DOI 10.7863/jum.2005.24.6.791
   Glenn OA, 2012, RADIOLOGY, V263, P843, DOI 10.1148/radiol.12102492
   Griffiths PD, 2017, ULTRASOUND OBST GYN, V50, P753, DOI 10.1002/uog.17502
   Guibaud L, 2016, ULTRASOUND OBST GYN, V48, P16, DOI 10.1002/uog.15926
   Guillemette-Artur P, 2016, PEDIATR RADIOL, V46, P1032, DOI 10.1007/s00247-016-3619-6
   Harreld JH, 2011, AM J NEURORADIOL, V32, P490, DOI 10.3174/ajnr.A2310
   Heaphy-Henault KJ, 2018, AM J NEURORADIOL, V39, P942, DOI 10.3174/ajnr.A5590
   HEISERMAN J, 1991, J ULTRAS MED, V10, P121
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Howe DT, 2012, ULTRASOUND OBST GYN, V39, P75, DOI 10.1002/uog.9069
   Huang H, 2014, INT J DEV NEUROSCI, V32, P11, DOI 10.1016/j.ijdevneu.2013.06.005
   Isaacs H, 2002, PEDIATR NEUROL, V27, P333, DOI 10.1016/S0887-8994(02)00459-9
   Jakab A, 2017, NEUROIMAGE-CLIN, V15, P601, DOI 10.1016/j.nicl.2017.06.013
   Jarre A, 2017, RADIOLOGIA-MADRID, V59, P226, DOI 10.1016/j.rx.2017.01.002
   Kandula T, 2015, J MED IMAG RADIAT ON, V59, P154, DOI 10.1111/1754-9485.12287
   Kasprian G, 2011, CEREB CORTEX, V21, P1076, DOI 10.1093/cercor/bhq179
   Kline-fath BM, 2015, 6 2 NORMAL BRAIN IMA
   Krishnamurthy U, 2015, J PERINAT MED, V43, P209, DOI 10.1515/jpm-2014-0268
   Kutuk MS, 2015, J CHILD NEUROL, V30, P1388, DOI 10.1177/0883073814556312
   Kutuk MS, 2014, CHILD NERV SYST, V30, P411, DOI 10.1007/s00381-013-2243-0
   Lacalm A, 2016, ULTRASOUND OBST GYN, V47, P117, DOI 10.1002/uog.15735
   Lerman-Sagie T, 2016, CAN J NEUROL SCI, V43, P611, DOI 10.1017/cjn.2016.271
   Malinger G, 2002, ULTRASOUND OBST GYN, V20, P51, DOI 10.1046/j.1469-0705.2002.00743.x
   Malinger G, 2007, ULTRASOUND OBST GYN, V29, P109, DOI 10.1002/uog.3909
   Manganaro L, 2017, PRENATAL DIAG, V37, P244, DOI 10.1002/pd.4990
   Mitter C, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00164
   Montenegro MA, 2002, ARCH NEUROL-CHICAGO, V59, P1147, DOI 10.1001/archneur.59.7.1147
   Rios LTM, 2012, J CLIN IMAG SCI, V2, DOI 10.4103/2156-7514.96546
   Nabavizadeh SA, 2014, AM J NEURORADIOL, V35, P1418, DOI 10.3174/ajnr.A3872
   Oh KY, 2005, RADIOGRAPHICS, V25, P647, DOI 10.1148/rg.253045103
   Ouyang A, 2015, METHODS, V73, P27, DOI 10.1016/j.ymeth.2014.10.025
   Ozcan UA, 2014, CLIN NEURORADIOL, V24, P165, DOI 10.1007/s00062-013-0213-2
   Perlman S, 2018, J MATERN-FETAL NEO M, V31, P1762, DOI 10.1080/14767058.2017.1326903
   Putbrese B, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160253
   Qiu AQ, 2015, ANNU REV PSYCHOL, V66, P853, DOI 10.1146/annurev-psych-010814-015340
   Raybaud C, 2013, NEURORADIOLOGY, V55, P1, DOI 10.1007/s00234-013-1244-8
   Raybaud C, 2010, NEURORADIOLOGY, V52, P447, DOI 10.1007/s00234-010-0696-3
   Recinos PF, 2012, NEUROSURG CLIN N AM, V23, P165, DOI 10.1016/j.nec.2011.09.006
   Sadler TW, 2015, LANGMANS MED EMBRYOL, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Salomon LJ, 2007, ULTRASOUND OBST GYN, V30, P61, DOI 10.1002/uog.4026
   Salomon LJ, 2011, ULTRASOUND OBST GYN, V37, P116, DOI 10.1002/uog.8831
   Sanapo L, 2017, PRENATAL DIAG, V37, P827, DOI 10.1002/pd.5096
   Santo S, 2012, ULTRASOUND OBST GYN, V40, P513, DOI 10.1002/uog.12315
   Sanz-Cortes M, 2015, AM J OBSTET GYNECOL, V212, DOI 10.1016/j.ajog.2015.01.041
   Scelsa B, 2018, EUR J PAEDIATR NEURO, V22, P919, DOI 10.1016/j.ejpn.2018.04.001
   Severino M, 2017, AM J NEURORADIOL, V38, P1643, DOI 10.3174/ajnr.A5245
   Society for Maternal-Fetal Medicine (SMFM), 2018, AM J OBSTET GYNECOL, DOI DOI 10.1016/J.AJOG.2018.04.039
   Stoler-Poria S, 2010, ULTRASOUND OBST GYN, V36, P154, DOI 10.1002/uog.7556
   Stutterd CA, 2014, AM J MED GENET C, V166, P227, DOI 10.1002/ajmg.c.31399
   Sztriha L, 2004, NEUROPEDIATRICS, V35, P346, DOI 10.1055/s-2004-830430
   Takahashi E, 2012, CEREB CORTEX, V22, P455, DOI 10.1093/cercor/bhr126
   Tinkle BT, 2005, AM J MED GENET A, V139A, P204, DOI 10.1002/ajmg.a.31024
   Toti P, 1998, PEDIATR RES, V44, P291, DOI 10.1203/00006450-199809000-00005
   Vezina G, 2015, PEDIATR RADIOL, V45, P433, DOI 10.1007/s00247-015-3282-3
   Victoria T, 2014, PEDIATR RADIOL, V44, P376, DOI 10.1007/s00247-013-2857-0
   Whitehead MT, 2015, CLIN PERINATOL, V42, P337, DOI 10.1016/j.clp.2015.02.007
   Whitehead MT, 2014, PEDIATR RADIOL, V44, P849, DOI 10.1007/s00247-014-2877-4
   Williams F, 2017, BRIT J RADIOL, V90, DOI 10.1259/bjr.20160902
   Winkler A, 2018, FETAL DIAGN THER, V44, P210, DOI 10.1159/000480500
   Zajac-Mnich M, 2014, POL J RADIOL, V79, P502, DOI 10.12659/PJR.890549
NR 96
TC 0
Z9 0
U1 0
U2 0
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 1071-9091
EI 1558-0776
J9 SEMIN PEDIATR NEUROL
JI Semin. Pediatr. Neurol.
PD APR
PY 2020
VL 33
AR UNSP 100801
DI 10.1016/j.spen.2020.100801
PG 17
WC Clinical Neurology; Pediatrics
SC Neurosciences & Neurology; Pediatrics
GA LM8HQ
UT WOS:000532489900005
PM 32331616
OA Bronze
DA 2020-07-08
ER

PT J
AU Shukla, R
   Shanmugam, RK
   Ramasamy, V
   Arora, U
   Batra, G
   Acklin, JA
   Krammer, F
   Lim, JK
   Swaminathan, S
   Khanna, N
AF Shukla, Rahul
   Shanmugam, Rajgokul K.
   Ramasamy, Viswanathan
   Arora, Upasana
   Batra, Gaurav
   Acklin, Joshua A.
   Krammer, Florian
   Lim, Jean K.
   Swaminathan, Sathyamangalam
   Khanna, Navin
TI Zika virus envelope nanoparticle antibodies protect mice without risk of
   disease enhancement
SO EBIOMEDICINE
LA English
DT Article
DE Zika virus vaccine; VLPs; Nanoparticles; Pichia pastoris; Dengue virus;
   Antibody-dependent enhancement; AG129; C57BL/6 Stat2(-/-)
ID DENGUE VIRUS; PICHIA-PASTORIS; DEPENDENT ENHANCEMENT; CROSS-REACTIVITY;
   EMERGENCE; INFECTION; NEUTRALIZATION; TRANSMISSION; VACCINES; MUTATION
AB Background: Zika virus (ZIKV), an arbovirus capable of causing neurological abnormalities, is a recognised human pathogen, for which a vaccine is required. As ZIKV antibodies can mediate antibody-dependent enhancement (ADE) of dengue virus (DENV) infection, a ZIKV vaccine must not only protect against ZIKV but must also not sensitise vaccinees to severe dengue.
   Methods: The N-terminal 80% of ZIKV envelope protein (80E) was expressed in Pichia pastoris and its capacity to self-assemble into particulate structures evaluated using dynamic light scattering and electron microscopy. Antigenic integrity of the 80E protein was evaluated using ZIKV-specific monoclonal antibodies. Its immunogenicity and protective efficacy were assessed in BALB/c and C57BL/6 Stat2(-/-) mice, respectively. Its capacity to enhance DENV and ZIKV infection was assessed in AG129 and C57BL/6 Stat2(-/-) mice, respectively.
   Findings: ZIKV-80E protein self-assembled into discrete nanoparticles (NPs), which preserved the antigenic integrity of neutralising epitopes on E domain III (EDIII) and elicited potent ZIKV-neutralising antibodies predominantly against this domain in BALB/c mice. These antibodies conferred statistically significant protection in vivo (p = 0.01, Mantel-Cox test), and did not exacerbate sub-lethal DENV-2 or ZIKV challenges in vivo.
   Interpretation: Yeast-expressed ZIKV-80E, which forms highly immunogenic EDIII-displaying NPs, elicits ZIKV EDIII-specific antibodies capable of offering significant protection in vivo, without the potential risk of ADE upon subsequent DENV-2 or ZIKV infection. This offers a promising vaccine candidate for further development. (C) 2020 The Authors. Published by Elsevier B.V.
C1 [Shukla, Rahul; Shanmugam, Rajgokul K.; Ramasamy, Viswanathan; Arora, Upasana; Swaminathan, Sathyamangalam; Khanna, Navin] Int Ctr Genet Engn & Biotechnol, Mol Med Div, Recombinant Gene Prod Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.
   [Batra, Gaurav; Khanna, Navin] NCR Biotech Sci Cluster, Translat Hlth Sci & Technol Inst, Faridabad, India.
   [Acklin, Joshua A.; Krammer, Florian; Lim, Jean K.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.
   [Arora, Upasana] Sun Pharmaceut Ind Ltd, R&D 3, Vaccine R&D, Gurugram, India.
RP Swaminathan, S; Khanna, N (corresponding author), Int Ctr Genet Engn & Biotechnol, Mol Med Div, Recombinant Gene Prod Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.
EM swami@icgeb.res.in; navin@icgeb.res.in
OI Shukla, Rahul/0000-0002-4320-9512; Swaminathan,
   Sathyamangalam/0000-0002-4388-2248
FU ICGEB; NIAIDUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [1R21AI129477]
FX This work was supported in part by intramural funds from ICGEB (NK) and
   NIAID grant 1R21AI129477 (FK). The funders had no role in any aspect of
   the performance of the study or in the decision to submit the work for
   publication.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Ahmad M, 2014, APPL MICROBIOL BIOT, V98, P5301, DOI 10.1007/s00253-014-5732-5
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Batra G, 2010, J BIOSCI BIOENG, V110, P408, DOI 10.1016/j.jbiosc.2010.05.001
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Boigard H, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005608
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2013, EPIDEMIOL INFECT, V141, P1080, DOI 10.1017/S0950268812001367
   Culshaw A, 2017, CURR OPIN IMMUNOL, V48, P1, DOI 10.1016/j.coi.2017.07.001
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Espinosa D, 2018, EBIOMEDICINE, V27, P61, DOI 10.1016/j.ebiom.2017.12.010
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Garg H, 2017, J VIROL, V91, DOI 10.1128/JVI.00834-17
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Harrison SC, 2016, NAT IMMUNOL, V17, P1010, DOI 10.1038/ni.3539
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hsieh SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100641
   Khetarpal N, 2017, AM J TROP MED HYG, V96, P126, DOI 10.4269/ajtmh.16-0503
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Pierson TC, 2013, FIELDS VIROLOGY, P747
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Rajpoot RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26904-5
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Richner JM, 2018, CURR OPIN IMMUNOL, V53, P130, DOI 10.1016/j.coi.2018.04.024
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Salvo MA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006210
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Screaton G, 2017, SCIENCE, V358, P863, DOI 10.1126/science.aaq1297
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shanmugam RK, 2019, PATHOG DIS, V77, DOI 10.1093/femspd/ftz026
   Shukla R, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02644
   Sirohi D, 3 8A RESOLUTION CRYO
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sumathy K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46375
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   The Lancet Infectious Diseases Editorial Board, 2018, LANCET INFECT DIS, V17, P1003
   The World Health Organization, 2020, VACC PIP TRACK
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   Vogl T, 2013, CURR OPIN BIOTECH, V24, P1094, DOI 10.1016/j.copbio.2013.02.024
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Watanabe S, 2015, J VIROL, V89, P5847, DOI 10.1128/JVI.00216-15
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 71
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2352-3964
J9 EBIOMEDICINE
JI EBioMedicine
PD APR
PY 2020
VL 54
AR UNSP 102738
DI 10.1016/j.ebiom.2020.102738
PG 14
WC Medicine, General & Internal; Medicine, Research & Experimental
SC General & Internal Medicine; Research & Experimental Medicine
GA LL5DR
UT WOS:000531578100004
PM 32305868
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Goncalves-Segundo, PR
AF Goncalves-Segundo, Paulo Roberto
TI Multimodal metaphors and practical argumentation: discussing rhetorical
   effects and modes of articulation between modalities
SO REVISTA DE ESTUDOS DA LINGUAGEM
LA English
DT Article
DE multimodal metaphor; multimodality; metaphor; argumentation; practical
   argumentation
AB This paper aims to discuss both a typology of articulation between verbal and pictorial modalities in the construal of metaphors and the potential pragmatic and rhetorical effects of the activation of multimodal metaphors in practical argumentation. To do so, we analyze six texts from governmental health campaigns in Brazil oriented towards the elimination of Aedes aegypti breeding grounds, the mosquito mainly responsible for the transmission of dengue fever, chikungunya and zika in the country. In terms of the expression of metaphorical vehicles and topics in each modality, we could identify, as a result, three main modes of articulation: autonomy, correlation and interdependence. For each mode, we showed some pragmatic and semantic effects, such as increasing metaphoricity, inducing reframing and refining referentiality. We frame this discussion by critically considering a series of different frameworks on metaphor studies, such as Lakoff and Johnson (1980), Forceville (2007), Muller (2008), Vereza (2007, 2017, 2018), Goncalves-Segundo and Zelic (2016) and Steen (2017). In terms of argumentative roles, we concluded that multimodal metaphors were relevant in construing the Negative Consequences of inaction in regard to the elimination of breeding grounds, hyperbolizing the lethal potential of the infections; in inducing the reader's readiness and tendency towards working collectively to achieve the campaign's intended Goals; and, finally, in generating humor in the construal of the campaign's Motivating Circumstances, in order to draw the reader's attention and identification towards this necessary social action. To support this debate, we drew mainly on Fairclough and Fairclough (2012), Macagno and Walton (2019) and Goncalves-Segundo (2019).
C1 [Goncalves-Segundo, Paulo Roberto] Univ Sao Paulo, Sao Paulo, SP, Brazil.
RP Goncalves-Segundo, PR (corresponding author), Univ Sao Paulo, Sao Paulo, SP, Brazil.
EM paulosegundo@usp.br
RI Goncalves-Segundo, Paulo Roberto/A-5089-2017
OI Goncalves-Segundo, Paulo Roberto/0000-0002-5592-8098
CR BENEDEK A., 2019, IMAGE METAPHOR NEW C
   CAMERON L, 1999, RES APPL METAPHOR, DOI [10.1017/CBO9781139524704, DOI 10.1017/CB09781139524704]
   Cameron L, 2006, APPL LINGUIST, V27, P671, DOI 10.1093/applin/aml032
   CHARTERIS- BLACK J., 2019, METAPHORS BREXIT NO, DOI [10.1007/978-3-030-28768-9, DOI 10.1007/978-3-030-28768-9]
   CharterisBlack J, 2004, CORPUS APPROACHES TO CRITICAL METAPHOR ANALYSIS, P1, DOI 10.1057/9780230000612
   CHILTON P. A., 2004, ANAL POLITICAL DISCO, DOI [10.4324/9780203561218, DOI 10.4324/9780203561218]
   DIENSTBACH D., 2017, FORUM LINGUISTICO, V14, P1767, DOI [10.5007/1984-8412.2017v14n1p1767, DOI 10.5007/1984-8412.2017V14N1P1767]
   Fairclough N., 2012, POLITICAL DISCOURSE, DOI [10.4324/9780203137888, DOI 10.4324/9780203137888]
   Fairclough Norman, 2003, ANAL DISCOURSE TEXTU, DOI [10.4324/9780203697078, DOI 10.4324/9780203697078]
   Fauconnier Gilles, 2002, WAY WE THINK CONCEPT
   FORCEVILLE C., 2007, PUBLIC J SEMIOTICS, V1, P15
   Forceville C, 2009, APPL COGN LINGUIST, V11, P19
   Forceville C, 2008, CAMB HANDB PSYCHOL, P462
   GONCALVES-SEGUNDO P.R., 2016, ANALISE DISCURSO ANA, P64
   GONCALVES- SEGUNDO P. R., 2019, EID A REV ELETRONICA, P109, DOI DOI 10.17648/EIDEA-19-V2-2498
   GONCALVES- SEGUNDO P. R., ALFA
   GONCALVES-SEGUNDO P. R., 2014, VEREDAS, V18, P32
   GONCALVES-SEGUNDO P. R, 2017, LETRAS, P69, DOI DOI 10.5902/2176148529571
   GONCALVES-SEGUNDO P. R., 2018, ANALISE DISCURSO CRI, P79
   GONCALVES-SEGUNDO P. R., 2019, MULTIMODALIDADE PRAT, P31, DOI DOI 10.5151/9788580394085-02
   GONCALVES- SEGUNDO P. R., 2018, SEM INT EST DISC ARG, P922
   GONCALVES-SEGUNDO P. R., 2016, LINHA AGUA SAO PAULO, V29, P69, DOI DOI 10.11606/ISSN.2236-4242.V29I2P69-96
   GONCALVES- SEGUNDO P. R., 2015, LINGUAGEM COGNICAO D, P163
   GRACIO R. A., 2010, THESIS, P434
   Grady JE, 2005, COGN LINGUIST RES, V29, P35
   Hart C., 2014, DISCOURSE GRAMMAR ID
   Hart C, 2010, CRITICAL DISCOURSE ANALYSIS AND COGNITIVE SCIENCE: NEW PERSPECTIVES ON IMMIGRATION DISCOURSE, P3
   Kovecses Zoltan, 2010, METAPHOR PRACTICAL I
   KRESS G, 2006, READING IMAGES GRAMM, DOI [10.4324/9780203619728, DOI 10.4324/9780203619728]
   LAKOFF G., 1980, METAPHORS WE LIVE BY, DOI DOI 10.7208/CHICAG0/9780226470993.001.0001
   MACAGNO F., 2019, EID A REV ELETRONICA, V19, P140
   Martin JR, 2007, LANGUAGE OF EVALUATION: APPRAISAL IN ENGLISH, P1, DOI 10.1057/9780230511910
   MORAIS A. R. A., 2015, THESIS, P249
   Muller C., 2008, METAPHORS DEAD ALIVE, DOI [10.7208/chicago/9780226548265.001.0001, DOI 10.7208/CHICAG0/9780226548265.001.0001]
   PEREZ SOBRINO P., 2017, MULTIMODAL METAPHOR, DOI [10.1075/ftl.2, DOI 10.1075/FTL.2]
   PLANTIN C., 2008, ARGUMENTACAO HIST TE
   Resende VD, 2020, REV ESTUD LING, V28, P565, DOI 10.17851/2237-2083.28.1.565-596
   Sperandio NE, 2015, ANTARES, V7, P3
   Steen G, 2017, INTERCULT PRAGMAT, V14, P1, DOI 10.1515/ip-2017-0001
   TALMY L., 2000, COGNITIVE SEMANTICS, DOI DOI 10.7551/MITPRESS/6847.001.0001
   TENUTA DE AZEVEDO A. M., 2011, CIENCIAS COGNICAO RI, V16, P65
   TOULMIN S., 2006, OS USOS DO ARGUMENTO
   Toulmin S., 1984, INTRO REASONING
   VEREZA S., 2018, REV LINGUAGEM FOCO F, V10, P13
   VEREZA Solange, 2007, LING DISCURSO, V7, P487
   Vereza SC, 2017, CAD ESTUD LINGUIST, V59, P135
   Walton DN, 1996, PHILOS RHETORIC, V29, P301
NR 47
TC 0
Z9 0
U1 0
U2 0
PU UNIV FEDERAL MINAS GERAIS, FAC LETRAS
PI BELO HORIZONTE
PA AV ANTONIO CARLOS, 6627 PAMPULHA, SALA 3025, BELO HORIZONTE, MG
   31270-901, BRAZIL
SN 0104-0588
EI 2237-2083
J9 REV ESTUD LING
JI Rev. Estud. Ling.
PD APR-JUN
PY 2020
VL 28
IS 2
BP 801
EP 844
DI 10.17851/2237-2083.28.2.801-844
PG 44
WC Language & Linguistics
SC Linguistics
GA LK7VU
UT WOS:000531070500006
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Lee, CYP
   Carissimo, G
   Chen, ZY
   Lum, FM
   Abu Bakar, F
   Rajarethinam, R
   Teo, TH
   Torres-Ruesta, A
   Renia, L
   Ng, LFP
AF Lee, Cheryl Yi-Pin
   Carissimo, Guillaume
   Chen, Zheyuan
   Lum, Fok-Moon
   Abu Bakar, Farhana
   Rajarethinam, Ravisankar
   Teo, Teck-Hui
   Torres-Ruesta, Anthony
   Renia, Laurent
   Ng, Lisa F. P.
TI Type I interferon shapes the quantity and quality of the anti-Zika virus
   antibody response
SO CLINICAL & TRANSLATIONAL IMMUNOLOGY
LA English
DT Article
DE antibodies; humoral response; mouse models; type I interferon; Zika
   virus
ID B-CELL; DENDRITIC CELLS; CHIKUNGUNYA VIRUS; MOUSE MODEL; T-CELL;
   INFECTION; PERSISTENCE; MICE; TRANSMISSION; ACTIVATION
AB Objectives Zika virus (ZIKV) is a mosquito-borne flavivirus that re-emerged in 2015. The association between ZIKV and neurological complications initiated the development of relevant animal models to understand the mechanisms underlying ZIKV-induced pathologies. Transient inhibition of the type I interferon (IFN) pathway through the use of an IFNAR1-blocking antibody, MAR1-5A3, could efficiently permit active virus replication in immunocompetent animals. Type I IFN signalling is involved in the regulation of humoral responses, and thus, it is crucial to investigate the potential effects of type I IFN blockade towards B-cell responses.
   Methods In this study, comparative analysis was conducted using serum samples collected from ZIKV-infected wild-type (WT) animals either administered with or without MAR1-5A3.
   Results Serological assays revealed a more robust ZIKV-specific IgG response and subtype switching upon inhibition of type I IFN due to the abundance of antigen availability. This observation was corroborated by an increase in germinal centres, plasma cells and germinal centre B cells. Interestingly, although both groups of animals recognised different B-cell linear epitopes in the E and NS1 regions, there was no difference in neutralising capacity. Further characterisation of these epitopes in the E protein revealed a detrimental role of antibodies that were generated in the absence of type I IFN.
   Conclusion This study highlights the role of type I IFN in shaping the anti-ZIKV antibody response to generate beneficial antibodies and will help guide development of better vaccine candidates triggering efficient neutralising antibodies and avoiding detrimental ones.
C1 [Lee, Cheryl Yi-Pin; Carissimo, Guillaume; Chen, Zheyuan; Lum, Fok-Moon; Abu Bakar, Farhana; Teo, Teck-Hui; Torres-Ruesta, Anthony; Renia, Laurent; Ng, Lisa F. P.] ASTAR, Singapore Immunol Network, Singapore, Singapore.
   [Lee, Cheryl Yi-Pin] Natl Univ Singapore, NUS Grad Sch Integrat Sci & Engn, Singapore, Singapore.
   [Chen, Zheyuan] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Belfast, Antrim, North Ireland.
   [Abu Bakar, Farhana] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Rajarethinam, Ravisankar] ASTAR, Inst Mol & Cell Biol, Singapore, Singapore.
   [Torres-Ruesta, Anthony; Ng, Lisa F. P.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.
   [Ng, Lisa F. P.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool, Merseyside, England.
   [Teo, Teck-Hui] Inst Pasteur, Unite Pathogenie Microbienne Mol, Paris, France.
RP Ng, LFP (corresponding author), ASTAR, Singapore Immunol Network, Singapore, Singapore.
EM lisa_ng@immunol.a-star.edu.sg
OI Carissimo, Guillaume/0000-0002-9703-9096; Torres-Ruesta,
   Anthony/0000-0003-0447-3131
FU Biomedical Research Council (BMRC)Agency for Science Technology &
   Research (ASTAR); BMRC A*STAR-led Zika Virus Consortium FundAgency for
   Science Technology & Research (ASTAR) [15/1/82/27/001]; Immunomonitoring
   Service Platform (ISP) [NRF2017_SISFP09]; A*STAR Graduate Scholarship
   (AGS)Agency for Science Technology & Research (ASTAR); A*STAR Singapore
   International Graduate Award (SINGA) scholarship
FX We thank SIgN mouse core for support in animal breeding. We acknowledge
   Kam Yiu-Wing, Chan Yi-Hao, and Siti Naqiah Binte Amrun for critical
   discussion and proofreading of the manuscript. This study was funded by
   core research grants provided to the Singapore Immunology Network
   (SIgN), Agency for Science, Technology and Research (A*STAR), by the
   Biomedical Research Council (BMRC), and also by the BMRC A*STAR-led Zika
   Virus Consortium Fund [project number: 15/1/82/27/001]. Flow cytometry
   platform is supported by the Immunomonitoring Service Platform (ISP),
   Grant ID: NRF2017_SISFP09. Cheryl YiPin Lee and Farhana Abu Bakar are
   supported by A*STAR Graduate Scholarship (AGS). Anthony Torres-Ruesta is
   supported by A*STAR Singapore International Graduate Award (SINGA)
   scholarship. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Anderson JF, 2002, EMERG INFECT DIS, V8, P107, DOI 10.3201/eid0801.010252
   Barrette RW, 2006, CLIN VACCINE IMMUNOL, V13, P802, DOI 10.1128/CVI.00422-05
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Best SM, 2006, FUTURE VIROL, V1, P447, DOI 10.2217/17460794.1.4.447
   Casadevall A, 2012, P NATL ACAD SCI USA, V109, P12272, DOI 10.1073/pnas.1209750109
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chen HW, 2014, J GEN VIROL, V95, P1983, DOI 10.1099/vir.0.067280-0
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   COUTELIER JP, 1987, J EXP MED, V165, P64, DOI 10.1084/jem.165.1.64
   da Silva SR, 2019, J MED VIROL, V91, P179, DOI 10.1002/jmv.25306
   de Alwis R, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001188
   Dong M, 2003, J VIROL, V77, P3119, DOI 10.1128/JVI.77.5.3119-3130.2003
   Elong Ngono A, 2019, PLOS PATHOG, V15, DOI DOI 10.1371/J0URNAL.PPAT.1007474
   Fallet B, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah6817
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Frumence E, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7020055
   Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   IMBACH PA, 1994, CLIN EXP IMMUNOL, V97, P25
   Jego Gaetan, 2005, V8, P124
   Jeurissen A, 2004, IMMUNOLOGY, V111, P1, DOI 10.1111/j.1365-2567.2004.01775.x
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kam YW, 2012, EMBO MOL MED, V4, P330, DOI 10.1002/emmm.201200213
   Kiefer K, 2012, IMMUNOL CELL BIOL, V90, P498, DOI 10.1038/icb.2012.10
   KLAUS GGB, 1979, IMMUNOLOGY, V38, P687
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1
   Lee CYP, 2018, MICROBES INFECT, V20, P635, DOI 10.1016/j.micinf.2018.02.009
   Lemke CD, 2004, J IMMUNOL, V172, P1916, DOI 10.4049/jimmunol.172.3.1916
   Liu HB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123035
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Lum FM, 2017, J INFECT DIS, V216, P182, DOI 10.1093/infdis/jix276
   Lum FM, 2013, J IMMUNOL, V190, P6295, DOI 10.4049/jimmunol.1300304
   Malkiel S, 2016, SYSTEMIC LUPUS ERYTH, P207
   Martin RM, 1998, J IMMUNOL METHODS, V212, P187, DOI 10.1016/S0022-1759(98)00015-5
   Mathew A, 2011, J INFECT DIS, V204, P1514, DOI 10.1093/infdis/jir607
   Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moseman EA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah3565
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Nish S, 2011, IMMUNITY, V34, P629, DOI 10.1016/j.immuni.2011.05.009
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Peng SL, 2002, P NATL ACAD SCI USA, V99, P5545, DOI 10.1073/pnas.082114899
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Rapti K, 2012, MOL THER, V20, P73, DOI 10.1038/mt.2011.177
   Rodriguez-Madoz JR, 2010, J VIROL, V84, P9760, DOI 10.1128/JVI.01051-10
   Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Sheehan KCF, 2006, J INTERF CYTOK RES, V26, P804, DOI 10.1089/jir.2006.26.804
   SHINOMIYA N, 1989, CELL IMMUNOL, V118, P239, DOI 10.1016/0008-8749(89)90375-4
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Swanson CL, 2010, J EXP MED, V207, P1485, DOI 10.1084/jem.20092695
   Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113
   Tan JJL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09479-5
   Taylor JM, 2008, MICROB PATHOGENESIS, V44, P20, DOI 10.1016/j.micpath.2007.06.006
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Welten SPM, 2016, J VIROL, V90, P4402, DOI 10.1128/JVI.03177-15
   Yuki N, 2012, P JPN ACAD B-PHYS, V88, P299, DOI 10.2183/pjab.88.299
   Zhu JG, 2007, J IMMUNOL, V178, P3505, DOI 10.4049/jimmunol.178.6.3505
NR 68
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2050-0068
J9 CLIN TRANSL IMMUNOL
JI Clin. Transl. Immunol.
PD APR
PY 2020
VL 9
IS 4
AR e1126
DI 10.1002/cti2.1126
PG 16
WC Immunology
SC Immunology
GA LJ8GR
UT WOS:000530399800004
PM 32346479
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Galli, L
   Bruschi, F
AF Galli, Luca
   Bruschi, Fabrizio
TI New strategies for the control of infectious and parasitic diseases in
   blood donors: the impact of pathogen inactivation methods
SO EUROBIOTECH JOURNAL
LA English
DT Review
DE blood donors; viruses; bacteria; protozoa; Pathogen inactivation
   methods; plasma; platelets; red cells
ID WAVELENGTH ULTRAVIOLET-LIGHT; IN-VITRO QUALITY; WHOLE-BLOOD; ZIKA VIRUS;
   CHIKUNGUNYA VIRUS; PHOTOCHEMICAL INACTIVATION; TRANSFUSION TRANSMISSION;
   TRYPANOSOMA-CRUZI; FUNCTIONAL-CHARACTERISTICS; SOLVENT/DETERGENT PLASMA
AB Around 70 infectious agents are possible threats for blood safety.
   The risk for blood recipients is increasing because of new emergent agents like West Nile, Zika and Chikungunya viruses, or parasites such as Plasmodium and Trypanosoma cruzi in non-endemic regions, for instance.
   Screening programmes of the donors are more and more implemented in several Countries, but these cannot prevent completely infections, especially when they are caused by new agents.
   Pathogen inactivation (PI) methods might overcome the limits of the screening and different technologies have been set up in the last years.
   This review aims to describe the most widely used methods focusing on their efficacy as well as on the preservation integrity of blood components.
C1 [Galli, Luca] Azienda USL Toscana Nord Ovest, Dept Clin Pathol, Via Cocchi 7-9, I-56121 Pisa, Italy.
   [Bruschi, Fabrizio] Univ Pisa, NTMS, Dept Translat Res, Via Roma 55, I-56126 Pisa, Italy.
RP Bruschi, F (corresponding author), Univ Pisa, NTMS, Dept Translat Res, Via Roma 55, I-56126 Pisa, Italy.
EM fabrizio.bruschi@med.unipi.it
CR Allain JP, 2016, LANCET, V387, P1753, DOI 10.1016/S0140-6736(16)00581-X
   Amar El-Dusouqui S, 2019, ISBT SCI SERIES, P1
   Angheben A, 2015, BLOOD TRANSFUS-ITALY, V13, P540, DOI 10.2450/2015.0040-15
   [Anonymous], 2012, BLOOD DON SEL GUID A
   Atreya C, 2019, TRANSFUSION, V59, P3002, DOI 10.1111/trf.15344
   Aubry M, 2017, TRANSFUSION, V57, P2888, DOI 10.1111/trf.14318
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Aydinok Y, 2019, BRIT J HAEMATOL, V186, P625, DOI 10.1111/bjh.15963
   Bah A, 2018, TRANSFUS APHER SCI, V57, P683, DOI 10.1016/j.transci.2018.09.004
   Bakkour S, 2016, TRANSFUSION, V56, P410, DOI 10.1111/trf.13360
   Bashir S, 2013, TRANSFUSION, V53, P990, DOI 10.1111/j.1537-2995.2012.03854.x
   Benjamin RJ, 2014, ISBT SCI SER, V9, P124, DOI 10.1111/voxs.12057
   Benjamin RJ, 2012, TRANSFUSION, V52, P1913, DOI 10.1111/j.1537-2995.2011.03554.x
   Benjamin RJ, 2012, TRANSFUSION, V52, p9S, DOI 10.1111/j.1537-2995.2012.03622.x
   Benjamin RJ, 2005, TRANSFUSION, V45, P1739, DOI 10.1111/j.1537-2995.2005.00583.x
   Bolton-Maggs P, 2016, 2015 ANN SHOT REPORT
   Brecher ME, 2000, TRANSFUSION, V40, P1308, DOI 10.1046/j.1537-2995.2000.40111308.x
   Brixner V, 2018, TRANSFUSION, V58, P905, DOI 10.1111/trf.14528
   Burt FJ, 2012, LANCET, V379, P662, DOI 10.1016/S0140-6736(11)60281-X
   Busch MP, 2019, BLOOD, V133, P1854, DOI 10.1182/blood-2018-11-833996
   Calba C, 2017, EUROSURVEILLANCE, V22, P5, DOI 10.2807/1560-7917.ES.2017.22.39.17-00647
   Canault M, 2010, BLOOD, V115, P1835, DOI 10.1182/blood-2009-03-211706
   Cancelas JA, 2017, VOX SANG, V112, P210, DOI 10.1111/vox.12500
   Cancelas JA, 2017, TRANSFUSION, V57, P1218, DOI 10.1111/trf.14084
   Cardo LJ, 2006, VOX SANG, V90, P85, DOI 10.1111/j.1423-0410.2005.00736.x
   Castro E, 2014, TRANSFUSION, V54, P2207, DOI 10.1111/trf.12598
   Castro G, 2018, TRANSFUSION, V58, P1506, DOI 10.1111/trf.14589
   Charrel RN, 2007, NEW ENGL J MED, V356, P769, DOI 10.1056/NEJMp078013
   Chatterjee Kabita, 2016, Asian J Transfus Sci, V10, P127, DOI 10.4103/0973-6247.187946
   Chen ZM, 2017, TRANSFUSION, V57, P1199, DOI 10.1111/trf.14035
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Cushing MM, 2019, TRANSFUSION, V59, P2974, DOI 10.1111/trf.15435
   Dean CL, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/jcm.00352-18, 10.1128/JCM.00352-18]
   Dijkstra-Tiekstra MJ, 2008, TRANSFUSION, V48, P2114, DOI 10.1111/j.1537-2995.2008.01849.x
   Doyle S, 2003, BLOOD COAGUL FIBRIN, V14, P283, DOI 10.1097/01.mbc.0000061298.28953.7d
   Drew VJ, 2017, BLOOD TRANSFUS-ITALY, V15, P512, DOI 10.2450/2017.0344-16
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Dupuis K, 2003, BLOOD, V102, p816A
   DUPUIS K, 2012, TRANSFUSION S3, V52, pA22
   EDQM (Council of Europe), 2017, GUID PRAP US QUAL AS
   Estcourt LJ, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009072.pub3
   Faddy HM, 2016, VOX SANG, V111, P235, DOI 10.1111/vox.12414
   Faddy HM, 2016, TRANSFUSION, V56, P1548, DOI 10.1111/trf.13519
   Faddy HM, 2015, TRANSFUSION, V55, P824, DOI 10.1111/trf.12899
   Fast LD, 2011, TRANSFUSION, V51, P1397, DOI 10.1111/j.1537-2995.2010.02984.x
   Ferraris P, 2019, MICROBES INFECT, V21, P353, DOI 10.1016/j.micinf.2019.04.005
   Feys HB, 2019, TRANSFUS MED REV, V33, P29, DOI 10.1016/j.tmrv.2018.06.002
   Freimanis G, 2013, TRANSFUSION, V53, P1429, DOI 10.1111/j.1537-2995.2012.03943.x
   Lidani KCF, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00166
   Fryk JJ, 2017, TRANSFUSION, V57, P2677, DOI 10.1111/trf.14256
   Fung MK, 2014, AABB TECHNICAL MANUA
   Gardiner EE, 2007, J THROMB HAEMOST, V5, P1530, DOI 10.1111/j.1538-7836.2007.02590.x
   Gerlich WH, 2010, DIGEST DIS, V28, P116, DOI 10.1159/000282074
   Gowland P, 2016, TRANSFUS MED HEMOTH, V43, P198, DOI 10.1159/000445195
   Gravemann U, 2019, TRANSFUSION, V59, P1324, DOI 10.1111/trf.15119
   Gravemann U, 2018, TRANSFUSION, V58, P2669, DOI 10.1111/trf.14957
   Grellier P, 2008, TRANSFUSION, V48, P1676, DOI 10.1111/j.1537-2995.2007.01762.x
   Guerri-Guttenberg RA, 2008, EUR HEART J, V29, P2587, DOI 10.1093/eurheartj/ehn424
   Haass KA, 2019, TRANSFUS MED REV, V33, P84, DOI 10.1016/j.tmrv.2019.01.001
   Hauser L, 2014, BLOOD, V123, P796, DOI 10.1182/blood-2013-09-524348
   Hayes C, 2019, TRANSFUSION, V9999, P1
   Hechler B, 2013, TRANSFUSION, V53, P1187, DOI 10.1111/j.1537-2995.2012.03923.x
   Hellstern P, 2011, TRANSFUS MED HEMOTH, V38, P65, DOI 10.1159/000323552
   Henschler R, 2011, TRANSFUS MED HEMOTH, V38, P33, DOI 10.1159/000324458
   HOROWITZ B, 1992, BLOOD, V79, P826
   Ignatova AA, 2016, VOX SANG, V110, P244, DOI 10.1111/vox.12364
   Irsch J, 2011, TRANSFUS MED HEMOTH, V38, P19, DOI 10.1159/000323937
   Johnson L, 2016, TRANSFUS MED HEMOTH, V43, P190, DOI 10.1159/000441830
   Kaiser-Guignard J, 2014, BLOOD REV, V28, P235, DOI 10.1016/j.blre.2014.07.005
   Keil SD, 2016, TRANSFUSION, V56, P2948, DOI 10.1111/trf.13860
   Kirby Institute UNSW Sydney and the Austraian Red Cross Blood Service, 2018, TRANSF TRASM INF AUS
   Klein HG, 2007, TRANSFUSION, V47, P2338, DOI 10.1111/j.1537-2995.2007.01512.x
   Klein SD, 2015, JOVE-J VIS EXP, V2015, P52820, DOI [10.3791/52820, DOI 10.3791/52820]
   Kleinman S, 2015, TRANSFUSION, V55, P2983, DOI 10.1111/trf.13259
   Koenigbauer UF, 2000, TRANSFUSION, V40, P1203, DOI 10.1046/j.1537-2995.2000.40101203.x
   Kumar V, 2004, PHOTOCHEM PHOTOBIOL, V80, P15, DOI 10.1562/2003-12-23-RA-036.1
   Kwon SY, 2014, VOX SANG, V107, P254, DOI 10.1111/vox.12158
   Laughhunn A, 2018, TRANSFUSION, V58, P748, DOI 10.1111/trf.14442
   Laughhunn A, 2017, TRANSFUSION, V57, P779, DOI 10.1111/trf.13993
   Lee LJ, 2018, TRANSFUS APHER SCI, V57, P233, DOI 10.1016/j.transci.2018.02.005
   Letowska M, 2016, TRANSFUSION, V56, pS39, DOI 10.1111/trf.13330
   Lin L, 2004, TRANSFUSION, V44, P1496, DOI 10.1111/j.1537-2995.2004.04125.x
   Lozano M, 2013, CURR OPIN HEMATOL, V20, P540, DOI 10.1097/MOH.0b013e328365a18f
   Ngo LT, 2013, TRANSFUS MED REV, V27, P119, DOI 10.1016/j.tmrv.2013.02.003
   Mangano VD, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2650-0
   Marietta M, 2016, BLOOD TRANSFUS-ITALY, V14, P277, DOI 10.2450/2016.0168-15
   Marschner S, 2011, TRANSFUS MED HEMOTH, V38, P8, DOI 10.1159/000324160
   Mastroianni MA, 2013, TRANSFUS APHER SCI, V49, P285, DOI 10.1016/j.transci.2013.06.009
   McCullough J, 2004, BLOOD, V104, P1534, DOI 10.1182/blood-2003-12-4443
   Merz EM, 2016, VOX SANG, V110, P258, DOI 10.1111/vox.12362
   Mohr H, 2009, TRANSFUSION, V49, P2612, DOI 10.1111/j.1537-2995.2009.02334.x
   Moody A, 2002, CLIN MICROBIOL REV, V15, P66, DOI 10.1128/CMR.15.1.66-78.2002
   Moshfegh K, 1998, BIOCHEM BIOPH RES CO, V249, P903, DOI 10.1006/bbrc.1998.9125
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Muller-Steinhardt M, 2012, VOX SANG, V102, P134, DOI 10.1111/j.1423-0410.2011.01531.x
   Mufti NA, 2010, BIOLOGICALS, V38, P14, DOI 10.1016/j.biologicals.2009.10.019
   Murphy WG, 2008, VOX SANG, V95, P13, DOI 10.1111/j.1423-0410.2008.01051.x
   Narayan S, 2019, 2018 ANN SHOT REPORT
   North AK, 2010, TRANSFUSION, V50, p38A
   Petersen LR, 2014, TRANSFUSION, V54, P1911, DOI 10.1111/trf.12790
   Petersen LR, 2013, JAMA-J AM MED ASSOC, V310, P308, DOI 10.1001/jama.2013.8042
   Picker SM, 2013, BLOOD TRANSFUS-ITALY, V11, P343, DOI 10.2450/2013.0218-12
   Pisani G, 2016, TRANSFUS MED HEMOTH, V43, P158, DOI 10.1159/000446219
   Pitkanen H, 2015, THROMB RES, V135, P167, DOI 10.1016/j.thromres.2014.10.020
   Prowse CV, 2013, VOX SANG, V104, P183, DOI 10.1111/j.1423-0410.2012.01662.x
   Rasongles P, 2009, TRANSFUSION, V49, P1083, DOI 10.1111/j.1537-2995.2009.02111.x
   Reesink HW, 2010, VOX SANG, V99, P85, DOI 10.1111/j.1423-0410.2010.01319.x
   Reid S, 2012, TRANSFUSION, V52, P2094, DOI 10.1111/j.1537-2995.2011.03558.x
   Restivo JSA, 2019, TRANSFUSION MED ANE, P205
   Riccardo F, 2019, EMERG INFECT DIS, V25, P2093, DOI 10.3201/eid2511.180949
   Ruane PH, 2004, TRANSFUSION, V44, P877, DOI 10.1111/j.1537-2995.2004.03355.x
   Rukoyatkina N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.459
   Sandgren P, 2011, VOX SANG, V101, P35, DOI 10.1111/j.1423-0410.2010.01454.x
   Schlenke P, 2014, TRANSFUS MED HEMOTH, V41, P309, DOI 10.1159/000365646
   SCHMUNIS GA, 1991, TRANSFUSION, V31, P547, DOI 10.1046/j.1537-2995.1991.31691306255.x
   Schubert P, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00129
   Schubert P, 2012, TRANSFUSION, V52, P397, DOI 10.1111/j.1537-2995.2011.03287.x
   Seed CR, 2005, TRANSFUS MED REV, V19, P229, DOI 10.1016/j.tmrv.2005.02.004
   Seghatchian J, 2012, TRANSFUS APHER SCI, V46, P221, DOI 10.1016/j.transci.2012.01.008
   Seltsam A, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00219
   Seltsam A, 2011, TRANSFUS MED HEMOTH, V38, P43, DOI 10.1159/000323845
   Simmons JD, 2017, J TRAUMA ACUTE CARE, V82, P1023, DOI 10.1097/TA.0000000000001421
   Steinmann E, 2013, TRANSFUSION, V53, P1010, DOI 10.1111/j.1537-2995.2012.03858.x
   Stivala S, 2017, HAEMATOLOGICA, V102, P1650, DOI 10.3324/haematol.2017.164137
   Stramer SL, 2012, TRANSFUSION, V52, P1657, DOI 10.1111/j.1537-2995.2012.03566.x
   Stramer SL, 2009, TRANSFUSION, V49, p1S, DOI 10.1111/j.1537-2995.2009.02279.x
   Tauszig ME, 2012, TRANSFUS APHER SCI, V46, P33, DOI 10.1016/j.transci.2011.10.025
   Vairo F, 2019, INFECT DIS CLIN N AM, V33, P1003, DOI 10.1016/j.idc.2019.08.006
   Van Aelst B, 2015, TRANSFUSION, V55, P2404, DOI 10.1111/trf.13137
   Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759
   van Doorn H Rogier, 2014, Medicine (Abingdon), V42, P60
   van Rhenen DJ, 2000, VOX SANG, V79, P206, DOI 10.1159/000056732
   Van Voorhis WC, 2003, ANTIMICROB AGENTS CH, V47, P475, DOI 10.1128/AAC.47.2.475-479.2003
   Vanlandingham DL, 2013, TRANSFUSION, V53, P284, DOI 10.1111/j.1537-2995.2012.03717.x
   Verra F, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2181-0
   Weaver SC, 2012, EXPERT REV VACCINES, V11, P1087, DOI [10.1586/erv.12.84, 10.1586/ERV.12.84]
   WHO, 2013, SUSTAINING THE DRIVE TO OVERCOME THE GLOBAL IMPACT OF NEGLECTED TROPICAL DISEASES: SECOND WHO REPORT ON NEGLECTED TROPICAL DISEASES, P1
   Wiltshire M, 2016, TRANSFUSION MED, V26, P208, DOI 10.1111/tme.12298
   Winter KM, 2014, TRANSFUSION, V54, P1798, DOI 10.1111/trf.12545
   World Health Organisation, 2009, CONTR PREV CHAG DIS
   World Health Organisation, 2010, SCREEN DON BLOOD TRA
   World Health Organization, 2017, GLOB STAT REP BLOOD
   World Health Organization, 2007, WHO CONS INT BIOL RE
   Zharikov S, 2013, BIOCHEM SOC T, V41, P118, DOI 10.1042/BST20120327
   Zou SM, 2010, TRANSFUSION, V50, P1495, DOI 10.1111/j.1537-2995.2010.02622.x
NR 145
TC 0
Z9 0
U1 0
U2 0
PU SCIENDO
PI WARSAW
PA BOGUMILA ZUGA 32A, WARSAW, MAZOVIA, POLAND
EI 2564-615X
J9 EUROBIOTECH J
JI EuroBiotech J.
PD APR
PY 2020
VL 4
IS 2
BP 53
EP 66
DI 10.2478/ebtj-2020-0007
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LG7LO
UT WOS:000528277900001
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Garcia, G
   Paul, S
   Beshara, S
   Ramanujan, VK
   Ramaiah, A
   Nielsen-Saines, K
   Li, MMH
   French, SW
   Morizono, K
   Kumar, A
   Arumugaswami, V
AF Garcia, Gustavo, Jr.
   Paul, Sayan
   Beshara, Sara
   Ramanujan, V. Krishnan
   Ramaiah, Arunachalam
   Nielsen-Saines, Karin
   Li, Melody M. H.
   French, Samuel W.
   Morizono, Kouki
   Kumar, Ashok
   Arumugaswami, Vaithilingaraja
TI Hippo Signaling Pathway Has a Critical Role in Zika Virus Replication
   and in the Pathogenesis of Neuroinflammation
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; WEST-NILE-VIRUS; STEM-CELL; MOUSE MODEL; HUMAN
   BRAIN; YAP; INFECTION; RESPONSES; AMPK; INHIBITION
AB Zika virus (ZIKV) is a reemerging human pathogen that causes congenital abnormalities, including microcephaly and eye disease. The cellular/molecular basis of ZIKV and host interactions inducing ocular and neuronal pathogenesis are unclear. Herein, we noted that the Hippo/Salvador-Warts-Hippo signaling pathway, which controls organ size through progenitor cell proliferation and differentiation, is dysregulated after ZIKV infection. In human fetal retinal pigment epithelial cells, there is an early induction of transcriptional coactivator, Yes-associated protein (YAP), which is later degraded with a corresponding activation of the TANK binding kinase 1/interferon regulatory factor 3 type I interferon pathway. YAP/transcriptional co-activator with a PDZ-binding domain (TAZ) silencing results in reduced ZIKV replication, indicating a direct role of Hippo pathway in regulating ZIKV infection. Using an in vivo Ifnar1(-/-) knockout mouse model, ZIKV infection was found to reduce YAP/TAZ protein levels while increasing phosphorylated YAP Ser127 in the retina and brain. Hippo pathway is activated in major cellular components of the blood-brain barrier, including endothelial cells and astrocytes. In addition, this result suggests AMP-activated protein kinase signaling pathway's role in regulating YAP/TAZ in ZIKV-infected cells. These data demonstrate that ZIKV infection might initiate a cross talk among AMP-activated protein kinase-Hippo-TBK1 pathways, which could regulate antiviral and energy stress responses during oculoneuronal inflammation.
C1 [Garcia, Gustavo, Jr.; Paul, Sayan; Beshara, Sara; Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA.
   [Li, Melody M. H.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA.
   [French, Samuel W.] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA.
   [Nielsen-Saines, Karin] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA.
   [Morizono, Kouki] Univ Calif Los Angeles, Div Hematol & Oncol, Los Angeles, CA USA.
   [Morizono, Kouki] Univ Calif Los Angeles, Dept Med, UCLA AIDS Inst, Los Angeles, CA 90024 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA USA.
   [Paul, Sayan] Manonmaniam Sundaranar Univ, Dept Biotechnol, Tirunelveli, India.
   [Ramanujan, V. Krishnan] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA.
   [Ramaiah, Arunachalam] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92717 USA.
   [Kumar, Ashok] Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI USA.
RP Arumugaswami, V (corresponding author), 10833 Le Conte Ave,CHS B2-049A, Los Angeles, CA 90095 USA.
EM varumugaswami@mednet.ucla.edu
RI Paul, Sayan/AAF-8813-2020
OI Paul, Sayan/0000-0001-6620-950X; Garcia Jr, Gustavo/0000-0002-1649-9251
FU California Institute for Regenerative Medicine Queste-Discovery Stage
   Research Projects grant [DISC2-10188]; NIHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA
   [R21AI095004, R01AI108400, R21AI135583]
FX Supported by the California Institute for Regenerative Medicine
   Queste-Discovery Stage Research Projects grant DISC2-10188 (V.A.), NIH
   award R21AI135583 (A.K.), and NIH grants R21AI095004 (K.M.) and
   R01AI108400 (K.M.).
CR Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824
   Akhtar Z, 2018, IT PROF, V20, P50, DOI 10.1109/MITP.2018.032501748
   Ballabh P, 2004, NEUROBIOL DIS, V16, P1, DOI 10.1016/j.nbd.2003.12.016
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Boro M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37695
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529
   Cheeran MCJ, 2005, J NEUROVIROL, V11, P512, DOI 10.1080/13550280500384982
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Cheng XY, 2017, ONCOTARGET, V8, P22513, DOI 10.18632/oncotarget.15116
   Committee for the Update of the Guide for the Care and Use of Laboratory Animals; National Research Council, 2011, GUIDE CARE USE LAB A
   Contreras D, 2017, BIORXIV
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Crequer A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044010
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200
   Fernandez MP, 2017, JAMA OPHTHALMOL, V135, P1163, DOI 10.1001/jamaophthalmol.2017.3595
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Garcia D, 2017, MOL CELL, V66, P789, DOI 10.1016/j.molcel.2017.05.032
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070
   Huang ZH, 2016, CEREB CORTEX, V26, P2299, DOI 10.1093/cercor/bhv292
   Hussmann KL, 2013, J VIROL, V87, P2814, DOI 10.1128/JVI.02577-12
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Kandilya D, 2019, EPIGENOMICS-UK, V11, P1143, DOI 10.2217/epi-2018-0180
   Katagiri K, 2009, EMBO J, V28, P1319, DOI 10.1038/emboj.2009.82
   Khomtchouk BB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176334
   Kumar A, 2016, CELL MICROBIOL, V18, P1815, DOI 10.1111/cmi.12625
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341
   Liu ZS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091416
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Mankouri J, 2011, REV MED VIROL, V21, P205, DOI 10.1002/rmv.687
   Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mizutani T, 2012, ONCOIMMUNOLOGY, V1, P1027, DOI 10.4161/onci.21284
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Mo JS, 2015, NAT CELL BIOL, V17, P500, DOI 10.1038/ncb3111
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005
   Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Potokar M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030691
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Prebil Mateja, 2011, Archives of Physiology and Biochemistry, V117, P64, DOI 10.3109/13813455.2010.539616
   R Core Team, 2016, R LANG ENV STAT COMP
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Singh PK, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00173-19
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Sorrentino G, 2014, NAT CELL BIOL, V16, P357, DOI 10.1038/ncb2936
   Tanaka K, 2017, CANCER LETT, V385, P215, DOI 10.1016/j.canlet.2016.10.020
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang WW, 2016, CELL REP, V17, P3091, DOI 10.1016/j.celrep.2016.11.070
   Thaker SK, 2019, CELL METAB, V29, P1206, DOI 10.1016/j.cmet.2019.01.024
   Tsui I, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-1104
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602
   Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113
   Wang YM, 2018, CELL REP, V25, P1304, DOI 10.1016/j.celrep.2018.10.001
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005
   Zhang Q, 2017, NAT CELL BIOL, V19, P362, DOI 10.1038/ncb3496
   Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907
   Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zhong WL, 2013, STEM CELLS DEV, V22, P2083, DOI 10.1089/scd.2012.0685
   Zhou DW, 2011, P NATL ACAD SCI USA, V108, pE1312, DOI 10.1073/pnas.1110428108
NR 80
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD APR
PY 2020
VL 190
IS 4
BP 844
EP 861
DI 10.1016/j.ajpath.2019.12.005
PG 18
WC Pathology
SC Pathology
GA LG1DH
UT WOS:000527849900011
PM 32035058
DA 2020-07-08
ER

PT J
AU Zhao, SY
   Cao, J
   Shi, QL
   Wang, ZJ
   Estill, J
   Lu, SY
   Luo, XF
   Zhao, JX
   Zhang, HR
   Wang, JJ
   Wang, Q
   Xun, YQ
   Zhang, JY
   Lv, M
   Liu, YL
   Nie, XM
   Wang, L
   Zhang, XZ
   Li, WG
   Liu, EM
   Wang, XH
   Chen, YL
AF Zhao, Siya
   Cao, Jin
   Shi, Qianling
   Wang, Zijun
   Estill, Janne
   Lu, Shuya
   Luo, Xufei
   Zhao, Junxian
   Zhang, Hairong
   Wang, Jianjian
   Wang, Qi
   Xun, Yangqin
   Zhang, Jingyi
   Lv, Meng
   Liu, Yunlan
   Nie, Xiaomin
   Wang, Ling
   Zhang, Xianzhuo
   Li, Weiguo
   Liu, Enmei
   Wang, Xiaohui
   Chen, Yaolong
CA COVID-19 Evidence Recommendations
TI A quality evaluation of guidelines on five different viruses causing
   public health emergencies of international concern
SO ANNALS OF TRANSLATIONAL MEDICINE
LA English
DT Review
DE Coronavirus; Ebola virus (EBOV); emergency; practice guideline; Zika
   virus
AB This project aims to evaluate the methods and reporting quality of practice guidelines of five different viruses that have caused Public Health Emergencies of International Concern (PHEIC) over 20 past years: the severe acute respiratory syndrome coronavirus (SARS-CoV), Ebola virus, Middle East respiratory syndrome coronavirus (MERS-CoV), Zika virus and the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We systematically searched databases, guideline websites and government health agency websites from their inception to February 02, 2020 to extract practice guidelines for SARS-CoV, Ebola virus, MERS-CoV, Zika virus, SARS-CoV-2 and the diseases they caused. The literature was screened independently by four researchers. Then, fifteen researchers evaluated the quality of included guidelines using the AGREE-. (Appraisal of Guidelines for Research and Evaluation., for methodological quality) instrument and RIGHT (Reporting Items for practice Guidelines in Healthcare, for reporting quality) statement. Finally, a total of 81 guidelines were included, including 21 SARS-CoV guidelines, 11 Ebola virus (EBOV) guidelines, 9 MERS-CoV guidelines, 10 Zika Virus guidelines and 30 SARS-CoV-2 guidelines. The evaluation of the methodological quality indicated that the mean scores of each domain for guidelines of each virus were all below 60%, the scores for guidelines in the domains of "clarity of presentation" being the highest and in the "editorial independence" lowest. The mean reporting rate of each domain for guidelines of each virus was also less than 60%: the reporting rates for the domain "background" were highest, and for the domain "funding and interests" lowest. The methodological and reporting quality of the practice guidelines for SARS-CoV, Ebola virus, MERS-CoV, Zika virus and SARS-CoV-2 guidelines tend to be low. We recommend to follow evidence-based methodology and the RIGHT statement on reporting when developing guidelines.
C1 [Zhao, Siya; Cao, Jin; Luo, Xufei; Zhao, Junxian; Wang, Jianjian; Xun, Yangqin; Zhang, Jingyi; Lv, Meng; Liu, Yunlan; Wang, Ling; Wang, Xiaohui] Lanzhou Univ, Sch Publ Hlth, Lanzhou 730000, Peoples R China.
   [Zhao, Siya; Shi, Qianling; Wang, Zijun; Lu, Shuya; Luo, Xufei; Zhang, Hairong; Wang, Jianjian; Xun, Yangqin; Zhang, Jingyi; Lv, Meng; Wang, Ling; Zhang, Xianzhuo; Chen, Yaolong] Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
   [Shi, Qianling; Zhang, Xianzhuo] Lanzhou Univ, Clin Med Coll 1, Lanzhou 730000, Peoples R China.
   [Estill, Janne] Univ Geneva, Inst Global Hlth, Geneva, Switzerland.
   [Estill, Janne] Univ Bern, Inst Math Stat & Actuarial Sci, Bern, Switzerland.
   [Lu, Shuya] Univ Elect Sci & Technol, Sch Med, Chengdu 611731, Peoples R China.
   [Lu, Shuya] Sichuan Prov Peoples Hosp, Dept Pediat, Chengdu 610072, Peoples R China.
   [Wang, Qi] McMaster Univ, Fac Hlth Sci, Hlth Policy PhD Program, Hamilton, ON, Canada.
   [Wang, Qi] McMaster Univ, McMaster Hlth Forum, Hamilton, ON, Canada.
   [Nie, Xiaomin] Lanzhou Univ, Clin Med Coll 2, Lanzhou 730030, Peoples R China.
   [Li, Weiguo; Liu, Enmei] Chongqing Med Univ, China Int Sci & Technol Cooperat Base Child Dev &, Natl Clin Res Ctr Child Hlth & Disorders,Children, Dept Resp,Minist Educ,Key Lab Child Dev & Disorde, Chongqing 400014, Peoples R China.
   [Li, Weiguo; Liu, Enmei] Chongqing Key Lab Pediat, Chongqing 400014, Peoples R China.
   [Chen, Yaolong] WHO Collaborating Ctr Guideline Implementat & Kn, Lanzhou 730000, Peoples R China.
   [Chen, Yaolong] GIN Guidelines Int Network Asia, Lanzhou 730000, Peoples R China.
   [Chen, Yaolong] Lanzhou Univ, Key Lab Evidence Based Med & Knowledge Translat G, Lanzhou 730000, Peoples R China.
   [Chen, Yaolong] Chinese GRADE Ctr, Lanzhou 730000, Peoples R China.
RP Wang, XH (corresponding author), Lanzhou Univ, Sch Publ Hlth, Lanzhou 730000, Peoples R China.; Chen, YL (corresponding author), Lanzhou Univ, Evidence Based Med Ctr, Sch Basic Med Sci, Lanzhou 730000, Peoples R China.
EM wangxiaohui@lzu.edu.cn; chenyaolong@vip.163.com
RI Luo, Xufei/AAO-8373-2020
FU 2020 Key R&D project of Gansu Province
FX This work was supported by 2020 Key R&D project of Gansu Province.
CR [Anonymous], 2020, REP TOOL PRACT GUID
   [Anonymous], 2020, APPRAISAL GUIDELINES
   Chen YL, 2017, ANN INTERN MED, V166, P128, DOI 10.7326/M16-1565
   Garritty CM, 2017, J CLIN EPIDEMIOL, V82, P47, DOI 10.1016/j.jclinepi.2016.08.010
   Norris SL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198125
   PLoS Medicine Editors, 2007, PLoS Med, V4, pe197
   Rose DA, 2017, AM J PUBLIC HEALTH, V107, pS126, DOI [10.2105/AJPH.2017.303947, 10.2105/ajph.2017.303947]
   Talisuna AO, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-019-0540-4
   Wang XQ, 2018, J CLIN EPIDEMIOL, V98, P1, DOI 10.1016/j.jclinepi.2017.12.021
   WHO, 2005, INT HLTH REG 2005
   World Health Organization, 2020, 33 WHO
   World Health Organization, 2020, DIS OUTBREAK NE 0208
   World Health Organization, 2014, WHO HDB GUID DEV
   World Health Organization, 2017, EM RESP FRAM
   World Health Organization, 2017, HLTH EM INT GUID WHO
   Yang KH, 2013, HEALTH RES POLICY SY, V11, DOI 10.1186/1478-4505-11-1
NR 16
TC 1
Z9 1
U1 1
U2 1
PU AME PUBL CO
PI SHATIN
PA FLAT-RM C 16F, KINGS WING PLAZA 1, NO 3 KWAN ST, SHATIN, HONG KONG
   00000, PEOPLES R CHINA
SN 2305-5839
EI 2305-5847
J9 ANN TRANSL MED
JI ANN. TRANSL. MED.
PD APR
PY 2020
VL 8
IS 7
AR 500
DI 10.21037/atm.2020.03.130
PG 14
WC Oncology; Medicine, Research & Experimental
SC Oncology; Research & Experimental Medicine
GA LF4KU
UT WOS:000527389200082
PM 32395544
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Valadares, M
   Pedroso, ACLO
   Santana, A
   da Silva, AM
   Costa, IS
   Almeida, MLD
   de Almeida, RP
AF Valadares, Marco
   Pedroso, Anne Carolyne Lelis Oliveira
   Santana, Alessandro
   da Silva, Angela Maria
   Costa, Isabela Soares
   Almeida, Maria Luiza Doria
   de Almeida, Roque Pacheco
TI Ocular Findings in Infants with Microcephaly Caused by Presumed
   Congenital Infection by Zika Virus in Sergipe
SO JOURNAL OF OPHTHALMOLOGY
LA English
DT Article
ID BRAZIL; TRANSMISSION; CHILD
AB This study aims at identifying ocular findings in infants with microcephaly associated with presumed intrauterine infection by ZIKV. A cross-sectional study included 62 outpatient infants with congenital microcephaly, presumably secondary to maternal ZIKV infection. The included infants had head circumference below -2 standard deviations, with negative maternal serology for toxoplasmosis, rubella, cytomegalovirus, syphilis, and HIV. Assessment of ocular alterations was performed through review of their medical records. Forty two (67.7%) of the children analyzed presented some degree of ocular alteration. Findings in the posterior segment occurred in 29 (46.8%) patients, including atrophy of the retinal pigmentary epithelium in 15 (24.2%) patients, chorioretinal scars in 14 (22.6%) patients, retinal coloboma in 6 (9.7%) patients, and punctate retinal hemorrhage in 1 (1.6%) patient. Other ocular alterations were seen in 15 (24.2%) patients, including pathological strabismus in 11 (17.7%) patients, congenital cataracts in 2 (3.2%) patients, and nystagmus in 2 (3.2%) patients. Functional alterations were seen in four (6.5%) children. More than one change occurred in 11 (17.7%) children, eight of whom had head circumferences below -3 standard deviations. Changes in both the eyes occurred in 22 (35.5%) children, while 20 (32.3%) children had unilateral involvement. Among the 42 children with any ocular alteration, 27 (64.3%) children presented with severe microcephaly (head circumference with standard deviation lower than -3). The majority of children with microcephaly, presumably secondary to maternal ZIKV infection, present ocular alterations, with a higher frequency of involvement in the fundus. Severe ocular alterations are related to severe microcephaly.
C1 [Valadares, Marco; Pedroso, Anne Carolyne Lelis Oliveira; Santana, Alessandro; da Silva, Angela Maria; Costa, Isabela Soares; Almeida, Maria Luiza Doria; de Almeida, Roque Pacheco] Univ Fed Sergipe, Dept Med, BR-49060100 Sergipe, Brazil.
RP Costa, IS (corresponding author), Univ Fed Sergipe, Dept Med, BR-49060100 Sergipe, Brazil.
EM valadaresmarco@uol.com.br; annepedroso@hotmail.com;
   alessandro-santana@uol.com.br; angelmar@infonet.com.br;
   isasoarescosta@hotmail.com; luiza.doria@gmail.com;
   roquepachecoalmeida@gmail.com
CR [Anonymous], 2016, 43 SECR EST SAUD SER
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Karabatsos N., 1985, INT CATALOGUE ARBOVI, V1147
   Ministerio da Saude (BR), 2016, B EPIDEMIOLOGICO, V46, P1
   Ministerio da Saude (BR), 2016, B EPIDEMIOLOGICO, V47
   PAHO/WHO, 2016, ZIK EP UPD 14 APR 20
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Ventura CV, 2016, ARQ BRAS OFTALMOL, V79, P1, DOI 10.5935/0004-2749.20160002
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Victora CG, 2016, LANCET, V387, P621, DOI 10.1016/S0140-6736(16)00273-7
   Woods CG, 2004, CURR OPIN NEUROBIOL, V14, P112, DOI 10.1016/j.conb.2004.01.003
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 20
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2090-004X
EI 2090-0058
J9 J OPHTHALMOL
JI J. Ophthalmol.
PD APR 1
PY 2020
VL 2020
AR 7092432
DI 10.1155/2020/7092432
PG 5
WC Medicine, Research & Experimental; Ophthalmology
SC Research & Experimental Medicine; Ophthalmology
GA LE7VB
UT WOS:000526930500011
PM 32318282
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mavragani, A
AF Mavragani, Amaryllis
TI Tracking COVID-19 in Europe: Infodemiology Approach
SO JMIR PUBLIC HEALTH AND SURVEILLANCE
LA English
DT Article
DE big data; coronavirus; COVID-19; infodemiology; infoveillance; Google
   Trends
AB Background: Infodemiology (ie, information epidemiology) uses web-based data to inform public health and policy. Infodemiology metrics have been widely and successfully used to assess and forecast epidemics and outbreaks.
   Objective: In light of the recent coronavirus disease (COVID-19) pandemic that started in Wuhan, China in 2019, online search traffic data from Google are used to track the spread of the new coronavirus disease in Europe.
   Methods: Time series from Google Trends from January to March 2020 on the Topic (Virus) of "Coronavirus" were retrieved and correlated with official data on COVID-19 cases and deaths worldwide and in the European countries that have been affected the most: Italy (at national and regional level), Spain, France, Germany, and the United Kingdom.
   Results: Statistically significant correlations are observed between online interest and COVID-19 cases and deaths. Furthermore, a critical point, after which the Pearson correlation coefficient starts declining (even if it is still statistically significant) was identified, indicating that this method is most efficient in regions or countries that have not yet peaked in COVID-19 cases.
   Conclusions: In the past, infodemiology metrics in general and data from Google Trends in particular have been shown to be useful in tracking and forecasting outbreaks, epidemics, and pandemics as, for example, in the cases of the Middle East respiratory syndrome, Ebola, measles, and Zika. With the COVID-19 pandemic still in the beginning stages, it is essential to explore and combine new methods of disease surveillance to assist with the preparedness of health care systems at the regional level.
C1 [Mavragani, Amaryllis] Univ Stirling, Fac Nat Sci, Dept Comp Sci & Math, Univ Campus, Stirling FK9 4LA, Scotland.
RP Mavragani, A (corresponding author), Univ Stirling, Fac Nat Sci, Dept Comp Sci & Math, Univ Campus, Stirling FK9 4LA, Scotland.
EM amaryllis.mavragani1@stir.ac.uk
RI Mavragani, Amaryllis/N-1417-2017; Karabulut, Erman/G-6679-2011
OI Mavragani, Amaryllis/0000-0001-6106-0873; Karabulut,
   Erman/0000-0002-0787-905X
CR [Anonymous], 2020, BBC NEWS
   [Anonymous], COR
   [Anonymous], GUARDIAN
   Bentley RA, 2009, PLOS CURR, V1, DOI 10.1371/currents.rrn1036
   Chen SQ, 2018, PROC SPIE, V10827, DOI 10.1117/12.2500147
   Du JC, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9413
   Eysenbach G, 2003, J MED INTERNET RES, V5, DOI 10.2196/jmir.5.2.e14
   Eysenbach G, 2011, AM J PREV MED, V40, pS154, DOI 10.1016/j.amepre.2011.02.006
   Eysenbach G, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1157
   Farhadloo M, 2018, JMIR PUBLIC HLTH SUR, V4, P57, DOI 10.2196/publichealth.8186
   Ferguson N., 2020, IMPACT NONPHARMACEUT, DOI [10.25561/77482, DOI 10.25561/77482]
   Hossain L, 2016, EPIDEMIOL INFECT, V144, P2136, DOI 10.1017/S095026881600039X
   Mavragani A., 2020, J MED INTERNET RES
   Mavragani A, 2018, BDCC, V2, P2, DOI [10.3390/bdcc2010002, DOI 10.3390/bdcc2010002]
   Mavragani A, 2019, JMIR PUBLIC HLTH SUR, V5, P59, DOI 10.2196/13439
   Mavragani A, 2018, J MED INTERNET RES, V20, DOI 10.2196/jmir.9366
   Ministero della Salute, NUOV COC
   Poletto C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1787-5
   Reuters, 2020, REUTERS
   Secon H, BUSINESS INSIDER
   Specktor B. LiveScience, 2020, LIVESCIENCE      MAR
   Van Elsland S., 2020, COVID 19 IMPERIAL RE
   van Lent LGG, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7219
   Walker PGT, GLOBAL IMPACT COVID
   Withnall A., 2020, INDEPENDENT
   World Health Organisation (WHO), 2020, ROLL UPD COR DIS COV
   World Health Organization, 2020, WHO ANN COVID 19 OUT
   Worldometer, COVID 19 COR PAND
NR 28
TC 2
Z9 2
U1 7
U2 7
PU JMIR PUBLICATIONS, INC
PI TORONTO
PA 130 QUEENS QUAY E, STE 1102, TORONTO, ON M5A 0P6, CANADA
SN 2369-2960
J9 JMIR PUBLIC HLTH SUR
JI JMIR Public Health Surveill.
PD APR-JUN
PY 2020
VL 6
IS 2
BP 233
EP 245
AR UNSP e18941
DI 10.2196/18941
PG 13
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LE6ES
UT WOS:000526817200025
PM 32250957
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Palmer, WH
   Dittmar, M
   Gordesky-Gold, B
   Hofmann, J
   Cherry, S
AF Palmer, William H.
   Dittmar, Mark
   Gordesky-Gold, Beth
   Hofmann, Jennifer
   Cherry, Sara
TI Drosophila melanogaster as a model for arbovirus infection of adult
   salivary glands
SO VIROLOGY
LA English
DT Article
DE Arbovirus; Innate immunity; Salivary gland; Drosophila melanogaster;
   Tissue barrier; Zika virus; Vesicular stomatitis virus
ID ANTIVIRAL IMMUNITY; DISTINCT ROLES; RNA; VIRUS; PROTEIN; INSECT;
   INTERFERENCE; VECTORS; REVEALS; INNATE
AB Arboviruses are an emerging threat to public health. Arbovirus transmission to vertebrates hinges on dissemination from the arthropod gastrointestinal tract, and ultimately infection of the arthropod salivary glands. Therefore, salivary gland immunity impacts arbovirus transmission; however, these immune responses are poorly understood. Here, we describe the utility of Drosophila melanogaster as a salivary gland infection model. First, we describe the use of a salivary gland-specific driver to launch RNA interference or virus replicon transgenes. Next, we infect flies with an arbovirus panel and find multiple viruses that infect Drosophila salivary glands, albeit inefficiently. We find that this infection is not controlled by antiviral RNA silencing; thus, we silence a panel of immune genes in the salivary glands, but do not observe changes in infection. These data suggest that Drosophila may be used to study salivary gland infection, and that there are likely unexplored pathways controlling infection of this tissue.
C1 [Palmer, William H.; Dittmar, Mark; Gordesky-Gold, Beth; Hofmann, Jennifer; Cherry, Sara] Univ Penn, Perelman Sch Med, Dept Microbiol, 472A Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.
RP Cherry, S (corresponding author), Univ Penn, Perelman Sch Med, Dept Microbiol, 472A Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.
EM cherrys@pennmedicine.upenn.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [2T32AI055400, RO1AI122749,
   RO1AI150246, R01AI140539]; Burroughs Wellcome Investigators in the
   Pathogenesis of Infectious Disease AwardBurroughs Wellcome Fund
FX We thank Richard Hardy for kindly sharing the SINVrep<SUP>GFP</SUP> fly
   line with us, Michael Diamond and Robert Tesh for arboviruses, Michael
   Diamond and Carolyn Coyne for sharing antibodies, the Bloomington and
   Vienna fly stock centers and community for flies. We thank members of
   the Cherry laboratory for advice and technical support. This work was
   supported by NIH grant 2T32AI055400 to W.H.P., and RO1AI122749,
   RO1AI150246 and R01AI140539 to S.C. Support was provided by the
   Burroughs Wellcome Investigators in the Pathogenesis of Infectious
   Disease Award to S.C.
CR Avadhanula V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000582
   Billes V, 2018, AUTOPHAGY, V14, P1499, DOI 10.1080/15548627.2018.1454569
   Buchon N, 2014, NAT REV IMMUNOL, V14, P796, DOI 10.1038/nri3763
   Buchon N, 2013, CELL REP, V3, P1725, DOI 10.1016/j.celrep.2013.04.001
   Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618
   Carissimo G, 2015, P NATL ACAD SCI USA, V112, pE176, DOI 10.1073/pnas.1412984112
   Chaverra-Rodriguez D, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05425-9
   Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021
   Ferreira AG, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004507
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Goic B, 2013, NAT IMMUNOL, V14, P396, DOI 10.1038/ni.2542
   Grubaugh ND, 2016, CELL HOST MICROBE, V19, P481, DOI 10.1016/j.chom.2016.03.002
   Hopkins KC, 2013, GENE DEV, V27, P1511, DOI 10.1101/gad.215384.113
   Kistler KE, 2015, CELL REP, V11, P51, DOI 10.1016/j.celrep.2015.03.009
   LaBeaud AD, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-1
   Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5
   Liu Y, 2018, CELL HOST MICROBE, V24, P57, DOI 10.1016/j.chom.2018.05.022
   Luplertlop N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001252
   Marianes A, 2013, ELIFE, V2, DOI 10.7554/eLife.00886
   Martins N, 2019, G3-GENES GENOM GENET, V9, P403, DOI 10.1534/g3.118.200872
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Mayer SV, 2017, ACTA TROP, V166, P155, DOI 10.1016/j.actatropica.2016.11.020
   Mondotte JA, 2018, NAT MICROBIOL, V3, P1394, DOI 10.1038/s41564-018-0265-9
   Mueller S, 2010, P NATL ACAD SCI USA, V107, P19390, DOI 10.1073/pnas.1014378107
   Mussabekova A, 2017, CELL MOL LIFE SCI, V74, P2039, DOI 10.1007/s00018-017-2453-9
   Nagy P, 2016, DIS MODEL MECH, V9, P501, DOI 10.1242/dmm.023416
   Nawa M, 2001, J VIROL METHODS, V92, P65, DOI 10.1016/S0166-0934(00)00274-3
   Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204
   Pal P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003312
   Palmer WH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10030118
   Pompon J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006535
   Ribeiro JMC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-6
   Robinson SW, 2013, NUCLEIC ACIDS RES, V41, pD744, DOI 10.1093/nar/gks1141
   Rose PP, 2011, CELL HOST MICROBE, V10, P97, DOI 10.1016/j.chom.2011.06.009
   Ruckert Claudia, 2014, VirusDisease, V25, P249, DOI 10.1007/s13337-014-0217-9
   Sansone CL, 2015, CELL HOST MICROBE, V18, P571, DOI 10.1016/j.chom.2015.10.010
   Schmid MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102568
   SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993
   Shelly S, 2009, IMMUNITY, V30, P588, DOI 10.1016/j.immuni.2009.02.009
   Sim S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002631
   Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005
   van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006
   Wang YH, 2018, DEV COMP IMMUNOL, V83, P12, DOI 10.1016/j.dci.2017.12.001
   Xu J, 2014, DEV COMP IMMUNOL, V42, P67, DOI 10.1016/j.dci.2013.05.002
   Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110
   Xu J, 2012, CELL HOST MICROBE, V12, P531, DOI 10.1016/j.chom.2012.08.011
   Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042
   Yasunaga A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003914
NR 48
TC 0
Z9 0
U1 4
U2 4
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD APR
PY 2020
VL 543
BP 1
EP 6
DI 10.1016/j.virol.2020.01.010
PG 6
WC Virology
SC Virology
GA LE7GE
UT WOS:000526889900001
PM 32056841
DA 2020-07-08
ER

PT J
AU Pielnaa, P
   Al-Saadawe, M
   Saro, A
   Dama, MF
   Zhou, M
   Huang, YX
   Huang, JF
   Xia, ZX
AF Pielnaa, Paul
   Al-Saadawe, Moyed
   Saro, Adonira
   Dama, Marcelllin Faniriantsoahenrio
   Zhou, Mei
   Huang, Yanxia
   Huang, Jufang
   Xia, Zanxian
TI Zika virus-spread, epidemiology, genome, transmission cycle, clinical
   manifestation, associated challenges, vaccine and antiviral drug
   development
SO VIROLOGY
LA English
DT Article
DE Zika virus (ZIKV); Microcephaly; Neurological complications; Sexual
   transmission; Vaccine development; Antiviral drug development
ID DENGUE VIRUS; INFECTION; HISTORY; BIOLOGY; OUTBREAK; AMERICA; ISLAND
AB Zika Virus (ZIKV) is a Flavivirus transmitted primarily via the bite of infected Aedes aegypti mosquitoes. Globally, 87 countries and territories have recorded autochthonous mosquito-borne transmission of ZIKV as at July 2019 and distributed across four of the six WHO Regions. Outbreaks of ZIKV infection peaked in 2016 and declined substantially throughout 2017 and 2018 in the Americas region. There is the likely risk for ZIKV to spread to more countries. There is also the potential for the re-emergence of ZIKV in all places with prior reports of the virus transmission. The current status of ZIKV transmission and spread is, however, a global health threat, and from the aforementioned, has the potential to re-emerge as an epidemic. This review summarizes the past and present spread of ZIKV outbreak-2007-2019, the genome, transmission cycle, clinical manifestations, vaccine and antiviral drug advancement.
C1 [Pielnaa, Paul; Saro, Adonira; Dama, Marcelllin Faniriantsoahenrio; Huang, Yanxia; Huang, Jufang] Cent South Univ, Sch Basic Med Sci, Dept Anat & Neurobiol, Changsha 410013, Peoples R China.
   [Al-Saadawe, Moyed; Zhou, Mei; Xia, Zanxian] Cent South Univ, Sch Life Sci, Dept Cell Biol, Changsha 410013, Peoples R China.
   [Huang, Jufang] Cent South Univ, Sch Life Sci, Changsha 410013, Peoples R China.
   [Xia, Zanxian] Cent South Univ, Hunan Key Lab Med Genet, Sch Life Sci, Hunan Key Lab Anim Models Human Dis, Changsha 410013, Peoples R China.
   [Xia, Zanxian] Cent South Univ, Ctr Med Genet, Sch Life Sci, Changsha 410013, Peoples R China.
RP Huang, JF; Xia, ZX (corresponding author), Cent South Univ, Sch Life Sci, Changsha 410013, Peoples R China.
EM huangjufang@csu.edu.cn; xiazanxian@sklmg.edu.cn
FU National Key Research and Development Program of China [2016YFD0500300];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [U1603126]; Open Project Program of the State Key
   Laboratory of Proteomics [SKLP-O201805]
FX This work was supported by the National Key Research and Development
   Program of China [2016YFC1200200and 2016YFD0500300(Z. Xia)], the
   National Natural Science Foundation of China [U1603126 (Z. Xia)], and
   the Open Project Program of the State Key Laboratory of Proteomics
   [SKLP-O201805 (Z. Xia)].
CR Abrams RPM, 2017, NEUROTHERAPEUTICS, V14, P1027, DOI 10.1007/s13311-017-0575-2
   Adebayo G, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000296
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Ali A, 2017, ASIAN PAC J TROP MED, V10, P301, DOI 10.1016/j.apjtm.2017.03.020
   Amraoui F, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006997
   Aubry M., 2019, New Microbes and New Infections, V29, DOI 10.1016/j.nmni.2019.01.009
   Baronti C, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00500-14
   Basu R, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0623-2
   Baz M, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030101
   Besnard M., 2014, EVIDENCE PERINATAL T
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Bonaldo MC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004816
   Bos S, 2018, VIROLOGY, V516, P265, DOI 10.1016/j.virol.2017.12.003
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Carlson CJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004968
   CDC, 2016, CDC ADDS NEW ZIK WAR
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DICK G.W.A., 1952, T R SOC TROP MED HYG, V46
   Dowd Kimberly A., 2016, RAPID DEV DNA VACCIN
   Du SY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09256-0
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Duffy, 2009, NEW ENGL J MED, V360, P24
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Faria N.R., 2018, EPIDEMIOLOGY ZIKA VI
   Fauci Anthony S., 2016, N ENGL J MED, V374
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gaudinski Martin R., 2017, SAFETY TOLERABILITY, DOI [10.1016/S0140-6736(17)33105-7., DOI 10.1016/S0140-6736(17)33105-7]
   Gustavo De Moraes C., 2018, CORRIGENDUM OPTIC NE, DOI [10.1099/jmmcr.0.005145., DOI 10.1099/JMMCR.0.005145]
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Herrera BB, 2017, J INFECT DIS, V215, P1546, DOI 10.1093/infdis/jix182
   Hill S.C., 2019, EMERGENCE ZIKA VIRUS, DOI [10.1101/520437., DOI 10.1101/520437]
   Hu T, 2019, VIROL SIN, V34, P1, DOI 10.1007/s12250-018-0078-2
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Javed F, 2018, J BASIC MICROB, V58, P3, DOI 10.1002/jobm.201700398
   Kakooza-Mwesige A, 2019, BRAIN RES BULL, V145, P2, DOI 10.1016/j.brainresbull.2018.12.019
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leier HC, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006952
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA
   Musso D., 2014, POTENTIAL ZIKA VIRUS
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nugent Elizabeth K., 2017, ZIKA VIRUS EPIDEMIOL, DOI [10.1016/j.amjms.2016.12.018., DOI 10.1016/J.AMJMS.2016.12.018]
   O'Reilly KM, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1158-8
   Oladapo OT, 2016, LANCET GLOB HEALTH, V4, pE510, DOI 10.1016/S2214-109X(16)30098-5
   PAHO, 2018, GUID SURV ZIKV
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pastorino B, 2019, AM J TROP MED HYG, V100, P639, DOI 10.4269/ajtmh.18-0439
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Plotkin Stanley A., 2015, ESTABLISHING GLOBAL
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   POLAND GA, 2019, ZIKA VACCINE DEV CUR, V94, P2572, DOI DOI 10.1016/J.MAYOCP.2019.05.016
   Randolph SE, 2010, NAT REV MICROBIOL, V8, P361, DOI 10.1038/nrmicro2336
   Rasmussen Sonja A., 2016, N ENGL J, V374
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rome Buathong, 2016, ZIKA VIRUS INFECT TH
   Sakkas H, 2016, J VECTOR DIS, V53, P305
   Salchuddin AR, 2017, ASIAN PAC J TROP MED, V10, P201, DOI 10.1016/j.apjtm.2017.03.002
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Sariol C.A., 2012, DETECTION GENETIC RE
   Sasmono RT, 2018, EMERG INFECT DIS, V24, P1740, DOI 10.3201/eid2409.180582
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Seixas G, 2013, MEM I OSWALDO CRUZ, V108, P3, DOI 10.1590/0074-0276130386
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stettler Karin, 2016, SPECIFICITY CROSS RE, V353, P6301
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Thane Hancock W., 2016, WHO CONFIRMS ZIKA VI
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Trew Deckard D., 2016, MALE TO MALE SEXUAL
   Tsegaye MM, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5726-9
   Tun MMN, 2018, AM J TROP MED HYG, V98, P868, DOI 10.4269/ajtmh.17-0708
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WHO, 2016, SAUDI MED J, V37
   WHO, 2019, COUNTR WITH ZIK AND
   WHO/PAHO, 2017, ZIK CAS CONG SYNDR A
   WHOc, 2018, CAS ZIK VIR DIS COUN
   WHOg, 2019, WHO REG OFF E MED
   WHOh, 2018, ZIK VIR INF IND
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   World Health Organization, 2017, WEEKL B OUTBR OTH EM
   World Health Organization, 2019, ZIK EP UPD JUL 2019
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yun SI, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00800-16
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 94
TC 0
Z9 0
U1 7
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD APR
PY 2020
VL 543
BP 34
EP 42
DI 10.1016/j.virol.2020.01.015
PG 9
WC Virology
SC Virology
GA LE7GE
UT WOS:000526889900006
PM 32056845
DA 2020-07-08
ER

PT J
AU Mayor, J
   Torriani, G
   Rothenberger, S
   Engler, O
AF Mayor, Jennifer
   Torriani, Giulia
   Rothenberger, Sylvia
   Engler, Olivier
TI T-cell immunoglobulin and mucin (TIM) contributes to the infection of
   human airway epithelial cells by pseudotype viruses containing Hantaan
   virus glycoproteins
SO VIROLOGY
LA English
DT Article
DE Hantavirus; TIM-1; Axl; Heparan sulfate; Hantaan virus; Andes virus;
   Apoptotic mimicry
ID RECEPTOR TYROSINE KINASE; PHOSPHATIDYLSERINE RECEPTORS;
   HEMORRHAGIC-FEVER; ZAIRE-EBOLAVIRUS; RENAL SYNDROME; DENGUE VIRUS; ZIKA
   VIRUS; ENTRY; AXL; HANTAVIRUSES
AB Hantaviruses are rodent-borne hemorrhagic fever viruses leading to serious diseases. Viral attachment and entry represent the first steps in virus transmission and are promising targets for antiviral therapeutic intervention. Here we investigated receptor use in human airway epithelium of the Old and New World hantaviruses Hantaan virus (HTNV) and Andes virus (ANDV). Using a biocontained recombinant vesicular stomatitis virus pseudotype platform, we provide first evidence for a role of the cellular phosphatidylserine (PS) receptors of the T-cell immunoglobulin and mucin (TIM) protein family in HTNV and ANDV infection. In line with previous studies, HTNV, but not ANDV, was able to use glycosaminoglycan heparan sulfate and alpha(v)beta(3) integrin as co-receptors. In sum, our studies demonstrate for the first time that hantaviruses make use of apoptotic mimicry for infection of human airway epithelium, which may explain why these viruses can easily break the species barrier.
C1 [Mayor, Jennifer; Torriani, Giulia; Rothenberger, Sylvia] Univ Hosp Ctr, Inst Microbiol, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.
   [Mayor, Jennifer; Torriani, Giulia; Rothenberger, Sylvia] Univ Lausanne, Rue Bugnon 48, CH-1011 Lausanne, Switzerland.
   [Mayor, Jennifer; Rothenberger, Sylvia; Engler, Olivier] Spiez Lab, CH-3700 Spiez, Switzerland.
RP Engler, O (corresponding author), Spiez Lab, CH-3700 Spiez, Switzerland.; Rothenberger, S (corresponding author), Lausanne Univ Hosp, Inst Microbiol, CH-1011 Lausanne, Switzerland.
EM Sylvia.Rothenberger-Aubert@chuv.ch; olivier.engler@babs.admin.ch
FU Swiss Federal Office for Civil Protection [353006233/Stm 353008560/Stm,
   35 3008553]; Swiss Lung Association [2016-06_Kunz]; University of
   Lausanne
FX The authors thank Professor Stefan Kunz for his contributions to the
   study of hemorrhagic fever viruses. We thank the virology team at Spiez
   Laboratory for helping to establish the Hantaan virus culture and
   validation experiment. We also thank Dr. Gert Zimmer for the gift of the
   VSV recombinant and critical reading of the manuscript and Dr. Nicole
   Tischler (Molecular Virology Laboratory, Fundacion Ciencia & Vida,
   Santiago, Chile) for the expression plasmid pI18 GPC ANDV. We further
   thank Dr. Connie Schmaljohn (USAMRIID, Fort Detrick, MD, USA) for the
   plasmid pWRG/HTNV-M, and Mark Page (The National Institute for
   Biological Standards and Control, South Mimms, UK) for the expression
   plasmid pCAGGS-GUI14. This research was supported by Swiss Federal
   Office for Civil Protection (Grants Nr. 353006233/Stm 353008560/Stm and
   35 3008553 to O.E. and S.K.), Swiss Lung Association (Grant Nr.:
   2016-06_Kunz to SK, OE and SR). JM was supported by funds from the
   University of Lausanne to Stefan Kunz.
CR Amara A, 2015, NAT REV MICROBIOL, V13, P461, DOI 10.1038/nrmicro3469
   Barth H, 2003, J BIOL CHEM, V278, P41003, DOI 10.1074/jbc.M302267200
   Bhattacharyya S, 2013, CELL HOST MICROBE, V14, P136, DOI 10.1016/j.chom.2013.07.005
   Brindley MA, 2011, VIROLOGY, V415, P83, DOI 10.1016/j.virol.2011.04.002
   Brouillette RB, 2018, J VIROL, V92, DOI [10.1128/jvi.00093-18, 10.1128/JVI.00093-18]
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Cifuentes-Munoz N, 2010, VIRUS RES, V153, P29, DOI 10.1016/j.virusres.2010.07.001
   de Souza AJ, 2005, P NATL ACAD SCI USA, V102, P17113, DOI 10.1073/pnas.0508643102
   Fernandez-Fernandez L, 2008, THROMB HAEMOSTASIS, V100, P604, DOI 10.1160/TH08-04-0253
   Gavrilovskaya IN, 1999, J VIROL, V73, P3951, DOI 10.1128/JVI.73.5.3951-3959.1999
   Gavrilovskaya IN, 1998, P NATL ACAD SCI USA, V95, P7074, DOI 10.1073/pnas.95.12.7074
   Grabiec AM, 2017, J ALLERGY CLIN IMMUN, V140, P1144, DOI 10.1016/j.jaci.2017.03.024
   HOLLAND JJ, 1989, J VIROL, V63, P5030, DOI 10.1128/JVI.63.12.5030-5036.1989
   Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997
   Hooper JW, 2001, J VIROL, V75, P8469, DOI 10.1128/JVI.75.18.8469-8477.2001
   Hunt CL, 2011, J VIROL, V85, P334, DOI 10.1128/JVI.01278-09
   Iwamoto K, 2007, BIOPHYS J, V93, P1608, DOI 10.1529/biophysj.106.101584
   Jangra RK, 2018, NATURE, V563, P559, DOI 10.1038/s41586-018-0702-1
   Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232
   Jonsson CB, 2010, CLIN MICROBIOL REV, V23, P412, DOI 10.1128/CMR.00062-09
   Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011
   Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108
   Krautkramer E, 2008, J VIROL, V82, P4257, DOI 10.1128/JVI.02210-07
   Kuroda M, 2015, J VIROL, V89, P6481, DOI 10.1128/JVI.03156-14
   LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X
   Manigold T, 2014, SWISS MED WKLY, V144, DOI 10.4414/smw.2014.13937
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mercer J, 2008, SCIENCE, V320, P531, DOI 10.1126/science.1155164
   Meyers JH, 2005, NAT IMMUNOL, V6, P455, DOI 10.1038/ni1185
   Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307
   Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009
   Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13
   Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a
   Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13
   Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012
   Muranyi W, 2005, J AM SOC NEPHROL, V16, P3669, DOI 10.1681/ASN.2005050561
   Myers SH, 2016, J MED CHEM, V59, P3593, DOI 10.1021/acs.jmedchem.5b01273
   O'Hearn A, 2015, J VIROL, V89, P5441, DOI 10.1128/JVI.03689-14
   Oppliger J, 2016, J VIROL, V90, P6412, DOI 10.1128/JVI.00257-16
   Popugaeva E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035587
   Raymond T, 2005, P NATL ACAD SCI USA, V102, P1163, DOI 10.1073/pnas.0406743102
   Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858
   Riblett AM, 2016, J VIROL, V90, P1414, DOI 10.1128/JVI.02055-15
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Richard AS, 2015, P NATL ACAD SCI USA, V112, P14682, DOI 10.1073/pnas.1508095112
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Rothlin CV, 2010, CURR OPIN IMMUNOL, V22, P740, DOI 10.1016/j.coi.2010.10.001
   Salvador B, 2013, J VIROL, V87, P3295, DOI 10.1128/JVI.01621-12
   Shimojima M, 2007, J INFECT DIS, V196, pS259, DOI 10.1086/520594
   Shimojima M, 2006, J VIROL, V80, P10109, DOI 10.1128/JVI.01157-06
   Tamhankar M, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1045-0
   Torriani G, 2019, VIROLOGY, V531, P57, DOI 10.1016/j.virol.2019.02.013
   Torriani G, 2019, J VIROL, V93, DOI 10.1128/JVI.01744-18
   Umetsu SE, 2005, NAT IMMUNOL, V6, P447, DOI 10.1038/ni1186
   Vaheri A, 2013, NAT REV MICROBIOL, V11, P539, DOI 10.1038/nrmicro3066
   Vaheri A, 2013, REV MED VIROL, V23, P35, DOI 10.1002/rmv.1722
   Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661
NR 60
TC 0
Z9 0
U1 7
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0042-6822
J9 VIROLOGY
JI Virology
PD APR
PY 2020
VL 543
BP 54
EP 62
DI 10.1016/j.virol.2020.02.002
PG 9
WC Virology
SC Virology
GA LE7GE
UT WOS:000526889900008
PM 32056847
DA 2020-07-08
ER

PT J
AU Attell, JE
   Rose, C
   Bertolli, J
   Kotzky, K
   Squires, J
   Krishna, NK
   Satterfield-Nash, A
   Peacock, G
   Pereira, IO
   Santelli, ACFES
   Smith, C
AF Attell, Jacob E.
   Rose, Charles
   Bertolli, Jeanne
   Kotzky, Kim
   Squires, Jane
   Krishna, Nevin K.
   Satterfield-Nash, Ashley
   Peacock, Georgina
   Pereira, Isabela
   Santelli, Ana Carolina Faria E. Silva
   Smith, Camille
TI Adapting the Ages and Stages Questionnaire to Identify and Quantify
   Development Among Children With Evidence of Zika Infection
SO INFANTS & YOUNG CHILDREN
LA English
DT Article
DE Ages and Stages Questionnaire; child development; developmental
   screening; microcephaly; neurotropic infection; quantitative methods;
   Zika virus
ID VIRUS-INFECTION; EARLY INTERVENTION; HIGH PREVALENCE; MENTAL-HEALTH;
   INFANTS; DIAGNOSIS; BRAZIL; DELAY
AB This article describes novel methods of applying the Ages and Stages Questionnaire-3rd edition (ASQ-3) to assess and quantify developmental delay among children following the 2015-2016 Zika virus outbreak in Brazil. Many of the children with Zika virus infection were expected to have severe developmental delay. However, administering the ASQ-3 to caregivers of these children according to standard protocol would have screened for the overall presence of delay but not the severity of delay. We adopted an amended protocol for administration of the ASQ-3 to quantify the developmental functioning of children severely affected by Zika virus infection in this investigation. Protocols for administering the ASQ-3 among this population were drafted in consultation with developmental measurement experts and are presented here. Specific developmental estimates are discussed, including developmental age equivalents, developmental quotients, and developmental quotient z scores. The calculations of these estimates are presented with examples in the context of the 2015-2016 Zika virus outbreak and associated microcephaly among prenatally infected children from 2 states in northeastern Brazil. Potential applications of these methods for estimating developmental ability among similar pediatric populations are discussed.
C1 [Attell, Jacob E.] Eagle Global Sci LLC, Atlanta, GA USA.
   [Rose, Charles] US Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Ft Collins, CO USA.
   [Bertolli, Jeanne; Peacock, Georgina] US Ctr Dis Control & Prevent, Div Human Dev & Disabil, Atlanta, GA USA.
   [Krishna, Nevin K.] US Ctr Dis Control & Prevent, Div State & Local Readiness, Atlanta, GA USA.
   [Smith, Camille] US Ctr Dis Control & Prevent, Div Congenital & Dev Disorders, Atlanta, GA USA.
   [Kotzky, Kim; Satterfield-Nash, Ashley] Oak Ridge Inst Sci & Educ, Div Human Dev & Disabil, Atlanta, GA USA.
   [Squires, Jane] Univ Oregon, Coll Educ, Ctr Human Dev, Eugene, OR 97403 USA.
   [Pereira, Isabela] US Ctr Dis Control & Prevent, Transmissible Dis Dept, Minist Hlth Brazil, Brasilia, DF, Brazil.
   [Pereira, Isabela] US Ctr Dis Control & Prevent, Div Global HIV & TB, Overseas Strategy & Management Branch Brazil, Brasilia, DF, Brazil.
   [Santelli, Ana Carolina Faria E. Silva] Booz Allen Hamilton LLC, Mclean, VA USA.
RP Attell, JE (corresponding author), Booz Allen Hamilton, Civil Serv Grp, 1349 W Peachtree St NW 1400, Atlanta, GA 30309 USA.
EM jacobattell@outlook.com
FU Office of Infectious Diseases, Bureau of Global Health, U.S. Agency for
   International Development (USAID)United States Agency for International
   Development (USAID); Centers for Disease Control and Prevention
   (CDC)United States Department of Health & Human ServicesCenters for
   Disease Control & Prevention - USA [NU2G GH001152]
FX This research was made possible through support provided by the Office
   of Infectious Diseases, Bureau of Global Health, U.S. Agency for
   International Development (USAID), under the terms of an Interagency
   Agreement with the Centers for Disease Control and Prevention (CDC) and
   Cooperative Agreement number NU2G GH001152.
CR Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Antezana L, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00590
   Blankson AN, 2017, EARLY EDUC DEV, V28, P1, DOI 10.1080/10409289.2016.1183434
   Bricker D, 2010, INFANT YOUNG CHILD, V23, P14, DOI 10.1097/IYC.0b013e3181c816cc
   Britton PN, 2018, J PAEDIATR CHILD H, V54, P289, DOI 10.1111/jpc.13728
   Chiu SH, 2010, J PEDIATR HEALTH CAR, V24, P73, DOI 10.1016/j.pedhc.2009.01.003
   Duby JC, 2006, PEDIATRICS, V118, P405, DOI 10.1542/peds.2006-1231
   Early Childhood Technical Assistance Center, 2015, STAT TERR DEF CRIT I
   Feinstein L, 2004, CHILD DEV, V75, P1329, DOI 10.1111/j.1467-8624.2004.00743.x
   Filgueiras A, 2013, EARLY HUM DEV, V89, P561, DOI 10.1016/j.earlhumdev.2013.02.005
   Gollenberg AL, 2010, CHILD CARE HLTH DEV, V36, P485, DOI 10.1111/j.1365-2214.2009.01041.x
   Gordon-Lipkin E, 2016, PEDIATR CLIN N AM, V63, P851, DOI 10.1016/j.pcl.2016.06.007
   Handal AJ, 2007, ENVIRON HEALTH PERSP, V115, P128, DOI 10.1289/ehp.9261
   Kapci EG, 2010, TOP EARLY CHILD SPEC, V30, P176, DOI 10.1177/0271121410373149
   Kerstjens JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133087
   Kotzky K, 2019, J DEV BEHAV PEDIATR, V40, P344, DOI 10.1097/DBP.0000000000000666
   Krow-Lucal ER, 2018, LANCET CHILD ADOLESC, V2, P204, DOI 10.1016/S2352-4642(18)30020-8
   Kvestad I, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-50
   Oberer N, 2018, HUM MOVEMENT SCI, V58, P69, DOI 10.1016/j.humov.2018.01.003
   Okereafor A, 2008, PEDIATRICS, V121, P906, DOI 10.1542/peds.2007-0770
   Polanska K, 2013, BIOMED RES INT, DOI 10.1155/2013/629716
   Pool J. L., 2008, THESIS
   Porter S, 2017, INFANT YOUNG CHILD, V30, P17, DOI 10.1097/IYC.0000000000000084
   Samms-Vaughan ME, 2014, INT J SPEECH-LANG PA, V16, P30, DOI 10.3109/17549507.2013.866271
   Santana C. M. T., 2015, GLOBAL PEDIAT HLTH, V2, P1
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Singh A, 2017, B MED HOSP INFANT M, V74, P5, DOI 10.1016/j.bmhimx.2016.07.008
   Squires J, 2009, ASQ 3 USERS GUIDE
   Squires JK, 1998, EARLY CHILD RES Q, V13, P345, DOI 10.1016/S0885-2006(99)80043-X
   Thomas KC, 2009, PSYCHIAT SERV, V60, P1323, DOI 10.1176/ps.2009.60.10.1323
   U.S. Centers for Disease Control and Prevention, 2018, DEV MON SCREEN
   Vejrup K, 2018, ENVIRON INT, V110, P71, DOI 10.1016/j.envint.2017.10.008
   Wei QW, 2015, PUBLIC HEALTH, V129, P1610, DOI 10.1016/j.puhe.2015.07.036
   Welsh JA, 2010, J EDUC PSYCHOL, V102, P43, DOI 10.1037/a0016738
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
NR 36
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0896-3746
EI 1550-5081
J9 INFANT YOUNG CHILD
JI Infants Young Child.
PD APR-JUN
PY 2020
VL 33
IS 2
BP 95
EP 107
DI 10.1097/IYC.0000000000000161
PG 13
WC Education, Special; Psychology, Developmental; Rehabilitation
SC Education & Educational Research; Psychology; Rehabilitation
GA LB3QF
UT WOS:000524551200002
DA 2020-07-08
ER

PT J
AU Gaba, A
   Soliman, GA
AF Gaba, Ann
   Soliman, Ghada A.
TI Congenital Zika Syndrome Background and Nutrition Care of Affected
   Infants
SO TOPICS IN CLINICAL NUTRITION
LA English
DT Review
DE birth defects; congenital Zika syndrome; feeding; infants; infectious
   disease; microcephaly; nutrition; Zika virus
ID UPDATE INTERIM GUIDANCE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; GROSS
   MOTOR FUNCTION; VIRUS-INFECTION; UNITED-STATES; BIRTH-DEFECTS; NEW-YORK;
   PEDIATRIC-GASTROENTEROLOGY; HEAD CIRCUMFERENCE; PREGNANT-WOMEN
AB Zika infection of pregnant women can result in infants with microcephaly and other severe birth defects. With these conditions come a variety of challenges that impair nutritional status. While Zika infection in the United States remains relatively rare, registered dietitian nutritionists should be prepared to assess and provide support to affected children. The most common nutrition-related consequences of Zika infection have some possible nutrition interventions to minimize their impact. The goal of nutritional care for infants and children with congenital Zika syndrome is to promote optimal functional capacity and quality of life.
C1 [Gaba, Ann; Soliman, Ghada A.] CUNY, Grad Sch Publ Hlth & Hlth Policy, Program Food & Nutr Publ Hlth, Dept Environm Occupat & Geospatial Hlth Sci, 55 West 125th St, New York, NY 10027 USA.
RP Gaba, A (corresponding author), CUNY, Grad Sch Publ Hlth & Hlth Policy, Program Food & Nutr Publ Hlth, Dept Environm Occupat & Geospatial Hlth Sci, 55 West 125th St, New York, NY 10027 USA.
EM Ann.Gaba@sph.cuny.edu
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Akkina R, 2017, ANTIVIR RES, V142, P21, DOI 10.1016/j.antiviral.2017.03.005
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Alves LV, 2018, J CHILD NEUROL, V33, P664, DOI 10.1177/0883073818780105
   American Academy of Pediatrics, 2012, POL STAT BREASTF US
   American College of Obstetricians and Gynecologists' Committee on Obstetric Practice, 2016, Obstet Gynecol, V127, pe86, DOI 10.1097/AOG.0000000000001318
   Andrew M. J., 2010, PAEDIAT CHILD HLTH, V20, P321, DOI DOI 10.1016/J.PAED.2010.02.005
   Andrew MJ, 2010, NUTR CLIN PRACT, V25, P357, DOI 10.1177/0884533610374061
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Armstrong P, 2016, MMWR-MORBID MORTAL W, V65, P286, DOI 10.15585/mmwr.mm6511e1
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Bailey DB, 2018, PEDIATRICS, V141, pS180, DOI 10.1542/peds.2017-2038G
   Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavalcanti DD, 2017, PLOS ONE, V12, pe0175065, DOI DOI 10.1371/JOURNAL.PONE.0175065.ECOLLECTION2017
   Cavalcanti MG, 2017, INT J INFECT DIS, V57, P70, DOI 10.1016/j.ijid.2017.01.042
   Center for Disease Control and Prevention (CDC), 2000, GROWTH CHARTS HEAD C
   Centers for Disease Control and Prevention, 2017, CUM ZIK VIR DIS CAS
   Centers for Disease Control and Prevention, 2018, ZIK VIR
   Centers for Disease Control and Prevention, 2016, CDC ISS INT TRAV GUI
   Centers for Disease Control and Prevention, 2018, CUM ZIK VIR DIS CAS
   Centers for Disease Control and Prevention, 2017, CAR BAB BORN BIRTH D
   Centers for Disease Control and Prevention, 2017, ZIK BAS VIR PROT IT
   Centers for Disease Control and Prevention, 2018, ZIK PREG DAT STAT
   Centers for Disease Control and Prevention (CDC), 2016, ZIK VIR CAS COUNTS U
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   COOKE RWI, 1977, EARLY HUM DEV, V1, P145, DOI 10.1016/0378-3782(77)90015-9
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   De Carvalho NS, 2016, BRAZ J INFECT DIS, V20, P282, DOI 10.1016/j.bjid.2016.02.006
   De Moraes CG, 2018, JMM CASE REP, V5, pe005145
   Dias JRD, 2018, PROG RETIN EYE RES, V66, P85, DOI 10.1016/j.preteyeres.2018.04.004
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dipasquale V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10060684
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fraiz LD, 2018, VACCINE, V36, P165, DOI 10.1016/j.vaccine.2017.11.021
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Freitas BD, 2017, CURR OPIN OPHTHALMOL, V28, P595, DOI 10.1097/ICU.0000000000000420
   Gianni ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep16603
   Graham KA, 2017, MMWR-MORBID MORTAL W, V66, P125, DOI 10.15585/mmwr.mm6605a1
   Guevara Jade Gieseke, 2018, J Med Case Rep, V12, P161, DOI 10.1186/s13256-018-1679-y
   HACK M, 1991, NEW ENGL J MED, V325, P231, DOI 10.1056/NEJM199107253250403
   Harris SR, 2015, CAN FAM PHYSICIAN, V61, P680
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Herrera-Anaya E, 2016, DEV MED CHILD NEUROL, V58, P936, DOI 10.1111/dmcn.13108
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Howard A, 2018, EMERG INFECT DIS, V24, P625, DOI 10.3201/eid2404.171545
   JAN C, 1978, B SOC PATHOL EXOT, V71, P140
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Khawar W, 2017, CUREUS, V9, DOI 10.7759/cureus.1099
   Kwok T'ng Chang, 2018, BMJ Paediatr Open, V2, pe000262, DOI 10.1136/bmjpo-2018-000262
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leandro CG, 2016, DEV MED CHILD NEUROL, V58, P893, DOI 10.1111/dmcn.13134
   Lessen R, 2015, J ACAD NUTR DIET, V115, P444, DOI 10.1016/j.jand.2014.12.014
   Luksic B, 2017, INT MED CASE REP J, V10, P117, DOI 10.2147/IMCRJ.S130210
   Macchini F, 2018, CLIN ENDOSC, V51, P260, DOI 10.5946/ce.2017.137
   Madad S, 2018, DISASTER MED PUBLIC, V6, P1
   Madad SS, 2016, MMWR-MORBID MORTAL W, V65, P1161, DOI 10.15585/mmwr.mm6542a2
   Mann TZ, 2018, PAEDIATR PERINAT EP, V32, P358, DOI 10.1111/ppe.12478
   Marchand V, 1998, Gastrointest Endosc Clin N Am, V8, P669
   Marchand V, 2006, J PEDIATR GASTR NUTR, V43, P123, DOI 10.1097/01.mpg.0000228124.93841.ea
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Marquezan MC, 2018, SURV OPHTHALMOL, V63, P166, DOI 10.1016/j.survophthal.2017.06.001
   McArthur MA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060143
   McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i855
   MCCRAE AWR, 1982, T ROY SOC TROP MED H, V76, P552, DOI 10.1016/0035-9203(82)90161-4
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Minar P, 2011, J PEDIATR GASTR NUTR, V53, P293, DOI 10.1097/MPG.0b013e318215c41b
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moffitt KB, 2016, BIRTH DEFECTS RES A, V106, P155, DOI 10.1002/bdra.23470
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Morain SR, 2017, NEW ENGL J MED, V377, P1505, DOI 10.1056/NEJMp1707273
   Moreira J, 2017, CLIN MICROBIOL INFEC, V23, P296, DOI 10.1016/j.cmi.2016.12.027
   Morens DM, 2017, J INFECT DIS, V216, pS857, DOI 10.1093/infdis/jix383
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Musso D, 2016, LANCET, V387, P1993, DOI 10.1016/S0140-6736(16)30428-7
   Neubauer V, 2013, ACTA PAEDIATR, V102, P883, DOI 10.1111/apa.12319
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P739, DOI [10.15585/mmwr.mm6529e1, 10.15585/mmwr.mm6539e1]
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Olusanya BO, 2012, NIGER J CLIN PRACT, V15, P142, DOI 10.4103/1119-3077.97288
   Olusanya BO, 2012, J FAM COMMUNITY MED, V19, P113, DOI 10.4103/2230-8229.98298
   Olusanya BO, 2012, INT HEALTH, V4, P128, DOI 10.1016/j.inhe.2011.12.006
   Pan American Health Organization (PAHO), 2017, REG ZIK EP UPD AM MA
   Penagini F, 2015, NUTRIENTS, V7, P9400, DOI 10.3390/nu7115469
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Quitadamo P, 2016, EUR J PAEDIATR NEURO, V20, P810, DOI 10.1016/j.ejpn.2016.05.019
   Ramenghi LA, 2007, J PEDIATR GASTR NUTR, V45, pS143, DOI 10.1097/01.mpg.0000302960.63052.fa
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Ricci D, 2008, EARLY HUM DEV, V84, P107, DOI 10.1016/j.earlhumdev.2007.03.010
   Romano C, 2018, DEV MED CHILD NEUROL, V60, P892, DOI 10.1111/dmcn.13921
   Romano C, 2017, J PEDIATR GASTR NUTR, V65, P242, DOI 10.1097/MPG.0000000000001646
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Russell S, 2017, PLOS CURR, V9, DOI 10.1371/currents.outbreaks.cd76717676629d47704170ecbdb5f820
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Sampathkumar P, 2016, MAYO CLIN PROC, V91, P514, DOI 10.1016/j.mayocp.2016.02.017
   Samuel G, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-4991-3
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Shiu C, 2018, EMERG INFECT DIS, V24, P1, DOI 10.3201/eid2401.170979
   SIMPSON D. I. H., 1964, TRANS ROY SOC TROP MED HYG, V58, P335, DOI 10.1016/0035-9203(64)90201-9
   Singh RK, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00087
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Squiers L, 2018, AM J TROP MED HYG, V98, P1837, DOI 10.4269/ajtmh.17-0898
   Srivastava R, 2010, PEDIATR ANN, V39, P225, DOI 10.3928/00904481-20100318-07
   STEVENSON RD, 1995, DEV MED CHILD NEUROL, V37, P124
   Tang BL, 2016, ARCH MICROBIOL, V198, P595, DOI 10.1007/s00203-016-1268-7
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   US Department of Health and Human Services, 2011, SURG GEN CALL ACT SU
   Valentine G, 2016, EXPERT REV ANTI-INFE, V14, P1127, DOI 10.1080/14787210.2016.1245614
   van den Engel-Hoek Lenie, 2015, J Neuromuscul Dis, V2, P357
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Wheeler AC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201495
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   White Hazel L, 2016, J Natl Black Nurses Assoc, V27, P46
   White MK, 2016, ANN NEUROL, V80, P479, DOI 10.1002/ana.24748
   WHO UNICEF, 2014, GLOB NUTR TARG 2025
   Wolford RW, 2018, ZIKA VIRUS
   World Health Organization, 2016, INF FEED AR ZIK VIR
   World Health Organization Regional Office for the Western Pacific Zika Incident Management, 2018, ZIK VIR CLASS TABL
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zacharias N, 2017, AJP REP, V7, P68, DOI 10.1055/s-0037-1601890
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 135
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0883-5691
EI 1550-5146
J9 TOP CLIN NUTR
JI Top. Clin. Nutr.
PD APR-JUN
PY 2020
VL 35
IS 2
BP 154
EP 167
DI 10.1097/TIN.0000000000000204
PG 14
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA LB7BO
UT WOS:000524787100008
DA 2020-07-08
ER

PT J
AU Quintana, VM
   Selisko, B
   Brunetti, JE
   Eydoux, C
   Guillemot, JC
   Canard, B
   Damonte, EB
   Julander, JG
   Castilla, V
AF Quintana, V. M.
   Selisko, B.
   Brunetti, J. E.
   Eydoux, C.
   Guillemot, J. C.
   Canard, B.
   Damonte, E. B.
   Julander, J. G.
   Castilla, V.
TI Antiviral activity of the natural alkaloid anisomycin against dengue and
   Zika viruses
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Flavivirus; Dengue; Zika; Anisomycin; Antiviral; p38
ID INDUCED APOPTOSIS; IN-VITRO; CELLS; DEHYDROEPIANDROSTERONE; INHIBITION;
   ANALOGS; NS5
AB Flaviviruses constitute a public health concern because of their global burden and the lack of specific antiviral treatment. Here we investigated the antiviral activity of the alkaloid anisomycin against dengue (DENV) and Zika (ZIKV) viruses. At non-cytotoxic concentrations, anisomycin strongly inhibited the replication of reference strains and clinical isolates of all DENV serotypes and Asian and African strains of ZIKV in Vero cells. Anisomycin also prevented DENV and ZIKV multiplication in human cell lines. While initial steps of DENV and ZIKV replicative cycle were unaffected, a high inhibition of viral protein expression was demonstrated after treatment with anisomycin. DENV RNA synthesis was strongly reduced in anisomycin treated cultures, but the compound did not exert a direct inhibitory effect on 2' O-methyltransferase or RNA polymerase activities of DENV NS5 protein. Furthermore, anisomycin-mediated activation of p38 signaling was not related to the antiviral action of the compound. The evaluation of anisomycin efficacy in a mouse model of ZIKV morbidity and mortality revealed that animals treated with a low dose of anisomycin exhibited a significant reduction in viremia levels and died significantly later than the control group. This protective effect was lost at higher doses, though. In conclusion, anisomycin is a potent and selective in vitro inhibitor of DENV and ZIKV that impairs a post-entry step of viral replication; and a low-dose anisomycin treatment may provide some minimal benefit in a mouse model.
C1 [Quintana, V. M.; Brunetti, J. E.; Damonte, E. B.; Castilla, V.] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Lab Virol,Dept Quim Biol,IQUIBICEN, Ciudad Univ,Pabellon 2,Piso 4, RA-1428 Buenos Aires, DF, Argentina.
   [Selisko, B.; Eydoux, C.; Guillemot, J. C.; Canard, B.] CNRS, 163 Ave Luminy, F-13288 Marseille 9, France.
   [Selisko, B.; Eydoux, C.; Guillemot, J. C.; Canard, B.] AMU, Lab Architecture & Fonct Macromol Biol AFMB, UMR 7257, 163 Ave Luminy, F-13288 Marseille 9, France.
   [Julander, J. G.] Utah State Univ, Inst Antiviral Res, Logan, UT 84322 USA.
RP Castilla, V (corresponding author), Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Lab Virol,Dept Quim Biol,IQUIBICEN, Ciudad Univ,Pabellon 2,Piso 4, RA-1428 Buenos Aires, DF, Argentina.
EM vmquintana@qb.fcen.uba.ar; barbara.selisko@afmb.univ-mrs.fr;
   jebrunetti@qb.fcen.uba.ar; cecilia.eydoux@afmb.univ-mrs.fr;
   jean-claude.guillemot@afmb.univ-mrs.fr; Bruno.Canard@afmb.univ-mrs.fr;
   edamonte@qb.fcen.uba.ar; justin.julander@usu.edu; viviana@qb.fcen.uba.ar
FU UBAUniversity of Buenos Aires [20020170100363BA]; ANPCyTANPCyT [PICT
   2015 3080]; CONICETConsejo Nacional de Investigaciones Cientificas y
   Tecnicas (CONICET) [PIP 0338]; National Institute of Allergy and
   Infectious Diseases, NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID)
   [HHSN272201700041I/HHSN27200004, Task A11]; Fulbright -BungeBorn
   Foundation; Company of Biologists
FX This work was supported by grants from UBA (20020170100363BA), ANPCyT
   (PICT 2015 3080), CONICET (PIP 0338), National Institute of Allergy and
   Infectious Diseases, NIH (contract HHSN272201700041I/HHSN27200004, Task
   A11). VMQ received Fulbright -Bunge&Born Foundation and The Company of
   Biologists fellowships. VMQ and JEB are fellows and EBD is researcher
   from CONICET.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Benmansour F, 2016, EUR J MED CHEM, V109, P146, DOI 10.1016/j.ejmech.2015.12.046
   Brunetti JE, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040199
   Carpp LN, 2014, MOL CELL PROTEOMICS, V13, P2836, DOI 10.1074/mcp.M114.038984
   Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019
   Chang CC, 2005, J GEN VIROL, V86, P2513, DOI 10.1099/vir.0.81123-0
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Coutard B, 2014, ANTIVIR RES, V106, P61, DOI 10.1016/j.antiviral.2014.03.013
   Croons V, 2009, J PHARMACOL EXP THER, V329, P856, DOI 10.1124/jpet.108.149948
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Garcia C.G., 2017, FRONT ANTIINFECT DRU, V7, P45
   Growcott EJ, 2018, J MED MICROBIOL, V67, P452, DOI 10.1099/jmm.0.000684
   Guarner J., 2019, SEMIN DIAGN PATHOL, P30041
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   HALL SS, 1983, J MED CHEM, V26, P469, DOI 10.1021/jm00358a003
   Hori T, 2008, CHEM-BIOL INTERACT, V172, P125, DOI 10.1016/j.cbi.2007.12.003
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Liu Y, 2014, LEUKEMIA LYMPHOMA, V55, P2179, DOI 10.3109/10428194.2013.866664
   LYNCH JE, 1954, ANTIBIOT CHEMOTHER, V4, P899
   Nikaido M, 2019, HISTOCHEM CELL BIOL, V151, P369, DOI 10.1007/s00418-018-1736-z
   Quintana VM, 2016, ANTIVIR RES, V134, P26, DOI 10.1016/j.antiviral.2016.08.018
   Roth H, 2017, MBIO, V8
   Selisko B, 2006, VIROLOGY, V351, P145, DOI 10.1016/j.virol.2006.03.026
   Stadheim TA, 2002, LEUKEMIA RES, V26, P55, DOI 10.1016/S0145-2126(01)00099-6
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Talarico LB, 2007, VIROLOGY, V363, P473, DOI 10.1016/j.virol.2007.01.043
   Tang ZL, 2012, TOXICOL LETT, V208, P1, DOI 10.1016/j.toxlet.2011.10.001
   Teramoto T, 2017, J BIOL CHEM, V292, P9465, DOI [10.1074/jbc.M117.775643, 10.1074/jbc.m117.775643]
   Torres NI, 2012, ANTIVIR RES, V95, P37, DOI 10.1016/j.antiviral.2012.05.002
   Wanisch K, 2008, NEUROBIOL LEARN MEM, V90, P485, DOI 10.1016/j.nlm.2008.02.007
   Whitby K, 2005, J VIROL, V79, P8698, DOI 10.1128/JVI.79.14.8698-8706.2005
   Zhang L, 2019, EMERG MICROBES INFEC, V8, P232, DOI 10.1080/22221751.2018.1559707
   Zou J, 2019, CURR OPIN VIROL, V35, P19, DOI 10.1016/j.coviro.2019.01.005
NR 35
TC 0
Z9 0
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD APR
PY 2020
VL 176
AR 104749
DI 10.1016/j.antiviral.2020.104749
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RW
UT WOS:000523597500005
PM 32081740
DA 2020-07-08
ER

PT J
AU Norman, FF
   Henriquez-Camacho, C
   Diaz-Menendez, M
   Chamorro, S
   Pou, D
   Molina, I
   Goikoetxea, J
   Rodriguez-Guardado, A
   Calabuig, E
   Crespillo, C
   Oliveira, I
   Perez-Molina, JA
   Lopez-Velez, R
AF Norman, Francesca F.
   Henriquez-Camacho, Cesar
   Diaz-Menendez, Marta
   Chamorro, Sandra
   Pou, Diana
   Molina, Israel
   Goikoetxea, Josune
   Rodriguez-Guardado, Azucena
   Calabuig, Eva
   Crespillo, Clara
   Oliveira, Ines
   Perez-Molina, Jose-Antonio
   Lopez-Velez, Rogelio
CA Redivi Study Grp
TI Imported Arbovirus Infections in Spain, 2009-2018
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID ZIKA VIRUS-DISEASE; CHIKUNGUNYA; DENGUE; TRANSMISSION; RECIPIENT;
   PATIENT; SEX
AB To determine the epidemiologic and clinical characteristics of patients in Spain with imported arbovirus infections, we analyzed 22,655 records from a collaborative network for January 2009-December 2018. Among 861 arbovirus infections, 845 were monoinfections (456 [53%] dengue, 280 [32.5%] chikungunya, 109 [12.7%] Zika) and 16 (1.8%) were co-infections. Most patients were travelers (56.3%) or immigrants returning to Spain after visiting friends or relatives (31.3%). Median patient age was 37 years; most (62.3%) were women and some (28.6%) had received pretravel advice. Only 12 patients were immunosuppressed. Six cases (all dengue monoinfections, none in immunosuppressed patients) were severe. Since 2014, nondengue arbovirus infections increased; until 2016, chikungunya and Zika were most common. Imported arbovirus infections (mostly dengue) were frequently diagnosed, although increased chikungunya and Zika virus infections coincided with their introduction and spread in the Americas. A large proportion of cases occurred in women of childbearing age, some despite receipt of pretravel advice.
C1 [Norman, Francesca F.; Henriquez-Camacho, Cesar; Chamorro, Sandra; Perez-Molina, Jose-Antonio; Lopez-Velez, Rogelio] Ramon y Cajal Univ Hosp, Madrid, Spain.
   [Diaz-Menendez, Marta; Crespillo, Clara] La Paz Carlos III Hosp, Madrid, Spain.
   [Pou, Diana; Molina, Israel; Oliveira, Ines] Vall dHebron Drassanes, Barcelona, Spain.
   [Goikoetxea, Josune] Cruces Univ Hosp, Bilbao, Spain.
   [Rodriguez-Guardado, Azucena] Asturias Cent Univ Hosp, Oviedo, Spain.
   [Calabuig, Eva] La Fe Valencia Univ Hosp, Valencia, Spain.
RP Norman, FF (corresponding author), Ramon & Cajal Hosp, Infect Dis Dept, Natl Referral Unit Trop Dis, Carretera Colmenar Km 9 1, Madrid 28034, Spain.
EM ffnorman@gmail.com
OI Perez-Molina, Jose Antonio/0000-0001-8735-4124
FU Red de Investigaci6n Colaborativa de Enfermedades Tropicales
   [16/0027/0020]
FX Redivi is supported by the Red de Investigaci6n Colaborativa de
   Enfermedades Tropicales, grant no. 16/0027/0020.
CR Bordi L, 2018, EMERG INFECT DIS, V24, P178, DOI 10.3201/eid2401.171605
   Calvet GA, 2016, J CLIN VIROL, V74, P1, DOI 10.1016/j.jcv.2015.11.014
   Calvet GA, 2018, JAIDS-J ACQ IMM DEF, V79, P237, DOI [10.1097/QAI.0000000000001777, 10.1097/qai.0000000000001777]
   Christian KA, 2017, HEALTH SECUR, V15, P453, DOI 10.1089/hs.2017.0004
   Collantes F, 2016, ACTA TROP, V164, P64, DOI 10.1016/j.actatropica.2016.08.023
   Delgado-Enciso I, 2018, EXP THER MED, V15, P2634, DOI 10.3892/etm.2017.5668
   Delgado-Enciso I, 2017, AM J TROP MED HYG, V96, P122, DOI 10.4269/ajtmh.16-0477
   European Centre for Disease Control and Prevention, 2018, COMM DIS THREATS REP
   European Centre for Disease Prevention and Control, 2019, SEX TRANSM DENG SPAI
   European Centre for Disease Prevention and Control, LOC TRANSM DENG FEV
   European Centre for Disease Prevention and Control, 2019, AUT CAS DENG SPAIN F
   Gallichotte EN, 2018, CELL REP, V25, P1214, DOI 10.1016/j.celrep.2018.10.006
   Gasperina DD, 2015, TRANSPL INFECT DIS, V17, P876, DOI 10.1111/tid.12453
   Grubaugh ND, 2019, NAT MICROBIOL, V4, P10, DOI 10.1038/s41564-018-0296-2
   Gupta RK, 2016, J CLIN EXP HEPATOL, V6, P59, DOI 10.1016/j.jceh.2016.01.005
   Hamer DH, 2017, ANN INTERN MED, V166, P913, DOI 10.7326/L17-0195
   Koeltz A, 2018, EMERG INFECT DIS, V24, P794, DOI 10.3201/eid2404.161536
   Leder K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185689
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Machado CM, 2017, BLOOD ADV, V1, P624, DOI 10.1182/bloodadvances.2016003285
   Norman FF, 2016, AM J TROP MED HYG, V95, P1166, DOI 10.4269/ajtmh.16-0426
   Paixao ES, 2018, EMERG INFECT DIS, V24, P1748, DOI 10.3201/eid2409.170361
   Peters CMM, 2018, J VECTOR DIS, V55, P137, DOI 10.4103/0972-9062.242561
   Polen KD, 2018, MMWR-MORBID MORTAL W, V67, P868, DOI 10.15585/mmwr.mm6731e2
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rosso F, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12978
   Schwartzmann PV, 2017, MAYO CLIN PROC, V92, P460, DOI 10.1016/j.mayocp.2016.12.019
   Silva MMO, 2019, CLIN INFECT DIS, V69, P1353, DOI 10.1093/cid/ciy1083
   Subbiah A, 2018, TRANSPL INFECT DIS, V20, DOI 10.1111/tid.12875
   Sulleiro E, 2019, TRAVEL MED INFECT DI, V29, P69, DOI 10.1016/j.tmaid.2019.03.006
   Vouga M, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz077
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Weerakkody RM, 2017, BMC NEPHROL, V18, DOI 10.1186/s12882-016-0428-y
   White SK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006505
   World Health Organization, 2005, WHO STAT 5 M EM COMM
   World Health Organization (WHO) and the Special Programme for Research and Training in Tropical diseases (TDR), DENG GUID DIAGN TREA
NR 36
TC 0
Z9 0
U1 1
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2020
VL 26
IS 4
BP 658
EP 666
DI 10.3201/eid2604.190443
PG 9
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LA7XJ
UT WOS:000524156300003
PM 32186486
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Mina, MJ
   Guterman, LB
   Allen, KE
   Omer, SB
AF Mina, Michael J.
   Guterman, L. Beryl
   Allen, Kristen E.
   Omer, Saad B.
TI Comprehensive Profiling of Zika Virus Risk with Natural and Artificial
   Mitigating Strategies, United States
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID PUERTO-RICO; OUTBREAK; DENGUE; FLORIDA
AB Zika virus is transitioning to become a long-term public health challenge, and countries should remain informed of the risk for emergence. We developed a stochastic epidemiologic model to profile risk for Zika virus emergence, including trimester-specific fetal risk across time, in all 3,208 counties in the United States, including Puerto Rico. Validation against known transmission in North America demonstrated accuracy to predict epidemic dynamics and absolute case counts across scales (R-2 = 0.98). We found that, although sporadic single transmission events could occur in most US counties, outbreaks will likely be restricted to the Gulf Coast region and to late spring through autumn. Seasonal fluctuations in birth rates will confer natural population-level protection against early-trimester infections. Overall, outbreak control will be more effective and efficient than prevention, and vaccination will be most effective at >70% coverage. Our county-level risk profiles should serve as a critical resource for resource allocation.
C1 [Mina, Michael J.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA.
   [Mina, Michael J.] Harvard Med Sch, Boston, MA 02115 USA.
   [Guterman, L. Beryl] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14203 USA.
   [Guterman, L. Beryl; Allen, Kristen E.] Emory Univ, Atlanta, GA 30322 USA.
   [Omer, Saad B.] Yale Inst Global Hlth, New Haven, CT USA.
   [Omer, Saad B.] Yale Sch Med, New Haven, CT USA.
   [Omer, Saad B.] Yale Sch Publ Hlth, New Haven, CT USA.
RP Guterman, LB (corresponding author), Univ Buffalo, Sch Med & Biomed Sci, 955 Main St, Buffalo, NY 14203 USA.
EM lberylguterman@gmail.com
CR Alshammari SA, 2018, INT J HEALTH SCI-IJH, V12, P77
   ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Cao Y, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2745299
   Castro LA, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2394-9
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Centers for Disease Control and Prevention, 2016, EST RANG AED ALB AED
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Dirlikov E, 2016, MMWR-MORBID MORTAL W, V65, P910, DOI 10.15585/mmwr.mm6534e1
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ellington SR, 2016, JAMA PEDIATR, V170, P940, DOI 10.1001/jamapediatrics.2016.2974
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Florida Department of Health, ZIK VIR
   Gerardin P, 2017, LANCET, V389, P151, DOI 10.1016/S0140-6736(17)30014-4
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hall V, 2018, MMWR-MORBID MORTAL W, V67, P265, DOI 10.15585/mmwr.mm6709a1
   Hay JA, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006991
   Jaenisch T, 2017, B WORLD HEALTH ORGAN, V95, P191, DOI [10.2471/BLT.16.178608, 10.2471/blt.16.178608]
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   McNeil Jr Donald G., 2016, NY TIMES
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Moody-Geissler S, 2013, 2014 CSTE ANN C NASH
   Pacheco O, 2016, NEW ENGL J MED
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Phadke VK, 2016, JAMA-J AM MED ASSOC, V315, P1149, DOI 10.1001/jama.2016.1353
   Puerto Rico Department of Health, WEEKL REP ARB DIS ZI
   Radke EG, 2012, EMERG INFECT DIS, V18, P135, DOI 10.3201/eid1801.110130
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Sun KY, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1185-5
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   World Health Organization, WHO RESP ZIK VIR
NR 37
TC 0
Z9 0
U1 0
U2 0
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2020
VL 26
IS 4
BP 700
EP 710
DI 10.3201/eid2604.181739
PG 11
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LA7XJ
UT WOS:000524156300008
PM 32043959
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Naik, S
   Robinson, ML
   Alexander, M
   Chandanwale, A
   Sambarey, P
   Kinikar, A
   Bharadwaj, R
   Sapkal, GN
   Chebrolu, P
   Deshpande, P
   Kulkarni, V
   Nimkar, S
   Mave, V
   Gupta, A
   Mathad, J
AF Naik, Shilpa
   Robinson, Matthew L.
   Alexander, Mallika
   Chandanwale, Ajay
   Sambarey, Pradip
   Kinikar, Aarti
   Bharadwaj, Renu
   Sapkal, Gajanan N.
   Chebrolu, Puja
   Deshpande, Prasad
   Kulkarni, Vandana
   Nimkar, Smita
   Mave, Vidya
   Gupta, Amita
   Mathad, Jyoti
TI Intensified Short Symptom Screening Program for Dengue Infection during
   Pregnancy, India
SO EMERGING INFECTIOUS DISEASES
LA English
DT Article
ID VERTICAL TRANSMISSION; COMPLICATIONS; OUTCOMES; RISK
AB Mosquitoborne diseases (e.g., malaria, dengue, and chikungunya) are endemic to India and pose diagnostic challenges during pregnancy. We evaluated an intensified short symptom screening program in India to diagnose dengue during pregnancy. During October 2017-January 2018, we screened pregnant women during antenatal surveillance for symptoms of mosquitoborne diseases (fever only, fever with conjunctivitis, fever with rash, or all 3 symptoms) within the previous 15 days. Of 5,843 pregnant women screened, 52 were enrolled and tested for dengue, chikungunya, and Zika viruses by using a Trioplex real-time reverse transcription PCR. Of 49 who had complete results, 7 (14%) were dengue positive. Of these, ocular pain was seen in 4 (57%) and conjunctivitis in 7 (100%). Intensified symptom screening using conjunctivitis, in addition to rash, in pregnant women with fever might improve dengue case detection and can be included in routine symptom screening during pregnancy.
C1 [Naik, Shilpa; Chandanwale, Ajay; Sambarey, Pradip; Kinikar, Aarti; Bharadwaj, Renu] Byramjee Jeejeebhoy Govt Med Coll, Pune, Maharashtra, India.
   [Naik, Shilpa; Chandanwale, Ajay; Sambarey, Pradip; Kinikar, Aarti; Bharadwaj, Renu] Sassoon Gen Hosp, Main Bldg,3rd Fl, Pune 411001, Maharashtra, India.
   [Robinson, Matthew L.; Gupta, Amita] Johns Hopkins Sch Med, Baltimore, MD USA.
   [Alexander, Mallika; Deshpande, Prasad; Kulkarni, Vandana; Nimkar, Smita; Mave, Vidya] Byramjee Jeejeebhoy Govt Med Coll, Johns Hopkins Clin Trials Unit, Pune, Maharashtra, India.
   [Sapkal, Gajanan N.] Natl Inst Virol, Pune, Maharashtra, India.
   [Chebrolu, Puja; Mathad, Jyoti] Weill Cornell Med Coll, New York, NY USA.
RP Naik, S (corresponding author), Sassoon Gen Hosp, Main Bldg,3rd Fl, Pune 411001, Maharashtra, India.; Naik, S (corresponding author), Byramjee Jeejeebhoy Med Coll, Dept Obstet & Gynaecol, Main Bldg,3rd Fl, Pune 411001, Maharashtra, India.
EM shilunnaik@yahoo.co.in
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [UM1AI069465, R01HD081929,
   K23AI129854, UMlAI104681, D43TW009574]; Kellen Foundation; Ujala
   Foundation; Gilead FoundationGilead Sciences; Wyncote Foundation
FX This study was supported, in part, by the National Institute of Allergy
   and Infectious Diseases, National Institutes of Health (grants
   UM1AI069465 and R01HD081929 to A.G., grant K23AI129854 to J.M., grant
   UMlAI104681 to M.L.R., and grant D43TW009574 to R.B.), as well as the
   Kellen Foundation, the Ujala Foundation, the Gilead Foundation, and the
   Wyncote Foundation.
CR Adam I, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-153
   Agrawal P, 2014, INDIAN J CLIN PRACTI, V24, P1053
   Basurko C, 2018, AM J TROP MED HYG, V98, P1826, DOI 10.4269/ajtmh.16-0794
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Beltran-Silva S. L., 2018, REV MED HOSP GEN MEX, V81, P146, DOI [10.1016/j.hgmx.2016.09.011, DOI 10.1016/J.HGMX.2016.09.011]
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carles G, 2016, LANCET INFECT DIS, V16, P765, DOI 10.1016/S1473-3099(16)00130-4
   Centers for Disease Control and Prevention, 2019, DENG LAB GUID DIAGN
   Centers for Disease Control and Prevention, 2019, DENG TEST GUID US
   Centers for Disease Control and Prevention, SYMPT WHAT DO YOU TH
   Chan DPL, 2006, EMERG INFECT DIS, V12, P285
   Chansamouth V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004577
   Chitra TV, 2011, J VECTOR DIS, V48, P210
   Friedman EE, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003226
   Ganeshkumar P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006618
   Gehlot H, 2017, INT J REPROD CONTRAC, V6, P3414, DOI [10.18203/2320-1770.ijrcog20173454, DOI 10.18203/2320-1770.IJRCOG20173454]
   Guabiraba R, 2014, IMMUNOLOGY, V141, P143, DOI 10.1111/imm.12188
   Kanakalatha DH, 2016, INT J REPROD CONTRAC, V5, P3959
   Machado CR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002217
   Machain-Williams C, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9643083
   Malhotra N, 2006, INT J GYNECOL OBSTET, V94, P131, DOI 10.1016/j.ijgo.2006.05.002
   Morgan-Ortiz Fred, 2014, Ginecol Obstet Mex, V82, P401
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pouliot SH, 2010, OBSTET GYNECOL SURV, V65, P107, DOI 10.1097/OGX.0b013e3181cb8fbc
   Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006
   Santiago GA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03772-1
   Seet RCS, 2007, J CLIN VIROL, V38, P101, DOI 10.1016/j.jcv.2006.11.002
   Sharma Swati, 2016, Infect Dis Obstet Gynecol, V2016, P5046091, DOI 10.1155/2016/5046091
   Sirinavin S, 2004, PEDIATR INFECT DIS J, V23, P1042, DOI 10.1097/01.inf.0000143644.95692.0e
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Waduge R, 2006, J CLIN VIROL, V37, P27, DOI 10.1016/j.jcv.2006.06.002
   WHO, 2018, DENG SEV DENG
   Yip VCH, 2012, OPHTHALMOL THER, V1, DOI 10.1007/s40123-012-0002-z
   Zhang H, 2017, MATH PROBL ENG, V2017, DOI 10.1155/2017/9843735
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 35
TC 0
Z9 0
U1 1
U2 1
PU CENTERS  DISEASE CONTROL & PREVENTION
PI ATLANTA
PA 1600 CLIFTON RD, ATLANTA, GA 30333 USA
SN 1080-6040
EI 1080-6059
J9 EMERG INFECT DIS
JI Emerg. Infect. Dis
PD APR
PY 2020
VL 26
IS 4
BP 738
EP 743
DI 10.3201/eid2604.191476
PG 6
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA LA7XJ
UT WOS:000524156300012
PM 32186485
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kwock, JT
   Handfield, C
   Suwanpradid, J
   Hoang, P
   McFadden, MJ
   Labagnara, KF
   Floyd, L
   Shannon, J
   Uppala, R
   Sarkar, MK
   Gudjonsson, JE
   Corcoran, DL
   Lazear, HM
   Sempowski, G
   Horner, SM
   MacLeod, AS
AF Kwock, Jeffery T.
   Handfield, Chelsea
   Suwanpradid, Jutamas
   Hoang, Peter
   McFadden, Michael J.
   Labagnara, Kevin F.
   Floyd, Lauren
   Shannon, Jessica
   Uppala, Ranjitha
   Sarkar, Mrinal K.
   Gudjonsson, Johann E.
   Corcoran, David L.
   Lazear, Helen M.
   Sempowski, Gregory
   Horner, Stacy M.
   MacLeod, Amanda S.
TI IL-27 signaling activates skin cells to induce innate antiviral proteins
   and protects against Zika virus infection
SO SCIENCE ADVANCES
LA English
DT Article
ID T-CELLS; GRANZYME-B; RIG-I; EXPRESSION; BETA; DIFFERENTIATION;
   PROLIFERATION; KERATINOCYTES; REPLICATION; MEMORY
AB In the skin, antiviral proteins and other immune molecules serve as the first line of innate antiviral defense. Here, we identify and characterize the induction of cutaneous innate antiviral proteins in response to IL-27 and its functional role during cutaneous defense against Zika virus infection. Transcriptional and phenotypic profiling of epidermal keratinocytes treated with IL-27 demonstrated activation of antiviral proteins OAS1, OAS2, OASL, and MX1 in the skin of both mice and humans. IL-27-mediated antiviral protein induction was found to occur in a STAT1- and IRF3-dependent but STAT2-independent manner. Moreover, using IL27ra mice, we demonstrate a significant role for IL-27 in inhibiting Zika virus morbidity and mortality following cutaneous, but not intravenous, inoculation. Together, our results demonstrate a critical and previously unrecognized role for IL-27 in cutaneous innate antiviral immunity against Zika virus.
C1 [Kwock, Jeffery T.; Handfield, Chelsea; Suwanpradid, Jutamas; Hoang, Peter; Floyd, Lauren; Shannon, Jessica; MacLeod, Amanda S.] Duke Univ, Dept Dermatol, Med Ctr, Durham, NC 27710 USA.
   [McFadden, Michael J.; Labagnara, Kevin F.; Horner, Stacy M.; MacLeod, Amanda S.] Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.
   [Shannon, Jessica; MacLeod, Amanda S.] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27710 USA.
   [Uppala, Ranjitha; Sarkar, Mrinal K.; Gudjonsson, Johann E.] Univ Michigan, Sch Med, Dept Dermatol, Ann Arbor, MI 48109 USA.
   [Corcoran, David L.] Duke Univ, Duke Ctr Genom & Computat Biol, Med Ctr, Durham, NC 27710 USA.
   [Lazear, Helen M.] Univ N Carolina, Dept Microbiol & Immunol, Sch Med, Chapel Hill, NC 27516 USA.
   [Sempowski, Gregory] Duke Univ, Duke Human Vaccine Inst, Sch Med, Durham, NC 27710 USA.
   [Sempowski, Gregory] Duke Univ, Duke Global Hlth Inst, Sch Med, Durham, NC 27705 USA.
RP MacLeod, AS (corresponding author), Duke Univ, Dept Dermatol, Med Ctr, Durham, NC 27710 USA.; MacLeod, AS (corresponding author), Duke Univ, Dept Mol Genet & Microbiol, Med Ctr, Durham, NC 27710 USA.; MacLeod, AS (corresponding author), Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27710 USA.
EM amanda.macleod@duke.edu
OI Kwock, Jeffery/0000-0002-0343-2453; Hoang, Peter/0000-0001-6259-5300;
   Horner, Stacy/0000-0002-9351-7409; Sarkar, Mrinal/0000-0001-8505-4259;
   McFadden, Michael/0000-0003-0303-6968; Shannon,
   Jessica/0000-0002-5309-9214; Handfield, Chelsea/0000-0003-4162-578X
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01 AI139207, R21AI139207,
   R21NS100545, R21AI129851, T32-CA009111, NIAMS P30-AR075043]; Dermatology
   Foundation Award; Duke PhysicianScientist Strong Start Award; Silab
   company partnership grant; NIH, National Institute of Allergy and
   Infectious DiseasesUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [UC6-AI058607]; Eugene A. Stead
   Student Research Fellowship; Poindexter Fellowship; Burroughs Wellcome
   FundBurroughs Wellcome Fund [1016810]
FX This work was supported by funds from NIH R01 AI139207 and R21AI139207
   (to A.S.M.). A.S.M. is/was supported by a Dermatology Foundation Award,
   a Duke PhysicianScientist Strong Start Award, and a Silab company
   partnership grant. NIH grants R21NS100545 (to S.M.H.), R21AI129851 (to
   S.M.H.), T32-CA009111 (M.J.M.), and NIAMS P30-AR075043 (to J.E.G.)
   provided additional support. The Virology Unit of the Duke Regional
   Biocontainment Laboratory received partial support for construction from
   the NIH, National Institute of Allergy and Infectious Diseases
   (UC6-AI058607). J.T.K. and C.H. were supported by the Eugene A. Stead
   Student Research Fellowship. C.H. was also supported by the Poindexter
   Fellowship. S.M.H. has an Investigator in the Pathogenesis of Infectious
   Disease Award from the Burroughs Wellcome Fund (1016810).
CR Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Bernard E, 2015, VIROLOGY, V476, P1, DOI 10.1016/j.virol.2014.11.013
   Cao YX, 2008, J IMMUNOL, V180, P922, DOI 10.4049/jimmunol.180.2.922
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chihara N, 2018, NATURE, V558, P454, DOI 10.1038/s41586-018-0206-z
   de Magalhaes-Barbosa MC, 2016, TRAVEL MED INFECT DI, V14, P458, DOI 10.1016/j.tmaid.2016.09.006
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   Drappier M, 2015, CURR OPIN VIROL, V15, P19, DOI 10.1016/j.coviro.2015.07.002
   Duangkhae P, 2018, J INVEST DERMATOL, V138, P618, DOI 10.1016/j.jid.2017.10.018
   Eyerich S, 2009, J CLIN INVEST, V119, P3573, DOI 10.1172/JCI40202
   Fakruddin JM, 2007, BLOOD, V109, P1841, DOI 10.1182/blood-2006-02-001578
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hamano S, 2003, IMMUNITY, V19, P657, DOI 10.1016/S1074-7613(03)00298-X
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Handfield C, 2018, TRENDS IMMUNOL, V39, P328, DOI 10.1016/j.it.2018.02.003
   Harker JA, 2018, J VIROL, V92, DOI 10.1128/JVI.02196-17
   Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004
   Hu W, 2015, P NATL ACAD SCI USA, V112, P13994, DOI 10.1073/pnas.1510760112
   Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]
   Kumar NP, 2015, IMMUN INFLAMM DIS, V3, P289, DOI 10.1002/iid3.68
   Kuo YP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006417
   Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010
   Lazear HM, 2019, IMMUNITY, V50, P907, DOI 10.1016/j.immuni.2019.03.025
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118
   Liang SC, 2006, J EXP MED, V203, P2271, DOI 10.1084/jem.20061308
   Liu ZZ, 2013, EUR J IMMUNOL, V43, P468, DOI 10.1002/eji.201242930
   Lucas S, 2003, P NATL ACAD SCI USA, V100, P15047, DOI 10.1073/pnas.2536517100
   MacLeod AS, 2016, ADV WOUND CARE, V5, P65, DOI 10.1089/wound.2014.0608
   MacLeod AS, 2013, J CLIN INVEST, V123, P4364, DOI 10.1172/JCI70064
   MacLeod DT, 2015, J INVEST DERMATOL, V135, P142, DOI 10.1038/jid.2014.330
   Mittal A, 2012, IMMUNOL CELL BIOL, V90, P831, DOI 10.1038/icb.2012.14
   Morishima N, 2005, J IMMUNOL, V175, P1686, DOI 10.4049/jimmunol.175.3.1686
   Pennock ND, 2014, P NATL ACAD SCI USA, V111, P16472, DOI 10.1073/pnas.1407393111
   Peters A, 2015, J IMMUNOL, V195, P4144, DOI 10.4049/jimmunol.1302246
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Refaat A, 2018, ONCOL LETT, V15, P4753, DOI 10.3892/ol.2018.8014
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Schneider R, 2011, EUR J IMMUNOL, V41, P47, DOI 10.1002/eji.201040804
   Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231
   Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sorensen OE, 2005, J IMMUNOL, V174, P4870, DOI 10.4049/jimmunol.174.8.4870
   Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458
   Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11
   Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07
   Villarino A, 2003, IMMUNITY, V19, P645, DOI 10.1016/S1074-7613(03)00300-5
   Wojno EDT, 2019, IMMUNITY, V50, P851, DOI 10.1016/j.immuni.2019.03.011
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yang B, 2017, J INVEST DERMATOL, V137, P1166, DOI 10.1016/j.jid.2017.01.010
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087
   Yoshida H, 2015, ANNU REV IMMUNOL, V33, P417, DOI 10.1146/annurev-immunol-032414-112134
   Zhu JZ, 2014, IMMUNITY, V40, P936, DOI 10.1016/j.immuni.2014.05.007
NR 58
TC 0
Z9 0
U1 3
U2 3
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 2375-2548
J9 SCI ADV
JI Sci. Adv.
PD APR
PY 2020
VL 6
IS 14
AR eaay3245
DI 10.1126/sciadv.aay3245
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KZ5KZ
UT WOS:000523302400007
PM 32270034
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chattu, VK
   Yaya, S
AF Chattu, Vijay Kumar
   Yaya, Sanni
TI Emerging infectious diseases and outbreaks: implications for women's
   reproductive health and rights in resource-poor settings
SO REPRODUCTIVE HEALTH
LA English
DT Editorial Material
DE Sexual and reproductive health and rights (SRHRs); Emerging and
   re-emerging infectious diseases (EIDs); Low; and middle-income countries
   (LMICs); Sustainable developmental goals (SDGs); Gender; Women;
   Covid-19; Ebola; Zika; SARS
ID EBOLA
AB This century is witnessing dramatic changes in the health needs of the world's populations. The double burden of infectious and chronic diseases constitutes major causes of morbidity and mortality. Over the last two decades, there has been a rise in infectious diseases, including the severe acute respiratory syndrome virus (SARS), the H1N1 pandemic influenza, the Ebolavirus and the Covid-19 virus. These diseases have rapidly spread across the world and have reminded us of the unprecedented connectivity that defines our modern civilization. Though some countries have made substantial progress toward improving global surveillance for emerging infectious diseases (EIDs), the vast majority of Low-and Middle-income Countries (LMICs) with fragile health systems and various system-related bottlenecks remain vulnerable to outbreaks and, as such, experience dramatic social and economic consequences when they are reported. Lessons learned from past outbreaks suggest that gender inequalities are common across a range of health issues relating to Sexual and Reproductive Health and Rights (SRHR), with women being particularly disadvantaged, partially due to the burden placed on them. Though these countries are striving to improve their health systems and be more inclusive to this vulnerable group, the national/ global outbreaks have burdened the overall system and thus paralyzed normal services dedicated to the delivery of Sexual and Reproductive Health (SRH) services. In this paper, we discuss the global commitments to SRH, the impact of the EIDs on the LMICs, the failure in the delivery of SRH services, and the strategies for successful implementation of recovery plans that must address the specific and differentiated needs of women and girls in resource-poor settings.
C1 [Chattu, Vijay Kumar] Univ Toronto, Dept Med, Toronto, ON, Canada.
   [Chattu, Vijay Kumar] St Michaels Hosp, Occupat Med Clin, Unity Hlth Toronto, Toronto, ON, Canada.
   [Chattu, Vijay Kumar] Global Inst Publ Hlth, Thiruvananthapuram, Kerala, India.
   [Yaya, Sanni] Univ Ottawa, Fac Social Sci, Sch Int Dev & Global Studies, Ottawa, ON, Canada.
   [Yaya, Sanni] Univ Oxford, George Inst Global Hlth, Oxford, England.
RP Yaya, S (corresponding author), Univ Ottawa, Fac Social Sci, Sch Int Dev & Global Studies, Ottawa, ON, Canada.; Yaya, S (corresponding author), Univ Oxford, George Inst Global Hlth, Oxford, England.
EM sanni.yaya@uOttawa.ca
RI Karabulut, Erman/G-6679-2011; Chattu, Vijay Kumar/C-2778-2014
OI Karabulut, Erman/0000-0002-0787-905X; Chattu, Vijay
   Kumar/0000-0001-9840-8335
CR African Development Bank, WOM RES INT GEND RES
   Ahmed Z, 2020, COVID 19 OUTBREAK PO
   [Anonymous], 2015, ARES701 UN
   [Anonymous], 2015, RAP ASS EB IMP REPR
   Chattu Vijay Kumar, 2017, J Family Med Prim Care, V6, P463, DOI 10.4103/jfmpc.jfmpc_75_17
   Ghebreyesus TA, 2018, LANCET, V391, P2583, DOI 10.1016/S0140-6736(18)30901-2
   Hewlett BS, 2003, EMERG INFECT DIS, V9, P1242
   Jamieson DJ, 2014, OBSTET GYNECOL, V124, P1005, DOI 10.1097/AOG.0000000000000533
   Johns Hopkins Medicine, WHAT AR EM INF DIS
   Kamara J, 2014, WE CAN NO LONGER IGN
   McKay G., 2019, NOT ALL BLEEDS IS EB
   Sikka V, 2016, J GLOB INFECT DIS, V8, P3, DOI 10.4103/0974-777X.176140
   Starrs AM, 2018, LANCET, V391, P2642, DOI 10.1016/S0140-6736(18)30293-9
   UNDP, AFR HUM DEV EMPL REP
   UNDP, CONFR GEND IMP EB VI
   UNICEF, 2014, SIERR LEON HLTH FAC
   *WHO, 2009, PAND H1N1 2009 UPD 7
   WHO, 2014, BRIEF GUID EM INF DI
   World Health Organization, COR DIS 2019 COV 19
   World Health Organization (WHO), 2020, SUMM TABL SARS CAS C
NR 20
TC 0
Z9 0
U1 16
U2 16
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD APR 1
PY 2020
VL 17
IS 1
AR 43
DI 10.1186/s12978-020-0899-y
PG 5
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KZ8AO
UT WOS:000523481300001
PM 32238177
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cassaniti, I
   Percivalle, E
   Adzasehoun, KMG
   Comolli, G
   Baldanti, F
AF Cassaniti, Irene
   Percivalle, Elena
   Adzasehoun, Kodjo Messan Guy
   Comolli, Giuditta
   Baldanti, Fausto
TI Dengue Virus-Specific Humoral and T Cellular Immune Response in Italian
   Residents and Travelers Returning from Endemic Areas
SO VECTOR-BORNE AND ZOONOTIC DISEASES
LA English
DT Article
DE Dengue virus; Zika virus; T cell response; ELISpot; NS3 protein
ID ORIGINAL ANTIGENIC SIN; ZIKA VIRUS; CROSS-REACTIVITY; ANTIBODIES;
   DISEASE; CD4(+); REGION; PCR
AB Dengue virus (DENV), a member of the family Flaviviridae, is the causative agent of dengue fever, the most prevalent mosquito-borne viral illness in humans, representing a major public health concern in the tropical countries. Although humoral immunity to DENV has been extensively studied and widely used, little is known about the potential diagnostic use of T cell response for DENV diagnosis. The aim of our study was to characterize the T cell immunity in subjects with acute or past DENV infection, using an original and easy to perform ex vivo ELISpot assay, and to evaluate the role of cross-reactivity between the four DENV serotypes and between DENV and Zika virus (ZIKV). As controls, DENV-seronegative healthy subjects were enrolled and a cutoff of positive DENV-specific T cell response was calculated. DENV-specific T cell response for at least one DENV serotype was detected among all DENV-specific neutralization positive subject. Furthermore, our data showed that in acute DENV infection, the DENV-specific effector memory T cell response against the relevant serotype was predominant. However, a high level of cross-reactivity among all DENV serotypes was also documented. DENV-specific T cell response was almost undetectable among DENV-seronegative subjects with ZIKV acute infection, supporting the hypothesis that the assay could be useful in differential diagnosis between ZIKV and DENV infection.
C1 [Cassaniti, Irene; Percivalle, Elena; Adzasehoun, Kodjo Messan Guy; Comolli, Giuditta; Baldanti, Fausto] Fdn IRCCS Policlin San Matteo, Microbiol & Virol Dept, Mol Virol Unit, Pavia, Italy.
   [Comolli, Giuditta] Fdn IRCCS Policlin San Matteo, Expt Res Labs, Biotechnol Area, Pavia, Italy.
   [Baldanti, Fausto] Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, I-27100 Pavia, Italy.
RP Baldanti, F (corresponding author), Univ Pavia, Dept Clin Surg Diagnost & Pediat Sci, I-27100 Pavia, Italy.
EM f.baldanti@smatteo.pv.it
RI Cassaniti, Irene/Y-9946-2019
OI Cassaniti, Irene/0000-0002-3385-2088; ADZASEHOUN, KODJO MESSAN
   GUY/0000-0003-3790-4225
CR Appanna R, 2007, CLIN VACCINE IMMUNOL, V14, P969, DOI 10.1128/CVI.00069-07
   Coller BAG, 2011, CURR OPIN IMMUNOL, V23, P391, DOI 10.1016/j.coi.2011.03.005
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Imrie A, 2007, J VIROL, V81, P10081, DOI 10.1128/JVI.00330-07
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Malavige GN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020581
   Malavige GN, 2004, POSTGRAD MED J, V80, P588, DOI 10.1136/pgmj.2004.019638
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Moran E, 2008, EUR J IMMUNOL, V38, P1050, DOI 10.1002/eji.200737699
   Olkowski S, 2013, J INFECT DIS, V208, P1026, DOI 10.1093/infdis/jit273
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Scaramozzino N, 2001, J CLIN MICROBIOL, V39, P1922, DOI 10.1128/JCM.39.5.1922-1927.2001
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Timiryasova TM, 2013, AM J TROP MED HYG, V88, P962, DOI 10.4269/ajtmh.12-0461
   Wallace D, 2013, CURR OPIN VIROL, V3, P352, DOI 10.1016/j.coviro.2013.05.014
   Weaver SC, 2009, INFECT GENET EVOL, V9, P523, DOI 10.1016/j.meegid.2009.02.003
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Xu X, 2016, NAT STRUCT MOL BIOL, V23, P456
   Zompi S, 2013, P NATL ACAD SCI USA, V110, P8761, DOI 10.1073/pnas.1306333110
NR 24
TC 2
Z9 2
U1 1
U2 1
PU MARY ANN LIEBERT, INC
PI NEW ROCHELLE
PA 140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN 1530-3667
EI 1557-7759
J9 VECTOR-BORNE ZOONOT
JI Vector-Borne Zoonotic Dis.
PD APR 1
PY 2020
VL 20
IS 4
BP 295
EP 302
DI 10.1089/vbz.2019.2515
PG 8
WC Public, Environmental & Occupational Health; Infectious Diseases
SC Public, Environmental & Occupational Health; Infectious Diseases
GA KY5WF
UT WOS:000522643200008
PM 31821105
DA 2020-07-08
ER

PT J
AU Ades, AE
   Thorne, C
   Soriano-Arandes, A
   Peckham, CS
   Brown, DW
   Lang, D
   Morris, JG
   Christie, CDC
   Giaquinto, C
AF Ades, A. E.
   Thorne, Claire
   Soriano-Arandes, Antoni
   Peckham, Catherine S.
   Brown, David W.
   Lang, Daniel
   Morris, J. Glenn
   Christie, Celia D. C.
   Giaquinto, Carlo
TI Researching Zika in pregnancy: lessons for global preparedness
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID CONGENITAL CYTOMEGALOVIRUS-INFECTION; TO-CHILD TRANSMISSION;
   HUMAN-IMMUNODEFICIENCY-VIRUS; UPDATE INTERIM GUIDANCE; PRENATAL
   TREATMENT; US TERRITORIES; HIV PREVALENCE; BIRTH-DEFECTS; UNITED-STATES;
   INFANTS BORN
AB Our understanding of congenital infections is based on prospective studies of women infected during pregnancy. The EU has funded three consortia to study Zika virus, each including a prospective study of pregnant women. Another multi-centre study has been funded by the US National Institutes of Health. This Personal View describes the study designs required to research Zika virus, and questions whether funding academics in the EU and USA to work with collaborators in outbreak areas is an effective strategy. 3 years after the 2015-16 Zika virus outbreaks, these collaborations have taught us little about vertical transmission of the virus. In the time taken to approve funding, agree contracts, secure ethics approval, and equip laboratories, Zika virus had largely disappeared. By contrast, prospective studies based on local surveillance and standard-of-care protocols have already provided valuable data. Threats to fetal and child health pose new challenges for global preparedness requiring support for the design and implementation of locally appropriate protocols. These protocols can answer the key questions earlier than externally designed studies and at lower cost. Local protocols can also provide a framework for recruitment of unexposed controls that are required to study less specific outcomes. Other priorities include accelerated development of non-invasive tests, and longer-term storage of neonatal and antenatal samples to facilitate retrospective reconstruction of cohort studies.
C1 [Ades, A. E.] Univ Bristol, Dept Populat Hlth Sci, Med Sch, Bristol BS8 2PS, Avon, England.
   [Thorne, Claire; Peckham, Catherine S.] UCL, Great Ormond St Inst Child Hlth, Populat Policy & Practice Programme, London, England.
   [Soriano-Arandes, Antoni] Hosp Univ Vall dHebron, Vall dHebron Res Inst, Pediat Infect Dis & Immunodeficiencies Unit, Barcelona, Spain.
   [Brown, David W.] Fundacao Oswaldo Cruz, Flavivirus Reference Lab, Rio De Janeiro, Brazil.
   [Lang, Daniel] Fdn Penta Onlus, Sao Paulo, Brazil.
   [Morris, J. Glenn] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Christie, Celia D. C.] Univ West Indies, Dept Child & Adolescent Hlth, Mona Campus, Kingston, Jamaica.
   [Giaquinto, Carlo] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy.
RP Ades, AE (corresponding author), Univ Bristol, Dept Populat Hlth Sci, Med Sch, Bristol BS8 2PS, Avon, England.
EM t.ades@bristol.ac.uk
RI Arandes, Antonio Soriano/Q-3348-2016
OI Arandes, Antonio Soriano/0000-0001-9613-7228; GIAQUINTO,
   CARLO/0000-0001-9365-0413
FU European Union's Horizon 2020 research and innovation programme [734857]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation programme under grant agreement No 734857. The
   sponsors had no role in the origination or writing of the report. We
   thank Tom Byrne for assistance in preparing the manuscript for
   publication.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Ades AE, 1999, AIDS, V13, P2437, DOI 10.1097/00002030-199912030-00016
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   AHLFORS K, 1982, ACTA PAEDIATR SCAND, V71, P109, DOI 10.1111/j.1651-2227.1982.tb09380.x
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Belete W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210866
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cardenas I, 2010, J IMMUNOL, V185, P1248, DOI 10.4049/jimmunol.1000289
   Carnicer-Pont D, 2015, GAC SANIT, V29, P347, DOI 10.1016/j.gaceta.2015.01.012
   Centers for Disease Control and Prevention, 2017, PROL IGM ANT RESP PE
   College National de Gynecologues at Obstetriciens Francais, 2016, VIR ZIKA FEMM ENC AG
   Conners EE, 2018, OBSTET GYNECOL, V132, P487, DOI [10.1097/AOG.0000000000002737, 10.1097/aog.0000000000002737]
   Dunn DT, 1996, J AM STAT ASSOC, V91, P935, DOI 10.2307/2291712
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gilbert RE, 2001, INT J EPIDEMIOL, V30, P1303, DOI 10.1093/ije/30.6.1303
   Gras L, 2001, INT J EPIDEMIOL, V30, P1309, DOI 10.1093/ije/30.6.1309
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Haddad LB, 2018, CLIN OBSTET GYNECOL, V61, P186, DOI 10.1097/GRF.0000000000000332
   Haut Conseil de la Sante Publique, 2016, AV REL ACT AV HCSP 2
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Jin L, 2002, B WORLD HEALTH ORGAN, V80, P76
   Kluberg Sheryl A, 2016, Emerg Infect Dis, V22, pE1, DOI 10.3201/eid2210.151956
   Koopmans M, 2019, LANCET INFECT DIS, V19, pE59, DOI 10.1016/S1473-3099(18)30497-3
   Korndewal MJ, 2016, EPIDEMIOL INFECT, V144, P1520, DOI 10.1017/S0950268815002708
   Krubiner Carleigh B, 2019, Vaccine, DOI 10.1016/j.vaccine.2019.01.011
   Li X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0095004, 10.1371/journal.pone.0098139]
   Mandelbrot L, 1996, AM J OBSTET GYNECOL, V175, P661
   Manikkavasagan G, 2010, EMERG INFECT DIS, V16, P1532, DOI 10.3201/eid1610.100560
   Ministerio da Saude Brasil, 2016, PROT AT SAUD RESP OC
   Ministerio da Saude Brasil, 2016, DIR EST PREC CRIANC
   MOK JQ, 1987, LANCET, V1, P1164
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oppenheim B, 2019, BMJ GLOB HEALTH, V4, P1
   Pacheco Oscar, 2016, N Engl J Med, DOI 10.1056/NEJMoa1604037
   Paixao ES, 2017, LANCET INFECT DIS, V17, P957, DOI 10.1016/S1473-3099(17)30366-3
   Pan American Health Organization WHO, 2017, ZIK EP UPD
   Pan American Health Organization WHO, 2015, EP AL ZIK VIR INF
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   PECKHAM CS, 1983, LANCET, V1, P1352
   Peeling RW, 2019, LANCET INFECT DIS, V19, pE172, DOI 10.1016/S1473-3099(18)30594-2
   Petersen EE, 2016, MMWR-MORBID MORTAL W, V65, P30, DOI 10.15585/mmwr.mm6502e1
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   PREECE PM, 1983, ARCH DIS CHILD, V58, P970, DOI 10.1136/adc.58.12.970
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Resti M, 1998, BMJ-BRIT MED J, V317, P437, DOI 10.1136/bmj.317.7156.437
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2
   Roa M, 2016, LANCET, V387, P843, DOI 10.1016/S0140-6736(16)00331-7
   Rodo C, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.02.008
   Rodo C, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2017.09.022
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Roth DAE, 2017, ARCH DIS CHILD-FETAL, V102, pF519, DOI 10.1136/archdischild-2016-311859
   Sands P, 2016, NEW ENGL J MED, V374, P1281, DOI 10.1056/NEJMsr1600236
   Schaub B, 2017, LANCET INFECT DIS, V17, P520, DOI [10.1016/S1473-3099(17)30102-0, 10.1016/s1473-3099(17)30102-0]
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   STAGNO S, 1982, NEW ENGL J MED, V306, P945, DOI 10.1056/NEJM198204223061601
   STAGNO S, 1986, JAMA-J AM MED ASSOC, V256, P1904, DOI 10.1001/jama.256.14.1904
   Subdireccio General de Vigilancia i Resposta a Emergencies de Salut Publica, 2016, PROT ACT DAV CAS FEB
   Therrell BL, 2015, SEMIN PERINATOL, V39, P171, DOI 10.1053/j.semperi.2015.03.002
   Thiebaut R, 2007, LANCET, V369, P115
   Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   WHO, 2016, SCREEN ASS MAN NEON
   WHO, 2016, PREGN MAN CONT ZIK V
   Wilder-Smith A, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1398485
   Wilson JMG, 1968, PRINCIPLES PRACTICE
NR 73
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD APR
PY 2020
VL 20
IS 4
BP E61
EP E68
DI 10.1016/S1473-3099(20)30021-9
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA KX7KB
UT WOS:000522055100006
PM 32085848
DA 2020-07-08
ER

PT J
AU Singh, S
   Singh, PK
   Suhail, H
   Arumugaswami, V
   Pellett, PE
   Giri, S
   Kumar, A
AF Singh, Sneha
   Singh, Pawan Kumar
   Suhail, Hamid
   Arumugaswami, Vaithilingaraja
   Pellett, Philip E.
   Giri, Shailendra
   Kumar, Ashok
TI AMP-Activated Protein Kinase Restricts Zika Virus Replication in
   Endothelial Cells by Potentiating Innate Antiviral Responses and
   Inhibiting Glycolysis
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID DENGUE VIRUS; INFECTION; FETAL; TARGET; SENSOR; BRAZIL; RISK
AB Viruses are known to perturb host cellular metabolism to enable their replication and spread. However, little is known about the interactions between Zika virus (ZIKV) infection and host metabolism. Using primary human retinal vascular endothelial cells and an established human endothelial cell line, we investigated the role of AMP-activated protein kinase (AMPK), a master regulator of energy metabolism, in response to ZIKV challenge. ZIKV infection caused a time-dependent reduction in the active phosphorylated state of AMPK and of its downstream target acetyl-CoA carboxylase. Pharmacological activation of AMPK using 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), metformin, and a specific AMPK alpha activator (GSK621) attenuated ZIKV replication. This activity was reversed by an AMPK inhibitor (compound C). Lentivirus-mediated knockdown of AMPK and the use of AMPK alpha(-/-) mouse embryonic fibroblasts provided further evidence that AMPK has an antiviral effect on ZIKV replication. Consistent with its antiviral effect, AMPK activation potentiated the expression of genes with antiviral properties (e.g., IFNs, OAS2, ISG15, and MX/) and inhibited inflammatory mediators (e.g., TNF-alpha and CCL5). Bioenergetic analysis showed that ZIKV infection evokes a glycolytic response, as evidenced by elevated extracellular acidification rate and increased expression of key glycolytic genes (GLUT1, HK2, TPI, and MCT4); activation of AMPK by AICAR treatment reduced this response. Consistent with this, 2-deoxyglucose, an inhibitor of glycolysis, augmented AMPK activity and attenuated ZIKV replication. Thus, our study demonstrates that the anti-ZIKV effect of AMPK signaling in endothelial cells is mediated by reduction of viral-induced glycolysis and enhanced innate antiviral responses.
C1 [Singh, Sneha; Singh, Pawan Kumar; Kumar, Ashok] Wayne State Univ, Dept Ophthalmol Visual & Anat Sci, Detroit, MI 48201 USA.
   [Suhail, Hamid; Giri, Shailendra] Henry Ford Hlth Syst, Dept Neurol, Detroit, MI 48202 USA.
   [Arumugaswami, Vaithilingaraja] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.
   [Pellett, Philip E.; Kumar, Ashok] Wayne State Univ, Dept Biochem Microbiol & Immunol, Detroit, MI 48201 USA.
RP Kumar, A (corresponding author), Wayne State Univ, Sch Med, Dept Ophthalmol Visual & Anat Sci, 4717 St Antoine St, Detroit, MI 48201 USA.
EM akuma@med.wayne.edu
OI Giri, Shailendra/0000-0002-7123-829X; Singh, Pawan
   Kumar/0000-0001-5517-1120
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R21AI135583,
   R01EY026964, R01 EY027381]
FX This work was supported by the National Institutes of Health
   (R21AI135583, R01EY026964, and R01 EY027381). The funders had no role in
   study design, data collection, and interpretation, or the decision to
   submit the work for publication.
CR Abbasi Aziz-un-Nisa, 2016, J Ayub Med Coll Abbottabad, V28, P1
   Araujo AQC, 2016, BRAIN, V139, P2122, DOI 10.1093/brain/aww158
   Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Dalrymple N, 2011, J VIROL, V85, P9478, DOI 10.1128/JVI.05008-11
   Dar S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09206-0
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Fan KR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01464
   Fay JR, 2009, CANCER PREV RES, V2, P301, DOI 10.1158/1940-6207.CAPR-08-0166
   Fontaine KA, 2015, J VIROL, V89, P2358, DOI 10.1128/JVI.02309-14
   Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710
   Giri S, 2004, J NEUROSCI, V24, P479, DOI 10.1523/JNEUROSCI.4288-03.2004
   Han J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193031
   Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249
   Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013
   Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311
   Hardie DG, 2002, BIOCHEM SOC T, V30, P1064, DOI 10.1042/BST0301064
   He M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00722
   Jamil Z, 2016, ASIAN PAC J TROP MED, V9, P606, DOI 10.1016/j.apjtm.2016.05.020
   Jampol LM, 2016, JAMA OPHTHALMOL, V134, P535, DOI 10.1001/jamaophthalmol.2016.0284
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152
   Kirchner J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26102-3
   Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x
   Kumar A, 2016, CELL MICROBIOL, V18, P1815, DOI 10.1111/cmi.12625
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Li Y, 2014, INVEST OPHTH VIS SCI, V55, P4461, DOI 10.1167/iovs.14-14451
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Mangalam AK, 2016, J IMMUNOL, V197, P747, DOI 10.4049/jimmunol.1501549
   Mankouri J, 2011, REV MED VIROL, V21, P205, DOI 10.1002/rmv.687
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Moreira D, 2016, CURR DRUG TARGETS, V17, P942, DOI 10.2174/1389450116666150416120559
   Moser TS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002661
   Moshfeghi DM, 2016, JAMA OPHTHALMOL, V134, P945, DOI 10.1001/jamaophthalmol.2016.1303
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Oliver GF, 2019, CLIN EXP OPHTHALMOL, V47, P372, DOI 10.1111/ceo.13450
   Panchaud A, 2016, CLIN MICROBIOL REV, V29, P659, DOI 10.1128/CMR.00014-16
   Prantner D, 2017, J BIOL CHEM, V292, P292, DOI 10.1074/jbc.M116.763268
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Rao EY, 2016, ONCOTARGET, V7, P33783, DOI 10.18632/oncotarget.9277
   Ribeiro LS, 2016, CURR OPIN VIROL, V18, P76, DOI 10.1016/j.coviro.2016.04.002
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Rossi SL, 2016, CELL STEM CELL, V19, P4, DOI 10.1016/j.stem.2016.06.009
   Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633
   Saggerson D, 2008, ANNU REV NUTR, V28, P253, DOI 10.1146/annurev.nutr.28.061807.155434
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Sanchez EL, 2015, VIROLOGY, V479, P609, DOI 10.1016/j.virol.2015.02.038
   Shah A, 2016, NEUROTOX RES, V30, P131, DOI 10.1007/s12640-016-9635-3
   Silwal P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113495
   Singh PK, 2019, OCUL SURF, V17, P551, DOI 10.1016/j.jtos.2019.03.006
   Singh PK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29329-2
   Singh PK, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92340
   Singh S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100530
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Sujobert P, 2015, CELL REP, V11, P1446, DOI 10.1016/j.celrep.2015.04.063
   Tebbe C, 2014, ONCOTARGET, V5, P4746, DOI 10.18632/oncotarget.2012
   Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vogel G, 2016, SCIENCE, V352, P1375, DOI 10.1126/science.352.6292.1375
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Watts A. G, 2018, J TRAVEL MED, V26
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang BB, 2009, CELL METAB, V9, P407, DOI 10.1016/j.cmet.2009.03.012
   Zhao ZY, 2017, INVEST OPHTH VIS SCI, V58, P4355, DOI 10.1167/iovs.17-22016
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 73
TC 0
Z9 0
U1 4
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD APR 1
PY 2020
VL 204
IS 7
BP 1810
EP 1824
DI 10.4049/jimmunol.1901310
PG 15
WC Immunology
SC Immunology
GA KX2SF
UT WOS:000521730100011
PM 32086387
DA 2020-07-08
ER

PT J
AU Nascimento-Carvalho, GC
   Nascimento-Carvalho, EC
   VanDuijn, MM
   Ramos, CL
   Vilas-Boas, AL
   Moreno-Carvalho, OA
   Zeneyedpour, L
   Ferwerda, G
   de Groot, R
   Luider, TM
   Nascimento-Carvalho, CM
AF Nascimento-Carvalho, Gustavo C.
   Nascimento-Carvalho, Eduardo C.
   VanDuijn, Martijn M.
   Ramos, Clara L.
   Vilas-Boas, Ana-Luisa
   Moreno-Carvalho, Otavio A.
   Zeneyedpour, Lona
   Ferwerda, Gerben
   de Groot, Ronald
   Luider, Theo M.
   Nascimento-Carvalho, Cristiana M.
TI Cerebrospinal fluid immunoglobulins are increased in neonates exposed to
   Zika virus during foetal life
SO JOURNAL OF INFECTION
LA English
DT Article
DE Cerebrospinal fluid; Congenital Zika virus infection; Immunoglobulins;
   Mass spectrometry; Microcephaly
ID IGM
AB Objective: To compare immunoglobulin levels in cerebrospinal fluid (CSF) of neonates exposed to Zika virus (ZIKV) during foetal life (cases) with levels in CSF of control neonates.
   Methods: We identified 16 neonates who underwent lumbar puncture (LP), during the ZIKV epidemic (December/2015 to March/2016) whose mothers reported ZIKV clinical symptoms during gestation (cases). Congenital microcephaly was defined as head circumference <= 31.9cm (boys) and <= 31.5 cm (girls) for term neonates, or <= 2 standard deviations below the mean for premature (<37 weeks) neonates. Subsequently, we identified neonates who underwent LP in the same lab and fulfilled criteria to be controls: age <= 4 days, CSF white blood cell count <= 8/mm(3), CSF protein <= 132mg/dL, CSF red blood cell count <= 1,000/mm(3), neither central nervous system illness, nor congenital infection, nor microcephaly. CSF immunoglobulin concentrations were measured by mass spectrometry.
   Results: 13 controls were included. IgM, IgA, IgG, IgK, and IgL were significantly higher among cases (p < 0.001). Eight (50%) ZIKV exposed infants had congenital microcephaly. These showed the strongest immunoglobulin elevation of the IgM and IgA classes.
   Conclusion: Neonates exposed to ZIKV infection during gestation present with elevated distinct immunoglobulins in CSF, both in cases that developed microcephaly and in cases that did not. (C) 2020 Published by Elsevier Ltd on behalf of The British Infection Association.
C1 [Nascimento-Carvalho, Gustavo C.; Nascimento-Carvalho, Eduardo C.; Ramos, Clara L.; Vilas-Boas, Ana-Luisa] Bahiana Fdn Sci Dev, Bahiana Sch Med, BR-40290000 Salvador, BA, Brazil.
   [VanDuijn, Martijn M.; Zeneyedpour, Lona; Luider, Theo M.] Erasmus MC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands.
   [Moreno-Carvalho, Otavio A.] Jose Silveira Fdn, Cerebrospinal Fluid Lab, BR-40170100 Salvador, BA, Brazil.
   [Ferwerda, Gerben; de Groot, Ronald] Radboudumc, Sect Paediat Infect Dis, Lab Med Immunol, Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands.
   [Ferwerda, Gerben; de Groot, Ronald] Radboudumc, Radboud Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Paediat, Sch Med, Rua Prof Aristides Novis 105, BR-40210630 Salvador, BA, Brazil.
RP Nascimento-Carvalho, CM (corresponding author), Univ Fed Bahia, Paediat, Sch Med, Rua Prof Aristides Novis 105, BR-40210630 Salvador, BA, Brazil.
EM gcn.carvalho@hotmail.com; educn.carvalho@hotmail.com;
   m.m.vanduijn@erasmusmc.nl; ccclr1@gmail.com; anapediatria@ig.com.br;
   otavioliquor@hotmail.com; l.zeneyedpour@erasmusmc.nl;
   Gerben.ferwerda@radboudumc.nl; Ronald.deGroot@radboudumc.nl;
   t.luider@erasmusmc.nl; nascimentocarvalho@hotmail.com
OI van Duijn, Martijn/0000-0002-6654-994X
FU Brazilian Council for Scientific and Technological Development
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [313466/2018-1]
FX This work was supported by the Brazilian Council for Scientific and
   Technological Development (CNPq) [grant number 313466/2018-1]. CNPq did
   not have any role in study design, data collection, analysis and
   interpretation, in the writing of this article, nor in the decision to
   submit this article for publication.
CR Ben-Hur H, 2005, INT J MOL MED, V16, P401
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Castanha PMS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007246
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chimelli L, 2018, CHILD NERV SYST, V34, P95, DOI 10.1007/s00381-017-3651-3
   Chong J, 2019, METABOLITES, V9, DOI 10.3390/metabo9030057
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i595
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Kadkhoda K, 2017, DIAGN MICR INFEC DIS, V88, P233, DOI 10.1016/j.diagmicrobio.2017.04.002
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Pomar L, 2018, BMJ-BRIT MED J, V363, DOI 10.1136/bmj.k4431
   Ramos CL, 2018, J INFECTION, V76, P565, DOI 10.1016/j.jinf.2018.02.004
   Reiber H, 1998, MULT SCLER, V4, P99, DOI 10.1177/135245859800400302
NR 18
TC 0
Z9 0
U1 1
U2 1
PU W B SAUNDERS CO LTD
PI LONDON
PA 32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND
SN 0163-4453
EI 1532-2742
J9 J INFECTION
JI J. Infect.
PD APR
PY 2020
VL 80
IS 4
BP 419
EP 425
DI 10.1016/j.jinf.2020.01.006
PG 7
WC Infectious Diseases
SC Infectious Diseases
GA KW5XS
UT WOS:000521239700007
PM 31981639
DA 2020-07-08
ER

PT J
AU Labeau, A
   Simon-Loriere, E
   Hafirassou, ML
   Bonnet-Madin, L
   Tessier, S
   Zamborlini, A
   Dupre, T
   Seta, N
   Schwartz, O
   Chaix, ML
   Delaugerre, C
   Amara, A
   Meertens, L
AF Labeau, Athena
   Simon-Loriere, Etienne
   Hafirassou, Mohamed-Lamine
   Bonnet-Madin, Lucie
   Tessier, Sarah
   Zamborlini, Alessia
   Dupre, Thierry
   Seta, Nathalie
   Schwartz, Olivier
   Chaix, Marie-Laure
   Delaugerre, Constance
   Amara, Ali
   Meertens, Laurent
TI A Genome-Wide CRISPR-Cas9 Screen Identifies the Dolichol-Phosphate
   Mannose Synthase Complex as a Host Dependency Factor for Dengue Virus
   Infection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE dengue fever; dengue virus; N-glycosylation; Zika virus; dolichol-
   phosphate mannose; glycoprotein folding
ID N-LINKED GLYCOSYLATION; JAPANESE ENCEPHALITIS-VIRUS; ENVELOPE PROTEIN;
   NS1 PROTEIN; ZIKA VIRUS; GLYCOPROTEINS; GLYCANS; MUTANT;
   PHOSPHATIDYLSERINE; OLIGOSACCHARIDES
AB Dengue virus (DENV) is a mosquito-borne flavivirus responsible for dengue disease, a major human health concern for which no specific therapies are available. Like other viruses, DENV relies heavily on the host cellular machinery for productive infection. In this study, we performed a genome-wide CRISPRCas9 screen using haploid HAP1 cells to identify host genes important for DENV infection. We identified DPM1 and -3, two subunits of the endoplasmic reticulum (ER) resident dolichol-phosphate mannose synthase (DPMS) complex, as host dependency factors for DENV and other related flaviviruses, such as Zika virus (ZIKV). The DPMS complex catalyzes the synthesis of dolichol-phosphate mannose (DPM), which serves as mannosyl donor in pathways leading to N-glycosylation, glycosylphosphatidylinositol (GPI) anchor biosynthesis, and C- or O-mannosylation of proteins in the ER lumen. Mutation in the DXD motif of DPM1, which is essential for its catalytic activity, abolished DPMS-mediated DENV infection. Similarly, genetic ablation of ALG3, a mannosyltransferase that transfers mannose to lipid-linked oligosaccharide (LLO), rendered cells poorly susceptible to DENV. We also established that in cells deficient for DPMS activity, viral RNA amplification is hampered and truncated oligosaccharides are transferred to the viral prM and E glycoproteins, affecting their proper folding. Overall, our study provides new insights into the host-dependent mechanisms of DENV infection and supports current therapeutic approaches using glycosylation inhibitors to treat DENV infection.
   IMPORTANCE Dengue disease, which is caused by dengue virus (DENV), has emerged as the most important mosquito-borne viral disease in humans and is a major global health concern. DENV encodes only few proteins and relies on the host cell machinery to accomplish its life cycle. The identification of the host factors important for DENV infection is needed to propose new targets for antiviral intervention. Using a genome-wide CRISPR-Cas9 screen, we identified DPM1 and -3, two subunits of the DPMS complex, as important host factors for the replication of DENV as well as other related viruses such as Zika virus. We established that DPMS complex plays dual roles during viral infection, both regulating viral RNA replication and promoting viral structural glycoprotein folding/stability. These results provide insights into the host molecules exploited by DENV and other flaviviruses to facilitate their life cycle.
C1 [Labeau, Athena; Hafirassou, Mohamed-Lamine; Bonnet-Madin, Lucie; Tessier, Sarah; Zamborlini, Alessia; Chaix, Marie-Laure; Delaugerre, Constance; Amara, Ali; Meertens, Laurent] Univ Paris, Hop St Louis, Inst Rech St Louis, INSERM U944,CNRS,UMR 7212,Genomes & Cell Biol Dis, Paris, France.
   [Simon-Loriere, Etienne] Inst Pasteur, GS Evolutionary Genom RNA Viruses, Paris, France.
   [Zamborlini, Alessia] Univ Paris Saclay, Univ Paris Sud, I2BC, CEA,CNRS, Gif Sur Yvette, France.
   [Dupre, Thierry; Seta, Nathalie] Hop Bichat Claude Bernard, Lab Biochim, Paris, France.
   [Schwartz, Olivier] Inst Pasteur, Virus & Immun Unit, CNRS, UMR3569, Paris, France.
   [Chaix, Marie-Laure; Delaugerre, Constance] Hop St Louis, AP HP, Lab Virol, Paris, France.
   [Chaix, Marie-Laure; Delaugerre, Constance] Hop St Louis, AP HP, Dept Malad Infect, Paris, France.
RP Amara, A; Meertens, L (corresponding author), Univ Paris, Hop St Louis, Inst Rech St Louis, INSERM U944,CNRS,UMR 7212,Genomes & Cell Biol Dis, Paris, France.
EM ali.amara@inserm.fr; laurent.meertens@inserm.fr
OI AMARA, Ali/0000-0002-0283-1815; SCHWARTZ, OLIVIER/0000-0002-0729-1475
FU French Government's Investissement d'Avenir program, Laboratoire
   d'Excellence Integrative Biology of Emerging Infectious DiseasesFrench
   National Research Agency (ANR) [ANR-10-LABX-62-IBEID]; Investissements
   d'Avenir programFrench National Research Agency (ANR)
   [ANR-10-IHUB-0002]; INSERMInstitut National de la Sante et de la
   Recherche Medicale (Inserm); ANR INCEPTION program (Investissements
   d'Avenir grant)French National Research Agency (ANR) [ANR-16-CONV-0005];
   French Ministry of ResearchMinistry of Research, France; ZIKAHOST
   [ANR-15-CE15-00029]
FX Work in A.A.'s lab has received funding from the French Government's
   Investissement d'Avenir program, Laboratoire d'Excellence Integrative
   Biology of Emerging Infectious Diseases (grant ANR-10-LABX-62-IBEID),
   the Investissements d'Avenir program (ANR-10-IHUB-0002), ZIKAHOST
   (ANR-15-CE15-00029), and INSERM. E.S.-L. received funding from the ANR
   INCEPTION program (Investissements d'Avenir grant ANR-16-CONV-0005).
   A.L. is supported by a scholarship from the French Ministry of
   Research.; We thank Ralf Bartenschlager (Heidelberg, Germany) for
   providing us with the DENV Renilla luciferase reporter virus (DVR2A). We
   thank Louis Lambrechts for the DENV1 KDH0026A strain. We thank Dorothee
   Misse for providing us the human foreskin fibroblasts (HFF1) and the
   Genomic Platform (Gustave Roussy Cancer Campus) facility for sequencing.
CR Acosta EG, 2014, ADV VIRUS RES, V88, P1, DOI 10.1016/B978-0-12-800098-4.00001-5
   Aebi M, 1996, GLYCOBIOLOGY, V6, P439, DOI 10.1093/glycob/6.4.439
   Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bradel-Tretheway BG, 2015, J VIROL, V89, P7235, DOI 10.1128/JVI.00773-15
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Carnec X, 2016, J VIROL, V90, P92, DOI 10.1128/JVI.01849-15
   Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021
   Colussi PA, 1997, P NATL ACAD SCI USA, V94, P7873, DOI 10.1073/pnas.94.15.7873
   Crabtree MB, 2005, ARCH VIROL, V150, P771, DOI 10.1007/s00705-004-0430-8
   Cueva R, 1996, BBA-GEN SUBJECTS, V1289, P336, DOI 10.1016/0304-4165(95)00171-9
   Dejarnac O, 2018, CELL REP, V23, P1779, DOI 10.1016/j.celrep.2018.04.013
   Esapa CT, 2003, FEBS LETT, V555, P209, DOI 10.1016/S0014-5793(03)01230-4
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Fischl Wolfgang, 2013, Methods Mol Biol, V1030, P205, DOI 10.1007/978-1-62703-484-5_17
   Frenkel Z, 2003, J BIOL CHEM, V278, P34119, DOI 10.1074/jbc.M305929200
   Gandini R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00187-2
   Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hafirassou ML, 2017, CELL REP, V21, P3900, DOI 10.1016/j.celrep.2017.11.094
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hebert DN, 2014, NAT CHEM BIOL, V10, P902, DOI 10.1038/nchembio.1651
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Imbach T, 2000, J CLIN INVEST, V105, P233, DOI 10.1172/JCI8691
   Julithe R, 2014, J VIROL, V88, P9049, DOI 10.1128/JVI.01161-14
   Kim JM, 2008, J VIROL, V82, P7846, DOI 10.1128/JVI.00789-08
   Korner C, 1999, EMBO J, V18, P6816, DOI 10.1093/emboj/18.23.6816
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lavie M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00910
   Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4
   Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116
   Lin DL, 2017, MBIO, V8, DOI [10.1128/mBio.00939-17, 10.1128/mbio.00939-17]
   Maeda Y, 2000, EMBO J, V19, P2475, DOI 10.1093/emboj/19.11.2475
   Maeda Y, 2001, EMBO J, V20, P250, DOI 10.1093/emboj/20.1.250
   Maeda Y, 2008, BBA-GEN SUBJECTS, V1780, P861, DOI 10.1016/j.bbagen.2008.03.005
   Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Meertens L, 2019, NATURE, V574, P259, DOI 10.1038/s41586-019-1578-4
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Mohorko E, 2011, J INHERIT METAB DIS, V34, P869, DOI 10.1007/s10545-011-9337-1
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2
   Pfeffer S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14516
   Pryor MJ, 1998, J GEN VIROL, V79, P2631, DOI 10.1099/0022-1317-79-11-2631
   Puttikhunt C, 2008, J MED VIROL, V80, P125, DOI 10.1002/jmv.21047
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Scaturro P, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005277
   Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005
   Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005
   Shi XH, 2004, J VIROL, V78, P5414, DOI 10.1128/JVI.78.10.5414-5422.2004
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   SODORA DL, 1989, J VIROL, V63, P5184, DOI 10.1128/JVI.63.12.5184-5193.1989
   Tajima S, 2008, VIRUS GENES, V36, P323, DOI 10.1007/s11262-008-0211-7
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Whiteman MC, 2015, J VIROL, V89, P1474, DOI 10.1128/JVI.02215-14
   Yap SSL, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01415
   Zai J, 2013, ACTA VIROL, V57, P27, DOI 10.4149/av_2013_01_27
   Zeidler JD, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030042
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zheng A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001157
NR 62
TC 0
Z9 0
U1 8
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD APR
PY 2020
VL 94
IS 7
AR e01751-19
DI 10.1128/JVI.01751-19
PG 18
WC Virology
SC Virology
GA KW0CT
UT WOS:000520841800014
PM 31915280
DA 2020-07-08
ER

PT J
AU Nolasco, D
   Oliveira, J
AF Nolasco, Diogo
   Oliveira, Jonice
TI Mining social influence in science and vice-versa: A topic correlation
   approach
SO INTERNATIONAL JOURNAL OF INFORMATION MANAGEMENT
LA English
DT Article
DE Topic modeling; Social networks; Science networks; Topic labeling;
   Influence mining; Topic similarity
ID NETWORKS; MENDELEY; TWEETS; IMPACT
AB There is no doubt that scientific discoveries have always brought changes to society. New technologies help solve social problems such as transportation and education, while research brings benefits such as curing diseases and improving food production. Despite the impacts caused by science and society on each other, this relationship is rarely studied and they are often seen as different universes. Previous literature focuses only on a single domain, detecting social demands or research fronts for example, without ever crossing the results for new insights. In this work, we create a system that is able to assess the relationship between social and scholar data using the topics discussed in social networks and research topics. We use the articles as science sensors and humans as social sensors via social networks. Topic modeling algorithms are used to extract and label social subjects and research themes and then topic correlation metrics are used to create links between them if they have a significant relationship. The proposed system is based on topic modeling, labeling and correlation from heterogeneous sources, so it can be used in a variety of scenarios. We make an evaluation of the approach using a large-scale Twitter corpus combined with a PubMed article corpus. In both of them, we work with data of the Zika epidemic in the world, as this scenario provides topics and discussions on both domains. Our work was capable of discovering links between various topics of different domains, which suggests that some of the relationships can be automatically inferred by the sensors. Results can open new opportunities for forecasting social behavior, assess community interest in a scientific subject or directing research to the population welfare.
C1 [Nolasco, Diogo] Univ Fed Rio de Janeiro, Programa Posgrad Informat, Av Athos,Silveira Ramos,274 Bl CCMN NCE, Rio De Janeiro, RJ, Brazil.
   [Oliveira, Jonice] Univ Fed Rio de Janeiro, Dept Ciencia Comp, Av Athos,Silveira Ramos,274 Bl Room 1038 NCE, Rio De Janeiro, RJ, Brazil.
RP Nolasco, D (corresponding author), Univ Fed Rio de Janeiro, Programa Posgrad Informat, Av Athos,Silveira Ramos,274 Bl CCMN NCE, Rio De Janeiro, RJ, Brazil.
EM diogo.sousa@ppgi.ufrj.br; jonice@dcc.ufrj.br
FU CAPESCAPES; CNPqNational Council for Scientific and Technological
   Development (CNPq); FAPERJCarlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX The authors would like to thank CAPES, CNPq, and FAPERJ for supporting
   this work.
CR Antonacci G, 2017, J KNOWL MANAG, V21, P1218, DOI 10.1108/JKM-11-2016-0504
   Badilescu-Buga E, 2013, INFORM PROCESS MANAG, V49, P902, DOI 10.1016/j.ipm.2013.02.001
   BBC, 2016, BBC
   Berry M. W. J. K., 2010, TEXT MINING APPL THE, DOI [10.1002/9780470689646, DOI 10.1002/9780470689646]
   Blei D. M., 2009, TEXT MINING CLASSIFI, P71, DOI DOI 10.1145/1143844.1143859
   Blei D, 2010, IEEE SIGNAL PROC MAG, V27, P55, DOI 10.1109/MSP.2010.938079
   Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993
   Boutellier R., 2008, MANAGING GLOBAL INNO, DOI [10.1007/978-3-540-68952-2, DOI 10.1007/978-3-540-68952-2]
   Campos R., 2018, P BIDU VLDB SHORT PA
   Campos R, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON INFORMATION REUSE AND INTEGRATION (IRI), P193, DOI 10.1109/IRI.2018.00036
   Chaney A. J. B., 2012, P 6 INT AAAI C WEBL, P419
   Cinelli M, 2017, J COMPLEX NETW, V5, P694, DOI 10.1093/comnet/cnx002
   Colladon AF, 2019, INT J INFORM MANAGE, V48, P254, DOI 10.1016/j.ijinfomgt.2018.09.009
   Colladon AF, 2018, J BUS RES, V88, P150, DOI 10.1016/j.jbusres.2018.03.026
   Colladon AF, 2017, INFORM PROCESS MANAG, V53, P1287, DOI 10.1016/j.ipm.2017.07.001
   Correa A. C., 2018, P BIDU VLDB FULL PAP
   Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309
   da Saude P., 2016, SITUACAO EPIDEMIOLOG
   de Oliveira J., 2007, ADV FUZZY CLUSTERING, DOI [10.1002/9780470061190.fmatter/summary, DOI 10.1002/9780470061190]
   Fundacao Oswaldo Cruz R., 2007, MIDIA MEIO EMERGENCI
   Gloor P, 2017, J BUS RES, V75, P67, DOI 10.1016/j.jbusres.2017.02.010
   Gloor PA, 2017, COMPUT HUM BEHAV, V71, P343, DOI 10.1016/j.chb.2017.02.017
   GREENE D, 2014, MACHINE LEARNING KNO
   Hassan F. S.-U., 2013, J CHEM INF MODEL, V53, P1689, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]
   Haustein S, 2014, IT-INF TECHNOL, V56, P207, DOI 10.1515/itit-2014-1048
   He Q., 2009, P 18 ACM C INF KNOWL, V18, P957, DOI DOI 10.1145/1645953.1646076
   Holmberg K., 2014, MEANING ALTMETRICS
   Hric D, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.031038
   Hughes A. L., 2009, TWITTER ADOPTION USE
   Jiang JC, 2017, INFORM PROCESS MANAG, V53, P1, DOI 10.1016/j.ipm.2016.06.003
   Kim D, 2011, LECT NOTES COMPUT SC, V6609, P163, DOI 10.1007/978-3-642-19437-5_13
   KULLBACK S, 1951, ANN MATH STAT, V22, P79, DOI 10.1214/aoms/1177729694
   Lauand B., 2016, CONTEXTUALIZACAO INF
   Li W., 2006, P 23 INT C MACH LEAR, P577, DOI DOI 10.1145/1143844.1143917
   Loach T. V., 2015, ISSI 2015 15 INT SOC, V6, DOI [10.6084/m9.figshare.1461693, DOI 10.6084/M9.FIGSHARE.1461693]
   Maflahi N, 2016, J ASSOC INF SCI TECH, V67, P191, DOI 10.1002/asi.23369
   Mamede K., 2018, P BIDU VLDB SHORT PA
   Mann GS, 2006, OPENING INFORMATION HORIZONS, P65
   Martin-Martin A., 2016, COUNTING HOUSE MEASU, DOI [10.13140/RG.2.1.4814.4402, DOI 10.13140/RG.2.1.4814.4402]
   Masuda N., 2016, WORLD SCI, DOI [10.1142/q0033, DOI 10.1142/Q0033]
   Mayworm J. G., 2018, P BIDU VLDB FULL PAP
   Mohammadi E, 2015, J ASSOC INF SCI TECH, V66, P1832, DOI 10.1002/asi.23286
   Monsores L., 2019, P IEEE WIC ACM INT C
   Maia LFMP, 2019, CAD SAUDE PUBLICA, V35, DOI [10.1590/0102-311X00220217, 10.1590/0102-311x00220217]
   Newman D., 2010, LANG TECHNOL
   Newman M., 2018, NETWORKS
   Nolasco Diogo, 2017, 2017 IEEE 15th Intl Conf on Dependable, Autonomic and Secure Computing, 15th Intl Conf on Pervasive Intelligence and Computing, 3rd Intl Conf on Big Data Intelligence and Computing and Cyber Science and Technology Congress(DASC/PiCom/DataCom/CyberSciTech). Proceedings, P820, DOI 10.1109/DASC-PICom-DataCom-CyberSciTec.2017.139
   Nolasco D., 2018, PUBLISH POSTIDENTIFI
   Nolasco D, 2019, FUTURE GENER COMP SY, V93, P290, DOI 10.1016/j.future.2018.09.008
   Nolasco D, 2016, P ANN HICSS, P358, DOI 10.1109/HICSS.2016.51
   Oliveira J, 2014, SOC NETW, V3, P134
   Oliveira J, 2014, JMIR MHEALTH UHEALTH, V2, DOI 10.2196/mhealth.2543
   Pagan M., 2016, ZIKA VIRUS PODE SER
   Peel L, 2018, P NATL ACAD SCI USA, V115, P4057, DOI 10.1073/pnas.1713019115
   Perianes-Rodriguez A, 2010, SCIENTOMETRICS, V82, P307, DOI 10.1007/s11192-009-0040-z
   Ramage D., 2009, P 2009 C EMP METH NA, V1, P248, DOI DOI 10.3115/1699510.1699543
   Sakaki T., 2009, WWW2010
   Sampaio J. O., 2016, EXPERT SYSTEMS APPL, V70, P1
   Shibata N, 2008, TECHNOVATION, V28, P758, DOI 10.1016/j.technovation.2008.03.009
   Shibata N, 2009, J AM SOC INF SCI TEC, V60, P571, DOI 10.1002/asi.20994
   Sonnert G, 2002, IVORY BRIDGES CONNEC
   Steyvers M., 2004, P 10 ACM SIGKDD INT, V315
   Steyvers Mark, 2007, HDB LATENT SEMANTIC, V427, P424, DOI DOI 10.1109/MSP.2010.938079
   Stroele V, 2011, J UNIVERS COMPUT SCI, V17, P1951
   Takahashi B, 2015, COMPUT HUM BEHAV, V50, P392, DOI 10.1016/j.chb.2015.04.020
   Verbeek A, 2002, SCIENTOMETRICS, V54, P399, DOI 10.1023/A:1016034516731
   Wang D, 2014, PROCEEDINGS OF THE 13TH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS (IPSN' 14), P35, DOI 10.1109/IPSN.2014.6846739
   Wang X., 2009, P 2 ACM INT C WEB SE, P192, DOI [10.1145/1498759.1498826, DOI 10.1145/1498759.1498826]
   WHO, 2016, MAPP SOC SCI RES ZIK
   WHO, 2017, WHO ZIK VIR RES AG
   Wolisz A., 2014, P 13 INT S INF PROC
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   Zhao S., 2011, HUMAN REAL TIME SENS
NR 73
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0268-4012
EI 1873-4707
J9 INT J INFORM MANAGE
JI Int. J. Inf. Manage.
PD APR
PY 2020
VL 51
AR UNSP 102017
DI 10.1016/j.ijinfomgt.2019.10.002
PG 14
WC Information Science & Library Science
SC Information Science & Library Science
GA KQ3OC
UT WOS:000516835200016
DA 2020-07-08
ER

PT J
AU Kerkhof, K
   Falconi-Agapito, F
   Van Esbroeck, M
   Talledo, M
   Arien, KK
AF Kerkhof, Karen
   Falconi-Agapito, Francesca
   Van Esbroeck, Marjan
   Talledo, Michael
   Arien, Kevin K.
TI Reliable Serological Diagnostic Tests for Arboviruses: Feasible or
   Utopia?
SO TRENDS IN MICROBIOLOGY
LA English
DT Review
ID ZIKA VIRUS IGM; ANTIBODY-DEPENDENT ENHANCEMENT; LINKED IMMUNOSORBENT
   ASSAYS; DENGUE-FEVER; CHIKUNGUNYA; INFECTION; EPITOPES; DISEASES;
   EUROPE; NEUTRALIZATION
AB Infections with arthropod-bome viruses are increasing globally as a result of climate and demographic changes, global dispersion of insect vectors, and increased air travel. The similar symptomatology of arboviral diseases and the cocirculation of different arboviruses in Africa, Asia, and South America complicate diagnosis. Despite the high sensitivity and specificity of molecular diagnostic tests, their utility is limited to the short viremic phase of arbovirus infections, and therefore the diagnosis of infection is frequently missed in clinical practice. Conversely, the duration of antibody responses provides a wider window of opportunity, making diagnosis more dependent on IgM/IgG detection. This review discusses the issues underlying the low specificity of antibody-detection assays, and addresses the challenges and strategies for discovering more specific biomarkers to enable a more accurate diagnosis.
C1 [Kerkhof, Karen; Falconi-Agapito, Francesca; Arien, Kevin K.] Inst Trop Med, Dept Biomed Sci, Unit Virol, Antwerp, Belgium.
   [Van Esbroeck, Marjan] Inst Trop Med, Natl Reference Ctr Arboviruses, Dept Clin Sci, Antwerp, Belgium.
   [Falconi-Agapito, Francesca; Talledo, Michael] Univ Peruana Cayetano Heredia, Inst Med Trop Alexander von Humboldt, Mol Epidemiol Lab, Lima, Peru.
   [Arien, Kevin K.] Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
RP Arien, KK (corresponding author), Inst Trop Med, Dept Biomed Sci, Unit Virol, Antwerp, Belgium.; Arien, KK (corresponding author), Univ Antwerp, Dept Biomed Sci, Antwerp, Belgium.
EM karien@itg.be
OI Falconi, Francesca/0000-0003-2359-7439
FU 'Vlaanderen Agentschap innoveren and ondernemen' (VLAIO Innovation
   Mandate); Belgian Development Cooperation program [DGD-FA4]; European
   Union's Horizon 2020 research and innovation program, under the ZikaPLAN
   grant [734584.4]
FX K.K. is a postdoctoral fellow funded by the 'Vlaanderen Agentschap
   innoveren and ondernemen' (VLAIO Innovation Mandate). F.F-A. is a
   predoctoral candidate funded by the Belgian Development Cooperation
   program (DGD-FA4). K.K.A. received funding from the European Union's
   Horizon 2020 research and innovation program, under the ZikaPLAN grant
   agreement 734584.4.
CR Ahmad T. A., 2016, TRIALS VACCINOLOGY, V5, P71, DOI DOI 10.1016/J.TRIVAC.2016.04.003
   Alves MJ, 2013, EUROSURVEILLANCE, V18, P2
   Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802
   Amin N, 2009, MALAYS J MED SCI, V16, P4
   Arien KK, 2018, LANCET GLOB HEALTH, V6, pE830, DOI 10.1016/S2214-109X(18)30295-X
   Avirutnan P, 2011, J IMMUNOL, V187, P424, DOI 10.4049/jimmunol.1100750
   Bai LL, 2015, RETROVIROLOGY, V12, DOI 10.1186/s12977-015-0233-x
   Balmaseda A, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01785-17, 10.1128/jcm.01785-17]
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bergamaschi G, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20081921
   Burki T, 2018, LANCET, V392, P1000, DOI 10.1016/S0140-6736(18)32286-4
   Caglioti C, 2013, NEW MICROBIOL, V36, P211
   Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578
   Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7
   Carmona SJ, 2015, MOL CELL PROTEOMICS, V14, P1871, DOI 10.1074/mcp.M114.045906
   Dutra HL, 2017, BIOESSAYS, V39, DOI 10.1002/bies.201600175
   Carter MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003424
   Casseb AD, 2014, J VENOM ANIM TOXINS, V20, DOI 10.1186/1678-9199-20-29
   Chang H.H., 2016, B WORLD HEALTH ORGAN, V95, P517
   Chao D., 2019, J CLIN MICROBIOL, V57, P1
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Cleton N.B., 2015, PLOS NEGLECT TROP D, V9, P1
   Cleton N, 2012, J CLIN VIROL, V55, P191, DOI 10.1016/j.jcv.2012.07.004
   Crill WD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004991
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Darwish NT, 2018, SENSOR ACTUAT B-CHEM, V255, P3316, DOI 10.1016/j.snb.2017.09.159
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Davis LE, 2008, NEUROL CLIN, V26, P1, DOI [10.1016/j.nc1.2008.03.012.North, DOI 10.1016/J.NC1.2008.03.012.NORTH]
   Delisle E, 2015, EUROSURVEILLANCE, V20, P8, DOI 10.2807/1560-7917.ES2015.20.17.21108
   Dighe SN, 2019, EUR J MED CHEM, V176, P431, DOI 10.1016/j.ejmech.2019.05.010
   Frei JC, 2015, VIROLOGY, V485, P371, DOI 10.1016/j.virol.2015.08.011
   GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Granger D, 2017, J CLIN MICROBIOL, V55, P2127, DOI [10.1128/JCM.00580-17, 10.1128/jcm.00580-17]
   Griffin I, 2019, EMERG INFECT DIS, V25, P299, DOI 10.3201/eid2502.181286
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P350
   Hang V. T., 2009, PLOS NEGLECT TROP D, V3, P1
   Hansen S., 2019, SCI REP, V9, P1
   Huits R, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofw273
   Hunsperger EA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003171
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Jespersen MC, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00298
   Johnson BW, 2016, AM J TROP MED HYG, V95, P182, DOI 10.4269/ajtmh.16-0013
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kelly-Cirino CD, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001179
   KOHLI E, 1993, VIROLOGY, V194, P110, DOI 10.1006/viro.1993.1240
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kurani S, 2018, CTS-CLIN TRANSL SCI, V11, P103, DOI 10.1111/cts.12529
   Kurolt IC, 2013, CLIN MICROBIOL INFEC, V19, pE163, DOI 10.1111/1469-0691.12104
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Land KJ, 2019, NAT MICROBIOL, V4, P46, DOI 10.1038/s41564-018-0295-3
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Lee AJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178199
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Luo R, 2019, CLIN MICROBIOL INFEC, V25, P659, DOI 10.1016/j.cmi.2019.01.002
   Matheus S, 2019, EMERG INFECT DIS, V25, P1153, DOI 10.3201/eid2506.180361
   Meghani Z, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006501
   Mishra N, 2018, MBIO, V9, DOI 10.1128/mBio.00095-18
   Mlera L, 2014, PATHOG DIS, V71, P135, DOI 10.1111/2049-632X.12178
   Munoz-Jordan JL, 2017, J INFECT DIS, V216, pS951, DOI 10.1093/infdis/jix502
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Narula A, 2018, INFECT GENET EVOL, V61, P4, DOI 10.1016/j.meegid.2018.03.007
   Ohst C, 2018, ADV EXP MED BIOL, V1062, P19, DOI 10.1007/978-981-10-8727-1_3
   Pal S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113411
   Patsoula E, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/2450682
   Peeling R.W, 2018, LANCET INFECT DIS, V3099, P1
   Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459
   Perez-Perez MJ, 2019, EXPERT OPIN DRUG DIS, V14, P855, DOI 10.1080/17460441.2019.1629413
   Perkins MD, 2017, LANCET, V390, P2111, DOI 10.1016/S0140-6736(17)31224-2
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Plennevaux E, 2018, CLIN INFECT DIS, V66, P1164, DOI 10.1093/cid/cix966
   Potocnakova L, 2016, J IMMUNOL RES, DOI 10.1155/2016/6760830
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Prince HE, 2011, CLIN VACCINE IMMUNOL, V18, P2183, DOI 10.1128/CVI.05425-11
   Ramanathan B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155900
   Rampling T, 2019, EMERG INFECT DIS, V25, P205, DOI 10.3201/eid2502.180798
   Rayichandran S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09914-3
   RIBEIRO GS, 2018, LANCET, V6, pE14
   Rizzoli A., 2015, EURO SURVEILL
   Rockstroh A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004218
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, P1, DOI DOI 10.1371/J0URNAL.PNTD.0006845
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   Safronetz D, 2017, EMERG INFECT DIS, V23, P1577, DOI 10.3201/eid2309.162043
   Sambri V, 2013, VIRUSES-BASEL, V5, P2329, DOI 10.3390/v5102329
   Sanchez-Trincado JL, 2017, J IMMUNOL RES, DOI 10.1155/2017/2680160
   Shan C, 2017, J CLIN MICROBIOL, V55, P3028, DOI [10.1128/JCM.00975-17, 10.1128/jcm.00975-17]
   Theel ES, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.01972-17, 10.1128/jcm.01972-17]
   Tirado SMC, 2003, VIRAL IMMUNOL, V16, P69, DOI 10.1089/088282403763635465
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   Toskin I., 2017, SEX TRANSM INFECT, V93, P581
   Usman Mirza M., 2016, SCI REP, V6, P1
   Valiant WG, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy151
   Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1
   Vaughan K, 2010, VIRAL IMMUNOL, V23, P259, DOI 10.1089/vim.2010.0006
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Vickers I, 2017, DIAGN MICR INFEC DIS, V89, P271, DOI 10.1016/j.diagmicrobio.2017.08.019
   Wasonga C., 2017, J BIOTECHNOL BIOCH, V3, P70
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Whiteman MC, 2018, AM J TROP MED HYG, V99, P1430, DOI 10.4269/ajtmh.17-0948
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
NR 108
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0966-842X
EI 1878-4380
J9 TRENDS MICROBIOL
JI Trends Microbiol.
PD APR
PY 2020
VL 28
IS 4
BP 276
EP 292
DI 10.1016/j.tim.2019.11.005
PG 17
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA KU3AC
UT WOS:000519578400007
PM 31864844
DA 2020-07-08
ER

PT J
AU Noske, GD
   Gawriljuk, VO
   Fernandes, RS
   Furtado, ND
   Bonaldo, MC
   Oliva, G
   Godoy, AS
AF Noske, Gabriela Dias
   Gawriljuk, Victor Oliveira
   Fernandes, Rafaela Sachetto
   Furtado, Nathalia Dias
   Bonaldo, Myrna Cristina
   Oliva, Glaucius
   Godoy, Andre Schutzer
TI Structural characterization and polymorphism analysis of the NS2B-NS3
   protease from the 2017 Brazilian circulating strain of Yellow Fever
   virus
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
LA English
DT Article
DE Yellow Fever virus; Flavivirus; Protease; NS3; NS2B
ID DENGUE VIRUS; ZIKA VIRUS; STRUCTURE REFINEMENT; CRYSTAL-STRUCTURE;
   HELICASE; MODEL; INHIBITION; ACTIVATION; FEATURES; COMPLEX
AB Background: The Yellow Fever virus (YFV) is transmitted by mosquitos and causes an infection with symptoms including fever, headaches and nausea. In 20-50% of the cases, the disease may evolve to a visceral stage, reaching high mortality rates. YFV NS2B-NS3 protease has been identified as an important drug target.
   Methods: Herein, we describe the crystal structure of the NS2B-NS3 protease from the 2017 YFV Brazilian circulating strain using X-ray crystallography. Furthermore, we used a combination of biochemical and biophysical assays to characterize the enzyme and investigate the impact of the polymorphisms observed in different YFV circulating strains.
   Results: Surprisingly, the crystal structure of YFV protease seems to adopt the closed conformation without the presence of a binding partner. Although D88E and K121R mutants exhibited a lower affinity for the substrate, both revealed to be more processive, resulting in a similar catalytic efficiency in relation to the WT protease. Still, both mutants showed an accentuated decrease in stability when compared with the WT.
   Conclusions: The crystal structure of YFV NS2B-NS3 in closed conformation might be an important tool for the development of new drugs, as well as understanding the activation mechanism of viral proteases. Biochemical analyses indicate that the NS2B-NS3 protease of the circulating strain of YFV is more stable than previous strains.
   General significance: The YFV NS2B-NS3 protease is the first flaviviral structure described in its closed conformation when in a free form, implying that external factors might induce the activation of the enzyme.
C1 [Noske, Gabriela Dias; Gawriljuk, Victor Oliveira; Fernandes, Rafaela Sachetto; Oliva, Glaucius; Godoy, Andre Schutzer] Univ Sao Paulo, Phys Inst Sao Carlos, Av Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, Brazil.
   [Furtado, Nathalia Dias; Bonaldo, Myrna Cristina] Fundacao Osvaldo Cruz, Inst Oswaldo Cruz, Lab Biol Mol & Flavivirus, Rio De Janeiro, Brazil.
RP Godoy, AS (corresponding author), Univ Sao Paulo, Phys Inst Sao Carlos, Av Joao Dagnone,1100 Jardim Santa Angelina, BR-13563120 Sao Carlos, Brazil.
EM andregodoy@ifsc.usp.br
RI Godoy, Andre/AAF-2432-2020
OI Godoy, Andre/0000-0002-0613-9164
FU Sao Paulo Research Foundation - FAPESP (CEPID)Fundacao de Amparo a
   Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07600-3, 2016/19712-9,
   2018/05130-3]; Diamond Light Source for beamtime [mx22129]; Preventing
   and Combating the Zika Virus; MCTIC/FNDCT- CNPq/MEC-CAPES/MS-Decit
   [426767/2018-7, 88881.130684/2016-01]; INOVA-Fiocruz [VPPIS-004-FIO18]
FX The authors would like to thank the funding from the Sao Paulo Research
   Foundation - FAPESP (CEPID grant #2013/07600-3 and post-doctoral grants
   2016/19712-9 and 2018/05130-3). The authors would like to thank Diamond
   Light Source for beamtime (proposal mx22129), and the staff of beamline
   124 for support. Part of this study is funded by grants from Preventing
   and Combating the Zika Virus, MCTIC/FNDCT- CNPq/MEC-CAPES/MS-Decit
   (Grants 426767/2018-7 and 88881.130684/2016-01) and INOVA-Fiocruz (Grant
   VPPIS-004-FIO18).
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Aleshin AE, 2007, PROTEIN SCI, V16, P795, DOI 10.1110/ps.072753207
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069
   Assenberg R, 2009, J VIROL, V83, P12895, DOI 10.1128/JVI.00942-09
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Carpp LN, 2011, MICROBES INFECT, V13, P85, DOI 10.1016/j.micinf.2010.10.010
   Chandramouli S, 2010, J VIROL, V84, P3059, DOI 10.1128/JVI.02044-09
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Godoy AS, 2019, CURR OPIN STRUC BIOL, V59, P65, DOI 10.1016/j.sbi.2019.02.014
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073
   Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gomez MM, 2018, J GEN VIROL, V99, P536, DOI 10.1099/jgv.0.001033
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Hayes EB, 2010, VACCINE, V28, P8073, DOI 10.1016/j.vaccine.2010.10.015
   Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978
   Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357
   Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337
   Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003
   Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.1218231, 10.1126/science.121823]
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li HD, 2019, NEURON, V101, P1089, DOI 10.1016/j.neuron.2019.01.010
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2010, J BIOL CHEM, V285, P18817, DOI 10.1074/jbc.M109.090936
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McGuinness I, 2017, NEUROHOSPITALIST, V7, P157, DOI 10.1177/1941874417708129
   Mir D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07873-7
   Monath T P, 2001, Lancet Infect Dis, V1, P11, DOI 10.1016/S1473-3099(01)00016-0
   Monath TP, 2012, EXPERT REV VACCINES, V11, P427, DOI [10.1586/erv.12.6, 10.1586/ERV.12.6]
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Noble CG, 2012, J VIROL, V86, P438, DOI 10.1128/JVI.06225-11
   Paules C.I., 2017, NEW ENGL J MED, V376, DOI [10.1056/NEJMpl 702172, DOI 10.1056/NEJMPL702172]
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, P1, DOI 10.1590/0074-02760170361
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004
   de Abreu FVS, 2019, MEM I OSWALDO CRUZ, V114, DOI 10.1590/0074-02760190076
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319
   Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X
   Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h
NR 55
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0304-4165
EI 1872-8006
J9 BBA-GEN SUBJECTS
JI Biochim. Biophys. Acta-Gen. Subj.
PD APR
PY 2020
VL 1864
IS 4
AR 129521
DI 10.1016/j.bbagen.2020.129521
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KT0FI
UT WOS:000518686000009
PM 31931019
DA 2020-07-08
ER

PT J
AU Clark, RD
   Thomas, AX
   Michels, S
   Mizerick, L
   Robak, L
   Demmler, GJ
   Chao, HT
   Mirzaa, G
AF Clark, R. D.
   Thomas, A. X.
   Michels, S.
   Mizerick, L.
   Robak, L.
   Demmler, G. J.
   Chao, H. T.
   Mirzaa, G.
TI ANKLE2-RELATED MICROCEPHALY PHENOTYPE OVERLAPS WITH ZIKA
SO AMERICAN JOURNAL OF MEDICAL GENETICS PART A
LA English
DT Meeting Abstract
CT 40th Annual David W. Smith Workshop on Malformations and Morphogenesis
CY AUG 23-28, 2019
CL Snowbird, UT
SP Natl Inst Child Hlth & Dev, Ctr Dis Control & Prevent, Saint Louis Univ, Dept Pediat, Div Med Genet, SSM Hlth Cardinal Glennon Childrens Hosp, Univ Utah Hlth, Dept Pediat, Div Med Genet
C1 [Clark, R. D.] Loma Linda Univ, Sch Med, Loma Linda, CA USA.
   [Thomas, A. X.; Mizerick, L.; Robak, L.; Demmler, G. J.; Chao, H. T.] Texas Childrens Hosp, Houston, TX 77030 USA.
   [Thomas, A. X.; Mizerick, L.; Robak, L.; Demmler, G. J.; Chao, H. T.] Baylor Coll Med, Houston, TX 77030 USA.
   [Michels, S.] Seattle Childrens Hosp, Seattle, WA USA.
   [Mirzaa, G.] Univ Washington, Sch Med, Seattle, WA USA.
   [Mirzaa, G.] Ctr Integrat Brain Res, Seattle, WA USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1552-4825
EI 1552-4833
J9 AM J MED GENET A
JI Am. J. Med. Genet. A
PD APR
PY 2020
VL 182
IS 4
BP 885
EP 886
PG 2
WC Genetics & Heredity
SC Genetics & Heredity
GA KS9PG
UT WOS:000518641400060
DA 2020-07-08
ER

PT J
AU Alzate, D
   Cajigas, S
   Robledo, S
   Muskus, C
   Orozco, J
AF Alzate, Daniel
   Cajigas, Sebastian
   Robledo, Sara
   Muskus, Carlos
   Orozco, Jahir
TI Genosensors for differential detection of Zika virus
SO TALANTA
LA English
DT Article
DE Genosensors; Zika-virus; Differencial-detection; Electrochemistry;
   Bioinformatics
ID DNA; AMPLIFICATION; SEQUENCE; SENSOR; LABEL; SERUM; ASSAY
AB Zika virus (ZIKV) is considered an emerging infectious disease of high clinical and epidemiological relevance. The epidemiological emergency generated by the virus in Latin America and Southeast Asia in 2014 evidenced the urgent need for rapid and acute diagnostic tools. The current laboratory diagnosis of ZIKV is based on molecular and serological methods. However, molecular tools need expensive and sophisticated equipment and trained personnel; and serological detection may suffer from cross-reactivity. In this context, genosensors offer an attractive alternative for field-ready, early and accurate diagnosis of ZIKV. This work reports on the development of genosensors for the differential detection of ZIKV and its discrimination from dengue (DENV) and chikungunya (CHIKV) homologous arboviruses. We designed specific capture and signal probes by bioinformatics, and prove their specificity to amplify the target genetic material by the polymerase chain reaction (PCR). The designed biotinylated capture and digoxigenin (Dig)-labeled signal probes hybridized the target in a sandwich-type format. An anti-Dig antibody labeled with the horseradish peroxidase (HRP) enzyme allowed for both optical and electrochemical detection. The genosensors detected the ZIKV genetic material in spiked serum, urine, and saliva samples and cDNA from infected patients, discriminating them from the DENV and ZIKV genetic material. The proposed system offers a step forward to the differential diagnosis of the ZIKV, closer to the patient, very promising for diagnosis and surveillance of this rapidly emerging disease.
C1 [Alzate, Daniel; Cajigas, Sebastian; Orozco, Jahir] Univ Antioquia, Max Planck Tandem Grp Nanobioengn, Complejo Ruta N,Calle 67 52-20, Medellin 050010, Colombia.
   [Robledo, Sara; Muskus, Carlos] Univ Antioquia, Fac Med, PECET, Calle 62 52-59, Medellin, Colombia.
RP Orozco, J (corresponding author), Univ Antioquia, Max Planck Tandem Grp Nanobioengn, Complejo Ruta N,Calle 67 52-20, Medellin 050010, Colombia.
EM grupotandem.nanobioe@udea.edu.co
FU COLCIENCIASDepartamento Administrativo de Ciencia, Tecnologia e
   Innovacion Colciencias [111574454836]; University of Antioquia; Max
   Planck SocietyMax Planck SocietyFoundation CELLEX [566-1]
FX The work has been funded by COLCIENCIAS, through the 111574454836
   project. J.O thanks support from The University of Antioquia and The Max
   Planck Society through the cooperation agreement 566-1, 2014. Authors
   thank Mr. Esteban Marin from the PECET (Universidad de Antioqula) for
   his technical support in the molecular methods. We acknowledge to Dr.
   Raquel E. Ocazionez from The Medical School, Centro de Investigaciones
   en Enfermedades Tropicales (Universidad Industrial de Santander) and Dr.
   Salim Mattar, Instituto de Investigaciones Biologicas del Tropico IIBT
   (Universidad de Cordoba) for providing us with virus isolates and serum
   samples from infected patients, respectively.
CR Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Alves RD, 2019, SENSOR ACTUAT B-CHEM, V296, DOI 10.1016/j.snb.2019.126681
   Cabral-Miranda G, 2018, BIOSENS BIOELECTRON, V113, P101, DOI 10.1016/j.bios.2018.04.058
   Camacho E, 2016, EMERG INFECT DIS, V22, P927, DOI 10.3201/eid2205.160023
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen JY, 2019, ANAL BIOANAL CHEM, V411, P2101, DOI 10.1007/s00216-019-01637-0
   Fernandez-Urquiza M, 2017, ONOMAZEIN, P1, DOI 10.7764/onomazein.35.01
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Gadia CLB, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2840-8
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Han D, 2017, BIOSENS BIOELECTRON, V93, P220, DOI 10.1016/j.bios.2016.08.115
   Huang KJ, 2015, BIOSENS BIOELECTRON, V67, P184, DOI 10.1016/j.bios.2014.08.010
   Johnsson L, 2002, FOOD AGR IMMUNOL, V14, P209, DOI [10.1080/09540100220145000, 10.1080/09540100220145000a]
   Koo B, 2017, BIOSENS BIOELECTRON, V90, P187, DOI 10.1016/j.bios.2016.11.051
   Krejbich-Trotot P, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-432
   Kuno G, 1998, J VIROL METHODS, V72, P27, DOI 10.1016/S0166-0934(98)00003-2
   Faria HAM, 2019, BIOSENS BIOELECTRON, V131, P149, DOI 10.1016/j.bios.2019.02.018
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Orozco J, 2016, TALANTA, V161, P560, DOI [10.1016/j.tal, 10.1016/j.talanta.2016.08.073]
   Orozco J, 2011, HARMFUL ALGAE, V10, P489, DOI 10.1016/j.hal.2011.03.004
   Orozco J, 2011, SENSOR ACTUAT B-CHEM, V153, P71, DOI 10.1016/j.snb.2010.10.016
   Orozco J, 2009, BIOELECTROCHEMISTRY, V75, P176, DOI 10.1016/j.bioelechem.2009.03.013
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Sun JB, 2018, MICROMACHINES-BASEL, V9, DOI 10.3390/mi9040142
   Takemura K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211517
   Tancharoen C, 2019, ACS SENSORS, V4, P69, DOI 10.1021/acssensors.8b00885
   Wang DM, 2019, ANALYST, V144, P310, DOI 10.1039/c8an01474d
   Wang L, 2019, BIOSENS BIOELECTRON, V131, P46, DOI 10.1016/j.bios.2019.01.040
   Warrilow D, 2002, J MED VIROL, V66, P524, DOI 10.1002/jmv.2176
   Wu RR, 2018, BIOSENS BIOELECTRON, V101, P52, DOI 10.1016/j.bios.2017.10.003
   Zhang J, 2006, J AM CHEM SOC, V128, P8575, DOI 10.1021/ja061521a
   Zhao XJ, 2003, J AM CHEM SOC, V125, P11474, DOI 10.1021/ja0358854
NR 32
TC 0
Z9 0
U1 45
U2 45
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0039-9140
EI 1873-3573
J9 TALANTA
JI Talanta
PD APR 1
PY 2020
VL 210
AR 120648
DI 10.1016/j.talanta.2019.120648
PG 8
WC Chemistry, Analytical
SC Chemistry
GA KM6EE
UT WOS:000514230600032
PM 31987197
DA 2020-07-08
ER

PT J
AU Ortega-Berlanga, B
   Hernandez-Adame, L
   del Angel-Olarte, C
   Aguilar, F
   Rosales-Mendoza, S
   Palestino, G
AF Ortega-Berlanga, Benita
   Hernandez-Adame, Luis
   del Angel-Olarte, Cesar
   Aguilar, Fernanda
   Rosales-Mendoza, Sergio
   Palestino, Gabriela
TI Optical and biological evaluation of upconverting Gd2O3:Tb3+/Er3+
   particles as microcarriers of a Zika virus antigenic peptide
SO CHEMICAL ENGINEERING JOURNAL
LA English
DT Article
DE Lanthanides; Upconversion; Adjuvant; Zika virus; Subunit vaccine;
   Humoral response; Bioconjugation
ID UP-CONVERSION; NANOPARTICLES; GD2O3; PROTECTION; EMISSION
AB New adjuvants are required in the field of vaccinology to enhance the immunogenicity and efficacy of subunit vaccines, which constitute a safer approach to protect against infectious diseases compared to whole pathogen-based vaccines. In the present study, rare-earth upconverting microparticles were explored as possible antigen carriers with adjuvant properties by using a peptide from the Zika virus, an emerging pathogen to which no vaccines are available. The Gd2O3:Tb3+/Er3+ (UpGO) carriers were prepared by hydrothermal synthesis and modified by a reaction with (3-Aminopropyl)triethoxysilane (APTES), in order to introduce reactive amine groups at their surfaces to anchor the ZK2 peptide. The system was fully characterized by X-ray diffraction (XRD), high-resolution transmission electron microscopy (HR-TEM), photoluminescence spectroscopy (PL), Fourier-transform infrared spectroscopy (FTIR), and dynamic light scattering (DLS). The results showed a stable colloidal system of APTES-UpGO with a high loading capacity of up to 0.480 mu g of ZK2 peptide per mu g of microparticles. For the in vivo studies, the system was administered to mice by the subcutaneous route and enhanced humoral responses were observed when UpGO was used as the antigen carrier as compared with the group immunized with the peptide alone. The immune response showed a Th2-polarization as revealed IgG subclass analysis. The present study provides new insights into the use of lanthanides-based materials as antigen carriers during vaccine development.
C1 [Ortega-Berlanga, Benita; Hernandez-Adame, Luis; del Angel-Olarte, Cesar; Aguilar, Fernanda; Rosales-Mendoza, Sergio; Palestino, Gabriela] Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Av Dr Manuel Nava 6, San Luis Potosi 78210, San Luis Potosi, Mexico.
   [Ortega-Berlanga, Benita; del Angel-Olarte, Cesar; Aguilar, Fernanda; Rosales-Mendoza, Sergio; Palestino, Gabriela] Univ Autonoma San Luis Potosi, Secc Biotecnol, Ctr Invest Ciencias Salud & Biomed, Av Sierra Leona 550,Lomas 2a Secc, San Luis Potosi 78210, San Luis Potosi, Mexico.
   [Hernandez-Adame, Luis] Inst Politecn Nacl, CONACYT Ctr Invest Biol Noroeste CIBNOR, 195 Playa Palo Santa Rita Sur, La Paz 23090, Bcs, Mexico.
RP Rosales-Mendoza, S; Palestino, G (corresponding author), Univ Autonoma San Luis Potosi, Fac Ciencias Quim, Av Dr Manuel Nava 6, San Luis Potosi 78210, San Luis Potosi, Mexico.
EM rosales.s@uaslp.mx; palestinogabriela@uaslp.mx
OI GABRIELA, PALESTINO/0000-0002-7535-9363
FU CONACyT MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT)
   [233531, 333161, CB-256063]
FX The authors thank Dr. Angel Gabriel Rodriguez-Vazquez from CIACYT-UASLP
   for the support to perform the RAMAN analysis; Lourdes
   Betancourt-Mendiola and Candida Anahi Cisneros-Covarrubias, Dania
   Govea-Alonso and Teresa Neri-Gomez for the support provided to edit the
   image of peptide adsorption mechanism, and perform cytotoxicity and
   immunization assays, respectively. We also thank CONACyT Mexico for the
   scholarship 233531 and 333161 granted to Benita Ortega-Berlanga and
   Cesar del Angel-Olarte; and research grant to SRM (CB-256063).
CR Alberto J, 2015, EXPERT REV VACCINES, V14, P1197, DOI 10.1586/14760584.2015.1064772
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Bouzigues C, 2011, ACS NANO, V5, P8488, DOI 10.1021/nn202378b
   Chen XY, 2007, J PHYS CHEM C, V111, P10404, DOI 10.1021/jp072980g
   Das GK, 2010, J BIOMED MATER RES A, V93A, P337, DOI 10.1002/jbm.a.32533
   del Angel-Olarte C, 2019, J ALLOY COMPD, V787, P1032, DOI 10.1016/j.jallcom.2019.02.113
   Dobrovolskaia MA, 2008, MOL PHARMACEUT, V5, P487, DOI 10.1021/mp800032f
   Hemmer E, 2017, J MATER CHEM B, V5, P4365, DOI 10.1039/c7tb00403f
   Hernandez-Adame L, 2019, EXPERT REV VACCINES, V18, P951, DOI 10.1080/14760584.2019.1647783
   Hernandez-Adame L, 2019, INT J BIOL MACROMOL, V134, P379, DOI 10.1016/j.ijbiomac.2019.05.065
   Hernandez-Adame L, 2018, SOLID STATE SCI, V84, P8, DOI 10.1016/j.solidstatesciences.2018.07.021
   Hernandez-Adame L, 2017, J BIOMED MATER RES B, V105, P605, DOI 10.1002/jbm.b.33577
   Hernandez-Adame L, 2014, CHEM ENG J, V258, P136, DOI 10.1016/j.cej.2014.07.067
   Dan HK, 2014, OPT MATER, V36, P639, DOI 10.1016/j.optmat.2013.10.045
   Jain A, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/6/065601
   Javid A, 2014, APPL BIOCHEM BIOTECH, V173, P36, DOI 10.1007/s12010-014-0740-6
   Kaasalainen M, 2012, INT J PHARMACEUT, V431, P230, DOI 10.1016/j.ijpharm.2012.04.059
   Kalkanidis M, 2006, METHODS, V40, P20, DOI 10.1016/j.ymeth.2006.05.018
   Karch CP, 2016, BIOCHEM PHARMACOL, V120, P1, DOI 10.1016/j.bcp.2016.05.001
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kryza D, 2011, BIOCONJUGATE CHEM, V22, P1145, DOI 10.1021/bc1005976
   Kurtz-Chalot A, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2738-y
   Lai YM, 2014, J ALLOY COMPD, V617, P597, DOI 10.1016/j.jallcom.2014.08.051
   Lambrecht BN, 2009, CURR OPIN IMMUNOL, V21, P23, DOI 10.1016/j.coi.2009.01.004
   Lechevallier S, 2012, LANGMUIR, V28, P3962, DOI 10.1021/la204469f
   Lee G, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070511
   Liu J., 2016, J PROFESSIONAL ISSUE, V3, P1, DOI DOI 10.1504/IJTM.2006.009968
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moon JJ, 2012, ADV MATER, V24, P3724, DOI 10.1002/adma.201200446
   Morrison C, 2016, NAT REV DRUG DISCOV, V15, P521, DOI 10.1038/nrd.2016.159
   Navarro-Tovar G, 2018, MATERIALS, V11, DOI 10.3390/ma11071083
   Negandaripour M, 2017, BIOTECHNOL ADV, V35, P575, DOI 10.1016/j.biotechadv.2017.05.002
   Ocampo-Perez R, 2019, SCI TOTAL ENVIRON, V655, P1397, DOI 10.1016/j.scitotenv.2018.11.283
   Palestino G, 2008, LANGMUIR, V24, P13765, DOI 10.1021/la8015707
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Poland GA, 2016, CURR OPIN VIROL, V17, P116, DOI 10.1016/j.coviro.2016.03.003
   Santos TH, 2018, CERAM INT, V44, P2745, DOI 10.1016/j.ceramint.2017.11.009
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sun SK, 2013, ANAL CHEM, V85, P8436, DOI 10.1021/ac401879y
   Tao WQ, 2014, NANOMEDICINE-UK, V9, P237, DOI 10.2217/nnm.13.58
   Tek S, 2019, PROC SPIE, V10892, DOI 10.1117/12.2512255
   Tian XM, 2014, J NANOPART RES, V16, DOI 10.1007/s11051-014-2594-9
   Venkatramu V, 2012, J MATER CHEM, V22, P13788, DOI 10.1039/c2jm31386c
   Ward J.W., 1994, HDB PHYS CHEM RARE E, P293
   Wen SH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04813-5
   Xiang J, 2015, ACS NANO, V9, P6401, DOI 10.1021/acsnano.5b02014
   Zacharias ZR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01953
   Zaman M, 2013, METHODS, V60, P226, DOI 10.1016/j.ymeth.2013.04.014
   Zha S, 2018, NANOSCALE, V10, P15632, DOI 10.1039/c8nr05015e
   Zhao GZ, 2017, EUR POLYM J, V93, P670, DOI 10.1016/j.eurpolymj.2017.02.014
   Zhao L, 2014, VACCINE, V32, P327, DOI 10.1016/j.vaccine.2013.11.069
   Zhou B, 2015, ADV MATER, V27, P6208, DOI 10.1002/adma.201503482
NR 52
TC 1
Z9 1
U1 57
U2 57
PU ELSEVIER SCIENCE SA
PI LAUSANNE
PA PO BOX 564, 1001 LAUSANNE, SWITZERLAND
SN 1385-8947
EI 1873-3212
J9 CHEM ENG J
JI Chem. Eng. J.
PD APR 1
PY 2020
VL 385
AR 123414
DI 10.1016/j.cej.2019.123414
PG 11
WC Engineering, Environmental; Engineering, Chemical
SC Engineering
GA KC9BF
UT WOS:000507465200111
DA 2020-07-08
ER

PT J
AU Henderson, EA
   Tam, CC
   Cheng, LW
   Ngono, AE
   Nguyen, AV
   Shresta, S
   McGee, M
   Padgett, H
   Grill, LK
   Shilman, MM
AF Henderson, Elizabeth A.
   Tam, Christina C.
   Cheng, Luisa W.
   Ngono, Annie Elong
   Anh-Viet Nguyen
   Shresta, Sujan
   McGee, Matt
   Padgett, Hal
   Grill, Laurence K.
   Shilman, Mikhail Martchenko
TI Investigation of the immunogenicity of Zika glycan loop
SO VIROLOGY JOURNAL
LA English
DT Article
DE Zika; Envelope; Glycan loop; Neutralizing antibodies
ID TOBACCO-MOSAIC-VIRUS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; PROTEIN;
   GLYCOSYLATION; NEUTRALIZATION; EFFICIENCY; ANTIGEN; POTENT
AB Background Zika virus (ZIKV) is a major human pathogen and member of the Flavivirus genus. Previous studies have identified neutralizing antibodies from Zika patients that bind to quaternary epitopes across neighboring envelope (E) proteins, called E dimer epitopes (EDE). An asparagine-linked glycan on the "glycan loop" (GL) of the ZIKV envelope protein protects the functionally important "fusion loop" on the opposite E subunit in the dimer, and EDE antibodies have been shown to bind to both of these loops. Human EDE antibodies have been divided into two subclasses based on how they bind to the glycan loop region: EDE1 antibodies do not require glycosylation for binding, while EDE2 antibodies strongly rely on the glycan for binding. Methods ZIKV GL was expressed on tobacco mosaic virus nanoparticles. Mice were immunized with GL or full-length monomeric E and the immune response was analyzed by testing the ability of sera and monoclonal antibodies to bind to GL and to neutralize ZIKV in in vitro cellular assay. Results We report here the existence of ZIKV moderately neutralizing antibodies that bind to E monomers through epitopes that include the glycan loop. We show that sera from human Zika patients contain antibodies capable of binding to the unglycosylated glycan loop in the absence of the rest of the envelope protein. Furthermore, mice were inoculated with recombinant E monomers and produced neutralizing antibodies that either recognize unglycosylated glycan loop or require glycan for their binding to monomeric E. We demonstrate that both types of antibodies neutralize ZIKV to some extent in a cellular virus neutralization assay. Conclusions Analogous to the existing EDE antibody nomenclature, we propose a new classification for antibodies that bind to E monomer epitopes (EME): EME1 and EME2 for those that do not require and those that do require glycan for binding to E, respectively.
C1 [Henderson, Elizabeth A.; Grill, Laurence K.; Shilman, Mikhail Martchenko] Henry E Riggs Sch Appl Life Sci, Keck Grad Inst, Claremont, CA 91711 USA.
   [Tam, Christina C.; Cheng, Luisa W.] USDA, Foodborne Toxin Detect & Prevent Res Unit, Western Reg Res Ctr, Albany, CA 94710 USA.
   [Ngono, Annie Elong; Anh-Viet Nguyen; Shresta, Sujan] La Jolla Inst Allergy & Immunol, Div Inflammat Biol, La Jolla, CA 92037 USA.
   [McGee, Matt; Padgett, Hal] Nov Biotech LLC, Vacaville, CA 95688 USA.
RP Grill, LK; Shilman, MM (corresponding author), Henry E Riggs Sch Appl Life Sci, Keck Grad Inst, Claremont, CA 91711 USA.
EM larry_grill@kgi.edu; mikhail_shilman@kgi.edu
FU City of Hope Comprehensive Cancer Center through the KL2 Mentored Career
   Development Award Program of the Inland California Translational
   Consortium [GR720001]; United States Department of Agriculture,
   Agricultural Research ServiceUnited States Department of Agriculture
   (USDA) [NP108, CRIS 2030-42000-049-00-D]
FX M.M.S. acknowledges support from City of Hope Comprehensive Cancer
   Center through the KL2 Mentored Career Development Award Program of the
   Inland California Translational Consortium (GR720001). LC and CT were
   funded by the United States Department of Agriculture, Agricultural
   Research Service, National Program project NP108, CRIS
   2030-42000-049-00-D.
CR Annamalai AS, 2017, J VIROL, V91, DOI [10.1128/JVI.01348-17, 10.1128/jvi.01348-17]
   BACHMANN MF, 1993, SCIENCE, V262, P1448, DOI 10.1126/science.8248784
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BIGBEE WL, 1983, MOL IMMUNOL, V20, P1353, DOI 10.1016/0161-5890(83)90166-9
   Bruckman MA, 2014, METHODS MOL BIOL, V1108, P173, DOI 10.1007/978-1-62703-751-8_13
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carbaugh DL, 2019, J VIROL, V93, DOI [10.1128/JVI.00113-19, 10.1128/jvi.00113-19]
   Carlin AF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0007053
   Carlin AF, 2018, P NATL ACAD SCI USA, V115, pE9172, DOI 10.1073/pnas.1807690115
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2014, METHODS MOL BIOL, V1138, P27, DOI 10.1007/978-1-4939-0348-1_3
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Fontes-Garfias CR, 2017, CELL REP, V21, P1180, DOI 10.1016/j.celrep.2017.10.016
   Frey A, 1998, J IMMUNOL METHODS, V221, P35, DOI 10.1016/S0022-1759(98)00170-7
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   Heinz FX, 2012, VACCINE, V30, P4301, DOI 10.1016/j.vaccine.2011.09.114
   Homan J, 2016, ANTIBODY MEDIATED EP, P1
   Hraber P, 2018, VACCINE, V36, P6911, DOI 10.1016/j.vaccine.2018.10.022
   Kimple ME, 2001, EMBO J, V20, P4414, DOI 10.1093/emboj/20.16.4414
   Koehler JW, 2011, ANTIVIR RES, V92, P461, DOI 10.1016/j.antiviral.2011.10.008
   Komarova TV, 2011, PLANT DERIVED VACCIN, P44
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Lambeth CR, 2005, J CLIN MICROBIOL, V43, P3267, DOI 10.1128/JCM.43.7.3267-3272.2005
   Lee E, 2010, J VIROL, V84, P5171, DOI 10.1128/JVI.01900-09
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Lindbo JA, 2007, PLANT PHYSIOL, V145, P1232, DOI 10.1104/pp.107.106377
   Liu RL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060621
   Liu XY, 2014, BIOTECHNOL BIOTEC EQ, V28, P408, DOI 10.1080/13102818.2014.925317
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   Lynch RM, 2019, J INFECT DIS, V219, P26, DOI 10.1093/infdis/jiy466
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   McComb RC, 2015, VACCINE, V33, P6745, DOI 10.1016/j.vaccine.2015.10.075
   McCormick AA, 2008, EXPERT REV VACCINES, V7, P33, DOI 10.1586/14760584.7.1.33
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mondotte JA, 2007, J VIROL, V81, P7136, DOI 10.1128/JVI.00116-07
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V2016, P65
   OHNO T, 1977, P NATL ACAD SCI USA, V74, P552, DOI 10.1073/pnas.74.2.552
   PADGETT HS, 1993, PLANT CELL, V5, P577, DOI 10.1105/tpc.5.5.577
   Public Health Emergency of International Concern (PHEIC), 2016, PUBL HLTH EM INT PHE
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shamloul M, 2014, JOVE-J VIS EXP, DOI 10.3791/51204
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Stanker LH, 2008, J IMMUNOL METHODS, V336, P1, DOI 10.1016/j.jim.2008.03.003
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   SUGASAWARA RJ, 1985, J IMMUNOL METHODS, V79, P263, DOI 10.1016/0022-1759(85)90106-1
   Turpin J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111338
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wen D, 2018, MBIO, V9, DOI [10.1128/mBio.00046-18, 10.1128/mbio.00046-18]
   Xu X, 2016, COMPUTATIONAL ANAL Z
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 58
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD MAR 31
PY 2020
VL 17
IS 1
AR 43
DI 10.1186/s12985-020-01313-1
PG 15
WC Virology
SC Virology
GA LA0ZP
UT WOS:000523685400002
PM 32234060
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jorge, FA
   Thomazella, MV
   Moreira, DD
   Lopes, LDG
   Teixeira, JJV
   Bertolini, DA
AF Jorge, Fernando A.
   Thomazella, Mateus, V
   Moreira, Deborah de Castro
   Lopes, Luciana D. G.
   Teixeira, Jorge J., V
   Bertolini, Dennis A.
TI Evolutions and upcoming on Zika virus diagnosis through an outbreak: A
   systematic review
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review
DE cross-reaction; diagnosis; immunology; PCR; serological; zika virus
ID NEUTRALIZING ANTIBODIES; MOLECULAR-DETECTION; RT-PCR; ASSAY; DENGUE;
   RNA; IMMUNOASSAY; SPECIMENS
AB Zika virus (ZIKV) is an enveloped, positive single-stranded sense RNA virus transmitted by Aedes species. Many efforts have been conducted to find a good, reliable and cost-effective test for ZIKV diagnosis. Diagnosis is still imprecise, expensive and there is not a standard model. We investigated the publications on ZIKV diagnostics and analyzed varieties of diagnostic methods, sensibility, specificity, and the evolution of new methodologies. Conducted in accordance with the PRISMA-P statement, three blocks of MeSH terms were assembled: group I: virus infection; group II: diagnostic methodologies; group III: characteristics and varieties on diagnostic methods. Search was performed on PubMed, Web of Science and SCOPUS databases. Eighteen articles were retrieved, reporting serological and molecular diagnostic techniques. Serum was used as the main biological material in the serological diagnosis, but urine and sperm were presented as an alternative. Molecular methods used structural and nonstructural regions of ZIKV genome. Experimental methodologies were more efficient, faster, and cheaper. Serological tests are faster and less expensive than molecular assays, but molecular assays are more specific. The use of both methodologies would be the most appropriate and reliable way to obtain correct diagnostic results.
C1 [Jorge, Fernando A.; Moreira, Deborah de Castro; Lopes, Luciana D. G.; Teixeira, Jorge J., V; Bertolini, Dennis A.] Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.
   [Thomazella, Mateus, V] Univ Sao Paulo, Sch Med, Med Res Lab, Sao Paulo, Brazil.
RP Jorge, FA (corresponding author), Univ Estadual Maringa, Dept Anal Clin & Biomed, Ctr Ciencias Saude, Av Colombo 5790,Bloco T-20 Sala 301, BR-87020900 Maringa, Parana, Brazil.
EM fajorge@gmail.com
OI Jorge, Fernando Americo/0000-0001-8994-5411; Thomazella,
   Mateus/0000-0002-1527-6910
CR Acharya D, 2016, SCI REP-UK, V6, DOI 10.1038/srep32227
   Adegoke O, 2017, BIOSENS BIOELECTRON, V94, P513, DOI 10.1016/j.bios.2017.03.046
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   [Anonymous], 2014, REV DIAGN TEST ZIK C, DOI [10.1007/s13398-014-0173-7.2, DOI 10.1007/S13398-014-0173-7.2]
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Calvo EP, 2016, ACTA TROP, V163, P32, DOI 10.1016/j.actatropica.2016.07.021
   Camacho SA, 2018, ACS SENSORS, V3, P587, DOI 10.1021/acssensors.7b00639
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2017, TROP MED INT HEALTH, V22, P594, DOI 10.1111/tmi.12857
   Cheng C, 2017, CHEMELECTROCHEM, V4, P485, DOI 10.1002/celc.201600831
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Draz MS, 2018, NANOSCALE, V10, P11841, DOI 10.1039/c8nr01646a
   Draz MS, 2018, ACS NANO, V12, P5709, DOI 10.1021/acsnano.8b01515
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Kim YH, 2018, KOREAN J PARASITOL, V56, P61, DOI 10.3347/kjp.2018.56.1.61
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lustig Y, 2017, J CLIN MICROBIOL, V55, P1894, DOI 10.1128/JCM.00346-17
   Macciocchi D, 2016, NEW MICROBIOL, V39, P287
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pessoa R, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.30.30302
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rubin EJ, 2016, NEW ENGL J MED, V374, P984, DOI 10.1056/NEJMe1601862
   Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1136/bmj.i4086]
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shrivastava Saurabh RamBihariLal, 2016, J Res Med Sci, V21, P55
   Shukla S, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01685
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Song H, 2016, NAT STRUCT MOL BIOL, V23, P456, DOI 10.1038/nsmb.3213
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Sumita LM, 2016, REV INST MED TROP SP, V58, DOI [10.1590/s1678-9946201658089, 10.1590/S1678-9946201658089]
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009
   Wong SJ, 2017, EBIOMEDICINE, V16, P136, DOI 10.1016/j.ebiom.2017.01.008
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
NR 54
TC 0
Z9 0
U1 8
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
PD MAY
PY 2020
VL 30
IS 3
AR e2105
DI 10.1002/rmv.2105
EA MAR 2020
PG 13
WC Virology
SC Virology
GA LS6WB
UT WOS:000522340200001
PM 32232942
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI In utero Zika virus exposure and schizophrenia
SO WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Joob B, 2017, CASE STUDY CASE REP, V7, P29
   Kim S, 2016, ADV LAB MED INT, V6, P37
   Pierson J, 2020, WORLD J BIOL PSYCHIA, V21, P2, DOI 10.1080/15622975.2018.1500027
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 4
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1562-2975
EI 1814-1412
J9 WORLD J BIOL PSYCHIA
JI World J. Biol. Psychiatry
PD JAN 2
PY 2020
VL 21
IS 1
BP 12
EP 12
DI 10.1080/15622975.2018.1533995
EA MAR 2020
PG 1
WC Psychiatry
SC Psychiatry
GA LE0QU
UT WOS:000523755500001
PM 30311817
DA 2020-07-08
ER

PT J
AU Anita, S
   Capasso, V
AF Anita, Sebastian
   Capasso, Vincenzo
TI Regional Control for Spatially Structured Mosquito Borne Epidemics
   Malaria as a Working Example
SO VIETNAM JOURNAL OF MATHEMATICS
LA English
DT Article; Early Access
DE Reaction-diffusion system; Regional control; Optimal control; Epidemic
   system; Malaria model; 35-XX
ID MODEL; SPREAD
AB Mosquitoes are among the most dangerous active vectors of diseases such as malaria, dengue, Zika, chikungunya. Malaria alone is responsible for an enormous amount of deaths all over the world, and in particular in subsaharian Africa. Various international programmes are devoted to identify optimal control measures for the reduction, if not eradication, of such diseases. Unfortunately, very often the entire domain of interest for the epidemic is either unknown, or difficult to reach for the implementation of suitable environmental sanitation programmes; on the other hand the costs of a global intervention are clearly unaffordable. This paper is meant to show that implementation of such programmes in a suitably chosen subregion is sufficient to lead to a minimal global cost in the whole habitat, and even to eventual eradication of the epidemic. ("Think globally, act locally"). As a case study, a conceptual mathematical model of malaria is presented here consisting of a spatially structured epidemic system. Significant model reductions have been introduced, in order to make the resulting reaction-diffusion system mathematically tractable. Only the dynamics of the infected mosquitoes and of the infected humans has been included, so that a two-component reaction-diffusion system is finally taken. Three actions (controls) are included here: killing mosquitoes, treating the infected humans and reducing the contact rate mosquitoes-humans. Hence, the problem which is faced here concerns the optimal choice of the region of intervention, by introducing a cost functional which takes into account the total cost of the damages produced by the disease, of the controls and of the intervention in a certain subdomain, for a finite time horizon case. The novelty of the present paper, with respect to previous papers by the same authors, concerns the mathematical problem of the optimal choice of the region of intervention, together with a conceptual algorithm for possible numerical implementations.
C1 [Anita, Sebastian] Alexandru Ioan Cuza Univ, Fac Math, Iasi 700506, Romania.
   [Anita, Sebastian] Romanian Acad, Octav Mayer Inst Math, Iasi 700506, Romania.
   [Capasso, Vincenzo] Univ Milano La Statale, ADAMSS Ctr Adv Appl Math & Stat Sci, I-20133 Milan, Italy.
RP Capasso, V (corresponding author), Univ Milano La Statale, ADAMSS Ctr Adv Appl Math & Stat Sci, I-20133 Milan, Italy.
EM sanita@uaic.ro; vincenzo.capasso@unimi.it
OI ANITA, Sebastian/0000-0001-5757-4580
FU European COST project: "Investigation and Mathematical Analysis of
   Avant-garde Disease Control via Mosquito NanoTech-Repellents" [CA16227]
FX This work has been carried out in the framework of the European COST
   project CA16227: "Investigation and Mathematical Analysis of Avant-garde
   Disease Control via Mosquito NanoTech-Repellents".
CR Ania S., 2011, ADV DYNAMICS CONTROL, P181
   Anita S, 2002, NONLINEAR ANAL-REAL, V3, P453, DOI 10.1016/S1468-1218(01)00025-6
   Anita S, 2019, MATH METHOD APPL SCI, V42, P2909, DOI 10.1002/mma.5560
   Anita S, 2012, DISCRETE CONT DYN-B, V17, P1673, DOI 10.3934/dcdsb.2012.17.1673
   Anita S, 2010, MATH METHOD APPL SCI, V33, P1235, DOI 10.1002/mma.1267
   Bacaer N, 2005, MATH BIOSCI ENG, V2, P227
   Barmak DH, 2016, PHYSICA A, V447, P129, DOI 10.1016/j.physa.2015.12.015
   Beretta E, 2018, MATH BIOSCI, V300, P87, DOI 10.1016/j.mbs.2018.03.024
   CAPASSO V, 1978, MATH BIOSCI, V42, P43, DOI 10.1016/0025-5564(78)90006-8
   CAPASSO V, 1984, J MATH ANAL APPL, V103, P575, DOI 10.1016/0022-247X(84)90147-1
   CAPASSO V, 1983, SIAM J APPL MATH, V43, P417, DOI 10.1137/0143027
   CAPASSO V, 2009, LECT NOTES BIOMATHEM, V97
   d'Onofrio A, 2009, J THEOR BIOL, V256, P473, DOI 10.1016/j.jtbi.2008.10.005
   Killeen GF, 2000, AM J TROP MED HYG, V62, P535, DOI 10.4269/ajtmh.2000.62.535
   McDonald G, 1952, TROP DIS B, V49, P813
   Modica L., 1977, B UNIONE MAT ITAL, V14, P285
   Molineaux L., 1980, GARKI PROJECT RES EP
   OSHER S, 2003, APPL MATH SCI, V153
   Otero M, 2008, B MATH BIOL, V70, P1297, DOI 10.1007/s11538-008-9300-y
   Shcherbacheva A, 2018, MATH BIOSCI, V295, P36, DOI 10.1016/j.mbs.2017.10.005
   Sochantha T, 2006, TROP MED INT HEALTH, V11, P1166, DOI 10.1111/j.1365-3156.2006.01673.x
   White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212
NR 22
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER SINGAPORE PTE LTD
PI SINGAPORE
PA #04-01 CENCON I, 1 TANNERY RD, SINGAPORE 347719, SINGAPORE
SN 2305-221X
EI 2305-2228
J9 VIETNAM J MATH
JI Vietnam J. Math.
DI 10.1007/s10013-020-00395-2
EA MAR 2020
PG 15
WC Mathematics
SC Mathematics
GA KX5NU
UT WOS:000521925300001
DA 2020-07-08
ER

PT J
AU Gongora-Rivera, F
   Grijalva, I
   Infante-Valenzuela, A
   Camara-Lemarroy, C
   Garza-Gonzalez, E
   Paredes-Cruz, M
   Grajales-Muniz, C
   Guerrero-Cantera, J
   Vargas-Ramos, I
   Soares, J
   Abrams, JY
   Styczynski, AR
   Camacho-Ortiz, A
   Villarino, ME
   Belay, ED
   Schonberger, LB
   Sejvar, JJ
AF Gongora-Rivera, Fernando
   Grijalva, Israel
   Infante-Valenzuela, Adrian
   Camara-Lemarroy, Carlos
   Garza-Gonzalez, Elvira
   Paredes-Cruz, Martin
   Grajales-Muniz, Concepcion
   Guerrero-Cantera, Jose
   Vargas-Ramos, Ignacio
   Soares, Jesus
   Abrams, Joseph Y.
   Styczynski, Ashley R.
   Camacho-Ortiz, Adrian
   Villarino, Margarita E.
   Belay, Ermias D.
   Schonberger, Lawrence B.
   Sejvar, James J.
CA GBS HU-IMSS Working Grp
TI Zika Virus infection and Guillain-Barre' syndrome in Northeastern
   Mexico: A case-control study
SO PLOS ONE
LA English
DT Article
ID OUTBREAK; COLOMBIA; HISTORY; STATES; CUCUTA
AB Background
   Beginning August 2017, we conducted a prospective case-control investigation in Monterrey, Mexico to assess the association between Zika virus (ZIKV) and Guillain-Barre' syndrome (GBS).
   Methods
   For each of 50 GBS case-patients, we enrolled 2-3 afebrile controls (141 controls in total) matched by sex, age group, and presentation to same hospital within 7 days.
   Results
   PCR results for ZIKV in blood and/or urine were available on all subjects; serum ZIKV IgM antibody for 52% of case-patients and 80% of controls. Subjects were asked about antecedent illness in the two months prior to neurological onset (for case-patients) or interview (for controls). Laboratory evidence of ZIKV infection alone (PCR+ or IgM+) was not significantly different between case-patients and controls (OR: 1.26, 95% CI: 0.45-3.54) but antecedent symptomatic ZIKV infection [a typical ZIKV symptom (rash, joint pain, or conjunctivitis) plus laboratory evidence of ZIKV infection] was higher among case-patients (OR: 12.45, 95% CI: 1.45-106.64). GBS case-patients with laboratory evidence of ZIKV infection were significantly more likely to have had typical ZIKV symptoms than controls with laboratory evidence of ZIKV infection (OR: 17.5, 95% CI: 3.2-96.6). This association remained significant even when only GBS case-patients who were afebrile for 5 days before onset were included in the analysis, (OR 9.57 (95% CI: 1.07 to 85.35).
   Conclusions
   During ZIKV epidemics, this study indicates that increases in GBS will occur primarily among those with antecedent symptomatic ZIKV.
C1 [Gongora-Rivera, Fernando; Infante-Valenzuela, Adrian; Camara-Lemarroy, Carlos] Univ Autonoma Nuevo Leon, Dept Neurol, Univ Hosp Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.
   [Grijalva, Israel; Paredes-Cruz, Martin; Guerrero-Cantera, Jose] UMAE Hosp Especialidades, Med Res Unit Neurol Dis, Ctr Med Nacl Siglo XXI, Inst Mexicano Seguro Social, Mexico City, DF, Mexico.
   [Garza-Gonzalez, Elvira] Univ Autonoma Nuevo Leon, Dept Gastroenterol, Univ Hosp Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.
   [Grajales-Muniz, Concepcion] Inst Mexicano Seguro Social, Epidemiol Surveillance Div Transmissible Dis, Epidemiol Surveillance Coordinat, Mexico City, DF, Mexico.
   [Vargas-Ramos, Ignacio] UMAE Hosp Especialidades 25, Dept Neurol, Inst Mexicano Seguro Social, Monterrey, Nuevo Leon, Mexico.
   [Soares, Jesus; Abrams, Joseph Y.; Belay, Ermias D.; Schonberger, Lawrence B.; Sejvar, James J.] Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Prion & Publ Hlth Off, Atlanta, GA 30333 USA.
   [Styczynski, Ashley R.] Stanford Univ, Dept Infect Dis, Palo Alto, CA 94304 USA.
   [Camacho-Ortiz, Adrian] Univ Autonoma Nuevo Leon, Dept Infect Dis, Univ Hosp Jose Eleuterio Gonzalez, Monterrey, Nuevo Leon, Mexico.
   [Villarino, Margarita E.] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, CDC Mexico Country Off, Atlanta, GA USA.
RP Sejvar, JJ (corresponding author), Ctr Dis Control & Prevent, Div High Consequence Pathogens & Pathol, Prion & Publ Hlth Off, Atlanta, GA 30333 USA.
EM zea3@cdc.gov
FU United States Centers for Disease Control and PreventionUnited States
   Department of Health & Human ServicesCenters for Disease Control &
   Prevention - USA
FX This study was supported by the United States Centers for Disease
   Control and Prevention. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Arcila-Londono X, 2012, SEMIN NEUROL, V32, P179, DOI 10.1055/s-0032-1329196
   Arias A, 2017, J CRIT CARE, V37, P19, DOI 10.1016/j.jcrc.2016.08.016
   Barbi L, 2018, BRAZ J INFECT DIS, V22, P137, DOI 10.1016/j.bjid.2018.02.005
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Del Carpio-Orantes L, 2018, Neurologia, DOI 10.1016/j.nrl.2018.05.002
   Diaz-Quinonez JA, 2015, EVIDENCE PRESENCE ZI, V52, P855, DOI [10.1007/s11262-016-1384-0, DOI 10.1007/S11262-016-1384-0]
   Dirlikov E, 2017, JAMA-J AM MED ASSOC, V318, P1498, DOI 10.1001/jama.2017.11483
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   Fritzell C, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006533
   Galindo-Fraga A, 2015, REV INVEST CLIN, V67, P329
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Joob B, 2018, ARQ NEURO-PSIQUIAT, V76, P63, DOI 10.1590/0004-282X20170173
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Moreira J, 2018, CLIN MICROBIOL INFEC, V24, P827, DOI 10.1016/j.cmi.2018.05.001
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Reveiz L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180220
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Wijdicks EFM, 2017, MAYO CLIN PROC, V92, P467, DOI 10.1016/j.mayocp.2016.12.002
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 28
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 26
PY 2020
VL 15
IS 3
AR e0230132
DI 10.1371/journal.pone.0230132
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LR8GI
UT WOS:000535934200018
PM 32214354
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Davidson, RB
   Hendrix, J
   Geiss, BJ
   McCullagh, M
AF Davidson, Russell B.
   Hendrix, Josie
   Geiss, Brian J.
   McCullagh, Martin
TI RNA-Dependent Structures of the RNA-Binding Loop in the Flavivirus NS3
   Helicase
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID MOLECULAR-DYNAMICS SIMULATIONS; BIOMOLECULAR SYSTEMS; NTPASE ACTIVITY;
   DENGUE VIRUS; PROTEIN; INHIBITORS; INSIGHTS; IDENTIFICATION;
   REPLICATION; ARGININE
AB The flavivirus NS3 protein is a helicase that has pivotal functions during the viral genome replication process, where it unwinds double-stranded RNA and translocates along the nucleic acid polymer in a nucleoside triphosphate hydrolysis-dependent mechanism. Crystallographic and computational studies of the flavivirus NS3 helicase have identified the RNA-binding loop as an interesting structural element that may function as a component of the RNA-enhanced NTPase activity observed for this family of helicases. Microsecond-long unbiased molecular dynamics and extensive replica exchange umbrella sampling simulations of the Zika NS3 helicase have been performed to investigate the RNA dependence of this loop's structural conformations. Specifically, the effect of the bound single-stranded RNA (ssRNA) oligomer on the putative "open" and "closed" conformations of this loop is studied. In the Apo substrate state, the two loop conformations are nearly isoergonic (Delta A(O -> C) = -0.22 kcal mol(-1)), explaining the structural ambiguity observed in Apo NS3h crystal structures. The bound ssRNA is seen to stabilize the "open" conformation (Delta A(O -> C) = 1.97 kcal mol(-1)) through direct protein-RNA interactions at the top of the loop. Interestingly, a small ssRNA oligomer bound over 13 A away from the loop is seen to affect the free energy surface to favor the "open" structure, while minimizing barriers between the two states. Both the mechanism of the "open" to "closed" transition and important residues of the RNA-binding loop structures are characterized. From these results, point mutations that are hypothesized to stabilize the "closed" RNA-binding loop and negatively impact RNA-binding and the RNA-enhanced NTPase activity are posited.
C1 [McCullagh, Martin] Oklahoma State Univ, Dept Chem, Stillwater, OK 74074 USA.
   [Davidson, Russell B.; Hendrix, Josie] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.
   [Geiss, Brian J.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA.
RP McCullagh, M (corresponding author), Oklahoma State Univ, Dept Chem, Stillwater, OK 74074 USA.
EM martin.mccullagh@okstate.edu
FU National Science FoundationNational Science Foundation (NSF)
   [ACI-1548562]; Extreme Science and Engineering Discovery Environment
   (XSEDE) [CHE160008]; National Science Foundation Research Experience for
   UndergraduatesNational Science Foundation (NSF) [CHE-1461040]; Fixman
   Summer Theory program; NIH/NCATS Colorado CTSAUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Center for Advancing Translational Sciences (NCATS) [UL1
   TR002535]
FX R.B.D. would like to acknowledge Dr. Peter Lake for insightful
   discussions. This work was supported by the National Science
   Foundation-supported (grant no. ACI-1548562) Extreme Science and
   Engineering Discovery Environment (XSEDE) (allocation no. CHE160008) and
   the National Science Foundation Research Experience for Undergraduates
   (CHE-1461040) and Fixman Summer Theory program to J.H. We would
   specifically like to acknowledge the San Diego Supercomputer Center
   Comet and Pittsburgh Super Computing Bridges resources used under XSEDE
   allocation CHE160008 awarded to MM. The multiple sequence alignment
   analysis, reported in the Supporting Information, was performed with
   computational resources provided by by NIH/NCATS Colorado CTSA grant
   number UL1 TR002535.
CR Banas P, 2010, J CHEM THEORY COMPUT, V6, P3836, DOI 10.1021/ct100481h
   Basavannacharya C, 2014, BIOCHEM BIOPH RES CO, V453, P539, DOI 10.1016/j.bbrc.2014.09.113
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232
   Borowski P, 2002, ACTA BIOCHIM POL, V49, P597
   Borowski P, 2001, J VIROL, V75, P3220, DOI 10.1128/JVI.75.7.3220-3229.2001
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12
   CALNAN BJ, 1991, SCIENCE, V252, P1167, DOI 10.1126/science.252.5009.1167
   Cao XC, 2016, NUCLEIC ACIDS RES, V44, P10505, DOI 10.1093/nar/gkw941
   Case D., 2016, AMBER16
   Case D. A, 2018, AMBER18
   CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045
   Cox Bryan D., 2015, Antiviral Chemistry & Chemotherapy, V24, P118, DOI 10.1177/2040206616653873
   Davidson RB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006103
   Du Pont KE, 2020, J BIOL CHEM, V295, P1551, DOI 10.1074/jbc.RA119.011922
   Ekins S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005023
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011
   Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412
   Fukunishi H, 2002, J CHEM PHYS, V116, P9058, DOI 10.1063/1.1472510
   Gu MG, 2016, J BIOL CHEM, V291, P14499, DOI 10.1074/jbc.M115.704379
   Gupta AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep32713
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55
   Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Kinney RM, 1997, VIROLOGY, V230, P300, DOI 10.1006/viro.1997.8500
   Klema VJ, 2015, VIRUSES-BASEL, V7, P4640, DOI 10.3390/v7082837
   Kumar S, 2000, PROTEIN SCI, V9, P10
   Kuo MD, 1996, J GEN VIROL, V77, P2077, DOI 10.1099/0022-1317-77-9-2077
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787
   MORRIS AL, 1992, PROTEINS, V12, P345, DOI 10.1002/prot.340120407
   Mottin M, 2017, BIOCHEM BIOPH RES CO, V492, P643, DOI 10.1016/j.bbrc.2017.03.070
   Munawar A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113664
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Ndjomou J, 2015, ACS CHEM BIOL, V10, P1887, DOI 10.1021/acschembio.5b00101
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Raney KD, 2010, J BIOL CHEM, V285, P22725, DOI 10.1074/jbc.R110.125294
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Stone J. E., 1998, THESIS
   Swarbrick CMD, 2017, NUCLEIC ACIDS RES, V45, DOI 10.1093/nar/gkx1127
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   TAO JS, 1992, P NATL ACAD SCI USA, V89, P2723, DOI 10.1073/pnas.89.7.2723
   Thiede EH, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4960649
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   Tsai CJ, 1999, P NATL ACAD SCI USA, V96, P9970, DOI 10.1073/pnas.96.18.9970
   Utama A, 2000, FEBS LETT, V465, P74, DOI 10.1016/S0014-5793(99)01705-6
   Wang CC, 2009, FEBS LETT, V583, P691, DOI 10.1016/j.febslet.2009.01.008
   WARRENER P, 1993, J VIROL, V67, P989, DOI 10.1128/JVI.67.2.989-996.1993
   WENGLER G, 1991, VIROLOGY, V184, P707, DOI 10.1016/0042-6822(91)90440-M
   Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x
NR 56
TC 0
Z9 0
U1 4
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
EI 1520-5207
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD MAR 26
PY 2020
VL 124
IS 12
BP 2371
EP 2381
DI 10.1021/acs.jpcb.0c00457
PG 11
WC Chemistry, Physical
SC Chemistry
GA LE6WN
UT WOS:000526864400008
PM 32105483
DA 2020-07-08
ER

PT J
AU Xu, JM
   Berastegui-Cabrera, J
   Chen, HY
   Pachon, J
   Zhou, J
   Sanchez-Cespedes, J
AF Xu, Jimin
   Berastegui-Cabrera, Judith
   Chen, Haiying
   Pachon, Jeronimo
   Zhou, Jia
   Sanchez-Cespedes, Javier
TI Structure-Activity Relationship Studies on Diversified Salicylamide
   Derivatives as Potent Inhibitors of Human Adenovirus Infection
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID STEM-CELL TRANSPLANTATION; ACYCLIC NUCLEOSIDE PHOSPHONATES; BIOLOGICAL
   EVALUATION; ZIKA VIRUS; BRINCIDOFOVIR; REPLICATION; RECIPIENTS;
   CIDOFOVIR; CMX001; NICLOSAMIDE
AB The effective treatment of adenovirus (HAdV) infections in immunocompromised patients still poses great challenges. Herein, we reported our continued efforts to optimize a series of salicylamide derivatives as potent inhibitors of HAdV infection. Of these, nine compounds (11, 13, 14, 17, 20, 58, 60, 62, and 70) showed significantly improved anti-HAdV activities with nanomolar to submicromolar IC50 values and high selectivity indexes (SI > 100), indicating better safety windows, compared to those of the lead compound niclosamide. Our mechanistic assays suggest that compounds 13, 62, and 70 exert their activities in the HAdV entry pathway, while compounds 14 and 60 likely target the HAdV DNA replication, and 11, 17, 20, and 58 inhibit later steps after DNA replication. Given the broad anti-viral activity profile of niclosamide, these derivatives may also offer therapeutic potential for other viral infections.
C1 [Xu, Jimin; Chen, Haiying; Zhou, Jia] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA.
   [Berastegui-Cabrera, Judith; Pachon, Jeronimo; Sanchez-Cespedes, Javier] Univ Seville, Inst Biomed Seville IBiS, Unit Infect Dis Microbiol & Prevent Med, Univ Hosp Virgen del Rocio,CSIC, E-41013 Seville, Spain.
   [Pachon, Jeronimo] Univ Seville, Dept Med, E-41009 Seville, Spain.
RP Zhou, J (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Chem Biol Program, Galveston, TX 77555 USA.; Sanchez-Cespedes, J (corresponding author), Univ Seville, Inst Biomed Seville IBiS, Unit Infect Dis Microbiol & Prevent Med, Univ Hosp Virgen del Rocio,CSIC, E-41013 Seville, Spain.
EM jizhou@utmb.edu; jsanchez-ibis@us.es
RI ; Sanchez Cespedes, Javier/B-1063-2014
OI Zhou, Jia/0000-0002-2811-1090; Berastegui Cabrera,
   Judith/0000-0002-9607-8317; Sanchez Cespedes, Javier/0000-0003-2707-1979
FU UTMB Technology Commercialization Program; John Sealy Memorial Endowment
   Fund; Institute for Translational Sciences (ITS) at UTMB; Spanish
   Network for Research in Infectious Diseases [REIPI RD16/0016/0009];
   European Development Regional Fund "A way to achieve Europe", Operative
   program Intelligent Growth 2014-2020; Carlos III Health
   InstituteInstituto de Salud Carlos III [DTS17/00130]; Spanish Adenovirus
   Network (AdenoNet) [BIO2015/68990-REDT]; program "Nicolas Monardes",
   Servicio Andaluz de Salud, Junta de Andalucia, SpainJunta de Andalucia
   [C0059-2018]
FX This work was supported by the UTMB Technology Commercialization
   Program, John Sealy Memorial Endowment Fund, and Institute for
   Translational Sciences (ITS) at UTMB, the Spanish Network for Research
   in Infectious Diseases (REIPI RD16/0016/0009), cofinanced by European
   Development Regional Fund "A way to achieve Europe", Operative program
   Intelligent Growth 2014-2020, the Carlos III Health Institute
   (DTS17/00130), and the Spanish Adenovirus Network (AdenoNet,
   BIO2015/68990-REDT) grants. J.S.-C. is a researcher belonging to the
   program "Nicolas Monardes" (C0059-2018), Servicio Andaluz de Salud,
   Junta de Andalucia, Spain.
CR Abbas S, 2017, INT J INFECT DIS, V62, P86, DOI 10.1016/j.ijid.2017.07.011
   Andersson EK, 2010, ANTIMICROB AGENTS CH, V54, P3871, DOI 10.1128/AAC.00203-10
   Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377
   Chamberlain JM, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01925-18
   Chen HJ, 2013, ACS MED CHEM LETT, V4, P180, DOI 10.1021/ml3003082
   Chen W, 2017, CELL SIGNAL, V41, P89, DOI 10.1016/j.cellsig.2017.04.001
   Chittick G, 2017, ANTIVIR RES, V143, P269, DOI 10.1016/j.antiviral.2017.01.009
   Echavarria M, 2008, CLIN MICROBIOL REV, V21, P704, DOI 10.1128/CMR.00052-07
   Fan XZ, 2019, TUBERCULOSIS, V116, pS28, DOI 10.1016/j.tube.2019.04.008
   Fang JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078425
   Florescu DF, 2015, PEDIATR INFECT DIS J, V34, P47, DOI 10.1097/INF.0000000000000487
   Florescu DF, 2014, EXPERT REV ANTI-INFE, V12, P1171, DOI 10.1586/14787210.2014.948847
   Florescu DF, 2012, BIOL BLOOD MARROW TR, V18, P731, DOI 10.1016/j.bbmt.2011.09.007
   Fonseca BD, 2012, J BIOL CHEM, V287, P17530, DOI 10.1074/jbc.M112.359638
   GREBER UF, 1993, CELL, V75, P477, DOI 10.1016/0092-8674(93)90382-Z
   Grimley MS, 2017, BIOL BLOOD MARROW TR, V23, P512, DOI 10.1016/j.bbmt.2016.12.621
   Grimley MS, 2015, BIOL BLOOD MARROW TR, V21, pS108, DOI 10.1016/j.bbmt.2014.11.136
   Grosso F, 2017, J VIROL, V91, DOI 10.1128/JVI.01623-16
   Hage E, 2015, J GEN VIROL, V96, P2734, DOI 10.1099/vir.0.000196
   Hamdy NA, 2013, ACTA POL PHARM, V70, P99
   Hartline CB, 2005, J INFECT DIS, V191, P396, DOI 10.1086/426831
   Hostetler KY, 2009, ANTIVIR RES, V82, pA84, DOI 10.1016/j.antiviral.2009.01.005
   Ison MG, 2006, CLIN INFECT DIS, V43, P331, DOI 10.1086/505498
   Jurgeit A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002976
   Kang DW, 2016, BIOORG MED CHEM LETT, V26, P5182, DOI 10.1016/j.bmcl.2016.09.071
   Kojaoghlanian T, 2003, REV MED VIROL, V13, P155, DOI 10.1002/rmv.386
   Lenaerts L, 2006, ANTIVIR RES, V71, P172, DOI 10.1016/j.antiviral.2006.04.007
   Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589
   Li YY, 2014, J INSECT PHYSIOL, V70, P8, DOI 10.1016/j.jinsphys.2014.08.005
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lion T, 2014, CLIN MICROBIOL REV, V27, P441, DOI 10.1128/CMR.00116-13
   Liu CH, 2013, VIRUS RES, V172, P9, DOI 10.1016/j.virusres.2012.12.001
   Lugthart G, 2015, BIOL BLOOD MARROW TR, V21, P293, DOI 10.1016/j.bbmt.2014.10.012
   Madrid PB, 2015, ACS INFECT DIS, V1, P317, DOI 10.1021/acsinfecdis.5b00030
   Marrugal-Lorenzo JA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37290-3
   Marrugal-Lorenzo JA, 2018, ANTIVIR RES, V159, P77, DOI 10.1016/j.antiviral.2018.09.011
   Martinez-Aguado P, 2015, DRUG DISCOV TODAY, V20, P1235, DOI 10.1016/j.drudis.2015.07.007
   Mazzotta S, 2020, EUR J MED CHEM, V185, DOI 10.1016/j.ejmech.2019.111840
   Mohamed MS, 2015, ARCH PHARM, V348, P194, DOI 10.1002/ardp.201400387
   Niu QL, 2019, J CLIN INVEST, V129, P3361, DOI 10.1172/JCI120633
   Oberg CT, 2012, J MED CHEM, V55, P3170, DOI 10.1021/jm201636v
   Prasad V.K., 2017, BIOL BLOOD MARROW TR, V23, P57
   Ren XM, 2010, ACS MED CHEM LETT, V1, P454, DOI 10.1021/ml100146z
   Robinson CM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01812
   Sanchez-Cespedes J, 2016, J MED CHEM, V59, P5432, DOI 10.1021/acs.jmedchem.6b00300
   Sanchez-Cespedes J, 2014, ANTIVIR RES, V108, P65, DOI 10.1016/j.antiviral.2014.05.010
   Sandkovsky U, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0416-y
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Sedlacek P, 2019, BIOL BLOOD MARROW TR, V25, P810, DOI 10.1016/j.bbmt.2018.12.753
   Stachulski AV, 2011, J MED CHEM, V54, P8670, DOI 10.1021/jm201264t
   Tippin TK, 2016, THER DRUG MONIT, V38, P777, DOI 10.1097/FTD.0000000000000353
   Toth K, 2008, P NATL ACAD SCI USA, V105, P7293, DOI 10.1073/pnas.0800200105
   Toth K, 2018, ANTIVIR RES, V153, P1, DOI 10.1016/j.antiviral.2018.03.001
   Wold WSM, 2019, FEMS MICROBIOL REV, V43, P380, DOI 10.1093/femsre/fuz008
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Xu JM, 2019, J MED CHEM, V62, P7941, DOI 10.1021/acs.jmedchem.9b00698
   Xu JM, 2019, BIOORG MED CHEM LETT, V29, P1399, DOI 10.1016/j.bmcl.2019.03.032
   Xu JM, 2014, ORG BIOMOL CHEM, V12, P3721, DOI 10.1039/c4ob00364k
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Ye N, 2016, ACS INFECT DIS, V2, P382, DOI 10.1021/acsinfecdis.6b00041
   Yusuf U, 2006, TRANSPLANTATION, V81, P1398, DOI 10.1097/01.tp.0000209195.95115.8e
NR 61
TC 1
Z9 2
U1 1
U2 1
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD MAR 26
PY 2020
VL 63
IS 6
BP 3142
EP 3160
DI 10.1021/acs.jmedchem.9b01950
PG 19
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA LE0HA
UT WOS:000526404600026
PM 32045239
DA 2020-07-08
ER

PT J
AU Albinsso, B
   Jaaskelaine, AE
   Varv, K
   Jelovse, M
   GeurtsvanKessel, C
   Ven, S
   Jarhul, JD
   Reuske, C
   Golovljova, I
   Avsic-Zupan, T
   Vapalaht, O
   Lundkvis, A
AF Albinsso, Bo
   Jaaskelaine, Anu E.
   Varv, Kairi
   Jelovse, Mateja
   GeurtsvanKessel, Corine
   Ven, Sirkka
   Jarhul, Josef D.
   Reuske, Chantal
   Golovljova, Irina
   Avsic-Zupan, Tatjana
   Vapalaht, Olli
   Lundkvis, Ake
TI Multi laboratory evaluation of ReaScan TBE IgM rapid test, 2016 to 2017
SO EUROSURVEILLANCE
LA English
DT Article
ID TICK-BORNE ENCEPHALITIS; SIBERIAN SUBTYPE; VIRUS-INFECTIONS; COMMERCIAL
   IGG; ELISA KITS; DIAGNOSIS; EPIDEMIOLOGY; ANTIBODIES; FOCUS; ASSAY
AB Tick-borne encephalitis (TBE) is a potentially severe neurological disease caused by TBE virus (TBEV). In Europe and Asia, TBEV infection has become a growing public health concern and requires fast and specific detection. Aim: In this observational study, we evaluated a rapid TBE IgM test, ReaScan TBE, for usage in a clinical laboratory setting. Methods: Patient sera found negative or positive for TBEV by serological and/or molecular methods in diagnostic laboratories of five European countries endemic for TBEV (Estonia, Finland, Slovenia, the Netherlands and Sweden) were used to assess the sensitivity and specificity of the test. The patients' diagnoses were based on other commercial or quality assured in-house assays, i.e. each laboratory's conventional routine methods. For specificity analysis, serum samples from patients with infections known to cause problems in serology were employed. These samples tested positive for e.g. Epstein-Barr virus, cytomegalovirus and Anaplasma phagocytophilum, or for flaviviruses other than TBEV, i.e. dengue, Japanese encephalitis, West Nile and Zika viruses. Samples from individuals vaccinated against flaviviruses other than TBEV were also included. Altogether, 172 serum samples from patients with acute TBE and 306 TBE IgM negative samples were analysed. Results: Compared with each laboratory's conventional methods, the tested assay had similar sensitivity and specificity (99.4% and 97.7%, respectively). Samples containing potentially interfering antibodies did not cause specificity problems. Conclusion: Regarding diagnosis of acute TBEV infections, ReaScan TBE offers rapid and convenient complementary IgM detection. If used as a stand-alone, it can provide preliminary results in a laboratory or point of care setting.
C1 [Albinsso, Bo; Varv, Kairi; Ven, Sirkka; Golovljova, Irina; Lundkvis, Ake] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.
   [Albinsso, Bo] Lab Clin Microbiol, Uppsala, Sweden.
   [Jaaskelaine, Anu E.; Vapalaht, Olli] Univ Helsinki, Dept Virol, Helsinki, Finland.
   [Jaaskelaine, Anu E.; Vapalaht, Olli] Helsinki Univ Hosp Lab Serv HUSLAB, Dept Virol & Immunol, Helsinki, Finland.
   [Varv, Kairi; Golovljova, Irina] Natl Inst Hlth Dev, Dept Virol & Immunol, Tallinn, Estonia.
   [GeurtsvanKessel, Corine; Reuske, Chantal] Erasmus MC, WHO Collaborating Ctr Arbovirus & Viral Haemorrha, Dept Virol, Rotterdam, Netherlands.
   [Jarhul, Josef D.] Uppsala Univ, Zoonosis Sci Ctr, Dept Med Sci, Uppsala, Sweden.
   [Jelovse, Mateja; Avsic-Zupan, Tatjana] Univ Ljubljana, Fac Med, Inst Microbiol & Immunol, Ljubljana, Slovenia.
   [Vapalaht, Olli] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.
   [Reuske, Chantal] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Bilthoven, Netherlands.
RP Lundkvis, A (corresponding author), Uppsala Univ, Zoonosis Sci Ctr, Dept Med Biochem & Microbiol, Uppsala, Sweden.
EM ake.lundkvist@imbim.uu.se
OI Vapalahti, Olli/0000-0003-2270-6824; Jaaskelainen,
   Anu/0000-0003-0451-6832
CR Ackermann-Gaumann R, 2018, TICKS TICK-BORNE DIS, V9, P956, DOI 10.1016/j.ttbdis.2018.03.031
   Ackermann-Gaumann R, 2019, VECTOR-BORNE ZOONOT, V19, P358, DOI 10.1089/vbz.2018.2359
   Agergaard CN, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.43.1900639
   Albinsson B, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.3.17-00838
   [Anonymous], 2011, Wkly Epidemiol Rec, V86, P241
   Beaute J, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.45.1800201
   Bogovic P, 2018, TICKS TICK-BORNE DIS, V9, P369, DOI 10.1016/j.ttbdis.2017.12.001
   Bogovic P, 2015, WORLD J CLIN CASES, V3, P430, DOI 10.12998/wjcc.v3.i5.430
   Charrel RN, 2004, CLIN MICROBIOL INFEC, V10, P1040, DOI 10.1111/j.1469-0691.2004.01022.x
   Dai XY, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0081-6
   Dekker M, 2019, TICKS TICK-BORNE DIS, V10, P176, DOI 10.1016/j.ttbdis.2018.10.008
   Dobler G, 2017, TBE THE BOOK
   Estrada-Pena A, 2014, ANTIVIR RES, V108, P104, DOI 10.1016/j.antiviral.2014.05.016
   Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003
   Gunther G, 1997, CLIN DIAGN VIROL, V8, P17, DOI 10.1016/S0928-0197(97)00273-0
   Holding M, 2020, EMERG INFECT DIS, V26, P90, DOI 10.3201/eid2601.191085
   Holzmann H, 2003, VACCINE, V21, pS36, DOI 10.1016/S0264-410X(02)00819-8
   Hudopisk N, 2013, EMERG INFECT DIS, V19, P806, DOI 10.3201/eid1905.121442
   Jaaskelainen A, 2003, J CLIN MICROBIOL, V41, P4336, DOI 10.1128/JCM.41.9.4336-4342.2003
   Jaaskelainen A, 2016, TICKS TICK-BORNE DIS, V7, P216, DOI 10.1016/j.ttbdis.2015.10.013
   Jaenson TGT, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1658-3
   Kaiser R, 2011, NERVENARZT, V82, P1020, DOI 10.1007/s00115-011-3254-2
   Kovalev SY, 2017, INFECT GENET EVOL, V55, P159, DOI 10.1016/j.meegid.2017.09.014
   Kuivanen S, 2018, EMERG INFECT DIS, V24, P946, DOI 10.3201/eid2405.171986
   LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Lindquist L, 2014, HAND CLINIC, V123, P531, DOI 10.1016/B978-0-444-53488-0.00025-0
   Lotric-Furlan S, 2017, J INTERN MED, V282, P142, DOI 10.1111/joim.12625
   Lotric-Furlan S, 2006, WIEN KLIN WOCHENSCHR, V118, P708, DOI 10.1007/s00508-006-0700-4
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   NIEDRIG M, 1994, ACTA VIROL, V38, P141
   Niesters HGM, 2000, J CLIN MICROBIOL, V38, P712, DOI 10.1128/JCM.38.2.712-715.2000
   PuchhammerStockl E, 1995, CLIN DIAGN VIROL, V4, P321, DOI 10.1016/0928-0197(95)00022-4
   Reusken C, 2019, J CLIN VIROL, V120, P78, DOI 10.1016/j.jcv.2019.09.009
   Ruzek D, 2019, ANTIVIR RES, V164, P23, DOI 10.1016/j.antiviral.2019.01.014
   Saksida A, 2018, EMERG INFECT DIS, V24, P1315, DOI 10.3201/eid2407.180059
   Schwaiger M, 2003, J CLIN VIROL, V27, P136, DOI 10.1016/S1386-6532(02)00168-3
   Suss J, 2010, TICKS TICK-BORNE DIS, V1, P1, DOI [10.1016/j.ttbdis.2010.01.003, 10.1016/j.ttbdis.2010.10.007]
   Taba P, 2017, EUR J NEUROL, V24, P1214, DOI 10.1111/ene.13356
   van den Doel P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003101
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Velay A, 2018, DIAGN MICR INFEC DIS, V90, P286, DOI 10.1016/j.diagmicrobio.2017.12.012
   Velay A, 2018, TICKS TICK-BORNE DIS, V9, P120, DOI 10.1016/j.ttbdis.2017.09.015
   Vene S, 1998, J VIROL METHODS, V73, P71, DOI 10.1016/S0166-0934(98)00041-X
   VENE S, 1995, CLIN DIAGN VIROL, V4, P43, DOI 10.1016/0928-0197(94)00060-8
NR 45
TC 0
Z9 0
U1 0
U2 0
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD MAR 26
PY 2020
VL 25
IS 12
BP 27
EP 36
AR 1900427
DI 10.2807/1560-7917.ES.2020.25.12.1900427
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA KX8UD
UT WOS:000522148900005
PM 32234120
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wilke, ABB
   Vasquez, C
   Carvajal, A
   Moreno, M
   Diaz, Y
   Belledent, T
   Gibson, L
   Petrie, WD
   Fuller, DO
   Beier, JC
AF Wilke, Andre B. B.
   Vasquez, Chalmers
   Carvajal, Augusto
   Moreno, Maday
   Diaz, Yadira
   Belledent, Teresa
   Gibson, Laurin
   Petrie, William D.
   Fuller, Douglas O.
   Beier, John C.
TI Cemeteries in Miami-Dade County, Florida are important areas to be
   targeted in mosquito management and control efforts
SO PLOS ONE
LA English
DT Article
ID AUTOCHTHONOUS DENGUE-FEVER; YELLOW-FEVER; ZIKA VIRUS; BIODIVERSITY;
   SHORTAGE; DIPTERA
AB Definable habitats at the neighborhood level provide a wide range of favorable habitats with optimal conditions and environmental resources for mosquito survival. Problematic habitats for controlling mosquitoes in urban environments such as tire shops, bromeliad patches, and construction sites must be taken into consideration in the development of effective mosquito management and control in urban areas. Cemeteries are often located in highly urbanized areas serving as a haven for populations of vector mosquito species due to the availability of natural resources present in most cemeteries. Even though Miami-Dade County, Florida was the most affected area in the United States during the Zika virus outbreak in 2016 and is currently under a mosquito-borne illness alert after 14 confirmed locally transmitted dengue cases, the role of cemeteries in the proliferation of vector mosquitoes is unknown. Therefore, our objective was to use a cross-sectional experimental design to survey twelve cemeteries across Miami-Dade County to assess if vector mosquitoes in Miami can be found in these areas. Our results are indicating that vector mosquitoes are able to successfully exploit the resources available in the cemeteries. Culex quinquefasciatus was the most abundant species but it was neither as frequent nor present in its immature form as Aedes aegypti and Aedes albopictus. This study revealed that vector mosquitoes, such as Ae. aegypti, Ae. albopictus, and Cx. quinquefasciatus are successfully exploiting the resources available in these areas being able to thrive and reach high numbers. Mosquito control strategies should consider both long-term strategies, based on changing human behavior to reduce the availability of aquatic habitats for vector mosquitoes; as well as short-term strategies such as drilling holes or adding larvicide to the flower vases. Simple practices would greatly help improve the effectiveness of mosquito management and control in these problematic urban habitats.
C1 [Wilke, Andre B. B.; Beier, John C.] Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
   [Vasquez, Chalmers; Carvajal, Augusto; Moreno, Maday; Diaz, Yadira; Belledent, Teresa; Gibson, Laurin; Petrie, William D.] Miami Dade Cty Mosquito Control Div, Miami, FL USA.
   [Fuller, Douglas O.] Univ Miami, Dept Geog & Reg Studies, Coral Gables, FL 33124 USA.
RP Wilke, ABB (corresponding author), Univ Miami, Miller Sch Med, Dept Publ Hlth Sci, Miami, FL 33136 USA.
EM axb1737@med.miami.edu
RI Wilke, Andre B B/J-9973-2014
OI Wilke, Andre B B/0000-0002-6629-7666
FU Miami-Dade Mosquito Control Division [1U01CK000510-03]
FX JCB Miami-Dade Mosquito Control Division JCB CDC (https://www.cdc.gov/)
   grant 1U01CK000510-03: Southeastern Regional Center of Excellence in
   Vector-Borne Diseases: The Gateway Program.
CR Abdul-Ghani R, 2019, ACTA TROP, V197, DOI 10.1016/j.actatropica.2019.105066
   Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Ajelli M, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005851
   [Anonymous], 2016, NAT NANOTECHNOL, V11, P1, DOI 10.1038/nnano.2015.333
   Barrett ADT, 2016, NEW ENGL J MED, V375, P301, DOI 10.1056/NEJMp1606997
   Benelli Giovanni, 2020, Trends Parasitol, DOI 10.1016/j.pt.2020.01.001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Centers for Disease Control and Prevention, 2020, IMP HUM DIS CAS REP
   Collins M. D., 2015, PLOS ONE, V10, P1
   Colwell R. K., 2009, PRINCETON GUIDE ECOL, P257, DOI DOI 10.1111/J.1442-9993.2012.02436.X
   COLWELL RK, 1994, PHILOS T R SOC B, V345, P101, DOI 10.1098/rstb.1994.0091
   Darsie Jr RF, 2000, KEYS ADULT FEMALES 4, V1
   Davalos-Becerril E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212987
   Florida Department of Health, 2019, MOSQ BORN ILLN ADV
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Gershman MD, 2017, MMWR-MORBID MORTAL W, V66, P457, DOI 10.15585/mmwr.mm6617e2
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Hamlet A, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006284
   Hammer O, 2001, PALAEONTOL ELECTRON, V4, P9, DOI DOI 10.1016/J.BCP.2008.05.025
   Jamison A, 2015, APPL GEOGR, V63, P418, DOI 10.1016/j.apgeog.2015.08.001
   Johnson MTJ, 2017, SCIENCE, V358, DOI 10.1126/science.aam8327
   Kamal M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0210122
   Kampen H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167948
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Lizzi KM, 2014, TRENDS PARASITOL, V30, P394, DOI 10.1016/j.pt.2014.06.001
   McKinney ML, 2006, BIOL CONSERV, V127, P247, DOI 10.1016/j.biocon.2005.09.005
   Messina JP, 2014, SCI DATA, V1, DOI 10.1038/sdata.2014.4
   Morris EK, 2014, ECOL EVOL, V4, P3514, DOI 10.1002/ece3.1155
   Mutebi JP, 2018, EMERG INFECT DIS, V24, P808, DOI 10.3201/eid2404.171919
   Nathan N, 2001, LANCET, V358, P2129, DOI 10.1016/S0140-6736(01)07185-9
   OMEARA GF, 1992, J AM MOSQUITO CONTR, V8, P1
   PAHO/WHO, 2019, REP CAS DENG FEV AM
   PAHO /WHO-Pan American Health Organization/World Health Organization, 2019, EP UPD YELL FEV
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Poletti P, 2011, PLOS ONE, V6
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006845
   Rosenberg Ronald, 2018, MMWR Morb Mortal Wkly Rep, V67, P496, DOI 10.15585/mmwr.mm6717e1
   Samy AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163863
   SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x
   SIMPSON EH, 1949, NATURE, V163, P688, DOI 10.1038/163688a0
   TOTHMERESZ B, 1995, J VEG SCI, V6, P283, DOI 10.2307/3236223
   Tothmeresz B., 1988, ABSTR BOT, V22, P149
   Trewin BJ, 2017, PLOS NEGLECT TROP D, V11, P1
   Troyo A, 2009, SINGAPORE J TROP GEO, V30, P265, DOI 10.1111/j.1467-9493.2009.00367.x
   Vezzani D, 2001, MEM I OSWALDO CRUZ, V96, P467, DOI 10.1590/S0074-02762001000400005
   Vezzani D, 2007, TROP MED INT HEALTH, V12, P299, DOI [10.1111/j.1365-3165.2006.01781.x, 10.1111/j.1365-3156.2006.01781.x]
   Walther D, 2017, ACTA TROP, V166, P186, DOI 10.1016/j.actatropica.2016.11.024
   Weitzel T, 2019, TRAVEL MED INFECT DI, V28, P1, DOI 10.1016/j.tmaid.2019.01.016
   Wilke AB, 2019, CURR OPIN INSECT SCI
   Wilke Andre B B, 2020, PLoS Negl Trop Dis, V14, pe0007864, DOI 10.1371/journal.pntd.0007864
   Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51787-5
   Wilke ABB, 2019, TRENDS PARASITOL, V35, P607, DOI 10.1016/j.pt.2019.05.009
   Wilke ABB, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45337-2
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217177
   Wilke ABB, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212688
   Wilke ABB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209625
   Wilke ABB, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2866-9
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
NR 60
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 24
PY 2020
VL 15
IS 3
AR e0230748
DI 10.1371/journal.pone.0230748
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ9GO
UT WOS:000535305100040
PM 32208462
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rao, L
   Tian, R
   Chen, XY
AF Rao, Lang
   Tian, Rui
   Chen, Xiaoyuan
TI Cell-Membrane-Mimicking Nanodecoys against Infectious Diseases
SO ACS NANO
LA English
DT Article
ID ZIKA VIRUS; NANOPARTICLES; LIPOSOMES; DELIVERY; VACCINE; TOXIN;
   LIPOPROTEIN; ANTIBODY; THERAPY
AB Infectious diseases are a leading cause of mortality worldwide, with viruses and bacteria in particular having enormous impacts on global healthcare. One major challenge in combatting such diseases is a lack of effective drugs or specific treatments. In addition, drug resistance to currently available therapeutics and adverse effects caused by long-term overuse are both serious public health issues. A promising treatment strategy is to employ cell-membrane mimics as decoys to trap and to detain the pathogens. In this Perspective, we briefly review the infection mechanisms adopted by different pathogens at the cellular membrane interface and highlight the applications of cell-membrane-mimicking nanodecoys for systemic protection against infectious diseases. We also discuss the implication of nanodecoy-pathogen complexes in the development of vaccines. We anticipate this Perspective will provide new insights on design and development of advanced materials against emerging infectious diseases.
C1 [Rao, Lang; Tian, Rui; Chen, Xiaoyuan] NIBIB, Lab Mol Imaging & Nanomed LOMIN, NIF, Bethesda, MD 20892 USA.
RP Chen, XY (corresponding author), NIBIB, Lab Mol Imaging & Nanomed LOMIN, NIF, Bethesda, MD 20892 USA.
EM shawn.chen@nih.gov
RI Rao, Lang/H-4666-2017; Chen, Xiaoyuan/D-1860-2014
OI Rao, Lang/0000-0001-5010-0729; Chen, Xiaoyuan/0000-0002-9622-0870
FU Intramural Research Program, National Institute of Biomedical Imaging
   and Bioengineering (NIBIB), National Institutes of Health (NIH)
FX We would like to thank Prof. Liangfang Zhang at University of
   California, San Diego, for manuscript discussion and editing. This work
   was supported by the Intramural Research Program, National Institute of
   Biomedical Imaging and Bioengineering (NIBIB), National Institutes of
   Health (NIH).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   BADIN J, 1970, J LAB CLIN MED, V75, P975
   BANGHAM AD, 1965, J MOL BIOL, V13, P253, DOI 10.1016/S0022-2836(65)80094-8
   Braden CR, 2013, EMERG INFECT DIS, V19, P864, DOI 10.3201/eid1906.130192
   Bricarello DA, 2012, TRENDS BIOTECHNOL, V30, P323, DOI 10.1016/j.tibtech.2012.03.002
   Bricarello DA, 2011, ACS NANO, V5, P42, DOI 10.1021/nn103098m
   Bricarello DA, 2010, J LIPID RES, V51, P2731, DOI 10.1194/jlr.M007401
   Chen ZW, 2019, ACCOUNTS CHEM RES, V52, P1255, DOI 10.1021/acs.accounts.9b00079
   Cohen ML, 2000, NATURE, V406, P762, DOI 10.1038/35021206
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006
   CRYZ SJ, 1982, INFECT IMMUN, V38, P21, DOI 10.1128/IAI.38.1.21-26.1982
   de Carvalho JV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113691
   Fang RH, 2018, ADV MATER, V30, DOI 10.1002/adma.201706759
   Fang RH, 2015, ADV DRUG DELIVER REV, V90, P69, DOI 10.1016/j.addr.2015.04.001
   Giles J, 2004, NATURE, V430, P126, DOI 10.1038/430126a
   Goyal AK, 2006, INT J PHARMACEUT, V309, P227, DOI 10.1016/j.ijpharm.2005.11.037
   Henry BD, 2015, NAT BIOTECHNOL, V33, P81, DOI 10.1038/nbt.3037
   Hooper LV, 2002, ANNU REV NUTR, V22, P283, DOI 10.1146/annurev.nutr.22.011602.092259
   Hu CMJ, 2015, NATURE, V526, P118, DOI 10.1038/nature15373
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P933, DOI [10.1038/NNANO.2013.254, 10.1038/nnano.2013.254]
   Hu CMJ, 2013, NAT NANOTECHNOL, V8, P336, DOI [10.1038/nnano.2013.54, 10.1038/NNANO.2013.54]
   Hu CMJ, 2011, P NATL ACAD SCI USA, V108, P10980, DOI 10.1073/pnas.1106634108
   Inal JM, 2013, BIOCHEM SOC T, V41, P258, DOI 10.1042/BST20120257
   ISEMAN MD, 1993, NEW ENGL J MED, V329, P784, DOI 10.1056/NEJM199309093291108
   Khezerlou A, 2018, MICROB PATHOGENESIS, V123, P505, DOI 10.1016/j.micpath.2018.08.008
   Li LL, 2014, ACS NANO, V8, P4975, DOI 10.1021/nn501040h
   Li Q., 2020, NEW ENGL J MED, DOI [10.1056/NEJMc2001468, DOI 10.1056/NEJMC2001468]
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Liu X, 2018, ANGEW CHEM INT EDIT, V57, P12499, DOI 10.1002/anie.201807212
   MAGEE WE, 1972, NATURE, V235, P339, DOI 10.1038/235339a0
   Moyes DL, 2016, NATURE, V532, P64, DOI 10.1038/nature17625
   NUSSBAUM O, 1987, J VIROL, V61, P2245, DOI 10.1128/JVI.61.7.2245-2252.1987
   Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301
   Parodi A, 2013, NAT NANOTECHNOL, V8, P61, DOI 10.1038/nnano.2012.212
   Pati R, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02224
   Rao L, 2019, NANO LETT, V19, P2215, DOI 10.1021/acs.nanolett.8b03913
   Rao L, 2018, ADV FUNCT MATER, V28, DOI 10.1002/adfm.201803531
   Rao L, 2018, ANGEW CHEM INT EDIT, V57, P986, DOI 10.1002/anie.201709457
   Rao L, 2017, ACS NANO, V11, P3496, DOI 10.1021/acsnano.7b00133
   Rao L, 2017, ADV FUNCT MATER, V27, DOI 10.1002/adfm.201604774
   Rao L, 2016, ADV MATER, V28, P3460, DOI 10.1002/adma.201506086
   Rao L, 2015, SMALL, V11, P6225, DOI 10.1002/smll.201502388
   Sullivan NJ, 2000, NATURE, V408, P605, DOI 10.1038/35046108
   Tanury P, 2010, ADV DRUG DELIVER REV, V62, P424, DOI 10.1016/j.addr.2009.11.014
   Thamphiwatana S, 2014, J MATER CHEM B, V2, P8201, DOI 10.1039/c4tb01110d
   Trkola A, 1996, NATURE, V384, P184, DOI 10.1038/384184a0
   Wei XL, 2018, ADV MATER, V30, DOI 10.1002/adma.201802233
   Westman J, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.13016
   Wu JT, 2020, LANCET, V395, P689, DOI 10.1016/S0140-6736(20)30260-9
   Zhang PF, 2015, P NATL ACAD SCI USA, V112, pE6129, DOI 10.1073/pnas.1505799112
   Zhang Y, 2019, ANGEW CHEM INT EDIT, V58, P11404, DOI 10.1002/anie.201906280
   Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017
   Zolnik BS, 2010, ENDOCRINOLOGY, V151, P458, DOI 10.1210/en.2009-1082
NR 55
TC 0
Z9 0
U1 9
U2 9
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
EI 1936-086X
J9 ACS NANO
JI ACS Nano
PD MAR 24
PY 2020
VL 14
IS 3
BP 2569
EP 2574
DI 10.1021/acsnano.0c01665
PG 6
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA LD8TZ
UT WOS:000526301400004
PM 32129977
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Sun, J
   Du, SY
   Zheng, ZH
   Cheng, G
   Jin, X
AF Sun, Jin
   Du, Senyan
   Zheng, Zhihang
   Cheng, Gong
   Jin, Xia
TI Defeat Dengue and Zika Viruses With a One-Two Punch of Vaccine and
   Vector Blockade
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Review
DE dengue virus; Zika virus; epidemiology; virology; protective immunity;
   vaccine; mosquitoes
ID CD8(+) T-CELL; ANTIBODY-DEPENDENT ENHANCEMENT; ORIGINAL ANTIGENIC SIN;
   NEUTRALIZING HUMAN-ANTIBODIES; FLAVIVIRUS-NAIVE ADULTS; HUMAN
   ENDOTHELIAL-CELLS; PRINCIPAL TARGET-CELLS; PROTECTIVE EFFICACY;
   HEALTHY-CHILDREN; AEDES-AEGYPTI
AB Dengue virus (DENV) and Zika virus (ZIKV) are two mosquito-borne flaviviruses afflicting nearly half of the world population. Human infection by these viruses can either be asymptomatic or manifest as clinical diseases from mild to severe. Despite more cases are presented as self-limiting febrile illness, severe dengue disease can be manifested as hemorrhagic fever and hemorrhagic shock syndrome, and ZIKV infection has been linked to increased incidence of peripheral neuropathy Guillain-Barre syndrome and central neural disease such as microcephaly. The current prevention and treatment of these infectious diseases are either non-satisfactory or entirely lacking. Because DENV and ZIKV have much similarities in genomic and structural features, almost identical mode of mosquito-mediated transmission, and probably the same pattern of host innate and adaptive immunity toward them, it is reasonable and often desirable to investigate these two viruses side-by-side, and thereby devise common countermeasures against both. Here, we review the existing knowledge on DENV and ZIKV regarding epidemiology, molecular virology, protective immunity and vaccine development, discuss recent new discoveries on the functions of flavivirus NS1 protein in viral pathogenesis and transmission, and propose a one-two punch strategy using vaccine and vector blockade to overcome antibody-dependent enhancement and defeat Dengue and Zika viruses.
C1 [Sun, Jin; Zheng, Zhihang; Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Viral Dis & Vaccine Translat Res Unit, Shanghai, Peoples R China.
   [Du, Senyan; Cheng, Gong] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.
   [Zheng, Zhihang] Univ Chinese Acad Sci, Chinese Acad Sci, Inst Pasteur Shanghai, Shanghai, Peoples R China.
   [Jin, Xia] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
RP Jin, X (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Viral Dis & Vaccine Translat Res Unit, Shanghai, Peoples R China.; Jin, X (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
EM xjin@ips.ac.cn
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [31670941]; Ministry of Science and Technology of
   People's Republic of ChinaMinistry of Science and Technology, China
   [2016YFC1201000]; Strategic Priority Research Program of the Chinese
   Academy of SciencesChinese Academy of Sciences [XDB29040000]; Science
   and Technology Commission of Shanghai MunicipalityScience & Technology
   Commission of Shanghai Municipality (STCSM) [19ZR1462900]
FX This work was supported by the grant: National Natural Science
   Foundation of China, 31670941; Ministry of Science and Technology of
   People's Republic of China, 2016YFC1201000; Strategic Priority Research
   Program of the Chinese Academy of Sciences, XDB29040000; and Science and
   Technology Commission of Shanghai Municipality, 19ZR1462900.
CR Abbink P, 2018, NAT MED, V24, P721, DOI 10.1038/s41591-018-0056-0
   [Anonymous], 1966, Bull World Health Organ, V35, P17
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Bailey MJ, 2019, MBIO, V10, DOI [10.1128/mBio.02861-18, 10.1128/mbio.02861-18]
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barnett R, 2017, LANCET, V390, P1941, DOI 10.1016/S0140-6736(17)32651-X
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.32.30316
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   Beckett CG, 2011, VACCINE, V29, P960, DOI 10.1016/j.vaccine.2010.11.050
   Beltramello M, 2010, CELL HOST MICROBE, V8, P271, DOI 10.1016/j.chom.2010.08.007
   BHAMARAPRAVATI N, 1987, B WORLD HEALTH ORGAN, V65, P189
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869
   Blackley S, 2007, J VIROL, V81, P13325, DOI 10.1128/JVI.01568-07
   Blaney JE, 2001, J VIROL, V75, P9731, DOI 10.1128/JVI.75.20.9731-9740.2001
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   Block OKT, 2010, VACCINE, V28, P8085, DOI 10.1016/j.vaccine.2010.10.004
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brandler S, 2005, AM J TROP MED HYG, V72, P74, DOI 10.4269/ajtmh.2005.72.74
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Cheng HJ, 2009, MOL IMMUNOL, V47, P398, DOI 10.1016/j.molimm.2009.08.033
   Clarke T, 2002, NATURE, V416, P672, DOI 10.1038/416672a
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Collins MH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124588
   Costa SM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025685
   Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dalrymple NA, 2012, J VIROL, V86, P6408, DOI 10.1128/JVI.00213-12
   Dayan GH, 2013, AM J TROP MED HYG, V89, P1058, DOI 10.4269/ajtmh.13-0304
   Dayan GH, 2013, VACCINE, V31, P5047, DOI 10.1016/j.vaccine.2013.08.088
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duangchinda T, 2010, P NATL ACAD SCI USA, V107, P16922, DOI 10.1073/pnas.1010867107
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Durbin AP, 2006, HUM VACCINES, V2, P255, DOI 10.4161/hv.2.6.3494
   Durbin AP, 2013, J INFECT DIS, V207, P957, DOI 10.1093/infdis/jis936
   Durbin AP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001267
   Durbin AP, 2005, J INFECT DIS, V191, P710, DOI 10.1086/427780
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Fatima K, 2018, J GLOB HEALTH, V8, DOI [10.7189/jogh.08-020312, 10.7189/jogh.08.020312]
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George SL, 2015, J INFECT DIS, V212, P1032, DOI 10.1093/infdis/jiv179
   Glasner DR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006673
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Govindarajan D, 2015, VACCINE, V33, P4105, DOI 10.1016/j.vaccine.2015.06.067
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Griffin BD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15743
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grifoni A, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01309
   Gubler D J, 1987, P R Health Sci J, V6, P107
   Guirakhoo F, 2000, J VIROL, V74, P5477, DOI 10.1128/JVI.74.12.5477-5485.2000
   Guirakhoo F, 2002, VIROLOGY, V298, P146, DOI 10.1006/viro.2002.1462
   Guirakhoo F, 2001, J VIROL, V75, P7290, DOI 10.1128/JVI.75.16.7290-7304.2001
   Guirakhoo F, 2006, HUM VACCINES, V2, P60, DOI 10.4161/hv.2.2.2555
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1983, AM J TROP MED HYG, V32, P154, DOI 10.4269/ajtmh.1983.32.154
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1966, B WORLD HEALTH ORGAN, V35, P3
   Halstead SB, 2019, LANCET CHILD ADOLESC, V3, P734, DOI 10.1016/S2352-4642(19)30205-6
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Hessert M, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007237
   Higgs S, 2006, AM J TROP MED HYG, V75, P986, DOI 10.4269/ajtmh.2006.75.986
   Holmes EC, 2003, INFECT GENET EVOL, V3, P19, DOI 10.1016/S1567-1348(03)00004-2
   Hss AS, 2013, VACCINE, V31, P5814, DOI 10.1016/j.vaccine.2013.10.013
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Jessie K, 2004, J INFECT DIS, V189, P1411, DOI 10.1086/383043
   Jin X, 2008, FUTURE VIROL, V3, P343, DOI 10.2217/17460794.3.4.343
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Khaiboullina S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00642
   Khaiboullina SF, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01465
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   KLIKS S, 1990, AIDS RES HUM RETROV, V6, P993, DOI 10.1089/aid.1990.6.993
   Kou Z, 2008, J MED VIROL, V80, P134, DOI 10.1002/jmv.21051
   KUNO G, 1993, T ROY SOC TROP MED H, V87, P103, DOI 10.1016/0035-9203(93)90444-U
   Lanata CF, 2012, VACCINE, V30, P5935, DOI 10.1016/j.vaccine.2012.07.043
   Leborgne C, 2019, CELL IMMUNOL, V342, DOI 10.1016/j.cellimm.2018.03.004
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200478
   Li M, 2017, SCI CHINA LIFE SCI, V60, P1396, DOI 10.1007/s11427-017-9192-0
   Liang HB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194860
   Lim MQ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02225
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Lin CF, 2005, J IMMUNOL, V174, P395, DOI 10.4049/jimmunol.174.1.395
   Lindenbach Brett D., 2007, FIELDS VIROLOGY, P1101
   Liu HT, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184207
   Liu IJ, 2011, J BIOL CHEM, V286, P9726, DOI 10.1074/jbc.M110.170993
   Liu JY, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.87, 10.1038/nmicrobiol.2016.87]
   Liu SF, 2016, CIRC RES, V119, P1183, DOI [10.1161/CIRCRESAHA.116.309866, 10.1161/circresaha.116.309866]
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144
   Manoff SB, 2019, HUM VACC IMMUNOTHER, V15, P2195, DOI 10.1080/21645515.2018.1546523
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Mantel N, 2011, VACCINE, V29, P6629, DOI 10.1016/j.vaccine.2011.06.101
   Marianneau P, 1999, J VIROL, V73, P5201, DOI 10.1128/JVI.73.6.5201-5206.1999
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Mcgee CE, 2008, J INFECT DIS, V197, P686, DOI 10.1086/527328
   Medina LO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02464
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Metz SW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12677-6
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mitragotri S, 2006, NAT REV DRUG DISCOV, V5, P543, DOI 10.1038/nrd2076
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Nancy P, 2012, SCIENCE, V336, P1317, DOI 10.1126/science.1220030
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Nguyen TPD, 2010, J IMMUNOL, V184, P7281, DOI 10.4049/jimmunol.0903262
   Osorio JE, 2015, VACCINE, V33, P7112, DOI 10.1016/j.vaccine.2015.11.022
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Packard RM, 2016, B HIST MED, V90, P193, DOI 10.1353/bhm.2016.0041
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Porter KR, 2012, VACCINE, V30, P336, DOI 10.1016/j.vaccine.2011.10.085
   Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352
   Prisant N, 2016, LANCET INFECT DIS, V16, P1000, DOI 10.1016/S1473-3099(16)30193-1
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Qian XY, 2017, DEVELOPMENT, V144, P952, DOI 10.1242/dev.140707
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Richner JM, 2017, CELL, V169, P176, DOI 10.1016/j.cell.2017.03.016
   Rivino L, 2013, J IMMUNOL, V191, P4010, DOI 10.4049/jimmunol.1301507
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Roche PA, 2015, NAT REV IMMUNOL, V15, P203, DOI 10.1038/nri3818
   Rodenhuis-Zybert IA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000718
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rothman Alan L, 2014, Curr Trop Med Rep, V1, P13
   Rouvinski A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15411
   Rouvinski A, 2015, NATURE, V520, P109, DOI 10.1038/nature14130
   RUSH B, 1951, AM J MED, V11, P546, DOI 10.1016/0002-9343(51)90035-6
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Sadegh-Nasseri S, 2019, MOL IMMUNOL, V113, P115, DOI 10.1016/j.molimm.2018.08.011
   Sanchez-San Martin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32400-7
   SANGKAWIBHA N, 1984, AM J EPIDEMIOL, V120, P653, DOI 10.1093/oxfordjournals.aje.a113932
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shan C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13589-1
   Shan C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00737-8
   Sharma M, 2020, J INFECT DIS, V221, P867, DOI 10.1093/infdis/jiz081
   Sirivichayakul C, 2016, J INFECT DIS, V213, P1562, DOI 10.1093/infdis/jiv762
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Slon-Campos JL, 2019, NAT IMMUNOL, V20, P1291, DOI 10.1038/s41590-019-0477-z
   Spiteri G, 2017, EUROSURVEILLANCE, V22, P14, DOI 10.2807/1560-7917.ES.2017.22.41.17-00254
   St John AL, 2019, NAT REV IMMUNOL, V19, P218, DOI 10.1038/s41577-019-0123-x
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sun J, 2017, VACCINE, V35, P6308, DOI 10.1016/j.vaccine.2017.09.063
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tamhankar M, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1200-2
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   Vannice KS, 2018, VACCINE, V36, P3411, DOI 10.1016/j.vaccine.2018.02.062
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wan SW, 2017, J IMMUNOL, V199, P2834, DOI 10.4049/jimmunol.1601523
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Wang R, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01113
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weiskopf D, 2016, J INFECT DIS, V214, P1117, DOI 10.1093/infdis/jiw309
   Weiskopf D, 2015, J INFECT DIS, V212, P1743, DOI 10.1093/infdis/jiv289
   Weiskopf D, 2015, J VIROL, V89, P120, DOI 10.1128/JVI.02129-14
   Weiskopf D, 2014, J VIROL, V88, P11383, DOI 10.1128/JVI.01108-14
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Whitehead SS, 2003, VACCINE, V21, P4307, DOI 10.1016/S0264-410X(03)00488-2
   Whitehead SS, 2003, J VIROL, V77, P1653, DOI 10.1128/JVI.77.2.1653-1657.2003
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   Williams KL, 2012, VIROLOGY, V429, P12, DOI 10.1016/j.virol.2012.03.003
   Wirawan M, 2019, STRUCTURE, V27, P253, DOI 10.1016/j.str.2018.10.009
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Xie XP, 2018, CELL HOST MICROBE, V24, P487, DOI 10.1016/j.chom.2018.09.008
   Yauch LE, 2010, J IMMUNOL, V185, P5405, DOI 10.4049/jimmunol.1001709
   Yauch LE, 2009, J IMMUNOL, V182, P4865, DOI 10.4049/jimmunol.0801974
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu IM, 2009, J VIROL, V83, P12101, DOI 10.1128/JVI.01637-09
   Yu IM, 2008, SCIENCE, V319, P1834, DOI 10.1126/science.1153264
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
   Zompi S, 2013, P NATL ACAD SCI USA, V110, P8761, DOI 10.1073/pnas.1306333110
   Zou J, 2018, EBIOMEDICINE, V36, P92, DOI 10.1016/j.ebiom.2018.08.056
NR 212
TC 0
Z9 0
U1 2
U2 2
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAR 20
PY 2020
VL 11
AR 362
DI 10.3389/fmicb.2020.00362
PG 21
WC Microbiology
SC Microbiology
GA LA0KV
UT WOS:000523647000001
PM 32265852
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Francis, S
   Crawford, J
   McKenzie, S
   Campbell, T
   Wright, D
   Hamilton, T
   Huntley-Jones, S
   Spence, S
   Belemvire, A
   Alavi, K
   Gutierrez, CT
AF Francis, Sheena
   Crawford, Jervis
   McKenzie, Sashell
   Campbell, Towanna
   Wright, Danisha
   Hamilton, Trevann
   Huntley-Jones, Sherine
   Spence, Simone
   Belemvire, Allison
   Alavi, Kristen
   Gutierrez, Carolina Torres
TI Comparative toxicity of larvicides and growth inhibitors on Aedes
   aegypti from select areas in Jamaica
SO ROYAL SOCIETY OPEN SCIENCE
LA English
DT Article
DE Aedes aegypti; insecticide resistance; temephos; Bti; growth inhibitors;
   Jamaica
ID INSECTICIDE RESISTANCE; ISRAELENSIS BTI; DIFLUBENZURON; REGULATORS;
   DIPTERA; DENGUE; PYRIPROXYFEN; POPULATIONS; CULICIDAE; VECTORS
AB Insecticide resistance has become problematic in tropical and subtropical regions, where Aedes mosquitoes and Aedes-borne arboviral diseases thrive. With the recent occurrence of chikungunya and the Zika virus in Jamaica, the Ministry of Health and Wellness, Jamaica, partnered with the United States Agency for International Development to implement multiple intervention activities to reduce the Aedes aegypti populations in seven parishes across the island and to assess the susceptibility of collected samples to various concentrations of temephos, Bacillus thuringiensis subsp. israelensis, (Bti), diflubenzuron and methoprene. Of the insecticides tested, only temephos has been used in routine larviciding activities in the island. The results showed that only temephos at concentrations 0.625 ppm and Bti at concentrations 6-8 ppm were effective at causing 98-100% mortality of local Ae. aegypti at 24 h exposure. Surprisingly, the growth inhibitors diflubenzuron and methoprene had minimal effect at preventing adult emergence in Ae. aegypti larvae in the populations tested. The results demonstrate the need for insecticide resistance testing as a routine part of vector control monitoring activies in order to determine useful tools that may be incorporated to reduce the abundance of Ae. aegypti.
C1 [Francis, Sheena; Wright, Danisha] Univ West Indies, Nat Prod Inst, Mona, Jamaica.
   [Francis, Sheena] Abt Associates Inc, 70 Half Way Tree Rd, Kingston, Jamaica.
   [Francis, Sheena; Crawford, Jervis; McKenzie, Sashell; Campbell, Towanna; Wright, Danisha; Hamilton, Trevann] Zika AIRS Project Jamaica, 70 Half Way Tree Rd, Kingston, Jamaica.
   [Huntley-Jones, Sherine] Minist Hlth & Wellness, Vector Control Unit, Kingston, Jamaica.
   [Spence, Simone] Minist Hlth & Wellness, Hlth Promot & Protect, Kingston, Jamaica.
   [Belemvire, Allison] USAID, Bur Global Hlth, Off Infect Dis, Arlington, TX USA.
   [Alavi, Kristen] USAID, Washington, DC USA.
   [Gutierrez, Carolina Torres] Abt Associates Inc, IDD, Rockville, MD 20852 USA.
RP Francis, S (corresponding author), Univ West Indies, Nat Prod Inst, Mona, Jamaica.; Francis, S (corresponding author), Abt Associates Inc, 70 Half Way Tree Rd, Kingston, Jamaica.; Francis, S (corresponding author), Zika AIRS Project Jamaica, 70 Half Way Tree Rd, Kingston, Jamaica.; Gutierrez, CT (corresponding author), Abt Associates Inc, IDD, Rockville, MD 20852 USA.
EM sheena.francis02@uwimona.edu.jm; aniloract@gmail.com
OI Francis, Sheena/0000-0002-2240-8627
FU United States Agency for International Development (USAID)United States
   Agency for International Development (USAID) [AID-GHN-I-00-09-00013,
   AID-OAA-TO-14-00035]
FX The activities of Zika AIRS project Jamaica were funded by United States
   Agency for International Development (USAID), Contract no.
   AID-GHN-I-00-09-00013; Task Order AID-OAA-TO-14-00035.
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   ALI A, 1995, J AM MOSQUITO CONTR, V11, P72
   ARIAS JR, 1975, J MED ENTOMOL, V12, P309, DOI 10.1093/jmedent/12.3.309
   Braga I, 2005, MEM I OSWALDO CRUZ, V100, P435, DOI 10.1590/S0074-02762005000400016
   Brogdon WG, 1998, EMERG INFECT DIS, V4, P605, DOI 10.3201/eid0404.980410
   Brown Michelle G., 2009, Human Antibodies, V18, P123, DOI 10.3233/HAB-2009-0207
   Cornel AJ, 2000, J AM MOSQUITO CONTR, V16, P223
   FOURNET F, 1993, J AM MOSQUITO CONTR, V9, P426
   Francis S, 2020, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.g1jwstqn5, DOI 10.5061/DRYAD.G1JWSTQN5]
   Francis S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179673
   Guidi V, 2011, APPL ENVIRON MICROB, V77, P3663, DOI 10.1128/AEM.00132-11
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Kamal Hany A., 2010, JOURNAL OF THE EGYPTIAN SOCIETY OF PARASITOLOGY, V40, P565
   Lacey LA, 2007, J AM MOSQUITO CONTR, V23, P133, DOI 10.2987/8756-971X(2007)23[133:BTSIAB]2.0.CO;2
   Marcombe S, 2011, AM J TROP MED HYG, V84, P118, DOI 10.4269/ajtmh.2011.10-0335
   Paeporn P., 2005, Dengue Bulletin, V29, P210
   PAHO. Pan American Health Organization, 2019, TECHN DOC IMPL INT B
   PAHO/WHO, 2017, ZIK EP REP JAM
   Paris M, 2011, PEST MANAG SCI, V67, P122, DOI 10.1002/ps.2046
   Paul A, 2005, J AM MOSQUITO CONTR, V21, P305, DOI 10.2987/8756-971X(2005)21[305:IRICPF]2.0.CO;2
   Polson KA, 2011, ACTA TROP, V117, P31, DOI 10.1016/j.actatropica.2010.09.005
   Rawlins S C, 1998, Rev Panam Salud Publica, V4, P243
   RAWLINS SC, 1995, J AM MOSQUITO CONTR, V11, P59
   Ritchie SA, 2010, AM J TROP MED HYG, V82, P1053, DOI 10.4269/ajtmh.2010.09-0603
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P608, DOI 10.2987/5738.1
   Seccacini E, 2008, J AM MOSQUITO CONTR, V24, P398, DOI 10.2987/5697.1
   Tetreau G, 2013, ARCH INSECT BIOCHEM, V82, P71, DOI 10.1002/arch.21076
   Webster-Kerr KR, 2016, W INDIAN MED J, V65, P243, DOI 10.7727/wimj.2016.488
   Webster-Kerr K, 2011, TROP MED INT HEALTH, V16, P298, DOI 10.1111/j.1365-3156.2010.02700.x
   *WHO, 1981, INSTR DET SUSC RES M
   WHO, 1996, 1996 EV TEST INS
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
NR 33
TC 0
Z9 0
U1 0
U2 0
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 2054-5703
J9 ROY SOC OPEN SCI
JI R. Soc. Open Sci.
PD MAR 18
PY 2020
VL 7
IS 3
AR 192041
DI 10.1098/rsos.192041
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LD0LV
UT WOS:000525725500001
PM 32269812
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vicenti, I
   Dragoni, F
   Giannini, A
   Giammarino, F
   Spinicci, M
   Saladini, F
   Boccuto, A
   Zazzi, M
AF Vicenti, Ilaria
   Dragoni, Filippo
   Giannini, Alessia
   Giammarino, Federica
   Spinicci, Michele
   Saladini, Francesco
   Boccuto, Adele
   Zazzi, Maurizio
TI Development of a Cell-Based Immunodetection Assay for Simultaneous
   Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus
   Replication
SO SLAS DISCOVERY
LA English
DT Article
DE ELISA; plaque assay; antiviral; flavivirus; cell-based assay
ID CELGOSIVIR; SOFOSBUVIR; INFECTION; MOSQUITOS; EFFICACY; PROTEIN
AB Practical cell-based assays can accelerate anti-Zika (ZIKV) and anti-dengue (DENV) virus drug discovery. We developed an immunodetection assay (IA), using a pan-flaviviral monoclonal antibody recognizing a conserved envelope domain. The final protocol includes a direct virus yield reduction assay (YRA) carried out in the human Huh7 cell line, followed by transfer of the supernatant to a secondary Huh7 culture to characterize late antiviral effects. Sofosbuvir and ribavirin were used to validate the assay, while celgosivir was used to evaluate the ability to discriminate between early and late antiviral activity. In the direct YRA, at 100, 50, and 25 TCID50, sofosbuvir IC50 values were 5.0 +/- 1.5, 2.7 +/- 0.5, 2.5 +/- 1.1 mu M against ZIKV and 16.6 +/- 2.8, 4.6 +/- 1.4, 2.6 +/- 2.2 mu M against DENV; ribavirin IC50 values were 6.8 +/- 4.0, 3.8 +/- 0.6, 4.5 +/- 1.4 mu M against ZIKV and 17.3 +/- 4.6, 7.6 +/- 1.2, 4.1 +/- 2.3 mu M against DENV. Sofosbuvir and ribavirin IC50 values determined in the secondary YRA were reproducible and comparable with those obtained by direct YRA and plaque reduction assay (PRA). In agreement with the proposed mechanism of late action, celgosivir was active against DENV only in the secondary YRA (IC50 11.0 +/- 1.0 mu M) and in PRA (IC50 10.1 +/- 1.1 mu M). The assay format overcomes relevant limitations of the gold standard PRA, allowing concurrent analysis of candidate antiviral compounds against different viruses and providing preliminary information about early versus late antiviral activity.
C1 [Vicenti, Ilaria; Dragoni, Filippo; Giannini, Alessia; Giammarino, Federica; Saladini, Francesco; Boccuto, Adele; Zazzi, Maurizio] Univ Siena, Dept Med Biotechnol, Viale Bracci 16, I-53100 Siena, Italy.
   [Spinicci, Michele] Careggi Univ Hosp, Unit Infect Dis, Florence, Toscana, Italy.
RP Vicenti, I (corresponding author), Univ Siena, Dept Med Biotechnol, Viale Bracci 16, I-53100 Siena, Italy.
EM ilariavicenti@gmail.com
RI Vicenti, Ilaria/AAP-9663-2020; Zazzi, Maurizio/K-3422-2018
OI vicenti, ilaria/0000-0002-4306-2960; Zazzi, Maurizio/0000-0002-0344-6281
FU PANVIR Project ("Preclinical Development of Novel Panviral Compounds
   within a Specialized Regional Network," FESR 2014-2020 Program, Tuscany
   Region, Italy)
FX The authors disclosed receipt of the following financial support for the
   research, authorship, and/or publication of this article: This work was
   partially supported by the PANVIR Project ("Preclinical Development of
   Novel Panviral Compounds within a Specialized Regional Network," FESR
   2014-2020 Program, Tuscany Region, Italy).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Chang JH, 2011, ANTIVIR RES, V89, P26, DOI 10.1016/j.antiviral.2010.11.002
   Cordeiro Marli Tenorio, 2019, Top Magn Reson Imaging, V28, P15, DOI 10.1097/RMR.0000000000000190
   Courageot MP, 2000, J VIROL, V74, P564, DOI 10.1128/JVI.74.1.564-572.2000
   Day CW, 2005, ANTIVIR RES, V67, P38, DOI 10.1016/j.antiviral.2005.04.002
   DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747
   Estofolete CF, 2019, J INFECT PUBLIC HEAL, V12, P178, DOI 10.1016/j.jiph.2018.09.007
   Gan CS, 2018, CHEM BIOL DRUG DES, V91, P448, DOI 10.1111/cbdd.13091
   Green N, 2008, EXPERT OPIN DRUG DIS, V3, P671, DOI 10.1517/17460441.3.6.671
   Guo DH, 2014, DNA CELL BIOL, V33, P20, DOI 10.1089/dna.2013.2193
   Han YS, 2018, J MED VIROL, V90, P796, DOI 10.1002/jmv.25031
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kraus AA, 2007, J CLIN MICROBIOL, V45, P3777, DOI 10.1128/JCM.00827-07
   Lee EM, 2019, ASSAY DRUG DEV TECHN, V17, P128, DOI 10.1089/adt.2018.881
   Liang GD, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.18
   Lo MK, 2003, J VIROL, V77, P12901, DOI 10.1128/JVI.77.23.12901-12906.2003
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Munjal A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01469
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Puertas MC, 2012, J CLIN MICROBIOL, V50, P3909, DOI 10.1128/JCM.01636-12
   Puig-Basagoiti F, 2005, ANTIMICROB AGENTS CH, V49, P4980, DOI 10.1128/AAC.49.12.4980-4988.2005
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Saladini F, 2018, J CLIN LAB ANAL, V32, DOI 10.1002/jcla.22206
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Silva JVJ, 2018, ACTA TROP, V182, P257, DOI 10.1016/j.actatropica.2018.03.009
   Sung C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004851
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tan KH, 2014, METHODS MOL BIOL, V1138, P99, DOI 10.1007/978-1-4939-0348-1_7
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Xie XP, 2015, ANTIVIR RES, V118, P39, DOI 10.1016/j.antiviral.2015.03.007
   Xu HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06612-2
   Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398
NR 47
TC 0
Z9 0
U1 5
U2 5
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 2472-5552
EI 2472-5560
J9 SLAS DISCOV
JI SLAS Discov.
PD JUN
PY 2020
VL 25
IS 5
SI SI
BP 506
EP 514
AR 2472555220911456
DI 10.1177/2472555220911456
EA MAR 2020
PG 9
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Chemistry, Analytical
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Chemistry
GA LP8JT
UT WOS:000523863000001
PM 32186426
DA 2020-07-08
ER

PT J
AU Cavalcanti, AFC
   Aguiar, Y
   Melo, ASD
   Cavalcanti, AL
   D'Avila, S
AF Cabral Cavalcanti, Alidianne Fabia
   Aguiar, Yeska
   De Oliveira Melo, Adriana Suely
   Cavalcanti, Alessandro Leite
   D'Avila, Sergio
TI Breastfeeding Behavior in Brazilian Children with Congenital Zika
   Syndrome
SO INTERNATIONAL JOURNAL OF DENTISTRY
LA English
DT Article
ID VIRUS-INFECTION; PREVALENCE; INFANTS
AB Congenital Zika Syndrome (CZS) is a condition that has emerged only recently, bringing together multiple changes, including significant changes in the stomatognathic system, which may compromise sucking behavior and consequently the breastfeeding practice. The aim of this study was to investigate the breastfeeding behaviors in children with CZS. A longitudinal study was carried out in two reference centers in Northeastern Brazil. The nonprobabilistic sample consisted of 79 children diagnosed with physical, neurological, and behavioral alterations compatible with CZS. Information regarding the child, nutritive, and nonnutritive sucking behavior and changes related to the sucking reflex was collected. Data were presented through descriptive and inferential statistics. In the bivariate analyses, the chi-squared test was used and 5% significance level was adopted. The majority of children had severe microcephaly (59.7%). Breastfeeding was performed at birth in most of CZS children (89.9%) but only 36.6% of them presented exclusive breastfeeding in the six months of life. Bottle feeding and pacifier were used in 89.9% and 55.7%, respectively. Sucking and swallowing difficulties and occurrence of gastroesophageal reflux were observed in 27.8%, 48.0%, and 29.2% of children, respectively. Early weaning was associated with bottle feeding (p=0.005) and pacifier sucking (p=0.003). Although breastfeeding practice at birth constitutes a behavior adopted by most of mothers, adherence to this exclusive habit until the first six months of life was low since the children presenting a large number of comorbidities with direct interference in the suction reflex, sucking, and swallowing difficulty.
C1 [Cabral Cavalcanti, Alidianne Fabia] State Univ Paraiba, Sch Dent, Campina Grande, Paraiba, Brazil.
   [Aguiar, Yeska] State Univ Paraiba, Sch Dent, Araruna, Brazil.
   [De Oliveira Melo, Adriana Suely] Univ Fed Campina Grande, Sch Med, Campina Grande, Paraiba, Brazil.
   [Cavalcanti, Alessandro Leite; D'Avila, Sergio] State Univ Paraiba, Postgrad Program Dent, Campina Grande, Paraiba, Brazil.
RP Cavalcanti, AL (corresponding author), State Univ Paraiba, Postgrad Program Dent, Campina Grande, Paraiba, Brazil.
EM alessandrouepb@gmail.com
RI Cavalcanti, Alessandro Leite/I-4286-2019
OI Cavalcanti, Alessandro Leite/0000-0003-3572-3332
FU National Council for Scientific and Technological Development
   (CNPq)-Research Productivity GrantNational Council for Scientific and
   Technological Development (CNPq) [302850/2016-3]
FX The authors would like to thank the Professor Joaquim Amorim Neto,
   Research Institute, and Mrs. Jeime Izer Bezerra de Freitas Leal from the
   Specialized Center for Rehabilitation. The authors would also like to
   acknowledge the National Council for Scientific and Technological
   Development (CNPq)-Research Productivity Grant (Process 302850/2016-3).
CR Andrew MJ, 2012, ARCH DIS CHILDHOOD-E, V97, P222, DOI 10.1136/archdischild-2011-300914
   [Anonymous], 2018, AM
   [Anonymous], 2010, PESQ PREV AL MAT MUN, V227
   Batista CLC, 2018, J PEDIAT-BRAZIL, V94, P596, DOI 10.1016/j.jped.2017.10.005
   Bourin P. F., 2017, PEDIAT ASPECT DYSPH, P213
   Brasil. Ministerio da Saude, 2016, EM SAUD PUBL IMP INT
   Brazil Ministerio da Saude, 2015, CADERNOS ATENCAO BAS
   Buccini GD, 2017, MATERN CHILD NUTR, V13, DOI 10.1111/mcn.12384
   Cavalcanti AFC, 2019, INT J PAEDIATR DENT, V29, P74, DOI 10.1111/ipd.12431
   Cavalcanti AL, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.69
   Cavalcanti AL, 2017, CONTEMP CLIN DENT, V8, P345, DOI 10.4103/0976-237X.214553
   Choi HJ, 2018, EARLY HUM DEV, V127, P42, DOI 10.1016/j.earlhumdev.2018.08.011
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   Aguiar YPC, 2018, PESQUI BRAS ODONTOPE, V18, DOI 10.4034/PBOCI.2018.181.16
   Deoni SCL, 2013, NEUROIMAGE, V82, P77, DOI 10.1016/j.neuroimage.2013.05.090
   Duijts L, 2010, PEDIATRICS, V126, pE18, DOI 10.1542/peds.2008-3256
   Genova L, 2018, REV CHIL PEDIATR-CHI, V89, P32, DOI 10.4067/S0370-41062018000100032
   Gomes Cristiane F., 2006, J. Pediatr. (Rio J.), V82, P103, DOI [10.2223/JPED.1456, 10.1590/S0021-75572006000200005]
   Hayes Donald K, 2020, Hawaii J Health Soc Welf, V79, P42
   Jardi C, 2018, INFANT BEHAV DEV, V50, P300, DOI 10.1016/j.infbeh.2017.05.009
   Leal MC, 2017, EMERG INFECT DIS, V23, P1253, DOI 10.3201/eid2308.170354
   Leventakou V, 2015, J EPIDEMIOL COMMUN H, V69, P232, DOI 10.1136/jech-2013-202500
   Marinho F, 2016, EPIDEMIOL SERV SAUDE, V25, P701, DOI [10.5123/S1679-49742016000400004, 10.5123/s1679-49742016000400004]
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Bomfim LTM, 2017, PESQUI BRAS ODONTOPE, V17, DOI 10.4034/PBOCI.2017.171.14
   Miotto MHMB, 2016, PESQUI BRAS ODONTOPE, V16, P393, DOI 10.4034/PBOCI.2016.161.41
   Raheel Hafsa, 2018, Sudan J Paediatr, V18, P28, DOI 10.24911/SJP.2018.1.5
   Raihan MJ, 2020, MATERN CHILD NUTR, DOI 10.1111/mcn.12971
   Rigotti RR, 2015, CIENC SAUDE COLETIVA, V20, P1235, DOI 10.1590/1413-81232015204.00782014
   Romero CC, 2011, J APPL ORAL SCI, V19, P161, DOI 10.1590/S1678-77572011000200013
   Silva R. B., 2018, COMPREHENSIVE CHILD, V10, P1
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Victora CG, 2016, LANCET, V387, P475, DOI 10.1016/S0140-6736(15)01024-7
   World Health Organisation Guideline, 2016, GUID INF FEED AR ZIK
   World Health Organization, 2018, BREASTFEEDING
NR 35
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1687-8728
EI 1687-8736
J9 INT J DENT
JI Int. J. Dent.
PD MAR 16
PY 2020
VL 2020
AR 1078250
DI 10.1155/2020/1078250
PG 6
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KZ0IW
UT WOS:000522956900001
PM 32256591
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Krause, PR
   Roberts, J
AF Krause, Philip R.
   Roberts, Jett
TI Scientific and Regulatory Considerations for Efficacy Studies of
   Cytomegalovirus Vaccines
SO JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE congenital CMV; CMV in transplantation; cytomegalovirus; vaccines
ID TRANSPLANT
AB The considerable public health burden due to cytomegalovirus (CMV) supports current interest in vaccine development. Clinical studies intended to support regulatory action should be designed to demonstrate substantial evidence of effectiveness. However, design and conduct of clinical endpoint studies may be hampered by low incidence of disease, especially for congenital CMV. Discussion and experience from other vaccines directed against congenital disease (including rubella and Zika) may be instructive. This article summarizes current scientific and US regulatory considerations related to design of studies of vaccines intended to prevent congenital CMV and complications of CMV in transplantation, as discussed at the 2018 workshop entitled "Cytomegalovirus Infection: Advancing Strategies for Prevention and Treatment."
C1 [Krause, Philip R.; Roberts, Jett] US FDA, Ctr Biol Evaluat & Res, Off Vaccines Res & Review, Silver Spring, MD USA.
RP Krause, PR (corresponding author), Rm 3234,Bldg 71,10903 New Hampshire Ave, Silver Spring, MD 20993 USA.
EM philip.krause@fda.hhs.gov
OI Krause, Philip/0000-0002-1045-7536
FU US Food and Drug Administration, Center for Biologics Evaluation and
   Research
FX This work was funded by the US Food and Drug Administration, Center for
   Biologics Evaluation and Research.
CR [Anonymous], 2018, PRNEWSWIRE
   Bernstein DI, 2016, VACCINE, V34, P313, DOI 10.1016/j.vaccine.2015.11.056
   Daum R., 2015, SUMMARY MINUTES 140
   de Vries JJC, 2013, REV MED VIROL, V23, P241, DOI 10.1002/rmv.1744
   Faure-Bardon V, 2019, CLIN INFECT DIS, V69, P1526, DOI 10.1093/cid/ciy1128
   Griffiths PD, 2011, LANCET, V377, P1256, DOI 10.1016/S0140-6736(11)60136-0
   Gruber MF, 2017, J INFECT DIS, V216, pS964, DOI 10.1093/infdis/jix433
   Izurieta HS, 2017, CLIN INFECT DIS, V64, P785, DOI 10.1093/cid/ciw854
   Izurieta HS, 2015, LANCET INFECT DIS, V15, P293, DOI 10.1016/S1473-3099(14)71087-4
   Krause PR, 2013, VACCINE, V32, P4, DOI 10.1016/j.vaccine.2013.09.042
   Ljungman P, 2020, CLIN INFECT DIS, V70, P1525, DOI 10.1093/cid/ciz490
   Marty FM, 2017, NEW ENGL J MED, V377, P2433, DOI 10.1056/NEJMoa1706640
   Pass RF, 2009, NEW ENGL J MED, V360, P1191, DOI 10.1056/NEJMoa0804749
   PLOTKIN SA, 1991, ANN INTERN MED, V114, P525, DOI 10.7326/0003-4819-114-7-525
   Plotkin SA, 2006, CLIN INFECT DIS, V43, pS164, DOI 10.1086/505950
   Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214
   US Food and Drug Administration, DRAFT GUID IN CYT TR
   Vannice KS, 2019, VACCINE, V37, P863, DOI 10.1016/j.vaccine.2018.12.040
   Vincenti F, 2018, AM J TRANSPLANT, V18, P2945, DOI 10.1111/ajt.14925
NR 19
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-1899
EI 1537-6613
J9 J INFECT DIS
JI J. Infect. Dis.
PD MAR 15
PY 2020
VL 221
SU 1
BP 103
EP 108
DI 10.1093/infdis/jiz523
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA LN1GN
UT WOS:000532693500011
PM 32134485
OA Bronze
DA 2020-07-08
ER

PT J
AU Cruvinel, VRN
   Zolnikov, TR
   Obara, MT
   de Oliveira, VTL
   Vianna, EN
   do Santos, FSG
   de Oliveira, KC
   Scott, JA
AF Nogueira Cruvinel, Vanessa Resende
   Zolnikov, Tara Rava
   Obara, Marcos Takashi
   Lopes de Oliveira, Valmir Teotonio
   Vianna, Elisa Neves
   Ganem do Santos, Fabiana Sherine
   de Oliveira, Kenia Cristina
   Scott, James A.
TI Vector-borne diseases in waste pickers in Brasilia, Brazil
SO WASTE MANAGEMENT
LA English
DT Article
DE Dengue fever; Arbovirus infections, waterborne diseases; Occupational
   health; Social conditions; Garbage
ID DENGUE
AB Solid waste management is a challenge in developing countries. The Structural dump in Brasilia, Brazil, was the largest Latin American open-air dump until its closure in 2018. Thus, this study sought to investigate the prevalence of self-reported dengue, Zika and Chikungunya arbovirus infections in waste pickers who worked at the dumpsite and assess its association with the sanitary conditions in their residences and workplaces. This research used a mixed methods study using a questionnaire for the quantitative method and semi-structured interviews for the qualitative portion. A cross-sectional, observational, epidemiological study along with a phenomenological study were carried out to characterize socio environmental, occupational and health-related aspects to vector-borne diseases in Structural dumpsite in Brazil. Of the 1,025 respondents, 301 (29.2%) reported to have gotten sick from dengue, Zika or chikungunya fevers. We found significant associations between place of residence of waste pickers (p = 0,003) and the work conditions, use of personal protective equipment (p < 0.001) and weekly workload (p = 0.04) and occurrence of vector-borne disease. Results were confirmed by qualitative data and geo-referencing, in relation to location of their homes and proximity to the dumpsite, as well as through the vulnerability due to their working conditions. This research confirms that waste pickers are highly susceptible to vector-borne diseases; this situation that needs to be immediately addressed by interdisciplinary and intersectoral approaches in waste management and public health. This information confirms vulnerability of waste pickers to diseases transmitted by Ae. aegypti mosquito as a result of sanitary conditions at their residence and workplace. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Nogueira Cruvinel, Vanessa Resende; Obara, Marcos Takashi; Lopes de Oliveira, Valmir Teotonio] Univ Brasilia, Fac Ceilandia, Brasilia, DF, Brazil.
   [Zolnikov, Tara Rava] Natl Univ, San Diego, CA USA.
   [Vianna, Elisa Neves] Minist Hlth, Gen Coordinat Natl Programs Control & Prevent Mal, Brasilia, DF, Brazil.
   [Ganem do Santos, Fabiana Sherine] Univ AutOnoma Barcelona, Barcelona, Spain.
   [Ganem do Santos, Fabiana Sherine] Fac Med, Barcelona, Spain.
   [de Oliveira, Kenia Cristina] Secretariat State Hlth Fed Dist, Brasilia, DF, Brazil.
   [de Oliveira, Kenia Cristina] Univ Brasilia, Brasilia, DF, Brazil.
   [Scott, James A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Div Occupat & Environm Hlth, Toronto, ON, Canada.
RP Cruvinel, VRN (corresponding author), Campus Univ Ctr Metropolitano, Brasilia, DF, Brazil.
EM vanessacruvinel@unb.br; james.scott@utoronto.ca
OI Takashi Obara, Marcos/0000-0001-6872-0096
FU University of Brasilia; School of Health Sciences (ESCS); Government of
   the Federal District (GDF); State Secretariat of Health of the Federal
   District, Brasilia (SESDF); Primary Healthcare Center; National Council
   for Scientific and Technological Development (CNPQ)National Council for
   Scientific and Technological Development (CNPq)
FX The authors wish to express their thanks to certain Brazilian
   institutions, without whose support it would not have been possible to
   carry out this study: the University of Brasilia, where the Brazilian
   lecturers and researchers work; the partnership with School of Health
   Sciences (ESCS); the Government of the Federal District (GDF) and State
   Secretariat of Health of the Federal District, Brasilia (SESDF); the
   Primary Healthcare Center where the study was carried out, its managers
   and the professionals who participated; The collaborator of the "Stop,
   Think and Discard"project; The Federal District's Urban Cleaning
   Service, Solid Waste Recycling Cooperatives, the waste pickers who
   participated in the study, and the National Council for Scientific and
   Technological Development (CNPQ), which supported one axis of the study
   by providing a post-doctoral internship grant.
CR Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007275
   Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822
   Brasil, 2003, NR6 MIN LAB
   Brasil, 2017, POLITICA NACL RESIDU
   Brasil, 2017, SAUDE BM SS V ANALIS
   Brasil. Ministerio da Saude, 2018, DESCR DOENC
   Brasil. Ministerio da Saude, 2013, LEV RAP IND AED LIRA
   Caprara A, 2009, CAD SAUDE PUBLICA, V25, pS125, DOI 10.1590/S0102-311X2009001300012
   Creswell J. W., 2014, RES DESIGN QUALITATI
   Cruvinel V, 2017, HEGEMONIA, V19, P67
   Cruvinel VRN, 2019, WASTE MANAGE, V99, P71, DOI 10.1016/j.wasman.2019.08.035
   Dieng H, 2018, ENVIRON SCI POLLUT R, V25, P13833, DOI 10.1007/s11356-017-1078-8
   Dieng H, 2017, ACTA TROP, V169, P84, DOI 10.1016/j.actatropica.2017.01.022
   Governo do Distrito Federal, 2015, PESQ DISTR AM DOM CO
   Governo do Distrito Federal, 2018, GDF SAL SIT SAUD DIS
   Governo do Distrito Federal, 2018, B EP DISTR FED 2018
   Hay SI, 2017, LANCET, V390, P1260, DOI 10.1016/S0140-6736(17)32130-X
   Hays D. G., 2012, QUALITATIVE INQUIRY
   Kenneson A., 2017, PLOS NEGLECTED TROP, V18, P2
   Kraemer, 2015, ELIFE, V2015
   Medronho RA, 2009, AM J TROP MED HYG, V80, P401, DOI 10.4269/ajtmh.2009.80.401
   Moustakas C., 1994, PHENOMENOLOGICAL RES
   Cruvinel VRN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6879-x
   Costa IMP, 2016, EPIDEMIOL SERV SAUDE, V25, P735, DOI [10.5123/S1679-49742016000400007, 10.5123/s1679-49742016000400007]
   Quintero J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-38
   Silva J.S., 2012, BRAZIL REV SOC BRA M, V45, P174
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tauil Pedro Luiz, 2002, Cad. Saúde Pública, V18, P867, DOI 10.1590/S0102-311X2002000300030
   Virgem M. R, 2014, REV SUBJECTIVIDADES, V14, P42
   WHO, 2009, WHO DENG GUID DIAGN
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   ZACARIAS I R., 2009, REV TEXTOS CONTEXTO, V8, P293
   Zolnikov TR, 2018, WASTE MANAGE, V80, P26, DOI 10.1016/j.wasman.2018.08.047
NR 33
TC 0
Z9 0
U1 1
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0956-053X
EI 1879-2456
J9 WASTE MANAGE
JI Waste Manage.
PD MAR 15
PY 2020
VL 105
BP 223
EP 232
DI 10.1016/j.wasman.2020.02.001
PG 10
WC Engineering, Environmental; Environmental Sciences
SC Engineering; Environmental Sciences & Ecology
GA KW0IL
UT WOS:000520856700022
PM 32087540
DA 2020-07-08
ER

PT J
AU Zhang, WH
   Xu, YF
   Zhao, FF
   Tarbe, M
   Zhou, SR
   Wang, WH
   Zhang, SY
   Zhang, W
   Xu, QP
   Shi, LN
   Yuan, F
   Lin, XW
   Liu, S
   Sun, J
   Zhao, JC
   Yang, YL
   Liang, XZ
   Zhong, J
   Long, G
   Qin, CF
   Leng, QB
   Tang, H
AF Zhang, Weihong
   Xu, Yongfen
   Zhao, Fanfan
   Tarbe, Marion
   Zhou, Shuru
   Wang, Weihong
   Zhang, Shengyuan
   Zhang, Wei
   Xu, Qiuping
   Shi, Lina
   Yuan, Feng
   Lin, Xinwen
   Liu, Shuai
   Sun, Jing
   Zhao, Jincun
   Yang, Yaling
   Liang, Xiaozhen
   Zhong, Jin
   Long, Gang
   Qin, Chengfeng
   Leng, Qibin
   Tang, Hong
TI The pre-existing cellular immunity to Japanese encephalitis virus
   heterotypically protects mice from Zika virus infection
SO SCIENCE BULLETIN
LA English
DT Article
DE Japanese encephalitis virus; Zika virus; CD8(+) T; Cross protection
ID ANTIBODY-DEPENDENT ENHANCEMENT; DENGUE VIRUS; CROSS-REACTIVITY; FEVER
AB Zika virus (ZIKV) and Japanese encephalitis virus (JEV) are closely related flaviviruses, ZIKV circulates in the population that has been JEV vaccinated in Southeast Asian countries. This alerts that a pre-existing immunity to JEV would impact ZIKV infection and/or pathogenesis. Herein we showed that the preexisting immunity to JEV SA14-14-2 vaccination provided an ample protection against non-lethal or lethal dose of ZIKV infection in mice. This was in sharp contrast to the passive immunization of JEV antibodies, which failed to affect ZIKV infection or pathogenesis in mice, albeit these antibodies exhibited cross-reactivity and antibody dependent enhancement (ADE) of ZIKV infection in vitro. Furthermore, we determined that JEV vaccine-elicited CD8(+) T cells were required to mediate the heterotypic protection of ZIKV infection, which cross-reacted to ZIKV E and NS5 antigens (E294-302 and NS5(2839-2848)). Adoptive transfer of these CD8(+) T cells could partially protect the mice from ZIKV challenge. Therefore, although short of epidemiological evidence, these results suggested that cross-reactive CD8(+) T cells activated by JEV vaccination could protect potential ZIKV infection in human populations. (C) 2019 Science China Press. Published by Elsevier B.V. and Science China Press. All rights reserved.
C1 [Zhang, Weihong; Zhou, Shuru; Tang, Hong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.
   [Zhang, Weihong; Xu, Yongfen; Zhao, Fanfan; Tarbe, Marion; Zhou, Shuru; Zhang, Wei; Xu, Qiuping; Shi, Lina; Yuan, Feng; Lin, Xinwen; Liu, Shuai; Liang, Xiaozhen; Zhong, Jin; Long, Gang; Leng, Qibin; Tang, Hong] Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.
   [Wang, Weihong; Zhang, Shengyuan] Chinese Acad Sci, Inst Biophys, CAS Key Lab Infect & Immun, Beijing 100101, Peoples R China.
   [Sun, Jing; Zhao, Jincun; Leng, Qibin] Guangzhou Med Univ, Affiliated Canc Hosp & Inst, State Key Lab Resp Dis, Guangzhou 510095, Peoples R China.
   [Yang, Yaling] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai 201508, Peoples R China.
   [Qin, Chengfeng] Beijing Inst Microbiol & Epidemiol, Dept Virol, State Key Lab Pathogen & Biosecur, Beijing 100071, Peoples R China.
   [Zhang, Weihong; Zhao, Fanfan; Wang, Weihong; Zhang, Shengyuan; Xu, Qiuping; Shi, Lina; Yuan, Feng; Lin, Xinwen; Liu, Shuai] Univ Chinese Acad Sci, Beijing 100049, Peoples R China.
RP Tang, H (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan 430071, Peoples R China.; Leng, QB; Tang, H (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, CAS Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China.; Leng, QB (corresponding author), Guangzhou Med Univ, Affiliated Canc Hosp & Inst, State Key Lab Resp Dis, Guangzhou 510095, Peoples R China.
EM qbleng@ips.ac.cn; htang@ips.ac.cn
RI Zhou, Shuru/AAO-3311-2020
FU CAS, ChinaChinese Academy of Sciences [XDB29030301]; Natural Sciences
   Foundation of Shanghai, China [19ZR1463100]; National Science and
   Technology Major Project, China [2018ZX10101004002004]
FX We thank Dr. Xiang xi Wang (Institute of Biophysics, CAS) for his
   generosity in providing recombinant JEV E protein and JEV specific
   antibodies (2F2 and 2H4), Dr. Zhong Huang (Institut Pasteur of Shanghai,
   CAS) for recombinant ZIKV E protein and mouse antisera against
   ZIKV-EDIII, and Dr. Xia Jin (Institut Pasteur of Shanghai, CAS) for
   broadly cross-reactive mAb 4G2 against flaviviruses. This work was
   supported by Grants from CAS, China (XDB29030301), Natural Sciences
   Foundation of Shanghai, China (19ZR1463100) and National Science and
   Technology Major Project, China (2018ZX10101004002004) to H.T.
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Cavalcanti LPD, 2016, J INFECT DEV COUNTR, V10, P563, DOI 10.3855/jidc.8575
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   Gao XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003015
   Garcia-Nicolas O, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050124
   Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   Halstead SB, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0022-2014
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Heinz FX, 2017, MICROBIOL MOL BIOL R, V81, DOI [10.1128/MMBR.00055-16, 10.1128/mmbr.00055-16]
   KLIKS SC, 1988, AM J TROP MED HYG, V38, P411, DOI 10.4269/ajtmh.1988.38.411
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Maeki T, 2019, J INFECT CHEMOTHER, V25, P786, DOI 10.1016/j.jiac.2019.04.003
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Montoya M, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002357
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Ngono AE, 2017, CELL HOST MICROBE, V21, P35, DOI 10.1016/j.chom.2016.12.010
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8
   Shinohara N, 2017, T ROY SOC TROP MED H, V111, P393, DOI 10.1093/trstmh/trx071
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tandan JB, 2007, VACCINE, V25, P5041, DOI 10.1016/j.vaccine.2007.04.052
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   Turtle L, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005263
   Turtle L, 2016, J EXP MED, V213, P1331, DOI 10.1084/jem.20151517
   Wang HY, 2015, THER CLIN RISK MANAG, V11, P435, DOI 10.2147/TCRM.S51168
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xia H, 2018, VIROL SIN, V33, P5, DOI 10.1007/s12250-018-0002-9
   Yun SI, 2014, HUM VACC IMMUNOTHER, V10, P263, DOI 10.4161/hv.26902
   Zaman K, 2014, VACCINE, V32, P6061, DOI 10.1016/j.vaccine.2014.09.012
   Zellweger RM, 2010, CELL HOST MICROBE, V7, P128, DOI 10.1016/j.chom.2010.01.004
   Zhao FF, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28890-0
NR 43
TC 1
Z9 1
U1 5
U2 5
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 2095-9273
EI 2095-9281
J9 SCI BULL
JI Sci. Bull.
PD MAR 15
PY 2020
VL 65
IS 5
BP 402
EP 409
DI 10.1016/j.scib.2019.11.006
PG 8
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KS6DG
UT WOS:000518396800011
OA Bronze
DA 2020-07-08
ER

PT J
AU Araujo, RV
   Feitosa-Suntheimer, F
   Gold, AS
   Londono-Renteria, B
   Colpitts, TM
AF Araujo, Ricardo Vieira Y.
   Feitosa-Suntheimer, Fabiana
   Gold, Alexander S.
   Londono-Renteria, Berlin
   Colpitts, Tonya M.
TI One-step RT-qPCR assay for ZIKV RNA detection in Aedes aegypti samples:
   a protocol to study infection and gene expression during ZIKV infection
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Zika virus; One-step qRT-PCR; Mosquito gene expression
ID DIPTERA-CULICIDAE; VECTOR COMPETENCE; IMMUNE-RESPONSE; VIRUS OUTBREAK;
   CLIMATE-CHANGE; TRANSMISSION; ALBOPICTUS
AB BackgroundZika virus (ZIKV) is transmitted to humans during the bite of an infected mosquito. In a scenario of globalization and climate change, the frequency of outbreaks has and will increase in areas with competent vectors, revealing a need for continuous improvement of ZIKV detection tools in vector populations. A simple, rapid and sensitive assay for viral detection is quantitative reverse transcription polymerase chain reaction (qRT-PCR), yet oligos optimized for ZIKV detection in mammalian cells and samples have repeatedly shown high background when used on mosquito ribonucleic acid (RNA). In this paper, we present a one-step qRT-PCR protocol that allows for the detection of ZIKV in mosquitoes and for the evaluation of gene expression from the same mosquito sample and RNA. This assay is a less expensive qRT-PCR approach than that most frequently used in the literature and has a much lower background, allowing confident detection.MethodsOur new oligo design to detect ZIKV RNA included in silico analysis of both viral and mosquito (Ae. aegypti and Ae. albopictus) genomes, targeting sequences conserved between Asian and African ZIKV lineages, but not matching Aedes genomes. This assay will allow researchers to avoid nonspecific amplification in insect samples due to viral integration into the mosquito genome, a phenomenon known to happen in wild and colonized populations of mosquitoes. Standard curves constructed with in vitro transcribed ZIKV RNA were used to optimize the sensitivity, efficiency and reproducibility of the assay.ResultsFinally, the assay was used with success to detect both ZIKV RNA in infected mosquitoes and to detect expression of the Defensin A gene, an antimicrobial peptide (AMP) involved in Aedes aegypti immune response to virus infection.ConclusionsThe experimental approach to detect ZIKV RNA in Aedes aegypti presented here has demonstrated to be specific, sensitive and reliable, and additionally it allows for the analysis of mosquito gene expression during ZIKV infection.
C1 [Araujo, Ricardo Vieira Y.; Feitosa-Suntheimer, Fabiana; Gold, Alexander S.; Colpitts, Tonya M.] Boston Univ, Sch Med, Dept Microbiol, Boston, MA 02118 USA.
   [Araujo, Ricardo Vieira Y.; Feitosa-Suntheimer, Fabiana; Gold, Alexander S.; Colpitts, Tonya M.] Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.
   [Araujo, Ricardo Vieira Y.] Minist Sci Technol Innovat & Commun, Climate Div, Brasilia, DF, Brazil.
   [Londono-Renteria, Berlin] Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.
RP Colpitts, TM (corresponding author), Boston Univ, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.
EM tmcol@bu.edu
RI Londono, Berlin/I-8830-2019
OI Londono, Berlin/0000-0001-5956-5274
FU Boston University Pilot Award
FX NEIDL funding and Boston University Pilot Award.
CR [Anonymous], 2015, Wkly Epidemiol Rec, V90, P609
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Boccolini D, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.35.30328
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caragata EP, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007443
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   de Castro MG, 2012, MEM I OSWALDO CRUZ, V107, P940, DOI 10.1590/S0074-02762012000700017
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diagne CT, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1231-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Evans BR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49660-6
   Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Garcia-Luna SM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006599
   Gonzalez MA, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3359-1
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Gutierrez-Lopez R, 2019, EMERG INFECT DIS, V25, P346, DOI 10.3201/eid2502.171123
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Heitmann A, 2017, EUROSURVEILLANCE, V22, P4, DOI 10.2807/1560-7917.ES.2017.22.2.30437
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hernandez-Triana LM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3467-y
   Hugo LE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007281
   Izquierdo-Suzan M, 2019, EMERG INFECT DIS, V25, P1477, DOI 10.3201/eid2508.181533
   Jansen S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0195-x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li CX, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.8
   Likos A, 2016, MMWR-MORBID MORTAL W, V65, P1032, DOI 10.15585/mmwr.mm6538e1
   Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Londono-Renteria B, 2017, J GEN VIROL, V98, P1702, DOI 10.1099/jgv.0.000833
   Londono-Renteria B, 2016, J MED ENTOMOL, V53, P505, DOI 10.1093/jme/tjw003
   Lowenberger C, 2001, INSECT BIOCHEM MOLEC, V31, P219, DOI 10.1016/S0965-1748(00)00141-7
   Magalhaes T, 2008, EXP PARASITOL, V120, P364, DOI 10.1016/j.exppara.2008.09.003
   Magalhaes T, 2018, INSECTS, V9, DOI 10.3390/insects9040177
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Martin E, 2019, ACTA TROP, V192, P129, DOI 10.1016/j.actatropica.2019.02.006
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nunez AI, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3620-7
   Olson KE, 2017, CURR OPIN INSECT SCI, V22, P45, DOI 10.1016/j.cois.2017.05.010
   Palatini U, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3903-3
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   Richard V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005024
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ryckebusch F, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112384
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685
   Tien WP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2373-4
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   Wu P, 2019, CELL HOST MICROBE, V25, P101, DOI 10.1016/j.chom.2018.11.004
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhao LM, 2018, J MED ENTOMOL, V55, P78, DOI 10.1093/jme/tjx174
   Zou Z, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002394
NR 65
TC 0
Z9 0
U1 3
U2 3
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 14
PY 2020
VL 13
IS 1
AR 128
DI 10.1186/s13071-020-4002-x
PG 10
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KW5EM
UT WOS:000521188000001
PM 32171303
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU de Oliveira, JF
   Pescarini, JM
   Rodrigues, MD
   Almeida, BD
   Henriques, CMP
   Gouveia, FC
   Rabello, ET
   Matta, GC
   Barreto, ML
   Sampaio, RB
AF de Oliveira, Juliane Fonseca
   Pescarini, Julia Moreira
   Rodrigues, Moreno de Souza
   Almeida, Bethania de Araujo
   Pessanha Henriques, Claudio Maierovitch
   Gouveia, Fabio Castro
   Rabello, Elaine Teixeira
   Matta, Gustavo Correa
   Barreto, Mauricio L.
   Sampaio, Ricardo Barros
TI The global scientific research response to the public health emergency
   of Zika virus infection
SO PLOS ONE
LA English
DT Article
ID BRAZIL
AB Background
   Science studies have been a field of research for different knowledge areas, and they have been successfully used to analyse the construction of scientific knowledge, practice and dissemination. In this study, we aimed to verify how the Zika epidemic has moulded the scientific articles published worldwide by analysing international collaborations and the knowledge landscape through time, as well as research topics and country involvement.
   Methodology
   We searched the Web of Science (WoS), Scopus and PubMed for studies published up to 31st December 2018 on Zika using the search terms "zika", "zkv" or "zikv". We analysed the scientific production regarding which countries have published the most, on which topics, as well as country level collaboration. We performed a scientometric analysis of research on Zika focusing on knowledge mapping and the scientific research path over time and space.
   Findings
   We found two well defined research areas divided into three subtopics accounting for six clusters. With regard to country analysis, the USA and Brazil were the countries with the highest numbers of publications on Zika. China entered as a new player focusing on specific research areas. When we took into consideration the epidemics and reported cases, Brazil and France were the leading research countries on related topics. As for international collaboration, the USA followed by England and France stand out as the main hubs. The research areas most published included public health-related topics from 2015 until the very beginning of 2016, followed by an increase in topics related to the clinical aspects of the disease in 2016 and the emergence of laboratory research in 2017/2018.
   Conclusions
   Mapping the response to Zika, a public health emergency, demonstrated a clear pattern of the participation of countries in the scientific advances. The pattern of knowledge production found in this study represented varying country perspectives, research capacity and interests based first on their level of exposure to the epidemic and second on their financial positions regarding science.
C1 [de Oliveira, Juliane Fonseca; Pescarini, Julia Moreira; Rodrigues, Moreno de Souza; Almeida, Bethania de Araujo; Barreto, Mauricio L.; Sampaio, Ricardo Barros] Fiocruz MS, Inst Goncalo Moniz, Ctr Integracao Dados & Conhecimentos Saude Cidacs, Salvador, BA, Brazil.
   [de Oliveira, Juliane Fonseca] Univ Porto, Ctr Matemat, Porto, Portugal.
   [Rodrigues, Moreno de Souza] Fiocruz MS, Lab Anal & Visualizacao Dados, Rondonia, Brazil.
   [Pessanha Henriques, Claudio Maierovitch; Sampaio, Ricardo Barros] Fiocruz MS, Gerencia Reg Brasilia, Brasilia, DF, Brazil.
   [Gouveia, Fabio Castro] Fiocruz MS, Casa Oswaldo Cruz, Rio De Janeiro, Brazil.
   [Rabello, Elaine Teixeira] Univ Estado Rio de Janeiro, Inst Med Social, Rio De Janeiro, Brazil.
   [Matta, Gustavo Correa] Fiocruz MS, Escola Nacl Saude Pobl, Rio De Janeiro, Brazil.
   [Rabello, Elaine Teixeira] Wageningen Univ & Res, Publ Adm & Policy Grp, Wageningen, Netherlands.
   [Barreto, Mauricio L.] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
RP de Oliveira, JF; Sampaio, RB (corresponding author), Fiocruz MS, Inst Goncalo Moniz, Ctr Integracao Dados & Conhecimentos Saude Cidacs, Salvador, BA, Brazil.; de Oliveira, JF (corresponding author), Univ Porto, Ctr Matemat, Porto, Portugal.; Sampaio, RB (corresponding author), Fiocruz MS, Gerencia Reg Brasilia, Brasilia, DF, Brazil.
EM julianlanzin@gmail.com; rsampaio.br@gmail.com
RI ; Sampaio, Ricardo Barros/F-9482-2018
OI De Araujo Almeida, Bethania/0000-0001-8918-2661; Sampaio, Ricardo
   Barros/0000-0002-6989-8555; Rodrigues, Moreno/0000-0002-1594-2311
FU Secretary of Health Surveillance, Brazilian Ministry of Health, through
   the Zika Platform; European UnionEuropean Union (EU) [734548]; Oswaldo
   Cruz Foundation/Vice-Presidency of Research and Biological
   Collections-Fiocruz/VPPCB; Newton Fund/British Council
FX This work is supported by the Secretary of Health Surveillance,
   Brazilian Ministry of Health, through the Zika Platform - a long-term
   surveillance platform for the Zika virus and microcephaly in Brazil, at
   the Center of Data and Knowledge Integration for Health (CIDACS-Fiocruz)
   This work was partially supported by the European Union's Horizon 2020
   Research and Innovation Programme under ZIKAlliance Grant Agreement no.
   734548, and by the Oswaldo Cruz Foundation/Vice-Presidency of Research
   and Biological Collections-Fiocruz/VPPCB and the Newton Fund/British
   Council.
CR Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132
   Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7
   Bastian M., 2009, P INT AAAI C WEBL SO, V8, P361, DOI DOI 10.1136/QSHC.2004.010033
   Beaumier CM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002448
   Centers for Disease Control and Prevention, ZIK US
   Crew B., 2019, NATURE INDEX
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Delwiche Frances A., 2018, Science & Technology Libraries, V37, P113, DOI 10.1080/0194262X.2018.1431589
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Commission, COMM ACT AR ZIK
   Foray D, 2012, RES POLICY, V41, P1697, DOI 10.1016/j.respol.2012.07.011
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   G-FINDER, 2017, NEGLECTED DIS RES DE
   GOV.UK, UK TREBL FUND TACKL
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Leydesdorff L, 2009, J AM SOC INF SCI TEC, V60, P348, DOI 10.1002/asi.20967
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Machado-Silva A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6842-x
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Martins MFM, 2016, REV ELETRON COMUN IN, V10, P1
   Melo MC, 2017, INT J CURRENT RES, V9, P46728
   PAHO, PAN AM HLTH ORG RESP
   PAHO/WHO, 2015, EP AL ZIK VIR INF
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Rodrigues M., 2019, ZIKA SIENCE
   ROMERO DE, 2019, CAD SAUDE PUBLICA, V35, DOI DOI 10.1590/0102-311X00220217
   Singh Nirmal, 2016, VirusDisease, V27, P303, DOI 10.1007/s13337-016-0339-3
   Van Eck NJ, 2007, STUD CLASS DATA ANAL, P299
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
NR 29
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 12
PY 2020
VL 15
IS 3
AR e0229790
DI 10.1371/journal.pone.0229790
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ9AF
UT WOS:000535288600023
PM 32163439
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rezende, HR
   Romano, CM
   Claro, IM
   Caleiro, GS
   Sabino, EC
   Felix, AC
   Bissoli, J
   Hill, S
   Faria, NR
   da Silva, TCC
   Santos, APB
   Cerutti, C
   Vicente, CR
AF Rezende, Helder Ricas
   Romano, Camila Malta
   Claro, Ingra Morales
   Caleiro, Giovana Santos
   Sabino, Ester Cerdeira
   Felix, Alvina Clara
   Bissoli, Jefferson
   Hill, Sarah
   Faria, Nuno Rodrigues
   Cardoso da Silva, Theresa Cristina
   Brioschi Santos, Ana Paula
   Cerutti Junior, Crispim
   Vicente, Creuza Rachel
TI First report of Aedes albopictus infected by Dengue and Zika virus in a
   rural outbreak in Brazil
SO PLOS ONE
LA English
DT Article
ID TIME RT-PCR; DIPTERA-CULICIDAE; VECTOR; STATE; CONTAINERS; TYPE-1; CITY
AB In Brazil, Dengue (DENV) and Zika (ZIKV) viruses are reported as being transmitted exclusively by Aedes aegypti in urban settings. This study established the vectors and viruses involved in an arbovirus outbreak that occurred in 2019 in a rural area of Espi ' rito Santo state, Brazil. Mosquitoes collected were morphologically identified, sorted in samples, and submitted to molecular analysis for arboviruses detection. Phylogenetic reconstruction was performed for the viral sequence obtained. All 393 mosquitoes were identified as Aedes albopictus. DENV-1 genotype V was present in one sample and another sample was positive for ZIKV. The DENV-1 clustered with viruses that have circulated in previous years in large urban centers of different regions in Brazil. This is the first report of A. albopictus infected by DENV and ZIKV during an outbreak in a rural area in Brazil, indicating its involvement in arboviral transmission. The DENV-1 strain found in the A. albopictus was not new in Brazil, being involved previously in epidemics related to A. aegypti, suggesting the potential to A. albopictus in transmitting viruses already circulating in the Brazilian population. This finding also indicates the possibility of these viruses to disperse across urban and rural settings, imposing additional challenges for the control of the diseases.
C1 [Rezende, Helder Ricas] Secretaria Estado Saude Espirito Santo, Nucleo Entomol & Malacol, Serra, ES, Brazil.
   [Romano, Camila Malta] Univ Sao Paulo, Hosp Clin HCFMUSP LIM52, Fac Med, Sao Paulo, SP, Brazil.
   [Claro, Ingra Morales; Sabino, Ester Cerdeira] Univ Sao Paulo, Fac Med, Dept Molestias Infecciosas & Parasitarias, Sao Paulo, SP, Brazil.
   [Caleiro, Giovana Santos; Felix, Alvina Clara] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil.
   [Bissoli, Jefferson] Secretaria Municipal Saude Linhares, Vigilancia Saude, Linhares, ES, Brazil.
   [Hill, Sarah; Faria, Nuno Rodrigues] Univ Oxford, Dept Zool, Oxford, England.
   [Cardoso da Silva, Theresa Cristina; Brioschi Santos, Ana Paula] Secretaria Estado Sande Espirito Santo, Vigilancia Saude, Vitoria, ES, Brazil.
   [Cerutti Junior, Crispim; Vicente, Creuza Rachel] Univ Fed Espirito Santo, Dept Med Social, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
RP Vicente, CR (corresponding author), Univ Fed Espirito Santo, Dept Med Social, Programa Posgrad Doencas Infecciosas, Vitoria, ES, Brazil.
EM vicentecrachel@gmail.com
OI Hill, Sarah/0000-0002-2995-2596
FU Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [15/05958-3,
   18/14389-0]
FX This research was supported by Fundacao de Amparo a Pesquisa do Estado
   de Sao Paulo (FAPESP) [grants number 15/05958-3, CMR; and 18/14389-0,
   ECS]. The funder had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Abilio AP, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006692
   Auteri M, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/3098575
   Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bezerra JMT, 2016, ACTA TROP, V164, P431, DOI 10.1016/j.actatropica.2016.10.010
   Bisanzio D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006298
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Brasil. Ministerio da Saude, 2015, PLAN NAC EP DENG
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, GUIA VIG SAUD
   Callahan JD, 2001, J CLIN MICROBIOL, V39, P4119, DOI 10.1128/JCM.39.11.4119-4124.2001
   Carneiro AR, 2012, MEM I OSWALDO CRUZ, V107, P805, DOI 10.1590/S0074-02762012000600016
   Carvalho RG, 2014, MEM I OSWALDO CRUZ, V109, P787, DOI 10.1590/0074-0276140304
   Cecilia D, 2015, ARCH VIROL, V160, P323, DOI 10.1007/s00705-014-2217-x
   Cecilio AB, 2009, BRAZ J BIOL, V69, P123, DOI 10.1590/S1519-69842009000100015
   Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102
   Consoli R.A.G.B., 1994, PRINCIPAIS MOSQUITOS
   da Silva VC, 2006, REV SAUDE PUBL, V40, P1106, DOI [10.1590/S0034-89102006000700021, 10.1590/s0034-89102006000700021]
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Albuquerque C M, 2000, Rev Saude Publica, V34, P314
   de Almeida PS, 2006, REV SAUDE PUBL, V40, P1094, DOI 10.1590/S0034-89102006000700019
   de Brito M, 2004, REV SAUDE PUBL, V38, P209, DOI 10.1590/S0034-89102004000200009
   de Bruycker-Nogueira F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35622-x
   de Figueiredo MLG, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-152
   Custodio JMD, 2019, REV INST MED TROP SP, V61, DOI [10.1590/S1678-9946201961018, 10.1590/s1678-9946201961018]
   DONALISIO MR, 2017, REV SAUDE PUBL, V51, DOI DOI 10.1590/S1518-8787
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Ferreira Neto J. A., 1987, Cadernos de Saude Publica, V3, P56, DOI 10.1590/S0102-311X1987000100006
   FORATTINI OP, 1986, REV SAUDE PUBL, V20, P244, DOI 10.1590/S0034-89101986000300009
   Gomes AC, 2005, REV SAUDE PUBL, V39, P106
   Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Heinisch MRS, 2019, ACTA TROP, V189, P104, DOI 10.1016/j.actatropica.2018.09.011
   Huhtamo E, 2010, J CLIN VIROL, V47, P49, DOI 10.1016/j.jcv.2009.11.001
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Pancetti FGM, 2015, REV SOC BRAS MED TRO, V48, P87, DOI 10.1590/0037-8682-0155-2014
   Montagner FRG, 2018, BRAZ J BIOL, V78, P233, DOI 10.1590/1519-6984.04416
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Pan American Health Organization, 2017, TOOL DIAGN CAR PAT S
   Pessanha José Eduardo Marques, 2011, Rev. Soc. Bras. Med. Trop., V44, P103, DOI 10.1590/S0037-86822011000100023
   Martins VEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041386
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Ramos-Castaneda J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005224
   de Abreu FVS, 2019, EMERG MICROBES INFEC, V8, P218, DOI 10.1080/22221751.2019.1568180
   Scolari F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02036
   SERUFO JC, 1993, MEM I OSWALDO CRUZ, V88, P503, DOI 10.1590/S0074-02761993000300025
   Smartt CT, 2017, J MED ENTOMOL, V54, P1085, DOI 10.1093/jme/tjx058
   TRPIS M, 1968, MOSQ NEWS, V28, P647
   World Health Organization, 2009, CDC PROT REAL TIME R
   World Health Organization, 2019, ZIK EP UPD
NR 51
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 12
PY 2020
VL 15
IS 3
AR e0229847
DI 10.1371/journal.pone.0229847
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ9AF
UT WOS:000535288600027
PM 32163449
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Lecouturier, V
   Pavot, V
   Berry, C
   Donadieu, A
   de Montfort, A
   Boudet, F
   Rokbi, B
   Jackson, N
   Heinrichs, J
AF Lecouturier, Valerie
   Pavot, Vincent
   Berry, Catherine
   Donadieu, Arnaud
   de Montfort, Aymeric
   Boudet, Florence
   Rokbi, Bachra
   Jackson, Nicolas
   Heinrichs, Jon
TI An optimized purified inactivated Zika vaccine provides sustained
   immunogenicity and protection in cynomolgus macaques
SO NPJ VACCINES
LA English
DT Article
ID DNA VACCINE; VIRUS; RHESUS; TRANSMISSION; PHASE-1; SAFETY; ASSAY
AB The recent spread of Zika virus (ZIKV) through the Americas and Caribbean and its devastating consequences for pregnant women and their babies have driven the search for a safe and efficacious ZIKV vaccine. Among the vaccine candidates, a first-generation ZIKV purified inactivated vaccine (ZPIV), adjuvanted with aluminum hydroxide, developed by the Walter Reed Army Institute of Research (WRAIR), has elicited high seroconversion rates in participants in three phase-I clinical trials. In collaboration with the WRAIR, Sanofi Pasteur (SP) optimized the production scale, culture and purification conditions, and increased the regulatory compliance, both of which are critical for clinical development and licensure of this vaccine. Using a clinical batch of the first-generation ZPIV as a benchmark, we report that different doses of the optimized vaccine (ZPIV-SP) elicited sustained neutralizing antibodies, specific T- and memory B-cells, and provided complete protection against a ZIKV challenge in cynomolgus macaques. These data provide evidence that the ZPIV-SP vaccine performs at least as well as the ZPIV vaccine, and provide support for continued development in the event of future ZIKV outbreaks.
C1 [Lecouturier, Valerie; Pavot, Vincent; Berry, Catherine; Donadieu, Arnaud; de Montfort, Aymeric; Boudet, Florence; Rokbi, Bachra; Jackson, Nicolas] Sanofi Pasteur, Res & Dev, Marcy Letoile, France.
   [Heinrichs, Jon] Sanofi Pasteur, Discovery Drive, Swiftwater, PA USA.
   [Jackson, Nicolas] CEPI, London, England.
RP Lecouturier, V (corresponding author), Sanofi Pasteur, Res & Dev, Marcy Letoile, France.
EM valerie.lecouturier@sanofi.com
FU Sanofi Pasteur; Federal funds from the Department of Health and Human
   Services, Office of the Assistant Secretary for Preparedness and
   Response, Biomedical Advanced Research and Development Authority
   [HHSO1002016000039C]
FX We are grateful to the US CDC, Fort Collins, for providing the ZIKV
   PRVABC59 strain. We thank Kenneth Eckels for providing ZPIV and
   generously sharing his expertize on ZIKV vaccines, and Nelson Michael
   and Kayvon Modjarrad from Walter Reed Army Institute of Research, USA,
   for critical discussion, review and edits of this manuscript. We also
   thank the Sanofi Pasteur PRD teams for producing and characterizing the
   ZPIV-SP vaccine. We thank Sandrine Montano, Florine Guillaume, Sandrine
   Raynaud, Sophie Fraysse, Terence Villa, and Jeremy Pontvianne for their
   contributions to the animal experiments and analytical assays. We thank
   Julie Piolat for her contribution to the statistical analysis of the
   results. We thank Lucie Engelhart and the staff of the animal facilities
   of Sanofi Pasteur for help with the in vivo studies. Medical writing and
   editorial assistance with the preparation of the manuscript was provided
   by a professional medical writer, Margaret Haugh (MediCom Consult,
   Villeurbanne, France), funded by Sanofi Pasteur. We also thank Sandrine
   Buisson for editorial assistance and manuscript coordination on behalf
   of Sanofi Pasteur. This study was funded by Sanofi Pasteur and Federal
   funds from the Department of Health and Human Services, Office of the
   Assistant Secretary for Preparedness and Response, Biomedical Advanced
   Research and Development Authority, under Contract No.
   HHSO1002016000039C.
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Deng YQ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01923-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Dowd KA, 2016, SCIENCE, V354, P237, DOI 10.1126/science.aai9137
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   Giel-Moloney M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31375-9
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Inoue T, 2018, IMMUNOL REV, V283, P138, DOI 10.1111/imr.12640
   Jahnmatz M, 2013, J IMMUNOL METHODS, V391, P50, DOI 10.1016/j.jim.2013.02.009
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Laffins MM, 2017, J AM ASSOC LAB ANIM, V56, P84
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lecouturier V, 2019, VACCINE, V37, P2679, DOI 10.1016/j.vaccine.2019.04.013
   Lucas CGO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05519-4
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nascimento EJM, 2019, AM J TROP MED HYG, V101, P708, DOI 10.4269/ajtmh.19-0270
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10
   Rao VB, 2019, NPJ CLIM ATMOS SCI, V2, DOI 10.1038/s41612-019-0061-0
   Siegrist C. -A, 2018, PLOTKINS VACCINES, P16
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   World Health Organization, 2019, ZIK EP UPD JUL 2019
NR 37
TC 0
Z9 0
U1 1
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD MAR 12
PY 2020
VL 5
IS 1
AR 19
DI 10.1038/s41541-020-0167-8
PG 10
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KV5FL
UT WOS:000520508300001
PM 32194996
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Redmond, SN
   Sharma, A
   Sharakhov, I
   Tu, ZJ
   Sharakhova, M
   Neafsey, DE
AF Redmond, Seth N.
   Sharma, Atashi
   Sharakhov, Igor
   Tu, Zhijian
   Sharakhova, Maria
   Neafsey, Daniel E.
TI Linked-read sequencing identifies abundant microinversions and
   introgression in the arboviral vector Aedes aegypti
SO BMC BIOLOGY
LA English
DT Article
DE Structural variation; Chromosomal inversions; Introgression; Aedes
   aegypti
ID ANOPHELES-GAMBIAE; CHROMOSOMAL INVERSIONS; MALARIA VECTOR;
   BINDING-PROTEINS; GENOME SEQUENCE; S FORMS; MOSQUITO; EVOLUTION;
   ADAPTATION; SPECIATION
AB Background Aedes aegypti is the principal mosquito vector of Zika, dengue, and yellow fever viruses. Two subspecies of Ae. aegypti exhibit phenotypic divergence with regard to habitat, host preference, and vectorial capacity. Chromosomal inversions have been shown to play a major role in adaptation and speciation in dipteran insects and would be of great utility for studies of Ae. aegypti. However, the large and highly repetitive genome of Ae. aegypti makes it difficult to detect inversions with paired-end short-read sequencing data, and polytene chromosome analysis does not provide sufficient resolution to detect chromosome banding patterns indicative of inversions. Results To characterize chromosomal diversity in this species, we have carried out deep Illumina sequencing of linked-read (10X Genomics) libraries in order to discover inversion loci as well as SNPs. We analyzed individuals from colonies representing the geographic limits of each subspecies, one contact zone between subspecies, and a closely related sister species. Despite genome-wide SNP divergence and abundant microinversions, we do not find any inversions occurring as fixed differences between subspecies. Many microinversions are found in regions that have introgressed and have captured genes that could impact behavior, such as a cluster of odorant-binding proteins that may play a role in host feeding preference. Conclusions Our study shows that inversions are abundant and widely shared among subspecies of Aedes aegypti and that introgression has occurred in regions of secondary contact. This library of 32 novel chromosomal inversions demonstrates the capacity for linked-read sequencing to identify previously intractable genomic rearrangements and provides a foundation for future population genetics studies in this species.
C1 [Redmond, Seth N.] Monash Univ, Inst Vector Borne Dis, Melbourne, Vic, Australia.
   [Redmond, Seth N.; Neafsey, Daniel E.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
   [Sharma, Atashi; Sharakhov, Igor; Tu, Zhijian; Sharakhova, Maria] Virginia Polytech Inst & State Univ, Fralin Life Sci Inst, Blacksburg, VA 24061 USA.
   [Neafsey, Daniel E.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.
RP Redmond, SN (corresponding author), Monash Univ, Inst Vector Borne Dis, Melbourne, Vic, Australia.; Redmond, SN (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.
EM seth.redmond@monash.edu
FU National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human ServicesUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [U19AI110818]; Broad Next10 Grant
FX This project has been funded in whole or in part with Federal funds from
   the National Institute of Allergy and Infectious Diseases, National
   Institutes of Health, Department of Health and Human Services, under
   Grant Number U19AI110818 to the Broad Institute. SNR was further
   supported by a Broad Next10 Grant.
CR Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185
   Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Ayala D, 2011, MOL BIOL EVOL, V28, P745, DOI 10.1093/molbev/msq248
   Bernhardt SA, 2009, INSECT MOL BIOL, V18, P557, DOI 10.1111/j.1365-2583.2009.00895.x
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biessmann H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009471
   Brito NF, 2016, J INSECT PHYSIOL, V95, P51, DOI 10.1016/j.jinsphys.2016.09.008
   Brooke BD, 2000, MED VET ENTOMOL, V14, P190, DOI 10.1046/j.1365-2915.2000.00222.x
   Campos J, 2003, MEM I OSWALDO CRUZ, V98, P387, DOI 10.1590/S0074-02762003000300017
   Cheng CD, 2012, GENETICS, V190, P1417, DOI 10.1534/genetics.111.137794
   Clarkson CS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5248
   COCKBURN AF, 1989, ARCH INSECT BIOCHEM, V10, P105, DOI 10.1002/arch.940100202
   Coluzzi M, 2002, SCIENCE, V298, P1415, DOI 10.1126/science.1077769
   COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1
   Crawford JE, 2017, BMC BIOL, V15, DOI 10.1186/s12915-017-0351-0
   Cruickshank TE, 2014, MOL ECOL, V23, P3133, DOI 10.1111/mec.12796
   Dagilis AJ, 2016, EVOLUTION, V70, P1465, DOI 10.1111/evo.12954
   Dickson LB, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004626
   Dobzhansky T, 1938, GENETICS, V23, P28
   DOBZHANSKY T, 1947, GENETICS, V32, P142
   Durand EY, 2011, MOL BIOL EVOL, V28, P2239, DOI 10.1093/molbev/msr048
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fontaine MC, 2015, SCIENCE, V347, DOI 10.1126/science.1258524
   Fouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034841
   Fuller ZL, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007526
   Gloria-Soria Andrea, 2019, PLoS Negl Trop Dis, V13, pe0007930, DOI 10.1371/journal.pntd.0007930
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gomes B, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-262
   Gomez-Diaz C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001546
   He C, 2020, MOL BIOL EVOL, V37, P881, DOI 10.1093/molbev/msz232
   Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181
   Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Krimbas KV, 1992, DROSOPHILA INVERSION
   Larter NK, 2016, ELIFE, V15, P5
   Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635
   Lee Y, 2013, P NATL ACAD SCI USA, V110, P19854, DOI 10.1073/pnas.1316851110
   Lobo NF, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-293
   LOUNIBOS LP, 1981, ECOL ENTOMOL, V6, P129, DOI 10.1111/j.1365-2311.1981.tb00601.x
   MACDONALD WW, 1965, ANN TROP MED PARASIT, V59, P74, DOI 10.1080/00034983.1965.11686285
   Main BJ, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006303
   Mangudo C, 2015, B ENTOMOL RES, V105, P679, DOI 10.1017/S0007485315000590
   Manoukis NC, 2008, P NATL ACAD SCI USA, V105, P2940, DOI 10.1073/pnas.0709806105
   Marsden CD, 2011, MOL ECOL, V20, P4983, DOI 10.1111/j.1365-294X.2011.05339.x
   Martin SH, 2015, MOL BIOL EVOL, V32, P244, DOI 10.1093/molbev/msu269
   Mastrobuoni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075162
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Matthews BJ, AEDES AEGYPTI GENOME
   McBride CS, 2014, NATURE, V515, P222, DOI 10.1038/nature13964
   Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]
   Miles A, 2017, NATURE, V552, P96, DOI 10.1038/nature24995
   Neafsey DE, 2015, SCIENCE, V347, DOI 10.1126/science.1258522
   Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498
   Pelletier J, 2010, J CHEM ECOL, V36, P245, DOI 10.1007/s10886-010-9762-x
   PETRARCA V, 1992, AM J TROP MED HYG, V46, P229, DOI 10.4269/ajtmh.1992.46.229
   Powell JR, 2017, AM J TROP MED HYG, V96, P157, DOI 10.4269/ajtmh.16-0693
   Redmond SN, AEDES AEGYPTI GLOBAL
   Riehle MM, 2017, ELIFE, V23, P6
   Sanford MR, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-225
   SHARMA GP, 1978, CYTOBIOS, V22, P169
   Simard Frederic, 2009, BMC Ecology, V9, P17, DOI 10.1186/1472-6785-9-17
   Stevison LS, 2011, GENOME BIOL EVOL, V3, P830, DOI 10.1093/gbe/evr081
   Sturtevant AH, 1921, P NATL ACAD SCI USA, V7, P235, DOI 10.1073/pnas.7.8.235
   TABACHNICK W J, 1991, American Entomologist, V37, P14
   Thompson MJ, 2014, HEREDITY, V113, P1, DOI 10.1038/hdy.2014.20
   Wellenreuther M, 2018, TRENDS ECOL EVOL, V33, P427, DOI 10.1016/j.tree.2018.04.002
   White BJ, 2009, GENETICS, V183, P275, DOI 10.1534/genetics.109.105817
   WHITE MJD, 1978, MODES SPECIATION
NR 69
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1741-7007
J9 BMC BIOL
JI BMC Biol.
PD MAR 12
PY 2020
VL 18
IS 1
AR 26
DI 10.1186/s12915-020-0757-y
PG 14
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KU8QL
UT WOS:000519976700001
PM 32164699
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU McMonagle, SK
AF McMonagle, Susannah K.
TI Zika, the Centers for Disease Control and Prevention, and Secrets
   Resorts: Using a viral outbreak to teach students about crisis
   communication
SO COMMUNICATION TEACHER
LA English
DT Article; Early Access
AB Courses: Public Relations, Organizational/Crisis Communication, Social Media in Organizations. Objective: The goal for this activity is for students to simulate an organizational response to an environmental/health crisis impacting their business operations. By working through various components of a crisis event, students apply theoretical learnings and create messages for both internal and external stakeholders utilizing a variety of communication channels, including social media.
C1 [McMonagle, Susannah K.] Eastern Univ, Dept Commun Studies, 1300 Eagle Rd, St Davids, PA 19087 USA.
RP McMonagle, SK (corresponding author), Eastern Univ, Dept Commun Studies, 1300 Eagle Rd, St Davids, PA 19087 USA.
EM smcmonag@eastern.edu
CR Auman C., 2011, COLL TEACHING, V59, P154, DOI DOI 10.1080/87567555.2011.602134
   Austin L, 2012, J APPL COMMUN RES, V40, P188, DOI 10.1080/00909882.2012.654498
   Coombs W.T., 2018, ONGOING CRISIS COMMU
   Coombs W. T., 2014, CRISIS MANAGEMENT CO
   Ekstein N., 2018, BLOOMBERG
   Freberg K, 2013, PUBLIC RELAT REV, V39, P185, DOI 10.1016/j.pubrev.2013.02.010
   Hansen A. J., 1994, TEACHING CASE METHOD
   Kellerman B, 2006, HARVARD BUS REV, V84, P72
   Lin XL, 2016, COMPUT HUM BEHAV, V65, P601, DOI 10.1016/j.chb.2016.05.080
   Lowe R, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15010096
   Lunce L. M., 2006, J APPL ED TECHNOLOGY, V3, P37
   McNeil Jr Donald G., 2016, NY TIMES
   Neubert J., 2016, 10 WAYS COMPETITIONS
   U.S. Department of Health and Human Services, 2017, ZIK 101
   Wendling C., 2013, OECD WORKING PAPERS, V25
NR 15
TC 0
Z9 0
U1 4
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1740-4622
EI 1740-4630
J9 COMMUN TEACH
JI Commun. Teach.
DI 10.1080/17404622.2020.1735643
EA MAR 2020
PG 7
WC Communication
SC Communication
GA KU7DQ
UT WOS:000519874200001
DA 2020-07-08
ER

PT J
AU Alaofi, AL
AF Alaofi, Ahmed L.
TI Probing the flexibility of Zika virus envelope protein DIII epitopes
   using molecular dynamics simulations
SO MOLECULAR SIMULATION
LA English
DT Article
DE Zika virus; envelope protein; DIII domain; molecular dynamics (MD)
   simulations; monoclonal antibodies
ID DOMAIN III; NEUTRALIZING ANTIBODIES; BINDING; RECOGNITION; SERVER
AB Zika virus (ZIKV) envelope protein (E) domain III (DIII) mediates viral attachment and fusion. The DIII facilitates cell receptor recognition, and includes several ZIKV antibody epitopes. The DIII is also considered as an antigenic target for ZIKV-neutralising antibodies. Understanding the flexibility and dynamical behaviour of ZIKV DIII can aid the design of vaccines against ZIKV. Using molecular dynamics (MD) simulations, the flexibility of DIII and its epitopes were characterised. The final structure from a 100 ns-long MD simulation was docked to anti-DIII ZIKV Fabs (ZV67 and ZV64). Interestingly, the analysis of the MD simulations revealed that the residues of the C-C' loop and the ABDE sheet epitopes (epitopes for moderately neutralising ZV64 and weakly neutralising ZV2 mAbs, respectively) were highly flexible, whereas the LR epitope for strongly neutralising ZV67 mAb was rigid.
C1 [Alaofi, Ahmed L.] King Saud Univ, Coll Pharm, Dept Pharmaceut, Bldg 23,Ground Floor,Off AA 67,POB 2457, Riyadh 11451, Saudi Arabia.
RP Alaofi, AL (corresponding author), King Saud Univ, Coll Pharm, Dept Pharmaceut, Bldg 23,Ground Floor,Off AA 67,POB 2457, Riyadh 11451, Saudi Arabia.
EM ahmedofi@ksu.edu.sa
FU Deanship of Scientific Research of King Saud UniversityDeanship of
   Scientific Research at King Saud University [R6-17-02-25]
FX This work was supported by the Deanship of Scientific Research of King
   Saud University under Grant [R6-17-02-25].
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Alaofi EF, 2015, J BIOMOLECULAR UNPUB
   Almeida RD, 2018, VACCINES-BASEL, V6, DOI 10.3390/vaccines6030062
   Anasir MI, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00738
   [Anonymous], PYMOL MOL GRAPH SYST
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   He LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep12501
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Jubb H, 2015, PROG BIOPHYS MOL BIO, V119, P2, DOI 10.1016/j.pbiomolbio.2015.01.009
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kong XT, 2018, PHYS CHEM CHEM PHYS, V20, P4851, DOI 10.1039/c7cp08241j
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kumar D, 2019, BIORXIV 2019 530600
   Kumar R, 2014, BIOPHYS J, V106, P1338, DOI 10.1016/j.bpj.2014.01.028
   Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Moraes AH, 2016, J VIROL, V90, P1802, DOI 10.1128/JVI.02314-15
   Negahdaripour M, 2018, INFECT GENET EVOL, V58, P96, DOI 10.1016/j.meegid.2017.12.008
   Pall S, 2015, LECT NOTES COMPUT SC, V8759, P3, DOI 10.1007/978-3-319-15976-8_1
   PORTA TUBIW, 2016, PORTA TUBIW
   Reboul CF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002404
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Yang CP, 2019, VIROL SIN, V34, P168, DOI 10.1007/s12250-019-00093-5
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 47
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0892-7022
EI 1029-0435
J9 MOL SIMULAT
JI Mol. Simul.
PD MAY 2
PY 2020
VL 46
IS 7
BP 541
EP 547
DI 10.1080/08927022.2020.1738424
EA MAR 2020
PG 7
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA LH4XO
UT WOS:000519455900001
DA 2020-07-08
ER

PT J
AU Zhou, YC
   Chen, D
   Yang, L
   Zou, WW
   Duan, ZL
   Zhang, YJ
   Wen, JS
AF Zhou, Yongchao
   Chen, Dong
   Yang, Lan
   Zou, Weiwei
   Duan, Zhiliang
   Zhang, Yanjun
   Wen, Jinsheng
TI Dengue virus envelope protein domain III-elicited antibodies mediate
   cross-protection against Zika virus in a mouse model
SO VIRUS RESEARCH
LA English
DT Article
DE Dengue virus; Zika virus; Envelope protein domain III; Antibody;
   Cross-protection; Mouse
ID INFECTION
AB Dengue virus (DENV) and Zika virus (ZIKV) are antigenically related mosquito-transmitted viruses which represent a big public health problem. Although the antigenic cross-reactivity between two viruses were intensively investigated at the antibody and T cell levels, how DENV envelope protein domain III (EDIII)-elicited antibodies (Abs) impact the outcome of ZIKV infection is uncertain. Here, our results show that the sera isolated from DENV-EDIII-immunized wild-type mice recognized ZIKV-EDIII and cross-neutralized ZIKV in vitro. Passive transfer of DENV-EDIII-immune sera protected 1-day-old mice against lethal ZIKV challenge. Finally, maternally acquired anti-DENV-EDIII Abs significantly increased the survival of 1-day-old mice born to DENV-EDIII-immunized mothers post ZIKV challenge. These results reveal that DENV-EDIII-induced Abs provide cross-protection against ZIKV and may not mediate the Ab-dependent enhancement of ZIKV infection at the concentration used here. The present study would contribute to the development and application of DENV-EDIII-based vaccines.
C1 [Zhou, Yongchao; Chen, Dong; Yang, Lan; Zou, Weiwei; Wen, Jinsheng] Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.
   [Zhang, Yanjun] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.
   [Chen, Dong] Sixth Peoples Hosp Wenzhou, Wenzhou 325000, Zhejiang, Peoples R China.
   [Wen, Jinsheng] Ningbo Univ, Sch Med, Dept Microbiol, Ningbo 315211, Zhejiang, Peoples R China.
   [Duan, Zhiliang] Second Hosp Ningbo, Dept Clin Lab, Ningbo 315000, Zhejiang, Peoples R China.
RP Wen, JS (corresponding author), Wenzhou Med Univ, Sch Basic Med Sci, Inst Arboviruses, Wenzhou 325000, Zhejiang, Peoples R China.; Zhang, YJ (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou 310051, Zhejiang, Peoples R China.
EM yjzhang@cdc.zj.cn; wenjinsheng@nbu.edu.cn
RI Zhou, Yongchao/AAR-5656-2020
FU Zhejiang Provincial Natural Science FoundationNatural Science Foundation
   of Zhejiang Province [LY17C010004]; National Natural Science Foundation
   of ChinaNational Natural Science Foundation of China [31870159,
   81672060]
FX This work was funded by the Zhejiang Provincial Natural Science
   Foundation (LY17C010004) and the National Natural Science Foundation of
   China (31870159 and 81672060). The funders had no role in the study
   design, data analysis, and preparation of the manuscript.
CR Aguiar M, 2018, LANCET, V391, P1769, DOI 10.1016/S0140-6736(18)30865-1
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bautista LE, 2018, ANN EPIDEMIOL, V28, P111, DOI 10.1016/j.annepidem.2017.11.010
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Cabral-Miranda G, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030072
   Campos JLS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181734
   Cerezo J, 2019, PROTEIN EXPRES PURIF, V153, P131, DOI 10.1016/j.pep.2018.09.009
   Chiang CY, 2014, VACCINE, V32, P1346, DOI 10.1016/j.vaccine.2014.01.041
   Chiang CY, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002432
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fahimi H, 2018, APPL MICROBIOL BIOT, V102, P2977, DOI 10.1007/s00253-018-8822-y
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Gintarong T, 2018, J VECTOR DIS, V55, P168, DOI 10.4103/0972-9062.242566
   Hart BE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005229
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Ko HY, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006827
   Li S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120717
   Manangeeswaran M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006004
   Musso D, 2018, LANCET INFECT DIS, V18, pE172, DOI 10.1016/S1473-3099(17)30446-2
   Poggianella M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003947
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Qi ZZ, 2012, CLIN VACCINE IMMUNOL, V19, P1746, DOI 10.1128/CVI.00455-12
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Rey FA, 2013, NATURE, V497, P443, DOI 10.1038/497443a
   Thomas SJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006593
   Wen JS, 2019, CURR OPIN IMMUNOL, V59, P1, DOI 10.1016/j.coi.2019.02.001
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, pE31, DOI 10.1016/S1473-3099(18)30494-8
   Yang M, 2017, VACCINE, V35, P4287, DOI 10.1016/j.vaccine.2017.04.052
   Zaneti AB, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00059
NR 34
TC 0
Z9 0
U1 6
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0168-1702
EI 1872-7492
J9 VIRUS RES
JI Virus Res.
PD MAR 12
PY 2020
VL 278
AR 197882
DI 10.1016/j.virusres.2020.197882
PG 8
WC Virology
SC Virology
GA KO3DZ
UT WOS:000515429400013
PM 31981774
DA 2020-07-08
ER

PT J
AU Alessa, M
   Alzahrani, M
   Alshehri, A
   Aljrboa, A
   Bustami, R
   Almangour, A
   Alsalem, A
   Gramish, J
   Khobrani, M
   Almangour, TA
AF Alessa, Mohammed
   Alzahrani, Mohammed
   Alshehri, Abdulmajeed
   Aljrboa, Amjad
   Bustami, Rami
   Almangour, Abdullah
   Alsalem, Abdulaziz
   Gramish, Jawaher
   Khobrani, Moteb
   Almangour, Thamer A.
TI Knowledge regarding Zika Virus Infection among Healthcare Providers in
   an Academic Tertiary Care Center in Riyadh, Saudi Arabia: A
   Cross-Sectional Survey Study
SO CANADIAN JOURNAL OF INFECTIOUS DISEASES & MEDICAL MICROBIOLOGY
LA English
DT Article
ID EMERGENCE
AB Background. Zika virus (ZIKV) has become a major concern across the world. It is highly necessary for healthcare providers (HCPs) to have sufficient knowledge about such a disease. The purpose of this study is to assess the knowledge regarding ZIKV among HCPs in Riyadh, Saudi Arabia. Materials and Methods. A cross-sectional survey study was conducted at a tertiary care center in Riyadh, KSA, during a two-month period from September 19, 2016 to November 19, 2016. Descriptive statistics were performed on data collected. For continuous variables, data were expressed as means +/- standard deviations (SDs), medians, and ranges. Proportions were used to describe categorical variables. Knowledge scores were evaluated and compared by demographic characteristics including age, designation, years of practice, and gender, using the t-test/Mann-Whitney U test or the Kruskal-Wallis test, as appropriate. Results. A total of 336 HCPs from different specialties (physicians, dentists, nurses, pharmacists, and nutritionists) completed the questionnaire. Significant differences in knowledge about ZIKV were observed by participant's age. Significantly higher knowledge levels were observed among older participants (45 years or more; p=0.011). A substantial difference in the knowledge level was observed by department, with pairwise comparisons showing significant differences in knowledge scores between all departments except for Pharmacy vs. Nutrition and Nursing vs. Internal Medicine. Knowledge scores were not significantly different by years of practice. Conclusion. Our study showed inadequate knowledge of HCPs from different specialties about ZIKV infection which needs to be improved in terms of infection prevention and control. Awareness about ZIKV infection should be ensured and maintained among HCPs to face any possible emergence in the region.
C1 [Alessa, Mohammed; Almangour, Abdullah; Alsalem, Abdulaziz; Almangour, Thamer A.] King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.
   [Alzahrani, Mohammed; Alshehri, Abdulmajeed; Aljrboa, Amjad; Bustami, Rami; Gramish, Jawaher] King Saud Bin Abdulaziz Univ Hlth Sci, Coll Pharm, POB 3660, Riyadh 11426, Saudi Arabia.
   [Alzahrani, Mohammed; Alshehri, Abdulmajeed; Gramish, Jawaher] KAIMRC, Riyadh 14611, Saudi Arabia.
   [Gramish, Jawaher] King Abdul Aziz Med City, Pharmaceut Care Serv, MC 1445, Riyadh, Saudi Arabia.
   [Khobrani, Moteb] King Khalid Univ, Coll Pharm, Dept Clin Pharm, Abha, Saudi Arabia.
RP Alessa, M (corresponding author), King Saud Univ, Coll Pharm, Dept Clin Pharm, Riyadh, Saudi Arabia.
EM m.alessa84@gmail.com
FU King Saud University, Riyadh, Saudi ArabiaDeanship of Scientific
   Research at King Saud University [RSP-2019/74]; King Abdullah
   International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia
FX The authors would like to thank all healthcare practitioners who
   participated in the study. Also, they would like to thank King Saud
   University, Riyadh, Saudi Arabia, for supporting this research project
   (RSP-2019/74). Lastly, they would like to thank King Abdullah
   International Medical Research Center (KAIMRC), Riyadh, Saudi Arabia,
   for supporting this research project.
CR [Anonymous], 2017, PREVENTION
   Cheema S, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2603-6
   Gubler DJ, 2017, J INFECT DIS, V216, pS860, DOI 10.1093/infdis/jix451
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Harapan H, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4297-4
   Harapan H, 2019, CLIN EPIDEMIOL GLOB, V7, P542, DOI 10.1016/j.cegh.2018.12.006
   Harapan H, 2017, ASIAN PAC J TROP MED, V10, P182, DOI 10.1016/j.apjtm.2017.01.018
   Khaiboullina S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02126
   Kwong JC, 2013, AM J TROP MED HYG, V89, P516, DOI 10.4269/ajtmh.13-0029
   Leung GHY, 2015, SE ASIAN J TROP MED, V46, P460
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Memish ZA, 2012, LANCET INFECT DIS, V12, P56, DOI 10.1016/S1473-3099(11)70337-1
   Moore KS, 2016, JNP-J NURSE PRACT, V12, P697, DOI 10.1016/j.nurpra.2016.09.012
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Shammas J., 2016, WORLDS 1 ZIKA VIRUS
   Swaminathan S, 2016, NEW ENGL J MED, V375, P1907, DOI 10.1056/NEJMc1610613
   Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721
NR 20
TC 1
Z9 1
U1 1
U2 1
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 1712-9532
EI 1918-1493
J9 CAN J INFECT DIS MED
JI Can. J. Infect. Dis. Med. Microbiol.
PD MAR 11
PY 2020
VL 2020
AR 8145219
DI 10.1155/2020/8145219
PG 6
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA KY4HE
UT WOS:000522529600002
PM 32256906
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kuehn, BM
AF Kuehn, Bridget M.
TI US Zika-Related Birth Defects in High-Transmission Areas
SO JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 0098-7484
EI 1538-3598
J9 JAMA-J AM MED ASSOC
JI JAMA-J. Am. Med. Assoc.
PD MAR 10
PY 2020
VL 323
IS 10
BP 917
EP 917
DI 10.1001/jama.2020.1934
PG 1
WC Medicine, General & Internal
SC General & Internal Medicine
GA KW1LV
UT WOS:000520933900022
PM 32154862
DA 2020-07-08
ER

PT J
AU Cutillo, G
   Saariaho, AH
   Meri, S
AF Cutillo, Gianni
   Saariaho, Anna-Helena
   Meri, Seppo
TI Physiology of gangliosides and the role of antiganglioside antibodies in
   human diseases
SO CELLULAR & MOLECULAR IMMUNOLOGY
LA English
DT Review
DE ganglioside; Guillain-Barre syndrome; complement; narcolepsy; sialic
   acid
ID GUILLAIN-BARRE-SYNDROME; SYSTEMIC-LUPUS-ERYTHEMATOSUS;
   CAMPYLOBACTER-JEJUNI; GM1 GANGLIOSIDE; LIPID RAFTS; ZIKA VIRUS;
   IN-VITRO; HAEMOPHILUS-INFLUENZAE; ANTECEDENT INFECTIONS; BRAIN
   GANGLIOSIDES
AB Gangliosides are structurally and functionally polymorphic sialic acid containing glycosphingolipids that are widely distributed in the human body. They play important roles in protecting us against immune attacks, yet they can become targets for autoimmunity and act as receptors for microbes, like the influenza viruses, and toxins, such as the cholera toxin. The expression patterns of gangliosides vary in different tissues, during different life periods, as well as in different animals. Antibodies against gangliosides (AGA) can target immune attack e.g., against neuronal cells and neutralize their complement inhibitory activity. AGAs are important especially in acquired demyelinating immune-mediated neuropathies, like Guillain-Barre syndrome (GBS) and its variant, the Miller-Fisher syndrome (MFS). They can emerge in response to different microbial agents and immunological insults. Thereby, they can be involved in a variety of diseases. In addition, antibodies against GM3 were found in the sera of patients vaccinated with Pandemrix (R), who developed secondary narcolepsy, strongly supporting the autoimmune etiology of the disease.
C1 [Cutillo, Gianni; Saariaho, Anna-Helena; Meri, Seppo] Univ Helsinki, Translat Immunol Res Program, Helsinki, Finland.
   [Cutillo, Gianni; Saariaho, Anna-Helena; Meri, Seppo] Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.
   [Cutillo, Gianni; Meri, Seppo] Humanitas Univ, Milan, Rozzano, Italy.
   [Meri, Seppo] Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland.
RP Meri, S (corresponding author), Univ Helsinki, Translat Immunol Res Program, Helsinki, Finland.; Meri, S (corresponding author), Univ Helsinki, Dept Bacteriol & Immunol, Helsinki, Finland.; Meri, S (corresponding author), Humanitas Univ, Milan, Rozzano, Italy.; Meri, S (corresponding author), Helsinki Univ Hosp Lab HUSLAB, Helsinki, Finland.
EM seppo.meri@helsinki.fi
OI Meri, Seppo/0000-0001-9142-501X
FU Sigrid Juselius FoundationSigrid Juselius Foundation; Academy of
   FinlandAcademy of Finland [292393]; Helsinki University Central Hospital
   [TYH2018313, TYH2019311]
FX This work was supported by the Sigrid Juselius Foundation, the Academy
   of Finland (292393) and Helsinki University Central Hospital
   (TYH2018313, TYH2019311) grants.
CR Alaedini A, 2006, J NEUROIMMUNOL, V177, P167, DOI 10.1016/j.jneuroim.2006.04.022
   Allos BM, 1998, EMERG INFECT DIS, V4, P263, DOI 10.3201/eid0402.980213
   Anaya JM, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0601-y
   Ariga T, 2014, J NEUROSCI RES, V92, P1227, DOI 10.1002/jnr.23411
   Ariga T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063326
   Aspelund A, 2015, J EXP MED, V212, P991, DOI 10.1084/jem.20142290
   Baskar D, 2018, NEUROL INDIA, V66, P1324, DOI 10.4103/0028-3886.241402
   Bernard-Valnet R, 2016, P NATL ACAD SCI USA, V113, P10956, DOI 10.1073/pnas.1603325113
   Blaum BS, 2015, NAT CHEM BIOL, V11, P77, DOI [10.1038/NCHEMBIO.1696, 10.1038/nchembio.1696]
   BLIX G, 1955, NATURE, V175, P340, DOI 10.1038/175340a0
   Bushara KO, 2005, GASTROENTEROLOGY, V128, pS92, DOI 10.1053/j.gastro.2005.02.018
   Canelle Q, 2016, HUM VACC IMMUNOTHER, V12, P2289, DOI 10.1080/21645515.2016.1168954
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Ceccarelli B, 1976, Adv Exp Med Biol, V71, P275
   CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0
   Conrad K, 2007, ANN NY ACAD SCI, V1109, P256, DOI 10.1196/annals.1398.031
   COSTALLAT LTL, 1990, CLIN RHEUMATOL, V9, P489, DOI 10.1007/BF02030510
   de Groot RCA, 2017, J INFECTION, V74, pS95, DOI 10.1016/S0163-4453(17)30198-6
   Desai BS, 2007, CELL TRANSPLANT, V16, P285, DOI 10.3727/000000007783464731
   Doppler K, 2016, BRAIN, V139, P2617, DOI 10.1093/brain/aww189
   Favoni V, 2018, J NEUROL SCI, V388, P192, DOI 10.1016/j.jns.2018.03.030
   Fehmi J, 2018, J NEUROL NEUROSUR PS, V89, P61, DOI 10.1136/jnnp-2016-315480
   FISHER M, 1956, NEW ENGL J MED, V255, P57, DOI 10.1056/NEJM195607122550201
   Fujimura H, 2013, HAND CLINIC, V115, P383, DOI 10.1016/B978-0-444-52902-2.00021-7
   Furukawa Koichi, 2014, Adv Neurobiol, V9, P307, DOI 10.1007/978-1-4939-1154-7_14
   Galeazzi M, 2000, J RHEUMATOL, V27, P135
   Ge SJ, 2016, DIABETES RES CLIN PR, V115, P68, DOI 10.1016/j.diabres.2016.02.005
   Giovannoni G, 2000, ANN NEUROL, V47, P684, DOI 10.1002/1531-8249(200005)47:5<684::AID-ANA27>3.3.CO;2-F
   Goodfellow JA, 2016, NAT REV NEUROL, V12, P723, DOI 10.1038/nrneurol.2016.172
   Groux-Degroote S, 2015, BIOCHEMISTRY-MOSCOW+, V80, P808, DOI 10.1134/S0006297915070020
   Groux-Degroote S, 2017, CHEMBIOCHEM, V18, P1146, DOI 10.1002/cbic.201600705
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899
   Hampson AW, 2006, MED J AUSTRALIA, V185, pS39
   Han F, 2011, ANN NEUROL, V70, P410, DOI 10.1002/ana.22587
   Hatzifilippou E, 2014, AM J ALZHEIMERS DIS, V29, P660, DOI 10.1177/1533317514534953
   Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9
   Irie S, 1996, J NEUROIMMUNOL, V68, P19, DOI 10.1016/0165-5728(96)00059-8
   Jacob L, 2015, BRAIN BEHAV IMMUN, V47, P44, DOI 10.1016/j.bbi.2014.11.004
   Jacobs BC, 1997, J NEUROL NEUROSUR PS, V62, P641, DOI 10.1136/jnnp.62.6.641
   Jacobs BC, 1998, NEUROLOGY, V51, P1110, DOI 10.1212/WNL.51.4.1110
   Janes PW, 2000, SEMIN IMMUNOL, V12, P23, DOI 10.1006/smim.2000.0204
   Johannis W, 2014, J CLIN NEUROSCI, V21, P488, DOI 10.1016/j.jocn.2013.07.041
   Jury EC, 2004, J CLIN INVEST, V113, P1176, DOI 10.1172/JCI200420345
   Kanda T, 2000, NEUROLOGY, V55, P585, DOI 10.1212/WNL.55.4.585
   KANDA T, 1994, J CELL BIOL, V126, P235, DOI 10.1083/jcb.126.1.235
   Kim WJ, 2015, VACCINE, V33, P4868, DOI 10.1016/j.vaccine.2015.07.055
   Kinashi T, 2011, METHODS MOL BIOL, V757, P261, DOI 10.1007/978-1-61779-166-6_17
   Koga M, 2005, NEUROLOGY, V64, P1605, DOI 10.1212/01.WNL.0000160399.08456.7C
   Koga M, 2015, J NEUROL, V262, P1954, DOI 10.1007/s00415-015-7806-4
   Kolesnick R, 2002, J CLIN INVEST, V110, P3, DOI 10.1172/JCI200216127
   Kollewe K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125339
   Koutsouraki E, 2014, J ALZHEIMERS DIS, V42, pS163, DOI 10.3233/JAD-132633
   Krammer F, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0002-y
   Kuwabara Satoshi, 2015, Brain Nerve, V67, P1371, DOI 10.11477/mf.1416200308
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Lardone RD, 2006, J NEUROIMMUNOL, V173, P174, DOI 10.1016/j.jneuroim.2005.11.017
   Lee J, 2017, SLEEP BREATH, V21, P967, DOI 10.1007/s11325-017-1545-y
   Lin L, 1999, CELL, V98, P365, DOI 10.1016/S0092-8674(00)81965-0
   Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Lucchetta M, 2010, MUSCLE NERVE, V41, P50, DOI 10.1002/mus.21326
   Luo G, 2018, P NATL ACAD SCI USA, V115, pE12323, DOI 10.1073/pnas.1818150116
   Masoudi S, 2014, VACCINE, V32, P2980, DOI 10.1016/j.vaccine.2014.03.085
   MEDOF ME, 1984, J EXP MED, V160, P1558, DOI 10.1084/jem.160.5.1558
   MERI S, 1990, P NATL ACAD SCI USA, V87, P3982, DOI 10.1073/pnas.87.10.3982
   MERI S, 1990, IMMUNOLOGY, V71, P1
   Meri S, 2016, FEBS LETT, V590, P2418, DOI 10.1002/1873-3468.12284
   Mignot E, 1997, SLEEP, V20, P1012
   Mitsui Y, 1999, MUSCLE NERVE, V22, P1461, DOI 10.1002/(SICI)1097-4598(199910)22:10<1461::AID-MUS19>3.3.CO;2-K
   Miura Y, 2014, J ALZHEIMERS DIS, V42, P1165, DOI 10.3233/JAD-140474
   Miyaji K, 2016, CARBOHYD RES, V434, P37, DOI 10.1016/j.carres.2016.08.004
   Mocchetti I, 2005, CELL MOL LIFE SCI, V62, P2283, DOI 10.1007/s00018-005-5188-y
   Moran AP, 2005, J NEUROIMMUNOL, V165, P179, DOI 10.1016/j.jneuroim.2005.04.013
   Moran AP, 1998, J INFECT DIS, V178, P1549, DOI 10.1086/314462
   Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171
   Mori M, 1999, NEUROLOGY, V52, P1282, DOI 10.1212/WNL.52.6.1282
   Nafissi Shahriar, 2013, Acta Med Iran, V51, P372
   Naik GS, 2017, NEUROL INDIA, V65, P1001, DOI 10.4103/neuroindia.NI_1226_15
   Neto JIS, 2004, ARQ NEURO-PSIQUIAT, V62, P969, DOI 10.1590/S0004-282X2004000600007
   Ngamukote S, 2007, J NEUROCHEM, V103, P2327, DOI 10.1111/j.1471-4159.2007.04910.x
   Nico D, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed.2018.00025, 10.3389/fmed2018.00025]
   Nicolae I, 2014, BMC INFECT DIS S4, V14, DOI [10.1186/1471-2334-14-S4-P25, DOI 10.1186/1471-2334-14-S4-P25]
   Nohynek H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033536
   O'Hanlon GM, 2001, BRAIN, V124, P893, DOI 10.1093/brain/124.5.893
   Ohkawa Y, 2010, J BIOL CHEM, V285, P27213, DOI 10.1074/jbc.M109.087791
   Ohmi Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206881
   Ohmi Y, 2011, J NEUROCHEM, V116, P926, DOI 10.1111/j.1471-4159.2010.07067.x
   Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069
   Palmano K, 2015, NUTRIENTS, V7, P3891, DOI 10.3390/nu7053891
   Partinen M, 2014, LANCET NEUROL, V13, P600, DOI 10.1016/S1474-4422(14)70075-4
   Pender MP, 2003, J CLIN NEUROSCI, V10, P63, DOI 10.1016/S0967-5868(02)00270-9
   Phongsisay V, 2008, J NEUROIMMUNOL, V205, P101, DOI 10.1016/j.jneuroim.2008.09.016
   Pike LJ, 2003, J LIPID RES, V44, P655, DOI 10.1194/jlr.R200021-JLR200
   Platt MP, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00442
   Plomp JJ, 2009, J PHYSIOL-LONDON, V587, P3979, DOI 10.1113/jphysiol.2009.171702
   Poropatich KO, 2010, J HEALTH POPUL NUTR, V28, P545, DOI 10.3329/jhpn.v28i6.6602
   Postiglione E, 2018, SLEEP MED REV, V38, P70, DOI 10.1016/j.smrv.2017.04.003
   Prendergast MM, 1998, INFECT IMMUN, V66, P3649, DOI 10.1128/IAI.66.8.3649-3655.1998
   Przybylska-Felus M, 2016, POL ARCH MED WEWN, V126, P763, DOI 10.20452/pamw.3512
   RAHMANN H, 1995, BEHAV BRAIN RES, V66, P105, DOI 10.1016/0166-4328(94)00131-X
   Rautemaa R, 2001, GASTROENTEROLOGY, V120, P470, DOI 10.1053/gast.2001.21197
   Rho Young Il, 2014, Korean J Pediatr, V57, P457, DOI 10.3345/kjp.2014.57.10.457
   Rodella U, 2017, DIS MODEL MECH, V10, P597, DOI 10.1242/dmm.027870
   Rodriguez Y, 2018, CELL MOL IMMUNOL, V15, P547, DOI 10.1038/cmi.2017.142
   Saariaho AH, 2015, J AUTOIMMUN, V63, P68, DOI 10.1016/j.jaut.2015.07.006
   Sabayan B, 2007, WORLD J GASTROENTERO, V13, P4784, DOI 10.3748/wjg.v13.i35.4784
   Sadatipour BT, 1998, ANN NEUROL, V44, P980, DOI 10.1002/ana.410440621
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Sauteur PMM, 2016, ANN NEUROL, V80, P566, DOI 10.1002/ana.24755
   SauteurI PMM, 2015, J PERIPHER NERV SYST, V20, P72, DOI 10.1111/jns.12121
   Scaioli V, 2004, J PERIPHER NERV SYST, V9, P92, DOI 10.1111/j.1085-9489.2004.09207.x
   Schnaar RL, 2016, J MOL BIOL, V428, P3325, DOI 10.1016/j.jmb.2016.05.020
   Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013
   Schneider JS, 1998, ANN NY ACAD SCI, V845, P363, DOI 10.1111/j.1749-6632.1998.tb09688.x
   Science M, 2014, J PEDIATR-US, V165, P779, DOI 10.1016/j.jpeds.2014.06.014
   Sequeira J, 2017, J NEUROVIROL, V23, P786, DOI 10.1007/s13365-017-0562-8
   Shahrizaila N, 2013, J NEUROL NEUROSUR PS, V84, P576, DOI 10.1136/jnnp-2012-302824
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Simpson MA, 2004, NAT GENET, V36, P1225, DOI 10.1038/ng1460
   Sivadon V, 2005, PATHOL BIOL, V53, P536, DOI 10.1016/j.patbio.2005.06.006
   Sonnino S, 2007, GLYCOBIOLOGY, V17, p1R, DOI 10.1093/glycob/cwl052
   Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103
   STEFANOVA I, 1991, SCIENCE, V254, P1016, DOI 10.1126/science.1719635
   Stevens O, 2017, JAMA NEUROL, V74, P26, DOI 10.1001/jamaneurol.2016.3541
   Sturkenboom MCJM, 2015, VACCINE, V33, pB6, DOI 10.1016/j.vaccine.2015.03.026
   Svennerholm L, 1980, Adv Exp Med Biol, V125, P11
   TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T
   Tam CC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000344
   Tatarelli P, 2016, INT J NEUROSCI, V126, P478, DOI 10.3109/00207454.2015.1033621
   Thorpy M, 2001, SLEEP MED, V2, P5, DOI 10.1016/S1389-9457(00)00081-2
   Uncini A, 2015, J NEUROL NEUROSUR PS, V86, P1186, DOI 10.1136/jnnp-2014-310097
   Vaarala O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114361
   Vajn K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075720
   VAKEVA A, 1994, IMMUNOLOGY, V82, P28
   Valentino P, 2009, MULT SCLER J, V15, P114, DOI 10.1177/1352458508096685
   Varki A., 2009, SIALIC ACIDS ESSENTI
   Varki A, 2008, TRENDS MOL MED, V14, P351, DOI 10.1016/j.molmed.2008.06.002
   Vucic S, 2009, J CLIN NEUROSCI, V16, P733, DOI 10.1016/j.jocn.2008.08.033
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wang L, 2017, MICROCHIM ACTA, V7, P1, DOI DOI 10.1038/SREP43760
   Willison HJ, 2001, J NEUROL SCI, V185, P1, DOI 10.1016/S0022-510X(01)00465-8
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
   Yanagisawa K, 2015, GLYCOCONJUGATE J, V32, P87, DOI 10.1007/s10719-015-9579-5
   Yu RK, 2011, J OLEO SCI, V60, P537, DOI 10.5650/jos.60.537
   Yuki N, 1997, J INFECT DIS, V176, pS150, DOI 10.1086/513800
   Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012
   Yuki N, 2011, J BIOMED BIOTECHNOL, V2011, P10
   Yuki N, 2012, P JPN ACAD B-PHYS, V88, P299, DOI 10.2183/pjab.88.299
   Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x
NR 150
TC 0
Z9 0
U1 6
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1672-7681
EI 2042-0226
J9 CELL MOL IMMUNOL
JI Cell. Mol. Immunol.
PD APR
PY 2020
VL 17
IS 4
BP 313
EP 322
DI 10.1038/s41423-020-0388-9
EA MAR 2020
PG 10
WC Immunology
SC Immunology
GA KZ6MJ
UT WOS:000518951400002
PM 32152553
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Thompson, R
   Del Campo, JM
   Constenla, D
AF Thompson, Ryan
   Del Campo, Jorge
   Constenla, Dagna
TI A review of the economic evidence of Aedes-borne arboviruses and
   Aedes-borne arboviral disease prevention and control strategies
SO EXPERT REVIEW OF VACCINES
LA English
DT Review
DE Economics; costing; cost-effectiveness; cost-benefit; delivery costs;
   dengue fever; yellow fever; Zika virus; chikungunya virus; vaccines;
   surveillance; prevention; control; Aedes-borne arboviruses
ID DENGUE VECTOR CONTROL; COST-UTILITY ANALYSIS; ZIKA VIRUS; VACCINATION
   PROGRAMS; BENEFIT-ANALYSIS; BURDEN; AMERICA; SYSTEM; FEVER; COLOMBIA
AB Introduction: Aedes-borne arboviruses contributes substantially to the disease and cost burden. Areas covered: We performed a systematic review of the economic evidence surrounding aedes-borne arboviruses and strategies to prevent and control these diseases to inform disease control policy decisions and research directions. We searched four databases covering an 18-year period (2000-2018) to identify arboviral disease-related cost of illness studies, cost studies of vector control and prevention strategies, cost-effectiveness analyses and cost-benefit analyses. We identified 74 published studies that revealed substantial global total costs in yellow fever virus and dengue virus ranging from 2.1 to 57.3 billion USD. Cost studies of vector control and surveillance programs are limited, but a few studies found that costs of vector control programs ranged from 5.62 to 73.5 million USD. Cost-effectiveness evidence was limited across Aedes-borne diseases, but generally found targeted dengue vaccination programs cost-effective. This review revealed insufficient economic evidence for vaccine introduction and implementation of surveillance and vector control programs. Expert opinion: Evidence of the economic burden of aedes-borne arboviruses and the economic impact of strategies for arboviral disease prevention and control is critical to inform policy decisions and to secure continued financial support for these preventive and control measures.
C1 [Thompson, Ryan; Constenla, Dagna] JHBSPH, IVAC, Dept Int Hlth, Baltimore, MD USA.
   [Del Campo, Jorge] HealthReveal, Dept Int Hlth, New York, NY USA.
   [Del Campo, Jorge] Johns Hopkins Int Vaccine Access Ctr, Baltimore, MD USA.
RP Constenla, D (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.
EM dconste1@jhu.edu
OI Thompson, Ryan/0000-0001-6965-7770
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Alfaro-Murillo JA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004743
   Alfonso-Sierra E, 2016, PATHOG GLOB HEALTH, V110, P14, DOI 10.1080/20477724.2016.1142057
   Alphey N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025384
   Anez G, 2006, REV PANAM SALUD PUBL, V19, P314, DOI 10.1590/S1020-49892006000500004
   Armien B, 2008, AM J TROP MED HYG, V79, P364, DOI 10.4269/ajtmh.2008.79.364
   Baly A, 2012, TROP MED INT HEALTH, V17, P123, DOI 10.1111/j.1365-3156.2011.02881.x
   Bangert M, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006796
   Cardona-Ospina JA, 2015, T ROY SOC TROP MED H, V109, P793, DOI 10.1093/trstmh/trv094
   Tiga DC, 2016, AM J TROP MED HYG, V94, P1085, DOI 10.4269/ajtmh.15-0896
   Carrasco LR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001426
   Rodriguez RC, 2015, AM J TROP MED HYG, V92, P709, DOI 10.4269/ajtmh.14-0386
   de Souza MDB, 2016, J BRAS REPROD ASSIST, V20, P195, DOI 10.5935/1518-0557.20160038
   Deen J, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002182
   Edillo FE, 2015, AM J TROP MED HYG, V92, P360, DOI 10.4269/ajtmh.14-0139
   El Fezzazi H, 2017, AM J TROP MED HYG, V97, P1898, DOI 10.4269/ajtmh.16-0952
   Toledo ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119373
   Fitzpatrick C, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005785
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015
   Gubler DJ, 2015, VACCINE, V33, P1233, DOI 10.1016/j.vaccine.2015.01.002
   Guzzetta G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005918
   Halasa YA, 2012, AM J TROP MED HYG, V86, P745, DOI 10.4269/ajtmh.2012.11-0784
   Hossain MS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006561
   Knerer G, 2014, VALUE HEALTH, V17, pA806, DOI 10.1016/j.jval.2014.08.523
   Lee BY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005531
   Lee BY, 2011, AM J TROP MED HYG, V84, P764, DOI 10.4269/ajtmh.2011.10-0624
   Lee JS, 2018, VACCINE, V36, P2346, DOI 10.1016/j.vaccine.2018.03.002
   Lee JS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003810
   Lee LK, 2013, T ROY SOC TROP MED H, V107, P37, DOI 10.1093/trstmh/trs009
   LEGORRETASOBERANIS, 2017, BMC PUBLIC HEALTH S1, V17, DOI DOI 10.1186/S12889-017-4304-X
   Levin A, 2007, VACCINE, V25, P6945, DOI 10.1016/j.vaccine.2007.06.065
   Li R, 2017, EMERG INFECT DIS, V23, P74, DOI 10.3201/eid2301.161322
   Lim JK, 2016, EXPERT REV VACCINES, V15, P529, DOI 10.1586/14760584.2016.1129279
   Lozano-Fuentes S, 2013, J MED ENTOMOL, V50, P879, DOI 10.1603/ME13008
   Luh DL, 2018, J INFECT PUBLIC HEAL, V11, P215, DOI 10.1016/j.jiph.2017.07.021
   Pham LD, 2017, CLINICOECONOMIC OUTC, V9, P1, DOI 10.2147/CEOR.S124023
   Luz PM, 2011, LANCET, V377, P1673, DOI 10.1016/S0140-6736(11)60246-8
   Mahoney RT, 2012, VACCINE, V30, P4892, DOI 10.1016/j.vaccine.2012.02.064
   McConnell K. John, 2003, Rev Panam Salud Publica, V14, P9, DOI 10.1590/S1020-49892003000600003
   Mendoza-Cano O, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14080890
   Mitra S, 2016, J VECTOR DIS, V53, P30
   Moher D, 2010, INT J SURG, V8, P336, DOI 10.1016/j.ijsu.2010.02.007
   Naing C, 2015, BLOOD COAGUL FIBRIN, V26, P403, DOI 10.1097/MBC.0000000000000280
   Vo TT, 2017, MALAYS J MED SCI, V24, P66, DOI 10.21315/mjms2017.24.3.8
   Okanurak K, 1997, Southeast Asian J Trop Med Public Health, V28, P711
   Orellano PW, 2008, REV PANAM SALUD PUBL, V24, P113
   Packierisamy PR, 2015, AM J TROP MED HYG, V93, P1020, DOI 10.4269/ajtmh.14-0667
   Packierisamy PR, 2015, ASIA-PAC J PUBLIC HE, V27, p73S, DOI 10.1177/1010539515589339
   Pepin KM, 2013, EMERG INFECT DIS, V19, P542, DOI 10.3201/eid1904.120117
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Quintero J, 2015, T ROY SOC TROP MED H, V109, P116, DOI 10.1093/trstmh/tru208
   Rapier CM, 1995, BJME, V8, pvii
   Rizzo N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-931
   Salmon-Mulanovich G, 2015, AM J TROP MED HYG, V93, P684, DOI 10.4269/ajtmh.14-0755
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Selck FW, 2014, VECTOR-BORNE ZOONOT, V14, P824, DOI 10.1089/vbz.2013.1528
   Seyler T, 2010, T ROY SOC TROP MED H, V104, P133, DOI 10.1016/j.trstmh.2009.07.014
   Shafie AA, 2017, PHARMACOECONOMICS, V35, P575, DOI 10.1007/s40273-017-0487-3
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Shepard DS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003306
   Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002
   Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002055
   Shepard DS, 2012, AM J TROP MED HYG, V87, P796, DOI 10.4269/ajtmh.2012.12-0019
   Shepard DS, 2011, AM J TROP MED HYG, V84, P200, DOI 10.4269/ajtmh.2011.10-0503
   Shepard DS, 2004, VACCINE, V22, P1275, DOI 10.1016/j.vaccine.2003.09.019
   Shim E, 2017, AM J TROP MED HYG, V96, P1227, DOI 10.4269/ajtmh.16-0810
   Shim E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175020
   Shim E, 2016, AM J TROP MED HYG, V95, P1137, DOI 10.4269/ajtmh.16-0194
   Shoukat A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1091-x
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Stahl HC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1048
   Suaya JA, 2007, TROP MED INT HEALTH, V12, P1026, DOI 10.1111/j.1365-3156.2007.01889.x
   Suaya JA, 2009, AM J TROP MED HYG, V80, P846, DOI 10.4269/ajtmh.2009.80.846
   Tarragona S, 2012, SALUD COLECT, V8, P151, DOI 10.1590/s1851-82652012000200004
   Tozan Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005961
   Tozan Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108017
   Turner HC, 2018, T ROY SOC TROP MED H, V112, P369, DOI 10.1093/trstmh/try057
   Uhart M, 2016, EUR J HEALTH ECON, V17, P497, DOI 10.1007/s10198-015-0694-9
   Undurraga EA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003547
   Vannice KS, 2015, VACCINE, V33, P7091, DOI 10.1016/j.vaccine.2015.09.053
   Machado AAV, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003104
   Orellano PW, 2016, VACCINE, V34, P616, DOI 10.1016/j.vaccine.2015.12.040
   Wettstein ZS, 2012, AM J TROP MED HYG, V87, P616, DOI 10.4269/ajtmh.2012.12-0146
   Whitehorn J, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003025
   WHO, 2019, 10 THREATS GLOB HLTH
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wilder-Smith A, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-212
   World Health Organization (WHO), 2018, REV SAG REC US DENG
   World Health Organization (WHO), 2018, MOSQ BORN DIS
   Yacoub S, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0147-9
   Zeng W, 2018, VACCINE, V36, P413, DOI 10.1016/j.vaccine.2017.11.064
   Zengbe-Acray Petronille, 2009, Sante Publique, V21, P383
   Zhang JH, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005784
NR 94
TC 0
Z9 0
U1 2
U2 2
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1476-0584
EI 1744-8395
J9 EXPERT REV VACCINES
JI Expert Rev. Vaccines
PD FEB 1
PY 2020
VL 19
IS 2
BP 143
EP 162
DI 10.1080/14760584.2020.1733419
EA MAR 2020
PG 20
WC Immunology
SC Immunology
GA KV6LF
UT WOS:000518746000001
PM 32077343
DA 2020-07-08
ER

PT J
AU Li, M
   Zhang, D
   Li, CT
   Zheng, ZF
   Fu, M
   Ni, FF
   Liu, YL
   Du, T
   Wang, HZ
   Griffin, GE
   Zhang, MD
   Hu, QX
AF Li, Mei
   Zhang, Di
   Li, Chuntian
   Zheng, Zifeng
   Fu, Ming
   Ni, Fengfeng
   Liu, Yalan
   Du, Tao
   Wang, Hanzhong
   Griffin, George E.
   Zhang, Mudan
   Hu, Qinxue
TI Characterization of Zika Virus Endocytic Pathways in Human Glioblastoma
   Cells
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; endocytosis; clathrin; cholesterol; Rab protein
ID ENCEPHALITIS-VIRUS; DENGUE-VIRUS; WEST-NILE; LIPID RAFTS; MEDIATED
   ENDOCYTOSIS; PRODUCTIVE ENTRY; CHOLESTEROL; MEMBRANE; FLAVIVIRUS;
   INFECTION
AB Zika virus (ZIKV) infections can cause microcephaly and neurological disorders. However, the early infection events of ZIKV in neural cells remain to be characterized. Here, by using a combination of pharmacological and molecular approaches and the human glioblastoma cell T98G as a model, we first observed that ZIKV infection was inhibited by chloroquine and NH4Cl, indicating a requirement of low intracellular pH. We further showed that dynamin is required as the ZIKV entry was affected by the specific inhibitor dynasore, small interfering RNA (siRNA) knockdown of dynamin, or by expressing the dominant-negative K44A mutant. Moreover, the ZIKV entry was significantly inhibited by chlorpromazine, pitstop2, or siRNA knockdown of clathrin heavy chain, indicating an involvement of clathrin-mediated endocytosis. In addition, genistein treatment, siRNA knockdown of caveolin-1, or overexpression of a dominant-negative caveolin mutant impacted the ZIKV entry, with ZIKV particles being observed to colocalize with caveolin-1, implying that caveola endocytosis can also be involved. Furthermore, we found that the endocytosis of ZIKV is dependent on membrane cholesterol, microtubules, and actin cytoskeleton. Importantly, ZIKV infection was inhibited by silencing of Rab5 and Rab7, while confocal microscopy showed that ZIKV particles localized in Rab5- and Rab7-postive endosomes. These results indicated that, after internalization, ZIKV likely moves to Rab5-positive early endosome and Rab7-positive late endosomes before delivering its RNA into the cytoplasm. Taken together, our study, for the first time, described the early infection events of ZIKV in human glioblastoma cell T98G.
C1 [Li, Mei; Zhang, Di; Li, Chuntian; Zheng, Zifeng; Fu, Ming; Ni, Fengfeng; Liu, Yalan; Zhang, Mudan; Hu, Qinxue] Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, State Key Lab Virol, Wuhan, Peoples R China.
   [Li, Mei; Zhang, Di; Li, Chuntian; Zheng, Zifeng; Fu, Ming; Ni, Fengfeng] Univ Chinese Acad Sci, Beijing, Peoples R China.
   [Du, Tao; Wang, Hanzhong] Chinese Acad Sci, Wuhan Inst Virol, CAS Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
   [Griffin, George E.; Hu, Qinxue] St Georges Univ London, Inst Infect & Immun, London, England.
RP Zhang, MD; Hu, QX (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Ctr Biosafety Mega Sci, State Key Lab Virol, Wuhan, Peoples R China.; Hu, QX (corresponding author), St Georges Univ London, Inst Infect & Immun, London, England.
EM mudan@wh.iov.cn; qhu@wh.iov.cn
OI Hu, Qinxue/0000-0002-4594-9215
FU National Mega-Projects against Infectious Diseases [2018ZX10301406-002,
   2018ZX10734401018-003, 2018ZX10301405-003]; Emergency Prevention and
   Control Capacity Program for New Severe Infectious diseases of National
   Institute for Viral Disease Control and Prevention; 135 Strategic
   Program of Chinese Academy of Sciences; Hotung Trust
FX This work was supported by the National Mega-Projects against Infectious
   Diseases (2018ZX10301406-002, 2018ZX10734401018-003, and
   2018ZX10301405-003), the Emergency Prevention and Control Capacity
   Program for New Severe Infectious diseases of National Institute for
   Viral Disease Control and Prevention, the 135 Strategic Program of
   Chinese Academy of Sciences, and the Hotung Trust.
CR Acosta EG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044835
   Acosta EG, 2009, CELL MICROBIOL, V11, P1533, DOI 10.1111/j.1462-5822.2009.01345.x
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Bharucha T, 2016, NEUROPATH APPL NEURO, V42, P317, DOI 10.1111/nan.12326
   BOLARD J, 1986, BIOCHIM BIOPHYS ACTA, V864, P257, DOI 10.1016/0304-4157(86)90002-X
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Carro AC, 2013, VIRUS RES, V174, P78, DOI 10.1016/j.virusres.2013.03.005
   Cramer LP, 1999, CURR BIOL, V9, P1095, DOI 10.1016/S0960-9822(99)80478-3
   DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915
   Das S, 2010, J NEUROCHEM, V115, P537, DOI 10.1111/j.1471-4159.2010.06951.x
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Doherty GJ, 2009, ANNU REV BIOCHEM, V78, P857, DOI 10.1146/annurev.biochem.78.081307.110540
   Dutta D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045799
   Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266
   Fietz SA, 2010, NAT NEUROSCI, V13, P690, DOI 10.1038/nn.2553
   FRA AM, 1995, P NATL ACAD SCI USA, V92, P8655, DOI 10.1073/pnas.92.19.8655
   Fukuhara T, 2011, MICROBES INFECT, V13, P405, DOI 10.1016/j.micinf.2011.01.005
   GOLLINS SW, 1986, J GEN VIROL, V67, P1941, DOI 10.1099/0022-1317-67-9-1941
   Hansen DV, 2010, NATURE, V464, P554, DOI 10.1038/nature08845
   Imelli N, 2004, J VIROL, V78, P3089, DOI 10.1128/JVI.78.6.3089-3098.2004
   Kalia M, 2013, J VIROL, V87, P148, DOI 10.1128/JVI.01399-12
   Kaufmann B, 2011, MICROBES INFECT, V13, P1, DOI 10.1016/j.micinf.2010.09.005
   Khaiboullina S, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00642
   Khaiboullina SF, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01465
   KILSDONK EPC, 1995, J BIOL CHEM, V270, P17250, DOI 10.1074/jbc.270.29.17250
   Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06
   Lee CJ, 2008, J VIROL, V82, P6470, DOI 10.1128/JVI.00117-08
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Li M, 2017, VIROLOGY, V510, P67, DOI 10.1016/j.virol.2017.07.008
   Li Q, 2017, ACS NANO, V11, P3890, DOI 10.1021/acsnano.7b00275
   Liu CC, 2017, J VIROL, V91, DOI [10.1128/JVI.01113-17, 10.1128/jvi.01113-17]
   Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002
   Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007
   Masuyama N, 2009, J BIOL CHEM, V284, P15927, DOI 10.1074/jbc.M109.005124
   Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Mercer J, 2010, ANNU REV BIOCHEM, V79, P803, DOI 10.1146/annurev-biochem-060208-104626
   Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Nawa M, 2003, J GEN VIROL, V84, P1737, DOI 10.1099/vir.0.18883-0
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Oh P, 1998, J CELL BIOL, V141, P101, DOI 10.1083/jcb.141.1.101
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Owczarek K, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0349-z
   Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x
   Patel KP, 2009, J VIROL, V83, P11064, DOI 10.1128/JVI.01016-09
   Persaud M, 2018, VIROLOGY, V518, P301, DOI 10.1016/j.virol.2018.03.009
   PITHA J, 1988, LIFE SCI, V43, P493, DOI 10.1016/0024-3205(88)90150-6
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Puerta-Guardo H, 2010, J GEN VIROL, V91, P394, DOI 10.1099/vir.0.015420-0
   Rahn E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025464
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   Sandvig K, 2008, HISTOCHEM CELL BIOL, V129, P267, DOI 10.1007/s00418-007-0376-5
   Schelhaas M, 2010, CELL MICROBIOL, V12, P1378, DOI 10.1111/j.1462-5822.2010.01510.x
   Shi Y, 2017, TRENDS BIOCHEM SCI, V42, P443, DOI 10.1016/j.tibs.2017.02.009
   Sieczkarski SB, 2002, J GEN VIROL, V83, P1535, DOI 10.1099/0022-1317-83-7-1535
   Silva MC, 2007, J VIROL, V81, P13640, DOI 10.1128/JVI.00857-07
   Smith AE, 2004, SCIENCE, V304, P237, DOI 10.1126/science.1094823
   Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997
   Suksanpaisan L, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-17
   Sum MSH, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/695283
   Tamhankar M, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1200-2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Taylor MP, 2011, NAT REV MICROBIOL, V9, P427, DOI 10.1038/nrmicro2574
   Vale-Costa S, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030064
   van der Schaar HM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000244
   Vasquez RJ, 1997, MOL BIOL CELL, V8, P973
   Vitelli R, 1997, J BIOL CHEM, V272, P4391, DOI 10.1074/jbc.272.7.4391
   Walsh D, 2019, TRENDS MICROBIOL, V27, P39, DOI 10.1016/j.tim.2018.06.008
   WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107
   Wang SB, 2016, VIROLOGY, V498, P116, DOI 10.1016/j.virol.2016.08.013
   Xu MY, 2016, J VIROL METHODS, V236, P93, DOI 10.1016/j.jviromet.2016.07.014
   Yang SB, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-258
   Yin X, 2016, J VIROL, V90, P4232, DOI 10.1128/JVI.02804-15
   Zheng ZF, 2018, J IMMUNOL, V201, P53, DOI 10.4049/jimmunol.1701507
   Zhu YZ, 2012, J VIROL, V86, P13407, DOI 10.1128/JVI.00903-12
NR 82
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD MAR 6
PY 2020
VL 11
AR 242
DI 10.3389/fmicb.2020.00242
PG 19
WC Microbiology
SC Microbiology
GA LE5OO
UT WOS:000526768600001
PM 32210929
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Epis, S
   Varotto-Boccazzi, I
   Crotti, E
   Damiani, C
   Giovati, L
   Mandrioli, M
   Biggiogera, M
   Gabrieli, P
   Genchi, M
   Polonelli, L
   Daffonchio, D
   Favia, G
   Bandi, C
AF Epis, Sara
   Varotto-Boccazzi, Ilaria
   Crotti, Elena
   Damiani, Claudia
   Giovati, Laura
   Mandrioli, Mauro
   Biggiogera, Marco
   Gabrieli, Paolo
   Genchi, Marco
   Polonelli, Luciano
   Daffonchio, Daniele
   Favia, Guido
   Bandi, Claudio
TI Chimeric symbionts expressing a Wolbachia protein stimulate mosquito
   immunity and inhibit filarial parasite development
SO COMMUNICATIONS BIOLOGY
LA English
DT Article
ID MAJOR SURFACE PROTEIN; ACETIC-ACID BACTERIA; ANOPHELES-STEPHENSI;
   DIROFILARIA-IMMITIS; DENGUE TRANSMISSION; BLOCKS DENGUE; ENDOSYMBIONTS;
   VECTOR; REFRACTORINESS; FALCIPARUM
AB Wolbachia can reduce the capability of mosquitoes to transmit infectious diseases to humans and is currently exploited in campaigns for the control of arboviruses, like dengue and Zika. Under the assumption that Wolbachia-mediated activation of insect immunity plays a role in the reduction of mosquito vectorial capacity, we focused our attention on the Wolbachia surface protein (WSP), a potential inductor of innate immunity. We hypothesized that the heterologous expression of this protein in gut- and tissue-associated symbionts may reduce parasite transmission. We thus engineered the mosquito bacterial symbiont Asaia to express WSP (Asaia(WSP)). Asaia(WSP) induced activation of the host immune response in Aedes aegypti and Anopheles stephensi mosquitoes, and inhibited the development of the heartworm parasite Dirofilaria immitis in Ae. aegypti. These results consolidate previous evidence on the immune-stimulating property of WSP and make Asaia(WSP) worth of further investigations as a potential tool for the control of mosquito-borne diseases.
   Epis and Varotto-Boccazzi et al. show that Wolbachia surface protein (WSP) activates host innate immunity in mosquitoes, inhibiting the development of the heartworm parasite in its insect host. This study suggests the possibility that the WSP-expressing symbiont may be harnessed to control mosquito-borne diseases.
C1 [Epis, Sara; Varotto-Boccazzi, Ilaria; Gabrieli, Paolo; Bandi, Claudio] Univ Milan, Dept Biosci, Milan, Italy.
   [Epis, Sara; Varotto-Boccazzi, Ilaria; Gabrieli, Paolo; Bandi, Claudio] Univ Milan, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy.
   [Epis, Sara; Varotto-Boccazzi, Ilaria; Damiani, Claudia; Gabrieli, Paolo; Favia, Guido; Bandi, Claudio] Italian Malaria Network, Ctr Interuniv Ric Malaria, Milan, Italy.
   [Crotti, Elena] Univ Milan, Dept Food Environm & Nutr Sci, Milan, Italy.
   [Damiani, Claudia; Favia, Guido] Univ Camerino, Sch Biosci & Vet Med, Camerino, Italy.
   [Giovati, Laura; Polonelli, Luciano] Univ Parma, Dept Med & Surg, Parma, Italy.
   [Mandrioli, Mauro] Univ Modena & Reggio Emilia, Dept Life Sci, Modena, Italy.
   [Biggiogera, Marco] Univ Pavia, Dept Biol & Biotechnol L Spallanzani, Pavia, Italy.
   [Genchi, Marco] Univ Parma, Dept Vet Sci, Parma, Italy.
   [Daffonchio, Daniele] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia.
RP Bandi, C (corresponding author), Univ Milan, Dept Biosci, Milan, Italy.; Bandi, C (corresponding author), Univ Milan, Pediat Clin Res Ctr Romeo & Enrica Invernizzi, Milan, Italy.; Bandi, C (corresponding author), Italian Malaria Network, Ctr Interuniv Ric Malaria, Milan, Italy.
EM claudio.bandi@unimi.it
RI EPIS, SARA/B-7708-2017; Mandrioli, Mauro/A-5804-2015
OI EPIS, SARA/0000-0001-8807-4802; Daffonchio, Daniele/0000-0003-0947-925X;
   Mandrioli, Mauro/0000-0002-2611-9777; Biggiogera,
   Marco/0000-0003-3834-6712; GIOVATI, LAURA/0000-0001-7514-1789
FU Cariplo FoundationFondazione Cariplo; Lombardy Region [2017-N.1656];
   MIUR PRIN (Italian Ministry of Education, University and Research,
   MIUR)Ministry of Education, Universities and Research (MIUR); King
   Abdullah University of Science and Technology (KAUST)King Abdullah
   University of Science & Technology; Transition Grant 2015-2017-Horizon
   2020 [G42F17000140001]
FX This study was supported by Cariplo Foundation and Lombardy Region to
   S.E. (2017-N.1656), by Transition Grant 2015-2017-Horizon 2020 to S.E.
   (G42F17000140001) and by the MIUR PRIN (Italian Ministry of Education,
   University and Research, MIUR) to C.B., L.P. and G.F. D.D. acknowledges
   the baseline funding support by King Abdullah University of Science and
   Technology (KAUST); S.E., C.B. and M.B. thank "Fondo per il
   finanziamento dei Dipartimenti universitari di eccellenza" (MIUR) of the
   Dept. of Biosciences (University of Milan) and of the Dept. of Biology
   and Biotechnology "L. Spallanzani" (University of Pavia). The authors
   thank Prof. L. Sacchi, Prof. F. Forlani and Prof. C. Bazzocchi for their
   suggestions and the UNITECH platform for the microscope image
   acquisition.
CR Ausubel FM, 2005, NAT IMMUNOL, V6, P973, DOI 10.1038/ni1253
   Baldini F, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3249-y
   Baldini F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4985
   Baldo L, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-48
   Bandi C, 1998, P ROY SOC B-BIOL SCI, V265, P2407, DOI 10.1098/rspb.1998.0591
   Bazzocchi C, 2007, PARASITE IMMUNOL, V29, P73, DOI 10.1111/j.1365-3024.2006.00915.x
   Bazzocchi C, 2003, VET PARASITOL, V117, P73, DOI 10.1016/j.vetpar.2003.07.013
   Bian GW, 2013, SCIENCE, V340, P748, DOI 10.1126/science.1236192
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Bilgo E, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2516-x
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bongio NJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143541
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bozic J, 2017, ENV MICROBIOL REP, V9, P642, DOI 10.1111/1758-2229.12569
   Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998
   Brattig NW, 2004, J IMMUNOL, V173, P437, DOI 10.4049/jimmunol.173.1.437
   Wilke ABB, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0959-2
   Cappelli A, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00836
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Chouaia B, 2014, GENOME BIOL EVOL, V6, P912, DOI 10.1093/gbe/evu062
   Crotti E, 2010, APPL ENVIRON MICROB, V76, P6963, DOI 10.1128/AEM.01336-10
   Crotti E, 2009, ENVIRON MICROBIOL, V11, P3252, DOI 10.1111/j.1462-2920.2009.02048.x
   Damiani C, 2008, CURR BIOL, V18, pR1087, DOI 10.1016/j.cub.2008.10.040
   Dodson BL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002965
   Eldering M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20440
   Epis S, 2012, EUR J CLIN MICROBIOL, V31, P1137, DOI 10.1007/s10096-011-1419-3
   Erturk-Hasdemir D, 2005, CELL, V123, P190, DOI 10.1016/j.cell.2005.10.005
   Favia G, 2007, P NATL ACAD SCI USA, V104, P9047, DOI 10.1073/pnas.0610451104
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gomes FM, 2017, P NATL ACAD SCI USA, V114, P12566, DOI 10.1073/pnas.1716181114
   Hughes GL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002043
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Kambris Z, 2009, SCIENCE, V326, P134, DOI 10.1126/science.1177531
   Kittayapong P, 2000, J MED ENTOMOL, V37, P340, DOI 10.1603/0022-2585(2000)037[0340:DADOWI]2.0.CO;2
   Kramer LH, 2005, VET IMMUNOL IMMUNOP, V106, P303, DOI 10.1016/j.vetimm.2005.03.011
   LENSKI RE, 1993, EXPERIENTIA, V49, P201, DOI 10.1007/BF01923527
   Luckhart S, 1998, P NATL ACAD SCI USA, V95, P5700, DOI 10.1073/pnas.95.10.5700
   Mancini MV, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1427-3
   Manfredini F, 2008, TISSUE CELL, V40, P103, DOI 10.1016/j.tice.2007.10.003
   Marcos-Atxutegi C, 2003, VET PARASITOL, V112, P117, DOI 10.1016/S0304-4017(02)00419-3
   Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mostafa HE, 2002, APPL ENVIRON MICROB, V68, P2619, DOI 10.1128/AEM.68.5.2619-2623.2002
   Murray JV, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00043
   Pan XL, 2018, ISME J, V12, P277, DOI 10.1038/ismej.2017.174
   Pinto SB, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-S1-S11
   Popovici J, 2010, MEM I OSWALDO CRUZ, V105, P957, DOI 10.1590/S0074-02762010000800002
   Rami A, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2955-9
   Rances E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002548
   Rasgon JL, 2006, APPL ENVIRON MICROB, V72, P6934, DOI 10.1128/AEM.01673-06
   Ricci I, 2002, J MED ENTOMOL, V39, P562, DOI 10.1603/0022-2585-39.4.562
   Rossi P, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0888-0
   Saint Andre AV, 2002, SCIENCE, V295, P1892, DOI 10.1126/science.1068732
   Shane JL, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06580-9
   Taylor MJ, 2005, ADV PARASIT, V60, P245, DOI 10.1016/S0065-308X(05)60004-8
   Thomas S, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006879
   Tiawsirisup Sonthaya, 2006, Southeast Asian J Trop Med Public Health, V37 Suppl 3, P110
   Volohonsky G, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006113
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Wang SB, 2017, SCIENCE, V357, P1399, DOI 10.1126/science.aan5478
   Weiss B, 2011, TRENDS PARASITOL, V27, P514, DOI 10.1016/j.pt.2011.05.001
   Williams CB, 1937, ANN APPL BIOL, V24, P404, DOI 10.1111/j.1744-7348.1937.tb05042.x
NR 63
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
EI 2399-3642
J9 COMMUN BIOL
JI Commun. Biol.
PD MAR 6
PY 2020
VL 3
IS 1
AR 105
DI 10.1038/s42003-020-0835-2
PG 10
WC Biology; Multidisciplinary Sciences
SC Life Sciences & Biomedicine - Other Topics; Science & Technology - Other
   Topics
GA KU4YT
UT WOS:000519717500003
PM 32144396
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Visser, TM
   de Cock, MP
   Hiwat, H
   Wongsokarijo, M
   Verhulst, NO
   Koenraadt, CJM
AF Visser, Tessa M.
   de Cock, Marieke P.
   Hiwat, Helene
   Wongsokarijo, Merril
   Verhulst, Niels O.
   Koenraadt, Constantianus J. M.
TI Optimisation and field validation of odour-baited traps for surveillance
   of Aedes aegypti adults in Paramaribo, Suriname
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Carbon dioxide; Host-seeking; Trapping; Odour-baited
   traps; Odour-blends
ID BG-SENTINEL TRAP; CARBON-DIOXIDE; DIPTERA-CULICIDAE; MOSQUITO
   ATTRACTION; HOST PREFERENCES; MALARIA; ALBOPICTUS; POPULATIONS;
   INTEGRATION; RESISTANCE
AB Background Emerging arboviral diseases like Zika, dengue and chikungunya that are transmitted by Aedes aegypti mosquitoes, are increasingly threatening human health. Blends of human-like synthetic chemical attractants can be used to attract host-seeking mosquitoes. The aim of this study was to test new combinations of traps and odour baits in the laboratory, followed by testing the best candidates in the field to improve Ae. aegypti monitoring and surveillance. Methods First, the BG-Suna trap was evaluated for capturing laboratory-reared Ae. aegypti by testing normal and inverted positions in screen cage tests. Secondly, the attractiveness of the MB5 blend, CO2, and their combination was tested. Thirdly, we tested the attractiveness of different trap types (BG-Suna, BG-Sentinel, MM-X and CDC light trap). Finally, we confirmed laboratory results in the field in Paramaribo, Suriname, using the MB5 and BG-Lure odour blends, CO2 and the BG-Sentinel and BG-Bowl trap using a Latin Square design. Results The MB5 blend in combination with CO2 outperformed traps baited only with CO2 or MB5 in screen cage tests (P < 0.0001). The BG-Sentinel trap performed equally well as the inverted BG-Suna and was taken to the field (P = 0.729). In the field, we captured Ae. aegypti, Cx. quinquefasciatus and Cx. nigripalpus. We confirmed the laboratory results and found that the combination of the MB5 blend and CO2 almost doubled Ae. aegypti female captures (P = 0.004) and more than doubled Culex spp. female captures (P = 0.005) compared to using only CO2. Interestingly, the MB5 blend outperformed the commercially available BG-Lure, in the BG-Sentinel (P < 0.001). The BG-Bowl also attracted Ae. aegypti when baited with the MB5 blend in similar numbers as the BG-Sentinel baited with the MB5 (P = 0.362). Conclusions Our study demonstrated that the BG-Sentinel trap baited with the MB5 blend and CO2 outperforms the current golden standard (BG-Sentinel trap with BG-Lure) for monitoring Ae. aegypti females and males, in both laboratory and field experiments. The BG-Bowl baited with the MB5 blend is a good candidate for home use. Finally, the results show that CO2 is an indispensable component of the attractive blend.
C1 [Visser, Tessa M.; de Cock, Marieke P.; Koenraadt, Constantianus J. M.] Wageningen Univ & Res, Dept Plant Sci, Entomol Lab, Wageningen, Netherlands.
   [Hiwat, Helene] Minist Hlth, Malaria Programme, Paramaribo, Suriname.
   [Wongsokarijo, Merril] Minist Hlth, Bur Publ Hlth, Paramaribo, Suriname.
   [Verhulst, Niels O.] Univ Zurich, Inst Parasitol, Vetsuisse Fac, Natl Ctr Vector Entomol, Zurich, Switzerland.
RP Visser, TM (corresponding author), Wageningen Univ & Res, Dept Plant Sci, Entomol Lab, Wageningen, Netherlands.
EM tessa.visser@wur.nl
OI Visser, Tessa/0000-0003-0899-7450
FU European Union's Horizon 2020 Research and Innovation Programme under
   ZIKAlliance Grant [734548]
FX This study was supported by the European Union's Horizon 2020 Research
   and Innovation Programme under ZIKAlliance Grant Agreement No. 734548.
CR Aldridge RL, 2016, J AM MOSQUITO CONTR, V32, P282, DOI 10.2987/16-6609.1
   Algemeen bureau voor de statistiek (ABS), 2013, 294201305 ABS
   Alvarez LC, 2013, J MED ENTOMOL, V50, P1031, DOI 10.1603/ME12254
   AMATALI MA, 1993, FRESHWATER ECOSYSTEM, P29
   Becker N, 2010, KEY FEMALE MOSQUITOE, P369
   Bohbot J, 2005, INSECT BIOCHEM MOLEC, V35, P961, DOI 10.1016/j.ibmb.2005.03.010
   Busula AO, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0635-1
   Carde RT, 2015, CURR BIOL, V25, pR793, DOI 10.1016/j.cub.2015.07.057
   Chadee DD, 2002, ANN TROP MED PARASIT, V96, pS47, DOI 10.1179/000349802125002365
   Codrington John, 2018, PLoS Curr, V10, DOI 10.1371/currents.outbreaks.ff0f6190d5431c2a2e824255eaeaf339
   Crepeau TN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060524
   Cribellier A, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180246
   Department of Epidemiology, 2017, REP SUSP CAS MAL CHI
   Dusfour I, 2011, MEM I OSWALDO CRUZ, V106, P346, DOI 10.1590/S0074-02762011000300015
   Englbrecht C, 2015, J AM MOSQUITO CONTR, V31, P16, DOI 10.2987/14-6444.1
   Farajollahi A, 2009, J MED ENTOMOL, V46, P919, DOI 10.1603/033.046.0426
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Fonseca-Gonzalez I, 2011, PEST MANAG SCI, V67, P430, DOI 10.1002/ps.2081
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   HARTBERG WK, 1971, B WORLD HEALTH ORGAN, V45, P847
   Hiscox A, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-257
   Hiwat H, 2011, J MED ENTOMOL, V48, P1039, DOI 10.1603/ME10245
   Hiwat H, 2013, ACAD J SURINAME, V4, P403
   Hiwat H, 2011, MEM I OSWALDO CRUZ, V106, P360, DOI 10.1590/S0074-02762011000300017
   Homan T, 2016, LANCET, V388, P1193, DOI 10.1016/S0140-6736(16)30445-7
   Jawara M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008167
   Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536
   Krockel U, 2006, J AM MOSQUITO CONTR, V22, P229, DOI 10.2987/8756-971X(2006)22[229:NTFSOA]2.0.CO;2
   Lacroix R, 2009, MED VET ENTOMOL, V23, P160, DOI 10.1111/j.1365-2915.2009.00806.x
   Lounibos LP, 1996, OIKOS, V77, P309, DOI 10.2307/3546070
   Luhken R, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-268
   Maciel-de-Freitas R, 2006, MEM I OSWALDO CRUZ, V101, P321, DOI 10.1590/S0074-02762006000300017
   Mboera LEG, 2000, MED VET ENTOMOL, V14, P257, DOI 10.1046/j.1365-2915.2000.00239.x
   Mburu MM, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1998-2
   McMeniman CJ, 2014, CELL, V156, P1060, DOI 10.1016/j.cell.2013.12.044
   Moutailler S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100904
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Mukabana WR, 2012, J CHEM ECOL, V38, P235, DOI 10.1007/s10886-012-0088-8
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Mweresa CK, 2016, J CHEM ECOL, V42, P508, DOI 10.1007/s10886-016-0711-1
   Njiru BN, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-39
   Owino EA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0866-6
   Owino EA, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-451
   Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633, DOI 10.5194/hess-11-1633-2007
   Pombi M, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0580-9
   Robinson A, 2018, P NATL ACAD SCI USA, V115, pE4209, DOI 10.1073/pnas.1721610115
   Rohde BB, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3647-9
   Schmied WH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-230
   Shone SM, 2006, J MED ENTOMOL, V43, P151, DOI 10.1603/0022-2585(2006)043[0151:TTOMVI]2.0.CO;2
   Smallegange RC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-292
   Smallegange RC, 2009, J CHEM ECOL, V35, P933, DOI 10.1007/s10886-009-9668-7
   Staunton KM, 2019, J MED ENTOMOL, V56, P1102, DOI 10.1093/jme/tjz018
   Takken W, 2017, CURR OPIN INSECT SCI, V20, P68, DOI 10.1016/j.cois.2017.03.011
   Takken W, 2013, ANNU REV ENTOMOL, V58, P433, DOI 10.1146/annurev-ento-120811-153618
   Unlu I, 2014, J AM MOSQUITO CONTR, V30, P122, DOI 10.2987/14-6401.1
   van de Straat B, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2923-7
   van Loon JJA, 2015, J CHEM ECOL, V41, P567, DOI 10.1007/s10886-015-0587-5
   Verhulst NO, 2015, J AM MOSQUITO CONTR, V31, P223, DOI 10.2987/moco-31-03-223-232.1
   Verhulst NO, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-28
   WHO, 2017, PTC DAT LYMPH FIL
   Wouthuyzen-Bakker M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.11.30488
   Xue RD, 2008, J AM MOSQUITO CONTR, V24, P249, DOI 10.2987/5701.1
NR 62
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD MAR 6
PY 2020
VL 13
IS 1
AR 121
DI 10.1186/s13071-020-4001-y
PG 14
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KT5GY
UT WOS:000519043800003
PM 32143711
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Talaga, S
   Dejean, A
   Azemar, F
   Dumont, Y
   Leroy, C
AF Talaga, Stanislas
   Dejean, Alain
   Azemar, Frederic
   Dumont, Yves
   Leroy, Celine
TI Impacts of biotic and abiotic parameters on immature populations of
   Aedes aegypti
SO JOURNAL OF PEST SCIENCE
LA English
DT Article
DE Biocontrol agents; Competition; Ecosystem services; Mosquito control;
   Predation; Mosquito management
ID RIO-DE-JANEIRO; MOSQUITO LARVAE; ALBOPICTUS; DENGUE; DISPERSAL; VECTOR;
   COMMUNITIES; BROMELIADS; CULICIDAE; HABITATS
AB In recent centuries, the mosquito Aedes aegypti has spread into most urban areas throughout the tropics. This species is considered the main vector of the chikungunya, dengue, yellow fever and Zika viruses and causes major public health issues. The aim of this study is to investigate the relative influence of biotic and abiotic parameters on immature populations of Ae. aegypti. During a one-year-long field experiment, we monitored 108 macroinvertebrate aquatic communities inhabiting four types of water containers across three different urbanized sites in a Neotropical city. A multimodel inference approach revealed that, in addition to abiotic parameters, biotic interactions with aquatic organisms had an important influence on the abundance of Ae. aegypti and that the urbanized site considered influences the outcomes of the interactions. Controphic species other than mosquitoes aided Ae. aegypti development, suggesting a mechanism of facilitation through a chain of processes. However, the abundance of Ae. aegypti was lowered by competition with native mosquito species in the slightly urbanized area and by predation in more urbanized areas. Competitive displacement and reduction, as well as predation by native aquatic organisms, can be considered a form of ecosystem service. The conservation and/or augmentation of natural enemies should improve the short- and long-term success of incompatible and/or sterile insect techniques, thus opening up perspectives for the future of mosquito management.
C1 [Talaga, Stanislas] Inst Pasteur, Vectopole Amazonien Emile Abonnenc, Cayenne, French Guiana.
   [Dejean, Alain; Azemar, Frederic] Univ Toulouse, Ecolab, CNRS, INPT,UPS, Toulouse, France.
   [Dejean, Alain; Leroy, Celine] Univ Guyane, Univ Antilles, AgroParisTech, UMR EcoFoG,CIRAD,CNRS,INRAE, Kourou, French Guiana.
   [Dumont, Yves] CIRAD, UMR AMAP, St Pierre, La Reunion, France.
   [Dumont, Yves; Leroy, Celine] Univ Montpellier, UMR AMAP, CIRAD, CNRS,INRAE,IRD, Montpellier, France.
   [Dumont, Yves] Univ Pretoria, Dept Math & Appl Math, Pretoria, South Africa.
RP Talaga, S (corresponding author), Inst Pasteur, Vectopole Amazonien Emile Abonnenc, Cayenne, French Guiana.
EM stanislas.talaga@gmail.com; alain.dejean@wanadoo.fr;
   frederic.azemar1@univ-tlse3.fr; yves.dumont@cirad.fr;
   celine.leroy@ird.fr
RI ; Dumont, Yves/O-3801-2017
OI Dejean, Alain/0000-0002-3561-2248; Dumont, Yves/0000-0003-4817-685X
FU `Investissement d'Avenir' grant by the French National Research Agency
   (CEBA)French National Research Agency (ANR) [ANR-10-LABX-25-01]
FX We are grateful to Andrea Yockey for proofreading the manuscript and to
   the municipality of Kourou (through the Service Departemental de
   Desinfection) for permitting us to work inside the city limits. We would
   also like to thank the Ringuet family and the French Centre de
   Cooperation Internationale en Recherche Agronomique pour le
   Developpement for allowing us to set up experimental sites on their
   properties. This study received financial support from an
   `Investissement d'Avenir' grant managed by the French National Research
   Agency (CEBA, ref. ANR-10-LABX-25-01).
CR ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Armitage P.D., 2012, CHIRONOMIDAE BIOL EC
   Beaulant A-L, 2017, RAPPORT PRELIMINAIRE
   Bin Cheung Y, 2002, STAT MED, V21, P1461, DOI 10.1002/sim.1088
   Blaustein L, 2007, ANNU REV ENTOMOL, V52, P489, DOI 10.1146/annurev.ento.52.110405.091431
   Burnham K. P., 2002, MODEL SELECTION MULT
   Cunha SP, 2002, REV SAUDE PUBL, V36, P244, DOI 10.1590/s0034-89102002000200018
   Cunze S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26092-2
   Daniela B, 2012, ORBIS, V8, P28
   Daugherty MP, 2003, AM MIDL NAT, V150, P181, DOI 10.1674/0003-0031(2003)150[0181:LSBFAA]2.0.CO;2
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Dufourd C, 2013, COMPUT MATH APPL, V66, P1695, DOI 10.1016/j.camwa.2013.03.024
   Epelboin Y, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760170398
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Focks DA, 2007, J AM MOSQUITO CONTR, V23, P118, DOI 10.2987/8756-971X(2007)23[118:TABA]2.0.CO;2
   Foster WA, 2019, MEDICAL AND VETERINARY ENTOMOLOGY, 3RD EDITION, P261, DOI 10.1016/B978-0-12-814043-7.00015-7
   Geoportail, 2019, CART DAT IGN
   GILLIES MT, 1981, B ENTOMOL RES, V71, P65, DOI 10.1017/S0007485300051038
   Griffith TB, 2018, DRAIN FLY PSYCHODA S
   HEARD SB, 1994, J ANIM ECOL, V63, P451, DOI 10.2307/5562
   Honorio NA, 2009, J MED ENTOMOL, V46, P1001, DOI 10.1603/033.046.0505
   Honorio NA, 2006, MEM I OSWALDO CRUZ, V101, P225, DOI 10.1590/S0074-02762006000200017
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Juliano SA, 2005, ECOL LETT, V8, P558, DOI 10.1111/j.1461-0248.2005.00755.x
   Juliano SA, 2009, ANNU REV ENTOMOL, V54, P37, DOI 10.1146/annurev.ento.54.110807.090611
   Lancaster J, 2013, AQUATIC ENTOMOLOGY, P1, DOI 10.1093/acprof:oso/9780199573219.001.0001
   Lane J, 1953, NEOTROPICAL CULICIDA, VI
   Lane J, 1953, NEOTROPICAL CULICIDA, V2
   Lopez LCS, 2005, HYDROBIOLOGIA, V549, P15, DOI 10.1007/s10750-005-1701-4
   Lopez LCS, 2011, HYDROBIOLOGIA, V665, P257, DOI 10.1007/s10750-011-0605-8
   Lounibos LP, 2007, J AM MOSQUITO CONTR, V23, P276, DOI 10.2987/8756-971X(2007)23[276:CDAR]2.0.CO;2
   Lounibos LP, 2003, ECOL ENTOMOL, V28, P551, DOI 10.1046/j.1365-2311.2003.00543.x
   Maneerat S, 2016, ECOL MODEL, V333, P66, DOI 10.1016/j.ecolmodel.2016.04.012
   Mellor PS, 2000, ANNU REV ENTOMOL, V45, P307, DOI 10.1146/annurev.ento.45.1.307
   Merritt R. W., 2008, INTRO AQUATIC INSECT
   Millenium Ecosystem Assessment, 2005, ECOSYSTEMS HUMAN WEL
   Mocellin MG, 2009, MEM I OSWALDO CRUZ, V104, P1171, DOI 10.1590/S0074-02762009000800015
   Mohajerani A, 2017, J ENVIRON MANAGE, V197, P522, DOI 10.1016/j.jenvman.2017.03.095
   Camara DCP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157120
   Powell JR, 2018, BIOSCIENCE, V68, P854, DOI 10.1093/biosci/biy119
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Quezede L, 2018, KOUROU HIST VILLE
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Riback TIS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134450
   Talaga S, 2018, INSECT SCI, V25, P1102, DOI 10.1111/1744-7917.12480
   Talaga S, 2017, URBAN ECOSYST, V20, P1001, DOI 10.1007/s11252-017-0653-6
   Talaga S, 2017, LANDSCAPE ECOL, V32, P1805, DOI 10.1007/s10980-017-0542-7
   Talaga S, 2016, EVOL ECOL, V30, P1133, DOI 10.1007/s10682-016-9862-3
   Talaga S, 2015, ECOL INDIC, V58, P1, DOI 10.1016/j.ecolind.2015.05.027
   Verdonschot PFM, 2014, LIMNOLOGICA, V45, P69, DOI 10.1016/j.limno.2013.11.002
   Yee DA, 2008, J MED ENTOMOL, V45, P581, DOI 10.1603/0022-2585(2008)45[581:TAHFMA]2.0.CO;2
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
NR 53
TC 0
Z9 0
U1 17
U2 17
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1612-4758
EI 1612-4766
J9 J PEST SCI
JI J. Pest Sci.
PD JUN
PY 2020
VL 93
IS 3
BP 941
EP 952
DI 10.1007/s10340-020-01214-w
EA MAR 2020
PG 12
WC Entomology
SC Entomology
GA LJ6LV
UT WOS:000518340800001
DA 2020-07-08
ER

PT J
AU Ozdener, MH
   Donadoni, M
   Cicalese, S
   Spielman, AI
   Garcia-Blanco, A
   Gordon, J
   Sariyer, IK
AF Ozdener, Mehmet Hakan
   Donadoni, Martina
   Cicalese, Stephanie
   Spielman, Andrew I.
   Garcia-Blanco, Alvaro
   Gordon, Jennifer
   Sariyer, Ilker Kudret
TI Zika virus infection in chemosensory cells
SO JOURNAL OF NEUROVIROLOGY
LA English
DT Article; Early Access
DE Olfactory cells; Taste cells; Zika virus (ZIKV); Chemosensory; Central
   nervous system; Infection
ID GUILLAIN-BARRE-SYNDROME; OUTBREAK; STRAIN
AB Zika virus (ZIKV) is an emerging virus belonging to the genus Flavivirus. ZIKV infection is a significant health concern, with increasing numbers of reports of microcephaly cases in fetuses and Guillain-Barre syndrome (GBS) in adults. Interestingly, chemosensory disturbances are also reported as one of the manifestations of GBS. ZIKV infects several human tissues and cell types in vitro and in vivo. However, there is no study demonstrating ZIKV infection and replication in chemosensory cells, including olfactory and taste cells. Taste papilla and olfactory cells are chemosensory receptor cells with unique histological, molecular, and physiological characteristics. Here we examined ZIKV infection (PRVABC59) in cultured human olfactory epithelial cells (hOECs) and fungiform taste papilla (HBO) cells in vitro, as well as in vivo mouse taste and olfactory epithelial and olfactory bulb tissues. Interestingly, while HBO cells showed resistance to ZIKV replication, hOECs were highly susceptible for ZIKV infection and replication. Further, we demonstrated the presence of ZIKV particles and expression of viral proteins in olfactory epithelium, as well as in olfactory bulb, but not in taste papillae, of immunocompromised mice (ifnar(/-)) infected with the PRVABC59 strain of ZIKV. These observations suggest that chemosensory cells in the olfactory neuroepithelium and olfactory bulb may be important tissues for ZIKV replication and dissemination.
C1 [Ozdener, Mehmet Hakan; Garcia-Blanco, Alvaro] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.
   [Donadoni, Martina; Cicalese, Stephanie; Gordon, Jennifer; Sariyer, Ilker Kudret] Temple Univ, Lewis Katz Sch Med, Dept Neurosci, 3500 North Broad St,Med Educ & Res Bldg,7th Floor, Philadelphia, PA 19140 USA.
   [Donadoni, Martina; Cicalese, Stephanie; Gordon, Jennifer; Sariyer, Ilker Kudret] Temple Univ, Ctr Neurovirol, Lewis Katz Sch Med, 3500 North Broad St,Med Educ & Res Bldg,7th Floor, Philadelphia, PA 19140 USA.
   [Spielman, Andrew I.] NYU, Coll Dent, New York, NY 10010 USA.
RP Ozdener, MH (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.; Sariyer, IK (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Neurosci, 3500 North Broad St,Med Educ & Res Bldg,7th Floor, Philadelphia, PA 19140 USA.; Sariyer, IK (corresponding author), Temple Univ, Ctr Neurovirol, Lewis Katz Sch Med, 3500 North Broad St,Med Educ & Res Bldg,7th Floor, Philadelphia, PA 19140 USA.
EM hozdener@monell.org; isariyer@temple.edu
FU NIDCD NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Deafness &
   Other Communication Disorders (NIDCD) [P30 DC011735]; NIMH NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH) [P30
   MH092177]
CR ASTIC L, 1993, BRAIN RES, V619, P146, DOI 10.1016/0006-8993(93)91606-S
   BEIDLER LM, 1965, J CELL BIOL, V27, P263, DOI 10.1083/jcb.27.2.263
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Borgmann-Winter KE, 2009, NEUROSCIENCE, V158, P642, DOI 10.1016/j.neuroscience.2008.09.059
   Borisevich V, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00252-17
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Dejima Sunao, 1995, No To Hattatsu, V27, P492
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Durrant DM, 2016, ACS CHEM NEUROSCI, V7, P464, DOI 10.1021/acschemneuro.6b00043
   Gomez G, 2000, J NEUROSCI RES, V62, P737, DOI 10.1002/1097-4547(20001201)62:5<737::AID-JNR14>3.0.CO;2-A
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Higuchi MA, 2015, INTERNAL MED, V54, P1543, DOI 10.2169/internalmedicine.54.3506
   Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Li SX, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010049
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   MCLAUGHLIN SK, 1992, NATURE, V357, P563, DOI 10.1038/357563a0
   Merkonidis C, 2015, EUR ARCH OTO-RHINO-L, V272, P1403, DOI 10.1007/s00405-014-3210-4
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morrison TE, 2017, J VIROL, V91, DOI 10.1128/JVI.00009-17
   Nyati KK, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/758639
   Odaka M, 2002, NEUROLOGY, V58, P1437, DOI 10.1212/WNL.58.9.1437
   Ozdener H, 2006, CHEM SENSES, V31, P279, DOI 10.1093/chemse/bjj030
   Ozdener H, 2012, JOVE-J VIS EXP, DOI 10.3791/3730
   Ozdener MH, 2011, CHEM SENSES, V36, P601, DOI 10.1093/chemse/bjr012
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rawson Nancy E, 2013, Methods Mol Biol, V945, P81, DOI 10.1007/978-1-62703-125-7_6
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rossler P, 1998, EUR J CELL BIOL, V77, P253
   Simon O, 2018, J NEUROVIROL, V24, P362, DOI 10.1007/s13365-018-0621-9
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   van Riel D, 2015, J PATHOL, V235, P277, DOI 10.1002/path.4461
   Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007
   Xu JJ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07756-x
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
NR 40
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 1355-0284
EI 1538-2443
J9 J NEUROVIROL
JI J. Neurovirol.
DI 10.1007/s13365-020-00835-2
EA MAR 2020
PG 11
WC Neurosciences; Virology
SC Neurosciences & Neurology; Virology
GA KS5IY
UT WOS:000518343300001
PM 32144727
DA 2020-07-08
ER

PT J
AU Fahsbender, E
   da-Costa, AC
   Gill, DE
   Milagres, FAD
   Brustulin, R
   Monteiro, FJC
   Rego, MOD
   Ribeiro, ESD
   Sabino, EC
   Delwart, E
AF Fahsbender, Elizabeth
   da-Costa, Antonio Charlys
   Gill, Danielle Elise
   Milagres, Flavio Augusto de Padua
   Brustulin, Rafael
   Monteiro, Fred Julio Costa
   Rego, Marlisson Octavio da Silva
   Ribeiro, Edcelha Soares D'Athaide
   Sabino, Ester Cerdeira
   Delwart, Eric
TI Plasma virome of 781 Brazilians with unexplained symptoms of arbovirus
   infection include a novel parvovirus and densovirus
SO PLOS ONE
LA English
DT Article
ID MERKEL CELL POLYOMAVIRUS; VIRAL NUCLEIC-ACIDS; HUMAN PEGIVIRUS 2;
   BLOOD-DONORS; DNA VIRUSES; GEMYCIRCULARVIRUS; GENERATION
AB Plasma from patients with dengue-like symptoms was collected in 2013 to 2016 from the Brazilian states of Tocantins and Amapa. 781 samples testing negative for IgM against Dengue, Zika, and Chikungunya viruses and for flaviviruses, alphaviruses and enteroviruses RNA using RT-PCRs were analyzed using viral metagenomics. Viral particles-associated nucleic acids were enriched, randomly amplified, and deep sequenced in 102 mini-pools generating over 2 billion reads. Sequence data was analyzed for the presence of known and novel eukaryotic viral reads. Anelloviruses were detected in 80%, human pegivirus 1 in 19%, and parvovirus B19 in 17% of plasma pools. HIV and enteroviruses were detected in two pools each. Previously uncharacterized viral genomes were also identified, and their presence in single plasma samples confirmed by PCR. Chapparvovirus and ambidensovirus genomes, both in the Parvoviridae family, were partially characterized showing 33% and 34% identity in their NS1 sequences to their closest relative. Molecular surveillance using pre-existing plasma from febrile patients provides a readily scalable approach for the detection of novel, potentially emerging, viruses.
C1 [Fahsbender, Elizabeth; Delwart, Eric] Vitalant Res Inst, San Francisco, CA 94118 USA.
   [Fahsbender, Elizabeth; Delwart, Eric] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94110 USA.
   [da-Costa, Antonio Charlys; Gill, Danielle Elise; Sabino, Ester Cerdeira] Univ Sao Paulo, Sch Med, Infect Dis, Sao Paulo, Brazil.
   [da-Costa, Antonio Charlys; Gill, Danielle Elise; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Trop Med, Infect Dis, Sao Paulo, Brazil.
   [Milagres, Flavio Augusto de Padua; Brustulin, Rafael] Hlth Tocantins, Publ Hlth Lab State LACEN TO, Palmas, TO, Brazil.
   [Milagres, Flavio Augusto de Padua; Brustulin, Rafael] Fed Univ Tocantins, Palmas, Tocantins, Brazil.
   [Monteiro, Fred Julio Costa; Rego, Marlisson Octavio da Silva; Ribeiro, Edcelha Soares D'Athaide] Hlth Amapa, Publ Hlth Lab State LACEN AP, Macapa, AP, Brazil.
RP Delwart, E (corresponding author), Vitalant Res Inst, San Francisco, CA 94118 USA.; Delwart, E (corresponding author), Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94110 USA.
EM edelwart@vitalant.org
OI Julio Costa Monteiro, Fred/0000-0002-1989-7810
FU Vitalant Research Institute; Grifols Diagnostic Solutions Inc.;
   FAPESPFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/00021-9, 2016/01735-2]; CNPqNational Council for Scientific and
   Technological Development (CNPq) [400354/2016-0]
FX This study was partially supported by Vitalant Research Institute, an
   unrestricted research grant from Grifols Diagnostic Solutions Inc.,
   FAPESP #2016/01735-2 and CNPq #400354/2016-0. Antonio Charlys da-Costa
   is funded by FAPESP #2017/00021-9. The specific roles of this author are
   articulated in the 'author contributions' section. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Asplund M, 2019, CLIN MICROBIOL INFEC, V25, P1277, DOI 10.1016/j.cmi.2019.04.028
   Baker KS, 2013, VIROLOGY, V441, P95, DOI 10.1016/j.virol.2013.03.014
   Berg MG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005325
   Brito F, 2018, VOX SANG, V113, P601, DOI 10.1111/vox.12695
   Chiu CY, 2019, NAT REV GENET, V20, P341, DOI 10.1038/s41576-019-0113-7
   Chivero ET, 2015, J GEN VIROL, V96, P1521, DOI 10.1099/vir.0.000086
   Chong R, 2019, J VIROL, V93, DOI [10.1128/JVI.00205-19, 10.1128/jvi.00205-19]
   Coller KE, 2020, EMERG INFECT DIS, V26, P265, DOI 10.3201/eid2602.190434
   Coller KE, 2016, J CLIN MICROBIOL, V54, P2023, DOI 10.1128/JCM.00515-16
   Cordey S, 2019, EMERG MICROBES INFEC, V8, P613, DOI 10.1080/22221751.2019.1603791
   Cordey S, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0025-1
   de Souza WM, 2017, J GEN VIROL, V98, P225, DOI 10.1099/jgv.0.000671
   de Villiers EM, 2009, J GEN VIROL, V90, P1999, DOI 10.1099/vir.0.011478-0
   Deng XT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv002
   Di Paola N, 2019, CLIN INFECT DIS, V68, P810, DOI 10.1093/cid/ciy630
   Du J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02815
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   El-Far M, 2004, VIRUS RES, V99, P17, DOI 10.1016/j.virusres.2003.09.010
   FAHSBENDER E, 2019, VIRUSES-BASEL, V11, DOI DOI 10.3390/V11050398
   Fukumoto H, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-84
   Furuta RA, 2015, TRANSFUSION, V55, P1889, DOI 10.1111/trf.13057
   Giry C, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1080-9
   Grard G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002924
   Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111
   Holmes EC, 2019, CLIN MICROBIOL INFEC, V25, P1167, DOI 10.1016/j.cmi.2019.06.019
   Jerome H, 2019, J INFECTION, V79, P383, DOI 10.1016/j.jinf.2019.08.003
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Jones MS, 2005, J VIROL, V79, P8230, DOI 10.1128/JVI.79.13.8230-8236.2005
   JOUSSET FX, 1993, VIRUS RES, V29, P99, DOI 10.1016/0168-1702(93)90052-O
   Kapoor A, 2015, MBIO, V6, DOI 10.1128/mBio.01466-15
   Kapusinszky B, 2017, J VIROL, V91, DOI 10.1128/JVI.00952-17
   Krupovic M, 2016, ARCH VIROL, V161, P2633, DOI 10.1007/s00705-016-2943-3
   Lamberto I, 2014, MICROBIOL RESOUR ANN, V2, DOI 10.1128/genomeA.00848-14
   Lau P, 2017, TRANSFUSION, V57, P1787, DOI 10.1111/trf.14148
   Laubscher F, 2019, MICROBIOL RESOUR ANN, V8, DOI 10.1128/MRA.00764-19
   Li L, 2015, J VIROL METHODS, V213, P139, DOI 10.1016/j.jviromet.2014.12.002
   Lima DA, 2019, VIRUS RES, V261, P9, DOI 10.1016/j.virusres.2018.12.005
   Liu S, 2016, P NATL ACAD SCI USA, V113, P12803, DOI 10.1073/pnas.1608013113
   Liu SY, 2018, CELL, V175, P347, DOI 10.1016/j.cell.2018.08.016
   Liu XP, 2020, VIROLOGY, V539, P80, DOI 10.1016/j.virol.2019.10.013
   Macera L, 2019, NEW MICROBIOL, V42, P118
   Moustafa A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006292
   Naccache SN, 2013, J VIROL, V87, P11966, DOI 10.1128/JVI.02323-13
   Ngoi CN, 2017, J GEN VIROL, V98, P517, DOI 10.1099/jgv.0.000762
   Ngoi CN, 2016, J GEN VIROL, V97, P3359, DOI 10.1099/jgv.0.000644
   Anh NT, 2019, J CLIN MICROBIOL, V57, DOI 10.1128/JCM.00386-19
   Anh NT, 2018, EMERG INFECT DIS, V24, P2063, DOI 10.3201/eid2411.180668
   Palinski RM, 2016, VIRUS GENES, V52, P564, DOI 10.1007/s11262-016-1322-1
   Pancaldi C, 2011, BLOOD, V117, P7099, DOI 10.1182/blood-2010-09-310557
   Patel P, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-58
   PENZES JJ, 2019, VIRUSES-BASEL, V11, DOI [DOI 10.3390/v11060525, DOI 10.3390/V11060525]
   Ramesh A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218318
   Reuter G, 2014, ARCH VIROL, V159, P2161, DOI 10.1007/s00705-014-2025-3
   Roediger B, 2018, CELL, V175, P530, DOI 10.1016/j.cell.2018.08.013
   Sauvage V, 2016, BLOOD TRANSFUS-ITALY, V14, P400, DOI 10.2450/2016.0160-15
   Sawaswong V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100971
   Schowalter RM, 2010, CELL HOST MICROBE, V7, P509, DOI 10.1016/j.chom.2010.05.006
   Shui JW, 2019, J GEN VIROL, V100, P968, DOI 10.1099/jgv.0.001266
   Somasekar S, 2017, CLIN INFECT DIS, V65, P1477, DOI 10.1093/cid/cix596
   Spandole S, 2015, ARCH VIROL, V160, P893, DOI 10.1007/s00705-015-2363-9
   Sridhar S, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz329
   Stremlau MH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003631
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   Tijssen P, 2016, J INVERTEBR PATHOL, V140, P83, DOI 10.1016/j.jip.2016.09.005
   Phan TG, 2018, VIRUS GENES, V54, P33, DOI 10.1007/s11262-017-1514-3
   Phan TG, 2016, ARCH VIROL, V161, P3231, DOI 10.1007/s00705-016-3002-9
   Phan TG, 2015, VIROLOGY, V482, P98, DOI 10.1016/j.virol.2015.03.011
   Uch R, 2015, EMERG INFECT DIS, V21, P2096, DOI 10.3201/eid2111.150486
   Wang Y, 2019, ARCH VIROL, V164, P3, DOI 10.1007/s00705-018-4037-x
   Williams SH, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00311-18
   Williams SH, 2018, MBIO, V9, DOI [10.1128/mBio.01354-17, 10.1128/mbio.01354-17]
   Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735
   Xie JT, 2011, VIROLOGY, V418, P49, DOI 10.1016/j.virol.2011.07.008
   Yang SX, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0589-0
   Yang WT, 2016, INFECT GENET EVOL, V41, P107, DOI 10.1016/j.meegid.2016.03.035
   Yinda CK, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey008
   Yozwiak NL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001485
   Zhang SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102724
   Zhang W, 2016, TRANSFUSION, V56, P2248, DOI 10.1111/trf.13692
NR 79
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD MAR 5
PY 2020
VL 15
IS 3
AR e0229993
DI 10.1371/journal.pone.0229993
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KX8CZ
UT WOS:000522104300001
PM 32134963
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hong, F
   Ma, D
   Wu, KY
   Mina, LA
   Luiten, RC
   Liu, Y
   Yan, H
   Green, AA
AF Hong, Fan
   Ma, Duo
   Wu, Kaiyue
   Mina, Lida A.
   Luiten, Rebecca C.
   Liu, Yan
   Yan, Hao
   Green, Alexander A.
TI Precise and Programmable Detection of Mutations Using Ultraspecific
   Riboregulators
SO CELL
LA English
DT Article
ID GREEN FLUORESCENT PROTEIN; NUCLEIC-ACID DETECTION; ZIKA VIRUS; RNA
   MODIFICATIONS; MAMMALIAN-CELLS; GENE-EXPRESSION; REGULATORS; DESIGN;
   THERMODYNAMICS; PREDICTION
AB The ability to identify single-nucleotide mutations is critical for probing cell biology and for precise detection of disease. However, the small differences in hybridization energy provided by single-base changes makes identification of these mutations challenging in living cells and complex reaction environments. Here, we report a class of de novodesigned prokaryotic riboregulators that provide ultraspecific RNA detection capabilities in vivo and in cell-free transcription-translation reactions. These single-nucleotide-specific programmable riboregulators (SNIPRs) provide over 100-fold differences in gene expression in response to target RNAs differing by a single nucleotide in E. coli and resolve single epitranscriptomic marks in vitro. By exploiting the programmable SNIPR design, we implement an automated design algorithm to develop riboregulators for a range of mutations associated with cancer, drug resistance, and genetic disorders. Integrating SNIPRs with portable paper-based cell-free reactions enables convenient isothermal detection of cancer-associated mutations from clinical samples and identification of Zika strains through unambiguous colorimetric reactions.
C1 [Hong, Fan; Ma, Duo; Wu, Kaiyue; Liu, Yan; Yan, Hao; Green, Alexander A.] Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Biodesign Inst, Tempe, AZ 85287 USA.
   [Hong, Fan; Ma, Duo; Wu, Kaiyue; Liu, Yan; Yan, Hao; Green, Alexander A.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.
   [Mina, Lida A.] Banner MD Anderson Canc Ctr, Hematol Oncol Dept, Gilbert, AZ 85234 USA.
   [Luiten, Rebecca C.] Banner MD Anderson Canc Ctr, Genet Dept, Gilbert, AZ 85234 USA.
RP Yan, H; Green, AA (corresponding author), Arizona State Univ, Biodesign Ctr Mol Design & Biomimet, Biodesign Inst, Tempe, AZ 85287 USA.; Yan, H; Green, AA (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85287 USA.
EM hao.yan@asu.edu; alexgreen@asu.edu
RI Green, Alexander/B-6512-2008
OI Green, Alexander/0000-0003-2058-1204
FU NIH Director's New Innovator AwardUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [1DP2GM126892];
   Gates FoundationGates Foundation [OPP1160667]; Arizona Biomedical
   Research Commission New Investigator Award [ADHS16-162400]; Alfred P.
   Sloan FellowshipAlfred P. Sloan Foundation [FG-2017-9108]; Gordon and
   Betty Moore FoundationGordon and Betty Moore Foundation [6984];
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1R21AI136571]; DARPA Young Faculty
   Award [D17AP00026]; Arizona State University
FX This work was supported by funds to A.A.G. from an NIH Director's New
   Innovator Award (1DP2GM126892), the Gates Foundation (OPP1160667), an
   Arizona Biomedical Research Commission New Investigator Award
   (ADHS16-162400), an Alfred P. Sloan Fellowship (FG-2017-9108), Gordon
   and Betty Moore Foundation (6984), NIH (1R21AI136571), a DARPA Young
   Faculty Award (D17AP00026), and Arizona State University. The views,
   opinions, and/or findings contained in this article are those of the
   authors and should not be interpreted as representing the official views
   or policies, either expressed or implied, of the NIH, DARPA, or the
   Department of Defense.
CR Abudayyeh OO, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5573
   Andersen JB, 1998, APPL ENVIRON MICROB, V64, P2240
   Antoniou AC, 2005, J MED GENET, V42, P602, DOI 10.1136/jmg.2004.024133
   Braselmann E, 2018, NAT CHEM BIOL, V14, P964, DOI 10.1038/s41589-018-0103-7
   Chappell J, 2015, NAT CHEM BIOL, V11, P214, DOI 10.1038/nchembio.1737
   Chen JS, 2018, SCIENCE, V360, P436, DOI 10.1126/science.aar6245
   Chen SX, 2016, J AM CHEM SOC, V138, P5076, DOI 10.1021/jacs.6b00277
   Chen SX, 2013, NAT CHEM, V5, P782, DOI [10.1038/NCHEM.1713, 10.1038/nchem.1713]
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai Q, 2017, NAT METHODS, V14, P695, DOI 10.1038/nmeth.4294
   Das R, 2010, NAT METHODS, V7, P291, DOI [10.1038/NMETH.1433, 10.1038/nmeth.1433]
   Davis AR, 2007, BIOCHEMISTRY-US, V46, P13425, DOI 10.1021/bi701311c
   Filonov GS, 2014, J AM CHEM SOC, V136, P16299, DOI 10.1021/ja508478x
   Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005
   Gootenberg JS, 2018, SCIENCE, V360, P439, DOI 10.1126/science.aaq0179
   Gootenberg JS, 2017, SCIENCE, V356, P438, DOI 10.1126/science.aam9321
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Green AA, 2017, METHODS MOL BIOL, V1632, P285, DOI 10.1007/978-1-4939-7138-1_19
   Green AA, 2017, NATURE, V548, P117, DOI 10.1038/nature23271
   Green AA, 2014, CELL, V159, P925, DOI 10.1016/j.cell.2014.10.002
   Grunweller A, 2003, NUCLEIC ACIDS RES, V31, P3185, DOI 10.1093/nar/gkg409
   Hanewich-Hollatz MH, 2019, ACS CENTRAL SCI, V5, P1241, DOI 10.1021/acscentsci.9b00340
   Harrington LB, 2018, SCIENCE, V362, P839, DOI 10.1126/science.aav4294
   Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8
   Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986
   Kim J, 2019, NAT CHEM BIOL, V15, P1173, DOI 10.1038/s41589-019-0388-1
   Lavickova B, 2019, ACS SYNTH BIOL, V8, P455, DOI 10.1021/acssynbio.8b00427
   Lucks JB, 2011, P NATL ACAD SCI USA, V108, P8617, DOI 10.1073/pnas.1015741108
   Ma D, 2018, SYN BIOL, V3, DOI 10.1093/synbio/ysy018
   Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700
   Miller V, 2000, AIDS, V14, P163, DOI 10.1097/00002030-200001280-00012
   Mousavi PS, 2020, NAT CHEM, V12, P48, DOI 10.1038/s41557-019-0366-y
   Mutalik VK, 2012, NAT CHEM BIOL, V8, P447, DOI [10.1038/NCHEMBIO.919, 10.1038/nchembio.919]
   Myhrvold C, 2018, SCIENCE, V360, P444, DOI 10.1126/science.aas8836
   Natoli ME, 2018, ANAL BIOCHEM, V544, P64, DOI 10.1016/j.ab.2017.12.008
   Noone AM, 2018, SEER CANC STAT REV
   Oesinghaus L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09953-w
   Paige JS, 2011, SCIENCE, V333, P642, DOI 10.1126/science.1207339
   Panpradist N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145962
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Pardee K, 2014, CELL, V159, P940, DOI 10.1016/j.cell.2014.10.004
   Piepenburg O, 2006, PLOS BIOL, V4, P1115, DOI 10.1371/journal.pbio.0040204
   Pilling LC, 2019, BMJ-BRIT MED J, V364, DOI 10.1136/bmj.k5222
   Ranasinghe RT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02714-7
   Rebbeck TR, 2015, JAMA-J AM MED ASSOC, V313, P1347, DOI 10.1001/jama.2014.5985
   Roberts L, 2017, SCIENCE, V358, P155, DOI 10.1126/science.358.6360.155
   Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109
   Roost C, 2015, J AM CHEM SOC, V137, P2107, DOI 10.1021/ja513080v
   Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045
   Serra MJ, 1995, METHOD ENZYMOL, V259, P242
   Shimizu Y, 2001, NAT BIOTECHNOL, V19, P751, DOI 10.1038/90802
   Siu KH, 2019, NAT CHEM BIOL, V15, P217, DOI 10.1038/s41589-018-0186-1
   Sulc P, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4881424
   Syvanen AC, 2001, NAT REV GENET, V2, P930, DOI 10.1038/35103535
   Takou D, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3871-0
   Varani G, 2000, EMBO REP, V1, P18, DOI 10.1093/embo-reports/kvd001
   Villarreal F, 2018, NAT CHEM BIOL, V14, P29, DOI [10.1038/NCHEMBIO.2514, 10.1038/nchembio.2514]
   Wang JS, 2015, NAT CHEM, V7, P545, DOI [10.1038/NCHEM.2266, 10.1038/nchem.2266]
   Weinreb C, 2016, CELL, V165, P963, DOI 10.1016/j.cell.2016.03.030
   Xu HT, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-14
   Xuan JJ, 2018, NUCLEIC ACIDS RES, V46, pD327, DOI 10.1093/nar/gkx934
   Zadeh JN, 2011, J COMPUT CHEM, V32, P170, DOI 10.1002/jcc.21596
   Zhang DY, 2012, NAT CHEM, V4, P208, DOI [10.1038/nchem.1246, 10.1038/NCHEM.1246]
   Zhang F, 2017, EBIOMEDICINE, V25, P95, DOI 10.1016/j.ebiom.2017.10.019
   Zuker M, 1999, NATO ASI 3 HIGH TECH, V70, P11
NR 65
TC 4
Z9 3
U1 18
U2 18
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 5
PY 2020
VL 180
IS 5
BP 1018
EP +
DI 10.1016/j.cell.2020.02.011
PG 31
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA KT7JN
UT WOS:000519189800018
PM 32109416
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Shang, P
   Zhu, MQ
   Wang, Y
   Zheng, XY
   Wu, XJ
   Zhu, J
   Feng, JC
   Zhang, HL
AF Shang, Pei
   Zhu, Mingqin
   Wang, Ying
   Zheng, Xiangyu
   Wu, Xiujuan
   Zhu, Jie
   Feng, Jiachun
   Zhang, Hong-Liang
TI Axonal variants of Guillain-Barre syndrome: an update
SO JOURNAL OF NEUROLOGY
LA English
DT Review; Early Access
DE Axonal GBS; Acute motor axonal neuropathy; Acute motor and sensory
   axonal neuropathy; Guillain-Barre syndrome
ID CAMPYLOBACTER-JEJUNI INFECTION; CERVICAL-BRACHIAL VARIANT; MILLER FISHER
   SYNDROME; ZIKA VIRUS-INFECTION; ANTIGANGLIOSIDE ANTIBODIES; INFLUENZA
   VACCINATION; CLINICAL-FEATURES; NERVE ULTRASOUND; INTERFERON-BETA;
   RABBIT MODEL
AB Axonal variants of Guillain-Barre syndrome (GBS) mainly include acute motor axonal neuropathy, acute motor and sensory axonal neuropathy, and pharyngeal-cervical-brachial weakness. Molecular mimicry of human gangliosides by a pathogen's lipooligosaccharides is a well-established mechanism for Campylobacter jejuni-associated GBS. New triggers of the axonal variants of GBS (axonal GBS), such as Zika virus, hepatitis viruses, intravenous administration of ganglioside, vaccination, and surgery, are being identified. However, the pathogenetic mechanisms of axonal GBS related to antecedent bacterial or viral infections other than Campylobacter jejuni remain unknown. Currently, autoantibody classification and serial electrophysiology are cardinal approaches to differentiate axonal GBS from the prototype of GBS, acute inflammatory demyelinating polyneuropathy. Newly developed technologies, including metabolite analysis, peripheral nerve ultrasound, and feature selection via artificial intelligence are facilitating more accurate diagnosis of axonal GBS. Nevertheless, some key issues, such as genetic susceptibilities, remain unanswered and moreover, current therapies bear limitations. Although several therapies have shown considerable benefits to experimental animals, randomized controlled trials are still needed to validate their efficacy.
C1 [Shang, Pei; Zhu, Mingqin; Wang, Ying; Zheng, Xiangyu; Wu, Xiujuan; Zhu, Jie; Feng, Jiachun] Jilin Univ, Hosp 1, Dept Neurol, Xinmin St 71, Changchun 130021, Peoples R China.
   [Zhu, Jie] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.
   [Zhang, Hong-Liang] Natl Nat Sci Fdn China, Dept Life Sci, Shuangqing Rd 83, Beijing 100085, Peoples R China.
RP Feng, JC (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Xinmin St 71, Changchun 130021, Peoples R China.; Zhang, HL (corresponding author), Natl Nat Sci Fdn China, Dept Life Sci, Shuangqing Rd 83, Beijing 100085, Peoples R China.
EM fengjcfrank@qq.com; drzhl@hotmail.com
RI Zhang, Hongliang/AAN-3077-2020
OI Zhang, Hongliang/0000-0001-9205-5559; Shang, Pei/0000-0003-4345-2165
FU National Key R&D Program of China [2017YFC0110304]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [31600820, 81771257]
FX The work was supported by grants from the National Key R&D Program of
   China (No. 2017YFC0110304 to JF), and the National Natural Science
   Foundation of China to (No. 31600820 to MZ and No. 81771257 to JF).
CR Al Othman B, 2019, CURR OPIN OPHTHALMOL, V30, P462, DOI 10.1097/ICU.0000000000000611
   Al-Saffar A, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00062
   Bae JS, 2014, J NEUROL NEUROSUR PS, V85, P905, DOI 10.1136/jnnp-2013-306212
   Benedetti L, 2019, J PERIPHER NERV SYST, V24, P80, DOI 10.1111/jns.12292
   Blum S, 2018, J NEUROIMMUNOL, V323, P109, DOI 10.1016/j.jneuroim.2018.07.016
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   BREMAN JG, 1984, AM J EPIDEMIOL, V119, P880, DOI 10.1093/oxfordjournals.aje.a113810
   Burnor E, 2018, NEUROLOGY, V90, pE31, DOI 10.1212/WNL.0000000000004773
   Caminero AS, 2013, NEUROLOGY, V80
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Che YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep20963
   Chen Y, 2020, EUR J EPIDEMIOL, V35, P363, DOI 10.1007/s10654-019-00596-1
   Chevret S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub3
   CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911
   Creange A, 2001, NEUROLOGY, V57, P1704, DOI 10.1212/WNL.57.9.1704
   Creange A, 2000, BIODRUGS, V14, P1
   Souza IND, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aar2749
   De Wals P, 2012, JAMA-J AM MED ASSOC, V308, P175, DOI 10.1001/jama.2012.7342
   Deceuninck G, 2018, EXPERT REV VACCINES, V17, P99, DOI 10.1080/14760584.2018.1388168
   DIEZTEJEDOR E, 1993, NEUROEPIDEMIOLOGY, V12, P251, DOI 10.1159/000110325
   Dimachkie MM, 2013, NEUROL CLIN, V31, P491, DOI 10.1016/j.ncl.2013.01.005
   Dirlikov E, 2018, JAMA NEUROL, V75, P1089, DOI 10.1001/jamaneurol.2018.1058
   Doets AY, 2018, BRAIN, V141, P2866, DOI 10.1093/brain/awy232
   Doets AY, 2018, CURR OPIN NEUROL, V31, P541, DOI 10.1097/WCO.0000000000000602
   Drenthen J, 2011, J NEUROL NEUROSUR PS, V82, P300, DOI 10.1136/jnnp.2010.226639
   FEASBY TE, 1991, J NEUROL NEUROSUR PS, V54, P51, DOI 10.1136/jnnp.54.1.51
   FEASBY TE, 1986, BRAIN, V109, P1115, DOI 10.1093/brain/109.6.1115
   FIGUERAS A, 1992, BRIT MED J, V305, P1330, DOI 10.1136/bmj.305.6865.1330
   Galban-Horcajo F, 2013, EUR J NEUROL, V20, P62, DOI 10.1111/j.1468-1331.2012.03767.x
   Gao Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5703279
   GeurtsvanKessel CH, 2018, ANN CLIN TRANSL NEUR, V5, P606, DOI 10.1002/acn3.556
   Gomez A, 2019, J PERIPHER NERV SYST, V24, P268, DOI 10.1111/jns.12340
   Govoni V, 2003, J NEUROL SCI, V216, P99, DOI 10.1016/S0022-510X(03)00215-6
   Govoni V, 1996, J NEUROL SCI, V137, P62, DOI 10.1016/0022-510X(95)00333-W
   Greco A, 2012, AUTOIMMUN REV, V12, P323, DOI 10.1016/j.autrev.2012.05.008
   Green DM, 2001, ARCH NEUROL-CHICAGO, V58, P1098, DOI 10.1001/archneur.58.7.1098
   Grimm A, 2017, J NEUROL, V264, P243, DOI 10.1007/s00415-016-8305-y
   Grimm A, 2015, CLIN NEUROPHYSIOL, V126, P2216, DOI 10.1016/j.clinph.2015.01.011
   Guillain G, 1916, B MEMOIRES SOCIETE M, V40, P1462
   Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005
   Hadden RDM, 1998, ANN NEUROL, V44, P780, DOI 10.1002/ana.410440512
   Halstead SK, 2008, J PERIPHER NERV SYST, V13, P228, DOI 10.1111/j.1529-8027.2008.00181.x
   Halstead SK, 2008, BRAIN, V131, P1197, DOI 10.1093/brain/awm316
   Hameed A, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e38
   Hamel J, 2018, MUSCLE NERVE, V57, P33, DOI 10.1002/mus.25702
   Hao YL, 2019, ANN CLIN TRANSL NEUR, DOI 10.1002/acn3.50946
   Hayat S, 2019, ANN CLIN TRANSL NEUR, V6, P1849, DOI 10.1002/acn3.50884
   He L, 2015, J NEUROSCI, V35, P6770, DOI 10.1523/JNEUROSCI.4926-14.2015
   Hernandez-Torruco J, 2014, COMPUT MATH METHOD M, DOI 10.1155/2014/432109
   HO TW, 1995, BRAIN, V118, P597, DOI 10.1093/brain/118.3.597
   Hosokawa T, 2016, J NEUROL, V263, P1709, DOI 10.1007/s00415-016-8192-2
   HUGHES RAC, 1993, LANCET, V341, P586
   Hughes RAC, 2020, J NEUROL NEUROSUR PS, V91, P111, DOI 10.1136/jnnp-2019-322361
   Hughes RAC, 2016, BRAIN, V139, P3041, DOI 10.1093/brain/aww247
   Hughes RAC, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub6
   Ilyas AA, 2001, RES COMMUN MOL PATH, V109, P115
   ILYAS AA, 1988, ANN NEUROL, V23, P440, DOI 10.1002/ana.410230503
   Inaloo S, 2014, IRAN J CHILD NEUROL, V8, P70
   IRIE F, 1994, BRAIN RES, V665, P161, DOI 10.1016/0006-8993(94)91169-X
   Ishii J, 2016, J NEUROL SCI, V364, P59, DOI 10.1016/j.jns.2016.03.008
   Islam B, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022862
   Islam Z, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192703
   Jahan I, 2017, J NEUROIMMUNOL, V310, P46, DOI 10.1016/j.jneuroim.2017.06.005
   Jiang H, 2010, INT J MOL SCI, V11, P1155, DOI 10.3390/ijms11031155
   Jin PP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131374
   Kaida K, 2009, GLYCOBIOLOGY, V19, P676, DOI 10.1093/glycob/cwp027
   Kalita J, 2019, PEDIATR CRIT CARE ME, V20, P652, DOI 10.1097/PCC.0000000000001935
   Kesici S, 2019, J CHILD NEUROL, V34, P277, DOI 10.1177/0883073819826225
   Khaiboullina S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02126
   Koga M, 2005, NEUROLOGY, V65, P1376, DOI 10.1212/01.wnl.0000176914.70893.14
   Koga M, 2015, J NEUROL, V262, P1954, DOI 10.1007/s00415-015-7806-4
   Koga M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124004
   Komagamine Tomoko, 2006, CNS & Neurological Disorders-Drug Targets, V5, P391, DOI 10.2174/187152706777950765
   Kornberg AJ, 1996, NEUROLOGY, V47, P1317, DOI 10.1212/WNL.47.5.1317
   Kusunoki S, 2001, NEUROLOGY, V57, P736, DOI 10.1212/WNL.57.4.736
   Kutlesa M, 2010, NEUROCRIT CARE, V13, P98, DOI 10.1007/s12028-010-9365-y
   Kuwabara S, 2013, LANCET NEUROL, V12, P1180, DOI 10.1016/S1474-4422(13)70215-1
   Kwong JC, 2013, LANCET INFECT DIS, V13, P769, DOI 10.1016/S1473-3099(13)70104-X
   Lardone RD, 2010, J NEUROL NEUROSUR PS, V81, P629, DOI 10.1136/jnnp.2009.183665
   Leonhard SE, 2019, NAT REV NEUROL, V15, P671, DOI 10.1038/s41582-019-0250-9
   Liu S, 2018, HUM VACC IMMUNOTHER, V14, P2568, DOI 10.1080/21645515.2018.1493415
   Liu SP, 2018, J NEUROL NEUROSUR PS, V89, P618, DOI 10.1136/jnnp-2017-316930
   Loshaj-Shala A, 2015, J NEUROIMMUNOL, V289, P168, DOI 10.1016/j.jneuroim.2015.11.005
   Lynch RM, 2019, J INFECT DIS, V219, P26, DOI 10.1093/infdis/jiy466
   Mathew T, 2017, J NEUROL SCI, V381, P652, DOI 10.1016/j.jns.2017.08.1834
   Mausberg AK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026280
   McGonigal R, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0291-x
   McGrogan A, 2009, NEUROEPIDEMIOLOGY, V32, P150, DOI 10.1159/000184748
   MCKHANN GM, 1993, ANN NEUROL, V33, P333, DOI 10.1002/ana.410330402
   Misawa S, 2018, LANCET NEUROL, V17, P519, DOI 10.1016/S1474-4422(18)30114-5
   Miyagi T, 2017, INTERNAL MED, V56, P1225, DOI 10.2169/internalmedicine.56.7807
   Mori M, 2000, BRAIN, V123, P2171, DOI 10.1093/brain/123.10.2171
   Motamed-Gorji N, 2017, CURR NEUROPHARMACOL, V15, P938, DOI 10.2174/1570159X14666161213114904
   Nelson KE, 2012, AM J EPIDEMIOL, V175, P1129, DOI 10.1093/aje/kws194
   Niu JW, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00399
   Notturno F, 2016, J NEUROL SCI, V365, P132, DOI 10.1016/j.jns.2016.02.053
   Odaka M, 2000, J NEUROL SCI, V175, P96, DOI 10.1016/S0022-510X(00)00287-2
   Ogawara K, 2000, ANN NEUROL, V48, P624, DOI 10.1002/1531-8249(200010)48:4<624::AID-ANA9>3.3.CO;2-F
   Ojha RP, 2014, HUM VACC IMMUNOTHER, V10, P232, DOI 10.4161/hv.26292
   Ostronoff F, 2008, BONE MARROW TRANSPL, V42, P71, DOI 10.1038/bmt.2008.81
   Park SJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37572-w
   Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Peng J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21025-5
   Peric S, 2014, J PERIPHER NERV SYST, V19, P317, DOI 10.1111/jns.12096
   Phongsisay V, 2008, J NEUROIMMUNOL, V205, P101, DOI 10.1016/j.jneuroim.2008.09.016
   Pritchard J, 2003, NEUROLOGY, V61, P1282, DOI 10.1212/01.WNL.0000092019.53628.88
   Pukin AV, 2011, GLYCOBIOLOGY, V21, P1642, DOI 10.1093/glycob/cwr093
   Rajabally YA, 2015, J NEUROL NEUROSUR PS, V86, P115, DOI 10.1136/jnnp-2014-307815
   Romio S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082222
   Saad K, 2016, THER ADV NEUROL DISO, V9, P3, DOI 10.1177/1756285615610471
   Saeed ML, 2019, CUREUS, V11, DOI 10.7759/cureus.4625
   Sakai H, 2012, J NEUROL NEUROSUR PS, V83, P467, DOI 10.1136/jnnp-2011-301102
   Salmon DA, 2013, LANCET, V381, P1461, DOI 10.1016/S0140-6736(12)62189-8
   Sanchez-San Martin C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32400-7
   Fadrique RS, 2019, REV ESP QUIM, V32, P288
   Sejvar JJ, 2011, NEUROEPIDEMIOLOGY, V36, P123, DOI 10.1159/000324710
   Sejvar JJ, 2011, VACCINE, V29, P599, DOI 10.1016/j.vaccine.2010.06.003
   Sekiguchi Y, 2016, EUR J NEUROL, V23, P1058, DOI 10.1111/ene.12983
   Sekiguchi Y, 2012, J NEUROL NEUROSUR PS, V83, P23, DOI 10.1136/jnnp-2011-300309
   Shahrizaila N, 2013, J NEUROL NEUROSUR PS, V84, P576, DOI 10.1136/jnnp-2012-302824
   Shi M, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00225
   Sivadon-Tardy V, 2014, EPIDEMIOL INFECT, V142, P1609, DOI 10.1017/S095026881300263X
   SLIMAN NA, 1978, BMJ-BRIT MED J, V1, P751, DOI 10.1136/bmj.1.6115.751
   Soltani ZE, 2019, EUR CYTOKINE NETW, V30, P1, DOI 10.1684/ecn.2019.0424
   Spatola M, 2016, NEUROLOGY, V86, P1780, DOI 10.1212/WNL.0000000000002558
   Staff Nathan P, 2014, Continuum (Minneap Minn), V20, P1293, DOI 10.1212/01.CON.0000455880.06675.5a
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Susuki K, 2012, EXP NEUROL, V233, P534, DOI 10.1016/j.expneurol.2011.11.039
   Svacina MKR, 2019, J NEUROIMMUNE PHARM, V14, P642, DOI 10.1007/s11481-019-09871-0
   Tang HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08338-7
   Telleman JA, 2018, MUSCLE NERVE, V57, P716, DOI 10.1002/mus.26029
   Tian J, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00714
   Tomikawa E, 2019, TOXICOL PATHOL, V47, P542, DOI 10.1177/0192623319838993
   Uncini A, 2010, J NEUROL NEUROSUR PS, V81, P1157, DOI 10.1136/jnnp.2010.208538
   Usuki S, 2010, J NEUROSCI RES, V88, P1651, DOI 10.1002/jnr.22330
   van den Berg B, 2014, NAT REV NEUROL, V10, P469, DOI 10.1038/nrneurol.2014.121
   Van der Meche FGA, 2001, EUR NEUROL, V45, P133, DOI 10.1159/000052111
   van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1
   van Doorn PA, 2010, J CLIN IMMUNOL, V30, pS74, DOI 10.1007/s10875-010-9407-4
   Vellozzi C, 2014, CLIN INFECT DIS, V58, P1149, DOI 10.1093/cid/ciu005
   Verboon C, 2020, J NEUROL NEUROSUR PS, V91, P113, DOI 10.1136/jnnp-2019-321496
   Verboon C, 2019, NEUROLOGY, V93, pE59, DOI 10.1212/WNL.0000000000007719
   Wakerley BR, 2014, NAT REV NEUROL, V10, P537, DOI 10.1038/nrneurol.2014.138
   Wakerley BR, 2014, J NEUROL NEUROSUR PS, V85, P339, DOI 10.1136/jnnp-2013-305397
   Wakisaka H, 2002, EXP NEUROL, V178, P68, DOI 10.1006/exnr.2002.8035
   Wang Y, 2017, ONCOTARGET, V8, P79991, DOI 10.18632/oncotarget.20620
   Wang YZ, 2017, EXP NEUROL, V291, P134, DOI 10.1016/j.expneurol.2017.02.010
   Wu XJ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001898
   Wu XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104074
   Ye YQ, 2013, MUSCLE NERVE, V47, P68, DOI 10.1002/mus.23477
   Ye YQ, 2010, MUSCLE NERVE, V42, P311, DOI 10.1002/mus.21701
   Yuki N, 2004, P NATL ACAD SCI USA, V101, P11404, DOI 10.1073/pnas.0402391101
   YUKI N, 1994, INFECT IMMUN, V62, P2101, DOI 10.1128/IAI.62.5.2101-2103.1994
   Yuki N, 2001, ANN NEUROL, V49, P712, DOI 10.1002/ana.1012
   YUKI N, 1993, J EXP MED, V178, P1771, DOI 10.1084/jem.178.5.1771
   Yuki N, 2012, P JPN ACAD B-PHYS, V88, P299, DOI 10.2183/pjab.88.299
   Yuki N, 2012, NEW ENGL J MED, V366, P2294, DOI 10.1056/NEJMra1114525
   Zeng YP, 2019, EUR NEUROL, V81, P231, DOI 10.1159/000503101
   Zhang DQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21890
   Zhang MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131730
NR 161
TC 1
Z9 1
U1 3
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-5354
EI 1432-1459
J9 J NEUROL
JI J. Neurol.
DI 10.1007/s00415-020-09742-2
EA MAR 2020
PG 18
WC Clinical Neurology
SC Neurosciences & Neurology
GA KS4TT
UT WOS:000518303800006
PM 32140865
DA 2020-07-08
ER

PT J
AU Ahmad, N
   Rehman, AU
   Badshah, SL
   Ullah, A
   Mohammad, A
   Khan, K
AF Ahmad, Nasir
   Rehman, Ashfaq Ur
   Badshah, Syed Lal
   Ullah, Asad
   Mohammad, Akhtar
   Khan, Khalid
TI Molecular dynamics simulation of zika virus NS5 RNA dependent RNA
   polymerase with selected novel non-nucleoside inhibitors
SO JOURNAL OF MOLECULAR STRUCTURE
LA English
DT Article
DE Zika virus; Non-structural RNA polymerase; Microcephaly; Docking score;
   Simulation
ID CRYSTAL-STRUCTURE; DISCOVERY; INFECTION; MECHANISM; PROTEIN; DOMAIN;
   RULE; M2
AB In the arbovirus family of flaviviruses, the important non-structural enzyme that is RNA-dependent RNA-polymerase (NS5 RdRp) is vital for replication. The normal mammalian host lack this enzyme, thus targeting this enzyme for drug discovery against Flaviviridae related infection makes it a suitable target. In this work, effective non-nucleoside blockers of the dengue NS5 (RdRp) were used to target the zika virus. Molecular interactions between selected compounds and the non-structural enzyme 5 RNA-dependent RNA-polymerase were obtained from molecular docking. The selected compounds exhibited high docking score, binding affinity and suitable protein-ligand interactions. Molecular dynamics simulations were subsequently used to get better idea of the interaction between the selected compounds and the binding pocket of the targeted non-structural-5 RNA dependent RNA polymerase of zika virus. Our study highlights the significance of in silico methods that provided a better approach in finding novel drugs for the containment of this viral disease. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Ahmad, Nasir; Badshah, Syed Lal; Ullah, Asad; Mohammad, Akhtar; Khan, Khalid] Islamia Coll Univ Peshawar, Dept Chem, Peshawar 25120, Pakistan.
   [Rehman, Ashfaq Ur] Shanghai Jiao Tong Univ, Natl Expt Teaching Ctr Life Sci & Biotechnol, Coll Life Sci & Biotechnol, State Key Lab Microbial Metab,Dept Bioinformat &, Shanghai 200240, Peoples R China.
RP Badshah, SL; Khan, K (corresponding author), Islamia Coll Univ Peshawar, Dept Chem, Peshawar 25120, Pakistan.
EM shahbiochemist@gmail.com; drkhalidchem@yahoo.com
RI Rehman, Ashfaq Ur/AAN-9806-2020; BADSHAH, SYED LAL/H-3197-2017
OI Ullah, ASAD/0000-0002-0142-8565; BADSHAH, SYED LAL/0000-0002-0229-1425
CR Ahmad SF, 2018, COMPUT BIOL CHEM, V74, P347, DOI 10.1016/j.compbiolchem.2018.04.010
   Badshah S. L., 2018, CURR TOP ZIKA, DOI [10.5772/intechopen.72507, DOI 10.5772/INTECHOPEN.72507]
   Badshah SL, 2019, BMC CHEM, V13, DOI 10.1186/s13065-019-0582-y
   Benet LZ, 2016, ADV DRUG DELIVER REV, V101, P89, DOI 10.1016/j.addr.2016.05.007
   Case D.A., 2017, AMBER 2017
   de Souza AS, 2016, CLIN INFECT DIS, V63, P1622, DOI 10.1093/cid/ciw613
   DeLano W.L., 2002, PYMOL MOL GRAPH SYST, DOI [10.1038/hr.2014.17, DOI 10.1038/HR.2014.17]
   Duan WQ, 2017, EMBO J, V36, P919, DOI 10.15252/embj.201696241
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Godoy AS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14764
   Homer RW, 2008, J CHEM INF MODEL, V48, P2294, DOI 10.1021/ci7004687
   Kaushik AC, 2018, ACS OMEGA, V3, P18214, DOI 10.1021/acsomega.8b01941
   Khan MT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44013-9
   Kumar YN, 2012, BIOINFORMATION, V8, P543, DOI 10.6026/97320630008543
   Li Q, 2018, RSC ADV, V8, P13067, DOI 10.1039/c8ra01545g
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P894, DOI 10.1016/S1473-3099(16)30153-0
   Maxian O, 2017, EPIDEMICS-NETH, V21, P48, DOI 10.1016/j.epidem.2017.06.003
   Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h
   Murakami KS, 2014, NUCLEIC ACIDS MOL BI, V30, P1, DOI 10.1007/978-3-642-39796-7
   Rehman AU, 2019, J CHEM INF MODEL, V59, P3229, DOI 10.1021/acs.jcim.9b00353
   Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p
   Seifert E, 2014, J CHEM INF MODEL, V54, P1552, DOI 10.1021/ci500161d
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Simeone RM, 2016, MMWR-MORBID MORTAL W, V65, P514, DOI 10.15585/mmwr.mm6520e1
   Surana P, 2014, NUCLEIC ACIDS RES, V42, P2758, DOI 10.1093/nar/gkt1106
   Vincetti P, 2015, J MED CHEM, V58, P4964, DOI 10.1021/acs.jmedchem.5b00108
   Walters WP, 2012, EXPERT OPIN DRUG DIS, V7, P99, DOI 10.1517/17460441.2012.648612
   Wang CH, 2018, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00087
   Yang JX, 2016, J CHEM INF MODEL, V56, P1184, DOI 10.1021/acs.jcim.6b00115
   Yap TL, 2007, J VIROL, V81, P4753, DOI 10.1128/JVI.02283-06
   Yokokawa F, 2016, J MED CHEM, V59, P3935, DOI 10.1021/acs.jmedchem.6b00143
   Zou J, 2019, CURR OPIN VIROL, V35, P19, DOI 10.1016/j.coviro.2019.01.005
NR 36
TC 2
Z9 2
U1 22
U2 22
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-2860
EI 1872-8014
J9 J MOL STRUCT
JI J. Mol. Struct.
PD MAR 5
PY 2020
VL 1203
AR 127428
DI 10.1016/j.molstruc.2019.127428
PG 9
WC Chemistry, Physical
SC Chemistry
GA JY5IN
UT WOS:000504448700056
DA 2020-07-08
ER

PT J
AU Yufika, A
   Wagner, AL
   Nawawi, Y
   Wahyuniati, N
   Anwar, S
   Yusri, F
   Haryanti, N
   Wijayanti, NP
   Rizal, R
   Fitriani, D
   Maulida, NF
   Syahriza, M
   Ikram, I
   Fandoko, TP
   Syahadah, M
   Asrizal, FW
   Aletta, A
   Haryanto, S
   Jamil, KF
   Mudatsir, M
   Harapan, H
AF Yufika, Amanda
   Wagner, Abram Luther
   Nawawi, Yusuf
   Wahyuniati, Nur
   Anwar, Samsul
   Yusri, Fitria
   Haryanti, Novi
   Wijayanti, Nanda Putri
   Rizal, Rizal
   Fitriani, Devi
   Maulida, Nurul Fadhliati
   Syahriza, Muhammad
   Ikram, Ikram
   Fandoko, Try Purwo
   Syahadah, Muniati
   Asrizal, Febrivan Wahyu
   Aletta, Alma
   Haryanto, Sotianingsih
   Jamil, Kurnia Fitri
   Mudatsir, Mudatsir
   Harapan, Harapan
TI Parents' hesitancy towards vaccination in Indonesia: A cross-sectional
   study in Indonesia
SO VACCINE
LA English
DT Article
DE Vaccine hesitancy; Vaccine coverage; Vaccine acceptance; Parents'
   hesitancy; Indonesia
ID ACCEPTANCE; CHILDREN; IMMUNIZATION; COUNTRIES; ATTITUDES; REFUSAL
AB Background: Hesitancy towards vaccination has been studied as a barrier to vaccination among children, as well as participation in vaccine trials. This study aimed to investigate hesitancy towards vaccination among parents in Indonesia, as a part of the Indonesia Zika Vaccine Study.
   Methods: A cross-sectional study was conducted in eleven regencies and municipalities in Aceh and West Sumatra province, Indonesia. Parents were recruited from families at outpatient clinics of community health centers or hospitals. The survey included various questions about sociodemographic factors and the Parent Attitudes about Childhood Vaccination (PACV) scale. Linear regression was employed to assess the association between explanatory variables and vaccine hesitancy.
   Results: A total of 956 parents were interviewed and 26.4% of participants had heard about Zika. Overall, 152 parents (15.9%) were vaccine hesitant, and this proportion was the highest in the safety and efficacy subdomain (61.6%). In the unadjusted analysis, having a diploma certificate, working in the health sector, and having heard about Zika were significantly associated with non-hesitancy towards children vaccination. Having heard about Zika was the only factor that was significantly associated with hesitancy towards vaccination in multivariate model (aOR: 0.43, 95% CI: 0.26-0.71). Mothers, younger parents (aged 20-29 years old), and those with only a primary school education were more concerned about vaccine safety and efficacy compared to fathers, older groups, and individuals with more education, respectively.
   Conclusions: Hesitancy towards pediatric vaccination is observed in 15% of respondents and most of the hesitancy was expressed in terms of vaccine safety and efficacy. Therefore, continuous dissemination of vaccine information needs to be carried out to earn parents' trust and increase vaccination coverage in Indonesia. (C) 2020 Elsevier Ltd. All rights reserved.
C1 [Yufika, Amanda; Wahyuniati, Nur; Ikram, Ikram; Jamil, Kurnia Fitri; Mudatsir, Mudatsir; Harapan, Harapan] Univ Syiah Kuala, Sch Med, Med Res Unit, Banda Aceh, Aceh, Indonesia.
   [Yufika, Amanda; Nawawi, Yusuf; Aletta, Alma] Univ Syiah Kuala, Sch Med, Dept Family Med, Banda Aceh, Aceh, Indonesia.
   [Wagner, Abram Luther] Univ Michigan, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Anwar, Samsul] Univ Syiah Kuala, Fac Math & Nat Sci, Dept Stat, Banda Aceh, Aceh, Indonesia.
   [Yusri, Fitria] Malikussaleh Univ, Sch Med, Lhokseumawe, Aceh, Indonesia.
   [Haryanti, Novi] Commun Hlth Ctr Meurah Mulia, North Aceh, Aceh, Indonesia.
   [Wijayanti, Nanda Putri] Community Hlth Ctr Tapaktuan, South Aceh, Aceh, Indonesia.
   [Rizal, Rizal] Bunda Hosp, Lhokseumawe, Aceh, Indonesia.
   [Fitriani, Devi] Community Hlth Ctr Teunom, Aceh Jaya, Aceh, Indonesia.
   [Maulida, Nurul Fadhliati] Meuraxa Hosp, Banda Aceh, Aceh, Indonesia.
   [Syahriza, Muhammad] Univ Syiah Kuala, Sch Med, Dept Publ Hlth & Community Med, Banda Aceh, Aceh, Indonesia.
   [Fandoko, Try Purwo] Community Hlth Ctr Gunung, Padang Panjang, West Sumatra, Indonesia.
   [Syahadah, Muniati] Community Hlth Ctr Lima Kaum, Tanah Datar, West Sumatra, Indonesia.
   [Asrizal, Febrivan Wahyu] Community Hlth Ctr Tanjung, Solok, West Sumatra, Indonesia.
   [Haryanto, Sotianingsih] Jambi Univ, Dept Clin Pathol, Fac Med & Hlth Sci, Jambi, Indonesia.
   [Jamil, Kurnia Fitri] Univ Syiah Kuala, Dept Internal Med, Sch Med, Banda Aceh, Aceh, Indonesia.
   [Mudatsir, Mudatsir; Harapan, Harapan] Univ Syiah Kuala, Sch Med, Trop Dis Ctr, Banda Aceh, Aceh, Indonesia.
   [Mudatsir, Mudatsir; Harapan, Harapan] Univ Syiah Kuala, Sch Med, Dept Microbiol, Banda Aceh, Aceh, Indonesia.
RP Harapan, H (corresponding author), Univ Syiah Kuala, Sch Med, Med Res Unit, Darussalam 23111, Banda Aceh, Indonesia.
EM harapan@unsyiah.ac.id
RI Wagner, Abram/X-6379-2019; Mudatsir, Mudatsir/Q-4999-2017
OI Wagner, Abram/0000-0003-4691-7802; /0000-0001-8726-0793; Mudatsir,
   Mudatsir/0000-0002-5643-9384; Yufika, Amanda/0000-0001-8408-9396
CR Azizi FSM, 2017, VACCINE, V35, P2955, DOI 10.1016/j.vaccine.2017.04.010
   Barbacariu CL, 2014, PROCD SOC BEHV, V149, P84, DOI 10.1016/j.sbspro.2014.08.165
   Berkley S, 2019, NATURE, V569, P309, DOI 10.1038/d41586-019-01493-z
   Bogoch II, 2016, LANCET INFECT DIS, V16, P1237, DOI 10.1016/S1473-3099(16)30270-5
   Bonett DG, 2000, PSYCHOMETRIKA, V65, P23, DOI 10.1007/BF02294183
   Corben P, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5389-6
   Dube E, 2015, EXPERT REV VACC, V14
   Dube E, 2014, VACCINE, V32, P6649, DOI 10.1016/j.vaccine.2014.09.039
   Esposito S, 2014, CLIN MICROBIOL INFEC, V20, P25, DOI 10.1111/1469-0691.12447
   Harapan H., 2017, Asian Pacific Journal of Tropical Disease, V7, P193, DOI 10.12980/apjtd.7.2017D6-386
   Harapan H, 2018, VIRUSES, V10, P14
   Harapan H, 2019, VACCINE, V37, P1398, DOI 10.1016/j.vaccine.2019.01.062
   Harapan H, 2016, VACCINE, V34, P3670, DOI 10.1016/j.vaccine.2016.05.026
   Hellyer JMH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029478
   Kemenkes RI, 2014, IMM TEACH BOOK BUK A
   Kesehatan B, BPJS KESEHATAN PRACT
   Larson HJ, 2019, HUM VACC IMMUNOTHER, DOI 10.1080/21645515.2019.1628510
   MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036
   Marti M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172310
   McKee Chephra, 2016, J Pediatr Pharmacol Ther, V21, P104, DOI 10.5863/1551-6776-21.2.104
   Munoz DC, 2015, INT J PUBLIC HEALTH, V60, P767, DOI 10.1007/s00038-015-0715-6
   Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477
   Opel DJ, 2013, JAMA PEDIATR, V167, P1065, DOI 10.1001/jamapediatrics.2013.2483
   Opel DJ, 2011, VACCINE, V29, P6598, DOI 10.1016/j.vaccine.2011.06.115
   Opel DJ, 2011, HUM VACCINES, V7, P419, DOI 10.4161/hv.7.4.14120
   Rainey JJ, 2011, VACCINE, V29, P8215, DOI 10.1016/j.vaccine.2011.08.096
   Rajamoorthy Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208402
   Ren J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0209117
   Ri K., 2018, HASIL UTAMA RISKESDA
   Seale H, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-99
   Smith LE, 2017, VACCINE, V35, P6059, DOI 10.1016/j.vaccine.2017.09.046
   Strelitz B, 2015, VACCINE, V33, P1802, DOI 10.1016/j.vaccine.2015.02.034
   Sun XD, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5734-9
   Wagner AL, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040155
   Wagner AL, 2017, VACCINE, V35, P4362, DOI 10.1016/j.vaccine.2017.06.077
   WHO, 2018, S E AS REG VACC ACT
   WHO, 2005, GLOB STAT IMM SAF RE
   WHO, 2018, WHO IMM COV FACT SHE
   World Health Organization, 10 THREATS GLOB HLTH
   Yaqub O, 2014, SOC SCI MED, V112, P1, DOI 10.1016/j.socscimed.2014.04.018
NR 40
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0264-410X
EI 1873-2518
J9 VACCINE
JI Vaccine
PD MAR 4
PY 2020
VL 38
IS 11
BP 2592
EP 2599
DI 10.1016/j.vaccine.2020.01.072
PG 8
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KX1PD
UT WOS:000521654200021
PM 32019704
DA 2020-07-08
ER

PT J
AU Kazmi, SS
   Ali, W
   Bibi, N
   Nouroz, F
AF Kazmi, Syeda Sidra
   Ali, Waqar
   Bibi, Nousheen
   Nouroz, Faisal
TI A review on Zika virus outbreak, epidemiology, transmission and
   infection dynamics
SO JOURNAL OF BIOLOGICAL RESEARCH-THESSALONIKI
LA English
DT Review
DE Zika virus; Aedes mosquito; Epidemiology; Guillain-Barre syndrome;
   Microcephaly; Treatment
ID PUBLIC-HEALTH; EMERGENCE; CHIKUNGUNYA; MOSQUITOS; BIOLOGY; FEVER
AB Zika virus (ZIKV) is a newly emergent relative of the Flaviviridae family and linked to dengue (DENV) and Chikungunya (CHIVKV). ZIKV is one of the rising pathogens promptly surpassing geographical borders. ZIKV infection was characterized by mild disease with fever, headache, rash, arthralgia and conjunctivitis, with exceptional reports of an association with Guillain-Barre syndrome (GBS) and microcephaly. However, since the end of 2015, an increase in the number of GBS associated cases and an astonishing number of microcephaly in fetus and new-borns in Brazil have been related to ZIKV infection, raising serious worldwide public health concerns. ZIKV is transmitted by the bite of infected female mosquitoes of Aedes species. Clarifying such worrisome relationships is, thus, a current unavoidable goal. Here, we extensively described the current understanding of the effects of ZIKV on heath, clinical manifestation, diagnosis and treatment options based on modern, alternative and complementary medicines regarding the disease.
C1 [Kazmi, Syeda Sidra; Ali, Waqar; Bibi, Nousheen; Nouroz, Faisal] Hazara Univ Mansehra, Dept Bioinformat, Mansehra, Pakistan.
   [Nouroz, Faisal] Hazara Univ Mansehra, Dept Bot, Mansehra, Pakistan.
RP Ali, W (corresponding author), Hazara Univ Mansehra, Dept Bioinformat, Mansehra, Pakistan.
EM waqarali@bs.qau.edu.pk
OI Ali, Waqar/0000-0002-9335-1082
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   [Anonymous], 2015, RAP RISK ASS ZIK VIR
   Australian government department of health, ZIKV INF CLIN PUBL H
   Bandyopadhyay B, 2010, AM J INFECT DIS, V6, P24, DOI 10.3844/ajidsp.2010.24.28
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bousta D, 2001, J ETHNOPHARMACOL, V74, P205, DOI 10.1016/S0378-8741(00)00346-9
   Burd I, 2016, J ASSIST REPROD GEN, V33, P439, DOI 10.1007/s10815-016-0687-3
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Christofferson RC, 2016, AM J TROP MED HYG, V95, P15, DOI 10.4269/ajtmh.15-0866
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ekins Sean, 2016, F1000Res, V5, P150, DOI 10.12688/f1000research.8013.1
   European Centre for Disease Prevention and Control, 2015, RAP RISK ASS ZIKV IN
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Fontes BM, 2016, ARQ BRAS OFTALMOL, V79, P63, DOI 10.5935/0004-2749.20160020
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Horwood P, 2013, WEST PAC SURVEILL RE, V4, DOI [10.5365/wpsar.2013.4.2.003, 10.5365/WPSAR.2013.4.2.003]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Jackman JA, 2018, NAT MATER, V17, P971, DOI 10.1038/s41563-018-0194-2
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   KIRYA BG, 1977, T ROY SOC TROP MED H, V71, P300, DOI 10.1016/0035-9203(77)90104-3
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   LaBeaud AD., 2016, ZIKV INFECT OVERVIEW
   Lan Phan Trong, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.1c8f631e0ef8cd7777d639eba48647fa
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610
   Malkki H, 2016, NAT REV NEUROL, V12, DOI [10.1038/nrneurol.2016.30, 10.1038/nrneurol.2016.139, 10.1038/nrneurol.2016.151, 10.1038/nrneurol.2016.175, 10.1038/nrneurol.2016.22, 10.1038/nrneurol.2016.117, 10.1038/nrneurol.2016.78, 10.1038/nrneurol.2016.79, 10.1038/nrneurol.2016.58, 10.1038/nrneurol.2016.52]
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Mittal J., 2014, J MED PLANTS STUD, V2, P32
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Musso D, 2015, CLIN MICROBIOL, V4, P1000222
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   National Center for Health Statistics key messages-ZIKV disease Centre of disease control, KEY MESS ZIKV DIS
   OLSON JG, 1981, T ROY SOC TROP MED H, V75, P389, DOI 10.1016/0035-9203(81)90100-0
   Organization Pan American Health, 2015, EP AL NEUR SYNDR CON
   Pan American Health Organization, 2015, ZIK VIR ZIKV SURV AM
   Pan American Health Organization (PAHO), 2016, EP UPD NEUR SYNDR CO
   Patwardhan B, 2004, CURR SCI INDIA, V86, P789
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pithadia AB, 2010, PHARMACOL REP, V62, P220, DOI 10.1016/S1734-1140(10)70261-9
   ProMED-mail, 2015, ZIK VIR AM ATL OC
   Purdue University, SCI DAILY
   Quanquin N, 2017, CURR OPIN PEDIATR, V29, P114, DOI 10.1097/MOP.0000000000000441
   Rajput H., 2013, NAT PROD CHEM RES, V1, P104
   Rita P., 2011, INT RES J PHARM, V2, P11
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   ROWSON JM, 1950, J PHARM PHARMACOL, V2, P201, DOI 10.1111/j.2042-7158.1950.tb12925.x
   Sassetti M, 2018, T ROY SOC TROP MED H, V112, P458, DOI 10.1093/trstmh/try074
   Saxena Shailendra K., 2016, VirusDisease, V27, P111, DOI 10.1007/s13337-016-0307-y
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Ulbricht Catherine, 2004, Journal of Herbal Pharmacotherapy, V4, P61, DOI 10.1080/J157v04n04_06
   Ullman D, 2003, J ALTERN COMPLEM MED, V9, P133, DOI 10.1089/107555303321223008
   WHO, 2016, ZIK VIR FACT SHEET
   Wong SSY, 2016, J FORMOS MED ASSOC, V115, P226, DOI 10.1016/j.jfma.2016.02.002
   Wongsurawat T, 2018, EMERG INFECT DIS, V24, P1758, DOI 10.3201/eid2409.180416
   World Health Organization, 2019, COUNTR TERR CURR PRE
   World Health Organization Regional Office for Africa, 2017, WEEKL B OUTBR OTH EM, V48
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 79
TC 0
Z9 0
U1 10
U2 10
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1790-045X
EI 2241-5793
J9 J BIOL RES-THESSALON
JI J. Biol. Res.
PD MAR 4
PY 2020
VL 27
IS 1
AR 5
DI 10.1186/s40709-020-00115-4
PG 11
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA KU7IT
UT WOS:000519887500001
PM 32158705
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rombi, F
   Bayliss, R
   Tuplin, A
   Yeoh, S
AF Rombi, Francesca
   Bayliss, Richard
   Tuplin, Andrew
   Yeoh, Sharon
TI The journey of Zika to the developing brain
SO MOLECULAR BIOLOGY REPORTS
LA English
DT Review
DE Zika virus; Microcephaly; Brain development
ID WEST-NILE-VIRUS; CONGENITAL CYTOMEGALOVIRUS-INFECTION; DENGUE VIRUS;
   HEPARAN-SULFATE; NEURAL PROGENITORS; CENTROSOMAL PROTEIN;
   CELL-PROLIFERATION; MAJOR DETERMINANT; MAMMALIAN TARGET; PREGNANT-WOMEN
AB Zika virus is a mosquito-borne Flavivirus originally isolated from humans in 1952. Following its re-emergence in Brazil in 2015, an increase in the number of babies born with microcephaly to infected mothers was observed. Microcephaly is a neurodevelopmental disorder, characterised phenotypically by a smaller than average head size, and is usually developed in utero. The 2015 outbreak in the Americas led to the World Health Organisation declaring Zika a Public Health Emergency of International Concern. Since then, much research into the effects of Zika has been carried out. Studies have investigated the structure of the virus, its effects on and evasion of the immune response, cellular entry including target receptors, its transmission from infected mother to foetus and its cellular targets. This review discusses current knowledge and novel research into these areas, in hope of developing a further understanding of how exposure of pregnant women to the Zika virus can lead to impaired brain development of their foetus. Although no longer considered an epidemic in the Americas, the mechanism by which Zika acts is still not comprehensively and wholly understood, and this understanding will be crucial in developing effective vaccines and treatments.
C1 [Rombi, Francesca; Bayliss, Richard; Tuplin, Andrew; Yeoh, Sharon] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.
   [Rombi, Francesca; Bayliss, Richard; Tuplin, Andrew; Yeoh, Sharon] Univ Leeds, Astbury Ctr Struct & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
RP Yeoh, S (corresponding author), Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.; Yeoh, S (corresponding author), Univ Leeds, Astbury Ctr Struct & Mol Biol, Leeds LS2 9JT, W Yorkshire, England.
EM S.Yeoh@leeds.ac.uk
CR Adibi JJ, 2016, LANCET, V387, P1587, DOI 10.1016/S0140-6736(16)00650-4
   Aguirre S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002934
   AHLFORS K, 1986, PEDIATRICS, V78, P1058
   Ahmad I, 2017, CLIN GENET, V92, P62, DOI 10.1111/cge.12955
   Alakbarzade V, 2015, NAT GENET, V47, P814, DOI 10.1038/ng.3313
   Asif A, 2017, VIRAL IMMUNOL, V30, P682, DOI 10.1089/vim.2017.0046
   Avsic Zupanc Tatjana, 2016, Zdr Varst, V55, P228
   Awad S, 2013, HUM MOL GENET, V22, P2200, DOI 10.1093/hmg/ddt072
   Ayala-Nunez NV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12408-x
   Banatvala JE, 2004, LANCET, V363, P1127, DOI 10.1016/S0140-6736(04)15897-2
   Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019
   Basit S, 2016, HUM GENET, V135, P1199, DOI 10.1007/s00439-016-1724-0
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Beatty PR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3787
   BELL TM, 1971, ARCH GES VIRUSFORSCH, V35, P183, DOI 10.1007/BF01249709
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Blackburn D, 2009, GLIA, V57, P1251, DOI 10.1002/glia.20848
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Brault JB, 2016, EBIOMEDICINE, V10, P71, DOI 10.1016/j.ebiom.2016.07.018
   Briant L, 2014, VIROLOGY, V464, P26, DOI 10.1016/j.virol.2014.06.023
   Brown AN, 2007, VIROLOGY, V368, P422, DOI 10.1016/j.virol.2007.06.033
   Brown NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069986
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chavali PL, 2017, SCIENCE, V357, P83, DOI 10.1126/science.aam9243
   Chen JF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4885
   Chen YP, 1997, NAT MED, V3, P866, DOI 10.1038/nm0897-866
   Cox J, 2006, TRENDS MOL MED, V12, P358, DOI 10.1016/j.molmed.2006.06.006
   Coyaud E, 2018, MOL CELL PROTEOMICS, V17, P2242, DOI 10.1074/mcp.TIR118.000800
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Der SD, 1998, P NATL ACAD SCI USA, V95, P15623, DOI 10.1073/pnas.95.26.15623
   Devakumar D, 2018, LANCET INFECT DIS, V18, pE1, DOI [10.1016/S1473-3099(17)30398-5, 10.1016/s1473-3099(17)30398-5]
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Ding Q, 2013, J HEPATOL, V59, P52, DOI 10.1016/j.jhep.2013.03.019
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   ECDC, 2015, RAP RISK ASS ZIK VIR
   Erdtmann L, 2003, J BIOL CHEM, V278, P18256, DOI 10.1074/jbc.M209732200
   Evans PD, 2004, HUM MOL GENET, V13, P489, DOI 10.1093/hmg/ddh055
   Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103
   Foster KG, 2010, J BIOL CHEM, V285, P14071, DOI 10.1074/jbc.R109.094003
   FOWLER KB, 1992, NEW ENGL J MED, V326, P663, DOI 10.1056/NEJM199203053261003
   Franke TF, 2008, ONCOGENE, V27, P6473, DOI 10.1038/onc.2008.313
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Germi R, 2002, VIROLOGY, V292, P162, DOI 10.1006/viro.2001.1232
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Golubeva VA, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010153
   GONZALEZ C, 1990, J CELL SCI, V96, P605
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Guernsey DL, 2010, AM J HUM GENET, V87, P40, DOI 10.1016/j.ajhg.2010.06.003
   HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Haydar TF, 1999, CEREB CORTEX, V9, P621, DOI 10.1093/cercor/9.6.621
   HEINZ FX, 1994, ARCH VIROL, P339
   Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85
   Hilgard P, 2000, HEPATOLOGY, V32, P1069, DOI 10.1053/jhep.2000.18713
   Hussain MS, 2013, HUM MOL GENET, V22, P5199, DOI 10.1093/hmg/ddt374
   Hussain MS, 2012, AM J HUM GENET, V90, P871, DOI 10.1016/j.ajhg.2012.03.016
   Jackson AP, 2002, AM J HUM GENET, V71, P136, DOI 10.1086/341283
   Jackson AP, 1998, AM J HUM GENET, V63, P541, DOI 10.1086/301966
   Jamieson CR, 2000, AM J HUM GENET, V67, P1575, DOI 10.1086/316909
   Jamieson CR, 1999, AM J HUM GENET, V65, P1465, DOI 10.1086/302640
   Jordan TX, 2017, J VIROL, V91, DOI 10.1128/JVI.02020-16
   Kadir R, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005919
   Kawasaki H, 2015, AM J PATHOL, V185, P1304, DOI 10.1016/j.ajpath.2015.01.032
   Khan MA, 2014, HUM MOL GENET, V23, P5940, DOI 10.1093/hmg/ddu318
   Kouprina N, 2004, PLOS BIOL, V2, P653, DOI 10.1371/journal.pbio.0020126
   Kousar R, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-119
   Kozak RA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100297
   Kroschewski H, 2003, VIROLOGY, V308, P92, DOI 10.1016/S0042-6822(02)00097-1
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal GF, 2003, J MED GENET, V40, P540, DOI 10.1136/jmg.40.7.540
   Lee CJ, 2005, J VIROL, V79, P8388, DOI 10.1128/JVI.79.13.8388-8399.2005
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Leis AA, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00170
   Lemke G, 2008, NAT REV IMMUNOL, V8, P327, DOI 10.1038/nri2303
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Li HD, 2016, CELL STEM CELL, V19, P593, DOI 10.1016/j.stem.2016.08.005
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Lossia OV, 2018, J NEUROVIROL, V24, P52, DOI 10.1007/s13365-017-0589-x
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009
   Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Montgomery SH, 2012, EVOLUTION, V66, P927, DOI 10.1111/j.1558-5646.2011.01487.x
   Morris-Rosendahl DJ, 2015, MOL CELL PROBE, V29, P271, DOI 10.1016/j.mcp.2015.05.015
   Moynihan L, 2000, AM J HUM GENET, V66, P724, DOI 10.1086/302777
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Nicholas AK, 2010, NAT GENET, V42, P1010, DOI 10.1038/ng.682
   Nitta S, 2013, HEPATOLOGY, V57, P46, DOI 10.1002/hep.26017
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   O'Leary DR, 2006, PEDIATRICS, V117, pE537, DOI 10.1542/peds.2005-2024
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Okamoto K, 2012, J GEN VIROL, V93, P761, DOI 10.1099/vir.0.037853-0
   Pagni S, 2012, IMMUNOL RES, V54, P152, DOI 10.1007/s12026-012-8334-2
   Paisley JE, 2006, PEDIATRICS, V117, P814, DOI 10.1542/peds.2005-1187
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541
   Reyes L, 2017, RESULTS PROBL CELL D, V62, P45, DOI 10.1007/978-3-319-54090-0_3
   Richard AS, 2017, P NATL ACAD SCI USA, V114, P2024, DOI 10.1073/pnas.1620558114
   Roberts E, 2002, J MED GENET, V39, P718, DOI 10.1136/jmg.39.10.718
   Rothlin CV, 2007, CELL, V131, P1124, DOI 10.1016/j.cell.2007.10.034
   Samuel MA, 2005, J VIROL, V79, P13350, DOI 10.1128/JVI.79.21.13350-13361.2005
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scaturro P, 2018, NATURE, V561, P253, DOI 10.1038/s41586-018-0484-5
   Shah PS, 2018, CELL, V175, P1931, DOI 10.1016/j.cell.2018.11.028
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Shives KD, 2014, J VIROL, V88, P9458, DOI 10.1128/JVI.01323-14
   SINHA SK, 1972, J MENT DEFIC RES, V16, P90
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Smith DW, 2016, LANCET, V387, P1486, DOI 10.1016/S0140-6736(16)00564-X
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Swartwout BK, 2017, PATHOGENS, V6, DOI 10.3390/pathogens6040049
   Szabo N, 2010, ACTA PAEDIATR, V99, P690, DOI 10.1111/j.1651-2227.2009.01666.x
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Teng Y, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00327
   Thornton GK, 2009, TRENDS GENET, V25, P501, DOI 10.1016/j.tig.2009.09.011
   van den Pol AN, 2007, J VIROL, V81, P332, DOI 10.1128/JVI.01592-06
   Von der Hagen M, 2014, DEV MED CHILD NEUROL, V56, P732, DOI 10.1111/dmcn.12425
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   Wen ZX, 2017, GENE DEV, V31, P849, DOI 10.1101/gad.298216.117
   WHO, 2016, SCREEN ASS MAN NEON
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yang XJ, 2006, VIRUS RES, V121, P134, DOI 10.1016/j.virusres.2006.02.004
   Yang YWJ, 2012, CELL, V151, P1097, DOI 10.1016/j.cell.2012.10.043
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Yoon KJ, 2017, CELL STEM CELL, V21, P349, DOI 10.1016/j.stem.2017.07.014
   Yu CY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002780
   Yu JSL, 2016, DEVELOPMENT, V143, P3050, DOI 10.1242/dev.137075
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang LJ, 2010, PROG MOL BIOL TRANSL, V93, P1, DOI 10.1016/S1877-1173(10)93001-9
   Zhong XY, 2005, CELL CYCLE, V4, P1227, DOI 10.4161/cc.4.9.2029
NR 156
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0301-4851
EI 1573-4978
J9 MOL BIOL REP
JI Mol. Biol. Rep.
PD APR
PY 2020
VL 47
IS 4
BP 3097
EP 3115
DI 10.1007/s11033-020-05349-y
EA MAR 2020
PG 19
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA LE1CZ
UT WOS:000518069700003
PM 32128708
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Rivera-Amarillo, C
   Camargo, A
AF Rivera-Amarillo, Claudia
   Camargo, Alejandro
TI Zika assemblages: women, populationism, and the geographies of
   epidemiological surveillance
SO GENDER PLACE AND CULTURE
LA English
DT Article
DE Assemblage; climate change; feminist geography; populationism; women;
   Zika
ID FEMINIST; GENDER; VIRUS
AB In 2016, during the Zika epidemic, scientists discovered another disturbing effect of the virus: pregnant women with the Zika virus faced the risk of having babies with microcephaly. Governments and international organizations responded by encouraging women to delay pregnancy and also by surveying their domestic spaces and water management practices. Feminist scholars and activists criticized these measures as ignoring barriers to quality reproductive health services and women's particular vulnerabilities to climate change, as the virus was soon associated with global warming. This article critically analyzes the unequal and differentiated position of women during the 2015-2016 Zika outbreak. Through the concept of the Zika assemblage, we discuss how populationist interventions upon women's bodies also involved particular representations of these bodies within different spaces and scales, from the household to the local and the global. We consider the geographical imaginaries and realities that shaped the identities and bodies of those women, as well as their connections with geopolitical notions of security and emergency. In this way, we expose how impoverished women from the Global South ended up bearing the responsibility to maintain an international epidemiological order. The article concludes with a reflection on the dissonance between populationist interventions and the root causes of climate change and environmental injustice.
C1 [Camargo, Alejandro] Univ Norte, Dept Hist & Social Sci, Barranquilla 081007, Colombia.
   [Camargo, Alejandro] Pontificia Univ Javeriana, Dept Anthropol, Bogota, Colombia.
RP Camargo, A (corresponding author), Univ Norte, Dept Hist & Social Sci, Barranquilla 081007, Colombia.
EM fcamargoa@uninorte.edu.co
RI Camargo, Alejandro/AAR-7724-2020
OI Camargo, Alejandro/0000-0002-5812-8416
CR Acevedo Tatiana, 2017, THESIS
   Amarillo Claudia Rivera, 2017, Sex., Salud Soc. (Rio J.), P199, DOI 10.1590/1984-6487.sess.2017.27.11.a
   Bhatia Rajani, GENDER PLACE CULTURE
   Bondi Liz, 2005, COMPANION FEMINIST G, P15
   Carvalho LP, 2017, CAD GENERO DIVERS, V3, P134
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Diniz D, 2016, DEV WORLD BIOETH, V16, P62, DOI 10.1111/dewb.12119
   Dixon DP, 2011, GENDER PLACE CULT, V18, P445, DOI 10.1080/0966369X.2011.583401
   England K, 2003, POLIT GEOGR, V22, P611, DOI 10.1016/S0962-6298(03)00065-9
   Fluri J, 2011, GENDER PLACE CULT, V18, P519, DOI 10.1080/0966369X.2011.583343
   Fluri J, 2012, ANTIPODE, V44, P31, DOI 10.1111/j.1467-8330.2010.00835.x
   Franklin Sarah, 2007, DOLLY MIXTURES
   Gonzalez Valdes Micaela, 2017, REV RED INTERCATEDRA, V6, P81
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Gutiérrez María-Teresa, 2010, Estud. Socio-Juríd, V12, P73
   Harman S, 2016, THIRD WORLD Q, V37, P524, DOI 10.1080/01436597.2015.1108827
   Hernandez Mario, 2002, OPS ESTADO COLOMBIAN, P1902
   Hoyos Rivera Antulio, 2010, Rev Cubana Salud Pública, V36, P149, DOI 10.1590/s0864-34662010000100015
   Hyndman J, 2004, POLIT GEOGR, V23, P307, DOI 10.1016/j.polgeo.2003.12.014
   Ingram A., 2005, GEOPOLITICS, V10, P522, DOI DOI 10.1080/14650040591003516
   Ingram A., 2008, FEAR CRITICAL GEOPOL, P75
   Kamradt-Scott A, 2016, LANCET, V387, P104, DOI 10.1016/S0140-6736(15)01128-9
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lakoff A, 2008, CULT ANTHROPOL, V23, P399, DOI 10.1111/j.1548-1360.2008.00013.x
   Marengo JA, 2015, CLIMATIC CHANGE, V129, P103, DOI 10.1007/s10584-014-1310-1
   Massaro VA, 2013, GEOGR COMPASS, V7, P567, DOI 10.1111/gec3.12054
   McClintock A., 1995, IMPERIAL LEATHER RAC
   Nail T, 2017, SUB-STANCE, V46, P21
   Nelson Lise, 2005, COMPANION FEMINIST G, P1
   Ojeda D, 2013, GEOPOLITICS, V18, P759, DOI 10.1080/14650045.2013.780037
   Ong A., 2005, GLOBAL ASSEMBLAGES T
   Paz S, 2016, LANCET, V387, P745, DOI 10.1016/S0140-6736(16)00256-7
   PORTO R., 2017, CAD GENERO DIVERS, V3, P158
   Raimondo M, 2005, GENDER PLACE CULT, V12, P53, DOI 10.1080/09663690500082950
   Richardson E, 2016, GLOB HEALTH-SCI PRAC, V4, P696, DOI 10.9745/GHSP-D-16-00282
   Rodriguez-Morales AJ, 2015, J INFECT DEV COUNTR, V9, P684, DOI 10.3855/jidc.7230
   Sharp J, 2007, PROG HUM GEOG, V31, P381, DOI 10.1177/0309132507077091
   Silva A, 2014, 2014 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE IN CONTROL AND AUTOMATION (CICA), P29
   Stepan Nancy, 1996, HOUR EUGENICS RACE G, DOI [10.1086/ahr/98.2.611, DOI 10.1086/AHR/98.2.611]
   Sultana F, 2018, WATER SECUR NEW WOR, P17, DOI 10.1007/978-3-319-64046-4_2
   Sultana Farhana, 2011, GENDERED GEOGRAPHIES, P293
   Tsing AL, 2015, MUSHROOM AT THE END OF THE WORLD: ON THE POSSIBILITY OF LIFE IN CAPITALIST RUINS, P1, DOI 10.1515/9781400873548
   Viveros-Vigoya Mara, 2006, MUJERES HOMBRES OTRA, P111
   Yang Y Tony, 2016, Prev Med Rep, V4, P444, DOI 10.1016/j.pmedr.2016.07.011
NR 44
TC 1
Z9 1
U1 3
U2 3
PU ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0966-369X
EI 1360-0524
J9 GENDER PLACE CULT
JI Gend. Place Cult.
PD MAR 3
PY 2020
VL 27
IS 3
BP 412
EP 428
DI 10.1080/0966369X.2018.1555518
PG 17
WC Geography; Women's Studies
SC Geography; Women's Studies
GA KQ7OK
UT WOS:000517109900007
DA 2020-07-08
ER

PT J
AU Kasthuri, M
   Li, CW
   Verma, K
   Russell, OO
   Dickson, L
   McCormick, L
   Bassit, L
   Amblard, F
   Schinazi, RF
AF Kasthuri, Mahesh
   Li, Chengwei
   Verma, Kiran
   Russell, Olivia Ollinger
   Dickson, Lyndsey
   McCormick, Louise
   Bassit, Leda
   Amblard, Franck
   Schinazi, Raymond F.
TI Synthesis of 4 '-Substituted-2 '-Deoxy-2 '-alpha-Fluoro Nucleoside
   Analogs as Potential Antiviral Agents
SO MOLECULES
LA English
DT Article
DE nucleoside; virus; polymerase inhibitors; respiratory syncytial virus;
   Zika; Dengue; West Nile; Chikungunya
AB Nucleoside analogs are widely used for the treatment of viral diseases (Hepatitis B/C, herpes and human immunodeficiency virus, HIV) and various malignancies. ALS-8176, a prodrug of the 4 ' -chloromethyl-2 ' -deoxy-2 ' -fluoro nucleoside ALS-8112, was evaluated in hospitalized infants for the treatment of respiratory syncytial virus (RSV), but was abandoned for unclear reasons. Based on the structure of ALS-8112, a series of novel 4 ' -modified-2 ' -deoxy-2 ' -fluoro nucleosides were synthesized. Newly prepared compounds were evaluated against RSV, but also against a panel of RNA viruses, including Dengue, West Nile, Chikungunya, and Zika viruses. Unfortunately, none of the compounds showed marked antiviral activity against these viruses.
C1 [Kasthuri, Mahesh; Li, Chengwei; Verma, Kiran; Russell, Olivia Ollinger; Dickson, Lyndsey; McCormick, Louise; Bassit, Leda; Amblard, Franck; Schinazi, Raymond F.] Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, 1760 Haygood Dr, Atlanta, GA 30322 USA.
RP Schinazi, RF (corresponding author), Emory Univ, Sch Med, Dept Pediat, Ctr AIDS Res,Lab Biochem Pharmacol, 1760 Haygood Dr, Atlanta, GA 30322 USA.
EM mahesh.kasthuri@emory.edu; cli35@emory.edu; kverma2@emory.edu;
   olivia.ollinger@emory.edu; lyndsey.dickson@emory.edu;
   alouisemccormick@gmail.com; leda.bassit@emory.edu; famblar@emory.edu;
   rschina@emory.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [1-R01-AI-132833, 5P30-AI-50409]
FX This work was supported in part by NIH Grant 1-R01-AI-132833, and
   5P30-AI-50409 (CFAR).
CR Beigelman L., 2012, U.S. Patent, Patent No. [US 20120070411, 20120070411, 20120070411A1]
   Coats SJ, 2014, ANTIVIR RES, V102, P119, DOI 10.1016/j.antiviral.2013.11.008
   DEKIMPE N, 1994, TETRAHEDRON LETT, V35, P8023, DOI 10.1016/0040-4039(94)80039-1
   Dolomanov OV, 2009, J APPL CRYSTALLOGR, V42, P339, DOI 10.1107/S0021889808042726
   Ehteshami M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02395-16
   Gavegnano Christina, 2017, Pathog Immun, V2, P199, DOI 10.20411/pai.v2i2.190
   Lai G, 2001, SYNTHETIC COMMUN, V31, P565, DOI 10.1081/SCC-100000583
   Levchenko K, 2016, J ORG CHEM, V81, P5803, DOI 10.1021/acs.joc.6b00628
   Lo MK, 2020, ANTIVIR RES, V175, DOI 10.1016/j.antiviral.2020.104712
   Malykhina O, 2011, J VIROL, V85, P4792, DOI 10.1128/JVI.02399-10
   Markowitz M, 2018, CURR OPIN HIV AIDS, V13, P294, DOI 10.1097/COH.0000000000000467
   Mitsuya H., 2019, HEP DART KAUAI HI US
   Patel K, 2019, J ANTIMICROB CHEMOTH, V74, P442, DOI 10.1093/jac/dky415
   Seley-Radtke KL, 2018, ANTIVIR RES, V154, P66, DOI 10.1016/j.antiviral.2018.04.004
   Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI 10.1107/S2053229614024218
   Shelton J, 2016, CHEM REV, V116, P14379, DOI 10.1021/acs.chemrev.6b00209
   Takamatsu Y, 2015, HEPATOLOGY, V62, P1024, DOI 10.1002/hep.27962
   VANLEUSE.AM, 1972, TETRAHEDRON LETT, P2369
   Wang GY, 2015, J MED CHEM, V58, P1862, DOI 10.1021/jm5017279
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 20
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1420-3049
J9 MOLECULES
JI Molecules
PD MAR 2
PY 2020
VL 25
IS 6
AR 1258
DI 10.3390/molecules25061258
PG 13
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LJ6BO
UT WOS:000530248700001
PM 32168734
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Batule, BS
   Seok, Y
   Kim, MG
AF Batule, Bhagwan S.
   Seok, Youngung
   Kim, Min-Gon
TI Paper-based nucleic acid testing system for simple and early diagnosis
   of mosquito-borne RNA viruses from human serum
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Nucleic acid testing; Paper microfluidics; Mosquito-borne diseases;
   Viral RNA extraction; RT-LAMP; Point-of-care diagnostics
ID RECOMBINASE POLYMERASE AMPLIFICATION; DNA EXTRACTION METHOD;
   INFECTIOUS-DISEASES; POINT; DEVICE; BLOOD; ASSAY; CHIP
AB The recent outbreaks of mosquito-borne diseases (e.g., zika, dengue, and chikungunya) increased public health burden in developing countries. To control the spread of these infectious diseases, a simple, economic, reliable, sensitive, and selective diagnostic platform is required. Considering demand for affordable and accessible methods, we have demonstrated a two-step strategy for extraction and detection of viral RNAs of infectious diseases within 1 h. Ready-to-use devices for viral RNA extraction and detection were successfully fabricated using paper as a substrate. Viral RNA (e.g., zika, dengue, and chikungunya) was captured and eluted using a handheld RNA extraction paper-strip device, and another paper-chip device was used for reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay with a detection limit of a single copy and 10 copies of viral RNA in phosphate buffer solution (PBS) and serum, respectively. With these proposed devices, we have detected viral RNAs of zika and dengue in clinical human serum samples. The proposed paper-based extraction and detection platforms could be employed for detection of infectious viral diseases from complex clinical samples in resource-limited settings.
C1 [Batule, Bhagwan S.; Seok, Youngung; Kim, Min-Gon] Gwangju Inst Sci & Technol, Sch Phys & Chem, Dept Chem, 261 Cheomdan Gwagiro, Gwangju 61005, South Korea.
RP Kim, MG (corresponding author), Gwangju Inst Sci & Technol, Sch Phys & Chem, Dept Chem, 261 Cheomdan Gwagiro, Gwangju 61005, South Korea.
EM mkim@gist.ac.kr
FU GIST (Gwangju Institute of Science and Technology), South Korea; Bio &
   Medical Technology Development Program of the National Research
   Foundation (NRF), South Korea - Ministry of Science ICT
   [NRF-2015M3A9E2031375]; Global Research Lab (GRL) Program, South Korea
   [NRF2013K1A1A2A02050616]
FX This research was supported by the GIST (Gwangju Institute of Science
   and Technology), South Korea, under the Practical Research and
   Development support program supervised by the GTI (GIST Technology
   Institute, South Korea), the Bio & Medical Technology Development
   Program of the National Research Foundation (NRF), South Korea funded by
   the Ministry of Science & ICT (NRF-2015M3A9E2031375), the Global
   Research Lab (GRL) Program, South Korea (NRF2013K1A1A2A02050616).
   Authors are thankful to Dr Sehee Jeong (APRI, GIST, Gwangju, South
   Korea) for extending experimental facilities for the oxygen plasma
   treatment.
CR Ahn H, 2018, ANAL CHEM, V90, P10211, DOI 10.1021/acs.analchem.8b01309
   andez S., 2018, REV MED HOSP GEN MEX, V81, P146
   Butzler MA, 2017, DIAGN MICR INFEC DIS, V89, P182, DOI 10.1016/j.diagmicrobio.2017.08.007
   Byrnes SA, 2015, LAB CHIP, V15, P2647, DOI 10.1039/c5lc00317b
   Chen P, 2019, SENSOR ACTUAT B-CHEM, V283, P472, DOI 10.1016/j.snb.2018.12.060
   Choi JR, 2016, ANALYST, V141, P2930, DOI 10.1039/c5an02532j
   Choi JR, 2016, LAB CHIP, V16, P611, DOI 10.1039/c5lc01388g
   Connelly JT, 2015, ANAL CHEM, V87, P7595, DOI 10.1021/acs.analchem.5b00411
   Draz MS, 2018, NANOSCALE, V10, P11841, DOI 10.1039/c8nr01646a
   Fronczek CF, 2014, RSC ADV, V4, P11103, DOI 10.1039/c3ra47688j
   Govindarajan AV, 2012, LAB CHIP, V12, P174, DOI 10.1039/c1lc20622b
   Hu J, 2014, BIOSENS BIOELECTRON, V54, P585, DOI 10.1016/j.bios.2013.10.075
   Jangam SR, 2013, BIOSENS BIOELECTRON, V42, P69, DOI 10.1016/j.bios.2012.10.024
   Jauset-Rubio M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37732
   Jiang X., 2018, ANGEW CHEM INT EDIT, V130, P17457
   Kaarj K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30797-9
   Kaur N, 2018, ANALYST, V143, P2213, DOI 10.1039/c7an01943b
   Trinh KTL, 2019, BIOSENS BIOELECTRON, V135, P120, DOI 10.1016/j.bios.2019.04.011
   Kim J, 2016, J MICROBIOL METH, V128, P24, DOI 10.1016/j.mimet.2016.06.001
   Kim TY, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8020081
   Kozel TR, 2017, J CLIN MICROBIOL, V55, P2313, DOI 10.1128/JCM.00476-17
   Lewis GG, 2012, ANGEW CHEM INT EDIT, V51, P12707, DOI 10.1002/anie.201207239
   Lin XY, 2018, ACS NANO, V12, P10281, DOI 10.1021/acsnano.8b05384
   Liu S, 2019, ANAL CHIM ACTA, V1080, P162, DOI 10.1016/j.aca.2019.07.011
   Lo SJ, 2013, LAB CHIP, V13, P2686, DOI 10.1039/c3lc50135c
   Lu JJ, 2012, ELECTROCHIM ACTA, V80, P334, DOI 10.1016/j.electacta.2012.07.024
   Magro L, 2017, LAB CHIP, V17, P2347, DOI 10.1039/c7lc00013h
   McFall SM, 2015, J VIROL METHODS, V214, P37, DOI 10.1016/j.jviromet.2015.01.005
   Naik P, 2019, SENSOR ACTUAT B-CHEM, V291, P74, DOI 10.1016/j.snb.2019.04.044
   Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007
   Ratajczak K, 2020, CARBOHYD POLYM, V229, DOI 10.1016/j.carbpol.2019.115463
   Ratajczak K, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070510
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rodriguez NM, 2016, LAB CHIP, V16, P753, DOI 10.1039/c5lc01392e
   Rohrman B, 2015, ANAL CHEM, V87, P1963, DOI 10.1021/ac504365v
   Rohrman BA, 2012, LAB CHIP, V12, P3082, DOI 10.1039/c2lc40423k
   Seok Y, 2019, BIOMED PHYS ENG EXPR, V5, DOI 10.1088/2057-1976/aaf3be
   Seok Y, 2017, THERANOSTICS, V7, P2220, DOI 10.7150/thno.18675
   Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003
   Souf S., 2016, BIOSCI HORIZ, V9, phzw010, DOI [10.1093/biohorizons/hzw010., DOI 10.1093/BIOHORIZONS/HZW010]
   Suaya J.A., 2007, SCI WORK GROUP M DEN
   Tang RH, 2017, LAB CHIP, V17, P1270, DOI 10.1039/c6lc01586g
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
   Xu GL, 2016, ANGEW CHEM INT EDIT, V55, P15250, DOI 10.1002/anie.201606060
   Yang ZG, 2018, ACS SENSORS, V3, P403, DOI 10.1021/acssensors.7b00825
   Ye X, 2018, ANAL CHIM ACTA, V1018, P78, DOI 10.1016/j.aca.2018.02.068
   Zou YP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003916
NR 48
TC 1
Z9 1
U1 46
U2 46
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAR 1
PY 2020
VL 151
AR 111998
DI 10.1016/j.bios.2019.111998
PG 7
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA LW0UV
UT WOS:000538862900032
PM 31999593
DA 2020-07-08
ER

PT J
AU Hsu, YP
   Li, NS
   Chen, YT
   Pang, HH
   Wei, KC
   Yang, HW
AF Hsu, Ying-Pei
   Li, Nan-Si
   Chen, Ying-Tzu
   Pang, Hao-Han
   Wei, Kuo-Chen
   Yang, Hung-Wei
TI A serological point-of-care test for Zika virus detection and infection
   surveillance using an enzyme-free vial immunosensor with a smartphone
SO BIOSENSORS & BIOELECTRONICS
LA English
DT Article
DE Zika virus; Vial immunosensor; Nanozyme; Serological point-of-care;
   Smartphone reader
ID DIAGNOSIS; NANOPARTICLES; NANOZYME; FLUID; IGM
AB Zika virus (ZIKV) is a mosquito-borne flavivirus (FLAV) that emerged in Brazil in 2015 and has rapidly spread to more than 50 countries worldwide. However, early, accurate, and specific point-of-care (POC) diagnosis of ZIKV is very difficult because most infected patients are asymptomatic or display nonspecific symptoms similar to those of other viral infections, and most of the analysis also requires instruments. Herein, an instrument-free ZIKV POC test using a drop of blood comprising a vial immunosensor, artificial nanozyme platinum/gold core-shell nanoparticles (Pt@Au NPs) as a signal probe, and a smartphone was developed to specifically detect ZIKV without cross-reaction with other FLAVs. A high sensitivity of 1 pg/mL ZIKV, desirable specificity, data storage, and geographic location surveillance were simultaneously achieved for the proposed POC test. Our POC test suitably met the urgent needs of ports of entry, airports, and endemic regions with stressed resources, as well as strict clinical requirements for ZIKV detection.
C1 [Hsu, Ying-Pei; Li, Nan-Si; Chen, Ying-Tzu; Pang, Hao-Han; Yang, Hung-Wei] Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 80424, Taiwan.
   [Hsu, Ying-Pei] Natl Sun Yat Sen Univ, Dept Mat & Optoelect Sci, Kaohsiung 80424, Taiwan.
   [Li, Nan-Si; Pang, Hao-Han] Natl Sun Yat Sen Univ, Inst Biomed Sci, Kaohsiung 80424, Taiwan.
   [Wei, Kuo-Chen] Chang Gung Mem Hosp, Dept Neurosurg, Taoyuan 33305, Taiwan.
   [Wei, Kuo-Chen] Chang Gung Univ, Sch Med, Taoyuan 33302, Taiwan.
RP Yang, HW (corresponding author), Natl Sun Yat Sen Univ, Inst Med Sci & Technol, Kaohsiung 80424, Taiwan.
EM howardyang@mail.nsysu.edu.tw
OI Li, Nan-Si/0000-0002-6991-6223
FU Ministry of Science and Technology [MOST106-2628-E-110-001-MY3,
   MOST106-2628-B-110-001-MY4]; National Health Research Institutes, Taiwan
   (R.O.C.)National Health Research Institutes - Taiwan
   [NHRI-EX-109-10502NI]
FX This work was financially supported by the Ministry of Science and
   Technology (MOST106-2628-E-110-001-MY3, MOST106-2628-B-110-001-MY4) and
   National Health Research Institutes (NHRI-EX-109-10502NI), Taiwan
   (R.O.C.). We would also like to thank the Chang Gung Memorial Hospital
   Microscopy Core Laboratory for their assistance with the TEM, SEM, and
   EDS techniques.
CR Bandodkar AJ, 2018, BIOSENS BIOELECTRON, V101, P181, DOI 10.1016/j.bios.2017.10.019
   Barbosa AI, 2015, BIOSENS BIOELECTRON, V70, P5, DOI 10.1016/j.bios.2015.03.006
   Cabral-Miranda G, 2018, BIOSENS BIOELECTRON, V113, P101, DOI 10.1016/j.bios.2018.04.058
   Calabria D, 2017, BIOSENS BIOELECTRON, V94, P124, DOI 10.1016/j.bios.2017.02.053
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chen G, 2019, SENSOR ACTUAT B-CHEM, V281, P253, DOI 10.1016/j.snb.2018.09.019
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Faria AM, 2019, TALANTA, V203, P153, DOI 10.1016/j.talanta.2019.04.080
   Hristov DR, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19030554
   Huang YY, 2019, CHEM REV, V119, P4357, DOI 10.1021/acs.chemrev.8b00672
   Jiang DW, 2019, CHEM SOC REV, V48, P3683, DOI 10.1039/c8cs00718g
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kanchi S, 2018, BIOSENS BIOELECTRON, V102, P136, DOI 10.1016/j.bios.2017.11.021
   L'Huillier AG, 2017, J CLIN MICROBIOL, V55, P2462, DOI 10.1128/JCM.00442-17
   Liao YH, 2018, ACS CENTRAL SCI, V4, P1403, DOI 10.1021/acscentsci.8b00471
   Lim SK, 2017, INFECT CHEMOTHER, V49, P91, DOI 10.3947/ic.2017.49.2.91
   Lin TY, 2018, J MATER CHEM B, V6, P3387, DOI 10.1039/c8tb00913a
   Loynachan CN, 2018, ACS NANO, V12, P279, DOI 10.1021/acsnano.7b06229
   Mahato K, 2019, BIOSENS BIOELECTRON, V128, P9, DOI 10.1016/j.bios.2018.12.006
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Pardee K, 2016, CELL, V165, P1255, DOI 10.1016/j.cell.2016.04.059
   Patel S, 2016, BIOCHEM RES INT, V2016, DOI 10.1155/2016/3130469
   Peng C, 2019, BIOSENS BIOELECTRON, V126, P581, DOI 10.1016/j.bios.2018.11.022
   Rong Z, 2019, ANAL CHIM ACTA, V1055, P140, DOI 10.1016/j.aca.2018.12.043
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Tancharoen C, 2019, ACS SENSORS, V4, P69, DOI 10.1021/acssensors.8b00885
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   Wei H, 2013, CHEM SOC REV, V42, P6060, DOI 10.1039/c3cs35486e
   Wu JJX, 2019, CHEM SOC REV, V48, P1004, DOI 10.1039/c8cs00457a
   Yang HW, 2011, BIOMATERIALS, V32, P6523, DOI 10.1016/j.biomaterials.2011.05.047
   Zhang WC, 2018, SENSOR ACTUAT B-CHEM, V265, P412, DOI 10.1016/j.snb.2018.03.082
NR 33
TC 0
Z9 0
U1 19
U2 19
PU ELSEVIER ADVANCED TECHNOLOGY
PI OXFORD
PA OXFORD FULFILLMENT CENTRE THE BOULEVARD, LANGFORD LANE, KIDLINGTON,
   OXFORD OX5 1GB, OXON, ENGLAND
SN 0956-5663
EI 1873-4235
J9 BIOSENS BIOELECTRON
JI Biosens. Bioelectron.
PD MAR 1
PY 2020
VL 151
AR 111960
DI 10.1016/j.bios.2019.111960
PG 9
WC Biophysics; Biotechnology & Applied Microbiology; Chemistry, Analytical;
   Electrochemistry; Nanoscience & Nanotechnology
SC Biophysics; Biotechnology & Applied Microbiology; Chemistry;
   Electrochemistry; Science & Technology - Other Topics
GA LW0UV
UT WOS:000538862900010
PM 31999574
DA 2020-07-08
ER

PT J
AU Duarte, AO
   Oliveira, JV
   Carvalho, TCX
   Pessoa, LD
   Magalhaes, C
   Lima, JGS
   Carvalho, DA
   dos Santos, DC
   Santos, CS
   Pessoa, R
   Souza, GB
   Calcagno, JI
   Santana, EM
   de Oliveira, AS
   Francisco, MVLD
   Costa, BGG
   Gomes, LN
   Romero, F
   Khouri, R
   Alcantara, LC
   Lima, FWD
   de Siqueira, IC
AF Duarte, Alan Oliveira
   Oliveira, Joao Vitor
   Xavier Carvalho, Tereza Cristina
   Pessoa, Lorena de Brito
   Magalhaes Filho, Claudio
   Souza Lima, Jessica Graziele
   Carvalho, Daniel Augusto
   dos Santos, Daiana Carlos
   Santos, Cleiton Silva
   Pessoa, Rosana
   Souza, Gloryane Bessa
   Calcagno, Juan Ignacio
   Santana, Edilene Mota
   de Oliveira, Aline Sousa
   de Oliveira Francisco, Marcos Vinicius Lima
   Gouvea Costa, Bernardo Gratival
   Gomes, Lillian Nunes
   Romero, Fernando
   Khouri, Ricardo
   Alcantara, Luiz Carlos, Jr.
   de Mendonca Lima, Fernanda Washington
   de Siqueira, Isadora Cristina
TI Maternal and congenital infections arising from Zika, dengue and
   Chikungunya arboviruses in Salvador, Brazil
SO TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
DE Chikungunya; congenital infection; microcephaly; seroprevalence; Zika
AB Background: Salvador was one of the Brazilian cities most affected during the 2015 Zika virus (ZIKV) outbreak.
   Methods: A cross-sectional study was performed with enrolment of parturients and their newborns.
   Results: Positive IgM antibodies for ZIKV, dengue (DENV) and Chikungunya (CHIKV) were present in 6.9, 11.9 and 22.8% of the parturients, and IgG antibodies were detected in 72.3, 92.3 and 38.6%, respectively. No cases of DENV congenital infection were identified. ZIKV and CHIKV congenital infections were observed in 16.5 and 13% of newborns, respectively.
   Conclusions: High exposure rates to the three arboviruses and the identification of newborns with ZIKV and CHIKV congenital infections reinforces the necessity of ZIKV and CHIKV prenatal and neonatal screening in endemic regions.
C1 [Duarte, Alan Oliveira; Santana, Edilene Mota; de Mendonca Lima, Fernanda Washington] Univ Fed Bahia, Fac Farm, Lab Imunol Doencas Infecciosas, BR-40170115 Salvador, BA, Brazil.
   [Oliveira, Joao Vitor; Pessoa, Lorena de Brito; Magalhaes Filho, Claudio; Souza Lima, Jessica Graziele; Carvalho, Daniel Augusto; dos Santos, Daiana Carlos; Santos, Cleiton Silva; de Oliveira, Aline Sousa; de Oliveira Francisco, Marcos Vinicius Lima; Gouvea Costa, Bernardo Gratival; Gomes, Lillian Nunes; Khouri, Ricardo; Alcantara, Luiz Carlos, Jr.; de Siqueira, Isadora Cristina] Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
   [Xavier Carvalho, Tereza Cristina; Pessoa, Rosana; Souza, Gloryane Bessa; Calcagno, Juan Ignacio; Romero, Fernando] Maternidade Referencia Prof Jose Maria Magalhaes, BR-40320350 Salvador, BA, Brazil.
   [Khouri, Ricardo] Univ Fed Bahia, Fac Med, Dept Patol & Med Legal, BR-40110100 Salvador, BA, Brazil.
RP de Siqueira, IC (corresponding author), Minist Saude, Fundacao Oswaldo Cruz, Inst Goncalo Moniz, BR-40296710 Salvador, BA, Brazil.
EM isadora.siqueira@fiocruz.br
FU National Council for Scientific and Technological DevelopmentNational
   Council for Scientific and Technological Development (CNPq)
   [425380/2016]; WHO's HRP/TDR/PAHO Joint Small Grants Program for
   research on the ZIKV outbreak in the Americas [770084-0/2017];
   Foundation of Support to Research of the State of Bahia
   [19.573.201.5418]
FX This work was supported by the National Council for Scientific and
   Technological Development [425380/2016], WHO's HRP/TDR/PAHO Joint Small
   Grants Program for research on the ZIKV outbreak in the Americas
   [770084-0/2017] and Foundation of Support to Research of the State of
   Bahia [19.573.201.5418].
CR Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
NR 3
TC 0
Z9 0
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0035-9203
EI 1878-3503
J9 T ROY SOC TROP MED H
JI Trans. Roy. Soc. Trop. Med. Hyg.
PD MAR
PY 2020
VL 114
IS 3
BP 222
EP 224
DI 10.1093/trstmh/trz098
PG 3
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LS6DO
UT WOS:000536472500009
PM 32142153
DA 2020-07-08
ER

PT J
AU Leung, C
AF Leung, Char
TI Estimated incubation period for mosquito-borne disease-related
   Guillain-Barre syndrome
SO CLINICAL EPIDEMIOLOGY AND GLOBAL HEALTH
LA English
DT Article
DE Guillain-Barre syndrome; Incubation period; Chikungunya; Zika;
   Post-infectious
ID ZIKA VIRUS-INFECTION; OUTBREAK
AB Purpose: Guillain-Barre syndrome (GBS) is a rare post-infectious peripheral polyneuropathy. Following the Zika virus epidemic in 2016, the WHO called for understanding Zika associated GBS through epidemiological studies. However, the incubation period of GBS remains little known and its characterisation is needed.
   Methods: Articles reporting the data of lag time between the symptom onset of Chikungunya or Zika and GBS were included for pooled analysis. Maximum likelihood estimation was adopted to estimate the incubation period distribution of GBS conditioned to that of the antecedent infection.
   Results: A total of 89 Chikungunya- and Zika-related GBS cases from 23 articles were identified. The incubation period distribution of GBS is lognormal distributed with the median of 13-14 days and does not depend on the antecedent infection.
   Conclusions: The incubation period of GBS follows Sartwell's model. It should be useful in confirming the association between infection and GBS in epidemiologic studies as well as to assist diagnosis and prognosis such as clinically assessing respiratory failure. It is also found that viral symptoms can occur prior to neurological symptoms, suggesting that GBS may be a parainfectious disease.
C1 [Leung, Char] Deakin Univ, 221 Burwood Highway, Melbourne, Vic 3125, Australia.
RP Leung, C (corresponding author), Deakin Univ, 221 Burwood Highway, Melbourne, Vic 3125, Australia.
EM char.leung@deakin.edu.au
OI Leung, Char/0000-0002-4215-4513
CR Agarwal A, 2017, J NEUROVIROL, V23, P504, DOI 10.1007/s13365-017-0516-1
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Ansari Behnaz, 2018, Adv Biomed Res, V7, P87, DOI 10.4103/abr.abr_50_17
   Balavoine S, 2017, AM J TROP MED HYG, V97, P356, DOI 10.4269/ajtmh.15-0753
   Beattie J, 2018, INFECT DIS CLIN PRAC, V26, pE80, DOI 10.1097/IPC.0000000000000654
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Ferreira MLB, 2017, AM J TROP MED HYG, V97, P1405, DOI 10.4269/ajtmh.17-0106
   CRAN, POST EST INC PER DIS
   do Rosario MS, 2016, AM J TROP MED HYG, V95, P1157, DOI 10.4269/ajtmh.16-0306
   Fabrizius RG, 2016, AM J TROP MED HYG, V95, P1161, DOI 10.4269/ajtmh.16-0397
   Farooq S, 2018, PAK J NEUROL SCI, V13, P13
   Garg M, 2017, J NEUROSCI RURAL PRA, V8, P325, DOI 10.4103/jnrp.jnrp_96_17R1
   Gonzalez-Escobar G, 2017, REV PANAM SALUD PUBL, V41
   Krow-Lucal ER, 2017, EMERG INFECT DIS, V23, P841, DOI 10.3201/eid2305.161715
   Langerak T, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00233
   Lebrun G, 2009, EMERG INFECT DIS, V15, P495, DOI 10.3201/eid1503.071482
   Lehmann Helmar C, 2012, J Peripher Nerv Syst, V17 Suppl 3, P57, DOI 10.1111/j.1529-8027.2012.00433.x
   Lessler J, 2016, B WORLD HEALTH ORGAN, V94, P841, DOI 10.2471/BLT.16.174540
   Soto-Hernandez JL, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00435
   Mahto SK, 2018, INDIAN J CRIT CARE M, V22, P306, DOI 10.4103/ijccm.IJCCM_459_17
   Mehta R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006212
   Mier-y-Teran-Romero L, 2018, BMC MED, V16, DOI [10.1186/S12916-018-1052-4, 10.1186/s12916-018-1052-4]
   Naikwadi A, 2019, BJR CASE REP, V5, DOI 10.1259/bjrcr.20180013
   Oehler E, 2015, EUROSURVEILLANCE, V20, P13, DOI 10.2807/1560-7917.ES.2015.20.48.30079
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Rivera-Concepcion JR, 2018, P R HEALTH SCI J, V37, pS93
   Rudolph KE, 2014, AM J TROP MED HYG, V90, P882, DOI 10.4269/ajtmh.13-0403
   Siu R, 2016, NEUROLOGY, V87, P1623, DOI 10.1212/WNL.0000000000003038
   Styczynski AR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005869
   Sudulagunta Sreenivasa Rao, 2015, Ger Med Sci, V13, pDoc16, DOI 10.3205/000220
   Tsunoda Ikuo, 2016, Acta Med Kinki Univ, V41, P37
   Sebastian UU, 2017, J CRIT CARE, V42, P275, DOI 10.1016/j.jcrc.2017.07.038
   Umapathi T, 2018, J PERIPHER NERV SYST, V23, P197, DOI 10.1111/jns.12284
   Vindas-Guerrero Sylvia, 2018, Acta méd. costarric, V60, P136
   Walgaard C, 2010, ANN NEUROL, V67, P781, DOI 10.1002/ana.21976
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1
NR 39
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER - DIVISION REED ELSEVIER INDIA PVT LTD
PI NEW DELHI
PA 17-A/1 MAIN RING ROAD, LAJPAT NAGAR IV, NEW DELHI, 110024, INDIA
SN 2452-0918
EI 2213-3984
J9 CLIN EPIDEMIOL GLOB
JI Clin. Epidemiol. Glob. Health
PD MAR
PY 2020
VL 8
IS 1
DI 10.1016/j.cegh.2019.08.007
PG 7
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA LO2TC
UT WOS:000533481900046
OA Bronze
DA 2020-07-08
ER

PT J
AU Cantero, C
   Cardozo, F
   Waggoner, JJ
   Pinsky, BA
   Espinola, A
   Infanzon, B
   Acosta, ME
   Aria, L
   de Guillen, YA
   Cuevas, T
   Rojas, V
   Segovia, C
   Centurion, A
   Rojas, A
AF Cantero, Cesar
   Cardozo, Fatima
   Waggoner, Jesse J.
   Pinsky, Benjamin A.
   Espinola, Anibal
   Infanzon, Belen
   Eugenia Acosta, Maria
   Aria, Laura
   Arevalo de Guillen, Yvalena
   Cuevas, Teresa
   Rojas, Vicenta
   Segovia, Clotilde
   Centurion, Ana
   Rojas, Alejandra
TI Implementation of a Multiplex rRT-PCR for Zika, Chikungunya, and Dengue
   Viruses: Improving Arboviral Detection in an Endemic Region
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID VIREMIA
AB Arboviral diagnosis has been complicated throughout the tropical and subtropical Americas by the recent co-circulation of Zika virus (ZIKV), chikungunya virus (CHIKV), and dengue virus (DENV). The aim of this study was to implement a multiplex real-time RT-PCR (rRT-PCR) for ZIKV, CHIKV, and DENV in Paraguay to test patients who were clinically suspected of having dengue. We tested 110 sera from patients who presented to the Hospital de Clinicas in 2016 and had testing for DENV nonstructural protein 1 (NS1; 40 positive and 70 negative). Using a composite reference standard, we confirmed 51 dengue cases (46.4%): 38/40 NS1 positive and 13/70 NS1 negative. Chikungunya virus and ZIKV were detected in one sample each, both were DENV NS1 negative. The NS1 test demonstrated good agreement with rRT-PCR for DENV. However, multiplex rRT-PCR identified a subset of dengue cases and additional arboviral infections that would not be detected if NS1 assays are relied upon for diagnosis.
C1 [Cantero, Cesar; Infanzon, Belen; Eugenia Acosta, Maria; Aria, Laura; Arevalo de Guillen, Yvalena; Rojas, Alejandra] Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Prod, Dr Villamayor Campus Univ, Asuncion 2169, Paraguay.
   [Cardozo, Fatima] Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Salud Publ, Asuncion, Paraguay.
   [Waggoner, Jesse J.] Emory Univ, Dept Med, Div Infect Dis, Atlanta, GA 30322 USA.
   [Waggoner, Jesse J.] Rollins Sch Publ Hlth, Dept Global Hlth, Atlanta, GA USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA.
   [Pinsky, Benjamin A.] Stanford Univ, Sch Med, Dept Med, Div Infect Dis & Geog Med, Palo Alto, CA 94304 USA.
   [Espinola, Anibal] Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Patol, Asuncion, Paraguay.
   [Cuevas, Teresa; Rojas, Vicenta; Segovia, Clotilde; Centurion, Ana] Univ Nacl Asuncion, Hosp Clin, Fac Ciencias Med, Asuncion, Paraguay.
RP Rojas, A (corresponding author), Univ Nacl Asuncion, Inst Invest Ciencias Salud, Dept Prod, Dr Villamayor Campus Univ, Asuncion 2169, Paraguay.
EM cesarcantero24@gmail.com; fati.cardozo@hotmail.com;
   jesse.waggoner@emoryhealthcare.org; bpinsky@stanford.edu;
   novastore83@gmail.com; beleninfanzon@gmail.com; maruhetter@yahoo.com.mx;
   lauraariazaya@yahoo.es; ivalenaguillen@yahoo.com;
   techicuevas@hotmail.com; vamaliar@gmail.com; clocuquejo@gmail.com;
   anacentu@hotmail.com; arojass@iics.una.py
OI Pinsky, Benjamin/0000-0001-8751-4810
FU Consejo Nacional de Ciencia y Tecnologia (CONACYT) of Paraguay, Programa
   de Vinculacion de Cientificos y TecnologosConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [PVCT 16-66]; Direccion General de Investigacion
   Cientifica y Tecnologica, Rectorado, Universidad Nacional Asuncion
   (DGICT-UNA)
FX The research was supported by a fellowship from the Consejo Nacional de
   Ciencia y Tecnologia (CONACYT) of Paraguay, awarded as part of the
   Programa de Vinculacion de Cientificos y Tecnologos, PVCT 16-66 (A. R.).
   The research was also supported by a grant from the Direccio n General
   de Investigacion Cientifica y Tecnologica, Rectorado, Universidad
   Nacional Asuncion (DGICT-UNA).
CR Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244
   Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014
   Sea VRF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064056
   Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   MSPyBS, 2016, B EP REP PAR, V52, P1
   MSPyBS, 2016, B EP REP PAR, V48, P1
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Tuan NM, 2017, CLIN INFECT DIS, V64, P656, DOI 10.1093/cid/ciw863
   Pok KY, 2010, VECTOR-BORNE ZOONOT, V10, P1009, DOI 10.1089/vbz.2008.0176
   Staikowsky F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007603
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Teoh B. T., 2016, SCI REP, V6, P1
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   Waggoner JJ, 2016, EMERG INFECT DIS, V22, P1295, DOI 10.3201/eid2207.160326
   Waggoner JJ, 2013, J CLIN MICROBIOL, V51, P2172, DOI 10.1128/JCM.00548-13
   Waggoner JJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002116
   Wallach JB, 2013, INTERPRETACAO EXAMES
   WHO, 2017, TOOL DIAGN CAR PAT S
NR 20
TC 0
Z9 0
U1 4
U2 4
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 2020
VL 102
IS 3
BP 625
EP 628
DI 10.4269/ajtmh.19-0707
PG 4
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK7ZO
UT WOS:000531080300023
PM 31933462
OA Bronze
DA 2020-07-08
ER

PT J
AU Anderson, EJ
   Ernst, KC
   Martins, FF
   Martins, CD
   Koss, MP
AF Anderson, Elizabeth J.
   Ernst, Kacey C.
   Martins, Francisco Fernando
   Martins, Cicera da Silva
   Koss, Mary P.
TI Women's Health Perceptions and Beliefs Related to Zika Virus Exposure
   during the 2016 Outbreak in Northern Brazil
SO AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE
LA English
DT Article
ID PREGNANT-WOMEN; UNITED-STATES; INFECTION; DENGUE; CARE; KNOWLEDGE
AB During the 2016 Zika pandemic in Brazil, women's perceptions of infection risk, ability to adhere to Zika prevention strategies, or access to services following exposure were not emphasized in the public health response. Women in Fortaleza, Brazil, responded to a questionnaire on social factors related to perceived Zika risk and access to health care in June 2016. Data were coded using prespecified categories, and response frequency was reported. Of 37 respondents, most reported a lack of public services to support mosquito control (n = 19) or delayed access to reproductive health care (n = 14). Only 22% described specific maternal risks or fetal outcomes as a consequence of Zika infection. Respondents indicated an overall disconnect between public health efforts and women's perceptions of their reproductive control, including limited support concerning microcephaly in infants. Interventions targeting Zika may require a greater emphasis on strengthening health systems and infrastructure to realistically prevent transmission.
C1 [Anderson, Elizabeth J.; Koss, Mary P.] Univ Arizona, Dept Hlth Promot Sci, 1295 N Martin Ave, Tucson, AZ 85721 USA.
   [Ernst, Kacey C.] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA.
   [Martins, Francisco Fernando; Martins, Cicera da Silva] Grp Desenvolvimento Familiar GDFAM, Fortaleza, Ceara, Brazil.
RP Anderson, EJ (corresponding author), Univ Arizona, Dept Hlth Promot Sci, 1295 N Martin Ave, Tucson, AZ 85721 USA.
EM andersone@email.arizona.edu; kernst@email.arizona.edu;
   franciscomff@yahoo.com.br; cicerafelipe@yahoo.com.br;
   mpk@email.arizona.edu
FU Tinker Foundation
FX Funding from the Tinker Foundation was used to support data collection.
CR Alves JCS, 2009, 26 IUSSP INT POP C M
   Anderson KN, 2017, BIRTH DEFECTS RES, V109, P669
   [Anonymous], 2019, WHO GUID PREV SEX TR
   Bernstein M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011999
   Bortz K, 2019, INFECT DIS CHILD, V32, P18
   Bwambale FM, 2013, J PUBLIC HEALTH RES, V2, P29, DOI 10.4081/jphr.2013.e6
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Castro MC, 2016, HEALTH SYST REFORM, V2, P119, DOI 10.1080/23288604.2016.1179085
   Claro L, 2006, COMMUNITY PARTICIPAT
   Cuadros A, 2016, WASHINGTON POST
   Curry CL, 2018, J OBSTET GYNAECOL RE, V44, P503, DOI 10.1111/jog.13533
   de Oliveira WK, 2017, NEW ENGL J MED, V376, P1591, DOI 10.1056/NEJMc1608612
   Degallier N, 2000, J AM MOSQUITO CONTR, V16, P114
   Diniz D, 2016, CAD SAUDE PUBLICA, V32, DOI 10.1590/0102-311X00046316
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Eleweke C. J., 2002, INT J INCLUSIVE EDUC, V6, P113, DOI [10.1080/13603110110067190, DOI 10.1080/13603110110067190]
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ficenec SC, 2019, AM J TROP MED HYG, V101, P484, DOI 10.4269/ajtmh.18-0934
   Gerberding JL, 2004, EMERG INFECT DIS, V10, P1965, DOI 10.3201/eid1011.040800
   Ghenai A, 2017, IEEE INT C HEALTHC I
   Gomez EJ, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2018-000862
   Gupta N, 2000, STUD FAMILY PLANN, V31, P228, DOI 10.1111/j.1728-4465.2000.00228.x
   Herber S, 2019, J PEDIAT-BRAZIL, V95, P600, DOI 10.1016/j.jped.2018.05.013
   Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687
   Lin HZ, 2017, SINGAP MED J, V58, P171, DOI 10.11622/smedj.2017026
   Mayring P., 2004, COMPANION QUALITATIV, V1, P159
   Monath TP, 2018, CHIKUNGUNYA ZIKA VIR, P367
   Mulligan K, 2015, PATHOG GLOB HEALTH, V109, P10, DOI 10.1179/2047773214Y.0000000168
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Oduyebo T, 2016, MMWR-MORBID MORTAL W, V65, P122, DOI 10.15585/mmwr.mm6505e2
   Oliveira JV, 2018, INT J INFECT DIS, V73, P182, DOI 10.1016/j.ijid.2018.04.3826
   Para-Mallam OJ, 2011, AFR NOTES B I AFR ST, V35, P26
   Patel N, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16071257
   Baran LCP, 2019, J AAPOS, V23, P215, DOI 10.1016/j.jaapos.2019.03.005
   Prue CE, 2017, MMWR-MORBID MORTAL W, V66, P909, DOI 10.15585/mmwr.mm6634a4
   Saiz JC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01554
   Sousa CA, 2018, REVISTAGAUCHA ENFERM, V39
   Stefanidis Anthony, 2017, JMIR Public Health Surveill, V3, pe22, DOI 10.2196/publichealth.6925
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   Ullstrom S, 2014, BMJ QUAL SAF, V23, P325, DOI 10.1136/bmjqs-2013-002035
   Victora CG, 2011, LANCET, V377, P1863, DOI 10.1016/S0140-6736(11)60138-4
   Vijaykumar S, 2018, AM J INFECT CONTROL, V46, P850, DOI 10.1016/j.ajic.2018.03.014
   Yubo Kou, 2017, Proceedings of the ACM on Human-Computer Interaction, V1, DOI 10.1145/3134696
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 46
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC TROP MED & HYGIENE
PI MCLEAN
PA 8000 WESTPARK DR, STE 130, MCLEAN, VA 22101 USA
SN 0002-9637
EI 1476-1645
J9 AM J TROP MED HYG
JI Am. J. Trop. Med. Hyg.
PD MAR
PY 2020
VL 102
IS 3
BP 629
EP 633
DI 10.4269/ajtmh.19-0311
PG 5
WC Public, Environmental & Occupational Health; Tropical Medicine
SC Public, Environmental & Occupational Health; Tropical Medicine
GA LK7ZO
UT WOS:000531080300024
PM 31933455
DA 2020-07-08
ER

PT J
AU Martins, MM
   Prata-Barbosa, A
   da Cunha, AJLA
AF Martins, Marlos Melo
   Prata-Barbosa, Arnaldo
   Ledo Alves da Cunha, Antonio Jose
TI Arboviral diseases in pediatrics
SO JORNAL DE PEDIATRIA
LA English
DT Review
DE Arboviruses; Child; Newborn; Dengue; Chikungunya; Zika
ID ZIKA VIRUS; CHIKUNGUNYA VIRUS; CLINICAL-ASPECTS; TRANSMISSION;
   INFECTION; CHILDREN
AB Objectives: To present the currently available evidence on transmission, clinical, diagnostic methods, treatment, and prevention methods of major arboviruses that occur in childhood.
   Source of data: Non-systematic review carried out in MEDLINE (PubMed), LILACS (VHL), Scopus, Web of Science, Cochrane, CAPES Portal, and Google Scholar databases for the past five years using the search terms arboviruses, dengue, chikungunya, Zika. Mayaro, and West Nile fever, as well as child, newborn, and adolescent.
   Synthesis of data: The main characteristic of arboviruses is the fact that part of their replication cycle occurs inside insect vectors, thus being classically transmitted to humans through the bite of mosquitoes (hematophagous arthropods), although non-vector transmission of these viruses is also possible in specific situations. These diseases remain a major public health challenge, due to the lack of specific antiviral treatment, the co-circulation of different arboviruses in endemic/epidemic regions, the lack of effective and safe immunizations for the vast majority of these viruses, and the great difficulty in vector control, especially in large urban centers.
   Conclusions: Children are especially vulnerable to this group of diseases due to characteristics that facilitate the development of the most severe forms. More detailed knowledge of this group of diseases allows the pediatrician to diagnose them earlier, implement the correct treatment, monitor warning signs for the most severe forms, and establish effective preventive measures. (C) 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [Martins, Marlos Melo] Univ Fed Rio de Janeiro, Maternidade Escola, Rio De Janeiro, RJ, Brazil.
   [Prata-Barbosa, Arnaldo] Inst Or Pesquisa & Ensino IDOR, Dept Pediat, Rio De Janeiro, RJ, Brazil.
   [Ledo Alves da Cunha, Antonio Jose] Univ Fed Rio de Janeiro, Fac Med, Dept Pediat, Rio De Janeiro, RJ, Brazil.
RP Martins, MM (corresponding author), Univ Fed Rio de Janeiro, Maternidade Escola, Rio De Janeiro, RJ, Brazil.
EM marlosmartins@globo.com
OI Martins, Marlos/0000-0002-5511-4764; Ledo Alves da Cunha, Antonio
   Jose/0000-0003-3592-1849
CR Acosta-Ampudia Y, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0163-5
   Adachi K, 2018, CURR OPIN PEDIATR, V30, P105, DOI 10.1097/MOP.0000000000000582
   Arragain L, 2017, J PEDIAT INF DIS SOC, V6, P324, DOI 10.1093/jpids/piw058
   Ayllon T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195014
   Barr KL, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030294
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brasil. Ministerio da Saade, INF TECN DENG
   Brasil. Ministerio da Saucle, FEBR AM SINT TRAT DI
   Brasil. Ministerio da Saude, COMB AO AED AEG PREV
   Brasil Ministerio da Saude. Secretaria de Atencao a Saude, 2018, FEBR AM GUIA PROF SA
   Brasil Ministerio da Saude Secretaria de Vigitancia em Departamento de Vigilancia das Doencas Transmissiveis, 2016, DENG DIAGN MAN CLIN
   Cardoso TF, 2019, ARCH DIS CHILD, V104, P199, DOI 10.1136/archdischild-2018-314782
   Centers for Disease Control and Prevetion-CDC, 2017, UPD GUID US LAB TEST
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Charlier C, 2017, LANCET CHILD ADOLESC, V1, P134, DOI 10.1016/S2352-4642(17)30021-4
   Cleto Thais Lira, 2016, Pediatr Neurol, V65, pe1, DOI 10.1016/j.pediatrneurol.2016.08.011
   Contopoulos-Ioannidis D, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006510
   da Cunha RV, 2017, MEM I OSWALDO CRUZ, V112, P523, DOI 10.1590/0074-02760170044
   David S, 2016, INFECT DIS-NOR, V48, P571, DOI 10.3109/23744235.2016.1164890
   Desai SK, 2017, AM J STEM CELLS, V6, P13
   Dhochak N, 2019, INDIAN J PEDIATR, V86, P287, DOI 10.1007/s12098-018-2794-x
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   HALSTEAD SB, 1970, YALE J BIOL MED, V42, P311
   Hendrixson DT, 2018, INFECT DIS CLIN N AM, V32, P215, DOI 10.1016/j.idc.2017.10.003
   Krutikov M, 2016, RAMBAM MAIMONIDES ME, V7, DOI 10.5041/RMMJ.10260
   KUMAR S, 2019, PEDIAT ONCALL J, V16, P531, DOI DOI 10.1111/IJAC.13145
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Lima-Camara TN, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006791, 10.1590/s1518-8787.2016050006791]
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P1106, DOI 10.1016/S1473-3099(16)30336-X
   Murray KO, 2017, EMERG INFECT DIS, P2399
   Paixao ES, 2016, LANCET INFECT DIS, V16, P857, DOI 10.1016/S1473-3099(16)00088-8
   Pan American Health Organization, 2017, TOOL DIAGN CAR PAT S
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Possas C, 2018, MEM I OSWALDO CRUZ, V113, DOI 10.1590/0074-02760180278
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Ritz N, 2015, PEDIATR INFECT DIS J, V34, P789, DOI 10.1097/INF.0000000000000716
   Simmons G, 2016, EMERG INFECT DIS, V22, P1221, DOI 10.3201/eid2207.160116
   Sociedade Brasileira de Pediatria. Departamento de Dermatologia, 2015, B TECNICO
   Van der Linden V, 2016, MMWR-MORBID MORTAL W, P651343
   Ward CE, 2018, PEDIATR EMERG CARE, V34, P510, DOI 10.1097/PEC.0000000000001529
   WHO, 2018, REV SAGE REC US DENG
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yang HM, 2017, MATH BIOSCI, V286, P1, DOI 10.1016/j.mbs.2017.01.006
NR 50
TC 0
Z9 0
U1 0
U2 0
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAR-APR
PY 2020
VL 96
SU 1
BP 2
EP 11
DI 10.1016/j.jped.2019.08.005
PG 10
WC Pediatrics
SC Pediatrics
GA LG5TX
UT WOS:000528163900002
PM 31605670
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU da Costa, BK
   Sato, DK
AF da Costa, Bruna Klein
   Sato, Douglas Kazutoshi
TI Viral encephalitis: a practical review on diagnostic approach and
   treatment
SO JORNAL DE PEDIATRIA
LA English
DT Review
DE Viral encephalitis; Diagnosis; Treatment
ID HERPES-SIMPLEX ENCEPHALITIS; SUBACUTE SCLEROSING-PANENCEPHALITIS; VIRUS;
   ENCEPHALOPATHY; MENINGOENCEPHALITIS; EPIDEMIOLOGY; ETIOLOGIES;
   MANAGEMENT; CHILDHOOD; OUTBREAK
AB Objectives: To review the diagnostic criteria for encephalitis and encephalopathy of presumed infectious etiology, as well as the diagnostic workup for viral encephalitis and its treatment approaches. The authors also intended to summarize relevant information on specific viruses frequently found in Brazil.
   Source of data: Literature search on Pubmed/MEDLINE using the following keywords: "viral", "encephalitis", "child", or "adolescents", filtering for articles on humans and in English.
   Summary of data: Viral encephalitis is the most common cause of encephalitis and is responsible for high rates of morbidity, permanent neurologic sequelae, and according to the virus, may have high mortality rates. The most common etiologies are herpesviruses 1 and 2 (HSV-1 and HSV-2), non-polio enterovirus, and arboviruses (in Brazil, dengue, Zika, and chikungunya). Other relevant etiologies are seasonal influenza, cytomegalovirus (CMV). Epstein-Barr virus (EBV), human herpesvirus 6 (HHV-6), and the re-emergent measles.
   Conclusion: Clinical data, laboratory results, and neuroimaging findings support the diagnosis of encephalitis and the specific viral etiology. To increase the likelihood of etiologic confirmation, it is important to know the best approach to collecting samples and to choose the best identification technique for each virus. The differential diagnosis of viral encephalitis includes other infections and immune-mediated inflammatory central nervous system disorders. (C) 2020 Sociedade Brasileira de Pediatria. Published by Elsevier Editora Ltda.
C1 [da Costa, Bruna Klein; Sato, Douglas Kazutoshi] Pontificia Univ Catolica Rio Grande do Sul PUC RS, Hosp Sao Lucas, Dept Neurol, Porto Alegre, RS, Brazil.
   [da Costa, Bruna Klein; Sato, Douglas Kazutoshi] Pontificia Univ Catolica Rio Grande do Sul PUC RS, Escola Med, Porto Alegre, RS, Brazil.
   [Sato, Douglas Kazutoshi] Pontificia Univ Catolica Rio Grande do Sul PUC RS, Inst Cerebro, Porto Alegre, RS, Brazil.
RP da Costa, BK (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUC RS, Hosp Sao Lucas, Dept Neurol, Porto Alegre, RS, Brazil.; da Costa, BK (corresponding author), Pontificia Univ Catolica Rio Grande do Sul PUC RS, Escola Med, Porto Alegre, RS, Brazil.
EM brunakleinc@gmail.com
RI Sato, Douglas K/F-2508-2013
OI Sato, Douglas K/0000-0002-7695-6020; Klein da Costa,
   Bruna/0000-0002-4752-2717
FU Coordenacaode Aperfeicoamento de Pessoal de Nivel Superior (CAPES) -
   Brazilian Federal Agency for Support andEvaluation of Graduate Education
   (PROEX Program)CAPES [001]
FX The authors would like to acknowledge the Coordenacaode Aperfeicoamento
   de Pessoal de Nivel Superior (CAPES), Finance Code 001 - Brazilian
   Federal Agency for Support andEvaluation of Graduate Education (PROEX
   Program).
CR Agut H, 2015, CLIN MICROBIOL REV, V28, P313, DOI 10.1128/CMR.00122-14
   Akhmadishina LV, 2015, EMERG INFECT DIS, V21, P1440, DOI 10.3201/eid2108.141084
   Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Casas-Alba D, 2017, CLIN MICROBIOL INFEC, V23, P874, DOI 10.1016/j.cmi.2017.03.016
   Cinque P, 1996, J NEUROL NEUROSUR PS, V61, P339, DOI 10.1136/jnnp.61.4.339
   Dalmau J, 2017, PHYSIOL REV, V97, P839, DOI 10.1152/physrev.00010.2016
   De Broucker T, 2012, CLIN MICROBIOL INFEC, V18, P808, DOI 10.1111/j.1469-0691.2011.03705.x
   Doja A, 2006, J CHILD NEUROL, V21, P384, DOI 10.1177/08830738060210051101
   Donoso Mantke O, 2008, EUROSURVEILLANCE, V13, P8017
   Gerardin P, 2016, NEUROLOGY, V86, P94, DOI 10.1212/WNL.0000000000002234
   Gilden D, 2009, LANCET NEUROL, V8, P731, DOI 10.1016/S1474-4422(09)70134-6
   Glaser CA, 2006, CLIN INFECT DIS, V43, P1565, DOI 10.1086/509330
   Gold JJ, 2014, PEDIATR NEUROL, V50, P318, DOI 10.1016/j.pediatrneurol.2013.12.014
   Guo Y, 2019, INT J INFECT DIS, V82, P106, DOI 10.1016/j.ijid.2019.02.045
   Gutierrez J, 2010, DEV MED CHILD NEUROL, V52, P901, DOI 10.1111/j.1469-8749.2010.03717.x
   Holt RL, 2016, J PEDIATR-US, V179, P259, DOI 10.1016/j.jpeds.2016.08.051
   Carod-Artal FJ, 2013, LANCET NEUROL, V12, P906, DOI 10.1016/S1474-4422(13)70150-9
   Johnson RT, 1998, VIRAL INFECT NERY SY
   Kennedy PGE, 2004, J NEUROL NEUROSUR PS, V75, pI10, DOI 10.1136/jnnp.2003.034280
   Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013
   KOSKINIEMI M, 1991, ANN NEUROL, V29, P492, DOI 10.1002/ana.410290508
   McGrath N, 1997, J NEUROL NEUROSUR PS, V63, P321, DOI 10.1136/jnnp.63.3.321
   Melenotte C, 2013, INT J INFECT DIS, V17, pE72, DOI 10.1016/j.ijid.2012.11.003
   MIZUGUCHI M, 1995, J NEUROL NEUROSUR PS, V58, P555, DOI 10.1136/jnnp.58.5.555
   Morishima T, 2007, CLIN INFECT DIS, V35, P517
   Notebaert A, 2013, PEDIATR NEUROL, V48, P135, DOI 10.1016/j.pediatrneurol.2012.10.003
   Pacheco Leonardo R., 2005, Rev. Assoc. Med. Bras., V51, P275, DOI 10.1590/S0104-42302005000500019
   Perez-Velez CM, 2007, CLIN INFECT DIS, V45, P950, DOI 10.1086/521895
   Pradhan F, 2017, AM J TROP MED HYG, V97, P340, DOI 10.4269/ajtmh.16-0921
   Raschilas F, 2002, CLIN INFECT DIS, V35, P254, DOI 10.1086/341405
   Soares CN, 2011, J NEUROL SCI, V303, P75, DOI 10.1016/j.jns.2011.01.012
   Sugaya N, 2000, PEDIATR INT, V42, P215, DOI 10.1046/j.1442-200x.2000.01200.x
   Tenembaum SN, 2017, NEUROIMAGING CTIN N, V27, P729
   Tunkel AR, 2008, CLIN INFECT DIS, V47, P303, DOI 10.1086/589747
   Venkatesan A, 2013, CLIN INFECT DIS, V57, P1114, DOI 10.1093/cid/cit458
   Wang GF, 2010, CURR OPIN NEUROL, V23, P305, DOI 10.1097/WCO.0b013e328338f6c9
   Wang IJ, 2007, EUR J PAEDIATR NEURO, V11, P63, DOI 10.1016/j.ejpn.2006.09.010
   Ward KN, 2007, J CLIN MICROBIOL, V45, P1298, DOI 10.1128/JCM.02115-06
   Weil AA, 2002, CLIN INFECT DIS, V34, P1154, DOI 10.1086/339550
   Whitley Richard J, 2005, Semin Pediatr Infect Dis, V16, P17, DOI 10.1053/j.spid.2004.09.007
NR 41
TC 1
Z9 1
U1 0
U2 0
PU SOC BRASIL PEDIATRIA
PI RIO DE JANEIRO, RJ
PA RUA SANTA CLARA 292, RIO DE JANEIRO, RJ, CEP 22401-01, BRAZIL
SN 0021-7557
EI 1678-4782
J9 J PEDIAT-BRAZIL
JI J. Pediatr.
PD MAR-APR
PY 2020
VL 96
SU 1
BP 12
EP 19
DI 10.1016/j.jped.2019.07.005
PG 8
WC Pediatrics
SC Pediatrics
GA LG5TX
UT WOS:000528163900003
PM 31513761
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Jugler, C
   Joensuu, J
   Chen, Q
AF Jugler, Collin
   Joensuu, Jussi
   Chen, Qiang
TI Hydrophobin-Protein A Fusion Protein Produced in Plants Efficiently
   Purified an Anti-West Nile Virus Monoclonal Antibody from Plant Extracts
   via Aqueous Two-Phase Separation
SO INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
LA English
DT Article
DE monoclonal antibody (mAb); aqueous two-phase separation (ATPS);
   hydrophobin; West Nile virus; plant-made antibody
ID RECOMBINANT PROTEINS; PURIFICATION; INFECTION; TOBACCO; PARTICLES; ZIKA
AB The development of monoclonal antibodies (mAbs) has provided vast opportunities to treat a wide range of diseases from cancer to viral infections. While plant-based production of mAbs has effectively lowered the upstream cost of mAb production compared to mammalian cell cultures, further optimization of downstream processing, especially in extending the longevity of Protein A resin by an effective bulk separation step, will further reduce the overall prohibitive cost of mAb production. In this study, we explored the feasibility of using aqueous two-phase separation (ATPS) in capturing and separating plant-made mAbs from host proteins. Our results demonstrated that an anti-West Nile virus mAb (E16) was efficiently separated from most plant host proteins by a single ATPS step, comprising the mixing of plant extracts containing Hydrophobin-Protein A fusion protein (HPA) and E16 and the subsequent incubation with an inexpensive detergent. This simple ATPS step yielded a highly enriched E16 mAb preparation with a recovery rate comparable to that of Protein A chromatography. The ATPS-enriched E16 retained its structural integrity and was fully functional in binding its target antigen. Notably, HPA-based ATPS was also effective in enriching E16 from plant host proteins when both HPA and E16 were produced in the same leaves, supporting the potential of further streamlining the downstream purification process. Thus, ATPS based on plant-produced HPA in unpurified extract is a cost-effective yet efficient initial capture step for purifying plant-made mAbs, which may significantly impact the approach of mAb purification.
C1 [Jugler, Collin; Chen, Qiang] Arizona State Univ, Biodesign Inst, Mail Zone 5401,1001 S McAllister Ave, Tempe, AZ 85287 USA.
   [Jugler, Collin; Chen, Qiang] Arizona State Univ, Sch Life Sci, Mail Zone 5401,1001 S McAllister Ave, Tempe, AZ 85287 USA.
   [Joensuu, Jussi] VTT Tech Res Ctr Finland Ltd, Espoo, Finland.
RP Chen, Q (corresponding author), Arizona State Univ, Biodesign Inst, Mail Zone 5401,1001 S McAllister Ave, Tempe, AZ 85287 USA.; Chen, Q (corresponding author), Arizona State Univ, Sch Life Sci, Mail Zone 5401,1001 S McAllister Ave, Tempe, AZ 85287 USA.
EM cjugler@asu.edu; jussi.joensuu@iki.fi; shawn.chen@asu.edu
OI chen, qiang/0000-0003-1498-7013
FU National Institute of Allergy and Infectious Diseases (NIAID)United
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [R33AI101329]
FX This work was supported in part by a grant from National Institute of
   Allergy and Infectious Diseases (NIAID) R33AI101329 to QC.
CR Bai Y, 2003, BIOTECHNOL BIOENG, V81, P855, DOI 10.1002/bit.10532
   BAUMAL R, 1971, J EXP MED, V134, P1316, DOI 10.1084/jem.134.5.1316
   Chen Q., 2008, BIOL ENG, V1, P291, DOI DOI 10.13031/201326854
   Chen Q, 2016, P NATL ACAD SCI USA, V113, P9404, DOI 10.1073/pnas.1610803113
   Chen Q, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/932161
   Chen Q, 2011, TRANSGENIC HORTICULTURAL CROPS: CHALLENGES AND OPPORTUNITIES, P83
   Chen QJ, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.127
   De Muynck B, 2010, PLANT BIOTECHNOL J, V8, P529, DOI 10.1111/j.1467-7652.2009.00494.x
   Dent M, 2016, J GEN VIROL, V97, P3280, DOI 10.1099/jgv.0.000635
   Dietrich C, 2003, J GEN VIROL, V84, P2871, DOI 10.1099/vir.0.19245-0
   Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042
   Feige MJ, 2010, TRENDS BIOCHEM SCI, V35, P189, DOI 10.1016/j.tibs.2009.11.005
   Fulton A, 2015, J CHROMATOGR A, V1389, P128, DOI 10.1016/j.chroma.2015.02.013
   Ghose S, 2007, BIOTECHNOL BIOENG, V96, P768, DOI 10.1002/bit.21044
   He JY, 2014, BIOMED RES INT, DOI 10.1155/2014/952865
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   Hey C, 2012, CHEM ENG TECHNOL, V35, P142, DOI 10.1002/ceat.201100259
   Hiatt A, 2014, P NATL ACAD SCI USA, V111, P5992, DOI 10.1073/pnas.1402458111
   Huang Z, 2010, BIOTECHNOL BIOENG, V106, P9, DOI 10.1002/bit.22652
   Huang Z, 2009, BIOTECHNOL BIOENG, V103, P706, DOI 10.1002/bit.22299
   Hurtado J, 2020, PLANT BIOTECHNOL J, V18, P266, DOI 10.1111/pbi.13194
   Iqbal M, 2016, BIOL PROCED ONLINE, V18, DOI 10.1186/s12575-016-0048-8
   Jiang CP, 2009, J CHROMATOGR A, V1216, P5849, DOI 10.1016/j.chroma.2009.06.013
   Joensuu JJ, 2010, PLANT PHYSIOL, V152, P622, DOI 10.1104/pp.109.149021
   Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834
   Kim ES, 2017, DRUGS, V77, P929, DOI 10.1007/s40265-017-0749-6
   Kurppa K, 2018, PLANT BIOTECHNOL J, V16, P404, DOI 10.1111/pbi.12780
   Lahtinen T, 2008, PROTEIN EXPRES PURIF, V59, P18, DOI 10.1016/j.pep.2007.12.014
   Lai HF, 2018, VACCINE, V36, P1846, DOI 10.1016/j.vaccine.2018.02.073
   Lai HF, 2014, PLANT BIOTECHNOL J, V12, P1098, DOI 10.1111/pbi.12217
   Lai HF, 2012, PLANT BIOTECHNOL J, V10, P95, DOI 10.1111/j.1467-7652.2011.00649.x
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Leuzinger K, 2013, JOVE-J VIS EXP, DOI 10.3791/50521
   Lico C, 2006, J GEN VIROL, V87, P3103, DOI 10.1099/vir.0.82097-0
   Linder MB, 2004, BIOCHEMISTRY-US, V43, P11873, DOI 10.1021/bi0488202
   Ma JKC, 2015, PLANT BIOTECHNOL J, V13, P1106, DOI 10.1111/pbi.12416
   Nandi S, 2016, MABS-AUSTIN, V8, P1456, DOI 10.1080/19420862.2016.1227901
   Pathak M, 2016, J CHROMATOGR A, V1459, P78, DOI 10.1016/j.chroma.2016.06.084
   Phoolcharoen W, 2011, PLANT BIOTECHNOL J, V9, P807, DOI 10.1111/j.1467-7652.2011.00593.x
   Qiu XG, 2014, NATURE, V514, P47, DOI 10.1038/nature13777
   Reuter LJ, 2017, BIOCONJUGATE CHEM, V28, P1639, DOI 10.1021/acs.bioconjchem.7b00075
   Show PL, 2015, CURR ORG CHEM, V19, P19, DOI 10.2174/1385272819666141107225446
   Valdes R, 2003, BIOCHEM BIOPH RES CO, V308, P94, DOI 10.1016/S0006-291X(03)01335-4
   WALTER H, 1991, ANAL BIOCHEM, V197, P1, DOI 10.1016/0003-2697(91)90348-W
   Yang M, 2018, PLANT BIOTECHNOL J, V16, P572, DOI 10.1111/pbi.12796
   Yang M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08247-9
NR 46
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1422-0067
J9 INT J MOL SCI
JI Int. J. Mol. Sci.
PD MAR
PY 2020
VL 21
IS 6
AR 2140
DI 10.3390/ijms21062140
PG 11
WC Biochemistry & Molecular Biology; Chemistry, Multidisciplinary
SC Biochemistry & Molecular Biology; Chemistry
GA LJ0UU
UT WOS:000529890200236
PM 32244994
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Cabral-Miranda, G
   Lim, SM
   Mohsen, MO
   Pobelov, IV
   Roesti, ES
   Heath, MD
   Skinner, MA
   Kramer, MF
   Martina, BEE
   Bachmann, MF
AF Cabral-Miranda, Gustavo
   Lim, Stephanie M.
   Mohsen, Mona O.
   Pobelov, Ilya V.
   Roesti, Elisa S.
   Heath, Matthew D.
   Skinner, Murray A.
   Kramer, Matthias F.
   Martina, Byron E. E.
   Bachmann, Martin F.
TI Zika Virus-Derived E-DIII Protein Displayed on Immunologically Optimized
   VLPs Induces Neutralizing Antibodies without Causing Enhancement of
   Dengue Virus Infectio (vol 7, 72, 2019)
SO VACCINES
LA English
DT Correction
C1 [Cabral-Miranda, Gustavo; Mohsen, Mona O.; Bachmann, Martin F.] Univ Oxford, Ctr Cellular & Mol Physiol CCMP, Nuffield Dept Med, Jenner Inst, Oxford OX1 2JD, England.
   [Cabral-Miranda, Gustavo; Mohsen, Mona O.; Roesti, Elisa S.; Bachmann, Martin F.] Univ Bern, Inselspital, RIA, Immunol, CH-3010 Bern, Switzerland.
   [Lim, Stephanie M.; Martina, Byron E. E.] Artemis Biosupport, NL-2629 Delft, Netherlands.
   [Pobelov, Ilya V.] Univ Bern, Dept Chem & Biochem, CH-3010 Bern, Switzerland.
   [Heath, Matthew D.; Skinner, Murray A.; Kramer, Matthias F.] Bencard Adjuvant Syst, Worthing BN14 8SA, England.
   [Martina, Byron E. E.] Erasmus MC, Dept Virosci, NL-3015 GD Rotterdam, Netherlands.
RP Cabral-Miranda, G; Bachmann, MF (corresponding author), Univ Oxford, Ctr Cellular & Mol Physiol CCMP, Nuffield Dept Med, Jenner Inst, Oxford OX1 2JD, England.; Cabral-Miranda, G; Bachmann, MF (corresponding author), Univ Bern, Inselspital, RIA, Immunol, CH-3010 Bern, Switzerland.
EM gcabral.miranda@gmail.com; s.lim@artemisonehealth.com;
   mmohsen@qf.org.qa; ilya.pobelov@dcb.unibe.ch;
   elisa.roesti@dbmr.unibe.ch; matthew.heath@allergytherapeutics.com;
   Murray.Skinner@allergytherapeutics.com; KramerM@bencard.com;
   b.martina@artemisonehealth.com; martin.bachmann@me.com
CR Cabral-Miranda G, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030072
NR 1
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD MAR
PY 2020
VL 8
IS 1
AR 94
DI 10.3390/vaccines8010094
PG 2
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LI4EV
UT WOS:000529439800093
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kreer, C
   Gruell, H
   Mora, T
   Walczak, AM
   Klein, F
AF Kreer, Christoph
   Gruell, Henning
   Mora, Thierry
   Walczak, Aleksandra M.
   Klein, Florian
TI Exploiting B Cell Receptor Analyses to Inform on HIV-1 Vaccination
   Strategies
SO VACCINES
LA English
DT Review
DE B lymphocytes; B cell receptors; antibodies; antibody repertoire;
   immunoglobulin; Rep-seq; Ig-seq; vaccination strategy; HIV-1; broadly
   neutralizing antibodies
ID HUMAN MONOCLONAL-ANTIBODIES; POTENT NEUTRALIZING ANTIBODIES;
   SINGLE-CELL; GENE-SEGMENT; HIV-1-NEUTRALIZING ANTIBODIES; ZIKA VIRUS;
   IMMUNOGLOBULIN HEAVY; MATURATION PATHWAY; VARIABLE REGIONS; STRUCTURAL
   BASIS
AB The human antibody repertoire is generated by the recombination of different gene segments as well as by processes of somatic mutation. Together these mechanisms result in a tremendous diversity of antibodies that are able to combat various pathogens including viruses and bacteria, or malignant cells. In this review, we summarize the opportunities and challenges that are associated with the analyses of the B cell receptor repertoire and the antigen-specific B cell response. We will discuss how recent advances have increased our understanding of the antibody response and how repertoire analyses can be exploited to inform on vaccine strategies, particularly against HIV-1.
C1 [Kreer, Christoph; Gruell, Henning; Klein, Florian] Univ Cologne, Lab Expt Immunol, Inst Virol, Fac Med, D-50931 Cologne, Germany.
   [Kreer, Christoph; Gruell, Henning; Klein, Florian] Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany.
   [Gruell, Henning; Klein, Florian] German Ctr Infect Res, Partner Site Bonn Cologne, D-50931 Cologne, Germany.
   [Mora, Thierry; Walczak, Aleksandra M.] Univ Paris, Sorbonne Univ, CNRS, Lab Phys,Ecole Normale Super,PSL Univ, Paris 75005, France.
   [Klein, Florian] Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
RP Klein, F (corresponding author), Univ Cologne, Lab Expt Immunol, Inst Virol, Fac Med, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Univ Hosp Cologne, D-50931 Cologne, Germany.; Klein, F (corresponding author), German Ctr Infect Res, Partner Site Bonn Cologne, D-50931 Cologne, Germany.; Klein, F (corresponding author), Univ Cologne, Ctr Mol Med Cologne CMMC, D-50931 Cologne, Germany.
EM christoph.kreer@uk-koeln.de; henning.gruell@uk-koeln.de;
   tmora@phys.ens.fr; awalczak@lpt.ens.fr; florian.klein@uk-koeln.de
OI Grull, Henning/0000-0002-0725-7138; Kreer, Christoph/0000-0002-9140-9850
FU German Center for Infection Research (DZIF); German Research
   FoundationGerman Research Foundation (DFG) [CRC 1279, CRC 1310];
   European Research CouncilEuropean Research Council (ERC) [ERC-StG639961,
   ERC-COG724208]
FX This work was supported by the German Center for Infection Research
   (DZIF), the German Research Foundation (CRC 1279, CRC 1310), and the
   European Research Council (ERC-StG639961 and ERC-COG724208).
CR Alt FW, 2013, CELL, V152, P417, DOI 10.1016/j.cell.2013.01.007
   Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243
   Bar-On Y, 2018, NAT MED, V24, P1701, DOI 10.1038/s41591-018-0186-4
   Barnes CO, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03632-y
   Bhiman JN, 2015, NAT MED, V21, P1332, DOI 10.1038/nm.3963
   Bonsignori M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aai7514
   Bonsignori M, 2016, CELL, V165, P449, DOI 10.1016/j.cell.2016.02.022
   Bornholdt ZA, 2016, SCIENCE, V351, P1078, DOI 10.1126/science.aad5788
   Boyd SD, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000540
   Boyer S, 2016, P NATL ACAD SCI USA, V113, P3482, DOI 10.1073/pnas.1517813113
   Bradbury ARM, 2011, NAT BIOTECHNOL, V29, P245, DOI 10.1038/nbt.1791
   Briggs AW, 2017, BIORXIV, DOI [10. 1101/134841, DOI 10.1101/134841]
   Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y
   Briney BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036750
   Bryson S, 2016, J IMMUNOL, V196, P4723, DOI 10.4049/jimmunol.1402890
   BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359
   BURTON DR, 1991, P NATL ACAD SCI USA, V88, P10134, DOI 10.1073/pnas.88.22.10134
   Busse CE, 2014, EUR J IMMUNOL, V44, P597, DOI 10.1002/eji.201343917
   Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011
   Caskey M, 2017, NAT MED, V23, P185, DOI 10.1038/nm.4268
   Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411
   Chaudhary N, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00462
   Chen WZ, 2012, EXP MOL PATHOL, V93, P399, DOI 10.1016/j.yexmp.2012.09.022
   Corrie BD, 2018, IMMUNOL REV, V284, P24, DOI 10.1111/imr.12666
   Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669
   Corti D, 2010, J CLIN INVEST, V120, P1663, DOI 10.1172/JCI41902
   De Benedictis P, 2016, EMBO MOL MED, V8, P407, DOI 10.15252/emmm.201505986
   de Costa D, 2010, J PROTEOME RES, V9, P2937, DOI 10.1021/pr901114w
   DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113
   DeKosky BJ, 2015, NAT MED, V21, P86, DOI 10.1038/nm.3743
   Doria-Rose NA, 2016, J VIROL, V90, P76, DOI 10.1128/JVI.01791-15
   Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036
   Ehrhardt SA, 2019, NAT MED, V25, P1589, DOI 10.1038/s41591-019-0602-4
   Elhanati Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0243
   Eyer K, 2017, NAT BIOTECHNOL, V35, P977, DOI 10.1038/nbt.3964
   Farci P, 2010, P NATL ACAD SCI USA, V107, P8766, DOI [10.1073/pnas.1003854107, 10.1073/pnas.1003833107]
   Freund NT, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal2144
   FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998
   Galson JD, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0322-z
   Gao F, 2014, CELL, V158, P481, DOI 10.1016/j.cell.2014.06.022
   Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677
   Georgiev IS, 2013, SCIENCE, V340, P751, DOI 10.1126/science.1233989
   Glanville J, 2011, P NATL ACAD SCI USA, V108, P20066, DOI 10.1073/pnas.1107498108
   Godoy-Lozano EE, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0276-1
   Goldstein LD, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0551-y
   Gorny MK, 2009, MOL IMMUNOL, V46, P917, DOI 10.1016/j.molimm.2008.09.005
   Greiff V, 2015, TRENDS IMMUNOL, V36, P738, DOI 10.1016/j.it.2015.09.006
   Havenar-Daughton C, 2018, CURR OPIN IMMUNOL, V53, P209, DOI 10.1016/j.coi.2018.08.002
   Havenar-Daughton C, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0381
   Haynes BF, 2012, NAT BIOTECHNOL, V30, P423, DOI 10.1038/nbt.2197
   Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781
   He LL, 2014, SCI REP-UK, V4, DOI 10.1038/srep06778
   Hicar MD, 2010, JAIDS-J ACQ IMM DEF, V54, P223, DOI 10.1097/QAI.0b013e3181dc98a3
   Hoehn KB, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0241
   Hoot S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003106
   HUANG C, 1991, J IMMUNOL METHODS, V141, P227, DOI 10.1016/0022-1759(91)90149-A
   Huang JH, 2016, IMMUNITY, V45, P1108, DOI 10.1016/j.immuni.2016.10.027
   Ibrahim SF, 2007, ADV BIOCHEM ENG BIOT, V106, P19, DOI 10.1007/10_2007_073
   Ippolito GC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035497
   Jackson KJL, 2014, CELL HOST MICROBE, V16, P105, DOI 10.1016/j.chom.2014.05.013
   Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195
   Joyce MG, 2016, CELL, V166, P609, DOI 10.1016/j.cell.2016.06.043
   Julg B, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal1321
   Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144
   Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018
   Klein F, 2012, J EXP MED, V209, P1469, DOI 10.1084/jem.20120423
   KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451
   Kong R, 2016, SCIENCE, V352, P828, DOI 10.1126/science.aae0474
   Kreer C., BIORXIV 2019 847574, DOI [10.1101/847574, DOI 10.1101/847574]
   KUPPERS R, 1993, EMBO J, V12, P4955, DOI 10.1002/j.1460-2075.1993.tb06189.x
   Kwong PD, 2018, IMMUNITY, V48, P855, DOI 10.1016/j.immuni.2018.04.029
   Landais E, 2017, IMMUNITY, V47, P990, DOI 10.1016/j.immuni.2017.11.002
   LARRICK JW, 1989, BIOCHEM BIOPH RES CO, V160, P1250, DOI 10.1016/S0006-291X(89)80138-X
   LeBien TW, 2008, BLOOD, V112, P1570, DOI 10.1182/blood-2008-02-078071
   Lee JH, 2017, IMMUNITY, V46, P690, DOI 10.1016/j.immuni.2017.03.017
   Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209
   Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053
   Lim TS, 2010, NEW BIOTECHNOL, V27, P108, DOI 10.1016/j.nbt.2010.01.001
   Lucas AH, 2003, CLIN IMMUNOL, V108, P119, DOI 10.1016/S1521-6616(03)00094-9
   Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752
   MacLeod DT, 2016, IMMUNITY, V44, P1215, DOI 10.1016/j.immuni.2016.04.016
   Marcou Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02832-w
   Mascola JR, 2013, IMMUNOL REV, V254, P225, DOI 10.1111/imr.12075
   Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046
   McDaniel JR, 2016, NAT PROTOC, V11, P429, DOI 10.1038/nprot.2016.024
   McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696
   Mendoza P, 2018, NATURE, V561, P479, DOI 10.1038/s41586-018-0531-2
   Miho E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00224
   Moldt B, 2012, P NATL ACAD SCI USA, V109, P18921, DOI 10.1073/pnas.1214785109
   Mora T., 2019, CURR OPIN SYST BIOL, V18, P104, DOI [10.1016/j.coisb.2019.10.001, DOI 10.1016/J.COISB.2019.10.001]
   Nielsen SCA, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat2004
   Olbrich A, 2019, J INFECT DIS, V220, P1209, DOI 10.1093/infdis/jiz274
   Ozawa T, 2006, BIOTECHNIQUES, V40, P469, DOI 10.2144/000112123
   Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764
   PARVIN JD, 1986, J VIROL, V59, P377, DOI 10.1128/JVI.59.2.377-383.1986
   Plouffe BD, 2015, REP PROG PHYS, V78, DOI 10.1088/0034-4885/78/1/016601
   Rijal P, 2019, CELL REP, V27, P172, DOI 10.1016/j.celrep.2019.03.020
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rollenske T, 2018, NAT IMMUNOL, V19, P617, DOI 10.1038/s41590-018-0106-2
   Rudicell RS, 2014, J VIROL, V88, P12669, DOI 10.1128/JVI.02213-14
   Sajadi MM, 2018, CELL, V173, P1783, DOI 10.1016/j.cell.2018.03.061
   Sanders RW, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003618
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sblattero D, 1998, IMMUNOTECHNOLOGY, V3, P271, DOI 10.1016/S1380-2933(97)10004-5
   Scheepers C, 2015, J IMMUNOL, V194, P4371, DOI 10.4049/jimmunol.1500118
   Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929
   Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930
   Schramm CA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01876
   Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046
   Sethna Z, 2019, BIOINFORMATICS, V35, P2974, DOI 10.1093/bioinformatics/btz035
   Setliff I, 2019, CELL, V179, P1636, DOI 10.1016/j.cell.2019.11.003
   Setliff I, 2018, CELL HOST MICROBE, V23, P845, DOI 10.1016/j.chom.2018.05.001
   Shembekar N, 2018, CELL REP, V22, P2206, DOI 10.1016/j.celrep.2018.01.071
   Shingai M, 2014, J EXP MED, V211, P2061, DOI 10.1084/jem.20132494
   Simonich CA, 2016, CELL, V166, P77, DOI 10.1016/j.cell.2016.05.055
   Singh M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11049-4
   Sok D, 2018, NAT IMMUNOL, V19, P1179, DOI 10.1038/s41590-018-0235-7
   Sok D, 2014, P NATL ACAD SCI USA, V111, P17624, DOI 10.1073/pnas.1415789111
   Sok D, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003754
   Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8
   Soto C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157409
   STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6
   Steichen JM, 2019, SCIENCE, V366, P1216, DOI 10.1126/science.aax4380
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Sui JH, 2009, NAT STRUCT MOL BIOL, V16, P265, DOI 10.1038/nsmb.1566
   Tan YC, 2014, CLIN IMMUNOL, V151, P55, DOI 10.1016/j.clim.2013.12.008
   Teng G, 2007, ANNU REV GENET, V41, P107, DOI 10.1146/annurev.genet.41.110306.130340
   Thomson CA, 2008, EMBO J, V27, P2592, DOI 10.1038/emboj.2008.179
   Tian CX, 2008, J IMMUNOL, V180, P3279, DOI 10.4049/jimmunol.180.5.3279
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080
   Umotoy J, 2019, IMMUNITY, V51, P141, DOI 10.1016/j.immuni.2019.06.004
   van Gils MJ, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.199
   Vander Heiden JA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02206
   Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032
   Vidarsson G, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00520
   Vollmers C, 2013, P NATL ACAD SCI USA, V110, P13463, DOI 10.1073/pnas.1312146110
   Walker LM, 2018, NAT REV IMMUNOL, V18, P297, DOI 10.1038/nri.2017.148
   Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746
   Walker LM, 2009, J MOL BIOL, V389, P365, DOI 10.1016/j.jmb.2009.04.019
   Waltari E, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00628
   Wardemann H, 2003, SCIENCE, V301, P1374, DOI 10.1126/science.1086907
   Weitkamp JH, 2005, J IMMUNOL, V174, P3454, DOI 10.4049/jimmunol.174.6.3454
   Weitkamp JH, 2003, J IMMUNOL, V171, P4680, DOI 10.4049/jimmunol.171.9.4680
   West AP, 2012, P NATL ACAD SCI USA, V109, pE2083, DOI 10.1073/pnas.1208984109
   Williams LD, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2200
   Willis JR, 2016, P NATL ACAD SCI USA, V113, P4446, DOI 10.1073/pnas.1518405113
   Wilson PC, 2012, NAT REV IMMUNOL, V12, P709, DOI 10.1038/nri3285
   Woda M, 2015, J IMMUNOL METHODS, V416, P167, DOI 10.1016/j.jim.2014.12.001
   Wu XL, 2015, CELL, V161, P470, DOI 10.1016/j.cell.2015.03.004
   Wu XL, 2011, SCIENCE, V333, P1593, DOI 10.1126/science.1207532
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Wu YL, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.79
   Wu YC, 2010, BLOOD, V116, P1070, DOI 10.1182/blood-2010-03-275859
   Xi HD, 2017, LAB CHIP, V17, P751, DOI 10.1039/c6lc01435f
   Xiao M, 2013, EXP MOL PATHOL, V95, P357, DOI 10.1016/j.yexmp.2013.10.004
   Yaari G, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00358
   Yacoob C, 2016, CELL REP, V17, P1560, DOI 10.1016/j.celrep.2016.10.017
   Yin L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00373
   Zhang Y, 2013, AIDS, V27, P2529, DOI 10.1097/QAD.0000000000000015
   Zhou TQ, 2015, CELL, V161, P1280, DOI 10.1016/j.cell.2015.05.007
   Zhou TQ, 2013, IMMUNITY, V39, P245, DOI 10.1016/j.immuni.2013.04.012
   Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819
   Zhu J, 2013, P NATL ACAD SCI USA, V110, pE4088, DOI 10.1073/pnas.1306262110
   Zhu J, 2013, P NATL ACAD SCI USA, V110, P6470, DOI 10.1073/pnas.1219320110
   Zhu J, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00315
NR 168
TC 1
Z9 1
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-393X
J9 VACCINES-BASEL
JI Vaccines
PD MAR
PY 2020
VL 8
IS 1
AR 13
DI 10.3390/vaccines8010013
PG 19
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA LI4EV
UT WOS:000529439800013
PM 31906351
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Colmant, AMG
   Bielefeldt-Ohmann, H
   Vet, LJ
   O'Brien, CA
   Bowen, RA
   Hartwig, AE
   Davis, S
   Piyasena, TBH
   Habarugira, G
   Harrison, JJ
   Hobson-Peters, J
   Hall, RA
AF Colmant, Agathe M. G.
   Bielefeldt-Ohmann, Helle
   Vet, Laura J.
   O'Brien, Caitlin A.
   Bowen, Richard A.
   Hartwig, Airn E.
   Davis, Steven
   Piyasena, Thisun B. H.
   Habarugira, Gervais
   Harrison, Jessica J.
   Hobson-Peters, Jody
   Hall, Roy A.
TI NS4/5 mutations enhance flavivirus Bamaga virus infectivity and
   pathogenicity in vitro and in vivo
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; VIRAL SPREAD; RNA; REPLICATION; IDENTIFICATION;
   DETERMINANTS; TRANSMISSION; CONTRIBUTES; LINEAGE; ROLES
AB Author summary
   Mosquito-borne pathogens include flaviviruses such as yellow fever virus, dengue virus and Zika virus, which continue to cause disease worldwide. Some of these flaviviruses have only recently emerged as major human pathogens, despite having been discovered decades ago. Determining the mechanisms of host-restriction of viruses with cryptic ecological niches will help us to understand how new viral diseases may emerge. In this study, we investigated the host-restriction of a recently discovered flavivirus, Bamaga virus. We demonstrated that the virus host-restriction observed in vertebrate cells only occurs at 37 degrees C, and that the virus can replicate efficiently at lower temperatures. We identified three amino acid substitutions located at two viral protease cleavage sites, which we have demonstrated are directly involved in BgV host-restriction in vitro and attenuation in vivo. Overall, our data provide new insight into mechanisms flavivirus attenuation and host-restriction in vertebrates.
   Flaviviruses such as yellow fever, dengue or Zika viruses are responsible for significant human and veterinary diseases worldwide. These viruses contain an RNA genome, prone to mutations, which enhances their potential to emerge as pathogens. Bamaga virus (BgV) is a mosquito-borne flavivirus in the yellow fever virus group that we have previously shown to be host-restricted in vertebrates and horizontally transmissible by Culex mosquitoes. Here, we aimed to characterise BgV host-restriction and to investigate the mechanisms involved. We showed that BgV could not replicate in a wide range of vertebrate cell lines and animal species. We determined that the mechanisms involved in BgV host-restriction were independent of the type-1 interferon response and RNAse L activity. Using a BgV infectious clone and two chimeric viruses generated as hybrids between BgV and West Nile virus, we demonstrated that BgV host-restriction occurred post-cell entry. Notably, BgV host-restriction was shown to be temperature-dependent, as BgV replicated in all vertebrate cell lines at 34 degrees C but only in a subset at 37 degrees C. Serial passaging of BgV in Vero cells resulted in adaptive mutants capable of efficient replication at 37 degrees C. The identified mutations resulted in amino acid substitutions in NS4A-S124F, NS4B-N244K and NS5-G2C, all occurring close to a viral protease cleavage site (NS4A/2K and NS4B/NS5). These mutations were reverse engineered into infectious clones of BgV, which revealed that NS4B-N244K and NS5-G2C were sufficient to restore BgV replication in vertebrate cells at 37 degrees C, while NS4A-S124F further increased replication efficiency. When these mutant viruses were injected into immunocompetent mice, alongside BgV and West Nile virus chimeras, infection and neurovirulence were enhanced as determined by clinical scores, seroconversion, micro-neutralisation, viremia, histopathology and immunohistochemistry, confirming the involvement of these residues in the attenuation of BgV. Our studies identify a new mechanism of host-restriction and attenuation of a mosquito-borne flavivirus.
C1 [Colmant, Agathe M. G.; Bielefeldt-Ohmann, Helle; Vet, Laura J.; O'Brien, Caitlin A.; Piyasena, Thisun B. H.; Habarugira, Gervais; Harrison, Jessica J.; Hobson-Peters, Jody; Hall, Roy A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
   [Bielefeldt-Ohmann, Helle; Habarugira, Gervais] Univ Queensland, Sch Vet Sci, Gatton, Qld, Australia.
   [Bowen, Richard A.; Hartwig, Airn E.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA.
   [Davis, Steven] Northern Terr Govt, Berrimah Vet Labs, Dept Primary Ind & Resources, Berrimah, NT, Australia.
RP Colmant, AMG; Hall, RA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.
EM agathe.colmant@uq.net.au; roy.hall@uq.edu.au
OI Vet, Laura/0000-0001-7587-2936; /0000-0002-1657-8558; Colmant,
   Agathe/0000-0002-2004-4073; Habarugira, Gervais/0000-0001-5858-0421
FU Australian Government Research Training Program ScholarshipAustralian
   GovernmentDepartment of Industry, Innovation and Science; National
   Health and Medical Research CouncilNational Health and Medical Research
   Council of Australia [APP1138611]
FX The Australian Government Research Training Program Scholarship
   (https://www.education.gov.au/research-training-program) funded Ph.D.
   students AMGC, LJV, CAO, TBPH, GH and JJH. This research was supported
   by the National Health and Medical Research Council
   (https://nhmrc.gov.au/) with Project grant APP1138611 awarded to HBO,
   JHP and RAH. The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR Aliota MT, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-293
   Aliota MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039387
   Ambrose RL, 2011, J VIROL, V85, P11274, DOI 10.1128/JVI.05864-11
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Bakonyi T, 2005, EMERG INFECT DIS, V11, P225, DOI 10.3201/eid1102.041028
   Bielefeldt-Ohmann H, 2008, J COMP PATHOL, V138, P72, DOI 10.1016/j.jcpa.2007.10.006
   Bielefeldt-Ohmann H, 2012, INT J EXP PATHOL, V93, P24, DOI 10.1111/j.1365-2613.2011.00795.x
   Blitvich BJ, 2015, VIRUSES-BASEL, V7, P1927, DOI 10.3390/v7041927
   Bosco-Lauth AM, 2018, AM J TROP MED HYG, V98, P841, DOI 10.4269/ajtmh.17-0730
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Clarke A, 2010, J ANIM ECOL, V79, P610, DOI 10.1111/j.1365-2656.2010.01672.x
   Clavijo A, 2000, J VIROL METHODS, V87, P13, DOI 10.1016/S0166-0934(00)00150-6
   Colmant AMG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006886
   Colmant AMG, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00262-17, 10.1128/msphere.00262-17]
   Colmant AMG, 2016, J GEN VIROL, V97, P1087, DOI 10.1099/jgv.0.000430
   DESMYTER J, 1968, J VIROL, V2, P955, DOI 10.1128/JVI.2.10.955-961.1968
   EMENY JM, 1979, J GEN VIROL, V43, P247, DOI 10.1099/0022-1317-43-1-247
   Foxman EF, 2016, P NATL ACAD SCI USA, V113, P8496, DOI 10.1073/pnas.1601942113
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hubalek Z, 2010, J MED ENTOMOL, V47, P466, DOI 10.1603/ME09219
   Kerle A, 2001, POSSUMS BRUSHTAILS R, V2001
   KHROMYKH AA, 1994, J VIROL, V68, P4580, DOI 10.1128/JVI.68.7.4580-4588.1994
   Liu WJ, 2003, J VIROL, V77, P7804, DOI 10.1128/JVI.77.14.7804-7813.2003
   LUDWIG GV, 1993, IN VITRO CELL DEV-AN, V29A, P296, DOI 10.1007/BF02633958
   MANDL CW, 1991, BIOTECHNIQUES, V10, P484
   May FJ, 2006, J GEN VIROL, V87, P329, DOI 10.1099/vir.0.81252-0
   Melville L, 2012, HUNTING VIRUSES CROC
   Melville L F, 2004, Vet Ital, V40, P502
   Ngo KA, 2019, VIROLOGY, V528, P30, DOI 10.1016/j.virol.2018.11.015
   Piyasena TBH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03120-1
   Prow NA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006788
   Prow NA, 2014, J VIROL, V88, P9947, DOI 10.1128/JVI.01304-14
   Puig-Basagoiti F, 2007, VIROLOGY, V361, P229, DOI 10.1016/j.virol.2006.11.012
   Pulit-Penaloza JA, 2012, VIROLOGY, V425, P82, DOI 10.1016/j.virol.2012.01.006
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Samuel MA, 2006, J VIROL, V80, P7009, DOI 10.1128/JVI.00489-06
   Scherbik SV, 2006, J VIROL, V80, P2987, DOI 10.1128/JVI.80.6.2987-2999.2006
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Smith EC, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006254
   Suen WW, 2016, J GEN VIROL, V97, P366, DOI 10.1099/jgv.0.000356
   TAYLOR RM, 1952, J IMMUNOL, V68, P473
   van den Hurk AF, 2003, MED VET ENTOMOL, V17, P403, DOI 10.1111/j.1365-2915.2003.00458.x
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Wicker JA, 2006, VIROLOGY, V349, P245, DOI 10.1016/j.virol.2006.03.007
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
NR 49
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008166
DI 10.1371/journal.pntd.0008166
PG 28
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400084
PM 32203536
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gurman, T
   Sara, AB
   Lorenzo, FV
   Luis, D
   Hunter, G
   Maloney, S
   Fujita-Conrads, R
   Leontsini, E
AF Gurman, Tilly
   Sara, Anne Ballard
   Lorenzo, Florentina Villanueva
   Luis, Desiree
   Hunter, Gabrielle
   Maloney, Sean
   Fujita-Conrads, Ryanne
   Leontsini, Elli
TI The role of gender in Zika prevention behaviors in the Dominican
   Republic: Findings and programmatic implications from a qualitative
   study
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID RIGHTS
AB Author summary
   Zika is an important epidemiological threat in Latin America, including the Dominican Republic. Because Zika disproportionately affects women, understanding gender's role in Zika prevention is key to strengthening current and future programs. We explored the role of gender in Zika among men and women in the Dominican Republic. Topics included perceptions about Zika and perceived feasibility/effectiveness of specific Zika-prevention behaviors. We uncovered that women are largely responsible for household chores-including cleaning water storage containers (a primary mosquito vector habitat)-with men as assistants. In addition, men described their role in the family as the protector. Finally, men and women believed that partners would perceive suggesting condom use or abstinence during pregnancy as a sign of infidelity. Study findings offer valuable programmatic implications that integrate gender-related considerations in social and behavior change programs related to Zika and other arboviruses. In the end, integrating gender in a way that is mindful of the local context while not exploiting existing gender roles is critical for reducing the burden of Zika and other similar mosquito-borne diseases in the Dominican Republic and throughout the region.
   Background
   Zika remains an epidemiological threat in Latin America, including the Dominican Republic. Although transmitted by the same mosquito as Dengue and Chikungunya, Zika is unique in the potentially harmful consequences for babies born to women infected during pregnancy. Experts highlight the feminization of Zika, in terms of burden of disease and women's caregiving responsibilities. Understanding gender's role in Zika prevention, therefore, is key to strengthening current and future programs.
   Methodology/Principal findings
   This qualitative study, comprised of 12 focus group discussions and eight in-depth interviews, explored gender's role in Zika among pregnant and non-pregnant women as well as male partners of pregnant women in the Dominican Republic. Topics included perceptions about Zika and perceived feasibility and effectiveness of prevention behaviors (e.g. cleaning water storage containers, using condoms during pregnancy). Researchers applied grounded theory through a process of deductive coding-classifying data around predetermined categories-followed by inductive coding-identifying themes that emerged from coded data. Study findings uncovered three ways in which gender may influence Zika prevention. First, women are largely responsible for household chores-including cleaning water storage containers-with men as assistants. Second, men described their role in the family as the protector. Finally, men and women believed that partners would perceive suggesting condom use or abstinence during pregnancy as a sign of infidelity.
   Conclusions
   Current/future Zika programs should address knowledge gaps, especially around water storage cleaning techniques and sexual transmission. Programs should also integrate gender into programming in culturally-relevant ways that avoid reinforcing stereotypes. Furthermore, programs should tailor activities for men, women, as well as the couple. In the end, integrating gender in a way that is mindful of the local context while not exploiting existing gender roles is critical for preventing Zika and similar mosquito-borne diseases, both in the Dominican Republic and throughout the region.
C1 [Gurman, Tilly; Sara, Anne Ballard; Luis, Desiree; Hunter, Gabrielle; Maloney, Sean; Fujita-Conrads, Ryanne] Johns Hopkins Ctr Commun Programs, Baltimore, MD 21202 USA.
   [Lorenzo, Florentina Villanueva] Univ Autonoma Santo Domingo, Santo Domingo, Dominican Rep.
   [Leontsini, Elli] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA.
RP Gurman, T (corresponding author), Johns Hopkins Ctr Commun Programs, Baltimore, MD 21202 USA.
EM tgurman@jhu.edu
FU American people through the United States Agency for International
   Development (USAID) under the Breakthrough ACTIONUnited States Agency
   for International Development (USAID) [AIDOAA-A-17-00017]
FX This research was made possible by the support of the American people
   through the United States Agency for International Development (USAID)
   under the Breakthrough ACTION Cooperative Agreement #AIDOAA-A-17-00017.
   Breakthrough ACTION is based at Johns Hopkins Center for Communication
   Programs (CCP). The contents of this manuscript are the sole
   responsibility of Breakthrough ACTION and do not necessarily reflect the
   views of USAID, the United States Government, or Johns Hopkins
   University. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR [Anonymous], 2015, MED LETT DRUGS THER, V57, P66
   Beare S, 2019, GLOB HEALTH-SCI PRAC, V7, P116, DOI 10.9745/GHSP-D-18-00356
   Bott S., 2012, VIOLENCE WOMEN LATIN
   Breakthrough A Breakthrough R U.S. Agency for International Development, 2018, ZIKA PREVENTION BEHA
   Cepeda Z., 2017, DOMINICAN REPUBLIC G
   CORBIN J, 1990, Z SOZIOL, V19, P418, DOI 10.1007/BF00988593
   Danis-Lozano R, 2002, SALUD PUBLICA MEXICO, V44, P237, DOI 10.1590/s0036-36342002000300007
   Davies SE, 2016, INT AFF, V92, P1041, DOI 10.1111/1468-2346.12704
   Demographic and Health Surveys (DHS), 2013, DOM REP DEM HLTH SUR
   FHI 360, 2012, GEND INT FRAM
   Velez ACG, 2016, REPROD HEALTH MATTER, V24, P57, DOI 10.1016/j.rhm.2016.11.008
   Guerra-Reyes L, 2019, CULT HEALTH SEX, V21, P309, DOI 10.1080/13691058.2018.1469790
   Heise L, 2019, LANCET, V393, P2440, DOI 10.1016/S0140-6736(19)30652-X
   International Center for Research on Women (ICRW), 2018, GEND EQ MAL ENG IT O
   Kumoji E, 2017, MONITORING OUTCOMES
   O'Manique C, 2018, ROUT STUD PUB HLTH, P112
   Oficina Nacional de Estadistica, 2009, SANT DOM CIFR
   Oficina Nacional de Estadistica, 2008, AZ CIFR
   Organization for Economic Co-operation and Development (OECD)., 2017, LAT AM CAR SOC I GEN
   Osamor PE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005127
   PAHO, 2017, ZIK EP UPD SIT SUMM
   PAHO, 2017, ZIK EP REP DOM REP
   Pan American Health Organization (PAHO), 2018, ZIK CAS CONG SYNDR A
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   WHO, 2018, ZIK VIR
   World Economic Forum, 2015, GLOB GEND GAP REP 20
NR 26
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0007994
DI 10.1371/journal.pntd.0007994
PG 17
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400080
PM 32142512
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hallet, E
   Flamand, C
   Rousset, D
   Bonifay, T
   Fritzell, C
   Matheus, S
   Dueymes, M
   Ntab, B
   Nacher, M
AF Hallet, Edouard
   Flamand, Claude
   Rousset, Dominique
   Bonifay, Timothee
   Fritzell, Camille
   Matheus, Severine
   Dueymes, Maryvonne
   Ntab, Balthazar
   Nacher, Mathieu
TI ZIKA Virus infection in pregnant women in French Guiana: More
   precarious-more at risk
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
AB Author summary
   A recent study in French Guiana suggested that populations living in precarious neighborhoods were more at risk for chikungunya CHIKV than those living in more privileged areas. The objective of the present study was to test the hypothesis that Zika virus (ZIKV) infection was more frequent in precarious pregnant women than in non-precarious pregnant women as reflected by their health insurance status. A multicenter cross-sectional study was conducted including ZIKV pregnant women with serological or molecular proof of ZIKV during their pregnancy between January and December 2016. Health insurance information was recorded at delivery, which allowed separating women into: undocumented foreigners, precarious but with residence permit, and non-precarious. Overall 6654 women were included. Among them, 1509 (22,7%) had confirmed ZIKV infection. The majority of women were precarious, but the proportion of precarious women was significantly greater in ZIKV-confirmed 728/906 (80.4%) than the ZIKV-negatives 1747/2533 (69.0%). Precariousness and undocumented status were associated with a higher prevalence of ZIKV acquisition during pregnancy. The present results illustrate that in French Guiana, as elsewhere, ZIKV transmission disproportionately affected the socially vulnerable pregnant women, presumably because of poorer housing conditions, and lack of vector control measures in poor neighborhoods.
   Background
   A recent study in French Guiana suggested that populations living in precarious neighborhoods were more at risk for Chikungunya CHIKV than those living in more privileged areas. The objective of the present study was to test the hypothesis that Zika virus (ZIKV) infection was more frequent in precarious pregnant women than in non-precarious pregnant women, as reflected by their health insurance status.
   Methods
   A multicentric cross-sectional study was conducted in Cayenne hospital including ZIKV pregnant women with serological or molecular proof of ZIKV during their pregnancy between January and December 2016. Health insurance information was recorded at delivery, which allowed separating women in: undocumented foreigners, precarious but with residence permit, and non-precarious.
   Results
   A total of 6654 women were included. Among them 1509 (22,7%) had confirmed ZIKV infection. Most women were precarious (2275/3439) but the proportion of precarious women was significantly greater in ZIKV-confirmed 728/906 (80.4%) than the ZIKV-negatives 1747/2533 (69.0%), p<0.0001. There were 1142 women classified as non-precarious, 1671 were precarious legal residents, and 1435 were precarious and undocumented. Precariousness and undocumented status were associated with a higher prevalence of ZIKV during pregnancy (adjusted prevalence ratio = 1.59 (95%CI = 1.29-1.97), p<0.0001), (adjusted prevalence ratio = 1.5 (95%CI = 1.2-1.8), p<0.0001), respectively.
   Conclusions
   These results illustrate that in French Guiana ZIKV transmission disproportionately affected the socially vulnerable pregnant women, presumably because of poorer housing conditions, and lack of vector control measures in poor neighborhoods.
C1 [Hallet, Edouard; Bonifay, Timothee; Nacher, Mathieu] Univ Guyane, DFR Sante, Cayenne, French Guiana.
   [Flamand, Claude; Fritzell, Camille] Inst Pasteur French Guiana, Epidmiol Unit, Cayenne, French Guiana.
   [Rousset, Dominique; Matheus, Severine] Inst Pasteur French Guiana, Arbovirus Natl Reference Ctr, Cayenne, French Guiana.
   [Dueymes, Maryvonne] Ctr Hosp Andree Rosemon, Cayenne, French Guiana.
   [Ntab, Balthazar] Ctr Hosp Ouest Guyanais, Med Informat Dept, St Laurent Du Maroni, French Guiana.
   [Nacher, Mathieu] Ctr Hosp Cayenne, INSERM 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana.
RP Nacher, M (corresponding author), Univ Guyane, DFR Sante, Cayenne, French Guiana.; Nacher, M (corresponding author), Ctr Hosp Cayenne, INSERM 1424, Ctr Invest Clin Antilles Guyane, Cayenne, French Guiana.
EM mathieu.nacher@ch-cayenne.fr
CR Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   [Anonymous], 2008, SOINS URGENTS ETRANG, V2
   Bonifay T, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx247
   Braga C, 2010, ACTA TROP, V113, P234, DOI 10.1016/j.actatropica.2009.10.021
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Diderichsen F, 2019, GLOB PUBLIC HEALTH, V14, P675, DOI 10.1080/17441692.2018.1532528
   Flamand C, 2017, EUROSURVEILLANCE, V22, P23, DOI 10.2807/1560-7917.ES.2017.22.44.17-00102
   Fritzell C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005081
   Honorio NA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000545
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Leneuve-Dorilas M, 2019, J MATERN-FETAL NEO M, V32, P1388, DOI 10.1080/14767058.2017.1403578
   Richard JB, 1 RESULTATS DU BAROM
   Valmy L, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1284-y
   Van Melle A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3895-6
   Villarroel PMS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006239
NR 15
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
DI 10.1371/journal.pntd.0008193; 10.1371/journal.pntd.0008193.r001;
   10.1371/journal.pntd.0008193.r002; 10.1371/journal.pntd.0008193.r003;
   10.1371/journal.pntd.0008193.r004; 10.1371/journal.pntd.0008193.r005;
   10.1371/journal.pntd.0008193.r006
PG 10
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400049
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Huang, BX
   Montgomery, BL
   Adamczyk, R
   Ehlers, G
   van den Hurk, AF
   Warrilow, D
AF Huang, Bixing
   Montgomery, Brian L.
   Adamczyk, Rebecca
   Ehlers, Gerhard
   van den Hurk, Andrew F.
   Warrilow, David
TI A LAMP-based colorimetric assay to expedite field surveillance of the
   invasive mosquito species Aedes aegypti and Aedes albopictus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID IDENTIFICATION
AB Author summary
   Two species of mosquitoes, Aedes aegypti and Aedes albopictus, are important mosquito vectors that transmit yellow fever, dengue, chikungunya and Zika viruses. There are limited vaccine and antiviral options to treat these diseases, and so vector control (chemical or biological) is the main strategy for preventing virus transmission. Active mosquito surveillance employing a range of methods is critical for guiding control programs. The context where surveillance is undertaken includes assessing population dynamics in areas where Ae. aegypti and Ae. albopictus are established and transmitting viruses; delimiting their range during incursions; detecting importations at first ports of entry; or conducting broad-scale presence/absence surveillance in regions vulnerable to invasion. Effective surveillance is underpinned by accurate and rapid identification of collected specimens. Molecular methods can complement more traditional morphological identification in instances when sample numbers are large, specimens are damaged, when related species share overlapping morphology or when diagnostic features in early instar larvae are not developed. Laboratory-based DNA tests are available; however, these require sophisticated equipment and incur lag time for the sample to be shipped and tested, which results in critical delay to implement rapid intervention. In this work, we have developed simple rapid tests to detect Ae. aegypti and Ae. albopictus that can be performed at or near the field sites, require only a single reaction temperature, and which give a visual colour change when a positive sample is detected. The assays identified all life stages and body components (legs and wings) tested, as well as adult specimens that were held in traps under field conditions for two weeks. They also detected a single 1st instar larva in a sample of >1,000 non-target mosquitoes to expedite ovitrap processing and subsequent morphological identification. The assays should be a useful adjunct to laboratory testing or could be employed as standalone tests.
   Background
   Yellow fever, dengue, chikungunya and Zika viruses are responsible for considerable morbidity and mortality in humans. Aedes aegypti and Aedes albopictus are the most important mosquito vectors involved in their transmission. Accurate identification of these species is essential for the implementation of control programs to limit arbovirus transmission, during suspected detections at ports of first entry, to delimit incursions or during presence/absence surveillance programs in regions vulnerable to invasion. We developed and evaluated simple and rapid colorimetric isothermal tests to detect these two mosquito species based on loop-mediated isothermal amplification (LAMP) targeting the ribosomal RNA internal transcribed spacer 1 (ITS1).
   Methodology/Principal findings
   Samples were prepared by homogenizing and heating at 99 C-o for 10 min before an aliquot was added to the LAMP reaction. After 40 min incubation at 65 C-o, a colour change indicated a positive result. The tests were 100% sensitive and species-specific, and demonstrated a limit of detection comparable with PCR-based detection (TaqMan chemistry). The LAMP assays were able to detect target species for various life stages tested (adult, 1(st) instar larva, 4(th) instar larva and pupa), and body components, such as legs, wings and pupal exuviae. Importantly, the LAMP assays could detect Ae. aegypti DNA in mosquitoes stored in Biogents Sentinel traps deployed in the field for 14 d. A single 1(st) instar Ae. aegypti larva could also be detected in a pool of 1,000 non-target 1(st) instar Aedes notoscriptus, thus expediting processing of ovitrap collections obtained during presence/absence surveys. A simple syringe-sponge protocol facilitated the concentration and collection of larvae from the ovitrap water post-hatch.
C1 [Huang, Bixing; van den Hurk, Andrew F.; Warrilow, David] Queensland Hlth, Publ Hlth Virol Lab, Forens & Sci Serv, Brisbane, Qld, Australia.
   [Montgomery, Brian L.] Metro South Hosp & Hlth Serv, Metro South Publ Hlth Unit, Brisbane, Qld, Australia.
   [Adamczyk, Rebecca; Ehlers, Gerhard] Cairns & Hinterland Hosp & Hlth Serv, Med Entomol, Trop Publ Hlth Serv, Cairns, Qld, Australia.
RP van den Hurk, AF; Warrilow, D (corresponding author), Queensland Hlth, Publ Hlth Virol Lab, Forens & Sci Serv, Brisbane, Qld, Australia.
EM Andrew.VanDenHurk@health.qld.gov.au; David.Warrilow@health.qld.gov.au
OI Warrilow, David/0000-0002-3221-7605
FU Queensland Health Forensic and Scientific Services [RSS19-006]
FX DW and AVDH were jointly awarded an internal research grant (RSS19-006).
   The funder was Queensland Health Forensic and Scientific Services
   (https://www.health.qld.gov.au/healthsupport/businesses/forensic-and-sci
   entificservices).The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Beebe NW, 2007, J MED ENTOMOL, V44, P376, DOI 10.1603/0022-2585(2007)44[376:APCRDT]2.0.CO;2
   Bhadra Sanchita, 2018, PLoS Negl Trop Dis, V12, pe0006671, DOI 10.1371/journal.pntd.0006671
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Darbro J, 2017, ECOL ECON, V142, P203, DOI 10.1016/j.ecolecon.2017.06.015
   Epelboin Y, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005933
   Goncalves DD, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3666-6
   Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Lamche Gisela D, 2003, Commun Dis Intell Q Rep, V27, P105
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Montgomery BL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005505
   Poon LLM, 2006, CLIN CHEM, V52, P303
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   da Silva SJR, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40960-5
   Schenkel CD, 2019, MED VET ENTOMOL, V33, P345, DOI 10.1111/mve.12366
   Schneider J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162493
   Timmins DR, 2018, J MED ENTOMOL, V55, P1638, DOI 10.1093/jme/tjy125
   Torres C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-240
   van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020
   van den Hurk AF, 2016, ONE HEALTH, V2, P19, DOI 10.1016/j.onehlt.2016.02.001
   Worobey J, 2013, J AM MOSQUITO CONTR, V29, P78, DOI 10.2987/12-6296R.1
NR 23
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008130
DI 10.1371/journal.pntd.0008130
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400016
PM 32130209
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kamgang, B
   Vazeille, M
   Tedjou, A
   Yougang, AP
   Wilson-Bahun, TA
   Mousson, L
   Wondji, CS
   Failloux, AB
AF Kamgang, Basile
   Vazeille, Marie
   Tedjou, Armel
   Yougang, Aurelie P.
   Wilson-Bahun, Theodel A.
   Mousson, Laurence
   Wondji, Charles S.
   Failloux, Anna-Bella
TI Different populations of Aedes aegypti and Aedes albopictus (Diptera:
   Culicidae) from Central Africa are susceptible to Zika virus infection
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID VECTOR COMPETENCE; TRANSMISSION; MOSQUITOS; OUTBREAK; AMERICA; ISLAND
AB Author summary
   Zika virus (ZIKV), isolated for the first time in Uganda in 1947, is transmitted to human beings mainly by the bite of an infected mosquitoes belonging to the Aedes genus notably Ae. aegypti and Ae. albopictus. Both Aedes species are present in Central Africa, however their epidemiological role is poorly characterized. Here, we assessed the ability of Ae. aegypti and Ae. albopictus collected in different ecological settings in Central Africa to transmit a ZIKV strain isolated in West Africa. Analysis showed that both Ae. aegypti and Ae. albopictus are able to transmit ZIKV but with higher overall transmission efficiency for Ae. aegypti compared to Ae. albopictus. In addition, disseminated infection and transmission rates for both Aedes species varied significantly according to the sampling location. Overall, our result suggests that in Central Africa, Ae. aegypti is more competent to transmit ZIKV than Ae. albopictus although parameters such as the feeding behaviour, longevity and mosquito densities can modulate pathogens transmission in nature. These findings could contribute to a better understanding of the epidemiological transmission of ZIKV in Central Africa and develop suitable strategy to prevent major ZIKV outbreaks in this region.
   Zika virus (ZIKV) is a Flavivirus (Flaviviridae) transmitted to humans mainly by the bite of an infected Aedes mosquitoes. Aedes aegypti is the primary epidemic vector of ZIKV and Ae. albopictus, the secondary one. However, the epidemiological role of both Aedes species in Central Africa where Ae. albopictus was recently introduced is poorly characterized. Field-collected strains of Ae. aegypti and Ae. albopictus from different ecological settings in Central Africa were experimentally infected with a ZIKV strain isolated in West Africa. Mosquitoes were analysed at 14- and 21-days post-exposure. Both Ae. aegypti and Ae. albopictus were able to transmit ZIKV but with higher overall transmission efficiency for Ae. aegypti (57.9%) compared to Ae. albopictus (41.5%). In addition, disseminated infection and transmission rates for both Ae. aegypti and Ae. albopictus varied significantly according to the location where they were sampled from. We conclude that both Ae. aegypti and Ae. albopictus are able to transmit ZIKV and may intervene as active Zika vectors in Central Africa. These findings could contribute to a better understanding of the epidemiological transmission of ZIKV in Central Africa and develop suitable strategy to prevent major ZIKV outbreaks in this region.
C1 [Kamgang, Basile; Tedjou, Armel; Yougang, Aurelie P.; Wilson-Bahun, Theodel A.; Wondji, Charles S.] Centre Res Infect Dis, Dept Med Entomol, Yaounde, Cameroon.
   [Vazeille, Marie; Mousson, Laurence; Failloux, Anna-Bella] Inst Pasteur, Dept Virol, Unit Arboviruses & Insect Vectors, Paris, France.
   [Tedjou, Armel; Yougang, Aurelie P.] Univ Yaounde I, Fac Sci, Dept Anim Biol, Yaounde, Cameroon.
   [Wilson-Bahun, Theodel A.] Marien Ngouabi Univ, Fac Sci & Technol, Brazzaville, Rep Congo.
   [Wondji, Charles S.] Univ Liverpool Liverpool Sch Trop Med, Vector Biol Dept, Liverpool, Merseyside, England.
RP Kamgang, B (corresponding author), Centre Res Infect Dis, Dept Med Entomol, Yaounde, Cameroon.
EM basile.kamgang@crid-cam.net
OI Kamgang, Basile/0000-0002-8883-4557
FU Wellcome Trust Training Fellowship in Public Health and Tropical
   Medicine [204862/Z/16/Z]; European UnionEuropean Union (EU) [731060,
   653316, 734548]
FX This study was primarily supported by the Wellcome Trust Training
   Fellowship in Public Health and Tropical Medicine (204862/Z/16/Z)
   awarded to BK. It was partly supported by the European Union's Horizon
   2020 research and innovation program under ZIKAlliance grant agreement
   no. 734548, and the European Union's Horizon 2020 research and
   innovation program under grant agreement No 731060 (Infravec2, Research
   Infrastructures for the control of vector-borne diseases;
   http://infravec2.eu/), and the European Union's Horizon 2020 Research
   and Innovation Program under EVAg grant agreement no. 653316
   (https://www.european-virus-archive.com/). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Atieh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep39384
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bosio CF, 2000, GENETICS, V156, P687
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dubrulle M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005895
   Duchemin JB, 2017, VIROL J, V14, DOI [10.1186/s12985-017-0772-y, 10.1186/s12985-017-0770-0]
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Fontenille D, 2001, EMERG INFECT DIS, V7, P1066, DOI 10.3201/eid0706.010631
   Gake B, 2017, BRAZ J INFECT DIS, V21, P481, DOI 10.1016/j.bjid.2017.03.018
   Geoffroy B, 1982, CULICIDES ARBOVIRUS
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hegde S, 2015, CURR OPIN VIROL, V15, P97, DOI 10.1016/j.coviro.2015.08.011
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Hery L, 2019, EMERG MICROBES INFEC, V8, P699, DOI 10.1080/22221751.2019.1615849
   Houe V, 2019, EMERG MICROBES INFEC, V8, P542, DOI 10.1080/22221751.2019.1599302
   Hugo LE, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007281
   Jupatanakul N, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005187
   Jupatanakul N, 2014, VIRUSES-BASEL, V6, P4294, DOI 10.3390/v6114294
   Jupille H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004901
   Kamgang Basile, 2018, Wellcome Open Res, V3, P79, DOI 10.12688/wellcomeopenres.14659.1
   Kamgang B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2408-x
   Kamgang B, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002590
   Kamgang B, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-57
   Kraemer MUG, 2017, T ROY SOC TROP MED H, V111, P527, DOI 10.1093/trstmh/try001
   Lourenco J, 2018, PLOS CURRENTS, V10, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   MARCHETTE NJ, 1969, AM J TROP MED HYG, V18, P411, DOI 10.4269/ajtmh.1969.18.411
   Mattingly P. F., 1957, Annals of Tropical Medicine and Parasitology, V51, P392
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Tedjou AN, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007137
   Tognarelli J, 2016, ARCH VIROL, V161, P665, DOI 10.1007/s00705-015-2695-5
   Vazeille M, 2019, EMERG MICROBES INFEC, V8, P1668, DOI 10.1080/22221751.2019.1689797
   World Health Organization, 2016, WHO STAT 1 M INT HLT
   2019, J CROHNS COLITIS S1, V13
NR 49
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008163
DI 10.1371/journal.pntd.0008163
PG 12
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400082
PM 32203510
OA DOAJ Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Mancini, MV
   Herd, CS
   Ant, TH
   Murdochy, SM
   Sinkins, SP
AF Mancini, Maria Vittoria
   Herd, Christie S.
   Ant, Thomas H.
   Murdochy, Shivan M.
   Sinkins, Steven P.
TI Wolbachia strain wAu efficiently blocks arbovirus transmission in Aedes
   albopictus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CHIKUNGUNYA VIRUS; DENGUE; AEGYPTI; DIPTERA; PROTECTION; DISPERSAL;
   INFECTION; EPIDEMIC; SPREAD; FEVER
AB The global incidence of arboviral diseases transmitted by Aedes mosquitoes, including dengue, chikungunya, yellow fever, and Zika, has increased dramatically in recent decades. The release of Aedes aegypti carrying the maternally inherited symbiont Wolbachia as an intervention to control arboviruses is being trialled in several countries. However, these efforts are compromised in many endemic regions due to the co-localization of the secondary vector Aedes albopictus, the Asian tiger mosquito. Ae. albopictus has an expanding global distribution following incursions into a number of new territories. To date, only the wMel and wPip strains of Wolbachia have been reported to be transferred into and characterized in this vector. A Wolbachia strain naturally infecting Drosophila simulans, wAu, was selected for transfer into a Malaysian Ae. albopictus line to create a novel triple-strain infection. The newly generated line showed self-compatibility, moderate fitness cost and complete resistance to Zika and dengue infections.
   Author summary
   Aedes albopictus, the invasive Asian tiger mosquito, is responsible for numerous outbreaks of important viruses such as dengue and Zika in various regions of the world. The need for alterative control interventions propelled the development of a novel approach that exploits a natural insect symbiont, Wolbachia; when transferred into non-native hosts, these maternally-inherited bacteria are able to interfere with the transmission of mosquito-borne viruses, and also provide reproductive advantages to the host, offering a promising tool for self-sustaining field applications. Currently, several field trials are ongoing for the primary vector of dengue and several other arboviruses, Aedes aegypti, providing encouraging results. In this study, Ae. albopictus has been targeted for a similar approach: this mosquito species naturally carries two strains of Wolbachia. The introduction of a third, non-native strain made this line less able to transmit dengue and Zika viruses and had an impact on its fitness.
C1 [Mancini, Maria Vittoria; Herd, Christie S.; Ant, Thomas H.; Murdochy, Shivan M.; Sinkins, Steven P.] Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
   [Herd, Christie S.] Univ Missouri, Dept Vet Pathobiol, Columbia, MO USA.
RP Sinkins, SP (corresponding author), Univ Glasgow, MRC, Ctr Virus Res, Glasgow, Lanark, Scotland.
EM steven.sinkins@glasgow.ac.uk
FU Wellcome TrustWellcome Trust [108508/Z/15/Z, 202888/Z/16/Z]
FX This work was supported by the Wellcome Trust grants 108508/Z/15/Z and
   202888/Z/16/Z to SPS (https://wellcome.ac.uk).The funders played no role
   in study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ant TH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2870-0
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Beckmann JF, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.7
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002152
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bonilauri P, 2008, EMERG INFECT DIS, V14, P852, DOI 10.3201/eid1405.071144
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Calvitti M, 2010, J MED ENTOMOL, V47, P179, DOI 10.1603/ME09140
   Cao LJ, 2019, INSECTS, V10, DOI 10.3390/insects10050126
   Caputo B, 2020, PEST MANAG SCI, V76, P1324, DOI 10.1002/ps.5643
   Chouin-Carneiro T, 2019, MED VET ENTOMOL, DOI [10.1111/mve.12384, DOI 10.1111/MVE.1238431120156]
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2015, EVOL APPL, V8, P751, DOI 10.1111/eva.12286
   Honorio NA, 2003, MEM I OSWALDO CRUZ, V98, P191, DOI 10.1590/S0074-02762003000200005
   Joanne Sylvia, 2014, Asian Pacific Journal of Tropical Biomedicine, V4, P557, DOI 10.12980/APJTB.4.2014APJTB-2014-0020
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kriesner P, 2018, EVOLUTION, V72, P1475, DOI 10.1111/evo.13506
   Kriesner P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003607
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   LePage DP, 2017, NATURE, V543, P243, DOI 10.1038/nature21391
   Liumbruno GM, 2008, BLOOD TRANSFUS-ITALY, V6, P199, DOI 10.2450/2008.0016-08
   Lozano-Fuentes S, 2018, J MED ENTOMOL, DOI [10.1093/jme/tjy114, DOI 10.1093/JME/TJY11430102327]
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Marini F, 2010, MED VET ENTOMOL, V24, P361, DOI 10.1111/j.1365-2915.2010.00898.x
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154
   Soumahoro MK, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001197
   Suh E, 2016, J MED ENTOMOL, V53, P1156, DOI 10.1093/jme/tjw084
   Suh E, 2009, APPL ENVIRON MICROB, V75, P7783, DOI 10.1128/AEM.01331-09
   Sutton ER, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-928
   Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002
   Tsetsarkin K, 2006, VECTOR-BORNE ZOONOT, V6, P325, DOI 10.1089/vbz.2006.6.325
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9
NR 49
TC 0
Z9 0
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0007926
DI 10.1371/journal.pntd.0007926
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400022
PM 32155143
OA DOAJ Gold, Green Accepted, Green Published
DA 2020-07-08
ER

PT J
AU Pedrosa, CDG
   Souza, LRQ
   Gomes, TA
   de Lima, CVF
   Ledur, PF
   Karmirian, K
   Barbeito-Andres, J
   Costa, MD
   Higa, LM
   Rossi, AD
   Bellio, M
   Tanuri, A
   Prata-Barbosa, A
   Tovar-Moll, F
   Garcez, PP
   Lara, FA
   Molica, RJR
   Rehen, SK
AF Pedrosa, Carolina da S. G.
   Souza, Leticia R. Q.
   Gomes, Tiago A.
   de Lima, Caroline V. F.
   Ledur, Pitia F.
   Karmirian, Karina
   Barbeito-Andres, Jimena
   Costa, Marcelo do N.
   Higa, Luiza M.
   Rossi, Atila D.
   Bellio, Maria
   Tanuri, Amilcar
   Prata-Barbosa, Arnaldo
   Tovar-Moll, Fernanda
   Garcez, Patricia P.
   Lara, Flavio A.
   Molica, Renato J. R.
   Rehen, Stevens K.
TI The cyanobacterial saxitoxin exacerbates neural cell death and brain
   malformations induced by Zika virus
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID BRAZIL; MICROCYSTINS; SURVEILLANCE; RAPHIDIOPSIS; RESERVOIRS;
   NOSTOCALES; INFECTION; OUTBREAKS; EXPOSURE; SODIUM
AB Author summary
   The uncontrolled spreading of cyanobacteria in drinking water reservoirs has been the cause of serious public health problems worldwide. Toxin-producing cyanobacterial blooms commonly occur during drought periods in the northeast (NE) region of Brazil. During Zika Virus (ZIKV) outbreak in 2015-16, Brazilian NE showed disproportionately higher microcephaly incidence. Here, we test the hypothesis that the cyanotoxin saxitoxin (STX) may act as a co-insult for ZIKV. Water quality surveillance data showed increased cyanobacteria population and higher STX amount in NE region during 2014-2018. In vitro, we observed that neural progenitor cell death was doubled after STX exposure to ZIKV-infected brain organoids. In vivo, chronic ingestion of STX during gestational period potentiated ZIKV-derived brain abnormalities in newborn mice. Our study provides new insights that may explain the discrepancies among Brazilian regions regarding CZS severity. Moreover, the data highlight the importance of cyanobacteria and cyanotoxin freshwater monitoring for future arbovirus outbreaks.
   The northeast (NE) region of Brazil commonly goes through drought periods, which favor cyanobacterial blooms, capable of producing neurotoxins with implications for human and animal health. The most severe dry spell in the history of Brazil occurred between 2012 and 2016. Coincidently, the highest incidence of microcephaly associated with the Zika virus (ZIKV) outbreak took place in the NE region of Brazil during the same years. In this work, we tested the hypothesis that saxitoxin (STX), a neurotoxin produced in South America by the freshwater cyanobacteria Raphidiopsis raciborskii, could have contributed to the most severe Congenital Zika Syndrome (CZS) profile described worldwide. Quality surveillance showed higher cyanobacteria amounts and STX occurrence in human drinking water supplies of NE compared to other regions of Brazil. Experimentally, we described that STX doubled the quantity of ZIKV-induced neural cell death in progenitor areas of human brain organoids, while the chronic ingestion of water contaminated with STX before and during gestation caused brain abnormalities in offspring of ZIKV-infected immunocompetent C57BL/6J mice. Our data indicate that saxitoxin-producing cyanobacteria is overspread in water reservoirs of the NE and might have acted as a co-insult to ZIKV infection in Brazil. These results raise a public health concern regarding the consequences of arbovirus outbreaks happening in areas with droughts and/or frequent freshwater cyanobacterial blooms.
C1 [Pedrosa, Carolina da S. G.; Souza, Leticia R. Q.; de Lima, Caroline V. F.; Ledur, Pitia F.; Karmirian, Karina; Prata-Barbosa, Arnaldo; Tovar-Moll, Fernanda; Rehen, Stevens K.] DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.
   [Gomes, Tiago A.; Karmirian, Karina; Barbeito-Andres, Jimena; Costa, Marcelo do N.; Tovar-Moll, Fernanda; Garcez, Patricia P.; Rehen, Stevens K.] Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
   [Gomes, Tiago A.; Lara, Flavio A.] Fiocruz MS, Oswaldo Cruz Inst, Lab Cellular Microbiol, Rio De Janeiro, RJ, Brazil.
   [Higa, Luiza M.; Rossi, Atila D.; Tanuri, Amilcar] Univ Fed Rio de Janeiro, Inst Biol, Dept Genet, Rio De Janeiro, RJ, Brazil.
   [Bellio, Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Rio De Janeiro, RJ, Brazil.
   [Molica, Renato J. R.] Univ Fed Rural Pernambuco, Acad Unit Garanhuns, Garanhuns, Pe, Brazil.
   [Barbeito-Andres, Jimena] Consejo Nacl Invest Cient & Tecn, ENyS, Inst Studies Neurosci & Complex Syst, Buenos Aires, DF, Argentina.
RP Rehen, SK (corresponding author), DOr Inst Res & Educ IDOR, Rio De Janeiro, RJ, Brazil.; Rehen, SK (corresponding author), Univ Fed Rio de Janeiro, Inst Biomed Sci, Rio De Janeiro, RJ, Brazil.
EM srehen@lance-ufrj.org
OI Rehen, Stevens/0000-0003-4216-9501
FU Fundacao de Amparo a Pesquisa do Estado do Rio de JaneiroCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/201.340/2016]; Coordenacao de Aperfeicoamento de Pessoal
   de Nivel SuperiorCAPES [88887.116625/2016-01, 440909/2016-3]; Conselho
   Nacional de Desenvolvimento Cientifico e TecnologicoNational Council for
   Scientific and Technological Development (CNPq) [440909/2016-3,
   441096/2016-6]; Financiadora de Estudos e ProjetosCiencia Tecnologia e
   Inovacao (FINEP) [01.08.0657.00, 01.12.0161.00]; Departamento de
   Vigilancia em Saude Ambiental e Saude do Trabalhador - DSAST
   [25380.001612/2017-70]; Banco Nacional de Desenvolvimento Economico e
   Social [10.2.0051.1]
FX This work was funded by Fundacao de Amparo a Pesquisa do Estado do Rio
   de Janeiro (E-26/201.340/2016), Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior (88887.116625/2016-01 and 440909/2016-3),
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (440909/2016-3 and 441096/2016-6), Banco Nacional de Desenvolvimento
   Economico e Social (10.2.0051.1), Financiadora de Estudos e Projetos
   (01.08.0657.00 and 01.12.0161.00) and Departamento de Vigilancia em
   Saude Ambiental e Saude do Trabalhador - DSAST (25380.001612/2017-70).
   The funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aguilera A, 2018, PHYCOLOGIA, V57, P130, DOI 10.2216/17-2.1
   [Anonymous], 2017, DIABETOLOGIE STOF S2, V12, pS94, DOI 10.1055/s-0043-115953
   [Anonymous], 2018, PLOS ONE, V13, P1, DOI DOI 10.3171/2018.1.JNS172645
   Azevedo SMFO, 2002, TOXICOLOGY, V181, P441, DOI 10.1016/S0300-483X(02)00491-2
   Blaha Ludek, 2009, Interdiscip Toxicol, V2, P36, DOI 10.2478/v10102-009-0006-2
   Bouvy M, 2000, AQUAT MICROB ECOL, V23, P13, DOI 10.3354/ame023013
   Brasil J, 2016, HYDROBIOLOGIA, V770, P145, DOI 10.1007/s10750-015-2578-5
   Burford MA, 2016, HARMFUL ALGAE, V54, P44, DOI 10.1016/j.hal.2015.10.012
   Carmichael WW, 2001, ENVIRON HEALTH PERSP, V109, P663, DOI 10.2307/3454781
   Carneiro RL, 2013, MAR DRUGS, V11, P2949, DOI 10.3390/md11082949
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chen X, 2018, TOXICOL MECH METHOD, V28, P335, DOI 10.1080/15376516.2017.1411413
   Costa I. A. S., 2006, Braz. J. Biol., V66, P211, DOI 10.1590/S1519-69842006000200005
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, P1, DOI DOI 10.1371/J0URNAL.PNTD.0005048
   Fonseca Jessica Roberts, 2015, Acta Limnol. Bras., V27, P78, DOI 10.1590/S2179-975X2814
   Galvao JA, 2009, TOXICON, V54, P891, DOI 10.1016/j.toxicon.2009.06.021
   Hoff-Risseti C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074238
   Lancaster M, 2015, EUR PMC FUNDERS GR, V9, P2329, DOI DOI 10.1038/nprot.2014.158
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Marengo JA, 2018, AN ACAD BRAS CIENC, V90, P1973, DOI 10.1590/0001-3765201720170206
   Martines RB, 2016, LANCET, V388, P898, DOI 10.1016/S0140-6736(16)30883-2
   Ministerio da Saude Secretaria de Vigilancia em Saude, 2017, MON CAS DENG DEBR CH, V48
   Moura AD, 2018, J LIMNOL, V77, P179, DOI 10.4081/jlimnol.2018.1646
   Mowe MAD, 2015, J LIMNOL, V74, P205, DOI 10.4081/jlimnol.2014.1005
   National Comprehensive Cancer Network, 2018, J NATL COMPR CANC NE, V16, P1
   O'Neill K, 2017, BASIC CLIN PHARMACOL, V120, P390, DOI 10.1111/bcpt.12701
   PAHO World Health Organization (WHO), 2017, ZIK SIT REP
   Planells-Cases R, 2000, BIOPHYS J, V78, P2878, DOI 10.1016/S0006-3495(00)76829-9
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Rufino R, 2016, CIENC SAUDE COLETIVA, V21, P777, DOI 10.1590/1413-81232015213.17002015
   Soares RM, 2006, ENVIRON TOXICOL, V21, P95, DOI 10.1002/tox.20160
   Soto-Liebe K, 2012, TOXICON, V60, P1324, DOI 10.1016/j.toxicon.2012.09.001
   Teixeira M da G, 1993, Bull Pan Am Health Organ, V27, P244
   VV.AA, 2012, COMPOSITE MAT HDB CM, V3, P1, DOI DOI 10.1515/2152-2812.1105
   Walter JM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00176
   World Health Organization (WHO), 2003, GUID SAF RECR WAT EN, V1, P136
NR 38
TC 1
Z9 1
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008060
DI 10.1371/journal.pntd.0008060
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400033
PM 32163415
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Shahid, U
   Farooqi, JQ
   Barr, KL
   Mahmood, SF
   Jamil, B
   Imitaz, K
   Azizullah, Z
   Malik, FR
   Prakoso, D
   Long, MT
   Khan, E
AF Shahid, Uzma
   Farooqi, Joveria Q.
   Barr, Kelli L.
   Mahmood, S. Faisal
   Jamil, Bushra
   Imitaz, Kehkashan
   Azizullah, Zahida
   Malik, Faisal R.
   Prakoso, Dhani
   Long, Maureen T.
   Khan, Erum
TI Comparison of clinical presentation and out-comes of Chikungunya and
   Dengue virus infections in patients with acute undifferentiated febrile
   illness from the Sindh region of Pakistan
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MANIFESTATIONS; OUTBREAK; FEVER
AB Author summary
   Chikungunya and Dengue viral infection are prevalent in South Asia. These are spread by mosquito bites and present as acute febrile illness with clinical presentation difficult to differentiate. In this study we analysed clinical findings of patients with lab confirmed Dengue virus and Chikungunya virus infection and compared the clinical symptoms to assess significant features that can differentiate the two infections at time of presentation to clinics and hospitals. The study was conducted at the Aga Khan University Hospital, Karachi Pakistan. Our study confirms presence of Chikungunya virus as an etiologic agent of fever among patients with dengue like illness in Sindh province of Pakistan. Presence of joint pains, central nervous symptoms were more common in CHKV patients, while gastrointestinal symptoms and elevated liver enzymes were more commonly associated with dengue patients. Both viruses are endemic in Pakistan and clinical and lab diagnosis is essential.
   Background
   Arboviruses are a cause of acute febrile illness and outbreaks worldwide. Recent outbreaks of Chikungunya virus (CHIKV) in dengue endemic areas have alarmed clinicians as unique clinical features differentiating CHIKV from Dengue virus (DENV) are limited. This has complicated diagnostic efforts especially in resource limited countries where lab testing is not easily available. Therefore, it is essential to analyse and compare clinical features of laboratory confirmed cases to assist clinicians in suspecting possible CHIKV infection at time of clinical presentation.
   Methodology
   A prospective point prevalence study was conducted, with the hypothesis that not all patients presenting with clinical suspicion of dengue infections at local hospitals are suffering from dengue and that other arboviruses such as Chikungunya, West Nile viruses, Japanese Encephalitis virus and Zika virus are co-circulating in the Sindh region of Pakistan. Out-patients and hospitalized (in-patients) of selected district hospitals in different parts of Sindh province of Pakistan were recruited. Patients with presumptive dengue like illness (Syndromic diagnosis) by the treating physicians were enrolled between 2015 and 2017.
   Current study is a subset of larger study mentioned above. Here-in we compared laboratory confirmed cases of CHIKV and DENV to assess clinical features and laboratory findings that may help differentiate CHIKV from DENV infection at the time of clinical presentation.
   Results
   Ninety-eight (n = 98) cases tested positive for CHIKV, by IgM and PCR and these were selected for comparative analysis with DENV confirmed cases (n = 171). On multivariable analysis, presence of musculoskeletal [OR = 2.5 (95% CI:1.6-4.0)] and neurological symptoms [OR = 4.4 (95% CI:1.9-10.2)], and thrombocytosis [OR = 2.2 (95% CI:1.1-4.0)] were associated with CHIKV infection, while atypical lymphocytes [OR = 8.3 (95% CI:4.2-16.7)] and thrombocytopenia [OR = 8.1 (95% CI:1.7-38.8)] were associated with DENV cases at time of presentation. These findings may help clinicians in differentiating CHIKV from DENV infection.
   Conclusion
   CHIKV is an important cause of illness amongst patients presenting with acute febrile illness in Sindh region of Pakistan. Arthralgia and encephalitis at time of presentation among patients with dengue-like illness should prompt suspicion of CHIKV infection, and laboratory confirmation must be sought.
C1 [Shahid, Uzma; Farooqi, Joveria Q.; Imitaz, Kehkashan; Azizullah, Zahida; Malik, Faisal R.; Khan, Erum] Aga Khan Univ, Dept Pathol & Lab Med, Karachi, Pakistan.
   [Barr, Kelli L.] Baylor Univ, Dept Biol, Waco, TX 76798 USA.
   [Mahmood, S. Faisal; Jamil, Bushra] Aga Khan Univ, Dept Med, Karachi, Pakistan.
   [Prakoso, Dhani; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL USA.
RP Khan, E (corresponding author), Aga Khan Univ, Dept Pathol & Lab Med, Karachi, Pakistan.
EM erum.khan@aku.edu
FU DEFENSE THREAT REDUCTION AGENCYUnited States Department of
   DefenseDefense Threat Reduction Agency [HDTRA1-09-14-FRCWMD-BAA]
FX This work was funded by DEFENSE THREAT REDUCTION AGENCY (www.drta.mil/)
   HDTRA1-09-14-FRCWMD-BAA to ML. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aamir UB, 2017, LANCET INFECT DIS, V17, P483, DOI 10.1016/S1473-3099(17)30191-3
   Ahmed NH, 2014, J VECTOR DIS, V51, P194
   Ali N, 2007, SCAND J INFECT DIS, V39, P1025, DOI 10.1080/00365540701411492
   [Anonymous], 2015, NEWS
   [Anonymous], 2012, DRUG SAFETY UPDATE, V6, pA1
   [Anonymous], 2009, EPIDEMIOLOGY INFECT, V137, P534
   Barr KL, 2018, FRONT PUBLIC HEALTH, V6, DOI 10.3389/fpubh.2018.00186
   Centers. for. Disease. Control and prevention, 2017, ARB DIS NEUR NONN 20
   Chahar HS, 2009, EMERG INFECT DIS, V15, P1077, DOI 10.3201/eid1507.080638
   CTaL JM, 2010, EPIDATA COMPREHENSIV
   Elsinga J, 2017, J INFECT DIS, V216, P573, DOI 10.1093/infdis/jix312
   Fernando S, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1656-2
   Gupta A, 2017, DEMOCRATIZ STUD, P55
   Iqtadar S, 2017, PAK J MED SCI, V33, P963, DOI 10.12669/pjms.334.13026
   Jahan Fridous, 2011, Asia Pac Fam Med, V10, P1, DOI 10.1186/1447-056X-10-1
   Khan E, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00008
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mehta R, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1978
   Naqvi S, 2017, CUREUS, V9, DOI 10.7759/cureus.1430
   Neogi D. K., 1995, Journal of Communicable Diseases, V27, P19
   Pancharoen Chitsanu, 2001, Southeast Asian Journal of Tropical Medicine and Public Health, V32, P341
   Patil SS, 2013, J CLIN DIAGN RES, V7, P1059, DOI 10.7860/JCDR/2013/5330.3061
   Pialoux G, 2007, LANCET INFECT DIS, V7, P319, DOI 10.1016/S1473-3099(07)70107-X
   Ramos-De La Medina A, 2011, GASTROENT HEPAT-BARC, V34, P243, DOI 10.1016/j.gastrohep.2011.01.012
   Rauf M, 2017, LANCET INFECT DIS, V17, P258, DOI 10.1016/S1473-3099(17)30074-9
   Ravi V, 2006, Indian J Med Microbiol, V24, P83
   Ray P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030025
   Reller ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082259
   Riaz Muhammad Mehmood, 2009, JPMA Journal of the Pakistan Medical Association, V59, P339
   Tournebize P, 2009, REV NEUROL-FRANCE, V165, P48, DOI 10.1016/j.neurol.2008.06.009
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Vega RM, 2016, AM J TROP MED HYG, V94, P1073, DOI 10.4269/ajtmh.15-0507
   World Health Organization, 2009, DENG GUID DIAGN TREA
   2014, REG ANESTH PAIN MED, V9
NR 34
TC 0
Z9 0
U1 1
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008086
DI 10.1371/journal.pntd.0008086
PG 13
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400081
PM 32203509
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Vera-Maloof, FZ
   Saavedra-Rodriguez, K
   Penilla-Navarro, RP
   Rodriguez-Ramirez, AD
   Dzul, F
   Manrique-Saide, P
   Black, WC
AF Vera-Maloof, Farah Z.
   Saavedra-Rodriguez, Karla
   Penilla-Navarro, Rosa P.
   Rodriguez-Ramirez, Americo
   Dzul, Felipe
   Manrique-Saide, Pablo
   Black, William C.
TI Loss of pyrethroid resistance in newly established laboratory colonies
   of Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID MUTATIONS; GENE
AB Background
   Resistance to pyrethroid insecticides in Aedes aegypti has become widespread after almost two decades of the frequent use of these pesticides to reduce arbovirus transmission. Despite this resistance, pyrethroids continue to be used because they are relatively inexpensive and have low human toxicity. Resistance management has been proposed as a way to retain the use of pyrethroids in natural populations. A key component of resistance management is the assumption that negative fitness is associated with resistance alleles such that resistance alleles will decline in frequency when the insecticides are removed. At least three studies in Ae. aegypti have demonstrated a decrease in pyrethroid resistance once the insecticide has been removed.
   Methods/Principal findings
   The present study aims to evaluate variation in the loss of pyrethroid resistance among newly established laboratory populations of Ae. aegypti from Mexico. Eight field collections were maintained for up to eight generations, and we recorded changes in the frequencies of the mutations at the V1,016I locus and at the F1,534C locus in the voltage-gated sodium channel gene (VGSC). I1,016 and C1,534 confer resistance. We also examined resistance ratios (RR) with type 1 and 2 pyrethroids.
   Author summary
   The author is interested in the evolution of genes that confer resistance to insecticides, especially when this evolution affects the binding of insecticides to their target sites. The Voltage-Gated Sodium Channel gene provides an excellent opportunity to understand how mutations at the target site(s) affect the evolution of resistance in many different pest insect species, including Aedes aegypti, which is the primary vector of the dengue, yellow fever, Zika and chikungunya viruses.
C1 [Vera-Maloof, Farah Z.; Saavedra-Rodriguez, Karla; Black, William C.] Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Campus Delivery, Ft Collins, CO 80523 USA.
   [Penilla-Navarro, Rosa P.; Rodriguez-Ramirez, Americo] Inst Nacl Salud Publ, Ctr Reg Invest Salud Publ, Tapachula, Chiapas, Mexico.
   [Dzul, Felipe] Ctr Nacl Programas Prevent & Control Enfermedades, Mexico City, DF, Mexico.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Parque Santa Lucia, Merida, Yucatan, Mexico.
RP Black, WC (corresponding author), Colorado State Univ, Coll Vet Med & Biomed Sci, Dept Microbiol Immunol & Pathol, Arthropod Borne & Infect Dis Lab, Campus Delivery, Ft Collins, CO 80523 USA.
EM wcb4@colostate.edu
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI121211]; International
   Collaborations in Infectious Disease Research Program [U01-AI-088647];
   Fogarty Training Grant "Training in Dengue Prevention and Control"
   [2D43TW001130-08]
FX Research reported in this publication was supported by the National
   Institute of Allergy and Infectious Diseases of the National Institutes
   of Health under Award Number R01AI121211 and the International
   Collaborations in Infectious Disease Research Program (U01-AI-088647).
   The content is solely the responsibility of the authors and does not
   necessarily represent the official views of the National Institutes of
   Health. Farah Vera-Maloof and Patricia Penilla were supported by the
   Fogarty Training Grant "Training in Dengue Prevention and Control"
   (2D43TW001130-08).
CR Amelia-Yap ZH, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2899-0
   Aponte HA, 2013, PESTIC BIOCHEM PHYS, V107, P226, DOI 10.1016/j.pestbp.2013.07.005
   Linss JGB, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-25
   BLACK WC, 1985, THEOR APPL GENET, V70, P491, DOI 10.1007/BF00305981
   Black WC, 1997, MOL BIOL INSECT DIS
   Brito LP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060878
   Chang C, 2012, PESTIC BIOCHEM PHYS, V104, P136, DOI 10.1016/j.pestbp.2012.06.003
   Cornel Anthony J, 2016, F1000Res, V5, P194, DOI 10.12688/f1000research.8107.2
   Dalla Bona AC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1634-y
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Chapadense FGG, 2015, REV SOC BRAS MED TRO, V48, P607, DOI 10.1590/0037-8682-0046-2015
   Grossman MK, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0022
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390
   Garcia GP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000531
   Puza B, 2015, BAYESIAN METHODS FOR STATISTICAL ANALYSIS, P365
   Saavedra-Rodriguez K, 2007, INSECT MOL BIOL, V16, P785, DOI 10.1111/j.1365-2583.2007.00774.x
   Saavedra-Rodriguez K, 2012, INSECT MOL BIOL, V21, P61, DOI 10.1111/j.1365-2583.2011.01113.x
   Saavedra-Rodriguez K, 2008, GENETICS, V180, P1137, DOI 10.1534/genetics.108.087924
   Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0
   Strode C, 2006, AM J TROP MED HYG, V75, P5
   Vera-Maloof FZ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004263
   Yanola J, 2011, TROP MED INT HEALTH, V16, P501, DOI 10.1111/j.1365-3156.2011.02725.x
NR 23
TC 0
Z9 0
U1 4
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0007753
DI 10.1371/journal.pntd.0007753
PG 20
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400077
PM 32176693
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Winokur, OC
   Main, BJ
   Nicholson, J
   Barker, CM
AF Winokur, Olivia C.
   Main, Bradley J.
   Nicholson, Jay
   Barker, Christopher M.
TI Impact of temperature on the extrinsic incubation period of Zika virus
   in Aedes aegypti
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID CULEX-TARSALIS DIPTERA; WEST-NILE-VIRUS; CLIMATE-CHANGE; TRANSMISSION;
   INFECTION; COMPETENCE; MODEL
AB Since Zika virus (ZIKV) emerged as a global human health threat, numerous studies have pointed to Aedes aegypti as the primary vector due to its high competence and propensity to feed on humans. The majority of vector competence studies have been conducted between 26-28 degrees C, but arboviral extrinsic incubation periods (EIPs), and therefore transmission efficiency, are known to be affected strongly by temperature. To better understand the relationship between ZIKV EIPs and temperature, we evaluated the effect of adult mosquito exposure temperature on ZIKV infection, dissemination, and transmission in Ae. aegypti at four temperatures: 18 degrees C, 21 degrees C, 26 degrees C, and 30 degrees C. Mosquitoes were exposed to viremic mice infected with a 2015 Puerto Rican ZIKV strain, and engorged mosquitoes were sorted into the four temperatures with 80% RH and constant access to 10% sucrose. ZIKV infection, dissemination, and transmission rates were assessed via RT-qPCR from individual mosquito bodies, legs and wings, and saliva, respectively, at three to five time points per temperature from three to 31 days, based on expectations from other flavivirus EIPs. The median time from ZIKV ingestion to transmission (median EIP, EIP50) at each temperature was estimated by fitting a generalized linear mixed model for each temperature. EIP50 ranged from 5.1 days at 30 degrees C to 24.2 days at 21 degrees C. At 26 degrees C, EIP50 was 9.6 days. At 18 degrees C, only 15% transmitted by day 31 so EIP50 could not be estimated. This is among the first studies to characterize the effects of temperature on ZIKV EIP in Ae. aegypti, and the first to do so based on feeding of mosquitoes on a live, viremic host. This information is critical for modeling ZIKV transmission dynamics to understand geographic and seasonal limits of ZIKV risk; it is especially relevant for determining risk in subtropical regions with established Ae. aegypti populations and relatively high rates of return travel from the tropics (e.g. California or Florida), as these regions typically experience cooler temperature ranges than tropical regions.
   Author summary
   Understanding how the environment affects Zika virus transmission is critical for protecting public health. Warmer temperatures accelerate mosquitoes' transmission of disease-causing pathogens, but this is not well-characterized for Zika virus in its primary vector, Aedes aegypti. In this study we measure the effect of a range of temperatures on Zika virus infection, dissemination, and transmission in Ae. aegypti and provide a mathematical equation that can be used in risk models to predict Zika virus transmission dynamics. We also explore how the effect of temperature on Zika virus transmission compares to the effects of temperature on other mosquito-borne viruses.
C1 [Winokur, Olivia C.; Main, Bradley J.; Nicholson, Jay; Barker, Christopher M.] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Winokur, Olivia C.] Univ Calif Davis, Grad Grp Entomol, Davis, CA 95616 USA.
   [Nicholson, Jay] Univ Western Australia, Sch Biomed Sci, Nedlands, WA, Australia.
RP Barker, CM (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
EM cmbarker@ucdavis.edu
OI Main, Bradley/0000-0002-8481-2721
FU National Aeronautics and Space Administration's Applied Sciences Program
   in Health and Air Quality [NNX15AF36G]; National Science Foundation
   Graduate Research FellowshipNational Science Foundation (NSF) [1650042];
   Pacific Southwest Regional Center of Excellence for Vector-Borne
   Diseases - U.S. Centers for Disease Control and Prevention [U01CK000516]
FX Financial support for this study was provided by National Aeronautics
   and Space Administration's Applied Sciences Program in Health and Air
   Quality (Grant NNX15AF36G). OCW also acknowledges support from the
   National Science Foundation Graduate Research Fellowship (Grant No.
   1650042). CMB acknowledges support from the Pacific Southwest Regional
   Center of Excellence for Vector-Borne Diseases funded by the U.S.
   Centers for Disease Control and Prevention (Cooperative Agreement
   U01CK000516). The funders had no role in study design, data collection
   and analysis, decision to publish, or preparation of the manuscript.
CR AITKEN THG, 1977, MOSQ NEWS, V37, P130
   Aubry F, 2018, WORLDWIDE SURVEY REV, P342741, DOI [10.1101/342741, DOI 10.1101/342741]
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171951
   Danforth ME, 2016, J MED ENTOMOL, V53, P681, DOI 10.1093/jme/tjw013
   Danforth ME, 2015, J MED ENTOMOL, V52, P1083, DOI 10.1093/jme/tjv082
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795
   Gould EA, 2009, T ROY SOC TROP MED H, V103, P109, DOI 10.1016/j.trstmh.2008.07.025
   Guerbois M, 2016, J INFECT DIS, V214, P1349, DOI 10.1093/infdis/jiw302
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hall-Mendelin S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004959
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   KRAMER LD, 1983, AM J TROP MED HYG, V32, P1130, DOI 10.4269/ajtmh.1983.32.1130
   Kudlacek ST, 2018, J BIOL CHEM, V293, P8922, DOI 10.1074/jbc.RA118.002658
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Main BJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006524
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Murdock CC, 2012, P ROY SOC B-BIOL SCI, V279, P3357, DOI 10.1098/rspb.2012.0638
   Murdock CC, 2012, NAT REV MICROBIOL, V10, P869, DOI 10.1038/nrmicro2900
   Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188
   Pompon J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01282-6
   R Core Team, 2018, R LANG ENV STAT COMP
   Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2
   Rochlin I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060874
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Stone M, 2017, TRANSFUSION, V57, P734, DOI 10.1111/trf.14031
   Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 38
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008047
DI 10.1371/journal.pntd.0008047
PG 15
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400062
PM 32187187
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, Y
   Yang, XY
   Yao, ZC
   Dong, XH
   Zhang, DR
   Hu, YW
   Zhang, SH
   Lin, JJ
   Chen, JH
   An, S
   Ye, HM
   Zhang, SQ
   Qiu, ZY
   He, ZJ
   Huang, MX
   Wei, GH
   Zhu, X
AF Wu, Yun
   Yang, Xinyu
   Yao, Zhicheng
   Dong, Xinhuai
   Zhang, Danrui
   Hu, Yiwen
   Zhang, Shihao
   Lin, Jiajie
   Chen, Jiahui
   An, Shu
   Ye, Hengming
   Zhang, Shuqing
   Qiu, Ziying
   He, Zhenjian
   Huang, Mingxing
   Wei, Guohong
   Zhu, Xun
TI C19orf66 interrupts Zika virus replication by inducing lysosomal
   degradation of viral NS3
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID AUTOPHAGY; MEMBRANE; PROTEINS
AB Author summary
   ZIKV represents a serious threat to global health with particular relevance to microcephaly and other congenital abnormalities in newborns, and Guillain-Barre syndrome, meningoencephalitis, multi-organ failure in adults. Despite the global health threat of Zika virus infection, there is currently no vaccine or effective antiviral therapy available for the disease. As widely recognized, interferon signaling is key to establishing a strong antiviral state in host cells, mainly mediated through the anti-viral effects of numerous interferon-stimulated genes (ISGs). This work described our novel finding of the antiviral effect of a novel ISG, C19orf66, and its underlying mechanisms. We identified C19orf66 as a novel ISG that exerts antiviral effects against ZIKV by specifically interacting and colocalizing with the ZIKV nonstructural (NS) protein NS3, which inducing NS3 degradation via a lysosome-dependent pathway. Thus, this work broadens the understanding of the pivotal roles of C19orf66 in the interaction between the host and ZIKV, which might further provide a rational basis for developing novel anti-ZIKV strategies.
   The rapidly emerging human health crisis associated with the Zika virus (ZIKV) epidemic and its link to severe complications highlights the growing need to identify the mechanisms by which ZIKV accesses hosts. Interferon response protects host cells against viral infection, while the cellular factors that mediate this defense are the products of interferon-stimulated genes (ISGs). Although hundreds of ISGs have been identified, only a few have been characterized for their antiviral potential, target specificity and mechanisms of action. In this work, we focused our investigation on the possible antiviral effect of a novel ISG, C19orf66 in response to ZIKV infection and the associated mechanisms. We found that ZIKV infection could induce C19orf66 expression in ZIKV-permissive cells, and such an overexpression of C19orf66 remarkably suppressed ZIKV replication. Conversely, the depletion of C19orf66 led to a significant increase in viral replication. Furthermore, C19orf66 was found to interact and co-localize with ZIKV nonstructural protein 3 (NS3), thus inducing NS3 degradation via a lysosome-dependent pathway. Taken together, this study identified C19orf66 as a novel ISG that exerts antiviral effects against ZIKV by specifically degrading a viral nonstructural protein. These findings uncovered an intriguing mechanism of C19orf66 that targeting NS3 protein of ZIKV, providing clues for understanding the actions of innate immunity, and affording the possible availability of new drug targets that can be used for therapeutic intervention.
C1 [Wu, Yun; Dong, Xinhuai; Zhang, Danrui; Zhang, Shihao; Lin, Jiajie; Chen, Jiahui; An, Shu; Ye, Hengming; Zhang, Shuqing; Qiu, Ziying; He, Zhenjian; Zhu, Xun] Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Peoples R China.
   [Wu, Yun; Chen, Jiahui; An, Shu; Zhang, Shuqing; Zhu, Xun] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Peoples R China.
   [Yang, Xinyu] Cent South Univ, Xiangya Hosp 3, Depatment Haematol, Changsha, Peoples R China.
   [Yao, Zhicheng] Sun Yat Sen Univ, Dept Gen Surg, Affiliated Hosp 3, Guangzhou, Peoples R China.
   [Dong, Xinhuai] Southern Med Univ, Shunde Hosp, Dept Ctr Translat Med, Foshan, Peoples R China.
   [Zhang, Danrui; Zhang, Shihao] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Basic Med, Guangzhou, Peoples R China.
   [Hu, Yiwen] Changsha Customs Dist PR China, Changsha, Peoples R China.
   [Lin, Jiajie] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Clin Med, Guangzhou, Peoples R China.
   [Ye, Hengming; Qiu, Ziying; He, Zhenjian] Sun Yat Sen Univ, Sch Publ Hlth, Guangzhou, Peoples R China.
   [Huang, Mingxing] Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 5, Zhuhai, Peoples R China.
   [Wei, Guohong] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou, Peoples R China.
RP Zhu, X (corresponding author), Sun Yat Sen Univ, Minist Educ, Key Lab Trop Dis Control, Guangzhou, Peoples R China.; Zhu, X (corresponding author), Sun Yat Sen Univ, Zhongshan Sch Med, Dept Microbiol, Guangzhou, Peoples R China.; Huang, MX (corresponding author), Sun Yat Sen Univ, Dept Infect Dis, Affiliated Hosp 5, Zhuhai, Peoples R China.; Wei, GH (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou, Peoples R China.
EM kindentstar@126.com; sanwgh@163.com; zhuxun8@mail.sysu.edu.cn
FU National Mega Project on Major Infectious Disease Prevention
   [2017ZX10103011]; Natural Science Foundation of ChinaNational Natural
   Science Foundation of China [81870960, 81571992, 81501744, 81330058];
   Guangdong Natural Science Funds for Distinguished Young Scholar
   [2014A030306023]; "Guangdong Te Zhi program" youth science and
   technology talent of project [2015TQ01R281]; Guangdong MEDP Fund
   [GDME-2018C004, GDOE [2019]A21]; Traditional Chinese Medicine of
   Guangdong Province [20181050]; Science and Technology Planning Project
   of Guangzhou [201704020226]
FX This work was supported by the National Mega Project on Major Infectious
   Disease Prevention (2017ZX10103011); the Natural Science Foundation of
   China (81870960, 81571992, 81501744, 81330058); Guangdong Natural
   Science Funds for Distinguished Young Scholar (2014A030306023);
   "Guangdong Te Zhi program" youth science and technology talent of
   project (2015TQ01R281); Guangdong MEDP Fund (GDME-2018C004); Guangdong
   MEPP Fund (GDOE [2019]A21); Traditional Chinese Medicine of Guangdong
   Province (20181050); the Science and Technology Planning Project of
   Guangzhou (201704020226). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Abbasi J, 2016, JAMA-J AM MED ASSOC, V316, P2588, DOI [10.1001/jama.2016.19328, 10.1001/jama.2016.18655]
   Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   [Anonymous], 2016, CLIN DIABETOL SA, V5, pA20
   Balinsky CA, 2017, J VIROL, V91, DOI [10.1128/JVI.01606-16, 10.1128/jvi.01606-16]
   Bauer PO, 2010, NAT BIOTECHNOL, V28, P256, DOI 10.1038/nbt.1608
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Fan XL, 2014, NAT NEUROSCI, V17, P471, DOI 10.1038/nn.3637
   Gannage M, 2009, CELL HOST MICROBE, V6, P367, DOI 10.1016/j.chom.2009.09.005
   He ZJ, 2018, J INFECT DIS, V217, P1942, DOI 10.1093/infdis/jiy129
   Lennemann NJ, 2017, AUTOPHAGY, V13, P322, DOI 10.1080/15548627.2016.1265192
   Li HD, 2016, NEURON, V92, P949, DOI 10.1016/j.neuron.2016.11.031
   Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028
   Pan T, 2018, J VIROL, V92, DOI [10.1128/JVI.01018-18, 10.1128/jvi.01018-18]
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314
   Saftig P, 2009, NAT REV MOL CELL BIO, V10, P623, DOI 10.1038/nrm2745
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scherer J, 2014, J CELL BIOL, V205, P163, DOI 10.1083/jcb.201307116
   Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907
   Seggewiss N, 2016, ARCH VIROL, V161, P43, DOI 10.1007/s00705-015-2634-5
   Spence JS, 2019, NAT CHEM BIOL, V15, P259, DOI 10.1038/s41589-018-0213-2
   Spuul P, 2010, J VIROL, V84, P7543, DOI 10.1128/JVI.00477-10
   Suzuki Y, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005357
   Tay MYF, 2018, ADV EXP MED BIOL, V1062, P147, DOI 10.1007/978-981-10-8727-1_11
   Wang HB, 2019, NAT CHEM BIOL, V15, P42, DOI 10.1038/s41589-018-0161-x
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Xie XP, 2016, CELL HOST MICROBE, V19, P566, DOI 10.1016/j.chom.2016.04.019
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang R, 2017, J VIROL, V91, DOI [10.1128/JVI.01148-17, 10.1128/jvi.01148-17]
NR 30
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008083
DI 10.1371/journal.pntd.0008083
PG 21
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400075
PM 32150556
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, YJ
   Amodio, M
   Vander Wyk, B
   Gerritsen, B
   Kumar, MM
   van Dijk, D
   Moon, K
   Wang, XM
   Malawista, A
   Richards, MM
   Cahill, ME
   Desai, A
   Sivadasan, J
   Venkataswamy, MM
   Ravi, V
   Fikrig, E
   Kumar, P
   Kleinstein, SH
   Krishnaswamy, S
   Montgomery, RR
AF Zhao, Yujiao
   Amodio, Matthew
   Vander Wyk, Brent
   Gerritsen, Bram
   Kumar, Mahesh M.
   van Dijk, David
   Moon, Kevin
   Wang, Xiaomei
   Malawista, Anna
   Richards, Monique M.
   Cahill, Megan E.
   Desai, Anita
   Sivadasan, Jayasree
   Venkataswamy, Manjunatha M.
   Ravi, Vasanthapuram
   Fikrig, Erol
   Kumar, Priti
   Kleinstein, Steven H.
   Krishnaswamy, Smita
   Montgomery, Ruth R.
TI Single cell immune profiling of dengue virus patients reveals intact
   immune responses to Zika virus with enrichment of innate immune
   signatures
SO PLOS NEGLECTED TROPICAL DISEASES
LA English
DT Article
ID WEST-NILE-VIRUS; SYSTEMS IMMUNOLOGY; T-CELLS; CUMULATIVE INCIDENCE;
   UNITED-STATES; INFECTION; ANTIBODIES; SUSCEPTIBILITY; TRANSMISSION;
   ENHANCEMENT
AB Author summary
   Mosquitoes carry many globally important human pathogens including a family of related viruses: dengue virus, West Nile virus, Yellow Fever virus, and recently of critical significance, Zika virus. The Zika virus epidemic emerged very rapidly in the susceptible South American population and in many cases immune responses were unable to control the infection. Immune history is a key element of susceptibility or resistance to severe disease. We examined whether pre-existing infection would skew or divert immune resources and might play a role in the severity of Zika infection in the Americas. Using samples from dengue patients and healthy controls from India, we tested functional responses to Zika virus in the context of pre-existing dengue infection. We quantified frequency and functional status of 36 individual cell subsets in depth using advanced profiling techniques and a novel deep learning algorithm. We showed an intact response to new infection with Zika virus which was enriched for early innate immune pathways and robust even during existing dengue infection. Thus, our study suggests that concurrent dengue infection would not be expected to impair immune responses to new infection with Zika virus.
   The genus Flavivirus contains many mosquito-borne human pathogens of global epidemiological importance such as dengue virus, West Nile virus, and Zika virus, which has recently emerged at epidemic levels. Infections with these viruses result in divergent clinical outcomes ranging from asymptomatic to fatal. Myriad factors influence infection severity including exposure, immune status and pathogen/host genetics. Furthermore, pre-existing infection may skew immune pathways or divert immune resources. We profiled immune cells from dengue virus-infected individuals by multiparameter mass cytometry (CyTOF) to define functional status. Elevations in IFN beta were noted in acute patients across the majority of cell types and were statistically elevated in 31 of 36 cell subsets. We quantified response to in vitro (re)infection with dengue or Zika viruses and detected a striking pattern of upregulation of responses to Zika infection by innate cell types which was not noted in response to dengue virus. Significance was discovered by statistical analysis as well as a neural network-based clustering approach which identified unusual cell subsets overlooked by conventional manual gating. Of public health importance, patient cells showed significant enrichment of innate cell responses to Zika virus indicating an intact and robust anti-Zika response despite the concurrent dengue infection.
C1 [Zhao, Yujiao; Vander Wyk, Brent; Wang, Xiaomei; Malawista, Anna; Richards, Monique M.; Cahill, Megan E.; Fikrig, Erol; Kumar, Priti; Montgomery, Ruth R.] Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.
   [Amodio, Matthew; van Dijk, David; Moon, Kevin; Krishnaswamy, Smita] Yale Sch Med, Dept Genet, New Haven, CT USA.
   [Gerritsen, Bram; Kleinstein, Steven H.] Yale Sch Med, Dept Pathol, New Haven, CT USA.
   [Kumar, Mahesh M.; Montgomery, Ruth R.] Yale Sch Med, Program Human Translat Immunol, New Haven, CT 06510 USA.
   [Desai, Anita; Venkataswamy, Manjunatha M.; Ravi, Vasanthapuram] Natl Inst Mental Hlth & NeuroSci NIMHANS, Dept Neurovirol, Bangalore, Karnataka, India.
   [Sivadasan, Jayasree] Apollo Hosp, Bangalore, Karnataka, India.
   [Kleinstein, Steven H.] Yale Sch Med, Program Computat Biol & Bioinformat, New Haven, CT USA.
RP Montgomery, RR (corresponding author), Yale Sch Med, Dept Internal Med, New Haven, CT 06510 USA.; Montgomery, RR (corresponding author), Yale Sch Med, Program Human Translat Immunol, New Haven, CT 06510 USA.
EM ruth.montgomery@yale.edu
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI089992]; Indo-U.S. Vaccine Action
   Program; Claude D. Pepper Older Americans Independence Center from the
   NIH/NIA [P30AG021342]; Department of Biotechnology, Government of
   IndiaDepartment of Biotechnology (DBT) India
   [BT/MB/Indo-US/HIPC/02/2013]
FX This work was supported in part by awards from the NIH (AI089992 to YZ,
   MA, BVW, BG, DvD, KM, XW, AM, MEC, EF, SHK, SK, RRM), the Indo-U.S.
   Vaccine Action Program (MMR, PK, XW, RRM), the Claude D. Pepper Older
   Americans Independence Center from the NIH/NIA (P30AG021342 to BVW), and
   Department of Biotechnology, Government of India
   (BT/MB/Indo-US/HIPC/02/2013 to MMK, AD, JS, MMV, VR). EF is an
   Investigator of the Howard Hughes Medical Institute. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Akondy RS, 2017, NATURE, V552, P362, DOI 10.1038/nature24633
   Amodio M, 2019, NAT METHODS, V16, P1139, DOI 10.1038/s41592-019-0576-7
   [Anonymous], 2015, AM J PHARM BENEFITS, V7, pe141
   [Anonymous], 2017, LANCET HIV, V2, pe115
   Arazi A, 2013, SEMIN IMMUNOL, V25, P193, DOI 10.1016/j.smim.2012.11.003
   Arjona A, 2011, CELL MICROBIOL, V13, P1648, DOI 10.1111/j.1462-5822.2011.01649.x
   Azeredo EL, 2010, IMMUNOLOGY, V130, P202, DOI 10.1111/j.1365-2567.2009.03224.x
   Badolato-Correa J, 2018, IMMUN INFLAMM DIS, V6, P194, DOI 10.1002/iid3.203
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhaumik SK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010019
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020
   Brusic V, 2014, NAT BIOTECHNOL, V32, P146, DOI 10.1038/nbt.2777
   Buffa S, 2013, AGE, V35, P2009, DOI 10.1007/s11357-012-9488-5
   Busch MP, 2008, J INFECT DIS, V198, P984, DOI 10.1086/591467
   Cahill ME, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3186-6
   Cahill ME, 2017, EMERG INFECT DIS, V23, P708, DOI 10.3201/eid2304.161669
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Campos MC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201452
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention CDC, 2018, W NIL VIR DIS CAS RE
   Chandele A, 2016, J VIROL, V90, P11259, DOI 10.1128/JVI.01424-16
   Colpitts TM, 2012, CLIN MICROBIOL REV, V25, P635, DOI 10.1128/CMR.00045-12
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cook S, 2006, ARCH VIROL, V151, P309, DOI 10.1007/s00705-005-0626-6
   Dash AP, 2013, J VECTOR DIS, V50, P77
   Davis MM, 2017, NAT IMMUNOL, V18, P725, DOI 10.1038/ni.3768
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Ganeshkumar P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006618
   Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4
   Glasner A, 2017, J VIROL, V91, DOI [10.1128/JVI.00785-17, 10.1128/jvi.00785-17]
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Gubler DJ, 2007, CLIN INFECT DIS, V45, P1039, DOI 10.1086/521911
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Halstead SB, 2009, ANN NY ACAD SCI, V1171, pE48, DOI 10.1111/j.1749-6632.2009.05052.x
   Hamlin RE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92424
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553
   Jamieson AM, 2013, SCIENCE, V340, P1230, DOI 10.1126/science.1233632
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114
   Kleinsteuber K, 2016, CYTOM PART A, V89A, P903, DOI 10.1002/cyto.a.22935
   Koyama S, 2008, CYTOKINE, V43, P336, DOI 10.1016/j.cyto.2008.07.009
   Lai CY, 2008, J VIROL, V82, P6631, DOI 10.1128/JVI.00316-08
   Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732
   Lan Nguyen Thi Phuong, 2011, Trop Med Health, V39, P73, DOI 10.2149/tmh.2011-S08
   Li M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200478
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindsey NP, 2007, JAMA-J AM MED ASSOC, V298, P619
   Luhn K, 2007, J EXP MED, V204, P979, DOI 10.1084/jem.20061381
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Montgomery RR, 2016, CYTOM PART A, V89A, P886, DOI 10.1002/cyto.a.22992
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067
   Nogueira ML, 2018, CLIN MICROBIOL INFEC, V24, P646, DOI 10.1016/j.cmi.2017.11.004
   Ormond-Parker L, 2012, ARCH SCI-NETHERLANDS, V12, P191, DOI 10.1007/s10502-011-9154-1
   Passos RD, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0312-8
   Petersen LR, 2013, EPIDEMIOL INFECT, V141, P591, DOI 10.1017/S0950268812001070
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qian F, 2015, CLIN VACCINE IMMUNOL, V22, P6, DOI 10.1128/CVI.00508-14
   Qian F, 2014, VIRAL IMMUNOL, V27, P39, DOI 10.1089/vim.2013.0074
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Robinson KM, 2015, CURR OPIN IMMUNOL, V34, P59, DOI 10.1016/j.coi.2015.02.002
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Ronca SE, 2019, EMERG INFECT DIS, V25, P325, DOI 10.3201/eid2502.180765
   Rothman AL, 2011, NAT REV IMMUNOL, V11, P532, DOI 10.1038/nri3014
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Sekiguchi DR, 2011, CYTOM PART B-CLIN CY, V80B, P291, DOI 10.1002/cyto.b.20594
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   The Lancet Public H, 2018, LANCET PUBLIC HLTH, V3, pe153, DOI 10.1016/S2468-2667(18)30053-7
   Tian Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01728-5
   Uraki R, 2017, J INFECT DIS, V215, P1720, DOI 10.1093/infdis/jix204
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Wang T, 2013, VIRUSES-BASEL, V5, P2298, DOI 10.3390/v5092298
   Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499
   Wickham H., 2017, TIDYVERSE EASILY INS
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Xiang Z, 2011, P 2 INT C BIOM ONT I
   Yao Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172625
   Yao Y, 2017, CYTOM PART B-CLIN CY, V92, P12, DOI 10.1002/cyto.b.21491
   Yao Y, 2014, J IMMUNOL METHODS, V415, P1, DOI 10.1016/j.jim.2014.10.010
   2018, LANCET GASTROENTEROL, V3, P141
NR 99
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1935-2735
J9 PLOS NEGLECT TROP D
JI Plos Neglect. Trop. Dis.
PD MAR
PY 2020
VL 14
IS 3
AR e0008112
DI 10.1371/journal.pntd.0008112
PG 25
WC Infectious Diseases; Parasitology; Tropical Medicine
SC Infectious Diseases; Parasitology; Tropical Medicine
GA LH2YY
UT WOS:000528655400041
PM 32150565
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Araujo, IF
   Loureiro, HA
   Marinho, VHS
   Neves, FB
   Sarquis, RSF
   Faustino, SMM
   Yoshioka, SA
   Ferreira, RMA
   Souto, RNP
   Ferreira, IM
AF Araujo, Inana F.
   Loureiro, Hellen A.
   Marinho, Victor H. S.
   Neves, Fernando B.
   Sarquis, Rosangela S. F.
   Faustino, Silvia M. M.
   Yoshioka, Sergio A.
   Ferreira, Ricardo M. A.
   Souto, Raimundo N. P.
   Ferreira, Irlon M.
TI Larvicidal activity of the methanolic, hydroethanolic and hexanic
   extracts from Acmella oleracea, solubilized with silk fibroin, against
   Aedes aegypti
SO BIOCATALYSIS AND AGRICULTURAL BIOTECHNOLOGY
LA English
DT Article
DE Dengue; Jambu; Silkworm cocoon; Chlorella vulgaris; Silk formulation
ID PHOTOSYNTHESIS
AB The Aedes aegypti mosquito is a vector that causes various diseases such as chikungunya fever, dengue and Zika, and therefore constitutes a public health problem. The present study was carried out to evaluate the larvicidal activity of different crude extracts (methanolic, hydroethanolic and hexanic) from leaves of Acmella oleracea solubilized in fibroin solution, as an alternative to the organic solvents that are used against Aedes aegypti. Using the Probit analysis, the hexane extract showed LC50 of 2.23 mu g/mL after 24 h, whereas the hydroethanolic and the methanolic extracts showed LC50 of 28.42 mu g/mL and 39.67 mu g/mL, respectively. These extracts also did not show toxicity towards Chlorella vulgaris after 30 days, which suggests that they can be used without causing environmental damage. Thus, A. oleracea extract dissolved in fibroin solution could be an alternative for control ling Ae. aegypti without causing damage to the environment.
C1 [Araujo, Inana F.; Loureiro, Hellen A.; Marinho, Victor H. S.; Neves, Fernando B.; Sarquis, Rosangela S. F.; Ferreira, Irlon M.] Univ Fed Amapa, Biocatalysis & Organ Synth Grp, Sch Appl Chem, Rod JK,Km 02, BR-68902280 Macapa, Amapa, Brazil.
   [Faustino, Silvia M. M.] Univ Fed Amapa, Algae Cultivat Lab, Rod JK,Km 02, BR-68902280 Macapa, Amapa, Brazil.
   [Yoshioka, Sergio A.] Univ Sao Paulo, Biochem & Biomat Lab, Inst Chem Sao Carlos, Ave Trabalhador Sao Carlense 400, BR-13560970 Sao Carlos, SP, Brazil.
   [Ferreira, Ricardo M. A.; Souto, Raimundo N. P.] Univ Fed Amapa, Arthropod Lab, Sch Biol, Rod JK,Km 02, BR-68902280 Macapa, Amapa, Brazil.
RP Ferreira, IM (corresponding author), Univ Fed Amapa, Biocatalysis & Organ Synth Grp, Sch Appl Chem, Rod JK,Km 02, BR-68902280 Macapa, Amapa, Brazil.
EM irlon.ferreira@gmail.com
OI FERREIRA, IRLON/0000-0002-4517-0105; Fauro de Araujo,
   Inana/0000-0002-3168-3137
FU Fundacao de Amparo a Pesquisa do Estado do Amapa (FAPEAP)
   [34568.515.22257.28052017]
FX The authors would like to acknowledge Fundacao de Amparo a Pesquisa do
   Estado do Amapa (FAPEAP, grant no. 34568.515.22257.28052017) for their
   financial support.
CR Aragao CF, 2018, ACTA TROP, V186, P1, DOI 10.1016/j.actatropica.2018.06.022
   Azeem M, 2019, IND CROP PROD, V140, DOI 10.1016/j.indcrop.2019.111609
   Barbosa AF, 2016, REV BRAS FARMACOGN, V26, P128, DOI 10.1016/j.bjp.2015.07.024
   Valotto CFB, 2011, REV SOC BRAS MED TRO, V44, P194, DOI 10.1590/s0037-86822011005000010
   Benelli G, 2019, J ETHNOPHARMACOL, V229, P272, DOI 10.1016/j.jep.2018.08.030
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P113
   Dallazen JL, 2018, FITOTERAPIA, V131, P225, DOI 10.1016/j.fitote.2018.11.001
   Zanotto PMD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01964
   de Araujo IF, 2018, S AFR J BOT, V117, P134, DOI 10.1016/j.sajb.2018.05.008
   Blanco VSD, 2018, J SUPERCRIT FLUID, V140, P372, DOI 10.1016/j.supflu.2018.07.028
   de Melo AR, 2018, ECOTOX ENVIRON SAFE, V154, P1, DOI 10.1016/j.ecoenv.2018.02.009
   Saenz ME, 2012, PESTIC BIOCHEM PHYS, V104, P50, DOI 10.1016/j.pestbp.2012.07.001
   Ferreira I.M., 2016, CATAL LETT, V1, P12
   Ferreira IM, 2017, RSC ADV, V7, P12650, DOI 10.1039/c7ra00083a
   Ferreira IM, 2014, BIOCATAL AGRIC BIOTE, V3, P358, DOI 10.1010/j.bcab.2014.04.001
   Gobbo-Neto L, 2007, QUIM NOVA, V30, P374, DOI 10.1590/S0100-40422007000200026
   Hansen H, 1998, ENVIRON HEALTH PERSP, V106, P1271, DOI 10.1289/ehp.98106s61271
   Jimenez D.E.Q., 2016, CURR MICROW CHEM, V3, p1 
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Liu CX, 2019, ENVIRON POLLUT, V250, P610, DOI 10.1016/j.envpol.2019.04.027
   Lu SZ, 2009, BIOMACROMOLECULES, V10, P1032, DOI 10.1021/bm800956n
   Ma JY, 2006, ECOTOX ENVIRON SAFE, V63, P268, DOI 10.1016/j.ecoenv.2004.12.002
   Maciel M.V, 2010, Rev. bras. plantas med., V12, P105, DOI 10.1590/S1516-05722010000100015
   MINOURA N, 1990, BIOMATERIALS, V11, P430, DOI 10.1016/0142-9612(90)90100-5
   Mitchell BE, 1998, J CHEM INF COMP SCI, V38, P489, DOI 10.1021/ci970117f
   Omondi WP, 2019, ACTA TROP, V200, DOI 10.1016/j.actatropica.2019.105163
   Pandey V, 2007, PARASITOL RES, V102, P171, DOI 10.1007/s00436-007-0763-9
   Pandiyan GN, 2019, ECOTOX ENVIRON SAFE, V174, P549, DOI 10.1016/j.ecoenv.2019.03.019
   Panneerselvam C, 2013, ASIAN PAC J TROP MED, V6, P102, DOI 10.1016/S1995-7645(13)60003-6
   Qian HF, 2009, CHEMOSPHERE, V75, P368, DOI 10.1016/j.chemosphere.2008.12.040
   Rodrigues ET, 2018, ECOTOX ENVIRON SAFE, V150, P224, DOI 10.1016/j.ecoenv.2017.12.047
   Sah MK, 2011, AFR J BIOTECHNOL, V10, P7878
   Seetharaman PK, 2018, BIOCATAL AGR BIOTECH, V16, P22, DOI 10.1016/j.bcab.2018.07.006
   Simas NK, 2013, PHYTOCHEM LETT, V6, P67, DOI 10.1016/j.phytol.2012.10.016
   Singh H, 2019, ACTA TROP, V199, DOI 10.1016/j.actatropica.2019.105114
   Wang M, 2004, MACROMOLECULES, V37, P6856, DOI 10.1021/ma048988v
   Weska RF, 2009, MATER RES-IBERO-AM J, V12, P233, DOI 10.1590/S1516-14392009000200020
   Whetstone PA, 2007, TOXICON, V49, P576, DOI 10.1016/j.toxicon.2006.11.009
   Yukseloglu SM, 2015, MICROELECTRON ENG, V146, P43, DOI 10.1016/j.mee.2015.04.008
NR 39
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
EI 1878-8181
J9 BIOCATAL AGR BIOTECH
JI Biocatal. Agric. Biotechnol.
PD MAR
PY 2020
VL 24
AR 101550
DI 10.1016/j.bcab.2020.101550
PG 6
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA LI3CQ
UT WOS:000529361100030
DA 2020-07-08
ER

PT J
AU Claus, C
   Jung, M
   Hubschen, JM
AF Claus, Claudia
   Jung, Matthias
   Hubschen, Judith M.
TI Pluripotent Stem Cell-Based Models: A Peephole into Virus Infections
   during Early Pregnancy
SO CELLS
LA English
DT Review
DE teratogenesis; embryonal development; interferon; placenta; blastocyst;
   iPSC; pluripotent stem cells; organoid; cytomegalovirus; Zika virus;
   rubella virus; congenital virus infection
ID CYTOMEGALOVIRUS CMV INFECTION; ZIKA VIRUS; RUBELLA-VIRUS; FETAL
   TRANSMISSION; CEREBRAL ORGANOIDS; SELF-ORGANIZATION; HUMAN EMBRYO;
   HEARING-LOSS; DIFFERENTIATION; SUSCEPTIBILITY
AB The rubella virus (RV) was the first virus shown to be teratogenic in humans. The wealth of data on the clinical symptoms associated with congenital rubella syndrome is in stark contrast to an incomplete understanding of the forces leading to the teratogenic alterations in humans. This applies not only to RV, but also to congenital viral infections in general and includes (1) the mode of vertical transmission, even at early gestation, (2) the possible involvement of inflammation as a consequence of an activated innate immune response, and (3) the underlying molecular and cellular alterations. With the progress made in the development of pluripotent stem cell-based models including organoids and embryoids, it is now possible to assess congenital virus infections on a mechanistic level. Moreover, antiviral treatment options can be validated, and newly emerging viruses with a potential impact on human embryonal development, such as that recently reflected by the Zika virus (ZIKV), can be characterized. Here, we discuss human cytomegalovirus (HCMV) and ZIKV in comparison to RV as viruses with well-known congenital pathologies and highlight their analysis on current models for the early phase of human development. This includes the implications of their genetic variability and, as such, virus strain-specific properties for their use as archetype models for congenital virus infections. In this review, we will discuss the use of induced pluripotent stem cells (iPSC) and derived organoid systems for the study of congenital virus infections with a focus on their prominent aetiologies, HCMV, ZIKV, and RV. Their assessment on these models will provide valuable information on how human development is impaired by virus infections; it will also add new insights into the normal progression of human development through the analysis of developmental pathways in the context of virus-induced alterations. These are exciting perspectives for both developmental biology and congenital virology.
C1 [Claus, Claudia] Univ Leipzig, Inst Virol, Johannisallee 30, D-04103 Leipzig, Germany.
   [Jung, Matthias] Martin Luther Univ Halle Wittenberg, Univ Clin & Outpatient Clin Psychiat, Psychotherapy, Psychosomat Med, D-06112 Halle, Saale, Germany.
   [Hubschen, Judith M.] Luxembourg Inst Hlth, Dept Infect & Immun, Infect Dis Res Unit, L-4354 Esch Sur Alzette, Luxembourg.
RP Claus, C (corresponding author), Univ Leipzig, Inst Virol, Johannisallee 30, D-04103 Leipzig, Germany.
EM claudia.claus@medizin.uni-leipzig.de; matthias.jung@uk-halle.de;
   Judith.Huebschen@lih.lu
OI Jung, Matthias/0000-0001-6808-6494
FU Leipzig University for Open Access Publishing
FX We acknowledge support from Leipzig University for Open Access
   Publishing. The authors want to thank Mario Honemann for critical
   reading of the manuscript. The wealth of the topics summarized in this
   review and the associated space limitations did not allow for an in
   depth citation of all available work. We apologize to the authors of
   studies missed or omitted.
CR Achberger K, 2019, ADV DRUG DELIVER REV, V140, P33, DOI 10.1016/j.addr.2018.05.005
   Adam MP, 2012, BIRTH DEFECTS RES A, V94, P664, DOI 10.1002/bdra.23029
   Adamo P, 2004, VIRAL IMMUNOL, V17, P87, DOI 10.1089/088282404322875485
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P337
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Belzile JP, 2014, J VIROL, V88, P4021, DOI 10.1128/JVI.03492-13
   Berger AA, 2015, J VIROL, V89, P11159, DOI 10.1128/JVI.01742-15
   Berger JL, 2018, SAGE OPEN, V8, DOI 10.1177/2158244017754119
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bilz NC, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080870
   Bilz NC, 2018, J VIROL, V92, DOI 10.1128/JVI.00934-18
   Blake LE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1490-5
   Boppana SB, 2017, J INFECT DIS, V216, pS912, DOI 10.1093/infdis/jix431
   Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467
   Bradford RD, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004774
   Brown KE, 2019, MMWR-MORBID MORTAL W, V68, P587, DOI 10.15585/mmwr.mm6826a3
   Brown RM, 2019, J VIROL, V93, DOI 10.1128/JVI.00957-19
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Care AS, 2013, J CLIN INVEST, V123, P3472, DOI 10.1172/JCI60561
   Cekinovic D, 2008, J VIROL, V82, P12172, DOI 10.1128/JVI.01214-08
   CHANTLER JK, 1980, J GEN VIROL, V50, P317, DOI 10.1099/0022-1317-50-2-317
   Chen HI, 2019, DEV DYNAM, V248, P53, DOI 10.1002/dvdy.24662
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chowdhury R, 2018, ANTIBODIES, V7, DOI 10.3390/antib7030023
   Corry J, 2017, P NATL ACAD SCI USA, V114, P9433, DOI 10.1073/pnas.1707513114
   D'Aiuto L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049700
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   de Caires LC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02790-9
   Deglincerti A, 2016, NATURE, V533, P251, DOI 10.1038/nature17948
   DELAHUNT CS, 1967, AM J OBSTET GYNECOL, V99, P580
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   Dietrich ML, 2019, OCHSNER J, V19, P123, DOI 10.31486/toj.18.0095
   Dobbins GC, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4681-0
   Dudgeon J A, 1976, J Clin Pathol Suppl (R Coll Pathol), V10, P99
   Dukhovny A, 2019, J VIROL, V93, DOI 10.1128/JVI.00211-19
   Dvash T, 2004, BEST PRACT RES CL OB, V18, P929, DOI 10.1016/j.bpobgyn.2004.06.005
   Eggenberger J, 2019, P NATL ACAD SCI USA, V116, P1384, DOI 10.1073/pnas.1812449116
   ENDERS G, 1988, LANCET, V1, P1445
   Enders G, 2011, J CLIN VIROL, V52, P244, DOI 10.1016/j.jcv.2011.07.005
   Esser-Nobis K, 2019, J VIROL, V93, DOI 10.1128/JVI.00640-19
   Fogarty NME, 2017, NATURE, V550, P67, DOI 10.1038/nature24033
   Fougerousse F, 2000, HUM MOL GENET, V9, P165, DOI 10.1093/hmg/9.2.165
   Fowler KB, 2006, J CLIN VIROL, V35, P226, DOI 10.1016/j.jcv.2005.09.016
   Fowler KB, 1997, J PEDIATR-US, V130, P624, DOI 10.1016/S0022-3476(97)70248-8
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gerrelli D, 2015, DEVELOPMENT, V142, P3073, DOI 10.1242/dev.122820
   GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Gregg N.M., 1991, PROBLEMS BIRTH DEFEC, V107, P170
   Grosse SD, 2008, J CLIN VIROL, V41, P57, DOI 10.1016/j.jcv.2007.09.004
   Hanna J, 2006, NAT MED, V12, P1065, DOI 10.1038/nm1452
   Heemskerk I, 2016, DEV DYNAM, V245, P976, DOI [10.1002/DVDY.24432, 10.1002/dvdy.24432]
   Hong S, 2007, MOL THER, V15, P1630, DOI 10.1038/sj.mt.6300251
   Hubschen J.M., 2018, RUBELLA CONGENITAL R, P608
   Jena MK, 2019, ARCH IMMUNOL THER EX, V67, P295, DOI 10.1007/s00005-019-00552-7
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   Kim In-Jeong, 2019, Trop Med Infect Dis, V4, DOI 10.3390/tropicalmed4020058
   Kim S, 2007, STEM CELLS DEV, V16, P537, DOI 10.1089/scd.2006.0088
   Krendl C, 2017, P NATL ACAD SCI USA, V114, pE9579, DOI 10.1073/pnas.1708341114
   Lazar M, 2016, EBIOMEDICINE, V3, P86, DOI 10.1016/j.ebiom.2015.11.050
   Lazarini F, 2018, J NEUROSCI, V38, P10424, DOI 10.1523/JNEUROSCI.0740-18.2018
   Lee JY, 2000, CLIN MICROBIOL REV, V13, P571, DOI 10.1128/CMR.13.4.571-587.2000
   Li YC, 2013, DEVELOPMENT, V140, P3965, DOI 10.1242/dev.092155
   Liu L, 2019, CELL DEATH DIFFER, V26, P2607, DOI 10.1038/s41418-019-0324-7
   Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B
   Maidji E, 2006, AM J PATHOL, V168, P1210, DOI 10.2353/ajpath.2006.050482
   Marin-Lopez A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010035
   Martinez-Torres AO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162403
   Massimiani M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010023
   Matsukage S, 2006, BIRTH DEFECTS RES A, V76, P115, DOI 10.1002/bdra.20233
   MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320
   Mor G, 2017, NAT REV IMMUNOL, V17, P469, DOI 10.1038/nri.2017.64
   PARKMAN PD, 1965, AM J DIS CHILD, V110, P390, DOI 10.1001/archpedi.1965.02090030410008
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Pomar L, 2017, ULTRASOUND OBST GYN, V49, P729, DOI 10.1002/uog.17404
   Trinh QD, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010023
   Racicot K, 2014, AM J REPROD IMMUNOL, V72, P107, DOI 10.1111/aji.12289
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Robinson N, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1985
   Rohani L, 2018, STEM CELL TRANSL MED, V7, P867, DOI 10.1002/sctm.18-0087
   Rossi AD, 2019, J INTERN MED, V285, P215, DOI 10.1111/joim.12829
   Rossi SL, 2016, AM J TROP MED HYG, V94, P1362, DOI 10.4269/ajtmh.16-0111
   Salinas S, 2017, J VIROL, V91, DOI [10.1128/JVI.02144-16, 10.1128/jvi.02144-16]
   Santos CNO, 2019, J INFECT DIS, V220, P1797, DOI 10.1093/infdis/jiz392
   Schleiss MR, 2008, J CLIN VIROL, V41, P224, DOI 10.1016/j.jcv.2007.10.008
   Shahbazi MN, 2016, NAT CELL BIOL, V18, P700, DOI 10.1038/ncb3347
   Shen H, 2018, NATURE, V559, P19, DOI 10.1038/d41586-018-05586-z
   Simonin Y, 2019, EBIOMEDICINE, V39, P315, DOI 10.1016/j.ebiom.2018.12.010
   Suarez NM, 2019, J INFECT DIS, V220, P781, DOI 10.1093/infdis/jiz208
   Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019
   Tan L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12063-2
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teissier N, 2014, J NEUROPATH EXP NEUR, V73, P143, DOI 10.1097/NEN.0000000000000038
   Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145
   TONDURY G, 1966, J PEDIATR-US, V68, P867, DOI 10.1016/S0022-3476(66)80204-4
   Udenze D, 2019, EMERG MICROBES INFEC, V8, P1098, DOI 10.1080/22221751.2019.1644967
   Vauloup-Fellous C, 2010, J CLIN MICROBIOL, V48, P2530, DOI 10.1128/JCM.00181-10
   Wang CY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18281-2
   Wang R, 2008, STEM CELLS DEV, V17, P279, DOI 10.1089/scd.2007.0084
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Weisblum Y, 2011, J VIROL, V85, P13204, DOI 10.1128/JVI.05749-11
   Wilkinson GWG, 2015, MED MICROBIOL IMMUN, V204, P273, DOI 10.1007/s00430-015-0411-4
   WILSON JG, 1959, ANAT REC, V133, P115, DOI 10.1002/ar.1091330202
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Wujcicka W, 2017, VIROL J, V14, DOI 10.1186/s12985-016-0679-z
   Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992
   Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011
   Zheng Y, 2019, NATURE, V573, P421, DOI 10.1038/s41586-019-1535-2
   Zhu ZR, 2013, DEVELOPMENT, V140, P705, DOI 10.1242/dev.086165
   Zhu Z, 2020, CELL STEM CELL, V26, P187, DOI 10.1016/j.stem.2019.11.016
   Zhu Z, 2010, J CLIN MICROBIOL, V48, P1775, DOI 10.1128/JCM.02055-09
   Zobel S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100540
NR 119
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2073-4409
J9 CELLS-BASEL
JI Cells
PD MAR
PY 2020
VL 9
IS 3
AR 542
DI 10.3390/cells9030542
PG 21
WC Cell Biology
SC Cell Biology
GA LI2TV
UT WOS:000529337400019
PM 32110999
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Saraiva, RG
   Dimopoulos, G
AF Saraiva, Raul G.
   Dimopoulos, George
TI Bacterial natural products in the fight against mosquito-transmitted
   tropical diseases
SO NATURAL PRODUCT REPORTS
LA English
DT Review
ID CYANOBACTERIAL ALKALOID NOSTOCARBOLINE; VITRO ANTIMALARIAL ACTIVITY;
   POTENT IN-VITRO; WEST NILE VIRUS; PLASMODIUM-FALCIPARUM; DENGUE-VIRUS;
   PROTEIN-SYNTHESIS; GUT MICROBIOTA; ANTIBIOTIC MICROCOCCIN; MEDICINAL
   CHEMISTRY
AB Covering: up to 2019 Secondary metabolites of microbial origin have long been acknowledged as medically relevant, but their full potential remains largely unexploited. Of the countless natural compounds discovered thus far, only 5-10% have been isolated from microorganisms. At the same time, while whole-genome sequencing has demonstrated that bacteria and fungi often encode natural products, only a few genera have yet been mined for new compounds. This review explores the contributions of bacterial natural products to combatting infection by malaria parasites, filarial worms, and arboviruses such as dengue, Zika, Chikungunya, and West Nile. It highlights how molecules isolated from microorganisms ranging from marine cyanobacteria to mosquito endosymbionts can be exploited as antimicrobials and antivirals. Pursuit of this mostly untapped source of chemical entities will potentially result in new interventions against these tropical diseases, which are urgently needed to combat the increase in the incidence of resistance.
C1 [Saraiva, Raul G.; Dimopoulos, George] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
RP Saraiva, RG (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.
EM rsaraiva@jhu.edu
OI Saraiva, Raul/0000-0002-9847-8277
FU Boehringer Ingelheim FondsBoehringer Ingelheim; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI141532, R01AI122743]
FX RGS acknowledges Boehringer Ingelheim Fonds for a doctoral fellowship.
   GD recognizes the National Institutes of Health for grants R01AI141532
   and R01AI122743. We thank Dr Deborah McClellan for editorial assistance.
CR ADAMCZESKI M, 1989, J AM CHEM SOC, V111, P647, DOI 10.1021/ja00184a037
   Adovelande J, 1996, LIFE SCI, V59, pPL309, DOI 10.1016/S0024-3205(96)00514-0
   AGTARAP A, 1967, J AM CHEM SOC, V89, P5737, DOI 10.1021/ja00998a062
   Almabruk KH, 2013, ORG LETT, V15, P1678, DOI 10.1021/ol4004614
   Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x
   Aminake MN, 2011, ANTIMICROB AGENTS CH, V55, P1338, DOI 10.1128/AAC.01096-10
   Ang KKH, 2000, ANTIMICROB AGENTS CH, V44, P1645, DOI 10.1128/AAC.44.6.1645-1649.2000
   Antoszczak M, 2019, EUR J MED CHEM, V166, P32, DOI 10.1016/j.ejmech.2019.01.035
   Antoszczak M, 2015, BIOACTIVE NATURAL PRODUCTS: CHEMISTRY AND BIOLOGY, P107
   Ashok P, 2013, MINI-REV MED CHEM, V13, P1778
   Ashour D. S., 2019, INT J ANTIMICROB AGE
   Auparakkitanon Saranya, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P619
   Azambuja P, 2005, TRENDS PARASITOL, V21, P568, DOI 10.1016/j.pt.2005.09.011
   Azambuja P, 2004, EXP PARASITOL, V107, P89, DOI 10.1016/j.exppara.2004.04.007
   Bahia AC, 2014, ENVIRON MICROBIOL, V16, P2980, DOI 10.1111/1462-2920.12381
   Bale JF, 2015, PEDIATR NEUROL, V53, P3, DOI 10.1016/j.pediatrneurol.2015.03.013
   Barbaras D, 2008, BIOORG MED CHEM LETT, V18, P4413, DOI 10.1016/j.bmcl.2008.06.049
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Bazzocchi C, 2008, INT J PARASITOL, V38, P1401, DOI 10.1016/j.ijpara.2008.03.002
   BeBoer C, 1976, J Antibiot (Tokyo), V29, P1182
   Becher PG, 2009, J APPL PHYCOL, V21, P103, DOI 10.1007/s10811-008-9335-3
   Becher PG, 2005, J NAT PROD, V68, P1793, DOI 10.1021/np050312l
   Begum AS, 2014, CHEM BIODIVERS, V11, P92, DOI 10.1002/cbdv.201300045
   Berdy J, 2005, J ANTIBIOT, V58, P1, DOI 10.1038/ja.2005.1
   Bharti H, 2018, CURR TOP MED CHEM, V18, P2029, DOI 10.2174/1568026619666181129125950
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   BHUYAN BK, 1962, APPL MICROBIOL, V10, P302, DOI 10.1128/AEM.10.4.302-304.1962
   Blom JF, 2006, ORG LETT, V8, P737, DOI 10.1021/ol052968b
   Bode E, 2015, CHEMBIOCHEM, V16, P1115, DOI 10.1002/cbic.201500094
   Boissiere Anne, 2012, PLoS Pathog, V8, pe1002742, DOI 10.1371/journal.ppat.1002742
   Borthwick AD, 2012, CHEM REV, V112, P3641, DOI 10.1021/cr200398y
   Brachmann AO, 2013, ADV BIOCHEM ENG BIOT, V135, P123, DOI 10.1007/10_2013_192
   Briolant S, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-141
   BROCKMANN H, 1955, CHEM BER-RECL, V88, P57, DOI 10.1002/cber.19550880111
   Buck M, 2016, SCI REP-UK, V6, DOI 10.1038/srep22806
   Budimulja AS, 1997, MOL BIOCHEM PARASIT, V84, P137, DOI 10.1016/S0166-6851(96)02781-8
   Bultel-Ponce V, 1999, MAR BIOTECHNOL, V1, P384, DOI 10.1007/PL00011792
   Caragata EP, 2019, CURR OPIN VIROL, V37, P26, DOI 10.1016/j.coviro.2019.05.005
   Carithers DS, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2116-6
   Carnio MC, 2001, EUR J BIOCHEM, V268, P6390, DOI 10.1046/j.0014-2956.2001.02591.x
   Carocci M, 2016, ANTIVIR RES, V128, P57, DOI 10.1016/j.antiviral.2016.02.005
   Castillo U, 2003, FEMS MICROBIOL LETT, V224, P183, DOI 10.1016/S0378-1097(03)00426-9
   CDC, 2013, PAR LYMPH FIL
   CDC, 2019, GUID TREATM MAL US
   Challinor VL, 2015, ANN NY ACAD SCI, V1354, P82, DOI 10.1111/nyas.12954
   Chen XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091809
   Cheng KCC, 2015, J NAT PROD, V78, P2411, DOI 10.1021/acs.jnatprod.5b00489
   Chua MJ, 2017, INT J PARASITOL-DRUG, V7, P42, DOI 10.1016/j.ijpddr.2016.12.005
   Cirimotich CM, 2011, SCIENCE, V332, P855, DOI 10.1126/science.1201618
   Clark BR, 2008, J NAT PROD, V71, P1530, DOI 10.1021/np800088a
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901
   Crump A, 2017, J ANTIBIOT, V70, P495, DOI 10.1038/ja.2017.11
   D'Alessandro S, 2015, ANTIMICROB AGENTS CH, V59, P5135, DOI 10.1128/AAC.04332-14
   Dahari Dhiana Efani, 2016, Trop Life Sci Res, V27, P53, DOI 10.21315/tlsr2016.27.2.5
   Dahl EL, 2006, ANTIMICROB AGENTS CH, V50, P3124, DOI 10.1128/AAC.00394-06
   Dai JK, 2018, EUR J MED CHEM, V157, P622, DOI 10.1016/j.ejmech.2018.08.027
   Degiacomi G, 2016, TUBERCULOSIS, V100, P95, DOI 10.1016/j.tube.2016.07.011
   Demain AL, 2009, J ANTIBIOT, V62, P5, DOI 10.1038/ja.2008.16
   Dennison NJ, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1468-2
   Dennison NJ, 2014, CURR OPIN INSECT SCI, V3, P6, DOI 10.1016/j.cois.2014.07.004
   DORMAN DE, 1976, HELV CHIM ACTA, V59, P2625, DOI 10.1002/hlca.19760590802
   Duguma D, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0475-8
   DUTTON CJ, 1995, NAT PROD REP, V12, P165, DOI 10.1039/np9951200165
   EBATA E, 1975, J ANTIBIOT, V28, P118, DOI 10.7164/antibiotics.28.118
   Edwards Rachel L, 2016, F1000Res, V5, P2514
   Engel JA, 2015, INT J PARASITOL-DRUG, V5, P117, DOI 10.1016/j.ijpddr.2015.05.004
   Euanorasetr J, 2019, J GEN APPL MICROBIOL, V65, P197, DOI 10.2323/jgam.2018.10.001
   Fernandes JF, 2015, FUTURE MICROBIOL, V10, P1375, DOI 10.2217/FMB.15.60
   Ferrer P, 2015, ANTIMICROB AGENTS CH, V59, P1418, DOI 10.1128/AAC.04642-14
   Ferrer P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037171
   Fichera ME, 1997, NATURE, V390, P407, DOI 10.1038/37132
   FORMICA JV, 1983, ANTIMICROB AGENTS CH, V24, P735, DOI 10.1128/AAC.24.5.735
   GACHON P, 1975, J ANTIBIOT, V28, P351, DOI 10.7164/antibiotics.28.351
   GACHON P, 1976, J ANTIBIOT, V29, P603, DOI 10.7164/antibiotics.29.603
   Gaillard T, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0980-0
   Gates B, 2014, DEADLIEST ANIMAL WOR
   Genes C, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-66
   Genilloud O, 2014, ANTON LEEUW INT J G, V106, P173, DOI 10.1007/s10482-014-0204-6
   Goma J, 1996, PARASITOLOGY, V112, P165, DOI 10.1017/S0031182000084729
   GORDEUK VR, 1992, BLOOD, V79, P308
   Greenwood D., 2012, ANTIBIOT CHEMOTHER, P259
   Griffin MO, 2010, AM J PHYSIOL-CELL PH, V299, pC539, DOI 10.1152/ajpcell.00047.2010
   Grundmann F, 2013, RSC ADV, V3, P22072, DOI 10.1039/c3ra44721a
   Gubler DJ, 2012, AM J TROP MED HYG, V86, P743, DOI 10.4269/ajtmh.2012.12-0157
   Gumila C, 1996, ANTIMICROB AGENTS CH, V40, P602, DOI 10.1128/AAC.40.3.602
   Gumila C, 1997, ANTIMICROB AGENTS CH, V41, P523, DOI 10.1128/AAC.41.3.523
   Gupta DK, 2014, MAR DRUGS, V12, P115, DOI 10.3390/md12010115
   Gutierrez M., 2012, J PHARM BIOALLIED SC, V4, P66
   Gutierrez M, 2010, J NAT PROD, V73, P709, DOI 10.1021/np9005184
   Hackett BA, 2018, P NATL ACAD SCI USA, V115, P4246, DOI 10.1073/pnas.1720032115
   Hayase H, 2015, BIOSCI BIOTECH BIOCH, V79, P633, DOI 10.1080/09168451.2014.987205
   HERSHKO C, 1992, J INORG BIOCHEM, V47, P267, DOI 10.1016/0162-0134(92)84072-U
   Hotchkiss R. D., 2006, ADV ENZYMOLOGY RELAT, V4, P153
   Isaka M, 2002, ANTIMICROB AGENTS CH, V46, P1112, DOI 10.1128/AAC.46.4.1112-1113.2002
   Jiang Z, 2000, NAT PROD LETT, V14, P435, DOI 10.1080/10575630008043781
   Johansson MA, 2015, TRENDS PARASITOL, V31, P43, DOI 10.1016/j.pt.2014.12.008
   Jomaa H, 1999, SCIENCE, V285, P1573, DOI 10.1126/science.285.5433.1573
   Kang S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003084
   Kaptein SJF, 2010, ANTIMICROB AGENTS CH, V54, P5269, DOI 10.1128/AAC.00686-10
   Karray F, 2010, J BACTERIOL, V192, P5813, DOI 10.1128/JB.00712-10
   KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758
   Kimura T, 2019, J ANTIBIOT, V72, P169, DOI 10.1038/s41429-018-0117-0
   KINASHI H, 1984, J ANTIBIOT, V37, P1333, DOI 10.7164/antibiotics.37.1333
   Kitani S, 2018, J ANTIBIOT, V71, P662, DOI 10.1038/s41429-018-0044-0
   Kronenwerth M, 2014, CHEM-EUR J, V20, P17478, DOI 10.1002/chem.201403979
   Kronenwerth M, 2014, EUR J ORG CHEM, V2014, P8026, DOI 10.1002/ejoc.201403346
   KUEMMERLE HP, 1985, INT J CLIN PHARM TH, V23, P521
   KUHN JG, 1989, EUR J CANCER CLIN ON, V25, P797, DOI 10.1016/0277-5379(89)90123-5
   Laing R, 2017, TRENDS PARASITOL, V33, P463, DOI 10.1016/j.pt.2017.02.004
   Laurent D, 2006, MAR BIOTECHNOL, V8, P433, DOI 10.1007/s10126-006-6100-y
   Lell B, 2002, ANTIMICROB AGENTS CH, V46, P2315, DOI 10.1128/AAC.46.8.2315-2320.2002
   Lim SP, 2013, VIRUSES-BASEL, V5, P2977, DOI 10.3390/v5122977
   Lin CK, 2017, PLANTA MED, V83, P158, DOI 10.1055/s-0042-112998
   Linington RG, 2008, J NAT PROD, V71, P22, DOI 10.1021/np070280x
   Linington RG, 2007, J NAT PROD, V70, P397, DOI 10.1021/np0605790
   Linington RG, 2009, J NAT PROD, V72, P14, DOI 10.1021/np8003529
   Lu WL, 2011, CHEM BIOL, V18, P425, DOI 10.1016/j.chembiol.2011.01.016
   Mabeza GF, 1999, PHARMACOL THERAPEUT, V81, P53, DOI 10.1016/S0163-7258(98)00037-0
   Macherla VR, 2005, J MED CHEM, V48, P3684, DOI 10.1021/jm048995+
   Mahajan G. B., 2015, USE THIOPEPTIDE COMP
   Maron MI, 2016, ANTIMICROB AGENTS CH, V60, P1492, DOI 10.1128/AAC.01928-15
   Maskey RP, 2004, J ANTIBIOT, V57, P771, DOI 10.7164/antibiotics.57.771
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McConkey GA, 1997, J BIOL CHEM, V272, P2046, DOI 10.1074/jbc.272.4.2046
   McFadden GI, 2011, PROTOPLASMA, V248, P641, DOI 10.1007/s00709-010-0250-5
   McPhail KL, 2007, J NAT PROD, V70, P984, DOI 10.1021/np0700772
   Mehner C, 2008, EUR J ORG CHEM, V2008, P1732, DOI 10.1002/ejoc.200701033
   MIYAMOTO M, 1977, J ANTIBIOT, V30, P340, DOI 10.7164/antibiotics.30.340
   Mobarra Naser, 2016, Int J Hematol Oncol Stem Cell Res, V10, P239
   Mombo-Ngoma G, 2018, CLIN INFECT DIS, V66, P1823, DOI 10.1093/cid/cix1122
   Mosso C, 2008, VIROLOGY, V378, P193, DOI 10.1016/j.virol.2008.05.012
   Muller KH, 2014, ANTIMICROB AGENTS CH, V58, P2905, DOI 10.1128/AAC.02284-13
   Murray KO, 2013, EMERG INFECT DIS, V19, P1836, DOI 10.3201/eid1911.130768
   Naghmouchi K, 2012, ARCH MICROBIOL, V194, P363, DOI 10.1007/s00203-011-0764-z
   NAKAMURA S, 1961, J ANTIBIOT, V14, P103
   Ngwa CJ, 2013, J MED ENTOMOL, V50, P404, DOI 10.1603/ME12180
   Nollmann FI, 2012, BEILSTEIN J ORG CHEM, V8, P528, DOI 10.3762/bjoc.8.60
   O'Neill PM, 2004, J MED CHEM, V47, P2945, DOI 10.1021/jm030571c
   Obonyo CO, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-2
   Okanya PW, 2011, J NAT PROD, V74, P603, DOI 10.1021/np100625a
   OMURA S, 1976, J ANTIBIOT, V29, P15, DOI 10.7164/antibiotics.29.15
   Osei-Poku J, 2012, MOL ECOL, V21, P5138, DOI 10.1111/j.1365-294X.2012.05759.x
   Otoguro K, 2010, J ANTIBIOT, V63, P381, DOI 10.1038/ja.2010.50
   Panchal M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.521
   Papireddy K, 2011, J MED CHEM, V54, P5296, DOI 10.1021/jm200543y
   Peng JN, 2010, J MED CHEM, V53, P61, DOI 10.1021/jm900672t
   Nguyen PC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11843-4
   Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105
   Point V, 2012, J MED CHEM, V55, P10204, DOI 10.1021/jm301216x
   Portmann C, 2008, J NAT PROD, V71, P1891, DOI 10.1021/np800409z
   Portmann C, 2014, J NAT PROD, V77, P557, DOI 10.1021/np400814w
   Prudhomme J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002335
   Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214
   Ramirez JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004398
   Rao KV, 2004, J NAT PROD, V67, P1314, DOI 10.1021/np0400095
   Rateb ME, 2015, J ANTIBIOT, V68, P540, DOI 10.1038/ja.2015.22
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rautenbach M, 2007, BBA-BIOMEMBRANES, V1768, P1488, DOI 10.1016/j.bbamem.2007.01.015
   Raveh A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082318
   Raza M, 2018, NANOSCALE, V10, P13773, DOI 10.1039/c8nr02442a
   Rickards RW, 1999, TETRAHEDRON, V55, P13513, DOI 10.1016/S0040-4020(99)00833-9
   Rogers MJ, 1998, ANTIMICROB AGENTS CH, V42, P715, DOI 10.1128/AAC.42.3.715
   Sabino C, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11060524
   SAKAI R, 1986, J AM CHEM SOC, V108, P6404, DOI 10.1021/ja00280a055
   Saraiva RG, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006443
   Saraiva RG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24296-0
   Saraiva RG, 2016, DEV COMP IMMUNOL, V64, P53, DOI 10.1016/j.dci.2016.01.015
   Sarr M. D., 2011, AM J TROP MED HYG, V85, P3
   Schiefer A, 2012, J INFECT DIS, V206, P249, DOI 10.1093/infdis/jis341
   Schulze CJ, 2015, J ORG CHEM, V80, P1312, DOI 10.1021/jo5024409
   Segata N, 2016, SCI REP-UK, V6, DOI 10.1038/srep24207
   Shao CL, 2015, J ORG CHEM, V80, P7849, DOI 10.1021/acs.joc.5b01264
   Short SM, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2822-8
   Short SM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005677
   Shum D, 2010, ASSAY DRUG DEV TECHN, V8, P553, DOI 10.1089/adt.2010.0321
   Simmons TL, 2008, J NAT PROD, V71, P1544, DOI 10.1021/np800110e
   Singh B, 2013, CURR COMPUT-AID DRUG, V9, P350, DOI 10.2174/15734099113099990020
   Smith H.A., 2003, HDB KNOWLEDGE MANAGE, pp353
   Spizek J, 2004, APPL MICROBIOL BIOT, V64, P455, DOI 10.1007/s00253-003-1545-7
   Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865
   Sumi CD, 2015, CAN J MICROBIOL, V61, P93, DOI 10.1139/cjm-2014-0613
   TAKAHASHI S, 1971, J ANTIBIOT, V24, P902, DOI 10.7164/antibiotics.24.902
   Taylor MJ, 2014, PARASITOLOGY, V141, P119, DOI 10.1017/S0031182013001108
   Teixeira RR, 2014, MOLECULES, V19, P8151, DOI 10.3390/molecules19068151
   Tenson T, 2003, J MOL BIOL, V330, P1005, DOI 10.1016/S0022-2836(03)00662-4
   Tomlinson SM, 2012, ANTIVIR RES, V93, P245, DOI 10.1016/j.antiviral.2011.12.003
   Tripathi A, 2011, PHYTOCHEMISTRY, V72, P2369, DOI 10.1016/j.phytochem.2011.08.019
   Tripathi A, 2010, J NAT PROD, V73, P1810, DOI 10.1021/np100442x
   VanderMolen KM, 2011, J ANTIBIOT, V64, P525, DOI 10.1038/ja.2011.35
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   Wang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024767
   Waters AL, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00054
   Weiss BL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007470
   Weissman KJ, 2007, TRENDS BIOTECHNOL, V25, P139, DOI 10.1016/j.tibtech.2007.02.004
   Wells TNC, 2015, NAT REV DRUG DISCOV, V14, P424, DOI 10.1038/nrd4573
   WESTLEY JW, 1974, J ANTIBIOT, V27, P288, DOI 10.7164/antibiotics.27.288
   WHO, 2018, EL YELL FEV EP EYE G, P2017
   WHO, 2017, WORLD MAL REP 2016
   WHO, 2015, GUID TREATM MAL
   Woo AJ, 1999, ANTIMICROB AGENTS CH, V43, P1662, DOI 10.1128/AAC.43.7.1662
   Wright AD, 2005, J NAT PROD, V68, P459, DOI 10.1021/np049640w
   Xu ZR, 2019, ACS CHEM BIOL, V14, P1174, DOI 10.1021/acschembio.9b00086
   YAGISHITA K, 1968, J ANTIBIOT, V21, P444, DOI 10.7164/antibiotics.21.444
   Yang CC, 2011, ANTIMICROB AGENTS CH, V55, P229, DOI 10.1128/AAC.00855-10
   Yeh E, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001138
   YOSHIMORI T, 1991, J BIOL CHEM, V266, P17707
   You ZY, 2019, APPL MICROBIOL BIOT, V103, P2873, DOI 10.1007/s00253-019-09641-1
   Yu ZG, 2012, ORG LETT, V14, P4946, DOI 10.1021/ol302298k
   Yu Z, 2011, ORG LETT, V13, P2034, DOI 10.1021/ol200420u
   Zhou QQ, 2013, CHEM-EUR J, V19, P16772, DOI 10.1002/chem.201302481
NR 212
TC 0
Z9 0
U1 7
U2 9
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 0265-0568
EI 1460-4752
J9 NAT PROD REP
JI Nat. Prod. Rep.
PD MAR 1
PY 2020
VL 37
IS 3
BP 338
EP 354
DI 10.1039/c9np00042a
PG 17
WC Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry,
   Organic
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry
GA LH3QW
UT WOS:000528703100002
PM 31544193
DA 2020-07-08
ER

PT J
AU Liu, Y
   Lillepold, K
   Semenza, JC
   Tozan, Y
   Quam, MBM
   Rocklov, J
AF Liu, Ying
   Lillepold, Kate
   Semenza, Jan C.
   Tozan, Yesim
   Quam, Mikkel B. M.
   Rocklov, Joacim
TI Reviewing estimates of the basic reproduction number for dengue, Zika
   and chikungunya across global climate zones
SO ENVIRONMENTAL RESEARCH
LA English
DT Review
DE Basic reproduction number; R-0; Zika virus; Dengue; Chikungunya;
   Arbovirus; Climate; Aedes aegypti; Aedes albopictus
ID AEDES-AEGYPTI DIPTERA; VECTOR-BORNE DISEASES; SAO-PAULO STATE;
   RIO-DE-JANEIRO; VIRUS-INFECTION; SRI-LANKA; OUTBREAK; FEVER;
   TRANSMISSION; EPIDEMIC
AB Background: Globally, dengue, Zika virus, and chikungunya are important viral mosquito-borne diseases that infect millions of people annually. Their geographic range includes not only tropical areas but also sub-tropical and temperate zones such as Japan and Italy. The relative severity of these arboviral disease outbreaks can vary depending on the setting. In this study we explore variation in the epidemiologic potential of outbreaks amongst these climatic zones and arboviruses in order to elucidate potential reasons behind such differences.
   Methodology: We reviewed the peer-reviewed literature (PubMed) to obtain basic reproduction number (R-0) estimates for dengue, Zika virus, and chikungunya from tropical, sub-tropical and temperate regions. We also computed R-0 estimates for temperate and sub-tropical climate zones, based on the outbreak curves in the initial outbreak phase. Lastly we compared these estimates across climate zones, defined by latitude.
   Results: Of 2115 studies, we reviewed the full text of 128 studies and included 65 studies in our analysis. Our results suggest that the R-0 of an arboviral outbreak depends on climate zone, with lower R-0 estimates, on average, in temperate zones (R-0 = 2.03) compared to tropical (R-0 = 3.44) and sub-tropical zones (R-0 = 10.29). The variation in R-0 was considerable, ranging from 0.16 to 65. The largest R-0 was for dengue (65) and was estimated by the Ross-Macdonald model in the tropical zone, whereas the smallest R-0 (0.16) was for Zika virus and was estimated statistically from an outbreak curve in the sub-tropical zone.
   Conclusions: The results indicate climate zone to be an important determinant of the basic reproduction number, R-0, for dengue, Zika virus, and chikungunya. The role of other factors as determinants of R-0, such as methods, environmental and social conditions, and disease control, should be further investigated. The results suggest that It o may increase in temperate regions in response to global warming, and highlight the increasing need for strengthening preparedness and control activities.
C1 [Liu, Ying] Xiamen Univ, Sch Int Business, Tan Kah Kee Coll, Zhangzhou 363105, Peoples R China.
   [Lillepold, Kate; Semenza, Jan C.] European Ctr Dis Prevent & Control, Stockholm, Sweden.
   [Tozan, Yesim] NYU, Coll Global Publ Hlth, New York, NY USA.
   [Quam, Mikkel B. M.; Rocklov, Joacim] Umea Univ, Dept Publ Hlth & Clin Med, Sect Sustainable Hlth, Umea, Sweden.
RP Rocklov, J (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Sect Sustainable Hlth, Umea, Sweden.
EM yingliu722@163.com; tozan@nyu.edu; joacim.rocklov@umu.se
OI Lillepold, Kate/0000-0001-6173-4452
FU Swedish Research Council FormasSwedish Research CouncilSwedish Research
   Council Formas [2018-01754, 2017-01300]; European UnionEuropean Union
   (EU) [734584]; ZikaPlan project
FX This work was funded by the The Swedish Research Council Formas grant
   No. 2018-01754, 2017-01300, and the ZikaPlan project funded by the
   European Union's Horizon 2020 research and innovation programme under
   Grant Agreement No. 734584.
CR Agusto FB, 2018, MATH BIOSCI, V305, P102, DOI 10.1016/j.mbs.2018.09.007
   Anaya JM, 2017, J AUTOIMMUN, V77, P123, DOI 10.1016/j.jaut.2016.12.007
   Aranda C., 2018, EURO SURVEILL, V23
   Bacaer N, 2007, B MATH BIOL, V69, P1067, DOI 10.1007/s11538-006-9166-9
   Baez-Hernandez N., 2017, BIORXIV, P1
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boelle PY, 2008, VECTOR-BORNE ZOONOT, V8, P207, DOI 10.1089/vbz.2006.0620
   Bowman LR, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006876
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004551
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Butterworth MK, 2017, ENVIRON HEALTH PERSP, V125, P579, DOI 10.1289/EHP218
   Cauchemez S., 2014, EURO SURVEILL, V194
   Ceccato P, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/595948
   Centers for Disease Control and Prevention (CDC), US BAS YELL 2020
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Cheng YH, 2018, INFECT DRUG RESIST, V11, P423, DOI 10.2147/IDR.S169820
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Chowell G, 2013, MATH BIOSCI ENG, V10, P1455, DOI 10.3934/mbe.2013.10.1455
   Chowell G, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks.f14b2217c902f453d9320a43a35b9583, DOI 10.1371/CURRENTS.OUTBREAKS.F14B2217C902F453D9320A43A35B9583]
   Chowell G, 2016, PHYS LIFE REV, V18, P66, DOI 10.1016/j.plrev.2016.07.005
   Coelho GE, 2008, MEM I OSWALDO CRUZ, V103, P535, DOI 10.1590/S0074-02762008000600004
   Coudeville L, 2016, VACCINE, V34, P6417, DOI 10.1016/j.vaccine.2015.11.023
   de los Reyes VA, 2018, J BIOL DYNAM, V12, P894, DOI 10.1080/17513758.2018.1535096
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Dinh L, 2016, THEOR BIOL MED MODEL, V13, DOI 10.1186/s12976-016-0046-1
   Dumont Y, 2008, MATH BIOSCI, V213, P80, DOI 10.1016/j.mbs.2008.02.008
   Dumont Y, 2010, MATH BIOSCI ENG, V7, P313, DOI 10.3934/mbe.2010.7.313
   Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026
   Enduri MK, 2017, MATH BIOSCI, V288, P140, DOI 10.1016/j.mbs.2017.03.007
   European Cente for Disease Control, 2013, ENV RISK MAPP AED AL
   Favier C, 2006, TROP MED INT HEALTH, V11, P332, DOI 10.1111/j.1365-3156.2006.01560.x
   Feng XM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38792-4
   Fontaine A, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007187
   Funk S, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005173
   Furuya Hiroyuki, 2017, Tokai J Exp Clin Med, V42, P160
   Furuya H, 2015, ENVIRON HEALTH PREV, V20, P466, DOI 10.1007/s12199-015-0488-9
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Guo CC, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00317
   Ho ZJM, 2017, LANCET INFECT DIS, V17, P813, DOI 10.1016/S1473-3099(17)30249-9
   Hsieh YH, 2009, TROP MED INT HEALTH, V14, P628, DOI 10.1111/j.1365-3156.2009.02277.x
   Hsieh YH, 2017, PEERJ, V5, DOI 10.7717/peerj.3015
   Hsieh YH, 2013, TROP MED INT HEALTH, V18, P830, DOI 10.1111/tmi.12105
   Hsieh YH, 2009, AM J TROP MED HYG, V80, P66, DOI 10.4269/ajtmh.2009.80.66
   Jafaruddin, 2015, COMPUT MATH METHOD M, DOI 10.1155/2015/206131
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lee Eva K, 2016, AMIA Annu Symp Proc, V2016, P743
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Li MI, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001792
   Liu-Helmersson J, 2016, EBIOMEDICINE, V7, P267, DOI 10.1016/j.ebiom.2016.03.046
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Liyanage P, 2019, LANCET PLANET HEALTH, V3, pE211, DOI 10.1016/S2542-5196(19)30057-9
   Lizarazo E, 2019, EMERG INFECT DIS, V25, P672, DOI 10.3201/eid2504.172121
   Maciel-De-Freitas R, 2008, CAD SAUDE PUBLICA, V24, P2747, DOI 10.1590/S0102-311X2008001200003
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Manica M., 2017, EURO SURVEILL, V22
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   MARQUES CA, 1994, T ROY SOC TROP MED H, V88, P58, DOI 10.1016/0035-9203(94)90498-7
   Massad E, 2003, REV SAUDE PUBL, V37, P477, DOI 10.1590/s0034-89102003000400013
   Massad E, 2010, TROP MED INT HEALTH, V15, P120, DOI 10.1111/j.1365-3156.2009.02413.x
   Massad E, 2008, J TRAVEL MED, V15, P147, DOI 10.1111/j.1708-8305.2008.00186.x
   Messina JP, 2019, NAT MICROBIOL, V4, P1508, DOI 10.1038/s41564-019-0476-8
   Monaghan AJ, 2018, CLIMATIC CHANGE, V146, P487, DOI 10.1007/s10584-016-1679-0
   Murdock CC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005640
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   MurraySmith S, 1996, AUST NZ J PUBL HEAL, V20, P545, DOI 10.1111/j.1467-842X.1996.tb01637.x
   Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]
   Nikbakht R, 2019, J RES MED SCI, V24, DOI 10.4103/jrms.JRMS_888_18
   Nishiura H, 2016, TRAVEL MED INFECT DI, V14, P274, DOI 10.1016/j.tmaid.2016.03.016
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   OhAinle M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003084
   Orellano P, 2017, REV PANAM SALUD PUBL, V41, DOI 10.26633/rpsp.2017.120
   Ospina J, 2017, TROP MED INT HEALTH, V22, P1249, DOI 10.1111/tmi.12924
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Ramadona AL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007298
   Reiter P, 2003, EMERG INFECT DIS, V9, P86
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   Riou J, 2017, EPIDEMICS-NETH, V19, P43, DOI 10.1016/j.epidem.2017.01.001
   Robinson M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003120
   Rocklov J, 2019, EMERG TOP LIFE SCI, V3, P133, DOI 10.1042/ETLS20180123
   Rocklov J, 2019, EMERG INFECT DIS, V25, P1041, DOI 10.3201/eid2506.180138
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rodriguez-Barraquer I, 2014, AM J EPIDEMIOL, V179, P353, DOI 10.1093/aje/kwt256
   Rojas DP, 2016, EURO SURVEILL, V21
   Sanches Rosangela Peregrina, 2016, Infect Dis Model, V1, P88, DOI 10.1016/j.idm.2016.08.002
   Sardar T, 2016, VIRULENCE, V7, P187, DOI 10.1080/21505594.2015.1096470
   Sardar T, 2015, MATH BIOSCI, V263, P18, DOI 10.1016/j.mbs.2015.01.009
   Sasmal SK, 2018, B MATH BIOL, V80, P3038, DOI 10.1007/s11538-018-0510-7
   Semenza J.C., 2019, TRANSBOUNDARY EMERGI
   Semenza JC, 2016, EMERG INFECT DIS, V22, P581, DOI [10.3201/eid2204.151073, 10.3201/eid2204]
   Semenza JC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003278
   Shutt DP, 2017, EPIDEMICS-NETH, V21, P63, DOI 10.1016/j.epidem.2017.06.005
   Smith DL, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002588
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Struchiner CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136286
   Tang B, 2016, J THEOR BIOL, V410, P65, DOI 10.1016/j.jtbi.2016.09.012
   Tangena JAA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005802
   Tatem AJ, 2006, P NATL ACAD SCI USA, V103, P6242, DOI 10.1073/pnas.0508391103
   Torres JR, 2017, J TROP MED-US, V2017, DOI 10.1155/2017/8045435
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   Vargas REM, 2010, INFECT GENET EVOL, V10, P580, DOI 10.1016/j.meegid.2010.01.004
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Wang LP, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07264-y
   Watson-Brown P, 2019, TRANSFUSION, V59, P648, DOI 10.1111/trf.15095
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yakob L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057448
NR 108
TC 0
Z9 0
U1 2
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0013-9351
EI 1096-0953
J9 ENVIRON RES
JI Environ. Res.
PD MAR
PY 2020
VL 182
AR 109114
DI 10.1016/j.envres.2020.109114
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KP2TP
UT WOS:000516094400103
PM 31927301
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Gamez, S
   Antoshechkin, I
   Mendez-Sanchez, SC
   Akbari, OS
AF Gamez, Stephanie
   Antoshechkin, Igor
   Mendez-Sanchez, Stelia C.
   Akbari, Omar S.
TI The Developmental Transcriptome of Aedes albopictus, a Major Worldwide
   Human Disease Vector
SO G3-GENES GENOMES GENETICS
LA English
DT Article
DE Aedes albopictus; transcriptome; development; Zika; dengue; Aedes
   aegypti; RNA-seq
ID YELLOW-FEVER MOSQUITO; AEGYPTI DIPTERA; INVASIVE MOSQUITO; RAPID
   EVOLUTION; GENE; EXPRESSION; CULICIDAE; SPREAD; ARBOVIRUS; DIAPAUSE
AB Aedes albopictus mosquitoes are important vectors for a number of human pathogens including the Zika, dengue, and chikungunya viruses. Capable of displacing Aedes aegypti populations, this mosquito adapts to cooler environments which increases its geographical range and transmission potential. There are limited control strategies for Aedes albopictus mosquitoes which is likely attributed to the lack of comprehensive biological studies on this emerging vector. To fill this void, here using RNAseq we characterized Aedes albopictus mRNA expression profiles at 34 distinct time points throughout development providing the first high-resolution comprehensive view of the developmental transcriptome of this worldwide human disease vector. This enabled us to identify several patterns of shared gene expression among tissues as well as sex-specific expression patterns. To illuminate the similarities and differences with Aedes aegypti, a related human disease vector, we also performed a comparative analysis between the two developmental transcriptomes, identifying life stages where the two species exhibit similar and distinct gene expression patterns. These findings provide insights into the similarities and differences between Aedes albopictus and Aedes aegypti mosquito biology. In summary, the results generated from this study should form the basis for future investigations on the biology of Aedes albopictus and provide a gold mine resource for the development of transgene-based vector control strategies.
C1 [Gamez, Stephanie; Mendez-Sanchez, Stelia C.; Akbari, Omar S.] Univ Calif San Diego, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.
   [Antoshechkin, Igor] CALTECH, Div Biol & Biol Engn, Pasadena, CA 91125 USA.
   [Mendez-Sanchez, Stelia C.] Univ Ind Santander, Grp Res Biochem & Microbiol, Grp Invest Bioquim & Microbiol GIBIM, Sch Chem, Bucaramanga, Colombia.
   [Akbari, Omar S.] UCSD, Tata Inst Genet & Soc, La Jolla, CA USA.
RP Akbari, OS (corresponding author), Univ Calif San Diego, 5101 TATA Hall,9500 Gilman Dr, La Jolla, CA 92093 USA.
EM oakbari@ucsd.edu
OI Gamez, Stephanie/0000-0003-0665-0066; Mendez-Sanchez,
   Stelia/0000-0002-2402-3632; Antoshechkin, Igor/0000-0002-9934-3040
FU UCSD; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI142443, K22AI113060]
FX This work was supported by funding from generous UCSD lab startup funds
   and NIH grants R21AI142443 and K22AI113060 awarded to O.S.A. We thank
   Vijaya Kumar for help with library preparations. Transcriptome
   sequencing was performed at the Millard and Muriel Jacobs Genetics and
   Genomics Laboratory at the California Institute of Technology. We also
   thank Dr. J. Wakoli Wekesa and the San Gabriel Valley Mosquito and
   Vector Control District for providing us with the Ae. albopictus
   mosquito eggs used in this study. O.S.A., and I.A. conceptualized the
   study. S.G. performed all sample preparations. I.A, S.G., and S.C.M
   performed the various bioinformatic analysis in the study. All authors
   contributed to the writing, analyzed the data, and approved the final
   manuscript.
CR Akbari OS, 2014, ACS SYNTH BIOL, V3, P915, DOI 10.1021/sb300079h
   Akbari OS, 2014, SCI REP-UK, V4, DOI 10.1038/srep03954
   Akbari OS, 2013, G3-GENES GENOM GENET, V3, P1493, DOI 10.1534/g3.113.006742
   Akbari OS, 2013, CURR BIOL, V23, P671, DOI 10.1016/j.cub.2013.02.059
   Diniz DFA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2235-0
   Armbruster PA, 2016, J MED ENTOMOL, V53, P1013, DOI 10.1093/jme/tjw037
   Bagny Beilhe L, 2013, MED VET ENTOMOL, V27, P387, DOI 10.1111/j.1365-2915.2012.01062.x
   Beilhe LB, 2012, BIOL INVASIONS, V14, P1623, DOI 10.1007/s10530-012-0177-1
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bian GW, 2008, INSECT BIOCHEM MOLEC, V38, P190, DOI 10.1016/j.ibmb.2007.10.008
   Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003
   Buchman A., 2019, BROAD DENGUE NEUTRAL, DOI [10.2139/ssrn.3398490, DOI 10.2139/SSRN.3398490]
   Buchman A, 2019, P NATL ACAD SCI USA, V116, P3656, DOI 10.1073/pnas.1810771116
   Buchman A, 2018, P NATL ACAD SCI USA, V115, P4725, DOI 10.1073/pnas.1713139115
   Buchman AB, 2018, ACS SYNTH BIOL, V7, P1359, DOI 10.1021/acssynbio.7b00451
   Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055
   Champer J, 2016, NAT REV GENET, V17, P146, DOI 10.1038/nrg.2015.34
   Chen XG, 2015, P NATL ACAD SCI USA, V112, pE5907, DOI 10.1073/pnas.1516410112
   Coates CJ, 1999, GENE, V226, P317, DOI 10.1016/S0378-1119(98)00557-5
   Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8
   Dana AN, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-5
   Degner EC, 2019, MOL CELL PROTEOMICS, V18, pS6, DOI 10.1074/mcp.RA118.001067
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567
   Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367
   Giglioli M. E. C., 1964, Rivista di Malariologia Rome, V43, P265
   Harrington LC, 2001, J MED ENTOMOL, V38, P411, DOI 10.1603/0022-2585-38.3.411
   Kalmykova AI, 2005, NUCLEIC ACIDS RES, V33, P2052, DOI 10.1093/nar/gki323
   Kandul N. P., 2019, DEV CONFINABLE GENE
   Kandul NP, 2020, G3-GENES GENOM GENET, V10, P827, DOI 10.1534/g3.119.400985
   Kandul NP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07964-7
   Kassambara A, 2015, GGPLOT2 GUIDE CREATE
   Kokoza V, 2000, P NATL ACAD SCI USA, V97, P9144, DOI 10.1073/pnas.160258197
   Kokoza VA, 2001, GENE, V274, P47, DOI 10.1016/S0378-1119(01)00602-3
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35
   Kumar L, 2007, BIOINFORMATION, V2, P5, DOI 10.6026/97320630002005
   Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108
   Li M, 2017, P NATL ACAD SCI USA, V114, pE10540, DOI 10.1073/pnas.1711538114
   Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Lucas KJ, 2013, TRENDS PARASITOL, V29, P295, DOI 10.1016/j.pt.2013.04.003
   Margam VM, 2006, J INSECT PHYSIOL, V52, P558, DOI 10.1016/j.jinsphys.2006.02.003
   Matthews BJ, 2018, NATURE, V563, P501, DOI 10.1038/s41586-018-0692-z
   Miesen P, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006017
   Miesen P, 2015, NUCLEIC ACIDS RES, V43, P6545, DOI 10.1093/nar/gkv590
   Moreira LA, 2000, P NATL ACAD SCI USA, V97, P10895, DOI 10.1073/pnas.97.20.10895
   Muzari MO, 2019, COMMUN DIS INTELL, V43, DOI 10.33321/cdi.2019.43.17
   Oliva CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078884
   OMEARA GF, 1995, J MED ENTOMOL, V32, P554, DOI 10.1093/jmedent/32.4.554
   Pages F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004691
   Pitts RJ, 2014, P NATL ACAD SCI USA, V111, P2566, DOI 10.1073/pnas.1322923111
   Ratsitorahina M, 2008, EMERG INFECT DIS, V14, P1135, DOI 10.3201/eid1407.071521
   Reiter P, 2006, LANCET INFECT DIS, V6, P463, DOI 10.1016/S1473-3099(06)70531-X
   Reynolds JA, 2012, J INSECT PHYSIOL, V58, P966, DOI 10.1016/j.jinsphys.2012.04.013
   Rezza G, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-72
   Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465
   Saboia-Vahia L, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-50
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Sieglaff DH, 2009, P NATL ACAD SCI USA, V106, P3053, DOI 10.1073/pnas.0813264106
   Smith RC, 2007, INSECT MOL BIOL, V16, P61, DOI 10.1111/j.1365-2583.2006.00701.x
   Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733
   Telang A, 2006, J EXP BIOL, V209, P645, DOI 10.1242/jeb.02026
   Telang A, 2013, J INSECT PHYSIOL, V59, P283, DOI 10.1016/j.jinsphys.2012.11.006
   Tripet F, 2011, AM J TROP MED HYG, V85, P265, DOI 10.4269/ajtmh.2011.10-0677
   Tsuda Y, 2006, J AM MOSQUITO CONTR, V22, P222, DOI 10.2987/8756-971X(2006)22[222:DSDOAA]2.0.CO;2
   Urbanski JM, 2010, J INSECT PHYSIOL, V56, P1147, DOI 10.1016/j.jinsphys.2010.03.008
   Urbanski JM, 2010, P ROY SOC B-BIOL SCI, V277, P2683, DOI 10.1098/rspb.2010.0362
   Valerio L, 2010, VECTOR-BORNE ZOONOT, V10, P291, DOI 10.1089/vbz.2009.0007
   Vazeille M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001168
   Vishnuvardhan S, 2013, J EXP ZOOL PART B, V320B, P105, DOI 10.1002/jez.b.22487
   Wang SH, 2011, P NATL ACAD SCI USA, V108, P21164, DOI 10.1073/pnas.1107892109
   Wang YH, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040213
   Whittle CA, 2017, GENETICS, V206, P2119, DOI 10.1534/genetics.117.201343
NR 76
TC 0
Z9 0
U1 0
U2 0
PU GENETICS SOCIETY AMERICA
PI BETHESDA
PA 9650 ROCKVILLE AVE, BETHESDA, MD 20814 USA
SN 2160-1836
J9 G3-GENES GENOM GENET
JI G3-Genes Genomes Genet.
PD MAR
PY 2020
VL 10
IS 3
BP 1051
EP 1062
DI 10.1534/g3.119.401006
PG 12
WC Genetics & Heredity
SC Genetics & Heredity
GA LH3TR
UT WOS:000528710500017
PM 31964684
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Afaq, S
   Atiya, A
   Malik, A
   Alwabli, AS
   Alzahrani, DA
   Al-Solami, HM
   Alzahrani, O
   Alam, Q
   Kamal, MA
   Abulfaraj, AA
   Alhebshi, AM
   Tarique, M
AF Afaq, Sarah
   Atiya, Akhtar
   Malik, Arshi
   Alwabli, Afaf S.
   Alzahrani, Dhafer A.
   Al-Solami, Habeeb M.
   Alzahrani, Othman
   Alam, Qamre
   Kamal, Mohammad Azhar
   Abulfaraj, Aala A.
   Alhebshi, Alawiah M.
   Tarique, Mohammed
TI Analysis of methyltransferase (MTase) domain from Zika virus (ZIKV)
SO BIOINFORMATION
LA English
DT Article
DE ZIKV; methyltransferase; beta turn; alpha-helix; SMART; Prosite; Pfam
   and InterProScan
ID NS5
AB A comprehensive analysis of methyltransferase (MTase) from Zika virus (ZIKV) is of interest in the development of drugs and biomarkers in the combat and care of ZIKA fever with impulsive joint pain and conjunctivitis. MTase sequence is homologous in several viral species. We analyzed the MTase domain from ZIKV using Bioinformatics tools such as SMART, PROSITE, PFAM, PANTHER, and InterProScan to glean insights on the sequence to structure to function data. We document inclusive information on MTase from ZIKV for application in the design of drugs and biomarkers to fight against the disease.
C1 [Afaq, Sarah; Malik, Arshi] King Khalid Univ, Coll Med, Dept Clin Biochem, Abha, Saudi Arabia.
   [Atiya, Akhtar] King Khalid Univ, Coll Pharm, Dept Pharmacognosy, Abha, Saudi Arabia.
   [Alwabli, Afaf S.; Alzahrani, Dhafer A.; Al-Solami, Habeeb M.; Alhebshi, Alawiah M.] King Abdulaziz Univ, Fac Sci, Dept Biol Sci, Jeddah 21589, Saudi Arabia.
   [Alzahrani, Othman] Univ Tabuk, Fac Sci, Dept Biol, Tabuk, Saudi Arabia.
   [Alam, Qamre] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Med Genom Res Dept, Minist Natl Guard Hlth Affairs, Riyadh, Saudi Arabia.
   [Kamal, Mohammad Azhar] Univ Jeddah, Fac Sci, Dept Biochem, Jeddah, Saudi Arabia.
   [Kamal, Mohammad Azhar] UJC SMR, Jeddah, Saudi Arabia.
   [Abulfaraj, Aala A.] King Abdulaziz Univ, Dept Biol Sci, Coll Sci & Arts, Rabigh Campus, Jeddah 21589, Saudi Arabia.
   [Tarique, Mohammed] Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
RP Afaq, S (corresponding author), King Khalid Univ, Coll Med, Dept Clin Biochem, Abha, Saudi Arabia.; Tarique, M (corresponding author), Jamia Millia Islamia, Ctr Interdisciplinary Res Basic Sci, New Delhi 110025, India.
EM safaq@kku.edu.sa; akhan@kku.edu.sa; amalik@kku.edu.sa;
   afafalwabli@yahoo.com; dalzahrani@kau.edu.sa; hmalsolami@kau.edu.sa;
   o-alzahrani@ut.edu.sa; alamqa@ngha.med.sa; makamal@uj.edu.sa;
   aaabulfaraj@kau.edu.sa; aalhebshi@kau.edu.sa; tariqueaiims@gmail.com
RI Alwabli, Afaf Salim/AAB-1155-2019
OI Alwabli, Afaf Salim/0000-0002-8795-8355
CR Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Coloma J, 2016, CELL REP, V16, P3097, DOI 10.1016/j.celrep.2016.08.091
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   LEWIS PN, 1973, BIOCHIM BIOPHYS ACTA, V303, P211, DOI 10.1016/0005-2795(73)90350-4
   Lim SP, 2011, J BIOL CHEM, V286, P6233, DOI 10.1074/jbc.M110.179184
   Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07
   Lu GL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003549
   MAY CE, 1987, THEOR APPL GENET, V74, P617, DOI 10.1007/BF00288861
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442
   Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154
   Tarique M, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00130
   Triunfol M, 2016, LANCET INFECT DIS, V16, P156, DOI 10.1016/S1473-3099(15)00548-4
   VENKATACHALAM CM, 1968, BIOPOLYMERS, V6, P1425, DOI 10.1002/bip.1968.360061006
   WILMOT CM, 1990, PROTEIN ENG, V3, P479, DOI 10.1093/protein/3.6.479
   Zhao YQ, 2015, P NATL ACAD SCI USA, V112, P14834, DOI 10.1073/pnas.1514978112
NR 19
TC 0
Z9 0
U1 0
U2 0
PU BIOMEDICAL INFORMATICS
PI TAMIL NADU
PA NO 42, 2ND MAIN RD, CHENNAI, TAMIL NADU, 600 020, INDIA
SN 0973-8894
EI 0973-2063
J9 BIOINFORMATION
JI Bioinformation
PD MAR
PY 2020
VL 16
IS 3
BP 229
EP 234
DI 10.6026/97320630016229
PG 6
WC Mathematical & Computational Biology
SC Mathematical & Computational Biology
GA LG6DV
UT WOS:000528190000004
PM 32308265
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Suresh, M
   Jeevanandam, J
   Chan, YS
   Danquah, MK
   Kalaiarasi, JMV
AF Suresh, M.
   Jeevanandam, Jaison
   Chan, Yen San
   Danquah, Michael K.
   Kalaiarasi, J. M. V.
TI Opportunities for Metal Oxide Nanoparticles as a Potential Mosquitocide
SO BIONANOSCIENCE
LA English
DT Review
DE Mosquitocides; MgO nanoparticles; Metal oxides; Mosquito-borne diseases;
   Larvicidal activity
ID TITANIUM-DIOXIDE NANOPARTICLES; BACILLUS-THURINGIENSIS-ISRAELENSIS;
   INSECTICIDE-TREATED NETS; AEDES-AEGYPTI L.; SYNTHESIZED SILVER
   NANOPARTICLES; ZIKA VIRUS OUTBREAK; WEST-NILE-VIRUS; LARVICIDAL
   ACTIVITY; MGO NANOPARTICLES; CULEX-QUINQUEFASCIATUS
AB Mosquito-borne diseases cause life-threatening challenges to public health, and their prevention is the key task of several parasitological techniques. In the past, conventional chemical and biological mosquitocides were highly utilized to regulate the mosquito population. However, these mosquitocidal agents possess drawbacks such as toxicity toward humans and resulted in mosquitoes with high resistance to mosquitocides. The technological improvements in the field of nanoparticles are widely used to overcome the drawback of conventional mosquitocides. Nanoparticles, especially nanosized metal oxides, seem to possess unique properties that can help in the formulation of the enhanced mosquitocidal agent. In this review article, magnesium oxide (MgO) nanoparticles have been proposed as an enhanced mosquitocidal agent and as an alternative to conventional mosquitocides. Additionally, a group of metal oxide nanoparticles is listed as mosquitocidal agents, and the proposed mechanism of MgO nanoparticle toxicity toward life stages of mosquitoes is also discussed.
C1 [Suresh, M.; Kalaiarasi, J. M. V.] Loyola Coll, LIFE, Postgrad & Res, Dept Adv Zool & Biotechnol, Chennai 600034, Tamil Nadu, India.
   [Jeevanandam, Jaison; Chan, Yen San] Curtin Univ, Fac Engn & Sci, Dept Chem Engn, CDT 250, Sarawak, Malaysia.
   [Danquah, Michael K.] Univ Tennessee, Chem Engn Dept, Chattanooga, TN 37403 USA.
RP Chan, YS (corresponding author), Curtin Univ, Fac Engn & Sci, Dept Chem Engn, CDT 250, Sarawak, Malaysia.
EM chanyensan@curtin.edu.my
OI Chan, Yen San/0000-0002-4274-0678
CR Abdelhameed RM, 2017, ACS APPL MATER INTER, V9, P22112, DOI 10.1021/acsami.7b03164
   Abinaya M, 2018, J TRACE ELEM MED BIO, V45, P93, DOI 10.1016/j.jtemb.2017.10.002
   Akram MW, 2018, J NANOMATER, V2018, DOI 10.1155/2018/4210920
   Akram MW, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23105-y
   Alencar EB, 2016, MED CHEM RES, V25, P2171, DOI 10.1007/s00044-016-1650-7
   Alkhaibari AM, 2018, J INVERTEBR PATHOL, V153, P38, DOI 10.1016/j.jip.2018.02.003
   Alphey L, 2014, ANNU REV ENTOMOL, V59, P205, DOI 10.1146/annurev-ento-011613-162002
   Alphey L, 2010, VECTOR-BORNE ZOONOT, V10, P295, DOI 10.1089/vbz.2009.0014
   Altinli M, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2777-9
   Alves TEP, 2018, MATER DESIGN, V146, P125, DOI 10.1016/j.matdes.2018.03.013
   Amer A, 2006, PARASITOL RES, V99, P466, DOI [10.1007/s00436-006-0182-3, 10.1007/s00436-006-0184-1]
   Anbu P, 2016, NAT PROD RES, V30, P2077, DOI 10.1080/14786419.2015.1114935
   Anees AM, 2008, PARASITOL RES, V103, P1451, DOI 10.1007/s00436-008-0991-7
   Contreras-Gutierrez MA, 2017, AM J TROP MED HYG, V97, P299, DOI 10.4269/ajtmh.16-0987
   Anogwih JA, 2015, BIOL CONTROL, V81, P31, DOI 10.1016/j.biocontrol.2014.11.001
   Ansari M. A., 2005, Journal of Vector Borne Diseases, V42, P95
   Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Araujo HRC, 2015, INSECTS, V6, P576, DOI 10.3390/insects6020576
   Ashokan AP, 2017, J CLUST SCI, V28, P205, DOI 10.1007/s10876-016-1075-y
   Assadi Z, 2018, J MOL LIQ, V250, P375, DOI 10.1016/j.molliq.2017.12.031
   Attaway DF, 2014, GEOSPATIAL HEALTH, V9, P119, DOI 10.4081/gh.2014.10
   Atyame CM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119288
   Auffan M, 2009, ENVIRON POLLUT, V157, P1127, DOI 10.1016/j.envpol.2008.10.002
   AYYUB P, 1995, PHYS REV B, V51, P6135, DOI 10.1103/PhysRevB.51.6135
   Azari-Hamidian S, 2017, ZOOTAXA, V4299, P141, DOI 10.11646/zootaxa.4299.1.11
   Azevedo-Santos VM, 2017, BIOSCIENCE, V67, P83, DOI 10.1093/biosci/biw156
   Azizi S, 2014, MATER LETT, V116, P275, DOI 10.1016/j.matlet.2013.11.038
   Balaji APB, 2017, J KING SAUD UNIV SCI, V29, P517, DOI 10.1016/j.jksus.2016.12.005
   Baldacchino F, 2015, PEST MANAG SCI, V71, P1471, DOI 10.1002/ps.4044
   Barbagallo M., 1996, ENDOCRINOLOGY VASCUL, P283
   Barbagallo Mario, 2003, Molecular Aspects of Medicine, V24, P39, DOI 10.1016/S0098-2997(02)00090-0
   Bayoh MN, 2003, B ENTOMOL RES, V93, P375, DOI 10.1079/BER2003259
   Becker N., 2010, MOSQUITOES THEIR CON, P483
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2017, J KING SAUD UNIV SCI, V29, P424, DOI 10.1016/j.jksus.2016.08.006
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P10218, DOI 10.1007/s11356-016-8146-3
   Benelli G, 2016, ENZYME MICROB TECH, V95, P58, DOI 10.1016/j.enzmictec.2016.08.022
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Benelli G, 2015, PARASITOL RES, V114, P391, DOI 10.1007/s00436-014-4286-x
   Bertinetti L, 2009, LANGMUIR, V25, P5647, DOI 10.1021/la804230j
   Betancourt A, 2016, J VECTOR ECOL, V41, P199
   Bhattacharya S, 2016, INT J FAUNA BIOL STU, V3, P124
   Blagrove MSC, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1739-3
   Bonds JAS, 2012, MED VET ENTOMOL, V26, P121, DOI 10.1111/j.1365-2915.2011.00992.x
   Bonin A, 2015, INFECT GENET EVOL, V35, P204, DOI 10.1016/j.meegid.2015.07.034
   Bourtzis K, 2016, ACTA TROP, V157, P115, DOI 10.1016/j.actatropica.2016.01.009
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Bouyer J, 2014, TRENDS PARASITOL, V30, P271, DOI 10.1016/j.pt.2014.04.002
   Bowatte G, 2013, BIOL CONTROL, V67, P469, DOI 10.1016/j.biocontrol.2013.10.005
   Cabrera MB, 2017, J FISH BIOL, V91, P704, DOI 10.1111/jfb.13370
   Cai YC, 2017, CERAM INT, V43, P1066, DOI 10.1016/j.ceramint.2016.10.041
   Campos D, 2016, CHEMOSPHERE, V149, P177, DOI 10.1016/j.chemosphere.2016.01.098
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Caraballo Hector, 2014, Emerg Med Pract, V16, P1
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Carvalho DO, 2014, ACTA TROP, V132, pS170, DOI 10.1016/j.actatropica.2013.09.023
   Chakraborty R, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa57b0
   Champakaew D, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1650-y
   Chandra G, 2008, INDIAN J MED RES, V127, P13
   Chen D, 2016, CERAM INT, V42, P3692, DOI 10.1016/j.ceramint.2015.10.123
   Choochote W, 2004, J VECTOR ECOL, V29, P340
   Churcher TS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006108
   Connolly Rod M., 2005, Wetlands Ecology and Management, V13, P149, DOI 10.1007/s11273-004-9569-z
   Coria C, 2008, BIORESOURCE TECHNOL, V99, P3066, DOI 10.1016/j.biortech.2007.06.012
   Cupp EW, 2004, AM J TROP MED HYG, V71, P272, DOI 10.4269/ajtmh.2004.71.272
   Curtis CF, 1996, MED VET ENTOMOL, V10, P1, DOI 10.1111/j.1365-2915.1996.tb00075.x
   da Silva GNS, 2016, PEST MANAG SCI, V72, P1883, DOI 10.1002/ps.4221
   Danbaba U.A., 2018, BIOMATH FORUM SOFIA, P81, DOI DOI 10.11145/TEXTS.2018.01.083
   Das N. G., 2003, Journal of Vector Borne Diseases, V40, P49
   Das N. G., 1999, Journal of Communicable Diseases, V31, P241
   Daures M, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0713-9
   David JP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0429
   de Baaij JHF, 2015, PHYSIOL REV, V95, P1, DOI 10.1152/physrev.00012.2014
   Dennett JA, 2003, J AM MOSQUITO CONTR, V19, P172
   Di DR, 2012, NANOMED-NANOTECHNOL, V8, P1233, DOI 10.1016/j.nano.2012.02.010
   Dupont-Rouzeyrol M, 2015, EMERG INFECT DIS, V21, P381, DOI 10.3201/eid2102.141553
   Effiom O. E., 2012, GLOBAL J SCI FRONTIE, V12, P1
   Ekanayake D. H., 2007, P PER U RES SESS SRI, V12, P98
   El-Husseini M. M., 2006, Arab Journal of Plant Protection, V24, P162
   Elemike EE, 2017, MOLECULES, V22, DOI 10.3390/molecules22050674
   Emameh RZ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-403
   Esmaeili Hamid Reza, 2017, Iranian Journal of Ichthyology, V4, P1
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   FAILLOUX AB, 1994, J MED ENTOMOL, V31, P639, DOI 10.1093/jmedent/31.5.639
   Falcaro P, 2016, COORDIN CHEM REV, V307, P237, DOI 10.1016/j.ccr.2015.08.002
   Farenhorst M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012081
   Farnesi LC, 2017, BIORXIV109223
   Federici BA, 2003, J EXP BIOL, V206, P3877, DOI 10.1242/jeb.00643
   Federici BA, 2007, J AM MOSQUITO CONTR, V23, P164, DOI 10.2987/8756-971X(2007)23[164:DRBFCO]2.0.CO;2
   Fernandez-Garcia M, 2011, ENCY INORGANIC BIOIN, V79479, P1
   Fierro J. L. G., 2005, METAL OXIDES CHEM AP
   Fischer M., 2015, DENGUE CHIKUNG UNPUB
   Fu PP, 2014, J FOOD DRUG ANAL, V22, P64, DOI 10.1016/j.jfda.2014.01.005
   Fujita R, 2017, ARCH VIROL, V162, P79, DOI 10.1007/s00705-016-3068-4
   Fujita-Becker S, 2005, J BIOL CHEM, V280, P6064, DOI 10.1074/jbc.M412473200
   Garziera L, 2017, ENTOMOL EXP APPL, V164, P327, DOI 10.1111/eea.12618
   Gayathri B, 2018, ARAB J CHEM, V11, P645, DOI 10.1016/j.arabjc.2016.05.010
   Genchi C, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-206
   George S, 2010, ACS NANO, V4, P15, DOI 10.1021/nn901503q
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Gingrich JB, 2005, J AM MOSQUITO CONTR, V21, P194, DOI 10.2987/8756-971X(2005)21[194:HPOSWN]2.0.CO;2
   Giovanni M, 2015, ENVIRON TOXICOL, V30, P1459, DOI 10.1002/tox.22015
   Gonsalves L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064081
   Gopinath K, 2015, J NANOSTRUCTURE CHEM, V5, P295, DOI 10.1007/s40097-015-0161-2
   Govindarajan M, 2016, J ASIA-PAC ENTOMOL, V19, P377, DOI 10.1016/j.aspen.2016.04.003
   Govindarajan M, 2015, INT J PURE APPL ZOOL, V3, P312
   Govindarajan M, 2016, PARASITOL RES, V115, P807, DOI 10.1007/s00436-015-4809-0
   Govindarajan M, 2010, ASIAN PAC J TROP MED, V3, P691, DOI 10.1016/S1995-7645(10)60167-8
   Graham K, 2005, MED VET ENTOMOL, V19, P72, DOI 10.1111/j.0269-283X.2005.00543.x
   Grieco JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000716
   Grieco JP, 2005, J AM MOSQUITO CONTR, V21, P404, DOI 10.2987/8756-971X(2006)21[404:ANHSST]2.0.CO;2
   Griffin L, 2014, J VECTOR ECOL, V39, P197, DOI 10.1111/j.1948-7134.2014.12087.x
   Han WW, 2015, TROP MED INT HEALTH, V20, P1239, DOI 10.1111/tmi.12538
   Harbach RE, 2007, ZOOTAXA, P591
   Hartman A, 2017, CLIN LAB MED, V37, P285, DOI 10.1016/j.cll.2017.01.004
   Hasanein P, 2007, EUR J PHARMACOL, V554, P123, DOI 10.1016/j.ejphar.2006.10.026
   Hay SI, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000209
   Hayashi H, 2010, MATERIALS, V3, P3794, DOI 10.3390/ma3073794
   Hayat S, 2018, MICROBIOL IMMUNOL, V62, P211, DOI 10.1111/1348-0421.12580
   He YP, 2016, J NANOBIOTECHNOL, V14, DOI 10.1186/s12951-016-0202-0
   Heffelfinger JD, 2017, MMWR-MORBID MORTAL W, V66, P579, DOI 10.15585/mmwr.mm6622a3
   Helinski MEH, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-41
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   HEMINGWAY J, 1995, MED VET ENTOMOL, V9, P423, DOI 10.1111/j.1365-2915.1995.tb00017.x
   HIROSE J, 1987, BIOCHEMISTRY-US, V26, P6561, DOI 10.1021/bi00394a041
   Hong TK, 2018, PESTIC BIOCHEM PHYS, V145, P29, DOI 10.1016/j.pestbp.2018.01.003
   Huang L, 2005, J INORG BIOCHEM, V99, P986, DOI 10.1016/j.jinorgbio.2004.12.022
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Ivask A, 2017, NANOTOXICOLOGY, V11, P150, DOI 10.1080/17435390.2017.1282049
   Ivask A, 2015, CURR TOP MED CHEM, V15, P1914, DOI 10.2174/1568026615666150506150109
   Iversen JO, 2017, HDB ZOONOSES, P25
   Jahangiri L, 2014, BASIC CLIN NEUROSCI, V5, P156
   Jeevanandam J., 2017, ENHANCED SYNTHESIS D
   Jeevanandam J, 2020, SUSTAINABLE NANOSCALE ENGINEERING: FROM MATERIALS DESIGN TO CHEMICAL PROCESSING, P83, DOI 10.1016/B978-0-12-814681-1.00004-7
   Jeevanandam J, 2018, BEILSTEIN J NANOTECH, V9, P1050, DOI 10.3762/bjnano.9.98
   Jeevanandam J, 2016, BIOCHIMIE, V128, P99, DOI 10.1016/j.biochi.2016.07.008
   Jeevanandam J, 2015, CURR PHARM BIOTECHNO, V16, P853, DOI 10.2174/1389201016666150727120618
   Jin CY, 2008, CHEM RES TOXICOL, V21, P1871, DOI 10.1021/tx800179f
   Jin T, 2011, J NANOPART RES, V13, P6877, DOI 10.1007/s11051-011-0595-5
   Jongthawin J, 2016, PARASITOL RES, V115, P2967, DOI 10.1007/s00436-016-5051-0
   JUTSUM AR, 1988, PHILOS T ROY SOC B, V318, P357, DOI 10.1098/rstb.1988.0014
   Kadammattil AV, 2018, J NANOSCI NANOTECHNO, V18, P2394, DOI 10.1166/jnn.2018.14542
   Khater H. F., 2018, LOCAL GLOBAL IMPACT
   Khater HF, 2019, MALARIA
   Klabunde KJ, 1996, J PHYS CHEM-US, V100, P12142, DOI 10.1021/jp960224x
   KNIPLING EF, 1959, SCIENCE, V130, P902, DOI 10.1126/science.130.3380.902
   Kokoza V, 2001, INSECT BIOCHEM MOLEC, V31, P1137, DOI 10.1016/S0965-1748(01)00120-5
   Koper OB, 1997, CHEM MATER, V9, P2468, DOI 10.1021/cm970357a
   Koper OB, 2002, CURR MICROBIOL, V44, P49, DOI 10.1007/s00284-001-0073-x
   Koudou BG, 2018, LANCET INFECT DIS, V18, pE214, DOI 10.1016/S1473-3099(18)30069-0
   Kovendan K, 2018, J CLUST SCI, V29, P345, DOI 10.1007/s10876-018-1331-4
   Krishnamoorthy K, 2012, J MATER CHEM, V22, P24610, DOI 10.1039/c2jm35087d
   Krishnamoorthy K, 2012, J NANOPART RES, V14, DOI 10.1007/s11051-012-1063-6
   Krishnamoorthy S, 2015, PARASITOL RES, V114, P1839, DOI 10.1007/s00436-015-4370-x
   Kumar D, 2018, PROCESS SAF ENVIRON, V116, P137, DOI 10.1016/j.psep.2018.02.001
   Kumar D, 2018, PARASITOL RES, V117, P377, DOI 10.1007/s00436-017-5711-8
   Kumar MS, 2008, ADV BIOL RES, V2, P39
   Kumar NS, 2016, IJAR, V2, P397
   Kumar R, 2015, ZOOL STUD, V54, DOI 10.1186/s40555-015-0132-9
   LACEY LA, 1990, J AM MOSQUITO CONTR, P1
   LACEY LA, 1986, ANNU REV ENTOMOL, V31, P265, DOI 10.1146/annurev.en.31.010186.001405
   Lambrechts L, 2008, TRENDS PARASITOL, V24, P4, DOI 10.1016/j.pt.2007.09.009
   Lebon C, 2018, BIORXIV274712
   Lee HL, 1997, J VECTOR ECOL, V22, P146
   Lee SE, 2000, J AM MOSQUITO CONTR, V16, P245
   Lees RS, 2015, CURR OPIN INSECT SCI, V10, P156, DOI 10.1016/j.cois.2015.05.011
   Lengeler C, 2004, COCHRANE DB SYST REV, P2, DOI [10.1002/14651858.CD000363.pub2, DOI 10.1002/14651858.CD000363.PUB2, 10.1002/14651858]
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Leung YH, 2014, SMALL, V10, P1171, DOI 10.1002/smll.201302434
   Libalova H, 2018, CHEMOSPHERE, V196, P482, DOI 10.1016/j.chemosphere.2017.12.182
   Lindsey ARI, 2018, GENOME BIOL EVOL, V10, P434, DOI 10.1093/gbe/evy012
   Liu JW, 1996, NAT BIOTECHNOL, V14, P343, DOI 10.1038/nbt0396-343
   Lozano LC, 2013, WORLD J MICROB BIOT, V29, P1383, DOI 10.1007/s11274-013-1301-9
   Lu LM, 2010, ELECTROANAL, V22, P471, DOI 10.1002/elan.200900429
   LUCK RF, 1975, ECOLOGY, V56, P893, DOI 10.2307/1936299
   Lungu M., 2015, NANOPARTICLES PROMIS
   Ma BR, 2018, J ENVIRON MANAGE, V222, P475, DOI 10.1016/j.jenvman.2018.05.089
   Mabaso MLH, 2004, TROP MED INT HEALTH, V9, P846, DOI 10.1111/j.1365-3156.2004.01263.x
   Madhiyazhagan P, 2015, PARASITOL RES, V114, P4305, DOI 10.1007/s00436-015-4671-0
   Magdolenova Z, 2014, NANOTOXICOLOGY, V8, P233, DOI 10.3109/17435390.2013.773464
   Maletz S, 2015, SCI TOTAL ENVIRON, V536, P729, DOI 10.1016/j.scitotenv.2015.07.053
   Mangalampalli B, 2018, J ENVIRON SCI, V66, P125, DOI 10.1016/j.jes.2017.05.012
   Mangalampalli B, 2018, ENVIRON TOXICOL, V33, P396, DOI 10.1002/tox.22526
   Mani TR, 2005, TROP MED INT HEALTH, V10, P1298, DOI 10.1111/j.1365-3156.2005.01522.x
   Marcondes CB, 2016, REV SOC BRAS MED TRO, V49, P4, DOI 10.1590/0037-8682-0220-2015
   Martinez-Ibarra JA, 2002, BIOCONTROL, V47, P481, DOI 10.1023/A:1015691831489
   Masi M, 2017, FITOTERAPIA, V116, P34, DOI 10.1016/j.fitote.2016.11.007
   Mathew N, 2009, PARASITOL RES, V104, P1017, DOI 10.1007/s00436-008-1284-x
   Matthews G, 2016, INT PEST CONTROL, V58, P84
   McKenna KP, 2011, ACS NANO, V5, P3003, DOI 10.1021/nn200062d
   Medlock JM, 2005, MED VET ENTOMOL, V19, P2, DOI 10.1111/j.0269-283X.2005.00547.x
   Mehlhorn H, 2005, PARASITOL RES, V95, P363, DOI 10.1007/s00436-004-1297-z
   Mirzaei H, 2012, CHINESE J CATAL, V33, P1502, DOI 10.1016/S1872-2067(11)60431-2
   Mishra A, 2018, MATH BIOSCI ENG, V15, P441, DOI 10.3934/mbe.2018020
   Mittal PK, 2011, INDIAN J MED RES, V133, P426
   Mohan Lalit, 2006, Entomological Research, V36, P220, DOI 10.1111/j.1748-5967.2006.00037.x
   Moiroux N, 2017, BIORXIV204651
   Moll RM, 2001, J MED ENTOMOL, V38, P29, DOI 10.1603/0022-2585-38.1.29
   Monaghan Andrew J, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.50dfc7f46798675fc63e7d7da563da76
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Mondal NK, 2016, INT J MOSQ RES, V6, P1
   MOOREN FC, 1994, BIOCHEM BIOPH RES CO, V204, P512, DOI 10.1006/bbrc.1994.2489
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Moussavi G, 2009, J HAZARD MATER, V168, P806, DOI 10.1016/j.jhazmat.2009.02.097
   Muley BP, 2009, TROP J PHARM RES, V8, P455
   Murugan K, 2016, ENTOMOL FOCUS, V4, P229, DOI 10.1007/978-3-319-24244-6_10
   Murugan K, 2018, ENVIRON SCI POLLUT R, V25, P10504, DOI 10.1007/s11356-017-0313-7
   Murugan K, 2018, J CLUST SCI, V29, P27, DOI 10.1007/s10876-017-1300-3
   Murugan K, 2017, J CLUST SCI, V28, P2337, DOI 10.1007/s10876-017-1228-7
   Murugan K, 2017, J CLUST SCI, V28, P393, DOI 10.1007/s10876-016-1107-7
   Murugan K, 2015, ENVIRON SCI POLLUT R, V22, P17053, DOI 10.1007/s11356-015-4920-x
   Murugan K, 2015, EXP PARASITOL, V153, P129, DOI 10.1016/j.exppara.2015.03.017
   Muthukumaran U, 2015, PARASITOL RES, V114, P989, DOI 10.1007/s00436-014-4265-2
   N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631
   Naranjo DP, 2016, VECTOR BIOL J, V1, P2
   Nathiya V., 2015, INT J MODN RES REVS, V3, P630
   Nauen R, 2007, PEST MANAG SCI, V63, P628, DOI 10.1002/ps.1406
   Ndava Jenias, 2018, International Journal of Mosquito Research, V5, P6
   Nilsson LKJ, 2018, FEMS MICROBIOL ECOL, V94, DOI 10.1093/femsec/fiy058
   Nouzova M, 2018, INSECT BIOCHEM MOLEC, V95, P10, DOI 10.1016/j.ibmb.2018.02.005
   Nyasembe VO, 2014, PHYTOCHEM LETT, V8, P196, DOI 10.1016/j.phytol.2013.10.003
   Odzak N, 2017, ENVIRON POLLUT, V226, P1, DOI 10.1016/j.envpol.2017.04.006
   Organization W. H, 2016, WORLD MAL REP 2015
   Oyedele AO, 2002, PHYTOMEDICINE, V9, P259, DOI 10.1078/0944-7113-00120
   Pacheco-Coral ADP, 2016, INT J INFECT DIS, V53, P159, DOI 10.1016/j.ijid.2016.11.389
   Pang YP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006851
   Paolisso G, 1997, AM J HYPERTENS, V10, P346, DOI 10.1016/S0895-7061(96)00342-1
   Parnia F, 2017, J PHARM PHARM SCI, V20, P148, DOI 10.18433/J3GP6G
   Paulraj M. G., 2016, Herbal insecticides: repellents and biomedicines: effectiveness and commercialization, P85
   Pavela R, 2016, CURR ORG CHEM, V20, P2674, DOI 10.2174/1385272820666151026231851
   Pavela R, 2016, EXP PARASITOL, V167, P103, DOI 10.1016/j.exppara.2016.05.010
   Perez-Mendoza J, 1999, J STORED PROD RES, V35, P107, DOI 10.1016/S0022-474X(98)00017-4
   Perumalsamy H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0848-8
   Pettit WJ, 2010, J AM MOSQUITO CONTR, V26, P387, DOI 10.2987/09-5962.1
   Pluess B, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006657.pub2
   Prabhu K., 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P124, DOI 10.1016/S2221-1691(11)60009-9
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Quinlan MM, 2018, VECTOR-BORNE ZOONOT, V18, P21, DOI 10.1089/vbz.2017.2192
   Raghavendra K, 2008, INDIAN J MED RES, V128, P22
   Rahman S, 1989, MANUAL ENTOMOLOGICAL, P82
   Rai M, 2017, INT J PHARMACEUT, V526, P254, DOI 10.1016/j.ijpharm.2017.04.042
   Raja A, 2018, J PHOTOCH PHOTOBIO B, V181, P53, DOI 10.1016/j.jphotobiol.2018.02.011
   Rajakumar G, 2015, PARASITOL RES, V114, P571, DOI 10.1007/s00436-014-4219-8
   Ramyadevi J, 2011, PARASITOL RES, V109, P1403, DOI 10.1007/s00436-011-2387-3
   Rao KV, 2008, J MATER SCI, V43, P146, DOI 10.1007/s10853-007-2131-7
   Reddy AC, 2000, 2 NAT C MAT MAN PROC, P121
   Resnick L. M., 1997, MAGNESIUM PATHOPHYSI
   Ricklin ME, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10832
   Riehle MA, 2005, INSECT BIOCHEM MOLEC, V35, P699, DOI 10.1016/j.ibmb.2005.02.008
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Rueda LM, 2008, HYDROBIOLOGIA, V595, P477, DOI 10.1007/s10750-007-9037-x
   Sadasivaiah S, 2007, AM J TROP MED HYG, V77, P249, DOI 10.4269/ajtmh.2007.77.249
   Sampath LDS, 2015, BIOCH ANAL BIOCH, V4, P1000182
   Saquib Q, 2012, TOXICOL IN VITRO, V26, P351, DOI 10.1016/j.tiv.2011.12.011
   Sarwar M, 2015, INTERNATIONAL JOURNA, V1, P161
   Sawai J, 2004, J APPL MICROBIOL, V96, P803, DOI 10.1111/j.1365-2672.2004.02234.x
   Scholte EJ, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.19
   Selvan SM, 2018, IET NANOBIOTECHNOL, V12, P1042, DOI 10.1049/iet-nbt.2018.5083
   Sha BY, 2011, COMPOS PART B-ENG, V42, P2136, DOI 10.1016/j.compositesb.2011.05.009
   Shaalan Essam Abdel-Salam, 2017, Asian Pacific Journal of Tropical Disease, V7, P106, DOI 10.12980/apjtd.7.2017D6-340
   Sharma SK, 2005, MED VET ENTOMOL, V19, P286, DOI 10.1111/j.1365-2915.2005.00571.x
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   SHEPLAY AW, 1982, J INSECT PHYSIOL, V28, P641, DOI 10.1016/0022-1910(82)90062-2
   Shik Choi， Kwang, 2015, [The Korean Journal of Mycology, 한국균학회지], V43, P77
   Simoes ML, 2017, DEV COMP IMMUNOL, V67, P257, DOI 10.1016/j.dci.2016.09.012
   Singh S, 2017, CHEM ENG J, V313, P283, DOI 10.1016/j.cej.2016.12.049
   Sohail, 2017, NANOSCI NANOTECH LET, V9, P1875, DOI 10.1166/nnl.2017.2586
   Somerton B, 2015, APPL ENVIRON MICROB, V81, P5115, DOI 10.1128/AEM.01037-15
   Su T, 2016, INSECTICIDES RESISTA
   Sulaiman S, 2002, J VECTOR ECOL, V27, P230
   Suman Thodhal Yoganandham, 2015, Asian Pacific Journal of Tropical Disease, V5, P224
   Surachetpong W, 2011, ANTIOXID REDOX SIGN, V14, P943, DOI 10.1089/ars.2010.3401
   Swaminathan R, 2003, Clin Biochem Rev, V24, P47
   Tami A, 2004, MALARIA J, V3, DOI 10.1186/1475-2875-3-19
   Tang ZX, 2014, BRAZ J CHEM ENG, V31, P591, DOI 10.1590/0104-6632.20140313s00002813
   Tavares M, 2018, INT J PHARMACEUT, V539, P190, DOI 10.1016/j.ijpharm.2018.01.046
   Tawatsin A, 2001, J VECTOR ECOL, V26, P76
   Thomas DD, 2000, SCIENCE, V287, P2474, DOI 10.1126/science.287.5462.2474
   Thomas MB, 2007, NAT REV MICROBIOL, V5, P377, DOI 10.1038/nrmicro1638
   Thorsell W, 1998, PHYTOMEDICINE, V5, P311, DOI 10.1016/S0944-7113(98)80072-X
   Tippelt L, 2017, PARASITOL RES, V116, P3437, DOI 10.1007/s00436-017-5652-2
   Tolle Michael A, 2009, Curr Probl Pediatr Adolesc Health Care, V39, P97, DOI 10.1016/j.cppeds.2009.01.001
   TORRENTE A, 1993, MEM I OSWALDO CRUZ, V88, P625, DOI 10.1590/S0074-02761993000400022
   Tso CP, 2010, WATER SCI TECHNOL, V61, P127, DOI 10.2166/wst.2010.787
   Turell MJ, 2015, J MED ENTOMOL, V52, P1111, DOI 10.1093/jme/tjv093
   Tyagi V, 2017, INT J MOSQ RES B, V4, P112
   ULLU E, 1990, NUCLEIC ACIDS RES, V18, P3319, DOI 10.1093/nar/18.11.3319
   Vajda EA, 2018, J MED ENTOMOL, V55, P477, DOI 10.1093/jme/tjx222
   van den Berg H, 2012, ENVIRON HEALTH PERSP, V120, P577, DOI 10.1289/ehp.1104340
   van den Berg H, 2009, ENVIRON HEALTH PERSP, V117, P1656, DOI 10.1289/ehp.0900785
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Venkatachalam MR, 2001, BIORESOURCE TECHNOL, V76, P287, DOI 10.1016/S0960-8524(00)00096-1
   Vijayakumar S, 2015, SPECTROCHIM ACTA A, V137, P886, DOI 10.1016/j.saa.2014.08.064
   Vilela R, 2015, EMERG INFECT DIS, V21, P290, DOI 10.3201/eid2102.141091
   Wang EC, 2014, INTEGR BIOL-UK, V6, P9, DOI 10.1039/c3ib40165k
   Wilke ABB, 2018, TRENDS PARASITOL, V34, P456, DOI 10.1016/j.pt.2018.02.003
   Wongrakpanich A, 2016, ENVIRON SCI-NANO, V3, P365, DOI 10.1039/c5en00271k
   World Health Organization ( WHO), 2003, WHOCDSWHOPESGCDPP200
   Wu TP, 2016, INSECTS, V7, DOI 10.3390/insects7040079
   Xu BQ, 2001, CATAL TODAY, V68, P217, DOI 10.1016/S0920-5861(01)00303-0
   Yakob L, 2016, LANCET GLOB HEALTH, V4, pE148, DOI 10.1016/S2214-109X(16)00048-6
   Yalwala S, 2016, J MED ENTOMOL, V53, P1242, DOI 10.1093/jme/tjw075
   Yewhalaw D, 2016, INSECTICIDES RESISTANCE, P189, DOI 10.5772/61570
   Zamanian M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004069
   Zareen S, 2016, INT J MOSQ RES A, V3, P48
   Zhang DJ, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2750-7
   Zhang DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135194
   Zhang WB, 2014, MACROMOLECULES, V47, P1221, DOI 10.1021/ma401724p
NR 311
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 2191-1630
EI 2191-1649
J9 BIONANOSCIENCE
JI BioNanoScience
PD MAR
PY 2020
VL 10
IS 1
BP 292
EP 310
DI 10.1007/s12668-019-00703-2
PG 19
WC Materials Science, Biomaterials
SC Materials Science
GA LG2DL
UT WOS:000527918000027
DA 2020-07-08
ER

PT J
AU Omar, NAS
   Fen, YW
   Abdullah, J
   Sadrolhosseini, AR
   Kamil, YM
   Fauzi, NIM
   Hashim, HS
   Mahdi, MA
AF Omar, Nur Alia Sheh
   Fen, Yap Wing
   Abdullah, Jaafar
   Sadrolhosseini, Amir Reza
   Kamil, Yasmin Mustapha
   Fauzi, Nurul Illya Muhamad
   Hashim, Hazwani Suhaila
   Mahdi, Mohd Adzir
TI Quantitative and Selective Surface Plasmon Resonance Response Based on a
   Reduced Graphene Oxide-Polyamidoamine Nanocomposite for Detection of
   Dengue Virus E-Proteins
SO NANOMATERIALS
LA English
DT Article
DE dengue virus; envelope proteins; graphene oxide; polyamidoamine; surface
   plasmon resonance
ID THIN-FILM; SENSING PROPERTIES; QUANTUM DOTS; BIOSENSOR; DIAGNOSIS;
   NANOMATERIALS; SPECTROSCOPY; PERFORMANCE; ANTIBODIES; ANTIGEN
AB Dengue viral infection is one of the most common deadliest diseases and has become a recurrent issue for public health in tropical countries. Although the spectrum of clinical diagnosis and treatment have recently been established, the efficient and rapid detection of dengue virus (DENV) during viremia and the early febrile phase is still a great challenge. In this study, a dithiobis (succinimidyl undecanoate, DSU)/amine-functionalized reduced graphene oxide--polyamidoamine dendrimer (DSU/amine-functionalized rGO-PAMAM) thin film-based surface plasmon resonance (SPR) sensor was developed for the detection of DENV 2 E-proteins. Different concentrations of DENV 2 E-proteins were successfully tested by the developed SPR sensor-based system. The performance of the developed sensor showed increased shift in the SPR angle, narrow full-width-half-maximum of the SPR curve, high detection accuracy, excellent figure of merit and signal-to-noise ratio, good sensitivity values in the range of 0.08-0.5 pM (S = 0.2576 degrees/pM, R-2 = 0.92), and a high equilibrium association constant (K-A) of 7.6452 TM-1. The developed sensor also showed a sensitive and selective response towards DENV 2 E-proteins compared to DENV 1 E-proteins and ZIKV (Zika virus) E-proteins. Overall, it was concluded that the Au/DSU/amine-functionalized rGO-PAMAM thin film-based SPR sensor has potential to serve as a rapid clinical diagnostic tool for DENV infection.
C1 [Omar, Nur Alia Sheh; Fen, Yap Wing; Sadrolhosseini, Amir Reza] Univ Putra Malaysia, Inst Adv Technol, Serdang 43400, Upm, Malaysia.
   [Fen, Yap Wing; Abdullah, Jaafar; Fauzi, Nurul Illya Muhamad; Hashim, Hazwani Suhaila] Univ Putra Malaysia, Fac Sci, Serdang 43400, Upm, Malaysia.
   [Kamil, Yasmin Mustapha] Univ Putra Malaysia, InnoHub Unit, inLAZER Dynam Sdn Bhd, Putra Sci Pk, Serdang 43400, Malaysia.
   [Mahdi, Mohd Adzir] Univ Putra Malaysia, Wireless & Photon Network Res Ctr, Fac Engn, Serdang 43400, Upm, Malaysia.
RP Fen, YW (corresponding author), Univ Putra Malaysia, Inst Adv Technol, Serdang 43400, Upm, Malaysia.; Fen, YW (corresponding author), Univ Putra Malaysia, Fac Sci, Serdang 43400, Upm, Malaysia.
EM nuralia.upm@gmail.com; yapwingfen@gmail.com; jafar@upm.edu.my;
   amir1348@gmail.com; yasminmustaphakamil@gmail.com;
   illyafauzi97@gmail.com; hazwanisuhaila@gmail.com; mam@upm.edu.my
OI Fen, Yap Wing/0000-0003-3475-7469
FU Exploratory Research Grant Scheme [ERGS/1/2012/STG08/UPM/01/29];
   Fundamental Research Grant Scheme [FRGS/1/2019/STG02/UPM/02/1]
FX The Exploratory Research Grant Scheme (ERGS/1/2012/STG08/UPM/01/29) and
   Fundamental Research Grant Scheme (FRGS/1/2019/STG02/UPM/02/1) supported
   this research.
CR Ahuja D., 2012, J SCI RES REV, V1
   Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002
   Balandin AA, 2011, NAT MATER, V10, P569, DOI [10.1038/NMAT3064, 10.1038/nmat3064]
   Barrero PR, 2004, VIRUS RES, V101, P135, DOI 10.1016/j.virusres.2003.12.033
   Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08
   Bharti JP, 2011, INT J PHARM SCI RES, V2, P1947, DOI 10.13040/IJPSR.0975-8232.2(8).1947-60
   Calabretta MK, 2007, BIOMACROMOLECULES, V8, P1807, DOI 10.1021/bm0701088
   Camara AR, 2013, OPT EXPRESS, V21, P27023, DOI 10.1364/OE.21.027023
   Cavalcanti IT, 2012, TALANTA, V91, P41, DOI 10.1016/j.talanta.2012.01.002
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Daaboul GG, 2012, IEEE J SEL TOP QUANT, V18, P1422, DOI 10.1109/JSTQE.2011.2180516
   Daniyal WMEMM, 2019, SPECTROCHIM ACTA A, V212, P25, DOI 10.1016/j.saa.2018.12.031
   Das M. K., 2013, J APPL PHARM SCI, V3, P142, DOI DOI 10.7324/JAPS.2013.3924
   Dhanoa A, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1731-8
   Fen YW, 2013, SENSOR REV, V33, P305, DOI 10.1108/SR-01-2012-604
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gelanew T, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0925-7
   Gilje S, 2007, NANO LETT, V7, P3394, DOI 10.1021/nl0717715
   Gomez-Navarro C, 2007, NANO LETT, V7, P3499, DOI 10.1021/nl072090c
   Green TA, 2007, GOLD BULL, V40, P105, DOI 10.1007/BF03215566
   Guo LL, 2018, POLYMERS-BASEL, V10, DOI 10.3390/polym10111199
   Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003
   Han X, 2019, MATERIALS, V12, DOI 10.3390/ma12091411
   Hidayah NMS, 2017, AIP CONF PROC, V1892, DOI 10.1063/1.5005764
   Nguyen HH, 2015, SENSORS-BASEL, V15, P10481, DOI 10.3390/s150510481
   Hoet RM, 2005, NAT BIOTECHNOL, V23, P344, DOI 10.1038/nbt1067
   Homola J, 2006, SPRINGER SER CHEM SE, V4, P45, DOI 10.1007/5346_014
   Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d
   Jahanshahi P, 2017, BIOENGINEERED, V8, P239, DOI 10.1080/21655979.2016.1223413
   Jha R, 2009, OPT LETT, V34, P749, DOI 10.1364/OL.34.000749
   Jilani A, 2017, MODERN TECHNOLOGIES FOR CREATING THE THIN-FILM SYSTEMS AND COATINGS, P137, DOI 10.5772/65702
   Kamil YM, 2018, SENSOR ACTUAT B-CHEM, V257, P820, DOI 10.1016/j.snb.2017.11.005
   Kuilla T, 2010, PROG POLYM SCI, V35, P1350, DOI 10.1016/j.progpolymsci.2010.07.005
   Kumarasamy V, 2007, SMJ Singapore Medical Journal, V48, P669
   Kushwaha AS, 2018, OPTIK, V172, P697, DOI 10.1016/j.ijleo.2018.07.066
   Lu C, 2016, LANGMUIR, V32, P10776, DOI 10.1021/acs.langmuir.6b03032
   Maharana PK, 2012, SENSOR ACTUAT B-CHEM, V169, P161, DOI 10.1016/j.snb.2012.04.051
   Martins TD, 2013, STATE OF THE ART IN BIOSENSORS - GENERAL ASPECTS, P111, DOI 10.5772/52330
   Navaee A, 2015, RSC ADV, V5, P59874, DOI 10.1039/c5ra07892j
   Navakul K, 2017, NANOMED-NANOTECHNOL, V13, P549, DOI 10.1016/j.nano.2016.08.009
   Omar Nur Alia Sheh, 2018, Sensing and Bio-Sensing Research, V20, P16, DOI 10.1016/j.sbsr.2018.06.001
   Omar NAS, 2019, OPT LASER TECHNOL, V114, P204, DOI 10.1016/j.optlastec.2019.01.038
   Omar NAS, 2018, OPTIK, V171, P934, DOI 10.1016/j.ijleo.2018.07.001
   Omar NAS, 2018, SENSOR REV, V38, P106, DOI 10.1108/SR-07-2017-0130
   Peltomaa R, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18124126
   Perrotton C, 2013, OPT EXPRESS, V21, P382, DOI 10.1364/OE.21.000382
   Pooja C, 2014, ASIAN PAC J TROP MED, V7, P169, DOI 10.1016/S1995-7645(14)60016-X
   Prabowo BA, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8030080
   Priyadarsini S, 2018, J NANOSTRUCTURE CHEM, V8, P123, DOI 10.1007/s40097-018-0265-6
   Ramdzan NSM, 2019, OPTIK, V178, P802, DOI 10.1016/j.ijleo.2018.10.071
   RICE CM, 1985, SCIENCE, V229, P726, DOI 10.1126/science.4023707
   Rich RL, 2008, J MOL RECOGNIT, V21, P355, DOI 10.1002/jmr.928
   Sabri N., 2015, RECENT TRENDS PHYS M, P299, DOI DOI 10.1007/978-981-287-128-2_19
   Salahudeen MS, 2017, SAUDI PHARM J, V25, P165, DOI 10.1016/j.jsps.2016.07.002
   Saleviter S, 2018, J NANOMATER, V2018, DOI 10.1155/2018/4324072
   Sarma S, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103182
   Shankaran DR, 2007, SENSOR ACTUAT B-CHEM, V121, P158, DOI 10.1016/j.snb.2006.09.014
   Sinitskii A, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3276912
   Sun HJ, 2013, MATER TODAY, V16, P433, DOI 10.1016/j.mattod.2013.10.020
   Suvarnaphaet P, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17102161
   Syahir Amir, 2015, Microarrays (Basel), V4, P228, DOI 10.3390/microarrays4020228
   Wilson RH, 2016, ADV PHYS-X, V1, P523, DOI 10.1080/23746149.2016.1221739
   Wong WR, 2016, BIOSENS BIOELECTRON, V78, P132, DOI 10.1016/j.bios.2015.11.030
   Xing F, 2012, SCI REP-UK, V2, DOI 10.1038/srep00908
   Yaacob M. H., 2018, IEEE J SEL TOP QUANT, V25, P1
   Yin LY, 2014, AIP ADV, V4, DOI 10.1063/1.4890100
   Yoon SJ, 2007, J OPT SOC AM A, V24, P2543, DOI 10.1364/JOSAA.24.002543
   Zainudin AA, 2018, SPECTROCHIM ACTA A, V191, P111, DOI 10.1016/j.saa.2017.10.013
   Zainudin AA, 2017, OPTIK, V144, P308, DOI 10.1016/j.ijleo.2017.07.001
   Zhang H, 2018, OPT EXPRESS, V26, P33226, DOI 10.1364/OE.26.033226
   Zhu JM, 2019, INT J NANOMED, V14, P835, DOI 10.2147/IJN.S184013
NR 71
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2079-4991
J9 NANOMATERIALS-BASEL
JI Nanomaterials
PD MAR
PY 2020
VL 10
IS 3
AR 569
DI 10.3390/nano10030569
PG 14
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA LD5SO
UT WOS:000526090400169
PM 32245185
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wright, WF
   Palisoc, K
   Pinto, CN
   Lease, JA
   Baghli, S
AF Wright, William F.
   Palisoc, Kathryn
   Pinto, Casey N.
   Lease, James A.
   Baghli, Salim
TI Hepatitis C Virus-Associated Acalculous Cholecystitis and Review of the
   Literature
SO CLINICAL MEDICINE & RESEARCH
LA English
DT Review
DE Hepatitis C virus; Acalculous cholecystitis; Viral cholecystitis
ID INFECTION; CYTOMEGALOVIRUS; PATIENT
AB Acute acalculous cholecystitis (AAC) is an infrequently encountered clinical condition associated with high morbidity and mortality. Viral infection associated AAC is rare, but it is most commonly associated with Epstein-Barr virus, cytomegalovirus, dengue virus, hepatitis A, hepatitis B, human immunodeficiency virus, disseminated visceral varicella-zoster virus infection, Zika virus, and hepatitis C. We report on a patient who was first diagnosed with a chronic hepatic C infection and subsequently with acalculous cholecystitis.
C1 [Wright, William F.; Pinto, Casey N.] Univ Pittsburgh, Dept Med, Div Infect Dis, Med Ctr Pinnacle, Harrisburg, PA 17101 USA.
   [Palisoc, Kathryn; Baghli, Salim] Univ Pittsburgh, Div Hosp Med, Dept Med, Med Ctr Mem, York, PA USA.
   [Pinto, Casey N.] Penn State Univ, Dept Publ Hlth Sci, University Pk, PA 16802 USA.
   [Lease, James A.] Univ Pittsburgh, Dept Pathol & Lab Med, Med Ctr Mem, York, PA USA.
RP Wright, WF (corresponding author), Univ Pittsburgh, Dept Med, Div Infect Dis, Med Ctr, 111 South Front St, Harrisburg, PA 17101 USA.
CR Agergaard J, 2015, INT J INFECT DIS, V35, P67, DOI 10.1016/j.ijid.2015.04.004
   BARIE PS, 1995, J AM COLL SURGEONS, V180, P232
   Bhatty Shaheen, 2009, JPMA Journal of the Pakistan Medical Association, V59, P519
   Braude MR, 2016, INTERN MED J, V46, P238, DOI 10.1111/imj.12977
   Bura M, 2015, ADV CLIN EXP MED, V24, P829, DOI 10.17219/acem/27566
   Chung RT, 2018, CLIN INFECT DIS, V67, P1477, DOI 10.1093/cid/ciy585
   GLENN F, 1979, ANN SURG, V189, P458
   GLENN F, 1982, ANN SURG, V195, P131, DOI 10.1097/00000658-198202000-00002
   Hakala T, 1997, BRIT J SURG, V84, P1249
   Kalliafas S, 1998, AM SURGEON, V64, P471
   KAVIN H, 1986, ANN INTERN MED, V104, P53, DOI 10.7326/0003-4819-104-1-53
   KESHAVJEE SH, 1993, CAN J SURG, V36, P321
   Laurila JJ, 2005, HISTOPATHOLOGY, V47, P485, DOI 10.1111/j.1365-2559.2005.02238.x
   Loriot MA, 1999, HEPATOLOGY, V29, P1587, DOI 10.1002/hep.510290527
   McChesney JA, 2003, DIGEST DIS SCI, V48, P1960, DOI 10.1023/A:1026118320460
   Meier M, 2005, CLIN GASTROENTEROL H, V3, pXXVI, DOI 10.1053/S1542-3565(04)00722-0
   Omar A, 2016, INT J SURG CASE REP, V19, P78, DOI 10.1016/j.ijscr.2015.12.020
   Ono SK, 2018, HEPATOLOGY, V67, P2051, DOI 10.1002/hep.29682
   SHAPIRO MJ, 1994, AM SURGEON, V60, P335
   Tresallet C, 2010, J RADIOL, V91, P813, DOI 10.1016/S0221-0363(10)70121-9
   Unal H, 2009, INT J INFECT DIS, V13, pE310, DOI 10.1016/j.ijid.2009.01.015
   Vespasiani-Gentilucci U, 2012, MODERN PATHOL, V25, P576, DOI 10.1038/modpathol.2011.197
   Yokoe M, 2018, J HEPATO-BIL-PAN SCI, V25, P41, DOI 10.1002/jhbp.515
NR 23
TC 0
Z9 0
U1 0
U2 0
PU MARSHFIELD CLINIC
PI MARSHFIELD
PA 1000 N OAK AVE, MAILSTOP ML7, MARSHFIELD, WI 54449 USA
SN 1539-4182
EI 1554-6179
J9 CLIN MED RES
JI Clin. Med. Res.
PD MAR 1
PY 2020
VL 18
IS 1
BP 33
EP 36
DI 10.3121/cmr.2019.1499
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA LD6ZA
UT WOS:000526178500006
PM 31511241
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Koenig, M
   Mitzey, A
   Murphy, M
   Treadway, T
   Simmons, H
   Mejia, A
   Weiler, A
   Bliss, M
   Rybarczyk, S
   Friedrich, T
   O'Connor, D
   Mohr, E
   Golos, T
AF Koenig, Michelle
   Mitzey, Ann
   Murphy, Megan
   Treadway, Taylor
   Simmons, Heather
   Mejia, Andres
   Weiler, Andrea
   Bliss, Mason
   Rybarczyk, Sierra
   Friedrich, Thomas
   O'Connor, David
   Mohr, Emma
   Golos, Thaddeus
TI Zika Virus Vertical Transmission Dynamics in the Pregnant Rhesus
   Macaque.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 67th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 10-14, 2020
CL Vancouver, CANADA
SP Soc Reproduct Investigat
C1 [Koenig, Michelle; Mitzey, Ann; Murphy, Megan; Treadway, Taylor; Simmons, Heather; Mejia, Andres; Weiler, Andrea; Bliss, Mason; Rybarczyk, Sierra; Friedrich, Thomas; O'Connor, David; Mohr, Emma; Golos, Thaddeus] Univ Wisconsin, Madison, WI USA.
NR 0
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2020
VL 27
IS SUPPL 1
SU 1
SI SI
MA T-129
BP 169A
EP 169A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA LC6HM
UT WOS:000525432600287
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, D
   Maxted, M
   Martin, A
   Dubois, M
   Papin, JF
   Myers, DA
AF Gurung, Sunam
   Reuter, Darlene
   Maxted, Marta
   Martin, Ashley
   Dubois, Molly
   Papin, James F.
   Myers, Dean A.
TI Early and Mid-Gestation Zika Virus (Zikv) Infection in the Olive Baboon
   (Papio anubis) Leads to Aberrant Formation of Fetal Cerebral Cortical
   Layers by Term Gestation.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 67th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 10-14, 2020
CL Vancouver, CANADA
SP Soc Reproduct Investigat
C1 [Gurung, Sunam; Reuter, Darlene; Maxted, Marta; Martin, Ashley; Dubois, Molly; Papin, James F.; Myers, Dean A.] OUHSC, Oklahoma City, OK USA.
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS103772, OD010988]
FX NIH: NS103772, OD010988.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2020
VL 27
IS SUPPL 1
SU 1
SI SI
MA S-083
BP 322A
EP 323A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA LC6HM
UT WOS:000525432601310
DA 2020-07-08
ER

PT J
AU Gurung, S
   Reuter, D
   Maxted, M
   Singleton, K
   Dubois, M
   Papin, JF
   Myers, DA
AF Gurung, Sunam
   Reuter, Darlene
   Maxted, Marta
   Singleton, Krista
   Dubois, Molly
   Papin, James F.
   Myers, Dean A.
TI Zika Virus (Zikv) Infection at Early or Mid-Gestation Results in
   Persistent Uterine and Lymph Node Infection and Adverse Fetal CNS
   Pathology by Term Gestation in the Olive Baboon (Papio anubis).
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 67th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 10-14, 2020
CL Vancouver, CANADA
SP Soc Reproduct Investigat
C1 [Gurung, Sunam; Reuter, Darlene; Maxted, Marta; Singleton, Krista; Dubois, Molly; Papin, James F.; Myers, Dean A.] OUHSC, Oklahoma City, OK USA.
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [NS103772, OD010988]
FX NIH: NS103772, OD010988
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2020
VL 27
IS SUPPL 1
SU 1
SI SI
MA S-105
BP 331A
EP 331A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA LC6HM
UT WOS:000525432601332
DA 2020-07-08
ER

PT J
AU Murphy, ME
   Block, LN
   Pearson, C
   Koski, M
   Wiepz, G
   Antony, K
   Morgan, T
   Nguyen, S
   Weiler, A
   Bliss, M
   Rybarczyk, S
   Friedrich, T
   Reyes, L
   Golos, T
AF Murphy, Megan E.
   Block, Lindsey N.
   Pearson, Cheyenne
   Koski, Madison
   Wiepz, Gregory
   Antony, Kathleen
   Morgan, Terry
   Nguyen, Sydney
   Weiler, Andrea
   Bliss, Mason
   Rybarczyk, Sierra
   Friedrich, Thomas
   Reyes, Leticia
   Golos, Thaddeus
TI Fetal Viral Burden and Placental Pathology with Intra-Amniotic Zika
   Virus Inoculation in Pregnant Macaques.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 67th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 10-14, 2020
CL Vancouver, CANADA
SP Soc Reproduct Investigat
C1 [Murphy, Megan E.; Block, Lindsey N.; Pearson, Cheyenne; Koski, Madison; Wiepz, Gregory; Antony, Kathleen; Nguyen, Sydney; Weiler, Andrea; Bliss, Mason; Rybarczyk, Sierra; Friedrich, Thomas; Reyes, Leticia; Golos, Thaddeus] Univ Wisconsin, Madison, WI USA.
   [Morgan, Terry] Oregon Hlth & Sci Univ, Portland, OR 97201 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2020
VL 27
IS SUPPL 1
SU 1
SI SI
MA S-135
BP 342A
EP 342A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA LC6HM
UT WOS:000525432601362
DA 2020-07-08
ER

PT J
AU Villazana-Kretzer, DL
   Go, J
   Damicis, JR
   Elisabeth, DM
   Napolitano, P
   Gale, M
   Ieronimakis, N
AF Villazana-Kretzer, Diana L.
   Go, Jenny
   Damicis, Jennifer R.
   Elisabeth, Dornisch M.
   Napolitano, Pete
   Gale, Michael, Jr.
   Ieronimakis, Nicholas
TI Zika Virus Infection Promotes Cell Death and Syncytia Remodeling in
   Human ex vivo Perfused Cotyledons.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 67th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 10-14, 2020
CL Vancouver, CANADA
SP Soc Reproduct Investigat
C1 [Villazana-Kretzer, Diana L.; Damicis, Jennifer R.; Elisabeth, Dornisch M.; Ieronimakis, Nicholas] Madigan Army Med Ctr, Tacoma, WA 98431 USA.
   [Go, Jenny; Napolitano, Pete; Gale, Michael, Jr.] Univ Washington, Med Ctr, Seattle, WA 98195 USA.
RI Go, Jennifer/AAQ-5306-2020
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2020
VL 27
IS SUPPL 1
SU 1
SI SI
MA S-152
BP 347A
EP 348A
PG 2
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA LC6HM
UT WOS:000525432601379
DA 2020-07-08
ER

PT J
AU Guo, XF
   Kayisli, U
   Semerci, N
   Sipe, B
   New, E
   Schatz, F
   Lockwood, C
   Guzeloglu-Kayisli, O
AF Guo, Xiaofang
   Kayisli, Umit
   Semerci, Nihan
   Sipe, Bradley
   New, Erika
   Schatz, Frederick
   Lockwood, Charles
   Guzeloglu-Kayisli, Ozlem
TI Trimester-Dependent Differential Induction of Anti-Viral and
   Inflammatory Genes in Decidual Cells by ZIKA Virus Infection.
SO REPRODUCTIVE SCIENCES
LA English
DT Meeting Abstract
CT 67th Annual Scientific Meeting of the
   Society-for-Reproductive-Investigation (SRI)
CY MAR 10-14, 2020
CL Vancouver, CANADA
SP Soc Reproduct Investigat
C1 [Guo, Xiaofang; Kayisli, Umit; Semerci, Nihan; Sipe, Bradley; New, Erika; Schatz, Frederick; Lockwood, Charles; Guzeloglu-Kayisli, Ozlem] Univ S Florida, Morsani Coll Med, Tampa, FL 33620 USA.
FU Florida Department of Health [7ZK23]
FX Supported by the Florida Department of Health (#7ZK23).
NR 0
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1933-7191
EI 1933-7205
J9 REPROD SCI
JI Reprod. Sci.
PD MAR
PY 2020
VL 27
IS SUPPL 1
SU 1
SI SI
MA S-217
BP 371A
EP 371A
PG 1
WC Obstetrics & Gynecology; Reproductive Biology
SC Obstetrics & Gynecology; Reproductive Biology
GA LC6HM
UT WOS:000525432601444
DA 2020-07-08
ER

PT J
AU Durand, GA
   Piorkowski, G
   Thirion, L
   Ninove, L
   Giron, S
   Zandotti, C
   Denis, J
   Badaut, C
   Failloux, AB
   Grard, G
   Leparc-Goffart, I
   de Lamballerie, X
AF Durand, Guillaume A.
   Piorkowski, Geraldine
   Thirion, Laurence
   Ninove, Laetitia
   Giron, Sandra
   Zandotti, Christine
   Denis, Jessica
   Badaut, Cyril
   Failloux, Anna-Bella
   Grard, Gilda
   Leparc-Goffart, Isabelle
   de Lamballerie, Xavier
TI Vector-Borne Transmission of the Zika Virus Asian Genotype in Europe
SO VIRUSES-BASEL
LA English
DT Article
DE arbovirus; zika; France; Aedes albopictus; autochthonous transmission;
   genotyping
AB Three autochthonous cases of Zika virus occurred in southern France in August 2019. Diagnosis relied on serology and transcription-mediated amplification. Attempts for virus isolation and ZIKV genome RT-PCR detection remained negative. Since the index case was not identified, we addressed the issue of genotyping and geographical origin by performing hemi-nested PCR and sequencing in the Pr gene. Analysis of 16 genotype-specific Single Nucleotides Polymorphisms identified the Asian genotype and suggested a Southeast Asia origin.
C1 [Durand, Guillaume A.; Denis, Jessica; Badaut, Cyril; Grard, Gilda; Leparc-Goffart, Isabelle] Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, F-13010 Marseille, France.
   [Durand, Guillaume A.; Piorkowski, Geraldine; Thirion, Laurence; Ninove, Laetitia; Zandotti, Christine; Grard, Gilda; Leparc-Goffart, Isabelle; de Lamballerie, Xavier] Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, F-13010 Marseille, France.
   [Giron, Sandra] French Natl Publ Hlth Agcy, Sante Publ France, F-13002 Marseille, France.
   [Denis, Jessica; Badaut, Cyril] Inst Rech Biomed Armees, Unite Biotherapies Antiinfect & Immunite, F-91220 Bretigny Sur Orge, France.
   [Failloux, Anna-Bella] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, F-75015 Paris, France.
RP Durand, GA (corresponding author), Inst Rech Biomed Armees, Natl Reference Lab Arboviruses, F-13010 Marseille, France.; Durand, GA (corresponding author), Aix Marseille Univ, UVE, IRD 190, Inserm 1207,IHU Mediterranee Infect, F-13010 Marseille, France.
EM guillaume.durand@inserm.fr; geraldine.piorkowski@inserm.fr;
   laurence.thirion@ird.fr; laetitia.ninove@ap-hm.fr;
   sandra.giron@santepubliquefrance.fr; christine.zandotti@ap-hm.fr;
   jessica.d03@orange.fr; cbadaut@gmail.com;
   anna-bella.failloux@pasteur.fr; gilda.grard@inserm.fr;
   isabelle.leparcgoffart@gmail.com; xavier.de-lamballerie@univ-amu.fr
OI FAILLOUX, Anna-Bella/0000-0001-6890-0820; Badaut,
   Cyril/0000-0002-0064-6384; Laurence, THIRION/0000-0003-4301-2944
CR Denis J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007747
   Giron S, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.45.1900655
   Moutailler S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100904
   Olschlager S, 2017, AM J TROP MED HYG, V97, P1070, DOI 10.4269/ajtmh.17-0268
   Pettersson JHO, 2016, MBIO, V7, DOI [10.1128/mBio.01239-16, 10.1128/mbio.01239-16]
   Pettersson JHO, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0082-5
   Ren P, 2017, J CLIN MICROBIOL, V55, P2198, DOI 10.1128/jcm.00603-17
   Vazeille M, 2019, EMERG MICROBES INFEC, V8, P1668, DOI 10.1080/22221751.2019.1689797
NR 8
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2020
VL 12
IS 3
AR 296
DI 10.3390/v12030296
PG 5
WC Virology
SC Virology
GA LC7BG
UT WOS:000525486800091
PM 32182748
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gwon, YD
   Strand, M
   Lindqvist, R
   Nilsson, E
   Saleeb, M
   Elofsson, M
   Overby, AK
   Evander, M
AF Gwon, Yong-Dae
   Strand, Marten
   Lindqvist, Richard
   Nilsson, Emma
   Saleeb, Michael
   Elofsson, Mikael
   Overby, Anna K.
   Evander, Magnus
TI Antiviral Activity of Benzavir-2 against Emerging Flaviviruses
SO VIRUSES-BASEL
LA English
DT Article
DE benzavir-2; flavivirus; Zika virus; antiviral drugs
ID BORNE ENCEPHALITIS-VIRUS; INFECTION; ACID; REPLICATION; INHIBITORS;
   COMPOUND; SCREEN
AB Most flaviviruses are arthropod-borne viruses, transmitted by either ticks or mosquitoes, and cause morbidity and mortality worldwide. They are endemic in many countries and have recently emerged in new regions, such as the Zika virus (ZIKV) in South-and Central America, the West Nile virus (WNV) in North America, and the Yellow fever virus (YFV) in Brazil and many African countries, highlighting the need for preparedness. Currently, there are no antiviral drugs available to treat flavivirus infections. We have previously discovered a broad-spectrum antiviral compound, benzavir-2, with potent antiviral activity against both DNA- and RNA-viruses. Our purpose was to investigate the inhibitory activity of benzavir-2 against flaviviruses. We used a ZIKV ZsGreen-expressing vector, two lineages of wild-type ZIKV, and other medically important flaviviruses. Benzavir-2 inhibited ZIKV derived reporter gene expression with an EC50 value of 0.8 +/- 0.1 mu M. Furthermore, ZIKV plaque formation, progeny virus production, and viral RNA expression were strongly inhibited. In addition, 2.5 mu M of benzavir-2 reduced infection in vitro in three to five orders of magnitude for five other flaviviruses: WNV, YFV, the tick-borne encephalitis virus, Japanese encephalitis virus, and dengue virus. In conclusion, benzavir-2 was a potent inhibitor of flavivirus infection, which supported the broad-spectrum antiviral activity of benzavir-2.
C1 [Gwon, Yong-Dae; Strand, Marten; Lindqvist, Richard; Nilsson, Emma; Overby, Anna K.; Evander, Magnus] Umea Univ, Dept Clin Microbiol, Virol, S-90185 Umea, Sweden.
   [Gwon, Yong-Dae; Lindqvist, Richard; Nilsson, Emma; Elofsson, Mikael; Overby, Anna K.; Evander, Magnus] Umea Univ, UCMR, S-90187 Umea, Sweden.
   [Lindqvist, Richard; Nilsson, Emma; Overby, Anna K.] Umea Univ, Lab Mol Infect Med Sweden MIMS, S-90187 Umea, Sweden.
   [Saleeb, Michael; Elofsson, Mikael] Umea Univ, Dept Chem, S-90187 Umea, Sweden.
RP Evander, M (corresponding author), Umea Univ, Dept Clin Microbiol, Virol, S-90185 Umea, Sweden.; Evander, M (corresponding author), Umea Univ, UCMR, S-90187 Umea, Sweden.
EM kwon.yongdae@umu.se; marten.strand@umu.se; richard.lindqvist@umu.se;
   emma.nilsson@umu.se; michael.saleeb@umu.se; mikael.elofsson@umu.se;
   anna.overby@umu.se; magnus.evander@umu.se
OI Elofsson, Mikael/0000-0002-3219-4669; Overby Wernstedt,
   Anna/0000-0001-6553-0940
FU Swedish Research CouncilSwedish Research Council [2016-06251]; County
   Councils of Northern Sweden; Laboratory for Molecular Infection Medicine
   Sweden (MIMS)
FX The research was supported by the Swedish Research Council grant
   2016-06251 (Magnus Evander), grants from the County Councils of Northern
   Sweden (Magnus Evander, Anna K. Overby), and the Laboratory for
   Molecular Infection Medicine Sweden (MIMS) (Anna K. Overby).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Anderson KB, 2007, LANCET, V369, P1452, DOI 10.1016/S0140-6736(07)60671-0
   Andersson EK, 2010, ANTIMICROB AGENTS CH, V54, P3871, DOI 10.1128/AAC.00203-10
   Baer A, 2014, JOVE-J VIS EXP, DOI 10.3791/52065
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Baz M, 2017, ANTIVIR THER, V22, P613, DOI 10.3851/IMP3180
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bernatchez JA, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00725-18
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Cai L, 2017, ARCH VIROL, V162, P2847, DOI 10.1007/s00705-017-3436-8
   Calvez E, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0166-2
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Contreras D, 2016, JOVE-J VIS EXP, DOI 10.3791/54767
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   Czekanska EM, 2011, METHODS MOL BIOL, V740, P27, DOI 10.1007/978-1-61779-108-6_5
   Fernandez-Garcia MD, 2009, CELL HOST MICROBE, V5, P318, DOI 10.1016/j.chom.2009.04.001
   Garcia-Nicolas O, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01206-18
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Islam MK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20362-9
   Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847
   Julander JG, 2009, ANTIMICROB AGENTS CH, V53, P202, DOI 10.1128/AAC.01074-08
   Kaptein SJF, 2016, CURR OPIN PHARMACOL, V30, P1, DOI 10.1016/j.coph.2016.06.002
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Knipe D.M., 2013, FIELDS VIROLOGY, P2
   Ladner J, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005366
   Lindqvist R, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1119-3
   Lopez-Denman AJ, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9010014
   Mateo R, 2015, MBIO, V6, DOI 10.1128/mBio.01960-15
   Meyer B, 2015, EMERG INFECT DIS, V21, P181, DOI 10.3201/eid2101.141342
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   MUSSGAY M, 1975, PROG MED VIROL, V19, P257
   Mutso M, 2017, J GEN VIROL, V98, P2712, DOI 10.1099/jgv.0.000938
   NIEDRIG M, 1994, ACTA VIROL, V38, P141
   Oberg CT, 2012, J MED CHEM, V55, P3170, DOI 10.1021/jm201636v
   Overby AK, 2010, J VIROL, V84, P8470, DOI 10.1128/JVI.00176-10
   Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/JVI.02054-17, 10.1128/jvi.02054-17]
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Schreur PJW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005800
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shum D, 2008, J ENZYM INHIB MED CH, V23, P931, DOI [10.1080/14756360701810082, 10.1080/14756360701810082 ]
   Smit JM, 2011, VIRUSES-BASEL, V3, P160, DOI 10.3390/v3020160
   Strand M, 2012, ANTIMICROB AGENTS CH, V56, P5735, DOI 10.1128/AAC.01072-12
   Yakimovich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138760
   Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398
NR 46
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2020
VL 12
IS 3
AR 351
DI 10.3390/v12030351
PG 17
WC Virology
SC Virology
GA LC7BG
UT WOS:000525486800013
PM 32235763
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Kolpikova, EP
   Tronco, AR
   Den Hartigh, AB
   Jackson, KJ
   Iwawaki, T
   Fink, SL
AF Kolpikova, Elena P.
   Tronco, Ana R.
   Den Hartigh, Andreas B.
   Jackson, Konner J.
   Iwawaki, Takao
   Fink, Susan L.
TI IRE1 alpha Promotes Zika Virus Infection via XBP1
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; flavivirus; endoplasmic reticulum; ER stress; unfolded
   protein response; IRE1 alpha; XBP1
ID UNFOLDED PROTEIN RESPONSE; REGULATED IRE1-DEPENDENT DECAY; HEPATITIS-C
   VIRUS; MESSENGER-RNA; ER STRESS; PATHWAY; REPLICATION; INHIBITION; ATF6;
   IRE1
AB Zika virus (ZIKV) is an emergent member of the Flaviviridae family which causes severe congenital defects and other major sequelae, but the cellular processes that support ZIKV replication are incompletely understood. Related flaviviruses use the endoplasmic reticulum (ER) as a membranous platform for viral replication and induce ER stress during infection. Our data suggest that ZIKV activates IRE1 alpha, a component of the cellular response to ER stress. IRE1 alpha is an ER-resident transmembrane protein that possesses a cytosolic RNase domain. Upon activation, IRE1 alpha initiates nonconventional cytoplasmic splicing of XBP1 mRNA. Spliced XBP1 encodes a transcription factor, which upregulates ER-related targets. We find that ZIKV infection induces XBP1 mRNA splicing and induction of XBP1 target genes. Small molecule inhibitors of IRE1 alpha, including those specific for the nuclease function, prevent ZIKV-induced cytotoxicity, as does genetic disruption of IRE1 alpha. Optimal ZIKV RNA replication requires both IRE1 alpha and XBP1. Spliced XBP1 has been described to cause ER expansion and remodeling and we find that ER redistribution during ZIKV infection requires IRE1 alpha nuclease activity. Finally, we demonstrate that inducible genetic disruption of IRE1 alpha and XBP1 impairs ZIKV replication in a mouse model of infection. Together, our data indicate that the ER stress response component IRE1 alpha promotes ZIKV infection via XBP1 and may represent a potential therapeutic target.
C1 [Kolpikova, Elena P.; Tronco, Ana R.; Den Hartigh, Andreas B.; Jackson, Konner J.; Fink, Susan L.] Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
   [Iwawaki, Takao] Kanazawa Med Univ, Med Res Inst, Dept Life Sci, Div Cell Med, Uchinada, Ishikawa 9200265, Japan.
RP Fink, SL (corresponding author), Univ Washington, Dept Lab Med, Seattle, WA 98195 USA.
EM elenako@uw.edu; atronco@uw.edu; ahartigh@uw.edu;
   konner.jackson@icloud.com; takao.iwawaki@gmail.com; sfink@uw.edu
OI Fink, Susan/0000-0003-1705-0103
FU National Institute of Allergy and Infectious Diseases of the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [K08AI119142, R21AI131269]
FX This work was supported by the National Institute of Allergy and
   Infectious Diseases of the National Institutes of Health under award
   numbers K08AI119142 and R21AI131269 (to S.L.F.). The content is solely
   the responsibility of the authors and does not necessarily represent the
   o fficial views of the National Institutes of Health.
CR Ambrose RL, 2013, J VIROL, V87, P2206, DOI 10.1128/JVI.02097-12
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Carletti T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11663-2
   Coelho DS, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00076
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   Cross BCS, 2012, P NATL ACAD SCI USA, V109, pE869, DOI 10.1073/pnas.1115623109
   Diamond MS, 2009, J INTERF CYTOK RES, V29, P521, DOI 10.1089/jir.2009.0069
   Fink SL, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai7814
   Gao WH, 2017, P NATL ACAD SCI USA, V114, P1027, DOI 10.1073/pnas.1619726114
   Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002
   Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Han J, 2017, GENE DEV, V31, P1417, DOI 10.1101/gad.297374.117
   Hetz C, 2013, NAT REV DRUG DISCOV, V12, P703, DOI 10.1038/nrd3976
   Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   Karagoz GE, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033886
   Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207
   Laguesse S, 2015, DEV CELL, V35, P553, DOI 10.1016/j.devcel.2015.11.005
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003
   Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903
   Li SS, 2015, CRIT REV MICROBIOL, V41, P150, DOI 10.3109/1040841X.2013.813899
   Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633
   Miner JJ, 2016, CELL REP, V16, P3208, DOI 10.1016/j.celrep.2016.08.079
   Monel B, 2017, EMBO J, V36, P1653, DOI 10.15252/embj.201695597
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Offerdahl DK, 2017, VIROLOGY, V501, P54, DOI 10.1016/j.virol.2016.11.002
   Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Pena J, 2011, J BIOL CHEM, V286, P14226, DOI 10.1074/jbc.M111.222703
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042
   Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010
   Shaily S, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2050
   Sharma M, 2017, J GEN VIROL, V98, P1027, DOI 10.1099/jgv.0.000792
   Sir D, 2008, HEPATOLOGY, V48, P1054, DOI 10.1002/hep.22464
   Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136
   Sutarjono B, 2019, J INFECT DIS, V219, P734, DOI 10.1093/infdis/jiy572
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448
   Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200
   Tufanli O, 2017, P NATL ACAD SCI USA, V114, pE1395, DOI 10.1073/pnas.1621188114
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664
   van Schadewijk A, 2012, CELL STRESS CHAPERON, V17, P275, DOI 10.1007/s12192-011-0306-2
   Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0
   Yu C, 2013, VIRUS RES, V178, P471, DOI 10.1016/j.virusres.2013.10.012
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398
   Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625
   Zheng YF, 2005, IEEE IPCCC, P43
NR 64
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2020
VL 12
IS 3
AR 278
DI 10.3390/v12030278
PG 14
WC Virology
SC Virology
GA LC7BG
UT WOS:000525486800053
PM 32138181
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Schwarz, ER
   Oliveira, LJ
   Bonfante, F
   Pu, RY
   Pozor, MA
   Maclachlan, NJ
   Beachboard, S
   Barr, KL
   Long, MT
AF Schwarz, Erika R.
   Oliveira, Lilian J.
   Bonfante, Francesco
   Pu, Ruiyu
   Pozor, Malgorzata A.
   Maclachlan, N. James
   Beachboard, Sarah
   Barr, Kelli L.
   Long, Maureen T.
TI Experimental Infection of Mid-Gestation Pregnant Female and Intact Male
   Sheep with Zika Virus
SO VIRUSES-BASEL
LA English
DT Article
DE Zika virus; ovine; mid-gestation; pregnancy; testes; animal mode
ID SEXUAL TRANSMISSION; CONGENITAL-MALFORMATIONS; TESTOSTERONE EXCESS;
   BORDER DISEASE; LATE-GESTATION; BIRTH-DEFECTS; UNITED-STATES; FETAL;
   INFANTS; MODEL
AB Zika virus (ZIKV) is an arbovirus that causes birth defects, persistent male infection, and sexual transmission in humans. The purpose of this study was to continue the development of an ovine ZIKV infection model; thus, two experiments were undertaken. In the first experiment, we built on previous pregnant sheep experiments by developing a mid-gestation model of ZIKV infection. Four pregnant sheep were challenged with ZIKV at 57-64 days gestation; two animals served as controls. After 13-15 days (corresponding with 70-79 days of gestation), one control and two infected animals were euthanized; the remaining animals were euthanized at 20-22 days post-infection (corresponding with 77-86 days of gestation). In the second experiment, six sexually mature, intact, male sheep were challenged with ZIKV and two animals served as controls. Infected animals were serially euthanized on days 2-6 and day 9 post-infection with the goal of isolating ZIKV from the male reproductive tract. In the mid-gestation study, virus was detected in maternal placenta and spleen, and in fetal organs, including the brains, spleens/liver, and umbilicus of infected fetuses. Fetuses from infected animals had visibly misshapen heads and morphometrics revealed significantly smaller head sizes in infected fetuses when compared to controls. Placental pathology was evident in infected dams. In the male experiment, ZIKV was detected in the spleen, liver, testes/epididymides, and accessory sex glands of infected animals. Results from both experiments indicate that mid-gestation ewes can be infected with ZIKV with subsequent disruption of fetal development and that intact male sheep are susceptible to ZIKV infection and viral dissemination and replication occurs in highly vascular tissues (including those of the male reproductive tract).
C1 [Schwarz, Erika R.; Pu, Ruiyu; Beachboard, Sarah; Long, Maureen T.] Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32608 USA.
   [Oliveira, Lilian J.] Univ Florida, Coll Vet Med, Dept Infect Dis & Immunol, Gainesville, FL 32608 USA.
   [Bonfante, Francesco] Inst Zooprofilatt Sperimentale Venezie, Div Comparat Biomed Sci, Lab Expt Anim Models, I-35020 Legnaro, Italy.
   [Pozor, Malgorzata A.] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32611 USA.
   [Maclachlan, N. James] Univ Calif Davis, Sch Vet Med, Dept Pathol Microbiol & Immunol, Davis, CA 95616 USA.
   [Barr, Kelli L.] Baylor Univ, Coll Arts & Sci, Dept Biol, Waco, TX 76798 USA.
RP Long, MT (corresponding author), Univ Florida, Coll Vet Med, Dept Comparat Diagnost & Populat Med, Gainesville, FL 32608 USA.
EM eschwarz@ufl.edu; lijoli@ufl.edu; fbonfante@izsvenezie.it; pur@ufl.edu;
   pozorm@ufl.edu; njmaclachlan@ucdavis.edu; sebeach@ufl.edu;
   kelli_barr@baylor.edu; longm@ufl.edu
RI Barr, Kelli L./I-7508-2019; bonfante, francesco/H-7436-2016
OI Barr, Kelli L./0000-0001-7943-7181; Long, Maureen/0000-0001-5337-9024;
   bonfante, francesco/0000-0002-1276-2710; Schwarz,
   Erika/0000-0002-6641-6063
FU European Union's Horizon 2020 Research and Innovation Program [734857];
   University of Florida Graduate School Fellowship; Fern Audette Endowed
   Professorship
FX This research was supported by the European Union's Horizon 2020
   Research and Innovation Program under grant agreement #734857.
   Additionally, support was provided by a University of Florida Graduate
   School Fellowship and by the Fern Audette Endowed Professorship.
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   BARLOW RM, 1972, J COMP PATHOL, V82, P151, DOI 10.1016/0021-9975(72)90057-6
   Barry JS, 2008, THERIOGENOLOGY, V69, P55, DOI 10.1016/j.theriogenology.2007.09.021
   Blache D, 2002, REPRODUCTION, P219
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brooks RB, 2016, MMWR-MORBID MORTAL W, V65, P915, DOI 10.15585/mmwr.mm6534e2
   da Silva LRC, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020051
   Carroll T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006537
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Chan JFW, 2016, EBIOMEDICINE, V14, P112, DOI 10.1016/j.ebiom.2016.11.017
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   CHUNG SI, 1990, AM J VET RES, V51, P1645
   Clancy CS, 2018, AM J PATHOL, V188, P904, DOI 10.1016/j.ajpath.2017.12.019
   Coelho FC, 2016, INT J INFECT DIS, V51, P128, DOI 10.1016/j.ijid.2016.08.023
   Counotte MJ, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002611
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Dudley DM, 2018, NAT MED, V24, P1104, DOI 10.1038/s41591-018-0088-5
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Duggal NK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22840-6
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   ENRIGHT FM, 1980, AM J VET RES, V41, P224
   Ferasyi TR, 2016, ENDOCRINOLOGY, V157, P2080, DOI 10.1210/en.2015-1913
   Foley GL, 2001, TOXICOL PATHOL, V29, P49, DOI 10.1080/019262301301418856
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gardner DS, 2002, PLACENTA, V23, P459, DOI 10.1053/plac.2002.0830
   Govero J, 2016, NATURE, V540, P438, DOI 10.1038/nature20556
   Gurung S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007507
   Gurung S, 2018, J VIROL, V92, DOI 10.1128/JVI.00186-18
   Harris HA, 1937, J ANAT, V71, P516
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Kikuti M, 2018, EUROSURVEILLANCE, V23, P44, DOI 10.2807/1560-7917.ES.2018.23.45.1700757
   Koide F, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.02028
   Kumar A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23899-x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li XF, 2016, EBIOMEDICINE, V12, P170, DOI 10.1016/j.ebiom.2016.09.022
   Long MT, 2006, J VET INTERN MED, V20, P608, DOI 10.1892/0891-6640(2006)20[608:DPOTEI]2.0.CO;2
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Magnani DM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04056-4
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   McDonald EM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006691
   Meneses JD, 2017, CLIN INFECT DIS, V64, P1302, DOI 10.1093/cid/cix166
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mirza FG, 2018, J MATERN-FETAL NEO M, V31, P797, DOI 10.1080/14767058.2017.1295443
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mlera L, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010042
   Mohr EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190617
   NETTLETON PF, 1995, BRIT VET J, V151, P615, DOI 10.1016/S0007-1935(95)80145-6
   Nettleton PF, 1998, VET RES, V29, P327
   Newman C, 2017, CURR OPIN VIROL, V25, P34, DOI 10.1016/j.coviro.2017.06.011
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   PARSONSON IM, 1981, AM J TROP MED HYG, V30, P660, DOI 10.4269/ajtmh.1981.30.660
   PARSONSON IM, 1988, J COMP PATHOL, V99, P215, DOI 10.1016/0021-9975(88)90073-4
   PELLEGRINI V, 1993, VACCINE, V11, P383, DOI 10.1016/0264-410X(93)90204-B
   Petitt M, 2017, CURR OPIN VIROL, V27, P48, DOI 10.1016/j.coviro.2017.11.008
   Puggioni G, 2018, J VIROL, V92, DOI 10.1128/JVI.01131-18
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Recabarren MP, 2013, REPRODUCTION, V145, P567, DOI 10.1530/REP-13-0006
   Recabarren SE, 2008, ENDOCRINOLOGY, V149, P6444, DOI 10.1210/en.2008-0785
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Rio DC, 2010, COLD SPRING HARB PRO, V2010, P5439, DOI DOI 10.1101/PDB.PROT5439
   Russell K, 2017, CLIN INFECT DIS, V64, P211, DOI 10.1093/cid/ciw692
   Sarno M, 2017, ULTRASOUND OBST GYN, V50, P717, DOI 10.1002/uog.17303
   Scheerlinck JPY, 2008, TRENDS BIOTECHNOL, V26, P259, DOI 10.1016/j.tibtech.2008.02.002
   Schwarz ER, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090795
   Seino KK, 2007, CLIN VACCINE IMMUNOL, V14, P1465, DOI 10.1128/CVI.00249-07
   Steyn C, 2001, EUR J OBSTET GYN R B, V98, P165, DOI 10.1016/S0301-2115(01)00321-9
   Szaba FM, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006994
   Tabata T, 2018, J INFECT DIS, V217, P1202, DOI 10.1093/infdis/jix552
   Tsetsarkin KA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07782-x
   United States Centers for Disease Control and Prevention, 2018, EM SIT MED DEV EM US
   Uraki R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602899
   van den Brom R, 2012, TIJDSCHR DIERGENEESK, V137, P106
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   van der Sluijs M, 2011, VET MICROBIOL, V149, P113, DOI 10.1016/j.vetmic.2010.11.002
   VATNICK I, 1991, J DEV PHYSIOL, V15, P351
   Vonnahme KA, 2008, BIOL REPROD, V79, P976, DOI 10.1095/biolreprod.108.070748
   Vonnahme KA, 2006, J ANIM SCI, V84, P3451, DOI 10.2527/jas.2006-132
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Walker CL, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.04.047
   Yasri S, 2018, AM J OBSTET GYNECOL, V219, P514, DOI 10.1016/j.ajog.2018.07.009
   Yun SI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080422
NR 88
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2020
VL 12
IS 3
AR 291
DI 10.3390/v12030291
PG 23
WC Virology
SC Virology
GA LC7BG
UT WOS:000525486800087
PM 32156037
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sun, F
   Xia, ZQ
   Han, YW
   Gao, MJ
   Wang, LY
   Wu, YL
   Sabatier, JM
   Miao, LX
   Cao, ZJ
AF Sun, Fang
   Xia, Zhiqiang
   Han, Yuewen
   Gao, Minjun
   Wang, Luyao
   Wu, Yingliang
   Sabatier, Jean-Marc
   Miao, Lixia
   Cao, Zhijian
TI Topology, Antiviral Functional Residues and Mechanism of IFITM1
SO VIRUSES-BASEL
LA English
DT Article
DE IFITM1; topology; antiviral functional residues; mechanism
ID ZIKA VIRUS; PROTEINS; INHIBITION
AB Interferon-inducible transmembrane proteins (IFITM1/2/3) have been reported to suppress the entry of a wide range of viruses. However, their antiviral functional residues and specific mechanisms are still unclear. Here, we firstly resolved the topology of IFITM1 on the plasma membrane where N-terminus points into the cytoplasm and C-terminus resides extracellularly. Further, KRRK basic residues of IFITM1 locating at 62-67 of the conserved intracellular loop (CIL) were found to play a key role in the restriction on the Zika virus (ZIKV) and dengue virus (DENV). Similarly, KRRK basic residues of IFITM2/3 also contributed to suppressing ZIKV replication. Finally, IFITM1 was revealed to be capable of restricting the release of ZIKV particles from endosome to cytosol so as to impede the entry of ZIKV into host cells, which was tightly related with the inhibition of IFITM1 on the acidification of organelles. Overall, our study provided topology, antiviral functional residues and the mechanism of interferon-inducible transmembrane proteins.
C1 [Sun, Fang; Xia, Zhiqiang; Han, Yuewen; Gao, Minjun; Wang, Luyao; Wu, Yingliang; Cao, Zhijian] Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Peoples R China.
   [Sabatier, Jean-Marc] Fac Med Secteur Nord Marseille, UMR 7051, Inst NeuroPhysiopathol, 51,Blvd Pierre Dramard,CS80011, F-13344 Marseille 15, France.
   [Miao, Lixia] Wuhan Univ, Sch Basic Med Sci, Dept Biochem, Wuhan 430071, Peoples R China.
   [Cao, Zhijian] Wuhan Univ, Ctr Fluorinated Pharmaceut, Hubei Prov Engn & Technol Res, Wuhan 430072, Peoples R China.
RP Cao, ZJ (corresponding author), Wuhan Univ, Coll Life Sci, Modern Virol Res Ctr, State Key Lab Virol, Wuhan 430072, Peoples R China.; Cao, ZJ (corresponding author), Wuhan Univ, Ctr Fluorinated Pharmaceut, Hubei Prov Engn & Technol Res, Wuhan 430072, Peoples R China.
EM 2016202040055@whu.edu.cn; 2016202040013@whu.edu.cn;
   2017282040174@whu.edu.cn; MinjunGao@Whu.edu.cn;
   2018202040036@whu.edu.cn; ylwu@whu.edu.cn; sabatier.jm1@libertysurf.fr;
   miaolixia@whu.edu.cn; zjcao@whu.edu.cn
OI SABATIER, Jean-Marc/0000-0002-9040-5647
FU National Science Fund of ChinaNational Natural Science Foundation of
   China [31872239, 31672311, 81630091]; International S&T Cooperation
   Program of China [52016G3110]; Hubei Science Fund [2016CFA018];
   Fundamental Research Funds for the Central Universities in China
   [2042017kf0242, 2042017kf0275]
FX This work was supported by grants from National Science Fund of China
   (Nos. 31872239, 31672311 and 81630091), International S&T Cooperation
   Program of China (No. 52016G3110), Hubei Science Fund (No. 2016CFA018)
   and Fundamental Research Funds for the Central Universities in China
   (Nos. 2042017kf0242 and 2042017kf0275).
CR Alteber Z, 2018, IMMUNOL CELL BIOL, V96, P284, DOI 10.1111/imcb.12000
   Amini-Bavil-Olyaee S, 2013, CELL HOST MICROBE, V13, P452, DOI 10.1016/j.chom.2013.03.006
   Anafu AA, 2013, J BIOL CHEM, V288, P17261, DOI 10.1074/jbc.M112.438515
   Bailey CC, 2014, ANNU REV VIROL, V1, P261, DOI 10.1146/annurev-virology-031413-085537
   Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017
   Calderon-Pelaez MA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01435
   Chesarino NM, 2017, EMBO REP, V18, P1740, DOI 10.15252/embr.201744100
   Desai TM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004048
   Everitt AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080723
   Feeley EM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002337
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Guy B, 2016, NAT REV MICROBIOL, V14, P45, DOI 10.1038/nrmicro.2015.2
   Hach JC, 2013, J VIROL, V87, P9923, DOI 10.1128/JVI.00621-13
   Hensen L, 2020, J VIROL, V94, DOI 10.1128/JVI.01223-19
   Himmelsbach Kiyoshi, 2018, World J Virol, V7, P10, DOI 10.5501/wjv.v7.i1.10
   John SP, 2013, J VIROL, V87, P7837, DOI 10.1128/JVI.00481-13
   Keryanov S, 2002, GENE, V292, P151, DOI 10.1016/S0378-1119(02)00647-9
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li FF, 2019, J BIOL CHEM, V294, P182, DOI 10.1074/jbc.RA118.005015
   Li K, 2015, J BIOL CHEM, V290, P4248, DOI 10.1074/jbc.M114.630780
   Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124
   Ling SL, 2016, SCI REP-UK, V6, DOI 10.1038/srep24029
   Narayana SK, 2015, J BIOL CHEM, V290, P25946, DOI 10.1074/jbc.M115.657346
   Perreira JM, 2013, J MOL BIOL, V425, P4937, DOI 10.1016/j.jmb.2013.09.024
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Scott CC, 2011, BIOESSAYS, V33, P103, DOI 10.1002/bies.201000108
   Siegrist F, 2011, J INTERF CYTOK RES, V31, P183, DOI 10.1089/jir.2010.0112
   Smith SE, 2014, CURR OPIN VIROL, V4, P71, DOI 10.1016/j.coviro.2013.11.004
   Szatmari Z, 2014, AUTOPHAGY, V10, P1154, DOI 10.4161/auto.29395
   Takeda M, 2019, CANCER RES, V79, P1426, DOI 10.1158/0008-5472.CAN-18-2192
   Wang LL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02725
   Warren CJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096579
   Weston S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104341
   Wrensch F, 2015, J INFECT DIS, V212, pS210, DOI 10.1093/infdis/jiv255
   Yanez DC, 2020, IMMUNOLOGY, V159, P365, DOI 10.1111/imm.13163
NR 36
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2020
VL 12
IS 3
AR 295
DI 10.3390/v12030295
PG 14
WC Virology
SC Virology
GA LC7BG
UT WOS:000525486800090
PM 32182730
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wei, KC
   Wei, WJ
   Liu, YS
   Yen, LC
   Chang, TH
AF Wei, Kai-Che
   Wei, Wan-Ju
   Liu, Yi-Shan
   Yen, Li-Chen
   Chang, Tsung-Hsien
TI Assessment of Prolonged Dengue Virus Infection in Dermal Fibroblasts and
   Hair-Follicle Dermal Papilla Cells
SO VIRUSES-BASEL
LA English
DT Article
DE dengue virus; hair loss; hair-follicle dermal papilla cells; dermal
   fibroblasts; inflammation
ID SIGNALING NETWORKS; GENE-EXPRESSION; ZIKA VIRUS; C-MYC; BETA;
   PROGRANULIN; MECHANISMS; RECEPTORS; RESPONSES; BIOLOGY
AB Dengue virus (DENV)-mediated hair loss is one of the post-dengue fatigue syndromes and its pathophysiology remains unknown. Whether long-term or persistent infection with DENV in the scalp results in hair loss is unclear. In this study, we cultured human dermal fibroblasts (WS1 cells) and primary human hair-follicle dermal papilla cells (HFDPCs) in the long term with DENV-2 infection. The production of virion, the expression of inflammatory and anti-virus genes, and their signaling transduction activity in the infected cells were analyzed. DENV-2 NS3 protein and DENV-2 5 ' UTR RNA were detected in fibroblasts and HFDPCs that were subjected to long-term infection with DENV-2 for 33 days. A significant amount of DENV-2 virion was produced by both WS1 cells and HFDPCs in the first two days of acute infection. The virion was also detected in WS1 cells that were infected in the long term, but HFDPCs failed to produce DENV-2 after long-term culture. Type I and type III interferons, and inflammatory cytokines were highly expressed in the acute phase of DENV infection in HFPDC and WS1 cells. However, in the long-term cultured cells, modest levels of anti-viral protein genes were expressed and we observed reduced signaling activity, which was correlated with the level of virus production changes. Long-term infection of DENV-2 downregulated the expression of hair growth regulatory factors, such as Rip1, Wnt1, and Wnt4. This in vitro study shows that the long-term infection with DENV-2 in dermal fibroblasts and dermal papilla cells may be involved with the prolonged-DENV-infection-mediated hair loss of post-dengue fatigue syndrome. However, direct evidence for viral replication in the human hair of a dengue victim or animal infection model is required.
C1 [Wei, Kai-Che; Wei, Wan-Ju] Kaohsiung Vet Gen Hosp, Dept Dermatol, Kaohsiung 81362, Taiwan.
   [Wei, Kai-Che] Yuh Ing Jr Coll Hlth Care & Management, Kaohsiung 80776, Taiwan.
   [Wei, Kai-Che] Natl Yang Ming Univ, Taipei 11211, Taiwan.
   [Liu, Yi-Shan] I Shou Univ, E Da Hosp, Dept Dermatol, Kaohsiung 84001, Taiwan.
   [Liu, Yi-Shan] Natl Kaohsiung Normal Univ, Grad Inst Sci Educ & Environm Educ, Kaohsiung 82446, Taiwan.
   [Yen, Li-Chen; Chang, Tsung-Hsien] Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei 11490, Taiwan.
RP Chang, TH (corresponding author), Natl Def Med Ctr, Dept & Grad Inst Microbiol & Immunol, Taipei 11490, Taiwan.
EM kcwei@vghks.gov.tw; wjwei@vghks.gov.tw; ed104456@edah.org.tw;
   yenlichen@mail.ndmctsgh.edu.tw; changth@mail.ndmctsgh.edu.tw
FU Ministry of Science and Technology of TaiwanMinistry of Science and
   Technology, Taiwan [MOST 106-2314-B-075B-007-MY2, MOST
   108-2314-B-075B-005]
FX This work was supported in part by grants from the Ministry of Science
   and Technology of Taiwan (MOST 106-2314-B-075B-007-MY2, MOST
   108-2314-B-075B-005).
CR Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793
   Arnold SJ, 2004, VIROLOGY, V324, P286, DOI 10.1016/j.virol.2004.03.036
   Biggs LC, 2018, ELIFE, V7, DOI 10.7554/eLife.36468
   Bull JJ, 2005, BRIT J DERMATOL, V152, P1125, DOI 10.1111/j.1365-2133.2005.06458.x
   Bustos-Arriaga J, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001420
   Tiga DC, 2016, AM J TROP MED HYG, V94, P1085, DOI 10.4269/ajtmh.15-0896
   Ramirez JAC, 2015, J INTERF CYTOK RES, V35, P421, DOI 10.1089/jir.2014.0129
   Chang C, 2016, J AUTOIMMUN, V68, P1, DOI 10.1016/j.jaut.2016.02.006
   Chang TH, 2006, MICROBES INFECT, V8, P157, DOI 10.1016/j.micinf.2005.06.014
   Chien YW, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3058-0
   Chu CB, 2017, DERMATOL SIN, V35, P124, DOI 10.1016/j.dsi.2017.03.005
   Dalrymple NA, 2015, MBIO, V6, DOI 10.1128/mBio.00553-15
   Dong L, 2017, J TISSUE ENG REGEN M, V11, P1479, DOI 10.1002/term.2046
   Dong L, 2014, SCI REP-UK, V4, DOI 10.1038/srep05432
   Douam F, 2017, MBIO, V8, DOI [10.1128/mBio.00819-17, 10.1128/mbio.00819-17]
   Driskell RR, 2011, J CELL SCI, V124, P1179, DOI 10.1242/jcs.082446
   Flores A, 2017, NAT CELL BIOL, V19, P1017, DOI 10.1038/ncb3575
   Garcia G, 2011, INT J INFECT DIS, V15, pE38, DOI 10.1016/j.ijid.2010.09.008
   Garcia M, 2017, EUR CYTOKINE NETW, V28, P41, DOI 10.1684/ecn.2017.0394
   Halstead S, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz062
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   HARN M-R, 1989, Kaohsiung Journal of Medical Sciences, V5, P58
   Hawkshaw NJ, 2019, BRIT J DERMATOL, DOI 10.1111/bjd.18356
   He ZJ, 2016, J VIROL, V90, P7219, DOI 10.1128/JVI.00221-16
   Hirsch AJ, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006219
   Hitani Akihiro, 2015, Kansenshogaku Zasshi, V89, P279
   Hung TM, 2019, TRENDS PARASITOL, V35, P673, DOI 10.1016/j.pt.2019.06.004
   Iannetta M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.34.30600
   Jensen S, 2012, J VIROL, V86, P2900, DOI 10.1128/JVI.05738-11
   Jensenius Mogens, 1997, Tidsskrift for den Norske Laegeforening, V117, P4230
   Kato M, 2009, J DERMATOL SCI, V53, P234, DOI 10.1016/j.jdermsci.2008.10.002
   Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Kumtornrut C, 2019, J DERMATOL SCI, V93, P150, DOI 10.1016/j.jdermsci.2019.01.007
   KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705
   KURANE I, 1992, ARCH VIROL, V124, P21, DOI 10.1007/BF01314622
   Lalle E, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.18.18-00197
   Lambotin M, 2010, NAT REV MICROBIOL, V8, P350, DOI 10.1038/nrmicro2332
   Lazear HM, 2015, IMMUNITY, V43, P15, DOI 10.1016/j.immuni.2015.07.001
   Magerl M, 2001, J INVEST DERMATOL, V116, P947, DOI 10.1046/j.0022-202x.2001.01368.x
   Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09
   Mason AR, 2017, J BIOL CHEM, V292, P3262, DOI 10.1074/jbc.M116.752006
   Mesev EV, 2019, NAT MICROBIOL, V4, P914, DOI 10.1038/s41564-019-0421-x
   Millar SE, 2002, J INVEST DERMATOL, V118, P216, DOI 10.1046/j.0022-202x.2001.01670.x
   Muhammad SA, 2019, J BIOL RES-THESSALON, V26, DOI 10.1186/s40709-019-0094-x
   Ng KH, 2019, CELL HOST MICROBE, V26, P601, DOI 10.1016/j.chom.2019.10.005
   Noisakran S, 2012, EXP HEMATOL, V40, P250, DOI 10.1016/j.exphem.2011.11.011
   Oshimori N, 2012, CELL STEM CELL, V10, P63, DOI 10.1016/j.stem.2011.11.005
   Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Plikus MV, 2012, J INVEST DERMATOL, V132, P1321, DOI 10.1038/jid.2012.38
   QIU FX, 1993, B WORLD HEALTH ORGAN, V71, P349
   Ramos HJ, 2011, CURR OPIN VIROL, V1, P167, DOI 10.1016/j.coviro.2011.04.004
   Ramos R, 2013, J INVEST DERMATOL, V133, P2306, DOI 10.1038/jid.2013.262
   Randall RE, 2017, CURR OPIN VIROL, V23, P35, DOI 10.1016/j.coviro.2017.03.001
   Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X
   Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613
   Rezza A, 2016, CELL REP, V14, P3001, DOI 10.1016/j.celrep.2016.02.078
   Seet RCS, 2007, J CLIN VIROL, V38, P1, DOI 10.1016/j.jcv.2006.10.011
   Shin H, 2016, ANN DERMATOL, V28, P600, DOI 10.5021/ad.2016.28.5.600
   Teixeira LD, 2017, REV INST MED TROP SP, V59, DOI [10.1590/S1678-9946201759065, 10.1590/s1678-9946201759065]
   Takasaki T, 2001, INTERVIROLOGY, V44, P48, DOI 10.1159/000050030
   Tripurani SK, 2018, MOL BIOL CELL, V29, P2784, DOI 10.1091/mbc.E18-08-0488
   Tristao-Sa R, 2012, REV SOC BRAS MED TRO, V45, P675, DOI 10.1590/S0037-86822012000600004
   Urcuqui-Inchima S, 2017, ANTIVIR RES, V147, P47, DOI 10.1016/j.antiviral.2017.09.017
   Wack A, 2015, NAT IMMUNOL, V16, P802, DOI 10.1038/ni.3212
   Wang N, 2012, ACTA HISTOCHEM, V114, P199, DOI 10.1016/j.acthis.2011.04.009
   Wei KC, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00268
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Zahn S, 2011, J INVEST DERMATOL, V131, P133, DOI 10.1038/jid.2010.244
   Zhang B, 2013, AUSTRALAS J DERMATOL, V54, P184, DOI 10.1111/ajd.12065
NR 73
TC 0
Z9 0
U1 0
U2 0
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1999-4915
J9 VIRUSES-BASEL
JI Viruses-Basel
PD MAR
PY 2020
VL 12
IS 3
AR 267
DI 10.3390/v12030267
PG 19
WC Virology
SC Virology
GA LC7BG
UT WOS:000525486800035
PM 32121148
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tizzoni, M
   Panisson, A
   Paolotti, D
   Cattuto, C
AF Tizzoni, Michele
   Panisson, Andre
   Paolotti, Daniela
   Cattuto, Ciro
TI The impact of news exposure on collective attention in the United States
   during the 2016 Zika epidemic
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID INFECTIOUS-DISEASES; COVERAGE; BEHAVIOR; SPREAD; VIRUS; MEDIA; RISK
AB In recent years, many studies have drawn attention to the important role of collective awareness and human behaviour during epidemic outbreaks. A number of modelling efforts have investigated the interaction between the disease transmission dynamics and human behaviour change mediated by news coverage and by information spreading in the population. Yet, given the scarcity of data on public awareness during an epidemic, few studies have relied on empirical data. Here, we use fine-grained, geo-referenced data from three online sources-Wikipedia, the GDELT Project and the Internet Archive-to quantify population-scale information seeking about the 2016 Zika virus epidemic in the U.S., explicitly linking such behavioural signal to epidemiological data. Geo-localized Wikipedia pageview data reveal that visiting patterns of Zika-related pages in Wikipedia were highly synchronized across the United States and largely explained by exposure to national television broadcast. Contrary to the assumption of some theoretical epidemic models, news volume and Wikipedia visiting patterns were not significantly correlated with the magnitude or the extent of the epidemic. Attention to Zika, in terms of Zika-related Wikipedia pageviews, was high at the beginning of the outbreak, when public health agencies raised an international alert and triggered media coverage, but subsequently exhibited an activity profile that suggests nonlinear dependencies and memory effects in the relation between information seeking, media pressure, and disease dynamics. This calls for a new and more general modelling framework to describe the interaction between media exposure, public awareness and disease dynamics during epidemic outbreaks.
   Author summary
   Despite its importance for public health policy-makers, understanding the impact of media coverage on collective attention during disease outbreaks remains an elusive research task, due to the lack of available data, especially at high spatial granularity. In this paper, we study the dynamics of collective attention received by the 2016 Zika epidemic in the USA and its interplay with the media coverage of the outbreak, at level of US states and cities. We measure the attention to Zika through geo-localized Wikipedia page view data, and we compare it with mentions of Zika in US news outlets and TV shows. We also compare the collective attention received by the outbreak with the incidence of Zika reported by the US Centers for Disease Control and Prevention in each state. We find that the attention dynamics was highly synchronized across states, irrespective of the local risk of transmission of the virus. By building a linear regression model, we show that the dynamics of collective attention is highly predictable, even at state level, only based on the national media coverage received by the outbreak.
C1 [Tizzoni, Michele; Panisson, Andre; Paolotti, Daniela; Cattuto, Ciro] ISI Fdn, Turin, Italy.
RP Tizzoni, M (corresponding author), ISI Fdn, Turin, Italy.
EM michele.tizzoni@isi.it
OI Panisson, Andre/0000-0002-3336-0374
FU Lagrange Project of the ISI Foundation - CRT Foundation
FX MT, AP, DP and CC acknowledge the support by the Lagrange Project of the
   ISI Foundation funded by the CRT Foundation. The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Alicino C, 2015, INFECT DIS POVERTY, V4, DOI 10.1186/s40249-015-0090-9
   Althouse BM, 2015, EPJ DATA SCI, V4, DOI 10.1140/epjds/s13688-015-0054-0
   Balashankar A, 2019, COMPASS '19 - PROCEEDINGS OF THE CONFERENCE ON COMPUTING & SUSTAINABLE SOCIETIES, P272, DOI 10.1145/3314344.3332498
   Bauch CT, 2013, SCIENCE, V342, P47, DOI 10.1126/science.1244492
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Collinson S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141423
   Collinson S, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-376
   Conway BA, 2015, J COMPUT-MEDIAT COMM, V20, P363, DOI 10.1111/jcc4.12124
   Ferguson N, 2007, NATURE, V446, P733, DOI 10.1038/446733a
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Ferron M, 2014, MEM STUD, V7, P22, DOI 10.1177/1750698013490590
   Fox S, 2013, PSYCHOL BEHAV ASPECT, P135
   Funk S, 2015, EPIDEMICS-NETH, V10, P21, DOI 10.1016/j.epidem.2014.09.005
   Funk S, 2010, J R SOC INTERFACE, V7, P1247, DOI 10.1098/rsif.2010.0142
   Funk S, 2009, P NATL ACAD SCI USA, V106, P6872, DOI 10.1073/pnas.0810762106
   Garcia-Gavilanes R, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602368
   Garcia-Gavilanes R, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160460
   Geiss S, 2016, NEW MEDIA SOC, V18, P2740, DOI 10.1177/1461444815600281
   Generous N, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003892
   Georgescu M, 2013, ELEARN SOFTW EDUC, P225
   Harvard TH, 2016, MANY US FAMILIES CON
   Jacobs W, 2017, COGENT SOC SCI, V3, DOI 10.1080/23311886.2017.1302785
   Keegan Brian, 2011, P 7 INT S WIK OP COL, P105, DOI [DOI 10.1145/2038558.2038577, 10.1145/2038558.2038577]
   King G, 2017, SCIENCE, V358, P776, DOI 10.1126/science.aao1100
   Leitao JC, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.150649
   Lessler J, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8160
   Lutkepohl H., 2005, NEW INTRO MULTIPLE T
   Malone RW, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004530
   McIver DJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003581
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Ophir Y, 2018, HEALTH SECUR, V16, P147, DOI 10.1089/hs.2017.0106
   Ophir Y, 2020, HEALTH COMMUN, V35, P35, DOI 10.1080/10410236.2018.1536958
   Osborne M, 2012, P WORKSH TIM AW INF
   Perra N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023084
   Pfaff B, 2008, J STAT SOFTW, V27, P1
   Poletti P, 2009, J THEOR BIOL, V260, P31, DOI 10.1016/j.jtbi.2009.04.029
   Poletto C, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1787-5
   Priedhorsky R, 2017, CSCW'17: PROCEEDINGS OF THE 2017 ACM CONFERENCE ON COMPUTER SUPPORTED COOPERATIVE WORK AND SOCIAL COMPUTING, P1812, DOI 10.1145/2998181.2998183
   Ratkiewicz J, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.158701
   Raude J, 2019, SOC SCI MED, V230, P184, DOI 10.1016/j.socscimed.2019.04.009
   Salathe M, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002616
   Sandman PM, 1993, RESPONDING COMMUNITY
   Shacham E, 2017, AM J PUBLIC HEALTH, V107, P724, DOI 10.2105/AJPH.2017.303670
   Shih TJ, 2008, MASS COMMUN SOC, V11, P141, DOI 10.1080/15205430701668121
   Smith KC, 2013, INFLUENZA OTHER RESP, V7, P847, DOI 10.1111/irv.12073
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Springborn M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0691-0
   Tausczik Y, 2012, HEALTH COMMUN, V27, P179, DOI 10.1080/10410236.2011.571759
   The Lancet HIV, 2016, LANCET HIV, V3, pe191
   Towers S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129179
   *US BUR CENS, ANN EST RES POP US R
   Vigna S, 2015, PROCEEDINGS OF THE 24TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW 2015), P1166, DOI 10.1145/2736277.2741088
   WHO, 2017, IEEE T POWER SYSTEMS, V1~14, DOI DOI 10.13155/46607
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   World Health Organization Regional Office for Europe, 2017, ZIK VIR EM MOSQ BORN
   Young ME, 2013, HEALTH RISK SOC, V15, P103, DOI 10.1080/13698575.2012.748884
   Young ME, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003552
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 59
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD MAR
PY 2020
VL 16
IS 3
AR e1007633
DI 10.1371/journal.pcbi.1007633; 10.1371/journal.pcbi.1007633.r001;
   10.1371/journal.pcbi.1007633.r002; 10.1371/journal.pcbi.1007633.r003;
   10.1371/journal.pcbi.1007633.r004
PG 18
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA KZ8AD
UT WOS:000523480200046
PM 32163409
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Joob, B
   Wiwanitkit, V
AF Joob, Beuy
   Wiwanitkit, Viroj
TI Cutaneous Manifestations of Zika
SO JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
LA English
DT Letter
C1 [Joob, Beuy] Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] Dr DY Patil Univ, Pune, Maharashtra, India.
RP Joob, B (corresponding author), Sanitat 1 Med Acad Ctr, Bangkok, Thailand.
EM beuyjoob@hotmail.com
CR Koh XQ, 2019, CURR INFECT DIS REP, V21, DOI 10.1007/s11908-019-0671-z
   Ramos W, 2020, J CUTAN MED SURG, V24, P33, DOI 10.1177/1203475419878160
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 3
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1203-4754
EI 1615-7109
J9 J CUTAN MED SURG
JI J. Cutan. Med. Surg.
PD MAR
PY 2020
VL 24
IS 2
BP 220
EP 220
DI 10.1177/1203475419893937
PG 1
WC Dermatology
SC Dermatology
GA LA4MC
UT WOS:000523921100028
PM 32208027
DA 2020-07-08
ER

PT J
AU Ramos, W
   Luna, M
   D?az, J
   Calder?n, M
   Alarc?n, T
   Jim?nez, G
   Gutierrez, EL
AF Ramos, Willy
   Luna, Miguel
   Diaz, Jesus
   Calderon, Maria
   Alarcon, Tania
   Jimenez, Gerardo
   Gutierrez, Ericson L.
TI Response to Letter to the Editor Regarding: "Cutaneous Manifestations of
   Zika"
SO JOURNAL OF CUTANEOUS MEDICINE AND SURGERY
LA English
DT Letter
DE Zika; rash
C1 [Ramos, Willy] Minist Hlth, Natl Ctr Epidemiol Control & Prevent Dis, Lima, Peru.
   [Ramos, Willy] Natl Univ San Marcos, Inst Clin Res, Lima, Peru.
   [Luna, Miguel; Alarcon, Tania] Reg Hlth Dept Ica, Epidemiol Off, Ica, Peru.
   [Diaz, Jesus; Jimenez, Gerardo] Santo Toribio Mogrovejo Univ, Chiclayo, Peru.
   [Calderon, Maria] HAMPI Consultoria Salud, Lima, Peru.
   [Calderon, Maria; Gutierrez, Ericson L.] Peruvian Natl Inst Hlth, Lima, Peru.
   [Gutierrez, Ericson L.] Univ San Martin Porres, Fac Human Med, Lima, Peru.
RP Gutierrez, EL (corresponding author), Peruvian Natl Inst Hlth, Lima, Peru.; Gutierrez, EL (corresponding author), Univ San Martin Porres, Fac Human Med, Lima, Peru.
EM eringunza@yahoo.es
RI Ramos, Willy/AAA-3747-2020
OI Ramos, Willy/0000-0003-1599-7811; Gutierrez, Ericson/0000-0003-4725-6284
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Khongwichit S, 2018, MICROBES INFECT, V20, P670, DOI 10.1016/j.micinf.2018.01.007
   Pan American Health Organization, 2016, CAS DEF
   Ramos W, 2020, J CUTAN MED SURG, V24, P33, DOI 10.1177/1203475419878160
   Weilg Claudia, 2018, BMC Res Notes, V11, P311, DOI 10.1186/s13104-018-3400-z
NR 5
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1203-4754
EI 1615-7109
J9 J CUTAN MED SURG
JI J. Cutan. Med. Surg.
PD MAR
PY 2020
VL 24
IS 2
BP 221
EP 222
DI 10.1177/1203475420902053
PG 2
WC Dermatology
SC Dermatology
GA LA4MC
UT WOS:000523921100029
PM 32208021
DA 2020-07-08
ER

PT J
AU Oyarzun-Arrau, A
   Alonso-Palomares, L
   Valiente-Echeverria, F
   Osorio, F
   Soto-Rifo, R
AF Oyarzun-Arrau, Aaron
   Alonso-Palomares, Luis
   Valiente-Echeverria, Fernando
   Osorio, Fabiola
   Soto-Rifo, Ricardo
TI Crosstalk between RNA Metabolism and Cellular Stress Responses during
   Zika Virus Replication
SO PATHOGENS
LA English
DT Review
DE ZIKV; flaviviruses; RNA metabolism; m(6)A; UPR; cellular stress
ID UNFOLDED PROTEIN RESPONSE; WEST-NILE-VIRUS; GRANULE FORMATION;
   STEM-CELLS; ER STRESS; INFECTION; PATHWAY; ACTIVATION; NS1; METHYLATION
AB Zika virus (ZIKV) is a mosquito-borne virus associated with neurological disorders such as Guillain-Barre syndrome and microcephaly. In humans, ZIKV is able to replicate in cell types from different tissues including placental cells, neurons, and microglia. This intricate virus-cell interaction is accompanied by virally induced changes in the infected cell aimed to promote viral replication as well as cellular responses aimed to counteract or tolerate the virus. Early in the infection, the 11-kb positive-sense RNA genome recruit ribosomes in the cytoplasm and the complex is translocated to the endoplasmic reticulum (ER) for viral protein synthesis. In this process, ZIKV replication is known to induce cellular stress, which triggers both the expression of innate immune genes and the phosphorylation of eukaryotic translation initiation factor 2 (eIF2 alpha), shutting-off host protein synthesis. Remodeling of the ER during ZIKV replication also triggers the unfolded protein response (UPR), which induces changes in the cellular transcriptional landscapes aimed to tolerate infection or trigger apoptosis. Alternatively, ZIKV replication induces changes in the adenosine methylation patterns of specific host mRNAs, which have different consequences in viral replication and cellular fate. In addition, the ZIKV RNA genome undergoes adenosine methylation by the host machinery, which results in the inhibition of viral replication. However, despite these relevant findings, the full scope of these processes to the outcome of infection remains poorly elucidated. This review summarizes relevant aspects of the complex crosstalk between RNA metabolism and cellular stress responses against ZIKV and discusses their possible impact on viral pathogenesis.
C1 [Oyarzun-Arrau, Aaron; Alonso-Palomares, Luis; Valiente-Echeverria, Fernando; Soto-Rifo, Ricardo] Univ Chile, Fac Med, Inst Biomed Sci, Mol & Cellular Virol Lab,Virol Program, Santiago 8380453, Chile.
   [Alonso-Palomares, Luis; Valiente-Echeverria, Fernando; Soto-Rifo, Ricardo] Univ Chile, HIV AIDS Workgrp, Fac Med, Santiago 8380453, Chile.
   [Osorio, Fabiola] Univ Chile, Fac Med, Inst Biomed Sci, Lab Immunol & Cellular Stress,Immunol Program, Santiago 8380453, Chile.
RP Soto-Rifo, R (corresponding author), Univ Chile, Fac Med, Inst Biomed Sci, Mol & Cellular Virol Lab,Virol Program, Santiago 8380453, Chile.; Soto-Rifo, R (corresponding author), Univ Chile, HIV AIDS Workgrp, Fac Med, Santiago 8380453, Chile.
EM aaron.oyarzuna@usach.cl; luis_alp88@hotmail.com; fvaliente@uchile.cl;
   fabiolaosorio@med.uchile.cl; rsotorifo@uchile.cl
RI Valiente-Echeverria, Fernando/I-6881-2018
OI Valiente-Echeverria, Fernando/0000-0001-9156-2516
FU CONICYTComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT) [2019-21190771]; Mexico City [SECTEI/138/2019]; FONDECYT
   ProgramComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT)CONICYT FONDECYT [1190156, 1180798]; Howard Hughes Medical
   InstituteHoward Hughes Medical Institute [55008744];
   ECOS-CONICYTComision Nacional de Investigacion Cientifica y Tecnologica
   (CONICYT) [ECOS180052]; FONDECYTComision Nacional de Investigacion
   Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT [1161212]
FX AO holds a CONICYT Doctoral fellowship No 2019-21190771. LAP is funded
   by a Postdoctoral fellowship No SECTEI/138/2019 from Mexico City. RSR
   and FVE are supported by the FONDECYT Program through grants No 1190156
   and No 1180798, respectively. FO is supported by an International
   Research Scholar grant from the Howard Hughes Medical Institute (No
   55008744), by an ECOS-CONICYT grant (ECOS180052) and by a FONDECYT grant
   No 1161212.
CR Alcendor DJ, 2017, J INFECT DIS, V216, P162, DOI 10.1093/infdis/jix171
   Alfano C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00094
   Alonso-Palomares LA, 2019, INTERVIROLOGY, V61, P255, DOI 10.1159/000499128
   Ambrose RL, 2011, J VIROL, V85, P2723, DOI 10.1128/JVI.02050-10
   Amorim R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005775
   Avirutnan P, 2006, J INFECT DIS, V193, P1078, DOI 10.1086/500949
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Beaver JT, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01640
   Bertolotti A, 2000, NAT CELL BIOL, V2, P326
   Bhattacharyya S, 2014, J GEN VIROL, V95, P71, DOI 10.1099/vir.0.057265-0
   Bidet K, 2018, ADV EXP MED BIOL, V1062, P45, DOI 10.1007/978-981-10-8727-1_4
   Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030
   Bonenfant G, 2019, J VIROL, V93, DOI [10.1128/JVI.00520-19, 10.1128/jvi.00520-19]
   Bowen JR, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006164
   Bright MD, 2015, MOL CELL BIOL, V35, P2186, DOI 10.1128/MCB.00013-15
   Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carletti T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11663-2
   Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282
   Chan SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00233
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   Chua JJE, 2005, VIRUS RES, V112, P85, DOI 10.1016/j.virusres.2005.03.025
   Ci YL, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201903062
   Cumberworth SL, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0450-8
   Dang JW, 2019, CELL REP, V27, P3618, DOI 10.1016/j.celrep.2019.05.059
   de Borba L, 2019, MBIO, V10, DOI 10.1128/mBio.02506-18
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Diop F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206093
   Dong HP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002642
   Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006
   Egan Philip A, 2013, Open Virol J, V7, P37, DOI 10.2174/1874357901307010037
   Emara MM, 2007, P NATL ACAD SCI USA, V104, P9041, DOI 10.1073/pnas.0703348104
   Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Foo SS, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.124152
   Funaoka Y, 2011, J VIROL, V85, P5986, DOI 10.1128/JVI.02583-10
   Gaete-Argel A, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00336
   Gim E, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e40
   Gladwyn-Ng I, 2018, NAT NEUROSCI, V21, P63, DOI 10.1038/s41593-017-0038-4
   Goertz GP, 2018, VIRUS RES, V254, P41, DOI 10.1016/j.virusres.2017.08.015
   Gokhale NS, 2020, MOL CELL, V77, P542, DOI 10.1016/j.molcel.2019.11.007
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gorman MJ, 2018, CELL HOST MICROBE, V23, P672, DOI 10.1016/j.chom.2018.04.003
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Grifoni A, 2017, J VIROL, V91, DOI [10.1128/JVI.01469-17, 10.1128/jvi.01469-17]
   Halbleib K, 2017, MOL CELL, V67, P673, DOI 10.1016/j.molcel.2017.06.012
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017
   Hastings AK, 2019, ISCIENCE, V13, P339, DOI 10.1016/j.isci.2019.03.003
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Hertzog J, 2018, EUR J IMMUNOL, V48, P1120, DOI 10.1002/eji.201847483
   Hill S.C., 2019, 520437 BIORXIV, DOI [10.1101/520437, DOI 10.1101/520437]
   Hillary RF, 2018, J BIOMED SCI, V25, DOI 10.1186/s12929-018-0453-1
   Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631
   Hou SM, 2017, J VIROL, V91, DOI 10.1128/JVI.00474-17
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048
   ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P268, DOI 10.1098/rspb.1957.0049
   Isaacs A., 2015, J IMMUNOL, V195, P268
   Isaacs A., 2015, J IMMUNOL, V195, P258
   Jiang DD, 2015, SEMIN CANCER BIOL, V33, P48, DOI 10.1016/j.semcancer.2015.04.010
   Junjhon J, 2014, J VIROL, V88, P4687, DOI 10.1128/JVI.00118-14
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12
   Kiermayr S, 2004, J VIROL, V78, P8078, DOI 10.1128/JVI.78.15.8078-8084.2004
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Lee YR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18909-3
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu T, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01925
   Liu WJ, 2005, J VIROL, V79, P1934, DOI 10.1128/JVI.79.3.1934-1942.2005
   Liu YH, 2019, AM J PHYSIOL-CELL PH, V317, pC762, DOI 10.1152/ajpcell.00212.2019
   Magoro T, 2019, J BIOL CHEM, V294, P14591, DOI 10.1074/jbc.RA119.007555
   Martinez ME, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002520
   Mason Christopher E, 2019, J Biomol Tech, V30, pS56
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   Maurel M, 2014, TRENDS BIOCHEM SCI, V39, P245, DOI 10.1016/j.tibs.2014.02.008
   McIntyre W, 2018, NUCLEIC ACIDS RES, V46, P5776, DOI 10.1093/nar/gky029
   Medigeshi GR, 2007, J VIROL, V81, P10849, DOI 10.1128/JVI.01151-07
   Meyer KD, 2019, BBA-GENE REGUL MECH, V1862, P301, DOI 10.1016/j.bbagrm.2018.10.006
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miranda J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101174
   Mohl BP, 2012, J VIROL, V86, P10724, DOI 10.1128/JVI.01667-12
   Munoz-Jordan JL, 2005, J VIROL, V79, P8004, DOI 10.1128/JVI.79.13.8004-8013.2005
   Nagler M, 2017, EXPERT REV MOL DIAGN, V17, P419, DOI 10.1080/14737159.2017.1304213
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Noorbakhsh F, 2019, IRAN J PUBLIC HEALTH, V48, P20
   Oikawa D, 2010, NUCLEIC ACIDS RES, V38, P6265, DOI 10.1093/nar/gkq452
   Ooi YS, 2019, NAT MICROBIOL, V4, P2369, DOI 10.1038/s41564-019-0518-2
   Peralta-Aros C, 2017, PEDIATR NEPHROL, V32, P897, DOI 10.1007/s00467-017-3588-5
   Pereira-Montecinos C, 2017, BBA-GENE REGUL MECH, V1860, P460, DOI 10.1016/j.bbagrm.2017.02.002
   Perera N, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12734
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01018
   Riedl W, 2019, CELL HOST MICROBE, V26, P493, DOI 10.1016/j.chom.2019.09.012
   Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1
   Roach T, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0824-7
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Rozpedek W, 2016, CURR MOL MED, V16, P533, DOI 10.2174/1566524016666160523143937
   Rubio RM, 2018, GENE DEV, V32, P1472, DOI 10.1101/gad.319475.118
   Sager G, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10100559
   Savidis G, 2016, CELL REP, V15, P2323, DOI 10.1016/j.celrep.2016.05.074
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Sher AA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00596
   Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025
   Sirohi D, 2017, J INFECT DIS, V216, pS935, DOI 10.1093/infdis/jix515
   Song YT, 2019, MBIO, V10, DOI [10.1128/mBio.00459-19, 10.1128/mbio.00459-19]
   Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6
   Sun GY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170462
   Tan ZY, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1311-5
   Tardif KD, 2004, J BIOL CHEM, V279, P17158, DOI 10.1074/jbc.M312144200
   Thaker SK, 2019, CELL METAB, V29, P1206, DOI 10.1016/j.cmet.2019.01.024
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Tonnerre P, 2020, NAT MICROBIOL, V5, P76, DOI 10.1038/s41564-019-0618-z
   Turpin J., 2019, OCTOBER, V2, DOI [10.20944/PREPRINTS201910.0024.V1, DOI 10.20944/PREPRINTS201910.0024.V1]
   Umareddy I, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-91
   Upton JP, 2012, SCIENCE, V338, P818, DOI 10.1126/science.1226191
   Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664
   Ventura CV, 2018, PEDIATRICS, V141, pS161, DOI [10.1542/peds.2017-2038E, 10.1542/peds.2017-2038e]
   Wang J, 2014, AUTOPHAGY, V10, P766, DOI 10.4161/auto.27954
   Wang L, 2016, CELL HOST MICROBE, V19, P561, DOI 10.1016/j.chom.2016.04.006
   Wang X, 2014, RNA BIOL, V11, P669, DOI 10.4161/rna.28829
   Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730
   Winkler CW, 2017, J IMMUNOL, V198, P3526, DOI 10.4049/jimmunol.1601949
   Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Yockey LJ, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao1680
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yu CY, 2006, J VIROL, V80, P11868, DOI 10.1128/JVI.00879-06
   Zaidi Mussaret B, 2018, JMM Case Rep, V5, pe005152, DOI 10.1099/jmmcr.0.005152
   Zanluca C, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2017.1402143
   Zheng YY, 2018, EMBO J, V37, DOI 10.15252/embj.201899347
NR 135
TC 0
Z9 0
U1 2
U2 2
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAR
PY 2020
VL 9
IS 3
AR 158
DI 10.3390/pathogens9030158
PG 18
WC Microbiology
SC Microbiology
GA LB0CL
UT WOS:000524306100069
PM 32106582
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Seong, RK
   Lee, JK
   Shin, OS
AF Seong, Rak-Kyun
   Lee, Jae Kyung
   Shin, Ok Sarah
TI Zika Virus-Induction of the Suppressor of Cytokine Signaling 1/3
   Contributes to the Modulation of Viral Replication
SO PATHOGENS
LA English
DT Article
DE suppressor of cytokine signaling; zika virus; interferon; antiviral
ID RIG-I; EXPRESSION; INFECTION; SOCS1; INFLAMMATION; PROTEINS; BRAIN;
   CELLS
AB Zika virus (ZIKV) is a mosquito-borne flavivirus that has emerged and caused global outbreaks since 2007. Although ZIKV proteins have been shown to suppress early anti-viral innate immune responses, little is known about the exact mechanisms. This study demonstrates that infection with either the African or Asian lineage of ZIKV leads to a modulated expression of suppressor of cytokine signaling (SOCS) genes encoding SOCS1 and SOCS3 in the following cell models: A549 human lung adenocarcinoma cells; JAr human choriocarcinoma cells; human neural progenitor cells. Studies of viral gene expression in response to SOCS1 or SOCS3 demonstrated that the knockdown of these SOCS proteins inhibited viral NS5 or ZIKV RNA expression, whereas overexpression resulted in an increased expression. Moreover, the overexpression of SOCS1 or SOCS3 inhibited the retinoic acid-inducible gene-I-like receptor-mediated activation of both type I and III interferon pathways. These results imply that SOCS upregulation following ZIKV infection modulates viral replication, possibly via the regulation of anti-viral innate immune responses.
C1 [Seong, Rak-Kyun; Lee, Jae Kyung; Shin, Ok Sarah] Korea Univ, Coll Med, Dept Biomed Sci, Bk21 Plus Program,Guro Hosp, Seoul 08308, South Korea.
RP Shin, OS (corresponding author), Korea Univ, Coll Med, Dept Biomed Sci, Bk21 Plus Program,Guro Hosp, Seoul 08308, South Korea.
EM cyeano66@naver.com; jae.lee0321@gmail.com; oshin@korea.ac.kr
OI Lee, Jae Kyung/0000-0002-9641-8473
FU Basic Science Research Program of the National Research Foundation of
   Korea (NRF); Ministry of Science, ICT & Future Planning
   [NRF-2019R1A2C1005961]
FX This research was funded by the Basic Science Research Program of the
   National Research Foundation of Korea (NRF), by the Ministry of Science,
   ICT & Future Planning (NRF-2019R1A2C1005961).
CR Ahmed CM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00574
   Ahmed CMI, 2010, J IMMUNOL, V185, P1103, DOI 10.4049/jimmunol.0902895
   Akhtar LN, 2011, J VIROL, V85, P1912, DOI 10.1128/JVI.01857-10
   Akhtar LN, 2010, J IMMUNOL, V185, P2393, DOI 10.4049/jimmunol.0903563
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Aslam R, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3506-5
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Blumer T, 2017, J BIOL CHEM, V292, P17928, DOI 10.1074/jbc.M117.788877
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Choi EJ, 2015, SCAND J IMMUNOL, V82, P337, DOI 10.1111/sji.12323
   Dhiman G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46389-0
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005704
   Elshahawi H, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040169
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hashimoto K, 2009, VIROLOGY, V391, P162, DOI 10.1016/j.virol.2009.06.026
   Hilton DJ, 1998, P NATL ACAD SCI USA, V95, P114, DOI 10.1073/pnas.95.1.114
   Jagger BW, 2017, CELL HOST MICROBE, V22, P366, DOI 10.1016/j.chom.2017.08.012
   Flores-Mendoza LK, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/5197592
   Kim JA, 2019, J INVEST DERMATOL, V139, P391, DOI 10.1016/j.jid.2018.07.038
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Kim KA, 2009, J HEPATOL, V50, P705, DOI 10.1016/j.jhep.2008.12.021
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lazear HM, 2016, J VIROL, V90, P4864, DOI 10.1128/JVI.00252-16
   Leal MC, 2016, MMWR-MORBID MORTAL W, V65, P917, DOI 10.15585/mmwr.mm6534e3
   Lee JK, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051101
   Li XM, 2014, VIRUSES-BASEL, V6, P4280, DOI 10.3390/v6114280
   Liu D, 2015, MOL CELL BIOL, V35, P2400, DOI 10.1128/MCB.00090-15
   Miner JJ, 2016, CELL STEM CELL, V18, P559, DOI 10.1016/j.stem.2016.04.009
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Oh SJ, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8040183
   Okumura A, 2015, J VIROL, V89, P10399, DOI 10.1128/JVI.01736-15
   Pauli EK, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000196
   Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034
   Ramirez-Martinez G, 2013, CYTOKINE, V62, P151, DOI 10.1016/j.cyto.2013.01.018
   Reichard AC, 2015, J INTERF CYTOK RES, V35, P32, DOI 10.1089/jir.2013.0070
   Shao RX, 2013, ANTIVIR RES, V97, P101, DOI 10.1016/j.antiviral.2012.12.001
   Sood V, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00114
   Steffensen MA, 2014, J VIROL, V88, P14090, DOI 10.1128/JVI.01346-14
   Sui HY, 2014, NUCLEIC ACIDS RES, V42, P583, DOI 10.1093/nar/gkt844
   Sun K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004560
   Sun XM, 2017, CELL REP, V21, P3471, DOI 10.1016/j.celrep.2017.11.087
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Ubol S, 2010, J INFECT DIS, V201, P923, DOI 10.1086/651018
   Wei HT, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003845
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Ye SY, 2015, J VIROL, V89, P2672, DOI 10.1128/JVI.03529-14
   Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093
   Zhang PP, 2014, HUM IMMUNOL, V75, P709, DOI 10.1016/j.humimm.2014.04.010
NR 51
TC 1
Z9 1
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2076-0817
J9 PATHOGENS
JI Pathogens
PD MAR
PY 2020
VL 9
IS 3
AR 163
DI 10.3390/pathogens9030163
PG 13
WC Microbiology
SC Microbiology
GA LB0CL
UT WOS:000524306100062
PM 32120897
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dragoni, F
   Boccuto, A
   Picarazzi, F
   Giannini, A
   Giammarino, F
   Saladini, F
   Mori, M
   Mastrangelo, E
   Zazzi, M
   Vicenti, I
AF Dragoni, Filippo
   Boccuto, Adele
   Picarazzi, Francesca
   Giannini, Alessia
   Giammarino, Federica
   Saladini, Francesco
   Mori, Mattia
   Mastrangelo, Eloise
   Zazzi, Maurizio
   Vicenti, Ilaria
TI Evaluation of sofosbuvir activity and resistance profile against West
   Nile virus in vitro
SO ANTIVIRAL RESEARCH
LA English
DT Article
ID DEPENDENT RNA-POLYMERASE; CRYSTAL-STRUCTURE; DENGUE; AGENTS
AB Sofosbuvir, a licensed nucleotide analog targeting hepatitis C virus (HCV) RNA-dependent RNA polymerase (RdRp), has been recently evaluated as a broad antiFlavivirus lead candidate revealing activity against Zika and Dengue viruses both in vitro and in animal models. In this study, the in vitro antiviral activity of sofosbuvir against West Nile virus (WNV) was determined by plaque assay (PA) and Immunodetection Assay (IA) in human cell lines and by enzymatic RdRp assay. By PA, the sofosbuvir half-maximal inhibitory concentration (IC50) was 1.2 +/- 0.3 mu M in Huh-7, 5.3 +/- 0.9 mu M in U87, 7.8 +/- 2.5 mu M in LN-18 and 63.4 +/- 14.1 mu M in A549 cells. By IA, anti-WNV activity was confirmed in both hepatic (Huh-7, 1.7 +/- 0.5 mu M) and neuronal (U87, 7.3 +/- 2.0 mu M) cell types. Sofosbuvir was confirmed to inhibit the purified WNV RdRp (IC50 11.1 +/- 4.6 mu M). In vitro resistance selection experiments were performed by propagating WNV in the Huh-7 cell line with two-fold increasing concentrations of sofosbuvir. At 80 mu M, a significantly longer time for viral breakthrough was observed compared with lower concentrations (18 vs. 7-9 days post infection; p = 0.029), along with the detection of the S604T mutation, corresponding to the well-known S282T substitution in the motif B of HCV NS5B, which confers resistance to sofosbuvir. Molecular docking experiments confirmed that the S604T mutation within the catalytic site of RdRp affected the binding mode of sofosbuvir. To our knowledge, this is the first report of the antiviral activity of sofosbuvir against WNV as well as of selection of mutants in vitro.
C1 [Dragoni, Filippo; Boccuto, Adele; Giannini, Alessia; Giammarino, Federica; Saladini, Francesco; Zazzi, Maurizio; Vicenti, Ilaria] Univ Siena, Dept Med Biotechnol, Siena, Italy.
   [Picarazzi, Francesca; Mori, Mattia] Univ Siena, Dept Biotechnol Chem & Pharm, Siena, Italy.
   [Mastrangelo, Eloise] CNR, Biophys Inst Milano, Milan, Italy.
RP Vicenti, I (corresponding author), Univ Siena, Dept Med Biotechnol, Siena, Italy.
EM ilariavicenti@gmail.com
RI Vicenti, Ilaria/AAP-9663-2020; Zazzi, Maurizio/K-3422-2018
OI Zazzi, Maurizio/0000-0002-0344-6281; Mori, Mattia/0000-0003-2398-1254
FU Regione Toscana (Tuscany Region) through the UNAVIR (FAS-Salute 2016: A
   novel strategy to combat multiple viral infections with one antiviral)
   project; Regione Toscana (Tuscany Region) through the PANVIR (POR-FESR
   2018: Preclinical development of innovative PANVIRal antivirals in a
   specialized regional NETwork) project
FX This work was supported by Regione Toscana (Tuscany Region) through the
   UNAVIR (FAS-Salute 2016: A novel strategy to combat multiple viral
   infections with one antiviral) and PANVIR (POR-FESR 2018: Preclinical
   development of innovative PANVIRal antivirals in a specialized regional
   NETwork) projects.
CR Acharya D, 2016, METHODS MOL BIOL, V1435, P249, DOI 10.1007/978-1-4939-3670-0_19
   Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Bell J.A., 2012, PRIMEX SCHRODINGER C, P534, DOI [10.1107/97809553602060000864., DOI 10.1107/97809553602060000864]
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Case D. A., 2018, AMBER
   Chancey C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/376230
   Dubankova A, 2019, ANTIVIR RES, V169, DOI 10.1016/j.antiviral.2019.104536
   Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01400-17, 10.1128/aac.01400-17]
   Ferreira AC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01389-18
   Gong Edwin Yunhao, 2013, Methods Mol Biol, V1030, P237, DOI 10.1007/978-1-62703-484-5_19
   Gotte M, 2016, NAT REV GASTRO HEPAT, V13, P338, DOI 10.1038/nrgastro.2016.60
   Han B, 2019, ANTIVIR RES, V170, DOI 10.1016/j.antiviral.2019.104574
   Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Lam AM, 2012, ANTIMICROB AGENTS CH, V56, P3359, DOI 10.1128/AAC.00054-12
   Latour DR, 2010, ANTIVIR RES, V87, P213, DOI 10.1016/j.antiviral.2010.05.003
   Lim SP, 2013, J BIOL CHEM, V288, P31105, DOI 10.1074/jbc.M113.508606
   Ma DL, 2009, ANTIVIR RES, V83, P53, DOI 10.1016/j.antiviral.2009.03.006
   Magurano F, 2012, CLIN MICROBIOL INFEC, V18, pE545, DOI 10.1111/1469-0691.12018
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Malet H, 2007, J BIOL CHEM, V282, P10678, DOI 10.1074/jbc.M607273200
   Meagher KL, 2003, J COMPUT CHEM, V24, P1016, DOI 10.1002/jcc.10262
   Mesci P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19526-4
   Murakami E, 2010, J BIOL CHEM, V285, P34337, DOI 10.1074/jbc.M110.161802
   Patel H, 2015, LANCET INFECT DIS, V15, P951, DOI 10.1016/S1473-3099(15)00134-6
   REED L. J., 1938, AMER JOUR HYG, V27, P493
   Sacramento CQ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40920
   Sebera J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29459-7
   Sejvar JJ, 2014, VIRUSES-BASEL, V6, P606, DOI 10.3390/v6020606
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Urbanowski MD, 2013, J VIROL, V87, P872, DOI 10.1128/JVI.02030-12
   Van Dycke J, 2018, J INFECT DIS, V218, P1753, DOI 10.1093/infdis/jiy398
   Vicenti I, 2018, VIRUS RES, V244, P64, DOI 10.1016/j.virusres.2017.11.003
   Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943
   Xu HT, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06612-2
   Xu HT, 2017, J ANTIMICROB CHEMOTH, V72, P727, DOI 10.1093/jac/dkw514
   Xu SM, 2017, ANTIVIR THER, V22, P587, DOI 10.3851/IMP3149
   Zhang B, 2008, J VIROL, V82, P7047, DOI 10.1128/JVI.00654-08
NR 38
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2020
VL 175
AR 104708
DI 10.1016/j.antiviral.2020.104708
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RS
UT WOS:000523597100005
PM 31931104
DA 2020-07-08
ER

PT J
AU Muller, C
   Obermann, W
   Schulte, FW
   Lange-Grunweller, K
   Oestereich, L
   Elgner, F
   Glitscher, M
   Hildt, E
   Singh, K
   Wendel, HG
   Hartmann, RK
   Ziebuhr, J
   Grunweller, A
AF Mueller, Christin
   Obermann, Wiebke
   Schulte, Falk W.
   Lange-Gruenweller, Kerstin
   Oestereich, Lisa
   Elgner, Fabian
   Glitscher, Mirco
   Hildt, Eberhard
   Singh, Kamini
   Wendel, Hans-Guido
   Hartmann, Roland K.
   Ziebuhr, John
   Gruenweller, Arnold
TI Comparison of broad-spectrum antiviral activities of the synthetic
   rocaglate CR-31-B (-) and the eIF4A-inhibitor Silvestrol
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Silvestrol; CR-31-B; Antiviral activity; eIF4A; Translation initiation;
   Rocaglates
ID VIRUS; TRANSLATION; CORONAVIRUS; INHIBITOR; FEVER; PCR
AB Rocaglates, a class of natural compounds isolated from plants of the genus Aglaia, are potent inhibitors of translation initiation. They are proposed to form stacking interactions with polypurine sequences in the 5'-untranslated region (UTR) of selected mRNAs, thereby clamping the RNA substrate onto eIF4A and causing inhibition of the translation initiation complex. Since virus replication relies on the host translation machinery, it is not surprising that the rocaglate Silvestrol has broad-spectrum antiviral activity. Unfortunately, synthesis of Silvestrol is sophisticated and time-consuming, thus hampering the prospects for further antiviral drug development. Here, we present the less complex structured synthetic rocaglate CR-31-B (-) as a novel compound with potent broad-spectrum antiviral activity in primary cells and in an ex vivo bronchial epithelial cell system. CR-31-B (-) inhibited the replication of corona-, Zika-, Lassa-, Crimean Congo hemorrhagic fever viruses and, to a lesser extent, hepatitis E virus (HEV) at non-cytotoxic low nanomolar concentrations. Since HEV has a polypurine-free 5'-UTR that folds into a stable hairpin structure, we hypothesized that RNA clamping by Silvestrol and its derivatives may also occur in a polypurine-independent but structure-dependent manner. Interestingly, the HEV 5'-UTR conferred sensitivity towards Silvestrol but not to CR-31-B (-). However, if an exposed polypurine stretch was introduced into the HEV 5'-UTR, CR-31-B (-) became an active inhibitor comparable to Silvestrol. Moreover, thermodynamic destabilization of the HEV 5'-UTR led to reduced translational inhibition by Silvestrol, suggesting differences between rocaglates in their mode of action, most probably by engaging Silvestrol's additional dioxane moiety.
C1 [Mueller, Christin; Ziebuhr, John] Justus Liebig Univ Giessen, Inst Med Virol, Schubertstr 81, D-35392 Giessen, Germany.
   [Obermann, Wiebke; Schulte, Falk W.; Lange-Gruenweller, Kerstin; Hartmann, Roland K.; Gruenweller, Arnold] Philipps Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.
   [Mueller, Christin; Ziebuhr, John] DZIF, Partner Site Giessen Marburg Langen, Marburg, Germany.
   [Oestereich, Lisa] Bernhard Nocht Inst Tropenmed, Abt Virol, Hamburg, Germany.
   [Oestereich, Lisa] DZIF, Partner Site Hamburg, Hamburg, Germany.
   [Elgner, Fabian; Glitscher, Mirco; Hildt, Eberhard] Paul Ehrlich Inst, Bundesinst Impfstoffe & Biomed Arzneimittel, Abt Virol, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
   [Singh, Kamini; Wendel, Hans-Guido] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10023 USA.
RP Grunweller, A (corresponding author), Philipps Univ Marburg, Inst Pharmazeut Chem, Marbacher Weg 6, D-35032 Marburg, Germany.
EM arnold.gruenweller@staff.uni-marburg.de
RI Hildt, Eberhard/A-1040-2015; Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X; Muller,
   Christin/0000-0002-6444-9478; Ziebuhr, John/0000-0002-5741-8825
FU LOEWE Center DRUID; German Center for Infection Research (DZIF);
   Giessen, Germany (TTU Emerging Infections); Hamburg, Germany (TTU
   Emerging Infections); Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [SFB 1021, CRU KFO309]; Leibniz Gesellschaft (Leibniz
   Best Minds)
FX The work was supported by the LOEWE Center DRUID (projects A2, B2 and D3
   to A.G., J.Z. and E.H.), the German Center for Infection Research
   (DZIF), partner sites Giessen and Hamburg, Germany (TTU Emerging
   Infections, to J.Z. and L.O.), Deutsche Forschungsgemeinschaft (SFB 1021
   `RNA viruses: RNA metabolism, pathogenesis and host response'; projects
   A01 and A02, to J.Z. and R.K.H., respectively; CRU KFO309, project P3 to
   J.Z.), and the Leibniz Gesellschaft (Leibniz Best Minds, to L.O.)
CR Bhat M, 2015, NAT REV DRUG DISCOV, V14, P261, DOI 10.1038/nrd4505
   Biedenkopf N, 2017, ANTIVIR RES, V137, P76, DOI 10.1016/j.antiviral.2016.11.011
   Chan K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13086-5
   Davies Donna E, 2014, Ann Am Thorac Soc, V11 Suppl 5, pS244, DOI 10.1513/AnnalsATS.201407-304AW
   Elgner F, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040149
   Glitscher M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10060301
   Gunther S, 2004, ANTIVIR RES, V63, P209, DOI 10.1016/j.antiviral.2004.05.001
   Henss L, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110592
   Johne R, 2014, J VIRAL HEPATITIS, V21, P447, DOI 10.1111/jvh.12157
   Lecompte E, 2006, EMERG INFECT DIS, V12, P1971
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Lwasaki S, 2019, MOL CELL, V73, P738, DOI 10.1016/j.molcel.2018.11.026
   Madhugiri R, 2016, ADV VIRUS RES, V96, P127, DOI 10.1016/bs.aivir.2016.08.007
   Muller C, 2018, J VIROL, V92, DOI 10.1128/JVI.01463-17
   Muller C, 2018, ANTIVIR RES, V150, P123, DOI 10.1016/j.antiviral.2017.12.010
   Olschlager S, 2011, J CLIN VIROL, V50, P90, DOI 10.1016/j.jcv.2010.09.018
   Pan L, 2014, NAT PROD REP, V31, P924, DOI 10.1039/c4np00006d
   Rubio CA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0476-1
   Saradhi UVRV, 2011, AAPS J, V13, P347, DOI 10.1208/s12248-011-9273-x
   Schlereth J, 2016, RNA BIOL, V13, P783, DOI 10.1080/15476286.2016.1194160
   Todt D, 2018, ANTIVIR RES, V157, P151, DOI 10.1016/j.antiviral.2018.07.010
   Too IHK, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006778
   Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485
NR 23
TC 1
Z9 1
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2020
VL 175
AR 104706
DI 10.1016/j.antiviral.2020.104706
PG 10
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RS
UT WOS:000523597100004
PM 31931103
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Quek, JP
   Liu, S
   Zhang, ZZ
   Li, Y
   Ng, EYH
   Loh, YR
   Hung, AW
   Luo, DH
   Kang, CB
AF Quek, Jun Ping
   Liu, Shuang
   Zhang, Zhenzhen
   Li, Yan
   Ng, Elizabeth Yihui
   Loh, Ying Ru
   Hung, Alvin W.
   Luo, Dahai
   Kang, CongBao
TI Identification and structural characterization of small molecule
   fragments targeting Zika virus NS2B-NS3 protease
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Zika Virus; Fragment-based drug discovery; Protease inhibitor;
   Structure; NMR; X-ray crystallography
ID DENGUE VIRUS; CRYSTAL-STRUCTURE; STD-NMR; DISCOVERY; DESIGN; REFINEMENT;
   INHIBITORS; INTERFACE; COMPLEX; BINDING
AB Zika virus (ZIKV) NS2B-NS3 protease is a validated antiviral target as it is essential for maturation of viral proteins. However, its negatively charged active site hinders the development of orthosteric small-molecule inhibitors. Fragment-based drug discovery (FBDD) is a powerful tool to generate novel chemical starting points against difficult drug targets. In this study, we sere ened a fragment compound library against the Zika protease using a primary thermal shift assay and identified twenty-two fragments which (bind to and) stabilize the protease. We then determined the X-ray crystal structures of two hits from different classes, all of which bind to the S1 pocket of the protease. We confirmed that these two fragments bind to the protease without inducing significant conformational changes using solution NMR spectroscopy. These fragment scaffolds serve as the starting point for subsequent lead compound development.
C1 [Quek, Jun Ping; Zhang, Zhenzhen; Luo, Dahai] Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.
   [Liu, Shuang; Li, Yan; Ng, Elizabeth Yihui; Loh, Ying Ru; Hung, Alvin W.; Kang, CongBao] ASTAR, EDDC, 10 Biopolis Rd,Chromos 05-01, Singapore 138670, Singapore.
   [Luo, Dahai] Nanyang Technol Univ, NTU Inst Struct Biol, EMB 06-01,59 Nanyang Dr, Singapore 636921, Singapore.
   [Liu, Shuang] Broad Inst MIT & Harvard, 415 Main St, Cambridge, MA 02142 USA.
   [Li, Yan] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathogen Biol, Sch Basic Med, 13 Hangkong Rd, Wuhan 430030, Hubei, Peoples R China.
RP Luo, DH (corresponding author), Nanyang Technol Univ, Lee Kong Chian Sch Med, EMB 03-07,59 Nanyang Dr, Singapore 636921, Singapore.; Hung, AW; Kang, CB (corresponding author), ASTAR, EDDC, 10 Biopolis Rd,Chromos 05-01, Singapore 138670, Singapore.
EM whung@eddc.a-star.edu.sg; luodahai@ntu.edu.sg; cbkang@eddc.a-star.edu.sg
OI Quek, Jun Ping/0000-0002-3827-8580
FU Lee Kong Chian School of Medicine, Nanyang Technological
   UniversityNanyang Technological University; Singapore National Research
   FoundationSingapore National Research Foundation
   [NRF2016NRF-CRP001-063]; Singapore National Medical Research
   CouncilNational Medical Research Council, Singapore [CBRG15May045];
   Singapore Ministry of Health's National Medical Research CouncilNational
   Medical Research Council, Singapore [NMRC/OFIRG/0051/2017]
FX We thank scientists from Australian Light Source MX beam-line and Swiss
   Light Source PX beam-line for their help with diffraction data
   collection. We also appreciate Prof Ho Sup Yoon and Dr Hong Ye for the
   help of NMR experiments. This work was supported by (1) a start-up grant
   from Lee Kong Chian School of Medicine, Nanyang Technological
   University, (2) Singapore National Research Foundation grant
   NRF2016NRF-CRP001-063, (3) Singapore National Medical Research Council
   grant CBRG15May045, to D.L. (3) Singapore Ministry of Health's National
   Medical Research Council (NMRC/OFIRG/0051/2017) to C.K.
CR Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925
   Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308
   Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Chen X, 2016, CELL RES, V26, P1260, DOI 10.1038/cr.2016.116
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109
   Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X
   Evans PR, 2007, ACTA CRYSTALLOGR D, V63, P58, DOI 10.1107/S090744490604604X
   Gruba N, 2018, ACS MED CHEM LETT, V9, P1025, DOI 10.1021/acsmedchemlett.8b00316
   Hajduk PJ, 2005, J MED CHEM, V48, P2518, DOI 10.1021/jm049131r
   Harner MJ, 2013, J BIOMOL NMR, V56, P65, DOI 10.1007/s10858-013-9740-z
   Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Koh-Stenta X, 2015, DRUG DES DEV THER, V9, P6389, DOI 10.2147/DDDT.S94207
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li Y, 2018, BIOCHEM BIOPH RES CO, V503, P691, DOI 10.1016/j.bbrc.2018.06.062
   Li Y, 2017, FEBS LETT, V591, P2338, DOI 10.1002/1873-3468.12741
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   Manzano M, 2014, METHODS MOL BIOL, V1138, P331, DOI 10.1007/978-1-4939-0348-1_20
   Mass N., 2007, Virologie (Montrouge), V11, P121
   Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q
   Ndeffo-Mbah ML, 2016, ANN INTERN MED, V165, P551, DOI 10.7326/M16-0919
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Noble CG, 2012, ANTIVIR RES, V96, P115, DOI 10.1016/j.antiviral.2012.09.007
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Phoo WW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13410
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Poulsen A, 2014, CURR PHARM DESIGN, V20, P3422, DOI 10.2174/13816128113199990633
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Schone T, 2017, ANTIVIR RES, V146, P174, DOI 10.1016/j.antiviral.2017.09.008
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Skora L, 2017, ACS MED CHEM LETT, V8, P632, DOI 10.1021/acsmedchemlett.7b00084
   Su XC, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000561
   Uchil PD, 2003, J BIOL CHEM, V278, P24388, DOI 10.1074/jbc.M301717200
   Viegas A, 2011, J CHEM EDUC, V88, P990, DOI 10.1021/ed101169t
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yildiz M., 2013, ACS CHEM BIOL, V17, P76
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
NR 49
TC 1
Z9 1
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2020
VL 175
AR 104707
DI 10.1016/j.antiviral.2020.104707
PG 7
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RS
UT WOS:000523597100008
PM 31953156
DA 2020-07-08
ER

PT J
AU Rut, W
   Groborz, K
   Zhang, LL
   Modrzycka, S
   Poreba, M
   Hilgenfeld, R
   Drag, M
AF Rut, Wioletta
   Groborz, Katarzyna
   Zhang, Linlin
   Modrzycka, Sylwia
   Poreba, Marcin
   Hilgenfeld, Rolf
   Drag, Marcin
TI Profiling of flaviviral NS2B-NS3 protease specificity provides a
   structural basis for the development of selective chemical tools that
   differentiate Dengue from Zika and West Nile viruses
SO ANTIVIRAL RESEARCH
LA English
DT Article
DE Proteolytic enzyme; Substrate specificity; Zika; West Nile; Dengue;
   Serine hydrolase
ID EXTENDED SUBSTRATE-SPECIFICITY; MEDICINAL CHEMISTRY; RAPID TEST;
   INHIBITORS; LIBRARY; INFECTION; DESIGN; NS1
AB West Nile virus (WNV) and Dengue virus (DENV) are mosquito-borne pathogenic flaviviruses. The NS2B-NS3 proteases found in these viruses are responsible for polyprotein processing and are therefore considered promising medical targets. Another ortholog of these proteases is found in Zika virus (ZIKV). In this work, we applied a combinatorial chemistry approach - Hybrid Combinatorial Substrate Library (HyCoSuL), to compare the substrate specificity profile at the P4-P1 positions of the NS2B-NS3 proteases found in all three viruses. The obtained data demonstrate that Zika and West Nile virus NS2B-NS3 proteases display highly overlapping substrate specificity in all binding pockets, while the Dengue ortholog has slightly different preferences toward natural and unnatural amino acids at the P2 and P4 positions. We used this information to extract specific peptide sequences recognized by the Dengue NS2B-NS3 protease. Next, we applied this knowledge to design a selective substrate and activity-based probe for the Dengue NS2B-NS3 protease. Our work provides a structural framework for the design of inhibitors, which could be used as a lead structure for drug development efforts.
C1 [Rut, Wioletta; Groborz, Katarzyna; Modrzycka, Sylwia; Poreba, Marcin; Drag, Marcin] Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.
   [Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, Ctr Struct & Cell Biol Med, Inst Biochem, Ratzeburger Allee 160, D-23562 Lubeck, Germany.
   [Zhang, Linlin; Hilgenfeld, Rolf] Univ Lubeck, German Ctr Infect Res DZIF, Hamburg Lubeck Borstel Riems Site, D-23562 Lubeck, Germany.
RP Rut, W; Drag, M (corresponding author), Wroclaw Univ Sci & Technol, Dept Chem Biol & Bioimaging, Wyb Wyspianskiego 27, PL-50370 Wroclaw, Poland.
EM wioletta.rut@pwr.edu.pl; marcin.drag@pwr.edu.pl
FU Foundation for Polish ScienceFoundation for Polish Science; DZIF [TI
   07.005]; National Science Centre in Poland
FX WR is a beneficiary of a START scholarship from the Foundation for
   Polish Science. The Drag laboratory is supported by Foundation for
   Polish Science and National Science Centre in Poland. DZIF grant TI
   07.005 to LZ is gratefully acknowledged.
CR Andries AC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1551-x
   Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642
   Baz M, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12030101
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosch I, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan1589
   D'Arcy A, 2006, ACTA CRYSTALLOGR F, V62, P157, DOI 10.1107/S1744309106001199
   ECDC, W NIL VIR TRANSM SEA, P2019
   ECDC, 2018, EP UPD W NIL VIR TRA
   Fry SR, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001199
   Gouvea IE, 2007, ARCH BIOCHEM BIOPHYS, V457, P187, DOI 10.1016/j.abb.2006.11.005
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   Guzman MG, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.55
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Han YS, 2018, EXPERT OPIN INV DRUG, V27, P951, DOI 10.1080/13543784.2018.1548609
   Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360
   Harris JL, 2000, P NATL ACAD SCI USA, V97, P7754, DOI 10.1073/pnas.140132697
   Kasperkiewicz P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132818
   Kasperkiewicz P, 2014, P NATL ACAD SCI USA, V111, P2518, DOI 10.1073/pnas.1318548111
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Lee J, 2015, DIAGN MICR INFEC DIS, V82, P128, DOI 10.1016/j.diagmicrobio.2015.03.009
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Leung D, 2001, J BIOL CHEM, V276, P45762, DOI 10.1074/jbc.M107360200
   Li J, 2005, J BIOL CHEM, V280, P28766, DOI 10.1074/jbc.M500588200
   Li Z, 2017, VIRAL PROTEASES AND THEIR INHIBITORS, P163, DOI 10.1016/B978-0-12-809712-0.00007-1
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Maly DJ, 2002, J ORG CHEM, V67, P910, DOI 10.1021/jo016140o
   Mueller NH, 2007, INT J BIOCHEM CELL B, V39, P606, DOI 10.1016/j.biocel.2006.10.025
   Ng NM, 2009, BIOL CHEM, V390, P401, DOI 10.1515/BC.2009.065
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Philpott DCE, 2019, EMERG INFECT DIS, V25, P256, DOI 10.3201/eid2502.181250
   Poreba M, 2017, NAT PROTOC, V12, P2189, DOI 10.1038/nprot.2017.091
   Poreba M, 2016, CELL CHEM BIOL, V23, P1023, DOI 10.1016/j.chembiol.2016.05.020
   Powers JC, 2002, CHEM REV, V102, P4639, DOI 10.1021/cr010182v
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Rut W, 2015, BIOL CHEM, V396, P329, DOI 10.1515/hsz-2014-0315
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Shiryaev SA, 2007, J VIROL, V81, P4501, DOI 10.1128/JVI.02719-06
   Sivaraman KK, 2013, J MED CHEM, V56, P5213, DOI 10.1021/jm4005972
   Skorenski M, 2019, J ENZYM INHIB MED CH, V34, P8, DOI 10.1080/14756366.2018.1506772
   SMITHBURN KC, 1946, AM J TROP MED, V26, P189
   Steuber H, 2015, TOP MED CHEM SER, V15, P93, DOI 10.1007/7355_2014_46
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Timiri AK, 2016, EUR J MED CHEM, V117, P125, DOI 10.1016/j.ejmech.2016.04.008
   Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Watanabe S, 2018, ACS INFECT DIS, V4, P1048, DOI 10.1021/acsinfecdis.8b00054
NR 48
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0166-3542
EI 1872-9096
J9 ANTIVIR RES
JI Antiviral Res.
PD MAR
PY 2020
VL 175
AR 104731
DI 10.1016/j.antiviral.2020.104731
PG 9
WC Pharmacology & Pharmacy; Virology
SC Pharmacology & Pharmacy; Virology
GA KZ9RS
UT WOS:000523597100010
PM 32014497
DA 2020-07-08
ER

PT J
AU Hengphasatporn, K
   Garon, A
   Wolschann, P
   Langer, T
   Yasuteru, S
   Huynh, TNT
   Chavasiri, W
   Saelee, T
   Boonyasuppayakorn, S
   Rungrotmongkol, T
AF Hengphasatporn, Kowit
   Garon, Arthur
   Wolschann, Peter
   Langer, Thierry
   Yasuteru, Shigeta
   Huynh, Thao N. T.
   Chavasiri, Warinthorn
   Saelee, Thanaphon
   Boonyasuppayakorn, Siwaporn
   Rungrotmongkol, Thanyada
TI Multiple Virtual Screening Strategies for the Discovery of Novel
   Compounds Active Against Dengue Virus: A Hit Identification Study
SO SCIENTIA PHARMACEUTICA
LA English
DT Article
DE dengue virus; envelope protein; fragment molecular orbital; molecular
   dynamics; pharmacophore-based screening
ID ANTIBODY-DEPENDENT ENHANCEMENT; MOLECULAR-ORBITAL METHOD; DRUG
   DISCOVERY; ZIKA VIRUS; DOCKING; PHARMACOPHORES; PERFORMANCE; CHALLENGES;
   PREDICTION; INFECTION
AB Dengue infection is caused by a mosquito-borne virus, particularly in children, which may even cause death. No effective prevention or therapeutic agents to cure this disease are available up to now. The dengue viral envelope (E) protein was discovered to be a promising target for inhibition in several steps of viral infection. Structure-based virtual screening has become an important technique to identify first hits in a drug screening process, as it is possible to reduce the number of compounds to be assayed, allowing to save resources. In the present study, pharmacophore models were generated using the common hits approach (CHA), starting from trajectories obtained from molecular dynamics (MD) simulations of the E protein complexed with the active inhibitor, flavanone (FN5Y). Subsequently, compounds presented in various drug databases were screened using the LigandScout 4.2 program. The obtained hits were analyzed in more detail by molecular docking, followed by extensive MD simulations of the complexes. The highest-ranked compound from this procedure was then synthesized and tested on its inhibitory efficiency by experimental assays.
C1 [Hengphasatporn, Kowit; Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.
   [Hengphasatporn, Kowit; Yasuteru, Shigeta] Univ Tsukuba, Ctr Computat Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.
   [Garon, Arthur; Wolschann, Peter; Langer, Thierry] Univ Vienna, Fac Life Sci, Dept Pharmaceut Chem, Althanstr 14, A-1090 Vienna, Austria.
   [Wolschann, Peter] Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria.
   [Huynh, Thao N. T.; Chavasiri, Warinthorn] Chulalongkorn Univ, Fac Sci, Ctr Excellence Nat Prod Chem, Dept Chem, Bangkok 10330, Thailand.
   [Saelee, Thanaphon; Boonyasuppayakorn, Siwaporn] Chulalongkorn Univ, Fac Med, Dept Microbiol, Appl Med Virol Res Unit, Bangkok 10330, Thailand.
   [Rungrotmongkol, Thanyada] Chulalongkorn Univ, Fac Sci, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Bangkok 10330, Thailand.
RP Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Fac Sci, Program Bioinformat & Computat Biol, Bangkok 10330, Thailand.; Rungrotmongkol, T (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biochem, Biocatalyst & Environm Biotechnol Res Unit, Bangkok 10330, Thailand.
EM kowith@ccs.tsukuba.ac.jp; arthur.garon@univie.ac.at;
   karl.peter.wolschann@univie.ac.at; thierry.langer@univie.ac.at;
   shigeta@ccs.tsukuba.ac.jp; thao.huynhthanh94@gmail.com;
   warinthorn.c@chula.ac.th; thanaphon.saelee@gmail.com;
   siwaporn.b@chula.ac.th; thanyada.r@chula.ac.th
RI Shigeta, Yasuteru/D-4714-2015
OI Shigeta, Yasuteru/0000-0002-3219-6007
FU National Research Council of Thailand and Health Systems Research
   Institute (HSRI); ASEAN-European Academic University Network
   (ASEA-UNINET)
FX This research was financially supported by the National Research Council
   of Thailand and Health Systems Research Institute (HSRI). Through travel
   grants for a short research visit, this research was also supported by
   the ASEAN-European Academic University Network (ASEA-UNINET).
CR Aguirre S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.37
   Akimoto N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01390-3
   [Anonymous], 2018, LANCET INFECT DIS, V18, P123, DOI DOI 10.1016/S1473-3099(18)30023-9
   Bajorath F, 2002, NAT REV DRUG DISCOV, V1, P882, DOI 10.1038/nrd941
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Berthold MR, 2008, STUD CLASS DATA ANAL, P319, DOI 10.1145/1656274.1656280
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonyasuppayakorn S, 2016, J VIROL METHODS, V237, P25, DOI 10.1016/j.jviromet.2016.08.009
   Braga RC, 2013, CURR TOP MED CHEM, V13, P1127, DOI 10.2174/1568026611313090010
   Brammer L, 2017, FARADAY DISCUSS, V203, P485, DOI 10.1039/c7fd00199a
   Campos JLS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01097-5
   Carneiro BM, 2016, VIROLOGY, V496, P215, DOI 10.1016/j.virol.2016.06.012
   Cavallo G, 2016, CHEM REV, V116, P2478, DOI 10.1021/acs.chemrev.5b00484
   Chen X, 2002, J CHEM INF COMP SCI, V42, P1407, DOI 10.1021/ci025531g
   Cruz-Oliveira C, 2015, FEMS MICROBIOL REV, V39, P155, DOI 10.1093/femsre/fuu004
   Csizmadia F, 1997, J PHARM SCI-US, V86, P865, DOI 10.1021/js960177k
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   DIXON SL, 1993, J COMPUT CHEM, V14, P1460, DOI 10.1002/jcc.540141208
   Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349
   Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010
   Ferreira LG, 2015, MOLECULES, V20, P13384, DOI 10.3390/molecules200713384
   FEYEREISEN M, 1993, CHEM PHYS LETT, V208, P359, DOI 10.1016/0009-2614(93)87156-W
   Flint J., 2015, PRINCIPLES VIROLOGY, VI
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Fuzo CA, 2014, J BIOMOL STRUCT DYN, V32, P1563, DOI 10.1080/07391102.2013.827132
   Gordon MS, 2005, THEORY AND APPLICATIONS OF COMPUTATIONAL CHEMISTRY: THE FIRST FORTY YEARS, P1167, DOI 10.1016/B978-044451719-7/50084-6
   Guner O, 2004, CURR MED CHEM, V11, P2991, DOI 10.2174/0929867043364036
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Hayes JM, 2017, NAT PROD DRUG DISC, P29, DOI 10.1016/B978-0-12-809450-1.00002-8
   Heinz FX, 2000, ADV VIRUS RES, V55, P231, DOI 10.1016/S0065-3527(00)55005-2
   Hengphasatporn K, 2019, J MOL LIQ, V274, P140, DOI 10.1016/j.molliq.2018.10.111
   Horvath D, 2011, METHODS MOL BIOL, V672, P261, DOI 10.1007/978-1-60761-839-3_11
   Hsu KC, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S1-S33
   Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Ishimoto T, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1857481
   Ismail NA, 2017, INTERDISCIP SCI, V9, P499, DOI 10.1007/s12539-016-0157-8
   Jadav SS, 2015, BIOORG MED CHEM LETT, V25, P1747, DOI 10.1016/j.bmcl.2015.02.059
   Kanyaboon P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35035-w
   Kicuntod J, 2016, J MOL GRAPH MODEL, V63, P91, DOI 10.1016/j.jmgm.2015.11.005
   Kitaura K, 2001, CHEM PHYS LETT, V336, P163, DOI 10.1016/S0009-2614(01)00099-9
   Kitchen DB, 2004, NAT REV DRUG DISCOV, V3, P935, DOI 10.1038/nrd1549
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Kumar A, 2015, METHODS, V71, P26, DOI 10.1016/j.ymeth.2014.07.007
   Kurauchi R, 2015, COMPUT THEOR CHEM, V1061, P12, DOI 10.1016/j.comptc.2015.02.016
   Langer T, 2004, Drug Discov Today Technol, V1, P203, DOI 10.1016/j.ddtec.2004.11.015
   Langer T, 2010, MOL INFORM, V29, P470, DOI 10.1002/minf.201000022
   Lee M, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S17-S6
   Leelananda SP, 2016, BEILSTEIN J ORG CHEM, V12, P2694, DOI 10.3762/bjoc.12.267
   Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Lisac K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07957-6
   Lu YX, 2007, INT J QUANTUM CHEM, V107, P1479, DOI 10.1002/qua.21279
   Manner S, 2013, INT J MOL SCI, V14, P19434, DOI 10.3390/ijms141019434
   Maruyama K, 2018, COMPUT THEOR CHEM, V1132, P23, DOI 10.1016/j.comptc.2018.04.001
   Mendez L, 2017, MOLECULES, V22, DOI 10.3390/molecules22091397
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Murgueitio Manuela S, 2012, Drug Discov Today Technol, V9, pe219, DOI 10.1016/j.ddtec.2012.07.009
   Mysinger MM, 2012, J MED CHEM, V55, P6582, DOI 10.1021/jm300687e
   Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v
   Nakano T, 2000, CHEM PHYS LETT, V318, P614, DOI 10.1016/S0009-2614(00)00070-1
   Nutho B, 2014, BEILSTEIN J ORG CHEM, V10, P2789, DOI 10.3762/bjoc.10.296
   Ota S, 2018, CHEM-BIO INFORM J, V18, P44, DOI 10.1273/cbij.18.44
   Rakers C, 2016, J BIOL CHEM, V291, P58, DOI 10.1074/jbc.M115.685610
   Rognan D, 2011, METH PRIN MED CHEM, V48, P153
   Sakkiah S, 2011, EUR J MED CHEM, V46, P2937, DOI 10.1016/j.ejmech.2011.04.018
   Sanders MPA, 2012, J CHEM INF MODEL, V52, P1607, DOI 10.1021/ci2005274
   Sanders MPA, 2012, MEDCHEMCOMM, V3, P28, DOI 10.1039/c1md00210d
   Sangpheak W, 2015, BEILSTEIN J ORG CHEM, V11, P2763, DOI 10.3762/bjoc.11.297
   Schmidt AG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000851
   SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112
   Schuster Daniela, 2006, Curr Drug Discov Technol, V3, P1, DOI 10.2174/157016306776637609
   Settivari RS, 2015, J AM ASSOC LAB ANIM, V54, P214
   Seyedi SS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24027
   Shin WJ, 2013, EXPERT OPIN DRUG DIS, V8, P411, DOI 10.1517/17460441.2013.767795
   Song CM, 2009, BRIEF BIOINFORM, V10, P579, DOI 10.1093/bib/bbp023
   Srivarangkul P, 2018, ANTIVIR RES, V151, P27, DOI 10.1016/j.antiviral.2018.01.010
   Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19
   Sumanasinghe N., 2018, RECENT ADV INFORM CO, P95
   Suroengrit A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14121-5
   Taft CA, 2008, J PHARM SCI-US, V97, P1089, DOI 10.1002/jps.21293
   Tambunan USF, 2015, DRUG TARGET INSIGHT, V9, P33, DOI 10.4137/DTI.S31566
   Virtanen SI, 2015, J MOL GRAPH MODEL, V62, P303, DOI 10.1016/j.jmgm.2015.10.012
   Voet A, 2011, BIOCHEM BIOPH RES CO, V405, P527, DOI 10.1016/j.bbrc.2011.01.053
   Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Wieder M, 2017, J CHEM INF MODEL, V57, P365, DOI 10.1021/acs.jcim.6b00674
   Wolber G, 2005, J CHEM INF MODEL, V45, P160, DOI 10.1021/ci049885e
   Wu GS, 2003, J COMPUT CHEM, V24, P1549, DOI 10.1002/jcc.10306
   Yang SY, 2010, DRUG DISCOV TODAY, V15, P444, DOI 10.1016/j.drudis.2010.03.013
   Yennamalli R, 2009, J COMPUT AID MOL DES, V23, P333, DOI 10.1007/s10822-009-9263-6
   Zhou ZG, 2008, ACS CHEM BIOL, V3, P765, DOI 10.1021/cb800176t
NR 93
TC 2
Z9 2
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 2218-0532
J9 SCI PHARM
JI Sci. Pharm.
PD MAR
PY 2020
VL 88
IS 1
AR 2
DI 10.3390/scipharm88010002
PG 19
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KZ8AG
UT WOS:000523480500008
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Munnink, BBO
   Nieuwenhuijse, DF
   Sikkema, RS
   Koopmans, M
AF Munnink, Bas B. Oude
   Nieuwenhuijse, David F.
   Sikkema, Reina S.
   Koopmans, Marion
TI Validating Whole Genome Nanopore Sequencing, using Usutu Virus as an
   Example
SO JOVE-JOURNAL OF VISUALIZED EXPERIMENTS
LA English
DT Article
DE Genetics; Issue 157; nanopore; sequencing; R10 flowcell; USUV;
   arboviruses; whole genome sequencing
ID ZIKA
AB Whole genome sequencing can be used to characterize and to trace viral outbreaks. Nanopore-based whole genome sequencing protocols have been described for several different viruses. These approaches utilize an overlapping amplicon-based approach which can be used to target a specific virus or group of genetically related viruses. In addition to confirmation of the virus presence, sequencing can be used for genomic epidemiology studies, to track viruses and unravel origins, reservoirs and modes of transmission. For such applications, it is crucial to understand possible effects of the error rate associated with the platform used. Routine application in clinical and public health settings require that this is documented with every important change in the protocol. Previously, a protocol for whole genome Usutu virus sequencing on the nanopore sequencing platform was validated (R9.4 flowcell) by direct comparison to Illumina sequencing. Here, we describe the method used to determine the required read coverage, using the comparison between the R10 flow cell and Illumina sequencing as an example.
C1 [Munnink, Bas B. Oude; Nieuwenhuijse, David F.; Sikkema, Reina S.; Koopmans, Marion] Erasmus MC, Who Collaborating Ctr Arbovirus & Viral Hemorrhag, Dept Virosci, ErasmusMC, Rotterdam, Netherlands.
RP Munnink, BBO (corresponding author), Erasmus MC, Who Collaborating Ctr Arbovirus & Viral Hemorrhag, Dept Virosci, ErasmusMC, Rotterdam, Netherlands.
EM b.oudemunnink@erasmusmc.nl
FU European UnionEuropean Union (EU) [643476]
FX This work has received funding from the European Union's Horizon 2020
   research and innovation programme under grant agreement No. 643476
   (COMPARE).
CR Bakonyi T, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.41.17-00644
   Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021
   Becker N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032604
   Benson DA, 2010, NUCLEIC ACIDS RES, V38, pD46, DOI 10.1093/nar/gkp1024
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Bonaldo MC, 2017, MEM I OSWALDO CRUZ, V112, P447, DOI 10.1590/0074-02760170134
   Brinkmann A, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.00466-19, 10.1128/jcm.00466-19]
   Cadar D, 2017, EUROSURVEILLANCE, V22, P9, DOI [10.2807/1560-7917.es.2017.22.14.30501, 10.2807/1560-7917.ES.2017.22.14.30501]
   Cadar D., 2017, EUROSURVEILLANCE, V22
   Clausen PTLC, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2336-6
   Diagne MM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020181
   Edgar R. C., NUCL ACIDS RES, V32, P1792
   Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria N. R., 2018, BIORXIV
   GitHub-nanoporetech/ flappie, 2019, GITHUB NANOPORETECH
   Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Luhken R, 2017, EMERG INFECT DIS, V23, P1991, DOI 10.3201/eid2312.171257
   Magi A., 2016, BRIEF BIOINFORM, V18
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Munnink BBO, 2019, INFECT GENET EVOL, V73, P49, DOI 10.1016/j.meegid.2019.04.015
   Nanopore Store, 2019, NANOPORE STORE R10 F
   Pecorari M., 2009, EURO SURVEILLANCE B, V14
   Pierro A, 2013, CLIN MICROBIOL INFEC, V19, pE451, DOI 10.1111/1469-0691.12241
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Rang FJ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1462-9
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Wick R. R., 2018, R R WICK GITHUB RRWI
   Wick RR, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1727-y
   Zaaijer HL, 2019, TRANSFUSION, V59, P2931, DOI 10.1111/trf.15444
NR 32
TC 0
Z9 0
U1 1
U2 1
PU JOURNAL OF VISUALIZED EXPERIMENTS
PI CAMBRIDGE
PA 1 ALEWIFE CENTER, STE 200, CAMBRIDGE, MA 02140 USA
SN 1940-087X
J9 JOVE-J VIS EXP
JI J. Vis. Exp.
PD MAR
PY 2020
IS 157
AR e60906
DI 10.3791/60906
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KZ5ES
UT WOS:000523286100073
PM 32225162
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Yamana, TK
   Shaman, J
AF Yamana, Teresa K.
   Shaman, Jeffrey
TI A framework for evaluating the effects of observational type and quality
   on vector-borne disease forecast
SO EPIDEMICS
LA English
DT Article
DE Infectious disease model; Infectious disease forecasting; Vector-borne
   disease; Disease surveillance data; Dengue; Zika; Mosquito-borne disease
ID SCALE DATA ASSIMILATION; KALMAN FILTER; AEDES-AEGYPTI; DENGUE;
   SURVEILLANCE; MODELS; VIRUS; TRANSMISSION; CHIKUNGUNYA; SYSTEMS
AB Recent research has advanced infectious disease forecasting from an aspiration to an operational reality. The accuracy of such operational forecasting depends on the quantity and quality of observations available for system optimization. In particular, for forecasting systems that use combined mechanistic model-inference approaches, a broad suite of epidemiological observations could be utilized, if these data were available in near real time. In cases where such data are limited, an in silica, synthetic framework for evaluating the potential benefits of observations on forecasting accuracy can allow researchers and public health officials to more optimally allocate resources for disease surveillance and monitoring. Here, we demonstrate the application of such a framework, using a model-inference system designed to predict dengue, and identify the type and quality of observations that would improve forecasting accuracy.
C1 [Yamana, Teresa K.; Shaman, Jeffrey] Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA.
RP Yamana, TK (corresponding author), Columbia Univ, Mailman Sch Publ Hlth, Dept Environm Hlth Sci, New York, NY 10032 USA.
EM tky2104@cumc.columbia.edu
OI Yamana, Teresa/0000-0001-8349-3151
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [GM110748,
   ES009089]; Defense Threat Reduction Agency of the US Department of
   Defense [HDTRA1-15-C-0018]
FX The research is supported by grant nos. GM110748 and ES009089 from the
   US National Institutes of Health, and contract HDTRA1-15-C-0018 from the
   Defense Threat Reduction Agency of the US Department of Defense. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Anderson JL, 2001, MON WEATHER REV, V129, P2884, DOI 10.1175/1520-0493(2001)129<2884:AEAKFF>2.0.CO;2
   ARNOLD CP, 1986, B AM METEOROL SOC, V67, P687, DOI 10.1175/1520-0477(1986)067<0687:OSSEPP>2.0.CO;2
   Atlas R, 1997, J METEOROL SOC JPN, V75, P111, DOI 10.2151/jmsj1965.75.1B_111
   Auerswald H, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040304
   Barbazan P, 2002, MICROBES INFECT, V4, P699, DOI 10.1016/S1286-4579(02)01589-7
   Beatty ME, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000890
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Chang FS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004043
   Chitnis N, 2006, SIAM J APPL MATH, V67, P24, DOI 10.1137/050638941
   Ferreira DAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2025-8
   Davis J.K., 2017, PLOS CURR, DOI [10.1371/currents.outbreaks.90e80717c4e67e1a830f17feeaaf85de.9:ecurrents.outbreaks.90e80717c4e67e1a830f17feeaaf85de, DOI 10.1371/CURRENTS.OUTBREAKS.90E80717C4E67E1A830F17FEEAAF85DE.9:ECURRENTS.OUTBREAKS.90E80717C4E67E1A830F17FEEAAF85DE]
   DeFelice NB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14592
   Emmerich P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002580
   Endy TP, 2010, FRONTIERS IN DENGUE VIRUS RESEARCH, P3
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Focks D.A., 2004, REV ENTOMOLOGICAL SA
   Fournet Florence, 2018, Infect Dis Poverty, V7, P99, DOI 10.1186/s40249-018-0473-9
   Hu WB, 2006, ECOL MODEL, V196, P505, DOI 10.1016/j.ecolmodel.2006.02.028
   Kilpatrick AM, 2013, AM J EPIDEMIOL, V178, P829, DOI 10.1093/aje/kwt046
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   KUO YH, 1985, MON WEATHER REV, V113, P1852, DOI 10.1175/1520-0493(1985)113<1852:TAOTMA>2.0.CO;2
   Laneria K, 2015, P NATL ACAD SCI USA, V112, P8786, DOI 10.1073/pnas.1419047112
   Lauer SA, 2018, P NATL ACAD SCI USA, V115, pE2175, DOI 10.1073/pnas.1714457115
   Lin CH, 2011, INT J ENV RES PUB HE, V8, P2798, DOI 10.3390/ijerph8072798
   Lowe R, 2016, ELIFE, V5, DOI 10.7554/eLife.11285
   Manore CA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005255
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Medeiros AS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194108
   Organization WH, 2003, GUID DENG SURV MOSQ
   Pena-Garcia VH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13070734
   Reich NG, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0414
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Shaman J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3837
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   Shi Y, 2016, ENVIRON HEALTH PERSP, V124, P1369, DOI 10.1289/ehp.1509981
   Sivagnaname N, 2012, INDIAN J MED RES, V136, P739
   Wu Y, 2016, EPIDEMIOL INFECT, V144, P1895, DOI 10.1017/S0950268816000297
   Yamana TK, 2017, ADV WATER RESOUR, V108, P416, DOI 10.1016/j.advwatres.2016.10.003
   Yamana TK, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0410
   Zhang FQ, 2006, MON WEATHER REV, V134, P722, DOI 10.1175/MWR3101.1
   Zhang FQ, 2004, MON WEATHER REV, V132, P1238, DOI 10.1175/1520-0493(2004)132<1238:IOIEAO>2.0.CO;2
NR 41
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1755-4365
J9 EPIDEMICS-NETH
JI Epidemics
PD MAR
PY 2020
VL 30
AR 100359
DI 10.1016/j.epidem.2019.100359
PG 8
WC Infectious Diseases
SC Infectious Diseases
GA KY6EB
UT WOS:000522664200001
PM 31439454
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Boydell, C
AF Boydell, Christine
TI The Mad Silkman: Zika and Lida Ascher Textiles and Fashion
SO COSTUME-THE JOURNAL OF THE COSTUME SOCIETY
LA English
DT Book Review
C1 [Boydell, Christine] De Montfort Univ, Leicester, Leics, England.
RP Boydell, C (corresponding author), De Montfort Univ, Leicester, Leics, England.
CR HLAVACOVA K, 2019, MAD SILKMAN ZIKA LID
NR 1
TC 0
Z9 0
U1 0
U2 0
PU EDINBURGH UNIV PRESS
PI EDINBURGH
PA THE TUN-HOLYROOD RD, 12 2F JACKSONS ENTRY, EDINBURGH EH8 8PJ, SCOTLAND
SN 0590-8876
EI 1749-6306
J9 COSTUME
JI Costume
PD MAR
PY 2020
VL 54
IS 1
BP 160
EP 161
PG 3
WC Humanities, Multidisciplinary
SC Arts & Humanities - Other Topics
GA KY2GG
UT WOS:000522388700014
DA 2020-07-08
ER

PT J
AU Akanda, AS
   Johnson, K
   Ginsberg, HS
   Couret, J
AF Akanda, Ali S.
   Johnson, Kristin
   Ginsberg, Howard S.
   Couret, Jannelle
TI Prioritizing Water Security in the Management of Vector-Borne Diseases:
   Lessons From Oaxaca, Mexico
SO GEOHEALTH
LA English
DT Editorial Material
DE Dengue; Aedes aegypti; Aedes albopictus; mosquito; water insecurity;
   Oaxaca
AB Changes in human water use, along with temperature and rainfall patterns, are facilitating habitat spread and distribution of Aedes aegypti and Aedes albopictus mosquitoes, the primary vectors for the transmission of Dengue, Chikungunya, and Zika viruses in the Americas. Artificial containers and wet spots provide major sources of mosquito larval habitat in residential areas. Mosquito abatement and control strategies remain the most effective public health interventions for minimizing the impact of these vector-borne diseases. Understanding how water insecurity is conducive to the establishment and elimination of endemic mosquito populations, particularly in arid or semiarid regions, is a vital component in shaping these intervention strategies.
   Plain Language Summary: As urban growth and climate change facilitates the spread of Aedes mosquitos, risking substantial increases in Dengue, Zika, and Chikungunya in the Americas, managing disease burden will rely on effective interventions to reduce water insecurity. We use the case of Oaxaca, Mexico, to illustrate the relationship between water insecurity, the establishment of mosquito habitat, and heightened disease risk from vector-borne diseases.
C1 [Akanda, Ali S.] Univ Rhode Isl, Civil & Environm Engn, Kingston, RI 02881 USA.
   [Johnson, Kristin] Univ Rhode Isl, Dept Polit Sci, Kingston, RI 02881 USA.
   [Ginsberg, Howard S.] Univ Rhode Isl, Dept Plant Sci & Entomol, Kingston, RI 02881 USA.
   [Ginsberg, Howard S.] US Geol Survey, Patuxent Wildlife Res Ctr, Kingston, RI USA.
   [Couret, Jannelle] Univ Rhode Isl, Dept Biol Sci, Kingston, RI 02881 USA.
RP Akanda, AS (corresponding author), Univ Rhode Isl, Civil & Environm Engn, Kingston, RI 02881 USA.
EM akanda@uri.edu
CR Akanda A.S., 2012, EOS T AM GEOPHYS UN, V93, P353, DOI DOI 10.1029/2012EO370001
   Akanda AS, 2018, LANCET PLANET HEALTH, V2, pE190, DOI 10.1016/S2542-5196(18)30063-9
   [Anonymous], 2018, MEXICO NEWS DAI 0825
   Baez-Hernandez N., 2017, MATH MODEL DENGUE CH
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Brady OJ, 2020, ANNU REV ENTOMOL, V65, P191, DOI 10.1146/annurev-ento-011019-024918
   Couret J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087468
   Davalos-Becerril E., 2019, PLOS ONE, V6, P1
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Fox J., 2018, BLOOMBERG OPINI 0818
   Gubler DJ, 2010, VECTOR BIOLOGY, ECOLOGY AND CONTROL, P39, DOI 10.1007/978-90-481-2458-9_4
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   INEGI, 2011, MEX CIFR INF NAC ENT
   Kraemer M. U., 2019, NATURE MICROBIOLOGY, V1
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Lucey DR, 2016, JAMA-J AM MED ASSOC, V315, P865, DOI 10.1001/jama.2016.0904
   Machado-Machado EA, 2012, APPL GEOGR, V33, P82, DOI 10.1016/j.apgeog.2011.06.011
   NIEBYLSKI ML, 1994, J AM MOSQUITO CONTR, V10, P447
   NSS Oaxaca, 2019, NSS OAXACA      0410
   Okuneye KO, 2017, J BIOL SYST, V25, P545, DOI 10.1142/S0218339017400046
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Perez-Ramirez G, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-260
   Ponlawat A, 2005, J MED ENTOMOL, V42, P844, DOI 10.1603/0022-2585(2005)042[0844:BFPOAA]2.0.CO;2
   Rivas MG, 2014, COMMUNITY DEV, V45, P2, DOI 10.1080/15575330.2013.868817
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Torres H. A., 2017, IMPARCIAL MAJOR 0913
NR 26
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2471-1403
J9 GEOHEALTH
JI GeoHealth
PD MAR
PY 2020
VL 4
IS 3
AR UNSP e2019GH000201
DI 10.1029/2019GH000201
PG 5
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KX6KH
UT WOS:000521987600001
PM 32185244
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Jorge, VD
   Albagli, S
AF Jorge, Vanessa de Arruda
   Albagli, Sarita
TI Research data sharing during the Zika virus public health emergency
SO INFORMATION RESEARCH-AN INTERNATIONAL ELECTRONIC JOURNAL
LA English
DT Article
AB Introduction. In a public health emergency, sharing of research data is acknowledged as essential to manage treatment and control of the disease. The objective of this study was to examine how researchers reacted during the Zika virus emergency in Brazil.
   Method. A literature review examined both unpublished reports and the published literature. Interviews were conducted with eleven researchers (from a sample of sixteen) in the Renezika network. Questions concerned sources of data used for research on the Zika virus, where this data was obtained, and what requirements by funding agencies influenced how data generated was shared - and how open the degree of sharing was.
   Analysis. A content analysis matrix was developed based on the results of the interviews. The data were organised acording to categories, subcategories, records units and frequency of records units.
   Results. Researchers stressed the importance of access to issue samples as well as pure research data. Collaboration - and publication - increased but also depended on trust in existing networks. Researchers were aware that many agencies and publishers required the deposit of research data in repositories - and several options existed for Zika research.
   Conclusions. The findings show that research data were shared, but not necessarily as open data. Trust was necessary between researchers, and researchers in developing countries needed to be assured about their rights and ownership of data, and publications using that data.
C1 [Jorge, Vanessa de Arruda] Oswaldo Cruz Fdn FIOCRUZ, Av Brazil 4365, Rio De Janeiro, Brazil.
   [Albagli, Sarita] Brazilian Inst Informat Sci & Technol, Rua Lauro Muller,455-4 Andar, Rio De Janeiro, Brazil.
   [Albagli, Sarita] IBICT, Postgrad Programme Informat Sci, Rio De Janeiro, Brazil.
   [Albagli, Sarita] Univ Fed Rio de Janeiro, UFRJ, Rio De Janeiro, Brazil.
RP Jorge, VD (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Av Brazil 4365, Rio De Janeiro, Brazil.
EM vanessaajorge@gmail.com; sarita.albagli@gmail.com
CR Albuquerque PC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005132
   Bardin L., 2011, ANALISE CONTEUDO
   Brazil. Ministerio da Sande, GUILL BARR CAUS SINT
   BRIET S, 1951, QUEST CE QUE DOCUMEN
   Buckland MK, 1997, J AM SOC INFORM SCI, V48, P804, DOI 10.1002/(SICI)1097-4571(199709)48:9<804::AID-ASI5>3.0.CO;2-V
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Araujo K. M., 2017, REV ELETRONICA COM S, V11, DOI [10.29397/reciis.v11i0.1391, DOI 10.29397/RECIIS.V11I0.1391]
   Diniz D., 2019, EL PAIS COM
   DINIZ Debora, 2016, ZIKA SERTAO NORDESTI
   Dye C, 2016, B WORLD HEALTH ORGAN, V94, P158, DOI 10.2471/BLT.16.170860
   Gadelha P., 2017, VIRUS ZIKA BRASIL RE, P73
   GloPID-R (Global Research Collaboration for Infectious Disease Preparedness), 2018, PRINC DAT SHAR PUBL
   Green B., 2017, BERKMAN KLEIN CTR RE, V2017-1, DOI [10.2139/ssrn.2924751, DOI 10.2139/SSRN.2924751]
   Henriques C. M., 2017, VIRUS ZIKA BRASIL RE, P15
   Johansson MA, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002549
   Jorge V. D. A., 2018, THESIS
   Lowrance WW, 2012, PRIVACY CONFIDENTIAL
   Machado-Silva A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6842-x
   Martins M. de F. M., 2016, REV ELETRONICA COMUN, V10, DOI [10.29397/reciis.v10i1.1096, DOI 10.29397/RECIIS.V10I1.1096]
   Open Knowledge Foundation, WHAT IS OP DAT
   Organisation For Economic Co-Operation And Development, 2007, OECD PRINC GUID ACC
   Pirmez C, 2016, MEM I OSWALDO CRUZ, V111, P285, DOI 10.1590/0074-02760160001
   SAYAO L. F., 2014, RECIIS, V8, P76
   Wellcome Trust, 2016, STAT DAT SHAR PUBL H
   Wilkinson MD, 2016, SCI DATA, V3, DOI 10.1038/sdata.2016.18
   World Health Organization, 2015, DEV GLOB NORMS SHAR
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 27
TC 0
Z9 0
U1 2
U2 2
PU UNIV SHEFFIELD DEPT INFORMATION STUDIES
PI SHEFFIELD
PA UNIV SHEFFIELD, WESTERN BANK, SHEFFIELD S10 2TN, S YORKS, ENGLAND
SN 1368-1613
J9 INFORM RES
JI Inf. Res.
PD MAR
PY 2020
VL 25
IS 1
AR 846
PG 17
WC Information Science & Library Science
SC Information Science & Library Science
GA KX5TF
UT WOS:000521941700003
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Shanmugaraj, B
   Siriwattananon, K
   Wangkanont, K
   Phoolcharoen, W
AF Shanmugaraj, Balamurugan
   Siriwattananon, Konlavat
   Wangkanont, Kittikhun
   Phoolcharoen, Waranyoo
TI Perspectives on monoclonal antibody therapy as potential therapeutic
   intervention for Coronavirus disease-19 (COVID-19)
SO ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY
LA English
DT Review
DE Coronavirus; Emerging threat; Monoclonal Antibody; Immunotherapy;
   Infectious diseases; Viruses; Zoonoses
ID ACUTE RESPIRATORY SYNDROME; RECEPTOR-BINDING DOMAIN; MERS-COV; SARS
   CORONAVIRUS; NEUTRALIZING ANTIBODY; STRUCTURAL DEFINITION; FUNCTIONAL
   RECEPTOR; SPIKE; PROTEIN; INFECTION
AB Last decade witnessed the outbreak of many life-threatening human pathogens including Nipah, Ebola, Chikungunya, Zika, Middle East respiratory syndrome coronavirus (MERS-CoV), Severe Acute respiratory syndrome coronavirus (SARS-CoV) and more recently novel coronavirus (2019-nCoV or SARS-CoV-2). The disease condition associated with novel coronavirus, referred to as Coronavirus disease (COVID-19). The emergence of novel coronavirus in 2019 in Wuhan, China marked the third highly pathogenic coronavirus infecting humans in the 21" century. The continuing emergence of coronaviruses at regular intervals poses a significant threat to human health and economy. Ironically, even after a decade of research on coronavirus, still there are no licensed vaccines or therapeutic agents to treat coronavirus infection which highlights an urgent need to develop effective vaccines or post-exposure prophylaxis to prevent future epidemics. Several clinical, genetic and epidemiological features of COVID-19 resemble SARS-CoV infection. Hence, the research advancements on SARS-CoV treatment might help scientific community in quick understanding of this virus pathogenesis and develop effective therapeutic/prophylactic agents to treat and prevent this infection. Monoclonal antibodies represent the major class of biotherapeutics for passive immunotherapy to fight against viral infection. The therapeutic potential of monoclonal antibodies has been well recognized in the treatment of many diseases. Here, we summarize the potential monoclonal antibody based therapeutic intervention for COVID-19 by considering the existing knowledge on the neutralizing monoclonal antibodies against similar coronaviruses SARS-CoV and MERS-CoV. Further research on COVID-19 pathogenesis could identify appropriate therapeutic targets to develop specific anti-virals against this newly emerging pathogen.
C1 [Shanmugaraj, Balamurugan; Siriwattananon, Konlavat; Phoolcharoen, Waranyoo] Chulalongkorn Univ, Res Unit Plant Produced Pharmaceut, Bangkok, Thailand.
   [Shanmugaraj, Balamurugan; Siriwattananon, Konlavat; Phoolcharoen, Waranyoo] Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Pharmaceut Bot, Bangkok, Thailand.
   [Wangkanont, Kittikhun] Chulalongkorn Univ, Fac Sci, Dept Biochem, Bangkok, Thailand.
RP Phoolcharoen, W (corresponding author), Chulalongkorn Univ, Res Unit Plant Produced Pharmaceut, Bangkok, Thailand.; Phoolcharoen, W (corresponding author), Chulalongkorn Univ, Fac Pharmaceut Sci, Dept Pharmacognosy & Pharmaceut Bot, Bangkok, Thailand.
EM Waranyoo.P@chula.ac.th
RI Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X
FU Second Century Fund (C2F), Chulalongkorn University
FX Author (BS) would like to acknowledge the Second Century Fund (C2F),
   Chulalongkorn University, for providing the fellowship.
CR Arabi Y, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1490-9
   Banerjee A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010041
   Bayry J, 2007, NAT CLIN PRACT RHEUM, V3, P262, DOI 10.1038/ncprheum0481
   Berry JD, 2010, MABS-AUSTIN, V2, P53, DOI 10.4161/mabs.2.1.10788
   Both L, 2013, VACCINE, V31, P1553, DOI 10.1016/j.vaccine.2013.01.025
   Carlos WG, 2020, AM J RESP CRIT CARE, V201, pP7, DOI 10.1164/rccm.2014P7
   Caskey M, 2015, NATURE, V522, P487, DOI 10.1038/nature14411
   Chan KH, 2013, J INFECTION, V67, P130, DOI 10.1016/j.jinf.2013.03.015
   Chen Z, 2017, J INFECT DIS, V215, P1807, DOI 10.1093/infdis/jix209
   Coleman CM, 2014, J VIROL, V88, P5209, DOI 10.1128/JVI.03488-13
   Coughlin MM, 2012, REV MED VIROL, V22, P2, DOI 10.1002/rmv.706
   Davey RT, 2016, NEW ENGL J MED, V375, P1448, DOI 10.1056/NEJMoa1604330
   de Wit E, 2013, P NATL ACAD SCI USA, V110, P16598, DOI 10.1073/pnas.1310744110
   Demurtas OC, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00054
   Dimitrov Dimiter S, 2012, Methods Mol Biol, V899, P1, DOI 10.1007/978-1-61779-921-1_1
   Du LY, 2017, EXPERT OPIN THER TAR, V21, P131, DOI 10.1080/14728222.2017.1271415
   Elshabrawy HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050366
   Gralinski LE, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12020135
   Greenough TC, 2005, J INFECT DIS, V191, P507, DOI 10.1086/427242
   Gupta P, 2016, MABS-AUSTIN, V8, P991, DOI 10.1080/19420862.2016.1167294
   Hiatt A, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.AID-0004-2012
   Houser KV, 2016, J INFECT DIS, V213, P1557, DOI 10.1093/infdis/jiw080
   Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200
   Jiang LW, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008140
   Kirchdoerfer RN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34171-7
   Kruse RL, 2020, F1OOORES, V9
   Lai CC, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105924
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301
   Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316
   Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145
   Li Y, 2015, CELL RES, V25, P1237, DOI 10.1038/cr.2015.113
   Lip KM, 2006, J VIROL, V80, P941, DOI 10.1128/JVI.80.2.941-950.2006
   Lu GW, 2013, NATURE, V500, P227, DOI 10.1038/nature12328
   Luke TC, 2006, ANN INTERN MED, V145, P599, DOI 10.7326/0003-4819-145-8-200610170-00139
   Mair-Jenkins J, 2015, J INFECT DIS, V211, P80, DOI 10.1093/infdis/jiu396
   Marasco WA, 2007, NAT BIOTECHNOL, V25, DOI 10.1038/nbt1363
   Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3
   Mupapa K, 1999, J INFECT DIS, V179, pS18, DOI 10.1086/514298
   Ng OW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102415
   Niu PH, 2018, SCI CHINA LIFE SCI, V61, P1280, DOI 10.1007/s11427-018-9343-8
   Niu PH, 2018, J INFECT DIS, V218, P1249, DOI 10.1093/infdis/jiy311
   Pak JE, 2009, J MOL BIOL, V388, P815, DOI 10.1016/j.jmb.2009.03.042
   Pallesen J, 2017, P NATL ACAD SCI USA, V114, pE7348, DOI 10.1073/pnas.1707304114
   Prabakaran P, 2006, J BIOL CHEM, V281, P15829, DOI 10.1074/jbc.M600697200
   Rabaan AA, 2017, J MED MICROBIOL, V66, P1261, DOI 10.1099/jmm.0.000565
   Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005
   Sainsbury F, 2020, CURR OPIN BIOTECH, V61, P110, DOI 10.1016/j.copbio.2019.11.002
   Schroeder HW, 2010, J ALLERGY CLIN IMMUN, V125, pS41, DOI 10.1016/j.jaci.2009.09.046
   Shanmugaraj B, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9020148
   Song ZQ, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010059
   Sparrow E, 2017, B WORLD HEALTH ORGAN, V95, P235, DOI [10.2471/BLT.16.178061, 10.2471/blt.16.178061]
   Sui JH, 2004, P NATL ACAD SCI USA, V101, P2536, DOI 10.1073/pnas.0307140101
   Sui JH, 2005, J VIROL, V79, P5900, DOI 10.1128/JVI.79.10.5900-5906.2005
   ter Meulen J, 2004, LANCET, V363, P2139, DOI 10.1016/S0140-6736(04)16506-9
   ter Meulen J, 2006, PLOS MED, V3, P1071, DOI 10.1371/journal.pmed.0030237
   van den Brink EN, 2005, J VIROL, V79, P1635, DOI 10.1128/JVI.79.3.1635-1644.2005
   van Doremalen N, 2017, ANTIVIR RES, V143, P30, DOI 10.1016/j.antiviral.2017.03.025
   Walls AC, 2019, CELL, V176, P1026, DOI 10.1016/j.cell.2018.12.028
   Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.02015-19
   Wang D, 2020, JAMA-J AM MED ASSOC, DOI [10.1001/ama.2020.1585, DOI 10.1001/AMA.2020.1585]
   Wang L, 2018, J VIROL, V92, DOI 10.1128/JVI.01060-18
   Wang LS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8712
   Wang NS, 2019, CELL REP, V28, P3395, DOI 10.1016/j.celrep.2019.08.052
   World Health Organization, COR DIS COVID 19 OUT
   World Health Organization, 2020, COR DIS 2019 COVID 1
   Wrapp D, 2020, BIORXIV, DOI [10.1101/2020.02.11.944462v1.full.pdf, DOI 10.1101/2020.02.11.944462V1.FULL.PDF]
   Xu JY, 2019, EMERG MICROBES INFEC, V8, P841, DOI 10.1080/22221751.2019.1624482
   Yeh KM, 2005, J ANTIMICROB CHEMOTH, V56, P919, DOI 10.1093/jac/dki346
   Ying TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9223
   Ying TL, 2015, MICROBES INFECT, V17, P142, DOI 10.1016/j.micinf.2014.11.008
   Ying TL, 2014, J VIROL, V88, P7796, DOI 10.1128/JVI.00912-14
   Yu XJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13133
   Yuan Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15092
   Zhang L, 2020, J MED VIROL, V92, P479, DOI 10.1002/jmv.25707
   Zhang SY, 2018, CELL REP, V24, P441, DOI 10.1016/j.celrep.2018.06.041
   Zhou HX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10897-4
   Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104
NR 78
TC 22
Z9 22
U1 33
U2 33
PU ALLERGY IMMUNOL SOC THAILAND
PI BANGKOK
PA DIV ALLERGY & CLINICAL IMMUNOLOGY, DEPT MEDICINE, CHULALONGKORN UNIV,
   BANGKOK 10330, THAILAND
SN 0125-877X
EI 2228-8694
J9 ASIAN PAC J ALLERGY
JI Asian Pac. J. Allergy Immunol.
PD MAR
PY 2020
VL 38
IS 1
BP 10
EP 18
DI 10.12932/AP-200220-0773
PG 9
WC Allergy; Immunology
SC Allergy; Immunology
GA KX4BQ
UT WOS:000521825200002
PM 32134278
OA Bronze
DA 2020-07-08
ER

PT J
AU Bonaparte, M
   Huleatt, J
   Hodge, S
   Zheng, L
   Lustig, Y
   DiazGranados, CA
   Ataman-Onal, Y
   Savarino, S
AF Bonaparte, Matthew
   Huleatt, James
   Hodge, Shekema
   Zheng, Lingyi
   Lustig, Yaniv
   DiazGranados, Carlos A.
   Ataman-Onal, Yasemin
   Savarino, Stephen
TI Evaluation of dengue serological tests available in Puerto Rico for
   identification of prior dengue infection for prevaccination screening
SO DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
LA English
DT Article
DE CYD-TDV; Dengvaxia; Dengue serostatus; Prior dengue infection;
   Prevaccination screening; Sensitivity; Specificity; Cross-reactivity;
   Flaviviruses
ID VACCINE; SAFETY; IMMUNOGENICITY; CHILDREN; ADULTS; TRIAL
AB We assessed a dengue IgG rapid diagnostic test (RDT) and IgG enzyme-linked immunosorbent assay (ELISA) to determine their suitability for dengue prevaccination screening. Each exhibited 2.99% specificity. The RDT demonstrated no Zika cross-reactivity, while the ELISA displayed greater sensitivity. Both could safely guide vaccination in Puerto Rico pending availability of improved serotests. (C) 2019 The Authors. Published by Elsevier B.V.
C1 [Bonaparte, Matthew; Huleatt, James; Hodge, Shekema; Zheng, Lingyi; DiazGranados, Carlos A.; Savarino, Stephen] Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [Lustig, Yaniv] Israel Minist Hlth, Publ Hlth Serv, Cent Virol Lab, Chaim Sheba Med Ctr, IL-52621 Ramat Gan, Israel.
   [Ataman-Onal, Yasemin] Sanofi Pasteur, 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.
RP Savarino, S (corresponding author), Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370 USA.
EM Matthew.Bonaparte@sanofi.com; James.Huleatt@sanofi.com;
   Shekema.Hodge@sanofi.com; Lingyi.Zheng@sanofi.com;
   Yaniv.Lustig@sheba.health.gov.il; Carlos.DiazGranados@sanofi.com;
   Yasemin.Ataman-Onal@sanofi.com; Stephen.Savarino@sanofi.com
FU Sanofi Pasteur
FX This work was supported by Sanofi Pasteur.
CR Biocan Diagnostics Inc, 2015, TELLMEFAST DENG IGG
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Capeding RZ, 2011, VACCINE, V29, P3863, DOI 10.1016/j.vaccine.2011.03.057
   Dubey AP, 2016, HUM VACC IMMUNOTHER, V12, P512, DOI 10.1080/21645515.2015.1076598
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Nascimento EJM, 2019, AM J TROP MED HYG, V101, P708, DOI 10.4269/ajtmh.19-0270
   Nascimento EJM, 2018, J VIROL METHODS, V257, P48, DOI 10.1016/j.jviromet.2018.03.007
   SciMedx, 2017, DENG IGG SER MIRCR E
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Villar LA, 2013, PEDIATR INFECT DIS J, V32, P1102, DOI 10.1097/INF.0b013e31829b8022
NR 11
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0732-8893
EI 1879-0070
J9 DIAGN MICR INFEC DIS
JI Diagn. Microbiol. Infect. Dis.
PD MAR
PY 2020
VL 96
IS 3
AR UNSP 114918
DI 10.1016/j.diagmicrobio.2019.114918
PG 4
WC Infectious Diseases; Microbiology
SC Infectious Diseases; Microbiology
GA KW1QW
UT WOS:000520947000007
PM 31839333
OA Other Gold
DA 2020-07-08
ER

PT J
AU Broeders, S
   Garlant, L
   Fraiture, MA
   Vandermassen, E
   Suin, V
   Vanhomwegen, J
   Dupont-Rouzeyrol, M
   Rousset, D
   Van Gucht, S
   Roosens, N
AF Broeders, Sylvia
   Garlant, Linda
   Fraiture, Marie-Alice
   Vandermassen, Els
   Suin, Vanessa
   Vanhomwegen, Jessica
   Dupont-Rouzeyrol, Myrielle
   Rousset, Dominique
   Van Gucht, Steven
   Roosens, Nancy
TI A new multiplex RT-qPCR method for the simultaneous detection and
   discrimination of Zika and chikungunya viruses
SO INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
LA English
DT Article
DE RT-qPCR; Zika virus; Chikungunya virus; Multiplex; Identification;
   Discrimination
ID POLYMERASE-CHAIN-REACTION; AUTOCHTHONOUS TRANSMISSION; SEXUAL
   TRANSMISSION; AEDES-ALBOPICTUS; REUNION ISLAND; YELLOW-FEVER; VIRAL
   LOAD; INFECTION; OUTBREAK; DENGUE
AB Objective: The re-emergence and spread of tropical viruses to new areas has raised a wave of concern worldwide. In order to treat patients at an early stage and prevent the diffusion of an outbreak, early diagnosis, and therefore fast and adequate detection, is needed. To this end, a multiplex reverse transcription real-time polymerase chain reaction TaqMan method was designed to detect Zika (ZIKV) and chikungunya (CHIKV) viruses simultaneously.
   Methods: Two methods targeting different genome segments were selected from the literature for each virus. These were adapted for high genome coverage and combined in a four-plex assay that was thoroughly validated in-house. The SCREENED tool was used to evaluate the sequence coverage of the method.
   Results: The full validation approach showed that the new four-plex method allows the specific and sensitive identification and discrimination of ZIKV and CHIKV in routine samples. The combination of two targets per virus allowing almost 100% coverage of about 500 genomes is shown for the first time.
   Conclusions: PCR is a reliable user-friendly technique that can be applied in remote areas. Such multiplex methods enable early and efficient diagnosis, leading to rapid treatment and effective confinement in outbreak cases. They may also serve as an aid for surveillance, and the full validation permits easy method-transfer allowing worldwide harmonization. (C) 2020 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
C1 [Broeders, Sylvia; Garlant, Linda; Fraiture, Marie-Alice; Vandermassen, Els; Roosens, Nancy] Sciensano, Transversal Act Appl Genom, J Wytsmanstr 14, B-1050 Brussels, Belgium.
   [Suin, Vanessa; Van Gucht, Steven] Sciensano, Viral Dis, J Wytsmanstr 14, B-1050 Brussels, Belgium.
   [Vanhomwegen, Jessica] Inst Pasteur France, CIBU, 25-28 Rue Docteur Roux, F-75724 Paris 15, France.
   [Dupont-Rouzeyrol, Myrielle] Inst Pasteur Nouvelle Caledonie, URE Dengue & Arboviroses, 11 Ave P Doumer,BP 61, Noumea 98845, New Caledonia.
   [Rousset, Dominique] Inst Pasteur Guyane, Lab Virol, 23 Ave Pasteur BP 6010, Cayenne 97306, French Guiana.
   [Broeders, Sylvia] Sciensano, Qual Labs, J Wytsmanstr 14, B-1050 Brussels, Belgium.
   [Garlant, Linda] European Commiss, Directorate Gen Joint Res Ctr, Directorate F Hlth Consumers & Reference Mat, Fraud Detect & Prevent Unit F4, Retieseweg 111, B-2440 Geel, Belgium.
RP Roosens, N (corresponding author), Sciensano, J Wytsmanstr 14, B-1050 Brussels, Belgium.
EM sylvia.broeders@sciensano.be; linda.garlant@sciensano.be;
   marie-alice.fraiture@sciensano.be; els.vandermassen@sciensano.be;
   vanessa.suin@sciensano.be; jvhomweg@pasteur.fr; mdupont@pasteur.nc;
   drousset@pasteur-cayenne.fr; steven.vangucht@sciensano.be;
   nancy.roosens@sciensano.be
FU project ORIENT-EXPRESS - WIV-ISP [0000754]; Arbo-VIRTUESS project -
   Actions Concertees Interpasteuriennes [ACIP 2014-053]
FX This work was supported by the project ORIENT-EXPRESS financed by the
   WIV-ISP(presently named Sciensano; RP-PJ project number 0000754) and
   partially by the Arbo-VIRTUESS project financed by the Actions
   Concertees Interpasteuriennes (project number ACIP 2014-053). These
   funding sources had no involvement in the study design, data
   collection/analysis/interpretation, or writing of the article. The
   authors are grateful to the service Mycology & Aerology (IHEM/BCCM
   collection Sciensano) and B. Lambrecht (Sciensano) for providing
   materials, and S. Lamoral (Sciensano) for technical support. The authors
   would also like to thank A. Perilhou and N. Jolly (Centre for
   Translational Science, Institut Pasteur Paris) for their expertise on
   ethical issues.
CR Aamir UB, 2017, LANCET INFECT DIS, V17, P483, DOI 10.1016/S1473-3099(17)30191-3
   AFNOR, 2003, 161402003 AFNOR ISO
   [Anonymous], 2011, ISO22118
   [Anonymous], 2006, ISO24276
   Anukumar B, 2014, J CLIN VIROL, V61, P152, DOI 10.1016/j.jcv.2014.06.003
   Armstrong P, 2016, MMWR MORB MORTAL WKL, V65
   Atkinson B, 2016, EMERG INFECT DIS, V22, P940, DOI 10.3201/eid2205.160107
   Aubry M, 2015, EMERG INFECT DIS, V21, P724, DOI 10.3201/eid2104.141741
   Aw PPK, 2014, METHODS MOL BIOL, V1138, P175, DOI 10.1007/978-1-4939-0348-1_12
   Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Beltrame A, 2007, EMERG INFECT DIS, V13, P1264, DOI 10.3201/eid1308.070161
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Broeders S, 2014, TRENDS FOOD SCI TECH, V37, P115, DOI 10.1016/j.tifs.2014.03.008
   Brouard C, 2008, TRANSFUSION, V48, P1333, DOI 10.1111/j.1537-2995.2008.01646.x
   Broutet N, 2016, NEW ENGL J MED, V374, P1506, DOI 10.1056/NEJMp1602708
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797
   Calvert AE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185340
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Capeding MR, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002331
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Charrel RN, 2014, CLIN MICROBIOL INFEC, V20, P662, DOI 10.1111/1469-0691.12694
   Chen LH, 2016, ANN INTERN MED, V164, P613, DOI 10.7326/M16-0150
   Corman VM, 2016, B WORLD HEALTH ORGAN, V94, P880, DOI 10.2471/BLT.16.175950
   Cunha MS, 2017, EMERG INFECT DIS, V23, P1737, DOI 10.3201/eid2310.161855
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Davidson A, 2016, MMWR MORB MORTAL WKL, V65
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Deblauwe I, 2015, PARASITOL RES, V114, P3469, DOI 10.1007/s00436-015-4575-z
   Deckard D. T., 2016, MMWR-MORBID MORTAL W, V2016, P65
   Delisle E, 2015, EURO SURVEILL, V20
   Drake JW, 1999, P NATL ACAD SCI USA, V96, P13910, DOI 10.1073/pnas.96.24.13910
   Drexler JF, 2007, J CLIN MICROBIOL, V45, P2061, DOI 10.1128/JCM.00136-07
   Ducheyne E, 2018, INT J HEALTH GEOGR, V17, DOI 10.1186/s12942-018-0125-0
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Duijster JW, 2016, INFECTION, V44, P797, DOI 10.1007/s15010-016-0906-y
   ECDC, EUR CTR DIS PREV CON
   ElWahed AA, 2017, PLOS CURR, V9
   EURL, 2010, CRLVL0407VP EURL
   FAGBAMI AH, 1979, J HYG-CAMBRIDGE, V83, P213, DOI 10.1017/S0022172400025997
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gerardin P, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002996
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873
   Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681
   Gregianini TS, 2017, REV MED VIROL, V27, DOI 10.1002/rmv.1943
   Grivard P, 2007, PATHOL BIOL, V55, P490, DOI 10.1016/j.patbio.2007.07.002
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hamer DH, 2014, ANN INTERN MED, V161, P827, DOI 10.7326/M14-1958
   Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13
   Hirayama T, 2012, J CLIN MICROBIOL, V50, P2047, DOI 10.1128/JCM.06557-11
   Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203
   Javelle E, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003603
   Jenkins GM, 2002, J MOL EVOL, V54, P156, DOI 10.1007/s00239-001-0064-3
   Johnson BW, 2016, J INFECT DIS, V214, pS471, DOI 10.1093/infdis/jiw274
   JOUBERT JJ, 1985, S AFR MED J, V67, P500
   Kabir I, 2017, LANCET INFECT DIS, V17, P1118, DOI 10.1016/S1473-3099(17)30564-9
   Kam YW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003445
   Kang JG, 2006, J MICROBIOL, V44, P572
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   KWOK S, 1990, NUCLEIC ACIDS RES, V18, P999, DOI 10.1093/nar/18.4.999
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2007, EMERG INFECT DIS, V13, P764, DOI 10.3201/eid1305.070015
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   LINDSEY HS, 1976, J CLIN MICROBIOL, V4, P503
   Litzba N, 2008, J VIROL METHODS, V149, P175, DOI 10.1016/j.jviromet.2008.01.004
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Mansuy JM, 2016, LANCET INFECT DIS, V16, P405, DOI 10.1016/S1473-3099(16)00138-9
   Maria AT, 2016, EUROSURVEILLANCE, V2016, P21
   Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000
   McCarthy M., ZIKA VIRUS WAS TRANS, P352
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Meltzer E, 2016, EMERG INFECT DIS, V22, P1521, DOI 10.3201/eid2208.160480
   Moi ML, 2017, LANCET INFECT DIS, V17, P805, DOI 10.1016/S1473-3099(17)30412-7
   Messina JP, 2015, NAT REV MICROBIOL, V13, P230, DOI 10.1038/nrmicro3430
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761
   Musso D, 2017, LANCET INFECT DIS, V17, P782, DOI 10.1016/S1473-3099(17)30251-7
   Musso D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0556-9
   Musso D, 2015, J CLIN VIROL, V68, P53, DOI 10.1016/j.jcv.2015.04.021
   Musso D, 2015, EMERG INFECT DIS, V21, P359, DOI 10.3201/eid2102.141363
   NCBI, VIR RES DAT
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Panning M, 2008, EMERG INFECT DIS, V14, P416, DOI 10.3201/eid1403.070906
   Parida MM, 2007, J CLIN MICROBIOL, V45, P351, DOI 10.1128/JCM.01734-06
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Patel P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004953
   Paty MC, 2014, EUROSURVEILLANCE, V19, P10, DOI 10.2807/1560-7917.ES2014.19.28.20856
   Paules CI, 2017, NEW ENGL J MED, V376, P1397, DOI 10.1056/NEJMp1702172
   Pongsiri P, 2012, ASIAN PAC J TROP MED, V5, P342, DOI 10.1016/S1995-7645(12)60055-8
   Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e
   Ramful D, 2007, PEDIATR INFECT DIS J, V26, P811, DOI 10.1097/INF.0b013e3180616d4f
   Rampal, 2007, J Assoc Physicians India, V55, P765
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Reiter P, 2010, EUROSURVEILLANCE, V15, P11
   Renault P, 2007, AM J TROP MED HYG, V77, P727
   Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6
   Rocklov J, 2016, EBIOMEDICINE, V9, P250, DOI 10.1016/j.ebiom.2016.06.009
   Rodrigues LC, 2016, LANCET, V387, P2070, DOI 10.1016/S0140-6736(16)00742-X
   Sadarangani SP, 2016, ANN ACAD MED SINGAP, V45, P381
   Saunders N, 2013, J CLIN VIROL, V56, P260, DOI 10.1016/j.jcv.2012.11.013
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Schilte C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002137
   Shan C, 2017, EBIOMEDICINE, V17, P157, DOI 10.1016/j.ebiom.2017.03.006
   Shinohara K, 2016, J TRAVEL MED, V23, DOI 10.1093/jtm/tav011
   Steinhagen K., 2015, EUROSURVEILLANCE, V2016, P21, DOI DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Tauro LB, 2017, J MED VIROL, V89, P1, DOI 10.1002/jmv.24696
   Thiberville SD, 2013, ANTIVIR RES, V99, P345, DOI 10.1016/j.antiviral.2013.06.009
   Tsai WY, 2018, EMERG INFECT DIS, V24, P1355, DOI 10.3201/eid2407.171170
   Vanneste K, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2313-0
   Wang SM, 2016, METHODS MOL BIOL, V1426, P105, DOI 10.1007/978-1-4939-3618-2_10
   Wang X, 2016, J VIROL METHODS, V238, P86, DOI 10.1016/j.jviromet.2016.10.010
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Whitehorn J, 2010, BRIT MED BULL, V95, P161, DOI 10.1093/bmb/ldq019
   WHO, ZIKV EP BRAZ FAST SP
   WHO, 2016, COUNTR TERR REP MOSQ
   WHO, 2016, SIT REPR ZIK VIR MIC
   Wielanek AC, 2007, NEUROLOGY, V69, P2105, DOI 10.1212/01.wnl.0000277267.07220.88
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   World Health Organization (WHO), 2016, DIS OUTBREAK NE 0208
   World Health Organization (WHO), 2018, DIS OUTBREAK NE 0208
   Zammarchi L, 2015, EUROSURVEILLANCE, V20, P14
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 136
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1201-9712
EI 1878-3511
J9 INT J INFECT DIS
JI Int. J. Infect. Dis.
PD MAR
PY 2020
VL 92
BP 160
EP 170
DI 10.1016/j.ijid.2019.12.028
PG 11
WC Infectious Diseases
SC Infectious Diseases
GA KT7KI
UT WOS:000519191900026
PM 31884173
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Honein, MA
   Woodworth, KR
   Gregory, CJ
AF Honein, Margaret A.
   Woodworth, Kate R.
   Gregory, Christopher J.
TI Neurodevelopmental Abnormalities Associated With In Utero Zika Virus
   Infection in Infants and Children-The Unfolding Story
SO JAMA PEDIATRICS
LA English
DT Editorial Material
ID UPDATE INTERIM GUIDANCE; UNITED-STATES; BIRTH-DEFECTS; TERRITORIES;
   MANAGEMENT
C1 [Honein, Margaret A.; Woodworth, Kate R.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy,Mailstop S106-3, Atlanta, GA 30341 USA.
   [Gregory, Christopher J.] Ctr Dis Control & Prevent, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA USA.
RP Honein, MA (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, 4770 Buford Hwy,Mailstop S106-3, Atlanta, GA 30341 USA.
EM mrh7@cdc.gov
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Centers for Disease Control and Prevention (CDC), US ZIK PREGN INF REG
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Faical Adriana Virginia, 2019, BMJ Paediatr Open, V3, pe000486, DOI 10.1136/bmjpo-2019-000486
   Hirai AH, 2018, JAMA PEDIATR, V172, P857, DOI 10.1001/jamapediatrics.2018.1524
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Honein MA, 2019, LANCET INFECT DIS, V19, P349, DOI 10.1016/S1473-3099(18)30793-X
   Lee Ellen H, 2019, J Pediatric Infect Dis Soc, DOI 10.1093/jpids/piz027
   Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
   Mulkey SB, 2019, JAMA PEDIATR, V173, P52, DOI 10.1001/jamapediatrics.2018.4138
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
NR 15
TC 0
Z9 0
U1 2
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD MAR
PY 2020
VL 174
IS 3
BP 237
EP 238
DI 10.1001/jamapediatrics.2019.5257
PG 2
WC Pediatrics
SC Pediatrics
GA KT8AB
UT WOS:000519233100006
PM 31904764
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   Arroyave-Wessel, M
   Peyton, C
   Bulas, DI
   Fourzali, Y
   Jiang, JJ
   Russo, S
   McCarter, R
   Msall, ME
   du Plessis, AJ
   DeBiasi, RL
   Cure, C
AF Mulkey, Sarah B.
   Arroyave-Wessel, Margarita
   Peyton, Colleen
   Bulas, Dorothy, I
   Fourzali, Yamil
   Jiang, JiJi
   Russo, Stephanie
   McCarter, Robert
   Msall, Michael E.
   du Plessis, Adre J.
   DeBiasi, Roberta L.
   Cure, Carlos
TI Neurodevelopmental Abnormalities in Children With In Utero Zika Virus
   Exposure Without Congenital Zika Syndrome
SO JAMA PEDIATRICS
LA English
DT Article
ID UPDATE INTERIM GUIDANCE; LENTICULOSTRIATE VASCULOPATHY; PREGNANCY
   OUTCOMES; PRESCHOOL-CHILDREN; UNITED-STATES; INFECTION; INFANTS;
   TERRITORIES; MANAGEMENT
AB Question Do newborns with in utero Zika virus exposure, normal fetal imaging result, and average head circumference measurement at birth have normal neurodevelopmental outcomes? Findings In this cohort study of 70 Colombian infants with in utero Zika virus exposure but without congenital Zika syndrome at birth, multidomain neurodevelopmental assessment scores deviated from normal scores as the children became older. Meaning Findings from this study suggest long-term neurodevelopmental monitoring should be performed for all infants with Zika virus exposure to ascertain the neurodevelopmental implications of the virus that may manifest with older age.
   Importance The number of children who were born to mothers with Zika virus (ZIKV) infection during pregnancy but who did not have apparent disability at birth is large, warranting the study of the risk for neurodevelopmental impairment in this population without congenital Zika syndrome (CZS). Objective To investigate whether infants without CZS but who were exposed to ZIKV in utero have normal neurodevelopmental outcomes until 18 months of age. Design, Setting, and Participants This cohort study prospectively enrolled a group of pregnant women with ZIKV in Atlantico Department, Colombia, and in Washington, DC. With this cohort, we performed a longitudinal study of infant neurodevelopment. Infants born between August 1, 2016, and November 30, 2017, were included if they were live born, had normal fetal brain findings on magnetic resonance imaging and ultrasonography, were normocephalic at birth, and had normal examination results without clinical evidence of CZS. Seventy-seven infants born in Colombia, but 0 infants born in the United States, met the inclusion criteria. Exposures Prenatal ZIKV exposure. Main Outcomes and Measures Infant development was assessed by the Warner Initial Developmental Evaluation of Adaptive and Functional Skills (WIDEA) and the Alberta Infant Motor Scale (AIMS) at 1 or 2 time points between 4 and 18 months of age. The WIDEA and AIMS scores were converted to z scores compared with normative samples. Longitudinal mixed-effects regression models based on bootstrap resampling methods estimated scores over time, accounting for gestational age at maternal ZIKV infection and infant age at assessment. Results were presented as slope coefficients with 2-tailed P values based on z statistics that tested whether the coefficient differed from 0 (no change). Results Of the 77 Colombian infants included in this cohort study, 70 (91%) had no CZS and underwent neurodevelopmental assessments. Forty infants (57%) were evaluated between 4 and 8 months of age at a median (interquartile range [IQR]) age of 5.9 (5.3-6.5) months, and 60 (86%) underwent assessment between 9 and 18 months of age at a median (IQR) age of 13.0 (11.2-16.4) months. The WIDEA total score (coefficients: age = -0.227 vs age(2) = 0.006; P < .003) and self-care domain score (coefficients: age = -0.238 vs age(2) = 0.01; P < .008) showed curvilinear associations with age. Other domain scores showed linear declines with increasing age based on coefficients for communication (-0.036; P = .001), social cognition (-0.10; P < .001), and mobility (-0.14; P < .001). The AIMS scores were similar to the normative sample over time (95% CI, -0.107 to 0.037; P = .34). Nineteen of 57 infants (33%) who underwent postnatal cranial ultrasonography had a nonspecific, mild finding. No difference was found in the decline of WIDEA z scores between infants with and those without cranial ultrasonography findings except for a complex interactive relationship involving the social cognition domain (P < .049). The AIMS z scores were lower in infants with nonspecific cranial ultrasonography findings (-0.49; P = .07). Conclusions and Relevance This study found that infants with in utero ZIKV exposure without CZS appeared at risk for abnormal neurodevelopmental outcomes in the first 18 months of life. Long-term neurodevelopmental surveillance of all newborns with ZIKV exposure is recommended.
   This cohort study analyzes the neurodevelopmental assessment scores and possible implications for developmental growth among infants born after prenatal exposure to Zika virus in Colombia.
C1 [Mulkey, Sarah B.; Arroyave-Wessel, Margarita; Bulas, Dorothy, I; Jiang, JiJi; Russo, Stephanie; McCarter, Robert; du Plessis, Adre J.; DeBiasi, Roberta L.] Childrens Natl Hosp, Washington, DC 20010 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.; DeBiasi, Roberta L.] George Washington Univ, Sch Med & Hlth Sci, Dept Pediat, Washington, DC 20052 USA.
   [Mulkey, Sarah B.; du Plessis, Adre J.] George Washington Univ, Dept Neurol, Sch Med & Hlth Sci, Washington, DC USA.
   [Peyton, Colleen] Northwestern Univ, Dept Phys Therapy & Human Movement Sci, Chicago, IL 60611 USA.
   [Bulas, Dorothy, I] George Washington Univ, Dept Radiol, Sch Med & Hlth Sci, Washington, DC USA.
   [Fourzali, Yamil] Sabbag Radiologos, Barranquilla, Colombia.
   [Msall, Michael E.] Univ Chicago, Kennedy Res Ctr Neurodev Disabil, Comer Childrens Hosp, Chicago, IL 60637 USA.
   [DeBiasi, Roberta L.] George Washington Univ, Dept Trop Med & Infect Dis, Sch Med & Hlth Sci, Washington, DC USA.
   [Cure, Carlos] BIOMELAB, Barranquilla, Colombia.
RP Mulkey, SB (corresponding author), Childrens Natl Hosp, Div Fetal & Transit Med, 111 Michigan Ave NW, Washington, DC 20010 USA.
EM sbmulkey@childrensnational.org
FU Thrasher Research Fund; National Institutes of Health National Center
   for Advancing Translational Sciences [UL1TR001876, KL2TR001877];
   Leadership Education in Neurodevelopmental and Related Disorders
   Training Program [HRSA/MCHB T73 MC11047]
FX This study was funded in part by a grant from the Thrasher Research Fund
   (Drs Mulkey [principal investigator], du Plessis, and DeBiasi); awards
   UL1TR001876 and KL2TR001877 from the National Institutes of Health
   National Center for Advancing Translational Sciences (Dr Mulkey); and
   grant HRSA/MCHB T73 MC11047 from the Leadership Education in
   Neurodevelopmental and Related Disorders Training Program (Dr Msall).
CR Adebanjo T, 2017, MMWR-MORBID MORTAL W, V66, P1089, DOI 10.15585/mmwr.mm6641a1
   Adhikari EH, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2017.01.018
   Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304
   Amir J, 2016, ARCH DIS CHILD-FETAL, V101, pF428, DOI 10.1136/archdischild-2015-308357
   Aragao MFVV, 2017, AM J NEURORADIOL, V38, P1427, DOI 10.3174/ajnr.A5216
   Cantey JB, 2015, EARLY HUM DEV, V91, P427, DOI 10.1016/j.earlhumdev.2015.04.005
   Centers for Disease Control and Prevention, WHO GROWTH STAND REC
   Connery AK, 2019, AM J TROP MED HYG, V100, P438, DOI 10.4269/ajtmh.18-0713
   Melo ASD, 2016, JAMA NEUROL, V73, P1407, DOI 10.1001/jamaneurol.2016.3720
   Einspieler C, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.7235
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Lage MLC, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16030309
   Landais A, 2017, J NEUROL SCI, V383, P211, DOI 10.1016/j.jns.2017.10.045
   LARCOS G, 1994, AM J ROENTGENOL, V162, P953, DOI 10.2214/ajr.162.4.8141023
   Lebel C, 2018, NEUROIMAGE, V182, P207, DOI 10.1016/j.neuroimage.2017.12.097
   McGraw KO, 1996, PSYCHOL METHODS, V1, P30, DOI 10.1037/1082-989X.1.4.390
   Mooney CZ, 1993, BOOTSTRAPPING NONPAR, DOI [10.4135/9781412983532, DOI 10.4135/9781412983532]
   Morales-Monforte E, 2017, DEV NEUROREHABIL, V20, P76, DOI 10.3109/17518423.2015.1066461
   Msall ME, 2005, MENT RETARD DEV D R, V11, P263, DOI 10.1002/mrdd.20073
   Msall ME, 2001, INFANT YOUNG CHILD, V14, P46, DOI 10.1097/00001163-200114010-00008
   Mulkey SB, 2019, JAMA PEDIATR, V173, P52, DOI 10.1001/jamapediatrics.2018.4138
   Mulkey SB, 2018, J NEUROL SCI, V387, P109, DOI 10.1016/j.jns.2018.01.032
   Mulkey SB, 2018, PEDIATR NEUROL, V78, P75, DOI 10.1016/j.pediatrneurol.2017.10.012
   Park J., 2010, THESIS
   Piper M.C., 1994, MOTOR ASSESSMENT DEV
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Russell K, 2016, MMWR-MORBID MORTAL W, V65, P870, DOI 10.15585/mmwr.mm6533e2
   Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1
   Shin HJ, 2015, J CLIN ULTRASOUND, V43, P367, DOI 10.1002/jcu.22196
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wu YW, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0191
   YAMASHITA Y, 1990, PEDIATR NEUROL, V6, P375, DOI 10.1016/0887-8994(90)90003-J
NR 34
TC 5
Z9 5
U1 2
U2 2
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD MAR
PY 2020
VL 174
IS 3
BP 269
EP 276
DI 10.1001/jamapediatrics.2019.5204
PG 8
WC Pediatrics
SC Pediatrics
GA KT8AB
UT WOS:000519233100010
PM 31904798
DA 2020-07-08
ER

PT J
AU Mulkey, SB
   Arroyave-Wessel, M
   Peyton, C
AF Mulkey, S. B.
   Arroyave-Wessel, M.
   Peyton, C.
TI Neurodevelopmental abnormalities in children with in utero Zika virus
   exposure without congenital Zika syndrome (vol 174, pg 269, 2020)
SO JAMA PEDIATRICS
LA English
DT Correction
CR Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204
NR 1
TC 0
Z9 0
U1 0
U2 0
PU AMER MEDICAL ASSOC
PI CHICAGO
PA 330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA
SN 2168-6203
EI 2168-6211
J9 JAMA PEDIATR
JI JAMA Pediatr.
PD MAR
PY 2020
VL 174
IS 3
BP 305
EP 305
DI 10.1001/jamapediatrics.2020.0174
PG 1
WC Pediatrics
SC Pediatrics
GA KT8AB
UT WOS:000519233100029
OA Bronze
DA 2020-07-08
ER

PT J
AU Bouthry, E
   Herve, A
   Brichler, S
   Poveda, JD
   Roque-Afonso, AM
   Vauloup-Fellous, C
AF Bouthry, Elise
   Herve, Anais
   Brichler, Segolene
   Poveda, Jean-Dominique
   Roque-Afonso, Anne-Marie
   Vauloup-Fellous, Christelle
TI Evaluation and optimisation of commercial Zika IgG avidity assay
SO JOURNAL OF CLINICAL VIROLOGY
LA English
DT Article
DE Zika virus; IgG avidity; Pregnancy
ID IMMUNOGLOBULIN-G AVIDITY; VIRUS; INFECTION; CYTOMEGALOVIRUS; PREGNANCY;
   RUBELLA; SERUM
AB Background: ZIKV infection has potentially severe consequences particularly in fetuses/newborns born to mothers that were infected early in pregnancy. Diagnosis relies on the detection of ZIKV IgM that can also be detected due to cross reactivity or to nonspecific polyclonal activation of the immune system. Therefore, in case of ZIKV IgM detection, identification of a recent infection can be of major importance for the optimal management of pregnant women.
   Objective: This study evaluates the performances of a commercially available assay to measure ZIKV-IgG avidity.
   Study design: A total of 110 serum or plasma samples collected from symptomatic or asymptomatic patients living or returning from a ZIKV endemic area were classified according to epidemiological and clinical information, and to serology and molecular assays' results. Samples were tested with the IgG ZIKV Avidity Test (DIA.PRO (R)) according to manufacturer's instruction and with a modified protocol.
   Results: By using the manufacturer's Avidity Index cut-off, distinction between recent and past infection was unclear with similar AIs in the two situations (p = 0.8872). Sensitivity and specificity in identifying recent infection were poor, 67.3 % and 4.5 % respectively. By using a modified protocol, a better discrimination was observed with significant differences between mean AIs (p = 0.0318), and with higher sensitivity and specificity, respectively 87.8 % and 100 %.
   Conclusion: Our results highlight that IgG ZIKV Avidity Test DIA.PRO (R) assay is not reliable enough to be used in clinical practice without modifications.
C1 [Bouthry, Elise; Herve, Anais; Roque-Afonso, Anne-Marie; Vauloup-Fellous, Christelle] Hop Paul Brousse, AP HP, Dept Virol, WHO Rubella NRL, F-94804 Villejuif, France.
   [Brichler, Segolene] Hop Avicenne, AP HP, Dept Virol, F-93000 Bobigny, France.
   [Poveda, Jean-Dominique] CERBA, 11 Rue Equerre, F-95310 St Ouen, France.
   [Roque-Afonso, Anne-Marie; Vauloup-Fellous, Christelle] Univ Paris Sud, INSERM U1193, F-94804 Villejuif, France.
   [Bouthry, Elise; Vauloup-Fellous, Christelle] Grp Rech Infect Pendant Grossesse GRIG, Villejuif, France.
RP Bouthry, E (corresponding author), Hop Paul Brousse, AP HP, Virol, F-94804 Villejuif, France.
EM elise.bouthry@aphp.fr
RI Roque-Afonso, Anne-Marie/D-5737-2014
OI Roque-Afonso, Anne-Marie/0000-0002-6612-2030
CR Amaro F, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020179
   Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   BLACKBURN NK, 1991, J MED VIROL, V33, P6, DOI 10.1002/jmv.1890330103
   Bouthry E, 2014, PRENATAL DIAG, V34, P1246, DOI 10.1002/pd.4467
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Conseil National Professionnel de Gynecologie et Obstetrique, 2016, VIR ZIK FEMM ENC AG
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Felix AC, 2017, J MED VIROL, V89, P1477, DOI 10.1002/jmv.24789
   Furuya AKM, 2019, CLIN SCI, V133, P859, DOI 10.1042/CS20180874
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Karacan M, 2014, ARCH GYNECOL OBSTET, V290, P1115, DOI 10.1007/s00404-014-3340-3
   Kneitz RH, 2004, BMC INFECT DIS, V4, DOI 10.1186/1471-2334-4-33
   Pan American Health Organization World Health Organization, 2019, CAS ZIK VIR DIS COUN
   Rabe IB, 2016, MMWR-MORBID MORTAL W, V65, P543, DOI 10.15585/mmwr.mm6521e1
   Roque-Afonso AM, 2004, J CLIN MICROBIOL, V42, P5121, DOI 10.1128/JCM.42.11.5121-5124.2004
   Sensini A, 2006, CLIN MICROBIOL INFEC, V12, P504, DOI 10.1111/j.1469-0691.2006.01444.x
   Vauloup-Fellous C, 2007, CLIN VACCINE IMMUNOL, V14, P644, DOI 10.1128/CVI.00032-07
   Vauloup-Fellous C, 2014, EUR J CLIN MICROBIOL, V33, P1365, DOI 10.1007/s10096-014-2080-4
   Vauloup-Fellous C, 2009, VIROLOGIE, V13, P145
NR 21
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1386-6532
EI 1873-5967
J9 J CLIN VIROL
JI J. Clin. Virol.
PD MAR
PY 2020
VL 124
AR 104260
DI 10.1016/j.jcv.2020.104260
PG 9
WC Virology
SC Virology
GA KT9AW
UT WOS:000519305900005
PM 32035400
DA 2020-07-08
ER

PT J
AU Gutierrez, B
   Wise, EL
   Pullan, ST
   Logue, CH
   Bowden, TA
   Escalera-Zamudio, M
   Trueba, G
   Nunes, MRT
   Faria, NR
   Pybus, OG
AF Gutierrez, Bernardo
   Wise, Emma L.
   Pullan, Steven T.
   Logue, Christopher H.
   Bowden, Thomas A.
   Escalera-Zamudio, Marina
   Trueba, Gabriel
   Nunes, Marcio R. T.
   Faria, Nuno R.
   Pybus, Oliver G.
TI Evolutionary Dynamics of Oropouche Virus in South America
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE Oropouche virus; arbovirus; bunyavirus; emerging infectious diseases;
   evolutionary biology; phylogenetic analysis
ID VALLEY FEVER VIRUS; NONSTRUCTURAL PROTEIN NSM; AMINO-ACID SITES;
   PHYLOGENETIC ANALYSIS; TERMINAL REGION; REASSORTMENT; TRANSMISSION;
   DISEASE; IDENTIFICATION; EPIDEMIOLOGY
AB The Amazon basin is home to numerous arthropod-borne viral pathogens that cause febrile disease in humans. Among these, Oropouche orthobunyavirus (OROV) is a relatively understudied member of the genus Orthobunyavirus, family Peribuoyaviridae, that causes periodic outbreaks in human populations in Brazil and other South American countries. Although several studies have described the genetic diversity of the virus, the evolutionary processes that shape the OROV genome remain poorly understood. Here, we present a comprehensive study of the genomic dynamics of OROV that encompasses phylogenetic analysis, evolutionary rate estimates, inference of natural selective pressures, recombination and reassortment, and structural analysis of OROV variants. Our study includes all available published sequences, as well as a set of new OROV genome sequences obtained from patients in Ecuador, representing the first set of genomes from this country. Our results show differing evolutionary processes on the three segments that comprise the viral genome. We infer differing times of the most recent common ancestors of the genome segments and propose that this can be explained by cryptic reassortment. We also present the discovery of previously unobserved putative N-linked glycosylation sites, as well as codons that evolve under positive selection on the viral surface proteins, and discuss the potential role of these features in the evolution of OROV through a combined phylogenetic and structural approach.
   IMPORTANCE The emergence and reemergence of pathogens such as Zika virus, chikungunya virus, and yellow fever virus have drawn attention toward other cocirculating arboviruses in South America. Oropouche virus (OROV) is a poorly studied pathogen responsible for over a dozen outbreaks since the early 1960s and represents a public health burden to countries such as Brazil, Panama, and Peru. OROV is likely underreported since its symptomatology can be easily confounded with other febrile illnesses (e.g., dengue fever and leptospirosis) and point-of-care testing for the virus is still uncommon. With limited data, there is a need to optimize the information currently available. Analysis of OROV genomes can help us understand how the virus circulates in nature and can reveal the evolutionary forces that shape the genetic diversity of the virus, which has implications for molecular diagnostics and the design of potential vaccines.
C1 [Gutierrez, Bernardo; Escalera-Zamudio, Marina; Faria, Nuno R.; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England.
   [Gutierrez, Bernardo] USFQ, Sch Biol & Environm Sci, Quito, Ecuador.
   [Wise, Emma L.] Univ Plymouth, Plymouth, Devon, England.
   [Wise, Emma L.; Pullan, Steven T.; Logue, Christopher H.] Publ Hlth England, Natl Infect Serv, Porton Down, England.
   [Logue, Christopher H.; Trueba, Gabriel] USFQ, Microbiol Inst, Quito, Ecuador.
   [Bowden, Thomas A.] Univ Oxford, Wellcome Ctr Human Genet, Div Struct Biol, Oxford, England.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.
   [Nunes, Marcio R. T.] Univ Texas Med Branch, Dept Pathol, Ctr Biodef & Emerging Infect Dis, Galveston, TX 77555 USA.
RP Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford, England.
EM oliver.pybus@zoo.ox.ac.uk
RI ; Trueba, Gabriel/F-9707-2015
OI Gutierrez, Bernardo/0000-0002-9220-2739; Escalera-Zamudio,
   Marina/0000-0002-4773-2773; Bowden, Thomas/0000-0002-8066-8785; Trueba,
   Gabriel/0000-0003-2617-9021
FU Public Health England; Universidad San Francisco de Quito; Medical
   Research CouncilMedical Research Council UK (MRC) [MR/L009528/1];
   FAPESP-MRC grant (CADDE) [FAPESP 2018/14389-0]; EMBO Long Term
   FellowshipEuropean Molecular Biology Organization (EMBO) [ALTF376-2017];
   Leverhulme Trust ECR Fellowship [ECF-2019-542]; 2017 Universities of
   Academic Excellence Scholarship Program of the Secretariat for Higher
   Education, Science, Technology, and Innovation of the Republic of
   Ecuador [ARSEQ-BEC-003163-2017]; CNPq (National Council for Scientific
   and Technological Development) grantNational Council for Scientific and
   Technological Development (CNPq) [302584/20115-3]; Wellcome
   TrustWellcome Trust [204311/Z/16/Z]; Royal SocietyRoyal Society of
   London [204311/Z/16/Z]; European Union Seventh Framework Program
   (FP7/2007-2013)/European Research Council [614725-PATHPHYLODYN]; 
   [203141/Z/16/Z]
FX The work leading to the generation of the sequences from these samples
   was funded by Public Health England as part of a PHE-funded Ph.D.
   studentship awarded to E.L.W., C.H.L., and S.T.P. and by the Universidad
   San Francisco de Quito. This study was supported by the Medical Research
   Council (MR/L009528/1 to T.A.B.) and by a FAPESP-MRC grant (CADDE,
   FAPESP 2018/14389-0 to N.R.F.). The Wellcome Centre for Human Genetics
   is supported by grant 203141/Z/16/Z. M.E.-Z. is supported by an EMBO
   Long Term Fellowship (ALTF376-2017) and a Leverhulme Trust ECR
   Fellowship (ECF-2019-542). B.G. is supported by the 2017 Universities of
   Academic Excellence Scholarship Program of the Secretariat for Higher
   Education, Science, Technology, and Innovation of the Republic of
   Ecuador (ARSEQ-BEC-003163-2017) and by Universidad San Francisco de
   Quito. M.R.T.N. is supported by CNPq (National Council for Scientific
   and Technological Development) grant 302584/20115-3. N.R.F. is supported
   by a Wellcome Trust and Royal Society Sir Henry Dale Fellowship (grant
   204311/Z/16/Z). O.G.P. is supported by the European Union Seventh
   Framework Program (FP7/2007-2013)/European Research Council
   (614725-PATHPHYLODYN).
CR Aguilar PV, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001315
   Allen ER, 2018, CELL REP, V25, P3750, DOI 10.1016/j.celrep.2018.12.001
   Alvarez-Falconi Pedro P., 2010, Rev. gastroenterol. Perú, V30, P334
   ANDERSON CR, 1961, AM J TROP MED HYG, V10, P574, DOI 10.4269/ajtmh.1961.10.574
   Anisimova M, 2002, MOL BIOL EVOL, V19, P950, DOI 10.1093/oxfordjournals.molbev.a004152
   Argimon S, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000093
   Bowden TA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003374
   Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05
   Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030
   Burton DR, 2002, NAT REV IMMUNOL, V2, P706, DOI 10.1038/nri891
   Cardoso BF, 2015, MEM I OSWALDO CRUZ, V110, P745, DOI 10.1590/0074-02760150123
   Crabtree MB, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001639
   da Costa VG, 2017, INT J INFECT DIS, V62, P84, DOI 10.1016/j.ijid.2017.07.016
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Drummond AJ, 2003, TRENDS ECOL EVOL, V18, P481, DOI 10.1016/S0169-5347(03)00216-7
   Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI 10.1093/molbev/msi103
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Eifan S, 2013, VIRUSES-BASEL, V5, P2447, DOI 10.3390/v5102447
   Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Forshey BM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000787
   Freire CCM, 2015, SCI REP-UK, V5, DOI 10.1038/srep11353
   Gerrard SR, 2007, VIROLOGY, V359, P459, DOI 10.1016/j.virol.2006.09.035
   Greninger AL, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0220-9
   Gutierrez B, 2018, BIORXIV, DOI [10.1101/682559, DOI 10.1101/682559]
   Halldorsson S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02789-2
   Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043
   Hart TJ, 2009, ZOONOSES PUBLIC HLTH, V56, P285, DOI 10.1111/j.1863-2378.2008.01166.x
   Hellert J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08832-8
   IROEGBU CU, 1981, J VIROL, V37, P383, DOI 10.1128/JVI.37.1.383-394.1981
   Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Lam TTY, 2013, EPIDEMICS-NETH, V5, P1, DOI 10.1016/j.epidem.2012.09.002
   Lemey P, 2012, BIOINFORMATICS, V28, P3248, DOI 10.1093/bioinformatics/bts580
   Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698
   Li S, 2016, CELL REP, V16, P278, DOI 10.1016/j.celrep.2016.06.039
   Manock SR, 2009, AM J TROP MED HYG, V81, P146, DOI 10.4269/ajtmh.2009.81.146
   Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003
   Murray GGR, 2016, METHODS ECOL EVOL, V7, P80, DOI 10.1111/2041-210X.12466
   Murrell B, 2015, MOL BIOL EVOL, V32, P1365, DOI 10.1093/molbev/msv035
   Murrell B, 2013, MOL BIOL EVOL, V30, P1196, DOI 10.1093/molbev/mst030
   Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764
   Navarro JC, 2016, AM J TROP MED HYG, V95, P328, DOI 10.4269/ajtmh.15-0679
   Nunes WRT, 2005, EMERG INFECT DIS, V11, P1610, DOI 10.3201/eid1110.050464
   Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081
   PHOENIX I, 2016, VIRUSES-BASEL, V8, DOI DOI 10.3390/V8050149
   Pollitt E, 2006, VIROLOGY, V348, P224, DOI 10.1016/j.virol.2005.12.026
   Pond SLK, 2005, MOL BIOL EVOL, V22, P1208, DOI 10.1093/molbev/msi105
   Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Rissanen I, 2017, J VIROL, V91, DOI 10.1128/JVI.00378-17
   Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316
   Rodrguez-Morales AJ, 2017, TRAVEL MED INFECT DI, V15, P72, DOI 10.1016/j.tmaid.2016.11.001
   Romero-Alvarez D, 2018, MICROBES INFECT, V20, P135, DOI 10.1016/j.micinf.2017.11.013
   Romero-Alvarez D, 2017, MEM I OSWALDO CRUZ, V112, P292, DOI 10.1590/0074-02760160415
   Saeed MF, 2001, VIRUS RES, V77, P25, DOI 10.1016/S0168-1702(01)00262-3
   Sakkas H, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040175
   Schr?dinger L., 2015, PYMOL MOL GRAPH SYST
   Seabright GE, 2019, J MOL BIOL, V431, P2223, DOI 10.1016/j.jmb.2019.04.016
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Shi XH, 2005, J VIROL, V79, P13725, DOI 10.1128/JVI.79.21.13725-13734.2005
   Shi XH, 2006, J VIROL, V80, P8089, DOI 10.1128/JVI.00579-06
   Shi XH, 2016, P NATL ACAD SCI USA, V113, P8825, DOI 10.1073/pnas.1603364113
   Smith MD, 2015, MOL BIOL EVOL, V32, P1342, DOI 10.1093/molbev/msv022
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Nunes MRT, 2019, INFECT GENET EVOL, V68, P16, DOI 10.1016/j.meegid.2018.11.020
   Terasaki K, 2013, J VIROL, V87, P676, DOI 10.1128/JVI.02192-12
   Terzian ACB, 2009, EMERG INFECT DIS, V15, P348, DOI 10.3201/eid1502.080401
   Tilston-Lunel NL, 2015, J GEN VIROL, V96, P1636, DOI 10.1099/vir.0.000108
   da Rosa JFT, 2017, AM J TROP MED HYG, V96, P1019, DOI 10.4269/ajtmh.16-0672
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   URQUIDI V, 1992, J GEN VIROL, V73, P2255, DOI 10.1099/0022-1317-73-9-2255
   Vasconcelos HB, 2009, J CLIN VIROL, V44, P129, DOI 10.1016/j.jcv.2008.11.006
   Vasconcelos HB, 2011, EMERG INFECT DIS, V17, P800, DOI 10.3201/eid1705.101333
   Watanabe Y, 2018, P NATL ACAD SCI USA, V115, P7320, DOI 10.1073/pnas.1803990115
   Watts DM, 1997, AM J TROP MED HYG, V56, P148, DOI 10.4269/ajtmh.1997.56.148
   Weaver S, 2018, MOL BIOL EVOL, V35, P773, DOI 10.1093/molbev/msx335
   Wernike K, 2017, SCI REP-UK, V7, DOI 10.1038/srep42500
   Wise EL, 2019, BIORXIV, DOI [10.1101/683953, DOI 10.1101/683953]
   Wise EL, 2018, EMERG INFECT DIS, V24, P935, DOI 10.3201/eid2405.171569
   Wohl S, 2016, ANNU REV VIROL, V3, P173, DOI 10.1146/annurev-virology-110615-035747
   Won SY, 2007, J VIROL, V81, P13335, DOI 10.1128/JVI.01238-07
   Won S, 2006, J VIROL, V80, P8274, DOI 10.1128/JVI.00476-06
NR 85
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e01127-19
DI 10.1128/JVI.01127-19
PG 17
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000001
PM 31801869
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, XD
   Deng, CL
   Yuan, ZM
   Ye, HQ
   Zhang, B
AF Li, Xiao-Dan
   Deng, Cheng-Lin
   Yuan, Zhi-Ming
   Ye, Han-Qing
   Zhang, Bo
TI Different Degrees of 5 '-to-3 ' DAR Interactions Modulate Zika Virus
   Genome Cyclization and Host-Specific Replication
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE DAR element; flavivirus; genome cyclization; host-specific replication;
   Zika virus
ID WEST-NILE-VIRUS; RNA-RNA INTERACTIONS; DE-NOVO SYNTHESIS; DENGUE-VIRUS;
   STRAND RNA; 3'-UNTRANSLATED REGION; SECONDARY STRUCTURES; VACCINE
   CANDIDATE; NONCODING REGION; VIRAL-RNA
AB Mosquito-borne flaviviruses, which include many important human pathogens, such as West Nile virus (WNV), dengue virus (DENY), and Zika virus (ZIKV), have caused numerous emerging epidemics in recent years. Details of the viral genome functions necessary for effective viral replication in mosquito and vertebrate hosts remain obscure. Here, using ZIKV as a model, we found that the conserved "downstream of AUG region" (DAR), which is known to be an essential element for genome cyclization, is involved in viral replication in a host-specific manner. Mutational analysis of the DAR element showed that a single-nucleotide mismatch between the 5' DAR and the 3' DAR had little effect on ZIKV replication in mammalian cells but dramatically impaired viral propagation in mosquito cells. The revertant viruses passaged in mosquito cells generated compensatory mutations restoring the base pairing of the DAR, further confirming the importance of the complementarity of the DAR in mosquito cells. We demonstrate that a single-nucleotide mutation in the DAR is sufficient to destroy long-range RNA interaction of the ZIKV genome and affects de novo RNA synthesis at 28 degrees C instead of 37 degrees C, resulting in the different replication efficiencies of the mutant viruses in mosquito and mammalian cells. Our results reveal a novel function of the circular form of the flavivirus genome in host-specific viral replication, providing new ideas to further explore the functions of the viral genome during host adaptation.
   IMPORTANCE Flaviviruses naturally cycle between the mosquito vector and vertebrate hosts. The disparate hosts provide selective pressures that drive virus genome evolution to maintain efficient replication during host alteration. Host adaptation may occur at different stages of the viral life cycle, since host-specific viral protein processing and virion conformations have been reported in the individual hosts. However, the viral determinants and the underlying mechanisms associated with host-specific functions remain obscure. In this study, using Zika virus, we found that the DAR-mediated genome cyclization regulates viral replication differently and is under different selection pressures in mammalian and mosquito cells. A more constrained complementarity of the DAR is required in mosquito cells than in mammalian cells. Since the DAR element is stably maintained among mosquito-borne flaviviruses, our findings could provide new information for understanding the role of flavivirus genome cyclization in viral adaptation and RNA evolution in the two hosts.
C1 [Li, Xiao-Dan; Deng, Cheng-Lin; Yuan, Zhi-Ming; Ye, Han-Qing; Zhang, Bo] Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
   [Li, Xiao-Dan] Hunan Normal Univ, Sch Med, Changsha, Peoples R China.
RP Ye, HQ; Zhang, B (corresponding author), Chinese Acad Sci, Ctr Biosafety Mega Sci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
EM yehq@wh.iov.cn; zhangbo@wh.iov.cn
OI Zhang, Bo/0000-0002-8895-3679
FU National Key Research and Development Program of China [2018YFA0507201];
   National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81572003]
FX This work was supported by the National Key Research and Development
   Program of China (2018YFA0507201) and the National Natural Science
   Foundation of China (81572003).; We are grateful to the Wuhan Key
   Laboratory of Special Pathogens and Biosafety for their helpful support
   during the course of the work.
CR Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Alvarez DE, 2005, J VIROL, V79, P6631, DOI 10.1128/JVI.79.11.6631-6643.2005
   Alvarez DE, 2008, VIROLOGY, V375, P223, DOI 10.1016/j.virol.2008.01.014
   Beckham JD, 2016, JAMA NEUROL, V73, P875, DOI 10.1001/jamaneurol.2016.0800
   Blaney JE, 2008, VACCINE, V26, P817, DOI 10.1016/j.vaccine.2007.11.082
   Bujalowski PJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00047-17
   CAHOUR A, 1995, VIROLOGY, V207, P68, DOI 10.1006/viro.1995.1052
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chiu WW, 2005, J VIROL, V79, P8303, DOI 10.1128/JVI.79.13.8303-8315.2005
   Clyde K, 2008, VIROLOGY, V379, P314, DOI 10.1016/j.virol.2008.06.034
   Davis WG, 2013, J VIROL, V87, P7622, DOI 10.1128/JVI.00212-13
   de Borba L, 2019, MBIO, V10, DOI 10.1128/mBio.02506-18
   de Borba L, 2015, J VIROL, V89, P3430, DOI 10.1128/JVI.02677-14
   De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   Deng CL, 2016, VIROL SIN, V31, P176, DOI 10.1007/s12250-016-3778-5
   Durbin AP, 2001, AM J TROP MED HYG, V65, P405, DOI 10.4269/ajtmh.2001.65.405
   Elghonemy S, 2005, VIROLOGY, V331, P238, DOI 10.1016/j.virol.2004.11.008
   Fernandez-Sanles A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00546
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Filomatori CV, 2011, J BIOL CHEM, V286, P6929, DOI 10.1074/jbc.M110.162289
   Friebe P, 2011, J VIROL, V85, P1900, DOI 10.1128/JVI.02037-10
   Friebe P, 2010, J VIROL, V84, P6103, DOI 10.1128/JVI.02042-09
   Friedrich S, 2018, J VIROL, V92, DOI 10.1128/JVI.01647-17
   Friedrich S, 2014, J VIROL, V88, P11586, DOI 10.1128/JVI.01283-14
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Holden KL, 2004, VIROLOGY, V329, P119, DOI 10.1016/j.virol.2004.08.004
   Huber RG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09391-8
   Junglen S, 2017, MSPHERE, V2, DOI [10.1128/mSphere.00375-16, 10.1128/msphere.00375-16]
   Khromykh AA, 2001, J VIROL, V75, P6719, DOI 10.1128/JVI.75.14.6719-6728.2001
   Li P, 2018, CELL HOST MICROBE, V24, P875, DOI 10.1016/j.chom.2018.10.011
   Li XF, 2017, THERANOSTICS, V7, P912, DOI 10.7150/thno.16615
   Liu Z. Y., 2016, ELIFE, V5, DOI [10.7554/eLife.17636, DOI 10.7554/ELIFE.17636]
   Liu ZY, 2013, J VIROL, V87, P6804, DOI 10.1128/JVI.00243-13
   Lodeiro MF, 2009, J VIROL, V83, P993, DOI 10.1128/JVI.01647-08
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Men RH, 1996, J VIROL, V70, P3930, DOI 10.1128/JVI.70.6.3930-3937.1996
   Mojica KDA, 2014, FEMS MICROBIOL ECOL, V89, P495, DOI 10.1111/1574-6941.12343
   Neeleman L, 2001, P NATL ACAD SCI USA, V98, P14286, DOI 10.1073/pnas.251542798
   Newburn LR, 2015, VIROLOGY, V479, P434, DOI 10.1016/j.virol.2015.02.032
   Nicholson BL, 2014, NAT REV MICROBIOL, V12, P493, DOI 10.1038/nrmicro3288
   Nomaguchi M, 2003, J VIROL, V77, P8831, DOI 10.1128/JVI.77.16.8831-8842.2003
   Ochsenreiter R, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030298
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Polacek C, 2009, J VIROL, V83, P1161, DOI 10.1128/JVI.01362-08
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Sakai M, 2014, J GEN VIROL, V95, P823, DOI 10.1099/vir.0.060046-0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Suzuki R, 2008, J VIROL, V82, P6942, DOI 10.1128/JVI.00662-08
   Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Villordo SM, 2013, J VIROL, V87, P9365, DOI 10.1128/JVI.00567-13
   Villordo SM, 2010, RNA, V16, P2325, DOI 10.1261/rna.2120410
   Ward AM, 2011, RNA BIOL, V8, P1173, DOI 10.4161/rna.8.6.17836
   Yocupicio-Monroy M, 2007, VIROLOGY, V357, P29, DOI 10.1016/j.virol.2006.07.042
   Zhang B, 2010, VIROLOGY, V408, P138, DOI 10.1016/j.virol.2010.09.033
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 64
TC 1
Z9 1
U1 5
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e01602-19
DI 10.1128/JVI.01602-19
PG 19
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000015
PM 31826997
OA Bronze
DA 2020-07-08
ER

PT J
AU Moreno, GK
   Newman, CM
   Koenig, MR
   Mohns, MS
   Weiler, AM
   Rybarczyk, S
   Weisgrau, KL
   Vosler, LJ
   Pomplun, N
   Schultz-Darken, N
   Rakasz, E
   Dudley, DM
   Friedrich, TC
   O'Connor, DH
AF Moreno, Gage K.
   Newman, Christina M.
   Koenig, Michelle R.
   Mohns, Mariel S.
   Weiler, Andrea M.
   Rybarczyk, Sierra
   Weisgrau, Kim L.
   Vosler, Logan J.
   Pomplun, Nicholas
   Schultz-Darken, Nancy
   Rakasz, Eva
   Dudley, Dawn M.
   Friedrich, Thomas C.
   O'Connor, David H.
TI Long-Term Protection of Rhesus Macaques from Zika Virus Reinfection
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE antibody; immunity; long-term immunity; Zika; Zika virus; arbovirus;
   flavivirus
ID DENGUE VIRUS; YELLOW-FEVER; VACCINE; SAFETY; IMMUNOGENICITY; IMMUNITY
AB By the end of the 2016 Zika virus (ZIKV) outbreak, it is estimated that there were up to 100 million infections in the Americas. In approximately one in seven infants born to mothers infected during pregnancy, ZIKV has been linked to microcephaly, developmental delays, or other congenital disorders collectively known as congenital Zika syndrome, as well as Guillain-Barre syndrome, in ZIKV-infected adults. It is a global health priority to develop a vaccine against ZIKV that elicits long-lasting immunity; however, the durability of immunity to ZIKV is unknown. Previous studies in mice and nonhuman primates have been crucial in vaccine development but have not defined the duration of immunity generated by ZIKV infection. In this study, we rechallenged five rhesus macaques with ZIKV 22 to 28 months after a primary ZIKV infection. We show that primary ZIKV infection generates high titers of neutralizing antibodies that protect from detectable plasma viremia following rechallenge and persist for at least 22 to 28 months. While additional longitudinal studies are necessary with longer time frames, this study establishes a new experimentally defined minimal length of protective ZIKV immunity.
   IMPORTANCE ZIKV emerged as a vector-borne pathogen capable of causing illness in infected adults and congenital birth defects in infants born to mothers infected during pregnancy. Despite the decrease in ZIKV cases since the 2015-2016 epidemic, questions concerning the prevalence and longevity of protective immunity have left vulnerable communities fearful that they may become the center of next ZIKV outbreak. Although preexisting herd immunity in regions of past outbreaks may dampen the potential for future outbreaks to occur, we currently do not know the longevity of protective immunity to ZIKV after a person becomes infected. Here, we establish a new experimentally defined minimal length of protective ZIKV immunity. We show that five rhesus macaques initially infected with ZIKV 22 to 28 months prior to rechallenge elicit a durable immune response that protected from detectable plasma viremia. This study establishes a new minimal length of protective immunity.
C1 [Moreno, Gage K.; Newman, Christina M.; Koenig, Michelle R.; Mohns, Mariel S.; Dudley, Dawn M.; O'Connor, David H.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.
   [Weiler, Andrea M.; Rybarczyk, Sierra; Weisgrau, Kim L.; Vosler, Logan J.; Pomplun, Nicholas; Schultz-Darken, Nancy; Rakasz, Eva; Friedrich, Thomas C.; O'Connor, David H.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
   [Friedrich, Thomas C.] Univ Wisconsin, Dept Pathobiol Sci, Madison, WI 53706 USA.
RP O'Connor, DH (corresponding author), Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI 53706 USA.; O'Connor, DH (corresponding author), Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA.
EM dhoconno@wisc.edu
OI Moreno, Gage/0000-0003-4738-5318
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Aid M, 2017, CELL, V169, P610, DOI 10.1016/j.cell.2017.04.008
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Althouse BM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001928
   Amanna IJ, 2016, EXPERT REV VACCINES, V15, P1519, DOI 10.1080/14760584.2016.1198259
   [Anonymous], 2013, Wkly Epidemiol Rec, V88, P269
   Balcombe JP, 2004, CONTEMP TOP LAB ANIM, V43, P42
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Brault AC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15039-8
   Breitbach ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007766
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Centers for Disease Control and Prevention, 2018, UND VACC WORK
   Cline AN, 2005, J MED PRIMATOL, V34, P303
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dong SP, 2018, VIROL SIN, V33, P125, DOI 10.1007/s12250-018-0007-4
   Dowd KA, 2016, CELL REP, V16, P1485, DOI 10.1016/j.celrep.2016.07.049
   Dudley DM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12204
   Dutta P, 2014, IMMUNOL REV, V262, P167, DOI 10.1111/imr.12219
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   Gardner CL, 2010, CLIN LAB MED, V30, P237, DOI 10.1016/j.cll.2010.01.001
   Huang HR, 2017, J VIROL, V91, DOI [10.1128/JVI.00900-17, 10.1128/jvi.00900-17]
   Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Li XF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02975-w
   Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4
   Liu LD, 2012, CLIN VACCINE IMMUNOL, V19, P73, DOI 10.1128/CVI.05388-11
   Marzi A, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00117
   Medina LO, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02464
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Moreira-Soto A, 2018, CLIN MICROBIOL INFEC, V24, DOI 10.1016/j.cmi.2018.01.026
   Moreno GK, 2019, BIORXIV, DOI [10.1101/712281, DOI 10.1101/712281]
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   NIH, 2011, GUIDE CARE USE LAB A
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pomplun N, 2015, CYTOM PART A, V87A, P890, DOI 10.1002/cyto.a.22727
   RAMAEKERS LHJ, 1975, ARCH DIS CHILD, V50, P555, DOI 10.1136/adc.50.7.555
   Rayner JO, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050229
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Richner JM, 2017, CELL, V168, P1114, DOI 10.1016/j.cell.2017.02.017
   Scott JM, 2018, J VIROL, V92, DOI 10.1128/JVI.00038-18
   Sen Kwek S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03337-2
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shim BS, 2019, MBIO, V10, DOI 10.1128/mBio.00758-19
   Slifka MK, 2014, VACCINE, V32, P2948, DOI 10.1016/j.vaccine.2014.03.078
   Tauber E, 2007, LANCET, V370, P1847, DOI 10.1016/S0140-6736(07)61780-2
   Tebas Pablo, 2017, N Engl J Med, DOI 10.1056/NEJMoa1708120
   Turner LH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006684
   Vasilakis N, 2011, NAT REV MICROBIOL, V9, P532, DOI 10.1038/nrmicro2595
   Weatherall DJ, 2006, US NONH PRIM RES WOR
   Xu K, 2018, J VIROL, V92, DOI [10.1128/JVI.01722-17, 10.1128/jvi.01722-17]
NR 58
TC 0
Z9 0
U1 0
U2 0
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 5
AR e01881-19
DI 10.1128/JVI.01881-19
PG 17
WC Virology
SC Virology
GA KN1BN
UT WOS:000514575000030
PM 31801867
OA Bronze
DA 2020-07-08
ER

PT J
AU Prado, R
   Macedo-Salles, PA
   Duprat, RC
   Baptista, ARS
   Feder, D
   Lima, JBP
   Butt, T
   Ratcliffe, NA
   Mello, CB
AF Prado, Rodrigo
   Macedo-Salles, Pamella A.
   Duprat, Rodrigo C.
   Baptista, Andrea R. S.
   Feder, Denise
   Pereira Lima, Jose Bento
   Butt, Tariq
   Ratcliffe, Norman A.
   Mello, Cicero Brasileiro
TI Action of Metarhizium brunneum (Hypocreales: Clavicipitaceae) Against
   Organophosphate- and Pyrethroid-Resistant Aedes aegypti (Diptera:
   Culicidae) and the Synergistic Effects of Phenylthiourea
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE mosquito vector; entomopathogenic fungi; phenylthiourea; larvicidal;
   insecticide resistance
ID ENTOMOPATHOGENIC FUNGI; BEAUVERIA-BASSIANA; INSECTICIDE RESISTANCE;
   ANISOPLIAE; VIRULENCE; GERMINATION; MOSQUITO; STRAINS; GROWTH; ZIKA
AB Dengue, yellow fever, Zika, and chikungunya arboviruses are endemic in tropical countries and are transmitted by Aedes aegypti. Resistant populations of this mosquito against chemical insecticides are spreading worldwide. This study aimed to evaluate the biological effects of exposure of pesticide-sensitive Ae. aegypti larvae (Rockefeller) to conidia of the entomopathogen, Metarhizium brunneum, laboratory strains ARSEF 4556 and V275, and any synergistic activity of phenylthiourea (PTU). In addition, to investigate the nature of any cross-resistance mechanisms, these M. brunneum strains were tested against the Rockefeller larvae and two temephos- and deltamethrin-resistant wild mosquito populations from Rio de Janeiro. Treatment of Rockefeller larvae with 10(6) conidia/ml of ARSEF 4556 and V275 fungal strains resulted in significant decreased survival rates to 40 and 53.33%, respectively (P < 0.0001), compared with untreated controls. In contrast, exposure to 10(4) or 10(5) conidia/ml showed no such significant survival differences. However, the addition of PTU to the conidia in the bioassays significantly increased mortalities in all groups and induced a molt block. Experiments also showed no differences in Ae. aegypti mortalities between the fungal treated, wild pesticide-resistant populations and the Rockefeller sensitive strain. The results show the efficacy of M. brunneum in controlling Ae. aegypti larvae and the synergistic role of PTU in this process. Importantly, there was no indication of any cross-resistance mechanisms between Ae. aegypti sensitive or resistant to pesticides following treatment with the fungi. These results further support using M. brunneum as an alternative biological control agent against mosquito populations resistant to chemical insecticides.
C1 [Prado, Rodrigo; Duprat, Rodrigo C.; Feder, Denise; Ratcliffe, Norman A.] Univ Fed Fluminense, GBG, Lab Biol Insetos, BR-24020141 Rio De Janeiro, RJ, Brazil.
   [Prado, Rodrigo; Mello, Cicero Brasileiro] Fundacao Oswaldo Cruz, Lab Insect Biochem & Physiol, Oswaldo Cruz Inst, BR-21040900 Rio De Janeiro, Brazil.
   [Macedo-Salles, Pamella A.; Baptista, Andrea R. S.] Univ Fed Fluminense, Lab Micol Med & Mol, BR-24210130 Rio De Janeiro, RJ, Brazil.
   [Pereira Lima, Jose Bento] Inst Oswaldo Cruz Fiocruz, Lab Fisiol & Controle Artropodes Vetores, BR-21040900 Rio De Janeiro, Brazil.
   [Pereira Lima, Jose Bento] Inst Biol Exercito, Lab Entomol, BR-20911270 Rio De Janeiro, RJ, Brazil.
   [Butt, Tariq; Ratcliffe, Norman A.] Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales.
RP Ratcliffe, NA (corresponding author), Univ Fed Fluminense, GBG, Lab Biol Insetos, BR-24020141 Rio De Janeiro, RJ, Brazil.; Ratcliffe, NA (corresponding author), Swansea Univ, Dept Biosci, Swansea SA2 8PP, W Glam, Wales.
EM n.a.ratcliffe@swansea.ac.uk
RI ; de Souza Baptista, Andrea Regina/L-5970-2016
OI MELLO, CICERO BRASILEIRO/0000-0002-0092-6829; de Souza Baptista, Andrea
   Regina/0000-0002-0461-7521
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC); Department for
   Environment, Food and Rural AffairsDepartment for Environment, Food &
   Rural Affairs (DEFRA); Forestry Commission; Natural Environment Research
   CouncilNERC Natural Environment Research Council; Scottish Government
   under Tree Health and Plant Biosecurity Initiative; Fundacao Carlos
   Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ),
   BrazilCarlos Chagas Filho Foundation for Research Support of the State
   of Rio de Janeiro (FAPERJ) [E-26/201.787/2017]; Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior (CAPES), BrazilCAPES;
   Economic and Social Research CouncilEconomic & Social Research Council
   (ESRC)
FX The authors thank Luciana dos Santos Dias (IBEX-RJ-Brazil) for technical
   assistance and to Dr. Fernando A. Genta (IOC-FIOCRUZ) for the
   suggestions that improved the paper. T.B. was supported by grants funded
   jointly by the Biotechnology and Biological Sciences Research Council,
   the Department for Environment, Food and Rural Affairs, the Economic and
   Social Research Council, the Forestry Commission, the Natural
   Environment Research Council and the Scottish Government, under the Tree
   Health and Plant Biosecurity Initiative. N.A.R. was supported by
   Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ), Brazil (E-26/201.787/2017) and R.P. (Fellowship) by
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES),
   Brazil.
CR Alkhaibari AM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005715
   Ansari MA, 2011, J APPL MICROBIOL, V110, P1460, DOI 10.1111/j.1365-2672.2011.04994.x
   BERESKY MA, 1977, J INVERTEBR PATHOL, V29, P74, DOI 10.1016/0022-2011(77)90175-6
   Borges P. F. C, 2018, THESIS, P171
   Braga IA, 2005, J MED ENTOMOL, V42, P830, DOI 10.1603/0022-2585(2005)042[0830:EOMAIG]2.0.CO;2
   Brito LP, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/2410819
   Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281
   Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469
   Bukhari T, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-23
   Burt FJ, 2017, LANCET INFECT DIS, V17, pE107, DOI 10.1016/S1473-3099(16)30385-1
   Butt TM, 2016, ADV GENET, V94, P307, DOI 10.1016/bs.adgen.2016.01.006
   Butt TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081686
   Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x
   Colon-Gonzalez FJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006007
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   David MR, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6257860
   de Faria MR, 2007, BIOL CONTROL, V43, P237, DOI 10.1016/j.biocontrol.2007.08.001
   Dias L. S, 2015, THESIS
   Dubovskiy IM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060248
   Frigo S. M., 1986, Anais da Escola Superior de Agricultura 'Luiz de Queiroz', Universidade de Sao Paulo, V43, P285
   Garcia GD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006227
   Gomes SA, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1280-9
   Greenfield BPJ, 2015, BIOCONTROL SCI TECHN, V25, P487, DOI 10.1080/09583157.2014.989813
   Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480
   HAJEK AE, 1994, ANNU REV ENTOMOL, V39, P293, DOI 10.1146/annurev.en.39.010194.001453
   Howard AFV, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-168
   HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E
   Hutwimmer S, 2008, J APPL MICROBIOL, V105, P2026, DOI 10.1111/j.1365-2672.2008.03872.x
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Lazzarini GMJ, 2006, MYCOL RES, V110, P485, DOI 10.1016/j.mycres.2005.12.001
   Liu NN, 2015, ANNU REV ENTOMOL, V60, P537, DOI 10.1146/annurev-ento-010814-020828
   Lu AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00252
   Luz C, 2012, ACTA TROP, V122, P29, DOI 10.1016/j.actatropica.2011.11.014
   Macoris MD, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006390
   Ministerio da Saude do Brasil, 2018, SVS MS, V49, P1
   Monath TP, 2015, J CLIN VIROL, V64, P160, DOI 10.1016/j.jcv.2014.08.030
   Montella IR, 2007, AM J TROP MED HYG, V77, P467, DOI 10.4269/ajtmh.2007.77.467
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727
   Paiva DR, 2017, AN ACAD BRAS CIENC, V89, P373, DOI 10.1590/0001-3765201720160615
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pedrini N, 2018, FUNGAL BIOL-UK, V122, P538, DOI 10.1016/j.funbio.2017.10.003
   Petlamul Wanida, 2012, Mycobiology, V40, P111, DOI 10.5941/MYCO.2012.40.2.111
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Poopathi S., 2006, BIOTECH MOL BIOL REV, V1, P51
   Pourseyed SH, 2010, VET PARASITOL, V172, P305, DOI 10.1016/j.vetpar.2010.05.014
   Priyanka Dhar, 2010, African Journal of Biochemistry Research, V4, P65
   Ramirez JL, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006433
   Riaz A, 2013, PAK J BOT, V45, P1099
   Ryazanova AD, 2012, J ENZYM INHIB MED CH, V27, P78, DOI 10.3109/14756366.2011.576010
   Shah FA, 2007, FEMS MICROBIOL LETT, V276, P60, DOI 10.1111/j.1574-6968.2007.00927.x
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   SILVA JC, 1986, J INVERTEBR PATHOL, V48, P368, DOI 10.1016/0022-2011(86)90066-2
   Simmons CP, 2015, VACCINE, V33, P7061, DOI 10.1016/j.vaccine.2015.09.103
   Tokarev YS, 2018, J INVERTEBR PATHOL, V157, P1, DOI 10.1016/j.jip.2018.07.002
   Medeiros PFV, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006734
   Von Seidlein L, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002219
   WHEATCRO.PE, 1972, NATURE-NEW BIOL, V235, P93
   World Health Organization (WHO), 2016, ZIK VIR COMPL 2016 P
   Yassine H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003029
   Zhang JX, 2017, INT J IMAGE DATA FUS, V8, P1, DOI 10.1080/19479832.2016.1160960
   Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P879, DOI 10.1080/09583150701593963
   Zimmermann G, 2007, BIOCONTROL SCI TECHN, V17, P553, DOI 10.1080/09583150701309006
NR 64
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2020
VL 57
IS 2
BP 454
EP 462
DI 10.1093/jme/tjz161
PG 9
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA KS8IS
UT WOS:000518550900013
PM 31559435
DA 2020-07-08
ER

PT J
AU Mitra, S
   Rodriguez, SD
   Vulcan, J
   Cordova, J
   Chung, HN
   Moore, E
   Kandel, Y
   Hansen, IA
AF Mitra, Soumi
   Rodriguez, Stacy D.
   Vulcan, Julia
   Cordova, Joel
   Chung, Hae-Na
   Moore, Emily
   Kandel, Yashoda
   Hansen, Immo A.
TI Efficacy of Active Ingredients From the EPA 25(B) List in Reducing
   Attraction of Aedes aegypti (Diptera: Culicidae) to Humans
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE Aedes albopictus; EPA 25 (B) list; essential oil; Y-tube olfactometer;
   repellent
ID ESSENTIAL OILS; INSECT REPELLENTS; LABORATORY EVALUATION;
   CHEMICAL-COMPOSITION; ANOPHELES-STEPHENSI; MOSQUITOS DIPTERA;
   CITRONELLA; PROTECTION; PESTICIDES; ALBOPICTUS
AB Mosquitoes of the Aedes genus are vectors for dengue, chikungunya, Zika, and yellow fever viruses. Mosquito repellents are an effective way to prevent mosquito bites and reduce the spread of mosquito-borne diseases. In the early 90s, the U.S. Environmental Protection Agency (EPA) published a list of active ingredients that pose minimum risk to human health that can be used as pesticides or repellents without passing the EPA registration process. The present study examined the efficacy of 21 of the active ingredients listed by the EPA 25 (B) exempt list and five commercially available sprays that only contained active ingredients from the EPA 25(B) list in repelling female Aedes aegypti (L.) females. We performed choice bioassays in a controlled laboratory environment, using a Y-tube olfactometer to determine attraction rates of humans to female Ae. aegypti in the presence of one of the 21 active ingredients and five commercially available repellent sprays. We found that cinnamon oil, peppermint oil, spearmint oil, lemongrass oil, and garlic oil reduced mosquito attraction to human odor. Of the five commercial repellent sprays, only one reduced mosquito attraction for up to 30 min in our assay. The EPA 25 (B) list contains active ingredients that under the conditions of our assay repel Ae. aegypti.
C1 [Mitra, Soumi; Rodriguez, Stacy D.; Vulcan, Julia; Cordova, Joel; Chung, Hae-Na; Moore, Emily; Kandel, Yashoda; Hansen, Immo A.] New Mexico State Univ, Dept Biol, 1200 S Horseshoe Dr, Las Cruces, NM 88003 USA.
RP Hansen, IA (corresponding author), New Mexico State Univ, Dept Biol, 1200 S Horseshoe Dr, Las Cruces, NM 88003 USA.
EM immoh@nmsu.edu
CR Ansari MA, 2000, BIORESOURCE TECHNOL, V71, P267, DOI 10.1016/S0960-8524(99)00079-6
   Attardo GM, 2005, INSECT BIOCHEM MOLEC, V35, P661, DOI 10.1016/j.ibmb.2005.02.013
   Baker B. P, 2018, ACTIVE INGREDIENTS E
   Barnard DR, 2004, J MED ENTOMOL, V41, P726, DOI 10.1603/0022-2585-41.4.726
   Barnard DR, 1999, J MED ENTOMOL, V36, P625, DOI 10.1093/jmedent/36.5.625
   BHUYAN M, 1974, INDIAN J EXP BIOL, V12, P575
   BUNKER C. W. O., 1925, American Journal of Tropical Medicine, V5, P359
   Campbell C, 2011, J APPL ENTOMOL, V135, P374, DOI 10.1111/j.1439-0418.2010.01570.x
   Campbell C, 2010, CAN ENTOMOL, V142, P405, DOI 10.4039/n10-032
   Chellappandian M, 2018, ENVIRON INT, V113, P214, DOI 10.1016/j.envint.2017.12.038
   Cheng SS, 2004, J AGR FOOD CHEM, V52, P4395, DOI 10.1021/jf0497152
   Choi WS, 2002, J AM MOSQUITO CONTR, V18, P348
   DAVIS EE, 1985, J MED ENTOMOL, V22, P237, DOI 10.1093/jmedent/22.3.237
   de Castro RD, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0947-2
   Debboun M, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P1
   Deletre E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082103
   Fradin MS, 2002, NEW ENGL J MED, V347, P13, DOI 10.1056/NEJMoa011699
   Gates B, 2014, DEADLIEST ANIMAL WOR
   Gillij YG, 2008, BIORESOURCE TECHNOL, V99, P2507, DOI 10.1016/j.biortech.2007.04.066
   Gonzales KK, 2015, PEERJ, V3, DOI 10.7717/peerj.938
   Goodyer L, 1998, AM J TROP MED HYG, V59, P323, DOI 10.4269/ajtmh.1998.59.323
   Hansen IA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00103
   Hussain AI, 2010, J SCI FOOD AGR, V90, P1827, DOI 10.1002/jsfa.4021
   Karna AK, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080434
   Kim SI, 2012, J MED ENTOMOL, V49, P876, DOI 10.1603/ME11127
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar P, 2011, IND CROP PROD, V34, P802, DOI 10.1016/j.indcrop.2011.02.019
   Kumar Sarita, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P85, DOI 10.1016/S2221-1691(11)60001-4
   Kuno G, 2010, J MED ENTOMOL, V47, P957, DOI 10.1603/ME10152
   Lee MY, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6860271
   Lindsay LR, 1996, J AM MOSQUITO CONTR, V12, P293
   Lolley Marina M., 1990, MD L REV, V49, P975
   Maia MF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-S1-S11
   Moore EL, 2018, PEERJ, V6, DOI 10.7717/peerj.5151
   Moore Sarah J., 2007, P3
   Moore SJ, 2007, J MED ENTOMOL, V44, P624, DOI 10.1603/0022-2585(2007)44[624:FEOTUP]2.0.CO;2
   Mossa ATH, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/4308054
   Muller GC, 2008, J AM MOSQUITO CONTR, V24, P150, DOI 10.2987/8756-971X(2008)24[150:IPAMAS]2.0.CO;2
   Muller GC, 2009, J VECTOR ECOL, V34, P2, DOI [10.3376/038.034.0102, 10.1111/j.1948-7134.2009.00002.x]
   Nentwig G, 2017, J MED ENTOMOL, V54, P150, DOI 10.1093/jme/tjw129
   Opender Koul, 2008, Biopesticides International, V4, P63
   Pohlit AM, 2011, PLANTA MED, V77, P598, DOI 10.1055/s-0030-1270723
   Prajapati V, 2005, BIORESOURCE TECHNOL, V96, P1749, DOI 10.1016/j.biortech.2005.01.007
   Rajan TV, 2005, MED VET ENTOMOL, V19, P84, DOI 10.1111/j.0269-283X.2005.00544.x
   Revay EE, 2013, ACTA TROP, V125, P226, DOI 10.1016/j.actatropica.2012.10.009
   Rodriguez SD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iew117
   Rodriguez SD, 2015, J INSECT SCI, V15, DOI 10.1093/jisesa/iev125
   Rose RI, 2001, EMERG INFECT DIS, V7, P17, DOI 10.3201/eid0701.010103
   Shaaya E, 1997, J STORED PROD RES, V33, P7, DOI 10.1016/S0022-474X(96)00032-X
   Sharifi-Rad J, 2017, MOLECULES, V22, DOI 10.3390/molecules22010070
   Singh N, 2014, J ECON ENTOMOL, V107, P2163, DOI 10.1603/EC14328
   Nerio LS, 2010, BIORESOURCE TECHNOL, V101, P372, DOI 10.1016/j.biortech.2009.07.048
   Tripathi AK, 2004, J MED ENTOMOL, V41, P691, DOI 10.1603/0022-2585-41.4.691
   Trongtokit Y, 2005, PHYTOTHER RES, V19, P303, DOI 10.1002/ptr.1637
   Waliwitiya R, 2009, PEST MANAG SCI, V65, P241, DOI 10.1002/ps.1675
   WHO, 2013, GUID EFF TEST SPAT R
   World Health Organization, 2014, GLOB BRIEF VECT BORN
   Wu Y, 2001, Afr J Med Med Sci, V30 Suppl, P52
   Xue RD, 2006, J AM MOSQUITO CONTR, V22, P126, DOI 10.2987/8756-971X(2006)22[126:LEOIRA]2.0.CO;2
NR 59
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2020
VL 57
IS 2
BP 477
EP 484
DI 10.1093/jme/tjz178
PG 8
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA KS8IS
UT WOS:000518550900015
PM 31612914
OA Other Gold
DA 2020-07-08
ER

PT J
AU Lajeunesse, MJ
   Avello, DA
   Behrmann, MS
   Buschbacher, TJ
   Carey, K
   Carroll, J
   Chafin, TJ
   Elkott, F
   Faust, AM
   Fauver, H
   Figueroa, GD
   Flaig, LL
   Gauta, SA
   Gonzalez, C
   Graham, RM
   Hamdan, K
   Hanlon, T
   Hashami, SN
   Huynh, D
   Knaffl, JL
   Lanzas, M
   Libell, NM
   McCabe, C
   Metzger, J
   Mitchell, I
   Morales, MA
   Nayyar, YR
   Perkins, A
   Phan, TA
   Pidgeon, NT
   Ritter, CL
   Rosales, VC
   Santiago, O
   Stephens, R
   Taylor, EJ
   Thomas, AJ
   Yanez, NE
AF Lajeunesse, Marc J.
   Avello, Daniel A.
   Behrmann, Morgan S.
   Buschbacher, Thomas J.
   Carey, Kayla
   Carroll, Jordyn
   Chafin, Timothy J.
   Elkott, Fatima
   Faust, Ami M.
   Fauver, Hope
   Figueroa, Gabriela D.
   Flaig, Louisa L.
   Gauta, Sarah A.
   Gonzalez, Cristian
   Graham, Rowan M.
   Hamdan, Khalid
   Hanlon, Thomas
   Hashami, Syad N.
   Huynh, Dora
   Knaffl, Jessica L.
   Lanzas, Milton
   Libell, Nicole M.
   McCabe, Casey
   Metzger, Jamie
   Mitchell, Isabella
   Morales, Marisol A.
   Nayyar, Yogi R.
   Perkins, Aaron
   Tam-Anh Phan
   Pidgeon, Nicholas T.
   Ritter, Camryn L.
   Rosales, Veronica C.
   Santiago, Olivia
   Stephens, Rebecca
   Taylor, Ethan J.
   Thomas, Anup J.
   Yanez, Nicholas E.
TI Infected Mosquitoes Have Altered Behavior to Repellents: A Systematic
   Review and Meta-analysis
SO JOURNAL OF MEDICAL ENTOMOLOGY
LA English
DT Article
DE feeding behavior; malaria; mosquito-borne disease; mosquito repellent
   and attractant
ID AEDES-AEGYPTI DIPTERA; BLOOD-FEEDING RESPONSES; DEET REPELLENCY; VIRUS;
   CULICIDAE; BIAS; MANIPULATION; PERSISTENCE; ALBOPICTUS; PARASITES
AB Here we conducted a systematic review and meta-analysis to reach a consensus on whether infected and uninfected mosquitoes respond differently to repellents. After screening 2,316 published studies, theses, and conference abstracts, we identified 18 studies that tested whether infection status modulated the effectiveness of repellents. Thirteen of these studies had outcomes available for meta-analysis, and overall, seven repellents were tested (typically DEET with 62% of outcomes), six mosquito species had repellence behaviors measured (typically Aedes aegypti (L.) (Diptera: Culicidae) mosquitoes with 71% of outcomes), and a broad diversity of infections were tested including Sindbis virus (Togaviridae: Alphavirus) (33% of outcomes), Dengue (Flaviviridae: Flavivirus) (31%), malaria (Plasmodium berghei Vincke & Lips (Haemospororida: Plasmodiidae) or P. falciparum Welch (Haemospororida: Plasmodiidae); 25%), Zika (Flaviviridae: Flavivirus) (7%), and microsporidia (4%). Pooling all outcomes with meta-analysis, we found that repellents were less effective against infected mosquitoes-marking an average 62% reduction in protective efficacy relative to uninfected mosquitoes (pooled odds ratio = 0.38, 95% confidence interval = 0.22-0.66; k = 96). Older infected mosquitoes were also more likely to show altered responses and loss of sensitivity to repellents, emphasizing the challenge of distinguishing between age or incubation period effects. Plasmodium- or Dengue-infected mosquitoes also did not show altered responses to repellents; however, Dengue-mosquito systems used inoculation practices that can introduce variability in repellency responses. Given our findings that repellents offer less protection against infected mosquitoes and that these vectors are the most dangerous in terms of disease transmission, then trials on repellent effectiveness should incorporate infected mosquitoes to improve predictability in blocking vector-human contact.
C1 [Lajeunesse, Marc J.; Avello, Daniel A.; Behrmann, Morgan S.; Buschbacher, Thomas J.; Carey, Kayla; Carroll, Jordyn; Chafin, Timothy J.; Elkott, Fatima; Faust, Ami M.; Fauver, Hope; Figueroa, Gabriela D.; Flaig, Louisa L.; Gauta, Sarah A.; Gonzalez, Cristian; Graham, Rowan M.; Hamdan, Khalid; Hanlon, Thomas; Hashami, Syad N.; Huynh, Dora; Knaffl, Jessica L.; Lanzas, Milton; Libell, Nicole M.; McCabe, Casey; Metzger, Jamie; Mitchell, Isabella; Morales, Marisol A.; Nayyar, Yogi R.; Perkins, Aaron; Tam-Anh Phan; Pidgeon, Nicholas T.; Ritter, Camryn L.; Rosales, Veronica C.; Santiago, Olivia; Stephens, Rebecca; Taylor, Ethan J.; Thomas, Anup J.; Yanez, Nicholas E.] Univ S Florida, Dept Integrat Biol, 4202 East Fowler Ave, Tampa, FL 33620 USA.
RP Lajeunesse, MJ (corresponding author), Univ S Florida, Dept Integrat Biol, 4202 East Fowler Ave, Tampa, FL 33620 USA.
EM lajeunesse@usf.edu
CR Anderson RA, 1999, P ROY SOC B-BIOL SCI, V266, P1729, DOI 10.1098/rspb.1999.0839
   [Anonymous], 2009, GUID EFF TEST MOSQ R
   Bagos PG, 2012, STAT MED, V31, P1418, DOI 10.1002/sim.4474
   Barnard DR, 2007, J MED ENTOMOL, V44, P1040, DOI 10.1603/0022-2585(2007)44[1040:MMCABR]2.0.CO;2
   Barnard DR, 1998, J MED ENTOMOL, V35, P340, DOI 10.1093/jmedent/35.3.340
   Bland JM, 2000, BRIT MED J, V320, P1468, DOI 10.1136/bmj.320.7247.1468
   Bockarie MJ, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-15
   BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V
   Copeland RS, 1995, J AM MOSQUITO CONTR, V11, P438
   Costantini C, 2004, T ROY SOC TROP MED H, V98, P644, DOI 10.1016/j.trstmh.2003.12.015
   Dowling T, 2013, THESIS
   Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629
   EPA, 2010, 8103700 EPA OPPTS
   Frances SP, 2011, J MED ENTOMOL, V48, P334, DOI 10.1603/ME10120
   Hedges L. V, 1986, STAT METHODS METAANA
   HEDGES LV, 1982, PSYCHOL BULL, V92, P490, DOI 10.1037/0033-2909.92.2.490
   Hurd H, 2003, ANNU REV ENTOMOL, V48, P141, DOI 10.1146/annurev.ento.48.091801.112722
   Ioannidis JPA, 2007, CAN MED ASSOC J, V176, P1091, DOI 10.1503/cmaj.060410
   Koella JC, 1996, PARASITOLOGY, V113, P105, DOI 10.1017/S0031182000066348
   Koricheva J, 2013, HDB METAANALYSIS ECO
   Lajeunesse MJ, 2016, METHODS ECOL EVOL, V7, P323, DOI 10.1111/2041-210X.12472
   Lajeunesse MJ, 2011, ECOLOGY, V92, P2049, DOI 10.1890/11-0423.1
   Lajeunesse MJ, 2013, HDB METAANALYSIS ECO, P195, DOI DOI 10.1515/9781400846184-015
   Lajeunesse MJ, 2013, HDB METAANALYSIS ECO, P348
   Leal WS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42826
   McCall JW, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2438-4
   MOORE J, 1993, J PARASITOL, V79, P1, DOI 10.2307/3283270
   Mulatier M, 2018, 11 EUR C ENT NAPL 2, P2
   Mulatier M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43195-6
   Mulatier M, 2018, J MED ENTOMOL, V55, P1542, DOI 10.1093/jme/tjy134
   Onyango S. P, 2014, REPELLENTS PRINCIPLE
   Poulin R, 2010, ADV STUD BEHAV, V41, P151, DOI 10.1016/S0065-3454(10)41005-0
   Qualls W. A, 2012, THESIS
   Qualls WA, 2015, INSECT REPELLENTS HANDBOOK, 2ND EDITION, P351
   Qualls WA, 2012, ACTA TROP, V122, P284, DOI 10.1016/j.actatropica.2012.01.012
   Qualls WA, 2012, J MED ENTOMOL, V49, P418, DOI 10.1603/ME11102
   Qualls WA, 2011, J MED ENTOMOL, V48, P1226, DOI 10.1603/ME10163
   ROBERT LL, 1991, J AM MOSQUITO CONTR, V7, P304
   Sugiharto VA, 2016, J MED ENTOMOL, V53, P687, DOI 10.1093/jme/tjw030
   Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105
   Thievent K, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2718-x
   Thievent K, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-2846-0
   Van Roey K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003326
   Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03
   XUE RD, 1995, J AM MOSQUITO CONTR, V11, P50
   Yang F, 2017, THESIS
NR 46
TC 0
Z9 0
U1 1
U2 1
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 0022-2585
EI 1938-2928
J9 J MED ENTOMOL
JI J. Med. Entomol.
PD MAR
PY 2020
VL 57
IS 2
BP 542
EP 550
DI 10.1093/jme/tjz209
PG 9
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA KS8IS
UT WOS:000518550900024
PM 31755530
DA 2020-07-08
ER

PT J
AU Zhang, QY
   Li, XF
   Niu, XL
   Li, N
   Wang, HJ
   Deng, CL
   Ye, HQ
   Huang, XY
   Chen, Q
   Xu, YP
   Dong, HL
   Li, XD
   Zhao, H
   Shi, PY
   Yuan, ZM
   Gong, P
   Fang, XY
   Qin, CF
   Zhang, B
AF Zhang, Qiu-Yan
   Li, Xiao-Feng
   Niu, Xiaolin
   Li, Na
   Wang, Hong-Jiang
   Deng, Cheng-Lin
   Ye, Han-Qing
   Huang, Xing-Yao
   Chen, Qi
   Xu, Yan-Peng
   Dong, Hao-Long
   Li, Xiao-Dan
   Zhao, Hui
   Shi, Pei-Yong
   Yuan, Zhi-Ming
   Gong, Peng
   Fang, Xianyang
   Qin, Cheng-Feng
   Zhang, Bo
TI Short Direct Repeats in the 3 ' Untranslated Region Are Involved in
   Subgenomic Flaviviral RNA Production
SO JOURNAL OF VIROLOGY
LA English
DT Article
DE sfRNA; direct repeats; West Nile virus; Flavivirus
ID WEST-NILE-VIRUS; ZIKA VIRUS; 3'-UNTRANSLATED REGION; DENGUE VIRUS;
   INTERFERON; TRANSLATION; PSEUDOKNOT; 3'UTR
AB Mosquito-borne flaviviruses consist of a positive-sense genome RNA flanked by the untranslated regions (UTRs). There is a panel of highly complex RNA structures in the UTRs with critical functions. For instance, Xrn1-resistant RNAs (xrRNAs) halt Xrn1 digestion, leading to the production of subgenomic flaviviral RNA (sfRNA). Conserved short direct repeats (DRs), also known as conserved sequences (CS) and repeated conserved sequences (RCS), have been identified as being among the RNA elements locating downstream of xrRNAs, but their biological function remains unknown. In this study, we revealed that the specific DRs are involved in the production of specific sfRNAs in both mammalian and mosquito cells. Biochemical assays and structural remodeling demonstrate that the base pairings in the stem of these DRs control sfRNA formation by maintaining the binding affinity of the corresponding xrRNAs to Xrn1. On the basis of these findings, we propose that DRs functions like a bracket holding the Xrn1-xrRNA complex for sfRNA formation.
   IMPORTANCE Flaviviruses include many important human pathogens. The production of subgenomic flaviviral RNAs (sfRNAs) is important for viral pathogenicity as a common feature of flaviviruses. sfRNAs are formed through the incomplete degradation of viral genomic RNA by the cytoplasmic 5'-3' exoribonuclease Xrn1 halted at the Xrn1-resistant RNA (xrRNA) structures within the 3'-UTR. The 3'-UTRs of the flavivirus genome also contain distinct short direct repeats (DRs), such as RCS3, CS3, RCS2, and CS2. However, the biological functions of these ancient primary DR sequences remain largely unknown. Here, we found that DR sequences are involved in sfRNA formation and viral virulence and provide novel targets for the rational design of live attenuated flavivirus vaccine.
C1 [Zhang, Qiu-Yan; Li, Na; Deng, Cheng-Lin; Ye, Han-Qing; Yuan, Zhi-Ming; Gong, Peng; Zhang, Bo] Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.
   [Li, Xiao-Feng; Wang, Hong-Jiang; Huang, Xing-Yao; Chen, Qi; Xu, Yan-Peng; Dong, Hao-Long; Zhao, Hui; Qin, Cheng-Feng] Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Niu, Xiaolin; Fang, Xianyang] Tsinghua Univ, Beijing Adv Innovat Ctr Struct Biol, Sch Life Sci, Beijing, Peoples R China.
   [Li, Xiao-Dan] Hunan Normal Univ, Sch Med, Changsha, Peoples R China.
   [Shi, Pei-Yong] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.
   [Zhang, Bo] Nankai Univ, Drug Discovery Ctr Infect Dis, Tianjin, Peoples R China.
RP Zhang, B (corresponding author), Chinese Acad Sci, Ctr Biosafety Megasci, Wuhan Inst Virol, Key Lab Special Pathogens & Biosafety, Wuhan, Peoples R China.; Qin, CF (corresponding author), Acad Mil Med Sci, Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Zhang, B (corresponding author), Nankai Univ, Drug Discovery Ctr Infect Dis, Tianjin, Peoples R China.
EM qincf@bmi.ac.cn; zhangbo@wh.iov.cn
FU National Key Research and Development Program of China [2016YFD0500400,
   2016YFD0500304, 2016YFC1200400]; National Natural Science Foundation of
   ChinaNational Natural Science Foundation of China [81572003, 31770190,
   81621005, 81522025]; National Science and Technology Major Project of
   China [2018ZX09711003, 2018ZX10101004, 2017ZX10304402]
FX This work was supported by the National Key Research and Development
   Program of China (2016YFD0500400, 2016YFD0500304, and 2016YFC1200400),
   the National Natural Science Foundation of China (81572003, 31770190,
   81621005, and 81522025) and the National Science and Technology Major
   Project of China (2018ZX09711003, 2018ZX10101004, and 2017ZX10304402).
CR Akiyama BM, 2016, SCIENCE, V354, P1148, DOI 10.1126/science.aah3963
   Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009
   Brinton MA, 2015, VIRUS RES, V206, P108, DOI 10.1016/j.virusres.2015.02.006
   Chang JH, 2011, NAT STRUCT MOL BIOL, V18, P270, DOI 10.1038/nsmb.1984
   Chang RY, 2013, VET MICROBIOL, V166, P11, DOI 10.1016/j.vetmic.2013.04.026
   Chapman EG, 2014, ELIFE, V3, DOI 10.7554/eLife.01892
   Chapman EG, 2014, SCIENCE, V344, P307, DOI 10.1126/science.1250897
   de Borba L, 2019, MBIO, V10, DOI 10.1128/mBio.02506-18
   Deng CL, 2017, J GEN VIROL, V98, P1739, DOI 10.1099/jgv.0.000862
   Filomatori CV, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006265
   Funk A, 2010, J VIROL, V84, P11407, DOI 10.1128/JVI.01159-10
   Goertz GP, 2016, J VIROL, V90, P10145, DOI 10.1128/JVI.00930-16
   Gokhale NS, 2017, CELL HOST MICROBE, V21, P1, DOI 10.1016/j.chom.2016.12.013
   Gritsun TS, 2007, VIROLOGY, V358, P258, DOI 10.1016/j.virol.2006.09.033
   Gritsun TS, 2007, ADV VIRUS RES, V69, P203, DOI 10.1016/S0065-3527(06)69005-2
   Gritsun TS, 2006, J GEN VIROL, V87, P2615, DOI 10.1099/vir.0.81950-0
   Gritsun TS, 2006, VIROLOGY, V350, P269, DOI 10.1016/j.virol.2006.03.002
   Kieft JS, 2015, RNA BIOL, V12, P1169, DOI 10.1080/15476286.2015.1094599
   Lo MK, 2003, J VIROL, V77, P10004, DOI 10.1128/JVI.77.18.10004-10014.2003
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Messing SAJ, 2009, STRUCTURE, V17, P472, DOI 10.1016/j.str.2008.12.022
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shan C, 2017, NAT MED, V23, P763, DOI 10.1038/nm.4322
   Shi PY, 2002, J VIROL, V76, P5847, DOI 10.1128/JVI.76.12.5847-5856.2002
   Silva PAGC, 2010, J VIROL, V84, P11395, DOI 10.1128/JVI.01047-10
   Villordo SM, 2016, TRENDS MICROBIOL, V24, P270, DOI 10.1016/j.tim.2016.01.002
   Villordo SM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004604
   Wei Y, 2009, AM J TROP MED HYG, V81, P817, DOI 10.4269/ajtmh.2009.08-0595
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Xie XP, 2013, J VIROL, V87, P4609, DOI 10.1128/JVI.02424-12
   Zou G, 2011, ANTIVIR RES, V91, P11, DOI 10.1016/j.antiviral.2011.05.001
NR 33
TC 0
Z9 0
U1 2
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0022-538X
EI 1098-5514
J9 J VIROL
JI J. Virol.
PD MAR
PY 2020
VL 94
IS 6
AR e01175-19
DI 10.1128/JVI.01175-19
PG 14
WC Virology
SC Virology
GA KS5ZP
UT WOS:000518387200002
PM 31896596
DA 2020-07-08
ER

PT J
AU Rodriguez, M
   Lord, A
   Sanabia, CC
   Silverio, A
   Chuang, M
   Dolan, SM
AF Rodriguez, Miguel
   Lord, Ayla
   Sanabia, Carolina C.
   Silverio, Abigail
   Chuang, Meleen
   Dolan, Siobhan M.
TI Understanding Zika virus as an STI: findings from a qualitative study of
   pregnant women in the Bronx
SO SEXUALLY TRANSMITTED INFECTIONS
LA English
DT Article
AB Objectives Pregnant women in the Bronx were at risk for travel-related Zika exposure in the USA between 2016 and 2017. This qualitative study explored the experiences of 13 pregnant women to learn about their knowledge of Zika and prevention measures.
   Methods In the summer of 2017, pregnant women at risk of travel-related Zika exposure were interviewed in either Spanish or English to learn about their experiences and transcripts were analysed using a grounded theory approach.
   Results Most participants were Latinas living in the Bronx, median age of 29 years and median household income between $26 000 and $50 000. Participants displayed a strong understanding of Zika transmission via mosquito bites yet lacked knowledge about its sexual transmission. Interviews revealed three key themes: (1) Zika as a new disease, (2) denial as a coping mechanism and (3) the recommendation to treat Zika as an STI. Women observed Zika as a brand new disease with early messages emphasising mosquito-borne transmission. They lacked awareness of newer messaging about sexual transmission. Furthermore, if women did read about risk of sexual transmission, many stated being in denial and struggling with recommendations to prevent sexual transmission. Barriers included problems changing travel plans and rejection of condom use. Women unanimously suggested labelling Zika as an STI and adding it to existing lists of STIs for messaging and outreach in community-based and clinical prevention.
   Conclusion Many pregnant women were unaware that Zika virus can be sexually transmitted due to: (1) novelty of Zika, (2) denial as a coping mechanism and (3) Zika not being listed along with well-known STIs. Overcoming these barriers via community-based as well as clinical education for pregnant women in the Bronx would be helpful in 2019 and beyond when the risk of travel-related Zika exposure remains a public health threat to optimal pregnancy outcomes.
C1 [Rodriguez, Miguel; Dolan, Siobhan M.] Albert Einstein Coll Med, Bronx, NY 10461 USA.
   [Lord, Ayla; Sanabia, Carolina C.; Silverio, Abigail; Chuang, Meleen; Dolan, Siobhan M.] Montefiore Hlth Syst, Obstet & Gynecol & Womens Hlth, Bronx, NY USA.
RP Dolan, SM (corresponding author), Albert Einstein Coll Med, Bronx, NY 10461 USA.
EM sdolan@montefiore.org
CR [Anonymous], 2016, DED VERS 7 0 23 WEB
   Auerbach C., 2003, QUALITATIVE DATA INT
   CDC, CDC TRAV AL ZIK PUER
   CDC, CDC TRAV AL ZIK DOM
   Centers for Disease Control and Prevention, 2017 CAS COUNTS US
   Dyer O, 2015, BMJ-BRIT MED J, P351
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   N Y gov, BRONX COUNT HLTH IND
   N Y gov, 2017, SEX TRANSM INF SURV
   NC Y, NEW YORK CIT DEP HLT
   Oduyebo T, 2017, MMWR-MORBID MORTAL W, V66, P781, DOI 10.15585/mmwr.mm6629e1
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Statistical Atlas, BRONX COUNT SUBH RAC
NR 13
TC 1
Z9 1
U1 1
U2 1
PU BMJ PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 1368-4973
EI 1472-3263
J9 SEX TRANSM INFECT
JI Sex. Transm. Infect.
PD MAR
PY 2020
VL 96
IS 2
BP 80
EP 84
DI 10.1136/sextrans-2019-054093
PG 5
WC Infectious Diseases
SC Infectious Diseases
GA KS3RR
UT WOS:000518230100002
PM 31350377
OA Bronze
DA 2020-07-08
ER

PT J
AU Fikatas, A
   Vervaeke, P
   Martinez-Gualda, B
   Marti-Mari, O
   Noppen, S
   Meyen, E
   Camarasa, MJ
   San-Felix, A
   Pannecouque, C
   Schols, D
AF Fikatas, Antonios
   Vervaeke, Peter
   Martinez-Gualda, Belen
   Marti-Mari, Olaia
   Noppen, Sam
   Meyen, Eef
   Camarasa, Maria-Jose
   San-Felix, Ana
   Pannecouque, Christophe
   Schols, Dominique
TI Tryptophan Trimers and Tetramers Inhibit Dengue and Zika Virus
   Replication by Interfering with Viral Attachment Processes
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
DE SPR; Zika; antivirals; dengue; envelope protein; virus attachment
ID HUMAN-IMMUNODEFICIENCY-VIRUS; DOMAIN-III; HIV; TRANSMISSION; DENDRIMERS;
   MECHANISM; SEQUENCE; HISTORY; DISEASE; TYPE-1
AB Here, we report a class of tryptophan trimers and tetramers that inhibit (at low micromolar range) dengue and Zika virus infection in vitro. These compounds (AL family) have three or four peripheral tryptophan moieties directly linked to a central scaffold through their amino groups; thus, their carboxylic acid groups are free and exposed to the periphery. Structure-activity relationship (SAR) studies demonstrated that the presence of extra phenyl rings with substituents other than COOH at the N1 or C2 position of the indole side chain is a requisite for the antiviral activity against both viruses. The molecules showed potent antiviral activity, with low cytotoxicity, when evaluated on different cell lines. Moreover, they were active against laboratory and clinical strains of all four serotypes of dengue virus as well as a selected group of Zika virus strains. Additional mechanistic studies performed with the two most potent compounds (AL439 and AL440) demonstrated an interaction with the viral envelope glycoprotein (domain III) of dengue 2 virus, preventing virus attachment to the host cell membrane. Since no antiviral agent is approved at the moment against these two flaviviruses, further pharmacokinetic studies with these molecules are needed for their development as future therapeutic/prophylactic drugs.
C1 [Fikatas, Antonios; Vervaeke, Peter; Noppen, Sam; Meyen, Eef; Pannecouque, Christophe; Schols, Dominique] Univ Leuven, KU Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst Med Res,Lab Virol & Chemotherapy, Leuven, Belgium.
   [Martinez-Gualda, Belen; Marti-Mari, Olaia; Camarasa, Maria-Jose; San-Felix, Ana] CSIC, IQM, Madrid, Spain.
   [Martinez-Gualda, Belen] Katholieke Univ Leuven, Rega Inst Med Res, Med Chem, Leuven, Belgium.
RP Schols, D (corresponding author), Univ Leuven, KU Leuven, Dept Microbiol Immunol & Transplantat, Rega Inst Med Res,Lab Virol & Chemotherapy, Leuven, Belgium.
EM dominique.schols@kuleuven.be
RI Schols, Dominique/S-9057-2017; Noppen, Sam/F-8681-2018
OI Schols, Dominique/0000-0003-3256-5850; Noppen, Sam/0000-0002-2831-5042
FU KU LeuvenKU Leuven; Fonds Wetenschappelijk Onderzoek (FWO)FWO
   [PF/10/018]; Spanish MINECO [SAF2015-64629-C2-1-R,
   SAF2015-64629-C2-2-R]; Spanish Agencia Estatal Consejo Superior de
   Investigaciones Cientificas (CSIC) [CSIC201680E079, 201980E028]; Spanish
   MEC/MINECO
FX This work was supported by KU Leuven and the Fonds Wetenschappelijk
   Onderzoek (FWO grant PF/10/018), the Spanish MINECO (projects
   SAF2015-64629-C2-1-R and SAF2015-64629-C2-2-R [MINECO/FEDER]), and the
   Spanish Agencia Estatal Consejo Superior de Investigaciones Cientificas
   (CSIC; projects CSIC201680E079 and 201980E028). The Spanish MEC/MINECO
   is also acknowledged for grants to B.M.-G. and O.M.-M.
CR Aguiar M, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005179
   Alhoot MA, 2013, INT J MED SCI, V10, P719, DOI 10.7150/ijms.5037
   Martinez-Vega RA, 2017, VACCINE, V35, P3910, DOI 10.1016/j.vaccine.2017.06.004
   Arnott JA, 2012, EXPERT OPIN DRUG DIS, V7, P863, DOI 10.1517/17460441.2012.714363
   Balzarini J, 2007, LANCET, V369, P787, DOI 10.1016/S0140-6736(07)60202-5
   Blackman MA, 2018, VIRAL IMMUNOL, V31, P117, DOI 10.1089/vim.2017.0145
   Cao B, 2017, J INTERF CYTOK RES, V37, P287, DOI 10.1089/jir.2017.0011
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Chavez JH, 2010, BIOLOGICALS, V38, P613, DOI 10.1016/j.biologicals.2010.07.004
   Dallmeier K, 2016, CELL HOST MICROBE, V20, P420, DOI 10.1016/j.chom.2016.09.011
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Dissanayake HA, 2018, REV MED VIROL, V28, DOI 10.1002/rmv.1971
   Gao Y, 2017, DEVELOPING SOLID ORAL DOSAGE FORMS: PHARMACEUTICAL THEORY AND PRACTICE, 2ND EDITION, P455, DOI 10.1016/B978-0-12-802447-8.00017-0
   Giannetti AM, 2008, J MED CHEM, V51, P574, DOI 10.1021/jm700952v
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Halstead SB, 2018, HUM VACC IMMUNOTHER, V14, P2158, DOI 10.1080/21645515.2018.1445448
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   IRIE K, 1989, GENE, V75, P197, DOI 10.1016/0378-1119(89)90266-7
   Keeney M, 2015, J MATER CHEM B, V3, P8757, DOI 10.1039/c5tb00450k
   Leydet A, 1997, J MED CHEM, V40, P350, DOI 10.1021/jm960348y
   Low JGH, 2017, J INFECT DIS, V215, pS96, DOI 10.1093/infdis/jiw423
   Lozier M, 2016, MMWR-MORBID MORTAL W, V65, P1219, DOI 10.15585/mmwr.mm6544a4
   Luscher-Mattli M, 2000, ANTIVIR CHEM CHEMOTH, V11, P249
   Maciel D, 2019, NANOSCALE, V11, P9679, DOI 10.1039/c9nr00303g
   Magnus Mariana Munari, 2018, Hematol., Transfus. Cell Ther., V40, P250, DOI 10.1016/j.htct.2018.01.011
   Martinez-Gualda B, 2020, J MED CHEM, V63, P349, DOI 10.1021/acs.jmedchem.9b01737
   Martinez-Gualda B, 2019, ANTIVIR RES, V168, P210, DOI 10.1016/j.antiviral.2019.06.006
   Marzinek JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19160
   Ming GL, 2017, CELL STEM CELL, V20, P749, DOI 10.1016/j.stem.2017.05.010
   Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005
   Olsen DB, 2004, ANTIMICROB AGENTS CH, V48, P3944, DOI 10.1128/AAC.48.10.3944-3953.2004
   OSATOMI K, 1990, VIROLOGY, V176, P643, DOI 10.1016/0042-6822(90)90037-R
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Pinto-Diaz CA, 2017, AUTOIMMUN REV, V16, P327, DOI 10.1016/j.autrev.2017.02.002
   Pirrone V, 2011, ANTIVIR RES, V90, P168, DOI 10.1016/j.antiviral.2011.03.176
   Raekiansyah M, 2017, TROP MED HEALTH, V45, DOI 10.1186/s41182-017-0072-7
   Roos RP, 2016, JAMA NEUROL, V73, P1395, DOI 10.1001/jamaneurol.2016.3677
   Saiz JC, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00411-17, 10.1128/aac.00411-17]
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Suwanmanee S, 2017, J MICROBIOL, V55, P81, DOI 10.1007/s12275-017-6494-4
   Tolou HJG, 2001, J GEN VIROL, V82, P1283, DOI 10.1099/0022-1317-82-6-1283
   Vacas-Cordoba E, 2016, INT J NANOMED, V11, P1281, DOI 10.2147/IJN.S96352
   Vervaeke P, 2015, REV MED VIROL, V25, P50, DOI 10.1002/rmv.1818
   Watterson D, 2012, J GEN VIROL, V93, P72, DOI 10.1099/vir.0.037317-0
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Witvrouw M, 2000, MOL PHARMACOL, V58, P1100
   Witvrouw M, 1997, GEN PHARMACOL-VASC S, V29, P497, DOI 10.1016/S0306-3623(96)00563-0
   Witvrouw M, 2000, J MED CHEM, V43, P778, DOI 10.1021/jm980263s
   Wu KP, 2003, J BIOL CHEM, V278, P46007, DOI 10.1074/jbc.M307776200
   Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhou YC, 2012, EXPERT REV ANTI-INFE, V10, P1129, DOI [10.1586/ERI.12.104, 10.1586/eri.12.104]
NR 54
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD MAR
PY 2020
VL 64
IS 3
AR e02130-19
DI 10.1128/AAC.02130-19
PG 15
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA KQ2MQ
UT WOS:000516763200061
PM 31932383
DA 2020-07-08
ER

PT J
AU Jash, A
   Govero, J
   Nair, S
   Diamond, MS
   Chheda, MG
AF Jash, Arijita
   Govero, Jennifer
   Nair, Sharmila
   Diamond, Michael S.
   Chheda, Milan G.
TI Leveraging Zika virus and the immune system to treat glioblastoma.
SO CANCER IMMUNOLOGY RESEARCH
LA English
DT Meeting Abstract
C1 [Jash, Arijita; Govero, Jennifer; Nair, Sharmila; Diamond, Michael S.; Chheda, Milan G.] Washington Univ, Sch Med, St Louis, MO USA.
NR 0
TC 0
Z9 0
U1 5
U2 5
PU AMER ASSOC CANCER RESEARCH
PI PHILADELPHIA
PA 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA
SN 2326-6066
EI 2326-6074
J9 CANCER IMMUNOL RES
JI Cancer Immunol. Res.
PD MAR
PY 2020
VL 8
IS 3
SU S
MA A13
BP 38
EP 38
PG 1
WC Oncology; Immunology
SC Oncology; Immunology
GA KS3CV
UT WOS:000518188200048
DA 2020-07-08
ER

PT J
AU Paz-Bailey, G
   Gregory, CJ
AF Paz-Bailey, Gabriela
   Gregory, Christopher J.
TI Balancing sensitivity and specificity of Zika virus case definitions
SO LANCET INFECTIOUS DISEASES
LA English
DT Editorial Material
ID DENGUE
C1 [Paz-Bailey, Gabriela] Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.
   [Gregory, Christopher J.] Ctr Dis Control & Prevent, Div Vector Borne Dis, Ft Collins, CO USA.
RP Paz-Bailey, G (corresponding author), Ctr Dis Control & Prevent, Div Vector Borne Dis, San Juan, PR 00920 USA.
EM gmb5@cdc.gov
CR Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Burger-Calderon R, 2020, LANCET INFECT DIS, V20, P371, DOI 10.1016/S1473-3099(19)30547-X
   Gregory CJ, 2010, AM J TROP MED HYG, V82, P922, DOI 10.4269/ajtmh.2010.09-0552
   Lindsey NP, 2020, CLIN INFECT DIS, V70, P227, DOI 10.1093/cid/ciz195
   Lozier MJ, 2018, J INFECT DIS, V217, P1678, DOI 10.1093/infdis/jix630
   Mitchell PK, 2019, AM J EPIDEMIOL, V188, P206, DOI 10.1093/aje/kwy189
   Nascimento EJM, 2019, AM J TROP MED HYG, V101, P708, DOI 10.4269/ajtmh.19-0270
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Russell Steven, 2017, PLoS Curr, V9, DOI 10.1371/currents.outbreaks.cd76717676629d47704170ecbdb5f820
   Shankar MB, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006650
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
NR 11
TC 0
Z9 0
U1 3
U2 3
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2020
VL 20
IS 3
BP 270
EP 272
DI 10.1016/S1473-3099(19)30686-3
PG 4
WC Infectious Diseases
SC Infectious Diseases
GA KR7RP
UT WOS:000517813700013
PM 31870904
OA Bronze
DA 2020-07-08
ER

PT J
AU Kazi, F
   Mushtaq, A
AF Kazi, Farooq
   Mushtaq, Ammara
TI The legacy of Zika virus
SO LANCET INFECTIOUS DISEASES
LA English
DT News Item
NR 0
TC 0
Z9 0
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2020
VL 20
IS 3
BP 294
EP 294
PG 1
WC Infectious Diseases
SC Infectious Diseases
GA KR7RP
UT WOS:000517813700037
DA 2020-07-08
ER

PT J
AU Burger-Calderon, R
   Carrillo, FB
   Gresh, L
   Ojeda, S
   Sanchez, N
   Plazaola, M
   Katzelnick, L
   Mercado, BL
   Monterrey, JC
   Elizondo, D
   Arguello, S
   Nunez, A
   Gordon, A
   Balmaseda, A
   Kuan, G
   Harris, E
AF Burger-Calderon, Raquel
   Carrillo, Fausto Bustos
   Gresh, Lionel
   Ojeda, Sergio
   Sanchez, Nery
   Plazaola, Miguel
   Katzelnick, Leah
   Mercado, Brenda Lopez
   Monterrey, Jairo Carey
   Elizondo, Douglas
   Arguello, Sonia
   Nunez, Andrea
   Gordon, Aubree
   Balmaseda, Angel
   Kuan, Guillermina
   Harris, Eva
TI Age-dependent manifestations and case definitions of paediatric Zika: a
   prospective cohort study
SO LANCET INFECTIOUS DISEASES
LA English
DT Article
ID VIRUS-INFECTION; OUTBREAK; DISEASE
AB Background Paedeatric Zika remains an understudied topic. WHO and the Pan American Health Organization (PAHO) Zika case definitions have not been assessed in children. We aimed to characterise clinical profiles and evaluate the diagnostic performance of the WHO and PAHO case definitions in a large cohort of paediatric Zika cases.
   Methods From January, 2016 to February, 2017, encompassing the major 2016 Zika epidemic, participants in the Pediatric Dengue Cohort Study (PDCS) in Managua, Nicaragua, were encouraged to visit the study health centre at first indication of any illness. PDCS participants were aged 2-14 years, healthy at enrolment, and recruited before the initiation of the present study. Molecular and serological assays were used to test participants exhibiting any of four broad clinical profiles suspected of resulting from a symptomatic Zika virus infection. These clinical profiles were: fever and at least two of headache, retro-orbital pain, myalgia, arthralgia, rash, haemorrhagic manifestations, and leukopenia; fever and at least two of nausea or vomiting, rash, aches and pains, positive tourniquet test, leukopenia, and any dengue warning sign; undifferentiated fever without evident cause, with or without any other clinical finding; and afebrile rash with or without any other clinical finding. We characterised acute clinical findings (signs, symptoms, and complete blood counts) in both Zika cases and non-Zika cases.
   Findings We prospectively followed a cohort of about 3700 children, of which 1110 were deemed eligible for inclusion. Four participants with laboratory-confirmed Zika (three co-infections with dengue virus, one missing complete blood count data) and two participants who were non-Zika cases (missing complete blood count data) were excluded from analysis. We analysed 556 laboratory-confirmed Zika and 548 non-Zika cases. The WHO case definition captured 176 confirmed Zika cases, and the PAHO definition 109 confirmed Zika cases, who presented with the most clinical findings and a dengue-like clinical profile. The remaining two thirds of Zika cases, principally characterised by undifferentiated fever or afebrile rash, were missed. Among Zika cases, rash (n=440)-particularly generalised erythematous rash (n=334)-fever (n=333), leukopenia (n=217), and headache (n=203) were most common and peaked within 3 days of illness onset. The most common Zika presentation over the first week of illness was rash only (n=80). The sensitivity of Zika case definitions increased across paediatric age (from 11.3% to 56.1% for the WHO case definition and from 6.0% to 36.6% for the PAHO case definition), as the prevalence of most clinical findings (particularly arthralgia) increased with age, irrespective of previous dengue virus infection. Consequently, Zika manifested differently across paediatric age; older Zika cases presented with a dengue-like clinical profile while younger Zika cases presented with undifferentiated fever or afebrile rash.
   Interpretation We provide the most thorough description of paediatric Zika to date. Most paediatric Zika cases go undetected under the WHO and PAHO case definitions, suggesting that current standards for Zika case ascertainment require revision. Zika manifests with mild but differing clinical profiles across paediatric age, presenting major challenges to diagnosis, surveillance, and efforts to control future Zika epidemics. Copyright (C) 2019 Elsevier Ltd. All rights reserved.
C1 [Burger-Calderon, Raquel; Carrillo, Fausto Bustos; Katzelnick, Leah; Harris, Eva] Univ Calif Berkeley, Sch Publ Hlth, Div Infect Dis & Vaccinol, Berkeley, CA 94720 USA.
   [Carrillo, Fausto Bustos] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA.
   [Burger-Calderon, Raquel; Gresh, Lionel; Ojeda, Sergio; Sanchez, Nery; Plazaola, Miguel; Mercado, Brenda Lopez; Monterrey, Jairo Carey; Elizondo, Douglas; Arguello, Sonia; Nunez, Andrea; Balmaseda, Angel] Sustainable Sci Inst, Managua, Nicaragua.
   [Nunez, Andrea; Balmaseda, Angel] Minist Hlth, Natl Virol Lab, Ctr Nacl Diagnost & Referencia, Managua, Nicaragua.
   [Gordon, Aubree] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.
   [Kuan, Guillermina] Minist Hlth, Ctr Salud Socrates Flores Vivas, Managua, Nicaragua.
RP Harris, E (corresponding author), Univ Calif Berkeley, Div Infect Dis & Vacdnol, Sch Publ Hlth, Berkeley, CA 94720 USA.
EM eharris@berkeley.edu
OI Bustos Carrillo, Fausto/0000-0002-7263-5625; Gresh,
   Lionel/0000-0002-2333-1748
FU US National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA
FX US National Institutes of Health.
CR Balmaseda A, 2010, J INFECT DIS, V201, P5, DOI 10.1086/648592
   Braga JU, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179725
   Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Gordon A, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002726
   Gordon A, 2018, CLIN INFECT DIS, V67, P1760, DOI 10.1093/cid/ciy356
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   Hastie T, 1986, STAT SCI, V1, P297, DOI DOI 10.1214/SS/1177013604
   Jimenez Corona ME, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.a2fe1b3d6d71e24ad2b5afe982824053, DOI 10.1371/CURRENTS.OUTBREAKS.A2FE1B3D6D71E24AD2B5AFE982824053]
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Katzelnick LC, 2016, P NATL ACAD SCI USA, V113, P728, DOI 10.1073/pnas.1522136113
   Kuan G, 2009, AM J EPIDEMIOL, V170, P120, DOI 10.1093/aje/kwp092
   Li JH, 2017, CLIN INFECT DIS, V64, P1445, DOI 10.1093/cid/cix137
   Lindsey NP, 2020, CLIN INFECT DIS, V70, P227, DOI 10.1093/cid/ciz195
   Mallet HP, 2015, BISES B INFORM SANIT, V13, P1
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nishiura H, 2016, INT J INFECT DIS, V45, P95, DOI 10.1016/j.ijid.2016.02.017
   PAHO/WHO, 2016, ZIK RES CAS DEF
   Pan American Health Organization, 2019, CUM CAS CAS ZIK VIR
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   US Census Bureau, 2018, INT DAT BAS
   Zambrana JV, 2018, P NATL ACAD SCI USA, V115, P9294, DOI 10.1073/pnas.1804672115
   Waggoner JJ, 2016, CLIN INFECT DIS, V63, P1584, DOI 10.1093/cid/ciw589
   World Health Organization, 2016, ZIK VIR DIS INT CAS
   World Health Organization, 2009, DENG GUID DIAGN TREA
   World Health Organization, 1997, DENG HAEM FEV DIAGN
NR 31
TC 2
Z9 2
U1 1
U2 1
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 1473-3099
EI 1474-4457
J9 LANCET INFECT DIS
JI Lancet Infect. Dis.
PD MAR
PY 2020
VL 20
IS 3
BP 371
EP 380
DI 10.1016/S1473-3099(19)30547-X
PG 10
WC Infectious Diseases
SC Infectious Diseases
GA KR7RP
UT WOS:000517813700050
PM 31870907
OA Bronze
DA 2020-07-08
ER

PT J
AU Bozlak, CEB
   Bozkurt, HB
AF Bozlak, Cigdem Eda Balkan
   Bozkurt, Hayrunnisa Bekis
TI Microcephaly Agent of Zika Virus and Unknowns by Healthcare Personnel
SO ERCIYES MEDICAL JOURNAL
LA English
DT Article
DE Health personnel; knowledge; Zika virus
ID INFECTION; DENGUE; STATES; TURKEY
AB Objective: The Zika virus is an important viral agent that presents the risk of pandemic disease. Infection with the virus can cause microcephaly in infants, as well as other potential effects. The aim of this study was to evaluate the level of knowledge about the Zika virus among healthcare personnel in Turkey.
   Materials and Methods: A total of 290 healthcare personnel from a secondary and a tertiary health institution were included in this study. The data were collected using a survey form prepared by the researchers and statistically analyzed.
   Results: Among the respondents, there was awareness of the Zika virus in 68.7%, 75.0%, 75.9%, and 77.0% of women, individuals over 35 years of age, doctors, and those with a healthcare career of at least 10 years, respectively. The results revealed that 58.9% knew the true means of transmission, 36.0% were aware of prevention efforts, 41.1% were familiar with potential complications, 0.5% reported knowledge of treatment, and 16.8% responded correctly regarding the availability of a vaccine. The primary source of information about the virus was TV and radio for 68.5% of the participants, and 3.6% cited scientific papers.
   Conclusion: The Zika virus is a potential pandemic agent. The knowledge level of the healthcare personnel studied was insufficient to meet such a challenge. The ministry of health and universities should provide the appropriate training to healthcare personnel.
C1 [Bozlak, Cigdem Eda Balkan] Kafkas Univ, Dept Med Microbiol, Fac Med, Kars, Turkey.
   [Bozkurt, Hayrunnisa Bekis] Kafkas Univ, Dept Pediat, Fac Med, Kars, Turkey.
RP Bozlak, CEB (corresponding author), Kafkas Univ, Hlth Res & Practice Hosp, Fac Med, Dept Microbiol, Kars, Turkey.
EM cigdemedabalkan@gmail.com
CR Abbink P, 2018, NAT REV MICROBIOL, V16, P594, DOI 10.1038/s41579-018-0039-7
   Akiner MM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004664
   Aryal S., 2015, ZIKA VIRUS STRUCTURE
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control An agency of the European Union, 2015, RAP RISK ASS ZIK VIR
   European Environment Agency, 2012, BIOG REG
   Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939
   Gupta Nidhi, 2016, Niger Postgrad Med J, V23, P33, DOI 10.4103/1117-1936.180179
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Honein MA, 2018, NEW ENGL J MED, V378, P1055, DOI 10.1056/NEJMe1801398
   Joob B, 2015, ANN TROP MED PUBLIC, V8, P145, DOI 10.4103/1755-6783.162402
   Ministry of Health Public Health Agency of Turkey, 2016, VECT ZOON DIS DEP DO
   Sahiner F, 2016, MIKROBIYOL BUL, V50, P333, DOI 10.5578/mb.24167
   Sari T, 2017, KLIMIK J, V30, P2, DOI 10.5152/kd.2017.01
   Schaffner F, 2014, LANCET INFECT DIS, V14, P1271, DOI 10.1016/S1473-3099(14)70834-5
   Sezen AI, 2018, MIKROBIYOL BUL, V52, P308, DOI 10.5578/mb.66991
   Staples JE, 2016, MMWR-MORBID MORTAL W, V65, P63, DOI 10.15585/mmwr.mm6503e3
   Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16
   WHO, 2017, ZIK SIT REP ZIK VIR
   World Health Organization, 2016, ZIK SIT REP ZIK VIR
   Zanluca C, 2016, MICROBES INFECT, V18, P295, DOI 10.1016/j.micinf.2016.03.003
NR 21
TC 0
Z9 0
U1 0
U2 0
PU ERCIYES UNIV SCH MEDICINE
PI KAYSERI
PA ERCIYES UNIV TIP FAK 38039 MELIKGAZI, KAYSERI, 00000, TURKEY
SN 2149-2247
EI 2149-2549
J9 ERCIYES MED J
JI Erciyes Med. J.
PD MAR
PY 2020
VL 42
IS 1
BP 89
EP 92
DI 10.14744/etd.2019.72473
PG 4
WC Medicine, General & Internal
SC General & Internal Medicine
GA KQ1YG
UT WOS:000516725700017
OA DOAJ Gold
DA 2020-07-08
ER

PT J
AU Santos, GR
   Pinto, CAL
   Prudente, RCS
   Bevilacqua, EMAF
   Witkin, SS
   Passos, SD
   Moron, AF
   Ventura, DF
   Massad, E
   Zanotto, PMA
   Rodrigues, LC
   Bertozzi, APAP
   Grion, AP
   Mingotti, AC
   Silva, ACB
   Martins, CMG
   Barreira, ER
   Fujiwara, DT
   Souza, FMS
   Velasco, FG
   Cangerana, F
   Arita, FN
   Hernandez, FDM
   Tabares, HS
   Milani, HJF
   Sampaio, MMSC
   Machado, MB
   Silva, MMA
   Rodrigues, MMD
   Almeida, MF
   Rizzo, MF
   Damico, FM
   Clemente, NS
   Cunha, MP
   Izbicki, R
   Gazeta, RE
   Dezena, RCAB
   Bonom, SHA
   Pour, SZ
   Uranjec, S
   Rosemberg, S
   Oyama, SMR
   Sarmento, SGP
   Quintella, TM
   Fajardo, TCG
   Ferrareto, TRG
   Rodrigues, WM
   Baran, L
   Soares, AP
   Costa, M
   Barboni, MTS
   Lima, D
   Franca, VCRM
   Vidal, KS
   Barbosa, AR
   Zanquetta, GU
   Silva, AB
AF Santos, Geovane R.
   Pinto, Clovis A. L.
   Prudente, Raphael C. S.
   Bevilacqua, Estela M. A. F.
   Witkin, Steven S.
   Passos, Saulo D.
   Moron, A. F.
   Ventura, D. F.
   Massad, E.
   Zanotto, P. M. A.
   Rodrigues, L. C.
   Bertozzi, A. P. A. P.
   Grion, A. P.
   Mingotti, A. C.
   Silva, A. C. B.
   Martins, C. M. G.
   Barreira, E. R.
   Fujiwara, D. T.
   Souza, F. M. S.
   Velasco, F. G.
   Cangerana, F.
   Arita, F. N.
   Hernandez, F. D. M.
   Tabares, H. S.
   Milani, H. J. F.
   Sampaio, M. M. S. C.
   Machado, M. B.
   Silva, M. M. A.
   Rodrigues, M. M. D.
   Almeida, M. F.
   Rizzo, M. F.
   Damico, F. M.
   Clemente, N. S.
   Cunha, M. P.
   Izbicki, R.
   Gazeta, R. E.
   Dezena, R. C. A. B.
   Bonom, S. H. A.
   Pour, S. Z.
   Uranjec, S.
   Rosemberg, S.
   Oyama, S. M. R.
   Sarmento, S. G. P.
   Quintella, T. M.
   Fajardo, T. C. G.
   Ferrareto, T. R. G.
   Rodrigues, W. M.
   Baran, L.
   Soares, A. P.
   Costa, M.
   Barboni, M. T. S.
   Lima, Ds
   Franca, V. C. R. M.
   Vidal, K. S.
   Barbosa, A. R.
   Zanquetta, G. U.
   Silva, A. B.
CA Zika Virus Cohort Study Grp
TI Histopathologic Changes in Placental Tissue Associated With Vertical
   Transmission of Zika Virus
SO INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
LA English
DT Article
DE Zika virus; Placenta; Congenital; pathology; Immunohistochemistry
ID BCL-2; EXPRESSION; INFECTION
AB Zika virus (ZIKV) is highly neurotropic after crossing the placenta, inducing teratogenic effects that result in delayed development and microcephaly in infants. The available evidence for vertical transmission of this infection is based on placental studies showing alterations in trophoblastic tissue. However, complete characterization of ZIKV-infected placenta and involved pathways has yet to be fully clarified. This case report of placental ZIKV infection describes morphologic and molecular changes in the placenta. Hyperplasia of placental Hofbauer cells in chorionic villi and numerous histiocyte-like cells in the decidua were observed. The decidua, fibroblasts, and chorion, as well as circulating cells in the intravascular compartment stained positive for ZIKV envelop protein. Deciduitis was present on the maternal surface of the placenta, with a prevalence of lymphocytes associated with vasculitis. A high level of uncommitted CD3(+) T lymphocytes were present, in addition to CD4(+) and CD8(+) cells. Elevated expression of the apoptosis inhibitor, Bcl-2, was observed in syncytiotrophoblasts. These parameters may promote the persistence of ZIKV in placental tissue and transmission to the fetus.
C1 [Santos, Geovane R.; Pinto, Clovis A. L.; Prudente, Raphael C. S.] Jundiai Med Sch, Dept Morphol & Pathol, Jundiai, Brazil.
   [Passos, Saulo D.] Jundiai Med Sch, Dept Pediat, Jundiai, Brazil.
   Jundiai Med Sch, Jundiai, Brazil.
   [Passos, Saulo D.] Jundiai Med Sch, Univ Teaching Hosp, Jundiai, Brazil.
   [Pinto, Clovis A. L.] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, SP, Brazil.
   [Bevilacqua, Estela M. A. F.] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, SP, Brazil.
   [Witkin, Steven S.] Univ Sao Paulo, Inst Trop Med, Sao Paulo, SP, Brazil.
   [Witkin, Steven S.] Weill Cornell Med, Dept Obstet & Gynecol, New York, NY USA.
RP Pinto, CAL (corresponding author), R Francisco Teles 250,Vila Arens 2, BR-13202550 Sao Paulo, SP, Brazil.
EM patologia@fmj.br
RI Bevilacqua, Estela/H-3354-2011; Clemente, Nuria Sanchez/AAL-4309-2020
OI Bevilacqua, Estela/0000-0003-4178-4625; Alexandrasmello@gmail.com,
   Alexandra/0000-0002-7996-873X; FAJARDO, THAMIRYS/0000-0003-1096-1078
FU Sao Paulo Research Foundation (FAPESP) (Sao Paulo, Brazil)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2016/08578-0]
FX This research work was developed by the Zika Virus Cohort Study Group at
   the Jundiai Medical School and was funded by the Sao Paulo Research
   Foundation (FAPESP) (Sao Paulo, Brazil) under reference number
   2016/08578-0.
CR Cao B, 2017, J EXP MED, V214, P2303, DOI 10.1084/jem.20170957
   De Falco M, 2001, HISTOCHEM J, V33, P421, DOI 10.1023/A:1013728012048
   Hirsch AJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02499-9
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Kim CJ, 1995, PATHOL RES PRACT, V191, P1239, DOI 10.1016/S0344-0338(11)81132-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Olagnier D, 2016, DNA CELL BIOL, V35, P367, DOI 10.1089/dna.2016.3404
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rabelo K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01704
   Rosenberg AZ, 2017, ARCH PATHOL LAB MED, V141, P43, DOI 10.5858/arpa.2016-0401-OA
   Soni S, 2010, ANAT HISTOL EMBRYOL, V39, P426, DOI 10.1111/j.1439-0264.2010.01012.x
   Straszewski-Chavez SL, 2004, MOL HUM REPROD, V10, P33, DOI 10.1093/molehr/gah001
NR 13
TC 1
Z9 1
U1 10
U2 10
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0277-1691
EI 1538-7151
J9 INT J GYNECOL PATHOL
JI Int. J. Gynecol. Pathol.
PD MAR
PY 2020
VL 39
IS 2
BP 157
EP 162
DI 10.1097/PGP.0000000000000586
PG 6
WC Obstetrics & Gynecology; Pathology
SC Obstetrics & Gynecology; Pathology
GA KO4UP
UT WOS:000515546900011
PM 30789499
DA 2020-07-08
ER

PT J
AU Bartsch, SM
   Asti, L
   Stokes-Cawley, OJ
   Sim, SY
   Bottazzi, ME
   Hotez, PJ
   Lee, BY
AF Bartsch, Sarah M.
   Asti, Lindsey
   Stokes-Cawley, Owen J.
   Sim, So Yoon
   Bottazzi, Maria Elena
   Hotez, Peter J.
   Lee, Bruce Y.
TI The Potential Economic Value of a Zika Vaccine for a Woman of
   Childbearing Age
SO AMERICAN JOURNAL OF PREVENTIVE MEDICINE
LA English
DT Article
ID ELIMINATION; EFFICACY; DISEASE; VIRUS; COST
AB Introduction: With Zika vaccine candidates under development and women of childbearing age being the primary target population, now is the time to map the vaccine (e.g., efficacy and duration of protection) and vaccination (e.g., cost) characteristic thresholds at which vaccination becomes cost effective, highly cost effective, and cost saving.
   Methods: A Markov model was developed (to represent 2019 circumstances, US$ and INT$, Region of the Americas) to simulate a woman of childbearing age and the potential risk and clinical course of a Zika infection.
   Results: Compared with no vaccination, vaccination was cost effective (incremental cost-effectiveness ratio: US$1,254-$82,900/disability-adjusted life years averted) when the risk of infection was >= 0.05%-0.08% (varying with country income), vaccine efficacy was >= 25%, and vaccination cost was US$1-$7,500 (INT$5-$10,000 depending on country income level). Vaccination was dominant (i.e., saved costs and provided beneficial health effects) when the infection risk was >= 0.1% for a vaccine efficacy >= 75% and when the infection risk was >= 0.5% for a vaccine efficacy >= 25%, for scenarios where vaccination conferred a 1-year duration of protection and cost <=$200. In some cases, the vaccine was cost effective when the risk was as low as 0.015%, the cost was as high as $7,500 (INT$10,000), the efficacy was as low as 25%, and the duration of protection was 1 year.
   Conclusions: The thresholds at which vaccination becomes cost effective and cost saving can provide targets for Zika vaccine development and implementation. (C) 2019 American Journal of Preventive Medicine. Published by Elsevier Inc. All rights reserved.
C1 [Bartsch, Sarah M.; Asti, Lindsey; Stokes-Cawley, Owen J.; Sim, So Yoon; Lee, Bruce Y.] CUNY, PHICOR, New York, NY 10021 USA.
   [Bottazzi, Maria Elena; Hotez, Peter J.] Baylor Coll Med, Natl Sch Trop Med, Houston, TX 77030 USA.
   [Bottazzi, Maria Elena; Hotez, Peter J.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Bottazzi, Maria Elena; Hotez, Peter J.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
RP Lee, BY (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Informat Computat & Operat Res, 615 N Wolfe St,Room W3501, Baltimore, MD 21205 USA.
EM brucelee@jhu.edu
OI Bottazzi, Maria Elena/0000-0002-8429-0476; Sim, So
   Yoon/0000-0002-3267-1867
FU Eunice Kennedy Shriver National Institute of Child Health and Human
   Development (NICHD) Office of Behavioral and Social Sciences Research
   (OBSSR) [U54HD070725]; Kennedy Shriver National Institute of Child
   Health and Human Development (NICHD) Global Obesity Prevention Center
   (GOPC) [U54HD070725]; NICHDUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [U01HD086861]; Agency for Healthcare Research and QualityUnited States
   Department of Health & Human ServicesAgency for Healthcare Research &
   Quality [R01HS023317]; National Institute of General Medical Sciences
   via Models of Infectious Diseases Agent Study [U24GM110707]; U.S. Agency
   for International DevelopmentUnited States Agency for International
   Development (USAID) [AID-OAA-A-15-00064]
FX This work was supported by the Eunice Kennedy Shriver National Institute
   of Child Health and Human Development (NICHD) Office of Behavioral and
   Social Sciences Research (OBSSR) and the Global Obesity Prevention
   Center (GOPC) via grant U54HD070725 and NICHD via U01HD086861, the
   Agency for Healthcare Research and Quality via grant R01HS023317, the
   National Institute of General Medical Sciences via Models of Infectious
   Diseases Agent Study grant U24GM110707, and the U.S. Agency for
   International Development under agreement number AID-OAA-A-15-00064. The
   funders had no role in the design and conduct of the study; collection,
   management, analysis, and interpretation of the data; or preparation,
   review, or approval of the manuscript. The authors of this manuscript
   are responsible for its content. Statements in the manuscript do not
   necessarily represent the official views of, or imply endorsement by,
   AHRQ or HHS.
CR Minsoko PA, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001685
   Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Basarab M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1049
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Butler D., 2012, NATURE, DOI [10.1038/nature.2012.11785., DOI 10.1038/NATURE.2012.11785]
   CDC National Center for Immunization and Respiratory Diseases, CDC SEAS FLU VACC EF
   Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P57
   Chen DS, 2009, J HEPATOL, V50, P805, DOI 10.1016/j.jhep.2009.01.002
   deQuadros CA, 1996, JAMA-J AM MED ASSOC, V275, P224, DOI 10.1001/jama.275.3.224
   Esposito S, 2017, AUTOIMMUN REV, V16, P96, DOI 10.1016/j.autrev.2016.09.022
   Fernandez-Salas I, 2015, ANTIVIR RES, V124, P30, DOI 10.1016/j.antiviral.2015.10.015
   Ferraris P, 2019, MICROBES INFECT, V21, P353, DOI 10.1016/j.micinf.2019.04.005
   Hamel R, 2016, MICROBES INFECT, V18, DOI 10.1016/j.micinf.2016.03.009
   Janusz CB, 2015, VACCINE, V33, pA53, DOI 10.1016/j.vaccine.2015.01.016
   Lee BY, 2015, VACCINE, V33, P4451, DOI 10.1016/j.vaccine.2015.07.033
   Lee BY, 2015, ADV PARASIT, V87, P329, DOI 10.1016/bs.apar.2015.01.002
   Lee BY, 2010, VACCINE, V28, P2806, DOI 10.1016/j.vaccine.2009.09.047
   McNeil D., 2012, NY TIMES
   Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257
   Pan American Health Organization WHO, 2019, EP UPD DENG
   Portnoy A, 2015, VACCINE, V33, pA99, DOI 10.1016/j.vaccine.2014.12.037
   Rolph MS, 2019, LANCET INFECT DIS, V19, P469, DOI 10.1016/S1473-3099(19)30169-0
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Scherwitzl I, 2017, CURR OPIN VIROL, V23, P95, DOI 10.1016/j.coviro.2017.04.002
   Sozou PD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046544
   WHO, 2018, ZIK VIR
   WHO Department of Reproductive Health and Research, 2011, FAM PLANN GLOB HDB P
   WHO. UN International children's Emergency Fund, 2017, WHO UNICEF ZIK VIR Z
   World Health Organization, 2002, WORLD HLTH REP 2002
   Zeng W, 2018, VACCINE, V36, P413, DOI 10.1016/j.vaccine.2017.11.064
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 34
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0749-3797
EI 1873-2607
J9 AM J PREV MED
JI Am. J. Prev. Med.
PD MAR
PY 2020
VL 58
IS 3
BP 370
EP 377
DI 10.1016/j.amepre.2019.10.023
PG 8
WC Public, Environmental & Occupational Health; Medicine, General &
   Internal
SC Public, Environmental & Occupational Health; General & Internal Medicine
GA KN4SU
UT WOS:000514829400012
PM 31980305
DA 2020-07-08
ER

PT J
AU Sharma, P
   Kaur, R
   Upadhyay, AK
   Kaushik, V
AF Sharma, Parul
   Kaur, Rajbir
   Upadhyay, Atul Kumar
   Kaushik, Vikas
TI In-Silico Prediction of Peptide Based Vaccine Against Zika Virus
SO INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS
LA English
DT Article
DE ZIKV; Glycoprotein; Docking; Simulation; Ligand; Epitope; MHC-I; MHC-II;
   Bioinformatics and molecular dynamics
ID INFECTION; DISEASE
AB Zika fever is a disease caused by Zika virus which is a mosquito-borne flavivirus and infection is through the bite of mosquito from the Aedes genus. Other mode of transmission of Zika fever is blood transfusion, which is thoroughly investigated. Prominent symptoms of Zika virus fever are mild fever, skin rash, conjunctivitis, muscle and joint pain, malaise or headache. These symptoms normally last for 2-7 days. There is currently no effective and easily affordable vaccine available against Zika virus. Keeping the current status in mind we have devised our objectives to design a peptide-based vaccine against Zika Virus using in-silico approach. The NS3 and NS5 proteins of Zika virus are well known of having important role in replication of the virus that is why we have targeted these proteins for epitope prediction. Prediction and screening of epitopes was performed using IEDB tool. We have also checked the efficacy of these screened epitopes with the help of IC50 value and docking score. "VEMGEAAAI" was found to be the high affinity binding epitope for MHC Class I and MHC Class II molecule. These findings conclude that the predicted epitope could well be used as a potential vaccine candidate for formulations of vaccines against Zika virus.
C1 [Sharma, Parul; Kaur, Rajbir; Upadhyay, Atul Kumar; Kaushik, Vikas] Lovely Profess Univ, Sch Bioengn & Biosci, Domain Bioinformat, Phagwara 144411, Punjab, India.
RP Kaushik, V (corresponding author), Lovely Profess Univ, Sch Bioengn & Biosci, Domain Bioinformat, Phagwara 144411, Punjab, India.
EM sharmaparul310194@gmail.com; rajbir.kaur145.rk@gmail.com;
   atul.20436@lpu.co.in; vikas.14664@lpu.co.in
RI Kaushik, Vikas/AAG-2963-2020
CR Alera MT, 2015, EMERG INFECT DIS, V21, P722, DOI 10.3201/eid2104.141707
   Atif M, 2016, INFECTION, V44, P695, DOI 10.1007/s15010-016-0935-6
   Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022
   Diallo D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109442
   Gaunt MW, 2001, J GEN VIROL, V82, P1867, DOI 10.1099/0022-1317-82-8-1867
   George S, 2011, MOL BIOL REP, V38, P1669, DOI 10.1007/s11033-010-0278-9
   Gourinat AC, 2015, EMERG INFECT DIS, V21, P84, DOI 10.3201/eid2101.140894
   Henderson BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025795
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289
   Pundir S, 2017, METHODS MOL BIOL, V1558, P41, DOI 10.1007/978-1-4939-6783-4_2
   Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481
   Shen YM, 2014, J CHEM THEORY COMPUT, V10, P4745, DOI 10.1021/ct500592m
   Tappe D, 2015, EMERG INFECT DIS, V21, P911, DOI 10.3201/eid2105.141960
   Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334
   Vita R, 2015, NUCLEIC ACIDS RES, V43, pD405, DOI 10.1093/nar/gku938
NR 18
TC 0
Z9 0
U1 2
U2 2
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1573-3149
EI 1573-3904
J9 INT J PEPT RES THER
JI Int. J. Pept. Res. Ther.
PD MAR
PY 2020
VL 26
IS 1
BP 85
EP 91
DI 10.1007/s10989-019-09818-2
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KN7IJ
UT WOS:000515007400009
DA 2020-07-08
ER

PT J
AU Wang, ZJ
   Merkenschlager, J
   Chen, ST
   Oliveira, TY
   Ramos, V
   Gordon, KM
   Yao, KH
   Jankovic, M
   Nussenzweig, M
   Escolano, A
AF Wang, Zijun
   Merkenschlager, Julia
   Chen, Spencer T.
   Oliveira, Thiago Y.
   Ramos, Victor
   Gordon, Kristie M.
   Yao, Kai-Hui
   Jankovic, Mila
   Nussenzweig, Michel
   Escolano, Amelia
TI Isolation of single HIV-1 Envelope specific B cells and antibody cloning
   from immunized rhesus macaques
SO JOURNAL OF IMMUNOLOGICAL METHODS
LA English
DT Article
DE Single HIV-1 Envelope-specific B cell sorting; Rhesus macaque antibody
   cloning; Monoclonal antibody production and screening
ID NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; BROAD
AB Antibody cloning from single B cells is an essential tool for characterizing humoral immune responses and obtaining valuable therapeutic and analytical reagents. Antibody cloning from individuals with high serologic titers to HIV-1, Influenza, Malaria and ZIKV has led to new insights that inform vaccine design efforts. In contrast to humans and mice, less is known about antibody cloning from single B cells in macaques. Here, we describe a protocol to identify and purify single antigen-specific macaque B cells, and subsequently clone and produce macaque monoclonal antibodies. The sorting strategy requires the use of a combination of fluorochrome labeled antigens and omission of anti-IgG antibodies that can interfere with antigen binding and vice versa. Optimized methods for macaque antibody gene amplification, DNA preparation for antibody production and antibody screening by ELISA are also presented.
C1 [Wang, Zijun; Merkenschlager, Julia; Chen, Spencer T.; Oliveira, Thiago Y.; Ramos, Victor; Gordon, Kristie M.; Yao, Kai-Hui; Jankovic, Mila; Nussenzweig, Michel; Escolano, Amelia] Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
   [Nussenzweig, Michel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.
RP Escolano, A (corresponding author), Rockefeller Univ, Lab Mol Immunol, New York, NY 10065 USA.
EM aescolano@rockefeller.edu
OI Ramos, Victor/0000-0001-7353-3420
FU National Institute of Allergy and Infectious Diseases (NIAID) of the
   National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Allergy & Infectious Diseases (NIAID) [HIVRAD P01
   AI100148]; NIH Center for HIV/AIDS Vaccine Immunology and Immunogen
   Discovery (CHAVI-ID) [1UM1 AI100663-01]; Robertson Fund of the
   Rockefeller University; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [K99/R00 9694871];
   China Scholarship CouncilChina Scholarship Council [201806370101]; EMBO
   fellowshipEuropean Molecular Biology Organization (EMBO); NIAID of the
   NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [F31AI147458]
FX We thank Pamela Bjorkman's laboratory for providing proteins, Malcolm
   Martin's laboratory for providing macaque LN cell homogenates, Wolfgang
   Uckert's laboratory for providing the retroviral vector MP71-Pre, Zoran
   Jankovic for laboratory support, Anna Gazumyan and all members of the
   Nussenzweig Laboratory for helpful discussion and advice. This work was
   supported by the following grants: National Institute of Allergy and
   Infectious Diseases (NIAID) of the National Institutes of Health (NIH)
   Grant HIVRAD P01 AI100148 (M.C.N.), NIH Center for HIV/AIDS Vaccine
   Immunology and Immunogen Discovery (CHAVI-ID) 1UM1 AI100663-01 (M.C.N.)
   and the Robertson Fund of the Rockefeller University (M.C.N.).
   Additional support included the NIH grant K99/R00 9694871 (A.E.), a
   scholarship from the China Scholarship Council (#201806370101) (Z.W), an
   EMBO fellowship (J.M.) and the NIAID of the NIH under fellowship number
   F31AI147458 (S.T.C). M.C.N. is a HHMI investigator.
CR Escolano A, 2019, NATURE, V570, P468, DOI 10.1038/s41586-019-1250-z
   Escolano A, 2017, J EXP MED, V214, P3, DOI 10.1084/jem.20161765
   Estes JD, 2018, NAT REV IMMUNOL, V18, P390, DOI 10.1038/s41577-018-0005-7
   Julien JP, 2019, NAT REV IMMUNOL, V19, P761, DOI 10.1038/s41577-019-0209-5
   Klein F, 2013, CELL, V153, P126, DOI 10.1016/j.cell.2013.03.018
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   Laursen NS, 2013, ANTIVIR RES, V98, P476, DOI 10.1016/j.antiviral.2013.03.021
   Martin M., 2011, EMBNET J, V17, P10, DOI DOI 10.14806/EJ.17.1.200
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Scheid JF, 2009, J IMMUNOL METHODS, V343, P65, DOI 10.1016/j.jim.2008.11.012
   Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
NR 13
TC 0
Z9 0
U1 2
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-1759
EI 1872-7905
J9 J IMMUNOL METHODS
JI J. Immunol. Methods
PD MAR
PY 2020
VL 478
AR UNSP 112734
DI 10.1016/j.jim.2019.112734
PG 6
WC Biochemical Research Methods; Immunology
SC Biochemistry & Molecular Biology; Immunology
GA KM6BL
UT WOS:000514223400010
PM 31866284
DA 2020-07-08
ER

PT J
AU Roner, MR
   Carraher, CE
   Miller, L
   Mosca, F
   Slawek, P
   Haky, JE
   Frank, J
AF Roner, Michael R.
   Carraher, Charles E., Jr.
   Miller, Lindsey
   Mosca, Francisca
   Slawek, Paul
   Haky, Jerome E.
   Frank, Jessica
TI Organotin Polymers as Antiviral Agents Including Inhibition of Zika and
   Vaccinia Viruses
SO JOURNAL OF INORGANIC AND ORGANOMETALLIC POLYMERS AND MATERIALS
LA English
DT Article
DE Zika virus; Vaccinia virus; Herpes simplex virus; Organotins; Organotin
   polymers
ID STRUCTURAL-CHARACTERIZATION; ANTICANCER; POLYESTERS; DIHALIDES; ABILITY;
   ABC/3TC
AB The ability to inhibit two important viruses is described. Two groups of polymers exhibited ability to totally inhibit the Zika virus. These polymers are derived from organotin dihalides and camphoric acid and lamivudine. This is the initial report of complete inhibition of the Zika virus by simple drugs. The ability to inhibit vaccinia virus is also reported. The inhibition of the vaccinia virus is shown by a number of organotin drugs including those also derived from lamivudine and camphoric acid and additional drugs derived from 3-amino-1,2,4-triazole, dicumarol, 4,6-diaminopyridine, alpha-cyano-4-hydroxcinnamic acid, and a variety of organotin polyethers including water soluble polymers derived from poly(ethylene glycol). All the drugs described in these studies are rapidly (< 30 s) synthesized using commercially available reactants at room temperature employing the interfacial reaction system that is employed industrially so that scale up to kilograms is relatively straight forward.
C1 [Roner, Michael R.; Miller, Lindsey] Univ Texas Arlington, Dept Biol, Arlington, TX 76010 USA.
   [Carraher, Charles E., Jr.; Mosca, Francisca; Slawek, Paul; Haky, Jerome E.; Frank, Jessica] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.
RP Roner, MR (corresponding author), Univ Texas Arlington, Dept Biol, Arlington, TX 76010 USA.; Carraher, CE (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA.
EM roner@uta.edu; carraher@fau.edu
CR Arimany-Nardi C, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00175
   Barot G, 2007, J INORG ORGANOMET P, V17, P595, DOI 10.1007/s10904-007-9158-8
   Carraher C, 1982, INTERFACIAL SYNTHESI
   Carraher CE, 2014, JCAMS, V2, P303, DOI 10.1080/22243682.2014.966274
   Carraher CE Jr, 2017, INTRO POLYM CHEM
   Carraher CE, 2007, J INORG ORGANOMET P, V17, P631, DOI 10.1007/s10904-007-9159-7
   Carraher CE, 2006, J INORG ORGANOMET P, V16, P249, DOI 10.1007/s10904-006-9050-y
   Carraher CE, 2018, J INORG ORGANOMET P, V28, P481, DOI 10.1007/s10904-017-0729-z
   Carraher CE, 2016, J INORG ORGANOMET P, V26, P1351, DOI 10.1007/s10904-016-0363-1
   Carraher CE, 2016, J INORG ORGANOMET P, V26, P1338, DOI 10.1007/s10904-016-0424-5
   Carraher CE, 2016, J MACROMOL SCI A, V53, DOI 10.1080/10601325.2016.1120172
   Carraher CE, 2015, INT J POLYM MATER PO, V64, P800, DOI 10.1080/00914037.2015.1030650
   Carraher CE, 2015, J INORG ORGANOMET P, V25, P386, DOI 10.1007/s10904-014-0048-6
   Carraher CE, 2014, J ORGANOMET CHEM, V751, P67, DOI 10.1016/j.jorganchem.2013.05.033
   Carraher Jr C, 2018, CARRAHERS POLYM CHEM
   Carraher Jr CE, 2017, INT J APPL PHARM BIO, V2, P1
   Flandre P, 2016, HIV MED, V17, P380, DOI 10.1111/hiv.12306
   JOKLIK WK, 1980, YALE J BIOL MED, V53, P27
   Millich F, 1977, INTERFACIAL SYNTHESI
   Morgan PW, 1965, CONDENSATION POLYM I
   Orkin C, 2018, HIV MED, V19, P18, DOI 10.1111/hiv.12534
   Palacios R, 2016, EUR J CLIN MICROBIOL, V35, P815, DOI 10.1007/s10096-016-2602-3
   Pandey G, 2016, ARTIF CELL NANOMED B, V44, P1867, DOI 10.3109/21691401.2015.1111229
   Riedel Stefan, 2005, Proc (Bayl Univ Med Cent), V18, P13
   Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009
   Roner MR, 2006, J POLYM MATER, V23, P153
   Roner MR, 2011, MATERIALS, V4, P991, DOI 10.3390/ma4060991
   Shoko C, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0082-0
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Verardi PH, 2012, HUM VACC IMMUNOTHER, V8, P961, DOI 10.4161/hv.21080
NR 30
TC 1
Z9 1
U1 5
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1574-1443
EI 1574-1451
J9 J INORG ORGANOMET P
JI J. Inorg. Organomet. Polym. Mater.
PD MAR
PY 2020
VL 30
IS 3
BP 684
EP 694
DI 10.1007/s10904-019-01250-9
PG 11
WC Polymer Science
SC Polymer Science
GA KI7HA
UT WOS:000511519400010
DA 2020-07-08
ER

PT J
AU Costa, ML
   Nobrega, GD
   Antolini-Tavares, A
AF Costa, Maria Laura
   Nobrega, Guilherme de Moraes
   Antolini-Tavares, Arthur
TI Key Infections in the Placenta
SO OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA
LA English
DT Article
DE Placenta; Congenital infection; TORCH
ID PARVOVIRUS B19 INFECTION; CONGENITAL-RUBELLA SYNDROME; ZIKA VIRUS;
   CYTOMEGALOVIRUS-INFECTION; TOXOPLASMA-GONDII; PREGNANCY; PROGRESS;
   TRANSMISSION; ELIMINATION; SYPHILIS
AB Congenital infections are an important cause of morbidity and mortality worldwide, especially in low-income settings. This review discusses the main pathways of infections and associated adverse maternal and fetal outcomes, considering the TORCH pathogens, including Zika virus; the acronym stands for Toxoplasma gondii infection, other (Listeria monocytogenes, Treponema pallidum, and parvovirus B19, among others, including Zika virus), rubella virus, cytomegalovirus, and herpes simplex viruses type 1 and type 2.
C1 [Costa, Maria Laura; Nobrega, Guilherme de Moraes] Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
   [Antolini-Tavares, Arthur] Univ Estadual Campinas, Sch Med, Dept Pathol Anat, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Sch Med, Dept Obstet & Gynecol, Rua Alexander Fleming 101, BR-13084881 Campinas, SP, Brazil.
EM mlaura@unicamp.br
OI de Moraes Nobrega, Guilherme/0000-0001-9406-4256
FU Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [409605/2016]
FX This work was supported by Grant CNPq #409605/2016 - Conselho Nacional
   de Desenvolvimento Cientifico e Tecnologico (CNPq).
CR Aguirre AA, 2019, ECOHEALTH, V16, P378, DOI 10.1007/s10393-019-01405-7
   Arora N, 2017, CELL HOST MICROBE, V21, P561, DOI 10.1016/j.chom.2017.04.007
   Bardaj A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005606
   Barron SD, 1995, SEMIN PERINATOL, V19, P493, DOI 10.1016/S0146-0005(05)80056-4
   Billington WD, 2003, J REPROD IMMUNOL, V60, P1, DOI 10.1016/S0165-0378(03)00083-4
   Burton GJ, 2018, AM J OBSTET GYNECOL, V218, pS745, DOI 10.1016/j.ajog.2017.11.577
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Courtier J, 2012, ULTRASOUND OBST GYN, V40, P604, DOI 10.1002/uog.11121
   Crane J, 2014, J OBSTET GYNAECOL CA, V36, P1107, DOI 10.1016/S1701-2163(15)30390-X
   De Beaudrap P, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1135-7
   Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X
   Driggers RW, 2017, NEW ENGL J MED, V37, P51, DOI DOI 10.1097/01.AOA.0000512046.09676.84
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Faye-Petersen OM, 2006, HDB PLACENTAL PATHOL
   Fried M, 2017, COLD SPRING HARB PER, V7
   Genest DR, 1996, HUM PATHOL, V27, P366, DOI 10.1016/S0046-8177(96)90110-0
   Grant GB, 2017, MMWR-MORBID MORTAL W, V66, P1256, DOI 10.15585/mmwr.mm6645a4
   Heerema-McKenney A, 2018, APMIS, V126, P570, DOI 10.1111/apm.12847
   Imanishi M, 2015, INFECT DIS OBSTET GY, V2015, P1
   Iwasenko JM, 2011, J INFECT DIS, V203, P1526, DOI 10.1093/infdis/jir121
   Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009
   Kitt E, 2017, JMM CASE REP, V4, P10
   Klugman D, 2010, PEDIATR CARDIOL, V31, P222, DOI 10.1007/s00246-009-9589-9
   Koi H, 2002, BIOL REPROD, V67, P1572, DOI 10.1095/biolreprod.102.004325
   Kontomanolis EN, 2018, CURR PEDIATR REV, V14, P239, DOI 10.2174/1573396314666180820154340
   Lamond NM, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020052
   Lamont RF, 2011, J PERINAT MED, V39, P227, DOI [10.1515/JPM.2011.035, 10.1515/jpm.2011.035]
   Lindsay DS, 2011, PARASITOLOGY, V138, P1829, DOI 10.1017/S0031182011001478
   Looker KJ, 2017, LANCET GLOB HEALTH, V5, pE300, DOI [10.1016/S2214-109X(16)30362-X, 10.1016/s2214-109x(16)30362-x]
   Looker KJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114989
   Mace G, 2014, J MATERN-FETAL NEO M, V27, P1375, DOI 10.3109/14767058.2013.853288
   Macnamara FN, 1954, T R SOC TROP MED HYG, V48
   Marin LJ, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0604-5
   Martinez-Quintana E, 2015, REV PANAM SALUD PUBL, V37, P179
   Matteelli A, 1997, ANN TROP MED PARASIT, V91, P803, DOI 10.1080/00034989760563
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nelson DM, 2015, AM J OBSTET GYNECOL, V213, pS12, DOI 10.1016/j.ajog.2015.08.015
   Nelson R, 2018, LANCET INFECT DIS, V18, P1186, DOI 10.1016/S1473-3099(18)30618-2
   Pandya Y, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01126
   Paquet C, 2018, J OBSTET GYNAECOL CA, V40, pE687, DOI 10.1016/j.jogc.2018.05.036
   Peeling RW, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.73
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Phipps EA, 2019, NAT REV NEPHROL, V15, P275, DOI 10.1038/s41581-019-0119-6
   Pistorius LR, 2008, FETAL DIAGN THER, V24, P491, DOI 10.1159/000180119
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Proenca-Modena JL, 2018, MICROBES INFECT, V20, P661, DOI 10.1016/j.micinf.2018.02.008
   Rawlinson WD, 2016, CURR OPIN INFECT DIS, V29, P615, DOI 10.1097/QCO.0000000000000317
   Schantz-Dunn Julianna, 2009, Rev Obstet Gynecol, V2, P186
   Sheffield JS, 2003, OBSTET GYNECOL, V102, P1396, DOI 10.1016/j.obstetgynecol.2003.08.015
   Silasi M, 2015, AM J REPROD IMMUNOL, V73, P199, DOI 10.1111/aji.12355
   Silk BJ, 2013, MMWR-MORBID MORTAL W, V62, P448
   Simoni MK, 2017, AM J REPROD IMMUNOL, V77, DOI 10.1111/aji.12613
   Spiteri G, 2019, EPIDEMIOL INFECT, V147, DOI [10.1017/S0950268819000281, 10.1017/s0950268819000281]
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Taylor M, 2018, LANCET GLOB HEALTH, V6, pE26, DOI 10.1016/S2214-109X(17)30422-9
   Tiwari SK, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.9
   Turrini F, 2016, NEW MICROBIOL, V39, P86
   Uneke Chigozie J, 2007, Yale J Biol Med, V80, P39
   Vazquez-Boland JA, 2017, MBIO, V8, DOI 10.1128/mBio.00949-17
   Versalovic J, 2011, MANUAL CLIN MICROBIO, DOI [10.1128/9781555816728, DOI 10.1128/9781555816728]
   Vinturache AE, 2016, SEMIN FETAL NEONAT M, V21, P94, DOI 10.1016/j.siny.2016.02.004
   Virginia B, 2015, MMWR-MORBID MORTAL W, V64, P1233
   Weichert A, 2010, FETAL DIAGN THER, V28, P225, DOI 10.1159/000320203
   *WHO, 2000, WHO TECH REP SER, V892, P1
   Xiong YQ, 2019, J CLIN VIROL, V114, P12, DOI 10.1016/j.jcv.2019.03.004
   Yazigi A, 2017, J MATERN-FETAL NEO M, V30, P274, DOI 10.3109/14767058.2016.1169526
   ZHANG LJ, 1995, J INFECT DIS, V171, P1002, DOI 10.1093/infdis/171.4.1002
   Zimmerman LA, 2019, MMWR-MORBID MORTAL W, V68, P396, DOI 10.15585/mmwr.mm6817a4
NR 70
TC 0
Z9 0
U1 5
U2 5
PU W B SAUNDERS CO-ELSEVIER INC
PI PHILADELPHIA
PA 1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN 0889-8545
EI 1558-0474
J9 OBSTET GYN CLIN N AM
JI Obstet. Gynecol. Clin. N. Am.
PD MAR
PY 2020
VL 47
IS 1
BP 133
EP +
DI 10.1016/j.ogc.2019.10.003
PG 15
WC Obstetrics & Gynecology
SC Obstetrics & Gynecology
GA KL2ZL
UT WOS:000513297000011
PM 32008664
DA 2020-07-08
ER

PT J
AU Kapiriri, L
   Ross, A
AF Kapiriri, Lydia
   Ross, Alison
TI The Politics of Disease Epidemics: a Comparative Analysis of the SARS,
   Zika, and Ebola Outbreaks
SO GLOBAL SOCIAL WELFARE
LA English
DT Article
DE Politics; Epidemics; SARs; Zika; Ebola
ID PUBLIC-HEALTH; SOCIAL INEQUALITIES; GLOBAL HEALTH; VIRUS DISEASE;
   LIBERIA; LESSONS; KNOWLEDGE; OCTOBER; BRAZIL; TRAVEL
AB Over the past few decades, disease outbreaks have become increasingly frequent and widespread. The epicenters of these outbreaks have differed, and could be linked to different economic contexts. Arguably, the responses to these outbreaks have been "political" and inherently burdensome to marginalized populations. Key lessons can be learned from exploring the narratives about the different epidemics in varying income settings. Based on a review of the published medical, social, and political literature, which was accessed using four electronic databases-PubMed, Sociological s, Scholars Portal, and Web of Science, the overall objective of this paper discuss scholars' narratives on the "politics" of Ebola in a low-income setting, Zika virus in a middle-income setting, and SARS in a high-income setting. Various themes of the politics of epidemics were prominent in the literature. The narratives demonstrated the influence of power in whose narratives and what narratives are presented in the literature. While marginalized populations were reported to have borne the brunt of all disease outbreaks in the different contexts, the prevalence of their narratives within the reviewed literature was limited. Regardless of income setting, there is a need to give voice to the most marginalized communities during an epidemic. The experiences and narratives of those most vulnerable to an epidemic-specifically poor communities-need to be represented in the literature. This could contribute to mitigating some of the negative impact of the politics in epidemics.
C1 [Kapiriri, Lydia; Ross, Alison] McMaster Univ, Dept Hlth Aging & Soc, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.
RP Kapiriri, L (corresponding author), McMaster Univ, Dept Hlth Aging & Soc, 1280 Main St West, Hamilton, ON L8S 4L8, Canada.
EM kapirir@mcmaster.ca
OI kapiriri, lydia/0000-0002-1237-6369
FU Canadian Institutes for Health ResearchCanadian Institutes of Health
   Research (CIHR)
FX LK's research is funded by the Canadian Institutes for Health Research.
   AR is a PhD candidate.
CR Abramowitz SA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003767
   Alexander KA, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003652
   Ali H, 2016, CLIM CHANG MANAG, P151, DOI 10.1007/978-3-319-24660-4_10
   Ali SH, 2008, CAN ETHN STUD, V40, P43, DOI 10.1353/ces.2008.0002
   Alsan MM, 2011, INFECT DIS CLIN N AM, V25, P611, DOI 10.1016/j.idc.2011.05.004
   Arima Y, 2014, UIRUSU, V65, P47
   Arya N, 2009, GLOB PUBLIC HEALTH, V4, P31, DOI 10.1080/17441690701438128
   Blair RA, 2017, SOC SCI MED, V172, P89, DOI 10.1016/j.socscimed.2016.11.016
   Bonneux L, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c3065
   Brym R., 2014, SOC
   Burkle FM, 2015, DISASTER MED PUBLIC, V9, P38, DOI 10.1017/dmp.2014.117
   Centre for Disease Control and Prevention, 2012, EP DIS OCC
   Cordner S, 2017, FORENSIC SCI INT, V279, P302, DOI 10.1016/j.forsciint.2017.04.010
   Davies SE, 2016, THIRD WORLD Q, V37, P419, DOI 10.1080/01436597.2015.1110015
   Diniz SG, 2016, MIDWIFERY, V35, P22, DOI 10.1016/j.midw.2016.02.011
   Evans M. R, 2010, J PUBLIC HLTH
   Fallah MP, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004260
   Farmer P, 1996, EMERG INFECT DIS, V2, P259, DOI 10.3201/eid0204.960402
   Fast S. M., 2015, PLOS CURRENTS OUTBRE
   Faust HS, 2009, PUBLIC HEALTH ETH-UK, V2, P105, DOI 10.1093/phe/php002
   Garbuglia Anna Rosa, 2016, Indian J Med Ethics, V1, P104
   Gautret P, 2016, TRAVEL MED INFECT DI, V14, P7, DOI 10.1016/j.tmaid.2015.12.004
   Gyawali N, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0132-y
   Hagan JE, 2015, MMWR-MORBID MORTAL W, V64, P183
   Hennigan T., 2016, BMJ-BRIT MED J, V352, P1226
   Holm S, 2009, J BIOETHIC INQ, V6, P197, DOI 10.1007/s11673-009-9160-7
   Imperato PJ, 2016, J COMMUN HEALTH, V41, P674, DOI 10.1007/s10900-016-0177-7
   Jacobs LA, 2007, LAW SOC REV, V41, P511, DOI 10.1111/j.1540-5893.2007.00313.x
   Jones J, 2011, J GLOB HEALTH, V1, P1
   Keil R., 2008, NETWORKED DIS EMERGI, P152
   Keil R, 2007, ANTIPODE, V39, P846, DOI 10.1111/j.1467-8330.2007.00555.x
   King N.B, 2008, NETWORKED DIS EMERGI, P201
   Kobayashi M, 2015, MMWR-MORBID MORTAL W, V64, P714
   Leach M., 2010, EPIDEMICS SCI GOVERN, P1, DOI 10.4324/
   Leach M, 2014, MED ANTHROPOL, V33, P240, DOI 10.1080/01459740.2013.842565
   Leach M, 2010, GLOBAL ENVIRON CHANG, V20, P369, DOI 10.1016/j.gloenvcha.2009.11.008
   Leung CS, 2008, J URBAN HEALTH, V85, P402, DOI 10.1007/s11524-008-9270-2
   Lima-Camara T. N, 2016, REV SAUDE PUBLICA, V50
   Lotufo PA, 2016, SAO PAULO MED J, V134, P95, DOI 10.1590/1516-3180.2016.13421602
   Lupton Kelly, 2016, Br J Nurs, V25, P200, DOI 10.12968/bjon.2016.25.4.198
   MacDougall H, 2007, J HIST MED ALL SCI, V62, P56, DOI 10.1093/jhmas/jrl042
   Maras MH, 2016, COMP STRATEGY
   Mazzu-Nascimento T, 2017, GENET MOL BIOL, V40, P387, DOI [10.1590/1678-4685-GMB-2016-0179, 10.1590/1678-4685-gmb-2016-0179]
   McNamara LA, 2016, MMWR-MORBID MORTAL W, V65, P35, DOI 10.15585/mmwr.su6503a6
   Merriam-Webster, 2016, POLITICS
   Morinet F, 2016, CURRENT RES TRANSLAT, V64, P53
   Mykhalovskiy E, 2006, CAN J PUBLIC HEALTH, V97, P42, DOI 10.1007/BF03405213
   Ng M.K, 2008, NETWORKED DIS EMERGI
   Nightingale P, 2010, EPIDEMICS SCI GOVERN, P165
   Nunes J, 2016, THIRD WORLD Q, V37, P542, DOI 10.1080/01436597.2015.1124724
   Nyenswah T, 2014, MMWR-MORBID MORTAL W, V63, P1082
   Ordaz-Nemeth I, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005450
   Paquin LJ, 2007, CAN J PUBLIC HEALTH, V98, P209, DOI 10.1007/BF03403714
   Pellecchia U, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143036
   Phua Kai-Lit, 2015, Infect Dis (Auckl), V8, P39, DOI 10.4137/IDRT.S31568
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Possas C, 2016, EPIDEMIOL HEALTH, V38, DOI 10.4178/epih.e2016023
   Roemer-Mahler A, 2016, THIRD WORLD Q, V37, P373, DOI 10.1080/01436597.2015.1118343
   Salehi R, 2006, CAN PUBLIC POL, V32, P373
   Scoones I, 2010, EPIDEMICS SCI GOVERN, P137
   Scott V, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3071-4
   Siegel S, 2015, ETHICS INT AFF, V29, P3, DOI 10.1017/S0892679414000720
   Silas L, 2006, HEALTHCARE PAPERS, V8, P8
   Slavov SN, 2016, BRAZ J MED BIOL RES, V49, DOI 10.1590/1414-431X20165420
   Stanturf JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137208
   Summers Andy, 2009, Emerg Nurse, V17, P16
   Tavares MP, 2016, CONTRACEPTION, V94, P109, DOI 10.1016/j.contraception.2016.04.006
   Teo P., 2008, NETWORKED DIS EMERGI, P86
   Tracy CS, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-470
   Washington ML, 2015, MMWR-MORBID MORTAL W, V64, P67
   Weizhen Dong, 2008, Promot Educ, V15, P53, DOI 10.1177/1025382308097699
   Wong WCW, 2007, AM J INFECT CONTROL, V35, P50, DOI 10.1016/j.ajic.2006.06.009
   World Health Organization, 2017, PREV SEX TRANSM ZIK
   World Health Organization, 2017, MICR
   World Health Organization, 2017, ZIK VIR
   World Health Organization, 2017, INF TRAV VIS ZIK AFF
   World Health Organization, 2017, SIT REP EB VIR DIS
NR 77
TC 2
Z9 2
U1 8
U2 8
PU SPRINGER INTERNATIONAL PUBLISHING AG
PI CHAM
PA GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND
SN 2196-8799
J9 GLOB SOC WELFARE
JI Glob. Soc. Welfare
PD MAR
PY 2020
VL 7
IS 1
BP 33
EP 45
DI 10.1007/s40609-018-0123-y
PG 13
WC Social Work
SC Social Work
GA KJ3KT
UT WOS:000511957300005
PM 32226719
OA Green Published, Other Gold
DA 2020-07-08
ER

PT J
AU Voss, S
   Nitsche, C
AF Voss, Saan
   Nitsche, Christoph
TI Inhibitors of the Zika virus protease NS2B-NS3
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Review
DE Flavivirus; Serine protease; Peptides; Allosteric inhibitors; Antivirals
ID HUMAN-ANTIBODY RESPONSES; DENGUE VIRUS; BROAD-SPECTRUM; MEDICINAL
   CHEMISTRY; ANTIVIRAL ACTIVITY; CRYSTAL-STRUCTURE; CROSS-REACTIVITY;
   INFECTION; DISCOVERY; SURAMIN
AB In recent years, the Zika virus has emerged from a neglected flavivirus to a health-threatening pathogen that causes epidemic outbreaks associated with neurological disorders and congenital malformations. In addition to vaccine development, the discovery of specific antiviral agents has been pursued intensely. The Zika virus protease NS2B-NS3 catalyses the processing of the viral precursor polyprotein as an essential step during viral replication. Since the epidemic Zika virus outbreak in the Americas, several inhibitors of this protease have been reported. Substrate-derived peptides revealed important structural information about the active site, whilst more drug-like small molecules have been discovered as allosteric inhibitors.
C1 [Voss, Saan; Nitsche, Christoph] Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
RP Nitsche, C (corresponding author), Australian Natl Univ, Res Sch Chem, Canberra, ACT 2601, Australia.
EM christoph.nitsche@anu.edu.au
FU Australian Research CouncilAustralian Research Council [DE190100015]
FX C.N. thanks the Australian Research Council for a Discovery Early Career
   Research Award (DE190100015).
CR Akaberi D, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1704882
   Albulescu IC, 2017, ANTIVIR RES, V143, P230, DOI 10.1016/j.antiviral.2017.04.016
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barrows NJ, 2018, CHEM REV, V118, P4448, DOI 10.1021/acs.chemrev.7b00719
   Bernatchez JA, 2020, J MED CHEM, V63, P470, DOI 10.1021/acs.jmedchem.9b00775
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Breitbach ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007766
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chong HY, 2019, VIRUS RES, V274, DOI 10.1016/j.virusres.2019.197770
   Coronado MA, 2018, ANTIVIR RES, V160, P118, DOI 10.1016/j.antiviral.2018.10.019
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   da Silva EF, 2019, BIOORGAN MED CHEM, V27, P3963, DOI 10.1016/j.bmc.2019.07.038
   de Leuw P, 2018, EXPERT OPIN PHARMACO, V19, P577, DOI 10.1080/14656566.2018.1454428
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Diamond MS, 2019, ANNU REV MED, V70, P121, DOI 10.1146/annurev-med-040717-051127
   Gaudinski MR, 2018, LANCET, V391, P552, DOI 10.1016/S0140-6736(17)33105-7
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Ghosh AK, 2016, J MED CHEM, V59, P5172, DOI 10.1021/acs.jmedchem.5b01697
   Grinter R., 2019, QUESTIONABLE LIGAND
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Hilgenfeld R, 2016, EMBO J, V35, P2631, DOI 10.15252/embj.201695871
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Ji MY, 2019, TOXINS, V11, DOI 10.3390/toxins11100584
   Kang CB, 2017, TRENDS MICROBIOL, V25, P797, DOI 10.1016/j.tim.2017.07.001
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   Li G, 2017, P NATL ACAD SCI USA, V114, pE376, DOI 10.1073/pnas.1619735114
   Li Y, 2018, STRUCTURE, V26, P555, DOI 10.1016/j.str.2018.02.005
   Li Y, 2017, STRUCTURE, V25, P1242, DOI 10.1016/j.str.2017.06.006
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Liang QM, 2016, CELL STEM CELL, V19, P663, DOI 10.1016/j.stem.2016.07.019
   Lim HJ, 2017, BIOTECHNOL LETT, V39, P415, DOI 10.1007/s10529-016-2261-6
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Luo DH, 2015, ANTIVIR RES, V118, P148, DOI 10.1016/j.antiviral.2015.03.014
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Lynch RM, 2019, J INFECT DIS, V219, P26, DOI 10.1093/infdis/jiy466
   Mahawaththa MC, 2017, ANTIVIR RES, V142, P141, DOI 10.1016/j.antiviral.2017.03.011
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Millies B, 2019, J MED CHEM, V62, P11359, DOI 10.1021/acs.jmedchem.9b01697
   Musso D, 2019, NEW ENGL J MED, V381, P1444, DOI 10.1056/NEJMra1808246
   Nitsche C, 2019, ORG LETT, V21, P4709, DOI 10.1021/acs.orglett.9b01545
   Nitsche Christoph, 2019, Biophys Rev, V11, P157, DOI 10.1007/s12551-019-00508-3
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nitsche C, 2018, ADV EXP MED BIOL, V1062, P175, DOI 10.1007/978-981-10-8727-1_13
   Nitsche C, 2017, J MED CHEM, V60, P511, DOI 10.1021/acs.jmedchem.6b01021
   Nitsche C, 2014, CHEM REV, V114, P11348, DOI 10.1021/cr500233q
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Parra B, 2016, NEW ENGL J MED, V375, P1513, DOI 10.1056/NEJMoa1605564
   Phoo WW, 2018, ANTIVIR RES, V160, P17, DOI 10.1016/j.antiviral.2018.10.006
   Pinkham AM, 2018, CHEM COMMUN, V54, P12357, DOI 10.1039/c8cc07448h
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rassias G, 2019, EUR J MED CHEM, V180, P536, DOI 10.1016/j.ejmech.2019.07.007
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Rivera-Correa J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007695
   Roy A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180632
   Rut W, 2017, ANTIVIR RES, V139, P88, DOI 10.1016/j.antiviral.2016.12.018
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X
   Shiryaev SA, 2017, ANTIVIR RES, V143, P218, DOI 10.1016/j.antiviral.2017.04.015
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tan CW, 2017, ANTIVIR RES, V143, P186, DOI 10.1016/j.antiviral.2017.04.017
   Wang LL, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02725
   WHO Region of the Americas/Pan American Health Organization, PLISA HLTH INF PLATF
   Wilder-Smith A, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1067-x
   World Health Organization, 2019, ZIK EP UPD VERS
   Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14
   Xu SQ, 2012, J MED CHEM, V55, P6881, DOI 10.1021/jm300655h
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zhang XW, 2019, MBIO, V10, DOI 10.1128/mBio.02375-19
   Zhang XW, 2019, EMERG MICROBES INFEC, V8, P585, DOI 10.1080/22221751.2019.1598291
   Zhang ZZ, 2016, SCIENCE, V354, P1597, DOI 10.1126/science.aai9309
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
NR 83
TC 0
Z9 0
U1 11
U2 11
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD MAR 1
PY 2020
VL 30
IS 5
AR 126965
DI 10.1016/j.bmcl.2020.126965
PG 8
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA KH4JO
UT WOS:000510612700013
PM 31980339
OA Bronze
DA 2020-07-08
ER

PT J
AU Carlson, JS
   Short, SM
   Anglero-Rodriguez, YI
   Dimopoulos, G
AF Carlson, Jenny S.
   Short, Sarah M.
   Anglero-Rodriguez, Yesseinia, I
   Dimopoulos, George
TI Larval exposure to bacteria modulates arbovirus infection and immune
   gene expression in adult Aedes aegypti
SO DEVELOPMENTAL AND COMPARATIVE IMMUNOLOGY
LA English
DT Article
DE Aedes aegypti; Dengue virus; Zika virus; Innate immunity; Bacteria;
   Transstadial
ID ANOPHELES-GAMBIAE DIPTERA; WING LENGTH; BODY-SIZE; CULICIDAE; PARASITE;
   DENSITY; TEMPERATURE; ACTIVATION; SURVIVAL; WEIGHT
AB Here we have investigated whether bacterial challenges to larval stages of Aedes aegypti can influence the adults' immune and vector competence for dengue and Zika viruses. We show that larval exposure to live Bacillus thuringiensis Berliner and Enterobacter luclwigii can result in the modulation of virus infection at the adult stage in the absence of bacterial carry-over between the two developmental stages. We observed a significant reduction in virus infection intensity in the mosquitoes exposed to bacteria as larvae but not re-exposed as adults. The pattern of immune gene transcript regulation after bacterial exposure varied between adults, depending on whether or not they had been exposed to bacteria as larvae. Adults exposed to bacteria as larvae showed an earlier immune gene mRNA enrichment when re-exposed as adults than did adults not exposed as larvae. Bacterial exposure of larvae appears to have only modest effects on adult fitness.
C1 [Carlson, Jenny S.; Short, Sarah M.; Anglero-Rodriguez, Yesseinia, I; Dimopoulos, George] Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
   [Short, Sarah M.] Ohio State Univ, Dept Entomol, 1735 Neil Ave, Columbus, OH 43210 USA.
RP Dimopoulos, G (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, W Harry Feinstone Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
EM gdimopo@jhu.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01AI141532,
   R21AI136456]; Bloomberg Philanthropies
FX We thank the Johns Hopkins Malaria Research Institute insectary for
   assistance with mosquito rearing. We thank Dr. Deborah McClellan for
   editorial assistance. This work has been supported by The National
   Institutes of Health grants R01AI141532 and R21AI136456, and the
   Bloomberg Philanthropies.
CR Aboagye-Antwi F, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-225
   Afrane YA, 2007, AM J TROP MED HYG, V77, P660, DOI 10.4269/ajtmh.2007.77.660
   Brown LD, 2019, ECOL EVOL, V9, P6082, DOI 10.1002/ece3.5192
   Brown LD, 2018, J INVERTEBR PATHOL, V151, P21, DOI 10.1016/j.jip.2017.10.008
   Chavshin AR, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0635-6
   Coon KL, 2017, P NATL ACAD SCI USA, V114, pE5362, DOI 10.1073/pnas.1702983114
   Coon KL, 2016, MOL ECOL, V25, P5806, DOI 10.1111/mec.13877
   Coon KL, 2014, MOL ECOL, V23, P2727, DOI 10.1111/mec.12771
   Das Suchismita, 2007, J Vis Exp, P220, DOI 10.3791/220
   Dickson LB, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700585
   Freitak D, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-56
   Freitak D, 2009, P ROY SOC B-BIOL SCI, V276, P2617, DOI 10.1098/rspb.2009.0323
   Gimnig JE, 2002, J MED ENTOMOL, V39, P162, DOI 10.1603/0022-2585-39.1.162
   Gimnig JE, 2001, J MED ENTOMOL, V38, P282, DOI 10.1603/0022-2585-38.2.282
   GRIMSTAD PR, 1991, J MED ENTOMOL, V28, P378, DOI 10.1093/jmedent/28.3.378
   Gusmao DS, 2007, MEM I OSWALDO CRUZ, V102, P919, DOI 10.1590/S0074-02762007000800005
   Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267
   Hernandez-Martinez P, 2010, ENVIRON MICROBIOL, V12, P2730, DOI 10.1111/j.1462-2920.2010.02241.x
   Kim CH, 2013, J INSECT PHYSIOL, V59, P604, DOI 10.1016/j.jinsphys.2013.03.010
   Koella JC, 1996, J MED ENTOMOL, V33, P261, DOI 10.1093/jmedent/33.2.261
   Lane D., 1991, NUCL ACID TECHNIQUES, V1991, P115, DOI DOI 10.1007/S00227-012-2133-0
   League GP, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2302-6
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   LYIMO EO, 1992, PARASITOLOGY, V104, P233, DOI 10.1017/S0031182000061667
   LYIMO EO, 1992, ENTOMOL EXP APPL, V63, P265, DOI 10.1007/BF00192775
   Meister S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000542
   Moller-Jacobs LL, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0593-4
   Moreno-Garcia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133240
   Moret Y, 2000, SCIENCE, V290, P1166, DOI 10.1126/science.290.5494.1166
   Moret Y, 2006, P R SOC B, V273, P1399, DOI 10.1098/rspb.2006.3465
   Okech BA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-50
   PACKER MJ, 1989, ECOL ENTOMOL, V14, P297, DOI 10.1111/j.1365-2311.1989.tb00960.x
   Paily KP, 2012, PARASITOL RES, V110, P2229, DOI 10.1007/s00436-011-2754-0
   Pham LN, 2008, INSECT IMMUNOLOGY, P97, DOI 10.1016/B978-012373976-6.50007-0
   Plaistow SJ, 2001, INT J PARASITOL, V31, P346, DOI 10.1016/S0020-7519(01)00115-1
   Pulkkinen K, 2004, ECOLOGY, V85, P823, DOI 10.1890/03-0185
   Pumpuni CB, 1996, AM J TROP MED HYG, V54, P214, DOI 10.4269/ajtmh.1996.54.214
   Ramirez JL, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001561
   Rani A, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-96
   SIEGEL JP, 1992, J MED ENTOMOL, V29, P711, DOI 10.1093/jmedent/29.4.711
   Sim S, 2014, VIRUSES-BASEL, V6, P4479, DOI 10.3390/v6114479
   Suwanchaichinda C, 1998, J MED ENTOMOL, V35, P157, DOI 10.1093/jmedent/35.2.157
   Vargas V, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00975
   Wang YG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023495
   World Health Organization, 2016, VECT BORN DIS
   ZAKHAROVA N F, 1990, Meditsinskaya Parazitologiya i Parazitarnye Bolezni, P3
NR 46
TC 0
Z9 0
U1 27
U2 27
PU ELSEVIER SCI LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND
SN 0145-305X
EI 1879-0089
J9 DEV COMP IMMUNOL
JI Dev. Comp. Immunol.
PD MAR
PY 2020
VL 104
AR 103540
DI 10.1016/j.dci.2019.103540
PG 8
WC Fisheries; Immunology; Zoology
SC Fisheries; Immunology; Zoology
GA KG0EO
UT WOS:000509614700015
PM 31726064
DA 2020-07-08
ER

PT J
AU Chouin-Carneiro, T
   Ant, TH
   Herd, C
   Louis, F
   Failloux, AB
   Sinkins, SP
AF Chouin-Carneiro, T.
   Ant, T. H.
   Herd, C.
   Louis, F.
   Failloux, A. B.
   Sinkins, S. P.
TI Wolbachia strain wAlbA blocks Zika virus transmission in Aedes aegypti
SO MEDICAL AND VETERINARY ENTOMOLOGY
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; dengue virus arbovirus; pathogen
   blocking; Wolbachia; Zika virus
ID CYTOPLASMIC INCOMPATIBILITY; DENSITY; DENGUE; SUPERGROUP; ARTHROPOD
AB Transinfections of the maternally transmitted endosymbiont Wolbachia pipientis can reduce RNA virus replication and prevent transmission by Aedes aegypti, and also have the capacity to invade wild-type populations, potentially reaching and maintaining high infection frequencies. Levels of virus transmission blocking are positively correlated with Wolbachia intracellular density. Despite reaching high densities in Ae. aegypti, transinfections of wAlbA, a strain native to Aedes albopictus, showed no blocking of Semliki Forest Virus in previous intrathoracic injection challenges. To further characterize wAlbA blocking in Ae. aegypti, adult females were intrathoracically challenged with Zika (ZIKV) and dengue viruses, and then fed a ZIKV-containing bloodmeal. No blocking was observed with either virus when challenged by intrathoracic injection. However, when ZIKV was delivered orally, wAlbA-infected females showed a significant reduction in viral replication and dissemination compared with uninfected controls, as well as a complete absence of virus in saliva. Although other Wolbachia strains have been shown to cause more robust viral blocking in Ae. aegypti, these findings demonstrate that, in principle, wAlbA could be used to reduce virus transmission in this species. Moreover, the results highlight the potential for underestimation of the strength of virus-blocking when based on intrathoracic injection compared with more natural oral challenges.
C1 [Chouin-Carneiro, T.; Louis, F.; Failloux, A. B.] Inst Pasteur, Dept Virol Arboviruses & Insect Vectors, Paris, France.
   [Ant, T. H.; Herd, C.; Sinkins, S. P.] Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
   [Ant, T. H.; Herd, C.; Sinkins, S. P.] Univ Lancaster, Biomed & Life Sci, Lancaster, England.
RP Sinkins, SP (corresponding author), Univ Glasgow, Ctr Virus Res, MRC, Glasgow G61 1QH, Lanark, Scotland.
EM steven.sinkins@glasgow.ac.uk
OI Herd, Christie/0000-0002-3539-1908
FU Medical Research CouncilMedical Research Council UK (MRC) [ZK/16-021];
   Wellcome TrustWellcome Trust [202888, 108508]
CR Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Blagrove MSC, 2012, P NATL ACAD SCI USA, V109, P255, DOI 10.1073/pnas.1112021108
   Bordenstein SR, 2009, MOL BIOL EVOL, V26, P231, DOI 10.1093/molbev/msn243
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   Casiraghi M, 2005, MICROBIOL-SGM, V151, P4015, DOI 10.1099/mic.0.28313-0
   Chrostek E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003896
   Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x
   Fraser JE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006751
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Gerth M, 2016, INFECT GENET EVOL, V43, P378, DOI 10.1016/j.meegid.2016.05.034
   Glowska E, 2015, INFECT GENET EVOL, V30, P140, DOI 10.1016/j.meegid.2014.12.019
   Hancock PA, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0319-5
   Hancock PA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001024
   Jansen VAA, 2008, P ROY SOC B-BIOL SCI, V275, P2769, DOI 10.1098/rspb.2008.0914
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Kambris Z, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001143
   Lu P, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001754
   Martinez J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004369
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Osborne SE, 2012, APPL ENVIRON MICROB, V78, P6922, DOI 10.1128/AEM.01727-12
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   SINKINS SP, 1995, P ROY SOC B-BIOL SCI, V261, P325, DOI 10.1098/rspb.1995.0154
   Turelli M, 1999, INSECT MOL BIOL, V8, P243, DOI 10.1046/j.1365-2583.1999.820243.x
   Turelli M, 2010, EVOLUTION, V64, P232, DOI 10.1111/j.1558-5646.2009.00822.x
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   zu Dohna H, 2018, ECOL EVOL, V8, P1945, DOI 10.1002/ece3.3789
NR 30
TC 2
Z9 2
U1 7
U2 7
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0269-283X
EI 1365-2915
J9 MED VET ENTOMOL
JI Med. Vet. Entomol.
PD MAR
PY 2020
VL 34
IS 1
BP 116
EP 119
DI 10.1111/mve.12384
PG 4
WC Entomology; Veterinary Sciences
SC Entomology; Veterinary Sciences
GA KH2NY
UT WOS:000510485800014
PM 31120156
OA Other Gold, Green Published, Green Accepted
DA 2020-07-08
ER

PT J
AU Zhang, J
   Chen, Y
   Zhao, YH
   Wolfram, D
   Ma, FC
AF Zhang, Jin
   Chen, Ye
   Zhao, Yuehua
   Wolfram, Dietmar
   Ma, Feicheng
TI Public health and social media: A study of Zika virus-related posts on
   Yahoo! Answers
SO JOURNAL OF THE ASSOCIATION FOR INFORMATION SCIENCE AND TECHNOLOGY
LA English
DT Article
ID TWITTER
AB This study investigates the content of questions and responses about the Zika virus on Yahoo! Answers as a recent example of how public concerns regarding an international health issue are reflected in social media. We investigate the contents of posts about the Zika virus on Yahoo! Answers, identify and reveal subject patterns about the Zika virus, and analyze the temporal changes of the revealed subject topics over 4 defined periods of the Zika virus outbreak. Multidimensional scaling analysis, temporal analysis, and inferential statistical analysis approaches were used in the study. A resulting 2-layer Zika virus schema, and term connections and relationships are presented. The results indicate that consumers' concerns changed over the 4 defined periods. Consumers paid more attention to the basic information about the Zika virus, and the prevention and protection from the Zika virus at the beginning of the outbreak of the Zika virus. During the later periods, consumers became more interested in the role that the government and health organizations played in the public health emergency.
C1 [Zhang, Jin; Wolfram, Dietmar] Univ Wisconsin, Sch Informat Studies, Milwaukee, WI 53201 USA.
   [Chen, Ye] Cent China Normal Univ, Sch Informat Management, Wuhan, Peoples R China.
   [Zhao, Yuehua] Nanjing Univ, Sch Informat Management, Nanjing, Peoples R China.
   [Ma, Feicheng] Wuhan Univ, Sch Informat Management, Wuhan, Peoples R China.
RP Zhang, J (corresponding author), Univ Wisconsin, Sch Informat Studies, Milwaukee, WI 53201 USA.
EM jzhang@uwm.edu; cheny@mail.ccnu.edu.cn; yuehua@nju.edu.cn;
   dwolfram@uwm.edu; fchma@whu.edu.cn
OI Zhao, Yuehua/0000-0002-8412-2878
CR Al-Qahtani AA, 2016, J INFECT DEV COUNTR, V10, P201, DOI 10.3855/jidc.8350
   Bazhuayu, 2013, BAZH BIG DAT
   Bowler L., 2012, P AM SOC INFORM SCI, P1, DOI DOI 10.1002/MEET.14504901052
   Bowler L., 2013, P ANN M ASS INFORM S, P1, DOI DOI 10.1002/MEET.14505001057
   Bragazzi NL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185263
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   CDC, 2016, ZIK VIR SYMPT
   CDC, 2016, ZIK VIR TRANSM RISKS
   Chen L., 2012, 21 INT C WORLD WID W
   Chua AYK, 2015, ONLINE INFORM REV, V39, P104, DOI 10.1108/OIR-10-2014-0232
   COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104
   Dredze M, 2016, VACCINE, V34, P3441, DOI 10.1016/j.vaccine.2016.05.008
   Durant K.T., 2010, 1 ACM INT HLTH INF S
   Durant Kathleen T, 2011, Int J Comput Models Algorithms Med, V2, P1, DOI 10.4018/jcmam.2011040101
   Fox S, 2014, SOCIAL LIFE HLTH INF
   Fu KW, 2016, AM J INFECT CONTROL, V44, P1700, DOI 10.1016/j.ajic.2016.04.253
   Glowacki EM, 2016, AM J INFECT CONTROL, V44, P1709, DOI 10.1016/j.ajic.2016.05.025
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Jin JH, 2015, INFORM MANAGE-AMSTER, V52, P840, DOI 10.1016/j.im.2015.07.005
   Kim S, 2009, J AM SOC INF SCI TEC, V60, P716, DOI 10.1002/asi.21026
   Li L., 2015, 24 INT C WORLD WID W
   Lu D., 2015, ICONFERENCE 2015 NEW
   Miller G.A., 1995, COMM ACM NEW YORK
   Miller M., 2017, JMIR PUBLIC HLTH SUR, V3, P1
   Mishra B, 2016, J POSTGRAD MED, V62, P249, DOI 10.4103/0022-3859.191006
   Morris M.R., 2010, 4 INT AAAI C WEBL SO
   Oh HJ, 2013, COMPUT HUM BEHAV, V29, P2072, DOI 10.1016/j.chb.2013.04.017
   Oh S., 2015, UNDERSTANDING HLTH I
   Oh S., 2012, P 91 ANN M TRANSP RE, P1
   Oh S, 2018, LECT NOTES COMPUT SC, V10100, P75, DOI 10.1007/978-3-319-90092-6_3
   Park H, 2016, J HEALTH COMMUN, V21, P188, DOI 10.1080/10810730.2015.1058435
   Ramo DE, 2015, AM J HEALTH PROMOT, V29, pE126, DOI 10.4278/ajhp.130326-QUAL-128
   Robillard JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069861
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Shoji Y., 2015, 7 INT C SOC INF BEIJ
   So J, 2016, HEALTH COMMUN, V31, P193, DOI 10.1080/10410236.2014.940675
   Srba I, 2016, ACM T WEB, V10, DOI 10.1145/2934687
   Tsuya A, 2014, J MED INTERNET RES, V16, P110, DOI 10.2196/jmir.3298
   World Health Organisation, 2016, WHO DIR GEN SUMM OUT
   World Health Organization. Fifth meeting of the Emergency Committee under the International Health Regulations, 2005, 5 M EM COMM INT HLTH
   Wu D., 2014, ICONFERENCE 2014 BER
   Yang HD, 2015, ACM T INTEL SYST TEC, V6, DOI 10.1145/2700482
   Zhang J, 2013, INFORM PROCESS MANAG, V49, P1019, DOI 10.1016/j.ipm.2013.04.003
   Zhang Jin, 2007, VISUALIZATION INFORM
   Zhang Y., 2014, P INTERSPEECH, P1, DOI DOI 10.1364/OFC.2014.M3A.6
NR 45
TC 0
Z9 0
U1 53
U2 53
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 2330-1635
EI 2330-1643
J9 J ASSOC INF SCI TECH
PD MAR
PY 2020
VL 71
IS 3
BP 282
EP 299
DI 10.1002/asi.24245
PG 18
WC Computer Science, Information Systems; Information Science & Library
   Science
SC Computer Science; Information Science & Library Science
GA KG0JV
UT WOS:000509628400003
DA 2020-07-08
ER

PT J
AU Leung, C
AF Leung, Char
TI A lesson learnt from the emergence of Zika virus: What flaviviruses can
   trigger Guillain-Barre syndrome?
SO JOURNAL OF MEDICAL VIROLOGY
LA English
DT Article; Early Access
DE amino acid sequence matching; flavivirus; Guillain-Barre syndrome; Zika
   virus
ID MURRAY VALLEY ENCEPHALITIS; ILHEUS-VIRUS; INFECTION; SOUTHERN; DISEASE
AB While Zika virus outbreaks raised the concern about rare viral infections in human, attention should also be paid to other Guillain-Barre syndrome (GBS) inducing viruses. This study aims to search for other flaviviruses likely to be associated with GBS. Amino acid (aa) sequence matching analysis was conducted to identify viruses molecularly similar to the Zika virus and human GBS-related proteins. A systematic review of clinical literature was performed to summarize the clinical findings of the GBS-associated flaviviruses identified in the aa sequence matching analysis. It was found that more than 10 pentapeptides were shared between 9 flaviviruses, Zika virus, and human GBS-related proteins. Twenty-six articles totaling 42 clinical cases were eligible for inclusion in the systematic review concerning the nine flaviviruses identified. While some patients showed signs of encephalitis, 5 out of 42 cases demonstrated typical GBS symptoms. Public health professionals should be aware of other GBS-associated flaviviruses and GBS cases with mild symptoms.
C1 [Leung, Char] Deakin Univ, 221 Burwood Hwy, Burwood, Vic 3215, Australia.
RP Leung, C (corresponding author), Deakin Univ, 221 Burwood Hwy, Burwood, Vic 3215, Australia.
EM char.leung@deakin.edu.au
RI Leung, Char/AAL-3251-2020
OI Leung, Char/0000-0002-4215-4513
CR AASKOV JG, 1993, T ROY SOC TROP MED H, V87, P452, DOI 10.1016/0035-9203(93)90032-L
   Aberle SW, 2018, EUROSURVEILLANCE, V23, P7, DOI 10.2807/1560-7917.ES.2018.23.43.1800545
   Ansari Behnaz, 2018, Adv Biomed Res, V7, P87, DOI 10.4103/abr.abr_50_17
   BOUGHTON CR, 1986, MED J AUSTRALIA, V145, P90, DOI 10.5694/j.1326-5377.1986.tb101087.x
   Braack L, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-017-2559-9
   Brown Alex, 2002, Commun Dis Intell Q Rep, V26, P39
   Burt FJ, 2014, FUTURE VIROL, V9, P993, DOI 10.2217/FVL.14.87
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cavrini F, 2009, EUROSURVEILLANCE, V14, P17
   Cordova S P, 2000, Commun Dis Intell, V24, P368
   DEARAUJO DG, 2017, VIGIL SANIT DEBATE, V5, P1
   Diagne MM, 2017, ONE HEALTH-AMSTERDAM, V3, P23, DOI 10.1016/j.onehlt.2017.02.001
   Figueiredo LTM, 2000, MICROBES INFECT, V2, P1643, DOI 10.1016/S1286-4579(00)01320-4
   Floridis John, 2018, Trop Med Infect Dis, V3, DOI 10.3390/tropicalmed3020049
   FRENCH EL, 1957, AM J TROP MED HYG, V6, P827, DOI 10.4269/ajtmh.1957.6.827
   Garg M, 2017, J NEUROSCI RURAL PRA, V8, P325, DOI 10.4103/jnrp.jnrp_96_17R1
   Goldman L, 2015, GOLDMAN CECIL MED, V2267
   Green DM, 2001, ARCH NEUROL-CHICAGO, V58, P1098, DOI 10.1001/archneur.58.7.1098
   Heckmann JG, 2019, ACTA NEUROL BELG, V119, P649, DOI 10.1007/s13760-019-01152-0
   HEYMANN C S, 1958, S Afr Med J, V32, P543
   Johnson BW, 2007, EMERG INFECT DIS, V13, P956, DOI 10.3201/eid1306.070118
   Jupp PG, 1998, J AM MOSQUITO CONTR, V14, P40
   Leonhard SE, 2019, NAT REV NEUROL, V15, P671, DOI 10.1038/s41582-019-0250-9
   Leung C, 2020, CLIN EPIDEMIOL GLOB, V8, DOI 10.1016/j.cegh.2019.08.007
   LOPES ODS, 1978, AM J EPIDEMIOL, V107, P444
   Lucchese G, 2016, AUTOIMMUN REV, V15, P801, DOI 10.1016/j.autrev.2016.03.020
   Macdonald J, 2010, EVOL BIOINFORM, V6, P91
   Mackenzie JS, 2009, ZOONOSES PUBLIC HLTH, V56, P338, DOI 10.1111/j.1863-2378.2008.01208.x
   Mattar VS, 2015, REV MVZ CORDOBA, V20, P4675
   McMahon AW, 2007, VACCINE, V25, P1727, DOI 10.1016/j.vaccine.2006.11.027
   Mein J, 1998, Commun Dis Intell, V22, P105
   Nagy A, 2019, EUROSURVEILLANCE, V24, P24, DOI 10.2807/1560-7917.ES.2019.24.28.1900038
   Niven DJ, 2017, EMERG INFECT DIS, V23, P280, DOI 10.3201/eid2302.161161
   Nóbrega Martha Elizabeth Brasil da, 2018, Epidemiol. Serv. Saúde, V27, pe2017039, DOI 10.5123/s1679-49742018000200016
   Oldstone MBA, 1998, FASEB J, V12, P1255
   Pecorari M, 2009, EUROSURVEILLANCE, V14, P15
   Poidinger M, 2000, VIRUS RES, V68, P7, DOI 10.1016/S0168-1702(00)00143-X
   PRIASLANDINEZ E, 1968, AM J TROP MED HYG, V17, P112, DOI 10.4269/ajtmh.1968.17.112
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Santini M, 2015, J NEUROVIROL, V21, P92, DOI 10.1007/s13365-014-0300-4
   Simonin Y, 2018, EMERG INFECT DIS, V24, P875, DOI 10.3201/eid2405.171122
   Smith DR, 2017, CRIT REV MICROBIOL, V43, P405, DOI [10.1080/1040841X.2016.1230974, 10.1080/1040841x.2016.1230974]
   SMITH DW, 1991, MED J AUSTRALIA, V154, P845, DOI 10.5694/j.1326-5377.1991.tb121382.x
   SMITHBURN K. C., 1959, S AFRICAN MED JOUR, V33, P959
   SPENCE L., 1962, TRANS ROY SOC TROP MED AND HYG, V56, P504, DOI 10.1016/0035-9203(62)90074-3
   SRIHONGS.S, 1971, T ROY SOC TROP MED H, V65, P541, DOI 10.1016/0035-9203(71)90179-9
   SRIHONGSE S, 1967, AM J TROP MED HYG, V16, P516, DOI 10.4269/ajtmh.1967.16.516
   Sudulagunta Sreenivasa Rao, 2015, Ger Med Sci, V13, pDoc16, DOI 10.3205/000220
   Venegas EA, 2012, EMERG INFECT DIS, V18, P516, DOI 10.3201/eid1803.111486
   Xiang JY, 2014, VIRAL IMMUNOL, V27, P418, DOI 10.1089/vim.2014.0049
NR 50
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0146-6615
EI 1096-9071
J9 J MED VIROL
JI J. Med. Virol.
DI 10.1002/jmv.25717
EA FEB 2020
PG 8
WC Virology
SC Virology
GA KQ5XA
UT WOS:000516993700001
PM 32077499
DA 2020-07-08
ER

PT J
AU Aronis, JM
   Ferraro, JP
   Gesteland, PH
   Tsui, FC
   Ye, Y
   Wagner, MM
   Cooper, GF
AF Aronis, John M.
   Ferraro, Jeffrey P.
   Gesteland, Per H.
   Tsui, Fuchiang
   Ye, Ye
   Wagner, Michael M.
   Cooper, Gregory F.
TI A Bayesian approach for detecting a disease that is not being modeled
SO PLOS ONE
LA English
DT Article
AB Over the past decade, outbreaks of new or reemergent viruses such as severe acute respiratory syndrome (SARS) virus, Middle East respiratory syndrome (MERS) virus, and Zika have claimed thousands of lives and cost governments and healthcare systems billions of dollars. Because the appearance of new or transformed diseases is likely to continue, the detection and characterization of emergent diseases is an important problem. We describe a Bayesian statistical model that can detect and characterize previously unknown and unmodeled diseases from patient-care reports and evaluate its performance on historical data.
C1 [Aronis, John M.; Tsui, Fuchiang; Ye, Ye; Wagner, Michael M.; Cooper, Gregory F.] Univ Pittsburgh, Dept Biomed Informat, Real Time Outbreak & Dis Surveillance RODS Lab, Pittsburgh, PA 15260 USA.
   [Ferraro, Jeffrey P.; Gesteland, Per H.] Univ Utah, Dept Biomed Informat, Salt Lake City, UT USA.
RP Aronis, JM (corresponding author), Univ Pittsburgh, Dept Biomed Informat, Real Time Outbreak & Dis Surveillance RODS Lab, Pittsburgh, PA 15260 USA.
EM jma18@pitt.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 LM011370];
   National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [1U24GM110707]
FX MMW was supported by R01 LM011370, National Institutes of Health,
   nih.gov, Probabilistic Disease Surveillance; and 1U24GM110707, National
   Institute of General Medical Sciences, nigms.nih.gov, Modeling
   Infectious Disease Agent Study (MIDAS). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Aliabadi N, 2016, EMERG INFECT DIS, V22, P1387, DOI 10.3201/eid2208.151949
   Brokopp C, 2006, HDB BIOSURVEILLANCE, P129
   Burkom H, 2015, ONLINE J PUBLIC HLTH
   Cooper GF, 2015, J BIOMED INFORM, V53, P15, DOI 10.1016/j.jbi.2014.08.011
   Dato V, 2006, HDB BIOSURVEILLANCE, P13
   for Disease Control C Prevention, 2014, 2014 ID ENT D68 CHIL
   for Disease Control C Prevention, 2014, NONP ENT
   Garcia YE, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/751738
   Grimmett B., 2014, CDC CONFIRMS EXISTEN
   Holmes EC, 2018, NATURE, V558, P180, DOI 10.1038/d41586-018-05373-w
   Kewish A., 2014, UNCOMMON RESP ILLNES
   Metcalf CJE, 2017, SCIENCE, V357, P149, DOI 10.1126/science.aam8335
   Moore A. W., 2006, HDB BIOSURVEILLANCE, P235
   Nobles M, 2019, ONLINE J PUBLIC HLTH
   Nobles M, 2014, ONLINE J PUBLIC HLTH
   Tsui F, 2017, J PUBLIC HLTH
   Uprety P, 2019, EMERGING INFECT DIS
   Velikina R, 2006, HDB BIOSURVEILLANCE, P67
   Wagner MM, 2006, HDB BIOSURVEILLANCE, P27
   Wagner MM, 2006, HDB BIOSURVEILLANCE, P89
   Wong WK, 2003, P 20 INT C MACH LEAR
   Wong WK, 2006, HDB BIOSURVEILLANCE, P217, DOI DOI 10.1016/B978-012369378-5/50016-8
NR 22
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2020
VL 15
IS 2
AR e0229658
DI 10.1371/journal.pone.0229658
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ8HR
UT WOS:000535239800021
PM 32109254
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pecanha, PM
   Gomes, SC
   Pone, SM
   Pone, MVD
   Vasconcelos, Z
   Zin, A
   Vilibor, RHH
   Costa, RP
   Meio, MDBB
   Nielsen-Saines, K
   Brasil, P
   Brickley, E
   Moreira, MEL
AF Pecanha, Pedro Massaroni
   Gomes Junior, Saint Clair
   Pone, Sheila Moura
   da Silva Pone, Marcos Vinicius
   Vasconcelos, Zilton
   Zin, Andrea
   Hasue Vilibor, Renata Hydee
   Costa, Roozemeria Pereira
   Barbosa Baker Meio, Maria Dalva
   Nielsen-Saines, Karin
   Brasil, Patricia
   Brickley, Elizabeth
   Lopes Moreira, Maria Elisabeth
TI Neurodevelopment of children exposed intra-uterus by Zika virus: A case
   series
SO PLOS ONE
LA English
DT Article
ID HEAD GROWTH; PRETERM INFANTS; INFECTION; BRAIN; STANDARDS; WEIGHT;
   BRAZIL; NEEDS
AB The main goal of this manuscript was to investigate the neurodevelopment of children exposed by Zika virus in the intrauterine period who are asymptomatic at birth. Newborns with documented Zika virus exposure during the intrauterine period who were asymptomatic at birth were followed in the first two years of life for neurodevelopment using Bayley III test. Children were classified as having normal or delayed neurodevelopment for age based on most recent Bayley III evaluation results. Eighty-four infants were included in the study. The first Bayley III evaluation was performed at a mean chronological age of 9.7 +/- 3.1 month; 13 children (15%) had a delay in one of the three domains, distributed as follow: 10 (12%) in the language domain and 3 (3.5%) in the motor domain. The most recent Bayley III evaluation was performed at a mean age 15.3 +/- 3.1 months; 42 children (50%) had a delay in one of the three domains: 4 (5%) in cognition, 31 (37%) in language, and 20 (24%) in motor performance. There were no statistical differences in Gender, Gestational Age, Birth Weight and Head Circurference at birth between children with normal and delayed neurodevelopment for age. A very high proportion of children exposed ZIKV during pregnancy who were asymptomatic at birth demonstrated a delay in neurodevelopment, mainly in the language domain, the first two years of life.
C1 [Pecanha, Pedro Massaroni; Gomes Junior, Saint Clair; Pone, Sheila Moura; da Silva Pone, Marcos Vinicius; Vasconcelos, Zilton; Zin, Andrea; Costa, Roozemeria Pereira; Barbosa Baker Meio, Maria Dalva; Lopes Moreira, Maria Elisabeth] Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
   [Hasue Vilibor, Renata Hydee] Univ Sao Paulo, Sao Paulo, Brazil.
   [Nielsen-Saines, Karin] UCLA, Los Angeles, CA USA.
   [Brasil, Patricia] Inst Nacl Infectol Fiocruz, Rio De Janeiro, Brazil.
   [Brickley, Elizabeth] London Sch Hyg & Trop Med, London, England.
RP Moreira, MEL (corresponding author), Inst Fernandes Figueira Fiocruz, Rio De Janeiro, Brazil.
EM bebethiff@gmail.com
FU European UnionEuropean Union (EU) [734584]; Wellcome TrustWellcome Trust
   [205377/Z/16/Z]; Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPqNational Council for Scientific and Technological
   Development (CNPq) [441098/2016-9]; FaperjCarlos Chagas Filho Foundation
   for Research Support of the State of Rio de Janeiro (FAPERJ)
   [E-26/202.979/2017]; PIP2/IFF/Fiocruz [IFF-002Fio1628]; NIH/NIAIDUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Allergy & Infectious
   Diseases (NIAID) [RO1-AI140718]
FX The author(s) received specific fundings for this work -European Union's
   Horizon 2020 Research and Innovation Programme under ZikaPLAN 734584
   Maria Elisabeth lopes Moreira - Wellcome Trust 205377/Z/16/Z Dr
   Elizabeth Brickley - Conselho Nacional de Desenvolvimento Cientifico e
   Tecnologico CNPq 441098/2016-9 Maria Elisabeth lopes Moreira - Faperj
   E-26/202.979/2017 Maria Elisabeth lopes Moreira - PIP2/IFF/Fiocruz
   IFF-002Fio1628 Maria Elisabeth lopes Moreira - NIH/NIAID - RO1-AI140718.
CR Adu-Afarwuah S, 2017, ANN NY ACAD SCI, V1392, P18, DOI 10.1111/nyas.13328
   [Anonymous], 2018, ED GLANC 2018
   BALLARD JL, 1979, J PEDIATR-US, V95, P769, DOI 10.1016/S0022-3476(79)80734-9
   Bayley N, 2006, BAYLEY SCALES INFANT
   Brasil. Ministerio da Saude. Secretaria de Vigilancia em Saude. Secretaria de Atenc Saude, 2016, GUID EARL STIM INF 3
   Britto PR, 2017, LANCET, V389, P91, DOI 10.1016/S0140-6736(16)31390-3
   Broussard CS, 2018, PEDIATRICS, V141, pS146, DOI 10.1542/peds.2017-2038C
   Chan JFW, 2016, J INFECTION, V72, P507, DOI 10.1016/j.jinf.2016.02.011
   Cheong JLY, 2008, PEDIATRICS, V121, pE1534, DOI 10.1542/peds.2007-2671
   Chimelli L, 2018, J NEUROPATH EXP NEUR, V77, P193, DOI 10.1093/jnen/nlx116
   Cooke RWI, 2006, ARCH DIS CHILD-FETAL, V91, pF17, DOI 10.1136/adc.2005.077438
   Coplan J., 1983, ELM SCALE EARLY LANG
   Countryeconomy.com, 2018, BRAZ NAT MIN WAG NMW
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548
   de Paiva GS, 2010, SAO PAULO MED J, V128, P276, DOI 10.1590/S1516-31802010000500007
   Dubowitz L, 2005, MENT RETARD DEV D R, V11, P52, DOI 10.1002/mrdd.20048
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   Gale CR, 2006, PEDIATRICS, V118, P1486, DOI 10.1542/peds.2005-2629
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Gilberti LDP, 1999, AN 6 C GOIAN PED GOI
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Kuban KCK, 2009, J PEDIATR-US, V155, P344, DOI 10.1016/j.jpeds.2009.04.002
   Martines RB, 2016, MMWR-MORBID MORTAL W, V65, P159, DOI 10.15585/mmwr.mm6506e1
   Martinot AJ, 2018, CELL, V173, P1111, DOI 10.1016/j.cell.2018.03.019
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Neubauer V, 2013, ACTA PAEDIATR, V102, P883, DOI 10.1111/apa.12319
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Raghuram K, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0216
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Saad T, 2018, CHILD NERV SYST, V34, P73, DOI 10.1007/s00381-017-3634-4
   Maria-Mengel MR, 2007, REV LAT-AM ENFERM, V15, P837, DOI 10.1590/S0104-11692007000700019
   Soriano-Arandes A, 2018, EXPERT REV ANTI-INFE, V16, P243, DOI 10.1080/14787210.2018.1438265
   Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6
   Waldorf KMA, 2018, NAT MED
   Waldorf KMA, 2013, REPRODUCTION, V146, pR151, DOI 10.1530/REP-13-0232
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Wu YH, 2018, CELL REP, V25, P1537, DOI 10.1016/j.celrep.2018.10.025
NR 41
TC 0
Z9 0
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 28
PY 2020
VL 15
IS 2
AR e0229434
DI 10.1371/journal.pone.0229434
PG 11
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LQ8HR
UT WOS:000535239800011
PM 32109947
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Yasri, S
   Wiwanitkit, V
AF Yasri, Sora
   Wiwanitkit, Viroj
TI Neuroimaging findings in congenital Zika virus syndrome
SO NEURORADIOLOGY JOURNAL
LA English
DT Letter
C1 [Yasri, Sora] KMT Primary Care Ctr, Bangkok, Thailand.
   [Wiwanitkit, Viroj] DY Patil Univ, Navi Mumbai, India.
RP Yasri, S (corresponding author), KMT Primary Care Ctr, Bangkok, Thailand.
EM sorayasri@outlook.co.th
CR Radaelli G, 2020, NEURORADIOL J, V33, P152, DOI 10.1177/1971400919896264
   Wiwanitkit S, 2016, ASIAN PAC J TROP MED, V9, P499, DOI 10.1016/j.apjtm.2016.03.036
NR 2
TC 0
Z9 0
U1 0
U2 0
PU SAGE PUBLICATIONS INC
PI THOUSAND OAKS
PA 2455 TELLER RD, THOUSAND OAKS, CA 91320 USA
SN 1971-4009
EI 2385-1996
J9 NEURORADIOL J
JI Neuradiology J.
PD APR
PY 2020
VL 33
IS 2
BP 159
EP 159
AR UNSP 1971400920908522
DI 10.1177/1971400920908522
EA FEB 2020
PG 1
WC Neuroimaging
SC Neurosciences & Neurology
GA LA1RS
UT WOS:000517071100001
PM 32107965
DA 2020-07-08
ER

PT J
AU Mbanzulu, KM
   Mboera, LEG
   Luzolo, FK
   Wumba, R
   Misinzo, G
   Kimera, SI
AF Mbanzulu, Kennedy M.
   Mboera, Leonard E. G.
   Luzolo, Flory K.
   Wumba, Roger
   Misinzo, Gerald
   Kimera, Sharadhuli I.
TI Mosquito-borne viral diseases in the Democratic Republic of the Congo: a
   review
SO PARASITES & VECTORS
LA English
DT Review
DE Mosquito-borne viruses; Epidemiology; Ecology; Democratic Republic of
   the Congo
ID WEST-NILE-VIRUS; YELLOW-FEVER; CLIMATE-CHANGE; OUTBREAK; IDENTIFICATION;
   KINSHASA
AB Background Mosquito-borne viral infections have in recent years, become a public health threat globally. This review aimed to provide an overview of the ecological and epidemiological profiles of mosquito-borne viral infections in the Democratic Republic of the Congo (DRC). Methods A search of literature was conducted using Google Scholar, PubMed and the WHO website using the following keywords: "Democratic Republic of the Congo", "Zaire", "Belgian Congo" and either of the following: "mosquito-borne virus", "arbovirus", "yellow fever", "dengue", "chikungunya", "West Nile", "Rift Valley fever", "O'nyong'nyong", "Zika", "epidemiology", "ecology", "morbidity", "mortality". Published articles in English or French covering a period between 1912 and October 2018 were reviewed. Results A total of 37 articles were included in the review. The findings indicate that the burden of mosquito-borne viral infections in DRC is increasing over time and space. The north-western, north-eastern, western and central regions have the highest burden of mosquito-borne viral infections compared to south and eastern highland regions. Yellow fever, chikungunya, dengue, Zika, Rift Valley fever, West Nile and O'nyong'nyong have been reported in the country. These mosquito-borne viruses were found circulating in human, wildlife and domestic animals. Yellow fever and chikungunya outbreaks have been frequently reported. Aedes aegypti and Ae. simpsoni were documented as the main vectors of most of the mosquito-borne viral infections. Heavy rains, human movements, forest encroachment and deforestation were identified as drivers of mosquito-borne viruses occurrence in DRC. Conclusions Mosquito-borne viral infections are becoming common and a serious public health problem in DRC. In the current context of climate change, there is urgent need to improve understanding on ecological and epidemiology of the diseases and strengthen surveillance systems for prompt response to epidemics in DRC.
C1 [Mbanzulu, Kennedy M.; Mboera, Leonard E. G.; Misinzo, Gerald; Kimera, Sharadhuli I.] Sokoine Univ Agr, SACIDS Africa Ctr Excellence Infect Dis Humans &, POB 3297, Morogoro, Tanzania.
   [Mbanzulu, Kennedy M.; Luzolo, Flory K.; Wumba, Roger] Univ Kinshasa, Dept Trop Med Infect & Parasit Dis, POB 747, Kinshasa, DEM REP CONGO.
   [Mbanzulu, Kennedy M.; Misinzo, Gerald] Sokoine Univ Agr, Dept Vet Microbiol Parasitol & Biotechnol, POB 3019, Morogoro, Tanzania.
   [Kimera, Sharadhuli I.] Sokoine Univ Agr, Dept Vet Med & Publ Hlth, POB 3021, Morogoro, Tanzania.
RP Mbanzulu, KM (corresponding author), Sokoine Univ Agr, SACIDS Africa Ctr Excellence Infect Dis Humans &, POB 3297, Morogoro, Tanzania.
EM mbanzulu.kennedy@sacids.org
FU Government of Tanzania through a World Bank WB-ACE II Grant [PAD1436]
FX KMM is a graduate student supported by a scholarship from the Government
   of Tanzania funding through a World Bank WB-ACE II Grant PAD1436 to
   SACIDS Africa Centre of Excellence for Infectious Diseases of Humans and
   Animals in Southern and Eastern Africa (SACIDS-ACE).
CR Alarcon-Elbal PM, 2018, INTERAMERICAN J MED, V1, pe201801003, DOI DOI 10.31005/IAJMH.V1I1.23
   Bobanga T, 2018, AFR ENTOMOL, V26, P234, DOI 10.4001/003.026.0234
   Bres P, 1973, B WORLD HEALTH ORGAN, V43, P223
   Cabre O, 2006, EMERG INFECT DIS, V12, P1958
   CORBOZ JR, 1948, HELV PHYSIOL PHARM A, V6, P247, DOI 10.1007/BF01733761
   Courtois G, 1962, ANN SOC BELG MED TR, V6, P859
   DAVIES FG, 1992, EPIDEMIOL INFECT, V108, P185, DOI 10.1017/S0950268800049633
   Davoust B, 2014, EMERG INFECT DIS, V20, P1415, DOI 10.3201/eid2008.130691
   DEPREZ G., 1920, Annales de la Societe Belge de Medecine Tropicale, V1, P61
   Georges Tshilenge M, 2018, J Vet Med, V2018, P4956378, DOI 10.1155/2018/4956378
   Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8
   Ido E, 2017, ANN AFR MED, V10, P1
   Kading RC, 2013, J WILDLIFE DIS, V49, P587, DOI 10.7589/2012-08-212
   Kajeguka DC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1511-5
   KARCH S, 1993, B SOC PATHOL EXOT, V86, P68
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lucasse C, 1961, B SOC PATHOL EXOT, V56, P156
   Makiala-Mandanda S, 2018, VECTOR-BORNE ZOONOT, V18, P364, DOI 10.1089/vbz.2017.2176
   Malekani MJ, 2014, ANN AFR MED, V7, P2
   Matiko MK, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006931
   Mbanzulu KM, 2017, INT J INFECT DIS, V57, P32, DOI 10.1016/j.ijid.2017.01.016
   Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389
   Chaves LSM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25344-5
   MOUCHET R., 1928, Annales de la Societe Belge de Medecine Tropicale, V8, P219
   Muyembe-Tamfum J J, 2003, Med Trop (Mars), V63, P637
   Nur YA, 1999, AM J TROP MED HYG, V61, P885, DOI 10.4269/ajtmh.1999.61.885
   Nyakarahuka L, 2016, PLOS NEGLECT TROP D, V2, pe0006412
   Osterrieth P, 1960, ANN SOC BELG MED TR, V4, P199
   Osterrieth P, 1961, ANN SOC BELG MED TR, V3, P207
   Osterrieth P, 1961, ANN SOC BELG MED TR, V1, P63
   Otshudiema JO, 2017, MMWR-MORBID MORTAL W, V66, P335, DOI 10.15585/mmwr.mm6612a5
   Oyas H, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006353
   Pastorino B, 2004, J MED VIROL, V74, P277, DOI 10.1002/jmv.20168
   Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853
   Rwaguma EB, 1997, EMERG INFECT DIS, V3, P77, DOI 10.3201/eid0301.970112
   SCHWETZ J., 1941, Annales de la Societe Belge de Medecine Tropicale, V21, P17
   SCHWETZ J., 1938, Annales de la Societe Belge de Medecine Tropicale, V18, P89
   SCHWETZ J., 1932, Annales de la Societe Belge de Medecine Tropicale, V12, P549
   SCHWETZ JAQUES, 1927, BULL SOC PATH EXOTIQUE, V20, P170
   Seidelin H, 2018, NOTES PROPHYLAXIE TR
   Smith KM, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-289
   Smithburn K, 1942, T R SOC TROP MED HYG, V36, P9, DOI [10.1016/S0035-9203(42)90051-8, DOI 10.1016/S0035-9203(42)90051-8]
   THIELE H, 1948, Z NATURFORSCH B, V3, P7
   Tshiabukole K, 2016, OALIBJ, V3, pe2952
   Tshilenge G, 2012, J VET RES, V79, P1
   UMUHOZA T, 2017, J S AFR VET ASSOC, V88, P1379
   United Nations Framework Convention on Climate Change, 2009, DEM REP CONG
   Van Den Berghe L, 1935, ANN SOC BELG MED TR, V15, P4
   Van Den Bossche D, 2015, EPIDEMIOL INFECT, V143, P2227, DOI 10.1017/S0950268814000685
   Van Der Bergher L, 1937, ANN SOC BELG MED TR, V4, P581
   Vasconcelos P F, 2001, Cad Saude Publica, V17 Suppl, P155, DOI 10.1590/S0102-311X2001000700025
   Weetman D, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020220
   WHO, 2013, YELL FEV DEM REP CON
   WHO, 2016, MAPP RISK DISTR EP W
   WHO, 2014, YELL FEV DEM REP CON
   WHO, 2016, SIT REP YELL FEV
   WHO, 2010, YELL FEV DEM REP CON
   Willcox AC, 2018, AM J TROP MED HYG, V99, P756, DOI 10.4269/ajtmh.18-0156
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
   Zahouili JBZ, 2017, PLOS ONE, V7, P12
NR 60
TC 0
Z9 0
U1 5
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 27
PY 2020
VL 13
IS 1
AR 103
DI 10.1186/s13071-020-3985-7
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KW3TO
UT WOS:000521089600002
PM 32103776
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Zhao, S
   Musa, SS
   Hebert, JT
   Cao, PH
   Ran, JJ
   Meng, JY
   He, DH
   Qin, J
AF Zhao, Shi
   Musa, Salihu S.
   Hebert, Jay T.
   Cao, Peihua
   Ran, Jinjun
   Meng, Jiayi
   He, Daihai
   Qin, Jing
TI Modelling the effective reproduction number of vector-borne diseases:
   the yellow fever outbreak in Luanda, Angola 2015-2016 as an example
SO PEERJ
LA English
DT Article
DE Reproduction number; Vector-borne disease; Epidemic; Mathematical
   modelling; Yellow fever; Angola; Luanda
ID ZIKA VIRUS OUTBREAK; CHIKUNGUNYA VIRUS; EPIDEMIC; SPREAD; DENGUE;
   DYNAMICS; INFLUENZA; INFERENCE; INTERVAL; IMPACT
AB The burden of vector-borne diseases (Dengue, Zika virus, yellow fever, etc.) gradually increased in the past decade across the globe. Mathematical modelling on infectious diseases helps to study the transmission dynamics of the pathogens. Theoretically, the diseases can be controlled and eventually eradicated by maintaining the effective reproduction number, (R-eff), strictly less than 1. We established a vector-host compartmental model, and derived (R-eff) for vector-borne diseases. The analytic form of the (R-eff) was found to be the product of the basic reproduction number and the geometric average of the susceptibilities of the host and vector populations. The (R-eff) formula was demonstrated to be consistent with the estimates of the 2015-2016 yellow fever outbreak in Luanda, and distinguished the second minor epidemic wave. For those using the compartmental model to study the vector-borne infectious disease epidemics, we further remark that it is important to be aware of whether one or two generations is considered for the transition "from host to vector to host" in reproduction number calculation.
C1 [Zhao, Shi; Qin, Jing] Hong Kong Polytech Univ, Sch Nursing, Hong Kong, Peoples R China.
   [Zhao, Shi] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Div Biostat, Hong Kong, Peoples R China.
   [Zhao, Shi] Chinese Univ Hong Kong, Shenzhen Res Inst, Clin Trials & Biostat Lab, Shenzhen, Peoples R China.
   [Musa, Salihu S.; Hebert, Jay T.; He, Daihai] Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
   [Cao, Peihua] Southern Med Univ, Zhujiang Hosp, Dept Hepatobiliary Surg 2, Guangzhou, Peoples R China.
   [Ran, Jinjun] Univ Hong Kong, Li Ka Shing Fac Med, Sch Publ Hlth, Hong Kong, Peoples R China.
   [Meng, Jiayi] Xian Int Studies Univ, Sch Econ & Finance, Xian, Peoples R China.
RP He, DH (corresponding author), Hong Kong Polytech Univ, Dept Appl Math, Hong Kong, Peoples R China.
EM daihai.he@polyu.edu.hk
FU Hong Kong Polytechnic UniversityHong Kong Polytechnic University
   [1-ZE8J]
FX This work was supported by a grant from the Hong Kong Polytechnic
   University (project no.: 1-ZE8J). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Ali ST, 2013, EPIDEMICS-NETH, V5, P157, DOI 10.1016/j.epidem.2013.08.001
   Barndorff-Nielsen O. E., 1994, INFERENCE ASYMPTOTIC
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Brauer F., 2001, MATH MODELS POPULATI, V40
   Brauer Fred, 2016, Infect Dis Model, V1, P79, DOI 10.1016/j.idm.2016.08.001
   Breto C, 2009, ANN APPL STAT, V3, P319, DOI 10.1214/08-AOAS201
   Caminade C, 2014, P NATL ACAD SCI USA, V111, P3286, DOI 10.1073/pnas.1302089111
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Champagne C, 2016, ELIFE, V5, DOI [10.7554/eLife.19874.001, 10.7554/eLife.19874]
   Chowell G, 2007, MATH BIOSCI, V208, P571, DOI 10.1016/j.mbs.2006.11.011
   Cori A, 2013, AM J EPIDEMIOL, V178, P1505, DOI 10.1093/aje/kwt133
   Cushing JM, 2016, J THEOR BIOL, V404, P295, DOI 10.1016/j.jtbi.2016.06.017
   Diekmann O, 2010, J R SOC INTERFACE, V7, P873, DOI 10.1098/rsif.2009.0386
   DIEKMANN O, 1990, J MATH BIOL, V28, P365
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005
   Earn DJ, 2008, MATH EPIDEMIOLOGY
   Fenwick A, 2012, PUBLIC HEALTH, V126, P233, DOI 10.1016/j.puhe.2011.11.015
   Ferguson NM, 2016, SCIENCE, V353, P353, DOI 10.1126/science.aag0219
   Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251
   Fischer M, 2014, MMWR-MORBID MORTAL W, V63, P500
   Fraser C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000758
   Gao DZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep28070
   Grenfell BT, 1995, ECOLOGY INFECT DIS N, V7
   He D, 2019, 657015 BIORXIV
   He DH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00253-1
   He DH, 2010, J R SOC INTERFACE, V7, P271, DOI 10.1098/rsif.2009.0151
   Heffernan JM, 2005, J R SOC INTERFACE, V2, P281, DOI 10.1098/rsif.2005.0042
   Ionides EL, 2006, P NATL ACAD SCI USA, V103, P18438, DOI 10.1073/pnas.0603181103
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Johansson MA, 2012, AM J TROP MED HYG, V86, P349, DOI 10.4269/ajtmh.2012.11-0432
   Johansson MA, 2010, AM J TROP MED HYG, V83, P183, DOI 10.4269/ajtmh.2010.09-0782
   Katriel G, 2011, J R SOC INTERFACE, V8, P856, DOI 10.1098/rsif.2010.0515
   Keeling M. J., 2011, MODELING INFECT DIS
   Kilpatrick AM, 2011, SCIENCE, V334, P323, DOI 10.1126/science.1201010
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Kucharski AJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004726
   Lin QY, 2018, STAT METHODS MED RES, V27, P1968, DOI 10.1177/0962280217746442
   Mideo N, 2008, P ROY SOC B-BIOL SCI, V275, P1217, DOI 10.1098/rspb.2007.1545
   Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8
   Musa SS, 2019, MATH BIOSCI ENG, V16, P3841, DOI 10.3934/mbe.2019190
   Niebylski ML, 1999, APPL ENVIRON MICROB, V65, P773
   Pinho STR, 2010, PHILOS T R SOC A, V368, P5679, DOI 10.1098/rsta.2010.0278
   Porta M, 2014, DICT EPIDEMIOLOGY
   Saad-Roy CM, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-2076-z
   Sang SW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003808
   Shaman J, 2012, P NATL ACAD SCI USA, V109, P20425, DOI 10.1073/pnas.1208772109
   Shearer FM, 2017, LANCET INFECT DIS, V17, P1209, DOI 10.1016/S1473-3099(17)30419-X
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Tang B, 2016, J THEOR BIOL, V410, P65, DOI 10.1016/j.jtbi.2016.09.012
   Tennant W, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006999
   Towers S, 2016, EPIDEMICS-NETH, V17, P50, DOI 10.1016/j.epidem.2016.10.003
   van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6
   van den Driessche Pauline, 2017, Infect Dis Model, V2, P288, DOI 10.1016/j.idm.2017.06.002
   Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255
   WALLINGA J, 2006, P BIOL SCI, V274, P599
   Wang Y, 2012, NONLINEAR ANAL-REAL, V13, P543, DOI 10.1016/j.nonrwa.2011.07.033
   Weaver SC, 2015, NEW ENGL J MED, V372, P1231, DOI 10.1056/NEJMra1406035
   White LF, 2008, STAT MED, V27, P2999, DOI 10.1002/sim.3136
   WHO, 2017, YELL FEV OUTBR ANG S
   Wu JT, 2016, LANCET, V388, P2904, DOI 10.1016/S0140-6736(16)31838-4
   Zhao S, 2019, T ROY SOC TROP MED H, V114, P62
   Zhao S, 2019, AM J TROP MED HYG, V101, P521, DOI 10.4269/ajtmh.18-1016
   Zhao S, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3602-9
   Zhao S, 2019, INT J INFECT DIS, V81, P251, DOI 10.1016/j.ijid.2019.02.030
   Zhao S, 2018, J THEOR BIOL, V454, P1, DOI 10.1016/j.jtbi.2018.05.017
NR 68
TC 0
Z9 0
U1 3
U2 3
PU PEERJ INC
PI LONDON
PA 341-345 OLD ST, THIRD FLR, LONDON, EC1V 9LL, ENGLAND
SN 2167-8359
J9 PEERJ
JI PeerJ
PD FEB 27
PY 2020
VL 8
AR e8601
DI 10.7717/peerj.8601
PG 21
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KQ8UD
UT WOS:000517196000004
PM 32149023
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Rathore, APS
   St John, AL
AF Rathore, Abhay P. S.
   St John, Ashley L.
TI Cross-Reactive Immunity Among Flaviviruses
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE flavivirus; dengue; Zika; yellow fever; tick-borne encephalitis;
   cross-protection; vector-borne
ID T-CELL-CLONES; JAPANESE ENCEPHALITIS-VIRUS; ANTIBODY-DEPENDENT
   ENHANCEMENT; TETRAVALENT DENGUE VACCINE; GROUP-B ARBOVIRUSES;
   WEST-NILE-VIRUS; ZIKA VIRUS; YELLOW-FEVER; HEALTHY-CHILDREN; INFECTION
AB Flaviviruses consist of significant human pathogens responsible for hundreds of millions of infections each year. Their antigenic relationships generate immune responses that are cross-reactive to multiple flaviviruses and their widespread and overlapping geographical distributions, coupled with increases in vaccination coverage, increase the likelihood of exposure to multiple flaviviruses. Depending on the antigenic properties of the viruses to which a person is exposed, flavivirus cross-reactivity can be beneficial or could promote immune pathologies. In this review we describe our knowledge of the functional immune outcomes that arise from varied flaviviral immune statuses. The cross-reactive antibody and T cell immune responses that are protective versus pathological are also addressed.
C1 [Rathore, Abhay P. S.; St John, Ashley L.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.
   [St John, Ashley L.] Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore, Singapore.
   [St John, Ashley L.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.
   [St John, Ashley L.] SingHlth Duke Natl Univ Singapore, Global Hlth Inst, Singapore, Singapore.
RP Rathore, APS; St John, AL (corresponding author), Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27710 USA.; St John, AL (corresponding author), Duke Natl Univ Singapore, Program Emerging Infect Dis, Med Sch, Singapore, Singapore.; St John, AL (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol & Immunol, Singapore, Singapore.; St John, AL (corresponding author), SingHlth Duke Natl Univ Singapore, Global Hlth Inst, Singapore, Singapore.
EM abhay.rathore@duke.edu; ashley.st.john@duke-nus.edu.sg
OI /0000-0003-2039-2964; St. John, Ashley/0000-0001-5098-1044
FU DukeNUS Medical School [MOE2019-T2-1-146, NRF2016NRF-CRP001-063]
FX This work was supported by start-up funding from DukeNUS Medical School
   and grants MOE2019-T2-1-146 and NRF2016NRF-CRP001-063 to AS.
CR Agrawal B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02631
   Aihara H, 1998, J VIROL, V72, P8032, DOI 10.1128/JVI.72.10.8032-8036.1998
   Arredondo-Garcia JL, 2018, CLIN MICROBIOL INFEC, V24, P755, DOI 10.1016/j.cmi.2018.01.018
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Biswal S, 2019, NEW ENGL J MED, V381, P2009, DOI 10.1056/NEJMoa1903869
   Blazquez AB, 2015, VIROLOGY, V482, P67, DOI 10.1016/j.virol.2015.03.020
   Bradt V, 2019, NPJ VACCINES, V4, DOI 10.1038/s41541-019-0133-5
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   CALISHER CH, 1989, J GEN VIROL, V70, P37, DOI 10.1099/0022-1317-70-1-37
   Camargos VN, 2019, EBIOMEDICINE, V44, P516, DOI 10.1016/j.ebiom.2019.05.014
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   CASALS J, 1954, J EXP MED, V99, P429, DOI 10.1084/jem.99.5.429
   CASALS JORDI, 1957, TRANS NEW YORK ACAD SCI, V19, P219
   Chan KR, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.164, 10.1038/nmicrobiol.2016.164]
   Chen LH, 2019, CLIN INFECT DIS, V68, P1761, DOI 10.1093/cid/ciy777
   Collins MH, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124588
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Culshaw A, 2017, NAT IMMUNOL, V18, P1228, DOI 10.1038/ni.3850
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   DEMADRID AT, 1974, J GEN VIROL, V23, P91, DOI 10.1099/0022-1317-23-1-91
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Fibriansah G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7341
   FONTENILLE D, 1994, AM J TROP MED HYG, V50, P570, DOI 10.4269/ajtmh.1994.50.570
   Franco LD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02260
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Grobbelaar AA, 2016, EMERG INFECT DIS, V22, P1854, DOI 10.3201/eid2210.160818
   Gubler DJ, 2019, BMJ-BRIT MED J, V367, DOI 10.1136/bmj.l5710
   Guy B, 2010, VACCINE, V28, P632, DOI 10.1016/j.vaccine.2009.09.098
   HENDERSON BE, 1970, AM J TROP MED HYG, V19, P110, DOI 10.4269/ajtmh.1970.19.110
   HILL AB, 1992, J GEN VIROL, V73, P1115, DOI 10.1099/0022-1317-73-5-1115
   ICTV, 10 ICTV
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Koblischke M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09331-w
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno G, 1998, J VIROL, V72, P73, DOI 10.1128/JVI.72.1.73-83.1998
   KURANE I, 1989, J EXP MED, V170, P763, DOI 10.1084/jem.170.3.763
   KURANE I, 1984, J VIROL, V52, P223, DOI 10.1128/JVI.52.1.223-230.1984
   Lindenbach BD, 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024
   MACNAMARA F. N., 1959, TRANS ROY SOC TROP MED AND HYG, V53, P202, DOI 10.1016/0035-9203(59)90072-0
   MAKINO Y, 1994, MICROBIOL IMMUNOL, V38, P951, DOI 10.1111/j.1348-0421.1994.tb02152.x
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Metz SW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12677-6
   Mongkolsapaya J, 2003, NAT MED, V9, P921, DOI 10.1038/nm887
   Moran E, 2008, EUR J IMMUNOL, V38, P1050, DOI 10.1002/eji.200737699
   Moureau G, 2010, VECTOR-BORNE ZOONOT, V10, P195, DOI 10.1089/vbz.2008.0216
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Norrby E, 2007, J EXP MED, V204, P2779, DOI 10.1084/jem.20072290
   Osorio JE, 2011, VACCINE, V29, P7251, DOI 10.1016/j.vaccine.2011.07.020
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629
   Rathore APS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav3208
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Robbiani DF, 2019, J EXP MED, V216, P2302, DOI 10.1084/jem.20191061
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Roehrig JT, 2002, CURR TOP MICROBIOL, V267, P223
   Roth C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01424
   Sabchareon A, 2002, AM J TROP MED HYG, V66, P264, DOI 10.4269/ajtmh.2002.66.264
   SABIN ALBERT B., 1952, AMER JOUR TROP MED AND HYG, V1, P30
   Saez-Llorens X, 2018, LANCET INFECT DIS, V18, P162, DOI 10.1016/S1473-3099(17)30632-1
   Salazar V, 2019, CELL REP, V26, P1585, DOI 10.1016/j.celrep.2019.01.052
   Saron WAA, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar4297
   Schwaiger J, 2014, J VIROL, V88, P7828, DOI 10.1128/JVI.00196-14
   Singh R, 2010, J INFECT DIS, V202, P223, DOI 10.1086/653486
   Spaulding AC, 1999, J VIROL, V73, P398, DOI 10.1128/JVI.73.1.398-403.1999
   St John AL, 2019, NAT REV IMMUNOL, V19, P218, DOI 10.1038/s41577-019-0123-x
   St John AL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003783
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Syenina A, 2015, ELIFE, V4, DOI 10.7554/eLife.05291
   Tajima S, 2005, VIROLOGY, V332, P38, DOI 10.1016/j.virol.2004.06.052
   Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238
   TRENT DW, 1977, J VIROL, V22, P608, DOI 10.1128/JVI.22.3.608-618.1977
   UREN MF, 1987, J GEN VIROL, V68, P2655, DOI 10.1099/0022-1317-68-10-2655
   van Meer MPA, 2017, J CLIN VIROL, V92, P25, DOI 10.1016/j.jcv.2017.05.001
   Weiskopf D, 2015, P NATL ACAD SCI USA, V112, pE4256, DOI 10.1073/pnas.1505956112
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   WESTAWAY EG, 1985, INTERVIROLOGY, V24, P183, DOI 10.1159/000149642
   Williams DT, 2001, AM J TROP MED HYG, V65, P379, DOI 10.4269/ajtmh.2001.65.379
   Yachi PP, 2006, IMMUNITY, V25, P203, DOI 10.1016/j.immuni.2006.05.015
   Yang HQ, 2016, ARCH VIROL, V161, P1517, DOI 10.1007/s00705-016-2817-8
NR 88
TC 2
Z9 2
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 26
PY 2020
VL 11
AR 334
DI 10.3389/fimmu.2020.00334
PG 9
WC Immunology
SC Immunology
GA LB7EF
UT WOS:000524794000001
PM 32174923
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hurtado-Monzon, AM
   Cordero-Rivera, CD
   Farfan-Morales, CN
   Osuna-Ramos, JF
   De Jesus-Gonzalez, LA
   Reyes-Ruiz, JM
   del Angel, RM
AF Mahely Hurtado-Monzon, Arianna
   Daniel Cordero-Rivera, Carlos
   Noe Farfan-Morales, Carlos
   Fidel Osuna-Ramos, Juan
   Adrian De Jesus-Gonzalez, Luis
   Manuel Reyes-Ruiz, Jose
   Maria del Angel, Rosa
TI The role of anti-flavivirus humoral immune response in protection and
   pathogenesis
SO REVIEWS IN MEDICAL VIROLOGY
LA English
DT Review; Early Access
DE ADE; antibodies; dengue; pathogenesis; protection; Zika
ID PROTEIN DOMAIN-III; ZIKA VIRUS-INFECTION; TETRAVALENT DENGUE VACCINE;
   NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; DEPENDENT ENHANCEMENT;
   MEDIATED NEUTRALIZATION; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS;
   CROSS-NEUTRALIZATION
AB Flavivirus infections are a public health threat in the world that requires the development of safe and effective vaccines. Therefore, the understanding of the anti-flavivirus humoral immune response is fundamental to future studies on flavivirus pathogenesis and the design of anti-flavivirus therapeutics. This review aims to provide an overview of the current understanding of the function and involvement of flavivirus proteins in the humoral immune response as well as the ability of the anti-envelope (anti-E) antibodies to interfere (neutralizing antibodies) or not (non-neutralizing antibodies) with viral infection, and how they can, in some circumstances enhance dengue virus infection on Fc gamma receptor (Fc gamma R) bearing cells through a mechanism known as antibody-dependent enhancement (ADE). Thus, the dual role of the antibodies against E protein poses a formidable challenge for vaccine development. Also, we discuss the roles of antibody binding stoichiometry (the concentration, affinity, or epitope recognition) in the neutralization of flaviviruses and the "breathing" of flavivirus virions in the humoral immune response. Finally, the relevance of some specific antibodies in the design and improvement of effective vaccines is addressed.
C1 [Mahely Hurtado-Monzon, Arianna; Daniel Cordero-Rivera, Carlos; Noe Farfan-Morales, Carlos; Fidel Osuna-Ramos, Juan; Adrian De Jesus-Gonzalez, Luis; Manuel Reyes-Ruiz, Jose; Maria del Angel, Rosa] IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Ciudad De Mexico, Mexico.
RP del Angel, RM (corresponding author), IPN, CINVESTAV, Ctr Res & Adv Studies, Dept Infect & Mol Pathogenesis, Ciudad De Mexico, Mexico.
EM rmangel@cinvestav.mx
OI Osuna-Ramos, Juan Fidel/0000-0001-8280-9812; Reyes-Ruiz, Jose
   Manuel/0000-0002-2379-8591; De Jesus Gonzalez, Luis
   Adrian/0000-0003-1415-6260; del Angel, Rosa/0000-0002-6785-2035; Cordero
   Rivera, Carlos Daniel/0000-0002-5052-2670
FU Consejo Nacional de Ciencia y TecnologiaConsejo Nacional de Ciencia y
   Tecnologia (CONACyT) [A1-S-9005]; Fundacion Miguel Aleman [2018]
FX Consejo Nacional de Ciencia y Tecnologia, Grant/Award Number: A1-S-9005;
   Fundacion Miguel Aleman, Grant/Award Number: 2018
CR Allison SL, 2001, J VIROL, V75, P4268, DOI 10.1128/JVI.75.9.4268-4275.2001
   Arredondo-Garcia JL, 2018, CLIN MICROBIOL INFEC, V24, P755, DOI 10.1016/j.cmi.2018.01.018
   Austin SK, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002930
   Bailey MJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07008-0
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barban V, 2012, VIROLOGY, V429, P91, DOI 10.1016/j.virol.2012.03.007
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Beasley DWC, 2002, J VIROL, V76, P13097, DOI 10.1128/JVI.76.24.13097-13100.2002
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Bhardwaj S, 2001, J VIROL, V75, P4002, DOI 10.1128/JVI.75.8.4002-4007.2001
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhaumik SK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010019
   Boigard H, 2018, VACCINE, V36, P7728, DOI 10.1016/j.vaccine.2018.10.072
   Budigi Y, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006209
   Burton DR, 2001, CURR TOP MICROBIOL, V260, P109
   Campos JLS, 2018, NAT IMMUNOL, V19, P1189, DOI 10.1038/s41590-018-0210-3
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cardoso SA, 2013, PROTEIN EXPRES PURIF, V92, P9, DOI 10.1016/j.pep.2013.08.014
   Castanha PMS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007246
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Clements DE, 2010, VACCINE, V28, P2705, DOI 10.1016/j.vaccine.2010.01.022
   Cockburn JJB, 2012, STRUCTURE, V20, P303, DOI 10.1016/j.str.2012.01.001
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Correia BE, 2014, NATURE, V507, P201, DOI 10.1038/nature12966
   Cox F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202820
   Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001
   Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2012, P NATL ACAD SCI USA, V109, P7439, DOI 10.1073/pnas.1200566109
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181
   DELLAPORTA AJ, 1978, J GEN VIROL, V38, P1, DOI 10.1099/0022-1317-38-1-1
   Deng YQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016059
   Dowd KA, 2018, ANNU REV VIROL, V5, P185, DOI 10.1146/annurev-virology-092917-043300
   Dowd KA, 2014, J VIROL, V88, P11726, DOI 10.1128/JVI.01140-14
   Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Emanuel J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29401-x
   Fibriansah G, 2016, ANTIVIR RES, V128, P7, DOI 10.1016/j.antiviral.2016.01.002
   Fibriansah G, 2014, EMBO MOL MED, V6, P358, DOI 10.1002/emmm.201303404
   Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13
   Forshey BM, 2016, J INFECT DIS, V214, P979, DOI 10.1093/infdis/jiw102
   Forshey BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004398
   Frei JC, 2018, J VIROL, V92, DOI [10.1128/JVI.01023-18, 10.1128/jvi.01023-18]
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goncalves A, 2018, J INFECT DIS, V217, P1060, DOI 10.1093/infdis/jix678
   Goncalvez AP, 2004, J VIROL, V78, P12910, DOI 10.1128/JVI.78.23.12910-12918.2004
   Gromowski GD, 2008, J VIROL, V82, P8828, DOI 10.1128/JVI.00606-08
   Gromowski GD, 2007, VIROLOGY, V366, P349, DOI 10.1016/j.virol.2007.05.042
   Guy B, 2015, VACCINE, V33, P7100, DOI 10.1016/j.vaccine.2015.09.108
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223
   HALSTEAD SB, 1973, J INFECT DIS, V128, P15, DOI 10.1093/infdis/128.1.15
   HALSTEAD SB, 1988, SCIENCE, V239, P476, DOI 10.1126/science.3277268
   HALSTEAD SB, 1979, J INFECT DIS, V140, P527, DOI 10.1093/infdis/140.4.527
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0
   Halstead SB, 2016, VACCINE, V34, P1643, DOI 10.1016/j.vaccine.2016.02.004
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   HENCHAL EA, 1988, J GEN VIROL, V69, P2101, DOI 10.1099/0022-1317-69-8-2101
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Huang KJ, 2006, J IMMUNOL, V176, P2825, DOI 10.4049/jimmunol.176.5.2825
   Hung NT, 2004, J INFECT DIS, V189, P221, DOI 10.1086/380762
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Keasey SL, 2017, CLIN VACCINE IMMUNOL, V24, DOI 10.1128/CVI.00036-17
   Khetarpal N, 2017, AM J TROP MED HYG, V96, P126, DOI 10.4269/ajtmh.16-0503
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Kreil TR, 1998, J VIROL, V72, P3076, DOI 10.1128/JVI.72.4.3076-3081.1998
   Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8
   Langerak T, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007640
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Li J, 2018, STRUCTURE, V26, P51, DOI 10.1016/j.str.2017.11.017
   Li L, 2008, SCIENCE, V319, P1830, DOI 10.1126/science.1153263
   Liu WQ, 2010, VIRUS GENES, V40, P53, DOI 10.1007/s11262-009-0418-2
   Lok SM, 2008, NAT STRUCT MOL BIOL, V15, P312, DOI 10.1038/nsmb.1382
   Lu XS, 2019, CELL REP, V26, P438, DOI 10.1016/j.celrep.2018.12.065
   Luo YY, 2015, APPL MICROBIOL BIOT, V99, P5917, DOI 10.1007/s00253-015-6538-9
   MANDL CW, 1989, J VIROL, V63, P564, DOI 10.1128/JVI.63.2.564-571.1989
   Mani S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064595
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Mary JA, 2018, VIRUS GENES, V54, P25, DOI 10.1007/s11262-017-1508-1
   Masel J, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007060
   Metz SW, 2018, VIROL J, V15, DOI 10.1186/s12985-018-0970-2
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Mota J, 2005, VACCINE, V23, P3469, DOI 10.1016/j.vaccine.2004.12.028
   Mukherjee S, 2014, J VIROL, V88, P7210, DOI 10.1128/JVI.03690-13
   Murin CD, 2019, NAT MICROBIOL, V4, P734, DOI 10.1038/s41564-019-0392-y
   Murphy BR, 2011, ANNU REV IMMUNOL, V29, P587, DOI 10.1146/annurev-immunol-031210-101315
   Nambala P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01797
   Nybakken GE, 2005, NATURE, V437, P764, DOI 10.1038/nature03956
   Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06
   Ong EZ, 2017, ANTIVIR RES, V144, P44, DOI 10.1016/j.antiviral.2017.05.007
   Pierson TC, 2008, CELL HOST MICROBE, V4, P229, DOI 10.1016/j.chom.2008.08.004
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson TC, 2015, PROG MOL BIOL TRANSL, V129, P141, DOI 10.1016/bs.pmbts.2014.10.005
   Pierson TC, 2012, STRUCTURE, V20, P200, DOI 10.1016/j.str.2012.01.014
   Pitisuttithum P, 2016, EXPERT REV VACCINES, V15, P795, DOI 10.1080/14760584.2016.1189331
   Poddar A, 2016, BMC BIOTECHNOL, V16, DOI 10.1186/s12896-016-0280-y
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Priyamvada L, 2017, J INFECT DIS, V216, pS906, DOI 10.1093/infdis/jix513
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Prompetchara Eakachai, 2019, Asian Pac J Allergy Immunol, DOI 10.12932/AP-100518-0309
   Pupo Maritza, 2004, Rev Cubana Med Trop, V56, P197
   Rainwater-Lovett K, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-233
   Rajpoot RK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26904-5
   Ramasamy V, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006191
   Rey FA, 2003, P NATL ACAD SCI USA, V100, P6899, DOI 10.1073/pnas.1332695100
   Reyes-Sandoval A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01651
   Ripoll DR, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00200
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06
   Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007
   Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200
   Sabchareon A, 2012, LANCET, V380, P1559, DOI 10.1016/S0140-6736(12)61428-7
   Salje H, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002952
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shrestha B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000823
   Shukla R, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02644
   Smith SA, 2014, J VIROL, V88, P12233, DOI 10.1128/JVI.00247-14
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Sukupolvi-Petty S, 2007, J VIROL, V81, P12816, DOI 10.1128/JVI.00432-07
   Swanstrom JA, 2016, MBIO, V7, DOI 10.1128/mBio.01123-16
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625
   Throsby M, 2006, J VIROL, V80, P6982, DOI 10.1128/JVI.00551-06
   Tripathi L, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01005
   Tsai WY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01372
   Urakami A, 2017, J VIROL, V91, DOI [10.1128/JVI.01181-17, 10.1128/jvi.01181-17]
   Valiant WG, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0132-z
   Volk DE, 2004, J BIOL CHEM, V279, P38755, DOI 10.1074/jbc.M402385200
   Waggoner JJ, 2016, J INFECT DIS, V214, P986, DOI 10.1093/infdis/jiw099
   Wahala WMPB, 2011, VIRUSES-BASEL, V3, P2374, DOI 10.3390/v3122374
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang R, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00147
   Wang TT, 2017, SCIENCE, V355, P395, DOI 10.1126/science.aai8128
   Watanabe S, 2019, J INFECT DIS, V219, P223, DOI 10.1093/infdis/jiy482
   Whitehead SS, 2016, EXPERT REV VACCINES, V15, P509, DOI 10.1586/14760584.2016.1115727
   Whitehead SS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005584
   WHO, 2018, WHO ZIK VIR SIT REP
   WHO, 2019, WHO FACT SHEET DENG
   Williams KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003157
   Ye Q, 2016, INFECT GENET EVOL, V43, P43, DOI 10.1016/j.meegid.2016.05.004
   Yi GH, 2017, EBIOMEDICINE, V25, P87, DOI 10.1016/j.ebiom.2017.10.006
   Yu S, 2004, BIOCHEMISTRY-US, V43, P9168, DOI 10.1021/bi049324g
   Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 150
TC 0
Z9 0
U1 5
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1052-9276
EI 1099-1654
J9 REV MED VIROL
JI Rev. Med. Virol.
AR e2100
DI 10.1002/rmv.2100
EA FEB 2020
PG 12
WC Virology
SC Virology
GA KP8VB
UT WOS:000516506500001
PM 32101633
DA 2020-07-08
ER

PT J
AU Trentini, DB
   Pecoraro, M
   Tiwary, S
   Cox, J
   Mann, M
   Hipp, MS
   Hartl, U
AF Trentini, Debora Broch
   Pecoraro, Matteo
   Tiwary, Shivani
   Cox, Juergen
   Mann, Matthias
   Hipp, Mark S.
   Hartl, Ulrich
TI Role for ribosome-associated quality control in sampling proteins for
   MHC class I-mediated antigen presentation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ribosome-associated quality control; Listerin; MHC-I; immunopeptidome
ID COMBINED TRANSMEMBRANE TOPOLOGY; MESSENGER-RNA SURVEILLANCE; SIGNAL
   PEPTIDE PREDICTION; E3 UBIQUITIN LIGASE; ZIKA VIRUS; ENDONUCLEOLYTIC
   CLEAVAGE; STALLED RIBOSOME; MATURE PROTEINS; CELL-PROTEINS; ER MEMBRANE
AB Mammalian cells present a fingerprint of their proteome to the adaptive immune system through the display of endogenous peptides on MHC-I complexes. MHC-I-bound peptides originate from protein degradation by the proteasome, suggesting that stably folded, long-lived proteins could evade monitoring. Here, we investigate the role in antigen presentation of the ribosome-associated quality control (RQC) pathway for the degradation of nascent polypeptides that are encoded by defective messenger RNAs and undergo stalling at the ribosome during translation. We find that degradation of model proteins by RQC results in efficient MHC-I presentation, independent of their intrinsic folding properties. Quantitative profiling of MHC-I peptides in wild-type and RQC-deficient cells by mass spectrometry showed that RQC substantially contributes to the composition of the immunopeptidome. Our results also identify endogenous substrates of the RQC pathway in human cells and provide insight into common principles causing ribosome stalling under physiological conditions.
C1 [Trentini, Debora Broch; Hipp, Mark S.; Hartl, Ulrich] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.
   [Pecoraro, Matteo; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany.
   [Tiwary, Shivani; Cox, Juergen] Max Planck Inst Biochem, Computat Syst Biochem Res Grp, D-82152 Martinsried, Germany.
   [Cox, Juergen] Univ Bergen, Dept Biol & Med Psychol, N-5009 Bergen, Norway.
   [Hipp, Mark S.] Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, NL-9713 Groningen, Netherlands.
   [Hipp, Mark S.] Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, D-26111 Oldenburg, Germany.
RP Hipp, MS; Hartl, U (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany.; Hipp, MS (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Biomed Sci Cells & Syst, NL-9713 Groningen, Netherlands.; Hipp, MS (corresponding author), Carl von Ossietzky Univ Oldenburg, Sch Med & Hlth Sci, D-26111 Oldenburg, Germany.
EM m.s.hipp@umcg.nl; uhartl@biochem.mpg.de
FU European Union's Horizon 2020 research and innovation program under the
   Marie Sklodowska-Curie GrantEuropean Union (EU) [749932]; European
   Commission 7th Research Framework ProgramEuropean Union (EU) [GA
   ERC-2012-SyG_318987-ToPAG]
FX This project has received funding from the European Union's Horizon 2020
   research and innovation program under the Marie Sklodowska-Curie Grant
   Agreement 749932, and from the European Commission 7th Research
   Framework Program Grant GA ERC-2012-SyG_318987-ToPAG. We thank Amgen
   scholar Evi Zhuleku for conducting protein synthesis experiments;
   Mi-Jeong Yoon and Young Jun Choe for sharing Listerin knockout and
   overexpression plasmids; and Martin Spitaler and Markus Oster from the
   Imaging Facility of the Max Planck Institute of Biochemistry for
   assistance with cell sorting and flow cytometry analysis. We are
   grateful to Prof. Kenneth L. Rock for providing the HeLa.K<SUP>b</SUP>
   cell line.
CR Anton LC, 2014, J LEUKOCYTE BIOL, V95, P551, DOI 10.1189/jlb.1113599
   Arakawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep30795
   Arthur LL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500154
   Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354
   Banaszynski LA, 2006, CELL, V126, P995, DOI 10.1016/j.cell.2006.07.025
   Bassani-Sternberg M, 2015, MOL CELL PROTEOMICS, V14, P658, DOI 10.1074/mcp.M114.042812
   Bengtson MH, 2010, NATURE, V467, P470, DOI 10.1038/nature09371
   Bohnert M, 2015, CURR OPIN STRUC BIOL, V33, P92, DOI 10.1016/j.sbi.2015.07.013
   Brandman O, 2016, NAT STRUCT MOL BIOL, V23, P7, DOI 10.1038/nsmb.3147
   Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044
   Chitwood PJ, 2018, CELL, V175, P1507, DOI 10.1016/j.cell.2018.10.009
   Chu J, 2009, P NATL ACAD SCI USA, V106, P2097, DOI 10.1073/pnas.0812819106
   Cohen-Kaplan V, 2016, INT J BIOCHEM CELL B, V79, P403, DOI 10.1016/j.biocel.2016.07.019
   Colbert JD, 2013, J IMMUNOL, V191, P5410, DOI 10.4049/jimmunol.1300078
   Defenouillere Q, 2013, P NATL ACAD SCI USA, V110, P5046, DOI 10.1073/pnas.1221724110
   Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z
   Dolan BP, 2011, J IMMUNOL, V186, P2065, DOI 10.4049/jimmunol.1003096
   Doma MK, 2006, NATURE, V440, P561, DOI 10.1038/nature04530
   Duttler S, 2013, MOL CELL, V50, P379, DOI 10.1016/j.molcel.2013.03.010
   Egeler EL, 2011, J BIOL CHEM, V286, P31328, DOI 10.1074/jbc.M111.264101
   ESQUIVEL F, 1992, J EXP MED, V175, P163, DOI 10.1084/jem.175.1.163
   Farfan-Arribas DJ, 2012, P NATL ACAD SCI USA, V109, P16998, DOI 10.1073/pnas.1210271109
   Fiebiger BM, 2012, EUR J IMMUNOL, V42, P3167, DOI 10.1002/eji.201242627
   Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338
   Garzia A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16056
   Guydosh NR, 2017, ELIFE, V6, DOI [10.7554/elife.29216, 10.7554/eLife.29216]
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631
   Hollien J, 2009, J CELL BIOL, V186, P323, DOI 10.1083/jcb.200903014
   Ikeuchi K, 2016, SCI REP-UK, V6, DOI 10.1038/srep28234
   Ito-Harashima S, 2007, GENE DEV, V21, P519, DOI 10.1101/gad.1490207
   Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009
   Jiang HY, 2005, J BIOL CHEM, V280, P14189, DOI 10.1074/jbc.M413660200
   Joazeiro CAP, 2017, ANNU REV CELL DEV BI, V33, P343, DOI 10.1146/annurev-cellbio-111315-125249
   Juszkiewicz S, 2018, MOL CELL, V72, P469, DOI 10.1016/j.molcel.2018.08.037
   Juszkiewicz S, 2017, MOL CELL, V65, P743, DOI 10.1016/j.molcel.2016.11.039
   Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256
   Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016
   Khan S, 2001, J IMMUNOL, V167, P4801, DOI 10.4049/jimmunol.167.9.4801
   Kostova KK, 2017, SCIENCE, V357, P414, DOI 10.1126/science.aam7787
   Letzring DP, 2013, RNA, V19, P1208, DOI 10.1261/rna.039446.113
   Lin DL, 2019, CELL REP, V27, P1666, DOI 10.1016/j.celrep.2019.04.051
   Lyumkis D, 2014, P NATL ACAD SCI USA, V111, P15981, DOI 10.1073/pnas.1413882111
   Mastrototaro L, 2016, SCI REP-UK, V6, DOI 10.1038/srep27999
   McShane E, 2016, CELL, V167, P803, DOI 10.1016/j.cell.2016.09.015
   Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106
   Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1
   Qian SB, 2006, J IMMUNOL, V177, P227, DOI 10.4049/jimmunol.177.1.227
   Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011
   Rock KL, 2014, TRENDS IMMUNOL, V35, P144, DOI 10.1016/j.it.2014.01.002
   ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6
   Rock KL, 1999, ANNU REV IMMUNOL, V17, P739, DOI 10.1146/annurev.immunol.17.1.739
   Savidis G, 2016, CELL REP, V16, P232, DOI 10.1016/j.celrep.2016.06.028
   Schubert U, 2000, NATURE, V404, P770
   Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018
   Sitron CS, 2019, NAT STRUCT MOL BIOL, V26, P450, DOI 10.1038/s41594-019-0230-1
   SUGAWARA S, 1987, J IMMUNOL METHODS, V100, P83
   Trentini D. B., 2019, ROLE RIBOSOMAL QUALI
   Tsuboi T, 2012, MOL CELL, V46, P518, DOI 10.1016/j.molcel.2012.03.013
   Vabulas RM, 2005, SCIENCE, V310, P1960, DOI 10.1126/science.1121925
   van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272
   Varshavsky A, 2017, ANNU REV BIOCHEM, V86, P123, DOI 10.1146/annurev-biochem-061516-044859
   von der Malsburg K, 2015, MOL BIOL CELL, V26, P2168, DOI 10.1091/mbc.E15-01-0040
   Wang RJ, 2018, GENOME RES, V28, P1427, DOI 10.1101/gr.237826.118
   Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522
   Yewdell J, 2002, MOL IMMUNOL, V39, P139, DOI 10.1016/S0161-5890(02)00097-4
   Yewdell JW, 2011, TRENDS IMMUNOL, V32, P548, DOI 10.1016/j.it.2011.08.001
   Yewdell JW, 1996, J IMMUNOL, V157, P1823
   Yewdell JW, 2003, NAT REV IMMUNOL, V3, P952, DOI 10.1038/nri1250
   York IA, 2002, NAT IMMUNOL, V3, P1177, DOI 10.1038/ni860
NR 70
TC 0
Z9 0
U1 4
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 25
PY 2020
VL 117
IS 8
BP 4099
EP 4108
DI 10.1073/pnas.1914401117
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KQ2PV
UT WOS:000516771500034
PM 32047030
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Roth, H
   Schneider, L
   Eberle, R
   Lausen, J
   Modlich, U
   Blumel, J
   Baylis, SA
AF Roth, Hanna
   Schneider, Lucas
   Eberle, Regina
   Lausen, Joern
   Modlich, Ute
   Bluemel, Johannes
   Baylis, Sally A.
TI Zika virus infection studies with CD34(+) hematopoietic and
   megakaryocyte-erythroid progenitors, red blood cells and platelets
SO TRANSFUSION
LA English
DT Article
ID VON-WILLEBRAND-FACTOR; PARVOVIRUS B19; WHOLE-BLOOD; STEM-CELLS; LINE;
   DISEASE; TARGETS; RNA; THROMBOCYTOPENIA; DIFFERENTIATION
AB BACKGROUND To date, several cases of transfusion-transmitted ZIKV infections have been confirmed. Multiple studies detected prolonged occurrence of ZIKV viral RNA in whole blood as compared to plasma samples indicating potential ZIKV interaction with hematopoietic cells. Also, infection of cells from the granulocyte/macrophage lineage has been demonstrated. Patients may develop severe thrombocytopenia, microcytic anemia, and a fatal course of disease occurred in a patient with sickle cell anemia suggesting additional interference of ZIKV with erythroid and megakaryocytic cells. Therefore, we analyzed whether ZIKV propagates in or compartmentalizes with hematopoietic progenitor, erythroid, and megakaryocytic cells.
   METHODS ZIKV RNA replication, protein translation and infectious particle formation in hematopoietic cell lines as well as primary CD34(+) HSPCs and ex vivo differentiated erythroid and megakaryocytic cells was monitored using qRT-PCR, FACS, immunofluorescence analysis and infectivity assays. Distribution of ZIKV RNA and infectious particles in spiked red blood cell (RBC) units or platelet concentrates (PCs) was evaluated.
   RESULTS While subsets of K562 and KU812Ep6(EPO) cells supported ZIKV propagation, primary CD34(+) HSPCs, MEP cells, RBCs, and platelets were non-permissive for ZIKV infection. In spiking studies, ZIKV RNA was detectable for 7 days in all fractions of RBC units and PCs, however, ZIKV infectious particles were not associated with erythrocytes or platelets.
   CONCLUSION Viral particles from plasma or contaminating leukocytes, rather than purified CD34(+) HSPCs or the cellular component of RBC units or PCs, present the greatest risk for transfusion-transmitted ZIKV infections.
C1 [Roth, Hanna; Bluemel, Johannes; Baylis, Sally A.] Paul Ehrlich Inst, Div Virol, Langen, Germany.
   [Eberle, Regina] Paul Ehrlich Inst, Div Immunol, Langen, Germany.
   [Modlich, Ute] Paul Ehrlich Inst, Div Vet Med, Langen, Germany.
   [Schneider, Lucas; Lausen, Joern] Goethe Univ, Inst Transfus Med & Immunohematol, Frankfurt, Hessen, Germany.
   [Schneider, Lucas; Lausen, Joern] German Red Cross Blood Serv, Frankfurt, Hessen, Germany.
   [Lausen, Joern] Inst Ind Genet, Dept Genet Eukaryotes, Stuttgart, Baden Wurttembe, Germany.
RP Roth, H (corresponding author), Paul Ehrlich Inst, Fed Inst Vaccines & Biomed, Paul Ehrlich Str 51-59, D-63225 Langen, Germany.
EM hanna.roth@pei.de
FU grant "Sicherheit von Blut(produkten) und Geweben hinsichtlich der
   Abwesenheit von Zikaviren" from the German Ministry of Health
FX This work was supported by grant "Sicherheit von Blut(produkten) und
   Geweben hinsichtlich der Abwesenheit von Zikaviren" from the German
   Ministry of Health.
CR AMINOFF D, 1980, AM J HEMATOL, V9, P381
   Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817
   Aoki T, 2017, MEMBRANES-BASEL, V7, DOI 10.3390/membranes7040056
   Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934
   Assinger A, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00649
   Attar A, 2014, GLOBAL J HEMATOL BLO, V1, P20, DOI DOI 10.15379/2408-9877.2014.01.01.4
   Aubry M, 2017, EMERG INFECT DIS, V23, P669, DOI 10.3201/eid2304.161549
   Aubry M, 2016, TRANSFUSION, V56, P33, DOI 10.1111/trf.13271
   Barjas-Castro ML, 2016, TRANSFUSION, V56, P1684, DOI 10.1111/trf.13681
   Baylis SA, 2017, TRANSFUSION, V57, P748, DOI 10.1111/trf.14026
   Bieber E, 2001, J REPROD MED, V46, P521
   Blumel J, 2017, TRANSFUSION, V57, P790, DOI 10.1111/trf.13873
   Blumel J, 2005, J VIROL, V79, P14197, DOI 10.1128/JVI.79.22.14197-14206.2005
   Bonig H, 2011, BUNDESGESUNDHEITSBLA, V54, P791, DOI 10.1007/s00103-011-1305-2
   Boller K, 1997, J VIROL, V71, P4581, DOI 10.1128/JVI.71.6.4581-4588.1997
   Bua G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148547
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chao CH, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007625
   Chevalier MS, 2017, EMERG INFECT DIS, V23, P790, DOI 10.3201/eid2305.161873
   Clark KB, 2016, VIROLOGY, V493, P162, DOI 10.1016/j.virol.2016.03.024
   Clark KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052902
   Coffey LL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171148
   Conde JN, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00213
   da Silva SR, 2019, J MED VIROL, V91, P179, DOI 10.1002/jmv.25306
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   European Centre for Disease Prevention and Control (ECDC), 2019, ZIK VIR TRANSM WORLD
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   FDA, 2018, REV REC RED RISK ZIK
   Frenkel LD, 2018, EUR J CLIN MICROBIOL, V37, P209, DOI 10.1007/s10096-017-3111-8
   FUKUDA T, 1987, BLOOD, V70, P612
   Galel SA, 2017, TRANSFUSION, V57, P762, DOI 10.1111/trf.14029
   Gallian P, 2017, BLOOD, V129, P263, DOI 10.1182/blood-2016-09-737981
   Garcez PP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31149-3
   Giannini S, 2019, PLATELETS, P79, DOI [10.1016/b978-0-12-813456-6.00004-7, DOI 10.1016/B978-0-12-813456-6.00004-7]
   Heck E, 2017, AM J TRANSPLANT, V17, P2227, DOI 10.1111/ajt.14334
   Henschler R, 2019, TRANSFUSION, V59, P1407, DOI 10.1111/trf.15174
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Hou WH, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2338-4
   Hsu AY, 2019, TRANSFUSION, V59, P2938, DOI 10.1111/trf.15416
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Jurado KA, 2017, NAT MICROBIOL, V2, P1460, DOI 10.1038/s41564-017-0049-7
   Karber G, 1931, N-S ARCH EX PATH PH, V162, P480, DOI 10.1007/BF01863914
   Karimi O, 2016, LANCET, V387, P939, DOI [10.1016/S0140-6736(16)00502-X, 10.1016/s0140-6736(16)00502-X]
   Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674
   KISHI K, 1985, LEUKEMIA RES, V9, P381, DOI 10.1016/0145-2126(85)90060-8
   Kolb-Maurer A, 2003, FEMS MICROBIOL LETT, V226, P203, DOI 10.1016/S0378-1097(03)00643-8
   Kratz-Albers K, 2000, EXP HEMATOL, V28, P335, DOI 10.1016/S0301-472X(99)00152-6
   LEARY JF, 1987, LEUKEMIA RES, V11, P807, DOI 10.1016/0145-2126(87)90065-8
   Leisi R, 2015, BIOCONJUGATE CHEM, V26, P1923, DOI 10.1021/acs.bioconjchem.5b00321
   Li BJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203331
   Liu ZY, 2019, NAT REV MICROBIOL, V17, P131, DOI 10.1038/s41579-018-0134-9
   Luck L, 2004, EXP HEMATOL, V32, P483, DOI 10.1016/j.exphem.2004.02.003
   Lustig Y, 2016, EUROSURVEILLANCE, V21, P7, DOI 10.2807/1560-7917.ES.2016.21.26.30269
   Mansuy JM, 2017, EMERG INFECT DIS, V23, P863, DOI 10.3201/eid2305.161631
   Marovich M, 2001, J INVEST DERM SYMP P, V6, P219, DOI 10.1046/j.0022-202x.2001.00037.x
   Masaki B, 2016, BLOOD, V73, P2003
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Miyagawa E, 1999, J VIROL METHODS, V83, P45, DOI 10.1016/S0166-0934(99)00105-6
   Mladinich MC, 2017, MBIO, V8, DOI [10.1128/mBio.00952-17, 10.1128/mbio.00952-17]
   Morinet F, 2011, STEM CELLS, V29, P1656, DOI 10.1002/stem.725
   Motta IJF, 2016, NEW ENGL J MED, V375, P1101, DOI 10.1056/NEJMc1607262
   Murray KO, 2017, EMERG INFECT DIS, V23, P99, DOI 10.3201/eid2301.161394
   Musso D, 2017, J MED VIROL, V89, P1505, DOI 10.1002/jmv.24735
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   OGAWA M, 1993, BLOOD, V81, P2844
   OGURA M, 1985, BLOOD, V66, P1384
   Podbielska M, 2004, ARCH BIOCHEM BIOPHYS, V429, P145, DOI 10.1016/j.abb.2004.06.018
   Prete A, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-119303
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Rios M, 2007, CLIN INFECT DIS, V45, P181, DOI 10.1086/518850
   Rondina MT, 2015, BLOOD, V126, P286, DOI 10.1182/blood-2015-05-647362
   Rosenstierne MW, 2018, EMERG INFECT DIS, V24, P948, DOI 10.3201/eid2405.180153
   Saa P, 2019, TRANSFUSION, V59, P3164, DOI 10.1111/trf.15484
   Schick PK, 1997, ARTERIOSCL THROM VAS, V17, P797, DOI 10.1161/01.ATV.17.4.797
   Sharp TM, 2016, CLIN INFECT DIS, V63, P1198, DOI 10.1093/cid/ciw476
   Simonin Y, 2016, EBIOMEDICINE, V12, P161, DOI 10.1016/j.ebiom.2016.09.020
   Spearman C, 1908, BRIT J PSYCHOL, V2, P227, DOI 10.1111/j.2044-8295.1908.tb00176.x
   Sridharan A, 2013, J VIROL, V87, P11648, DOI 10.1128/JVI.01156-13
   Srour EF, 1991, BLOOD CELLS
   TABILIO A, 1984, EMBO J, V3, P453, DOI 10.1002/j.1460-2075.1984.tb01827.x
   Tadkalkar N, 2019, INDIAN J HEMATOL BLO, V35, P502, DOI 10.1007/s12288-018-1058-2
   Tan CW, 2019, EMERG MICROBES INFEC, V8, P426, DOI 10.1080/22221751.2019.1590130
   Thompson AJ, 2019, CURR OPIN VIROL, V34, P117, DOI 10.1016/j.coviro.2019.01.004
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Trosemeier JH, 2016, MICROBIOL RESOUR ANN, V4, DOI 10.1128/genomeA.00917-16
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Vielle NJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23734-3
   Wasik BR, 2016, TRENDS MICROBIOL, V24, P991, DOI 10.1016/j.tim.2016.07.005
   WHO, 2016, MAINT SAF AD BLOOD S
   Williamson PC, 2017, TRANSFUSION, V57, P770, DOI 10.1111/trf.14041
   Willis E, 2017, VIROLOGY, V508, P1, DOI 10.1016/j.virol.2017.04.031
   Wong KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036435
   World Health Organization, 2019, COUNTR TERR CURR PRE
   World Health Organization, 2016, SIT REP ZIK VIR MICR
   World Health Organization (WHO), 2005, WHO STAT 1 M INT HLT
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
NR 100
TC 0
Z9 0
U1 0
U2 0
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0041-1132
EI 1537-2995
J9 TRANSFUSION
JI Transfusion
PD MAR
PY 2020
VL 60
IS 3
BP 561
EP 574
DI 10.1111/trf.15692
EA FEB 2020
PG 14
WC Hematology
SC Hematology
GA KR7VW
UT WOS:000514933200001
PM 32086956
OA Other Gold
DA 2020-07-08
ER

PT J
AU Venceslau, EM
   Guida, JPS
   Nobrega, GD
   Samogim, AP
   Parise, PL
   Japecanga, RR
   de Toledo-Teixeira, DA
   Forato, J
   Antolini-Tavares, A
   Souza, A
   Altemani, A
   Consonni, SR
   Passini, R
   Amaral, E
   Proenca-Modena, JL
   Costa, ML
AF Venceslau, Emanuella Meneses
   Siqueira Guida, Jose Paulo
   Nobrega, Guilherme de Moraes
   Samogim, Ana Paula
   Parise, Pierina Lorencini
   Japecanga, Rodolfo Rosa
   de Toledo-Teixeira, Daniel Augusto
   Forato, Julia
   Antolini-Tavares, Arthur
   Souza, Arethusa
   Altemani, Albina
   Consonni, Silvio Roberto
   Passini, Renato
   Amaral, Eliana
   Proenca-Modena, Jose Luiz
   Costa, Maria Laura
CA Zika-Unicamp Network
TI Adequate Placental Sampling for the Diagnosis and Characterization of
   Placental Infection by Zika Virus
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; placenta; viral persistence; pregnancy; systematic sampling;
   qRT-PCR
ID SEXUAL TRANSMISSION; COLLECTION; LESIONS
AB The detection of Zika virus (ZIKV) in immunoprivileged anatomical sites, potential sites for viral persistence, may guide the confirmation of undefined cases of ZIKV infection and also bring to light unknown pathways of viral transmission. Thus, this study aimed to characterize ZIKV infection in stratified, standardized placental samples in women with exanthematic febrile manifestations during pregnancy and compare findings to the standard investigation protocol of official health agencies. To this end, a case series of placental findings within a prospective cohort study was conducted over a period of 24 months. Serum/urine were obtained at the time of clinical case identification. Placental sampling was performed following standard investigation protocol (samples of 1.0 cm sent to a reference laboratory) and in a systematic way at various regions, such as chorionic plate, chorionic villi, basal plate, amniotic membrane, and umbilical cord, for subsequent ZIKV identification and quantification. Clinical information was obtained and histological preparation with hematoxylin-eosin staining for morphological evaluation was performed. This case series included 17 placentas systematically collected. Of these, 14 were positive by qRT-PCR for ZIKV, 5 in the umbilical cord, 7 in the amniotic membrane, 7 in the chorionic plate, 13 in the chorionic villi, and 7 in the basal plate, whereas none were reported by the reference laboratory. The most common morphological and anatomopathological findings were increased stromal cellularity, villitis, calcification, maternal vascular malperfusion, placental hypoplasia, and maternal-fetal hemorrhage (intervillous thrombi). Seven women presented positive testing for ZIKV in serological and/or molecular tests during gestation in urine. While viral quantification in urine ranged from 10(1) to 10(3) FFU eq/ml, that in different placental regions ranged from 10(3) to 10(8) FFU eq/g. Thus, ZIKV can infect different regions of the placenta and umbilical cord of pregnant women, showing that the systematic collection and adequate storage of the placenta is fundamental for the detection of ZIKV in this organ. The detection of ZIKV in the placenta after several months of initial symptoms suggests that this tissue may be a site for viral persistence during pregnancy.
C1 [Venceslau, Emanuella Meneses; Siqueira Guida, Jose Paulo; Japecanga, Rodolfo Rosa; Passini, Renato; Amaral, Eliana; Costa, Maria Laura] Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, Brazil.
   [Nobrega, Guilherme de Moraes; Samogim, Ana Paula; Parise, Pierina Lorencini; de Toledo-Teixeira, Daniel Augusto; Forato, Julia; Proenca-Modena, Jose Luiz] Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, Brazil.
   [Antolini-Tavares, Arthur; Souza, Arethusa; Altemani, Albina] Univ Estadual Campinas, Sch Med Sci, Dept Pathol Anat, Campinas, Brazil.
   [Consonni, Silvio Roberto] Univ Estadual Campinas, Inst Biol, Dept Biochem & Tissue Biol, Campinas, Brazil.
RP Costa, ML (corresponding author), Univ Estadual Campinas, Sch Med Sci, Dept Obstet & Gynecol, Campinas, Brazil.; Proenca-Modena, JL (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Genet Evolut Microbiol & Immunol, Campinas, Brazil.
EM jimodena@unicamp.br; mlaura@unicamp.br
RI Angerami, Rodrigo Nogueira/A-8926-2013; Freitas, Andre Ricardo
   Ribas/L-1969-2016; de Toledo Teixeira, Daniel Augusto/C-6940-2017
OI Angerami, Rodrigo Nogueira/0000-0002-4976-9238; Freitas, Andre Ricardo
   Ribas/0000-0003-0291-7771; de Toledo Teixeira, Daniel
   Augusto/0000-0002-4055-058X; Consonni, Silvio
   Roberto/0000-0003-3149-021X
FU FAPESP (Fundacao de Amparo a Pesquisa do Estado) [2016/00194-8]; CNPq
   (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico)National
   Council for Scientific and Technological Development (CNPq)
   [409605/2016-6]; CAPESCAPES [88882.329828/2019]; CNPqNational Council
   for Scientific and Technological Development (CNPq) [409605/2016-6,
   119172/2018-6]; Student Aid System; FAPESP fellowshipsFundacao de Amparo
   a Pesquisa do Estado de Sao Paulo (FAPESP) [2017/26908-0, 2017/02402-0]
FX This work was financed by the FAPESP (Fundacao de Amparo a Pesquisa do
   Estado)-2016/00194-8 and CNPq (Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico)409605/2016-6. EV is supported by CAPES
   (88882.329828/2019). GN is supported by CNPq (119172/2018-6). AS is
   supported by the Student Aid System. PP and DT-T are supported by the
   FAPESP fellowships (2017/26908-0 and 2017/02402-0). MC has CNPq support
   #409605/2016-6. EA is CNPq research fellow. The funders had no role in
   the study design, data collection and analysis, decision to publish, or
   preparation of this manuscript.
CR Beaufrere A, 2019, BRAIN PATHOL, V29, P114, DOI 10.1111/bpa.12644
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Burton GJ, 2014, PLACENTA, V35, P9, DOI 10.1016/j.placenta.2013.11.005
   Burton GJ, 2015, AM J OBSTET GYNECOL, V213, DOI 10.1016/j.ajog.2015.07.050
   Chimelli L, 2017, ACTA NEUROPATHOL, V133, P983, DOI 10.1007/s00401-017-1699-5
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   de Noronha L, 2016, MEM I OSWALDO CRUZ, V111, P287, DOI 10.1590/0074-02760160085
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Frendo JL, 2003, MOL CELL BIOL, V23, P3566, DOI 10.1128/MCB.23.10.3566-3574.2003
   Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006
   Instituto de Pesquisa Economica Aplicada [IPEA], 2018, MIN PLAN DES GEST EP
   Jurado KA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88461
   Khong TY, 2016, ARCH PATHOL LAB MED, V140, P698, DOI 10.5858/arpa.2015-0225-CC
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Mi S, 2000, NATURE, V403, P785
   Ministerio da Saude, 2019, B EP
   Ministerio da Saude, 2015, PROT VIG RESP OC MIC
   Ministerio da Saude, 2017, VIR ZIK BRAS RESP SE
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Nelson DM, 2015, AM J OBSTET GYNECOL, V213, pS12, DOI 10.1016/j.ajog.2015.08.015
   Neto A. R. M., 2011, COMMUN CIENCIAS SAUD, V22, P21
   Oehler E, 2013, EUROSURVEILLANCE, V2014, P19, DOI DOI 10.2807/1560-7917.ES2014.19.9.20720
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pomar Leo, 2019, Ultrasound Obstet Gynecol, DOI 10.1002/uog.21936
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Romero R, 2018, J PERINAT MED, V46, P613, DOI 10.1515/jpm-2018-0055
   Sharp TM, 2019, MMWR RECOMM REP, V68, P1, DOI 10.15585/mmwr.rr6801a1
   Simmonds P, 2017, J GEN VIROL, V98, P2, DOI 10.1099/jgv.0.000672
   Singh RK, 2016, VET QUART, V36, P150, DOI 10.1080/01652176.2016.1188333
   Tamblyn JA, 2013, PLACENTA, V34, P846, DOI 10.1016/j.placenta.2013.07.002
   Turmel JM, 2016, LANCET, V387, P2501, DOI 10.1016/S0140-6736(16)30775-9
   van der Eijk AA, 2016, NEW ENGL J MED, V375, P1002, DOI 10.1056/NEJMc1605898
   Wolfe LM, 2014, PLACENTA, V35, P645, DOI 10.1016/j.placenta.2014.05.005
   Xavier Analúcia R., 2017, J. Bras. Patol. Med. Lab., V53, P252, DOI 10.5935/1676-2444.20170039
NR 36
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 21
PY 2020
VL 11
AR 112
DI 10.3389/fmicb.2020.00112
PG 11
WC Microbiology
SC Microbiology
GA LA0IL
UT WOS:000523640800001
PM 32153521
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Arias-Arias, JL
   MacPherson, DJ
   Hill, ME
   Hardy, JA
   Mora-Rodriguez, R
AF Arias-Arias, Jorge L.
   MacPherson, Derek J.
   Hill, Maureen E.
   Hardy, Jeanne A.
   Mora-Rodriguez, Rodrigo
TI A fluorescence-activatable reporter of flavivirus NS2B?NS3 protease
   activity enables live imaging of infection in single cells and viral
   plaques
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
DE cell death; dengue virus (DENV); flavivirus; fluorescence; protease;
   cell-based reporter; internal cleavage; NS2B?NS3; plaque assay; Zika
   virus (ZIKV)
ID DENGUE-VIRUS; ANIMAL-MODELS; NS1
AB The genus Flavivirus in the family Flaviviridae comprises many medically important viruses, such as dengue virus (DENV), Zika virus (ZIKV), and yellow fever virus. The quest for therapeutic targets to combat flavivirus infections requires a better understanding of the kinetics of virus?host interactions during infections with native viral strains. However, this is precluded by limitations of current cell-based systems for monitoring flavivirus infection in living cells. In the present study, we report the construction of fluorescence-activatable sensors to detect the activities of flavivirus NS2B?NS3 serine proteases in living cells. The system consists of GFP-based reporters that become fluorescent upon cleavage by recombinant DENV-2/ZIKV proteases in vitro. A version of this sensor containing the flavivirus internal NS3 cleavage site linker reported the highest fluorescence activation in stably transduced mammalian cells upon DENV-2/ZIKV infection. Moreover, the onset of fluorescence correlated with viral protease activity. A far-red version of this flavivirus sensor had the best signal-to-noise ratio in a fluorescent Dulbecco's plaque assay, leading to the construction of a multireporter platform combining the flavivirus sensor with reporter dyes for detection of chromatin condensation and cell death, enabling studies of viral plaque formation with single-cell resolution. Finally, the application of this platform enabled the study of cell-population kinetics of infection and cell death by DENV-2, ZIKV, and yellow fever virus. We anticipate that future studies of viral infection kinetics with this reporter system will enable basic investigations of virus?host interactions and facilitate future applications in antiviral drug research to manage flavivirus infections.
C1 [Arias-Arias, Jorge L.; Mora-Rodriguez, Rodrigo] Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, Ciudad Univ Rodrigo Facio, San Jose 115012060, Costa Rica.
   [MacPherson, Derek J.; Hill, Maureen E.; Hardy, Jeanne A.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.
RP Mora-Rodriguez, R (corresponding author), Univ Costa Rica, Ctr Invest Enfermedades Trop, Fac Microbiol, Ciudad Univ Rodrigo Facio, San Jose 115012060, Costa Rica.
EM rodrigo.morarodriguez@ucr.ac.cr
OI Mora-Rodriguez, Rodrigo/0000-0001-7964-3575
FU Universidad de Costa Rica Project [VI-803-B9-505]; National Science
   FoundationNational Science Foundation (NSF) [NSF CBET1511367];
   International Centre for Genetic Engineering and Biotechnology Grant
   [CRP/CRI18-02]
FX This work was supported by Universidad de Costa Rica Project
   VI-803-B9-505 (to J. L. A.-A. and R. M.-R.), National Science Foundation
   Grant NSF CBET1511367 (to J. A. H.), and International Centre for
   Genetic Engineering and Biotechnology Grant CRP/CRI18-02 (to R. M.-R).
   The authors declare that they have no conflicts of interest with the
   contents of this article.
CR Acosta EG, 2016, CURR OPIN VIROL, V20, P47, DOI 10.1016/j.coviro.2016.09.003
   ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Anfasa F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00817
   Arias-Arias JL, 2018, AM J TROP MED HYG, V99, P1451, DOI 10.4269/ajtmh.18-0175
   Balsitis SJ, 2009, AM J TROP MED HYG, V80, P416, DOI 10.4269/ajtmh.2009.80.416
   Bera AK, 2007, J BIOL CHEM, V282, P12883, DOI 10.1074/jbc.M611318200
   Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chan KWK, 2015, ANTIVIR RES, V123, P5, DOI 10.1016/j.antiviral.2015.08.013
   Chung KM, 2007, J VIROL, V81, P9551, DOI 10.1128/JVI.00879-07
   Constant DA, 2018, P NATL ACAD SCI USA, V115, P10136, DOI 10.1073/pnas.1805195115
   d'H?relle F., 1926, NATURE, V118, P183, DOI [10.1038/118183a0, DOI 10.1038/118183A0]
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   Diamond MS, 2000, J VIROL, V74, P7814, DOI 10.1128/JVI.74.17.7814-7823.2000
   DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747
   Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4
   Ghosh Roy Sounak, 2014, World J Biol Chem, V5, P93, DOI 10.4331/wjbc.v5.i2.93
   Goh KCM, 2016, SCI REP-UK, V6, DOI 10.1038/srep26100
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Guan B, 2011, CANCER RES, V71, P6718, DOI 10.1158/0008-5472.CAN-11-1562
   Hill ME, 2019, BIOCHEMISTRY-US, V58, P776, DOI 10.1021/acs.biochem.8b00978
   Hill ME, 2018, ACS CHEM BIOL, V13, P2398, DOI 10.1021/acschembio.8b00508
   Hsieh MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188170
   Ishikawa T, 2014, VACCINE, V32, P1326, DOI 10.1016/j.vaccine.2014.01.040
   Kato F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16475-2
   Kim YM, 2013, J BIOL CHEM, V288, P12891, DOI 10.1074/jbc.M112.442723
   Kummerer BM, 2018, ADV EXP MED BIOL, V1062, P165, DOI 10.1007/978-981-10-8727-1_12
   Leavesley SJ, 2016, CYTOM PART A, V89A, P325, DOI 10.1002/cyto.a.22851
   Li SH, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-64
   Limonta D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110646
   Lindenbach B., 2013, FIELDS VIROLOGY, V1, P712
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   LIPRANDI F, 1981, J GEN VIROL, V56, P363, DOI 10.1099/0022-1317-56-2-363
   Liu J, 2018, INT J BIOL SCI, V14, P1099, DOI 10.7150/ijbs.26400
   McFadden MJ, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020095
   Medin CL, 2015, J VIROL METHODS, V211, P55, DOI 10.1016/j.jviromet.2014.10.010
   Medina Freddy, 2012, Curr Protoc Microbiol, VChapter 15, DOI 10.1002/9780471729259.mc15d02s27
   MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985
   Nicholls SB, 2013, PROTEIN SCI, V22, P247, DOI 10.1002/pro.2188
   Nicholls SB, 2011, J BIOL CHEM, V286, P24977, DOI 10.1074/jbc.M111.221648
   Normile D, 2017, SCIENCE, V358, P1514, DOI 10.1126/science.358.6370.1514
   Petrova E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010068
   Reynolds ES, 2017, COMPARATIVE MED, V67, P232
   Schmid B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005345
   Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089
   Scott LJ, 2016, DRUGS, V76, P1301, DOI 10.1007/s40265-016-0626-8
   Shiryaev SA, 2007, BIOCHEM J, V401, P743, DOI 10.1042/BJ20061136
   Soto-Garita C, 2016, AM J TROP MED HYG, V95, P201, DOI 10.4269/ajtmh.15-0835
   Tamura T, 2018, J VIROL, V92, DOI 10.1128/JVI.01582-17
   Teo KF, 1997, J GEN VIROL, V78, P337, DOI 10.1099/0022-1317-78-2-337
   Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37
   WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8
   Wu P, 2013, BIOPHYS J, V104, P1605, DOI 10.1016/j.bpj.2013.01.058
   Xie XP, 2016, EBIOMEDICINE, V12, P156, DOI 10.1016/j.ebiom.2016.09.013
   Yakimovich A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138760
   Zakaria MK, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00398
NR 56
TC 0
Z9 0
U1 3
U2 3
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 21
PY 2020
VL 295
IS 8
BP 2212
EP 2226
DI 10.1074/jbc.RA119.011319
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA KR0SI
UT WOS:000517330200006
PM 31919100
OA Bronze
DA 2020-07-08
ER

PT J
AU Campos, EVR
   de Oliveira, JL
   Abrantes, DC
   Rogerio, CB
   Bueno, C
   Miranda, VR
   Monteiro, RA
   Fraceto, LF
AF Campos, Estefania Vangelie Ramos
   de Oliveira, Jhones Luiz
   Abrantes, Daniele Carvalho
   Rogerio, Carolina Barbara
   Bueno, Carolina
   Miranda, Vanessa Regina
   Monteiro, Renata Aparecida
   Fraceto, Leonardo Fernandes
TI Recent Developments in Nanotechnology for Detection and Control of Aedes
   aegypti-Borne Diseases
SO FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY
LA English
DT Review
DE Aedes aegypti; vector control; biosensors; larvicides; arboviruses;
   nanobiotechnology
ID SYNTHESIZED SILVER NANOPARTICLES; ZIKA-VIRUS; GREEN SYNTHESIS; ESSENTIAL
   OIL; REPELLENT FORMULATIONS; ANOPHELES-STEPHENSI; LARVICIDAL ACTIVITY;
   DENGUE; BIOSENSOR; EXTRACT
AB Arboviruses such as yellow fever, dengue, chikungunya and zika are transmitted mainly by the mosquito vector Aedes aegypti. Especially in the tropics, inefficacy of mosquito control causes arboviruses outbreaks every year, affecting the general population with debilitating effects in infected individuals. Several strategies have been tried to control the proliferation of A. aegypti using physical, biological, and chemical control measures. Other methods are currently under research and development, amongst which the use of nanotechnology has attracted a lot of attention of the researchers in relation to the production of more effective repellents and larvicides with less toxicity, and development of rapid sensors for the detection of virus infections. In this review, the utilization of nano-based formulations on control and diagnosis of mosquito-borne diseases were discussed. We also emphasizes the need for future research for broad commercialization of nano-based formulations in world market aiming a positive impact on public health.
C1 [Campos, Estefania Vangelie Ramos] Fed Univ ABC, Human & Nat Sci Ctr, Santo Andre, SP, Brazil.
   [de Oliveira, Jhones Luiz; Abrantes, Daniele Carvalho; Rogerio, Carolina Barbara; Bueno, Carolina; Miranda, Vanessa Regina; Monteiro, Renata Aparecida; Fraceto, Leonardo Fernandes] Sao Paulo State Univ UNESP, Inst Sci & Technol, Sorocaba, Brazil.
RP Fraceto, LF (corresponding author), Sao Paulo State Univ UNESP, Inst Sci & Technol, Sorocaba, Brazil.
EM leonardo.fraceto@unesp.br
FU MCTIC-CNPq/MEC-CAPES/MS-Decit/FNDCT [14/2016, CNPq: 440350/2016-6,
   CAPES: 88881.130834/2016-01]; Sao Paulo State Research Foundation
   (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)
   [2017/24402-1, 2018/14743-0, 2018/02404-5]
FX The authors are grateful for financial support provided by
   MCTIC-CNPq/MEC-CAPES/MS-Decit/FNDCT No. 14/2016-Prevencao e Combate ao
   virus Zika-Processo CNPq: 440350/2016-6 e Processo CAPES:
   88881.130834/2016-01. The authors thank the Sao Paulo State Research
   Foundation (FAPESP) for scholarships awarded to EC (#2017/24402-1), DA
   (#2018/14743-0), and CR (2018/02404-5).
CR Afsahi S, 2018, BIOSENS BIOELECTRON, V100, P85, DOI 10.1016/j.bios.2017.08.051
   Agnihotri A, 2019, TEXT INST BOOK SER, P307, DOI 10.1016/B978-0-08-102491-1.00011-3
   Ahmed T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16173165
   Akahata W., 2017, ZIKA VIRUS VIRUS PAR
   Al-Dhabi NA, 2018, NANOMATERIALS-BASEL, V8, DOI 10.3390/nano8070500
   Alharbi NS, 2018, J TRACE ELEM MED BIO, V50, P146, DOI 10.1016/j.jtemb.2018.06.016
   Ali ZA, 2017, IET NANOBIOTECHNOL, V11, P152, DOI 10.1049/iet-nbt.2015.0123
   Amaha Nebyu Daniel, 2018, BMC Res Notes, V11, P904, DOI 10.1186/s13104-018-4000-7
   Ariffin SAB, 2014, ADV MATER RES-SWITZ, V832, P113, DOI 10.4028/www.scientific.net/AMR.832.113
   Awad M. A. G., 2016, SYNTHESIS NANOPARTIC
   Aytur T, 2006, J IMMUNOL METHODS, V314, P21, DOI 10.1016/j.jim.2006.05.006
   Baeumner A. J., 2005, MICROFLUIDIC BIOSENS
   Balaji APB, 2017, J KING SAUD UNIV SCI, V29, P517, DOI 10.1016/j.jksus.2016.12.005
   Balasubramani S, 2017, ENVIRON SCI POLLUT R, V24, P15125, DOI 10.1007/s11356-017-9118-y
   Barradas TN, 2016, CURR DRUG DELIV, V13, P221, DOI 10.2174/1567201813666151207110515
   Barrett T. W., 2018, U.S. Patent, Patent No. [20180067107A1, 20180067107]
   Basso CR, 2018, VIROLOGY, V513, P85, DOI 10.1016/j.virol.2017.10.001
   Batool K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30741-x
   Beech R., 2018, BIOSENSOR DIS INFECT
   Benelli G, 2018, ENVIRON SCI POLLUT R, V25, P12329, DOI [10.1007/s11356-018-1850-4, 10.1007/s11356-017-9752-4]
   Benelli G, 2017, J KING SAUD UNIV SCI, V29, P424, DOI 10.1016/j.jksus.2016.08.006
   Benelli G, 2016, INSECTS, V7, DOI 10.3390/insects7040052
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Berini P. S. J., 2018, LONG RANGE SURFACE P
   Bhuvaneswari R, 2016, J KING SAUD UNIV SCI, V28, P318, DOI 10.1016/j.jksus.2015.10.006
   Bosak A, 2019, RSC ADV, V9, P23752, DOI 10.1039/c9ra02089f
   Braga L., 2015, BIOSENSORS DETECTION
   Brister M., 2012, TRANSCUTANEOUS ANAL
   Thanh BT, 2019, J NANOMATER, V2019, DOI 10.1155/2019/2182471
   Cabarcos E. J. L., 2017, BIOSENSOR DETECTION
   Carrell C, 2019, MICROELECTRON ENG, V206, P45, DOI 10.1016/j.mee.2018.12.002
   Cecchetto J, 2017, BIOSENS BIOELECTRON, V87, P949, DOI 10.1016/j.bios.2016.08.097
   Pessoa LZD, 2018, REV BRAS FARMACOGN, V28, P618, DOI 10.1016/j.bjp.2018.07.003
   Dias ACMS, 2013, BIOSENS BIOELECTRON, V44, P216, DOI 10.1016/j.bios.2012.12.033
   Dinda S.C., 2018, UNRAVELING SAFETY PR, DOI [10.5772/intechopen.74802., DOI 10.5772/INTECHOPEN.74802]
   Duran N, 2016, J BRAZIL CHEM SOC, V27, P1139, DOI 10.5935/0103-5053.20160122
   Eboigbodin KE, 2016, DIAGN MICR INFEC DIS, V86, P369, DOI 10.1016/j.diagmicrobio.2016.08.027
   Elumalai Devan, 2017, Parasite Epidemiol Control, V2, P15, DOI 10.1016/j.parepi.2017.09.001
   Eyupoglu S, 2019, TEXT RES J, V89, P1417, DOI 10.1177/0040517518773370
   Ferreira TP, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007624
   Fletcher S. J., 2009, AUTOFEEDBACK LOOP BI
   Forgearini JC, 2016, J NANOSCI NANOTECHNO, V16, P1301, DOI 10.1166/jnn.2016.11665
   Fraceto L. F., 2018, SISTEMAS NANOESTRUTU
   Galvao JG, 2019, PEST MANAG SCI, V75, P452, DOI 10.1002/ps.5138
   Garcia AA, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7030047
   Gomes GM, 2019, J APPL POLYM SCI, V136, DOI 10.1002/app.47139
   Govindarajan M, 2016, J PHOTOCH PHOTOBIO B, V162, P646, DOI 10.1016/j.jphotobiol.2016.07.036
   Hameed A., 2019, J MED CHEM SCI, V2, P9, DOI 10.26655/jmchemsci.2019.6.2
   Hao J., 2018, U.S. Patent, Patent No. 20180246084
   Hoag G. E., 2011, GREEN SYNTHESIS NANO
   Hua S, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00790
   Huang SQ, 2010, LAB CHIP, V10, P2925, DOI 10.1039/c005227b
   Ishwarya R, 2017, J PHOTOCH PHOTOBIO B, V174, P133, DOI 10.1016/j.jphotobiol.2017.07.026
   Ishwarya R, 2018, J PHOTOCH PHOTOBIO B, V178, P249, DOI 10.1016/j.jphotobiol.2017.11.006
   Iswardy E, 2017, BIOSENS BIOELECTRON, V95, P174, DOI 10.1016/j.bios.2017.04.011
   Jeevanandam J, 2018, BEILSTEIN J NANOTECH, V9, P1050, DOI 10.3762/bjnano.9.98
   Jones AAD, 2019, TRENDS BIOTECHNOL, V37, P117, DOI 10.1016/j.tibtech.2018.06.003
   Kadam SL, 2019, COLLOID SURFACE A, V582, DOI 10.1016/j.colsurfa.2019.123883
   Kah M, 2018, ENVIRON SCI-NANO, V5, P882, DOI [10.1039/c8en00038g, 10.1039/C8EN00038G]
   Kah M, 2018, NAT NANOTECHNOL, V13, P677, DOI 10.1038/s41565-018-0131-1
   Khater H. F., 2019, MALARIA, DOI [10.5772/intechopen.87436, DOI 10.5772/INTECHOPEN.87436]
   Koczula KM, 2016, ESSAYS BIOCHEM, V60, P111, DOI 10.1042/EBC20150012
   Kumar D, 2018, PARASITOL RES, V117, P377, DOI 10.1007/s00436-017-5711-8
   Kumar S, 2015, NANOMEDICINE-UK, V10, P2451, DOI [10.2217/NNM.15.112, 10.2217/nnm.15.112]
   Kumar VA, 2017, J PHOTOCH PHOTOBIO B, V171, P1, DOI 10.1016/j.jphotobiol.2017.04.022
   Laury-Kleintop L., 2015, BIOCOATED PIEZOELECT
   Laux P, 2018, ARCH TOXICOL, V92, P121, DOI 10.1007/s00204-017-2144-1
   Li J, 2019, TALANTA, V205, DOI 10.1016/j.talanta.2019.06.091
   Liu S., 2013, ENV FRIENDLY SYNTHET
   Lucia A, 2017, PEERJ, V5, DOI 10.7717/peerj.3171
   Magro M, 2019, J PHOTOCH PHOTOBIO B, V194, P21, DOI 10.1016/j.jphotobiol.2019.03.004
   Marinero-Caceres E. E., 2017, FUNCTIONALIZED PARTI
   Mazlan NF, 2019, TALANTA, V198, P358, DOI 10.1016/j.talanta.2019.02.036
   Misni N, 2017, J VECTOR DIS, V54, P44
   Munoz V, 2019, MATER LETT, V253, P289, DOI 10.1016/j.matlet.2019.06.091
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Nakata Y, 2015, J MATH BIOL, V70, P1411, DOI 10.1007/s00285-014-0801-z
   Nalini M., 2017, EGYPTIAN J BASIC APP, V4, P212, DOI DOI 10.1016/j.ejbas.2017.04.005
   Nawaz MH, 2018, ANAL CHIM ACTA, V1026, P1, DOI 10.1016/j.aca.2018.04.032
   Nicolini AM, 2017, J BIOL ENG, V11, DOI 10.1186/s13036-016-0046-z
   Omar Nur Alia Sheh, 2018, Sensing and Bio-Sensing Research, V20, P16, DOI 10.1016/j.sbsr.2018.06.001
   Osanloo M, 2019, POLYM BULL, DOI 10.1007/s00289-019-03042-0
   Parisi C, 2015, NANO TODAY, V10, P124, DOI 10.1016/j.nantod.2014.09.009
   Pashchenko O, 2018, ACS INFECT DIS, V4, P1162, DOI 10.1021/acsinfecdis.8b00023
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Paula C. A. D., 2017, SISTEMA NANOMETRICO
   Pinto IC, 2017, DRUG DEV IND PHARM, V43, P67, DOI 10.1080/03639045.2016.1220564
   Priye A, 2017, SCI REP-UK, V7, DOI 10.1038/srep44778
   Ragavan V. V., 2011, INTEGRATED MICROCHIP
   Ramanibai R, 2016, J ASIA-PAC ENTOMOL, V19, P603, DOI 10.1016/j.aspen.2016.06.007
   RAMAR M, 2017, J ENTOMOL ZOOL STU W, V5, P1769
   RASHID JIA, 2018, BIOSCI BIOTECHNOL RE, V15, P245, DOI DOI 10.13005/bbra/2628
   Rong Z, 2019, ANAL CHIM ACTA, V1055, P140, DOI 10.1016/j.aca.2018.12.043
   Roni M, 2015, ECOTOX ENVIRON SAFE, V121, P31, DOI 10.1016/j.ecoenv.2015.07.005
   Sabalza M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192398
   Sajid M, 2015, ENVIRON SCI POLLUT R, V22, P4122, DOI 10.1007/s11356-014-3994-1
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Schnell-Inderst P, 2018, J CLIN EPIDEMIOL, V94, P46, DOI 10.1016/j.jclinepi.2017.10.007
   SETHI RS, 1994, BIOSENS BIOELECTRON, V9, P243, DOI 10.1016/0956-5663(94)80127-4
   Sharma D. H. K., 2019, ASIAN J PHARM, V13, DOI [10.22377/ajp.v13i01.3005, DOI 10.22377/AJP.V13I01.3005]
   Silva LS, 2019, J SCI FOOD AGR, V99, P685, DOI 10.1002/jsfa.9233
   Singhal C, 2018, PROCESS BIOCHEM, V74, P35, DOI 10.1016/j.procbio.2018.08.020
   Sintubin L, 2012, BIOTECHNOL BIOENG, V109, P2422, DOI 10.1002/bit.24570
   Soares S, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00360
   Song JZ, 2016, ANAL CHEM, V88, P7289, DOI 10.1021/acs.analchem.6b01632
   Soutschek E., 2019, U.S. Patent, Patent No. 20190227065
   Starpharma, 2016, STARPH VIVAGEL ACT Z
   Suganya P, 2017, J PHOTOCH PHOTOBIO B, V173, P404, DOI 10.1016/j.jphotobiol.2017.06.004
   Tancharoen C, 2019, ACS SENSORS, V4, P69, DOI 10.1021/acssensors.8b00885
   Tavares M, 2018, INT J PHARMACEUT, V539, P190, DOI 10.1016/j.ijpharm.2018.01.046
   Theillet G, 2018, ARCH VIROL, V163, P1757, DOI 10.1007/s00705-018-3776-z
   Thomas J., 2019, ANTIPARASITIC COMPOS
   Tian B, 2016, BIOSENS BIOELECTRON, V86, P420, DOI 10.1016/j.bios.2016.06.085
   Tripathy S, 2017, BIOSENS BIOELECTRON, V90, P378, DOI 10.1016/j.bios.2016.12.008
   Udayabhanu J, 2018, J PHOTOCH PHOTOBIO B, V178, P496, DOI 10.1016/j.jphotobiol.2017.12.005
   Veerakumar K, 2014, PARASITOL RES, V113, P1775, DOI 10.1007/s00436-014-3823-y
   Ventola C Lee, 2017, P T, V42, P742
   Vinayagam S, 2018, SPECTROCHIM ACTA A, V202, P346, DOI 10.1016/j.saa.2018.05.047
   Vo-Dinh T., 2004, MULTIFUNCTIONAL MULT
   Wasik D, 2017, BIOSENS BIOELECTRON, V91, P811, DOI 10.1016/j.bios.2017.01.017
   Gonzalez JOW, 2017, ENVIRON SCI POLLUT R, V24, P17006, DOI 10.1007/s11356-017-9327-4
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Willenberg B. J., 2018, PASSIVE INSECT SURVE
   Wolkowicz R., 2018, COMPOSITIONS CELL BA
   Yaren O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2382-0
   Yen CW, 2015, LAB CHIP, V15, P1638, DOI 10.1039/c5lc00055f
   Yrad FM, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9030074
   Yujia G H., 2015, GREEN SYNTHESIS METH
   Yusoh SN, 2019, MATER RES EXPRESS, V6, DOI 10.1088/2053-1591/ab3571
   Yuzon K, 2019, BIOCHIP J, V13, DOI 10.1007/s13206-019-3305-5
   Zhang B, 2017, NAT MED, V23, P548, DOI 10.1038/nm.4302
   Zhang YF, 2019, CHEM ENG J, V361, P1381, DOI 10.1016/j.cej.2018.10.132
NR 132
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 2296-4185
J9 FRONT BIOENG BIOTECH
JI Front. Bioeng. Biotechnol.
PD FEB 20
PY 2020
VL 8
AR 102
DI 10.3389/fbioe.2020.00102
PG 17
WC Biotechnology & Applied Microbiology; Multidisciplinary Sciences
SC Biotechnology & Applied Microbiology; Science & Technology - Other
   Topics
GA KZ8DC
UT WOS:000523487900001
PM 32154233
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Chiu, CF
   Chu, LW
   Liao, IC
   Simanjuntak, Y
   Lin, YL
   Juan, CC
   Ping, YH
AF Chiu, Chi-Fen
   Chu, Li-Wei
   Liao, I-Chen
   Simanjuntak, Yogy
   Lin, Yi-Ling
   Juan, Chi-Chang
   Ping, Yueh-Hsin
TI The Mechanism of the Zika Virus Crossing the Placental Barrier and the
   Blood-Brain Barrier
SO FRONTIERS IN MICROBIOLOGY
LA English
DT Article
DE Zika virus; placental barrier; blood-brain barrier; tight junction;
   transcytosis; single-virus imaging; ZO-1; Occludin
ID JAPANESE ENCEPHALITIS-VIRUS; INFECTION; TRANSCYTOSIS; CONNECTIONS;
   ANTIBODIES; JUNCTIONS; PROTEINS
AB Zika virus (ZIKV) infection causes severe neurological symptoms in adults and fetal microcephaly and the virus is detected in the brain of microcephaly and meningoencephalitis patient. However, the mechanism of ZIKV crossing the physiological barrier to the central nervous systems (CNS) remains elusive. The placental barrier and the blood brain barrier (BBB) protect the fetus from pathogens and ensure healthy brain development during pregnancy. In this study, we used human placenta trophoblasts cells (JEG-3) and human brain-derived endothelial cells (hCMEC/D3) as in vitro models of the physiological barriers. Results showed that ZIKV could infect JEG-3 cells effectively and reduce the amounts of ZO-1 and occludin between adjacent cells by the proteasomal degradation pathway, suggesting that the permeability of the barrier differentially changed in response to ZIKV infection, allowing the virus particle to cross the host barrier. In contrast, ZIKV could infect hCMEC/D3 cells without disrupting the BBB barrier permeability and tight junction protein expression. Although no disruption to the BBB was observed during ZIKV infection, ZIKV particles were released on the basal side of the BBB model and infected underlying cells. In addition, we observed that fluorescence-labeled ZIKV particles could cross the in vitro placenta barrier and BBB model by transcytosis and the action of transcytosis could be blocked by either low temperature or pharmacological inhibitors of endocytosis. In summary, the ZIKV uses a cell-type specific paracellular pathway to cross the placenta monolayer barrier by disrupting cellular tight junction. In addition, the ZIKV can also cross both the placenta barrier and the BBB by transcytosis. Our study provided new insights into on the mechanism of the cellular barrier penetration of ZIKV particles.
C1 [Chiu, Chi-Fen; Chu, Li-Wei; Liao, I-Chen; Ping, Yueh-Hsin] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei, Taiwan.
   [Simanjuntak, Yogy; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan.
   [Juan, Chi-Chang] Natl Yang Ming Univ, Dept & Inst Physiol, Taipei, Taiwan.
   [Ping, Yueh-Hsin] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan.
RP Ping, YH (corresponding author), Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei, Taiwan.; Ping, YH (corresponding author), Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan.
EM yhping@ym.edu.tw
OI Ping, Yueh-Hsin/0000-0003-2604-9913
FU Higher Education Sprout Project by the Ministry of Education (MOE) in
   Taiwan [107AC-D101, 107AC-D962]; Ministry of Science and Technology,
   TaiwanMinistry of Science and Technology, Taiwan [MOST
   106-2320-B-010-014, MOST 108-2320-B-010-031]; National Yang-Ming
   University -Far Eastern Memorial Hospital Joint Research Program
   [108DN01]
FX This work was supported by the Higher Education Sprout Project by the
   Ministry of Education (MOE) in Taiwan (107AC-D101 and 107AC-D962) to
   Y-HP, the research grants from the Ministry of Science and Technology,
   Taiwan (MOST 106-2320-B-010-014 and MOST 108-2320-B-010-031 to Y-HP),
   and the grant from the National Yang-Ming University -Far Eastern
   Memorial Hospital Joint Research Program (108DN01) to Y-HP.
CR Al-Obaidi MMJ, 2017, VIRUS RES, V233, P17, DOI 10.1016/j.virusres.2017.02.012
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Ayloo S, 2019, CURR OPIN NEUROBIOL, V57, P32, DOI 10.1016/j.conb.2018.12.014
   Bhat P, 2007, J VIROL, V81, P7200, DOI 10.1128/JVI.02371-06
   Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7
   Burton GJ, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0066
   Caine EA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110598
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Chu LW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194893
   Chu LW, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.1.011018
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412
   Daniels BP, 2015, CLIN PHARMACOL THER, V97, P372, DOI 10.1002/cpt.75
   Delorme-Axford E, 2014, ANNU REV VIROL, V1, P133, DOI 10.1146/annurev-virology-031413-085524
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   dos Santos T, 2016, NEW ENGL J MED, V375, P1598, DOI 10.1056/NEJMc1609015
   Fitzgerald B, 2018, JAMA-J AM MED ASSOC, V319, P1195, DOI 10.1001/jama.2018.0126
   Goasdoue K, 2017, PLACENTA, V54, P111, DOI 10.1016/j.placenta.2016.12.005
   Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038
   Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012
   Hoen B, 2018, NEW ENGL J MED, V378, P985, DOI 10.1056/NEJMoa1709481
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Leibrand CR, 2017, NEUROSCI LETT, V640, P136, DOI 10.1016/j.neulet.2016.12.073
   Liou ML, 1998, CELL TISSUE RES, V293, P389, DOI 10.1007/s004410051130
   Mateo M, 2015, J CELL SCI, V128, P431, DOI 10.1242/jcs.159400
   Mittal R, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00486
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Morad G, 2019, ACS NANO, V13, P13853, DOI 10.1021/acsnano.9b04397
   Mustafa YM, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00525
   Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646
   Papa MP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02557
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Roe K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102598
   Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0
   Rothbauer M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06364-z
   Sevvana M, 2018, STRUCTURE, V26, P1169, DOI 10.1016/j.str.2018.05.006
   Simister NE, 1997, J REPROD IMMUNOL, V37, P1, DOI 10.1016/S0165-0378(97)00068-5
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Soares CN, 2016, J CLIN VIROL, V83, P63, DOI 10.1016/j.jcv.2016.08.297
   Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210
   Tuma PL, 2003, PHYSIOL REV, V83, P871, DOI 10.1152/physrev.00001.2003
   Vu K, 2009, EUKARYOT CELL, V8, P1803, DOI 10.1128/EC.00240-09
   Zimmerman MG, 2018, CELL HOST MICROBE, V24, P731, DOI 10.1016/j.chom.2018.10.008
NR 45
TC 0
Z9 0
U1 8
U2 8
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-302X
J9 FRONT MICROBIOL
JI Front. Microbiol.
PD FEB 20
PY 2020
VL 11
AR 214
DI 10.3389/fmicb.2020.00214
PG 15
WC Microbiology
SC Microbiology
GA KT6MA
UT WOS:000519127300001
PM 32153526
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Sabino-Silva, R
   Jardim, ACG
   Siqueira, WL
AF Sabino-Silva, Robinson
   Jardim, Ana Carolina Gomes
   Siqueira, Walter L.
TI Coronavirus COVID-19 impacts to dentistry and potential salivary
   diagnosis
SO CLINICAL ORAL INVESTIGATIONS
LA English
DT Letter
ID RESPIRATORY SYNDROME CORONAVIRUS; ZIKA VIRUS
C1 [Sabino-Silva, Robinson; Siqueira, Walter L.] Univ Saskatchewan, Coll Dent, Saskatoon, SK, Canada.
   [Sabino-Silva, Robinson] Univ Fed Uberlandia, Inst Biomed Sci, Dept Physiol, Uberlandia, MG, Brazil.
   [Jardim, Ana Carolina Gomes] Univ Fed Uberlandia, Inst Biomed Sci, Lab Virol, Uberlandia, MG, Brazil.
RP Siqueira, WL (corresponding author), Univ Saskatchewan, Coll Dent, Saskatoon, SK, Canada.
EM walter.siqueira@usask.ca
RI Ribeiro, Nuno/AAH-2299-2020; Karabulut, Erman/G-6679-2011; Jardim, Ana
   Carolina Gomes/H-3615-2012
OI Karabulut, Erman/0000-0002-0787-905X; Jardim, Ana Carolina
   Gomes/0000-0002-6348-7923
FU Canadian Institutes of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR) [106657, 97577]; Royal Society-Newton Advanced
   Fellowship [NA 150195]; FAPEMIG (Minas Gerais Research Foundation)Minas
   Gerais State Research Foundation (FAPEMIG) [SICONV 793988/2013,
   APQ-02872-16, APQ-03385-18]; CNPq (National Counsel of Technological and
   Scientific Development)National Council for Scientific and Technological
   Development (CNPq) [311219/2019-5]; CNPqNational Council for Scientific
   and Technological Development (CNPq); CAPES (Coordination for the
   Improvement of Higher Education)CAPES; FAPEMIGMinas Gerais State
   Research Foundation (FAPEMIG) [CNPq-465669/2014-0]
FX This research was supported by the Canadian Institutes of Health
   Research (CIHR grant nos. 106657 and 97577). The authors received
   financial support from the Royal Society-Newton Advanced Fellowship
   (grant reference NA 150195) and FAPEMIG (Minas Gerais Research
   Foundation - SICONV 793988/2013; APQ-02872-16 and APQ-03385-18). ACGJ
   received productivity fellowship (311219/2019-5) from the CNPq (National
   Counsel of Technological and Scientific Development). The Brazilian
   funding agencies CNPq, CAPES (Coordination for the Improvement of Higher
   Education), and FAPEMIG provide financial support to the National
   Institute of Science and Technology in Theranostics and
   Nanobiotechnology - INCT-Teranano (CNPq-465669/2014-0).
CR [Anonymous], 2020, LANCET, V395, P311, DOI 10.1016/S0140-6736(20)30186-0
   Barzon L, 2016, EUROSURVEILLANCE, V21, P2, DOI 10.2807/1560-7917.ES.2016.21.10.30159
   Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9
   de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13
   European Centre for Disease Prevention and Control (ECDC), EUR SURV HUM INF NOV
   Group of Interventional Respiratory Medicine Chinese Thoracic Society, 2020, EXP CONS BRONCH EP 2, V43, pE006, DOI 10.3760/cma.j.issn.1001-0939.2020.0006
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Hui DSC, 2019, INFECT DIS CLIN N AM, V33, P869, DOI 10.1016/j.idc.2019.07.001
   Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781
   Liu L, 2011, J VIROL, V85, P4025, DOI 10.1128/JVI.02292-10
   Lu BJ, 2010, IMMUNOLOGY, V130, P254, DOI 10.1111/j.1365-2567.2010.03231.x
   Segal A, 2008, EUR J DENT EDUC, V12, P22, DOI 10.1111/j.1600-0579.2007.00477.x
   Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494
   Silva-Boghossian CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075898
   To Kelvin Kai-Wang, 2020, Clin Infect Dis, DOI 10.1093/cid/ciaa149
   Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585
   World Health Organization (WHO), 2020, GLOB SURV HUM INF NO
   World Health Organization-WHO, 2020, CHINA DIS OUTBR 0112
   Wu AP, 2020, CELL HOST MICROBE, V27, P325, DOI 10.1016/j.chom.2020.02.001
   Xie XJ, 2009, J R SOC INTERFACE, V6, pS703, DOI 10.1098/rsif.2009.0388.focus
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
   Zhu N, 2019, NEW ENGL J MED, DOI DOI 10.1056/NEJM0A2001017
   Zuanazzi D, 2017, J DENT RES, V96, P1078, DOI 10.1177/0022034517723325
NR 23
TC 23
Z9 23
U1 45
U2 45
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 1432-6981
EI 1436-3771
J9 CLIN ORAL INVEST
JI Clin. Oral Investig.
PD APR
PY 2020
VL 24
IS 4
BP 1619
EP 1621
DI 10.1007/s00784-020-03248-x
EA FEB 2020
PG 3
WC Dentistry, Oral Surgery & Medicine
SC Dentistry, Oral Surgery & Medicine
GA KY6FO
UT WOS:000516286500001
PM 32078048
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU He, XE
   Lang, XY
   Yu, JH
   Zhu, L
   Qin, ZR
   Liu, XL
   Chen, P
   Dai, CGQ
   Chen, TT
   Li, XJ
   Chen, YY
   Zhou, DR
   Fang, WY
   Xiao, WW
   Zhang, B
   Xie, Q
   Wu, QH
   Zhao, W
AF He, Xiaoen
   Lang, Xinyue
   Yu, Jianhai
   Zhu, Li
   Qin, Zhiran
   Liu, Xuling
   Chen, Pei
   Dai, Chengguqiu
   Chen, Tingting
   Li, Xujuan
   Chen, Yangyang
   Zhou, Dongrui
   Fang, Wanyi
   Xiao, Weiwei
   Zhang, Bao
   Xie, Qian
   Wu, Qinghua
   Zhao, Wei
TI The effects of Japanese encephalitis virus antibodies on Zika virus
   infection
SO MEDICAL MICROBIOLOGY AND IMMUNOLOGY
LA English
DT Article
DE Zika virus; Japanese encephalitis virus antibody; Antibody-dependent
   enhancement(ADE); Neutralisation
ID WEST-NILE-VIRUS; DENGUE VIRUS; MEDIATED NEUTRALIZATION; DEPENDENT
   ENHANCEMENT; MONOCLONAL-ANTIBODY; CROSS-REACTIVITY; MAINLAND CHINA;
   FLAVIVIRUSES; VACCINE; SERA
AB Recently, Zika virus (ZIKV) has become more widespread, thus attracting global attention. The vaccine against Japanese encephalitis virus (JEV) is currently used in China, being included in planned immunisation regimes. Although ZIKV and JEV are closely related mosquito-borne Flaviviruses, and a complex cross-immune response within flaviviruses has been demonstrated, the effect of JEV vaccination on ZIKV infection has not been well described. Thus, this study aimed to explore the impact of different titres of anti-JEV antibodies (Abs) against ZIKV infection using sera from healthy human donors in Guangzhou and anti-JEV rabbit polyclonal antibodies (pAbs) in vitro and vivo. Human anti-JEV Ab titres were tested at decreasing concentrations as the age increased. A neutralising effect on ZIKV infection was observed when anti-JEV Ab titres in human sera or rabbit pAbs were high (the corresponding age was under 30 years). Even though a lower titre in human sera showed no apparent effect, whereas rabbit pAbs had an antibody-dependent enhancement(ADE)effect, we proved an ADE effect in vivo for the first time. This study suggests that individuals over 60 years of age are at high risk for JEV and ZIKV infection, and screening this age group for infection should strengthen. Furthermore, a deep exploration of the relationship between anti-JEV Abs and ZIKV infection is needed.
C1 [He, Xiaoen; Lang, Xinyue; Yu, Jianhai; Zhu, Li; Qin, Zhiran; Liu, Xuling; Chen, Pei; Dai, Chengguqiu; Chen, Tingting; Li, Xujuan; Chen, Yangyang; Zhou, Dongrui; Fang, Wanyi; Xiao, Weiwei; Zhang, Bao; Xie, Qian; Wu, Qinghua; Zhao, Wei] Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Peoples R China.
   [Wu, Qinghua; Zhao, Wei] Southern Med Univ, Sch Pharm, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Guangzhou 510515, Peoples R China.
RP Wu, QH; Zhao, W (corresponding author), Southern Med Univ, Sch Publ Hlth, Guangdong Prov Key Lab Trop Dis Res, Guangzhou 510515, Peoples R China.; Wu, QH; Zhao, W (corresponding author), Southern Med Univ, Sch Pharm, Guangzhou Key Lab Drug Res Emerging Virus Prevent, Guangzhou 510515, Peoples R China.
EM hexiaoen24@163.com; 443606623@qq.com; chienhai@163.com; zhuli89@126.com;
   baobaofei666666@outlook.com; maiblume@163.com; 1243176588@qq.com;
   854635381@qq.com; 214960734@qq.com; murong816@outlook.com;
   sanjinchunqiu@163.com; xinggui2012@gmail.com; fwy0713@163.com;
   xweiwei74@126.com; zhangb@smu.edu.cn; xiyuxie89@126.com;
   wuqh@smu.edu.cn; zhaowei@smu.edu.cn
OI Zhou, Dongrui/0000-0003-1776-6582
FU National Key R and D Program of China [2018YFC1602206]; National Natural
   Science Foundation of ChinaNational Natural Science Foundation of China
   [31470271, 81730110]; Guangdong and Guangzhou Science and Technology
   Program key projects [2018B020207006, 201803040006]; special fund for
   science and technology innovation cultivation of Guangdong university
   students in 2018 Climbing Program [pdjhb0103]
FX This research was funded by the National Key R and D Program of China
   (grant no. 2018YFC1602206), National Natural Science Foundation of China
   (Grant no. 31470271, 81730110), Guangdong and Guangzhou Science and
   Technology Program key projects (Grant no. 2018B020207006 and
   201803040006) and special fund for science and technology innovation
   cultivation of Guangdong university students in 2018 Climbing Program
   (pdjhb0103).
CR Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bhaumik SK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010019
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Charles A. S., 2016, PLOS CURR, V8, P97
   Chen J, 2016, MOL MED REP, V14, P1799, DOI 10.3892/mmr.2016.5454
   Chen LM, 2017, ANTIVIR RES, V141, P140, DOI 10.1016/j.antiviral.2017.02.009
   Chokephaibulkit K, 2016, VACCINE, V34, P5664, DOI 10.1016/j.vaccine.2016.09.018
   Dai LP, 2016, IUBMB LIFE, V68, P783, DOI 10.1002/iub.1556
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng WL, 2014, VIRUS RES, V179, P133, DOI 10.1016/j.virusres.2013.10.022
   FAGBAMI A, 1988, AM J TROP MED HYG, V38, P205, DOI 10.4269/ajtmh.1988.38.205
   FAGBAMI A H, 1986, African Journal of Medicine and Medical Sciences, V15, P103
   FAGBAMI AH, 1987, CYTOBIOS, V49, P49
   Gao XY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003015
   Gu WH, 2015, J GEN VIROL, V96, P1712, DOI 10.1099/vir.0.000118
   HALSTEAD SB, 1977, J EXP MED, V146, P201, DOI 10.1084/jem.146.1.201
   Heinz FX, 2012, J CLIN VIROL, V55, P289, DOI 10.1016/j.jcv.2012.08.024
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Kanesa-Thasan N, 2002, AM J TROP MED HYG, V66, P115, DOI 10.4269/ajtmh.2002.66.115
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Li JQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19953
   Li X, 2014, HUM VACC IMMUNOTHER, V10, P3579, DOI 10.4161/21645515.2014.980197
   Luo L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0352-9
   Ma ZY, 2017, CELL MOL IMMUNOL, V14, P997, DOI 10.1038/cmi.2017.43
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   Moi ML, 2013, T ROY SOC TROP MED H, V107, P51, DOI 10.1093/trstmh/trs007
   Monath TP, 2002, AM J TROP MED HYG, V66, P113, DOI 10.4269/ajtmh.2002.66.113
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Pan JR, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004936
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Paul LM, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.72
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12700
   Raboni SM, 2017, TRANSPL INFECT DIS, V19, DOI 10.1111/tid.12719
   Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8
   Saokaew N, 2014, LETT APPL MICROBIOL, V58, P270, DOI 10.1111/lam.12186
   Sariol CA, 2018, TRENDS MICROBIOL, V26, P186, DOI 10.1016/j.tim.2017.10.004
   Smith DR, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005296
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06
   Takasaki T, 2003, VACCINE, V21, P4514, DOI 10.1016/S0264-410X(03)00507-3
   Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Xiong Yiquan, 2014, Nan Fang Yi Ke Da Xue Xue Bao, V34, P1822
   Yang L, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.57
   Zhang XC, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110338
   Zhou Y, 2013, VIROLOGY, V439, P57, DOI 10.1016/j.virol.2013.01.022
NR 50
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0300-8584
EI 1432-1831
J9 MED MICROBIOL IMMUN
JI Med. Microbiol. Immunol.
PD APR
PY 2020
VL 209
IS 2
BP 177
EP 188
DI 10.1007/s00430-020-00658-2
EA FEB 2020
PG 12
WC Immunology; Microbiology
SC Immunology; Microbiology
GA KZ3FB
UT WOS:000516424700001
PM 32078028
DA 2020-07-08
ER

PT J
AU Lai, ZZ
   Ho, YJ
   Lu, JW
AF Lai, Zheng-Zong
   Ho, Yi-Jung
   Lu, Jeng-Wei
TI Cephalotaxine inhibits Zika infection by impeding viral replication and
   stability
SO BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
LA English
DT Article
DE Antiviral; Cephalotaxine; Viral production; Replication; Dengue virus;
   Zika virus
ID CHIKUNGUNYA VIRUS; HOMOHARRINGTONINE; AMERICA; SCREEN; BRAZIL
AB The Zika virus (ZIKV) is a mosquito-borne flavivirus that has reemerged as a serious public health problem around the world. Syndromes of infected people range from asymptomatic infections to severe neurological disorders, such as Guillain-Barre syndrome and microcephaly. Screening anti-ZIKV drugs derived from Chinese medicinal herbs is one method of identifying antiviral agents. In this paper, we report that (1) Cephalotaxine (CET), an alkaloid isolated from Cephalotaxus drupacea, was effective in inhibiting ZIKV activity in vitro (i.e., in Vero and A549 cell lines) and (2) the mechanisms which underlie these effects involve virucidal activity and a decrease in viral replication. Specifically, CET was found to decrease ZIKV RNA and viral protein expression, inhibit ZIKV replication, and inhibit ZIKV mRNA/protein production. We also determined that CET is effective in inhibiting dengue virus 1-4 (DENV1-4). Taken together, our findings indicate that CET could be an effective lead compound in the treatment of ZIKV and also suggest that further investigation and development of CET-derived drugs may lead to a new class of anti-Flavivirus medications. (C) 2019 Elsevier Inc. All rights reserved.
C1 [Lai, Zheng-Zong] Natl Def Med Ctr, Dept & Grad Inst Pharmacol, Taipei, Taiwan.
   [Lai, Zheng-Zong] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pharm Practice, Taipei, Taiwan.
   [Lai, Zheng-Zong] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan.
   [Ho, Yi-Jung] Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.
   [Ho, Yi-Jung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.
   [Lu, Jeng-Wei] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
RP Ho, YJ (corresponding author), Natl Def Med Ctr, Sch Pharm, Taipei, Taiwan.; Lu, JW (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.
EM jengweilu@gmail.com
FU Ministry of Science and Technology at Taiwan [MOST 107-2320-B-016-006-,
   MOST 108-2320-B-016 -011 -MY2]; Ministry of National Defense at Taiwan
   [MAB-108-061]
FX The authors' work was supported in part by grants from the Ministry of
   Science and Technology (MOST 107-2320-B-016-006-and MOST 108-2320-B-016
   -011 -MY2), and the grants from Ministry of National Defense
   (MAB-108-061) at Taiwan.
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Agbulos D.S., 2016, CURR PROTOC MICROBIO, V43
   [Anonymous], 2016, Wkly Epidemiol Rec, V91, P73
   Batista MN, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010049
   Cao JZ, 2015, ANTIVIR RES, V114, P1, DOI 10.1016/j.antiviral.2014.11.010
   Chen JL, 2017, CELL REP, V21, P1588, DOI 10.1016/j.celrep.2017.10.059
   Chibueze EC, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0285-6
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Efferth T, 2003, N-S ARCH PHARMACOL, V367, P56, DOI 10.1007/s00210-002-0632-0
   Espano E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47956-1
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   FRESNO M, 1977, EUR J BIOCHEM, V72, P323, DOI 10.1111/j.1432-1033.1977.tb11256.x
   Hennessey M, 2016, MMWR-MORBID MORTAL W, V65, P55, DOI 10.15585/mmwr.mm6503e1
   Ho YJ, 2019, BIOCHEM BIOPH RES CO, V518, P732, DOI 10.1016/j.bbrc.2019.08.120
   Ho YJ, 2018, ANTIVIR RES, V159, P134, DOI 10.1016/j.antiviral.2018.10.005
   HUANG MT, 1975, MOL PHARMACOL, V11, P511
   Jia KT, 2018, MAR BIOTECHNOL, V20, P35, DOI 10.1007/s10126-017-9785-1
   Kaur P, 2013, ANTIMICROB AGENTS CH, V57, P155, DOI 10.1128/AAC.01467-12
   Kim JE, 2019, J MICROBIOL, V57, P74, DOI 10.1007/s12275-019-8514-z
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   Lee JL, 2019, ANTIVIR RES, V167, P13, DOI 10.1016/j.antiviral.2019.04.003
   Lu JW, 2017, BIOCHEM BIOPH RES CO, V491, P595, DOI 10.1016/j.bbrc.2017.07.157
   Lu SQ, 2014, J HEMATOL ONCOL, V7, DOI 10.1186/1756-8722-7-2
   Perard-Viret J, 2017, ALKALOIDS-CHEM BIOL, V78, P205, DOI 10.1016/bs.alkal.2017.07.001
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Romero MR, 2007, PLANTA MED, V73, P552, DOI 10.1055/s-2007-967184
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Zammarchi L, 2015, J CLIN VIROL, V63, P32, DOI 10.1016/j.jcv.2014.12.005
   Zhou DC, 1995, B CANCER, V82, P987
NR 30
TC 1
Z9 1
U1 3
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0006-291X
EI 1090-2104
J9 BIOCHEM BIOPH RES CO
JI Biochem. Biophys. Res. Commun.
PD FEB 19
PY 2020
VL 522
IS 4
BP 1052
EP 1058
DI 10.1016/j.bbrc.2019.12.012
PG 7
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA LB5XZ
UT WOS:000524710200037
PM 31818462
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Bugert, JJ
   Hucke, F
   Zanetta, P
   Bassetto, M
   Brancale, A
AF Bugert, J. J.
   Hucke, F.
   Zanetta, P.
   Bassetto, M.
   Brancale, A.
TI Antivirals in medical biodefense
SO VIRUS GENES
LA English
DT Review
DE Medical biodefense; Antiviral; BSL3; 4 viral pathogens
ID CHIKUNGUNYA VIRUS-INFECTION; CONGO HEMORRHAGIC-FEVER; HUMAN
   INFLUENZA-VIRUSES; INHIBITS ZIKA VIRUS; IN-VITRO; FAVIPIRAVIR T-705;
   VACCINIA-VIRUS; EBOLA-VIRUS; EFFICACY; RIBAVIRIN
AB The viruses historically implicated or currently considered as candidates for misuse in bioterrorist events are poxviruses, filoviruses, bunyaviruses, orthomyxoviruses, paramyxoviruses and a number of arboviruses causing encephalitis, including alpha- and flaviviruses. All these viruses are of concern for public health services when they occur in natural outbreaks or emerge in unvaccinated populations. Recent events and intelligence reports point to a growing risk of dangerous biological agents being used for nefarious purposes. Public health responses effective in natural outbreaks of infectious disease may not be sufficient to deal with the severe consequences of a deliberate release of such agents. One important aspect of countermeasures against viral biothreat agents are the antiviral treatment options available for use in post-exposure prophylaxis. These issues were adressed by the organizers of the 16th Medical Biodefense Conference, held in Munich in 2018, in a special session on the development of drugs to treat infections with viruses currently perceived as a threat to societies or associated with a potential for misuse as biothreat agents. This review will outline the state-of-the-art methods in antivirals research discussed and provide an overview of antiviral compounds in the pipeline that are already approved for use or still under development.
C1 [Bugert, J. J.; Hucke, F.; Zanetta, P.] Bundeswehr Inst Microbiol, Neuherbergstr 11, D-80937 Munich, Germany.
   [Bassetto, M.] Swansea Univ, Dept Chem, Swansea SA2 8PP, W Glam, Wales.
   [Brancale, A.] Cardiff Univ, Sch Pharm & Pharmaceut Sci, Med Chem, Cardiff CF10 3NB, Wales.
RP Bugert, JJ (corresponding author), Bundeswehr Inst Microbiol, Neuherbergstr 11, D-80937 Munich, Germany.
EM Joachim1Bugert@bundeswehr.org
RI Zanetta, Paola/AAE-2801-2019; Bassetto, Marcella/F-7998-2016
OI Zanetta, Paola/0000-0001-8547-3090; Bassetto,
   Marcella/0000-0002-2491-5868
FU STAN [59-2016-01]
FX Funding was provided by Bundeswehr (Grant No. STAN 59-2016-01).
CR Abdelnabi R, 2018, ANTIVIR RES, V149, P113, DOI 10.1016/j.antiviral.2017.09.016
   Abdelnabi R, 2017, J VIROL, V91, DOI 10.1128/JVI.00487-17
   Abdelnabi R, 2015, ANTIVIR RES, V121, P59, DOI 10.1016/j.antiviral.2015.06.017
   Ahmed A, 2019, ANTIVIR RES, V164, P61, DOI 10.1016/j.antiviral.2019.02.002
   Altmann SE, 2012, ANTIVIR RES, V93, P305, DOI 10.1016/j.antiviral.2011.12.001
   Galvao MGA, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002745.pub4
   Aman MJ, 2009, ANTIVIR RES, V83, P245, DOI 10.1016/j.antiviral.2009.06.001
   Ang BSP, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01875-17
   Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1321
   Bassetto M, 2013, ANTIVIR RES, V98, P12, DOI 10.1016/j.antiviral.2013.01.002
   Baz M, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10110610
   Beineke A, 2015, ONE HEALTH, V1, P49, DOI 10.1016/j.onehlt.2015.09.002
   Bichon A, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000009154
   Bixler SL, 2018, ANTIVIR RES, V151, P50, DOI 10.1016/j.antiviral.2017.12.020
   Bixler SL, 2018, ANTIVIR RES, V151, P97, DOI 10.1016/j.antiviral.2017.12.021
   Bray M, 2003, ANTIVIR RES, V57, P53, DOI 10.1016/S0166-3542(02)00200-0
   Bray M, 2002, ANTIVIR RES, V54, P1, DOI 10.1016/S0166-3542(02)00005-0
   Bugert JJ, 1999, NEPHROL DIAL TRANSPL, V14, P1843, DOI 10.1093/ndt/14.8.1843
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Callaway E, 2019, NATURE, V575, P425, DOI 10.1038/d41586-019-03490-8
   Cannalire R, 2019, ANTIVIR RES, V167, P6, DOI 10.1016/j.antiviral.2019.03.004
   Caroline AL, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002790
   Chan JFW, 2018, ANTIVIR RES, V160, P38, DOI 10.1016/j.antiviral.2018.10.007
   Chan JFW, 2017, ANTIVIR RES, V141, P29, DOI 10.1016/j.antiviral.2017.02.002
   Chang JH, 2013, ANTIVIR RES, V98, P432, DOI 10.1016/j.antiviral.2013.03.023
   Chittick G, 2017, ANTIVIR RES, V143, P269, DOI 10.1016/j.antiviral.2017.01.009
   Cryer M, 2017, PHARM BIOL, V55, P1586, DOI 10.1080/13880209.2017.1310907
   Dahl, 1986, MEASLES DANGEROUS IL
   Dawes BE, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25780-3
   De Burghgraeve T, 2013, ANTIVIR RES, V98, P242, DOI 10.1016/j.antiviral.2013.01.011
   De Clercq E, 2002, ANTIVIR RES, V55, P1, DOI 10.1016/S0166-3542(02)00008-6
   De Clercq E, 2016, CLIN MICROBIOL REV, V29, P695, DOI 10.1128/CMR.00102-15
   de Freitas CS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007072
   Delang L, 2018, ANTIVIR RES, V153, P85, DOI 10.1016/j.antiviral.2018.03.003
   Delaune D, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10010003
   Dixon David, 2005, NEVER COME PEACE PON
   Dyer O, 2019, BMJ-BRIT MED J, V365, DOI 10.1136/bmj.l4062
   European Center for Disease Control (ECDC), 2016, HANT INF ANN EP REP
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Ferreira AC, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.01389-18
   Ferreira-Ramos AS, 2019, ANTIVIR RES, V163, P59, DOI 10.1016/j.antiviral.2019.01.003
   Osuna-Ramos JF, 2018, ANTIVIR RES, V160, P151, DOI 10.1016/j.antiviral.2018.10.024
   Fields B.N., 2013, FIELDS VIROLOGY
   Forrester NL, 2012, J VIROL, V86, P2729, DOI 10.1128/JVI.05591-11
   Foster SA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9110320
   Franco Evelyn J., 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618807580
   Fraser-bell CJ, 2019, GLOB BIOSECUR, DOI [10.31646/gbio.43, DOI 10.31646/GBIO.43]
   FREESTONE DS, 1985, ANTIVIR RES, V5, P307, DOI 10.1016/0166-3542(85)90001-4
   Furuta Y, 2002, ANTIMICROB AGENTS CH, V46, P977, DOI 10.1128/AAC.46.4.977-981.2002
   Furuta Y, 2017, P JPN ACAD B-PHYS, V93, P449, DOI 10.2183/pjab.93.027
   Garcia-Nicolas O, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01206-18
   Garske T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001638
   Goldhill DH, 2018, P NATL ACAD SCI USA, V115, P11613, DOI 10.1073/pnas.1811345115
   Gowen BB, 2008, ANTIVIR RES, V78, P79, DOI 10.1016/j.antiviral.2007.10.002
   Gowen BB, 2010, ANTIVIR RES, V86, P121, DOI 10.1016/j.antiviral.2009.10.015
   Grosenbach DW, 2018, NEW ENGL J MED, V379, P44, DOI [10.1056/nejmoa1705688, 10.1056/NEJMoa1705688]
   Grossi IM, 2017, ANTIVIR RES, V143, P278, DOI 10.1016/j.antiviral.2017.04.002
   Gubareva LV, 2017, ANTIVIR RES, V146, P12, DOI 10.1016/j.antiviral.2017.08.004
   Guerrero NAS, 2018, ANTIVIR RES, V160, P137, DOI 10.1016/j.antiviral.2018.10.026
   Hawley RJ, 2001, ANNU REV MICROBIOL, V55, P235, DOI 10.1146/annurev.micro.55.1.235
   Hawman DW, 2018, ANTIVIR RES, V157, P18, DOI 10.1016/j.antiviral.2018.06.013
   HAY AJ, 1985, EMBO J, V4, P3021, DOI 10.1002/j.1460-2075.1985.tb04038.x
   Holcakova Jitka, 2010, Antiviral Chemistry & Chemotherapy, V20, P133, DOI 10.3851/IMP1460
   Holzmann H, 2016, MED MICROBIOL IMMUN, V205, P201, DOI 10.1007/s00430-016-0451-4
   Hotard AL, 2017, ANTIVIR RES, V144, P147, DOI 10.1016/j.antiviral.2017.06.011
   Huggins J, 1999, J INFECT DIS, V179, pS240, DOI 10.1086/514316
   HUGGINS JW, 1989, REV INFECT DIS, V11, pS750
   Hwang J, 2019, ANTIVIR RES, V161, P163, DOI 10.1016/j.antiviral.2018.11.017
   Ippolito G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-31
   Jabbari A, 2012, CASP J INTERN MED, V3, P443
   Jeulin H, 2009, ANTIVIR RES, V81, P261, DOI 10.1016/j.antiviral.2008.12.006
   Johnson S, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012713.pub2
   Jonsson CB, 2008, ANTIVIR RES, V78, P162, DOI 10.1016/j.antiviral.2007.10.012
   Jonsson CB, 2019, ANTIVIR RES, V167, P25, DOI 10.1016/j.antiviral.2019.04.004
   Kachko A, 2018, J VIROL, V92, DOI 10.1128/JVI.01742-17
   Kalbermatter D, 2019, VIRUS RES, V259, P28, DOI 10.1016/j.virusres.2018.10.003
   Kim JA, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020072
   Klempa B, 2003, J CLIN MICROBIOL, V41, P4894, DOI 10.1128/JCM.41.10.4894-4897.2003
   Koban R, 2018, ANTIVIR RES, V150, P20, DOI 10.1016/j.antiviral.2017.12.005
   Koksal I, 2010, J CLIN VIROL, V47, P65, DOI 10.1016/j.jcv.2009.11.007
   Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470
   Koszalka P, 2019, ANTIVIR RES, V164, P91, DOI 10.1016/j.antiviral.2019.02.007
   Krumm SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008517
   Kuo SC, 2016, ANTIVIR RES, V134, P89, DOI 10.1016/j.antiviral.2016.07.025
   La Frazia S, 2018, ANTIVIR RES, V157, P159, DOI 10.1016/j.antiviral.2018.06.008
   Lam SK, 2003, ANTIVIR RES, V57, P113, DOI 10.1016/S0166-3542(02)00204-8
   Levi LI, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7050133
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Lieberherr C, 2017, PLANTA MED, V83, P232, DOI 10.1055/s-0042-111825
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   Luby SP, 2013, ANTIVIR RES, V100, P38, DOI 10.1016/j.antiviral.2013.07.011
   Lundberg L, 2018, ANTIVIR RES, V157, P57, DOI 10.1016/j.antiviral.2018.07.005
   Madu IG, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007439
   MALINOSKI FJ, 1990, ANTIVIR RES, V13, P139, DOI 10.1016/0166-3542(90)90029-7
   Marano G, 2017, BLOOD TRANSFUS-ITALY, V15, P489, DOI 10.2450/2017.0215-17
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   Matusali G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020175
   Mazzon M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020176
   MCCORMICK JB, 1986, NEW ENGL J MED, V314, P20, DOI 10.1056/NEJM198601023140104
   McGuigan C, 2013, J MED CHEM, V56, P1311, DOI 10.1021/jm301778x
   McGuigan C, 2010, BIOORG MED CHEM LETT, V20, P4850, DOI 10.1016/j.bmcl.2010.06.094
   Mercer J, 2009, NAT CELL BIOL, V11, P510, DOI 10.1038/ncb0509-510
   Milligan GN, 2018, ANTIVIR RES, V154, P104, DOI 10.1016/j.antiviral.2018.04.012
   Mohr EL, 2015, ANTIVIR RES, V120, P40, DOI 10.1016/j.antiviral.2015.05.003
   Monath TP, 2008, ANTIVIR RES, V78, P116, DOI 10.1016/j.antiviral.2007.10.009
   Mucker EM, 2013, ANTIMICROB AGENTS CH, V57, P6246, DOI 10.1128/AAC.00977-13
   Mumtaz N, 2017, ANTIVIR RES, V146, P161, DOI 10.1016/j.antiviral.2017.09.004
   Nannetti G, 2019, ANTIVIR RES, V165, P55, DOI 10.1016/j.antiviral.2019.03.003
   NATO AMed p-6, 1996, HDB MED ASP NUCL B 2
   Nelson DR, 2012, ANN HEPATOL, V11, P15, DOI 10.1016/S1665-2681(19)31482-6
   Nolte J, 2016, DZIF ANN M 24 26 NOV
   Noshi T, 2018, ANTIVIR RES, V160, P109, DOI 10.1016/j.antiviral.2018.10.008
   Nuth M, 2019, ANTIVIR RES, V162, P178, DOI 10.1016/j.antiviral.2018.12.011
   Olschlager S, 2011, ANTIVIR RES, V91, P89, DOI 10.1016/j.antiviral.2011.05.006
   Oo A, 2018, ANTIVIR RES, V150, P101, DOI 10.1016/j.antiviral.2017.12.012
   Parker S, 2008, ANTIVIR RES, V77, P39, DOI 10.1016/j.antiviral.2007.08.003
   Parker S, 2014, ANTIVIR RES, V111, P42, DOI 10.1016/j.antiviral.2014.08.003
   Petersen E, 2019, INFECT DIS CLIN N AM
   Pires MA, 2018, ANTIVIR RES, V152, P36, DOI 10.1016/j.antiviral.2018.02.005
   Pollara JJ, 2010, ANTIVIR RES, V88, P287, DOI 10.1016/j.antiviral.2010.09.017
   Quick J, 2016, NATURE, V530, P228, DOI 10.1038/nature16996
   Ravichandran R, 2008, J INFECT DEV COUNTR, V2, P140, DOI 10.3855/T2.2.140
   Reeves PM, 2005, NAT MED, V11, P1361, DOI 10.1038/nm1205-1361b
   Reeves PM, 2005, NAT MED, V11, P731, DOI 10.1038/nm1265
   Robert MA, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.05.003
   Rosenke K, 2018, EMERG INFECT DIS, V24, P1696, DOI 10.3201/eid2409.180233
   Rothan HA, 2016, ANTIVIR RES, V127, P50, DOI 10.1016/j.antiviral.2016.01.006
   Schmidt-Chanasit J, 2010, J VIROL, V84, P459, DOI 10.1128/JVI.01226-09
   Sheahan Timothy P, 2020, Nat Commun, V11, P222, DOI 10.1038/s41467-019-13940-6
   Sheahan TP, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal3653
   Singh R, 2018, INDIAN J MED PAEDIAT, V39, P1, DOI 10.4103/ijmpo.ijmpo_12_17
   Slusarczyk Magdalena, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618775243
   Smee DF, 2003, ANTIVIR RES, V57, P41, DOI 10.1016/S0166-3542(02)00199-7
   Smee DF, 2018, ANTIVIR RES, V160, P48, DOI 10.1016/j.antiviral.2018.10.013
   Smith D. R., 2010, VIRUS ADAPTATION TRE, V2, P9, DOI [10.2147/vaat.s6903, DOI 10.2147/VAAT.S6903]
   Taylor R, 2016, J INFECT PUBLIC HEAL, V9, P220, DOI 10.1016/j.jiph.2016.04.002
   Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326
   Tilmanis D, 2017, ANTIVIR RES, V147, P142, DOI 10.1016/j.antiviral.2017.10.002
   Trost LC, 2015, ANTIVIR RES, V117, P115, DOI 10.1016/j.antiviral.2015.02.007
   VANEEDEN PJ, 1985, S AFR MED J, V68, P718
   Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012
   WALTON TE, 1988, ARBOVIRUSES EPIDEMIO
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Warren TK, 2014, NATURE, V508, P402, DOI 10.1038/nature13027
   Westover JB, 2018, ANTIVIR RES, V156, P38, DOI 10.1016/j.antiviral.2018.05.013
   Whitehouse ER, 2019, MMWR-MORBID MORTAL W, V68, P943, DOI 10.15585/mmwr.mm6842a2
   WHO, 2019, UPD EB DRUG TRAIL
   WHO, 2016, LASS FEV GERM
   WHO, 2012, WHO ROADMAP NECTECTE
   WHO, 2018, GLOB STRAT EL YELL F
   Yakimovich A, 2017, J VIROL, V91, DOI 10.1128/JVI.00838-17
   Yoon JJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00766-18;e00766-18
   Zanetta P, 2019, THESIS
   Zhou Y, 2015, ANTIVIR RES, V116, P76, DOI 10.1016/j.antiviral.2015.01.011
NR 154
TC 1
Z9 1
U1 6
U2 6
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0920-8569
EI 1572-994X
J9 VIRUS GENES
JI Virus Genes
PD APR
PY 2020
VL 56
IS 2
BP 150
EP 167
DI 10.1007/s11262-020-01737-5
EA FEB 2020
PG 18
WC Genetics & Heredity; Virology
SC Genetics & Heredity; Virology
GA KW7AM
UT WOS:000516248600001
PM 32076918
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Dallimore, T
   Goodson, D
   Batke, S
   Strode, C
AF Dallimore, Thom
   Goodson, David
   Batke, Sven
   Strode, Clare
TI A potential global surveillance tool for effective, low-cost sampling of
   invasive Aedes mosquito eggs from tyres using adhesive tape
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Aedes albopictus; AIMs; Mosquito; Surveillance; Eggs;
   Tyres; Dengue; Zika
ID ALBOPICTUS DIPTERA-CULICIDAE; AUTOCHTHONOUS DENGUE-FEVER; STEGOMYIA
   ALBOPICTUS; MOLECULAR-IDENTIFICATION; MULTIPLEX PCR; LUCKY BAMBOO; ZIKA
   VIRUS; AEGYPTI; DISPERSAL; CHIKUNGUNYA
AB Background The international movement of used tyres is a major factor responsible for global introductions of Aedes invasive mosquitoes (AIMs) (Diptera: Culicidae) that are major disease vectors (e.g. dengue, Zika, chikungunya and yellow fever). Surveillance methods are restricted by expense, availability and efficiency to detect all life stages. Currently, no tested method exists to screen imported used tyres for eggs in diapause, the life stage most at risk from accidental introduction. Here we test the efficiency of adhesive tape as an affordable and readily available material to screen tyres for eggs, testing its effect on hatch rate, larval development, DNA amplification and structural damage on the egg surface. Results We demonstrated that the properties of adhesive tape can influence pick up of dormant eggs attached to dry surfaces. Tapes with high levels of adhesion, such as duct tape, removed eggs with high levels of efficiency (97% +/- 3.14). Egg numbers collected from cleaned used tyres were found to explain larval hatch rate success well, particularly in subsequent larval to adult emergence experiments. The strength of this relationship decreased when we tested dirty tyres. Damage to the exochorion was observed following scanning electron microscopy (SEM), possibly resulting in the high variance in the observed model. We found that five days was the optimal time for eggs to remain on all tested tapes for maximum return on hatch rate success. Tape type did not inhibit amplification of DNA of eggs from three, five or ten days of exposure. Using this DNA, genotyping of AIMs was possible using species-specific markers. Conclusions We demonstrated for the first time that adhesive tapes are effective at removing AIM eggs from tyres. We propose that this method could be a standardised tool for surveillance to provide public health authorities and researchers with an additional method to screen tyre cargo. We provide a screening protocol for this purpose. This method has a global applicability and in turn can lead to increased predictability of introductions and improve screening methods at high risk entry points.
C1 [Dallimore, Thom; Goodson, David; Batke, Sven; Strode, Clare] Edge Hill Univ, Dept Biol, St Helens Rd, Ormskirk L39 4QP, Lancs, England.
RP Strode, C (corresponding author), Edge Hill Univ, Dept Biol, St Helens Rd, Ormskirk L39 4QP, Lancs, England.
EM Strodecl@edgehill.ac.uk
FU Edge Hill University's 'Research Investment Fund' [RDSTRO15]
FX The work was funded by Edge Hill University's 'Research Investment Fund'
   (RDSTRO15).
CR BECKEL W. E., 1958, CANADIAN JOUR ZOOL, V36, P541, DOI 10.1139/z58-050
   Becker N, 2013, PARASITOL RES, V112, P1787, DOI 10.1007/s00436-012-3230-1
   Beebe NW, 2007, J MED ENTOMOL, V44, P376, DOI 10.1603/0022-2585(2007)44[376:APCRDT]2.0.CO;2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bosworth AB, 1998, J AM MOSQUITO CONTR, V14, P46
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Brown JE, 2011, EMERG INFECT DIS, V17, P2335, DOI 10.3201/eid1712.110992
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Carabali M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1058-x
   Carroll MJ, 2011, GLOBAL CHANGE BIOL, V17, P2991, DOI 10.1111/j.1365-2486.2011.02416.x
   Christophers R, 1960, AEDES AEGYPTI L YELL
   Clements A.N., 1992, BIOL MOSQUITOES DEV
   Cook S, 2005, J MED ENTOMOL, V42, P19, DOI 10.1603/0022-2585(2005)042[0019:MMFMIO]2.0.CO;2
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Dallimore T, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2251-0
   Das B, 2012, TROP MED INT HEALTH, V17, P235, DOI 10.1111/j.1365-3156.2011.02899.x
   Demeulemeester Julie, 2014, Journal of the European Mosquito Control Association, V32, P14
   Doosti S, 2016, IRAN J PUBLIC HEALTH, V45, P1064
   ECDC, 2012, GUID SURV INV MOSQ E
   Eritja R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12652-5
   Farnesi LC, 2015, J INSECT PHYSIOL, V83, P43, DOI 10.1016/j.jinsphys.2015.10.006
   Gatherer D, 2016, J GEN VIROL, V97, P269, DOI 10.1099/jgv.0.000381
   Goubert C, 2017, MOL ECOL, V26, P3968, DOI 10.1111/mec.14184
   Gould EA, 2010, CLIN MICROBIOL INFEC, V16, P1702, DOI 10.1111/j.1469-0691.2010.03386.x
   Grubaugh ND, 2018, CELL, V172, P1160, DOI 10.1016/j.cell.2018.02.027
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Higa Y, 2010, JPN J INFECT DIS, V63, P312
   Hill LA, 2008, AM J TROP MED HYG, V79, P866, DOI 10.4269/ajtmh.2008.79.866
   Hofhuis A, 2009, VECTOR-BORNE ZOONOT, V9, P217, DOI 10.1089/vbz.2008.0071
   Huang XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081887
   JUPP PG, 1992, J AM MOSQUITO CONTR, V8, P321
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar K, 2014, J INSECTS, V2014, P951015, DOI [10.1155/2014/951015, DOI 10.1155/2014/951015]
   Kutsuna S, 2015, EMERG INFECT DIS, V21, P517, DOI [10.3201/eid2103.141662, 10.3201/eid2103/141662]
   Lima A, 2016, AM J TROP MED HYG, V94, P231, DOI 10.4269/ajtmh.15-0351
   Lounibos LP, 2016, J INFECT DIS, V214, pS453, DOI 10.1093/infdis/jiw285
   Lounibos LP, 2002, ANNU REV ENTOMOL, V47, P233, DOI 10.1146/annurev.ento.47.091201.145206
   Maciel-De-Freitas R, 2007, AM J TROP MED HYG, V76, P659, DOI 10.4269/ajtmh.2007.76.659
   Manoj PDS, 2015, IEEE T COMPUT, V64, P3022, DOI 10.1109/TC.2015.2389827
   Medlock JM, 2017, LANCET INFECT DIS, V17, P140, DOI 10.1016/S1473-3099(17)30024-5
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   MORLAN HB, 1963, PUBLIC HEALTH REP, V78, P711, DOI 10.2307/4591909
   Munstermann L. E., 1997, The molecular biology of insect disease vectors: a methods manual., P13
   Munstermann L.E., 1985, P7
   Musso D, 2014, CLIN MICROBIOL INFEC, V20, pO595, DOI 10.1111/1469-0691.12707
   Ngoagouni C, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0808-3
   Noireau F, 2002, MEM I OSWALDO CRUZ, V97, P61, DOI 10.1590/S0074-02762002000100009
   PADMAJA K, 1981, MOSQ NEWS, V41, P674
   Porse Charsey Cole, 2015, Emerg Infect Dis, V21, P1827, DOI 10.3201/3210.150494
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rey Jorge R, 2014, Insects, V5, P991, DOI 10.3390/insects5040991
   Rezende GL, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-82
   Ross PA, 2019, EVOL APPL, V12, P572, DOI 10.1111/eva.12740
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Russell BM, 2001, J MED ENTOMOL, V38, P441, DOI 10.1603/0022-2585-38.3.441
   SCHAFFNER E, 2001, MOUSTIQUES EUROPE LO
   Schaffner F, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-142
   Schaffner F, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-209
   Schneider J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162493
   Scholte EJ, 2010, EUROSURVEILLANCE, V15, P10
   Silver J.B., 2008, MOSQUITO ECOLOGY FIE
   Suman DS, 2011, ARTHROPOD STRUCT DEV, V40, P479, DOI 10.1016/j.asd.2011.04.003
   Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006
   TRPIS M, 1986, AM J TROP MED HYG, V35, P1263, DOI 10.4269/ajtmh.1986.35.1263
   van de Vossenberg BTLH, 2015, J MED ENTOMOL, V52, P336, DOI 10.1093/jme/tjv020
   Vaux AGC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0936-9
   Vazquez-Prokopec GM, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000858
   Venturi G, 2017, EUROSURVEILLANCE, V22, P11, DOI 10.2807/1560-7917.ES.2017.22.39.17-00646
   Werblow A, 2016, MED VET ENTOMOL, V30, P8, DOI 10.1111/mve.12154
   Zamora-Delgado J, 2015, REV COLOMB ENTOMOL, V41, P212
   Zheng ML, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0951-x
NR 74
TC 0
Z9 0
U1 4
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 19
PY 2020
VL 13
IS 1
AR 91
DI 10.1186/s13071-020-3939-0
PG 16
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KQ9GK
UT WOS:000517228800002
PM 32075683
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Berry, IM
   Rutvisuttinunt, W
   Sippy, R
   Beltran-Ayala, E
   Figueroa, K
   Ryan, S
   Srikanth, A
   Stewart-Ibarra, AM
   Endy, T
   Jarman, RG
AF Maljkovic Berry, Irina
   Rutvisuttinunt, Wiriya
   Sippy, Rachel
   Beltran-Ayala, Efrain
   Figueroa, Katherine
   Ryan, Sadie
   Srikanth, Abhinaya
   Stewart-Ibarra, Anna M.
   Endy, Timothy
   Jarman, Richard G.
TI The origins of dengue and chikungunya viruses in Ecuador following
   increased migration from Venezuela and Colombia
SO BMC EVOLUTIONARY BIOLOGY
LA English
DT Article
DE Dengue; Chikungunya; Ecuador; Venezuela; Colombia; Dissemination
ID AEDES-AEGYPTI; HISTORY; EMERGENCE; RESOURCE; IMPACT
AB Background In recent years, Ecuador and other South American countries have experienced an increase in arboviral diseases. A rise in dengue infections was followed by introductions of chikungunya and Zika, two viruses never before seen in many of these areas. Furthermore, the latest socioeconomic and political instability in Venezuela and the mass migration of its population into the neighboring countries has given rise to concerns of infectious disease spillover and escalation of arboviral spread in the region. Results We performed phylogeographic analyses of dengue (DENV) and chikungunya (CHIKV) virus genomes sampled from a surveillance site in Ecuador in 2014-2015, along with genomes from the surrounding countries. Our results revealed at least two introductions of DENV, in 2011 and late 2013, that initially originated from Venezuela and/or Colombia. The introductions were subsequent to increases in the influx of Venezuelan and Colombian citizens into Ecuador, which in 2013 were 343% and 214% higher than in 2009, respectively. However, we show that Venezuela has historically been an important source of DENV dispersal in this region, even before the massive exodus of its population, suggesting already established paths of viral distribution. Like DENV, CHIKV was introduced into Ecuador at multiple time points in 2013-2014, but unlike DENV, these introductions were associated with the Caribbean. Our findings indicated no direct CHIKV connection between Ecuador, Colombia, and Venezuela as of 2015, suggesting that CHIKV was, at this point, not following the paths of DENV spread. Conclusion Our results reveal that Ecuador is vulnerable to arbovirus import from many geographic locations, emphasizing the need of continued surveillance and more diversified prevention strategies. Importantly, increase in human movement along established paths of viral dissemination, combined with regional outbreaks and epidemics, may facilitate viral spread and lead to novel virus introductions. Thus, strengthening infectious disease surveillance and control along migration routes and improving access to healthcare for the vulnerable populations is of utmost importance.
C1 [Maljkovic Berry, Irina; Rutvisuttinunt, Wiriya; Figueroa, Katherine; Srikanth, Abhinaya; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
   [Sippy, Rachel; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Beltran-Ayala, Efrain] Tech Univ Machala, Dept Med, Machala, El Oro, Ecuador.
   [Ryan, Sadie] Univ Florida, Dept Geog, Quantitat Dis Ecol & Conservat QDEC Lab, Gainesville, FL 32611 USA.
   [Ryan, Sadie] Univ Florida, Emerging Pathogens Inst, Gainesville, FL USA.
   [Stewart-Ibarra, Anna M.; Endy, Timothy] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] InterAmer Inst Global Change Res IAI, Dept Montevideo, Montevideo, Uruguay.
   [Endy, Timothy] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
RP Berry, IM (corresponding author), Walter Reed Army Inst Res, Viral Dis Branch, Silver Spring, MD 20910 USA.
EM irina.maljkovicberry.ctr@mail.mil
OI Maljkovic Berry, Irina/0000-0001-8555-5352
FU Armed Forces Health Surveillance Branch (AFHSB); Global Emerging
   Infections Surveillance (GEIS) [P0108_18_WR]
FX This work was funded by the Armed Forces Health Surveillance Branch
   (AFHSB) and its Global Emerging Infections Surveillance (GEIS) Section,
   FY2018 ProMIS ID P0108_18_WR.
CR Agarwal A, 2016, VIROLOGY, V497, P59, DOI 10.1016/j.virol.2016.06.025
   [Anonymous], 1997, Rev Panam Salud Publica, V1, P68
   [Anonymous], 2019, EC REG INT ENTR EX
   [Anonymous], 2015, GADM DAT GLOB ADM AR
   [Anonymous], 2017, ARCGIS V10 6 1
   [Anonymous], 2018, VEN SIT
   Berry IM, 2019, AM J TROP MED HYG, V100, P1249, DOI 10.4269/ajtmh.18-0980
   Camacho D, 2017, ACTA TROP, V174, P88, DOI 10.1016/j.actatropica.2017.06.026
   CAMARGO S, 1967, B WORLD HEALTH ORGAN, V36, P602
   Campos TD, 2018, INT J GENOMICS, DOI 10.1155/2018/6941735
   CAREY D E, 1971, Journal of the History of Medicine and Allied Sciences, V26, P243
   Carrington CVF, 2005, J VIROL, V79, P14680, DOI 10.1128/JVI.79.23.14680-14687.2005
   Centers for Disease Control (CDC), 1989, MMWR Morb Mortal Wkly Rep, V38, P419
   de Bruycker-Nogueira F, 2016, INFECT GENET EVOL, V45, P454, DOI 10.1016/j.meegid.2016.09.025
   Dick OB, 2012, AM J TROP MED HYG, V87, P584, DOI 10.4269/ajtmh.2012.11-0770
   Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214
   Dutra KR, 2017, J MED VIROL, V89, P966, DOI 10.1002/jmv.24729
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Franco L, 2015, Clin Microbiol Infect, V21, DOI 10.1016/j.cmi.2015.03.016
   Grillet ME, 2019, LANCET INFECT DIS, V19, pE149, DOI 10.1016/S1473-3099(18)30757-6
   Guindon S, 2009, METHODS MOL BIOL, V537, P113, DOI 10.1007/978-1-59745-251-9_6
   Halstead SB, 2015, EMERG INFECT DIS, V21, P557, DOI 10.3201/eid2104.141723
   Hatcher EL, 2017, NUCLEIC ACIDS RES, V45, pD482, DOI 10.1093/nar/gkw1065
   Ibarra AMS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078263
   Jaramillo-Ochoa R, 2019, EMERG INFECT DIS, V25, P834, DOI 10.3201/eid2504.181355
   Jimeaez-Silva CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203090
   Khanal K., 2014, PLOS CURR OUTBREAKS, VI, P1
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Leparc-Goffart I, 2014, LANCET, V383, P514, DOI 10.1016/S0140-6736(14)60185-9
   Lizarazo E, 2019, EMERG INFECT DIS, V25, P672, DOI 10.3201/eid2504.172121
   Nasserie T, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/taz028
   Paniz-Mondolfi AE, 2019, EMERG INFECT DIS, V25, P625, DOI 10.3201/eid2504.181305
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Reed W, 1900, Public Health Pap Rep, V26, P37
   Rodriguez-Morales AJ, 2019, J TRAVEL MED, V26, DOI 10.1093/jtm/tay162
   Rodriguez-Morales AJ, 2015, J CLIN VIROL, V66, P60, DOI 10.1016/j.jcv.2015.02.020
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007213
   Stewart-Ibarra AM, 2018, AM J TROP MED HYG, V98, P1444, DOI 10.4269/ajtmh.17-0762
   Tian HY, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005694
   Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201
   Tsetsarkin KA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5084
   Tsetsarkin KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002412
   Tsetsarkin KA, 2011, P NATL ACAD SCI USA, V108, P7872, DOI 10.1073/pnas.1018344108
   Tuite AR, 2018, J TRAVEL MED, V25, DOI 10.1093/jtm/tay077
   UNHCR, 2018, NUMB REF MIGR VEN RE
   Weaver SC, 2015, ANTIVIR RES, V120, P32, DOI 10.1016/j.antiviral.2015.04.016
   Wesolowski A, 2015, P NATL ACAD SCI USA, V112, P11887, DOI 10.1073/pnas.1504964112
   Wilder-Smith A, 2008, MED CLIN N AM, V92, P1377, DOI 10.1016/j.mcna.2008.07.002
   Wilson ME, 2003, J APPL MICROBIOL, V94, p1S
   Carrillo-Hernandez MY, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2976-1
NR 54
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2148
J9 BMC EVOL BIOL
JI BMC Evol. Biol.
PD FEB 19
PY 2020
VL 20
IS 1
AR 31
DI 10.1186/s12862-020-1596-8
PG 12
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA KQ9UM
UT WOS:000517267000001
PM 32075576
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reynolds, CJ
   Watber, P
   Santos, CNO
   Ribeiro, DR
   Alves, JC
   Fonseca, ABL
   Bispo, AJB
   Porto, RLS
   Bokea, K
   de Jesus, AMR
   de Almeida, RP
   Boyton, RJ
   Altmann, DM
AF Reynolds, Catherine J.
   Watber, Patricia
   Santos, Camilla Natalia Oliveira
   Ribeiro, Danielle Rodrigues
   Alves, Juliana Cardoso
   Fonseca, Adriana B. L.
   Bispo, Ana J. B.
   Porto, Roseane L. S.
   Bokea, Kalliopi
   De Jesus, Amelia Maria Ribeiro
   De Almeida, Roque Pacheco
   Boyton, Rosemary J.
   Altmann, Daniel M.
TI Strong CD4 T Cell Responses to Zika Virus Antigens in a Cohort of Dengue
   Virus Immune Mothers of Congenital Zika Virus Syndrome Infants
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE zika virus; dengue virus; T cell epitope; flavivirus; cross-reactivity;
   microcephaly; adaptive immunity
ID ANTIBODY-DEPENDENT ENHANCEMENT; CROSS-REACTIVITY; PROFILE
AB Background: There is an urgent need to understand the complex relationship between cross-reactive anti-viral immunity, disease susceptibility, and severity in the face of differential exposure to related, circulating Flaviviruses. Co-exposure to Dengue virus and Zika virus in Brazil is a case in point. A devastating aspect of the 2015-2016 South American Zika outbreak was the dramatic increase in numbers of infants born with microcephaly to mothers exposed to Zika virus during pregnancy. It has been proposed that this is more likely to ensue from Zika infection in women lacking cross-protective Dengue immunity. In this case series we measure the prevalence of Dengue immunity in a cohort of mothers exposed to Zika virus during pregnancy in the 2015-2016 Zika outbreak that gave birth to an infant affected by microcephaly and explore their adaptive immunity to Zika virus.
   Results: Fifty women from Sergipe, Brazil who gave birth to infants with microcephaly following Zika virus exposure during the 2015-16 outbreak were tested for serological evidence of Dengue exposure and IFN gamma ELISpot spot forming cell (SFC) response to Zika virus. The majority (46/50) demonstrated Dengue immunity. IFN gamma ELISpot responses to Zika virus antigens showed the following hierarchy: Env>NS1>NS3>C protein. Twenty T cell epitopes from Zika virus Env were identified. Responses to Zika virus antigens Env and NS1 were polyfunctional with cells making IFN gamma, TNF alpha, IL-4, IL-13, and IL-10. In contrast, responses to NS5 only produced the immune regulatory TGF beta 1 cytokine. There were SFC responses against Zika virus Env (1-20) and variant peptide sequences from West Nile virus, Dengue virus 1-4 and Yellow Fever virus.
   Conclusion: Almost all the women in our study showed serological evidence of Dengue immunity, suggesting that microcephaly can occur in DENV immune mothers. T cell immunity to Zika virus showed a multifunctional response to the antigens Env and NS1 and immune regulatory responses to NS5 and C protein. Our data support an argument that different viral products may skew the antiviral response to a more pro or anti-inflammatory outcome, with an associated impact on immunopathogenesis.
C1 [Reynolds, Catherine J.; Watber, Patricia; Bokea, Kalliopi; Boyton, Rosemary J.] Imperial Coll London, Fac Med, Dept Infect Dis, London, England.
   [Santos, Camilla Natalia Oliveira; Ribeiro, Danielle Rodrigues; Alves, Juliana Cardoso] Univ Fed Sergipe, Grad Program Hlth Sci, Mol Biol Lab, Univ Hosp, Aracaju, Brazil.
   [Fonseca, Adriana B. L.; Bispo, Ana J. B.; Porto, Roseane L. S.] Univ Fed Sergipe, Pediat Div, Microcephaly Clin, Univ Hosp, Aracaju, Brazil.
   [De Jesus, Amelia Maria Ribeiro; De Almeida, Roque Pacheco] Univ Fed Sergipe, Dept Med, Mol Biol Lab, Univ Hosp, Aracaju, Brazil.
   [Altmann, Daniel M.] Imperial Coll London, Fac Med, Dept Immunol & Inflammat, London, England.
RP Boyton, RJ (corresponding author), Imperial Coll London, Fac Med, Dept Infect Dis, London, England.; Altmann, DM (corresponding author), Imperial Coll London, Fac Med, Dept Immunol & Inflammat, London, England.
EM r.boyton@imperial.ac.uk; d.altmann@imperial.ac.uk
FU MRC-Newton Wellcome Trust/FAPESP Zika Rapid Response Project
   [ZK/16-104]; Innovate UK [87242-544164]; NIH NIAIDUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID)
   [HHSN272201400049C, UWSC9568]; FINEP grant (Financiadora de Estudos e
   Projetos) [0116005600]; Coordenacao de Aperfeicoamento de Pessoal de
   Nivel Superior-Brazil (CAPES)CAPES [001]; CNPqNational Council for
   Scientific and Technological Development (CNPq)
FX This research was supported by the following grants: MRC-Newton Wellcome
   Trust/FAPESP Zika Rapid Response Project (ZK/16-104), Innovate UK
   (87242-544164), and the NIH NIAID (Contract Number: HHSN272201400049C,
   Subcontract number: UWSC9568). This study was supported in part by a
   FINEP grant (Financiadora de Estudos e Projetos) number 0116005600 and
   the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brazil
   (CAPES)-Finance Code 001. AJ and RA are sponsored by CNPq. The funding
   bodies had no role in the design of the study, data collection,
   analysis, and interpretation of data, writing the manuscript or decision
   to publish.
CR Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Terzian ACB, 2017, CLIN INFECT DIS, V65, P1260, DOI 10.1093/cid/cix558
   Brown JA, 2019, IMMUNITY, V50, P751, DOI 10.1016/j.immuni.2019.01.005
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   GRIFONI A, 2017, J VIROL, V91, DOI DOI 10.1128/JVI.01469-17
   Grifoni A, 2018, J IMMUNOL, V201, P3487, DOI 10.4049/jimmunol.1801090
   Herrera BB, 2018, J VIROL, V92, DOI 10.1128/JVI.01992-17
   Jayaratne HE, 2018, IMMUNOLOGY, V154, P89, DOI 10.1111/imm.12863
   Jurado KA, 2018, NAT MICROBIOL, V3, P141, DOI 10.1038/s41564-017-0060-z
   Kam YW, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92428
   Kempen JH, 2011, AM J OPHTHALMOL, V151, P7, DOI 10.1016/j.ajo.2010.08.047
   Koblischke M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01196
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Ngono AE, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007474
   Pantoja P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15674
   Pardy RD, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006184
   Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113
   Regla-Nava JA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05458-0
   Reynolds CJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18781-1
   Steinhagen K, 2016, EUROSURVEILLANCE, V21, P13, DOI 10.2807/1560-7917.ES.2016.21.50.30426
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Tillu H, 2016, EUR J CLIN MICROBIOL, V35, P453, DOI 10.1007/s10096-015-2561-0
   Wen J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01669-z
   Wen JS, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.36
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Xu Xiaojun, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.9aa2e1fb61b0f632f58a098773008c4b
NR 26
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 18
PY 2020
VL 11
AR 185
DI 10.3389/fimmu.2020.00185
PG 11
WC Immunology
SC Immunology
GA KS9CQ
UT WOS:000518605700001
PM 32132999
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Giovanetti, M
   Faria, NR
   Lourenco, J
   de Jesus, JG
   Xavier, J
   Claro, IM
   Kraemer, MUG
   Fonseca, V
   Dellicour, S
   Theze, J
   Salles, FD
   Graf, T
   Silveira, PP
   do Nascimento, VA
   de Souza, VC
   Iani, FCD
   Castilho-Martins, EA
   Cruz, LN
   Wallau, G
   Fabri, A
   Levy, F
   Quick, J
   de Azevedo, V
   Aguiar, RS
   de Oliveira, T
   de Menezes, CB
   Castilho, MD
   Terra, TM
   da Silva, MS
   de Filippis, AMB
   de Abreu, AL
   Oliveira, WK
   Croda, J
   de Albuquerque, CFC
   Nunes, MRT
   Sabino, EC
   Loman, N
   Naveca, FG
   Pybus, OG
   Alcantara, LC
AF Giovanetti, Marta
   Faria, Nuno Rodrigues
   Lourenco, Jose
   de Jesus, Jaqueline Goes
   Xavier, Joilson
   Claro, Ingra Morales
   Kraemer, Moritz U. G.
   Fonseca, Vagner
   Dellicour, Simon
   Theze, Julien
   Salles, Flavia da Silva
   Graf, Tiago
   Silveira, Paola Paz
   do Nascimento, Valdinete Alves
   de Souza, Victor Costa
   de Melo Iani, Felipe Campos
   Castilho-Martins, Emerson Augusto
   Cruz, Laura Nogueira
   Wallau, Gabriel
   Fabri, Allison
   Levy, Flavia
   Quick, Joshua
   de Azevedo, Vasco
   Aguiar, Renato Santana
   de Oliveira, Tulio
   de Menezes, Camila Botto
   Castilho, Marcia da Costa
   Terra, Tirza Matos
   da Silva, Marineide Souza
   Bispo de Filippis, Ana Maria
   de Abreu, Andre Luiz
   Oliveira, Wanderson Kleber
   Croda, Julio
   Campelo de Albuquerque, Carlos F.
   Nunes, Marcio R. T.
   Sabino, Ester Cerdeira
   Loman, Nicholas
   Naveca, Felipe Gomes
   Pybus, Oliver G.
   Alcantara, Luiz Carlos
TI Genomic and Epidemiological Surveillance of Zika Virus in the Amazon
   Region
SO CELL REPORTS
LA English
DT Article
ID PHYLOGENETIC ANALYSIS; TRANSMISSION; OUTBREAK; SPREAD; BRAZIL;
   OROPOUCHE; REVEALS; MODELS; ANGOLA; FEVER
AB Zika virus (ZIKV) has caused an explosive epidemic linked to severe clinical outcomes in the Americas. As of June 2018, 4,929 ZIKV suspected infections and 46 congenital syndrome cases had been reported in Manaus, Amazonas, Brazil. Although Manaus is a key demographic hub in the Amazon region, little is known about the ZIKV epidemic there, in terms of both transmission and viral genetic diversity. Using portable virus genome sequencing, we generated 59 ZIKV genomes in Manaus. Phylogenetic analyses indicated multiple introductions of ZIKV from northeastern Brazil to Manaus. Spatial genomic analysis of virus movement among six areas in Manaus suggested that populous northern neighborhoods acted as sources of virus transmission to other neighborhoods. Our study revealed how the ZIKV epidemic was ignited and maintained within the largest urban metropolis in the Amazon. These results might contribute to improving the public health response to outbreaks in Brazil.
C1 [Giovanetti, Marta; de Jesus, Jaqueline Goes; Fabri, Allison; Levy, Flavia; Bispo de Filippis, Ana Maria; Alcantara, Luiz Carlos] Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.
   [Giovanetti, Marta; Faria, Nuno Rodrigues; Xavier, Joilson; Fonseca, Vagner; de Melo Iani, Felipe Campos; de Azevedo, Vasco; Alcantara, Luiz Carlos] Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.
   [Faria, Nuno Rodrigues; Lourenco, Jose; Kraemer, Moritz U. G.; Theze, Julien; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
   [Claro, Ingra Morales; Salles, Flavia da Silva; Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop, Sao Paulo, Brazil.
   [Fonseca, Vagner; de Oliveira, Tulio] Univ KwaZulu Natal, Coll Hlth Sci, KwaZulu Natal Res Innovat & Sequencing Platform K, ZA-4001 Durban, South Africa.
   [Dellicour, Simon] Univ Libre Bruxelles, Spatial Epidemiol Lab, Brussels, Belgium.
   [Dellicour, Simon] Katholieke Univ Leuven, Dept Microbiol & Immunol, Rega Inst, Lab Clin & Epidemiol Virol, Leuven, Belgium.
   [Graf, Tiago; Silveira, Paola Paz; Aguiar, Renato Santana] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Salvador, BA, Brazil.
   [do Nascimento, Valdinete Alves; de Souza, Victor Costa; Naveca, Felipe Gomes] Fiocruz MS, Inst Leonidas & Maria Deane, Lab Ecol Doencas Transmissiveis Amazonia, Manaus, Amazonas, Brazil.
   [de Melo Iani, Felipe Campos] Fundacao Ezequiel Dias, Lab Cent Saude Publ, Belo Horizonte, MG, Brazil.
   [Castilho-Martins, Emerson Augusto] Univ Fed Amapa, Fac Med, Macapa, Brazil.
   [Cruz, Laura Nogueira; de Abreu, Andre Luiz] Minist Saude CGLAB SVS MS, Secretaria Vigilancia Saude, Coordenacao Geral Lab Saude Publ, Brasilia, DF, Brazil.
   [Wallau, Gabriel] Fundacao Oswaldo Cruz, Inst Aggeu Magalhaes, Recife, PE, Brazil.
   [Quick, Joshua; Loman, Nicholas] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.
   [de Menezes, Camila Botto] Univ Estado Amazonas, Manaus, Amazonas, Brazil.
   [Castilho, Marcia da Costa] Fundacao Med Trop Doutor Heitor Vieira Dourado, Dept Virol, Manaus, Amazonas, Brazil.
   [Terra, Tirza Matos; da Silva, Marineide Souza] Lab Cent Saude Publ Amazonas, Manaus, Amazonas, Brazil.
   [Oliveira, Wanderson Kleber] MS, SVS, Brasilia, DF, Brazil.
   [Croda, Julio] Minist Saude DEVIT SVS MS, Secretaria Vigilancia Saude, Dept Vigilancia Doencas Transmissiveis, Brasilia, DF, Brazil.
   [Campelo de Albuquerque, Carlos F.] OMS, OPAS, Brasilia, DF, Brazil.
   [Nunes, Marcio R. T.] Minist Hlth, Evandro Chagas Inst, Ctr Technol Innovat, Ananindeua, Para, Brazil.
RP Alcantara, LC (corresponding author), Inst Oswaldo Cruz Fiocruz, Lab Flavivirus, Rio De Janeiro, Brazil.; Faria, NR; Alcantara, LC (corresponding author), Univ Fed Minas Gerais, Lab Genet Celular & Mol, ICB, Belo Horizonte, MG, Brazil.; Faria, NR; Pybus, OG (corresponding author), Univ Oxford, Dept Zool, Oxford OX1 3PS, England.
EM nuno.faria@zoo.ox.ac.uk; oliver.pybus@zoo.ox.ac.uk;
   luiz.alcantara@ioc.fiocruz.br
RI Fonseca, Vagner/R-5813-2019; Graf, Tiago/S-8535-2019; Castilho-Martins,
   Emerson Augusto/I-2094-2014; Wallau, Gabriel/B-5911-2008
OI Fonseca, Vagner/0000-0001-5521-6448; Graf, Tiago/0000-0003-4921-7975;
   Alcantara, Luiz/0000-0002-6769-9931; Castilho-Martins, Emerson
   Augusto/0000-0003-0542-4294; Wallau, Gabriel/0000-0002-1419-5713; da
   Silva Sales, Flavia Cristina/0000-0002-9048-0030
FU Decit/SCTIE/MoH; CNPqNational Council for Scientific and Technological
   Development (CNPq) [440685/2016-8, 440856/2016-7]; CAPESCAPES
   [88887.130716/2016-00, 88881.130825/2016-00, 88887.130823/201600];
   European Union (EU) Horizon 2020 Programme through ZIKAllianceEuropean
   Union (EU) [PRES-005-FEX-17-4-2-33]; Oxford Martin School; Branco Weiss
   Fellowship - Society in Science; Google Faculty Award; Training Grant
   from the National Institute of Child Health and Human Development
   [T32HD040128]; Fonds National de la Recherche Scientifique (FNRS;
   Belgium)Fonds de la Recherche Scientifique - FNRS; FaperjCarlos Chagas
   Filho Foundation for Research Support of the State of Rio de Janeiro
   (FAPERJ) [E-26/2002.930/2016]; International Development Research Centre
   (IDRC) Canada [108411-001]; EU Horizon 2020 Programme through ZikaPlan
   and ZikAction [734584, 734857]; Fundacao de Amparo a Pesquisa do Estado
   do Rio de Janeiro (FAPERJ)Carlos Chagas Filho Foundation for Research
   Support of the State of Rio de Janeiro (FAPERJ)
FX We thank Oxford Nanopore Technologies for technical support and QIAGEN
   for support of the ZIBRA-2 (Zika in Brazil Real Time Analyses-Second
   Round) project with reagents and equipment. This work was supported by
   Decit/SCTIE/MoH and CNPq (440685/2016-8 and 440856/2016-7); by CAPES
   (88887.130716/2016-00, 88881.130825/2016-00, and 88887.130823/201600);
   by the European Union (EU) Horizon 2020 Programme through ZIKAlliance
   (PRES-005-FEX-17-4-2-33); and by the Oxford Martin School. M.U.G.K. is
   supported by The Branco Weiss Fellowship - Society in Science,
   administered by ETH Zurich, and acknowledges funding from a Google
   Faculty Award and a Training Grant from the National Institute of Child
   Health and Human Development (T32HD040128). S.D. is supported by Fonds
   National de la Recherche Scientifique (FNRS; Belgium). The activities of
   the A.M.B.F. laboratory were supported by the Faperj under the grant no.
   E-26/2002.930/2016, by the International Development Research Centre
   (IDRC) Canada under the grant 108411-001) and the EU Horizon 2020
   Programme through ZikaPlan and ZikAction (grants 734584 and 734857).
   M.G. is supported by Fundacao de Amparo a Pesquisa do Estado do Rio de
   Janeiro (FAPERJ).
CR Azevedo RSS, 2009, EMERG INFECT DIS, V15, P1830, DOI 10.3201/eid1511.090461
   Bogoch II, 2016, LANCET, V387, P335, DOI 10.1016/S0140-6736(16)00080-5
   Caminade C, 2017, P NATL ACAD SCI USA, V114, P119, DOI 10.1073/pnas.1614303114
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   da Costa CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006594
   Azevedo RDD, 2007, EMERG INFECT DIS, V13, P912
   Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088
   Faria NR, 2018, SCIENCE, V361, P894, DOI 10.1126/science.aat7115
   Faria NR, 2017, NATURE, V546, P406, DOI 10.1038/nature22401
   Faria NR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15152-8
   Faria NR, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0356-2
   Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302
   Fonseca V., 2019, PLOS NEGLECT TROP D, V213, P72
   Gill MS, 2013, MOL BIOL EVOL, V30, P713, DOI 10.1093/molbev/mss265
   Grubaugh ND, 2019, CELL, V178, P1057, DOI 10.1016/j.cell.2019.07.018
   Grubaugh ND, 2017, NATURE, V546, P401, DOI 10.1038/nature22400
   Hagan JE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004275
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   Hill SC, 2019, LANCET INFECT DIS, V19, P1138, DOI 10.1016/S1473-3099(19)30293-2
   Izquierdo-Suzan M, 2019, EMERG INFECT DIS, V25, P1477, DOI 10.3201/eid2508.181533
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kraemer MUG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41192-3
   Kraemer MUG, 2019, EPIDEMIOL INFECT, V147, DOI 10.1017/S0950268818002881
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2017, LANCET INFECT DIS, V17, P330, DOI [10.1016/S1473-3099(16)30513-8, 10.1016/s1473-3099(16)30513-8]
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520
   Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003
   Loman NJ, 2014, BIOINFORMATICS, V30, P3399, DOI 10.1093/bioinformatics/btu555
   Lourenco J., 2017, ELIFE, V6, P290
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Naveca FG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007065
   Naveca FG, 2017, MEM I OSWALDO CRUZ, V112, P510, DOI 10.1590/0074-02760160062
   Nunes MRT, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002769
   Oboist U, 2019, METHODS ECOL EVOL, V10, P1357, DOI 10.1111/2041-210X.13205
   Perez-Guzman P.N., 2018, PLOS CURR, V10, P16
   Perkins TA, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.126, 10.1038/nmicrobiol.2016.126]
   Petersen LR, 2016, NEW ENGL J MED, V375, P294, DOI 10.1056/NEJMc1606769
   Quick J, 2017, NAT PROTOC, V12, P1261, DOI 10.1038/nprot.2017.066
   Rambaut A, 2018, SYST BIOL, V67, P901, DOI 10.1093/sysbio/syy032
   Rambaut A, 2016, VIRUS EVOL, V2, DOI 10.1093/ve/vew007
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Secretaria de Vigilancia em Saude Ministerio da Saude, 2019, B EPIDEMIOLOGICO
   Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021
   Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033
   Suchard MA, 2018, VIRUS EVOL, V4, DOI 10.1093/ve/vey016
   Sun JF, 2017, J INFECTION, V75, P356, DOI 10.1016/j.jinf.2017.07.001
   Nunes MRT, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0348-x
   Nunes MRT, 2012, EMERG INFECT DIS, V18, P1858, DOI 10.3201/eid1811.120217
   Theze J, 2018, CELL HOST MICROBE, V23, P855, DOI [10.1016/j.chom.2018.04.017, 10.101]
   Vasconcelos L., 2001, P 1 WORLD PLANN C AC, V32, P11
   VASCONCELOS PFC, 1992, CIENC CULT-SAO PAULO, V44, P117
   Wickham H., 2016, ELEGANT GRAPHICS DAT
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   Yu GC, 2018, MOL BIOL EVOL, V35, P3041, DOI 10.1093/molbev/msy194
   Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192
   Zhang Q, 2017, P NATL ACAD SCI USA, V114, pE4334, DOI 10.1073/pnas.1620161114
NR 64
TC 0
Z9 0
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 2211-1247
J9 CELL REP
JI Cell Reports
PD FEB 18
PY 2020
VL 30
IS 7
BP 2275
EP 2283
DI 10.1016/j.celrep.2020.01.085
PG 9
WC Cell Biology
SC Cell Biology
GA KN4QZ
UT WOS:000514824500019
PM 32075736
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Karthi, S
   Vinothkumar, M
   Karthic, U
   Manigandan, V
   Saravanan, R
   Vasantha-Srinivasan, P
   Kamaraj, C
   Shivakumar, MS
   De Mandal, S
   Velusamy, A
   Krutmuang, P
   Senthil-Nathan, S
AF Karthi, Sengodan
   Vinothkumar, Manohar
   Karthic, Uthirarajan
   Manigandan, Venkatesan
   Saravanan, Ramachandran
   Vasantha-Srinivasan, Prabhakaran
   Kamaraj, Chinnaperumal
   Shivakumar, Muthugounder S.
   De Mandal, Surajit
   Velusamy, Arumugam
   Krutmuang, Patcharin
   Senthil-Nathan, Sengottayan
TI Biological effects of Avicennia marina (Forssk.) vierh. extracts on
   physiological, biochemical, and antimicrobial activities against three
   challenging mosquito vectors and microbial pathogens
SO ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH
LA English
DT Article
DE Mangrove; Vectors; GC-MS; Pathogens; Detoxifying; Enzymes
ID IN-VITRO; ANTIPLASMODIAL ACTIVITY; MEDICINAL-PLANTS; DENGUE; FIGHT;
   NANOPARTICLES
AB Mosquitoes are principal vector of several vector-borne diseases affecting human beings leading to thousands of deaths per year and responsible for transmitting diseases like malaria, dengue, chikungunya, yellow fever, Zika virus, Japanese encephalitis, and lymphatic filariasis. In the present study, we evaluated the different solvent extracts of mangrove Avicennia marina for their toxicity against larvae of three major mosquito vectors, as well as selected microbial pathogens. The larvicidal mortality of third instars was observed after 24 h. Highest larval mortality was found for the acetone extract of A. marina against Culex quinquefasciatus (LC50 = 0.197 mg/ml; LC90 = 1.5011 mg/ml), Anopheles stephensi (LC50 = 0.176 mg/ml; LC90 = 3.6290 mg/ml), and Aedes aegypti (LC50 = 0.164 mg/ml; LC90 = 4.3554 mg/ml). GC-MS analysis of acetone extract revealed 5 peaks, i.e., 1-hexyl-2-nitrocyclohexane (3.229%), eicosanoic acid (40.582%), cis-9-hexadecenal (70.54%), oleic acid (4.646%), and di-N-decylsulfone (5.136%). Parallel to larvicidal assay, sub-lethal dosage acetone extracts severely affected the enzyme regulations (alpha,beta-carboxylesterase, GST and CYP450) of third instars. Larval and pupal durations increased in all treatment sub-lethal dosage (0.127, 0.151, 0.177, and 0.197 mg/ml), whereas egg hatchability and means of fecundity decreased compared to control. The survival rate was reduced statistically in Cx. quinquefasciatus (chi(2) = 23.77, df = 1, P = 0.001) in all the treatment dosages as compared to the control. Antimicrobial activity assays showed significant growth inhibition post treatment with acetone and methanol extracts against Salmonella typhimurium, Klebsiella pneumoniae, Pseudomonas aeruginosa, Staphylococcus pneumoniae, Escherichia coli, and Shigella flexneri. Overall, these results indicated the potential employment of A. marina extracts as a source of natural mosquitocidal and antimicrobial compounds of green-based environment.
C1 [Karthi, Sengodan; Vinothkumar, Manohar; Karthic, Uthirarajan] KS Rangasamy Coll Arts & Sci Autonomous, Dept Biochem, Namakkal 637215, Tamil Nadu, India.
   [Karthi, Sengodan; Senthil-Nathan, Sengottayan] Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.
   [Manigandan, Venkatesan; Saravanan, Ramachandran] Chettinad Acad Res & Educ, Dept Med Biotechnol, Chennai, Tamil Nadu, India.
   [Vasantha-Srinivasan, Prabhakaran] St Peters Inst Higher Educ & Res, Dept Biotechnol, Chennai 600054, Tamil Nadu, India.
   [Kamaraj, Chinnaperumal; Shivakumar, Muthugounder S.] Periyar Univ, Dept Biotechnol, Salem 636011, Tamil Nadu, India.
   [De Mandal, Surajit] South China Agr Univ, Coll Agr, Guangzhou 510642, Peoples R China.
   [Velusamy, Arumugam] Bharathidasan Univ, Dept Environm Biotechnol, Trichy 620024, Tamil Nadu, India.
   [Krutmuang, Patcharin] Chiang Mai Univ, Fac Agr, Dept Entomol & Plant Pathol, Chiang Mai 50200, Thailand.
RP Karthi, S (corresponding author), KS Rangasamy Coll Arts & Sci Autonomous, Dept Biochem, Namakkal 637215, Tamil Nadu, India.; Karthi, S; Senthil-Nathan, S (corresponding author), Manonmaniam Sundaranar Univ, Sri Paramakalyani Ctr Excellence Environm Sci, Div Biopesticides & Environm Toxicol, Tirunelveli 627412, Tamil Nadu, India.; Krutmuang, P (corresponding author), Chiang Mai Univ, Fac Agr, Dept Entomol & Plant Pathol, Chiang Mai 50200, Thailand.
EM karthientomology@gmail.com; patcharink26@gmail.com; senthil@msuniv.ac.in
CR Aktar Md Wasim, 2009, Interdiscip Toxicol, V2, P1, DOI 10.2478/v10102-009-0001-7
   Benelli G, 2017, ENTOMOL GEN, V36, P309, DOI 10.1127/entomologia/2017/0496
   Benelli G, 2017, ACTA TROP, V174, P91, DOI 10.1016/j.actatropica.2017.06.028
   Benelli G, 2016, PARASITOL RES, V115, P23, DOI 10.1007/s00436-015-4800-9
   Benelli G, 2015, PARASITOL RES, V114, P1613, DOI 10.1007/s00436-015-4351-0
   Bhattacharya S, 2003, ECON BOT, V57, P118, DOI 10.1663/0013-0001(2003)057[0118:IOSMAO]2.0.CO;2
   Chellappandian M, 2018, ENVIRON INT, V113, P214, DOI 10.1016/j.envint.2017.12.038
   Clarkson C, 2004, J ETHNOPHARMACOL, V92, P177, DOI 10.1016/j.jep.2004.02.011
   El-Tahir A, 1999, PHYTOTHER RES, V13, P474, DOI 10.1002/(SICI)1099-1573(199909)13:6&lt;474::AID-PTR482&gt;3.0.CO;2-6
   Finney D.T., 1971, PROBIT ANAL
   Ganesh K. N., 2002, Indian Journal of Experimental Biology, V40, P583
   Gerhardt P., 1981, MANUAL METHODS GEN B
   Goindin D, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0254-x
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Hadjiakhoondi A, 2005, IRAN J PHARM SCI, V1, P81
   Hussein MA, 2017, J FLUORESC, V27, P1129, DOI 10.1007/s10895-017-2048-8
   KABARU J.M., 2001, AFRICAN J SCI TECHNO, V2, P44
   Kamaraj C, 2011, INDIAN J MED RES, V134, P101
   KAMIMURA H, 1992, J PHARMACOBIO-DYNAM, V15, P215, DOI 10.1248/bpb1978.15.215
   Kelly G S, 1999, Altern Med Rev, V4, P29
   Kirubakaran Suyambulingam Arunachalam, 2014, Archives of Phytopathology and Plant Protection, V47, P977, DOI 10.1080/03235408.2013.828388
   Lumjuan N, 2011, INSECT BIOCHEM MOLEC, V41, P203, DOI 10.1016/j.ibmb.2010.12.005
   Martinez AM, 2007, REV FACULTAD QUIMICA, V14, P90
   Mujeeb F, 2014, BIOMED RES INT, DOI 10.1155/2014/497606
   Murugan K, 2015, PARASITOL RES, V114, P4349, DOI 10.1007/s00436-015-4676-8
   Namazi R, 2013, IRAN J PHARM RES, V12, P435
   Philbert A, 2017, TROP MED INT HEALTH, V22, P388, DOI 10.1111/tmi.12850
   Ramesh Kumar K, 2014, J NANOMED NANOTECHNO, V5, P1
   Samee H, 2009, J ZHEJIANG UNIV-SC B, V10, P147, DOI 10.1631/jzus.B0820185
   Sathishkumar M, 2009, COLLOID SURFACE B, V73, P332, DOI 10.1016/j.colsurfb.2009.06.005
   Sonia A. S. G., 2012, GLOBAL J PHARM, V6, P1
   STLEGER RJ, 1986, J INVERTEBR PATHOL, V48, P85, DOI 10.1016/0022-2011(86)90146-1
   Suganya G, 2014, PARASITOL RES, V113, P1673, DOI 10.1007/s00436-014-3811-2
   Thanigaivel A, 2017, ARCH INSECT BIOCHEM, V94, DOI 10.1002/arch.21384
   Vasantha-Srinivasan P, 2018, ENVIRON SCI POLLUT R, V25, P10434, DOI 10.1007/s11356-017-9714-x
   Vijayasanthi M., 2012, Hygeia - Journal for Drugs and Medicine, V4, P91
   WHO, 2013, DENGUE AND SEVERE DE
   WHO-World Health Organization, 2005, GUID LAB FIELD TEST
NR 38
TC 0
Z9 0
U1 3
U2 3
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0944-1344
EI 1614-7499
J9 ENVIRON SCI POLLUT R
JI Environ. Sci. Pollut. Res.
PD MAY
PY 2020
VL 27
IS 13
BP 15174
EP 15187
DI 10.1007/s11356-020-08055-1
EA FEB 2020
PG 14
WC Environmental Sciences
SC Environmental Sciences & Ecology
GA LP3KX
UT WOS:000516330600004
PM 32072409
DA 2020-07-08
ER

PT J
AU Fan, YJ
   Scott, JG
AF Fan, Yinjun
   Scott, Jeffrey G.
TI The F1534C voltage-sensitive sodium channel mutation confers 7-to
   16-fold resistance to pyrethroid insecticides in Aedes aegypti
SO PEST MANAGEMENT SCIENCE
LA English
DT Article
DE insecticide resistance; Vssc; F1534C; pyrethroids; DDT
ID KDR MUTATIONS
AB BACKGROUND Recent outbreaks of dengue and Zika have emphasized the importance to effectively control Aedes aegypti, which vectors the viruses causing these diseases. Pyrethroid insecticides are primarily used to control adult A. aegypti, especially during disease outbreaks. However, pyrethroid resistance in A. aegypti is an increasing problem. Mutations in the voltage-sensitive sodium channel (Vssc) are a common mechanism of pyrethroid resistance. The F1534C mutation is common and distributed globally in A. aegypti populations, but previous studies disagree about the role of this mutation in conferring resistance to pyrethroid insecticides.
   RESULTS We isolated a congenic strain (1534C:ROCK) which was closely related to a susceptible strain Rockefeller (ROCK), but was homozygous for the 1534C Vssc allele. We determined resistance levels against eight insecticides that target the VSSC: six pyrethroids, DDT and DCJW (the bioactivated metabolite of indoxacarb). The resistance levels ranged from 7- to 16-fold, and resistance was inherited as an incompletely recessive trait. We also found a novel 367I+1520I+1534C allele, in addition to the 1534C and 1520I+1534C alleles, in mosquitoes from Thailand. The T1520I mutation did not increase pyrethroid resistance beyond what was conferred by the F1534C mutation alone.
   CONCLUSION The F1534C Vssc mutation is common in A. aegypti populations and confers 7- to 16-fold resistance to pyrethroids, DDT, and DCJW in Aedes aegypti. These resistance levels are considerably less than previously reported for the S989P+V1016G mutations. Our results provide useful information for resistance management, specifically the levels of resistance conferred by the most common Vssc mutation in A. aegypti. (c) 2020 Society of Chemical Industry
C1 [Fan, Yinjun; Scott, Jeffrey G.] Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.
   [Fan, Yinjun] China Agr Univ, Dept Entomol, Beijing, Peoples R China.
RP Scott, JG (corresponding author), Cornell Univ, Dept Entomol, Comstock Hall, Ithaca, NY 14853 USA.
EM jgs5@comell.edu
FU China Scholarship CouncilChina Scholarship Council [201706350254]
FX We thank L. Smith for the KDR:ROCK strain. We thank J. Freeman, J. Silva
   and R. Mertz for their helpful comments on the manuscript. YF was
   supported by a fellowship from the China Scholarship Council (grant no.
   201706350254).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Al Nazawi AM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2096-6
   Badolo A, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007439
   Burton MJ, 2011, INSECT BIOCHEM MOLEC, V41, P723, DOI 10.1016/j.ibmb.2011.05.004
   Chang C, 2009, INSECT BIOCHEM MOLEC, V39, P272, DOI 10.1016/j.ibmb.2009.01.001
   Chen ML, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007432
   Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012
   Du YZ, 2016, INSECTS, V7, DOI 10.3390/insects7040060
   Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110
   Estep AS, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006544
   Fan Y, 2020, PLOS NEGL TROP DIS
   Finney D.T., 1971, PROBIT ANAL
   Granada Y, 2018, INSECTS, V9, DOI 10.3390/insects9010023
   Haddi K, 2017, SCI REP-UK, V7, DOI 10.1038/srep46549
   Hamid PH, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189680
   Hamid PH, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2215-4
   Harris AF, 2010, AM J TROP MED HYG, V83, P277, DOI 10.4269/ajtmh.2010.09-0623
   Hirata K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003085
   Hsu JC, 2011, PESTIC BIOCHEM PHYS, V100, P57, DOI 10.1016/j.pestbp.2011.02.005
   Kasai S, 2019, EUROSURVEILLANCE, V24, P48, DOI 10.2807/1560-7917.ES.2019.24.5.1700847
   Kasai S, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002948
   Kawada H, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004780
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kushwah RBS, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003332
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Li CX, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0933-z
   LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6
   Moyes CL, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005625
   Murcia O, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3309-y
   Plernsub S, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1713-0
   Saavedra-Rodriguez K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25222-0
   Scott JG, 2019, ANNU REV ENTOMOL, V64, P243, DOI 10.1146/annurev-ento-011118-112420
   Seixas G, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005799
   SHONO T, 1985, J PESTIC SCI, V10, P141
   Silva JJ, 2020, INSECT MOL BIOL, V29, P9, DOI 10.1111/imb.12605
   Smith LB, 2019, PESTIC BIOCHEM PHYS, V160, P119, DOI 10.1016/j.pestbp.2019.07.011
   Smith LB, 2018, PEST MANAG SCI, V74, P737, DOI 10.1002/ps.4771
   Smith LB, 2016, PESTIC BIOCHEM PHYS, V133, P1, DOI 10.1016/j.pestbp.2016.03.005
   Sombie A, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-018-0134-5
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Stenhouse SA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-253
   STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325
   Sun H, 2016, INSECT MOL BIOL, V25, P126, DOI 10.1111/imb.12206
NR 43
TC 1
Z9 1
U1 13
U2 13
PU JOHN WILEY & SONS LTD
PI CHICHESTER
PA THE ATRIUM, SOUTHERN GATE, CHICHESTER PO19 8SQ, W SUSSEX, ENGLAND
SN 1526-498X
EI 1526-4998
J9 PEST MANAG SCI
JI Pest Manag. Sci.
PD JUN
PY 2020
VL 76
IS 6
BP 2251
EP 2259
DI 10.1002/ps.5763
EA FEB 2020
PG 9
WC Agronomy; Entomology
SC Agriculture; Entomology
GA LK0KB
UT WOS:000514303600001
PM 31981401
DA 2020-07-08
ER

PT J
AU Sippy, R
   Rivera, GE
   Sanchez, V
   Heras, F
   Morejon, B
   Beltran, E
   Hikida, RS
   Lopez-Latorre, MA
   Aguirre, A
   Stewart-Ibarra, AM
   Larsen, DA
   Neira, M
AF Sippy, Rachel
   Rivera, Galo E.
   Sanchez, Valeria
   Heras, Froilan
   Morejon, Bianca
   Beltran, Efrain
   Hikida, Robert S.
   Lopez-Latorre, Maria A.
   Aguirre, Alex
   Stewart-Ibarra, Anna M.
   Larsen, David A.
   Neira, Marco
TI Ingested insecticide to control Aedes aegypti: developing a novel dried
   attractive toxic sugar bait device for intra-domiciliary control
SO PARASITES & VECTORS
LA English
DT Article
DE Aedes aegypti; Vector control; Toxic sugar bait; Attractive bait;
   Semi-field; Dengue; Arbovirus; ATSB
ID NONTARGET ORGANISMS; DENGUE VECTOR; MOSQUITOS; ALBOPICTUS; DIPTERA;
   RESISTANCE; CULICIDAE; TRAP; ATSB
AB Background Illnesses transmitted by Aedes aegypti (Linnaeus, 1762) such as dengue, chikungunya and Zika comprise a considerable global burden; mosquito control is the primary public health tool to reduce disease transmission. Current interventions are inadequate and insecticide resistance threatens the effectiveness of these options. Dried attractive bait stations (DABS) are a novel mechanism to deliver insecticide to Ae. aegypti. The DABS are a high-contrast 28 inch(2) surface coated with dried sugar-boric acid solution. Aedes aegypti are attracted to DABS by visual cues only, and the dried sugar solution elicits an ingestion response from Ae. aegypti landing on the surface. The study presents the development of the DABS and tests of their impact on Ae. aegypti mortality in the laboratory and a series of semi-field trials. Methods We conducted multiple series of laboratory and semi-field trials to assess the survivability of Ae. aegypti mosquitoes exposed to the DABS. In the laboratory experiments, we assessed the lethality, the killing mechanism, and the shelf life of the device through controlled experiments. In the semi-field trials, we released laboratory-reared female Ae. aegypti into experimental houses typical of peri-urban tropical communities in South America in three trial series with six replicates each. Laboratory experiments were conducted in Quito, Ecuador, and semi-field experiments were conducted in Machala, Ecuador, an area with abundant wild populations of Ae. aegypti and endemic arboviral transmission. Results In the laboratory, complete lethality was observed after 48 hours regardless of physiological status of the mosquito. The killing mechanism was determined to be through ingestion, as the boric acid disrupted the gut of the mosquito. In experimental houses, total mosquito mortality was greater in the treatment house for all series of experiments (P < 0.0001). Conclusions The DABS devices were effective at killing female Ae. aegypti under a variety of laboratory and semi-field conditions. DABS are a promising intervention for interdomiciliary control of Ae. aegypti and arboviral disease prevention.
C1 [Sippy, Rachel; Sanchez, Valeria; Heras, Froilan; Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Sippy, Rachel] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Rivera, Galo E.; Morejon, Bianca; Lopez-Latorre, Maria A.; Aguirre, Alex; Neira, Marco] Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer, Quito, Ecuador.
   [Rivera, Galo E.] Max Plank Inst Infect Biol, Vector Biol Grp, Berlin, Germany.
   [Sanchez, Valeria; Heras, Froilan; Beltran, Efrain] Univ Tecn Machala, Unidad Acad Ciencias Quim & Salud, Machala, Ecuador.
   [Morejon, Bianca] Kansas State Univ, Coll Arts & Sci, Biol Div, Manhattan, KS 66506 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] SUNY Upstate Med Univ, Dept Publ Hlth & Preventat Med, Syracuse, NY 13210 USA.
   [Lopez-Latorre, Maria A.] Univ Amer, Med Sch, Coll Hlth Sci, Quito, Ecuador.
   [Stewart-Ibarra, Anna M.] InterAmer Inst Global Change Res IAI, Montevideo, Uruguay.
   [Larsen, David A.] Syracuse Univ, Dept Publ Hlth, Syracuse, NY 13244 USA.
   [Hikida, Robert S.] Ohio Univ, Athens, OH 45701 USA.
RP Neira, M (corresponding author), Pontificia Univ Catolica Ecuador, Ctr Res Hlth Latin Amer, Quito, Ecuador.; Stewart-Ibarra, AM (corresponding author), InterAmer Inst Global Change Res IAI, Montevideo, Uruguay.; Larsen, DA (corresponding author), Syracuse Univ, Dept Publ Hlth, Syracuse, NY 13244 USA.
EM astewart@dir.iai.int; dalarsen@syr.edu; mvneira@puce.edu.ec
FU Pontificia Universidad Catolica del Ecuador's Internal Research Grant
   [L13234]; Syracuse University
FX Laboratory work was Funded by Pontificia Universidad Catolica del
   Ecuador's Internal Research Grant L13234, awarded to MN. Semi-field work
   was funded by a seed grant from the Syracuse University, awarded to DL.
CR [Anonymous], 2019, EP UPD DENG, P2019
   Barrera R, 2013, J AM MOSQUITO CONTR, V29, P358, DOI 10.2987/13-6343.1
   Boyer S, 2018, MICROBES INFECT, V20, P646, DOI 10.1016/j.micinf.2018.01.006
   Chanda E, 2016, EMERG INFECT DIS, V22, P773, DOI 10.3201/eid2205.150984
   Dennis EJ, 2019, CURR BIOL, V29, P1551, DOI 10.1016/j.cub.2019.04.004
   FAY RW, 1970, MOSQ NEWS, V30, P20
   Fikrig K, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1946-y
   Fiorenzano JM, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040398
   FOSTER WA, 1995, ANNU REV ENTOMOL, V40, P443, DOI 10.1146/annurev.en.40.010195.002303
   Garcia-Rejon J, 2008, AM J TROP MED HYG, V79, P940, DOI 10.4269/ajtmh.2008.79.940
   Harrington LC, 2005, AM J TROP MED HYG, V72, P209, DOI 10.4269/ajtmh.2005.72.209
   Hemingway J, 2000, ANNU REV ENTOMOL, V45, P371, DOI 10.1146/annurev.ento.45.1.371
   Hemme RR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000634
   Heydari N, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14020196
   Junnila A, 2015, ACTA TROP, V152, P195, DOI 10.1016/j.actatropica.2015.09.006
   Khallaayoune K, 2013, ENVIRON ENTOMOL, V42, P1040, DOI 10.1603/EN13119
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuno G, 1995, EPIDEMIOL REV, V17, P321, DOI 10.1093/oxfordjournals.epirev.a036196
   LEA ARDEN O., 1965, MOSQUITO NEWS, V25, P65
   Maia MF, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2171-2
   Martinez-Ibarra JA, 1997, J MED ENTOMOL, V34, P589, DOI 10.1093/jmedent/34.6.589
   Meunier N, 2003, J NEUROBIOL, V56, P139, DOI 10.1002/neu.10235
   Muller GC, 2010, J MED ENTOMOL, V47, P63, DOI 10.1603/033.047.0108
   Olliaro P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005967
   Oxborough RM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1201-1
   Qualls WA, 2016, J AM MOSQUITO CONTR, V32, P292, DOI 10.2987/16-6589.1
   Qualls WA, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0819-8
   Qualls WA, 2014, ACTA TROP, V131, P104, DOI 10.1016/j.actatropica.2013.12.004
   Revay EE, 2014, PARASITOL RES, V113, P73, DOI 10.1007/s00436-013-3628-4
   Ryan SJ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007448
   Scott JM, 2017, J MED ENTOMOL, V54, P236, DOI 10.1093/jme/tjw133
   Scott-Fiorenzano JM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1937-z
   Sissoko F, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214170
   Spencer CY, 2005, J AM MOSQUITO CONTR, V21, P177, DOI 10.2987/8756-971X(2005)21[177:FVITDV]2.0.CO;2
   Stewart ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084168
   Tenywa FC, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1994-6
   VANHANDEL E, 1994, J AM MOSQUITO CONTR, V10, P149
   Xue RD, 2003, J ECON ENTOMOL, V96, P1559, DOI 10.1603/0022-0493-96.5.1559
   Xue RD, 2008, J AM MOSQUITO CONTR, V24, P415, DOI 10.2987/5683.1
   Xue RD, 2006, J AM MOSQUITO CONTR, V22, P497, DOI 10.2987/8756-971X(2006)22[497:AOBABT]2.0.CO;2
   Yuval B., 1992, Bulletin of the Society for Vector Ecology, V17, P150
NR 41
TC 0
Z9 0
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 17
PY 2020
VL 13
IS 1
AR 78
DI 10.1186/s13071-020-3930-9
PG 11
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KQ7WZ
UT WOS:000517132800005
PM 32066486
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Carvalho, MDCG
   Ximenes, RAA
   Montarroyos, UR
   da Silva, PFS
   Andrade-Valenca, LPA
   Eickmann, SH
   Ramos, RC
   Rocha, MAW
   de Araujo, TVB
   de Albuquerque, MDPM
   Martelli, CMT
   de Souza, WV
   Brickley, EB
   Miranda, DD
AF Carvalho, Maria Durce C. G.
   Ximenes, Ricardo A. A.
   Montarroyos, Ulisses R.
   da Silva, Paula F. S.
   Andrade-Valenca, Luciana P. A.
   Eickmann, Sophie H.
   Ramos, Regina C.
   Rocha, Maria Angela W.
   de Araujo, Thalia V. B.
   de Albuquerque, Maria de Fatima P. M.
   Martelli, Celina M. T.
   de Souza, Wayner V.
   Brickley, Elizabeth B.
   Miranda-Filho, Democrito de B.
CA Microcephaly Epidemic Res Grp
TI Early epilepsy in children with Zika-related microcephaly in a cohort in
   Recife, Brazil: Characteristics, electroencephalographic findings, and
   treatment response
SO EPILEPSIA
LA English
DT Article
DE congenital Zika syndrome; epilepsy; microcephaly; seizure; Zika virus
ID VIRUS-INFECTION; ASSOCIATION; INFANTS; EEG
AB Objective To estimate the incidence of epilepsy in children with Zika-related microcephaly in the first 24 months of life; to characterize the associated clinical and electrographic findings; and to summarize the treatment responses.
   Methods We followed a cohort of children, born during the 2015-2016 Zika virus (ZIKV) epidemic in Brazil, with congenital microcephaly and evidence of congenital ZIKV infection on neuroimaging and/or laboratory testing. Neurological assessments were performed at <= 3, 6, 12, 15, 18, 21, and 24 months of life. Serial electroencephalograms were performed over the first 24 months.
   Results We evaluated 91 children, of whom 48 were female. In this study sample, the cumulative incidence of epilepsy was 71.4% in the first 24 months, and the main type of seizure was infantile spasms (83.1%). The highest incidence of seizures occurred between 3 and 9 months of age, and the risk remained high until 15 months of age. The incidence of infantile spasms peaked between 4 and 7 months and was followed by an increased incidence of focal epilepsy cases after 12 months of age. Neuroimaging results were available for all children, and 100% were abnormal. Cortical abnormalities were identified in 78.4% of the 74 children evaluated by computed tomography and 100% of the 53 children evaluated by magnetic resonance imaging. Overall, only 46.1% of the 65 children with epilepsy responded to treatment. The most commonly used medication was sodium valproate with or without benzodiazepines, levetiracetam, phenobarbital, and vigabatrin.
   Significance Zika-related microcephaly was associated with high risk of early epilepsy. Seizures typically began after the third month of life, usually as infantile spasms, with atypical electroencephalographic abnormalities. The seizure control rate was low. The onset of seizures in the second year was less frequent and, when it occurred, presented as focal epilepsy.
C1 [Carvalho, Maria Durce C. G.; Ximenes, Ricardo A. A.; Montarroyos, Ulisses R.; da Silva, Paula F. S.; Andrade-Valenca, Luciana P. A.; Ramos, Regina C.; Rocha, Maria Angela W.; Miranda-Filho, Democrito de B.] Univ Pernambuco, Recife, PE, Brazil.
   [Ximenes, Ricardo A. A.; Andrade-Valenca, Luciana P. A.; Eickmann, Sophie H.; de Araujo, Thalia V. B.] Univ Fed Pernambuco, Recife, PE, Brazil.
   [de Albuquerque, Maria de Fatima P. M.; Martelli, Celina M. T.; de Souza, Wayner V.] Fiocruz Pernambuco, Aggeu Magalhaes Res Ctr, Recife, PE, Brazil.
   [Brickley, Elizabeth B.] London Sch Hyg & Trop Med, London, England.
RP Carvalho, MDCG (corresponding author), Hosp Univ Oswaldo Cruz, Setor Neurol, Rua Arnobio Marques 310, BR-50100130 Recife, PE, Brazil.
EM mdurce2@gmail.com
RI Montarroyos, Ulisses/AAJ-7527-2020
OI Turchi Martelli, Celina Maria/0000-0002-2491-0688
FU European Union's Horizon 2020 Research and Innovation program under the
   ZikaPLAN grant [734584]; Wellcome TrustWellcome Trust [201870/Z/16/Z,
   205377/Z/16/Z, MC_PC_15088]; UK Department for International Development
   [201870/Z/16/Z, 205377/Z/16/Z]; Wellcome Trust Research Enrichment in
   Epidemic Situations [107779/Z/15/Z, ER1505, ER1601]; Medical Research
   Council on behalf of the Newton Fund; Fundacao de Amparo a Ciencia e
   Tecnologia de PE-FACEPE [APQ-0192-4.01/17, APQ-0172-4.01/16];
   Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-BrasilCAPES
   [001]; Conselho Nacional de Desenvolvimento Cientifico e
   TecnologicoNational Council for Scientific and Technological Development
   (CNPq) [309722/2017-9, 306708/2014-0]; Secretaria de Vigilancia em
   Saude/Ministerio da Saude de Brasil Resposta a Emergencia em Saude
   Publica-Zika virus e Microcefalia [837058/2016]; Conselho Nacional de
   Desenvolvimento Cientifico e TecnologicoNational Council for Scientific
   and Technological Development (CNPq); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel SuperiorCAPES; Departamento de Ciencia e Tecnologia
   [440839/2016-5]
FX This work was supported by the European Union's Horizon 2020 Research
   and Innovation program (https://ec.europa.eu/programmes/horizon2020/)
   under the ZikaPLAN grant agreement (No. 734584 to R.A.A.X.),
   (https://zikaplan.tghn.org/); Wellcome Trust and the UK Department for
   International Development (201870/Z/16/Z to D.B.M.-F. & 205377/Z/16/Z to
   R.A.A.X.; https://wellcome.ac.uk/); Wellcome Trust Research Enrichment
   in Epidemic Situations (107779/Z/15/Z; with ER1505 & ER1601 to
   R.A.A.X.); Medical Research Council on behalf of the Newton Fund and
   Wellcome Trust (MC_PC_15088; https://mrc.ukri.org/); Fundacao de Amparo
   a Ciencia e Tecnologia de PE-FACEPE (APQ-0192-4.01/17 to Programa de
   Pos-Graduacao em Ciencias da Saude-UPE and APQ-0172-4.01/16 to
   D.B.M.-F.; http://www.facepe.br/); Coordenacao de Aperfeicoamento de
   Pessoal de Nivel Superior-Brasil, Finance Code 001; scholarships from
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (309722/2017-9 to R.A.A.X., 306708/2014-0 to C.M.T.M.;
   http://www.cnpq.br/); Secretaria de Vigilancia em Saude/Ministerio da
   Saude de Brasil Resposta a Emergencia em Saude Publica-Zika virus e
   Microcefalia (837058/2016 to R.A.A.X.); Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento
   de Pessoal de Nivel Superior (http://www.capes.gov.br/); and
   Departamento de Ciencia e Tecnologia
   (http://rebrats.saude.gov.br/noticias/59DECIT) for Prevencao e Combate
   ao virus Zika I (440839/2016-5 to R.A.A.X.). The funders had no role in
   study design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Albuquerque MDPM, 2016, EMERG INFECT DIS, V22, P1090, DOI [10.32032/eid2206.160062, 10.3201/eid2206.160062]
   Alves LV, 2018, J CHILD NEUROL, V33, P664, DOI 10.1177/0883073818780105
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Castanha PMS, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007246
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Carvalho MDCG, 2017, CLIN NEUROPHYSIOL, V128, P204, DOI 10.1016/j.clinph.2016.11.004
   de Araujo TVB, 2016, LANCET INFECT DIS, V16, P1356, DOI 10.1016/S1473-3099(16)30318-8
   Driggers RW, 2016, NEW ENGL J MED, V374, P2142, DOI 10.1056/NEJMoa1601824
   Franca GVA, 2016, LANCET, V388, P891, DOI 10.1016/S0140-6736(16)30902-3
   GIBBS EL, 1954, PEDIATRICS, V13, P66
   Guerrini R, 2005, J CHILD NEUROL, V20, P287, DOI 10.1177/08830738050200040401
   Herbst SM, 2016, BRAIN DEV-JPN, V38, P399, DOI 10.1016/j.braindev.2015.10.001
   HRACHOVY RA, 1984, EPILEPSIA, V25, P317, DOI 10.1111/j.1528-1157.1984.tb04195.x
   International League Against Epilepsy, W SYNDR OV
   International League Against Epilepsy, LISS
   Kane Nick, 2017, Clin Neurophysiol Pract, V2, P170, DOI 10.1016/j.cnp.2017.07.002
   Klase ZA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004877
   Kwak M, 2018, PEDIATR NEUROL, V83, P14, DOI 10.1016/j.pediatrneurol.2018.03.008
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Lux AL, 2004, EPILEPSIA, V45, P1416, DOI 10.1111/j.0013-9580.2004.02404.x
   Menascu S, 2013, SEIZURE-EUR J EPILEP, V22, P189, DOI 10.1016/j.seizure.2012.12.001
   Miranda DD, 2016, AM J PUBLIC HEALTH, V106, P598, DOI 10.2105/AJPH.2016.303115
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moon HM, 2013, WIRES DEV BIOL, V2, P229, DOI 10.1002/wdev.67
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Oliveira J, 2018, AM J TROP MED HYG, V98, P1860, DOI 10.4269/ajtmh.17-1020
   Oxford University, 2016, INTERGROWTH 21
   Parrini E, 2016, MOL SYNDROMOL, V7, P220, DOI 10.1159/000448639
   Scheffer IE, 2017, EPILEPSIA, V58, P512, DOI 10.1111/epi.13709
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Shao Q, 2016, DEVELOPMENT, V143, P4127, DOI 10.1242/dev.143768
   Suzuki Y, 2008, BRAIN DEV-JPN, V30, P420, DOI 10.1016/j.braindev.2007.12.004
   Thurman DJ, 2011, EPILEPSIA, V52, P2, DOI 10.1111/j.1528-1167.2011.03121.x
   van der Linden H, 2018, NEW ENGL J MED, V379, P891, DOI 10.1056/NEJMc1716070
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   WHO, CHILD GROWTH STAND
   Wu KY, 2016, CELL RES, V26, P645, DOI 10.1038/cr.2016.58
   Ximenes RAA, 2019, PLOS NEGLECT TROP D, V13, P1
NR 39
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0013-9580
EI 1528-1167
J9 EPILEPSIA
JI Epilepsia
PD MAR
PY 2020
VL 61
IS 3
BP 509
EP 518
DI 10.1111/epi.16444
EA FEB 2020
PG 10
WC Clinical Neurology
SC Neurosciences & Neurology
GA KV6TM
UT WOS:000513734500001
PM 32065676
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Hubner, AY
   Hovick, SR
AF Hubner, Austin Y.
   Hovick, Shelly R.
TI Understanding Risk Information Seeking and Processing during an
   Infectious Disease Outbreak: The Case of Zika Virus
SO RISK ANALYSIS
LA English
DT Article
DE Emerging risk; information seeking; risk perception; systematic
   processing; Zika virus
ID CLIMATE-CHANGE; SELF-EFFICACY; UNITED-STATES; MEDIA; KNOWLEDGE;
   BEHAVIOR; MODEL; PRISM; UNCERTAINTY; INFLUENZA
AB This study draws on the Planned Risk Information Seeking Model (PRISM) to assess Zika virus information seeking and systematic processing, paying particular attention to the relationship between perceived knowledge and knowledge insufficiency. Novel risks, such as Zika, provide an interesting context for examining whether information-seeking models, such as PRISM, are able to predict information seeking when available information is limited or scarce. A cross-sectional, online study of men and women of childbearing age (N = 494) residing in the state of Florida was conducted. Our results provide some support for the PRISM for predicting Zika information seeking intention, as well as systematic processing of information. We also found that individuals with high levels of perceived knowledge were more likely to report high level of knowledge insufficiency, illustrating that contextual factors may impact the fit of risk information seeking models.
C1 [Hubner, Austin Y.; Hovick, Shelly R.] Ohio State Univ, Sch Commun, Columbus, OH 43210 USA.
RP Hubner, AY (corresponding author), Ohio State Univ, Derby Hall 3056, Columbus, OH 43210 USA.
EM hubner.9@osu.edu
CR Afifi WA, 2004, COMMUN THEOR, V14, P167, DOI 10.1093/ct/14.2.167
   Aiken L. S., 2012, HDB HLTH PSYCHOL, P113
   Ajzen I, 2002, J APPL SOC PSYCHOL, V32, P665, DOI 10.1111/j.1559-1816.2002.tb00236.x
   AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T
   Anker AE, 2011, PATIENT EDUC COUNS, V82, P346, DOI 10.1016/j.pec.2010.12.008
   Avery EJ, 2017, PUBLIC RELAT REV, V43, P468, DOI 10.1016/j.pubrev.2017.02.018
   BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191
   Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5
   Booth M, 2018, ADV PARASIT, V100, P39, DOI 10.1016/bs.apar.2018.02.001
   Brown M.W., 1993, TESTING STRUCTURAL E
   Brug J, 2009, INT J BEHAV MED, V16, P3, DOI 10.1007/s12529-008-9000-x
   Centers for Disease Control and Prevention, 2019, ZIK
   CHAIKEN S, 1980, J PERS SOC PSYCHOL, V39, P752, DOI 10.1037/0022-3514.39.5.752
   Darrow W, 2018, HEALTH EDUC BEHAV, V45, P967, DOI 10.1177/1090198118760687
   Dunwoody S., 2015, SAGE HDB RISK COMMUN, P102, DOI 10.4135/9781483387918.n14
   EAGLY AH, 1984, ADV EXP SOC PSYCHOL, V17, P267, DOI 10.1016/S0065-2601(08)60122-7
   Eastin MS, 2015, HUM COMMUN RES, V41, P603, DOI 10.1111/hcre.12062
   Falk JH, 2007, PUBLIC UNDERST SCI, V16, P455, DOI 10.1177/0963662506064240
   Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297
   Fishbein M., 2009, EMERGING THEORIES HL, P97
   FREIMUTH VS, 1989, SEARCHING HLTH INFOR
   Griffin R. J., 2013, COMMUNICATION YB, V36, P323
   Griffin R. J., 1999, ANN CONV INT COMM AS
   Griffin RJ, 1999, ENVIRON RES, V80, pS230, DOI 10.1006/enrs.1998.3940
   Griffin RJ, 2008, SCI COMMUN, V29, P285, DOI 10.1177/1075547007312309
   Hayes A.F., 2017, INTRO MEDIATION MODE
   Hayes EB, 2009, EMERG INFECT DIS, V15, P1347, DOI 10.3201/eid1509.090442
   Hennessey M, 2016, AM J TRANSPLANT, V16, P1031, DOI 10.1111/ajt.13743
   Ho SS, 2014, SCI COMMUN, V36, P270, DOI 10.1177/1075547013520238
   Holland K, 2012, J RISK RES, V15, P657, DOI 10.1080/13669877.2011.652651
   Hong S, 2006, RISK ANAL, V26, P1247, DOI 10.1111/j.1539-6924.2006.00812.x
   Hovick SR, 2014, HEALTH COMMUN, V29, P656, DOI 10.1080/10410236.2012.763204
   Hovick SR, 2014, J HEALTH COMMUN, V19, P511, DOI 10.1080/10810730.2013.821556
   Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118
   Ibuka Y, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-296
   Isaacson R., 2006, J SCHOLARSHIP TEACH, V6, P39
   JOHNSON JD, 1993, HUM COMMUN RES, V19, P343, DOI 10.1111/j.1468-2958.1993.tb00305.x
   Kahlor LA, 2007, MEDIA PSYCHOL, V10, P414, DOI 10.1080/15213260701532971
   Kahlor LA, 2019, INT J DISAST RISK RE, V37, DOI 10.1016/j.ijdrr.2019.101147
   Kahlor L, 2006, SCI COMMUN, V28, P163, DOI 10.1177/1075547006293916
   Kahlor L, 2010, HEALTH COMMUN, V25, P345, DOI 10.1080/10410231003775172
   KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x
   Kellens W, 2012, RISK ANAL, V32, P1369, DOI 10.1111/j.1539-6924.2011.01743.x
   Kline R. B., 2005, METHODOLOGY SOCIAL S
   Lambert SD, 2007, QUAL HEALTH RES, V17, P1006, DOI 10.1177/1049732307305199
   Li CH, 2016, BEHAV RES METHODS, V48, P936, DOI 10.3758/s13428-015-0619-7
   Lipsitch M, 2009, NEW ENGL J MED, V361, P112, DOI 10.1056/NEJMp0904380
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Muthen L. K., 2011, MPLUS USERS GUIDE 19
   Natter HM, 2005, APPL COGNITIVE PSYCH, V19, P123, DOI 10.1002/acp.1068
   Painter JE, 2017, VACCINE, V35, P960, DOI 10.1016/j.vaccine.2016.12.050
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pew Research Center, 2016, MOST US PUBL THINK Z
   Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553
   Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879
   Renn O, 2011, WIRES CLIM CHANGE, V2, P154, DOI 10.1002/wcc.99
   Sharma M, 2017, AM J INFECT CONTROL, V45, P301, DOI 10.1016/j.ajic.2016.08.022
   Shim M, 2006, J HEALTH COMMUN, V11, P157, DOI 10.1080/10810730600637475
   Slovic P, 1980, SOC RISK ASSESSMENT, P181, DOI DOI 10.1007/978-1-4899-0445-4
   Southwell BG, 2016, EMERG INFECT DIS, V22, P1320, DOI 10.3201/eid2207.160415
   Sumi-Akamaru H, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0298-3
   Thompson Erika L, 2018, Health Lit Res Pract, V2, pe78, DOI 10.3928/24748307-20180226-01
   Tobias S., 2002, 20023 COLL ENTR EX B
   Trumbo CW, 2002, J COMMUN, V52, P367, DOI 10.1111/j.1460-2466.2002.tb02550.x
   United States Census Bureau, 2019, FLOR STAT QUICK FACT
   Willoughby JF, 2016, J HEALTH COMMUN, V21, P696, DOI 10.1080/10810730.2016.1153764
   Witte K., 1998, THEORY BASED INTERVE
   Worland J., 2016, TIME
   Yang JZ, 2019, RISK ANAL, V39, P1708, DOI 10.1111/risa.13282
   Yang ZJ, 2014, COMMUN RES, V41, P935, DOI 10.1177/0093650213479795
   Yang ZJ, 2014, J COMMUN, V64, P20, DOI 10.1111/jcom.12071
   Yang ZJ, 2013, SCI COMMUN, V35, P189, DOI 10.1177/1075547012441873
   Young ME, 2013, HEALTH RISK SOC, V15, P103, DOI 10.1080/13698575.2012.748884
NR 73
TC 0
Z9 0
U1 12
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0272-4332
EI 1539-6924
J9 RISK ANAL
JI Risk Anal.
PD JUN
PY 2020
VL 40
IS 6
BP 1212
EP 1225
DI 10.1111/risa.13456
EA FEB 2020
PG 14
WC Public, Environmental & Occupational Health; Mathematics,
   Interdisciplinary Applications; Social Sciences, Mathematical Methods
SC Public, Environmental & Occupational Health; Mathematics; Mathematical
   Methods In Social Sciences
GA LZ4XQ
UT WOS:000513773500001
PM 32067244
DA 2020-07-08
ER

PT J
AU Blaizot, R
   Ouattara, E
   Receveur, MC
   Mechain, M
   Pistone, T
   Malvy, D
   Duvignaud, A
AF Blaizot, R.
   Ouattara, E.
   Receveur, M. C.
   Mechain, M.
   Pistone, T.
   Malvy, D.
   Duvignaud, A.
TI Dermatoses in international travellers seen at Bordeaux teaching
   hospital travel clinic, 2015-2018: a GeoSentinel-based study
SO CLINICAL AND EXPERIMENTAL DERMATOLOGY
LA English
DT Article; Early Access
ID SPECTRUM
AB Skin disorders are frequent in travellers, but data vary between different studies. The objectives of the current study were to describe imported dermatoses in the Bordeaux GeoSentinel prospective database between August 2015 and March 2018. During the study period, 1025 travellers were seen in the clinic, 201 of them with dermatoses. Patients with skin disorders were more likely to be aged > 60 years (OR = 1.88, 95% CI 1.22-2.89), to be tourists (OR 3.04, 95% CI 2.03-4.55) and to have travelled to South America (OR = 2.18, 95% CI 1.29-3.67), and less likely to have sought pretravel advice (OR = 0.53, 95% CI 0.31-0.91). Skin bacterial infections (19.4%) and Zika virus infections (18.4%) were the most common dermatoses. Dengue fever and bacterial skin infections were the leading causes of hospitalization. The contribution of tropical diseases to imported dermatoses remains important. Lack of pretravel advice puts tourists at risk of significant diseases such as dengue fever, Zika virus and bacterial infections.
C1 [Blaizot, R.; Ouattara, E.; Receveur, M. C.; Mechain, M.; Pistone, T.; Malvy, D.; Duvignaud, A.] CHU Bordeaux, Div Trop Med & Clin Int Hlth, Dept Infect Dis & Trop Med, 1 Rue Jean Burguet, F-33000 Bordeaux, France.
   [Ouattara, E.; Pistone, T.; Malvy, D.; Duvignaud, A.] Univ Bordeaux, ISPED, Inserm Infect Dis Lower Income Countries 1219, Bordeaux, France.
RP Blaizot, R (corresponding author), CHU Bordeaux, Div Trop Med & Clin Int Hlth, Dept Infect Dis & Trop Med, 1 Rue Jean Burguet, F-33000 Bordeaux, France.
EM blaizot.romain@gmail.com
OI Blaizot, Romain/0000-0003-3695-6824
CR Ansart S, 2007, AM J TROP MED HYG, V76, P184, DOI 10.4269/ajtmh.2007.76.184
   Freedman DO, 2006, NEW ENGL J MED, V354, P119, DOI 10.1056/NEJMoa051331
   Garcia-Bujalance S, 2017, J CLIN VIROL, V96, P110, DOI 10.1016/j.jcv.2017.10.006
   Herbinger KH, 2011, TROP MED INT HEALTH, V16, P1457, DOI 10.1111/j.1365-3156.2011.02840.x
   Lederman ER, 2008, INT J INFECT DIS, V12, P593, DOI 10.1016/j.ijid.2007.12.008
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Stevens Michael S, 2015, CMAJ Open, V3, pE119, DOI 10.9778/cmajo.20140082
   Stienlauf S, 2005, J TRAVEL MED, V12, P136, DOI 10.2310/7060.2005.12308
NR 8
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0307-6938
EI 1365-2230
J9 CLIN EXP DERMATOL
JI Clin. Exp. Dermatol.
DI 10.1111/ced.14170
EA FEB 2020
PG 4
WC Dermatology
SC Dermatology
GA KL8RT
UT WOS:000513686600001
PM 31916616
OA Other Gold, Green Accepted
DA 2020-07-08
ER

PT J
AU Beys-da-Silva, WO
   Quincozes-Santos, A
   Tureta, EF
   Rosa, RL
   Berger, M
   Bobermin, LD
   Souza, DO
   Guimaraes, JA
   Santi, L
AF Beys-da-Silva, Walter O.
   Quincozes-Santos, Andre
   Tureta, Emanuela F.
   Rosa, Rafael L.
   Berger, Markus
   Bobermin, Larissa D.
   Souza, Diogo O.
   Guimaraes, Jorge A.
   Santi, Lucelia
TI Association between Zika virus and future neurological diseases
SO JOURNAL OF THE NEUROLOGICAL SCIENCES
LA English
DT Letter
DE Zika virus; Brain diseases; Infection; Outbreak; Brazil
ID RESPONSES
C1 [Beys-da-Silva, Walter O.; Tureta, Emanuela F.; Rosa, Rafael L.; Santi, Lucelia] Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.
   [Beys-da-Silva, Walter O.; Rosa, Rafael L.; Berger, Markus; Guimaraes, Jorge A.; Santi, Lucelia] Hosp Clin Porto Alegre, Ctr Pesquisa Expt, Porto Alegre, RS, Brazil.
   [Quincozes-Santos, Andre; Bobermin, Larissa D.; Souza, Diogo O.] Univ Fed Rio Grande do Sul, Inst Ciencias Basicas Saude, Dept Bioquim, Porto Alegre, RS, Brazil.
RP Beys-da-Silva, WO (corresponding author), Univ Fed Rio Grande do Sul, Fac Farm, Av Ipiranga 2752,Suit 709, Porto Alegre, RS, Brazil.
EM walter.beys@ufrgs.br
RI Santi, Lucelia/AAB-8349-2020; Berger, Markus/U-7682-2019; Santi,
   Lucelia/AAK-9527-2020; Beys-da-Silva, Walter O/M-3760-2018;
   Quincozes-Santos, Andre/AAO-2714-2020; Souza, Diogo/J-8894-2014
OI Santi, Lucelia/0000-0002-5698-7006; Berger, Markus/0000-0001-7670-2584;
   Beys-da-Silva, Walter O/0000-0001-8329-7839; Souza,
   Diogo/0000-0002-4322-0404; Quincozes-Santos, Andre/0000-0001-8611-4890
FU Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES)CAPES;
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico
   (CNPq)National Council for Scientific and Technological Development
   (CNPq) [440763/2016-9]
FX The authors would like to thank the Brazilian funding agencies
   Coordenacao de Aperfeicoamento Pessoal de Nivel Superior (CAPES) and
   Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq),
   and the funding provided by the Edital
   MCTIC/FNDCT-CNPq/MEC-CAPES/MS-Decit/, project #440763/2016-9 for
   supporting the ZIKA Taskforce.
CR Beys-da-Silva WO, 2019, MOL NEUROBIOL, V56, P4708, DOI 10.1007/s12035-018-1417-x
   Blasco H, 2014, CURR MED CHEM, V21, P3551, DOI 10.2174/0929867321666140916120118
   Davis AC, 2016, HANDBOOK ON PERSONALIZED LEARNING FOR STATES, DISTRICTS, AND SCHOOLS, P37
   Dehhaghi M, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00466
   Delpech JC, 2019, TRENDS NEUROSCI, V42, P361, DOI 10.1016/j.tins.2019.02.007
   Farah R, 2018, BIOMED J, V41, P63, DOI 10.1016/j.bj.2018.03.004
   Figueiredo CP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11866-7
   McGrath EL, 2017, STEM CELL REP, V8, P715, DOI 10.1016/j.stemcr.2017.01.008
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Peltier DC, 2013, J VIROL, V87, P1821, DOI 10.1128/JVI.02858-12
   Pereira L, 2018, ANNU REV VIROL, V5, P273, DOI 10.1146/annurev-virology-092917-043236
   Platt DJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aao7090
   Rappaport Noa, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0124s47
   Rosa RL, 2020, J NEUROVIROL, V26, P77, DOI 10.1007/s13365-019-00799-y
   Schipper HM, 2019, PROG NEUROBIOL, V172, P40, DOI 10.1016/j.pneurobio.2018.06.008
   Shi Y, 2018, NAT REV IMMUNOL, V18, P759, DOI 10.1038/s41577-018-0051-1
   Waldorf KMA, 2018, TRENDS MICROBIOL, V26, P729, DOI 10.1016/j.tim.2018.05.011
   Walker CL, 2019, AM J OBSTET GYNECOL, V220, P45, DOI 10.1016/j.ajog.2018.08.035
   Wang MD, 2017, NEUROTOXICOLOGY, V61, P101, DOI 10.1016/j.neuro.2016.06.015
NR 19
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0022-510X
EI 1878-5883
J9 J NEUROL SCI
JI J. Neurol. Sci.
PD FEB 15
PY 2020
VL 409
AR UNSP 116617
DI 10.1016/j.jns.2019.116617
PG 3
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA KO3DU
UT WOS:000515428900037
PM 31835212
DA 2020-07-08
ER

PT J
AU Fuzo, CA
   de Araujo, LFL
   Pontes, RD
   Evora, PM
   Stabeli, RG
AF Fuzo, Carlos Alessandro
   de Araujo, Luiz Felipe Lemes
   Pontes, Rafael de Souza
   Evora, Patricia Martinez
   Stabeli, Rodrigo Guerino
TI Adjacent dimer epitope of envelope protein as an important region for
   Zika virus serum neutralization: a computational investigation
SO JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
LA English
DT Article; Early Access
DE Zika virus neutralization; conservation analysis; epitope mapping;
   molecular dynamics simulation; neutralizing antibodies
ID DENGUE VIRUS; HUMAN-ANTIBODIES; STRUCTURAL BASIS; VERSION; POTENT;
   PREDICTION; INFECTION
AB The recent emergence of Zika virus (ZIKV) has affected many countries, with severe clinical manifestations such as fetal microcephaly and Guillain-Barre syndrome. However, even though it is a major public health concern, there is no approved treatment available. Structural knowledge of the main neutralization regions of the envelope (E) protein of ZIKV and its interactions with neutralizing antibodies (nAbs) are crucial for the rational development of subunit vaccines and establishment of antibody-based interventions. In this study we screened from public data hot spot epitopes in conserved regions of ZIKV E protein that are nAbs targets. The result points to a conserved epitope located at domain II of the ZIKV E protein, namely adjacent dimer epitope, which is the ZIKV-117 and Z20 nAbs target. Although these two nAbs have been isolated from different donors, we have demonstrated, from structural and energetic details obtained by molecular dynamics of native and mutants, that hot spots residues of the epitope are the same for these nAbs, thereby indicating that they may share similar binding and neutralization mechanism. This convergence of information between these nAbs is important because both are potential targets for the development of therapies against ZIKV and only Z20 has its sequence and its complex structure with ZIKV E protein determined. Finally, these findings also contribute to existing knowledge, by fine mapping of the epitope/paratope residue pairs that are important for biotechnological development of therapies such as epitope mimetics for subunit vaccines and the rational design for antibody-based interventions against ZIKV. Communicated by Ramaswamy H. Sarma
C1 [Fuzo, Carlos Alessandro; de Araujo, Luiz Felipe Lemes; Pontes, Rafael de Souza; Evora, Patricia Martinez; Stabeli, Rodrigo Guerino] Fundacao Oswaldo Cruz Fiocruz SP, Plataforma Pesquisa Med Translac, Ave Bandeirantes 3900,Campus USP Ribeirao Preto, Sao Paulo, Brazil.
   [Fuzo, Carlos Alessandro] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, Ribeirao Preto, SP, Brazil.
   [de Araujo, Luiz Felipe Lemes; Pontes, Rafael de Souza; Evora, Patricia Martinez; Stabeli, Rodrigo Guerino] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Bioquim & Imunol, Ribeirao Preto, SP, Brazil.
RP Fuzo, CA; Stabeli, RG (corresponding author), Fundacao Oswaldo Cruz Fiocruz SP, Plataforma Pesquisa Med Translac, Ave Bandeirantes 3900,Campus USP Ribeirao Preto, Sao Paulo, Brazil.
EM cafuzo@usp.br; rodrigo.stabeli@fiocruz.br
FU Conselho Nacional de Desenvolvimento Cientifico e TecnologicoNational
   Council for Scientific and Technological Development (CNPq)
   [118449/2017-6]
FX This work was supported by the Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico [fellowship number 118449/2017-6].
CR Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001
   Akaberi D, 2019, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1704882
   Anandakrishnan R, 2012, NUCLEIC ACIDS RES, V40, pW537, DOI 10.1093/nar/gks375
   [Anonymous], 2015, PYMOL MOL GRAPH SYST
   Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   BARLOW DJ, 1983, J MOL BIOL, V168, P867, DOI 10.1016/S0022-2836(83)80079-5
   BARLOW DJ, 1986, NATURE, V322, P747, DOI 10.1038/322747a0
   Barone D, 2017, J BIOMOL STRUCT DYN, V35, P805, DOI 10.1080/07391102.2016.1162198
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Bojanowski M, 2016, ALLUVIAL R PACKAGE C
   Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964
   Contreras-Riquelme S, 2018, PEERJ, V6, DOI 10.7717/peerj.5998
   Monteiro LMC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193514
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   Tosta SFD, 2020, J BIOMOL STRUCT DYN, DOI 10.1080/07391102.2019.1707120
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Dunbar J, 2016, NUCLEIC ACIDS RES, V44, pW474, DOI 10.1093/nar/gkw361
   Echave J, 2016, NAT REV GENET, V17, P109, DOI 10.1038/nrg.2015.18
   Fernandez E, 2017, NAT IMMUNOL, V18, P1261, DOI 10.1038/ni.3849
   Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   HEINZ FX, 1994, ARCH VIROL, P339
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   HOCKNEY RW, 1974, J COMPUT PHYS, V14, P148, DOI 10.1016/0021-9991(74)90010-2
   Huerta-Cepas J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-24
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Kielian M, 2006, VIROLOGY, V344, P38, DOI 10.1016/j.virol.2005.09.036
   Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005
   Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711
   Mecharles S, 2016, LANCET, V387, P1481, DOI 10.1016/S0140-6736(16)00644-9
   Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h
   MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Nayak A, 2015, J BIOMOL STRUCT DYN, V33, P1682, DOI 10.1080/07391102.2014.967300
   Oehler E., 2014, Eurosurveillance, V19, P20720
   Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859
   Premkumar L, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01504-17
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Sabetian S, 2019, J BIOMOL STRUCT DYN, V37, P2546, DOI 10.1080/07391102.2018.1491890
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Tharakaraman K, 2018, CELL HOST MICROBE, V23, P618, DOI 10.1016/j.chom.2018.04.004
   Van Regenmortal Marc H. V., 1996, Methods (Orlando), V9, P465, DOI 10.1006/meth.1996.0054
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033
   Eswar Narayanan, 2006, Curr Protoc Bioinformatics, VChapter 5, pUnit, DOI [10.1002/cpps.20, 10.1002/0471140864.ps0209s50, 10.1002/cpbi.3, 10.1002/0471250953.bi0506s15]
   Wickham H., 2016, GGPLOT2 ELEGANT GRAP
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Zhang S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13679
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 62
TC 1
Z9 1
U1 1
U2 1
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 0739-1102
EI 1538-0254
J9 J BIOMOL STRUCT DYN
JI J. Biomol. Struct. Dyn.
DI 10.1080/07391102.2020.1728385
EA FEB 2020
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA KO0JS
UT WOS:000515232700001
PM 32090677
DA 2020-07-08
ER

PT J
AU Arista-Jalife, A
   Nakano, M
   Garcia-Nonoal, Z
   Robles-Camarillo, D
   Perez-Meana, H
   Arista-Viveros, HA
AF Arista-Jalife, Antonio
   Nakano, Mariko
   Garcia-Nonoal, Zaira
   Robles-Camarillo, Daniel
   Perez-Meana, Hector
   Antonio Arista-Viveros, Heriberto
TI Aedes mosquito detection in its larval stage using deep neural networks
SO KNOWLEDGE-BASED SYSTEMS
LA English
DT Article
DE Mosquito larval surveillance; Deep neural networks; Automatic
   segmentation; Vector control; Dengue fever; Zika fever
ID DENGUE; ZIKA
AB Dengue, Chikungunya and Zika viruses cause dangerous infections in tropical and subtropical regions throughout the world. The World Health Organization estimates that one out of every three persons in the entire human population is in danger of contracting one of these diseases from a single mosquito bite. Currently, these viral infections are not preventable by vaccines and there is not a direct treatment that can effectively diminish the viral infection, which causes a wide range of pathologies, including severe joint pain, internal blood loss, permanent neurological damage in unborn children and even death. Due to this grim scenario, the best and maybe the only line of defense against these diseases is the effective surveillance, control and suppression of the mosquitoes that transmit these viruses: Aedes aegypti and Aedes albopictus. In this paper, we present a complete solution that is capable of identifying the Aedes aegypti and Aedes albopictus mosquito in the larval stage, which is easily disposable, restricted to water bodies, and incapable of transmitting diseases according to the Centers for Disease Control and Prevention (CDC). Our proposal is based on deep neural networks (DNN) that effectively recognize larval samples with an accuracy of 94.19%, which is better than other state-of-the-art automatic methods. Additionally, the capabilities of our proposed DNN allow us to automatically crop the region of interest (ROI) with an accuracy of 92.85% and then automatically classify the region as Aedes positive or Aedes negative, without further human intervention and in less than a second, accelerating the response time for biological control from days to seconds. Our proposal includes hardware designs that allow inexpensive implementation, making it suitable for isolated communities, underdeveloped countries, and rural or urban areas. (C) 2019 Elsevier B.V. All rights reserved.
C1 [Arista-Jalife, Antonio; Nakano, Mariko; Garcia-Nonoal, Zaira; Perez-Meana, Hector] Inst Politecn Nacl, ESIME Culhuacan, Av Sta Ana 1000, Mexico City, DF, Mexico.
   [Robles-Camarillo, Daniel] Univ Politecn Pachuca, Pachuca, Hidalgo, Mexico.
   [Antonio Arista-Viveros, Heriberto] Hosp Gen Mexico City, Mexico City, DF, Mexico.
RP Nakano, M (corresponding author), Inst Politecn Nacl, ESIME Culhuacan, Av Sta Ana 1000, Mexico City, DF, Mexico.
EM arista.antonio@gmail.com; mnakano@ipn.mx
CR [Anonymous], 2018, LANCET INFECT DIS, V18, P123, DOI [10.1016/S1473-3099(17)30752-1, 10.1016/S1473-3099(18)30023-9]
   [Anonymous], 2015, METH GUID LARV PUP S
   [Anonymous], 2018, THES TOP 15 DEADL AN
   Arista-Jalife A., 2018, INT C INT SOFTW METH, V17
   Centers for Disease Control and Prevention, 2017, SURV CONTR AED AEG A
   Centers for Disease Control and Protection, 2017, EST RANG AED AEG AED
   Crete F, 2007, PROC SPIE, V6492, DOI 10.1117/12.702790
   D'Ortenzio E, 2016, NEW ENGL J MED, V374, P2195, DOI 10.1056/NEJMc1604449
   Deng C, 2017, IEEE T SYST MAN CYB, P1
   Endo K, 2019, TISSUE ENG PT A, V25, P901, DOI [10.1089/ten.tea.2018.0177, 10.1089/ten.TEA.2018.0177]
   Everingham M, 2010, INT J COMPUT VISION, V88, P303, DOI 10.1007/s11263-009-0275-4
   Fuchida M, 2017, APPL SCI-BASEL, V7, DOI 10.3390/app7010051
   Fujita H, 2019, INFORM SCIENCES, V486, P231, DOI 10.1016/j.ins.2019.02.065
   Gaburro J, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1870-1
   Garcia-Nonoal Z., 2017, P CAIP, P271
   Giovanetti M., 2018, CLIN MICROBIOL INFEC
   Girshick R, 2014, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2014.81
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Gvozden G, 2018, J VIS COMMUN IMAGE R, V50, P145, DOI 10.1016/j.jvcir.2017.11.017
   Hopp MJ, 2001, CLIMATIC CHANGE, V48, P441, DOI 10.1023/A:1010717502442
   KENDALL MG, 1979, ADV THEORY STAT
   Li X, 2002, IEEE IMAGE PROC, P449
   Li Z, 2005, P IFIP INT C ART INT
   Lin J, 2018, OCUL IMMUNOL INFLAMM, V26, P680, DOI 10.1080/09273948.2016.1263340
   Lin TY, 2014, LECT NOTES COMPUTER, V8693
   Liu W., 2016, P EUR C COMP VIS, V9905, P1
   Madariaga M, 2016, BRAZ J INFECT DIS, V20, P91, DOI 10.1016/j.bjid.2015.10.004
   Matta D., 2019, PLOS ONE, V14
   Mittal A, 2013, IEEE SIGNAL PROC LET, V20, P209, DOI 10.1109/LSP.2012.2227726
   Mittal A, 2012, IEEE T IMAGE PROCESS, V21, P4695, DOI 10.1109/TIP.2012.2214050
   Moore A, 2002, ANN ENTOMOL SOC AM, V95, P1, DOI 10.1603/0013-8746(2002)095[0001:AIOOSA]2.0.CO;2
   Musso D, 2015, LANCET, V386, P243, DOI 10.1016/S0140-6736(15)61273-9
   Oehler E, 2013, EUROSURVEILLANCE, V19, P9
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Patterson J, 2016, WEST J EMERG MED, V17, P671, DOI 10.5811/westjem.2016.9.30904
   Ren SQ, 2017, IEEE T PATTERN ANAL, V39, P1137, DOI 10.1109/TPAMI.2016.2577031
   Rossi G., ILLUSTRATIVE CLUE ID
   Sanchez-Ortiz A., 2017, INT C EL COMM COMP C, P155
   Shepard DS, 2016, LANCET INFECT DIS, V16, P935, DOI 10.1016/S1473-3099(16)00146-8
   Simonyan K., 2014, 14091556 ARXIV, DOI DOI 10.1016/J.INFSOF.2008.09.005
   Tan JH, 2017, INFORM SCIENCES, V420, P66, DOI 10.1016/j.ins.2017.08.050
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tzutalin. Labellmg, 2015, TZUTALIN LABELLMG FR
   Wang EY, 2000, J VIROL, V74, P3227, DOI 10.1128/JVI.74.7.3227-3234.2000
   Winskill P, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-68
   World Health Organization, 2016, DENG VACC WHO POS PA, V91, P349
NR 46
TC 0
Z9 0
U1 7
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0950-7051
EI 1872-7409
J9 KNOWL-BASED SYST
JI Knowledge-Based Syst.
PD FEB 15
PY 2020
VL 189
AR 104841
DI 10.1016/j.knosys.2019.07.012
PG 16
WC Computer Science, Artificial Intelligence
SC Computer Science
GA KH9FS
UT WOS:000510955100001
DA 2020-07-08
ER

PT J
AU Prochazkova, E
   Hrebabecky, H
   Dejmek, M
   Sala, M
   Smidkova, M
   Tloustova, E
   Zbornikova, E
   Eyer, L
   Ruzek, D
   Nencka, R
AF Prochazkova, Eliska
   Hrebabecky, Hubert
   Dejmek, Milan
   Sala, Michal
   Smidkova, Marketa
   Tloustova, Eva
   Zbornikova, Eva
   Eyer, Ludek
   Ruzek, Daniel
   Nencka, Radim
TI Could 5 '-N and S ProTide analogues work as prodrugs of antiviral
   agents?
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Antiviral; Nucleotide; Prodrug; ProTide; HCV; P-31 NMR spectroscopy
ID NUCLEOSIDE INHIBITORS; VIRUS; DERIVATIVES; EFFICACY; GS-5734; EBOLA
AB The nucleoside/nucleotide derived antiviral agents have been the most important components of antiviral therapy used in clinics. Recently, the focus of the medicinal chemists within this exciting research field has been affected mainly by the lack of effective therapies for the Hepatitis C virus (HCV) infection and several other "neglected" diseases caused by viruses such as Zika or Dengue. 2'-Methyl modified nucleosides and their monophosphate prodrugs (ProTides) have revolutionized the therapies for HCV in the last few years and, according to the latest research efforts, have also brought a promise for treatment of diseases caused by other members of Flaviviridae family. Here, we report on the design and synthesis of 5'-N and S modified ProTides derived from 2'-methyladenosine. We studied potential applicability of these derivatives as prodrugs of this archetypal antiviral compound.
C1 [Prochazkova, Eliska; Hrebabecky, Hubert; Dejmek, Milan; Sala, Michal; Smidkova, Marketa; Tloustova, Eva; Zbornikova, Eva; Nencka, Radim] Czech Acad Sci, Inst Organ Chem & Biochem, Prague 11610, Czech Republic.
   [Eyer, Ludek; Ruzek, Daniel] Vet Res Inst, Dept Virol, Brno 62100, Czech Republic.
   [Eyer, Ludek; Ruzek, Daniel] Czech Acad Sci, Inst Parasitol, Biol Ctr, Ceske Budejovice 37005, Czech Republic.
RP Prochazkova, E (corresponding author), Czech Acad Sci, Inst Organ Chem & Biochem, Prague 11610, Czech Republic.
OI Dejmek, Milan/0000-0002-8195-971X
FU Ministry of Health of the Czech RepublicMinistry of Health, Czech
   Republic [16-34238A]; Czech Academy of SciencesCzech Academy of Sciences
   [RVO: 61388963]; European Regional Development FundEuropean Union (EU);
   OP RDE [CZ.02.1.01/0.0/0.0/16_019/0000729]; Ministry of Education of the
   Czech RepublicMinistry of Education, Youth & Sports - Czech Republic
   [LO1302]; Gilead Sciences, Inc.Gilead Sciences
FX This work was funded by Ministry of Health of the Czech Republic (grant
   No. 16-34238A). The project was supported by the Czech Academy of
   Sciences (RVO: 61388963) and European Regional Development Fund; OP RDE;
   Project: "Chemical biology for drugging undruggable targets
   (ChemBioDrug)" (No. CZ.02.1.01/0.0/0.0/16_019/0000729). The work of MS
   was supported by Project InterBioMed LO1302 from the Ministry of
   Education of the Czech Republic. The work was also supported by Gilead
   Sciences, Inc. We would like to acknowledge Kvetoslava Kertisova and
   Sarka Vrsnikova for HR-MS analysis of the unstable intermediate. We are
   also obliged to Anthony Allan for reading the manuscript.
CR Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210
   Behnam MAM, 2016, J MED CHEM, V59, P5622, DOI 10.1021/acs.jmedchem.5b01653
   Botting C, 2012, EXPERT OPIN DRUG DIS, V7, P417, DOI 10.1517/17460441.2012.673579
   Cho A, 2012, BIOORG MED CHEM LETT, V22, P4127, DOI 10.1016/j.bmcl.2012.04.065
   Eyer Ludek, 2018, Antiviral Chemistry & Chemotherapy, V26, DOI 10.1177/2040206618761299
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Eyer L, 2015, ANTIMICROB AGENTS CH, V59, P5483, DOI 10.1128/AAC.00807-15
   Gollnest T, 2016, ANGEW CHEM INT EDIT, V55, P5255, DOI 10.1002/anie.201511808
   Gollnest T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9716
   Hrebabecky H, 2015, ORG BIOMOL CHEM, V13, P9300, DOI 10.1039/c5ob00987a
   Huchting J, 2018, J MED CHEM, V61, P6193, DOI 10.1021/acs.jmedchem.8b00617
   Kok WM, 2016, EXPERT OPIN DRUG DIS, V11, P433, DOI 10.1517/17460441.2016.1160887
   Lawitz E, 2013, NEW ENGL J MED, V368, P1878, DOI 10.1056/NEJMoa1214853
   Lim SP, 2015, ANTIVIR RES, V119, P57, DOI 10.1016/j.antiviral.2015.04.010
   Lo MK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43395
   MCGUIGAN C, 1993, J MED CHEM, V36, P1048, DOI 10.1021/jm00060a013
   McGuigan C, 1996, J MED CHEM, V39, P1748, DOI 10.1021/jm950605j
   Mehellou Y, 2009, CHEMMEDCHEM, V4, P1779, DOI 10.1002/cmdc.200900289
   Mejdrova I, 2015, J MED CHEM, V58, P3767, DOI 10.1021/acs.jmedchem.5b00499
   Mello C, 2014, ANTIMICROB AGENTS CH, V58, P1546, DOI 10.1128/AAC.01746-13
   Prochazkova E, 2019, ORG BIOMOL CHEM, V17, P315, DOI 10.1039/c8ob02870b
   Siegel D, 2017, J MED CHEM, V60, P1648, DOI 10.1021/acs.jmedchem.6b01594
   Sinokrot H, 2017, MOLECULES, V22, DOI 10.3390/molecules22101736
   Sofia MJ, 2012, J MED CHEM, V55, P2481, DOI 10.1021/jm201384j
   WALTON E, 1966, J AM CHEM SOC, V88, P4524, DOI 10.1021/ja00971a051
   Warren TK, 2016, NATURE, V531, P381, DOI 10.1038/nature17180
   Weinschenk L, 2015, J MED CHEM, V58, P6114, DOI 10.1021/acs.jmedchem.5b00737
   Yates MK, 2019, ANTIVIR RES, V162, P5, DOI 10.1016/j.antiviral.2018.11.016
NR 29
TC 0
Z9 0
U1 31
U2 31
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD FEB 15
PY 2020
VL 30
IS 4
AR 126897
DI 10.1016/j.bmcl.2019.126897
PG 4
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA KD6PP
UT WOS:000507987200013
PM 31882298
DA 2020-07-08
ER

PT J
AU Wang, YX
   Zhou, R
   Quan, YN
   Chen, SM
   Shi, XP
   Li, YP
   Cen, S
AF Wang, Yixuan
   Zhou, Rui
   Quan, Yanni
   Chen, Shumin
   Shi, Xingpeng
   Li, Yanping
   Cen, Shan
TI Design, synthesis, and evaluation of novel
   4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile compounds as Zika
   inhibitors
SO BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
LA English
DT Article
DE Zika virus inhibitors; Synthesis;
   4-Amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile; Antiviral;
   Structure-activity relationship; Cytopathic effect
ID VIRUS NS2B-NS3 PROTEASE; DISCOVERY; INFECTION
AB The prevalence of Zika virus (ZIKV) has become widespread in recent years. ZIKV infection is associated with severe congenital CNS malformations in both newborns and adults. However, neither vaccines nor therapeutics are available to control ZIKV infection until now. We started by hit screening our in-house small molecule library, then designed, synthesized, and evaluated a new class of 1, 4-bibenzylsubstituted piperazine derivatives for their cytopathic effect (CPE) protection effect in a ZIKV-infected Vero E6 cellular assay. A preliminary structure-activity relationship study identified five novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile analogs with obvious CPE reduction effects against ZIKV at micromolar concentrations. Moreover, compound 3p exerted a significant antiviral effect on both Zika RNA replication and virus protein expression in a dose-dependent manner at low micromolar concentrations. This study demonstrated the potential of a novel 4-amino-2-(4-benzylpiperazin-1-yl)methylbenzonitrile scaffold for the development of anti-ZIKV candidates.
C1 [Wang, Yixuan; Zhou, Rui; Quan, Yanni; Chen, Shumin; Shi, Xingpeng; Li, Yanping; Cen, Shan] Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, CAMS Key Lab Antiviral Drug Res, 1 Tiantanxili, Beijing 100050, Peoples R China.
RP Li, YP; Cen, S (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Med Biotechnol, CAMS Key Lab Antiviral Drug Res, 1 Tiantanxili, Beijing 100050, Peoples R China.
EM liyanping@imb.pumc.edu.cn; shancen@imb.pumc.edu.cn
OI Li, Yanping/0000-0002-5771-0252
FU CAMS Innovation Fund for Medical Sciences [2016-I2M-3-022,
   2018-I2M-3-004]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81202414]; National Science and
   Technology Major Projects for New Drugs Innovation of China
   [2017ZX09201006-012]
FX This study was supported by CAMS Innovation Fund for Medical Sciences
   (Grant No. 2016-I2M-3-022, 2018-I2M-3-004), National Natural Science
   Foundation of China (Grant No. 81202414) and National Science and
   Technology Major Projects for New Drugs Innovation of China (Grant No.
   2017ZX09201006-012).
CR Adcock RS, 2017, ANTIVIR RES, V138, P47, DOI 10.1016/j.antiviral.2016.11.018
   Bullard-Feibelman KM, 2017, ANTIVIR RES, V137, P134, DOI 10.1016/j.antiviral.2016.11.023
   Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322
   Deng YQ, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw175
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Durbin A, 2017, EXPERT REV VACCINES, V16, P781, DOI 10.1080/14760584.2017.1345309
   Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636
   Hercik K, 2017, ARCH VIROL, V162, P2091, DOI 10.1007/s00705-017-3345-x
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Julander JG, 2017, ANTIVIR RES, V137, P14, DOI 10.1016/j.antiviral.2016.11.003
   Lei J, 2016, SCIENCE, V353, P503, DOI 10.1126/science.aag2419
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Musso D, 2015, EMERG INFECT DIS, V21, P1887, DOI 10.3201/eid2110.151125
   Tong X, 2018, ANTIVIR RES, V149, P34, DOI 10.1016/j.antiviral.2017.11.004
   World Health Organization, 2019, ZIK EP
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Yuan SF, 2017, ANTIVIR RES, V145, P33, DOI 10.1016/j.antiviral.2017.07.007
   Zmurko J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004695
NR 21
TC 0
Z9 0
U1 5
U2 5
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-894X
EI 1464-3405
J9 BIOORG MED CHEM LETT
JI Bioorg. Med. Chem. Lett.
PD FEB 15
PY 2020
VL 30
IS 4
AR 126906
DI 10.1016/j.bmcl.2019.126906
PG 5
WC Chemistry, Medicinal; Chemistry, Organic
SC Pharmacology & Pharmacy; Chemistry
GA KD6PP
UT WOS:000507987200019
PM 31902708
DA 2020-07-08
ER

PT J
AU Teixeira, FME
   Pietrobon, AJ
   Oliveira, LD
   Oliveira, LMD
   Sato, MN
AF Teixeira, Franciane Mouradian Emidio
   Pietrobon, Anna Julia
   Oliveira, Luana de Mendonca
   Oliveira, Luanda Mara da Silva
   Sato, Maria Notomi
TI Maternal-Fetal Interplay in Zika Virus Infection and Adverse Perinatal
   Outcomes
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Review
DE maternal-fetal; neonatal; Zika virus; adverse effects; congenital
   infections
ID REGULATORY T-CELLS; NATURAL-KILLER-CELLS; UTERINE NK CELLS; DENDRITIC
   CELLS; IMMUNE-SYSTEM; VERTICAL TRANSMISSION; DECIDUAL MACROPHAGES;
   NEONATAL MACROPHAGES; NEURAL PROGENITORS; DENGUE INFECTION
AB During pregnancy, the organization of complex tolerance mechanisms occurs to assure non-rejection of the semiallogeneic fetus. Pregnancy is a period of vulnerability to some viral infections, mainly during the first and second trimesters, that may cause congenital damage to the fetus. Recently, Zika virus (ZIKV) infection has gained great notoriety due to the occurrence of congenital ZIKV syndrome, characterized by fetal microcephaly, which results from the ability of ZIKV to infect placental cells and neural precursors in the fetus. Importantly, in addition to the congenital effects, studies have shown that perinatal ZIKV infection causes a number of disorders, including maculopapular rash, conjunctivitis, and arthralgia. In this paper, we contextualize the immunological aspects involved in the maternal-fetal interface and vulnerability to ZIKV infection, especially the alterations resulting in perinatal outcomes. This highlights the need to develop protective maternal vaccine strategies or interventions that are capable of preventing fetal or even neonatal infection.
C1 [Teixeira, Franciane Mouradian Emidio; Pietrobon, Anna Julia; Oliveira, Luana de Mendonca; Oliveira, Luanda Mara da Silva; Sato, Maria Notomi] Univ Sao Paulo, Lab Dermatol & Immunodeficiencies, Sch Med, Dept Dermatol,LIM 56, Sao Paulo, Brazil.
   [Teixeira, Franciane Mouradian Emidio; Pietrobon, Anna Julia; Oliveira, Luana de Mendonca; Oliveira, Luanda Mara da Silva; Sato, Maria Notomi] Univ Sao Paulo, Inst Trop Med Sao Paulo, Sao Paulo, Brazil.
   [Teixeira, Franciane Mouradian Emidio; Pietrobon, Anna Julia; Oliveira, Luana de Mendonca; Sato, Maria Notomi] Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
RP Sato, MN (corresponding author), Univ Sao Paulo, Lab Dermatol & Immunodeficiencies, Sch Med, Dept Dermatol,LIM 56, Sao Paulo, Brazil.; Sato, MN (corresponding author), Univ Sao Paulo, Inst Trop Med Sao Paulo, Sao Paulo, Brazil.; Sato, MN (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Immunol, Sao Paulo, Brazil.
EM marisato@usp.br
FU Laboratorio de Investigacao Medica, Unidade 56, Department of
   Dermatology, School of Medicine, University of Sao Paulo, Brazil;
   Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de
   Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2018/18230-6,
   2017/18199-9]
FX This work was supported by the Laboratorio de Investigacao Medica,
   Unidade 56, Department of Dermatology, School of Medicine, University of
   Sao Paulo, Brazil; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo
   (FAPESP/n. 2018/18230-6 and n. 2017/18199-9).
CR Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Adamski A, 2018, J INFECTION, V76, P529, DOI 10.1016/j.jinf.2018.02.010
   Adkins B, 2004, NAT REV IMMUNOL, V4, P553, DOI 10.1038/nri1394
   Aksoy E, 2007, BLOOD, V109, P2887, DOI 10.1182/blood-2006-06-027862
   Alam A, 2016, IMMUNOLOGY, V149, P386, DOI 10.1111/imm.12656
   Alimonti JB, 2018, FLUIDS BARRIERS CNS, V15, DOI 10.1186/s12987-018-0100-y
   Anderson T, 2019, B WORLD HEALTH ORGAN, V97, P6, DOI 10.2471/BLT.19.020119
   ARAGAO MDV, 2016, BMJ-BRIT MED J, V353, DOI DOI 10.1136/BMJ.I2444
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Askelund K, 2004, PLACENTA, V25, P140, DOI 10.1016/S0143-4004(03)00182-6
   ATHANASSAKIS I, 1995, AM J REPROD IMMUNOL, V34, P281, DOI 10.1111/j.1600-0897.1995.tb00954.x
   Avelino-Silva VL, 2018, REV INST MED TROP SP, V60, DOI [10.1590/S1678-9946201860064, 10.1590/s1678-9946201860064]
   BARKOVICH AJ, 1994, AM J NEURORADIOL, V15, P703
   Barrett ADT, 2018, NPJ VACCINES, V3, DOI 10.1038/s41541-018-0061-9
   Barthel A, 2013, CLIN INFECT DIS, V57, P415, DOI 10.1093/cid/cit227
   Basurko C, 2009, EUR J OBSTET GYN R B, V147, P29, DOI 10.1016/j.ejogrb.2009.06.028
   Bayer A, 2016, CELL HOST MICROBE, V19, P705, DOI 10.1016/j.chom.2016.03.008
   Bentlin MR, 2011, EMERG INFECT DIS, V17, P1779, DOI 10.3201/eid1709.110242
   Besnard M, 2014, EUROSURVEILLANCE, V19, P13, DOI 10.2807/1560-7917.ES2014.19.13.20751
   Bhatnagar J, 2017, EMERG INFECT DIS, V23, P405, DOI 10.3201/eid2303.161499
   Blohm GM, 2018, CLIN INFECT DIS, V66, P1120, DOI 10.1093/cid/cix968
   BORTHWICK GM, 1988, PLACENTA, V9, P81, DOI 10.1016/0143-4004(88)90075-6
   Bot A, 1997, INT IMMUNOL, V9, P1641, DOI 10.1093/intimm/9.11.1641
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Brito CAA, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3313-4
   Brown AS, 2010, AM J PSYCHIAT, V167, P261, DOI 10.1176/appi.ajp.2009.09030361
   BULMER JN, 1991, HUM REPROD, V6, P791, DOI 10.1093/oxfordjournals.humrep.a137430
   Cavalcanti AFC, 2019, INT J PAEDIATR DENT, V29, P74, DOI 10.1111/ipd.12431
   CAIRESJUNIOR LC, 2018, NAT COMM, V0009
   Castillo-Solorzano C, 2011, J INFECT DIS, V204, pS571, DOI 10.1093/infdis/jir472
   Centers for Disease Control and Prevention (CDC), 2002, MMWR Morb Mortal Wkly Rep, V51, P1135
   Cerdeira AS, 2013, J IMMUNOL, V190, P3939, DOI 10.4049/jimmunol.1202582
   CHAOUAT G, 1995, J IMMUNOL, V154, P4261
   Chiossone L, 2014, HAEMATOLOGICA, V99, P448, DOI 10.3324/haematol.2013.091421
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Co EC, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.099465
   Cohen J, 2017, SCIENCE, V357, P241, DOI 10.1126/science.357.6348.241
   Colt S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005528
   Coyne CB, 2016, NAT REV MICROBIOL, V14, P707, DOI 10.1038/nrmicro.2016.125
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Cupedo T, 2005, EUR J IMMUNOL, V35, P383, DOI 10.1002/eji.200425763
   Dang J, 2016, CELL STEM CELL, V19, P258, DOI 10.1016/j.stem.2016.04.014
   Danis B, 2008, EUR J IMMUNOL, V38, P507, DOI 10.1002/eji.200737760
   Darrasse-Jeze G, 2005, BLOOD, V105, P4715, DOI 10.1182/blood-2004-10-4051
   de Brito CA, 2009, IMMUNOTHERAPY-UK, V1, P883, DOI 10.2217/IMT.09.38
   de Noronha L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02266
   Dollard SC, 2007, REV MED VIROL, V17, P355, DOI 10.1002/rmv.544
   Dupont-Rouzeyrol M, 2016, LANCET, V387, P1051, DOI 10.1016/S0140-6736(16)00624-3
   El Costa H, 2008, J IMMUNOL, V181, P3009, DOI 10.4049/jimmunol.181.5.3009
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Faas MM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00298
   Ferraris P, 2019, EMERG MICROBES INFEC, V8, P1003, DOI 10.1080/22221751.2019.1637283
   Freour T, 2016, EUROSURVEILLANCE, V21, P10, DOI 10.2807/1560-7917.ES.2016.21.23.30254
   Fu BQ, 2013, P NATL ACAD SCI USA, V110, pE231, DOI 10.1073/pnas.1206322110
   Gamliel M, 2018, IMMUNITY, V48, P951, DOI 10.1016/j.immuni.2018.03.030
   Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574
   Gerardin P, 2008, PLOS MED, V5, P413, DOI 10.1371/journal.pmed.0050060
   Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671
   Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637
   Giovanetti M, 2018, CLIN MICROBIOL INFEC, V24, P1111, DOI 10.1016/j.cmi.2018.06.008
   Goodman Alyson B, 2016, MMWR Morb Mortal Wkly Rep, V65, P1082, DOI 10.15585/mmwr.mm6539e2
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Griffin I, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-2044
   Grischott F, 2016, TRAVEL MED INFECT DI, V14, P313, DOI 10.1016/j.tmaid.2016.07.002
   Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477
   Hammack C, 2019, J VIROL, V93, DOI 10.1128/JVI.00638-19
   Hanners NW, 2016, CELL REP, V15, P2315, DOI 10.1016/j.celrep.2016.05.075
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Hastings AK, 2017, YALE J BIOL MED, V90, P325
   Haynes BF, 1998, IMMUNOL RES, V18, P175, DOI 10.1007/BF02788778
   Hazin AN, 2016, NEW ENGL J MED, V374, P2193, DOI 10.1056/NEJMc1603617
   Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2
   Hoeffel G, 2012, J EXP MED, V209, P1167, DOI 10.1084/jem.20120340
   Holmes VA, 2003, CYTOKINE, V21, P265, DOI 10.1016/S1043-4666(03)00097-8
   Holt PG, 2000, ALLERGY, V55, P688, DOI 10.1034/j.1398-9995.2000.00118.x
   Hu BX, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0882-6
   Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2
   Hunt JS, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-S1-S10
   HUNT JS, 1987, J IMMUNOL, V138, P2481
   Ishitani A, 2006, J REPROD IMMUNOL, V69, P101, DOI 10.1016/j.jri.2005.10.004
   Jabrane-Ferrat N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01397
   Carod-Artal FJ, 2018, EXPERT REV ANTI-INFE, V16, P399, DOI 10.1080/14787210.2018.1466702
   Joguet G, 2017, LANCET INFECT DIS, V17, P1200, DOI 10.1016/S1473-3099(17)30444-9
   Juch H, 2012, WIEN MED WOCHENSCHR, V162, P196, DOI 10.1007/s10354-012-0070-7
   Jung JY, 2016, IMMUNOLOGY, V149, P35, DOI 10.1111/imm.12625
   Kachikis A, 2016, J INFECTION, V72, pS83, DOI 10.1016/j.jinf.2016.04.027
   Kanswal S, 2008, J IMMUNOL, V181, P976, DOI 10.4049/jimmunol.181.2.976
   Karwowski MP, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2016-0621
   Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535
   King A, 2000, HUM REPROD UPDATE, V6, P28, DOI 10.1093/humupd/6.1.28
   Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187
   Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481
   Koopman LA, 2003, J EXP MED, V198, P1201, DOI 10.1084/jem.20030305
   Kopcow HD, 2005, P NATL ACAD SCI USA, V102, P15563, DOI 10.1073/pnas.0507835102
   Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z
   La Pine TR, 2003, PEDIATR RES, V54, P276, DOI 10.1203/01.PDR.0000072515.10652.87
   LABARRERE CA, 1990, TRANSPLANTATION, V50, P812, DOI 10.1097/00007890-199011000-00014
   Larocca RA, 2019, CELL HOST MICROBE, V26, P591, DOI 10.1016/j.chom.2019.10.001
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Lash GE, 2006, J LEUKOCYTE BIOL, V80, P572, DOI 10.1189/jlb.0406250
   Laskarin G, 2008, AM J REPROD IMMUNOL, V59, P433, DOI 10.1111/j.1600-0897.2008.00599.x
   Leber A, 2010, AM J REPROD IMMUNOL, V63, P445, DOI 10.1111/j.1600-0897.2010.00821.x
   Lebov JF, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2589-8
   Leite RC, 2014, J CLIN VIROL, V60, P16, DOI [10.1016/j.jcv.2014.02.009, 10.1016/J.JCV.2014.02.009]
   Magnani DM, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan8184
   Mansuy JM, 2019, EMERG INFECT DIS, V25, P823, DOI 10.3201/eid2504.171886
   Marodi L, 2001, CLIN EXP IMMUNOL, V126, P456, DOI 10.1046/j.1365-2249.2001.01693.x
   Marques VD, 2019, PEDIATR NEUROL, V91, P3, DOI 10.1016/j.pediatrneurol.2018.11.003
   Matsuda K, 1996, J MED VIROL, V48, P199
   Matusali G, 2018, J CLIN INVEST, V128, P4697, DOI [10.1172/JCI121735, 10.1172/jci121735]
   McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795
   Medin CL, 2017, ARCH PATHOL LAB MED, V141, P33, DOI 10.5858/arpa.2016-0409-RA
   Mehrjardi MZ, 2017, JPN J RADIOL, V35, P341, DOI 10.1007/s11604-017-0641-z
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Ministerio da Saude B . Secretaria de Vigilancia em Saude, 2019, MIN SAUD B B EP, V22
   Miyazaki S, 2003, J LEUKOCYTE BIOL, V74, P514, DOI 10.1189/jlb.1102566
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Mold JE, 2008, SCIENCE, V322, P1562, DOI 10.1126/science.1164511
   Mor G, 2010, AM J REPROD IMMUNOL, V63, P425, DOI 10.1111/j.1600-0897.2010.00836.x
   Murphy SP, 1998, MOL REPROD DEV, V51, P1
   Naruse K, 2009, HUM REPROD, V24, P553, DOI 10.1093/humrep/den408
   Neu N, 2015, CLIN PERINATOL, V42, P77, DOI 10.1016/j.clp.2014.11.001
   Ngono AE, 2018, ANNU REV IMMUNOL, V36, P279, DOI 10.1146/annurev-immunol-042617-053142
   Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1
   Ning F, 2016, AM J REPROD IMMUNOL, V75, P298, DOI 10.1111/aji.12477
   Ohkawara T, 2015, BRAIN DEV-JPN, V37, P88, DOI 10.1016/j.braindev.2014.03.007
   Ostrander Betsy, 2019, Handb Clin Neurol, V162, P133, DOI 10.1016/B978-0-444-64029-1.00006-0
   PAHO/WHO Pan American Health Organization/World Health Organization, 2017, ZIK EP REP BRAZ
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Patterson PH, 2011, TRENDS MOL MED, V17, P389, DOI 10.1016/j.molmed.2011.03.001
   Paul AM, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02028
   Paz-Bailey G, 2018, NEW ENGL J MED, V379, P1234, DOI 10.1056/NEJMoa1613108
   Pihlgren M, 2003, J IMMUNOL, V170, P2824, DOI 10.4049/jimmunol.170.6.2824
   Pinninti SG, 2018, SEMIN PERINATOL, V42, P168, DOI 10.1053/j.semperi.2018.02.004
   Plaks V, 2008, J CLIN INVEST, V118, P3954, DOI 10.1172/JCI36682
   Poland GA, 2018, LANCET INFECT DIS, V18, pE211, DOI 10.1016/S1473-3099(18)30063-X
   PrabhuDas M, 2015, NAT IMMUNOL, V16, P328, DOI 10.1038/ni.3131
   Prata-Barbos A, 2019, J PEDIAT-BRAZIL, V95, pS30, DOI 10.1016/j.jped.2018.10.016
   Prazeres J, 2016, BRAZIL JAMA OPHTHALM, V134, P529, DOI [DOI 10.1001/JAMA0PHTHALM0L.2016.0267, 10.1001/jamaophthalmol.2016.0267]
   Pridjian G, 2016, BIRTH DEFECTS RES A, V106, P716, DOI 10.1002/bdra.23523
   Prisant N, 2017, CLIN INFECT DIS, V64, P107, DOI 10.1093/cid/ciw669
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Read JS, 2018, JAMA PEDIATR, V172, P686, DOI 10.1001/jamapediatrics.2018.0870
   Record M, 2014, PLACENTA, V35, P297, DOI 10.1016/j.placenta.2014.02.009
   Regla-Nava JA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007080
   Renneson J, 2009, EUR J IMMUNOL, V39, P2789, DOI 10.1002/eji.200939414
   Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   Richner JM, 2017, CELL, V170, P273, DOI 10.1016/j.cell.2017.06.040
   Rose S, 2007, J IMMUNOL, V178, P2667, DOI 10.4049/jimmunol.178.5.2667
   Rudolph MD, 2018, NAT NEUROSCI, V21, P765, DOI 10.1038/s41593-018-0128-y
   Salinas JL, 2017, J NEUROL SCI, V381, P272, DOI 10.1016/j.jns.2017.09.001
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Schneider C, 2014, NAT IMMUNOL, V15, P1026, DOI 10.1038/ni.3005
   Schumacher A, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00196
   Schumacher A, 2009, J IMMUNOL, V182, P5488, DOI 10.4049/jimmunol.0803177
   Schwartz DA, 2017, ARCH GYNECOL OBSTET, V295, P1361, DOI 10.1007/s00404-017-4361-5
   Selkov SA, 2013, PLACENTA, V34, P836, DOI 10.1016/j.placenta.2013.05.007
   Siegrist CA, 2001, VACCINE, V19, P3331, DOI 10.1016/S0264-410X(01)00028-7
   Siewiera J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10183
   Siewiera J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003257
   Song BH, 2017, J NEUROIMMUNOL, V308, P50, DOI 10.1016/j.jneuroim.2017.03.001
   Sotelo JR, 2017, EMERG INFECT DIS, V23, P854, DOI 10.3201/eid2305.161538
   Sykes L, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/967629
   Tabata T, 2016, CELL HOST MICROBE, V20, P155, DOI 10.1016/j.chom.2016.07.002
   Tai P, 2008, J CELL PHYSIOL, V214, P456, DOI 10.1002/jcp.21221
   Tai WB, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-017-0007-8
   Tan PC, 2008, OBSTET GYNECOL, V111, P1111, DOI 10.1097/AOG.0b013e31816a49fc
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Tilburgs T, 2008, J IMMUNOL, V180, P5737, DOI 10.4049/jimmunol.180.8.5737
   Tripathi S, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006258
   Tripp RA, 2016, EXPERT REV VACCINES, V15, P1083, DOI 10.1080/14760584.2016.1192474
   Tsuda S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01934
   United Nations Inter-agency Group for Child Mortality Estimation (UN IGME), 2019, LEV TRENDS CHILD MOR
   Vacca P, 2006, BLOOD, V108, P4078, DOI 10.1182/blood-2006-04-017343
   Valentine GC, 2018, AM J OBSTET GYNECOL, V219, DOI 10.1016/j.ajog.2018.06.005
   Vermillion MS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14575
   Vesnaver TV, 2017, BJOG-INT J OBSTET GY, V124, P521, DOI 10.1111/1471-0528.14423
   Walteros DM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220049
   Wang R, 2018, VACCINE, V36, P3522, DOI 10.1016/j.vaccine.2018.04.051
   Wang SC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1642-x
   Webster RB, 2007, J BIOL CHEM, V282, P700, DOI 10.1074/jbc.M609501200
   WHO World Health Organization, 2019, WHO VACC PIP TRACK
   Winterberg T, 2015, EUR J IMMUNOL, V45, P214, DOI 10.1002/eji.201444468
   Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348
   Yang SW, 2017, J REPROD IMMUNOL, V124, P30, DOI 10.1016/j.jri.2017.09.012
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
   Zhang XM, 2017, NAT REV IMMUNOL, V17, P495, DOI 10.1038/nri.2017.54
   Zhang ZW, 2017, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00206
   Zhao JX, 2007, J REPROD IMMUNOL, V75, P71, DOI 10.1016/j.jri.2007.06.052
   Zhou WS, 2019, EMERG MICROBES INFEC, V8, P307, DOI 10.1080/22221751.2019.1578188
   Zhu XL, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0572-7
   Zorrilla CD, 2017, J INFECT DIS, V216, pS891, DOI 10.1093/infdis/jix448
   Zumla A, 2014, NEW ENGL J MED, V371, P1076, DOI 10.1056/NEJMc1408436
NR 198
TC 1
Z9 1
U1 3
U2 3
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 14
PY 2020
VL 11
AR 175
DI 10.3389/fimmu.2020.00175
PG 15
WC Immunology
SC Immunology
GA KR2VP
UT WOS:000517478100001
PM 32117303
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Li, AX
   Wang, WB
   Wang, YC
   Chen, KL
   Xiao, F
   Hu, DW
   Hui, LX
   Liu, WY
   Feng, YQ
   Li, G
   Tan, QP
   Liu, YL
   Wu, KL
   Wu, JG
AF Li, Aixin
   Wang, Wenbiao
   Wang, Yingchong
   Chen, Keli
   Xiao, Feng
   Hu, Dingwen
   Hui, Lixia
   Liu, Weiyong
   Feng, Yuqian
   Li, Geng
   Tan, Qiuping
   Liu, Yingle
   Wu, Kailang
   Wu, Jianguo
TI NS5 Conservative Site Is Required for Zika Virus to Restrict the RIG-I
   Signaling
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE IRF3; IFN-beta; methyltransferase; NS5; RIG-I; ubiquitination; ZIKV
ID INTERFERON-PRODUCTION; CRYSTAL-STRUCTURE; RECEPTORS; EVASION; BETA; IRF3
AB During host-virus co-evolution, cells develop innate immune systems to inhibit virus invasion, while viruses employ strategies to suppress immune responses and maintain infection. Here, we reveal that Zika virus (ZIKV), a re-emerging arbovirus causing public concerns and devastating complications, restricts host immune responses through a distinct mechanism. ZIKV nonstructural protein 5 (NS5) interacts with the host retinoic acid-inducible gene I (RIG-I), an essential signaling molecule for defending pathogen infections. NS5 subsequently represses K63-linked polyubiquitination of RIG-I, attenuates the phosphorylation and nuclear translocation of interferon regulatory factor 3 (IRF3), and inhibits the expression and production of interferon-beta (IFN-beta), thereby restricting the RIG-I signaling pathway. Interestingly, we demonstrate that the methyltransferase (MTase) domain of NS5 is required for the repression of RIG-I ubiquitination, IRF3 activation, and IFN-beta production. Detailed studies further reveal that the conservative active site D146 of NS5 is critical for the suppression of the RIG-I signaling. Therefore, we uncover an essential role of NS5 conservative site D146 in ZIKV-mediated repression of innate immune system, illustrate a distinct mechanism by which ZIKV evades host immune responses, and discover a potential target for anti-viral infection.
C1 [Li, Aixin; Wang, Yingchong; Chen, Keli; Xiao, Feng; Hu, Dingwen; Hui, Lixia; Liu, Weiyong; Wu, Kailang; Wu, Jianguo] Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China.
   [Wang, Wenbiao; Feng, Yuqian; Li, Geng; Liu, Yingle; Wu, Jianguo] Jinan Univ, Inst Med Microbiol, Guangzhou Key Lab Virol, Guangzhou, Peoples R China.
   [Tan, Qiuping] Guangdong LongFan Biol Sci & Technol Co, Foshan, Peoples R China.
RP Wu, KL; Wu, JG (corresponding author), Wuhan Univ, Coll Life Sci, State Key Lab Virol, Wuhan, Peoples R China.; Liu, YL; Wu, JG (corresponding author), Jinan Univ, Inst Med Microbiol, Guangzhou Key Lab Virol, Guangzhou, Peoples R China.
EM mvlwu@whu.edu.cn; wukailang@whu.edu.cn; jwu@whu.edu.cn
RI Li, Aixin/AAO-7926-2020
OI Li, Aixin/0000-0002-3158-0170
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81730061, 81471942]; National Health and Family
   Planning Commission of China (National Mega Project on Major Infectious
   Disease Prevention) [2017ZX10103005, 2017ZX10202201]; China Postdoctoral
   Science FoundationChina Postdoctoral Science Foundation [2018T110923]
FX This work was supported by the National Natural Science Foundation of
   China (81730061 and 81471942), the National Health and Family Planning
   Commission of China (National Mega Project on Major Infectious Disease
   Prevention) (2017ZX10103005 and 2017ZX10202201), and China Postdoctoral
   Science Foundation (2018T110923).
CR Arimoto KI, 2018, J LEUKOCYTE BIOL, V103, P1099, DOI 10.1002/JLB.2MIR0817-342R
   Borden EC, 2019, NAT REV DRUG DISCOV, V18, P219, DOI 10.1038/s41573-018-0011-2
   Chattopadhyay S, 2017, PROTEIN CELL, V8, P165, DOI 10.1007/s13238-016-0334-x
   Chazal M, 2018, CELL REP, V24, P320, DOI 10.1016/j.celrep.2018.06.047
   Coutard B, 2017, J VIROL, V91, DOI 10.1128/JVI.02202-16
   Ding Q, 2018, P NATL ACAD SCI USA, V115, pE6310, DOI 10.1073/pnas.1803406115
   Ding Z, 2014, J VIROL, V88, P8936, DOI 10.1128/JVI.00700-14
   Dixit E, 2010, CELL, V141, P668, DOI 10.1016/j.cell.2010.04.018
   Duong V, 2017, INT J INFECT DIS, V54, P121, DOI 10.1016/j.ijid.2016.11.420
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732
   Grant A, 2016, CELL HOST MICROBE, V19, P882, DOI 10.1016/j.chom.2016.05.009
   Hardison SE, 2012, NAT IMMUNOL, V13, P817, DOI 10.1038/ni.2369
   Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kumar A, 2016, EMBO REP, V17, P1766, DOI 10.15252/embr.201642627
   Lee I, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10050233
   Li SF, 2018, CELL PHYSIOL BIOCHEM, V51, P2377, DOI 10.1159/000495897
   Lin SL, 2019, VIROLOGY, V527, P180, DOI 10.1016/j.virol.2018.11.009
   Liu YL, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00662
   Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003
   Ma WQ, 2016, CELL, V167, P1511, DOI 10.1016/j.cell.2016.11.016
   Nitatpattana N, 2018, MICROBIOL RESOUR ANN, V6, DOI [10.1128/genomeA.00121-18, 10.1128/genomea.00121-18]
   NOVICK D, 1994, CELL, V77, P391, DOI 10.1016/0092-8674(94)90154-6
   Okamoto M, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01942
   Oshiumi H, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00200
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Rajsbaum R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003059
   Rommer PS, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01564
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022
   Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x
   Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005
   Upadhyay AK, 2017, ACTA CRYSTALLOGR F, V73, P116, DOI 10.1107/S2053230X17001601
   Verhelst K, 2013, BIOCHEM PHARMACOL, V85, P873, DOI 10.1016/j.bcp.2013.01.007
   Wang AY, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.141
   Wang WB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02645-3
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Wu YX, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.6
   Xia HJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02816-2
   Ye J, 2013, VACCINE, V31, P461, DOI 10.1016/j.vaccine.2012.11.015
   Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681
   Zhang HL, 2017, J VIROL, V91, DOI [10.1128/jvi.02396-16, 10.1128/JVI.02396-16]
   Zhao BY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14762
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
NR 45
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 14
PY 2020
VL 11
AR 51
DI 10.3389/fimmu.2020.00051
PG 14
WC Immunology
SC Immunology
GA KR2VG
UT WOS:000517477200001
PM 32117232
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Castanha, PMS
   Erdos, G
   Watkins, SC
   Falo, LD
   Marques, ETA
   Barratt-Boyes, SM
AF Castanha, Priscila M. S.
   Erdos, Geza
   Watkins, Simon C.
   Falo, Louis D., Jr.
   Marques, Ernesto T. A.
   Barratt-Boyes, Simon M.
TI Reciprocal immune enhancement of dengue and Zika virus infection in
   human skin
SO JCI INSIGHT
LA English
DT Article
ID ANTIBODY-DEPENDENT ENHANCEMENT; FC-GAMMA-RECEPTORS; MONOCLONAL-ANTIBODY;
   LANGERHANS CELLS; DENDRITIC CELLS; RISK-FACTOR; DISEASE; KERATINOCYTES;
   PATHOGENESIS; MACROPHAGES
AB Dengue virus (DENV) and Zika virus (ZIKV) are closely related mosquito-borne flaviviruses that co-circulate in tropical regions and constitute major threats to global human health. Whether preexisting immunity to one virus affects disease caused by the other during primary or secondary infections is unknown but is critical in preparing for future outbreaks and predicting vaccine safety. Using a human skin explant model, we show that DENV-3 immune sera increased recruitment and infection of Langerhans cells, macrophages, and dermal dendritic cells following inoculation with DENV-2 or ZIKV. Similarly, ZIKV immune sera enhanced infection with DENV-2. Immune sera increased migration of infected Langerhans cells to the dermis and emigration of infected cells out of skin. Heterotypic immune sera increased viral RNA in the dermis almost 10-fold and reduced the amount of virus required to infect a majority of myeloid cells by 100- to 1000-fold. Enhancement was associated with cross-reactive IgG and induction of IL-10 expression and was mediated by both CD32 and CD64 Fc gamma receptors. These findings reveal that preexisting heterotypic immunity greatly enhances DENV and ZIKV infection, replication, and spread in human skin. This relevant tissue model will be valuable in assessing the efficacy and risk of dengue and Zika vaccines in humans.
C1 [Castanha, Priscila M. S.; Marques, Ernesto T. A.; Barratt-Boyes, Simon M.] Univ Pittsburgh, Dept Infect Dis & Microbiol, Pittsburgh, PA 15260 USA.
   [Castanha, Priscila M. S.] Univ Pernambuco, Biol Sci Inst, Recife, PE, Brazil.
   [Castanha, Priscila M. S.] Univ Pernambuco, Fac Med Sci, Recife, PE, Brazil.
   [Castanha, Priscila M. S.; Marques, Ernesto T. A.] Fundacao Oswaldo Cruz, Aggeu Magalhaes Inst, Recife, PE, Brazil.
   [Erdos, Geza; Falo, Louis D., Jr.] Univ Pittsburgh, Dept Dermatol, Pittsburgh, PA 15260 USA.
   [Watkins, Simon C.] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15260 USA.
   [Watkins, Simon C.] Univ Pittsburgh, Dept Cell Biol, Pittsburgh, PA 15260 USA.
   [Watkins, Simon C.; Barratt-Boyes, Simon M.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.
RP Barratt-Boyes, SM (corresponding author), Univ Pittsburgh, 2133 Publ Hlth Bldg,130 De Soto St, Pittsburgh, PA 15260 USA.; Marques, ETA (corresponding author), Univ Pittsburgh, 2131 Publ Hlth Bldg,130 De Soto St, Pittsburgh, PA 15260 USA.
EM marques@pitt.edu; smbb@pitt.edu
RI CASTANHA, PRISCILA/G-1785-2012
OI CASTANHA, PRISCILA/0000-0002-1220-5308; Erdos, Geza/0000-0001-7530-7371
FU Coordination for the Improvement of Higher Education Personnel,
   Brazilian Ministry of Education [440891/2016-7]; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R21AI147017]
FX We thank Parichat Duangkhae for initial work establishing the
   experimental system used in these studies, Jeffrey Gusenoff and J. Peter
   Rubin for providing surgical specimens, and staff in the Department of
   Plastic Surgery at the University of Pittsburgh for coordinating
   specimen collection and delivery. PMSC was partially supported by a
   scholarship from the Coordination for the Improvement of Higher
   Education Personnel, Brazilian Ministry of Education (440891/2016-7,
   National Postdoctoral Program). This study was supported in part by
   National Institutes of Health grant R21AI147017 to SMBB.
CR Balsitis SJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000790
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   de Araujo TVB, 2018, LANCET INFECT DIS, V18, P328, DOI 10.1016/S1473-3099(17)30727-2
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Boonnak K, 2013, J IMMUNOL, V190, P5659, DOI 10.4049/jimmunol.1203052
   Boonnak K, 2011, J VIROL, V85, P1671, DOI 10.1128/JVI.00220-10
   Butthep P, 2012, PEDIATR INFECT DIS J, V31, pE232, DOI 10.1097/INF.0b013e31826fd456
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Castanha PMS, 2017, J INFECT DIS, V215, P781, DOI 10.1093/infdis/jiw638
   Castanha PMS, 2016, J INFECT DIS, V214, P265, DOI 10.1093/infdis/jiw143
   Cerny D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004548
   Collins MH, 2017, EMERG INFECT DIS, V23, P773, DOI 10.3201/eid2305.161630
   Conway MJ, 2014, J VIROL, V88, P164, DOI 10.1128/JVI.02235-13
   Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477
   Cox J, 2012, J VIROL, V86, P7637, DOI 10.1128/JVI.00534-12
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   de Alwis R, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004386
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Duangkhae P, 2018, J INVEST DERMATOL, V138, P618, DOI 10.1016/j.jid.2017.10.018
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Flipse J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29201
   Fowler AM, 2018, CELL HOST MICROBE, V24, P743, DOI 10.1016/j.chom.2018.09.015
   George J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10901-1
   Goncalvez AP, 2007, P NATL ACAD SCI USA, V104, P9422, DOI 10.1073/pnas.0703498104
   Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582
   Guzman MG, 2013, ARCH VIROL, V158, P1445, DOI 10.1007/s00705-013-1645-3
   Halstead SB, 2002, EMERG INFECT DIS, V8, P1474, DOI 10.3201/eid0812.020170
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15
   Hasan SS, 2018, NAT STRUCT MOL BIOL, V25, P13, DOI 10.1038/s41594-017-0010-8
   Hristodorov D, 2014, MABS-AUSTIN, V6, P1283, DOI 10.4161/mabs.32182
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   KLIKS SC, 1989, AM J TROP MED HYG, V40, P444, DOI 10.4269/ajtmh.1989.40.444
   Korkmaz E, 2015, ACTA BIOMATER, V24, P96, DOI 10.1016/j.actbio.2015.05.036
   Limon-Flores AY, 2005, INT J EXP PATHOL, V86, P323, DOI 10.1111/j.0959-9673.2005.00445.x
   Magalhaes T, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006055
   McCracken MK, 2014, J VIROL, V88, P1881, DOI 10.1128/JVI.01218-13
   Modhiran N, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000924
   Nascimento EJM, 2018, J VIROL METHODS, V257, P62, DOI 10.1016/j.jviromet.2018.04.009
   Nestle FO, 2009, NAT REV IMMUNOL, V9, P679, DOI 10.1038/nri2622
   Ng JKW, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004031
   Payne AF, 2006, J VIROL METHODS, V134, P183, DOI 10.1016/j.jviromet.2006.01.003
   Pingen M, 2016, IMMUNITY, V44, P1455, DOI 10.1016/j.immuni.2016.06.002
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rathakrishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052215
   Rodrigo WWSI, 2006, J VIROL, V80, P10128, DOI 10.1128/JVI.00792-06
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Rosales C, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00280
   Schmid MA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005676
   Schmid MA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004541
   Shah DK, 2013, MABS-AUSTIN, V5, P297, DOI 10.4161/mabs.23684
   Styer LM, 2007, PLOS PATHOG, V3, P1262, DOI 10.1371/journal.ppat.0030132
   Styer LM, 2011, J VIROL, V85, P1517, DOI 10.1128/JVI.01112-10
   Taylor A, 2015, IMMUNOL REV, V268, P340, DOI 10.1111/imr.12367
   TIGALONOWA M, 1991, ACTA DERM-VENEREOL, V71, P99
   Vaughn DW, 2000, J INFECT DIS, V181, P2, DOI 10.1086/315215
   Vogelpoel LTC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00079
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wu SJL, 2000, NAT MED, V6, P816, DOI 10.1038/77553
   Yeh WT, 2006, FEMS IMMUNOL MED MIC, V48, P84, DOI 10.1111/j.1574-695X.2006.00127.x
NR 61
TC 0
Z9 0
U1 1
U2 1
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
EI 2379-3708
J9 JCI INSIGHT
JI JCI Insight
PD FEB 13
PY 2020
VL 5
IS 3
AR e133653
DI 10.1172/jci.insight.133653
PG 14
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA KN0RT
UT WOS:000514547000017
PM 31910161
OA Bronze, Green Published
DA 2020-07-08
ER

PT J
AU Chen, WC
   Simanjuntak, Y
   Chu, LW
   Ping, YH
   Lee, YL
   Lin, YL
   Li, WS
AF Chen, Wei-Chia
   Simanjuntak, Yogy
   Chu, Li-Wei
   Ping, Yueh-Hsin
   Lee, Yi-Ling
   Lin, Yi-Ling
   Li, Wen-Shan
TI Benzenesulfonamide Derivatives as Calcium/Calmodulin-Dependent Protein
   Kinase Inhibitors and Antiviral Agents against Dengue and Zika Virus
   Infections
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID BINDING; CAMKII; PATHOGENESIS
AB Emerging and resurging mosquito-borne flaviviruses are an important public health challenge. The increased prevalence of dengue virus (DENY) infection has had a significant socioeconomic impact on epidemic countries. The recent outbreak of Zika virus (ZIKV) has created an international public health emergency because ZIKV infection has been linked to congenital defects and Guillain-Barre syndrome. To develop potentially prophylactic antiviral drugs for combating these acute infectious diseases, we have targeted the host calcium/calmodulin-dependent kinase II (CaMKII) for inhibition. By using CaMKII structure-guided inhibitor design, we generated four families of benzenesulfonamide (BSA) derivatives for SAR analysis. Among these substances, N-(4-cyclohepty1-4-oxobuty1)-4-methoxy-N-phenylbenzenesulfonamide (9) showed superior properties as a lead CaMKII inhibitor and antiviral agent. BSA 9 inhibited CaMKII activity with an IC50 value of 0.79 mu M and displayed EC50 values of 1.52 mu M and 1.91 mu M against DENY and ZIKV infections of human neuronal BE(2)C cells, respectively. Notably, 9 significantly reduced the viremia level and increased animal survival time in mouse-challenge models.
C1 [Simanjuntak, Yogy; Lee, Yi-Ling; Lin, Yi-Ling] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.
   [Lin, Yi-Ling] Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.
   [Chen, Wei-Chia; Li, Wen-Shan] Acad Sinica, Inst Chem, Taipei 11529, Taiwan.
   [Li, Wen-Shan] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan.
   [Li, Wen-Shan] Taipei Med Univ, Ph Program Biotechnol Res & Dev, Taipei 11031, Taiwan.
   [Li, Wen-Shan] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung 80708, Taiwan.
   [Chen, Wei-Chia] Natl Taiwan Normal Univ, Dept Chem, Taipei 11677, Taiwan.
   [Chu, Li-Wei; Ping, Yueh-Hsin] Natl Yang Ming Univ, Inst Biophoton, Taipei 11221, Taiwan.
   [Chu, Li-Wei] Acad Sinica, Res Ctr Appl Sci, Taipei 11529, Taiwan.
   [Ping, Yueh-Hsin] Natl Yang Ming Univ, Dept & Inst Pharmacol, Taipei 11221, Taiwan.
RP Simanjuntak, Y; Lin, YL (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.; Lin, YL (corresponding author), Acad Sinica, Genom Res Ctr, Taipei 11529, Taiwan.; Li, WS (corresponding author), Acad Sinica, Inst Chem, Taipei 11529, Taiwan.; Li, WS (corresponding author), Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung 80424, Taiwan.; Li, WS (corresponding author), Taipei Med Univ, Ph Program Biotechnol Res & Dev, Taipei 11031, Taiwan.; Li, WS (corresponding author), Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung 80708, Taiwan.
EM yogy@ibms.sinica.edu.tw; yll@ibms.sinica.edu.tw;
   wenshan@gate.sinica.edu.tw
OI Ping, Yueh-Hsin/0000-0003-2604-9913; Li, Wen-Shan/0000-0002-8359-4582;
   Simanjuntak, Yogy/0000-0002-8983-0451
FU Academia SinicaAcademia Sinica - Taiwan [AS-SUMMIT-109,
   AS-KPQ-109-BioMed]; Ministry of Science and Technology, TaiwanMinistry
   of Science and Technology, Taiwan [MOST 108-3114-Y-001-002, MOST
   108-2321-B-001-011, MOST 108-2320-B-001-030-MY3, MOST
   108-3111-Y-001-056, MOST 108-2113-M-001-020, MOST 108-2320-B-010-031]
FX We thank Taiwan CDC for Zika virus (PRVABC59). We also thank the core
   facility of Institute of Biomedical Sciences for technical assistance.
   Instrumentation support was provided by the NMR and Mass Spectrometry
   facilities of the Institute of Chemistry at Academia Sinica, Taiwan.
   This study was financially supported by Academia Sinica (Grants
   AS-SUMMIT-109 and AS-KPQ-109-BioMed) and Ministry of Science and
   Technology, Taiwan (Grants MOST 108-3114-Y-001-002, MOST
   108-2321-B-001-011, MOST 108-2320-B-001-030-MY3, MOST
   108-3111-Y-001-056, MOST 108-2113-M-001-020, and MOST
   108-2320-B-010-031).
CR Agbulos Darrell S, 2016, Curr Protoc Microbiol, V43, DOI 10.1002/cpmc.19
   Alexander B, 1999, J PHARMACOL TOXICOL, V41, P55, DOI 10.1016/S1056-8719(98)00038-0
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Boothe JR, 2017, J ORG CHEM, V82, P2777, DOI 10.1021/acs.joc.7b00041
   Calderon-Pelaez MA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01435
   Ceballos-Olvera I, 2010, VIROLOGY, V396, P30, DOI 10.1016/j.virol.2009.10.019
   Chen JQ, 2016, CHEM COMMUN, V52, P6455, DOI 10.1039/c6cc02007k
   Chen ST, 2008, NATURE, V453, P672, DOI 10.1038/nature07013
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Coultrap SJ, 2012, TRENDS NEUROSCI, V35, P607, DOI 10.1016/j.tins.2012.05.003
   De Tulleo L, 1998, EMBO J, V17, P4585, DOI 10.1093/emboj/17.16.4585
   Durbin JE, 1996, CELL, V84, P443, DOI 10.1016/S0092-8674(00)81289-1
   Ebenebe OV, 2018, HEART LUNG CIRC, V27, P560, DOI 10.1016/j.hlc.2017.12.003
   Feng Y, 2015, J ORG CHEM, V80, P1952, DOI 10.1021/jo502604p
   Fournier D, 2011, EUR J MED CHEM, V46, P4227, DOI 10.1016/j.ejmech.2011.06.027
   Genheden S, 2015, EXPERT OPIN DRUG DIS, V10, P449, DOI 10.1517/17460441.2015.1032936
   Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366
   Gubler Duane J., 2002, Trends in Microbiology, V10, P100, DOI 10.1016/S0966-842X(01)02288-0
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Haqshenas G, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau9894
   Hunter AD, 1997, J CHEM EDUC, V74, P905, DOI [10.1021/ed074p905, DOI 10.1021/ED074P905]
   Jin YF, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040155
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kikue N, 2015, HETEROCYCLES, V90, P540, DOI 10.3987/COM-14-S(K)57
   Leyssen P, 2000, CLIN MICROBIOL REV, V13, P67, DOI 10.1128/CMR.13.1.67-82.2000
   Liang JJ, 2011, CELL MICROBIOL, V13, P1358, DOI 10.1111/j.1462-5822.2011.01624.x
   Lin RJ, 2013, NUCLEIC ACIDS RES, V41, P3314, DOI 10.1093/nar/gkt019
   Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998
   Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573
   Miner JJ, 2017, CELL HOST MICROBE, V21, P134, DOI 10.1016/j.chom.2017.01.004
   Miyamoto H, 2013, TETRAHEDRON, V69, P9481, DOI 10.1016/j.tet.2013.08.057
   Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15
   Pellicena P, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00021
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105
   Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z
   Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029
   Saha S, 2006, BIOCHEM BIOPH RES CO, V350, P444, DOI 10.1016/j.bbrc.2006.09.066
   Simanjuntak Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006854
   Simanjuntak Y, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00651
   SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E
   Wang JL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000809
   Yang XX, 2013, NEUROPSYCH DIS TREAT, V9, P1213, DOI 10.2147/NDT.S45422
   Yilmaz M, 2013, BIOSCIENCE REP, V33, P259, DOI 10.1042/BSR20120116
NR 48
TC 0
Z9 0
U1 6
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD FEB 13
PY 2020
VL 63
IS 3
BP 1313
EP 1327
DI 10.1021/acs.jmedchem.9b01779
PG 15
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA KM6AU
UT WOS:000514221700026
PM 31972088
DA 2020-07-08
ER

PT J
AU Park, C
   Kim, WB
   Cho, SY
   Oh, EJ
   Lee, H
   Kang, K
   Lee, Y
   Lee, DG
AF Park, Chulmin
   Kim, Won-Bok
   Cho, Sung-Yeon
   Oh, Eun-Jee
   Lee, Hyeyoung
   Kang, Kyungjoon
   Lee, Yoonsuk
   Lee, Dong-Gun
TI A Simple Method for the Design and Development of Flavivirus NS1
   Recombinant Proteins Using an In Silico Approach
SO BIOMED RESEARCH INTERNATIONAL
LA English
DT Article
ID JAPANESE ENCEPHALITIS-VIRUS; LINKED IMMUNOSORBENT ASSAYS; WEST-NILE;
   DENGUE; ANTIBODY; INFECTIONS; RESPONSES; SECRETION; DIAGNOSIS; CLIMATE
AB Even in countries that are currently not facing a flavivirus epidemic, the spread of mosquito-borne flaviviruses presents an increasing public threat, owing to climate change, international travel, and other factors. Many of these countries lack the resources (viral strains, clinical specimens, etc.) needed for the research that could help cope with the threat imposed by flaviviruses, and therefore, an alternative approach is needed. Using an in silico approach to global databases, we aimed to design and develop flavivirus NS1 recombinant proteins with due consideration towards antigenic variation. NS1 genes analyzed in this study included a total of 6,823 sequences, from Dengue virus (DENV), Japanese encephalitis virus (JEV), West Nile virus (WNV), Zika virus (ZIKV), and Yellow fever virus (YKV). We extracted and analyzed 316 DENV NS1 sequence types (STs), 59 JEV STs, 75 WNV STs, 30 YFV STs, and 43 ZIKV STs using a simple algorithm based on phylogenetic analysis. STs were reclassified according to the variation of the major epitope by MHC II binding. 78 DENV epitope type (EpT), 29 JEV EpTs, 29 WNV EpTs, 12 YFV EpTs, and 5 ZIKV EpTs were extracted according to their major epitopes. Also, frequency results showed that there were dominant EpTs in all flavivirus. Fifteen STs were selected and purified for the expression of recombinant antigen in Escherichia coli by sodium dodecyl sulfate extraction. Our study details a novel in silico approach for the development of flavivirus diagnostics, including a simple way to screen the important peptide regions.
C1 [Park, Chulmin; Kim, Won-Bok; Cho, Sung-Yeon; Lee, Dong-Gun] Catholic Univ Korea, Coll Med, Vaccine Bio Res Inst, Seoul 06591, South Korea.
   [Cho, Sung-Yeon; Lee, Dong-Gun] Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 06591, South Korea.
   [Oh, Eun-Jee] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Lab Med, Seoul, South Korea.
   [Lee, Hyeyoung] Catholic Kwandong Univ, Int St Marys Hosp, Coll Med, Dept Lab Med, Incheon 22711, South Korea.
   [Kang, Kyungjoon; Lee, Yoonsuk] Boditech Med Inc, 43 Geodudanji 1 Gil, Chunchon 24398, Gangwon Do, South Korea.
RP Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Vaccine Bio Res Inst, Seoul 06591, South Korea.; Lee, DG (corresponding author), Catholic Univ Korea, Coll Med, Dept Internal Med, Div Infect Dis, Seoul 06591, South Korea.
EM micropak@catholic.ac.kr; skaks301@naver.com; cho.sy@catholic.ac.kr;
   ejoh@catholic.ac.kr; shomermaid@catholic.ac.kr; kkj@boditech.co.kr;
   lys@boditech.co.kr; symonlee@catholic.ac.kr
OI Lee, Dong-Gun/0000-0003-4655-0641; Kim, Won-Bok/0000-0002-9111-0365;
   Cho, Sung-Yeon/0000-0001-5392-3405; Oh, Eun-Jee/0000-0001-5870-915X;
   Lee, Hyeyoung/0000-0001-8871-5091
FU Korea Health Technology R&D Project through the Korea Health Industry
   Development Institute (KHIDI) - Ministry of Health & Welfare, Republic
   of Korea [HI16C0338]
FX This research was supported by a grant from the Korea Health Technology
   R&D Project through the Korea Health Industry Development Institute
   (KHIDI) and funded by the Ministry of Health & Welfare, Republic of
   Korea (no. HI16C0338).
CR Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Cardosa MJ, 2002, BMC MICROBIOL, V2, DOI 10.1186/1471-2180-2-9
   Chao DY, 2015, J CLIN MICROBIOL, V53, P557, DOI 10.1128/JCM.02735-14
   Chin JX, 2014, BIOINFORMATICS, V30, P2210, DOI 10.1093/bioinformatics/btu192
   Daep CA, 2014, J NEUROVIROL, V20, P539, DOI 10.1007/s13365-014-0285-z
   Galula JU, 2016, J CLIN MICROBIOL, V54, P412, DOI 10.1128/JCM.02469-15
   Gao XJ, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3173-y
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Gubler DJ, 2004, COMP IMMUNOL MICROB, V27, P319, DOI 10.1016/j.cimid.2004.03.013
   Hansen JE, 2006, SCIENCE, V311, P469
   Huang YJS, 2014, VIRUSES-BASEL, V6, P4703, DOI 10.3390/v6114703
   Jespersen MC, 2017, NUCLEIC ACIDS RES, V45, pW24, DOI 10.1093/nar/gkx346
   JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275
   Konishi E, 2002, VACCINE, V21, P98, DOI 10.1016/S0264-410X(02)00433-4
   Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msv279, 10.1093/molbev/msw054]
   Kuno Goro, 2003, Adv Virus Res, V61, P3, DOI 10.1016/S0065-3527(03)61001-8
   Lindenbach BD, 2003, ADV VIRUS RES, V59, P23, DOI 10.1016/S0065-3527(03)59002-9
   Macdonald J, 2005, J VIROL, V79, P13924, DOI 10.1128/JVI.79.22.13924-13933.2005
   Mackenzie JM, 1996, VIROLOGY, V220, P232, DOI 10.1006/viro.1996.0307
   Mansfield KL, 2011, J GEN VIROL, V92, P2821, DOI 10.1099/vir.0.031641-0
   MASON PW, 1989, VIROLOGY, V169, P354, DOI 10.1016/0042-6822(89)90161-X
   Moutaftsi M, 2006, NAT BIOTECHNOL, V24, P817, DOI 10.1038/nbt1215
   Nascimento EJM, 2018, J VIROL METHODS, V257, P48, DOI 10.1016/j.jviromet.2018.03.007
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Rastogi M, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0590-7
   Rivino L, 2013, J VIROL, V87, P2693, DOI 10.1128/JVI.02675-12
   Schlager B, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-95
   Shu PY, 2001, VACCINE, V19, P1753, DOI 10.1016/S0264-410X(00)00391-1
   Somnuke P, 2011, VIROLOGY, V413, P253, DOI 10.1016/j.virol.2011.02.022
   TAMURA K, 1993, MOL BIOL EVOL, V10, P512
   Tesh RB, 2002, EMERG INFECT DIS, V8, P245, DOI 10.3201/eid0803.010238
   Wang P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-568
   Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048
   Weiskopf D, 2013, P NATL ACAD SCI USA, V110, pE2046, DOI 10.1073/pnas.1305227110
   Young PR, 2000, J CLIN MICROBIOL, V38, P1053, DOI 10.1128/JCM.38.3.1053-1057.2000
NR 36
TC 0
Z9 0
U1 0
U2 0
PU HINDAWI LTD
PI LONDON
PA ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND
SN 2314-6133
EI 2314-6141
J9 BIOMED RES INT
JI Biomed Res. Int.
PD FEB 13
PY 2020
VL 2020
AR 3865707
DI 10.1155/2020/3865707
PG 13
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA KR4NR
UT WOS:000517597300004
PM 32104691
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Reusken, CBEM
   Broberg, EK
   Haagmans, B
   Meijer, A
   Corman, VM
   Papa, A
   Charrel, R
   Drosten, C
   Koopmans, M
   Leitmeyer, K
AF Reusken, Chantal B. E. M.
   Broberg, Eeva K.
   Haagmans, Bart
   Meijer, Adam
   Corman, Victor M.
   Papa, Anna
   Charrel, Remi
   Drosten, Christian
   Koopmans, Marion
   Leitmeyer, Katrin
CA EVD-LabNet
   ERLI-Net
TI Laboratory readiness and response for novel coronavirus (2019-nCoV) in
   expert laboratories in 30 EU/EEA countries, January 2020
SO EUROSURVEILLANCE
LA English
DT Article
ID ZIKA VIRUS; QUALITY
AB Timely detection of novel coronavirus (2019-nCoV) infection cases is crucial to interrupt the spread of this virus. We assessed the required expertise and capacity for molecular detection of 2019-nCoV in specialised laboratories in 30 European Union/European Economic Area (EU/EEA) countries. Thirty-eight laboratories in 24 EU/EEA countries had diagnostic tests available by 29 January 2020. A coverage of all EU/EEA countries was expected by mid-February. Availability of primers/probes, positive controls and personnel were main implementation barriers.
C1 [Reusken, Chantal B. E. M.; Haagmans, Bart; Koopmans, Marion] Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Rotterdam, Netherlands.
   [Reusken, Chantal B. E. M.; Meijer, Adam] Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
   [Broberg, Eeva K.; Leitmeyer, Katrin] European Ctr Dis Prevent & Control, Solna, Sweden.
   [Corman, Victor M.; Drosten, Christian] Charite Univ Med Berlin, Inst Virol, Berlin, Germany.
   [Corman, Victor M.; Drosten, Christian] German Ctr Infect Res DZIF, Berlin, Germany.
   [Papa, Anna] Aristotle Univ Thessaloniki, Med Sch, Dept Microbiol, Thessaloniki, Greece.
   [Charrel, Remi] Aix Marseille Univ, Unite Virus Emergents, IRD 190, Inserm 1207,IHU Mediterranee Infect, Marseille, France.
RP Reusken, CBEM (corresponding author), Natl Inst Publ Hlth & Environm, Ctr Infect Dis Control, Rotterdam, Netherlands.; Reusken, CBEM (corresponding author), Erasmus MC, Virosci Dept, Rotterdam, Netherlands.
EM chantal.reusken@rivm.nl
RI Ribeiro, Nuno/AAH-2299-2020; Corman, Victor Max/K-1319-2019; Karabulut,
   Erman/G-6679-2011
OI Corman, Victor Max/0000-0002-3605-0136; Karabulut,
   Erman/0000-0002-0787-905X; Haagmans, Bart/0000-0001-6221-2015
CR Bogoch II, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa008
   Charrel R, 2017, J CLIN MICROBIOL, V55, P3219, DOI 10.1128/JCM.00987-17
   Chinazzi M, PRELIMINARY ASSESSME
   Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045
   European Centre for Disease Control and Prevention (ECDC), NOV COR CAS DEF EUR
   European Centre for Disease Prevention and Control (ECDC), NOV COR
   Hadjinicolaou AV, 2011, ARCH VIROL, V156, P671, DOI 10.1007/s00705-010-0906-7
   Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5
   Lai S, PRELIMINARY RISK ANA
   Mogling R, 2017, EUROSURVEILLANCE, V22, P18, DOI 10.2807/1560-7917.ES.2017.22.36.30609
   Pullano G, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.4.2000057
   Romette JL, 2018, ANTIVIR RES, V158, P127, DOI 10.1016/j.antiviral.2018.07.017
   Rothe C, 2020, NEW ENGL J MED, V382, P970, DOI 10.1056/NEJMc2001468
   Tan W, 2020, CHINA CDC WEEKLY, V2, P61, DOI DOI 10.1056/NEJM0A2001017
   World Health Organization, NOV COR 2019 NCOV TE
NR 15
TC 12
Z9 12
U1 15
U2 15
PU EUR CENTRE DIS PREVENTION & CONTROL
PI STOCKHOLM
PA TOMTEBODAVAGEN 11A, STOCKHOLM, 171 83, SWEDEN
SN 1560-7917
J9 EUROSURVEILLANCE
JI Eurosurveillance
PD FEB 13
PY 2020
VL 25
IS 6
BP 7
EP 12
AR 2000082
DI 10.2807/1560-7917.ES.2020.25.6.2000082
PG 6
WC Infectious Diseases
SC Infectious Diseases
GA KM9CR
UT WOS:000514439600002
PM 32046815
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Wu, YW
   Chen, MC
   Chen, YH
AF Wu, Yan-Wei
   Chen, Mei-Chin
   Chen, Yu-Hung
TI Potential Zika Vaccine: Encapsulated Nanocomplex Promotes Both
   T(H)1/T(H)2 Responses in Mice
SO ADVANCED THERAPEUTICS
LA English
DT Article
DE chitosan; nanocomplex; T helper 1; 2 responses; Zika virus; gamma-PGA
ID ADJUVANTS; DELIVERY
AB The concept of vaccination originated from the discovery that cowpox inoculation can prevent infection from the smallpox virus. Subsequent studies have addressed the roles of lymphocytes in induction, education, and memory of host immunity targeting foreign antigens. However, antigens alone stimulate poor immunogenicity, requiring an immunological adjuvant. Common adjuvants include inactivated toxins from bacteria or aluminium hydroxide/phosphate. Although several new adjuvants are being developed, polarized immunity and safety are still of concern. To address these limitations, in the present study, two biodegradable polymers are utilized, chitosan and gamma-polyglutamic acid (gamma-PGA), to encapsulate inactivated Zika virus (iZV) as a nanocomplex (iZV-NC) vaccine by the electro-kinetic approach. iZV-NC vaccine elicited both anti-ZV IgG1/2a antibodies, correcting to T helper (T-H) 2/1 responses in BALB/c mice. Further, these antibodies have the ability to neutralize ZV infection. Additionally, CD4/8 T cells are shown to be activated by ex vivo treatment of iZV, showing established immunity against ZV. Taken together, these results suggest that iZV-NC can produce balanced T(H)1/2 responses compared to the aluminum adjuvant, thereby providing novel insights into the immune mechanism through which NC acts against infectious diseases in humans.
C1 [Wu, Yan-Wei; Chen, Yu-Hung] Natl Cheng Kung Univ, Coll Med, Dept Med, 1 Univ Rd, Tainan 701, Taiwan.
   [Chen, Mei-Chin] Natl Cheng Kung Univ, Dept Chem Engn, 1 Univ Rd, Tainan 701, Taiwan.
RP Chen, YH (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Med, 1 Univ Rd, Tainan 701, Taiwan.
EM second@mail.ncku.edu.tw
OI Chen, Yu-Hung/0000-0003-3524-629X; Wu, Yan-Wei/0000-0002-0918-9319
FU Ministry of Science and Technology (MOST), TaiwanMinistry of Science and
   Technology, Taiwan; BRIM Biotechnology, Inc., Taiwan; Laboratory Animal
   Center, College of Medicine, National Cheng Kung University, Taiwan;
   Core Research Laboratory, College of Medicine, National Cheng Kung
   University, Taiwan
FX This study was supported by the Ministry of Science and Technology
   (MOST), Taiwan and BRIM Biotechnology, Inc., Taiwan. The manuscript was
   written through contributions of all authors. All authors had approved
   the final version of the manuscript. The authors thank the Centers for
   Disease Control (CDC), Ministry of Health and Welfare, Taiwan for
   providing the Zika virus in this study. Additionally, they are grateful
   for the support of the Laboratory Animal Center and Core Research
   Laboratory, College of Medicine, National Cheng Kung University, Taiwan.
   The protocol of animal experiments followed the ARRIVE guidelines, and
   was approved by the Laboratory Animal Center, College of Medicine,
   National Cheng Kung University, Taiwan (IACUC Approval number: 108036).
CR Bagre AP, 2013, INT J PHARMACEUT, V456, P31, DOI 10.1016/j.ijpharm.2013.08.037
   Baud D, 2017, LANCET, V390, P2099, DOI [10.1016/S0140-6736(17)31450-2, 10.1016/s0140-6736(17)31450-2]
   Baumgarth N, 2013, IMMUNOL REV, V255, P82, DOI 10.1111/imr.12094
   Brewer JM, 1999, J IMMUNOL, V163, P6448
   Brito LA, 2011, J PHARM SCI-US, V100, P34, DOI 10.1002/jps.22267
   Burgdorf S, 2007, SCIENCE, V316, P612, DOI 10.1126/science.1137971
   Del Giudice G, 2018, SEMIN IMMUNOL, V39, P14, DOI 10.1016/j.smim.2018.05.001
   Huber SR, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00171
   Klasse PJ, 2014, ADV BIOL, V2014, P1, DOI [10.1155/2014/157895, DOI 10.1155/2014/157895]
   Koppolu B, 2013, BIOMATERIALS, V34, P2359, DOI 10.1016/j.biomaterials.2012.11.066
   Lee S, 2015, IMMUNE NETW, V15, P51, DOI 10.4110/in.2015.15.2.51
   Lin Y. S., 2018, [No title captured], Patent No. [US10052390B2, 10052390]
   Lin Y. S., 2014, [No title captured], Patent No. [EP2754436A1, 2754436]
   Lin Y. S., 2016, [No title captured], Patent No. [CN103910892B, 103910892]
   Lin Y. S., 2015, [No title captured], Patent No. [TW1511744, 1511744]
   Liu YW, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01411
   Plans-Rubio P, 2012, PREV MED, V55, P72, DOI 10.1016/j.ypmed.2012.02.015
   Singh B, 2018, INT J BIOL MACROMOL, V110, P54, DOI 10.1016/j.ijbiomac.2017.10.101
   Teixeira R, 2013, BRAZ J INFECT DIS, V17, P194, DOI 10.1016/j.bjid.2012.10.010
   Tomljenovic L, 2011, CURR MED CHEM, V18, P2630, DOI 10.2174/092986711795933740
   Vorou R, 2016, INT J INFECT DIS, V48, P85, DOI 10.1016/j.ijid.2016.05.014
   Xing YY, 2015, BIOCHEM BIOPH RES CO, V462, P269, DOI 10.1016/j.bbrc.2015.04.130
   Yoshikawa T, 2008, BIOCHEM BIOPH RES CO, V366, P408, DOI 10.1016/j.bbrc.2007.11.153
   Zaharoff DA, 2007, VACCINE, V25, P2085, DOI 10.1016/j.vaccine.2006.11.034
NR 24
TC 0
Z9 0
U1 2
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
EI 2366-3987
J9 ADV THER-GERMANY
JI Adv. Therap.
PD MAR
PY 2020
VL 3
IS 3
AR UNSP 1900197
DI 10.1002/adtp.201900197
EA FEB 2020
PG 6
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KU8EL
UT WOS:000513846700001
DA 2020-07-08
ER

PT J
AU Anderson, KB
   Stewart-Ibarra, AM
   Buddhari, D
   Ayala, EFB
   Sippy, RJ
   Iamsirithaworn, S
   Ryan, SJ
   Fernandez, S
   Jarman, RG
   Thomas, SJ
   Endy, TP
AF Anderson, Kathryn B.
   Stewart-Ibarra, Anna M.
   Buddhari, Darunee
   Beltran Ayala, Efrain Felix
   Sippy, Rachel J.
   Iamsirithaworn, Sopon
   Ryan, Sadie J.
   Fernandez, Stefan
   Jarman, Richard G.
   Thomas, Stephen J.
   Endy, Timothy P.
TI Key Findings and Comparisons From Analogous Case-Cluster Studies for
   Dengue Virus Infection Conducted in Machala, Ecuador, and Kamphaeng
   Phet, Thailand
SO FRONTIERS IN PUBLIC HEALTH
LA English
DT Article
DE dengue; epidemiology; observational study; Thailand; Ecuador
ID PRIMARY-SCHOOL CHILDREN; SURVEILLANCE; ASSAY; ZIKA; FORCE
AB Dengue viruses (DENV) pose a significant and increasing threat to human health across broad regions of the globe. Currently, prevention, control, and treatment strategies are limited. Promising interventions are on the horizon, including multiple vaccine candidates under development and a renewed and innovative focus on controlling the vector, Aedes aegypti. However, significant gaps persist in our understanding of the similarities and differences in DENV epidemiology across regions of potential implementation and evaluation. In this manuscript, we highlight and compare findings from two analogous cluster-based studies for DENV transmission and pathogenesis conducted in Thailand and Ecuador to identify key features and questions for further pursuit. Despite a remarkably similar incidence of DENV infection among enrolled neighborhood contacts at the two sites, we note a higher occurrence of secondary infection and severe illness in Thailand compared to Ecuador. A higher force of infection in Thailand, defined as the incidence of infection among susceptible individuals, is suggested by the higher number of captured Aedes mosquitoes per household, the increasing proportion of asymptomatic infections with advancing age, and the high proportion of infections identified as secondary-type infections by serology. These observations should be confirmed in long-term, parallel prospective cohort studies conducted across regions, which would advantageously permit characterization of baseline immune status (susceptibility) and contemporaneous assessment of risks and risk factors for dengue illness.
C1 [Anderson, Kathryn B.; Stewart-Ibarra, Anna M.; Sippy, Rachel J.; Thomas, Stephen J.; Endy, Timothy P.] SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.
   [Anderson, Kathryn B.; Buddhari, Darunee; Fernandez, Stefan] Armed Forces Res Inst Med Sci, Bangkok, Thailand.
   [Anderson, Kathryn B.; Thomas, Stephen J.; Endy, Timothy P.] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.
   [Anderson, Kathryn B.; Thomas, Stephen J.; Endy, Timothy P.] SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.
   [Stewart-Ibarra, Anna M.] Interamer Inst Global Change Res IAI, Dept Montevideo, Montevideo, Uruguay.
   [Beltran Ayala, Efrain Felix] Carrera Med Univ Tecn Machala, Machala, Ecuador.
   [Sippy, Rachel J.; Ryan, Sadie J.] Univ Florida, Dept Geog, Gainesville, FL 32611 USA.
   [Iamsirithaworn, Sopon] Minist Publ Hlth Thailand, Nonthaburi, Thailand.
   [Ryan, Sadie J.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Jarman, Richard G.] Walter Reed Army Inst Res, Silver Spring, MD USA.
RP Anderson, KB (corresponding author), SUNY Upstate Med Univ, Dept Med, Syracuse, NY 13210 USA.; Anderson, KB (corresponding author), Armed Forces Res Inst Med Sci, Bangkok, Thailand.; Anderson, KB (corresponding author), SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA.; Anderson, KB (corresponding author), SUNY Upstate Med Univ, Inst Global Hlth & Translat Sci, Syracuse, NY 13210 USA.; Ryan, SJ (corresponding author), Univ Florida, Dept Geog, Gainesville, FL 32611 USA.; Ryan, SJ (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM andekath@upstate.edu; sjryan@ufl.edu
FU R01 award from the National Institutes of HealthUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USA
   [GM83224-01A1]; Department of Defense Global Emerging Infection
   Surveillance (GEIS) [P0220_13_OT]; Department of Medicine of SUNY
   Upstate Medical University; NSF DEB EEID [1518681]; NSF DEB RAPID
   [1641145]
FX The Thai research study presented here was funded by an R01 award from
   the National Institutes of Health (PI: TE, GM83224-01A1). This
   Ecuadorian research study was supported, in part, by the Department of
   Defense Global Emerging Infection Surveillance (GEIS) grant
   (P0220_13_OT) and the Department of Medicine of SUNY Upstate Medical
   University. AS-I and SR were additionally supported by NSF DEB EEID
   1518681 and NSF DEB RAPID 1641145.
CR Alava A., 2005, REV ECUAT HIG MED TR, V42, P11
   Anderson KB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001311
   Balmaseda A, 2017, P NATL ACAD SCI USA, V114, P8384, DOI 10.1073/pnas.1704984114
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Carvalho DO, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003864
   Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139
   Egger JR, 2008, B WORLD HEALTH ORGAN, V86, P187, DOI 10.2471/BLT.07.040170
   Endy TP, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000975
   Endy TP, 2002, AM J EPIDEMIOL, V156, P52, DOI 10.1093/aje/kwf006
   Endy TP, 2002, AM J EPIDEMIOL, V156, P40, DOI 10.1093/aje/kwf005
   Fried JR, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000617
   Gordon A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002462
   Gutierrez E., 2005, REV ECUAT HIG MED TR, V42, P35
   Halstead SB, 2019, LANCET CHILD ADOLESC, V3, P734, DOI 10.1016/S2352-4642(19)30205-6
   Imai N, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004833
   Imai N, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003719
   INNIS BL, 1989, AM J TROP MED HYG, V40, P418, DOI 10.4269/ajtmh.1989.40.418
   Kamal SM, 2006, PARASITE IMMUNOL, V28, P483, DOI 10.1111/j.1365-3024.2006.00909.x
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Reiner RC, 2014, P NATL ACAD SCI USA, V111, pE2694, DOI 10.1073/pnas.1314933111
   Rocha C, 2009, AM J TROP MED HYG, V80, P656, DOI 10.4269/ajtmh.2009.80.656
   Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7
   Santiago GA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002311
   Sippy R, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007360
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Stewart-Ibarra AM, 2018, AM J TROP MED HYG, V98, P1444, DOI 10.4269/ajtmh.17-0762
   Alera MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004337
   Thomas SJ, 2015, AM J TROP MED HYG, V93, P24, DOI 10.4269/ajtmh.14-0242
   Tsai WY, 2018, EMERG INFECT DIS, V24, P1355, DOI 10.3201/eid2407.171170
   World Health Organization, 2018, EC WHO UNICEF EST IM
   World Health Organization, 2019, WHO VACC PREV DIS MO
   Xavier-Carvalho C, 2017, INFECT GENET EVOL, V56, P99, DOI 10.1016/j.meegid.2017.11.009
   Yung CF, 2015, AM J TROP MED HYG, V92, P999, DOI 10.4269/ajtmh.14-0628
NR 36
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2296-2565
J9 FRONT PUBLIC HEALTH
JI Front. Public Health
PD FEB 12
PY 2020
VL 8
AR 2
DI 10.3389/fpubh.2020.00002
PG 12
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KS0WZ
UT WOS:000518033900001
PM 32117847
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bernal, L
   Dussan, J
AF Bernal, Laura
   Dussan, Jenny
TI Synergistic effect of Lysinibacillus sphaericus and glyphosate on
   temephos-resistant larvae of Aedes aegypti
SO PARASITES & VECTORS
LA English
DT Article
DE Lysinibacillus sphaericus; Aedes aegypti; Glyphosate; Synergy
ID HEALTH; MODE
AB BackgroundGlyphosate-based herbicides are one of the most commonly used compounds to control perennial weeds around the world. This compound is very persistent in the environment and tends to filter into aquatic ecosystems, affecting non-target species such as mosquito larvae. Aedes aegypti mosquitoes are vectors of multiple arboviruses such as dengue and Zika. Glyphosate can be degraded into non-harmful environmental compounds by Lysinibacillus sphaericus, a spore forming bacterium which can also kill Ae. aegypti larvae. In this study, we assessed the effect of glyphosate concentrations, typically used in Colombia, on the entomopathogenic activity of L. sphaericus against Ae. aegypti larvae.MethodsBioassays and toxicity curves were performed to compare the larval mortality between different treatments with and without bacteria and glyphosate (Roundup 747 (R)). Larvae were exposed to both bacteria and glyphosate by adding the compound on chloride-free water. Comparisons were made using both probit regression and ANOVA analysis.ResultsANOVA showed a significant difference in larval mortality when adding glyphosate and L. sphaericus at the same time. Thus, a positive synergic effect on larval mortality was found when L. sphaericus and glyphosate were mixed. According to probit analysis, median lethal dose (LD50) for bacterial mixture was of 10(6.23) UFC/ml and for glyphosate was 2.34 g/l.ConclusionsA positive synergic effect on the mortality of larval Ae. aegypti when exposed to L. sphaericus mixture and glyphosate was found. Molecular studies focusing on the toxin production of L. sphaericus are required to understand more about this synergistic effect.
C1 [Bernal, Laura; Dussan, Jenny] Univ Los Andes, Dept Biol Sci, Microbiol Res Ctr CIMIC, Carrera 1 18 A-12, Bogota 111711, Colombia.
RP Dussan, J (corresponding author), Univ Los Andes, Dept Biol Sci, Microbiol Res Ctr CIMIC, Carrera 1 18 A-12, Bogota 111711, Colombia.
EM jdussan@uniandes.edu.co
OI Dussan G., Jenny/0000-0002-9901-1214
FU Universidad de los Andes; Microbiological Research Center (CIMIC)
FX This study was funded by the Research Fund at the vice-rectory of
   investigations at Universidad de los Andes and the Microbiological
   Research Center (CIMIC).
CR Adnan M, 2019, MICROB PATHOGENESIS, V129, P7, DOI 10.1016/j.micpath.2019.01.042
   Rojas-Pinzon PA, 2017, WORLD J MICROB BIOT, V33, DOI 10.1007/s11274-017-2348-9
   Rojas-Pinzon PA, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2171-z
   Aponte A, 2019, ACTA TROP, V191, P146, DOI 10.1016/j.actatropica.2018.12.021
   Bara JJ, 2014, PARASITOL RES, V113, P2879, DOI 10.1007/s00436-014-3949-y
   Battaglin WA, 2005, J AM WATER RESOUR AS, V41, P323, DOI 10.1111/j.1752-1688.2005.tb03738.x
   Berry C, 2012, J INVERTEBR PATHOL, V109, P1, DOI 10.1016/j.jip.2011.11.008
   Betz FS, 2000, REGUL TOXICOL PHARM, V32, P156, DOI 10.1006/rtph.2000.1426
   Camacho A, 2017, J HEALTH ECON, V54, P147, DOI 10.1016/j.jhealeco.2017.04.005
   Vega-Paez JD, 2019, MATERIALS, V12, DOI 10.3390/ma12081296
   Dussan J, 2006, REV COLOMB BIOTECNOL, V4, P89
   Vargas JE, 2016, BIOMED ENVIRON SCI, V29, P187, DOI 10.3967/bes2016.023
   Espana VAA, 2018, SCI TOTAL ENVIRON, V618, P199, DOI 10.1016/j.scitotenv.2017.10.245
   Gonzalez-Valenzuela LE, 2018, ENVIRON SCI POLLUT R, V25, P22790, DOI 10.1007/s11356-018-2364-9
   Herbert LT, 2014, J EXP BIOL, V217, P3457, DOI 10.1242/jeb.109520
   la Cecilia D, 2018, ENVIRON POLLUT, V233, P201, DOI 10.1016/j.envpol.2017.10.017
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Filha MHNLS, 2014, ADV INSECT PHYSIOL, V47, P89, DOI 10.1016/B978-0-12-800197-4.00003-8
   Naureen Z, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01477
   Nishiwaki H, 2007, APPL ENVIRON MICROB, V73, P3404, DOI 10.1128/AEM.00021-07
   Osten JRV, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14060595
   Rodriguez MP, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9100217
   Peruzzo PJ, 2008, ENVIRON POLLUT, V156, P61, DOI 10.1016/j.envpol.2008.01.015
   R Development Core Team, 2015, R LANG ENV STAT COMP
   Riaz MA, 2009, AQUAT TOXICOL, V93, P61, DOI 10.1016/j.aquatox.2009.03.005
   Rincon-Ruiz A, 2013, GEOFORUM, V46, P60, DOI 10.1016/j.geoforum.2012.12.009
   Rodrigues LD, 2019, MUTAT RES-GEN TOX EN, V842, P94, DOI 10.1016/j.mrgentox.2019.05.002
   Rojas-Pinzon PA, 2018, APPL ENTOMOL ZOOL, V53, P183, DOI 10.1007/s13355-017-0534-8
   Santacoloma L, 2012, BIOMEDICA, V32, P333, DOI [10.7705/biomedica.v32i3.680, 10.1590/S0120-41572012000300004]
   Sihtmae M, 2013, APPL SOIL ECOL, V72, P215, DOI 10.1016/j.apsoil.2013.07.005
   Sikorski L, 2019, AQUAT TOXICOL, V209, P70, DOI 10.1016/j.aquatox.2019.01.021
   Sviridov A V, 2015, Prikl Biokhim Mikrobiol, V51, P183
   Tsui MTK, 2003, CHEMOSPHERE, V52, P1189, DOI 10.1016/S0045-6535(03)00306-0
   Xu JW, 2019, FOOD CONTROL, V106, DOI 10.1016/j.foodcont.2019.106710
NR 34
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 12
PY 2020
VL 13
IS 1
AR 68
DI 10.1186/s13071-020-3928-3
PG 6
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KN5HI
UT WOS:000514867500004
PM 32051012
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Bonezi, V
   Cataneo, AHD
   Branquinho, MSF
   Silva, MBB
   Gonzalez-Dias, P
   Pereira, SS
   Ferreira, LCD
   Nakaya, HI
   Campa, A
   Wowk, PF
   Silveira, ELV
AF Bonezi, Vivian
   Cataneo, Allan H. D.
   Branquinho, Maryana S. F.
   Silva, Maysa B. B.
   Gonzalez-Dias, Patricia
   Pereira, Samuel S.
   de Souza Ferreira, Luis C.
   Nakaya, Helder, I
   Campa, Ana
   Wowk, Pryscilla F.
   Silveira, Eduardo L., V
TI Flavivirus-Mediating B Cell Differentiation Into Antibody-Secreting
   Cells in Humans Is Associated With the Activation of the Tryptophan
   Metabolism
SO FRONTIERS IN IMMUNOLOGY
LA English
DT Article
DE Dengue virus; B cell differentiation; antibody-secreting cells;
   tryptophan metabolism; flaviviruses
ID DENGUE VIRUS-INFECTION; HUMAN MONOCLONAL-ANTIBODIES; INDOLEAMINE
   2,3-DIOXYGENASE; INTERFERON-GAMMA; PLASMABLAST RESPONSE; IMMUNE
   ACTIVATION; SERUM; LYMPHOCYTES; DEFICIENCY; INHIBITION
AB Patients infected with the Dengue virus (DENV) often present with a massive generation of DENV-specific antibody-secreting cells (ASCs) in the blood. In some cases, these ASCs represent more than 50% of the circulating B cells, a higher magnitude than those induced by other infections, vaccinations, and plasma cell lymphomas. However, it remains unclear how the DENV infection elicits this colossal response. To address this issue, we utilised an in vitro strategy to induce human PBMCs of healthy individuals incubated with DENV particles (DENV4 TVP/360) to differentiate into ASCs. As controls, PBMCs were incubated with a mitogen cocktail or supernatants of uninfected C6/36 cells (mock). The ASC phenotype and function were increasingly detected in the DENV and mitogen-cultured PBMCs as compared to mock-treated cells. In contrast to the in vivo condition, secreted IgG derived from the PBMC-DENV culture was not DENV-specific. Lower ASC numbers were observed when inactivated viral particles or purified B cells were added to the cultures. The physical contact was essential between B cells and the remaining PBMCs for the DENV-mediated ASC response. Considering the evidence for the activation of the tryptophan metabolism detected in the serum of Dengue patients, we assessed its relevance in the DENV-mediated ASC differentiation. For this, tryptophan and its respective metabolites were quantified in the supernatants of cell cultures through mass spectrophotometry. Tryptophan depletion and kynurenine accumulation were found in the supernatants of PBMC-DENV cultures, which presented enhanced detection of indoleamine 2,3-dioxygenase 1 and 2 transcripts as compared to controls. In PBMC-DENV cultures, tryptophan and kynurenine levels strongly correlated to the respective ASC numbers, while the kynurenine levels were directly proportional to the secreted IgG titers. Contrastingly, PBMCs incubated with Zika or attenuated Yellow Fever viruses showed no correlation between their kynurenine concentrations and ASC numbers. Therefore, our data revealed the existence of distinct pathways for the DENV-mediated ASC differentiation and suggest the involvement of the tryptophan metabolism in this cellular process triggered by flavivirus infections.
C1 [Bonezi, Vivian; Branquinho, Maryana S. F.; Silva, Maysa B. B.; Gonzalez-Dias, Patricia; Nakaya, Helder, I; Campa, Ana; Silveira, Eduardo L., V] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
   [Cataneo, Allan H. D.; Wowk, Pryscilla F.] Fiocruz Parana, Lab Virol Mol, ICC, Curitiba, Parana, Brazil.
   [Gonzalez-Dias, Patricia; Nakaya, Helder, I] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.
   [Pereira, Samuel S.; de Souza Ferreira, Luis C.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.
RP Silveira, ELV (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.
EM eduardosilveira@usp.br
RI Wowk, Pryscilla Fanini/AAR-7230-2020; Silveira, Eduardo L V/E-5733-2014
OI Silveira, Eduardo L V/0000-0001-8333-2884; Wowk,
   Pryscilla/0000-0002-8976-2647
FU CNPqNational Council for Scientific and Technological Development (CNPq)
   [420616/2016-0]; FapespFundacao de Amparo a Pesquisa do Estado de Sao
   Paulo (FAPESP) [2017/11931-6]; Programa de Apoio aos Novos Docentes
   (University of Sao Paulo)
FX This study was supported by CNPq (Grant No. 420616/2016-0), Fapesp
   (Grant No. 2017/11931-6), and Programa de Apoio aos Novos Docentes
   (University of Sao Paulo). VB was a Capes and CNPq fellow during
   different periods of her graduation.
CR Adam I, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1486353
   Appanna R, 2016, EBIOMEDICINE, V12, P178, DOI 10.1016/j.ebiom.2016.09.003
   Arnold J, 2016, CELL DEATH DIFFER, V23, P853, DOI 10.1038/cdd.2015.149
   Avery DT, 2003, J CLIN INVEST, V112, P286, DOI 10.1172/JCI200318025
   Badawy AAB, 2017, INT J TRYPTOPHAN RES, V10, DOI 10.1177/1178646917691938
   Barnes NA, 2009, J IMMUNOL, V183, P5768, DOI 10.4049/jimmunol.0803480
   Becerra A, 2009, J GEN VIROL, V90, P810, DOI 10.1099/vir.0.004416-0
   Buckner CM, 2013, J VIROL, V87, P5800, DOI 10.1128/JVI.00094-13
   Yam-Puc JC, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00188
   CASTELLA A, 1985, AM J CLIN PATHOL, V84, P423
   Cepok S, 2007, ANN NEUROL, V62, P458, DOI 10.1002/ana.21195
   Chahroudi A, 2012, SCIENCE, V335, P1188, DOI 10.1126/science.1217550
   CHESS Q, 1984, DIAGN CLIN IMMUNOL, V2, P148
   Crotty S, 2004, J IMMUNOL METHODS, V286, P111, DOI 10.1016/j.jim.2003.12.015
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Donald CL, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005048
   Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533
   Finger E, 2017, BLOOD, V130
   Fornecker LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37273-4
   Garcia M, 2017, IMMUNOLOGY, V151, P122, DOI 10.1111/imm.12713
   Garcia-Bates TM, 2013, J IMMUNOL, V190, P80, DOI 10.4049/jimmunol.1103350
   Gawoski JM, 2003, ARCH PATHOL LAB MED, V127, P1026
   Grohmann U, 2002, NAT IMMUNOL, V3, P1097, DOI 10.1038/ni846
   Haltaufderhyde K, 2018, J INFECT DIS, V218, P1675, DOI 10.1093/infdis/jiy360
   Harrington L, 2008, INFECT IMMUN, V76, P3045, DOI 10.1128/IAI.00193-08
   Heine G, 2014, EUR J IMMUNOL, V44, P1615, DOI 10.1002/eji.201343822
   Huengsberg M, 1998, CLIN CHEM, V44, P858
   Human Protein Atlas, 2019, BLOOD ATL WARS MON S
   Hwu P, 2000, J IMMUNOL, V164, P3596, DOI 10.4049/jimmunol.164.7.3596
   Khadka S, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.012187-1, 10.1074/mcp.M111.012187]
   Khetarpal N, 2016, J IMMUNOL RES, DOI 10.1155/2016/6803098
   Kuczera D, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0548-9
   KURANE I, 1986, J GEN VIROL, V67, P1653, DOI 10.1099/0022-1317-67-8-1653
   KURANE I, 1991, J CLIN INVEST, V88, P1473, DOI 10.1172/JCI115457
   KURANE I, 1988, J GEN VIROL, V69, P445, DOI 10.1099/0022-1317-69-2-445
   Kwissa M, 2014, CELL HOST MICROBE, V16, P115, DOI 10.1016/j.chom.2014.06.001
   LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803
   Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Marchevsky RS, 2006, BIOLOGICALS, V34, P191, DOI 10.1016/j.biologicals.2005.09.005
   Matsushita N, 2016, SCI REP-UK, V6, DOI 10.1038/srep31266
   McElroy AK, 2015, P NATL ACAD SCI USA, V112, P4719, DOI 10.1073/pnas.1502619112
   McLean JE, 2011, J BIOL CHEM, V286, P22147, DOI 10.1074/jbc.M110.192500
   MIZUMA H, 1987, CLIN EXP IMMUNOL, V68, P5
   Modhiran N, 2017, IMMUNOL CELL BIOL, V95, P491, DOI 10.1038/icb.2017.5
   Modhiran N, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3863
   Munn DH, 1999, J EXP MED, V189, P1363, DOI 10.1084/jem.189.9.1363
   Ninomiya S, 2008, BLOOD, V112, P971
   Nivarthi UK, 2019, EBIOMEDICINE, V41, P465, DOI 10.1016/j.ebiom.2019.02.060
   OLESKE J, 1983, JAMA-J AM MED ASSOC, V249, P2345, DOI 10.1001/jama.249.17.2345
   Pone EJ, 2015, AUTOIMMUNITY, V48, P1, DOI 10.3109/08916934.2014.993027
   Price MJ, 2018, CELL REP, V23, P3152, DOI 10.1016/j.celrep.2018.05.053
   Priyamvada L, 2016, J VIROL, V90, P5574, DOI 10.1128/JVI.03203-15
   Ricciardi MJ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006000
   RIZVI N, 1989, IMMUNOLOGY, V67, P38
   Rogers TF, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan6809
   Romano A, 2018, BLOOD, V132, P4511, DOI [10.1182/blood-2018-99-116447, DOI 10.1182/BLOOD-2018-99-116447]
   Shinde R, 2015, J IMMUNOL, V195, P2374, DOI 10.4049/jimmunol.1402854
   Silveira ELV, 2017, J IMMUNOL, V199, P1003, DOI 10.4049/jimmunol.1700256
   Silveira GF, 2018, J VIROL, V92, DOI [10.1128/JVI.02181-17, 10.1128/jvi.02181-17]
   Sinclair LV, 2018, NAT COMMUN, V9, DOI [10.1038/S41467-018-04366-7, 10.1038/s41467-018-04366-7]
   Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3
   Spudich SS, 2016, CURR OPIN HIV AIDS, V11, P226, DOI 10.1097/COH.0000000000000243
   Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439
   TAYLOR MW, 1991, FASEB J, V5, P2516
   Tsai WY, 2013, J VIROL, V87, P12562, DOI 10.1128/JVI.00871-13
   Utay NS, 2016, CURR OPIN HIV AIDS, V11, P131, DOI 10.1097/COH.0000000000000242
   Correa ARV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143391
   WERNER ER, 1988, BIOL CHEM H-S, V369, P337, DOI 10.1515/bchm3.1988.369.1.337
   World Health Organization, 2019, FACT SHEET DENG SEV
   Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890
   Wrammert J, 2012, J VIROL, V86, P2911, DOI 10.1128/JVI.06075-11
   Yoshikawa T, 2010, EUR J HAEMATOL
   Zhang Y, 2015, INT IMMUNOL, V27, P521, DOI 10.1093/intimm/dxv034
NR 75
TC 0
Z9 0
U1 1
U2 1
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1664-3224
J9 FRONT IMMUNOL
JI Front. Immunol.
PD FEB 11
PY 2020
VL 11
AR 20
DI 10.3389/fimmu.2020.00020
PG 13
WC Immunology
SC Immunology
GA KR5CK
UT WOS:000517636300001
PM 32117223
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ray, U
   Chouhan, U
   Verma, N
AF Ray, Upasana
   Chouhan, Usha
   Verma, Neha
TI Comparative study of machine learning approaches for classification and
   prediction of selective caspase-3 antagonist for Zika virus drugs
SO NEURAL COMPUTING & APPLICATIONS
LA English
DT Article; Early Access
DE Caspase-3; QSAR; Machine learning; Antagonist
ID INHIBITORS; OUTBREAK
AB Zika virus (ZIKV) infection is an enervating and fast-growing disease. The increasing incidences of birth defects (microcephaly) in newborns due to ZIKV represent a public health problem. The viral infection is characterized by an increase in cell death of human neural progenitors and astrocytes, which can be inhibited by suppressing infection-induced caspase-3 activity. The aim of the present work is to develop classification models for the prediction of highly active and low active caspase-3 antagonists and to seek the important structural features related to the high anti-ZIKV property. Here, machine learning (ML) is applied in quantitative structure-activity relationship (QSAR) study. QSAR study is performed on the dataset by means of ML approaches, i.e., multiple linear regression (MLR), linear discriminant analysis (LDA), least square support vector machine (LS-SVM), deep neural net (DNN), k-nearest neighbor (KNN), naive Bayes (NB) and random forest (RF). MLR, LDA are used for feature selection process and DNN, LS-SVM, KNN, NB, RF classifier for classification. The obtained results confirmed the discriminative capacity of the calculated descriptors. A good correlation is found by regression analysis between the observed and predicted activities as evident by their R-2 (0.895) and Rpred 2 (0.716) for the molecular descriptor dataset, R-2 (0.892) and Rpred 2 (0.736) for fingerprint dataset. The classification model obtained using RF (85.71%, 97.57%) and DNN (85.71%, 91.07%) classifier gave better accuracy than other approaches in fingerprint dataset and molecular descriptor dataset, respectively. This work provides an effective method to screen caspase-3 antagonists that will help out further in drug design for Zika virus.
C1 [Ray, Upasana; Chouhan, Usha; Verma, Neha] Maulana Azad Natl Inst Technol, Dept Math Bioinformat & Comp Applicat, Bhopal 462003, India.
RP Ray, U (corresponding author), Maulana Azad Natl Inst Technol, Dept Math Bioinformat & Comp Applicat, Bhopal 462003, India.
EM ur.172104108@manit.ac.in; chouhanu@manit.ac.in
FU M.P Council of Science & Technology, Bhopal, India at Maulana Azad
   National Institute of Technology, Bhopal [1253/CST/RD/2016]
FX The authors are highly thankful to the M.P Council of Science &
   Technology, Bhopal, India (Grant No. 1253/CST/R&D/2016) for providing
   support in carrying out this work at Maulana Azad National Institute of
   Technology, Bhopal.
CR [Anonymous], 2017, MATLAB VERS 9 2 0
   Araujo LM, 2016, ARQ NEURO-PSIQUIAT, V74, P253, DOI 10.1590/0004-282X20160035
   Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x
   Hughes TB, 2015, ACS CENTRAL SCI, V1, P168, DOI 10.1021/acscentsci.5b00131
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   KACHIGAN SK, 1986, STAT ANAL INTERDISCI
   Kirkpatrick LA, 2012, SIMPLE GUIDE IBM SPS
   Luco JM, 1997, J CHEM INF COMP SCI, V37, P392, DOI 10.1021/ci960487o
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Mendelsohn LD, 2004, J CHEM INF COMP SCI, V44, P2225, DOI 10.1021/ci040123t
   Metsis V., 2006, P 3 C EM ANT CEAS 06, V17, P28
   METZ CE, 1978, SEMIN NUCL MED, V8, P283, DOI 10.1016/S0001-2998(78)80014-2
   Mitchell T. M., 2006, DISCIPLINE MACHINE L
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Melo CFOR, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00031
   Fontes CAP, 2016, NEURORADIOLOGY, V58, P837, DOI 10.1007/s00234-016-1687-9
   Pelckmans K.S. J. A. K., 2002, TUTORIAL KULEUVEN ES, V142, P1
   Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Roth A, 2014, EUROSURVEILLANCE, V19, P2, DOI 10.2807/1560-7917.ES2014.19.41.20929
   Suykens JAK, 1999, NEURAL PROCESS LETT, V9, P293, DOI 10.1023/A:1018628609742
   Takaku T, 2015, BIOL PHARM BULL, V38, P930, DOI 10.1248/bpb.b14-00883
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707
NR 30
TC 0
Z9 0
U1 1
U2 1
PU SPRINGER LONDON LTD
PI LONDON
PA 236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND
SN 0941-0643
EI 1433-3058
J9 NEURAL COMPUT APPL
JI Neural Comput. Appl.
DI 10.1007/s00521-019-04626-7
EA FEB 2020
PG 18
WC Computer Science, Artificial Intelligence
SC Computer Science
GA KP3AG
UT WOS:000516112000001
DA 2020-07-08
ER

PT J
AU Hladish, TJ
   Pearson, CAB
   Ben Toh, K
   Rojas, DP
   Manrique-Saide, P
   Vazquez-Prokopec, GM
   Halloran, ME
   Longini, IM
AF Hladish, Thomas J.
   Pearson, Carl A. B.
   Ben Toh, Kok
   Rojas, Diana Patricia
   Manrique-Saide, Pablo
   Vazquez-Prokopec, Gonzalo M.
   Halloran, M. Elizabeth
   Longini, Ira M., Jr.
TI Designing effective control of dengue with combined interventions
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE dengue; vector control; dengue vaccines; mathematical modeling
ID VACCINE; CHILDREN; HEALTHY; SAFETY; IMMUNOGENICITY; EFFICACY; AMERICA;
   ASIA
AB Viruses transmitted by Aedes mosquitoes, such as dengue, Zika, and chikungunya, have expanding ranges and seem unabated by current vector control programs. Effective control of these pathogens likely requires integrated approaches. We evaluated dengue management options in an endemic setting that combine novel vector control and vaccination using an agent-based model for Yucatan, Mexico, fit to 37 y of data. Our intervention models are informed by targeted indoor residual spraying (TIRS) experiments; trial outcomes and World Health Organization (WHO) testing guidance for the only licensed dengue vaccine, CYD-TDV; and preliminary results for in-development vaccines. We evaluated several implementation options, including varying coverage levels; staggered introductions; and a one-time, large-scale vaccination campaign. We found that CYD-TDV and TIRS interfere: while the combination outperforms either alone, performance is lower than estimated from their separate benefits. The conventional model hypothesized for in-development vaccines, however, performs synergistically with TIRS, amplifying effectiveness well beyond their independent impacts. If the preliminary performance by either of the in-development vaccines is upheld, a one-time, large-scale campaign followed by routine vaccination alongside aggressive new vector control could enable short-term elimination, with nearly all cases avoided for a decade despite continuous dengue reintroductions. If elimination is impracticable due to resource limitations, less ambitious implementations of this combination still produce amplified, longer-lasting effectiveness over single-approach interventions.
C1 [Hladish, Thomas J.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA.
   [Hladish, Thomas J.; Longini, Ira M., Jr.] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
   [Pearson, Carl A. B.] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1E 7HT, England.
   [Pearson, Carl A. B.] London Sch Hyg & Trop Med, Ctr Math Modelling Infect Dis, London WC1E 7HT, England.
   [Pearson, Carl A. B.] Stellenbosch Univ, South African Ctr Epidemiol Modelling & Anal, ZA-7600 Stellenbosch, South Africa.
   [Ben Toh, Kok] Univ Florida, Sch Nat Resources & Environm, Gainesville, FL 32611 USA.
   [Rojas, Diana Patricia; Longini, Ira M., Jr.] Univ Florida, Dept Biostat, Gainesville, FL 32611 USA.
   [Rojas, Diana Patricia] James Cook Univ, Div Publ Hlth & Trop Med, Townsville, Qld 4814, Australia.
   [Manrique-Saide, Pablo] Univ Autonoma Yucatan, Collaborat Unit Entomol Bioassays, Merida 9700, Mexico.
   [Vazquez-Prokopec, Gonzalo M.] Emory Univ, Dept Environm Sci, Atlanta, GA 30332 USA.
   [Halloran, M. Elizabeth] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA 98109 USA.
   [Halloran, M. Elizabeth; Longini, Ira M., Jr.] Ctr Inference & Dynam Infect Dis, Seattle, WA 98109 USA.
   [Halloran, M. Elizabeth] Univ Washington, Dept Biostat, Seattle, WA 98195 USA.
RP Hladish, TJ (corresponding author), Univ Florida, Dept Biol, Gainesville, FL 32611 USA.; Hladish, TJ (corresponding author), Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA.
EM tjhladish@gmail.com
OI Pearson, Carl/0000-0003-0701-7860; Halloran, M
   Elizabeth/0000-0002-3127-1757; Hladish, Thomas/0000-0003-1819-6235
FU NIH/National Institute of General Medical Sciences Grant [U54 GM111274];
   NSF Grant Division of Environmental Biology/Ecology and Evolution of
   Infectious Diseases (DEB/EEID) [1640698]
FX This project was funded in part by NIH/National Institute of General
   Medical Sciences Grant U54 GM111274 and NSF Grant Division of
   Environmental Biology/Ecology and Evolution of Infectious Diseases
   (DEB/EEID) 1640698. We also thank Juliet R. C. Pulliam and Stefan
   Flasche for feedback on the draft manuscript.
CR Achee NL, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003655
   Barrett ADT, 2018, SCIENCE, V361, P847, DOI 10.1126/science.aau8225
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bowman LR, 2016, PLOS NEGLECT TROP D, V10, P3, DOI DOI 10.1371/J0URNAL.PNTD.0004551
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Capeding MR, 2014, LANCET, V384, P1358, DOI 10.1016/S0140-6736(14)61060-6
   Chadee DD, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-255
   Dunbar M. W., PLOS NEGLECTED TROP, V13
   Dzul-Manzanilla F, 2017, J MED ENTOMOL, V54, P501, DOI 10.1093/jme/tjw203
   Esu E, 2010, TROP MED INT HEALTH, V15, P619, DOI 10.1111/j.1365-3156.2010.02489.x
   Ferguson NM, 2016, SCIENCE, V353, P1033, DOI 10.1126/science.aaf9590
   Flasche S, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002181
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hladish T. J., SEQUENTIAL MONTE CAR
   Hladish TJ, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006570
   Hladish TJ, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004661
   Johansson MA, 2011, VACCINE, V29, P5860, DOI 10.1016/j.vaccine.2011.06.042
   Katzelnick LC, 2018, P NATL ACAD SCI USA, V115, P10762, DOI 10.1073/pnas.1809253115
   Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836
   Kirkpatrick BD, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1517
   Kirkpatrick BD, 2015, J INFECT DIS, V212, P702, DOI 10.1093/infdis/jiv082
   San Martin JL, 2010, AM J TROP MED HYG, V82, P128, DOI 10.4269/ajtmh.2010.09-0346
   Okamoto KW, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004695
   Olivera-Botello G, 2016, J INFECT DIS, V214, P994, DOI 10.1093/infdis/jiw297
   Ooi EE, 2006, EMERG INFECT DIS, V12, P887, DOI 10.3201/10.3201/eid1206.051210
   Osorio JE, 2014, LANCET INFECT DIS, V14, P830, DOI 10.1016/S1473-3099(14)70811-4
   Pearson CAB, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2019.0234
   Perkel JM, 2016, NAT BIOTECHNOL, V34, P449, DOI 10.1038/nbt0516-449
   Reiner RC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004588
   Roiz D, 2018, PLOS NEGLECT TROP D, V12, P1, DOI DOI 10.1371/J0URNAL.PNTD.0006845
   Saez-Llorens X, 2017, LANCET INFECT DIS, V17, P615, DOI 10.1016/S1473-3099(17)30166-4
   Schwartz LM, 2015, VACCINE, V33, P3293, DOI 10.1016/j.vaccine.2015.05.010
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Vazquez-Prokopec GM, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602024
   Villar L, 2015, NEW ENGL J MED, V372, P113, DOI 10.1056/NEJMoa1411037
   Wilder-Smith A, 2019, LANCET INFECT DIS, V19, pE31, DOI 10.1016/S1473-3099(18)30494-8
   World Health Organization, 2009, DENG GUID DIAGN TREA
   Yang Y, 2018, CLIN INFECT DIS, V66, P178, DOI [10.1093/cid/cix766, 10.1093/cid/cix883]
   2018, VACCINE, V37, P4848
NR 39
TC 0
Z9 0
U1 1
U2 1
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 11
PY 2020
VL 117
IS 6
BP 3319
EP 3325
DI 10.1073/pnas.1903496117
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KM1RM
UT WOS:000513898000076
PM 31974303
OA Green Accepted, Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Pascini, TV
   Ramalho-Ortigao, M
   Ribeiro, JM
   Jacobs-Lorena, M
   Martins, GF
AF Pascini, Tales Vicari
   Ramalho-Ortigao, Marcelo
   Ribeiro, Jose Marcos
   Jacobs-Lorena, Marcelo
   Martins, Gustavo Ferreira
TI Transcriptional profiling and physiological roles of Aedes aegypti
   spermathecal-related genes
SO BMC GENOMICS
LA English
DT Article
DE Ae; Aegypti; Insect reproduction; Sperm; Spermatheca; Transcriptome
ID ANOPHELES-GAMBIAE; QUANTITATIVE PCR; FINE-STRUCTURE; SPERM STORAGE;
   ATROPHIN; INSECT; RNA; CONTRIBUTES; ACTIVATION; INHIBITOR
AB BackgroundSuccessful mating of female mosquitoes typically occurs once, with the male sperm being stored in the female spermatheca for every subsequent oviposition event. The female spermatheca is responsible for the maintenance, nourishment, and protection of the male sperm against damage during storage. Aedes aegypti is a major vector of arboviruses, including Yellow Fever, Dengue, Chikungunya, and Zika. Vector control is difficult due to this mosquito high reproductive capacity.ResultsFollowing comparative RNA-seq analyses of spermathecae obtained from virgin and inseminated females, eight transcripts were selected based on their putative roles in sperm maintenance and survival, including energy metabolism, chitin components, transcriptional regulation, hormonal signaling, enzymatic activity, antimicrobial activity, and ionic homeostasis. In situ RNA hybridization confirmed tissue-specific expression of the eight transcripts. Following RNA interference (RNAi), observed outcomes varied between targeted transcripts, affecting mosquito survival, egg morphology, fecundity, and sperm motility within the spermathecae.ConclusionsThis study identified spermatheca-specific transcripts associated with sperm storage in Ae. aegypti. Using RNAi we characterized the role of eight spermathecal transcripts on various aspects of female fecundity and offspring survival. RNAi-induced knockdown of transcript AeSigP-66,427, coding for a Na+/Ca2+ protein exchanger, specifically interfered with egg production and reduced sperm motility. Our results bring new insights into the molecular basis of sperm storage and identify potential targets for Ae. aegypti control.
C1 [Pascini, Tales Vicari; Martins, Gustavo Ferreira] Univ Fed Vicosa, Dept Biol Gera, BR-36570900 Vicosa, MG, Brazil.
   [Ramalho-Ortigao, Marcelo] Uniformed Serv Univ Hlth Sci, Dept Prevent Med & Biostat, Div Trop Publ Hlth, 4301 Jones Bridge Rd,Rm A-3083, Bethesda, MD 20814 USA.
   [Ribeiro, Jose Marcos] NIAID, Sect Vector Biol, Lab Malaria & Vector Res, NIH, 12735 Twinbrook Pkwy,Rm 2E32D, Rockville, MD 20852 USA.
   [Jacobs-Lorena, Marcelo] Johns Hopkins Bloomberg Sch Publ Hlth, Malaria Res Inst, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.
RP Martins, GF (corresponding author), Univ Fed Vicosa, Dept Biol Gera, BR-36570900 Vicosa, MG, Brazil.
EM gmartins@ufv.br
RI Martins, Gustavo Ferreira/AAL-7744-2020; Pascini, Tales/AAM-2655-2020
OI Martins, Gustavo Ferreira/0000-0003-0614-8551; 
FU Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior -BrasilCAPES
   [CAPES -001, PVE 88881.030429/2013-01]; Conselho Nacional de
   Desenvolvimento Cientifico e Tecnologico -BrasilNational Council for
   Scientific and Technological Development (CNPq) [CNPq -404844/2018-9];
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [R01 AI031478];
   Intramural Research Program of the National Institute of Allergy and
   Infectious Diseases (Vector-Borne Diseases: Biology of Vector Host
   Relationship) [Z01 AI000810-19]
FX This study was financed, in part, by grants from the Coordenacao de
   Aperfeicoamento de Pessoal de Nivel Superior -Brasil (CAPES -001 and PVE
   88881.030429/2013-01) and Conselho Nacional de Desenvolvimento
   Cientifico e Tecnologico -Brasil and (CNPq -404844/2018-9) to GFM and a
   grant from the National Institutes of Health (R01 AI031478) to MJL. JMR
   was supported by the Intramural Research Program of the National
   Institute of Allergy and Infectious Diseases (Vector-Borne Diseases:
   Biology of Vector Host Relationship, Z01 AI000810-19).
CR Alfonso-Parra C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004451
   Allen AK, 2008, DEVELOPMENT, V135, P311, DOI 10.1242/dev.015156
   [Anonymous], 2012, GLOB STRAT DENG PREV
   Arakane Y, 2011, INSECT BIOCHEM MOLEC, V41, P42, DOI 10.1016/j.ibmb.2010.09.011
   Baldini F, 2012, PATHOG GLOB HEALTH, V106, P82, DOI 10.1179/2047773212Y.0000000016
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Birol I, 2009, BIOINFORMATICS, V25, P2872, DOI 10.1093/bioinformatics/btp367
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   BRIEGEL H, 1990, J INSECT PHYSIOL, V36, P165, DOI 10.1016/0022-1910(90)90118-Y
   Brubaker-Purkey BJ, 2013, J INSECT SCI, V13, DOI 10.1673/031.013.6801
   Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052
   Carrasquilla MC, 2015, J INSECT PHYSIOL, V75, P1, DOI 10.1016/j.jinsphys.2015.01.015
   Cattenoz PB, 2016, SCI REP-UK, V6, DOI 10.1038/srep37792
   Catteruccia F, 2005, NAT BIOTECHNOL, V23, P1414, DOI 10.1038/nbt1152
   Chagas AC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-875
   Charroux B, 2006, DEV BIOL, V291, P278, DOI 10.1016/j.ydbio.2005.12.012
   CLEMENTS AN, 1967, J INSECT PHYSIOL, V13, P1825, DOI 10.1016/0022-1910(67)90018-2
   Donze O, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e46
   Drake LL, 2012, JOVE-J VIS EXP, V65, P2
   DYBAS LK, 1981, EVOLUTION, V35, P168, DOI 10.1111/j.1558-5646.1981.tb04869.x
   Dzaki N, 2017, SCI REP-UK, V7, DOI 10.1038/srep43618
   Gabrieli P, 2014, P NATL ACAD SCI USA, V111, P16353, DOI 10.1073/pnas.1410488111
   Garver Lindsey, 2007, J Vis Exp, P230, DOI 10.3791/230
   Gonzalez AN, 2018, APIDOLOGIE, V49, P224, DOI 10.1007/s13592-017-0546-y
   Gotoh A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05818-8
   Haecker A, 2007, PLOS BIOL, V5, P1298, DOI 10.1371/journal.pbio.0050145
   Iida K, 2004, J EXP BIOL, V207, P675, DOI 10.1242/jeb.00816
   Iida K, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-75
   Islam MS, 2006, ZYGOTE, V14, P133, DOI 10.1017/S0967199406003698
   Jiang XF, 2015, GENOME BIOL EVOL, V7, P1914, DOI 10.1093/gbe/evv115
   Jing YP, 2018, J BIOL CHEM, V293, P20112, DOI 10.1074/jbc.RA118.005692
   JONES JC, 1965, BIOL BULL, V129, P134, DOI 10.2307/1539773
   Karim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028525
   Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020
   King-Jones K, 2005, CELL, V121, P773, DOI 10.1016/j.cell.2005.03.030
   Klowden MJ, 2006, J INSECT PHYSIOL, V52, P679, DOI 10.1016/j.jinsphys.2006.03.006
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Mansur JE, 2014, INSECT BIOCHEM MOLEC, V51, P110, DOI 10.1016/j.ibmb.2013.12.006
   Mehranian M, 2018, INT J TROP INSECT SC, V38, P105, DOI 10.1017/S1742758417000364
   Merzendorfer H, 2003, J EXP BIOL, V206, P4393, DOI 10.1242/jeb.00709
   Muthukrishnan S, 2016, EXTRACELLULAR COMPOS, P31
   Ou QX, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001160
   Pascini TV, 2013, ANN ENTOMOL SOC AM, V106, P857, DOI 10.1603/AN13079
   Pascini TV, 2017, ZOOLOGY, V121, P56, DOI 10.1016/j.zool.2016.12.001
   Pascini TV, 2012, MEM I OSWALDO CRUZ, V107, P705, DOI 10.1590/S0074-02762012000600001
   Pereira R, 2017, ASIAN J ANDROL, V19, P5, DOI 10.4103/1008-682X.167716
   Qian C, 2015, TOXINS, V7, P2888, DOI 10.3390/toxins7082888
   Raphemot R, 2014, INSECT BIOCHEM MOLEC, V51, P10, DOI 10.1016/j.ibmb.2014.05.002
   Ribeiro JMC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151400
   Ribeiro JMC, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002594
   Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004
   Rogers DW, 2008, P NATL ACAD SCI USA, V105, P19390, DOI 10.1073/pnas.0809723105
   ROTH TF, 1964, J CELL BIOL, V20, P313, DOI 10.1083/jcb.20.2.313
   Rubio M, 2013, INSECT BIOCHEM MOLEC, V43, P1009, DOI 10.1016/j.ibmb.2013.08.003
   Shaw WR, 2014, P NATL ACAD SCI USA, V111, P5854, DOI 10.1073/pnas.1401715111
   Shepard AR, 2005, ANAL BIOCHEM, V344, P287, DOI 10.1016/j.ab.2005.06.005
   Shiba K, 2006, CELL MOTIL CYTOSKEL, V63, P623, DOI 10.1002/cm.20149
   Shukla E, 2015, GLYCOBIOLOGY, V25, P357, DOI 10.1093/glycob/cwu125
   Sirot LK, 2009, ADV GENET, V68, P23, DOI 10.1016/S0065-2660(09)68002-0
   Su YH, 2002, P NATL ACAD SCI USA, V99, P6743, DOI 10.1073/pnas.102186699
   Team R, 2013, R LANG ENV STAT COMP
   VERMA LR, 1973, COMP BIOCHEM PHYSIOL, V44, P1325, DOI 10.1016/0300-9629(73)90272-7
   VERMA LR, 1978, APIDOLOGIE, V9, P167, DOI 10.1051/apido:19780301
   Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3
   WANG L, 2008, NUCL RECEPT SIGNAL, V6, P1, DOI DOI 10.1621/nrs.06009
   Warnes G, 2016, PACKAGE GPLOTS TITLE
   Watanabe RMO, 2010, BIOCHIMIE, V92, P933, DOI 10.1016/j.biochi.2010.03.024
   Wolfner MF, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001191
   Xie YL, 2014, BIOINFORMATICS, V30, P1660, DOI 10.1093/bioinformatics/btu077
NR 69
TC 0
Z9 0
U1 2
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD FEB 10
PY 2020
VL 21
IS 1
AR 143
DI 10.1186/s12864-020-6543-y
PG 18
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA KW2BX
UT WOS:000520975800002
PM 32041546
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ekwudu, O
   Devine, GJ
   Aaskov, JG
   Frentiu, FD
AF Ekwudu, O'mezie
   Devine, Gregor J.
   Aaskov, John G.
   Frentiu, Francesca D.
TI Wolbachia strain wAlbB blocks replication of flaviviruses and
   alphaviruses in mosquito cell culture
SO PARASITES & VECTORS
LA English
DT Article
DE Arbovirus; Mosquito; Dengue; Zika; Ross River Virus; West Nile; Sindbis
ID WEST-NILE-VIRUS; ZIKA VIRUS; AEDES; INFECTION; DISEASE; DENGUE;
   ESTABLISHMENT; CHIKUNGUNYA; HUMANS
AB Background Wolbachia pipientis are bacterial endosymbionts of arthropods currently being implemented as biocontrol agents to reduce the global burden of arboviral diseases. Some strains of Wolbachia, when introduced into Aedes aegypti mosquitoes, reduce or block the replication of RNA viruses pathogenic to humans. The wAlbB strain of Wolbachia was originally isolated from Aedes albopictus, and when transinfected into Ae. aegypti, persists in mosquitoes under high temperature conditions longer than other strains. The utility of wAlbB to block a broad spectrum of RNA viruses has received limited attention. Here we test the ability of wAlbB to reduce or block the replication of a range of Flavivirus and Alphavirus species in cell culture. Methods The C6/36 mosquito cell line was stably infected with the wAlbB strain using the shell-vial technique. The replication of dengue, West Nile and three strains of Zika (genus Flavivirus), and Ross River, Barmah Forest and Sindbis (genus Alphavirus) viruses was compared in wAlbB-infected cells with Wolbachia-free controls. Infectious virus titres were determined using either immunofocus or plaque assays. A general linear model was used to test for significant differences in replication between flaviviruses and alphaviruses. Results Titres of all viruses were significantly reduced in cell cultures infected with wAlbB versus Wolbachia-free controls. The magnitude of reduction in virus yields varied among virus species and, within species, also among the strains utilized. Conclusion Our results suggest that wAlbB infection of arthropods could be used to reduce transmission of a wide range of pathogenic RNA viruses.
C1 [Ekwudu, O'mezie; Aaskov, John G.; Frentiu, Francesca D.] Queensland Univ Technol, Sch Biomed Sci, Herston, Qld 4006, Australia.
   [Ekwudu, O'mezie; Aaskov, John G.; Frentiu, Francesca D.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Herston, Qld 4006, Australia.
   [Ekwudu, O'mezie] Chukwuemeka Odumegwu Ojukwu Univ, Dept Microbiol, Uli, Nigeria.
   [Ekwudu, O'mezie; Devine, Gregor J.] Queensland Inst Med Res Berghofer, Mosquito Control Lab, Herston, Qld 4006, Australia.
RP Frentiu, FD (corresponding author), Queensland Univ Technol, Sch Biomed Sci, Herston, Qld 4006, Australia.; Frentiu, FD (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Herston, Qld 4006, Australia.
EM francesca.frentiu@qut.edu.au
RI Devine, Gregor J/H-1141-2014
OI Devine, Gregor J/0000-0001-6312-0390; Frentiu,
   Francesca/0000-0001-8628-4216
FU National Health and Medical Research CouncilNational Health and Medical
   Research Council of Australia [APP1020817]; Queensland University of
   Technology (QUT); Institute for Health and Biomedical Innovation (IHBI);
   government of Nigeria through the TeTFund Scholarship; QUT
   part-scholarship
FX The study was funded by a National Health and Medical Research Council
   grant to FDF (APP1020817) and internal Queensland University of
   Technology (QUT) and Institute for Health and Biomedical Innovation
   (IHBI) grants. OE was funded by the government of Nigeria through the
   TeTFund Scholarship and a QUT part-scholarship.
CR AASKOV JG, 1981, AM J TROP MED HYG, V30, P1053, DOI 10.4269/ajtmh.1981.30.1053
   Aliota MT, 2016, SCI REP-UK, V6, DOI 10.1038/srep28792
   Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004677
   Ant TH, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006815
   Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060
   Bhattacharya T, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006427
   Bian GW, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000833
   Brackney DE, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000856
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Caragata EP, 2016, TRENDS PARASITOL, V32, P207, DOI 10.1016/j.pt.2015.10.011
   Dutra HLC, 2016, CELL HOST MICROBE, V19, P771, DOI 10.1016/j.chom.2016.04.021
   de Oliveira CD, 2015, B ENTOMOL RES, V105, P305, DOI 10.1017/S0007485315000085
   Dobson SL, 2002, APPL ENVIRON MICROB, V68, P656, DOI 10.1128/AEM.68.2.656-660.2002
   Dunstan RA, 2008, AUST NZ J PUBL HEAL, V32, P354, DOI 10.1111/j.1753-6405.2008.00254.x
   Ferguson NM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010370
   Frentiu FD, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002688
   Frentiu FD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013398
   Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460
   Hoffmann AA, 2011, NATURE, V476, P454, DOI 10.1038/nature10356
   Hoffmann AA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003115
   Hubalek Z, 2000, VIRAL IMMUNOL, V13, P415, DOI 10.1089/vim.2000.13.415
   Hussain M, 2013, J VIROL, V87, P851, DOI 10.1128/JVI.01837-12
   IGARASHI A, 1978, J GEN VIROL, V40, P531, DOI 10.1099/0022-1317-40-3-531
   Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84
   Joubert DA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005434
   Koh C, 2019, VIRUS EVOL, V5, DOI 10.1093/ve/vez012
   Kurkela S, 2008, EMERG INFECT DIS, V14, P41, DOI 10.3201/eid1401.070510
   Lindsey ARI, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040141
   Marfin AA, 2001, CLIN INFECT DIS, V33, P1713, DOI 10.1086/322700
   McMeniman CJ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000748
   McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042
   Mousson L, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001989
   Nazni WA, 2019, CURR BIOL, V29, P4241, DOI 10.1016/j.cub.2019.11.007
   O'Neill SL, 2018, GATES OPEN RES, V2, P36, DOI [10.12688/gatesopenres.12844.1, DOI 10.12688/GATESOPENRES.12844.1]
   ONeill SL, 1997, INSECT MOL BIOL, V6, P33, DOI 10.1046/j.1365-2583.1997.00157.x
   Rainey SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005536
   Raquin V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125066
   Ritchie SA, 2018, TRENDS PARASITOL, V34, P217, DOI 10.1016/j.pt.2017.11.011
   Ross PA, 2019, ANNU REV GENET, V53, P93, DOI 10.1146/annurev-genet-112618-043609
   Ross PA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007357
   Ross PA, 2018, INSECTS, V9, DOI 10.3390/insects9030078
   Ross PA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006006
   Ross PA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004320
   Russell RC, 1998, J VECTOR ECOL, V23, P1
   Schultz MJ, 2018, MBIO, V9, DOI [10.1128/mBio.00738-18, 10.1128/mbio.00738-18]
   Schultz MJ, 2017, J VIROL, V91, DOI 10.1128/JVI.00339-17
   Terradas G, 2017, CURR OPIN INSECT SCI, V22, P37, DOI 10.1016/j.cois.2017.05.005
   TESH RB, 1982, ANNU REV MED, V33, P31, DOI 10.1146/annurev.me.33.020182.000335
   Nguyen TH, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1174-x
   Ulrich JN, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004873
   van den Hurk AF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001892
   Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355
   Werren JH, 1997, ANNU REV ENTOMOL, V42, P587, DOI 10.1146/annurev.ento.42.1.587
   Werren JH, 2008, NAT REV MICROBIOL, V6, P741, DOI 10.1038/nrmicro1969
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Xi ZY, 2005, INSECT BIOCHEM MOLEC, V35, P903, DOI 10.1016/j.ibmb.2005.03.015
   Xi ZY, 2005, SCIENCE, V310, P326, DOI 10.1126/science.1117607
   Ye YXH, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003894
   Yeap HL, 2011, GENETICS, V187, P583, DOI 10.1534/genetics.110.122390
   Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544
NR 62
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1756-3305
J9 PARASITE VECTOR
JI Parasites Vectors
PD FEB 10
PY 2020
VL 13
IS 1
AR 54
DI 10.1186/s13071-020-3936-3
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA KW1KC
UT WOS:000520929400001
PM 32041638
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Araujo, KM
   Bressan, AL
   Azulay-Abulafia, L
AF Araujo, Karin M.
   Bressan, Aline L.
   Azulay-Abulafia, Luna
TI Zika, chikungunya, and dengue infections as exacerbating factors of
   psoriasis in patients receiving biological therapy
SO INTERNATIONAL JOURNAL OF DERMATOLOGY
LA English
DT Letter
C1 [Araujo, Karin M.; Bressan, Aline L.; Azulay-Abulafia, Luna] Univ Estado Rio De Janeiro, Dept Dermatol, Rio De Janeiro, Brazil.
RP Azulay-Abulafia, L (corresponding author), Univ Estado Rio De Janeiro, Dept Dermatol, Rio De Janeiro, Brazil.
EM lunaazulay@gmail.com
OI ARAUJO, KARIN MILLENI/0000-0003-2421-3978
CR Andersen LK, 2017, INT J DERMATOL, V56, pe84, DOI 10.1111/ijd.13509
   Mondolfi AEP, 2018, CLIN EXP DERMATOL, V43, P171, DOI 10.1111/ced.13294
   Plachouri KM, 2019, INT J DERMATOL, V58, P1008, DOI 10.1111/ijd.14436
   Seetharam KA, 2011, J DERMATOL, V38, P1033, DOI 10.1111/j.1346-8138.2011.01200.x
   Weaver SC, 2018, ANNU REV MED, V69, P395, DOI 10.1146/annurev-med-050715-105122
NR 5
TC 0
Z9 0
U1 1
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0011-9059
EI 1365-4632
J9 INT J DERMATOL
JI Int. J. Dermatol.
PD JUN
PY 2020
VL 59
IS 6
BP E209
EP E211
DI 10.1111/ijd.14785
EA FEB 2020
PG 3
WC Dermatology
SC Dermatology
GA LM9RA
UT WOS:000512111300001
PM 32039473
DA 2020-07-08
ER

PT J
AU Benelli, G
   Pavela, R
   Rakotosaona, R
   Nzekoue, FK
   Canale, A
   Nicoletti, M
   Maggi, F
AF Benelli, Giovanni
   Pavela, Roman
   Rakotosaona, Rianasoambolanoro
   Nzekoue, Franks Kamgang
   Canale, Angelo
   Nicoletti, Marcello
   Maggi, Filippo
TI Insecticidal and mosquito repellent efficacy of the essential oils from
   stem bark and wood of Hazomalania voyronii
SO JOURNAL OF ETHNOPHARMACOLOGY
LA English
DT Article
DE Aedes aegypti; Culex quinquefasciatus; Dengue; Insecticides; Mosquito
   repellent; Musca domestica; Spodoptera littoralis; Zika virus
ID PLANT MYROTHAMNUS-MOSCHATUS; APIACEAE ESSENTIAL OILS;
   BIOLOGICAL-ACTIVITIES; CHEMICAL-COMPOSITION; LARVICIDAL ACTIVITY; MAJOR
   COMPONENTS; CULEX; L.; DIPTERA; CONSTITUENTS
AB Ethnopharmacological relevance: The use of Hazomalania voyronii, popularly known as hazomalana, to repel mosquitoes and resist against insect attacks is handed down from generation to generation in Madagascar. In the present study, we investigated the ability of the essential oils (EOs) obtained from the stem wood, fresh and dry bark of H. voyronii to keep important mosquito vectors (Aedes aegypti and Culex quinquefasciatus) away, as well as their toxicity on three insect species of agricultural and public health importance (Cx. quinquefasciatus, Musca domestica and Spodoptera littoralis).
   Materials and methods: Hydrodistillation was used to obtain EOs from stem wood, fresh and dry bark. The chemical compositions were achieved by gas chromatography-mass spectrometry (GC-MS). Toxicity assays using stem wood and bark EOs were performed on larvae of Cx. quinquefasciatus and S. littoralis, and adults of M. domestica by WHO and topical application methods, respectively. Mosquito repellent activity of the most effective EO, i.e. the bark one, was determined on human volunteers by arm-in-cage tests, and results were compared with that of the commercial repellent N,N-ddiethyl-m-toluamide (DEET).
   Results: The H. voyronii EOs were characterized by oxygenated monoterpenes with perilla aldehyde (30.9-47.9%) and 1,8-cineole (19.7-33.2%) as the main constituents. The fresh and dry bark EOs were the most active on Cx. quinquefasciatus and S. littoralis larvae, respectively, with LC50/LD50 of 65.5 mg L-1, and 50.5 mu g larva(-1); the EOs from wood and fresh bark displayed the highest toxicity on M. domestica (LD50 values 60.8 and 65.8 mu g adult(-1), respectively). Repellence assay revealed an almost complete protection (> 80%) from both mosquito species for 30 min when pure fresh bark EO was applied on the volunteers' arm, while DEET 10% repelled > 80% of the mosquitoes up to 120 min from application.
   Conclusion: The traditional use of the bark EO to repel insects has been demonstrated although an extended-release formulation based on H. voyronii EOs is needed to increase the repellent effect over time. A wide spectrum of insecticidal activity has been provided as well, suggesting a possible use of H. voyronii EOs in the fabrication of green repellents and insecticides useful to control mosquito vectors and agricultural pests.
C1 [Benelli, Giovanni; Canale, Angelo] Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.
   [Pavela, Roman] Crop Res Inst, Prague, Czech Republic.
   [Pavela, Roman] Czech Univ Life Sci, Dept Plant Protect, Prague, Czech Republic.
   [Rakotosaona, Rianasoambolanoro] Assoc Fdn Rakoto Ratsimamanga, Inst Malgache Recherches Appl, Antananarivo, Madagascar.
   [Nzekoue, Franks Kamgang; Maggi, Filippo] Univ Camerino, Sch Pharm, Camerino, Italy.
   [Nicoletti, Marcello] Sapienza Univ, Dept Environm Biol, Rome, Italy.
RP Benelli, G (corresponding author), Univ Pisa, Dept Agr Food & Environm, Pisa, Italy.; Pavela, R (corresponding author), Crop Res Inst, Prague, Czech Republic.
EM giovanni.benelli@unipi.it; pavela@vurv.cz; rravalison@gmail.com;
   astride.kamgang@unicam.it; angelo.canale@unipi.it;
   marcello.nicoletti@uniroma1.it; filippo.maggi@unicam.it
RI Pavela, Roman/Q-8647-2016
OI Kamgang Nzekoue, Astride Franks/0000-0002-6137-6744
FU FAR 2014-2015 (Fondo di Ateneo per la Ricerca) of the University of
   Camerino; Ministry of Agriculture of the Czech RepublicMinistry of
   Agriculture, Czech Republic; Ministry of Agriculture of the Czech
   RepublicMinistry of Agriculture, Czech Republic [MZE-R00418]
FX This work was supported by the FAR 2014-2015 (Fondo di Ateneo per la
   Ricerca) of the University of Camerino. R. Pavela would like to thank
   the Ministry of Agriculture of the Czech Republic for financial support
   of the botanical pesticide and basic substances research. Financial
   support for this work was provided by the Ministry of Agriculture of the
   Czech Republic (Project MZE-R00418).
CR Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a
   Allorge L, 2003, FABULEUSE ODYSSEE PL
   Araujo ECC, 2003, J AGR FOOD CHEM, V51, P3760, DOI 10.1021/jf021074s
   Benelli G, 2019, ENTOMOL GEN, V39, P9, DOI 10.1127/entomologia/2019/0662
   Benelli G, 2019, ENTOMOL GEN, V39, P61, DOI 10.1127/entomologia/2019/0787
   Benelli G, 2018, IND CROP PROD, V122, P308, DOI 10.1016/j.indcrop.2018.05.032
   Benelli G, 2018, NAT PROD RES, V32, P1690, DOI 10.1080/14786419.2017.1396590
   Benelli G, 2018, ACTA TROP, V179, P47, DOI 10.1016/j.actatropica.2017.12.025
   Benelli G, 2017, IND CROP PROD, V103, P19, DOI 10.1016/j.indcrop.2017.03.032
   Benelli G, 2017, IND CROP PROD, V96, P186, DOI 10.1016/j.indcrop.2016.11.059
   Boiteau P., 1999, DICT NOMS MALGACHES, VI
   CFPF (Centre De Formation Professionnelle Forestiere), 2008, FICH TECHN VERS FRAN
   Finney DJ, 1971, PROBIT ANAL, P68, DOI DOI 10.1007/BF02431962
   Hebeish A, 2008, CARBOHYD POLYM, V74, P268, DOI 10.1016/j.carbpol.2008.02.013
   Hierro I, 2006, PHYTOMEDICINE, V13, P527, DOI 10.1016/j.phymed.2005.05.001
   Ikbal C, 2019, J PEST SCI, V92, P971, DOI 10.1007/s10340-019-01089-6
   KARR LL, 1988, J PESTIC SCI, V13, P287
   KLOCKE JA, 1987, J CHEM ECOL, V13, P2131, DOI 10.1007/BF01012562
   Kordali S, 2006, IND CROP PROD, V23, P162, DOI 10.1016/j.indcrop.2005.05.005
   Kumar P, 2013, PARASITOL RES, V112, P69, DOI 10.1007/s00436-012-3105-5
   Lupi E, 2013, TRAVEL MED INFECT DI, V11, P374, DOI 10.1016/j.tmaid.2013.10.005
   Maggi F., 2018, Mosquito-borne diseases: implications for public health, P69
   Maggi F, 2015, FLAVOUR FRAG J, V30, P139, DOI 10.1002/ffj.3221
   Maggi F, 2010, CHEM BIODIVERS, V7, P447, DOI 10.1002/cbdv.200900091
   Nicoletti M, 2012, NAT PROD RES, V26, P2291, DOI 10.1080/14786419.2012.665916
   Park CG, 2016, IND CROP PROD, V89, P507, DOI 10.1016/j.indcrop.2016.06.008
   Pavela R, 2017, S AFR J BOT, V108, P359, DOI 10.1016/j.sajb.2016.08.017
   Pavela R, 2008, PHYTOTHER RES, V22, P274, DOI 10.1002/ptr.2300
   Pavela R, 2017, IND CROP PROD, V109, P603, DOI 10.1016/j.indcrop.2017.09.013
   Pavela R, 2015, IND CROP PROD, V76, P174, DOI 10.1016/j.indcrop.2015.06.050
   Ramisiray G, 1901, THESIS
   Randrianarivo E, 2013, CHEM BIODIVERS, V10, P1987, DOI 10.1002/cbdv.201300179
   Rasoanaivo P, 2013, CHEM BIODIVERS, V10, P1876, DOI 10.1002/cbdv.201300147
   RATSIMAMANGAURVERG S, 1994, PHYTOTHER RES, V8, P18, DOI 10.1002/ptr.2650080105
   RICE PJ, 1994, J ECON ENTOMOL, V87, P1172, DOI 10.1093/jee/87.5.1172
   Ruphin F.P., 2014, J ADV MED LIFE SCI, V1
   Tabanca N, 2015, IND CROP PROD, V65, P36, DOI 10.1016/j.indcrop.2014.11.043
   Traboulsi AF, 2005, PEST MANAG SCI, V61, P597, DOI 10.1002/ps.1017
   van den Hurk AF, 2017, LANCET INFECT DIS, V17, P1014, DOI 10.1016/S1473-3099(17)30518-2
   *WHO, 1996, CTDWHOPESIC961, P69
   Wilke ABB, 2020, ENTOMOL GEN, V40, P15, DOI 10.1127/entomologia/2019/0776
   You CX, 2014, IND CROP PROD, V61, P331, DOI 10.1016/j.indcrop.2014.07.021
   Zhu JW, 2006, J AM MOSQUITO CONTR, V22, P515, DOI 10.2987/8756-971X(2006)22[515:ARALAO]2.0.CO;2
NR 43
TC 1
Z9 1
U1 22
U2 30
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0378-8741
EI 1872-7573
J9 J ETHNOPHARMACOL
JI J. Ethnopharmacol.
PD FEB 10
PY 2020
VL 248
AR 112333
DI 10.1016/j.jep.2019.112333
PG 7
WC Plant Sciences; Chemistry, Medicinal; Integrative & Complementary
   Medicine; Pharmacology & Pharmacy
SC Plant Sciences; Pharmacology & Pharmacy; Integrative & Complementary
   Medicine
GA JW8QY
UT WOS:000503312800046
PM 31654797
DA 2020-07-08
ER

PT J
AU Mayank
   Kumar, D
   Kaur, N
   Giri, R
   Singh, N
AF Mayank
   Kumar, Deepak
   Kaur, Navneet
   Giri, Rajanish
   Singh, Narinder
TI A biscoumarin scaffold as an efficient anti-Zika virus lead with
   NS3-helicase inhibitory potential: in vitro and in silico investigations
SO NEW JOURNAL OF CHEMISTRY
LA English
DT Article
ID HELICASE; BINDING
AB As a way to investigate new antiviral leads against Zika virus (ZIKV), we have targeted the NS3 helicase (NS3H) protein with biscoumarin derivatives. The NS3H protein from ZIKV is important, as it plays a significant role in the viral genome replication process. We have assessed the NTPase modulatory effects of biscoumarin derivatives against the NTPase activity of NS3H through in vitro enzymatic studies. Subsequently, to explore the mechanism, detailed computational studies were conducted. The NS3H protein has two binding cavities: one is the NTPase binding cavity where ATP binds, and the other is an RNA binding cavity for the binding of RNA molecules. Biscoumarin derivatives were found to be efficient in binding to both cavities, i.e., the NTPase and RNA binding cavities of the NS3H protein. A biscoumarin derivative with the best binding affinity for the NTPase binding cavity and the lowest binding affinity for the RNA binding groove revealed the best in vitro NTPase inhibitory activity. Also, the biscoumarin derivative with the lowest binding affinity for the NTPase binding cavity and higher binding affinity for the RNA binding cavity revealed the worst NTPase inhibitory activity under the same in vitro assay conditions. Here, we concluded that biscoumarin derivatives are modulators of the NS3H protein and they can be considered as promising anti-viral lead molecules. The structural activity relationships (SARs) of the biscoumarin derivatives in relation to their NTPase inhibitory activities were established, and we reported two derivatives, namely MN-9 and MN-10, as potential NS3H-NTPase inhibitor molecules.
C1 [Mayank; Singh, Narinder] Indian Inst Technol Ropar, Dept Chem, Rupnagar 140001, Punjab, India.
   [Kumar, Deepak; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175005, Himachal Prades, India.
   [Kaur, Navneet] Panjab Univ, Dept Chem, Chandigarh 160014, India.
RP Singh, N (corresponding author), Indian Inst Technol Ropar, Dept Chem, Rupnagar 140001, Punjab, India.; Giri, R (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi 175005, Himachal Prades, India.; Kaur, N (corresponding author), Panjab Univ, Dept Chem, Chandigarh 160014, India.
EM navneetkaur@pu.ac.in; rajanishgiri@iitmandi.ac.in; nsingh@iitrpr.ac.in
RI Giri, Rajanish/Q-6530-2018
OI Giri, Rajanish/0000-0002-2046-836X
FU DST-SERB Govt of Indian [ODF/2018/001061]; IIT Ropar; DBT grant, India
   [BT/11/IYBA/2018/06]; ICMR fellowship, India
FX Mayank is thankful to DST-SERB Govt of Indian for an Overseas Visiting
   Doctoral Fellowship (ODF/2018/001061). Mayank is also thankful to IIT
   Ropar for a Senior research fellowship. RG is thankful to DBT grant,
   India (BT/11/IYBA/2018/06) and DK is supported by an ICMR fellowship,
   India.
CR Aagaard K, 2017, AM J OBSTET GYNECOL, V216, pS5
   Aier I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34984
   Aldrich CC, 2016, ACS INFECT DIS, V2, P310, DOI 10.1021/acsinfecdis.6b00072
   Bruns CJ, 2014, ANGEW CHEM INT EDIT, V53, P1953, DOI 10.1002/anie.201308498
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Collins MH, 2019, ACS INFECT DIS, V5, P1055, DOI 10.1021/acsinfecdis.9b00003
   Davidson RB, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006103
   Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311
   Giri R, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00144
   Grover A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S7-S20
   Hassan MZ, 2016, EUR J MED CHEM, V123, P236, DOI 10.1016/j.ejmech.2016.07.056
   Hu YX, 2019, ACS INFECT DIS, V5, P1070, DOI 10.1021/acsinfecdis.9b00047
   Jain R, 2016, NAT STRUCT MOL BIOL, V23, P752, DOI 10.1038/nsmb.3258
   Jurado K. A., 2017, NAT MICROBIOL, P1
   Kumar A, 2018, ACS OMEGA, V3, P18132, DOI 10.1021/acsomega.8b01002
   Kumar D., 2019, 530600 BIORXIV, P530600
   Lee H, 2017, ANTIVIR RES, V139, P49, DOI 10.1016/j.antiviral.2016.12.016
   Mayank, 2019, COMPUT BIOL CHEM, V83, DOI 10.1016/j.compbiolchem.2019.107104
   Mayank, 2018, INTEGR BIOL-UK, V10, P646, DOI 10.1039/c8ib00095f
   Mayank, 2017, NEW J CHEM, V41, P3872, DOI 10.1039/c6nj03763a
   Mayank, 2016, COMPUT BIOL CHEM, V62, P145, DOI 10.1016/j.compbiolchem.2015.08.001
   Mayank, 2015, PHYTOCHEMISTRY, V116, P12, DOI 10.1016/j.phytochem.2015.05.006
   Mishra PM, 2018, J MOL BIOL, V430, P2372, DOI 10.1016/j.jmb.2017.10.018
   Mottin M, 2018, DRUG DISCOV TODAY, V23, P1833, DOI 10.1016/j.drudis.2018.06.014
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Paixao ES, 2016, AM J PUBLIC HEALTH, V106, P606, DOI 10.2105/AJPH.2016.303112
   Pandey RK, 2017, J BIOMOL STRUCT DYN, V35, P141, DOI 10.1080/07391102.2015.1135298
   Rajah MM, 2016, ACS INFECT DIS, V2, P763, DOI 10.1021/acsinfecdis.6b00161
   Shan C, 2016, ACS INFECT DIS, V2, P170, DOI 10.1021/acsinfecdis.6b00030
   Sharma N, 2017, INT J BIOL MACROMOL, V104, P1046, DOI 10.1016/j.ijbiomac.2017.06.105
   Sindhu J, 2019, NEW J CHEM, V43, P2065, DOI 10.1039/c8nj05756g
   Singh K., 2017, IJEDR, V5, P1249
   Tian HL, 2016, PROTEIN CELL, V7, P562, DOI 10.1007/s13238-016-0293-2
   van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2
   Wakui N, 2018, J MOL GRAPH MODEL, V79, P166, DOI 10.1016/j.jmgm.2017.11.011
   Zavrsnik D, 2011, MOLECULES, V16, P6023, DOI 10.3390/molecules16076023
NR 36
TC 1
Z9 1
U1 0
U2 0
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1144-0546
EI 1369-9261
J9 NEW J CHEM
JI New J. Chem.
PD FEB 7
PY 2020
VL 44
IS 5
BP 1872
EP 1880
DI 10.1039/c9nj05225a
PG 9
WC Chemistry, Multidisciplinary
SC Chemistry
GA KI5HX
UT WOS:000511381800023
DA 2020-07-08
ER

PT J
AU Jones, R
   Kulkarni, MA
   Davidson, TMV
   Talbot, B
AF Jones, Reilly
   Kulkarni, Manisha A.
   Davidson, Thomas M., V
   Talbot, Benoit
CA RADAM-LAC Res Team
TI Arbovirus vectors of epidemiological concern in the Americas: A scoping
   review of entomological studies on Zika, dengue and chikungunya virus
   vectors
SO PLOS ONE
LA English
DT Review
ID AEDES-AEGYPTI MOSQUITOS; RIO-DE-JANEIRO; VERTICAL TRANSMISSION;
   DIPTERA-CULICIDAE; CULEX-QUINQUEFASCIATUS; NATURAL INFECTION; 1ST
   REPORT; ALBOPICTUS; COMPETENCE; SPREAD
AB Background
   Three arthropod-borne viruses (arboviruses) causing human disease have been the focus of a large number of studies in the Americas since 2013 due to their global spread and epidemiological impacts: Zika, dengue, and chikungunya viruses. A large proportion of infections by these viruses are asymptomatic. However, all three viruses are associated with moderate to severe health consequences in a small proportion of cases. Two mosquito species, Aedes aegypti and Aedes albopictus, are among the world's most prominent arboviral vectors, and are known vectors for all three viruses in the Americas.
   Objectives
   This review summarizes the state of the entomological literature surrounding the mosquito vectors of Zika, dengue and chikungunya viruses and factors affecting virus transmission. The rationale of the review was to identify and characterize entomological studies that have been conducted in the Americas since the introduction of chikungunya virus in 2013, encompassing a period of arbovirus co-circulation, and guide future research based on identified knowledge gaps.
   Methods
   The preliminary search for this review was conducted on PubMed (National Library of Health, Bethesda, MD, United States). The search included the terms 'zika' OR 'dengue' OR 'chikungunya' AND 'vector' OR 'Aedes aegypti' OR 'Aedes albopictus'. The search was conducted on March 1st of 2018, and included all studies since January 1st of 2013.
   Results
   A total of 96 studies were included in the scoping review after initial screening and subsequent exclusion of out-of-scope studies, secondary data publications, and studies unavailable in English language.
   Key findings
   We observed a steady increase in number of publications, from 2013 to 2018, with half of all studies published from January 2017 to March 2018. Interestingly, information on Zika virus vector species composition was abundant, but sparse on Zika virus transmission dynamics. Few studies examined natural infection rates of Zika virus, vertical transmission, or co-infection with other viruses. This is in contrast to the wealth of research available on natural infection and co-infection for dengue and chikungunya viruses, although vertical transmission research was sparse for all three viruses.
C1 [Jones, Reilly] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.
   [Kulkarni, Manisha A.; Talbot, Benoit] Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.
   [Davidson, Thomas M., V] Univ Toronto, Dept Human Biol, Toronto, ON, Canada.
   Univ Hlth Network, Toronto Gen Hosp Res Inst, Toronto, ON, Canada.
   Univ Los Andes, Ctr Invest Trop Microbiol & Parasitol, Bogota, Colombia.
   York Univ, Dept Math & Stat, Toronto, ON, Canada.
   UNaM CONICET, IBS, Grp Invest Appl Genet GIGA, Posadas, Argentina.
   Univ Laica Elroy Alfaro Manabi, Sch Med, Manta, Ecuador.
   [RADAM-LAC Res Team] Inst Nacl Invest Salud PUbl, Ctr Invest Arthropod Vectors, Quito, Ecuador.
RP Talbot, B (corresponding author), Univ Ottawa, Sch Epidemiol & Publ Hlth, Ottawa, ON, Canada.
EM benoit.talbot@uottawa.ca
OI Miretti, Marcos/0000-0001-8179-1606
FU Canadian Institutes for Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); International Development Research Centre
   (IDRC)'s CIHR-IDRC Canada-Latin America; Caribbean Zika Virus Research
   Program; Ontario Ministry of Research, Innovation and Science
FX This study was funded by a grant from the Canadian Institutes for Health
   Research (CIHR) and International Development Research Centre (IDRC)'s
   CIHR-IDRC Canada-Latin America and Caribbean Zika Virus Research Program
   to the RADAM-LAC Research Team, and an Early Researcher Award from the
   Ontario Ministry of Research, Innovation and Science to MK.; This
   research is part of an international project entitled Research on
   Arbovirus Dynamics and Mitigation-Latin America and Canada' (RADAM-LAC),
   with field study sites in Colombia, Ecuador and Argentina. The RADAM-LAC
   Research Team consists of Beate Sander, Camila Gonza ' lez, Jianhong Wu,
   Manisha A. Kulkarni, Marcos Miretti, Mauricio Espinel and Varsovia
   Cevallos.
CR Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239
   Aliota MT, 2016, EMERG INFECT DIS, V22, P1857, DOI 10.3201/eid2210.161082
   Althouse BM, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005055
   Alto BW, 2018, J MED ENTOMOL, V55, P217, DOI 10.1093/jme/tjx182
   Alto BW, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005724
   Alto BW, 2014, J VECTOR ECOL, V39, P406, DOI 10.1111/jvec.12116
   Oliveira RDAB, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/s1679-49742018000100014, 10.5123/S1679-49742018000100014]
   Ayllon T, 2017, EMERG INFECT DIS, V23, P1411, DOI 10.3201/eid2308.162007
   Azar SR, 2017, AM J TROP MED HYG, V97, P330, DOI 10.4269/ajtmh.16-0969
   Bara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126703
   Bolling BG, 2015, AM J TROP MED HYG, V92, P422, DOI 10.4269/ajtmh.14-0330
   Buckner EA, 2016, J MED ENTOMOL, V53, P91, DOI 10.1093/jme/tjv145
   Buckner EA, 2013, J MED ENTOMOL, V50, P1291, DOI 10.1603/ME13047
   Calderon-Arguedas O, 2015, J VECTOR ECOL, V40, P184, DOI 10.1111/jvec.12149
   Campbell KM, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003957
   Carbajo AE, 2015, MEM I OSWALDO CRUZ, V110, P259, DOI 10.1590/0074-02760150005
   Cecilio SG, 2015, J VECTOR ECOL, V40, P71, DOI 10.1111/jvec.12134
   Centre for Disease Control, 2019, CLIN GUID DENG
   Cevallos V, 2018, ACTA TROP, V177, P74, DOI 10.1016/j.actatropica.2017.09.029
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   Cigarroa-Toledo N, 2016, EMERG INFECT DIS, V22, P1804, DOI 10.3201/eid2210.152087
   Ciota AT, 2017, EMERG INFECT DIS, V23, P1110, DOI 10.3201/eid2307.161633
   Secundino NFC, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2286-2
   Costa-da-Silva AL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174081
   Cromwell EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005429
   CRUZ LCT, 2015, REV SOC BRAS MED TRO, V48, P18, DOI DOI 10.1590/0037-8682-0264-2014
   da Costa CF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2194-5
   Ferreira DAD, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2025-8
   Taranto MFD, 2015, TROP MED INT HEALTH, V20, P77, DOI 10.1111/tmi.12402
   Diaz-Gonzalez EE, 2015, AM J TROP MED HYG, V93, P1325, DOI 10.4269/ajtmh.15-0450
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dodson BL, 2017, PEERJ, V5, DOI 10.7717/peerj.3096
   Dong SZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005976
   dos Santos TP, 2017, ACTA TROP, V176, P140, DOI 10.1016/j.actatropica.2017.07.014
   Dzul-Manzanilla F, 2015, J AM MOSQUITO CONTR, V31, P275, DOI 10.2987/moco-31-03-275-277.1
   Eisen L, 2014, J MED ENTOMOL, V51, P885, DOI 10.1603/ME14008
   Ernst KC, 2017, J MED ENTOMOL, V54, P204, DOI 10.1093/jme/tjw141
   Espinosa M, 2014, REV INST MED TROP SP, V56, P165, DOI 10.1590/S0036-46652014000200013
   Evans MV, 2017, ELIFE, V6, DOI 10.7554/eLife.22053
   Farraudiere L, 2017, REV PANAM SALUD PUBL, V41
   Fernandes RS, 2017, MEM I OSWALDO CRUZ, V112, P577, DOI 10.1590/0074-02760170145
   Fernandes RS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004993
   Ferreira-de-Brito A, 2016, MEM I OSWALDO CRUZ, V111, P655, DOI 10.1590/0074-02760160332
   Fitzgibbon WE, 2017, THEOR BIOL MED MODEL, V14, DOI 10.1186/s12976-017-0051-z
   Gendernalik A, 2017, AM J TROP MED HYG, V96, P1338, DOI 10.4269/ajtmh.16-0963
   Gómez-Palacio Andrés, 2017, Biomédica, V37, P135, DOI [10.7705/biomedica.v37i0.3474, 10.7705/biomedica.v34i2.3474]
   Goncalves CM, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-320
   Guedes DRD, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.59
   Haby MM, 2018, B WORLD HEALTH ORGAN, V96, P402, DOI 10.2471/BLT.17.201541
   HAN ZP, 2017, PLOS ONE, V12
   Hart CE, 2017, EMERG INFECT DIS, V23, P559, DOI 10.3201/eid2303.161636
   Hill CL, 2014, ACTA TROP, V140, P151, DOI 10.1016/j.actatropica.2014.07.015
   Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434
   Kamgang B, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2408-x
   Kang DS, 2017, ACTA TROP, V174, P97, DOI 10.1016/j.actatropica.2017.06.018
   Kenney JL, 2017, AM J TROP MED HYG, V96, P1235, DOI 10.4269/ajtmh.16-0865
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Krauer F, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002203
   Lana RM, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006070
   Ledermann JP, 2017, REV PANAM SALUD PUBL, V41
   Lee JS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2577-4
   Liebman KA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002702
   Liu-Helmersson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089783
   Lo D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192120
   Lourenco J, 2017, ELIFE, V6, DOI [10.7554/elife.29820, 10.7554/eLife.29820]
   Lourenco-de-Oliveira R, 2018, J GEN VIROL, V99, P258, DOI 10.1099/jgv.0.000949
   Lourenco-de-Oliveira R, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005698
   Lourenco-de-Oliveira R, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-610
   Maciel-de-Freitas R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065252
   Majumder Maimuna S, 2016, JMIR Public Health Surveill, V2, pe30, DOI 10.2196/publichealth.5814
   Manore CA, 2014, J THEOR BIOL, V356, P174, DOI 10.1016/j.jtbi.2014.04.033
   Marini G, 2017, EUROSURVEILLANCE, V22, P7, DOI 10.2807/1560-7917.ES.2017.22.37.30612
   Martinez NE, 2014, J AM MOSQUITO CONTR, V30, P143, DOI 10.2987/14-6402.1
   Masud MA, 2017, BIOSYSTEMS, V156, P23, DOI 10.1016/j.biosystems.2017.03.005
   Miller MJ, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003383
   Monaghan AJ, 2016, PLOS CURR, V8, DOI [10.1371/currents.outbreaks, DOI 10.1371/CURRENTS.OUTBREAKS]
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Muturi EJ, 2017, TROP MED INT HEALTH, V22, P399, DOI 10.1111/tmi.12846
   Nakkhara P, 2013, T ROY SOC TROP MED H, V107, P789, DOI 10.1093/trstmh/trt083
   Nuckols JT, 2015, J MED ENTOMOL, V52, P447, DOI 10.1093/jme/tjv017
   O'Donnell KL, 2017, J MED ENTOMOL, V54, P1354, DOI 10.1093/jme/tjx087
   Ospina J, 2017, TROP MED INT HEALTH, V22, P1249, DOI 10.1111/tmi.12924
   Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363
   Perez-Perez J, 2017, BIOMEDICA, V37, DOI [10.7705/biomedica.v37i0.3467, 10.7705/biomedica.v34i2.3467]
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Quiner CA, 2014, J VIROL, V88, P13125, DOI 10.1128/JVI.01822-14
   Quintero-Gil DC, 2014, J INFECT DEV COUNTR, V8, P876, DOI 10.3855/jidc.3978
   Reiner RC, 2014, EPIDEMICS-NETH, V6, P30, DOI 10.1016/j.epidem.2013.12.003
   Rojas DP, 2016, EUROSURVEILLANCE, V21, P26, DOI 10.2807/1560-7917.ES.2016.21.28.30283
   Roundy CM, 2017, EMERG INFECT DIS, V23, P625, DOI 10.3201/eid2304.161484
   Ruckert C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15412
   Serra OP, 2016, MEM I OSWALDO CRUZ, V111, P20, DOI 10.1590/0074-02760150270
   Serrato-Salas J, 2018, DEV COMP IMMUNOL, V84, P28, DOI 10.1016/j.dci.2018.01.022
   Siraj AS, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005797
   Souza-Neto JA, 2019, INFECT GENET EVOL, V67, P191, DOI 10.1016/j.meegid.2018.11.009
   Stewart-Ibarra AM, 2013, AM J TROP MED HYG, V88, P971, DOI 10.4269/ajtmh.12-0478
   Sylvestre G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059933
   Taber ED, 2017, J VECTOR ECOL, V42, P3, DOI 10.1111/jvec.12234
   Thangamani S, 2016, AM J TROP MED HYG, V95, P1169, DOI 10.4269/ajtmh.16-0448
   Tricco AC, 2018, ANN INTERN MED, V169, P467, DOI 10.7326/M18-0850
   Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0
   Vega-Rua A, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003780
   Vega-Rua A, 2014, J VIROL, V88, P6294, DOI 10.1128/JVI.00370-14
   Velazquez-Castro J, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006234
   Villela DAM, 2017, EPIDEMIOL INFECT, V145, P1649, DOI 10.1017/S0950268817000358
   Waddell LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156376
   Wagman J, 2013, J AM MOSQUITO CONTR, V29, P380, DOI 10.2987/13-6364.1
   Weaver SC, 2016, ANTIVIR RES, V130, P69, DOI 10.1016/j.antiviral.2016.03.010
   Weger-Lucarelli J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005101
   WHO, 2018, ZIK VIR
   Xiao FZ, 2014, ARCH VIROL, V159, P3053, DOI 10.1007/s00705-014-2051-1
   Yactayo S, 2016, J INFECT DIS, V214, pS441, DOI 10.1093/infdis/jiw390
   Yang HM, 2017, MATH BIOSCI, V286, P1, DOI 10.1016/j.mbs.2017.01.006
   Yang HM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152186
   Zeller H, 2016, J INFECT DIS, V214, pS436, DOI 10.1093/infdis/jiw391
NR 116
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 6
PY 2020
VL 15
IS 2
AR e0220753
DI 10.1371/journal.pone.0220753
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP9GK
UT WOS:000534623800003
PM 32027652
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Gokhale, NS
   McIntyre, ABR
   Mattocks, MD
   Holley, CL
   Lazear, HM
   Mason, CE
   Horner, SM
AF Gokhale, Nandan S.
   McIntyre, Alexa B. R.
   Mattocks, Melissa D.
   Holley, Christopher L.
   Lazear, Helen M.
   Mason, Christopher E.
   Horner, Stacy M.
TI Altered m(6)A Modification of Specific Cellular Transcripts Affects
   Flaviviridae Infection
SO MOLECULAR CELL
LA English
DT Article
ID HEPATITIS-C VIRUS; MESSENGER-RNA MODIFICATIONS; GENE-EXPRESSION; INNATE
   IMMUNITY; RIG-I; TRANSLATION; METHYLATION; PROTEIN; REVEALS; WRITERS
AB The RNA modification N-6-methyladenosine (m(6)A) modulates mRNA fate and thus affects many biological processes. We analyzed m(6)A across the transcriptome following infection by dengue virus (DENV), Zika virus (ZIKV), West Nile virus (WNV), and hepatitis C virus (HCV). We found that infection by these viruses in the Flaviviridae family alters m(6)A modification of specific cellular transcripts, including RIOK3 and CIRBP. During viral infection, the addition of m(6)A to RIOK3 promotes its translation, while loss of m(6)A in CIRBP promotes alternative splicing. Importantly, viral activation of innate immune sensing or the endoplasmic reticulum (ER) stress response contributes to the changes in m(6)A in RIOK3 or CIRBP, respectively. Further, several transcripts with infection-altered m(6)A profiles, including RIOK3 and CIRBP, encode proteins that influence DENV, ZIKV, and HCV infection. Overall, this work reveals that cellular signaling pathways activated during viral infection lead to alterations in m(6)A modification of host mRNAs to regulate infection.
C1 [Gokhale, Nandan S.; Holley, Christopher L.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27705 USA.
   [Holley, Christopher L.; Horner, Stacy M.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA.
   [McIntyre, Alexa B. R.; Mason, Christopher E.] Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.
   [McIntyre, Alexa B. R.; Mason, Christopher E.] Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA.
   [McIntyre, Alexa B. R.] Triinst Program Computat Biol & Med, New York, NY 10065 USA.
   [Mattocks, Melissa D.; Lazear, Helen M.] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.
   [Mason, Christopher E.] Weill Cornell Med, HRH Prince Alwaleed Bin Talal Abdulaziz Alsaud In, New York, NY 10065 USA.
   [Mason, Christopher E.] Weill Cornell Med, WorldQuant Initiat Quantitat Predict, New York, NY 10065 USA.
   [Mason, Christopher E.] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.
RP Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Mol Genet & Microbiol, Durham, NC 27705 USA.; Horner, SM (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27705 USA.; Mason, CE (corresponding author), Weill Cornell Med, Dept Physiol & Biophys, New York, NY 10065 USA.; Mason, CE (corresponding author), Weill Cornell Med, Inst Computat Biomed, New York, NY 10065 USA.; Mason, CE (corresponding author), Weill Cornell Med, HRH Prince Alwaleed Bin Talal Abdulaziz Alsaud In, New York, NY 10065 USA.; Mason, CE (corresponding author), Weill Cornell Med, WorldQuant Initiat Quantitat Predict, New York, NY 10065 USA.; Mason, CE (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.
EM chm2042@med.cornell.edu; stacy.horner@duke.edu
OI Gokhale, Nandan/0000-0002-4459-4053; McIntyre,
   Alexa/0000-0001-6965-6292; Holley, Christopher/0000-0002-2870-3352;
   Horner, Stacy/0000-0002-9351-7409
FU Burroughs Wellcome FundBurroughs Wellcome Fund; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [R01AI125416, R21AI129851,
   5P30AI064518, R01MH117406, R03HL135475]; American Heart
   AssociationAmerican Heart Association [17PRE33670017]; National Science
   and Engineering Research Council of CanadaNatural Sciences and
   Engineering Research Council of Canada; Bert L. and N. Kuggie Vallee
   Foundation; WorldQuant Foundation; Pershing Square Sohn Cancer Research
   Alliance; NASANational Aeronautics & Space Administration (NASA)
   [NNX14AH50G]; UNC Lineberger Comprehensive Cancer Center
FX We thank Moonhee Park, Xinhe Yin, Dr. Olga Ilkayeva, Dr. Christopher
   Nicchitta, and Dr. Heather Vincent for experimental help and advice;
   colleagues who provided reagents (see STAR Methods); NEB for gift of
   anti-m6A antibodies; the Metabolomics Core at the Duke Molecular
   Physiology Institute; the Duke Functional Genomics Core Facility; the
   Epigenomics Core and the Scientific Computing Unit at Weill Cornell; and
   Dr. Kate Meyer and Horner lab members for manuscript discussion. This
   work was supported by funds from Burroughs Wellcome Fund (S.M.H.) and
   National Institutes of Health: R01AI125416, R21AI129851 (S.M.H. and
   C.E.M.), 5P30AI064518 (S.M.H.), R01MH117406 (C.E.M.), and R03HL135475
   (C.L.H). Other funding sources include: American Heart Association
   (N.S.G. Pre-doctoral Fellowship, 17PRE33670017), National Science and
   Engineering Research Council of Canada (A.B.R.M. PGS-D funding), Bert L.
   and N. Kuggie Vallee Foundation, WorldQuant Foundation, Pershing Square
   Sohn Cancer Research Alliance, NASA (NNX14AH50G), and startup funds from
   the UNC Lineberger Comprehensive Cancer Center (H.M.L. and M.D.M).
CR Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011
   Aligeti M, 2015, J VIROL, V89, P11523, DOI 10.1128/JVI.01185-15
   Arnaud N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010575
   Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678
   Basanta-Sanchez M, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv971
   Beachboard DC, 2019, J BIOL CHEM, V294, P14231, DOI 10.1074/jbc.RA119.007917
   Blazquez AB, 2014, FRONT MICROBIOL, V5, DOI [10.3389/fmicb.2014.00266, 10.3389/fmicb.2014.00797]
   Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d
   Carletti T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11663-2
   Chan SW, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00233
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Conway JR, 2017, BIOINFORMATICS, V33, P2938, DOI 10.1093/bioinformatics/btx364
   Courtney DG, 2017, CELL HOST MICROBE, V22, P377, DOI 10.1016/j.chom.2017.08.004
   Cui XD, 2018, IEEE ACM T COMPUT BI, V15, P526, DOI 10.1109/TCBB.2015.2403355
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003
   Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635
   Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112
   Edupuganti RR, 2017, NAT STRUCT MOL BIOL, V24, P870, DOI 10.1038/nsmb.3462
   Engel M, 2018, NEURON, V99, P389, DOI 10.1016/j.neuron.2018.07.009
   Feng J, 2014, J VIROL, V88, P7987, DOI 10.1128/JVI.00643-14
   Fink J, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000086
   Garaigorta U, 2009, CELL HOST MICROBE, V6, P513, DOI 10.1016/j.chom.2009.11.004
   Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711
   Gokhale NS, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006188
   Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015
   Gokhale NS, 2014, FUTURE VIROL, V9, P1061, DOI 10.2217/FVL.14.89
   Gonzales-van Horn SR, 2017, CELL HOST MICROBE, V21, P661, DOI 10.1016/j.chom.2017.05.008
   Han DL, 2019, NATURE, V566, P270, DOI 10.1038/s41586-019-0916-x
   Hao HJ, 2019, NUCLEIC ACIDS RES, V47, P362, DOI 10.1093/nar/gky1007
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Hesser CR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006995
   Holbrook MR, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9050097
   Horner SM, 2013, NAT MED, V19, P879, DOI 10.1038/nm.3253
   Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108
   Huang HL, 2019, NATURE, V567, P414, DOI 10.1038/s41586-019-1016-7
   Huang HL, 2018, NAT CELL BIOL, V20, P285, DOI 10.1038/s41556-018-0045-z
   Imam H, 2018, P NATL ACAD SCI USA, V115, P8829, DOI 10.1073/pnas.1808319115
   Ke SD, 2017, GENE DEV, V31, P990, DOI 10.1101/gad.301036.117
   Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002
   Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112
   Kumar M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26350
   Lee JS, 2012, AM J TRANSL RES, V4, P102
   Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10
   Li ZJ, 2017, CANCER CELL, V31, P127, DOI 10.1016/j.ccell.2016.11.017
   Liao Y, 2017, INT J CANCER, V141, P2164, DOI 10.1002/ijc.30833
   Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002
   Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]
   Lin SB, 2016, MOL CELL, V62, P335, DOI 10.1016/j.molcel.2016.03.021
   Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016
   Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/NMETH.3453, 10.1038/nmeth.3453]
   Liu H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11713-9
   Liu L, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1808-4
   Liu NA, 2017, NUCLEIC ACIDS RES, V45, P6051, DOI 10.1093/nar/gkx141
   Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234
   Liu Y, 2019, SCIENCE, V365, P1171, DOI 10.1126/science.aax4468
   Louloupi A, 2018, CELL REP, V23, P3429, DOI 10.1016/j.celrep.2018.05.077
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Luna JM, 2015, CELL, V160, P1099, DOI 10.1016/j.cell.2015.02.025
   Mauer J, 2018, FEBS LETT, V592, P2012, DOI 10.1002/1873-3468.13092
   McIntyre ABR, 2019, LIMITS DETECTION M6A, DOI [10.1101/657130, DOI 10.1101/657130]
   McIntyre W, 2018, NUCLEIC ACIDS RES, V46, P5776, DOI 10.1093/nar/gky029
   Meyer KD, 2017, ANNU REV CELL DEV BI, V33, P319, DOI 10.1146/annurev-cellbio-100616-060758
   Meyer KD, 2015, CELL, V163, P999, DOI 10.1016/j.cell.2015.10.012
   Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003
   Mizrahi O, 2018, MOL CELL, V72, P862, DOI 10.1016/j.molcel.2018.09.003
   Munoz-Jordan JL, 2010, VIRUSES-BASEL, V2, P676, DOI 10.3390/v2020676
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Park SM, 2014, J EXP MED, V211, P71, DOI 10.1084/jem.20130736
   Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342
   QUERY CC, 1987, CELL, V51, P211, DOI 10.1016/0092-8674(87)90148-6
   Quicke KM, 2016, CELL HOST MICROBE, V20, P83, DOI 10.1016/j.chom.2016.05.015
   Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199
   Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616
   Rosenberg BR, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007290
   Roth H, 2017, MBIO, V8, DOI [10.1128/mbio.02150-16, 10.1128/mBio.02150-16]
   Rubio RM, 2018, GENE DEV, V32, P1472, DOI 10.1101/gad.319475.118
   Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106
   Saletore Y, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-175
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048
   Schwerk J, 2015, CURR OPIN VIROL, V12, P75, DOI 10.1016/j.coviro.2015.02.006
   Sergushichev A.A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]
   Sessions OM, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002107
   Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967
   Shan JX, 2009, MOL CELL BIOCHEM, V332, P113, DOI 10.1007/s11010-009-0180-8
   Shi HL, 2019, MOL CELL, V74, P640, DOI 10.1016/j.molcel.2019.04.025
   Shi HL, 2018, NATURE, V563, P249, DOI 10.1038/s41586-018-0666-1
   Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15
   Slobodin B, 2017, CELL, V169, P326, DOI 10.1016/j.cell.2017.03.031
   Stern-Ginossar N, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033001
   Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005
   Su AI, 2002, P NATL ACAD SCI USA, V99, P15669, DOI 10.1073/pnas.202608199
   Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800
   Suthar MS, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003541
   Takashima K, 2015, CELL REP, V11, P192, DOI 10.1016/j.celrep.2015.03.027
   Tan B, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0056-8
   Thrift AP, 2017, NAT REV GASTRO HEPAT, V14, P122, DOI 10.1038/nrgastro.2016.176
   Tirumuru N, 2016, ELIFE, V5, DOI 10.7554/eLife.15528
   Tsai K, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006919
   Vaquero-Garcia J, 2016, ELIFE, V5, DOI 10.7554/eLife.11752
   Vazquez C, 2019, J VIROL, V93, DOI 10.1128/JVI.00725-19
   Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416
   Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6
   Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014
   Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870
   Willemsen J, 2017, MOL CELL, V65, P403, DOI 10.1016/j.molcel.2016.12.021
   Williams GD, 2019, ANNU REV VIROL, V6, P235, DOI 10.1146/annurev-virology-092818-015559
   Winkler R, 2019, NAT IMMUNOL, V20, P173, DOI 10.1038/s41590-018-0275-z
   Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012
   Yang Y, 2018, CELL RES, V28, P616, DOI 10.1038/s41422-018-0040-8
   Ye FC, 2017, J VIROL, V91, DOI 10.1128/JVI.00466-17
   Yue YA, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0019-0
   Zanini F, 2018, ELIFE, V7, DOI 10.7554/eLife.32942
   Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137
   Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151
   Zhong X, 2018, CELL REP, V25, P1816, DOI 10.1016/j.celrep.2018.10.068
   Zhou J, 2018, MOL CELL, V69, P636, DOI 10.1016/j.molcel.2018.01.019
   Zhou KI, 2019, MOL CELL, V76, P70, DOI 10.1016/j.molcel.2019.07.005
NR 119
TC 4
Z9 4
U1 13
U2 13
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1097-2765
EI 1097-4164
J9 MOL CELL
JI Mol. Cell
PD FEB 6
PY 2020
VL 77
IS 3
BP 542
EP +
DI 10.1016/j.molcel.2019.11.007
PG 22
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA KK7QC
UT WOS:000512932100010
PM 31810760
DA 2020-07-08
ER

PT J
AU Vazquez, C
   Jurado, KA
AF Vazquez, Christine
   Jurado, Kellie Ann
TI Playing Favorites: Integrin alpha v beta 5 Mediates Preferential Zika
   Infection of Neural Stem Cells
SO CELL STEM CELL
LA English
DT Editorial Material
ID VIRUS
AB The molecular basis dictating specificity of Zika virus infection in neural stem cells (NSCs) remains elusive. Two recent papers in Cell Stem Cell (Zhu et al., 2020) and Cell Reports (Wang et al., 2020) identify integrin alpha v beta 5 as an internalization factor that increases susceptibility in NSCs and glioblastoma stem cells.
C1 [Vazquez, Christine; Jurado, Kellie Ann] Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
RP Jurado, KA (corresponding author), Univ Penn, Dept Microbiol, Philadelphia, PA 19104 USA.
EM kellie.jurado@pennmedicine.upenn.edu
CR Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Hastings AK, 2017, CELL REP, V19, P558, DOI 10.1016/j.celrep.2017.03.058
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Wang S., 2020, CELL STEM CELL, V30
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
   Zhu ZX, 2020, CELL STEM CELL, V26, P294, DOI 10.1016/j.stem.2020.01.001
NR 10
TC 1
Z9 1
U1 1
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD FEB 6
PY 2020
VL 26
IS 2
BP 133
EP 135
DI 10.1016/j.stem.2020.01.007
PG 4
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA KK7XJ
UT WOS:000512951100005
PM 32032522
DA 2020-07-08
ER

PT J
AU Zhu, Z
   Mesci, P
   Bernatchez, JA
   Gimple, RC
   Wang, XX
   Schafer, ST
   Wettersten, HI
   Beck, S
   Clark, AE
   Wu, QL
   Prager, BC
   Kim, LJY
   Dhanwani, R
   Sharma, S
   Garancher, A
   Weis, SM
   Mack, SC
   Negraes, PD
   Trujillo, CA
   Penalva, LO
   Feng, J
   Lan, Z
   Zhang, R
   Wessel, AW
   Dhawan, S
   Diamond, MS
   Chen, CC
   Wechsler-Reya, RJ
   Gage, FH
   Hu, HZ
   Siqueira-Neto, JL
   Muotri, AR
   Cheresh, DA
   Rich, JN
AF Zhu, Zhe
   Mesci, Pinar
   Bernatchez, Jean A.
   Gimple, Ryan C.
   Wang, Xiuxing
   Schafer, Simon T.
   Wettersten, Hiromi, I
   Beck, Sungjun
   Clark, Alex E.
   Wu, Qiulian
   Prager, Briana C.
   Kim, Leo J. Y.
   Dhanwani, Rekha
   Sharma, Sonia
   Garancher, Alexandra
   Weis, Sara M.
   Mack, Stephen C.
   Negraes, Priscilla D.
   Trujillo, Cleber A.
   Penalva, Luiz O.
   Feng, Jing
   Lan, Zhou
   Zhang, Rong
   Wessel, Alex W.
   Dhawan, Sanjay
   Diamond, Michael S.
   Chen, Clark C.
   Wechsler-Reya, Robert J.
   Gage, Fred H.
   Hu, Hongzhen
   Siqueira-Neto, Jair L.
   Muotri, Alysson R.
   Cheresh, David A.
   Rich, Jeremy N.
TI Zika Virus Targets Glioblastoma Stem Cells through a SOX2-Integrin
   alpha(v)beta(5) Axis
SO CELL STEM CELL
LA English
DT Article
ID TUMOR-INITIATING CELLS; WEST-NILE-VIRUS; DRUGGABLE VULNERABILITY; HUMAN
   BRAIN; INFECTION; CANCER; MODEL; ENTRY; AXL; VISUALIZATION
AB Zika virus (ZIKV) causes microcephaly by killing neural precursor cells (NPCs) and other brain cells. ZIKV also displays therapeutic oncolytic activity against glioblastoma (GBM) stem cells (GSCs). Here we demonstrate that ZIKV preferentially infected and killed GSCs and stem-like cells in medulloblastoma and ependymoma in a SOX2-dependent manner. Targeting SOX2 severely attenuated ZIKV infection, in contrast to AXL. As mechanisms of SOX2-mediated ZIKV infection, we identified inverse expression of antiviral interferon response genes (ISGs) and positive correlation with integrin alpha(v) (ITGAV). ZIKV infection was disrupted by genetic targeting of ITGAV or its binding partner ITGB5 and by an antibody specific for integrin alpha(v)beta(5). ZIKV selectively eliminated GSCs from species-matched human mature cerebral organoids and GBM surgical specimens, which was reversed by integrin alpha(v)beta(5) inhibition. Collectively, our studies identify integrin alpha(v)beta(5) as a functional cancer stem cell marker essential for GBM maintenance and ZIKV infection, providing potential brain tumor therapy.
C1 [Zhu, Zhe; Gimple, Ryan C.; Wang, Xiuxing; Wu, Qiulian; Prager, Briana C.; Kim, Leo J. Y.; Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Div Regenerat Med, Dept Med, La Jolla, CA 92037 USA.
   [Zhu, Zhe; Mesci, Pinar; Gimple, Ryan C.; Wang, Xiuxing; Wettersten, Hiromi, I; Wu, Qiulian; Prager, Briana C.; Weis, Sara M.; Negraes, Priscilla D.; Trujillo, Cleber A.; Muotri, Alysson R.; Rich, Jeremy N.] Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.
   [Mesci, Pinar; Negraes, Priscilla D.; Trujillo, Cleber A.; Muotri, Alysson R.] Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Pediat, La Jolla, CA 92307 USA.
   [Mesci, Pinar; Siqueira-Neto, Jair L.] Univ Calif San Diego, Sch Med, Stem Cell Program, Dept Cellular & Mol Med, La Jolla, CA 92307 USA.
   [Bernatchez, Jean A.; Beck, Sungjun] Univ Calif San Diego, Ctr Discovery & Innovat Parasit Dis, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92037 USA.
   [Gimple, Ryan C.; Prager, Briana C.; Kim, Leo J. Y.] Case Western Reserve Univ, Sch Med, Med Scientist Training Program, Cleveland, OH 44106 USA.
   [Gimple, Ryan C.; Prager, Briana C.; Kim, Leo J. Y.] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44106 USA.
   [Schafer, Simon T.; Gage, Fred H.] Salk Inst Biol Studies, Lab Genet, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.
   [Wettersten, Hiromi, I; Weis, Sara M.; Cheresh, David A.] Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, La Jolla, CA 92037 USA.
   [Clark, Alex E.] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92037 USA.
   [Clark, Alex E.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92037 USA.
   [Prager, Briana C.] Cleveland Clin, Lerner Coll Med, Cleveland, OH 44195 USA.
   [Dhanwani, Rekha; Sharma, Sonia] La Jolla Inst Allergy & Immunol, 9420 Athena Circle, La Jolla, CA 92037 USA.
   [Garancher, Alexandra; Wechsler-Reya, Robert J.] NCI, Tumor Initiat & Maintenance Program, Designated Canc Ctr, Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA 92037 USA.
   [Mack, Stephen C.] Texas Childrens Hosp, Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.
   [Penalva, Luiz O.] UTHSCSA, Childrens Canc Res Inst, San Antonio, TX 78229 USA.
   [Feng, Jing; Lan, Zhou; Hu, Hongzhen] Washington Univ, Sch Med St Louis, Ctr Study Itch, Dept Anesthesiol, St Louis, MO 63130 USA.
   [Zhang, Rong; Wessel, Alex W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63130 USA.
   [Zhang, Rong; Wessel, Alex W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63130 USA.
   [Zhang, Rong; Wessel, Alex W.; Diamond, Michael S.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.
   [Zhang, Rong; Wessel, Alex W.; Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr, Immunol Program, St Louis, MO 63130 USA.
   [Zhang, Rong; Wessel, Alex W.; Diamond, Michael S.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr, Immunotherapy Program, St Louis, MO 63130 USA.
   [Dhawan, Sanjay; Chen, Clark C.] Univ Minnesota, Dept Neurosurg, Minneapolis, MN 55455 USA.
   [Rich, Jeremy N.] Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92037 USA.
RP Rich, JN (corresponding author), Univ Calif San Diego, Sch Med, Div Regenerat Med, Dept Med, La Jolla, CA 92037 USA.; Muotri, AR; Rich, JN (corresponding author), Sanford Consortium Regenerat Med, 2880 Torrey Pines Scen Dr, La Jolla, CA 92037 USA.; Muotri, AR (corresponding author), Univ Calif San Diego, Sch Med, Rady Childrens Hosp San Diego, Dept Pediat, La Jolla, CA 92307 USA.; Siqueira-Neto, JL (corresponding author), Univ Calif San Diego, Sch Med, Stem Cell Program, Dept Cellular & Mol Med, La Jolla, CA 92307 USA.; Cheresh, DA (corresponding author), Univ Calif San Diego, Moores Canc Ctr, Dept Pathol, La Jolla, CA 92037 USA.; Rich, JN (corresponding author), Univ Calif San Diego, Sch Med, Dept Neurosci, La Jolla, CA 92037 USA.
EM jairlage@ucsd.edu; muotri@ucsd.edu; dcheresh@ucsd.edu;
   drjeremyrich@gmail.com
RI Siqueira-Neto, Jair L/D-6040-2012; Zhu, Zhe/H-6009-2019
OI Siqueira-Neto, Jair L/0000-0001-9574-8174; Zhu, Zhe/0000-0002-5385-948X;
   Mesci, Pinar/0000-0003-3402-5671
FU CIRM Major Facilities grant [FA1-00607]; International Rett Syndrome
   Foundation (IRSF) mentored training fellowship; California Institute for
   Regenerative MedicineCalifornia Institute for Regenerative Medicine
   [DISC2-09649]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [CA217065, CA217066,
   CA203101, CA159859, CA199376, NS097649-01, CA240953-01, NS096368,
   R01DK103901, R01AA027065, MH107367, N5105969, CA045726, CA050286,
   CA197718, CA154130, CA169117, CA171652, NS087913, NS089272]
FX We thank Drs. Peter Yingxiao Wang and Hsin-Hung Lin (UC, San Diego) for
   the PGK-EGFP lentiviral vector and Dr. Elsa Molina (UC, San Diego Stem
   Cell Genomics Core) for technical assistance with experiments using the
   NanoString nCounter Sprint. We also acknowledge access and use of the
   UCSD Screening Core to perform part of the experiments presented in this
   manuscript. This work was made possible in part by CIRM Major Facilities
   grant FA1-00607 (to the Sanford Consortium for Regenerative Medicine).
   P.M. has an International Rett Syndrome Foundation (IRSF) mentored
   training fellowship. A.R.M. is supported by the California Institute for
   Regenerative Medicine (DISC2-09649). These studies were supported by the
   NIH through CA217065 (to R.C.G.); CA217066 (to B.C.P.); CA203101 (to
   L.J.Y.K.); CA159859 and CA199376 (to S.S.); NS097649-01 and CA240953-01
   (to C.C.C.); NS096368 (to R.J.W.-R.); R01DK103901 and R01AA027065 (to
   H.H.); MH107367 and N5105969 (to A.R.M.); CA045726 and CA050286 (to
   D.A.C.); and CA197718, CA154130, CA169117, CA171652, NS087913, and
   NS089272 (to J.N.R.).
CR Allen C, 2013, GENE THER, V20, P444, DOI 10.1038/gt.2012.62
   Bach P, 2013, CANCER RES, V73, P865, DOI 10.1158/0008-5472.CAN-12-2221
   Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236
   Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010
   Boonnak K, 2008, J VIROL, V82, P3939, DOI 10.1128/JVI.02484-07
   Bowman RL, 2017, NEURO-ONCOLOGY, V19, P139, DOI 10.1093/neuonc/now247
   Brinton MA, 2014, VIRUSES-BASEL, V6, P13, DOI 10.3390/v6010013
   BUETOW MP, 1991, RADIOGRAPHICS, V11, P1087, DOI 10.1148/radiographics.11.6.1749851
   Chailangkarn T, 2016, NATURE, V536, P338, DOI 10.1038/nature19067
   Chen J, 2018, NAT MICROBIOL, V3, P302, DOI 10.1038/s41564-017-0092-4
   Chen Q, 2018, MBIO, V9, DOI 10.1128/mBio.01683-18
   Chu JJH, 2004, J BIOL CHEM, V279, P54533, DOI 10.1074/jbc.M410208200
   Cosset E, 2017, CANCER CELL, V32, P856, DOI 10.1016/j.ccell.2017.10.016
   Darmanis S, 2017, CELL REP, V21, P1399, DOI 10.1016/j.celrep.2017.10.030
   Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748
   Donato M, 2013, GENOME RES, V23, P1885, DOI 10.1101/gr.153551.112
   Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607
   Drost J, 2018, NAT REV CANCER, V18, P407, DOI 10.1038/s41568-018-0007-6
   Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI 10.1093/nar/gkx1132
   Fan WC, 2017, RES VET SCI, V111, P67, DOI 10.1016/j.rvsc.2016.12.007
   Foo SS, 2017, NAT MICROBIOL, V2, P1558, DOI 10.1038/s41564-017-0016-3
   Foreman PM, 2017, NEUROTHERAPEUTICS, V14, P333, DOI 10.1007/s13311-017-0516-0
   Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Geer LY, 2010, NUCLEIC ACIDS RES, V38, pD492, DOI 10.1093/nar/gkp858
   Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004
   Heymann DL, 2016, LANCET, V387, P719, DOI 10.1016/S0140-6736(16)00320-2
   Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008
   Hubert CG, 2016, CANCER RES, V76, P2465, DOI 10.1158/0008-5472.CAN-15-2402
   Ianevski A, 2017, BIOINFORMATICS, V33, P2413, DOI 10.1093/bioinformatics/btx162
   Josupeit R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050138
   Kaid C, 2018, CANCER RES, V78, P3363, DOI [10.1158/0008-5472.CAN-17-3201, 10.1158/0008-5472.can-17-3201]
   Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962
   Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092
   Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260
   Liu F, 2015, MOL CELL, V60, P307, DOI 10.1016/j.molcel.2015.09.002
   Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8
   Mack SC, 2019, J EXP MED, V216, P1071, DOI 10.1084/jem.20190196
   Mack SC, 2018, NATURE, V553, P101, DOI 10.1038/nature25169
   Marchetto MCN, 2010, CELL, V143, P527, DOI 10.1016/j.cell.2010.10.016
   Medigeshi GR, 2008, J VIROL, V82, P5212, DOI 10.1128/JVI.00008-08
   Meertens L, 2017, CELL REP, V18, P324, DOI 10.1016/j.celrep.2016.12.045
   Melo ASO, 2016, ULTRASOUND OBST GYN, V47, P6, DOI 10.1002/uog.15831
   Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984
   Mesci P, 2018, HUM MOL GENET, V27, P41, DOI 10.1093/hmg/ddx382
   Michlmayr D, 2017, NAT MICROBIOL, V2, P1462, DOI 10.1038/s41564-017-0035-0
   Milde T, 2011, ACTA NEUROPATHOL, V122, P637, DOI 10.1007/s00401-011-0866-3
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nowakowski TJ, 2016, CELL STEM CELL, V18, P591, DOI 10.1016/j.stem.2016.03.012
   Ogawa J, 2018, CELL REP, V23, P1220, DOI 10.1016/j.celrep.2018.03.105
   Oh Y, 2017, NAT NEUROSCI, V20, P1209, DOI 10.1038/nn.4612
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Petersen E, 2016, INT J INFECT DIS, V44, P11, DOI 10.1016/j.ijid.2016.02.001
   Poirot L, 2015, CANCER RES, V75, P3853, DOI 10.1158/0008-5472.CAN-14-3321
   Pollen AA, 2015, CELL, V163, P55, DOI 10.1016/j.cell.2015.09.004
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033
   Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257
   Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500
   Retallack H, 2016, P NATL ACAD SCI USA, V113, P14408, DOI 10.1073/pnas.1618029113
   Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007
   Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754
   Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287
   Sarkar A, 2013, CELL STEM CELL, V12, P15, DOI 10.1016/j.stem.2012.12.007
   Schafer ST, 2019, NAT NEUROSCI, V22, P243, DOI 10.1038/s41593-018-0295-x
   Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]
   Schmidt K, 2013, J GEN VIROL, V94, P1723, DOI 10.1099/vir.0.052613-0
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Seguin L, 2017, CANCER DISCOV, V7, P1464, DOI 10.1158/2159-8290.CD-17-0539
   Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Singh SK, 2003, CANCER RES, V63, P5821
   Slenter DN, 2018, NUCLEIC ACIDS RES, V46, pD661, DOI 10.1093/nar/gkx1064
   Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.2
   Souza BSF, 2016, SCI REP-UK, V6, DOI 10.1038/srep39775
   Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330
   Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102
   Suva ML, 2014, CELL, V157, P580, DOI 10.1016/j.cell.2014.02.030
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247
   Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009
   Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017
   Trujillo CA, 2019, CELL STEM CELL, V25, P558, DOI 10.1016/j.stem.2019.08.002
   Wakimoto H, 2009, CANCER RES, V69, P3472, DOI 10.1158/0008-5472.CAN-08-3886
   Wang XX, 2018, CELL STEM CELL, V22, P514, DOI 10.1016/j.stem.2018.03.011
   Wang XX, 2017, CANCER RES, V77, P4947, DOI 10.1158/0008-5472.CAN-17-0114
   Wang XX, 2017, NAT NEUROSCI, V20, P661, DOI 10.1038/nn.4537
   Wells MF, 2016, CELL STEM CELL, V19, P703, DOI 10.1016/j.stem.2016.11.011
   WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E
   Wu A, 2010, NEURO-ONCOLOGY, V12, P1113, DOI 10.1093/neuonc/noq082
   Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018
   Zemp FJ, 2013, NEURO-ONCOLOGY, V15, P904, DOI 10.1093/neuonc/not035
   Zhou J, 2018, P NATL ACAD SCI USA, V115, P6822, DOI 10.1073/pnas.1806308115
   Zhu Z, 2017, J EXP MED, V214, P2843, DOI 10.1084/jem.20171093
NR 99
TC 3
Z9 3
U1 10
U2 10
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1934-5909
EI 1875-9777
J9 CELL STEM CELL
JI Cell Stem Cell
PD FEB 6
PY 2020
VL 26
IS 2
BP 187
EP +
DI 10.1016/j.stem.2019.11.016
PG 28
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA KK7XJ
UT WOS:000512951100010
PM 31956038
DA 2020-07-08
ER

PT J
AU Sinigaglia, A
   Peta, E
   Riccetti, S
   Barzon, L
AF Sinigaglia, Alessandro
   Peta, Elektra
   Riccetti, Silvia
   Barzon, Luisa
TI New avenues for therapeutic discovery against West Nile virus
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Review
DE West Nile virus; Antiviral drug; drug discovery; Flavivirus; Therapeutic
   antibody; Vaccine; siRNA; NS3; NS5; Zika virus
ID HUMANIZED MONOCLONAL-ANTIBODY; NONSTRUCTURAL PROTEIN NS1; DEPENDENT
   RNA-POLYMERASE; AMINO-ACID SUBSTITUTION; BROAD-SPECTRUM; ANTIVIRAL
   ACTIVITY; ENVELOPE PROTEIN; PEPTIDOMIMETIC INHIBITORS; MEDIATED
   NEUTRALIZATION; PROTECTIVE EFFICACY
AB Introduction: West Nile virus (WNV) is a neurotropic mosquito-borne flavivirus, which is endemic in many countries, especially in Europe and in North America, where the virus has increased its activity in the recent years. No vaccines nor antiviral drugs are available for the prevention and treatment of WNV infection in humans. Areas covered: This review article describes viral and host targets that have been addressed by anti-WNV drug discovery studies and summarizes the most relevant anti-WNV candidate compounds identified so far, focusing on those showing antiviral efficacy in in vivo models and broad-spectrum anti-flavivirus activity. Expert opinion: The most promising anti-WNV drug candidates target conserved enzymatic motifs in viral NS3 protease and NS5 polymerase and are effective against different flaviviruses. Targeting host factors required for viral infection and replication and modulation of host innate antiviral response are also promising approaches, which may lead to the development of compounds with broad-spectrum antiviral activity, a desirable feature for an antiviral drug.
C1 [Sinigaglia, Alessandro; Peta, Elektra; Riccetti, Silvia; Barzon, Luisa] Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
RP Barzon, L (corresponding author), Univ Padua, Dept Mol Med, Via A Gabelli 63, I-35121 Padua, Italy.
EM luisa.barzon@unipd.it
RI Barzon, Luisa/K-7961-2016
OI Barzon, Luisa/0000-0003-0720-8456
CR Abdelnabi R, 2017, J VIROL, V91, DOI 10.1128/JVI.00487-17
   Avirutnan P, 2010, J EXP MED, V207, P793, DOI 10.1084/jem.20092545
   Backus KM, 2016, NATURE, V534, P570, DOI 10.1038/nature18002
   Balasubramanian A, 2016, ANTIVIR RES, V134, P6, DOI 10.1016/j.antiviral.2016.08.014
   Barzon L, 2018, J CLIN VIROL, V107, P38, DOI 10.1016/j.jcv.2018.08.007
   Barzon L, 2018, EXPERT OPIN BIOL TH, V18, P851, DOI 10.1080/14712598.2018.1499721
   Barzon L, 2016, FEMS MICROBIOL LETT, V363, DOI 10.1093/femsle/fnw202
   Barzon L, 2015, EXPERT REV ANTI-INFE, V13, P327, DOI 10.1586/14787210.2015.1007044
   Behnam MAM, 2015, J MED CHEM, V58, P9354, DOI 10.1021/acs.jmedchem.5b01441
   Beigel JH, 2010, ANTIMICROB AGENTS CH, V54, P2431, DOI 10.1128/AAC.01178-09
   Beloor J, 2018, CELL HOST MICROBE, V23, P549, DOI 10.1016/j.chom.2018.03.001
   Biedenbender R, 2011, J INFECT DIS, V203, P75, DOI 10.1093/infdis/jiq003
   Blazquez AB, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10020091
   Blazquez AB, 2016, FRONT MICROBIOL, V7, DOI [10.3389/fmicb.2016.00296, 10.3389/fmicb.2010.00296]
   Boldescu V, 2017, NAT REV DRUG DISCOV, V16, P565, DOI 10.1038/nrd.2017.33
   Bollati M, 2010, ANTIVIR RES, V87, P125, DOI 10.1016/j.antiviral.2009.11.009
   Boriskin YS, 2008, CURR MED CHEM, V15, P997, DOI 10.2174/092986708784049658
   Brai A, 2019, J MED CHEM, V62, P2333, DOI 10.1021/acs.jmedchem.8b01403
   Brai A, 2016, P NATL ACAD SCI USA, V113, P5388, DOI 10.1073/pnas.1522987113
   Brecher M, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006411
   Brecher M, 2015, ACS INFECT DIS, V1, P340, DOI 10.1021/acsinfecdis.5b00070
   Bullard KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130083
   Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P15, DOI 10.1128/AAC.01429-12
   Cannalire R, 2019, ANTIVIR RES, V167, P6, DOI 10.1016/j.antiviral.2019.03.004
   Center for Disease Control and Prevention (CDC), 2018, W NIL VIR DIS THER
   Chabierski S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066507
   Chahar HS, 2013, VIROLOGY, V436, P1, DOI 10.1016/j.virol.2012.09.041
   Chang JH, 2009, ANTIMICROB AGENTS CH, V53, P1501, DOI 10.1128/AAC.01457-08
   Chappell KJ, 2006, J BIOL CHEM, V281, P38448, DOI 10.1074/jbc.M607641200
   Chen H, 2013, ANTIVIR RES, V97, P232, DOI 10.1016/j.antiviral.2012.12.012
   Chen S, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100291
   Cheng F, 2018, J VIROL, V92, DOI 10.1128/JVI.02019-17
   Chowers MY, 2001, EMERG INFECT DIS, V7, P675
   Chung KY, 2010, VIROLOGY, V402, P52, DOI 10.1016/j.virol.2010.03.011
   Chung KM, 2006, P NATL ACAD SCI USA, V103, P19111, DOI 10.1073/pnas.0605668103
   Dayan GH, 2012, VACCINE, V30, P6656, DOI 10.1016/j.vaccine.2012.08.063
   De Filette M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091631
   De Maio FA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005841
   de Wispelaere M, 2018, CELL CHEM BIOL, V25, P1006, DOI 10.1016/j.chembiol.2018.05.011
   de Wispelaere M, 2017, ANTIVIR RES, V139, P171, DOI 10.1016/j.antiviral.2016.12.017
   Deardorff ER, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002335
   Dong HP, 2010, J BIOL CHEM, V285, P32586, DOI 10.1074/jbc.M110.129197
   Durbin AP, 2013, VACCINE, V31, P5772, DOI 10.1016/j.vaccine.2013.07.064
   Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003
   Escribano-Romero E, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.01400-17, 10.1128/aac.01400-17]
   Eyer L, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/aac.02093-18, 10.1128/AAC.02093-18]
   Eyer L, 2017, ANTIVIR RES, V142, P63, DOI 10.1016/j.antiviral.2017.03.012
   Eyer L, 2016, ANTIVIR RES, V133, P119, DOI 10.1016/j.antiviral.2016.07.018
   Eyer L, 2016, J INFECT DIS, V214, P707, DOI 10.1093/infdis/jiw226
   Ezgimen M, 2012, ANTIVIR RES, V94, P18, DOI [10.1016/j.antiviral.2012.02.003, 10.1016/j.antivira1.2012.02.003]
   Faustino AF, 2015, ACS CHEM BIOL, V10, P517, DOI 10.1021/cb500640t
   Fraser JE, 2014, J INFECT DIS, V210, P1780, DOI 10.1093/infdis/jiu319
   Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015
   Gack MU, 2016, CURR OPIN VIROL, V20, P119, DOI 10.1016/j.coviro.2016.09.013
   Gao YJ, 2013, CHEMMEDCHEM, V8, P1554, DOI 10.1002/cmdc.201300244
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Gnann JW, 2019, EMERG INFECT DIS, V25, P2064, DOI 10.3201/eid2511.190537
   Goo L, 2019, NAT MICROBIOL, V4, P71, DOI 10.1038/s41564-018-0283-7
   Guerrero NAS, 2018, ANTIVIR RES, V160, P137, DOI 10.1016/j.antiviral.2018.10.026
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hackett BA, 2019, MBIO, V10, DOI 10.1128/mBio.01446-19
   Hammamy MZ, 2013, CHEMMEDCHEM, V8, P231, DOI 10.1002/cmdc.201200497
   Haussig JM, 2018, EUROSURVEILLANCE, V23, P32
   Haviernik J, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10040184
   He JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093541
   Hoenen A, 2007, J GEN VIROL, V88, P3013, DOI 10.1099/vir.0.83125-0
   Hrnicek MJ, 2004, AM J GASTROENTEROL, V99, P957, DOI 10.1111/j.1572-0241.2004.40130.x
   Ivanova T, 2017, CHEMMEDCHEM, V12, P1953, DOI 10.1002/cmdc.201700596
   Jia F, 2010, ARCH VIROL, V155, P1325, DOI 10.1007/s00705-010-0702-4
   de Oya NJ, 2019, EMERG MICROBES INFEC, V8, P624, DOI 10.1080/22221751.2019.1604084
   de Oya NJ, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.00360-18
   Jordan I, 2000, J INFECT DIS, V182, P1214, DOI 10.1086/315847
   Kalil AC, 2005, CLIN INFECT DIS, V40, P764, DOI 10.1086/427945
   Kampmann T, 2009, ANTIVIR RES, V84, P234, DOI 10.1016/j.antiviral.2009.09.007
   Kouretova J, 2017, J ENZYM INHIB MED CH, V32, P712, DOI 10.1080/14756366.2017.1306521
   Krishnan MN, 2014, VIRUSES-BASEL, V6, P683, DOI 10.3390/v6020683
   Kumar P, 2007, NATURE, V448, P39, DOI 10.1038/nature05901
   Lai HF, 2010, P NATL ACAD SCI USA, V107, P2419, DOI 10.1073/pnas.0914503107
   Laurent-Rolle M, 2010, J VIROL, V84, P3503, DOI 10.1128/JVI.01161-09
   Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054
   Lee E, 2006, ANTIVIR RES, V69, P31, DOI 10.1016/j.antiviral.2005.08.006
   Leneva IA, 2009, ANTIVIR RES, V81, P132, DOI 10.1016/j.antiviral.2008.10.009
   Li KL, 2012, J MED CHEM, V55, P3319, DOI 10.1021/jm300021v
   Li MH, 2019, NAT MICROBIOL, V4, P985, DOI 10.1038/s41564-019-0375-z
   Li Z, 2018, ANTIVIR RES, V150, P217, DOI 10.1016/j.antiviral.2017.12.018
   Li Z, 2017, CELL RES, V27, P1046, DOI 10.1038/cr.2017.88
   Lieberman MM, 2009, CLIN VACCINE IMMUNOL, V16, P1332, DOI 10.1128/CVI.00119-09
   Lim HA, 2011, EUR J MED CHEM, V46, P3130, DOI 10.1016/j.ejmech.2011.04.055
   Liu WJ, 2006, J VIROL, V80, P2396, DOI 10.1128/JVI.80.5.2396-2404.2006
   Lopez-Denman AJ, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12848
   Low JG, 2014, LANCET INFECT DIS, V14, P706, DOI 10.1016/S1473-3099(14)70730-3
   Luo DH, 2008, EMBO J, V27, P3209, DOI 10.1038/emboj.2008.232
   Luthra P, 2018, ANTIVIR RES, V158, P288, DOI 10.1016/j.antiviral.2018.08.012
   Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003
   Magnusson SE, 2014, VACCINE, V32, P800, DOI 10.1016/j.vaccine.2013.12.030
   Makhoul B, 2009, ISR MED ASSOC J, V11, P151
   Malet H, 2008, ANTIVIR RES, V80, P23, DOI 10.1016/j.antiviral.2008.06.007
   Manokaran G, 2015, SCIENCE, V350, P217, DOI 10.1126/science.aab3369
   Marceau CD, 2016, NATURE, V535, P159, DOI 10.1038/nature18631
   Martinez AA, 2018, EUR J MED CHEM, V157, P1202, DOI 10.1016/j.ejmech.2018.08.077
   Martins AS, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00008
   Martins IC, 2012, BIOCHEM J, V444, P405, DOI 10.1042/BJ20112219
   Mastrangelo E, 2012, J ANTIMICROB CHEMOTH, V67, P1884, DOI 10.1093/jac/dks147
   McDonald E, 2019, MMWR-MORBID MORTAL W, V68, P673, DOI 10.15585/mmwr.mm6831a1
   Medigeshi GR, 2016, ANTIMICROB AGENTS CH, V60, P6709, DOI 10.1128/AAC.01367-16
   Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005
   Mentre F, 2015, LANCET INFECT DIS, V15, P150, DOI 10.1016/S1473-3099(14)71047-3
   Merino-Ramos T, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00376-17, 10.1128/aac.00376-17]
   Merino-Ramos T, 2016, ANTIMICROB AGENTS CH, V60, P307, DOI 10.1128/AAC.01578-15
   Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165
   Morelli MC, 2010, CLIN INFECT DIS, V51, pE34, DOI 10.1086/655146
   Morrey JD, 2007, ANTIMICROB AGENTS CH, V51, P2396, DOI 10.1128/AAC.00147-07
   Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293
   Morrey John D., 2004, Antiviral Chemistry & Chemotherapy, V15, P101
   Morrey JD, 2008, ANTIVIR RES, V80, P377, DOI 10.1016/j.antiviral.2008.07.009
   Nall TA, 2004, J BIOL CHEM, V279, P48535, DOI 10.1074/jbc.M406810200
   Nelson J, 2015, ANTIVIR RES, V122, P39, DOI 10.1016/j.antiviral.2015.07.008
   Neufeldt CJ, 2018, NAT REV MICROBIOL, V16, P125, DOI 10.1038/nrmicro.2017.170
   Nitsche C, 2019, ACS MED CHEM LETT, V10, P168, DOI 10.1021/acsmedchemlett.8b00535
   Nybakken GE, 2006, J VIROL, V80, P11467, DOI 10.1128/JVI.01125-06
   O'Rourke A, 2018, MOLECULES, V23, DOI 10.3390/molecules23061472
   Oliphant T, 2005, NAT MED, V11, P522, DOI 10.1038/nm1240
   Oliveira AFCD, 2018, EUR J MED CHEM, V149, P98, DOI 10.1016/j.ejmech.2018.02.037
   Oliveira ERA, 2017, VIRUS RES, V227, P115, DOI 10.1016/j.virusres.2016.10.005
   Patel S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070603
   Pattabhi S, 2016, J VIROL, V90, P2372, DOI 10.1128/JVI.02202-15
   Pecheur EI, 2016, J VIROL, V90, P3086, DOI 10.1128/JVI.02077-15
   Perera-Lecoin Manuel, 2013, Viruses, V6, P69, DOI 10.3390/v6010069
   Pierson TC, 2007, CELL HOST MICROBE, V1, P135, DOI 10.1016/j.chom.2007.03.002
   Pierson Theodore C., 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000665
   Pijlman GP, 2008, CELL HOST MICROBE, V4, P579, DOI 10.1016/j.chom.2008.10.007
   Pinkham AM, 2018, J MED CHEM, V61, P980, DOI 10.1021/acs.jmedchem.7b01409
   Prochnow H, 2020, J VIROL, V94, DOI 10.1128/JVI.01471-19
   Puerta-Guardo H, 2019, CELL REP, V26, P1598, DOI 10.1016/j.celrep.2019.01.036
   Puschnik AS, 2017, CELL REP, V21, P3032, DOI 10.1016/j.celrep.2017.11.054
   Qing M, 2010, ANTIMICROB AGENTS CH, V54, P3686, DOI 10.1128/AAC.00561-10
   Rathore APS, 2011, ANTIVIR RES, V92, P453, DOI 10.1016/j.antiviral.2011.10.002
   Rausch K, 2017, CELL REP, V18, P804, DOI 10.1016/j.celrep.2016.12.068
   Rey FA, 2018, EMBO REP, V19, P206, DOI 10.15252/embr.201745302
   Richardson RB, 2018, NAT MICROBIOL, V3, P1214, DOI 10.1038/s41564-018-0244-1
   Roby JA, 2014, VIRUSES-BASEL, V6, P404, DOI 10.3390/v6020404
   Samuel GH, 2018, TRENDS MICROBIOL, V26, P447, DOI 10.1016/j.tim.2017.12.005
   Sayce AC, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004524
   Scaturro P, 2014, J VIROL, V88, P11540, DOI 10.1128/JVI.01745-14
   Schuller A, 2011, ANTIVIR RES, V92, P96, DOI 10.1016/j.antiviral.2011.07.002
   Schuessler A, 2012, J VIROL, V86, P5708, DOI 10.1128/JVI.00207-12
   Shiryaev SA, 2006, BIOCHEM J, V393, P503, DOI 10.1042/BJ20051374
   Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866
   Sinigaglia A, 2019, EUROSURVEILLANCE, V24, P2, DOI 10.2807/1560-7917.ES.2019.24.21.1900261
   Sinigaglia A, 2018, EXPERT OPIN DRUG DIS, V13, P825, DOI 10.1080/17460441.2018.1515909
   Skorenski M, 2019, J ENZYM INHIB MED CH, V34, P8, DOI 10.1080/14756366.2018.1506772
   Smeraski CA, 2011, ANTIVIR RES, V91, P43, DOI 10.1016/j.antiviral.2011.04.011
   Smith HL, 2011, J INFECT DIS, V203, P513, DOI 10.1093/infdis/jiq074
   Soto-Acosta R, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006257
   Soto-Acosta R, 2014, ANTIVIR RES, V109, P132, DOI 10.1016/j.antiviral.2014.07.002
   Stahla-Beek HJ, 2012, J VIROL, V86, P8730, DOI 10.1128/JVI.00384-12
   Stoermer MJ, 2008, J MED CHEM, V51, P5714, DOI 10.1021/jm800503y
   Sun HY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010054
   Suthar MS, 2013, NAT REV MICROBIOL, V11, P115, DOI 10.1038/nrmicro2950
   Sweeney NL, 2015, ACS INFECT DIS, V1, P140, DOI 10.1021/id5000458
   Szretter KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002698
   Tarantino D, 2016, ANTIVIR RES, V134, P226, DOI 10.1016/j.antiviral.2016.09.007
   Ulbert S, 2019, HUM VACC IMMUNOTHER, V10, P1
   Ulbert S, 2014, FUTURE MICROBIOL, V9, P1221, DOI [10.2217/FMB.14.67, 10.2217/fmb.14.67]
   Valiente-Echeverria F, 2015, REV MED VIROL, V25, P286, DOI 10.1002/rmv.1845
   Van Hoeven N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149610
   Van Slyke GA, 2012, VIROLOGY, V427, P18, DOI 10.1016/j.virol.2012.01.036
   Varghese FS, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02227-16, 10.1128/aac.02227-16]
   Vazquez-Calvo A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01314
   Vernekar SKV, 2015, J MED CHEM, V58, P4016, DOI 10.1021/acs.jmedchem.5b00327
   Verstrepen BE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112568
   Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150
   Wang CL, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007938
   Wang P, 2014, CHEMMEDCHEM, V9, P1522, DOI 10.1002/cmdc.201300505
   Watanabe S, 2016, ANTIVIR RES, V127, P10, DOI 10.1016/j.antiviral.2015.12.008
   Watanabe S, 2012, ANTIVIR RES, V96, P32, DOI 10.1016/j.antiviral.2012.07.008
   Wen JL, 2004, J VIROL, V78, P12225, DOI 10.1128/JVI.78.22.12225-12235.2004
   WESTAWAY EG, 1987, ARCH VIROL, V94, P215, DOI 10.1007/BF01310715
   Westaway EG, 1997, J VIROL, V71, P6650, DOI 10.1128/JVI.71.9.6650-6661.1997
   Whiteman MC, 2011, VACCINE, V29, P9702, DOI 10.1016/j.vaccine.2011.09.036
   Wichit S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03316-5
   Wilder-Smith A, 2019, LANCET, V393, P350, DOI 10.1016/S0140-6736(18)32560-1
   Wilson JR, 2008, J VIROL, V82, P8262, DOI 10.1128/JVI.00226-08
   Woods CW, 2019, VACCINE, V37, P4222, DOI 10.1016/j.vaccine.2018.12.026
   Yang SNY, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8030281
   Yao Y, 2019, J AM CHEM SOC, V141, P6832, DOI 10.1021/jacs.9b02505
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Zhang HL, 2017, J VIROL, V91, DOI [10.1128/jvi.02396-16, 10.1128/JVI.02396-16]
   Zmurko J, 2015, REV MED VIROL, V25, P205, DOI 10.1002/rmv.1835
   Zou G, 2009, VIROLOGY, V384, P242, DOI 10.1016/j.virol.2008.11.003
NR 190
TC 0
Z9 0
U1 7
U2 7
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1746-0441
EI 1746-045X
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD MAR 3
PY 2020
VL 15
IS 3
SI SI
BP 333
EP 348
DI 10.1080/17460441.2020.1714586
EA FEB 2020
PG 16
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA KO4TL
UT WOS:000512784900001
PM 32017639
DA 2020-07-08
ER

PT J
AU Diniz, D
   Ali, M
   Ambrogi, I
   Brito, L
AF Diniz, Debora
   Ali, Moazzam
   Ambrogi, Ilana
   Brito, Luciana
TI Understanding sexual and reproductive health needs of young women living
   in Zika affected regions: a qualitative study in northeastern Brazil
SO REPRODUCTIVE HEALTH
LA English
DT Article
DE Zika virus; Sexual and reproductive health; Public health; Young women;
   Brazil
ID PREGNANCY
AB Background In 2016, the World Health Organization declared a Public Health Emergency of International Concern due to Zika's association with microcephaly and other neurological disorders. Brazil was the epicenter of this epidemic and the most affected region has the lowest Human Development Index and the highest rates of adolescent pregnancy. Despite the end of the epidemic, Brazil continues to be the epicenter of Zika illness. This study examined the barriers faced by young women who seek sexual and reproductive health (SRH) care services living in affected areas and their attitudes towards SRH needs and the available services. Methods Individual semi-structured interviews were conducted with 22 young women, aged 14-24 years in three Zika affected municipalities in the Brazilian Northeast. This qualitative research used thematic analysis for data analysis. Results Almost half (n = 10) of the participants had their first pregnancy during adolescence (from 12 to 19), all of which were unintended. Lack of information and barriers to access family planning were found to contribute to the unmet need for contraception. Participants reported knowledge gaps about contraception. Zika was not considered a health concern and participants were unaware of the possibility of Zika's sexual transmission. Conclusions The young women's knowledge and attitudes towards their SRH needs highlight the barriers to access care. It also implies that comprehensive, biopsychosocial and political, understanding is necessary in order to adequately provide SRH to this population and meet their needs. The government should place women at the center of any public health response to an emergency affecting women of reproductive age and focus on improving access to information and family planning services in a culturally and age appropriate manner.
C1 [Diniz, Debora] IPPF WHR, Caixa Postal 8011, BR-70094971 Brasilia, DF, Brazil.
   [Ali, Moazzam] World Hlth Org, Dept Reprod Hlth & Res RHR, Ave Appia 20, CH-1211 Geneva 27, Switzerland.
   [Ambrogi, Ilana] Anis Inst Bioeth, Caixa Postal 8011, BR-70094971 Brasilia, DF, Brazil.
   [Brito, Luciana] Anis Inst Bioeth, Res, Caixa Postal 8011, BR-70094971 Brasilia, DF, Brazil.
RP Ali, M (corresponding author), World Hlth Org, Dept Reprod Hlth & Res RHR, Ave Appia 20, CH-1211 Geneva 27, Switzerland.; Brito, L (corresponding author), Anis Inst Bioeth, Res, Caixa Postal 8011, BR-70094971 Brasilia, DF, Brazil.
EM alimoa@who.int; l.brito@anis.org.br
OI Brito, Luciana/0000-0001-8752-2386
FU  [5149]
FX The study is funded by Large Anonymous Donor under the Grant ID 5149 for
   Women, Communities, and Health Systems in the Context of Zika. The
   funding sources did not play a role in the study design, in the writing
   of the report, or in the decision to submit the article for publication.
CR [Anonymous], 2016, PROTOCOLOS ATENCAO B
   Bahamondes L, 2017, HUM REPROD, V32, P88, DOI 10.1093/humrep/dew310
   Braun V., 2006, QUALITATIVE RES PSYC, V3, P2, DOI [DOI 10.1191/1478088706QP0630A, 10.1191/1478088706qp063oa, DOI 10.1191/1478088706qp063oa]
   Castro MC, 2018, P NATL ACAD SCI USA, V115, P6177, DOI 10.1073/pnas.1718476115
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Conroy KN, 2016, J PEDIATR ADOL GYNEC, V29, P312, DOI 10.1016/j.jpag.2015.12.003
   Corbin J., 2008, BASICS QUALITATIVE R
   Crosby RA, 2002, AM J OBSTET GYNECOL, V186, P251, DOI 10.1067/mob.2002.120081
   Curtis Siân L., 2012, Rev. bras. estud. popul., V29, P191, DOI 10.1590/S0102-30982012000100012
   Diniz D, 2017, ZIKA BRAZIL WOMEN CH
   Diniz D, 2017, DEV WORLD BIOETH, V17, P142, DOI 10.1111/dewb.12175
   Diniz D, 2017, INT J GYNECOL OBSTET, V136, P105, DOI 10.1002/ijgo.12018
   Farias MR, 2016, REV SAUDE PUBL, V50, DOI [10.1590/S1518-8787.2016050006176, 10.1590/s1518-8787.2016050006176]
   Goodman M, 2017, AM J OBSTET GYNECOL, V216, DOI 10.1016/j.ajog.2016.12.015
   Grace KT, 2018, TRAUMA VIOLENCE ABUS, V19, P371, DOI 10.1177/1524838016663935
   Guttmacher Institute, 2016, COSTS BEN M CONTR NE, V19
   Hadley A, 2016, J ADOLESCENT HEALTH, V59, P68, DOI 10.1016/j.jadohealth.2016.03.023
   Le HH, 2014, IN J WOMENS HEALTH, V6, P663, DOI 10.2147/IJWH.S61543
   Liang ELM, 2013, ADOLESCENT PREGNANCY
   Makuch MY, 2011, CONTRACEPTION, V84, P622, DOI 10.1016/j.contraception.2011.03.010
   Marteleto LJ, 2017, POPUL DEV REV, V43, P199, DOI 10.1111/padr.12074
   Ministerio da Saude, SINASC SIST INF NASC
   Ministerio da Saude, 2009, PESQ NAC DEM SAUD CR
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, B EP, V50
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2016, SECR VIG SAUD PROTOC
   Ministerio da Saude. Secretaria de Vigilancia em Saude, 2019, B EP, V50
   O'Connell C, 2019, INT J GYNECOL OBSTET, V144, P116, DOI 10.1002/ijgo.12693
   Oringanje C, 2016, COCHRANE DB SYST REV, V2, DOI 10.1002/14651858.CD005215.pub3
   de Leon RGP, 2019, LANCET GLOB HEALTH, V7, pE227, DOI 10.1016/S2214-109X(18)30481-9
   Potter JE, 2010, POPUL DEV REV, V36, P283, DOI 10.1111/j.1728-4457.2010.00330.x
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Russo JA, 2013, J ADOLESCENT HEALTH, V52, pS14, DOI 10.1016/j.jadohealth.2013.02.003
   Schuck-Paim C, 2016, PLOS CURR, DOI [10.1371/currents.outbreaks.7038a6813f734c1db547240c2a0ba291, DOI 10.1371/CURRENTS.0UTBREAKS.7038A6813F734C1DB547240C2A0BA291]
   Sedgh G, 2016, UNMET NEED CONTRACEP, V115, P6177
   Sheeder J, 2010, J PEDIATR ADOL GYNEC, V23, P86, DOI 10.1016/j.jpag.2009.06.002
   Theme-Filha MM, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0227-8
   UNFPA, 2017, SIT POP MUND 2017
   World Health Organization, 2016, 5 M EM COMM INT HLTH
NR 38
TC 0
Z9 0
U1 1
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1742-4755
J9 REPROD HEALTH
JI Reprod. Health
PD FEB 6
PY 2020
VL 17
IS 1
AR 22
DI 10.1186/s12978-020-0869-4
PG 8
WC Public, Environmental & Occupational Health
SC Public, Environmental & Occupational Health
GA KJ3YP
UT WOS:000511995400001
PM 32028969
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ambagala, A
   Truong, T
   Cottam-Birt, C
   Berhane, Y
   Gerdts, V
   Karniychuk, U
   Safronetz, D
   Babiuk, S
AF Ambagala, Aruna
   Truong, Thang
   Cottam-Birt, Colleen
   Berhane, Yohannes
   Gerdts, Volker
   Karniychuk, Uladzimir
   Safronetz, David
   Babiuk, Shawn
TI Susceptibility of Chicken Embryos, Sheep, Cattle, Pigs, and Chickens to
   Zika Virus Infection
SO FRONTIERS IN VETERINARY SCIENCE
LA English
DT Article
DE Zika virus; embryo; tissue tropism; susceptibility; chicken
ID ANIMALS; OUTBREAK; DISEASE
AB The susceptibility of sheep, cattle, pigs, chickens and chicken embryos to Zika virus infection was evaluated by experimental inoculation with Zika virus Thailand strain isolated from a Canadian traveler in 2013. The inoculated animals did not develop any clinical signs of disease nor evidence of Zika virus replication in peripheral blood, cerebrospinal fluid and tissues including brain and spinal cord assessed by real-time RT-PCR. Sera were also negative for Zika virus antibodies by Zika virus neutralization assays as well as Zika virus immunoperoxidase staining of Zika infected Vero cells. Chicken embryos were inoculated by different routes including yolk sac (4 day old embryos), chorioallantoic membrane (8 day old embryos), amniotic fluid (8 day old embryos) and intravenous routes (12 day old embryos). Virus replication in chicken embryos was observed in the brain and body tissues following intravenous (IV), yolk sac (YS), chorioallantoic membrane (CAM), and amniotic fluid (AF) inoculation routes. The highest mortality was observed in embryos inoculated via yolk sac. The dead embryos showed diffuse muscular hemorrhages. The yolk sac inoculated chicken embryos showed delayed hatching and displayed neurological signs immediately after hatching. These studies demonstrate that 8 week old sheep, 6 month old cattle, 4 week old pigs, and 4 week old chickens are not susceptible to Zika virus infection when inoculated experimentally and therefore unlikely to pose a risk as Zika virus reservoirs. However, chicken embryos are highly susceptible to Zika virus resulting in clinical disease of chicks after hatching. This study demonstrates that Zika virus has a tropism for embryonic tissue and that chicken embryos can be used as a model to study Zika virus replication and pathogenesis.
C1 [Ambagala, Aruna; Truong, Thang; Cottam-Birt, Colleen; Berhane, Yohannes; Babiuk, Shawn] Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.
   [Ambagala, Aruna; Berhane, Yohannes] Univ Manitoba, Dept Anim Sci, Winnipeg, MB, Canada.
   [Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Vaccine & Infect Dis Org, Int Vaccine Ctr VIDO InterVac, Saskatoon, SK, Canada.
   [Gerdts, Volker; Karniychuk, Uladzimir] Univ Saskatchewan, Dept Vet Microbiol, Saskatoon, SK, Canada.
   [Safronetz, David] Publ Hlth Agcy Canada, Zoonot Dis & Special Pathogens, Winnipeg, MB, Canada.
   [Babiuk, Shawn] Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.
RP Babiuk, S (corresponding author), Canadian Food Inspect Agcy, Natl Ctr Foreign Anim Dis, Winnipeg, MB, Canada.; Babiuk, S (corresponding author), Univ Manitoba, Dept Immunol, Winnipeg, MB, Canada.
EM shawn.babiuk@canada.ca
FU Canadian Food Inspection Agency; Public Health Agency of Canada
FX This work was funded through the Canadian Food Inspection Agency and the
   Public Health Agency of Canada.
CR Bingham AM, 2016, MMWR-MORBID MORTAL W, V65, P475, DOI 10.15585/mmwr.mm6518e2
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   Cao-Lormeau VM, 2014, EMERG INFECT DIS, V20, P1085, DOI 10.3201/eid2006.140138
   Chan JFW, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.99
   Chaves BA, 2019, J MED ENTOMOL, V56, P1739, DOI 10.1093/jme/tjz110
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Darbellay J, 2017, EBIOMEDICINE, V25, P73, DOI 10.1016/j.ebiom.2017.09.021
   Darbellay J, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2016.133
   DARWISH MA, 1983, T ROY SOC TROP MED H, V77, P442, DOI 10.1016/0035-9203(83)90106-2
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowall SD, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004658
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   El Costa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep35296
   Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151
   Goodfellow FT, 2016, STEM CELLS DEV, V25, P1691, DOI 10.1089/scd.2016.0231
   Halliday JEB, 2007, J R SOC INTERFACE, V4, P973, DOI 10.1098/rsif.2007.0237
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   Kleber de Oliveira Wanderson, 2016, MMWR Morb Mortal Wkly Rep, V65, P242, DOI 10.15585/mmwr.mm6509e2
   Komar N, 2001, ANN NY ACAD SCI, V951, P58
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lazear HM, 2016, CELL HOST MICROBE, V19, P720, DOI 10.1016/j.chom.2016.03.010
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Nguyen SM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006378
   OLSON JG, 1983, ANN TROP MED PARASIT, V77, P131, DOI 10.1080/00034983.1983.11811687
   Osuna CE, 2016, NAT MED, V22, P1448, DOI 10.1038/nm.4206
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Ragan IK, 2017, VECTOR-BORNE ZOONOT, V17, P161, DOI 10.1089/vbz.2016.2099
   Thawani A, 2018, CELL REP, V23, P692, DOI 10.1016/j.celrep.2018.03.080
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Willard KA, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120383
   Yockey LJ, 2016, CELL, V166, P1247, DOI 10.1016/j.cell.2016.08.004
   Zhang ZY, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01127
NR 33
TC 0
Z9 0
U1 0
U2 0
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
EI 2297-1769
J9 FRONT VET SCI
JI Front. Vet. Sci.
PD FEB 5
PY 2020
VL 7
AR 23
DI 10.3389/fvets.2020.00023
PG 8
WC Veterinary Sciences
SC Veterinary Sciences
GA KO9TP
UT WOS:000515889400001
PM 32118055
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Tian, A
   Muffat, J
   Li, Y
AF Tian, Ai
   Muffat, Julien
   Li, Yun
TI Studying Human Neurodevelopment and Diseases Using 3D Brain Organoids
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE Brain organoid; pluripotent stem cells; CRISPR; neurological disorders;
   evolution
ID PLURIPOTENT STEM-CELLS; FUNCTIONAL CORTICAL-NEURONS; ZIKA
   VIRUS-INFECTION; MICROGLIA-LIKE CELLS; CEREBRAL ORGANOIDS; REGULATES
   NEUROGENESIS; SELF-ORGANIZATION; DIFFERENTIATION; MODELS; GENERATION
AB In vitro differentiation of pluripotent stem cells provides a systematic platform to study development and disease. Recent advances in brain organoid technology have created new opportunities to investigate the formation and function of the human brain, under physiological and pathological conditions. Brain organoids can be generated to model the cellular and structural development of the human brain, and allow the investigation of the intricate interactions between resident neural and glial cell types. Combined with new advances in gene editing, imaging, and genomic analysis, brain organoid technology can be applied to address questions pertinent to human brain development, disease, and evolution. However, the current iterations of brain organoids also have limitations in faithfully recapitulating the in vivo processes. In this perspective, we evaluate the recent progress in brain organoid technology, and discuss the experimental considerations for its utilization.
C1 [Tian, Ai; Muffat, Julien] Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 0A4, Canada.
   [Muffat, Julien; Li, Yun] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.
   [Li, Yun] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada.
RP Muffat, J (corresponding author), Hosp Sick Children, Program Neurosci & Mental Hlth, Toronto, ON M5G 0A4, Canada.; Muffat, J; Li, Y (corresponding author), Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada.; Li, Y (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 0A4, Canada.
EM julien.muffat@sickkids.ca; yun.li@sickkids.ca
FU Canada Research Chairs ProgramCanada Research Chairs; National Sciences
   and Engineering Research Council of CanadaNatural Sciences and
   Engineering Research Council of Canada; Simons Foundation [SFARI
   479754]; Ontario Institute for Regenerative Medicine; Canada First
   Research Excellence Fund
FX J.M. was supported by the Canada Research Chairs Program,and the
   National Sciences and Engineering Research Council of Canada. Y.L. was
   supported by Simons Foundation SFARI 479754 and the Ontario Institute
   for Regenerative Medicine. This research was part of the University of
   Toronto's Medicine by Design initiative, which received funding from the
   Canada First Research Excellence Fund. We thank members of the Y.L. and
   J.M. laboratories for helpful discussions.
CR Abud EM, 2017, NEURON, V94, P278, DOI 10.1016/j.neuron.2017.03.042
   Amiri A, 2018, SCIENCE, V362, P1268, DOI 10.1126/science.aat6720
   Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304
   Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007
   Bian S, 2018, NAT METHODS, V15, P631, DOI 10.1038/s41592-018-0070-7
   Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330
   Blair JD, 2018, NAT MED, V24, P1568, DOI 10.1038/s41591-018-0139-y
   Brownjohn PW, 2018, STEM CELL REP, V10, P1294, DOI 10.1016/j.stemcr.2018.03.003
   Bystron I, 2008, NAT REV NEUROSCI, V9, P110, DOI 10.1038/nrn2252
   Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112
   Cardenas A, 2018, CELL, V174, P590, DOI 10.1016/j.cell.2018.06.007
   Cederquist GY, 2019, NAT BIOTECHNOL, V37, P436, DOI 10.1038/s41587-019-0085-3
   Douvaras P, 2017, STEM CELL REP, V8, P1516, DOI 10.1016/j.stemcr.2017.04.023
   Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002
   Fiddes IT, 2018, CELL, V173, P1356, DOI 10.1016/j.cell.2018.03.051
   Fischer A, 2013, TRENDS MOL MED, V19, P302, DOI 10.1016/j.molmed.2013.02.004
   Florio M, 2018, ELIFE, V7, DOI 10.7554/eLife.32332
   Florio M, 2015, SCIENCE, V347, P1465, DOI 10.1126/science.aaa1975
   Garcez PP, 2016, SCIENCE, V352, P816, DOI 10.1126/science.aaf6116
   Giandomenico SL, 2019, NAT NEUROSCI, V22, P669, DOI 10.1038/s41593-019-0350-2
   Guo L, 2019, AM J HUM GENET, V104, P925, DOI 10.1016/j.ajhg.2019.03.004
   Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017
   Heide M, 2018, CURR OPIN CELL BIOL, V55, P8, DOI 10.1016/j.ceb.2018.06.006
   Hu WF, 2014, ANNU REV GENOM HUM G, V15, P195, DOI 10.1146/annurev-genom-090413-025600
   Itskovitz-Eldor J, 2000, MOL MED, V6, P88, DOI 10.1007/BF03401776
   Javed AO, 2018, CELL REP, V25, P368, DOI 10.1016/j.celrep.2018.09.032
   Jin MY, 2017, SCI REP-UK, V7, DOI 10.1038/srep39902
   Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005
   Julia TCW, 2017, STEM CELL REP, V9, P600, DOI 10.1016/j.stemcr.2017.06.018
   Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110
   Kawada J, 2017, STEM CELL REP, V9, P1441, DOI 10.1016/j.stemcr.2017.09.021
   Kelava I, 2016, CELL STEM CELL, V18, P736, DOI 10.1016/j.stem.2016.05.022
   Kim H, 2019, STEM CELL REP, V12, P518, DOI 10.1016/j.stemcr.2019.01.020
   Klaus J, 2019, NAT MED, V25, P561, DOI 10.1038/s41591-019-0371-0
   Knight GT, 2018, ELIFE, V7, DOI 10.7554/eLife.37549
   Lager AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06102-7
   Lancaster MA, 2014, NAT PROTOC, V9, P2329, DOI 10.1038/nprot.2014.158
   Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517
   Lee JH, 2012, NAT GENET, V44, P941, DOI 10.1038/ng.2329
   Li QY, 2018, NAT REV IMMUNOL, V18, P225, DOI 10.1038/nri.2017.125
   Li X, 2018, STEM CELL REP, V11, P998, DOI 10.1016/j.stemcr.2018.08.019
   Li Y, 2019, P NATL ACAD SCI USA, V116, P9527, DOI 10.1073/pnas.1900867116
   Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017
   Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029
   Lin YT, 2018, NEURON, V98, P1141, DOI 10.1016/j.neuron.2018.05.008
   Linkous A, 2019, CELL REP, V26, P3203, DOI 10.1016/j.celrep.2019.02.063
   Luo CY, 2016, CELL REP, V17, P3369, DOI 10.1016/j.celrep.2016.12.001
   Madhavan M, 2018, NAT METHODS, V15, P700, DOI 10.1038/s41592-018-0081-4
   Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034
   Marton RM, 2019, NAT NEUROSCI, V22, P484, DOI 10.1038/s41593-018-0316-9
   McBride KL, 2010, AUTISM RES, V3, P137, DOI 10.1002/aur.132
   Mellios N, 2018, MOL PSYCHIATR, V23, P1051, DOI 10.1038/mp.2017.86
   Muffat J, 2018, P NATL ACAD SCI USA, V115, P7117, DOI 10.1073/pnas.1719266115
   Muffat J, 2016, NAT MED, V22, P1358, DOI 10.1038/nm.4189
   Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051
   Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786
   Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009
   O'Neill AC, 2018, CELL REP, V25, P2729, DOI 10.1016/j.celrep.2018.11.029
   Oosterhof N, 2019, AM J HUM GENET, V104, P936, DOI 10.1016/j.ajhg.2019.03.010
   Ormel PR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06684-2
   Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003
   Pandya H, 2017, NAT NEUROSCI, V20, P753, DOI 10.1038/nn.4534
   Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]
   Poduri A, 2012, NEURON, V74, P41, DOI 10.1016/j.neuron.2012.03.010
   Pollen AA, 2019, CELL, V176, P743, DOI 10.1016/j.cell.2019.01.017
   Qi YC, 2017, NAT BIOTECHNOL, V35, P154, DOI 10.1038/nbt.3777
   Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032
   Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047
   Raja WK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161969
   RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425
   Riviere JB, 2012, NAT GENET, V44, P934, DOI 10.1038/ng.2331
   Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896
   Sato T, 2013, SCIENCE, V340, P1190, DOI 10.1126/science.1234852
   Sloan SA, 2018, NAT PROTOC, V13, P2062, DOI 10.1038/s41596-018-0032-7
   Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035
   Srikanth P, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0122-x
   Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707
   Suzuki IK, 2018, CELL, V173, P1370, DOI 10.1016/j.cell.2018.03.067
   Takata K, 2017, IMMUNITY, V47, P183, DOI 10.1016/j.immuni.2017.06.017
   Tchieu J, 2019, NAT BIOTECHNOL, V37, P267, DOI 10.1038/s41587-019-0035-0
   Velasco S, 2019, NATURE, V570, P523, DOI 10.1038/s41586-019-1289-x
   Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7
   Watanabe M, 2017, CELL REP, V21, P517, DOI 10.1016/j.celrep.2017.09.047
   Wimmer RA, 2019, NATURE, V565, P505, DOI 10.1038/s41586-018-0858-8
   Xiang YF, 2019, CELL STEM CELL, V24, P487, DOI 10.1016/j.stem.2018.12.015
   Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007
   Xu M, 2016, NAT MED, V22, P1101, DOI 10.1038/nm.4184
   Yang N, 2017, NAT METHODS, V14, P621, DOI [10.1038/nmeth.4291, 10.1038/NMETH.4291]
   Yang N, 2013, NAT BIOTECHNOL, V31, P434, DOI 10.1038/nbt.2564
   Ye F, 2017, NEURON, V96, P1041, DOI 10.1016/j.neuron.2017.10.010
   Yoon SJ, 2019, NAT METHODS, V16, P75, DOI 10.1038/s41592-018-0255-0
   Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129
   Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029
   Zheng W, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00239
   Zhou T, 2017, CELL STEM CELL, V21, P274, DOI 10.1016/j.stem.2017.06.017
   Zhu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054552
NR 96
TC 2
Z9 2
U1 14
U2 14
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 5
PY 2020
VL 40
IS 6
BP 1186
EP 1193
DI 10.1523/JNEUROSCI.0519-19.2019
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA KK6WS
UT WOS:000512880800002
PM 32024767
DA 2020-07-08
ER

PT J
AU Gahlaut, SK
   Savargaonkar, D
   Sharan, C
   Yadav, S
   Mishra, P
   Singh, JP
AF Gahlaut, S. K.
   Savargaonkar, D.
   Sharan, C.
   Yadav, Sarjana
   Mishra, P.
   Singh, J. P.
TI SERS Platform for Dengue Diagnosis from Clinical Samples Employing a
   Hand Held Raman Spectrometer
SO ANALYTICAL CHEMISTRY
LA English
DT Article
ID SURFACE-ENHANCED RAMAN; NONSTRUCTURAL PROTEIN NS1; GLANCING ANGLE
   DEPOSITION; SCULPTURED THIN-FILMS; E. COLI; IMMUNOASSAY; FABRICATION;
   CORRELATE; CELLS; ZIKA
AB Dengue is a serious global health concern especially in tropical and subtropical countries. About 2.5 billion of the world's population is at risk for dengue infection. Early diagnosis is the key to prevent the deterioration of health of the patient to severe illness. Laboratory diagnosis of dengue is essential for providing appropriate supportive treatment to dengue patients with febrile illness, which is difficult to diagnose clinically. Here, we demonstrate surface enhanced Raman scattering (SERS) based diagnosis of dengue virus in clinical blood samples collected from total of 102 subjects. All of the samples were well characterized by conventional NS1 antigen and IgM antibody ELISA kits. The silver nanorods array fabricated by glancing angle deposition technique were employed as SERS substrates. A small amount of patient blood serum (5 mu L) was taken for analysis and the report was prepared within a minute. SERS spectra of pure NS1 protein as well as spiked in serum was also recorded separately. Principal component analysis (PCA) was employed as the statistical tool to differentiate dengue positive, dengue negative, and healthy subjects on the basis of their respective SERS spectra. This method provides a sensitive, rapid, and field deployable diagnosis of dengue at the early stage (within 5 days of the onset of symptoms).
C1 [Gahlaut, S. K.; Sharan, C.; Yadav, Sarjana; Mishra, P.; Singh, J. P.] Indian Inst Technol Delhi, New Delhi, India.
   [Savargaonkar, D.] ICMR Natl Inst Malaria Res, Dwarka, India.
RP Singh, JP (corresponding author), Indian Inst Technol Delhi, New Delhi, India.
EM jpsingh@physics.iitd.ac.in
OI Singh, Jitendra Pratap/0000-0001-8145-0561; GAHLAUT, SHASHANK
   K./0000-0002-0956-8810
FU IMPRINT India, Govt. of India [6695]; Department of Science and
   Technology, Govt. of IndiaDepartment of Science & Technology (India);
   ICMR-National Institute of Virology
FX The authors acknowledge project IMPRINT India (project no. 6695), Govt.
   of India for financial support and nanoscale research facility (NRF) IIT
   Delhi for providing characterization facilities. The author (S.K.G.)
   acknowledges the Department of Science and Technology, Govt. of India
   for providing INSPIRE fellowship. We are thankful to the director of
   ICMR-NIMR for providing laboratory facilities. The support in the form
   of IgM ELISA kits by ICMR-National Institute of Virology is also
   gratefully acknowledged. The study was approved by the Institutional
   Ethics Committee of ICMRNIMR Written informed consent was obtained from
   the healthy volunteers. Ethics committee approval was obtained to use
   anonymized dengue positive and negative samples for the study.
CR Almond LM, 2014, GASTROINTEST ENDOSC, V79, P37, DOI 10.1016/j.gie.2013.05.028
   Amin A, 2017, J RAMAN SPECTROSC, V48, P705, DOI 10.1002/jrs.5110
   Amorim JH, 2014, VIRUS RES, V181, P53, DOI 10.1016/j.virusres.2014.01.001
   [Anonymous], 2014, NATL GUIDELINES CLIN
   [Anonymous], 2009, SPEC PROGRAM RES TRA, P147
   Bilal M, 2016, LASER PHYS LETT, V13, DOI 10.1088/1612-2011/13/9/095603
   Blacksell SD, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/151967
   Camacho SA, 2018, ACS SENSORS, V3, P587, DOI 10.1021/acssensors.7b00639
   Chaney SB, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1988980
   Chen FN, 2016, NANOMED-NANOTECHNOL, V12, P1445, DOI 10.1016/j.nano.2016.03.001
   Chen J, 2014, SENSOR ACTUAT B-CHEM, V191, P485, DOI 10.1016/j.snb.2013.10.038
   Flamand M, 1999, J VIROL, V73, P6104, DOI 10.1128/JVI.73.7.6104-6110.1999
   Gahlaut SK, 2019, BIOSENS BIOELECTRON, V126, P478, DOI 10.1016/j.bios.2018.11.025
   Gahlaut SK, 2017, ANAL CHEM, V89, P13582, DOI 10.1021/acs.analchem.7b04064
   Ganeshkumar P, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006618
   Goel P, 2015, ACS APPL MATER INTER, V7, P8419, DOI 10.1021/acsami.5b01530
   Guzman MG, 2015, LANCET, V385, P453, DOI 10.1016/S0140-6736(14)60572-9
   Hawkeye MM, 2014, WILEY SER MATER ELEC, DOI 10.1002/9781118847510
   Hawkeye MM, 2007, J VAC SCI TECHNOL A, V25, P1317, DOI 10.1116/1.2764082
   Huh YS, 2009, LAB CHIP, V9, P433, DOI 10.1039/b809702j
   Jacobs MG, 2000, FASEB J, V14, P1603, DOI 10.1096/fj.14.11.1603
   Karabacak T, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.125408
   Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667
   Kumar S, 2015, CHEM COMMUN, V51, P12411, DOI 10.1039/c5cc03604f
   Le Ru EC, 2007, J PHYS CHEM C, V111, P13794, DOI 10.1021/jp0687908
   Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813
   Liu YJ, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075436
   MONATH TP, 1994, P NATL ACAD SCI USA, V91, P2395, DOI 10.1073/pnas.91.7.2395
   Morchang A, 2011, VIRUS RES, V156, P25, DOI 10.1016/j.virusres.2010.12.012
   Ngo HT, 2014, ANALYST, V139, P5655, DOI [10.1039/c4an01077a, 10.1039/C4AN01077A]
   Pasteur S., 2018, DENGVAXIA PROTECTIVE
   Paul AM, 2015, J PHYS CHEM C, V119, P23669, DOI 10.1021/acs.jpcc.5b07387
   Premasiri WR, 2005, J PHYS CHEM B, V109, P312, DOI 10.1021/jp040442n
   Reddy MN, 2017, PEERJ, V5, DOI 10.7717/peerj.2970
   Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7
   Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562
   Sanchez-Purra M, 2017, ACS INFECT DIS, V3, P767, DOI 10.1021/acsinfecdis.7b00110
   Savargaonkar D, 2018, INT J INFECT DIS, V74, P41, DOI 10.1016/j.ijid.2018.06.020
   Shanmukh S, 2006, NANO LETT, V6, P2630, DOI 10.1021/nl061666f
   Singh JP, 2012, J PHYS CHEM C, V116, P20550, DOI 10.1021/jp305061s
   Singh JP, 2012, NANOSCALE, V4, P3410, DOI 10.1039/c2nr00020b
   Singh MP, 2010, J CLIN MICROBIOL, V48, P4688, DOI 10.1128/JCM.01668-10
   Sinha SS, 2016, ACCOUNTS CHEM RES, V49, P2725, DOI 10.1021/acs.accounts.6b00384
   Song CY, 2016, NANOSCALE, V8, P17365, DOI 10.1039/c6nr05504d
   Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820
   Srivastava SK, 2015, ANALYST, V140, P3201, DOI 10.1039/c5an00209e
   Srivastava SK, 2014, SMALL, V10, P3579, DOI 10.1002/smll.201303218
   Wang SM, 2010, AM J TROP MED HYG, V83, P690, DOI 10.4269/ajtmh.2010.10-0117
   Watanabe S, 2012, J VIROL, V86, P5508, DOI 10.1128/JVI.07081-11
   World Health Organisation, 2018, WORLD HLTH STAT MON
   Xu H, 2006, J CLIN MICROBIOL, V44, P2872, DOI 10.1128/JCM.00777-06
   Zhao YP, 2006, J PHYS CHEM B, V110, P3153, DOI 10.1021/jp057406o
NR 52
TC 0
Z9 0
U1 63
U2 63
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0003-2700
EI 1520-6882
J9 ANAL CHEM
JI Anal. Chem.
PD FEB 4
PY 2020
VL 92
IS 3
BP 2527
EP 2534
DI 10.1021/acs.analchem.9b04129
PG 8
WC Chemistry, Analytical
SC Chemistry
GA KI7DF
UT WOS:000511509400025
PM 31909593
DA 2020-07-08
ER

PT J
AU Jackson, NAC
   Kester, KE
   Casimiro, D
   Gurunathan, S
   DeRosa, F
AF Jackson, Nicholas A. C.
   Kester, Kent E.
   Casimiro, Danilo
   Gurunathan, Sanjay
   DeRosa, Frank
TI The promise of mRNA vaccines: a biotech and industrial perspective
SO NPJ VACCINES
LA English
DT Review
ID CAP ANALOGS; TRANSLATIONAL EFFICIENCY; PROTECTIVE EFFICACY; ZIKA VIRUS;
   IN-VIVO; RIG-I; IMMUNOGENICITY; SELF; DELIVERY; PROTEIN
AB mRNA technologies have the potential to transform areas of medicine, including the prophylaxis of infectious diseases. The advantages for vaccines range from the acceleration of immunogen discovery to rapid response and multiple disease target manufacturing. A greater understanding of quality attributes that dictate translation efficiency, as well as a comprehensive appreciation of the importance of mRNA delivery, are influencing a new era of investment in development activities. The application of translational sciences and growing early-phase clinical experience continue to inform candidate vaccine selection. Here we review the state of the art for the prevention of infectious diseases by using mRNA and pertinent topics to the biotechnology and pharmaceutical industries.
C1 [Jackson, Nicholas A. C.] Coalit Epidem Preparedness Innovat CEPI, Gibbs Bldg,215 Euston Rd, London NW1 2BE, England.
   [Kester, Kent E.; Casimiro, Danilo; Gurunathan, Sanjay] Sanofi Pasteur, 1 Discovery Dr, Swiftwater, PA 18370 USA.
   [DeRosa, Frank] Translate Bio, 29 Hartwell Ave, Lexington, MA 02421 USA.
RP Jackson, NAC (corresponding author), Coalit Epidem Preparedness Innovat CEPI, Gibbs Bldg,215 Euston Rd, London NW1 2BE, England.
EM nick.jackson@cepi.net
RI Kester, Kent/AAF-8235-2020
OI Kester, Kent/0000-0002-5056-0802
CR Feldman RA, 2019, VACCINE, V37, P3326, DOI 10.1016/j.vaccine.2019.04.074
   Alberer M, 2017, LANCET, V390, P1511, DOI 10.1016/S0140-6736(17)31665-3
   An D, 2017, CELL REP, V21, P3548, DOI 10.1016/j.celrep.2017.11.081
   Anderson BR, 2010, NUCLEIC ACIDS RES, V38, P5884, DOI 10.1093/nar/gkq347
   Andries O, 2015, J CONTROL RELEASE, V217, P337, DOI 10.1016/j.jconrel.2015.08.051
   [Anonymous], 2019, MOD 2Q 2019 REP
   Asrani KH, 2018, RNA BIOL, V15, P914, DOI 10.1080/15476286.2018.1475178
   Bahl K, 2017, MOL THER, V25, P1316, DOI 10.1016/j.ymthe.2017.03.035
   Cheng WF, 2001, J VIROL, V75, P2368, DOI 10.1128/JVI.75.5.2368-2376.2001
   Cooper MM, 2019, EXPERT REV VACCINES, V18, P241, DOI 10.1080/14760584.2019.1580577
   DeRosa F, 2016, GENE THER, V23, P699, DOI 10.1038/gt.2016.46
   DeRosa F, 2019, MOL THER, V27, P878, DOI 10.1016/j.ymthe.2019.03.001
   Devarkar SC, 2016, P NATL ACAD SCI USA, V113, P596, DOI 10.1073/pnas.1515152113
   Durymanov M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00971
   *EMEA, 2005, EMEACHMPVEG134716200
   Fenton OS, 2016, ADV MATER, V28, P2939, DOI 10.1002/adma.201505822
   Food and Drug Administration, 2007, FR, V70, P22664
   Goldstrohm AC, 2008, NAT REV MOL CELL BIO, V9, P337, DOI 10.1038/nrm2370
   Grudzien E, 2004, RNA, V10, P1479, DOI 10.1261/rna.7380904
   Grudzien-Nogalska E, 2007, METHOD ENZYMOL, V431, P203, DOI 10.1016/S0076-6879(07)31011-2
   Grudzien-Nogalska E, 2007, RNA, V13, P1745, DOI 10.1261/rna.701307
   Habjan M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003663
   Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019
   Jagger BW, 2019, J INFECT DIS, V220, P1577, DOI 10.1093/infdis/jiz338
   John S, 2018, VACCINE, V36, P1689, DOI 10.1016/j.vaccine.2018.01.029
   Kallen KJ, 2013, HUM VACC IMMUNOTHER, V9, P2263, DOI 10.4161/hv.25181
   Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695
   Kauffman KJ, 2016, BIOMATERIALS, V109, P78, DOI 10.1016/j.biomaterials.2016.09.006
   Kauffman KJ, 2015, NANO LETT, V15, P7300, DOI 10.1021/acs.nanolett.5b02497
   Kore AR, 2009, J AM CHEM SOC, V131, P6364, DOI 10.1021/ja901655p
   Kose N, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw6647
   Kowalski PS, 2019, MOL THER, V27, P710, DOI 10.1016/j.ymthe.2019.02.012
   Kudla G, 2006, PLOS BIOL, V4, P933, DOI 10.1371/journal.pbio.0040180
   Lassig C, 2017, J BIOL CHEM, V292, P9000, DOI 10.1074/jbc.R117.788398
   Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103
   Li B, 2019, WIRES NANOMED NANOBI, V11, DOI 10.1002/wnan.1530
   Lima SA, 2017, NAT STRUCT MOL BIOL, V24, P1057, DOI 10.1038/nsmb.3499
   Ljungberg K, 2015, EXPERT REV VACCINES, V14, P177, DOI 10.1586/14760584.2015.965690
   Lutz J, 2017, NPJ VACCINES, V2, DOI 10.1038/s41541-017-0032-6
   MARTIN SA, 1975, J BIOL CHEM, V250, P9330
   Maruggi G, 2019, MOL THER, V27, P757, DOI 10.1016/j.ymthe.2019.01.020
   Midoux P, 2015, EXPERT REV VACCINES, V14, P221, DOI 10.1586/14760584.2015.986104
   MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783
   Moderna Inc, 2019, EXH 99 3
   Monk KWC, 1997, BIOPHYS J, V73, P2534, DOI 10.1016/S0006-3495(97)78282-1
   Pardi N, 2018, J EXP MED, V215, P1571, DOI 10.1084/jem.20171450
   Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243
   Pardi N, 2017, NATURE, V543, P248, DOI 10.1038/nature21428
   Petsch B, 2012, NAT BIOTECHNOL, V30, P1210, DOI 10.1038/nbt.2436
   Potapov V, 2018, NUCLEIC ACIDS RES, V46, P5753, DOI 10.1093/nar/gky341
   Presnyak V, 2015, CELL, V160, P1111, DOI 10.1016/j.cell.2015.02.029
   Ramani S, 2018, CURR OPIN VIROL, V29, P79, DOI 10.1016/j.coviro.2018.04.001
   Rong MQ, 1998, P NATL ACAD SCI USA, V95, P515, DOI 10.1073/pnas.95.2.515
   Rydzik AM, 2017, NUCLEIC ACIDS RES, V45, P8661, DOI 10.1093/nar/gkx569
   Sabnis S, 2018, MOL THER, V26, P1509, DOI 10.1016/j.ymthe.2018.03.010
   Sharma M, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7030089
   Shaw C, 2019, INT J INFECT DIS, V79, P17, DOI 10.1016/j.ijid.2018.11.058
   Stanton MG, 2018, NUCLEIC ACID THER, V28, P158, DOI 10.1089/nat.2018.0726
   Stepinski J, 2001, RNA, V7, P1486
   Swaminathan G, 2016, VACCINE, V34, P110, DOI 10.1016/j.vaccine.2015.10.132
   Tanguay RL, 1996, MOL CELL BIOL, V16, P146
   Tatematsu M, 2018, J INNATE IMMUN, V10, P398, DOI 10.1159/000494034
   Thess A, 2015, MOL THER, V23, P1456, DOI 10.1038/mt.2015.103
   TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298
   Tsui NBY, 2002, CLIN CHEM, V48, P1647
   von Niessen AGO, 2019, MOL THER, V27, P824, DOI 10.1016/j.ymthe.2018.12.011
   Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024
   Weide B, 2008, J IMMUNOTHER, V31, P180, DOI 10.1097/CJI.0b013e31815ce501
   Weissman D., 2012, METHODS MOL BIOL MET, V969, P43
   Wu M, 2018, 6 INT MRNA INTERPLAN
   Xu XX, 2018, PROTEIN CELL, V9, P246, DOI 10.1007/s13238-017-0431-5
   Zust R, 2011, NAT IMMUNOL, V12, P137, DOI 10.1038/ni.1979
NR 72
TC 2
Z9 2
U1 11
U2 11
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2059-0105
J9 NPJ VACCINES
JI npj Vaccines
PD FEB 4
PY 2020
VL 5
IS 1
AR 11
DI 10.1038/s41541-020-0159-8
PG 6
WC Immunology; Medicine, Research & Experimental
SC Immunology; Research & Experimental Medicine
GA KH7VP
UT WOS:000510858100001
PM 32047656
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Qu, PK
   Zhang, C
   Li, M
   Ma, WM
   Xiong, P
   Liu, QW
   Zou, G
   Lavillette, D
   Yin, FF
   Jin, X
   Huang, Z
AF Qu, Panke
   Zhang, Chao
   Li, Min
   Ma, Weimin
   Xiong, Pei
   Liu, Qingwei
   Zou, Gang
   Lavillette, Dimitri
   Yin, Feifei
   Jin, Xia
   Huang, Zhong
TI A new class of broadly neutralizing antibodies that target the glycan
   loop of Zika virus envelope protein
SO CELL DISCOVERY
LA English
DT Article
ID DENGUE VIRUS; MONOCLONAL-ANTIBODIES; DEPENDENT ENHANCEMENT;
   CROSS-REACTIVITY; STRUCTURAL BASIS; INFECTION; DISEASE; IDENTIFICATION;
   REPLICATION; OUTBREAK
AB Zika virus (ZIKV) infection poses a serious threat to human health. However, no licensed vaccine or therapeutic drug is currently available for ZIKV. We have previously shown that recombinant ZIKV E80 protein induced potent neutralizing antibody response and protected mice from lethal viral challenge. In the present study, we isolated five ZIKV neutralizing monoclonal antibodies (mAbs) from E80-immunized mice. These five mAbs specifically bound and neutralized Asian-lineage ZIKV strains. Epitope mapping revealed that all of the five mAbs recognized a novel linear epitope located on the glycan loop of E protein domain I. Sequence alignment revealed that the epitope was extremely conserved in ZIKV but highly variable between ZIKV and other flaviviruses. Thus, these five mAbs form a new class of anti-ZIKV antibodies exhibiting broad-spectrum neutralization on Asian-lineage ZIKV. A representative of this mAb class, 5F8, was found to exert inhibitory function in vitro primarily at the early stage of the post-attachment viral entry process. Importantly, mAb 5F8 was able to confer full protection in a mouse model of ZIKV lethal infection. Our results have strong implications for developing anti-ZIKV vaccines and therapeutic mAbs.
C1 [Qu, Panke; Zhang, Chao; Li, Min; Ma, Weimin; Xiong, Pei; Liu, Qingwei; Zou, Gang; Lavillette, Dimitri; Jin, Xia; Huang, Zhong] Chinese Acad Sci, Univ Chinese Acad Sci, Ctr Biosafety Mega Sci, Inst Pasteur Shanghai,CAS Key Lab Mol Virol & Imm, Shanghai 200031, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Univ Hong Kong Joint Lab Trop Infect Dis, Haikou 571101, Hainan, Peoples R China.
   [Yin, Feifei] Hainan Med Univ, Dept Minist Educ, Key Lab Translat Med Trop Dis, Haikou 571101, Hainan, Peoples R China.
RP Jin, X; Huang, Z (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Ctr Biosafety Mega Sci, Inst Pasteur Shanghai,CAS Key Lab Mol Virol & Imm, Shanghai 200031, Peoples R China.; Yin, FF (corresponding author), Hainan Med Univ, Univ Hong Kong Joint Lab Trop Infect Dis, Haikou 571101, Hainan, Peoples R China.
EM yinfeifeiff@163.com; xjin@ips.ac.cn; huangzhong@ips.ac.cn
FU Chinese Ministry of Science and Technology for EU-China
   Inter-governmental S&T Cooperation program [2016YFE0133500]; Chinese
   Academy of SciencesChinese Academy of Sciences [XDB29040300,
   153831KYSB20170043]; National Major R&D Program of China
   [2016YFC1201000]; European Union Horizon 2020 Research and Innovation
   program [734548]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81860367]; Key Research and
   Development Plan of Hainan Province, Ministry of Science and Technology
   [ZDYF2017091]; Higher Educational Scientific Research Project of Hainan
   Province, the Ministry of Education [Hnky2017ZD-16]
FX This study was supported by a grant (2016YFE0133500) from the Chinese
   Ministry of Science and Technology for EU-China Inter-governmental S&T
   Cooperation program, grants (XDB29040300 and 153831KYSB20170043) from
   the Chinese Academy of Sciences, a grant (2016YFC1201000) from the
   National Major R&D Program of China, a grant (ZIKAlliance Grant
   Agreement 734548) from the European Union Horizon 2020 Research and
   Innovation program, a grant (81860367) from the National Natural Science
   Foundation of China, a grant (no. ZDYF2017091) from the Key Research and
   Development Plan of Hainan Province, Ministry of Science and Technology,
   and a grant (no. Hnky2017ZD-16) from the Higher Educational Scientific
   Research Project of Hainan Province, the Ministry of Education. We thank
   the Microorganisms & Viruses Culture Collection Center, Wuhan Institute
   of Virology, Chinese Academy of Sciences, for providing the ZIKV strain
   SZ-WIV01.
CR Aliota MT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005168
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   Calvet G, 2016, LANCET INFECT DIS, V16, P653, DOI 10.1016/S1473-3099(16)00095-5
   Cao-Lormeau VM, 2016, LANCET, V387, P1531, DOI 10.1016/S0140-6736(16)00562-6
   Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6
   Cordeiro MT, 2016, LANCET, V387, P1811, DOI 10.1016/S0140-6736(16)30253-7
   Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515
   Deng YQ, 2016, SCI CHINA LIFE SCI, V59, P428, DOI 10.1007/s11427-016-5043-4
   DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4
   Dowd KA, 2011, VIROLOGY, V411, P306, DOI 10.1016/j.virol.2010.12.020
   Duffy MR, 2009, NEW ENGL J MED, V360, P2536, DOI 10.1056/NEJMoa0805715
   Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9
   Fernandez E, 2017, CURR OPIN VIROL, V23, P59, DOI 10.1016/j.coviro.2017.03.006
   Goo L, 2018, VIROLOGY, V515, P191, DOI 10.1016/j.virol.2017.12.032
   Halstead SB, 2010, LANCET INFECT DIS, V10, P712, DOI 10.1016/S1473-3099(10)70166-3
   Hasan SS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14722
   Kawiecki AB, 2016, J INFECT DIS, V214, P1357, DOI 10.1093/infdis/jiw377
   Kindhauser MK, 2016, B WORLD HEALTH ORGAN, V94, P675, DOI 10.2471/BLT.16.171082
   Knipe D.M., 2013, FIELDS VIROLOGY
   Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994
   Ku ZQ, 2015, J VIROL, V89, P12084, DOI 10.1128/JVI.02189-15
   Ku ZQ, 2012, J VIROL METHODS, V186, P193, DOI 10.1016/j.jviromet.2012.06.025
   Ladhani SN, 2016, ARCH DIS CHILD, V101, P600, DOI 10.1136/archdischild-2016-310590
   Li C, 2016, CELL STEM CELL, V19, P120, DOI 10.1016/j.stem.2016.04.017
   Long F, 2019, P NATL ACAD SCI USA, V116, P1591, DOI 10.1073/pnas.1815432116
   MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1
   Miner JJ, 2016, CELL, V165, P1080, DOI 10.1016/j.cell.2016.05.008
   Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651
   Modis Y, 2003, P NATL ACAD SCI USA, V100, P6986, DOI 10.1073/pnas.0832193100
   Posen HJ, 2016, BMJ GLOB HEALTH, V1, DOI 10.1136/bmjgh-2016-000087
   Priyamvada L, 2016, P NATL ACAD SCI USA, V113, P7852, DOI 10.1073/pnas.1607931113
   Qu PK, 2018, ANTIVIR RES, V154, P97, DOI 10.1016/j.antiviral.2018.04.010
   REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Shi JP, 2013, VACCINE, V31, P2130, DOI 10.1016/j.vaccine.2013.02.051
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505
   Waldorf KMA, 2016, NAT MED, V22, P1256, DOI 10.1038/nm.4193
   Wang QH, 2017, J VIROL, V91, DOI 10.1128/JVI.01049-17
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wang S, 2017, CELL RES, V27, P158, DOI 10.1038/cr.2016.144
   Ye XH, 2014, J VIROL, V88, P72, DOI 10.1128/JVI.01848-13
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
   Zou G, 2011, J BIOL CHEM, V286, P14362, DOI 10.1074/jbc.M110.214189
NR 49
TC 0
Z9 0
U1 2
U2 2
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 2056-5968
J9 CELL DISCOV
JI Cell Discov.
PD FEB 4
PY 2020
VL 6
IS 1
AR 5
DI 10.1038/s41421-019-0140-8
PG 14
WC Cell Biology
SC Cell Biology
GA KH8MK
UT WOS:000510904600001
PM 32025335
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Oliveira, JF
   Rodrigues, MS
   Skalinski, LM
   Santos, AES
   Costa, LC
   Cardim, LL
   Paixao, ES
   Costa, MDN
   Oliveira, WK
   Barreto, ML
   Teixeira, MG
   Andrade, RFS
AF Oliveira, Juliane F.
   Rodrigues, Moreno S.
   Skalinski, Lacita M.
   Santos, Aline E. S.
   Costa, Larissa C.
   Cardim, Luciana L.
   Paixao, Enny S.
   Costa, Maria da Conceicao N.
   Oliveira, Wanderson K.
   Barreto, Mauricio L.
   Teixeira, Maria Gloria
   Andrade, Roberto F. S.
TI Interdependence between confirmed and discarded cases of dengue,
   chikungunya and Zika viruses in Brazil: A multivariate time-series
   analysis
SO PLOS ONE
LA English
DT Article
AB The co-circulation of different arboviruses in the same time and space poses a significant threat to public health given their rapid geographic dispersion and serious health, social, and economic impact. Therefore, it is crucial to have high quality of case registration to estimate the real impact of each arboviruses in the population. In this work, a Vector Autoregressive (VAR) model was developed to investigate the interrelationships between discarded and confirmed cases of dengue, chikungunya, and Zika in Brazil. We used data from the Brazilian National Notifiable Diseases Information System (SINAN) from 2010 to 2017. There were three peaks in the series of dengue notification in this period occurring in 2013, 2015 and in 2016. The series of reported cases of both Zika and chikungunya reached their peak in late 2015 and early 2016. The VAR model shows that the Zika series have a significant impact on the dengue series and vice versa, suggesting that several discarded and confirmed cases of dengue could actually have been cases of Zika. The model also suggests that the series of confirmed and discarded chikungunya cases are almost independent of the cases of Zika, however, affecting the series of dengue. In conclusion, co-circulation of arboviruses with similar symptoms could have lead to misdiagnosed diseases in the surveillance system. We argue that the routinely use of mathematical and statistical models in association with traditional symptom-surveillance could help to decrease such errors and to provide early indication of possible future outbreaks. These findings address the challenges regarding notification biases and shed new light on how to handle reported cases based only in clinical-epidemiological criteria when multiples arboviruses co-circulate in the same population.
C1 [Oliveira, Juliane F.; Rodrigues, Moreno S.; Costa, Larissa C.; Cardim, Luciana L.; Paixao, Enny S.; Barreto, Mauricio L.; Andrade, Roberto F. S.] Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.
   [Oliveira, Juliane F.] Univ Porto CMUP, Dept Math, Ctr Math, Porto, Portugal.
   [Rodrigues, Moreno S.] Fundacao Oswaldo Cruz, Porto Velho, Rondonia, Brazil.
   [Skalinski, Lacita M.] Univ Estadual Santa Cruz, Ilheus, BA, Brazil.
   [Skalinski, Lacita M.; Santos, Aline E. S.; Costa, Maria da Conceicao N.; Barreto, Mauricio L.; Teixeira, Maria Gloria] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.
   [Paixao, Enny S.] London Sch Hyg & Trop Med, London, England.
   [Oliveira, Wanderson K.] Minist Saude, Secretaria Vigilancia Saude, Brasilia, DF, Brazil.
   [Andrade, Roberto F. S.] Univ Fed Bahia, Inst Fis, Salvador, BA, Brazil.
RP Oliveira, JF (corresponding author), Fundacao Oswaldo Cruz, Inst Goncalo Moniz, Ctr Data & Knowledge Integrat Hlth CIDACS, Salvador, BA, Brazil.; Oliveira, JF (corresponding author), Univ Porto CMUP, Dept Math, Ctr Math, Porto, Portugal.
EM julianlanzin@gmail.com
RI L. Barreto, Mauricio/B-1752-2008; Fonseca de Oliveira,
   Juliane/W-6438-2018
OI L. Barreto, Mauricio/0000-0002-0215-4930; Fonseca de Oliveira,
   Juliane/0000-0002-7167-8754; Rodrigues, Moreno/0000-0002-1594-2311
FU Center of Data and Knowledge Integration for Health (CIDACS) through
   theZika Platform-a long-term surveillance platform for the Zika virus
   and microcephaly, Unified Health System (SUS) - Brazilian Ministry of
   Health; Wellcome TrustWellcome Trust [213589/Z/18/Z]
FX This work is supported by the Center of Data and Knowledge Integration
   for Health (CIDACS) through the Zika Platform-a long-term surveillance
   platform for the Zika virus and microcephaly, Unified Health System
   (SUS) - Brazilian Ministry of Health. ESP is funded by the Wellcome
   Trust (grant number 213589/Z/18/Z) The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR [Anonymous], 2010, 9 PYTH SCI C
   Barbosa JR, 2015, EPIDEMIOL SERV SAUDE, V24, P49, DOI 10.5123/S1679-49742015000100006
   BRASIL. Ministerio da Saude. Secretaria de Vigilancia em Saude, GUIA VIG EP
   Campos GS, 2015, EMERG INFECT DIS, V21, P1885, DOI 10.3201/eid2110.150847
   de Oliveira WK, 2017, LANCET, V390, P861, DOI 10.1016/S0140-6736(17)31368-5
   Diggle P., 1990, TIME SERIES BIOSTATI
   Donalisio MR, 2017, REV SAUDE PUBL, V51, DOI [10.1590/S1518-8787.2017051006889, 10.1590/s1518-8787.2017051006889]
   Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008
   Lutkepohl H., 2005, NEW INTRO MULTIPLE T
   Nimmannitya S, 1969, AM J TROPICAL MED HY
   Oliveira JF, MULTIVARIATE TIME SE
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Ribeiro GS, 2018, LANCET GLOB HEALTH, V6, pE140, DOI 10.1016/S2214-109X(17)30496-5
   Siggiridou E, 2016, IEEE T SIGNAL PROCES, V64, P1759, DOI 10.1109/TSP.2015.2500893
   Silva MM, 2018, CONCOMITANT TRANSMIS
   Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496
   Teixeira MG, 2015, EMERG INFECT DIS, V21, P906, DOI 10.3201/eid2105.141727
   Waggoner JJ, 2016, CLIN INFECT DIS
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Helth Organization, GLOB STRAT DENG PREV
NR 20
TC 0
Z9 0
U1 2
U2 2
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD FEB 3
PY 2020
VL 15
IS 2
AR e0228347
DI 10.1371/journal.pone.0228347
PG 13
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA LP9DJ
UT WOS:000534615800031
PM 32012191
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Ci, YL
   Liu, ZY
   Zhang, NN
   Niu, YQ
   Yang, Y
   Xu, CM
   Yang, W
   Qin, CF
   Shi, L
AF Ci, Yali
   Liu, Zhong-Yu
   Zhang, Na-Na
   Niu, Yuqiang
   Yang, Yang
   Xu, Caimin
   Yang, Wei
   Qin, Cheng-Feng
   Shi, Lei
TI Zika NS1-induced ER remodeling is essential for viral replication
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID NONSTRUCTURAL PROTEINS NS1; TERMINAL AMPHIPATHIC HELIX; DENGUE VIRUS;
   MEMBRANE ASSOCIATION; ACTIVATION; SYNAPTOTAGMIN; ORGANELLES; CURVATURE;
   MUTATION; NS4A
AB Zika virus (ZIKV), a recently emerged member of the flavivirus family, forms replication compartments at the ER during its lifecycle. The proteins that are responsible for the biogenesis of replication compartments are not well defined. Here, we show that Zika nonstructural protein 1 (NS1)-induced ER remodeling is essential for viral replication. NS1 expressed in the ER lumen induced ER perinuclear aggregation with an ultrastructure resembling that of the replication compartment. Data from model membrane system indicated that the membrane-binding and membrane-remodeling properties of NS1 depend on its hydrophobic insertion into the membrane. These findings demonstrate that NS1 plays a crucial role in flavivirus replication compartment formation by remodeling the ER structure.
C1 [Ci, Yali; Yang, Yang; Xu, Caimin; Shi, Lei] Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Peoples R China.
   [Ci, Yali; Yang, Yang; Xu, Caimin; Shi, Lei] Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China.
   [Ci, Yali; Yang, Yang; Xu, Caimin; Shi, Lei] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Biochem & Mol Biol, Beijing, Peoples R China.
   [Liu, Zhong-Yu] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Guangzhou, Peoples R China.
   [Liu, Zhong-Yu; Zhang, Na-Na; Qin, Cheng-Feng] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.
   [Niu, Yuqiang; Yang, Wei] Chinese Acad Med Sci, Inst Pathogen Biol, Beijing, Peoples R China.
   [Qin, Cheng-Feng] First Hosp Jilin Univ, Changchun, Peoples R China.
RP Shi, L (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, State Key Lab Med Mol Biol, Beijing, Peoples R China.; Shi, L (corresponding author), Peking Union Med Coll, Sch Basic Med, Beijing, Peoples R China.; Qin, CF (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.; Yang, W (corresponding author), Chinese Acad Med Sci, Inst Pathogen Biol, Beijing, Peoples R China.; Qin, CF (corresponding author), First Hosp Jilin Univ, Changchun, Peoples R China.
EM wyang@ipb.pumc.edu.cn; qincf@bmi.ac.cn; shilei@ibms.pumc.edu.cn
OI Qin, Cheng-Feng/0000-0002-0632-2807; Shi, Lei/0000-0003-0752-1346
FU National Natural Science Foundation of ChinaNational Natural Science
   Foundation of China [81622028, 31470813, 81925003, 31770190]; 1000
   Talents Plan Youth program; Chinese Academy ofMedical Sciences
   Innovation Fund for Medical Sciences [2016-I2M-3-020]; Chinese Academy
   of Medical Sciences [2016ZX310192, 2016RC310037, 2016RC310031]
FX We appreciate funding from the National Natural Science Foundation of
   China (81622028 and 31470813 to L. Shi; 81925003 and 31770190 to C.F.
   Qin), the 1000 Talents Plan Youth program (to L. Shi), the Chinese
   Academy ofMedical Sciences Innovation Fund for Medical Sciences
   (2016-I2M-3-020), and the Chinese Academy of Medical Sciences
   (2016ZX310192, 2016RC310037, and 2016RC310031) to support the project.
CR Akey DL, 2014, SCIENCE, V343, P881, DOI 10.1126/science.1247749
   Aktepe TE, 2017, CELL REP, V21, P1639, DOI 10.1016/j.celrep.2017.10.055
   Apte-Sengupta S, 2014, CURR OPIN VIROL, V9, P134, DOI 10.1016/j.coviro.2014.09.020
   Belov GA, 2007, J VIROL, V81, P9259, DOI 10.1128/JVI.00840-07
   Berger N, 2001, INT J PHARM, V223, P55, DOI 10.1016/S0378-5173(01)00721-9
   Brown WC, 2016, NAT STRUCT MOL BIOL, V23, P865, DOI 10.1038/nsmb.3268
   CHAMBERS TJ, 1990, ANNU REV MICROBIOL, V44, P649, DOI 10.1146/annurev.mi.44.100190.003245
   Chen JC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005053
   CHO MW, 1994, VIROLOGY, V202, P129, DOI 10.1006/viro.1994.1329
   Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014
   den Boon JA, 2010, ANNU REV MICROBIOL, V64, P241, DOI 10.1146/annurev.micro.112408.134012
   Elazar M, 2004, J VIROL, V78, P11393, DOI 10.1128/JVI.78.20.11393-11400.2004
   Frost A, 2009, CELL, V137, P191, DOI 10.1016/j.cell.2009.04.010
   Fulton BO, 2017, J VIROL, V91, DOI 10.1128/JVI.00698-17
   Glasner DR, 2018, ANNU REV VIROL, V5, P227, DOI 10.1146/annurev-virology-101416-041848
   Gouttenoire J, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004501
   Gutsche I, 2011, P NATL ACAD SCI USA, V108, P8003, DOI 10.1073/pnas.1017338108
   Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050
   Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020
   Jarsch IK, 2016, J CELL BIOL, V214, P375, DOI 10.1083/jcb.201604003
   Li JQ, 2018, ANTIVIR RES, V150, P148, DOI 10.1016/j.antiviral.2017.12.017
   Lindenbach BD, 1999, J VIROL, V73, P4611, DOI 10.1128/JVI.73.6.4611-4621.1999
   Lindenbach BD, 1997, J VIROL, V71, P9608, DOI 10.1128/JVI.71.12.9608-9617.1997
   Liu Y, 2017, NATURE, V545, P482, DOI 10.1038/nature22365
   Liu ZY, 2017, J VIROL, V91, DOI [10.1128/jvi.00484-17, 10.1128/JVI.00484-17]
   Ma WQ, 2017, CELL, V168, P542, DOI 10.1016/j.cell.2017.01.009
   Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   Miller EA, 2010, CURR OPIN CELL BIOL, V22, P447, DOI 10.1016/j.ceb.2010.04.003
   Miller S, 2007, J BIOL CHEM, V282, P8873, DOI 10.1074/jbc.M609919200
   Muylaert IR, 1997, J VIROL, V71, P291, DOI 10.1128/JVI.71.1.291-298.1997
   Niepmann M, 2013, CURR TOP MICROBIOL, V369, P143, DOI 10.1007/978-3-642-27340-7_6
   Paul D, 2015, ANNU REV VIROL, V2, P289, DOI 10.1146/annurev-virology-100114-055007
   Paul D, 2014, CELL HOST MICROBE, V16, P569, DOI 10.1016/j.chom.2014.10.008
   Plaszczyca A, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007736
   Ravindran MS, 2016, NAT REV MICROBIOL, V14, P407, DOI 10.1038/nrmicro.2016.60
   Reiss S, 2011, CELL HOST MICROBE, V9, P32, DOI 10.1016/j.chom.2010.12.002
   Roosendaal J, 2006, J VIROL, V80, P4623, DOI 10.1128/JVI.80.9.4623-4632.2006
   Selisko B, 2014, CURR OPIN VIROL, V9, P74, DOI 10.1016/j.coviro.2014.09.011
   Shan C, 2016, CELL HOST MICROBE, V19, P891, DOI 10.1016/j.chom.2016.05.004
   Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016
   Stern O, 2013, J VIROL, V87, P4080, DOI 10.1128/JVI.01900-12
   Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016
   Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196
   Watterson D, 2016, ANTIVIR RES, V130, P7, DOI 10.1016/j.antiviral.2016.02.014
   Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007
   Wikan N, 2016, LANCET INFECT DIS, V16, pE119, DOI 10.1016/S1473-3099(16)30010-X
   Xu XY, 2016, EMBO J, V35, P2170, DOI 10.15252/embj.201695290
   Youn S, 2012, J VIROL, V86, P7360, DOI 10.1128/JVI.00157-12
   Yuan L, 2017, SCIENCE, V358, P933, DOI 10.1126/science.aam7120
NR 50
TC 1
Z9 1
U1 2
U2 2
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD FEB 3
PY 2020
VL 219
IS 2
DI 10.1083/jcb.201903062
PG 13
WC Cell Biology
SC Cell Biology
GA LD0PJ
UT WOS:000525735100005
PM 31868887
OA Bronze
DA 2020-07-08
ER

PT J
AU Wu, F
   Zhao, S
   Yu, B
   Chen, YM
   Wang, W
   Song, ZG
   Hu, Y
   Tao, ZW
   Tian, JH
   Pei, YY
   Yuan, ML
   Zhang, YL
   Dai, FH
   Liu, Y
   Wang, QM
   Zheng, JJ
   Xu, L
   Holmes, EC
   Zhang, YZ
AF Wu, Fan
   Zhao, Su
   Yu, Bin
   Chen, Yan-Mei
   Wang, Wen
   Song, Zhi-Gang
   Hu, Yi
   Tao, Zhao-Wu
   Tian, Jun-Hua
   Pei, Yuan-Yuan
   Yuan, Ming-Li
   Zhang, Yu-Ling
   Dai, Fa-Hui
   Liu, Yi
   Wang, Qi-Min
   Zheng, Jiao-Jiao
   Xu, Lin
   Holmes, Edward C.
   Zhang, Yong-Zhen
TI A new coronavirus associated with human respiratory disease in China
SO NATURE
LA English
DT Article
ID MULTIPLE SEQUENCE ALIGNMENT; SARS-LIKE CORONAVIRUS; MAXIMUM-LIKELIHOOD;
   VIRUS; BATS; IDENTIFICATION; PERFORMANCE; DIVERSITY; HKU1
AB Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health(1-3). Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing(4) of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae, which is designated here 'WH-Human 1' coronavirus (and has also been referred to as '2019-nCoV'). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China(5). This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.
C1 [Wu, Fan; Chen, Yan-Mei; Song, Zhi-Gang; Pei, Yuan-Yuan; Zhang, Yu-Ling; Dai, Fa-Hui; Liu, Yi; Wang, Qi-Min; Zheng, Jiao-Jiao; Xu, Lin; Holmes, Edward C.; Zhang, Yong-Zhen] Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.
   [Zhao, Su; Hu, Yi; Tao, Zhao-Wu; Yuan, Ming-Li] Huazhong Univ Sci & Technol, Tongji Med Coll, Cent Hosp Wuhan, Dept Pulm & Crit Care Med, Wuhan, Peoples R China.
   [Yu, Bin; Tian, Jun-Hua] Wuhan Ctr Dis Control & Prevent, Wuhan, Peoples R China.
   [Wang, Wen; Zhang, Yong-Zhen] China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Zoonosis, Beijing, Peoples R China.
   [Holmes, Edward C.] Univ Sydney, Sch Life & Environm Sci, Marie Bashir Inst Infect Dis & Biosecur, Sydney, NSW, Australia.
   [Holmes, Edward C.] Univ Sydney, Sch Med Sci, Sydney, NSW, Australia.
   [Zhang, Yong-Zhen] Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
RP Zhang, YZ (corresponding author), Fudan Univ, Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China.; Zhang, YZ (corresponding author), China Ctr Dis Control & Prevent, Natl Inst Communicable Dis Control & Prevent, Dept Zoonosis, Beijing, Peoples R China.; Zhang, YZ (corresponding author), Fudan Univ, Sch Publ Hlth, Shanghai, Peoples R China.
EM zhangyongzhen@shphc.org.cn
RI Karabulut, Erman/G-6679-2011
OI Karabulut, Erman/0000-0002-0787-905X; Hu, Yi/0000-0002-2882-5210
FU Special National Project on investigation of basic resources of China
   [SQ2019FY010009]; National Natural Science Foundation of ChinaNational
   Natural Science Foundation of China [81861138003, 31930001]; ARC
   Australian Laureate FellowshipAustralian Research Council [FL170100022]
FX This study was supported by the Special National Project on
   investigation of basic resources of China (grant SQ2019FY010009) and the
   National Natural Science Foundation of China (grants 81861138003 and
   31930001). E.C.H. is supported by an ARC Australian Laureate Fellowship
   (FL170100022).
CR Bermingham A, 2012, EUROSURVEILLANCE, V17, P6
   Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170
   Cao Y, 2014, BIOINFORMATICS, V30, P1674, DOI 10.1093/bioinformatics/btu104
   Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Ge XY, 2013, NATURE, V503, P535, DOI 10.1038/nature12711
   Gorbalenya A. E, 2020, SEVERE ACUTE RESP SY, DOI [10.1101/2020.02.07.93786, DOI 10.1101/2020.02.07.93786]
   Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883
   Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010
   HAMRE D, 1966, P SOC EXP BIOL MED, V121, P190, DOI 10.3181/00379727-121-30734
   Hu B, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006698
   Hu D, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0155-5
   Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116
   Hwang WC, 2006, J BIOL CHEM, V281, P34610, DOI 10.1074/jbc.M603275200
   Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010
   Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]
   Lau SKP, 2005, P NATL ACAD SCI USA, V102, P14040, DOI 10.1073/pnas.0506735102
   Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692
   Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480
   Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324
   Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391
   Lin XD, 2017, VIROLOGY, V507, P1, DOI 10.1016/j.virol.2017.03.019
   Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999
   Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467
   MCINTOSH K, 1967, P NATL ACAD SCI USA, V58, P2268, DOI 10.1073/pnas.58.6.2268
   McMullan LK, 2019, LANCET INFECT DIS, V19, P1023, DOI 10.1016/S1473-3099(19)30291-9
   Menachery VD, 2015, NAT MED, V21, P1508, DOI 10.1038/nm.3985
   Ren W, 2008, J VIROL, V82, P1899, DOI 10.1128/JVI.01085-07
   Shi M, 2018, NATURE, V556, P197, DOI 10.1038/s41586-018-0012-7
   Shi M, 2016, NATURE, V540, P539, DOI 10.1038/nature20167
   Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121
   van der Hoek L, 2004, NAT MED, V10, P368, DOI 10.1038/nm1024
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Wang W, 2017, J VIROL, V91, DOI [10.1128/JVI.00764-17, 10.1128/jvi.00764-17]
   Wang W, 2015, VIROLOGY, V474, P19, DOI 10.1016/j.virol.2014.10.017
   Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427
   Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775
   Woo PCY, 2005, J VIROL, V79, P884, DOI 10.1128/JVI.79.2.884-895.2005
   World Health Organization, 2020, WHO DIR GEN REM MED
   Xu L, 2016, VIROL SIN, V31, P69, DOI 10.1007/s12250-016-3727-3
   Yadav PD, 2019, EMERG INFECT DIS, V25, P1003, DOI 10.3201/eid2505.181076
   Yang XL, 2016, J VIROL, V90, P3253, DOI 10.1128/JVI.02582-15
   Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7
NR 43
TC 345
Z9 374
U1 187
U2 187
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD MAR
PY 2020
VL 579
IS 7798
BP 265
EP +
DI 10.1038/s41586-020-2008-3
EA FEB 2020
PG 17
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA KU0CC
UT WOS:000518098100002
PM 32015508
OA Other Gold, Green Published
DA 2020-07-08
ER

PT J
AU Dussupt, V
   Sankhala, RS
   Gromowski, GD
   Donofrio, G
   De La Barreras, RA
   Larocca, RA
   Zaky, W
   Mendez-Rivera, L
   Choe, M
   Davidsons, E
   McCracken, MK
   Brien, JD
   Abbink, P
   Bai, HJ
   Bryans, AL
   Bias, CH
   Berry, IM
   Boteros, N
   Cooks, T
   Doria-Rose, NA
   Escuers, AGI
   Frimpong, JA
   Geretzt, A
   Hernanders, M
   Hollidge, BS
   Jian, NB
   Kabra, K
   Leggat, DJ
   Liu, JY
   Pinto, AK
   Rutvisuttinunt, W
   Setliff, I
   Tran, U
   Townsley, S
   Doranzs, BJ
   Rolland, M
   McDermott, AB
   Georgiev, IS
   Thomas, R
   Robb, ML
   Eckels, KH
   Barranco, E
   Koren, M
   Smith, DR
   Jarman, RG
   George, SL
   Stephenson, KE
   Barouch, DH
   Modjarradl, K
   Michaels, NL
   Joyce, MG
   Krebs, SJ
AF Dussupt, Vincent
   Sankhala, Rajeshwer S.
   Gromowski, Gregory D.
   Donofrio, Gina
   De La Barreras, Rafael A.
   Larocca, Rafael A.
   Zaky, Weam
   Mendez-Rivera, Letzibeth
   Choe, Misook
   Davidsons, Edgar
   McCracken, Michael K.
   Brien, James D.
   Abbink, Peter
   Bai, Hongjun
   Bryans, Aubrey L.
   Bias, Candace Hope
   Berry, Irina Maljkovic
   Boteros, Nubia
   Cooks, Tanya
   Doria-Rose, Nicole A.
   Grinyo i Escuers, Ariadna
   Frimpong, Justice Akuoku
   Geretzt, Aviva
   Hernanders, Mayda
   Hollidge, Bradley S.
   Jian, Ningbo
   Kabra, Kareem
   Leggat, David J.
   Liu, Jinyan
   Pinto, Amelia K.
   Rutvisuttinunt, Wiriya
   Setliff, Ian
   Tran, Ursula
   Townsley, Samantha
   Doranzs, Benjamin J.
   Rolland, Morgane
   McDermott, Adrian B.
   Georgiev, Ivelin S.
   Thomas, Rasmi
   Robb, Merlin L.
   Eckels, Kenneth H.
   Barranco, Elizabeth
   Koren, Michael
   Smith, Darci R.
   Jarman, Richard G.
   George, Sarah L.
   Stephenson, Kathryn E.
   Barouch, Dan H.
   Modjarradl, Kayvon
   Michaels, Nelson L.
   Joyce, M. Gordon
   Krebs, Shelly J.
TI Potent Zika and dengue cross-neutralizing antibodies induced by Zika
   vaccination in a dengue-experienced donor
SO NATURE MEDICINE
LA English
DT Article
ID MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; VIRUS-VACCINE; RT-PCR;
   IDENTIFICATION; IMMUNOGENICITY; DETERMINANTS; EFFICIENT; DESIGN; SAFETY
AB Zika virus (ZIKV) has caused significant disease, with widespread cases of neurological pathology and congenital neurologic defects. Rapid vaccine development has led to a number of candidates capable of eliciting potent ZIKV-neutralizing antibodies (reviewed in refs. (1-3)). Despite advances in vaccine development, it remains unclear how ZIKV vaccination affects immune responses in humans with prior flavivirus immunity. Here we show that a single-dose immunization of ZIKV purified inactivated vaccine (ZPIV)(4-7) in a dengue virus (DENV)-experienced human elicited potent cross-neutralizing antibodies to both ZIKV and DENV. Using a unique ZIKV virion-based sorting strategy, we isolated and characterized multiple antibodies, including one termed MZ4, which targets a novel site of vulnerability centered on the Envelope (E) domain I/III linker region and protects mice from viremia and viral dissemination following ZIKV or DENV-2 challenge. These data demonstrate that Zika vaccination in a DENV-experienced individual can boost pre-existing flavivirus immunity and elicit protective responses against both ZIKV and DENV. ZPIV vaccination in Puerto Rican individuals with prior flavivirus experience yielded similar cross-neutralizing potency after a single vaccination, highlighting the potential benefit of ZIKV vaccination in flavivirus-endemic areas.
   Zika virus vaccination elicits Zika and dengue virus cross-neutralizing antibodies in flavivirus-exposed individuals, potentially enhancing the protective efficacy of the vaccine in flavivirus-endemic regions.
C1 [Dussupt, Vincent; Sankhala, Rajeshwer S.; Donofrio, Gina; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Bai, Hongjun; Geretzt, Aviva; Jian, Ningbo; Tran, Ursula; Townsley, Samantha; Rolland, Morgane; Thomas, Rasmi; Modjarradl, Kayvon; Joyce, M. Gordon; Krebs, Shelly J.] Walter Reed Army Inst Res, Emerging Infect Dis Branch, Ctr Infect Dis Res, Silver Spring, MD 20910 USA.
   [Dussupt, Vincent; Sankhala, Rajeshwer S.; Donofrio, Gina; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Bai, Hongjun; Geretzt, Aviva; Jian, Ningbo; Tran, Ursula; Townsley, Samantha; Rolland, Morgane; Thomas, Rasmi; Robb, Merlin L.; Joyce, M. Gordon; Krebs, Shelly J.] Walter Reed Army Inst Res, US Mil HIV Res Program, Ctr Infect Dis Res, Silver Spring, MD 20910 USA.
   [Dussupt, Vincent; Sankhala, Rajeshwer S.; Donofrio, Gina; Zaky, Weam; Mendez-Rivera, Letzibeth; Choe, Misook; Bai, Hongjun; Geretzt, Aviva; Jian, Ningbo; Tran, Ursula; Townsley, Samantha; Rolland, Morgane; Thomas, Rasmi; Robb, Merlin L.; Joyce, M. Gordon; Krebs, Shelly J.] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.
   [Gromowski, Gregory D.; McCracken, Michael K.; Berry, Irina Maljkovic; Rutvisuttinunt, Wiriya; Koren, Michael; Jarman, Richard G.] Walter Reed Army Inst Res, Viral Dis Branch, Ctr Infect Dis Res, Silver Spring, MD USA.
   [De La Barreras, Rafael A.; Bias, Candace Hope; Boteros, Nubia; Cooks, Tanya; Kabra, Kareem; Eckels, Kenneth H.] Walter Reed Army Inst Res, Pilot Bioprod Facil, Ctr Enabling Capabil, Silver Spring, MD USA.
   [Larocca, Rafael A.; Abbink, Peter; Liu, Jinyan; Stephenson, Kathryn E.; Barouch, Dan H.] Harvard Med Sch, Ctr Virol & Vaccine Res, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.
   [Larocca, Rafael A.; Abbink, Peter; Liu, Jinyan; Stephenson, Kathryn E.; Barouch, Dan H.] Ragon Inst MGH, Cambridge, MA USA.
   [Davidsons, Edgar; Bryans, Aubrey L.; Grinyo i Escuers, Ariadna; Hernanders, Mayda; Doranzs, Benjamin J.] Integral Mol, Philadelphia, PA USA.
   [Brien, James D.; Pinto, Amelia K.] St Louis Univ, Sch Med, Dept Mol Microbiol & Immunol, St Louis, MO USA.
   [Doria-Rose, Nicole A.; Leggat, David J.; McDermott, Adrian B.] NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.
   [Frimpong, Justice Akuoku; Hollidge, Bradley S.; Smith, Darci R.] US Army, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA.
   [Setliff, Ian; Georgiev, Ivelin S.] Vanderbilt Univ, Med Ctr, Vanderbilt Vaccine Ctr, Nashville, TN USA.
   [Barranco, Elizabeth] Ponce Hlth Sci Univ, CAIMED Ctr, Ponce, PR USA.
   [George, Sarah L.] St Louis Univ, Sch Med, Dept Internal Med, Div Infect Dis Allergy & Immunol, St Louis, MO USA.
   [George, Sarah L.] St Louis VA Med Ctr, St Louis, MO USA.
   [Michaels, Nelson L.] Walter Reed Army Inst Res, Ctr Infect Dis Res, Silver Spring, MD USA.
   [Smith, Darci R.] Naval Med Res Ctr, Immunodiagnost Dept, Biol Def Res Directorate, Ft Detrick, MD USA.
RP Joyce, MG; Krebs, SJ (corresponding author), Walter Reed Army Inst Res, Emerging Infect Dis Branch, Ctr Infect Dis Res, Silver Spring, MD 20910 USA.; Joyce, MG; Krebs, SJ (corresponding author), Walter Reed Army Inst Res, US Mil HIV Res Program, Ctr Infect Dis Res, Silver Spring, MD 20910 USA.; Joyce, MG; Krebs, SJ (corresponding author), Henry M Jackson Fdn Adv Mil Med, Bethesda, MD 20817 USA.
EM gjoyce@eidresearch.org; skrebs@hivresearch.org
RI Setliff, Ian/AAE-3603-2020; Thomas, Rasmi/AAI-4921-2020; Assumpcao
   Larocca, Rafael/H-1655-2015
OI Setliff, Ian/0000-0003-4726-6132; Dussupt, Vincent/0000-0002-8579-6356;
   Assumpcao Larocca, Rafael/0000-0002-9995-1804
FU US Department of the Army; Defense Health Agency [0130602D16]; US
   Department of Defense, Defense Health AgencyUnited States Department of
   Defense [0130602D16]; Henry M. Jackson Foundation; Harvard Catalyst,
   Harvard Clinical and Translational Science Center (National Center for
   Research Resources and the National Center for Advancing Translational
   Sciences, National Institutes of Health) [UL1 TR001102]; Harvard
   University; Vaccine Treatment Evaluation Unit (VTEU) at Saint Louis
   University [HHSN2722013000021I]; National Institute of Allergy and
   Infectious Diseases, National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Allergy & Infectious Diseases (NIAID);
   Henry M. Jackson Foundation [W81XWH-07-2-0067]; National Institute of
   General Medical Sciences from the National Institutes of Health at the
   Advanced Photon Source, Argonne National Laboratory [P41 GM103403];
   UChicago Argonne for the US Department of Energy, Office of Biological
   and Environmental Research [DE-AC02-06CH11357]; DOE Office of Science by
   Brookhaven National LaboratoryUnited States Department of Energy (DOE)
   [DE-SC0012704]; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HHSN272201400058C]
FX We sincerely thank the clinical trial participants and staff. In
   addition, we thank M. Creegan, M. Eller and the MHRP FlowCore facility
   for help with FACS sorting and C. Kuklis, Q. Chen, D. Barvir, A.
   Srikanth, T. Li, C. Fung, B. Yadav, B. Sumlin, G. Ballarini, N. Burrell,
   R. Olson and A. Dean for technical support. X-ray diffraction data were
   collected at beamlines at the Advanced Photon Source, Argonne National
   Laboratory, and the National Synchrotron Light Source II. This work was
   primarily funded by the US Department of the Army and the Defense Health
   Agency (0130602D16) to K.M. Work at BIDMC under D.B. was performed with
   support from the US Department of Defense, Defense Health Agency
   (0130602D16), the Henry M. Jackson Foundation and the Harvard Catalyst,
   Harvard Clinical and Translational Science Center (National Center for
   Research Resources and the National Center for Advancing Translational
   Sciences, National Institutes of Health Award UL1 TR001102) and with
   financial contributions from Harvard University and its affiliated
   academic healthcare centers. The ZPIV vaccine trial in Puerto Rico was
   funded by the Vaccine Treatment Evaluation Unit (VTEU) at Saint Louis
   University (contract no. HHSN2722013000021I) under S.L.G. The network of
   VTEUs is supported by the National Institute of Allergy and Infectious
   Diseases, part of the National Institutes of Health. The funders of the
   clinical trials were involved in the clinical study design, clinical
   study operations and approval of the clinical protocols. The ZPIV
   program leads (K.M. and N.L.M.) and the study sponsors had final
   responsibility for the decision to submit for publication. This work was
   supported by a cooperative agreement (W81XWH-07-2-0067) between the
   Henry M. Jackson Foundation for the Advancement of Military Medicine and
   the US Department of Defense (DoD) under the leadership of N.L.M. and
   M.R. The Structural Biology Center (SBC) and Northeastern Collaborative
   Access Team (NE-CAT) beamlines are funded by the National Institute of
   General Medical Sciences from the National Institutes of Health (P41
   GM103403) at the Advanced Photon Source, Argonne National Laboratory.
   SBC-CAT is operated by UChicago Argonne for the US Department of Energy,
   Office of Biological and Environmental Research under contract no.
   DE-AC02-06CH11357. This research used ID-17-1 (AMX) beamline of the
   National Synchrotron Light Source II, a US Department of Energy (DOE)
   Office of Science User Facility operated for the DOE Office of Science
   by Brookhaven National Laboratory under contract no. DE-SC0012704. In
   addition, this work was supported by NIH contract no. HHSN272201400058C
   to B.J.D. Material has been reviewed by the Walter Reed Army Institute
   of Research. The content is solely the responsibility of the authors and
   does not necessarily represent the official views of Harvard Catalyst,
   Harvard University and its affiliated academic healthcare centers or the
   National Institutes of Health. The opinions or assertions contained
   herein are the private views of the authors, and are not to be construed
   as official, or as reflecting true views of the Department of the Army
   or the Department of Defense. The investigators have adhered to the
   policies for protection of human subjects as prescribed in AR 70-25.
CR Abbink P, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aao4163
   Abbink P, 2016, SCIENCE, V353, P1129, DOI 10.1126/science.aah6157
   Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938
   Barouch DH, 2017, IMMUNITY, V46, P176, DOI 10.1016/j.immuni.2017.02.005
   CHAPPEL MS, 1991, P NATL ACAD SCI USA, V88, P9036, DOI 10.1073/pnas.88.20.9036
   Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073
   Cockburn JJB, 2012, EMBO J, V31, P767, DOI 10.1038/emboj.2011.439
   Cox KS, 2016, MABS-AUSTIN, V8, P129, DOI 10.1080/19420862.2015.1109757
   Dai LP, 2016, CELL HOST MICROBE, V19, P696, DOI 10.1016/j.chom.2016.04.013
   Davidson E, 2014, IMMUNOLOGY, V143, P13, DOI 10.1111/imm.12323
   Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058
   Doria-Rose NA, 2014, NATURE, V509, P55, DOI 10.1038/nature13036
   Gallichotte EN, 2015, MBIO, V6, DOI 10.1128/mBio.01461-15
   GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548
   HENCHAL EA, 1982, AM J TROP MED HYG, V31, P830, DOI 10.4269/ajtmh.1982.31.830
   Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001
   Klungthong C, 2015, J CLIN VIROL, V63, P25, DOI 10.1016/j.jcv.2014.12.009
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Larocca RA, 2016, NATURE, V536, P474, DOI 10.1038/nature18952
   Liao HX, 2009, J VIROL METHODS, V158, P171, DOI 10.1016/j.jviromet.2009.02.014
   Lu XS, 2019, CELL REP, V26, P438, DOI 10.1016/j.celrep.2018.12.065
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   McCracken MK, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006487
   Men R, 2004, J VIROL, V78, P4665, DOI 10.1128/JVI.78.9.4665-4674.2004
   Modjarrad K, 2018, LANCET, V391, P563, DOI 10.1016/S0140-6736(17)33106-9
   Morabito KM, 2017, J INFECT DIS, V216, pS957, DOI 10.1093/infdis/jix464
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pierson TC, 2018, NATURE, V560, P573, DOI 10.1038/s41586-018-0446-y
   Renner M, 2018, NAT IMMUNOL, V19, P1248, DOI 10.1038/s41590-018-0227-7
   Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024
   Robinson LN, 2015, CELL, V162, P493, DOI 10.1016/j.cell.2015.06.057
   Rodriguez-Barraquer I, 2019, SCIENCE, V363, P607, DOI 10.1126/science.aav6618
   Sapparapu G, 2016, NATURE, V540, P443, DOI 10.1038/nature20564
   Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316
   Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103
   Thomas SJ, 2013, AM J TROP MED HYG, V88, P73, DOI 10.4269/ajtmh.2012.12-0361
   Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017
   Wang JQ, 2017, CELL, V171, P229, DOI 10.1016/j.cell.2017.09.002
   Wang QH, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aai8336
   Wu XL, 2010, SCIENCE, V329, P856, DOI 10.1126/science.1187659
   Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382
   Zhao HY, 2016, CELL, V166, P1016, DOI 10.1016/j.cell.2016.07.020
NR 42
TC 0
Z9 0
U1 7
U2 7
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD FEB
PY 2020
VL 26
IS 2
BP 228
EP +
DI 10.1038/s41591-019-0746-2
EA FEB 2020
PG 27
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA KK7DU
UT WOS:000510822600002
PM 32015557
OA Green Published, Bronze
DA 2020-07-08
ER

PT J
AU Ventura, PA
   Lage, MLC
   de Carvalho, AL
   Fernandes, AS
   Taguchi, TB
   Nascimento-Carvalho, CM
AF Ventura, Paloma A.
   Lage, Maria-Lucia C.
   de Carvalho, Alessandra L.
   Fernandes, Adriana S.
   Taguchi, Tania B.
   Nascimento-Carvalho, Cristiana M.
TI Early Gross Motor Development Among Brazilian Children with Microcephaly
   Born Right After Zika Virus Infection Outbreak
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Article
DE Zika virus; cerebral palsy; congenital microcephaly; developmental
   delay; gross motor skills
ID CEREBRAL-PALSY; INFANTS
AB Objective: To assess the gross motor development of children with presumed congenital Zika virus (ZIKV) infection over the first 2 years of their lives. Methods: Seventy-seven children were assessed at the median ages of 11, 18, and 24 months, using the evaluative instrument Gross Motor Function Measure (GMFM-66). At the third assessment, the children with diagnoses of cerebral palsy (CP) were classified by severity through the Gross Motor Function Classification System (GMFCS) and stratified by topography indicating the predominantly affected limbs. With these instruments in combination and using the motor development curves as reference, the rate of development and functional ability were estimated. Results: At 2 years of age, all children had the diagnosis of CP. Seventy-four (96.1%) presented gross motor skills similar to those of children aged 4 months or younger, according to the World Health Organization's standard. The GMFM-66 median score among the 73 (94.8%) children with quadriplegia and GMFCS level V showed significant change between 11 and 18 months (p < 0.001) and between 11 and 24 months (p < 0.001). No significant difference (p = 0.076) was found between 18 and 24 months. Conclusion: Despite showing some gross motor progress during the initial 18 months of life, these children with presumed congenital ZIKV infection and CP experienced severe motor impairment by 2 years of age. According to the motor development curves, these children with quadriplegia have probably already reached about 90% of their motor development potential.
C1 [Ventura, Paloma A.; Lage, Maria-Lucia C.; Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Sch Med, Postgrad Program Hlth Sci, Salvador, BA, Brazil.
   [Ventura, Paloma A.; de Carvalho, Alessandra L.; Fernandes, Adriana S.; Taguchi, Tania B.] SARAH Network Rehabil Hosp, Salvador, BA, Brazil.
   [Nascimento-Carvalho, Cristiana M.] Univ Fed Bahia, Dept Paediat, Sch Med, Salvador, BA, Brazil.
RP Ventura, PA (corresponding author), SARAH Salvador Hosp, Ave Tancredo Neves 2782, BR-41820900 Salvador, BA, Brazil.
EM molima2010@gmail.com
CR [Anonymous], 2016, PROT VIG RESP OC MIC, P55
   Ashwal S, 2009, NEUROLOGY, V73, P887, DOI 10.1212/WNL.0b013e3181b783f7
   Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412
   Cardoso CW, 2015, EMERG INFECT DIS, V21, P2274, DOI 10.3201/eid2112.151167
   Cardoso TF, 2019, ARCH DIS CHILD, V104, P199, DOI 10.1136/archdischild-2018-314782
   Carvalho AL, 2019, CLIN MICROBIOL INFEC, V25, P524, DOI 10.1016/j.cmi.2018.12.021
   Ferreira HNC, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061107
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   del Campo M, 2017, AM J MED GENET A, V173, P841, DOI 10.1002/ajmg.a.38170
   Delaney A, 2018, MMWR-MORBID MORTAL W, V67, P91, DOI 10.15585/mmwr.mm6703a2
   Gorter JW, 2004, DEV MED CHILD NEUROL, V46, P461, DOI 10.1017/S0012162204000763
   Hanna SE, 2008, PHYS THER, V88, P596, DOI 10.2522/ptj.20070314
   Kapogiannis BG, 2017, JAMA PEDIATR, V171, P478, DOI 10.1001/jamapediatrics.2017.0002
   Marques FJP, 2019, J CHILD NEUROL, V34, P81, DOI 10.1177/0883073818811234
   Martorell R, 2006, ACTA PAEDIATR, V95, P86, DOI 10.1080/08035320500495563
   Melo A, 2019, DEV MED CHILD NEUROL
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   da Silva AAM, 2016, EMERG INFECT DIS, V22, P1953, DOI 10.3201/eid2211.160956
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   Novak I, 2017, JAMA PEDIATR, V171, P897, DOI 10.1001/jamapediatrics.2017.1689
   Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x
   Pessoa A, 2018, PEDIATRICS, V141, pS167, DOI 10.1542/peds.2017-2038F
   Rosenbaum P, 2006, DEV MED CHILD NEUROL, V48, P4, DOI 10.1017/S001216226000028
   Rosenbaum PL, 2002, JAMA-J AM MED ASSOC, V288, P1357, DOI 10.1001/jama.288.11.1357
   RUSSELL DJ, 1989, DEV MED CHILD NEUROL, V31, P341
   Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2
   Schuler-Faccini L, 2016, MMWR-MORBID MORTAL W, V65, P59, DOI 10.15585/mmwr.mm6503e2
   Soares-Marangoni DD, 2019, DEV NEUROREHABIL, V22, P71, DOI 10.1080/17518423.2018.1437843
   van der Linden V, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3899
   Aragao MDV, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1901
   Wheeler AC, 2018, PEDIATRICS, V141, pS154, DOI [10.1542/peds.2017-2038D, 10.1542/peds.2017-2038d]
   Zafeiriou DI, 2004, PEDIATR NEUROL, V31, P1, DOI 10.1016/j.pediatrneurol.2004.01.012
NR 32
TC 0
Z9 0
U1 1
U2 1
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD FEB-MAR
PY 2020
VL 41
IS 2
BP 134
EP 140
DI 10.1097/DBP.0000000000000722
PG 7
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA LE6SH
UT WOS:000526852800080
PM 31453893
DA 2020-07-08
ER

PT J
AU Leyser, M
   Marques, F
   Amarante, C
   Elias, MA
   Klein, R
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda
   Amarante, Claret
   Elias, Marco Aurelio
   Klein, Renata
   Nascimento, Osvaldo J. M.
TI Developmental Outcomes in a Cohort of Infants Born With Congenital ZIKA
   Syndrome
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Meeting Abstract
C1 [Leyser, Marcio] Univ Iowa, Iowa City, IA USA.
   [Marques, Fernanda; Amarante, Claret; Elias, Marco Aurelio; Klein, Renata] SARAH Network Rehabil Hosp, Rio De Janeiro, Brazil.
   [Nascimento, Osvaldo J. M.] Fluminense Fed Univ, Niteroi, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD FEB-MAR
PY 2020
VL 41
IS 2
MA 79
BP S18
EP S19
PG 2
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA LE6SH
UT WOS:000526852800042
DA 2020-07-08
ER

PT J
AU Leyser, M
   Marques, F
   Teixeira, MC
   Barra, R
   Almeida, A
   Penna, P
   Carvalho, R
   Gonsalves, M
   Nascimento, OJM
AF Leyser, Marcio
   Marques, Fernanda
   Teixeira, Marta Cristina
   Barra, Rafael
   Almeida, Alexandre
   Penna, Patricia
   Carvalho, Ricardo
   Gonsalves, Marcia
   Nascimento, Osvaldo J. M.
TI Clinical and Brain-Related Anatomo-Physiological Findings in a Cohort of
   Infants Born with Congenital ZIKA Syndrome
SO JOURNAL OF DEVELOPMENTAL AND BEHAVIORAL PEDIATRICS
LA English
DT Meeting Abstract
C1 [Leyser, Marcio] Univ Iowa, Iowa City, IA USA.
   [Marques, Fernanda; Teixeira, Marta Cristina; Barra, Rafael; Almeida, Alexandre; Penna, Patricia; Carvalho, Ricardo; Gonsalves, Marcia] SARAH Network Rehabil Hosp, Rio De Janeiro, Brazil.
   [Nascimento, Osvaldo J. M.] Fluminense Fed Univ, Niteroi, RJ, Brazil.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 0196-206X
EI 1536-7312
J9 J DEV BEHAV PEDIATR
JI J. Dev. Behav. Pediatr.
PD FEB-MAR
PY 2020
VL 41
IS 2
MA 80
BP S19
EP S19
PG 1
WC Behavioral Sciences; Psychology, Developmental; Pediatrics
SC Behavioral Sciences; Psychology; Pediatrics
GA LE6SH
UT WOS:000526852800043
DA 2020-07-08
ER

PT J
AU Lima, DD
   Baran, LCP
   Hamer, RD
   da Costa, MF
   Vidal, KS
   Damico, FM
   Barboni, MTS
   Franca, VDRD
   Martins, CMG
   Tabares, HS
   Dias, SL
   Silva, LA
   Decleva, D
   Zatz, M
   Bertozzi, APAP
   Gazeta, RE
   Passos, SD
   Ventura, DF
AF Lima, Diego da Silva
   Portnoi Baran, Luiz Claudio
   Hamer, Russell David
   da Costa, Marcelo Fernandes
   Vidal, Kallene Summer
   Damico, Francisco Max
   Salgueiro Barboni, Mirella Telles
   Rodrigues de Matos Franca, Valtenice de Cassia
   Gomes Martins, Cristiane Maria
   Tabares, Heydi Segundo
   Dias, Sarah Leonardo
   Silva, Leonardo Aparecido
   Decleva, Diego
   Zatz, Mayana
   Antunes Pascalicchio Bertozzi, Ana Paula
   Gazeta, Rosa Estela
   Passos, Saulo Duarte
   Ventura, Dora Fix
TI Longitudinal visual acuity development in ZIKV-exposed children
SO JOURNAL OF AAPOS
LA English
DT Article
ID OPTICAL COHERENCE TOMOGRAPHY; OPHTHALMIC MANIFESTATIONS; MACULAR
   ATROPHY; EFFECTS MODELS; VIRUS; INFANTS; RISK
AB PURPOSE To follow the visual acuity development of children exposed to or infected with the Zika virus (ZIKV) during gestation and to relate potential visual acuity deficits to their clinical condition.
   METHODS In this prospective study, visual acuity was measured via Teller Acuity Cards in three groups of children: (1) those with confirmed ZIKV exposure (ZE) through the mother only, (2) those with confirmed infection (ZI), and (3) unaffected controls. Visual acuity was measured 2-4 times in each child during the first 30 months of age.
   RESULTS The study included 22 children in the ZE group, 11 in the ZI group, and 27 controls. Visual acuity developed normally in both patient groups, including infected patients (ZI) that did not manifest clinical symptoms. In a small subgroup of patients with characteristics consistent with congenital Zika syndrome (CZS), visual acuity was within normative values, with the exception of single child with chorioretinal atrophy.
   CONCLUSIONS In this southeastern Brazil study cohort, visual acuity development seemed to progress normally in infected children without CZS symptoms.
C1 [Lima, Diego da Silva; Portnoi Baran, Luiz Claudio; Hamer, Russell David; da Costa, Marcelo Fernandes; Vidal, Kallene Summer; Damico, Francisco Max; Salgueiro Barboni, Mirella Telles; Rodrigues de Matos Franca, Valtenice de Cassia; Gomes Martins, Cristiane Maria; Tabares, Heydi Segundo; Dias, Sarah Leonardo; Silva, Leonardo Aparecido; Decleva, Diego; Ventura, Dora Fix] Univ Sao Paulo, Inst Psychol, Dept Expt Psychol, Sao Paulo, Brazil.
   [Hamer, Russell David] Florida Atlantic Univ, Dept Psychol, Boca Raton, FL 33431 USA.
   [Damico, Francisco Max] Univ Sao Paulo, Sao Paulo Med Sch, Dept Ophthalmol, Sao Paulo, Brazil.
   [Salgueiro Barboni, Mirella Telles] Semmelweis Univ, Dept Ophthalmol, Budapest, Hungary.
   [Zatz, Mayana] Univ Sao Paulo, Stem Cell & Human Genome Res Ctr, Biosci Inst, Sao Paulo, Brazil.
   [Antunes Pascalicchio Bertozzi, Ana Paula; Gazeta, Rosa Estela; Passos, Saulo Duarte] Jundiai Med Sch, Jundiai, Brazil.
RP Lima, DD (corresponding author), Univ Sao Paulo, Inst Psychol, Av Prof Mello Moraes 1721, BR-05508030 Sao Paulo, SP, Brazil.
EM limads@usp.br
FU Sao Paulo Research Foundation (FAPESP)Fundacao de Amparo a Pesquisa do
   Estado de Sao Paulo (FAPESP) [2014/26818-2, 2016/24631-8, 2016/14793-0,
   2017/16948-4, 2016/22007-5, 2013/05942-4]; Coordination for the
   Improvement of Higher Education (CAPES)CAPES [3263/2013]; National
   Council for Scientific and Technological Development (CNPq)National
   Council for Scientific and Technological Development (CNPq)
   [404239/2016-1]
FX This study was funded by the Sao Paulo Research Foundation (FAPESP)
   through Thematic Project grant 2014/26818-2, Master's Scholarships
   grants 2016/24631-8 (DSL), 2016/14793-0 (LCPB), and 2017/16948-4 (LAS),
   Scholarship Abroad grants 2016/22007-5 (MTSB), and Post-Doctorate
   Program grant 2013/05942-4; by the Coordination for the Improvement of
   Higher Education (CAPES), through Pr~oAmazonia grant 3263/2013 and also
   by the National Council for Scientific and Technological Development
   (CNPq) grant 404239/2016-1 (MTSB). Those agencies played no direct role
   in the design or execution of the study or in decisions related to
   manuscript preparation and submission.
CR Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01
   Clemente NS, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027947
   de Miranda HA, 2016, OPHTHALMOLOGY, V123, P1788, DOI 10.1016/j.ophtha.2016.05.001
   Campos AGD, 2016, ARQ BRAS OFTALMOL, V79, P400, DOI 10.5935/0004-2749.20160112
   de Oliveira-Szejnfeld PS, 2016, RADIOLOGY, V281, P203, DOI 10.1148/radiol.2016161584
   DOBSON V, 1980, INVEST OPHTH VIS SCI, V19, P1498
   Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267
   Johansson MA, 2016, NEW ENGL J MED, V375, P1, DOI 10.1056/NEJMp1605367
   LAIRD NM, 1982, BIOMETRICS, V38, P963, DOI 10.2307/2529876
   Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287
   Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065
   Ministerio da Saude, 2018, B EPIDEMIOLOGICO, V49
   Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982
   Mysorekar IU, 2016, NEW ENGL J MED, V375, P481, DOI 10.1056/NEJMcibr1605445
   van den Pol AN, 2017, J NEUROSCI, V37, P2161, DOI 10.1523/JNEUROSCI.3124-16.2017
   Pedrosa CSG, 2019, CYANOBACTERIAL SAXIT
   Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113
   Baran LCP, 2019, J AAPOS, V23, P215, DOI 10.1016/j.jaapos.2019.03.005
   Rice ME, 2018, MMWR-MORBID MORTAL W, V67, P858, DOI 10.15585/mmwr.mm6731e1
   SALOMAO SR, 1995, INVEST OPHTH VIS SCI, V36, P657
   TELLER DY, 1986, DEV MED CHILD NEUROL, V28, P779
   Teller DY, 2005, TELLER ACUITY CARDS
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P1420, DOI 10.1001/jamaophthalmol.2016.4283
   Ventura CV, 2016, JAMA OPHTHALMOL, V134, P912, DOI 10.1001/jamaophthalmol.2016.1784
   Ventura CV, 2016, LANCET, V387, P2502, DOI 10.1016/S0140-6736(16)30776-0
   Ventura CV, 2016, LANCET, V387, P228, DOI 10.1016/S0140-6736(16)00006-4
   Ventura LO, 2017, J AAPOS, V21, P480, DOI 10.1016/j.jaapos.2017.07.206
   Ventura LO, 2017, J AAPOS, V21, P295, DOI 10.1016/j.jaapos.2017.04.003
   Vercosa I, 2017, J AAPOS, V21, P300, DOI 10.1016/j.jaapos.2017.05.024
   Yepez JB, 2017, JAMA OPHTHALMOL, V135, P440, DOI 10.1001/jamaophthalmol.2017.0561
   Zin AA, 2017, JAMA PEDIATR, V171, P847, DOI 10.1001/jamapediatrics.2017.1474
NR 31
TC 0
Z9 0
U1 1
U2 1
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 1091-8531
EI 1528-3933
J9 J AAPOS
JI J. AAPOS
PD FEB
PY 2020
VL 24
IS 1
AR UNSP 23.e1
DI 10.1016/j.jaapos.2019.11.005
PG 6
WC Ophthalmology; Pediatrics
SC Ophthalmology; Pediatrics
GA LE8SJ
UT WOS:000526995200012
PM 31926367
DA 2020-07-08
ER

PT J
AU Pasquali, S
   Mariani, L
   Calvitti, M
   Moretti, R
   Ponti, L
   Chiari, M
   Sperandio, G
   Gilioli, G
AF Pasquali, S.
   Mariani, L.
   Calvitti, M.
   Moretti, R.
   Ponti, L.
   Chiari, M.
   Sperandio, G.
   Gilioli, G.
TI Development and calibration of a model for the potential establishment
   and impact of Aedes albopictus in Europe
SO ACTA TROPICA
LA English
DT Article
DE Population dynamics; Ae. albopictus; Stage-structured population;
   Demographic model
ID TEMPERATURE-DEPENDENT DEVELOPMENT; SPATIAL-DISTRIBUTION;
   POPULATION-DYNAMICS; DIPTERA-CULICIDAE; CLIMATE-CHANGE; SKUSE DIPTERA;
   GLOBAL RISK; AEGYPTI; VECTOR; DENGUE
AB The Asian tiger mosquito (Aedes albopictus) is one of the most invasive disease vectors worldwide. The species is a competent vector of dengue, chikungunya, Zika viruses and other severe parasites and pathogens threatening human health. The capacity of this mosquito to colonize and establish in new areas (including temperate regions) is enhanced by its ability of producing diapausing eggs that survive relatively cold winters. The main drivers of population dynamics for this mosquito are water and air temperature and photoperiod. In this paper, we present a mechanistic model that predicts the potential distribution, abundance and activity of Asian tiger mosquito in Europe. The model includes a comprehensive description of: i) the individual life-history strategies, including diapause, ii) the influence of weather-driven individual physiological responses on population dynamics and iii) the density-dependent regulation of larval mortality rate. The model is calibrated using field data from several locations along an altitudinal gradient in the Italian Alps, which enabled accurate prediction of cold temperature effects on population abundance, including identification of conditions that prevent overwintering of the species. Model predictions are consistent with the most updated information on species' presence and absence. Predicted population abundance shows a clear south-north decreasing gradient. A similar yet less evident pattern in the activity of the species is also predicted. The model represents a valuable tool for the development of strategies aimed at the management of Ae. albopictus and for the implementation of effective control measures against vector-borne diseases in Europe.
C1 [Pasquali, S.] CNR IMATI Enrico Magenes, Via A Corti 12, I-20133 Milan, Italy.
   [Mariani, L.] Lombard Museum Agr Hist, Via Celoria 2, I-20133 Milan, Italy.
   [Mariani, L.] Univ Milan, DiSAA, Via Celoria 2, I-20133 Milan, Italy.
   [Calvitti, M.; Moretti, R.; Ponti, L.] Casaccia Res Ctr, ENEA Italian Natl Agcy New Technol Energy & Susta, Biotechnol & Agroind Div, Via Anguillarese 301, I-00123 Rome, Italy.
   [Ponti, L.] Www Casasglobal Org, Ctr Anal Sustainable Agr Syst, Kensington, CA 94707 USA.
   [Chiari, M.] DG Welf, UO Vet, Pzza Citta Lombardia 1, I-20124 Milan, Italy.
   [Sperandio, G.; Gilioli, G.] Univ Brescia, DMMT, Viale Europa 11, I-25123 Brescia, Italy.
   [Sperandio, G.] Univ Modena & Reggio Emilia, Dept Life Sci, Via G Amendola 2, I-42122 Reggio Emilia, Italy.
RP Pasquali, S (corresponding author), CNR IMATI Enrico Magenes, Via A Corti 12, I-20133 Milan, Italy.
EM sara.pasquali@mi.imati.cnr.it
RI Ponti, Luigi/A-3603-2011
OI Ponti, Luigi/0000-0003-4972-8265
CR Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340
   Angelini R., 2007, WKLY RELEASES 1997 2, V12, P3260
   Benedict MQ, 2007, VECTOR-BORNE ZOONOT, V7, P76, DOI 10.1089/vbz.2006.0562
   Bourtzis K, 2014, ACTA TROP, V132, pS150, DOI 10.1016/j.actatropica.2013.11.004
   Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338
   Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351
   Briere JF, 1999, ENVIRON ENTOMOL, V28, P22, DOI 10.1093/ee/28.1.22
   Buffoni G, 2007, J MATH BIOL, V54, P555, DOI 10.1007/s00285-006-0058-2
   Calado Daniéla C., 2002, Rev. Bras. entomol., V46, P93, DOI 10.1590/S0085-56262002000100011
   Calvitti M, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-254
   Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138
   Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135
   Couto-Lima D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05186-3
   de Wit C.T., 1978, SIMULATION ASSIMILAT, P140
   Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105
   Ding FY, 2018, ACTA TROP, V178, P155, DOI 10.1016/j.actatropica.2017.11.020
   ECDC and EFSA, 2019, MOSQ MAPS
   Erguler K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174293
   Erguler K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149282
   Erickson RA, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/3/034003
   Erickson RA, 2010, ECOL MODEL, V221, P1273, DOI 10.1016/j.ecolmodel.2010.01.018
   European Centre for Disease Prevention and Control (ECDC), 2009, 0905 ECDC
   Fischer D, 2014, EUROSURVEILLANCE, V19, P34, DOI 10.2807/1560-7917.ES2014.19.6.20696
   Gilioli G., 2017, Bulletin OEPP, V47, P213, DOI 10.1111/epp.12377
   Gilioli G., 2015, C IMP ENV CHANG INF
   Gilioli G, 2017, INT J BIOMETEOROL, V61, P1899, DOI 10.1007/s00484-017-1376-3
   Gilioli G, 2017, ENVIRON IMPACT ASSES, V65, P1, DOI 10.1016/j.eiar.2017.03.008
   Gilioli G, 2016, ECOL MODEL, V320, P348, DOI 10.1016/j.ecolmodel.2015.10.018
   Gilioli G, 2014, PEST MANAG SCI, V70, P1611, DOI 10.1002/ps.3734
   Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2
   Gratz NG, 2004, MED VET ENTOMOL, V18, P215, DOI 10.1111/j.0269-283X.2004.00513.x
   Guo XX, 2013, ACTA TROP, V128, P566, DOI 10.1016/j.actatropica.2013.08.006
   Gutierrez AP, 2019, MED VET ENTOMOL, V33, P282, DOI 10.1111/mve.12362
   Gutierrez AP, 2013, ENVIRON ENTOMOL, V42, P395, DOI 10.1603/EN12018
   GUTIERREZ AP, 1996, APPL POPULATION ECOL
   Guzzetta G, 2016, EUROSURVEILLANCE, V21, P5, DOI 10.2807/1560-7917.ES.2016.21.15.30199
   Guzzetta G, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004762
   HIEN D S, 1975, Acta Parasitologica Polonica, V23, P553
   Jia PF, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2071-2
   Jia PF, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1448-y
   Knudsen A. B., 1995, Parassitologia (Rome), V37, P91
   Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4
   Kontodimas DC, 2004, ENVIRON ENTOMOL, V33, P1, DOI 10.1603/0046-225X-33.1.1
   Kraemer MUG, 2019, NAT MICROBIOL, V4, P854, DOI 10.1038/s41564-019-0376-y
   Kraemer MUG, 2015, ELIFE, V4, DOI 10.7554/eLife.08347
   Kuhlisch C, 2018, ACTA TROP, V188, P78, DOI 10.1016/j.actatropica.2018.08.019
   La Ruche G, 2010, EUROSURVEILLANCE, V15, P2
   Lacour G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145311
   Lanzarone E, 2017, J MATH BIOL, V75, P759, DOI 10.1007/s00285-017-1099-4
   Larnier K, 2010, KNOWL MANAG AQUAT EC, DOI 10.1051/kmae/2010031
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Manica M, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.44.17-00685
   Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2
   Medlock JM, 2012, VECTOR-BORNE ZOONOT, V12, P435, DOI 10.1089/vbz.2011.0814
   Metelmann S, 2019, J R SOC INTERFACE, V16, DOI 10.1098/rsif.2018.0761
   Monteiro LCC, 2007, NEOTROP ENTOMOL, V36, P966, DOI 10.1590/S1519-566X2007000600021
   Moore CG, 1997, EMERG INFECT DIS, V3, P329, DOI 10.3201/eid0303.970309
   Mordecai EA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005568
   Moretti R, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3208-7
   Moretti R, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006626
   Pasquali S, 2019, ECOL MODEL, V402, P45, DOI 10.1016/j.ecolmodel.2019.03.019
   Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005
   Petric M, 2017, CLIMATIC CHANGE, V142, P361, DOI 10.1007/s10584-017-1946-8
   Poletti P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018860
   Proestos Y, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0554
   Reiter P, 1998, J AM MOSQUITO CONTR, V14, P83
   REITER P, 1987, J AM MOSQUITO CONTR, V3, P494
   Rossi V, 2019, AGRONOMY-BASEL, V9, DOI 10.3390/agronomy9110710
   Rudolf I, 2018, ACTA TROP, V185, P239, DOI 10.1016/j.actatropica.2018.05.020
   Sallam MF, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14101230
   Santos J, 2017, ACTA TROP, V168, P80, DOI 10.1016/j.actatropica.2017.01.015
   Sanz-Aguilar A, 2018, MED VET ENTOMOL, V32, P443, DOI 10.1111/mve.12317
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Soberon J, 2011, REV MEX BIODIVERS, V82, P1348
   Soberon J, 2009, P NATL ACAD SCI USA, V106, P19644, DOI 10.1073/pnas.0901637106
   Stanaway JD, 2016, LANCET INFECT DIS, V16, P712, DOI 10.1016/S1473-3099(16)00026-8
   Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100
   Trajer A, 2014, IDOJARAS, V118, P19
   Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698
   Zheng B, 2018, ECOL MODEL, V387, P38, DOI 10.1016/j.ecolmodel.2018.09.004
NR 80
TC 0
Z9 0
U1 4
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0001-706X
EI 1873-6254
J9 ACTA TROP
JI Acta Trop.
PD FEB
PY 2020
VL 202
AR UNSP 105228
DI 10.1016/j.actatropica.2019.105228
PG 9
WC Parasitology; Tropical Medicine
SC Parasitology; Tropical Medicine
GA LD1KV
UT WOS:000525791600030
PM 31678121
OA Green Published
DA 2020-07-08
ER

PT J
AU Zhang, YD
   Ibaraki, M
   Schwartz, FW
AF Zhang, Yiding
   Ibaraki, Motomu
   Schwartz, Franklin W.
TI Disease surveillance using online news: Dengue and zika in tropical
   countries
SO JOURNAL OF BIOMEDICAL INFORMATICS
LA English
DT Article
DE Disease surveillance; Newspaper; Text mining; Dengue fever; Zika
ID URBANIZATION; SYSTEM; TEXT
AB Background: Around the world in tropical areas, certain vector-borne diseases have become endemic and hyperendemic. Among the developing nations, there are common difficulties in establishing the incidences of various diseases, especially vector-borne diseases with complex etiologies and a broad spectrum of presentations. One alternative approach to characterization of the disease outbreaks examines the possibilities of developing proxy information from online news articles. Such sources are being evaluated for applications to disease surveillance, early outbreak detection, and epidemiology research. Our study here looks to examine the potential of news articles in elucidating outbreaks of dengue in India and zika disease in Brazil.
   Objective: This study is designed to assess the potential usefulness of news articles in tracking case numbers of dengue and zika through an improved understanding of how news outlets report on disease. We specifically examine the possibilities of providing near real-time reporting on the development of outbreaks of dengue and zika.
   Methods: Newspaper articles related to dengue fever and zika disease in India and Brazil, respectively were extracted from the LexisNexis database. We targeted news articles available from five popular international news sources and two local newspapers in each country. The news articles were processed to provide yearly and weekly time series in the number of articles concerned with dengue and zika to test their potential suitability as proxies for disease prevalence. The collections of articles were analyzed using a text mining tool-kit that subdivides a collections of news articles into smaller clusters to study the topical focus of articles and their relevance to tracking diseases.
   Results: For dengue fever in India, the local newspapers provide a better source of information than international newspapers. The multi-year analysis (2010-2016) suggests that the numbers of dengue cases are strongly correlated with the numbers of news reports, with an R-2 value of 0.88. For zika disease in Brazil, the news reports provided useful information on the timing of the zika outbreak. Reporting increase sharply at the beginning of 2016, peaked in weeks 5 to 8, and decreased sharply. The numbers of articles remained low for the remainder of 2016 and 2017. Comparisons with reported case again show article numbers to be a useful proxy of prevalence of zika in Brazil.
   Conclusions: The paper describes a strategy that applies newspaper as proxies to monitor outbreaks of infectious diseases and to study the epidemiology. It has potential applicability in some developing countries and regions with relatively poor medical infrastructures and records. Clearly, large national newspapers in India provide a better source of information on diseases than international outlets. This approach has potential with selected diseases in a few selected countries. Article numbers internationally appear to vary in proportion to the perceived health impact.
C1 [Zhang, Yiding] Ohio State Univ, Environm Sci Grad Program, 234 Mendenhall Lab,125 South Oval Mall, Columbus, OH 43210 USA.
   [Ibaraki, Motomu; Schwartz, Franklin W.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.
RP Zhang, YD (corresponding author), Ohio State Univ, Environm Sci Grad Program, 234 Mendenhall Lab,125 South Oval Mall, Columbus, OH 43210 USA.
EM zhang.1381@osu.edu; ibaraki.1@osu.edu; schwartz.11@osu.edu
OI Zhang, Yiding/0000-0001-5839-5402
CR Abrams C., 2016, WALL STR J
   Albin A, 2014, JMIR MED INF, V2, P221, DOI 10.2196/medinform.3387
   Barcellos C, 2016, EMERG INFECT DIS, V22, P1894, DOI 10.3201/eid2211.160901
   Brownstein JS, 2008, PLOS MED, V5, P1019, DOI 10.1371/journal.pmed.0050151
   Butler D, 2013, NATURE, V494, P155, DOI 10.1038/494155a
   CDC, 2018, WORLD MAP AR RISK ZI
   Corley CD, 2010, INT J ENV RES PUB HE, V7, P596, DOI 10.3390/ijerph7020596
   Doss CGP, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-016-0234-6
   Ghazinour Kambiz, 2013, Advances in Artificial Intelligence. 26th Canadian Conference on Artificial Intelligence, Canadian AI 2013. Proceedings, P25, DOI 10.1007/978-3-642-38457-8_3
   Grein TW, 2000, EMERG INFECT DIS, V6, P97, DOI 10.3201/eid0602.000201
   Gubler Duane J, 2011, Trop Med Health, V39, P3, DOI 10.2149/tmh.2011-S05
   Gulland A, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i657
   Gupta N, 2012, INDIAN J MED RES, V136, P373
   Hirschman L, 2002, BIOINFORMATICS, V18, P1553, DOI 10.1093/bioinformatics/18.12.1553
   Ikejezie J, 2017, AM J TRANSPLANT, V17, P1681, DOI 10.1111/ajt.14333
   Ji XN, 2019, IEEE T VIS COMPUT GR, V25, P2181, DOI 10.1109/TVCG.2019.2903946
   Ji XN, 2017, STUD HEALTH TECHNOL, V245, P422, DOI 10.3233/978-1-61499-830-3-422
   Ji XN, 2017, J BIOMED INFORM, V69, P33, DOI 10.1016/j.jbi.2017.03.007
   Ji Xiaonan, 2015, AMIA Annu Symp Proc, V2015, P1927
   Ji Xiaonan, 2015, JMIR Med Inform, V3, pe28, DOI 10.2196/medinform.3982
   Lee K, 2013, 19TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'13), P1474
   Moore M, 2003, INT J HYG ENVIR HEAL, V206, P269, DOI 10.1078/1438-4639-00223
   Murhekar M, 2019, INT J INFECT DIS, V84, pS10, DOI 10.1016/j.ijid.2019.01.004
   Murray Natasha Evelyn Anne, 2013, Clin Epidemiol, V5, P299, DOI 10.2147/CLEP.S34440
   Mutheneni SR, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.57
   Ngai EWT, 2009, EXPERT SYST APPL, V36, P2592, DOI 10.1016/j.eswa.2008.02.021
   Ngai EWT, 2011, DECIS SUPPORT SYST, V50, P559, DOI 10.1016/j.dss.2010.08.006
   Pan American Health Organization / World Health Organization, 2017, ZIK EP REP BRAZ, DOI [10.1126/science.aaf5036., DOI 10.1126/SCIENCE.AAF5036]
   Plourde AR, 2016, EMERG INFECT DIS, V22, P1185, DOI 10.3201/eid2207.151990
   Pruitt SL, 2005, CONTRACEPTION, V71, P14, DOI 10.1016/j.contraception.2004.07.012
   Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338
   Ratageri Vinod H., 2005, Indian Journal of Pediatrics, V72, P705, DOI 10.1007/BF02724083
   Rortais A, 2010, FOOD RES INT, V43, P1553, DOI 10.1016/j.foodres.2010.04.009
   Schwartz FW, 2019, GROUNDWATER, V57, P205, DOI 10.1111/gwat.12851
   Shepard DS, 2014, AM J TROP MED HYG, V91, P1235, DOI 10.4269/ajtmh.14-0002
   Teixeira MG, 2016, AM J PUBLIC HEALTH, V106, P601, DOI 10.2105/AJPH.2016.303113
   Times of India, 2018, TIMES INDIA
   Toblin RL, 2008, J SAFETY RES, V39, P445, DOI 10.1016/j.jsr.2008.06.002
   Villanes A, 2018, AM J TROP MED HYG, V98, P181, DOI 10.4269/ajtmh.17-0253
   Weaver DA, 2008, J MASS COMMUN Q, V85, P515, DOI 10.1177/107769900808500303
   Zhang C, 2013, 2013 15TH IEEE INTERNATIONAL CONFERENCE ON COMMUNICATION TECHNOLOGY (ICCT), P93, DOI 10.1109/ICCT.2013.6820353
   Zhang YD, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0189-y
   Zhang YD, 2018, GROUNDWATER, V56, P993, DOI 10.1111/gwat.12804
NR 43
TC 0
Z9 0
U1 2
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1532-0464
EI 1532-0480
J9 J BIOMED INFORM
JI J. Biomed. Inform.
PD FEB
PY 2020
VL 102
AR UNSP 103374
DI 10.1016/j.jbi.2020.103374
PG 10
WC Computer Science, Interdisciplinary Applications; Medical Informatics
SC Computer Science; Medical Informatics
GA LD0PK
UT WOS:000525735200005
PM 31911171
DA 2020-07-08
ER

PT J
AU Leal, SD
   Varela, IBF
   Goncalves, AAL
   Monteiro, DDS
   de Sousa, CMR
   Mendonca, MLL
   De Pina, AJ
   Alves, MJ
   Osorio, HC
AF Leal, Silvania Da Veiga
   Fernandes Varela, Isaias Baptista
   Lopes Goncalves, Aderitow Augusto
   Sousa Monteiro, Davidson Daniel
   Ramos de Sousa, Celivianne Marisia
   Lima Mendonca, Maria da Luz
   De Pina, Adilson Jose
   Alves, Maria Joao
   Osorio, Hugo Costa
TI Abundance and Updated Distribution of Aedes aegypti (Diptera: Culicidae)
   in Cabo Verde Archipelago: A Neglected Threat to Public Health
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE Aedes aegypti; arboviruses; larval index; surveillance; control; Cabo
   Verde
ID CAPE-VERDE; CONTAINER PRODUCTIVITY; SANTIAGO ISLAND; CLIMATE-CHANGE;
   DENGUE; INDEXES; RISK; EPIDEMIOLOGY; DISTRICT; DISEASES
AB Background: Mosquito-borne viruses, such as Zika, dengue, yellow fever, and chikungunya, are important causes of human diseases nearly worldwide. The greatest health risk for arboviral disease outbreaks is the presence of the most competent and highly invasive domestic mosquito, Aedes aegypti. In Cabo Verde, two recent arbovirus outbreaks were reported, a dengue outbreak in 2009, followed by a Zika outbreak in 2015. This study is the first entomological survey for Ae. aegypti that includes all islands of Cabo Verde archipelago, in which we aim to evaluate the actual risk of vector-borne arboviruses as a continuous update of the geographical distribution of this species. Methods: In order to assess its current distribution and abundance, we undertook a mosquito larval survey in the nine inhabited islands of Cabo Verde from November 2018 to May 2019. Entomological larval survey indices were calculated, and the abundance analyzed. We collected and identified 4045 Ae. aegypti mosquitoes from 264 positive breeding sites in 22 municipalities and confirmed the presence of Ae. aegypti in every inhabited island. Results: Water drums were found to be the most prevalent containers (n = 3843; 62.9%), but puddles (n = 27; 0.4%) were the most productive habitats found. The overall average of the House, Container, and Breteau larval indices were 8.4%, 4.4%, and 10.9, respectively. However, 15 out of the 22 municipalities showed that the Breteau Index was above the epidemic risk threshold. Conclusion: These results suggest that if no vector control measures are considered to be in place, the risk of new arboviral outbreaks in Cabo Verde is high. The vector control strategy adopted must include measures of public health directed to domestic water storage and management.
C1 [Leal, Silvania Da Veiga; Fernandes Varela, Isaias Baptista; Lopes Goncalves, Aderitow Augusto; Sousa Monteiro, Davidson Daniel; Ramos de Sousa, Celivianne Marisia; Lima Mendonca, Maria da Luz] Inst Nacl Saude Publ, Lab Entomol Med, Praia 719, Cape Verde.
   [De Pina, Adilson Jose] Minist Saude & Seguranca Social, Programa Preeliminacao Paludismo, CCS SIDA, Varzea 855, Praia, Cape Verde.
   [Alves, Maria Joao; Osorio, Hugo Costa] Ctr Estudos Vectores & Doencas Infecciosas, Inst Nacl Saude Doutor Ricardo Jorge, Ave Liberdade 5, P-2965575 Aguas De Moura, Portugal.
   [Alves, Maria Joao; Osorio, Hugo Costa] Univ Lisbon, Inst Saude Ambiental, Fac Med, Ave Prof Egas Moniz,Piso 0,Ala C, P-1649028 Lisbon, Portugal.
RP Leal, SD (corresponding author), Inst Nacl Saude Publ, Lab Entomol Med, Praia 719, Cape Verde.
EM silvania.leal@insp.gov.cv; IsaiasB.Varela@insp.gov.cv;
   Aderitow.Goncalves@insp.gov.cv; Davidson.Monteiro@insp.gov.cv;
   Celivianne.Sousa@insp.gov.cv; Mariadaluz.Lima@insp.gov.cv;
   Adilson.Pina@ccssida.gov.cv; m.joao.alves@insa.min-saude.pt;
   hugo.osorio@insa.min-saude.pt
RI ; Osorio, Hugo/J-7802-2015
OI da Veiga Leal, silvania/0000-0003-4567-1097; Alves, Maria
   Joao/0000-0003-0065-9000; DePina, Adilson/0000-0002-2403-5078; Osorio,
   Hugo/0000-0001-6704-740X
FU National Institute of Public Health of Cabo Verde grant
   [65.06.01.04.29.01]
FX This research as also the APC were funded by the National Institute of
   Public Health of Cabo Verde grant number 65.06.01.04.29.01.-Reforco Do
   Laboratorio Nacional De Saude Publica.
CR Aagaard-Hansen J, 2010, TROP MED INT HEALTH, V15, P1281, DOI 10.1111/j.1365-3156.2010.02629.x
   Alves Joana, 2014, Zoologia Caboverdiana, V5, P14
   Alves J, 2010, J VECTOR ECOL, V35, P307, DOI 10.1111/j.1948-7134.2010.00087.x
   Andrew J., 2013, Annual Review & Research in Biology, V3, P52
   Azari-Hamidian S, 2009, ZOOTAXA, P1
   Balasubramanian R., 2015, International Journal of Mosquito Research, V2, P14
   Bowman LR, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002848
   Brady OJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001760
   Braga IA, 2007, EPIDEMIOL SERV SAUDE, V16, P279
   BRETEAU H, 1954, Bull World Health Organ, V11, P453
   Cambournac F.J.C., 1988, Anais do Instituto de Higiene e Medicina Tropical, V10, P41
   Centeio R.A.G., 2015, THESIS
   CONNOR M. E., 1923, American Journal of Tropical Medicine, V3, P9
   Dehghan H, 2016, J ARTHROPOD-BORNE DI, V10, P292
   Dia I, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-238
   Diagne CT, 2014, AM J TROP MED HYG, V91, P635, DOI 10.4269/ajtmh.13-0627
   Duarte Elves Heleno, 2013, Arq. Inst. Biol., V80, P359, DOI 10.1590/S1808-16572013000300015
   Duarte Elves Heleno, 2012, Zoologia Caboverdiana, V3, P29
   Ferede G, 2018, EPIDEMIOL HEALTH, V40, DOI 10.4178/epih.e2018015
   da Moura AJF, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0706-8
   Focks D.A., 2004, REV ENTOMOLOGICAL SA
   Fofana Diakarida, 2019, Journal of Parasitology Research, P4914137, DOI 10.1155/2019/4914137
   Githeko AK, 2000, B WORLD HEALTH ORGAN, V78, P1136
   Gloria-Soria A, 2016, MOL ECOL, V25, P5377, DOI 10.1111/mec.13866
   Gould E, 2017, ONE HEALTH-AMSTERDAM, V4, P1, DOI 10.1016/j.onehlt.2017.06.001
   Guedes DRD, 2017, J INSECT SCI, V17, DOI 10.1093/jisesa/iex057
   Hapuarachchi HC, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1606-z
   Instituto Nacional de Estatistica, 2017, INQ MULT CONT IMC VC
   Instituto Nacional de Estatistica, 2015, INQ DESP REC FAM IDR
   Instituto Nacional de Estatistica, 2017, PIB COMP AN CONT NAC
   Instituto Nacional de Estatistica, 2013, PROJ DEM CAB VERD 20
   Instituto Nacional de Estatistica, 2010, REC GER POP RGPH 201
   Instituto Nacional de Estatistica, 2016, INQ MULT CONT 2016
   Koh BKW, 2008, ANN ACAD MED SINGAP, V37, P538
   Krishnan J, 2018, J VECTOR DIS, V55, P189, DOI 10.4103/0972-9062.249127
   Ler TS, 2011, WEST PAC SURVEILL RE, V2, P24, DOI [10.5365/WPSAR.2010.1.1.011, 10.5365/wpsar.2010.1.1.011]
   Leta S, 2018, INT J INFECT DIS, V67, P25, DOI 10.1016/j.ijid.2017.11.026
   Lobban R.A., 2018, CAPE VERDE CRIOULO C
   Lourenco J., 2017, BIORXIV, DOI 10.1371/currents.outbreaks.19433b1e4d007451c691f138e1e67e8c
   Maciel-De-Freitas R, 2007, MEM I OSWALDO CRUZ, V102, P489, DOI 10.1590/S0074-02762007005000056
   McMichael AJ, 2006, LANCET, V367, P859, DOI 10.1016/S0140-6736(06)68079-3
   Ministry of Health Cape Verde, 2012, EL MAL CAS STUD 2 MO
   NATHAN MB, 1993, J AM MOSQUITO CONTR, V9, P1
   Paixao ES, 2018, BMJ GLOB HEALTH, V3, DOI 10.1136/bmjgh-2017-000530
   Powell JR, 2018, AM J TROP MED HYG, V98, P1563, DOI 10.4269/ajtmh.17-0866
   Powell JR, 2013, MEM I OSWALDO CRUZ, V108, P11, DOI 10.1590/0074-0276130395
   Ribeiro H., 1995, B SOC PORTUGUESA ENT
   Ribeiro H., 1980, JUNTA INVESTIG CIENT, V135, P141
   Rocha HDR, 2015, ACTA TROP, V152, P66, DOI 10.1016/j.actatropica.2015.08.013
   Salgueiro P, 2019, EVOL APPL, V12, P1797, DOI 10.1111/eva.12834
   Sanchez L, 2006, EMERG INFECT DIS, V12, P800
   Sanchez L, 2010, TROP MED INT HEALTH, V15, P173, DOI 10.1111/j.1365-3156.2009.02437.x
   Sharma A, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00110
   Sulaiman S, 1996, J AM MOSQUITO CONTR, V12, P494
   Thammapalo S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000263
   Vazeille M, 2013, VECTOR-BORNE ZOONOT, V13, P37, DOI 10.1089/vbz.2012.0982
   Weaver SC, 2010, ANTIVIR RES, V85, P328, DOI 10.1016/j.antiviral.2009.10.008
   Wijegunawardana NDAD, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/2950216
   Wilder-Smith Annelies, 2017, Lancet Infect Dis, V17, pe101, DOI 10.1016/S1473-3099(16)30518-7
   World Health Organization, 2016, WHOZIKVVC162
   World Health Organization, 2015, ZIK VIR INF CAP VERD
   World Health Organization, 2009, DENG FEV CAP VERD
   World Health Organization, 1972, WKLY EPIDEMIOL REC, V47, P73
NR 63
TC 0
Z9 0
U1 1
U2 1
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2020
VL 17
IS 4
AR 1291
DI 10.3390/ijerph17041291
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KY2GF
UT WOS:000522388500167
PM 32079356
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

PT J
AU Weinstein, JS
   Leslie, TF
   von Fricken, ME
AF Weinstein, Joshua S.
   Leslie, Timothy F.
   von Fricken, Michael E.
TI Spatial Associations Between Land Use and Infectious Disease: Zika Virus
   in Colombia
SO INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH
LA English
DT Article
DE zika virus; ZIKV; Colombia; infectious disease; vector-borne; land use;
   landscape metrics; linear density; proportion abundance; patch density
ID DEFORESTATION; VECTOR; PREVENTION; MALARIA
AB Land use boundaries represent human-physical interfaces where risk of vector-borne disease transmission is elevated. Land development practices, coupled with rural and urban land fragmentation, increases the likelihood that immunologically naive humans will encounter infectious vectors at land use interfaces. This research consolidated land use classes from the GLC-SHARE dataset; calculated landscape metrics in linear (edge) density, proportion abundance, and patch density; and derived the incidence rate ratios of the Zika virus occurrence in Colombia, South America during 2016. Negative binomial regression was used to evaluate vector-borne disease occurrence counts in relation to Population Density, Average Elevation, Per Capita Gross Domestic Product, and each of three landscape metrics. Each kilometer of border length per square kilometer of area increase in the linear density of the Cropland and Grassland classes is associated with an increase in Zika virus risk. These spatial associations inform a risk reduction approach to rural and urban morphology and land development that emphasizes simple and compact land use geometry that decreases habitat availability for mosquito vectors of Zika virus.
C1 [Weinstein, Joshua S.; Leslie, Timothy F.] George Mason Univ, Geog & Geoinformat Sci Dept, 4400 Univ Dr, Fairfax, VA 22030 USA.
   [von Fricken, Michael E.] George Mason Univ, Dept Global & Community Hlth, 4400 Univ Dr, Fairfax, VA 22030 USA.
RP Weinstein, JS (corresponding author), George Mason Univ, Geog & Geoinformat Sci Dept, 4400 Univ Dr, Fairfax, VA 22030 USA.
EM jweinst3@masonlive.gmu.edu; tleslie@gmu.edu; mvonfric@gmu.edu
OI Leslie, Timothy/0000-0002-4928-3705; von Fricken,
   Michael/0000-0003-2938-4549
CR Afrane YA, 2005, J MED ENTOMOL, V42, P974, DOI 10.1603/0022-2585(2005)042[0974:EOMCCB]2.0.CO;2
   Ali S, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005135
   Arsenault J, 2013, SPAT SPATIO-TEMPORAL, V7, P11, DOI 10.1016/j.sste.2013.04.004
   CDC Case Counts, 2016, CAS COUNTS US 2016
   Ceccato P., 2005, Parassitologia (Rome), V47, P81
   Chouin-Carneiro T, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004543
   DANE, 2017, COL GDP
   dos Santos TP, 2018, EMERG MICROBES INFEC, V7, DOI 10.1038/s41426-018-0194-y
   Etter A, 2006, AGR ECOSYST ENVIRON, V114, P369, DOI 10.1016/j.agee.2005.11.013
   GADM, 2015, GADM DAT GLOB ADM AR
   Hay SI, 1998, PARASITOL TODAY, V14, P306, DOI 10.1016/S0169-4758(98)01285-X
   Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1
   Kalluri S, 2007, PLOS PATHOG, V3, P1361, DOI 10.1371/journal.ppat.0030116
   Lambin EF, 2010, INT J HEALTH GEOGR, V9, DOI 10.1186/1476-072X-9-54
   Latham J., 2014, GLOBAL LAND COVER SH
   Lourenco-de-Oliveira R, 2004, J VECTOR ECOL, V29, P94
   McFarlane RA, 2013, INT J ENV RES PUB HE, V10, P2699, DOI 10.3390/ijerph10072699
   McMichael AJ, 2004, PHILOS T ROY SOC B, V359, P1049, DOI 10.1098/rstb.2004.1480
   Messina JP, 2016, ELIFE, V5, DOI 10.7554/eLife.15272
   Morse SS, 2012, LANCET, V380, P1956, DOI 10.1016/S0140-6736(12)61684-5
   Murray KA, 2013, CURR OPIN VIROL, V3, P79, DOI 10.1016/j.coviro.2013.01.006
   Patz JA, 2008, MED CLIN N AM, V92, P1473, DOI 10.1016/j.mcna.2008.07.007
   Peterson A Townsend, 2016, PLoS Curr, V8, DOI 10.1371/currents.outbreaks.a832cf06c4bf89fb2e15cb29d374f9de
   Pike BL, 2010, CLIN INFECT DIS, V50, P1636, DOI 10.1086/652860
   Rodriguez D.M., 2016, MIER Y TERAN ROMERO
   Rodriguez-Morales Alfonso J, 2017, Infez Med, V25, P241
   Schuurman Nadine, 2006, Int J Health Geogr, V5, P43, DOI 10.1186/1476-072X-5-43
   Shragai T, 2017, ANN NY ACAD SCI, V1399, P61, DOI 10.1111/nyas.13306
   Soghigian J, 2017, BMC EVOL BIOL, V17, DOI 10.1186/s12862-017-1092-y
   Steiger DBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1675-2
   Teng Y, 2017, J INFECTION, V74, P484, DOI 10.1016/j.jinf.2017.01.015
   Vanwambeke SO, 2011, TROP MED INT HEALTH, V16, P174, DOI 10.1111/j.1365-3156.2010.02671.x
   Vittor AY, 2006, AM J TROP MED HYG, V74, P3, DOI 10.4269/ajtmh.2006.74.3
   Wade J., 2016, ZIKA BITES COLOMBIAN
   WALSH JF, 1993, PARASITOLOGY, V106, pS55, DOI 10.1017/S0031182000086121
   WANG MH, 1993, REMOTE SENS ENVIRON, V45, P261, DOI 10.1016/0034-4257(93)90109-B
   Wilcox B. A., 2006, Unasylva (English ed.), V57, P11
   Wilcox Bruce A., 2005, EcoHealth, V2, P244, DOI 10.1007/s10393-005-8961-3
   Wilkinson DA, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0403
   Woolhouse M, 2012, PHILOS T R SOC B, V367, P2864, DOI 10.1098/rstb.2011.0354
   Zahouli JBZ, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005751
NR 41
TC 0
Z9 0
U1 4
U2 4
PU MDPI
PI BASEL
PA ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND
EI 1660-4601
J9 INT J ENV RES PUB HE
JI Int. J. Environ. Res. Public Health
PD FEB
PY 2020
VL 17
IS 4
AR 1127
DI 10.3390/ijerph17041127
PG 11
WC Environmental Sciences; Public, Environmental & Occupational Health
SC Environmental Sciences & Ecology; Public, Environmental & Occupational
   Health
GA KY2GF
UT WOS:000522388500003
PM 32053906
OA DOAJ Gold, Green Published
DA 2020-07-08
ER

EF